Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A4GALT	"A14GALT, Gb3S, P(k), P1"	ENSG00000128274	"Alpha 1,4-galactosyltransferase (P blood group)"	Q9NPC4	22	42692121-42721298	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 70.7;Proximal tubular cells: 91.0;Urothelial cells: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.7;ASC TERT1: 31.3;RPTEC TERT1: 27.1;TIME: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001141			Uncertain	Mitochondria		NA	NA		22000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA001141: AB_1078139"	"unprognostic (2.59e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.24e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.74e-1)"	41.5	14.3	6.2	6.1	6.0	4.1	31.3	5.0	8.0	29.6	8.0	30.9	4.5	28.1	3.3	30.6	29.2	4.4	77.0	6.2	5.3	51.3	4.3	26.0	6.8	7.8	5.8	7.8	6.2	1.2	16.7	9.1	5.6	35.1	1.7	0.3	36.1	21.3	19.4	20.8	18.2	6.9	6.0	16.2	26.6	6.2	7.1	1.6	25.1	6.3	5.1	38.1	38.2	6.0	1.2	13.6	0.0	0.0	38.7	31.3	20.1	5.5	5.8	1.2	2.1	4.3	2.2	13.6	9.4	9.7	6.7	1.3	12.9	6.5	0.2	0.0	2.7	0.3	21.1	0.5	11.5	0.0	0.9	18.6	1.8	5.5	0.9	1.8	4.7	0.0	0.1	0.0	5.1	19.0	0.0	0.0	1.6	0.9	3.3	0.0	3.0	1.4	27.1	23.4	0.2	0.0	16.9	0.3	0.0	2.4	10.6	1.6	29.3	0.0	2.6	24.3	7.3	2.8	13.1	0.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	6.2	6.0	5.0	8.0	6.2	5.3	7.8	5.8	5.6	6.0	7.1	6.0	47.1	0.0	0.5	0.3	1.6	9.2	28.9	70.7	0.0	0.1	4.2	1.5	15.8	1.5	41.2	18.4	0.0	48.7	0.4	0.2	13.7	23.1	0.7	11.1	10.3	43.7	0.0	10.7	0.1	1.1	35.3	43.8	2.6	17.4	1.3	0.2	30.7	0.2	5.3	0.0	0.1	0.0	14.2	1.0	11.8	4.4	46.3	4.0	7.2	7.5	30.0	0.8	0.0	0.5	0.0	3.6	0.0	30.1	0.1	40.1	0.0	91.0	12.1	0.6	39.5	7.6	29.3	0.6	0.6	1.2	8.8	9.4	1.5	19.9	0.1	74.7
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 67.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Extravillous trophoblasts: 71.3;Hepatocytes: 29.3;Spermatogonia: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.3	2.8	6.2	1.9	6.8	0.3	4.7	3.8	9.8	9.8	11.3	6.2	1.6	10.5	5.9	2.6	6.3	3.9	2.7	6.5	6.7	6.8	67.1	4.9	0.7	5.8	5.6	4.7	5.6	6.0	6.1	1.9	6.5	14.4	5.0	11.8	1.7	5.3	4.0	1.4	2.3	7.3	4.8	1.7	3.6	8.2	6.1	1.5	7.5	2.4	0.8	6.4	5.7	8.7	3.5	8.5	25.0	0.0	4.9	18.9	9.0	8.7	4.2	4.9	5.0	8.4	1.0	0.1	1.4	9.8	6.5	2.9	11.3	4.1	3.4	0.0	9.7	0.0	10.0	14.0	3.9	0.1	3.8	7.7	2.5	4.0	5.1	13.5	4.7	11.4	1.5	0.1	19.0	8.9	4.3	0.1	19.0	9.6	7.6	0.0	7.8	0.0	4.4	15.3	20.1	23.5	7.0	1.7	8.5	8.0	0.1	1.7	3.2	12.5	13.4	14.3	13.9	0.1	0.0	0.1	12.5	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	6.8	3.8	9.8	6.5	6.7	5.8	5.6	6.5	4.8	6.1	8.7	0.9	0.0	5.9	22.2	0.3	0.9	2.8	0.9	6.2	6.0	3.9	1.0	1.2	1.5	2.1	0.0	2.1	2.8	0.0	0.7	0.0	1.6	0.5	3.7	7.4	0.7	6.7	0.0	15.4	2.2	71.3	3.2	3.1	6.0	0.0	6.2	0.7	29.3	1.6	0.0	13.6	2.8	0.0	0.3	0.9	1.4	1.2	0.4	1.8	5.6	0.0	2.7	0.0	17.6	14.0	1.1	1.6	2.2	0.0	4.0	0.2	8.4	8.5	9.1	6.6	3.9	4.2	14.5	27.1	3.0	0.4	5.6	0.3	3.3	3.1	1.8
AARS1	"AARS, AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase 1"	P49588	16	70251983-70289707	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 25.1;Cytotrophoblasts: 63.0;Extravillous trophoblasts: 29.9;Hofbauer cells: 27.1;Syncytiotrophoblasts: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034261, HPA040870, HPA044223"	Supported		Supported	Cytosol		NA	NA		620000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	43.7	54.7	60.1	33.4	64.3	7.9	41.4	73.3	88.6	42.1	49.2	48.9	26.0	49.8	49.6	29.5	40.4	22.3	47.9	62.8	71.7	43.6	72.0	45.3	30.0	78.6	68.6	37.3	75.8	74.9	50.1	35.6	84.9	40.0	26.2	59.3	53.3	47.2	62.4	28.8	32.7	47.8	66.3	38.3	51.8	23.8	74.8	36.4	66.6	39.7	35.5	45.9	32.8	83.9	123.7	192.8	52.9	205.7	127.3	115.0	125.7	97.7	135.3	119.7	151.8	162.5	163.2	140.4	127.2	99.3	90.8	137.2	160.5	133.1	170.7	63.2	54.7	135.6	78.0	152.2	348.0	74.4	77.2	133.9	193.8	228.1	508.4	91.4	120.3	209.3	176.0	173.4	91.3	282.0	89.4	85.0	104.3	160.0	108.5	170.4	36.1	317.0	84.7	60.3	67.9	57.3	269.5	62.3	246.1	75.8	197.7	181.3	75.2	85.2	82.9	84.9	78.8	233.8	174.2	258.2	155.4	124.9	175.9	6.5	7.8	2.7	11.9	13.2	13.0	12.8	9.7	11.7	11.9	9.1	11.2	12.2	0.1	22.7	14.1	7.0	8.0	12.6	60.1	64.3	73.3	88.6	62.8	71.7	78.6	68.6	84.9	66.3	74.8	83.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	63.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	29.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	52.0	0.2	0.0	0.0	0.0
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122064583-122144308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Hepatocytes: 113.9;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.5;NTERA-2: 55.3;SuSa: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		Yes	No		19000		"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	9.7	5.9	10.0	1.8	12.2	0.2	8.4	10.3	14.4	8.2	15.5	5.2	0.9	9.5	7.5	3.2	11.7	2.1	9.2	9.4	10.6	13.9	44.3	6.3	1.4	11.6	11.0	25.2	4.8	7.1	3.5	3.2	11.4	5.4	1.4	3.7	3.5	4.8	8.6	2.8	3.6	4.4	10.1	2.9	5.5	2.2	11.0	1.5	4.7	6.2	1.4	6.9	6.2	11.8	0.1	0.0	21.9	41.5	27.3	13.5	9.4	5.4	8.0	7.3	9.1	12.6	0.1	0.0	0.2	6.6	8.3	4.1	33.5	16.8	9.6	0.0	12.2	9.4	4.3	12.5	22.0	0.0	2.9	12.2	0.5	9.2	7.1	18.9	19.8	12.1	2.7	15.5	5.1	0.1	0.9	0.0	55.3	0.1	1.7	11.8	16.3	0.3	5.3	2.4	2.7	0.7	1.5	0.0	5.3	37.8	0.5	0.0	8.1	13.6	3.4	7.0	8.3	3.5	3.0	0.0	4.9	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	12.2	10.3	14.4	9.4	10.6	11.6	11.0	11.4	10.1	11.0	11.8	16.0	9.6	37.8	145.9	2.1	6.2	9.0	2.8	14.8	7.0	8.7	6.3	9.7	14.3	5.6	14.7	16.7	11.6	1.5	0.6	0.0	2.7	12.2	4.1	24.0	11.7	3.0	5.2	5.0	1.8	3.3	14.4	5.6	7.7	3.8	18.1	24.7	113.9	1.5	11.8	4.4	2.6	2.0	2.2	2.5	7.4	19.0	1.4	12.4	35.6	0.0	8.9	0.0	106.1	132.5	2.3	2.5	24.5	1.6	4.7	5.4	8.6	0.9	3.3	19.7	38.9	15.8	12.4	2.4	7.8	4.7	5.1	2.1	8.0	1.9	4.8
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.9;kidney: 133.3;liver: 345.6;pancreas: 138.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	3.3	27.7	94.6	4.7	105.4	2.2	5.1	85.2	103.4	3.8	70.7	7.6	43.6	3.8	9.6	7.7	6.2	4.4	14.1	90.2	120.7	133.3	345.6	4.5	5.0	90.8	107.4	10.5	138.3	8.2	55.8	3.4	137.6	21.7	7.8	29.6	6.5	3.5	1.6	2.7	20.1	2.7	88.1	4.1	7.4	13.4	137.9	4.2	29.3	1.4	5.9	9.9	4.1	70.9	0.7	0.2	32.1	18.7	5.0	1.7	2.0	4.2	2.2	1.8	0.7	12.7	0.9	4.0	1.4	2.3	1.2	8.3	2.1	7.7	2.4	2.3	2.1	5.5	0.1	127.5	8.1	1.3	8.3	6.5	3.4	3.2	1.4	0.9	0.6	10.7	1.1	2.6	0.6	81.9	2.1	0.6	2.8	23.2	0.3	9.7	67.4	1.8	1.2	20.9	5.1	15.7	1.9	1.0	0.2	6.2	42.6	3.4	0.6	0.8	5.7	2.7	0.1	3.0	0.3	0.8	0.8	5.7	4.2	0.7	1.9	2.7	1.5	2.2	0.7	0.6	1.0	1.1	1.2	1.2	0.7	1.1	6.1	1.2	4.2	0.2	1.1	1.2	94.6	105.4	85.2	103.4	90.2	120.7	90.8	107.4	137.6	88.1	137.9	70.9	1.7	0.0	6.9	39.5	6.1	1.5	4.0	3.3	2.2	27.3	9.1	5.0	10.8	20.0	5.8	1.8	4.2	1.4	5.3	8.9	23.5	1.6	13.0	12.9	6.2	2.4	15.6	13.9	41.8	6.2	1.5	3.2	5.6	12.9	1.3	59.5	7.1	268.2	5.2	35.3	95.0	3.9	2.0	15.7	7.4	8.7	3.7	8.2	1.8	19.7	6.5	48.6	9.2	76.9	17.7	6.8	6.1	4.5	1.0	7.4	15.7	94.9	3.6	5.8	0.0	4.3	3.8	3.7	0.9	9.5	0.6	1.4	6.3	2.3	6.9	5.0
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503017-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 101.7;intestine: 70.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 95.8;Distal enterocytes: 109.9;Microglial cells: 570.6;Paneth cells: 106.2;Proximal enterocytes: 204.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 27.2;NK-cell: 17.9"	"Group enriched"	"Detected in many"	9	"NK-cells: 17.9;T-cells: 27.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 67.3;HEK 293: 20.4;HEL: 37.7;Hep G2: 18.5;RPTEC TERT1: 24.2;SH-SY5Y: 78.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	101.7	14.1	3.9	13.6	1.9	3.6	13.7	17.6	6.4	5.3	16.6	26.4	11.0	3.6	3.1	5.0	15.5	1.9	15.3	15.6	33.7	28.0	6.4	3.2	17.6	14.4	2.2	2.0	1.4	0.5	2.3	19.7	4.2	18.2	2.2	1.2	3.1	0.2	1.5	70.7	9.8	15.1	4.2	2.1	0.9	19.3	2.7	1.9	1.4	3.5	3.6	1.7	14.3	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.1	4.3	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	20.4	37.7	4.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	24.2	0.2	0.9	78.9	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	4.0	0.0	0.9	7.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	11.1	0.0	27.2	0.8	2.7	6.8	0.0	2.5	1.7	6.6	0.2	17.9	0.0	0.1	0.0	2.5	14.1	13.6	13.7	17.6	15.3	15.6	17.6	14.4	19.7	15.1	19.3	14.3	17.1	0.0	3.0	3.9	9.9	0.8	0.1	0.0	1.2	1.9	0.4	3.9	3.0	95.8	0.6	49.7	0.0	5.8	24.7	109.9	5.9	13.8	27.3	0.6	0.6	52.9	0.0	7.8	16.1	1.9	0.2	3.7	0.0	0.7	3.8	0.3	2.5	38.4	0.4	0.0	11.4	15.8	0.0	0.6	1.2	3.8	0.9	1.6	0.0	570.6	0.2	0.2	32.0	6.0	3.2	8.1	106.2	0.0	4.6	0.2	204.6	57.7	0.7	1.1	0.0	0.4	1.3	0.4	0.9	0.2	0.6	9.9	24.5	0.1	19.9	0.3
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209772-219218994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.2	8.7	4.3	3.4	3.9	10.4	7.6	3.2	4.6	7.7	4.4	6.5	6.9	8.4	8.2	11.4	9.6	7.1	8.5	4.0	5.1	5.2	15.9	5.9	1.9	4.4	4.2	12.9	5.7	4.8	6.0	3.1	6.2	8.0	3.3	3.0	6.2	8.6	30.4	6.8	6.3	7.9	4.1	3.9	7.9	18.0	5.7	2.6	10.7	9.8	2.9	14.9	7.9	5.0	0.3	22.9	4.7	28.8	30.8	11.1	27.6	8.5	7.9	9.2	9.2	35.5	5.0	0.3	42.8	8.6	5.0	49.1	0.6	3.6	3.0	15.0	4.7	36.3	24.9	65.8	37.0	0.0	12.0	16.3	4.2	6.2	0.1	13.9	16.3	4.8	31.4	4.4	6.3	12.0	2.3	0.1	7.2	53.6	9.2	12.3	14.3	1.6	5.1	0.4	16.6	17.8	17.6	41.4	18.7	17.4	12.4	0.8	7.5	12.5	0.5	16.9	10.3	11.2	9.6	0.1	14.0	0.4	17.0	0.7	0.4	0.0	0.7	0.4	0.2	1.0	0.5	0.2	0.3	0.8	1.2	0.8	0.0	0.4	0.3	2.3	0.5	1.0	4.3	3.9	3.2	4.6	4.0	5.1	4.4	4.2	6.2	4.1	5.7	5.0	0.2	0.0	0.0	14.7	0.3	0.3	0.0	0.5	1.2	1.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.8	1.2	0.3	0.6	0.4	0.0	1.3	12.9	0.0	0.1	0.7	5.1	0.2	0.0	0.5	0.0	0.4	0.1	0.0	10.9	0.3	0.0	0.3	0.4	1.0	0.3	0.3	0.0	3.7	0.0	0.3	0.0	13.6	5.6	0.3	0.0	0.4	0.5	0.0	0.5	0.2	2.2	0.8	0.0	0.4	0.3	1.0	0.3	2.8	0.3	0.3	0.1	0.4	0.2	0.1
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692253	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.1;liver: 50.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 231.6;Distal enterocytes: 265.1;Gastric mucus-secreting cells: 271.7;Hepatocytes: 192.9;Paneth cells: 194.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.1;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"A549: 79.4;CAPAN-2: 60.6;HeLa: 36.9;OE19: 89.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.1	59.1	0.1	3.4	1.8	0.8	4.2	0.2	0.7	2.1	0.0	18.9	12.0	1.1	1.8	7.5	1.0	11.9	0.9	0.3	0.3	8.0	50.4	4.8	1.9	5.9	0.8	0.7	22.6	0.8	0.8	1.1	3.5	5.9	8.7	0.4	7.0	5.5	0.2	7.1	11.9	1.3	1.7	3.4	17.1	1.0	2.5	0.3	5.5	0.0	1.7	6.3	3.6	2.4	5.7	79.4	0.0	0.3	4.4	6.9	0.1	10.4	13.1	0.7	0.7	4.2	60.6	0.0	8.0	20.6	14.5	14.5	0.0	1.0	1.0	0.0	0.0	1.7	36.9	24.2	17.2	0.0	0.0	7.5	5.6	2.9	6.2	8.5	1.4	0.0	0.2	0.0	8.0	18.9	0.0	0.0	0.1	89.7	10.1	0.1	0.0	0.3	33.4	34.2	0.1	0.6	19.2	3.1	0.0	0.1	2.6	0.0	17.3	0.5	3.4	0.2	8.5	0.1	0.0	0.0	8.2	0.0	0.9	0.2	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.3	6.4	0.1	0.5	5.4	0.1	1.8	0.2	0.7	0.3	0.3	5.9	0.8	3.5	1.7	2.5	2.4	0.7	19.2	5.5	0.0	1.8	9.4	122.2	47.1	42.7	1.6	1.9	6.9	3.1	231.6	19.5	14.7	0.0	0.4	0.0	265.1	5.9	100.1	82.9	5.9	8.8	2.7	23.5	0.0	4.3	106.1	3.7	3.6	271.7	30.5	0.0	3.1	3.9	192.9	26.1	1.7	0.9	96.2	12.2	33.0	11.4	118.6	9.0	31.6	3.6	2.8	8.7	2.9	1.0	0.5	0.5	105.9	194.7	3.0	2.1	104.6	57.2	10.8	2.7	0.3	0.0	1.9	5.6	0.9	0.8	12.7	10.5	1.0	2.6	0.1	111.0	118.4
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 20.1;pituitary gland: 34.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	0.4	2.8	2.6	0.0	3.7	0.0	1.8	3.9	5.2	3.5	0.0	0.7	0.5	2.6	1.4	0.1	0.6	0.0	1.6	3.1	1.4	0.5	0.1	5.0	0.0	3.3	2.7	0.4	20.1	0.2	34.4	0.4	3.3	2.1	0.3	2.2	0.0	1.5	1.5	0.2	1.0	0.2	0.6	0.1	6.1	0.4	1.2	0.0	3.4	0.6	0.0	0.4	1.3	3.5	0.0	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	3.9	5.2	3.1	1.4	3.3	2.7	3.3	0.6	1.2	3.5	0.3	0.0	0.0	19.6	0.3	0.0	0.1	0.0	0.0	39.0	5.3	3.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.5	17.9	0.3	22.0	0.0	48.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	39.3	0.7	0.0	0.3	0.5	0.0	0.0	0.1	0.0	3.7	0.0	1.9	0.0	39.2	7.6	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.0	0.7	2.0	0.1	0.8	0.0	0.1	0.0	0.1	2.6	0.1	0.2
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145098288-145129524	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Translation regulation"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol		No	No		380000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB012476: , HPA036846: AB_2675346"	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	30.0	21.5	11.2	33.6	12.5	27.2	33.1	13.7	16.0	20.7	10.7	22.7	20.2	24.4	16.0	35.1	22.5	22.4	24.9	12.5	14.3	23.8	39.7	18.5	40.5	12.6	11.2	29.1	29.4	27.0	10.0	28.7	14.4	19.4	27.7	14.4	24.1	16.9	28.0	25.2	17.7	28.9	13.8	26.4	20.1	26.5	11.8	34.2	26.9	30.3	42.1	40.5	15.9	18.1	117.1	61.2	89.5	62.2	74.6	107.5	89.4	124.6	86.4	145.1	101.3	95.5	105.9	187.6	39.3	109.2	77.7	75.4	132.5	157.7	193.1	108.6	82.9	106.9	44.0	80.6	98.3	244.3	81.3	80.0	108.4	153.8	213.7	74.8	157.4	139.1	219.5	136.1	156.3	70.4	234.5	82.2	74.8	177.5	142.9	124.0	107.9	135.7	108.1	79.9	111.1	55.1	74.7	124.6	89.5	66.7	74.2	98.1	105.3	143.3	89.4	101.3	152.5	120.6	209.6	199.5	87.7	214.6	163.7	2.2	10.0	0.9	12.3	13.1	25.4	13.2	15.4	16.0	19.5	13.0	21.0	18.1	0.8	16.4	13.4	10.9	18.5	14.8	11.2	12.5	13.7	16.0	12.5	14.3	12.6	11.2	14.4	13.8	11.8	18.1	56.4	25.6	18.7	15.3	55.9	59.9	109.0	38.7	45.5	37.2	35.0	30.6	24.0	17.2	45.4	25.8	20.9	39.4	44.4	9.8	39.2	39.4	40.1	29.0	61.8	53.7	20.4	47.5	24.2	28.2	45.1	50.6	35.7	23.4	32.9	50.3	21.4	32.9	41.5	42.1	27.8	22.5	24.4	22.4	40.3	15.4	46.9	34.6	19.6	12.2	33.2	18.1	33.0	18.1	37.5	39.1	10.3	34.6	58.3	112.2	8.0	39.8	28.5	34.9	32.9	71.7	47.5	92.4	79.4	65.5	59.5	26.5	47.2	98.4	36.6	72.2
ABHD10	FLJ11342	ENSG00000144827	"Abhydrolase domain containing 10, depalmitoylase"	Q9NUJ1	3	111979010-111993368	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036991, HPA036992, HPA066081"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No		71000	"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610"	"unprognostic (1.65e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.76e-2)"	11.0	21.9	23.0	10.6	25.3	10.9	15.0	24.5	29.3	11.3	22.9	14.1	11.7	11.1	50.8	8.2	14.9	10.1	25.0	23.9	24.6	49.4	34.4	10.1	17.9	23.5	23.2	19.8	13.7	16.7	27.9	10.8	23.7	20.4	14.7	27.0	25.5	13.7	14.1	10.0	10.3	10.0	24.4	14.6	14.9	16.4	26.3	21.8	31.1	19.6	16.2	9.5	8.3	25.3	40.2	34.1	36.4	12.0	20.5	27.5	19.8	41.4	21.5	33.0	31.7	35.3	22.4	36.0	22.6	17.2	22.7	21.6	16.3	23.0	44.9	12.1	20.6	29.7	15.4	30.7	16.3	60.3	30.4	16.9	16.7	17.0	42.4	22.7	35.9	42.1	13.9	14.9	36.7	13.7	56.9	27.9	23.7	43.8	53.2	50.9	23.4	16.7	34.6	17.1	24.6	17.9	33.2	23.7	39.8	14.3	26.8	21.8	20.6	19.7	25.3	14.4	21.7	23.6	9.0	61.4	20.1	32.4	21.5	29.4	16.5	25.2	9.8	21.6	16.8	26.2	12.2	11.3	28.1	21.6	15.4	13.9	2.5	11.4	17.3	17.8	13.2	16.1	23.0	25.3	24.5	29.3	23.9	24.6	23.5	23.2	23.7	24.4	26.3	25.3	9.1	0.0	7.2	11.1	19.7	7.0	10.2	12.1	14.2	21.8	12.7	10.9	26.1	7.2	12.4	11.0	8.4	19.2	16.1	7.0	35.2	5.2	1.0	11.1	10.3	8.8	12.1	24.2	16.0	7.8	14.9	12.3	12.8	6.8	9.5	9.5	10.0	26.2	14.1	42.1	16.2	13.4	6.1	19.5	7.0	3.0	10.5	11.0	10.6	15.0	10.7	20.4	12.3	14.6	15.6	5.4	4.0	7.5	25.0	5.1	7.0	42.5	19.5	16.2	0.0	7.9	8.9	29.7	37.0	13.6	8.2	5.5	14.6	19.2	12.1	4.5
ABHD14A	"DKFZP564O243, DORZ1"	ENSG00000248487	"Abhydrolase domain containing 14A"	Q9BUJ0	3	51971426-51981199	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 124.3;Rod photoreceptor cells: 115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 79.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038153, HPA056913"	Approved		Enhanced	Vesicles		NA	NA		420000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA038153: AB_2675868, HPA056913: AB_2683275"	"unprognostic (4.15e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.30e-2)"	23.5	48.6	65.2	8.3	64.5	13.5	18.4	72.3	78.0	25.1	67.6	18.1	10.6	15.0	28.3	8.4	24.2	12.1	36.1	64.8	69.3	35.3	26.1	14.3	11.4	59.6	60.0	27.1	26.6	27.1	49.6	8.9	59.7	19.0	6.9	43.5	23.2	14.5	34.8	7.6	12.9	7.5	59.2	14.6	17.7	13.2	69.4	11.5	32.8	39.1	8.4	19.4	16.7	59.8	6.9	12.9	8.2	24.7	79.8	39.9	4.5	9.0	14.8	10.6	14.3	14.8	27.0	7.8	6.0	22.4	12.1	6.2	9.0	10.0	3.4	25.1	10.0	22.7	37.4	50.0	22.4	31.4	29.0	37.9	6.6	9.0	4.6	23.7	13.8	14.6	9.3	25.4	16.8	7.8	14.5	31.8	4.7	32.4	30.4	10.3	4.2	73.9	20.7	10.6	16.8	26.1	22.5	4.7	13.5	1.7	7.1	33.7	8.2	9.6	10.4	23.4	10.7	37.0	37.4	6.6	18.1	49.6	14.1	6.9	20.3	15.2	94.0	12.7	96.5	49.0	80.9	83.5	36.2	41.5	73.7	79.0	2.1	45.5	8.6	46.0	88.4	54.9	65.2	64.5	72.3	78.0	64.8	69.3	59.6	60.0	59.7	59.2	69.4	59.8	15.9	6.4	21.7	0.0	20.2	9.7	25.1	29.0	4.0	90.8	21.0	22.9	24.3	20.0	20.8	33.1	25.0	10.3	29.6	7.1	33.2	15.5	4.7	23.5	18.0	14.1	40.2	2.5	0.0	12.4	15.3	36.9	4.6	14.9	15.2	12.8	17.2	16.2	29.3	58.9	0.0	14.0	24.4	14.2	18.5	24.9	88.0	14.6	12.4	0.0	7.4	59.9	41.2	0.0	0.0	17.1	5.6	33.1	16.3	17.0	13.8	124.3	29.5	115.2	19.7	24.7	16.8	18.2	57.8	1.8	5.5	4.9	28.9	20.6	15.3	19.5
ABHD14A-ACY1		ENSG00000114786	"ABHD14A-ACY1 readthrough"		3	51974706-51989183	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.8;Collecting duct cells: 5.5;Distal tubular cells: 3.9;Proximal tubular cells: 16.8;Theca cells: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											"HPA036174, HPA036175, HPA038153"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"			"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.90e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.11e-4)"	0.5	0.8	0.1	0.1	0.1	0.0	0.4	0.6	0.4	0.2	0.2	0.2	0.0	0.6	0.0	0.2	0.5	0.1	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.2	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.7	0.2	0.2	0.0	0.2	0.2	0.4	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.4	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.4	0.5	1.2	0.9	0.8	0.6	0.7	1.1	1.0	0.5	0.7	1.0	0.0	1.1	0.6	0.6	1.0	0.5	0.1	0.1	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.2	1.4	0.0	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.2	3.2	0.0	0.0	1.8	5.5	0.0	0.0	0.9	0.1	3.9	1.5	0.0	0.4	1.4	0.6	0.0	0.8	1.0	1.2	0.0	1.0	2.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.5	1.2	2.0	0.0	0.0	0.0	0.0	0.2	16.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	6.3	0.0	0.0
ABHD18	"C4orf29, FLJ21106"	ENSG00000164074	"Abhydrolase domain containing 18"	Q0P651	4	127965306-128039953	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050168, HPA051676"	Approved		Approved	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA050168: AB_2681040, HPA051676: AB_2681571"	"unprognostic (1.91e-1)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.74e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.32e-2)"	"prognostic favorable (9.13e-4)"	4.3	4.2	2.4	5.3	3.0	5.8	4.0	6.5	3.3	4.3	2.0	5.3	7.1	4.0	4.2	4.0	4.5	2.4	13.5	2.5	3.7	4.6	8.4	3.9	5.8	2.4	2.2	5.1	8.9	3.3	5.2	2.9	2.6	3.6	5.1	5.4	4.8	2.2	10.9	5.5	7.0	3.2	1.8	4.8	4.6	1.9	2.9	5.9	4.8	11.7	4.9	4.1	4.1	3.2	4.2	3.5	4.1	5.3	3.2	4.4	6.1	4.0	3.2	3.5	4.6	7.8	7.7	11.1	6.5	2.0	3.3	4.0	8.7	4.7	3.8	9.2	2.8	8.2	5.1	6.7	4.4	13.9	10.1	3.4	3.2	3.7	2.4	4.1	6.3	8.4	13.8	8.0	3.3	7.4	18.7	6.8	4.3	8.7	3.1	10.2	1.4	7.2	5.2	4.2	9.4	3.4	4.1	6.8	4.1	5.8	6.0	5.7	5.4	2.3	3.1	5.7	4.0	14.8	15.4	13.2	4.0	14.7	3.7	13.6	5.7	8.7	5.0	5.0	3.9	6.3	6.3	6.0	4.7	7.8	7.2	7.1	12.1	4.5	3.7	7.8	7.2	2.9	2.4	3.0	6.5	3.3	2.5	3.7	2.4	2.2	2.6	1.8	2.9	3.2	8.4	6.4	15.4	0.0	17.6	0.0	8.7	0.0	17.1	13.5	5.9	3.7	0.0	8.6	5.6	7.3	20.9	5.5	13.5	7.9	0.0	5.1	3.5	6.3	5.7	6.9	6.1	27.3	0.0	7.3	4.7	4.8	23.4	8.2	1.3	10.6	11.4	23.4	7.8	18.5	0.0	9.6	0.0	17.6	0.0	1.6	6.2	12.9	0.0	0.0	15.9	5.1	12.3	0.0	0.0	7.5	5.6	5.7	21.3	10.2	13.9	8.5	3.6	19.8	13.1	8.0	4.2	9.2	4.8	12.0	0.0	9.2	14.5	7.8	8.4	9.4
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2, acylglycerol lipase"	P08910	15	89087459-89202355	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.8;Hepatocytes: 402.5;Late spermatids: 462.1;Oligodendrocyte precursor cells: 421.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 69.8;neutrophil: 52.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEL: 340.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	18.5	36.3	20.0	20.2	20.9	34.9	22.5	40.2	27.2	19.5	130.3	21.1	47.9	20.7	56.1	17.4	23.4	47.2	36.1	29.0	20.3	22.4	137.6	45.3	14.7	13.3	32.4	24.5	57.9	18.4	14.0	11.1	13.5	44.2	18.9	14.5	12.7	18.6	21.8	13.1	35.9	22.4	11.0	24.6	72.9	52.0	24.2	15.5	17.1	46.3	16.1	31.1	9.6	16.4	33.0	62.3	14.7	16.3	29.2	39.0	8.2	21.4	62.5	19.8	18.6	15.7	55.3	9.4	23.9	27.4	54.1	42.6	32.4	26.4	28.0	48.1	15.8	340.5	14.0	12.8	14.8	24.2	74.4	20.1	18.6	70.1	45.5	33.7	25.3	20.7	30.3	27.4	56.3	13.3	15.0	5.8	6.6	76.9	18.1	20.7	32.2	71.9	27.0	51.5	25.2	39.0	41.4	19.4	34.4	13.5	21.7	18.6	38.6	70.9	23.7	24.2	55.8	23.5	49.3	10.9	58.2	21.5	55.4	8.4	13.4	69.8	3.5	11.3	2.1	2.4	3.2	3.4	7.1	2.2	3.2	3.2	52.2	11.2	17.8	5.7	8.7	6.9	20.0	20.9	40.2	27.2	29.0	20.3	13.3	32.4	13.5	11.0	24.2	16.4	43.4	96.1	118.1	87.5	10.7	18.6	47.3	27.0	7.4	25.5	26.6	17.8	52.0	130.1	82.1	42.3	18.8	4.6	53.7	65.9	1.9	48.9	331.8	28.3	36.8	27.7	48.7	40.8	103.6	85.2	7.7	26.6	103.0	25.9	60.7	18.5	21.0	402.5	40.8	20.2	114.7	58.7	87.5	59.2	26.6	462.1	32.9	67.3	58.7	46.9	46.4	45.5	36.0	421.2	54.4	106.4	38.0	59.8	27.4	171.1	53.1	18.0	158.0	14.7	78.9	36.1	53.4	119.8	13.2	20.8	17.5	2.6	24.5	35.2	38.7	117.5
ABHD3	LABH3	ENSG00000158201	"Abhydrolase domain containing 3, phospholipase"	Q8WU67	18	21650901-21704780	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 187.7;Paneth cells: 126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 209.6;RPMI-8226: 233.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010729	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA010729: AB_1844449"	"unprognostic (1.46e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.58e-2)"	17.1	7.3	13.3	25.2	13.8	17.6	15.7	16.8	21.9	12.6	23.2	63.5	44.1	8.1	9.1	18.1	12.0	20.8	7.5	13.2	14.0	14.5	39.3	15.7	29.8	14.2	15.6	12.5	12.3	16.0	11.4	19.8	16.2	11.1	65.7	5.8	14.5	6.2	14.4	6.3	56.3	9.7	13.2	24.0	35.6	6.3	16.2	21.4	22.9	7.9	25.8	15.3	12.8	15.9	29.0	20.6	19.8	12.7	12.3	8.2	0.1	18.6	7.6	13.1	17.6	21.6	29.1	82.3	33.2	6.2	58.6	93.6	32.5	15.3	18.1	52.1	21.9	9.0	35.7	37.5	18.7	39.6	28.9	7.3	17.7	19.2	8.8	6.5	8.7	28.0	23.4	47.9	11.6	11.7	38.5	43.6	9.7	92.1	47.8	209.6	15.0	233.5	36.4	27.6	16.6	7.5	42.5	37.6	11.2	21.3	11.7	68.9	6.9	12.7	18.2	22.6	29.3	53.1	37.5	84.9	16.1	50.9	29.4	89.3	24.7	29.3	25.3	44.4	19.8	16.2	22.7	24.8	15.2	12.6	18.2	23.2	81.6	18.6	61.8	10.2	44.9	24.3	13.3	13.8	16.8	21.9	13.2	14.0	14.2	15.6	16.2	13.2	16.2	15.9	8.4	9.6	9.3	42.4	22.8	33.4	40.8	21.6	18.2	14.3	12.9	6.2	4.6	40.0	25.4	3.7	47.9	30.6	24.4	187.7	1.9	52.9	4.1	32.6	9.9	9.5	36.4	10.3	27.2	27.5	22.7	10.6	32.1	49.4	11.4	1.2	10.4	31.6	68.5	0.0	30.9	57.9	52.9	31.9	47.2	1.5	7.5	26.4	32.0	33.7	29.6	7.8	26.8	17.1	10.7	51.1	126.6	6.4	45.5	32.0	93.8	8.8	40.8	15.7	13.1	6.8	13.2	4.1	9.7	22.4	15.2	94.3	38.3	5.4	36.8	36.8
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 67.8;neutrophil: 42.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 67.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	38.8	12.5	6.7	8.5	8.6	39.6	27.9	10.5	8.9	9.8	6.0	12.3	9.9	5.7	4.1	31.1	5.1	11.6	13.4	6.8	7.4	12.0	21.7	16.4	3.4	9.2	8.2	4.6	16.0	12.2	5.6	10.2	9.1	7.1	7.5	6.3	27.4	8.4	15.0	38.0	10.5	9.3	9.3	9.4	12.1	10.8	8.4	6.8	15.5	18.5	7.9	16.7	16.9	11.9	18.9	6.8	8.2	9.7	32.0	12.8	17.1	77.4	27.1	18.8	14.9	9.4	6.4	16.2	10.9	23.2	15.8	5.8	16.5	18.5	22.6	58.4	13.2	36.6	24.4	7.5	15.7	9.2	13.2	13.0	64.6	31.3	28.5	18.8	33.3	10.8	23.9	14.2	46.9	11.0	7.6	6.9	22.8	16.7	20.4	3.1	24.1	8.6	27.9	40.4	10.6	13.6	36.9	20.5	9.8	9.8	18.9	8.9	19.3	18.1	13.6	35.0	34.5	11.1	34.0	7.7	20.3	17.3	16.0	67.8	14.7	9.5	2.3	7.9	1.7	3.5	1.7	2.7	6.8	4.0	1.6	2.5	42.5	2.0	5.7	1.9	4.8	5.3	6.7	8.6	10.5	8.9	6.8	7.4	9.2	8.2	9.1	9.3	8.4	11.9	117.5	25.6	51.8	12.7	44.8	39.9	27.5	25.9	88.8	11.9	149.9	116.2	10.3	14.3	49.6	27.6	27.1	16.7	80.3	65.0	33.2	57.5	19.5	47.5	49.0	34.6	36.2	69.0	24.1	61.5	24.9	53.7	67.8	114.0	16.5	8.8	18.2	12.7	18.0	3.3	24.1	23.7	34.6	44.1	17.4	17.1	5.3	79.8	7.2	11.2	35.9	11.0	12.3	18.1	28.8	75.2	49.8	5.7	41.8	25.5	98.5	39.8	19.1	17.4	0.0	32.0	46.4	47.3	41.9	111.7	40.9	205.4	42.6	15.2	21.9	71.6
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6, acylglycerol lipase"	Q9BV23	3	58237532-58295693	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 60.6;Oligodendrocytes: 88.6;Proximal enterocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	12.2	12.9	24.0	6.4	33.9	0.9	8.9	34.1	32.4	4.4	19.4	12.7	39.5	6.1	14.7	6.4	9.1	5.8	5.7	31.6	26.9	35.6	64.9	8.5	8.0	31.7	32.3	5.0	2.7	8.9	16.6	6.4	31.7	5.5	11.1	9.2	4.0	14.3	4.6	25.5	52.3	9.2	28.8	35.0	12.9	3.9	35.5	5.5	9.1	5.4	7.6	5.8	5.9	49.8	3.5	12.0	1.8	8.5	23.2	4.2	21.2	8.9	8.1	9.2	12.5	6.9	4.8	6.6	0.8	4.7	28.5	9.9	8.3	3.9	8.4	11.3	4.2	5.7	8.1	9.7	7.8	1.7	28.1	3.9	18.4	8.8	3.8	10.6	5.0	10.6	6.8	15.0	7.2	2.6	11.7	0.7	6.1	28.5	27.3	4.2	3.8	14.8	14.5	4.8	10.8	4.4	9.9	5.1	19.0	3.7	3.6	4.5	5.8	6.6	7.0	16.6	10.8	4.2	13.5	0.3	17.1	16.9	9.3	0.0	2.2	1.7	1.6	7.4	1.5	3.6	0.9	1.9	3.7	2.5	0.9	1.1	0.0	0.7	5.2	5.4	1.2	1.0	24.0	33.9	34.1	32.4	31.6	26.9	31.7	32.3	31.7	28.8	35.5	49.8	27.1	0.0	1.8	11.4	13.6	8.7	3.0	2.7	6.2	13.3	2.1	1.5	5.6	5.7	4.9	3.7	4.2	2.0	7.7	11.2	1.9	3.0	1.0	9.8	7.9	14.1	0.0	5.7	33.6	1.9	0.9	2.9	7.7	1.5	11.4	10.1	21.4	60.6	8.9	15.2	34.3	4.0	0.0	16.7	20.0	0.7	6.8	12.1	3.6	11.2	11.5	11.2	6.2	37.7	88.6	1.9	1.4	8.2	2.0	1.8	55.1	17.4	13.8	3.3	0.0	2.9	3.9	0.5	2.2	6.9	24.6	0.5	5.1	16.0	5.8	2.0
ABITRAM	"C9orf6, CG-8, FAM206A, FLJ20457, Simiate"	ENSG00000119328	"Actin binding transcription modulator"	Q9NX38	9	108934400-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.7;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 10.6;Fibroblasts: 4.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035917, HPA035918"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	14.2	11.9	17.2	10.0	18.7	15.6	17.2	16.8	21.9	12.5	18.7	14.9	14.4	13.6	25.1	16.4	21.5	10.9	15.8	17.7	17.3	13.6	14.6	12.7	9.0	16.8	17.1	13.5	13.3	23.2	13.9	12.5	17.2	12.1	16.2	24.7	15.3	14.2	13.2	24.5	13.1	12.5	17.5	8.5	14.5	20.2	17.5	11.9	19.0	11.8	12.0	11.9	11.4	18.3	18.5	19.8	19.5	23.4	36.2	44.6	28.1	17.1	20.0	17.0	13.9	29.5	9.7	17.0	9.8	16.6	22.3	41.3	17.2	18.3	16.0	10.4	17.6	10.5	25.8	27.0	30.7	40.4	13.3	25.3	33.6	20.7	47.6	20.9	23.7	26.1	39.7	16.6	20.3	53.0	28.9	16.3	22.6	55.9	28.7	13.9	33.9	18.9	22.5	19.2	26.7	13.7	27.0	23.3	30.1	20.0	31.6	21.4	14.9	9.2	16.9	39.3	21.7	14.7	38.5	12.6	30.1	15.6	13.4	38.8	31.2	31.0	14.8	33.4	22.6	16.5	23.1	19.6	35.5	10.8	22.9	17.6	37.4	21.1	34.6	37.0	21.1	20.1	17.2	18.7	16.8	21.9	17.7	17.3	16.8	17.1	17.2	17.5	17.5	18.3	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713016-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 71.2;Oligodendrocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	50.9	30.7	27.4	25.3	38.9	23.4	45.8	33.6	31.4	60.5	40.4	96.4	23.1	63.0	11.6	33.8	55.6	35.7	36.1	26.6	28.3	23.1	17.5	37.3	16.3	39.3	38.5	56.0	24.9	32.5	34.9	26.5	35.8	43.5	26.7	14.2	32.4	33.6	29.4	36.3	45.2	41.2	31.3	23.3	51.6	20.1	34.9	22.4	46.7	30.8	15.4	79.3	42.7	41.3	22.5	48.3	53.6	62.9	76.5	93.3	18.8	38.8	60.4	44.8	38.1	36.4	28.3	32.3	22.3	52.0	47.6	42.5	23.5	36.0	30.7	20.6	16.3	23.7	84.1	33.4	51.8	36.5	32.3	68.8	37.2	80.6	50.0	64.1	61.0	47.9	135.8	26.5	54.9	42.0	49.2	30.5	57.9	34.3	33.8	55.9	67.9	35.9	45.0	25.7	47.9	60.1	66.1	23.5	29.2	31.0	46.2	33.1	71.1	170.7	44.1	66.3	62.6	8.4	20.3	47.9	72.1	27.6	55.1	0.0	0.7	0.3	0.6	0.4	0.8	1.3	0.6	0.6	0.7	0.4	0.6	0.5	0.0	0.8	1.9	1.0	0.3	0.6	27.4	38.9	33.6	31.4	26.6	28.3	39.3	38.5	35.8	31.3	34.9	41.3	16.2	9.6	13.6	54.9	4.7	9.2	7.3	9.8	5.2	8.2	11.6	10.2	6.2	7.2	7.2	14.7	12.5	13.6	12.1	21.2	1.9	14.4	5.9	8.6	29.7	18.1	22.1	4.6	52.5	11.1	4.3	36.7	5.6	12.4	2.5	22.1	20.3	15.9	16.6	10.1	63.7	17.5	6.1	16.4	11.7	8.8	28.0	10.2	5.4	71.2	6.6	19.2	6.2	66.9	116.0	17.9	18.3	25.6	5.6	8.6	11.6	10.3	7.8	9.1	19.7	29.5	19.8	16.9	16.5	6.6	6.8	15.2	7.9	20.1	21.4	7.2
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099330-179229684	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 166.8;Langerhans cells: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 73.5;TIME: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212"	"unprognostic (3.05e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (8.40e-4)"	9.3	3.2	5.9	4.9	6.7	2.7	5.7	6.1	6.1	5.4	2.0	4.6	2.8	3.7	2.7	2.5	3.2	11.8	3.9	7.4	5.0	3.6	2.7	6.5	2.7	3.8	4.4	3.5	5.7	4.2	3.8	4.1	3.9	3.5	3.3	9.2	3.5	2.6	3.1	4.2	3.2	4.5	3.0	2.7	3.7	4.4	5.6	4.1	3.8	4.2	2.5	6.4	4.0	4.8	24.2	13.1	8.7	5.8	7.3	16.8	5.3	26.3	21.6	31.9	23.1	9.9	7.2	13.7	18.9	19.2	21.7	11.0	12.6	9.1	44.6	8.5	11.4	6.7	12.4	4.9	13.3	7.5	2.1	15.6	11.6	45.3	73.5	13.9	36.2	7.0	16.1	3.8	42.6	6.5	5.9	4.0	8.3	5.0	4.3	8.6	14.4	6.5	10.8	4.0	5.2	11.9	22.0	7.0	53.8	13.2	6.2	6.4	70.7	33.3	24.5	15.7	42.8	7.0	9.3	14.1	15.6	4.0	32.4	1.4	0.3	0.0	0.5	0.1	0.2	0.5	0.3	0.3	0.2	0.7	0.4	0.5	0.6	0.5	0.1	0.5	0.2	0.1	5.9	6.7	6.1	6.1	7.4	5.0	3.8	4.4	3.9	3.0	5.6	4.8	33.5	22.4	24.0	44.1	14.4	46.9	43.6	16.3	12.5	40.0	18.7	9.5	8.9	22.8	10.8	11.0	166.8	9.3	7.7	15.5	11.7	14.3	15.6	12.3	23.4	67.2	27.0	9.9	81.6	13.9	8.2	67.6	10.2	21.5	17.1	19.5	31.1	15.3	22.9	25.2	62.0	11.0	10.2	34.9	188.1	32.2	15.2	67.7	69.4	45.0	13.9	11.3	8.2	72.4	57.1	45.5	16.0	13.5	10.3	42.6	9.9	9.4	11.0	35.7	6.6	32.3	30.5	17.8	30.5	11.5	38.4	10.4	12.4	11.6	14.9	25.3
ABRAXAS2	"ABRO1, Em:AC068896.4, FAM175B, KIAA0157"	ENSG00000165660	"Abraxas 2, BRISC complex subunit"	Q15018	10	124801819-124836667	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Collecting duct cells: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037591, HPA037592, HPA074089"	Approved		Supported	Cytosol		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	9.1	10.5	8.0	10.3	8.3	12.3	12.2	8.0	9.9	8.8	6.6	9.9	10.2	9.4	9.3	9.8	9.0	8.2	10.0	8.4	8.6	12.3	13.7	9.3	12.5	7.8	8.4	10.4	8.3	12.7	3.9	10.3	8.5	9.5	10.3	5.3	8.5	8.8	19.0	11.6	10.8	10.5	7.7	10.0	9.5	6.7	8.2	12.9	12.7	16.2	13.3	9.7	6.8	7.9	22.2	14.9	15.7	21.6	19.9	19.6	13.5	22.4	35.1	26.2	24.1	12.1	20.9	24.7	18.6	24.4	14.2	24.4	25.0	21.0	27.5	21.6	17.2	18.8	11.8	15.0	25.4	32.6	18.9	21.6	25.1	25.8	46.4	28.3	20.1	21.7	20.0	16.6	21.6	14.5	25.1	29.1	13.5	20.0	13.8	20.0	16.6	15.1	19.5	11.1	10.8	19.8	17.9	17.0	24.4	15.8	14.0	22.2	17.4	14.0	11.2	16.5	27.1	17.2	17.1	23.6	18.3	15.9	10.1	22.8	10.5	9.8	7.6	14.5	10.5	10.5	8.8	10.6	12.9	11.6	9.3	10.3	4.1	7.7	11.8	8.7	11.4	7.0	8.0	8.3	8.0	9.9	8.4	8.6	7.8	8.4	8.5	7.7	8.2	7.9	15.1	25.6	14.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	9.4	10.3	0.0	0.0	6.2	23.9	0.0	16.9	7.0	0.0	17.6	13.7	0.0	11.1	15.6	6.3	0.0	0.0	0.0	12.5	13.0	5.5	0.0	12.3	12.6	12.4	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	20.7	0.0	0.0	0.0	0.0	10.2	0.0	0.0	1.6	0.0	0.0	18.6	12.4	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	16.0	4.3	13.5	0.0	0.0
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150987-34358010	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 126.2;Syncytiotrophoblasts: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"eosinophil: 5.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.6;granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA020065: AB_1844459, HPA030699: AB_2673576"	"unprognostic (3.00e-1)"	"prognostic unfavorable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	2.3	13.0	7.9	2.0	12.6	2.5	2.0	18.1	6.7	8.1	1.2	3.4	8.8	6.1	4.4	4.1	4.6	2.1	12.8	5.3	8.5	9.4	11.6	2.9	2.1	24.1	16.3	2.5	2.3	0.5	3.5	3.2	16.7	4.9	2.5	2.6	6.7	4.3	16.9	6.8	7.0	2.5	12.7	0.9	2.5	2.7	15.9	2.4	2.0	7.2	2.0	3.6	5.6	20.3	5.6	16.2	6.4	1.8	1.7	0.1	6.4	3.2	2.5	2.8	5.3	4.0	4.0	0.2	5.3	4.1	16.5	10.5	3.6	3.7	2.3	0.2	8.8	0.1	9.8	17.4	1.0	8.9	1.2	0.9	2.0	5.6	2.4	10.1	0.0	0.7	1.9	0.5	1.8	13.8	0.3	10.7	8.0	8.1	8.8	1.7	3.8	6.3	10.0	13.0	8.1	6.6	8.1	24.6	6.5	4.2	5.3	3.8	0.9	3.1	0.5	9.8	5.8	0.9	0.4	0.1	7.1	2.5	9.7	0.0	0.1	5.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	7.9	12.6	18.1	6.7	5.3	8.5	24.1	16.3	16.7	12.7	15.9	20.3	0.7	0.0	2.3	18.9	1.1	4.7	3.2	1.3	1.2	2.1	3.0	3.3	10.0	2.8	1.1	12.9	0.0	2.7	2.5	12.2	5.9	4.6	1.2	3.4	4.5	0.9	7.2	0.0	4.0	4.5	1.1	5.8	4.6	10.7	1.3	0.3	0.0	6.8	0.8	0.0	8.9	2.3	4.1	0.8	6.1	0.3	1.2	1.2	1.8	6.5	9.3	7.5	0.0	50.3	126.2	10.5	9.1	6.0	2.1	9.3	15.5	2.0	0.3	0.6	0.0	4.3	2.4	0.5	1.1	1.0	4.8	28.3	2.9	0.4	2.9	7.5
AC004556.3		ENSG00000276345	"39S ribosomal protein L23, mitochondrial"		Unmapped	2585-11802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"heart muscle: 24.0"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 35.6;Hofbauer cells: 23.3"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 94.7;K-562: 75.5;MOLT-4: 85.4;NB-4: 160.6;PC-3: 141.1;WM-115: 113.7"									HPA050406	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"		"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"																		3.8	0.0	2.5	4.0	3.0	0.0	19.4	2.8	3.2	0.0	2.6	10.3	0.1	5.0	14.3	0.0	4.9	5.9	24.0	2.4	2.7	6.7	8.5	1.6	0.0	3.1	3.7	6.3	6.8	0.0		2.1	3.4	5.0	0.0	1.2	7.5	0.3	14.5	5.1	9.9	0.5	2.4	4.1	5.0	2.4	2.8	9.9	2.6	0.0	0.1	4.5		2.8	0.2	0.0	0.1	0.1	0.0	0.0	42.0	27.8	43.4	46.5	33.2	94.7	0.8	0.1	0.1	0.0	0.0	0.6	0.7	0.3	18.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	51.1	0.0	31.4	48.3	75.5	42.5	0.4	0.4	85.4	160.6	0.0	0.2	141.1	0.5	22.8	0.2	44.0	27.1	0.2	0.6	0.0	0.2	0.1	0.0	70.4	0.0	0.0	0.0	0.1	0.3	0.4	0.5	0.3	0.1	0.8	0.3	113.7	12.3	3.4	2.2	1.7	6.2	1.4	1.7	2.5	3.5	3.0	2.0	2.6	2.9	1.0	2.1	2.8	2.8	4.0	2.1	2.5	3.0	2.8	3.2	2.4	2.7	3.1	3.7	3.4	2.4	2.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	35.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0
AC005833.1		ENSG00000255639	"Novel protein"		12	4649101-4774184	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 23.1;tongue: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA012638, HPA042268, HPA073212"	Supported		Approved	Nucleoplasm,Mitochondria		No	NA			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Mitochondria"		"HPA012638: AB_2294503, HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-2)"			"unprognostic (5.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.10e-1)"			"unprognostic (1.31e-1)"	"unprognostic (6.29e-3)"		"unprognostic (2.94e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.16e-1)"	2.1	1.3	1.1	3.8	1.4	2.0	2.6	1.3	1.6	1.9	0.9	14.6	14.2	1.2	1.0	2.2	1.7	1.3	7.0	1.2	1.3	6.8	6.4	1.4	1.7	1.3	1.3	1.0	0.5	7.0		1.9	1.4	1.8	23.1	0.7	2.5	2.4	2.2	1.0	14.5	3.2	1.3	1.3	2.6	3.4	1.3	2.9	1.6	18.4	3.4	2.8		1.5	4.4	7.0	5.1	3.4	3.4	3.5	11.8	3.7	5.2	10.4	8.6	13.6	7.6	8.8	1.0	5.7	6.5	6.0	9.3	6.4	11.9	8.9	5.0	10.0	7.4	8.9	7.1	9.6	3.0	5.0	6.0	5.6	10.2	4.0	10.6	5.9	7.0	19.9	7.8	5.0	3.6	3.3	16.5	10.2	2.2	6.5	9.6	6.0	8.6	8.2	2.7	2.3	5.3	9.5	4.6	11.7	1.8	3.0	5.1	4.7	9.5	2.5	8.3	1.3	4.6	10.6	3.5	4.5	4.5	3.6	7.4	2.6	5.2	7.4	5.9	6.0	4.9	5.7	9.6	3.9	4.1	4.0	0.3	5.6	6.9	8.7	6.7	14.7	1.1	1.4	1.3	1.6	1.2	1.3	1.3	1.3	1.4	1.3	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC008397.2		ENSG00000285188	"Novel protein"		19	18207961-18255419	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"stomach 1: 3.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.0;Alveolar cells type 1: 9.6;Alveolar cells type 2: 10.6;Breast glandular cells: 2.2;Breast myoepithelial cells: 4.6"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.2"									"HPA048975, HPA054218"	Uncertain		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA					"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "																		0.1	0.0	1.8	0.1	2.3	0.0	0.0	1.2	2.3	0.3	1.2	1.2	0.8	0.7	1.9	0.1	0.7	0.3	0.5	2.1	1.5	0.4	0.0	1.2	0.0	1.3	1.5	0.2	0.4	0.0		0.6	1.4	0.2	1.0	0.0	0.0	0.7	2.4	0.0	0.5	0.5	1.3	0.4	3.6	0.3	1.6	0.0	0.0	2.6	0.0	0.1		1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.3	1.2	2.3	2.1	1.5	1.3	1.5	1.4	1.3	1.6	1.6	2.0	9.6	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AC012254.6		ENSG00000288607	"Elongin A3 family member B"	Q3SY89	18	47022287-47023927	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	34	"brain: 3.4;choroid plexus: 3.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	2.0	0.0	2.7	0.0	0.0	0.9	1.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	3.4	3.2	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0		2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.7	0.9	1.3	1.1	1.1	3.4	3.2	2.7	1.8	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012254.7		ENSG00000288631	"Elongin A3"	Q8NG57	18	47028202-47029842	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"brain: 3.9;choroid plexus: 4.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	2.0	0.0	2.8	0.0	0.0	1.5	1.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	3.9	3.8	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0		1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.8	1.5	1.8	1.6	1.9	3.9	3.8	2.7	1.1	3.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC013489.1		ENSG00000173867	"Novel transcript"		15	88459501-88546585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"granulocytes: 1.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA048873: AB_2680541"	"unprognostic (3.32e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	0.4	0.4	0.6	0.2	0.6	0.4	1.1	0.7	0.7	0.4	0.9	0.5	0.3	2.2	1.0	0.3	1.0	0.5	0.8	0.5	0.9	0.7	0.8	0.5	0.4	0.6	0.6	2.2	1.0	0.7		0.5	0.7	0.6	0.6	1.3	0.4	0.7	1.4	0.3	0.4	0.9	0.6	0.7	0.4	0.4	0.7	0.5	0.7	1.2	0.5	0.3		0.8	0.3	0.6	0.5	0.8	1.2	0.6	0.6	1.0	0.7	1.0	0.7	0.6	1.1	0.9	0.7	1.2	0.7	0.6	2.1	0.6	0.9	0.3	1.0	1.0	0.5	0.8	0.4	0.8	0.7	1.0	1.1	0.7	0.8	0.4	0.5	1.2	1.0	0.9	0.1	0.4	1.0	0.5	0.6	0.7	0.2	0.4	0.7	1.2	0.6	0.8	0.6	0.4	0.9	0.4	1.4	1.0	0.7	1.5	0.8	0.7	0.5	0.9	0.9	0.5	0.9	0.6	0.9	0.7	0.5	0.0	0.5	0.3	0.7	0.9	0.8	0.9	0.9	0.8	0.8	0.7	1.0	1.1	0.0	0.9	0.6	0.6	0.8	0.9	0.6	0.6	0.7	0.7	0.5	0.9	0.6	0.6	0.7	0.6	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC024592.3		ENSG00000267740	"Novel protein"		19	5866171-5903787	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 3.1;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA072209			Uncertain	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA072209: AB_2686495"					"unprognostic (2.12e-2)"					"unprognostic (2.24e-1)"				"unprognostic (3.38e-1)"				1.1	1.9	0.8	0.2	0.8	1.0	1.0	0.8	1.5	1.1	1.1	1.6	0.8	0.9	0.2	2.2	0.6	0.6	2.6	0.9	0.9	1.3	2.4	1.0	0.3	0.9	1.0	1.1	1.0	0.2	1.0	0.3	1.1	1.1	0.0	0.3	1.1	0.2	2.3	1.2	1.0	0.6	0.9	1.1	1.1	0.7	1.0	0.6	0.8	1.2	0.4	1.2	1.4	0.9	3.5	4.6	1.4	3.9	2.7	0.5	1.2	2.3	3.2	4.3	3.0	1.7	2.9	2.9	2.2	1.8	2.0	2.4	0.9	2.7	0.8	1.2	1.4	0.7	1.8	3.9	1.8	1.3	1.5	1.1	4.5	3.3	1.5	1.3	1.4	4.1	1.2	3.7	0.6	2.9	4.8	1.0	2.2	1.5	2.2	4.5	1.4	3.7	2.0	1.1	2.3	3.2	1.7	2.3	2.5	0.6	1.4	4.3	2.8	0.8	2.1	5.3	4.6	3.4	4.1	1.6	2.7	4.6	1.9	4.4	4.8	2.3	3.2	4.3	2.8	4.2	3.4	3.1	5.0	4.0	3.8	3.1	2.7	3.6	3.9	6.2	4.4	8.1	0.8	0.8	0.8	1.5	0.9	0.9	0.9	1.0	1.1	0.9	1.0	0.9	0.1	3.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
AC026464.4		ENSG00000260914	"Novel protein"		16	69299682-69322700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060092			Approved	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Midbody		"HPA060092: AB_2684203"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-1)"			"unprognostic (7.34e-2)"	"unprognostic (8.50e-2)"		"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"		"unprognostic (3.50e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.51e-4)"	"unprognostic (1.69e-1)"		"unprognostic (2.76e-1)"	"unprognostic (5.11e-2)"	44.1	30.4	24.3	29.1	27.0	28.6	31.8	26.0	37.3	28.4	14.9	36.4	30.5	32.6	12.3	41.7	29.4	22.0	43.2	28.4	27.4	30.3	20.7	28.8	28.0	28.5	25.1	33.7	47.2	47.6	16.1	29.4	29.1	27.7	26.4	35.4	36.1	26.6	156.6	34.6	35.1	31.7	25.2	29.9	31.7	18.7	27.4	26.2	30.3	97.2	30.0	32.2	28.3	30.1	64.9	56.5	65.5	62.3	48.9	51.3	36.9	80.1	53.7	83.6	54.6	72.3	35.1	61.6	81.7	64.5	42.9	49.7	62.2	54.6	52.9	38.2	30.0	48.9	30.1	37.3	61.5	62.3	49.8	43.7	73.8	69.2	75.7	47.9	70.0	52.4	63.2	29.6	68.7	84.5	62.1	30.8	53.1	42.7	27.0	94.3	37.4	82.1	38.7	41.2	67.7	38.1	107.8	35.6	47.7	39.9	50.7	43.0	74.0	77.7	55.5	67.8	61.3	101.4	78.6	147.0	78.7	23.3	94.8	16.1	25.4	36.1	31.0	20.7	28.4	23.0	27.4	36.9	26.8	20.2	27.7	27.4	17.1	22.5	28.3	18.5	28.5	33.7	24.3	27.0	26.0	37.3	28.4	27.4	28.5	25.1	29.1	25.2	27.4	30.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC087721.2		ENSG00000285920	"Novel protein"		15	41284007-41380996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 5.3;Club cells: 5.6;granulocytes: 3.8;Respiratory ciliated cells: 2.9"					"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											"HPA042904, HPA074847"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"																		0.8	1.5	0.3	1.8	0.2	2.9	1.3	2.1	1.0	1.0	0.1	1.8	1.7	0.9	0.3	1.6	0.7	1.1	0.8	0.1	0.3	1.1	1.7	1.0	2.4	0.4	0.6	1.5	0.6	0.9		1.3	0.5	0.7	1.9	1.8	0.6	1.1	3.1	1.0	1.4	1.1	0.2	1.6	1.2	2.9	0.6	2.6	0.7	1.9	2.5	1.5		0.4	3.7	1.2	6.6	5.5	2.5	3.7	3.4	3.8	2.9	4.8	4.7	2.0	4.1	2.8	4.0	2.2	4.4	8.7	10.1	5.3	4.1	7.2	3.6	9.4	3.8	3.6	2.0	14.2	8.2	2.1	3.3	3.3	8.8	1.9	4.7	10.6	8.7	11.0	4.3	1.8	5.5	4.5	6.9	9.2	5.5	7.6	5.0	4.3	4.6	4.0	6.6	6.0	6.6	3.9	2.6	7.0	6.6	8.5	4.3	2.8	5.5	3.2	5.8	5.6	10.7	9.4	2.4	8.7	5.6	0.1	0.4	1.0	0.2	0.4	0.3	0.4	0.5	0.4	0.6	0.3	0.2	0.2	0.1	0.3	0.5	0.9	0.9	0.5	0.3	0.2	2.1	1.0	0.1	0.3	0.4	0.6	0.5	0.2	0.6	0.4	0.0	6.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
AC090373.2		ENSG00000288616	"Elongin A3 family member D"	A6NLF2	18	46962768-46964408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	37	"brain: 3.4;choroid plexus: 4.0"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	1.4	0.0	2.2	0.0	0.0	1.2	1.4	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	3.4	1.9	0.0	0.0	0.0		0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0		1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	1.2	1.4	1.0	0.9	3.4	1.9	2.4	0.8	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC092143.1		ENSG00000198211	"Novel protein (MC1R-TUBB3 readthrough)"		16	89919165-89936092	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	12	"testis: 6.6"	"Cell type enriched"	"Detected in single"	15	"Fibroblasts: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 10.7"									"CAB011512, HPA043640, HPA046280"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612"					"unprognostic (2.90e-4)"				"unprognostic (6.87e-2)"									0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC138696.1		ENSG00000264668	"Novel protein"		8	143247110-143276403	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.7;MOLT-4: 1.2"									"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"		"Cluster 34: Mesenchymal cell lines - ECM organization"		"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (2.24e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-3)"		"unprognostic (1.87e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.06e-1)"	0.3	0.3	0.2	0.0	0.3	0.0	0.2	0.1	0.5	0.3	0.0	0.4	0.1	0.6	0.0	0.1	0.7	0.0	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.2	0.4	0.4	0.6	0.1	0.2	0.0	0.3	0.3	0.0	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.3	1.7	0.1	0.1	0.5	1.1	0.6	0.2	0.0	0.7	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	1.0	0.4	0.0	0.3	0.2	0.3	0.4	0.0	0.0	0.0	0.0	1.2	0.0	1.1	0.1	0.3	0.6	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.2	1.1	0.0	0.8	0.2	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC213203.1		ENSG00000268674		P0DMU3	Unmapped	35407-35916	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enriched"	"Detected in single"	5	"brain: 1.8"	"Not detected"	"Not detected"							"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043267, HPA043292, HPA077864"	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"				"Intermediate filaments"		"HPA043267: , HPA043292: , HPA077864: AB_2686862"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3		0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.8	0.3	0.1	0.2	0.3	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACAD9	"MGC14452, NPD002"	ENSG00000177646	"Acyl-CoA dehydrogenase family member 9"	Q9H845	3	128879596-128924003	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037716, HPA046720"	Supported		Enhanced	Mitochondria		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA037716: AB_10673638, HPA046720: AB_2679773"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.67e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-3)"	"prognostic favorable (4.32e-8)"	"unprognostic (1.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.96e-2)"	16.7	20.5	9.0	6.1	8.5	4.7	14.5	9.6	10.2	14.4	9.1	13.6	9.0	14.6	7.7	23.2	12.9	7.3	21.9	8.3	8.7	15.6	20.6	11.0	6.6	8.2	8.7	12.9	14.4	27.7	14.6	8.4	8.4	12.1	9.4	4.1	14.2	12.0	30.4	48.0	11.2	11.1	7.4	12.2	15.9	12.5	8.7	12.1	13.6	28.7	11.2	12.9	14.5	9.0	46.2	22.6	18.0	12.6	28.7	20.7	17.5	22.4	26.2	43.6	36.8	33.3	27.1	33.3	21.1	29.5	29.0	35.5	33.8	45.9	32.8	21.2	23.1	29.3	46.8	24.4	21.6	23.9	10.6	22.5	16.8	23.6	26.7	25.1	35.8	25.2	14.4	11.4	29.5	46.5	36.7	19.0	9.9	49.3	33.8	25.5	17.4	35.1	30.9	25.1	19.0	11.6	37.0	32.9	23.2	17.4	44.5	54.8	18.2	13.2	13.4	14.2	20.3	14.5	5.8	28.3	28.3	21.4	22.7	2.4	15.1	4.9	8.3	18.3	7.8	8.1	7.6	7.3	17.5	5.4	6.2	8.0	0.7	6.8	25.2	9.9	8.3	12.1	9.0	8.5	9.6	10.2	8.3	8.7	8.2	8.7	8.4	7.4	8.7	9.0	10.4	16.0	21.7	13.1	9.3	6.2	11.4	16.7	8.6	14.1	11.9	9.5	30.5	15.7	14.8	14.7	10.4	26.2	10.5	11.7	21.5	20.6	20.2	10.4	11.5	11.2	5.4	14.3	14.3	17.8	18.8	12.9	16.8	12.9	16.5	12.0	15.7	26.7	31.5	10.1	17.7	7.4	16.2	9.5	4.0	17.3	10.2	10.8	16.0	7.5	13.4	15.0	12.3	6.0	12.2	14.1	8.7	14.7	9.5	8.1	9.4	26.3	12.0	11.9	13.1	12.7	14.9	22.6	9.6	13.5	14.2	30.6	8.2	18.1	14.3	8.4
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724431-75787575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 367.3;skeletal muscle: 380.0;tongue: 475.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 373.1;Distal tubular cells: 344.4;Hepatocytes: 261.2;Proximal tubular cells: 564.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 289.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		930000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	81.9	82.2	25.2	24.3	25.0	17.3	69.9	26.6	42.2	29.3	30.4	46.8	103.9	20.0	25.3	51.3	30.6	27.8	217.8	24.3	25.9	295.9	367.3	22.6	42.6	26.9	26.8	35.7	35.9	66.3	19.2	16.9	25.8	26.8	49.5	21.2	31.4	26.2	380.0	14.4	75.6	25.5	26.2	27.4	52.8	35.7	25.8	29.7	38.4	475.9	44.3	32.7	21.3	25.2	25.8	20.5	61.0	26.8	53.1	42.1	17.5	48.1	40.4	46.1	38.5	38.3	39.5	289.1	40.7	34.4	39.0	22.8	54.9	41.8	57.8	113.0	25.5	94.4	58.5	58.3	36.4	80.0	23.9	50.7	23.5	39.8	22.8	35.0	36.2	56.6	102.3	60.4	50.5	9.6	96.3	40.6	50.2	80.4	49.5	118.8	83.8	30.6	77.9	70.7	33.8	43.0	38.0	111.6	102.0	43.1	32.7	107.6	20.2	29.9	29.6	26.6	78.1	38.6	62.0	128.1	25.8	67.0	35.3	15.3	14.2	19.3	17.1	20.9	27.3	40.7	17.8	21.5	21.4	24.6	20.3	23.6	0.5	25.0	20.4	23.2	19.5	19.5	25.2	25.0	26.6	42.2	24.3	25.9	26.9	26.8	25.8	26.2	25.8	25.2	42.9	57.7	58.3	29.7	56.5	27.3	41.8	69.0	44.3	39.0	49.0	40.9	373.1	52.9	63.0	58.8	25.0	35.8	39.4	42.6	344.4	37.9	55.4	27.1	32.2	36.2	40.7	67.6	51.6	26.5	19.5	47.6	26.0	25.4	44.9	61.5	43.9	261.2	75.7	30.3	46.7	38.7	63.1	45.6	22.2	24.4	46.9	38.2	51.6	19.7	32.8	53.7	29.9	36.2	36.0	21.2	49.7	45.5	74.9	24.2	88.0	564.8	106.7	30.0	0.0	38.6	43.7	76.3	86.1	46.6	27.0	15.3	39.4	72.5	46.7	35.9
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725774-120740008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 245.5;skeletal muscle: 158.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 303.1;Hepatocytes: 203.3;Paneth cells: 185.7;Proximal enterocytes: 435.0;Undifferentiated cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	50.3	52.7	13.3	11.1	15.4	14.3	40.9	13.6	16.6	11.2	13.7	74.0	84.8	10.2	0.9	14.1	10.2	8.5	90.5	12.3	13.8	51.9	245.5	13.4	6.4	14.6	14.2	8.6	33.1	4.7	9.2	7.5	13.1	13.9	21.3	0.9	19.2	7.2	158.2	13.7	73.2	5.8	14.0	31.6	34.5	20.3	16.0	6.6	21.9	79.7	3.4	18.0	12.7	14.8	3.2	11.4	0.6	9.7	12.9	5.1	11.1	4.7	4.6	6.0	4.5	8.9	8.0	0.3	11.9	3.9	2.7	5.2	6.6	2.1	0.8	16.7	8.2	8.2	3.6	19.3	9.3	0.7	36.0	15.4	3.1	2.6	0.2	1.8	6.1	20.6	6.9	0.1	2.7	6.8	11.7	19.2	2.0	10.6	4.6	8.6	4.2	2.2	11.3	18.2	1.1	6.0	9.7	0.0	15.8	0.9	7.7	13.1	6.9	0.2	4.7	4.5	0.9	15.3	9.3	4.1	10.2	7.0	4.1	8.3	15.3	7.5	13.7	16.3	9.3	6.3	12.2	14.2	13.2	8.9	15.3	14.4	1.4	19.9	10.2	11.0	14.7	12.8	13.3	15.4	13.6	16.6	12.3	13.8	14.6	14.2	13.1	14.0	16.0	14.8	18.8	12.8	13.7	10.1	6.7	6.6	9.5	21.1	4.0	1.0	25.0	14.9	44.0	27.1	13.0	18.4	0.0	78.8	9.8	303.1	50.9	35.2	23.5	12.8	8.2	13.4	45.6	38.5	2.3	32.6	31.3	18.1	28.5	10.8	19.1	12.8	19.2	203.3	55.1	1.7	2.8	105.3	20.3	21.0	8.9	36.5	21.5	15.3	17.8	0.0	26.1	13.6	18.6	3.0	3.6	26.7	185.7	18.0	7.9	8.3	435.0	94.8	7.3	0.6	6.6	13.2	12.7	41.5	8.1	9.4	4.5	75.5	11.9	140.6	185.9	12.7
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 360.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 499.5;Proximal tubular cells: 137.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	14.8	27.4	8.0	7.1	8.5	3.8	23.9	13.9	10.3	7.8	13.1	15.9	52.4	9.9	7.7	12.6	9.7	7.6	38.5	8.6	6.7	90.2	360.1	12.7	8.2	6.3	7.6	12.8	15.8	33.4	8.8	5.1	6.8	22.7	16.8	12.4	15.7	11.2	42.4	9.8	11.0	8.5	5.9	6.4	14.0	8.4	8.0	7.4	12.3	69.1	10.3	10.8	8.1	8.4	15.4	10.9	7.9	14.5	10.6	13.1	7.0	9.3	18.8	9.2	9.1	9.6	4.9	16.0	6.3	7.9	5.6	6.3	12.5	6.5	15.1	10.6	12.9	8.3	3.3	54.8	7.5	12.0	7.6	9.7	6.5	5.8	5.3	13.5	9.0	13.2	8.1	11.5	11.5	7.1	11.4	9.8	4.8	8.5	6.7	13.4	16.6	5.1	13.1	16.9	1.4	9.1	14.3	4.2	14.4	7.5	12.9	5.8	9.5	4.9	4.4	11.4	11.4	12.9	15.5	8.5	7.6	11.1	3.8	17.4	4.5	11.8	8.8	4.7	10.2	5.5	8.1	7.6	6.4	5.7	7.4	8.3	2.9	8.5	2.9	3.8	7.1	5.7	8.0	8.5	13.9	10.3	8.6	6.7	6.3	7.6	6.8	5.9	8.0	8.4	7.7	28.9	53.1	29.4	11.6	9.3	9.2	8.2	14.2	17.4	58.6	27.8	80.7	37.1	21.1	11.0	10.4	20.1	8.7	11.2	46.9	7.3	7.0	6.8	9.1	8.2	12.1	21.4	39.8	4.8	3.5	10.6	10.7	18.8	3.8	29.1	15.4	499.5	7.3	21.9	49.6	13.7	26.4	17.4	5.9	8.1	13.4	7.1	7.2	12.2	7.9	12.0	7.2	15.6	38.3	4.6	13.1	10.9	9.1	19.8	9.2	137.9	15.2	7.7	19.7	12.3	11.0	8.5	3.7	14.7	13.8	30.1	13.3	18.9	18.3	12.0
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225266	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 850.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		98000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	197.9	405.2	120.1	78.7	131.0	103.5	142.9	128.4	126.7	110.5	170.6	157.3	306.2	98.5	44.4	181.0	94.0	92.6	576.8	117.8	125.0	215.3	517.4	106.7	52.0	127.5	125.3	80.9	236.5	159.6	189.6	112.0	124.8	133.2	131.6	34.9	158.5	113.9	850.4	135.7	270.6	110.6	118.2	132.2	186.4	75.9	132.0	83.4	159.3	817.1	82.9	137.1	115.3	122.7	193.7	162.5	65.8	92.4	271.2	99.2	135.9	156.5	169.0	136.9	84.5	67.2	155.3	90.4	109.0	260.0	49.7	147.9	43.8	135.5	119.6	295.9	47.1	50.6	120.9	101.1	131.2	49.0	129.5	112.5	122.0	114.7	178.5	212.6	124.8	111.3	73.3	110.2	222.7	65.3	49.6	68.4	34.3	178.4	91.9	70.4	78.3	227.2	305.1	155.0	19.1	47.3	206.8	224.8	110.8	60.6	102.8	74.9	151.5	127.5	101.6	75.9	149.9	104.5	59.1	5.2	230.7	85.7	94.9	24.2	96.1	121.3	39.1	57.8	35.7	25.2	32.5	43.8	99.9	24.6	23.7	29.1	20.2	37.8	39.3	80.4	31.8	79.4	120.1	131.0	128.4	126.7	117.8	125.0	127.5	125.3	124.8	118.2	132.0	122.7	109.9	60.9	81.9	143.3	72.3	87.3	336.0	322.4	91.6	42.0	157.7	104.5	451.4	138.7	206.7	202.3	62.6	482.9	87.7	484.2	185.9	310.8	133.0	87.2	52.7	77.4	179.3	65.2	40.9	77.0	197.8	118.6	406.7	88.5	88.4	121.1	53.6	365.4	182.4	33.7	33.4	251.8	233.9	67.9	94.6	249.9	124.5	101.5	81.8	34.7	274.9	40.7	73.2	23.1	24.5	106.1	388.9	132.8	172.3	369.0	489.8	345.8	144.1	41.3	105.2	88.3	147.4	114.3	47.8	113.8	87.5	663.3	75.5	169.2	316.8	367.5
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108116695-108147603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 622.7;liver: 969.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 508.4;Distal tubular cells: 698.5;Hepatocytes: 663.4;Proximal tubular cells: 1484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 420.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		1400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	135.4	151.3	45.2	24.3	45.3	38.4	56.9	47.1	60.1	41.0	91.8	96.3	103.9	44.0	34.1	45.0	39.1	25.6	289.4	42.7	46.8	622.7	969.5	43.7	28.2	44.8	45.2	64.7	110.6	95.9	30.9	24.7	45.2	45.6	85.6	26.2	104.1	60.2	461.1	45.3	53.2	57.1	46.7	29.3	81.9	66.3	45.6	19.1	65.5	410.8	29.7	44.1	34.6	47.7	76.9	57.7	48.2	139.3	155.9	138.7	25.1	71.7	78.8	77.7	91.7	168.1	77.3	41.3	116.8	83.6	119.7	78.1	142.3	70.3	83.3	84.9	114.6	117.4	64.6	163.9	107.6	112.9	64.9	124.6	77.1	69.2	127.4	91.5	85.0	92.3	172.1	61.8	128.6	45.8	57.4	122.4	48.2	103.1	135.0	88.1	96.9	420.4	114.7	50.4	75.7	88.1	111.6	152.7	83.0	37.0	132.2	97.6	87.4	83.2	44.5	73.5	88.8	18.9	57.8	77.7	37.6	233.1	59.6	1.4	17.1	4.7	25.3	25.5	29.9	29.2	28.8	30.0	33.5	13.8	25.5	22.4	1.8	13.4	27.8	11.3	35.7	23.4	45.2	45.3	47.1	60.1	42.7	46.8	44.8	45.2	45.2	46.7	45.6	47.7	50.5	54.5	91.8	17.9	37.2	43.1	52.2	48.9	23.9	30.1	34.6	29.6	508.4	78.6	33.5	104.8	27.1	39.9	29.2	125.0	698.5	43.1	345.7	62.2	42.1	62.5	30.0	74.7	35.1	60.5	41.5	57.1	29.0	25.7	27.8	48.6	99.2	663.4	97.9	38.7	37.8	38.5	97.6	73.6	27.8	65.3	66.5	39.1	58.7	30.0	50.1	39.1	25.7	22.6	26.5	33.8	93.8	82.4	52.7	27.8	51.4	1484.0	101.8	28.8	65.7	54.2	69.2	172.7	27.2	39.2	48.4	25.2	38.1	61.6	84.5	24.4
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159762045-159779112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 231.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 262.1;Early spermatids: 187.0;Exocrine glandular cells: 176.6;Hepatocytes: 214.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	10.9	21.6	22.2	18.5	24.4	22.4	23.6	30.2	30.0	12.8	20.1	38.5	31.2	10.9	40.0	32.6	11.4	10.6	9.4	22.7	27.6	27.0	231.3	20.2	25.0	39.4	26.3	17.3	9.4	12.5	3.2	11.8	39.1	35.6	33.8	19.5	15.5	9.3	4.9	18.1	17.9	15.8	24.8	9.7	19.5	28.6	24.4	39.4	9.0	7.1	36.7	13.7	9.1	28.1	70.1	58.8	451.9	160.8	57.2	111.6	14.4	57.4	70.5	141.8	244.5	234.0	87.1	55.9	29.0	48.7	458.2	64.5	174.8	465.8	166.7	35.2	174.4	127.4	97.2	418.8	62.0	81.4	35.8	62.2	40.1	231.1	92.9	21.4	68.8	160.1	139.9	104.3	85.5	113.0	137.0	154.0	142.8	65.5	41.7	83.9	94.4	173.1	377.2	93.7	107.8	63.2	67.5	43.3	26.2	18.5	83.4	157.3	39.2	50.3	45.7	72.1	154.0	47.7	89.0	142.0	15.7	151.2	77.1	30.1	24.9	46.7	47.9	33.9	47.3	46.6	54.1	47.8	34.7	51.4	53.3	43.2	11.0	41.3	23.6	30.4	79.0	46.2	22.2	24.4	30.2	30.0	22.7	27.6	39.4	26.3	39.1	24.8	24.4	28.1	11.8	12.8	45.4	15.3	25.8	26.1	32.4	262.1	22.2	19.4	33.4	24.5	1.2	42.9	115.5	20.2	2.1	53.7	28.6	34.7	70.5	78.8	187.0	14.3	9.9	18.8	17.2	38.5	14.3	176.6	97.0	21.6	9.7	25.9	13.3	47.7	16.1	214.8	58.1	13.5	14.7	23.6	83.4	14.8	29.8	128.8	13.7	25.7	30.2	1.0	58.9	22.5	30.9	13.0	17.5	65.6	28.8	19.2	25.5	38.7	15.4	50.0	30.1	24.7	0.0	25.1	44.9	28.5	45.6	43.0	21.0	35.2	31.0	102.5	33.0	38.9
ACBD4	FLJ13322	ENSG00000181513	"Acyl-CoA binding domain containing 4"	Q8NC06	17	45132600-45144181	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.0"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051772	Approved		Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Vesicles"		"HPA051772: AB_2681603"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (2.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.53e-4)"	11.1	17.2	14.4	6.3	14.1	4.1	12.9	13.9	16.6	19.1	13.1	21.2	29.9	14.4	4.0	7.1	22.3	6.6	11.8	13.4	13.9	24.6	93.0	9.6	9.9	14.2	14.0	19.3	20.0	14.5	15.8	4.3	13.4	21.6	5.7	10.3	14.1	12.2	6.8	9.0	25.9	5.7	14.5	16.2	14.7	4.2	14.2	5.4	21.1	5.1	6.4	15.7	13.6	13.2	7.9	15.4	1.9	4.2	3.5	6.4	5.1	2.9	6.1	4.7	9.2	6.0	10.8	8.4	7.4	4.3	2.8	7.3	2.6	4.8	1.9	12.2	5.9	4.2	11.3	12.0	7.5	1.6	11.1	6.4	4.6	1.7	2.4	16.1	4.6	7.7	2.7	13.1	2.3	5.3	6.0	2.1	0.3	8.3	4.2	4.8	0.5	18.8	11.8	5.1	3.1	1.4	2.1	3.1	8.9	1.0	20.1	3.0	1.7	1.2	3.6	1.8	1.8	20.4	5.9	2.6	6.8	2.1	2.0	4.4	2.3	3.5	2.9	2.6	3.2	3.7	3.4	3.2	2.0	5.0	3.7	4.3	0.5	4.0	1.7	1.3	4.3	3.2	14.4	14.1	13.9	16.6	13.4	13.9	14.2	14.0	13.4	14.5	14.2	13.2	5.7	3.2	3.0	12.4	7.8	1.9	5.9	3.9	2.8	16.6	7.4	6.9	9.7	14.3	2.6	3.7	22.9	6.3	5.9	9.6	7.9	7.3	1.4	2.0	2.7	5.3	6.0	2.1	7.2	7.1	1.3	7.3	4.6	3.6	8.2	7.4	5.0	21.8	5.3	11.8	8.5	7.8	6.1	1.9	2.6	5.0	6.8	3.1	3.6	2.8	4.5	14.7	5.2	4.5	1.9	5.6	12.5	7.5	5.2	3.1	56.8	25.6	2.6	16.8	6.6	8.7	7.7	2.5	5.2	3.1	1.8	6.3	6.4	4.4	9.1	2.8
ACCSL		ENSG00000205126	"1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like"	Q4AC99	11	44047981-44059977	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.0;Excitatory neurons: 2.6;Inhibitory neurons: 2.7;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.8"	"Cancer enriched"	"Detected in single"	22	"melanoma: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA065042			Approved	Cytosol		NA	NA						"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA065042: "					"unprognostic (2.37e-2)"				"unprognostic (2.91e-1)"				"unprognostic (9.76e-5)"	"unprognostic (7.42e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866917-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	64.9	30.2	24.0	43.9	27.2	34.7	46.7	33.6	55.5	33.2	22.5	35.4	49.3	34.4	34.7	30.5	36.0	31.1	27.1	24.7	66.5	47.5	27.5	35.3	42.7	80.3	48.6	21.3	46.3	37.4	22.4	42.4	76.5	62.6	35.7	23.2	39.1	28.5	15.3	28.9	43.7	42.5	34.2	39.1	38.9	32.2	43.1	48.4	30.8	14.9	40.3	36.7	29.2	43.7	127.1	423.2	194.8	168.8	296.1	274.4	178.3	174.0	188.0	213.7	266.3	217.9	141.8	204.7	108.8	245.2	200.6	197.2	253.9	298.0	177.8	184.9	243.0	117.3	228.3	227.5	136.9	191.9	147.1	219.8	88.3	376.9	75.6	140.0	228.7	155.0	147.4	158.5	180.4	130.0	317.8	107.6	127.6	84.8	75.7	205.2	236.2	262.2	221.0	222.4	364.7	200.2	124.5	382.8	133.7	167.6	229.4	181.0	248.4	165.7	135.5	169.0	291.0	91.9	127.0	193.0	280.3	145.7	137.5	32.2	29.2	36.5	30.9	30.9	29.1	21.6	24.4	27.7	33.0	18.3	18.1	20.3	14.6	24.0	39.8	19.1	34.3	33.8	24.0	27.2	33.6	55.5	24.7	66.5	80.3	48.6	76.5	34.2	43.1	43.7	28.2	28.9	26.2	12.4	20.5	25.0	10.0	25.4	12.5	12.1	38.6	21.6	12.6	31.5	21.0	23.9	4.2	22.6	25.9	26.7	11.7	33.8	73.3	31.6	35.3	33.4	65.9	34.3	10.9	33.6	46.5	28.9	23.4	29.2	15.2	28.7	41.4	53.0	31.0	18.5	14.7	54.0	20.3	39.0	25.9	17.5	61.8	27.6	32.0	16.9	42.9	7.6	25.7	11.6	13.6	42.9	16.2	51.1	17.4	35.9	40.4	87.0	31.1	9.4	13.1	17.6	25.7	17.9	36.0	21.6	33.0	22.2	25.1	49.0	22.2	15.5
ACMSD		ENSG00000153086	"Aminocarboxymuconate semialdehyde decarboxylase"	Q8TDX5	2	134838616-134902034	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"kidney: 141.1;liver: 162.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 120.2;Proximal tubular cells: 408.1"	"Group enriched"	"Detected in some"	23	"liver cancer: 21.2;renal cancer: 19.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"RPTEC TERT1: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010533, HPA011179"	Enhanced		Approved	Cytosol		NA	NA		12000	"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA010533: AB_1844517, HPA011179: AB_1844516"	"unprognostic (1.06e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (2.39e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.65e-5)"	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	7.1	0.2	0.0	0.3	141.1	162.5	0.1	0.3	0.8	0.2	0.7	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.6	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.3	0.8	0.3	1.2	0.2	0.5	0.1	0.6	0.3	26.7	0.4	1.0	0.3	0.1	0.3	0.4	0.8	0.2	0.7	1.0	0.0	0.4	0.2	0.8	0.2	0.1	0.5	0.2	0.3	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.3	0.0	0.3	0.8	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.2	50.1	0.0	9.2	0.0	0.0	0.0	0.0	54.8	0.2	0.0	0.0	0.1	0.0	0.0	2.7	8.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	120.2	0.0	0.0	7.3	0.0	0.0	1.9	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.0	0.0	2.5	1.9	0.1	0.0	0.0	0.0	0.0	0.0	408.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6393767	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 128.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 137.2;Late spermatids: 160.8;Proximal enterocytes: 179.4;Proximal tubular cells: 253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"NK-cell: 40.2;plasmacytoid DC: 35.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 35.7;NK-cells: 40.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		26000	"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	11.3	20.4	72.8	18.7	72.8	14.7	9.9	56.2	108.2	17.8	16.7	32.7	55.1	18.2	5.5	35.0	11.0	8.2	17.3	75.1	107.2	47.8	22.0	17.9	22.4	96.1	88.5	11.2	9.0	3.8	65.1	10.4	128.7	12.9	21.4	24.5	11.9	6.9	5.2	27.1	56.1	23.5	46.9	20.7	19.2	38.1	83.9	28.3	6.1	4.7	19.4	18.0	23.5	68.4	117.6	100.0	96.6	104.6	21.7	35.6	36.4	98.6	50.6	142.7	85.1	347.7	37.0	142.4	70.6	80.4	110.3	113.0	156.9	263.2	53.2	126.0	136.7	75.2	74.4	124.9	88.7	88.8	59.9	32.1	49.6	118.2	139.2	38.1	81.2	174.8	62.3	29.8	76.8	136.6	187.0	94.0	48.5	116.9	228.2	219.9	110.6	95.6	80.9	44.2	52.6	149.1	88.9	134.5	317.9	47.3	47.9	41.2	133.0	129.1	75.4	129.6	158.9	24.9	110.6	202.1	81.8	153.7	80.3	0.0	0.3	0.2	7.3	1.2	1.8	2.1	5.8	6.2	5.4	0.7	2.0	3.9	0.7	40.2	0.9	35.7	8.2	5.3	72.8	72.8	56.2	108.2	75.1	107.2	96.1	88.5	128.7	46.9	83.9	68.4	3.4	6.4	16.4	9.4	4.9	31.7	16.5	24.2	12.5	46.8	4.1	7.5	9.8	8.6	14.9	9.2	10.4	20.9	14.4	45.4	15.6	22.7	95.5	4.0	6.1	19.1	4.8	26.5	38.6	7.2	29.7	11.5	19.9	7.6	137.2	13.2	8.6	16.8	30.1	47.1	38.9	110.2	36.7	4.8	85.9	160.8	3.7	13.4	39.2	5.6	15.7	12.8	8.2	22.6	21.0	23.2	41.8	7.2	9.3	9.5	179.4	253.7	7.1	24.4	0.0	6.7	17.6	37.8	28.0	26.2	29.5	17.2	21.7	13.7	51.3	19.6
ACOX3		ENSG00000087008	"Acyl-CoA oxidase 3, pristanoyl"	O15254	4	8366282-8440723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035840, HPA035841"	Uncertain		Supported	Peroxisomes		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Peroxisomes		"HPA035840: AB_10696514, HPA035841: AB_10671940"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	7.7	8.8	5.8	6.4	5.2	4.4	12.2	3.8	7.2	9.5	5.9	8.4	8.9	5.6	4.3	26.6	6.6	5.9	16.2	5.3	4.9	6.5	14.9	7.2	6.6	5.9	4.6	7.5	12.0	7.1	4.5	8.4	4.7	10.5	6.3	3.8	15.4	8.4	6.4	12.5	8.9	11.4	4.2	5.3	10.1	2.9	5.0	4.6	8.5	5.6	8.5	10.1	13.7	7.1	8.9	9.6	10.5	14.1	11.0	18.7	17.2	11.1	15.1	18.5	16.1	4.8	11.7	11.9	11.7	22.8	25.0	5.4	4.6	14.4	14.3	4.1	4.5	5.2	8.2	14.8	18.3	10.7	9.4	18.9	12.1	16.7	6.5	13.3	22.1	13.1	7.0	10.6	16.1	8.2	11.4	15.6	5.9	11.3	16.4	11.8	17.3	14.3	11.2	12.4	5.1	11.7	14.2	7.2	7.3	8.6	7.2	14.9	21.7	18.2	5.9	7.5	11.8	7.9	5.6	5.4	23.2	13.1	11.8	0.1	13.2	3.3	6.1	15.2	6.3	5.4	7.1	7.8	17.8	4.9	6.5	6.7	3.1	9.5	14.4	21.4	10.4	9.4	5.8	5.2	3.8	7.2	5.3	4.9	5.9	4.6	4.7	4.2	5.0	7.1	6.2	6.4	5.9	14.7	4.8	4.5	7.6	12.3	8.6	8.2	11.6	7.6	9.4	10.0	9.8	11.0	33.3	23.9	7.7	10.9	3.9	17.3	4.4	13.1	4.2	5.6	1.8	3.0	13.2	13.7	9.3	6.6	10.2	10.0	0.0	21.7	4.6	14.2	10.2	1.7	14.2	4.9	14.2	4.1	4.4	3.3	6.8	5.3	5.4	6.5	7.6	3.8	2.1	12.5	14.5	16.9	7.4	11.3	5.6	9.1	18.3	8.2	11.2	18.6	0.0	3.8	6.9	2.4	2.3	14.1	5.8	74.6	6.0	6.0	7.5	11.4
ACSBG2	"BGR, DKFZp434K1635, PRTD-NY3"	ENSG00000130377	"Acyl-CoA synthetase bubblegum family member 2"	Q5FVE4	19	6135247-6193094	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	89	"testis: 129.3"	"Group enriched"	"Detected in some"	75	"Early spermatids: 533.6;Late spermatids: 1782.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043421, HPA051013"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA043421: AB_10794182, HPA051013: AB_2681311"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.96e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.70e-4)"	0.1	0.0	0.2	0.0	0.2	0.0	0.2	1.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	129.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.2	0.3	0.1	0.7	0.3	0.2	0.1	0.2	0.9	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	533.6	0.0	0.1	0.6	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	1782.3	11.8	0.8	0.0	1.9	0.0	0.0	0.0	1.5	3.1	0.0	0.0	7.2	0.0	0.0	0.0	1.9	0.0	0.0	6.6	0.0	0.1	15.4	9.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 217.8;intestine: 418.0;liver: 165.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 87.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	23.8	4.2	13.1	29.0	12.6	16.2	21.3	13.0	15.5	51.4	10.4	111.7	358.9	30.3	217.8	7.9	45.0	21.5	9.4	12.1	13.4	9.0	165.5	35.6	28.0	14.4	13.1	17.0	5.5	2.2	2.6	8.6	14.9	12.3	116.6	1.5	5.5	20.3	3.9	3.4	418.0	15.5	14.0	25.7	44.2	9.6	15.3	16.4	7.2	8.8	28.0	76.3	7.6	13.2	38.6	0.9	0.7	0.1	2.5	0.4	3.3	1.1	7.3	0.3	0.6	34.8	138.8	46.7	8.4	1.9	6.8	0.3	0.0	0.2	0.8	39.4	0.0	36.5	1.3	60.9	8.8	57.3	59.2	5.9	0.0	0.8	0.0	2.7	2.8	0.0	0.1	20.6	0.1	0.0	0.1	26.3	0.1	32.2	1.3	12.9	0.2	28.6	3.8	143.3	0.1	0.9	55.8	21.0	0.1	0.1	0.1	31.7	40.5	0.5	0.4	2.2	2.5	14.8	0.1	22.6	1.2	70.5	0.1	27.4	15.1	27.5	25.2	27.9	24.9	16.3	20.4	27.8	31.1	13.1	13.8	21.4	3.9	26.1	27.7	9.8	41.5	21.1	13.1	12.6	13.0	15.5	12.1	13.4	14.4	13.1	14.9	14.0	15.3	13.2	23.4	12.8	51.3	0.0	20.1	3.8	10.3	10.7	8.6	0.1	7.0	4.6	1.7	12.8	23.6	0.0	4.2	1.8	10.5	164.9	0.0	13.3	92.6	159.9	37.6	24.7	40.8	10.7	1.3	6.4	2.6	5.7	41.8	292.3	17.2	0.5	16.1	88.6	18.9	0.0	1.1	79.0	0.0	22.4	57.8	42.6	15.8	24.9	3.6	17.8	11.5	0.1	16.5	1.0	1.0	48.0	122.4	12.0	20.3	7.1	462.5	0.2	8.2	1.2	0.0	0.8	3.3	4.0	1.9	3.3	1.7	0.7	24.0	6.4	103.3	50.0
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261210	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 46.5;Astrocytes: 167.8;Early spermatids: 52.9;Hepatocytes: 53.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"basophil: 7.0;neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3;ASC TERT1: 16.1;Hep G2: 42.6;hTERT-RPE1: 14.0;RH-30: 19.1;SK-BR-3: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	22.7	14.5	5.2	1.5	5.1	0.1	7.3	5.2	5.3	8.3	9.3	2.2	0.7	9.1	12.1	1.5	8.0	8.1	6.8	4.7	4.9	25.9	40.0	6.4	1.5	5.5	6.4	16.7	2.0	13.7	4.4	4.0	5.2	5.7	1.0	4.8	12.1	5.5	3.5	1.7	1.5	6.3	4.9	2.1	1.4	2.3	6.5	1.1	8.8	5.7	1.1	2.8	5.0	5.5	0.0	0.2	3.4	0.0	14.3	16.1	0.1	2.2	11.0	1.7	1.9	0.4	0.1	0.0	0.0	5.0	5.2	0.1	0.0	0.0	1.0	0.0	2.2	0.0	0.0	42.6	4.8	0.1	0.0	10.8	0.0	0.5	0.0	14.0	0.4	0.0	0.0	0.0	7.8	1.0	0.1	0.2	4.8	0.0	0.0	0.0	19.1	2.7	0.1	0.1	3.1	0.0	0.0	18.0	0.1	7.1	7.9	0.5	0.0	2.8	2.7	0.2	1.2	0.1	0.1	0.1	3.5	0.0	3.4	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	5.2	5.1	5.2	5.3	4.7	4.9	5.5	6.4	5.2	4.9	6.5	5.5	1.3	22.4	46.5	167.8	0.2	0.9	9.5	0.0	2.2	37.8	5.6	3.0	21.8	14.3	3.2	12.9	4.2	1.5	0.1	0.1	5.9	6.4	52.9	3.9	14.8	1.5	0.0	0.0	1.5	2.9	0.8	12.1	0.0	2.7	0.0	8.8	1.8	53.6	0.7	28.6	1.6	0.1	0.0	3.2	0.6	9.4	23.9	0.8	0.0	35.6	0.1	16.4	0.0	16.6	0.7	0.1	0.1	23.7	0.0	3.0	1.1	31.7	3.7	5.3	6.6	18.6	9.9	4.6	0.6	0.4	0.1	0.5	0.6	13.2	1.2	3.7
ACTL6B	"ACTL6, BAF53B"	ENSG00000077080	"Actin like 6B"	O94805	7	100643097-100656448	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 20.7;pituitary gland: 15.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.0;Excitatory neurons: 22.1;Horizontal cells: 6.7;Inhibitory neurons: 19.0"	"Group enriched"	"Detected in some"	11	"glioma: 3.9;pancreatic cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	76	"SCLC-21H: 28.5;SH-SY5Y: 28.7"	"Low region specificity"	"Detected in all"							HPA045126	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli rim, Mitotic chromosome"		"HPA045126: AB_10961265"	"unprognostic (3.31e-2)"	"unprognostic (6.89e-2)"		"unprognostic (4.59e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.27e-3)"	"unprognostic (4.81e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-4)"	"unprognostic (1.64e-1)"	"unprognostic (6.84e-2)"		"unprognostic (2.01e-2)"	0.0	1.8	13.8	0.0	14.5	0.0	0.0	9.4	20.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.9	8.5	0.0	0.0	0.0	0.0	4.4	1.8	0.0	0.8	0.1	15.3	0.0	4.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.5	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.5	9.4	20.7	14.9	8.5	4.4	1.8	4.3	1.7	3.9	11.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	8.0	0.0	0.1	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	22.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	19.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	0.0	1.2	0.0	3.5	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ACTL8	CT57	ENSG00000117148	"Actin like 8"	Q9H568	1	17755333-17827063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"testis: 7.1"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 50.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"U-266/84: 245.3"					"Not detected"	"Not detected"			HPA027176			Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA027176: AB_1844553"	"unprognostic (1.79e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.89e-1)"		"unprognostic (1.43e-1)"	"unprognostic (5.49e-2)"		"unprognostic (4.68e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.4	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.2	0.0	11.0	0.3	0.2	0.6	0.0	1.5	0.0	0.0	0.1	1.4	0.0	0.5	1.4	0.0	3.3	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.5	13.3	0.0	2.4	0.0	0.0	9.2	5.9	0.1	0.0	0.0	27.5	0.0	0.0	0.4	0.0	0.0	5.2	0.5	0.0	0.5	0.4	0.0	0.0	0.1	1.9	0.2	0.1	245.3	0.1	4.9	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	50.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0
ACTR6	"ARP6, FLJ13433"	ENSG00000075089	"Actin related protein 6"	Q9GZN1	12	100199122-100241865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038587, HPA038588"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA038587: AB_10670781, HPA038588: AB_10672719"	"unprognostic (1.24e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (7.70e-9)"	"unprognostic (4.11e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.40e-2)"	15.0	16.7	17.6	12.8	17.7	7.4	28.9	18.2	24.5	13.9	17.9	14.6	15.2	15.2	18.1	13.8	14.2	10.3	17.5	18.2	19.8	22.1	19.6	12.2	20.8	18.0	18.6	17.9	5.0	20.8	4.5	17.0	19.1	16.8	15.3	20.6	15.3	15.9	14.3	13.6	14.4	14.4	18.3	16.1	10.6	21.3	17.7	20.4	16.3	15.8	19.2	17.1	4.5	20.8	60.2	23.5	27.1	35.9	22.4	28.3	63.3	26.0	22.6	25.0	18.2	15.2	17.8	32.9	24.7	19.5	18.8	23.0	36.5	22.5	34.3	48.9	33.8	22.8	22.2	17.7	23.6	33.7	17.7	17.4	27.7	20.2	25.8	38.5	28.9	38.0	36.9	10.5	29.2	15.5	33.7	50.8	31.6	22.5	34.2	27.0	27.3	41.4	27.3	35.8	24.8	47.0	35.3	62.5	36.5	22.4	40.6	39.5	18.8	18.4	12.3	20.5	23.7	23.6	55.6	42.8	12.1	21.2	21.7	5.7	6.4	10.0	15.2	11.5	19.3	12.6	17.9	20.3	8.2	12.1	19.4	19.6	3.0	19.4	13.2	12.0	20.5	12.1	17.6	17.7	18.2	24.5	18.2	19.8	18.0	18.6	19.1	18.3	17.7	20.8	33.5	16.0	17.7	6.5	25.8	22.9	36.2	72.4	29.6	32.7	26.5	23.9	34.8	8.6	38.1	23.9	18.8	55.6	36.9	9.9	46.9	21.4	135.2	56.8	27.7	20.7	12.5	21.7	20.9	12.0	68.4	25.0	12.2	28.9	33.0	19.1	16.1	16.4	23.7	33.7	23.2	11.3	73.2	19.1	13.4	34.3	20.2	17.5	32.0	13.1	19.5	27.0	25.7	17.1	17.4	13.2	10.0	22.6	19.7	24.7	11.7	67.9	67.9	32.8	32.9	27.8	36.8	80.8	19.9	23.8	19.7	96.0	36.6	23.8	13.3	33.8
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157876330	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 6.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: AB_2732526"	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.17e-4)"	20.8	10.4	17.3	12.9	12.7	1.8	18.8	14.0	15.4	28.1	17.4	16.5	10.9	24.4	32.7	11.3	17.0	24.2	19.7	26.3	12.8	26.4	22.7	17.5	8.8	13.7	12.9	21.2	10.0	8.5	10.9	17.6	13.7	15.1	12.6	6.3	18.8	15.3	21.5	13.9	10.5	34.5	12.6	8.3	14.7	5.2	16.3	7.5	40.5	13.3	8.2	20.9	15.5	11.8	6.1	13.1	14.4	18.5	65.0	70.6	18.9	43.4	71.3	33.7	36.1	10.1	13.4	0.2	18.2	45.6	32.3	16.9	10.5	22.5	36.8	43.0	8.7	25.7	7.2	14.4	54.7	2.0	28.5	89.5	41.4	69.8	84.2	42.8	38.7	6.7	9.5	6.7	45.2	11.1	0.4	0.4	21.4	8.7	21.7	4.1	19.6	5.7	45.4	24.5	12.4	14.9	17.0	9.7	64.5	22.2	5.3	7.0	54.0	50.9	16.8	25.3	17.1	4.7	3.5	0.3	52.2	1.6	58.1	2.9	1.7	0.1	0.5	1.0	0.7	0.8	4.9	1.3	1.3	0.2	1.6	0.7	0.2	1.2	1.4	1.4	6.6	1.1	17.3	12.7	14.0	15.4	26.3	12.8	13.7	12.9	13.7	12.6	16.3	11.8	9.6	9.6	9.0	22.9	1.8	9.8	7.7	12.6	12.5	10.4	8.0	9.8	12.7	11.5	12.4	7.3	0.0	8.4	1.1	4.8	5.9	9.9	1.0	5.9	12.9	17.3	4.2	1.7	34.0	17.8	5.3	20.3	8.2	6.5	5.1	4.2	18.2	13.3	7.0	3.3	34.2	4.5	24.4	13.0	8.7	2.0	20.2	7.6	3.6	106.8	5.5	6.6	2.1	42.3	22.9	17.2	4.1	15.8	6.4	13.0	3.7	15.5	13.6	2.1	13.1	16.3	19.3	0.4	2.7	4.0	7.5	10.5	4.3	3.5	4.3	8.8
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053237-75069483	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		89000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	13.7	38.4	46.2	15.2	48.6	21.1	22.1	49.9	65.5	17.3	50.8	21.5	15.6	14.4	36.7	20.8	29.6	10.2	17.0	45.0	54.0	29.1	9.6	19.7	27.7	50.7	49.7	13.6	12.4	21.1	36.5	15.3	51.8	17.3	26.9	44.0	15.8	15.0	34.0	35.0	21.1	15.6	46.6	16.5	19.3	26.9	50.4	39.7	30.1	21.1	28.1	16.1	17.6	56.0	78.9	43.1	60.9	37.4	24.5	26.6	32.6	44.7	17.2	45.5	63.5	42.8	86.9	86.5	26.4	18.2	25.7	68.1	39.9	19.1	73.8	127.8	49.3	57.6	123.6	32.1	14.3	36.6	56.8	14.9	27.7	61.5	30.0	28.8	60.0	80.9	45.2	103.0	60.0	52.3	82.7	67.7	18.6	67.6	40.8	64.7	80.8	41.2	62.2	39.0	112.0	44.5	29.5	20.8	74.2	29.1	44.5	35.4	27.3	29.5	55.6	61.3	48.4	23.8	52.4	94.6	46.1	42.5	32.8	5.3	2.8	17.5	10.9	6.2	12.7	13.7	18.3	12.9	5.1	14.1	15.4	14.5	1.2	14.0	10.5	10.3	24.6	6.7	46.2	48.6	49.9	65.5	45.0	54.0	50.7	49.7	51.8	46.6	50.4	56.0	18.5	6.4	9.1	17.0	18.2	28.7	44.4	54.1	30.1	38.6	20.8	24.0	21.2	31.5	28.9	66.2	12.5	27.3	18.7	24.5	39.2	20.6	31.6	89.2	18.4	26.5	30.1	47.5	17.8	18.7	33.7	22.7	13.7	17.8	12.0	19.8	10.4	5.7	22.3	43.7	25.0	25.2	73.2	6.6	11.7	11.0	16.8	12.3	39.2	15.9	10.1	23.2	16.5	16.1	44.4	20.2	20.6	16.6	16.9	20.2	16.7	22.3	137.9	32.4	26.3	11.1	31.5	89.8	14.1	23.8	24.0	13.7	22.3	20.4	33.8	34.4
ADA	ADA1	ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 507.2;lymphoid tissue: 259.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.4;Extravillous trophoblasts: 128.2;NK-cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 168.5;NK-cell: 94.5;non-classical monocyte: 362.8;plasmacytoid DC: 218.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 218.6;monocytes: 362.8;NK-cells: 94.5"	"Group enriched"	"Detected in many"	5	"JURKAT: 570.9;MOLT-4: 1915.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (6.77e-5)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	16.6	6.3	6.9	18.5	8.2	20.2	10.9	6.8	9.4	7.3	5.6	5.7	507.2	3.8	1.7	9.0	5.6	9.2	17.8	6.9	7.0	3.3	4.4	6.2	33.4	7.2	8.2	2.1	5.3	1.5	1.3	4.6	7.2	4.3	3.6	0.3	4.7	2.8	5.3	6.0	17.9	5.7	6.1	17.5	46.0	2.4	8.7	259.0	5.8	6.4	26.4	9.3	5.4	8.8	14.0	37.7	19.2	13.2	35.6	48.7	30.5	13.7	7.8	13.2	9.3	17.5	14.8	38.4	15.8	17.9	24.7	2.2	13.2	55.1	7.3	2.9	17.2	7.8	6.6	13.5	15.0	6.3	20.3	234.3	23.2	5.1	9.0	12.6	50.3	570.9	20.4	30.7	6.0	33.1	1915.5	28.9	5.2	17.2	13.5	102.3	25.8	95.0	2.3	0.0	0.7	9.3	20.2	4.4	24.2	24.0	4.5	19.1	16.9	10.1	18.6	20.5	2.8	40.1	27.3	82.3	3.5	32.5	9.0	0.5	9.8	1.2	43.3	168.5	27.8	7.5	35.5	51.0	35.2	7.6	27.3	38.6	2.5	94.5	362.8	218.6	29.8	57.4	6.9	8.2	6.8	9.4	6.9	7.0	7.2	8.2	7.2	6.1	8.7	8.8	18.2	0.0	1.9	2.9	13.5	12.9	3.4	10.0	13.6	0.0	2.7	3.2	2.1	0.0	4.8	1.8	0.0	2.9	76.4	0.8	0.0	3.7	0.4	0.7	9.1	17.0	0.0	10.7	0.2	19.7	128.2	19.7	14.8	0.8	0.0	3.5	7.1	3.6	28.5	0.0	0.2	1.5	10.2	20.8	25.5	1.8	42.3	27.6	8.8	3.7	37.4	3.8	56.7	0.5	9.4	10.7	0.3	2.6	31.4	6.0	0.7	3.0	2.4	0.0	13.1	1.9	14.1	0.3	6.2	12.9	13.9	3.7	30.9	6.8	4.9	2.7
ADAL		ENSG00000168803	"Adenosine deaminase like"	Q6DHV7	15	43330672-43354569	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 81.3;Rod photoreceptor cells: 84.8;Spermatocytes: 99.5;Spermatogonia: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039879, HPA048175, HPA058795"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear speckles, Vesicles"	"HPA039879: , HPA048175: AB_2680298, HPA058795: "	"unprognostic (1.65e-2)"	"unprognostic (1.53e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (7.64e-9)"	"unprognostic (2.37e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.44e-2)"	6.2	6.6	6.7	4.2	7.1	4.4	5.9	7.6	9.6	3.6	10.2	5.7	5.8	4.3	8.4	4.1	3.3	3.8	20.9	6.3	7.4	11.9	8.2	3.5	4.8	6.7	7.2	3.6	3.6	10.4	6.1	2.7	7.0	6.2	4.8	21.2	4.2	6.4	20.4	2.6	4.6	4.7	6.9	3.8	4.0	11.1	7.1	5.4	10.9	23.4	4.8	4.6	3.0	7.4	6.8	3.4	13.3	15.1	5.5	7.1	6.3	8.1	8.2	12.6	19.3	14.2	3.5	8.0	13.0	8.9	16.7	7.5	0.0	5.7	10.8	8.5	8.0	19.0	23.1	12.0	6.9	0.0	14.8	9.1	10.3	8.5	8.7	8.1	2.7	19.4	21.1	16.2	13.2	4.6	12.3	9.7	5.5	7.8	4.6	15.9	19.9	12.7	11.0	4.1	16.3	11.6	13.1	11.7	12.4	7.2	12.5	12.5	3.7	21.9	10.6	16.6	16.5	16.6	29.9	3.4	12.2	21.2	18.1	5.9	1.4	3.8	2.4	2.0	1.8	2.0	2.2	1.9	2.0	1.6	2.3	2.9	1.1	2.3	1.9	2.9	4.5	1.3	6.7	7.1	7.6	9.6	6.3	7.4	6.7	7.2	7.0	6.9	7.1	7.4	5.9	9.6	10.3	32.7	10.0	7.0	7.4	9.3	7.4	40.7	9.2	9.9	51.2	10.0	6.9	18.4	81.3	7.1	13.3	7.0	58.7	8.9	17.6	10.6	10.3	8.2	7.7	19.1	24.4	8.5	7.0	10.4	5.1	6.8	7.6	15.7	11.0	30.8	8.9	42.1	26.7	7.2	10.2	8.8	7.0	12.7	9.6	8.9	8.8	10.3	5.4	35.5	24.7	19.1	18.3	5.7	1.3	8.6	6.9	7.1	13.0	29.0	10.9	84.8	6.6	11.6	7.3	99.5	82.5	8.8	4.4	2.6	7.0	12.6	11.6	4.4
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9556732	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	10.3	5.5	8.7	9.1	8.6	5.8	10.4	7.8	10.6	8.7	9.5	5.4	4.1	7.2	11.4	10.0	6.5	9.0	6.7	8.6	9.4	4.7	4.6	14.6	8.5	9.7	8.3	8.9	4.1	7.9	4.2	20.1	9.4	4.0	6.8	4.5	6.2	6.3	6.9	11.1	6.1	8.6	8.3	9.3	5.1	9.9	9.1	9.6	6.6	6.8	12.7	10.4	7.1	10.4	10.0	18.2	23.2	25.9	45.9	34.7	45.4	8.6	25.4	16.1	24.6	19.2	31.6	33.4	18.1	18.8	42.1	21.9	16.4	29.4	22.6	8.4	12.1	15.8	14.7	13.9	68.0	20.7	17.8	41.2	32.2	25.1	47.5	26.6	46.0	8.7	30.0	12.3	17.3	8.7	8.5	23.4	19.2	13.7	4.6	14.3	21.6	20.5	25.8	18.7	11.7	28.6	14.9	16.5	30.1	27.0	6.6	19.4	29.0	25.5	12.0	19.1	22.1	15.1	17.5	29.6	20.2	11.1	31.1	5.0	3.7	2.8	1.0	3.7	1.9	1.7	0.9	1.1	2.3	0.9	0.9	1.0	5.5	1.2	2.5	0.7	1.1	0.9	8.7	8.6	7.8	10.6	8.6	9.4	9.7	8.3	9.4	8.3	9.1	10.4	53.8	48.1	66.9	19.6	34.5	130.0	48.2	37.0	19.9	25.2	40.8	26.4	3.6	27.1	38.8	31.3	54.2	29.8	37.7	20.7	5.9	23.7	72.1	30.0	32.0	45.1	19.7	16.8	66.7	19.4	45.1	44.1	13.7	51.5	30.9	31.3	41.4	13.5	34.6	10.1	46.2	13.8	12.2	80.4	84.5	16.0	19.0	76.9	40.9	42.2	40.3	12.9	16.5	26.7	41.5	20.9	18.3	16.1	23.2	57.2	12.9	7.0	37.2	41.4	39.5	79.4	27.3	35.7	35.2	33.7	154.7	56.0	30.1	17.7	15.4	104.3
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 63.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.0;Early spermatids: 19.3;Excitatory neurons: 12.4;Inhibitory neurons: 12.4;Late spermatids: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1300000000	120000000	"Cluster 34: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	2.5	2.8	6.9	0.5	7.3	0.6	2.8	7.6	10.0	5.0	5.3	4.3	3.2	4.2	2.9	2.4	5.7	1.2	6.0	7.1	6.2	9.6	63.8	2.8	0.9	7.0	6.7	6.7	6.2	1.5	12.5	0.8	7.1	6.4	0.9	1.1	2.5	1.4	4.3	2.6	4.4	0.6	6.3	2.6	9.8	13.5	7.2	0.8	6.1	1.4	0.5	4.4	3.1	7.1	0.0	0.8	1.9	2.6	1.5	1.3	0.8	0.7	0.5	0.2	0.3	0.3	2.1	0.2	0.9	0.4	0.6	0.3	0.1	0.4	0.1	1.2	1.7	0.2	0.9	0.4	1.1	0.0	0.7	3.6	0.9	0.2	0.7	1.2	0.1	1.3	0.0	0.8	0.3	3.3	0.0	0.9	2.0	1.1	1.1	0.2	0.2	0.9	0.8	0.8	1.3	4.0	1.4	0.6	1.2	3.9	3.7	0.4	0.5	1.5	0.8	0.9	0.0	1.7	0.3	0.3	1.1	0.2	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	7.3	7.6	10.0	7.1	6.2	7.0	6.7	7.1	6.3	7.2	7.1	0.9	0.0	2.0	16.0	1.2	0.3	0.3	0.9	0.0	1.7	1.4	1.9	4.2	4.3	2.4	0.0	0.0	0.2	0.2	1.0	1.9	0.6	19.3	3.6	1.6	0.9	1.2	0.0	12.4	0.4	0.3	1.5	4.6	3.3	0.0	3.0	5.0	1.6	0.2	3.3	12.4	1.3	0.0	0.6	0.0	13.6	0.9	0.3	0.0	7.5	0.0	1.7	0.0	2.0	5.5	0.3	3.0	1.5	0.4	0.4	1.5	0.9	0.7	1.8	0.0	0.4	0.7	6.0	3.9	0.3	0.4	0.1	0.5	1.7	0.9	0.3
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;ovary: 10.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 7.3;Excitatory neurons: 44.7;Fibroblasts: 13.7;Granulosa cells: 22.2;Theca cells: 15.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.9;SuSa: 3.5;U-2197: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	5.4	0.2	1.4	0.4	1.9	0.5	0.7	17.0	2.6	1.4	0.0	0.7	0.6	1.3	1.6	1.5	0.7	6.4	0.2	3.4	0.0	3.5	0.4	0.7	0.2	0.2	0.2	10.4	4.5	0.1	0.0	0.2	0.7	0.1	0.3	1.2	0.2	0.5	0.2	0.4	0.5	1.1	0.0	0.2	0.2	0.4	0.0	0.2	0.3	0.2	0.1	1.0	0.6	1.8	1.7	1.7	1.7	0.1	0.1	0.3	0.2	0.0	0.0	0.4	0.5	0.0	1.4	0.1	2.1	0.0	3.0	0.1	0.0	0.0	0.4	0.1	0.9	0.3	2.8	0.0	0.0	0.2	0.0	0.0	0.0	3.9	0.1	0.5	0.0	0.3	0.6	0.4	0.7	0.0	0.4	0.2	1.1	0.0	1.6	0.4	2.2	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	3.5	0.1	0.1	0.1	2.1	3.0	5.8	1.4	0.9	0.3	0.1	3.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	1.9	17.0	2.6	3.4	0.0	0.2	0.2	0.7	0.0	0.0	1.8	0.7	0.0	0.6	2.6	0.0	0.0	0.0	0.0	0.6	2.0	0.7	0.4	0.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	5.0	0.1	0.0	0.0	44.7	0.0	0.0	13.7	0.5	0.5	0.0	22.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	6.9	1.6	0.1	0.0	0.0	0.0	0.0	0.1	15.9	0.0	0.0
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435034	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.0;placenta: 20.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 36.8;Granulosa cells: 15.0;Muller glia cells: 13.7;Oligodendrocytes: 16.9;Rod photoreceptor cells: 7.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.6;HUVEC TERT2: 8.0;SuSa: 10.6;TIME: 2.5;U-87 MG: 4.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.3"	"Low region specificity"	"Detected in all"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"	Yes	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	3.1	0.1	1.3	0.3	3.0	0.0	2.9	11.0	2.5	1.2	0.5	0.0	0.1	0.8	0.0	0.1	0.2	0.6	0.0	1.8	2.7	0.2	0.0	0.1	0.1	4.3	2.4	0.1	0.3	0.0	0.8	20.6	3.7	0.4	0.0	2.0	1.3	0.1	0.6	0.1	0.0	0.6	1.7	0.0	0.0	0.2	2.4	0.9	0.0	0.0	0.0	0.9	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.6	0.0	0.5	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.0	11.0	2.5	1.8	2.7	4.3	2.4	3.7	1.7	2.4	5.9	36.8	0.0	0.0	4.6	0.1	0.1	0.1	0.0	0.0	1.8	1.5	4.3	0.6	0.0	0.0	1.8	2.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.6	0.0	0.1	1.2	0.0	0.3	0.0	15.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	1.1	0.2	0.6	0.0	0.1	0.3	0.0	0.1	0.0	0.0
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"		5	129460281-129738683	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	10	"brain: 3.3;cervix: 10.2;endometrium 1: 9.8;placenta: 3.7;smooth muscle: 5.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 82.6;Inhibitory neurons: 79.7;Oligodendrocytes: 31.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7;testis cancer: 1.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 15.9;SH-SY5Y: 34.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 2.6"	"Low region specificity"	"Detected in many"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"	Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Midbody"		"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.0	0.6	1.0	0.0	3.3	0.0	0.0	0.0	1.5	10.2	0.1	0.2	0.1	9.8	0.0	0.2	0.2	0.0	0.2	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	3.7	0.0	0.1	0.3	0.5	0.3	0.0	0.5	0.0	0.1	5.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	15.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	34.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.3	0.0	1.5	0.8	0.2	0.0	0.5	0.0	0.0	0.3	0.6	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.4	0.0	0.0	1.8	0.0	15.6	0.0	0.3	0.0	0.0	1.5	0.5	8.9	0.2	0.0	0.0	82.6	0.2	0.7	1.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	79.7	0.1	0.0	0.0	0.3	0.7	0.0	0.1	0.0	1.0	0.0	1.1	0.0	12.5	31.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.4	0.1	0.1	0.0	5.2	0.1	0.1	0.3	0.0
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	41.2	4.8	4.0	12.2	5.0	0.1	19.0	5.5	5.3	16.2	7.9	8.1	1.2	13.2	1.1	5.3	10.2	7.8	15.6	4.4	5.6	9.5	2.7	13.6	1.9	10.8	8.1	7.3	9.8	6.3	2.2	31.7	8.5	7.9	2.7	1.4	3.2	3.7	7.4	2.6	3.7	12.1	8.0	4.1	4.7	0.8	8.1	1.0	7.3	7.3	1.1	22.5	9.0	6.4	0.0	1.2	13.9	0.0	0.6	0.1	1.3	0.2	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.0	8.8	2.6	0.0	0.0	0.5	0.0	23.6	0.0	0.5	0.0	0.3	0.1	0.0	0.0	7.5	1.1	0.0	0.0	2.4	0.1	27.1	0.3	0.1	128.3	0.0	0.0	0.0	40.5	0.0	0.7	5.4	0.8	0.4	0.0	0.8	0.0	0.0	0.0	0.5	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.0	5.5	5.3	4.4	5.6	10.8	8.1	8.5	8.0	8.1	6.4	166.3	3.2	4.8	84.2	0.0	17.5	87.2	0.0	4.6	0.0	6.9	15.9	6.6	2.8	2.6	38.6	2.1	1.0	0.2	1.1	0.0	69.7	0.9	13.2	179.1	221.0	1.2	0.0	4.2	3.3	0.6	31.4	1.5	33.8	0.0	8.4	27.1	0.3	7.5	0.0	14.3	1.1	0.0	0.3	20.1	0.4	2.5	2.7	26.6	21.5	0.0	0.2	0.0	26.7	0.6	45.5	1.0	2.2	0.0	115.7	0.0	10.8	0.1	0.1	0.0	20.7	94.8	0.3	0.7	1.3	13.5	1.6	3.2	12.1	0.9	36.7
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase RNA specific"	P55265	1	154581695-154628013	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	41.9	44.7	30.4	57.2	29.9	47.1	41.1	18.0	35.1	49.4	16.3	42.9	46.4	50.2	26.3	37.9	50.3	45.6	36.1	31.5	40.0	51.7	56.1	54.6	66.1	32.1	33.8	54.9	40.6	62.8	53.9	46.5	34.8	42.8	44.4	47.9	59.4	43.0	18.8	39.9	52.8	56.6	39.2	73.5	40.3	34.4	37.8	85.2	47.1	27.6	65.0	50.5	40.0	25.5	93.2	103.1	84.4	104.8	87.4	88.5	97.8	59.5	132.7	209.8	183.4	87.8	85.3	162.6	97.7	98.7	112.4	85.4	111.9	115.5	109.8	159.1	52.3	84.9	66.2	48.4	96.7	122.8	83.8	86.2	84.7	100.4	104.1	81.2	104.5	112.4	82.4	111.6	72.0	107.8	165.0	43.3	139.7	125.5	74.6	140.1	74.2	131.2	67.6	106.1	84.8	100.2	104.4	167.9	126.2	128.1	113.4	148.2	94.3	67.5	68.5	58.8	71.5	132.9	179.0	177.6	70.2	78.4	81.0	7.8	8.1	15.0	10.8	9.9	10.2	9.0	10.6	11.2	7.8	5.8	9.8	10.0	29.1	8.6	9.4	6.3	9.1	7.4	30.4	29.9	18.0	35.1	31.5	40.0	32.1	33.8	34.8	39.2	37.8	25.5	73.3	83.3	51.2	37.5	80.5	33.3	39.4	39.9	32.5	94.5	43.6	36.6	22.1	45.8	44.0	47.8	95.9	41.2	103.0	73.3	9.8	49.2	4.2	48.9	61.0	86.7	63.1	45.2	44.8	66.9	57.8	49.1	56.6	52.4	62.1	88.6	84.9	93.8	53.5	168.2	53.2	53.9	34.6	104.1	43.9	13.1	73.7	78.0	19.6	32.8	110.2	37.9	126.7	38.2	39.7	69.6	62.7	59.0	87.5	61.1	86.7	42.5	50.0	80.2	52.6	40.1	45.2	11.4	35.0	37.9	40.3	31.5	85.6	66.5	56.2	53.8
ADAT3	TAD3	ENSG00000213638	"Adenosine deaminase tRNA specific 3"		19	1905399-1913447	"Human disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 9.1;Gastric mucus-secreting cells: 8.2;Squamous epithelial cells: 13.7;Suprabasal keratinocytes: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 13.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA058899	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA058899: AB_2683847"	"unprognostic (1.79e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.43e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.55e-3)"	3.3	4.6	1.6	0.8	3.1	0.7	3.1	2.8	2.6	4.2	1.2	7.7	7.5	3.5	0.2	10.6	3.7	0.2	2.8	1.1	1.4	7.9	5.4	3.7	0.5	5.6	3.1	3.1	6.3	0.1	3.3	0.2	4.0	6.4	0.7	0.0	8.1	0.4	1.9	13.9	6.6	0.1	3.1	6.1	4.7	2.9	3.3	0.1	4.5	0.2	0.3	2.8	5.3	6.1	4.9	1.2	0.7	1.0	0.4	0.0	5.9	1.7	0.3	0.6	0.9	1.9	1.5	2.8	0.7	0.2	0.3	3.1	0.2	0.2	0.0	6.9	12.5	0.7	3.7	2.5	0.2	1.3	8.8	0.0	0.2	0.8	0.0	0.1	0.6	0.8	8.1	1.5	0.4	1.0	2.3	4.2	6.5	0.2	8.4	7.6	1.1	4.8	0.7	1.2	2.6	6.4	2.1	5.0	2.5	0.3	3.9	1.0	1.6	0.6	2.8	2.4	3.7	2.7	2.6	2.5	0.5	1.3	1.6	0.2	1.2	0.0	1.3	0.7	1.4	0.9	2.0	2.3	1.7	2.5	1.4	2.3	0.3	4.1	1.1	13.2	2.6	0.8	1.6	3.1	2.8	2.6	1.1	1.4	5.6	3.1	4.0	3.1	3.3	6.1	1.1	0.0	1.5	0.0	2.9	6.1	1.0	1.0	9.1	0.0	4.0	1.8	0.6	1.5	0.5	0.0	0.0	1.8	5.5	4.1	1.9	1.5	0.1	6.3	1.2	1.4	1.2	0.4	0.0	0.7	2.4	1.6	8.2	3.1	0.0	0.5	2.2	0.8	1.8	0.0	0.0	1.1	0.0	1.4	3.1	0.6	0.0	2.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	4.3	0.7	6.4	0.3	4.2	4.0	2.3	0.0	0.0	0.8	1.2	0.8	3.1	13.7	11.1	4.5	3.6	0.8	1.7	1.2
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	104.4	70.0	96.4	60.7	119.7	65.9	89.1	86.7	117.7	96.5	46.4	127.9	65.5	121.4	57.9	71.9	96.3	69.0	111.2	99.2	90.9	74.1	53.7	93.5	65.3	91.5	100.4	129.5	56.4	67.5	70.1	66.0	92.3	86.1	62.7	269.1	61.9	107.3	166.3	69.4	92.3	110.2	76.0	88.9	84.3	53.2	113.2	76.0	71.7	115.0	62.1	115.3	82.9	116.2	74.7	61.2	142.0	73.8	205.8	152.6	53.2	123.2	146.9	125.6	105.3	90.5	91.8	38.7	63.0	212.3	146.6	46.6	107.5	103.4	104.3	49.9	49.4	109.5	50.4	87.9	100.4	65.8	74.7	151.6	95.2	110.4	44.0	130.1	158.5	71.9	116.0	90.8	145.1	43.7	203.7	91.6	80.0	67.9	85.7	89.1	78.6	45.7	91.2	162.2	84.8	110.0	88.9	35.8	76.9	107.0	84.2	61.7	193.4	102.1	52.4	84.7	103.0	72.5	63.3	48.9	98.2	80.4	100.9	20.1	7.6	35.5	19.1	7.3	17.6	23.8	10.6	16.3	12.0	31.2	9.8	11.8	10.5	27.2	11.4	25.4	14.8	16.0	96.4	119.7	86.7	117.7	99.2	90.9	91.5	100.4	92.3	76.0	113.2	116.2	89.3	70.5	45.4	141.3	66.5	26.9	29.8	33.0	27.9	99.5	41.2	41.5	78.0	40.0	46.3	60.7	402.4	35.5	84.0	51.3	15.6	37.3	48.5	43.9	61.2	89.4	57.7	57.9	85.7	45.8	32.5	72.9	39.8	58.1	37.3	53.0	84.3	41.8	41.8	111.0	83.2	39.3	28.5	51.6	42.2	35.9	77.6	47.4	35.6	72.1	58.3	233.8	120.5	68.9	178.6	53.2	39.4	121.9	49.7	35.8	48.6	44.6	40.4	624.3	98.6	58.4	73.1	45.3	33.2	30.5	36.7	36.5	55.6	80.7	45.1	33.0
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598967-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;choroid plexus: 6.0;fallopian tube: 7.5;testis: 26.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 305.4;Endometrial ciliated cells: 57.1;Late spermatids: 74.8;Respiratory ciliated cells: 92.5;Spermatocytes: 68.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"HDLM-2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria		No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA036340: AB_2675071, HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.3	0.1	0.4	6.0	0.3	0.0	0.1	0.2	0.0	7.5	0.0	0.0	0.8	0.8	0.0	0.0	1.4	0.0	5.5	3.8	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	26.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.3	0.1	0.8	0.8	5.5	3.8	2.4	3.0	1.0	1.0	0.0	3.2	1.5	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.0	9.5	0.0	4.2	0.0	0.0	0.4	0.0	0.0	305.4	57.1	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	2.0	0.0	1.9	74.8	2.8	0.4	0.0	1.0	0.0	0.2	0.0	0.5	0.2	0.0	0.3	2.6	0.0	0.1	0.0	0.1	92.5	0.1	0.0	0.0	0.9	68.4	3.3	0.0	0.0	0.0	0.1	0.0	0.7	0.0
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	306	"liver: 2739.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	8.9	0.3	0.5	0.1	0.5	6.6	0.3	0.0	0.0	0.7	2739.1	0.8	0.0	0.1	0.1	0.1	1.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1501.5;liver: 5858.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1501.5	140.2	2.2	36.4	3.4	0.1	924.6	1.9	9.0	41.0	13.5	202.2	38.5	161.4	74.8	105.8	385.0	145.1	215.3	2.0	1.9	66.7	5858.7	373.2	25.8	4.7	2.2	117.7	49.1	7.8	24.2	6.8	3.2	26.7	114.7	0.1	67.9	26.7	66.6	159.2	237.1	73.4	4.4	72.7	141.1	2.8	2.2	19.8	94.5	228.2	16.0	287.9	118.7	2.4	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	1.9	9.0	2.0	1.9	4.7	2.2	3.2	4.4	2.2	2.4	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336497-99352746	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"intestine: 598.1;liver: 2062.2;stomach 1: 570.6"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 699.4;Gastric mucus-secreting cells: 611.2;Hepatocytes: 440.6;Undifferentiated cells: 420.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;ASC TERT1: 3.6;HSkMC: 11.9;RPMI-8226: 2.1"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		31000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	22.9	0.8	0.1	29.8	0.1	0.0	19.2	0.1	0.1	4.7	0.0	329.5	598.1	5.1	7.2	5.1	5.8	51.6	5.9	0.1	0.0	19.6	2062.2	2.9	0.6	0.1	0.1	4.0	16.7	0.1	1.6	0.1	0.1	9.4	191.9	0.0	19.3	6.2	23.9	0.7	190.7	16.3	0.1	0.7	570.6	0.8	0.1	0.5	2.9	31.1	0.5	5.9	3.6	0.2	0.0	2.1	0.0	0.0	1.4	3.6	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	1.1	0.3	11.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.8	0.2	0.0	0.1	0.1	0.8	2.1	0.8	0.0	0.3	1.1	0.5	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.1	3.2	7.3	0.7	1.3	0.0	4.0	0.0	25.0	0.0	0.1	0.3	1.0	64.3	24.8	29.5	0.0	0.0	0.1	108.4	0.0	159.5	2.3	1.3	0.8	1.2	21.6	29.5	0.3	699.4	0.0	21.1	611.2	1.3	0.0	0.0	13.2	440.6	0.0	0.0	0.2	86.3	0.0	13.2	0.0	1.0	10.5	0.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	66.3	120.8	0.0	0.6	3.1	59.4	1.4	43.7	0.0	0.0	1.3	2.0	0.0	0.7	10.6	0.0	0.0	1.8	1.6	420.5	3.6
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5151.4"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Cluster 34: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	2.1	0.8	0.5	0.4	0.4	0.4	4.3	1.2	1.0	1.5	0.0	0.6	164.1	0.2	0.5	0.8	0.3	0.4	0.2	0.4	0.7	1.5	5151.4	0.2	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.3	0.6	0.8	2.6	0.5	0.6	0.9	22.9	0.1	0.0	0.6	0.6	1.0	0.5	0.0	0.4	2.1	0.1	0.3	3.4	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.2	1.0	0.4	0.7	0.1	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151202-74709963	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 151.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 245.3;Inhibitory neurons: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409, HPA075222"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		920000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: "	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.93e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	23.9	15.5	13.0	16.9	18.7	28.6	27.4	13.5	17.7	17.5	11.6	17.9	16.9	10.8	16.5	47.3	16.5	11.4	27.2	13.9	15.2	35.8	151.2	24.4	22.8	14.0	15.0	8.3	18.8	44.2	14.9	26.6	16.5	14.9	19.5	16.1	20.0	16.0	41.5	33.9	12.4	14.8	14.2	15.0	12.1	15.5	14.1	27.0	38.2	47.1	34.5	24.5	24.7	15.8	177.3	37.4	37.2	50.5	37.1	54.7	88.2	140.8	105.4	103.8	114.5	114.0	172.6	86.3	34.2	57.7	51.3	151.1	44.1	150.1	167.0	59.1	51.3	55.6	59.8	122.8	41.7	87.6	22.5	51.1	95.5	77.4	191.7	79.0	91.2	38.7	41.8	28.4	78.8	101.7	102.5	129.0	9.9	80.0	276.3	100.6	63.7	69.4	117.1	92.7	29.5	33.8	63.6	239.7	49.5	34.7	159.7	69.3	82.8	34.3	67.0	93.2	123.0	40.5	48.3	98.1	65.0	127.6	22.1	2.3	34.2	4.1	12.9	65.5	29.9	103.7	28.2	24.1	83.1	155.0	21.3	19.2	11.1	20.7	80.4	57.6	55.7	36.3	13.0	18.7	13.5	17.7	13.9	15.2	14.0	15.0	16.5	14.2	14.1	15.8	9.8	83.3	75.8	136.5	84.2	94.2	73.5	102.0	105.9	16.3	26.2	26.0	67.8	38.6	72.4	31.3	56.3	136.7	25.9	11.0	92.0	83.2	80.7	40.6	18.8	14.9	10.8	27.7	245.3	67.5	139.5	27.0	23.0	55.6	21.5	9.7	17.2	130.1	39.3	11.8	287.7	12.1	44.7	25.2	50.0	26.9	16.8	33.7	48.0	198.6	44.1	14.1	11.3	140.8	165.4	62.7	10.4	12.0	39.1	92.1	5.0	64.5	33.5	25.0	6.6	20.4	26.0	17.4	14.3	96.7	97.0	107.3	32.7	17.0	20.5	66.3
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346461-40390463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 345.1;tongue: 242.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		NA	NA		440000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavorable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	29.8	33.9	10.6	31.1	11.2	40.6	33.1	12.5	13.3	30.7	12.9	36.5	22.7	34.9	21.9	29.8	33.5	20.6	47.4	10.9	10.6	33.6	32.1	22.7	46.9	10.5	11.7	33.5	45.2	29.3	22.0	30.2	10.9	23.8	35.4	10.3	25.7	22.3	345.1	22.2	28.8	41.1	10.0	33.5	28.0	29.2	10.5	50.5	29.6	242.3	48.5	36.0	25.2	10.8	98.0	110.2	88.3	124.9	62.6	89.5	106.5	82.0	85.2	187.3	138.1	189.0	51.9	279.0	73.2	102.3	84.9	67.3	203.5	137.4	187.7	75.3	197.5	126.5	98.4	166.5	134.6	423.0	96.3	97.7	76.5	161.5	169.8	91.3	138.9	127.3	153.1	114.3	136.4	105.0	130.2	131.2	152.5	121.3	119.3	195.1	203.6	198.2	118.9	67.8	58.8	54.4	106.2	54.1	170.7	78.5	76.8	134.7	91.2	93.3	173.7	85.3	168.8	109.0	212.6	218.2	80.9	149.5	97.7	29.0	47.2	19.9	35.5	55.2	49.5	34.6	76.1	48.5	68.1	33.5	58.3	45.0	4.1	48.2	49.7	34.4	81.7	62.3	10.6	11.2	12.5	13.3	10.9	10.6	10.5	11.7	10.9	10.0	10.5	10.8	10.0	12.8	10.8	9.4	28.3	18.1	18.8	48.6	23.9	16.1	14.8	15.0	30.0	30.0	20.8	3.7	37.5	85.3	15.5	13.0	7.9	61.3	44.0	5.6	9.2	21.6	13.8	54.6	11.4	43.7	78.9	21.2	21.4	5.6	36.8	8.8	28.9	25.6	60.3	6.7	10.7	24.1	24.4	44.8	26.7	25.2	24.8	22.7	12.4	1.0	41.9	45.1	19.6	9.5	9.8	33.7	15.6	14.3	52.4	21.3	21.4	19.7	12.3	18.1	26.3	38.5	20.8	61.2	82.8	35.7	15.2	33.1	32.2	8.7	37.7	14.1
ADSS2	ADSS	ENSG00000035687	"Adenylosuccinate synthase 2"	P30520	1	244408494-244451909	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.4;Cytotrophoblasts: 49.3;dendritic cells: 59.6;Extravillous trophoblasts: 97.2;Hofbauer cells: 35.8;Syncytiotrophoblasts: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		690000	"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.8	20.5	17.8	28.1	22.0	43.9	34.6	21.7	26.7	25.9	17.0	28.7	28.7	23.4	29.8	32.6	23.9	21.0	8.9	19.2	21.1	32.9	24.3	25.3	31.9	21.9	19.6	21.7	19.8	27.6	14.5	28.6	23.1	25.3	29.8	11.4	22.8	25.6	10.8	33.2	27.1	25.2	19.6	23.7	35.0	70.3	20.9	33.8	34.9	8.4	34.9	36.2	21.5	28.7	89.9	48.6	41.6	36.9	47.6	67.8	76.2	88.5	74.4	62.3	47.0	64.6	84.5	79.7	57.1	68.9	26.6	66.1	45.9	58.0	69.5	59.6	81.0	53.1	47.8	49.3	57.1	127.1	65.6	46.8	68.5	58.1	58.3	72.1	225.6	43.3	94.0	57.7	62.7	21.6	82.3	85.0	110.5	85.0	53.1	74.9	39.4	86.5	103.8	55.2	56.2	49.2	75.2	69.0	91.4	43.9	48.0	66.7	99.4	57.1	31.3	67.0	93.7	69.1	97.2	60.0	47.2	146.8	86.3	48.3	22.8	20.0	20.4	29.9	22.0	15.3	18.6	17.8	20.1	12.3	15.6	17.9	17.5	23.6	33.6	7.9	22.3	18.8	17.8	22.0	21.7	26.7	19.2	21.1	21.9	19.6	23.1	19.6	20.9	28.7	26.4	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	49.3	59.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	97.2	9.3	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	54.0	11.0	0.0	0.0	0.0
AEN	"FLJ12484, FLJ12562, ISG20L1"	ENSG00000181026	"Apoptosis enhancing nuclease"	Q8WTP8	15	88621337-88632281	"Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 62.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 38.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048599			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Nuclear membrane"	"HPA048599: AB_2756313"	"unprognostic (8.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.52e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.00e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.10e-2)"	9.1	12.2	6.8	10.7	7.1	17.7	6.0	6.6	6.8	6.8	7.0	8.4	5.1	7.6	9.6	9.6	7.0	12.5	7.3	6.3	11.5	9.0	13.5	10.1	12.8	8.6	7.7	8.0	20.9	4.4	22.4	6.9	7.7	12.1	8.6	1.0	8.3	8.2	15.1	7.2	9.1	10.1	8.1	15.2	13.2	9.8	9.5	10.7	10.3	3.7	11.9	11.5	5.9	7.7	14.9	64.5	39.6	34.2	17.4	20.7	83.7	51.5	46.8	39.1	47.8	53.8	28.2	63.6	16.1	28.3	35.0	20.9	148.0	42.1	32.6	15.7	58.2	34.0	26.4	89.9	42.0	28.5	32.8	25.6	36.4	48.5	39.7	14.0	33.0	20.6	54.6	35.2	48.3	34.4	35.5	24.0	96.0	30.8	36.9	45.4	28.2	46.9	16.5	31.9	31.1	28.5	20.8	23.7	40.1	90.7	19.7	32.0	29.9	39.5	55.1	16.2	70.5	67.0	48.5	54.7	36.0	31.5	79.1	0.0	2.3	0.8	6.2	3.7	12.0	10.9	10.8	8.4	5.2	10.3	11.6	10.6	0.6	3.9	4.9	3.1	19.6	9.2	6.8	7.1	6.6	6.8	6.3	11.5	8.6	7.7	7.7	8.1	9.5	7.7	6.9	6.4	8.1	4.2	21.0	18.6	25.8	6.2	12.0	1.2	21.4	15.4	3.9	8.6	12.9	1.8	0.0	4.7	8.4	5.6	3.9	11.4	23.6	22.5	5.3	7.6	9.0	11.8	20.5	7.6	16.3	9.0	11.7	17.7	2.5	12.3	2.5	6.3	4.5	1.7	16.0	9.9	26.4	4.7	26.4	62.7	4.4	7.8	14.2	3.7	14.2	3.1	9.2	9.0	2.5	11.5	6.2	2.6	26.9	27.8	2.3	5.5	5.4	0.9	13.1	12.0	11.6	10.2	18.2	10.9	28.3	6.2	14.9	6.8	9.7	25.4
AFAP1L2	"Em:AC005383.4, FLJ14564, KIAA1914, XB130"	ENSG00000169129	"Actin filament associated protein 1 like 2"	Q8N4X5	10	114294824-114404756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 64.5;parathyroid gland: 68.7;thyroid gland: 82.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 40.5;Microglial cells: 34.7;Oligodendrocyte precursor cells: 122.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 74.4;CAPAN-2: 77.4;EFO-21: 56.4;HaCaT: 98.7;RPMI-8226: 51.3;RPTEC TERT1: 59.7"	"Low region specificity"	"Detected in all"							HPA037843	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Cytosol"		"HPA037843: AB_10669990"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-1)"	7.6	2.4	15.7	4.2	12.9	0.1	10.2	21.5	13.1	21.8	5.9	13.0	3.9	23.9	13.2	9.3	22.9	4.5	4.7	11.8	12.4	17.6	1.7	5.3	4.3	12.9	12.8	15.1	11.9	68.7	2.4	18.4	13.6	13.1	5.1	3.7	6.9	23.9	3.0	9.8	6.4	18.9	13.6	64.5	5.9	1.4	13.3	13.5	82.2	4.4	7.6	5.9	14.7	13.5	74.4	10.8	10.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.1	77.4	0.1	56.4	0.6	1.1	98.7	0.2	27.2	0.2	1.5	0.1	0.0	0.7	0.0	3.0	0.0	2.7	0.0	28.9	8.1	7.1	0.3	0.3	2.8	0.0	0.2	0.0	3.1	1.9	0.1	0.5	2.0	0.5	0.9	0.8	51.3	59.7	0.6	0.3	0.5	2.3	1.7	2.9	16.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.6	1.1	1.2	0.0	1.6	0.3	0.9	0.1	0.4	0.0	0.1	1.8	0.6	15.7	12.9	21.5	13.1	11.8	12.4	12.9	12.8	13.6	13.6	13.3	13.5	14.6	0.0	0.0	0.7	1.2	12.4	7.3	3.1	5.2	0.8	1.8	5.3	2.2	0.0	1.8	40.5	0.0	1.5	2.4	8.1	0.0	0.6	1.0	5.3	7.4	14.5	0.0	0.8	6.5	14.3	1.2	10.7	3.1	9.5	0.0	0.3	13.2	0.0	0.5	1.7	10.1	1.8	0.0	0.0	3.7	3.0	3.1	0.5	5.4	34.7	0.6	3.2	0.0	122.6	0.6	23.2	1.7	1.9	0.1	3.7	2.2	0.4	1.5	0.6	19.7	21.4	24.7	0.0	0.8	2.3	6.8	0.3	3.4	2.4	2.2	4.3
AFF1	"AF-4, AF4, MLLT2, PBM1"	ENSG00000172493	"AF4/FMR2 family member 1"	P51825	4	86935002-87141054	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 225.2;Microglial cells: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069947			Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Mitochondria"		"HPA069947: AB_2686219"	"unprognostic (1.01e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-2)"	33.2	18.0	10.7	18.1	11.8	35.0	22.8	8.1	13.0	24.8	51.4	25.9	18.2	25.6	11.8	19.1	21.4	19.6	19.6	10.2	10.0	32.8	24.8	20.7	16.3	16.3	9.8	28.8	28.2	31.8	12.5	26.8	11.8	18.2	22.5	63.6	24.0	22.8	55.6	23.4	19.4	31.9	9.1	19.4	19.0	6.9	14.2	22.8	54.9	41.8	13.4	18.5	19.0	12.0	15.3	13.5	11.3	12.0	18.3	21.6	15.9	15.1	22.2	11.3	16.7	14.7	27.8	17.3	20.2	18.7	14.4	6.8	18.0	22.8	15.7	29.8	7.2	36.0	38.3	12.3	14.1	35.0	27.4	17.7	16.1	19.4	17.0	16.4	42.1	14.1	22.5	47.5	4.8	4.1	31.6	10.1	15.0	25.6	4.8	24.7	6.7	22.2	33.1	14.5	25.6	4.7	23.1	15.0	7.2	23.5	9.0	28.9	21.3	20.9	18.8	12.9	8.5	41.0	24.8	29.6	17.1	39.5	7.7	5.4	7.4	17.6	8.8	5.4	9.8	12.0	11.8	8.9	8.5	14.5	6.0	5.8	28.4	7.7	3.3	20.7	11.3	4.2	10.7	11.8	8.1	13.0	10.2	10.0	16.3	9.8	11.8	9.1	14.2	12.0	88.0	41.7	55.6	125.7	29.3	24.1	20.2	17.8	33.6	41.7	20.6	11.6	119.8	40.0	28.4	92.0	225.2	1.4	29.1	40.7	3.9	11.9	7.2	32.4	39.1	50.2	32.3	54.5	69.2	12.6	4.2	36.3	42.8	46.2	25.2	40.3	65.0	34.2	13.0	18.5	47.5	35.8	16.2	41.7	32.8	9.3	29.2	34.8	23.2	202.4	16.5	21.4	16.5	74.4	84.0	13.1	31.4	28.6	53.9	21.9	29.8	50.3	36.0	147.2	26.3	41.9	31.2	3.8	11.3	45.3	31.7	32.8	26.4	13.3	29.0	15.8
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"liver: 3.7"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 107.5;Proximal tubular cells: 101.6"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 208.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	192	"Hep G2: 2165.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	150000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.7	5.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.7	2.8	0.3	0.0	0.1	0.0	0.1	2.5	107.5	2.3	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	101.6	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	1.5	0.2	0.1	0.2	0.0
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 219.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 219.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	6.3	2.5	85.4	10.0	69.0	14.5	1.8	0.6	219.9	0.8	0.0	2.2	2.9	2.0	0.3	2.3	1.0	4.3	23.5	162.1	0.0	0.8	1.1	3.4	16.9	0.0	0.0	1.5	3.7	1.8	7.5	2.5	0.0	1.9	1.5	4.6	2.3	0.8	15.1	3.2	5.8	1.0	0.0	11.4	3.3	1.0	0.0	15.0	2.5	9.9	11.3	3.2	1.0	38.7	7.3	10.5	19.8	5.8	0.0	0.0	11.3	4.8	0.9	0.1	0.5	1.2	6.6	18.4	1.5	0.0	3.6	4.4	0.1	0.2	0.0	20.3	3.1	20.5	1.6	3.4	0.1	21.2	40.3	0.0	0.0	0.1	0.1	8.4	0.0	21.3	0.0	39.8	0.0	12.6	37.4	13.5	3.2	2.3	10.6	15.5	98.8	13.4	0.0	6.0	5.6	20.5	2.6	3.6	4.3	0.1	2.6	14.8	11.2	5.5	9.0	10.5	3.6	16.8	10.9	9.4	9.8	13.9	9.4	3.8	0.5	0.6	2.7	0.8	2.9	1.2	2.8	3.0	0.8	0.8	1.1	1.7	3.8	1.4	0.4	0.8	4.2	1.1	85.4	69.0	0.6	219.9	162.1	0.0	0.0	0.0	0.0	0.0	0.0	38.7	3.6	3.2	1.1	0.0	5.7	0.0	0.3	0.0	0.0	10.0	0.8	0.5	5.8	1.5	0.6	0.0	0.0	0.1	16.4	0.2	0.0	0.1	0.4	0.1	0.7	4.2	0.0	2.1	22.2	0.0	0.2	0.9	2.0	0.2	2.5	0.0	1.1	0.1	1.3	8.4	12.3	0.5	0.0	2.2	1.1	1.1	0.0	3.0	0.0	1.9	3.9	0.5	17.5	5.0	1.2	0.1	0.1	0.7	11.4	0.3	0.3	0.1	0.0	2.3	32.9	2.2	16.2	0.8	0.4	0.2	0.4	0.0	16.4	0.3	0.2	0.0
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"parathyroid gland: 49.9;testis: 192.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	8.8	16.7	8.4	8.0	7.4	13.6	12.4	7.8	8.2	14.4	9.5	16.2	8.8	14.0	26.0	18.3	20.8	14.3	12.7	7.3	11.3	22.5	7.2	11.2	10.7	8.3	7.8	14.4	15.0	49.9	12.5	11.2	8.9	15.2	11.5	16.3	21.2	16.5	7.1	20.5	9.9	14.6	6.1	8.5	11.8	192.9	9.1	15.6	28.5	6.5	8.6	14.9	7.3	7.5	55.0	34.7	55.4	37.2	11.6	23.0	62.9	10.9	23.5	30.9	31.9	30.2	40.5	30.3	34.0	18.9	43.4	24.6	44.8	49.4	33.9	25.9	66.8	44.5	42.0	65.7	23.6	21.6	14.4	24.4	36.7	27.1	22.0	46.9	32.8	43.5	38.9	23.8	30.3	21.5	63.2	32.3	39.4	39.4	23.7	64.5	62.9	48.0	31.9	13.6	37.1	53.6	21.5	16.7	35.0	53.9	24.9	16.3	16.4	28.6	39.2	13.8	23.9	47.7	27.2	62.4	31.8	24.4	26.1	8.8	1.8	4.5	3.3	1.1	2.5	4.6	4.1	4.6	4.1	2.3	3.6	2.2	1.1	8.5	0.7	2.3	2.8	3.8	8.4	7.4	7.8	8.2	7.3	11.3	8.3	7.8	8.9	6.1	9.1	7.5	3.6	0.0	10.1	5.2	6.3	3.3	8.3	7.2	13.6	5.7	8.6	6.7	6.7	10.0	6.8	9.2	0.0	14.7	1.8	5.9	19.6	8.3	302.7	13.0	3.9	4.9	2.4	11.6	7.9	6.0	7.9	6.4	5.6	5.8	1.3	14.1	6.4	4.1	5.2	0.0	9.1	8.4	6.1	3.1	3.5	338.0	10.5	8.0	7.2	6.5	4.9	6.8	0.0	10.1	10.1	5.0	7.6	11.3	17.1	6.0	6.3	25.0	10.7	10.0	0.0	4.2	7.0	156.8	41.2	16.3	2.7	8.3	5.0	9.4	8.6	10.5
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 638.7;intestine: 1224.0;stomach 1: 1402.3"	"Cell type enhanced"	"Detected in many"		"Club cells: 1515.8;Distal enterocytes: 1026.4;Gastric mucus-secreting cells: 2605.5;Intestinal goblet cells: 3710.4;Paneth cells: 1101.6;Undifferentiated cells: 1543.1;Urothelial cells: 1017.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 475.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	15	"OE19: 20084.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		38000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	2.1	0.7	0.0	66.6	0.0	0.0	72.3	0.2	0.5	638.7	0.0	768.1	486.0	14.1	389.1	16.2	306.4	275.8	0.2	0.1	0.0	11.2	0.9	50.7	0.6	0.0	0.1	0.3	22.1	0.1	31.4	1.6	0.0	227.3	1224.0	0.0	475.3	181.0	0.2	2.5	379.2	45.2	0.0	0.9	1402.3	0.9	0.0	1.7	7.4	0.1	7.2	160.8	4.0	0.1	0.3	265.5	0.0	0.3	0.0	0.1	2.6	0.0	0.0	0.0	0.0	43.5	39.7	0.0	0.2	0.0	6.6	25.2	0.0	34.5	0.2	0.0	0.0	0.0	0.9	3.8	0.0	0.0	1.0	0.0	88.5	0.0	11.4	0.4	0.4	0.3	0.0	0.0	0.2	44.7	1.3	1.8	0.8	20084.0	154.2	1.0	0.0	5.2	631.3	371.6	1.7	2.1	0.0	98.8	0.0	1.0	1319.9	0.0	0.0	0.7	1.2	0.9	0.2	1.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	51.3	293.1	0.0	19.0	2.8	127.1	539.8	0.6	0.0	169.3	137.4	0.2	268.8	1515.8	80.9	0.0	6.0	0.4	1026.4	0.0	74.1	4.6	301.9	33.9	4.8	522.1	0.0	0.1	835.1	4.5	6.0	2605.5	365.3	43.9	0.0	0.0	1.7	240.8	0.0	0.1	3710.4	386.6	0.8	0.3	0.4	0.3	6.5	3.6	0.0	1.0	0.0	0.0	0.0	0.0	303.1	1101.6	0.0	2.6	426.9	517.9	0.2	781.0	0.0	0.0	0.0	76.9	0.4	0.2	5.3	2.8	3.3	13.1	0.0	1543.1	1017.8
AHCYL2	"IRBIT2, KIAA0828, long-IRBIT"	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 488.0;intestine: 177.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 567.4;Distal enterocytes: 334.0;Excitatory neurons: 131.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 235.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 40: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	7.1	10.2	25.4	15.6	35.9	3.2	8.4	27.2	34.4	10.6	488.0	157.4	57.8	9.1	7.2	9.6	7.4	55.8	4.6	47.3	32.5	28.5	7.7	65.8	10.8	30.3	28.1	11.4	13.7	19.2	21.3	12.1	22.5	9.3	177.4	57.8	30.6	7.0	37.3	24.3	38.6	11.8	27.8	7.0	41.9	10.5	39.0	9.4	42.6	27.7	9.4	16.1	7.6	25.2	8.7	13.5	25.4	15.3	6.8	9.9	5.4	6.8	9.4	7.5	6.6	7.9	5.7	5.3	6.9	7.4	15.9	6.0	12.8	10.7	8.3	235.7	16.0	12.4	14.5	6.4	4.0	9.3	15.4	9.1	13.5	6.0	9.1	12.7	15.1	10.1	5.8	28.7	9.9	8.2	13.7	12.1	12.7	8.6	9.5	9.0	6.9	14.4	15.0	11.5	11.6	7.3	15.5	6.5	9.3	21.0	6.1	6.6	8.6	6.4	3.6	16.9	7.2	12.0	14.6	7.2	16.4	9.8	9.9	0.1	0.4	0.7	0.3	0.9	0.4	0.3	0.5	0.2	0.4	0.1	0.4	0.1	0.1	1.3	0.4	0.1	1.8	0.2	25.4	35.9	27.2	34.4	47.3	32.5	30.3	28.1	22.5	27.8	39.0	25.2	4.7	60.9	98.6	567.4	9.3	15.6	5.1	7.2	31.3	10.8	4.8	4.3	7.3	18.6	16.4	5.5	6.2	12.5	2.2	334.0	11.7	4.5	61.7	5.9	5.3	5.2	9.1	3.4	131.2	5.3	2.9	3.6	30.1	8.7	5.7	6.0	5.7	6.0	4.7	5.0	115.5	32.9	6.1	10.0	6.1	30.6	4.1	7.3	24.9	99.3	7.7	91.0	2.1	127.2	77.5	6.2	71.8	6.8	7.4	6.2	27.0	17.1	8.7	5.9	6.6	5.1	4.3	5.1	2.3	17.8	9.8	15.2	7.3	8.3	46.1	15.1
AHNAK2	C14orf78	ENSG00000185567	"AHNAK nucleoprotein 2"	Q8IVF2	14	104937244-104978374	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 305.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 114.3;Basal respiratory cells: 83.8;Horizontal cells: 60.6;Ionocytes: 61.1;Pancreatic endocrine cells: 68.2;Respiratory ciliated cells: 66.8;Squamous epithelial cells: 63.7;Suprabasal keratinocytes: 164.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 135.1;HBEC3-KT: 124.9;hTCEpi: 308.7;hTERT-HME1: 130.3;TIME: 138.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"medulla oblongata: 11.3;midbrain: 10.6;pons: 13.2;spinal cord: 38.9;thalamus: 15.0"	"HPA000878, HPA002940, HPA004145, HPA020111"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		40000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371"	"unprognostic (3.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.31e-3)"	"unprognostic (9.55e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (3.43e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.23e-5)"	30.4	2.3	9.8	2.4	9.9	0.0	16.4	9.3	15.9	84.5	4.6	105.3	1.4	64.3	2.9	114.1	29.2	5.1	4.5	9.7	16.0	3.5	6.2	5.1	0.1	38.1	15.3	3.5	1.6	0.7	3.4	1.8	40.8	18.6	8.6	19.0	24.0	28.6	3.6	305.9	20.2	31.6	12.4	0.9	25.2	7.7	18.1	0.4	2.8	4.5	4.7	49.4	86.6	18.5	2.9	107.6	0.1	6.0	120.0	135.1	0.2	10.5	22.3	3.8	1.9	0.3	38.9	0.1	14.5	82.9	85.3	62.9	0.3	124.9	1.7	0.0	0.4	0.0	67.5	0.5	11.0	0.0	3.8	17.6	308.7	12.1	130.3	52.3	54.7	0.0	0.0	0.2	62.8	8.0	0.0	0.0	0.3	9.5	42.9	0.3	5.7	0.1	84.4	0.0	0.6	0.6	46.2	0.1	2.3	2.8	6.0	0.0	138.4	29.3	17.9	33.8	9.9	0.0	0.0	0.0	88.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.8	9.9	9.3	15.9	9.7	16.0	38.1	15.3	40.8	12.4	18.1	18.5	3.8	12.8	1.1	0.3	0.0	114.3	4.9	83.8	13.1	8.9	2.2	1.3	1.5	0.0	38.2	1.8	2.1	0.2	0.3	0.4	0.0	11.9	24.2	16.0	10.5	13.0	0.0	0.0	8.2	8.7	0.5	31.9	0.0	18.9	17.1	0.1	3.6	2.1	1.0	60.6	5.1	0.0	61.1	0.3	12.7	3.1	0.6	0.7	32.0	3.7	0.0	3.2	0.0	1.5	3.3	68.2	0.0	0.4	0.0	4.5	0.0	0.3	66.8	13.9	0.0	13.1	8.6	0.4	4.3	63.7	164.7	0.1	0.9	0.1	0.2	6.2
AIDA	"C1orf80, FLJ12806"	ENSG00000186063	"Axin interactor, dorsalization associated"	Q96BJ3	1	222668013-222713210	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027935	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA027935: AB_10602226"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	72.3	36.1	53.6	39.1	63.8	21.9	40.2	57.1	66.5	47.8	47.1	50.0	25.3	36.1	56.1	45.2	31.3	40.8	45.8	51.7	62.0	39.3	49.0	46.2	51.2	63.0	58.4	40.6	32.5	32.5	21.4	47.8	62.8	35.1	36.1	19.4	28.0	42.1	28.4	26.6	28.9	54.2	58.9	37.4	28.2	44.3	58.5	33.8	37.5	49.7	52.9	47.2	31.2	69.6	74.3	56.2	65.5	70.4	181.2	169.9	71.4	135.7	145.0	95.1	87.0	64.3	62.0	39.5	67.2	161.7	73.4	44.8	81.4	89.9	115.4	59.6	30.0	50.4	64.2	61.9	95.2	62.5	28.4	104.0	78.9	113.4	108.9	102.4	117.8	49.6	77.1	54.3	180.8	27.6	40.9	38.4	163.6	83.9	118.8	43.8	183.9	57.9	110.9	49.7	43.1	72.1	91.0	53.4	83.8	100.3	43.5	38.5	94.1	127.4	62.9	124.9	162.7	40.3	80.4	35.2	118.1	38.7	128.0	5.7	2.8	2.9	5.7	4.4	4.8	14.2	7.2	6.2	2.5	13.8	7.4	5.8	1.6	3.5	5.0	7.2	10.2	4.1	53.6	63.8	57.1	66.5	51.7	62.0	63.0	58.4	62.8	58.9	58.5	69.6	80.2	22.4	49.9	6.5	57.9	32.5	36.2	19.8	20.5	18.8	20.8	18.0	8.6	27.1	18.7	33.1	33.3	20.6	46.5	19.0	29.4	38.6	20.4	27.1	48.9	52.4	36.1	46.7	8.9	37.9	55.0	52.6	12.8	46.6	3.8	32.4	43.9	36.9	31.5	23.5	11.1	22.4	22.4	37.8	40.2	23.8	60.3	42.5	37.4	30.9	58.9	32.1	38.1	10.6	10.0	51.1	19.8	50.8	32.1	61.2	24.4	54.4	32.8	13.8	32.9	66.1	43.9	35.3	17.9	26.6	30.3	9.0	28.0	32.0	17.8	33.7
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 173.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Plasma membrane, Cytosol"	"HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.92e-4)"	39.6	13.5	7.5	6.3	8.1	1.9	31.2	7.3	8.0	6.9	8.6	12.9	9.3	7.8	9.0	13.3	6.8	5.0	17.0	6.9	7.7	10.4	21.9	9.3	5.1	8.2	7.3	7.9	5.0	3.2	5.6	4.1	6.9	9.9	7.1	2.4	7.6	7.7	9.8	5.6	11.5	5.0	6.2	7.7	9.9	3.9	8.3	2.4	14.6	7.3	3.6	12.0	6.3	6.5	26.5	45.2	1.1	11.3	26.2	9.8	0.3	10.4	25.5	21.0	23.6	35.3	49.8	3.8	25.8	14.5	27.5	27.9	12.7	3.8	5.9	50.8	1.9	0.2	27.3	173.3	56.1	0.3	6.4	13.3	8.4	33.8	7.2	13.2	9.5	1.7	20.5	21.9	11.0	33.5	1.2	1.3	4.5	21.2	14.6	0.8	4.2	12.4	11.4	19.2	3.6	0.8	19.1	16.6	29.8	1.8	0.7	7.2	12.0	0.5	25.3	15.6	30.8	16.2	32.7	7.3	14.0	0.9	13.9	1.0	0.5	0.5	1.8	0.5	1.5	1.7	0.6	1.5	0.4	1.5	0.8	1.3	0.5	4.0	0.5	0.2	1.3	0.7	7.5	8.1	7.3	8.0	6.9	7.7	8.2	7.3	6.9	6.2	8.3	6.5	11.6	6.4	14.1	7.2	5.0	2.3	15.0	8.4	2.8	5.7	5.5	4.7	13.8	8.6	10.5	18.4	0.0	13.9	1.4	53.1	3.9	40.7	24.1	6.0	7.7	4.8	12.0	7.0	8.2	21.9	3.0	11.2	14.3	6.2	11.4	22.3	1.8	25.0	10.2	1.7	5.2	7.1	14.2	3.3	3.3	47.0	5.3	6.7	8.8	4.7	34.4	4.8	1.0	5.5	3.5	40.8	22.7	4.5	17.0	14.6	28.7	22.6	9.5	2.1	19.7	11.8	12.8	6.2	3.9	5.1	1.4	18.6	3.8	8.8	13.7	20.4
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143341058	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 235.8"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 245.4;Proximal tubular cells: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	42.0	29.8	43.7	10.4	44.6	31.6	30.0	43.3	46.1	17.6	48.2	23.0	46.6	14.4	33.0	34.1	34.4	24.5	54.1	44.1	49.1	102.0	235.8	19.9	10.7	45.0	43.4	34.7	31.0	31.0	36.6	11.9	46.4	22.7	18.8	33.9	19.8	24.1	23.7	16.8	45.9	15.2	47.1	20.1	20.8	15.7	51.0	6.8	42.9	32.5	14.8	29.4	26.1	52.5	32.6	25.2	20.6	56.9	29.7	22.3	7.6	28.3	57.1	26.8	61.9	37.5	81.5	20.0	40.5	66.1	41.7	42.0	26.5	79.2	64.2	67.2	63.0	5.6	35.6	157.3	40.8	46.0	2.7	32.9	76.7	35.7	129.6	88.2	10.9	30.8	4.0	67.6	59.3	45.6	14.2	9.8	40.8	37.4	27.6	20.2	61.6	36.6	100.6	77.6	75.5	42.4	35.5	33.2	17.2	36.0	31.7	96.0	3.0	25.2	27.8	22.7	33.4	99.6	95.1	2.1	59.7	9.5	26.9	12.0	6.2	9.6	6.6	29.3	15.1	9.6	12.4	10.6	33.0	5.6	13.1	10.0	11.3	11.8	35.4	2.9	9.7	9.2	43.7	44.6	43.3	46.1	44.1	49.1	45.0	43.4	46.4	47.1	51.0	52.5	40.8	16.0	27.7	114.9	22.0	25.0	51.8	82.5	27.9	68.3	69.9	65.4	73.7	72.9	66.9	51.5	25.0	79.6	8.6	12.6	52.8	60.3	22.4	99.8	25.9	32.8	39.5	29.3	204.3	31.5	10.5	42.2	26.0	83.1	36.8	90.9	36.8	229.6	32.7	53.8	245.4	33.3	59.0	40.1	42.3	7.0	32.0	37.2	55.2	100.2	18.2	74.3	8.2	105.1	172.9	25.8	65.2	38.4	47.7	35.3	232.9	261.5	69.1	36.9	32.9	41.7	50.8	5.6	17.3	53.1	45.7	108.1	18.5	61.5	42.4	53.2
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709556-4742043	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 242.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 305.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 485.4;HEL: 273.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063324	Enhanced		Supported	Mitochondria		NA	NA		31000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA063324: AB_2684985"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	75.5	62.9	30.1	23.7	36.9	20.1	39.7	33.5	34.9	41.0	56.2	67.4	68.3	41.9	31.2	61.2	34.4	35.9	100.6	27.0	40.6	101.4	199.9	34.9	29.6	32.8	38.1	47.8	38.9	66.8	22.2	35.1	33.7	49.2	59.6	16.8	38.7	42.6	242.8	47.4	62.5	41.7	33.5	33.0	69.5	11.2	37.9	35.1	49.9	159.6	34.4	48.7	39.7	36.5	44.1	30.7	55.5	22.6	75.3	55.5	4.9	60.4	116.1	30.4	45.5	5.7	43.6	39.5	20.4	63.5	16.6	29.3	40.8	48.0	51.2	485.4	37.1	273.3	56.1	91.3	58.5	28.7	14.1	87.9	41.4	26.4	36.0	70.4	91.2	38.2	22.1	49.6	91.8	22.5	27.5	65.6	53.3	77.1	15.4	38.2	21.1	19.2	82.1	55.7	98.3	63.6	65.7	18.5	35.1	53.7	26.5	53.2	65.9	25.7	28.8	70.1	43.6	15.5	10.5	50.3	46.9	19.9	18.9	13.3	10.2	32.2	27.6	8.1	25.5	12.1	21.6	25.7	19.6	12.3	28.4	29.2	2.8	27.4	6.5	26.3	31.8	21.1	30.1	36.9	33.5	34.9	27.0	40.6	32.8	38.1	33.7	33.5	37.9	36.5	58.3	57.7	80.3	78.0	34.0	74.2	76.4	87.4	84.2	10.7	58.8	28.3	182.9	68.6	71.0	66.2	22.9	95.5	34.6	129.9	258.2	84.8	3.7	40.7	30.6	65.7	109.6	68.1	23.4	69.6	17.0	83.4	87.1	37.8	46.2	75.8	79.2	305.6	47.5	15.2	55.8	104.2	73.2	46.9	41.4	4.5	108.7	34.7	74.7	22.5	40.9	28.2	33.0	44.7	87.0	67.3	78.7	149.7	62.8	166.7	111.8	183.5	52.8	11.0	105.2	76.0	60.8	6.4	14.1	152.5	104.4	214.0	36.4	68.5	145.5	151.6
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 185.9;Late spermatids: 275.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	46.0	58.0	18.7	12.5	19.6	11.6	40.0	20.6	27.1	26.1	19.8	40.8	15.2	32.4	21.6	29.7	29.6	7.7	48.4	19.8	20.3	54.9	46.6	29.5	13.0	19.7	20.1	32.6	35.8	11.6	28.6	12.1	19.5	32.9	12.6	23.2	30.9	8.3	79.8	20.6	30.1	9.5	18.7	28.0	36.4	43.3	19.5	13.3	33.0	23.3	12.5	35.5	28.0	20.7	40.3	18.8	28.0	42.6	43.6	26.3	51.1	59.3	18.6	23.8	30.7	56.0	35.5	82.1	54.9	23.4	62.2	14.0	37.2	23.3	40.0	33.1	15.7	40.7	47.8	44.9	33.0	49.5	17.1	14.0	33.3	23.0	37.0	25.0	14.8	45.8	36.6	29.3	28.6	42.1	50.2	31.4	25.0	17.9	10.5	55.8	34.5	44.5	40.3	31.3	14.4	13.3	28.2	26.4	44.6	21.3	25.1	54.7	29.5	20.4	34.6	41.4	47.6	33.1	74.4	75.3	29.8	69.3	28.9	25.2	16.8	20.1	19.2	22.1	20.3	29.8	22.8	24.9	24.8	26.1	24.5	26.3	2.7	24.1	21.0	29.9	25.8	13.3	18.7	19.6	20.6	27.1	19.8	20.3	19.7	20.1	19.5	18.7	19.5	20.7	51.5	22.4	30.0	14.0	33.9	0.0	95.7	0.0	33.6	19.8	57.3	86.6	55.6	18.6	16.7	23.9	10.4	86.7	27.2	16.8	185.9	75.6	174.9	36.4	34.6	38.6	9.7	29.2	14.8	78.5	95.1	47.3	16.8	30.2	21.5	31.7	30.7	42.5	71.3	20.2	15.4	21.3	0.0	30.6	0.0	275.9	33.5	32.2	0.0	6.5	42.4	58.7	34.0	13.0	17.0	59.1	25.5	32.0	29.4	116.6	48.6	149.8	18.2	29.3	52.6	40.9	50.0	56.5	37.9	24.3	0.0	66.2	27.6	44.7	32.9	88.1
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 76.3;Respiratory ciliated cells: 152.0;Spermatocytes: 174.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.6"	"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	3.5	3.1	8.1	3.3	9.9	3.7	4.8	13.5	17.2	3.5	10.9	4.6	3.6	4.3	7.6	4.3	7.9	3.5	4.9	6.4	11.0	5.3	3.1	4.1	4.2	8.8	10.7	3.6	3.4	9.2	7.7	3.1	9.5	3.9	4.5	14.1	5.1	3.9	4.8	3.9	3.6	3.9	10.7	4.0	4.5	16.6	8.7	7.6	6.9	3.5	3.6	3.4	3.2	13.4	2.3	1.6	6.6	11.5	6.1	3.7	4.8	3.5	4.3	3.6	4.9	2.6	4.6	4.9	1.7	3.4	7.9	3.7	1.9	3.9	7.6	10.2	4.0	3.8	3.8	2.6	4.8	4.4	2.3	3.1	7.3	6.6	8.6	8.8	4.2	7.2	3.6	4.0	2.7	4.7	4.1	3.2	1.5	5.1	2.5	5.5	3.7	4.7	5.0	4.3	7.8	6.4	4.2	3.9	5.9	3.7	5.1	5.8	5.2	3.1	2.2	5.1	2.3	2.0	1.8	2.8	6.8	5.9	2.0	17.1	2.8	7.1	5.1	1.5	4.4	13.1	4.9	6.2	2.1	10.8	6.2	5.4	5.6	5.6	4.8	3.1	3.9	1.6	8.1	9.9	13.5	17.2	6.4	11.0	8.8	10.7	9.5	10.7	8.7	13.4	13.3	28.9	17.2	21.2	13.6	2.7	7.7	14.7	3.4	18.3	10.4	6.7	18.9	5.7	19.9	9.2	14.6	3.4	8.6	13.1	0.0	9.1	70.9	76.3	5.4	10.0	19.8	4.2	34.8	4.5	1.5	6.0	12.2	7.3	22.1	10.6	8.9	2.1	3.6	20.2	37.0	15.5	14.2	5.3	3.9	41.7	7.5	5.6	5.4	25.3	5.0	12.6	18.6	22.6	46.9	7.4	8.9	6.4	5.5	5.6	22.9	6.8	152.0	50.7	26.3	9.1	6.9	174.3	34.1	4.0	2.6	5.6	10.3	4.7	11.4	7.9
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 84.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	11.4	13.3	10.5	12.3	12.4	10.6	12.3	11.4	13.6	11.5	15.1	11.4	9.5	12.4	8.8	10.6	10.4	10.7	7.4	11.3	11.6	13.1	8.1	11.0	16.0	9.9	10.7	13.5	8.4	15.1	7.5	12.2	10.6	10.9	11.6	15.3	9.8	11.7	7.2	9.5	10.1	13.3	10.4	14.9	11.1	14.2	13.8	14.1	15.1	9.4	12.5	11.3	10.2	14.7	18.1	21.3	13.9	9.7	18.0	22.5	25.7	20.6	21.9	22.4	26.7	23.2	10.6	15.4	13.6	16.4	19.4	18.8	18.1	17.2	30.4	12.8	15.4	13.2	20.2	11.4	17.0	9.7	20.7	19.1	21.1	20.5	25.1	25.0	18.3	18.5	8.6	7.5	23.6	13.1	18.1	14.3	9.1	25.1	7.2	11.8	45.5	8.1	18.7	11.3	4.7	14.1	23.6	11.0	19.7	84.8	26.7	10.7	16.1	17.2	14.2	14.8	19.3	9.3	10.7	18.8	22.8	11.5	17.0	4.9	9.7	12.6	8.6	14.4	8.0	8.4	8.4	9.4	8.5	9.2	10.0	8.9	33.8	7.6	13.9	6.3	7.1	4.3	10.5	12.4	11.4	13.6	11.3	11.6	9.9	10.7	10.6	10.4	13.8	14.7	13.4	3.2	12.3	71.2	24.4	7.0	9.7	8.9	10.2	24.6	11.1	9.0	8.4	21.5	11.9	5.5	16.7	14.9	16.8	15.8	1.9	9.9	12.8	11.0	14.8	12.6	7.2	15.2	55.1	7.2	11.1	11.7	14.8	10.8	10.1	18.0	16.8	13.6	16.5	33.7	54.6	9.9	12.2	35.1	10.5	13.9	15.2	21.4	5.4	61.8	32.3	11.7	25.7	51.8	78.5	7.9	15.2	13.9	11.2	15.6	14.6	5.7	15.3	23.2	19.7	10.5	11.2	23.1	23.6	11.0	7.7	14.0	19.0	15.6	11.8	12.1
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239967-151358559	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 352.6;Endothelial cells: 278.4;Fibroblasts: 270.0;Muller glia cells: 583.0;Pancreatic endocrine cells: 322.1;Spermatocytes: 325.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 39.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	235	"basophil: 37.2"	"Lineage enriched"	"Detected in single"	235	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in many"		"REH: 193.0;TIME: 188.2;U-251 MG: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	105.6	16.0	13.8	17.1	16.6	2.2	59.7	99.7	57.5	19.8	4.5	60.1	8.6	31.1	9.3	18.6	31.2	31.5	51.8	14.7	66.8	35.8	30.6	44.3	6.9	67.0	35.3	87.8	10.8	1.6	23.3	38.3	74.7	23.1	13.2	109.4	6.5	20.8	11.9	9.4	24.9	42.9	10.9	14.3	25.6	100.0	39.4	5.9	22.1	14.5	3.4	33.0	21.2	24.3	7.8	37.8	53.2	0.1	98.2	145.9	18.8	43.9	23.7	19.3	19.4	0.9	141.6	0.0	17.1	33.2	160.4	1.0	102.2	32.5	17.2	50.2	37.6	0.6	40.8	35.6	10.9	0.0	9.6	104.0	0.0	81.9	4.3	25.4	127.8	0.6	9.8	0.9	70.7	0.5	0.3	0.1	33.3	0.1	43.9	193.0	2.3	0.2	110.2	6.3	37.9	22.0	14.1	0.5	24.9	74.6	2.8	0.5	188.2	2.6	34.0	110.4	202.9	0.4	0.1	0.2	63.2	0.1	37.4	37.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	16.6	99.7	57.5	14.7	66.8	67.0	35.3	74.7	10.9	39.4	24.3	352.6	12.8	16.2	34.3	6.8	19.6	19.6	63.2	1.2	14.5	1.2	3.9	12.1	5.7	31.1	51.5	2.1	2.4	0.9	1.2	1.9	107.0	101.4	14.2	195.4	278.4	1.8	3.2	75.8	6.7	10.1	270.0	3.6	31.6	64.2	14.7	194.5	4.8	26.9	0.0	33.3	0.7	4.1	15.7	45.4	116.3	39.7	13.9	58.7	37.5	0.6	583.0	1.0	59.8	5.1	322.1	1.1	110.6	6.7	49.5	0.0	89.4	6.0	31.0	98.6	208.3	243.0	325.4	33.0	1.6	11.4	10.0	5.1	9.3	2.5	105.3
AKIRIN2	"C6orf166, dJ486L4.2, FLJ10342"	ENSG00000135334	"Akirin 2"	Q53H80	6	87674860-87702233	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA064239			Supported	Nucleoplasm		No	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA064239: AB_2685222"	"unprognostic (9.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.62e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	32.9	37.1	29.0	23.8	32.5	70.5	26.0	26.5	37.6	22.7	27.8	19.8	12.7	24.6	23.7	33.2	22.6	15.3	30.9	34.0	34.0	20.8	31.2	33.2	28.4	26.9	28.8	25.6	13.2	17.8	23.4	18.5	26.4	17.0	12.5	29.7	24.5	11.7	97.4	22.9	22.9	16.4	29.5	49.0	16.8	24.1	35.7	31.2	17.2	42.6	30.3	23.2	25.0	30.9	23.9	24.7	71.0	40.1	43.1	29.6	41.4	41.1	25.7	33.2	32.3	39.7	18.0	62.2	44.1	42.1	55.1	36.2	39.1	29.6	37.9	79.2	48.5	36.3	21.8	89.7	47.1	31.4	30.2	34.6	29.9	41.0	40.2	32.5	36.6	24.3	71.2	42.2	43.5	30.7	9.9	64.9	51.0	20.3	38.1	38.7	50.2	25.7	41.7	20.8	53.0	50.3	24.9	14.8	44.2	40.1	17.9	73.9	47.6	27.5	18.8	23.5	54.6	40.9	48.4	38.8	30.4	40.2	45.1	76.1	57.8	64.8	28.1	73.2	29.2	41.6	27.4	27.6	55.0	32.6	21.4	23.1	144.4	36.6	75.6	75.1	39.1	35.0	29.0	32.5	26.5	37.6	34.0	34.0	26.9	28.8	26.4	29.5	35.7	30.9	49.9	25.6	19.8	10.4	88.2	96.5	192.2	101.9	80.8	13.0	31.8	28.8	22.5	35.8	43.7	18.4	8.4	45.1	94.4	17.1	45.0	30.9	58.0	44.9	34.3	45.6	12.1	45.4	15.6	14.7	71.0	51.1	16.3	39.9	33.6	47.2	44.6	29.9	77.0	11.8	14.8	10.9	69.2	104.4	167.0	100.9	35.8	142.8	74.7	19.7	46.7	80.5	33.0	17.6	15.1	29.6	21.7	28.2	69.4	119.7	19.0	53.5	17.9	17.0	6.6	62.2	39.9	70.6	63.0	92.6	92.9	136.5	99.5	54.2	12.6	191.0
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108963484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 4.8"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 80.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;hTCEpi: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030270, HPA030271, HPA030272"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.0	0.0	1.6	0.0	1.5	0.1	0.0	1.8	2.5	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	80.6	0.3	5.1	1.4	0.0	0.0	1.0	0.2	0.8	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.7	0.0	0.0	0.3	17.8	2.5	0.1	1.8	0.0	0.0	0.4	0.0	3.5	3.1	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.9	0.6	1.4	0.1	0.1	0.7	0.1	0.7	0.5	0.0
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442356-134459284	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"adrenal gland: 3039.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 649.2;Cytotrophoblasts: 1105.1;Extravillous trophoblasts: 1284.9;Ionocytes: 697.8;Syncytiotrophoblasts: 2022.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 1667.3;BJ hTERT+: 3096.2;RPTEC TERT1: 1447.8;U-87 MG: 1343.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	65.1	3039.1	83.1	38.4	89.3	21.9	52.3	91.8	97.4	41.4	80.9	40.1	20.5	42.4	44.0	28.2	38.7	40.2	208.2	84.1	92.5	218.0	19.3	55.0	74.6	101.6	96.9	60.5	34.4	111.2	76.5	203.7	104.9	34.4	30.9	36.5	41.9	332.7	330.0	26.6	50.8	39.6	91.4	62.8	51.4	44.9	88.7	54.9	44.3	396.9	62.5	67.3	35.0	101.4	184.2	1667.3	186.5	261.4	785.9	212.3	494.6	177.2	3096.2	259.3	335.0	75.8	170.6	0.0	79.2	301.5	1143.3	78.6	204.0	175.3	206.6	65.2	168.2	93.4	225.0	230.1	1117.9	0.1	0.8	196.9	133.4	367.6	98.3	252.8	370.3	181.1	0.1	62.4	292.4	3.5	283.3	131.0	309.2	13.9	1.8	292.9	116.5	138.8	1447.8	915.5	137.1	301.6	1261.5	1.5	134.3	121.3	0.6	140.6	289.6	254.5	116.0	22.7	195.6	168.2	196.9	470.0	1343.5	0.7	153.0	125.7	106.4	5.6	147.6	72.3	135.2	133.0	124.7	144.5	145.3	121.7	162.9	156.7	8.5	119.7	39.2	20.4	94.9	230.2	83.1	89.3	91.8	97.4	84.1	92.5	101.6	96.9	104.9	91.4	88.7	101.4	34.1	12.8	19.4	9.1	50.3	20.6	55.3	66.1	20.5	36.2	11.7	27.9	202.4	25.8	26.4	649.2	8.4	1105.1	35.1	2.3	164.4	112.7	5.0	6.1	20.9	50.9	31.0	20.2	10.5	41.5	1284.9	100.3	20.4	5.9	53.8	59.8	82.1	2.6	394.1	72.3	18.7	15.1	697.8	172.8	53.9	14.5	79.2	127.7	30.2	14.0	76.3	49.3	66.9	5.5	12.4	51.0	4.5	77.5	72.6	25.6	0.3	60.2	24.9	24.1	59.2	98.9	54.5	22.6	100.2	10.5	11.6	2022.4	49.9	70.5	6.7	54.2
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527567-134541412	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 224.5;intestine: 614.8;stomach 1: 432.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 193.0;Distal enterocytes: 201.0;Gastric mucus-secreting cells: 542.3;Proximal enterocytes: 327.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	104	"A549: 2959.1;Hep G2: 835.6;OE19: 3141.0"	"Low region specificity"	"Detected in all"							"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted to digestive system"	NA	NA		67000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.9	5.5	0.1	7.9	0.0	0.2	0.4	0.3	0.1	73.9	0.0	73.4	614.8	0.5	0.1	224.5	0.9	176.1	0.2	0.1	0.1	12.2	40.0	0.4	0.3	0.0	0.0	0.2	0.7	0.0	4.8	0.1	0.1	1.3	45.6	0.1	32.4	0.2	3.7	7.7	354.8	3.2	0.1	0.1	432.5	0.6	0.0	5.5	0.6	5.9	7.7	65.8	145.6	0.2	0.0	2959.1	0.0	0.0	0.7	2.3	9.0	0.3	1.1	0.2	0.0	5.9	0.9	0.0	1.1	1.6	4.6	6.2	0.0	4.0	0.2	0.1	0.0	0.0	1.9	835.6	0.7	0.0	0.6	0.1	13.8	0.7	0.0	4.0	0.5	0.0	0.0	0.0	0.6	5.4	0.1	1.3	0.5	3141.0	2.3	0.3	0.0	2.7	1.5	2.7	1.0	1.5	1.8	1.3	0.1	0.1	0.0	0.1	1.9	1.2	1.2	0.2	1.0	0.4	0.1	0.0	22.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.0	2.8	2.1	52.1	3.4	0.0	0.1	0.0	0.7	193.0	13.5	0.0	0.0	0.3	0.0	201.0	0.0	31.5	0.7	2.9	0.1	0.2	3.5	2.7	0.0	27.5	0.1	4.4	542.3	1.0	0.0	0.0	2.2	62.9	0.0	0.0	0.1	29.5	4.1	0.6	0.3	0.7	3.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	66.9	42.5	1.9	1.7	1.0	327.1	3.8	4.8	0.0	0.0	3.7	1.5	0.0	0.1	96.0	10.4	0.3	0.5	0.0	73.0	11.4
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549110-134579875	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"breast: 166.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Fibroblasts: 2.9;Late spermatids: 3.6;Skeletal myocytes: 12.5;Syncytiotrophoblasts: 10.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 15.8;HDLM-2: 12.8;Hep G2: 11.2;SK-BR-3: 5.1;U-87 MG: 6.7"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 5: Breast - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (8.36e-4)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.90e-5)"	0.4	0.1	0.4	0.2	1.4	0.0	166.7	0.3	0.5	1.1	0.0	0.8	14.0	0.0	0.2	3.2	0.0	5.2	0.1	0.4	1.1	0.1	2.1	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.6	0.3	1.8	0.0	7.8	1.1	4.5	0.0	0.7	0.0	12.0	0.5	1.4	0.2	0.1	18.8	0.3	0.9	2.6	1.5	0.1	15.8	0.1	0.0	0.6	0.5	0.9	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	12.8	0.0	0.1	0.2	11.2	0.0	0.2	0.5	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.2	3.1	0.4	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.6	5.1	0.0	0.1	0.0	0.3	0.0	0.1	0.7	0.3	0.0	0.2	0.2	0.2	6.7	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.5	0.4	1.1	0.6	1.1	0.6	0.7	1.4	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.5	0.1	0.0	0.7	0.0	0.3	10.4	0.1	0.0	0.0	0.1
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 623.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 253.8;Basal squamous epithelial cells: 262.4;Cholangiocytes: 284.5;Exocrine glandular cells: 328.0;Hepatocytes: 597.7;Squamous epithelial cells: 229.3;Urothelial cells: 306.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2;lung cancer: 53.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	8	"ASC diff: 2988.3;Hep G2: 5415.7;OE19: 2297.1"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	185.7	14.3	12.3	13.5	16.5	5.8	116.2	16.0	11.5	12.9	6.9	23.2	25.3	6.6	6.6	103.9	11.5	65.7	135.5	10.9	18.7	45.4	623.2	28.9	4.7	22.1	18.4	15.5	23.3	0.8	9.7	1.7	23.2	17.3	12.2	11.5	73.7	12.5	120.4	35.3	23.4	8.7	19.6	4.1	142.9	13.0	22.2	4.6	46.7	27.3	7.8	71.1	31.3	20.3	0.0	429.6	2.4	426.7	2988.3	358.2	0.2	13.7	95.9	5.4	4.1	8.4	0.5	0.0	6.1	97.7	72.5	3.6	1.6	22.4	2.5	0.1	0.2	12.6	65.6	5415.7	30.0	1.8	0.0	183.9	27.3	44.2	26.7	0.4	10.2	2.9	95.8	0.4	74.7	2.4	0.1	0.4	1.2	2297.1	1.5	0.1	0.8	4.2	24.3	81.4	0.4	1.7	23.8	0.7	0.8	1.3	0.5	7.8	85.3	36.0	2.3	97.6	4.5	1.6	0.5	0.3	129.3	12.1	0.9	1.5	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.2	0.1	0.2	12.3	16.5	16.0	11.5	10.9	18.7	22.1	18.4	23.2	19.6	22.2	20.3	21.6	67.3	34.4	2.0	2.4	21.2	27.8	253.8	262.4	3.1	7.6	1.0	3.2	284.5	144.5	62.5	0.0	0.1	0.2	5.9	13.7	67.0	24.0	3.3	1.7	17.1	1.8	52.6	3.4	328.0	0.1	176.3	139.1	4.6	4.5	0.8	21.0	597.7	0.4	0.0	3.1	6.8	20.3	16.1	15.6	9.9	151.6	3.3	106.7	13.1	4.6	51.5	0.0	4.5	0.5	120.2	3.6	147.4	0.4	41.3	20.2	61.9	72.2	4.5	0.0	16.4	24.3	1.9	1.1	229.3	20.5	0.1	2.1	6.4	20.3	306.0
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 341.5;liver: 481.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	341.5	20.8	9.8	10.0	11.6	1.0	205.6	10.7	12.9	17.4	8.1	37.1	29.6	5.6	3.3	202.5	8.6	98.1	83.8	7.2	16.6	43.0	481.9	23.5	2.1	18.7	13.7	10.4	11.8	1.1	8.1	0.8	17.1	11.7	13.3	15.2	116.5	12.9	286.9	42.5	33.7	9.2	11.5	2.1	137.0	11.8	16.8	4.4	38.3	36.5	9.3	253.9	47.0	9.7	0.0	2054.8	2.4	214.1	2439.5	83.4	0.1	0.7	8.6	0.9	2.0	8.1	0.2	0.4	11.5	14.2	10.0	57.8	0.2	10.7	1.2	0.6	0.2	0.7	516.4	3926.2	4.6	0.4	0.9	218.3	126.4	10.5	10.4	0.7	0.9	0.3	81.9	0.3	20.4	3.3	0.2	0.0	0.7	2684.9	0.8	0.3	0.6	34.6	19.0	1178.9	1.2	0.4	21.2	0.3	0.1	0.4	0.5	4.0	8.6	5.1	1.8	74.6	0.8	0.6	0.6	0.3	25.9	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	11.6	10.7	12.9	7.2	16.6	18.7	13.7	17.1	11.5	16.8	9.7	15.2	12.8	2.8	0.0	0.9	11.9	9.5	141.7	20.5	1.9	0.8	1.4	5.5	102.9	128.8	0.0	0.0	0.0	0.0	10.3	0.0	18.3	17.3	0.7	0.5	7.5	1.8	8.0	2.6	103.3	0.1	44.2	133.5	0.8	0.0	0.1	10.8	397.4	0.1	3.3	4.2	5.4	46.8	12.0	7.8	7.8	79.2	1.0	8.8	19.7	0.6	39.6	0.0	5.5	0.3	90.0	6.6	78.6	0.8	23.7	15.9	3.6	40.3	3.0	0.0	5.3	13.9	0.2	0.3	112.9	13.5	0.0	1.3	0.4	8.5	271.9
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 441.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 83.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 244.0;gdT-cell: 102.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 244.0;T-cells: 102.6"	"Cell line enhanced"	"Detected in many"		"A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	164.4	50.2	31.1	25.4	34.6	42.3	115.2	32.1	42.4	21.9	30.2	185.9	441.3	25.9	4.4	53.2	42.1	261.1	42.9	31.5	35.6	177.7	268.0	48.3	7.6	30.3	33.9	17.8	36.4	22.5	10.4	4.7	32.3	10.3	98.0	19.1	40.5	19.4	116.9	27.0	270.9	39.2	30.3	3.8	237.4	10.0	31.5	37.4	26.4	34.8	6.6	84.7	22.2	31.1	0.1	1615.1	1.1	413.0	811.9	292.2	1.0	0.0	21.4	0.4	1.4	47.6	24.5	0.2	78.7	19.4	45.0	11.5	1.5	28.8	1.1	3.0	0.5	3.2	438.4	699.6	4.3	0.7	0.2	160.9	57.1	20.0	0.7	25.8	28.1	3.4	10.8	0.0	42.6	3.8	9.8	2.6	0.7	3025.3	4.3	3.3	9.6	43.7	149.0	639.2	1.0	2.9	232.2	0.0	0.3	0.9	0.5	0.2	221.7	5.2	4.7	87.8	3.1	0.7	0.7	0.3	45.8	62.8	4.4	244.0	2.9	4.8	102.6	0.9	6.9	0.0	19.0	18.7	2.1	0.5	11.6	8.9	7.3	21.1	1.4	39.6	21.4	42.4	31.1	34.6	32.1	42.4	31.5	35.6	30.3	33.9	32.3	30.3	31.5	31.1	144.2	44.8	5.3	4.9	4.3	12.0	3.7	393.1	2.8	2.0	15.8	5.5	3.9	0.0	172.9	36.8	0.0	0.4	64.4	133.8	43.0	114.6	3.3	67.5	4.5	67.5	19.2	34.9	2.5	722.5	0.0	44.3	158.0	66.4	5.7	0.1	0.0	0.0	1.6	1.7	3.2	65.9	61.1	0.0	14.0	4.9	78.3	14.8	21.4	7.5	4.1	132.7	202.9	14.6	0.0	266.1	219.6	106.8	3.1	1.3	576.9	601.8	112.8	5.3	26.3	15.5	20.3	0.5	4.3	20.2	10.7	0.0	14.4	7.8	196.9	46.4
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 717.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	41.8	0.0	0.0	0.0	0.3	717.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138118305	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"liver: 426.9"	"Group enriched"	"Detected in some"	31	"Early spermatids: 65.4;Hepatocytes: 110.3;Late spermatids: 126.1"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		61000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	426.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	110.3	0.4	0.0	0.2	0.2	0.0	3.2	0.4	126.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	1.6	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2
AKT1	"AKT, PKB, PRKBA, RAC, RAC-alpha"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 558.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	71.5	102.7	45.9	57.7	45.5	51.2	61.2	43.7	53.2	52.0	50.4	85.0	50.8	59.5	23.2	70.7	53.7	50.0	105.9	45.2	44.3	54.3	97.3	69.2	51.9	50.5	45.7	43.7	94.3	53.0	35.9	55.4	45.0	67.2	39.6	25.1	67.7	73.0	58.1	45.0	53.3	63.4	47.4	63.7	77.8	23.9	48.0	52.4	52.3	64.9	40.3	72.6	48.4	43.3	77.3	150.5	124.6	186.9	95.2	97.7	136.9	142.3	171.5	204.6	163.6	96.8	92.8	91.2	105.5	196.6	102.8	99.4	89.5	131.9	90.1	214.3	36.2	70.6	90.4	103.2	104.6	117.5	178.0	140.0	109.1	102.9	68.1	98.2	154.4	87.5	62.1	102.2	134.1	558.3	145.3	146.8	32.6	153.5	107.2	137.5	111.9	60.5	94.8	189.5	141.2	117.2	117.3	152.2	88.9	56.8	195.7	170.2	123.5	133.2	63.2	192.3	145.1	105.4	52.6	80.7	113.7	96.7	162.0	6.4	9.9	61.5	10.0	10.3	7.2	5.5	8.7	11.4	7.0	7.2	4.6	10.1	22.6	11.0	12.4	10.0	9.0	6.3	45.9	45.5	43.7	53.2	45.2	44.3	50.5	45.7	45.0	47.4	48.0	43.3	45.8	16.0	27.4	16.6	13.7	12.4	20.0	17.3	15.9	26.3	58.0	39.9	16.1	32.9	17.7	22.0	12.5	19.4	54.2	40.9	13.7	23.6	1.9	17.9	28.1	27.5	30.0	11.3	8.2	35.2	31.8	24.0	26.0	24.8	2.5	40.4	23.2	42.9	23.2	42.1	13.0	37.3	22.4	23.3	21.4	3.3	28.6	28.0	10.6	6.5	23.1	51.2	24.7	8.0	9.6	53.3	22.1	30.9	10.3	38.8	23.5	17.9	14.2	26.6	26.3	24.9	29.1	1.8	5.3	16.2	13.9	23.4	23.3	34.0	33.7	33.4
AL031681.2		ENSG00000288000	"Novel protein"		20	43458054-43541881	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059648			Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA							Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL031777.2		ENSG00000282988	"Novel protein"		6	26195595-26199293	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.1;Extravillous trophoblasts: 6.7;Hofbauer cells: 9.1;Syncytiotrophoblasts: 20.7"					"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 16.9;neutrophil: 30.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in some"		"K-562: 6.9;SiHa: 7.7;T-47d: 4.6;U-2 OS: 5.1;U-266/70: 9.3;U-266/84: 5.6"									HPA041189	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA041189: AB_2677357"																		0.6	0.3	0.5	0.2	0.6	1.5	1.1	1.3	1.2	2.0	1.6	0.7	0.3	0.1	0.0	3.4	0.4	0.1	0.4	0.6	0.5	0.8	1.9	2.2	0.3	1.2	0.8	0.4	0.1	0.1	0.3	0.3	1.1	2.5	0.3	0.1	0.5	0.0	0.0	0.8	0.6	0.1	1.0	2.0	0.5	0.7	1.0	0.8	0.4	0.0	0.1	0.4	2.4	1.4	0.2	0.7	0.2	0.7	1.5	0.1	0.5	0.6	0.1	1.2	0.4	0.2	0.5	0.1	2.0	0.1	0.5	1.4	0.1	0.0	0.2	2.6	0.2	0.4	2.1	0.3	0.1	0.1	0.9	1.0	0.0	0.1	0.3	0.2	0.0	0.6	6.9	1.5	0.0	1.0	0.1	0.4	0.2	2.6	1.6	0.2	0.1	3.0	0.0	0.0	0.6	0.2	7.7	0.5	0.3	0.3	4.6	0.0	0.0	0.7	5.1	0.0	0.0	9.3	5.6	0.7	0.0	1.9	0.7	16.9	0.6	5.1	1.6	0.7	3.6	2.1	0.8	1.1	2.3	4.7	0.8	0.5	30.6	0.9	1.5	5.2	2.3	1.1	0.5	0.6	1.3	1.2	0.6	0.5	1.2	0.8	1.1	1.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0
AL035461.3		ENSG00000286235	"Novel protein"		20	5950949-6039856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.0"									"HPA045141, HPA066433"			Approved	Nucleoplasm,Cytosol		NA	NA					"Cluster 37: Hep G2 - Hepatocyte cell processes"		Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "																		0.9	0.9	0.1	1.0	0.1	0.4	2.6	0.1	0.3	1.8	0.1	1.5	1.4	1.3	1.5	1.4	1.3	0.8	1.5	0.1	0.1	1.5	1.1	1.2	1.4	0.1	0.1	1.6	0.8	1.4		1.8	0.1	1.7	2.6	2.2	0.5	1.5	0.3	0.7	1.6	2.1	0.1	0.9	1.0	2.0	0.1	2.3	1.2	2.9	2.4	1.0		0.1	0.5	5.4	5.0	2.4	5.4	4.7	0.7	1.2	4.5	4.3	4.7	7.3	3.0	1.6	0.1	3.7	3.2	0.4	8.4	6.6	7.1	0.3	0.0	7.2	2.5	18.0	0.8	2.4	1.1	2.8	1.7	4.1	4.0	3.7	2.4	3.0	0.4	2.0	5.2	2.0	3.5	0.7	2.7	6.9	0.1	2.2	3.2	1.8	4.0	4.9	2.6	2.1	0.0	10.8	1.2	6.7	1.4	5.6	0.0	1.6	0.8	0.8	1.2	0.1	0.2	0.9	1.4	4.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL132671.2		ENSG00000282218	"Novel protein, GOPC-ROS1 readthrough"		6	117318211-117573571	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Alveolar cells type 2: 1.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"U-138 MG: 8.9"	"Low region specificity"	"Detected in all"							HPA019477	Uncertain		Approved	"Golgi apparatus"		NA	NA					"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"		"HPA019477: AB_1849890"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL139260.3		ENSG00000274944	"Novel protein"		1	38864501-38881617	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 5.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.7;Endometrial ciliated cells: 1.3;Glandular and luminal cells: 2.1;Respiratory ciliated cells: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA041188, HPA078331"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (8.00e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-3)"	"unprognostic (4.27e-4)"	"unprognostic (4.64e-7)"	"unprognostic (2.59e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.54e-3)"	"unprognostic (6.09e-6)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-3)"	1.4	2.0	0.0	0.9	0.0	0.4	0.4	0.0	0.9	0.5	0.0	2.7	1.7	0.3	0.0	2.7	0.7	0.2	0.4	0.0	0.0	1.1	1.8	0.4	2.5	0.0	0.0	0.4	0.5	0.0	0.9	0.6	0.0	0.7	1.6	0.0	2.4	0.0	0.3	1.5	1.2	0.0	0.0	1.2	1.6	5.1	0.0	0.4	0.6	0.0	0.5	0.9	1.0	0.0	16.7	1.3	3.7	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	8.0	17.5	2.8	14.5	0.0	0.3	11.1	0.0	0.0	0.0	9.2	2.3	1.4	2.7	2.2	0.0	19.3	5.4	0.0	0.0	0.8	0.5	1.2	0.9	0.0	6.4	4.7	1.1	4.1	8.7	20.6	7.7	8.5	9.8	9.8	7.7	17.9	0.0	8.6	7.0	3.6	9.2	7.5	2.1	3.1	5.0	6.1	6.8	2.2	7.6	7.7	16.0	1.8	17.3	12.9	8.2	7.5	2.2	0.0	0.4	0.0	0.0	0.5	0.2	1.2	0.0	0.1	1.7	1.3	0.1	0.0	0.9	0.0	1.4	3.1	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AL353671.1		ENSG00000288684	"Novel protein"		9	32455323-32552603	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.4"	"Low cell line specificity"	"Detected in some"											"HPA047193, HPA073217"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 36: HEL - Hemostasis"		"Plasma membrane, Cytosol"		"HPA047193: AB_2679978, HPA073217: "																		0.7	0.1	0.5	0.3	0.5	0.2	0.2	0.4	0.5	0.4	0.5	0.3	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.3	0.6	0.3	0.5	0.2	0.0	0.9	0.9	0.1	0.0	0.8		0.1	0.9	0.2	0.2	0.0	0.2	0.4	0.4	0.2	0.3	0.2	0.5	0.2	0.2	0.1	0.8	0.5	0.1	0.5	0.1	0.2		0.9	0.3	0.5	0.6	0.1	0.8	0.7	0.2	1.4	0.7	0.7	1.4	0.7	0.0	0.4	0.2	0.6	0.9	0.1	0.2	0.7	0.0	1.3	0.4	1.8	0.7	0.0	0.4	0.8	0.1	0.7	0.5	0.6	1.0	0.8	1.1	1.3	0.2	0.1	0.7	0.0	0.3	0.7	0.3	0.9	0.1	1.4	0.3	0.1	0.3	0.7	0.6	1.4	0.5	0.2	0.2	0.1	0.1	0.0	0.5	0.6	0.5	0.6	0.4	0.3	0.5	0.4	0.4	0.2	0.0	1.7	0.4	1.6	0.5	0.4	0.3	0.5	0.5	0.6	0.3	0.3	0.6	0.5	5.4	0.4	0.3	0.1	0.8	0.3	0.5	0.5	0.4	0.5	0.3	0.6	0.9	0.9	0.9	0.5	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL441992.2		ENSG00000286112	"Kynurenine aminotransferase 1"		9	128819663-128881931	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 1.9"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"											"HPA021176, HPA021177, HPA027736"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"		"Cluster 16: U-266 - Nucleosome"		Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"																		0.3	0.1	0.6	0.2	0.7	0.5	0.2	1.5	1.9	0.2	0.5	0.2	0.2	0.3	0.5	0.2	0.3	0.2	0.1	0.6	0.3	0.1	0.3	0.1	0.3	0.4	0.3	0.3	0.2	0.1		0.3	0.4	0.3	0.1	1.1	0.2	0.4	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.3	0.5	0.3	0.1	0.4	0.2	0.2		1.3	0.4	1.5	1.0	0.6	1.2	0.4	1.2	1.0	0.1	0.7	0.6	1.1	0.4	1.1	0.5	0.6	0.7	1.2	0.6	1.1	0.1	0.9	1.3	1.0	1.4	0.8	0.2	0.9	0.4	0.4	0.5	0.9	0.4	0.7	0.3	1.0	1.6	0.2	0.2	0.5	0.9	0.7	0.9	1.3	1.1	1.2	1.1	0.3	0.2	0.3	0.6	1.0	0.9	0.0	0.2	0.7	0.2	0.3	1.0	0.7	0.6	0.3	0.7	1.2	2.6	0.9	0.3	0.7	0.3	0.8	0.9	0.2	1.0	0.3	0.9	1.4	0.7	0.7	0.7	1.1	0.8	0.8	0.6	1.3	0.5	1.9	0.8	0.5	0.6	0.7	1.5	1.9	0.6	0.3	0.4	0.3	0.4	0.2	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL512785.2		ENSG00000254706	"Novel protein"		1	162365407-162383531	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.6;HEL: 12.0"	"Low region specificity"	"Detected in all"							"HPA052251, HPA074060"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"		Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"unprognostic (1.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.50e-1)"		"unprognostic (9.12e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.57e-1)"		"unprognostic (3.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.07e-2)"		"unprognostic (1.19e-2)"	"unprognostic (6.10e-2)"	1.1	0.6	0.5	0.3	1.2	1.2	1.8	2.3	0.6	1.9	3.5	2.1	2.1	0.9	0.0	1.0	1.2	2.4	0.7	0.6	1.4	1.2	2.7	1.0	0.2	3.8	1.6	0.3	3.2	1.0	0.4	0.7	2.5	1.1	0.5	0.0	5.0	3.9	0.2	1.1	1.4	0.7	2.6	0.1	2.1	1.5	1.4	0.2	0.1	0.2	0.1	0.7	0.3	4.1	7.6	0.0	4.0	4.4	0.2	0.0	0.0	0.8	0.5	0.4	0.0	1.7	2.6	0.0	5.8	0.0	1.5	3.0	0.4	0.5	0.0	0.1	3.9	12.0	0.0	2.8	0.1	0.2	0.0	0.8	0.2	0.0	0.5	0.7	1.5	0.9	1.2	0.2	0.2	2.7	0.4	0.0	3.5	2.1	3.0	0.3	0.1	0.0	1.4	2.7	1.7	1.9	2.6	0.4	1.9	0.5	4.3	0.0	2.1	0.1	1.0	0.1	1.8	5.8	0.0	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	2.3	0.6	0.6	1.4	3.8	1.6	2.5	2.6	1.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL592490.1		ENSG00000197991	"Novel protein"		13	61409858-61427849	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062669			Approved	"Vesicles,Cytokinetic bridge"		Yes	NA						"Cluster 11: Alveolar cells - Smell perception"	Vesicles	"Cytokinetic bridge"	"HPA062669: AB_2732687"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 720.5;liver: 548.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 243.1;Syncytiotrophoblasts: 309.2;Theca cells: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 233.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 233.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	34.5	720.5	24.8	23.9	25.1	176.7	28.7	37.9	82.5	20.5	35.7	43.6	44.9	19.0	28.1	36.4	15.3	32.7	116.2	26.6	28.1	45.7	548.8	47.8	22.9	27.2	25.4	17.1	19.6	60.3	15.7	36.8	33.2	23.1	41.6	20.6	42.8	27.2	110.9	24.3	39.3	23.9	24.9	19.5	45.9	18.6	31.8	23.5	22.1	106.6	28.2	73.8	23.5	28.3	36.2	55.0	38.0	35.4	57.9	43.1	103.1	51.8	47.7	67.6	65.3	73.6	66.2	33.6	12.7	36.4	137.0	20.9	55.1	42.6	54.7	65.9	21.6	43.2	41.2	56.4	81.8	70.8	83.0	54.0	39.1	107.7	35.7	25.0	62.8	57.7	25.8	27.0	62.4	29.5	33.9	107.3	33.0	41.1	93.4	20.0	23.9	53.3	59.8	213.9	20.2	13.3	83.9	40.9	47.2	30.5	23.5	99.9	45.7	37.6	37.1	78.5	76.2	39.5	73.8	50.5	42.1	75.5	61.1	233.9	33.4	103.2	22.9	42.9	37.4	23.1	23.9	26.0	29.8	21.5	21.1	23.3	49.6	30.9	39.0	17.1	35.7	25.1	24.8	25.1	37.9	82.5	26.6	28.1	27.2	25.4	33.2	24.9	31.8	28.3	28.4	35.3	60.3	5.2	14.9	17.3	17.2	36.1	15.9	16.6	28.6	19.6	107.5	25.8	37.7	23.9	4.2	81.9	25.1	68.5	56.7	35.5	10.2	20.2	9.3	27.6	34.6	11.2	6.2	31.3	28.2	19.6	42.3	25.3	95.4	13.1	18.5	243.1	69.1	11.8	6.2	24.3	34.6	13.0	20.8	4.1	13.4	36.4	5.4	8.4	49.1	9.7	11.3	4.0	8.4	42.3	28.1	16.6	14.0	16.0	35.6	36.1	40.6	9.2	13.1	9.1	27.5	25.5	22.3	21.4	16.2	309.2	25.1	187.2	24.3	26.4
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605941-95656711	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 120.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	15.3	16.1	12.2	21.2	12.6	16.7	20.2	12.4	13.1	33.4	21.0	51.9	89.3	18.5	30.9	21.0	21.9	25.2	11.5	12.2	13.6	17.7	24.3	10.8	22.0	12.4	14.7	16.7	61.8	33.5	28.2	26.3	13.1	24.2	49.3	11.4	120.1	24.9	4.3	22.4	73.1	26.3	12.7	12.1	40.5	11.7	14.0	17.2	37.5	5.5	26.9	25.2	14.3	13.1	66.5	61.6	57.9	152.7	76.0	72.9	62.2	75.6	112.8	75.1	93.7	124.4	51.6	223.7	68.9	119.7	36.2	85.6	117.1	77.8	84.6	64.0	92.0	71.2	40.5	177.9	49.7	125.6	76.1	77.0	46.8	61.5	119.1	124.5	79.9	82.6	67.5	46.0	57.1	95.0	114.5	80.5	68.6	109.2	60.7	105.9	66.3	76.9	88.3	49.7	57.5	56.9	60.1	47.1	56.9	66.0	70.5	57.9	66.7	31.1	49.0	80.9	88.2	52.4	41.7	135.8	60.4	142.8	40.7	0.1	2.6	0.2	27.3	5.2	28.7	23.0	24.5	28.3	9.6	16.1	20.7	23.1	0.5	26.3	8.3	5.9	25.8	15.5	12.2	12.6	12.4	13.1	12.2	13.6	12.4	14.7	13.1	12.7	14.0	13.1	4.6	6.4	9.2	7.2	12.6	11.2	8.3	8.9	14.2	6.3	15.6	12.4	4.6	11.5	14.3	20.2	0.0	43.9	6.7	80.5	1.9	13.7	1.3	12.7	18.1	8.0	19.8	17.9	15.7	21.1	31.6	16.2	18.8	16.9	8.2	81.6	5.3	27.3	11.5	10.1	13.6	41.3	8.2	3.5	3.8	1.6	9.3	3.5	16.0	11.2	2.6	7.1	8.2	17.6	12.8	11.7	56.4	12.0	30.1	18.4	79.4	8.4	15.2	3.4	0.0	10.5	10.1	8.2	9.9	17.6	8.1	30.2	9.0	10.8	38.7	9.4
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900671-73080442	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1500.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"classical monocyte: 87.3"	"Lineage enriched"	"Detected in many"	33	"monocytes: 87.3"	"Cell line enhanced"	"Detected in many"		"A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"midbrain: 378.3"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	109.4	182.4	51.3	28.4	71.9	31.8	64.3	125.1	72.4	121.8	35.7	218.2	549.7	139.3	583.4	41.3	184.3	175.4	53.7	64.6	62.1	335.4	1500.8	142.6	31.2	93.4	370.7	222.7	498.1	24.3	164.4	32.0	84.7	57.2	88.8	0.4	104.5	245.4	66.7	17.2	304.3	117.0	104.2	77.5	568.5	149.5	74.5	19.8	211.7	83.0	21.6	31.6	90.7	106.1	0.0	4019.8	0.4	0.0	22.4	0.2	1.4	139.6	0.0	0.1	0.1	136.2	0.0	0.1	50.5	0.0	0.3	2.6	0.0	0.2	0.1	0.4	0.1	232.1	0.6	1269.3	13.7	0.6	0.3	6.7	0.1	0.0	0.0	0.3	143.0	0.0	16.9	0.0	153.3	7.2	0.2	1.8	0.7	7.2	0.4	0.5	44.0	1.8	710.6	1.1	0.3	1.4	0.3	0.4	2.9	0.2	0.0	0.5	0.7	0.0	3.5	0.5	0.3	0.4	0.2	1.0	0.0	1.7	0.4	0.0	87.3	1.4	0.0	14.9	0.0	0.0	0.2	0.1	1.4	0.7	0.0	0.0	2.6	0.0	1.1	1.0	0.0	30.3	51.3	71.9	125.1	72.4	64.6	62.1	93.4	370.7	84.7	104.2	74.5	106.1	4.9	96.1	107.6	31.3	6.9	2.7	18.3	168.3	1.2	0.4	12.6	1.7	4.3	187.3	361.1	115.8	0.0	1.7	0.1	20.2	389.4	71.6	12.6	6.3	125.2	26.4	54.9	96.1	3.5	349.7	1.0	102.7	258.4	8.1	158.9	0.2	133.5	624.4	134.4	0.0	0.5	168.9	138.4	109.6	5.1	37.8	406.4	61.7	7.2	17.8	46.0	0.0	2.1	0.0	0.7	128.4	77.4	207.3	1.3	2.0	267.4	375.4	583.7	0.3	26.3	334.2	28.6	8.6	4.6	21.5	3.1	2.5	8.8	129.6	131.7	26.5
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 134.5;urinary bladder: 125.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 175.4;Endometrial stromal cells: 247.9;Leydig cells: 194.5;Prostatic glandular cells: 580.3;Urothelial cells: 468.7"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 80.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 363.3;HaCaT: 441.7;HBEC3-KT: 1096.9;hTERT-RPE1: 347.7;U-2197: 619.0;U-87 MG: 484.7;WM-115: 516.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"olfactory bulb: 4.5;spinal cord: 15.8"	"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	83.7	11.4	3.0	41.5	2.7	0.6	30.5	4.7	5.2	37.1	16.2	16.6	15.0	8.2	30.3	28.7	24.9	17.0	12.4	3.1	1.9	8.2	5.3	9.8	3.0	4.8	3.4	6.1	15.0	9.0	7.5	8.4	2.6	134.5	8.9	0.3	93.7	49.3	5.9	3.9	25.2	40.8	2.8	3.1	12.8	16.6	3.3	1.6	2.5	6.9	15.7	125.1	22.3	3.9	363.3	43.5	0.6	0.7	75.0	32.8	1.4	3.2	3.2	1.9	0.8	1.0	285.8	2.6	4.7	97.1	55.7	441.7	8.8	1096.9	6.7	0.1	2.0	1.7	20.1	0.3	25.5	1.4	1.9	23.5	29.8	24.4	4.5	347.7	4.0	0.0	0.7	2.4	1.8	3.8	0.2	1.2	9.0	9.6	316.3	0.7	4.2	2.3	0.2	283.6	0.3	25.4	113.9	94.9	33.3	3.6	9.3	3.2	58.3	0.3	1.0	619.0	14.2	0.7	3.4	1.5	484.7	0.2	516.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	2.7	4.7	5.2	3.1	1.9	4.8	3.4	2.6	2.8	3.3	3.9	10.0	16.0	6.3	0.3	0.5	0.6	175.4	70.5	4.6	0.0	64.6	18.9	2.0	1.5	141.6	103.0	0.0	9.6	0.9	1.0	3.9	70.5	1.2	20.6	247.9	11.6	3.5	0.0	2.9	1.4	0.5	48.9	1.1	11.7	5.7	0.0	1.8	0.1	1.2	0.0	2.3	2.1	30.5	0.0	1.3	8.5	194.5	3.3	0.0	1.0	0.6	0.0	0.0	36.7	4.6	29.4	0.0	135.4	0.0	580.3	0.1	0.7	78.7	0.0	13.1	20.4	11.5	0.5	0.9	2.9	1.6	4.9	2.0	1.5	0.8	468.7
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392702-38398661	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 172.7;smooth muscle: 128.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 183.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	21.2	10.4	3.2	31.4	3.2	2.9	8.9	4.1	4.0	8.5	6.4	61.5	22.9	57.7	5.7	32.7	34.9	29.0	14.7	2.7	4.8	59.2	172.7	7.3	5.1	3.5	3.3	12.6	11.3	8.5	2.5	5.2	4.3	36.9	35.5	1.5	11.1	54.5	55.8	6.3	24.8	128.0	3.4	7.2	28.2	8.3	4.0	5.1	15.4	35.9	5.6	85.1	10.5	4.1	72.2	65.5	19.8	31.8	27.6	32.5	15.8	33.6	16.9	27.8	28.3	44.2	13.7	45.2	19.7	47.4	42.0	10.0	66.0	71.4	27.4	50.8	28.5	22.4	44.7	132.2	20.0	36.0	24.0	39.0	15.3	22.6	19.5	56.6	26.8	10.6	65.6	42.8	42.8	27.3	0.1	14.4	59.1	183.3	29.0	14.9	119.9	34.5	25.1	31.7	43.3	19.9	25.7	16.7	19.4	20.6	15.9	27.9	18.2	31.9	52.4	26.9	42.5	6.5	13.2	17.8	16.4	36.0	22.1	0.3	4.2	0.2	6.7	9.2	9.6	5.5	6.5	6.1	9.5	2.6	5.1	6.2	1.0	8.0	11.9	1.2	5.0	5.3	3.2	3.2	4.1	4.0	2.7	4.8	3.5	3.3	4.3	3.4	4.0	4.1	3.3	9.6	1.7	0.0	3.7	1.0	5.7	9.4	2.2	1.2	3.7	4.2	6.6	85.8	3.8	16.5	2.1	2.0	1.2	12.8	17.6	64.1	0.6	2.3	6.4	4.7	15.6	12.8	0.5	6.9	46.6	6.6	8.2	3.4	8.9	12.8	8.9	128.1	7.2	0.0	1.1	25.5	6.1	4.1	2.4	2.2	6.5	4.2	0.0	0.0	5.5	2.1	0.0	0.5	0.5	15.0	7.7	6.8	3.7	6.1	10.3	165.0	0.3	0.7	0.0	6.0	16.1	0.6	0.8	2.1	1.0	1.8	3.3	91.7	71.7	2.8
ALDH1L1	"10-fTHF, FDH, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 369.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 633.3;Proximal tubular cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		3000000		"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	76.4	37.2	53.4	2.0	63.2	0.4	28.8	55.9	63.6	15.6	37.7	10.1	0.2	7.2	2.5	6.6	16.0	2.3	26.5	47.5	56.2	116.6	369.7	3.1	0.3	56.7	52.9	45.3	44.3	15.1	4.5	0.0	53.0	14.6	5.4	8.7	88.6	6.9	90.7	3.5	5.6	2.0	48.4	0.4	9.5	15.0	53.9	3.7	2.6	59.9	4.6	28.3	6.4	46.0	1.3	0.0	0.0	0.0	36.5	0.0	0.4	0.3	1.5	0.4	0.6	0.0	3.2	2.6	10.2	0.0	2.1	0.4	0.6	1.5	0.7	0.0	0.2	0.1	0.3	78.1	10.6	10.6	0.2	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	82.0	1.6	0.0	0.0	0.2	0.3	1.1	0.0	0.1	0.2	45.0	0.7	219.1	0.4	0.3	1.3	10.6	0.0	0.6	0.1	0.0	0.3	1.4	6.2	0.0	0.1	44.8	14.8	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	63.2	55.9	63.6	47.5	56.2	56.7	52.9	53.0	48.4	53.9	46.0	0.8	0.0	6.0	92.7	4.6	0.1	53.5	9.1	1.8	0.2	14.4	2.2	16.1	38.6	44.0	12.9	0.0	0.0	0.1	7.2	72.4	2.9	22.3	57.2	5.2	4.6	1.2	34.7	0.6	5.6	0.2	9.1	0.0	3.6	27.8	12.4	17.2	633.3	0.1	0.0	3.0	17.6	2.0	24.5	1.9	35.0	26.4	9.3	3.6	3.7	0.0	40.0	0.0	11.1	0.2	2.2	0.4	22.6	0.0	12.2	0.8	197.4	32.2	1.4	6.6	10.5	5.3	1.6	4.3	1.7	0.0	0.1	2.8	0.9	5.6	61.7
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105107643	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"pancreas: 40.7;salivary gland: 13.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.1;Inhibitory neurons: 24.0;Oligodendrocyte precursor cells: 25.1;Plasma cells: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.8;ASC TERT1: 85.2;fHDF/TERT166: 102.4;HHSteC: 55.6;HSkMC: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria		No	No				"Cluster 25: Pancreas - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA039481: AB_10795465, HPA059282: AB_2732633"	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	3.7	0.6	1.3	3.1	1.2	0.6	2.3	2.3	1.6	5.3	0.7	2.2	2.6	2.0	1.0	1.3	1.5	2.8	1.9	1.1	1.6	0.4	0.2	1.8	1.0	1.4	1.3	0.6	40.7	0.6	1.3	1.1	1.5	3.6	2.3	0.7	13.0	4.6	0.8	1.0	1.4	4.2	1.8	0.7	3.3	1.1	1.6	0.5	2.1	1.2	1.7	3.4	1.5	2.5	13.0	1.3	0.7	27.3	62.8	85.2	1.6	40.8	26.0	5.2	13.5	1.6	0.0	0.0	1.6	102.4	0.2	0.1	0.1	1.0	6.5	0.0	0.3	0.8	0.1	3.4	55.6	5.3	0.1	69.7	3.1	13.6	25.2	0.0	3.0	0.2	2.1	37.7	10.6	0.0	0.0	0.3	1.6	0.0	0.3	0.0	0.1	4.3	0.0	0.0	9.4	4.5	0.0	8.3	20.5	0.4	6.0	44.0	0.3	3.9	3.8	0.0	2.2	45.5	12.8	0.1	16.2	19.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.2	2.3	1.6	1.1	1.6	1.4	1.3	1.5	1.8	1.6	2.5	1.4	0.0	0.6	3.3	2.6	0.5	0.1	0.7	0.0	1.7	0.3	1.1	1.6	0.0	0.2	0.0	0.0	0.2	1.5	0.1	0.0	0.3	4.1	0.7	8.5	0.9	0.0	0.0	23.1	9.8	0.6	10.5	1.5	1.6	0.0	0.1	1.1	0.0	0.4	5.0	24.0	0.0	0.0	0.6	1.7	5.9	3.7	1.0	5.4	1.0	4.0	1.3	0.0	25.1	8.5	3.7	0.0	6.8	14.6	0.4	0.0	0.1	0.2	0.8	0.0	3.6	8.4	1.7	0.1	0.0	0.6	0.3	0.9	0.1	0.1	0.2
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 496.1;salivary gland: 128.0;stomach 1: 224.8"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 389.5;Basal squamous epithelial cells: 274.3;Club cells: 150.1;Gastric mucus-secreting cells: 437.9;Respiratory ciliated cells: 412.7;Squamous epithelial cells: 342.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.4;lung cancer: 60.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"A549: 5094.7;OE19: 6071.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		52000	"Cluster 22: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	1.7	1.0	0.4	1.3	0.7	0.1	3.2	0.3	0.4	6.7	17.5	4.5	6.2	0.3	0.2	496.1	5.5	10.3	0.3	1.0	0.4	1.3	1.9	10.9	0.5	0.6	2.1	0.4	0.5	0.0	0.9	0.0	0.5	1.9	3.3	0.1	128.0	1.5	1.3	72.6	3.5	0.4	0.9	0.9	224.8	1.6	1.3	0.6	0.5	0.3	33.7	6.2	22.3	0.9	0.1	5094.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	10.7	246.5	0.0	2.7	0.5	2.0	29.3	0.7	12.8	0.0	0.0	0.8	0.1	116.6	1.0	0.3	0.1	0.5	0.0	14.9	0.5	0.4	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.1	0.3	0.4	6071.6	19.8	0.0	0.0	0.0	0.0	87.0	0.2	0.6	24.8	0.0	0.0	0.2	0.2	0.9	0.6	0.3	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.4	1.0	0.4	0.6	2.1	0.5	0.9	1.3	0.9	0.7	3.2	5.5	0.0	0.7	44.1	46.8	389.5	274.3	0.0	0.1	1.5	0.4	2.8	150.1	0.0	0.0	0.0	0.0	5.1	0.0	1.4	1.5	12.4	0.2	1.3	1.8	0.0	0.1	0.5	0.0	1.6	437.9	0.8	2.5	0.3	1.4	3.2	0.2	0.0	0.0	4.8	83.4	0.3	1.8	5.2	0.9	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	9.5	4.7	1.9	3.2	5.8	3.4	5.0	412.7	0.2	0.0	1.7	20.1	1.7	8.6	342.2	32.0	0.0	0.5	0.2	8.4	64.3
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19685760	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 288.6"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 285.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		32000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Endoplasmic reticulum, Cytosol"		"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	75.2	203.0	23.1	15.2	32.5	9.3	34.9	24.8	27.7	49.4	71.7	49.6	68.1	29.4	41.7	131.3	38.3	70.5	44.6	29.0	27.9	173.0	288.6	59.1	14.9	23.3	26.3	32.3	52.3	40.6	21.9	11.8	23.5	75.0	36.5	40.8	61.7	41.5	53.0	207.6	71.8	30.2	25.1	19.4	81.5	26.9	24.8	23.0	75.1	100.9	36.4	24.2	40.5	33.6	27.7	147.0	29.2	58.5	88.7	89.4	19.1	12.3	29.9	24.4	27.6	63.2	52.5	12.3	35.9	50.5	29.3	99.0	59.8	125.2	19.9	36.2	42.5	5.3	120.9	142.8	12.2	30.6	5.4	42.9	137.6	22.9	12.2	49.7	49.2	25.5	2.2	0.6	37.3	45.3	0.7	25.2	32.3	285.4	78.5	38.6	64.1	25.3	17.5	132.3	46.3	30.4	98.9	38.4	35.3	152.2	78.1	35.0	46.7	10.1	28.7	68.8	45.6	11.3	28.6	15.5	47.4	0.3	48.3	0.8	21.1	17.5	6.3	18.3	9.9	5.2	6.0	6.1	20.7	4.9	6.8	6.3	2.2	15.0	20.6	1.3	11.3	11.0	23.1	32.5	24.8	27.7	29.0	27.9	23.3	26.3	23.5	25.1	24.8	33.6	22.1	176.3	86.5	14.7	13.3	57.1	143.9	85.1	287.4	15.3	13.6	24.0	54.1	105.8	86.5	33.1	12.5	12.5	8.2	48.9	43.0	97.5	79.6	47.5	13.4	19.5	16.2	8.2	30.5	52.0	4.6	39.9	87.7	36.9	29.7	34.6	13.6	116.7	24.6	6.7	20.1	27.7	26.4	21.7	15.1	19.5	55.9	23.5	7.2	13.1	25.7	105.9	8.2	19.6	29.1	43.9	28.7	80.5	28.6	104.2	90.6	119.2	59.2	21.4	13.1	70.1	22.1	15.5	24.0	232.6	90.2	1.4	13.2	29.1	46.0	51.4
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902724	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 200.4;liver: 436.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.0;Hepatocytes: 385.1;Proximal tubular cells: 279.4;Syncytiotrophoblasts: 86.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 83.7;SK-BR-3: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		58000	"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	70.8	16.1	73.9	3.9	88.9	11.7	21.6	73.8	95.9	12.6	106.5	6.8	1.6	9.8	4.7	36.3	8.3	5.5	33.0	68.2	73.8	200.4	436.6	6.2	3.4	72.9	82.8	7.3	4.6	23.0	9.7	13.2	70.0	29.5	2.7	6.5	9.1	27.1	74.2	19.2	4.7	7.1	65.6	7.5	12.5	3.2	92.4	11.7	7.1	74.8	4.2	19.3	16.8	66.1	12.7	17.8	9.5	29.2	40.0	5.7	25.2	13.1	7.1	11.8	9.5	13.7	8.9	8.8	16.6	15.6	5.7	34.0	16.7	35.4	4.5	4.8	15.9	5.9	5.0	83.7	12.6	4.4	15.1	15.6	19.2	6.5	6.6	9.0	13.5	14.0	21.0	5.7	8.1	32.3	4.3	20.2	4.7	26.0	10.1	27.9	8.4	10.0	12.1	32.0	19.6	7.6	21.9	85.0	16.1	14.7	38.7	6.3	11.3	10.2	14.0	12.2	4.5	7.1	17.9	2.5	3.4	33.7	13.5	0.0	2.7	1.5	0.6	3.6	0.5	0.8	0.3	0.8	4.4	0.7	0.2	0.5	0.3	0.1	2.0	1.5	0.6	1.5	73.9	88.9	73.8	95.9	68.2	73.8	72.9	82.8	70.0	65.6	92.4	66.1	2.6	0.0	2.8	27.1	4.3	7.5	17.9	12.5	17.6	3.7	9.8	8.5	20.9	34.3	2.9	46.0	10.4	78.0	2.0	2.0	46.9	6.5	0.5	1.1	1.7	3.1	2.4	32.2	1.2	0.9	12.6	3.2	7.7	3.9	4.5	2.1	15.4	385.1	13.8	20.2	1.6	3.6	6.1	17.2	1.4	0.6	1.2	4.7	3.6	1.9	10.9	14.0	1.0	5.5	1.3	2.5	1.8	2.6	4.4	12.0	0.3	279.4	1.7	4.8	6.6	2.6	4.7	2.2	3.9	21.7	5.4	86.6	2.6	4.5	4.0	9.5
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494867-24537207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 136.6;U-698: 173.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		50000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	9.4	6.1	27.8	5.9	28.9	4.4	5.2	25.0	32.7	5.4	18.8	8.5	11.8	4.8	3.7	7.3	19.0	5.1	14.5	26.5	32.8	27.8	98.8	6.4	13.6	26.7	35.0	7.3	8.2	19.4	5.8	2.4	27.3	8.2	7.1	11.0	5.2	5.2	57.9	9.5	8.0	3.1	29.4	6.8	7.7	4.5	34.0	26.8	17.0	33.8	12.9	6.7	8.4	24.9	11.5	9.3	6.5	10.1	0.1	0.0	11.7	0.8	2.0	2.4	1.6	35.1	2.5	136.6	21.1	1.0	2.2	0.1	10.5	1.3	1.5	14.7	20.2	20.7	5.9	42.4	1.6	32.2	2.7	1.0	4.4	0.2	0.0	7.1	0.1	34.7	10.4	0.0	1.8	23.3	40.4	19.0	2.7	18.4	5.5	46.1	1.4	1.3	7.7	19.6	11.7	10.5	12.1	1.2	13.2	2.8	19.4	17.5	0.2	1.1	6.7	0.3	7.1	19.4	32.2	173.7	0.2	9.8	1.4	0.3	0.0	0.1	1.0	0.0	1.9	2.2	1.4	1.5	0.1	2.0	3.8	3.4	0.2	0.8	0.1	2.4	0.9	0.7	27.8	28.9	25.0	32.7	26.5	32.8	26.7	35.0	27.3	29.4	34.0	24.9	2.9	16.0	25.3	14.0	9.7	1.7	5.6	8.2	2.2	12.9	7.5	3.4	34.8	11.5	9.4	7.3	16.7	6.1	7.4	6.1	1.9	1.6	0.8	15.2	5.0	3.7	8.4	16.0	18.1	1.0	5.2	3.5	5.6	5.4	7.0	13.5	6.8	90.7	3.9	16.8	32.4	11.7	2.0	3.8	1.8	0.3	3.4	1.7	1.8	8.4	0.2	11.8	3.1	11.6	2.4	1.3	7.7	4.5	12.2	4.1	13.4	26.8	12.8	6.9	0.0	6.9	2.3	1.7	6.6	8.7	3.0	1.9	5.4	8.0	17.0	13.1
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056847-74084492	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 379.1;liver: 367.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 201.5;Hepatocytes: 523.6;Proximal tubular cells: 962.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 43.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 43.2"	"Cell line enhanced"	"Detected in all"		"T-47d: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	38.7	14.7	58.6	4.8	66.0	3.3	14.4	58.8	59.3	17.3	61.4	15.2	26.6	11.4	9.8	9.8	12.8	9.4	40.3	51.0	54.0	379.1	367.1	9.4	5.1	63.3	54.0	28.3	23.4	37.0	6.6	7.6	55.6	25.4	15.8	15.2	19.8	16.1	27.5	6.2	23.4	9.0	56.4	5.4	24.0	17.1	69.8	5.7	28.3	34.8	5.3	11.4	7.0	62.6	8.9	7.8	11.0	23.5	39.3	19.2	17.5	6.3	11.8	6.8	11.5	17.3	10.2	10.5	13.6	13.5	5.3	4.8	24.9	7.0	14.5	9.5	3.5	5.1	8.0	19.2	45.0	2.7	2.4	28.2	12.0	8.7	20.7	17.0	12.0	23.7	8.1	14.7	4.6	36.2	7.6	4.0	8.7	32.6	5.2	15.1	11.2	14.6	9.2	5.8	4.4	7.0	21.0	21.9	5.7	18.0	57.5	9.6	3.8	7.4	9.0	11.7	2.4	9.3	18.9	10.2	9.9	3.2	7.3	29.1	6.2	43.2	6.9	4.8	10.6	7.2	7.8	8.4	9.2	6.1	9.9	7.0	2.4	9.7	4.2	5.3	6.1	4.9	58.6	66.0	58.8	59.3	51.0	54.0	63.3	54.0	55.6	56.4	69.8	62.6	15.4	38.5	60.4	24.5	11.8	9.2	26.8	10.0	20.5	20.6	28.4	18.9	81.4	67.2	22.9	66.2	4.2	31.0	7.1	18.9	201.5	11.6	23.4	26.2	27.5	27.0	16.9	28.6	5.5	3.1	14.8	25.9	34.7	90.2	7.6	27.1	87.4	523.6	17.7	11.8	10.0	39.3	8.2	26.5	8.9	19.0	28.9	13.4	24.9	1.9	15.8	98.5	9.2	12.5	23.4	4.1	16.3	48.2	8.0	27.6	55.3	962.4	15.4	17.0	13.1	25.6	16.9	11.0	4.2	25.2	7.4	30.6	11.0	10.2	35.7	17.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595362	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 256.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		430000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	23.7	38.3	46.6	9.1	47.6	1.8	47.1	43.7	45.8	32.7	40.7	29.5	23.7	25.1	8.8	35.9	28.8	19.1	27.9	44.7	43.2	115.1	162.2	15.7	8.6	43.1	43.5	65.3	27.0	34.0	8.8	44.9	42.6	42.0	27.4	19.7	40.6	27.9	12.2	29.4	21.0	23.6	44.8	7.0	23.6	12.3	44.0	18.3	47.6	26.5	17.1	18.1	20.9	45.2	64.9	41.9	116.6	193.4	95.5	56.4	147.8	76.1	93.4	86.5	110.5	118.6	60.7	0.0	75.5	60.0	36.1	47.1	36.5	256.2	78.8	0.1	44.6	12.3	63.1	102.1	46.3	0.2	0.0	69.0	59.2	67.3	47.7	64.2	70.0	0.0	0.0	0.1	77.1	42.1	2.6	0.3	79.4	47.5	35.2	38.9	131.8	0.0	81.2	48.4	39.4	47.2	0.0	41.1	44.7	89.0	75.2	2.7	86.1	24.8	75.6	28.8	53.1	0.1	0.1	0.4	13.4	0.2	40.6	0.7	0.2	0.1	0.1	0.0	0.2	0.8	0.2	0.1	1.8	0.6	1.2	0.6	0.1	0.1	0.0	6.4	0.0	0.4	46.6	47.6	43.7	45.8	44.7	43.2	43.1	43.5	42.6	44.8	44.0	45.2	17.6	16.0	29.3	99.3	5.0	25.9	59.5	110.0	87.0	23.6	40.6	91.1	39.9	27.1	43.5	42.3	22.9	414.1	3.7	15.2	76.3	43.5	31.4	18.7	44.3	19.1	21.7	5.2	16.0	13.8	107.8	34.0	27.0	21.4	7.0	50.4	18.9	74.6	51.1	25.2	21.5	25.9	20.3	9.4	7.6	41.7	25.4	9.1	55.2	12.2	7.5	102.1	0.0	41.7	30.0	12.6	15.6	37.2	2.0	27.5	23.4	302.1	23.4	13.6	19.7	19.4	25.8	1.0	5.1	59.2	16.1	222.3	4.6	39.3	46.4	50.4
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 311.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	119.2	105.5	49.6	29.8	51.0	24.8	76.8	49.3	60.3	51.5	62.5	45.7	54.8	38.6	93.4	105.6	50.2	32.0	48.2	47.4	57.5	142.4	206.5	38.5	40.3	50.5	52.1	53.6	44.0	81.9	39.9	38.0	51.4	65.3	50.6	46.4	104.1	45.6	93.6	54.7	48.6	42.0	50.7	37.9	39.5	63.4	49.3	39.0	123.0	56.4	60.1	39.4	43.9	55.6	55.7	53.5	48.7	44.1	152.1	132.8	40.7	71.9	101.5	70.8	61.0	33.4	40.7	0.1	67.1	64.8	34.9	42.8	40.0	70.3	83.0	25.9	50.6	35.3	34.7	36.5	78.2	56.0	36.1	86.0	34.8	75.2	62.5	97.8	62.2	45.9	56.9	48.4	111.7	33.4	37.6	57.6	71.3	145.1	64.7	31.7	62.0	74.3	92.5	52.0	57.7	39.8	51.4	57.1	67.4	65.6	108.8	84.0	61.9	42.5	41.5	52.4	37.1	44.7	62.5	54.8	47.9	52.6	41.7	61.8	35.2	50.9	45.5	37.7	48.8	49.9	43.8	49.6	34.5	46.8	43.8	50.4	51.3	43.0	45.3	21.6	69.8	45.6	49.6	51.0	49.3	60.3	47.4	57.5	50.5	52.1	51.4	50.7	49.3	55.6	56.2	16.0	47.6	12.7	43.3	32.6	43.3	43.8	68.3	25.0	83.0	54.6	46.5	55.8	36.8	51.5	22.9	48.5	39.3	43.9	97.8	42.9	45.4	27.7	39.1	49.4	55.8	28.2	5.6	37.0	76.4	60.6	36.2	20.4	38.0	60.9	59.3	158.8	61.9	13.5	8.3	56.9	32.6	59.1	24.9	39.8	95.4	43.8	56.9	6.5	34.6	311.5	39.1	12.1	12.2	32.2	33.1	115.5	34.8	39.6	80.3	204.4	59.4	28.9	26.3	32.5	40.1	85.6	49.9	123.8	51.9	38.2	43.7	148.4	63.6	28.3
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 26754.8;tongue: 9180.4"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 3267.9;Extravillous trophoblasts: 2322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004177, CAB006252"	Supported		Approved	Cytosol		NA	NA		640000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	569.3	696.4	616.8	443.1	697.4	732.5	512.6	617.3	719.7	566.0	617.0	774.1	517.9	533.7	201.0	1302.0	449.7	420.5	2286.1	731.9	652.0	709.0	217.1	425.6	358.2	762.3	654.0	510.4	390.5	943.1	525.1	351.4	763.9	457.7	400.1	465.2	904.9	597.6	26754.8	643.4	488.3	465.2	545.5	417.5	595.0	138.7	657.8	280.9	454.5	9180.4	478.3	761.8	740.3	558.7	2206.1	1620.4	477.9	1542.8	714.6	808.5	1520.8	1297.9	1336.2	1291.6	1603.0	1158.1	1643.6	1487.6	2072.2	1318.6	708.6	1632.6	966.8	2829.1	939.3	658.5	1272.9	1219.3	1202.7	2591.1	1112.5	1793.8	1251.3	1115.7	979.6	1455.4	968.9	2119.7	965.4	686.9	1070.0	951.1	1393.4	3136.7	1100.2	1477.0	1192.8	848.1	1346.6	1613.9	765.2	3353.2	1629.4	1230.5	950.7	668.5	808.6	3368.5	1213.9	591.2	1433.0	1194.7	1162.5	1892.3	750.3	1046.7	1430.0	1861.5	1387.3	1369.3	3524.5	1715.9	1532.9	2050.6	2694.7	2081.7	1008.7	2466.5	1138.1	908.5	1091.7	1047.0	2182.7	877.9	1027.4	996.9	2531.7	819.9	2780.2	824.0	1476.3	4372.2	616.8	697.4	617.3	719.7	731.9	652.0	762.3	654.0	763.9	545.5	657.8	558.7	17.0	12.8	32.4	83.2	281.2	792.0	716.4	3267.9	784.8	387.4	34.4	21.6	1968.4	273.1	1385.1	42.3	118.9	1194.1	107.9	1834.8	111.6	120.9	258.8	15.8	11.8	261.1	323.9	215.8	66.2	76.2	2322.1	329.7	513.3	16.1	196.5	18.7	289.5	102.0	1181.9	733.6	70.0	755.1	1265.4	632.2	715.4	1152.4	380.8	388.8	924.9	50.6	417.7	662.1	328.5	40.2	60.8	126.2	1497.1	405.1	409.4	676.9	1755.7	75.8	700.9	298.9	486.4	680.9	572.9	25.8	123.6	1174.6	684.5	1361.3	294.3	15.2	937.7	1146.2
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28576948	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1384.6;choroid plexus: 589.6;retina: 1183.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.5;Horizontal cells: 274.2;Muller glia cells: 127.1;Proximal enterocytes: 120.0;Rod photoreceptor cells: 348.5"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 250.9;U-266/70: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		150000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	87.0	24.3	953.6	12.7	909.7	23.6	42.5	1238.3	1162.3	39.3	589.6	18.5	18.7	17.9	10.9	40.8	14.3	10.9	285.5	955.7	958.0	16.8	98.3	13.7	19.3	1297.5	962.6	39.1	4.9	12.1	30.6	4.1	1384.6	18.9	14.7	1183.1	19.9	15.8	4.8	74.5	43.9	12.4	926.9	24.4	23.3	14.2	1090.2	9.6	7.4	8.1	30.5	19.0	47.0	886.1	29.9	2.1	13.7	55.7	29.9	32.9	2.9	16.7	37.7	12.9	76.0	17.9	3.0	14.9	17.3	15.5	3.3	36.9	10.3	102.3	23.4	12.4	8.9	28.3	11.6	30.4	25.8	10.0	29.2	27.8	13.9	1.5	24.0	1.7	5.3	29.7	19.3	71.9	10.7	15.1	11.9	32.0	20.8	6.7	15.3	9.5	1.6	250.9	1.9	4.3	36.2	61.9	9.1	67.3	0.5	20.8	36.6	21.2	3.5	1.2	5.3	2.1	2.4	161.0	51.4	10.9	105.2	28.0	1.9	0.5	7.4	3.0	21.6	8.7	30.6	24.0	29.5	17.8	9.4	25.1	37.7	28.4	18.0	29.4	5.3	4.6	40.9	19.0	953.6	909.7	1238.3	1162.3	955.7	958.0	1297.5	962.6	1384.6	926.9	1090.2	886.1	4.2	0.0	15.8	97.6	9.8	7.5	20.3	80.5	8.6	112.5	9.0	11.0	22.1	11.5	29.3	7.3	106.3	1.1	9.5	31.7	3.9	21.9	0.9	1.0	3.0	11.3	21.6	3.2	19.2	10.2	6.5	5.8	6.6	1.2	13.3	4.9	14.3	93.1	5.4	274.2	41.3	12.9	28.5	4.4	5.3	1.3	9.3	3.1	24.9	21.5	34.1	127.1	12.3	26.7	16.8	12.4	12.4	10.1	2.6	6.1	120.0	2.1	11.8	348.5	13.1	6.4	10.1	0.3	3.2	7.9	10.9	1.5	17.0	11.7	5.1	7.8
ALG10	"ALG10A, DIE2, FLJ14751"	ENSG00000139133	"ALG10 alpha-1,2-glucosyltransferase"	Q5BKT4	12	34022468-34029694	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.88e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.29e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.45e-2)"	2.3	2.6	1.3	2.7	1.5	4.1	2.8	1.7	1.1	1.9	0.9	2.3	1.6	2.2	2.7	2.1	3.4	1.8	1.0	0.8	1.5	1.9	2.9	1.8	3.7	1.9	1.2	2.3	1.5	2.3	0.6	2.3	1.6	2.6	1.9	3.3	1.5	1.9	0.9	1.9	1.8	2.1	1.6	2.9	2.0	2.6	1.3	3.6	2.8	1.3	2.9	1.3	0.9	2.2	5.3	5.8	4.0	7.0	4.6	4.3	14.0	5.1	4.7	5.4	9.8	8.8	12.6	10.3	7.3	2.6	8.2	7.8	7.9	6.8	7.9	13.0	7.2	9.2	6.7	3.9	1.8	11.4	8.1	4.0	3.6	11.3	9.3	2.6	3.7	8.1	13.9	13.6	5.5	6.8	8.4	6.3	15.1	3.2	7.7	6.5	14.8	8.3	3.2	7.8	3.8	3.0	9.4	3.8	5.6	11.7	8.6	3.2	7.5	7.4	10.7	11.3	6.5	7.4	14.7	17.3	5.0	4.8	6.2	0.0	1.0	1.7	0.6	0.4	0.9	0.8	0.9	0.4	0.6	0.8	1.1	1.3	0.1	0.8	0.5	0.7	1.2	0.5	1.3	1.5	1.7	1.1	0.8	1.5	1.9	1.2	1.6	1.6	1.3	2.2	3.0	6.4	0.5	1.3	5.1	1.5	3.0	4.3	2.8	4.6	2.0	1.7	0.8	2.8	5.1	5.5	4.2	6.8	3.5	1.4	1.9	2.4	1.0	3.1	2.8	2.3	1.2	7.0	1.5	3.8	5.5	2.7	3.1	2.2	1.3	3.6	0.7	2.9	3.3	1.7	1.8	1.7	2.0	2.8	1.9	0.3	1.5	2.2	0.0	1.9	3.3	3.4	1.0	2.5	1.8	3.3	0.6	1.2	4.0	0.8	1.2	1.3	3.9	4.2	0.0	2.5	2.0	12.4	5.8	4.3	2.7	3.1	3.2	2.6	1.9	1.8
ALG10B	KCR1	ENSG00000175548	"ALG10 alpha-1,2-glucosyltransferase B"	Q5I7T1	12	38316762-38329721	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (4.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.58e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	2.9	3.5	2.1	3.0	2.3	4.3	5.2	3.1	2.5	2.8	1.8	2.1	2.4	3.7	3.7	1.8	3.4	2.6	2.2	1.8	2.0	3.3	3.7	2.5	4.6	2.5	2.3	5.0	2.9	3.7	1.1	5.0	2.6	3.4	2.6	9.1	2.8	2.2	1.5	4.3	2.6	2.5	2.6	4.6	3.7	2.6	2.2	4.0	4.2	2.4	3.7	1.5	1.4	3.1	5.1	4.6	6.1	6.2	3.0	5.5	6.3	4.0	2.0	5.3	4.6	1.7	15.2	8.0	7.2	2.3	4.1	5.3	5.7	4.4	7.6	5.2	6.8	8.4	8.4	3.5	3.5	11.3	6.1	3.1	5.7	7.5	5.5	4.7	4.2	10.4	9.6	4.6	4.8	3.9	7.5	8.9	7.8	0.5	4.6	2.5	13.2	6.3	4.4	6.4	1.8	6.3	7.1	2.3	5.0	6.6	10.6	4.6	3.3	5.5	6.6	4.9	5.2	3.6	10.1	12.5	4.7	7.7	7.3	0.3	0.4	0.6	0.3	0.5	0.5	0.4	0.3	0.4	0.3	1.3	0.5	0.7	0.1	0.4	0.4	0.7	1.2	0.3	2.1	2.3	3.1	2.5	1.8	2.0	2.5	2.3	2.6	2.6	2.2	3.1	7.1	6.4	13.9	9.1	2.6	2.0	3.4	3.3	4.0	14.9	5.0	3.8	3.9	0.0	7.0	3.7	33.3	16.1	2.1	0.9	7.9	4.3	0.3	6.5	6.2	5.7	0.0	2.5	4.8	5.8	9.6	4.8	2.0	4.6	1.3	9.5	6.8	7.1	4.8	10.1	5.7	1.9	4.1	1.6	2.0	1.8	4.1	3.1	1.8	10.3	2.5	8.0	1.0	9.0	9.1	4.5	2.0	5.7	1.6	2.0	2.6	2.6	5.2	14.5	6.6	6.5	3.2	10.7	4.7	3.1	1.8	8.1	3.0	4.6	2.3	2.3
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13 UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002853, HPA005498"	Approved		Approved	Vesicles,Cytosol		NA	NA		11000000	"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA002853: AB_1078131, HPA005498: "	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	15.1	17.9	10.5	18.8	11.7	16.6	18.3	11.5	19.0	17.2	12.3	18.2	13.7	16.1	20.5	14.7	15.4	16.4	13.2	10.2	13.8	21.0	23.8	13.8	23.4	12.6	12.1	15.8	14.7	23.4	17.9	14.1	13.3	17.7	19.4	11.8	15.6	13.4	9.2	19.4	17.3	17.5	11.4	18.5	15.5	17.4	11.8	17.3	18.2	9.9	20.1	21.3	14.7	16.6	22.3	24.4	21.8	13.8	13.8	19.6	12.3	17.7	18.3	22.4	27.5	24.9	23.1	19.5	33.0	24.7	46.5	12.6	26.1	12.5	23.5	14.4	17.6	10.7	26.1	28.4	20.3	19.5	40.5	23.6	22.8	18.0	38.6	23.3	24.8	21.8	23.9	53.5	22.5	55.8	16.4	17.6	19.9	66.3	33.6	12.8	13.9	26.7	36.6	34.0	13.1	19.1	25.2	15.2	16.3	21.7	13.6	18.5	16.7	19.2	9.7	24.9	34.4	25.8	47.1	31.5	20.5	25.5	15.2	39.5	15.8	16.6	9.5	16.3	9.3	10.6	10.6	9.2	18.5	12.1	13.0	10.8	3.0	4.6	12.9	9.5	14.6	9.6	10.5	11.7	11.5	19.0	10.2	13.8	12.6	12.1	13.3	11.4	11.8	16.6	50.9	16.0	30.8	33.6	127.9	35.2	65.8	53.5	33.6	15.1	33.9	31.6	18.7	22.8	36.0	18.4	10.4	27.3	73.9	39.2	45.0	37.4	21.1	48.2	31.1	37.4	26.5	27.1	64.7	52.1	39.1	34.6	37.2	47.9	109.8	15.7	28.2	28.4	42.5	11.8	57.4	49.0	46.8	39.2	52.3	9.4	21.5	56.1	28.4	83.4	41.8	16.0	29.9	41.7	77.5	58.0	55.6	16.1	60.4	46.9	38.5	55.5	35.3	16.5	26.3	38.7	46.2	32.6	22.4	26.5	35.4	48.7	71.1	28.8	32.8	64.6
ALG5	bA421P11.2	ENSG00000120697	"ALG5 dolichyl-phosphate beta-glucosyltransferase"	Q9Y673	13	36949738-37000763	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007989	Approved		Approved	Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA007989: AB_1078132"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (7.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.86e-1)"	29.1	32.3	12.1	19.6	13.3	26.9	41.6	13.4	25.7	34.2	14.9	36.0	27.1	23.5	77.9	21.7	23.3	23.2	18.5	12.4	13.7	41.2	61.9	24.5	20.7	13.5	13.1	20.6	90.1	40.2	18.7	25.4	14.0	26.5	46.4	11.2	51.9	30.9	18.5	20.9	27.6	23.4	13.6	23.6	36.6	15.2	12.6	22.7	54.9	10.5	28.9	30.5	21.6	14.8	24.3	35.0	31.5	29.4	95.1	61.8	22.5	63.9	81.1	63.7	53.7	71.0	84.1	35.2	25.9	45.7	55.0	57.5	41.9	55.0	62.6	37.4	77.7	77.2	27.5	40.1	85.1	69.6	43.7	62.7	88.8	49.4	60.6	41.5	47.7	43.9	39.8	49.7	59.9	45.6	47.4	59.8	29.1	188.2	27.5	54.3	30.4	102.5	71.5	49.8	25.2	45.5	29.2	62.8	34.2	25.4	34.4	79.1	36.1	32.7	20.4	37.2	45.8	35.8	28.8	37.4	51.2	41.9	57.1	59.1	55.7	26.2	53.4	62.3	54.4	44.1	49.1	55.6	57.1	40.2	46.4	47.2	5.8	54.7	53.0	109.0	65.7	69.2	12.1	13.3	13.4	25.7	12.4	13.7	13.5	13.1	14.0	13.6	12.6	14.8	52.0	51.3	51.9	11.1	51.5	34.7	45.9	142.9	27.3	19.8	50.2	42.5	14.2	61.5	86.0	53.3	10.4	81.4	49.4	28.9	23.5	93.5	33.7	31.5	44.1	45.5	36.1	25.9	19.5	140.2	74.4	46.0	32.1	40.1	29.2	25.9	37.9	77.3	69.7	11.8	22.4	76.3	111.9	37.1	52.1	25.8	40.0	39.4	80.0	14.0	45.2	36.6	25.7	18.1	30.6	85.9	50.9	38.4	166.6	56.4	51.4	62.7	43.8	25.2	46.0	34.4	70.7	57.6	23.7	33.6	30.3	81.3	43.0	58.5	62.2	50.7
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996049-7010754	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 34.6;esophagus: 49.4;vagina: 105.7"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 25.5;HEL: 40.4"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		49000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	1.0	1.5	0.9	3.2	1.5	4.7	0.3	0.1	1.4	34.6	0.6	0.4	1.8	2.2	0.0	49.4	1.2	3.1	1.4	0.4	0.4	0.5	0.2	1.1	3.9	1.3	0.7	1.3	1.9	0.0	0.1	1.1	1.0	0.8	0.1	3.1	20.2	0.0	1.6	21.7	2.0	0.2	0.1	3.3	1.1	1.3	1.2	0.0	1.9	0.1	3.8	1.5	105.7	3.4	25.5	4.2	1.9	1.4	0.0	0.0	1.7	1.6	0.0	0.0	0.0	3.7	0.9	1.3	0.9	0.0	1.4	3.2	0.0	0.1	0.0	2.8	3.2	40.4	6.8	2.8	0.1	0.4	6.5	0.0	0.1	0.0	0.0	2.4	0.0	2.8	2.7	1.4	0.0	0.3	0.5	0.9	1.3	0.2	0.8	1.4	0.8	0.7	0.0	3.2	0.1	0.9	0.7	0.8	0.4	2.4	1.5	1.1	4.6	2.2	1.2	2.1	1.1	0.8	0.3	0.7	1.2	3.0	1.0	2.1	0.9	1.8	0.7	0.4	0.5	1.1	0.5	0.7	0.7	0.6	0.2	0.3	4.5	0.7	0.4	1.3	0.3	13.6	0.9	1.5	0.1	1.4	0.4	0.4	1.3	0.7	1.0	0.1	1.2	3.4	0.0	0.0	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	17.3	0.0	1.0	0.8	0.0	0.0	2.5	2.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.5	1.1	0.0	0.1	0.1	0.0	2.0
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	24.7	60.7	19.5	27.9	16.7	4.2	22.9	18.0	25.8	3.4	26.0	5.0	2.6	5.8	1.3	4.1	10.4	3.9	16.4	17.8	18.8	45.7	56.3	54.9	6.4	21.7	17.7	2.8	3.9	3.3	9.3	3.1	22.4	7.1	1.5	18.8	6.4	9.2	1.1	4.2	7.5	3.5	18.2	45.5	4.7	4.2	21.3	1.5	8.6	5.7	5.9	9.7	3.3	17.3	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.5	16.7	18.0	25.8	17.8	18.8	21.7	17.7	22.4	18.2	21.3	17.3	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078328	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 10947.9"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 10517.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	173	"Hep G2: 1398.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		47000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.7	0.2	0.1	0.0	0.1	0.0	6.4	0.3	0.4	0.2	0.3	0.3	2.3	0.1	0.4	0.3	0.4	160.4	0.5	0.1	0.1	11.0	10947.9	0.3	0.0	0.1	0.1	0.2	125.3	0.0	0.2	0.4	0.1	0.2	0.5	0.2	0.1	0.0	0.2	0.3	0.7	0.0	0.1	3.1	2.6	1.0	0.1	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	6.7	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	1.8	0.0	1.8	2.1	0.2	0.9	0.5	0.0	0.0	0.0	3.2	0.0	3.0	1.0	1398.1	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.3	0.0	0.9	3.1	0.0	0.2	8.1	0.4	5.9	0.6	1.7	0.0	2.8	1.1	0.0	0.1	0.0	0.2	1.0	0.0	0.8	0.0	0.4	1.0	0.3	1.5	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.0	19.1	1.5	0.6	0.0	2.2	0.0	1.9	0.4	0.2	2585.0	0.6	1.8	0.0	0.1	0.0	0.6	3.9	216.5	30.4	0.2	0.1	10.0	2.4	219.2	0.1	28.2	0.8	0.1	0.0	1.0	0.0	0.0	181.3	10517.4	0.7	0.0	0.1	1.6	0.0	243.7	0.5	59.4	0.6	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	14.9	1.7	0.0	0.0	0.6	0.6	13.7	0.0	0.0	0.0	0.0	0.5	0.6	0.2	1.1	0.4	1.4	14.3	0.0	1.2	0.3
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7;skeletal muscle: 27.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.7	8.2	6.5	11.2	6.1	0.4	5.5	11.8	0.3	6.9	1.4	5.1	3.0	0.4	2.6	0.7	1.7	1.7	7.6	6.9	5.8	60.7	2.3	4.4	15.5	8.6	1.4	3.3	0.7	0.5	2.0	9.5	2.8	0.2	1.8	2.0	0.2	27.3	5.8	5.0	0.6	2.7	5.9	4.8	13.1	8.0	0.6	0.9	0.9	0.4	0.3	0.2	15.4	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.2	11.2	5.5	11.8	7.6	6.9	15.5	8.6	9.5	2.7	8.0	15.4	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.1;Hofbauer cells: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	14.7	20.2	2.7	5.6	3.4	5.5	13.7	2.4	4.8	12.9	2.8	12.6	9.1	12.2	0.7	10.6	10.8	4.3	7.0	3.3	2.0	18.7	13.8	12.2	7.9	3.4	3.1	9.3	8.2	3.1	8.5	4.5	2.8	10.8	0.8	0.4	13.7	3.2	8.8	15.4	17.3	1.4	2.4	26.1	9.9	37.0	4.2	3.7	12.1	1.3	1.9	10.9	9.8	4.3	9.6	11.7	3.1	6.7	3.5	2.5	15.4	9.0	3.4	7.4	9.0	8.7	16.9	4.4	4.4	1.7	14.0	9.3	1.7	2.5	0.2	6.0	7.8	6.6	13.8	12.7	12.9	4.6	16.8	6.6	2.5	4.9	0.8	1.8	4.0	12.5	14.3	9.3	3.1	19.0	7.8	11.7	6.7	0.8	10.1	29.6	4.4	14.0	2.4	5.4	10.3	9.9	5.7	13.1	21.4	0.5	13.1	1.5	6.9	7.4	11.3	14.3	4.7	15.7	14.1	8.9	8.1	9.5	7.4	9.5	3.3	9.6	4.8	7.5	3.8	6.4	3.5	2.9	1.2	4.1	2.7	2.4	8.4	3.1	9.9	9.9	3.8	2.9	2.7	3.4	2.4	4.8	3.3	2.0	3.4	3.1	2.8	2.4	4.2	4.3	8.0	3.2	11.6	1.3	16.7	8.9	5.2	3.2	4.0	10.3	13.6	11.6	2.5	10.0	5.2	5.5	6.2	16.7	16.4	16.2	5.9	30.3	64.1	6.0	4.1	8.3	12.6	11.0	1.6	17.0	27.1	9.9	7.1	5.2	7.0	13.1	18.2	11.9	127.0	23.5	1.1	12.8	6.1	47.6	12.1	27.4	10.5	28.9	19.6	1.9	26.9	11.0	20.6	0.5	0.8	14.5	26.4	6.4	11.5	4.1	59.4	48.9	9.1	13.0	0.0	7.8	8.4	52.9	16.3	5.1	8.9	27.9	13.2	7.6	10.4	4.2
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.5;ovary: 33.1"	"Group enriched"	"Detected in some"	4	"granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HEL: 40.1;K-562: 22.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 9.4"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.6	41.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.5	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.2	33.1	12.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.2	0.1	0.1	0.0	0.0	5.7	0.7	9.1	0.5	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	40.1	0.0	0.8	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	3.5	2.6	0.0	0.1	1.5	0.0	4.2	0.1	2.1	0.1	2.7	0.0	0.1	26.0	36.1	11.4	0.3	0.1	0.0	0.0	0.0	0.0	1.2	0.0	2.5	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.3	0.0	0.0	0.3	0.8	94.9	0.1	0.0
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Horizontal cells: 52.2;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 19.4;eosinophil: 19.2;intermediate monocyte: 40.7;myeloid DC: 18.9;neutrophil: 61.1;non-classical monocyte: 44.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 18.9;granulocytes: 61.1;monocytes: 44.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760"	Approved		Enhanced	Cytosol		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA027137: AB_2672129, HPA045760: AB_2679443"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	9.3	17.5	31.2	12.0	41.6	28.6	7.4	22.9	34.7	13.1	36.6	7.5	10.7	11.5	4.1	7.2	13.1	8.8	7.2	34.8	37.0	10.5	16.2	13.4	7.6	34.7	31.7	17.5	10.0	9.4	45.8	7.6	33.6	10.8	4.1	10.5	9.2	12.0	3.3	8.5	10.8	7.1	27.9	19.0	8.6	4.3	39.3	4.9	10.6	1.5	5.9	7.5	11.4	29.0	20.6	22.5	20.5	20.1	18.0	18.7	8.6	25.6	57.2	24.9	25.0	19.1	7.0	10.5	21.8	39.1	16.0	11.3	15.8	20.0	13.4	13.0	20.7	46.0	15.6	19.3	24.9	15.7	45.7	23.3	13.2	32.5	24.1	28.2	26.7	17.0	17.4	13.0	16.0	23.2	26.7	29.0	20.6	17.1	22.9	18.6	15.8	17.3	24.2	8.7	19.3	22.4	17.4	19.8	24.6	5.7	10.4	16.2	16.7	27.7	39.0	33.7	25.4	48.4	28.4	12.1	50.8	25.9	35.1	0.5	19.4	19.2	5.3	40.7	8.0	5.3	5.2	4.9	18.9	2.7	6.4	5.1	61.1	4.3	44.6	2.6	4.0	12.3	31.2	41.6	22.9	34.7	34.8	37.0	34.7	31.7	33.6	27.9	39.3	29.0	3.6	3.2	5.5	13.7	9.4	8.9	5.4	5.0	9.1	41.0	8.8	11.4	3.2	12.8	5.4	0.0	62.6	4.9	10.0	4.2	7.9	9.8	3.5	4.4	9.4	7.1	17.5	5.0	13.3	11.2	8.6	12.6	14.3	5.5	3.8	11.0	6.1	20.5	10.8	52.2	17.6	9.6	2.0	42.1	42.0	1.3	13.1	52.5	5.4	6.5	16.1	10.5	6.2	12.1	10.6	10.3	3.0	21.4	11.1	11.1	6.1	4.5	4.2	7.2	13.1	8.8	10.6	4.2	3.8	7.9	8.1	2.6	15.4	8.5	10.7	4.0
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.9;skeletal muscle: 73.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.2;CAPAN-2: 34.6;HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA		77000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	4.2	19.6	10.8	20.7	22.5	62.9	3.0	19.1	15.3	6.0	10.8	4.9	6.5	4.2	4.0	7.6	11.1	6.4	2.9	10.4	15.9	7.8	1.8	6.9	17.6	21.1	20.5	2.6	3.3	24.1	18.2	4.1	20.5	7.4	6.6	7.5	6.4	3.5	73.3	15.6	7.8	4.4	14.0	12.1	6.7	1.8	21.4	13.9	3.6	9.3	20.3	9.7	7.9	30.2	14.1	2.0	0.5	0.2	7.1	5.0	0.8	12.4	44.2	3.0	3.1	6.9	34.6	5.1	1.2	5.7	11.9	8.6	0.2	11.8	8.8	12.7	0.5	12.5	1.8	1.0	2.4	17.2	36.0	18.5	17.9	6.0	7.7	7.5	1.4	8.3	19.4	5.3	10.1	0.5	10.2	22.3	1.6	1.1	12.2	3.7	15.9	18.2	0.6	11.5	5.1	2.6	2.7	0.4	0.8	1.0	0.4	5.8	3.4	13.7	0.2	9.6	0.5	4.8	2.9	5.5	15.7	16.9	0.3	9.5	6.4	19.4	2.2	3.9	5.4	7.7	3.3	2.6	4.2	5.3	3.6	2.5	8.4	3.8	1.7	2.7	2.1	2.8	10.8	22.5	19.1	15.3	10.4	15.9	21.1	20.5	20.5	14.0	21.4	30.2	0.5	0.0	3.9	5.2	14.3	12.5	10.6	8.1	4.0	23.6	1.6	1.8	6.3	5.7	9.8	14.7	2.1	0.9	1.6	1.9	17.6	2.9	7.3	14.0	1.7	1.6	10.2	20.2	11.9	1.6	1.5	8.1	3.1	2.9	12.0	0.9	1.1	0.7	14.5	0.0	7.0	3.9	20.3	15.2	7.6	20.6	0.9	18.3	3.6	28.1	14.0	6.5	1.0	5.0	111.8	6.3	3.0	0.0	1.7	26.5	4.9	0.8	24.2	1.3	0.0	12.3	1.9	0.4	0.6	2.2	12.5	1.2	6.6	0.3	2.2	16.8
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1161.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	112.1	120.5	104.8	52.1	108.6	109.3	103.4	110.9	149.5	85.9	100.7	126.0	61.0	86.4	39.0	125.8	80.3	58.0	231.3	106.4	106.8	127.3	185.7	89.3	73.0	110.0	105.1	76.4	108.1	59.0	92.0	54.8	105.0	105.7	27.3	19.3	117.6	42.0	272.8	99.7	83.4	36.5	110.4	86.7	117.9	189.7	113.0	50.1	90.6	126.5	34.0	95.9	94.7	118.1	262.4	605.0	139.0	209.7	118.7	132.8	164.3	123.4	100.6	111.4	127.1	248.6	226.9	82.1	133.3	114.4	121.8	148.9	58.1	166.4	40.5	122.5	437.1	126.8	257.9	379.0	131.3	95.3	103.6	145.6	151.8	120.4	98.2	73.4	184.9	111.9	173.7	233.8	120.8	474.1	225.5	150.6	131.2	259.2	448.7	92.3	136.2	168.0	104.9	229.3	175.8	282.6	133.5	205.7	253.8	96.7	254.1	222.7	108.4	215.0	169.5	229.4	234.1	110.5	52.1	107.0	228.7	144.5	177.7	495.1	419.8	418.8	229.7	359.9	218.7	309.0	232.0	252.9	348.0	296.2	223.0	212.3	212.1	258.5	345.4	581.1	297.9	506.0	104.8	108.6	110.9	149.5	106.4	106.8	110.0	105.1	105.0	110.4	113.0	118.1	137.2	128.2	157.2	11.4	110.5	148.6	215.0	406.1	145.7	59.5	272.5	332.7	360.2	201.6	272.3	198.6	20.9	467.8	119.5	239.6	522.3	260.6	451.9	157.0	151.3	152.9	190.3	201.6	9.8	337.7	524.6	182.9	124.4	169.5	108.3	158.3	159.2	496.4	448.2	33.7	10.2	272.6	319.4	174.6	194.3	1161.0	181.7	170.1	261.5	13.1	251.4	227.7	176.1	7.1	17.0	324.3	274.0	164.7	226.8	334.2	290.7	548.0	199.8	78.9	105.2	115.9	245.0	435.8	252.5	257.4	186.7	508.7	117.3	156.0	271.4	307.0
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188560	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB018692: AB_2258285, HPA066539: AB_2685688"	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favorable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favorable (3.67e-4)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.4	17.7	8.8	11.3	9.6	15.0	15.8	8.9	13.4	15.2	8.6	14.4	11.9	15.8	3.1	15.8	14.7	8.6	15.6	9.7	8.1	14.2	20.2	13.1	14.5	11.5	9.1	15.2	20.7	7.4	13.8	7.2	10.2	17.5	3.1	4.3	18.2	8.9	18.9	19.2	16.5	5.3	8.1	19.9	17.0	25.5	8.8	10.2	15.5	8.3	6.1	13.8	13.4	12.9	20.9	45.6	10.7	17.5	12.6	7.5	33.5	18.5	11.5	16.9	12.8	27.8	20.9	22.4	21.3	12.3	15.8	41.9	12.9	13.8	2.5	28.9	22.5	13.3	55.1	24.9	14.9	20.7	22.1	15.0	10.9	11.3	6.1	8.3	20.8	20.7	20.3	26.4	8.0	58.2	24.7	28.7	21.6	27.4	34.6	29.3	26.5	41.4	13.1	18.1	14.1	21.3	28.2	36.5	11.9	5.1	39.2	27.8	22.4	24.8	19.8	30.1	16.7	12.9	20.5	24.5	20.1	14.1	18.3	0.3	0.6	0.1	0.5	0.6	0.3	0.3	0.3	0.4	0.5	0.2	0.3	0.4	0.2	0.3	0.9	0.6	0.3	1.1	8.8	9.6	8.9	13.4	9.7	8.1	11.5	9.1	10.2	8.1	8.8	12.9	9.3	0.0	0.5	6.2	12.2	9.3	7.9	14.2	6.2	5.7	13.0	12.6	3.2	11.5	11.5	11.0	4.2	25.9	11.1	19.0	13.7	10.0	40.5	4.2	4.0	9.0	10.2	9.5	2.4	10.9	11.1	9.0	27.0	5.0	11.4	8.5	12.1	11.1	15.6	1.7	2.5	19.1	12.2	8.8	7.8	58.4	11.1	7.6	14.2	1.0	13.9	3.7	6.2	1.5	4.3	8.6	8.0	9.4	15.3	6.8	21.2	15.8	10.2	4.7	0.0	9.8	17.4	40.5	26.4	11.9	9.5	24.5	9.4	5.9	15.4	7.1
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	14.4	19.0	11.8	14.0	14.3	12.6	15.7	12.7	16.1	20.1	11.8	18.8	10.6	21.4	16.7	36.2	18.0	11.4	22.7	13.0	12.9	18.6	13.3	13.7	18.0	12.3	11.7	16.7	14.1	24.9	14.7	8.5	12.4	18.5	16.2	13.2	20.5	17.5	33.8	18.0	14.5	21.1	12.4	16.6	15.7	30.1	12.1	24.0	20.2	24.9	20.7	19.0	24.8	12.8	49.7	66.8	47.8	40.9	48.8	24.6	27.4	33.9	30.6	61.1	42.2	68.5	30.8	78.6	33.5	45.8	35.2	49.1	71.8	46.5	61.8	42.0	57.8	69.3	46.0	57.3	35.5	62.5	31.6	27.0	32.7	53.0	35.0	43.6	60.1	55.2	110.7	16.4	48.7	53.0	95.6	46.7	42.0	48.1	57.6	72.8	47.2	93.1	41.4	62.5	61.8	35.4	53.2	41.2	57.3	41.9	87.1	56.0	38.2	36.3	34.1	32.6	40.6	27.4	59.5	105.6	40.5	52.6	42.9	20.2	12.1	20.5	18.2	17.2	21.7	14.3	19.6	17.7	20.1	18.7	16.1	17.5	9.3	24.3	15.9	10.9	26.1	14.4	11.8	14.3	12.7	16.1	13.0	12.9	12.3	11.7	12.4	12.4	12.1	12.8	13.1	16.0	18.4	17.6	12.9	10.1	19.6	16.5	13.1	18.5	12.8	11.6	17.5	10.0	22.6	12.9	20.9	12.4	10.7	9.2	11.7	16.9	7.6	22.8	18.6	15.7	10.8	33.6	28.1	15.2	10.1	16.9	16.3	15.3	15.8	42.5	11.7	13.4	22.4	21.9	22.6	10.8	32.6	17.9	6.6	12.7	18.3	12.5	17.8	13.1	14.7	16.1	11.3	22.6	29.3	16.2	8.9	21.8	11.4	20.0	7.3	15.0	18.4	22.9	13.1	15.9	16.2	74.1	42.2	38.3	13.4	7.3	14.0	32.4	14.9	17.5
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	52	"liver: 3018.1"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 4816.3"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.5;myeloid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Hep G2: 152.2;OE19: 116.1"	"Low region specificity"	"Detected in all"							HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	410000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	37.6	3.0	3.6	6.0	3.5	1.0	37.8	3.5	4.9	38.2	5.6	32.6	23.2	23.4	17.9	9.8	30.5	28.5	16.9	3.6	4.9	18.4	3018.1	18.5	3.5	4.5	4.2	58.1	30.8	5.3	5.0	3.8	4.3	32.7	45.7	2.2	52.6	13.3	6.2	27.4	27.1	10.4	4.5	7.4	58.2	10.2	3.7	1.5	8.8	10.5	4.1	24.8	31.4	4.8	3.7	9.9	2.3	0.0	23.9	27.8	0.3	4.8	8.8	1.1	4.0	5.9	5.1	0.4	1.5	12.0	8.0	3.8	2.8	3.1	1.3	18.4	3.8	0.9	5.1	152.2	5.0	4.0	0.5	22.2	2.5	1.5	5.1	11.8	5.7	4.2	0.2	27.0	3.5	0.7	0.9	1.2	0.7	116.1	10.7	0.7	3.9	11.3	2.3	2.9	0.0	0.4	4.6	1.7	6.5	5.1	4.0	0.7	6.0	1.9	2.8	1.7	0.7	5.9	4.8	0.5	3.2	2.0	5.0	0.0	24.5	0.0	0.6	2.9	0.4	5.8	1.2	1.1	14.5	4.9	0.3	0.2	0.4	0.0	0.1	2.3	0.8	7.1	3.6	3.5	3.5	4.9	3.6	4.9	4.5	4.2	4.3	4.5	3.7	4.8	9.7	28.9	17.7	0.0	9.7	27.1	43.3	39.2	14.2	0.1	33.8	24.8	0.8	194.5	24.6	11.0	0.0	1.6	0.7	32.5	11.7	40.0	1.0	6.2	9.7	11.0	71.0	27.8	0.0	31.6	5.3	48.8	56.1	24.9	0.0	10.7	62.4	4816.3	15.9	0.0	0.0	171.9	12.2	95.9	18.7	2.9	71.1	13.8	23.2	0.0	4.9	10.1	0.0	0.0	0.0	21.6	33.3	24.0	11.7	43.7	91.3	61.2	76.5	0.6	13.1	29.7	17.7	1.0	1.3	9.4	52.4	9.3	5.6	0.5	51.6	39.2
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
ANKRD11	"LZ16, T13"	ENSG00000167522	"Ankyrin repeat domain 11"	Q6UB99	16	89267630-89490561	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019288, HPA041593, HPA049470"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780"	"unprognostic (7.31e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.16e-1)"	24.2	21.1	33.1	26.0	29.3	53.9	14.5	23.2	39.1	18.0	18.7	17.6	21.4	22.0	12.8	22.5	18.4	18.6	22.3	36.8	22.1	15.7	12.2	18.9	26.3	29.8	25.7	29.2	26.6	24.7	24.1	17.9	25.3	16.1	13.6	14.1	20.1	17.0	24.8	35.0	21.0	14.5	19.2	26.6	21.7	18.4	26.7	24.9	19.4	15.0	19.0	19.3	16.5	28.8	55.5	67.9	66.8	51.5	40.3	41.4	64.5	61.7	41.1	36.5	25.8	79.7	57.8	51.0	41.6	44.9	41.1	54.6	46.0	56.8	41.2	25.5	55.3	40.3	49.3	64.7	60.8	30.0	44.0	46.4	56.4	47.9	61.5	52.8	44.4	84.1	88.4	39.6	46.5	52.5	50.1	75.2	58.8	28.7	61.9	101.6	77.0	43.3	38.0	45.7	39.1	47.9	89.0	18.5	65.1	33.9	43.3	46.6	83.2	76.4	71.4	42.9	68.7	71.5	27.1	62.9	61.6	48.6	42.2	7.6	2.9	3.0	2.7	3.1	3.1	2.6	3.1	3.3	1.6	3.0	2.7	2.4	8.5	7.1	5.1	5.4	3.3	1.5	33.1	29.3	23.2	39.1	36.8	22.1	29.8	25.7	25.3	19.2	26.7	28.8	133.0	131.4	103.0	94.7	136.3	116.5	150.3	49.5	91.6	181.3	57.4	65.8	233.3	84.4	52.5	71.7	158.4	42.7	203.7	109.7	31.3	80.1	118.5	200.9	162.6	135.4	106.9	58.5	122.1	72.7	36.3	118.2	96.8	312.8	55.7	164.5	80.7	69.4	48.4	156.5	97.7	89.8	30.5	63.5	117.9	39.5	103.8	112.0	48.0	119.0	110.9	83.1	146.2	117.1	110.0	122.4	66.9	106.1	143.3	147.6	64.6	35.1	45.6	112.9	39.5	148.3	126.3	92.2	98.9	102.6	122.2	38.7	133.8	137.4	87.3	179.0
ANKRD13D		ENSG00000172932	"Ankyrin repeat domain 13D"	Q6ZTN6	11	67289300-67302485	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 63.9;SK-MEL-30: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039950	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA039950: AB_10796337"	"unprognostic (1.10e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (5.73e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.74e-2)"	12.0	14.7	13.3	6.8	14.3	0.3	11.4	10.9	20.7	19.5	10.8	13.8	3.1	12.5	2.9	24.4	15.3	7.9	12.0	16.5	12.9	16.2	8.9	13.8	15.0	13.8	11.7	14.1	9.5	6.0	28.9	5.2	15.1	23.8	2.3	2.0	14.4	7.3	3.7	15.0	13.8	6.5	10.2	39.2	12.8	12.1	15.8	10.0	11.2	3.8	5.7	17.5	20.5	19.6	9.7	7.2	5.8	12.3	10.9	10.1	3.8	7.0	8.4	7.2	5.6	6.4	10.1	11.6	12.4	5.6	10.7	12.4	4.5	8.6	1.0	19.9	5.3	11.6	11.3	4.3	16.8	14.0	27.8	10.4	11.8	6.2	6.8	14.1	9.5	9.2	6.3	12.4	8.0	14.1	18.0	63.9	2.5	19.8	10.1	28.5	4.9	9.9	13.6	6.0	6.0	9.8	7.0	16.7	57.0	4.5	14.3	33.1	7.7	7.1	6.1	7.9	8.2	9.8	9.4	5.6	17.4	21.4	8.2	6.6	0.6	5.7	2.0	2.1	1.3	0.8	1.5	2.8	1.2	0.5	0.5	3.2	1.9	3.1	1.4	1.8	1.6	1.2	13.3	14.3	10.9	20.7	16.5	12.9	13.8	11.7	15.1	10.2	15.8	19.6	23.2	0.0	18.8	18.9	22.2	14.1	11.7	15.4	17.6	61.1	21.5	20.8	7.0	8.6	14.5	16.5	75.0	8.3	73.6	7.5	1.9	8.3	18.0	27.7	19.7	17.9	10.8	8.2	29.8	6.9	9.0	15.7	20.4	18.0	25.3	25.7	22.1	3.0	20.0	42.1	29.7	7.9	18.3	52.0	21.4	6.0	22.1	45.8	12.4	18.7	49.7	20.8	49.4	17.6	18.4	9.9	4.6	17.0	30.7	19.9	2.3	2.6	30.4	51.7	13.1	13.6	18.5	3.1	8.1	19.3	25.1	7.5	49.9	28.9	8.4	19.8
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 337.8;Inhibitory neurons: 315.8;Oligodendrocyte precursor cells: 275.0;Oligodendrocytes: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	13.7	13.5	15.6	13.6	16.7	9.2	20.0	23.1	20.4	16.8	16.8	15.8	14.8	14.7	18.5	14.5	18.2	12.4	14.5	16.2	21.1	19.6	20.6	14.2	15.1	15.7	15.9	17.8	18.0	24.5	14.4	19.0	16.0	15.1	19.0	36.0	16.7	13.7	23.2	17.2	15.2	16.4	12.3	15.1	15.7	11.1	18.5	27.2	17.9	26.1	17.7	17.7	12.8	20.1	25.6	27.7	43.1	34.2	47.4	41.5	23.5	36.9	43.1	32.5	31.1	33.9	32.8	69.2	29.9	38.0	17.1	20.9	54.4	32.6	44.6	27.1	23.1	47.1	29.5	49.4	25.4	62.2	27.9	35.2	34.8	46.6	36.9	33.6	43.8	27.9	67.2	24.8	39.4	23.7	51.3	22.1	28.0	33.0	27.6	40.5	47.3	28.8	34.5	38.1	41.6	28.2	35.7	39.7	18.9	33.5	21.3	24.3	53.2	34.0	32.6	30.8	29.3	20.5	11.1	51.5	27.6	26.8	35.6	1.6	1.7	1.8	3.0	1.1	1.5	1.8	1.8	2.0	1.4	2.6	1.7	2.0	1.9	5.6	1.3	4.4	1.2	1.1	15.6	16.7	23.1	20.4	16.2	21.1	15.7	15.9	16.0	12.3	18.5	20.1	42.9	48.1	52.9	194.9	30.9	76.1	36.9	33.9	67.2	57.2	38.6	31.2	82.2	35.8	45.5	40.5	123.0	31.8	40.0	52.8	7.9	30.9	12.7	46.0	57.9	52.2	45.1	36.1	337.8	28.9	24.6	44.8	51.5	60.8	31.6	53.4	43.9	49.7	27.3	69.0	315.8	45.6	26.4	31.2	34.7	5.5	35.1	35.0	28.4	181.8	34.8	30.5	50.4	275.0	296.5	30.2	25.7	37.6	44.2	52.8	39.4	25.4	30.5	84.1	19.7	58.5	48.5	28.1	30.8	64.9	81.3	33.8	32.4	47.6	48.3	48.4
ANKRD18A	"FLJ35740, KIAA2015"	ENSG00000180071	"Ankyrin repeat domain 18A"	Q8IVF6	9	38571358-38620596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 18.2;brain: 21.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.3;Excitatory neurons: 24.8;Inhibitory neurons: 26.8;Oligodendrocytes: 118.1;Rod photoreceptor cells: 31.2;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 17.9"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.94e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.14e-1)"	0.0	0.1	3.0	0.3	9.1	18.2	0.4	3.6	3.7	0.4	0.0	0.5	0.3	0.2	0.2	0.8	0.5	0.4	0.6	3.1	5.1	0.9	0.7	0.3	0.2	12.6	6.0	0.0	2.2	0.6	1.0	0.1	14.3	0.9	0.7	5.0	0.4	0.1	0.0	1.3	0.7	0.2	5.1	0.1	1.0	7.2	8.4	0.3	2.2	0.0	0.1	0.2	0.4	21.9	4.8	3.7	3.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.9	0.0	0.0	0.9	3.5	3.4	0.0	0.0	5.2	0.0	5.6	2.9	0.0	17.9	0.5	0.0	2.3	0.0	3.1	1.7	0.0	7.2	1.7	0.4	0.3	4.6	0.1	0.9	3.7	6.2	2.1	0.0	6.5	6.8	2.1	2.0	1.5	3.0	2.4	0.5	0.2	7.1	2.6	8.3	4.5	0.0	1.3	0.1	0.0	0.3	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.0	9.1	3.6	3.7	3.1	5.1	12.6	6.0	14.3	5.1	8.4	21.9	0.1	0.0	1.5	1.0	0.1	0.6	2.0	1.5	3.4	3.8	2.3	2.4	9.4	1.5	3.7	1.8	2.1	0.0	0.1	0.8	1.9	5.4	8.0	33.3	1.7	0.2	4.2	0.0	24.8	2.4	0.9	0.2	7.7	19.2	0.0	14.7	0.0	0.5	0.1	0.0	26.8	3.3	2.0	0.0	0.3	2.2	0.6	0.2	0.0	1.0	0.4	9.2	0.0	18.1	118.1	3.9	2.6	0.4	0.1	1.9	1.6	0.3	11.0	31.2	0.0	0.0	0.3	53.5	4.3	3.8	1.7	0.0	1.4	0.3	2.3	1.4
ANKRD18B	bA255A11.3	ENSG00000230453	"Ankyrin repeat domain 18B"	A2A2Z9	9	33524394-33573009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 34.5;choroid plexus: 10.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.4;Excitatory neurons: 13.8;Muller glia cells: 22.3;Spermatocytes: 41.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 27.5"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-2)"	"unprognostic (6.43e-5)"	"unprognostic (4.89e-2)"	"unprognostic (9.75e-4)"	"unprognostic (8.25e-2)"	"unprognostic (5.18e-2)"	0.4	0.2	16.8	0.0	17.5	0.1	0.1	34.5	30.1	0.2	10.6	0.0	0.0	0.1	0.1	1.9	0.2	0.4	0.0	18.2	13.6	0.0	0.0	0.1	0.1	22.3	15.7	0.0	0.0	0.0	0.4	0.2	21.4	1.2	0.0	1.9	0.1	0.0	0.7	2.2	0.0	0.0	12.7	0.3	0.0	3.9	14.5	0.0	0.2	0.1	0.1	0.7	0.9	17.0	10.0	8.8	0.6	0.1	0.2	1.5	0.9	2.1	2.1	2.7	2.9	2.1	0.2	0.2	0.4	0.3	2.9	2.2	5.9	2.1	3.6	0.1	5.2	10.2	13.1	1.5	0.0	3.5	0.6	0.8	3.6	3.7	9.3	0.7	5.0	0.0	5.5	0.5	3.0	1.7	0.0	27.5	9.1	0.2	4.8	0.0	13.0	2.0	1.6	2.4	0.3	8.5	4.2	0.3	0.4	5.5	7.5	13.4	4.6	1.5	5.8	4.4	3.9	1.5	0.8	0.0	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	17.5	34.5	30.1	18.2	13.6	22.3	15.7	21.4	12.7	14.5	17.0	0.0	0.0	0.0	0.7	0.0	2.0	5.4	2.9	1.2	8.5	0.5	0.9	3.1	4.3	2.8	1.8	0.0	0.0	0.0	0.6	0.0	0.8	34.4	12.1	0.2	0.3	0.0	0.0	13.8	0.5	0.4	0.1	0.0	4.0	0.0	12.1	0.4	0.1	0.2	0.0	9.0	2.0	4.1	0.0	0.3	3.7	0.6	0.2	0.0	1.9	0.0	22.3	0.0	4.0	0.8	0.4	1.7	0.7	0.0	2.5	0.3	0.1	9.8	5.5	0.0	0.5	0.5	41.4	2.1	6.2	3.3	0.0	0.2	0.0	1.3	3.9
ANKRD20A1	"ANKRD20A, DKFZp434A171"	ENSG00000260691	"Ankyrin repeat domain 20 family member A1"	Q5TYW2	9	67832765-67920552	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;testis: 4.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.8;Excitatory neurons: 14.8;Inhibitory neurons: 9.0;Oligodendrocyte precursor cells: 12.5;Spermatocytes: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 8.7;U-266/70: 8.7;U-266/84: 5.6"									"HPA043239, HPA046346, HPA046695, HPA047112, HPA047167, HPA047766, HPA049923, HPA051288, HPA051753"	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA043239: , HPA046346: AB_2679631, HPA046695: , HPA047112: , HPA047167: , HPA047766: , HPA049923: AB_2680954, HPA051288: AB_2681421, HPA051753: AB_2681592"	"unprognostic (4.92e-1)"	"unprognostic (4.31e-3)"			"unprognostic (3.97e-1)"			"unprognostic (2.30e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"		0.4	0.2	0.8	0.1	2.6	0.5	0.4	0.1	3.3	0.3	0.0	0.4	0.1	0.2	0.3	0.8	0.4	0.2	0.9	1.3	0.2	0.3	0.2	0.5	0.1	0.4	0.1	0.2	1.0	0.2	0.7	0.0	0.7	0.4	0.7	0.8	0.4	0.2	0.1	0.4	0.3	0.2	0.1	0.7	0.1	4.4	0.4	0.3	0.4	0.0	0.0	0.1	0.4	2.9	0.2	0.2	1.3	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.3	0.5	0.9	0.3	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.2	0.3	1.4	0.3	8.7	0.0	0.0	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.3	0.4	0.8	8.7	5.6	0.0	0.3	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	2.6	0.1	3.3	1.3	0.2	0.4	0.1	0.7	0.1	0.4	2.9	0.0	3.2	2.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.3	1.2	0.2	0.0	0.8	0.0	0.0	14.8	1.8	0.0	0.3	1.5	0.1	1.3	0.5	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.6	0.0	0.0	12.5	0.3	0.5	2.5	0.0	0.0	0.0	1.8	0.0	2.2	0.0	0.0	0.0	0.2	10.3	1.9	0.7	0.0	0.0	0.4	0.0	1.3	0.1
ANKRD36	UNQ2430	ENSG00000135976	"Ankyrin repeat domain 36"	A6QL64	2	97113153-97264521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.0;retina: 20.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 240.8;Inhibitory neurons: 255.3;Oligodendrocyte precursor cells: 155.3;Oligodendrocytes: 217.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (4.24e-3)"	"unprognostic (7.59e-2)"	"unprognostic (6.15e-3)"	"unprognostic (9.86e-2)"	"unprognostic (9.83e-3)"	"unprognostic (5.25e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.75e-1)"	1.8	1.6	5.8	2.7	8.3	11.8	3.2	25.0	7.8	2.2	0.3	1.8	1.8	3.6	4.2	1.0	2.1	1.9	1.3	5.3	4.0	0.9	0.6	2.4	2.9	7.1	2.0	4.5	1.8	1.8	1.9	1.3	8.2	2.3	2.6	20.3	2.1	1.4	0.7	3.2	1.8	2.3	1.5	3.3	2.8	7.1	6.2	3.1	2.1	0.5	2.2	1.4	1.8	9.5	4.4	1.4	3.9	2.4	0.9	2.1	1.5	2.1	1.3	1.5	1.5	1.3	2.3	5.5	1.0	1.4	1.2	2.9	1.4	1.9	1.3	2.9	2.4	4.7	6.4	2.4	0.4	3.8	1.9	1.4	0.9	1.2	1.9	2.2	2.9	8.9	3.6	10.1	0.8	1.0	4.4	4.4	0.9	0.4	2.8	5.0	1.9	2.2	0.8	2.3	3.3	2.2	2.3	1.3	0.7	1.5	1.4	1.9	3.9	4.2	3.8	4.1	2.3	6.5	2.8	5.1	2.2	4.5	1.0	9.2	2.2	3.1	7.2	1.0	7.4	9.2	7.1	6.1	0.9	8.1	7.2	7.5	3.3	4.9	2.3	10.1	6.6	2.0	5.8	8.3	25.0	7.8	5.3	4.0	7.1	2.0	8.2	1.5	6.2	9.5	16.9	44.8	27.4	85.5	27.8	15.7	8.4	28.2	14.2	51.0	9.0	11.2	26.2	2.8	31.5	7.3	75.0	1.4	38.2	4.9	0.0	7.1	70.7	39.6	22.2	19.3	13.8	14.3	240.8	18.6	5.6	19.5	84.6	19.3	26.6	39.4	11.7	1.1	5.1	21.9	255.3	10.5	12.2	3.8	26.2	14.3	26.1	10.2	39.2	46.9	6.1	9.3	26.8	155.3	217.7	9.5	3.6	18.0	56.3	5.9	2.2	2.7	43.2	65.0	0.0	36.4	20.7	123.4	22.1	9.8	9.2	0.4	39.6	9.1	8.1	14.1
ANKRD36B	"FLJ21281, KIAA1641"	ENSG00000196912	"Ankyrin repeat domain 36B"	Q8N2N9	2	97492663-97589965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 73.4;Oligodendrocytes: 71.1;Plasma cells: 81.7;Spermatocytes: 76.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.03e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.20e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.13e-6)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.71e-3)"	"unprognostic (6.98e-2)"	4.4	1.8	3.0	1.6	4.8	21.5	4.7	13.7	5.8	4.7	0.0	3.2	1.0	4.1	2.3	1.8	5.0	1.7	2.7	3.1	2.5	2.4	1.1	3.0	2.6	4.7	1.2	5.3	6.1	1.0	2.9	0.8	5.3	3.4	2.8	10.1	4.3	1.4	1.3	4.1	3.5	2.8	1.0	3.1	3.2	13.1	4.1	2.9	2.7	0.2	1.9	3.1	3.1	7.2	2.9	1.4	1.4	1.7	1.1	2.8	1.8	1.5	1.2	1.0	1.1	1.8	3.2	4.7	1.1	1.5	1.0	0.4	1.1	1.1	1.1	1.5	2.2	3.6	3.5	1.3	0.8	2.6	1.6	1.5	1.5	1.5	2.4	2.8	1.4	7.1	3.8	5.0	1.2	0.5	3.0	3.3	0.9	0.5	1.4	3.2	0.6	0.7	1.4	2.1	1.8	2.3	1.2	0.7	0.9	3.1	1.6	2.0	2.6	1.5	1.8	2.5	2.8	3.9	5.7	3.3	1.9	3.9	1.3	1.9	0.1	0.2	0.6	0.1	0.6	0.6	0.8	0.5	0.1	1.0	0.9	0.6	0.1	0.8	0.0	0.8	0.4	0.1	3.0	4.8	13.7	5.8	3.1	2.5	4.7	1.2	5.3	1.0	4.1	7.2	14.6	12.8	15.0	27.1	28.3	0.0	6.9	0.0	20.5	36.7	5.4	7.4	15.4	5.7	17.3	9.2	20.9	1.4	15.4	5.9	0.0	9.4	48.9	29.6	10.1	12.5	14.4	16.4	68.5	14.0	3.9	11.4	73.4	14.1	22.8	23.4	4.2	0.7	3.4	16.8	68.7	12.6	0.0	1.2	0.0	7.3	12.8	9.5	0.0	19.7	7.3	6.8	12.3	42.3	71.1	9.7	3.6	7.5	81.7	5.0	2.5	1.3	16.8	34.1	6.6	25.2	9.9	76.4	11.1	24.0	0.0	0.1	35.2	7.1	6.7	12.4
ANKRD36C	DKFZp667P0924	ENSG00000174501	"Ankyrin repeat domain 36C"	Q5JPF3	2	95836919-95991831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 615.1;Gastric mucus-secreting cells: 498.9;Inhibitory neurons: 290.7;Pancreatic endocrine cells: 311.5;Urothelial cells: 411.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 30.9"									"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.35e-6)"	"unprognostic (9.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	2.0	1.5	5.3	2.1	9.3	16.3	6.1	24.0	8.9	2.6	1.5	2.8	1.2	3.8	2.3	2.3	3.1	4.8	1.4	4.2	9.3	1.2	0.6	2.6	3.5	9.4	5.9	6.0	1.8	1.6	1.6	1.5	11.3	1.9	2.6	10.6	14.6	1.5	0.7	3.6	1.6	1.9	2.6	2.9	5.4	12.0	9.7	6.5	1.6	0.9	2.9	3.2	1.9	25.8	8.4	1.6	3.3	2.3	2.1	5.7	1.3	1.9	1.4	2.5	3.3	1.9	1.9	8.3	2.5	1.4	2.5	1.9	3.0	1.5	3.2	4.8	4.1	3.2	4.5	2.4	0.5	9.9	2.4	1.7	1.2	2.0	1.0	2.5	4.3	11.7	3.3	10.2	2.8	1.2	7.7	3.7	0.7	0.4	30.9	4.0	2.5	3.3	1.3	1.6	3.0	2.7	1.3	2.1	1.3	1.2	1.0	2.3	4.8	3.1	3.4	2.4	2.4	3.8	3.4	8.9	0.9	6.7	1.3	48.0	3.3	2.8	20.8	0.5	13.4	17.1	16.7	13.9	2.5	19.5	14.5	14.2	0.2	12.6	1.0	35.0	15.6	1.3	5.3	9.3	24.0	8.9	4.2	9.3	9.4	5.9	11.3	2.6	9.7	25.8	32.3	38.5	19.9	123.1	26.9	10.7	53.4	33.6	11.4	84.4	38.4	20.8	29.1	4.3	91.0	9.2	79.2	0.3	47.2	23.5	0.0	226.3	118.4	42.6	28.7	25.8	21.0	27.1	227.9	615.1	0.8	26.3	498.9	25.8	34.1	41.3	15.4	1.5	8.3	33.7	290.7	70.2	12.2	7.0	14.7	17.7	32.6	15.9	14.2	46.9	27.4	15.8	50.4	147.8	177.7	311.5	8.4	36.5	48.7	145.8	7.7	0.9	82.3	72.9	19.7	56.1	31.0	178.7	22.4	7.7	7.4	0.3	47.5	13.1	22.0	411.9
ANKRD42	"FLJ37874, PPP1R79, SARP"	ENSG00000137494	"Ankyrin repeat domain 42"	Q8N9B4	11	83193712-83260694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 170.5;Late spermatids: 63.2;Respiratory ciliated cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039917	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039917: AB_10672894"	"unprognostic (6.59e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.90e-1)"	5.2	13.3	8.0	5.2	8.9	9.0	6.0	4.3	11.8	7.4	15.8	5.8	5.2	6.0	19.7	4.8	15.8	7.6	5.3	11.6	14.3	11.1	4.7	6.6	3.8	10.0	9.2	8.7	5.9	12.3	13.1	3.9	7.9	7.2	4.2	17.8	6.0	7.4	2.7	5.5	4.9	5.3	7.6	4.5	6.2	37.2	10.7	2.8	11.8	2.2	4.1	7.3	5.5	8.2	5.6	9.7	4.7	9.5	14.3	15.0	4.1	11.4	8.8	6.7	4.1	5.9	6.8	2.2	14.1	10.3	13.4	11.9	5.0	7.8	5.5	3.2	3.7	4.0	14.5	4.0	10.0	11.6	9.0	8.9	8.8	17.0	8.9	12.3	7.0	4.0	12.0	2.0	9.8	7.9	1.7	12.2	3.9	8.8	6.1	2.7	6.5	2.8	21.8	6.6	3.7	4.9	14.9	9.2	2.9	6.1	13.9	6.2	10.2	10.2	7.1	37.1	5.4	2.9	7.1	4.5	7.9	6.7	4.3	5.7	2.6	3.2	2.9	3.0	1.9	5.0	2.5	2.9	3.5	3.8	1.2	2.0	2.0	4.4	8.0	1.4	1.1	1.7	8.0	8.9	4.3	11.8	11.6	14.3	10.0	9.2	7.9	7.6	10.7	8.2	7.6	9.6	16.0	7.5	8.5	11.2	21.5	6.5	4.0	3.9	11.9	9.8	7.8	8.6	8.0	7.3	39.6	3.1	7.1	5.2	9.8	7.7	170.5	53.1	21.9	8.5	3.0	2.1	33.3	6.7	3.3	13.0	7.7	15.4	13.9	7.8	9.3	4.8	5.0	1.7	27.3	3.1	12.2	7.2	9.9	63.2	8.7	8.8	7.2	7.5	7.3	7.4	2.1	4.5	2.9	5.7	4.9	10.5	4.7	10.6	5.8	14.8	61.6	22.4	13.1	16.6	9.0	55.5	17.3	4.7	15.3	5.5	9.1	14.5	3.9	11.5
ANKRD54	LIAR	ENSG00000100124	"Ankyrin repeat domain 54"	Q6NXT1	22	37830855-37849327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071287	Approved		Approved	Nucleoplasm,Microtubules,Midbody		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Microtubules, Midbody"	Nucleoplasm	"HPA071287: AB_2686380"	"unprognostic (5.36e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.38e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-3)"	8.6	18.7	22.4	5.9	20.8	6.9	9.1	22.6	23.3	13.0	28.7	16.4	7.1	12.9	7.8	14.0	23.8	6.3	12.4	23.0	26.2	14.9	15.6	8.4	6.4	22.6	24.7	17.8	18.1	11.7	19.2	5.4	21.6	13.7	6.6	6.3	13.9	11.0	12.6	11.3	8.9	9.5	22.0	9.2	10.9	30.9	26.1	10.4	13.8	8.7	7.2	14.0	10.9	20.3	18.5	18.6	15.4	23.0	19.9	11.3	8.1	24.8	19.2	41.1	25.2	11.8	7.3	17.8	10.1	16.5	13.3	16.4	19.5	14.1	19.9	14.2	39.5	9.3	17.3	28.3	17.7	17.8	20.8	10.1	14.2	22.6	13.3	10.3	25.5	13.1	11.9	12.7	19.1	19.8	17.6	21.1	4.4	24.5	16.5	20.2	18.3	11.3	23.2	6.4	26.4	14.1	20.7	18.8	30.8	7.0	19.3	28.0	15.1	24.5	25.6	12.9	18.6	13.3	11.7	14.3	20.1	15.1	17.9	3.5	4.5	2.2	5.4	5.5	5.4	3.9	5.1	4.0	5.7	5.2	5.3	2.6	2.7	10.2	9.3	5.3	2.4	3.3	22.4	20.8	22.6	23.3	23.0	26.2	22.6	24.7	21.6	22.0	26.1	20.3	8.4	12.8	14.5	11.8	14.4	15.8	11.0	12.4	12.0	18.3	16.9	15.6	8.1	24.3	12.2	18.4	29.2	20.9	14.0	19.9	39.2	17.1	6.4	47.8	12.6	10.9	9.0	12.8	9.4	14.7	17.7	12.3	12.2	8.5	9.5	23.3	13.6	12.0	13.2	26.9	9.4	14.3	12.2	12.5	10.7	7.7	18.0	8.8	10.6	2.8	9.2	18.5	17.5	13.6	8.6	11.3	15.3	21.4	8.4	11.4	19.2	22.0	48.2	23.2	6.6	13.1	13.4	65.6	42.1	12.7	17.6	16.8	13.3	25.4	20.7	9.9
ANKRD61		ENSG00000157999	"Ankyrin repeat domain 61"	A6NGH8	7	6031376-6036552	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"bone marrow: 6.1;testis: 5.6"	"Group enriched"	"Detected in some"	21	"Early spermatids: 58.5;Late spermatids: 23.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029511, HPA050732"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA029511: AB_10602430, HPA050732: "	"unprognostic (1.40e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-1)"	0.4	0.4	0.2	0.6	0.3	6.1	0.5	1.2	0.4	0.4	0.8	0.4	0.5	0.4	0.0	0.3	0.4	0.2	0.4	0.1	0.4	0.2	0.4	0.4	0.8	0.4	0.3	0.5	0.7	0.0	0.4	0.4	0.6	0.3	0.0	0.7	0.6	0.0	0.5	1.2	0.6	0.1	0.1	0.7	0.6	5.6	0.5	0.1	0.6	0.2	0.0	0.3	0.4	1.1	1.4	3.4	1.2	1.7	0.2	0.1	1.6	0.9	0.2	0.3	0.3	1.7	3.5	0.7	0.3	0.1	1.6	1.3	0.6	0.0	0.3	0.2	0.4	1.0	9.3	0.2	0.1	1.0	1.5	0.2	0.7	0.3	0.6	0.8	0.3	1.1	1.2	1.0	0.4	2.3	0.2	1.1	0.6	0.3	0.4	1.0	0.3	0.2	0.3	1.7	0.8	1.5	0.9	1.0	0.1	1.7	1.7	0.6	0.7	1.4	2.9	1.7	1.0	0.9	1.1	0.5	0.4	0.9	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.2	0.4	0.1	0.4	0.4	0.3	0.6	0.1	0.5	1.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	58.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.9	0.0	0.2	0.0	0.0	0.2	0.0	1.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD7	TSA806	ENSG00000106013	"Ankyrin repeat domain 7"	Q92527	7	118214669-118496171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	431	"testis: 860.1"	"Group enriched"	"Detected in some"	61	"Early spermatids: 3367.0;Late spermatids: 861.1;Spermatocytes: 3073.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;JURKAT: 4.6;SCLC-21H: 7.8;U-266/70: 9.8;WM-115: 3.1"									"HPA043489, HPA052941"			Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA043489: AB_10959304, HPA052941: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-4)"		"unprognostic (3.13e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.49e-2)"		"unprognostic (1.69e-1)"	"unprognostic (5.51e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.57e-4)"	"unprognostic (3.32e-2)"	0.1	0.5	0.3	0.1	0.4	0.0	0.5	0.0	0.7	0.3	0.1	0.2	0.5	0.1	1.9	0.1	0.4	0.1	0.3	0.4	1.0	0.7	0.2	0.1	0.2	0.6	0.7	0.2	0.7	0.1	0.7	0.0	0.9	0.6	0.1	0.3	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.1	860.1	1.1	0.1	0.9	0.1	0.2	0.1	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.3	1.2	0.0	2.3	0.0	0.0	0.2	0.1	1.2	0.8	0.0	0.0	0.0	1.4	0.0	0.0	1.7	0.3	0.5	0.0	0.3	0.0	4.6	0.0	1.7	1.1	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	2.0	0.0	0.0	1.5	0.0	0.0	1.0	0.3	0.0	0.8	0.2	0.0	9.8	0.5	0.4	1.4	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.7	0.4	1.0	0.6	0.7	0.9	0.1	1.1	0.5	0.3	0.0	0.0	0.3	0.3	0.0	0.3	0.4	0.0	0.9	0.1	0.3	0.5	1.5	0.1	0.0	0.0	0.1	0.0	0.1	5.9	0.2	3367.0	0.5	0.3	1.6	0.0	0.4	2.8	0.2	0.1	0.2	0.0	0.0	0.0	1.2	0.4	0.0	0.1	3.3	2.8	0.0	0.0	0.0	0.0	861.1	39.4	2.7	1.8	1.0	0.0	1.8	0.0	0.0	1.0	0.1	0.0	29.3	0.1	0.1	0.0	2.0	0.2	0.0	26.3	0.2	0.2	3073.6	29.9	0.0	0.1	0.0	0.1	2.5	0.0	0.1
ANKS3	"FLJ32345, FLJ32767, KIAA1977"	ENSG00000168096	"Ankyrin repeat and sterile alpha motif domain containing 3"	Q6ZW76	16	4696510-4734378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Rod photoreceptor cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041409, HPA041482"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA041409: AB_10794375, HPA041482: AB_10795594"	"unprognostic (3.02e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-3)"	5.1	4.9	5.5	2.4	5.6	1.9	4.6	6.1	7.9	7.3	5.3	8.7	2.6	6.3	1.5	3.9	6.8	2.9	4.9	5.3	5.7	7.9	5.0	4.6	3.0	5.4	5.4	8.7	5.5	2.8	7.2	2.4	5.7	6.9	1.2	2.5	6.5	4.0	6.5	4.3	4.1	2.8	5.1	4.3	4.9	5.0	5.5	2.0	6.2	3.3	2.0	6.9	5.7	6.0	2.5	29.4	3.7	8.3	7.1	5.8	8.6	11.0	8.9	10.0	8.9	15.3	6.1	5.5	13.4	7.4	3.9	4.9	8.2	6.0	4.4	7.2	15.6	5.2	14.6	3.8	7.7	2.8	4.3	3.7	6.2	9.6	9.2	6.0	1.9	3.6	12.4	1.7	5.9	9.3	5.5	10.3	10.0	3.7	5.4	8.6	9.3	10.0	7.6	3.1	12.1	11.6	5.7	8.3	4.7	2.1	8.2	3.6	3.4	7.3	9.9	13.7	5.7	8.6	16.4	8.6	4.0	2.8	8.5	0.0	0.4	0.0	0.8	0.5	1.2	1.2	1.0	0.7	0.8	1.3	1.5	0.9	0.0	0.6	0.6	2.2	0.7	0.5	5.5	5.6	6.1	7.9	5.3	5.7	5.4	5.4	5.7	5.1	5.5	6.0	9.0	6.4	14.3	18.3	9.9	7.6	13.2	12.9	8.0	42.9	11.6	11.0	4.9	14.3	11.7	22.0	110.5	12.6	9.9	9.8	19.6	16.5	6.1	10.1	15.1	9.4	9.0	5.5	28.8	8.6	8.5	13.1	13.7	6.8	0.0	21.4	14.6	8.1	8.1	50.5	27.7	13.6	14.2	4.4	4.3	6.4	27.1	4.9	10.6	6.5	12.5	12.5	20.6	17.1	21.2	13.3	13.3	28.2	7.5	16.1	8.8	16.1	15.1	92.2	6.6	13.8	12.3	29.1	25.4	6.0	9.7	6.7	10.6	19.1	12.8	6.2
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389821-36453791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 266.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 156.4;Oligodendrocytes: 441.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 655.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.2	0.7	59.8	5.2	134.5	36.4	2.0	125.1	72.7	1.8	18.4	6.0	4.4	1.8	0.2	10.4	0.9	2.1	0.8	59.3	83.6	0.4	1.2	1.4	6.7	162.3	106.5	0.9	0.6	0.2	0.2	8.9	160.2	0.9	8.0	0.3	1.7	0.4	0.3	13.6	4.3	14.9	99.2	1.2	4.8	12.4	102.3	16.0	0.8	0.3	9.5	3.2	3.2	266.0	476.1	96.5	79.3	61.0	10.7	26.9	85.6	292.5	169.3	344.4	256.0	66.4	142.7	23.9	82.1	148.6	182.8	237.0	63.4	170.7	655.4	16.1	46.0	32.7	104.8	55.8	1.7	47.3	36.7	6.0	7.7	225.3	147.2	40.8	109.3	31.2	69.6	48.8	284.4	71.0	40.0	54.8	88.5	71.9	102.3	29.1	238.2	15.9	76.5	76.5	33.5	39.5	154.1	175.8	26.1	109.6	119.0	53.6	104.5	214.2	239.0	127.6	346.6	20.1	34.2	43.2	72.9	74.9	460.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.3	59.8	134.5	125.1	72.7	59.3	83.6	162.3	106.5	160.2	99.2	102.3	266.0	0.4	0.0	1.1	2.3	1.0	14.1	1.9	8.3	7.4	0.0	1.9	2.0	0.6	0.0	3.2	0.0	0.0	13.8	1.1	2.8	0.0	0.7	156.4	18.9	3.2	1.9	0.0	35.3	3.4	0.2	23.2	6.9	10.2	12.8	0.0	15.4	1.1	0.5	9.8	0.0	5.7	3.4	6.1	1.6	5.9	53.3	1.2	2.7	0.0	0.0	0.0	0.0	0.0	1.5	441.3	0.6	0.1	0.0	8.8	1.6	0.8	0.3	10.4	0.0	0.0	0.4	5.2	20.0	17.7	27.1	9.2	2.9	2.6	1.7	6.0	3.3
ANO9	"PIG5, TMEM16J, TP53I5"	ENSG00000185101	"Anoctamin 9"	A1A5B4	11	417933-442011	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.2;skin 1: 27.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.0;Intestinal goblet cells: 50.5;Paneth cells: 50.5;Proximal enterocytes: 87.7;Undifferentiated cells: 45.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 26.1"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	48	"B-cells: 2.1;NK-cells: 4.1;T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.2;CAPAN-2: 29.5;HaCaT: 16.8;RPMI-8226: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039948, HPA040112"	Approved		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA039948: AB_2676765, HPA040112: "	"unprognostic (3.62e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.98e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (8.81e-4)"	0.7	0.1	0.0	7.0	0.0	2.2	1.7	0.0	0.0	1.1	0.2	16.0	34.2	0.5	7.0	6.3	1.2	2.0	0.1	0.0	0.0	3.7	0.3	2.9	12.0	0.0	0.0	0.1	6.5	0.7	1.3	0.1	0.0	2.9	9.1	0.0	3.0	0.7	0.0	27.8	30.0	0.8	0.0	4.7	7.0	0.2	0.0	9.0	2.4	0.1	8.7	2.4	3.4	0.0	2.7	0.6	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	3.1	29.5	1.9	1.4	0.0	0.1	16.8	0.0	7.0	0.0	2.1	0.0	0.0	0.6	5.1	0.0	0.4	0.0	0.0	5.6	0.0	1.2	0.1	0.0	4.5	0.1	1.9	0.0	3.8	0.5	0.1	0.0	6.0	0.0	0.1	0.0	20.6	5.1	4.4	1.6	0.0	0.3	7.3	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	5.5	2.1	6.5	3.3	0.0	0.8	3.7	2.8	0.0	4.1	0.0	0.0	8.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.7	0.3	9.1	5.2	4.6	15.3	6.2	0.0	5.5	3.9	2.4	8.6	9.1	3.7	0.0	0.3	3.0	81.0	0.0	10.5	0.8	4.9	1.0	0.8	15.5	0.0	0.3	6.5	3.7	0.6	29.0	11.0	0.0	0.0	0.7	0.3	0.4	0.0	0.2	50.5	14.2	0.3	1.9	0.1	0.0	1.2	3.6	0.0	1.3	0.0	0.0	0.0	0.0	9.0	50.5	0.0	5.0	2.7	87.7	3.7	9.2	0.0	0.0	0.1	1.0	0.2	0.2	7.0	6.3	0.1	12.8	0.0	45.2	5.7
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151865-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 7527.7"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 3632.9;Syncytiotrophoblasts: 7071.8;Urothelial cells: 4808.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 2816.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		3000000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	719.8	60.3	27.5	268.3	35.1	2132.2	442.6	24.8	44.4	952.0	32.8	152.7	64.1	116.2	58.6	7527.7	264.6	329.4	145.3	28.4	53.4	67.9	54.7	470.4	67.9	55.5	46.4	109.4	61.8	28.2	98.1	559.4	36.5	165.3	103.2	6.5	1547.5	154.9	47.6	213.8	88.7	261.5	40.4	79.6	90.2	17.9	45.9	109.9	206.8	89.1	1485.5	386.3	1536.1	43.2	960.2	1485.7	65.8	68.4	905.8	855.6	4.2	1614.6	1008.5	656.3	441.9	43.5	841.0	2.2	520.1	1426.5	1441.9	1147.7	142.6	984.1	516.8	541.6	10.3	73.2	398.5	1.4	719.4	160.9	34.7	495.7	800.6	664.7	1294.6	604.0	947.8	85.4	309.3	39.5	822.6	4.3	287.0	87.7	82.6	379.7	597.6	0.9	369.1	3.2	1495.9	200.4	1.0	0.7	556.6	14.7	377.9	862.7	3.5	24.3	1176.2	761.8	478.9	1058.2	845.1	6.8	2.0	3.6	1757.9	147.8	1171.2	2816.9	1237.6	2227.6	744.1	328.7	757.0	13.7	662.7	664.5	1513.3	3.3	190.7	348.5	128.4	443.6	324.0	53.2	134.5	2021.5	27.5	35.1	24.8	44.4	28.4	53.4	55.5	46.4	36.5	40.4	45.9	43.2	447.4	583.3	415.2	1.6	39.0	846.7	2486.8	2417.6	1748.3	0.1	225.0	417.1	22.5	58.6	2214.7	62.5	0.0	1543.4	602.1	32.2	0.0	167.4	8.2	2037.4	241.6	362.2	5.3	81.2	3.7	23.1	1747.7	732.0	86.6	1993.5	2550.6	0.1	136.7	6.5	593.8	0.0	0.1	20.8	1330.6	545.0	1190.3	7.3	222.4	901.7	307.7	29.0	575.0	0.2	319.3	0.5	0.6	733.2	5.5	9.4	140.4	1552.2	0.1	5.7	1996.9	0.0	65.7	728.2	413.3	2.3	4.0	3632.9	597.7	7071.8	1348.3	3.0	12.6	4808.1
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039233-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5"	"Group enriched"	"Detected in all"	6	"B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3"	"Cell line enhanced"	"Detected in many"		"HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	4.7	1.3	3.2	12.1	3.2	19.8	3.9	3.0	3.8	3.5	3.5	2.5	3.3	2.4	1.7	1.8	3.3	3.5	2.9	2.8	2.9	2.0	1.3	4.6	26.1	3.4	3.3	1.2	0.8	0.6	1.1	3.2	3.2	2.7	2.7	0.1	1.7	1.2	2.5	2.1	8.2	2.1	3.5	15.8	3.3	1.5	3.3	25.2	2.7	3.0	17.2	3.2	3.8	4.0	2.1	2.1	1.6	1.2	2.6	8.0	0.4	0.5	0.3	0.5	0.6	3.9	1.9	6.8	6.5	1.6	2.2	0.8	5.0	0.5	0.5	13.3	4.0	2.2	5.9	1.8	4.1	2.6	0.8	27.7	0.2	2.4	0.2	0.1	16.2	33.1	1.5	8.9	2.1	3.1	30.0	4.1	0.0	1.7	14.8	30.9	3.6	3.9	0.7	1.1	5.7	0.0	2.7	0.7	0.7	0.2	0.7	4.9	9.9	0.5	0.0	0.8	2.5	4.4	6.7	3.3	3.6	117.7	1.4	5.6	3.5	1.7	53.9	2.5	63.5	34.3	56.1	59.9	3.5	32.9	96.3	72.1	3.2	24.8	8.1	5.2	66.5	26.6	3.2	3.2	3.0	3.8	2.8	2.9	3.4	3.3	3.2	3.5	3.3	4.0	32.2	0.0	9.9	0.0	23.8	3.7	1.4	0.3	2.2	0.1	1.9	2.2	1.3	4.3	1.5	0.0	0.0	0.4	36.4	0.5	0.0	0.1	4.0	1.1	5.0	24.8	1.8	8.2	0.0	0.0	1.1	7.2	1.5	0.8	15.2	4.1	38.2	1.4	8.7	0.0	0.0	0.1	2.0	18.2	5.6	1.5	1.5	7.5	7.2	0.0	7.1	0.2	47.4	0.0	0.0	0.1	0.0	0.4	7.8	1.2	1.0	0.4	2.0	0.0	0.0	3.4	3.7	0.7	1.6	1.2	2.3	0.4	66.0	0.3	0.5	1.4
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551747-78610451	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 337.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 322.7;Alveolar cells type 1: 589.7;Ductal cells: 434.5;Exocrine glandular cells: 305.3;Pancreatic endocrine cells: 754.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	320	"neutrophil: 207.7"	"Lineage enriched"	"Detected in single"	327	"granulocytes: 207.7"	"Cell line enhanced"	"Detected in many"		"A-431: 419.5;CACO-2: 403.5;CAPAN-2: 563.7;EFO-21: 334.7;hTERT-HME1: 566.3;OE19: 502.1;RPTEC TERT1: 477.8"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Supported	"Plasma membrane"		NA	NA		6400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favorable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	52.9	3.1	16.5	22.7	17.3	337.7	43.8	14.5	28.2	19.6	11.7	27.7	15.8	12.5	3.7	55.2	16.8	17.3	51.2	14.2	21.6	24.9	3.9	144.4	2.4	19.9	16.1	2.5	32.7	34.0	5.9	81.5	20.8	68.0	26.7	1.6	119.5	12.9	28.3	10.0	13.3	20.1	14.6	21.6	90.5	1.9	19.9	7.1	83.7	36.7	12.7	10.2	15.6	14.7	419.5	77.7	1.3	0.9	1.0	0.9	0.6	4.9	0.4	11.0	10.9	403.5	563.7	0.1	334.7	14.4	0.4	161.6	0.1	300.0	16.0	1.4	3.3	36.4	142.0	23.9	45.9	5.9	0.2	2.4	262.6	4.1	566.3	60.1	118.9	9.0	0.7	0.3	1.9	15.9	1.7	0.2	13.0	502.1	55.4	0.0	0.8	0.0	477.8	45.2	0.3	0.3	235.5	58.2	16.6	186.1	9.9	4.3	153.2	0.6	52.6	0.2	93.0	3.1	5.1	2.2	0.0	0.4	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	207.7	0.1	0.6	0.1	0.0	2.9	16.5	17.3	14.5	28.2	14.2	21.6	19.9	16.1	20.8	14.6	19.9	14.7	322.7	589.7	47.3	0.0	1.1	24.9	81.8	144.9	1.8	0.2	27.6	85.9	8.6	55.8	175.2	38.6	0.0	212.6	1.0	35.4	17.6	434.5	1.1	33.7	4.4	84.6	5.4	3.2	0.9	305.3	106.2	16.9	99.9	58.1	5.1	0.1	23.2	0.6	18.9	0.0	0.3	33.4	122.1	0.3	0.3	0.3	3.1	6.9	5.4	42.2	21.0	1.2	0.0	1.0	0.6	754.2	61.6	0.4	0.6	158.6	11.5	5.5	89.6	0.4	0.0	7.6	18.7	1.1	0.6	21.9	6.7	62.8	2.3	1.3	29.7	46.7
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667946-121696995	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1156.8;Extravillous trophoblasts: 1125.1;Syncytiotrophoblasts: 1140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		NA	NA		5000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.01e-5)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (9.29e-7)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.26e-4)"	490.6	286.5	111.7	241.7	126.3	96.2	314.0	136.9	144.7	429.1	137.7	181.9	96.5	288.7	162.6	135.1	225.0	273.1	213.9	106.4	134.7	216.2	149.5	299.0	136.2	151.2	129.6	224.7	162.9	133.7	176.7	466.0	150.4	211.7	155.5	78.1	273.8	250.5	85.2	132.5	130.9	370.3	134.3	175.7	186.0	110.4	154.3	63.3	182.9	114.8	135.2	298.1	178.6	157.3	463.5	339.6	438.0	256.1	2094.3	1645.5	503.4	1582.7	1464.9	841.3	744.8	246.2	200.6	35.7	282.9	2224.8	581.7	165.4	287.3	727.6	762.2	335.1	171.2	105.0	281.6	647.4	1213.9	221.1	178.3	945.5	344.7	705.1	665.9	927.4	1120.9	25.2	106.0	271.8	2133.5	306.7	225.5	75.1	231.9	417.7	718.5	8.2	1014.5	72.6	1368.9	66.3	117.1	141.4	579.7	227.6	1515.2	872.3	201.5	261.2	830.6	1322.1	632.1	955.2	478.0	240.8	308.6	76.0	847.8	123.5	1586.2	122.2	725.8	359.9	104.8	830.5	136.0	127.3	158.8	131.9	745.6	89.5	51.3	74.6	157.9	48.4	798.0	91.2	289.9	773.3	111.7	126.3	136.9	144.7	106.4	134.7	151.2	129.6	150.4	134.3	154.3	157.3	286.5	243.6	233.9	13.7	85.0	199.3	266.4	395.9	76.2	6.8	101.6	107.4	88.3	265.9	257.2	132.4	25.0	1156.8	53.2	15.6	297.4	703.5	16.2	239.7	318.1	287.7	48.6	29.0	15.4	338.2	1125.1	564.7	91.3	312.6	148.7	177.5	186.4	54.8	753.2	13.5	7.1	110.9	187.2	446.5	705.1	41.4	379.9	544.0	352.2	45.0	412.5	161.4	13.4	23.1	26.8	501.1	31.2	366.3	203.1	473.8	15.3	194.3	268.9	30.0	295.9	443.1	377.2	15.9	28.6	101.1	140.8	1140.8	122.0	185.7	43.2	188.2
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100706-151157785	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 343.8;monocytes: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 861.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		1800000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	292.9	135.4	98.1	164.2	104.1	109.7	188.3	94.0	150.6	148.9	151.8	196.0	44.5	181.5	105.0	94.7	149.9	108.7	188.7	102.5	123.1	82.6	214.4	131.6	161.8	144.2	109.4	181.7	78.3	29.6	161.9	141.1	146.2	124.9	78.2	133.6	70.3	208.6	331.3	62.7	119.9	300.1	92.3	150.9	111.4	52.5	127.4	160.8	86.7	371.5	176.4	206.5	107.4	104.8	3.0	30.4	212.8	317.1	861.2	417.8	55.1	397.4	526.4	323.5	477.6	106.7	15.6	26.9	138.5	578.6	268.1	0.5	165.9	200.2	300.3	110.5	52.1	15.3	62.1	204.7	295.0	97.6	94.7	508.6	1.5	282.3	42.0	476.9	420.6	197.5	22.0	396.1	737.6	100.4	181.8	151.7	56.2	1.2	92.4	120.4	592.9	31.0	42.2	0.3	12.2	49.3	39.9	282.7	175.6	308.4	488.3	201.1	326.8	296.6	84.2	19.4	107.1	205.4	289.5	4.5	154.5	459.7	46.2	89.7	89.4	82.9	290.4	54.7	190.4	175.4	213.4	263.3	118.3	179.0	145.8	181.6	17.6	261.9	25.0	30.2	190.9	331.7	98.1	104.1	94.0	150.6	102.5	123.1	144.2	109.4	146.2	92.3	127.4	104.8	90.3	16.0	17.3	19.2	146.8	11.0	11.5	2.2	1.8	16.5	30.7	24.0	59.5	12.8	1.1	23.9	6.2	64.3	110.3	0.3	25.4	6.5	56.9	1.8	38.5	45.6	21.4	36.4	36.5	17.8	33.7	105.9	9.2	1.7	57.5	343.8	57.1	147.1	85.4	15.2	36.3	2.4	0.0	41.0	77.8	46.8	123.3	41.2	55.2	10.3	445.2	45.6	187.4	18.6	5.6	12.1	1.2	211.4	120.3	7.3	1.0	48.4	4.7	125.8	230.1	55.3	150.6	2.5	1.5	0.6	8.1	177.2	143.4	149.4	2.5	1.5
AP001267.5		ENSG00000285827	"Novel protein"		11	118401602-118482737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 7.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 24.1;Club cells: 14.9;granulocytes: 20.2;Respiratory ciliated cells: 13.8"					"Region enhanced"	"Detected in many"		"cerebellum: 3.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA044629	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA044629: AB_2679028"																		1.2	1.2	0.7	1.5	0.9	7.2	1.3	3.8	1.3	0.8	0.4	1.3	1.8	0.8	1.1	0.6	0.8	0.7	1.2	0.7	1.4	1.2	1.2	0.9	2.4	0.2	0.1	0.8	0.8	1.6		0.7	0.2	1.4	1.2	1.5	1.4	0.8	1.5	0.5	1.8	0.8	0.0	1.0	1.4	0.7	0.2	2.6	1.1	1.8	1.3	1.0		1.6	3.1	0.7	2.0	2.7	0.9	0.8	3.8	1.5	1.2	1.9	1.9	3.3	2.5	2.6	3.6	1.9	4.0	2.4	2.8	2.4	2.8	4.0	1.8	4.3	1.2	1.6	1.8	2.9	3.0	1.4	1.3	2.3	3.0	1.2	2.4	6.1	3.4	6.7	1.7	2.4	4.5	5.7	1.7	5.5	2.6	3.9	2.2	3.4	3.4	1.2	3.3	2.3	2.4	1.2	1.5	3.0	1.9	1.5	1.3	2.0	4.2	1.1	1.9	1.7	1.6	5.2	0.7	3.1	1.0	5.5	5.1	6.0	4.9	4.2	4.1	6.1	4.4	4.0	5.0	5.1	4.2	4.0	4.1	3.7	4.0	7.2	5.8	10.6	0.7	0.9	3.8	1.3	0.7	1.4	0.2	0.1	0.2	0.0	0.2	1.6	0.0	16.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
AP002495.1		ENSG00000254469	"XRCC1 N-terminal domain containing 1-like"	Q6ZNB5	11	71865504-71928665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 2.2;Hofbauer cells: 2.0;Respiratory ciliated cells: 1.5;Syncytiotrophoblasts: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051121, HPA051124"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoli	"Mitotic chromosome"	"HPA051121: AB_2681349, HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	1.9	2.1	1.9	2.2	2.8	4.7	3.2	4.3	2.6	2.8	2.8	2.2	2.6	3.7	5.3	2.6	2.4	2.1	2.1	1.7	2.2	2.9	2.2	1.8	4.2	2.5	1.5	4.6	3.1	2.9	2.5	2.0	2.4	3.1	3.5	7.3	2.2	2.8	1.6	4.2	2.6	2.4	0.6	2.9	2.4	3.3	2.8	3.2	3.2	1.5	3.4	2.3	2.2	5.0	2.6	6.2	4.7	4.5	1.8	1.6	3.1	2.9	2.3	3.1	3.0	6.5	6.4	5.8	2.6	2.0	3.9	8.4	4.9	3.3	3.2	8.4	4.5	9.4	7.7	4.2	1.1	4.2	3.1	2.2	1.6	5.2	3.6	2.6	4.9	8.0	6.3	7.6	3.0	4.9	4.8	3.5	4.9	9.6	4.5	3.6	16.3	4.0	3.5	3.1	6.9	6.6	4.6	4.1	9.2	3.3	5.1	2.3	4.6	2.5	4.1	4.9	1.9	5.5	8.4	7.0	4.0	4.6	3.7	2.7	1.9	1.7	2.9	3.0	1.7	2.5	5.1	3.8	2.2	3.3	4.8	4.1	2.0	1.2	1.9	4.8	4.9	1.9	1.9	2.8	4.3	2.6	1.7	2.2	2.5	1.5	2.4	0.6	2.8	5.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0
AP002748.5		ENSG00000256349	"Novel protein"		11	66509079-66533613	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 2.9;choroid plexus: 1.9;retina: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 9.7;THP-1: 2.8"									HPA058283	Uncertain		Approved	Midbody		Yes	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"		Midbody		"HPA058283: AB_2683667"																		0.0	0.1	2.1	0.0	2.2	0.0	0.2	1.9	2.9	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.0	2.3	0.4	0.2	0.2	0.2	2.3	2.1	0.0	0.9	0.2	0.0	0.2	2.3	0.1	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.1	0.1	0.0	2.4	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.6	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.4	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.7	0.0	0.2	0.6	0.2	0.0	0.1	1.1	0.1	0.0	1.3	0.1	0.4	0.0	0.6	0.3	0.6	9.7	0.8	0.0	0.8	0.0	0.0	0.7	1.4	0.2	0.1	0.2	0.5	0.4	0.2	0.9	2.8	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	2.2	1.9	2.9	2.0	2.3	2.3	2.1	2.3	2.3	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP003419.1		ENSG00000256514	"Novel protein"		11	67351572-67373584	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.5;Club cells: 1.8;granulocytes: 3.8;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 160.8"									HPA078008			Approved	"Centriolar satellite"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Centriolar satellite"		"HPA078008: "										"unprognostic (1.64e-3)"			"unprognostic (1.63e-1)"			"unprognostic (2.44e-1)"		23.9	26.6	48.0	45.6	50.8	38.9	26.6	51.4	57.0	28.9	47.4	68.1	46.8	14.8	38.4	46.1	25.4	49.9	44.4	47.0	50.4	32.0	91.9	36.6	83.5	51.9	49.9	23.6	68.1	20.1	14.6	28.7	51.2	36.7	71.9	8.2	42.0	32.1	37.4	30.6	44.0	34.1	51.8	38.5	45.9	20.5	53.9	58.0	25.9	75.0	123.1	47.0	11.3	54.3	14.4	14.9	8.1	12.1	81.4	124.2	3.4	18.9	82.0	26.0	26.9	0.0	160.8	15.4	49.2	122.4	48.9	19.3	8.1	102.3	15.5	10.1	0.2	17.3	2.3	0.0	122.6	5.4	40.2	122.2	96.3	64.0	111.7	115.7	80.3	31.0	7.1	41.8	94.7	3.9	13.5	15.4	3.3	138.1	1.0	15.7	22.0	18.9	80.9	2.5	1.4	6.1	13.9	17.6	53.9	34.4	50.4	19.4	45.8	42.5	7.0	42.8	8.6	16.5	2.4	25.6	99.3	12.2	25.8	43.2	39.6	74.0	45.8	48.6	43.7	87.9	60.8	60.3	39.1	96.3	61.9	51.7	34.6	24.3	90.4	72.9	84.0	62.0	48.0	50.8	51.4	57.0	47.0	50.4	51.9	49.9	51.2	51.8	53.9	54.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 subunit gamma 1"	O43747	16	71729000-71809201	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 268.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		62000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: AB_2677370"	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	19.0	25.7	15.4	23.4	16.4	76.7	24.8	19.6	20.8	20.3	26.9	23.6	22.6	17.8	25.5	26.7	18.0	18.9	13.6	16.8	14.9	36.4	33.2	21.4	24.6	14.4	14.5	15.3	24.2	40.4	16.8	17.5	15.8	22.5	25.7	52.8	22.6	16.3	28.2	26.6	23.6	16.1	13.5	22.4	29.3	30.7	15.6	24.9	24.0	36.5	30.4	20.6	18.4	24.3	43.9	62.4	46.3	48.1	48.2	45.4	41.0	44.6	42.1	56.8	54.5	64.3	47.1	55.0	41.9	60.4	41.5	55.4	62.7	49.3	74.4	21.6	33.8	36.2	31.7	46.5	28.9	44.7	114.1	39.1	33.4	76.0	46.9	36.1	50.2	35.8	47.8	23.0	56.1	80.0	39.2	35.3	43.7	34.6	26.8	62.9	37.3	59.3	53.7	49.3	42.5	25.5	55.7	34.8	24.5	46.6	61.0	33.7	60.2	49.4	37.9	27.3	32.9	35.1	50.2	109.2	40.3	34.4	43.3	5.7	6.9	10.0	6.7	7.6	6.8	5.4	5.9	7.5	7.5	5.7	4.6	5.8	14.9	6.7	6.4	5.2	6.6	4.2	15.4	16.4	19.6	20.8	16.8	14.9	14.4	14.5	15.8	13.5	15.6	24.3	32.6	32.1	31.1	42.4	34.2	28.8	27.4	17.3	22.8	26.8	47.6	25.4	13.4	35.8	25.2	36.8	73.0	14.4	40.6	39.3	19.6	21.1	268.8	55.8	37.9	26.0	23.4	9.9	54.2	21.8	13.3	24.0	46.4	84.8	21.0	26.2	21.4	58.5	16.7	30.3	59.0	25.7	12.2	30.4	27.2	130.7	17.7	32.4	23.2	36.5	25.1	16.4	24.7	53.8	79.2	30.5	24.2	19.9	30.6	36.9	30.5	46.4	31.7	66.6	19.7	33.0	26.4	35.8	37.1	32.4	38.6	24.5	33.4	23.0	26.4	47.8
AP3D1	ADTD	ENSG00000065000	"Adaptor related protein complex 3 subunit delta 1"	O14617	19	2100988-2164468	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074408			Approved	Cytosol		No	No		28000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA074408: AB_2686686"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (4.24e-2)"	"unprognostic (8.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.37e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (8.11e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.73e-2)"	30.0	40.7	39.0	36.3	39.0	27.6	28.8	29.4	55.1	29.5	39.4	36.2	35.8	35.1	16.6	38.2	32.5	28.0	43.7	45.0	39.8	35.8	40.9	31.1	37.2	39.4	43.3	29.8	63.9	40.0	56.4	33.4	48.0	31.3	22.5	29.6	48.0	34.0	61.1	30.0	35.4	32.8	26.0	34.8	37.7	44.9	38.9	33.2	43.9	40.3	27.6	34.3	25.5	34.5	114.8	117.5	68.5	105.0	85.7	71.8	83.9	90.3	87.9	94.2	85.2	134.8	61.8	61.7	51.0	134.1	115.7	76.4	99.2	109.7	61.1	89.9	94.6	80.5	74.7	106.3	149.9	88.4	102.5	89.5	72.3	98.1	141.6	79.7	92.6	44.2	84.2	210.9	84.1	84.4	85.6	46.8	102.8	78.2	74.2	90.3	75.0	83.4	70.7	162.7	97.4	81.1	82.3	85.7	154.2	62.5	83.2	101.0	121.7	89.7	37.7	123.4	106.7	176.5	184.6	78.6	122.5	57.4	91.5	0.2	3.3	2.9	3.5	3.6	5.6	2.4	3.4	4.1	3.9	2.9	2.7	3.4	3.4	5.5	3.0	7.5	2.1	2.2	39.0	39.0	29.4	55.1	45.0	39.8	39.4	43.3	48.0	26.0	38.9	34.5	29.5	60.9	61.7	41.4	35.5	20.3	41.3	20.3	36.5	66.6	39.5	26.5	77.7	44.3	34.1	40.5	35.5	55.3	32.5	79.5	21.5	53.3	70.7	34.4	36.9	37.1	47.8	42.9	24.1	74.2	71.9	38.2	69.8	48.9	17.1	38.9	29.6	49.2	66.9	48.8	30.2	68.8	18.3	38.4	30.2	68.6	37.9	43.4	39.2	18.7	31.7	55.5	29.9	21.1	28.3	67.7	54.0	38.0	67.6	65.5	52.6	36.0	30.3	43.9	19.7	37.8	33.6	105.3	129.5	38.0	23.3	78.0	36.9	39.6	56.8	59.4
AP4B1	"BETA-4, SPG47"	ENSG00000134262	"Adaptor related protein complex 4 subunit beta 1"	Q9Y6B7	1	113894194-113905201	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028162, HPA028652"	Approved		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA028162: AB_10610976, HPA028652: AB_10601451"	"unprognostic (8.90e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (8.60e-7)"	"unprognostic (3.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (5.08e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.55e-2)"	9.7	8.5	12.5	11.1	13.1	20.5	9.3	14.6	14.6	11.9	10.9	11.5	10.6	9.7	14.2	12.1	11.0	7.0	11.2	13.0	13.0	9.7	8.4	9.5	14.3	11.6	11.4	13.7	14.0	4.8	13.7	5.9	11.8	9.6	12.7	20.0	7.6	6.2	11.7	11.5	12.8	9.1	11.5	20.1	10.4	11.1	13.3	16.1	11.0	9.1	13.9	9.2	10.0	13.3	11.0	9.8	10.0	11.8	15.7	14.1	6.4	10.1	9.8	13.0	14.0	6.8	7.7	21.5	15.9	12.4	6.5	9.7	11.3	13.4	16.5	16.6	9.8	17.6	13.6	8.3	9.5	19.6	17.3	16.1	6.7	25.5	15.3	7.8	22.7	20.9	12.3	18.5	17.6	65.2	15.6	21.6	9.4	7.7	19.0	15.0	19.5	13.3	13.2	5.5	10.2	8.5	10.1	19.1	7.8	9.5	5.7	15.4	21.8	15.0	13.9	17.4	20.8	15.2	15.8	21.3	24.6	26.0	25.1	15.9	10.5	8.6	14.7	10.8	15.6	9.5	11.7	12.6	12.9	11.9	12.7	11.1	1.2	12.2	8.5	9.1	10.4	9.5	12.5	13.1	14.6	14.6	13.0	13.0	11.6	11.4	11.8	11.5	13.3	13.3	7.2	3.2	6.7	7.5	12.3	3.6	3.3	5.4	4.6	6.8	3.2	4.3	8.7	5.7	11.9	3.7	31.3	3.8	12.0	7.8	1.9	7.7	3.6	4.6	4.7	7.6	3.0	18.1	11.4	26.8	3.5	7.0	11.2	5.2	2.5	4.5	7.5	4.1	5.2	8.4	11.6	5.3	6.1	7.3	4.9	2.3	2.8	6.9	7.2	7.5	6.1	4.7	3.1	11.6	10.0	10.9	6.9	4.9	7.4	2.8	6.5	3.3	5.2	21.0	13.1	6.1	6.2	16.4	11.5	5.7	3.7	1.6	14.8	6.4	9.0	3.3
AP5B1	"AP-5, DKFZp761E198, PP1030"	ENSG00000254470	"Adaptor related protein complex 5 subunit beta 1"	Q2VPB7	11	65773898-65780976	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 44.0"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"neutrophil: 25.0"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 25.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065739, HPA067880"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Golgi apparatus"	"HPA065739: AB_2685550, HPA067880: AB_2685914"	"unprognostic (3.64e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.67e-1)"	8.3	4.8	3.2	6.9	2.6	44.0	6.6	5.8	3.6	5.4	1.3	6.0	5.7	7.1	2.0	10.2	5.2	3.1	5.0	3.6	1.2	5.7	5.8	8.7	4.7	3.9	1.5	2.9	10.3	6.4	3.5	3.8	3.0	5.0	3.0	2.5	7.0	4.5	9.6	9.1	6.8	3.2	1.1	10.0	6.0	2.5	1.8	4.8	4.9	3.4	4.3	6.6	5.1	1.6	12.8	9.8	2.8	14.3	8.6	4.1	16.4	5.3	6.2	6.1	4.7	7.7	6.0	7.8	9.4	6.3	12.4	15.8	8.7	4.3	2.9	12.1	10.1	7.0	12.0	3.8	5.8	9.9	13.3	7.0	10.1	4.0	2.9	6.0	5.2	13.6	15.6	9.7	3.6	9.2	5.5	10.5	4.6	4.4	10.1	17.3	0.5	16.8	5.9	15.8	2.7	5.4	4.1	2.6	26.0	3.7	4.4	14.1	7.6	10.2	8.6	13.6	6.0	10.0	11.2	8.1	7.5	8.5	10.5	1.1	1.7	0.6	0.5	1.0	0.2	0.3	0.2	0.2	0.5	0.3	0.3	0.2	25.0	0.4	1.3	0.3	0.2	0.8	3.2	2.6	5.8	3.6	3.6	1.2	3.9	1.5	3.0	1.1	1.8	1.6	2.0	0.0	8.8	6.2	3.9	2.4	12.3	4.3	7.4	5.0	4.2	2.0	1.6	2.8	3.7	7.3	14.6	7.6	5.9	12.8	1.9	8.9	1.4	6.3	2.9	3.0	3.0	0.0	3.6	13.6	18.2	2.9	6.6	10.7	2.5	5.3	1.4	7.1	14.0	11.8	3.2	3.8	6.1	12.4	2.1	0.7	0.6	11.6	7.2	3.7	17.8	3.0	6.2	1.0	2.2	9.4	6.9	3.8	3.6	5.6	10.1	8.8	2.9	8.0	0.0	3.7	3.0	0.6	4.7	6.0	2.3	34.9	4.3	2.0	4.5	10.0
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 subunit sigma 1"	Q9NUS5	20	3820524-3828838	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328"	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favorable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	6.0	11.5	7.1	5.5	7.7	7.4	5.8	6.4	8.2	4.8	8.1	6.2	6.3	5.7	3.0	7.4	4.7	4.6	11.3	7.3	6.7	9.4	14.6	5.4	5.5	6.8	6.5	5.8	7.5	7.8	7.5	5.4	6.5	6.9	4.4	3.4	8.7	3.6	19.2	5.3	6.4	3.9	6.3	8.2	6.4	11.2	6.6	4.3	9.4	10.0	3.8	5.4	5.1	6.5	18.1	33.8	4.6	3.1	6.2	8.0	5.7	10.8	8.6	10.4	8.3	28.5	18.9	10.4	11.3	11.4	19.7	15.9	3.9	17.4	3.6	5.7	10.9	17.3	10.1	25.3	10.7	12.0	10.0	13.7	9.7	13.0	10.3	7.0	12.4	12.4	12.4	19.8	14.0	29.4	28.0	10.5	4.2	13.0	27.3	11.7	7.8	10.8	11.8	14.4	14.2	5.7	10.6	32.4	18.2	3.1	15.9	5.9	16.9	21.7	10.3	11.3	20.6	10.6	12.6	5.7	7.5	10.6	19.0	2.2	7.5	4.6	10.2	11.9	7.8	5.4	8.5	8.4	9.9	7.0	7.8	7.3	1.7	6.2	6.7	7.7	9.9	6.5	7.1	7.7	6.4	8.2	7.3	6.7	6.8	6.5	6.5	6.3	6.6	6.5	4.0	0.0	10.6	2.3	5.9	1.7	4.4	8.0	7.4	15.3	4.9	4.3	11.2	11.5	5.9	3.7	10.4	19.4	3.8	8.4	11.7	11.1	3.7	5.1	6.2	8.6	12.6	9.9	1.9	12.7	13.3	6.8	14.8	5.2	14.0	6.6	6.1	9.4	15.5	25.2	2.1	7.3	8.2	6.9	2.0	3.6	5.9	7.3	5.4	4.7	11.0	12.8	8.2	2.5	1.7	10.2	8.8	4.1	8.6	3.6	11.2	8.5	4.5	20.8	13.1	5.8	4.5	19.4	10.9	6.8	1.0	18.5	6.2	10.9	7.4	3.0
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438341-26567803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 145.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.2;dendritic cells: 149.1;Kupffer cells: 117.7;Macrophages: 93.4;Microglial cells: 381.3;NK-cells: 134.9;T-cells: 125.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 182.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 101.0;MOLT-4: 87.7;REH: 195.4;U-698: 204.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA017009: AB_2669505, HPA063903: AB_2685147"	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favorable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	30.7	4.7	7.0	47.8	8.0	45.5	14.5	10.4	7.6	3.5	5.7	6.1	7.1	2.2	1.6	3.4	5.9	11.6	5.7	7.6	10.4	5.0	38.3	15.5	50.0	16.4	12.5	1.5	4.3	1.6	2.8	8.8	18.0	2.6	6.7	0.6	5.1	2.1	1.4	3.4	17.8	7.5	16.0	56.6	9.2	0.8	15.5	145.4	3.5	2.7	44.3	10.5	3.6	27.3	0.1	1.8	0.0	0.0	12.8	21.2	11.3	37.0	7.2	20.8	19.8	0.0	0.0	101.0	0.5	24.9	22.2	0.1	0.0	0.0	28.6	0.0	0.0	73.3	0.2	0.0	0.0	13.9	0.1	30.3	0.0	0.7	0.0	2.6	0.0	40.5	0.1	62.0	0.0	0.0	87.7	19.5	0.1	7.9	0.0	195.4	0.1	72.4	5.8	0.0	0.1	0.0	3.4	0.3	0.1	0.3	0.1	47.6	0.1	0.0	0.5	6.8	0.1	16.8	0.0	204.7	16.9	71.0	0.0	81.5	23.8	58.5	30.2	23.6	24.9	32.6	25.8	25.9	15.4	39.5	29.3	28.8	182.9	19.1	38.9	50.3	27.2	13.4	7.0	8.0	10.4	7.6	7.6	10.4	16.4	12.5	18.0	16.0	15.5	27.3	3.2	0.0	25.3	1.6	88.2	1.1	0.1	0.1	0.6	0.1	1.6	3.2	1.0	8.6	2.6	3.7	0.0	2.2	149.1	0.1	0.0	3.9	0.4	0.7	12.8	4.7	0.0	28.2	1.1	0.0	20.7	15.0	3.6	0.4	23.4	0.1	6.8	28.9	59.9	0.0	2.9	0.2	0.0	117.7	18.4	0.3	0.0	93.4	3.6	381.3	65.2	0.0	134.9	4.0	1.5	0.1	0.1	0.0	41.7	0.1	0.0	5.1	3.7	0.2	0.0	0.9	11.3	0.1	1.1	0.4	0.1	1.4	125.9	0.4	0.1	0.1
APBB2	"FE65L, FE65L1, MGC35575"	ENSG00000163697	"Amyloid beta precursor protein binding family B member 2"	Q92870	4	40810027-41216714	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Group enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 586.1;Oligodendrocytes: 803.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"naive B-cell: 5.6"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 138.7;TIME: 192.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023542	Approved		Approved	Mitochondria		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA023542: AB_1844909"	"unprognostic (4.43e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (5.91e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.19e-3)"	"unprognostic (9.35e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.61e-1)"	41.6	9.1	23.1	5.4	42.3	8.6	25.1	38.1	24.5	16.1	3.7	13.9	8.3	14.0	5.9	8.9	13.1	16.1	21.5	20.6	30.6	16.5	14.7	18.6	7.4	42.9	39.6	32.1	10.8	8.5	8.5	17.6	39.5	8.7	7.7	15.7	8.6	9.8	28.7	12.6	7.0	14.9	25.2	14.8	11.3	8.5	36.7	13.2	33.6	21.7	5.6	10.7	13.1	72.9	19.4	9.4	20.6	28.8	64.9	50.7	45.2	38.5	45.8	14.0	24.5	34.1	40.2	33.9	20.7	16.5	44.5	5.6	36.5	49.4	25.0	1.1	7.3	0.4	23.5	21.1	65.0	19.2	1.1	76.7	24.6	42.5	43.0	58.2	138.7	19.0	1.1	0.7	86.1	16.3	6.3	3.6	17.1	9.8	17.9	50.9	58.6	38.4	19.9	8.9	27.2	15.4	11.7	6.6	6.9	23.7	17.2	2.2	192.3	20.1	59.5	13.8	61.1	8.1	18.5	41.2	20.7	30.8	24.6	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	5.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	23.1	42.3	38.1	24.5	20.6	30.6	42.9	39.6	39.5	25.2	36.7	72.9	58.8	80.1	14.5	46.7	5.0	10.7	3.8	10.4	7.4	7.6	25.5	13.6	22.5	12.8	6.3	9.2	6.2	14.4	0.5	5.2	7.9	3.8	14.5	5.6	32.8	39.4	3.0	5.3	121.3	6.4	2.8	25.2	12.8	7.5	1.3	13.5	47.2	13.8	3.2	62.2	171.3	4.0	16.2	4.0	6.7	23.1	35.8	2.5	7.2	164.9	0.1	9.3	0.0	586.1	803.4	6.2	6.7	37.2	0.2	2.7	5.5	6.3	4.0	7.6	59.2	43.2	51.4	3.8	10.8	7.3	11.9	6.0	1.2	24.0	7.4	3.6
APC2	APCL	ENSG00000115266	"APC regulator of WNT signaling pathway 2"	O95996	19	1446302-1473244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 64.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 142.4;Bipolar cells: 50.4;Excitatory neurons: 26.8;Horizontal cells: 45.4;Inhibitory neurons: 27.5;Muller glia cells: 29.4;Oligodendrocyte precursor cells: 28.1"	"Cancer enriched"	"Detected in some"	27	"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.8;SCLC-21H: 9.3;SH-SY5Y: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078002			Supported	"Cytokinetic bridge,Midbody,Cytosol"		Yes	No				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytokinetic bridge, Midbody"	Cytosol	"HPA078002: AB_2686874"	"unprognostic (1.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.88e-5)"	"unprognostic (3.64e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.49e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.98e-3)"	0.1	2.4	41.5	0.0	27.3	0.0	0.0	41.4	42.4	0.1	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.3	37.1	20.8	0.0	0.0	0.0	0.0	64.5	42.3	0.0	0.3	0.0	6.2	0.0	54.9	0.1	0.0	2.7	0.2	0.0	0.2	0.1	0.4	0.1	38.3	0.0	0.3	1.0	54.6	0.0	0.1	0.0	0.0	0.1	0.2	49.0	0.2	0.6	7.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.0	1.0	0.1	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.0	9.3	31.7	1.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.6	0.1	0.1	1.7	0.5	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	27.3	41.4	42.4	37.1	20.8	64.5	42.3	54.9	38.3	54.6	49.0	0.3	0.0	0.0	142.4	0.3	0.0	0.2	0.2	1.2	50.4	0.4	0.4	3.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.5	0.5	0.5	0.0	0.0	26.8	0.0	0.1	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.1	45.4	27.5	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	29.4	2.1	28.1	17.8	0.0	0.0	0.7	0.0	0.1	0.2	0.2	0.0	11.1	0.0	0.6	0.4	0.4	0.7	2.4	0.0	0.0	0.3	0.2	0.1	0.2
APCDD1L	FLJ90166	ENSG00000198768	"APC down-regulated 1 like"	Q8NCL9	20	58459101-58515399	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 19.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 9.1;Breast myoepithelial cells: 7.7;Fibroblasts: 3.6;Oligodendrocyte precursor cells: 6.0;Skeletal myocytes: 8.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 94.5;hTEC/SVTERT24-B: 32.7;HUVEC TERT2: 33.6;TIME: 56.1;U-87 MG: 36.5"					"Not detected"	"Not detected"			HPA067015	Uncertain		Uncertain	Mitochondria		No	No				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA067015: AB_2685764"	"unprognostic (2.61e-1)"	"unprognostic (8.26e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.35e-5)"	"unprognostic (4.09e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.06e-4)"	"unprognostic (7.63e-4)"	"unprognostic (2.14e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.55e-13)"	"unprognostic (5.01e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.81e-3)"	0.4	0.4	0.2	0.2	0.0	0.0	4.8	0.5	0.1	1.7	0.0	1.0	0.1	1.8	0.0	0.5	0.0	0.7	1.4	0.1	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.5	0.6	0.0	19.2	1.3	0.6	0.8	0.4	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.4	3.1	0.0	16.8	0.1	1.9	1.4	0.0	5.6	0.0	0.0	94.5	0.5	1.1	0.0	3.3	3.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.6	0.0	32.7	0.5	6.8	33.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	56.1	12.6	0.9	0.0	16.5	0.0	0.0	0.0	36.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.1	0.0	0.3	0.4	0.0	0.0	9.1	7.7	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.7	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	6.0	0.5	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	8.4	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674014-49683971	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		2300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	21.7	43.6	18.0	30.7	18.0	42.3	26.8	17.9	22.8	24.8	27.7	48.5	48.6	19.7	24.7	40.2	33.7	22.3	40.6	17.7	19.9	65.8	63.3	26.8	35.2	19.2	21.3	24.6	34.8	63.0	38.3	31.9	24.3	31.0	51.7	12.9	34.0	29.5	103.8	32.8	35.1	28.1	16.8	27.2	35.5	18.7	20.0	37.3	48.6	103.9	43.4	35.0	21.2	16.7	101.2	79.2	84.2	110.8	71.3	48.3	113.6	64.2	79.3	87.4	91.2	130.1	101.7	127.1	70.0	71.7	78.9	89.8	95.1	143.4	64.2	61.9	41.0	138.8	123.4	105.1	72.0	145.5	204.7	55.0	106.5	49.2	101.4	85.5	78.7	86.4	86.6	59.8	86.0	90.8	105.3	76.6	50.4	140.5	75.3	38.4	72.8	165.1	169.9	226.7	40.4	71.2	72.4	166.7	78.9	61.0	112.1	77.2	36.1	53.8	93.0	83.6	86.8	69.8	54.5	77.7	91.7	104.1	78.7	57.9	43.0	52.8	44.8	47.6	34.8	33.3	36.3	41.9	43.6	27.6	37.9	37.4	13.6	39.0	47.6	35.1	50.4	51.9	18.0	18.0	17.9	22.8	17.7	19.9	19.2	21.3	24.3	16.8	20.0	16.7	5.4	41.7	25.3	7.5	20.1	8.7	23.3	50.2	11.4	6.8	20.8	15.9	46.8	30.0	39.4	27.6	12.5	83.7	16.5	83.2	43.0	44.4	6.4	16.6	13.8	9.0	26.5	43.8	4.8	34.7	64.8	16.4	41.8	20.5	23.5	20.0	13.2	74.7	51.1	8.4	4.7	47.1	63.1	35.9	11.9	10.9	15.2	23.2	21.4	2.8	26.8	30.4	27.8	3.0	2.0	39.0	35.8	13.5	39.4	18.0	85.4	80.7	19.4	11.1	13.1	10.6	25.2	33.2	28.5	30.6	9.2	62.1	23.9	28.5	74.0	23.7
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm		Yes	No		330000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	83.9	103.6	56.9	82.8	58.1	154.9	103.2	60.0	67.5	80.4	57.9	89.1	107.5	97.2	66.5	80.5	99.1	79.7	76.6	57.5	60.3	82.8	104.6	61.0	112.4	58.9	58.3	146.3	92.2	88.3	39.3	57.3	59.5	69.3	92.7	52.9	66.0	80.2	102.9	83.4	73.0	95.7	59.5	68.9	85.4	21.5	60.1	125.0	93.2	71.9	121.2	103.8	65.8	62.6	249.3	296.8	267.8	247.2	180.9	259.3	226.5	227.3	245.7	333.3	287.4	216.9	240.7	477.9	198.4	176.4	178.1	262.5	317.5	242.1	304.8	214.7	135.9	195.5	162.8	368.9	189.5	623.1	193.2	270.6	261.6	217.6	212.6	267.2	282.3	193.9	228.4	153.6	270.7	240.0	404.7	264.7	260.3	282.4	269.5	441.5	297.7	200.8	281.7	327.1	315.2	201.8	248.5	305.2	253.1	185.0	186.4	276.7	186.0	175.0	292.8	177.9	216.6	203.1	375.8	327.7	77.8	390.7	224.7	0.9	106.7	7.5	79.6	93.4	108.4	154.8	98.9	95.4	208.6	140.5	133.1	117.7	6.8	97.6	60.1	235.6	65.8	200.3	56.9	58.1	60.0	67.5	57.5	60.3	58.9	58.3	59.5	59.5	60.1	62.6	63.8	64.1	57.6	11.8	120.3	106.4	101.1	192.9	136.1	57.5	131.3	136.8	50.1	111.5	117.1	68.0	41.7	200.1	114.1	32.4	150.6	152.7	19.9	65.0	161.1	75.6	120.0	135.6	20.6	104.5	212.6	88.7	72.9	82.0	81.6	165.5	42.1	70.8	175.6	28.6	19.5	85.4	138.4	96.7	89.4	5.8	80.5	95.2	64.0	11.2	121.9	77.4	75.2	22.6	19.4	78.2	73.1	64.3	71.1	60.4	66.2	170.1	64.6	51.6	52.6	87.5	174.2	8.5	43.0	106.4	97.0	101.5	75.1	198.4	157.6	76.8
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	143	"intestine: 304.3;liver: 1191.0"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 2967.4;Proximal enterocytes: 1585.9"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 1079.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	100000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	2.7	0.0	0.1	0.2	0.2	0.1	0.9	0.1	0.1	0.7	0.2	0.4	181.4	0.2	0.0	0.1	0.1	0.5	5.2	0.1	0.3	0.3	1191.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.1	0.5	304.3	0.2	0.2	0.5	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1079.8	0.0	0.6	0.1	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	277.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	1.6	3.5	0.0	104.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	52.8	2967.4	0.1	0.0	0.2	30.8	0.0	69.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.5	1.5	0.0	0.0	1585.9	0.6	0.0	0.0	0.0	1.1	0.2	0.5	0.3	0.0	0.0	0.0	3.9	0.9	14.5	0.0
APOBEC3F	"ARP8, BK150C2.4.MRNA, KA6"	ENSG00000128394	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3F"	Q8IUX4	22	39040604-39055972	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.9"									HPA073637			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA073637: "	"unprognostic (1.38e-3)"	"unprognostic (1.28e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (8.28e-4)"	2.2	6.3	2.2	9.2	2.1	3.3	2.5	2.2	2.7	4.0	3.4	3.5	3.7	4.1	6.3	2.4	8.3	3.5	5.5	2.0	2.2	3.4	2.9	3.4	15.7	3.1	2.6	8.8	3.0	5.2	3.4	2.2	2.8	4.8	2.8	1.1	4.9	5.2	0.6	1.6	3.8	4.5	2.3	11.9	4.8	8.2	2.5	5.3	3.0	1.3	14.5	4.5	3.2	2.9	4.9	4.2	1.8	6.2	4.9	7.1	2.2	4.2	6.9	8.8	14.0	3.9	9.1	12.9	4.1	8.9	7.7	6.5	1.7	6.0	3.8	11.7	5.3	16.5	0.5	2.5	8.6	3.6	7.0	9.5	3.0	5.0	1.5	5.1	8.5	3.5	1.3	19.9	4.8	3.9	4.0	2.7	0.8	0.5	0.7	6.1	0.7	2.5	8.1	6.6	0.9	1.5	4.7	1.2	2.5	3.5	4.7	1.9	2.3	2.0	5.0	0.4	2.0	3.4	1.7	0.5	5.6	1.9	3.1	3.2	4.7	9.4	8.5	9.1	9.8	27.7	5.6	9.0	6.0	34.2	3.4	5.6	3.1	14.6	14.5	4.6	8.4	7.4	2.2	2.1	2.2	2.7	2.0	2.2	3.1	2.6	2.8	2.3	2.5	2.9	1.6	0.0	0.5	0.0	9.8	0.9	4.9	6.3	2.2	0.0	2.1	2.2	5.9	8.6	4.2	0.0	0.0	2.0	7.6	0.8	1.9	7.4	2.4	4.8	3.8	2.6	1.2	2.1	0.1	3.9	1.4	2.9	2.6	3.6	2.5	11.0	3.6	1.6	5.9	0.0	0.0	2.2	4.1	2.2	1.4	5.2	5.0	2.8	5.4	2.8	5.3	2.2	8.2	0.5	0.0	4.8	3.6	6.4	9.6	4.5	0.5	5.3	4.6	0.2	0.0	1.0	2.6	0.3	0.4	1.6	0.9	1.6	5.4	7.8	1.5	5.9
APOBEC3G	"bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019"	ENSG00000239713	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3G"	Q9HC16	22	39077067-39087743	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 145.4;monocytes: 69.1;NK-cells: 251.3;Plasma cells: 69.5;T-cells: 120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.0;Daudi: 38.3;HDLM-2: 31.8;Karpas-707: 44.2"									"HPA001812, HPA073637"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA001812: AB_1078175, HPA073637: "	"prognostic favorable (4.78e-4)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.18e-3)"	"prognostic favorable (6.03e-5)"	"unprognostic (2.37e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.13e-3)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.66e-13)"	"unprognostic (3.41e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.91e-2)"	"prognostic favorable (6.30e-4)"	5.5	8.1	3.3	21.7	3.2	15.9	8.6	3.4	4.6	7.7	2.9	7.6	5.5	10.3	10.4	6.1	21.1	11.1	4.3	3.0	4.0	4.1	5.7	14.5	45.9	3.9	3.7	22.7	1.7	4.8	3.5	5.0	3.9	7.8	9.4	1.4	8.5	22.4	1.2	1.6	9.6	9.6	4.0	28.2	10.0	20.1	3.4	25.9	5.8	2.7	35.1	15.7	6.4	4.5	4.5	0.1	0.0	0.0	5.0	9.7	0.3	1.0	16.8	19.9	30.0	1.6	22.6	38.3	0.5	7.3	11.6	0.1	0.2	1.3	6.0	31.8	0.1	23.1	0.0	0.2	21.8	7.1	10.1	14.3	0.5	10.9	2.4	0.0	2.4	1.2	1.9	44.2	3.1	0.0	7.6	7.7	0.6	0.0	1.7	15.3	0.0	25.8	0.0	19.6	0.0	0.0	0.5	0.0	2.0	1.7	0.0	13.2	0.0	2.8	0.2	0.0	0.0	0.0	3.5	0.5	3.2	6.9	5.0	30.7	42.3	28.7	363.8	98.1	207.6	84.9	108.8	281.7	52.4	66.1	34.3	160.2	34.8	232.2	123.0	28.1	92.3	297.8	3.3	3.2	3.4	4.6	3.0	4.0	3.9	3.7	3.9	4.0	3.4	4.5	8.4	3.2	8.9	1.0	55.7	1.8	15.5	27.0	4.6	0.4	3.0	6.6	3.7	7.2	14.4	0.0	2.1	3.9	145.4	0.6	5.9	11.7	47.2	5.7	6.4	8.9	6.0	8.6	0.1	2.3	1.1	10.0	2.0	3.9	12.6	62.5	11.4	0.9	30.6	0.0	0.1	1.9	10.2	20.4	9.8	13.7	19.0	21.3	7.2	3.7	69.1	8.1	251.3	0.5	0.0	2.2	1.8	9.1	69.5	16.0	0.1	2.1	12.1	1.2	19.7	4.7	10.1	1.3	1.6	2.0	1.3	1.0	120.5	20.3	1.5	18.0
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	563	"liver: 17965.3"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 7680.6"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 1253.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.9	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.2	0.2	0.3	0.8	2.5	0.1	1.0	0.2	0.8	2.8	0.6	0.2	0.0	31.9	17965.3	5.6	0.3	0.2	0.1	0.2	10.9	0.0	0.2	0.4	0.1	0.2	0.7	0.2	0.1	0.3	0.1	0.2	1.0	0.0	0.1	4.3	3.8	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	33.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	1.4	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.4	0.0	2.6	1.4	1253.3	0.0	6.4	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.4	0.5	0.2	0.0	0.2	0.1	0.6	31.5	0.0	0.8	6.4	0.1	0.0	0.9	0.4	0.0	3.4	0.1	0.2	0.0	0.0	0.0	1.7	0.2	0.1	0.1	0.0	0.8	0.1	2.9	15.3	2.4	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	12.3	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	183.0	0.6	0.0	0.0	0.0	0.0	0.2	3.9	0.8	0.2	0.2	0.0	5.2	0.0	109.7	0.2	2.3	0.6	0.0	0.0	0.1	0.0	0.0	120.0	7680.6	0.5	0.0	0.2	0.4	0.0	182.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.0	0.4	25.6	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	8.8	0.0	0.8	0.0
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 32.7;Enteroendocrine cells: 14.9;Glandular and luminal cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.6;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;monocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.7;HDLM-2: 109.9;HSkMC: 16.1;K-562: 23.7;SCLC-21H: 47.9"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA049797: AB_2680887, HPA055435: AB_2682816"	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favorable (2.40e-6)"	13.5	1.0	0.8	6.0	0.8	1.5	14.7	0.9	2.2	4.6	0.5	3.3	4.8	3.9	1.6	4.3	5.9	6.3	5.3	0.9	1.6	8.1	2.0	12.8	4.7	2.5	1.3	3.9	1.0	0.3	9.4	3.3	1.9	14.7	3.4	0.1	5.8	3.4	1.1	4.1	3.8	2.4	1.0	3.2	4.9	0.7	1.1	2.9	3.2	1.3	1.8	12.1	3.6	0.8	0.0	0.0	0.0	0.0	0.2	2.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	109.9	0.0	5.7	0.0	0.0	0.1	0.0	0.2	16.1	0.0	0.0	0.0	0.0	0.8	0.0	23.7	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.0	47.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.8	0.8	0.9	2.2	0.9	1.6	2.5	1.3	1.9	1.0	1.1	0.8	7.0	0.0	6.7	0.3	0.2	1.3	0.7	1.5	0.0	0.3	4.6	2.2	1.1	1.5	3.4	0.0	0.0	0.5	0.1	0.0	3.9	0.2	0.0	32.7	12.4	6.6	14.9	4.2	0.0	0.7	1.0	10.4	0.0	52.6	2.5	0.0	2.5	0.4	2.3	1.7	0.1	0.8	0.0	6.2	6.5	0.0	2.8	8.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	1.2	0.2	0.3	4.2	0.0	0.0	9.0	1.9	0.0	0.0	0.0	1.1	6.2	1.3	0.5	0.4	1.9
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 124.5"	"Cell type enriched"	"Detected in many"	4	"Adipocytes: 781.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 24.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 36.7;HDLM-2: 19.3;hTERT-RPE1: 15.1"	"Group enriched"	"Detected in all"	4	"basal ganglia: 5.7;olfactory bulb: 20.1"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Approved	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA052462: AB_2681841, HPA058882: AB_2683844"	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	124.5	15.6	35.2	15.4	28.7	0.3	90.6	29.8	41.8	43.8	22.5	12.4	3.9	15.7	2.3	35.3	30.5	34.4	55.8	26.9	30.7	20.0	17.7	17.1	5.6	37.6	34.0	6.9	24.0	28.0	10.5	86.6	38.1	12.8	12.0	5.8	10.3	5.6	34.3	18.4	10.7	52.5	30.3	6.1	12.1	3.0	43.6	10.6	64.8	28.8	3.3	28.3	18.1	29.3	6.4	0.2	36.7	1.2	1.1	2.1	0.3	6.0	9.9	6.0	8.7	2.4	6.5	2.0	0.5	2.3	2.1	2.0	1.4	0.3	10.1	19.3	1.4	0.5	2.0	0.0	2.2	1.0	0.6	1.4	1.7	2.1	4.7	15.1	4.6	3.5	0.5	2.5	3.1	1.3	1.0	1.1	0.2	1.5	1.1	2.9	0.8	0.9	0.7	0.6	3.1	3.4	5.7	0.5	13.6	0.6	0.2	3.1	5.6	1.3	2.0	8.1	5.5	1.8	0.9	1.4	2.0	4.0	6.9	2.2	0.3	0.2	0.3	0.1	0.4	1.0	0.7	0.5	0.2	0.8	0.5	0.3	1.6	0.3	0.2	0.6	1.1	0.1	35.2	28.7	29.8	41.8	26.9	30.7	37.6	34.0	38.1	30.3	43.6	29.3	781.6	6.4	5.3	17.3	15.9	18.1	2.5	1.4	6.8	4.4	5.4	5.8	11.9	4.3	5.9	0.0	4.2	2.9	13.3	5.3	0.0	1.1	2.9	0.7	7.2	169.4	3.6	18.9	5.3	0.4	1.4	25.0	1.1	1.3	7.6	5.8	62.4	3.8	6.6	3.3	7.0	6.3	2.0	14.2	27.1	2.1	4.4	6.6	28.4	32.8	5.9	39.6	29.9	5.0	28.5	1.2	0.6	0.4	5.7	2.9	2.3	0.5	5.4	4.8	111.7	17.5	193.5	5.5	1.0	2.3	15.5	1.0	18.3	1.1	9.3	3.7
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811937	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	118.5	161.2	30.1	73.6	30.1	103.1	112.3	32.0	39.5	109.6	39.3	121.0	72.2	81.2	25.5	231.1	87.6	31.4	70.2	29.9	32.0	128.7	190.4	85.8	83.8	32.9	31.3	73.3	169.4	66.1	64.9	37.0	32.1	113.6	40.2	5.1	119.8	44.6	62.7	240.1	106.8	29.8	33.7	128.6	131.8	35.2	35.1	77.2	96.9	23.8	64.5	95.7	153.7	35.7	157.9	228.3	44.9	200.4	54.2	106.0	232.2	117.1	105.0	136.0	52.6	237.6	189.0	145.5	221.9	68.4	65.0	165.3	74.8	195.4	27.5	102.9	417.7	124.3	106.5	253.0	168.1	87.4	97.7	113.1	207.6	109.0	139.4	63.7	172.6	244.6	266.6	107.9	71.4	586.0	242.1	254.7	169.4	169.5	288.8	259.2	69.2	351.5	156.3	107.0	218.2	132.4	223.5	130.7	131.2	41.9	427.9	171.1	111.4	122.5	104.9	99.5	118.0	205.9	186.5	408.8	179.9	228.4	110.5	77.7	544.5	202.8	474.5	473.5	631.7	501.1	612.0	510.3	562.4	517.3	557.8	475.3	31.8	501.8	322.1	731.6	551.8	998.0	30.1	30.1	32.0	39.5	29.9	32.0	32.9	31.3	32.1	33.7	35.1	35.7	146.5	115.4	147.4	5.9	247.0	319.0	320.0	375.7	207.7	19.9	346.2	479.7	46.9	230.2	206.8	92.0	6.2	265.0	262.3	273.1	406.9	404.3	11.8	124.6	180.3	163.1	210.8	150.6	5.1	442.6	401.5	170.3	192.7	148.4	131.9	154.9	147.8	309.6	348.0	15.2	4.4	386.4	160.7	253.9	336.1	35.4	239.9	214.6	297.1	3.7	449.4	78.7	355.3	2.5	7.2	392.3	228.3	135.4	171.6	404.3	349.2	647.9	125.5	20.4	39.5	135.6	186.5	18.4	126.9	358.8	494.7	172.7	285.7	339.5	426.7	385.2
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32886601-33025130	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	9.7	14.8	14.6	7.0	14.8	11.0	10.4	14.8	20.2	9.1	13.9	10.2	8.6	8.6	7.6	14.7	8.9	4.9	9.9	14.8	15.0	13.6	15.6	9.3	8.1	14.7	14.6	8.5	9.6	12.1	7.6	7.8	15.0	9.6	11.2	8.0	9.0	6.6	9.8	15.3	8.3	8.6	14.2	8.9	9.7	14.7	15.2	9.3	7.0	6.9	11.0	10.4	9.6	15.0	36.2	26.1	18.4	17.1	19.0	17.4	25.6	24.8	26.0	28.7	31.5	35.1	12.7	27.8	14.6	21.1	18.4	19.4	33.7	32.8	35.1	39.2	11.2	17.9	32.5	37.8	24.4	29.4	15.1	23.8	36.3	32.5	37.9	16.9	26.8	20.2	27.0	24.2	26.0	15.6	24.4	43.2	33.5	24.4	29.0	21.2	14.4	21.5	25.2	21.2	15.6	11.1	21.4	18.0	15.5	17.9	23.0	11.4	17.7	16.2	21.1	29.9	25.0	11.1	21.2	27.5	23.4	23.8	13.2	3.3	14.7	13.4	12.2	15.6	15.2	16.3	12.8	14.6	17.6	16.1	16.0	12.1	5.9	23.1	21.7	15.2	17.3	16.1	14.6	14.8	14.8	20.2	14.8	15.0	14.7	14.6	15.0	14.2	15.2	15.0	14.8	19.2	29.0	31.3	16.9	16.7	23.1	32.9	22.2	15.2	17.9	17.0	14.9	21.5	23.1	9.2	10.4	27.7	15.1	12.6	29.4	25.3	55.6	19.7	18.3	13.3	16.8	20.0	27.3	28.2	27.7	15.6	19.4	18.1	16.5	17.8	8.9	21.4	18.8	13.5	29.0	15.3	34.6	14.7	9.9	48.7	13.4	15.0	14.2	15.9	19.3	18.3	15.5	23.6	43.0	31.9	6.8	10.5	28.3	24.0	13.9	31.7	25.4	16.6	13.1	13.5	20.2	42.2	26.9	25.8	21.2	27.9	15.9	20.5	16.3	23.1
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441156-33447596	"Blood group antigen proteins, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1526.1;skin 1: 581.9;urinary bladder: 688.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1923.3;Basal prostatic cells: 982.0;Collecting duct cells: 1609.3;Prostatic glandular cells: 1430.8;Squamous epithelial cells: 2189.3;Suprabasal keratinocytes: 2485.4;Urothelial cells: 2455.4"	"Group enriched"	"Detected in all"	5	"cervical cancer: 319.0;head and neck cancer: 283.7;lung cancer: 146.8;urothelial cancer: 221.3"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 5.3;medulla oblongata: 16.0;pons: 21.0"	"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 181.7;T-reg: 205.4"	"Lineage enriched"	"Detected in many"	18	"T-cells: 205.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 127.1;HeLa: 213.2;JURKAT: 130.7;RT4: 216.6;SK-BR-3: 149.7;U-266/70: 151.2;U-266/84: 213.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	10.9	2.1	1.5	16.8	0.4	19.7	36.6	2.4	3.4	173.3	1.4	10.3	73.4	10.9	2.9	1526.1	25.4	9.4	31.5	5.3	0.4	131.7	118.6	114.0	16.1	16.0	1.6	12.1	43.1	2.0	2.8	6.0	21.0	85.6	10.1	1.7	399.7	36.8	5.3	581.9	100.5	3.2	0.2	110.1	35.9	2.8	0.8	233.9	2.3	26.7	172.5	688.6	529.9	0.9	0.6	38.6	1.9	0.0	67.7	12.2	1.0	0.3	0.9	0.9	1.1	20.5	12.0	0.5	9.1	0.0	0.5	127.1	6.2	0.7	0.2	61.6	6.0	4.3	213.2	1.9	0.4	1.3	1.3	1.9	6.5	0.5	0.2	0.2	0.5	130.7	67.4	58.8	6.9	29.1	60.4	23.0	5.3	88.6	0.7	0.9	94.3	10.8	1.3	216.6	1.7	4.7	32.3	149.7	0.1	8.0	0.9	10.6	1.2	0.0	1.0	0.4	0.4	151.2	213.6	14.5	0.5	0.4	0.2	1.6	0.5	0.1	20.2	0.4	181.7	11.3	171.9	52.8	0.3	3.0	97.3	47.1	2.3	3.0	0.5	11.1	205.4	43.0	1.5	0.4	2.4	3.4	5.3	0.4	16.0	1.6	21.0	0.2	0.8	0.9	9.2	38.5	249.9	0.0	42.4	1923.3	982.0	381.4	811.0	9.7	56.8	27.8	3.4	157.3	436.3	1609.3	2.1	0.9	21.6	2.7	0.0	37.4	2.2	82.3	21.4	37.1	8.3	71.4	0.3	48.9	2.0	27.5	16.3	96.2	20.8	0.2	16.4	137.3	2.2	0.0	0.1	104.0	315.3	3.5	122.9	0.6	33.2	15.3	158.3	0.0	1.6	0.4	4.1	0.5	0.2	28.5	8.1	1.2	246.9	1430.8	343.1	31.9	546.0	0.5	0.0	10.2	35.8	0.7	1.9	2189.3	2485.4	50.2	73.4	1.6	7.3	2455.4
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852043-26865771	"Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 440.5;lung: 114.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 1102.6;Alveolar cells type 2: 342.3;Astrocytes: 487.7;Muller glia cells: 227.2"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.4;RPTEC TERT1: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		0.1	0.1	272.7	0.0	298.7	0.0	0.3	282.0	246.3	0.6	62.9	0.3	0.0	0.0	0.8	0.9	1.1	0.1	2.8	283.6	440.5	2.3	0.9	114.8	0.3	250.5	351.2	2.5	0.2	2.2	3.7	0.0	333.3	0.4	0.0	60.2	0.7	0.2	60.1	0.1	0.1	0.0	333.0	0.5	11.4	0.5	387.1	0.2	14.7	20.9	0.1	0.1	0.1	376.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	272.7	298.7	282.0	246.3	283.6	440.5	250.5	351.2	333.3	333.0	387.1	376.0	0.0	1102.6	342.3	487.7	0.0	0.0	0.8	0.6	0.0	3.1	0.8	0.9	13.9	4.3	76.6	3.7	6.2	0.0	0.0	0.1	3.9	0.3	0.0	0.7	0.1	1.8	0.0	0.0	3.0	0.0	0.0	0.8	0.0	0.0	3.8	0.0	0.0	0.5	0.0	1.7	1.1	0.0	0.0	0.0	0.3	0.0	5.0	0.8	0.0	9.4	0.0	227.2	0.0	12.1	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	23.1	9.1	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	2.0
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040624: AB_2677050, HPA055647: AB_2682874"	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	3.7	3.9	4.5	3.4	5.7	4.0	5.9	7.8	5.2	5.7	3.9	4.2	3.4	4.5	4.1	3.5	4.4	3.1	2.7	4.7	5.0	5.2	4.0	3.6	4.2	4.1	4.7	5.0	4.1	5.2	2.5	4.4	4.5	4.0	4.2	8.0	3.3	3.7	2.8	4.2	3.6	3.8	4.5	4.7	3.8	5.6	4.9	7.0	5.4	3.5	4.7	4.0	3.5	5.8	5.3	13.5	8.7	9.3	11.6	10.7	4.5	6.4	8.1	8.3	7.4	6.1	3.2	4.3	4.0	10.8	5.4	8.2	14.8	9.1	9.1	6.1	6.0	13.8	11.4	5.6	6.6	11.3	6.2	8.4	5.9	6.5	6.9	7.7	7.1	3.3	9.9	4.2	8.3	3.6	6.6	7.5	8.7	12.2	5.5	8.9	15.0	4.3	8.3	9.2	9.5	7.4	10.3	9.7	2.3	7.6	6.9	8.7	9.3	6.1	3.4	4.3	5.7	5.0	6.6	8.5	7.7	9.6	6.3	3.6	2.0	1.2	2.6	2.2	2.3	1.6	2.3	2.6	1.7	2.3	2.3	2.6	1.0	2.1	1.4	2.3	2.0	1.4	4.5	5.7	7.8	5.2	4.7	5.0	4.1	4.7	4.5	4.5	4.9	5.8	27.0	12.8	26.0	45.4	27.9	9.6	13.7	17.0	15.4	28.6	19.9	15.6	14.7	17.2	28.1	14.7	114.7	16.4	31.4	18.2	3.9	13.4	38.2	20.6	26.7	24.1	13.2	21.0	39.8	14.3	14.4	18.6	20.4	22.1	24.1	28.8	31.1	18.5	14.9	25.2	44.0	19.1	12.2	18.6	5.1	8.4	20.8	21.8	16.0	29.0	27.9	14.3	22.6	42.3	42.2	18.5	12.1	18.4	22.9	18.8	17.4	12.9	27.1	41.1	6.6	42.8	16.9	19.4	22.2	22.4	9.7	13.3	27.0	46.5	21.6	13.5
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445136-74455005	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.9;placenta: 328.8;urinary bladder: 145.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1119.1;Basal prostatic cells: 1254.3;Macrophages: 1271.1;Paneth cells: 909.8;Urothelial cells: 2102.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 67.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"basophil: 11.0;eosinophil: 11.8;NK-cell: 3.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 11.8;NK-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 379.0;HBEC3-KT: 648.1;hTCEpi: 644.0;hTERT-HME1: 1365.7;MCF7: 416.8"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 1.2"	"Low region specificity"	"Detected in many"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	48.1	4.6	0.1	36.7	0.1	129.9	61.6	0.1	0.8	19.2	1.8	18.7	3.3	3.7	0.2	43.4	13.2	74.1	20.5	0.3	0.1	2.5	4.0	36.1	1.9	0.3	0.2	12.4	4.5	1.5	9.5	328.8	0.8	6.5	18.9	0.1	11.7	0.7	18.4	15.3	10.2	6.5	0.2	10.0	20.2	9.3	0.4	7.1	5.4	0.8	3.0	145.6	13.8	0.4	15.9	107.3	0.0	0.0	0.9	1.4	0.0	3.2	5.0	0.7	2.9	379.0	59.8	0.0	8.0	0.0	0.0	17.4	0.1	648.1	6.5	0.1	0.0	0.4	2.8	18.0	191.9	2.3	0.4	5.9	644.0	37.8	1365.7	0.9	0.2	0.4	1.6	0.7	14.4	416.8	0.2	0.0	0.0	78.6	42.8	0.0	0.1	0.1	36.4	2.9	0.5	0.2	22.2	1.2	0.0	0.4	11.6	0.1	1.0	0.0	15.3	5.3	0.1	0.9	0.0	0.1	0.0	0.0	1.7	11.0	0.0	11.8	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.3	0.2	0.0	0.1	3.8	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.3	0.2	0.8	0.2	0.4	0.4	670.0	198.7	301.9	0.0	190.7	1119.1	1254.3	73.0	303.9	0.0	801.5	460.2	49.0	62.9	183.9	51.5	0.0	1.8	836.1	878.0	0.0	61.8	70.4	167.7	12.3	32.2	41.6	18.5	0.0	10.2	1.5	80.8	254.9	193.1	680.5	0.9	10.8	4.2	32.2	0.0	0.5	393.5	8.2	250.4	196.4	12.1	0.3	1271.1	33.8	0.0	1.7	0.8	20.6	0.0	0.0	497.1	909.8	1.2	352.1	115.3	55.7	0.7	53.3	0.2	19.7	10.3	20.2	68.3	51.1	194.5	342.4	1.1	473.6	1.2	308.9	2102.9
ARFRP1	"ARL18, ARP, Arp1"	ENSG00000101246	"ADP ribosylation factor related protein 1"	Q13795	20	63698642-63708025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047028, HPA050634"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA047028: AB_2679908, HPA050634: AB_2681196"	"unprognostic (6.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.39e-1)"	26.8	27.8	23.4	14.0	23.4	10.0	25.0	22.8	29.1	31.8	22.4	29.3	18.9	29.3	5.3	36.2	27.9	8.8	41.0	22.7	22.7	34.1	36.5	26.0	17.8	23.1	23.2	29.3	24.4	12.6	25.1	11.6	23.1	32.4	8.4	5.5	22.4	16.0	31.8	22.9	27.2	10.1	22.7	42.0	24.6	20.1	24.5	17.7	25.6	15.5	11.2	29.5	28.3	23.9	26.5	31.9	10.1	10.6	10.0	10.8	14.6	31.8	21.1	67.7	24.6	60.0	22.4	32.4	21.6	18.8	27.3	35.8	11.0	35.5	11.9	11.3	16.5	23.8	36.1	52.2	34.7	27.3	21.5	15.1	45.2	17.8	21.6	17.9	25.1	30.5	36.0	24.1	16.9	14.9	54.0	37.7	15.8	19.5	46.7	42.3	14.0	33.4	14.5	21.7	16.9	17.3	32.3	46.5	11.4	6.1	20.5	34.8	20.0	39.6	15.9	14.9	32.6	24.9	11.1	25.1	26.5	17.9	22.8	44.3	30.9	23.5	41.5	31.6	34.7	32.6	37.5	39.8	28.3	33.7	46.8	41.5	15.7	37.6	34.7	49.2	32.3	36.5	23.4	23.4	22.8	29.1	22.7	22.7	23.1	23.2	23.1	22.7	24.5	23.9	40.7	12.8	11.9	12.4	25.9	13.9	25.5	26.1	19.4	44.6	20.8	28.7	34.0	8.6	15.8	25.8	20.9	42.2	28.0	48.9	39.2	31.2	12.8	13.5	27.0	34.3	26.4	25.7	10.6	20.4	25.5	31.6	18.3	10.7	24.7	28.4	24.3	18.4	36.9	37.0	10.6	31.6	18.3	20.7	15.3	10.5	23.9	24.1	24.9	5.6	41.0	40.8	29.9	4.0	11.9	51.6	34.6	29.7	23.4	22.9	52.4	33.4	12.3	42.3	19.7	21.8	35.1	44.5	32.7	22.4	14.2	30.2	30.7	35.7	33.1	17.0
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568137	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: AB_2683236"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (7.34e-5)"	35.0	25.5	17.9	4.5	18.4	11.0	36.3	19.5	25.2	43.7	13.5	41.2	3.5	43.1	6.2	30.8	47.0	2.9	31.1	17.8	16.4	28.2	22.9	46.3	6.7	15.2	15.6	50.4	29.3	3.7	34.1	6.1	15.3	34.7	4.7	8.6	35.1	4.5	28.4	32.1	42.6	6.3	15.3	40.8	38.2	23.7	16.2	7.0	36.3	7.5	5.7	35.6	37.6	18.2	10.5	9.4	26.0	6.4	9.0	4.6	9.1	10.2	6.5	9.1	6.6	16.8	8.3	21.5	6.1	9.2	8.4	6.9	17.4	9.9	11.4	24.5	12.3	18.8	9.2	11.6	9.3	36.0	8.2	5.0	6.8	6.9	7.2	9.2	8.1	13.0	13.4	11.4	11.4	7.7	16.4	13.9	18.6	23.6	4.0	17.3	19.7	8.9	10.6	7.3	7.0	13.8	9.9	12.7	6.1	17.6	5.8	27.0	9.2	7.5	6.2	5.9	10.0	11.1	14.2	27.4	10.6	15.6	6.7	44.6	24.2	17.2	15.4	17.7	14.1	30.2	13.5	12.1	17.1	32.4	15.3	14.6	45.7	18.8	14.8	34.2	15.7	12.8	17.9	18.4	19.5	25.2	17.8	16.4	15.2	15.6	15.3	15.3	16.2	18.2	342.0	141.1	230.6	198.8	242.0	261.7	268.5	179.3	186.1	222.7	153.9	104.0	88.3	90.1	204.9	114.0	135.5	141.9	329.3	195.3	99.7	120.7	42.0	201.2	308.3	298.1	187.7	160.3	208.8	113.2	137.7	204.7	355.7	290.6	168.7	331.2	280.2	81.5	101.3	304.5	155.6	218.5	148.5	90.7	186.2	34.0	255.1	142.1	128.1	161.1	182.1	223.3	301.8	200.6	367.2	145.0	173.8	217.7	194.9	251.0	153.7	58.6	190.7	271.2	216.9	179.6	196.8	199.8	125.9	164.1	262.3	185.2	257.8	280.7	193.1	316.0
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639941	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.2;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 38.7;Extravillous trophoblasts: 23.7;Granulosa cells: 21.1;Plasma cells: 18.6;Spermatocytes: 24.7;Spermatogonia: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040830, HPA066481"	Enhanced		Approved	Nucleoli,Cytosol		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoli	"HPA040830: AB_10805830, HPA066481: "	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.05e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.7	0.9	2.0	7.9	2.5	24.2	1.7	2.1	2.1	1.5	1.2	7.5	6.1	1.5	1.0	5.3	0.8	1.7	0.7	1.7	1.9	0.6	1.3	1.7	13.5	2.6	3.0	0.6	2.6	1.2	0.7	4.3	2.6	0.6	8.8	0.5	1.2	0.5	0.9	4.4	7.6	4.8	2.5	2.8	3.6	8.6	2.2	26.1	1.3	0.4	14.3	2.8	1.9	3.0	80.8	69.4	73.1	46.2	5.0	13.0	39.6	78.5	50.2	80.0	63.3	52.2	41.5	43.5	23.7	49.9	91.3	56.9	55.3	43.8	110.9	83.5	27.4	132.6	68.9	33.5	2.0	103.8	55.5	4.3	5.5	61.6	50.9	15.2	61.5	94.4	101.0	112.7	95.3	31.7	58.6	39.7	44.6	71.6	44.5	67.8	141.7	38.2	28.4	41.6	64.7	44.5	72.9	46.2	17.6	37.6	63.6	115.8	35.3	102.5	74.1	42.0	87.2	38.3	63.7	123.7	44.4	129.1	91.8	0.1	0.3	0.8	0.5	0.5	0.2	0.3	1.0	0.9	0.4	0.2	0.4	0.5	0.0	0.1	0.1	0.2	0.8	0.3	2.0	2.5	2.1	2.1	1.7	1.9	2.6	3.0	2.6	2.5	2.2	3.0	0.7	0.0	2.3	0.3	4.6	4.8	1.1	2.4	2.2	0.2	1.3	1.7	0.9	4.3	1.9	1.8	0.0	9.8	2.9	6.2	0.0	0.8	4.7	3.8	2.6	2.0	0.0	38.7	1.0	0.8	23.7	3.5	8.6	2.8	0.0	21.1	1.8	2.1	9.5	0.0	0.6	7.8	0.0	6.5	4.2	5.0	0.6	3.5	0.0	1.0	3.9	0.1	2.1	0.5	1.4	0.5	2.9	0.4	18.6	1.4	1.1	0.4	1.4	1.0	6.6	1.4	3.3	24.7	22.6	10.5	2.3	3.1	5.4	2.0	14.1	2.1
ARHGAP19	"FLJ00194, MGC14258"	ENSG00000213390	"Rho GTPase activating protein 19"	Q14CB8	10	97222173-97292673	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035777, HPA043231"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane"		"HPA035777: AB_2674777, HPA043231: AB_10796791"	"unprognostic (5.88e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.29e-2)"	3.2	2.1	2.4	7.1	3.9	18.8	7.6	2.9	2.0	3.7	0.6	4.3	3.6	5.5	2.6	4.0	4.7	3.4	3.3	1.6	3.2	3.9	2.4	4.7	13.3	4.3	3.2	9.3	1.6	5.5	0.5	5.3	4.4	3.6	4.5	3.2	3.2	3.0	1.8	3.6	5.3	4.5	3.3	7.9	3.6	18.5	2.9	21.3	3.2	4.2	13.2	2.9	2.0	5.9	18.5	6.0	31.9	56.0	2.1	8.3	9.8	9.0	9.1	13.9	9.9	11.2	16.1	40.9	7.4	6.2	8.3	12.3	27.1	11.2	17.8	20.4	14.7	27.0	7.8	7.8	2.1	42.1	27.8	4.2	3.9	9.8	22.3	4.7	19.6	57.3	27.1	21.0	12.1	8.9	39.3	9.1	16.9	12.2	5.5	45.5	27.1	11.4	4.2	7.8	2.5	14.5	6.7	3.1	14.5	11.9	19.4	22.2	9.1	5.7	6.8	8.9	23.6	18.6	20.7	54.3	7.0	48.7	6.4	21.5	7.2	11.1	5.0	6.8	4.7	5.5	4.9	4.7	5.4	5.3	5.6	5.0	15.8	4.4	6.1	3.0	6.3	5.5	2.4	3.9	2.9	2.0	1.6	3.2	4.3	3.2	4.4	3.3	2.9	5.9	5.8	3.2	3.2	0.0	4.1	0.9	1.4	2.8	3.4	2.8	3.6	8.8	1.9	2.8	1.6	0.0	0.0	2.0	3.6	2.2	0.0	1.3	9.1	2.4	2.6	5.4	0.0	6.7	0.0	1.6	3.5	3.9	1.5	3.6	5.1	5.6	11.7	2.6	3.5	6.7	0.0	1.9	2.0	9.3	1.9	6.3	3.4	6.1	1.8	0.0	5.4	1.7	5.2	0.0	0.0	1.4	2.9	4.1	5.8	2.6	2.6	0.7	4.8	1.3	0.0	3.1	2.2	13.7	10.4	5.3	2.4	1.0	3.5	3.4	3.5	1.6
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 440.8;Endothelial cells: 298.6;Prostatic glandular cells: 593.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A-431: 118.8;hTERT-HME1: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	32.9	3.7	7.0	2.8	5.5	0.1	30.3	22.5	8.0	8.8	7.3	9.4	2.1	7.4	5.3	4.5	10.2	6.5	19.2	4.6	5.5	23.7	16.8	27.1	4.9	6.8	6.1	10.2	7.4	6.5	6.2	17.4	7.1	11.2	3.2	14.9	12.1	7.0	11.6	14.7	6.4	5.6	6.4	21.7	10.4	5.8	8.6	3.0	22.8	12.7	2.8	8.0	9.3	5.1	118.8	4.8	7.0	0.1	26.7	57.5	24.5	38.6	62.9	31.0	45.1	13.7	5.4	0.0	85.2	76.5	36.3	24.8	0.2	27.4	63.9	0.1	4.1	0.4	6.6	7.6	2.7	0.0	0.0	11.7	5.4	23.7	100.9	36.4	88.0	0.1	0.0	0.0	32.1	4.7	2.2	0.1	9.0	0.6	82.1	1.4	5.6	0.0	82.7	10.8	0.1	1.5	24.1	20.5	2.0	26.5	5.6	0.4	84.2	20.0	26.2	29.7	32.3	0.1	0.1	0.2	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	5.5	22.5	8.0	4.6	5.5	6.8	6.1	7.1	6.4	8.6	5.1	440.8	51.3	18.4	26.4	2.9	23.5	239.2	31.7	4.6	16.0	87.3	46.1	26.0	31.5	39.6	130.6	18.8	29.5	2.0	0.9	54.8	83.5	94.1	36.9	11.4	298.6	0.0	3.2	11.3	17.2	102.6	63.6	20.9	106.2	3.8	13.8	177.1	56.1	3.0	92.5	24.1	1.0	6.1	13.6	17.9	24.4	24.5	6.2	26.6	208.9	2.5	94.2	0.0	2.0	3.5	55.7	0.1	21.8	0.1	593.9	0.1	78.1	12.5	81.2	190.7	58.2	127.8	80.3	116.5	1.7	17.2	14.1	4.1	11.1	1.6	146.9
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058346-131089885	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"adrenal gland: 105.4;brain: 144.3;pituitary gland: 176.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast glandular cells: 2.7;Oligodendrocyte precursor cells: 1.0;Skeletal myocytes: 1.5"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	161	"SH-SY5Y: 176.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 89.4"	"Low region specificity"	"Detected in many"			"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		0.2	105.4	20.1	0.0	3.7	0.0	1.4	0.8	3.2	1.6	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	13.5	132.5	0.0	0.0	0.0	0.0	35.0	46.1	0.0	0.0	0.0	176.9	0.1	144.3	0.2	0.1	0.0	0.2	0.0	6.6	0.1	0.0	0.0	4.7	0.0	0.1	0.8	52.1	0.4	0.1	1.1	0.0	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	176.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	3.7	0.8	3.2	13.5	132.5	35.0	46.1	144.3	4.7	52.1	10.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ARHGAP39	"CrGAP, KIAA1688, Vilse"	ENSG00000147799	"Rho GTPase activating protein 39"	Q9C0H5	8	144529179-144605816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.3;Endometrial ciliated cells: 31.4;Excitatory neurons: 41.7;Inhibitory neurons: 33.1;Oligodendrocytes: 30.8;Respiratory ciliated cells: 27.6;Rod photoreceptor cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044491			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Nucleoplasm, Microtubules, Cytokinetic bridge"	"HPA044491: AB_10794775"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-7)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.97e-2)"	1.6	3.9	4.3	0.8	5.2	0.0	3.4	2.3	9.4	4.9	1.2	4.5	1.7	2.8	0.8	5.0	8.2	0.7	1.9	8.5	2.3	4.9	1.6	2.7	0.3	8.4	5.9	2.6	5.2	1.3	9.9	0.7	5.5	4.2	0.6	3.1	3.5	1.4	0.7	5.2	2.7	0.5	4.7	1.3	2.0	21.8	3.5	0.7	7.5	0.1	0.1	1.9	3.1	9.5	8.3	8.1	3.8	5.8	0.7	0.6	7.2	2.1	0.7	2.6	1.6	5.2	4.8	0.8	5.4	0.8	2.7	7.0	1.8	2.0	0.5	0.0	7.2	0.1	5.8	3.4	1.3	0.0	0.8	0.5	3.2	3.3	1.4	1.3	0.8	0.4	7.7	0.0	1.1	13.4	4.6	0.0	4.0	3.4	11.4	4.3	3.0	3.2	2.1	4.1	10.9	7.7	6.2	2.1	3.8	1.4	9.0	1.2	2.0	1.9	0.1	6.6	4.5	0.0	0.1	0.3	3.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.2	2.3	9.4	8.5	2.3	8.4	5.9	5.5	4.7	3.5	9.5	0.8	3.2	2.3	34.3	0.6	3.7	0.6	1.9	2.2	7.2	5.0	3.3	1.6	0.0	2.8	3.7	20.9	0.6	0.1	7.5	0.0	2.4	3.9	31.4	2.8	1.1	0.0	0.0	41.7	2.5	0.9	1.2	1.1	6.0	0.0	6.0	0.7	1.4	0.5	3.3	33.1	4.2	4.1	0.0	0.4	3.1	2.1	0.2	5.4	1.0	0.0	3.6	0.0	15.6	30.8	1.4	7.9	8.2	0.0	1.0	3.3	1.5	27.6	24.5	6.6	2.5	2.1	8.5	11.2	2.1	3.0	0.5	0.3	3.1	5.2	0.7
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 119.1;lymphoid tissue: 120.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.3;dendritic cells: 70.0;Hofbauer cells: 86.6;Kupffer cells: 77.2;Macrophages: 76.0;NK-cells: 70.0;T-cells: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 103.0;HL-60: 76.7;Karpas-707: 90.8;MOLT-4: 93.0;RPMI-8226: 180.7;THP-1: 83.7;U-698: 90.4;U-937: 79.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA000301, HPA001012, HPA001083"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA000301: , HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favorable (3.94e-5)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	20.0	12.5	5.2	52.2	5.4	119.1	13.4	6.9	6.5	9.9	15.0	18.6	14.2	9.7	3.1	7.0	12.9	14.4	10.3	5.7	6.3	22.6	8.6	36.2	73.8	10.9	8.3	5.4	5.9	1.7	8.6	21.2	9.3	11.1	6.9	1.2	9.2	3.8	4.3	5.0	49.7	6.5	8.2	120.9	12.6	7.2	8.5	42.7	10.9	1.5	33.7	11.6	9.2	10.0	1.5	0.6	1.0	5.9	0.2	0.0	2.5	1.0	0.4	0.1	0.2	0.4	42.8	103.0	5.9	0.1	0.8	1.2	4.6	0.2	0.0	27.8	3.4	44.4	0.5	1.7	3.6	76.7	59.7	0.2	0.4	0.0	0.3	0.5	9.1	22.4	0.5	90.8	0.5	4.6	93.0	1.5	3.7	0.4	0.3	44.6	12.0	180.7	0.4	0.7	8.4	12.1	0.9	2.1	0.9	1.2	19.0	83.7	1.9	0.3	1.3	0.9	0.5	60.1	55.8	90.4	0.7	79.9	0.2	10.9	26.1	35.4	26.2	42.4	18.6	18.0	18.8	21.1	25.5	16.9	17.4	17.4	22.4	16.0	59.4	31.6	23.5	26.1	5.2	5.4	6.9	6.5	5.7	6.3	10.9	8.3	9.3	8.2	8.5	10.0	16.0	9.6	22.7	2.6	65.3	3.4	0.6	0.2	0.0	13.7	2.4	6.1	48.3	1.5	2.7	18.4	4.2	1.9	70.0	9.5	5.9	0.9	0.1	2.4	1.4	13.0	4.8	11.3	2.1	0.6	1.9	3.5	7.1	1.5	34.2	7.7	4.2	0.5	86.6	3.3	1.4	6.6	0.0	77.2	31.5	0.2	0.9	76.0	10.6	19.7	42.5	1.9	70.0	2.0	0.7	0.2	0.5	0.0	32.9	0.5	3.0	0.8	8.7	4.6	0.0	7.1	2.6	0.7	5.2	1.6	1.7	1.4	69.5	1.1	5.0	0.4
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"breast: 32.4;epididymis: 35.7;esophagus: 28.7;skin 1: 45.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 14.7;Breast myoepithelial cells: 8.6;Club cells: 4.3;Collecting duct cells: 3.7;Early spermatids: 7.2;Late spermatids: 4.3;Respiratory ciliated cells: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.3;HBEC3-KT: 13.6;RPTEC TERT1: 11.7;SK-BR-3: 12.7;T-47d: 15.4"	"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		No	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.1	0.0	0.3	0.0	1.3	0.0	32.4	0.1	0.6	3.2	0.2	0.0	1.7	0.7	35.7	28.7	0.1	0.1	0.0	0.2	0.3	5.6	0.1	0.8	0.0	0.3	1.8	0.0	0.3	0.0	0.0	0.0	0.8	4.6	0.0	0.0	3.6	7.9	0.4	45.3	0.0	0.0	0.2	0.0	4.6	2.7	0.6	0.0	0.9	0.0	3.7	3.2	7.4	0.2	4.5	0.0	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.0	0.1	0.2	0.9	0.0	3.6	0.0	0.0	0.0	0.0	13.6	0.2	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	12.7	0.0	1.6	15.4	0.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.6	0.2	0.3	0.3	1.8	0.8	0.2	0.6	0.2	0.1	0.0	1.5	0.7	0.0	0.3	0.0	1.8	0.0	0.0	14.7	8.6	0.1	0.0	4.3	3.7	0.0	0.0	0.2	0.0	0.0	0.0	7.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.4	3.4	0.0	0.0	0.0	0.3	0.7	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942031-14961728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 1579.9;lymphoid tissue: 1075.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 703.8;Extravillous trophoblasts: 667.6;granulocytes: 700.2;Hofbauer cells: 915.2;Kupffer cells: 742.6;Macrophages: 672.9;NK-cells: 999.0;T-cells: 895.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 1636.5;HL-60: 1927.3;HMC-1: 2070.0;JURKAT: 1421.7;MOLT-4: 2313.6;REH: 1912.5;U-698: 1750.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol		NA	NA		61000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB018584: AB_647972, HPA051235: AB_2681398"	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.42e-4)"	188.8	74.1	48.7	521.0	51.2	1579.9	170.4	56.0	77.6	85.4	57.9	112.9	79.6	68.0	48.4	82.9	85.3	165.9	110.7	49.4	56.4	95.9	139.0	280.3	905.3	68.5	65.4	27.6	32.2	54.1	35.4	143.8	68.4	68.8	142.4	5.3	122.3	66.3	56.3	74.2	201.6	144.3	61.8	592.6	108.1	19.5	65.6	1075.8	110.6	79.0	1036.8	290.4	67.4	79.6	147.8	5.5	5.8	327.3	23.7	17.6	2.1	6.0	1.8	2.3	1.6	19.3	156.9	1210.9	74.3	28.0	1.9	171.1	0.0	270.8	17.9	2.3	0.0	1636.5	3.5	0.7	5.2	1927.3	2070.0	2.5	37.5	0.8	24.2	5.6	929.0	1421.7	8.7	454.5	28.8	0.8	2313.6	1382.4	7.1	3.3	1.7	1912.5	21.3	540.3	52.7	845.5	1.3	1.4	1.8	205.7	2.5	14.1	10.9	1385.1	1171.8	4.6	11.5	2.2	36.2	74.5	13.0	1750.9	5.3	1339.7	2.4	5890.8	2659.3	6464.2	2731.2	3085.1	2695.1	2676.3	3099.3	3090.3	2210.1	2532.9	2986.0	3120.5	5422.5	2408.4	3802.9	955.6	5589.7	9860.2	48.7	51.2	56.0	77.6	49.4	56.4	68.5	65.4	68.4	61.8	65.6	79.6	189.6	60.9	143.0	0.7	575.2	68.2	51.9	11.1	5.7	0.6	99.7	64.5	14.0	11.5	79.5	58.8	0.0	89.6	703.8	5.3	17.6	21.9	1.5	3.2	6.1	175.6	1.2	182.1	0.7	342.7	667.6	47.3	42.3	3.6	700.2	0.4	342.3	11.1	915.2	0.0	0.2	2.2	8.2	742.6	487.7	4.1	53.4	672.9	90.7	26.2	451.3	3.3	999.0	0.5	0.1	53.5	16.3	58.6	292.5	6.9	0.2	9.2	39.0	1.2	243.3	10.3	187.9	1.2	2.3	5.5	56.1	68.0	895.2	14.9	6.7	94.7
ARHGEF15	"ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF"	ENSG00000198844	"Rho guanine nucleotide exchange factor 15"	O94989	17	8310241-8322514	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.7;breast: 41.6"	"Group enriched"	"Detected in some"	4	"Adipocytes: 66.4;Endothelial cells: 48.9;Hepatic stellate cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	48	"HUVEC TERT2: 40.4;TIME: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044443, HPA063495"			Supported	"Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA044443: AB_10960424, HPA063495: AB_2685023"	"unprognostic (3.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.82e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-3)"	47.7	5.9	4.6	4.1	4.2	0.0	41.6	4.1	4.7	8.7	3.0	6.9	3.1	10.9	1.6	4.8	9.8	7.3	35.5	4.1	4.1	15.8	2.9	22.1	3.1	4.7	4.5	3.8	4.2	3.4	4.0	14.7	4.8	8.0	2.0	0.2	5.1	3.5	13.2	7.7	6.5	7.2	4.0	7.9	6.9	2.2	5.2	1.6	12.4	10.9	1.8	12.3	8.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	49.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.2	4.1	4.7	4.1	4.1	4.7	4.5	4.8	4.0	5.2	3.6	66.4	0.0	3.0	0.3	0.5	2.8	0.3	0.0	0.6	0.8	0.5	0.4	8.9	2.8	0.0	1.8	0.0	0.0	0.2	0.1	0.0	0.0	3.3	0.4	0.2	48.9	0.0	0.0	0.2	0.0	0.1	1.0	0.0	1.3	0.0	0.0	37.1	0.0	0.1	0.0	0.5	0.0	0.0	1.4	2.8	4.4	0.0	0.5	7.2	11.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.1	0.0	1.6	1.5	0.4	0.2	0.2	1.0	0.1	0.3	0.7	0.0	0.3
ARHGEF19	"FLJ33962, WGEF"	ENSG00000142632	"Rho guanine nucleotide exchange factor 19"	Q8IW93	1	16197854-16212652	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 26.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 17.6;HaCaT: 14.4;T-47d: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068108			Approved	"Nuclear bodies"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA068108: AB_2685956"	"unprognostic (2.19e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-2)"	"prognostic favorable (6.53e-4)"	"unprognostic (4.01e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (3.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.80e-1)"	2.9	10.1	0.9	2.7	0.7	0.9	5.0	0.7	1.3	8.7	0.8	2.8	2.3	6.0	1.1	15.9	6.4	2.1	2.2	0.7	0.9	4.2	1.5	3.2	1.6	0.9	0.8	6.9	7.9	2.1	1.8	3.1	0.7	8.4	0.9	0.2	17.2	4.5	0.8	26.3	3.0	1.5	0.7	2.8	6.2	1.5	0.8	1.8	12.0	0.4	2.3	6.1	11.4	0.7	17.6	4.6	2.4	4.9	0.3	1.4	0.9	4.3	4.1	2.4	3.3	6.9	2.7	0.0	3.4	3.9	1.8	14.4	1.0	1.6	0.6	2.9	0.4	1.4	11.7	0.5	5.7	0.8	5.6	4.4	0.9	6.3	1.8	0.5	0.7	5.5	3.2	3.8	1.0	3.7	2.0	2.0	0.7	2.5	4.9	6.8	2.2	4.1	0.9	1.3	1.7	2.9	3.3	2.0	0.8	0.2	25.7	2.9	1.8	0.0	7.6	3.9	0.0	4.1	6.7	1.0	0.0	4.3	6.6	0.0	0.5	0.4	0.9	0.2	0.9	0.7	0.8	0.7	0.6	0.5	0.8	0.4	0.0	0.8	0.0	0.6	0.5	0.5	0.9	0.7	0.7	1.3	0.7	0.9	0.9	0.8	0.7	0.7	0.8	0.7	6.1	6.4	6.0	1.3	3.9	4.7	9.3	8.8	14.2	0.5	8.6	8.0	0.5	2.8	8.8	0.0	0.0	1.7	6.5	3.8	0.0	5.7	0.2	7.0	4.5	4.6	0.0	4.2	0.0	5.7	4.9	4.5	3.6	7.8	9.5	2.1	7.5	1.0	2.6	0.0	0.1	5.2	8.2	4.4	1.4	0.0	7.8	1.9	3.6	2.8	2.4	5.3	7.2	1.0	0.0	4.7	5.2	3.4	3.1	2.3	2.5	1.6	4.0	0.3	0.0	4.7	3.9	1.8	6.8	10.7	7.7	1.2	5.4	3.0	4.7	6.4
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing X-linked 1"	Q9P291	X	101550547-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 74.9;ASC TERT1: 66.9;BJ hTERT+ SV40 Large T+ RasG12V: 78.2;LHCN-M2: 70.7;RH-30: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000268, HPA005685, CAB020695"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Cytosol"	"CAB020695: , HPA000268: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	24.4	34.0	16.8	8.8	18.4	3.1	21.9	14.9	21.9	32.3	18.2	31.4	7.0	30.4	21.2	11.4	25.2	17.5	32.8	18.0	19.5	13.7	4.0	16.5	5.5	16.2	17.9	48.3	12.8	16.9	25.9	14.9	18.8	24.3	7.6	12.0	14.1	23.0	27.7	10.9	12.0	21.2	15.6	14.1	14.8	5.9	17.7	6.3	16.4	25.5	3.4	23.2	21.7	17.9	2.1	0.6	16.0	0.0	74.9	66.9	0.2	25.5	49.7	31.4	78.2	0.0	0.4	0.0	21.3	39.3	34.2	2.1	0.0	3.7	17.7	0.1	0.0	14.9	5.1	0.0	39.6	0.0	0.2	56.5	4.8	23.8	0.0	25.9	19.2	0.0	0.3	0.3	70.7	1.0	0.0	0.1	23.1	0.0	0.2	0.0	87.8	0.1	21.6	0.0	15.8	13.1	0.0	0.3	45.9	4.4	2.5	11.0	25.6	18.9	10.0	55.5	0.3	0.0	0.3	0.0	18.6	0.0	12.1	0.0	3.3	0.4	0.0	3.1	0.5	0.0	0.4	0.3	7.7	0.2	1.1	2.7	0.1	1.8	0.9	4.0	0.8	1.6	16.8	18.4	14.9	21.9	18.0	19.5	16.2	17.9	18.8	15.6	17.7	17.9	27.6	25.6	7.4	8.5	0.7	33.1	22.9	5.0	18.2	32.2	19.1	17.4	59.7	7.2	4.1	23.9	6.2	1.6	3.7	0.6	13.7	21.1	0.3	10.4	23.2	29.9	5.4	4.2	9.5	7.1	2.6	53.2	9.2	11.2	24.1	20.0	20.7	0.8	27.9	21.9	11.8	2.2	2.0	9.5	33.4	2.0	47.2	17.5	58.7	4.7	5.7	36.0	0.0	11.1	8.4	5.6	0.1	44.4	0.4	20.6	0.6	13.6	3.6	13.9	46.0	60.6	39.9	1.6	0.7	3.8	21.7	2.6	2.3	35.6	2.5	7.5
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing X-linked 2"	Q7L311	X	101655281-101659850	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 154.8"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 59.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 164.1;NTERA-2: 117.2;SuSa: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	17.0	46.2	28.7	11.5	29.1	0.5	17.6	22.8	29.7	36.9	26.5	25.4	5.4	30.6	154.8	9.2	28.8	20.6	33.2	29.1	31.6	28.3	3.2	16.8	8.5	25.9	26.2	47.8	18.9	71.2	78.3	26.3	27.5	28.3	7.9	15.3	44.5	67.9	6.2	6.5	13.0	32.3	23.4	21.3	16.3	5.8	28.1	7.7	59.7	7.5	6.5	26.9	20.1	25.4	0.0	0.0	50.8	0.4	43.6	39.4	0.4	56.0	70.4	1.4	1.4	0.0	21.8	0.0	0.0	74.6	0.0	1.5	0.0	1.3	0.6	0.0	2.0	0.2	60.9	0.0	46.4	0.4	0.1	63.7	17.6	43.5	0.4	68.3	59.7	0.0	0.2	0.3	164.1	0.0	0.0	0.6	117.2	3.4	0.3	14.5	88.9	0.3	2.8	0.0	20.4	36.6	0.0	0.2	1.7	90.3	25.9	0.1	13.0	61.9	65.1	38.8	0.4	0.0	0.0	0.2	55.7	0.1	1.2	0.0	0.4	0.0	1.0	0.9	0.4	2.8	0.9	0.9	0.7	4.0	2.4	2.5	0.0	2.8	0.6	0.9	0.7	1.1	28.7	29.1	22.8	29.7	29.1	31.6	25.9	26.2	27.5	23.4	28.1	25.4	10.4	16.0	6.4	8.5	8.2	4.2	16.4	5.8	21.1	12.5	18.0	20.8	28.7	5.7	11.4	33.1	8.4	1.2	2.4	0.1	3.9	9.6	0.2	11.2	23.4	13.3	9.1	3.2	15.4	2.0	0.7	28.4	4.6	15.2	2.5	18.1	19.2	0.7	3.8	1.7	14.3	3.0	2.0	2.4	6.5	1.3	24.2	7.4	5.4	11.2	7.1	9.3	0.0	16.1	14.0	2.2	0.1	24.5	2.8	16.5	0.3	4.3	4.9	11.3	59.2	31.8	23.9	1.4	1.9	3.8	3.0	5.1	2.5	4.6	1.6	7.2
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.1;lymphoid tissue: 22.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 45.6;Excitatory neurons: 78.8;Pancreatic endocrine cells: 86.9;Prostatic glandular cells: 109.0;Urothelial cells: 128.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.4"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 121.9;U-2197: 159.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA059074: AB_2683897"	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.0	1.0	1.3	10.0	6.4	2.3	2.1	0.0	3.6	5.8	0.0	2.5	2.8	1.2	0.2	28.1	0.9	3.6	0.8	2.8	1.6	1.1	4.7	2.3	5.2	0.0	0.5	0.2	1.3	1.5	0.8	2.8	0.0	1.1	3.2	0.4	7.2	0.6	0.2	7.6	2.6	4.6	0.0	1.0	10.9	2.7	0.6	4.4	0.6	0.8	22.2	14.7	11.9	2.2	76.0	19.2	4.2	1.6	3.6	11.0	58.3	26.3	34.5	16.8	26.2	18.2	57.4	0.6	14.4	12.6	51.9	30.6	12.3	92.1	42.7	121.9	15.7	14.6	11.7	15.2	4.8	29.6	6.1	4.0	8.1	58.8	45.6	28.9	80.0	17.7	7.5	29.8	19.6	9.2	16.2	16.2	32.1	25.7	65.8	29.8	68.2	4.7	14.1	42.8	13.6	2.2	13.5	2.1	0.4	10.0	2.9	9.7	54.6	54.2	31.4	159.5	110.0	4.4	8.4	0.1	46.5	23.5	10.9	1.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	1.3	6.4	0.0	3.6	2.8	1.6	0.0	0.5	0.0	0.0	0.6	2.2	2.1	3.2	1.3	1.3	0.4	0.8	45.6	8.6	1.2	0.9	1.6	0.8	0.9	11.5	7.5	9.2	0.0	1.9	0.3	1.5	0.0	22.1	3.8	7.9	0.7	6.9	1.2	3.4	78.8	27.4	4.0	3.2	28.1	11.8	0.0	5.3	2.5	3.5	1.4	0.0	24.8	3.3	2.0	2.5	5.4	4.4	0.0	2.9	1.8	7.5	15.7	0.0	0.0	8.5	2.3	86.9	1.4	0.0	3.4	109.0	1.7	0.6	2.7	0.1	0.0	1.7	3.6	3.1	4.7	6.6	2.3	4.2	1.3	0.2	2.1	128.2
ARSI	"FLJ16069, SPG66"	ENSG00000183876	"Arylsulfatase family member I"	Q5FYB1	5	150296343-150339307	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 12.1;Fibroblasts: 10.8;Melanocytes: 21.4;Smooth muscle cells: 6.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 15.7;HaCaT: 31.4;Hep G2: 19.9;hTEC/SVTERT24-B: 30.9;U-87 MG: 39.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA038386, HPA038398"	Uncertain		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA038386: AB_10669781, HPA038398: AB_2675995"	"unprognostic (6.08e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.77e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.39e-7)"	"unprognostic (7.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.19e-4)"	1.2	0.3	1.6	2.3	2.6	0.6	0.4	2.5	2.1	2.7	0.7	1.6	0.6	3.1	0.6	1.8	2.1	1.1	1.3	1.4	1.8	0.7	0.4	4.5	0.3	3.6	2.4	0.4	0.4	0.6	1.0	2.8	3.9	1.7	0.4	0.4	0.5	0.8	0.8	4.8	0.7	2.8	2.6	0.8	0.8	0.4	2.8	0.3	0.2	0.5	0.4	3.8	2.7	5.5	1.0	3.8	1.1	0.0	0.0	0.8	0.0	8.1	12.1	15.7	11.5	1.1	1.8	0.0	3.1	11.5	1.3	31.4	0.2	5.3	5.6	0.0	0.1	0.0	0.4	19.9	1.5	0.0	0.0	0.8	3.4	30.9	0.9	10.7	0.2	0.0	0.0	0.2	2.5	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.1	0.4	0.0	0.2	0.0	6.7	0.9	1.3	11.2	0.0	0.0	0.0	0.3	10.2	0.3	0.0	0.0	0.0	0.0	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.6	2.5	2.1	1.4	1.8	3.6	2.4	3.9	2.6	2.8	5.5	0.1	0.0	0.0	0.3	0.0	12.1	0.0	2.4	0.0	0.1	0.1	0.4	1.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.0	1.1	10.8	0.0	0.0	4.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.1	0.0	0.8	0.2	0.6	0.0	21.4	0.0	0.0	3.9	0.0	0.0	2.5	0.4	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.3	0.0	1.8	6.6	0.1	0.9	0.9	4.7	1.4	1.1	0.0	0.0	0.0
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 35.3;Astrocytes: 44.1;Basal prostatic cells: 60.3;Prostatic glandular cells: 49.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 46.4;HUVEC TERT2: 42.2;LHCN-M2: 42.8;TIME: 53.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036481, HPA036482"	Uncertain		Enhanced	"Actin filaments"	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"		"HPA036481: AB_2675146, HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	1.8	1.3	1.5	1.3	1.1	0.0	1.0	5.0	1.4	4.5	0.2	2.4	0.6	2.0	0.9	3.1	2.8	3.6	2.5	1.2	0.9	2.7	1.7	3.3	0.6	0.9	1.1	2.0	1.1	3.0	0.7	4.3	0.7	3.9	3.3	0.6	5.8	2.2	0.2	0.7	0.7	2.2	0.6	0.2	3.5	0.1	1.9	1.5	0.7	0.6	0.3	3.8	2.1	1.1	2.7	5.3	0.6	0.0	10.1	20.5	0.0	46.4	35.5	29.0	11.3	1.3	3.4	0.0	5.7	22.6	10.3	5.0	0.2	11.7	36.2	0.0	2.1	0.0	4.2	0.0	30.6	0.0	0.0	12.7	11.5	19.7	40.0	20.5	42.2	0.0	0.0	0.0	42.8	0.4	0.0	0.0	1.5	0.0	8.4	0.0	5.1	0.0	38.0	0.0	0.0	1.7	3.1	0.5	2.2	7.5	0.2	0.0	53.6	33.3	8.7	5.0	22.3	0.0	0.0	0.0	16.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	5.0	1.4	1.2	0.9	0.9	1.1	0.7	0.6	1.9	1.1	0.7	35.3	9.8	44.1	0.2	2.9	60.3	23.7	15.9	0.2	4.7	2.9	1.3	11.5	10.8	25.8	0.0	0.3	0.1	7.0	0.0	9.2	0.0	6.2	21.1	4.3	23.4	0.0	27.1	0.9	0.2	13.6	4.6	8.2	0.0	0.0	4.2	1.2	0.5	1.7	1.5	17.3	16.2	0.3	1.6	0.3	2.5	0.3	3.6	7.5	0.0	6.8	1.0	3.0	0.5	5.2	5.0	1.5	0.0	49.6	0.1	4.1	4.6	0.2	0.0	8.6	10.5	0.1	0.3	16.9	1.1	0.4	0.6	3.3	4.1	25.6
ARSL	"ARSE, CDPX, CDPX1"	ENSG00000157399	"Arylsulfatase L"	P51690	X	2934521-2968475	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.6;liver: 86.3;pancreas: 105.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 34.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6"					"Low region specificity"	"Detected in all"			"HPA060518, HPA070651"	Approved		Supported	"Golgi apparatus"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA060518: AB_2684301, HPA070651: AB_2732160"	"unprognostic (2.07e-1)"	"unprognostic (6.60e-3)"	"prognostic favorable (8.95e-4)"	"unprognostic (8.74e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.76e-2)"	0.4	0.7	2.6	2.2	2.7	0.3	1.1	2.1	2.8	1.7	4.5	20.8	17.9	3.2	2.2	0.4	4.1	8.2	1.0	2.8	2.6	36.6	86.3	2.7	0.1	2.8	2.8	7.1	105.2	0.0	0.7	0.7	2.9	0.5	16.7	0.3	1.3	2.9	0.2	0.2	13.6	1.9	2.4	0.0	2.9	0.4	2.6	0.0	0.2	0.3	0.1	0.5	1.6	2.3	4.5	68.9	8.2	0.0	3.3	4.0	1.3	3.9	6.4	4.0	4.0	42.7	0.0	0.0	13.7	0.1	30.8	0.0	0.0	0.9	2.3	0.0	4.5	0.0	0.0	64.1	1.8	0.0	0.1	9.6	0.0	3.8	0.0	7.3	3.8	0.0	0.0	0.1	10.5	0.1	0.0	0.0	33.6	2.4	0.2	2.8	1.1	0.3	7.1	0.0	0.1	0.2	0.0	0.0	2.6	13.7	0.0	0.2	5.0	0.1	0.2	0.0	7.4	0.0	0.0	0.1	9.1	0.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	2.1	2.8	2.8	2.6	2.8	2.8	2.9	2.4	2.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ASF1A	"CIA, DKFZP547E2110"	ENSG00000111875	"Anti-silencing function 1A histone chaperone"	Q9Y294	6	118894152-118909171	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030502, HPA071495"			Enhanced	Nucleoplasm		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA030502: AB_2673504, HPA071495: AB_2686404"	"unprognostic (7.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.02e-7)"	"unprognostic (8.28e-2)"	"unprognostic (8.42e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.95e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.09e-3)"	7.4	10.2	13.0	8.7	14.4	8.3	12.5	14.8	17.1	8.5	11.2	9.4	7.7	10.6	13.0	8.9	10.5	7.9	13.3	12.4	14.2	12.6	12.0	13.4	16.0	13.6	13.7	17.5	9.4	15.8	6.3	8.2	14.0	9.8	10.9	11.5	10.7	11.0	16.6	11.6	8.8	7.4	14.5	11.5	10.9	9.7	13.9	24.4	15.1	16.1	15.1	9.4	6.7	15.7	14.7	9.2	31.2	21.2	26.0	15.2	25.3	19.3	18.8	24.3	27.2	11.7	12.2	24.0	30.8	13.7	21.5	15.3	27.2	24.7	30.8	17.5	25.4	35.1	20.7	72.9	18.5	60.6	17.4	13.8	24.3	21.2	32.0	32.6	32.9	75.2	55.2	61.9	28.9	15.7	70.8	47.4	12.9	21.6	30.5	38.7	13.1	30.1	32.7	18.4	20.1	15.8	19.6	19.4	23.3	9.8	11.4	55.3	29.1	11.3	17.0	16.1	30.1	19.4	34.5	35.6	29.7	47.5	25.0	18.8	15.4	32.9	40.3	17.1	56.5	35.7	64.0	51.8	34.1	24.7	69.0	56.8	2.7	34.3	23.1	26.1	83.9	47.4	13.0	14.4	14.8	17.1	12.4	14.2	13.6	13.7	14.0	14.5	13.9	15.7	16.0	16.0	22.6	11.1	24.7	29.4	14.8	36.7	28.5	16.7	14.0	19.2	27.1	18.6	23.0	9.2	4.2	67.5	19.8	11.6	62.6	33.9	40.9	10.2	13.9	23.3	29.5	82.1	5.8	23.5	71.5	24.0	17.9	9.1	22.8	39.9	17.2	15.1	24.6	25.2	6.3	12.4	10.2	16.3	16.7	10.8	25.4	16.5	16.0	9.4	24.9	27.8	24.7	9.0	10.0	20.7	10.1	23.3	22.7	10.9	11.5	27.2	21.2	13.7	13.1	17.0	37.2	32.7	48.0	20.8	33.0	46.7	49.1	28.1	17.5	12.5
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like, histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105493-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	28.9	18.9	19.7	17.9	20.3	31.6	21.4	19.2	21.5	19.9	14.7	22.5	18.2	22.0	17.1	23.8	20.1	17.4	21.3	20.2	17.4	23.3	23.6	18.5	27.9	16.7	16.1	26.2	17.7	24.8	12.0	22.1	16.7	19.9	22.3	21.7	20.6	21.0	32.4	20.4	18.3	24.2	16.5	18.9	22.1	41.3	19.0	33.6	21.1	27.7	28.3	18.5	16.1	18.1	45.6	23.3	39.8	39.8	26.3	34.0	49.8	44.1	45.7	53.5	47.0	24.9	21.1	51.4	38.2	37.1	27.2	27.5	49.0	24.8	50.4	20.3	22.4	200.3	22.9	51.7	39.4	32.0	41.3	28.6	22.9	25.0	27.7	28.1	43.9	48.0	138.2	40.0	53.7	26.1	91.9	40.7	51.7	39.3	15.6	38.2	42.9	23.4	28.9	33.1	18.3	32.4	33.5	22.5	38.4	37.1	27.4	40.4	33.5	35.3	35.0	50.4	37.6	37.8	48.7	44.9	35.2	44.7	49.7	39.9	23.0	55.9	16.8	26.8	18.1	19.6	18.8	20.0	27.7	19.2	19.3	18.4	19.2	26.1	25.8	15.8	21.3	21.6	19.7	20.3	19.2	21.5	20.2	17.4	16.7	16.1	16.7	16.5	19.0	18.1	11.1	12.8	15.8	18.3	14.3	6.9	9.3	13.3	10.8	12.9	9.6	8.0	18.1	8.6	15.9	12.9	10.4	37.0	15.9	11.5	7.9	21.2	10.8	12.7	13.2	14.0	10.8	62.1	19.7	28.7	37.2	17.3	8.6	10.8	19.6	38.2	12.8	11.9	24.2	6.7	21.4	11.6	12.2	17.2	5.7	13.0	23.3	17.0	23.2	15.9	29.2	17.8	19.6	17.6	16.5	21.3	8.9	20.7	8.4	6.2	12.8	17.1	18.0	15.5	13.1	14.6	20.7	69.6	33.9	11.6	6.8	30.9	11.9	37.3	10.9	7.4
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97851677-97872542	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 121.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 233.9;Late spermatids: 217.0;Smooth muscle cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 8.9;T-cells: 14.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol		No	No		47000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.79e-5)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	17.3	18.0	49.9	19.5	52.3	13.7	17.8	52.7	66.3	19.9	28.2	24.5	9.7	19.0	31.5	27.0	20.1	11.2	19.4	55.3	51.0	28.9	9.3	25.6	28.8	58.7	43.5	20.8	121.4	26.3	44.1	4.6	59.4	21.5	19.9	35.3	41.6	14.5	8.0	22.9	22.6	18.0	43.6	30.3	46.0	33.3	49.7	13.3	27.5	8.6	25.7	21.7	18.6	63.8	124.6	46.6	51.6	415.9	35.3	57.9	109.1	85.7	62.5	41.6	134.8	64.2	49.3	101.7	45.3	189.8	92.3	57.4	118.2	151.2	102.2	122.4	85.3	31.0	24.6	50.8	347.8	207.1	89.9	106.2	508.8	55.8	361.2	23.5	41.4	94.4	177.1	365.2	76.3	286.5	6.4	54.4	68.1	308.4	125.4	14.0	10.0	282.7	28.4	22.3	218.1	156.7	23.2	136.7	499.0	60.6	57.1	139.1	7.6	21.6	138.5	56.7	40.7	412.6	239.7	401.1	288.7	90.3	220.8	1.9	0.3	0.4	3.6	1.1	4.3	8.9	7.2	3.4	1.5	6.0	10.1	5.5	1.8	2.0	1.0	0.2	14.2	3.3	49.9	52.3	52.7	66.3	55.3	51.0	58.7	43.5	59.4	43.6	49.7	63.8	5.8	9.6	7.2	11.1	14.4	12.4	26.1	20.9	6.2	20.3	9.7	11.2	7.6	7.2	12.3	9.2	25.0	3.1	6.7	10.5	7.9	30.9	233.9	2.9	8.6	6.7	24.4	46.1	51.8	61.6	7.8	8.9	14.3	4.5	8.2	8.8	2.9	1.3	1.1	25.2	48.6	19.6	32.6	1.3	3.2	217.0	9.6	2.1	8.8	5.6	7.3	9.2	5.2	16.1	16.9	36.6	14.7	9.4	19.9	26.1	1.1	3.9	4.5	24.9	6.6	10.2	112.3	3.4	20.2	5.5	10.9	5.6	11.2	6.0	9.9	14.9
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 386.9"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 890.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	386.9	160.3	64.7	50.6	69.2	16.9	106.9	102.3	88.9	65.6	84.4	78.8	45.6	49.3	44.7	71.4	46.9	61.0	111.3	64.5	58.4	59.5	74.9	74.1	20.3	54.0	69.2	62.2	44.7	38.7	36.3	47.9	52.2	48.3	84.9	219.5	101.9	70.2	357.6	35.2	45.5	67.5	44.8	28.6	105.0	16.5	71.8	16.7	97.0	182.7	28.5	112.2	43.8	60.4	460.3	652.3	89.9	55.1	392.1	370.1	31.2	804.0	741.3	336.3	350.1	113.1	594.2	35.3	54.3	474.6	270.3	167.5	56.2	281.1	570.0	13.6	57.0	81.1	372.5	310.3	251.2	12.5	12.9	306.5	61.9	187.6	237.4	657.2	144.8	18.0	22.2	32.1	300.2	97.4	3.3	16.6	51.7	441.6	383.4	22.3	97.0	7.3	206.2	374.0	93.1	32.1	249.9	116.1	101.7	49.0	47.7	22.2	456.7	338.0	174.3	313.0	288.0	20.2	27.1	1.5	890.1	7.5	231.4	1.9	8.3	0.3	2.5	2.9	4.7	5.5	3.5	2.4	10.0	5.0	4.9	2.5	25.4	8.7	1.8	34.0	4.0	4.1	64.7	69.2	102.3	88.9	64.5	58.4	54.0	69.2	52.2	44.8	71.8	60.4	79.1	195.5	244.0	366.6	13.8	47.0	160.7	126.0	68.9	138.3	83.7	58.4	228.6	37.1	157.5	86.5	294.0	118.1	40.3	57.0	15.6	144.2	1.6	51.4	65.8	85.9	116.5	13.0	93.1	180.4	107.1	132.0	73.9	115.4	8.2	34.5	42.8	62.6	72.2	127.9	98.9	215.1	52.9	26.6	44.1	3.1	70.8	48.1	42.7	61.8	20.0	468.8	2.1	154.8	53.5	257.7	32.3	57.6	15.9	148.2	34.3	34.6	66.6	158.8	46.0	114.4	92.7	3.4	16.8	101.7	50.3	48.0	13.6	131.2	67.3	254.2
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase and isoaspartyl peptidase 1"	Q7L266	11	62337448-62393412	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.7;cervix: 121.7;testis: 100.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 277.9;eosinophil: 269.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 277.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	13.8	3.7	94.2	6.5	95.4	14.4	12.0	92.5	103.5	121.7	71.7	14.2	6.8	26.4	3.1	2.1	68.1	11.2	6.2	87.1	93.3	42.5	10.2	25.8	5.6	87.5	102.7	1.8	13.4	2.3	21.2	3.2	87.6	23.8	17.1	17.8	13.2	7.2	7.3	2.9	9.5	4.4	83.4	4.7	15.1	100.5	112.7	10.3	6.7	3.0	4.7	4.3	2.0	90.0	2.4	19.5	20.9	27.2	0.1	0.0	16.4	2.3	0.8	3.6	3.5	32.0	8.5	1.9	85.2	0.3	9.3	1.8	83.9	0.7	4.2	2.6	34.4	1.2	28.1	23.5	0.6	24.0	30.8	0.8	0.2	1.6	0.4	1.3	39.4	47.8	24.5	21.5	0.9	37.5	65.3	15.9	28.5	13.6	15.2	26.1	12.5	11.8	73.3	5.9	112.3	16.1	16.4	28.2	14.4	21.2	15.0	12.1	2.0	0.4	15.4	1.2	9.5	32.8	33.6	3.0	0.8	12.3	9.7	277.9	68.6	269.5	2.8	50.8	1.9	2.4	1.0	3.3	39.7	1.5	2.3	3.4	16.3	11.5	38.5	7.2	0.8	24.2	94.2	95.4	92.5	103.5	87.1	93.3	87.5	102.7	87.6	83.4	112.7	90.0	29.2	6.4	27.8	56.8	5.2	3.4	2.5	2.2	0.6	24.4	13.8	6.6	2.4	42.9	4.1	22.0	33.3	2.3	3.2	14.0	133.1	30.3	372.5	414.6	39.9	31.2	47.2	14.1	13.9	22.3	2.4	4.0	19.9	437.1	80.9	16.6	49.2	3.7	25.0	16.8	18.6	67.4	6.1	11.4	6.4	597.6	8.7	26.9	1.8	9.4	10.5	80.8	4.1	15.1	22.0	7.8	7.5	7.2	13.9	35.4	2.9	214.1	5.4	37.1	13.1	7.7	6.1	534.3	48.6	0.1	1.3	0.8	7.8	10.8	36.0	15.9
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444961-130501274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 1284.8;liver: 2037.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 398.7;Hepatocytes: 1062.0;Proximal enterocytes: 618.2;Proximal tubular cells: 1408.9;Urothelial cells: 413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 893.9;HaCaT: 850.4;hTCEpi: 817.8;RPMI-8226: 1444.5;THP-1: 1061.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		6400000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	215.0	146.8	29.6	51.3	29.7	0.2	168.2	25.0	31.0	67.0	61.7	157.2	124.5	111.3	124.8	51.1	166.3	110.2	66.5	31.5	38.3	1284.8	2037.7	52.9	7.5	40.2	42.2	57.2	68.4	11.4	45.0	50.6	51.7	56.2	167.9	6.9	119.4	132.6	74.4	131.3	194.8	61.2	28.4	20.0	53.2	35.9	38.4	7.8	92.3	71.4	15.6	288.7	66.6	25.3	124.5	11.9	13.7	23.1	88.4	223.1	43.6	146.2	893.9	28.2	85.5	52.5	34.0	0.4	95.9	300.2	8.2	850.4	59.9	5.2	19.5	21.7	27.1	0.3	18.3	137.3	305.4	18.3	1.6	148.2	817.8	45.4	81.2	0.3	1.1	384.0	5.3	530.6	28.8	619.8	7.2	262.7	19.2	635.9	26.7	1.7	15.4	1444.5	78.8	61.3	342.4	5.8	515.4	534.7	41.5	53.5	366.1	1061.5	0.4	11.3	68.3	2.3	13.0	88.1	91.5	32.1	219.0	137.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	29.6	29.7	25.0	31.0	31.5	38.3	40.2	42.2	51.7	28.4	38.4	25.3	72.1	25.6	28.6	2.6	21.3	70.5	55.7	179.8	53.5	0.1	23.7	17.3	5.4	138.7	104.4	47.8	0.0	178.5	0.4	398.7	133.1	116.5	1.2	4.7	30.5	68.0	12.0	93.7	2.2	110.5	8.9	21.5	20.4	6.2	5.7	55.5	65.7	1062.0	14.7	0.0	8.0	186.8	24.4	40.1	6.5	7.8	31.1	8.0	3.6	7.5	1.6	10.6	0.0	0.0	0.2	70.8	310.4	124.8	11.7	104.0	618.2	1408.9	32.7	0.4	0.0	18.7	13.4	1.4	2.6	23.5	17.5	144.1	11.5	62.0	165.6	413.2
ASTN2	KIAA0634	ENSG00000148219	"Astrotactin 2"	O75129	9	116423112-117415070	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 354.6;Excitatory neurons: 370.0;Inhibitory neurons: 1011.0;Late spermatids: 228.2;Oligodendrocyte precursor cells: 900.3;Oligodendrocytes: 225.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027035	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA027035: AB_1845122"	"unprognostic (3.25e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.93e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	3.3	9.8	26.1	2.7	26.3	3.6	4.3	39.0	36.0	5.3	9.0	5.2	3.4	3.2	3.9	2.2	8.0	2.5	22.5	27.0	25.8	5.5	4.1	2.2	2.4	29.3	36.2	2.8	6.7	3.1	11.6	1.8	28.7	25.2	3.2	13.4	5.8	11.3	7.3	2.4	4.1	2.8	21.4	2.4	5.6	17.6	35.0	6.0	1.8	5.6	1.8	3.2	3.5	39.2	3.7	12.0	4.3	7.1	7.6	7.0	15.4	5.7	2.3	2.5	2.8	8.1	4.4	8.8	6.1	3.8	9.3	1.3	11.5	0.6	3.1	4.8	2.9	3.1	5.8	17.0	3.0	1.8	6.2	9.5	1.1	7.8	0.7	5.4	1.8	10.5	3.9	5.9	7.9	3.8	4.1	1.4	13.2	10.6	6.4	4.9	27.5	2.5	8.0	12.3	6.3	37.9	6.8	2.0	4.8	14.5	15.5	1.3	3.5	5.9	9.1	5.6	4.9	9.0	5.0	8.3	10.5	2.0	25.8	2.5	0.4	0.5	2.8	0.3	3.6	1.5	3.1	2.4	0.2	1.6	3.0	2.5	1.9	5.9	0.6	0.9	8.8	1.0	26.1	26.3	39.0	36.0	27.0	25.8	29.3	36.2	28.7	21.4	35.0	39.2	0.6	6.4	8.9	354.6	1.1	1.3	3.2	0.4	1.2	4.9	4.2	4.8	22.7	2.8	5.0	1.8	10.4	0.4	1.0	0.4	3.9	0.8	122.5	4.7	5.5	1.3	12.6	0.4	370.0	1.1	0.4	4.9	4.1	0.7	6.3	37.0	0.7	2.9	3.2	10.1	1011.0	1.0	0.0	0.0	1.6	228.2	2.8	1.0	0.0	36.5	0.2	3.0	0.0	900.3	225.9	0.5	2.1	5.7	3.6	11.7	5.7	6.9	11.7	5.1	0.0	1.9	2.0	7.7	13.2	0.3	0.6	0.3	3.8	1.9	1.8	2.2
ATAD2	"ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000"	ENSG00000156802	"ATPase family AAA domain containing 2"	Q6PL18	8	123319850-123416350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 79.1;Spermatocytes: 106.0;Spermatogonia: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 294.4"					"Low region specificity"	"Detected in all"			"HPA029424, CAB056158"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB056158: AB_2665580, HPA029424: AB_10611680"	"unprognostic (1.56e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.02e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.33e-15)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.17e-2)"	2.9	3.4	3.8	7.7	3.6	26.5	6.8	2.6	3.9	12.8	2.0	5.3	5.0	4.3	3.8	6.8	3.4	3.2	5.8	3.2	4.5	1.4	9.9	4.1	14.4	2.9	3.8	7.0	3.3	1.9	3.9	4.8	2.6	10.3	6.9	1.4	4.3	4.7	9.3	6.8	5.2	4.1	2.8	4.9	4.7	18.9	5.1	28.3	3.9	3.2	12.8	4.8	3.9	2.8	103.7	39.6	55.0	19.0	9.7	12.3	24.3	79.2	27.2	66.8	73.9	30.1	43.8	67.2	23.6	25.2	26.5	48.3	74.2	25.6	106.1	94.3	39.0	121.2	41.0	61.4	3.8	44.6	57.4	4.1	3.8	63.6	21.0	14.3	20.7	38.6	57.7	66.4	50.4	107.1	129.5	32.8	10.0	77.8	38.4	66.5	65.6	36.4	23.8	46.7	70.2	30.5	114.4	294.4	20.8	22.1	60.2	41.2	13.0	50.4	69.3	40.2	96.6	21.2	40.7	60.8	32.9	72.9	40.4	5.3	0.8	3.3	1.6	0.8	2.2	2.6	2.3	2.7	1.4	1.5	1.5	1.7	0.2	2.5	1.9	0.1	4.6	1.0	3.8	3.6	2.6	3.9	3.2	4.5	2.9	3.8	2.6	2.8	5.1	2.8	4.8	6.4	11.0	9.4	18.5	15.8	27.9	9.1	14.2	2.8	17.3	21.2	27.3	2.8	10.2	3.7	4.2	14.9	15.3	9.0	1.9	3.5	54.9	7.9	17.3	9.6	1.2	79.1	25.6	2.2	26.2	17.1	13.3	17.5	14.5	37.9	7.1	16.3	11.2	1.7	16.4	13.1	4.1	8.2	6.9	24.4	7.5	11.7	1.8	14.0	6.3	6.3	17.5	11.6	2.8	3.5	4.3	13.9	34.0	20.7	3.1	1.0	5.4	1.9	0.0	9.5	17.5	106.0	82.4	23.7	12.1	13.5	22.8	3.7	14.6	24.5
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family AAA domain containing 5"	Q96QE3	17	30831966-30895869	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 59.3;Spermatocytes: 73.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"	Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	0.7	0.4	0.3	2.1	0.2	12.3	1.2	2.6	0.5	0.8	0.1	1.2	1.4	1.0	0.4	1.3	0.7	0.5	0.4	0.3	0.2	0.4	0.5	0.8	3.6	0.2	0.1	0.9	0.5	0.3	0.5	1.4	0.3	0.6	1.6	2.5	0.7	0.4	0.4	2.5	1.4	0.6	0.1	1.4	1.1	2.0	0.3	5.3	0.6	0.1	2.9	0.6	0.9	0.6	7.2	6.0	14.0	13.3	0.3	1.4	5.5	6.3	3.2	6.9	9.8	6.6	5.1	19.5	5.9	2.9	4.7	13.0	9.1	4.7	12.4	4.4	7.9	11.7	8.0	4.6	0.2	23.1	9.2	0.6	0.6	10.1	3.5	1.4	3.6	18.7	18.7	15.9	4.6	4.2	26.1	11.5	8.2	5.3	2.9	17.6	26.4	9.3	1.8	7.6	8.1	7.2	7.0	4.0	3.7	7.6	7.6	10.2	2.8	8.3	11.3	12.0	11.4	5.2	5.9	24.0	3.6	10.7	8.4	0.4	0.2	0.3	0.3	0.3	0.2	0.3	0.1	0.2	0.1	0.4	0.2	0.2	0.6	0.6	0.1	0.5	0.3	0.1	0.3	0.2	2.6	0.5	0.3	0.2	0.2	0.1	0.3	0.1	0.3	0.6	4.3	3.2	4.1	6.8	9.9	4.7	3.1	2.6	3.4	19.3	4.7	5.1	2.7	0.0	2.6	3.7	0.0	21.7	10.7	6.6	0.0	4.1	13.9	4.4	8.5	5.4	0.0	59.3	20.4	2.9	21.1	5.4	9.7	5.1	3.8	32.6	2.9	0.7	8.7	11.8	17.4	8.6	2.0	2.8	7.4	7.8	3.7	5.7	7.2	11.2	10.0	2.9	12.3	16.6	14.9	4.0	2.4	2.2	24.4	2.4	2.3	0.5	2.7	21.3	0.0	7.4	6.5	73.3	34.5	9.3	4.5	7.9	10.5	8.4	13.0	2.3
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.6;Late spermatids: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 8.0;AN3-CA: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus, Cytosol"		"HPA046816: AB_2679822, HPA050999: AB_2681303"	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.35e-4)"	5.3	6.0	2.3	0.6	2.9	0.6	7.6	1.8	3.3	12.4	0.9	8.6	0.5	9.7	3.6	7.6	9.8	0.7	5.5	2.6	3.3	11.3	7.6	5.8	0.6	2.3	2.7	13.4	6.0	0.2	21.3	0.4	2.5	13.5	0.6	2.5	7.7	0.3	4.9	6.6	7.8	0.7	1.9	5.6	7.4	13.5	2.5	0.7	9.3	0.0	0.7	9.2	8.4	3.1	1.4	0.7	8.0	5.3	0.9	0.7	0.6	0.3	0.0	0.2	0.4	2.3	1.4	0.1	1.1	1.1	2.2	1.5	2.5	0.9	0.0	1.0	4.2	0.1	0.1	2.6	0.4	0.5	1.1	1.4	0.5	0.3	0.0	1.0	0.5	3.8	1.5	0.0	1.3	1.5	1.0	0.3	0.4	2.2	0.0	1.0	0.1	0.4	1.3	2.4	0.3	3.2	0.6	0.6	0.4	0.0	2.9	0.4	1.0	3.0	1.3	0.0	0.5	0.9	2.5	0.8	1.6	3.4	2.1	0.5	0.4	0.3	0.1	0.3	0.1	0.5	0.2	0.1	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.5	0.1	0.1	2.3	2.9	1.8	3.3	2.6	3.3	2.3	2.7	2.5	1.9	2.5	3.1	6.2	0.0	1.5	14.7	6.4	5.6	14.0	16.9	14.2	9.0	9.4	11.4	1.9	5.7	8.6	14.7	10.4	11.9	4.1	7.6	7.9	11.9	87.6	9.0	7.7	7.9	18.0	3.0	7.8	4.5	6.3	6.9	8.2	8.0	1.3	16.0	3.3	2.9	6.1	1.7	11.4	8.9	14.2	1.6	3.1	42.4	4.1	3.1	0.0	5.6	9.1	12.5	6.2	16.6	13.1	9.3	10.8	8.6	4.1	11.6	9.7	5.4	10.8	10.7	6.6	8.0	7.8	12.4	11.8	8.0	5.4	8.9	4.7	6.1	11.1	15.3
ATF1	TREB36	ENSG00000123268	"Activating transcription factor 1"	P18846	12	50763710-50821162	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016222, HPA055069, HPA055406"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807"	"unprognostic (1.71e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.65e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.94e-2)"	"unprognostic (4.31e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.27e-1)"	"unprognostic (8.75e-2)"	13.8	21.2	4.9	15.8	5.1	14.8	16.8	14.2	7.1	16.7	8.2	18.0	16.0	18.2	13.7	17.0	17.8	16.5	14.6	4.8	7.9	17.4	20.8	15.8	21.5	5.3	5.8	23.1	9.1	19.8	10.1	16.7	5.4	14.3	18.6	11.9	14.5	13.5	32.4	10.4	14.7	16.7	5.4	17.9	14.3	8.6	6.6	29.2	22.7	23.7	21.5	16.5	12.9	6.9	28.6	20.4	21.0	21.4	29.0	30.4	52.2	29.5	50.7	45.7	35.8	41.7	43.7	38.7	47.6	34.5	20.0	22.8	24.9	30.6	47.6	39.0	25.8	42.8	43.1	22.6	56.5	62.3	39.6	33.7	45.7	32.8	52.8	47.6	22.5	27.1	53.2	36.2	33.9	42.4	39.6	37.3	30.0	33.0	32.1	37.5	32.3	45.9	33.6	19.5	27.9	14.9	61.8	26.5	44.7	28.5	37.3	37.6	16.1	32.1	38.2	26.4	24.1	20.2	25.8	63.6	30.9	33.9	15.3	6.6	17.9	42.7	20.2	18.8	23.1	20.2	21.7	24.1	21.1	21.7	26.4	20.4	11.2	20.8	12.7	9.6	28.8	19.1	4.9	5.1	14.2	7.1	4.8	7.9	5.3	5.8	5.4	5.4	6.6	6.9	25.5	54.5	18.5	22.2	41.5	75.3	48.4	34.8	52.3	12.1	26.0	18.5	14.6	15.7	26.7	12.9	0.0	34.6	25.4	23.4	52.8	24.9	9.2	24.6	20.8	23.8	6.0	46.7	25.8	21.1	77.1	33.1	14.3	21.0	10.1	14.1	20.0	16.2	27.5	13.5	29.2	18.7	24.4	25.2	48.4	5.9	32.0	24.2	23.2	16.9	24.6	14.2	27.8	12.5	25.3	22.8	17.9	27.8	22.1	43.7	20.7	34.6	19.9	7.2	39.5	34.1	33.7	10.9	10.3	30.3	54.6	80.6	38.4	20.4	22.8	36.9
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1462.0;Endometrial ciliated cells: 1049.4;Glandular and luminal cells: 1429.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.4;intermediate monocyte: 4.0;myeloid DC: 1.6;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	15	"dendritic cells: 1.6;granulocytes: 6.4;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 131.5;HDLM-2: 100.4;SuSa: 155.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 9.3"	HPA001562	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	176.1	82.8	14.2	63.3	17.7	45.3	97.6	16.5	18.7	106.2	17.1	66.6	21.0	108.6	9.3	128.4	122.6	135.0	113.7	14.4	20.2	98.1	139.9	116.0	20.8	21.1	16.7	40.2	67.2	48.8	45.0	66.3	17.2	116.3	60.0	16.2	33.1	24.1	30.7	154.9	45.6	313.0	15.4	24.4	104.8	3.9	18.8	84.5	181.1	30.0	3.1	281.2	55.2	25.0	21.1	1.2	40.7	8.7	3.9	10.4	131.5	14.7	11.9	12.5	29.8	27.7	15.5	0.4	6.5	0.9	68.0	11.6	24.6	4.0	20.5	100.4	24.6	1.6	11.6	10.0	72.9	9.0	22.7	18.3	65.3	34.9	80.4	2.4	2.6	23.9	10.0	77.0	1.9	2.8	27.5	5.9	29.2	11.5	9.2	8.1	27.1	18.4	1.8	3.0	18.3	18.4	19.1	34.2	59.0	155.0	19.9	6.5	2.4	3.6	19.5	12.3	6.7	60.4	27.9	7.4	11.9	4.8	10.8	6.4	0.7	0.0	0.3	4.0	0.3	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.2	0.0	6.3	0.8	0.0	0.7	14.2	17.7	16.5	18.7	14.4	20.2	21.1	16.7	17.2	15.4	18.8	25.0	568.2	423.1	146.5	1.6	55.3	202.8	866.2	236.1	1462.0	4.4	753.9	510.9	689.3	92.9	136.0	55.2	0.0	178.9	100.3	611.7	1.9	186.2	3.7	1049.4	318.2	176.2	889.6	2.7	2.6	122.7	330.8	452.6	966.9	1429.3	78.6	5.6	30.7	25.8	103.7	1.7	2.4	758.4	114.0	29.8	282.8	2.8	17.4	351.8	174.3	3.7	32.3	39.9	0.0	1.5	10.8	185.7	484.8	1.2	161.0	457.5	421.3	3.3	133.2	5.3	98.6	279.4	573.7	2.2	3.1	474.6	202.7	420.6	97.1	5.8	349.6	263.6
ATG12	"APG12, APG12L"	ENSG00000145782	"Autophagy related 12"	O94817	5	115828200-115841837	"Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013272, HPA068989"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB013272: AB_2533272, HPA068989: "	"unprognostic (2.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (5.11e-2)"	15.5	10.5	12.3	10.7	12.7	11.3	10.2	12.9	16.9	12.0	10.5	10.4	11.6	10.8	11.9	11.3	9.8	11.6	9.7	12.6	13.3	7.1	18.4	10.4	13.6	13.2	13.2	12.0	9.5	7.4	8.7	13.6	13.7	10.8	11.1	9.6	7.9	10.9	11.1	9.0	11.9	12.7	12.7	11.2	8.8	9.4	12.8	14.0	8.6	12.6	11.6	11.8	8.8	15.0	20.7	10.9	26.3	24.1	42.9	57.4	20.0	34.9	38.3	22.6	36.5	15.8	16.5	17.8	14.5	32.1	35.3	11.3	20.5	29.4	36.4	93.2	20.2	11.5	13.0	14.8	33.7	12.8	22.0	43.0	31.5	25.1	29.6	26.3	27.6	19.0	16.8	24.4	43.5	13.5	27.2	20.2	17.9	15.7	23.6	19.8	25.4	25.7	15.7	13.7	25.8	27.6	37.3	14.7	36.6	20.0	20.3	19.2	28.3	41.3	18.9	38.2	36.0	18.7	31.5	28.9	37.7	27.2	39.6	15.4	11.5	19.3	11.8	13.6	16.5	12.3	14.3	11.7	10.3	12.2	14.6	14.1	20.9	14.4	17.4	13.8	12.3	11.0	12.3	12.7	12.9	16.9	12.6	13.3	13.2	13.2	13.7	12.7	12.8	15.0	52.5	44.8	41.0	17.0	82.8	85.8	65.4	81.6	44.3	42.3	46.8	36.1	45.2	38.6	56.9	25.8	77.2	61.8	92.3	50.3	37.2	60.6	28.7	49.0	60.7	55.1	41.8	23.8	28.5	81.6	134.1	75.2	36.2	55.8	96.9	48.8	47.5	57.9	68.2	30.3	26.5	54.5	59.0	72.1	69.8	14.9	64.0	53.7	53.4	19.7	76.8	34.1	99.9	26.7	35.5	105.5	45.8	53.8	50.1	68.4	56.3	44.3	49.7	59.2	26.3	39.5	50.5	50.0	45.1	40.0	84.7	88.7	78.8	45.1	46.0	78.1
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311956-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 171.4;Extravillous trophoblasts: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		3900000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	24.8	26.0	19.8	31.7	23.4	26.4	33.9	21.4	23.5	22.2	18.8	36.4	32.0	30.0	20.3	19.4	29.4	20.4	21.3	19.6	21.5	32.7	34.6	18.0	44.9	20.5	21.5	32.0	26.2	29.6	18.6	37.3	23.3	28.7	47.5	19.1	18.8	38.4	43.2	23.8	27.2	37.0	21.0	27.6	24.5	20.1	22.9	41.8	22.5	25.4	51.8	29.1	17.6	27.5	102.2	133.8	85.1	144.0	112.5	113.2	40.6	105.4	91.9	117.4	134.9	278.6	157.3	149.6	122.8	110.0	164.5	106.7	187.8	157.0	169.5	113.4	189.3	179.1	108.7	271.5	145.4	226.1	92.0	98.4	119.8	154.7	188.5	82.0	79.7	144.5	237.0	124.4	166.3	178.7	203.4	112.1	330.3	167.4	84.9	185.8	117.3	133.4	126.4	146.5	129.3	87.8	84.3	103.1	124.3	189.2	169.7	82.9	70.2	96.0	101.2	127.3	65.8	160.3	195.7	300.1	85.6	124.5	146.8	12.6	16.4	0.4	34.6	23.5	59.1	56.6	49.0	53.8	36.3	39.9	50.0	46.9	1.8	55.4	21.1	31.7	50.2	29.0	19.8	23.4	21.4	23.5	19.6	21.5	20.5	21.5	23.3	21.0	22.9	27.5	7.2	12.8	19.3	18.6	34.7	15.0	28.2	55.0	30.7	10.0	18.2	16.1	21.1	28.6	33.3	23.9	4.2	171.4	23.3	17.6	27.4	45.2	1.1	20.7	28.2	6.1	19.2	32.2	15.4	49.3	166.3	25.3	22.4	20.8	25.3	32.9	5.3	22.2	52.4	10.1	15.4	33.8	26.4	14.4	10.8	1.7	23.9	20.2	30.2	2.8	26.1	21.3	26.8	16.6	25.7	32.4	28.5	34.3	36.3	24.0	18.8	52.7	27.3	14.7	26.3	19.2	29.0	3.3	43.8	24.6	8.5	95.4	29.8	40.7	58.4	18.1
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222832-108369102	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;NK-cells: 339.8;Oligodendrocytes: 217.6;Rod photoreceptor cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	6.2	7.4	8.2	17.5	15.0	16.2	8.5	17.0	12.3	8.7	16.1	6.7	5.2	10.0	9.9	4.0	7.5	8.2	7.0	7.3	11.3	5.8	7.8	7.6	33.7	15.8	13.1	15.8	14.8	9.3	12.1	8.0	17.0	6.3	7.0	20.6	11.4	6.1	4.4	7.5	12.6	6.9	10.3	22.2	8.6	5.2	12.7	18.2	8.8	6.0	25.9	7.1	6.9	28.8	4.3	6.8	14.8	7.6	20.2	29.1	3.1	10.9	13.5	6.4	11.3	7.1	10.3	18.3	14.0	10.2	9.6	7.7	11.6	10.8	9.0	12.3	5.7	15.2	8.7	10.2	10.5	16.4	17.0	18.3	6.3	10.0	21.2	15.2	14.1	16.5	12.4	9.9	14.3	3.4	10.6	18.5	9.8	8.6	7.4	9.7	9.7	24.9	8.1	7.5	9.0	10.5	11.1	4.7	20.6	13.2	9.3	10.1	23.7	15.8	8.4	7.3	9.0	6.2	7.0	78.3	7.0	19.0	18.8	21.3	5.5	4.0	16.5	5.7	11.1	11.6	11.7	12.5	2.6	13.0	21.1	20.4	9.9	9.7	13.3	6.2	6.1	5.3	8.2	15.0	17.0	12.3	7.3	11.3	15.8	13.1	17.0	10.3	12.7	28.8	23.7	38.5	20.8	62.7	146.4	12.6	17.5	21.1	28.5	111.0	19.6	14.2	39.9	12.8	19.5	22.0	210.6	16.9	140.2	4.2	5.9	9.9	19.2	14.4	52.1	25.9	20.4	39.1	70.2	12.3	13.2	39.0	12.8	20.9	13.3	45.9	32.9	23.3	29.1	60.6	82.8	14.9	26.4	96.4	34.0	5.1	39.4	69.2	26.6	178.9	63.2	27.3	339.8	85.5	217.6	7.6	7.6	27.8	96.5	9.1	8.9	11.1	16.0	200.1	26.3	41.4	29.2	31.5	37.4	15.8	12.4	4.2	147.7	52.3	11.5	10.2
ATMIN	"ASCIZ, KIAA0431, ZNF822"	ENSG00000166454	"ATM interactor"	O43313	16	81035842-81047350	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 180.6;Late spermatids: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054967, HPA066900"	Approved		Supported	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA054967: AB_2682654, HPA066900: AB_2685744"	"unprognostic (9.92e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-1)"	15.9	12.7	18.9	11.4	19.6	7.9	14.4	18.2	23.5	13.5	14.6	12.9	12.8	13.8	18.0	18.9	11.4	11.5	14.2	19.6	21.6	19.7	17.9	10.7	13.9	19.6	21.7	14.3	16.1	27.0	13.1	20.4	22.8	17.6	13.7	10.3	12.8	14.8	16.0	17.6	12.9	13.7	17.6	12.9	12.7	22.6	21.5	15.6	20.6	17.0	15.0	14.2	12.0	18.4	26.7	22.0	28.6	33.7	30.6	21.3	42.8	17.1	24.8	15.9	8.8	14.9	14.9	20.8	21.8	25.6	18.3	25.3	28.1	14.7	20.3	13.8	15.6	14.3	13.3	17.4	28.3	24.7	21.6	22.7	24.7	15.4	24.7	26.7	16.6	20.0	22.8	12.4	22.9	42.9	19.9	18.0	33.6	16.6	16.3	34.5	13.8	12.2	25.0	27.5	22.8	29.5	54.3	16.8	14.3	23.7	28.5	22.0	22.0	20.3	20.6	19.9	16.2	19.7	31.6	50.4	18.7	16.1	19.3	0.5	0.8	0.5	1.9	0.6	1.4	1.5	2.0	1.7	0.8	1.6	1.7	1.9	0.2	1.9	0.6	1.0	2.2	0.6	18.9	19.6	18.2	23.5	19.6	21.6	19.6	21.7	22.8	17.6	21.5	18.4	38.6	9.6	19.2	10.7	11.7	12.0	16.3	10.0	10.2	24.9	20.7	16.9	18.6	20.0	15.5	23.9	20.9	42.3	25.8	21.4	11.7	12.6	180.6	13.3	37.2	19.3	11.5	7.4	16.1	14.0	38.4	17.9	15.8	22.4	16.5	15.2	22.9	21.6	29.7	13.5	17.7	13.7	6.1	23.9	6.0	288.9	19.9	14.3	14.2	3.7	19.2	32.5	12.3	8.0	16.9	18.5	11.2	19.5	15.0	15.1	19.9	20.8	7.5	16.6	13.1	24.2	18.0	28.6	25.4	17.2	15.3	30.1	15.5	21.6	16.0	18.4
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Golgi apparatus"	"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	10.2	10.4	12.3	8.9	22.0	18.2	6.1	18.3	16.8	13.0	5.7	4.4	9.9	10.1	5.8	7.0	8.7	15.0	21.4	9.7	12.5	12.7	10.1	39.5	5.8	25.3	22.2	6.5	12.4	23.1	16.2	10.1	22.9	4.3	3.2	14.9	9.0	3.9	13.1	8.9	8.3	9.1	15.7	8.9	5.3	8.9	21.9	8.2	13.9	17.3	6.1	6.5	5.9	40.2	28.0	14.0	17.5	20.5	8.7	11.7	30.9	13.0	7.6	10.9	8.8	44.5	31.5	14.1	15.5	11.0	14.0	23.2	15.8	10.8	10.5	14.2	14.9	16.3	11.9	23.3	13.6	30.8	25.5	7.9	8.2	13.2	8.0	8.8	29.0	12.6	11.4	2.3	7.7	10.5	14.1	19.4	7.5	31.8	9.9	12.2	7.1	8.1	59.3	6.4	27.8	7.7	12.7	16.3	10.7	22.4	6.2	40.4	19.2	0.0	23.3	14.1	9.9	7.4	15.5	5.9	4.8	28.3	12.2	0.0	1.1	1.7	0.4	1.6	0.3	0.6	0.2	0.2	0.6	1.8	0.3	0.2	3.1	0.0	1.5	0.5	0.0	0.3	12.3	22.0	18.3	16.8	9.7	12.5	25.3	22.2	22.9	15.7	21.9	40.2	25.6	218.0	215.0	22.2	11.3	10.8	3.4	4.9	1.2	42.0	5.2	3.7	42.3	31.5	29.4	16.5	235.6	1.7	7.0	2.4	5.9	32.7	0.9	51.2	24.2	34.2	12.0	3.8	35.0	11.4	32.2	16.5	8.6	176.3	12.0	62.2	27.1	16.5	20.7	13.5	32.5	3.5	14.2	33.6	16.9	1.9	11.1	29.3	10.6	48.7	36.9	11.0	6.2	33.7	138.3	24.3	6.1	4.9	7.7	7.7	10.5	15.7	13.3	44.8	0.0	9.5	12.8	4.0	10.1	6.3	9.7	8.6	8.4	8.7	5.9	3.9
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.4;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 56.2;Club cells: 50.0;Intestinal goblet cells: 82.3;Oligodendrocyte precursor cells: 58.8;Respiratory ciliated cells: 78.2;Undifferentiated cells: 77.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 24.5;OE19: 44.4;RT4: 19.3;SK-BR-3: 33.0;T-47d: 11.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.0	0.0	1.4	2.4	1.4	11.0	2.5	0.5	1.3	6.4	0.5	30.1	27.3	1.0	0.1	4.7	6.8	4.6	0.0	1.3	1.1	1.8	0.1	10.5	0.0	1.0	0.9	0.0	0.7	3.3	1.0	0.9	1.0	12.5	37.4	0.9	19.6	0.2	0.1	26.0	20.3	0.6	0.6	0.4	5.9	0.4	1.1	0.0	8.9	0.0	0.5	4.0	4.6	0.8	6.2	0.4	0.9	0.1	0.0	0.0	6.4	0.2	0.0	0.0	0.0	5.8	5.2	0.0	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	44.4	0.1	0.0	0.0	0.2	0.0	19.3	4.9	0.0	0.0	33.0	0.2	0.9	11.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	1.4	0.5	1.3	1.3	1.1	1.0	0.9	1.0	0.6	1.1	0.8	0.0	32.1	56.2	4.2	0.0	0.6	14.3	39.9	0.6	1.3	20.8	3.2	0.8	5.7	50.0	0.0	0.0	2.0	0.1	44.4	0.0	9.0	3.2	26.8	2.5	0.7	34.2	0.0	8.3	2.5	2.4	0.5	22.4	28.0	8.9	0.0	0.0	0.1	0.3	0.0	1.8	82.3	8.2	0.0	1.2	1.9	0.0	0.6	1.8	1.0	0.0	1.9	0.0	58.8	2.4	4.7	29.2	0.0	0.0	13.8	10.2	1.8	78.2	5.2	0.0	0.1	1.8	0.8	1.0	1.5	1.1	24.1	0.9	0.2	77.1	9.9
ATP5F1A	"ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM"	ENSG00000152234	"ATP synthase F1 subunit alpha"	P25705	18	46080248-46104334	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1760.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 784.3;Distal tubular cells: 1173.9;Extravillous trophoblasts: 463.0;Proximal tubular cells: 939.6;Syncytiotrophoblasts: 578.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013067, HPA040622, HPA044202"	Enhanced		Supported	Mitochondria		NA	NA		8800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855"	"unprognostic (3.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (4.60e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.87e-3)"	251.3	453.6	198.6	177.7	209.2	210.5	260.4	233.0	251.4	195.5	401.9	414.0	438.9	192.6	225.6	362.6	227.2	146.3	1498.3	207.7	246.0	730.4	441.6	175.1	223.7	234.6	237.8	211.1	299.9	868.5	277.4	201.7	226.0	211.4	419.8	465.4	307.4	265.9	1602.0	290.3	335.0	233.0	205.4	226.8	419.1	167.6	226.7	277.3	261.4	1760.3	337.6	244.9	224.7	209.6	355.2	353.0	459.6	434.3	546.0	601.8	508.6	399.5	562.4	601.0	522.8	532.7	271.9	833.2	238.9	487.4	322.3	641.7	801.1	614.1	556.4	373.0	450.3	551.7	413.3	667.2	357.1	1182.7	501.6	559.2	422.3	434.6	448.2	481.3	630.4	442.5	454.0	477.2	521.8	367.6	612.8	579.7	432.3	344.5	367.6	596.5	533.8	1131.4	816.2	849.7	465.7	434.7	293.3	361.5	506.9	428.6	466.3	679.3	370.4	328.7	282.7	174.9	354.9	542.5	501.5	533.0	328.1	698.0	358.7	119.1	573.9	162.7	353.6	511.8	455.9	492.3	422.7	388.4	959.5	392.9	503.3	421.7	55.9	414.5	485.1	468.3	527.4	1339.1	198.6	209.2	233.0	251.4	207.7	246.0	234.6	237.8	226.0	205.4	226.7	209.6	79.2	169.9	167.8	0.0	49.9	0.0	0.0	0.0	0.0	0.0	205.7	169.8	0.0	0.0	100.3	171.0	0.0	784.3	86.3	0.0	1173.9	358.3	0.0	125.3	163.3	73.0	0.0	0.0	0.0	269.7	463.0	97.8	0.0	119.3	89.6	198.7	0.0	0.0	409.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	179.9	0.0	0.0	0.0	0.0	199.1	0.0	0.0	24.0	0.0	0.0	939.6	95.5	0.0	0.0	0.0	87.1	0.0	0.0	0.0	0.0	578.2	54.6	319.2	0.0	0.0
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56645984	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2590.4;tongue: 3205.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 821.1;Distal tubular cells: 1238.5;Extravillous trophoblasts: 592.7;Hofbauer cells: 608.9;Proximal tubular cells: 951.7;Syncytiotrophoblasts: 1138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria		NA	NA		19000000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavorable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	432.7	555.5	217.6	300.5	231.4	465.8	301.5	281.6	303.8	241.8	443.3	741.6	689.5	235.4	223.4	527.6	277.9	225.7	2011.6	233.0	307.1	945.9	609.3	253.4	294.6	264.2	242.9	200.2	301.7	1311.6	252.6	301.4	280.4	280.9	767.6	484.2	407.7	356.4	2590.4	398.6	575.5	332.5	230.9	272.5	494.9	236.0	277.5	390.9	342.8	3205.3	458.3	404.1	311.2	244.7	693.6	834.9	632.3	1003.6	578.3	596.7	1159.8	683.2	645.6	1179.1	663.9	1375.7	755.6	1236.3	723.0	863.5	482.9	906.1	1378.1	851.5	1039.4	579.9	987.5	1333.1	726.4	872.5	716.6	1509.7	912.9	755.1	843.3	918.0	1171.2	870.2	985.8	901.7	1246.3	1363.1	992.2	671.5	1134.4	941.3	1085.9	905.6	1637.6	1079.3	711.0	1603.5	1315.6	1196.7	737.5	658.2	1042.3	1481.3	1214.0	663.4	1404.1	1151.8	657.6	454.8	507.9	671.9	751.0	659.5	865.7	1254.8	684.7	1007.8	718.4	403.5	549.4	281.8	293.5	643.6	326.3	303.2	275.4	313.6	713.4	248.4	221.0	266.8	137.1	296.9	750.6	360.9	372.9	1077.1	217.6	231.4	281.6	303.8	233.0	307.1	264.2	242.9	280.4	230.9	277.5	244.7	172.3	134.6	173.2	0.0	48.6	0.0	0.0	0.0	0.0	0.0	176.8	149.1	0.0	0.0	81.1	277.7	0.0	821.1	141.5	0.0	1238.5	517.7	0.0	194.1	169.2	115.7	0.0	0.0	0.0	367.9	592.7	115.0	0.0	163.3	145.1	267.6	0.0	0.0	608.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.3	0.0	0.0	281.2	0.0	0.0	0.0	0.0	333.3	0.0	0.0	26.8	0.0	0.0	951.7	102.7	0.0	0.0	0.0	151.1	0.0	0.0	0.0	0.0	1138.6	77.4	518.4	0.0	0.0
ATP5MG	"ATP5JG, ATP5L"	ENSG00000167283	"ATP synthase membrane subunit g"	O75964	11	118401606-118431496	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1407.2;Distal tubular cells: 2907.4;Hofbauer cells: 1367.3;Proximal tubular cells: 2520.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044629	Approved		Supported	Mitochondria		NA	NA		44000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA044629: AB_2679028"	"unprognostic (1.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.41e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (6.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.05e-2)"	119.8	137.2	154.2	103.3	158.5	165.6	132.5	158.5	184.3	81.1	168.3	153.6	146.4	79.3	143.3	116.9	96.5	68.1	329.8	157.2	160.8	205.1	154.5	77.9	150.0	155.5	153.1	112.0	110.9	140.7	49.5	83.7	154.0	83.5	164.3	100.8	133.9	92.2	340.7	55.3	118.2	95.2	153.6	86.0	112.3	46.9	155.5	204.1	87.5	373.6	183.1	105.3	41.5	154.7	163.1	87.9	209.3	183.1	167.6	198.0	200.1	149.0	175.9	138.4	146.6	259.9	259.9	314.3	352.7	167.5	206.2	190.4	204.4	214.8	155.3	247.6	138.0	472.8	112.5	197.4	175.3	279.3	210.2	207.1	203.4	169.0	162.9	164.1	189.8	216.6	227.4	253.1	199.5	305.8	365.2	497.3	130.1	427.9	224.0	247.0	174.9	422.9	371.1	260.3	184.3	161.9	232.3	361.1	161.9	221.6	303.0	307.7	172.8	123.0	144.7	109.2	190.9	112.8	184.8	402.1	93.8	353.0	154.7	325.4	437.2	299.0	241.8	360.8	339.7	462.7	398.8	321.5	481.2	378.5	472.9	379.7	214.8	357.2	333.3	534.3	464.5	1112.1	154.2	158.5	158.5	184.3	157.2	160.8	155.5	153.1	154.0	153.6	155.5	154.7	324.3	362.2	364.1	0.0	211.2	0.0	0.0	0.0	0.0	0.0	893.9	1061.2	0.0	0.0	166.5	610.6	0.0	1407.2	378.3	0.0	2907.4	748.6	0.0	449.8	327.9	188.9	0.0	0.0	0.0	986.0	935.6	204.7	0.0	404.6	258.6	368.2	0.0	0.0	1367.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	427.7	0.0	0.0	678.1	0.0	0.0	0.0	0.0	922.2	0.0	0.0	94.9	0.0	0.0	2520.3	188.0	0.0	0.0	0.0	217.5	0.0	0.0	0.0	0.0	1001.4	224.2	370.0	0.0	0.0
ATP5MGL	"ATP5K2, ATP5L2, dJ222E13.5"	ENSG00000249222	"ATP synthase membrane subunit g like"	Q7Z4Y8	22	42639803-42640601	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;brain: 2.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 11.6;Distal tubular cells: 5.9;Extravillous trophoblasts: 7.7;Hofbauer cells: 11.2;Syncytiotrophoblasts: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044629	Uncertain		Uncertain	Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA044629: AB_2679028"	"unprognostic (4.53e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-3)"	0.1	0.0	0.7	0.0	0.5	1.4	0.0	2.7	1.1	0.0	0.8	0.0	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.6	1.0	0.1	0.0	0.1	0.3	1.3	0.6	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.3	0.0	0.1	0.9	0.1	0.0	0.3	0.1	0.2	0.1	1.3	0.0	0.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.9	0.1	0.2	0.2	0.1	0.3	0.7	0.5	2.7	1.1	0.6	1.0	1.3	0.6	0.7	0.3	1.3	1.6	1.1	0.0	2.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	1.8	0.0	11.6	0.7	0.0	5.9	0.6	0.0	0.8	0.8	0.9	0.0	0.0	0.0	1.1	7.7	1.0	0.0	1.3	2.5	1.2	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.6	0.8	1.2	0.0	0.0
ATP5PB	ATP5F1	ENSG00000116459	"ATP synthase peripheral stalk-membrane subunit b"	P24539	1	111448864-111462773	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.8;tongue: 131.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 346.5;Distal tubular cells: 461.8;Extravillous trophoblasts: 405.2;Hofbauer cells: 373.0;Proximal tubular cells: 434.6;Syncytiotrophoblasts: 347.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046067, HPA057347"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA046067: AB_10960850, HPA057347: AB_2683416"	"unprognostic (4.18e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.18e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.26e-9)"	"prognostic favorable (8.07e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	19.3	15.7	10.3	11.5	12.5	15.3	18.8	14.5	27.4	17.4	3.9	51.6	28.8	16.6	16.0	26.8	23.9	16.3	109.0	12.1	10.2	40.3	40.2	13.7	24.0	13.4	12.0	19.2	18.5	33.8	7.1	21.6	14.9	22.3	33.6	28.5	29.8	18.7	135.8	15.7	19.0	17.9	9.6	15.2	22.6	15.5	12.8	15.7	31.1	131.0	22.4	21.9	7.4	14.1	55.6	17.6	44.1	36.9	35.6	34.2	34.1	57.0	68.9	67.3	54.7	31.8	29.1	84.9	52.3	45.5	14.3	56.1	69.4	79.5	65.1	61.9	33.2	76.1	21.3	21.5	26.0	98.3	70.8	30.3	40.9	69.3	66.9	17.7	60.0	11.9	78.7	33.6	46.3	35.4	153.3	30.0	34.9	19.2	90.5	41.2	143.6	34.0	54.7	26.0	37.2	13.4	49.4	72.7	55.6	12.6	54.8	46.0	50.6	32.0	49.1	59.4	61.2	41.8	44.5	172.1	70.8	77.6	60.8	3.5	15.4	7.1	14.8	10.0	12.2	12.9	15.1	13.3	16.1	15.2	16.9	10.4	4.8	9.8	9.0	9.2	15.1	44.2	10.3	12.5	14.5	27.4	12.1	10.2	13.4	12.0	14.9	9.6	12.8	14.1	73.2	67.3	83.8	0.0	31.5	0.0	0.0	0.0	0.0	0.0	112.9	155.3	0.0	0.0	57.6	125.0	0.0	346.5	56.4	0.0	461.8	237.3	0.0	132.5	111.0	58.8	0.0	0.0	0.0	196.7	405.2	57.0	0.0	125.4	89.6	82.1	0.0	0.0	373.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.8	0.0	0.0	98.8	0.0	0.0	0.0	0.0	162.6	0.0	0.0	9.8	0.0	0.0	434.6	74.3	0.0	0.0	0.0	58.0	0.0	0.0	0.0	0.0	347.7	41.8	208.0	0.0	0.0
ATP5PF	"ATP5, ATP5A, ATP5J, ATPM, CF6"	ENSG00000154723	"ATP synthase peripheral stalk subunit F6"	P18859	21	25716503-25735673	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1595.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 2375.2;Proximal tubular cells: 1906.2;Syncytiotrophoblasts: 708.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031069	Supported		Supported	Mitochondria		NA	NA		820000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA031069: AB_10603676"	"unprognostic (3.52e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.83e-2)"	"prognostic favorable (2.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-2)"	274.6	276.3	291.2	136.4	295.4	175.1	205.5	302.5	424.4	156.3	316.1	333.5	276.4	128.8	368.1	258.1	129.9	129.7	1052.1	295.2	306.2	489.5	756.3	110.8	166.4	299.3	297.8	127.2	188.2	458.8	140.4	171.5	295.7	160.1	314.4	249.5	214.6	228.5	1161.7	113.6	250.6	189.8	298.7	111.2	226.9	131.5	299.4	217.5	166.0	1595.8	210.9	194.9	138.4	299.6	355.9	260.0	314.5	351.4	344.8	313.5	389.4	305.8	373.0	305.8	300.8	607.6	274.4	439.3	194.2	312.9	467.8	191.5	441.3	379.2	339.2	373.1	441.1	910.6	520.6	618.4	386.8	673.2	284.5	303.1	471.2	284.0	258.6	399.9	363.0	412.2	582.2	522.9	458.2	416.3	468.6	683.2	562.3	824.0	460.7	358.0	606.5	840.0	669.8	504.6	360.2	394.1	516.5	521.7	493.0	449.4	376.5	590.5	260.6	219.6	266.6	209.3	265.9	501.7	954.7	568.2	341.5	707.8	283.1	444.8	447.0	443.7	293.3	487.1	316.1	475.1	385.5	368.6	531.9	399.7	377.4	370.7	292.3	389.9	505.7	504.0	520.3	661.3	291.2	295.4	302.5	424.4	295.2	306.2	299.3	297.8	295.7	298.7	299.4	299.6	532.1	169.9	179.3	0.0	56.0	0.0	0.0	0.0	0.0	0.0	346.3	468.4	0.0	0.0	105.9	419.3	0.0	652.7	116.4	0.0	2375.2	447.0	0.0	299.2	257.6	150.6	0.0	0.0	0.0	472.5	522.8	135.6	0.0	308.5	109.7	341.2	0.0	0.0	522.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.2	0.0	0.0	226.4	0.0	0.0	0.0	0.0	427.1	0.0	0.0	21.4	0.0	0.0	1906.2	142.1	0.0	0.0	0.0	161.4	0.0	0.0	0.0	0.0	708.2	79.2	387.8	0.0	0.0
ATP5PO	"ATP5O, ATPO, OSCP"	ENSG00000241837	"ATP synthase peripheral stalk subunit OSCP"	P48047	21	33903453-33915814	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1601.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 610.3;Distal tubular cells: 1794.2;Extravillous trophoblasts: 623.2;Hofbauer cells: 627.0;Proximal tubular cells: 1236.8;Syncytiotrophoblasts: 542.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB016209, HPA041394"	Enhanced		Approved	Mitochondria		NA	NA		150000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB016209: AB_631361, HPA041394: AB_2677450"	"unprognostic (2.08e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.89e-3)"	213.0	181.0	282.7	147.9	289.4	310.6	280.4	306.0	417.7	204.8	325.2	351.9	357.2	169.2	251.1	288.3	216.7	157.9	1114.5	291.2	317.4	458.0	401.8	148.9	243.3	298.2	290.8	273.1	196.7	432.9	108.0	192.2	296.5	158.0	391.9	219.4	236.3	202.0	1063.7	188.4	293.8	217.4	290.9	143.4	304.2	150.3	291.4	281.7	224.4	1601.7	292.9	242.3	161.6	292.4	398.4	187.3	491.1	486.6	340.0	435.1	554.6	218.5	394.4	371.4	361.9	553.5	372.7	531.5	187.2	345.1	355.2	217.5	549.0	764.7	440.6	400.0	544.0	790.3	260.4	513.5	389.7	603.7	260.9	445.8	467.9	358.4	581.9	407.0	522.8	421.2	656.3	665.9	488.5	402.5	461.6	593.0	561.3	992.2	540.1	471.6	490.1	1007.5	1032.8	337.0	404.4	232.1	380.2	559.7	525.7	425.6	562.9	660.5	291.0	236.8	280.6	423.0	252.6	429.1	524.2	559.7	438.2	1046.2	349.3	329.7	561.5	407.8	335.9	596.2	400.9	575.4	439.5	404.8	753.0	487.3	540.9	459.4	136.2	412.6	539.8	445.4	585.3	1077.9	282.7	289.4	306.0	417.7	291.2	317.4	298.2	290.8	296.5	290.9	291.4	292.4	195.8	243.6	191.1	0.0	82.1	0.0	0.0	0.0	0.0	0.0	282.6	476.1	0.0	0.0	121.3	222.5	0.0	610.3	81.3	0.0	1794.2	394.5	0.0	133.0	140.9	87.3	0.0	0.0	0.0	420.2	623.2	109.7	0.0	114.8	114.8	198.9	0.0	0.0	627.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	131.2	0.0	0.0	218.1	0.0	0.0	0.0	0.0	331.9	0.0	0.0	17.8	0.0	0.0	1236.8	102.0	0.0	0.0	0.0	119.0	0.0	0.0	0.0	0.0	542.1	67.4	208.9	0.0	0.0
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522582	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 130.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 294.0;Rod photoreceptor cells: 403.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	17.7	28.2	30.6	18.0	35.2	21.5	16.3	16.8	42.7	13.4	0.0	22.1	34.6	20.9	19.6	17.4	17.1	22.7	18.9	43.6	44.1	37.4	21.0	24.1	13.1	25.6	26.2	20.0	17.4	86.0	39.0	21.2	34.6	17.4	20.5	130.7	13.5	18.6	59.3	28.1	24.3	21.5	12.1	21.8	16.3	18.7	30.9	15.2	30.3	25.3	14.9	11.9	12.8	27.2	18.4	37.0	22.1	40.1	36.5	31.7	12.9	12.7	23.3	26.4	34.2	23.9	39.9	3.4	22.6	26.2	36.2	38.7	34.5	21.5	30.4	28.3	36.2	29.2	27.3	19.0	22.7	12.8	50.9	23.5	30.3	42.4	18.0	32.6	18.9	13.2	108.0	111.3	39.7	15.8	5.1	11.3	14.3	23.9	0.4	0.2	23.0	51.2	30.2	14.4	60.9	32.0	19.7	17.7	37.1	28.8	43.0	19.0	11.4	22.3	0.9	33.0	15.3	45.0	66.1	6.8	29.7	0.2	26.5	21.6	14.5	11.2	1.0	4.4	1.6	4.7	0.7	0.2	12.2	7.3	1.2	0.9	18.7	0.1	3.3	6.2	3.7	6.6	30.6	35.2	16.8	42.7	43.6	44.1	25.6	26.2	34.6	12.1	30.9	27.2	20.0	19.2	48.0	47.0	23.0	19.8	56.7	15.7	32.5	164.8	15.7	16.5	21.1	28.6	18.3	14.7	294.0	34.3	16.7	46.2	11.7	16.3	4.0	32.8	27.4	22.2	84.9	45.8	125.0	18.5	15.7	31.0	23.4	74.0	24.1	74.5	16.4	37.8	53.8	95.9	112.3	27.3	12.2	37.8	29.2	3.9	17.4	42.8	40.9	38.4	17.7	59.3	3.1	61.3	80.5	24.2	37.6	23.7	13.8	32.7	56.9	32.5	11.4	403.4	6.6	39.4	32.3	38.8	18.2	21.7	20.2	99.9	6.9	35.0	24.5	14.9
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747033-113812056	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 463.7;Late spermatids: 870.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 79.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	18.1	32.2	40.1	21.6	46.4	16.6	24.5	14.7	53.0	25.3	62.4	22.1	18.5	14.2	15.1	22.7	19.0	20.9	9.0	47.5	58.5	92.7	36.4	24.5	25.1	39.6	23.0	11.3	20.9	60.1	17.1	24.5	39.0	20.9	22.5	58.7	37.5	14.9	7.9	25.0	15.9	15.8	16.9	26.5	22.1	18.1	28.4	22.9	40.8	11.0	28.0	19.6	14.2	21.9	61.7	27.4	33.9	29.7	70.0	30.9	36.0	32.7	49.4	33.7	46.1	52.4	48.3	50.4	75.5	48.0	37.3	39.1	77.5	43.2	43.8	23.1	21.4	44.8	39.3	40.6	57.6	33.2	50.0	42.0	29.1	43.7	30.2	52.0	55.7	25.1	52.0	37.0	50.5	40.5	24.4	14.9	42.8	42.9	34.3	20.8	24.6	57.4	92.5	58.0	65.4	24.1	57.3	38.6	44.9	46.4	58.5	26.6	51.4	31.1	23.1	21.7	19.8	38.4	44.5	46.2	61.1	41.2	35.3	26.8	37.0	12.8	6.3	27.7	5.9	8.2	5.6	6.0	38.8	6.8	5.4	6.2	79.2	9.2	23.9	10.8	8.1	16.7	40.1	46.4	14.7	53.0	47.5	58.5	39.6	23.0	39.0	16.9	28.4	21.9	18.8	28.9	35.0	43.4	24.2	30.3	15.9	30.3	23.9	94.1	27.9	17.1	10.4	31.5	32.9	99.3	41.7	22.0	20.8	38.3	82.2	29.5	463.7	41.7	24.5	26.8	55.8	49.6	119.4	27.5	22.6	17.9	20.9	100.6	10.8	19.4	36.0	74.3	74.3	101.0	107.7	25.4	197.4	104.7	73.3	870.3	18.0	70.9	46.2	34.7	82.8	45.6	11.3	54.3	53.2	27.1	30.5	23.0	23.6	25.6	24.1	80.8	38.3	44.4	6.6	15.3	21.6	28.7	15.7	40.8	47.9	43.9	19.0	25.8	27.2	26.8
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935900-70965431	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 127.4;salivary gland: 139.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	2.2	0.5	0.5	0.2	0.3	0.0	11.8	0.7	0.9	31.1	0.0	0.6	0.5	1.4	1.2	1.6	12.8	0.2	1.1	0.2	0.0	127.4	0.2	1.7	0.5	0.1	0.0	1.2	3.3	0.8	4.2	17.9	0.1	2.0	0.1	3.9	139.8	1.4	0.5	32.5	0.6	0.8	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.2	0.0	0.6	0.8	0.3	0.4	0.3	0.6	1.3	2.6	3.1	21.6	0.4	0.2	0.0	0.0	0.1	2.0	0.1	0.2	1.2	0.0	20.3	0.7	0.0	0.0	0.5	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.3	3.1	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.3	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.2	0.5	1.5	0.7	49.2	0.1	2.7	0.6	0.0	0.4	0.6	0.2	0.9	0.5	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.7	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	3.2	0.0	0.3	0.0	0.1	1.3	1.7	0.0	0.9	5.6	3.7	0.4	0.0	13.9	0.0	8.4	197.3	0.1	0.6	49.0	0.1	1.5	0.0	0.1	1.1	0.0	0.0	1.0	0.6	38.3	3.8	0.0	0.1	0.0	0.0	0.0	0.1	11.7	1.7	0.4	0.0	321.4	0.0	0.3	0.1	0.0	0.1	30.2	0.0	0.0	0.5	1.0	1.0	0.1	0.4	0.0	1.2	0.0	0.6	0.3	0.2	2.6	3.8	0.0	1.1	1.0	0.4	1.2	0.0	0.4	64.9	0.1	0.1	0.1	0.6
ATP6V1D	"ATP6M, VATD, VMA8"	ENSG00000100554	"ATPase H+ transporting V1 subunit D"	Q9Y5K8	14	67294371-67360265	"Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 365.9;Proximal tubular cells: 365.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031515, HPA057316"	Enhanced		Approved	Nucleoplasm		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA031515: AB_10600785, HPA057316: AB_2683409"	"unprognostic (1.10e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.60e-13)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.44e-2)"	43.4	116.2	98.0	32.2	103.2	28.8	43.8	91.8	119.7	40.3	101.8	52.9	40.4	34.3	72.5	96.7	48.1	38.7	136.6	107.2	103.5	129.8	51.7	37.5	33.3	96.1	98.4	26.1	36.2	88.8	65.8	43.4	106.7	55.7	57.5	78.0	45.1	49.8	78.5	40.4	41.7	46.4	95.1	24.3	43.8	42.5	99.7	52.4	89.5	108.5	46.3	54.5	54.1	99.6	242.5	64.7	96.2	62.4	80.2	82.8	73.5	199.1	109.4	145.8	109.1	76.2	85.2	24.8	73.9	155.1	105.3	89.2	72.6	117.9	195.7	82.5	50.8	23.4	74.5	51.0	144.0	24.9	64.8	65.1	77.7	105.4	73.1	131.4	97.6	58.6	50.2	55.3	206.6	78.5	66.5	46.2	60.7	104.6	83.3	48.8	84.2	32.8	171.2	104.3	120.2	49.8	122.9	65.4	145.6	96.2	98.3	53.4	123.8	162.4	121.6	77.6	120.1	55.8	46.1	33.4	150.2	44.1	96.1	106.7	77.5	92.8	48.5	78.8	40.8	39.9	53.2	52.7	83.4	42.0	41.6	41.7	94.0	48.9	83.5	73.9	78.8	65.0	98.0	103.2	91.8	119.7	107.2	103.5	96.1	98.4	106.7	95.1	99.7	99.6	31.3	54.5	63.0	13.4	27.6	96.2	66.6	112.3	26.2	60.0	44.8	41.8	160.8	55.8	85.0	82.8	54.2	92.3	51.4	91.6	365.9	125.9	190.3	120.8	44.1	40.7	54.4	78.1	22.7	48.9	85.5	51.5	42.3	71.8	41.2	39.8	27.5	45.8	132.0	87.5	21.0	49.4	175.0	44.6	61.0	97.9	32.9	62.2	80.0	6.5	58.5	89.4	47.4	9.5	22.1	121.5	78.7	50.8	21.3	65.9	80.9	365.5	184.1	94.2	13.1	44.5	64.1	100.1	61.5	78.4	138.4	205.9	40.8	71.6	40.6	113.8
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587706-114598915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		96000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	79.5	140.2	70.5	80.5	71.1	131.4	108.4	74.0	101.1	85.0	85.0	70.5	59.4	92.4	177.3	132.5	71.3	64.6	93.0	72.1	79.4	138.1	125.9	84.9	115.4	75.4	79.1	106.2	72.5	172.9	135.1	91.2	80.2	132.7	65.5	91.2	111.9	55.1	124.0	98.1	69.2	60.6	71.5	93.9	121.1	75.4	75.6	104.2	99.2	113.0	100.8	106.8	94.0	75.4	83.6	71.0	153.2	38.8	111.0	84.5	148.3	125.2	86.6	88.5	63.4	92.3	94.8	74.2	106.8	80.0	183.2	179.0	105.6	84.6	79.3	63.2	73.8	72.3	84.4	143.4	156.8	173.1	135.1	105.2	227.9	72.7	87.3	104.1	91.0	123.1	136.0	164.4	131.6	159.0	164.6	113.6	187.0	222.2	126.8	159.0	95.0	126.7	195.2	128.4	113.8	156.3	159.7	284.0	487.6	143.9	235.0	202.5	118.9	80.1	68.9	132.3	142.0	213.6	474.5	139.6	106.8	97.2	112.0	490.1	327.8	495.0	212.6	331.2	264.9	549.6	288.8	255.8	255.0	501.7	374.7	305.5	405.4	255.4	348.4	401.5	398.9	756.7	70.5	71.1	74.0	101.1	72.1	79.4	75.4	79.1	80.2	71.5	75.6	75.4	230.6	160.3	176.6	19.6	353.9	519.0	492.9	1068.9	277.7	170.5	470.4	494.1	151.6	163.0	629.7	331.1	41.7	346.1	268.2	198.5	970.5	374.1	85.7	381.6	223.8	227.7	360.7	157.6	35.0	263.6	336.5	247.0	231.4	594.9	267.4	156.8	219.2	337.1	548.1	164.9	37.4	346.8	1133.2	350.1	517.8	60.3	306.0	382.4	494.5	20.6	699.7	360.9	261.6	20.1	22.9	430.5	218.1	250.9	255.0	686.5	176.7	1021.5	426.3	158.6	236.7	155.6	393.0	400.6	326.7	361.4	576.7	757.4	304.0	280.3	201.6	852.2
ATP6V1H	"CGI-11, SFD, SFDalpha, SFDbeta, VMA13"	ENSG00000047249	"ATPase H+ transporting V1 subunit H"	Q9UI12	8	53715543-53843558	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009532, HPA023421"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		8300	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB009532: AB_667834, HPA023421: AB_1845202"	"unprognostic (1.67e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.30e-2)"	"prognostic favorable (1.46e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	24.1	44.6	42.5	15.9	46.7	25.6	26.0	27.5	58.8	23.9	30.2	31.6	12.9	25.4	32.9	34.1	22.6	20.7	31.2	57.4	38.0	60.5	19.1	24.2	21.4	30.5	30.2	24.1	17.4	47.7	42.4	23.9	32.7	30.2	20.4	37.4	28.7	27.4	37.8	35.2	19.1	24.1	29.4	20.3	31.8	18.5	31.0	26.6	52.4	27.3	22.0	28.5	26.4	37.9	42.8	35.6	29.8	31.8	50.9	32.9	23.4	40.5	44.5	54.8	56.7	33.5	54.1	27.2	38.7	40.9	69.7	67.8	52.6	58.9	56.1	39.9	35.8	28.8	34.3	40.9	69.1	19.6	31.8	46.5	82.3	37.2	66.4	52.5	37.8	28.9	39.4	14.0	81.6	36.0	30.6	32.5	27.4	37.0	17.4	28.2	10.6	18.6	88.4	67.4	23.5	34.9	28.7	54.6	79.5	34.4	64.0	16.3	43.2	24.4	19.7	54.6	25.5	25.9	30.4	32.3	57.8	27.4	27.5	25.7	14.8	36.2	13.2	16.6	14.9	13.6	14.3	15.4	20.2	12.0	14.4	16.0	14.5	22.6	23.4	15.9	20.7	11.8	42.5	46.7	27.5	58.8	57.4	38.0	30.5	30.2	32.7	29.4	31.0	37.9	18.2	38.5	27.4	84.2	39.0	29.6	40.1	55.5	42.1	72.8	27.8	21.0	28.9	38.6	50.3	58.8	112.6	76.0	35.9	39.0	105.7	49.1	8.3	94.1	27.7	25.4	35.3	27.0	154.7	31.1	43.6	23.6	26.0	145.7	15.8	22.0	28.9	21.9	64.7	62.2	105.8	17.4	75.3	43.0	103.6	8.5	43.2	52.9	30.2	42.2	35.1	48.4	37.0	58.3	57.7	44.1	30.1	48.2	20.9	32.5	31.4	64.9	39.6	76.4	19.7	16.8	24.6	28.5	52.9	37.6	31.4	100.0	38.1	36.4	21.8	41.4
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA009137: AB_2668214, HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.6	0.9	1.3	0.6	1.2	2.2	1.7	2.0	2.1	1.8	0.8	2.9	10.6	1.5	0.1	0.7	2.0	7.0	2.1	2.5	1.4	2.2	8.6	1.4	0.3	0.8	1.2	1.9	2.0	6.4	1.2	7.1	1.1	2.0	2.7	3.7	3.0	0.9	1.1	1.0	6.0	1.7	0.5	0.4	4.4	8.4	1.7	0.7	1.2	1.8	0.2	1.6	1.2	0.7	0.8	2.8	5.2	4.5	1.0	0.8	32.8	1.5	0.5	1.6	1.2	21.1	0.1	0.1	0.6	2.7	3.6	0.3	4.0	4.4	1.0	0.4	7.5	53.0	0.5	14.7	1.4	0.6	11.8	1.9	4.7	0.2	2.0	2.1	3.7	3.7	14.4	0.2	1.5	1.0	0.2	0.9	1.7	6.6	1.8	2.0	1.4	0.0	22.5	3.4	3.3	2.2	1.9	2.8	1.8	5.5	8.0	0.5	2.0	0.3	1.7	2.8	0.6	0.6	0.7	0.2	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.0	2.1	2.5	1.4	0.8	1.2	1.1	0.5	1.7	0.7	5.4	6.4	0.0	10.7	0.9	0.4	0.7	1.7	0.0	3.1	2.3	1.8	2.1	4.3	5.2	1.8	22.9	14.3	1.8	6.6	0.0	1.6	30.2	2.4	1.3	2.7	2.4	4.2	24.5	1.0	5.5	2.1	9.2	4.2	0.0	13.3	3.9	23.6	2.3	0.0	25.4	3.4	4.1	0.8	0.3	74.2	2.1	0.2	1.8	15.0	0.2	0.2	0.0	12.1	4.3	2.0	3.0	0.7	0.2	1.3	11.4	2.2	4.3	6.1	6.6	1.0	1.4	2.2	1.7	0.7	0.4	4.5	0.2	0.4	5.0	1.2
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1218.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Region enhanced"	"Detected in all"		"white matter: 84.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	2.8	8.9	5.8	9.5	26.7	23.4	3.7	3.6	18.3	2.1	0.0	12.8	4.2	2.4	12.2	2.2	2.4	2.5	8.4	14.5	11.7	3.8	1.7	11.8	15.0	9.5	4.4	16.2	7.0	36.0	2.2	2.4	9.5	8.3	11.7	19.4	4.4	5.3	10.0	1.7	8.9	2.8	18.1	9.0	12.5	2.1	9.5	9.9	39.7	15.6	11.8	2.5	1.5	84.5	0.0	0.1	0.4	27.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	0.4	46.3	12.6	0.2	0.0	2.4	6.5	0.1	0.0	7.4	4.5	16.4	1.6	0.7	0.1	4.0	0.3	0.4	0.0	0.0	0.0	0.6	0.2	10.3	0.0	5.1	0.0	2.0	6.0	1.4	2.0	1.9	0.6	16.1	0.0	5.3	9.5	0.6	4.9	14.8	0.3	9.4	0.0	1.1	3.1	0.0	0.4	0.0	2.0	0.5	0.0	1.7	0.0	9.4	0.7	5.6	0.2	0.0	0.6	0.6	3.7	0.2	1.9	1.5	1.1	4.1	0.6	2.5	1.7	4.4	0.5	2.2	2.5	2.4	1.0	0.6	5.8	26.7	3.6	18.3	14.5	11.7	9.5	4.4	9.5	18.1	9.5	84.5	26.1	28.9	80.1	136.1	23.3	1.5	1.8	0.6	2.2	19.7	4.0	1.5	14.4	0.0	5.3	5.5	81.3	0.0	52.9	48.4	3.9	0.2	4.6	1.3	1.3	13.6	84.6	13.9	295.9	2.5	0.1	4.8	19.9	4.2	8.2	26.5	16.8	1.1	1.6	62.2	255.9	28.6	0.0	8.8	4.6	2.9	3.4	8.9	3.6	31.9	5.1	2.2	33.0	144.8	1218.1	0.6	10.2	1.9	37.6	9.6	45.6	2.0	0.3	38.1	0.0	6.3	2.7	1.5	3.6	5.0	1.4	0.0	51.6	8.6	25.0	3.0
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 90.2;RT4: 168.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	9.1	5.4	1.3	8.5	2.0	1.2	9.5	3.6	3.9	16.3	3.0	76.2	30.3	5.9	3.5	14.8	10.6	18.0	4.4	1.7	1.1	6.6	7.7	8.3	2.2	2.1	1.1	2.1	23.3	9.7	2.7	6.9	2.0	17.6	61.7	0.6	20.6	11.5	1.9	8.4	38.2	8.3	1.0	4.6	46.1	0.6	1.9	1.5	22.0	1.8	3.6	30.0	13.0	3.0	32.0	10.7	0.1	0.6	10.5	19.2	11.9	62.6	63.6	67.4	40.4	8.0	24.3	1.5	19.3	90.2	22.3	44.9	0.2	13.9	64.3	0.2	1.1	0.2	2.6	2.5	2.2	0.4	0.6	2.9	12.6	20.8	34.0	39.5	33.0	0.3	0.3	0.7	34.1	15.6	0.1	0.3	0.3	35.5	3.3	0.3	0.2	0.0	7.9	168.1	0.8	0.7	1.3	32.5	0.1	0.5	10.3	0.6	35.3	48.3	2.0	7.7	14.2	0.4	0.4	0.5	1.1	0.4	2.8	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.0	0.2	0.1	0.0	0.0	1.3	2.0	3.6	3.9	1.7	1.1	2.1	1.1	2.0	1.0	1.9	3.0	25.9	19.2	27.0	11.1	4.1	7.8	66.7	20.6	10.2	0.7	28.4	10.4	5.4	27.1	48.9	40.5	0.0	25.6	0.6	279.7	0.0	27.0	2.8	26.3	4.0	30.8	68.4	0.4	61.2	53.1	2.7	7.1	98.4	40.1	4.5	0.9	33.2	19.1	2.4	6.7	11.7	180.5	22.4	2.8	4.0	0.4	0.3	1.0	7.2	37.5	0.9	0.1	0.0	20.6	10.7	38.5	116.7	0.0	0.9	70.8	58.2	0.2	44.7	1.2	13.1	2.8	20.7	0.3	1.5	28.0	16.3	10.9	1.7	2.3	185.7	119.2
ATPAF2	"ATP12, Atp12p, LP3663, MGC29736"	ENSG00000171953	"ATP synthase mitochondrial F1 complex assembly factor 2"	Q8N5M1	17	17977409-18039209	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 104.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023329, HPA059422"	Supported		Enhanced	Cytosol		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA023329: AB_1845209, HPA059422: AB_2684011"	"unprognostic (3.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.70e-3)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.00e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.15e-1)"	"unprognostic (2.62e-2)"	8.6	18.5	7.4	8.6	7.6	15.9	8.7	8.3	11.1	8.4	8.3	11.1	8.7	6.8	8.7	14.4	8.1	4.9	23.9	7.5	9.1	16.1	19.7	7.8	10.5	7.9	8.1	7.3	9.8	26.3	9.3	7.7	8.4	9.1	10.4	6.4	10.7	6.6	24.7	14.6	10.2	8.4	7.8	10.4	12.0	10.9	7.8	10.8	10.6	27.8	14.5	9.1	9.5	8.4	13.0	24.1	15.4	14.7	15.1	16.2	15.6	11.2	16.4	23.7	20.1	31.8	19.3	26.0	24.6	19.5	13.1	19.9	14.8	24.1	20.7	20.9	11.7	5.8	14.8	18.6	25.5	8.2	17.3	19.5	16.8	21.4	11.9	16.7	27.4	21.3	9.3	8.9	13.1	26.8	19.4	12.8	10.4	48.3	13.3	19.8	27.1	29.9	19.0	11.4	9.9	13.5	14.9	7.6	14.0	104.2	24.4	16.2	11.6	6.0	12.4	22.2	10.9	6.2	8.4	9.6	10.7	11.9	31.4	7.8	41.5	14.7	9.3	28.6	10.4	27.9	6.9	8.9	49.2	19.7	10.7	8.0	3.0	8.9	22.3	41.6	12.9	20.7	7.4	7.6	8.3	11.1	7.5	9.1	7.9	8.1	8.4	7.8	7.8	8.4	8.8	6.4	7.8	9.4	20.3	15.3	12.0	23.7	9.6	10.5	13.9	10.8	28.2	20.0	14.4	12.9	33.3	32.5	20.7	10.9	66.5	19.3	52.9	10.5	6.0	10.0	14.5	13.7	13.7	12.3	30.9	9.1	8.2	8.5	13.3	25.7	9.3	20.8	45.5	10.1	14.1	18.2	16.2	22.3	22.5	42.6	6.5	18.2	17.8	7.5	28.1	13.8	13.4	9.0	9.6	16.0	24.4	6.8	18.6	13.8	25.8	58.8	17.2	17.7	0.0	8.4	10.4	28.2	20.9	17.6	18.9	28.7	9.0	15.9	20.5	12.3
ATPSCKMT	"FAM173B, JS-2"	ENSG00000150756	"ATP synthase c subunit lysine N-methyltransferase"	Q6P4H8	5	10225507-10249897	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.1;Cytotrophoblasts: 5.9;Extravillous trophoblasts: 4.1;Fibroblasts: 2.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 2.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074513			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"HPA074513: AB_2686698"	"prognostic unfavorable (1.32e-6)"	"unprognostic (8.87e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.03e-1)"	8.5	10.3	12.4	5.4	13.0	3.9	6.6	13.5	15.5	5.7	13.8	7.4	6.1	6.9	9.1	5.8	6.5	7.2	6.9	11.7	14.3	9.0	9.9	5.1	7.8	13.2	13.6	6.3	5.1	17.1	9.9	4.1	13.2	8.8	8.7	5.0	7.4	8.3	6.7	5.8	5.6	7.5	12.0	4.5	6.2	5.7	13.4	6.9	8.8	7.4	6.8	7.1	5.3	14.8	14.1	13.3	13.9	13.8	12.7	9.8	4.8	20.4	9.2	9.2	8.0	14.1	21.0	16.8	35.2	13.0	27.7	9.6	19.6	17.0	15.8	30.9	13.2	14.5	47.6	11.4	9.7	22.8	16.5	9.1	18.3	17.4	5.5	11.8	19.7	17.8	19.9	18.0	26.6	11.9	11.6	20.2	9.1	29.9	17.4	15.8	9.7	15.9	24.6	16.5	11.1	10.9	69.3	24.5	12.2	10.5	25.7	23.2	11.2	22.4	13.9	14.2	14.9	11.9	14.5	19.7	14.1	25.3	9.0	3.2	5.8	8.1	4.3	6.7	5.3	3.8	4.2	5.5	5.8	2.6	4.1	5.4	2.2	3.8	5.5	2.1	5.4	2.6	12.4	13.0	13.5	15.5	11.7	14.3	13.2	13.6	13.2	12.0	13.4	14.8	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	5.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449007-142578733	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	3.0	8.6	0.7	4.1	1.1	1.2	3.2	0.9	1.4	3.8	3.7	2.7	1.7	3.3	2.3	3.1	3.3	3.4	2.3	1.2	1.9	3.7	3.6	2.9	4.8	1.5	1.2	2.7	3.8	5.2	3.7	3.1	1.4	3.0	2.9	2.9	3.5	2.5	2.9	2.7	3.1	3.2	1.0	4.2	2.8	5.2	1.2	4.9	5.0	1.4	4.6	4.1	2.7	1.2	28.6	13.2	7.1	7.0	9.6	13.6	8.8	14.8	8.4	10.1	9.7	6.4	6.8	19.9	14.6	10.1	14.6	16.1	10.9	12.8	15.0	7.5	7.9	11.9	8.2	4.1	4.2	20.5	5.3	9.8	4.8	9.5	10.3	5.8	11.6	8.7	8.2	7.5	9.6	7.5	13.9	2.6	7.3	15.6	9.6	11.8	12.5	13.5	6.3	11.1	5.2	5.1	28.6	8.3	8.0	7.8	12.0	5.4	14.6	10.5	4.9	12.3	15.2	10.8	7.4	18.5	13.8	6.5	8.5	0.0	0.3	0.0	0.5	0.4	1.0	0.1	0.3	0.5	0.7	0.3	0.4	0.4	0.0	1.3	0.2	0.2	0.4	0.2	0.7	1.1	0.9	1.4	1.2	1.9	1.5	1.2	1.4	1.0	1.2	1.2	11.5	6.4	10.6	39.2	22.4	4.0	7.2	8.8	14.2	14.1	9.2	6.5	7.6	5.7	10.1	3.7	37.5	7.7	14.9	3.5	0.0	5.9	16.4	18.8	18.6	10.2	7.7	14.5	93.0	4.9	3.6	8.3	14.8	10.3	1.3	16.3	7.9	7.3	6.4	8.4	94.4	4.8	14.2	9.4	4.0	8.7	6.5	12.8	10.6	73.1	12.0	6.0	9.2	65.4	71.9	6.4	1.8	7.2	23.1	8.1	1.9	6.5	25.4	23.6	0.0	14.6	9.8	50.1	18.5	14.7	4.5	5.1	15.1	13.8	7.6	6.1
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 582.5;Inhibitory neurons: 519.0;Oligodendrocyte precursor cells: 318.2;Oligodendrocytes: 466.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: AB_2686306"	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	4.1	4.0	3.2	5.9	5.3	2.6	4.1	0.0	14.4	8.4	0.0	8.8	3.8	10.9	4.3	5.0	6.2	5.7	5.8	8.4	0.0	4.1	4.7	6.9	4.2	0.0	1.3	5.4	4.8	5.5	6.5	4.9	0.0	7.4	3.8	13.9	4.6	6.2	14.6	5.7	4.8	7.5	0.0	5.7	5.3	3.0	3.9	2.6	6.1	14.8	3.1	6.7	6.6	0.8	4.5	2.6	0.9	0.0	4.4	5.9	5.8	4.8	11.2	2.9	3.3	2.8	2.8	0.2	6.3	9.3	3.7	4.2	0.3	3.0	4.2	2.6	4.7	0.7	4.4	9.0	7.0	4.2	7.0	4.6	5.7	6.1	5.1	11.2	5.9	0.9	0.0	5.3	2.4	2.3	0.3	4.8	0.9	1.4	4.3	0.3	5.8	4.0	4.0	7.6	0.3	2.5	4.4	5.5	9.1	8.4	3.6	7.2	9.1	4.0	6.1	4.8	4.4	30.7	19.2	0.2	2.6	4.3	10.0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.5	0.7	0.2	0.0	0.0	0.4	1.3	0.0	0.2	0.1	0.4	0.3	3.2	5.3	0.0	14.4	8.4	0.0	0.0	1.3	0.0	0.0	3.9	0.8	16.0	48.1	25.9	206.3	20.7	91.4	72.2	22.8	48.9	39.8	20.7	14.4	35.9	25.8	26.0	11.0	100.1	0.6	48.4	23.6	7.9	16.7	4.3	80.5	144.4	21.7	1.2	5.7	582.5	8.5	4.0	32.9	22.4	75.8	38.7	67.4	17.2	25.2	22.4	38.7	519.0	16.5	2.0	39.6	79.1	3.3	10.5	41.7	32.0	217.4	42.3	24.1	33.0	318.2	466.8	32.3	16.3	28.2	82.6	56.6	13.9	8.8	33.2	99.9	52.6	19.0	41.6	1.0	6.9	60.9	48.7	0.4	61.5	6.4	7.7	63.8
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.1;testis: 30.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Mitotic spindle, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	1.3	2.3	1.3	10.4	1.6	15.3	2.2	2.4	1.4	1.4	0.6	10.8	11.7	1.5	0.8	7.5	1.2	2.0	5.3	0.8	1.0	2.3	5.0	2.2	20.9	1.7	1.2	8.4	2.0	1.8	0.6	8.1	1.4	1.1	12.9	3.0	1.9	1.3	8.7	3.5	9.3	4.9	1.3	5.2	4.9	30.8	1.6	20.2	1.4	8.2	22.1	2.9	2.6	1.3	179.9	127.2	84.5	61.2	4.9	10.8	106.3	145.2	66.8	339.7	142.9	361.4	124.8	58.4	96.2	59.2	176.2	142.2	152.4	96.4	360.0	52.4	57.5	102.6	128.9	229.8	2.8	140.4	140.4	5.1	10.1	117.3	104.5	26.7	80.7	93.2	121.8	45.3	146.9	182.1	85.3	108.9	78.3	145.6	129.8	62.9	163.4	65.9	56.0	46.8	73.9	39.6	200.5	228.8	94.2	77.3	137.9	86.1	47.1	149.7	145.3	83.0	208.6	62.3	78.9	100.5	80.5	80.9	127.0	0.2	3.5	4.3	1.2	5.9	1.8	2.5	2.0	1.1	3.7	0.8	0.9	0.9	2.3	1.4	3.4	0.8	4.7	1.7	1.3	1.6	2.4	1.4	0.8	1.0	1.7	1.2	1.4	1.3	1.6	1.3	2.5	0.0	2.8	0.3	7.4	1.1	1.2	5.6	0.6	1.0	4.3	6.2	5.6	1.5	2.3	3.7	2.1	34.5	8.3	8.3	1.9	4.0	33.9	2.0	2.3	3.1	6.0	81.6	1.1	4.9	67.1	7.0	13.7	3.4	54.1	12.3	3.6	2.6	17.5	1.7	1.5	10.8	2.0	3.5	7.6	16.3	1.5	11.7	0.0	1.0	12.0	3.7	3.1	1.0	2.0	5.2	2.8	0.4	10.1	2.0	5.1	4.2	1.5	2.7	6.6	2.2	7.7	168.2	30.8	8.3	1.1	8.2	8.0	8.7	15.5	1.5
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"Activator of transcription and developmental regulator AUTS2"	Q8WXX7	7	69598296-70793506	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 598.7;Excitatory neurons: 871.5;Inhibitory neurons: 1405.7;Microglial cells: 583.7;Oligodendrocytes: 1231.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 8.1;naive B-cell: 9.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 82.8;REH: 84.1;SCLC-21H: 112.5;T-47d: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	8.7	5.2	50.4	9.1	41.1	8.5	17.2	10.6	19.0	7.9	0.0	11.3	6.8	7.4	6.2	11.5	7.0	13.3	5.5	21.8	32.0	13.9	20.2	10.8	4.8	40.6	25.9	14.6	5.7	11.3	9.7	4.1	23.0	11.3	10.0	11.0	48.2	5.7	15.2	20.5	15.6	7.5	14.0	6.5	10.5	7.9	37.3	10.7	5.8	5.2	6.3	10.5	10.5	8.7	0.3	7.5	82.8	4.3	5.4	3.2	0.9	5.2	0.0	0.4	0.5	29.1	0.3	13.0	1.9	5.0	0.5	27.1	10.0	11.5	2.3	60.5	22.4	6.2	7.8	0.3	2.4	0.1	0.4	8.6	15.2	12.5	3.1	3.0	0.0	13.5	0.6	6.5	7.2	4.8	1.2	2.4	59.0	18.9	0.1	84.1	40.0	39.8	0.0	12.5	112.5	61.3	5.3	9.2	0.2	35.4	80.0	0.1	0.0	0.3	27.1	8.8	52.6	0.2	0.2	43.1	0.1	0.2	0.2	1.0	0.2	0.1	1.4	0.1	1.9	8.1	0.9	1.4	0.6	9.4	0.1	0.8	0.4	1.5	0.1	2.8	0.2	0.6	50.4	41.1	10.6	19.0	21.8	32.0	40.6	25.9	23.0	14.0	37.3	8.7	13.7	19.2	38.2	598.7	19.9	28.6	21.1	25.0	34.7	37.2	72.9	41.5	20.8	11.5	22.2	9.2	16.7	1.2	103.2	23.5	5.9	13.1	31.8	11.5	36.0	15.9	28.9	5.2	871.5	1.3	0.1	19.3	4.1	11.0	0.0	44.4	12.1	28.8	0.8	63.9	1405.7	23.4	38.7	2.6	17.1	27.7	15.8	5.5	17.8	583.7	0.8	11.2	25.7	292.0	1231.2	3.9	15.3	14.7	37.7	32.6	15.3	12.4	20.3	20.7	26.3	13.7	17.2	10.1	16.9	20.3	16.1	1.4	35.5	10.4	25.3	26.6
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976042	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 2809.6;salivary gland: 3847.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	74000000000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	128.6	3.9	17.1	2.7	28.8	0.4	1061.4	23.1	18.8	3.4	16.0	6.7	30.9	1.5	2.5	22.0	3.0	38.7	114.7	14.9	22.2	326.8	2809.6	14.8	0.4	20.2	23.3	6.0	752.1	0.1	1.3	0.5	27.1	1051.4	4.2	3.6	3847.3	40.2	1.7	206.8	28.6	0.3	14.0	1.4	315.2	25.9	21.4	0.8	1.9	2.3	1.5	5.8	7.5	24.5	0.2	0.0	0.0	0.0	11.3	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.0	14.2	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.3	0.1	56.6	4.9	1.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	29.9	0.0	0.0	0.0	5.1	0.2	158.9	0.0	0.0	1.7	130.4	0.0	0.0	0.0	2.0	1.0	25.4	13.0	0.0	41.8	0.0	0.0	0.5	0.1	1.8	0.9	1.9	0.8	0.4	0.0	0.5	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	28.8	23.1	18.8	14.9	22.2	20.2	23.3	27.1	14.0	21.4	24.5	9.9	22.4	276.8	0.0	14.7	4.2	422.1	25.3	0.0	0.0	1315.5	704.8	115.9	451.8	63.0	5.5	2.1	0.0	10.4	5.5	46.9	11.7	1.9	1.4	1.2	14.2	12.4	85.5	0.1	254.2	0.0	7.7	94.8	5.5	3.8	1.2	65.3	4270.8	0.0	0.0	0.1	13.1	901.3	93.1	0.7	4.2	0.9	14.8	62.2	1.0	2.0	23.7	0.0	7.5	7.3	221.5	6.4	0.0	0.3	1691.9	15.3	596.1	6.3	0.3	0.0	0.0	11.9	7.4	0.4	9.9	9.7	0.0	12.3	0.1	12.6	674.2
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"bone marrow: 1578.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.5;Breast myoepithelial cells: 4.6;Endometrial ciliated cells: 8.9;Erythroid cells: 8.8;Respiratory ciliated cells: 4.5;Skeletal myocytes: 5.7;Spermatogonia: 6.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Cell line enriched"	"Detected in some"	15	"THP-1: 659.5"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA		320000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA055851: AB_2682943, HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.8	0.2	0.4	0.0	0.4	1578.1	1.5	0.2	0.9	0.2	0.2	0.2	0.0	0.5	0.0	0.1	1.4	0.0	2.0	0.4	0.3	0.4	2.8	15.9	0.6	0.3	0.3	0.2	0.2	0.0	0.9	0.9	0.4	0.4	0.0	0.0	2.6	0.0	0.5	0.6	0.2	0.0	0.2	33.1	0.2	2.4	0.4	3.1	0.5	0.0	0.0	0.3	0.2	0.3	1.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	44.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.6	659.5	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.6	0.0	34.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.2	0.9	0.4	0.3	0.3	0.3	0.4	0.2	0.4	0.3	3.5	0.0	0.0	0.0	0.6	0.0	0.1	1.2	0.0	0.0	4.5	4.6	0.7	0.0	0.5	0.0	0.0	0.2	2.8	0.6	0.0	0.1	0.0	8.9	1.2	1.0	0.0	8.8	0.8	0.0	0.3	0.8	0.0	2.3	0.0	0.1	0.0	0.4	3.2	0.0	1.4	0.4	0.0	3.7	0.4	0.7	0.0	3.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.2	0.0	4.5	0.0	0.0	5.7	1.2	0.1	6.4	0.9	0.1	0.0	1.0	0.0	0.6	0.0
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253253-183298504	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 76.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 151.2;Distal enterocytes: 150.4;Squamous epithelial cells: 169.9;Syncytiotrophoblasts: 157.9;Urothelial cells: 144.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 5.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 5.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 82.4;HBEC3-KT: 70.3;hTCEpi: 83.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 14.7"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	11.9	2.4	3.3	13.7	3.5	76.5	5.5	2.3	3.2	6.0	0.9	22.6	38.2	5.1	9.1	37.5	9.6	21.3	3.5	3.7	4.0	3.8	3.3	15.0	1.1	5.6	3.8	4.6	7.5	3.5	5.7	13.9	4.6	7.9	19.6	1.2	10.1	3.3	7.4	10.3	42.0	6.7	4.3	1.6	11.3	7.3	3.5	7.6	5.2	4.5	5.3	24.2	13.8	5.5	46.2	4.4	23.8	14.7	19.5	57.0	21.5	0.7	1.1	4.6	3.8	9.0	23.6	0.0	2.7	0.1	82.4	20.6	24.7	70.3	3.9	0.1	15.3	2.4	1.9	0.0	24.8	23.4	10.9	27.0	83.5	3.7	62.1	6.2	43.4	0.1	26.6	0.1	38.1	0.0	0.1	7.6	10.1	26.9	38.5	7.3	12.0	0.1	14.4	12.7	1.0	22.6	12.7	0.1	5.3	10.6	0.0	28.0	64.6	1.1	9.0	1.4	11.0	0.0	0.0	0.0	8.8	54.1	23.8	0.0	1.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.2	0.3	3.3	3.5	2.3	3.2	3.7	4.0	5.6	3.8	4.6	4.3	3.5	5.5	151.2	6.4	17.5	2.3	1.2	65.1	70.2	35.8	101.3	10.0	18.4	10.4	2.2	21.5	40.5	5.5	22.9	31.0	1.9	150.4	1.9	18.0	13.4	58.0	13.1	26.3	38.2	6.3	1.8	11.8	10.7	9.2	70.3	55.3	14.0	2.4	2.2	0.6	29.6	3.3	1.5	88.2	34.6	15.6	123.2	26.5	1.5	76.8	12.4	80.6	9.4	3.1	0.0	4.5	0.8	35.7	126.4	0.4	1.4	43.1	74.9	4.8	118.5	13.1	0.0	23.6	5.4	7.9	0.8	169.9	84.8	157.9	4.3	0.2	36.2	144.4
B3GNTL1	B3GNT8	ENSG00000175711	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1"	Q67FW5	17	82942155-83051810	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 19.9;Respiratory ciliated cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.1;HL-60: 27.0;THP-1: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023585, HPA024547"	Supported		Approved	"Nucleoli,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli, Nucleoli fibrillar center"	Vesicles	"HPA023585: AB_2061075, HPA024547: AB_1845240"	"unprognostic (1.51e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.61e-7)"	"unprognostic (9.95e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (4.17e-9)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.39e-3)"	2.9	2.8	1.8	2.9	2.1	7.8	2.4	1.4	2.3	3.5	3.9	2.0	1.7	3.7	1.2	2.4	3.7	1.3	3.0	1.9	1.4	1.9	2.4	3.0	2.3	1.3	1.5	3.9	2.3	0.8	2.6	1.4	1.6	2.6	0.9	0.5	2.1	1.5	3.8	2.3	2.1	1.8	1.3	4.2	2.0	3.0	2.1	2.3	2.4	1.4	1.1	3.1	2.5	1.6	11.9	7.8	0.2	3.7	2.1	6.6	4.7	4.2	3.7	4.8	3.7	4.7	25.1	5.8	8.1	5.2	11.7	2.2	1.9	0.0	4.1	8.9	5.1	12.2	12.6	16.0	7.5	27.0	0.5	2.4	2.1	2.9	4.8	2.4	5.9	8.9	5.4	5.5	3.9	2.7	7.6	10.3	1.8	8.1	5.6	9.8	0.9	0.4	2.7	2.5	2.4	0.9	3.6	2.7	3.7	3.4	0.0	25.5	9.7	9.2	6.2	1.4	7.6	1.1	2.9	4.4	10.3	3.6	1.3	3.0	6.0	1.0	2.8	5.9	4.4	3.0	4.4	3.3	10.4	5.5	3.9	4.7	19.0	3.2	3.2	4.1	13.5	4.0	1.8	2.1	1.4	2.3	1.9	1.4	1.3	1.5	1.6	1.3	2.1	1.6	2.6	3.2	4.5	4.6	2.9	1.0	2.0	4.4	3.4	3.5	3.0	3.0	2.8	1.5	6.4	5.5	4.2	5.7	3.6	1.3	1.9	1.9	15.3	6.8	4.2	2.3	1.2	7.6	11.3	1.0	3.1	4.0	3.1	1.9	7.0	7.6	1.4	2.0	7.7	3.3	9.2	1.5	6.1	7.3	2.8	19.9	3.1	8.9	1.8	6.5	5.5	1.3	8.2	5.0	4.7	2.1	2.7	4.9	5.2	2.8	0.2	2.4	20.7	3.5	0.0	2.5	2.3	0.9	5.0	5.6	1.7	1.9	6.8	4.8	3.5	2.1
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	459939-563509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 61.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.2	7.0	0.5	3.2	0.7	2.1	1.3	0.0	1.0	7.4	1.0	18.4	1.0	6.2	2.7	7.5	3.7	2.2	23.9	0.5	0.0	4.6	0.1	5.2	0.1	0.0	0.0	0.4	2.6	16.9	9.3	0.1	0.0	2.0	12.5	0.1	4.8	0.7	1.5	14.8	2.0	2.2	0.0	0.3	61.0	8.0	0.0	2.3	2.3	0.1	0.7	1.4	5.6	0.7	0.0	0.0	0.3	1.2	0.0	0.0	33.5	0.0	0.0	0.0	0.0	8.0	6.6	0.0	0.9	0.0	0.7	3.6	8.0	1.1	0.1	13.2	12.5	0.0	0.0	1.8	0.0	0.1	5.3	0.0	5.3	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.1	14.8	10.5	0.6	0.5	5.0	0.0	7.1	6.8	3.8	2.7	0.8	0.3	1.0	4.9	0.8	2.9	0.0	0.0	2.7	0.2	0.9	0.0	0.0	0.0	0.0	9.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	7.0	1.3	0.3	7.5	6.0	3.4	0.0	0.6	2.9	0.6	15.1	1.5	6.2	9.2	0.0	0.0	0.6	81.1	0.0	12.0	26.3	20.4	4.8	0.6	10.3	0.0	32.6	4.8	0.1	1.6	128.0	47.4	0.0	0.1	0.0	0.1	0.7	0.0	5.2	18.6	2.0	0.0	1.1	89.2	0.0	0.5	0.0	2.8	0.6	0.0	0.0	1.0	3.6	16.6	33.4	0.0	0.2	12.7	1.9	0.2	9.1	0.2	0.0	0.2	0.8	2.8	1.3	0.9	17.3	0.0	1.5	1.9	26.1	14.4
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 215.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 346.6;SiHa: 635.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		97000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	52.4	39.2	5.6	43.9	5.1	80.2	91.1	7.3	6.4	64.9	17.9	38.0	21.9	35.7	35.7	49.7	49.3	47.8	55.4	5.4	6.8	42.1	89.4	50.1	33.3	8.6	6.4	77.4	43.9	77.1	21.2	52.9	7.7	38.8	34.3	26.2	70.3	34.0	30.9	35.8	28.1	55.2	8.1	39.7	52.1	38.3	8.3	26.8	60.8	16.7	41.2	79.4	44.9	9.4	99.1	71.8	13.1	18.1	64.9	113.7	235.9	100.6	125.7	59.5	58.8	44.0	112.1	37.8	62.4	147.3	77.2	51.9	13.7	124.5	59.4	346.6	13.6	21.6	277.6	34.1	127.4	17.9	35.0	128.0	218.1	68.0	82.2	127.6	64.0	11.5	24.9	45.5	57.0	86.1	16.3	35.4	8.1	54.1	21.8	21.0	12.2	25.1	177.0	84.6	9.8	12.7	635.5	122.2	25.8	40.4	154.8	32.3	59.9	42.2	49.4	137.2	39.8	7.6	17.9	23.3	131.0	24.2	15.8	30.6	33.2	20.3	45.2	30.5	59.2	87.1	30.4	40.7	23.3	69.9	17.9	23.3	96.5	72.4	24.8	215.3	22.0	24.0	5.6	5.1	7.3	6.4	5.4	6.8	8.6	6.4	7.7	8.1	8.3	9.4	104.4	86.6	71.9	3.3	112.0	141.9	53.0	59.2	75.7	3.8	215.8	66.7	37.2	88.6	59.5	167.3	20.9	94.9	206.2	146.1	15.6	78.2	21.9	108.6	39.7	60.6	8.4	12.8	4.1	125.9	155.8	99.9	80.0	163.7	36.8	19.6	91.1	195.4	53.9	0.0	4.5	64.0	24.4	82.3	333.3	11.1	50.7	129.0	96.0	33.7	31.3	7.7	39.1	3.0	1.0	157.8	57.4	44.4	116.4	89.0	23.9	57.7	33.8	40.1	52.6	80.0	50.8	6.4	13.8	86.1	108.4	173.9	92.7	33.9	41.6	93.2
B4GALT5	beta4GalT-V	ENSG00000158470	"Beta-1,4-galactosyltransferase 5"	O43286	20	49632945-49713878	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 128.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077777			Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA077777: "	"unprognostic (7.98e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.69e-2)"	28.7	47.8	14.7	21.7	14.5	93.7	18.6	14.6	16.1	21.2	6.5	24.9	25.3	23.5	8.6	37.3	18.5	31.5	20.5	15.5	18.1	22.8	25.8	27.3	9.6	14.7	19.2	19.0	12.6	11.3	12.6	27.2	15.4	17.1	23.7	7.7	19.0	21.9	67.1	7.9	21.3	37.6	14.6	27.6	25.8	22.3	19.0	8.1	11.5	24.3	11.5	51.4	17.2	12.0	48.8	55.0	71.4	30.4	72.8	49.3	62.4	23.5	43.7	104.8	50.0	71.1	59.0	14.8	98.0	39.0	99.1	75.4	45.5	35.0	61.3	45.6	12.5	39.4	28.8	42.9	22.9	51.6	73.7	74.3	32.2	45.5	21.8	96.5	64.8	25.9	64.5	8.9	30.8	24.1	3.1	47.3	37.4	47.8	35.3	26.6	61.9	21.4	50.6	34.0	84.9	43.0	83.6	105.3	47.8	52.5	24.1	70.0	50.1	62.7	50.5	33.6	49.8	10.9	10.0	35.2	32.6	48.5	40.7	1.4	1.0	2.6	1.4	1.0	1.5	0.2	0.6	1.3	0.7	0.3	0.1	0.9	6.6	1.2	1.1	0.6	0.8	0.4	14.7	14.5	14.6	16.1	15.5	18.1	14.7	19.2	15.4	14.6	19.0	12.0	39.5	16.0	43.1	36.2	5.8	18.9	27.3	39.7	7.4	8.3	17.3	18.2	18.3	42.9	84.5	36.8	10.4	23.4	21.3	61.3	1.9	35.3	5.2	59.1	28.4	42.7	34.3	33.2	52.1	19.7	27.7	27.3	17.9	100.8	83.2	36.2	58.5	22.7	24.5	11.8	59.5	21.3	40.7	28.2	81.5	6.8	19.9	45.0	21.4	30.9	21.4	5.6	20.6	25.6	42.5	39.7	34.1	32.7	7.3	66.8	13.4	33.5	57.0	4.9	26.3	29.9	25.9	10.3	16.0	27.5	17.5	5.6	17.4	33.1	20.0	128.9
BAALC		ENSG00000164929	"BAALC binder of MAP3K1 and KLF4"	Q8WXS3	8	103140713-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 300.9;choroid plexus: 108.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 67.8;Astrocytes: 198.2;Excitatory neurons: 131.4;Inhibitory neurons: 62.3;Muller glia cells: 132.4;Oligodendrocyte precursor cells: 125.7"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"NK-cell: 3.7"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 51.7;BJ hTERT+: 18.1;SCLC-21H: 27.9;SH-SY5Y: 20.5;U-87 MG: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: AB_2685971"	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	9.3	15.6	196.7	2.1	209.2	3.4	7.0	182.2	226.6	1.6	108.2	3.1	0.9	1.7	0.4	0.7	3.8	1.6	3.1	201.1	206.8	4.3	2.9	7.3	1.4	240.0	237.4	3.3	2.1	0.4	25.9	5.3	219.5	1.1	1.6	19.4	1.0	0.9	2.0	2.0	2.7	1.8	229.2	14.5	2.4	1.3	300.9	0.6	4.5	1.4	0.8	2.5	1.4	205.3	0.5	3.0	51.7	0.5	0.5	14.9	0.0	2.6	18.1	0.1	0.2	0.5	0.1	0.2	0.5	10.1	0.2	0.8	0.9	0.1	0.1	0.1	3.1	0.5	0.8	0.1	1.2	0.0	1.1	3.0	2.9	0.6	0.0	2.7	0.4	0.1	0.0	0.4	0.1	0.4	0.0	0.2	1.3	0.4	1.0	0.2	0.3	1.2	0.0	0.1	27.9	20.5	0.6	0.0	0.1	4.5	0.2	0.3	3.0	16.0	1.0	0.4	1.0	0.0	0.2	0.2	75.7	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	196.7	209.2	182.2	226.6	201.1	206.8	240.0	237.4	219.5	229.2	300.9	205.3	67.8	0.0	1.8	198.2	0.3	5.5	0.7	4.5	0.6	2.1	2.0	1.1	0.8	17.2	5.9	0.0	0.0	0.1	2.1	0.3	7.9	32.0	2.9	15.6	2.3	33.4	17.8	6.1	131.4	25.6	0.1	1.6	0.0	34.0	0.0	0.0	23.6	0.8	0.9	0.0	62.3	3.4	22.4	1.3	6.2	8.7	1.5	2.1	14.2	18.7	4.6	132.4	2.1	125.7	46.1	4.1	1.2	0.0	0.8	0.8	0.1	0.1	21.7	3.3	0.0	2.1	8.1	0.1	0.1	0.3	4.0	0.0	1.3	0.3	0.1	1.1
BABAM1	"C19orf62, FLJ20571, HSPC142, MERIT40, NBA1"	ENSG00000105393	"BRISC and BRCA1 A complex member 1"	Q9NWV8	19	17267376-17281249	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054386, HPA068786, HPA077609"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: "	"unprognostic (5.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.74e-2)"	45.8	54.1	51.9	40.0	55.4	70.4	46.8	44.7	66.7	49.9	39.4	60.6	41.6	50.3	28.7	48.3	44.5	28.9	72.1	58.3	53.9	53.3	55.3	42.8	55.4	50.4	51.5	44.2	49.9	46.8	32.2	46.7	54.1	48.0	36.3	26.4	50.2	37.1	134.1	46.1	50.6	37.3	44.0	60.7	54.2	41.6	51.4	51.3	37.3	96.9	51.3	49.2	43.4	54.7	126.8	69.5	68.8	66.0	72.9	51.9	154.9	73.5	96.0	143.2	142.1	78.2	146.5	87.8	172.1	102.2	64.9	61.2	79.7	102.2	89.1	127.5	130.9	78.6	91.6	99.0	60.4	142.4	96.0	79.6	68.3	96.4	56.1	79.3	122.5	123.9	132.9	101.1	103.3	104.1	138.7	135.8	182.0	106.3	147.0	95.5	92.2	119.4	104.1	62.1	66.3	120.3	90.5	92.8	84.6	77.2	81.4	115.2	91.7	87.8	55.7	108.8	124.3	133.1	172.5	119.7	125.6	187.0	85.5	201.3	154.3	167.7	132.9	148.1	128.3	141.9	121.7	129.2	161.3	143.4	111.8	109.9	37.9	114.3	147.8	134.3	180.2	214.1	51.9	55.4	44.7	66.7	58.3	53.9	50.4	51.5	54.1	44.0	51.4	54.7	40.8	12.8	29.7	11.1	45.0	34.9	41.5	63.4	19.4	21.9	53.9	60.7	37.8	41.5	44.9	35.0	14.6	172.4	51.0	51.1	101.8	70.1	65.8	18.4	30.4	39.9	43.8	78.5	18.6	72.4	155.4	41.4	26.0	28.1	46.3	54.3	40.0	50.4	98.7	16.8	16.2	60.6	48.8	46.8	45.6	106.3	36.7	43.2	65.8	8.4	80.4	35.3	68.0	8.5	12.3	69.8	63.8	44.4	51.7	44.6	68.1	89.3	23.5	18.5	39.5	34.7	52.5	57.8	74.2	27.9	41.3	158.0	46.4	43.0	64.7	45.5
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.4;Late spermatids: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 150.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 150.2;monocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	15.8	12.1	12.3	27.8	13.3	89.4	13.3	27.6	16.0	18.1	9.9	13.4	17.4	19.8	9.7	23.0	9.1	26.1	13.2	10.5	19.5	16.0	30.5	21.4	16.9	23.0	28.4	11.6	17.2	8.3	3.3	50.6	31.0	13.3	13.2	12.0	17.4	8.6	26.3	23.3	17.4	15.9	14.2	20.7	13.5	27.3	16.6	14.2	12.6	12.8	14.8	29.8	13.1	12.3	21.5	8.6	26.1	6.8	20.2	57.7	16.3	23.0	55.0	21.8	24.3	18.1	28.9	25.5	18.0	21.1	22.7	11.1	15.7	30.9	38.6	21.3	13.3	78.7	18.9	18.6	26.8	22.8	28.1	30.3	46.4	42.8	63.4	25.7	11.7	13.9	40.6	129.7	30.2	7.6	19.5	13.0	40.3	8.4	8.9	19.8	61.8	33.1	11.5	16.8	10.8	12.2	12.6	23.5	29.0	26.0	17.1	27.1	29.6	21.3	29.4	23.1	11.8	74.9	51.9	26.9	17.3	27.8	64.9	72.4	51.1	38.6	5.0	40.1	4.1	10.3	8.3	4.3	24.9	13.7	11.9	6.0	150.2	7.1	46.0	6.0	14.8	15.3	12.3	13.3	27.6	16.0	10.5	19.5	23.0	28.4	31.0	14.2	16.6	12.3	31.9	28.9	15.3	12.1	90.6	59.0	53.2	17.9	19.4	16.6	18.3	15.1	20.7	15.7	23.1	14.7	18.8	13.7	33.0	30.7	7.9	19.8	164.4	32.2	45.9	26.0	30.9	33.0	5.1	16.6	15.7	31.3	30.5	64.1	48.6	13.6	22.1	20.9	22.0	13.5	36.9	24.7	12.2	57.1	113.8	422.4	13.4	113.8	21.4	68.4	109.1	10.2	24.7	33.7	25.0	28.2	38.2	14.3	87.8	50.7	25.5	12.8	15.7	12.6	32.9	54.7	36.6	31.5	28.4	34.7	58.1	39.7	31.3	17.4	11.7	48.4
BAG6	"BAT3, D6S52E, G3, Scythe"	ENSG00000204463	"BAG cochaperone 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 261.8;Late spermatids: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		26000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103"	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	70.1	77.3	10.4	18.1	11.5	24.1	67.7	11.9	10.8	68.0	23.3	69.2	38.1	72.2	26.3	73.6	67.0	15.2	96.3	11.3	12.3	58.1	65.4	71.3	24.6	12.9	11.8	76.0	64.1	23.9	65.4	21.8	13.3	62.2	24.8	16.0	70.7	12.3	204.6	84.2	76.4	17.4	10.0	76.4	65.3	136.8	13.4	23.1	74.6	51.8	28.0	69.8	64.7	12.5	28.3	47.3	63.7	63.0	28.7	47.8	49.0	33.1	34.1	49.1	42.5	121.2	26.5	44.0	98.2	101.2	72.1	22.3	17.3	110.7	19.1	45.4	139.8	62.2	18.8	77.5	42.5	47.4	125.6	37.2	52.8	27.0	24.0	52.9	47.9	76.3	85.7	46.1	82.6	34.4	25.4	46.7	20.1	16.7	23.8	37.0	26.3	52.1	38.3	31.2	29.4	41.6	22.7	27.3	42.0	16.8	112.6	91.2	31.8	57.8	40.0	28.2	53.6	59.9	87.0	88.4	56.0	45.8	40.2	3.3	2.5	2.8	2.2	3.0	1.7	1.4	1.0	1.1	2.2	1.3	1.2	1.4	1.5	1.6	3.4	1.6	0.9	1.9	10.4	11.5	11.9	10.8	11.3	12.3	12.9	11.8	13.3	10.0	13.4	12.5	39.0	48.1	39.9	11.1	39.0	32.1	39.0	44.5	23.3	28.4	34.5	30.2	77.7	42.9	51.3	36.8	18.8	62.2	33.0	82.4	31.3	66.0	261.8	39.1	22.4	40.8	76.7	52.2	7.6	50.0	67.1	38.4	40.8	34.1	48.2	41.4	38.6	45.4	55.9	50.5	8.6	56.4	61.1	39.9	29.9	483.4	33.2	40.5	28.4	12.2	38.5	34.0	44.3	5.0	10.8	64.0	63.4	39.5	51.6	35.0	105.6	47.9	54.6	48.3	39.5	35.4	65.8	115.0	87.9	33.3	35.5	119.4	34.8	31.7	68.8	40.1
BAMBI	NMA	ENSG00000095739	"BMP and activin membrane bound inhibitor"	Q13145	10	28677510-28682932	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 81.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 174.7;Breast myoepithelial cells: 163.2;Granulosa cells: 334.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 166.7;SK-MEL-30: 199.0;SuSa: 357.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010819, HPA010866"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Lipid droplets"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nucleoli fibrillar center, Lipid droplets"	"HPA010819: AB_2668371, HPA010866: AB_10601686"	"unprognostic (7.02e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (5.25e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.10e-2)"	4.4	44.1	13.8	2.3	16.3	6.0	23.7	18.4	17.6	5.7	20.7	3.8	1.6	17.9	2.9	2.1	6.3	5.4	43.5	13.6	15.9	19.9	23.9	12.0	2.0	19.9	16.9	81.6	6.9	8.2	8.5	39.3	21.1	7.4	4.7	13.4	6.4	16.7	1.8	5.4	2.1	12.2	16.6	18.0	3.8	8.7	14.8	0.4	1.2	1.9	1.4	30.0	5.4	22.7	1.0	41.0	4.2	2.2	4.8	0.1	24.5	9.7	3.5	15.4	10.0	166.7	17.3	0.5	5.7	7.4	8.8	12.2	10.2	1.6	7.2	10.1	21.0	39.5	6.2	63.7	5.9	2.4	51.5	3.7	2.3	10.4	1.6	96.7	2.4	2.1	22.1	18.7	3.1	70.1	0.2	3.3	71.6	34.5	9.9	0.3	7.8	3.6	12.9	40.4	6.8	5.2	13.2	78.5	199.0	357.8	23.2	3.0	0.3	10.4	7.3	17.0	4.7	0.5	15.0	0.0	1.0	8.9	67.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	16.3	18.4	17.6	13.6	15.9	19.9	16.9	21.1	16.6	14.8	22.7	6.6	9.6	5.9	15.0	5.7	4.0	7.6	0.6	13.1	14.3	174.7	163.2	34.9	58.6	3.5	11.0	4.2	12.0	9.3	33.8	1.9	20.8	0.1	14.3	15.3	7.3	26.8	0.0	0.5	0.2	22.2	46.1	58.6	21.1	1.3	334.8	14.6	16.0	6.7	6.7	0.2	3.8	0.0	1.6	4.2	1.2	3.4	5.4	16.0	15.9	0.7	50.2	0.0	46.3	21.2	12.1	34.6	2.2	4.3	10.8	1.1	16.1	1.4	5.9	0.0	4.2	42.7	1.9	15.5	13.5	1.3	8.5	7.8	6.2	3.8	14.1
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809683	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 68.6;Basal prostatic cells: 62.2;Suprabasal keratinocytes: 74.4;Urothelial cells: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119"	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	1.8	0.6	3.0	2.7	4.6	11.4	2.9	2.2	2.7	3.1	0.2	2.9	2.3	3.3	2.6	5.1	1.9	2.0	1.5	2.3	4.1	0.8	1.0	2.5	5.5	3.8	3.2	2.3	1.6	2.3	1.2	2.3	3.9	2.9	3.6	2.0	1.9	3.6	4.2	8.8	2.1	3.9	3.9	2.6	1.9	6.6	4.1	7.0	1.4	2.3	6.6	2.1	3.8	4.2	12.3	8.8	20.2	9.3	2.7	4.0	12.0	17.3	10.6	17.8	21.8	12.0	12.2	12.6	7.6	8.5	9.5	12.7	16.5	10.5	22.7	11.5	6.4	12.5	13.8	8.7	0.9	13.9	12.7	4.7	1.1	15.0	8.1	4.5	6.1	14.7	7.9	36.0	13.7	10.7	27.9	12.5	14.3	7.9	3.7	24.7	19.8	11.2	3.9	14.0	5.8	8.8	15.0	14.7	5.3	10.9	16.3	13.4	4.7	18.0	14.0	11.7	13.6	10.2	12.6	28.0	7.6	11.3	13.4	3.9	2.0	5.8	4.6	4.0	3.2	9.7	5.4	5.5	3.6	8.2	2.4	4.0	0.3	7.3	3.8	6.9	17.1	2.3	3.0	4.6	2.2	2.7	2.3	4.1	3.8	3.2	3.9	3.9	4.1	4.2	12.3	6.4	2.2	14.7	13.0	68.6	62.2	13.0	14.2	3.3	9.9	14.1	17.4	17.2	12.7	9.2	0.0	18.2	11.3	8.2	3.9	8.0	9.2	13.3	11.9	9.6	1.2	34.5	5.5	6.9	16.0	10.0	10.2	18.0	15.2	28.2	10.0	4.2	12.5	1.7	15.4	13.1	8.2	10.1	12.2	5.7	6.2	11.2	3.6	15.9	16.6	4.4	9.2	19.6	31.7	6.5	6.5	10.1	22.0	22.9	3.2	0.7	12.3	6.8	19.7	15.4	16.9	27.6	43.4	28.6	74.4	5.1	13.4	10.5	14.7	67.2
BBS1	FLJ23590	ENSG00000174483	"Bardet-Biedl syndrome 1"	Q8NFJ9	11	66510606-66533613	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Olfaction, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.9;Excitatory neurons: 28.5;Inhibitory neurons: 28.4;Microglial cells: 14.0;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA058283	Uncertain		Uncertain	Midbody		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Midbody		"HPA058283: AB_2683667"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.61e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.87e-4)"	10.5	15.2	11.5	4.9	13.0	2.9	11.9	10.8	17.8	18.9	13.9	18.0	6.5	20.7	17.7	9.0	28.0	12.6	10.1	11.6	12.7	24.2	7.0	10.4	5.1	10.2	13.5	27.5	13.5	38.0	17.9	8.2	10.1	15.8	7.3	21.4	16.8	22.0	8.1	9.6	9.4	14.1	10.5	6.0	13.8	10.5	13.3	8.0	27.1	8.2	5.0	15.4	10.9	10.7	5.7	6.0	13.7	5.4	24.9	17.2	6.3	4.8	9.6	6.3	6.0	9.5	10.1	0.8	10.0	11.5	5.6	10.6	10.1	10.6	6.8	5.2	5.8	2.5	8.9	5.3	11.7	4.7	1.8	17.7	9.7	9.7	7.1	17.8	8.9	8.5	5.5	4.3	7.8	5.1	3.7	4.1	10.4	18.0	10.5	9.2	9.0	7.4	19.3	6.4	14.0	9.3	8.1	8.7	18.6	6.6	18.7	2.5	8.7	5.0	5.7	6.0	1.6	3.1	1.5	1.4	16.3	1.3	5.4	0.0	1.5	0.2	1.8	1.6	2.6	2.2	2.5	2.0	1.2	1.1	1.7	2.2	0.9	3.1	3.0	0.5	0.8	1.9	11.5	13.0	10.8	17.8	11.6	12.7	10.2	13.5	10.1	10.5	13.3	10.7	0.5	0.0	2.2	19.9	2.5	0.5	1.3	1.6	0.6	3.9	0.9	1.0	0.5	1.5	1.1	0.0	8.4	1.6	0.5	0.6	0.0	0.8	4.1	2.3	1.8	1.3	1.2	3.0	28.5	0.4	0.6	3.1	7.1	0.9	0.0	2.9	0.7	0.3	0.6	0.0	28.4	0.7	2.0	0.9	0.7	2.6	0.9	0.5	0.0	14.0	0.8	1.7	1.0	13.6	9.0	0.4	0.5	1.5	2.5	0.8	0.4	1.7	9.2	10.8	0.0	1.5	1.6	4.9	2.6	2.2	1.0	1.0	1.4	2.0	0.9	0.9
BCAS1	"AIBC1, NABC1, PMES-2"	ENSG00000064787	"Brain enriched myelin associated protein 1"	O75363	20	53936777-54070594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 890.2;choroid plexus: 301.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 182.6;Gastric mucus-secreting cells: 202.9;Intestinal goblet cells: 371.4;Oligodendrocyte precursor cells: 538.8;Oligodendrocytes: 718.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 44.2;OE19: 90.0;RT4: 179.5;SK-BR-3: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033558, HPA051816, HPA054745"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles		"CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.77e-3)"	1.2	0.2	506.5	6.4	627.9	0.1	3.4	551.3	890.2	7.3	301.2	69.5	19.0	1.3	2.2	7.2	1.5	8.6	0.4	421.4	525.8	3.3	0.4	2.9	0.6	749.3	660.7	0.4	0.9	0.0	1.0	0.1	649.9	33.4	74.3	0.2	22.3	0.3	0.5	1.4	31.1	2.8	584.8	0.5	159.8	3.4	562.0	0.7	0.3	0.8	6.5	35.7	7.5	724.7	0.0	8.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.7	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	27.8	0.2	0.0	0.3	4.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	44.2	0.1	0.2	0.2	90.0	0.0	2.3	0.0	1.2	0.0	179.5	0.2	0.1	0.0	368.6	0.4	0.0	12.2	0.0	0.0	0.0	0.1	3.2	0.0	0.9	0.5	1.0	0.9	0.0	0.3	0.3	0.1	0.0	0.2	0.0	1.2	0.6	0.4	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.1	0.1	506.5	627.9	551.3	890.2	421.4	525.8	749.3	660.7	649.9	584.8	562.0	724.7	0.8	9.6	1.1	1.6	2.8	0.8	6.3	8.5	0.6	0.1	6.2	1.9	2.2	7.2	35.9	3.7	0.0	0.2	0.4	182.6	1.9	2.9	15.6	9.4	11.1	0.4	8.4	0.0	1.6	22.5	0.1	0.8	202.9	11.8	4.5	0.0	0.4	0.1	0.1	0.0	2.5	371.4	18.3	0.0	2.5	16.1	0.3	1.7	16.0	0.0	0.0	0.8	0.0	538.8	718.8	22.9	102.0	0.0	1.0	21.3	12.0	0.1	100.5	0.5	0.0	1.4	2.2	15.4	6.1	0.3	0.3	0.0	1.7	0.4	35.6	56.7
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA038011: AB_2675784"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	40.0	35.1	37.7	38.3	39.1	62.4	52.4	41.1	43.4	31.4	42.3	37.6	32.3	31.0	54.6	38.5	33.0	26.6	48.0	37.5	38.7	55.3	67.9	27.2	49.3	38.3	38.3	42.8	47.1	41.6	24.8	32.5	39.2	42.4	41.1	55.7	58.2	28.6	77.5	31.8	31.7	31.4	38.7	29.8	42.8	48.3	39.0	50.0	39.8	63.6	48.7	55.9	30.1	40.8	225.6	114.4	126.9	141.3	70.9	77.2	105.9	117.9	112.1	142.3	131.2	188.2	146.4	156.6	72.1	108.6	107.1	121.4	219.3	167.0	197.6	145.3	148.5	157.9	97.5	210.0	89.4	219.7	96.1	79.9	98.7	170.1	178.3	108.0	137.7	145.1	177.7	78.1	122.5	134.7	142.7	220.4	98.2	188.0	170.2	134.7	133.5	94.3	126.6	106.0	67.2	68.5	88.1	142.4	149.9	102.7	76.9	96.3	93.0	65.9	116.9	98.2	215.9	79.3	94.9	233.0	129.7	112.5	52.0	30.3	68.3	41.1	56.2	86.6	77.8	76.8	63.7	61.9	75.2	71.4	71.1	64.4	11.2	68.2	94.3	65.0	75.6	48.1	37.7	39.1	41.1	43.4	37.5	38.7	38.3	38.3	39.2	38.7	39.0	40.8	21.6	64.1	67.9	16.6	46.9	66.9	59.3	60.6	58.1	24.2	32.2	27.3	80.4	28.6	67.0	23.9	22.9	41.4	28.2	16.7	78.2	52.7	14.7	37.6	36.6	30.4	25.8	47.3	21.3	44.1	38.0	43.2	40.2	33.2	27.1	33.6	23.2	50.4	35.8	16.8	21.0	23.1	42.7	28.9	22.2	9.4	37.0	29.3	23.2	11.2	36.2	30.2	28.8	22.1	25.7	45.1	19.6	31.2	57.7	51.9	22.7	62.4	74.7	25.1	26.3	47.5	37.5	105.3	117.2	57.8	52.1	33.8	38.6	28.3	33.3	55.5
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoplasm,Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	19.7	10.7	7.3	7.6	8.3	8.2	22.3	11.5	7.8	11.7	11.6	22.5	11.5	9.2	7.1	10.3	11.5	7.8	18.8	8.8	7.0	31.8	78.4	7.3	8.8	10.7	9.2	14.6	12.9	19.7	7.2	4.8	13.1	15.9	20.7	7.9	26.6	11.3	10.9	8.5	12.4	9.4	11.8	6.3	17.6	13.1	8.7	9.1	15.5	15.3	9.1	11.2	7.6	16.0	13.8	5.1	18.8	25.3	18.6	16.1	14.9	9.7	19.8	15.4	21.0	8.3	18.5	38.9	10.1	23.1	18.0	13.6	10.6	12.7	21.5	48.8	15.6	19.4	12.6	11.3	20.7	27.7	8.3	15.6	12.8	10.7	13.3	13.8	18.6	29.8	16.6	33.8	35.0	7.6	10.3	16.3	14.0	30.1	6.5	25.5	58.3	33.8	43.2	20.7	12.6	17.8	16.2	13.4	9.9	20.6	17.3	21.1	8.0	9.2	6.3	8.5	13.0	24.0	25.2	12.9	11.3	20.4	14.2	3.4	4.2	1.0	10.1	5.1	13.3	10.6	8.3	8.5	8.3	12.7	11.0	11.6	0.8	17.4	5.9	12.9	20.3	6.1	7.3	8.3	11.5	7.8	8.8	7.0	10.7	9.2	13.1	11.8	8.7	16.0	8.4	9.6	21.0	296.5	11.5	8.5	12.5	21.1	15.9	7.8	19.6	14.7	29.3	8.6	18.0	5.5	2.1	17.0	9.1	17.5	27.4	8.2	110.9	8.3	10.3	8.0	12.0	10.3	72.0	10.4	8.3	13.7	15.3	17.6	16.5	19.2	11.0	66.5	12.2	3.3	94.9	31.3	10.2	9.1	9.0	13.7	8.7	5.4	16.0	59.0	7.3	15.5	10.3	98.5	101.7	5.4	10.4	8.6	8.4	6.2	11.5	33.1	13.5	8.7	6.6	11.1	9.4	15.2	5.6	20.1	12.4	10.4	9.9	15.5	17.4	10.9
BCL3	"BCL4, D19S37"	ENSG00000069399	"BCL3 transcription coactivator"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 172.4;Squamous epithelial cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.5;neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.3;Karpas-707: 54.1;SiHa: 69.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: AB_2680074"	"prognostic favorable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	65.1	43.6	6.7	25.0	6.3	54.0	37.2	6.4	7.8	26.8	7.9	39.7	32.2	26.8	1.7	67.5	35.9	13.4	36.3	5.9	7.2	56.6	161.8	87.3	11.6	11.6	7.8	23.7	37.4	3.1	25.2	7.9	8.1	43.4	9.3	1.3	40.9	8.9	17.8	28.3	44.2	11.7	8.0	58.7	35.9	9.6	8.5	6.6	36.8	4.9	12.7	37.6	37.7	6.4	9.8	33.5	0.7	17.5	6.1	12.6	1.7	5.8	6.3	3.7	5.3	6.9	17.8	9.5	13.4	11.5	18.5	10.5	2.4	9.9	2.3	67.3	0.6	1.1	18.9	9.3	14.6	0.7	28.2	22.5	7.8	8.1	9.9	16.6	10.0	0.0	1.2	54.1	2.2	8.4	0.0	7.4	0.9	15.1	12.8	4.3	6.5	3.4	16.5	19.9	0.0	0.9	69.7	35.7	1.9	1.1	12.7	7.6	16.8	11.8	11.6	18.5	2.2	50.1	21.4	10.1	22.1	1.2	9.2	0.4	2.7	5.5	0.8	1.8	1.1	1.5	1.0	1.3	2.6	1.3	0.5	0.7	19.8	2.3	1.1	3.1	1.7	1.0	6.7	6.3	6.4	7.8	5.9	7.2	11.6	7.8	8.1	8.0	8.5	6.4	56.3	19.2	51.3	2.6	43.9	46.7	38.8	22.4	172.4	2.3	106.8	62.0	3.0	42.9	28.6	12.9	0.0	0.6	33.4	60.6	9.8	31.8	11.8	49.4	34.2	76.3	21.5	4.2	0.5	68.7	6.8	47.8	128.0	70.0	38.0	1.4	38.9	35.5	16.1	8.4	0.8	56.2	8.2	30.5	110.8	2.7	13.4	86.6	40.9	1.0	28.4	2.2	2.1	0.0	0.1	43.0	40.0	4.5	100.4	58.9	56.6	17.7	20.5	0.6	6.6	43.3	40.1	0.5	2.0	146.0	61.1	1.4	46.2	0.3	34.5	51.2
BCL6B	"BAZF, ZBTB28, ZNF62"	ENSG00000161940	"BCL6B transcription repressor"	Q8N143	17	7023050-7030290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 37.8;Endothelial cells: 45.0;Hepatic stellate cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 53.2;HUVEC TERT2: 96.2;TIME: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059147, HPA075112"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA059147: AB_2683928, HPA075112: AB_2732279"	"unprognostic (5.61e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (8.56e-5)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.26e-2)"	29.8	5.6	8.1	5.7	7.0	0.1	15.4	6.2	9.2	5.7	4.4	4.4	3.2	7.7	0.7	3.8	5.1	13.4	23.3	6.5	6.9	13.4	4.0	28.9	5.5	7.8	7.1	2.9	3.8	3.1	5.5	19.9	7.3	4.5	2.2	0.6	4.0	3.5	11.5	4.4	4.9	7.7	6.6	13.0	4.3	2.0	10.1	2.0	12.0	14.7	2.1	7.9	4.8	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	18.2	0.0	0.0	0.5	0.0	53.2	0.0	0.0	0.0	0.1	0.0	96.2	0.2	3.4	0.4	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	38.2	0.8	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.2	9.2	6.5	6.9	7.8	7.1	7.3	6.6	10.1	6.7	37.8	3.2	4.2	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	45.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	23.6	0.2	0.1	0.0	0.0	0.2	0.0	1.9	2.3	0.0	0.0	0.3	3.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.2	0.0	0.9	0.8	0.6	1.5	0.4	1.3	0.1	0.2	0.9	0.0	0.5
BCL9		ENSG00000116128	"BCL9 transcription coactivator"	O00512	1	147541501-147626216	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Oligodendrocyte precursor cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020274	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA020274: AB_2670400"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	3.7	6.2	6.1	4.5	5.6	3.2	3.9	7.6	5.8	10.8	1.1	8.6	4.8	14.4	13.7	4.9	16.4	4.6	7.7	5.6	7.1	6.8	3.5	4.5	3.9	6.0	5.2	14.6	5.0	10.8	7.2	4.1	4.1	9.1	6.9	7.4	7.5	11.1	8.1	7.1	4.7	13.9	4.1	3.1	6.2	5.5	4.9	11.1	6.8	6.2	4.4	7.1	6.5	4.8	5.5	5.3	36.4	27.2	4.1	4.8	7.1	4.4	6.9	4.7	4.6	6.9	8.1	5.2	9.6	4.1	7.9	4.3	23.3	8.0	4.4	12.4	6.5	2.5	5.7	4.6	3.5	1.6	7.2	4.8	6.7	5.6	4.1	8.4	7.4	16.8	4.9	8.3	4.2	12.4	13.1	1.2	43.2	11.0	11.5	13.8	9.2	10.1	18.4	6.0	10.0	21.4	4.9	9.0	8.6	33.3	11.4	2.5	5.5	3.3	15.5	9.4	7.1	36.6	10.0	9.7	8.4	1.4	16.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.2	6.1	5.6	7.6	5.8	5.6	7.1	6.0	5.2	4.1	4.1	4.9	4.8	4.6	0.0	2.2	39.5	2.1	3.1	6.0	2.8	14.8	12.1	10.1	5.0	7.4	7.2	2.9	12.9	2.1	2.1	1.2	3.2	11.7	4.4	10.5	21.0	17.5	4.1	28.3	0.0	12.9	4.7	2.5	7.5	2.6	24.6	8.8	12.8	5.7	3.7	1.3	6.7	20.7	7.9	4.1	1.9	1.4	5.3	9.6	1.9	0.0	8.4	1.1	4.8	4.1	31.2	24.2	4.5	1.4	7.9	4.4	6.1	1.3	7.0	4.8	3.1	0.0	6.8	7.3	4.0	8.6	9.7	3.7	2.1	3.6	4.8	6.6	3.3
BCO1	"BCDO, BCDO1, BCMO, BCMO1, FLJ10730"	ENSG00000135697	"Beta-carotene oxygenase 1"	Q9HAY6	16	81238689-81291142	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.0;intestine: 14.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Distal enterocytes: 4.8;Excitatory neurons: 8.0;Intestinal goblet cells: 5.5;Proximal enterocytes: 13.6;Proximal tubular cells: 8.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.5;EFO-21: 8.7;HAP1: 3.3;NTERA-2: 4.6;RPTEC TERT1: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043811			Uncertain	"Actin filaments,Centriolar satellite"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments, Centriolar satellite"		"HPA043811: AB_10962487"	"unprognostic (2.78e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.01e-4)"	"unprognostic (1.65e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	1.8	0.2	1.3	0.0	0.1	0.0	1.2	0.2	5.0	2.6	9.3	0.6	0.2	0.3	0.4	1.2	0.0	2.5	0.2	3.5	0.8	0.2	0.0	0.4	0.4	0.9	0.3	0.0	0.7	0.0	0.1	0.5	3.0	0.2	0.5	1.5	0.1	0.3	14.6	0.3	0.1	0.0	1.9	0.1	0.7	0.2	0.1	0.0	0.0	0.2	0.4	0.6	0.0	11.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	2.3	0.0	8.7	0.0	0.3	0.1	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.6	0.8	0.0	0.0	0.0	0.0	8.6	0.3	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.0	1.2	2.5	0.2	0.4	0.4	0.1	0.1	0.7	0.6	0.0	0.0	0.0	6.2	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	1.8	0.0	0.5	0.0	4.8	0.0	0.6	0.1	0.9	1.1	0.1	1.2	0.0	8.0	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.4	0.3	0.1	0.0	3.7	5.5	0.0	0.0	0.0	0.3	1.5	0.1	0.0	1.0	0.0	0.0	0.0	2.5	1.0	0.6	2.1	1.2	0.0	0.1	13.6	8.8	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.7	0.0	0.3	0.1	0.0	3.0	0.7
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR activator of RhoGEF and GTPase"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	19.4	11.1	34.3	11.0	65.7	34.6	17.4	15.9	30.7	14.3	10.6	11.7	10.0	12.3	16.1	24.5	12.1	9.3	12.2	45.0	22.2	21.1	13.8	18.6	13.7	27.1	26.5	9.4	14.6	20.6	25.0	10.3	24.1	11.8	7.6	7.4	18.3	10.1	5.8	23.5	10.2	8.8	20.9	11.4	16.1	11.0	35.0	14.7	19.7	5.7	10.8	15.3	14.3	14.1	47.6	20.1	30.3	31.2	17.7	12.1	45.6	16.8	15.7	15.2	12.2	35.6	18.7	32.9	30.5	14.4	14.7	47.6	3.6	46.8	4.3	63.3	32.3	28.8	27.7	28.6	22.9	26.9	14.6	10.2	31.1	22.8	19.8	27.0	53.6	23.3	112.5	15.1	7.0	31.3	25.4	21.4	25.8	37.4	19.5	32.9	12.4	21.7	23.7	29.6	27.7	26.3	30.7	26.1	12.6	19.3	16.6	21.7	61.4	9.1	1.0	14.9	14.0	3.4	14.8	11.7	23.4	20.1	14.3	0.0	0.5	0.0	3.1	0.2	1.1	0.6	1.5	1.6	0.4	0.6	1.3	1.7	0.5	1.5	0.5	0.4	0.8	1.4	34.3	65.7	15.9	30.7	45.0	22.2	27.1	26.5	24.1	20.9	35.0	14.1	19.3	9.6	11.5	51.2	4.5	15.4	11.9	18.2	6.2	22.9	17.1	9.9	7.5	17.2	20.9	18.4	22.9	14.0	23.9	17.7	9.8	14.4	5.6	22.1	8.0	27.8	19.9	5.5	24.6	16.6	6.8	7.1	11.7	31.4	10.8	9.9	70.6	22.1	7.2	23.5	20.7	13.9	12.2	9.3	11.1	13.5	8.7	9.2	5.4	18.7	6.6	13.2	15.5	32.2	7.0	27.7	8.1	5.7	10.7	11.8	10.7	18.2	12.5	9.4	0.0	4.0	6.8	2.7	7.3	9.3	15.8	10.8	10.3	10.0	13.7	13.3
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103077592-103099870	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 162.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 211.3;Proximal tubular cells: 795.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	45.0	96.6	23.3	4.3	25.8	3.5	39.7	27.0	27.3	46.6	27.1	31.8	39.4	31.2	16.6	27.2	43.4	14.9	46.6	20.3	27.8	162.1	70.5	35.9	6.7	28.4	26.5	54.8	23.2	30.8	29.2	7.7	27.0	31.9	10.3	8.5	32.8	14.1	24.6	26.1	39.6	9.6	25.2	21.2	38.9	14.8	28.2	17.5	62.9	16.7	7.3	37.1	37.3	26.5	3.1	5.3	26.5	10.0	30.4	29.4	3.4	6.7	17.8	6.9	10.6	3.4	11.8	12.4	11.1	10.2	2.1	1.5	17.3	10.1	8.2	8.2	8.5	1.5	6.4	8.1	15.0	7.4	2.1	24.8	9.1	10.6	2.6	23.0	20.7	14.3	8.0	5.5	24.1	1.0	37.2	6.3	9.6	2.0	2.1	24.5	30.7	7.9	46.4	3.6	4.5	12.0	12.8	6.7	7.9	9.6	5.7	5.3	9.9	10.7	3.4	5.5	3.7	8.1	7.9	12.5	11.8	8.9	5.4	2.6	2.5	0.2	7.6	1.4	8.8	4.8	6.6	6.0	3.2	6.7	9.8	10.4	0.4	6.5	0.2	5.0	10.2	4.0	23.3	25.8	27.0	27.3	20.3	27.8	28.4	26.5	27.0	25.2	28.2	26.5	37.7	32.1	57.8	33.6	10.2	30.3	47.1	59.4	36.5	2.5	31.9	36.1	9.6	64.3	46.9	108.5	0.0	7.9	19.0	18.0	211.3	58.2	1.9	60.6	45.5	30.3	22.9	16.4	1.2	21.3	18.5	75.2	41.8	27.9	19.6	39.1	27.8	71.6	20.4	3.3	3.8	24.4	46.8	10.9	16.9	4.8	69.9	12.5	23.2	14.0	14.9	50.4	14.4	3.5	21.8	23.0	18.6	77.8	8.0	18.9	162.3	795.7	48.7	3.8	13.1	40.9	36.5	0.9	4.0	25.9	26.7	3.4	18.2	52.6	37.6	37.5
BEND6	"bA203B9.1, C6orf65, FLJ30162"	ENSG00000151917	"BEN domain containing 6"	Q5SZJ8	6	56955107-57027346	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.9;retina: 11.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.6;Excitatory neurons: 87.3;Horizontal cells: 42.1;Inhibitory neurons: 118.6;Oligodendrocyte precursor cells: 49.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 8.8"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 8.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 28.8;fHDF/TERT166: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031605, HPA052973"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA031605: AB_10602395, HPA052973: AB_2682002"	"unprognostic (4.27e-1)"	"unprognostic (7.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.18e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.84e-6)"	"unprognostic (9.27e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.98e-3)"	1.2	2.1	12.1	1.5	14.2	0.7	0.6	30.5	30.9	4.0	2.9	1.4	0.5	2.8	0.7	1.2	1.0	3.8	2.4	12.6	16.0	0.6	0.2	0.6	0.9	19.5	16.0	2.0	0.4	0.7	1.7	2.0	20.4	2.4	1.5	11.8	0.5	2.4	3.9	1.0	0.7	3.6	12.1	0.8	0.8	1.0	15.7	1.1	0.8	0.6	0.8	2.8	1.7	21.7	5.4	2.2	1.3	0.6	17.6	28.8	4.9	16.1	15.6	7.1	8.2	0.2	2.4	0.1	5.2	28.7	9.9	0.7	1.8	0.8	8.7	2.4	1.0	3.6	7.5	0.4	4.7	10.3	0.2	12.7	4.5	9.8	4.3	11.9	4.7	13.3	4.6	9.2	14.3	5.5	6.2	2.5	4.4	0.3	1.3	0.1	0.2	2.6	2.6	5.4	6.1	6.2	10.8	1.3	1.4	6.1	0.3	5.9	6.1	21.5	0.7	14.5	3.6	12.6	15.2	4.3	12.6	6.5	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	8.8	0.0	0.1	12.1	14.2	30.5	30.9	12.6	16.0	19.5	16.0	20.4	12.1	15.7	21.7	0.4	0.0	0.0	16.6	0.3	0.9	0.2	0.2	0.0	82.6	0.2	1.1	3.6	0.0	0.7	0.0	4.2	0.5	10.8	0.0	0.0	0.2	0.6	0.5	11.9	0.2	0.0	0.0	87.3	0.4	1.6	5.6	0.0	0.5	0.0	13.5	1.1	0.0	0.1	42.1	118.6	0.0	0.0	0.0	4.0	0.8	1.8	1.1	3.6	13.1	0.3	4.9	0.0	49.8	22.9	0.6	0.0	3.0	0.0	0.4	0.0	1.0	0.0	4.8	0.0	8.7	2.7	0.7	5.8	0.2	1.0	0.0	0.1	4.4	0.0	0.1
BEND7	"C10orf30, FLJ40283"	ENSG00000165626	"BEN domain containing 7"	Q8N7W2	10	13438484-13528974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 167.3;Late spermatids: 268.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;hTERT-RPE1: 17.3"									HPA037835	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center, Vesicles"		"HPA037835: AB_10669722"	"unprognostic (6.22e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.20e-3)"	8.0	6.0	4.7	2.4	4.9	0.7	9.4	6.5	4.7	7.4	4.9	11.2	16.5	7.3	13.6	2.2	12.4	6.5	7.4	5.0	4.9	18.5	9.0	9.1	1.1	5.1	5.9	8.3	12.1	14.8	10.3	4.3	5.9	5.7	6.6	15.4	15.1	6.5	16.4	3.2	19.3	6.1	4.7	3.0	11.2	16.3	5.6	0.5	23.5	13.3	1.0	6.8	4.4	4.4	9.9	5.9	6.0	2.2	0.1	0.0	8.7	3.8	0.1	9.3	5.6	2.4	17.5	0.0	5.1	7.3	5.2	0.4	9.8	2.1	8.3	0.0	8.7	0.0	0.0	11.4	3.9	0.0	0.0	0.2	5.7	1.2	0.0	17.3	10.3	1.4	4.3	0.0	9.3	4.0	0.1	0.0	1.8	0.0	1.0	0.0	4.4	0.0	8.0	1.3	0.4	4.7	10.7	0.0	0.1	9.1	0.1	4.7	9.2	1.1	13.8	11.6	4.8	0.0	0.0	0.0	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.7	4.9	6.5	4.7	5.0	4.9	5.1	5.9	5.9	4.7	5.6	4.4	33.6	22.4	11.6	23.5	1.9	3.4	23.6	1.1	1.8	14.4	15.4	11.4	11.0	22.8	9.8	20.2	8.4	3.0	2.6	13.2	3.9	13.0	167.3	25.0	5.8	16.7	7.8	0.0	7.5	16.5	2.9	8.0	9.7	36.2	6.3	14.7	22.5	9.6	3.0	1.7	10.2	8.5	6.1	9.4	1.9	268.7	5.0	2.5	3.6	24.4	4.5	20.3	12.3	47.7	0.7	21.8	9.5	6.0	0.5	23.9	45.2	52.0	9.7	32.2	0.0	14.1	8.4	21.5	20.0	3.3	1.8	2.5	3.5	3.4	10.3	36.1
BET1L	"GOLIM3, GS15"	ENSG00000177951	"Bet1 golgi vesicular membrane trafficking protein like"	Q9NYM9	11	167784-207428	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039819	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA039819: AB_10673020"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.49e-2)"	36.2	38.2	26.8	29.4	28.2	18.0	35.5	26.5	27.6	43.2	33.2	37.0	29.1	37.0	37.3	30.1	38.8	27.5	34.3	25.6	27.1	40.4	53.5	35.4	32.9	31.0	28.5	53.6	79.9	39.9	56.0	29.8	28.0	43.4	29.8	17.1	52.9	41.6	22.5	36.1	39.4	31.3	27.5	39.4	43.1	33.0	27.5	28.2	37.5	23.4	35.7	37.4	33.2	30.1	46.2	37.6	22.0	27.3	66.5	58.3	31.8	48.1	62.8	50.6	51.5	47.3	43.4	40.5	22.9	87.7	36.4	42.1	25.6	44.0	38.3	31.6	27.7	37.5	21.5	48.2	61.4	43.2	70.2	66.2	58.1	29.8	79.6	58.7	34.7	28.2	55.7	41.3	32.7	25.0	31.7	27.3	33.6	66.8	42.3	32.6	32.6	27.7	41.8	20.3	23.9	29.0	42.9	68.5	47.7	31.5	35.2	33.6	38.6	39.0	18.0	16.0	24.0	72.2	35.9	35.6	52.7	35.6	36.4	58.5	19.0	66.0	28.4	27.5	34.1	31.9	32.5	29.1	19.0	25.0	37.4	29.6	43.5	27.9	25.8	22.1	27.4	32.5	26.8	28.2	26.5	27.6	25.6	27.1	31.0	28.5	28.0	27.5	27.5	30.1	9.8	12.8	17.0	3.9	23.0	9.3	16.8	12.8	16.5	6.8	21.3	19.0	14.5	15.7	10.7	14.7	8.4	15.8	16.9	24.4	21.5	12.8	58.8	8.6	13.2	10.6	7.8	12.0	3.6	23.4	28.2	19.4	20.9	10.1	38.0	10.2	18.2	39.3	22.7	3.3	4.4	23.1	14.2	16.4	12.7	142.9	22.1	18.4	7.2	2.8	14.8	9.1	10.3	4.0	4.7	18.6	26.1	18.8	68.3	29.2	39.2	28.7	12.6	10.4	6.6	12.8	15.9	47.2	21.8	11.9	11.6	26.3	19.4	8.9	17.1	29.3
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064171	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 439.4;pituitary gland: 399.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 354.2;Granulosa cells: 260.7;Horizontal cells: 363.4;Muller glia cells: 716.1;Rod photoreceptor cells: 142.2"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 607.0;HBF TERT88: 680.4;HL-60: 1562.2;hTERT-RPE1: 1044.5;SCLC-21H: 465.3;U-937: 484.1"									"HPA045384, HPA078630"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA045384: AB_2679305, HPA078630: "	"prognostic favorable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.34e-2)"	1.5	83.8	253.7	3.8	260.1	42.7	2.5	201.9	317.4	5.5	142.9	10.5	5.0	15.6	55.5	0.8	21.4	1.3	16.7	274.9	439.4	10.7	4.2	2.8	1.2	222.6	248.2	20.2	71.6	112.0	399.2	0.4	261.1	6.7	4.3	173.0	2.3	3.6	0.6	1.0	6.3	4.8	203.1	2.5	8.6	92.9	265.5	3.5	26.0	0.8	0.4	0.8	2.9	223.9	0.7	0.0	37.6	0.1	0.0	0.1	1.1	21.6	0.0	412.1	607.0	0.0	0.1	0.1	0.8	158.1	130.0	0.4	0.0	0.5	680.4	0.2	1.2	129.2	0.0	85.2	6.9	1562.2	2.6	9.2	0.0	89.3	0.1	1044.5	0.1	120.8	0.2	0.2	84.6	0.0	294.7	0.2	337.9	97.8	62.0	0.2	0.7	7.6	0.0	0.3	465.3	266.6	0.5	0.6	1.9	5.9	0.3	432.4	0.0	0.1	140.2	1.1	16.7	71.9	2.9	0.7	54.4	484.1	27.2	0.4	0.2	3.4	0.3	0.0	0.3	0.5	0.9	0.5	0.0	1.0	1.4	0.6	0.5	0.9	0.2	0.1	0.4	0.7	253.7	260.1	201.9	317.4	274.9	439.4	222.6	248.2	261.1	203.1	265.5	223.9	1.1	0.0	0.5	16.3	1.2	8.7	11.1	0.0	1.2	354.2	7.2	32.5	9.6	31.5	0.7	5.5	39.6	0.2	0.2	0.4	72.4	6.1	12.1	1.4	0.6	5.3	79.6	0.8	64.6	13.8	0.2	3.9	8.2	2.8	0.0	260.7	30.4	1.2	1.4	363.4	56.1	6.9	10.2	4.0	1.2	31.8	8.1	2.2	7.2	12.2	1.5	716.1	0.0	32.6	20.9	6.3	3.3	2.6	0.0	7.5	0.8	19.5	0.0	142.2	0.0	15.9	14.4	38.5	13.8	0.0	6.5	0.5	2.0	0.2	3.5	1.7
BEX2	DJ79P11.1	ENSG00000133134	"Brain expressed X-linked 2"	Q9BXY8	X	103309346-103311007	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 194.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 418.7;Muller glia cells: 285.9;Proximal tubular cells: 201.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 52.7;NK-cells: 62.0;T-cells: 68.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 94.7;NTERA-2: 91.4;SCLC-21H: 135.2;SH-SY5Y: 61.4"									"HPA045384, HPA078630"	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA045384: AB_2679305, HPA078630: "	"unprognostic (7.56e-2)"	"unprognostic (7.08e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (8.54e-7)"	"unprognostic (3.21e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.27e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (7.36e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.22e-3)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.05e-13)"	"unprognostic (4.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	5.8	73.6	133.5	6.8	134.9	13.7	19.4	119.0	167.3	16.4	98.2	10.2	3.4	27.6	123.8	9.9	15.5	7.6	29.5	134.4	153.2	58.7	2.5	12.7	14.2	120.7	125.6	62.8	35.5	123.1	194.6	8.0	123.7	24.2	6.0	83.5	26.7	21.0	9.1	17.1	14.0	8.7	117.7	18.5	16.7	43.1	138.6	21.0	103.3	11.5	16.9	8.7	10.7	132.2	0.0	2.8	11.3	0.1	0.2	0.0	45.5	0.3	6.1	7.7	11.3	8.4	3.8	0.0	31.6	0.0	55.4	2.0	0.1	9.4	6.6	0.1	25.4	1.4	1.4	0.4	46.0	0.1	25.4	2.8	94.7	3.7	29.1	17.8	0.5	33.6	17.4	0.7	1.0	4.2	20.1	0.2	91.4	0.0	8.4	0.1	0.0	0.2	3.8	3.7	135.2	61.4	5.9	1.4	22.2	10.7	11.2	0.1	0.0	0.1	9.0	0.3	2.1	30.8	21.6	0.1	15.3	0.0	1.3	13.4	0.4	1.1	21.8	0.4	31.0	52.7	43.8	25.7	1.6	42.3	68.6	50.0	1.4	62.0	0.1	10.0	33.7	18.4	133.5	134.9	119.0	167.3	134.4	153.2	120.7	125.6	123.7	117.7	138.6	132.2	3.7	16.0	68.5	15.0	41.6	31.6	95.6	17.4	100.7	184.7	65.8	145.5	27.0	60.1	43.4	114.0	43.8	72.2	20.9	5.0	418.7	47.5	17.9	11.6	3.3	13.7	100.5	9.4	56.7	42.7	19.9	13.1	23.0	17.0	12.7	87.6	3.6	0.9	7.0	121.1	53.0	29.6	16.2	0.3	5.3	69.4	15.8	4.6	26.6	7.5	2.5	285.9	27.8	35.2	25.8	19.8	8.4	22.2	16.5	64.5	3.7	201.3	9.0	120.5	6.6	32.0	11.4	16.8	5.8	25.7	26.7	63.8	30.2	22.3	22.3	51.1
BFSP1	"CP115, CP94, filensin, LIFL-H"	ENSG00000125864	"Beaded filament structural protein 1"	Q12934	20	17493905-17569220	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 5.7;NK-cells: 17.5;Spermatogonia: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.8;RPTEC TERT1: 19.5;SK-BR-3: 10.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"amygdala: 2.5;cerebral cortex: 3.2;hippocampal formation: 3.6"	"HPA040748, HPA042038"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040748: AB_10963786, HPA042038: AB_10964054"	"unprognostic (2.24e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-6)"	"unprognostic (5.11e-2)"	"unprognostic (5.53e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.35e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.50e-2)"	1.1	1.3	2.0	0.5	2.2	0.4	1.1	1.6	2.1	1.3	2.0	1.3	0.3	1.8	1.4	1.1	1.3	1.3	0.7	2.2	2.1	3.7	0.3	1.7	0.3	1.7	1.8	1.5	1.9	1.0	0.9	1.9	1.8	1.2	0.5	0.4	1.5	1.1	0.3	1.0	0.7	1.1	1.5	0.4	0.9	3.8	2.1	0.2	2.5	0.4	0.3	1.3	0.9	2.4	0.8	8.1	2.6	0.3	0.7	2.6	0.4	2.0	9.5	1.3	1.2	3.7	7.0	0.0	1.6	1.2	5.1	1.2	2.8	1.6	1.0	1.8	2.1	0.6	1.2	1.1	1.5	0.5	0.9	3.1	4.9	0.7	2.3	10.8	5.7	0.5	0.3	0.4	4.2	1.6	0.0	1.2	6.1	5.2	2.2	0.0	1.8	0.4	19.5	1.5	2.7	0.3	2.4	10.6	4.3	1.2	5.2	1.8	6.5	0.3	0.6	0.7	2.0	0.0	0.1	0.0	1.4	0.0	1.6	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.0	0.2	2.0	2.2	1.6	2.1	2.2	2.1	1.7	1.8	1.8	1.5	2.1	2.4	3.8	3.2	1.7	0.7	0.0	0.9	0.5	0.7	0.0	0.2	1.9	1.5	1.2	1.5	0.4	0.0	0.0	1.2	2.6	0.1	1.9	0.8	1.3	1.1	0.4	3.1	0.0	0.8	2.1	0.9	1.7	1.2	1.5	0.6	0.0	0.2	3.9	0.2	0.5	0.0	1.2	0.2	0.0	0.0	0.8	5.7	1.8	0.2	1.8	2.8	0.0	1.0	17.5	0.5	1.1	0.8	0.0	0.0	0.4	0.4	0.0	0.3	1.8	0.1	0.0	0.5	1.0	1.1	11.9	1.1	0.9	0.4	1.0	0.4	0.3	0.5
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111809-79132288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	83	"kidney: 778.9;liver: 1141.8"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 604.2;Proximal tubular cells: 996.1"	"Group enriched"	"Detected in some"	4	"liver cancer: 90.6;renal cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.6;NTERA-2: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		No	NA		10000000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favorable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.7	0.3	0.3	0.0	0.8	0.0	0.5	0.0	0.5	0.3	0.1	0.6	1.2	0.2	1.8	0.1	0.2	0.2	0.2	0.5	0.3	778.9	1141.8	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	3.2	0.3	0.3	0.5	0.4	0.0	0.0	11.6	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.5	0.3	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	4.3	0.0	16.5	0.0	0.0	0.0	0.0	78.2	0.0	0.5	0.1	0.8	0.8	0.0	13.5	0.9	0.0	0.1	0.1	8.2	0.2	0.0	0.1	8.9	604.2	0.0	0.0	0.2	0.4	0.0	12.2	0.0	0.5	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	2.6	0.0	0.0	0.0	996.1	0.0	0.4	0.0	0.2	0.1	0.2	1.0	0.0	0.0	0.1	4.2	0.5	0.1	0.3
BICC1		ENSG00000122870	"BicC family RNA binding protein 1"	Q9H694	10	58512872-58831435	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 120.5;Cholangiocytes: 158.7;Collecting duct cells: 86.5;Ductal cells: 98.5;Fibroblasts: 79.6;Microglial cells: 165.8;Proximal tubular cells: 148.2"	"Group enriched"	"Detected in all"	4	"pancreatic cancer: 9.2;renal cancer: 25.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 59.1;BJ hTERT+: 61.4;CACO-2: 93.1;RPTEC TERT1: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070797			Approved	Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Centrosome	"HPA070797: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.79e-2)"	"unprognostic (6.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.40e-3)"	"unprognostic (7.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.94e-2)"	10.6	6.1	0.3	4.0	0.5	0.3	8.7	0.0	1.6	5.8	1.9	4.5	1.2	4.9	4.0	3.5	7.5	11.6	10.5	0.6	1.0	28.6	2.4	5.8	2.4	1.2	0.6	13.9	16.9	0.8	3.6	3.6	0.2	3.8	4.1	1.4	4.3	4.2	7.6	6.1	2.7	4.7	1.2	2.9	2.7	3.1	0.7	1.4	4.6	6.2	2.7	5.5	5.6	0.7	0.0	59.1	0.8	0.0	17.9	23.0	0.0	38.5	61.4	34.4	40.4	93.1	12.3	0.0	39.8	39.3	8.8	0.8	6.1	7.0	47.4	0.1	5.9	0.0	7.4	0.1	11.5	0.0	0.0	36.0	2.2	26.9	28.6	42.3	0.1	0.0	0.0	0.2	13.4	0.1	0.0	0.0	0.5	0.0	3.8	0.0	14.3	0.0	140.8	7.1	0.2	7.3	0.1	0.4	3.4	2.4	0.0	0.6	0.0	8.2	7.7	1.4	5.0	0.0	0.0	0.1	23.8	0.0	7.8	6.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.5	0.1	0.0	0.3	0.5	0.0	1.6	0.6	1.0	1.2	0.6	0.2	1.2	0.7	0.7	4.1	0.0	0.5	120.5	1.5	7.1	1.3	1.3	0.6	0.6	1.1	4.3	3.3	158.7	1.7	86.5	0.0	0.4	0.1	0.3	78.2	98.5	5.2	43.8	14.4	1.4	3.6	0.0	70.4	3.5	0.2	79.6	0.5	7.2	0.0	4.2	3.3	1.4	3.5	0.0	37.2	1.2	0.0	0.6	18.5	3.2	71.1	1.7	21.4	165.8	1.1	10.1	0.0	25.6	2.7	35.3	1.2	50.0	0.3	2.4	0.0	148.2	14.1	0.2	6.6	40.0	9.8	0.1	3.9	0.3	4.7	4.1	1.5	8.7	1.6	0.1
BICDL2	CCDC64B	ENSG00000162069	"BICD family like cargo adaptor 2"	A1A5D9	16	3027682-3036944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 104.8;pancreas: 127.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 52.2;Breast myoepithelial cells: 22.1;Ductal cells: 34.3;Endometrial ciliated cells: 28.9;Exocrine glandular cells: 49.8;Glandular and luminal cells: 28.3;Pancreatic endocrine cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;BEWO: 15.4;CAPAN-2: 14.4;HaCaT: 22.5;MCF7: 22.8;RT4: 10.8;SK-BR-3: 11.0;T-47d: 14.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.7"	HPA043251	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Intermediate filaments, Actin filaments, Cytosol"		"HPA043251: AB_10794925"	"unprognostic (2.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.06e-3)"	"unprognostic (9.65e-5)"	"unprognostic (5.79e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.32e-2)"	"prognostic favorable (9.04e-4)"	0.4	0.0	0.2	1.9	0.2	0.0	8.6	0.4	0.4	20.7	0.1	25.1	10.4	0.7	2.6	104.8	6.0	3.4	0.0	0.2	0.1	5.8	0.9	5.9	0.0	0.6	0.3	0.1	127.2	4.1	1.5	0.3	0.8	16.8	6.4	0.0	44.4	3.2	0.6	43.8	13.5	0.2	0.2	0.2	21.5	0.1	0.3	0.2	6.1	0.0	3.1	11.4	44.3	0.2	9.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	2.6	14.4	0.0	0.0	0.0	0.0	22.5	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	6.4	0.0	0.1	0.0	0.2	0.0	10.8	0.2	0.1	0.0	11.0	0.0	0.3	14.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.2	0.1	0.6	0.3	0.8	0.2	0.3	0.2	0.3	12.8	18.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	52.2	22.1	0.0	0.0	12.4	16.5	0.0	4.5	1.3	0.0	3.9	34.3	0.0	28.9	2.8	0.5	0.0	0.0	0.0	49.8	6.1	0.6	0.0	28.3	2.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.1	0.0	0.0	0.2	12.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.6	0.3	0.0	0.0
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	23.2	27.6	18.4	25.8	19.6	36.4	28.2	20.0	23.4	27.5	22.5	27.2	23.6	25.7	30.2	18.1	19.7	24.8	23.6	17.9	19.9	28.8	44.3	22.6	34.5	19.7	19.4	21.8	33.7	20.4	18.8	29.4	19.8	21.4	26.0	22.2	21.1	16.1	29.7	18.2	25.2	21.6	20.1	26.7	23.5	24.6	18.8	50.6	22.2	32.9	27.1	30.4	20.4	24.9	34.0	24.7	37.3	29.3	46.1	63.3	23.9	128.3	48.8	71.9	43.4	30.9	81.7	37.1	123.5	59.2	40.3	36.7	24.5	33.8	85.7	50.0	12.6	37.2	17.6	37.8	46.9	22.9	23.0	40.8	64.4	41.2	52.3	66.2	50.1	22.2	34.4	0.2	131.0	10.9	24.3	20.1	18.1	40.1	23.7	11.9	48.4	24.9	55.4	38.5	15.5	20.3	44.7	26.9	40.7	56.7	42.5	27.3	82.7	150.7	34.4	46.2	84.2	14.9	21.9	25.0	32.6	28.2	112.5	97.2	43.3	104.4	22.9	42.2	18.9	15.7	21.5	21.3	33.8	15.1	27.4	27.7	67.6	34.3	46.7	20.4	33.2	27.5	18.4	19.6	20.0	23.4	17.9	19.9	19.7	19.4	19.8	20.1	18.8	24.9	61.8	41.7	41.1	17.0	52.6	67.2	109.2	53.6	39.9	24.4	52.3	52.8	58.6	67.2	49.5	64.4	29.2	38.4	77.9	85.7	43.0	49.8	20.8	63.2	54.0	51.0	48.5	80.0	22.4	73.7	27.8	55.9	28.5	85.7	62.7	43.7	59.3	182.1	41.5	20.2	21.7	54.3	46.8	84.3	71.5	11.2	36.4	71.1	51.6	26.2	81.2	34.3	55.6	21.6	33.1	54.5	71.1	29.0	49.2	75.0	82.1	110.1	56.6	31.0	26.3	45.7	48.9	44.7	42.4	28.4	62.8	35.2	57.1	36.4	44.2	82.5
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Protease inhibitor, Repressor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;lymphoid tissue: 41.0;testis: 19.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.7;Early spermatids: 94.1;Erythroid cells: 166.7;Extravillous trophoblasts: 162.0;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 14.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Cytokinetic bridge"		"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.28e-6)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	0.9	1.1	0.3	8.5	0.5	37.9	5.1	0.6	0.6	1.9	0.4	6.7	7.9	1.6	0.0	12.8	0.6	1.1	0.5	0.4	0.4	0.7	2.1	1.9	16.2	0.6	0.6	0.4	0.6	0.2	0.2	6.1	0.5	0.6	8.0	0.1	1.8	0.2	1.1	5.8	7.6	4.3	0.4	5.8	3.7	19.6	1.0	41.0	0.4	0.1	16.3	2.6	3.2	0.8	139.1	126.2	111.3	121.5	6.7	11.3	41.0	103.6	57.5	144.0	94.2	104.0	52.9	140.7	41.5	60.5	108.7	71.9	113.6	66.6	125.2	48.2	157.5	93.2	71.4	123.1	0.8	90.8	67.0	3.9	4.5	79.8	59.2	21.0	103.5	104.3	118.8	116.0	112.6	79.7	195.5	86.2	83.4	96.3	218.0	100.5	180.2	108.4	34.5	50.2	136.8	94.8	80.3	88.6	71.7	54.1	117.5	84.8	39.5	173.1	152.6	76.0	150.4	83.3	72.2	163.3	63.3	37.8	154.4	0.0	0.0	0.0	0.7	0.0	0.1	2.4	4.1	2.8	0.8	0.2	0.0	0.4	0.5	2.4	0.0	0.2	14.1	3.1	0.3	0.5	0.6	0.6	0.4	0.4	0.6	0.6	0.5	0.4	1.0	0.8	1.2	0.0	20.0	0.0	15.9	8.2	3.7	12.2	2.8	0.7	7.7	8.6	2.3	2.8	10.8	0.0	0.0	74.7	3.3	10.7	0.0	2.0	94.1	5.4	5.1	8.8	3.0	166.7	0.4	0.0	162.0	15.1	8.6	6.9	9.5	42.7	12.8	2.7	52.1	0.0	0.2	17.1	10.2	13.7	13.8	68.4	3.1	9.6	1.8	0.0	0.6	0.4	7.2	0.0	0.3	0.4	2.5	0.7	50.2	2.8	3.2	0.1	2.6	0.5	6.6	0.9	15.2	191.1	58.2	31.3	6.5	19.2	10.1	3.4	38.8	6.3
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	4.6	4.7	3.1	6.7	9.7	11.3	8.9	13.9	5.7	7.7	6.3	7.6	5.0	6.8	5.2	5.3	6.2	5.8	4.9	4.6	3.7	7.6	8.9	5.4	9.6	6.4	5.5	12.0	14.7	10.9	2.9	6.9	7.3	6.2	7.5	15.5	5.5	5.9	6.1	6.7	5.4	6.1	4.4	8.5	7.1	6.8	5.6	14.7	11.4	8.8	9.7	7.2	3.1	16.3	21.7	17.8	16.1	7.9	14.9	19.1	11.3	10.8	14.1	11.0	11.3	14.2	5.7	23.6	7.3	19.7	13.2	10.1	22.9	15.1	13.9	18.8	10.5	31.2	11.3	10.7	7.9	32.4	11.9	12.4	6.9	18.0	16.2	10.1	17.7	5.4	25.6	10.0	11.9	9.3	15.5	7.5	11.7	9.2	10.5	14.6	26.6	8.2	9.2	23.4	11.7	18.4	18.6	10.8	8.2	12.5	6.4	11.5	28.7	13.0	13.3	9.1	15.3	13.9	20.0	30.6	10.1	15.1	8.7	9.7	0.9	0.6	1.3	0.7	1.8	0.8	1.0	1.2	0.7	1.8	1.1	1.4	1.5	1.6	1.5	1.6	1.0	0.5	3.1	9.7	13.9	5.7	4.6	3.7	6.4	5.5	7.3	4.4	5.6	16.3	53.9	32.1	30.5	239.3	74.8	46.0	28.6	34.7	41.5	60.8	40.0	23.4	45.8	38.6	42.7	36.8	191.8	35.0	93.4	70.1	1.9	26.9	45.9	39.3	58.0	49.8	32.5	34.3	272.0	31.2	22.0	39.7	68.3	63.1	29.9	52.1	45.7	47.5	29.8	69.0	291.3	43.3	26.4	54.7	60.0	17.6	45.4	59.1	23.2	202.4	67.2	34.9	64.9	231.8	361.3	34.3	30.3	59.0	70.9	46.4	48.5	22.6	30.6	88.2	39.5	56.0	49.1	53.7	46.2	49.7	54.8	38.0	72.4	52.8	45.3	44.0
BLCAP	BC10	ENSG00000166619	"BLCAP apoptosis inducing factor"	P62952	20	37492472-37527931	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 466.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 358.9"	"Low region specificity"	"Detected in all"							HPA047390			Approved	Nucleoli		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli		"HPA047390: AB_2680025"	"unprognostic (1.05e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.28e-5)"	65.3	56.2	161.7	27.2	189.7	35.9	59.5	106.0	147.2	49.3	159.6	54.9	51.1	34.5	52.5	86.3	141.0	29.0	75.7	147.4	163.5	60.5	101.0	37.3	40.0	123.5	137.6	40.8	27.3	50.8	149.1	76.0	145.4	59.5	52.2	70.9	57.2	56.3	466.4	88.3	48.0	34.0	108.3	46.8	39.2	30.6	197.8	41.6	45.5	120.2	53.1	72.5	60.0	117.3	138.0	38.8	45.8	48.6	86.2	66.0	63.8	64.3	62.2	56.4	45.5	137.9	109.3	70.7	62.1	90.1	53.7	259.1	34.4	268.1	57.5	14.7	31.5	23.2	94.0	130.5	55.8	46.5	29.9	84.8	283.9	54.3	101.0	46.1	79.6	51.3	22.7	51.9	114.1	77.0	39.0	37.1	36.9	77.6	109.6	36.6	171.0	47.2	64.6	358.9	41.8	50.2	77.3	221.2	54.7	46.5	73.6	44.4	75.2	144.6	37.2	51.3	28.2	28.1	37.5	34.2	60.4	42.4	26.5	74.9	56.6	69.9	45.2	56.0	49.6	93.9	51.3	48.4	52.8	113.6	67.1	52.6	59.3	48.2	53.8	22.6	55.4	52.8	161.7	189.7	106.0	147.2	147.4	163.5	123.5	137.6	145.4	108.3	197.8	117.3	24.4	80.1	31.0	14.0	38.4	147.0	97.3	135.9	137.1	43.0	29.0	60.8	56.8	30.0	68.7	40.5	22.9	115.1	25.5	72.4	82.2	35.7	73.7	58.8	26.3	54.0	40.9	15.6	26.8	33.9	84.8	29.5	17.9	18.1	29.2	32.1	89.6	81.0	55.8	42.1	29.8	58.8	52.9	41.9	36.2	161.7	29.8	29.1	35.6	13.1	30.1	64.0	24.7	16.6	11.4	54.0	31.4	59.5	16.5	88.6	69.9	55.7	63.2	36.2	32.9	28.6	27.0	30.8	27.1	66.8	122.9	65.0	26.1	54.0	33.3	133.4
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564599	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 39.1;lymphoid tissue: 46.7"	"Cell type enriched"	"Detected in some"	11	"B-cells: 116.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 183.4;naive B-cell: 131.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 183.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 106.6;REH: 29.9;RPMI-8226: 38.5;U-698: 48.6;U-87 MG: 22.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB005093, HPA069571"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.1	0.0	9.1	0.0	2.6	0.2	0.0	0.0	0.0	0.0	2.6	0.5	0.1	0.0	1.2	0.2	0.5	0.1	0.0	0.0	1.2	0.7	0.8	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.0	0.7	0.0	0.3	0.0	39.1	0.1	0.0	46.7	2.1	0.1	0.0	2.5	1.2	0.0	27.9	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	29.9	0.0	38.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	5.4	10.2	48.6	22.7	0.0	0.0	0.2	0.1	0.2	2.0	0.0	37.9	183.4	1.4	4.6	0.1	131.5	0.9	0.4	0.7	0.1	0.1	17.5	1.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	116.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.1	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	4.0	0.1	0.1	0.0
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248203-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 130.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		42000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	20.6	13.5	13.4	18.2	15.0	18.1	20.4	15.9	17.6	19.1	14.5	18.8	12.4	21.2	21.1	28.3	14.7	18.4	15.6	13.5	15.2	22.0	14.0	16.0	26.0	15.6	14.1	13.9	26.8	21.7	9.7	27.4	15.4	14.4	15.4	14.7	15.6	14.4	28.8	130.3	18.3	22.4	14.7	20.6	16.2	15.9	14.2	36.3	16.5	19.0	26.9	17.9	21.5	16.2	40.3	62.9	61.5	41.6	40.6	43.8	27.8	36.5	24.0	59.1	50.8	93.2	11.9	119.5	63.3	31.1	26.1	27.1	135.5	52.8	50.1	31.5	101.4	73.5	54.6	80.0	58.3	136.1	43.2	50.5	3.5	46.5	26.5	47.1	87.2	98.2	157.9	47.6	24.6	31.0	168.1	98.6	57.2	0.0	29.2	143.0	154.5	78.9	46.8	35.6	135.1	48.4	32.6	63.2	42.2	106.6	42.9	68.5	54.5	35.0	69.2	16.0	66.0	55.8	124.1	159.3	26.7	0.2	47.6	0.0	8.8	1.5	15.3	6.2	25.3	6.5	18.2	20.2	10.1	7.3	16.4	17.8	1.2	16.3	3.3	10.1	20.0	9.9	13.4	15.0	15.9	17.6	13.5	15.2	15.6	14.1	15.4	14.7	14.2	16.2	21.0	3.2	12.6	13.4	8.8	15.9	16.7	10.6	19.4	20.2	10.3	6.6	17.8	12.8	4.0	11.0	12.5	49.6	15.6	7.6	7.9	17.4	8.4	7.4	28.2	24.0	18.0	22.5	19.0	14.2	38.0	18.3	11.2	7.0	43.8	30.5	25.7	6.9	25.0	13.5	20.9	8.4	6.1	18.9	7.1	6.6	16.1	13.0	10.6	18.7	12.2	9.9	22.6	29.1	22.6	7.2	9.6	24.8	20.0	13.0	11.5	20.0	5.5	15.7	6.6	12.9	19.7	14.9	29.1	24.0	12.6	27.5	20.9	34.8	11.5	7.6
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465764	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 625.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 3131.8;Hofbauer cells: 1099.2;Proximal enterocytes: 864.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 465.2"	"Group enriched"	"Detected in all"	7	"dendritic cells: 343.3;monocytes: 465.2"	"Cell line enhanced"	"Detected in many"		"A549: 506.6;K-562: 506.8;OE19: 451.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	115.7	76.8	46.6	48.2	46.9	625.2	93.8	49.4	61.0	86.2	52.1	78.5	75.1	59.0	20.5	188.8	69.3	50.9	125.6	44.5	48.0	103.1	266.2	102.8	58.9	56.0	48.6	66.7	73.2	46.1	25.2	52.1	58.5	74.3	30.3	5.5	89.4	42.2	210.4	83.9	72.2	31.7	49.8	166.7	138.4	10.2	52.3	27.5	64.5	94.1	25.3	81.0	96.5	53.4	227.9	506.6	7.3	77.7	73.7	70.2	57.3	28.0	88.7	39.3	75.4	103.4	203.8	74.3	212.3	56.3	126.8	73.1	30.4	64.6	10.5	123.8	20.0	114.9	73.4	62.4	169.8	1.6	32.2	69.2	119.4	52.4	34.2	40.1	41.8	27.4	506.8	137.0	51.0	359.2	6.1	7.2	1.9	451.4	133.8	54.0	23.4	120.3	50.9	146.5	0.4	10.5	84.5	224.5	84.4	13.2	221.5	17.6	39.2	99.4	103.9	156.4	15.9	71.7	92.1	28.5	259.1	46.2	39.0	45.5	465.2	18.0	29.2	220.9	27.0	58.2	24.3	24.5	343.3	37.5	24.7	19.3	58.4	27.4	117.7	75.8	37.3	259.4	46.6	46.9	49.4	61.0	44.5	48.0	56.0	48.6	58.5	49.8	52.3	53.4	74.6	221.2	164.5	9.4	34.4	129.4	348.5	337.9	103.6	11.2	93.8	143.0	130.5	164.5	184.2	97.5	6.2	84.9	39.5	343.6	266.1	234.2	10.0	56.5	46.3	51.1	44.9	3131.8	5.2	267.3	94.7	112.5	280.3	83.1	43.1	31.0	57.1	680.8	1099.2	10.1	5.1	223.5	158.7	627.7	165.4	23.6	124.2	286.7	144.1	13.1	219.8	88.0	32.0	2.0	5.6	260.4	464.0	94.0	25.7	229.7	864.3	488.3	139.1	13.5	32.9	65.4	146.0	2.6	4.0	160.3	130.4	74.7	34.5	34.7	191.0	260.5
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726099-7881728	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.0;Hepatic stellate cells: 16.8;Inhibitory neurons: 22.8;Microglial cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 37.0;HUVEC TERT2: 149.6;Karpas-707: 81.6;SiHa: 70.0;TIME: 74.3;U-266/84: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	46000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	16.5	3.1	5.1	2.2	5.9	0.4	12.7	3.9	6.2	3.2	7.8	3.7	3.0	3.5	0.6	2.0	2.4	2.1	5.1	3.9	3.7	17.8	1.9	9.1	1.5	4.9	4.5	8.2	0.6	0.6	4.6	18.1	4.7	2.8	2.7	0.1	2.3	2.6	3.1	3.5	3.0	2.3	4.8	4.6	4.7	2.2	5.7	0.9	1.5	1.3	2.4	3.3	3.0	4.1	0.9	2.4	0.3	0.0	0.4	0.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	37.0	1.1	1.6	0.5	1.1	0.2	0.0	0.0	5.7	15.9	21.8	1.4	0.8	1.1	16.7	0.0	0.0	0.7	2.4	9.6	149.6	0.0	0.0	81.6	0.0	0.3	0.0	0.0	0.8	0.5	12.0	0.6	0.0	15.3	0.5	0.0	12.3	0.0	70.0	0.0	0.0	9.3	0.0	0.0	74.3	0.0	4.7	0.5	2.6	11.3	41.3	0.1	2.3	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.1	5.9	3.9	6.2	3.9	3.7	4.9	4.5	4.7	4.8	5.7	4.1	23.0	0.0	0.5	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3.5	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.8	0.2	8.9	0.0	0.0	7.8	0.0	0.1	2.0	0.0	2.0	0.0	1.5	16.8	0.6	0.3	0.0	22.8	0.0	0.0	0.8	2.1	4.2	0.0	1.5	1.8	74.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.8	0.3	0.0	0.0	0.3	0.0	0.0	4.7	0.4	0.1	1.3	0.1	0.1	0.3	0.4	0.4	0.0	0.0
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1 ribosome biogenesis factor"	Q14692	10	42782795-42834937	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Mitotic chromosome"		"HPA036589: AB_10601460, HPA043081: AB_2678305"	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	8.1	8.3	6.5	8.9	7.2	10.7	8.5	8.6	8.2	8.2	8.5	7.7	6.3	8.2	6.8	9.6	7.3	5.1	9.0	6.1	7.8	8.1	8.1	7.6	10.0	7.4	7.8	8.4	8.8	11.4	7.6	8.2	7.7	7.3	7.9	6.5	8.8	6.9	17.7	10.2	7.8	7.7	6.5	8.7	7.4	8.1	7.0	9.6	7.2	13.4	10.8	10.1	8.3	7.2	32.0	26.7	25.3	29.0	18.8	15.5	24.5	26.1	27.5	30.3	25.9	37.1	24.4	16.9	18.1	22.7	17.0	27.3	42.0	33.8	39.4	24.7	29.3	22.7	20.7	31.9	16.2	61.7	20.4	13.9	16.9	32.7	31.5	16.9	23.2	19.4	40.4	17.7	21.8	27.1	34.6	20.3	32.3	22.0	28.0	31.3	26.7	18.1	16.8	27.7	19.3	20.4	22.9	25.1	21.7	26.2	30.6	17.6	28.3	14.0	50.7	28.4	43.2	14.1	18.7	48.5	20.5	44.9	11.0	3.8	4.6	2.7	7.2	8.2	8.5	8.7	8.9	7.9	7.5	6.1	9.6	8.3	0.6	6.1	7.1	3.9	6.9	5.3	6.5	7.2	8.6	8.2	6.1	7.8	7.4	7.8	7.7	6.5	7.0	7.2	25.6	32.1	33.1	19.6	29.7	22.9	33.9	28.4	14.2	20.7	18.8	17.1	48.0	20.0	37.4	23.9	10.4	27.7	23.6	10.2	21.5	32.3	14.6	28.8	34.5	31.3	16.8	19.5	31.4	34.9	30.0	26.4	16.3	30.0	22.1	36.8	21.4	18.6	19.7	21.9	28.8	11.5	22.4	15.3	22.6	12.1	23.6	19.9	33.8	10.3	35.2	12.8	24.7	20.1	24.0	38.2	8.9	16.6	31.3	32.2	8.8	30.1	49.5	28.7	19.7	35.3	31.4	40.3	56.1	17.1	25.4	24.9	25.3	33.5	18.7	41.4
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"epididymis: 102.6"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 28.2;Hepatic stellate cells: 93.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	77	"granulocytes: 7.6"	"Cell line enriched"	"Detected in some"	119	"HUVEC TERT2: 353.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	7.7	0.3	0.3	1.7	0.5	7.1	4.9	0.3	0.6	1.7	1.1	3.8	4.4	2.3	102.6	2.3	2.6	2.6	8.8	0.3	0.3	0.6	0.7	3.0	1.5	0.3	0.4	0.9	0.9	0.3	0.2	4.7	0.3	0.9	2.4	0.0	1.1	0.9	1.3	1.6	4.8	2.6	0.3	2.2	1.4	0.2	0.4	0.7	2.0	2.2	0.4	2.6	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	353.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.4	14.1	0.0	1.1	1.3	0.0	0.4	0.7	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.2	0.0	28.2	4.2	3.2	1.3	0.2	0.0	1.1	4.6	0.2	0.0	0.1	93.9	0.7	0.1	0.0	1.2	0.1	2.0	0.0	1.1	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.8	0.0	0.0	0.3	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.4	0.4
BNC1	"BNC, HsT19447"	ENSG00000169594	"Basonuclin 1"	Q01954	15	83255903-83284714	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.0;esophagus: 12.5;testis: 30.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 88.6;Early spermatids: 45.5;Late spermatids: 103.4;Suprabasal keratinocytes: 58.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 51.1;HBEC3-KT: 116.6;hTCEpi: 128.1;hTERT-HME1: 123.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063183, HPA066947, HPA077428"			Enhanced	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345"	"unprognostic (1.86e-3)"	"unprognostic (1.08e-1)"		"unprognostic (7.89e-3)"	"unprognostic (5.55e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.89e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (8.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.01e-2)"	15.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	3.1	0.0	0.1	0.0	0.0	8.1	12.5	0.9	0.1	1.4	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.7	0.0	1.0	0.0	1.8	0.0	0.2	0.0	0.1	2.0	0.2	0.0	9.3	0.0	0.0	0.0	0.0	0.1	30.8	0.3	4.2	0.1	0.3	2.1	0.3	6.5	0.4	25.9	0.1	0.0	0.0	4.2	6.4	0.0	2.0	0.3	21.9	30.3	0.0	0.5	0.0	1.0	13.8	0.0	51.1	2.7	116.6	39.3	0.0	0.2	0.0	0.0	0.0	32.6	0.0	0.0	5.6	128.1	19.6	123.8	4.5	21.7	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	0.0	11.6	0.0	0.0	14.2	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	88.6	14.8	15.5	14.8	0.0	0.0	0.1	0.4	1.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	5.5	103.4	0.6	0.1	8.8	1.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7	0.0	1.2	0.0	0.1	1.7	0.0	0.0	2.7	0.6	22.2	6.5	21.7	58.4	0.0	0.0	0.0	0.0	4.8
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26383054-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 913.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (7.59e-3)"	130.6	53.4	42.7	37.2	60.4	192.6	77.9	55.6	62.0	63.9	38.9	39.6	22.2	52.8	66.3	48.3	50.5	54.7	63.2	50.0	49.6	79.4	45.4	62.9	39.4	60.7	54.0	119.7	20.1	55.1	25.4	104.5	58.4	44.4	28.2	146.5	44.1	64.4	38.9	71.5	28.4	51.3	46.6	40.7	28.9	68.6	48.8	39.9	41.9	31.7	52.1	48.9	49.5	80.8	90.6	33.8	79.1	53.9	214.5	134.0	66.8	89.0	259.9	81.9	179.6	15.3	42.7	27.7	82.5	169.0	113.4	44.8	39.6	114.5	270.0	17.8	21.8	114.9	32.0	26.9	119.3	10.3	191.1	162.5	89.2	92.9	55.3	269.2	106.2	66.9	52.6	65.0	173.7	39.1	72.7	38.5	26.2	56.7	36.6	38.4	99.9	55.6	85.3	58.3	83.9	74.4	43.2	8.8	70.0	85.9	43.7	21.7	140.4	152.2	64.6	96.2	20.5	93.2	46.0	36.8	232.6	20.6	35.1	334.9	298.3	182.9	39.5	154.8	34.9	68.4	58.4	43.3	166.9	78.0	89.3	65.5	369.0	47.6	104.1	38.0	86.1	239.3	42.7	60.4	55.6	62.0	50.0	49.6	60.7	54.0	58.4	46.6	48.8	80.8	118.3	86.6	157.4	28.7	72.2	98.8	56.0	231.7	82.6	142.5	90.6	85.3	34.0	50.1	126.4	103.0	33.3	33.2	55.6	32.7	49.0	115.4	194.1	173.5	140.8	101.2	120.6	913.9	50.6	39.1	166.5	179.9	38.7	341.2	120.9	96.5	167.0	32.2	132.1	82.4	39.4	46.8	118.0	221.3	300.4	206.7	320.3	233.6	106.7	30.0	165.0	406.4	32.0	29.1	75.8	154.1	39.8	347.5	64.6	83.6	44.0	306.4	107.6	64.0	144.7	59.1	183.9	154.4	110.7	65.4	126.6	162.5	67.0	117.6	27.6	79.3
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135400-74147912	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 173.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 313.2;Distal tubular cells: 352.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: AB_2682063"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	35.6	39.3	52.1	22.6	54.3	40.8	31.4	58.9	66.1	20.2	55.0	46.5	33.8	24.5	25.1	31.7	20.8	11.9	101.0	52.7	56.5	59.8	33.7	23.5	22.2	57.0	53.8	16.6	44.7	56.2	29.6	14.2	56.0	25.4	37.6	35.7	39.7	23.7	117.8	16.6	28.9	22.6	54.7	21.9	41.1	15.8	53.7	24.8	28.8	173.9	21.6	27.1	24.3	55.3	102.8	134.0	44.8	46.2	81.5	78.3	113.9	92.5	54.5	104.0	72.0	176.6	45.4	67.2	79.7	82.4	99.3	53.2	107.9	135.4	95.8	126.5	172.8	85.4	88.3	269.8	76.1	167.3	39.0	62.2	96.6	100.9	124.2	45.9	79.4	144.3	183.2	73.7	116.0	163.6	136.4	123.1	66.9	196.8	198.6	88.5	120.1	132.0	138.8	106.2	70.4	40.7	68.3	106.8	123.3	62.0	62.6	102.8	42.6	83.9	142.9	93.8	185.4	67.5	135.3	92.7	87.6	131.8	73.8	14.7	14.2	3.9	68.3	29.9	75.7	45.4	92.7	72.6	37.8	44.5	79.3	68.7	3.0	51.7	33.5	65.1	91.2	40.6	52.1	54.3	58.9	66.1	52.7	56.5	57.0	53.8	56.0	54.7	53.7	55.3	54.7	9.6	29.8	8.5	33.2	22.7	44.5	111.8	43.3	29.9	82.0	109.5	313.2	44.3	50.1	84.6	16.7	54.9	42.8	125.4	352.1	93.2	20.0	67.0	46.2	45.5	76.1	138.2	14.3	111.4	167.5	48.6	58.1	61.5	25.4	31.9	36.4	113.3	113.9	26.9	15.0	128.3	83.4	32.1	28.9	10.2	32.9	32.2	99.6	3.7	59.4	61.8	62.8	7.5	7.7	95.0	70.9	46.3	76.1	50.9	85.6	266.4	51.2	52.6	19.7	39.6	64.4	66.8	80.5	101.0	16.9	22.3	45.1	83.0	176.2	52.0
BOP1	KIAA0124	ENSG00000261236	"BOP1 ribosomal biogenesis factor"	Q14137	8	144262045-144291438	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 223.5"	"Low region specificity"	"Detected in all"							"HPA047869, HPA066764"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA047869: AB_2680193, HPA066764: AB_2685716"	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	18.1	17.8	6.8	8.8	6.9	9.7	16.3	7.7	10.9	16.1	3.5	17.3	5.6	18.2	1.0	26.0	13.2	2.8	24.4	7.6	5.5	16.7	21.5	13.3	8.0	7.1	6.0	11.1	32.0	5.6	16.9	3.7	6.5	15.3	1.9	1.1	13.2	3.1	76.6	21.4	14.9	3.1	4.7	20.4	15.4	20.1	6.2	5.4	17.0	8.1	3.6	19.3	16.5	6.1	45.0	87.4	11.8	50.6	6.4	7.7	41.4	30.5	6.5	30.3	19.1	66.3	25.4	54.1	50.1	11.6	11.5	34.9	21.2	36.2	6.9	47.8	82.5	68.4	54.4	49.7	15.1	30.8	35.6	15.5	17.0	25.2	22.1	5.7	18.8	48.3	70.1	18.1	11.9	112.8	82.4	37.6	28.3	45.1	223.5	61.4	17.6	82.2	12.5	30.1	64.7	25.8	32.5	41.9	20.3	5.5	30.6	27.7	36.6	27.8	83.3	37.1	88.5	16.5	11.7	45.6	20.3	48.6	36.7	0.0	2.2	1.3	1.9	2.3	2.1	2.5	2.2	2.5	3.0	1.8	2.0	1.8	0.1	1.8	2.0	2.0	2.0	1.2	6.8	6.9	7.7	10.9	7.6	5.5	7.1	6.0	6.5	4.7	6.2	6.1	12.8	9.6	5.1	3.9	16.7	0.5	18.7	0.0	13.1	9.8	12.7	13.8	7.2	10.0	3.7	11.0	0.0	25.2	20.9	18.7	5.9	25.8	11.2	7.5	10.7	12.0	26.9	22.1	4.4	21.7	45.3	13.2	17.3	8.3	10.2	13.5	4.6	14.8	21.5	15.2	3.5	11.5	0.0	11.1	0.0	24.3	10.5	12.8	0.0	1.0	16.2	16.7	18.6	5.0	2.8	26.4	11.3	9.8	25.4	39.5	11.3	17.2	1.5	4.6	13.1	12.9	15.1	13.9	53.4	25.7	0.1	17.8	11.8	29.6	31.8	14.3
BORCS5	"LOH12CR1, LOH1CR12"	ENSG00000165714	"BLOC-1 related complex subunit 5"	Q969J3	12	12357078-12471233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 42.6;T-cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039509, HPA043627"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"		"HPA039509: AB_2676550, HPA043627: AB_2678588"	"unprognostic (1.82e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (6.78e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.51e-2)"	6.3	8.1	5.1	2.5	7.1	6.2	6.1	5.2	6.4	6.6	2.3	5.8	1.7	5.8	5.8	8.0	5.7	2.4	7.1	4.1	5.8	5.9	8.5	6.5	2.9	5.6	5.4	4.9	7.2	3.8	7.1	2.7	6.2	5.9	2.2	2.8	5.4	1.9	8.4	8.7	4.7	3.0	4.7	6.2	5.9	9.1	5.4	3.1	4.6	3.3	3.9	5.6	6.8	8.2	3.9	4.1	2.9	3.0	6.4	8.7	3.3	3.4	3.9	4.1	5.1	10.0	3.9	4.9	2.0	5.5	2.9	2.7	5.0	4.9	4.4	14.0	4.5	2.7	3.9	5.7	6.1	2.9	3.8	4.9	3.5	5.6	6.5	6.5	4.9	6.1	3.8	6.6	5.4	8.4	4.2	3.0	9.0	4.1	2.6	3.4	4.1	5.3	5.1	2.6	3.6	4.1	3.3	3.0	7.5	9.6	2.3	3.1	4.1	2.7	6.1	3.5	3.1	3.4	3.2	11.1	5.8	4.4	4.6	2.8	6.1	9.5	10.1	10.3	11.9	7.7	11.5	11.2	7.3	5.9	7.6	7.7	6.7	12.4	6.7	5.1	14.2	7.0	5.1	7.1	5.2	6.4	4.1	5.8	5.6	5.4	6.2	4.7	5.4	8.2	11.1	9.6	2.3	0.0	37.9	0.0	11.9	0.0	10.8	16.9	10.5	8.4	0.0	10.0	2.5	7.3	12.5	9.2	42.6	2.2	9.8	9.5	5.6	8.8	9.0	6.7	4.9	5.9	0.0	12.4	11.7	8.3	19.9	8.9	2.5	7.4	6.1	5.1	14.5	13.5	0.0	3.8	0.0	11.0	0.0	3.9	5.3	26.3	0.0	0.0	19.0	12.5	14.4	0.0	0.0	9.5	3.5	7.2	33.0	9.1	10.3	14.1	2.9	16.6	26.3	8.3	8.1	23.4	8.6	14.6	0.0	14.5	39.5	7.5	4.6	8.3
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 110.4;liver: 84.8"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 99.7;Proximal tubular cells: 336.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		NA	NA		14000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favorable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	24.1	15.3	9.4	3.9	9.8	3.5	11.2	9.5	14.5	9.3	11.8	10.6	33.8	7.0	28.8	13.2	11.1	8.9	11.6	10.1	10.8	110.4	84.8	5.2	4.4	9.8	10.2	6.5	11.5	10.8	12.7	5.0	10.7	6.8	9.4	4.2	11.3	4.7	15.5	11.2	32.8	5.8	8.6	3.9	10.0	5.0	9.8	4.8	5.5	12.5	5.9	9.0	9.1	10.8	12.0	13.8	26.8	30.6	22.5	16.2	10.2	7.1	8.7	8.6	11.4	12.4	15.3	18.6	19.7	9.2	21.4	22.1	11.7	8.0	7.6	24.8	10.5	2.7	5.4	21.8	7.9	6.3	1.8	16.9	14.1	6.3	6.0	17.7	15.5	18.8	7.2	3.0	19.9	18.2	14.8	8.3	22.5	21.1	21.9	16.1	17.7	27.9	19.7	30.3	31.7	23.3	13.2	9.0	58.4	39.4	25.6	2.2	7.7	12.5	3.4	13.1	4.9	8.6	27.8	20.4	3.5	4.0	18.4	13.6	9.8	0.0	8.2	12.9	10.9	17.5	9.7	8.4	15.3	12.8	9.1	12.7	0.6	14.6	7.8	8.4	5.4	7.5	9.4	9.8	9.5	14.5	10.1	10.8	9.8	10.2	10.7	8.6	9.8	10.8	15.9	6.4	9.3	11.1	8.2	8.9	8.6	26.0	10.8	11.1	15.1	19.0	4.8	31.5	19.3	16.5	20.9	28.6	5.6	13.6	70.5	28.1	0.5	13.6	14.0	9.1	16.1	6.9	9.3	13.5	32.2	12.2	11.2	8.2	2.5	31.8	6.1	70.9	23.7	16.8	12.8	14.9	38.7	2.2	8.3	1.6	14.9	8.0	32.0	10.3	13.9	12.2	7.2	9.0	4.7	19.6	14.8	13.9	4.5	8.4	99.7	336.3	38.2	6.9	6.6	19.0	12.5	6.8	20.6	13.9	9.2	14.0	7.6	32.9	19.0	8.1
BRAF	BRAF1	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924929	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 252.3;Inhibitory neurons: 242.4;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 202.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001328, CAB004552, HPA071048"	Approved		Approved	Vesicles,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	Cytosol	"CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336"	"unprognostic (2.98e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.46e-2)"	8.8	5.8	6.3	5.6	7.7	15.9	8.8	12.5	8.7	8.2	5.4	8.6	4.7	8.3	8.3	7.5	8.0	5.8	7.6	8.3	6.7	7.6	6.6	9.9	6.9	4.0	3.6	9.8	8.3	11.5	9.0	7.2	4.6	8.2	5.4	17.0	7.2	5.9	8.6	10.4	6.9	6.0	3.1	6.7	7.8	13.7	5.2	8.7	10.2	8.4	6.4	9.9	8.5	6.7	6.3	5.2	7.7	9.4	9.1	11.8	12.3	6.8	7.5	5.4	7.6	5.7	6.7	10.8	5.0	7.3	8.4	3.4	6.8	5.5	10.0	9.8	5.4	7.1	5.1	5.2	7.6	11.7	6.8	7.9	6.1	6.0	12.0	8.2	6.6	7.7	11.3	19.1	9.8	3.3	15.6	12.0	6.9	6.2	3.1	10.1	6.5	8.9	5.3	11.9	8.9	7.3	7.9	4.9	7.3	7.5	4.5	7.8	9.7	5.9	4.3	12.9	5.5	21.6	12.9	16.7	9.7	11.3	6.6	1.9	1.0	4.1	1.5	0.9	1.0	1.3	1.5	1.2	0.8	1.1	2.6	1.3	2.0	3.5	1.3	1.0	1.5	0.6	6.3	7.7	12.5	8.7	8.3	6.7	4.0	3.6	4.6	3.1	5.2	6.7	43.4	22.4	45.7	151.1	58.4	21.5	24.6	6.0	23.3	29.7	31.2	21.2	19.8	10.0	18.7	25.8	35.5	15.7	73.5	8.8	7.9	14.3	68.6	50.6	37.4	23.4	19.2	14.9	252.3	9.8	12.9	22.0	21.9	69.2	24.7	45.5	9.3	9.6	9.4	25.2	242.4	9.8	8.2	13.6	37.1	36.5	16.4	30.1	16.0	126.5	14.6	11.3	15.5	206.1	202.6	15.4	8.1	10.1	48.7	23.8	8.0	13.4	20.0	33.0	6.6	24.1	24.7	43.8	26.0	14.5	24.0	75.5	41.4	30.9	8.7	33.4
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685956	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Group enriched"	"Detected in all"	7	"Early spermatids: 319.6;Late spermatids: 380.1;Spermatocytes: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: AB_2683827"	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.6	8.8	7.8	7.9	9.2	33.6	9.2	9.8	9.8	8.0	7.3	9.6	9.2	8.8	6.9	9.5	8.5	7.5	9.7	8.1	8.8	8.5	10.0	8.0	10.5	8.8	9.2	9.8	8.2	10.5	6.2	10.6	8.8	8.3	9.2	9.1	8.4	8.3	19.8	12.8	8.8	9.4	8.5	9.0	7.7	67.2	8.4	12.8	9.9	14.0	10.8	9.2	8.1	10.6	14.6	21.1	16.9	19.5	17.7	14.8	28.2	20.0	16.7	22.8	17.5	28.6	10.0	28.0	11.7	19.1	12.9	17.6	23.8	16.4	24.2	18.0	15.4	34.8	12.9	19.4	22.2	30.7	22.5	16.9	22.8	19.7	31.8	19.6	20.0	19.0	36.7	8.9	19.0	18.6	25.7	29.6	22.8	15.4	22.1	23.6	18.4	25.1	15.0	30.3	20.9	15.5	23.5	19.8	19.5	19.3	21.7	19.3	18.8	14.6	13.5	13.3	14.4	22.6	30.9	30.4	13.8	16.8	16.3	22.7	16.8	32.3	17.5	17.5	17.3	16.1	18.5	17.9	15.1	16.5	17.1	17.6	32.7	23.1	14.6	10.9	24.7	16.1	7.8	9.2	9.8	9.8	8.1	8.8	8.8	9.2	8.8	8.5	8.4	10.6	11.6	22.4	11.2	14.7	14.9	11.2	8.9	9.7	12.0	8.9	8.8	7.5	12.7	17.2	10.8	11.0	29.2	13.7	13.7	15.4	5.9	13.5	319.6	11.9	11.6	11.4	9.6	22.9	24.7	7.7	14.9	12.3	15.3	12.4	8.2	13.3	10.4	9.1	10.9	3.3	23.3	12.9	14.2	9.8	11.5	380.1	13.4	11.7	3.6	10.3	19.7	8.6	17.5	13.0	23.3	14.5	12.7	13.5	15.0	13.4	13.5	14.6	13.8	11.8	6.6	11.6	15.1	147.8	38.6	15.4	12.6	22.4	13.5	10.2	11.0	14.5
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2 DNA repair associated"	P51587	13	32315086-32400268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 3.1;testis: 2.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 115.4;Spermatogonia: 85.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.0	1.3	0.0	5.8	0.5	0.0	0.0	0.2	0.2	0.7	0.5	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.3	2.1	0.1	0.1	0.1	0.1	0.0	0.0	1.0	0.1	0.1	0.8	0.0	0.2	0.0	0.0	0.7	0.5	0.3	0.1	0.9	0.6	2.7	0.2	3.1	0.2	0.0	2.0	0.5	0.2	0.1	4.7	4.0	6.0	5.0	0.6	1.4	7.0	4.8	3.1	5.5	5.0	10.6	6.0	15.9	3.2	2.1	7.6	6.1	5.5	2.9	10.5	10.5	3.1	10.3	2.5	3.5	0.1	15.4	4.9	0.2	0.0	10.3	6.9	0.4	4.5	8.1	7.0	5.5	6.4	5.1	11.8	8.3	8.3	4.9	2.3	11.4	17.3	3.0	1.4	5.4	2.4	4.6	5.9	2.4	2.2	2.2	2.9	7.3	1.3	6.3	6.8	7.0	6.7	2.0	3.3	8.0	2.7	5.7	5.8	0.0	0.3	1.5	0.5	0.7	0.1	1.7	0.4	0.4	0.3	2.2	0.5	0.4	0.8	0.5	0.8	3.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	4.4	9.6	2.6	0.0	12.4	2.5	3.3	2.5	2.2	0.0	4.3	3.3	1.9	0.0	1.8	0.0	0.0	14.1	10.5	4.8	0.0	2.5	5.2	4.4	6.3	5.5	1.2	29.5	0.7	1.6	12.7	5.8	10.7	4.6	3.8	26.9	1.4	0.8	9.5	0.0	0.5	4.4	0.0	7.5	11.0	4.4	2.1	14.4	3.6	4.7	20.1	0.3	0.0	0.0	0.6	1.2	1.8	1.2	27.8	1.2	1.0	0.6	2.9	0.0	13.1	8.3	5.3	115.4	85.6	8.0	1.3	5.5	7.9	4.2	7.8	2.3
BRF1	"BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90"	ENSG00000185024	"BRF1 RNA polymerase III transcription initiation factor subunit"	Q92994	14	105209286-105315589	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051918, HPA074990"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA051918: AB_2681663, HPA074990: "	"unprognostic (1.98e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.52e-4)"	"unprognostic (2.67e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.25e-6)"	"unprognostic (8.83e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.52e-1)"	10.5	11.4	19.7	5.5	22.2	6.5	10.5	23.1	23.6	12.5	12.9	11.1	7.6	12.1	4.2	10.4	12.8	6.0	12.2	17.1	19.2	11.6	13.1	8.4	8.1	31.8	24.9	13.0	15.1	10.3	20.4	6.0	29.7	12.0	4.2	7.5	10.1	6.3	17.7	11.2	10.3	4.6	18.7	12.6	11.2	14.6	25.4	7.3	10.5	9.6	5.8	11.5	9.9	37.4	12.6	28.0	11.8	25.3	10.3	11.4	11.9	17.4	11.2	15.4	12.2	20.2	18.8	9.4	16.9	12.0	7.5	24.2	14.4	11.7	8.4	25.2	14.2	11.5	15.1	9.9	11.5	13.7	24.3	11.3	10.1	9.3	11.5	7.8	11.3	19.7	13.1	7.5	7.6	40.9	16.2	17.1	8.6	20.7	27.7	28.2	8.1	9.6	7.6	29.9	37.5	27.8	18.4	14.0	16.0	5.4	33.4	18.9	16.8	12.1	9.6	22.7	14.2	13.8	11.5	8.9	14.5	11.3	16.9	0.4	1.2	2.0	1.6	1.0	1.1	1.5	1.1	1.6	1.2	1.4	1.4	1.3	0.5	2.5	4.0	3.1	1.6	1.6	19.7	22.2	23.1	23.6	17.1	19.2	31.8	24.9	29.7	18.7	25.4	37.4	11.5	3.2	5.9	17.6	11.4	7.5	7.1	4.5	8.6	18.8	10.7	9.0	8.5	2.8	6.3	3.7	16.7	11.4	15.5	16.2	3.9	5.8	2.3	26.5	10.9	9.5	9.6	6.3	18.3	7.1	8.9	7.7	14.8	16.5	2.5	16.0	8.9	11.3	7.2	30.3	20.8	11.7	4.1	6.7	10.3	1.4	6.5	7.8	8.8	10.3	5.3	7.1	4.1	15.1	34.2	4.8	6.5	4.5	13.4	7.7	8.9	6.1	12.4	20.0	0.0	9.6	8.2	9.2	12.7	7.7	8.8	9.3	11.6	13.2	12.5	5.1
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"Biogenesis of ribosomes BRX1"	Q8TDN6	5	34915677-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039614			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Mitotic chromosome"		"HPA039614: AB_10963698"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.6	17.1	13.3	17.6	13.8	37.1	24.7	15.2	18.7	15.1	12.8	15.6	12.9	17.4	17.8	17.7	16.1	12.2	14.7	13.2	14.1	15.1	18.5	13.0	26.4	13.7	13.6	18.5	13.7	18.2	9.5	25.7	13.8	15.7	17.1	11.6	12.9	14.5	10.4	14.6	12.8	16.1	13.9	14.3	13.1	13.9	13.5	20.7	15.8	12.2	25.8	30.1	12.3	15.2	66.1	57.0	64.2	87.1	26.0	37.8	121.6	74.9	52.7	100.0	63.5	74.5	81.0	138.8	38.7	45.5	113.5	52.1	108.5	79.8	117.3	75.1	101.3	93.9	125.7	71.9	67.4	150.8	63.8	44.4	49.8	93.3	85.9	31.0	48.5	72.9	158.4	43.8	66.2	63.6	108.3	163.9	101.0	75.2	86.8	94.6	112.5	60.5	59.3	70.7	75.1	68.8	157.6	109.7	76.1	50.0	66.4	92.7	28.4	78.7	87.5	58.1	151.0	39.3	87.7	177.6	66.3	171.3	100.3	15.0	21.4	10.0	34.5	21.0	50.1	63.7	43.2	44.3	27.8	49.9	53.3	46.6	1.2	43.7	30.6	37.5	43.5	44.6	13.3	13.8	15.2	18.7	13.2	14.1	13.7	13.6	13.8	13.9	13.5	15.2	35.5	28.9	30.7	8.5	40.0	108.7	114.3	110.2	55.2	20.8	27.3	41.3	23.2	25.8	63.0	23.9	12.5	127.1	37.0	13.5	49.0	52.5	24.8	29.9	45.1	40.6	21.0	45.2	11.9	42.7	100.6	44.4	19.4	31.6	20.2	30.0	20.0	11.9	42.7	21.9	13.4	19.0	63.1	10.7	20.1	8.4	39.4	18.4	32.0	4.7	31.1	22.3	21.6	10.6	13.6	44.7	13.1	29.0	21.4	70.9	9.9	37.9	45.8	37.2	6.6	54.3	55.7	59.9	77.6	46.0	95.8	126.1	37.1	31.7	31.9	85.1
BRPF1	BR140	ENSG00000156983	"Bromodomain and PHD finger containing 1"	P55201	3	9731729-9748015	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003359	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA003359: AB_1078217"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.51e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.67e-3)"	8.0	7.1	4.7	6.9	6.9	23.5	7.7	9.9	7.4	8.2	3.8	8.3	4.8	9.5	4.4	8.6	8.8	5.5	7.3	6.7	3.8	6.2	5.5	7.9	8.9	4.7	4.2	9.3	7.3	7.7	6.7	6.5	4.3	7.5	4.0	4.0	9.1	5.0	9.5	10.9	8.3	5.4	3.1	10.5	7.5	14.4	5.2	11.9	9.0	6.8	7.6	7.9	7.8	5.5	9.9	17.2	12.5	8.2	8.9	8.6	82.4	12.6	7.5	14.3	10.2	12.1	8.3	18.6	6.0	11.6	13.5	8.2	15.3	12.0	9.0	20.1	17.9	21.4	33.8	9.8	11.4	30.6	20.0	8.5	9.8	19.8	13.1	7.2	10.8	17.5	25.2	15.9	8.3	24.3	19.8	25.7	20.6	6.7	15.9	28.7	10.6	12.3	6.7	14.5	8.9	15.2	12.7	9.0	10.1	8.2	9.8	31.4	14.1	15.9	13.6	14.5	24.0	13.4	18.1	31.5	13.1	25.9	15.1	1.0	0.9	1.4	1.3	0.8	2.0	0.6	0.9	1.2	0.8	0.5	1.1	1.3	0.8	4.2	0.7	1.9	0.7	0.8	4.7	6.9	9.9	7.4	6.7	3.8	4.7	4.2	4.3	3.1	5.2	5.5	7.9	16.0	10.0	2.6	6.8	14.1	5.1	3.9	8.0	4.6	9.2	7.0	3.7	2.8	6.2	7.3	6.2	4.2	13.0	9.4	0.0	4.1	3.9	4.2	6.9	9.7	10.2	9.7	3.4	5.5	5.5	5.8	7.7	7.0	8.8	7.3	11.0	3.5	6.4	8.4	2.4	5.0	2.0	5.6	9.2	1.2	6.5	6.9	1.8	2.8	6.3	5.2	5.2	4.0	2.9	6.1	3.1	6.0	7.9	5.1	4.9	2.1	4.3	5.1	6.6	11.3	7.7	16.6	13.9	9.9	18.5	3.7	10.8	5.6	6.1	6.8
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	6.6	11.9	3.5	7.6	4.3	12.1	8.4	9.0	5.4	8.4	0.1	13.1	11.7	11.9	6.1	7.9	8.8	8.6	7.3	5.5	1.9	11.8	6.9	7.4	6.2	0.6	1.4	11.9	18.0	14.5	4.4	7.5	0.7	9.6	12.9	6.4	15.7	10.9	12.1	12.6	13.8	10.2	0.3	9.0	10.7	19.9	2.1	9.4	12.1	12.2	6.2	7.4	4.7	4.0	10.6	10.0	24.6	19.4	13.3	11.2	21.0	15.6	16.3	21.5	16.9	29.4	9.8	16.3	16.4	15.4	27.0	10.0	21.8	11.2	18.8	15.6	13.5	11.5	9.3	17.6	14.0	9.1	15.5	14.4	9.4	25.6	12.8	15.6	16.3	7.7	24.5	14.6	11.9	15.0	10.4	3.9	12.4	12.9	8.5	29.9	10.1	5.1	6.9	21.4	35.0	11.0	12.7	13.8	12.9	15.1	15.4	24.6	17.2	22.3	18.9	6.1	18.3	12.0	16.8	12.1	3.7	14.1	26.9	0.7	0.0	0.3	0.4	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.1	3.5	4.3	9.0	5.4	5.5	1.9	0.6	1.4	0.7	0.3	2.1	4.0	5.7	6.4	12.7	8.8	5.6	9.6	7.2	4.6	9.6	9.0	21.1	11.7	13.7	10.0	7.3	5.5	6.2	4.8	9.7	28.1	0.0	6.6	15.3	7.3	10.9	7.2	19.7	5.7	16.6	10.8	4.1	9.8	10.2	12.7	2.5	16.6	9.7	18.2	4.5	0.0	11.4	27.5	6.1	5.7	6.6	14.0	11.1	4.9	7.2	6.5	5.4	6.1	9.2	13.6	11.0	11.2	13.6	9.4	10.5	11.3	21.5	13.5	4.5	7.2	0.0	11.1	8.0	25.7	17.5	7.3	11.4	8.2	6.3	14.2	16.2	10.2
BTBD16	"C10orf87, Em:AC061711.1, FLJ25359"	ENSG00000138152	"BTB domain containing 16"	Q32M84	10	122271296-122338159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 8.3;testis: 7.8;urinary bladder: 20.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 123.2;Late spermatids: 69.9"	"Cancer enriched"	"Detected in many"	14	"urothelial cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"RT4: 33.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA040529, HPA057638"	Uncertain		Uncertain	Nucleoli,Cytosol		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Nucleoli	Cytosol	"HPA040529: AB_2677022, HPA057638: "	"unprognostic (1.41e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.12e-2)"	"unprognostic (9.44e-3)"	0.1	0.0	1.0	0.0	1.4	0.0	0.5	1.2	2.3	0.3	0.7	0.5	0.0	0.1	0.3	0.1	0.4	0.2	0.0	1.1	1.2	0.3	4.0	0.2	0.0	1.4	1.4	0.0	0.1	0.0	0.4	0.1	1.4	0.8	0.0	0.0	0.4	0.0	0.3	8.3	0.1	0.1	1.3	0.0	0.1	7.8	1.2	0.0	0.4	0.0	0.1	20.2	0.5	2.1	0.0	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	1.5	33.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	1.4	1.2	2.3	1.1	1.2	1.4	1.4	1.4	1.3	1.2	2.1	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.2	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.4	123.2	0.6	0.0	0.2	0.0	0.0	0.9	0.7	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.0	0.4	69.9	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.5	9.8	1.1	3.8	0.4	0.0	0.1	0.2	1.0	3.1	0.0	0.0	0.4	0.2	10.0	0.8	0.0	3.1	0.1	0.4	0.0	0.0	2.9
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637528-110678063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 11.9;lymphoid tissue: 27.5;testis: 30.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 24.8;Granulosa cells: 66.1;Plasma cells: 35.2;Spermatocytes: 85.6;Spermatogonia: 20.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 221.5"	"Region enhanced"	"Detected in single"		"white matter: 1.7"	"Not detected"	"Not detected"			HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	0.5	0.4	0.1	8.4	0.3	11.9	1.2	0.1	0.1	0.9	0.0	4.3	4.0	1.0	3.5	4.7	0.5	0.9	0.6	0.1	0.1	0.3	0.6	1.2	15.9	0.1	0.6	0.4	0.2	0.7	0.0	3.2	0.3	0.3	5.7	0.1	0.9	0.1	0.1	2.7	3.5	2.2	0.0	5.6	1.9	30.3	0.4	27.5	0.4	0.2	17.0	2.4	1.6	0.3	96.0	29.4	68.5	46.8	3.8	5.3	38.8	50.9	32.9	85.6	62.3	58.3	55.0	64.7	30.9	30.1	80.1	43.2	93.9	35.0	105.7	51.4	45.6	221.5	26.2	50.6	0.8	63.5	57.0	1.7	2.8	65.2	33.1	12.7	49.8	73.2	96.8	126.5	76.8	33.7	126.3	39.0	71.2	39.4	55.3	69.3	64.2	102.7	18.3	27.0	48.3	21.4	34.2	31.4	27.2	44.1	24.0	60.6	19.1	39.7	57.5	28.8	69.0	67.3	65.5	75.4	24.2	48.6	69.8	1.1	0.0	0.2	0.2	0.0	0.3	0.5	0.9	0.5	0.1	0.5	0.6	0.4	0.0	0.5	0.0	0.9	1.5	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.3	0.0	0.4	0.3	0.2	0.0	1.5	0.0	5.5	0.5	0.5	2.0	0.6	0.0	0.9	0.8	1.1	0.0	1.6	0.0	0.0	5.8	2.5	2.4	0.0	0.3	13.5	4.5	1.5	1.1	0.0	24.8	0.2	0.0	9.8	2.2	2.0	2.2	0.0	66.1	1.8	0.3	8.1	0.0	0.2	3.1	4.1	1.6	1.4	7.5	0.3	2.0	0.0	0.0	0.6	0.0	0.0	0.5	1.0	0.1	0.0	0.4	35.2	0.5	0.3	0.1	1.8	0.0	6.6	0.2	3.7	85.6	20.0	4.0	0.4	0.7	2.9	0.5	5.9	0.9
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221123	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;lymphoid tissue: 35.7;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.5;Spermatocytes: 79.2;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA008419			Supported	Cytosol		Yes	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (7.43e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	0.4	0.5	0.1	6.7	0.1	17.8	1.6	0.3	0.2	1.0	7.7	4.6	4.7	1.2	0.3	5.2	0.6	0.6	0.3	0.3	0.1	0.3	0.4	1.0	12.6	0.0	0.1	0.2	0.2	0.2	0.1	3.4	0.1	0.4	6.0	0.1	0.9	0.2	0.0	3.5	4.1	2.1	0.0	3.1	2.4	22.2	0.2	35.7	0.5	0.0	15.0	1.5	1.7	0.0	66.5	32.8	103.0	41.5	2.5	7.1	33.2	60.9	34.2	64.6	55.7	48.1	25.0	59.7	33.5	22.7	59.0	72.6	98.8	33.2	70.5	51.8	52.1	86.4	83.6	45.5	0.2	79.0	45.7	1.6	2.0	39.2	37.1	12.9	47.7	66.5	76.4	61.7	65.6	22.5	62.5	48.9	70.2	55.6	36.8	66.5	83.7	45.2	19.9	33.1	67.1	40.8	38.0	35.9	13.3	45.1	41.9	40.9	27.6	49.3	51.8	49.2	55.5	32.1	58.2	95.6	26.3	87.8	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	3.2	1.1	0.3	1.8	0.8	0.3	1.0	1.8	0.7	0.9	2.0	0.8	0.0	1.9	0.0	0.0	5.4	0.6	1.8	0.0	0.4	3.0	0.9	1.4	1.0	0.0	23.5	0.7	0.0	6.7	2.4	5.6	2.1	0.0	12.9	1.1	0.3	5.2	0.0	0.7	2.5	0.0	1.9	1.7	3.3	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.5	0.4	12.6	0.3	0.3	0.1	0.2	0.2	6.6	0.2	1.7	79.2	26.8	6.9	0.3	0.8	1.8	0.8	5.4	0.6
BUD13	"Cwc26, fSAP71, MGC13125"	ENSG00000137656	"BUD13 homolog"	Q9BRD0	11	116748170-116772987	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038340, HPA038341"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038340: AB_2675967, HPA038341: AB_10671528"	"unprognostic (1.89e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.07e-5)"	"unprognostic (1.77e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-1)"	10.8	7.5	7.4	12.2	8.9	12.7	13.5	10.5	9.3	11.8	8.5	11.9	11.0	15.4	10.5	11.4	13.7	8.1	8.0	7.3	8.8	9.1	9.7	12.2	16.4	8.6	8.1	16.0	11.3	10.5	8.0	11.0	8.8	10.2	13.4	10.6	10.1	10.6	12.3	11.2	12.8	12.8	7.7	12.7	11.3	21.6	8.5	25.5	12.0	14.0	18.8	11.0	11.2	10.4	22.4	12.0	33.3	20.1	10.4	12.5	16.6	21.6	23.9	24.3	23.5	28.6	33.0	47.1	26.8	17.9	25.4	30.7	27.2	16.8	26.6	27.8	11.1	55.1	8.8	21.8	12.7	46.9	31.6	11.3	19.2	20.6	20.8	15.6	24.0	46.1	36.0	22.8	20.2	17.7	57.5	41.0	20.0	31.6	19.0	42.9	28.6	36.3	17.0	25.5	19.7	26.2	25.3	18.3	10.0	21.0	25.1	30.6	13.7	27.7	17.5	14.3	29.0	9.3	12.4	39.1	9.0	42.6	25.3	15.8	7.6	20.2	10.0	7.8	10.8	10.4	8.6	7.9	8.2	7.4	9.5	8.1	9.1	7.5	8.7	7.2	8.1	5.7	7.4	8.9	10.5	9.3	7.3	8.8	8.6	8.1	8.8	7.7	8.5	10.4	11.7	9.6	5.6	6.2	14.3	7.6	10.8	7.1	11.4	6.8	6.6	6.0	4.9	2.8	6.5	9.2	12.5	9.2	9.5	11.7	7.9	8.5	13.5	10.4	8.7	8.5	9.6	17.7	7.2	8.1	10.5	7.8	7.1	9.3	11.4	9.6	7.1	8.0	8.2	3.3	6.8	6.9	2.0	12.0	6.7	5.3	9.0	7.8	7.2	3.7	9.4	7.3	26.8	9.0	11.2	6.4	8.5	10.9	16.6	6.4	15.4	5.8	10.9	7.3	6.6	8.5	7.7	51.2	21.8	11.0	4.8	9.9	13.1	7.9	11.3	7.0
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23 rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 119.9;Endometrial ciliated cells: 133.6;Exocrine glandular cells: 140.8;Pancreatic endocrine cells: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 712.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	39.8	49.2	34.5	40.0	36.7	58.7	43.4	36.4	39.8	36.3	41.0	48.6	47.0	38.6	72.3	41.7	58.9	34.5	87.9	36.1	39.0	53.3	47.2	38.5	52.6	37.0	36.1	37.8	70.8	49.2	45.1	30.7	36.3	37.8	47.7	20.3	55.9	42.2	128.0	43.8	40.3	41.4	36.4	42.1	44.9	130.0	36.6	44.7	56.5	78.4	51.7	51.9	32.8	38.5	142.1	151.8	53.6	429.2	72.0	64.2	91.1	95.1	83.3	118.5	96.1	211.4	182.6	163.6	48.9	99.5	204.0	97.0	124.8	91.0	108.4	116.6	147.1	72.0	174.8	86.7	91.2	200.3	98.8	57.3	102.2	103.2	93.9	59.7	77.4	130.3	285.4	288.9	103.7	219.6	128.0	277.8	130.2	317.8	172.2	110.5	106.8	712.0	132.5	100.2	163.4	124.4	126.3	329.2	146.5	53.0	207.9	159.0	85.2	101.8	130.3	130.0	208.3	99.5	192.6	275.5	232.3	155.6	218.0	54.8	64.9	60.6	112.0	74.2	124.9	175.3	127.1	122.5	122.9	153.5	132.8	121.5	11.9	125.4	68.0	190.9	150.6	132.6	34.5	36.7	36.4	39.8	36.1	39.0	37.0	36.1	36.3	36.4	36.6	38.5	67.0	44.8	64.5	0.0	26.5	0.0	0.0	0.0	0.0	0.0	75.4	85.7	0.0	0.0	42.7	46.0	0.0	75.7	64.1	0.0	97.8	119.9	0.0	133.6	51.2	28.6	0.0	0.0	0.0	140.8	82.7	24.5	0.0	79.6	46.7	49.2	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	21.2	0.0	0.0	0.0	0.0	126.0	0.0	0.0	16.5	0.0	0.0	103.5	78.7	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	106.7	28.1	73.0	0.0	0.0
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137157	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.8;skeletal muscle: 43.9;tongue: 29.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 29.7;WM-115: 30.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	0.7	2.6	2.3	7.1	0.2	1.5	5.8	3.6	2.5	4.6	14.9	1.4	5.8	1.7	5.3	2.8	1.8	27.8	2.7	4.3	1.6	0.3	1.9	0.6	7.3	5.6	1.0	0.6	0.7	2.4	3.5	7.4	5.2	3.3	0.2	1.4	10.0	43.9	0.7	3.0	17.7	5.2	0.3	6.9	11.5	5.2	0.2	1.3	29.3	0.4	9.3	2.2	10.8	1.3	2.0	7.6	1.3	10.9	14.9	3.3	5.8	4.1	8.8	11.6	0.5	0.0	0.0	0.0	10.9	14.7	0.1	3.3	2.0	8.1	0.0	2.8	0.0	1.0	0.3	2.4	0.0	0.6	8.7	6.9	13.6	1.1	6.6	4.0	3.3	0.1	19.3	19.7	0.1	0.2	1.0	1.6	0.0	0.0	5.7	29.7	0.0	0.0	0.0	9.9	17.1	3.7	0.1	7.7	5.5	0.0	20.0	8.9	14.0	0.0	0.0	15.3	1.8	0.8	0.0	8.3	0.0	30.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	7.1	5.8	3.6	2.7	4.3	7.3	5.6	7.4	5.2	5.2	10.8	2.1	0.0	0.0	1.6	0.0	0.3	0.4	0.1	0.6	0.0	0.4	1.0	34.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	36.1	1.9	4.4	3.1	0.0	0.0	3.3	0.0	0.2	2.6	0.0	6.0	0.0	0.9	2.2	0.1	2.3	0.0	0.6	0.0	0.0	0.0	1.9	55.3	1.2	0.5	0.0	3.7	1.0	0.0	0.0	5.0	17.8	0.1	0.0	3.4	0.0	0.5	0.1	0.1	0.1	0.0	13.1	11.8	4.4	24.4	5.4	0.1	0.9	0.1	0.2	1.3	0.0	0.3
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921499-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	10.7	10.1	6.0	8.2	6.1	7.4	8.8	5.7	6.2	6.4	5.8	6.8	4.7	8.2	5.4	9.2	8.5	5.4	7.2	6.1	6.7	6.5	10.7	5.1	8.4	6.0	6.7	8.1	11.6	6.5	3.6	10.0	6.9	6.8	7.0	2.5	4.8	6.5	20.1	8.0	4.0	11.9	5.9	5.8	5.5	7.9	6.6	12.2	5.2	10.8	13.2	15.4	5.9	6.2	50.6	52.1	30.2	54.2	21.8	25.5	59.7	44.0	21.6	66.7	48.9	72.1	15.7	78.2	43.9	32.9	51.9	34.3	91.6	61.0	58.0	30.1	89.2	72.7	37.3	81.5	38.6	58.8	36.0	30.1	39.5	67.2	62.1	16.9	50.5	47.3	96.1	26.0	48.7	70.8	74.2	68.3	29.0	162.4	50.9	77.9	38.2	57.3	45.2	37.9	65.6	37.4	30.0	37.8	58.2	26.3	38.0	58.6	39.3	49.0	53.5	31.4	77.2	24.6	33.0	185.8	14.5	57.9	49.9	0.0	3.8	0.7	4.3	3.9	5.9	3.8	2.5	3.5	6.0	5.5	1.6	3.3	0.5	6.1	3.0	9.2	3.3	2.3	6.0	6.1	5.7	6.2	6.1	6.7	6.0	6.7	6.9	5.9	6.6	6.2	6.4	0.0	3.9	0.7	6.7	31.0	34.5	19.2	8.6	2.8	8.6	8.5	2.8	5.7	9.5	1.8	4.2	22.1	4.8	4.6	3.9	21.4	10.4	7.9	12.1	10.9	5.4	6.3	2.8	17.5	24.4	11.4	4.6	9.8	2.5	11.4	3.9	6.8	12.0	0.0	2.5	6.5	12.2	1.0	7.3	6.8	8.1	5.1	8.8	1.9	6.6	4.4	9.2	4.0	2.8	23.5	2.9	7.2	4.9	26.2	2.2	10.5	5.1	3.4	6.6	16.1	13.8	10.8	25.7	14.0	25.3	29.1	4.1	18.2	11.4	32.2
C10orf82	"Em:AC016825.4, MGC33547"	ENSG00000165863	"Chromosome 10 open reading frame 82"	Q8WW14	10	116663696-116670264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 84.5"	"Group enriched"	"Detected in some"	113	"Early spermatids: 1053.9;Late spermatids: 1926.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	103	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	103	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;Hep G2: 2.8;NTERA-2: 1.4;SuSa: 2.5;T-47d: 3.5"	"Not detected"	"Not detected"							HPA043022			Approved	Mitochondria		Yes	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA043022: "	"unprognostic (9.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.52e-2)"		"unprognostic (3.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	0.3	1.7	0.3	0.2	0.2	0.0	0.9	0.1	0.4	0.4	0.0	0.9	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.8	1.2	0.0	0.0	0.0	0.3	0.5	3.6	1.1	0.0	1.0	0.0	0.4	0.9	0.2	0.1	0.2	0.7	0.0	0.2	0.4	0.0	0.2	0.1	0.4	84.5	0.9	0.0	1.6	0.1	0.0	0.3	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.8	0.3	0.5	0.4	0.2	0.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	1.1	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1053.9	0.3	0.2	0.5	1.2	0.0	0.5	0.2	0.1	0.1	0.0	0.7	0.0	5.6	0.0	0.0	0.1	0.0	1.8	1.1	0.0	0.0	0.0	1926.7	9.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.3	0.0	0.7	0.1	0.1	0.0	0.0	13.1	0.4	0.2	10.5	8.0	0.0	0.0	0.0	0.1	8.0	1.2	0.3
C11orf24	DM4E3	ENSG00000171067	"Chromosome 11 open reading frame 24"	Q96F05	11	68261338-68272001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 107.7;Proximal enterocytes: 162.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 222.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012411, HPA012748"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012411: , HPA012748: AB_1845526"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.91e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.60e-9)"	"unprognostic (2.18e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.67e-3)"	25.0	17.6	8.9	20.7	12.2	4.7	21.0	12.1	12.7	23.3	8.2	29.2	53.8	39.2	7.3	15.5	22.2	17.6	31.5	9.7	10.5	17.0	87.4	24.1	15.5	14.4	11.6	19.3	27.3	7.3	14.5	16.1	12.5	22.9	17.4	3.0	34.0	17.6	13.7	15.4	59.4	32.6	11.0	20.8	23.6	14.6	12.8	6.4	17.0	15.2	16.7	22.3	19.4	15.2	44.8	45.5	26.4	51.6	62.1	62.5	29.7	105.4	67.5	51.8	53.1	96.2	26.9	20.1	31.7	131.3	47.2	49.4	39.1	47.4	33.2	22.1	23.1	21.4	44.8	65.3	50.1	18.3	68.7	52.1	34.6	78.8	32.0	31.0	21.2	10.6	37.9	32.2	44.6	55.7	4.5	26.4	44.2	72.1	53.8	8.2	44.8	104.1	23.9	21.1	17.3	31.8	33.3	27.1	222.8	21.8	25.6	15.3	23.3	80.8	50.2	103.3	47.3	39.4	41.4	18.8	65.1	14.1	79.9	16.7	12.1	12.6	14.0	19.0	9.4	26.7	7.9	8.9	19.5	35.7	7.3	7.7	1.8	9.9	14.1	26.7	8.4	12.6	8.9	12.2	12.1	12.7	9.7	10.5	14.4	11.6	12.5	11.0	12.8	15.2	6.8	9.6	3.6	3.3	25.5	14.0	12.2	11.7	9.6	4.8	8.2	8.9	10.4	11.5	6.9	9.2	2.1	11.9	12.4	36.2	1.9	21.9	3.5	5.3	17.8	6.6	4.8	9.1	4.1	31.5	30.7	21.1	18.3	6.8	45.0	5.0	9.3	107.7	15.8	0.0	4.2	50.0	6.1	12.9	23.5	7.1	14.0	12.3	28.4	5.6	14.9	6.8	18.6	6.6	8.5	26.9	16.6	16.1	67.0	13.0	162.5	10.6	9.4	2.9	13.1	11.2	20.2	20.7	27.1	9.6	11.2	10.5	6.5	9.6	15.5	10.6
C11orf53	MGC50104	ENSG00000150750	"Chromosome 11 open reading frame 53"	Q8IXP5	11	111245726-111286401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 3.4;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 14.3;Early spermatids: 38.1;Exocrine glandular cells: 56.6;Late spermatids: 12.4;Respiratory ciliated cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"OE19: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA056128, HPA073101"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Vesicles	"HPA056128: AB_2683046, HPA073101: "	"unprognostic (3.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.84e-2)"		"unprognostic (1.94e-1)"		"unprognostic (8.07e-3)"		"unprognostic (5.60e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.50e-1)"		"unprognostic (9.95e-2)"	"unprognostic (8.66e-2)"		"unprognostic (3.52e-2)"	0.9	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	1.4	0.9	0.9	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.6	1.3	0.4	0.7	0.0	0.3	1.0	0.0	2.1	0.0	1.8	0.0	1.2	0.0	0.0	0.0	3.4	5.5	0.0	0.4	0.0	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.0	0.0	0.1	0.1	14.3	3.3	0.0	0.0	0.0	0.1	1.5	0.0	1.9	38.1	0.0	1.4	0.0	7.7	0.0	0.1	56.6	0.1	1.9	3.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	3.0	8.2	0.0	0.0	12.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.2	0.3	4.0	0.0	9.9	0.0	0.0	0.1	0.6	1.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	4.4
C11orf68	"BLES03, P5326"	ENSG00000175573	"Chromosome 11 open reading frame 68"	Q9H3H3	11	65916810-65919062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045938	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA045938: AB_10961633"	"unprognostic (3.18e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.50e-3)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.18e-1)"	36.0	29.3	68.1	14.9	70.3	10.1	33.5	74.7	82.3	50.4	59.4	50.1	17.2	56.1	39.0	29.7	40.5	20.7	50.7	71.0	65.1	31.2	28.0	31.9	24.8	69.0	67.0	43.4	27.2	25.6	24.0	23.4	67.6	42.6	15.7	12.5	30.9	31.7	81.1	32.8	31.0	27.0	66.3	41.6	32.8	53.9	67.9	29.1	32.6	51.4	21.3	45.9	39.5	71.4	76.4	33.6	20.4	22.2	70.0	67.3	17.6	59.7	90.2	74.3	45.2	12.6	83.9	15.6	40.6	89.5	118.6	24.0	15.9	36.6	39.8	24.2	16.1	18.5	23.4	33.2	55.7	14.9	23.7	62.9	53.8	53.9	58.9	76.6	56.1	26.1	25.1	37.7	136.2	34.5	19.7	35.9	20.5	16.5	165.8	28.8	23.1	44.4	39.6	14.5	13.9	21.6	23.1	30.1	59.8	21.0	39.0	14.0	61.4	118.0	57.9	162.1	30.9	25.3	11.9	13.1	69.8	11.1	94.1	6.8	2.5	3.7	5.3	3.9	3.8	3.0	3.4	4.4	2.0	5.3	5.2	5.2	9.1	3.8	2.1	2.7	4.2	2.2	68.1	70.3	74.7	82.3	71.0	65.1	69.0	67.0	67.6	66.3	67.9	71.4	17.8	16.0	5.1	6.5	7.3	15.3	32.9	4.2	6.8	11.4	14.7	22.5	16.6	14.3	2.3	16.5	10.4	16.4	14.5	10.8	7.9	14.5	7.9	8.1	17.8	13.8	4.8	2.1	7.9	11.7	16.5	18.5	7.1	11.8	3.8	12.9	18.2	10.5	14.2	16.8	7.5	13.1	4.1	13.9	7.5	24.5	21.5	8.7	10.6	7.5	14.1	26.7	22.6	4.5	8.6	19.3	3.4	35.3	3.6	23.2	11.8	5.4	1.9	9.9	19.7	13.5	16.4	15.0	17.1	6.2	12.8	21.9	8.3	23.3	9.2	31.3
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"	Q7Z7L8	11	43925342-43943878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 750.2;ovary: 721.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 796.5;Endometrial stromal cells: 906.3;Fibroblasts: 801.3;Granulosa cells: 982.4;Peritubular cells: 474.3;Smooth muscle cells: 1942.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"SH-SY5Y: 197.7"	"Low region specificity"	"Detected in all"							HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"	478.3	199.0	28.7	39.2	24.3	4.9	203.5	26.1	34.2	305.0	18.4	151.0	19.7	283.4	8.7	44.8	750.2	61.1	269.3	24.8	44.4	226.8	179.2	377.9	6.8	93.8	42.4	721.3	60.7	3.2	126.5	15.4	38.5	157.3	8.4	1.3	22.2	14.3	110.8	97.2	130.3	28.4	35.1	54.4	240.2	67.8	44.5	5.0	119.4	10.3	0.7	176.3	148.1	21.0	0.0	0.0	0.0	0.0	4.0	2.0	1.1	0.3	1.3	0.0	0.1	0.1	0.0	0.0	0.5	0.5	2.1	0.1	0.4	0.0	0.0	0.0	2.9	6.2	0.1	0.0	0.8	0.5	0.6	0.3	0.1	1.4	0.0	0.0	1.2	2.1	2.3	0.0	0.0	0.0	2.4	2.7	1.7	0.0	0.9	10.3	0.7	4.7	0.0	0.0	2.2	197.7	0.0	0.0	19.4	5.5	0.0	2.3	2.7	9.2	3.8	2.3	0.2	22.5	0.2	3.2	7.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	24.3	26.1	34.2	24.8	44.4	93.8	42.4	38.5	35.1	44.5	21.0	796.5	6.4	139.9	0.0	1.9	92.9	15.2	1.6	5.2	15.4	8.2	13.7	6.0	0.0	1.9	0.0	2.1	1.5	13.7	0.3	0.0	4.5	4.3	34.1	906.3	260.3	0.0	2.7	0.0	0.6	4.4	801.3	4.1	183.3	13.9	982.4	172.7	6.4	3.8	1.7	0.0	0.2	0.0	8.4	171.8	13.9	215.6	27.1	174.3	0.0	0.1	2.7	0.0	0.0	0.0	1.9	0.0	474.3	9.4	73.6	0.0	0.0	0.9	9.3	302.4	173.2	1942.9	2.1	1.5	6.5	88.5	3.1	14.2	243.9	0.1	50.5
C12orf40	FLJ40126	ENSG00000180116	"Chromosome 12 open reading frame 40"	Q86WS4	12	39626167-39908300	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;Late spermatids: 5.2;Spermatocytes: 33.2;Spermatogonia: 7.6"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039032			Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA039032: AB_2676316"					"unprognostic (1.75e-1)"								"unprognostic (2.76e-6)"	"unprognostic (3.45e-1)"	"unprognostic (1.96e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	7.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0
C12orf54	MGC35033	ENSG00000177627	"Chromosome 12 open reading frame 54"	Q6X4T0	12	48482498-48496524	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	39	"testis: 40.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2541.6"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.9;head and neck cancer: 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HBEC3-KT: 2.7"					"Not detected"	"Not detected"			HPA073090			Approved	"Intermediate filaments"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Intermediate filaments"		"HPA073090: "	"unprognostic (2.59e-3)"	"unprognostic (5.49e-2)"	"unprognostic (7.94e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.99e-2)"		"unprognostic (5.96e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.37e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.92e-1)"	0.0	0.4	0.3	0.0	0.4	0.0	0.2	0.2	1.0	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.5	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.3	0.1	0.0	40.4	0.3	0.0	0.0	0.2	0.6	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.0	0.3	0.2	0.5	0.4	0.5	0.3	0.3	0.5	0.0	0.0	2.6	8.1	0.0	5.1	38.6	19.5	1.2	0.2	0.2	0.1	0.7	0.0	4.5	0.0	0.0	0.1	0.0	0.0	1.9	0.1	543.1	0.0	0.0	1.2	0.0	0.0	5.3	0.0	0.2	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	9.1	0.0	2.0	0.0	1.8	2541.6	10.8	1.4	0.0	2.8	0.0	0.3	0.0	4.5	2.5	0.0	0.0	13.2	0.0	6.4	0.0	1.9	1.9	0.2	6.6	4.3	1.0	11.5	6.5	5.9	2.3	0.0	0.5	0.4	0.0	10.8
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123233385-123258079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 60.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favorable (7.82e-5)"	7.3	12.6	16.2	10.2	16.1	9.0	8.0	23.0	19.6	13.0	13.5	10.9	11.4	12.1	13.8	9.5	11.4	8.2	15.0	16.0	13.2	12.6	14.5	8.9	18.2	12.6	12.3	17.2	8.5	10.2	19.7	7.3	14.9	13.7	8.2	15.7	16.2	9.0	13.0	13.8	11.3	7.0	8.8	12.8	10.6	16.7	14.8	60.0	12.3	12.5	13.4	10.3	11.0	18.3	28.4	20.5	20.8	39.1	12.0	11.1	13.7	22.3	16.5	25.1	18.0	21.8	15.8	36.1	20.3	8.4	23.5	20.4	25.7	12.5	25.0	29.2	22.5	44.0	20.7	18.6	26.1	20.4	19.7	14.2	33.2	18.9	35.1	37.0	17.0	53.6	45.6	13.4	16.7	12.3	46.2	39.3	13.7	25.6	31.7	35.7	25.9	33.5	22.8	13.0	40.7	18.2	24.0	8.8	23.4	16.5	18.3	24.7	14.8	23.1	27.3	23.3	24.4	22.7	28.3	32.6	17.1	26.2	28.1	85.3	12.9	50.6	53.9	14.9	67.6	83.9	72.3	71.9	21.7	73.5	96.6	78.2	11.8	63.3	16.3	36.6	73.1	33.5	16.2	16.1	23.0	19.6	16.0	13.2	12.6	12.3	14.9	8.8	14.8	18.3	46.0	41.7	47.7	9.8	54.3	45.4	36.7	29.4	59.2	34.5	23.3	50.0	52.7	14.3	18.0	25.8	14.6	41.1	56.2	16.4	60.7	20.7	22.9	12.2	24.2	27.9	9.6	37.0	13.7	10.8	22.8	41.3	23.0	11.2	15.2	24.1	18.5	33.5	14.3	45.4	15.9	20.7	28.5	9.2	24.2	6.2	37.9	19.7	24.9	7.5	26.3	35.7	44.3	14.6	10.4	13.6	17.4	42.2	42.2	22.8	19.9	39.3	14.8	36.6	13.1	42.7	33.1	115.2	59.7	40.6	36.1	10.8	63.0	43.3	20.8	8.0
C12orf66	FLJ32549	ENSG00000174206	"Chromosome 12 open reading frame 66"	Q96MD2	12	64186316-64222296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046743, HPA052855"	Uncertain		Supported	"Lysosomes,Cytokinetic bridge"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Lysosomes	"Cytokinetic bridge"	"HPA046743: AB_2679782, HPA052855: AB_2681973"	"unprognostic (7.44e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.07e-2)"	2.9	4.2	3.6	3.4	5.3	1.7	5.4	4.0	4.8	2.8	1.9	2.8	3.1	2.6	4.8	4.2	3.9	2.5	2.3	3.5	4.3	5.5	8.6	2.8	4.9	4.0	4.4	3.9	5.2	5.7	2.6	2.1	4.5	2.3	3.1	1.6	2.9	2.3	4.4	5.6	2.5	2.3	3.7	5.0	3.0	3.4	4.3	3.3	5.6	3.2	4.8	2.6	3.0	6.8	5.5	8.7	1.6	4.7	4.3	7.2	4.5	3.0	3.7	4.4	2.7	2.7	4.3	17.4	4.1	2.4	7.1	6.3	6.9	5.3	4.7	13.3	4.6	6.3	2.1	2.5	5.6	6.9	3.6	5.6	9.0	5.7	10.3	5.0	3.2	12.0	8.8	11.3	4.4	10.6	7.9	6.0	7.7	6.5	6.8	4.0	4.9	13.4	6.6	6.4	3.8	3.8	4.9	6.7	4.8	4.2	10.8	4.4	2.5	4.4	2.9	4.4	2.9	14.9	13.2	9.7	6.6	5.9	5.0	0.5	2.6	0.2	3.3	2.6	5.7	8.5	6.4	5.0	4.3	7.2	8.7	8.4	0.2	4.0	1.8	3.1	10.8	4.2	3.6	5.3	4.0	4.8	3.5	4.3	4.0	4.4	4.5	3.7	4.3	6.8	3.4	3.2	2.7	5.5	9.3	2.4	8.8	3.4	7.4	2.1	5.9	4.1	2.7	7.2	5.5	9.2	2.1	6.3	4.0	1.9	9.8	4.1	9.2	3.3	4.0	3.9	4.2	3.4	7.1	5.2	3.9	3.5	7.1	3.6	1.3	3.6	1.8	10.8	4.9	0.0	5.5	2.7	4.1	6.3	2.6	7.3	4.7	4.3	1.8	1.0	2.1	2.5	1.0	3.5	17.4	2.6	2.6	1.9	2.8	4.7	2.1	12.9	2.4	1.6	0.0	7.4	2.8	4.4	8.8	6.9	4.3	1.8	5.8	4.3	3.7	4.3
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 4.8;salivary gland: 4.6;testis: 10.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 92.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	16	"hypothalamus: 2.9;thalamus: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	0.3	1.8	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.8	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.5	4.8	0.0	0.0	1.1	0.0	2.7	4.6	0.1	3.0	0.0	0.1	0.1	0.0	0.0	0.3	10.8	2.4	0.1	0.2	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	6.2	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.7	0.0	0.1	0.0	28.3	0.0	0.0	2.0	0.0	23.9	0.3	3.0	0.0	1.4	0.0	6.2	0.0	0.4	1.7	0.1	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	12.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.9	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.9	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	1.0	0.0	12.3	0.0	1.0	0.7	0.0	0.0	0.7	0.0	0.8	0.0	0.0	1.2	1.1	0.0	10.0	0.2	92.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C16orf70	"C16orf6, FLJ12076, lin-10, LIN10"	ENSG00000125149	"Chromosome 16 open reading frame 70"	Q9BSU1	16	67109941-67148544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 47.9;Oligodendrocytes: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041131, HPA041214"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA041131: AB_10795487, HPA041214: AB_10794267"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.15e-2)"	11.3	10.0	15.6	7.6	16.6	18.1	11.1	15.5	17.4	13.2	10.8	10.2	7.3	11.2	8.9	17.8	10.6	7.5	10.3	18.5	13.6	14.0	57.3	9.8	9.2	15.7	16.1	11.1	8.3	16.1	10.9	11.8	17.0	14.4	10.1	8.1	12.0	8.5	29.7	30.4	10.0	10.8	16.2	14.7	8.6	13.8	15.6	9.2	9.0	15.3	11.7	10.5	14.6	21.4	13.7	19.3	19.0	19.9	23.6	13.9	44.5	15.4	16.6	30.7	33.3	22.1	11.7	13.9	13.3	18.2	16.9	18.0	23.7	14.9	39.7	7.1	19.7	10.6	12.2	47.4	14.5	10.9	58.0	14.1	20.6	30.2	13.9	16.6	17.3	17.5	17.5	5.8	19.4	13.6	21.2	16.6	21.5	18.4	29.4	29.5	32.2	21.9	13.4	8.2	24.5	13.2	46.2	10.7	12.0	18.7	22.0	9.0	13.4	21.5	18.4	15.5	13.5	8.8	17.3	41.3	19.4	10.9	17.5	3.2	17.4	6.1	4.4	12.2	5.9	6.9	6.6	8.1	14.6	4.5	6.8	6.3	6.2	5.9	13.6	4.8	7.2	8.9	15.6	16.6	15.5	17.4	18.5	13.6	15.7	16.1	17.0	16.2	15.6	21.4	5.1	6.4	5.9	11.1	6.6	9.1	2.5	5.1	19.4	7.4	8.7	6.7	1.3	1.5	3.2	0.0	0.0	8.8	5.0	4.9	5.9	4.4	1.6	12.9	8.5	6.2	7.2	11.1	20.4	2.9	9.5	5.1	8.6	30.6	9.5	8.7	5.0	47.9	18.6	10.1	18.5	8.4	4.1	13.5	7.8	1.6	4.7	13.2	10.6	17.8	13.3	2.7	3.1	11.1	41.6	4.8	8.6	6.4	7.5	4.6	5.4	10.3	11.0	5.9	13.1	5.3	6.4	24.7	24.8	20.5	12.1	7.0	6.7	8.2	5.7	1.3
C17orf100	LOC388327	ENSG00000256806	"Chromosome 17 open reading frame 100"	A8MU93	17	6651762-6693202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.9;Late spermatids: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.0;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA046824			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA046824: AB_2679825"	"unprognostic (9.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.65e-2)"	0.9	1.6	4.1	1.7	4.9	0.5	1.5	3.3	4.8	1.9	2.2	1.6	3.0	1.6	2.2	4.3	2.0	1.1	0.6	3.5	4.5	2.4	3.6	1.2	3.2	3.2	3.7	1.3	4.5	3.5	9.5	0.8	3.2	2.5	1.5	5.3	2.8	1.0	0.6	7.3	3.0	0.8	3.4	2.9	2.4	5.5	4.1	1.7	3.3	0.8	1.2	1.9	2.3	3.9	1.1	2.1	4.6	1.5	0.7	1.3	2.2	0.6	3.4	1.4	2.7	3.2	1.5	1.3	2.3	1.1	3.6	4.1	0.9	2.2	2.0	5.6	6.3	1.2	2.4	10.0	1.6	0.2	3.2	1.8	2.1	0.7	1.5	4.1	0.8	6.7	1.6	1.2	1.8	2.4	1.4	2.1	0.6	1.9	1.4	2.6	0.8	2.0	2.9	1.0	4.8	9.4	2.9	0.3	3.4	1.4	2.5	0.3	1.3	1.3	2.6	0.8	1.1	1.7	1.2	0.8	1.1	0.4	3.1	3.9	0.9	4.0	1.2	1.3	1.6	2.3	2.2	1.4	1.6	2.5	2.5	1.4	0.8	1.4	1.3	0.5	1.5	0.9	4.1	4.9	3.3	4.8	3.5	4.5	3.2	3.7	3.2	3.4	4.1	3.9	1.7	0.0	1.7	0.0	3.2	2.8	5.4	4.8	8.0	3.8	4.9	5.0	0.4	0.0	4.9	0.0	2.1	1.7	0.6	3.8	1.9	4.1	32.9	3.0	3.0	1.8	7.7	1.3	1.4	3.2	1.8	1.6	4.1	2.9	8.9	4.7	0.0	0.0	1.2	1.7	1.4	7.1	10.2	0.0	1.3	48.7	0.9	0.7	1.8	1.0	1.2	5.1	1.0	1.5	2.2	3.3	2.6	1.9	0.9	4.5	9.0	2.1	2.4	5.8	6.6	1.9	3.0	16.4	4.6	7.0	3.0	1.5	1.7	3.8	3.9	5.1
C17orf50		ENSG00000270806	"Chromosome 17 open reading frame 50"	Q8WW18	17	35760887-35765079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"testis: 105.6"	"Group enriched"	"Detected in some"	45	"Early spermatids: 769.0;Late spermatids: 1197.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HaCaT: 3.7;MOLT-4: 1.0"	"Not detected"	"Not detected"							"HPA043184, HPA063464"			Supported	Nucleoplasm		Yes	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA043184: AB_2678358, HPA063464: "	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.12e-3)"		"unprognostic (2.04e-2)"		"unprognostic (1.97e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.54e-2)"	0.1	0.1	1.2	0.0	0.9	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.8	0.7	0.1	0.0	0.1	0.0	0.4	0.7	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	105.6	0.6	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.7	0.4	0.0	0.7	1.2	1.4	0.0	0.1	0.0	1.4	0.0	0.2	1.2	0.9	0.0	1.0	0.8	0.7	0.4	0.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.4	0.5	0.6	0.3	0.0	0.1	9.2	0.0	0.0	0.2	0.4	0.0	0.0	769.0	1.8	0.0	0.5	1.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	2.0	0.0	0.0	1197.7	8.4	0.4	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.2	5.7	0.0	0.1	0.4	1.0	1.5	0.2	6.6	0.0	0.2	21.8	7.2	0.0	0.0	0.0	0.1	0.1	0.5	0.1
C17orf80	"FLJ20721, HLC-8, MIG3, SPEP1"	ENSG00000141219	"Chromosome 17 open reading frame 80"	Q9BSJ5	17	73232233-73248947	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 170.0;Late spermatids: 100.8;Spermatocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012896	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA012896: AB_1850766"	"unprognostic (9.22e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.43e-4)"	"unprognostic (5.55e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.37e-1)"	8.6	10.1	10.0	9.5	10.1	3.1	11.2	12.7	12.1	11.9	9.2	11.6	10.5	14.5	9.7	8.8	12.2	8.9	15.8	9.7	10.2	12.7	9.9	9.2	13.7	8.3	9.2	17.2	9.3	16.6	10.6	12.5	8.4	12.6	10.0	23.3	10.8	11.9	24.6	8.7	9.8	12.8	9.0	10.8	10.3	39.7	9.6	17.9	16.1	21.8	12.2	9.1	6.9	9.9	20.0	20.6	28.1	17.2	20.2	17.2	27.2	25.6	22.2	35.6	33.6	19.7	16.1	37.7	17.8	13.2	24.2	19.5	39.4	14.7	41.4	13.8	26.8	34.6	21.5	23.3	17.6	37.0	19.7	13.5	18.1	23.8	19.5	17.8	30.9	25.1	38.3	21.9	24.0	11.5	43.1	17.5	22.3	22.1	22.1	25.7	77.2	19.3	18.4	14.9	34.3	30.8	13.7	24.7	30.0	44.0	27.1	23.0	17.1	37.1	34.0	12.1	24.8	24.7	31.9	35.8	14.9	16.5	24.1	17.3	3.3	4.8	6.6	4.0	6.6	4.9	4.9	5.9	3.8	4.7	4.5	6.6	1.6	4.4	4.4	5.8	7.2	3.4	10.0	10.1	12.7	12.1	9.7	10.2	8.3	9.2	8.4	9.0	9.6	9.9	10.3	6.4	15.1	10.7	6.4	5.0	2.1	3.0	8.6	10.3	6.1	7.2	20.2	5.7	7.9	5.5	20.9	9.5	14.9	4.6	9.8	6.1	170.0	8.9	12.3	11.0	5.4	1.3	10.8	3.8	5.8	9.6	5.6	7.0	7.6	11.8	5.0	4.6	5.0	8.4	10.9	3.8	6.1	5.1	2.6	100.8	5.3	4.8	1.8	9.4	5.9	10.6	4.1	10.1	9.0	4.5	5.1	7.5	5.9	2.1	6.6	7.5	15.8	15.8	0.0	10.5	7.7	67.1	13.6	7.1	4.4	16.8	5.5	17.9	4.8	1.4
C17orf98	LOC388381	ENSG00000275489	"Chromosome 17 open reading frame 98"	A8MV24	17	38835086-38841438	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 19.5"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 263.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"hTCEpi: 5.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051696	Uncertain		Approved	"Nucleoli,Intermediate filaments"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Intermediate filaments"	Nucleoli	"HPA051696: AB_2681576"	"unprognostic (2.30e-1)"			"unprognostic (3.25e-4)"	"unprognostic (1.46e-1)"					"unprognostic (3.01e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.58e-2)"	"unprognostic (9.02e-2)"		0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	5.6	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	263.7	0.2	0.1	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.2	29.4	1.2	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	3.3	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0
C18orf25	"Ark2N, ARKL1, MGC12909, RNF111L1"	ENSG00000152242	"Chromosome 18 open reading frame 25"	Q96B23	18	46173553-46266992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051314, HPA051899"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA051314: AB_2681438, HPA051899: AB_2681657"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.46e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.97e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	8.5	6.9	9.0	8.9	8.9	34.1	10.4	12.3	10.3	11.9	18.1	8.1	7.7	9.2	7.9	37.5	9.6	6.5	15.8	8.0	8.2	8.8	8.1	9.6	12.1	10.2	12.9	9.2	6.0	18.8	6.2	8.2	11.2	8.3	9.2	27.6	13.3	7.5	23.3	13.2	8.9	9.4	7.4	11.1	8.7	12.0	10.2	15.0	11.9	16.0	15.4	9.8	16.4	9.1	18.4	17.9	14.8	16.9	10.4	9.3	19.0	26.0	13.8	27.3	23.1	13.9	20.5	14.0	24.1	17.7	9.8	40.9	27.7	17.7	29.5	23.5	8.9	12.4	16.0	10.6	17.9	23.5	16.0	8.7	20.2	31.9	26.3	15.9	11.0	12.9	14.1	16.3	15.3	13.7	17.9	11.9	13.2	6.3	7.0	16.0	17.6	20.7	26.1	32.5	20.7	10.8	19.1	13.4	13.7	17.9	8.8	14.3	16.0	24.7	17.6	6.0	24.3	21.3	19.7	22.3	12.8	24.4	27.0	4.9	8.9	18.6	6.3	9.9	11.2	6.9	12.3	9.6	8.8	9.0	8.6	6.8	22.7	3.5	14.3	12.6	8.7	6.9	9.0	8.9	12.3	10.3	8.0	8.2	10.2	12.9	11.2	7.4	10.2	9.1	18.4	12.8	9.1	16.0	19.2	25.2	10.4	11.5	11.4	14.5	13.4	9.9	30.4	5.7	9.5	14.7	20.9	8.1	26.1	15.1	1.9	9.1	2.4	42.1	14.4	16.2	12.0	16.8	62.5	6.5	10.5	12.1	13.7	39.2	15.2	9.9	11.7	13.0	9.1	13.5	45.2	10.0	6.1	13.1	18.0	3.5	8.1	12.9	7.2	22.5	11.1	12.4	9.2	25.6	25.9	20.4	10.1	10.5	16.5	13.0	9.2	7.6	16.9	30.6	19.7	14.8	11.8	20.6	14.9	14.2	31.8	24.4	18.6	6.6	10.1	23.3
C19orf25	FLJ36666	ENSG00000119559	"Chromosome 19 open reading frame 25"	Q9UFG5	19	1461143-1479219	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050270, HPA067491"	Approved		Approved	"Intermediate filaments"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"		"HPA050270: AB_2681069, HPA067491: AB_2685849"	"unprognostic (5.82e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.51e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-3)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.35e-2)"	"prognostic favorable (9.20e-8)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-3)"	14.4	23.5	33.3	8.8	33.2	7.8	15.9	31.1	43.8	17.7	29.3	18.0	15.6	15.8	5.3	20.4	15.7	8.1	21.2	31.6	30.0	31.0	29.5	14.8	15.0	35.3	33.1	15.9	19.9	15.6	27.1	8.6	32.0	22.1	5.2	6.9	17.6	8.1	16.2	17.3	17.7	6.1	32.7	23.4	17.8	22.0	34.0	9.7	23.8	7.4	7.0	17.5	15.6	36.7	25.0	19.2	11.6	18.3	11.0	10.0	23.4	24.4	16.8	25.5	23.5	27.4	12.1	14.2	18.7	13.0	12.1	30.1	17.9	15.0	6.0	44.7	27.1	17.3	12.2	32.3	23.6	27.5	33.5	9.2	33.2	10.7	17.2	18.3	13.2	29.3	46.1	32.7	16.6	13.9	25.6	21.8	36.2	15.2	29.5	41.4	16.0	36.5	17.8	16.7	19.8	26.5	18.0	23.0	28.5	6.0	33.4	31.8	16.3	19.8	22.4	40.6	23.4	46.3	26.7	24.2	20.4	27.4	35.1	50.1	32.1	59.1	41.3	33.0	33.5	36.6	37.9	35.7	23.4	45.6	38.2	30.9	52.0	30.5	27.7	47.6	52.6	38.6	33.3	33.2	31.1	43.8	31.6	30.0	35.3	33.1	32.0	32.7	34.0	36.7	24.2	16.0	8.7	10.4	44.3	19.2	30.5	27.3	18.8	62.7	28.9	29.7	10.3	21.5	19.9	51.5	64.6	41.5	45.2	68.1	49.0	40.1	6.2	14.7	21.0	23.0	50.6	17.2	14.5	46.1	33.3	21.7	31.1	19.3	11.4	30.4	29.3	18.2	35.9	97.6	11.5	33.7	34.6	27.9	24.9	7.3	26.4	26.4	24.9	8.4	56.7	49.2	82.4	14.1	20.6	52.6	52.0	21.8	26.7	33.5	83.2	35.5	15.3	87.8	46.0	20.0	24.1	33.8	33.0	14.8	19.7	52.9	47.3	36.1	38.2	33.6
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304164-38305006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 515.3;skin 1: 331.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2060.3;Pancreatic endocrine cells: 2590.4;Paneth cells: 1697.3;Proximal enterocytes: 1756.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"myeloid DC: 22.2"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 22.2"	"Cell line enhanced"	"Detected in many"		"A-431: 745.5;A549: 1228.0;CAPAN-2: 767.1;HBEC3-KT: 744.6;hTCEpi: 799.2;OE19: 678.3;PC-3: 659.8"	"Not detected"	"Not detected"							"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	43.1	5.0	2.8	17.6	3.1	3.6	25.5	2.9	4.4	82.4	2.9	187.5	186.7	6.1	0.6	515.3	91.5	49.5	32.9	2.3	2.6	28.2	1.3	91.3	0.9	3.1	3.0	4.6	8.9	0.5	12.7	7.9	3.4	26.2	104.1	0.1	123.3	18.3	3.9	331.1	189.5	4.0	2.5	10.7	151.5	1.5	3.8	4.1	18.9	4.3	30.8	102.2	224.3	2.5	745.5	1228.0	0.0	0.6	0.0	0.0	1.2	1.0	0.0	0.0	0.0	77.1	767.1	0.0	394.2	0.0	0.7	300.1	0.0	744.6	0.0	0.4	0.5	0.4	244.2	20.0	5.4	0.0	0.2	0.0	799.2	0.3	493.3	3.3	10.2	0.9	0.4	0.5	0.8	220.4	0.1	1.9	0.4	678.3	659.8	0.2	0.2	2.8	469.5	255.2	0.8	0.8	416.6	340.8	0.8	1.6	103.7	2.3	141.6	0.5	201.9	0.7	2.8	0.7	2.4	3.7	0.1	0.2	0.2	2.1	0.6	2.2	0.2	0.0	0.4	0.1	0.5	0.1	22.2	1.4	0.7	0.3	1.0	0.4	0.1	1.8	0.0	18.2	2.8	3.1	2.9	4.4	2.3	2.6	3.1	3.0	3.4	2.5	3.8	2.5	29.1	535.2	172.9	0.0	5.4	225.3	28.4	508.7	436.5	0.0	32.5	25.5	2.4	267.4	418.0	55.2	0.0	8.6	1.7	2060.3	1.9	207.7	0.7	144.3	26.0	18.4	76.1	3.6	0.1	753.8	1.3	44.7	353.7	273.2	38.2	3.7	3.6	0.4	1.3	0.0	0.0	842.0	99.7	1.4	15.1	5.1	4.1	32.9	1.8	0.0	4.9	0.0	0.0	0.0	0.0	2590.4	1697.3	0.0	5.7	35.7	1756.4	51.7	212.5	0.0	0.0	0.4	14.3	1.8	1.9	629.0	348.4	3.1	7.9	0.0	691.9	188.4
C19orf38	HIDE1	ENSG00000214212	"Chromosome 19 open reading frame 38"	A8MVS5	19	10836575-10869790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 98.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 90.1;Langerhans cells: 33.4;Macrophages: 59.2;monocytes: 86.7;Plasma cells: 24.7;Spermatocytes: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"classical monocyte: 282.3;eosinophil: 169.4;intermediate monocyte: 312.5;myeloid DC: 162.2;neutrophil: 230.1;non-classical monocyte: 392.8"	"Group enriched"	"Detected in all"	20	"dendritic cells: 162.2;granulocytes: 230.1;monocytes: 392.8"	"Cell line enriched"	"Detected in some"	4	"U-937: 50.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA012150, HPA055027"			Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA012150: AB_10603448, HPA055027: "	"unprognostic (6.65e-3)"	"prognostic favorable (2.43e-4)"	"unprognostic (6.44e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.56e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.75e-7)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.11e-2)"	3.6	1.0	3.5	11.2	3.9	98.0	1.2	4.2	4.5	2.1	3.5	1.8	1.7	1.0	2.7	1.0	2.3	2.9	0.9	3.4	4.1	1.2	3.2	6.1	5.2	5.2	4.3	2.0	1.7	0.4	0.8	1.8	5.2	1.3	1.2	0.7	0.9	0.9	2.7	0.5	2.3	3.4	4.6	21.7	1.6	11.1	4.0	3.2	0.5	1.5	3.0	4.6	1.6	6.0	2.4	0.1	0.2	0.4	2.2	1.2	0.2	0.4	0.1	0.4	0.9	0.2	0.4	5.9	0.5	0.0	0.2	0.2	0.3	0.3	0.3	2.7	0.6	0.3	0.0	0.0	1.6	3.9	0.6	6.0	0.7	1.0	0.3	0.1	0.1	0.6	0.3	12.2	0.2	2.2	0.2	9.3	0.5	0.4	0.4	4.5	0.0	3.1	0.0	0.2	0.3	0.1	1.2	0.0	0.9	0.1	0.2	8.7	0.0	0.1	0.0	1.1	0.1	7.3	3.7	1.7	0.0	50.9	0.0	7.8	282.3	169.4	0.6	312.5	1.6	13.0	0.8	0.8	162.2	8.5	4.9	1.5	230.1	8.0	392.8	3.6	2.3	157.7	3.5	3.9	4.2	4.5	3.4	4.1	5.2	4.3	5.2	4.6	4.0	6.0	0.3	0.0	1.8	1.6	10.6	0.8	0.4	2.1	1.2	0.1	0.6	0.5	1.1	0.0	1.7	1.8	2.1	1.0	0.7	0.3	0.0	0.1	3.7	0.9	0.3	1.1	0.0	4.8	0.9	1.3	0.9	1.6	4.1	1.0	2.5	0.3	0.4	1.1	22.3	0.0	0.9	0.6	2.0	90.1	33.4	6.1	0.9	59.2	1.8	0.0	86.7	3.1	4.1	0.0	3.1	0.1	3.5	0.7	24.7	0.3	0.2	0.7	5.1	1.1	6.6	0.5	0.6	28.5	19.2	0.3	0.9	0.7	2.1	0.1	0.6	0.6
C19orf53	"HSPC023, LYDG10"	ENSG00000104979	"Chromosome 19 open reading frame 53"	Q9UNZ5	19	13774456-13778773	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059928, HPA061291"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA059928: AB_2684165, HPA061291: AB_2684469"	"unprognostic (3.94e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.85e-2)"	95.6	117.7	154.3	52.1	157.8	80.4	88.9	161.0	209.6	97.0	148.4	94.3	45.4	91.6	85.6	92.3	87.6	49.8	155.6	154.4	163.8	124.4	111.0	80.1	76.9	159.4	159.9	111.7	95.5	92.8	111.6	40.2	157.8	98.8	41.6	35.7	76.9	52.8	167.6	95.2	72.4	63.0	157.5	82.1	91.2	51.6	158.0	101.5	90.4	107.2	70.8	88.6	82.6	157.3	176.4	249.9	123.0	98.9	169.6	191.1	80.1	167.0	145.5	201.0	200.7	235.8	83.5	95.4	198.2	202.4	146.6	90.1	111.6	250.1	102.7	113.5	362.3	90.1	254.6	260.5	174.9	140.7	109.4	237.8	174.7	188.1	105.9	129.0	171.0	136.6	140.9	154.2	157.9	406.2	193.6	145.9	152.6	133.8	441.8	105.7	94.9	160.5	177.1	221.3	108.6	132.4	115.1	130.8	172.5	89.2	120.0	139.0	118.4	221.9	89.2	239.4	227.5	172.3	240.3	144.4	132.3	157.6	121.8	264.1	220.1	275.7	211.0	238.2	240.4	333.2	270.7	248.4	202.2	321.1	318.1	289.7	107.1	184.7	214.3	289.4	337.9	496.3	154.3	157.8	161.0	209.6	154.4	163.8	159.4	159.9	157.8	157.5	158.0	157.3	167.0	115.4	97.8	13.7	205.2	291.1	260.1	349.2	147.4	50.5	258.7	352.9	263.3	213.1	207.8	268.5	22.9	218.6	176.5	230.1	628.0	242.5	176.8	229.3	189.8	194.4	227.3	174.0	10.5	335.2	406.3	184.4	109.6	233.0	128.7	132.4	179.9	367.5	368.2	35.3	10.2	254.3	236.0	247.1	287.1	621.4	218.7	187.5	231.3	5.6	338.9	220.3	260.6	6.6	18.8	269.6	272.8	182.4	164.1	360.5	353.9	820.0	189.3	65.9	92.1	138.5	206.0	102.6	137.0	187.7	348.5	213.0	216.0	169.8	257.5	345.2
C19orf54	FLJ41131	ENSG00000188493	"Chromosome 19 open reading frame 54"	Q5BKX5	19	40740856-40751553	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059043, HPA059628"	Approved		Approved	"Intermediate filaments,Centriolar satellite"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Intermediate filaments"	"Centriolar satellite"	"HPA059043: AB_2683886, HPA059628: AB_2684087"	"unprognostic (3.18e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.33e-2)"	5.8	10.1	6.2	6.9	7.7	6.0	5.8	7.3	6.6	4.7	6.8	8.1	10.5	5.1	6.4	6.0	4.9	6.2	7.2	6.1	6.0	9.1	15.3	8.8	5.5	8.4	7.3	3.8	8.6	5.7	4.6	4.8	7.7	6.2	7.1	5.3	5.6	4.5	15.3	5.9	10.7	4.0	6.8	9.8	7.5	8.4	7.1	5.5	7.8	10.3	6.0	6.3	5.0	8.7	7.6	16.6	13.9	12.4	7.4	10.0	10.2	5.4	7.0	9.5	8.9	11.3	11.3	16.5	13.6	6.4	4.7	12.0	23.0	9.2	7.8	11.5	20.7	10.3	24.4	14.3	22.5	7.1	8.8	15.2	4.8	9.3	19.9	11.7	5.7	22.1	13.3	22.8	6.7	9.0	10.0	8.2	10.5	17.4	6.0	18.9	14.2	14.3	9.6	14.5	11.3	7.0	19.5	8.1	8.4	15.3	8.4	9.6	4.8	11.7	11.7	6.1	3.7	25.6	18.9	13.0	11.3	15.4	8.3	0.4	4.5	1.3	1.3	3.8	0.5	1.2	1.1	0.7	5.7	0.9	1.1	1.0	1.0	0.8	5.1	3.5	1.9	1.9	6.2	7.7	7.3	6.6	6.1	6.0	8.4	7.3	7.7	6.8	7.1	8.7	2.9	3.2	8.9	6.2	2.9	1.7	3.7	3.3	5.2	1.6	4.2	3.0	8.0	2.8	1.2	5.5	2.1	7.9	2.5	5.5	3.9	3.4	6.7	3.3	3.7	3.5	1.2	4.6	0.4	2.5	6.6	2.3	7.7	3.1	0.0	4.1	1.8	6.4	8.4	0.0	0.7	5.0	4.1	10.7	1.6	2.9	2.5	7.2	0.0	1.0	8.2	2.2	1.0	1.5	3.4	2.0	4.8	1.2	5.4	2.4	12.3	6.7	2.9	3.8	0.0	1.9	2.3	17.8	12.0	4.4	1.7	5.6	2.8	6.1	5.5	2.8
C19orf73	FLJ10490	ENSG00000221916	"Chromosome 19 open reading frame 73"	Q9NVV2	19	49118402-49119143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5"									HPA062719	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA062719: AB_2684847"	"unprognostic (3.02e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (3.05e-1)"	"unprognostic (9.00e-5)"	"unprognostic (1.19e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.13e-3)"	0.9	1.3	3.7	0.4	3.9	0.1	1.5	5.8	4.6	0.7	2.3	1.7	2.1	1.0	1.3	2.0	0.5	0.3	1.7	4.2	3.7	1.7	3.4	1.0	0.2	4.1	3.7	0.2	4.8	0.8	3.8	0.2	3.9	1.5	0.7	1.0	2.5	0.4	1.8	2.5	1.5	0.2	3.9	1.8	1.4	1.3	3.9	0.6	1.9	0.9	0.3	0.7	1.2	4.5	1.7	2.1	0.8	4.0	1.3	0.2	0.9	0.5	0.3	0.8	0.6	0.1	0.9	1.2	0.4	0.3	1.2	1.1	1.0	0.1	0.1	2.4	8.5	1.1	1.6	1.4	1.3	0.0	0.4	0.1	2.7	0.6	2.2	0.6	0.1	4.2	2.0	2.0	0.4	1.8	1.4	1.3	0.6	1.8	0.4	1.2	1.6	1.6	1.5	0.7	4.2	1.9	0.8	1.0	1.6	0.5	1.0	0.4	0.8	1.0	1.8	0.3	0.4	1.2	2.5	1.4	0.7	1.5	1.2	0.0	2.0	0.4	1.6	1.3	2.7	1.5	1.2	1.5	3.4	4.4	2.4	1.8	0.0	5.0	2.8	2.7	1.2	1.5	3.7	3.9	5.8	4.6	4.2	3.7	4.1	3.7	3.9	3.9	3.9	4.5	1.6	0.0	0.0	1.3	2.8	2.2	10.3	2.9	4.0	3.9	6.1	6.1	0.7	4.3	2.6	3.7	0.0	1.0	1.0	3.5	3.9	2.6	0.5	1.4	1.1	1.7	3.0	5.7	1.3	2.0	0.9	1.3	3.1	1.0	0.0	0.3	2.2	7.2	1.3	1.7	1.4	4.8	10.2	0.8	0.6	0.7	0.0	1.5	3.6	0.0	0.9	6.9	4.1	1.5	3.0	1.7	1.9	1.5	3.3	8.6	5.0	8.9	2.5	4.8	0.0	1.1	1.6	0.7	4.9	5.4	2.6	0.4	1.7	2.6	5.0	4.1
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 50.2;Suprabasal keratinocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavorable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	8.8	10.7	7.7	7.3	6.8	8.0	9.7	7.1	7.5	8.9	5.9	7.2	8.2	10.2	10.0	10.1	9.8	6.9	8.3	7.0	7.5	9.2	7.8	5.5	11.9	7.0	8.1	13.4	14.6	15.0	6.1	10.4	7.6	10.6	5.6	5.3	12.3	10.1	9.7	10.5	5.7	8.2	7.9	7.7	6.9	8.3	10.3	9.1	11.4	10.0	9.7	8.1	7.9	8.2	17.7	20.1	16.9	27.8	14.5	10.4	38.5	20.9	14.7	30.7	22.6	30.8	20.8	25.0	24.4	9.2	14.2	25.3	31.5	21.2	31.3	40.3	35.1	28.3	20.7	19.5	27.9	31.6	18.0	14.2	25.7	30.4	39.8	13.4	15.7	21.6	57.2	29.5	17.7	12.1	30.9	13.9	52.9	18.1	38.0	30.2	35.4	69.0	16.4	14.9	50.8	24.4	18.4	27.9	43.1	16.9	15.7	13.9	10.6	30.7	19.3	25.0	40.8	24.0	29.0	52.0	15.4	30.4	33.0	3.5	9.7	6.9	18.9	7.9	29.9	21.2	22.8	18.3	11.6	18.7	28.8	25.0	1.9	24.8	8.8	54.1	12.5	15.0	7.7	6.8	7.1	7.5	7.0	7.5	7.0	8.1	7.6	7.9	10.3	8.2	10.9	6.4	7.9	4.2	12.9	50.2	24.1	5.9	22.8	10.1	15.6	15.1	5.5	5.7	10.8	3.7	10.4	14.9	12.2	6.7	13.7	10.5	1.5	5.8	12.8	11.5	4.2	45.3	9.5	7.3	14.0	14.4	6.1	6.2	11.4	9.6	6.4	6.6	5.4	16.8	7.2	5.1	8.2	4.4	9.0	1.0	9.9	4.8	12.4	4.7	7.3	10.4	17.5	5.0	5.0	10.2	8.1	13.9	10.9	21.3	5.5	8.9	5.6	14.6	0.0	17.5	8.5	25.7	25.5	15.5	62.1	7.9	12.0	11.9	8.3	13.2
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018522-207032756	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 102.3;lung: 72.9;stomach 1: 58.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 176.3;Alveolar cells type 2: 99.4;Club cells: 68.5;Urothelial cells: 128.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 65.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 57.7;CAPAN-2: 99.5;HaCaT: 123.1;HBEC3-KT: 118.6;hTCEpi: 61.4;RPTEC TERT1: 56.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		180000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.4	0.0	1.6	0.0	0.8	10.4	0.0	0.1	15.1	0.0	8.9	24.5	0.2	0.7	102.3	2.6	9.8	0.5	0.0	0.0	8.4	0.5	72.9	0.0	0.0	0.0	0.1	12.9	0.0	0.3	0.2	0.0	50.9	8.4	0.0	29.4	1.9	0.5	37.7	20.3	0.3	0.0	0.2	58.7	0.9	0.0	0.3	4.2	0.5	16.1	20.6	31.2	0.0	57.7	7.7	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.1	99.5	0.0	6.5	0.0	0.0	123.1	0.0	118.6	0.0	0.1	0.0	10.6	1.0	1.6	0.0	0.0	0.6	0.0	61.4	0.0	34.2	0.0	0.0	0.2	6.9	0.1	0.0	0.1	0.1	0.2	0.1	37.3	3.3	0.0	0.0	0.2	56.4	15.1	0.1	0.3	1.1	11.1	0.5	0.4	0.2	0.2	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	176.3	99.4	0.0	0.3	20.8	53.0	26.8	10.8	0.0	5.4	7.2	49.9	30.0	68.5	11.0	0.0	0.1	0.1	40.7	15.6	24.3	5.7	6.7	1.4	1.7	10.7	0.0	0.1	24.4	0.0	1.6	50.4	14.9	6.3	0.0	0.0	0.0	0.2	0.0	0.1	19.8	12.2	0.0	1.2	5.5	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	60.7	35.3	0.0	0.3	56.5	31.8	0.3	41.0	0.0	0.0	0.0	2.8	0.1	0.0	24.3	23.3	0.0	0.3	0.1	8.9	128.1
C1orf159	FLJ20584	ENSG00000131591	"Chromosome 1 open reading frame 159"	Q96HA4	1	1081818-1116361	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.9;Late spermatids: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010019, HPA075399"	Approved		Approved	"Nucleoli rim,Mitotic chromosome,Intermediate filaments"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim, Mitotic chromosome"	"Intermediate filaments"	"HPA010019: AB_1078885, HPA075399: "	"unprognostic (2.79e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (1.34e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.62e-4)"	4.0	4.8	9.6	1.6	8.0	2.4	3.8	0.9	10.4	5.3	3.2	6.1	1.8	4.2	1.1	8.6	4.8	2.2	4.3	9.4	1.0	7.7	6.7	3.9	1.8	6.3	2.7	4.3	3.7	0.7	5.3	1.4	2.8	6.9	0.6	1.6	4.6	2.3	2.2	5.0	4.1	0.5	0.7	5.5	6.0	22.9	5.4	1.8	4.5	0.3	0.9	5.5	5.9	6.9	15.7	12.0	5.6	10.0	1.5	1.6	13.3	9.0	2.1	7.8	5.1	6.5	14.7	4.3	10.8	2.8	6.4	12.2	2.5	7.1	2.2	8.6	18.2	3.1	19.6	7.0	3.6	5.5	7.3	3.2	2.8	3.3	1.6	2.3	3.8	6.4	18.6	3.1	2.8	11.9	10.2	13.2	4.7	5.9	19.7	12.0	6.7	8.5	4.7	4.7	11.8	16.1	6.8	12.2	7.6	1.6	7.8	6.5	5.2	8.3	8.8	11.9	9.2	5.6	8.3	7.8	6.8	14.9	6.5	8.1	2.6	1.4	2.6	2.6	2.8	2.5	2.5	3.0	1.7	2.2	2.5	2.6	0.5	2.7	1.8	2.2	0.9	2.3	9.6	8.0	0.9	10.4	9.4	1.0	6.3	2.7	2.8	0.7	5.4	6.9	6.3	0.0	7.7	20.2	3.4	7.5	3.6	6.2	4.6	5.9	8.9	6.6	2.3	5.7	7.1	9.2	4.2	5.0	4.9	13.6	1.9	8.2	60.9	8.6	8.2	4.4	4.2	5.2	26.5	7.0	14.0	4.2	20.4	9.0	5.7	9.0	3.3	5.3	3.9	13.5	21.8	7.4	6.1	1.0	4.8	124.1	2.8	3.9	3.6	2.8	6.0	3.2	9.2	10.6	24.5	7.8	3.5	1.5	6.9	5.1	3.4	1.8	10.4	8.2	0.0	3.5	4.8	18.3	6.8	4.2	7.0	4.9	4.6	4.4	9.4	4.9
C1orf226	FLJ13137	ENSG00000239887	"Chromosome 1 open reading frame 226"	A1L170	1	162378841-162386812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 21.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2;Early spermatids: 22.7;Hepatocytes: 30.0;Late spermatids: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 14.0;HEL: 18.4;OE19: 16.0"					"Low region specificity"	"Detected in all"			"HPA052251, HPA074060"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"prognostic favorable (2.60e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.71e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-3)"	"prognostic favorable (4.44e-5)"	"unprognostic (9.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.13e-4)"	1.9	9.6	3.5	1.1	3.6	2.0	8.1	4.6	3.1	3.8	5.1	9.3	5.6	2.4	2.4	4.1	3.2	3.4	3.4	3.7	5.1	11.3	21.9	2.5	0.4	7.2	4.0	1.2	3.7	4.0	9.9	2.4	5.3	4.8	9.7	7.0	8.5	7.7	0.6	5.2	7.9	2.4	5.8	0.6	8.7	4.0	3.5	0.4	0.8	0.6	1.5	2.5	2.2	7.3	14.0	0.9	13.1	8.9	0.4	0.0	0.2	0.9	1.4	0.8	0.5	2.0	7.2	0.0	9.5	0.3	4.7	10.3	3.7	0.9	0.7	0.1	4.4	18.4	0.8	10.2	0.3	0.0	0.0	1.4	1.1	0.0	0.5	3.9	3.2	2.3	1.7	0.1	0.2	5.6	0.5	0.0	6.3	16.0	7.5	0.3	2.2	0.0	12.1	7.0	5.9	3.7	4.6	1.6	3.1	5.3	5.7	0.9	3.1	0.1	1.4	0.1	4.0	6.3	0.0	0.0	2.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	4.6	3.1	3.7	5.1	7.2	4.0	5.3	5.8	3.5	7.3	2.5	3.2	2.6	0.3	0.1	0.8	1.7	1.1	0.6	0.8	10.3	14.9	3.4	4.3	2.4	14.7	29.2	0.1	0.1	11.6	0.0	0.9	22.7	2.6	1.1	2.2	2.4	0.0	2.8	2.3	0.1	0.7	0.0	4.2	0.0	3.4	4.2	30.0	0.1	6.7	1.8	11.6	4.1	1.0	0.7	38.4	2.1	0.1	0.0	3.7	0.0	5.0	0.0	6.6	3.7	1.7	3.6	1.9	0.0	2.6	7.7	0.2	2.7	0.4	0.0	0.2	0.6	1.1	0.9	0.6	1.4	0.1	0.3	0.5	7.1	2.5
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	11.3	12.5	20.6	6.3	20.4	14.3	11.7	19.5	24.4	15.5	18.2	13.4	7.9	13.4	5.5	18.8	13.0	4.0	9.4	20.5	20.3	11.2	11.6	8.6	9.0	20.8	19.7	16.1	12.9	7.4	9.9	7.1	20.6	14.2	3.9	2.7	12.5	8.5	9.6	19.6	10.5	5.0	19.2	10.8	12.3	7.5	20.3	9.2	12.1	3.5	7.3	14.4	14.7	21.0	22.2	24.3	17.0	10.9	8.2	8.3	40.0	16.8	7.4	14.6	10.9	24.1	22.2	22.7	35.6	6.6	10.3	25.4	16.0	16.6	5.3	24.6	76.7	13.9	20.1	23.1	13.3	32.0	16.7	7.6	19.5	14.3	13.1	9.2	16.1	26.1	35.2	13.3	10.7	27.8	42.0	44.4	34.4	28.5	55.6	32.1	24.2	36.4	13.6	18.2	28.1	27.2	16.0	29.4	23.3	4.5	31.0	29.2	15.1	11.8	18.1	32.7	37.2	23.9	12.7	21.6	14.2	18.3	19.2	14.9	29.0	43.3	28.2	35.9	35.2	37.2	31.1	30.7	37.6	29.9	36.1	30.2	4.7	35.9	34.9	49.3	34.7	17.5	20.6	20.4	19.5	24.4	20.5	20.3	20.8	19.7	20.6	19.2	20.3	21.0	37.7	22.4	22.4	10.4	29.8	66.8	35.5	58.5	47.3	51.4	41.1	50.9	18.1	28.6	31.0	38.6	18.8	76.2	49.8	61.6	45.0	38.0	4.4	28.2	31.7	33.9	26.3	57.4	12.9	39.5	59.3	34.3	25.0	43.7	24.7	36.9	32.2	24.4	40.4	47.1	10.1	58.8	54.9	24.2	72.7	5.5	51.3	29.8	32.0	2.8	32.4	42.5	30.9	9.5	14.3	37.5	43.5	46.6	28.1	37.4	47.8	38.3	25.1	54.5	65.7	31.6	44.7	44.0	50.0	54.1	80.6	28.3	47.2	28.0	56.6	25.8
C1orf74	"FLJ25078, URLC4"	ENSG00000162757	"Chromosome 1 open reading frame 74"	Q96LT6	1	209779208-209784559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 6.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 14.9;Glandular and luminal cells: 28.4;Squamous epithelial cells: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028496	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA028496: AB_10602698"	"unprognostic (3.25e-1)"	"prognostic unfavorable (8.52e-6)"	"unprognostic (8.41e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.40e-2)"	0.6	0.9	0.7	2.4	0.7	1.1	2.2	1.8	0.7	0.9	0.2	1.6	1.3	0.8	2.0	4.0	1.1	0.9	1.5	0.7	0.9	1.9	1.7	0.9	4.3	0.8	0.8	0.9	0.8	1.2	0.8	1.1	0.8	1.6	2.0	0.9	1.9	0.9	1.0	6.7	2.8	0.6	0.7	4.2	1.7	1.3	1.1	2.1	1.2	0.9	2.4	1.9	1.7	0.8	4.7	2.4	1.5	0.8	2.0	2.3	3.5	2.6	3.4	3.1	3.2	4.9	3.5	4.9	1.5	1.7	1.9	9.3	0.9	7.6	3.6	4.9	3.1	3.2	1.7	0.4	2.8	4.6	1.4	1.4	6.6	3.9	6.3	2.6	1.8	6.6	6.5	3.5	2.7	2.4	3.9	4.7	6.4	3.2	4.1	4.0	7.2	6.9	2.7	4.0	6.0	6.5	3.5	2.7	4.0	3.4	4.2	2.4	1.7	2.6	3.1	2.7	4.2	3.2	3.4	5.4	2.3	3.7	3.8	4.7	0.8	0.7	1.3	0.9	0.9	1.8	0.6	1.0	1.6	3.7	1.1	1.2	0.5	1.5	0.5	2.7	0.6	0.9	0.7	0.7	1.8	0.7	0.7	0.9	0.8	0.8	0.8	0.7	1.1	0.8	0.6	3.2	2.2	0.0	1.1	2.2	6.1	4.6	6.8	1.6	3.7	2.8	2.0	0.0	1.8	0.0	0.0	3.9	1.5	3.5	7.9	1.9	0.1	14.9	1.8	0.8	3.6	2.1	0.5	2.0	5.0	0.9	2.6	28.4	1.3	2.2	1.4	2.3	2.8	1.7	0.6	5.9	0.0	1.3	0.3	0.6	2.5	1.6	0.0	1.0	1.3	2.2	0.0	0.0	0.3	4.1	3.5	0.0	0.6	5.1	2.4	7.4	1.8	1.3	0.0	0.4	1.0	3.6	4.7	25.0	4.8	4.0	1.1	2.8	3.4	12.1
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180166-37199385	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.7;placenta: 29.6"	"Cell type enriched"	"Detected in many"	11	"Extravillous trophoblasts: 398.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 114.2;RT4: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	No	No	354000000		"Cluster 48: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	4.9	6.7	4.4	6.6	4.5	1.6	4.0	4.3	5.3	11.1	4.3	5.5	1.6	31.7	1.4	2.7	7.0	8.8	3.7	4.5	4.3	7.4	13.0	5.2	5.1	5.1	4.5	5.5	3.5	2.2	2.5	29.6	4.8	6.8	3.6	0.5	3.2	2.9	1.5	5.0	5.4	8.2	4.4	6.5	3.5	6.2	4.8	2.4	3.8	0.7	2.3	5.6	4.3	6.3	17.7	20.5	10.7	3.6	1.8	21.3	32.6	3.4	6.8	2.8	2.0	3.8	24.7	0.1	14.1	6.0	1.5	34.9	0.4	8.4	1.2	4.9	2.6	2.8	8.3	3.8	7.1	0.1	2.3	29.2	4.9	2.3	0.6	7.3	25.5	0.8	0.1	7.7	1.1	114.2	0.0	0.5	7.1	2.5	0.3	0.2	0.1	2.8	24.5	50.7	1.8	14.6	1.0	19.7	2.8	5.5	7.0	0.5	9.4	1.1	5.6	0.4	0.1	15.5	0.4	0.1	2.1	2.0	3.2	0.4	0.1	0.5	0.2	0.2	0.2	0.2	0.4	0.3	0.1	0.7	0.9	0.7	0.5	1.5	0.1	0.3	1.4	0.3	4.4	4.5	4.3	5.3	4.5	4.3	5.1	4.5	4.8	4.4	4.8	6.3	3.2	0.0	0.0	13.7	2.9	1.5	2.1	1.9	0.6	1.0	8.6	4.2	1.8	1.5	2.2	1.8	0.0	8.1	1.5	7.9	1.9	3.4	2.0	4.8	30.8	6.8	0.0	0.8	3.3	1.1	398.9	7.6	2.0	9.6	1.3	19.8	10.0	7.2	9.3	0.0	4.3	3.1	0.0	1.9	1.4	8.9	0.6	1.2	5.4	3.7	1.1	4.5	1.0	4.0	7.8	2.7	2.8	0.4	3.4	0.8	2.0	1.6	2.7	0.9	0.0	2.2	7.5	7.2	4.5	1.0	0.3	34.5	3.1	7.6	4.4	1.5
C20orf173	dJ477O4.4	ENSG00000125975	"Chromosome 20 open reading frame 173"	Q96LM9	20	35523186-35529652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 35.5"	"Group enriched"	"Detected in some"	76	"Early spermatids: 473.3;Late spermatids: 156.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA076859			Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA076859: "										"unprognostic (1.90e-1)"				"unprognostic (1.03e-1)"				0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	473.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	156.5	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C20orf194	DKFZp434N061	ENSG00000088854	"Chromosome 20 open reading frame 194"	Q5TEA3	20	3249306-3407669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 226.9;Cone photoreceptor cells: 202.3;Excitatory neurons: 205.6;Inhibitory neurons: 163.1;Oligodendrocyte precursor cells: 135.7;Oligodendrocytes: 191.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052103, HPA067418"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center, Cytosol"		"HPA052103: AB_2681727, HPA067418: AB_2685835"	"unprognostic (9.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (9.58e-3)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.52e-2)"	11.8	9.5	19.7	5.2	22.4	3.6	8.7	18.5	20.1	10.1	6.8	14.4	4.1	10.4	5.4	8.4	9.8	8.3	15.3	19.5	21.4	11.2	2.6	10.0	4.5	21.5	22.9	12.3	6.3	4.2	8.8	9.1	21.1	8.6	4.3	16.4	5.8	11.6	32.3	5.6	6.6	12.9	19.6	7.3	9.7	10.4	21.8	3.8	9.6	11.6	2.9	12.6	8.9	26.0	4.0	3.6	9.7	4.7	19.7	21.6	1.1	9.2	10.3	6.0	7.5	0.0	4.3	0.0	2.5	12.3	7.7	4.7	3.7	9.1	8.2	0.9	1.8	1.1	1.4	10.0	9.2	1.2	0.5	17.7	6.9	7.9	6.8	8.6	12.2	3.5	2.0	0.0	8.9	1.8	2.5	6.5	2.9	2.2	2.3	2.9	8.8	0.1	7.8	8.1	1.9	5.7	4.1	7.2	12.0	8.3	6.8	11.3	13.7	7.5	3.2	4.7	4.5	0.1	0.0	0.0	2.4	1.2	5.8	0.4	0.8	0.0	0.5	0.4	0.2	0.2	0.3	0.4	0.9	0.4	0.1	0.3	0.0	0.0	0.4	1.0	0.4	0.2	19.7	22.4	18.5	20.1	19.5	21.4	21.5	22.9	21.1	19.6	21.8	26.0	23.6	28.9	9.2	226.9	3.7	6.9	6.7	10.8	8.6	35.1	10.1	10.8	28.5	15.7	10.3	12.9	202.3	1.8	8.9	0.1	1.9	9.1	31.8	10.6	15.9	20.1	0.0	4.0	205.6	4.7	5.4	13.4	19.4	12.1	14.0	53.3	25.7	2.3	19.6	30.3	163.1	0.5	4.1	34.0	25.5	8.9	19.9	22.4	8.8	89.9	14.1	10.0	3.1	135.7	191.2	9.4	14.8	13.5	1.5	5.4	7.4	8.4	21.8	13.9	13.1	18.4	22.2	28.5	25.0	7.2	5.7	1.8	7.8	16.4	1.4	5.2
C2orf16	DKFZp434G118	ENSG00000221843	"Chromosome 2 open reading frame 16"	Q68DN1	2	27537386-27582721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 21.4"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 94.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.4;SiHa: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052136, HPA056962"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA052136: AB_2681742, HPA056962: AB_2683290"	"unprognostic (4.32e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.79e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.53e-3)"	0.1	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.2	0.2	0.3	0.1	0.2	0.2	1.2	0.1	0.1	0.3	0.1	0.5	0.3	0.0	0.5	0.0	0.3	0.2	0.0	1.5	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.4	21.4	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.2	0.6	0.6	0.9	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.8	0.3	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.1	1.2	0.5	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.5	0.8	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.5	0.2	0.0	0.6	2.4	0.4	1.8	0.4	0.2	0.1	0.4	0.4	1.1	0.5	0.8	0.3	0.4	0.1	0.0	0.7	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	94.1	0.3	0.2	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	14.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C2orf68		ENSG00000168887	"Chromosome 2 open reading frame 68"	Q2NKX9	2	85605254-85612066	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051143	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane, Mitochondria"	Nucleoli	"HPA051143: AB_2681360"	"unprognostic (1.71e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.76e-6)"	"unprognostic (4.24e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.81e-3)"	11.0	9.4	8.8	10.0	11.6	10.5	12.6	15.4	9.9	18.7	10.7	13.6	11.0	15.7	12.2	12.1	15.2	6.6	12.3	8.6	9.4	12.8	11.7	14.0	14.2	11.7	10.8	20.4	17.2	8.5	14.0	12.5	11.0	16.4	10.9	20.0	16.4	10.7	21.8	16.3	16.6	9.9	9.8	16.9	14.3	9.5	10.2	13.7	16.3	9.8	13.9	13.6	15.4	15.2	8.8	7.9	15.7	11.5	14.2	7.6	10.2	4.3	5.6	6.7	8.7	7.1	10.6	12.4	6.0	7.3	6.0	10.4	7.9	7.5	7.2	6.8	19.1	21.1	13.8	8.5	11.2	12.3	11.4	11.3	9.7	4.4	12.7	10.6	10.1	14.7	10.7	12.4	6.3	9.3	13.3	13.4	6.9	10.2	7.3	14.8	27.8	11.5	8.5	10.1	19.8	14.2	6.5	8.5	9.0	8.7	9.1	6.5	7.0	4.8	12.8	5.9	4.2	17.9	11.8	10.8	7.2	12.9	6.0	32.7	30.5	59.0	22.4	21.8	21.3	14.6	21.1	21.0	22.4	20.7	30.5	28.2	49.2	31.2	27.0	15.2	17.7	16.7	8.8	11.6	15.4	9.9	8.6	9.4	11.7	10.8	11.0	9.8	10.2	15.2	8.2	64.1	63.1	15.0	18.6	5.9	18.2	10.0	9.6	17.4	16.0	12.3	10.7	37.1	24.3	35.0	35.5	47.2	24.4	24.6	17.6	17.9	4.8	9.4	8.7	13.9	19.2	19.5	2.7	19.8	17.7	12.9	17.9	9.6	34.7	15.6	17.9	25.3	23.3	25.2	6.8	16.9	12.2	34.9	14.3	12.8	24.2	26.0	14.2	15.0	31.4	12.3	38.1	10.1	16.9	19.4	14.0	13.5	13.6	14.4	32.7	26.6	21.0	27.0	19.7	13.7	8.5	37.2	20.1	27.4	9.8	24.9	18.1	10.0	15.8	19.2
C2orf76	"AIM29, LOC130355, MGC104437"	ENSG00000186132	"Chromosome 2 open reading frame 76"	Q3KRA6	2	119302225-119366834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 78.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044977, HPA055362"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA044977: AB_10961918, HPA055362: AB_2682794"	"unprognostic (4.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (3.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.19e-2)"	20.2	19.7	23.2	10.2	23.3	10.0	22.4	23.8	29.5	13.0	21.3	12.3	6.9	17.1	43.4	16.2	20.5	12.6	16.1	22.2	23.5	19.9	14.1	9.9	15.2	24.3	23.2	17.8	15.7	20.6	10.7	11.3	24.4	16.0	11.7	9.4	16.0	15.4	10.3	20.6	7.6	16.7	24.2	10.9	11.3	19.3	23.0	13.5	20.5	14.5	14.0	13.9	10.9	26.6	17.0	15.7	22.4	14.3	31.7	38.3	12.8	23.4	16.7	15.0	16.3	10.1	11.3	20.7	40.6	24.7	17.4	7.8	10.1	14.9	15.0	17.7	33.5	39.1	11.7	13.5	21.8	15.0	24.6	20.4	25.3	21.3	13.8	19.3	21.7	15.7	12.6	19.6	22.5	25.7	15.7	28.5	12.4	13.3	12.4	9.6	4.7	29.1	33.9	18.0	14.8	16.7	17.0	24.1	33.7	21.0	13.2	52.5	20.3	17.4	13.5	14.6	12.7	12.8	22.5	22.1	17.5	11.1	20.0	29.1	20.9	21.9	19.9	20.2	18.0	20.0	15.2	18.3	21.3	14.7	13.8	19.3	37.2	32.5	12.7	20.1	16.8	11.9	23.2	23.3	23.8	29.5	22.2	23.5	24.3	23.2	24.4	24.2	23.0	26.6	30.3	6.4	11.4	22.5	11.1	25.0	17.2	47.7	17.1	3.3	18.5	19.7	18.5	12.8	24.4	14.7	0.0	26.4	15.2	7.1	78.2	14.7	11.7	27.6	15.4	20.4	10.9	16.4	12.4	17.8	32.4	20.7	9.7	19.7	22.2	8.4	15.0	11.6	26.7	1.7	8.6	11.2	22.4	15.0	23.4	7.7	19.3	13.8	44.4	12.2	20.6	19.8	26.8	14.6	25.2	14.0	9.2	17.0	8.9	11.8	12.2	47.0	42.8	4.6	6.6	13.8	18.8	38.8	22.4	18.8	35.7	20.7	15.3	11.4	10.0	13.0
C3orf18	G20	ENSG00000088543	"Chromosome 3 open reading frame 18"	Q9UK00	3	50558025-50571027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 29.3;Early spermatids: 54.2;Late spermatids: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.2;NK-cells: 2.0;T-cells: 6.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.8"	"Group enriched"	"Detected in all"	4	"cerebellum: 28.2;olfactory bulb: 27.5"	"Low region specificity"	"Detected in all"			HPA012105	Approved		Approved	Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA012105: AB_1845717"	"unprognostic (9.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (2.80e-9)"	"unprognostic (7.65e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	6.1	8.7	23.0	2.9	23.6	0.9	5.6	30.0	24.0	10.8	25.8	11.9	1.8	10.6	4.4	3.5	9.3	3.6	33.3	22.2	25.6	9.4	4.9	3.7	3.8	23.6	24.9	12.6	6.6	27.3	12.5	2.1	23.2	9.2	2.6	28.4	7.1	9.8	36.2	3.1	5.3	9.5	22.8	5.2	10.1	19.7	25.1	3.1	9.0	26.8	3.6	9.5	6.4	22.1	1.8	2.7	3.1	0.6	10.1	9.0	1.0	11.1	17.2	9.9	7.2	0.2	2.8	2.3	2.6	15.2	9.3	0.2	0.0	4.3	5.2	48.8	0.3	5.0	6.9	0.8	5.0	0.0	6.0	8.9	0.6	9.6	0.5	7.9	1.9	7.2	1.1	2.2	5.9	0.4	0.4	1.5	3.8	1.9	12.3	1.0	0.3	2.7	0.6	0.4	3.4	16.1	2.9	0.6	0.3	3.5	3.4	1.3	0.6	9.9	7.7	18.1	1.4	2.8	2.5	0.3	14.0	5.1	0.2	0.0	0.4	0.7	5.1	0.1	6.3	2.2	4.3	4.8	0.4	1.4	5.0	6.1	0.0	2.0	0.1	0.8	2.2	2.5	23.0	23.6	30.0	24.0	22.2	25.6	23.6	24.9	23.2	22.8	25.1	22.1	1.8	0.0	1.1	8.1	2.2	1.1	1.1	0.9	1.2	10.2	1.8	2.0	29.3	0.0	1.4	1.8	8.4	0.4	1.3	0.3	3.9	2.1	54.2	1.1	2.3	2.6	1.8	0.0	5.6	1.8	0.8	4.9	1.5	0.5	0.0	3.1	2.5	2.2	1.6	1.7	8.3	0.7	0.0	1.3	0.3	62.6	4.7	1.1	0.0	3.7	8.9	12.4	3.1	3.0	3.3	0.7	0.1	4.1	1.6	0.5	0.1	3.5	1.2	17.3	13.1	5.6	5.3	2.7	2.5	0.1	0.4	0.1	3.0	2.7	0.3	0.2
C3orf52	"FLJ23186, TTMP"	ENSG00000114529	"Chromosome 3 open reading frame 52"	Q5BVD1	3	112086335-112131004	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 17.4;skin 1: 26.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 129.6;Pancreatic endocrine cells: 82.8;Prostatic glandular cells: 75.6;Syncytiotrophoblasts: 75.0;Urothelial cells: 132.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.4;U-698: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007678, HPA008119, HPA011968"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826"	"unprognostic (8.86e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.49e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-6)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.59e-2)"	1.2	1.0	0.1	1.2	0.2	0.6	2.7	0.2	0.3	0.7	0.2	7.5	3.3	0.9	0.0	2.6	0.7	5.0	4.0	0.2	0.1	4.8	0.3	3.8	1.2	0.0	0.1	0.2	17.4	0.0	2.0	3.3	0.1	1.7	13.7	0.1	3.8	3.4	0.5	26.3	5.2	0.9	0.1	0.7	13.7	0.9	0.3	6.6	7.6	0.1	2.0	5.8	1.6	0.1	11.0	2.0	4.2	0.0	0.6	0.0	1.8	15.5	6.7	10.1	11.3	26.4	10.1	0.4	1.9	3.1	4.4	8.7	6.1	0.3	19.4	0.0	2.8	7.9	1.8	1.9	4.6	0.0	0.1	0.6	8.7	5.2	15.0	5.4	2.2	0.0	2.8	2.8	7.5	1.7	0.3	0.0	12.3	7.9	0.6	0.3	13.2	0.0	18.1	16.5	0.5	0.9	2.4	5.2	6.3	6.8	9.5	0.0	5.8	3.6	5.5	0.0	0.0	3.9	0.0	30.1	2.7	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.8	16.0	10.0	0.3	1.6	32.5	129.6	10.0	45.5	0.0	14.8	3.3	2.1	4.3	19.3	18.4	0.0	18.1	0.7	30.4	0.0	26.3	24.2	24.8	3.1	3.5	11.9	0.0	3.2	35.9	25.6	4.7	64.2	44.1	0.0	0.4	0.4	0.0	1.9	0.0	0.6	56.6	8.2	0.3	2.7	23.3	0.3	1.0	1.8	1.0	2.6	0.0	0.0	0.5	0.3	82.8	30.7	0.4	4.6	75.6	7.8	2.1	14.8	0.0	0.0	4.6	4.7	3.2	5.3	44.0	33.5	75.0	2.0	3.0	8.9	132.5
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088860-207099993	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 471.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 597.6"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"CACO-2: 116.4;HeLa: 46.2;Hep G2: 151.6;OE19: 57.1"					"Not detected"	"Not detected"			"HPA000925, HPA051620"	Approved		Uncertain	"Golgi apparatus"	"Secreted to blood"	NA	NA	265000000000	1100000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"HPA000925: , HPA051620: AB_2681554"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	3.0	0.1	0.0	3.4	0.0	0.0	1.8	0.0	0.1	2.8	0.0	3.6	3.8	0.1	0.0	0.2	0.5	3.1	0.1	0.0	0.0	0.4	471.3	1.5	0.4	0.0	0.0	44.2	9.1	0.0	0.0	6.2	0.1	0.0	1.8	0.0	0.5	0.0	0.1	0.2	4.4	0.6	0.0	0.4	8.4	0.7	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.4	5.8	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	46.2	151.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	12.8	2.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	7.3	2.2	0.5	54.3	3.2	0.0	0.0	1.0	0.2	10.2	1.9	11.4	4.1	0.7	0.1	0.8	1.8	8.0	0.1	88.8	0.3	3.4	5.6	0.8	0.0	0.3	9.7	597.6	2.1	0.0	0.2	5.6	0.0	13.1	0.3	2.8	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	69.2	15.9	0.0	0.1	0.2	4.3	0.0	2.2	0.0	0.0	1.1	0.4	0.1	0.4	0.0	0.0	0.1	1.1	143.8	4.8	0.1
C6orf52		ENSG00000137434	"Chromosome 6 open reading frame 52"	Q5T4I8	6	10671418-10694797	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 46.4;Endometrial ciliated cells: 44.9;Late spermatids: 27.3;Respiratory ciliated cells: 37.7;Spermatocytes: 36.1;Spermatogonia: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 6.1;U-266/84: 6.4"					"Not detected"	"Not detected"			HPA051142	Uncertain		Approved	"Nuclear speckles,Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	"Intermediate filaments"	"HPA051142: AB_2681359"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.50e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.65e-2)"	1.0	1.8	2.2	0.5	2.2	0.3	1.1	2.3	4.0	0.7	3.1	0.8	3.3	0.5	3.5	0.6	3.3	0.2	0.6	2.2	2.5	4.4	0.7	1.0	0.4	2.6	2.7	1.1	2.2	0.3	2.0	0.2	2.6	2.0	0.3	0.8	0.8	0.5	0.5	1.3	0.7	0.3	2.4	0.7	1.6	13.7	2.3	0.5	0.8	0.2	0.6	0.6	0.5	2.8	1.0	2.0	1.8	1.7	0.6	0.0	3.3	0.3	0.0	0.2	0.4	2.7	1.6	0.2	2.9	0.0	2.8	0.2	1.8	0.0	0.6	1.2	4.5	0.8	0.5	0.5	0.0	1.2	0.5	0.3	2.6	0.7	1.0	0.4	0.0	1.9	3.6	0.3	0.7	6.1	1.5	6.1	1.9	1.4	2.3	1.3	0.4	0.9	0.8	0.5	3.8	2.1	0.8	0.5	3.9	2.3	0.2	1.0	0.7	1.4	0.5	1.0	1.4	2.6	6.4	1.4	2.3	0.9	1.6	0.0	0.2	2.4	0.6	0.5	0.2	0.2	0.7	0.6	0.5	0.3	0.3	0.3	0.3	0.7	0.3	0.4	3.1	0.3	2.2	2.2	2.3	4.0	2.2	2.5	2.6	2.7	2.6	2.4	2.3	2.8	0.7	0.0	2.7	3.3	1.2	1.5	2.0	4.2	0.0	1.6	3.2	3.7	1.3	1.5	2.6	3.7	2.1	2.9	0.2	1.6	5.9	4.1	46.4	44.9	0.9	1.9	3.0	0.0	0.9	6.1	2.3	1.1	2.0	2.5	0.0	0.6	1.4	1.9	1.2	1.7	1.0	1.2	0.0	0.3	1.0	27.3	2.1	0.6	3.6	0.0	1.6	3.3	1.0	0.0	3.5	2.8	2.7	0.0	2.5	2.0	1.3	9.6	37.7	0.9	0.0	1.1	2.1	36.1	20.4	0.6	1.4	1.4	0.4	0.4	1.7	1.0
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330955-68819023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;fallopian tube: 9.1;parathyroid gland: 7.4"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 396.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.3;HEK 293: 2.3;LHCN-M2: 2.7;RH-30: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: AB_2682030"	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	2.7	0.3	4.0	0.2	5.4	0.5	0.7	3.6	3.9	2.1	2.0	0.2	0.2	0.6	0.6	1.0	9.1	0.6	0.7	6.2	3.8	0.4	0.2	2.5	0.2	6.4	10.2	0.4	1.1	7.4	1.7	0.3	4.6	2.1	0.3	1.0	0.6	1.0	0.3	0.9	0.2	0.1	4.0	0.2	0.8	0.7	6.7	0.8	0.4	0.9	0.2	0.4	0.2	6.1	0.1	0.0	0.3	0.1	0.6	1.0	0.1	0.9	2.3	0.3	0.3	0.1	0.2	0.1	0.3	0.5	0.1	0.1	0.1	0.3	0.1	0.0	2.3	0.3	0.5	0.2	0.1	0.0	0.2	0.1	0.3	0.4	0.8	0.1	0.0	0.3	0.1	0.4	2.7	0.3	0.0	0.2	1.0	0.0	0.0	0.1	2.7	0.0	0.2	0.2	0.5	0.0	0.1	0.1	0.0	0.2	1.4	0.1	0.0	0.4	0.2	1.6	0.0	0.4	0.0	0.0	0.1	0.1	0.4	0.5	0.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.3	0.2	0.3	0.5	0.2	0.1	0.4	0.1	0.1	4.0	5.4	3.6	3.9	6.2	3.8	6.4	10.2	4.6	4.0	6.7	6.1	0.2	16.0	18.7	9.4	0.0	1.7	0.8	0.2	0.0	1.5	0.2	0.0	1.2	0.0	3.9	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.5	26.4	0.7	0.5	0.0	0.0	79.2	0.0	0.3	1.9	0.0	4.3	1.3	0.1	0.0	0.0	0.3	0.0	396.6	0.1	0.0	0.0	1.2	1.3	0.3	0.4	1.8	3.7	0.1	0.0	0.0	9.5	10.1	0.5	0.0	0.4	0.0	0.8	0.0	0.0	20.8	0.7	0.0	0.6	1.7	0.6	0.4	0.1	0.9	0.4	0.4	0.2	0.0	0.4
C9orf153	bA507D14.1	ENSG00000187753	"Chromosome 9 open reading frame 153"	Q5TBE3	9	86220265-86259657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 20.8"	"Group enriched"	"Detected in some"	26	"Early spermatids: 268.6;Late spermatids: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.3"	"Not detected"	"Not detected"							HPA079466			Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies, Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA079466: "	"unprognostic (2.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.30e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-6)"	"unprognostic (9.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.10e-1)"	0.1	0.4	0.3	0.4	0.2	2.6	0.2	1.4	0.9	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.5	0.5	0.6	0.2	0.1	0.1	0.0	0.9	0.6	0.1	0.1	0.6	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.2	0.3	20.8	0.5	0.1	0.2	0.1	0.0	0.0	0.0	1.3	0.2	0.8	0.0	0.4	0.0	0.4	0.3	0.2	0.0	0.0	0.2	0.0	0.6	0.8	0.2	0.2	0.5	0.2	0.0	0.0	0.1	0.1	0.3	0.0	1.3	0.2	0.1	0.2	0.2	0.1	0.6	0.1	0.0	0.0	0.3	0.9	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.7	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.6	0.1	0.2	0.4	0.1	0.3	0.0	0.1	0.4	0.8	1.6	0.2	0.3	0.6	0.1	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.5	0.3	0.2	0.2	0.1	1.5	0.3	0.2	1.4	0.9	0.2	0.2	0.5	0.6	0.6	0.0	0.5	1.3	0.3	0.0	0.0	9.8	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	268.6	0.4	0.5	0.7	0.0	0.0	4.8	0.0	0.1	0.4	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.4	244.8	2.8	0.1	1.8	1.0	0.1	0.4	2.1	6.6	9.7	0.1	0.0	0.7	0.4	0.3	0.0	0.1	0.0	0.1	0.0	1.3	0.7	1.8	1.9	0.0	0.1	0.1	0.2	0.3	0.1	0.2
C9orf72	"DENND9, DENNL72, MGC23980"	ENSG00000147894	"C9orf72-SMCR8 complex subunit"	Q96LT7	9	27535640-27573866	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 24.3;classical monocyte: 32.0;intermediate monocyte: 44.7;myeloid DC: 25.2;neutrophil: 34.3;non-classical monocyte: 36.9"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.2;granulocytes: 34.3;monocytes: 44.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Intracellular and membrane"	Yes	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	11.7	12.1	9.5	16.6	9.5	25.3	9.4	21.0	12.5	9.8	12.4	8.8	6.8	12.0	11.3	7.6	16.0	10.2	9.3	9.7	13.5	7.0	16.0	17.7	9.2	14.6	11.9	24.2	9.6	6.9	16.2	12.1	12.5	14.2	7.8	31.3	6.7	5.8	14.9	8.8	8.3	8.6	12.4	16.8	7.8	17.6	11.3	11.1	13.1	9.9	8.8	9.2	8.5	14.5	4.4	3.7	28.7	4.4	5.7	7.0	4.4	5.9	4.9	3.5	1.8	0.4	1.4	10.2	3.7	5.3	7.5	3.1	9.4	7.2	2.5	19.8	3.6	4.9	11.0	3.0	8.9	3.4	5.2	7.3	8.6	0.8	16.1	3.5	7.6	11.1	9.8	18.6	4.3	0.8	6.6	5.0	14.2	6.8	16.0	2.4	9.5	5.1	2.8	3.3	9.9	24.4	4.0	4.4	3.7	10.9	3.7	2.9	6.6	0.0	14.5	8.6	4.0	4.8	15.8	6.8	11.4	11.0	3.8	24.3	32.0	2.4	1.9	44.7	3.3	3.4	2.7	2.5	25.2	2.5	4.6	2.9	34.3	4.3	36.9	3.9	4.0	10.0	9.5	9.5	21.0	12.5	9.7	13.5	14.6	11.9	12.5	12.4	11.3	14.5	15.4	16.0	14.7	19.2	43.2	35.9	50.7	15.0	26.2	22.1	7.2	6.6	15.6	4.3	15.2	7.3	20.9	21.2	11.7	5.0	1.9	8.4	2.6	94.4	11.8	15.0	11.4	3.0	53.0	9.3	7.3	18.7	16.8	57.6	16.5	18.4	8.2	9.3	25.8	11.8	58.9	12.5	10.2	71.9	127.8	4.2	6.2	94.8	19.6	42.2	58.2	45.2	3.1	30.2	60.9	8.6	11.1	3.8	10.7	30.0	4.1	5.4	80.7	27.5	0.0	17.5	20.6	29.2	20.9	15.2	29.1	34.6	18.2	7.9	5.1	37.6
C9orf78	"CSU2, HCA59, HSPC220"	ENSG00000136819	"Chromosome 9 open reading frame 78"	Q9NZ63	9	129827290-129835863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 414.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021216, HPA021232, HPA021242"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838"	"unprognostic (1.00e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (3.49e-7)"	"unprognostic (5.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	38.4	36.9	53.7	33.4	55.5	113.6	35.7	53.8	62.3	35.3	49.7	41.7	27.2	36.1	35.4	36.9	32.4	31.3	37.5	54.0	55.4	47.8	61.0	29.7	49.6	55.5	55.3	36.3	38.2	29.2	29.4	27.9	54.8	35.5	33.5	20.7	35.5	30.8	67.6	40.9	37.1	29.1	54.4	37.3	36.5	33.2	56.5	60.5	37.9	36.5	44.4	40.9	34.3	56.3	36.0	36.3	36.9	59.8	66.4	44.4	44.4	51.7	41.0	44.7	32.5	37.0	38.3	57.9	41.6	60.5	72.6	71.8	52.8	41.9	36.9	57.2	37.8	92.1	63.6	40.8	42.7	131.5	91.1	39.2	78.2	56.5	47.9	44.2	42.9	242.6	235.4	68.3	57.3	87.4	175.0	160.3	53.2	143.9	81.4	47.8	57.1	117.8	46.3	24.9	31.6	60.0	76.2	73.0	63.3	35.8	63.9	88.6	47.2	68.5	50.1	68.2	63.6	30.2	94.6	89.9	57.1	105.1	57.3	164.4	82.1	219.5	150.2	131.0	150.4	105.3	156.0	164.3	69.7	106.5	174.8	159.8	63.8	147.9	172.7	82.7	184.6	138.6	53.7	55.5	53.8	62.3	54.0	55.4	55.5	55.3	54.8	54.4	56.5	56.3	55.7	89.8	84.6	7.8	93.9	78.1	64.8	60.2	55.2	39.8	57.3	58.5	55.5	57.2	81.6	57.0	37.5	71.9	160.1	60.7	125.2	65.1	58.8	46.7	57.7	58.4	84.4	414.9	12.5	89.6	78.3	55.4	39.3	41.1	134.1	34.8	45.7	83.3	66.3	32.0	12.8	64.5	109.9	66.6	78.2	17.7	59.0	75.0	72.9	8.4	102.6	62.3	178.2	5.0	9.9	65.7	44.0	60.9	73.9	68.4	102.8	183.4	72.8	35.1	78.9	59.9	68.0	119.8	117.7	63.2	85.0	67.6	172.4	45.3	58.0	55.9
C9orf85	MGC61599	ENSG00000155621	"Chromosome 9 open reading frame 85"	Q96MD7	9	71911510-71986054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 112.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050767, HPA076627"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA050767: AB_2681229, HPA076627: "	"unprognostic (7.81e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.18e-2)"	7.5	6.6	7.5	6.4	9.0	6.0	8.9	8.2	7.8	9.2	5.0	7.8	11.9	7.3	5.7	9.9	6.5	6.8	6.2	7.0	7.2	7.1	7.9	5.0	8.7	8.5	7.6	9.5	7.8	4.9	5.9	8.4	8.2	7.2	7.5	6.3	8.9	5.0	8.7	11.2	8.2	6.3	6.5	6.7	6.8	5.4	8.2	8.5	8.5	8.4	8.0	9.8	8.4	12.9	11.6	7.5	12.6	10.4	12.7	23.4	12.8	13.8	22.0	11.1	11.0	1.5	6.4	18.5	6.9	12.1	11.7	20.1	13.4	13.6	15.4	12.9	6.5	11.3	10.3	9.5	13.9	16.7	8.5	19.2	18.2	11.4	25.2	17.5	13.8	17.1	13.8	11.8	14.5	5.7	20.4	11.8	11.6	17.8	17.6	11.6	22.4	0.5	16.3	16.7	10.1	13.9	7.0	17.8	25.0	13.8	6.0	9.6	12.1	10.2	13.3	23.7	10.6	12.0	21.7	8.5	14.0	12.6	6.5	15.1	6.6	10.6	9.9	7.5	10.5	8.7	8.4	8.5	7.3	8.6	10.2	10.8	7.6	13.0	6.8	10.5	8.4	7.4	7.5	9.0	8.2	7.8	7.0	7.2	8.5	7.6	8.2	6.5	8.2	12.9	19.2	6.4	17.0	35.6	15.7	7.6	13.6	12.8	25.6	10.9	13.9	22.9	14.0	8.6	12.6	5.5	8.4	20.3	18.4	25.2	21.5	14.2	10.8	9.4	19.7	15.0	6.6	8.2	27.4	19.9	19.0	14.1	19.9	10.8	18.4	13.7	18.5	9.7	14.8	5.0	19.2	23.4	10.2	16.1	8.9	7.5	20.8	15.2	3.6	24.4	17.7	12.5	33.0	44.2	112.1	17.8	30.6	13.2	9.5	12.7	29.3	22.8	8.4	13.0	13.1	19.3	17.3	20.6	14.6	23.2	9.8	10.8	16.2	21.9	16.8	27.0
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Proximal enterocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 15.6;OE19: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA		27000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	1.8	2.1	1.2	1.2	1.2	0.3	2.3	1.4	1.3	2.1	0.7	2.5	12.0	0.9	0.6	5.0	1.1	5.4	3.6	1.0	1.7	5.7	3.7	2.4	0.6	0.9	1.5	1.1	1.1	9.0	2.9	0.3	0.8	1.2	3.0	2.3	4.8	0.7	0.4	5.6	14.6	0.8	0.6	0.7	5.9	0.7	1.1	0.7	5.0	0.3	2.9	2.1	2.5	1.3	0.2	0.4	0.8	0.1	0.5	0.6	0.4	1.0	1.1	0.1	2.9	7.2	5.4	0.4	0.5	1.2	6.0	2.3	2.2	2.9	0.2	1.6	0.9	15.6	2.0	6.7	1.4	0.2	0.6	2.2	0.5	0.2	1.2	1.8	1.6	0.6	4.0	2.9	2.6	0.0	0.3	0.2	0.4	30.6	0.4	0.2	2.2	0.1	8.1	0.3	0.2	0.0	0.5	0.0	1.6	1.0	0.5	0.8	1.5	2.8	3.9	0.1	1.6	1.1	0.6	1.9	5.7	2.2	2.6	0.7	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	1.2	1.2	1.4	1.3	1.0	1.7	0.9	1.5	0.8	0.6	1.1	1.3	1.7	3.2	12.4	7.2	2.9	1.8	2.7	2.7	3.4	1.8	7.0	4.7	6.4	4.3	10.5	12.9	33.3	0.3	2.1	12.3	9.8	4.0	11.3	4.7	2.5	2.7	4.8	3.2	12.2	1.6	0.3	2.9	9.7	7.7	0.0	0.3	8.6	5.8	1.1	0.0	13.7	4.3	2.0	2.5	3.3	13.1	0.0	3.0	5.4	1.9	1.0	1.9	8.2	16.1	4.4	4.4	4.3	0.0	6.9	1.9	52.6	21.0	9.5	5.1	0.0	8.1	1.9	1.3	2.1	9.1	3.1	0.3	2.2	1.0	5.4	2.4
CA5B		ENSG00000169239	"Carbonic anhydrase 5B"	Q9Y2D0	X	15688830-15788411	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 37.9;Muller glia cells: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.3;fHDF/TERT166: 27.0;hTERT-HME1: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA012618	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA012618: AB_1846000"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.59e-5)"	"unprognostic (2.50e-1)"	"unprognostic (6.89e-4)"	"unprognostic (4.11e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.66e-6)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.08e-1)"	5.9	3.1	5.3	4.2	5.8	3.5	8.3	3.9	5.4	21.5	5.8	2.8	1.6	7.3	2.6	6.5	7.5	7.3	4.0	3.9	7.3	4.8	2.1	6.0	5.6	8.4	6.5	11.9	3.4	9.1	2.4	3.1	6.9	4.8	3.6	10.5	4.5	4.6	1.6	5.7	2.6	7.6	6.3	4.3	4.4	10.3	6.1	4.3	7.2	5.4	6.8	5.2	5.5	4.6	4.3	2.6	2.9	4.8	8.5	22.3	1.7	4.4	5.6	3.2	4.6	1.3	2.8	1.2	4.5	27.0	6.1	4.6	10.3	5.0	5.7	1.2	4.8	2.3	3.3	1.1	8.3	3.0	5.0	5.3	5.3	4.3	34.2	5.7	4.8	3.5	1.2	3.0	15.4	2.3	2.5	2.3	1.2	0.8	18.6	1.4	2.1	2.2	4.9	3.1	2.6	5.3	6.1	2.2	3.8	3.4	3.1	3.0	6.5	3.8	2.5	20.4	2.5	2.2	2.4	1.4	4.2	6.0	7.2	4.4	3.9	0.4	16.7	4.8	14.5	4.6	16.6	15.5	4.7	5.0	12.1	10.4	2.2	11.0	3.1	0.7	14.3	10.0	5.3	5.8	3.9	5.4	3.9	7.3	8.4	6.5	6.9	6.3	6.1	4.6	9.6	0.0	7.9	14.0	19.1	4.2	6.3	3.4	6.2	9.5	7.3	5.2	2.4	0.0	7.1	1.8	16.7	1.8	37.9	1.6	1.9	4.4	1.1	9.6	7.1	13.9	3.0	11.2	11.5	4.0	1.8	10.5	11.7	6.2	2.5	6.7	6.1	2.7	1.9	1.7	11.8	2.2	8.2	9.3	11.1	1.8	7.8	10.8	3.6	19.7	9.1	35.9	32.0	8.5	10.6	4.1	1.6	5.3	18.7	11.5	1.2	2.9	12.2	7.8	6.6	8.1	8.3	4.2	5.6	5.5	4.5	1.9	30.0	12.1	1.5	7.9
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673918-35681159	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"stomach 1: 289.3"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 275.3;Cholangiocytes: 62.9;Early spermatids: 205.8;Gastric mucus-secreting cells: 259.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 85.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A-431: 189.3;HDLM-2: 98.1;hTERT-RPE1: 113.1;U-87 MG: 374.4"	"Region enhanced"	"Detected in many"		"cerebellum: 12.3"	"Low region specificity"	"Detected in all"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	3.8	0.4	0.0	0.2	0.0	0.0	0.1	5.6	0.6	0.5	0.0	0.6	14.5	0.2	0.1	0.8	0.4	24.4	2.0	0.2	0.1	0.2	1.3	0.2	0.0	0.0	0.1	0.7	6.6	0.0	0.5	0.0	0.2	0.5	0.0	1.0	0.1	0.1	0.1	8.2	13.6	0.1	0.0	0.0	289.3	5.5	0.5	0.0	0.0	0.0	0.0	0.7	0.7	0.0	189.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	3.6	0.3	2.5	0.0	0.1	0.0	0.1	0.0	0.5	5.7	0.0	0.9	1.5	98.1	0.0	0.0	0.7	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.3	113.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.2	0.5	0.0	0.0	10.6	0.0	0.6	1.6	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	18.9	0.4	0.0	4.7	0.0	0.4	0.1	374.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.6	0.2	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	4.5	0.7	275.3	0.0	0.4	0.1	0.0	0.4	62.9	28.1	0.0	0.0	0.0	0.0	0.1	0.0	49.1	205.8	0.0	0.1	0.2	0.0	0.0	0.1	50.9	0.6	1.2	259.5	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.6	4.0	18.3	0.0	0.0	19.6	1.5	0.1	0.0	0.0	0.6	1.3	0.0	0.0	0.0	26.6	0.0	0.7	0.3	0.8	0.7	0.1	5.5	0.0	0.0	0.0	1.5	0.9	4.0	0.0	3.1	0.3	0.1	0.7	5.3	0.4
CABLES1	"FLJ35924, HsT2563"	ENSG00000134508	"Cdk5 and Abl enzyme substrate 1"	Q8TDN4	18	23134564-23260467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 70.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 258.2;Glandular and luminal cells: 54.3;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in all"	5	"melanoma: 38.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 154.3;U-266/70: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073649			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA073649: AB_2732233"	"unprognostic (1.27e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.71e-6)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.81e-2)"	17.1	3.3	63.9	2.1	67.9	2.6	13.8	36.8	54.8	6.9	17.1	5.2	7.5	9.4	3.2	6.9	10.9	5.2	4.6	44.9	53.5	13.1	9.9	21.5	2.8	39.6	59.0	3.7	3.0	21.9	4.0	10.4	40.8	3.7	5.1	8.0	22.3	4.5	1.5	17.2	6.7	6.6	31.2	3.7	14.5	3.5	70.2	4.9	15.0	1.8	2.3	5.4	7.8	33.3	13.1	14.4	11.8	0.9	7.1	0.3	20.4	3.1	17.3	4.2	2.5	9.5	23.0	0.7	13.3	14.9	42.3	11.4	9.0	2.3	3.2	0.3	19.4	1.0	38.7	37.1	6.2	2.5	1.0	4.2	2.1	5.3	6.1	26.8	47.1	2.3	0.5	16.2	11.7	30.2	0.1	8.8	7.5	64.5	46.6	3.1	42.2	50.6	21.2	31.5	11.2	8.2	26.1	32.5	154.3	8.3	52.4	7.2	79.3	47.9	0.5	1.6	3.8	216.0	88.9	27.4	0.2	19.2	16.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	63.9	67.9	36.8	54.8	44.9	53.5	39.6	59.0	40.8	31.2	70.2	33.3	2.9	22.4	27.4	258.2	3.8	5.1	2.0	1.4	5.2	4.1	9.2	6.7	1.4	7.2	2.3	3.7	29.2	0.9	1.3	8.5	1.9	1.1	2.0	11.6	4.4	6.0	3.5	1.3	19.2	2.3	1.1	4.1	10.2	54.3	0.0	14.8	25.0	9.3	16.6	0.0	22.2	4.6	0.0	3.5	3.1	3.5	0.0	4.7	28.4	41.2	0.0	1.4	0.0	163.3	1.4	2.4	5.2	6.0	3.6	0.6	6.7	14.3	1.8	18.7	0.0	5.0	2.1	0.2	3.2	1.6	6.7	0.3	1.4	0.5	2.1	2.2
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"	Q5VU97	1	64470129-64693058	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Astrocytes: 283.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 41.3;NTERA-2: 56.5;SuSa: 35.4;U-2197: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA		310000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	11.1	13.1	17.5	2.0	18.7	0.1	11.8	6.4	11.3	11.9	22.8	2.9	1.5	10.8	9.1	3.7	14.4	4.5	4.0	14.9	12.9	6.3	1.8	9.0	1.9	12.0	18.1	22.6	7.3	6.9	9.1	10.2	10.9	8.2	2.7	6.4	8.2	7.6	2.9	7.7	3.5	9.6	8.6	4.5	6.7	2.3	18.9	5.1	6.4	5.4	1.6	6.0	10.6	5.7	0.3	1.7	41.3	6.1	16.1	5.6	0.0	5.9	7.8	10.0	9.7	24.8	0.2	0.0	16.8	9.7	8.0	3.1	23.4	5.0	10.4	4.6	12.2	8.9	2.9	0.0	0.0	3.8	0.1	5.0	3.4	1.2	6.2	6.0	5.7	6.0	0.0	0.0	0.0	0.7	0.8	0.0	56.5	0.3	4.2	5.2	4.2	0.0	0.0	1.3	2.1	23.5	12.7	0.0	5.2	35.4	1.7	0.5	3.7	1.0	7.3	29.1	5.3	0.0	0.0	0.0	1.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.5	18.7	6.4	11.3	14.9	12.9	12.0	18.1	10.9	8.6	18.9	5.7	25.2	6.4	49.9	283.7	0.1	17.3	7.5	6.1	6.8	15.5	8.3	7.0	1.3	0.0	11.5	3.7	0.0	0.0	0.2	0.1	0.0	2.3	9.5	14.0	8.1	20.2	0.0	0.0	19.4	2.7	0.1	11.1	5.6	16.9	2.5	26.0	4.2	1.3	0.2	0.0	6.9	0.2	4.1	0.3	6.1	4.1	14.3	0.8	1.8	24.4	0.2	6.4	0.0	57.8	1.8	1.2	0.1	3.0	0.0	2.0	0.5	4.2	10.2	1.3	6.6	25.2	6.4	0.5	0.8	2.9	14.8	0.0	0.9	0.8	0.5	5.1
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 251.2;Inhibitory neurons: 354.1;Microglial cells: 126.5;Oligodendrocyte precursor cells: 197.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 22.7;RPMI-8226: 55.5;SK-BR-3: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.1	6.6	7.0	0.2	4.3	0.7	1.8	2.3	10.4	6.0	0.0	1.5	1.7	3.7	7.3	0.5	7.7	2.0	0.6	3.6	0.8	2.2	1.0	3.7	0.1	0.0	1.2	0.5	2.8	1.2	3.5	0.6	0.4	3.0	1.5	4.3	0.5	1.8	0.2	0.7	2.4	0.7	3.5	1.8	0.8	1.6	6.1	0.2	2.9	0.2	0.1	0.6	0.1	6.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.1	0.1	0.0	0.4	0.9	0.0	0.0	0.2	55.5	0.5	3.6	4.7	2.1	0.3	10.1	1.1	0.0	2.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	4.3	2.3	10.4	3.6	0.8	0.0	1.2	0.4	3.5	6.1	6.0	0.6	3.2	36.2	7.8	0.6	0.9	0.8	4.6	2.2	33.3	7.2	1.8	2.3	10.0	9.1	1.8	35.5	0.9	0.5	3.0	0.0	7.2	4.9	4.3	40.1	2.4	59.4	2.7	251.2	2.3	0.2	3.4	5.1	3.3	12.6	1.7	0.0	3.4	0.2	8.4	354.1	3.8	2.0	0.8	4.0	8.3	4.4	2.1	5.4	126.5	0.5	4.0	0.0	197.5	29.9	3.8	5.6	27.1	0.1	1.7	9.5	2.7	9.5	12.9	0.0	0.2	8.6	1.0	3.7	0.5	1.0	0.3	1.7	9.6	7.6	0.9
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362613-50504244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		9700000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.6	4.7	1.3	5.2	1.2	1.2	9.9	6.9	1.4	0.3	1.6	1.2	1.6	0.9	0.6	1.1	0.7	8.4	0.7	13.9	2.3	0.3	49.1	1.2	8.3	8.4	2.1	4.3	2.5	7.1	1.8	14.0	3.0	1.9	8.6	1.3	1.1	1.8	2.6	1.6	1.2	4.8	1.4	4.1	6.5	11.4	1.0	2.2	1.5	0.5	0.5	0.7	2.1	0.0	0.1	3.0	6.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.2	24.8	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.4	0.0	1.1	0.1	0.2	7.9	0.2	0.5	0.2	0.0	0.7	0.0	0.0	18.6	192.7	0.6	0.4	0.0	5.5	1.5	0.0	0.0	0.1	1.8	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.9	0.7	0.9	0.7	0.0	0.5	1.2	0.7	0.0	0.9	0.0	0.1	1.2	0.4	4.7	5.2	9.9	6.9	0.7	13.9	8.3	8.4	14.0	4.8	11.4	2.1	0.4	76.9	182.3	4.2	0.4	1.5	0.4	0.0	1.8	21.5	2.5	1.7	4.6	0.0	2.5	1.8	20.9	0.0	6.8	0.8	0.0	0.2	0.7	0.1	0.4	0.6	1.2	2.7	7.8	0.0	0.0	1.5	3.1	0.2	20.3	0.3	0.4	0.0	0.1	0.0	36.0	11.0	0.0	0.0	0.4	4.0	0.3	0.4	0.0	1.9	0.1	4.3	15.5	6.0	0.9	0.4	0.3	1.9	2.9	0.7	0.2	0.7	2.2	9.8	13.1	2.4	2.4	2.6	11.2	0.2	0.6	0.3	2.9	3.4	0.6	0.3
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217369-27243943	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA065158, HPA069341"	Supported		Supported	Cytosol		NA	No		260000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB007781: AB_562057, HPA065158: , HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	15.0	13.5	12.7	12.4	14.1	9.0	14.9	12.7	15.5	19.8	12.2	16.5	8.5	23.8	9.9	19.2	19.3	7.7	11.6	12.3	12.8	18.0	27.8	12.3	14.9	13.8	13.5	22.3	22.3	5.9	18.7	7.5	14.5	15.2	7.8	5.0	12.3	8.8	10.3	18.7	16.1	11.9	12.7	20.1	14.0	22.2	14.2	11.6	15.8	5.9	10.5	16.9	15.8	15.2	75.2	66.4	28.9	58.4	46.1	37.6	22.9	31.0	21.4	38.3	27.0	75.7	29.2	66.4	27.4	28.5	29.6	41.4	85.7	41.1	28.5	43.8	69.2	95.2	55.0	40.0	23.0	75.7	46.2	28.8	33.1	55.7	63.0	17.8	41.6	60.6	68.3	36.0	34.2	74.8	48.7	112.0	69.7	31.3	49.7	84.0	86.5	69.5	28.6	37.6	57.9	29.1	43.3	30.5	37.4	21.3	23.9	31.3	37.7	57.7	47.5	45.5	63.5	74.0	51.8	135.2	23.3	71.7	51.0	0.0	0.8	0.4	3.1	1.5	2.5	3.4	4.4	5.2	1.9	3.1	2.8	2.8	0.5	2.7	0.9	3.4	5.9	2.0	12.7	14.1	12.7	15.5	12.3	12.8	13.8	13.5	14.5	12.7	14.2	15.2	4.2	3.2	3.9	12.7	5.3	3.7	4.3	5.0	5.7	10.6	7.1	8.6	8.3	10.0	4.7	1.8	16.7	5.9	3.9	3.9	0.0	6.1	1.5	2.9	7.9	5.1	6.6	9.7	5.6	3.7	6.6	7.0	6.1	4.3	4.5	16.9	3.3	6.6	7.7	6.7	5.7	5.8	0.0	3.0	1.9	1.9	6.2	3.6	3.6	6.5	4.7	4.1	5.2	8.5	7.4	5.9	1.9	9.8	7.3	8.0	2.5	2.0	3.5	6.8	0.0	8.2	5.2	5.6	12.1	6.2	3.4	2.2	5.1	9.7	7.5	2.2
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970729	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 916.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1190.3;Leydig cells: 1745.0;Peritubular cells: 2005.6;Sertoli cells: 2294.3;Smooth muscle cells: 2549.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 736.3;fHDF/TERT166: 1202.8;U-138 MG: 733.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		39000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	225.8	119.2	27.3	164.9	35.0	1.3	161.1	28.1	47.6	241.6	37.2	916.1	80.3	523.3	150.7	275.6	304.4	203.2	115.0	26.9	29.1	134.7	224.4	155.5	75.4	32.3	30.4	326.2	52.5	32.7	53.3	430.0	30.9	348.9	149.8	13.1	70.3	781.7	46.5	76.0	233.1	688.4	27.9	129.2	324.2	52.7	33.4	28.5	114.1	75.2	34.4	505.3	208.0	28.8	115.9	75.3	163.3	146.1	572.7	464.8	161.6	661.6	736.3	227.2	246.6	138.3	3.5	0.7	153.3	1202.8	148.1	26.9	106.0	202.3	308.4	1.5	38.9	4.0	87.8	94.7	375.6	1.5	0.8	360.9	153.6	252.8	147.4	343.6	193.0	0.0	0.6	1.6	338.7	0.3	0.6	3.2	197.7	0.1	25.6	1.4	146.6	2.3	46.9	32.2	29.0	72.1	235.3	31.7	90.0	491.0	7.2	1.4	508.5	733.2	130.0	143.8	230.3	0.9	1.1	1.3	259.0	0.8	573.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	2.9	27.3	35.0	28.1	47.6	26.9	29.1	32.3	30.4	30.9	27.9	33.4	28.8	400.6	22.4	17.6	43.1	7.3	420.4	379.6	218.8	164.4	172.0	115.5	466.1	456.5	228.8	33.5	44.1	6.2	202.7	5.0	0.3	23.5	392.6	61.0	89.4	1190.3	432.9	3.6	16.0	95.4	23.6	903.9	886.9	16.3	206.2	5.1	251.0	422.0	638.4	43.5	92.5	58.3	1.2	28.5	21.0	112.8	83.6	1745.0	38.8	336.2	94.6	8.4	140.6	6.2	98.5	158.8	146.0	0.2	2005.6	4.2	456.9	0.1	332.1	11.3	21.2	2294.3	326.1	2549.3	12.1	12.2	70.1	171.8	276.6	27.5	414.1	0.8	36.7
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206079	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 91.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 184.3;non-classical monocyte: 216.9"	"Lineage enriched"	"Detected in many"	7	"monocytes: 216.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA051109: AB_2681346"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	5.2	5.1	2.9	14.5	2.9	4.5	3.1	3.9	3.8	9.2	12.6	70.1	91.9	3.3	1.4	2.1	19.3	18.7	1.2	3.1	2.7	29.1	15.0	5.1	3.9	2.8	2.7	1.7	7.0	0.9	3.5	5.4	2.9	6.2	64.7	4.3	2.2	4.4	3.4	4.8	76.0	7.3	2.4	5.9	15.6	3.3	3.0	4.5	1.6	0.7	4.0	3.5	2.3	3.3	3.4	11.6	7.9	4.8	1.6	1.7	5.7	2.2	2.3	4.8	3.0	22.1	29.8	3.7	3.0	1.9	3.7	15.1	18.2	2.8	2.0	3.3	16.9	6.7	21.6	7.9	3.5	5.8	14.7	1.6	4.4	1.8	3.4	3.0	5.9	10.8	6.2	3.9	0.7	10.2	14.5	12.6	8.5	24.1	3.4	30.1	8.1	8.2	1.3	6.0	4.4	4.3	3.5	3.2	9.9	3.1	2.8	12.6	3.5	5.0	4.5	9.2	8.7	14.4	9.4	10.0	3.3	14.9	2.2	0.1	43.7	0.2	0.1	184.3	0.6	0.6	0.6	0.2	29.1	0.1	0.5	0.3	21.3	0.0	216.9	1.4	0.4	18.3	2.9	2.9	3.9	3.8	3.1	2.7	2.8	2.7	2.9	2.4	3.0	3.3	1.3	0.0	1.5	3.3	0.7	1.5	0.8	2.8	1.8	11.1	0.4	0.1	0.3	12.8	15.8	3.7	0.0	0.5	0.3	49.2	0.0	2.5	6.5	9.4	0.6	6.4	7.7	1.3	3.8	4.3	0.5	3.2	31.6	0.4	0.0	0.4	5.0	8.1	3.9	8.4	4.0	17.1	0.0	11.7	1.5	0.5	3.7	8.1	0.0	4.7	3.9	2.0	2.1	3.0	3.4	3.0	39.3	6.8	2.4	1.1	36.2	25.4	107.8	3.1	0.0	1.1	0.7	0.0	0.4	1.3	2.0	0.1	1.2	0.1	21.1	1.1
CALN1	CABP8	ENSG00000183166	"Calneuron 1"	Q9BXU9	7	71779491-72447151	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 11.3;brain: 44.3;lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 88.8;Excitatory neurons: 130.6;Inhibitory neurons: 212.7;Oligodendrocyte precursor cells: 44.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Karpas-707: 44.5"	"Low region specificity"	"Detected in all"							"HPA036278, HPA036708"	Approved		Uncertain	"Vesicles,Plasma membrane"		No	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Plasma membrane"	"HPA036278: AB_10673125, HPA036708: "	"unprognostic (6.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.67e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.99e-1)"	0.1	11.3	12.2	0.0	18.5	0.6	0.2	44.3	15.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	25.4	40.6	0.0	0.2	0.0	0.0	27.9	17.0	0.1	1.0	0.0	0.5	0.0	30.2	0.2	0.1	1.9	0.0	1.1	0.0	3.5	0.0	0.0	15.2	0.0	0.0	3.2	8.3	24.7	0.1	0.0	0.0	0.0	3.2	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	44.5	0.0	0.0	0.1	0.0	6.0	0.0	0.0	7.1	0.0	0.8	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	7.2	0.1	0.0	7.0	7.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	18.5	44.3	15.0	25.4	40.6	27.9	17.0	30.2	15.2	8.3	26.5	0.0	0.0	0.0	88.8	0.0	2.3	0.4	0.0	0.0	3.8	0.0	0.6	5.6	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	0.1	0.1	0.3	0.0	2.1	130.6	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.4	0.4	0.1	0.0	212.7	1.5	0.0	0.3	0.7	7.0	0.0	0.1	0.0	14.0	0.0	0.2	1.0	44.7	15.7	0.0	0.1	0.7	0.0	0.2	0.0	0.1	0.0	0.8	0.0	6.1	0.2	8.8	12.8	0.0	9.8	0.1	0.2	0.2	0.1	0.1
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349547-12835545	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 57.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 167.4;Cone photoreceptor cells: 392.0;Excitatory neurons: 416.9;Inhibitory neurons: 233.6;Microglial cells: 168.6;Rod photoreceptor cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 14.9;basal ganglia: 16.7;cerebral cortex: 35.6;hippocampal formation: 29.6;white matter: 14.5"	"Immune cell enhanced"	"Detected in all"		"eosinophil: 75.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 75.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 113.8;U-266/70: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	6.6	4.8	14.9	8.4	16.7	6.8	4.3	4.5	35.6	7.4	1.1	11.4	3.5	3.2	2.8	8.6	3.8	5.9	14.6	29.6	0.6	2.6	8.2	7.5	9.6	3.7	0.1	2.7	16.9	0.9	2.8	2.9	0.0	4.7	12.4	57.9	4.3	7.0	1.5	18.5	6.3	5.2	0.7	10.9	3.1	6.1	1.3	23.5	13.0	2.3	12.6	7.1	9.2	14.5	0.3	6.1	6.8	0.3	4.0	1.4	0.4	0.9	2.2	1.4	2.0	8.6	4.8	3.4	0.7	0.6	3.4	3.2	8.4	1.2	1.1	113.8	4.1	13.6	19.4	0.4	1.1	0.3	11.8	0.2	5.2	2.7	0.2	14.6	0.8	7.2	0.4	0.4	1.7	7.2	26.9	5.6	4.6	0.0	2.7	20.2	3.7	6.4	0.2	6.5	10.4	4.8	13.2	4.9	0.0	0.9	3.4	3.3	0.3	5.6	8.1	18.1	4.0	50.3	16.8	11.3	8.2	8.8	0.1	19.5	4.9	75.1	3.8	7.1	3.9	12.1	3.3	4.8	9.3	14.7	3.8	2.6	29.8	3.1	8.7	2.8	1.1	3.4	14.9	16.7	4.5	35.6	29.6	0.6	3.7	0.1	0.0	0.7	1.3	14.5	12.5	3.2	25.2	130.6	68.0	22.9	8.6	26.3	13.1	167.4	3.4	1.7	17.1	12.8	36.6	1.8	392.0	0.2	22.1	36.7	0.0	9.0	20.4	3.6	4.0	13.7	16.1	7.6	416.9	22.0	0.9	30.4	2.0	2.0	23.4	2.0	15.0	13.7	16.0	45.4	233.6	27.4	10.2	50.1	61.2	9.2	23.6	36.2	3.6	168.6	34.8	24.2	30.9	111.6	7.2	10.5	42.8	60.9	23.9	4.9	2.0	1.2	27.5	214.2	26.3	7.2	10.2	4.8	11.0	24.6	41.2	0.3	21.6	8.7	33.2	20.9
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	"Calcium/calmodulin dependent protein kinase kinase 1"	Q8N5S9	17	3860315-3894891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.9;Excitatory neurons: 52.7;Rod photoreceptor cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 21.5;basal ganglia: 24.2;cerebral cortex: 54.4;hippocampal formation: 24.8;white matter: 31.9"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.3;U-87 MG: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009111, HPA028062"	Approved		Supported	Cytosol		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB009111: AB_2068406, HPA028062: AB_1845954"	"unprognostic (1.39e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.40e-3)"	"unprognostic (2.94e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.70e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.10e-1)"	6.0	10.7	21.5	5.2	24.2	4.1	5.4	5.6	54.4	12.7	0.0	10.2	2.9	13.1	4.8	6.8	7.0	3.6	5.7	24.8	0.8	3.6	1.0	5.0	2.6	6.0	1.9	8.1	12.7	4.1	24.4	2.0	6.6	8.2	2.7	12.0	29.9	10.4	3.4	15.9	6.9	5.8	0.6	9.6	4.2	10.1	5.0	5.1	7.6	1.6	2.3	16.1	13.8	31.9	7.0	11.8	1.2	5.9	4.1	7.2	0.4	4.7	5.1	4.4	2.0	4.3	2.1	4.2	5.0	9.1	4.6	20.3	3.2	5.8	2.7	0.1	10.7	4.8	28.3	1.6	4.2	0.7	3.6	5.5	4.9	8.4	2.8	3.8	2.0	6.0	3.8	0.2	2.2	1.9	6.0	2.7	1.3	10.1	11.0	3.0	5.1	4.8	4.8	4.4	6.7	3.8	1.8	13.9	3.1	0.7	5.3	1.6	2.8	7.6	10.2	9.9	4.0	0.5	0.3	0.1	27.9	4.0	1.0	0.0	0.9	1.9	0.2	2.0	0.5	0.0	0.3	0.2	0.8	0.0	0.3	0.1	2.7	0.0	2.1	0.4	0.0	0.7	21.5	24.2	5.6	54.4	24.8	0.8	6.0	1.9	6.6	0.6	5.0	31.9	5.5	6.4	12.5	8.1	7.0	3.7	2.1	1.5	1.8	41.9	2.5	1.3	6.3	0.0	3.3	1.8	16.7	0.3	3.4	1.7	0.0	0.4	0.1	1.7	7.8	5.6	4.2	0.4	52.7	1.6	0.1	5.5	0.5	1.6	17.1	0.9	2.9	0.6	4.3	8.4	13.9	1.3	2.0	3.2	3.3	1.3	1.2	6.9	8.8	9.4	0.8	4.7	2.1	4.0	3.5	0.6	0.6	1.2	2.2	2.2	0.2	0.3	1.5	25.1	0.0	2.0	1.7	0.1	1.1	4.1	5.4	0.3	2.9	1.2	2.1	1.1
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49869935	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 91.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.2;Early spermatids: 6.3;Excitatory neurons: 32.7;Inhibitory neurons: 27.0;Late spermatids: 7.8"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.6;CACO-2: 6.1;HAP1: 10.3;NTERA-2: 34.1;RPMI-8226: 6.9;SCLC-21H: 17.7;SH-SY5Y: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	0.0	0.8	66.5	0.0	91.8	0.0	0.0	0.0	84.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	19.0	0.1	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	0.1	0.0	12.9	0.0	0.1	2.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.2	7.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.1	0.9	0.2	34.1	0.0	0.2	1.3	0.0	6.9	0.0	0.0	17.7	8.3	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.5	91.8	0.0	84.9	73.3	19.0	0.2	8.7	0.0	12.9	37.2	39.2	0.0	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	12.2	0.1	0.1	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	1.2	0.0	32.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	27.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	4.7	0.0	0.2	0.0	2.5	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.3	0.0	0.0	0.1	0.0
CAMSAP1	"DKFZp434F195, FLJ31228"	ENSG00000130559	"Calmodulin regulated spectrin associated protein 1"	Q5T5Y3	9	135808487-135907546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 105.5"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 339.9;Rod photoreceptor cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020527, HPA024161"	Approved		Supported	"Mitotic spindle,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Mitotic spindle, Cytosol"		"HPA020527: , HPA024161: AB_1845967"	"unprognostic (3.18e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	"prognostic favorable (3.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-3)"	6.7	7.4	12.5	5.5	12.7	10.3	5.4	12.7	12.6	9.2	2.5	7.4	3.2	7.5	5.2	20.0	7.7	5.2	7.8	14.1	9.8	5.1	4.3	6.8	5.8	8.3	9.3	10.7	7.9	6.1	8.7	5.2	8.8	6.2	3.5	105.5	7.5	6.5	32.8	10.4	4.4	6.9	5.6	5.3	5.0	18.1	11.5	11.1	4.4	17.5	6.9	7.4	11.7	11.6	15.4	22.3	36.0	25.5	8.2	7.1	17.6	12.2	10.2	13.0	9.8	19.7	13.2	7.1	17.0	15.4	16.7	30.8	19.0	13.2	9.7	24.0	10.5	10.3	24.9	9.9	12.4	18.0	14.8	9.5	16.3	16.6	22.6	12.3	14.8	15.5	21.4	15.0	17.1	27.5	16.8	11.0	20.4	18.2	15.8	32.5	29.7	17.4	12.8	18.7	39.1	38.2	15.6	11.2	17.0	11.7	15.9	14.6	18.3	24.6	19.0	18.3	20.9	7.3	14.7	19.2	16.0	12.0	14.5	1.5	0.3	0.0	0.2	0.4	0.4	0.6	0.4	0.3	0.2	0.1	0.3	0.4	0.1	0.2	0.3	0.2	0.3	0.3	12.5	12.7	12.7	12.6	14.1	9.8	8.3	9.3	8.8	5.6	11.5	11.6	6.3	6.4	3.9	31.6	5.5	22.7	17.4	10.8	9.6	34.4	11.8	9.8	14.0	4.3	15.7	3.7	339.9	12.6	5.8	4.5	0.0	11.8	13.1	41.5	13.2	8.8	12.6	6.6	37.7	8.9	3.5	6.6	8.2	32.4	6.3	20.4	7.5	8.2	10.3	16.8	34.1	4.4	10.2	8.1	13.5	15.8	5.9	11.7	12.4	25.3	12.2	19.2	4.1	27.2	35.9	15.7	3.0	6.0	11.9	14.2	2.7	4.3	37.1	236.1	13.1	16.8	11.7	24.4	34.4	35.2	31.7	5.6	6.5	15.6	4.5	24.8
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987675	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	15.8	15.6	10.7	13.6	15.9	10.3	15.0	5.2	36.7	14.8	0.0	19.6	10.3	17.0	4.4	14.4	14.4	8.7	17.7	24.2	3.4	16.0	12.9	18.4	9.7	10.0	4.4	14.8	17.5	19.2	26.0	7.4	8.5	15.1	10.8	10.7	13.9	11.6	38.0	17.4	19.0	14.2	0.5	21.6	18.6	14.5	7.3	10.4	17.0	27.5	9.5	16.0	13.0	18.4	13.2	23.2	4.2	6.1	27.8	19.0	8.6	12.4	13.8	11.6	10.1	5.9	3.6	15.5	11.9	19.7	9.8	13.1	16.2	19.5	6.6	21.8	20.7	9.8	13.3	6.6	15.9	5.8	40.4	13.4	24.0	10.8	17.1	14.0	19.6	11.8	16.2	13.9	11.0	8.8	10.3	3.7	0.6	15.6	9.5	8.9	4.8	6.1	13.1	13.8	5.8	5.1	7.8	14.1	3.8	7.2	12.6	5.6	25.6	9.1	5.3	9.8	20.6	6.8	8.0	5.6	22.4	11.5	9.2	0.5	1.2	0.9	1.3	1.6	1.0	0.6	0.6	1.2	0.7	0.4	0.8	1.0	3.0	0.6	4.9	1.1	0.5	1.4	10.7	15.9	5.2	36.7	24.2	3.4	10.0	4.4	8.5	0.5	7.3	18.4	15.2	3.2	11.3	11.4	9.2	6.9	3.7	11.6	8.6	14.7	11.9	8.9	8.0	12.8	6.9	11.0	10.4	5.9	9.0	16.1	1.9	7.9	30.1	5.9	12.6	10.0	11.4	7.4	17.9	11.2	9.6	12.3	20.4	11.6	13.3	14.7	16.8	15.3	8.5	35.3	15.7	13.9	20.3	16.7	10.2	54.3	10.2	13.1	3.6	4.7	14.9	6.5	12.3	9.0	9.5	10.6	13.9	9.4	9.0	6.3	20.1	15.4	6.1	11.2	13.1	7.9	14.8	7.2	6.9	8.8	10.4	12.4	11.4	14.4	12.2	4.1
CAND1	"DKFZp434M1414, KIAA0829, TIP120, TIP120A"	ENSG00000111530	"Cullin associated and neddylation dissociated 1"	Q86VP6	12	67269358-67319953	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055748, HPA062833, HPA069053"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		5900000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074"	"unprognostic (1.50e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	18.4	23.1	19.6	19.9	21.4	22.6	25.9	25.3	21.8	21.4	15.9	19.8	19.5	21.2	27.8	22.5	19.2	18.3	12.6	20.9	21.7	24.3	27.4	16.8	27.5	18.8	19.0	25.0	18.7	28.3	19.3	23.2	21.2	22.4	20.6	37.5	16.5	20.0	9.9	29.3	18.5	21.6	19.5	19.1	18.2	27.8	19.5	38.8	26.0	11.4	30.8	23.3	19.3	19.5	62.1	62.6	93.1	66.6	69.7	54.3	62.4	60.2	51.6	62.0	54.2	58.4	34.5	132.9	51.0	60.6	38.9	57.8	101.1	68.3	70.6	50.8	60.5	75.1	46.5	55.7	45.7	89.5	40.9	51.5	51.0	56.8	51.9	75.8	58.7	63.9	60.4	72.3	67.7	61.0	81.6	60.3	98.8	47.4	43.1	78.4	79.8	56.3	57.3	103.9	95.2	47.3	74.9	68.0	49.9	77.8	73.2	40.7	50.3	49.0	31.5	34.1	46.1	23.5	31.1	111.5	58.3	52.2	51.4	9.3	6.4	7.4	14.0	7.4	17.0	10.9	16.8	15.3	10.0	14.7	17.7	14.9	2.7	19.0	14.0	8.6	19.3	5.7	19.6	21.4	25.3	21.8	20.9	21.7	18.8	19.0	21.2	19.5	19.5	19.5	37.6	60.9	36.3	38.5	61.2	58.1	50.2	51.6	57.5	92.4	51.4	40.6	17.0	42.9	42.0	44.1	116.7	37.4	61.5	47.3	13.7	30.7	3.9	45.2	53.9	44.6	45.4	34.9	48.8	28.6	42.7	47.7	41.3	51.1	7.6	71.0	40.4	49.8	31.3	87.5	61.7	50.4	34.6	42.4	52.4	11.0	69.0	35.9	33.8	32.8	54.6	53.8	48.4	49.8	63.5	35.2	28.6	60.9	55.1	56.6	59.8	32.3	55.3	115.3	26.3	52.1	50.7	82.5	47.7	47.1	63.9	44.6	59.3	66.4	46.5	64.2
CAP1	CAP	ENSG00000131236	"Cyclase associated actin cytoskeleton regulatory protein 1"	Q01518	1	40040233-40072649	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 832.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 1954.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030124	Approved		Approved	Cytosol		NA	NA		73000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA030124: AB_10600799"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.44e-6)"	"unprognostic (5.37e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	175.2	96.8	78.6	275.0	92.3	314.9	137.5	87.6	95.3	131.2	77.8	223.7	143.7	207.2	100.4	196.2	134.2	135.3	82.3	82.6	85.3	130.7	124.4	181.7	266.8	98.0	87.6	87.7	67.8	115.1	62.8	184.2	94.4	105.0	210.4	63.4	117.4	140.1	48.1	120.2	165.0	236.6	89.7	206.1	147.8	75.0	91.5	186.8	106.8	56.0	326.4	231.2	130.4	107.9	435.9	185.1	216.4	134.8	310.6	290.5	338.9	749.8	437.7	398.9	399.9	272.5	440.1	339.5	295.7	598.7	275.7	267.1	265.8	535.7	548.1	461.6	164.9	520.2	188.7	216.8	286.4	326.9	1417.9	297.5	280.6	612.5	345.4	456.5	346.4	185.7	201.6	215.0	621.7	129.2	265.4	194.9	367.7	312.1	207.9	197.0	297.6	198.6	451.3	452.0	107.5	222.9	308.7	366.4	523.8	443.1	170.0	1954.7	628.9	347.3	317.9	188.0	641.4	178.9	381.8	301.0	451.5	353.8	466.9	1371.5	776.8	2592.7	665.8	1097.6	526.2	328.0	473.4	643.9	868.3	325.6	397.1	537.9	1560.4	479.8	1402.6	333.8	701.5	1838.4	78.6	92.3	87.6	95.3	82.6	85.3	98.0	87.6	94.4	89.7	91.5	107.9	132.5	121.8	90.9	17.6	179.0	112.3	149.0	236.2	48.9	40.8	81.8	89.9	15.7	80.1	161.8	114.0	27.1	212.9	206.9	372.1	111.6	364.1	411.3	94.5	109.8	163.2	76.1	73.4	22.3	272.3	439.6	107.9	74.5	182.9	229.1	70.9	167.0	77.0	426.0	42.1	16.7	180.2	142.4	411.6	333.3	480.3	88.0	390.8	99.6	25.3	606.5	160.9	315.1	13.0	30.4	832.7	202.0	176.8	117.1	130.7	159.7	142.1	105.6	49.5	164.3	68.9	207.1	118.0	67.9	97.2	132.8	237.8	238.0	74.8	151.5	221.4
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394753-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm		Yes	No		5400000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	92.4	26.3	42.8	82.4	44.2	159.3	94.9	46.3	79.6	119.1	37.5	56.9	30.3	50.0	46.2	289.5	48.7	44.4	19.2	41.7	51.1	201.1	8.9	175.7	117.9	60.2	46.3	19.7	44.9	151.7	27.2	26.1	57.2	76.5	42.9	4.2	111.8	38.0	16.5	219.9	54.2	24.5	57.5	46.2	94.4	26.0	66.1	58.0	162.3	5.8	109.5	97.1	174.8	79.4	165.5	75.9	0.7	6.9	50.2	102.8	83.7	59.6	6.1	51.2	49.8	9.4	563.6	28.1	96.6	116.0	64.0	181.1	0.2	113.7	23.0	142.0	4.4	74.3	128.0	29.3	40.6	44.8	972.7	93.8	80.5	53.8	70.3	3.6	37.5	143.8	8.2	60.1	38.1	150.1	101.3	414.8	23.2	166.5	112.8	87.3	13.3	11.8	220.6	77.7	0.8	1.4	86.9	128.4	722.2	44.2	40.0	513.5	148.7	111.6	26.8	4.6	2.4	1.4	6.2	10.3	259.5	569.5	1.5	1136.5	1139.3	712.7	12.2	431.6	39.2	575.6	107.8	41.1	1363.2	516.8	30.5	13.9	162.9	605.5	131.3	959.7	122.1	977.9	42.8	44.2	46.3	79.6	41.7	51.1	60.2	46.3	57.2	57.5	66.1	79.4	6.6	19.2	24.5	3.3	84.7	121.2	167.5	265.0	60.9	0.8	86.8	70.4	1.3	51.5	119.6	316.3	0.0	34.3	91.5	211.0	211.3	113.8	4.1	33.0	10.3	16.2	28.8	16.0	0.2	91.5	324.0	34.7	124.9	63.9	548.8	1.2	3.6	1.1	1107.4	1.7	0.2	55.9	50.8	141.6	337.2	15.2	46.9	432.1	147.7	1.0	432.4	43.6	11.3	0.5	0.1	405.8	205.4	22.6	17.2	106.0	74.1	168.5	48.8	1.7	13.1	2.0	54.0	9.6	33.1	167.4	169.5	35.7	101.9	0.9	83.9	253.1
CAPN7	PalBH	ENSG00000131375	"Calpain 7"	Q9Y6W3	3	15206152-15252916	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004745, HPA046617"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Centrosome	"HPA004745: , HPA046617: AB_2679721"	"unprognostic (2.70e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.85e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.05e-2)"	13.9	11.9	4.6	11.6	5.9	13.2	16.6	12.5	5.4	16.9	9.3	12.1	12.9	16.1	14.9	11.4	14.4	11.1	11.6	4.1	8.1	15.2	19.1	12.1	14.3	5.9	5.7	19.8	15.3	20.1	9.2	12.9	5.5	14.1	12.2	28.5	13.9	12.7	25.3	11.6	13.6	13.8	6.0	11.4	14.0	12.1	6.8	16.9	23.5	16.5	15.7	10.2	9.8	9.7	14.3	18.5	15.1	9.5	26.0	20.1	51.4	18.1	20.8	22.1	16.7	13.3	10.0	24.6	12.3	20.7	13.6	9.7	22.5	23.3	19.0	23.7	17.5	30.8	24.8	17.7	19.3	25.1	15.0	13.9	33.2	28.7	14.1	20.9	15.9	23.3	30.3	25.1	21.6	20.8	17.9	10.5	14.5	20.7	17.7	10.2	25.1	17.1	16.4	25.8	12.2	15.8	29.5	15.7	20.8	19.2	27.9	25.8	14.4	19.8	14.9	25.9	21.4	17.2	37.1	12.4	18.1	18.0	17.5	4.6	3.0	5.1	3.3	2.5	5.3	3.5	3.6	2.8	2.9	3.1	4.9	4.6	1.8	3.6	4.4	2.4	3.0	3.0	4.6	5.9	12.5	5.4	4.1	8.1	5.9	5.7	5.5	6.0	6.8	9.7	15.8	12.8	23.6	44.1	35.0	21.4	13.5	10.6	47.3	42.7	20.3	16.0	33.2	8.6	20.6	1.8	56.3	21.2	21.7	11.2	9.8	12.6	15.5	32.2	31.5	19.0	20.9	14.9	60.2	16.9	12.6	27.6	30.1	29.9	15.8	28.9	14.6	20.8	12.2	55.5	65.8	11.3	4.1	11.9	23.0	14.8	24.8	20.9	21.4	49.6	18.4	31.2	10.3	73.9	86.0	13.0	6.9	26.4	52.8	20.0	16.7	15.2	34.9	98.1	39.5	31.5	24.8	26.8	17.8	29.7	23.2	26.1	34.2	21.1	11.8	14.3
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665723	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"stomach 1: 291.1"	"Cell type enriched"	"Detected in many"	6	"Gastric mucus-secreting cells: 910.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 125.9;RT4: 76.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: AB_2686646"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.3	0.2	4.7	6.3	1.0	0.1	14.9	0.1	1.7	1.1	2.3	23.6	8.0	0.1	11.1	0.6	1.3	14.3	0.0	2.3	3.6	1.7	0.3	21.3	0.1	2.7	1.5	0.2	2.9	0.0	0.1	0.3	1.1	2.9	33.0	0.3	8.5	1.4	0.8	2.3	4.6	1.1	2.0	0.3	291.1	0.6	1.8	0.0	0.2	0.0	0.3	12.3	0.7	2.5	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.8	0.0	4.6	0.0	0.1	0.0	0.2	8.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.2	125.9	3.8	0.1	0.0	0.0	1.3	76.8	1.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	4.7	1.0	0.1	1.7	2.3	3.6	2.7	1.5	1.1	2.0	1.8	2.5	0.4	28.9	131.7	1.6	1.8	0.1	6.5	1.9	0.0	0.0	19.9	7.9	2.6	10.0	55.9	25.8	0.0	0.2	0.2	90.9	0.0	3.8	2.3	2.0	0.3	0.7	3.0	0.0	0.6	21.6	0.0	0.3	910.8	2.1	10.8	5.2	0.0	0.3	0.6	0.0	0.1	61.9	4.1	0.0	0.8	6.7	1.8	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	36.1	42.6	3.4	3.5	4.0	2.1	1.5	15.0	0.0	0.0	0.3	0.8	0.4	1.0	0.0	0.0	0.1	1.4	2.9	21.2	31.2
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566684-55567687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 85.7;skin 1: 102.4"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 87.8;Basal squamous epithelial cells: 117.3;Squamous epithelial cells: 108.6;Suprabasal keratinocytes: 149.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.8;intermediate monocyte: 1.0"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.8;monocytes: 1.0"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 223.0"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA059749: AB_2732639, HPA076768: AB_2732322"	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.4	0.0	0.4	0.1	0.7	0.6	6.6	0.9	0.5	14.3	0.4	0.0	0.0	0.1	0.2	85.7	0.8	0.0	0.1	0.5	0.6	0.0	0.1	0.2	0.0	1.5	0.9	0.1	0.1	0.0	0.1	0.3	1.6	4.2	0.0	0.1	16.8	0.1	0.7	102.4	0.1	0.0	1.1	0.1	0.1	0.0	1.1	0.2	0.3	0.0	18.6	18.1	33.5	1.5	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	23.0	0.0	1.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.7	0.8	0.0	223.0	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	1.1	0.1	7.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	1.2	0.0	0.1	3.8	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.7	0.9	0.5	0.5	0.6	1.5	0.9	1.6	1.1	1.1	1.5	0.6	0.0	0.5	0.0	0.0	87.8	10.0	13.7	117.3	0.0	0.2	0.3	0.0	0.0	11.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.8	7.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.5	0.7	0.0	0.0	108.6	149.3	2.3	0.2	0.1	0.0	15.4
CAPRIN1	"caprin-1, GPIAP1, M11S1, RNG105"	ENSG00000135387	"Cell cycle associated protein 1"	Q14444	11	34051731-34102610	"Predicted intracellular proteins"	Differentiation	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.0;Late spermatids: 289.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018126, HPA063617"	Approved		Enhanced	Cytosol		NA	NA		43000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018126: AB_1849929, HPA063617: AB_2685062"	"unprognostic (3.79e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (8.67e-8)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	45.2	30.6	26.1	42.2	28.6	70.3	56.8	25.0	30.9	56.8	21.8	48.8	46.0	52.7	30.5	47.1	61.8	41.7	44.9	28.7	28.3	49.9	39.9	43.3	42.9	26.1	26.7	60.5	47.5	59.9	21.6	53.8	27.3	45.7	60.5	58.7	38.6	53.5	45.3	30.3	41.1	66.2	32.3	40.1	42.1	123.0	26.9	77.6	53.3	54.0	62.6	58.9	31.8	36.7	134.7	168.8	245.6	137.2	180.9	182.5	117.5	168.0	175.8	202.4	188.2	154.9	80.8	211.1	104.9	213.9	169.4	173.1	311.9	204.3	244.9	134.7	155.5	174.1	153.3	131.9	109.4	282.0	122.8	164.0	109.2	129.1	236.3	174.7	204.2	153.7	228.1	103.6	211.3	114.5	243.7	55.8	114.8	155.3	150.6	191.8	339.2	93.7	120.4	263.1	155.5	147.7	202.6	101.1	88.8	150.5	183.5	104.4	205.3	172.7	116.4	167.9	190.8	110.9	175.5	238.7	117.2	116.3	191.7	25.0	33.3	13.9	18.8	39.7	27.3	19.4	20.9	23.2	39.0	17.8	21.6	21.1	13.5	30.7	43.4	18.2	28.1	31.0	26.1	28.6	25.0	30.9	28.7	28.3	26.1	26.7	27.3	32.3	26.9	36.7	42.1	35.3	43.5	37.9	46.0	77.8	45.5	51.5	68.9	38.1	63.7	43.9	55.4	24.3	37.2	64.4	18.8	46.7	47.2	46.0	31.3	56.6	483.0	90.0	116.5	52.1	71.8	79.0	37.4	60.1	60.2	54.6	65.7	132.2	17.1	63.1	39.7	46.1	57.2	25.2	38.8	51.1	54.9	75.8	72.3	289.3	47.8	57.9	39.2	37.5	57.0	36.7	35.0	44.2	53.1	71.3	40.4	72.6	83.0	72.7	42.9	47.4	49.5	32.3	39.5	40.4	64.3	201.7	74.8	93.2	72.9	45.8	46.5	53.9	65.5	77.7
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine	Q13938	19	5912339-5916211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 334.8"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8"					"Low region specificity"	"Detected in all"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favorable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	12.2	25.9	37.5	10.9	35.1	10.0	11.6	55.0	30.1	47.2	55.4	16.1	6.9	21.7	4.6	12.9	334.8	11.2	13.5	40.2	69.6	38.3	21.5	49.5	12.2	72.6	105.3	13.8	24.0	3.3	27.9	9.3	85.7	40.4	2.8	2.2	24.9	30.9	4.3	16.2	18.7	2.3	60.9	25.2	37.5	6.4	50.0	5.7	30.8	1.1	4.2	44.2	13.7	66.1	2.2	2.3	0.9	6.3	2.1	3.2	4.0	0.7	0.7	0.3	0.6	1.5	13.8	0.9	4.0	1.5	0.7	2.3	0.1	0.6	0.0	4.7	1.9	0.8	4.8	4.7	2.5	0.8	3.5	4.1	4.2	0.4	0.8	4.0	1.0	4.7	0.7	5.4	0.7	4.4	2.4	4.0	0.7	19.4	12.6	3.1	0.3	4.7	1.8	6.2	1.0	4.9	1.0	65.1	6.6	2.0	4.3	4.7	1.5	0.6	0.4	4.6	17.1	19.8	6.5	1.1	7.7	1.8	2.8	0.4	0.7	0.3	1.7	0.6	0.9	0.9	1.0	1.3	0.8	1.8	0.8	0.7	0.7	1.8	0.4	1.5	1.0	0.8	37.5	35.1	55.0	30.1	40.2	69.6	72.6	105.3	85.7	60.9	50.0	66.1	5.3	12.8	16.5	11.1	3.3	4.8	32.1	122.8	1.8	2.5	8.9	8.8	2.2	0.0	161.5	121.4	4.2	24.3	7.4	5.3	35.2	34.7	6.5	2622.9	48.3	5.5	19.2	0.4	2.6	5.9	22.8	12.9	33.6	330.8	6.3	8.1	0.0	0.0	5.2	6.7	3.2	25.1	197.4	0.0	5.9	5.7	4.7	6.6	10.6	6.5	3.0	7.7	9.2	3.5	12.9	36.9	3.3	4.9	3.8	20.4	4.2	4.5	1557.4	4.2	6.6	3.5	42.7	0.4	0.6	0.9	4.1	20.5	9.2	3.3	9.3	128.6
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 11.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 85.5;Excitatory neurons: 133.8;Inhibitory neurons: 95.8;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 102.6;Respiratory ciliated cells: 77.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039542, HPA040004"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Vesicles, Centrosome"	"HPA039542: , HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	1.0	1.5	1.2	0.3	1.2	0.5	1.4	1.7	4.0	1.2	8.8	1.0	0.6	2.0	3.7	1.3	10.0	1.3	2.3	1.1	3.1	2.7	1.8	2.4	0.3	5.5	4.3	1.6	0.9	3.9	2.5	0.1	2.5	2.0	0.6	11.8	2.4	1.3	1.7	0.9	0.6	0.6	2.7	1.0	1.3	3.8	2.3	0.6	4.0	3.2	0.3	0.7	0.7	2.6	0.7	2.1	0.6	0.1	1.0	0.7	0.0	0.4	0.1	1.1	1.2	0.0	1.0	0.2	1.8	0.3	0.4	0.5	0.0	1.0	0.8	0.7	0.3	0.9	0.4	0.0	0.0	0.1	0.0	0.3	0.5	0.9	0.2	6.8	0.1	0.7	0.2	0.3	1.5	0.0	1.0	0.8	0.3	0.0	0.3	0.0	0.0	0.1	1.5	0.0	1.2	0.6	0.1	0.0	0.6	0.1	0.7	0.3	0.5	1.0	0.5	0.2	0.1	0.1	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.0	1.2	1.2	1.7	4.0	1.1	3.1	5.5	4.3	2.5	2.7	2.3	2.6	3.3	9.6	2.8	85.5	1.7	1.8	2.6	2.9	7.4	1.5	3.1	3.0	8.2	1.5	11.5	5.5	4.2	1.2	0.9	0.4	5.9	1.1	35.8	24.3	2.1	2.3	0.0	4.6	133.8	1.7	0.6	4.8	4.6	0.9	0.0	6.0	3.3	2.4	0.5	1.7	95.8	1.3	2.0	1.6	1.7	14.9	6.2	1.3	0.0	46.9	0.1	6.7	2.1	117.1	102.6	0.6	0.3	7.2	2.5	1.0	0.5	3.5	77.2	22.4	0.0	3.8	3.8	8.5	1.6	4.1	0.6	0.3	1.6	3.3	0.8	0.6
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904288-35938779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"fallopian tube: 110.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 167.1;Endometrial ciliated cells: 400.1;Late spermatids: 148.9;Respiratory ciliated cells: 709.5"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 14.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.7;REH: 8.0;U-698: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules		No	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Microtubules"		"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.0	0.0	3.3	0.0	2.8	0.2	0.1	1.9	2.1	2.5	25.4	0.0	0.0	2.0	8.4	0.0	110.9	0.0	0.0	2.1	3.6	0.8	0.0	7.7	0.0	9.9	10.2	0.1	0.5	1.2	13.6	0.0	7.5	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	8.0	0.0	0.1	9.9	4.0	6.6	5.4	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.3	6.2	0.0	0.0	2.2	0.0	1.0	0.1	0.0	0.1	0.0	4.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.0	1.2	2.1	0.0	0.5	0.0	0.0	19.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	2.8	1.9	2.1	2.1	3.6	9.9	10.2	7.5	8.0	4.0	7.6	0.0	3.2	7.3	0.3	0.0	0.0	0.1	58.0	0.0	0.0	0.2	0.0	0.0	0.0	66.2	1.8	0.0	0.0	0.0	0.0	1.9	0.1	167.1	400.1	2.4	0.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	4.7	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	65.1	0.0	0.0	148.9	0.9	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.5	0.0	1.6	709.5	0.0	0.0	0.0	19.2	21.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line subunit beta"	P47756	1	19338775-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1188.8;Late spermatids: 3669.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		6600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	210.2	193.0	126.1	196.7	126.9	154.3	189.1	128.8	133.4	233.9	129.0	294.5	149.1	254.5	145.8	265.1	199.9	144.2	207.5	139.9	129.8	161.3	127.7	217.9	223.8	133.7	128.6	205.1	94.2	128.6	121.5	178.7	132.5	200.9	214.2	123.8	152.5	177.9	301.8	195.1	220.6	241.4	126.3	215.9	192.6	216.2	135.8	237.1	155.2	214.2	271.8	230.3	222.2	143.8	263.9	146.4	260.0	179.3	355.6	467.0	187.9	435.9	430.0	364.0	377.5	189.6	338.1	179.7	186.4	533.5	218.7	212.0	224.0	297.9	424.3	280.0	160.5	340.1	170.6	298.3	355.0	236.5	533.6	424.0	243.4	314.9	292.6	300.5	338.6	204.5	132.1	229.7	393.9	185.1	270.5	307.0	200.5	343.8	155.3	223.4	184.6	225.2	507.6	133.0	158.0	123.4	255.2	200.6	299.3	229.5	222.2	199.6	351.5	237.9	207.0	409.4	208.7	156.0	188.8	217.4	314.1	306.8	261.5	456.1	358.2	1077.5	304.0	542.3	265.0	266.1	318.5	329.4	362.3	203.7	263.5	293.7	576.3	196.7	703.0	199.1	404.2	597.6	126.1	126.9	128.8	133.4	139.9	129.8	133.7	128.6	132.5	126.3	135.8	143.8	197.7	99.3	68.9	52.9	160.3	156.3	282.8	263.0	103.6	93.9	106.9	117.7	87.6	112.9	143.5	101.2	41.7	338.0	247.5	301.7	297.4	322.1	1188.8	86.7	122.2	182.4	141.2	89.4	49.8	256.5	396.4	178.9	101.9	96.8	147.5	164.6	156.0	98.7	800.9	77.4	67.5	278.7	215.7	302.6	276.7	3669.8	232.7	311.2	144.1	124.6	561.5	151.1	338.8	42.7	64.9	349.6	295.2	302.4	103.4	206.8	235.6	251.2	122.6	93.2	243.3	97.8	262.6	119.0	81.5	150.3	182.7	342.2	268.2	197.9	193.8	280.5
CARD10	"BIMP1, CARMA3"	ENSG00000100065	"Caspase recruitment domain family member 10"	Q9BWT7	22	37490362-37519542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.5;Ductal cells: 25.4;Endothelial cells: 24.8;Pancreatic endocrine cells: 39.4;Paneth cells: 27.6;Proximal enterocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.5;U-2197: 82.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029359, HPA055612"	Approved		Approved	"Vesicles,Intermediate filaments,Cytosol"		No	No				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Intermediate filaments"	Cytosol	"HPA029359: AB_10601354, HPA055612: AB_2682861"	"unprognostic (9.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (7.73e-6)"	"unprognostic (3.66e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.31e-2)"	"unprognostic (9.69e-2)"	10.0	8.4	3.7	5.0	3.3	0.1	10.5	2.9	4.0	6.5	2.8	13.3	34.1	6.0	1.3	8.4	7.5	7.8	10.7	3.1	3.0	14.9	12.4	6.1	2.1	4.7	3.3	3.1	9.2	2.7	2.1	4.7	5.0	5.4	8.8	0.3	19.0	4.2	8.0	9.7	35.9	4.2	3.3	4.1	9.9	15.0	4.2	0.8	6.8	8.2	1.0	6.1	5.8	2.9	31.3	23.1	4.1	3.0	0.1	8.7	19.6	2.8	6.5	12.8	10.0	14.2	21.8	0.0	10.8	5.4	12.4	43.0	4.9	56.5	3.9	0.1	11.8	0.7	15.6	22.1	5.4	0.5	1.9	2.9	11.5	24.5	31.2	10.2	26.1	0.0	3.3	0.0	9.9	11.0	0.1	2.0	7.2	17.0	13.2	0.0	38.9	3.0	19.1	5.4	1.5	2.4	21.0	9.5	2.1	5.0	10.1	1.7	35.0	9.5	26.9	82.8	16.4	0.1	0.0	0.0	30.2	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.3	2.9	4.0	3.1	3.0	4.7	3.3	5.0	3.3	4.2	2.9	22.6	0.0	2.0	0.0	0.2	8.5	6.8	3.4	2.2	1.2	3.9	4.3	3.7	10.0	1.6	3.7	0.0	0.4	0.2	35.5	1.9	25.4	7.8	3.3	0.4	24.8	7.7	0.0	0.1	19.6	1.6	1.9	15.8	6.2	0.0	0.4	17.9	4.8	0.1	0.0	0.6	19.8	4.1	0.0	1.2	8.6	0.0	0.4	5.4	3.7	0.0	0.0	0.0	0.0	0.1	39.4	27.6	0.7	0.2	8.6	35.5	12.4	1.2	0.2	0.0	6.2	1.1	0.4	3.4	2.5	3.8	0.0	0.6	1.0	11.3	9.7
CARF	"ALS2CR8, FLJ21579, NYD-SP24"	ENSG00000138380	"Calcium responsive transcription factor"	Q8N187	2	202912214-202988263	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 66.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034557, HPA043191"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA034557: AB_10601663, HPA043191: AB_2732503"	"unprognostic (4.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.58e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	4.5	5.3	4.2	5.7	8.6	5.4	7.7	6.4	5.1	5.9	2.5	5.2	4.5	9.4	9.9	5.5	6.8	6.0	4.9	4.4	5.0	6.8	4.5	5.1	8.8	5.9	6.0	7.9	3.9	7.8	5.1	4.7	6.5	6.7	6.0	16.1	4.6	6.4	4.5	7.4	4.9	6.6	4.6	7.5	6.0	21.5	5.5	9.4	10.6	5.4	7.8	5.7	5.0	12.3	2.5	2.4	6.1	5.4	4.5	9.5	4.7	3.7	4.7	3.8	3.4	2.8	6.2	3.8	1.6	4.3	4.6	4.5	3.2	2.7	4.3	3.0	1.7	5.9	3.0	1.7	3.8	3.5	2.9	7.8	5.2	3.3	8.6	9.6	2.3	13.9	2.5	15.5	5.9	4.9	7.2	5.6	2.6	1.6	3.5	5.1	4.2	3.1	6.9	2.6	4.3	4.6	4.0	2.2	1.7	7.7	3.6	6.5	2.7	7.1	1.8	4.6	2.4	13.7	8.4	4.2	6.1	4.1	4.4	1.4	1.0	0.8	2.2	1.9	2.4	2.0	2.2	2.1	1.2	2.4	3.1	2.2	0.4	8.8	1.1	1.9	4.7	0.6	4.2	8.6	6.4	5.1	4.4	5.0	5.9	6.0	6.5	4.6	5.5	12.3	5.6	9.6	15.7	28.7	14.6	3.2	3.9	5.5	5.2	33.5	6.7	5.5	6.6	7.2	14.1	14.7	18.8	4.2	9.2	2.7	11.7	4.4	19.0	7.1	5.0	5.6	1.8	7.6	21.5	2.4	9.3	7.4	5.6	2.9	20.3	19.6	8.2	3.2	3.9	26.9	25.0	4.7	6.1	8.2	3.7	16.7	10.8	4.9	1.8	16.9	5.9	9.6	18.6	39.2	66.1	2.9	3.2	9.4	4.0	2.0	9.5	5.8	17.7	31.1	6.6	7.1	5.6	37.2	8.6	4.4	2.7	1.8	10.2	10.5	6.2	2.7
CARS1	CARS	ENSG00000110619	"Cysteinyl-tRNA synthetase 1"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.3;Cardiomyocytes: 8.8;Cytotrophoblasts: 22.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 22.0;Syncytiotrophoblasts: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol		NA	NA		200000	"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	22.1	17.4	8.1	12.0	8.5	7.3	19.9	8.7	21.6	13.6	8.4	21.8	12.0	15.9	7.5	19.2	12.8	10.3	13.3	8.2	9.8	13.7	21.1	17.5	12.7	9.6	9.9	8.9	32.8	9.6	18.6	10.3	10.6	12.7	12.8	5.3	20.6	6.8	31.7	23.8	17.4	16.0	9.7	17.2	23.5	16.8	9.9	14.6	17.3	14.7	17.8	18.1	14.9	11.5	29.2	14.0	17.8	55.6	67.3	61.4	16.2	70.0	78.6	46.7	84.1	34.2	64.7	43.1	20.1	88.2	0.0	68.7	58.3	78.6	64.0	123.7	13.5	24.4	23.7	25.8	161.1	50.9	50.2	102.2	64.1	40.1	46.8	0.0	62.3	103.6	42.2	147.0	47.1	41.9	35.7	0.0	65.2	97.9	25.0	17.2	29.7	54.9	0.0	46.1	39.0	49.7	17.1	48.1	80.1	13.3	0.0	0.1	21.8	19.5	18.2	48.2	0.2	107.8	106.8	27.2	0.1	26.6	40.3	16.3	18.6	13.5	20.9	15.4	17.4	10.9	18.3	18.6	19.4	8.5	9.9	16.0	25.4	23.7	37.9	7.5	27.0	19.2	8.1	8.5	8.7	21.6	8.2	9.8	9.6	9.9	10.6	9.7	9.9	11.5	10.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	22.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	40.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	32.3	1.4	0.0	0.0	0.0
CARS2	FLJ12118	ENSG00000134905	"Cysteinyl-tRNA synthetase 2, mitochondrial"	Q9HA77	13	110641412-110713603	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 204.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041776	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA041776: AB_2677666"	"unprognostic (2.34e-3)"	"unprognostic (9.50e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.71e-2)"	18.3	24.4	8.8	18.9	9.3	28.4	15.0	16.3	13.3	20.3	15.8	20.8	17.5	16.0	13.7	18.6	16.4	11.1	25.9	9.7	9.3	15.4	19.9	16.7	19.3	9.0	9.3	15.3	15.8	15.0	17.6	12.1	9.7	15.2	13.8	9.2	18.9	12.3	45.8	17.6	18.5	12.6	9.2	17.8	17.2	11.2	9.7	12.9	14.3	26.7	14.1	17.7	15.9	10.5	116.0	37.7	21.2	52.6	55.7	51.7	28.7	49.9	45.7	49.6	60.6	53.5	50.7	53.5	68.4	55.4	75.6	61.0	36.6	63.8	40.2	49.2	58.5	33.5	79.6	63.8	58.5	83.0	39.3	66.7	50.7	43.3	51.8	35.5	36.0	40.9	23.2	16.6	71.2	27.2	37.5	27.6	18.4	88.9	36.8	54.2	15.6	22.3	54.2	33.4	37.7	28.9	40.7	62.0	61.1	22.7	29.8	94.0	32.5	41.8	15.6	53.2	51.6	29.0	35.8	32.4	204.5	50.1	41.9	0.0	2.9	0.4	1.1	3.3	1.2	1.8	0.3	0.4	2.4	0.8	1.1	0.5	1.7	0.4	4.6	2.0	0.4	1.1	8.8	9.3	16.3	13.3	9.7	9.3	9.0	9.3	9.7	9.2	9.7	10.5	18.2	9.6	15.9	24.5	24.4	12.9	24.2	10.3	8.6	21.4	21.8	23.4	39.3	18.6	9.5	27.6	25.0	26.7	28.2	17.6	50.9	17.7	66.5	24.1	21.7	13.6	18.7	10.7	29.2	4.7	29.1	21.6	18.8	27.3	16.5	45.3	9.3	26.6	26.9	23.5	25.1	17.7	12.2	31.2	9.0	221.4	20.5	32.8	12.4	24.4	51.4	24.3	14.4	14.1	26.6	12.1	10.8	18.0	18.6	18.2	23.0	38.1	10.6	25.9	6.6	29.2	24.7	8.6	7.5	22.3	13.5	16.8	19.8	44.2	28.5	17.6
CASD1	"C7orf12, FLJ21213, FLJ21879"	ENSG00000127995	"CAS1 domain containing 1"	Q96PB1	7	94509219-94557019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.7;Inhibitory neurons: 108.5;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044404	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA044404: AB_10964353"	"unprognostic (4.02e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.04e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.83e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.59e-3)"	11.1	25.3	11.4	9.6	14.0	6.0	15.7	11.1	12.9	11.3	4.8	16.5	6.5	14.1	14.6	6.3	11.0	10.0	17.1	14.9	17.4	12.4	9.0	11.3	12.5	8.8	10.7	16.4	9.8	13.8	8.7	12.3	12.9	13.9	19.3	22.1	20.3	9.4	14.1	3.8	6.1	11.0	11.3	10.6	7.3	13.1	14.6	11.2	16.0	19.6	10.8	9.1	4.3	14.0	5.5	10.4	34.7	12.9	10.4	12.3	5.9	7.2	12.8	7.9	10.2	6.5	13.2	13.9	18.5	9.8	14.1	3.0	8.8	2.5	15.4	22.2	7.1	12.3	8.5	11.9	8.8	20.5	0.0	11.4	9.2	7.2	10.3	15.4	12.6	16.0	6.7	29.3	19.6	8.0	28.5	11.6	17.7	7.7	8.2	19.3	28.0	10.8	15.9	14.9	13.1	44.5	11.4	20.7	7.4	24.9	5.4	12.8	6.7	19.6	15.5	16.2	10.6	28.0	28.1	28.5	10.7	4.7	12.9	0.0	0.2	0.0	0.6	0.2	1.6	0.6	0.9	0.8	0.4	0.5	0.9	0.7	0.0	0.6	0.2	0.3	0.6	0.2	11.4	14.0	11.1	12.9	14.9	17.4	8.8	10.7	12.9	11.3	14.6	14.0	26.2	28.9	26.3	76.0	15.4	4.6	5.8	5.8	4.0	56.4	14.4	12.8	21.1	17.2	12.8	20.2	18.8	14.2	14.6	29.7	3.9	5.1	3.4	18.0	13.1	16.4	7.2	4.6	93.7	5.6	5.7	14.6	5.1	9.9	10.2	23.7	16.1	13.3	8.8	67.3	108.5	30.2	2.0	9.8	5.5	7.0	11.5	10.8	24.9	61.8	7.1	23.3	10.3	122.6	170.3	6.8	11.8	9.8	9.2	10.0	0.6	10.8	18.1	31.4	19.7	41.2	12.2	9.6	12.8	4.7	4.5	16.8	12.2	25.8	19.5	4.5
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 66.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.4;NK-cells: 132.8;Plasma cells: 73.4;T-cells: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	11.5	10.2	1.7	28.6	2.0	66.6	13.9	1.3	2.1	9.6	4.2	16.1	20.5	8.5	13.2	12.9	14.1	13.2	5.2	2.1	1.8	10.7	14.1	19.6	37.7	3.4	3.0	7.7	7.8	2.9	3.4	9.9	2.7	6.9	17.6	4.6	8.4	7.3	3.3	12.1	26.0	9.9	2.4	37.1	15.9	4.3	2.6	24.4	7.9	3.0	29.7	18.0	8.6	2.4	33.6	26.6	7.7	22.2	20.7	29.7	12.0	13.8	13.2	16.0	26.2	36.1	54.9	3.7	29.6	10.7	28.7	16.2	17.2	16.1	31.3	21.1	15.4	31.0	21.9	35.1	17.1	25.6	33.8	25.9	38.0	30.1	23.9	13.4	15.1	26.9	28.6	69.1	14.7	13.1	32.1	25.9	12.6	17.5	23.7	24.7	15.9	55.4	30.8	35.3	2.3	1.1	17.9	29.8	18.0	7.0	8.0	19.1	19.6	17.3	18.0	9.0	10.9	63.1	30.2	21.2	25.3	33.1	16.6	76.1	39.5	77.1	70.7	51.2	66.0	40.9	57.8	75.9	41.6	24.0	37.0	47.2	153.6	70.6	51.5	18.6	75.0	40.6	1.7	2.0	1.3	2.1	2.1	1.8	3.4	3.0	2.7	2.4	2.6	2.4	8.5	25.6	26.7	0.7	50.0	7.5	13.0	6.1	10.2	2.1	12.9	9.3	2.5	10.0	13.0	5.5	10.4	8.5	107.4	37.0	15.6	12.3	5.9	25.6	8.1	10.1	4.2	10.5	2.5	8.4	12.1	9.5	19.4	27.2	24.6	10.4	5.3	11.7	11.9	0.0	1.3	15.2	4.1	25.3	15.7	1.9	2.5	25.0	7.2	10.3	35.6	0.2	132.8	1.0	0.5	11.2	30.1	0.7	73.4	9.7	22.3	23.6	14.2	0.4	0.0	4.5	3.7	0.8	0.4	13.1	7.7	3.4	86.9	10.6	17.4	12.7
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834310-191847088	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 1296.7;Alveolar cells type 1: 413.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 49.0;neutrophil: 24.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 49.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 162.3;HEL: 119.8;HUVEC TERT2: 362.3;LHCN-M2: 561.1;TIME: 148.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		Yes	No		88000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: AB_2684688"	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.45e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	164.9	25.1	17.9	13.0	20.1	6.5	60.9	16.9	20.2	56.8	13.1	69.4	11.5	38.9	13.2	48.2	53.9	51.8	96.7	15.1	16.5	25.9	31.2	93.9	15.3	19.5	17.3	53.0	22.5	12.9	7.1	34.0	19.5	30.2	24.9	1.1	7.1	30.0	32.3	6.9	21.1	58.1	15.9	111.9	15.0	4.3	22.3	4.1	78.3	59.9	5.6	42.7	19.5	17.0	0.0	20.2	6.8	0.1	1.0	3.4	0.1	4.1	3.5	0.8	1.5	0.0	0.0	0.1	24.8	162.3	0.0	3.4	0.0	31.8	2.3	0.1	0.0	119.8	1.4	45.6	43.6	0.0	0.0	8.4	20.5	3.4	9.6	2.2	362.3	0.0	43.9	0.0	561.1	0.0	0.0	0.1	0.1	0.0	1.0	0.0	32.3	0.2	41.7	0.0	0.0	0.1	0.0	0.0	0.0	9.1	0.0	0.1	148.9	0.0	12.4	7.4	0.0	0.0	0.0	0.1	0.0	1.0	0.0	49.0	2.4	1.2	0.2	0.8	0.3	0.1	0.0	0.0	2.3	0.3	0.2	0.0	24.3	1.3	1.5	3.1	0.5	121.3	17.9	20.1	16.9	20.2	15.1	16.5	19.5	17.3	19.5	15.9	22.3	17.0	1296.7	413.5	76.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	15.6	0.0	0.0	81.7	0.0	0.0	0.2	2.6	0.0	5.9	1.6	0.0	0.4	5.4	164.5	0.0	0.0	0.0	0.2	0.2	15.0	0.0	0.6	185.4	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	29.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.1	1.5	16.4	0.0	0.0
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 113.7;Inhibitory neurons: 112.5;Oligodendrocyte precursor cells: 123.1;T-cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	17.3	5.8	5.6	6.7	4.6	11.9	11.0	17.4	5.9	6.8	5.8	6.3	6.2	6.3	4.3	3.5	8.8	8.4	12.2	5.2	7.3	4.3	4.4	9.9	14.5	4.4	5.3	10.0	3.6	2.3	3.8	6.5	5.7	4.7	5.1	9.2	6.7	2.3	7.8	6.8	8.2	3.0	2.0	8.5	8.3	6.4	6.5	4.3	9.1	5.1	6.9	10.0	6.5	4.0	2.4	3.2	10.7	5.4	11.8	12.1	6.8	7.6	4.0	2.3	3.7	4.1	2.6	5.2	5.4	4.2	3.6	3.9	1.5	1.4	2.8	3.8	4.0	2.8	16.1	2.7	17.7	2.0	2.0	11.9	4.3	6.2	16.7	8.5	7.9	5.2	3.0	15.5	5.0	2.8	2.9	1.3	3.6	2.9	4.4	6.1	3.1	0.9	5.9	10.2	8.2	8.9	9.5	1.1	11.9	7.3	2.4	4.3	4.8	32.0	2.6	4.5	2.0	8.8	0.7	8.3	8.6	1.7	2.1	0.7	1.4	2.8	8.9	0.9	7.9	2.1	4.6	5.1	1.3	4.8	3.9	7.0	1.0	10.2	2.0	3.1	5.7	1.7	5.6	4.6	17.4	5.9	5.2	7.3	4.4	5.3	5.7	2.0	6.5	4.0	26.0	16.0	6.1	57.8	43.1	10.8	6.9	35.6	25.6	42.6	12.0	9.7	43.7	2.8	13.7	12.9	27.1	10.1	113.7	12.8	5.9	8.4	34.1	20.9	47.0	34.0	12.6	10.8	48.9	7.8	83.2	55.2	43.8	26.4	8.8	21.3	33.2	8.1	13.9	3.3	112.5	18.8	6.1	13.5	17.1	14.4	7.5	14.6	16.0	74.9	9.0	7.5	59.8	123.1	100.3	15.5	8.6	10.9	53.1	8.9	17.6	3.9	20.2	28.9	6.6	23.6	28.9	11.1	13.3	10.3	7.0	45.4	111.5	5.5	9.9	7.0
CBLN3		ENSG00000139899	"Cerebellin 3 precursor"	Q6UW01	14	24426545-24430954	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 93.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 3.0;Theca cells: 5.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	11	"cerebellum: 93.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.4;HDLM-2: 17.2;HSkMC: 23.3;Karpas-707: 18.3;U-266/70: 12.8"	"Region enriched"	"Detected in many"	25	"cerebellum: 429.5"	"Region enriched"	"Detected in many"	42	"cerebellum: 446.5"	HPA041266	Enhanced	Supported	Approved	Nucleoplasm	"Secreted in brain"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA041266: AB_10674430"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.39e-4)"	"unprognostic (5.39e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (6.20e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.02e-2)"	7.3	17.1	2.7	8.3	3.0	0.6	4.7	93.9	7.0	4.6	2.1	4.2	2.1	2.7	7.4	2.9	4.0	5.6	3.7	2.4	3.3	4.4	6.0	4.8	13.7	3.9	5.8	10.1	2.0	2.9	4.2	3.7	8.4	4.5	2.1	0.5	4.3	3.1	1.8	3.5	5.4	2.2	3.2	13.7	3.3	5.1	3.4	3.9	4.5	0.6	9.1	4.9	4.6	4.8	1.5	1.3	0.7	2.5	6.2	13.4	0.4	5.5	11.1	2.1	2.7	0.7	2.6	2.4	1.2	3.4	2.4	0.3	0.8	2.9	1.4	17.2	0.6	0.0	5.2	1.1	3.3	0.4	0.9	23.3	1.3	2.7	2.1	8.8	1.9	1.0	0.7	18.3	2.8	0.8	0.0	0.7	0.1	1.5	1.5	0.0	0.0	1.8	1.2	0.5	0.9	0.5	0.5	0.1	0.8	0.3	0.8	0.6	8.7	7.7	1.5	3.2	0.3	12.8	3.2	2.7	0.4	1.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.0	93.9	7.0	2.4	3.3	3.9	5.8	8.4	3.2	3.4	4.8	1.4	0.0	0.0	0.0	2.6	0.4	0.6	1.5	0.0	0.0	0.8	1.0	0.5	0.0	0.4	0.0	0.0	0.9	3.0	0.8	0.0	1.1	0.0	0.3	2.0	0.8	0.0	0.4	0.3	1.1	0.6	2.6	0.0	0.5	0.0	0.9	0.0	0.2	0.9	0.0	0.1	0.5	0.0	0.3	0.4	0.3	2.5	0.7	0.0	1.0	2.6	1.2	0.0	0.0	0.0	0.8	0.0	1.5	0.1	0.5	0.9	0.8	1.4	0.2	0.0	0.7	1.4	0.0	0.2	0.2	0.6	0.8	0.2	5.7	0.6	0.6
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36135079-36146562	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.3;salivary gland: 41.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 102.5;Basal squamous epithelial cells: 107.0;Peritubular cells: 75.6;Squamous epithelial cells: 230.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"B-cells: 23.9;NK-cells: 11.5;T-cells: 33.7"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 64.9"	"Region enhanced"	"Detected in all"		"basal ganglia: 48.6"	"Low region specificity"	"Detected in many"			HPA018434	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	NA		2800000	"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	17.3	2.3	12.8	4.0	14.7	1.4	15.3	13.9	19.8	12.4	11.2	7.8	3.0	7.5	11.0	56.3	8.8	6.5	6.1	13.2	12.4	2.7	0.8	4.6	2.9	12.8	12.1	11.2	1.6	0.6	2.4	2.9	12.3	9.9	3.6	0.6	41.4	5.1	3.1	21.6	5.4	6.1	12.0	3.1	5.2	3.1	12.2	2.0	4.6	7.8	7.6	11.6	16.8	12.4	33.5	9.5	4.0	8.2	31.0	47.8	5.9	35.4	42.4	40.6	32.1	0.4	6.9	0.0	10.2	37.2	13.7	15.0	5.5	7.2	16.2	45.3	17.2	1.4	10.0	0.3	2.6	0.1	0.1	6.8	0.8	28.1	3.6	19.1	24.9	3.7	0.0	0.3	12.1	25.4	3.1	14.7	3.2	10.3	41.5	6.7	7.6	64.9	13.7	14.2	2.1	2.9	27.3	32.6	53.3	2.2	9.8	3.9	17.1	25.7	2.2	28.8	35.0	1.5	0.6	0.0	26.9	0.9	47.3	0.0	0.6	0.1	2.2	0.5	3.0	23.6	25.1	7.7	2.4	23.9	33.7	23.5	0.9	11.5	1.0	0.7	10.9	11.5	12.8	14.7	13.9	19.8	13.2	12.4	12.8	12.1	12.3	12.0	12.2	12.4	41.7	0.0	3.2	6.8	5.2	71.0	22.1	102.5	107.0	0.8	23.1	38.6	0.2	2.8	23.0	0.0	0.0	1.2	2.9	1.9	9.8	4.7	0.7	13.1	7.5	26.5	0.0	1.7	3.9	0.7	0.3	53.4	7.7	14.7	5.7	1.1	14.3	0.3	8.4	0.0	5.5	12.6	69.2	3.8	41.3	4.0	67.7	5.8	65.8	2.8	20.9	1.9	0.0	1.5	0.5	2.6	1.7	75.6	1.4	43.4	1.3	0.2	13.1	0.6	0.0	21.4	19.7	0.4	0.2	230.4	46.7	0.3	7.0	1.0	8.1	21.1
CBY3		ENSG00000204659	"Chibby family member 3"	A6NI87	5	179678560-179681034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 15.4"	"Group enriched"	"Detected in some"	117	"Early spermatids: 211.1;Late spermatids: 351.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.3;HeLa: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069037	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA069037: AB_2686069"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.68e-3)"	"unprognostic (7.69e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.10e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.76e-3)"	"unprognostic (7.85e-2)"	"unprognostic (5.04e-3)"	"unprognostic (4.98e-2)"	0.2	0.4	0.4	0.0	0.3	0.0	0.3	0.5	0.4	0.6	0.0	0.6	0.1	0.5	0.0	0.2	0.7	0.0	0.4	0.2	0.1	0.4	0.2	0.2	0.2	0.6	0.2	0.8	0.9	0.0	0.9	0.0	0.4	0.5	0.0	0.4	0.5	0.0	0.4	0.3	0.5	0.0	0.1	0.4	0.4	15.4	0.4	0.0	0.6	0.0	0.0	0.5	0.4	0.5	0.0	0.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.2	0.3	0.2	0.5	0.1	0.2	0.9	0.5	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.4	0.3	0.5	0.4	0.2	0.1	0.6	0.2	0.4	0.1	0.4	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	211.1	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	351.4	1.5	0.2	0.0	1.9	0.0	0.0	0.0	1.0	2.4	0.0	0.0	1.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC102A	MGC10992	ENSG00000135736	"Coiled-coil domain containing 102A"	Q96A19	16	57512181-57536571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040598, HPA040958"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA040598: AB_10794035, HPA040958: AB_10794156"	"unprognostic (3.46e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.40e-3)"	"unprognostic (4.08e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.42e-3)"	5.0	3.7	1.8	2.7	1.6	0.5	4.8	1.7	2.4	10.9	4.1	11.1	2.3	11.0	1.1	3.5	8.8	1.5	6.8	1.6	1.7	5.2	1.5	4.5	3.0	2.5	2.4	8.0	3.3	1.5	2.3	2.5	2.0	8.4	0.5	0.1	4.0	3.8	1.6	4.9	4.7	2.4	2.1	5.1	4.8	3.0	2.4	1.6	5.8	0.5	1.7	11.9	8.2	1.5	6.6	7.9	3.0	4.3	1.0	1.4	6.2	4.2	2.3	2.4	1.2	3.2	7.5	6.0	16.4	1.3	3.2	4.8	1.5	2.2	0.9	4.9	6.8	0.8	3.8	1.3	3.7	0.4	7.7	3.5	1.4	2.0	0.5	5.2	1.9	2.1	4.6	0.0	0.8	2.7	5.4	5.3	7.1	0.7	14.6	4.8	3.4	2.4	3.0	1.0	0.5	7.8	6.6	2.1	3.2	1.1	4.5	2.9	5.2	4.4	14.5	0.4	3.8	6.9	2.7	2.2	2.5	2.1	7.4	0.0	0.0	0.0	1.1	0.0	0.9	0.9	0.2	1.2	0.0	0.5	0.5	0.8	0.1	0.6	0.0	0.3	0.0	0.2	1.8	1.6	1.7	2.4	1.6	1.7	2.5	2.4	2.0	2.1	2.4	1.5	8.8	0.0	3.0	0.7	8.2	12.9	8.0	2.4	14.8	0.0	4.9	10.3	3.1	5.7	2.2	7.3	0.0	1.6	16.3	0.5	9.8	1.9	0.6	6.0	8.5	10.6	0.0	3.4	0.0	0.9	1.1	13.2	2.0	1.8	0.0	14.6	7.1	0.9	0.3	0.0	0.1	1.0	0.0	0.6	2.8	1.3	19.6	1.5	1.8	1.0	0.5	3.5	18.6	0.0	0.0	0.9	0.1	34.6	18.8	10.6	1.1	10.5	3.1	0.2	19.7	10.8	11.8	2.8	8.9	2.3	5.7	0.3	10.5	3.3	1.0	3.2
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 9.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA041925: AB_2677750, HPA043219: AB_2678368"	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"	12.0	21.7	27.8	5.1	32.7	2.6	11.9	20.4	37.6	11.4	17.7	18.7	4.1	13.4	6.4	8.0	13.3	6.5	21.9	33.0	22.4	29.1	24.3	9.4	10.3	21.8	23.1	12.7	9.8	13.6	27.3	5.1	21.1	15.2	2.7	6.5	11.1	11.2	24.5	9.3	13.7	7.1	18.4	18.2	13.7	20.8	23.5	4.7	16.7	20.2	9.0	12.8	8.3	24.7	8.7	33.6	14.4	25.3	10.1	9.6	2.0	7.4	12.9	25.0	21.0	7.3	13.2	25.6	5.6	13.8	0.7	7.3	24.6	16.0	7.1	1.3	82.2	26.7	23.4	13.3	30.1	1.8	14.3	15.6	1.9	5.9	1.4	17.4	8.0	16.0	20.1	15.7	12.5	2.3	16.3	10.8	6.9	0.8	18.3	25.5	7.3	17.7	25.9	0.8	15.8	29.4	5.9	41.3	14.7	8.5	17.9	17.3	9.0	7.7	7.9	0.7	5.5	9.3	3.5	33.0	20.7	8.4	0.6	0.0	2.3	0.0	0.4	1.5	1.4	7.2	0.4	0.6	2.9	9.6	3.1	1.9	0.0	0.8	0.1	8.9	0.3	1.7	27.8	32.7	20.4	37.6	33.0	22.4	21.8	23.1	21.1	18.4	23.5	24.7	12.0	0.0	1.3	8.8	18.1	2.5	6.0	14.0	12.0	22.3	16.0	17.1	23.8	11.5	6.5	20.2	4.2	13.5	6.8	4.6	41.1	19.6	4.0	3.9	7.2	10.8	4.9	4.2	6.4	7.2	15.0	9.7	11.7	3.3	8.9	10.5	10.0	17.5	17.5	37.0	6.4	8.7	8.2	9.4	6.4	2.7	14.0	7.9	3.6	3.7	11.7	34.1	3.1	4.5	3.6	8.7	8.0	18.8	7.0	6.0	10.6	69.4	3.2	9.7	13.1	9.3	9.0	4.7	30.2	10.3	3.7	8.8	3.9	18.9	6.0	5.7
CCDC120	JM11	ENSG00000147144	"Coiled-coil domain containing 120"	Q96HB5	X	49053572-49069857	"Cancer-related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 29.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 20.9;BEWO: 28.6;HaCaT: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000561			Uncertain	Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA000561: AB_2244190"	"unprognostic (1.65e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.34e-3)"	3.1	2.6	5.2	2.1	5.0	2.3	4.4	7.6	6.4	10.6	4.5	5.2	8.7	4.4	5.7	35.9	5.0	2.5	1.8	5.0	4.8	9.1	6.6	4.3	2.0	3.9	4.0	6.3	8.0	3.8	9.3	4.0	3.9	7.7	2.2	2.0	12.0	4.0	0.7	29.3	7.4	1.6	3.0	3.8	6.8	3.4	4.9	2.9	6.0	0.5	3.9	5.3	16.1	3.5	20.9	2.8	4.5	0.2	0.0	0.0	28.6	0.7	1.0	1.5	2.4	6.9	8.7	0.8	3.2	1.2	3.4	19.5	3.4	11.7	0.1	5.4	6.6	2.0	5.0	2.4	1.5	0.1	3.4	2.5	9.0	1.9	0.5	3.1	2.5	5.4	2.9	0.2	0.0	17.5	7.5	0.5	5.1	9.8	0.1	6.6	3.3	2.0	8.8	11.0	6.0	4.7	3.6	7.2	2.2	6.1	17.7	2.8	1.2	0.1	5.2	0.2	0.2	6.6	4.8	0.1	0.2	0.1	0.9	1.1	0.2	0.5	0.3	0.0	0.2	0.2	0.4	0.3	0.0	0.6	0.4	0.3	1.0	0.4	0.1	0.6	0.1	0.1	5.2	5.0	7.6	6.4	5.0	4.8	3.9	4.0	3.9	3.0	4.9	3.5	1.7	6.4	3.1	2.0	2.5	5.1	3.5	7.1	4.0	6.8	8.2	5.6	1.3	4.3	6.0	12.9	4.2	12.7	2.2	5.6	0.0	5.1	0.1	8.5	2.2	2.7	6.0	1.7	4.8	6.5	3.2	2.9	9.7	11.5	0.0	4.9	2.5	2.5	2.3	10.1	6.2	6.2	2.0	1.2	1.5	0.5	2.1	0.9	0.0	2.8	0.4	3.3	2.1	2.5	0.7	14.4	8.3	1.2	1.5	6.3	9.0	3.1	5.0	6.8	0.0	2.6	1.5	1.4	2.4	9.0	9.2	16.8	2.3	2.3	4.6	11.4
CCDC126	FLJ23031	ENSG00000169193	"Coiled-coil domain containing 126"	Q96EE4	7	23597382-23644708	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.6"	"Group enriched"	"Detected in all"	18	"Early spermatids: 642.3;Late spermatids: 490.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"basophil: 479.0"	"Lineage enriched"	"Detected in all"	23	"granulocytes: 479.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010969, HPA026883"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		39000000	"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"HPA010969: , HPA026883: AB_1846131"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-1)"	6.5	7.5	3.7	4.5	4.1	7.6	8.4	6.5	4.9	6.6	2.5	5.2	8.6	7.2	4.8	5.9	6.4	5.9	5.0	3.6	4.6	7.2	11.6	6.1	8.9	5.0	5.2	6.8	8.4	11.7	4.3	4.5	4.5	5.5	6.1	8.4	5.4	5.5	7.1	4.8	7.0	6.2	4.6	6.3	6.5	34.6	4.7	5.4	9.4	10.0	8.8	6.3	4.4	4.1	6.0	4.1	8.9	11.3	14.6	8.1	20.4	7.4	7.3	6.2	9.0	4.3	1.9	12.8	11.3	6.2	11.8	3.4	3.9	3.5	8.1	2.7	5.1	2.2	1.6	5.6	5.8	5.9	10.9	8.7	10.0	2.0	1.9	5.2	8.4	5.3	5.2	3.5	7.6	2.8	4.1	7.1	4.2	7.9	5.1	2.7	14.0	3.9	6.5	2.7	5.4	10.2	7.6	7.2	5.6	13.8	6.1	5.4	10.2	3.7	6.5	8.4	5.9	9.9	10.5	9.2	4.1	8.5	20.2	479.0	18.0	86.7	14.7	17.0	17.6	20.7	15.8	17.0	15.6	19.3	19.2	15.0	35.2	16.8	17.1	3.2	19.3	15.6	3.7	4.1	6.5	4.9	3.6	4.6	5.0	5.2	4.5	4.6	4.7	4.1	17.3	6.4	8.1	12.7	12.8	19.1	7.9	8.0	13.6	14.1	15.4	10.7	9.0	12.8	8.2	12.9	8.4	10.2	9.3	7.3	7.9	10.1	642.3	11.1	9.0	10.8	15.0	4.8	14.0	9.1	6.8	11.5	13.3	9.5	7.0	3.7	10.8	15.2	6.9	8.4	17.4	8.7	16.2	7.9	9.6	490.0	11.5	9.5	14.2	12.2	11.4	7.7	14.4	18.6	20.1	10.4	7.3	14.3	12.8	8.3	8.4	8.9	14.6	14.1	13.1	12.0	12.9	31.1	26.3	12.1	23.7	20.2	11.3	29.2	5.9	6.9
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666737-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA052637: AB_2681894, HPA053914: AB_2682306"	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	8.2	9.5	13.8	12.3	13.7	17.7	7.6	13.5	17.5	10.7	14.2	9.3	11.4	7.5	5.5	23.1	7.8	6.1	6.5	13.7	13.8	10.2	10.8	7.7	16.3	14.4	14.3	6.7	8.2	7.0	6.2	7.7	14.7	11.7	5.8	2.8	9.9	6.4	7.7	22.8	10.7	6.0	13.4	15.6	8.8	10.4	14.5	11.8	7.8	4.5	11.5	9.8	13.8	14.3	38.0	62.8	21.5	35.3	13.9	13.1	35.2	41.6	19.7	53.0	30.6	55.1	22.8	33.8	22.4	21.2	36.6	47.9	34.5	43.8	30.6	19.4	51.7	51.6	30.1	48.0	20.7	46.6	37.5	19.8	26.3	47.6	26.3	14.6	37.4	41.1	53.3	19.1	28.3	34.5	45.7	56.6	46.9	32.9	59.8	55.4	34.6	24.1	19.8	29.6	45.1	57.7	41.1	87.8	37.1	28.9	58.8	48.3	27.8	82.0	53.5	34.9	65.9	53.1	28.7	36.8	30.8	42.9	48.8	2.2	7.7	11.7	11.5	9.6	6.3	10.4	8.7	8.8	7.5	13.2	9.2	8.8	3.3	13.1	11.9	12.9	9.8	5.9	13.8	13.7	13.5	17.5	13.7	13.8	14.4	14.3	14.7	13.4	14.5	14.3	17.9	22.4	17.0	5.9	29.8	31.7	22.8	19.7	74.6	6.8	17.4	13.7	6.7	15.7	20.9	12.9	2.1	25.7	31.5	19.7	19.6	25.2	1.7	26.5	32.9	20.3	7.2	37.5	4.5	21.4	41.0	16.5	29.0	29.4	19.6	28.1	15.4	11.8	24.3	18.5	4.6	17.0	14.2	12.9	11.5	1.7	13.7	16.8	16.0	4.7	24.2	13.8	37.0	4.0	5.0	35.2	16.0	13.5	25.7	40.0	12.4	15.9	21.6	9.1	6.6	13.7	22.3	30.8	44.9	57.0	34.4	20.8	29.7	22.8	22.4	24.2
CCDC144A	"FLJ43983, KIAA0565"	ENSG00000170160	"Coiled-coil domain containing 144A"	A2RUR9	17	16689537-16777881	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 9.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Early spermatids: 59.1;Rod photoreceptor cells: 49.4;Spermatocytes: 165.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basal ganglia: 2.4;cerebellum: 7.6;cerebral cortex: 6.9;hippocampal formation: 4.9;white matter: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.5;TIME: 8.5"									"HPA022996, HPA047220, HPA047851, HPA066260"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 6: Brain - Smell perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: "	"unprognostic (8.54e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-1)"	1.3	1.3	0.6	2.1	2.4	4.2	1.5	7.6	6.9	1.1	0.0	1.7	0.7	3.5	2.5	0.8	1.6	1.2	1.2	4.9	0.0	0.5	1.1	1.3	1.7	0.8	0.0	4.5	2.7	0.4	1.6	2.7	0.8	1.5	0.9	7.4	1.2	1.0	1.0	2.5	1.0	1.6	0.0	1.8	1.5	9.1	0.0	3.3	0.8	2.3	1.2	1.6	0.9	3.9	0.5	3.4	0.8	2.1	3.0	9.5	0.4	0.2	0.0	0.2	0.2	4.4	0.1	0.5	2.8	6.2	0.2	5.3	4.4	0.3	0.2	3.2	0.2	0.4	0.5	0.3	0.2	0.7	2.7	1.7	0.1	2.1	0.2	0.9	0.1	0.1	0.4	0.3	2.0	0.1	0.0	1.1	0.6	0.9	0.4	1.4	0.2	0.1	0.1	4.1	1.1	1.2	0.6	0.2	1.2	1.5	3.4	0.1	8.5	0.7	0.4	4.6	1.4	5.7	6.3	0.2	0.3	6.2	1.6	0.2	0.1	0.0	0.5	0.1	0.3	0.2	0.5	0.3	0.1	0.1	0.9	0.5	0.2	0.2	0.4	0.2	0.5	0.0	0.6	2.4	7.6	6.9	4.9	0.0	0.8	0.0	0.8	0.0	0.0	3.9	5.9	0.0	14.9	15.7	3.1	4.0	6.4	1.9	0.0	40.8	4.5	2.5	2.8	2.8	2.9	0.0	54.2	4.9	6.4	1.7	0.0	1.8	59.1	8.0	25.8	9.1	1.2	1.7	21.2	0.0	7.1	9.7	2.0	10.4	26.0	6.2	3.6	2.0	4.2	33.7	19.8	2.4	2.0	6.8	7.7	6.5	7.2	6.3	5.4	1.0	3.6	7.1	6.2	17.1	4.0	1.7	3.8	9.1	1.7	8.6	1.2	1.1	3.9	49.4	6.6	11.7	10.2	165.9	36.1	0.2	3.7	1.9	6.9	22.2	2.1	4.6
CCDC148	MGC125588	ENSG00000153237	"Coiled-coil domain containing 148"	Q8NFR7	2	158171073-158456753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 3.0;testis: 3.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Early spermatids: 39.4;Excitatory neurons: 33.6;Inhibitory neurons: 53.0;Oligodendrocytes: 38.6;Respiratory ciliated cells: 34.1;Rod photoreceptor cells: 30.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;HBF TERT88: 1.8;RPTEC TERT1: 1.9;SCLC-21H: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042626	Uncertain		Uncertain	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA042626: AB_10806244"	"unprognostic (1.88e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.94e-4)"	"unprognostic (3.29e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.54e-4)"	"unprognostic (6.57e-3)"	0.2	0.3	0.5	0.0	0.6	0.0	1.0	0.9	0.4	0.7	3.0	0.0	0.0	0.4	1.2	0.1	1.8	0.3	0.1	0.5	0.4	2.4	0.1	0.4	0.0	0.9	0.7	0.7	0.2	2.5	1.0	0.0	0.6	0.3	0.0	2.0	0.6	0.4	0.0	0.2	0.0	0.1	0.5	0.0	0.1	3.4	0.5	0.0	1.0	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.4	0.7	0.0	0.0	0.0	0.5	0.0	0.5	1.1	0.5	2.7	0.0	0.1	0.4	0.2	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.9	0.2	2.0	0.1	0.3	0.2	0.2	0.6	1.2	0.1	0.0	0.2	0.4	0.1	0.1	0.3	0.6	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.9	0.4	0.5	0.4	0.9	0.7	0.6	0.5	0.5	0.3	1.1	0.0	1.5	13.4	0.2	0.0	2.6	4.2	1.2	10.9	3.8	4.6	3.0	0.0	3.0	7.3	56.3	0.0	0.0	0.0	13.7	5.5	39.4	15.2	0.6	1.5	0.0	0.0	33.6	2.0	0.0	0.6	0.0	2.8	0.0	1.3	1.1	1.3	0.1	5.0	53.0	0.0	10.2	0.3	0.0	7.7	0.9	1.0	0.0	5.6	0.8	6.0	0.0	19.6	38.6	2.6	0.0	1.9	0.0	1.2	0.0	6.4	34.1	30.8	6.6	1.6	0.7	22.6	4.0	0.6	0.4	0.0	0.2	1.3	0.1	1.7
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 42.8;Erythroid cells: 26.3;Late spermatids: 25.8;Spermatocytes: 99.7;Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	0.7	0.3	0.5	0.9	0.8	2.1	2.8	0.5	0.6	0.6	0.3	0.8	0.7	0.6	1.5	0.8	1.1	0.5	0.2	0.6	0.5	0.6	1.3	0.7	1.2	0.9	0.6	0.8	0.8	0.6	0.5	0.7	0.6	1.6	0.8	1.7	3.9	0.5	0.1	2.1	0.7	0.6	0.7	0.8	0.6	10.5	0.7	2.8	0.7	0.2	1.4	0.5	0.6	1.2	5.4	1.0	6.9	0.0	0.5	1.9	0.0	5.7	6.9	5.3	6.5	0.1	4.4	6.3	4.9	2.0	10.5	4.2	2.9	3.8	9.4	5.3	1.1	7.7	0.8	1.6	0.2	2.3	4.3	0.5	2.7	11.0	5.5	1.0	4.0	7.8	5.2	6.3	11.2	1.2	4.9	2.6	1.6	4.6	6.3	5.9	12.6	2.0	0.8	2.1	3.9	3.4	3.3	0.4	1.5	3.3	7.9	2.0	2.9	10.8	2.4	4.8	7.2	1.5	1.8	5.3	1.5	12.6	7.3	4.0	0.5	0.8	1.0	0.7	1.1	0.3	0.9	1.7	0.1	0.7	1.2	1.4	0.4	1.1	0.8	0.5	1.7	0.5	0.5	0.8	0.5	0.6	0.6	0.5	0.9	0.6	0.6	0.7	0.7	1.2	2.4	3.2	1.1	5.2	2.3	5.0	2.1	2.2	2.2	6.4	4.2	2.8	0.6	0.0	2.9	0.0	0.0	0.9	2.9	1.1	0.0	2.3	42.8	2.6	2.0	3.4	1.2	26.3	1.2	3.5	0.4	2.5	3.6	1.4	8.9	4.4	1.4	1.4	3.2	3.3	2.0	2.1	0.0	2.6	3.3	25.8	4.4	2.6	3.6	1.0	0.7	3.6	8.2	5.0	6.1	1.8	0.5	2.2	1.2	1.1	0.2	1.0	5.3	2.8	6.6	2.2	2.3	99.7	34.5	3.2	3.8	0.1	3.4	0.9	1.7	1.2
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553043-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 194.5;Excitatory neurons: 92.4;Inhibitory neurons: 70.6;Late spermatids: 172.4;Spermatocytes: 148.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.5;HEL: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	0.8	1.1	2.3	0.7	2.8	2.1	1.6	3.7	3.2	1.4	0.0	0.9	0.8	5.8	1.1	1.0	2.0	1.5	1.0	2.5	0.3	1.2	0.4	1.1	1.1	1.5	0.3	2.9	1.3	1.4	1.1	0.9	2.0	1.1	1.1	5.5	0.8	1.2	0.8	2.4	1.0	3.3	0.2	0.6	1.4	11.3	0.5	4.8	2.0	1.1	1.0	0.8	0.9	3.3	1.4	0.7	1.6	1.6	0.9	1.9	1.0	1.0	0.8	1.0	1.1	0.4	0.6	7.5	0.5	0.6	1.9	0.3	0.7	1.0	1.1	1.6	0.7	11.7	1.2	1.0	1.3	1.6	1.4	1.1	1.9	0.8	1.5	0.8	0.5	4.1	0.3	2.0	1.2	0.5	3.3	1.5	1.3	0.6	1.6	3.8	1.2	0.2	0.7	1.1	2.3	1.1	2.1	0.7	2.8	1.3	0.9	1.1	0.8	2.1	1.2	0.6	0.7	1.1	1.4	4.8	0.9	1.0	1.5	2.4	0.2	0.0	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	2.3	2.8	3.7	3.2	2.5	0.3	1.5	0.3	2.0	0.2	0.5	3.3	4.4	0.0	7.5	56.8	2.6	2.8	5.8	1.8	7.4	27.7	5.0	8.0	8.5	0.0	5.9	3.7	16.7	6.7	1.4	3.6	5.9	2.9	194.5	24.3	7.8	3.8	1.2	3.8	92.4	3.5	4.1	5.7	8.2	12.9	1.3	7.6	3.3	0.8	1.9	10.1	70.6	3.5	6.1	1.0	1.1	172.4	5.9	2.1	0.0	16.9	1.6	12.5	5.2	54.8	63.1	2.5	1.0	6.0	1.9	0.8	2.8	2.1	12.0	44.0	13.1	11.6	5.7	148.2	40.6	5.4	3.3	5.6	3.6	10.7	4.9	3.7
CCDC184	"C12orf68, LOC387856"	ENSG00000177875	"Coiled-coil domain containing 184"	Q52MB2	12	48183644-48185926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.5;Late spermatids: 15.1;Sertoli cells: 46.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;AF22: 6.3;hTERT-RPE1: 2.4;SH-SY5Y: 4.3;U-2 OS: 2.5;U-87 MG: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039947, HPA041715"	Uncertain		Approved	Mitochondria,Cytosol		No	No				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Mitochondria, Cytosol"		"HPA039947: AB_2676764, HPA041715: AB_2677634"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.36e-2)"	1.1	5.3	12.3	0.9	12.0	0.1	1.0	11.2	21.4	3.5	1.1	1.8	0.2	5.4	0.3	0.9	1.0	1.3	2.3	10.8	25.7	0.7	0.3	0.8	0.2	18.3	12.5	7.5	0.6	5.8	11.6	2.3	24.5	1.4	0.4	5.0	0.4	0.8	0.9	0.4	0.9	1.4	7.5	0.9	1.0	6.2	11.9	0.0	0.9	0.4	0.0	2.0	1.5	10.8	0.0	2.7	6.3	0.2	0.5	0.5	0.0	0.2	1.2	0.3	0.5	0.3	0.1	0.0	0.1	0.2	1.6	0.1	0.6	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.3	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.7	2.5	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	12.0	11.2	21.4	10.8	25.7	18.3	12.5	24.5	7.5	11.9	10.8	1.2	0.0	0.0	2.6	1.1	0.0	0.1	0.0	6.2	2.3	0.3	1.9	0.6	0.0	0.6	0.0	0.0	0.7	2.0	0.1	0.0	0.3	62.5	0.4	9.4	3.1	5.3	0.0	5.6	0.0	0.6	11.2	1.1	0.2	0.0	4.2	6.8	0.0	0.9	5.0	12.7	0.0	0.0	0.3	0.0	15.1	0.3	0.5	0.0	1.0	0.0	3.0	0.0	1.5	1.1	0.1	0.0	2.2	0.2	0.1	0.0	0.0	5.1	7.0	46.0	8.6	7.6	12.7	1.8	2.2	0.0	1.5	3.2	1.8	0.0	0.0
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 36.4;Respiratory ciliated cells: 57.6;Spermatocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.0;intermediate monocyte: 2.2;memory B-cell: 3.5;naive B-cell: 2.2;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.5;granulocytes: 1.0;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: AB_2684591"	"prognostic favorable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (3.18e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.6	4.8	11.8	1.3	11.9	0.4	3.3	11.3	15.9	5.9	12.3	3.8	1.9	3.2	1.9	2.1	11.2	3.1	1.3	11.8	12.0	11.8	3.6	2.9	1.4	11.6	11.8	2.4	5.6	6.2	12.9	1.0	11.7	7.2	2.1	6.6	4.4	5.0	0.8	1.1	2.4	1.3	11.8	2.4	3.8	19.1	12.3	0.9	9.1	0.2	1.0	4.1	2.4	11.5	4.7	2.8	1.2	1.4	1.2	0.8	2.7	0.2	1.9	1.4	2.4	1.8	13.4	3.8	5.0	0.5	4.0	4.7	0.7	6.5	1.3	3.9	1.6	1.9	1.7	0.5	1.3	0.6	3.2	0.3	0.6	4.5	0.4	4.3	1.1	1.4	0.8	1.4	2.0	4.0	0.2	1.4	2.7	4.2	2.2	1.3	0.0	0.7	5.5	1.8	2.9	2.6	4.0	2.3	2.6	2.5	6.7	0.1	0.3	2.1	5.9	1.5	0.7	0.5	1.8	0.8	5.3	0.5	1.7	0.0	0.4	1.0	0.3	2.2	0.2	3.5	0.1	0.1	0.4	2.2	0.0	0.0	0.4	0.3	1.8	0.3	0.0	0.2	11.8	11.9	11.3	15.9	11.8	12.0	11.6	11.8	11.7	11.8	12.3	11.5	1.7	3.2	7.2	17.0	2.3	1.1	7.9	26.5	9.1	8.9	13.3	12.1	1.0	12.8	22.0	9.2	6.2	5.6	0.9	11.3	21.5	9.4	20.7	30.9	2.4	2.1	36.4	1.3	17.7	7.2	2.2	2.5	21.9	6.9	2.5	1.6	2.5	2.6	3.3	3.3	10.0	13.6	14.2	2.0	2.2	11.7	2.1	3.6	3.6	1.9	2.7	10.2	0.0	5.0	2.4	6.5	8.3	3.0	1.8	5.7	6.3	11.5	57.6	15.4	0.0	2.9	3.8	50.6	19.9	3.9	0.9	2.5	1.3	3.9	10.2	11.4
CCDC58	FLJ33273	ENSG00000160124	"Coiled-coil domain containing 58"	Q4VC31	3	122359591-122383231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 114.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051965	Approved		Approved	Nucleoli,Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoli	"HPA051965: AB_2681676"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.64e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.84e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (7.29e-4)"	14.7	21.0	16.9	15.7	17.8	18.0	19.0	18.2	28.2	10.7	18.4	28.5	22.5	11.7	24.6	23.2	10.6	13.4	27.3	17.1	17.6	46.8	49.8	9.0	23.3	17.8	18.1	13.1	13.8	14.9	7.8	14.4	18.2	11.1	29.1	17.1	11.3	10.6	78.8	15.0	18.6	11.4	17.4	12.1	16.4	9.4	18.1	16.2	18.3	47.2	21.5	22.6	12.5	18.3	135.1	41.9	78.2	50.2	28.5	39.8	100.6	50.5	54.3	119.4	116.4	118.4	66.4	98.0	84.6	38.6	92.7	91.9	127.9	86.3	142.5	34.1	45.3	115.9	28.5	145.6	47.5	174.5	39.5	33.0	43.9	73.5	79.8	50.7	55.9	85.8	133.6	41.6	63.7	67.2	111.7	123.6	150.0	147.2	78.1	72.8	92.9	120.1	83.7	70.3	78.8	38.4	58.5	61.5	150.5	65.3	61.2	112.8	32.6	66.4	86.1	28.6	102.3	32.9	47.5	217.4	75.7	83.3	60.0	0.9	7.7	2.7	15.2	16.7	18.0	20.9	19.9	20.1	16.5	19.2	23.0	22.2	1.4	19.2	14.2	29.2	17.2	6.7	16.9	17.8	18.2	28.2	17.1	17.6	17.8	18.1	18.2	17.4	18.1	18.3	5.7	3.2	17.0	8.1	18.1	15.3	19.1	21.4	21.1	10.5	14.1	10.4	32.0	20.0	22.2	12.9	10.4	21.8	8.4	19.6	54.8	31.4	0.5	24.7	20.5	13.7	5.4	14.1	11.3	30.0	44.7	12.8	16.8	26.2	21.5	14.4	10.8	50.5	17.8	0.0	13.2	27.7	16.2	8.7	7.6	1.5	12.8	8.9	8.8	2.8	19.8	9.7	16.5	11.6	11.8	31.9	14.7	8.2	12.5	30.7	23.9	114.0	22.5	9.6	13.1	15.1	41.8	23.1	31.0	30.8	18.5	15.2	10.9	11.8	35.1	23.0
CCDC6	"D10S170, H4, PTC, TPC, TST1"	ENSG00000108091	"Coiled-coil domain containing 6"	Q16204	10	59788747-59906556	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019049, HPA019051"	Enhanced		Supported	Cytosol		No	No		12000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA019049: AB_1846163, HPA019051: AB_1846164"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.98e-3)"	"prognostic favorable (5.48e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (4.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.19e-2)"	11.9	12.2	21.1	13.9	23.4	16.8	22.4	10.2	20.0	23.4	8.5	23.5	22.8	24.9	16.7	34.1	25.3	16.7	10.0	24.9	21.4	21.2	12.1	17.3	21.4	12.4	15.8	15.7	25.2	17.9	11.5	13.2	17.4	19.4	19.8	18.3	29.0	14.3	17.3	28.6	16.2	30.8	11.9	14.7	18.6	11.4	20.8	12.1	18.3	12.2	21.6	17.3	23.1	12.6	42.9	38.0	18.7	41.9	27.8	41.6	37.9	20.6	27.2	20.2	23.7	74.4	81.8	36.5	30.2	34.6	11.7	61.7	37.7	37.5	30.0	55.1	18.7	29.8	29.1	45.5	33.5	34.5	26.9	30.3	48.7	33.7	81.8	28.3	30.2	20.4	22.6	22.7	26.6	57.6	14.5	19.8	29.9	40.1	25.6	19.2	30.5	23.0	33.9	36.2	19.0	16.6	26.1	107.8	23.1	24.1	68.7	18.4	31.1	18.8	33.9	29.3	34.9	12.0	14.9	16.3	29.6	64.6	11.9	0.0	2.0	0.0	1.0	2.3	1.1	4.3	1.5	1.3	5.0	4.9	1.3	1.0	0.1	0.8	1.3	1.3	1.4	1.0	21.1	23.4	10.2	20.0	24.9	21.4	12.4	15.8	17.4	11.9	20.8	12.6	24.0	99.3	25.9	45.1	41.6	95.0	51.7	25.3	70.0	15.1	51.2	38.7	16.5	28.6	46.3	25.8	41.7	37.8	31.4	42.6	29.4	50.2	27.6	105.2	54.6	22.4	27.0	25.7	83.2	65.3	18.8	27.8	39.8	134.5	29.1	45.2	17.2	20.1	23.1	16.8	58.4	38.9	30.5	40.7	35.3	80.6	24.5	36.4	16.0	32.8	23.0	11.5	13.4	55.3	34.2	50.2	25.0	19.5	26.4	52.2	47.1	48.4	28.1	49.8	19.7	31.4	27.0	2.3	22.4	92.3	80.1	27.0	24.3	32.5	46.3	46.1
CCDC63	"FLJ35843, ODA5"	ENSG00000173093	"Coiled-coil domain containing 63"	Q8NA47	12	110846769-110907535	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.3"	"Group enriched"	"Detected in some"	32	"Early spermatids: 305.6;Late spermatids: 241.7"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"MCF7: 4.4"									HPA061568			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA061568: AB_2684561"					"unprognostic (1.98e-2)"	"unprognostic (1.05e-1)"		"unprognostic (1.17e-1)"	"unprognostic (2.65e-1)"					"unprognostic (5.59e-2)"	"unprognostic (1.09e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	305.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	241.7	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	4.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621837	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	2.7	3.1	3.8	3.6	3.7	3.0	5.2	3.7	4.3	4.8	4.2	4.0	3.0	4.1	5.3	2.5	5.7	3.4	2.9	3.7	4.2	4.1	2.0	3.6	4.9	3.8	3.7	6.0	3.3	5.4	4.5	3.3	3.9	4.0	4.1	7.8	3.3	3.6	4.5	2.5	2.8	4.9	3.8	4.3	3.2	3.7	3.7	5.1	4.9	2.6	4.9	3.7	3.1	3.8	5.6	2.0	5.8	3.7	8.9	5.2	4.6	6.8	6.4	9.1	7.8	4.3	4.3	15.6	1.6	3.8	5.8	2.8	3.4	6.5	10.1	5.6	4.0	9.5	9.0	4.6	6.2	12.8	3.3	4.9	8.8	7.7	5.1	8.0	6.0	7.7	9.3	2.4	7.2	4.7	10.0	7.5	9.7	4.8	7.5	3.4	5.2	8.6	5.3	1.9	2.2	4.2	8.7	5.5	5.2	4.9	1.9	5.2	3.1	6.6	5.2	6.3	9.9	4.7	5.3	8.0	4.9	14.3	5.5	10.0	1.5	3.5	4.1	2.0	5.4	2.7	7.0	5.0	1.1	1.6	8.0	5.8	0.3	5.1	2.4	1.0	14.8	2.6	3.8	3.7	3.7	4.3	3.7	4.2	3.8	3.7	3.9	3.8	3.7	3.8	39.7	22.4	22.6	42.7	41.3	28.2	20.1	30.5	15.9	68.5	18.5	21.0	30.5	30.0	29.0	22.0	108.4	23.0	51.5	7.7	29.4	23.7	202.5	58.1	33.5	28.8	21.0	40.8	93.2	10.5	14.6	29.9	18.8	13.9	34.2	38.3	37.9	8.5	18.4	52.2	95.8	11.4	22.4	35.8	27.9	109.6	54.0	20.7	26.6	51.5	56.1	36.8	105.0	70.9	96.7	14.1	9.8	47.8	28.1	25.5	11.5	20.3	51.5	111.5	32.9	38.6	30.9	55.8	46.8	12.1	29.5	16.4	51.7	33.6	14.5	11.4
CCDC68	SE57-1	ENSG00000166510	"Coiled-coil domain containing 68"	Q9H2F9	18	54901509-54959461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.8;placenta: 32.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 95.2;Early spermatids: 95.4;Pancreatic endocrine cells: 87.9;Paneth cells: 68.7;Proximal enterocytes: 61.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 10.8;HHSteC: 13.6;HSkMC: 14.9;RT4: 10.5;TIME: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA040865, HPA048197"	Supported		Approved	"Golgi apparatus,Cytosol"		No	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA040865: AB_2677176, HPA048197: AB_2680310"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.38e-1)"	5.5	3.8	1.6	4.1	1.5	0.4	3.4	1.4	2.7	4.2	2.3	18.9	20.2	3.3	0.8	1.8	2.4	5.1	5.7	1.5	3.6	2.8	9.5	13.0	0.8	2.0	2.3	15.7	2.8	0.8	3.6	32.4	2.0	4.2	18.2	0.6	1.8	1.3	1.5	0.9	24.8	2.7	1.2	7.2	14.3	8.8	3.3	0.6	2.6	4.4	1.3	2.3	1.8	1.3	10.8	3.3	0.0	0.0	3.0	8.3	0.0	0.3	4.2	0.6	0.7	5.9	6.2	0.0	7.6	0.0	0.1	0.1	0.7	6.8	0.5	0.0	1.6	0.8	3.6	1.2	13.6	0.0	0.0	14.9	0.0	3.2	0.1	0.0	4.9	0.0	0.0	0.1	0.4	0.8	0.0	0.2	0.0	7.6	3.6	0.3	0.0	0.3	1.2	10.5	0.1	2.5	3.3	1.0	0.1	1.2	0.0	0.0	28.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.6	1.5	1.4	2.7	1.5	3.6	2.0	2.3	2.0	1.2	3.3	1.3	38.5	19.2	10.3	0.3	1.0	0.3	7.4	4.8	1.2	0.1	2.0	1.9	5.5	10.0	13.3	1.8	0.0	2.3	0.3	95.2	1.9	7.2	95.4	15.0	2.5	40.8	6.0	3.6	5.7	35.6	2.7	9.6	38.2	27.1	8.8	2.6	37.5	7.0	0.4	0.0	0.5	21.8	8.2	3.2	1.3	36.7	3.4	0.6	0.0	12.2	1.0	3.3	1.0	0.0	0.1	87.9	68.7	0.7	0.0	32.4	61.1	5.3	4.2	0.2	6.6	0.9	3.0	1.2	2.2	1.1	0.0	6.0	0.4	3.8	20.2	6.4
CCDC7	"BIOT2, C10orf68, FLJ13031, FLJ32762"	ENSG00000216937	"Coiled-coil domain containing 7"	Q96M83	10	32446140-32882874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"brain: 28.1;testis: 78.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 489.6;Late spermatids: 914.3;Oligodendrocytes: 161.0;Spermatocytes: 176.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA075536			Approved	"Nucleoli,Mitotic spindle,Cytosol"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	"Mitotic spindle, Cytosol"	"HPA075536: AB_2686755"	"unprognostic (3.43e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.65e-5)"	"unprognostic (6.95e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.95e-5)"	"unprognostic (7.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	1.0	1.2	10.9	0.9	20.3	2.4	1.3	28.1	14.5	1.4	0.0	1.1	1.2	1.3	1.5	1.2	0.8	1.1	1.1	3.1	8.9	1.1	0.7	1.2	1.6	13.7	9.1	1.5	1.5	0.8	1.7	0.9	17.0	1.1	1.5	3.0	0.8	1.3	0.7	0.7	1.0	1.2	10.7	1.1	1.2	78.0	15.6	0.8	1.9	0.6	1.4	0.8	1.0	23.7	1.4	1.5	0.4	1.8	1.2	0.9	0.6	1.2	0.4	0.4	1.2	0.3	2.0	1.0	0.6	0.8	1.1	0.6	0.7	0.7	1.6	3.6	0.2	0.5	1.3	0.4	2.1	0.6	0.9	0.8	0.3	0.8	0.3	0.8	0.5	1.6	0.8	3.4	1.5	0.2	0.4	0.3	0.4	0.7	1.4	0.9	1.9	0.1	1.2	0.3	0.9	1.0	0.2	0.2	0.9	0.5	1.0	0.8	2.0	1.0	1.2	1.3	0.7	1.1	0.8	1.0	1.3	4.0	0.6	0.0	0.3	0.0	1.7	0.2	1.7	1.2	2.7	1.5	0.1	0.6	2.9	2.0	0.0	1.8	0.1	1.0	2.0	0.3	10.9	20.3	28.1	14.5	3.1	8.9	13.7	9.1	17.0	10.7	15.6	23.7	7.4	6.4	8.6	87.8	4.8	1.9	1.1	0.5	2.2	8.9	4.1	3.9	7.2	0.0	3.0	1.8	4.2	0.7	6.2	2.0	1.9	4.6	489.6	5.0	6.1	3.5	3.0	2.1	84.3	3.4	1.1	3.7	4.1	5.4	12.6	7.0	0.0	0.0	1.7	0.0	103.3	2.8	0.0	0.0	1.2	914.3	9.6	3.1	1.8	93.7	2.4	3.5	4.1	96.0	161.0	2.8	0.5	7.2	3.8	0.5	2.4	1.1	1.1	23.1	13.1	6.0	3.6	176.0	9.4	1.3	1.1	0.1	8.6	4.6	2.1	0.6
CCDC71	FLJ12800	ENSG00000177352	"Coiled-coil domain containing 71"	Q8IV32	3	49162535-49166331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047547	Uncertain		Approved	"Nuclear membrane"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"		"HPA047547: AB_2680083"	"unprognostic (1.06e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.71e-3)"	"unprognostic (7.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (9.65e-9)"	"unprognostic (3.53e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.14e-2)"	13.0	15.4	5.0	9.6	5.4	7.3	14.5	5.4	6.2	13.6	4.9	9.9	8.3	14.9	9.6	13.8	16.4	9.1	12.2	5.0	5.9	10.6	12.6	11.1	13.5	5.3	5.4	18.2	9.5	13.6	9.6	10.1	5.4	12.0	7.6	3.4	12.5	10.5	14.8	13.0	10.7	10.0	5.3	13.3	10.5	12.2	5.4	13.0	16.1	9.5	9.5	12.9	11.9	5.3	12.6	16.9	19.4	18.8	21.8	15.8	18.6	15.2	21.8	26.1	22.9	17.6	19.8	11.2	13.0	26.2	20.9	13.0	19.3	40.7	9.3	24.9	14.0	22.7	22.0	17.9	25.7	18.3	16.5	26.9	31.4	31.0	23.7	19.4	25.8	26.7	23.1	4.6	21.1	26.9	31.8	11.2	30.2	18.8	18.1	11.5	10.8	10.5	24.8	24.0	9.8	21.3	15.5	16.3	18.5	15.6	21.7	30.2	17.1	18.3	19.4	18.3	20.0	17.5	8.2	15.6	13.3	17.2	20.7	0.0	1.0	0.4	0.9	1.7	1.4	0.5	0.8	1.2	0.9	1.3	1.2	0.8	0.9	4.8	1.3	0.3	1.0	0.6	5.0	5.4	5.4	6.2	5.0	5.9	5.3	5.4	5.4	5.3	5.4	5.3	5.1	6.4	1.5	1.6	7.9	2.7	12.5	23.8	6.8	1.5	7.5	8.5	1.4	5.7	11.2	7.3	0.0	23.3	4.1	8.3	25.4	21.3	9.3	2.4	3.5	8.0	8.4	11.8	2.1	11.8	16.5	7.7	7.1	1.8	2.5	6.5	16.1	9.3	20.1	0.0	2.0	8.4	24.4	5.6	2.1	10.2	11.8	5.3	5.4	6.5	8.8	3.6	12.3	1.0	1.0	15.2	9.3	13.5	9.3	10.8	10.4	14.1	7.1	1.2	13.1	4.1	7.0	10.6	18.4	9.2	2.7	22.4	5.8	6.6	8.2	11.5
CCDC74A	FLJ40345	ENSG00000163040	"Coiled-coil domain containing 74A"	Q96AQ1	2	131527675-131533666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 73.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 424.4;Late spermatids: 274.9;Respiratory ciliated cells: 166.1;Spermatocytes: 154.2;Theca cells: 211.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 28.6;SCLC-21H: 23.2"									HPA060727			Uncertain	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA060727: "	"prognostic favorable (5.11e-4)"	"unprognostic (2.89e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.70e-7)"	"unprognostic (7.28e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.53e-2)"	3.3	32.7	10.6	1.2	9.6	0.1	9.6	7.3	11.3	17.6	29.3	6.9	1.1	12.8	8.9	3.0	34.5	7.0	3.5	11.1	12.2	8.9	1.2	6.2	1.3	12.1	12.8	14.8	2.6	20.4	34.7	1.1	10.5	15.8	1.7	2.0	3.1	6.3	0.5	4.9	2.5	3.0	10.5	1.2	3.2	73.5	15.1	5.3	7.3	0.8	0.8	14.5	8.0	8.0	0.0	5.9	6.0	0.3	8.4	20.2	0.5	5.1	8.4	4.6	3.4	0.2	8.9	2.3	3.1	7.9	7.7	4.6	2.6	1.5	1.9	6.1	11.1	0.0	6.2	0.2	1.0	0.2	0.5	6.6	0.6	4.5	0.0	9.0	1.8	12.7	3.4	6.5	4.2	3.8	13.3	3.6	28.6	2.3	3.8	6.4	0.0	2.7	11.8	0.1	23.2	16.9	0.6	0.8	0.9	2.3	8.2	1.3	1.9	1.4	4.3	18.0	3.9	1.3	1.2	0.8	19.0	0.6	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	9.6	7.3	11.3	11.1	12.2	12.1	12.8	10.5	10.5	15.1	8.0	0.8	0.0	0.5	1.6	0.3	5.1	12.2	21.6	14.2	1.0	34.8	28.4	0.5	4.3	15.8	7.3	0.0	0.5	1.1	0.8	7.9	9.4	424.4	88.2	7.6	1.4	7.7	0.0	3.7	0.7	0.4	11.1	1.1	4.7	0.0	30.4	1.4	0.1	0.3	0.0	2.4	0.6	16.2	0.0	5.9	274.9	37.0	0.8	1.8	1.0	0.0	14.2	0.0	1.0	0.5	2.7	0.5	68.4	0.9	7.4	0.1	2.6	166.1	1.1	0.0	2.5	14.2	154.2	18.8	7.2	6.0	0.3	1.2	211.1	2.4	7.2
CCDC74B	DKFZp434E2321	ENSG00000152076	"Coiled-coil domain containing 74B"	Q96LY2	2	130139287-130145134	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 55.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 322.3;Late spermatids: 129.6;Respiratory ciliated cells: 70.3;Spermatocytes: 142.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.2;SH-SY5Y: 14.8"									HPA060727			Uncertain	Vesicles		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA060727: "	"prognostic favorable (4.46e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.43e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-4)"	"unprognostic (8.31e-3)"	"unprognostic (9.94e-3)"	1.5	1.9	3.5	0.3	3.6	0.0	2.4	2.6	4.3	17.0	7.6	1.6	0.2	8.9	0.8	0.4	14.1	1.4	1.5	4.1	5.4	3.8	0.1	2.8	0.3	6.2	7.2	5.0	0.8	11.1	19.7	0.2	5.1	7.1	0.1	0.6	0.6	2.8	0.2	1.0	0.7	1.2	5.7	0.4	1.5	55.4	6.1	0.6	7.0	0.0	0.2	2.4	3.6	3.9	0.0	1.9	2.8	0.1	2.5	5.4	0.6	2.2	1.1	0.3	0.5	0.9	0.7	0.1	3.5	2.0	3.2	1.0	0.2	0.3	0.4	2.0	5.5	0.0	7.0	0.1	0.3	0.1	0.2	1.1	0.0	0.9	0.0	3.4	0.1	1.3	0.1	1.7	0.8	2.1	0.0	0.0	5.7	0.5	5.9	4.6	0.0	3.2	1.7	0.0	10.2	14.8	1.6	0.1	0.2	0.6	5.9	0.7	0.4	1.1	4.8	5.9	0.5	0.1	0.3	0.0	6.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	2.6	4.3	4.1	5.4	6.2	7.2	5.1	5.7	6.1	3.9	0.2	3.2	0.5	1.6	0.1	0.5	3.0	6.3	1.2	0.5	6.1	9.5	0.4	1.5	4.3	5.5	0.0	0.2	0.2	0.1	3.9	1.5	322.3	42.8	9.9	0.2	11.4	0.0	1.6	0.2	0.8	3.6	0.0	2.2	0.0	7.8	0.0	0.0	0.3	3.3	1.1	0.1	2.0	0.0	0.2	129.6	10.2	0.6	0.0	1.0	0.0	6.2	0.0	0.5	0.3	0.0	0.1	12.4	0.1	3.9	0.0	1.2	70.3	0.1	0.0	0.9	3.2	142.7	16.4	0.7	1.1	0.1	0.3	28.8	0.1	0.7
CCDC82	FLJ23518	ENSG00000149231	"Coiled-coil domain containing 82"	Q8N4S0	11	96349241-96389956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 493.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038704, HPA070631"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA038704: AB_10674835, HPA070631: "	"unprognostic (3.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.94e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	22.2	15.1	16.5	19.6	19.7	17.1	17.6	32.0	26.6	15.9	8.7	18.1	13.0	18.4	13.9	10.4	15.9	16.8	13.7	17.4	24.6	16.6	22.1	17.9	23.4	18.2	16.5	18.3	13.8	11.8	18.2	17.4	19.5	13.0	13.3	43.2	12.8	15.8	14.3	14.3	16.9	13.8	12.4	20.3	16.7	23.7	17.9	22.3	17.9	14.9	20.1	16.7	14.5	31.1	12.9	17.9	52.4	21.0	35.9	30.0	20.8	47.0	28.0	29.9	42.4	31.1	41.3	26.1	42.8	23.1	50.5	29.1	17.5	14.7	42.5	44.5	11.7	49.1	42.7	26.0	25.6	41.5	33.2	18.3	9.2	58.9	22.8	28.0	35.9	25.3	31.4	28.1	40.5	1.1	34.9	40.2	12.0	21.6	12.7	23.7	44.2	21.0	22.6	32.9	9.6	22.7	26.6	2.7	23.0	35.5	5.0	19.5	42.6	50.1	28.1	43.7	25.3	9.5	29.9	36.0	16.2	30.7	38.6	59.4	12.5	25.1	23.7	15.2	24.5	22.5	24.7	23.6	14.0	19.3	26.9	25.5	17.9	35.7	16.2	18.7	28.5	17.9	16.5	19.7	32.0	26.6	17.4	24.6	18.2	16.5	19.5	12.4	17.9	31.1	57.9	19.2	31.4	30.7	32.9	30.5	27.0	31.5	19.4	58.9	14.0	18.5	37.2	18.6	28.9	31.3	100.1	16.6	55.1	10.7	27.4	34.6	493.8	57.6	37.0	53.6	19.8	16.4	67.0	17.5	20.5	44.9	13.7	26.4	40.4	36.4	38.6	32.1	25.2	32.0	67.0	9.0	24.4	27.4	38.4	76.8	43.8	32.5	26.6	23.4	37.2	41.6	42.2	54.3	119.7	32.3	12.2	42.9	27.2	14.5	8.8	40.1	71.8	50.6	32.9	45.4	48.4	85.4	57.0	13.0	20.5	8.2	40.7	24.9	10.3	18.7
CCDC85C		ENSG00000205476	"Coiled-coil domain containing 85C"	A6NKD9	14	99500190-99604207	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058346, HPA061922"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Cell Junctions"	"Nucleoplasm, Nuclear bodies, Mitotic chromosome"	"HPA058346: AB_2683686, HPA061922: "	"unprognostic (7.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (5.70e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.68e-3)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.14e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.81e-3)"	5.2	22.0	26.4	4.3	32.9	9.7	7.1	72.9	27.1	5.8	20.6	31.3	18.7	15.4	14.3	28.3	11.3	5.4	19.6	24.8	20.9	14.4	18.2	8.1	2.5	30.8	24.1	5.1	18.5	16.4	17.0	8.6	27.0	15.0	11.1	34.7	26.4	16.2	20.7	19.4	17.7	13.1	24.5	3.6	19.2	8.5	28.6	5.0	9.3	5.6	7.5	16.1	8.9	21.0	48.4	43.4	52.7	31.7	0.7	0.2	48.9	16.0	16.2	31.4	18.1	52.9	49.8	0.3	61.7	18.2	8.6	63.3	39.2	38.4	19.5	79.2	23.3	2.5	43.6	36.1	4.2	0.5	4.9	0.1	19.9	9.0	25.9	18.6	9.9	27.9	11.8	7.2	3.9	80.3	21.8	6.6	19.3	55.4	44.7	32.1	22.1	10.8	22.3	18.8	26.0	32.6	40.7	21.5	9.5	19.9	46.9	9.8	22.6	6.2	51.5	22.4	16.2	11.2	15.8	0.4	1.0	4.3	4.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.4	0.1	26.4	32.9	72.9	27.1	24.8	20.9	30.8	24.1	27.0	24.5	28.6	21.0	8.5	22.4	5.6	15.7	6.7	8.8	8.7	4.0	13.6	35.2	12.1	9.3	3.0	5.7	7.3	1.8	62.6	6.3	3.9	21.2	0.0	7.6	3.1	18.8	8.1	9.2	9.6	3.4	2.8	9.4	4.5	6.2	17.3	35.6	6.3	14.1	5.3	16.7	1.8	1.7	5.4	9.6	6.1	1.6	1.2	2.1	0.6	5.0	8.8	4.7	0.4	30.6	1.0	1.5	11.7	17.4	13.2	0.7	10.4	11.0	23.3	6.5	3.0	51.7	0.0	5.7	4.1	1.4	3.5	20.4	14.1	4.9	8.3	2.3	13.0	12.0
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842113-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 377.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	25.6	26.7	12.0	14.3	13.3	10.2	20.8	13.1	14.2	12.9	11.2	14.1	11.4	16.7	3.5	19.4	15.2	6.9	16.0	12.7	13.5	19.2	13.7	11.8	11.6	13.2	13.5	13.8	23.9	377.6	24.9	11.6	13.7	23.9	5.8	8.2	12.2	8.6	34.7	22.7	12.3	10.4	12.3	12.7	16.4	48.9	12.7	8.8	12.9	13.7	8.5	20.2	14.5	14.1	83.4	110.2	26.5	76.1	21.8	35.7	36.3	54.3	42.4	98.1	52.4	95.0	53.7	98.9	100.7	31.0	69.7	73.3	94.2	65.7	48.2	35.7	101.3	51.0	45.8	133.2	70.7	80.7	82.6	39.5	48.7	90.2	61.8	14.3	75.8	53.5	166.0	46.9	50.3	97.3	125.2	122.6	107.0	48.6	156.3	81.4	39.6	253.5	37.2	33.8	59.9	38.9	34.7	79.5	64.6	17.6	80.8	30.3	45.9	93.6	59.6	131.6	118.2	41.0	66.5	109.2	78.2	86.0	118.6	1.7	13.5	4.2	9.1	29.4	9.7	9.4	9.6	8.3	29.8	9.0	11.5	10.2	1.0	6.9	9.3	16.6	9.7	10.1	12.0	13.3	13.1	14.2	12.7	13.5	13.2	13.5	13.7	12.3	12.7	14.1	9.3	0.0	2.2	2.0	8.9	37.0	22.2	5.7	28.5	12.1	9.9	10.3	0.6	4.3	4.0	1.8	8.4	17.2	5.7	5.3	7.9	18.6	25.6	6.8	9.4	12.7	7.2	8.8	2.0	12.2	20.4	10.2	9.7	7.7	5.1	7.9	3.6	3.1	18.4	3.3	1.7	5.7	6.1	2.5	16.5	15.0	11.5	7.3	16.0	1.0	5.3	3.9	4.1	1.0	1.3	19.2	3.6	6.0	8.6	24.0	4.4	7.3	1.3	8.3	19.7	10.7	19.1	74.6	18.8	21.2	31.0	8.2	7.0	12.5	11.3	18.8
CCHCR1	"C6orf18, HCR"	ENSG00000204536	"Coiled-coil alpha-helical rod protein 1"	Q8TD31	6	31142439-31158238	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 138.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.7;Endometrial ciliated cells: 68.0;Glandular and luminal cells: 161.9;Late spermatids: 160.7;Spermatocytes: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 38.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054167			Supported	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA054167: AB_2682403"	"unprognostic (6.68e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-2)"	10.4	7.6	1.4	2.8	1.4	1.3	11.8	1.6	2.3	18.1	1.5	16.2	10.1	12.4	5.7	15.1	18.7	1.7	11.7	1.5	1.6	19.7	12.2	9.0	6.9	1.6	1.4	19.0	14.5	1.3	9.3	0.9	1.9	19.9	3.3	1.2	11.4	4.0	19.3	17.4	14.7	1.6	1.0	13.3	13.9	138.9	2.2	2.1	16.1	1.1	1.7	13.4	15.4	1.5	38.9	3.0	9.8	1.6	6.1	7.4	8.8	3.3	1.1	0.5	1.2	14.9	0.7	5.1	17.6	8.5	23.1	1.6	0.6	15.4	1.5	5.8	23.9	18.1	13.2	11.7	3.7	0.4	11.5	9.7	1.8	6.9	1.5	7.2	8.1	27.2	7.3	10.3	4.1	2.8	6.7	19.9	0.6	1.4	0.2	12.0	13.8	9.6	9.6	3.8	29.2	4.9	11.7	0.0	2.8	6.0	4.2	9.3	1.0	14.5	4.8	0.3	9.4	23.7	14.7	20.7	3.1	4.4	1.5	0.2	0.6	0.5	0.9	0.3	0.8	0.3	0.8	1.4	0.5	0.6	1.3	1.3	0.0	1.0	0.4	1.2	1.5	0.6	1.4	1.4	1.6	2.3	1.5	1.6	1.6	1.4	1.9	1.0	2.2	1.5	8.0	3.2	5.1	10.4	7.7	9.7	13.0	12.8	8.6	9.6	8.2	10.9	8.7	11.5	11.0	3.7	0.0	3.1	5.4	41.9	11.7	8.9	89.7	68.0	19.0	6.7	29.3	6.3	5.2	10.5	7.5	7.7	28.5	161.9	0.0	15.0	5.7	7.5	6.8	15.2	4.3	27.6	0.0	5.0	3.7	160.7	9.9	5.4	7.2	1.9	8.4	5.1	9.2	0.5	1.8	8.4	17.3	11.7	6.7	9.0	36.2	7.6	15.9	2.3	6.6	9.2	8.6	68.6	21.1	7.3	5.8	1.4	6.0	14.7	35.9	8.3
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36001553	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 83.0;liver: 31.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 35.4;OE19: 28.7"									HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	3270000	11000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Vesicles	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (3.02e-4)"	0.2	0.4	0.1	7.8	0.1	0.1	0.4	0.1	0.3	0.3	0.0	59.7	37.6	0.1	0.0	0.2	9.6	9.2	0.0	0.1	0.1	10.0	31.6	2.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	83.0	0.0	0.1	0.1	0.0	0.1	62.0	1.4	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	4.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.1	7.2	5.0	0.0	0.0	0.0	0.0	262.6	0.0	0.0	0.0	12.2	0.1	0.7	71.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	8.9	0.0	2.5	40.2	0.1	0.0	0.0	208.3	2.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	380.6	0.0	0.0	0.0	461.4	61.3	76.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	138.2	0.2
CCN2	"CTGF, IGFBP8"	ENSG00000118523	"Cellular communication network factor 2"	P29279	6	131948176-131951372	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 101.2;Cardiomyocytes: 38.7;Extravillous trophoblasts: 47.1;Fibroblasts: 261.8;Smooth muscle cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive B-cell: 8.1"	"Lineage enriched"	"Detected in single"	81	"B-cells: 8.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 1605.0;HUVEC TERT2: 1377.0;TIME: 2874.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	No	No	1010000	5900000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	265.9	107.5	18.9	168.0	18.8	2.0	206.4	16.3	34.0	531.0	31.5	148.8	43.7	418.5	34.4	271.9	243.8	441.4	371.8	25.8	14.2	235.7	82.9	226.3	73.6	18.8	32.1	77.0	194.0	43.0	44.8	198.2	20.2	364.6	136.1	2.4	138.2	154.3	51.8	155.1	151.2	576.3	14.2	569.1	182.6	24.7	20.8	49.5	464.7	61.9	14.9	324.0	102.5	18.2	4.6	7.5	126.8	3.7	279.9	158.5	1.8	373.1	178.2	226.8	119.4	0.2	12.2	0.6	1605.0	482.7	185.0	6.2	4.2	26.4	211.3	2.5	3.5	0.2	55.7	137.3	109.6	0.3	0.5	232.2	5.9	163.9	40.2	340.7	1377.0	0.0	0.4	0.3	650.8	2.5	0.5	1.2	61.8	41.3	21.7	32.6	6.0	0.7	81.9	0.4	0.5	0.8	38.3	62.2	18.3	308.5	6.1	3.1	2874.4	311.6	242.4	397.8	694.0	11.5	1.7	4.1	42.5	0.7	399.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.9	18.8	16.3	34.0	25.8	14.2	18.8	32.1	20.2	14.2	20.8	18.2	101.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.0	17.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	47.1	261.8	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.4	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823883	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.6;lymphoid tissue: 46.9;retina: 31.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Erythroid cells: 102.1;Extravillous trophoblasts: 92.8;Plasma cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.4;white matter: 7.6"					"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	1.5	1.2	2.5	11.4	2.5	38.6	2.5	3.5	4.7	4.3	2.5	9.8	10.1	2.5	0.6	8.4	2.2	1.8	1.3	2.3	2.4	1.5	1.6	1.8	25.0	2.8	2.7	3.8	0.8	0.6	2.7	10.5	2.6	1.9	11.5	31.7	1.8	0.8	0.7	6.7	9.9	4.0	2.6	4.6	4.4	6.2	2.6	46.9	1.2	0.5	24.4	2.9	3.9	3.5	177.1	45.3	120.5	51.8	6.4	16.3	98.8	119.7	52.8	156.7	115.6	99.4	106.5	161.2	31.7	63.8	55.0	58.0	154.2	71.1	128.0	77.8	70.8	129.7	56.0	96.9	1.5	197.0	88.0	4.2	5.3	65.1	38.7	24.7	95.4	84.3	187.9	156.9	126.1	63.8	251.8	113.1	95.5	109.9	49.8	114.1	233.5	78.2	44.8	34.6	51.0	53.8	63.1	76.0	32.4	89.8	63.7	81.9	56.5	72.7	109.3	77.4	115.9	98.0	112.3	181.9	41.5	197.6	82.4	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.2	0.1	0.8	0.1	0.0	3.1	0.9	2.5	2.5	3.5	4.7	2.3	2.4	2.8	2.7	2.6	2.6	2.6	3.5	0.8	0.0	1.1	1.6	5.7	2.8	1.5	5.5	1.8	2.9	1.9	1.8	0.8	0.0	1.6	0.0	12.5	47.9	1.9	4.9	0.0	0.7	9.6	0.6	2.7	3.3	1.2	102.1	3.3	0.2	92.8	6.3	9.2	2.1	0.0	18.1	4.2	0.9	25.3	0.0	4.1	7.7	8.2	6.9	3.6	2.1	0.9	3.6	1.8	2.8	0.2	1.2	0.0	4.5	5.2	0.5	3.1	1.2	35.5	3.3	1.8	0.2	2.5	14.2	0.0	0.9	6.0	10.3	17.7	24.0	1.3	8.5	6.3	1.4	19.9	2.1
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167135-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.9;lymphoid tissue: 76.2"	"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.0;white matter: 8.3"	"Not detected"	"Not detected"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	4.0	5.1	4.0	26.0	3.9	52.9	10.0	6.0	4.9	6.3	2.8	22.2	20.9	7.7	5.4	36.0	8.2	4.0	3.0	3.8	4.0	4.8	4.3	3.9	54.5	6.2	4.4	5.0	4.2	5.8	2.6	20.8	6.5	3.8	29.5	5.7	6.5	3.9	3.4	14.5	19.5	14.4	3.5	11.1	10.8	32.9	5.2	76.2	9.3	2.0	67.0	8.4	10.4	4.0	466.0	317.1	423.5	377.1	22.2	37.1	980.2	201.3	150.8	521.3	437.0	471.2	423.9	285.2	239.1	187.6	594.2	284.2	432.4	442.8	577.2	281.4	217.2	181.6	243.2	323.2	6.8	160.5	197.7	16.6	27.7	300.5	207.2	47.7	282.8	274.2	223.5	217.9	430.2	441.4	220.5	184.7	236.7	153.3	199.3	228.4	305.2	288.2	192.6	168.2	212.7	133.5	347.7	160.3	141.9	236.4	306.4	162.5	119.8	114.4	368.5	207.6	510.2	109.2	216.6	399.8	158.8	271.9	358.6	3.1	2.0	1.5	3.2	5.1	4.5	15.4	8.3	7.4	6.0	11.1	2.7	2.6	1.3	8.2	2.4	5.0	17.6	6.2	4.0	3.9	6.0	4.9	3.8	4.0	6.2	4.4	6.5	3.5	5.2	4.0	4.0	0.0	0.5	2.0	11.8	11.5	7.2	32.1	4.6	4.8	9.8	12.3	1.9	1.5	8.8	5.5	2.1	108.2	8.3	9.5	1.9	6.5	110.2	15.2	7.4	6.6	1.2	76.2	2.7	1.4	723.1	18.3	21.4	13.0	2.5	63.0	8.9	3.2	60.2	0.0	2.1	13.8	73.2	12.0	7.2	17.8	3.1	9.7	3.6	1.0	2.7	3.9	2.1	0.5	1.0	2.4	1.5	2.6	24.1	4.5	2.5	5.6	13.1	4.1	6.6	4.9	18.5	74.3	62.2	37.4	7.2	41.5	8.0	11.8	33.4	7.8
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CCND1	"BCL1, D11S287E, PRAD1, U21B31"	ENSG00000110092	"Cyclin D1"	P24385	11	69641156-69654474	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation"	"Cyclin, Repressor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 499.7;Ductal cells: 504.0;Pancreatic endocrine cells: 622.1;Urothelial cells: 412.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 874.2;WM-115: 1239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000024, HPA027802"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB000024: AB_563678, HPA027802: AB_2672390"	"unprognostic (4.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.57e-1)"	55.6	29.2	12.1	10.0	14.6	1.5	40.2	15.0	11.9	17.0	33.4	19.8	22.7	14.8	27.6	72.9	30.8	19.5	64.9	10.8	14.6	32.2	107.3	61.1	10.5	17.5	15.5	4.6	86.3	82.7	25.7	63.7	18.3	53.3	17.2	3.2	30.4	50.4	3.6	120.3	16.0	23.3	15.9	37.2	52.7	3.2	21.7	9.9	45.5	5.2	19.0	29.5	43.9	24.0	467.3	183.0	59.5	1.8	178.3	186.7	127.4	717.5	264.9	82.1	47.6	206.9	349.9	0.1	317.6	375.5	137.2	332.1	6.5	195.2	146.0	1.2	36.5	0.3	46.7	211.7	43.3	3.3	6.7	106.5	37.9	116.0	44.0	192.5	142.1	0.2	0.6	1.3	654.2	197.1	0.4	26.6	109.0	190.7	198.3	1.2	187.9	11.3	379.4	282.8	10.0	231.4	9.2	167.7	458.4	143.5	102.6	9.5	600.4	399.5	111.0	176.1	496.2	874.2	559.4	1.5	341.6	5.9	1239.0	0.2	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	1.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.1	14.6	15.0	11.9	10.8	14.6	17.5	15.5	18.3	15.9	21.7	24.0	84.6	182.7	115.6	0.3	8.3	202.5	234.7	499.7	133.1	2.3	163.4	140.0	80.0	92.9	271.6	125.0	2.1	10.9	2.4	44.8	31.3	504.0	0.4	104.2	23.5	141.0	56.5	2.5	0.5	142.6	1.2	67.6	127.4	199.5	29.1	0.0	98.2	165.2	75.0	0.0	2.2	42.6	75.3	18.8	61.9	2.0	4.1	23.6	51.6	17.8	2.4	79.1	0.0	49.8	0.3	622.1	118.0	57.6	0.5	262.0	19.4	57.1	85.9	3.1	131.5	13.0	184.8	0.5	23.4	292.3	351.1	2.5	8.8	3.4	82.2	412.6
CCND2		ENSG00000118971	"Cyclin D2"	P30279	12	4269771-4305353	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 354.3;Granulosa cells: 438.5;Langerhans cells: 255.3;Plasma cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 152.4;HBEC3-KT: 136.6;HDLM-2: 238.8;Karpas-707: 287.9;RH-30: 202.7;RPMI-8226: 114.2"									"HPA049138, HPA054196"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA049138: AB_2680650, HPA054196: AB_2682412"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.52e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (7.06e-2)"	20.0	52.6	5.4	8.7	12.9	20.3	13.0	0.0	13.5	26.9	0.0	40.8	17.4	26.1	7.5	12.2	22.1	2.7	51.9	14.4	1.1	9.7	1.9	17.2	5.3	9.6	0.2	14.2	24.5	9.9	23.5	12.9	2.7	20.7	10.4	0.7	10.8	9.1	1.8	12.6	25.9	9.8	7.8	19.7	12.7	4.0	0.0	3.2	20.3	0.0	5.1	26.5	19.9	4.5	0.0	0.0	152.4	0.0	10.1	0.4	0.0	0.0	0.0	0.0	0.0	62.8	0.0	0.0	0.4	0.0	0.0	16.2	0.1	136.6	0.0	238.8	2.5	0.7	0.0	0.0	0.0	57.0	12.6	23.8	2.4	0.0	97.0	0.0	0.0	0.8	17.0	287.9	6.8	0.0	0.0	52.8	50.8	0.0	0.0	0.0	202.7	114.2	0.0	8.1	0.0	0.0	0.0	0.0	0.0	89.6	0.0	0.0	4.2	0.0	39.3	0.0	0.0	1.4	60.7	0.0	0.0	32.3	0.0	6.6	0.4	4.7	11.1	0.0	17.1	3.1	16.3	13.8	0.4	1.7	10.4	12.1	1.1	9.4	0.0	1.1	13.6	6.8	5.4	12.9	0.0	13.5	14.4	1.1	9.6	0.2	2.7	7.8	0.0	4.5	23.9	60.9	46.6	10.1	82.9	106.8	23.9	73.4	174.2	7.6	3.4	41.8	354.3	2.8	37.4	12.9	0.0	4.0	128.7	37.5	0.0	3.1	0.8	3.3	110.8	35.7	64.8	37.2	54.1	68.3	2.7	123.6	4.6	3.6	55.8	438.5	19.6	2.2	13.0	3.3	55.2	147.7	12.2	11.9	255.3	3.3	52.5	39.3	39.2	19.7	9.8	170.0	89.6	55.3	4.0	20.7	49.4	124.1	371.2	35.8	34.4	1.4	10.3	6.5	26.3	21.4	112.6	0.8	5.1	50.9	39.6	6.3	122.6	41.5	159.7	8.4
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811991-29824312	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8;placenta: 30.8"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 1756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"BEWO: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.2	5.7	1.9	4.3	2.1	35.8	0.8	2.8	2.7	1.0	0.9	3.9	3.0	1.4	0.6	4.4	0.9	1.0	2.3	2.0	2.5	1.0	0.7	1.1	6.1	2.0	2.1	0.8	1.8	2.8	0.9	30.8	2.0	1.0	4.7	2.0	1.5	1.4	2.1	4.1	2.5	2.2	1.7	4.2	2.1	12.1	2.5	4.5	1.6	1.8	7.8	3.0	1.8	2.3	15.6	31.8	24.3	34.0	5.2	6.0	293.1	24.7	5.3	10.8	13.2	33.0	31.2	13.3	55.9	11.1	14.0	4.9	28.8	12.8	15.2	41.9	17.7	11.2	30.0	34.5	4.1	44.0	28.7	6.2	7.1	14.8	1.9	3.4	13.3	13.2	45.6	5.8	16.8	24.4	24.5	13.0	40.1	36.2	7.2	36.2	28.6	10.1	8.4	24.6	20.5	17.4	35.4	42.7	3.9	35.4	9.5	32.7	8.0	25.0	92.8	14.9	16.9	24.1	18.2	91.6	13.8	5.6	13.7	0.0	0.0	0.0	0.1	0.5	0.3	0.6	0.1	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.3	0.1	1.9	2.1	2.8	2.7	2.0	2.5	2.0	2.1	2.0	1.7	2.5	2.3	3.1	0.0	0.6	0.7	4.8	4.8	1.5	0.3	2.2	2.9	8.2	11.3	3.1	0.0	1.4	0.0	0.0	122.4	3.7	3.5	0.0	0.4	14.6	7.5	4.1	1.9	3.0	30.7	2.9	0.7	1756.5	6.0	5.6	20.1	0.0	4.6	1.4	0.2	43.4	3.3	5.1	3.3	0.0	1.0	2.5	3.6	1.2	4.2	1.8	0.0	0.2	1.7	0.0	2.5	1.3	1.4	2.2	2.2	18.4	2.2	1.0	0.4	0.1	1.1	6.6	4.1	3.4	25.0	17.6	8.5	6.0	115.7	4.5	6.9	4.9	3.5
CCNG1	CCNG	ENSG00000113328	"Cyclin G1"	P51959	5	163437569-163446151	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 265.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB000350	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB000350: "	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.89e-2)"	51.2	48.8	21.0	30.4	23.0	38.3	67.2	22.9	25.8	63.4	27.8	68.0	137.2	50.5	73.4	47.8	61.8	56.7	50.4	19.1	23.4	123.5	129.6	33.4	49.0	24.7	21.6	112.0	74.4	39.7	14.6	54.0	25.0	71.4	87.0	21.3	56.3	55.7	163.6	23.5	109.1	52.3	23.5	35.5	57.3	20.7	21.7	50.3	62.4	120.6	47.0	59.7	33.8	28.6	54.9	59.8	246.6	138.8	207.9	397.3	258.2	74.1	181.2	73.8	165.2	130.4	109.4	134.1	73.7	100.1	121.7	22.2	137.2	185.0	107.9	63.7	171.9	106.6	71.7	230.0	226.4	49.9	68.9	433.8	105.6	73.3	75.1	221.5	241.1	88.3	92.3	92.8	253.4	33.8	89.6	66.5	113.3	40.1	52.7	74.6	120.7	75.2	179.5	209.4	57.6	65.6	0.4	30.5	154.0	155.2	115.5	155.8	140.5	47.6	101.0	40.8	66.2	81.5	34.2	87.7	84.3	81.4	80.6	44.5	25.6	31.0	35.8	36.1	53.9	55.4	63.2	49.3	59.6	33.9	84.5	72.0	10.9	40.7	36.7	22.6	80.9	63.9	21.0	23.0	22.9	25.8	19.1	23.4	24.7	21.6	25.0	23.5	21.7	28.6	20.8	25.6	20.0	7.5	67.3	57.2	94.7	64.7	103.0	12.4	64.4	33.0	52.9	77.2	39.7	36.8	0.0	138.7	49.8	48.2	162.4	73.0	8.1	30.6	27.5	43.5	71.0	96.3	8.4	119.0	107.7	57.1	110.6	46.1	43.7	108.8	61.1	51.7	60.0	15.2	8.8	113.2	44.7	74.8	70.5	6.1	75.8	60.8	37.4	15.0	52.0	29.9	54.6	4.5	12.7	91.1	80.2	72.2	63.5	107.2	223.4	265.9	11.2	10.8	39.5	42.4	73.4	8.8	12.1	61.5	44.2	97.3	76.4	81.5	182.7	104.3
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747426-132754403	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;intestine: 3.6"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 3.5;Muller glia cells: 4.9;Plasma cells: 4.8;Undifferentiated cells: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"MOLT-4: 25.7"					"Low region specificity"	"Detected in all"			HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA056288: AB_2683086"	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.2	0.3	1.2	0.9	1.9	0.1	0.2	1.3	1.5	0.5	0.0	2.6	3.6	0.1	0.3	0.1	0.3	0.4	0.3	0.9	0.8	3.1	0.0	0.5	0.8	2.2	1.3	0.2	1.2	0.0	0.6	0.1	1.6	0.9	2.7	1.1	2.6	1.3	0.3	0.3	2.1	0.1	0.9	0.4	2.4	0.7	1.5	1.5	0.4	0.0	0.9	0.9	0.2	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.4	0.0	0.6	25.7	0.1	0.4	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.3	1.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	4.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.8	0.1	1.2	1.9	1.3	1.5	0.9	0.8	2.2	1.3	1.6	0.9	1.5	4.3	0.2	0.0	0.5	0.0	0.9	0.1	0.4	0.8	0.0	0.1	0.4	0.1	0.6	0.0	0.4	0.0	0.0	0.4	0.1	3.4	3.9	0.4	2.2	0.4	0.0	0.1	1.2	0.0	0.6	1.5	0.2	0.3	7.1	0.5	1.3	0.0	0.0	0.0	0.1	1.7	0.5	3.5	0.0	0.0	0.0	2.1	0.3	0.4	0.0	0.0	0.0	4.9	0.0	1.0	2.4	1.5	2.3	0.0	4.8	0.6	1.8	0.3	1.0	0.2	0.0	0.1	0.2	0.2	0.7	0.0	0.1	0.0	1.9	0.1	4.2	0.6
CCNQ	"CycM, FAM58A"	ENSG00000262919	"Cyclin Q"	Q8N1B3	X	153587925-153600045	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 72.4;Extravillous trophoblasts: 98.6;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050137, HPA059843"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA050137: AB_2681029, HPA059843: AB_2684140"	"unprognostic (3.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.25e-2)"	11.8	12.8	19.9	8.2	21.3	7.3	11.7	19.6	24.9	11.9	15.6	16.2	8.9	12.9	12.7	13.1	11.1	4.0	33.9	20.8	20.5	13.5	13.2	10.6	12.5	23.2	21.6	10.5	15.0	10.3	23.6	9.2	23.4	13.6	8.0	6.4	12.9	8.8	34.3	12.1	13.6	6.1	20.0	17.2	13.3	6.2	21.2	9.0	11.1	13.6	12.2	14.0	11.7	24.9	43.7	31.2	12.1	43.5	20.9	11.2	18.7	25.0	21.8	23.5	23.6	33.3	14.3	34.9	44.6	25.1	35.3	26.7	38.4	22.6	22.2	20.3	39.2	7.8	19.4	23.5	19.0	28.2	18.9	14.1	20.1	15.7	16.1	10.0	19.0	16.1	10.6	15.6	19.1	50.5	19.7	38.0	15.1	44.4	52.4	22.6	20.0	17.8	17.0	17.6	16.0	21.1	12.0	19.3	34.4	11.9	7.3	25.0	14.6	20.5	29.3	46.7	38.5	21.8	23.1	43.4	18.5	45.4	15.7	0.0	1.6	4.9	2.7	1.4	1.0	6.1	2.3	1.9	1.3	4.1	2.5	1.7	0.9	0.7	0.8	1.2	3.4	1.1	19.9	21.3	19.6	24.9	20.8	20.5	23.2	21.6	23.4	20.0	21.2	24.9	21.0	3.2	13.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	24.1	31.0	0.0	0.0	3.1	7.3	0.0	40.7	20.4	0.0	72.4	23.3	0.0	11.9	17.3	7.8	0.0	0.0	0.0	37.1	98.6	8.4	0.0	8.7	2.5	16.3	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	22.7	0.0	0.0	0.0	0.0	34.0	0.0	0.0	5.9	0.0	0.0	41.6	2.2	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	120.9	10.0	18.4	0.0	0.0
CCNYL1	FLJ40432	ENSG00000163249	"Cyclin Y like 1"	Q8N7R7	2	207711540-207761839	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 62.7;Paneth cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046825	Approved		Approved	"Plasma membrane"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA046825: AB_10963934"	"unprognostic (2.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.12e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.96e-3)"	12.8	4.7	3.8	10.6	4.9	9.9	7.1	2.8	5.3	8.2	3.7	15.3	11.7	5.0	5.2	17.8	4.2	7.9	6.1	5.2	5.1	10.9	12.4	11.8	8.6	4.8	4.2	3.4	13.7	4.2	4.5	13.6	5.1	4.8	13.3	9.0	6.9	4.8	7.8	3.9	11.3	8.7	4.2	8.1	11.0	16.2	4.5	6.1	11.4	4.4	9.3	10.4	9.5	6.8	25.7	11.0	14.5	20.4	18.6	21.2	83.3	15.6	25.8	15.7	17.7	51.1	23.7	9.9	14.2	28.6	38.5	17.4	17.7	29.4	15.2	3.7	13.5	13.3	12.8	41.6	18.7	11.9	15.2	10.7	12.0	20.0	20.9	13.8	52.5	11.5	6.8	9.4	21.9	13.6	10.5	11.2	28.1	10.3	12.2	9.4	12.4	8.0	16.2	19.5	3.5	10.8	18.5	8.0	23.5	33.6	7.2	31.5	27.3	17.7	16.6	23.2	10.5	5.6	8.4	13.4	18.5	13.5	15.4	0.7	1.1	0.5	0.3	0.6	0.4	0.3	0.5	0.5	0.5	1.1	0.4	0.8	1.3	0.6	0.5	0.5	0.4	0.3	3.8	4.9	2.8	5.3	5.2	5.1	4.8	4.2	5.1	4.2	4.5	6.8	31.8	3.2	19.1	10.1	14.1	12.2	13.8	7.6	5.7	6.2	10.0	10.0	9.0	2.8	8.5	23.9	10.4	12.6	13.2	62.7	1.9	5.8	13.7	13.6	7.7	17.0	9.6	6.5	34.1	14.7	42.9	11.4	25.0	20.4	5.7	5.8	23.9	12.5	16.2	5.0	11.6	13.1	8.2	17.5	29.9	10.9	2.8	18.7	8.8	7.5	20.8	10.2	7.2	14.6	28.7	13.9	121.3	3.8	7.7	16.1	10.1	12.6	6.3	12.3	0.0	16.0	10.4	23.9	9.5	7.6	10.5	7.7	10.9	4.3	17.0	18.0
CCPG1	"CPR8, KIAA1254"	ENSG00000260916	"Cell cycle progression 1"	Q9ULG6	15	55340032-55408510	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 279.2;neutrophil: 296.6"	"Group enriched"	"Detected in all"	7	"granulocytes: 296.6;monocytes: 84.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 223.9;Karpas-707: 337.4;U-266/84: 259.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009432, HPA026861"	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA009432: AB_2668242, HPA026861: AB_1846192"	"unprognostic (3.14e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (5.07e-4)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (1.15e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.72e-2)"	38.9	37.8	24.0	23.7	27.7	63.8	34.1	23.1	28.4	61.1	36.8	33.3	24.3	26.7	36.1	20.1	22.0	53.8	56.2	24.7	26.9	51.5	66.9	39.3	22.2	18.4	17.3	22.9	84.8	73.3	32.3	27.4	17.7	41.0	33.2	48.2	77.1	42.3	53.0	13.5	25.6	33.5	17.2	28.7	47.5	29.6	27.3	12.2	84.4	35.3	24.2	29.9	9.7	22.9	13.9	47.7	10.9	24.4	173.6	59.3	15.5	30.0	56.4	17.2	26.1	14.4	23.5	20.8	99.5	97.5	33.6	18.7	9.5	25.1	14.4	55.5	14.2	28.1	58.4	12.8	223.9	39.6	84.2	49.5	59.8	35.6	34.4	143.3	65.2	0.8	47.7	337.4	55.1	17.9	0.2	19.3	6.5	54.4	11.8	6.2	17.4	84.8	36.1	10.1	14.0	21.5	35.3	19.5	151.4	35.0	31.0	85.1	65.7	50.8	11.1	38.9	20.4	65.2	259.6	13.0	95.6	77.2	41.0	220.8	59.4	279.2	26.8	50.7	22.5	18.1	16.6	20.7	27.6	13.4	13.9	20.0	296.6	25.7	84.2	4.7	23.0	32.9	24.0	27.7	23.1	28.4	24.7	26.9	18.4	17.3	17.7	17.2	27.3	22.9	92.3	115.4	118.1	0.0	44.6	15.4	30.3	99.2	13.6	68.7	40.2	40.1	14.4	50.1	136.5	88.3	93.8	29.3	42.9	43.7	5.9	60.9	136.2	49.6	41.0	60.1	16.7	25.2	0.0	145.3	23.2	78.6	33.1	62.3	39.1	30.0	76.1	96.1	51.0	85.8	0.0	28.8	114.0	55.9	25.2	216.1	56.5	71.7	48.0	0.0	89.8	72.6	38.1	0.0	0.0	67.6	45.1	116.6	180.8	42.6	29.5	36.7	123.8	128.0	52.6	80.2	48.1	43.3	41.1	11.8	16.6	24.6	41.8	70.0	16.2	21.8
CCR10	GPR2	ENSG00000184451	"C-C motif chemokine receptor 10"	P46092	17	42678889-42683917	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 14.1;Bipolar cells: 12.8;Plasma cells: 62.7;Sertoli cells: 19.7;Smooth muscle cells: 16.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"plasmacytoid DC: 24.7;T-reg: 72.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 24.7;T-cells: 72.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.4;RPMI-8226: 6.5;U-266/70: 17.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB011684, HPA048007, HPA069188"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100"	"unprognostic (3.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.18e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-11)"	"unprognostic (2.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-1)"	4.5	2.1	1.1	0.7	1.1	0.2	5.2	3.1	2.7	6.6	0.0	4.8	1.8	8.5	0.3	0.8	8.5	0.2	4.4	0.7	6.5	2.8	0.8	4.1	0.3	3.9	4.6	6.2	2.3	0.0	20.2	0.7	6.6	3.8	0.2	0.7	2.2	0.6	4.7	1.5	3.1	0.5	1.0	3.2	2.6	4.0	4.0	0.2	2.8	0.4	0.0	2.4	3.2	1.2	0.5	0.8	0.8	4.7	0.3	0.7	1.1	1.7	0.5	0.2	0.4	0.7	0.3	0.1	0.3	0.3	1.6	0.8	0.0	0.1	0.1	2.0	1.2	0.0	3.2	0.4	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.5	0.1	0.3	2.6	8.4	0.0	0.3	0.1	2.4	0.6	0.0	1.2	0.6	0.1	6.5	1.1	0.0	0.7	1.0	0.4	0.0	0.2	0.3	0.8	0.9	1.9	2.1	0.5	0.7	0.2	17.1	8.4	2.5	1.3	0.6	0.9	0.0	0.6	0.2	0.4	0.1	0.3	5.3	10.9	5.4	0.4	5.9	1.3	1.8	0.2	0.2	0.4	24.7	72.4	1.5	1.1	1.1	3.1	2.7	0.7	6.5	3.9	4.6	6.6	1.0	4.0	1.2	7.3	0.0	0.0	0.7	14.1	0.8	0.3	0.4	0.6	12.8	1.0	1.3	2.1	0.0	0.1	0.0	0.0	0.2	0.6	0.0	3.9	0.3	0.5	1.6	2.9	2.9	1.8	0.0	5.1	0.5	0.3	5.4	1.5	0.9	0.0	0.6	2.2	0.2	1.9	1.7	4.6	0.6	2.0	2.5	3.7	2.5	5.6	1.2	5.4	0.0	3.8	2.5	2.1	1.0	1.3	0.3	0.1	2.6	62.7	0.3	0.2	0.7	1.0	3.2	19.7	2.3	16.7	1.6	2.1	0.3	0.3	0.0	2.9	1.9	0.7	0.1
CCR2	"CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R"	ENSG00000121807	"C-C motif chemokine receptor 2"	P41597	3	46353744-46360940	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 40.4;Kupffer cells: 43.1;Macrophages: 25.2;monocytes: 34.9;Plasma cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 560.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 185.5;THP-1: 89.8;U-266/70: 416.5;U-266/84: 177.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 2.4"	"CAB003793, HPA063255"	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoli fibrillar center"	"CAB003793: AB_344889, HPA063255: "	"unprognostic (1.09e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.49e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.16e-4)"	"unprognostic (8.06e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.19e-1)"	2.6	1.9	0.1	25.9	0.1	1.9	3.1	0.1	0.2	1.6	0.3	4.6	7.5	1.2	0.9	1.2	1.2	3.4	1.1	0.1	0.1	1.2	2.1	5.8	11.6	0.4	0.2	1.1	0.8	0.3	0.2	0.8	0.2	1.2	5.1	0.0	3.1	1.7	0.5	1.9	5.7	7.1	0.3	20.4	5.2	1.0	0.2	4.3	1.1	0.5	7.2	5.5	1.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.7	0.0	185.5	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.3	416.5	177.7	0.0	0.1	3.3	0.1	560.9	146.2	2.6	11.9	12.8	89.2	7.9	24.3	20.2	145.2	1.8	0.6	0.7	3.8	14.0	0.4	113.6	11.4	81.6	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.2	0.3	0.2	0.3	0.1	0.0	1.3	0.0	5.8	0.3	0.0	0.0	0.6	0.0	0.1	0.1	0.3	1.5	0.0	0.0	0.0	0.1	40.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	4.4	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.0	1.8	0.9	0.8	0.0	0.0	0.0	0.0	43.1	10.5	0.7	0.0	25.2	0.0	0.0	34.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	8.2	0.1	0.1	0.0
CCT2	Cctb	ENSG00000166226	"Chaperonin containing TCP1 subunit 2"	P78371	12	69585426-69601570	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1471.3;Spermatocytes: 625.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003197, HPA003198"	Enhanced		Supported	Cytosol		NA	NA		3500000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003197: AB_1078425, HPA003198: AB_1078424"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (8.38e-4)"	"prognostic unfavorable (3.61e-9)"	"unprognostic (5.28e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (6.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.21e-2)"	64.0	69.9	56.8	77.7	61.3	140.5	85.5	62.4	70.6	51.9	68.4	70.6	53.2	66.9	43.7	69.4	69.5	54.7	68.6	60.6	64.4	92.9	72.2	46.6	94.9	62.4	59.5	65.2	53.3	71.6	37.8	70.2	62.5	57.9	85.9	57.5	45.4	52.5	103.9	55.9	51.5	83.3	62.2	51.5	52.0	216.0	59.8	100.7	56.1	73.2	108.8	106.6	49.6	63.8	266.1	388.1	343.8	330.7	154.2	174.5	392.3	280.4	203.8	448.0	276.1	529.7	121.7	572.6	266.2	222.9	281.8	250.2	538.2	313.0	536.6	319.1	398.6	418.7	313.5	331.8	171.8	520.1	255.5	152.7	195.3	425.9	248.1	308.7	296.4	311.4	519.2	165.0	410.2	378.9	496.0	446.7	482.4	273.2	403.7	389.3	375.9	373.1	369.4	476.9	334.1	281.3	291.0	314.2	289.2	284.3	411.4	371.6	196.0	231.4	292.2	275.0	427.3	203.5	409.6	614.6	201.9	354.8	290.8	36.6	41.0	12.5	47.3	66.0	72.7	74.2	54.0	61.5	72.9	60.7	62.2	68.5	3.7	65.3	62.1	66.9	63.7	70.0	56.8	61.3	62.4	70.6	60.6	64.4	62.4	59.5	62.5	62.2	59.8	63.8	80.4	35.3	47.4	17.3	97.2	136.6	233.9	173.8	126.3	51.1	70.1	89.7	81.5	57.2	110.8	80.9	79.2	189.1	93.3	48.1	92.0	198.8	1471.3	150.9	126.5	95.3	106.2	226.4	21.5	128.4	209.1	102.1	60.6	107.1	105.4	112.3	52.5	46.2	127.1	42.1	31.3	94.4	109.9	44.3	74.9	430.3	76.7	70.5	46.2	11.2	87.7	67.9	57.7	21.6	20.6	150.7	50.8	66.5	100.7	165.8	34.4	127.4	127.5	56.6	85.5	128.4	178.3	625.4	391.5	112.1	117.3	153.4	93.9	154.1	154.8	161.9
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868085-61888671	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1700000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	66.4	67.0	60.4	59.9	62.6	64.9	90.2	67.1	114.9	68.4	66.7	65.1	45.8	68.7	50.8	75.6	74.4	43.1	67.0	62.3	65.7	73.5	63.7	48.7	81.4	63.9	62.6	109.3	95.3	62.8	45.9	65.8	66.1	57.8	58.9	56.8	53.7	57.5	96.7	66.4	48.5	72.0	70.4	55.3	64.5	77.6	66.0	83.3	65.3	74.0	92.0	68.4	61.2	80.0	274.5	313.6	203.1	190.1	166.2	251.5	342.5	244.6	174.3	345.6	230.4	550.5	193.2	437.9	239.7	176.5	354.6	192.4	405.8	313.9	362.3	216.0	398.9	280.4	149.4	347.7	149.3	347.8	179.1	215.0	214.4	278.8	287.2	259.5	293.3	220.0	406.5	137.2	297.5	246.4	299.6	451.2	365.3	364.2	276.0	336.9	319.2	297.4	237.5	186.2	177.6	148.8	177.2	221.9	324.5	235.7	161.9	245.6	185.2	190.6	275.5	143.3	400.1	205.3	297.3	739.8	188.9	391.7	255.7	58.2	60.7	25.0	83.2	88.9	106.9	93.6	87.1	100.8	100.4	88.6	112.9	112.2	8.4	107.5	103.3	64.3	100.7	125.2	60.4	62.6	67.1	114.9	62.3	65.7	63.9	62.6	66.1	70.4	66.0	80.0	111.8	73.7	54.3	20.9	125.4	152.6	350.8	206.6	136.1	52.9	131.3	136.4	47.7	82.9	116.7	73.5	14.6	256.5	106.5	52.8	135.0	156.0	250.0	111.9	117.2	118.0	140.6	156.9	28.0	130.6	284.9	114.9	67.8	92.8	95.8	148.2	95.3	79.4	163.5	32.0	31.3	105.9	175.0	105.0	112.4	72.1	88.3	110.2	94.3	30.0	125.8	64.9	71.1	26.7	40.8	143.9	61.4	97.8	111.9	200.3	67.9	165.2	143.1	63.3	92.1	117.2	297.8	338.8	153.2	151.2	151.3	180.6	146.6	173.7	138.2	203.8
CCT6A	"CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20"	ENSG00000146731	"Chaperonin containing TCP1 subunit 6A"	P40227	7	56051685-56063989	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 1612.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Supported		Approved	Cytosol		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (9.00e-10)"	"unprognostic (1.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.44e-3)"	58.5	58.8	48.3	66.6	50.5	67.0	59.7	52.6	71.1	43.5	55.9	52.6	53.2	52.0	38.2	68.1	50.9	39.8	56.7	50.2	56.4	72.5	53.3	41.1	69.6	52.5	52.9	42.1	60.8	69.4	39.1	56.4	53.9	44.9	60.1	46.5	45.5	49.4	124.3	58.0	51.8	61.4	53.2	46.1	52.2	49.5	53.5	61.3	49.7	85.5	81.1	72.1	47.6	55.3	1612.6	357.8	211.6	322.5	145.7	181.6	243.2	293.0	165.4	284.4	227.7	407.0	196.7	487.8	222.9	192.1	511.6	333.2	438.2	339.2	390.0	276.8	328.1	306.1	337.0	363.8	157.3	444.1	240.5	157.1	191.1	287.8	284.4	224.8	283.7	221.2	682.0	121.2	325.5	199.2	346.4	392.7	449.3	356.6	466.8	315.1	213.9	284.8	321.6	302.3	280.3	282.0	259.2	440.7	272.6	321.8	324.6	341.6	238.6	194.1	372.4	651.4	617.1	146.7	321.5	596.7	194.4	389.0	658.4	21.0	69.9	34.0	57.8	87.7	77.3	65.9	59.7	63.3	96.5	50.4	59.8	64.8	8.4	77.7	103.0	54.0	68.3	81.2	48.3	50.5	52.6	71.1	50.2	56.4	52.5	52.9	53.9	53.2	53.5	55.3	94.6	89.8	106.4	13.1	83.3	108.8	201.4	175.3	91.6	60.2	77.4	83.2	114.0	65.8	187.7	47.8	27.1	199.6	93.4	56.6	88.0	263.1	22.5	209.6	121.0	129.4	102.1	163.4	19.3	274.2	264.8	97.0	88.2	133.8	131.7	123.4	71.0	66.7	148.2	38.7	23.7	94.2	124.1	83.5	79.2	19.5	70.5	104.0	58.7	19.7	206.9	80.7	80.3	18.1	22.7	245.6	66.7	90.7	106.4	184.8	65.2	146.4	190.3	60.8	59.2	99.1	136.3	115.0	219.8	160.9	109.7	199.9	91.8	189.7	138.6	145.9
CCT6B	"Cctz2, TSA303"	ENSG00000132141	"Chaperonin containing TCP1 subunit 6B"	Q92526	17	34927859-34981078	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"testis: 126.1"	"Group enriched"	"Detected in many"	27	"Early spermatids: 448.5;Late spermatids: 185.2;Spermatocytes: 490.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"unprognostic (1.56e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.99e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.56e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.82e-7)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-1)"	"unprognostic (4.23e-4)"	"unprognostic (1.49e-1)"	2.9	3.3	1.9	0.8	2.3	3.8	5.5	2.0	2.7	2.2	1.6	1.7	1.4	1.9	5.5	1.8	2.7	0.9	1.7	1.7	2.0	4.0	5.0	1.2	1.4	2.2	2.1	2.4	2.6	2.5	2.7	0.6	2.3	2.7	1.1	2.3	3.3	2.6	5.1	2.7	1.4	1.6	2.3	1.6	2.0	126.1	2.0	1.6	2.9	3.8	1.7	1.9	1.5	2.7	0.7	1.0	2.6	1.1	3.3	2.0	0.9	1.3	5.3	2.2	3.1	0.7	2.1	5.0	0.5	2.4	1.6	1.0	0.1	0.7	0.7	0.5	1.9	0.7	0.3	0.6	4.5	2.4	0.7	2.7	1.3	0.2	2.6	0.4	0.6	0.8	0.5	5.0	2.4	1.9	0.5	5.2	1.4	0.4	0.6	2.4	1.2	12.2	1.4	0.8	3.0	1.5	2.4	0.9	4.1	0.6	1.9	2.4	0.5	1.0	0.1	1.2	0.6	4.4	1.0	4.7	1.1	1.5	1.3	0.0	1.1	0.9	0.6	1.1	0.6	0.9	0.7	0.4	2.6	0.8	1.0	1.0	0.0	1.6	1.1	0.6	0.3	0.6	1.9	2.3	2.0	2.7	1.7	2.0	2.2	2.1	2.3	2.3	2.0	2.7	2.4	0.0	3.1	4.6	2.6	2.4	2.8	3.2	6.2	1.5	8.7	7.0	4.2	4.3	3.9	1.8	0.0	1.8	4.0	0.9	3.9	3.4	448.5	8.8	3.7	2.1	0.0	0.8	3.9	8.0	0.5	3.5	1.5	3.6	2.5	4.6	0.7	3.1	1.5	0.0	3.7	2.3	6.1	2.2	4.0	185.2	10.8	2.9	5.4	4.7	1.6	8.7	4.1	7.1	10.7	2.7	1.6	4.1	3.9	2.1	0.7	6.9	8.8	2.5	0.0	3.7	3.0	490.2	13.5	3.1	2.6	0.8	2.7	6.9	1.8	3.6
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	72.7	125.0	62.5	99.1	67.0	99.5	100.4	70.3	84.0	78.5	78.0	87.9	77.9	74.8	88.2	83.7	80.9	64.3	116.3	66.9	74.7	102.7	92.7	70.1	140.8	64.5	65.3	88.0	95.3	100.0	40.6	107.0	69.0	77.1	102.1	71.3	70.7	72.5	121.1	75.0	78.6	85.5	66.7	88.9	68.8	79.1	68.7	141.2	78.5	145.2	154.3	122.3	50.3	66.1	437.4	243.1	319.4	233.3	220.4	302.3	350.9	340.5	219.1	386.2	317.5	548.6	269.0	858.8	229.1	237.1	466.8	174.4	632.2	391.7	441.1	364.0	348.1	1185.2	289.8	384.3	227.0	609.0	335.6	229.0	244.9	448.6	372.6	278.6	368.1	379.7	935.8	519.0	404.1	270.9	456.6	359.4	572.6	433.6	310.6	411.7	596.5	547.4	409.1	283.2	316.7	231.6	334.1	356.6	364.7	347.5	319.9	526.7	267.4	221.3	613.7	216.7	439.7	329.2	651.8	695.1	256.3	704.5	339.0	79.9	110.1	54.4	56.9	120.9	79.6	79.8	76.3	73.4	133.3	61.8	85.5	82.1	11.5	87.7	132.2	83.5	92.7	127.4	62.5	67.0	70.3	84.0	66.9	74.7	64.5	65.3	69.0	66.7	68.7	66.1	66.9	64.1	61.7	15.0	120.1	143.1	197.6	278.6	70.0	85.6	88.4	76.5	75.7	90.1	150.0	75.4	18.8	268.9	122.1	67.3	144.8	194.1	17.0	106.6	92.8	94.8	97.0	150.2	26.7	138.0	275.8	93.4	52.0	73.7	112.8	135.6	55.3	53.4	170.5	77.4	31.3	106.2	201.4	115.6	122.4	20.5	84.2	109.9	115.6	26.2	226.6	96.1	97.9	13.6	21.4	131.2	92.1	92.9	130.7	185.9	107.4	189.7	147.7	84.6	105.2	88.7	214.7	170.1	176.8	90.2	131.4	285.3	105.1	254.5	161.1	170.6
CCZ1	"C7orf28A, CCZ1A, CGI-43"	ENSG00000122674	"CCZ1 homolog, vacuolar protein trafficking and biogenesis associated"	P86791	7	5898725-5926550	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (1.91e-1)"	"unprognostic (2.97e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.10e-1)"	"unprognostic (9.25e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-1)"	32.5	55.8	10.7	12.8	10.9	26.9	30.2	12.2	13.7	28.7	12.9	31.1	13.0	29.7	9.4	40.8	25.2	10.3	31.3	11.4	10.5	27.3	27.3	26.0	15.4	10.7	10.4	23.0	27.3	29.9	24.9	12.2	10.6	24.6	16.0	12.6	32.1	11.9	43.2	30.3	26.9	13.9	10.5	31.5	29.0	22.1	11.0	20.5	25.5	13.0	16.2	31.7	28.9	11.6	52.2	29.8	30.3	27.1	41.8	35.4	15.3	15.6	30.1	23.1	25.0	9.1	27.2	42.8	4.8	40.8	61.9	27.8	16.6	26.7	26.5	16.2	37.3	18.1	30.2	16.8	38.0	13.1	7.1	40.5	42.4	15.6	19.5	42.5	57.2	25.4	52.4	29.7	38.8	26.9	16.8	56.9	39.5	26.4	28.3	36.0	13.8	28.9	21.1	38.3	23.9	31.9	15.3	36.6	13.6	57.9	26.1	21.0	27.7	28.8	57.4	18.7	25.7	13.6	24.6	58.0	9.6	30.8	41.6	3.1	1.9	2.7	1.8	2.3	1.4	1.3	2.2	2.2	1.8	1.3	1.5	1.6	3.4	3.0	2.4	1.8	4.6	0.7	10.7	10.9	12.2	13.7	11.4	10.5	10.7	10.4	10.6	10.5	11.0	11.6	30.7	3.2	23.5	15.7	26.3	45.2	30.6	21.2	9.6	59.2	29.5	20.2	11.0	24.3	24.0	31.3	62.6	45.0	47.2	38.0	31.3	61.0	6.5	18.7	18.1	35.0	29.9	26.7	20.2	71.4	35.9	26.7	11.2	21.3	15.8	21.1	76.4	17.6	35.7	23.5	20.5	30.8	50.8	39.0	61.6	4.9	37.9	27.5	46.2	8.4	80.8	41.5	72.1	15.6	28.7	74.0	30.1	36.1	14.3	26.2	40.2	21.9	32.9	69.2	78.9	19.4	32.0	40.6	34.5	11.0	54.1	34.9	32.8	38.2	34.4	33.7
CCZ1B	"C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819"	ENSG00000146574	"CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated"	P86790	7	6794134-6826770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (8.06e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.24e-1)"	28.9	40.3	19.6	25.1	20.0	37.1	28.8	20.6	26.2	18.5	22.4	31.3	27.5	28.5	40.3	42.5	25.6	28.4	28.6	19.5	20.3	28.8	24.1	23.5	38.0	19.8	19.6	18.2	21.1	73.1	9.1	26.7	19.8	20.8	27.2	32.4	32.9	19.0	35.8	30.2	22.0	22.5	20.7	25.4	30.8	23.5	20.5	38.8	24.6	53.5	35.5	39.4	9.3	21.6	120.6	31.6	66.8	138.5	49.7	51.5	67.2	64.1	69.4	58.1	61.4	32.4	65.7	52.2	57.0	72.0	132.5	68.7	87.9	60.5	62.4	31.1	51.8	33.6	40.7	72.0	54.3	165.4	104.1	37.9	37.6	51.1	30.2	40.0	57.9	108.6	63.5	49.2	62.6	124.7	84.2	81.5	171.2	78.2	66.7	67.3	123.1	59.4	41.8	66.4	87.1	161.5	62.4	117.6	78.8	65.9	94.0	185.0	71.1	27.7	93.7	78.2	116.5	52.9	104.8	45.6	53.9	176.4	120.9	21.8	5.5	10.2	5.3	8.0	6.3	6.1	6.7	7.8	8.3	5.1	4.5	5.8	4.6	10.6	15.5	6.3	15.7	3.4	19.6	20.0	20.6	26.2	19.5	20.3	19.8	19.6	19.8	20.7	20.5	21.6	9.5	6.4	12.7	11.1	17.4	8.4	7.8	8.6	8.0	10.4	10.9	10.0	7.3	2.8	10.7	3.7	14.6	8.0	12.9	18.7	15.6	20.1	3.7	16.0	11.1	8.9	18.6	9.0	19.6	28.1	11.7	9.2	9.2	10.3	2.5	6.6	15.7	7.1	9.8	16.8	19.0	17.5	6.1	11.1	22.8	2.2	7.2	11.2	14.2	8.4	24.7	11.5	17.5	14.6	23.6	24.8	11.9	10.5	7.6	9.6	7.1	12.4	23.7	11.4	19.7	8.1	9.0	12.0	8.9	11.0	12.5	7.9	11.1	5.7	15.3	11.9
CD180	"LY64, Ly78, RP105"	ENSG00000134061	"CD180 molecule"	Q99467	5	67179613-67196799	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 53.6;Hofbauer cells: 78.6;Kupffer cells: 23.5;Macrophages: 17.5;monocytes: 13.8;Plasma cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 77.0;naive B-cell: 78.9"	"Group enriched"	"Detected in many"	25	"B-cells: 78.9;dendritic cells: 23.5;monocytes: 34.5"	"Group enriched"	"Detected in some"	10	"Daudi: 45.2;Karpas-707: 41.1;U-266/70: 33.1;U-266/84: 49.0;U-698: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003740	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle"		Yes	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nucleoli, Mitotic spindle"	"HPA003740: AB_1078450"	"unprognostic (9.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.85e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	1.6	0.7	0.7	9.7	0.7	2.4	6.7	0.6	1.2	0.5	0.4	2.1	2.0	0.5	0.2	0.4	0.4	1.6	0.4	0.8	0.7	0.3	2.5	1.6	23.2	1.5	1.5	0.2	0.3	0.2	0.1	3.2	2.0	0.5	2.7	0.3	1.1	0.4	0.1	0.2	3.9	1.8	1.0	12.9	2.2	0.4	1.8	2.5	0.3	0.2	23.3	3.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.2	33.1	49.0	12.3	0.0	2.7	0.0	0.3	11.8	0.9	0.0	20.4	0.0	77.0	0.1	0.1	22.1	78.9	0.0	0.0	0.9	1.8	34.5	23.5	0.1	8.5	0.7	0.7	0.6	1.2	0.8	0.7	1.5	1.5	2.0	1.0	1.8	2.1	0.1	0.0	0.5	0.3	53.6	0.4	0.1	0.0	0.0	0.1	1.8	1.1	0.7	1.5	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	2.2	0.1	0.0	0.6	0.0	1.7	0.0	0.2	0.3	0.4	0.0	0.1	2.5	0.0	0.0	0.3	78.6	0.0	0.0	0.0	0.0	23.5	8.0	1.0	0.0	17.5	0.0	1.9	13.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	39.6	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.7	2.2	0.0	0.1	0.1
CD207	"CLEC4K, Langerin"	ENSG00000116031	"CD207 molecule"	Q9UJ71	2	70830211-70835816	"CD markers, Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 87.7"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.0;Langerhans cells: 9.7;Macrophages: 7.6;Melanocytes: 5.4;Suprabasal keratinocytes: 5.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"myeloid DC: 1.1"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.1"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002222, HPA011216"	Enhanced		Uncertain	Cytosol		No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB002222: AB_563850, HPA011216: AB_1078453"	"unprognostic (1.45e-2)"	"unprognostic (8.28e-3)"	"unprognostic (9.34e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.92e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	0.4	0.1	0.0	0.3	0.0	0.0	3.2	0.0	0.0	1.6	0.1	1.2	3.7	0.8	0.4	17.8	0.9	2.0	0.2	0.0	0.0	0.1	0.7	1.6	0.9	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	2.4	2.7	5.5	1.1	0.8	0.8	87.7	4.9	0.7	0.0	3.7	1.4	0.5	0.0	3.4	0.1	0.3	4.8	1.4	1.7	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.6	4.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.2	0.0	7.6	5.4	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.0
CD24	CD24A	ENSG00000272398	"CD24 molecule"	P25063	6	106969831-106975627	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 1630.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1572.7;Distal tubular cells: 1590.6;Exocrine glandular cells: 3454.1;Glandular and luminal cells: 1441.8;Pancreatic endocrine cells: 1694.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"eosinophil: 86.2;memory B-cell: 61.1;naive B-cell: 39.7"	"Group enriched"	"Detected in many"	237	"B-cells: 61.1;granulocytes: 86.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 989.4;RPTEC TERT1: 4702.6;RT4: 931.5;SK-BR-3: 1352.5"									"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavorable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	7.1	61.9	23.3	139.1	28.8	704.5	468.1	6.4	30.0	288.0	36.7	1071.8	89.0	181.5	229.6	1456.5	242.9	874.3	5.1	45.0	29.2	775.6	30.2	61.6	77.8	26.6	26.0	2.2	1383.4	2.5	12.5	151.7	17.2	148.8	740.8	2.6	952.4	546.9	1.4	77.2	69.8	117.7	19.5	29.6	601.7	4.9	38.6	15.2	1630.2	1.1	445.0	168.9	468.3	50.7	363.2	225.2	3.9	28.6	0.7	0.3	405.8	0.4	2.6	2.0	1.2	3.3	1.9	35.4	106.0	0.1	14.6	730.6	124.1	275.6	1.5	1.0	1.7	1.0	254.2	16.3	0.2	5.1	1.8	2.1	316.1	3.6	18.0	16.9	1.6	1.4	8.3	0.8	6.6	465.6	2.4	2.6	989.4	800.1	85.6	846.8	0.5	3.5	4702.6	931.5	612.4	448.7	250.0	1352.5	1.4	437.1	635.6	2.1	1.6	0.8	4.0	3.1	11.8	1.0	2.0	475.2	5.0	2.9	1.6	0.3	0.1	86.2	0.0	0.0	0.0	61.1	0.0	0.0	0.0	39.7	0.0	0.1	2.1	0.1	0.3	0.1	0.0	2.0	23.3	28.8	6.4	30.0	45.0	29.2	26.6	26.0	17.2	19.5	38.6	50.7	10.2	157.0	83.5	0.7	157.5	0.0	70.4	0.0	7.4	5.8	1109.4	325.4	1.5	1112.3	98.4	1302.1	2.1	749.2	13.7	1572.7	1590.6	1274.1	22.5	1237.6	254.2	38.6	575.4	5.3	0.6	3454.1	885.0	29.9	567.2	1441.8	10.8	0.6	97.5	9.7	70.8	0.0	5.7	463.6	0.0	7.6	0.0	53.4	10.2	17.6	0.0	1.0	32.6	1.0	0.0	0.0	0.1	1694.3	865.2	2.2	1.0	810.2	12.3	538.5	376.8	0.7	6.6	2.9	18.1	0.6	7.2	587.7	0.0	558.3	28.1	0.0	932.8	1043.7
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314494-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 237.3;breast: 155.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 155.4;Fibroblasts: 166.9;Leydig cells: 74.9;Smooth muscle cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive CD8 T-cell: 21.8"	"Lineage enriched"	"Detected in single"	144	"T-cells: 21.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 492.4;ASC TERT1: 481.9;BJ: 222.2;BJ hTERT+: 330.1;fHDF/TERT166: 451.1;HSkMC: 516.8;U-2197: 794.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		43000000	"Cluster 32: T-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA051856: AB_2681640"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	237.3	12.9	2.3	39.3	2.4	0.4	155.5	2.2	4.0	87.2	1.5	31.7	7.8	52.2	6.9	19.6	60.8	32.3	30.3	2.2	2.2	18.7	3.6	36.5	6.2	2.4	2.6	23.9	11.7	3.3	8.8	67.4	2.2	17.8	7.4	0.4	18.2	19.4	15.8	51.0	27.2	26.5	2.0	7.2	26.3	5.0	3.9	5.3	35.0	6.5	2.6	63.4	61.5	2.0	0.0	0.0	4.9	0.0	492.4	481.9	0.3	222.2	330.1	16.3	15.1	0.1	0.0	0.0	5.8	451.1	0.0	0.0	0.2	0.2	3.5	0.0	0.0	0.0	0.1	3.3	97.5	0.0	0.0	516.8	0.0	21.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.4	3.2	2.5	0.0	1.4	9.5	0.0	0.2	0.0	0.0	2.8	7.6	0.0	1.2	0.0	13.4	0.5	0.4	0.1	0.0	0.8	794.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	2.6	0.0	0.1	3.1	21.8	0.0	0.0	0.0	0.0	0.0	2.5	2.3	2.4	2.2	4.0	2.2	2.2	2.4	2.6	2.2	2.0	3.9	2.0	15.0	0.0	0.0	1.3	1.3	12.5	0.0	0.0	0.6	0.1	1.2	1.5	2.2	0.0	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.2	0.3	5.3	155.4	5.8	0.0	0.0	0.0	0.0	2.5	166.9	13.3	3.1	0.0	0.0	2.5	0.0	6.0	0.0	0.0	0.0	0.0	0.3	14.4	2.3	74.9	1.6	12.4	1.9	0.6	2.9	1.0	0.0	0.0	0.3	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.1	32.9	5.5	59.3	0.1	0.1	0.8	8.2	4.4	6.9	1.1	0.0	0.1
CD2BP2	"LIN1, PPP1R59, Snu40, U5-52K"	ENSG00000169217	"CD2 cytoplasmic tail binding protein 2"	O95400	16	30350773-30355308	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041508, HPA061309"	Enhanced		Enhanced	"Nuclear speckles,Cytosol"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear speckles"	Cytosol	"HPA041508: AB_2677523, HPA061309: AB_2684476"	"unprognostic (5.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	31.1	49.3	38.9	34.0	39.7	23.9	32.9	38.0	41.5	39.6	34.0	39.3	29.9	45.0	24.9	35.3	41.0	22.0	35.2	39.9	41.2	42.8	27.3	32.8	38.8	41.4	39.8	36.9	40.7	42.5	42.7	24.4	39.1	38.3	23.7	16.2	30.0	35.5	46.9	33.6	35.2	31.6	39.0	46.4	36.9	24.0	41.6	35.7	42.5	26.6	43.7	37.0	30.1	42.0	55.4	65.7	54.4	49.4	44.3	41.9	46.0	60.0	71.5	66.8	71.3	50.6	64.9	84.6	72.3	65.5	61.4	59.4	57.0	70.3	53.6	50.6	66.6	35.9	67.7	60.3	63.6	51.3	63.4	45.2	58.7	74.2	47.3	45.6	70.3	62.1	41.4	63.2	67.7	132.1	71.6	43.6	73.8	42.9	38.5	104.2	45.3	64.3	54.2	54.7	44.7	85.1	40.2	69.9	42.0	44.7	66.4	41.1	50.6	76.3	53.3	38.9	53.1	105.0	82.3	78.5	52.5	47.2	64.0	107.4	61.7	116.6	71.3	76.3	56.8	87.5	57.3	66.7	55.8	97.3	47.6	58.9	121.9	74.5	102.7	67.1	94.4	79.6	38.9	39.7	38.0	41.5	39.9	41.2	41.4	39.8	39.1	39.0	41.6	42.0	38.1	32.1	29.0	7.2	39.5	28.8	49.6	58.4	31.9	29.8	33.2	29.6	26.5	45.8	41.2	36.8	20.9	61.0	57.0	50.5	60.7	83.6	19.9	41.7	30.7	42.8	33.0	22.3	6.7	97.5	58.1	36.4	28.1	45.2	47.6	33.4	28.2	13.9	69.7	11.8	7.1	32.7	36.7	38.3	23.6	14.2	35.4	34.0	39.2	8.4	84.1	47.6	97.9	3.5	10.7	87.8	64.9	35.7	52.7	40.7	60.3	81.5	46.3	29.0	39.5	30.5	44.6	38.5	40.1	27.4	30.4	88.7	41.9	38.9	31.6	50.7
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1533.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1"	"Group enriched"	"Detected in all"	46	"dendritic cells: 507.1;monocytes: 962.6"	"Group enriched"	"Detected in some"	4	"ASC diff: 322.6;HEL: 158.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 16.9"	"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		5300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	1533.6	24.6	3.4	51.7	2.5	148.2	540.4	1.6	2.0	11.6	2.7	40.5	113.6	8.7	38.2	19.6	40.5	84.0	540.9	2.6	6.9	7.0	80.8	131.2	18.8	22.0	21.2	4.0	31.2	25.0	2.0	413.3	15.7	5.0	40.9	0.3	31.9	8.6	248.5	28.6	119.7	39.4	14.0	309.9	31.2	7.7	24.0	22.1	69.1	381.6	7.2	22.2	13.4	3.9	0.0	0.0	1.0	0.2	322.6	3.3	0.7	0.9	10.7	0.1	0.1	0.0	0.0	0.1	0.6	1.4	0.3	0.1	4.3	0.5	0.1	0.6	0.4	158.1	0.5	25.7	0.2	0.1	0.1	31.0	12.6	0.1	0.2	7.7	0.9	0.0	5.8	0.0	1.8	0.2	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5	0.1	0.9	1.3	0.8	0.6	0.3	2.7	11.1	19.3	0.4	0.5	0.5	0.6	0.3	0.2	0.8	0.4	0.1	54.3	41.8	12.3	962.6	3.7	1.9	270.6	2.1	3.6	0.6	0.6	507.1	0.5	0.8	0.4	15.8	5.9	72.0	128.3	1.5	692.4	3.4	2.5	1.6	2.0	2.6	6.9	22.0	21.2	15.7	14.0	24.0	3.9	3219.2	6.4	63.1	0.0	7.9	7.4	0.2	3.0	0.6	0.2	189.9	24.8	623.1	4.3	9.8	7.3	0.0	10.1	55.0	0.0	0.0	0.2	11.7	5.0	5.9	303.3	0.0	419.5	6.3	0.0	11.1	69.6	1.1	38.4	15.2	0.6	406.2	9.0	1369.8	0.0	2.2	0.6	8.2	153.7	67.3	3.9	0.6	159.6	16.0	17.8	255.2	0.0	7.2	0.5	1.3	0.1	0.0	0.0	4.2	0.8	9.9	0.4	1.2	0.3	696.8	33.1	452.1	4.6	0.7	0.8	4.7	18.3	5.9	1.9	0.2	0.3
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"	16.6	7.0	7.5	100.2	7.4	155.2	6.5	9.4	13.7	4.2	5.9	13.9	8.2	3.7	0.7	7.3	5.8	13.9	5.2	6.3	11.4	7.6	6.4	46.9	215.0	17.0	12.0	1.7	3.2	1.8	3.4	15.1	16.5	6.9	3.8	0.3	11.5	2.8	1.9	4.1	116.3	3.9	16.7	235.7	14.8	7.4	15.6	57.5	8.3	2.4	88.0	19.1	5.2	28.7	0.2	0.6	1.5	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	306.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	49.5	0.2	53.1	0.0	0.5	0.0	9.4	290.0	0.0	0.0	0.0	0.0	0.2	0.0	18.5	2.6	16.3	0.0	0.0	0.4	5.8	0.2	0.0	0.0	2.9	0.3	110.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	109.0	0.8	0.3	1.0	0.2	0.0	0.3	0.1	69.4	0.2	81.4	0.1	550.2	658.2	829.6	353.2	601.6	357.4	1511.6	426.3	376.2	449.7	1722.2	435.3	368.6	903.8	321.8	747.8	586.3	467.1	816.2	7.5	7.4	9.4	13.7	6.3	11.4	17.0	12.0	16.5	16.7	15.6	28.7	7.1	9.6	14.3	0.3	1643.9	11.7	1.3	0.1	4.6	12.1	4.6	12.1	1.6	2.8	2.5	1.8	6.2	1.9	489.6	2.2	0.0	0.5	94.2	1.2	1.9	9.7	1.2	67.7	0.1	0.0	2.3	6.9	11.7	1.5	264.6	0.3	11.4	4.1	345.3	0.0	0.2	1.7	0.0	272.0	358.4	221.3	2.8	319.7	28.4	21.5	365.0	1.1	394.4	0.0	0.1	0.0	8.0	0.7	119.8	1.1	0.6	2.9	0.9	6.3	0.0	3.2	5.7	1.1	1.3	2.6	11.8	2.9	390.3	0.9	1.9	1.1
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853232	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.3"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 18.3"	"Group enriched"	"Detected in all"	5	"B-cells: 9.9;dendritic cells: 5.8;NK-cells: 18.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 128.0;Karpas-707: 34.7;MOLT-4: 32.6;REH: 26.0;RPMI-8226: 20.9;U-266/70: 26.9;U-698: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	3.1	2.4	2.5	13.1	3.8	13.6	2.0	2.7	2.5	0.7	0.9	4.5	5.8	0.9	1.2	1.1	3.0	1.9	3.8	3.5	6.6	0.8	3.3	6.3	23.4	3.3	5.5	0.7	0.3	0.1	1.8	0.5	3.4	13.2	3.5	0.2	2.6	19.7	21.4	0.3	5.3	1.4	2.8	17.0	3.0	1.0	3.9	63.3	2.0	3.4	18.0	6.8	0.5	4.6	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	128.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	17.0	0.2	34.7	0.0	0.0	32.6	7.9	0.2	0.0	0.0	26.0	0.1	20.9	0.0	0.0	0.2	1.5	0.0	0.2	0.5	0.3	0.1	5.7	0.5	0.0	0.1	0.1	0.0	26.9	0.2	24.3	0.4	6.2	0.3	0.1	1.9	0.1	1.2	2.4	0.3	9.9	1.5	1.2	4.7	7.7	2.4	1.9	1.4	18.3	1.9	5.8	2.4	4.4	2.5	3.8	2.7	2.5	3.5	6.6	3.3	5.5	3.4	2.8	3.9	4.6	0.8	3.2	15.1	86.5	59.7	0.0	0.4	0.6	0.6	0.1	0.1	0.0	1.0	0.0	11.6	0.0	10.4	0.2	33.8	0.2	0.0	0.0	2.5	4.0	1.4	2.7	0.0	78.6	0.4	0.0	0.2	2.7	2.0	0.3	38.2	0.8	2.9	4.3	4.4	0.0	0.4	1.3	0.0	44.3	0.8	0.7	0.0	17.7	7.2	5.6	3.1	0.0	79.3	1.0	1.8	0.0	0.3	0.0	378.4	8.1	0.2	0.1	42.5	0.1	13.1	1.5	7.6	2.9	1.7	1.6	0.0	0.5	26.5	0.0	1.6	0.2
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 640.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3"	"Group enriched"	"Detected in all"	21	"NK-cells: 202.2;T-cells: 501.3"	"Group enriched"	"Detected in some"	67	"JURKAT: 544.9;MOLT-4: 764.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	6.4	5.6	0.9	85.8	1.1	36.7	6.7	0.9	1.2	7.1	1.3	15.3	22.0	5.8	4.6	9.5	5.4	20.1	3.8	0.7	1.0	3.5	9.7	23.0	209.6	1.8	0.9	3.8	2.2	0.7	1.0	1.6	1.4	6.6	19.3	0.0	11.6	3.0	1.9	5.4	36.4	5.1	1.2	78.9	24.4	1.7	1.3	640.4	5.3	1.6	147.0	24.8	4.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	544.9	0.9	2.0	0.0	0.0	764.9	0.6	0.3	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	1.6	8.0	9.8	0.0	0.6	0.0	16.4	1.8	2.4	490.6	1.3	420.8	1.6	414.4	463.5	1.5	2.1	491.7	501.3	12.2	202.2	2.0	8.6	426.3	333.0	0.9	1.1	0.9	1.2	0.7	1.0	1.8	0.9	1.4	1.2	1.3	1.6	4.9	0.0	8.6	0.0	12.9	5.2	0.3	0.0	0.0	0.0	3.8	4.8	0.3	0.0	0.6	1.8	0.0	0.2	213.6	0.4	0.0	0.2	7.0	0.5	0.9	2.5	0.0	6.9	0.1	0.0	0.0	5.3	24.5	0.9	7.6	0.0	8.9	2.4	0.3	0.0	0.1	0.0	0.0	7.6	8.3	0.2	0.0	12.6	12.4	1.0	8.4	0.0	154.5	0.0	0.1	0.0	1.1	0.0	41.4	0.1	0.2	2.1	0.0	0.0	0.0	1.3	2.7	0.0	0.0	1.6	5.4	0.3	601.4	0.0	0.6	0.3
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 504.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1650.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		1200000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	143.7	42.4	29.2	218.0	33.9	308.1	164.7	63.0	25.1	146.0	16.8	91.1	53.0	200.4	20.1	227.8	69.0	129.7	30.4	33.0	116.5	31.3	31.0	214.1	108.8	114.9	102.3	11.7	263.2	6.0	8.1	74.1	118.3	87.3	111.5	38.0	504.2	57.0	17.1	433.3	60.8	175.8	114.3	83.8	61.5	6.6	62.8	64.2	76.2	27.7	188.7	235.2	193.4	114.9	493.0	448.6	4.3	1.2	252.6	691.5	1.6	962.2	740.3	521.3	288.2	30.4	150.4	0.7	126.5	1350.2	1065.4	820.1	9.9	1013.9	716.4	110.3	6.2	18.9	198.3	0.3	262.3	254.6	1124.3	315.4	778.3	693.2	552.7	1650.0	184.3	0.1	4.0	157.9	518.9	3.0	25.6	166.9	9.8	8.7	136.4	1.4	89.3	7.5	777.4	138.1	2.0	1.4	185.2	5.5	462.8	38.6	25.7	15.1	547.3	646.6	120.0	815.8	1006.0	281.6	327.7	3.7	980.4	145.1	969.8	127.4	403.0	35.4	140.6	257.8	196.5	122.5	210.1	186.5	229.0	90.0	179.7	153.6	92.6	322.3	356.1	79.9	309.7	437.3	29.2	33.9	63.0	25.1	33.0	116.5	114.9	102.3	118.3	114.3	62.8	114.9	41.0	96.1	361.8	54.5	250.1	999.7	297.7	335.3	228.2	0.6	139.6	71.2	8.6	27.1	125.6	20.2	2.1	4.5	257.0	14.0	1.9	992.1	41.3	43.6	395.4	50.9	100.1	94.4	0.4	869.6	3.6	282.2	39.8	196.9	763.2	25.2	13.2	3.6	226.6	0.0	0.4	93.3	30.5	474.3	1934.2	24.3	22.4	523.9	604.7	8.4	594.2	29.6	62.8	0.5	11.2	813.1	10.9	0.4	216.3	386.7	6.0	1.6	18.8	2.0	157.8	197.2	227.9	0.4	0.4	279.3	1024.9	17.9	430.8	1.0	79.1	330.7
CD74	DHLAG	ENSG00000019582	"CD74 molecule"	P04233	5	150400041-150412969	"Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 5258.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0"	"Group enriched"	"Detected in all"	6	"B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002506, HPA010592, CAB079994"	Enhanced		Supported	"Golgi apparatus"		NA	NA		210000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482"	"prognostic favorable (1.06e-4)"	"unprognostic (1.48e-2)"	"unprognostic (4.80e-3)"	"prognostic favorable (6.53e-6)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.24e-2)"	1512.1	976.5	338.1	2741.2	301.9	984.3	1157.2	365.5	474.4	1562.8	429.1	992.3	1826.2	593.6	490.6	618.8	1139.0	1477.9	604.0	306.7	506.8	1271.1	1142.0	3786.3	4995.6	598.7	431.8	464.3	392.4	390.6	469.3	305.7	533.4	556.7	1155.8	58.1	1999.3	911.8	307.2	682.4	2438.8	1014.2	514.2	4897.4	1511.5	207.5	514.4	2160.2	853.5	374.2	5258.9	1557.5	483.5	771.8	35.7	0.3	1.5	2.4	2.3	2.5	11.0	0.0	0.0	0.7	0.6	443.0	2171.7	3523.2	124.2	0.0	9.2	9.4	0.0	0.0	0.1	4787.6	0.0	109.1	1.2	250.2	6.6	9.2	6.5	24.5	0.0	0.8	0.0	0.6	0.0	0.0	8.0	1270.7	0.4	0.0	4.2	14.0	5.3	0.0	0.1	3026.0	5.2	2014.2	9.0	133.5	5.1	8.2	5.5	4.7	94.9	19.2	81.2	414.4	5.6	10.3	9.9	9.0	4.5	1443.4	170.7	1978.6	745.9	154.2	678.6	410.8	11041.2	3996.9	808.7	15961.1	899.9	26889.3	688.4	1188.4	23750.6	27930.3	378.9	646.6	839.6	2378.1	8003.3	16940.0	2157.2	17779.7	338.1	301.9	365.5	474.4	306.7	506.8	598.7	431.8	533.4	514.2	514.4	771.8	2080.4	419.9	2160.4	0.7	10167.0	715.9	154.0	762.2	398.4	1.7	220.3	437.5	69.6	401.7	1063.3	502.1	0.0	28.3	3199.0	139.7	117.4	1264.4	10.4	111.3	11.5	1787.6	242.9	562.5	0.7	527.5	32.6	278.6	538.2	85.5	417.2	113.4	514.7	52.5	4361.8	1.7	0.6	475.7	390.6	5201.6	23363.4	31.3	117.1	7290.2	1197.1	137.7	10305.9	16.8	403.7	0.5	1.4	384.2	487.3	17.7	2068.3	174.9	5034.4	815.8	1153.1	10.0	164.3	45.1	146.7	2.8	12.6	170.9	575.8	41.6	790.7	12.9	450.7	743.4
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 137.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		550000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	81.4	11.9	2.7	43.5	2.6	16.4	41.0	2.8	6.5	23.9	6.5	13.8	9.8	17.8	6.1	19.0	23.4	39.7	34.3	2.7	3.5	25.6	16.3	64.6	14.0	5.4	4.3	6.2	13.2	10.8	6.6	137.6	5.4	11.3	12.1	1.4	9.7	10.9	24.2	12.2	14.5	43.5	4.0	23.4	13.0	4.6	7.1	9.3	21.4	34.4	10.6	41.3	12.8	3.5	0.2	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	346.0	0.0	0.9	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.9	0.2	27.8	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	105.3	442.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	593.5	0.1	0.0	25.8	0.4	0.3	16.8	0.0	0.0	0.2	0.1	9.1	0.0	0.0	0.0	27.8	0.1	7.5	1.2	0.5	9.9	2.7	2.6	2.8	6.5	2.7	3.5	5.4	4.3	5.4	4.0	7.1	3.5	321.5	3.2	7.4	0.0	2.4	15.0	1.0	0.0	6.2	0.0	1.0	1.8	14.3	5.7	3.7	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.4	0.4	0.7	309.2	0.0	1.3	0.0	0.0	0.5	9.8	0.5	0.4	5.1	0.0	162.8	1.9	19.9	0.0	0.2	0.0	0.0	156.4	52.5	0.8	1.8	102.4	8.8	4.7	131.8	0.2	6.2	0.0	0.1	0.1	0.0	27.8	2.1	4.1	0.0	0.3	3.0	0.1	19.7	5.7	8.0	0.0	0.2	1.6	10.1	0.4	2.4	3.0	0.0	4.0
CDADC1	NYD-SP15	ENSG00000102543	"Cytidine and dCMP deaminase domain containing 1"	Q9BWV3	13	49247925-49293485	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 174.6;Late spermatids: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047615, HPA058314"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA047615: AB_2680104, HPA058314: AB_2683677"	"unprognostic (2.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (6.03e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.40e-2)"	"unprognostic (8.27e-3)"	5.0	6.8	4.9	2.3	4.5	6.3	4.2	5.8	6.5	4.0	5.8	4.7	3.1	3.8	5.1	3.2	4.2	2.7	4.3	4.5	5.5	9.5	8.1	3.5	3.1	4.9	5.4	4.5	2.7	5.5	3.2	2.0	5.1	3.9	3.2	5.2	3.4	4.4	4.4	2.2	3.0	3.7	4.7	4.1	3.9	7.9	5.6	4.3	9.4	5.2	2.6	3.5	3.6	5.4	2.1	2.6	2.2	2.7	10.8	5.9	1.1	5.0	3.1	2.5	2.6	2.6	1.7	2.9	1.0	2.2	2.4	3.6	4.6	2.2	3.2	6.3	3.7	3.3	2.5	2.7	4.7	6.3	1.7	4.1	5.5	2.3	3.0	4.4	3.7	5.6	2.1	2.1	3.2	0.7	6.0	5.1	0.8	3.6	2.2	4.0	2.4	2.9	3.6	0.7	1.3	1.1	3.4	2.1	2.9	1.4	1.5	5.4	2.8	1.3	2.4	3.5	2.4	0.6	2.4	1.8	1.1	7.2	3.7	9.9	1.1	0.9	1.4	0.9	1.5	0.4	1.0	1.9	0.8	0.6	0.9	1.3	1.2	1.2	1.8	0.8	1.6	0.9	4.9	4.5	5.8	6.5	4.5	5.5	4.9	5.4	5.1	4.7	5.6	5.4	12.4	6.4	12.4	9.4	6.6	8.0	7.3	10.7	11.4	12.7	8.5	9.7	15.0	5.7	8.6	18.4	12.5	4.6	19.1	4.7	9.8	5.3	174.6	12.6	14.6	8.7	6.7	10.3	16.0	10.7	10.9	17.1	6.6	6.0	24.7	10.0	11.7	11.5	6.2	3.3	21.4	6.9	4.1	9.1	8.3	77.7	15.8	9.9	7.2	3.7	5.4	25.9	9.2	14.1	12.4	6.7	5.7	14.3	10.6	7.3	7.9	25.4	18.9	12.2	0.0	15.3	17.8	39.3	15.5	7.7	5.4	2.5	14.1	17.2	6.0	5.7
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358981-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.6	1.5	0.6	16.2	1.1	53.9	5.2	0.8	1.3	3.5	0.4	14.8	13.7	2.3	2.5	27.2	1.7	1.2	0.9	0.7	1.1	2.3	1.7	2.5	32.6	1.3	1.1	0.7	0.6	0.2	0.3	9.7	1.1	0.8	16.0	0.2	4.4	0.7	0.3	11.3	12.2	7.3	0.8	11.7	7.0	49.1	1.7	52.6	1.7	0.2	50.8	3.3	7.0	1.3	311.9	148.2	202.8	133.4	6.9	17.6	193.5	140.3	125.0	400.0	211.4	234.5	250.9	178.3	80.1	130.1	140.6	212.8	225.3	267.9	331.5	140.8	165.6	261.4	143.6	147.3	2.1	184.3	91.4	6.0	12.4	278.2	249.6	35.1	172.2	167.5	120.2	119.3	184.0	120.4	179.2	113.5	257.2	147.0	196.9	255.8	277.9	112.9	98.5	81.3	119.2	58.9	248.1	165.8	76.6	154.9	116.3	231.7	90.2	118.9	276.2	133.7	445.0	90.6	86.7	185.7	85.2	227.6	181.6	0.0	0.1	0.0	0.3	0.0	0.0	4.2	3.2	3.5	0.9	0.9	0.1	0.3	0.7	9.5	0.0	0.2	11.6	2.8	0.6	1.1	0.8	1.3	0.7	1.1	1.3	1.1	1.1	0.8	1.7	1.3	2.1	0.0	1.1	0.0	12.2	10.5	3.8	17.6	6.2	0.5	6.4	9.7	0.7	1.5	4.8	0.0	0.0	65.0	2.8	16.9	0.0	2.2	135.0	14.6	2.4	4.5	0.0	96.0	0.2	0.4	146.2	9.3	11.7	4.6	0.0	46.5	7.9	1.3	37.4	0.0	0.0	18.5	24.4	6.2	7.5	18.5	2.8	9.3	0.0	0.0	1.8	0.3	0.0	0.0	1.6	0.7	0.5	1.9	34.4	2.7	3.2	3.1	8.3	2.9	0.0	1.0	25.4	126.5	39.8	47.3	8.4	10.7	5.1	1.6	37.5	7.4
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188417	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.7	0.9	0.8	3.3	0.8	15.3	1.1	0.7	1.0	0.6	0.7	3.5	2.0	0.6	0.9	2.4	0.2	0.3	0.4	0.8	2.0	0.7	0.8	0.3	4.4	1.1	1.9	2.2	0.7	0.8	0.8	2.6	1.7	0.6	3.9	2.0	0.8	0.6	0.4	0.6	1.8	1.1	0.8	2.0	0.9	13.3	2.0	8.8	1.8	0.3	5.6	0.9	0.9	0.7	22.2	10.7	50.0	27.2	1.7	3.2	34.2	29.9	11.3	36.7	29.6	46.8	11.2	64.9	11.4	8.0	23.4	16.3	86.6	20.6	38.6	21.4	45.1	83.8	19.0	23.1	1.7	59.4	23.4	1.7	3.1	45.8	19.6	4.6	14.1	47.8	67.6	33.6	20.1	11.8	74.8	46.6	73.4	20.2	24.2	33.2	32.9	35.1	9.5	20.7	23.5	28.8	18.6	21.6	9.5	31.7	11.3	41.9	7.2	18.0	27.7	20.3	41.4	16.7	54.2	101.5	13.5	65.2	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.0	0.8	2.0	1.1	1.9	1.7	0.8	2.0	0.7	0.3	0.0	0.0	1.0	1.1	0.4	0.4	0.8	1.8	0.5	1.2	1.0	111.2	0.0	0.1	0.0	2.1	4.2	0.2	2.4	0.0	0.4	18.3	0.5	0.9	2.7	1.2	8.0	0.2	0.9	7.4	1.5	1.5	1.3	0.0	4.6	1.4	0.3	3.1	0.0	0.5	2.0	0.0	0.6	0.9	31.8	1.5	0.5	0.0	0.0	0.1	1.1	0.0	0.5	0.0	1.1	0.8	1.9	13.0	0.7	0.4	0.4	0.2	0.4	0.0	0.1	2.2	14.5	16.3	4.3	0.0	0.3	0.6	2.4	4.1	0.5
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 7.2;NK-cells: 18.1;T-cells: 28.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	29.2	15.6	30.5	28.8	32.4	29.4	25.1	39.2	33.2	41.7	23.2	37.6	14.4	35.0	9.4	27.1	31.5	17.9	16.3	27.6	32.5	31.3	24.8	78.4	47.6	31.3	29.9	37.4	12.8	3.8	45.7	31.1	30.2	25.4	11.3	7.8	16.7	8.9	10.5	21.8	41.2	14.2	27.4	56.1	30.1	12.4	30.9	44.7	41.8	6.3	32.8	35.8	30.2	35.8	129.6	273.2	36.5	60.0	43.8	43.0	19.3	63.3	95.3	103.1	75.9	49.2	182.9	91.3	27.5	65.4	253.5	183.5	50.6	105.8	50.2	36.2	54.4	49.4	88.5	59.6	178.4	38.6	25.0	41.1	85.0	95.4	115.7	35.6	58.4	44.2	33.3	232.7	63.1	105.5	119.0	57.7	27.3	90.9	116.9	62.0	102.6	67.5	73.2	12.2	25.8	56.9	148.6	140.8	78.1	31.7	48.1	20.4	48.6	55.1	66.2	101.5	85.0	57.8	97.8	36.8	28.1	38.0	54.6	3.9	2.4	0.0	22.7	3.4	21.3	5.8	22.6	23.3	2.4	7.2	18.6	21.6	0.3	18.1	1.7	1.3	28.2	11.2	30.5	32.4	39.2	33.2	27.6	32.5	31.3	29.9	30.2	27.4	30.9	35.8	14.0	9.6	21.7	18.6	21.7	11.2	6.0	10.9	7.4	14.4	4.8	5.5	8.6	8.6	4.5	7.3	2.1	11.9	30.6	5.8	0.0	9.9	0.7	2.7	20.6	27.1	7.8	32.6	39.2	4.8	17.7	15.7	17.3	5.4	1.3	11.5	14.3	13.7	30.4	3.3	38.0	10.4	12.2	14.8	9.4	1.1	7.2	12.4	17.8	6.5	8.8	8.3	44.3	22.6	13.2	15.0	4.3	9.1	49.6	6.0	5.5	11.1	3.7	2.6	0.0	26.5	14.0	2.3	12.3	10.3	11.2	3.6	36.4	7.1	10.9	4.4
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285269-138338355	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 8.9;testis: 18.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 42.1;Spermatocytes: 53.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	0.2	0.2	0.2	2.1	0.2	5.8	0.7	0.3	0.3	0.3	0.2	3.4	3.0	0.4	0.2	1.4	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.3	3.2	0.2	0.3	0.0	0.4	0.1	0.1	1.2	0.2	0.2	4.1	0.1	0.3	0.1	0.0	1.4	3.0	0.8	0.1	0.9	1.1	18.1	0.2	8.9	0.1	0.0	4.6	0.5	0.5	0.2	27.9	11.0	38.4	28.9	0.9	3.6	9.9	16.4	17.5	36.2	50.3	27.3	52.8	13.3	13.8	10.1	40.5	14.9	31.7	25.9	34.9	11.1	21.5	9.6	15.0	21.2	0.3	6.3	10.0	0.8	0.9	22.0	18.0	3.8	24.6	28.9	14.8	24.2	22.9	15.5	19.3	16.7	9.7	22.3	12.2	11.9	34.2	15.0	6.4	8.4	19.2	11.9	36.8	11.0	16.9	32.6	18.7	13.9	7.2	19.9	16.8	13.9	26.5	15.0	13.4	13.0	8.3	14.3	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.1	0.0	0.0	1.3	0.9	0.6	0.3	1.1	1.8	0.0	0.9	0.8	0.3	0.0	0.2	0.0	0.0	5.0	0.5	1.8	0.0	0.1	41.4	0.4	0.9	0.6	0.0	9.5	1.3	0.0	6.9	1.1	3.6	1.2	0.0	5.5	1.4	0.4	2.7	0.0	1.0	3.9	2.0	0.6	0.5	42.1	1.8	1.2	0.0	1.0	0.6	0.0	0.0	1.0	0.3	0.0	1.4	0.4	4.5	0.3	0.9	0.1	0.1	0.0	0.0	0.2	0.9	53.6	13.0	4.3	0.4	1.4	0.6	0.2	4.9	0.6
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34, ubiqiutin conjugating enzyme"	P49427	19	531760-542092	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 249.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311, HPA074334"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: "	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	35.1	36.7	52.0	13.3	51.2	34.5	34.2	51.5	63.0	36.9	47.5	62.5	17.8	33.5	14.1	40.5	33.6	10.1	80.0	52.7	48.7	32.1	88.0	32.1	12.5	51.0	50.7	35.6	58.5	18.7	43.4	29.2	50.8	36.9	11.5	28.2	34.2	19.3	105.0	51.8	27.6	18.5	48.2	31.0	38.6	100.2	52.7	16.4	26.7	63.2	9.7	43.7	34.2	52.7	54.8	54.6	66.4	54.7	29.2	28.4	68.5	47.8	36.1	50.2	51.9	86.1	32.8	29.5	49.3	34.1	30.1	36.9	52.1	40.2	25.0	49.2	146.0	27.8	35.5	94.5	73.6	39.0	32.4	36.4	58.9	42.2	43.6	38.8	60.6	41.2	120.3	57.5	33.8	80.7	53.3	53.6	85.3	39.4	51.7	49.1	35.1	51.2	38.0	32.4	87.2	65.9	41.5	42.1	85.2	53.2	34.0	57.4	50.5	36.5	43.7	86.2	65.2	57.7	47.3	40.1	50.0	55.6	38.8	3.2	2.5	4.7	1.6	2.7	1.1	2.3	2.1	2.9	2.0	1.0	1.6	1.6	8.2	1.2	3.5	1.6	2.5	1.0	52.0	51.2	51.5	63.0	52.7	48.7	51.0	50.7	50.8	48.2	52.7	52.7	39.4	0.0	5.4	21.9	11.4	46.8	17.5	5.4	16.5	35.5	43.4	47.1	27.7	27.1	3.5	14.7	25.0	44.3	30.9	47.4	13.7	24.9	63.9	29.6	28.3	27.7	13.2	77.7	8.3	20.5	55.4	21.4	16.8	42.3	0.0	28.1	15.7	41.1	27.9	16.8	6.3	34.0	14.2	14.5	38.6	249.4	18.0	20.6	19.6	2.8	15.1	68.9	20.6	6.6	12.9	45.0	27.0	15.1	25.0	34.8	25.9	18.9	5.5	44.3	13.1	22.6	34.9	22.4	54.6	15.2	54.7	63.1	22.0	27.1	23.7	27.9
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22025511-22101360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	No		2700000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: AB_2732138"	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	177.4	116.1	91.7	160.2	96.5	402.9	142.7	100.1	113.8	128.6	98.4	198.2	142.3	131.3	99.8	162.3	124.8	131.7	117.0	95.2	108.8	158.8	153.5	154.1	167.9	115.5	103.7	105.9	82.5	128.4	59.6	170.3	108.4	108.3	185.4	95.9	103.8	107.5	119.9	132.0	156.9	175.0	107.4	157.5	159.9	64.2	102.2	157.7	110.6	120.9	216.8	194.8	114.9	127.1	341.9	146.4	272.2	222.0	295.0	306.4	274.2	347.3	318.8	365.5	336.2	178.0	374.5	253.1	272.8	416.7	136.2	210.7	241.1	369.3	431.1	332.4	180.1	438.1	184.5	225.4	259.1	388.5	350.5	285.6	396.6	341.0	195.2	234.7	535.6	157.8	250.8	273.4	430.2	135.6	242.9	307.5	170.2	242.9	179.3	199.6	297.6	243.3	316.2	301.3	183.4	175.8	293.4	228.7	263.4	296.3	242.3	219.1	466.3	265.3	265.2	349.3	207.8	148.6	355.9	305.8	234.5	419.3	277.6	244.3	200.6	255.1	142.4	282.3	144.3	108.0	152.0	146.7	162.3	103.4	109.5	143.5	308.3	145.0	352.2	107.2	157.4	244.8	91.7	96.5	100.1	113.8	95.2	108.8	115.5	103.7	108.4	107.4	102.2	127.1	502.1	60.9	51.8	20.9	301.0	450.6	385.5	266.0	136.1	119.1	281.1	179.6	86.9	231.6	168.0	312.6	18.8	349.6	470.1	434.9	375.6	441.3	38.0	350.5	356.5	307.7	300.4	243.0	58.5	441.9	499.6	225.2	152.4	425.8	163.6	138.2	277.0	230.9	439.2	106.0	71.0	315.4	187.2	585.4	875.2	41.3	157.8	443.4	423.4	53.4	654.9	102.5	286.3	41.7	72.9	570.5	369.7	177.1	192.9	323.1	283.1	578.2	176.2	65.2	236.7	174.2	308.3	155.3	116.2	176.6	556.6	551.6	379.2	178.6	286.7	469.6
CDC42BPA	"FLJ23347, KIAA0451, MRCK, MRCKA, PK428"	ENSG00000143776	"CDC42 binding protein kinase alpha"	Q5VT25	1	226989865-227318474	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 320.3;Excitatory neurons: 447.6;Inhibitory neurons: 479.0;Oligodendrocyte precursor cells: 444.3;Oligodendrocytes: 671.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB070414, HPA071252"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Intermediate filaments"		"CAB070414: AB_11156796, HPA071252: AB_2686374"	"unprognostic (3.67e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-2)"	15.6	12.5	26.3	5.5	32.4	3.5	12.2	33.5	30.0	15.8	12.2	21.2	14.7	15.0	7.7	10.1	12.6	13.7	16.4	24.9	25.2	17.3	14.7	12.3	2.0	25.7	26.8	14.0	13.1	19.7	14.6	12.7	27.0	15.8	10.3	23.7	7.6	14.9	11.4	6.3	12.9	14.5	19.8	6.6	22.4	24.4	29.7	2.2	8.1	13.6	1.8	23.0	11.3	37.0	22.6	21.1	21.9	10.4	21.5	26.4	7.7	25.4	35.7	17.2	17.9	17.1	50.1	0.1	26.6	42.4	13.0	10.3	16.3	14.2	20.9	0.1	13.2	17.4	25.5	6.7	24.3	14.1	7.5	18.6	17.9	27.8	27.8	21.3	58.0	13.6	45.1	0.1	28.2	6.2	0.4	2.5	18.0	29.3	20.0	0.0	37.0	0.1	27.7	43.1	15.7	22.9	43.0	17.8	24.8	13.4	23.1	0.8	59.0	31.3	16.2	36.1	33.9	0.1	0.1	0.1	41.4	0.0	42.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.3	32.4	33.5	30.0	24.9	25.2	25.7	26.8	27.0	19.8	29.7	37.0	82.6	41.7	35.7	320.3	0.8	11.7	26.0	15.9	12.0	97.7	14.0	12.8	59.9	30.0	38.9	44.1	118.9	5.9	1.8	49.3	13.7	26.0	128.0	18.7	45.1	68.4	26.4	45.6	447.6	41.1	7.3	44.4	92.8	25.7	7.0	21.5	47.8	28.9	3.7	223.8	479.0	30.5	22.4	4.4	9.9	132.3	44.1	6.4	16.0	180.8	5.9	33.4	0.0	444.3	671.8	65.1	74.0	85.4	1.8	30.1	50.7	41.3	24.8	66.9	78.9	64.0	68.4	45.6	57.7	8.0	8.0	1.4	1.3	23.4	34.4	43.1
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560480-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 245.6;Exocrine glandular cells: 226.0;Pancreatic endocrine cells: 266.2;Urothelial cells: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 7.3;intermediate monocyte: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006379, HPA076536"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA006379: AB_1078486, HPA076536: "	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	76.3	91.2	55.7	16.7	107.5	1.6	58.0	89.9	73.3	68.2	17.6	43.7	31.1	70.7	4.1	93.1	61.0	40.8	53.8	55.9	67.3	50.2	133.1	65.2	11.3	102.8	104.5	60.9	161.6	16.5	18.8	31.8	97.4	41.5	14.4	2.6	102.7	23.9	13.1	71.2	32.7	19.6	70.2	26.2	155.9	23.6	87.5	2.7	33.7	11.1	10.4	38.4	69.6	151.5	125.2	35.4	15.1	67.9	23.7	40.2	73.3	69.9	41.0	78.9	54.3	87.8	15.9	0.2	24.2	81.4	25.4	95.0	17.8	35.1	26.0	15.5	60.7	0.5	33.9	53.6	167.7	0.3	0.6	74.9	52.1	65.0	61.5	63.1	59.2	0.1	78.9	0.7	33.0	42.6	0.3	0.5	13.6	96.5	79.6	0.4	27.5	2.4	27.9	1.9	0.4	2.6	51.2	112.3	112.4	20.6	50.3	11.0	91.6	163.9	98.2	80.0	98.6	0.2	0.8	0.3	65.3	0.7	135.6	0.4	7.3	0.0	0.1	1.9	0.1	0.0	0.1	0.1	2.4	0.3	0.0	0.2	0.2	0.4	0.1	0.3	0.0	3.4	55.7	107.5	89.9	73.3	55.9	67.3	102.8	104.5	97.4	70.2	87.5	151.5	62.4	6.4	19.5	2.3	1.8	46.9	87.2	51.4	21.1	0.1	59.2	31.8	3.5	134.4	41.1	12.9	0.0	98.2	2.0	41.6	1.9	245.6	3.7	4.3	20.0	54.7	11.5	0.0	0.1	226.0	110.3	32.1	133.0	9.0	2.5	1.7	69.7	35.6	13.2	1.7	0.2	66.6	30.5	5.9	29.3	1.7	39.4	5.3	21.4	4.7	8.9	12.8	0.0	2.0	42.7	266.2	45.8	35.3	0.6	122.4	17.5	11.4	14.7	0.3	39.5	22.8	49.5	2.0	0.6	55.9	52.0	112.2	2.2	7.0	61.1	161.3
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287879-40304657	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2;lymphoid tissue: 17.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 500.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	2.1	1.9	0.5	13.7	0.8	27.2	3.4	0.2	1.9	3.2	0.0	8.4	7.5	2.2	1.1	5.7	1.0	2.8	0.6	1.1	0.1	0.5	3.0	1.4	16.4	0.1	0.0	0.9	1.9	0.8	0.5	9.3	0.3	1.1	8.7	0.5	1.3	1.2	0.3	2.8	6.7	3.7	0.0	3.7	3.6	10.1	0.2	16.7	1.7	0.5	17.1	4.3	1.8	0.6	155.1	119.0	115.1	86.5	6.7	12.7	118.0	159.9	49.0	149.2	166.5	135.8	64.9	123.9	99.6	35.9	85.9	214.0	112.2	76.2	148.9	64.5	98.4	96.2	122.3	134.6	4.4	133.3	55.1	4.7	8.1	156.4	107.1	14.8	46.9	84.2	183.0	109.0	71.9	95.8	199.3	43.3	101.6	96.9	48.7	145.0	286.8	119.9	30.3	184.8	85.6	76.9	146.9	500.3	55.4	100.3	100.8	120.0	34.7	95.5	146.3	170.8	196.1	46.1	103.6	222.8	84.6	93.9	109.2	0.1	0.1	0.0	0.8	0.0	0.5	0.4	0.6	1.1	0.7	0.3	0.4	1.1	0.1	1.5	0.0	3.6	2.4	0.6	0.5	0.8	0.2	1.9	1.1	0.1	0.1	0.0	0.3	0.0	0.2	0.6	2.2	0.0	2.0	0.7	4.9	4.2	1.1	3.7	3.4	0.2	2.1	2.2	0.9	1.5	1.3	0.0	0.0	23.2	2.3	7.8	0.0	1.3	2.2	1.3	2.9	2.1	0.0	37.2	2.0	0.6	34.6	5.6	3.6	5.1	0.0	8.1	1.1	0.9	8.3	0.0	0.7	6.1	0.0	1.3	2.1	1.0	2.8	1.5	0.0	0.0	0.0	0.4	2.1	0.0	0.2	1.5	3.0	0.7	31.6	1.3	0.8	0.2	0.2	0.3	13.1	0.6	4.6	69.5	57.2	9.1	1.6	16.7	3.3	1.9	9.3	2.4
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500851-91525764	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.8;Erythroid cells: 23.1;Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	1.9	2.7	3.6	6.0	3.8	13.8	2.1	6.3	4.8	2.1	1.6	3.0	3.1	1.8	1.7	3.5	1.3	1.7	1.4	3.8	3.4	4.3	1.5	4.2	9.3	2.9	3.7	2.5	1.6	0.8	4.0	5.9	3.1	1.9	4.6	14.1	1.7	1.4	0.5	5.1	3.7	2.4	2.8	12.1	1.8	16.9	3.2	10.9	1.7	0.5	9.4	2.4	2.3	3.5	32.0	9.4	59.1	17.3	1.4	7.6	18.8	12.0	9.1	22.6	24.3	19.6	10.8	22.5	16.1	7.7	19.8	13.7	39.8	13.5	29.4	36.8	34.3	33.7	27.9	9.5	2.1	37.0	11.9	4.2	4.0	21.0	11.9	4.1	8.9	30.9	44.8	31.4	15.2	11.8	31.5	33.5	48.9	17.2	21.6	38.9	49.5	14.5	10.2	24.0	44.7	18.6	37.5	10.2	21.6	14.3	9.8	18.2	7.3	25.8	22.7	20.6	17.9	11.6	15.6	57.9	9.4	36.0	9.4	0.0	1.0	0.0	3.8	0.7	3.2	0.9	2.8	3.5	2.3	0.9	1.5	3.0	0.1	1.6	0.2	1.4	4.6	1.4	3.6	3.8	6.3	4.8	3.8	3.4	2.9	3.7	3.1	2.8	3.2	3.5	1.9	0.0	1.1	3.3	3.2	5.9	1.2	2.7	3.4	8.2	14.4	1.4	2.1	0.0	1.3	1.8	0.0	8.2	4.1	0.6	3.9	1.5	37.8	1.1	4.9	4.1	0.0	23.1	18.3	2.6	6.3	3.1	2.6	1.9	4.5	15.4	4.2	0.2	2.7	3.3	19.6	1.8	6.1	2.2	2.9	18.7	0.9	1.6	3.6	5.6	2.1	1.6	6.2	16.6	3.1	1.2	1.7	0.7	7.1	0.9	0.5	0.4	2.0	5.1	6.6	1.5	4.1	30.5	21.4	4.3	3.7	2.2	5.3	7.6	3.6	1.0
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121983-193254815	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002326, CAB016359, HPA069324"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA002326: , HPA069324: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	11.3	9.5	5.8	7.3	6.9	8.9	10.7	6.1	7.3	11.1	4.5	10.2	5.6	10.3	8.5	8.4	7.2	5.9	9.6	4.6	8.1	10.4	9.2	7.9	7.5	6.9	7.2	11.5	6.4	12.9	5.6	9.4	7.9	15.1	9.0	10.1	7.7	9.7	12.2	7.0	7.7	10.3	7.9	8.6	7.0	5.9	6.5	10.6	13.1	5.6	7.9	9.7	8.5	8.3	9.3	2.4	16.6	11.5	18.3	18.9	4.9	6.7	16.1	19.5	16.4	6.5	12.3	10.5	5.2	20.4	8.8	10.7	16.8	14.9	24.7	6.1	4.1	7.3	8.1	7.2	16.1	16.0	11.6	13.7	16.0	14.9	17.7	20.6	17.8	11.1	8.1	14.2	28.8	3.5	13.9	9.2	11.9	21.9	2.5	10.6	7.0	15.0	26.6	8.2	3.9	12.3	8.6	26.8	22.3	21.0	18.3	14.0	9.2	19.3	2.2	16.4	12.6	12.2	7.2	7.6	11.9	10.2	30.1	2.2	0.5	0.7	0.8	1.0	1.2	0.9	1.1	0.6	0.6	0.5	1.4	1.2	0.3	1.3	0.8	1.0	0.9	0.4	5.8	6.9	6.1	7.3	4.6	8.1	6.9	7.2	7.9	7.9	6.5	8.3	44.5	35.3	25.4	54.5	44.9	37.2	35.6	38.4	36.5	30.4	24.4	21.8	44.5	25.8	27.2	33.1	35.5	25.0	48.0	18.2	33.2	37.5	19.7	24.6	39.6	38.0	11.4	40.8	71.9	32.2	42.0	39.1	28.1	30.8	41.1	17.6	25.4	17.2	31.6	21.9	76.4	15.8	34.6	27.4	49.1	8.5	33.5	38.3	28.4	54.4	46.0	35.2	41.2	78.4	112.3	35.5	16.9	36.1	50.3	34.9	19.2	36.3	20.6	36.7	26.3	49.0	48.3	55.6	33.0	36.8	34.9	38.0	44.4	30.3	18.6	27.9
CDCA2	"PPP1R81, Repo-Man"	ENSG00000184661	"Cell division cycle associated 2"	Q69YH5	8	25459199-25507911	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.5;lymphoid tissue: 11.4;testis: 19.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 23.3;Early spermatids: 49.9;Erythroid cells: 19.0;Late spermatids: 24.2;Spermatocytes: 66.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA026293, HPA030049"	Enhanced		Supported	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA026293: AB_1846384, HPA030049: AB_10600862"	"unprognostic (2.12e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.47e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.30e-14)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.30e-2)"	0.2	0.0	0.0	2.6	0.0	6.5	0.6	0.1	0.0	0.2	0.1	1.9	1.6	0.3	0.0	1.4	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.2	5.3	0.2	0.2	0.0	0.0	0.0	0.0	1.2	0.2	0.1	2.2	0.1	0.2	0.0	0.0	1.1	1.8	0.8	0.0	0.8	0.9	19.4	0.3	11.4	0.1	0.1	6.7	0.6	0.3	0.1	36.5	30.2	29.4	24.2	2.3	4.5	20.2	37.7	22.6	32.9	32.4	25.7	15.8	42.6	16.0	16.2	34.6	31.6	42.9	20.0	48.5	16.2	12.0	43.2	22.4	15.2	0.6	18.4	19.4	2.5	1.0	23.5	15.8	3.3	24.5	24.5	33.6	45.8	30.6	13.9	54.5	8.7	31.0	24.1	14.5	26.3	33.4	15.2	9.2	18.7	12.0	13.3	33.3	16.1	14.3	14.7	17.4	9.4	16.6	23.9	39.3	44.7	35.6	7.1	16.5	44.4	17.7	24.3	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	1.1	0.0	2.7	1.1	0.5	1.7	0.0	0.7	0.9	0.8	23.3	0.0	0.2	0.0	0.0	7.2	0.5	1.8	0.0	0.2	49.9	0.8	1.2	1.1	0.0	19.0	0.2	0.0	13.4	2.5	4.1	1.4	0.0	8.8	1.1	0.1	4.1	0.0	0.1	1.3	0.0	2.9	0.6	24.2	1.2	2.1	0.0	0.0	0.6	0.1	2.1	0.5	0.6	0.2	0.1	0.0	15.8	0.5	0.5	1.2	0.9	0.5	13.1	0.1	2.1	66.6	27.8	10.7	0.9	1.6	2.9	1.3	3.6	0.5
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.4;lymphoid tissue: 27.6;testis: 37.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.8;T-reg: 2.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.8;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			"HPA023691, HPA076007"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023691: AB_1846392, HPA076007: "	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.4	1.2	1.3	10.5	1.3	53.4	2.0	0.8	1.8	1.9	0.9	6.8	5.8	1.3	0.3	9.3	0.9	0.9	0.9	1.5	0.9	0.9	1.3	1.9	17.0	1.6	1.3	0.6	0.7	0.4	0.5	6.5	1.6	0.8	7.7	0.5	1.4	0.5	0.6	4.2	5.8	3.1	0.8	6.6	3.1	37.8	1.8	27.6	0.6	0.4	16.2	2.2	2.8	1.3	131.7	74.9	67.2	57.3	4.5	7.3	57.8	92.7	37.4	103.6	81.5	77.7	75.4	121.3	52.3	29.4	120.8	87.9	110.3	49.5	98.6	122.0	52.2	107.7	54.4	64.1	0.4	116.8	81.8	2.5	4.5	96.3	44.0	10.8	32.6	138.4	126.6	206.6	63.5	109.2	164.7	116.9	107.8	63.0	92.4	140.4	76.8	111.9	21.2	49.6	89.1	68.4	59.3	80.7	62.8	41.6	104.7	54.7	19.9	92.7	97.2	99.5	101.7	106.9	187.8	195.4	37.2	69.5	97.4	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.5	0.3	0.4	0.5	0.0	0.3	0.0	2.8	0.3	0.3	2.0	0.7	1.3	1.3	0.8	1.8	1.5	0.9	1.6	1.3	1.6	0.8	1.8	1.3	0.9	0.0	0.5	0.0	4.6	3.8	1.2	1.3	0.6	0.6	2.3	4.4	1.0	0.0	0.8	0.0	2.1	19.7	2.2	4.6	1.9	0.8	56.5	1.1	1.5	2.3	0.0	21.8	1.1	0.8	38.3	3.5	3.1	1.5	3.8	14.5	1.1	0.0	11.7	1.7	0.6	4.7	2.0	2.8	1.5	116.9	2.8	1.7	0.0	1.0	2.1	0.9	2.1	0.0	0.6	0.6	0.1	1.5	16.2	1.1	1.1	0.6	0.4	0.2	0.0	0.5	2.7	50.4	31.1	7.1	1.0	3.7	4.2	1.9	9.4	1.6
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.4;lymphoid tissue: 50.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 45.7;Intestinal goblet cells: 40.7;Leydig cells: 53.7;Undifferentiated cells: 124.2"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 43.3"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 279.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA005565: AB_2078680"	"unprognostic (1.67e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.96e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.97e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.53e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.47e-2)"	1.7	0.3	0.7	13.1	0.6	23.0	2.4	0.5	0.7	12.6	6.5	25.5	30.7	13.8	3.3	10.1	3.8	1.5	0.8	0.7	1.2	0.5	0.3	1.6	37.5	0.7	0.9	1.1	1.7	0.3	0.1	7.4	0.7	3.0	29.5	0.4	2.5	1.2	3.1	11.7	32.4	3.4	0.7	2.4	14.3	6.0	1.2	50.1	0.5	0.8	41.2	2.8	6.7	1.0	44.2	33.3	76.4	83.3	3.6	14.0	79.9	26.0	9.2	60.3	67.2	51.6	54.4	122.1	32.2	15.8	23.5	45.0	122.4	46.6	87.0	59.2	67.4	27.6	24.6	66.0	3.8	181.2	25.1	11.4	3.9	32.8	27.3	7.8	28.0	158.1	67.4	27.2	17.7	35.4	279.7	181.7	90.4	103.4	22.7	194.4	58.2	77.3	29.5	38.2	22.3	39.2	40.8	13.4	22.0	67.9	0.3	70.5	13.0	39.3	16.8	12.9	48.5	7.4	17.1	173.0	24.4	99.8	34.0	0.0	0.5	0.0	1.1	0.0	0.4	1.9	3.0	5.9	3.5	0.3	0.2	1.0	0.2	3.2	0.0	0.5	7.9	2.3	0.7	0.6	0.5	0.7	0.7	1.2	0.7	0.9	0.7	0.7	1.2	1.0	1.0	0.0	0.6	0.7	3.0	20.3	14.9	3.3	14.8	0.0	2.6	6.5	1.1	0.0	0.3	0.0	0.0	45.7	1.6	17.1	0.0	0.2	0.9	3.2	33.0	3.4	12.2	33.6	0.1	0.2	29.9	4.1	22.4	6.8	0.0	18.5	0.0	0.2	10.4	0.0	10.5	40.7	4.1	1.0	4.4	2.2	53.7	2.3	3.6	0.0	1.2	0.7	0.0	0.5	0.1	1.0	11.1	34.6	3.8	5.3	11.9	0.0	0.1	0.0	0.0	1.1	7.2	13.8	28.9	21.8	15.9	10.1	9.1	2.7	124.2	3.8
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900899-21945903	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 51.0;Spermatogonia: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 101.0;naive B-cell: 124.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory bulb: 10.1"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	5.9	1.4	3.9	15.0	9.1	51.7	15.7	5.7	5.2	8.7	17.8	17.0	10.7	13.8	5.5	11.2	11.5	8.1	25.3	3.9	3.5	2.8	4.8	14.0	37.1	6.9	4.8	21.8	13.0	1.8	1.1	4.7	3.8	7.3	19.0	5.1	9.0	7.6	6.2	18.5	13.6	11.9	5.0	13.3	17.8	18.5	7.8	49.0	29.8	3.4	31.8	6.3	8.1	9.8	84.5	27.6	26.0	0.6	14.5	17.9	0.0	65.9	58.2	51.8	73.5	11.3	75.4	173.6	21.8	59.3	102.4	51.1	41.4	69.4	103.6	0.3	28.6	42.3	83.8	7.4	21.1	111.1	0.4	35.2	12.7	40.0	116.9	54.9	104.8	133.5	58.3	0.1	41.4	34.5	146.1	46.1	153.2	17.4	36.2	141.0	94.0	119.8	15.4	14.8	96.9	79.7	30.3	19.9	29.9	34.4	45.6	54.6	43.0	57.1	68.5	101.3	83.8	90.6	63.6	223.0	55.7	154.6	54.5	1.1	2.3	43.2	2.2	3.8	0.3	101.0	6.4	3.2	14.9	124.5	30.9	12.8	3.8	3.4	4.9	75.9	9.9	12.2	3.9	9.1	5.7	5.2	3.9	3.5	6.9	4.8	3.8	5.0	7.8	9.8	1.0	19.2	31.5	7.5	51.0	27.1	23.7	6.9	17.1	1.5	12.5	20.7	38.7	11.5	19.0	0.0	2.1	0.5	30.7	8.4	3.9	8.9	7.3	5.4	2.7	4.8	10.7	21.9	0.5	6.2	0.3	13.4	18.3	5.3	8.8	14.9	1.4	4.0	10.8	13.5	1.0	26.1	8.2	15.2	3.5	5.2	4.1	7.0	8.8	1.9	1.6	2.4	1.0	15.1	8.7	3.9	7.4	2.6	20.2	14.2	1.5	0.1	4.2	2.7	13.1	6.8	12.4	4.6	63.5	9.6	7.7	0.3	5.4	8.3	23.0	6.2
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692481-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.0	1.1	0.7	7.9	1.0	33.5	2.0	0.2	0.9	1.7	0.0	9.4	8.3	1.3	1.8	9.2	1.0	1.1	0.6	0.5	0.4	0.8	1.3	1.5	19.5	0.6	0.4	0.6	0.8	0.5	0.6	4.4	0.5	0.7	11.3	1.9	1.8	0.5	0.3	6.3	7.3	2.8	0.3	4.9	4.9	22.5	0.6	38.8	0.6	0.5	22.7	2.0	2.9	0.7	108.5	45.5	84.4	62.1	3.6	7.0	57.2	79.6	39.5	137.2	96.6	71.9	78.8	130.2	31.5	50.5	54.5	59.4	97.8	52.4	141.9	86.8	44.9	116.8	49.2	57.3	0.8	113.8	58.4	2.8	3.8	77.1	67.3	15.3	60.9	91.1	100.7	135.6	99.1	47.7	106.1	68.9	98.8	61.7	62.8	102.2	115.6	74.4	31.0	43.8	75.4	33.3	87.5	40.6	52.4	71.7	60.1	42.4	37.3	67.8	70.6	39.2	126.0	91.4	128.1	176.3	31.6	104.7	79.6	0.0	0.7	1.3	1.5	1.6	2.8	1.7	3.6	2.2	0.7	1.4	1.1	2.3	3.0	4.1	3.9	1.2	5.9	1.7	0.7	1.0	0.2	0.9	0.5	0.4	0.6	0.4	0.5	0.3	0.6	0.7	0.8	0.0	0.5	1.3	4.8	3.3	0.8	2.4	1.8	1.3	1.9	1.5	0.7	2.8	0.4	0.0	0.0	17.1	1.9	12.4	0.0	1.2	1.0	1.7	1.6	1.9	3.6	34.1	1.2	0.6	26.0	2.9	6.6	2.5	0.0	12.0	3.6	1.0	11.6	1.7	0.9	8.2	2.0	3.5	1.9	2.8	1.5	3.7	1.8	0.0	1.6	0.1	2.1	0.5	0.9	2.4	4.0	1.2	15.8	1.3	1.9	0.6	4.7	1.0	19.7	0.2	6.3	76.8	42.0	17.1	2.7	2.9	5.5	1.2	13.2	1.2
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737292-68835537	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 197.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 451.6;Glandular and luminal cells: 321.0;Pancreatic endocrine cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.7;plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 683.3;CACO-2: 241.9;CAPAN-2: 328.1;HaCaT: 318.7;hTCEpi: 217.2;MCF7: 199.6;OE19: 207.2;RT4: 237.7;T-47d: 209.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA		78000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.0	0.2	1.5	16.1	2.0	6.5	64.2	0.6	1.9	30.0	19.3	127.5	133.9	9.6	39.5	76.9	51.5	45.7	0.3	1.5	1.3	39.8	97.2	36.8	5.6	2.0	1.3	1.3	84.0	197.8	8.0	60.9	1.3	91.7	131.0	0.1	71.9	41.7	0.3	107.7	127.9	5.1	2.1	10.3	104.2	0.4	2.3	20.1	162.7	0.1	29.0	58.2	38.1	2.7	147.0	14.8	0.0	0.5	0.0	0.0	683.3	0.0	0.0	0.0	0.0	241.9	328.1	0.0	3.1	0.0	0.0	318.7	0.0	156.3	0.0	28.6	3.5	0.1	0.7	48.0	0.0	0.0	0.6	0.0	217.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	199.6	0.2	1.0	5.5	207.2	0.8	0.1	0.1	2.1	53.9	237.7	8.5	0.8	1.4	0.2	58.9	91.8	209.2	0.4	0.0	0.4	0.9	0.7	0.6	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.1	1.5	2.0	0.6	1.9	1.5	1.3	2.0	1.3	1.3	2.1	2.3	2.7	0.6	131.4	69.8	0.7	1.4	94.1	130.3	73.8	45.5	0.0	137.6	83.6	0.9	128.7	95.3	163.7	0.0	117.6	2.5	451.6	1.9	129.1	0.1	159.3	29.2	4.4	86.7	9.0	0.7	113.5	29.6	3.4	132.0	321.0	1.3	2.8	0.4	63.4	11.7	0.0	1.4	208.3	75.3	1.2	13.4	0.0	0.3	3.2	53.4	1.0	3.3	0.0	0.0	0.5	32.1	264.6	204.6	0.4	2.2	195.5	159.5	4.5	118.2	0.0	0.0	0.0	7.1	0.1	0.1	100.6	131.6	50.5	2.7	0.0	154.8	251.5
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404784	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 235.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 311.9;Endothelial cells: 206.1;Hepatic stellate cells: 185.6;Late spermatids: 84.6;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 752.5;TIME: 655.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1300000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	84.5	13.8	16.3	14.9	15.9	0.2	71.4	15.1	16.6	16.2	11.3	16.8	7.9	19.9	8.6	12.4	17.1	29.7	84.4	13.8	14.6	19.1	24.0	95.0	13.1	16.7	16.6	8.1	7.7	10.3	7.4	235.9	17.9	11.6	10.2	1.3	12.0	9.1	41.8	16.7	17.0	27.8	15.5	20.4	13.3	10.5	22.6	5.2	37.5	58.9	7.9	22.1	14.2	15.5	0.5	0.6	4.6	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	119.8	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	752.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	15.7	0.0	2.4	0.0	0.1	655.1	0.0	0.9	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	15.9	15.1	16.6	13.8	14.6	16.7	16.6	17.9	15.5	22.6	15.5	311.9	0.0	6.2	1.3	0.7	4.1	0.0	0.0	1.8	0.0	1.0	2.7	17.9	5.7	0.6	1.8	0.0	6.6	0.5	0.0	0.0	0.2	33.5	0.5	0.6	206.1	0.0	10.7	0.1	0.0	48.9	7.1	0.0	1.3	3.8	0.0	185.6	1.7	2.3	0.0	0.1	0.0	0.0	35.7	6.3	84.6	6.2	1.2	12.4	28.1	0.1	0.3	0.0	0.5	0.1	0.0	0.0	2.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.4	10.9	0.3	0.3	3.0	80.7	1.5	3.0	0.1	0.2
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193686-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 14.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Excitatory neurons: 67.1;Oligodendrocyte precursor cells: 60.8;Pancreatic endocrine cells: 63.8;Proximal tubular cells: 171.1;Sertoli cells: 46.0;Smooth muscle cells: 69.5"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 477.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		9600000		"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	5.0	1.1	3.2	1.4	9.3	0.2	2.6	2.2	3.7	4.3	0.5	1.3	1.3	2.3	1.8	2.4	6.8	9.2	2.0	2.2	7.4	14.8	0.7	4.5	0.6	4.9	9.5	0.7	0.7	1.1	1.0	3.6	6.0	1.1	0.9	1.5	0.7	1.8	1.2	1.0	1.2	2.6	3.2	0.8	1.0	0.3	9.8	0.4	2.3	1.6	0.7	2.3	1.9	3.9	0.1	1.9	62.2	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.2	0.0	0.1	477.1	0.3	0.0	0.0	49.6	0.1	0.0	0.6	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	17.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	9.4	0.0	0.2	0.0	10.9	0.1	14.0	0.0	1.8	0.0	0.0	0.1	0.2	19.3	0.1	0.2	0.0	0.1	1.8	5.9	1.5	0.1	0.4	1.1	0.1	0.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	9.3	2.2	3.7	2.2	7.4	4.9	9.5	6.0	3.2	9.8	3.9	5.7	0.0	0.5	7.2	2.4	0.9	0.1	36.5	0.0	10.8	0.1	0.4	3.1	48.6	7.0	11.0	0.0	0.0	0.0	0.0	27.4	37.2	0.2	2.9	0.6	5.3	0.0	0.0	67.1	3.0	0.0	2.9	0.0	2.9	0.0	4.1	0.0	0.1	0.1	0.0	33.6	0.0	0.0	0.0	2.5	0.1	0.3	1.3	0.0	39.4	1.0	0.3	0.0	60.8	5.5	63.8	0.0	0.4	0.0	1.2	0.0	171.1	1.1	0.8	46.0	0.6	69.5	0.0	0.4	0.1	1.0	0.0	1.8	0.2	0.0	0.1
CDH8		ENSG00000150394	"Cadherin 8"	P55286	16	61647242-62037035	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 22.4"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 220.8;Inhibitory neurons: 236.4;Oligodendrocytes: 145.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.0;fHDF/TERT166: 6.3;HaCaT: 14.4;LHCN-M2: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014908, HPA076441"	Approved		Approved	"Plasma membrane"		NA	NA		870000		"Cluster 65: Brain - Ion transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014908: AB_1845908, HPA076441: "	"unprognostic (1.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.91e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	0.1	0.1	7.2	0.0	9.9	0.0	0.3	0.0	22.4	0.4	0.0	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.2	16.3	5.7	0.0	0.0	0.1	0.0	6.4	9.8	1.7	0.0	0.1	0.7	0.3	18.4	0.4	0.1	2.2	0.4	5.0	0.4	0.1	0.2	0.4	7.6	0.0	0.1	0.3	9.1	0.5	0.1	0.9	0.0	0.4	0.1	2.5	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.3	0.0	14.4	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	17.3	0.0	0.0	0.0	1.3	0.0	1.3	0.0	0.0	1.1	0.0	1.9	0.1	0.1	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.9	0.0	22.4	16.3	5.7	6.4	9.8	18.4	7.6	9.1	2.5	0.4	0.0	0.5	3.9	0.0	0.1	0.8	1.3	1.2	15.1	0.1	0.9	1.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.9	0.1	0.1	0.5	0.0	0.0	220.8	0.0	0.2	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	236.4	0.0	2.0	0.0	0.0	1.3	0.0	0.1	0.0	8.4	0.0	0.7	0.0	7.5	145.7	0.0	0.0	0.4	0.0	0.3	0.0	0.2	2.7	0.7	0.0	0.7	4.7	1.3	2.5	0.5	0.1	0.3	0.1	0.1	0.0	0.8
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.2;lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.2;T-reg: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003387, CAB003799, CAB079974"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		51000	"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	3.8	1.8	0.9	17.0	1.0	53.2	7.4	0.9	1.5	5.2	0.9	17.6	16.3	7.1	12.2	17.5	3.7	4.3	1.4	0.9	1.0	3.1	3.2	4.7	40.6	1.2	1.2	2.3	0.8	2.5	4.1	19.4	1.1	1.7	20.8	1.3	3.2	5.2	1.4	13.2	14.5	8.0	0.9	9.0	10.1	25.1	1.4	74.0	3.6	2.2	47.5	7.1	6.9	1.0	249.9	93.5	241.1	96.0	15.4	23.6	99.0	183.8	132.7	218.8	209.0	218.9	213.7	226.2	69.6	50.6	79.6	149.9	166.2	106.8	225.8	162.3	121.1	119.4	84.4	128.1	2.8	184.5	117.6	4.7	10.4	142.1	137.0	49.6	133.3	146.2	185.1	270.3	246.9	66.3	234.0	131.1	106.6	149.3	193.1	199.7	224.5	111.3	84.3	81.4	112.7	98.7	123.5	184.9	96.3	130.0	199.9	111.5	55.4	92.8	197.9	99.1	255.8	104.9	180.8	205.6	79.9	203.5	117.6	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.7	1.3	0.3	0.4	0.2	0.7	0.0	3.2	0.1	0.9	3.4	0.9	0.9	1.0	0.9	1.5	0.9	1.0	1.2	1.2	1.1	0.9	1.4	1.0	7.7	0.0	3.2	0.3	7.1	39.8	5.4	29.9	2.8	1.1	5.3	6.1	0.8	0.0	10.2	18.4	0.0	80.9	3.6	8.9	3.9	0.8	18.7	10.8	6.2	10.5	3.0	209.6	0.4	0.0	144.6	13.3	13.3	9.4	0.0	51.5	7.5	1.3	57.2	0.0	0.2	14.6	30.5	20.5	18.1	10.4	2.1	16.5	1.8	1.9	1.0	1.0	3.1	0.0	0.1	0.4	0.7	0.7	32.1	4.3	2.2	3.0	17.6	0.7	0.0	0.5	24.6	110.0	39.6	33.8	18.6	22.0	10.3	2.1	26.6	10.4
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696354	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (3.63e-4)"	30.1	38.5	20.2	10.4	20.4	19.5	26.7	20.3	32.8	49.3	22.0	38.2	22.7	25.9	8.7	35.3	36.3	8.6	27.3	21.0	19.5	52.9	77.0	31.0	14.7	18.6	18.7	43.2	49.2	13.5	55.5	12.5	19.6	39.1	11.3	7.6	24.8	7.5	33.8	32.1	36.1	8.2	17.0	37.5	38.5	17.0	18.4	10.8	54.5	4.1	7.0	32.3	36.5	19.1	27.5	17.8	13.9	5.8	5.7	11.0	14.2	22.3	12.6	15.2	4.9	13.1	21.2	23.9	9.8	19.3	9.1	15.5	5.8	30.8	9.3	5.3	14.1	9.7	21.0	1.7	23.4	15.8	17.1	13.3	10.7	9.3	15.3	10.3	27.0	16.1	25.5	3.2	17.7	36.6	19.5	45.0	28.5	29.7	13.1	26.5	19.0	34.1	27.9	21.2	10.1	29.6	28.0	13.0	6.8	15.2	30.3	25.0	24.1	9.1	26.6	10.1	15.4	11.7	6.4	7.5	16.4	25.0	15.5	5.1	14.0	4.2	14.8	19.7	12.8	7.8	13.2	10.7	18.1	9.0	15.1	12.6	1.5	20.4	15.4	12.4	11.6	11.4	20.2	20.4	20.3	32.8	21.0	19.5	18.6	18.7	19.6	17.0	18.4	19.1	28.2	12.8	26.6	35.3	21.2	15.4	24.2	26.9	23.3	17.2	24.5	25.1	6.5	38.6	20.0	27.6	25.0	28.6	26.7	44.8	43.0	28.6	6.1	20.7	21.9	23.0	67.7	15.4	44.5	12.5	19.8	19.6	85.1	16.9	9.5	40.3	21.8	41.1	18.8	18.5	33.3	49.4	26.4	17.4	16.0	8.8	23.9	17.0	19.6	17.8	15.5	8.5	26.8	24.6	20.0	13.6	41.5	12.4	20.8	30.7	58.3	53.7	28.1	32.3	6.6	11.4	16.3	27.3	28.7	22.4	15.5	27.9	22.0	54.8	58.2	22.9
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 101.5;Oligodendrocytes: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 134.8;TIME: 160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	21.4	11.2	26.3	18.9	45.9	48.1	18.4	23.0	34.7	13.2	8.3	17.0	11.9	26.2	9.1	14.6	13.9	16.2	11.4	36.7	28.6	11.6	16.3	20.6	21.7	23.2	23.0	15.7	10.5	10.6	8.0	31.8	23.0	14.0	12.2	19.3	8.7	11.1	8.8	11.0	11.5	29.5	27.4	21.8	10.5	26.6	28.5	24.8	11.6	12.3	22.2	17.1	12.8	54.0	15.4	12.5	32.5	8.9	15.9	41.2	24.1	34.8	46.9	29.1	27.2	7.7	8.8	22.7	23.0	24.5	15.6	13.8	19.8	20.9	39.5	24.9	15.5	32.7	8.5	10.9	34.4	17.9	18.4	30.0	21.3	43.0	77.1	51.8	134.8	18.9	24.7	18.1	66.8	9.5	17.0	28.1	14.4	7.6	22.8	29.2	18.0	19.8	35.1	12.7	17.1	11.7	19.9	18.4	25.9	24.7	14.0	15.7	160.5	25.6	10.0	13.8	18.7	26.0	21.1	24.1	9.6	7.6	19.2	66.7	6.4	17.1	22.2	9.3	24.0	17.5	17.9	25.1	10.0	16.6	25.0	21.7	23.2	31.4	9.0	7.3	15.8	16.6	26.3	45.9	23.0	34.7	36.7	28.6	23.2	23.0	23.0	27.4	28.5	54.0	58.1	16.0	6.5	54.5	37.3	26.8	10.7	8.6	19.4	11.8	13.8	9.8	11.9	7.2	10.3	9.2	16.7	12.0	64.4	7.2	0.0	4.9	3.3	17.6	10.0	51.7	15.0	17.9	101.5	3.6	27.9	24.0	21.4	17.2	18.3	8.9	34.2	10.8	12.1	5.0	59.2	7.9	4.1	14.5	20.7	4.1	9.9	16.7	17.8	64.6	8.6	22.6	32.0	52.3	259.2	7.4	3.4	9.4	64.7	12.5	6.5	8.6	15.4	9.6	6.6	22.7	22.0	8.8	21.6	24.2	25.9	13.7	63.2	10.7	6.0	15.1
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504596-205532793	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 179.6;heart muscle: 116.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 462.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 32.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.5;HeLa: 35.3;hTERT-RPE1: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"		No	No				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Actin filaments"		"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.81e-5)"	6.1	9.0	68.6	4.1	131.1	1.1	5.1	141.2	82.6	10.9	40.0	13.1	28.8	8.6	3.4	5.7	8.6	10.4	116.3	57.8	90.8	26.5	10.6	11.0	2.8	179.2	148.1	12.6	16.9	7.8	11.5	16.1	147.7	9.2	9.2	13.3	29.2	23.6	6.1	3.3	24.9	7.0	115.2	9.5	35.8	1.6	122.1	3.6	9.5	5.3	3.7	5.7	7.5	179.6	22.2	1.4	0.2	1.3	0.0	0.0	22.6	0.4	4.1	1.0	5.5	9.4	17.8	12.4	3.2	0.2	1.9	21.2	4.9	38.5	0.9	3.4	3.8	3.0	35.3	10.5	4.0	0.1	0.2	2.5	1.9	0.1	0.8	32.2	0.0	18.4	0.1	15.2	0.3	17.7	1.2	0.6	18.4	6.1	0.9	1.6	0.1	16.6	3.6	13.5	7.9	2.8	6.4	3.2	14.2	24.5	15.3	6.2	0.0	0.0	8.1	0.1	0.1	4.1	2.1	2.5	0.2	9.4	3.7	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	68.6	131.1	141.2	82.6	57.8	90.8	179.2	148.1	147.7	115.2	122.1	179.6	4.6	0.0	0.5	12.4	1.0	3.4	6.9	17.4	11.4	7.0	4.6	5.6	29.6	5.7	6.8	73.5	0.0	5.7	0.2	12.1	7.9	18.5	2.4	2.1	0.7	2.9	6.0	1.3	12.0	6.7	2.3	3.8	15.8	4.6	0.0	13.3	2.5	3.7	5.3	0.0	4.5	12.9	2.0	3.8	4.5	4.0	0.9	3.8	3.6	12.2	4.4	28.2	1.0	4.5	462.9	6.5	111.2	1.5	0.9	10.8	35.6	18.7	3.3	1.2	6.6	5.8	12.8	6.6	17.0	5.3	1.3	1.9	1.4	22.7	13.7	9.2
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966781-55972789	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Extravillous trophoblasts: 84.7;Melanocytes: 87.2;Syncytiotrophoblasts: 170.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 540.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	15.3	9.2	3.5	16.3	3.4	36.0	14.2	3.6	4.9	13.4	6.4	12.5	9.8	13.7	6.3	14.9	13.7	10.8	10.9	3.5	3.8	14.7	16.2	22.9	21.6	4.7	4.0	16.3	10.0	7.9	4.9	47.3	4.1	12.6	14.9	6.5	10.9	14.3	7.0	22.7	12.3	19.5	4.2	14.5	12.2	6.6	4.1	37.2	9.6	8.1	24.8	18.1	12.9	3.9	81.7	39.1	93.6	52.4	19.2	24.9	172.2	98.9	53.5	123.3	114.8	89.4	76.3	77.5	70.9	37.9	46.4	50.8	73.4	44.9	126.8	86.9	68.0	89.0	65.0	34.6	6.3	70.4	61.4	12.6	10.9	83.8	29.1	36.1	63.1	76.8	85.6	68.0	88.3	60.8	149.9	61.7	36.9	55.8	60.7	143.7	86.2	57.1	36.5	77.1	37.4	48.1	114.1	41.7	540.3	54.9	88.9	51.1	34.5	82.9	76.3	65.0	71.0	37.4	46.3	95.5	47.4	51.1	74.2	3.6	2.6	2.2	4.7	2.7	4.6	6.5	2.1	3.5	1.9	3.7	2.0	3.7	1.2	3.4	1.2	7.9	5.4	3.3	3.5	3.4	3.6	4.9	3.5	3.8	4.7	4.0	4.1	4.2	4.1	3.9	17.9	16.0	4.8	1.3	7.3	28.0	23.9	6.2	12.5	0.0	14.5	8.9	3.1	11.5	7.6	1.8	0.0	92.8	7.1	3.7	1.9	11.5	0.6	7.4	6.5	18.2	5.4	14.7	0.1	5.7	84.7	15.7	9.2	13.0	10.8	12.0	10.4	9.1	13.3	1.7	0.1	7.2	6.1	4.7	43.8	0.8	14.9	4.9	87.2	1.9	28.4	4.2	5.2	0.0	0.5	12.3	1.5	4.5	11.8	13.4	2.8	4.5	4.4	3.6	0.0	10.1	11.6	3.1	7.4	14.5	31.4	170.7	9.6	4.8	9.7	19.3
CDK2AP1	"doc-1, DOC1, DORC1, p12DOC-1, ST19"	ENSG00000111328	"Cyclin dependent kinase 2 associated protein 1"	O14519	12	123250112-123272334	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 44.3;intermediate monocyte: 152.6;myeloid DC: 52.5;non-classical monocyte: 175.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 52.5;monocytes: 175.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019377, HPA057648, HPA068833"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB019377: , HPA057648: AB_2683488, HPA068833: AB_2686046"	"unprognostic (1.56e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.77e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (5.27e-7)"	"unprognostic (9.32e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.18e-1)"	96.1	82.8	239.4	62.7	255.4	70.6	105.0	270.5	285.1	114.8	199.5	111.8	40.1	111.9	127.7	115.1	81.5	87.7	95.1	238.3	272.2	82.2	56.7	78.3	51.0	296.1	256.0	56.0	53.2	72.3	88.8	64.4	288.2	103.5	63.1	43.4	158.8	97.7	91.5	68.1	53.9	120.3	292.7	48.6	84.9	69.1	260.8	86.0	61.4	109.9	56.5	124.9	105.3	288.3	125.7	172.4	451.1	481.5	352.6	443.9	81.8	399.1	369.6	311.1	234.7	131.0	117.5	0.1	174.9	611.4	115.9	111.3	484.0	261.3	256.1	77.6	120.7	66.4	98.0	208.4	192.0	104.9	68.7	282.8	267.0	180.2	116.9	283.4	449.4	151.0	90.6	0.5	594.9	244.3	140.3	170.2	296.1	154.9	129.2	528.7	193.0	54.0	259.7	295.2	416.7	496.5	290.9	141.5	412.0	119.4	272.5	104.3	273.2	286.5	149.1	172.9	267.6	21.0	41.6	116.1	156.6	48.9	640.9	15.9	44.3	21.3	0.5	152.6	1.9	0.9	0.5	0.9	52.5	0.1	0.3	0.5	1.5	1.3	175.4	4.2	0.4	29.7	239.4	255.4	270.5	285.1	238.3	272.2	296.1	256.0	288.2	292.7	260.8	288.3	10.4	28.9	39.7	32.0	3.0	1.3	1.5	8.7	18.2	0.3	6.9	8.8	1.8	8.6	21.7	12.9	0.0	1.6	1.4	12.3	1.9	24.0	30.7	8.0	31.6	14.0	7.7	13.7	12.2	16.7	3.3	13.8	19.9	7.6	19.0	3.2	16.4	6.9	6.0	3.3	5.0	16.7	4.1	26.0	4.9	131.8	13.4	18.8	3.6	14.0	11.4	19.4	1.0	17.1	25.0	24.3	12.5	14.3	2.8	0.4	5.4	3.4	12.5	0.3	0.0	3.2	10.3	1.4	8.1	46.9	2.8	1.4	1.9	1.0	16.2	0.9
CDK3		ENSG00000250506	"Cyclin dependent kinase 3"	Q00526	17	76000906-76005999	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 5.3;Breast myoepithelial cells: 5.0;Glandular and luminal cells: 5.2;Granulosa cells: 6.3;Ionocytes: 10.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA007420	Uncertain		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA007420: AB_1078490"	"unprognostic (6.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.80e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.75e-7)"	"unprognostic (4.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (4.47e-4)"	12.7	11.0	11.4	7.7	11.8	10.6	12.2	11.5	13.8	15.7	12.0	14.9	10.4	11.5	10.7	11.1	13.7	10.3	8.4	11.3	12.2	18.4	34.8	14.2	10.5	12.0	11.7	15.9	15.1	4.8	19.7	8.9	12.2	25.7	10.1	6.9	13.6	8.4	3.6	24.7	14.7	7.6	11.5	21.9	12.2	15.6	11.8	5.8	19.5	3.3	10.5	10.8	13.3	13.6	5.5	7.5	13.5	6.5	7.3	9.0	26.1	4.6	4.6	8.0	7.4	7.0	11.0	6.5	4.5	5.7	4.6	11.6	10.2	4.1	5.6	3.3	14.1	12.7	17.8	7.3	6.7	5.9	14.9	8.7	10.8	7.3	5.1	13.0	6.9	4.1	5.6	4.5	4.3	12.1	6.3	21.8	6.3	3.8	8.4	10.4	5.2	7.2	6.9	15.8	8.4	22.0	3.8	12.0	3.2	14.2	17.4	10.9	5.5	16.4	9.6	5.4	6.7	9.9	7.2	6.2	5.4	5.5	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	11.4	11.8	11.5	13.8	11.3	12.2	12.0	11.7	12.2	11.5	11.8	13.6	4.3	0.0	0.0	0.0	0.5	2.7	0.0	4.0	0.0	0.0	5.3	5.0	0.3	0.0	2.2	0.0	0.0	0.0	3.1	0.0	1.9	2.0	0.0	2.9	3.9	1.4	0.0	0.0	0.0	2.3	0.0	1.3	0.0	5.2	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	4.4	0.0	0.0	1.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	1.2	2.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.7	0.0	1.0	2.8	0.0	0.0
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"glioma: 175.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 2594.8;LHCN-M2: 2819.4;RH-30: 8902.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	69.7	87.8	35.0	52.8	37.9	72.0	76.6	37.7	36.9	84.3	35.9	62.6	40.2	97.4	64.2	57.2	69.4	57.1	58.9	33.6	37.1	58.5	51.5	58.0	66.8	37.1	36.9	97.3	70.9	63.5	67.7	52.4	36.8	52.7	63.3	14.5	54.4	54.1	48.2	58.9	47.2	80.4	37.3	51.5	54.8	24.1	37.3	67.6	66.0	52.7	70.6	71.6	60.7	37.6	207.1	235.7	295.7	268.0	253.7	220.7	210.4	116.1	347.9	468.5	385.7	338.2	189.1	297.4	200.2	173.6	293.2	158.0	396.3	2594.8	354.9	150.9	209.0	275.4	149.5	237.9	297.0	309.7	182.5	221.5	180.9	294.2	326.7	326.4	304.8	280.0	301.3	242.7	2819.4	304.9	296.7	256.5	347.0	208.0	249.8	267.3	8902.5	272.1	147.2	320.6	271.2	251.7	205.3	150.2	310.0	195.1	202.8	380.7	146.1	233.6	217.0	265.8	233.1	122.2	206.1	450.8	214.1	291.3	286.9	9.5	46.5	10.3	79.6	65.6	81.8	93.5	70.0	72.5	66.7	90.0	93.0	84.4	4.4	56.6	41.9	84.9	57.0	73.6	35.0	37.9	37.7	36.9	33.6	37.1	37.1	36.9	36.8	37.3	37.3	37.6	47.1	22.4	30.8	7.8	40.0	89.7	78.6	83.4	74.0	15.9	67.2	82.2	0.7	51.5	35.3	47.8	10.4	82.9	26.1	15.9	70.5	93.1	13.5	14.9	77.7	50.8	45.6	98.0	5.2	62.5	134.5	79.4	28.5	22.6	69.1	60.2	39.7	35.8	132.9	18.5	6.7	42.2	40.7	25.1	44.1	8.0	64.0	31.2	53.4	6.5	41.9	51.4	29.9	5.5	8.0	48.3	18.9	63.2	57.8	113.9	14.0	80.9	7.4	17.9	32.9	62.1	61.9	32.1	48.3	74.5	86.1	46.8	32.3	78.8	78.7	49.4
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053815-151057897	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	6.3	16.8	50.2	9.4	53.2	11.2	8.6	44.9	65.8	8.6	40.0	9.3	10.9	6.7	24.9	10.2	8.2	9.5	9.8	57.5	50.9	13.5	12.5	8.3	9.8	48.6	45.3	4.5	9.5	22.8	14.7	8.6	48.4	8.8	9.9	11.3	9.6	10.2	8.5	9.5	8.6	10.4	43.2	9.4	7.9	4.9	50.1	14.2	10.0	7.2	11.6	8.8	6.0	50.9	31.9	40.8	37.3	59.7	48.8	36.1	17.8	24.4	41.7	47.9	40.3	31.2	31.0	34.7	71.3	31.8	63.5	23.5	67.8	40.6	22.6	24.9	43.3	38.2	32.4	30.7	31.6	29.0	64.4	37.9	28.7	39.0	13.5	62.8	38.8	57.6	36.3	24.0	50.7	68.4	76.4	57.9	39.3	57.2	80.5	38.9	14.8	41.5	46.2	27.9	23.0	97.8	30.9	37.7	43.8	36.0	18.6	25.9	22.7	42.2	10.3	31.2	39.2	52.1	61.4	13.7	66.4	46.5	75.8	18.9	39.4	20.1	13.5	46.2	11.1	13.3	12.8	13.6	44.7	12.8	9.8	11.8	5.7	19.9	36.4	26.9	31.9	23.8	50.2	53.2	44.9	65.8	57.5	50.9	48.6	45.3	48.4	43.2	50.1	50.9	7.6	0.0	6.0	1.6	6.2	3.6	8.2	18.0	6.2	12.1	9.6	10.4	3.1	8.6	14.7	11.0	2.1	26.8	5.4	8.0	39.2	21.4	0.8	14.9	10.9	8.9	9.0	12.2	5.8	18.9	12.3	7.6	9.7	9.3	30.5	23.6	7.9	11.1	41.9	0.0	6.4	8.9	18.3	21.9	6.2	1.3	4.7	16.6	10.6	1.9	19.9	12.6	12.3	1.5	3.7	22.8	15.0	11.3	12.4	4.3	20.2	35.7	14.4	7.1	6.6	4.5	13.1	3.9	11.2	11.4	6.3	9.0	7.3	14.2	9.5	9.0
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981781	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favorable (7.31e-5)"	45.8	48.2	83.8	42.0	85.7	52.3	48.7	83.7	111.3	58.1	100.4	53.0	54.5	42.4	91.9	52.8	54.2	46.1	39.2	85.5	85.5	60.2	80.6	44.6	51.7	86.4	84.7	69.5	133.6	53.6	93.0	34.3	85.7	62.6	53.8	34.1	77.0	48.5	29.6	43.5	68.5	33.8	83.1	81.4	81.8	83.5	86.6	44.2	73.2	28.1	54.8	48.1	48.3	86.7	72.7	116.5	60.8	114.6	52.6	53.3	112.7	51.4	63.9	52.3	51.0	92.5	72.3	88.7	107.8	55.5	35.2	72.8	41.6	61.4	59.3	127.0	58.1	43.4	157.9	123.8	58.7	50.0	47.5	60.7	51.5	45.9	91.8	64.2	52.8	169.1	49.6	80.8	52.9	140.3	128.3	79.2	38.5	87.4	55.0	74.6	101.4	101.7	52.8	91.3	43.0	104.1	38.3	37.1	51.7	65.3	84.5	65.4	38.9	43.6	38.2	53.1	66.8	106.8	102.9	54.2	54.3	69.1	53.5	20.8	62.6	54.8	33.8	63.8	36.8	40.9	31.4	30.6	50.1	44.7	28.0	31.4	30.5	45.3	67.4	46.0	32.9	41.3	83.8	85.7	83.7	111.3	85.5	85.5	86.4	84.7	85.7	83.1	86.6	86.7	31.3	25.6	62.6	60.7	61.8	33.6	63.3	89.3	50.7	52.0	52.8	40.4	28.4	44.3	84.1	40.5	31.3	68.8	44.9	56.5	50.9	56.8	53.0	35.7	32.9	32.1	61.6	22.9	31.1	67.7	57.4	44.7	147.8	42.5	69.6	68.3	27.5	55.6	61.7	57.2	27.9	70.8	71.2	33.6	40.7	36.3	40.7	44.1	46.2	25.3	47.6	45.1	33.0	25.6	50.6	37.1	60.9	29.7	87.2	49.0	77.2	45.1	85.2	52.6	32.9	34.3	33.2	132.8	45.7	31.0	25.9	61.6	53.0	38.6	56.8	56.6
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836573	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 215.9;Erythroid cells: 213.5;Late spermatids: 237.0;Oligodendrocytes: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 378.4;REH: 173.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	3.7	7.3	6.7	4.7	7.1	18.1	4.9	5.4	5.1	4.8	2.6	5.9	6.1	3.1	2.1	4.2	2.9	3.6	4.7	4.0	5.0	4.4	5.9	4.1	6.6	6.3	6.7	2.7	6.2	9.9	1.7	17.3	6.3	3.0	7.5	0.5	5.7	4.2	1.0	6.8	7.2	3.2	5.8	4.9	9.1	3.3	9.6	41.1	2.4	2.3	6.2	3.8	4.6	8.8	27.1	11.3	34.9	23.9	10.6	11.5	5.8	27.2	18.4	14.3	13.5	34.7	20.9	21.7	14.4	19.9	8.4	15.8	20.8	42.6	34.4	43.0	10.6	50.8	23.3	34.7	6.3	33.0	2.7	11.5	23.1	17.9	90.8	13.4	5.6	75.1	49.3	55.5	26.7	5.9	378.4	3.8	9.8	37.4	9.1	173.7	112.0	36.4	20.3	0.7	18.1	113.8	3.7	9.8	17.1	26.0	0.6	54.9	19.3	44.1	63.7	18.0	54.2	27.4	0.5	27.6	6.9	112.1	60.8	0.9	0.2	0.6	0.6	0.4	0.9	0.2	0.6	0.8	0.5	0.3	0.7	0.7	0.1	0.7	0.4	0.9	0.3	0.3	6.7	7.1	5.4	5.1	4.0	5.0	6.3	6.7	6.3	5.8	9.6	8.8	38.6	25.6	3.7	2.9	17.7	60.3	23.5	55.0	62.6	0.4	20.7	21.2	18.1	22.8	32.8	22.0	0.0	53.8	30.5	12.1	9.8	37.0	215.9	3.1	29.0	30.7	16.8	213.5	114.7	23.3	5.3	28.5	42.3	6.9	25.3	39.2	11.4	27.0	16.0	0.0	60.3	63.7	28.5	23.0	48.6	237.0	5.0	27.6	19.6	108.7	22.4	0.8	39.1	119.6	235.3	94.7	22.8	3.4	85.3	47.1	20.1	8.2	11.9	0.0	6.6	100.8	32.2	2.7	33.6	36.7	50.4	17.6	42.5	62.8	92.7	27.3
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790792	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	44.6	60.8	44.3	23.7	43.7	47.0	40.3	40.8	53.8	55.5	35.4	49.3	19.7	49.3	21.1	35.4	65.6	23.7	40.4	50.8	42.0	44.5	65.1	47.2	35.1	44.7	44.1	88.5	44.4	19.2	67.0	18.7	41.1	44.1	12.2	11.1	29.7	23.3	28.3	38.7	40.9	19.1	42.7	65.6	37.4	44.3	42.1	31.9	42.1	17.1	20.9	38.9	40.5	44.4	22.5	40.5	24.9	27.6	27.6	21.4	32.1	22.9	33.3	23.4	20.9	30.3	25.0	39.5	25.7	26.0	32.1	44.2	16.5	37.3	8.9	34.8	19.0	37.1	45.2	25.3	40.2	36.3	56.5	37.9	44.5	24.8	27.7	30.0	48.5	34.8	32.6	51.7	21.2	60.1	39.5	54.5	55.0	34.3	41.9	112.2	21.2	57.0	34.2	24.9	24.5	29.2	34.5	35.8	20.9	19.3	45.0	33.9	56.4	27.8	30.9	24.1	22.3	92.5	76.4	34.7	26.1	24.4	25.9	4.1	3.7	5.8	10.3	5.1	10.1	3.6	5.7	8.3	4.8	6.6	6.3	7.9	5.4	22.4	7.5	9.9	4.4	3.6	44.3	43.7	40.8	53.8	50.8	42.0	44.7	44.1	41.1	42.7	42.1	44.4	43.1	12.8	12.4	39.8	27.1	24.1	27.6	15.8	18.8	13.9	17.9	10.9	14.1	20.0	10.8	11.0	2.1	22.5	28.5	17.1	15.6	31.3	4.4	26.4	22.7	35.6	19.2	15.4	18.1	37.2	22.3	23.0	24.5	25.3	25.3	18.1	33.5	26.4	23.3	25.2	17.0	12.7	8.2	18.8	23.4	6.2	19.6	24.2	16.0	22.5	44.7	17.5	33.0	12.5	16.8	32.9	13.7	31.2	22.2	28.9	14.5	16.7	20.4	7.9	0.0	21.6	22.1	8.9	22.9	19.9	22.0	51.3	24.7	54.5	13.7	31.4
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 216.6;Horizontal cells: 80.8;Inhibitory neurons: 116.1;Oligodendrocytes: 79.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A549: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	2.0	1.6	4.9	1.1	6.7	2.5	2.5	0.0	11.7	3.9	0.0	1.9	0.9	2.6	1.9	3.5	1.7	1.8	3.8	6.8	0.0	3.5	1.2	4.6	0.8	0.0	2.5	3.8	2.4	2.4	1.7	3.2	0.0	3.6	1.2	12.2	2.2	2.3	1.7	2.2	0.9	2.5	0.0	1.2	2.4	7.1	5.7	1.7	3.0	2.0	1.1	2.7	3.4	5.4	1.1	10.0	2.6	2.2	2.4	3.6	1.7	1.7	3.0	2.0	2.5	3.3	1.5	1.5	0.3	1.0	4.5	0.5	3.2	1.8	4.3	0.4	1.7	0.1	5.5	2.1	1.1	0.2	0.7	1.7	1.9	5.4	4.9	1.3	1.0	1.6	0.2	1.5	2.7	1.0	0.6	0.8	5.2	0.9	2.3	0.6	3.0	0.1	1.8	7.1	0.5	3.2	2.7	0.9	1.5	4.4	1.3	0.4	6.2	2.5	1.7	5.5	1.3	0.3	0.1	0.3	1.4	0.4	3.0	5.7	0.5	1.1	0.3	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	2.0	0.2	0.3	0.5	0.1	0.1	4.9	6.7	0.0	11.7	6.8	0.0	0.0	2.5	0.0	0.0	5.7	5.4	9.4	25.6	24.8	37.5	2.8	0.9	10.7	0.7	4.6	19.0	7.9	6.3	12.9	5.7	5.3	7.3	33.3	27.4	3.8	1.3	7.9	7.7	34.3	6.5	8.4	6.3	2.4	2.7	216.6	9.6	3.1	7.4	7.7	7.9	1.3	3.9	6.1	3.4	4.2	80.8	116.1	1.6	2.0	4.4	0.5	55.3	5.9	4.9	0.0	34.7	4.6	23.5	0.0	41.7	79.7	8.2	0.8	5.3	4.3	16.2	0.6	8.9	4.0	20.4	32.9	7.2	8.4	5.8	10.1	4.2	1.3	47.3	2.3	5.7	1.8	22.9
CDKN1A	"CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1"	ENSG00000124762	"Cyclin dependent kinase inhibitor 1A"	P38936	6	36676460-36687337	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 74.5"	"Group enriched"	"Detected in many"	9	"B-cells: 20.7;dendritic cells: 21.5;monocytes: 74.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 798.5;HSkMC: 586.5;hTCEpi: 775.8;LHCN-M2: 604.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 76.0"	"Low region specificity"	"Detected in all"			"CAB000064, HPA005946, CAB069401"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477"	"unprognostic (7.99e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-5)"	"unprognostic (1.57e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-2)"	"unprognostic (7.55e-3)"	"prognostic favorable (4.95e-5)"	"unprognostic (8.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-2)"	322.1	98.1	47.0	62.1	48.1	72.7	144.2	47.3	60.9	123.3	85.9	119.0	115.2	74.4	41.0	203.2	213.9	132.6	170.6	47.2	49.5	149.9	173.4	182.2	17.3	63.7	54.6	184.9	130.5	70.1	104.4	44.7	53.4	91.4	108.2	29.2	79.1	29.4	241.6	224.4	130.0	114.3	55.0	34.4	121.3	47.0	50.3	59.7	77.5	26.9	21.8	212.7	142.3	53.6	27.0	108.1	80.1	2.0	273.3	490.3	149.5	435.6	344.8	52.3	203.7	9.6	25.3	18.3	15.5	267.9	48.0	60.2	3.7	477.7	82.4	36.2	22.0	3.0	85.8	137.0	798.5	0.5	127.7	586.5	775.8	476.2	147.1	309.3	275.3	1.4	5.1	120.8	604.2	57.4	3.9	11.3	10.2	112.8	15.5	54.4	67.1	31.9	91.2	201.5	36.7	35.6	101.3	8.4	21.3	185.2	32.7	111.2	155.8	91.5	86.9	6.2	36.4	202.0	42.9	54.5	118.7	9.9	261.0	0.0	22.8	0.5	0.5	52.2	0.8	20.7	1.1	0.6	20.0	16.2	0.3	0.4	4.2	0.7	74.5	21.5	2.9	34.2	47.0	48.1	47.3	60.9	47.2	49.5	63.7	54.6	53.4	55.0	50.3	53.6	571.2	83.3	45.1	1.0	126.9	440.5	340.1	293.1	512.8	0.8	203.9	187.6	151.6	41.5	214.4	68.0	0.0	42.1	56.4	505.3	46.9	217.6	0.9	227.9	57.3	327.1	175.5	5.7	0.5	264.7	52.8	302.4	150.9	199.2	104.4	20.4	71.7	68.9	72.9	0.0	0.4	197.1	156.6	62.0	556.0	3.9	34.5	277.6	218.7	5.6	280.6	58.4	2.1	0.0	0.5	429.9	466.1	16.6	376.4	201.7	383.2	17.2	215.1	3.1	26.3	303.6	471.6	1.2	1.7	620.9	672.0	155.3	106.0	10.7	75.8	478.0
CDKN1B	"KIP1, P27KIP1"	ENSG00000111276	"Cyclin dependent kinase inhibitor 1B"	P46527	12	12715058-12722369	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003691, CAB021888, HPA059086"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900"	"unprognostic (5.67e-2)"	"unprognostic (9.76e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.90e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	53.4	44.7	53.6	40.1	70.6	68.1	50.2	73.4	81.3	55.3	43.1	43.9	44.5	41.0	24.5	29.1	47.3	24.6	32.9	47.9	58.9	30.2	35.2	38.9	55.3	58.6	58.3	66.1	23.9	34.4	24.4	41.0	61.2	35.9	32.5	55.3	36.3	33.4	81.4	45.4	40.7	24.8	55.1	55.1	30.0	25.8	58.3	71.8	33.7	63.4	39.9	32.0	44.5	91.2	37.1	16.6	94.5	16.6	32.0	18.0	46.1	31.5	53.8	46.0	56.4	47.7	40.4	0.3	12.5	19.6	16.6	34.2	44.9	16.7	41.1	62.4	31.5	28.8	46.5	53.2	42.5	24.5	18.6	19.8	35.3	15.2	44.0	107.8	27.8	54.5	31.5	101.6	16.6	45.9	32.7	35.3	38.0	32.1	16.8	25.2	30.9	63.1	22.5	38.6	35.6	58.4	48.9	34.8	65.8	33.7	18.6	54.6	19.1	22.6	34.9	20.7	33.3	86.1	59.4	33.2	28.2	36.6	22.5	6.2	3.8	8.6	5.9	3.5	6.1	6.8	7.7	7.2	3.6	5.0	8.0	6.1	20.9	7.3	5.5	3.9	12.3	4.0	53.6	70.6	73.4	81.3	47.9	58.9	58.6	58.3	61.2	55.1	58.3	91.2	64.2	44.8	29.3	6.2	126.2	52.6	20.7	21.0	115.5	45.6	39.5	30.1	39.1	21.5	27.1	9.2	27.1	42.9	92.5	32.3	15.6	10.8	70.0	31.2	35.8	51.1	45.7	70.5	8.1	9.3	47.6	39.3	25.5	34.3	31.0	21.3	47.2	30.7	26.8	10.1	13.4	41.4	24.4	55.3	66.0	67.7	55.9	65.1	74.7	23.4	31.6	182.9	60.8	6.0	29.5	10.1	21.3	26.7	121.2	30.3	33.4	16.9	36.4	29.4	92.1	20.2	53.5	7.7	10.8	102.3	52.6	39.0	166.1	20.9	41.9	22.7
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967752-21995301	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 49.9;ovarian cancer: 57.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 37.4"	"Group enriched"	"Detected in many"	6	"B-cells: 15.6;T-cells: 37.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA		18000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	3.7	10.1	7.4	1.7	8.3	1.3	3.1	5.9	8.5	1.1	31.7	1.9	0.8	0.7	1.0	7.4	2.2	0.5	0.7	6.7	6.4	0.5	0.7	2.3	2.1	7.4	5.8	0.8	1.5	2.1	33.7	2.6	7.2	2.1	0.7	0.1	1.6	1.6	0.6	0.9	3.6	0.3	6.2	5.5	3.9	14.8	8.0	2.1	1.3	0.0	2.5	2.4	2.3	9.2	11.8	0.0	1.7	82.2	0.8	0.9	39.1	15.9	0.0	111.7	196.0	19.1	289.2	47.1	167.7	9.5	0.0	36.0	34.3	211.0	91.4	212.2	389.7	0.1	311.1	13.6	8.8	22.4	17.3	21.2	0.0	112.2	61.9	236.3	11.7	0.0	0.1	188.4	105.7	0.8	1.9	0.0	2.6	24.2	185.9	0.2	80.2	166.3	23.4	0.0	195.2	14.0	219.9	36.6	318.7	9.4	42.8	0.7	39.5	0.9	2.6	0.3	0.5	84.7	49.6	177.8	0.2	62.9	1.0	1.5	2.1	0.3	9.9	1.3	14.1	11.1	11.4	17.6	0.3	15.6	0.6	6.7	0.5	0.8	4.2	0.0	37.4	3.6	7.4	8.3	5.9	8.5	6.7	6.4	7.4	5.8	7.2	6.2	8.0	9.2	1.6	0.0	0.0	1.0	11.5	1.8	2.3	170.1	0.0	0.6	6.1	10.4	4.2	0.0	145.9	11.0	0.0	27.9	6.2	8.1	0.0	29.7	227.5	36.4	6.7	2.6	70.9	0.0	1.2	26.4	43.8	7.7	0.0	6.2	4.5	4.6	1.4	0.3	7.6	0.0	3.5	6.3	122.1	10.5	4.2	447.9	3.1	2.9	8.8	7.5	16.2	0.9	5.2	4.5	6.6	417.7	12.1	1.9	38.7	35.4	32.8	0.0	221.9	0.1	0.0	1.1	20.8	7.2	6.2	7.2	0.4	9.2	12.7	11.0	3.8	54.4
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126879-5197887	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.3	13.8	30.0	9.1	32.4	13.0	10.6	22.9	28.6	10.5	2.1	13.0	5.2	11.5	8.2	9.2	10.7	8.9	24.8	30.3	34.6	14.6	12.8	13.4	8.8	27.2	36.1	9.3	6.5	17.3	14.4	9.9	37.4	13.4	10.7	31.5	7.6	16.7	9.7	5.9	10.1	18.0	18.8	9.4	10.6	11.7	42.5	13.3	12.5	12.7	12.6	10.8	7.7	21.7	25.4	27.4	28.1	13.7	16.4	14.9	11.7	13.9	28.5	22.7	32.2	17.8	23.8	19.8	6.8	26.4	41.1	36.5	23.1	29.5	23.9	18.4	6.8	23.5	7.9	27.0	15.3	13.9	8.1	12.8	16.1	29.8	11.5	20.3	30.7	26.5	11.6	23.9	21.4	4.6	30.1	5.7	12.1	12.4	7.6	25.0	22.5	9.4	14.5	25.0	11.4	15.5	15.3	26.2	34.6	33.8	16.4	6.7	25.4	15.6	11.6	14.1	14.0	20.8	160.2	15.9	7.4	11.7	8.1	55.3	17.3	21.2	15.2	14.7	16.6	12.1	15.6	17.3	13.8	11.4	12.0	11.8	49.7	12.0	13.4	10.9	19.5	23.7	30.0	32.4	22.9	28.6	30.3	34.6	27.2	36.1	37.4	18.8	42.5	21.7	43.3	19.2	15.7	36.9	36.2	17.6	30.3	33.0	14.2	60.1	17.7	14.4	55.2	18.6	19.6	33.1	95.9	22.2	29.6	15.3	5.9	33.1	71.6	20.1	14.0	42.3	10.7	14.9	39.3	22.7	40.0	17.9	15.3	21.5	21.0	20.5	27.8	21.7	60.8	43.7	52.0	12.4	12.2	36.6	26.1	33.3	16.1	31.5	32.0	21.5	38.7	21.9	28.8	28.6	56.1	31.7	20.3	24.8	48.9	23.1	15.7	13.2	23.5	65.5	19.7	19.7	52.1	26.8	34.7	14.8	15.3	16.3	36.7	13.0	13.1	29.1
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573686-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 559.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 1103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	117.0	68.6	39.1	113.7	42.0	161.3	73.0	40.6	42.9	59.3	48.3	80.0	57.5	60.6	54.9	78.7	51.6	76.4	74.5	37.0	47.1	64.4	112.9	83.6	159.3	46.0	41.8	57.9	84.3	85.8	43.0	108.5	46.0	43.2	70.8	49.2	52.7	47.7	250.9	55.0	65.5	75.7	44.6	121.6	89.0	95.9	45.8	194.5	97.4	155.9	165.6	104.3	49.3	47.8	376.2	85.5	147.6	98.0	166.7	203.6	174.5	201.6	261.1	197.6	194.7	213.4	147.0	473.9	298.0	227.4	229.2	158.2	213.5	202.0	366.4	306.1	80.1	282.3	93.2	130.9	258.2	318.7	173.4	194.7	206.7	178.2	473.4	139.6	254.5	137.9	205.7	309.9	289.5	107.1	260.9	180.9	148.9	161.6	108.2	156.8	197.6	382.2	206.9	150.7	116.5	87.8	192.0	140.4	246.0	210.0	456.3	190.8	316.4	209.4	198.5	168.5	202.7	446.9	363.2	1103.9	117.0	187.8	124.7	14.3	10.5	17.6	13.0	12.3	13.5	11.1	12.2	13.2	9.7	7.0	9.7	15.2	9.7	6.4	13.7	15.9	24.0	5.7	39.1	42.0	40.6	42.9	37.0	47.1	46.0	41.8	46.0	44.6	45.8	47.8	116.3	57.7	69.8	7.2	114.9	145.9	217.3	19.5	63.7	22.6	97.6	77.2	86.2	74.4	34.4	84.6	10.4	51.6	169.7	158.0	37.2	42.1	324.7	174.0	160.5	99.5	47.2	59.5	13.2	87.6	82.0	93.7	88.7	314.4	45.0	63.0	91.1	97.2	118.5	23.5	12.3	102.4	10.2	146.8	117.7	559.5	34.2	145.0	55.2	17.8	100.4	109.5	90.6	8.0	14.5	88.1	101.2	35.7	239.4	320.2	26.9	74.4	27.4	29.9	26.3	120.9	92.5	21.2	30.9	94.0	128.3	35.2	126.5	124.4	90.1	219.5
CDX2	CDX3	ENSG00000165556	"Caudal type homeobox 2"	Q99626	13	27960918-27969315	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 41.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 287.5;Intestinal goblet cells: 214.5;Paneth cells: 181.7;Proximal enterocytes: 226.9;Undifferentiated cells: 194.4"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 63.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002221, HPA045669, HPA049580"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823"		"unprognostic (1.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.92e-1)"		"unprognostic (8.11e-3)"	"unprognostic (4.19e-6)"	"unprognostic (1.73e-4)"		"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.51e-2)"		"unprognostic (6.07e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-1)"	0.1	0.0	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	41.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	31.3	0.0	0.0	0.1	0.0	0.0	35.9	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	4.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.7	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	0.0	287.5	0.0	28.9	0.0	0.0	0.0	0.0	62.4	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	214.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.9	181.7	0.0	0.0	0.2	226.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.4	0.0	194.4	0.3
CEACAM18		ENSG00000213822	"CEA cell adhesion molecule 18"	A8MTB9	19	51478622-51490952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	26	"intestine: 10.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.8;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"CACO-2: 4.3;OE19: 3.5;RT4: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059487	Uncertain		Approved	Midbody		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Midbody		"HPA059487: AB_2684036"			"unprognostic (1.12e-1)"								"unprognostic (1.87e-2)"			"unprognostic (1.00e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CEBPA	"C/EBP-alpha, CEBP"	ENSG00000245848	"CCAAT enhancer binding protein alpha"	P49715	19	33299934-33302534	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 98.7;liver: 194.7;skin 1: 118.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.6;Hepatocytes: 106.5;Hofbauer cells: 87.0;Suprabasal keratinocytes: 171.8;Syncytiotrophoblasts: 212.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 16.0;classical monocyte: 7.1;intermediate monocyte: 12.3;myeloid DC: 5.1;non-classical monocyte: 15.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 5.1;granulocytes: 16.0;monocytes: 15.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 196.9;Hep G2: 110.9;NB-4: 114.1;THP-1: 407.7;U-937: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052734, HPA065037, HPA067937"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927"	"unprognostic (1.80e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.95e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-2)"	98.7	2.9	16.2	5.7	17.9	22.6	67.7	18.3	26.9	8.7	10.4	21.0	21.2	2.9	0.8	20.9	4.3	3.0	2.8	15.7	18.8	3.6	194.7	25.5	9.1	27.4	22.4	1.3	9.7	26.8	2.6	16.0	21.3	8.8	11.5	0.6	9.8	3.4	19.1	118.7	20.8	2.5	25.7	7.7	12.5	1.0	24.5	4.1	6.5	4.5	6.3	8.7	14.8	34.8	2.5	5.1	0.1	7.1	55.8	0.0	196.9	0.1	1.5	0.1	0.0	24.8	0.1	0.0	3.0	0.0	1.1	9.4	5.8	0.6	0.0	35.8	7.2	0.1	0.1	110.9	0.9	36.6	42.1	2.2	25.4	0.0	0.2	0.0	0.0	2.8	2.4	0.0	0.0	12.7	0.2	114.1	5.0	61.8	2.7	0.0	0.4	1.1	0.2	17.7	0.4	1.7	0.7	0.5	0.8	6.2	13.7	407.7	0.1	0.1	0.8	0.1	0.9	0.4	0.0	0.2	0.0	130.9	0.0	16.0	7.1	0.0	0.8	12.3	0.7	0.0	0.1	0.5	5.1	0.1	0.2	0.4	2.5	0.0	15.7	0.2	0.0	2.1	16.2	17.9	18.3	26.9	15.7	18.8	27.4	22.4	21.3	25.7	24.5	34.8	5.4	16.0	37.8	0.0	2.8	37.3	20.8	3.3	22.2	0.7	6.2	12.2	0.4	57.2	5.1	0.0	0.0	40.3	14.4	91.6	3.9	0.5	0.0	0.8	0.8	4.9	4.2	5.7	1.9	5.8	44.3	9.5	12.8	1.3	1.3	0.0	2.2	106.5	87.0	0.0	0.3	24.8	4.1	35.0	27.4	0.2	3.1	42.9	5.4	17.8	28.2	8.4	6.2	1.0	0.4	1.9	30.6	1.5	2.0	15.1	42.5	4.9	5.1	0.5	0.0	4.1	3.1	0.2	0.7	29.7	171.8	212.3	5.0	0.3	51.5	12.2
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT enhancer binding protein beta"	P17676	20	50190830-50192668	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 765.6;Suprabasal keratinocytes: 800.1;Syncytiotrophoblasts: 1409.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 16.7;monocytes: 7.7"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 169.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	160.7	125.5	26.6	63.9	29.4	43.2	86.5	24.4	29.8	95.5	36.7	60.0	13.1	72.4	5.8	43.2	94.9	27.6	59.3	29.7	32.4	39.3	228.7	139.5	11.2	34.8	36.4	89.6	35.6	10.8	28.4	37.8	29.2	60.3	7.1	4.6	49.1	12.3	202.2	99.1	43.4	15.5	35.7	93.1	57.7	9.0	33.3	6.3	57.5	44.3	7.3	64.9	67.2	31.5	26.4	11.8	1.3	13.9	63.7	24.9	112.7	34.9	54.6	23.5	20.7	12.0	23.9	17.1	64.5	14.5	115.4	35.3	3.7	34.2	15.9	12.5	8.3	5.2	15.0	17.8	78.3	8.7	32.9	26.7	88.5	29.9	52.9	49.0	3.3	17.4	25.4	31.0	15.0	9.9	4.1	19.0	7.3	24.8	33.6	12.3	3.4	20.1	7.9	6.3	6.7	4.4	28.9	70.7	169.6	7.4	18.8	48.1	4.5	48.6	37.2	42.1	34.0	64.6	29.5	15.9	88.7	19.6	21.6	8.6	3.5	12.5	0.5	6.8	0.1	0.6	0.4	0.6	1.5	0.3	0.4	0.2	16.7	0.5	7.7	0.0	0.3	0.8	26.6	29.4	24.4	29.8	29.7	32.4	34.8	36.4	29.2	35.7	33.3	31.5	83.3	35.3	67.6	16.3	64.2	724.2	371.8	48.3	241.9	3.9	244.6	244.5	48.7	130.1	35.6	46.0	0.0	185.0	208.1	83.4	31.3	32.9	9.9	305.3	417.4	74.9	66.7	33.9	18.4	13.2	681.2	605.1	102.4	410.5	51.4	10.8	94.9	402.7	345.7	3.3	8.6	102.5	24.4	500.4	438.5	10.6	129.5	765.6	217.1	37.5	159.0	87.6	61.8	0.5	1.8	19.2	60.9	96.3	102.7	346.5	61.9	74.2	29.8	5.6	157.8	466.2	356.7	1.1	13.3	162.1	800.1	1409.9	159.3	68.2	63.4	359.6
CEBPD	"C/EBP-delta, CELF, CRP3, NF-IL6-beta"	ENSG00000221869	"CCAAT enhancer binding protein delta"	P49716	8	47736913-47738164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1541.7;Basal prostatic cells: 1435.6;Basal squamous epithelial cells: 2487.0;Prostatic glandular cells: 1668.5;Skeletal myocytes: 1386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 54.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 54.9;monocytes: 19.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.9;HHSteC: 66.8;HSkMC: 66.7;NB-4: 148.7;SiHa: 58.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA067581			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA067581: AB_2685865"	"prognostic favorable (2.28e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.87e-7)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.40e-2)"	251.6	72.0	33.4	62.1	35.2	34.3	168.0	37.2	42.0	99.7	43.9	143.5	26.7	82.8	2.7	85.4	192.0	14.7	136.9	35.8	63.6	106.9	207.8	157.5	8.7	81.5	49.3	265.3	81.9	7.6	117.4	50.0	49.5	151.1	12.1	16.9	89.3	19.4	133.0	106.9	79.6	21.6	46.5	109.7	116.3	14.3	47.4	18.5	103.5	21.6	6.6	168.1	139.9	44.6	9.5	7.4	0.3	0.1	41.5	43.2	51.9	24.1	18.7	6.8	14.4	14.8	14.8	0.1	17.3	6.6	5.8	9.9	1.7	12.9	2.1	0.1	3.9	0.5	6.0	6.3	66.8	4.1	0.0	66.7	33.7	1.6	16.0	4.3	1.4	0.4	4.1	7.3	2.5	2.9	0.1	148.7	2.8	6.2	2.5	0.1	5.1	0.5	20.6	7.8	2.8	1.0	58.7	7.7	6.3	2.6	6.4	33.5	6.2	1.5	3.9	15.6	1.5	0.1	0.1	0.1	7.9	0.1	0.3	2.3	19.9	10.6	2.1	8.4	6.2	0.1	0.3	1.2	7.4	0.6	0.0	0.0	54.9	3.7	3.2	0.2	0.3	2.8	33.4	35.2	37.2	42.0	35.8	63.6	81.5	49.3	49.5	46.5	47.4	44.6	1541.7	102.5	196.3	31.3	14.9	663.5	1435.6	98.7	2487.0	6.0	551.3	617.1	79.2	185.8	76.5	224.3	6.2	189.8	152.8	59.2	217.2	50.7	3.5	287.0	418.9	547.9	23.4	30.3	12.5	77.2	457.9	1377.3	387.3	621.0	5.1	96.4	269.5	157.7	220.3	1.7	2.5	44.3	42.7	520.1	502.0	21.5	435.5	912.6	268.6	29.0	163.5	321.9	150.4	6.0	0.5	53.2	58.4	144.8	34.9	1668.5	127.1	353.4	54.9	17.3	466.8	1386.3	1290.5	3.7	13.9	940.2	817.5	351.9	122.7	85.9	73.2	814.5
CECR2	KIAA1740	ENSG00000099954	"CECR2 histone acetyl-lysine reader"	Q9BXF3	22	17359949-17558149	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;retina: 15.6;skeletal muscle: 21.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 109.4;Cone photoreceptor cells: 168.9;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 137.7;Rod photoreceptor cells: 94.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 14.4;K-562: 8.3;NTERA-2: 22.8;SCLC-21H: 10.1;SuSa: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002943	Approved		Approved	Nucleoplasm,Vesicles		No	No				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA002943: AB_1078496"	"unprognostic (2.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.92e-3)"	"unprognostic (7.48e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.13e-6)"	"unprognostic (1.13e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.94e-2)"	0.7	0.4	5.2	0.2	12.8	0.5	1.0	22.5	8.3	1.4	1.2	1.2	0.2	2.3	0.6	0.4	1.7	0.2	3.4	5.3	8.0	1.3	7.6	2.6	0.1	9.8	9.0	2.9	2.6	0.0	6.4	1.0	8.7	1.0	0.3	15.6	0.9	0.2	21.8	0.9	0.5	0.9	5.4	0.4	0.5	3.5	9.8	0.2	2.2	10.6	0.2	1.3	1.0	12.7	0.2	0.1	15.5	5.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.7	0.1	14.4	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	8.3	0.0	0.0	0.1	0.0	0.5	22.8	0.0	0.0	1.8	1.0	0.1	0.0	5.1	10.1	0.0	0.0	0.2	0.9	9.0	1.6	2.5	0.1	0.1	3.4	0.0	0.0	5.8	1.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	12.8	22.5	8.3	5.3	8.0	9.8	9.0	8.7	5.4	9.8	12.7	1.9	6.4	10.6	109.4	0.3	0.0	1.1	0.2	0.0	22.1	0.7	0.6	11.8	0.0	0.8	1.8	168.9	10.1	0.0	0.0	0.0	0.1	6.3	6.3	6.2	2.0	0.0	0.0	2.3	0.2	2.5	3.1	0.0	17.2	0.0	3.5	4.2	10.7	0.7	5.0	4.3	0.0	0.0	0.3	0.3	4.0	1.2	1.4	0.0	34.7	0.2	18.3	0.0	120.1	137.7	0.1	0.0	1.2	0.8	1.8	0.0	1.4	0.9	94.1	6.6	33.9	3.2	1.9	15.9	0.1	0.1	33.0	0.2	0.4	0.0	3.6
CELF2	"BRUNOL3, CUGBP2, Etr-3, NAPOR-2"	ENSG00000048740	"CUGBP Elav-like family member 2"	O95319	10	10798397-11336675	"Predicted intracellular proteins"	"mRNA processing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.0;Excitatory neurons: 1676.4;Inhibitory neurons: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 200.2;HMC-1: 186.2;REH: 86.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016395, HPA035813"	Enhanced		Supported	"Nucleoplasm,Vesicles,Midbody ring"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Midbody ring"	"CAB016395: AB_2086271, HPA035813: AB_2674797"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.45e-1)"	39.6	5.7	33.7	30.7	42.7	78.9	17.7	0.2	42.0	14.2	0.0	16.5	9.2	15.0	5.0	21.4	13.3	17.2	37.5	42.5	7.2	3.0	4.3	28.2	42.4	0.9	13.9	46.8	4.4	3.5	6.5	8.6	0.4	14.1	17.9	35.4	9.6	12.2	17.6	8.6	23.4	23.2	8.6	31.1	10.3	7.6	23.7	60.7	8.5	15.0	29.4	16.2	8.0	21.0	0.1	0.0	47.6	0.0	7.4	2.7	5.3	7.0	0.2	1.1	0.2	0.1	0.0	0.1	5.3	6.1	0.0	0.1	6.8	0.2	0.4	40.4	11.9	200.2	0.7	0.0	1.7	58.0	186.2	3.0	0.3	0.4	0.0	0.7	6.7	70.6	9.3	80.7	59.6	0.0	71.9	42.0	19.3	0.0	0.0	86.7	50.8	18.0	3.4	0.0	7.1	0.5	0.1	0.2	51.1	15.2	0.0	39.0	0.1	8.9	2.5	29.9	0.1	30.7	30.1	9.3	2.9	68.8	21.6	68.0	43.2	90.8	54.8	57.5	69.2	48.1	54.1	60.5	53.4	51.0	56.1	52.7	115.1	73.5	67.8	37.9	60.9	63.5	33.7	42.7	0.2	42.0	42.5	7.2	0.9	13.9	0.4	8.6	23.7	21.0	20.4	160.3	147.3	558.0	165.6	19.9	3.4	5.8	12.5	68.2	18.8	13.7	122.7	5.7	22.4	12.9	102.2	1.1	233.5	11.8	15.6	1.6	135.9	5.3	11.3	34.7	59.3	45.2	1676.4	2.1	0.9	106.0	11.2	17.0	128.5	0.7	13.2	5.1	90.0	134.6	576.9	37.5	24.4	261.4	134.3	110.3	111.6	192.9	115.6	376.6	263.6	90.5	256.4	324.7	21.6	1.5	16.9	89.5	124.3	10.1	2.4	1.0	5.8	99.2	52.6	117.6	33.7	4.1	11.5	5.7	14.5	1.9	232.5	8.5	23.8	2.4
CELF4	BRUNOL4	ENSG00000101489	"CUGBP Elav-like family member 4"	Q9BZC1	18	37243040-37565827	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 122.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 126.4;Excitatory neurons: 197.7;Horizontal cells: 294.4;Inhibitory neurons: 197.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SCLC-21H: 46.7;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013322, HPA037986"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA013322: , HPA037986: AB_10673035"	"unprognostic (7.87e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.42e-7)"	"unprognostic (2.95e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-3)"	"unprognostic (6.13e-2)"	0.6	11.5	102.9	1.1	104.8	0.3	0.4	59.5	122.2	0.3	11.1	1.9	0.8	0.4	0.6	0.5	0.4	1.2	1.0	96.4	81.2	1.5	0.3	0.6	0.8	58.3	69.7	1.3	3.9	0.3	28.4	0.8	71.4	0.8	0.4	21.4	1.7	0.2	11.0	1.3	1.2	0.5	34.6	1.1	1.7	3.6	57.4	0.0	1.5	0.2	0.1	0.2	0.5	94.4	0.1	0.1	0.7	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.3	1.0	0.0	0.2	0.6	0.1	0.0	0.0	0.8	0.4	0.0	1.8	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.8	0.0	0.3	0.1	0.5	1.7	0.0	0.3	0.1	0.0	2.1	0.0	0.1	46.7	11.7	1.1	0.3	0.1	0.3	0.2	0.1	0.0	1.4	0.7	0.3	0.2	2.9	0.5	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.9	104.8	59.5	122.2	96.4	81.2	58.3	69.7	71.4	34.6	57.4	94.4	0.2	0.0	0.0	22.5	0.8	0.4	1.4	0.9	0.0	126.4	0.4	0.5	1.9	0.0	0.3	0.0	41.7	0.3	0.1	0.2	0.0	0.4	46.9	0.7	0.9	4.1	12.7	0.0	197.7	1.1	0.3	1.2	2.0	1.2	0.0	1.8	0.7	0.0	8.6	294.4	197.5	2.5	6.1	0.0	0.0	22.6	0.6	0.3	0.0	14.0	0.0	7.3	0.0	19.1	12.3	2.6	0.2	5.3	0.0	2.7	4.4	6.7	0.3	22.0	0.0	4.3	8.2	12.6	7.6	0.0	0.6	0.3	0.3	1.5	3.5	1.2
CEMIP2	TMEM2	ENSG00000135048	"Cell migration inducing hyaluronidase 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 92.5;placenta: 79.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 105.8;dendritic cells: 378.1;Glandular and luminal cells: 137.3;Plasma cells: 155.1;Syncytiotrophoblasts: 89.8;T-cells: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 143.4;BEWO: 117.4;OE19: 144.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017080, HPA044889"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA017080: , HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	25.1	5.4	9.7	24.8	6.5	29.7	11.1	9.7	8.3	5.1	15.0	24.2	27.2	7.2	2.7	6.6	5.6	41.5	7.7	19.0	2.8	10.4	60.2	35.0	23.1	4.1	3.6	2.2	19.3	92.5	4.6	79.6	4.9	7.0	28.0	17.3	11.1	8.0	4.8	6.1	23.7	11.7	4.1	15.9	33.2	6.8	8.2	18.6	9.4	8.6	20.7	32.0	3.4	5.5	22.5	85.0	143.4	6.6	13.7	22.9	117.4	81.7	48.7	51.6	40.5	24.3	31.3	0.4	20.0	18.8	11.6	35.2	38.6	9.9	73.2	2.5	11.2	38.9	20.9	68.7	23.9	0.4	9.8	28.0	11.4	38.9	8.1	14.0	68.2	3.3	4.7	10.2	28.8	15.1	4.1	0.6	28.2	144.3	8.6	3.3	39.9	2.4	31.6	60.4	6.3	0.6	19.3	12.5	20.5	45.2	8.8	1.3	30.3	33.7	38.3	17.4	39.3	1.8	37.8	0.9	6.1	3.9	43.7	0.1	1.3	3.1	1.4	1.1	0.3	0.4	1.5	1.3	0.5	3.0	2.1	1.0	2.3	0.3	1.0	0.1	2.3	0.9	9.7	6.5	9.7	8.3	19.0	2.8	4.1	3.6	4.9	4.1	8.2	5.5	105.8	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	0.0	58.7	46.7	0.0	0.0	0.0	14.7	0.0	47.9	378.1	0.0	0.0	20.2	0.0	42.1	24.2	14.7	0.0	0.0	0.0	36.2	14.4	4.3	0.0	137.3	0.0	3.8	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	30.8	0.0	0.0	155.1	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	89.8	86.1	3.1	0.0	0.0
CENATAC	"CCDC84, DLNB14"	ENSG00000186166	"Centrosomal AT-AC splicing factor"	Q86UT8	11	118998138-119015793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.1;Cardiomyocytes: 8.5;Cytotrophoblasts: 15.3;dendritic cells: 12.1;Hofbauer cells: 9.2;Plasma cells: 8.1;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039906, HPA071715"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA039906: AB_2676740, HPA071715: AB_2686436"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (8.14e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	11.1	14.0	6.8	2.0	6.9	3.5	11.1	7.3	11.5	14.2	8.6	13.6	1.9	9.5	3.0	11.2	11.7	1.3	12.7	6.8	7.0	15.4	19.0	15.4	2.9	6.8	6.9	11.0	11.2	2.2	15.1	1.7	6.9	16.2	1.7	3.6	10.4	2.7	10.9	13.0	13.9	1.8	6.7	21.7	10.7	7.0	7.0	2.8	15.3	2.1	2.8	13.1	11.8	7.2	3.8	3.2	2.7	3.7	2.7	0.9	3.0	3.4	3.5	2.9	1.8	19.1	2.4	1.4	10.7	3.8	4.5	9.8	1.3	1.8	2.9	5.3	2.2	6.4	6.2	5.5	2.6	2.7	3.5	1.1	1.9	2.9	3.3	3.0	1.7	4.3	1.4	4.8	2.9	6.1	7.0	5.1	3.7	5.6	8.6	9.5	5.5	6.4	4.4	5.6	3.8	2.6	8.6	2.4	0.8	4.3	7.7	2.7	1.9	2.8	13.7	4.0	2.3	3.9	4.0	5.8	2.3	5.3	5.3	0.4	1.3	2.6	2.7	0.9	3.4	4.1	3.6	3.0	2.2	4.2	3.4	2.6	2.1	3.7	0.9	2.6	5.8	1.9	6.8	6.9	7.3	11.5	6.8	7.0	6.8	6.9	6.9	6.7	7.0	7.2	9.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	15.3	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.3	1.7	0.0	0.0	0.0
CEND1	"BM88, FLJ90066"	ENSG00000184524	"Cell cycle exit and neuronal differentiation 1"	Q8N111	11	787115-790113	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 234.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 94.2;Excitatory neurons: 42.9;Horizontal cells: 75.7;Inhibitory neurons: 45.6;Rod photoreceptor cells: 25.5"	"Cancer enriched"	"Detected in many"	13	"glioma: 24.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.6;Karpas-707: 31.0;SCLC-21H: 54.1;SH-SY5Y: 20.4;U-266/70: 21.1;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042527	Enhanced	Supported	Approved	Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA042527: AB_2678038"	"unprognostic (4.62e-3)"	"unprognostic (1.34e-4)"	"unprognostic (9.66e-3)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (2.20e-3)"	"unprognostic (4.11e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.24e-3)"	"unprognostic (1.94e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	0.1	5.5	55.0	1.0	78.8	0.0	0.1	56.9	234.7	0.2	20.0	4.0	0.6	0.9	0.2	0.4	0.1	0.0	1.1	67.4	79.3	1.2	0.3	0.2	0.3	103.8	57.9	0.2	0.2	0.3	26.0	0.0	93.4	3.2	0.1	7.6	0.2	1.5	0.2	0.2	1.4	0.5	21.6	0.3	0.9	0.3	106.3	0.0	0.2	0.0	0.1	0.8	1.1	116.6	0.0	0.7	0.7	1.4	0.2	0.3	0.2	1.3	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.5	13.6	0.5	0.0	0.0	0.0	8.5	0.3	0.0	0.1	0.0	0.1	0.0	5.3	0.6	0.0	0.8	0.0	0.0	0.2	0.0	0.0	31.0	0.5	0.1	0.3	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	54.1	20.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	1.2	0.9	21.1	6.2	1.3	28.6	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	55.0	78.8	56.9	234.7	67.4	79.3	103.8	57.9	93.4	21.6	106.3	116.6	0.1	0.0	0.0	17.6	0.5	0.1	0.1	0.0	0.0	94.2	0.0	0.0	0.5	0.0	0.0	0.0	10.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.4	0.6	0.0	0.0	42.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	75.7	45.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	6.5	0.0	6.7	0.0	15.1	10.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	25.5	0.0	0.1	1.7	0.0	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0
CENPC	"CENP-C, CENPC1, hcp-4, MIF2"	ENSG00000145241	"Centromere protein C"	Q03188	4	67468762-67545503	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049740, HPA058252"			Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"HPA049740: , HPA058252: AB_2683654"	"unprognostic (4.35e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.31e-3)"	"unprognostic (7.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (6.40e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (3.22e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.32e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-3)"	1.5	1.6	2.5	1.0	3.2	3.6	3.3	5.6	2.6	2.8	0.2	2.0	1.1	3.1	2.3	1.5	2.9	1.1	1.5	2.2	2.0	2.0	1.4	1.5	1.8	1.3	1.8	5.6	3.8	1.5	2.5	1.3	1.7	2.9	1.2	2.7	2.0	1.6	1.1	2.3	1.8	1.5	1.3	2.0	2.1	1.7	1.7	2.0	3.1	1.1	1.5	2.0	2.3	2.8	0.4	0.5	1.6	0.9	1.9	1.1	0.9	0.6	0.5	0.7	0.5	0.7	1.3	2.7	0.8	0.8	0.2	0.8	2.2	0.9	1.2	0.8	0.4	2.1	0.9	0.9	0.6	3.9	0.8	1.4	0.3	0.5	1.3	1.2	0.4	1.8	3.0	1.6	1.1	0.7	5.3	3.5	1.8	0.8	0.3	2.4	4.0	0.9	1.0	0.8	2.8	1.3	1.2	2.5	0.7	1.6	0.7	1.3	0.4	1.0	0.5	0.7	0.5	1.3	0.5	2.7	1.1	2.2	0.6	0.5	0.2	0.5	0.7	0.4	0.3	0.8	0.8	0.9	0.2	1.1	1.2	0.9	0.2	0.5	0.2	0.4	0.4	0.2	2.5	3.2	5.6	2.6	2.2	2.0	1.3	1.8	1.7	1.3	1.7	2.8	53.1	32.1	35.5	38.8	68.4	15.2	25.3	17.7	35.9	53.7	26.0	32.3	24.3	18.6	31.6	16.5	14.6	20.2	75.0	17.7	11.7	13.5	4.1	21.0	39.0	33.7	13.1	31.7	58.5	16.7	12.9	41.3	35.7	25.1	26.6	39.8	23.2	14.1	12.8	52.2	57.0	18.4	18.3	16.7	7.9	5.5	34.8	26.7	16.0	31.9	27.4	31.6	60.8	46.3	74.6	14.6	13.0	25.6	89.1	15.3	24.2	20.4	27.2	29.0	19.7	54.1	34.2	47.2	44.4	34.7	9.2	18.3	69.8	43.3	16.4	23.9
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664571	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.8;lymphoid tissue: 33.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	0.8	1.1	0.1	4.4	0.1	28.8	1.8	0.0	0.3	1.3	0.5	5.8	6.1	1.8	0.1	8.6	0.6	0.7	0.4	0.3	0.0	0.4	0.9	0.9	8.5	0.3	0.5	0.7	0.3	0.2	0.1	3.1	0.3	0.5	5.7	1.0	1.4	0.1	0.2	6.2	4.3	2.5	0.2	2.4	2.6	10.5	0.5	33.0	0.4	0.6	10.0	1.4	2.6	0.3	123.7	68.4	144.3	75.8	5.4	7.2	56.3	74.6	30.3	43.9	42.8	54.6	74.1	116.3	43.1	41.7	39.8	74.7	89.9	49.2	74.1	102.6	56.6	96.0	111.4	78.6	0.8	137.0	50.5	2.7	3.8	63.3	72.3	12.7	46.9	52.6	88.4	68.0	79.4	47.0	81.5	54.3	127.9	36.8	30.0	85.7	203.7	38.6	43.2	30.3	67.4	91.2	100.7	66.2	38.9	76.2	79.1	51.9	61.7	78.9	92.2	66.2	155.9	51.6	60.7	108.7	34.4	96.7	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.3	0.5	0.3	0.2	0.5	0.3	3.0	0.0	3.1	0.0	11.5	9.3	2.8	11.2	3.4	4.7	10.0	6.7	1.9	1.5	9.9	0.0	0.0	53.3	10.8	19.1	0.0	2.0	84.4	30.1	19.3	12.4	0.0	268.7	1.3	0.4	78.8	19.0	32.1	25.2	1.3	165.8	8.9	2.6	32.2	1.7	0.8	20.1	14.2	16.6	6.6	19.8	1.2	16.2	1.8	1.0	0.7	1.4	5.2	0.0	0.1	0.5	1.1	3.0	25.9	2.3	2.1	0.1	16.7	3.1	0.0	8.3	23.9	107.5	107.1	44.6	5.5	5.1	23.3	11.7	41.3	3.7
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189574-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.8;testis: 29.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 74.5;Spermatocytes: 222.7;Spermatogonia: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.2	2.0	1.4	7.5	1.7	33.8	7.7	1.7	2.0	3.9	1.0	7.4	6.5	4.5	2.1	7.5	4.0	1.8	4.0	1.5	1.6	1.6	3.6	2.8	17.7	1.6	1.5	3.9	1.5	2.0	1.4	5.2	1.6	3.3	8.1	2.5	2.9	2.3	4.0	9.2	5.9	3.7	1.4	5.2	3.7	29.7	1.6	18.5	2.5	4.0	18.8	3.8	4.4	2.2	64.6	19.4	88.6	70.2	5.8	18.3	48.0	31.2	32.6	66.9	71.8	26.5	79.6	138.9	36.6	18.1	39.1	47.0	59.0	70.4	85.1	42.7	41.4	32.7	32.5	26.4	2.0	47.1	32.1	7.1	14.6	43.6	47.7	18.9	23.2	73.7	58.7	53.3	52.2	35.6	152.4	67.3	78.1	20.7	17.0	93.2	118.2	108.2	21.1	22.9	61.6	81.9	34.6	22.8	27.5	47.7	31.9	31.4	11.4	33.4	56.1	44.5	78.7	65.5	106.3	111.8	51.1	94.2	64.7	1.0	2.0	3.0	4.7	3.5	7.7	13.3	7.9	6.0	3.1	14.1	9.9	8.6	0.4	8.6	4.2	6.7	9.7	4.8	1.4	1.7	1.7	2.0	1.5	1.6	1.6	1.5	1.6	1.4	1.6	2.2	4.8	0.0	2.6	1.0	18.3	36.7	17.7	17.4	9.6	3.4	10.8	11.7	3.3	4.3	7.1	0.0	0.0	37.4	9.2	5.1	0.0	12.3	26.5	5.5	5.1	6.9	1.2	74.5	1.3	9.1	49.0	7.4	2.6	4.8	5.1	22.4	4.6	1.1	17.0	0.0	1.1	9.5	12.2	7.5	18.2	22.5	3.7	6.3	8.8	1.0	4.3	7.3	6.2	1.0	0.9	7.0	2.5	4.9	14.4	6.9	1.4	3.4	10.8	3.5	19.7	6.4	9.3	222.7	222.8	12.1	19.2	10.0	12.0	6.9	15.9	15.2
CENPV	"CENP-V, p30, PRR6"	ENSG00000166582	"Centromere protein V"	Q7Z7K6	17	16342534-16353656	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 100.4;Spermatogonia: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.3;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 106.4;JURKAT: 105.1;NTERA-2: 103.4"	"Low region specificity"	"Detected in all"							"HPA042529, HPA042616"	Enhanced		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Midbody, Cytosol"	"HPA042529: AB_10793882, HPA042616: AB_10794050"	"unprognostic (7.64e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.60e-3)"	4.0	4.7	11.7	0.6	11.3	5.1	4.6	9.3	11.7	4.4	7.1	9.1	9.8	5.9	3.5	0.5	6.6	1.3	5.6	11.9	13.2	3.4	10.7	2.6	1.2	11.6	11.0	6.2	4.0	3.9	7.0	1.2	10.0	3.1	8.0	4.0	1.5	4.0	21.1	0.8	10.6	4.0	11.6	1.1	13.2	10.3	11.4	17.1	2.4	9.5	1.2	4.2	1.7	11.9	10.7	20.4	106.4	53.4	3.0	2.7	18.2	8.7	8.6	26.5	20.0	20.5	4.7	42.5	17.0	6.5	4.9	3.2	69.3	0.6	16.8	0.0	85.9	10.1	5.0	41.1	29.2	10.1	0.0	7.6	2.8	31.6	18.7	3.0	15.2	105.1	17.4	0.0	8.0	1.8	80.2	34.2	103.4	69.1	0.0	57.1	4.1	4.9	6.1	15.4	56.8	43.9	22.2	0.3	5.2	48.6	0.3	24.8	1.0	0.0	8.6	1.2	0.0	0.0	0.0	24.9	0.0	14.0	0.6	0.0	0.0	1.3	0.1	0.0	0.0	1.4	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	11.7	11.3	9.3	11.7	11.9	13.2	11.6	11.0	10.0	11.6	11.4	11.9	13.3	0.0	2.7	3.9	13.7	1.0	29.7	0.5	4.6	40.0	22.5	31.6	4.2	30.0	4.4	1.8	4.2	19.6	19.6	43.0	31.3	7.5	16.3	2.6	32.4	5.0	39.4	12.6	18.9	23.3	22.1	9.2	59.1	2.7	5.7	39.7	1.8	50.1	6.0	11.8	21.8	63.0	0.0	1.4	0.7	9.0	8.7	4.6	8.8	3.7	2.0	45.9	13.4	19.6	11.7	17.8	83.9	11.7	10.7	38.0	100.4	43.5	2.5	15.0	26.3	4.2	17.9	81.6	124.2	2.5	2.6	6.4	10.7	8.7	78.9	45.0
CEP112	"CCDC46, MGC33887"	ENSG00000154240	"Centrosomal protein 112"	Q8N8E3	17	65635537-66192133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Group enriched"	"Detected in many"	8	"Early spermatids: 1061.4;Late spermatids: 1606.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 32.0;RH-30: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069724			Approved	"Nucleoplasm,Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Centrosome"	"Midbody ring, Cytosol"	"HPA069724: "	"unprognostic (9.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.48e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	11.3	3.9	5.0	2.7	5.4	1.7	9.5	7.1	5.8	8.3	11.9	7.8	2.0	8.5	8.2	4.3	8.3	7.0	8.0	7.4	5.1	5.6	3.2	7.4	2.5	5.8	5.7	8.2	4.6	8.7	8.3	7.2	4.2	7.2	3.1	25.4	3.0	7.9	8.8	3.3	2.9	8.0	3.4	8.8	4.2	49.0	5.5	2.8	7.1	14.0	1.7	5.4	5.9	3.4	5.0	10.5	13.3	3.8	6.9	14.0	0.4	4.5	7.7	5.5	5.0	1.5	2.0	1.6	4.3	9.8	15.5	0.6	2.9	2.9	7.8	2.6	4.8	0.3	4.7	1.9	2.9	0.6	0.2	8.4	4.8	5.2	1.6	11.0	16.8	2.7	0.3	5.0	32.0	0.7	5.3	0.4	1.3	1.1	4.4	1.5	75.9	0.4	6.0	0.3	3.5	7.4	4.7	0.5	3.6	11.4	3.8	0.4	7.9	14.3	8.2	3.9	6.7	2.3	2.1	0.2	4.4	0.2	5.3	1.3	0.4	0.4	0.3	0.2	0.6	0.3	0.8	0.3	0.2	0.8	0.5	0.3	1.3	0.8	0.2	1.4	0.5	0.1	5.0	5.4	7.1	5.8	7.4	5.1	5.8	5.7	4.2	3.4	5.5	3.4	39.7	9.6	35.8	83.6	1.1	2.5	2.9	2.2	2.2	36.7	2.7	5.5	28.3	4.3	15.3	1.8	20.9	0.7	0.8	1.5	1.9	7.4	1061.4	15.3	15.8	25.4	1.8	0.4	117.4	4.7	1.5	12.4	1.5	3.3	2.5	11.2	19.2	0.2	1.8	1.7	103.8	0.3	0.0	0.8	11.3	1606.0	24.8	2.3	14.2	99.3	0.0	14.7	1.0	29.7	6.6	4.4	0.5	19.9	0.4	1.5	0.0	4.3	23.7	154.3	13.1	43.7	12.5	40.6	16.5	2.4	1.6	0.1	2.5	3.1	1.5	1.3
CEP131	"AZ1, AZI1, KIAA1118"	ENSG00000141577	"Centrosomal protein 131"	Q9UPN4	17	81189593-81222999	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024019	Approved		Supported	"Microtubules,Cytokinetic bridge,Centriolar satellite"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Microtubules	"Cytokinetic bridge, Centriolar satellite"	"HPA024019: AB_1845227"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (9.68e-5)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.32e-3)"	9.1	8.6	6.7	5.2	6.4	10.2	10.3	7.8	10.0	14.7	7.5	9.8	4.6	11.4	0.9	9.1	11.5	2.0	16.8	6.5	5.8	11.7	6.8	10.7	7.9	6.8	6.2	12.8	10.1	2.2	15.4	4.1	6.2	12.0	0.8	1.8	9.3	2.1	11.1	10.5	10.3	1.6	5.7	19.0	9.9	28.2	6.7	3.5	10.3	2.0	2.2	10.4	10.7	6.8	21.1	20.0	10.6	19.4	1.7	2.7	33.6	14.4	2.5	10.3	7.9	23.8	10.5	14.8	8.0	3.5	6.3	14.9	3.1	7.0	2.5	6.2	26.8	14.3	32.7	41.3	2.9	12.5	30.6	2.3	4.6	7.5	2.1	3.3	7.3	15.6	10.6	8.5	2.7	23.5	29.0	24.3	9.5	6.1	17.7	29.0	12.1	6.1	3.9	18.4	24.2	27.2	18.5	11.4	18.0	3.9	17.2	12.3	10.0	18.6	32.1	16.7	19.2	22.0	4.0	11.3	9.6	10.7	13.5	2.1	0.8	0.5	1.2	2.3	0.3	2.9	0.7	1.1	1.8	1.7	1.1	0.8	1.3	1.0	4.6	2.0	0.1	0.8	6.7	6.4	7.8	10.0	6.5	5.8	6.8	6.2	6.2	5.7	6.7	6.8	6.5	0.0	4.4	5.5	6.6	0.0	3.4	0.0	3.4	5.8	3.3	4.4	13.4	2.8	1.3	3.7	6.2	8.7	4.8	5.6	0.0	4.5	14.0	8.4	3.5	6.0	6.7	5.7	2.1	3.7	7.2	6.9	6.6	2.8	15.9	9.3	2.5	1.7	5.2	5.0	2.9	5.1	0.0	1.9	0.0	17.9	9.6	3.6	0.0	1.0	1.3	6.0	7.2	2.5	2.8	5.2	0.8	3.0	4.4	1.2	1.8	1.4	3.6	6.9	0.0	4.3	5.7	14.7	20.5	3.7	0.0	6.0	3.5	8.4	7.9	2.7
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227643	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.3;Oligodendrocytes: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	2.0	1.5	1.1	2.3	1.9	2.4	2.6	1.8	1.6	2.4	3.2	1.9	1.2	3.7	2.2	1.8	3.7	2.8	1.6	0.8	1.3	2.5	1.4	2.7	2.2	1.4	1.6	4.1	2.1	4.2	1.2	2.5	1.5	2.4	2.6	2.8	1.9	2.3	1.0	2.3	1.7	2.6	1.3	2.3	2.7	8.6	1.6	3.9	3.5	1.6	2.3	2.1	1.4	3.0	2.5	1.1	7.1	7.8	4.2	6.1	4.6	2.8	2.7	3.9	4.6	3.2	3.4	2.7	2.6	2.2	6.7	3.8	4.2	2.6	6.2	7.0	2.8	5.0	5.1	2.4	2.1	5.5	4.6	2.9	1.9	3.9	1.5	5.0	4.4	3.7	10.2	3.1	2.8	1.3	1.4	3.3	4.8	1.7	1.6	7.6	9.3	1.5	2.9	2.3	4.6	5.7	2.0	1.1	2.1	5.1	2.5	3.7	3.5	3.8	3.4	3.4	3.1	2.3	3.3	1.6	2.4	2.9	4.8	0.0	0.2	0.3	0.4	0.2	0.5	0.5	0.3	0.3	0.1	0.3	0.2	0.4	0.5	0.0	0.2	0.4	0.0	0.2	1.1	1.9	1.8	1.6	0.8	1.3	1.4	1.6	1.5	1.3	1.6	3.0	13.6	32.1	17.6	42.7	9.6	0.0	6.7	0.0	4.6	5.9	6.1	7.1	11.2	4.3	6.8	9.2	12.5	6.5	7.0	7.0	5.9	12.6	141.3	43.2	18.3	11.3	11.4	10.8	35.0	7.1	5.9	13.3	8.6	11.3	18.3	18.0	7.9	4.2	5.5	28.6	29.2	4.7	0.0	7.9	0.0	57.9	11.8	9.9	0.0	36.5	7.6	9.2	6.2	54.3	64.0	6.8	12.7	12.0	3.7	2.5	5.6	6.8	39.4	14.3	13.1	13.8	10.9	58.7	20.0	3.6	0.0	3.8	8.5	13.4	5.0	4.1
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 67.6;Excitatory neurons: 94.4;Inhibitory neurons: 91.3;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039392, HPA040503"	Uncertain		Supported	Centrosome,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	2.9	2.2	5.0	4.6	7.6	10.8	4.9	9.8	5.2	4.7	0.0	4.5	4.0	6.4	3.9	3.7	4.9	5.7	3.6	4.1	2.4	2.8	2.9	4.4	6.9	4.1	4.7	9.9	4.6	4.7	2.5	4.6	3.6	4.0	5.4	6.8	4.1	3.5	1.8	3.5	4.7	4.6	3.4	5.2	4.7	9.3	5.0	11.6	5.5	3.9	5.6	4.1	2.5	9.7	13.5	7.2	19.1	10.1	8.1	12.6	6.1	9.2	12.1	14.3	15.1	9.9	5.8	15.2	6.1	9.4	10.4	6.4	16.7	8.8	16.8	6.0	6.0	13.8	11.3	5.2	4.3	22.2	10.2	8.8	3.2	12.0	10.9	8.2	11.9	10.7	19.3	9.9	11.3	6.8	19.2	9.6	6.1	24.9	4.4	16.3	14.9	7.9	4.9	13.6	13.9	7.8	14.7	7.2	4.4	9.0	5.8	11.3	12.1	11.2	26.2	12.9	12.8	6.6	10.1	17.0	7.2	9.9	11.0	0.4	0.6	0.5	0.9	0.4	0.7	0.5	0.6	0.6	0.3	1.3	0.6	1.0	0.6	0.2	1.7	0.5	0.5	0.3	5.0	7.6	9.8	5.2	4.1	2.4	4.1	4.7	3.6	3.4	5.0	9.7	13.3	9.6	12.8	67.6	11.4	1.9	3.9	4.3	5.2	13.1	6.4	5.8	28.7	4.3	9.3	7.3	22.9	5.3	13.7	7.6	0.0	4.7	23.3	11.0	11.8	8.5	0.0	18.7	94.4	3.6	3.3	10.5	15.8	12.1	2.5	40.9	8.2	6.5	4.6	11.8	91.3	8.7	4.1	10.1	3.9	14.2	10.2	10.1	1.8	62.8	15.3	6.5	14.4	76.9	90.6	4.8	5.7	13.9	15.0	5.5	4.5	1.2	8.0	17.8	26.3	11.3	8.1	33.5	24.0	8.5	3.1	1.9	12.3	60.6	8.0	7.6
CEP295NL	"DDC8, KIAA1731NL"	ENSG00000178404	"CEP295 N-terminal like"	Q96MC4	17	78870910-78903217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 9.2;testis: 33.6"	"Group enriched"	"Detected in some"	133	"Early spermatids: 298.6;Late spermatids: 504.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;Karpas-707: 1.1;TIME: 1.2;U-2 OS: 1.9"	"Not detected"	"Not detected"							"HPA023609, HPA024619, HPA025717"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900"	"unprognostic (1.68e-3)"	"unprognostic (4.56e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.03e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.75e-3)"	0.1	0.1	1.9	0.0	2.2	1.3	0.1	0.5	2.8	0.4	1.6	0.1	0.0	0.2	0.0	0.5	0.2	0.0	0.1	0.9	1.8	0.0	0.0	0.1	0.0	2.8	1.9	0.3	0.1	0.0	0.1	0.1	3.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.0	0.3	0.1	33.6	3.3	0.0	0.0	0.0	0.0	0.1	0.3	9.2	0.3	0.0	0.0	0.3	0.1	0.2	1.4	0.6	0.0	0.2	0.3	0.1	0.2	0.0	0.4	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.3	0.0	0.4	1.2	0.5	1.9	0.6	0.2	0.4	0.6	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	1.9	2.2	0.5	2.8	0.9	1.8	2.8	1.9	3.4	1.0	3.3	9.2	0.7	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	298.6	0.3	1.7	0.5	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.5	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	504.5	2.8	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	3.0	1.4	0.1	0.0	0.0	0.1	0.7	0.0	0.1
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496612-93529092	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4;testis: 21.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA023430	Approved		Approved	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	1.3	0.6	0.0	7.6	0.0	5.0	1.4	0.0	0.2	1.7	0.0	7.0	6.7	1.4	0.1	7.3	0.4	1.4	0.3	0.0	0.1	0.3	0.6	1.3	14.7	0.1	0.3	0.2	0.2	0.2	0.3	3.5	0.2	0.3	8.8	0.0	1.2	0.3	0.1	4.5	6.3	5.2	0.0	2.4	4.6	21.7	0.4	27.4	0.5	0.2	15.5	3.1	2.3	0.1	208.5	81.5	53.0	67.7	5.8	12.0	29.6	112.4	78.2	103.5	106.4	87.2	108.6	55.4	48.2	72.8	69.6	115.4	64.8	54.8	123.4	167.2	33.7	21.0	49.2	29.9	0.6	36.3	46.3	2.8	3.8	110.6	133.5	30.7	97.1	89.9	19.3	101.8	118.5	48.3	96.3	54.8	20.9	64.2	58.8	41.3	86.9	30.3	47.1	25.5	21.7	30.7	86.3	26.3	64.9	40.1	68.9	36.4	61.4	65.3	90.6	90.5	186.7	45.1	66.1	66.8	51.0	134.8	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.1	0.2	0.0	1.3	0.0	2.7	3.6	0.9	1.9	0.0	0.0	1.8	2.0	0.4	2.8	0.2	0.0	0.0	7.7	0.9	3.3	0.0	0.6	29.4	1.7	2.0	1.5	0.0	2.5	0.5	0.2	17.1	2.3	8.2	3.6	0.0	19.8	2.2	0.3	12.9	0.0	0.3	4.5	4.1	7.0	5.1	8.2	0.3	5.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.4	14.8	1.1	0.4	0.0	0.2	0.0	0.0	0.5	4.5	77.3	17.3	16.1	1.3	1.5	4.3	1.6	7.9	1.7
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CERT1	"CERT, COL4A3BP, GPBP, STARD11"	ENSG00000113163	"Ceramide transporter 1"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;Cardiomyocytes: 37.1;Cytotrophoblasts: 17.7;dendritic cells: 20.2;Extravillous trophoblasts: 16.8;Hofbauer cells: 36.8;Plasma cells: 12.4;Syncytiotrophoblasts: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 132.3;WM-115: 118.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: AB_2678075"	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	38.1	26.1	12.4	16.5	16.1	27.2	17.6	18.0	15.4	33.9	14.0	20.8	18.7	20.6	15.1	24.9	22.4	23.3	20.8	14.0	15.1	27.9	31.2	24.3	20.3	14.7	17.5	23.1	16.4	26.1	8.0	22.9	16.7	24.3	19.6	18.2	14.0	19.9	28.9	18.7	21.1	18.3	14.7	25.3	23.5	28.8	15.5	21.2	49.9	28.3	22.7	23.7	16.0	17.6	44.9	22.7	21.6	19.0	132.3	36.6	29.0	24.8	30.8	18.8	24.8	34.4	25.3	21.5	52.3	26.9	25.8	26.7	33.4	34.4	28.6	27.1	15.2	18.2	24.4	18.4	33.6	18.2	20.1	27.9	23.8	22.3	24.9	30.5	22.1	28.3	33.0	32.0	25.0	23.0	21.6	13.2	27.9	10.2	16.8	18.0	28.5	20.2	30.5	54.0	16.4	16.5	31.6	21.6	31.8	45.4	21.3	30.5	30.1	12.6	15.1	22.8	20.3	29.1	41.6	24.8	21.4	30.7	118.2	9.6	19.8	16.0	8.2	22.4	7.8	9.1	8.3	7.7	14.5	9.1	7.7	7.8	29.6	7.8	25.4	8.3	13.0	9.0	12.4	16.1	18.0	15.4	14.0	15.1	14.7	17.5	16.7	14.7	15.5	17.6	23.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	17.7	20.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	16.8	10.5	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	27.8	3.8	0.0	0.0	0.0
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 2517.1"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 613.4;Hepatocytes: 2420.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"classical monocyte: 109.6;myeloid DC: 114.5"	"Group enriched"	"Detected in many"	22	"dendritic cells: 114.5;monocytes: 109.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 700.9;THP-1: 688.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	94.9	14.1	0.9	3.2	1.2	27.0	43.6	0.8	1.8	26.6	3.7	82.3	24.0	60.4	7.5	41.1	54.6	272.9	66.1	1.0	1.4	6.7	2517.1	167.8	1.8	2.3	1.2	20.3	8.8	0.7	3.7	8.5	1.5	39.2	12.3	2.9	41.4	36.4	5.2	14.0	27.4	40.4	1.0	41.0	56.1	7.8	1.1	2.5	9.9	9.4	1.0	57.7	17.7	1.1	0.7	4.4	0.0	0.0	90.8	0.6	3.1	0.3	0.0	0.0	0.0	43.5	0.0	0.0	19.4	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.9	700.9	0.0	1.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	40.8	0.1	0.6	0.0	0.0	1.5	6.7	0.0	0.5	0.0	0.1	3.2	0.1	1.1	0.9	0.0	688.0	0.1	0.0	0.4	0.2	0.5	2.2	0.1	1.0	0.0	151.7	0.0	0.0	109.6	0.5	4.5	6.1	1.5	1.1	0.7	5.0	114.5	1.2	0.7	1.1	0.6	0.3	1.6	6.8	0.4	58.0	0.9	1.2	0.8	1.8	1.0	1.4	2.3	1.2	1.5	1.0	1.1	1.1	2.0	16.0	67.6	0.0	11.3	16.7	5.3	6.8	1.2	0.0	1.2	8.1	0.8	613.4	31.5	16.5	0.0	0.5	12.2	0.1	0.0	15.4	79.6	1.0	10.6	8.9	37.5	177.7	0.0	18.7	2.2	57.4	1.1	0.2	6.3	0.0	66.0	2420.8	18.1	0.0	0.0	12.2	4.1	107.3	26.7	197.8	18.6	58.7	39.2	1.0	39.6	10.4	7.2	0.0	0.0	0.9	1.3	98.9	1.8	1.5	0.6	0.9	169.0	0.9	0.0	9.8	9.8	1.0	2.3	20.6	11.6	0.8	16.9	0.9	0.7	2.6
CETN3	CEN3	ENSG00000153140	"Centrin 3"	O15182	5	90392257-90409766	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 130.4"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 469.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035608, HPA063704"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA035608: AB_10601098, HPA063704: AB_2685097"	"unprognostic (2.08e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	17.4	21.6	18.5	14.7	20.6	7.6	24.0	19.3	26.3	20.6	19.0	16.9	9.7	20.0	21.8	13.5	22.7	10.3	22.1	18.3	20.0	19.8	13.5	13.4	19.1	21.2	19.6	31.0	9.3	24.4	16.8	19.3	21.2	19.0	19.6	35.3	15.1	14.7	14.4	15.4	10.6	13.9	19.3	15.1	12.9	130.4	19.8	20.6	15.2	14.1	21.0	11.3	11.7	27.1	38.4	18.7	66.2	13.4	38.8	49.2	39.5	41.2	25.4	39.7	47.1	25.5	45.3	71.7	40.4	20.2	76.9	26.2	58.5	57.4	63.5	59.6	27.2	36.4	26.9	32.6	27.3	26.9	22.2	32.7	36.6	29.4	49.1	42.5	24.1	56.8	47.2	30.9	44.3	26.5	46.2	42.6	23.2	14.0	42.6	40.6	45.7	37.0	35.1	14.5	36.0	37.2	40.2	19.9	31.7	59.1	37.7	36.6	28.0	22.6	32.7	32.0	55.7	28.6	55.5	63.6	26.9	60.5	23.3	19.7	9.9	14.8	12.9	13.1	13.7	27.3	14.3	14.6	11.3	21.8	20.4	16.3	1.2	17.3	16.6	30.6	13.3	6.9	18.5	20.6	19.3	26.3	18.3	20.0	21.2	19.6	21.2	19.3	19.8	27.1	19.5	19.2	38.7	13.4	17.8	14.3	34.3	70.3	22.2	19.3	23.5	25.7	53.0	27.1	37.5	36.8	18.8	69.4	13.4	11.9	95.9	21.8	20.2	41.4	26.6	22.4	24.0	54.1	8.4	10.0	69.5	33.0	6.1	24.4	6.3	19.6	48.5	42.2	26.0	21.9	12.6	21.2	48.8	19.2	5.1	38.5	44.1	10.3	19.6	8.4	19.6	84.0	17.5	15.1	34.1	12.8	21.4	32.4	8.4	16.5	8.5	46.2	75.9	24.4	59.2	14.2	23.8	469.5	66.3	19.6	15.8	41.7	15.0	17.2	24.8	21.6
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.7;choroid plexus: 18.2;fallopian tube: 57.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 32.4;Endometrial ciliated cells: 99.6;Respiratory ciliated cells: 81.6;Spermatocytes: 33.9"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.5;glioma: 1.7;lung cancer: 0.6;ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;MCF7: 2.1;OE19: 2.7;REH: 1.4;T-47d: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.0	0.3	3.8	0.0	4.3	0.0	0.1	2.3	2.9	2.3	18.2	0.1	0.7	1.1	0.1	0.2	57.8	0.2	0.0	4.0	4.1	0.3	0.2	4.4	0.0	10.7	13.7	0.2	0.2	0.3	3.2	0.2	8.4	0.3	0.0	2.4	1.2	0.2	0.0	0.2	0.7	0.0	9.9	0.0	0.1	12.2	3.9	0.3	0.6	0.3	0.0	0.1	0.1	6.6	0.8	0.8	0.0	0.3	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.1	0.0	0.3	0.1	2.7	0.0	1.4	0.0	0.0	0.2	0.4	0.3	0.0	0.3	0.5	0.0	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	4.3	2.3	2.9	4.0	4.1	10.7	13.7	8.4	9.9	3.9	6.6	0.2	0.0	2.3	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.3	0.0	9.9	0.0	6.2	0.8	0.0	0.0	1.9	0.1	32.4	99.6	0.9	0.3	0.0	0.0	9.7	0.2	0.2	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	6.4	1.8	0.0	0.0	1.0	0.0	0.7	0.0	7.1	1.1	0.1	0.0	1.9	0.0	0.3	0.0	0.5	81.6	3.1	0.0	0.1	0.2	33.9	0.8	0.0	0.0	1.0	0.1	0.1	0.0	0.1
CFAP53	"CCDC11, FLJ32743"	ENSG00000172361	"Cilia and flagella associated protein 53"	Q96M91	18	50227193-50266495	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Ciliopathy, Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 28.5;testis: 79.6"	"Group enriched"	"Detected in many"	14	"Early spermatids: 809.6;Endometrial ciliated cells: 331.5;Late spermatids: 528.4;Respiratory ciliated cells: 216.5;Spermatocytes: 481.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.7"									"HPA041069, HPA066142"	Enhanced		Approved	Midbody		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Midbody		"HPA041069: AB_10805835, HPA066142: AB_2732739"	"unprognostic (1.73e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.85e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.61e-3)"	0.3	1.2	3.0	0.4	3.4	0.7	1.1	5.0	3.2	2.0	8.5	0.5	0.2	1.1	5.7	0.4	28.5	0.7	0.5	3.1	3.7	2.7	0.4	3.3	0.3	6.8	7.8	1.0	1.1	2.5	3.3	0.3	6.0	0.9	0.2	3.5	0.6	1.2	2.3	1.0	0.4	0.3	5.3	0.4	0.5	79.6	3.4	0.5	3.9	0.4	0.2	0.6	0.6	5.0	1.2	0.8	0.5	1.0	0.7	1.3	0.9	0.2	0.1	0.1	0.2	0.1	1.0	0.7	0.7	0.3	0.3	0.5	0.3	0.5	0.2	0.5	0.7	0.3	0.3	0.1	0.3	0.5	0.4	0.4	2.0	0.5	4.7	1.1	0.3	1.9	1.4	0.4	0.3	1.2	1.2	0.2	0.2	0.2	0.5	0.1	0.2	1.0	1.4	0.0	0.8	0.6	0.1	0.0	0.4	1.3	0.6	0.1	0.0	0.7	0.5	0.4	0.4	2.1	0.8	0.1	0.7	0.5	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.2	0.0	0.2	0.2	0.0	3.0	3.4	5.0	3.2	3.1	3.7	6.8	7.8	6.0	5.3	3.4	5.0	0.6	6.4	4.2	2.6	0.6	0.0	2.0	0.0	1.8	4.3	4.7	3.8	0.4	0.0	21.1	9.2	8.4	1.7	0.2	0.3	9.8	3.4	809.6	331.5	3.8	1.4	0.0	0.4	3.8	0.6	0.5	2.2	2.6	7.9	1.3	1.4	1.8	1.0	0.4	1.7	4.4	0.2	0.0	0.0	0.0	528.4	8.4	1.3	0.0	2.8	1.0	2.7	1.0	3.0	6.5	0.8	0.1	5.7	0.9	1.3	0.8	20.5	216.5	10.5	6.6	2.1	0.7	481.5	32.5	1.3	0.0	0.7	1.0	1.7	0.4	1.1
CFAP77	"C9orf171, FLJ46082"	ENSG00000188523	"Cilia and flagella associated protein 77"	Q6ZQR2	9	132410043-132573319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 11.5;fallopian tube: 29.7;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 127.1;Endometrial ciliated cells: 58.4;Late spermatids: 47.6;Respiratory ciliated cells: 36.5;Spermatocytes: 25.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021329, HPA024647, HPA061069"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657"	"unprognostic (7.28e-4)"	"unprognostic (5.68e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.74e-1)"		"unprognostic (3.01e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	0.0	0.0	1.2	0.0	1.0	0.0	0.0	2.0	0.1	1.2	11.5	0.0	0.0	0.5	0.2	0.0	29.7	0.0	2.4	1.0	1.5	0.1	0.0	2.1	0.0	4.1	6.0	0.0	0.1	0.0	0.6	0.0	3.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	19.3	1.4	0.2	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	2.0	0.1	1.0	1.5	4.1	6.0	3.1	3.3	1.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	58.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.3	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	36.5	3.8	0.0	0.0	0.0	25.5	3.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1
CFAP99		ENSG00000206113	"Cilia and flagella associated protein 99"		4	2418974-2462942	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"brain: 4.8;choroid plexus: 5.8;fallopian tube: 3.9;retina: 1.5;testis: 5.3"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Early spermatids: 11.6;Endometrial ciliated cells: 13.6;Late spermatids: 11.2;Rod photoreceptor cells: 5.5;Spermatocytes: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA071642			Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA071642: "	"unprognostic (7.54e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.93e-5)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.49e-1)"	0.0	0.8	0.5	0.0	0.5	0.0	0.0	0.8	0.3	0.2	5.8	0.0	0.0	0.2	0.1	0.0	3.9	0.0	0.0	0.9	0.8	0.2	0.1	0.6	0.0	3.2	4.8	0.0	0.3	0.0	0.8	0.0	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	5.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.8	0.3	0.9	0.8	3.2	4.8	1.8	2.0	1.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	0.0	1.8	3.7	4.2	0.0	0.0	0.0	0.0	0.2	11.6	13.6	0.2	0.1	0.0	0.0	1.2	0.6	0.1	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	11.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	1.5	2.9	5.5	0.0	0.0	0.0	14.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2
CFL1	CFL	ENSG00000172757	"Cofilin 1"	P23528	11	65823022-65862026	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013086, CAB033687, CAB037077, HPA053761"	Approved		Supported	Cytosol		NA	NA		290000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB013086: AB_2533565, CAB033687: AB_1121774, CAB037077: AB_1078547, HPA053761: AB_2682251"	"unprognostic (1.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.59e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.88e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	609.5	435.4	578.8	932.7	598.8	1322.1	514.5	590.1	661.2	451.5	475.3	1145.1	1169.2	713.1	343.2	706.0	481.5	413.6	501.9	637.3	599.8	612.5	471.0	683.4	987.6	626.4	571.5	344.7	264.6	301.8	340.6	479.2	622.1	440.6	990.3	208.9	453.1	457.6	261.9	503.1	1120.7	847.3	608.3	775.2	633.8	267.4	632.2	939.6	370.9	230.6	1100.5	682.9	471.2	695.4	2284.3	1783.6	1908.5	1529.8	1142.6	1157.0	1031.6	2309.7	1942.4	2457.5	1460.7	1012.4	1815.2	1700.8	1755.3	2925.7	1780.5	1623.2	1389.2	2103.8	1824.9	1869.0	718.2	2185.8	1271.2	1162.1	1222.6	1890.2	2854.6	1339.3	1412.4	2166.7	1108.0	1494.0	2663.1	1099.4	1037.6	1648.5	2635.7	2133.0	2739.4	2965.4	2095.8	1985.4	1432.7	2050.3	941.1	2181.9	1847.8	1468.6	952.7	2106.6	1250.6	1733.6	1682.2	1053.4	2104.1	1427.8	2330.5	2087.3	1603.5	2672.6	2194.0	1193.1	2065.2	2251.0	2146.2	1161.7	2004.4	1690.2	2720.0	2973.1	2534.0	2955.4	1964.6	1561.4	1992.5	2296.2	3343.8	1527.0	1459.3	1905.2	2946.2	1961.1	3255.3	2558.6	2696.1	6842.2	578.8	598.8	590.1	661.2	637.3	599.8	626.4	571.5	622.1	608.3	632.2	695.4	805.5	246.8	223.0	24.5	890.8	1349.3	1253.3	1197.1	598.8	198.5	655.2	646.0	74.8	459.0	595.7	520.5	58.4	1239.8	1439.8	2052.9	892.1	2114.0	459.4	376.6	648.1	918.4	779.0	557.7	38.8	1965.0	2470.6	579.0	642.8	603.3	598.2	527.4	698.2	436.3	2911.0	203.6	30.3	1448.8	891.1	1185.5	1706.6	373.2	352.2	1474.2	985.4	38.4	2903.8	478.3	2075.2	22.6	62.0	3082.4	1894.7	502.9	639.1	991.2	2279.4	1246.5	295.5	118.0	420.7	448.2	1184.3	177.4	412.8	703.8	1267.4	1732.4	1276.2	621.7	1315.3	1383.3
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34709113-34714823	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 372.8;skeletal muscle: 719.9;tongue: 686.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 522.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		47000000	"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	48.7	52.5	71.7	28.6	98.7	18.1	24.6	90.3	116.1	39.8	53.9	92.5	14.3	73.4	19.5	69.0	42.6	24.1	372.8	69.4	85.0	31.4	125.9	24.9	10.7	85.7	83.6	41.2	9.4	24.4	10.9	35.3	88.7	75.4	28.1	41.0	17.1	107.3	719.9	8.2	24.0	115.0	74.7	12.7	36.1	21.7	81.2	10.4	29.4	686.4	9.9	56.8	24.3	130.5	87.1	77.7	49.5	32.0	51.1	185.6	27.9	146.6	170.5	145.6	151.4	61.9	38.5	30.6	58.5	245.2	104.9	17.1	107.4	32.5	268.6	4.2	45.0	6.6	87.4	144.5	81.6	8.2	5.3	139.3	12.4	122.2	67.7	96.8	145.9	4.5	9.9	26.8	186.9	25.5	6.3	4.3	16.3	15.4	118.9	5.4	158.1	4.7	55.1	17.7	10.3	41.7	96.6	21.5	51.2	36.2	47.8	7.5	124.6	140.9	93.0	66.1	72.9	34.3	22.8	11.7	51.7	11.4	34.5	1.8	1.0	1.3	1.9	1.0	3.1	4.9	2.2	2.1	1.6	3.0	1.7	1.8	0.3	1.8	0.4	1.6	2.1	0.9	71.7	98.7	90.3	116.1	69.4	85.0	85.7	83.6	88.7	74.7	81.2	130.5	39.6	105.8	41.6	6.2	17.0	20.0	88.6	31.3	23.9	62.8	19.6	16.6	522.2	22.8	26.3	22.0	20.9	32.2	11.5	0.9	60.7	45.2	2.6	40.3	60.5	45.1	9.5	11.4	9.6	39.7	60.5	69.9	6.1	56.2	5.7	25.8	47.2	112.0	15.6	77.4	14.2	2.4	57.0	15.7	14.4	10.1	57.2	10.6	30.2	11.2	5.7	112.9	15.5	8.0	93.8	24.7	4.0	98.6	60.4	84.0	1.0	101.9	24.7	57.8	32.9	83.9	115.8	49.3	51.9	16.1	19.5	21.3	21.1	47.9	4.6	58.5
CGNL1	"FLJ14957, JACOP, KIAA1749, PCING"	ENSG00000128849	"Cingulin like 1"	Q0VF96	15	57375967-57550717	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 87.2;Astrocytes: 79.7;Hepatic stellate cells: 58.5;Hepatocytes: 65.5;Microglial cells: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 52.7;SuSa: 37.6;TIME: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013500, HPA056911, HPA069214"	Enhanced		Supported	"Nuclear bodies,Cell Junctions"		No	No				"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"	"Nuclear bodies"	"CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102"	"unprognostic (1.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.51e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.18e-2)"	5.0	11.5	23.6	1.5	23.0	0.0	19.8	19.8	18.5	32.0	47.2	3.2	1.2	17.8	4.4	11.0	8.9	2.8	20.1	18.6	24.2	68.3	36.0	21.0	1.1	28.9	28.2	5.8	18.6	9.6	4.1	28.8	27.7	28.7	2.3	12.3	32.3	16.2	0.7	11.5	2.5	10.8	20.0	0.4	15.5	6.6	29.9	4.6	19.8	1.9	3.2	8.9	20.2	15.7	0.0	1.3	13.1	0.0	0.0	0.0	0.2	0.2	2.9	1.1	2.4	8.4	0.1	0.0	11.4	1.7	1.9	0.0	6.2	0.1	1.8	0.1	1.0	0.1	0.1	5.7	0.2	0.1	0.0	0.4	0.4	1.3	0.0	4.4	52.7	0.5	0.0	0.0	2.1	2.4	0.0	0.2	6.5	3.7	0.6	0.1	6.6	0.3	4.4	0.0	0.3	0.7	0.0	5.1	0.0	37.6	0.5	0.6	32.5	0.0	3.3	0.1	1.9	0.0	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	23.0	19.8	18.5	18.6	24.2	28.9	28.2	27.7	20.0	29.9	15.7	3.9	51.3	87.2	79.7	0.2	4.6	13.4	5.1	4.6	0.4	27.4	27.1	21.0	10.0	11.7	22.0	0.0	1.0	1.6	0.9	41.1	9.9	3.0	11.0	9.4	21.8	13.1	2.7	0.7	13.2	1.0	17.1	11.2	11.8	1.3	3.5	58.5	65.5	0.3	0.0	1.9	3.7	18.3	1.6	4.9	18.1	19.9	0.9	7.2	156.4	0.6	43.7	0.0	11.1	1.5	4.3	1.2	27.8	0.0	18.6	0.2	39.4	2.2	1.4	0.0	6.6	2.3	0.6	0.6	0.8	2.4	1.4	1.2	0.6	2.2	7.0
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314482-114337626	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	9.9	7.1	3.4	9.8	3.3	14.2	9.5	6.6	5.2	8.1	3.8	8.7	10.0	8.5	8.0	6.4	9.8	7.6	6.2	3.0	4.3	8.9	15.2	8.9	15.7	2.7	3.4	12.1	15.4	9.3	3.6	9.9	3.4	10.0	9.9	9.1	8.4	9.3	7.9	9.2	8.0	10.1	2.3	9.6	7.7	6.9	2.7	16.5	10.7	9.7	17.3	7.5	4.4	3.1	36.9	15.8	56.6	24.2	20.1	30.9	24.3	38.2	32.0	35.6	39.4	23.5	22.0	75.2	15.1	30.0	22.3	23.0	41.8	30.6	52.7	29.8	50.0	49.7	21.8	20.7	22.5	73.3	28.3	30.4	18.8	27.8	27.3	12.6	17.4	25.8	32.1	20.3	46.1	14.6	48.6	21.4	43.1	45.2	20.2	48.1	26.9	26.0	27.0	22.2	27.5	32.8	22.2	49.2	36.7	39.1	28.2	61.3	19.3	19.5	30.8	20.7	23.6	25.7	27.9	80.4	38.6	42.7	38.1	7.5	3.3	4.4	3.7	4.0	4.6	5.4	3.3	3.7	3.9	5.8	2.6	3.0	0.8	3.5	6.6	12.5	2.4	2.1	3.4	3.3	6.6	5.2	3.0	4.3	2.7	3.4	3.4	2.3	2.7	3.1	11.2	9.6	9.6	3.6	13.9	3.3	6.6	7.6	10.8	12.5	11.3	10.8	5.7	11.5	4.1	12.9	4.2	14.2	18.1	9.3	13.7	11.7	1.0	8.5	14.8	10.9	10.8	24.4	6.1	11.4	18.1	11.5	10.2	8.3	10.1	13.1	13.9	21.6	21.7	15.2	7.8	12.5	6.1	20.7	7.8	1.6	11.8	13.0	12.4	7.5	18.4	8.8	17.5	4.0	8.0	10.9	7.8	11.3	17.6	13.2	12.5	17.0	7.6	10.9	6.6	11.7	10.5	10.6	20.7	13.1	3.8	7.9	11.4	12.4	11.4	3.5
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93027996	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060744: AB_2684353, HPA060960: AB_2684398"	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	13.9	12.3	22.7	20.7	25.5	73.5	20.4	42.0	32.7	15.7	32.0	15.2	14.8	19.4	29.1	14.6	16.2	15.6	12.0	21.3	24.7	16.9	15.4	21.6	26.4	29.0	23.3	26.1	19.6	18.2	16.6	20.5	24.5	20.4	14.8	30.8	21.2	13.4	17.4	18.8	18.7	13.3	22.1	23.3	17.7	20.8	25.9	27.0	26.3	14.7	25.4	13.7	16.1	27.6	21.3	11.6	30.6	13.6	17.9	45.3	23.0	19.4	20.0	13.0	16.1	14.5	27.4	5.2	16.1	17.3	22.1	31.1	17.6	19.5	18.0	0.1	10.6	25.3	26.1	12.9	24.6	27.1	19.0	28.7	23.0	15.5	31.1	26.8	22.4	36.7	26.8	57.1	19.9	13.1	14.2	14.0	19.5	10.5	12.6	19.9	27.6	28.4	13.3	28.5	16.8	18.1	34.2	12.3	25.9	30.6	14.1	22.6	36.2	10.7	13.9	9.3	12.8	53.4	23.2	21.6	15.9	15.9	9.4	35.9	10.8	27.7	22.1	6.6	21.8	48.7	21.5	20.5	7.4	39.6	30.1	22.1	53.7	20.6	13.4	27.9	24.9	10.9	22.7	25.5	42.0	32.7	21.3	24.7	29.0	23.3	24.5	22.1	25.9	27.6	59.3	70.5	176.3	182.2	137.8	164.3	112.3	102.3	153.7	71.4	62.6	46.5	42.3	37.1	137.3	46.0	91.8	30.7	116.3	59.6	3.9	36.1	56.5	96.9	61.7	58.6	59.3	65.4	161.5	38.3	28.5	64.5	96.4	189.8	99.3	70.7	25.0	34.9	24.8	57.2	146.2	54.9	91.6	55.1	297.4	39.2	34.8	89.5	96.0	119.9	50.7	34.2	48.4	140.8	155.9	64.2	61.6	37.6	133.0	110.0	39.9	11.5	93.9	82.2	32.9	52.7	64.4	15.3	14.7	125.2	180.7	60.5	153.2	42.9	51.5	143.6
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884796-7912760	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Supported	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Centriolar satellite"	"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	28.2	29.3	19.9	35.0	27.9	42.7	28.4	0.0	39.9	71.6	0.0	55.3	16.7	63.9	31.2	35.1	56.8	27.8	21.2	35.8	7.0	38.3	5.7	32.4	41.3	4.9	2.4	60.0	34.8	44.7	47.7	16.6	1.1	68.7	22.1	19.0	40.3	38.0	8.0	32.7	34.6	45.0	3.1	31.5	36.3	20.9	8.0	58.2	44.9	9.1	36.7	41.2	42.8	21.4	44.9	108.7	61.6	81.2	72.2	60.9	32.8	51.7	66.1	40.8	43.5	21.1	36.7	122.8	38.3	73.0	34.0	59.6	117.7	52.5	53.0	65.5	67.2	62.7	148.5	2.7	38.3	17.8	112.1	79.2	27.5	55.4	36.9	108.7	76.9	54.1	41.5	2.0	38.8	42.6	48.2	19.6	9.8	45.3	40.3	137.8	82.1	19.3	40.0	107.7	41.9	56.3	126.4	47.9	24.6	16.9	55.7	27.1	99.7	89.4	68.8	22.3	72.5	8.8	1.6	68.3	46.1	47.4	77.6	1.7	2.6	3.3	4.1	1.4	3.6	1.1	4.2	4.0	1.3	1.2	4.6	3.1	2.8	3.2	3.2	3.0	2.5	2.5	19.9	27.9	0.0	39.9	35.8	7.0	4.9	2.4	1.1	3.1	8.0	21.4	20.9	32.1	63.2	10.4	19.6	36.6	47.6	21.1	65.4	60.7	43.8	34.2	14.3	17.2	35.2	80.9	8.4	16.8	57.3	39.8	17.6	22.9	11.3	48.6	51.9	29.4	56.8	19.1	20.6	23.4	20.5	39.9	31.1	70.7	39.9	59.7	22.9	2.7	9.0	45.4	25.2	17.0	12.2	24.7	34.7	18.5	44.4	26.7	8.8	6.5	43.7	12.4	59.8	12.1	2.5	20.9	10.8	57.2	17.4	55.5	10.9	9.7	24.8	17.3	26.3	31.8	43.5	25.5	46.8	52.8	20.5	16.4	62.9	52.0	30.3	60.3
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 502.5;Rod photoreceptor cells: 766.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420, HPA066155"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 14: REH - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	7.4	6.6	13.6	6.0	19.3	21.7	11.5	31.1	9.4	10.1	2.1	8.1	5.4	9.7	6.2	7.7	9.0	8.1	7.1	6.4	17.1	11.1	6.9	7.0	6.9	13.3	17.1	12.7	6.4	10.2	5.0	8.7	16.9	8.4	7.8	28.9	8.5	8.7	7.2	6.3	5.7	7.9	10.1	7.7	9.6	4.9	14.2	9.9	12.2	12.8	6.7	7.1	6.2	17.6	10.4	12.0	25.0	20.8	20.0	28.6	4.4	18.0	13.8	9.9	4.3	6.8	9.1	14.0	11.3	16.8	6.9	12.5	14.0	10.4	14.0	5.0	10.2	18.4	12.0	4.6	13.5	25.3	15.8	19.9	9.5	15.2	18.3	12.9	14.7	8.3	22.2	4.5	13.0	4.2	13.1	5.9	9.6	3.1	8.7	46.2	28.8	5.8	6.4	9.7	10.4	11.7	16.6	5.4	12.3	9.7	6.0	12.0	28.3	18.1	8.9	6.6	12.0	13.1	9.7	21.9	13.2	11.3	17.9	102.0	25.5	27.5	15.7	21.9	24.5	38.9	10.7	17.6	16.2	46.6	8.5	12.0	8.6	38.3	39.4	126.7	6.1	5.4	13.6	19.3	31.1	9.4	6.4	17.1	13.3	17.1	16.9	10.1	14.2	17.6	146.3	70.5	74.7	426.4	111.5	57.2	123.4	107.7	96.8	318.9	81.3	89.9	39.0	55.8	81.5	90.1	502.5	17.4	112.1	80.8	46.9	60.4	16.4	71.8	109.3	97.5	87.6	67.7	272.9	36.7	31.2	117.2	109.1	69.9	96.7	121.8	107.4	66.4	69.0	220.4	297.3	89.7	69.2	67.8	50.7	19.1	108.4	88.6	67.6	319.5	89.3	153.3	98.9	462.4	312.0	39.0	100.5	123.4	70.3	98.2	76.1	60.8	72.3	766.6	59.2	157.2	106.1	105.7	50.9	75.4	75.0	24.9	60.5	89.3	72.1	83.4
CHID1	"FLJ42707, MGC3234, SI-CLP"	ENSG00000177830	"Chitinase domain containing 1"	Q9BWS9	11	867859-915058	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 404.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039374	Uncertain		Uncertain	"Nucleoplasm,Intermediate filaments"	"Intracellular and membrane"	No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Intermediate filaments"		"HPA039374: AB_10673609"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.96e-2)"	"prognostic favorable (6.76e-4)"	"unprognostic (4.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.89e-2)"	43.9	63.3	43.1	22.7	44.1	46.2	40.2	41.0	51.7	44.5	60.0	34.2	30.9	38.0	89.5	34.8	63.5	41.3	54.4	44.1	47.2	52.5	85.8	30.9	27.2	42.9	42.9	58.0	149.9	46.1	62.8	42.7	42.5	42.3	29.7	25.2	82.2	41.3	37.0	34.9	27.7	35.7	42.6	71.6	47.1	74.1	45.7	20.1	47.3	31.1	20.2	34.3	35.3	47.0	75.6	71.7	53.2	131.6	203.3	107.5	90.1	83.2	97.0	78.8	76.7	78.7	214.6	61.1	75.1	121.7	78.4	145.2	53.1	95.9	57.3	53.7	131.9	44.1	25.9	75.1	92.6	102.9	37.4	104.1	59.2	53.9	77.2	130.3	67.2	76.6	81.2	152.6	55.8	52.9	58.4	134.0	47.2	141.6	107.3	49.0	50.9	111.8	57.5	21.5	101.8	84.5	90.3	124.0	78.4	53.0	50.4	156.8	66.6	89.6	38.9	25.3	68.3	88.9	81.4	36.0	100.2	88.6	71.7	21.1	50.4	19.2	34.7	45.0	37.1	45.7	33.2	36.8	74.0	32.1	34.9	35.3	6.2	43.4	45.6	69.6	32.4	46.0	43.1	44.1	41.0	51.7	44.1	47.2	42.9	42.9	42.5	42.6	45.7	47.0	33.0	41.7	36.7	4.2	28.6	22.8	62.2	78.9	22.2	38.5	69.9	75.7	25.6	51.5	49.0	53.3	18.8	121.3	34.4	25.2	72.4	62.3	120.9	44.0	44.4	31.5	53.3	56.4	7.8	58.3	79.7	69.6	20.9	36.8	29.2	107.6	50.0	91.2	81.1	30.3	7.8	42.8	57.0	66.6	24.7	404.8	62.7	34.0	55.2	1.9	35.2	60.6	20.6	6.0	6.8	38.0	43.2	58.3	123.7	86.5	71.5	85.1	45.7	53.2	52.6	45.9	41.7	208.3	139.9	37.2	23.3	91.5	19.2	85.4	59.9	62.6
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851413-11854444	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 361.4"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Midbody	Nucleoplasm	"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favorable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	43.3	35.7	24.5	36.2	25.9	61.2	29.0	19.6	25.4	25.6	30.0	39.1	38.7	28.3	26.2	39.1	24.8	39.3	40.7	25.9	25.6	33.1	31.1	29.7	29.9	21.9	23.2	29.6	24.8	39.9	29.3	27.8	22.6	27.8	37.5	17.6	29.5	35.0	361.4	40.4	48.8	23.6	20.3	30.2	30.5	14.0	24.0	46.0	52.2	53.2	24.8	49.5	23.8	23.6	30.0	28.8	36.5	31.1	46.9	32.7	52.9	31.4	52.6	21.0	27.9	37.5	29.4	18.5	45.9	34.2	35.0	25.0	16.8	43.7	18.5	17.2	20.8	13.5	43.6	31.1	34.6	51.7	22.3	47.7	92.5	23.5	53.9	46.8	30.7	41.6	23.1	23.4	33.3	37.3	36.1	39.6	15.3	94.9	14.3	18.4	18.8	32.1	56.5	40.5	35.5	35.5	53.1	24.7	50.5	33.9	20.2	47.2	45.2	46.7	24.5	37.3	34.0	27.8	34.3	23.5	43.3	23.8	22.7	32.5	38.8	66.7	15.4	35.7	14.3	14.7	14.3	18.5	30.2	14.7	17.6	16.4	77.9	18.3	36.6	26.7	21.5	29.2	24.5	25.9	19.6	25.4	25.9	25.6	21.9	23.2	22.6	20.3	24.0	23.6	71.2	67.3	47.0	0.0	152.9	419.6	141.8	291.8	216.9	30.5	71.3	59.4	21.7	52.9	157.7	132.4	8.4	135.9	171.0	281.4	60.7	123.0	80.4	146.6	110.2	69.9	143.8	40.4	0.0	80.3	144.4	99.3	70.8	298.3	149.9	38.4	52.8	44.1	118.0	28.6	0.0	104.6	111.9	139.9	440.8	42.6	37.9	354.5	158.3	0.0	102.1	32.2	78.2	0.0	0.0	134.0	393.7	37.2	21.8	93.9	179.2	139.1	84.8	16.8	78.9	61.2	94.5	16.0	21.1	177.1	514.7	253.2	135.5	43.9	96.8	252.2
CHMP4C	"MGC22825, Shax3, VPS32C"	ENSG00000164695	"Charged multivesicular body protein 4C"	Q96CF2	8	81732448-81759515	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 71.6;Pancreatic endocrine cells: 78.7;Proximal enterocytes: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 37.2;CAPAN-2: 41.5;hTCEpi: 51.4;hTERT-HME1: 41.6;OE19: 73.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023763, HPA023799"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Microtubules, Cytokinetic bridge"		"HPA023763: , HPA023799: AB_1846670"	"unprognostic (3.98e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (7.54e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.99e-2)"	"prognostic favorable (1.96e-6)"	"unprognostic (3.29e-3)"	"unprognostic (4.95e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (6.45e-4)"	1.7	5.8	1.2	2.1	1.3	1.2	16.6	1.6	1.3	7.5	2.8	16.2	41.8	2.3	5.8	22.6	8.7	8.0	3.6	1.1	1.0	13.9	7.7	7.2	0.5	1.5	1.4	0.5	20.1	15.8	10.1	5.8	1.5	10.0	14.8	0.2	28.1	7.6	0.2	29.1	31.7	0.8	1.1	8.5	23.7	1.1	1.4	1.9	17.5	0.5	5.2	9.7	14.2	2.0	37.2	7.6	0.0	0.2	0.0	0.0	16.6	1.9	2.2	0.1	0.0	14.3	41.5	0.1	28.8	0.0	6.4	22.1	0.2	15.7	0.0	0.0	17.9	0.7	9.9	13.6	0.8	0.1	0.1	0.0	51.4	0.0	41.6	15.3	0.0	0.0	10.0	12.4	0.0	18.4	0.1	0.3	0.1	73.1	14.9	0.1	0.0	8.3	36.3	22.0	7.9	0.1	9.9	16.3	0.1	8.5	23.9	0.2	0.0	0.1	8.9	0.1	0.2	6.5	4.3	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.9	0.0	0.1	0.0	0.1	1.2	1.3	1.6	1.3	1.1	1.0	1.5	1.4	1.5	1.1	1.4	2.0	5.3	25.6	21.5	0.0	3.2	4.6	35.4	17.1	18.2	0.0	27.2	29.3	4.1	21.5	22.4	5.5	0.0	40.2	0.6	42.0	25.4	47.4	0.4	18.6	2.9	4.0	9.1	1.7	0.1	71.6	38.9	1.0	25.5	31.0	1.3	6.5	4.2	7.6	4.4	0.0	0.1	36.4	12.2	0.3	0.7	1.3	0.0	0.9	8.8	1.0	0.0	0.0	1.0	0.0	0.1	78.7	52.8	0.0	5.7	28.9	80.4	22.6	19.1	0.0	0.0	0.2	7.0	0.3	0.7	25.0	17.5	44.5	1.3	0.1	34.4	33.6
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282070	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol		Yes	No		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	54.6	54.6	48.3	36.7	49.2	30.5	49.6	50.4	63.8	56.4	50.0	55.7	55.2	41.3	48.1	64.6	43.8	42.1	50.8	49.0	50.3	77.8	56.3	53.5	41.6	50.4	49.7	42.9	32.7	63.9	49.7	63.8	50.7	54.8	55.9	53.8	43.7	39.4	48.2	47.0	59.2	33.9	52.7	43.5	54.6	36.2	49.4	44.9	55.8	44.3	38.1	49.7	56.5	56.9	92.2	66.5	67.0	43.5	99.0	89.0	61.9	90.1	99.7	138.3	152.6	50.9	56.9	49.0	96.3	84.3	95.9	39.2	70.5	72.8	111.1	102.5	49.3	41.5	129.7	55.8	85.9	53.4	78.8	95.6	131.3	93.6	86.4	114.5	73.3	68.3	44.9	63.6	110.5	41.3	56.1	164.1	61.8	70.1	80.6	34.0	59.2	32.9	115.2	48.7	32.7	83.6	91.0	53.4	87.2	77.8	54.2	82.7	74.4	69.5	73.0	60.2	80.8	42.3	87.6	57.0	100.5	36.0	45.6	98.6	50.3	106.3	25.3	56.5	27.6	31.0	33.7	33.8	46.5	26.4	30.6	29.4	129.4	47.4	67.3	71.2	43.4	51.3	48.3	49.2	50.4	63.8	49.0	50.3	50.4	49.7	50.7	52.7	49.4	56.9	182.7	89.8	59.0	14.0	52.9	188.1	156.2	372.5	71.7	63.7	85.2	75.1	64.7	94.4	228.6	110.3	27.1	172.0	77.4	241.0	285.7	141.7	245.2	228.0	90.6	133.8	80.2	90.1	19.6	86.1	186.1	104.4	56.1	167.0	58.4	66.5	97.5	70.5	154.9	26.9	19.0	137.9	246.2	100.9	103.2	35.9	93.2	95.3	117.4	15.0	166.3	156.2	38.1	14.6	26.8	151.9	247.9	104.6	45.2	182.4	226.3	355.2	328.9	68.2	85.5	97.0	130.0	99.5	68.7	70.1	236.3	259.0	68.5	71.4	78.5	246.0
CHP2		ENSG00000166869	"Calcineurin like EF-hand protein 2"	O43745	16	23755026-23758935	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 305.0;skin 1: 149.7"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 345.0;Paneth cells: 274.0;Proximal enterocytes: 654.2;Undifferentiated cells: 205.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.3;hTERT-RPE1: 10.2;NB-4: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055198, CAB072806"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB072806: , HPA055198: "	"unprognostic (4.82e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.54e-1)"		"unprognostic (4.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.31e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.21e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.84e-2)"	"unprognostic (9.01e-2)"	0.4	0.2	1.1	3.8	1.1	2.2	4.3	3.6	1.3	14.0	0.0	146.7	305.0	0.9	1.1	0.6	0.9	0.4	0.4	0.7	1.6	4.1	0.7	0.6	0.8	0.5	0.1	0.4	0.5	0.1	0.0	1.4	0.9	3.8	147.4	1.3	0.8	4.5	1.2	149.7	250.5	6.5	0.1	0.3	1.1	7.3	0.9	0.5	0.6	0.2	0.4	9.0	4.2	2.9	1.0	2.2	0.5	0.6	1.2	1.3	1.2	2.9	1.1	0.3	1.0	0.5	2.3	0.4	0.9	2.5	1.2	1.4	0.4	2.9	0.6	0.7	0.2	0.5	4.1	1.6	1.7	0.3	0.7	0.9	0.8	2.5	7.3	10.2	1.1	0.3	1.2	1.0	1.2	0.1	0.1	8.7	0.3	0.5	2.1	0.2	0.1	1.4	1.1	0.7	0.6	0.7	0.8	0.2	0.0	0.6	0.2	0.2	1.3	0.5	0.6	0.7	0.1	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.1	0.1	0.0	0.0	1.1	1.1	3.6	1.3	0.7	1.6	0.5	0.1	0.9	0.1	0.9	2.9	0.0	0.0	0.0	0.0	0.0	10.3	8.7	6.1	0.0	0.0	0.0	0.1	0.1	0.0	24.4	1.8	0.0	0.9	0.0	345.0	0.0	0.0	0.6	1.3	0.5	0.2	9.1	0.0	0.0	0.0	4.1	0.2	0.0	3.6	4.5	0.7	0.0	0.0	0.1	0.0	0.0	70.0	12.2	0.0	1.6	0.5	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	274.0	0.0	0.0	2.5	654.2	12.9	4.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	67.5	0.7	0.2	0.2	205.4	29.9
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.7	31.7	9.5	17.4	9.3	23.1	13.6	3.8	12.9	14.6	13.5	17.4	13.0	19.5	10.3	14.0	14.6	15.1	19.8	9.6	11.6	14.9	20.4	17.6	16.6	11.1	8.7	14.0	26.2	13.2	43.7	16.1	10.0	19.1	9.0	2.9	22.2	12.9	8.1	14.7	18.9	14.9	5.4	28.9	20.1	9.6	10.5	10.9	17.6	5.0	10.7	16.7	13.6	6.7	27.9	22.3	14.7	43.1	50.0	49.2	22.2	57.3	88.4	30.5	37.1	14.9	46.1	8.4	98.7	91.6	41.5	34.3	6.5	40.8	13.1	32.1	20.3	8.9	25.4	21.0	46.7	18.2	70.9	75.8	22.7	28.9	10.3	63.1	48.6	13.8	8.6	23.7	49.2	45.7	17.0	70.6	19.7	11.6	25.6	15.8	8.7	28.1	29.6	21.7	15.9	28.1	30.7	29.8	15.2	11.0	11.6	29.4	66.9	33.6	5.6	45.2	49.3	43.3	6.8	12.3	122.3	23.9	46.6	0.9	4.4	6.2	4.0	3.6	3.7	1.9	2.1	3.6	4.7	2.0	1.4	1.6	7.2	2.0	3.9	6.9	2.4	3.3	9.5	9.3	3.8	12.9	9.6	11.6	11.1	8.7	10.0	5.4	10.5	6.7	8.3	9.6	11.8	2.3	11.2	4.6	6.6	15.1	6.2	8.8	10.5	5.6	1.9	10.0	11.7	11.0	4.2	11.5	23.4	21.3	1.9	12.4	0.6	6.5	11.0	8.9	8.4	8.6	6.1	16.8	16.3	13.3	18.8	9.0	6.3	14.6	12.5	9.6	12.6	25.2	5.0	12.0	14.2	10.9	6.8	1.0	17.1	11.1	7.2	3.7	11.0	5.3	11.3	5.5	1.8	17.7	17.4	15.1	26.5	11.5	8.5	3.5	8.8	7.4	19.7	7.8	14.6	5.0	3.1	6.6	4.4	10.3	13.0	15.8	9.8	10.5
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;salivary gland: 17.5"	"Group enriched"	"Detected in many"	28	"Excitatory neurons: 802.9;Inhibitory neurons: 624.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 17.2;SH-SY5Y: 53.5;U-266/70: 21.7;U-266/84: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.3	0.4	4.6	0.8	7.3	0.2	0.8	0.0	11.8	0.4	0.0	7.0	1.4	1.9	0.4	7.5	0.8	0.7	0.4	7.5	0.0	1.1	0.4	1.1	0.1	0.0	0.0	4.8	10.6	0.5	0.5	0.8	0.0	1.1	2.8	1.7	17.5	3.0	0.0	1.3	1.5	4.1	0.0	0.7	5.0	2.5	4.1	0.1	2.0	0.1	0.1	7.0	0.4	2.9	0.0	0.1	0.4	0.4	0.0	0.0	0.9	0.6	0.1	0.3	0.1	0.0	0.0	0.0	2.1	0.0	0.0	5.8	0.6	3.8	2.7	0.0	3.7	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	1.1	9.1	0.9	1.4	0.0	0.0	4.6	4.6	9.1	0.0	1.1	17.2	0.7	0.8	0.1	53.5	0.0	0.1	0.1	4.0	1.8	0.0	0.3	2.3	0.8	0.1	0.5	21.7	16.3	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	7.3	0.0	11.8	7.5	0.0	0.0	0.0	0.0	0.0	4.1	2.9	6.1	0.0	3.7	6.2	0.0	0.0	2.1	0.0	0.6	19.0	4.6	3.2	1.2	0.0	0.8	0.0	0.0	3.2	0.3	11.0	1.9	0.4	19.6	0.1	0.1	3.0	3.5	4.6	802.9	17.3	0.7	3.9	11.7	0.2	1.3	7.5	4.2	0.3	0.5	0.0	624.0	6.0	0.0	0.0	0.0	3.9	0.0	0.2	7.2	22.5	0.0	0.3	0.0	8.5	11.2	2.6	25.3	0.4	0.2	2.5	2.2	1.4	1.6	0.6	0.0	0.2	1.1	12.9	3.0	0.2	0.0	0.5	0.1	0.8	15.5	0.2
CHRNA2		ENSG00000120903	"Cholinergic receptor nicotinic alpha 2 subunit"	Q15822	8	27459756-27479883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 72.1;prostate: 29.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.5;Inhibitory neurons: 14.8;Prostatic glandular cells: 2.4;Theca cells: 3.4"	"Cancer enriched"	"Detected in single"	421	"prostate cancer: 30.2"	"Region enhanced"	"Detected in many"		"thalamus: 72.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA048348			Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge"	"HPA048348: "	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"			"unprognostic (2.23e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.29e-3)"			"unprognostic (1.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.47e-1)"		0.0	0.5	15.8	0.2	5.5	0.9	1.4	38.1	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	8.0	0.0	0.0	0.2	0.1	15.7	21.5	0.0	0.2	0.0	0.3	0.0	3.5	29.0	0.0	3.7	0.0	0.0	0.1	0.2	0.2	0.0	2.3	0.1	0.0	0.0	72.1	2.9	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	15.8	5.5	38.1	2.9	0.7	8.0	15.7	21.5	3.5	2.3	72.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 39.3;lymphoid tissue: 65.8;retina: 53.5"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 164.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 356.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Enhanced		Supported	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nuclear speckles"	"HPA029430: AB_10603785"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.48e-1)"	0.3	39.3	4.4	5.1	2.0	0.0	0.1	6.3	1.0	1.0	0.3	8.1	1.5	0.5	0.0	0.1	0.0	0.3	0.4	0.7	2.3	0.0	0.0	0.2	0.3	3.1	6.4	0.1	0.2	0.0	1.1	0.1	10.0	0.2	4.0	53.5	0.1	0.0	0.1	0.7	3.0	3.7	0.3	0.1	2.8	1.0	9.2	65.8	0.2	0.0	0.8	0.2	0.7	1.0	0.1	0.3	0.7	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	8.8	0.0	0.0	0.3	1.4	0.5	0.4	0.1	0.0	0.1	4.0	0.0	0.3	0.0	0.0	0.0	0.0	22.6	0.2	0.0	0.0	0.3	7.1	0.0	1.6	0.1	0.2	0.4	0.3	0.1	0.0	0.4	67.7	356.1	0.3	0.1	0.1	0.5	0.4	0.0	0.0	0.1	1.7	0.1	0.4	0.2	0.7	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	2.0	6.3	1.0	0.7	2.3	3.1	6.4	10.0	0.3	9.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	0.0	0.0	0.0	164.7	0.0	0.0	0.2	1.9	0.0	3.7	0.1	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.7	0.4	3.6	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.1	0.3	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.1
CHST10	HNK-1ST	ENSG00000115526	"Carbohydrate sulfotransferase 10"	O43529	2	100391860-100417668	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 21.5;Muller glia cells: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012884, HPA051545"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		680000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA012884: AB_1846710, HPA051545: AB_2681529"	"unprognostic (5.40e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.27e-1)"	4.3	6.7	26.5	4.2	28.2	3.2	5.1	24.3	33.6	7.1	18.8	6.3	2.3	11.5	13.3	4.2	9.7	5.5	11.0	27.2	23.2	4.3	1.2	8.1	4.4	24.6	26.4	12.7	5.6	9.6	11.5	8.2	23.2	8.0	2.4	9.4	6.1	5.2	6.0	2.2	3.6	12.0	24.8	5.0	4.4	6.1	28.6	5.7	10.0	8.3	5.4	5.5	3.7	25.1	0.2	14.6	28.4	14.6	8.5	11.9	14.2	16.7	11.8	22.4	14.3	0.3	8.5	20.4	14.1	10.1	39.6	0.0	20.2	2.2	14.3	29.1	21.2	10.5	8.3	23.1	10.1	21.5	26.5	8.8	2.7	10.6	2.0	10.7	17.8	19.5	31.0	0.1	9.7	4.8	19.1	16.8	42.0	0.2	17.7	13.6	17.6	0.2	6.2	6.4	30.5	24.9	1.2	0.1	23.3	20.0	7.8	29.0	16.4	15.5	24.5	11.7	15.7	0.0	0.1	21.2	19.0	18.7	18.6	0.0	0.0	0.0	1.3	0.0	0.4	0.8	0.2	1.0	0.2	0.6	0.3	0.7	0.0	0.0	0.0	1.1	0.0	0.5	26.5	28.2	24.3	33.6	27.2	23.2	24.6	26.4	23.2	24.8	28.6	25.1	2.8	16.0	3.1	21.5	4.4	0.9	1.1	0.3	0.6	9.7	2.4	2.0	6.3	1.5	4.4	1.8	0.0	5.4	2.3	0.0	3.9	3.5	1.5	2.7	6.7	4.9	1.8	3.0	10.7	2.9	10.5	5.0	0.0	6.2	0.0	6.5	0.4	0.0	6.2	6.7	7.5	0.0	0.0	0.8	1.1	0.4	2.1	1.3	0.0	6.5	3.2	16.7	1.0	12.5	5.9	2.2	0.0	5.3	2.3	1.5	0.0	1.1	0.7	4.8	0.0	3.7	3.5	1.5	5.1	0.3	0.6	1.4	3.4	8.5	0.1	0.2
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119771-143124014	"Metabolic proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 114.4;NK-cells: 233.8;Plasma cells: 79.3;Sertoli cells: 92.1;Theca cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.3;NK-cell: 4.9;non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	5	"monocytes: 11.4;NK-cells: 4.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 57.7;ASC TERT1: 58.8;HEL: 48.2;HHSteC: 118.4;HMC-1: 55.4;HSkMC: 62.3;U-266/70: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: AB_2668861"	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	7.7	2.7	17.8	8.1	13.7	16.8	6.3	16.7	14.6	5.7	6.0	3.0	2.1	8.4	1.4	1.1	2.1	1.7	5.6	9.7	13.4	8.4	1.3	7.5	7.7	31.0	18.4	4.9	1.3	0.9	6.9	10.3	28.1	7.4	1.1	11.0	2.7	9.9	1.6	4.4	7.5	3.7	21.4	18.2	3.4	1.7	28.7	14.5	6.7	0.8	5.4	7.1	7.6	48.4	0.0	0.3	3.1	2.6	57.7	58.8	0.2	3.3	9.5	2.3	2.1	0.0	0.0	0.6	2.0	2.3	3.1	0.1	2.3	8.2	1.2	0.8	1.5	48.2	0.1	0.0	118.4	1.2	55.4	62.3	9.7	3.1	10.1	3.6	3.6	7.2	5.5	2.9	15.4	0.0	9.1	12.2	16.5	0.0	8.0	0.5	1.0	0.1	1.7	2.2	3.7	0.0	0.7	0.0	5.6	2.9	0.0	1.9	12.3	7.0	4.1	9.5	13.9	52.4	0.8	3.3	13.8	9.3	37.4	0.7	0.5	0.7	0.3	4.3	0.0	1.1	0.1	0.2	1.6	0.8	0.6	0.5	0.3	4.9	11.4	0.1	0.5	0.9	17.8	13.7	16.7	14.6	9.7	13.4	31.0	18.4	28.1	21.4	28.7	48.4	11.3	0.0	0.0	3.6	17.7	2.4	7.3	2.5	0.0	25.0	2.8	2.7	1.4	0.0	1.8	3.7	2.1	0.6	41.9	0.0	0.0	0.4	0.2	5.7	29.8	9.4	0.0	39.1	6.8	0.2	0.6	14.4	2.0	6.5	11.4	12.5	3.6	0.4	2.8	1.7	8.1	0.0	0.0	10.3	32.2	1.3	12.8	20.2	17.8	1.0	13.6	114.4	233.8	2.5	6.1	5.9	0.0	2.2	79.3	13.1	0.0	0.0	0.1	23.8	92.1	0.8	20.2	0.0	2.2	0.1	0.6	1.0	9.8	58.1	1.3	14.8
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Component of inhibitor of nuclear factor kappa B kinase complex"	O15111	10	100188300-100229596	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	13.5	10.3	6.6	11.7	7.6	19.6	10.8	7.1	8.3	8.4	8.3	11.9	12.8	8.8	9.1	9.7	7.5	9.0	6.8	6.4	9.2	21.0	17.0	10.2	12.7	7.3	7.5	5.6	11.5	14.0	6.5	10.5	7.6	9.6	13.3	8.0	8.8	9.0	14.2	6.9	10.8	11.8	7.7	9.9	11.2	8.3	8.7	14.3	11.1	11.7	12.6	13.6	6.4	8.7	27.7	22.9	23.0	34.4	21.6	19.3	17.6	34.3	33.5	31.3	38.0	25.9	15.9	37.2	19.7	23.5	21.8	26.7	38.7	18.2	34.9	39.8	33.5	24.7	18.0	28.7	18.4	46.2	34.8	15.5	19.1	36.2	35.0	21.8	22.7	30.1	28.5	29.9	34.6	16.7	36.9	28.4	15.0	21.8	16.5	23.7	25.5	17.0	19.9	17.6	13.7	20.3	18.6	14.2	30.9	18.0	28.5	27.8	23.9	19.6	21.9	21.5	39.7	34.9	33.7	35.7	21.3	36.9	15.8	1.0	1.2	2.1	0.9	1.9	1.5	1.6	1.1	1.6	1.4	1.0	1.3	1.5	2.8	1.8	1.3	0.8	1.2	0.5	6.6	7.6	7.1	8.3	6.4	9.2	7.3	7.5	7.6	7.7	8.7	8.7	11.4	12.8	11.5	17.9	10.8	19.8	7.1	5.1	8.0	6.3	7.3	4.8	9.2	7.2	5.9	5.5	2.1	6.5	14.1	12.2	11.7	7.1	7.6	8.9	8.6	8.4	6.0	12.0	22.7	11.8	7.8	6.5	7.7	12.7	8.2	6.2	7.1	14.4	10.6	13.5	21.3	8.0	8.2	16.9	12.7	8.0	6.2	11.7	7.2	19.7	15.6	4.5	9.2	20.6	27.7	10.4	6.0	6.0	18.5	9.6	9.5	20.0	6.4	5.0	19.7	7.8	12.0	16.4	12.9	13.2	19.0	13.8	11.1	10.1	6.6	10.6
CIAO2A	"CIA2A, FAM96A, FLJ22875"	ENSG00000166797	"Cytosolic iron-sulfur assembly component 2A"	Q9H5X1	15	64072565-64093857	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 262.4"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 74.8;Cytotrophoblasts: 116.5;Extravillous trophoblasts: 100.6;Hofbauer cells: 218.2;Syncytiotrophoblasts: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: AB_2685105"	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	27.8	68.6	23.1	53.6	26.0	70.7	48.5	25.7	26.7	31.5	39.1	82.8	107.9	22.6	41.1	30.1	32.1	43.0	78.0	22.0	24.6	81.3	262.4	43.4	105.3	26.1	24.0	20.6	59.8	75.5	24.6	65.5	26.6	39.1	68.4	24.7	44.0	26.8	125.5	19.4	86.8	23.8	26.4	52.8	68.8	20.7	26.9	60.3	80.2	97.4	66.9	46.3	20.3	32.0	114.6	168.6	104.3	71.7	91.7	110.7	61.2	92.7	105.4	120.2	133.5	157.7	172.9	186.9	157.4	56.2	155.7	118.3	197.9	90.2	95.4	171.3	124.2	156.2	137.7	161.2	70.7	240.5	123.1	90.8	87.2	76.7	67.6	84.5	130.1	118.5	222.3	148.8	89.5	197.8	100.1	202.8	144.6	148.9	96.3	154.5	139.8	410.4	154.3	127.0	112.2	87.5	76.8	150.9	180.6	113.9	120.6	243.6	83.0	98.2	129.4	104.7	193.6	144.4	353.8	186.4	109.5	429.3	96.9	122.4	255.8	117.0	67.3	254.1	83.0	346.0	94.8	88.1	231.6	345.5	75.5	74.4	132.0	86.9	228.3	386.5	146.1	269.0	23.1	26.0	25.7	26.7	22.0	24.6	26.1	24.0	26.6	26.4	26.9	32.0	10.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	116.5	10.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	100.6	13.2	0.0	0.0	0.0	0.0	0.0	0.0	218.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	88.8	2.0	0.0	0.0	0.0
CIAPIN1	"Anamorsin, CIAE2"	ENSG00000005194	"Cytokine induced apoptosis inhibitor 1"	Q6FI81	16	57428187-57447420	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 259.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041350, HPA042182"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		21000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA041350: AB_10796665, HPA042182: AB_10794646"	"unprognostic (1.78e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.41e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.86e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.16e-1)"	19.1	32.8	22.1	19.7	22.3	20.6	18.9	23.2	26.8	16.3	26.3	29.4	21.3	16.3	15.5	30.2	16.1	16.6	38.7	22.5	23.8	30.8	27.3	19.9	24.2	24.3	23.2	12.9	19.6	37.4	17.7	31.6	23.8	18.0	25.9	20.9	19.7	16.3	41.3	28.3	20.9	22.0	20.7	21.6	22.3	68.0	25.1	31.0	18.4	38.4	34.3	24.3	20.2	21.8	51.8	77.8	80.4	61.4	46.5	31.8	67.5	52.7	51.2	102.6	48.1	87.6	40.3	55.0	75.8	46.9	32.4	95.9	113.2	82.2	86.5	32.7	68.2	71.4	63.6	91.6	74.6	88.2	67.7	48.8	88.7	74.9	94.5	40.5	101.9	69.3	101.4	30.7	60.9	51.5	81.1	71.1	100.8	60.3	114.8	146.0	93.6	112.7	69.6	57.7	68.7	85.8	126.4	86.2	56.6	64.6	61.7	76.5	63.2	42.3	52.1	42.4	64.7	76.8	113.4	175.0	51.1	78.9	68.0	53.6	80.5	54.2	74.2	79.2	68.1	65.7	60.8	78.4	94.6	72.6	128.5	115.1	19.8	91.1	64.7	79.8	74.5	153.8	22.1	22.3	23.2	26.8	22.5	23.8	24.3	23.2	23.8	20.7	25.1	21.8	25.3	16.0	22.0	7.8	16.0	14.3	13.9	59.4	8.6	29.2	17.5	18.3	36.1	20.0	28.4	22.0	10.4	90.4	21.8	17.0	39.2	55.4	19.3	14.4	19.1	28.5	18.6	21.9	15.7	51.8	50.0	19.2	19.4	15.1	10.8	28.1	17.9	20.3	40.0	23.5	16.4	17.8	52.9	13.9	13.2	33.6	14.0	17.4	24.9	7.5	42.9	27.9	23.7	11.1	10.6	54.6	23.9	20.7	14.4	23.2	25.5	37.4	14.1	17.8	39.5	11.8	21.3	259.9	69.8	23.2	15.9	106.2	19.3	43.4	28.0	15.2
CILK1	"ICK, KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Ciliogenesis associated kinase 1"	Q9UPZ9	6	53001279-53061824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.0;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 33.9;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	7.9	17.9	10.2	4.9	11.0	2.7	10.7	8.4	9.7	8.9	5.1	8.7	9.8	8.0	5.5	8.6	7.4	6.9	8.5	6.8	7.8	4.5	7.5	6.3	5.2	9.4	11.6	9.5	5.0	7.3	1.7	12.1	8.8	9.9	10.7	17.4	17.9	7.3	4.0	8.7	10.4	7.4	8.8	5.6	12.9	4.5	14.9	10.1	6.3	5.0	6.2	6.5	5.8	12.8	7.8	2.9	14.6	10.0	8.9	14.0	17.0	6.9	12.4	10.8	12.3	4.1	2.4	5.7	4.0	21.0	3.5	5.0	17.6	7.1	14.2	19.9	7.0	4.2	3.3	22.3	4.5	5.2	5.4	12.5	7.6	4.6	5.3	7.7	10.2	12.1	8.1	22.6	24.9	6.7	5.6	6.4	5.6	27.0	6.3	8.8	6.5	7.5	4.5	5.6	23.6	10.6	6.7	16.3	9.6	14.2	9.5	10.9	8.5	17.2	8.0	6.5	17.1	6.3	4.8	2.2	3.5	5.0	8.5	2.8	1.0	2.2	1.7	0.8	1.5	1.2	1.2	1.4	1.0	1.5	1.4	1.2	0.5	1.1	0.9	1.4	1.7	0.8	10.2	11.0	8.4	9.7	6.8	7.8	9.4	11.6	8.8	8.8	14.9	12.8	6.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	20.6	5.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	33.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	58.1	0.8	0.0	0.0	0.0
CISH	"CIS, CIS-1, G18, SOCS"	ENSG00000114737	"Cytokine inducible SH2 containing protein"	Q9NSE2	3	50606489-50611774	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 38.5;Distal tubular cells: 58.7;Proximal tubular cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 316.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034039, HPA040812"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Cytokinetic bridge"	"CAB034039: AB_2080282, HPA040812: AB_2677148"	"unprognostic (2.36e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (8.54e-2)"	"unprognostic (9.38e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (6.97e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (2.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	19.0	4.8	1.0	8.7	1.0	7.6	24.5	1.1	1.3	10.0	1.9	9.9	10.2	9.4	3.1	9.6	9.8	4.5	26.5	0.9	1.4	47.6	60.7	28.0	8.5	2.8	1.9	14.5	20.2	22.1	14.3	23.2	2.2	7.5	8.9	0.3	13.1	8.9	40.0	13.3	8.8	4.9	1.7	9.9	10.4	2.3	1.6	9.7	36.4	5.2	6.7	5.9	10.0	1.5	2.4	0.8	2.8	5.9	0.7	3.4	2.5	0.6	0.6	0.3	0.4	2.3	0.6	0.0	2.0	0.9	1.3	2.8	4.7	3.8	0.3	316.3	0.8	18.7	1.8	2.5	2.1	2.5	22.0	14.2	1.6	0.7	1.3	0.2	0.6	2.0	75.6	0.6	0.6	14.8	4.1	17.4	2.7	8.7	2.9	1.8	1.2	19.4	6.3	2.7	1.4	4.7	1.0	37.7	0.7	0.8	20.9	15.4	0.5	0.8	2.2	2.8	1.4	0.3	0.4	0.0	0.5	22.7	0.4	21.3	10.2	13.7	33.8	6.2	51.1	0.9	54.0	41.6	7.0	0.4	40.5	40.6	8.6	2.0	3.9	4.6	35.3	19.6	1.0	1.0	1.1	1.3	0.9	1.4	2.8	1.9	2.2	1.7	1.6	1.5	7.1	3.2	38.5	0.0	1.8	8.0	7.4	1.9	10.2	0.7	18.3	12.1	14.3	0.0	6.7	18.4	0.0	9.1	14.1	8.9	58.7	11.7	2.6	6.6	4.3	3.5	2.4	11.6	0.1	16.4	4.0	11.6	3.6	8.5	1.3	16.9	2.2	7.0	12.7	0.0	0.0	9.6	2.0	8.4	10.0	0.6	8.4	12.8	1.8	1.0	17.3	0.1	14.4	0.0	0.0	7.2	6.7	3.8	4.0	3.0	6.5	58.2	0.8	0.2	13.1	7.6	8.8	1.0	1.3	7.3	8.9	15.9	31.0	3.4	12.1	3.6
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 67.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 122.9;Granulosa cells: 88.6;Spermatocytes: 151.7;Spermatogonia: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA008410, HPA027821"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centrosome"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Centrosome	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	6.0	6.4	3.7	10.0	3.8	67.8	5.7	10.8	5.3	3.2	1.3	8.9	12.1	5.1	4.4	10.4	3.5	4.1	6.0	3.2	4.1	5.1	4.0	5.3	19.4	4.8	3.8	3.2	1.5	4.3	4.5	10.6	5.2	5.6	9.5	7.7	4.6	4.2	2.9	13.9	9.5	8.5	3.3	9.4	5.4	32.5	3.7	33.7	6.3	3.4	20.2	7.2	5.0	3.1	77.6	40.0	155.7	76.4	19.7	19.5	39.6	124.7	70.7	137.4	87.2	59.7	92.3	142.5	19.3	89.2	65.7	86.2	107.6	61.7	188.8	103.0	90.4	129.8	42.6	41.4	8.6	129.7	50.4	14.5	24.6	64.5	83.3	41.2	84.0	62.0	55.3	58.1	152.8	36.0	91.2	64.8	92.2	116.6	42.4	86.2	88.6	62.6	42.1	40.9	47.6	62.4	68.9	49.0	37.1	78.7	54.4	61.7	56.7	38.7	60.9	62.0	124.1	33.4	56.3	173.9	27.3	67.3	105.7	86.0	14.1	22.0	10.3	21.0	9.3	25.3	15.7	12.8	15.8	33.0	12.0	10.4	4.3	5.8	28.7	32.8	33.6	10.0	3.7	3.8	10.8	5.3	3.2	4.1	4.8	3.8	5.2	3.3	3.7	3.1	6.7	6.4	2.8	5.2	41.2	15.0	4.5	32.8	22.2	13.1	11.2	13.2	10.8	2.8	11.4	1.8	6.2	44.3	30.9	7.5	9.8	4.9	41.3	19.4	16.1	12.7	7.2	122.9	10.3	6.0	38.1	12.1	10.7	10.1	16.5	88.6	17.5	5.5	31.8	1.7	12.4	13.6	20.3	24.5	13.7	51.7	7.5	18.5	0.0	6.5	22.9	12.9	5.2	3.5	2.0	2.6	4.6	17.0	30.8	3.7	6.3	9.4	3.7	6.6	6.6	7.6	12.1	151.7	87.5	41.3	15.3	10.0	27.1	29.6	17.9	3.9
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736349-112764664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 13.1;lymphoid tissue: 12.1;testis: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	0.4	0.1	0.2	2.6	0.2	13.1	0.4	0.4	0.3	0.4	0.0	1.6	1.5	0.3	0.1	2.3	0.1	0.3	0.0	0.2	0.1	0.1	0.3	0.3	5.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.2	0.2	0.3	0.0	0.0	1.5	1.1	1.1	0.0	0.9	1.0	4.5	0.2	12.1	0.2	0.0	5.2	0.8	0.6	0.2	47.9	9.6	35.4	16.2	2.0	3.3	7.2	38.5	32.2	37.9	36.1	8.7	13.3	32.0	15.5	15.1	48.3	18.0	20.4	19.6	64.1	44.8	8.9	53.6	12.7	7.7	0.1	25.2	30.9	0.9	1.9	47.4	27.2	10.1	17.5	22.8	14.3	44.9	31.2	6.9	31.0	10.6	15.4	20.0	29.5	22.3	37.0	8.4	6.9	18.7	19.7	12.7	15.2	12.8	13.3	13.2	12.4	11.8	12.9	42.7	33.7	34.5	28.5	9.9	20.1	26.6	18.5	18.1	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.2	0.6	0.0	1.2	3.3	2.1	2.7	0.6	0.0	0.5	0.8	0.5	1.5	0.4	0.0	0.0	11.1	1.3	1.3	0.0	0.4	2.4	1.1	1.6	1.1	0.0	25.2	0.3	0.4	10.6	2.0	1.5	2.1	0.0	12.5	2.9	0.1	6.6	0.0	0.2	3.1	2.0	1.9	1.4	2.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	5.6	1.1	0.1	0.1	0.4	0.0	0.0	0.4	2.8	33.0	35.7	9.5	1.7	1.0	2.5	0.7	3.8	1.1
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 119.7;Spermatocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Centrosome"		NA	Yes		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centrosome"	"Nucleoli, Nucleoli rim"	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	12.8	30.7	15.9	15.1	19.5	25.9	14.9	30.8	24.3	11.7	5.2	18.5	12.6	15.7	12.2	13.0	11.5	12.2	21.3	21.4	18.0	11.5	45.5	10.4	18.4	21.0	17.4	27.8	9.0	21.2	12.5	17.3	22.9	15.9	17.2	57.0	9.1	13.2	37.8	13.7	12.3	19.3	17.5	11.9	16.1	33.0	20.2	36.4	9.6	28.8	18.5	13.5	10.8	24.6	104.7	95.8	212.6	90.8	48.7	73.0	48.3	117.1	69.4	107.8	114.6	76.8	33.3	104.5	41.0	76.0	117.0	116.2	144.0	62.7	134.3	102.0	107.6	176.6	80.2	78.4	35.0	139.6	76.7	37.0	34.0	60.3	125.6	56.1	79.3	97.9	129.5	103.8	89.2	71.2	127.9	39.2	114.7	78.8	73.0	131.2	210.0	98.3	34.7	63.3	96.8	83.9	149.8	56.9	57.3	88.9	103.9	39.1	64.0	106.2	92.9	180.8	176.2	59.2	137.3	158.6	66.5	64.9	105.9	4.6	4.2	4.6	6.1	6.2	5.9	6.5	4.5	6.9	6.1	6.2	5.4	5.8	0.7	8.6	6.2	3.9	5.6	3.1	15.9	19.5	30.8	24.3	21.4	18.0	21.0	17.4	22.9	17.5	20.2	24.6	13.4	25.6	23.6	32.3	17.4	8.5	11.0	17.9	16.5	19.3	11.6	12.3	65.2	12.8	18.8	9.2	37.5	19.4	11.2	13.3	9.8	12.2	119.7	19.7	21.0	16.5	12.1	32.6	61.9	7.8	15.0	27.8	29.0	18.8	37.9	55.5	11.7	8.1	18.7	13.5	63.1	16.9	16.2	17.6	5.6	50.7	19.6	19.6	7.2	30.9	16.5	16.2	16.5	32.6	51.7	13.7	15.2	29.0	26.4	14.2	9.1	9.3	30.7	25.6	19.7	18.0	21.4	107.4	59.3	24.3	11.6	11.5	16.1	83.3	19.8	9.7
CKB	CKBB	ENSG00000166165	"Creatine kinase B"	P12277	14	103519667-103522833	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 694.7;intestine: 653.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 2767.4;Distal enterocytes: 4691.8;Distal tubular cells: 2281.3;Horizontal cells: 5042.4;Muller glia cells: 3639.8;Rod photoreceptor cells: 3789.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"non-classical monocyte: 290.8"	"Lineage enriched"	"Detected in many"	18	"monocytes: 290.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 455.8;HEK 293: 1399.8;SCLC-21H: 792.2;SH-SY5Y: 352.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001254, CAB047313"	Enhanced		Supported	Cytosol		No	No		38000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB047313: , HPA001254: AB_1078528"	"unprognostic (9.97e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (4.02e-8)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.13e-1)"	90.7	60.0	471.6	25.8	627.0	3.2	47.2	641.1	694.7	105.2	192.7	653.4	36.0	222.6	16.0	54.5	197.9	17.9	269.8	428.7	482.3	161.0	9.0	60.3	4.0	427.5	440.4	58.8	27.7	108.2	74.0	4.7	345.1	301.8	151.9	471.3	37.9	208.3	80.0	76.5	120.8	113.8	434.5	6.8	479.9	97.6	596.2	2.8	87.9	47.1	5.1	298.4	101.6	383.6	2.4	54.5	321.1	14.7	4.4	2.3	6.3	37.5	0.3	2.4	1.4	455.8	7.3	0.4	36.9	29.1	9.9	70.2	109.9	1.5	0.2	9.6	1399.8	111.0	242.1	165.4	16.6	0.7	87.9	14.7	0.6	3.9	0.8	3.3	0.0	5.1	198.7	3.7	4.8	20.0	2.3	3.9	109.1	48.3	213.6	13.9	6.8	275.9	65.9	2.5	792.2	352.2	65.3	10.6	25.2	21.6	21.1	40.9	2.2	1.5	56.3	4.7	147.3	21.1	2.7	7.2	6.4	2.1	14.1	2.4	0.5	14.6	0.3	28.5	0.4	0.0	0.2	0.1	16.4	0.2	0.1	0.5	1.0	0.2	290.8	0.0	0.7	6.0	471.6	627.0	641.1	694.7	428.7	482.3	427.5	440.4	345.1	434.5	596.2	383.6	14.8	195.5	103.5	515.8	13.5	153.7	296.2	257.6	56.3	2767.4	41.5	48.9	553.5	145.8	117.9	114.0	1909.9	4.4	3.4	4691.8	2281.3	127.6	445.8	773.2	205.7	60.8	467.1	9.9	178.0	42.5	11.7	96.6	359.4	408.5	28.6	476.1	74.6	9.2	8.2	5042.4	147.0	726.0	187.2	2.8	44.9	147.4	304.1	39.8	181.5	88.1	74.2	3639.8	0.0	93.5	161.2	131.4	1996.9	1089.3	6.6	279.8	9.5	118.0	456.1	3789.9	59.2	15.4	222.6	127.3	97.4	22.1	175.2	41.6	19.1	12.2	755.6	220.1
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979251	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 651.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.37e-1)"	59.0	31.9	15.0	33.6	15.8	117.7	67.8	16.4	19.8	44.3	15.0	49.4	40.8	35.0	36.8	61.6	40.9	22.2	35.5	15.4	16.2	37.9	73.3	29.0	71.3	17.5	15.8	31.7	22.4	35.5	18.4	50.6	17.7	26.1	50.5	6.0	28.4	32.9	14.5	51.2	44.3	34.8	17.4	37.0	35.5	48.6	15.7	88.7	30.1	23.5	74.1	30.1	42.6	18.8	459.2	616.5	455.9	245.3	66.9	68.1	361.4	209.1	166.8	463.4	367.8	599.9	653.4	433.8	345.9	143.2	251.2	410.6	468.0	305.2	428.7	392.9	293.9	294.6	249.9	426.5	19.4	359.7	257.9	39.8	132.2	391.4	532.8	91.5	232.5	298.2	486.6	566.8	353.9	452.8	337.3	273.9	575.3	442.1	547.6	334.8	373.6	554.3	165.6	164.2	184.3	463.9	313.6	292.0	347.3	530.2	391.6	492.9	126.0	282.5	292.4	237.0	505.3	348.9	734.7	617.0	179.6	300.1	399.8	2.2	13.0	6.9	19.8	82.0	24.4	74.2	28.0	27.1	22.1	70.4	34.0	32.8	1.7	28.7	105.4	92.6	33.3	28.1	15.0	15.8	16.4	19.8	15.4	16.2	17.5	15.8	17.7	17.4	15.7	18.8	31.7	12.8	33.3	1.3	46.5	217.6	101.3	170.6	74.0	3.4	90.6	140.5	9.2	87.2	63.1	29.5	0.0	224.0	40.7	48.3	80.3	93.0	15.8	43.1	24.6	51.9	20.4	140.1	0.8	112.1	651.8	84.6	20.9	28.3	21.0	66.7	29.6	89.8	132.1	1.7	0.8	57.4	120.1	46.0	121.0	21.7	76.1	37.4	113.8	0.0	41.3	20.7	20.6	0.5	3.5	119.0	41.7	45.9	38.4	130.2	63.1	87.5	52.1	3.0	19.7	50.6	53.0	124.7	151.0	74.9	203.6	131.9	40.7	27.2	80.0	99.5
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311195-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 177.3;testis: 186.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 474.6;Spermatocytes: 692.7;Spermatogonia: 503.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 187.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	13.6	82.9	9.6	38.5	10.0	177.3	20.1	11.9	26.9	10.1	11.8	44.1	43.3	13.0	8.8	53.2	12.1	18.7	10.3	12.7	10.3	35.6	31.2	24.0	102.8	10.5	10.1	9.4	4.2	19.8	4.8	44.3	11.0	15.0	41.0	27.9	10.8	17.8	9.4	19.9	33.1	17.6	10.6	32.6	20.4	186.3	10.8	121.1	12.8	4.8	84.7	26.5	19.9	11.3	685.9	570.1	342.6	230.6	98.7	89.1	249.5	396.1	211.4	428.1	340.0	236.1	328.6	504.9	228.4	149.1	761.4	466.5	415.5	305.1	488.2	398.1	335.5	257.5	378.9	637.5	42.4	531.7	281.2	33.0	69.2	307.2	269.1	162.9	403.2	409.1	313.2	430.6	556.0	509.1	420.7	928.3	501.6	795.5	521.5	358.4	376.4	303.7	342.8	153.5	288.4	171.7	328.7	314.9	324.5	318.4	379.7	304.2	231.4	184.1	350.3	449.6	588.2	345.9	759.2	415.3	271.3	303.1	268.5	40.8	19.5	44.1	22.6	26.5	25.3	61.3	30.4	21.9	22.5	44.7	16.3	21.8	14.5	40.9	14.8	187.9	62.7	23.6	9.6	10.0	11.9	26.9	12.7	10.3	10.5	10.1	11.0	10.6	10.8	11.3	138.6	38.5	103.9	0.3	175.7	280.2	92.1	126.1	259.0	4.1	107.2	169.0	61.3	5.7	49.9	14.7	0.0	231.1	201.1	79.4	23.5	20.1	37.3	149.7	66.4	66.1	122.3	266.9	1.2	11.2	379.4	63.1	74.9	250.2	145.0	144.7	29.3	25.0	184.6	0.0	1.9	164.9	111.9	40.5	474.6	77.0	25.7	164.3	140.5	1.9	31.0	26.1	28.8	1.0	1.1	31.1	67.1	16.6	89.3	72.1	37.6	209.7	32.8	7.3	46.0	75.2	206.5	692.7	503.6	197.5	299.1	199.5	156.0	70.3	162.7	102.1
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11848079	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	13.6	14.8	19.1	7.5	19.1	7.7	11.9	17.3	21.3	14.8	8.2	13.7	6.3	12.6	8.7	7.4	12.6	4.9	13.2	18.0	23.5	11.8	13.7	13.8	7.4	29.6	29.5	18.6	9.2	6.0	20.2	6.4	32.1	12.5	4.8	15.2	7.8	5.5	11.6	9.8	13.0	7.3	15.4	12.0	10.5	17.1	22.5	5.3	14.4	8.1	6.1	11.5	11.1	19.4	5.1	6.4	13.9	11.1	15.2	15.4	3.8	4.1	11.1	7.1	11.7	8.6	15.9	7.9	4.4	5.5	19.3	8.8	9.0	8.8	6.7	3.6	4.5	9.4	13.8	12.1	20.1	3.9	7.6	10.1	6.2	12.7	7.7	9.4	6.9	9.6	10.6	11.7	7.8	3.1	5.7	13.4	5.7	3.3	4.5	7.0	7.4	8.6	9.7	4.4	5.7	9.6	3.9	5.1	13.0	9.5	5.0	10.6	7.4	6.5	7.0	10.1	3.3	7.2	4.0	17.6	8.5	10.2	5.3	0.0	0.8	0.0	0.4	0.6	0.3	0.6	0.2	0.3	0.6	0.9	0.2	0.3	0.0	0.1	1.6	0.6	0.0	0.4	19.1	19.1	17.3	21.3	18.0	23.5	29.6	29.5	32.1	15.4	22.5	19.4	6.4	19.2	23.6	6.8	12.5	3.4	3.7	5.1	6.2	21.7	5.6	4.7	23.5	8.6	7.0	3.7	14.6	3.7	2.5	5.8	0.0	4.5	15.0	7.7	6.6	6.5	6.6	8.2	9.0	4.6	2.9	8.5	12.2	9.8	2.5	12.6	7.1	7.9	7.5	26.9	9.4	2.9	4.1	10.8	7.8	9.0	7.5	10.2	1.8	9.4	7.4	7.7	3.1	9.0	8.8	5.6	4.4	7.2	3.9	4.7	6.3	3.9	8.9	17.0	0.0	8.9	6.4	9.3	9.8	4.8	3.1	4.1	3.8	8.0	3.2	4.5
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"lung: 252.2;stomach 1: 724.9"	"Group enriched"	"Detected in some"	53	"Alveolar cells type 1: 1602.5;Alveolar cells type 2: 431.2;Gastric mucus-secreting cells: 1153.4;Pancreatic endocrine cells: 442.5"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.6;stomach cancer: 186.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"OE19: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"		"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.3	0.3	0.3	0.4	0.4	0.1	0.2	1.0	0.5	0.4	2.2	0.7	1.5	0.2	0.5	0.6	0.5	3.3	9.7	0.3	0.2	0.2	0.1	252.2	0.0	0.9	0.9	0.5	0.8	0.0	0.5	0.3	0.5	0.2	0.2	0.7	0.3	0.4	0.1	1.1	0.8	0.1	0.7	0.5	724.9	1.3	0.5	0.1	0.1	0.0	0.7	0.2	0.3	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.5	15.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.5	0.3	0.2	0.9	0.9	0.5	0.7	0.5	0.2	0.0	1602.5	431.2	1.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	17.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.3	0.2	0.6	0.0	0.0	0.5	11.4	0.0	1.4	1153.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	2.0	0.0	1.9	0.0	0.1	0.0	0.0	0.2	442.5	0.0	0.0	1.3	0.0	0.0	0.1	0.7	1.3	0.0	0.9	0.1	15.3	11.9	0.0	0.0	0.0	1.3	0.0	0.0	0.1
CLK4		ENSG00000113240	"CDC like kinase 4"	Q9HAZ1	5	178602664-178630615	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 297.5;Late spermatids: 518.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043746	Approved		Approved	"Actin filaments"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Actin filaments"		"HPA043746: AB_2678650"	"unprognostic (9.46e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.90e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-3)"	13.8	11.9	14.0	7.8	14.9	10.4	13.6	22.9	20.1	20.1	14.0	14.4	9.4	12.8	11.9	10.1	13.7	9.8	13.0	14.1	14.5	13.4	13.7	10.8	17.6	15.0	14.0	18.3	17.6	7.9	10.3	10.8	15.2	16.7	6.6	34.4	13.0	8.3	17.8	15.1	12.6	5.5	14.0	18.6	12.5	15.2	14.2	16.6	16.6	21.1	10.0	12.5	21.0	19.3	8.1	7.2	6.8	10.0	19.9	15.9	11.2	7.6	8.8	4.5	8.4	7.7	6.6	4.6	6.0	3.2	5.2	10.4	8.9	6.0	7.5	16.8	6.8	1.8	15.2	8.8	7.4	3.8	5.7	7.2	8.8	7.6	9.6	15.1	3.2	3.1	4.1	13.4	5.5	3.3	5.2	13.8	3.4	5.4	4.5	4.8	6.0	6.7	4.2	2.3	7.4	5.0	8.4	4.7	8.4	3.8	5.1	8.0	6.9	9.5	3.4	4.9	8.4	8.4	3.5	3.5	6.8	9.0	5.0	7.7	5.9	12.7	8.9	4.1	12.6	12.8	9.5	8.4	5.9	10.2	12.2	9.5	16.1	8.4	4.3	7.4	9.6	4.9	14.0	14.9	22.9	20.1	14.1	14.5	15.0	14.0	15.2	14.0	14.2	19.3	31.9	16.0	27.8	45.7	57.8	31.9	44.5	18.4	40.9	70.8	23.5	21.6	22.9	11.5	23.7	14.7	39.6	20.1	52.1	12.2	5.9	9.4	297.5	22.8	30.1	25.4	6.0	38.7	79.6	4.7	18.4	29.2	20.4	19.8	27.9	36.1	18.9	13.0	10.1	28.6	40.5	10.7	14.2	13.9	24.7	518.3	30.7	21.4	16.0	43.1	18.3	29.6	27.8	61.9	60.6	7.2	16.5	29.3	36.5	23.9	25.0	10.1	26.8	81.3	19.7	17.1	30.9	30.3	18.4	19.7	24.6	15.9	42.0	24.1	10.2	26.9
CLNS1A	"CLCI, ICln"	ENSG00000074201	"Chloride nucleotide-sensitive channel 1A"	P54105	11	77514936-77637794	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017840, HPA031707, HPA031708, HPA032045"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol		No	No		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nucleoplasm, Microtubules"	"CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123"	"unprognostic (1.30e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.12e-3)"	"unprognostic (5.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	53.1	88.7	86.1	63.1	91.8	72.3	79.9	89.3	92.7	62.2	82.0	72.7	49.7	63.5	99.6	85.3	74.8	53.2	76.4	79.9	94.1	59.6	105.6	45.7	99.5	88.0	86.6	103.3	90.0	60.2	54.0	65.6	89.8	61.2	77.5	97.0	58.2	57.5	98.4	54.0	53.6	56.8	90.5	61.9	65.7	45.7	87.9	102.8	79.0	100.7	105.4	74.6	61.0	94.8	138.4	134.7	216.6	160.7	157.1	224.8	86.8	119.1	181.3	189.0	168.9	326.5	190.0	308.6	194.5	144.6	148.1	162.8	263.0	245.6	227.2	178.6	160.1	301.9	161.7	188.8	132.5	451.8	134.1	182.9	278.9	165.9	311.7	185.5	217.4	187.1	404.8	91.9	186.6	205.0	299.2	364.5	205.7	458.8	243.9	161.5	419.8	332.7	136.7	191.9	219.0	250.1	158.2	177.7	112.1	155.2	241.8	195.8	144.4	138.7	171.2	274.4	116.8	184.3	276.6	330.1	55.0	166.9	114.4	48.1	100.6	39.1	61.1	107.1	68.9	96.5	76.1	66.3	138.7	99.5	91.1	77.8	7.1	101.2	93.6	85.3	72.8	105.7	86.1	91.8	89.3	92.7	79.9	94.1	88.0	86.6	89.8	90.5	87.9	94.8	47.9	16.0	20.3	14.7	91.6	82.7	107.0	248.2	116.7	67.2	75.4	78.6	71.6	71.4	102.6	58.8	50.1	132.9	70.0	27.4	84.1	76.4	17.0	45.1	57.4	53.1	31.8	123.6	21.7	87.5	145.9	72.5	43.8	34.5	78.0	117.0	57.5	62.2	91.1	58.9	24.3	65.3	87.5	108.7	99.3	13.6	87.7	74.9	76.5	10.3	153.8	221.9	57.7	17.6	24.9	65.4	54.3	68.4	64.8	108.2	79.3	97.6	71.6	60.3	52.6	61.8	54.5	116.0	109.4	128.0	86.1	80.6	69.2	126.7	112.5	103.9
CLP1	"hClp1, HEAB"	ENSG00000172409	"Cleavage factor polyribonucleotide kinase subunit 1"	Q92989	11	57648188-57661865	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057770	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA057770: AB_2683523"	"unprognostic (1.33e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.07e-1)"	8.9	7.4	3.1	10.1	3.6	26.1	9.2	3.9	4.4	7.1	4.4	9.0	8.7	7.7	7.6	9.2	7.3	5.9	6.5	3.3	3.3	8.0	10.1	7.3	10.8	3.3	3.1	6.8	7.4	6.8	4.4	9.2	3.7	5.6	8.6	3.2	6.7	7.1	8.2	9.0	8.4	8.9	3.4	10.0	8.1	8.4	3.3	11.2	7.2	9.3	13.1	8.6	5.0	3.7	21.2	22.2	21.0	21.6	22.3	14.4	19.7	21.4	23.2	30.1	25.8	21.4	18.4	35.1	24.3	18.9	24.2	25.9	29.2	34.5	34.2	24.3	18.0	19.4	13.5	21.7	17.7	28.5	22.2	17.4	24.0	26.9	18.6	11.9	27.7	17.4	30.4	11.9	24.9	14.8	21.8	32.9	31.8	24.3	22.2	21.7	32.1	37.5	16.5	15.0	11.1	22.3	19.1	17.2	28.7	21.7	32.7	23.2	20.0	16.0	21.7	27.7	15.9	18.6	26.4	39.3	17.3	16.3	17.3	31.2	19.0	20.0	15.9	16.4	18.9	15.6	14.1	16.4	19.0	14.3	16.4	14.9	21.7	13.6	15.9	10.8	16.2	12.3	3.1	3.6	3.9	4.4	3.3	3.3	3.3	3.1	3.7	3.4	3.3	3.7	6.1	9.6	5.1	1.0	8.5	19.4	10.7	13.4	16.5	4.3	6.0	6.2	2.4	7.2	10.5	0.0	6.2	16.5	12.7	4.8	9.8	12.9	32.5	6.7	5.7	7.3	2.4	12.2	1.9	11.7	13.9	7.4	3.1	7.1	8.2	4.9	4.2	3.5	11.0	5.0	1.8	3.2	8.2	6.0	6.9	4.1	5.6	5.8	8.8	1.0	15.0	3.3	7.2	2.5	1.4	9.8	4.7	8.6	5.9	4.7	6.2	10.1	6.4	3.1	6.6	10.4	6.9	9.4	12.0	9.3	14.5	13.5	9.7	6.5	4.6	7.8
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit X"	O76031	15	65148219-65185342	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA		65000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA040262: AB_10793961, HPA048199: AB_2680312"	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	7.9	10.8	9.2	6.1	9.7	8.0	9.3	9.5	11.0	7.6	7.4	9.2	8.8	7.8	8.6	13.3	7.9	6.3	14.1	7.8	8.3	12.2	32.9	6.5	9.1	9.8	8.9	9.4	9.4	11.9	4.6	9.8	8.5	8.0	8.0	10.1	7.6	6.0	26.8	14.7	7.4	7.1	8.8	8.4	9.2	9.1	9.4	10.6	9.8	24.0	9.9	7.9	8.9	10.1	8.1	13.7	11.7	14.8	12.2	15.5	12.5	9.2	10.2	9.8	10.3	13.7	11.1	25.0	7.5	12.3	7.3	16.9	43.2	12.1	10.5	9.9	7.9	18.9	12.8	17.4	17.3	24.4	10.5	18.6	16.2	9.0	17.1	11.3	12.6	13.3	17.6	8.6	11.7	10.3	11.6	21.4	13.1	16.0	6.1	22.4	13.9	26.1	18.6	18.5	10.1	8.1	12.4	19.3	13.8	15.3	8.9	20.3	11.2	9.8	8.7	8.0	8.7	9.2	15.0	13.0	9.6	30.4	7.8	2.2	4.1	6.5	4.3	3.5	3.9	4.4	3.7	3.2	3.9	3.9	5.0	4.0	6.4	4.7	3.3	5.9	3.5	2.7	9.2	9.7	9.5	11.0	7.8	8.3	9.8	8.9	8.5	8.8	9.4	10.1	16.4	35.3	35.5	15.3	23.6	19.2	18.8	20.9	18.8	32.3	17.0	15.6	69.9	27.1	29.5	33.1	14.6	41.0	28.5	16.7	21.5	36.8	104.5	24.4	28.7	21.0	10.3	56.8	15.6	31.6	29.2	25.5	33.6	27.5	16.4	37.8	21.0	90.1	22.6	32.0	15.2	20.3	28.5	28.3	16.6	242.3	28.9	20.3	17.8	16.9	34.1	25.9	20.6	12.5	23.9	29.0	18.2	29.7	30.8	24.9	23.1	33.8	27.7	27.2	26.3	23.1	30.1	45.0	30.6	29.1	30.1	89.2	24.4	59.0	24.3	25.5
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769978	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low region specificity"	"Detected in many"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	0.5	0.2	0.7	3.2	0.6	11.3	0.5	0.6	1.4	0.2	0.4	1.4	1.0	0.4	0.7	0.9	0.2	0.3	0.1	1.3	0.3	0.2	0.5	0.4	4.9	0.4	0.4	0.1	0.1	0.2	0.0	1.5	0.6	0.2	2.0	6.8	0.2	0.1	0.6	1.2	1.0	0.9	0.2	1.3	0.9	5.7	0.6	7.9	0.2	0.0	5.2	0.6	0.4	0.9	22.0	17.5	37.8	19.9	2.6	4.8	14.1	43.6	12.0	31.0	41.3	27.9	19.6	45.7	13.9	11.8	22.7	21.4	37.1	14.9	48.1	31.6	16.8	64.5	38.1	12.6	0.1	54.0	36.8	1.0	0.6	53.8	3.7	3.7	16.9	27.1	44.2	30.8	30.3	14.1	56.9	13.1	36.0	14.9	12.2	36.0	57.0	13.8	6.4	35.3	14.0	16.2	37.7	11.6	7.4	25.6	10.0	21.1	12.5	44.6	33.8	27.6	49.3	11.1	29.1	47.1	14.1	37.4	37.0	1.1	0.3	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.2	1.0	0.5	0.2	0.2	0.3	0.3	0.7	0.6	0.6	1.4	1.3	0.3	0.4	0.4	0.6	0.2	0.6	0.9	2.6	0.0	0.5	0.3	6.5	5.6	5.7	4.4	1.2	9.4	2.9	3.8	1.4	2.8	2.7	0.0	12.5	19.7	4.6	12.8	0.0	1.6	7.9	1.0	3.6	3.6	1.2	55.6	1.6	0.6	41.1	5.2	4.6	3.3	1.3	12.0	2.2	0.4	16.9	1.7	1.5	9.4	2.0	3.0	8.2	6.1	2.5	5.8	3.6	0.0	9.1	9.4	4.1	0.0	0.6	1.4	9.5	0.4	32.5	1.8	0.4	0.2	0.0	101.0	6.6	5.3	8.7	281.1	263.3	5.8	2.0	10.4	7.2	1.2	12.0	3.9
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 18.2;brain: 26.7;ovary: 64.7"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 552.2"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 32.7;SCLC-21H: 14.5;SuSa: 42.7;THP-1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		Yes	No		130000		"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	18.2	4.8	17.3	0.3	15.3	0.0	8.8	0.0	26.7	4.2	0.0	1.4	0.5	5.1	0.7	1.0	4.7	2.1	6.1	23.4	0.0	4.3	0.8	1.1	2.7	13.3	3.1	64.7	1.6	0.8	0.9	0.9	9.1	5.3	0.8	2.7	1.3	1.1	1.6	2.0	1.3	6.8	0.0	0.1	1.0	0.6	0.0	0.7	2.8	2.2	0.2	1.6	3.2	15.6	0.0	0.0	5.1	0.0	2.2	0.6	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.1	0.0	32.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	2.1	0.0	0.0	0.0	42.7	2.2	9.4	0.0	1.0	0.5	1.4	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	15.3	0.0	26.7	23.4	0.0	13.3	3.1	9.1	0.0	0.0	15.6	2.1	0.0	0.0	18.3	0.0	0.5	0.3	0.0	8.6	1.8	10.9	2.2	8.0	0.0	0.6	3.7	0.0	0.2	0.1	0.0	1.9	0.2	39.8	0.5	8.9	0.8	0.0	0.0	552.2	0.2	0.0	9.1	0.0	0.2	0.0	25.0	2.2	0.0	0.1	0.0	111.5	0.0	0.0	0.3	1.5	31.1	28.0	0.8	0.0	5.6	0.0	0.8	0.0	108.6	29.4	0.0	0.0	0.7	0.0	5.0	0.0	32.3	3.0	3.8	0.0	28.3	13.7	0.8	0.8	0.4	0.0	0.0	0.7	0.5	0.0	0.3
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CLUH	"CLU1, KIAA0664"	ENSG00000132361	"Clustered mitochondria homolog"	O75153	17	2689386-2712663	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CACO-2: 266.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031505, HPA044346"	Uncertain		Supported	"Nuclear bodies,Vesicles"		NA	NA		5500	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Nuclear bodies"	"HPA031505: AB_2673912, HPA044346: AB_10962153"	"unprognostic (3.48e-2)"	"unprognostic (3.97e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.64e-2)"	"unprognostic (5.11e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.26e-2)"	30.8	56.7	13.8	18.1	12.7	14.3	28.5	16.3	18.3	19.8	19.7	45.9	46.6	21.3	1.9	67.7	19.2	15.4	80.8	14.5	11.2	50.6	135.0	19.6	14.6	14.6	13.2	17.0	50.4	15.6	20.3	9.0	15.3	24.7	13.2	7.2	32.1	11.8	127.8	47.5	34.2	8.5	9.3	25.2	35.1	25.2	17.3	6.4	25.2	52.9	11.1	29.6	29.2	11.2	69.5	131.9	8.9	33.3	20.2	14.1	99.9	34.9	13.0	41.9	31.0	266.2	30.0	122.6	41.5	19.4	26.9	127.6	45.3	52.9	14.7	43.6	86.4	68.0	112.2	93.9	17.1	53.7	44.1	22.6	29.7	48.9	24.7	9.4	20.5	43.3	81.8	42.2	11.7	79.8	69.6	58.0	28.2	35.8	67.8	104.7	37.0	70.8	26.0	117.3	43.9	32.6	40.0	129.4	44.4	6.6	72.7	31.3	33.7	33.7	44.9	92.2	80.5	18.2	22.9	49.7	35.4	73.2	41.6	0.0	2.2	0.0	1.7	3.1	1.3	2.2	1.0	0.9	2.4	2.2	2.3	2.1	0.2	0.6	2.0	2.7	1.5	0.9	13.8	12.7	16.3	18.3	14.5	11.2	14.6	13.2	15.3	9.3	17.3	11.2	5.8	6.4	20.9	20.9	6.5	30.5	12.0	11.7	16.5	18.5	23.5	22.7	42.1	41.5	16.7	18.4	22.9	9.7	7.6	47.8	11.7	18.4	1.8	12.7	10.8	8.5	25.8	22.1	9.9	18.3	8.2	6.8	22.4	24.6	1.3	18.1	6.8	122.1	13.1	8.4	11.4	38.8	14.2	10.3	6.3	4.0	5.0	7.9	21.4	4.7	7.4	6.5	2.1	7.5	6.2	19.6	21.2	6.0	11.7	22.9	39.2	35.1	14.1	17.1	6.6	12.3	11.3	8.6	17.5	42.4	35.5	8.2	7.2	43.3	68.3	22.5
CMTM5	"CKLFSF5, FLJ37521"	ENSG00000166091	"CKLF like MARVEL transmembrane domain containing 5"	Q96DZ9	14	23376773-23379772	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 182.4;choroid plexus: 49.5"	"Cell type enhanced"	"Detected in some"		"Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2"	"Group enriched"	"Detected in some"	37	"glioma: 8.4;melanoma: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 20.8"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 20.8"	"Cell line enriched"	"Detected in some"	7	"HEL: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052338	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		540000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA052338: AB_2681793"	"unprognostic (2.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.40e-2)"		"unprognostic (8.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.24e-4)"	"unprognostic (3.03e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	1.1	1.0	75.6	0.5	119.1	8.2	0.9	123.8	101.7	2.8	49.5	5.8	0.5	0.8	1.1	1.2	1.2	2.1	22.7	73.9	85.2	0.5	0.3	1.5	0.2	150.9	106.2	0.8	0.2	0.1	0.6	0.7	135.2	2.1	0.8	2.3	2.2	3.2	3.1	0.7	1.7	0.8	113.4	2.8	1.4	0.1	110.2	0.1	0.5	0.9	0.0	1.2	2.6	182.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.2	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.2	20.8	0.7	0.9	0.1	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.4	30.0	75.6	119.1	123.8	101.7	73.9	85.2	150.9	106.2	135.2	113.4	110.2	182.4	0.5	0.0	0.0	6.5	0.4	1.0	0.1	0.0	1.2	0.2	1.3	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.4	0.0	0.0	93.7	5.4	0.0	1.5	32.0	0.0	20.6	106.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	3.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391698-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 102.3;Ductal cells: 105.6;Hofbauer cells: 120.3;Kupffer cells: 110.7;Langerhans cells: 102.8;monocytes: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 135.4;hTERT-RPE1: 135.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077409			Approved	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA077409: AB_2686838"	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	22.8	10.4	7.5	20.7	7.7	43.7	32.6	8.6	12.9	15.2	8.7	8.4	5.3	11.1	10.9	3.9	38.7	16.0	10.1	7.3	8.2	22.1	10.1	33.0	32.2	8.9	8.3	5.5	19.9	4.0	3.7	19.2	9.2	12.1	9.3	0.6	13.1	19.9	4.0	10.1	18.3	10.5	8.7	49.3	13.4	8.6	9.5	46.1	20.5	3.1	31.4	24.1	7.2	10.8	0.4	15.8	32.8	40.2	29.8	29.0	93.4	15.5	18.0	26.5	24.3	18.0	135.4	0.1	46.7	18.1	33.0	17.4	40.6	69.1	23.2	0.0	32.8	18.5	0.1	40.6	120.8	4.7	29.0	31.0	9.0	27.2	42.6	135.1	60.0	0.2	15.8	40.9	19.6	0.4	0.2	42.9	39.7	7.0	71.7	90.5	12.3	85.0	37.7	30.9	1.6	33.9	2.0	2.6	80.8	13.9	21.3	48.7	36.2	25.3	25.5	27.9	54.4	11.6	4.6	0.2	9.3	57.9	54.2	32.4	198.7	110.8	21.3	196.8	12.7	44.2	72.1	44.2	106.8	34.7	76.5	54.1	77.3	21.6	173.6	45.0	164.1	112.6	7.5	7.7	8.6	12.9	7.3	8.2	8.9	8.3	9.2	8.7	9.5	10.8	10.3	25.6	16.7	1.0	65.5	9.8	20.2	102.3	1.8	0.5	63.4	86.0	2.1	28.6	51.9	18.4	0.0	22.2	25.0	2.0	0.0	105.6	0.2	17.4	12.8	24.2	17.3	11.6	0.5	15.5	10.0	15.2	26.0	33.1	29.8	29.0	20.7	1.3	120.3	1.7	1.4	4.4	40.7	110.7	102.8	1.2	1.5	77.2	24.9	20.6	108.1	1.4	12.3	1.0	0.3	91.8	8.1	1.2	62.9	42.0	1.2	27.5	23.3	0.2	6.6	1.2	13.5	1.2	10.4	0.9	5.5	6.8	57.4	6.1	2.8	16.3
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	20.1	22.1	21.0	19.2	21.2	30.9	19.5	20.3	22.9	23.6	18.6	26.8	18.1	23.1	17.4	16.9	22.4	15.1	25.1	20.7	22.0	19.4	21.8	20.4	25.3	21.5	21.0	28.0	22.1	27.5	26.0	24.9	20.3	21.9	15.2	28.5	21.7	18.4	30.1	23.2	23.2	20.4	20.2	28.8	21.9	62.9	23.5	30.9	20.3	23.4	25.6	21.6	20.0	20.2	23.5	21.9	31.0	50.7	34.2	31.1	37.4	27.5	37.7	68.1	75.9	33.3	15.3	48.6	30.5	40.7	63.8	25.7	39.7	28.4	51.7	33.8	35.2	26.8	26.8	37.2	26.3	38.9	17.6	27.1	20.9	37.6	26.7	35.7	32.2	44.3	60.6	34.5	36.3	38.5	49.8	34.6	15.6	15.7	20.7	39.0	36.7	28.1	22.0	28.2	34.2	25.6	30.8	23.4	40.2	22.1	39.8	29.7	30.0	40.7	30.3	16.3	31.1	39.3	21.8	253.0	16.0	40.1	45.6	4.2	5.4	3.5	4.9	7.1	4.1	5.5	4.3	5.2	5.1	3.8	4.7	3.9	3.3	5.6	5.5	4.2	6.1	4.6	21.0	21.2	20.3	22.9	20.7	22.0	21.5	21.0	20.3	20.2	23.5	20.2	11.3	9.6	9.2	5.9	12.0	3.6	3.9	4.0	8.6	14.2	6.3	5.5	10.4	8.6	11.5	7.3	33.3	18.0	15.4	5.3	0.0	4.5	20.2	7.7	15.4	9.6	8.4	6.5	15.1	8.5	8.0	8.8	11.7	8.9	3.8	24.9	7.9	10.1	7.5	11.8	13.9	8.4	4.1	7.5	2.3	11.3	7.8	9.5	3.6	14.0	11.5	8.8	7.2	10.6	14.2	8.5	3.3	6.8	12.4	4.3	4.7	4.0	11.2	11.9	6.6	8.5	13.5	16.8	10.6	5.8	4.7	20.8	11.5	22.0	6.9	3.6
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129167827-129183922	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA063097: AB_2684939"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	292.7	308.2	175.2	181.1	184.0	254.1	274.6	198.6	211.3	295.9	175.7	314.1	198.5	285.8	197.6	264.6	275.7	195.1	487.2	170.6	184.3	231.6	433.7	258.3	251.0	182.7	175.1	385.8	307.4	277.9	169.5	214.3	187.1	256.6	219.0	231.8	250.8	282.4	1207.6	288.0	199.2	234.9	195.6	200.7	262.1	131.2	181.9	254.2	261.8	797.9	250.7	317.5	269.2	211.7	452.7	266.4	369.9	294.6	355.2	303.9	294.9	344.2	535.7	362.2	412.4	389.2	305.7	589.8	292.2	318.1	269.6	328.3	484.3	396.4	484.6	404.5	357.9	569.2	251.7	420.2	355.7	622.4	314.5	295.5	449.2	254.8	897.8	247.6	324.1	328.1	437.6	391.9	384.0	538.9	578.6	454.1	452.7	399.7	439.1	502.4	343.4	707.7	379.1	425.4	501.2	402.8	271.5	263.0	766.3	214.4	305.6	421.3	347.9	268.4	266.2	374.1	353.7	367.3	365.4	932.3	277.3	419.2	362.4	1077.7	810.5	930.9	551.8	596.8	699.0	691.0	658.8	595.3	552.8	603.8	700.3	610.5	1102.3	601.1	485.5	320.4	704.3	2029.8	175.2	184.0	198.6	211.3	170.6	184.3	182.7	175.1	187.1	195.6	181.9	211.7	253.7	259.6	263.9	27.1	292.8	524.7	417.0	262.9	259.6	153.7	177.5	272.5	608.0	141.5	235.1	79.1	33.3	252.3	188.1	143.9	373.7	226.9	36.0	141.4	195.1	267.5	171.3	246.5	28.2	290.7	396.6	309.4	142.8	172.8	314.5	173.0	167.0	138.5	246.5	92.5	33.7	178.6	140.4	194.4	463.0	42.9	316.0	232.4	318.4	35.6	392.7	350.3	236.9	32.6	42.8	230.1	158.0	319.7	311.7	405.1	196.5	237.4	164.8	153.8	263.0	343.6	571.0	305.2	271.5	286.5	586.7	291.7	304.2	277.7	213.6	376.2
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390297	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 952.0;esophagus: 3093.3;vagina: 1442.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 57.9;Breast myoepithelial cells: 51.6;Squamous epithelial cells: 71.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"memory B-cell: 61.2;naive B-cell: 70.2"	"Lineage enriched"	"Detected in many"	12	"B-cells: 70.2"	"Cell line enhanced"	"Detected in many"		"A549: 18.1;HEK 293: 25.7;MCF7: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Microtubules	"Cytokinetic bridge"	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favorable (4.02e-5)"	"unprognostic (2.45e-1)"	4.3	5.3	1.8	0.4	4.2	0.6	12.9	1.9	2.2	952.0	1.3	3.2	0.4	1.5	7.3	3093.3	1.6	0.1	1.9	1.9	2.8	2.3	1.4	0.9	0.7	2.1	1.9	1.0	3.3	1.6	2.2	0.1	1.7	8.6	1.3	0.1	661.6	1.1	1.7	555.6	3.5	0.5	1.7	3.3	3.3	2.4	2.9	2.8	1.8	0.0	276.8	2.4	1442.7	1.6	6.0	18.1	0.4	1.6	0.8	0.9	0.2	1.0	0.3	0.4	0.4	1.0	1.6	5.1	8.0	0.2	1.2	2.4	1.5	2.3	0.1	0.0	25.7	0.4	6.9	1.9	0.0	0.0	0.1	1.8	4.0	1.0	0.0	0.1	0.0	4.7	1.1	0.2	0.0	12.6	0.1	0.1	6.6	8.1	5.4	2.2	0.3	2.9	1.6	2.3	2.7	7.7	3.4	5.1	2.5	2.7	6.2	2.6	0.0	0.0	5.3	0.2	0.1	5.8	7.6	3.6	0.1	2.2	0.3	0.1	4.6	0.1	1.7	3.9	0.4	61.2	1.3	1.2	5.9	70.2	0.6	0.9	1.3	0.0	0.9	1.3	0.1	2.2	1.8	4.2	1.9	2.2	1.9	2.8	2.1	1.9	1.7	1.7	2.9	1.6	32.7	3.2	2.2	0.0	24.6	4.6	16.8	28.5	14.8	0.1	57.9	51.6	0.8	2.8	20.2	33.1	0.0	0.2	2.1	24.5	7.9	13.1	1.5	20.6	3.9	9.3	32.5	3.6	0.1	2.5	0.3	2.3	4.6	23.9	4.5	7.2	3.9	0.7	5.7	0.0	0.2	33.4	14.2	3.8	7.7	3.9	5.3	6.3	3.6	0.0	6.4	0.3	7.2	0.0	0.1	2.4	39.4	4.5	0.5	11.5	43.8	12.3	10.5	0.1	0.0	0.9	8.0	0.4	17.4	71.8	12.9	0.3	1.3	1.1	41.8	27.0
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel subunit beta 1"	Q14028	16	57882340-57971128	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"retina: 600.2"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 331.5;Rod photoreceptor cells: 1111.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.5;RPMI-8226: 1.8;SCLC-21H: 5.0;SiHa: 2.9;SK-BR-3: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.5"					"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.1	2.5	15.5	1.1	13.2	0.2	0.0	0.0	20.4	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.1	0.3	0.0	24.5	24.8	0.0	0.1	0.1	0.2	2.8	3.2	0.0	0.5	0.0	0.2	0.4	4.4	0.0	0.4	600.2	0.0	0.1	0.0	0.2	0.6	0.1	2.4	0.1	0.0	0.4	36.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.5	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.6	5.0	0.0	2.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.5	13.2	0.0	20.4	24.5	24.8	2.8	3.2	4.4	2.4	36.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.0	61.6	0.3	0.0	1.1	0.0	0.1	0.0	331.5	6.9	0.0	0.0	0.0	0.4	1.6	0.9	0.1	4.2	0.0	0.0	3.2	0.4	0.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.4	25.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	89.5	0.0	1.0	0.1	0.2	1.1	0.0	0.0	0.2	0.0	0.3	0.0	1111.1	0.0	0.1	0.2	0.5	0.7	0.0	0.0	1.4	0.1	0.1	0.0	0.2
CNN1	"Sm-Calp, SMCC"	ENSG00000130176	"Calponin 1"	P51911	19	11538767-11550323	"Cancer-related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 1872.4;intestine: 2657.3;smooth muscle: 2207.8"	"Group enriched"	"Detected in many"	5	"Breast myoepithelial cells: 191.0;Early spermatids: 335.0;Late spermatids: 554.6;Peritubular cells: 221.2;Smooth muscle cells: 180.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 142.1;stomach cancer: 103.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 91.5;BJ hTERT+: 34.9;BJ hTERT+ SV40 Large T+: 48.0;BJ hTERT+ SV40 Large T+ RasG12V: 64.6;HBF TERT88: 71.2;K-562: 35.8;SuSa: 72.5;U-2 OS: 34.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000007, HPA014263"	Enhanced		Approved	"Actin filaments"		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Actin filaments"		"CAB000007: AB_2082148, HPA014263: AB_1847039"	"unprognostic (4.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (5.43e-6)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.78e-3)"	"unprognostic (6.11e-3)"	115.6	58.4	6.4	160.6	8.3	0.0	89.7	5.7	14.2	366.9	7.5	2657.3	136.3	1872.4	177.0	677.5	655.6	234.3	274.1	6.8	8.5	42.9	10.6	98.7	7.3	6.1	6.8	114.1	24.2	3.0	9.0	28.4	6.3	676.0	326.4	0.7	61.6	1585.7	21.8	57.8	431.3	2207.8	6.1	22.1	673.7	91.4	7.5	2.6	38.5	11.7	0.9	1386.6	305.7	6.3	0.1	1.3	5.9	1.0	0.6	0.2	3.2	91.5	34.9	48.0	64.6	27.9	0.0	0.4	2.7	26.1	4.4	0.3	0.0	0.0	71.2	0.0	0.2	0.1	0.1	2.3	2.5	0.0	0.4	3.0	0.1	28.7	0.1	1.6	0.0	0.0	35.8	0.0	0.0	0.0	0.3	3.8	2.9	0.0	0.7	0.2	0.6	3.8	0.0	0.0	0.1	1.3	0.1	0.2	0.2	72.5	0.1	0.1	0.4	0.4	34.6	1.2	1.2	0.1	0.4	0.1	3.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.4	8.3	5.7	14.2	6.8	8.5	6.1	6.8	6.3	6.1	7.5	6.3	2.4	0.0	0.0	0.0	0.2	4.8	4.1	1.6	0.6	0.0	4.2	191.0	51.4	0.0	0.3	1.8	0.0	0.8	0.7	0.0	0.0	14.5	335.0	3.1	20.7	2.4	0.0	0.0	0.5	0.4	1.0	21.5	0.5	0.7	0.0	0.5	6.8	0.0	2.3	0.0	0.3	0.0	0.0	0.0	9.4	554.6	8.4	0.9	3.6	2.8	0.6	0.5	0.0	0.0	0.1	0.9	0.0	221.2	0.0	4.0	0.0	0.4	0.4	0.0	39.5	1.1	180.9	8.3	19.5	0.4	7.1	0.7	1.1	0.7	0.0	1.1
CNTD1	"CNTD, FLJ40137"	ENSG00000176563	"Cyclin N-terminal domain containing 1"	Q8N815	17	42798800-42811587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"testis: 42.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 70.5;Late spermatids: 124.8;Respiratory ciliated cells: 47.0;Spermatocytes: 150.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.9;ASC diff: 1.6;SiHa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072363			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA072363: "	"unprognostic (5.92e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.29e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.89e-7)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.81e-4)"	0.3	0.2	0.9	0.0	0.9	0.1	1.8	1.2	1.9	0.1	0.1	0.8	0.1	0.1	1.4	0.0	0.7	0.0	0.1	0.9	1.0	1.5	0.0	0.5	0.0	1.0	0.9	0.4	1.0	0.3	0.0	0.1	0.9	1.3	1.9	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.8	0.1	3.3	42.4	0.8	0.0	0.3	0.6	0.0	0.2	0.0	1.9	2.9	0.3	0.2	0.5	1.6	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.5	0.1	0.3	0.0	0.8	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.9	1.2	1.9	0.9	1.0	1.0	0.9	0.9	0.8	0.8	1.9	1.2	3.2	4.6	2.3	1.0	0.4	0.5	0.4	0.0	1.7	5.5	2.2	1.1	1.5	2.1	0.0	0.0	0.3	1.2	1.4	5.9	0.2	70.5	5.4	1.7	0.8	0.0	2.7	1.9	0.4	0.4	1.9	4.1	1.6	6.3	0.2	0.4	1.1	0.3	6.7	1.6	5.3	4.1	1.0	0.7	124.8	2.5	1.1	0.0	0.0	0.2	1.0	0.0	2.0	1.1	0.4	0.4	1.2	0.7	5.6	0.9	0.5	47.0	0.7	6.6	1.0	1.7	150.2	17.1	0.0	0.6	0.3	0.9	0.5	2.7	2.3
COA5	"C2orf64, FLJ27524, MGC52110, Pet191"	ENSG00000183513	"Cytochrome c oxidase assembly factor 5"	Q86WW8	2	98599314-98608515	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 180.0;Proximal tubular cells: 175.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA057768	Uncertain		Supported	Mitochondria		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA057768: AB_2683521"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.32e-3)"	"unprognostic (3.71e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.00e-5)"	14.9	20.9	39.7	10.4	40.9	9.7	18.5	46.0	46.0	19.0	35.6	21.4	14.7	18.5	29.8	11.7	19.2	11.0	21.2	40.1	40.4	26.6	22.8	12.9	16.3	40.7	40.8	21.2	15.6	22.0	23.5	13.4	40.6	19.8	14.4	38.4	15.1	17.6	28.5	16.8	17.7	12.4	40.3	19.4	17.8	12.9	42.6	17.3	22.5	22.0	15.5	18.1	14.1	44.1	18.5	7.9	24.4	17.5	28.1	22.6	20.4	10.6	8.5	11.4	11.8	16.3	15.1	9.6	18.4	8.7	21.7	13.1	21.2	11.5	13.8	24.5	18.5	13.3	15.2	26.0	20.4	13.1	11.6	22.7	23.6	8.1	10.5	19.7	12.0	26.6	18.6	10.8	12.4	14.6	17.2	22.9	16.9	19.8	16.7	10.4	17.2	21.1	24.8	9.9	18.4	23.1	9.1	11.3	27.6	27.4	13.9	26.4	11.1	17.2	15.3	10.4	9.0	17.6	25.0	12.0	21.0	28.0	14.5	20.2	24.9	29.4	23.9	23.5	20.3	23.6	21.0	22.5	24.0	25.3	25.5	25.5	28.0	20.1	25.8	31.2	31.1	22.9	39.7	40.9	46.0	46.0	40.1	40.4	40.7	40.8	40.6	40.3	42.6	44.1	39.5	16.0	28.7	10.4	27.3	10.5	26.3	46.5	28.5	25.5	45.5	62.6	66.6	37.1	32.6	47.8	6.2	36.9	34.8	26.3	180.0	43.4	28.0	52.8	30.4	30.6	27.0	29.4	12.0	24.5	38.8	29.8	21.9	35.6	26.6	33.3	31.8	63.6	52.8	21.9	12.4	37.2	59.0	38.1	12.5	14.9	32.6	30.5	28.4	4.7	41.3	51.4	54.6	8.5	19.1	30.8	29.6	35.0	24.0	34.4	46.1	175.0	49.2	32.0	13.1	23.5	29.7	118.4	33.8	32.5	11.6	32.7	23.5	46.1	33.2	33.6
COG8	"DOR1, FLJ22315"	ENSG00000213380	"Component of oligomeric golgi complex 8"	Q96MW5	16	69320140-69339583	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041406, HPA049429"	Approved		Supported	"Golgi apparatus"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA041406: AB_2677459, HPA049429: AB_2680763"	"unprognostic (4.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.12e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.47e-7)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.35e-2)"	9.9	14.5	19.7	8.5	23.2	6.5	11.1	23.2	24.4	9.8	24.0	10.5	10.5	10.8	14.1	9.9	13.9	7.7	11.2	19.4	19.7	13.4	15.0	10.2	11.3	21.1	20.6	13.7	14.2	19.9	12.0	7.9	21.2	10.3	9.9	7.7	13.8	10.6	18.1	16.3	10.0	10.5	20.3	10.9	11.2	20.3	20.9	12.2	13.0	15.8	11.3	9.4	7.7	28.1	13.2	28.5	18.2	26.7	30.1	21.0	19.4	16.9	18.6	23.0	18.7	26.2	19.8	23.7	18.1	23.0	12.4	24.9	29.5	24.3	19.8	11.9	26.4	17.0	19.9	35.0	21.3	21.1	14.8	25.2	23.5	25.2	14.7	22.2	22.6	20.4	35.4	5.7	16.7	38.3	19.4	31.3	32.2	17.8	20.5	35.6	12.6	33.3	23.6	11.1	26.0	31.1	37.5	15.0	17.5	18.4	35.4	17.8	20.5	16.8	14.4	15.8	14.1	31.3	27.1	36.8	17.3	18.8	19.2	41.4	19.6	20.6	17.8	19.0	19.6	13.3	19.2	18.2	18.6	19.0	17.4	16.7	15.6	22.2	17.6	10.7	19.6	16.8	19.7	23.2	23.2	24.4	19.4	19.7	21.1	20.6	21.2	20.3	20.9	28.1	3.2	9.6	9.7	1.3	9.4	4.2	10.4	5.8	5.2	18.9	7.3	6.7	0.0	24.3	10.6	11.0	18.8	15.0	5.0	12.6	1.9	7.6	17.4	6.1	6.4	7.2	12.7	5.5	1.9	8.0	9.1	7.4	7.1	4.6	7.0	9.0	15.7	28.5	9.5	11.8	2.0	11.7	20.3	7.9	3.3	4.8	12.8	3.1	5.4	1.0	8.4	12.1	10.3	2.0	2.6	5.4	9.5	15.8	9.0	9.6	19.3	15.3	10.2	19.9	13.1	15.5	6.2	9.9	13.6	7.2	4.1	9.2	8.3	5.4	16.7	7.2
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938199-56961050	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 98.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.2;Late spermatids: 591.1;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA057480, CAB069400"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	7.7	7.2	6.6	8.8	6.8	19.9	12.2	9.7	8.9	9.2	7.3	9.2	10.2	10.4	11.6	9.7	9.8	7.1	8.0	6.6	7.0	8.7	13.0	7.6	12.8	6.7	6.7	11.9	8.7	12.3	6.2	13.0	7.4	9.3	10.6	12.6	9.8	7.7	11.5	9.8	10.0	8.5	6.8	10.3	9.2	98.5	6.6	13.2	12.1	9.1	13.5	9.3	8.7	8.1	25.0	18.6	37.4	14.5	12.5	14.9	25.8	17.5	16.4	26.1	27.7	25.6	21.0	29.9	34.6	14.0	19.5	14.1	25.6	20.2	37.1	36.1	32.3	48.7	17.4	29.2	13.5	41.5	28.5	13.9	24.7	19.7	21.1	15.5	22.6	17.4	42.9	24.3	24.8	31.6	32.9	26.3	22.0	27.4	18.4	15.5	45.9	23.9	18.1	24.7	31.6	31.2	11.7	11.5	30.1	21.5	41.8	40.0	16.0	30.2	22.7	14.8	23.0	35.6	47.7	34.5	15.8	22.7	18.8	22.3	13.3	17.5	15.5	12.6	17.5	27.6	17.0	16.6	13.5	25.0	19.5	18.9	8.1	16.0	17.2	16.4	18.6	10.1	6.6	6.8	9.7	8.9	6.6	7.0	6.7	6.7	7.4	6.8	6.6	8.1	21.3	12.8	21.0	6.8	26.5	18.7	39.5	34.0	21.1	35.9	21.6	22.5	14.1	22.8	28.3	14.7	37.5	42.2	26.2	12.5	13.7	30.1	249.2	22.7	23.1	26.6	23.9	17.5	8.8	27.7	32.3	23.5	18.3	19.9	22.2	20.3	22.5	23.9	22.7	25.2	10.9	16.5	16.2	16.5	10.4	591.1	42.3	12.3	3.6	10.3	19.6	28.5	34.0	9.5	13.3	23.5	17.3	30.5	15.1	32.2	16.6	23.0	22.0	52.4	13.1	24.9	21.9	142.2	46.8	20.3	22.7	29.1	23.3	17.1	20.8	29.0
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118909-116158747	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.5;choroid plexus: 39.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 26.6;Inhibitory neurons: 6.3;Microglial cells: 8.4;Oligodendrocytes: 27.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 42.8;pancreatic cancer: 51.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 39.7"					"Low region specificity"	"Detected in many"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		160000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.3	0.0	2.2	0.2	8.6	0.3	0.3	4.6	4.5	1.2	39.9	0.2	0.0	0.3	0.0	0.0	0.0	8.9	0.3	1.3	3.3	0.4	0.2	2.8	0.6	7.7	5.6	3.9	3.3	2.5	0.4	0.1	7.1	1.9	0.1	0.9	2.6	0.8	0.1	0.4	0.1	0.5	4.3	2.5	0.1	0.2	6.3	0.1	0.7	0.0	1.9	0.2	0.1	15.5	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.2	2.9	0.4	6.0	0.1	0.0	0.1	0.0	1.0	0.0	0.7	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.0	39.7	0.0	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	6.3	0.1	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	8.6	4.6	4.5	1.3	3.3	7.7	5.6	7.1	4.3	6.3	15.5	2.6	0.0	0.6	3.9	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.1	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.4	26.6	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.4	0.0	2.2	0.0	2.5	27.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.2	5.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1
COL11A1	"CO11A1, COLL6, DFNA37, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 20.1;retina: 9.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 83.9;Excitatory neurons: 99.5;Oligodendrocyte precursor cells: 557.4;Theca cells: 139.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 116.9;BJ: 43.2;BJ hTERT+ SV40 Large T+ RasG12V: 85.3;HBF TERT88: 48.7;HSkMC: 142.5;SuSa: 60.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		640000		"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Endoplasmic reticulum"		"HPA058335: AB_2683682"	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	0.6	0.6	4.3	0.3	3.1	0.0	0.4	1.6	4.6	0.9	2.8	0.4	0.1	0.5	0.1	0.0	0.0	3.1	0.0	2.4	2.5	0.1	0.0	0.3	0.1	2.5	3.7	0.6	0.7	0.2	3.3	20.1	2.2	0.2	0.3	9.6	1.5	0.8	0.1	1.4	0.1	0.3	1.0	0.5	0.1	1.4	2.2	0.0	0.1	0.1	0.0	0.2	0.1	2.1	0.0	0.8	116.9	0.0	4.6	5.9	0.0	43.2	16.1	23.3	85.3	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	142.5	0.0	1.1	0.0	17.7	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	8.1	0.0	0.1	0.0	7.4	0.0	15.2	0.0	0.1	0.0	0.0	0.1	0.0	60.5	0.0	0.1	0.0	0.6	27.0	0.0	4.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	3.1	1.6	4.6	2.4	2.5	2.5	3.7	2.2	1.0	2.2	2.1	0.0	0.0	2.2	83.9	0.0	1.8	0.0	0.0	0.0	9.4	0.1	4.2	0.5	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	21.0	0.1	0.9	2.2	0.0	0.0	99.5	0.0	0.8	18.7	0.0	0.0	2.5	8.3	0.0	0.0	0.3	0.0	32.9	0.0	0.0	0.0	1.3	4.0	1.2	0.2	10.6	29.0	0.0	29.8	0.0	557.4	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	2.6	0.5	0.8	0.0	1.1	0.3	0.2	139.6	0.0	0.0
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 229.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 307.0;Endothelial cells: 190.5;Fibroblasts: 202.3;Leydig cells: 326.8;Peritubular cells: 483.3;Theca cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 26.4;BJ hTERT+: 55.6;HDLM-2: 24.5;K-562: 18.8;U-2197: 45.6;U-87 MG: 20.6;WM-115: 31.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"spinal cord: 44.3"	"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		28000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	84.7	36.9	0.6	50.6	0.9	0.1	46.7	0.8	1.0	31.2	4.0	44.5	12.9	53.8	19.2	26.9	17.3	42.8	58.0	0.4	0.8	12.9	1.0	11.1	10.4	0.6	0.9	23.2	26.8	11.8	6.0	229.2	0.7	21.6	16.3	0.0	35.9	14.3	56.5	15.1	17.7	108.9	0.6	3.7	27.3	27.0	2.4	13.0	21.1	34.4	8.6	42.1	15.1	0.7	0.0	0.0	0.1	0.0	4.6	2.6	0.1	26.4	55.6	1.4	0.5	0.0	0.0	0.2	0.7	5.8	0.2	0.1	0.0	0.0	0.2	24.5	0.0	0.3	12.9	0.0	1.1	0.4	2.5	7.6	0.0	6.0	0.2	0.0	0.0	0.0	18.8	0.0	2.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	14.7	0.2	0.0	0.0	0.1	0.1	0.8	3.9	7.4	0.3	0.2	0.6	0.0	0.1	0.6	45.6	0.5	0.2	0.0	0.0	20.6	0.2	31.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.9	0.8	1.0	0.4	0.8	0.6	0.9	0.7	0.6	2.4	0.7	307.0	0.0	0.0	0.7	0.5	19.5	0.1	0.0	5.2	0.0	2.6	4.1	8.1	0.0	0.0	0.0	0.0	3.8	1.8	0.0	0.0	2.4	5.7	3.9	103.4	190.5	0.0	0.0	0.4	0.8	3.7	202.3	0.5	2.2	0.0	0.3	0.0	0.0	7.6	0.0	2.9	0.0	0.0	0.3	27.2	22.5	326.8	3.1	17.8	46.9	0.6	0.0	1.0	1.0	0.3	0.6	0.0	483.3	0.3	1.2	0.0	0.5	0.0	0.0	13.1	107.8	52.8	1.9	1.2	1.3	16.3	7.7	2.1	333.4	0.0	0.7
COL16A1		ENSG00000084636	"Collagen type XVI alpha 1 chain"	Q07092	1	31652263-31704319	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 109.0;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 122.0;Peritubular cells: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 133.1;ASC TERT1: 102.9;BJ hTERT+: 115.9;fHDF/TERT166: 106.5;HSkMC: 98.7;U-2197: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA027237			Uncertain	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		960000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA027237: AB_10600699"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (4.00e-9)"	"unprognostic (9.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.15e-2)"	33.6	17.3	19.0	14.4	44.7	0.3	41.0	35.9	32.4	169.7	7.6	78.9	14.8	93.6	23.7	22.4	37.4	39.4	33.6	18.9	29.8	11.5	3.2	31.1	8.5	55.5	43.2	177.9	7.8	3.5	28.6	21.1	48.6	102.8	10.9	8.8	35.5	91.3	8.4	69.3	35.8	56.2	34.0	9.9	42.1	40.9	40.3	5.6	46.8	7.4	4.1	106.9	86.8	57.5	0.1	2.0	0.0	0.1	133.1	102.9	14.6	60.5	115.9	15.1	16.1	0.4	11.0	0.0	1.9	106.5	2.3	48.3	0.0	65.8	3.5	0.0	0.2	0.0	8.1	21.3	45.1	0.0	0.3	98.7	44.6	43.2	22.7	3.8	0.1	0.3	0.0	0.2	2.1	0.0	0.1	0.5	0.1	0.4	0.2	0.2	1.3	0.4	0.0	0.4	1.5	2.7	7.3	1.2	9.6	0.5	1.2	0.0	0.2	52.3	52.5	92.1	1.3	0.1	0.2	0.0	36.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	44.7	35.9	32.4	18.9	29.8	55.5	43.2	48.6	34.0	40.3	57.5	4.3	9.6	3.9	109.0	0.1	30.7	14.8	37.5	15.9	2.4	7.9	21.3	8.4	0.0	9.8	18.4	2.1	1.9	0.6	2.0	0.0	4.6	13.6	2.6	11.5	2.8	27.6	0.4	23.9	0.7	3.8	54.3	8.2	2.4	7.0	0.2	5.0	0.0	1.3	0.0	8.2	30.9	8.2	0.6	11.4	26.8	43.8	0.7	14.2	10.3	0.0	31.3	0.0	62.4	122.0	1.2	4.7	91.4	0.3	9.3	16.8	2.1	15.0	2.5	0.0	5.4	25.0	14.9	3.8	1.9	21.2	2.2	2.2	0.5	6.8	15.3
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104085880	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 580.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 227.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.0"	"Low region specificity"	"Detected in many"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	1.5	0.4	0.8	6.6	1.1	12.2	37.3	1.0	1.4	50.1	0.6	37.4	10.7	0.6	6.6	116.6	1.1	0.3	0.5	0.5	0.6	0.3	0.3	0.9	0.1	0.6	0.7	0.2	0.4	0.0	1.2	35.4	0.6	17.9	27.3	0.0	82.2	9.6	0.5	580.3	37.2	1.0	0.5	2.3	19.8	25.4	0.6	42.7	5.1	0.0	19.8	9.9	102.0	0.8	26.3	0.4	1.5	0.2	0.1	0.0	80.6	0.5	0.3	0.1	0.2	0.3	204.3	0.0	5.1	0.3	3.9	463.8	0.7	745.8	0.7	0.0	0.7	0.0	0.3	0.2	0.1	0.0	0.4	0.7	914.1	0.5	783.7	0.2	3.5	0.1	0.1	0.9	0.0	0.0	0.0	0.3	1.7	5.1	2.6	0.0	0.0	0.3	35.9	26.4	0.2	0.3	0.0	0.2	0.9	4.0	0.2	0.0	1.5	0.5	5.0	0.3	5.5	0.1	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	1.0	1.4	0.5	0.6	0.6	0.7	0.6	0.5	0.6	0.8	1.0	0.0	1.1	0.7	0.3	585.7	17.7	136.0	299.9	0.6	1.7	85.5	1.1	0.0	16.5	0.0	0.0	10.2	0.3	211.5	0.0	0.8	14.2	23.7	2.3	3.7	2.4	0.0	0.1	0.9	18.9	2.4	23.0	8.1	0.0	0.1	0.0	0.0	1.3	0.0	0.2	5.7	6.1	0.0	28.9	3.6	0.3	0.7	33.8	0.0	0.0	0.4	0.0	0.0	0.4	78.8	35.7	0.7	1.4	16.6	108.5	0.1	5.9	0.4	0.0	0.4	3.0	22.7	1.5	31.9	139.4	5.6	1.3	0.1	21.6	10.7
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50184101-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1331.8;gallbladder: 1211.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 2044.3;Fibroblasts: 1944.4;Leydig cells: 556.0;Smooth muscle cells: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1689.5;BJ: 3428.1;fHDF/TERT166: 5206.1;HSkMC: 2490.3;U-138 MG: 2687.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 115.9"	"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		80000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	312.1	39.9	1.8	272.8	5.3	4.5	184.9	1.3	15.9	1331.8	12.0	223.2	37.7	531.4	23.4	110.2	234.1	1211.3	126.6	1.5	1.9	34.7	29.7	139.0	78.1	3.2	1.4	377.3	39.8	14.1	80.5	503.5	2.0	137.5	46.5	0.4	51.3	98.6	21.2	362.0	86.6	801.2	2.2	46.9	109.9	38.2	17.3	14.4	50.8	13.0	21.1	616.3	342.2	6.7	6.0	5.0	16.4	3.2	702.9	1689.5	29.2	3428.1	915.8	826.6	517.6	64.2	14.6	0.6	7.8	5206.1	5.7	9.1	8.3	3.4	150.1	5.2	6.1	0.4	92.2	4.2	1309.3	1.2	0.8	2490.3	45.7	1016.2	4.6	126.9	0.5	4.8	2.2	0.4	425.4	8.5	1.4	1.0	17.0	10.7	10.5	6.1	2.1	2.7	3.9	0.2	2.0	8.8	5.6	5.0	0.2	245.4	39.8	0.6	1.5	2687.4	562.6	405.0	16.2	2.8	5.9	0.7	200.1	1.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.3	1.3	15.9	1.5	1.9	3.2	1.4	2.0	2.2	17.3	6.7	66.9	9.6	13.8	0.0	2.1	188.0	12.4	31.6	10.8	0.2	9.1	10.0	12.5	5.7	13.2	7.3	0.0	45.7	1.7	1.4	0.0	13.3	1.9	64.6	2044.3	33.4	3.0	0.0	0.1	4.2	45.5	1944.4	17.9	49.2	2.5	8.1	378.0	3.4	67.6	0.0	0.3	5.4	6.1	0.3	318.1	18.2	556.0	13.1	188.5	12.2	0.0	2.5	0.0	0.0	0.0	23.8	0.3	268.1	1.3	10.7	0.1	0.7	9.8	0.2	78.9	74.8	1024.9	4.0	2.6	4.3	163.5	111.8	29.4	57.3	2.9	9.1
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394895-94431227	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 1831.7;gallbladder: 1378.0;smooth muscle: 1416.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 774.5;Fibroblasts: 2148.2;Glandular and luminal cells: 592.2;Leydig cells: 991.9;Peritubular cells: 501.0;Smooth muscle cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3899.2;ASC TERT1: 4637.0;BJ: 3995.6;BJ hTERT+: 2901.2;fHDF/TERT166: 13615.1;HSkMC: 4058.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 133.7"	"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		27000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	514.8	52.4	6.8	266.2	9.3	2.0	314.5	7.1	17.4	1831.7	18.1	175.7	61.1	411.2	61.6	263.2	206.6	1378.0	275.4	6.0	6.8	40.8	27.4	229.5	91.6	8.7	6.7	297.2	57.1	32.5	33.5	624.6	7.9	196.2	141.8	1.6	60.2	232.3	51.6	424.6	103.2	1416.9	8.8	69.3	89.1	136.6	15.6	32.8	86.4	102.1	60.1	805.6	295.2	8.2	0.1	0.0	22.8	1488.5	3899.2	4637.0	1.3	3995.6	2901.2	642.6	850.5	0.0	2.8	0.3	2.7	13615.1	0.0	0.6	2.2	1.5	160.9	0.1	0.2	0.1	0.0	0.0	1018.6	1.1	0.5	4058.4	0.1	507.9	2.4	0.3	0.5	0.0	0.3	0.3	551.0	0.0	0.6	1.5	2.5	0.0	6.3	0.5	0.8	0.8	0.1	0.0	12.9	1.4	0.3	1.0	0.1	296.0	2.1	0.1	15.9	1626.3	0.8	1022.7	115.5	1.2	0.1	0.4	408.6	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	9.3	7.1	17.4	6.0	6.8	8.7	6.7	7.9	8.8	15.6	8.2	112.9	3.2	12.9	1.0	0.8	223.1	0.7	9.3	4.6	0.2	7.2	8.6	21.7	0.0	3.3	1.8	0.0	31.5	2.5	0.0	0.0	3.0	8.4	183.2	774.5	57.2	0.0	0.0	0.0	0.2	31.7	2148.2	26.5	592.2	10.1	16.4	258.8	1.9	116.9	0.0	0.1	0.0	0.0	1.0	394.5	45.1	991.9	16.7	238.3	97.4	2.6	3.2	0.0	0.0	0.2	5.2	0.0	501.0	4.5	1.0	0.0	0.5	0.8	0.4	302.4	249.9	770.7	9.9	4.5	6.2	187.4	70.7	30.6	214.8	0.0	0.8
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535873	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 21.1;Excitatory neurons: 23.4;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 12.5;Respiratory ciliated cells: 16.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.3;U-266/70: 9.8;U-266/84: 2.8;WM-115: 4.9"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 3.6"	"Region enriched"	"Detected in some"	31	"spinal cord: 33.5"	"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	1.0	3.2	0.8	1.6	1.0	0.3	2.8	1.9	2.7	3.3	1.4	11.7	1.2	2.2	14.1	2.1	4.9	1.5	3.7	1.1	0.9	6.3	0.7	1.2	0.2	0.9	3.6	1.2	5.8	0.2	11.2	0.5	1.4	3.9	4.1	6.7	18.2	5.1	5.9	2.1	3.4	1.7	0.2	0.4	6.5	3.7	1.1	0.2	1.2	3.2	0.1	2.9	4.5	1.5	1.5	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.4	0.0	0.0	1.1	0.4	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.2	1.4	0.1	0.2	0.0	0.7	0.9	0.3	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1	0.5	0.7	0.1	0.5	1.3	0.0	9.8	2.8	0.0	0.2	0.6	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.8	1.0	1.9	2.7	1.1	0.9	0.9	3.6	1.4	0.2	1.1	1.5	0.4	0.0	4.1	39.5	0.0	0.3	0.1	0.2	0.0	5.3	1.6	1.5	0.9	0.0	3.3	3.7	18.8	0.3	0.1	0.8	0.0	0.1	2.0	21.1	0.5	0.1	0.0	0.0	23.4	0.2	0.0	3.1	0.0	3.9	1.3	0.5	1.8	0.0	0.1	5.0	22.6	0.5	0.0	0.3	0.3	1.1	0.9	0.1	0.0	7.5	0.0	2.2	0.0	12.5	9.1	0.4	5.4	0.7	0.0	0.1	0.2	0.5	16.3	5.4	0.0	1.8	0.2	0.9	1.0	0.1	0.1	0.3	0.1	0.2	0.3	0.1
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972967-48004554	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, FDA approved drug targets, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 19.1;pituitary gland: 9.2;retina: 5.6;stomach 1: 12.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Enteroendocrine cells: 43.9;Late spermatids: 9.7;Muller glia cells: 22.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 156.3;HAP1: 98.9;HEK 293: 36.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002214, HPA055753"	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	No	NA		1400000		"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (7.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.0	0.2	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.2	1.3	0.0	0.0	9.2	0.3	0.3	1.0	0.3	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.5	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.7	0.0	0.0	0.0	98.9	0.0	0.0	0.0	36.3	0.2	0.0	5.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	2.9	0.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	11.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.3	0.2	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.0	0.6	5.7	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	15.4	0.3	0.1	0.2	43.9	0.0	0.2	0.0	0.3	0.5	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	9.7	0.9	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	1.7	0.0	0.9	0.3	0.6	1.1	0.0	0.0	0.8	0.1	0.1	1.7	0.1
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641803-134844843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 146.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.1;Fibroblasts: 134.9;Leydig cells: 61.2;Sertoli cells: 52.6;Skeletal myocytes: 78.3;Smooth muscle cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 446.6;fHDF/TERT166: 414.6;HeLa: 297.0;HHSteC: 265.8;SiHa: 290.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	No	No		15000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	39.3	12.0	1.3	39.1	1.5	1.0	20.0	1.9	2.7	146.6	3.4	72.0	13.5	118.2	11.1	23.2	59.6	77.6	32.8	1.2	1.9	11.5	7.6	35.7	5.5	4.0	2.5	51.9	7.0	6.8	6.6	95.8	1.3	43.8	16.3	3.1	9.3	28.9	10.2	24.6	22.0	89.6	1.8	17.6	31.4	6.2	4.6	2.3	10.1	7.3	2.9	51.6	63.4	1.4	0.6	16.7	13.0	20.7	192.2	202.4	7.9	446.6	89.0	73.6	78.6	0.2	0.3	0.0	95.3	414.6	39.8	5.6	0.0	0.1	21.3	0.1	1.0	0.3	297.0	0.1	265.8	0.2	2.7	200.0	0.2	71.1	5.6	0.0	89.2	0.1	0.1	1.2	39.5	4.1	0.3	0.9	7.6	0.0	8.5	15.7	50.3	1.8	0.1	0.1	5.3	2.5	290.0	1.8	0.2	173.7	0.6	0.2	152.6	154.4	61.9	190.4	93.7	0.3	0.2	0.4	121.6	0.1	26.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.9	2.7	1.2	1.9	4.0	2.5	1.3	1.8	4.6	1.4	7.9	0.0	1.8	0.7	0.3	14.5	3.5	0.8	3.4	8.5	0.8	2.7	9.0	0.0	0.0	1.8	2.1	6.4	0.3	0.0	1.9	2.2	5.5	4.2	141.1	8.8	0.0	0.0	6.6	0.0	12.3	134.9	1.5	4.8	0.0	1.2	21.8	0.0	8.9	0.0	1.2	0.0	0.0	0.3	15.3	15.6	61.2	1.5	7.2	12.2	0.0	6.4	0.0	5.5	0.3	1.3	0.0	38.7	0.3	1.0	0.0	0.3	0.0	1.2	52.6	78.3	57.5	0.5	0.8	0.6	7.7	10.4	2.6	11.7	0.0	0.4
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098112-46132848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 453.2;Fibroblasts: 1455.4;Leydig cells: 605.5;Peritubular cells: 472.1;Smooth muscle cells: 555.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 4.5;MAIT T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1155.7;ASC TERT1: 2116.9;BJ: 1073.7;BJ hTERT+: 982.8;fHDF/TERT166: 775.0;HHSteC: 1129.2;HSkMC: 1524.4;U-138 MG: 1128.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 49.6"	"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		8200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	732.4	96.2	10.1	219.9	10.8	4.5	455.0	8.7	14.4	873.3	21.6	1287.5	97.7	1001.7	36.5	178.8	675.1	283.8	484.3	10.0	14.9	96.5	97.6	394.2	55.7	14.0	19.4	723.6	78.6	24.0	112.2	335.3	11.2	569.9	60.2	0.9	156.2	274.6	123.4	390.6	402.2	275.4	9.8	175.1	441.6	77.0	11.7	35.6	201.3	67.2	25.6	918.6	595.9	12.3	9.4	12.5	34.8	31.2	1155.7	2116.9	10.0	1073.7	982.8	265.5	121.5	2.3	42.4	0.2	79.2	775.0	170.8	0.9	8.1	0.7	21.7	0.8	12.3	0.2	0.2	0.2	1129.2	0.5	4.8	1524.4	0.2	503.6	10.2	0.1	0.6	0.6	0.6	0.8	108.7	5.2	0.4	2.4	19.3	0.0	130.5	0.4	66.9	1.8	0.0	0.1	1.1	54.2	41.6	0.6	0.7	19.4	1.2	6.6	0.2	1128.1	131.5	421.5	270.3	0.7	0.4	0.9	578.1	0.5	164.8	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.4	2.4	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.1	0.5	10.1	10.8	8.7	14.4	10.0	14.9	14.0	19.4	11.2	9.8	11.7	12.3	127.3	3.2	0.6	2.0	3.1	164.4	4.3	0.6	9.1	0.7	12.7	33.5	8.7	4.3	0.6	7.3	0.0	17.6	41.2	0.4	0.0	15.1	4.0	13.2	453.2	101.4	0.0	2.7	0.1	0.4	25.1	1455.4	13.3	10.3	0.0	36.1	123.1	1.4	35.3	0.0	0.8	0.1	0.0	3.1	219.7	23.7	605.5	11.7	181.5	44.0	2.4	3.1	32.0	0.0	0.1	5.9	1.0	472.1	12.1	11.2	0.0	0.4	0.1	0.5	295.9	284.8	555.2	3.7	11.5	4.6	140.4	40.4	32.7	125.3	0.4	3.9
COL7A1	"EBD1, EBDCT, EBR1"	ENSG00000114270	"Collagen type VII alpha 1 chain"	Q02388	3	48564073-48595329	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 98.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 72.5;Basal respiratory cells: 59.3;Basal squamous epithelial cells: 67.2;Endometrial stromal cells: 45.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 41.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 65.7;HaCaT: 63.5;HBEC3-KT: 100.6;HDLM-2: 97.8;HeLa: 146.2;SiHa: 82.8"									"CAB016357, HPA018877, HPA042420"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		6000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	Vesicles	"CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990"	"unprognostic (2.69e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (6.31e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.86e-2)"	0.8	1.1	1.4	3.8	1.0	0.1	4.9	2.8	2.1	24.3	0.4	2.9	1.7	12.1	6.7	21.8	6.4	4.0	3.2	0.3	6.5	7.4	1.3	1.7	1.2	7.0	3.2	3.4	0.4	0.0	2.5	1.6	3.0	34.2	0.9	1.4	11.5	12.2	3.5	98.2	4.1	2.5	2.6	6.5	2.1	3.6	6.5	1.2	0.5	0.6	1.3	6.6	29.2	0.6	0.2	25.4	1.2	0.5	9.2	12.3	31.0	65.7	40.8	16.9	10.0	0.4	0.5	0.1	2.0	15.0	15.4	63.5	0.0	100.6	3.1	97.8	0.5	0.2	146.2	4.3	25.6	0.0	0.4	19.9	58.8	34.4	26.8	23.1	0.0	0.7	0.5	0.7	2.0	0.3	0.0	0.9	3.1	1.3	1.3	0.5	2.2	0.2	9.2	0.2	0.2	0.2	82.8	0.1	0.8	3.7	1.3	0.3	0.0	5.6	3.2	3.2	50.1	1.8	1.8	0.1	49.0	0.4	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	2.8	2.1	0.3	6.5	7.0	3.2	3.0	2.6	6.5	0.6	0.4	0.0	0.0	10.7	0.2	72.5	24.1	59.3	67.2	17.7	1.0	10.2	6.6	0.0	10.6	11.0	10.4	1.4	0.1	0.6	0.0	0.9	11.8	3.1	45.3	1.4	1.8	0.0	6.8	0.7	1.0	8.3	1.1	4.0	0.0	0.8	0.4	0.7	1.6	8.4	11.6	0.7	0.0	0.3	4.2	6.3	5.0	0.8	8.8	8.4	0.1	2.6	0.0	4.0	4.4	15.6	0.1	5.7	0.0	5.7	0.2	0.3	2.5	12.9	0.0	2.0	13.4	2.6	1.5	11.3	24.2	1.2	0.8	5.0	0.2	5.8
COLGALT1	"FLJ22329, GLT25D1"	ENSG00000130309	"Collagen beta(1-O)galactosyltransferase 1"	Q8NBJ5	19	17555649-17583162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 76.2;Hofbauer cells: 91.0;Kupffer cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047821	Approved		Approved	Vesicles	"Intracellular and membrane"	No	No		9700	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA047821: AB_2680168"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (2.92e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (3.83e-4)"	38.6	14.3	5.9	38.1	6.9	32.9	27.5	7.9	8.4	31.1	10.6	27.7	16.2	28.4	4.4	17.9	26.5	19.0	22.4	7.1	9.1	12.7	16.3	34.9	29.7	12.1	9.3	23.5	15.8	9.0	10.1	40.9	12.3	15.5	15.2	3.2	15.9	16.3	15.1	23.9	24.7	35.4	7.6	39.5	18.2	11.9	18.9	9.9	14.7	7.5	15.8	28.1	22.8	12.6	103.1	118.0	56.7	79.8	222.3	136.3	90.9	95.9	55.1	121.8	125.9	90.4	159.6	53.0	164.7	166.9	104.2	91.5	58.4	110.6	73.4	29.5	94.9	51.2	147.4	87.9	121.6	123.0	147.8	115.2	97.6	136.7	56.7	49.7	138.8	33.3	105.5	25.8	45.1	45.6	61.9	81.1	43.0	75.8	115.3	65.2	73.8	80.9	26.4	67.2	41.2	29.9	102.8	80.6	97.0	36.7	41.9	177.7	98.7	240.8	67.7	215.3	156.2	45.4	125.1	58.3	142.7	232.4	113.0	1.7	25.7	12.5	5.2	28.1	2.8	3.5	4.8	4.9	18.1	3.3	3.4	5.3	3.6	2.1	20.8	7.0	3.1	14.5	5.9	6.9	7.9	8.4	7.1	9.1	12.1	9.3	12.3	7.6	18.9	12.6	35.0	19.2	23.5	11.1	10.3	19.5	7.0	10.4	10.8	3.7	8.8	9.5	11.2	10.0	15.5	11.0	6.2	7.9	28.6	14.7	0.0	13.1	3.6	8.5	28.5	29.3	5.4	10.3	10.9	8.2	76.2	30.9	20.9	13.6	8.8	20.3	7.9	14.2	91.0	13.5	9.9	15.1	4.1	70.7	24.1	3.1	19.0	59.6	17.8	19.7	26.6	2.3	10.3	6.6	12.8	10.4	7.6	21.8	6.0	9.5	9.5	4.4	8.7	3.6	13.1	9.5	24.3	2.5	13.1	13.8	20.9	8.3	12.0	24.9	18.2	8.4
COMP	"EDM1, EPD1, MED, PSACH, THBS5"	ENSG00000105664	"Cartilage oligomeric matrix protein"	P49747	19	18782773-18791305	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cell adhesion"	Heparin-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 77.6;heart muscle: 65.3;skin 1: 80.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 19.3;Early spermatids: 37.0;Fibroblasts: 32.0;Glandular and luminal cells: 32.0;Late spermatids: 75.3;Spermatocytes: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 859.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077555			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		1500000000		"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA077555: "	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (9.08e-5)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (5.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (6.95e-4)"	77.6	0.2	0.0	1.1	0.2	0.0	11.0	1.3	0.2	7.5	0.0	2.3	0.0	4.6	7.6	9.5	1.2	16.1	65.3	0.0	0.0	5.2	0.3	8.0	3.6	0.3	0.1	0.4	2.8	2.2	0.4	8.2	0.1	10.2	0.0	0.0	14.1	6.7	18.0	80.6	0.9	12.1	0.3	0.3	2.5	14.9	0.0	0.1	10.3	0.6	0.3	6.5	22.7	0.1	0.0	0.0	0.0	0.0	178.4	0.4	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	859.6	0.0	0.2	1.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.3	0.0	0.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.2	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.1	3.2	0.5	0.0	0.0	11.5	0.6	19.3	0.0	1.4	0.3	0.3	0.8	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	37.0	2.8	3.7	1.0	0.0	0.0	0.1	0.2	0.2	32.0	0.0	32.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	1.3	0.0	0.0	10.7	75.3	0.9	0.7	10.6	0.0	0.1	1.6	0.0	0.0	0.1	0.2	0.0	0.7	0.0	0.3	0.0	0.0	0.7	0.4	6.6	2.4	4.2	16.8	1.6	0.0	7.1	0.5	1.0	0.0	0.2	0.3
COPE	epsilon-COP	ENSG00000105669	"COPI coat complex subunit epsilon"	O14579	19	18899514-18919387	"Metabolic proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034345, HPA041605, HPA043576"	Supported		Enhanced	"Golgi apparatus"		NA	NA		66000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563"	"unprognostic (1.48e-1)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.75e-2)"	102.3	163.7	127.2	85.5	133.4	159.6	100.3	139.4	176.0	101.3	131.3	113.8	90.5	104.1	45.0	160.3	89.8	44.1	135.2	122.4	131.0	141.9	194.3	108.3	91.7	140.6	132.0	80.8	152.0	80.8	160.1	59.3	130.0	127.4	37.7	23.5	144.2	65.4	128.0	120.9	107.8	42.9	137.1	150.0	126.8	171.9	135.9	82.4	123.7	50.0	56.9	99.2	107.1	151.2	186.7	177.4	99.3	177.3	89.0	104.7	287.2	159.2	150.8	174.8	198.7	215.1	148.2	150.8	210.5	134.9	112.9	123.2	82.5	161.0	33.9	94.2	369.9	89.6	150.9	331.1	236.1	180.0	221.1	128.3	149.2	106.2	115.6	92.5	138.9	170.5	140.2	373.6	90.0	443.0	196.9	341.0	188.4	243.0	420.2	222.4	89.6	448.2	115.8	185.4	138.8	222.4	100.0	159.1	181.1	44.9	134.8	291.3	140.9	110.5	81.5	283.3	170.9	357.7	337.5	187.7	189.1	309.9	187.3	656.0	598.5	639.1	337.1	533.1	298.1	391.2	321.9	298.6	528.4	381.9	236.4	270.9	594.9	344.4	468.5	659.3	449.3	930.0	127.2	133.4	139.4	176.0	122.4	131.0	140.6	132.0	130.0	137.1	135.9	151.2	110.5	3.2	16.2	22.2	204.7	159.8	197.9	390.9	54.1	53.2	140.5	111.6	10.4	111.5	205.8	115.8	29.2	386.5	242.8	408.9	463.7	323.7	179.7	134.4	131.8	127.1	168.5	130.5	8.6	368.7	439.1	140.7	166.2	187.8	102.9	176.7	113.6	153.4	447.2	57.2	11.3	445.5	303.2	189.4	286.8	381.0	144.8	217.8	245.5	4.7	373.5	251.9	187.4	8.5	20.8	336.7	421.4	133.2	417.5	255.7	425.6	493.1	152.6	72.1	124.9	92.8	200.5	178.4	202.1	108.6	196.6	542.2	174.9	235.3	297.4	267.2
COPG1	COPG	ENSG00000181789	"COPI coat complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		57000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	84.7	111.0	66.6	59.0	68.2	59.4	79.8	69.5	80.7	100.4	93.0	107.6	86.7	75.5	157.4	86.8	70.0	53.8	95.5	70.3	73.7	82.7	149.5	84.4	54.8	74.3	71.5	77.9	162.4	96.3	139.0	81.9	77.4	107.7	109.8	33.4	130.7	72.7	75.7	74.4	86.7	72.2	66.4	81.9	114.0	46.5	73.2	53.5	83.3	43.2	67.1	67.2	72.2	73.2	167.8	83.2	119.1	104.0	272.8	219.0	126.9	266.3	251.8	179.5	225.2	153.9	101.2	91.1	150.8	380.7	145.6	98.4	99.5	157.2	193.6	112.0	41.4	151.9	103.2	252.6	247.9	116.4	156.4	230.9	135.6	143.8	235.0	196.1	164.3	68.9	54.2	213.6	219.2	253.4	68.7	117.7	71.3	243.6	100.9	73.3	111.8	178.3	227.3	136.7	74.1	86.1	204.2	150.3	255.9	129.8	167.1	167.6	223.9	96.9	91.7	207.2	104.2	165.7	86.1	158.9	236.4	86.9	190.0	79.1	49.9	37.2	44.1	59.2	53.6	24.9	39.8	43.9	57.0	26.9	30.0	36.2	37.2	57.0	57.3	52.2	43.8	56.2	66.6	68.2	69.5	80.7	70.3	73.7	74.3	71.5	77.4	66.4	73.2	73.2	16.6	16.0	31.5	7.8	19.2	8.8	16.9	35.4	12.0	9.2	18.9	8.6	23.3	17.2	34.6	27.6	4.2	55.6	19.7	77.0	43.0	44.5	10.4	26.2	27.7	22.8	38.6	22.9	14.1	46.5	63.1	32.5	53.0	36.9	15.2	28.6	28.9	56.5	39.0	5.0	14.8	75.1	22.4	31.2	14.8	4.7	41.0	21.6	23.2	7.5	36.5	12.7	18.6	4.5	11.8	40.8	44.6	31.2	68.4	24.4	64.5	39.5	32.6	7.1	19.7	20.2	33.3	24.3	17.0	16.4	10.2	72.2	19.4	27.7	44.6	20.6
COPS2	"ALIEN, CSN2, TRIP15"	ENSG00000166200	"COP9 signalosome subunit 2"	P61201	15	49106068-49155661	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016867, HPA018271, HPA061071"	Approved		Supported	"Vesicles,Cytokinetic bridge"		Yes	No		190000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Vesicles	"Cytokinetic bridge"	"HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424"	"unprognostic (3.47e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.10e-3)"	61.7	43.4	24.8	34.4	28.5	124.5	67.0	35.0	36.8	61.9	25.3	43.2	43.3	58.4	44.0	63.2	43.2	53.7	61.5	26.1	30.4	60.8	57.6	35.0	45.5	30.9	27.7	76.7	54.0	65.7	26.4	45.0	32.8	45.2	41.6	32.2	40.0	47.0	92.6	35.5	37.2	56.5	35.2	32.0	36.4	51.0	27.5	49.6	61.8	112.1	48.8	59.0	35.3	41.7	92.0	53.1	111.6	94.4	134.2	189.9	76.7	157.3	149.8	135.4	123.5	113.0	49.1	151.1	105.2	152.2	108.7	131.9	160.3	130.9	148.0	103.3	64.5	141.0	105.4	91.7	102.6	134.7	70.7	161.2	104.3	110.4	193.3	149.3	144.0	82.5	184.4	78.8	149.3	49.5	72.3	67.3	72.6	128.4	68.9	78.2	105.2	227.7	143.5	136.5	108.4	78.6	90.7	96.4	127.8	129.4	95.6	133.3	93.4	132.1	71.0	249.6	167.9	71.0	196.3	191.0	123.4	215.1	109.4	11.7	17.9	12.2	13.1	23.5	24.4	14.6	19.7	19.2	21.0	13.9	24.8	16.2	7.4	16.6	22.9	13.3	28.4	16.0	24.8	28.5	35.0	36.8	26.1	30.4	30.9	27.7	32.8	35.2	27.5	41.7	72.8	76.9	56.1	14.4	50.0	87.1	57.1	90.8	80.8	23.2	47.6	59.3	104.3	27.1	69.8	23.9	10.4	56.1	48.2	18.5	54.8	40.3	28.2	56.7	91.6	53.6	20.8	50.1	35.2	29.9	71.0	79.6	36.2	94.0	52.6	39.3	46.1	32.5	43.9	33.7	36.1	25.1	32.6	47.5	44.9	21.6	55.3	46.1	35.6	19.7	49.3	24.8	27.8	21.6	48.7	35.9	21.6	53.4	63.5	53.0	41.0	84.8	47.4	19.7	19.7	74.6	109.0	93.1	43.3	63.2	98.9	131.9	54.0	58.6	34.6	64.4
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036894, HPA042828"	Approved		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: AB_2678191"	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	25.6	38.6	28.4	22.0	30.7	41.0	32.0	26.9	33.5	31.7	26.0	27.4	23.1	30.8	28.8	30.5	26.0	22.5	59.7	30.6	35.0	38.8	29.2	22.2	29.9	28.4	29.9	31.9	24.6	43.7	39.2	30.2	32.0	30.3	25.1	45.6	23.7	30.5	104.8	26.7	22.0	33.3	28.7	22.5	22.4	45.0	30.8	36.2	38.4	84.1	32.7	31.8	23.5	28.9	51.7	30.4	64.1	59.0	56.0	71.7	34.8	67.2	85.7	74.8	66.0	43.7	51.8	86.9	57.3	140.5	41.3	37.7	80.6	68.9	101.1	55.6	56.9	50.4	43.5	42.1	46.3	86.8	135.6	54.4	47.0	55.8	47.8	56.2	101.1	53.5	65.2	48.0	91.9	43.4	105.0	63.6	35.3	81.1	40.6	74.0	48.8	48.1	59.8	47.2	67.7	39.6	45.0	69.4	43.5	43.8	52.7	46.4	66.7	52.2	55.1	39.7	48.6	49.8	32.7	96.8	50.3	55.2	52.8	91.4	37.0	55.2	43.0	50.4	53.9	39.7	47.1	49.7	45.3	38.9	44.7	48.1	8.2	54.6	59.8	29.0	47.6	52.3	28.4	30.7	26.9	33.5	30.6	35.0	28.4	29.9	32.0	28.7	30.8	28.9	25.6	12.8	20.1	21.9	34.1	42.8	42.2	94.5	23.3	38.7	20.1	23.4	81.3	20.0	51.5	20.2	31.3	82.5	36.5	14.5	90.1	42.4	130.6	24.9	27.6	31.9	31.2	26.5	34.7	33.2	62.7	39.9	15.3	21.3	34.2	38.2	20.0	22.4	49.0	26.9	32.9	22.0	67.1	29.2	29.2	38.3	30.7	27.2	33.8	18.7	37.8	62.5	37.0	28.6	32.9	28.2	22.1	42.9	28.6	20.5	22.6	75.7	37.9	44.6	32.9	34.1	42.5	121.2	50.2	29.7	35.2	95.0	32.8	53.3	26.3	34.3
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369401-99394195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 51.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.8;Distal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	6.4	10.1	13.4	5.2	14.3	4.6	8.6	14.7	18.0	5.6	13.7	10.7	8.2	5.2	7.6	9.3	5.1	3.5	30.9	13.8	13.9	12.7	15.1	3.5	5.6	13.8	14.0	6.8	6.6	14.2	8.5	3.0	13.9	7.7	12.5	11.9	9.6	8.4	37.3	6.9	6.6	6.3	13.7	6.4	7.4	3.0	13.8	7.9	5.2	51.1	7.1	6.8	6.5	13.7	20.2	11.4	13.5	19.2	8.6	9.6	18.4	17.0	10.5	25.2	29.0	15.9	8.5	19.6	11.1	12.8	16.3	18.3	22.7	26.6	30.6	21.0	29.1	24.1	15.5	17.1	11.3	35.0	9.0	6.1	16.0	14.9	14.9	5.5	15.6	23.8	37.2	14.5	13.6	19.8	15.5	29.0	16.4	19.7	21.7	7.5	13.8	26.1	19.9	17.3	21.0	11.2	11.8	18.0	22.9	9.0	22.1	22.8	5.6	10.9	16.0	17.0	26.4	5.1	10.0	30.9	14.0	33.6	16.4	14.1	2.9	2.4	5.0	6.9	5.8	5.6	6.4	8.1	7.3	2.5	10.5	7.8	0.4	10.1	6.1	4.9	5.2	4.7	13.4	14.3	14.7	18.0	13.8	13.9	13.8	14.0	13.9	13.7	13.8	13.7	4.7	3.2	3.7	6.5	3.9	4.5	6.8	26.1	7.4	8.1	5.0	6.3	42.8	5.7	11.2	3.7	0.0	14.0	2.2	3.7	33.2	11.5	0.5	3.5	4.9	5.5	0.0	8.2	10.6	10.5	13.3	5.9	3.6	2.6	1.3	6.6	3.3	8.6	6.8	6.7	13.2	7.3	24.4	1.3	3.5	0.3	8.1	2.4	5.4	1.0	2.0	13.2	4.1	4.5	7.6	9.2	5.8	6.0	4.7	2.4	5.2	12.0	4.9	8.7	6.6	6.5	10.6	3.6	10.9	8.0	4.3	6.3	3.7	11.1	9.8	4.7
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 56.9"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.4	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.4	4.5	56.9	0.0	0.3	1.0	0.1	1.9	0.0	0.7	0.6	0.5	0.2	1.1	1.9	0.4	0.1	2.3	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.3	0.1	0.1	0.1	0.1	1.2	3.9	0.1	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.7	0.6	0.1	0.1	0.3	0.1	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807068	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria		NA	NA		55000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	473.1	393.5	874.4	232.5	881.4	583.2	437.1	896.5	971.9	373.1	882.6	690.5	585.9	301.8	478.8	597.2	355.8	246.9	2047.0	869.5	909.5	632.7	611.2	318.6	412.8	896.4	891.1	366.2	490.4	900.7	362.1	256.7	908.6	377.1	707.7	261.2	421.2	312.3	1333.3	552.5	529.5	301.4	877.2	405.9	650.3	191.1	922.9	479.9	361.5	2063.3	538.7	422.6	420.9	881.0	433.7	677.7	460.2	616.8	823.6	761.2	785.7	379.6	771.2	702.3	346.7	1170.2	636.6	698.6	454.2	610.5	389.9	855.1	657.2	765.3	622.2	238.7	678.1	392.9	554.8	1093.8	741.9	362.9	282.0	893.1	1162.8	579.2	786.0	739.1	746.4	563.6	672.3	280.4	602.5	1510.6	730.9	1116.7	623.0	954.1	796.3	816.9	287.5	616.7	1066.7	840.2	543.2	441.1	807.4	513.2	656.2	489.6	753.2	996.6	529.9	355.5	409.5	330.7	419.0	561.4	562.5	1646.3	542.4	702.2	410.6	633.9	1373.2	805.2	700.3	1199.6	868.1	1302.9	930.5	833.2	1480.8	1231.2	1169.3	968.8	513.9	840.6	1089.3	1105.6	1106.1	2815.9	874.4	881.4	896.5	971.9	869.5	909.5	896.4	891.1	908.6	877.2	922.9	881.0	552.0	275.7	398.1	45.1	925.3	1129.4	1242.3	2031.6	1121.8	280.2	1365.2	1553.2	3479.9	1086.6	942.3	632.7	131.3	1223.1	714.3	1863.5	2752.8	1091.1	539.4	480.5	468.0	629.7	1009.6	524.6	44.0	1316.2	1094.7	591.2	813.0	575.6	521.4	554.3	660.7	1314.7	1602.3	212.0	51.7	1782.5	1125.0	1488.5	1376.5	1155.4	498.9	1010.5	1145.5	35.6	1451.7	562.9	785.8	35.7	65.5	1463.7	1950.7	357.7	726.2	1370.7	3811.3	2936.3	545.4	349.9	355.0	481.8	678.0	358.6	321.7	1721.9	1361.7	1481.9	816.5	1020.3	2147.9	1941.7
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354719	"Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 90.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Late spermatids: 27.4;Respiratory ciliated cells: 12.6;Spermatocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 24.9;SCLC-21H: 10.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.7	0.1	0.3	1.0	0.2	1.1	0.9	1.0	0.5	0.4	0.4	6.7	0.2	0.2	1.2	1.2	0.7	0.2	0.1	0.3	0.3	0.8	0.1	0.3	0.2	0.3	0.5	0.5	0.2	0.0	0.9	0.2	0.4	0.7	4.8	0.4	1.4	0.2	0.3	2.5	0.3	0.2	0.1	0.3	0.2	90.5	0.3	3.3	0.1	0.0	1.9	0.5	0.9	0.6	3.1	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.2	24.9	0.1	0.2	0.3	0.3	1.8	0.7	0.2	0.2	0.9	0.7	0.0	2.0	0.1	0.3	0.2	1.8	0.2	2.7	0.5	0.6	1.7	0.0	0.1	0.4	0.2	0.0	0.6	0.1	0.2	0.6	2.6	0.5	0.1	0.0	0.2	0.1	0.4	10.1	0.3	0.4	0.1	0.0	0.6	0.4	0.0	0.5	0.2	0.5	0.1	0.3	1.6	1.4	0.1	0.1	0.3	0.1	0.8	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.2	0.2	1.5	0.5	0.2	0.4	0.2	0.3	0.3	0.2	1.0	0.5	0.3	0.3	0.3	0.5	0.4	0.1	0.3	0.6	0.2	0.0	0.5	0.0	0.0	0.5	0.7	3.5	1.2	2.4	0.9	1.3	0.6	0.0	2.1	0.0	4.2	0.5	1.8	8.0	0.0	0.5	36.0	1.3	0.5	0.2	1.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.0	0.2	0.0	0.0	0.1	3.3	0.1	1.3	4.1	0.0	0.0	27.4	0.6	0.3	0.0	0.0	0.0	1.4	2.1	0.0	0.1	9.6	4.1	0.0	0.3	0.7	3.4	0.1	12.6	5.4	0.0	0.4	0.5	61.1	1.7	0.3	0.4	0.4	0.6	0.1	6.5	2.3
COX6C		ENSG00000164919	"Cytochrome c oxidase subunit 6C"	P09669	8	99873200-99893707	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA014295, CAB016244"	Enhanced		Supported	Mitochondria		NA	NA		210000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB016244: AB_2085703, HPA014295: AB_2668966"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	134.0	147.5	180.8	52.9	183.9	152.6	125.7	186.1	291.0	166.4	190.2	268.1	334.8	194.0	175.6	197.3	189.5	20.4	781.6	191.8	195.6	254.9	328.5	108.4	71.1	186.0	188.4	161.9	107.3	101.7	159.5	89.9	189.2	162.6	110.4	147.0	108.1	58.1	666.1	121.4	172.3	42.7	182.4	122.9	180.0	170.8	192.7	44.8	129.1	554.1	51.5	188.7	148.6	188.9	137.6	57.8	63.8	251.3	140.0	100.5	103.1	44.5	42.7	30.1	34.3	54.7	284.5	326.8	320.1	70.1	47.7	176.4	36.4	363.3	51.0	60.5	89.1	684.6	66.9	160.4	88.9	319.3	201.9	95.1	475.3	26.0	56.4	129.2	45.1	103.8	49.8	571.1	51.6	134.2	337.9	289.6	117.9	205.5	127.7	381.0	21.2	320.6	453.4	713.3	191.8	115.2	30.9	654.2	351.5	65.0	461.7	201.1	40.1	220.4	286.0	235.8	63.8	140.7	126.3	209.6	310.2	128.2	200.8	345.8	134.7	114.1	177.8	210.5	189.0	209.7	270.6	193.5	212.9	189.8	319.7	294.9	16.6	187.7	266.5	301.9	272.7	252.9	180.8	183.9	186.1	291.0	191.8	195.6	186.0	188.4	189.2	182.4	192.7	188.9	527.8	403.8	485.1	29.7	382.1	490.8	493.5	1431.9	279.4	217.6	561.3	642.7	2146.4	491.8	731.2	605.1	102.2	978.9	416.1	1263.2	2226.5	673.6	834.3	579.3	778.7	436.9	807.5	400.2	27.6	849.4	853.9	502.0	440.4	551.9	362.5	219.3	384.1	1855.5	1066.5	156.5	33.5	1221.3	1027.4	451.1	539.5	266.5	664.8	440.8	732.8	23.4	778.0	545.0	449.0	22.6	32.1	808.6	1338.7	587.5	412.2	448.4	2173.5	1791.0	702.9	282.0	493.0	367.1	555.9	1180.5	505.2	666.4	640.6	1784.9	452.1	428.0	1246.7	715.5
COX7A2L	"COX7AR, COX7RP, EB1, SIG81"	ENSG00000115944	"Cytochrome c oxidase subunit 7A2 like"	O14548	2	42333546-42425088	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059124, CAB073545"			Enhanced	Nucleoli,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"CAB073545: , HPA059124: AB_2683912"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.02e-1)"	79.5	222.7	53.9	18.7	57.5	56.9	78.3	53.1	62.5	93.0	56.1	84.0	32.5	74.8	42.8	60.8	81.0	22.7	102.6	56.2	56.9	130.2	113.9	64.0	32.3	54.8	53.2	127.6	89.8	71.8	128.0	22.8	55.9	71.6	39.2	62.4	67.2	32.4	83.3	72.1	66.0	28.0	53.0	65.9	99.9	54.5	54.8	42.0	56.6	39.3	35.0	74.2	70.4	53.4	72.1	50.7	49.0	54.0	92.4	121.8	55.8	58.2	85.8	51.5	66.0	56.9	48.9	63.1	54.8	71.9	70.0	30.3	65.5	65.9	80.1	99.5	47.5	46.0	31.9	95.5	106.2	66.5	42.5	123.7	128.6	55.5	132.6	78.5	77.4	49.7	64.1	101.1	83.9	68.6	75.3	96.8	45.3	91.6	48.1	40.7	87.5	51.6	84.6	57.4	55.8	63.7	25.7	60.4	166.1	58.2	43.2	73.3	60.1	45.4	61.2	55.3	57.1	84.1	98.7	46.0	63.1	68.8	39.9	103.7	78.6	43.2	57.9	71.1	75.6	72.6	70.4	67.1	84.4	61.9	77.8	67.0	34.1	69.1	80.1	99.0	87.3	189.3	53.9	57.5	53.1	62.5	56.2	56.9	54.8	53.2	55.9	53.0	54.8	53.4	150.7	32.1	76.3	11.4	152.5	265.6	197.9	387.2	135.5	114.8	206.8	237.6	158.7	171.6	173.4	149.0	37.5	228.1	163.4	103.8	645.6	239.1	27.4	189.5	133.3	144.0	288.7	188.7	28.2	229.5	316.2	128.5	123.8	175.9	87.0	155.8	132.1	222.3	234.0	131.2	26.1	285.8	282.8	236.3	225.1	26.3	161.8	161.6	220.5	19.7	298.4	326.8	166.9	13.6	24.5	202.1	173.0	158.7	167.7	214.2	247.1	492.4	160.9	123.6	111.7	137.6	175.2	220.4	270.8	162.7	245.5	329.6	161.8	296.2	257.0	241.7
CPEB1	"CPEB, FLJ13203"	ENSG00000214575	"Cytoplasmic polyadenylation element binding protein 1"	Q9BZB8	15	82543201-82648861	"Predicted intracellular proteins"	"mRNA processing, Translation regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.6;testis: 32.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.0;Inhibitory neurons: 44.3;Oligodendrocytes: 196.5;Spermatocytes: 34.1;Spermatogonia: 62.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 37.9;U-2197: 106.0;U-87 MG: 39.1"									HPA040396			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA040396: AB_2676960"	"unprognostic (3.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.50e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	2.8	5.0	10.4	1.3	18.6	0.2	2.5	20.3	18.6	9.3	4.5	6.8	1.2	4.2	7.9	3.6	8.3	4.0	2.9	12.7	17.0	1.2	0.2	1.6	0.5	21.3	21.7	14.3	1.3	0.8	21.8	0.3	24.0	2.3	2.4	4.5	1.5	3.7	2.4	1.9	2.5	3.4	15.0	0.6	2.5	32.4	20.4	0.4	2.3	10.5	0.5	7.7	6.1	33.6	0.1	3.6	0.3	0.4	2.6	0.2	0.1	2.8	0.3	1.8	1.4	0.2	0.1	0.0	6.3	1.1	19.5	0.1	5.1	0.0	0.4	0.0	4.2	0.1	0.1	0.1	1.8	0.1	2.3	1.4	0.0	3.5	0.0	0.2	0.0	7.6	8.9	0.2	1.3	0.2	0.6	0.1	8.2	0.1	1.0	0.0	0.2	0.1	0.0	0.1	10.5	2.4	9.2	0.5	37.9	11.2	0.1	1.1	0.1	18.9	7.5	106.0	6.0	5.3	14.3	1.4	39.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	18.6	20.3	18.6	12.7	17.0	21.3	21.7	24.0	15.0	20.4	33.6	0.3	0.0	0.0	19.6	0.1	0.8	0.3	0.0	0.0	11.5	0.6	0.3	1.9	0.0	0.0	0.0	10.4	0.0	0.1	0.1	0.0	0.1	12.6	0.5	1.4	0.2	0.0	0.0	70.0	0.0	0.0	5.9	0.5	0.1	1.3	0.3	0.4	0.0	0.3	11.8	44.3	0.0	0.0	0.0	0.8	20.0	4.1	0.4	5.4	10.3	0.1	5.2	0.0	10.1	196.5	0.1	0.0	2.2	0.2	0.5	0.0	0.4	2.2	4.3	6.6	1.9	1.8	34.1	62.3	0.0	0.6	0.1	0.4	0.0	0.0	0.1
CPEB2		ENSG00000137449	"Cytoplasmic polyadenylation element binding protein 2"	Q7Z5Q1	4	15002481-15070153	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 127.6;Oligodendrocytes: 406.5;Suprabasal keratinocytes: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072513			Approved	Cytosol		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA072513: AB_2686529"	"unprognostic (6.59e-2)"	"unprognostic (4.21e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	9.6	6.0	13.2	5.1	21.9	26.5	12.3	18.8	21.9	9.8	5.6	11.5	8.4	7.4	8.3	13.3	6.0	9.5	7.3	14.6	15.0	12.0	17.6	8.4	5.6	22.4	16.6	6.3	4.4	16.3	4.2	6.4	20.7	8.4	9.7	16.1	8.1	10.7	5.8	23.5	8.7	8.6	18.7	5.8	10.7	37.9	17.3	4.5	4.8	6.2	6.4	8.0	13.2	45.5	2.9	18.1	1.9	0.7	13.1	26.2	3.6	10.8	6.7	5.8	4.6	0.3	4.2	1.9	2.1	10.1	11.8	3.5	3.9	2.6	3.6	4.8	1.5	0.5	16.3	3.5	6.1	1.0	2.6	12.3	12.5	15.6	14.7	8.7	6.1	0.3	0.4	13.2	26.9	1.5	0.2	4.7	1.7	5.9	2.8	0.3	1.8	0.8	57.3	2.6	1.7	11.1	3.1	2.4	10.6	8.7	1.5	12.2	11.7	24.0	2.1	15.3	6.1	9.0	1.3	1.0	19.3	10.6	9.5	0.0	0.2	0.6	0.1	0.1	0.5	0.0	0.2	0.1	0.2	0.1	0.3	0.1	1.1	0.5	0.1	0.1	0.1	0.1	13.2	21.9	18.8	21.9	14.6	15.0	22.4	16.6	20.7	18.7	17.3	45.5	24.9	32.1	14.2	55.8	8.1	85.8	12.2	6.8	58.1	8.6	31.2	17.8	22.3	12.8	9.3	31.3	27.1	1.4	10.7	26.4	1.9	4.6	64.5	38.4	9.9	14.7	10.2	3.8	58.2	4.9	1.8	13.4	15.3	50.7	10.8	1.8	13.2	23.8	11.2	15.2	127.6	13.1	4.1	14.1	31.0	20.3	6.2	20.3	53.4	39.4	6.6	8.5	3.1	89.5	406.5	7.0	16.9	8.2	17.5	11.8	18.7	14.8	5.1	19.3	0.0	20.7	16.5	16.6	4.6	77.0	129.4	1.4	11.0	3.6	8.1	17.0
CPEB3	KIAA0940	ENSG00000107864	"Cytoplasmic polyadenylation element binding protein 3"	Q8NE35	10	92046692-92291078	"Predicted intracellular proteins"	"Translation regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 32.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 176.0;Early spermatids: 226.2;Excitatory neurons: 233.7;Inhibitory neurons: 286.9;Late spermatids: 408.9;Oligodendrocyte precursor cells: 148.8;Oligodendrocytes: 128.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.1;U-266/70: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070942			Approved	"Nucleoplasm,Plasma membrane,Midbody,Cytosol"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane, Midbody"	"HPA070942: "	"unprognostic (4.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.95e-5)"	"prognostic favorable (5.06e-5)"	"unprognostic (4.09e-4)"	"unprognostic (2.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.84e-9)"	"unprognostic (3.33e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.40e-1)"	1.9	3.9	6.1	1.8	7.2	1.7	3.2	6.2	17.3	2.5	2.1	2.3	3.1	1.9	4.5	4.6	1.8	2.0	5.1	6.4	4.3	4.6	32.2	2.2	1.9	10.4	5.6	3.5	3.5	3.2	4.0	1.6	11.0	4.2	2.6	7.1	7.5	2.4	19.7	4.0	3.0	2.0	1.4	2.6	2.8	12.9	4.4	1.5	6.5	9.5	2.1	1.9	3.1	7.0	0.9	0.2	0.3	1.9	0.5	0.5	0.7	0.8	0.6	1.2	0.9	0.6	1.9	1.1	1.0	0.3	0.5	2.5	0.9	0.6	0.7	1.1	0.9	1.4	1.3	0.8	1.4	0.6	1.4	0.4	1.5	0.6	2.4	1.0	1.1	1.3	0.9	12.1	0.5	0.7	0.9	0.8	0.2	1.3	0.9	1.1	1.6	2.1	1.2	0.4	1.4	0.5	0.8	2.2	1.6	1.0	2.7	1.6	0.8	0.6	0.6	0.4	0.7	6.3	1.7	1.1	0.3	2.2	0.1	2.6	0.4	0.8	0.2	0.5	0.2	0.7	0.1	0.3	0.3	0.1	0.1	0.1	0.5	0.2	0.6	0.2	0.1	0.2	6.1	7.2	6.2	17.3	6.4	4.3	10.4	5.6	11.0	1.4	4.4	7.0	6.1	6.4	7.0	176.0	6.2	8.8	4.0	4.0	7.4	26.0	20.5	10.7	25.3	5.7	4.4	12.9	50.1	2.1	3.0	11.3	5.9	3.2	226.2	9.0	3.0	7.1	19.8	3.6	233.7	2.6	1.6	5.5	4.1	10.8	3.8	4.1	12.5	75.2	4.8	30.3	286.9	9.9	8.2	23.9	3.4	408.9	5.9	10.3	5.4	87.1	8.9	3.2	4.1	148.8	128.6	3.2	4.0	7.9	4.2	10.7	10.1	5.0	8.7	24.7	0.0	4.4	4.1	13.2	7.2	22.0	13.9	1.2	3.3	3.4	5.9	6.5
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065876, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA065876: , HPA072634: AB_2686541"	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	61.0	47.9	15.5	50.5	15.2	70.9	58.5	14.5	17.5	68.7	17.0	65.4	32.5	74.1	58.5	58.7	62.4	48.3	38.4	15.2	15.8	44.1	38.7	59.6	52.3	16.9	14.6	64.7	48.4	38.6	52.1	69.8	15.4	52.3	47.4	17.7	51.6	41.9	43.7	63.4	62.9	70.3	14.5	78.3	51.0	25.5	14.9	82.8	60.2	33.6	81.8	64.4	59.8	19.6	264.1	202.5	112.0	47.3	14.3	18.6	85.4	123.9	219.8	295.0	192.1	590.5	111.2	181.6	115.8	185.3	251.6	98.1	88.1	233.7	182.8	34.7	65.7	459.1	149.9	440.5	131.9	151.5	61.9	121.6	235.8	118.1	139.0	178.9	188.1	183.9	61.4	90.3	144.0	142.9	226.0	201.9	27.8	264.2	187.6	159.1	334.0	125.4	119.9	183.9	78.9	87.9	277.2	129.6	188.1	31.1	134.3	148.8	123.6	306.6	56.4	101.3	131.6	61.5	66.9	126.9	222.7	81.8	69.6	53.6	102.9	180.5	119.3	100.5	164.8	120.8	115.2	112.5	143.7	113.8	111.3	113.6	140.4	206.7	98.8	78.0	153.7	164.5	15.5	15.2	14.5	17.5	15.2	15.8	16.9	14.6	15.4	14.5	14.9	19.6	47.0	19.2	37.3	33.6	55.2	55.1	71.8	82.3	44.9	34.6	40.2	46.0	15.7	32.9	56.5	25.8	20.9	125.1	73.4	26.8	25.4	72.7	39.6	23.3	44.1	53.2	33.6	42.5	37.2	37.8	76.7	56.2	25.0	28.3	48.2	59.9	34.6	23.3	62.4	21.9	33.7	30.8	81.4	43.0	79.6	9.6	54.7	45.5	48.0	30.0	85.0	24.8	62.8	32.6	39.4	44.2	34.0	61.7	60.2	78.6	38.2	34.8	33.9	18.1	46.0	47.0	55.0	13.1	22.9	41.4	49.0	106.3	77.0	65.9	41.2	71.7
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98579446-98593648	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 352.8;Extravillous trophoblasts: 75.9;Oligodendrocytes: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HEL: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Supported	Mitochondria		No	No		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	8.1	10.0	19.7	11.4	28.2	44.1	7.2	24.0	31.7	9.1	13.5	10.0	21.2	10.1	7.2	16.1	7.4	8.1	8.6	19.5	22.4	6.5	35.3	7.5	12.3	30.8	24.9	10.7	7.2	9.5	5.4	18.0	29.8	8.4	12.0	4.5	7.6	7.9	11.2	13.1	15.2	9.0	24.5	9.5	9.4	4.7	25.1	12.8	7.1	9.8	12.3	8.1	10.9	41.8	47.9	22.9	19.9	35.4	36.5	26.9	56.6	30.0	21.7	30.7	34.7	38.2	14.7	5.0	33.1	16.2	33.6	34.1	24.9	32.8	51.9	15.4	21.6	166.4	12.9	49.9	18.5	35.7	37.8	21.2	27.0	29.0	12.0	35.9	29.6	20.2	32.2	20.9	29.1	14.8	36.2	30.4	23.4	26.6	41.0	25.4	45.0	22.1	26.2	19.8	13.1	13.0	32.0	10.9	96.2	22.1	16.7	22.5	24.9	45.1	44.0	26.1	22.4	31.6	26.8	26.7	44.6	38.3	33.7	0.0	0.6	0.0	0.3	0.3	0.7	0.5	0.6	0.8	0.5	0.5	0.2	0.8	0.0	0.6	0.2	0.3	0.3	0.2	19.7	28.2	24.0	31.7	19.5	22.4	30.8	24.9	29.8	24.5	25.1	41.8	6.4	3.2	8.7	9.1	5.6	7.4	3.9	7.3	11.4	4.3	6.0	4.6	8.0	7.2	4.2	3.7	8.4	23.9	6.5	7.9	1.9	3.7	0.1	5.2	8.6	7.4	8.4	352.8	17.7	1.7	75.9	9.4	10.2	5.0	1.3	7.0	11.7	36.4	12.7	0.0	12.3	9.1	4.1	11.3	10.0	0.2	7.5	11.4	12.4	11.2	12.7	5.8	3.1	13.0	99.1	3.2	4.1	7.9	10.4	5.2	9.4	6.3	5.0	5.0	13.1	6.4	7.2	0.3	6.1	12.2	10.2	10.7	12.7	9.7	9.9	4.2
CPPED1	"CSTP1, FLJ11151"	ENSG00000103381	"Calcineurin like phosphoesterase domain containing 1"	Q9BRF8	16	12659799-12803887	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 105.2;monocytes: 127.4;Syncytiotrophoblasts: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 674.2"	"Group enriched"	"Detected in all"	28	"dendritic cells: 168.5;granulocytes: 674.2;monocytes: 320.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 144.2;HMC-1: 129.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040938, HPA041970"	Uncertain		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Plasma membrane"	"HPA040938: AB_10673443, HPA041970: AB_2677774"	"prognostic unfavorable (9.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (1.62e-9)"	"unprognostic (5.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.40e-2)"	12.5	9.4	9.1	19.3	14.1	14.0	8.2	13.0	11.4	11.0	7.3	13.3	21.3	7.9	5.1	25.2	7.1	11.2	10.1	8.3	13.3	33.7	34.4	13.7	11.7	14.0	13.1	7.6	4.8	3.9	4.1	18.5	14.4	11.1	14.8	3.7	13.1	8.6	8.2	6.5	21.4	12.9	11.3	29.8	8.7	15.5	12.2	9.2	13.2	9.6	16.6	11.5	8.8	17.3	5.0	29.7	3.3	7.7	12.0	25.3	0.5	54.1	14.5	28.4	23.1	14.5	15.2	7.3	54.6	39.6	12.5	0.4	0.0	13.5	29.3	17.0	8.2	62.5	4.2	144.2	7.4	0.1	129.9	25.4	3.0	2.5	20.2	0.1	43.1	9.9	22.1	4.3	70.4	6.3	5.6	29.1	8.7	2.4	4.2	11.9	18.8	15.6	43.0	9.4	15.3	10.0	0.2	48.5	20.0	15.3	10.5	13.7	65.0	40.6	8.5	0.2	0.1	0.1	1.0	11.6	9.1	31.7	8.8	57.1	224.0	146.1	9.1	320.0	7.8	10.8	7.6	10.0	168.5	8.4	2.4	5.7	674.2	13.5	320.8	41.1	13.8	129.7	9.1	14.1	13.0	11.4	8.3	13.3	14.0	13.1	14.4	11.3	12.2	17.3	12.3	9.6	16.7	8.1	8.7	4.6	3.4	4.9	4.6	3.3	4.7	4.7	10.7	10.0	11.4	14.7	8.4	105.2	18.5	9.2	60.7	43.1	3.6	5.3	13.5	16.7	6.0	31.7	13.1	12.8	15.6	12.6	4.1	9.4	54.4	8.1	7.5	45.8	47.1	10.1	10.2	9.3	6.1	80.3	30.7	4.1	15.5	59.0	7.2	30.0	127.4	13.5	8.2	21.1	70.9	31.9	18.3	24.0	4.4	3.2	40.6	66.0	13.4	6.1	26.3	17.6	11.9	2.5	9.9	14.8	4.5	131.9	8.3	13.6	15.4	1.7
CPSF1	CPSF160	ENSG00000071894	"Cleavage and polyadenylation specific factor 1"	Q10570	8	144393229-144409335	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065167, HPA068906"			Enhanced	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA065167: AB_2685426, HPA068906: AB_2686055"	"unprognostic (6.37e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.54e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.90e-2)"	"unprognostic (9.66e-3)"	39.1	52.0	16.2	11.0	16.6	20.4	45.5	15.9	23.3	53.5	16.2	54.8	27.4	48.8	3.8	49.2	49.1	9.0	44.9	15.9	14.9	52.2	76.3	43.3	12.3	16.8	14.9	56.6	88.6	6.1	78.0	6.8	17.1	61.7	4.2	5.2	49.6	7.6	41.0	55.3	68.1	5.7	14.6	70.5	68.9	132.0	15.6	15.0	52.9	5.2	6.8	41.2	44.0	16.2	21.4	29.4	26.3	27.7	13.8	11.0	25.7	19.6	12.4	15.8	16.3	29.8	27.0	24.6	18.7	14.8	10.7	19.1	14.9	16.7	4.4	22.2	43.0	48.3	37.4	48.6	11.7	18.6	28.8	12.1	6.9	14.5	8.5	9.5	21.2	40.1	41.1	20.4	8.0	90.7	48.8	38.6	15.9	17.9	41.0	34.7	10.6	19.9	17.0	31.1	21.3	21.1	25.4	15.7	14.8	7.4	27.9	20.5	18.4	10.8	41.3	23.9	22.3	12.1	10.2	23.3	14.6	31.0	13.1	3.8	5.1	3.3	4.8	6.1	5.1	4.0	5.2	5.1	5.7	4.8	4.5	4.3	0.9	4.0	6.2	2.6	6.7	4.2	16.2	16.6	15.9	23.3	15.9	14.9	16.8	14.9	17.1	14.6	15.6	16.2	10.1	16.0	22.5	10.1	9.5	10.1	4.0	6.6	6.2	9.6	15.1	16.9	8.3	20.0	10.7	9.2	12.5	10.1	14.5	26.4	1.9	9.5	19.5	9.6	7.8	11.7	13.1	15.8	9.4	11.5	11.5	10.7	21.9	11.8	14.0	20.7	8.9	8.1	15.1	8.4	6.9	28.6	8.2	12.4	12.4	40.4	14.0	11.7	14.2	3.7	11.9	5.0	10.3	5.5	6.5	10.5	8.8	16.1	17.9	4.1	24.0	6.2	11.7	14.4	6.6	7.7	9.0	36.5	23.1	12.2	12.4	7.3	11.5	7.6	30.3	4.3
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239569-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	23.8	26.3	14.4	35.8	13.9	71.9	23.8	30.5	16.8	27.5	1.8	24.0	26.2	28.4	38.6	27.8	25.3	18.3	21.5	14.5	18.0	20.8	20.6	22.5	46.9	6.1	5.6	40.5	23.9	28.3	26.5	25.0	8.4	23.1	24.8	43.5	26.0	20.2	27.9	24.6	25.4	23.7	8.2	27.1	26.6	22.3	12.6	43.6	26.6	17.0	40.8	25.6	25.2	12.3	97.5	80.3	115.7	81.7	43.8	49.7	87.1	62.7	74.1	87.3	82.0	83.8	64.8	153.6	62.6	63.9	48.5	89.2	114.5	73.7	92.3	101.4	78.1	124.3	85.7	97.1	65.4	170.1	87.1	60.0	57.2	70.4	28.7	58.2	68.3	90.6	130.1	159.6	73.3	112.9	159.9	110.3	112.3	80.4	67.8	159.9	91.6	108.2	68.9	113.4	97.0	85.4	83.7	77.7	88.9	68.8	93.2	118.5	79.1	65.4	80.0	62.6	104.5	101.9	88.5	190.9	53.1	97.5	85.9	44.3	26.0	29.9	27.9	32.6	29.5	32.8	30.8	29.1	39.0	28.9	23.4	28.2	7.7	30.2	28.7	27.8	47.2	19.7	14.4	13.9	30.5	16.8	14.5	18.0	6.1	5.6	8.4	8.2	12.6	12.3	29.1	12.8	24.9	53.2	49.9	76.0	46.7	55.7	43.3	56.5	30.0	24.5	31.7	30.0	39.9	18.4	37.5	64.6	51.1	22.5	37.2	59.6	18.7	35.6	40.2	35.0	52.5	47.1	97.6	56.8	85.7	36.6	33.6	37.9	34.9	54.0	23.6	23.0	39.5	89.2	115.4	32.6	75.3	29.3	39.7	19.8	56.8	37.1	24.9	53.4	53.5	37.8	45.3	137.2	126.0	61.1	23.3	53.0	56.3	37.4	25.4	26.6	28.0	45.8	39.5	37.4	56.0	68.1	69.4	43.9	59.1	51.2	38.5	54.1	36.2	51.5
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 110.0;Hepatocytes: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria		NA	NA		45000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	24.3	27.7	16.0	22.3	18.4	38.9	22.7	20.2	17.3	20.4	32.0	67.4	70.7	25.1	7.3	22.0	25.4	27.7	25.4	14.7	17.7	38.4	67.9	25.3	15.9	20.6	22.0	18.3	23.6	27.6	14.3	18.4	19.3	20.3	44.6	22.6	26.0	21.9	9.9	17.0	71.3	34.9	15.9	27.4	35.6	13.5	22.1	14.0	15.4	14.3	12.3	18.7	18.0	13.9	29.4	50.9	7.3	48.6	31.2	28.0	2.1	22.9	18.8	17.7	3.6	2.0	96.0	0.1	82.2	60.4	62.2	93.5	63.9	13.6	5.3	46.8	6.3	71.5	52.3	24.0	46.4	41.9	82.6	29.2	6.6	35.5	21.4	24.1	63.5	28.2	7.6	56.8	16.5	83.6	34.4	73.7	0.8	149.7	53.2	94.7	1.2	127.1	41.7	71.7	1.0	31.8	63.0	119.9	20.2	4.8	107.4	40.0	64.5	38.3	0.9	77.7	33.5	43.9	60.1	29.2	40.3	30.3	42.8	8.2	6.6	9.5	7.3	7.7	4.2	1.9	4.4	4.4	4.4	2.0	2.7	5.5	3.2	4.9	6.7	10.4	2.8	2.7	16.0	18.4	20.2	17.3	14.7	17.7	20.6	22.0	19.3	15.9	22.1	13.9	44.4	38.5	28.8	35.6	13.5	9.4	11.0	9.0	28.5	4.8	9.6	7.6	25.5	22.8	18.0	23.9	64.6	15.9	39.3	110.0	19.6	13.8	14.7	33.2	22.6	30.4	16.2	30.9	5.6	9.5	3.9	16.6	31.1	56.7	29.7	23.0	40.7	108.3	15.7	1.7	5.7	48.9	10.2	39.1	11.5	43.9	9.6	24.6	0.0	28.1	31.4	12.7	23.7	7.1	1.7	8.5	43.4	32.0	28.6	9.6	83.4	11.8	23.8	43.0	39.5	18.3	21.1	14.5	10.0	14.8	7.7	7.8	24.0	17.3	67.4	9.2
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196792-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.2"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 85.1;Hepatocytes: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	12.9	14.3	6.6	9.4	8.2	5.4	13.6	7.9	7.3	10.3	16.8	35.4	32.4	6.8	10.5	14.2	10.5	9.5	19.5	6.1	7.1	35.1	91.2	11.5	10.6	8.1	7.5	10.2	21.7	27.3	6.7	18.0	8.0	12.2	32.8	7.1	14.6	11.7	17.3	6.7	24.9	11.4	7.7	8.7	18.4	12.9	9.0	10.2	12.5	33.1	13.2	11.1	4.5	8.9	16.0	8.3	17.2	17.8	14.6	11.3	17.5	9.8	13.2	17.5	17.5	8.6	14.5	28.9	14.6	9.2	20.1	19.1	35.1	25.1	15.1	17.0	16.0	21.8	9.9	6.4	25.9	15.9	19.5	23.0	23.2	13.8	11.1	18.6	15.4	26.5	20.9	9.9	13.1	12.8	10.7	13.0	29.8	38.4	20.0	13.2	16.2	34.4	22.9	22.0	25.3	14.4	22.1	30.3	39.7	36.6	32.3	32.2	8.7	8.4	6.1	16.5	8.5	26.3	19.8	16.2	11.6	20.6	12.4	5.6	14.1	14.6	7.2	20.0	8.1	5.3	6.3	8.4	17.9	7.4	10.5	7.2	5.3	6.9	20.5	8.9	9.9	10.3	6.6	8.2	7.9	7.3	6.1	7.1	8.1	7.5	8.0	7.7	9.0	8.9	5.0	12.8	24.1	4.2	7.8	1.8	5.2	20.5	5.2	6.0	7.5	7.0	18.1	15.7	11.4	11.0	14.6	85.1	4.5	49.3	25.4	12.9	1.1	10.9	8.1	5.9	14.5	9.4	1.5	10.5	20.3	7.2	18.3	10.3	2.5	12.7	8.9	88.8	26.3	15.2	2.0	26.6	16.2	15.1	7.2	2.8	6.8	10.5	7.2	1.9	20.2	11.6	6.2	2.5	4.5	10.5	25.6	5.3	9.1	4.9	38.6	41.0	7.6	11.0	6.6	7.5	8.4	49.9	31.3	13.8	2.6	54.6	6.9	25.6	29.5	5.7
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1189.7;vagina: 604.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 485.4;Breast glandular cells: 224.2;Club cells: 266.7;Squamous epithelial cells: 714.0;Urothelial cells: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1592.5;MCF7: 625.9;T-47d: 1201.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 36.0"	HPA004135	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		76000	"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	22.2	8.0	9.6	4.8	11.5	5.7	104.5	10.5	18.8	273.7	29.4	13.3	0.9	76.3	4.7	1189.7	83.1	18.2	5.5	10.7	12.8	12.0	2.3	6.4	3.9	8.0	8.2	6.2	3.4	55.1	43.5	40.5	7.8	34.8	4.8	4.5	93.5	57.1	5.0	179.0	3.9	57.0	7.4	7.9	5.6	5.3	12.0	15.5	14.5	1.8	76.2	81.2	604.9	10.1	103.4	5.4	115.3	1.6	147.1	218.0	0.4	215.4	1592.5	17.3	21.3	184.9	369.8	1.6	103.1	234.0	2.2	131.2	28.1	0.8	5.1	2.9	8.1	0.1	13.5	1.6	29.0	0.3	2.5	69.3	10.6	25.4	0.5	13.8	0.7	2.0	1.0	2.2	1.9	625.9	1.7	1.9	136.5	12.3	57.3	1.7	0.8	3.4	2.3	4.0	280.7	20.2	3.0	366.2	1.5	214.9	1201.3	0.7	0.2	4.2	63.1	35.5	13.4	9.8	23.8	1.3	28.6	1.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.6	11.5	10.5	18.8	10.7	12.8	8.0	8.2	7.8	7.4	12.0	10.1	7.0	0.0	2.6	1.3	1.8	65.0	131.2	485.4	104.2	1.8	224.2	96.8	0.7	1.5	266.7	16.5	2.1	53.9	4.9	0.9	0.0	12.6	2.2	18.0	51.9	10.3	0.0	0.0	3.1	5.2	6.2	168.4	1.1	29.3	0.0	0.5	6.4	0.2	10.0	0.0	1.8	0.9	40.7	0.0	55.4	1.0	19.9	3.9	62.2	0.0	0.0	1.0	0.0	1.5	0.3	18.1	0.2	37.6	0.2	194.9	0.1	0.3	28.2	0.6	0.0	4.3	40.0	2.0	6.1	714.0	190.7	18.1	7.6	4.8	1.7	506.4
CRACDL	"C2orf55, KIAA1211L, MGC42367"	ENSG00000196872	"CRACD like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;epididymis: 31.6"	"Cell type enriched"	"Detected in some"	9	"Adipocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"amygdala: 12.8;basal ganglia: 20.0;cerebral cortex: 30.8;hippocampal formation: 29.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.0;HDLM-2: 61.7;Karpas-707: 17.4;MCF7: 16.3;SiHa: 17.3;SK-BR-3: 22.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"amygdala: 19.1;basal ganglia: 45.5;cerebral cortex: 36.9;hippocampal formation: 54.9;olfactory bulb: 15.9"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"		Yes	No				"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Microtubules, Centrosome"	"Cytokinetic bridge"	"HPA051082: AB_2681337, HPA061678: AB_2684584"	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (2.22e-2)"	5.0	0.9	12.8	1.5	20.0	0.5	5.1	0.0	30.8	5.1	0.0	5.9	8.0	2.1	31.6	11.2	22.6	2.9	3.4	29.7	0.0	4.1	0.3	6.0	0.8	0.0	0.0	0.6	4.7	7.7	6.6	4.5	0.0	2.3	4.6	0.1	11.0	4.6	1.7	6.4	7.5	2.3	0.0	1.3	8.3	6.2	0.0	1.0	5.0	1.5	1.8	2.2	5.5	3.6	8.4	0.4	0.2	3.2	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.4	4.9	0.0	10.4	0.0	0.2	7.4	0.3	0.4	0.0	61.7	1.2	0.0	0.5	0.5	0.0	0.0	0.1	0.3	2.3	0.1	1.2	0.1	2.5	0.0	0.0	17.4	0.0	16.3	0.2	1.3	0.1	8.3	0.9	0.0	0.0	0.8	3.2	6.5	5.8	0.9	17.3	22.5	0.1	0.0	8.7	1.4	10.7	0.0	1.3	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	20.0	0.0	30.8	29.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
CRAMP1	"CRAMP1L, KIAA1426"	ENSG00000007545	"Cramped chromatin regulator homolog 1"	Q96RY5	16	1612337-1677908	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041752	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA041752: AB_10796459"	"unprognostic (3.67e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.78e-4)"	"unprognostic (4.17e-2)"	"unprognostic (8.53e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.86e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	8.0	7.5	7.4	5.6	6.2	13.5	9.0	15.0	6.9	11.1	5.9	10.9	8.1	10.3	6.2	9.0	10.7	5.4	8.3	6.6	4.6	9.4	6.3	9.9	7.6	5.4	5.2	12.5	8.8	5.7	12.4	6.9	5.3	12.0	5.4	9.9	8.4	6.4	7.9	11.0	9.5	6.7	3.2	11.0	9.0	22.9	5.5	10.7	12.7	4.8	6.0	9.6	9.5	7.1	8.5	15.5	15.6	14.5	9.8	9.7	20.3	14.4	7.5	11.5	8.2	11.2	14.0	12.0	12.3	9.9	7.1	15.3	18.7	10.0	10.3	12.7	22.6	14.2	16.0	6.9	7.1	19.0	20.6	8.5	12.6	14.5	12.1	11.2	12.4	17.9	19.6	7.1	6.3	12.4	14.8	10.6	14.9	4.9	8.7	51.2	8.4	16.1	8.2	7.5	16.6	14.0	15.8	11.3	8.3	10.9	9.9	24.3	15.2	11.9	12.8	11.4	13.9	15.0	23.3	24.3	3.7	13.0	10.8	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.3	0.0	0.1	7.4	6.2	15.0	6.9	6.6	4.6	5.4	5.2	5.3	3.2	5.5	7.1	10.4	16.0	17.0	0.0	2.7	0.0	5.2	0.0	12.0	8.6	9.3	8.0	0.0	4.3	8.6	9.2	18.8	4.7	12.8	6.1	1.9	5.5	28.0	11.1	14.5	6.8	2.4	4.6	0.0	2.0	3.0	5.4	5.1	15.3	5.1	11.0	6.8	4.3	5.6	3.3	0.0	6.6	0.0	8.2	0.0	9.6	4.4	4.3	0.0	0.0	6.6	6.2	4.1	0.0	0.0	7.1	4.7	6.8	4.7	9.9	6.0	1.6	2.9	17.9	6.6	7.1	5.2	17.3	18.4	9.4	0.0	5.3	5.2	5.6	5.5	5.9
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974361	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 106.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 49.9;Breast myoepithelial cells: 40.1;Intestinal goblet cells: 56.9;Prostatic glandular cells: 49.3"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 81.8;OE19: 82.7;SK-BR-3: 174.6;T-47d: 139.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Nuclear membrane"	Mitochondria	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	6.3	8.5	3.5	4.5	3.8	7.6	48.2	4.6	4.7	30.5	4.4	11.5	11.4	12.9	13.0	8.2	19.2	6.7	5.0	3.3	3.5	10.5	14.0	5.8	5.9	3.9	4.1	17.4	13.2	6.7	6.1	6.3	3.7	106.2	15.2	4.9	43.9	7.6	5.6	10.2	9.0	5.7	3.9	7.5	29.3	5.3	3.6	12.0	11.3	5.3	7.4	6.8	6.9	4.7	7.5	10.6	9.8	10.9	6.9	10.0	24.7	6.2	7.2	8.3	7.3	5.1	31.0	13.9	31.7	2.6	6.1	12.0	14.5	9.7	4.5	11.4	5.9	10.3	11.7	8.9	5.6	4.9	8.5	10.9	9.2	7.9	17.9	7.5	7.4	16.5	8.1	16.9	3.8	81.8	9.3	3.8	6.7	82.7	12.7	20.9	10.3	26.1	9.0	5.3	18.5	20.1	6.6	174.6	16.8	12.8	139.9	14.9	4.5	2.5	7.3	5.2	4.9	31.4	17.3	10.6	5.3	8.5	8.2	1.5	2.9	2.2	3.4	1.2	4.5	4.5	1.9	2.4	5.0	4.8	1.8	3.5	0.1	9.4	1.7	5.7	1.8	2.5	3.5	3.8	4.6	4.7	3.3	3.5	3.9	4.1	3.7	3.9	3.6	4.7	7.2	6.4	13.1	3.6	6.2	2.9	13.1	10.1	6.8	5.3	49.9	40.1	2.0	7.2	20.3	1.8	2.1	12.9	5.6	3.6	9.8	14.0	0.4	10.6	5.2	6.9	9.0	8.6	0.4	13.3	17.0	4.8	10.7	13.5	5.7	8.7	4.2	14.2	5.4	0.0	0.4	56.9	6.1	7.5	2.0	0.6	7.2	5.1	5.4	0.0	2.8	6.6	8.2	1.5	2.2	7.9	4.3	2.2	5.3	49.3	4.0	4.1	16.6	8.8	19.7	3.1	5.0	7.4	10.6	6.3	3.0	4.2	4.5	7.6	10.9	7.0
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880713	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	17.4	10.6	5.8	17.1	5.2	52.9	16.8	25.4	11.5	20.9	3.7	18.8	12.5	26.5	12.4	16.5	22.4	16.6	14.4	5.9	3.1	12.0	14.3	15.9	17.6	8.9	6.8	37.3	29.7	18.5	11.3	16.9	2.9	16.1	14.1	13.8	17.2	16.2	29.6	21.0	16.4	19.6	0.4	21.0	16.3	33.2	7.9	29.1	23.3	28.9	20.7	16.6	16.5	6.4	12.3	31.0	39.3	17.4	23.5	23.1	20.4	17.4	28.9	29.2	28.2	28.2	22.4	33.7	20.1	33.3	18.7	23.2	45.7	14.2	32.9	57.5	18.5	26.6	29.2	17.9	26.0	26.9	36.5	20.7	14.2	32.5	38.9	18.0	22.3	17.0	30.9	44.8	16.0	42.0	17.9	13.0	32.3	11.7	12.7	83.4	31.1	26.1	11.2	16.2	32.6	21.5	29.5	28.7	16.8	25.3	25.6	25.9	34.7	35.5	35.2	18.4	16.0	20.8	24.3	63.7	7.2	15.8	25.6	1.9	1.1	0.9	1.7	1.5	0.8	3.7	0.8	1.3	0.7	2.1	0.8	1.1	6.7	1.4	2.9	1.5	0.8	0.9	5.8	5.2	25.4	11.5	5.9	3.1	8.9	6.8	2.9	0.4	7.9	6.4	48.1	44.8	51.6	91.1	38.3	56.2	31.0	16.0	27.3	34.2	34.4	25.7	41.2	40.0	28.0	11.0	25.0	17.4	50.1	31.2	5.9	20.9	43.0	37.2	56.4	35.7	15.0	33.4	88.7	20.3	11.3	39.5	32.1	63.5	30.4	53.1	32.5	29.5	20.9	28.6	89.8	25.3	18.3	44.0	42.8	80.2	56.5	49.0	17.8	87.1	52.5	34.5	43.3	111.6	101.2	27.5	19.5	51.1	35.6	39.8	25.2	10.9	28.2	17.6	46.0	75.8	44.9	35.1	42.2	34.6	58.8	30.8	44.2	36.2	24.6	44.2
CREG1	CREG	ENSG00000143162	"Cellular repressor of E1A stimulated genes 1"	O75629	1	167529117-167553805	"Predicted secreted proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 545.7;Kupffer cells: 559.7;monocytes: 322.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 55.4;classical monocyte: 128.4;eosinophil: 75.7;intermediate monocyte: 75.7;myeloid DC: 89.9;neutrophil: 43.7;non-classical monocyte: 72.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 89.9;granulocytes: 75.7;monocytes: 128.4"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 1237.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056390			Approved	Vesicles,Microtubules	"Secreted to blood"	NA	NA		520000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Microtubules	Vesicles	"HPA056390: AB_2683113"	"unprognostic (3.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.54e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.99e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.16e-1)"	130.5	127.7	37.5	79.0	41.1	125.9	109.7	39.0	45.9	76.8	47.8	77.1	60.3	61.8	109.7	91.7	70.9	128.2	82.2	36.5	40.4	132.1	295.2	99.1	98.9	46.0	39.1	84.2	70.7	75.4	64.8	110.8	44.4	62.9	82.7	80.0	104.5	74.6	71.4	109.8	63.0	77.9	45.7	136.9	61.4	50.1	49.3	35.5	125.8	78.2	63.5	116.3	63.3	61.2	93.5	41.5	21.1	43.5	325.8	89.8	53.0	39.2	17.8	30.7	39.8	67.8	104.4	101.7	112.2	43.6	57.2	143.3	24.3	84.9	20.9	140.3	82.3	41.5	31.1	37.9	111.5	93.6	295.2	94.5	250.5	35.6	38.7	42.7	10.3	35.9	218.5	405.0	42.6	39.2	19.6	95.9	22.8	214.0	63.9	32.5	58.8	1237.2	54.7	64.9	14.0	25.7	98.1	132.8	112.8	70.1	175.5	252.7	19.1	8.0	39.6	126.2	25.9	79.4	168.4	67.7	131.6	96.0	16.3	55.4	128.4	75.7	5.1	75.7	8.0	4.3	7.5	6.5	89.9	2.1	16.6	8.8	43.7	11.0	72.3	6.2	3.9	57.6	37.5	41.1	39.0	45.9	36.5	40.4	46.0	39.1	44.4	45.7	49.3	61.2	44.7	35.3	90.1	5.9	15.3	44.1	49.1	23.1	56.9	17.9	61.7	63.8	55.7	65.8	32.2	55.2	89.6	91.5	18.3	15.6	23.5	36.0	27.6	33.9	19.3	34.2	29.3	124.8	24.7	39.7	41.7	78.4	21.9	64.1	29.9	62.0	48.2	90.3	545.7	15.2	22.1	44.5	14.2	559.7	57.6	27.4	43.5	213.8	24.9	26.2	322.8	30.5	6.2	10.1	14.6	21.0	31.5	28.6	27.8	34.0	46.3	60.6	18.5	31.5	13.1	43.2	40.8	65.5	42.0	86.3	51.1	126.7	17.3	38.9	50.4	44.0
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819985-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 137.3;Fibroblasts: 185.5;Leydig cells: 271.5;Peritubular cells: 265.9;Skeletal myocytes: 146.2;Smooth muscle cells: 341.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 87.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 87.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.7;BEWO: 69.2;HHSteC: 161.4;HSkMC: 68.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 15.6"	"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	No	219000000000		"Cluster 1: Neutrophils - Mixed function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA030054: AB_2732452, HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	113.4	29.0	3.3	46.6	4.9	8.1	64.2	3.9	4.6	112.9	2.6	88.9	10.8	115.7	20.3	39.9	129.0	104.0	36.6	3.7	5.2	40.9	17.1	92.7	7.3	5.9	5.5	80.7	23.5	2.5	19.3	122.7	5.9	98.9	18.1	2.4	18.1	27.7	15.0	36.7	58.5	95.0	4.4	24.9	65.9	21.5	4.3	8.2	47.9	12.2	3.7	119.9	69.8	5.7	0.9	2.2	0.6	6.0	43.7	16.2	69.2	34.5	30.4	27.2	19.1	4.7	2.9	0.1	3.0	30.5	8.0	1.0	0.1	0.1	27.3	0.0	0.2	0.5	0.9	0.1	161.4	0.0	0.3	68.0	0.1	8.0	0.1	9.0	0.2	0.0	0.3	0.3	3.1	1.4	0.3	1.7	2.0	4.6	2.0	0.1	0.3	0.4	0.2	5.5	6.7	0.5	8.1	3.5	0.7	9.4	13.7	0.9	3.8	0.4	1.8	28.3	1.0	0.4	0.1	5.8	0.2	0.5	4.1	14.8	20.2	0.7	0.0	1.2	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.0	87.2	0.0	0.0	0.1	0.0	4.2	3.3	4.9	3.9	4.6	3.7	5.2	5.9	5.5	5.9	4.4	4.3	5.7	5.9	3.2	2.3	0.7	0.7	46.1	8.6	0.6	9.6	0.5	3.9	7.6	8.6	2.8	1.6	0.0	0.0	7.4	0.8	1.8	0.0	1.4	12.6	7.0	137.3	21.7	3.0	0.0	2.2	0.5	42.4	185.5	27.0	6.3	7.0	11.5	38.6	0.8	4.7	1.7	1.5	4.1	0.0	36.6	39.6	19.6	271.5	14.8	48.0	9.4	41.5	5.1	3.1	54.3	0.6	0.9	0.3	265.9	0.9	17.1	0.2	0.1	0.9	0.7	92.1	146.2	341.2	1.0	1.9	3.7	42.8	9.0	5.4	5.7	2.2	6.5
CRTC2	TORC2	ENSG00000160741	"CREB regulated transcription coactivator 2"	Q53ET0	1	153947669-153958615	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028454, HPA028465"	Supported		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028454: AB_10599617, HPA028465: AB_10601991"	"unprognostic (4.91e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (4.32e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (7.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.12e-5)"	32.9	28.6	26.1	20.5	28.1	27.9	29.6	26.6	30.2	33.7	24.3	28.5	11.1	27.2	15.7	25.7	29.2	13.7	26.0	25.2	26.6	31.1	35.1	38.8	28.8	29.2	28.0	40.5	26.3	21.0	24.9	15.8	26.9	29.0	12.6	10.0	27.0	16.7	36.6	34.8	34.7	17.2	25.5	55.9	27.9	21.4	28.2	23.6	32.3	18.5	25.3	28.5	29.2	28.7	24.2	17.9	17.1	19.6	27.2	19.8	25.2	12.8	27.2	24.9	20.3	18.5	24.0	22.8	20.4	23.2	16.8	27.0	20.5	26.8	13.9	29.5	25.7	11.2	18.8	14.4	27.4	19.0	18.7	26.1	25.5	27.6	22.3	19.7	23.3	12.8	19.2	27.1	18.0	38.4	20.6	29.9	12.8	26.1	19.5	15.5	11.7	19.6	26.3	19.4	14.2	23.2	21.5	43.3	32.7	16.5	20.9	37.3	17.7	20.0	17.9	21.7	22.9	43.6	30.7	15.7	18.4	15.9	15.1	3.2	2.2	5.0	2.3	3.5	2.0	2.5	2.5	2.6	1.9	3.2	1.6	2.0	5.7	2.9	2.7	2.6	1.9	1.0	26.1	28.1	26.6	30.2	25.2	26.6	29.2	28.0	26.9	25.5	28.2	28.7	17.8	6.4	10.0	10.4	22.3	24.6	6.9	11.1	13.6	6.3	14.6	12.8	6.0	11.5	8.7	12.9	4.2	9.7	23.0	15.9	1.9	9.0	1.4	13.4	15.0	13.7	16.1	9.7	7.4	10.2	9.4	11.1	14.3	27.7	8.2	6.1	12.5	12.8	10.9	1.7	6.9	13.8	6.1	14.6	23.6	1.2	12.2	17.4	3.6	6.5	11.8	4.8	19.6	6.0	11.1	15.0	5.0	15.1	20.6	12.6	9.8	4.0	7.3	6.9	6.6	9.3	12.1	17.0	12.0	12.7	22.6	12.2	19.6	6.1	7.9	13.0
CRTC3	FLJ21868	ENSG00000140577	"CREB regulated transcription coactivator 3"	Q6UUV7	15	90529923-90645345	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043735, HPA063691"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA043735: AB_10794286, HPA063691: AB_2685092"	"unprognostic (7.60e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.30e-1)"	27.0	15.5	16.8	14.2	25.3	10.7	21.7	20.0	19.8	26.3	10.1	28.4	7.3	26.0	10.9	12.5	23.8	14.8	19.8	17.0	16.4	14.5	13.2	23.2	15.8	21.8	23.1	36.8	10.7	13.8	9.9	17.1	21.1	18.8	9.4	13.5	17.4	17.0	19.9	19.1	16.6	20.9	16.3	13.3	15.2	16.8	23.2	15.0	22.3	17.4	15.7	28.4	18.3	31.6	9.6	15.1	9.7	16.7	21.6	15.7	46.0	11.7	16.0	17.6	15.9	12.4	9.3	0.2	8.3	23.8	14.9	15.2	15.1	9.8	13.2	16.3	18.8	23.7	83.9	6.1	24.8	6.5	38.8	17.2	16.3	14.5	19.3	13.2	12.5	10.2	12.8	5.5	13.6	11.5	2.6	9.7	3.7	2.7	7.2	8.3	16.3	0.5	6.6	20.3	18.5	16.5	34.7	11.6	19.3	10.8	11.2	12.2	16.4	19.7	14.9	19.0	14.0	7.3	10.2	7.2	8.0	12.6	9.8	21.4	2.6	1.5	3.5	0.8	3.8	2.9	4.3	3.7	1.6	5.0	6.1	3.9	0.5	3.3	0.3	2.1	4.4	3.4	16.8	25.3	20.0	19.8	17.0	16.4	21.8	23.1	21.1	16.3	23.2	31.6	17.9	6.4	9.2	44.1	35.6	23.6	27.8	8.0	13.1	24.9	15.7	12.7	17.0	14.3	7.8	12.9	27.1	14.8	30.0	8.6	1.9	14.9	29.3	6.6	18.5	20.4	15.6	17.1	70.1	10.7	43.3	23.2	14.8	12.7	23.5	34.8	24.7	16.2	15.3	57.2	72.4	9.1	6.1	18.2	18.8	24.3	26.8	21.7	17.8	39.4	20.6	17.7	58.7	75.4	160.8	11.1	10.9	43.6	21.3	26.2	6.4	11.0	2.8	59.7	46.0	30.5	45.8	10.2	17.8	11.4	24.0	17.8	36.0	13.7	11.3	38.2
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908564-111923722	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Eye lens protein"	"Cancer-related genes, Cardiomyopathy, Cataract, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5623.2;heart muscle: 10683.1;skeletal muscle: 6972.0;tongue: 9406.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 2889.5;Cardiomyocytes: 6878.2;Muller glia cells: 1664.3;Proximal tubular cells: 7285.9"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"ASC diff: 2663.1;fHDF/TERT166: 775.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000		"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337"	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.70e-5)"	1035.0	106.6	2466.0	113.9	3113.8	0.4	592.2	3032.2	5623.2	439.1	2077.7	678.9	24.6	351.4	179.1	312.2	204.0	71.7	10683.1	2424.9	2666.2	2123.2	37.2	253.4	15.0	3215.2	2856.7	136.0	50.6	24.9	209.2	107.8	3147.1	317.9	78.2	478.7	428.7	358.5	6972.0	317.3	158.5	338.1	2877.3	88.5	263.8	23.5	2815.5	20.9	477.7	9406.7	34.4	490.0	477.5	4060.6	0.1	0.5	0.1	45.0	2663.1	90.9	15.0	54.5	2.5	0.8	2.5	1.7	0.2	0.0	41.7	775.8	0.2	2.0	1.8	2.3	1.4	0.3	0.0	0.0	11.9	3.9	16.9	0.4	0.7	77.1	11.1	0.6	6.2	44.3	0.2	0.0	4.6	2.5	169.5	0.1	0.1	1.1	0.5	0.0	1.0	0.2	0.0	0.6	29.8	0.8	0.1	0.4	5.3	9.1	39.8	63.5	4.9	0.0	1.7	310.1	105.0	6.5	4.1	0.5	0.1	0.6	7.1	0.4	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2466.0	3113.8	3032.2	5623.2	2424.9	2666.2	3215.2	2856.7	3147.1	2877.3	2815.5	4060.6	38.4	83.3	4.1	96.0	51.3	174.9	2889.5	32.1	72.8	16.2	334.4	696.1	6878.2	84.4	15.2	1338.9	18.8	3.9	6.8	0.4	677.0	320.3	24.7	345.4	265.3	88.4	7.1	0.0	6.7	11.5	7.4	880.6	0.0	1008.4	0.0	16.1	35.7	0.7	5.8	10.1	12.6	2.4	8.2	0.3	85.8	12.6	228.6	67.7	483.8	11.2	3.6	1664.3	0.0	7.5	615.7	12.1	0.0	187.7	1.6	855.4	0.0	7285.9	23.2	59.4	138.1	799.9	1053.3	21.6	1.4	56.5	155.1	33.4	55.4	6.7	1.2	249.0
CRYBB3	CRYB3	ENSG00000100053	"Crystallin beta B3"	P26998	22	25199858-25207359	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 2.6;Distal tubular cells: 1.9;granulocytes: 4.5;Muller glia cells: 4.3;Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.4;HEK 293: 1.4;HeLa: 1.8;hTERT-HME1: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA055840	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA055840: AB_2682939"	"unprognostic (1.36e-2)"	"unprognostic (6.27e-4)"	"unprognostic (6.30e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-3)"	0.2	0.5	0.9	0.1	0.6	0.0	0.7	0.0	1.0	0.5	0.0	0.6	0.3	0.3	0.2	0.6	0.4	0.4	0.5	0.9	0.0	2.0	2.0	0.3	0.1	0.0	0.1	0.1	0.3	0.0	0.3	0.1	0.0	0.8	0.4	0.7	1.0	0.4	0.7	0.9	0.7	0.1	0.0	0.1	0.5	0.2	0.5	0.2	1.3	0.1	0.3	0.1	0.4	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.2	1.4	0.8	0.6	0.0	0.0	1.4	0.0	1.8	1.0	0.0	0.0	0.0	0.0	0.7	0.4	1.2	0.2	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.5	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	1.0	0.9	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.6	0.3	0.4	1.5	0.1	0.0	0.0	0.0	0.0	2.6	1.9	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.3	10.5	0.4	0.3	0.0	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.1	0.0	0.3	0.1
CRYBG3	DKFZp667G2110	ENSG00000080200	"Crystallin beta-gamma domain containing 3"	Q68DQ2	3	97822011-97944984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 122.6;Bipolar cells: 123.6;Early spermatids: 121.4;Late spermatids: 131.8;Oligodendrocytes: 128.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.6;granulocytes: 1.5;monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075635			Approved	"Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA075635: "	"unprognostic (1.88e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.10e-2)"	"unprognostic (3.41e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.86e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (1.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.38e-3)"	10.6	2.8	5.3	5.5	12.6	0.8	7.7	9.2	8.0	8.0	3.4	7.0	3.6	6.6	2.7	8.9	5.6	5.3	6.5	5.3	10.6	4.9	3.2	5.7	3.4	15.5	10.0	3.5	5.4	3.7	1.2	10.7	16.0	5.0	7.6	7.8	6.3	4.1	7.5	12.9	4.5	6.4	11.3	4.0	5.3	14.0	10.0	2.8	26.6	9.9	4.5	7.5	4.6	17.2	16.5	6.1	3.5	4.2	11.1	11.8	6.2	5.8	5.3	4.2	6.3	0.4	5.4	0.1	1.9	10.1	6.2	10.5	7.0	4.9	8.0	20.4	3.8	4.1	2.7	2.1	5.8	6.1	1.0	7.7	4.9	5.3	5.8	6.9	8.2	1.3	0.3	3.0	7.4	0.2	2.2	0.7	3.0	4.5	5.5	0.0	12.3	2.1	6.1	10.9	39.2	3.0	12.2	4.8	3.9	2.2	4.2	6.8	10.9	8.9	6.9	5.2	7.1	5.0	0.1	3.7	9.3	3.5	5.8	1.5	1.4	0.0	0.1	0.9	0.2	0.1	0.2	0.2	1.4	0.2	0.1	0.1	0.0	0.0	1.0	3.6	0.0	0.3	5.3	12.6	9.2	8.0	5.3	10.6	15.5	10.0	16.0	11.3	10.0	17.2	122.6	32.1	19.6	48.0	4.2	5.1	7.0	3.7	23.9	123.6	13.7	9.3	37.6	1.5	16.9	18.4	6.2	4.0	13.8	6.0	1.9	8.8	121.4	32.6	48.9	52.1	12.7	2.5	37.5	13.1	11.3	38.0	18.3	22.7	0.0	68.0	15.0	5.1	6.6	13.5	23.0	8.3	2.0	17.4	3.0	131.8	8.4	18.9	8.8	37.5	22.1	29.4	1.0	10.6	128.3	13.2	8.7	4.5	12.0	7.1	2.5	2.8	21.3	9.6	39.5	29.2	18.2	49.6	9.5	24.5	6.1	2.3	3.0	14.0	5.2	7.0
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 331.0;liver: 282.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 160.0;Distal tubular cells: 226.9;Hepatocytes: 200.6;Proximal tubular cells: 526.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 439.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021921, HPA023290"	Approved		Supported	Cytosol		NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	19.8	34.2	19.2	12.9	19.8	2.2	39.0	19.3	36.0	54.6	54.2	21.4	51.2	40.8	120.6	29.0	50.0	68.9	45.6	21.6	23.3	331.0	282.9	32.4	24.4	21.3	24.9	31.6	64.6	52.9	17.0	16.8	24.4	38.8	22.0	15.3	25.0	56.9	25.1	22.2	44.0	40.1	21.1	19.4	25.1	9.2	24.5	33.9	44.5	23.0	23.8	40.8	21.7	24.9	12.1	112.2	57.6	16.3	64.4	70.2	38.6	36.5	57.1	51.8	57.4	88.9	46.1	64.9	62.0	71.3	92.2	31.0	47.2	46.0	83.6	75.2	19.2	27.0	32.2	179.0	33.8	23.1	52.6	33.1	40.0	82.8	15.1	49.1	43.7	35.9	85.9	22.8	109.2	27.0	42.3	38.6	43.1	93.6	72.6	26.8	53.6	23.7	439.4	36.0	15.9	27.9	8.5	60.1	41.2	64.3	54.0	7.7	21.9	12.3	30.7	38.8	55.7	16.2	33.3	32.1	99.4	9.0	35.6	13.1	9.4	1.9	32.1	15.1	26.2	32.8	31.6	30.3	17.1	26.5	27.4	29.5	1.5	30.3	17.9	14.4	42.3	18.8	19.2	19.8	19.3	36.0	21.6	23.3	21.3	24.9	24.4	21.1	24.5	24.9	6.9	28.9	22.6	4.9	20.4	17.8	28.0	32.4	24.5	4.0	16.8	16.8	32.3	84.4	15.7	160.0	2.1	13.5	8.6	6.6	226.9	53.8	0.2	54.8	7.8	8.0	6.7	8.4	4.5	32.4	18.1	20.7	20.9	27.0	14.5	7.8	12.8	200.6	18.5	0.0	4.4	12.0	8.2	15.7	13.7	2.1	20.8	11.4	10.6	4.7	7.1	7.7	11.3	7.1	9.1	31.2	14.5	20.7	20.5	10.2	79.1	526.6	17.3	2.9	0.0	10.6	16.2	1.7	7.4	19.7	21.2	7.3	16.9	13.8	16.2	17.0
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 164.0;Spermatogonia: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol		No	Yes		320000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavorable (6.91e-4)"	23.6	24.5	16.0	29.0	20.2	26.4	34.2	26.6	21.1	25.7	12.9	23.6	19.8	28.1	23.8	38.2	27.0	19.0	24.7	17.1	18.0	29.8	30.9	19.7	35.0	21.0	17.3	27.2	20.4	30.8	13.6	37.5	22.8	25.8	28.7	23.2	21.7	25.6	39.8	34.4	19.2	35.0	21.1	20.3	20.7	87.7	17.0	40.7	23.4	41.5	42.8	27.5	22.2	29.1	224.3	152.4	182.1	140.9	69.0	88.5	196.7	172.1	90.5	528.1	222.0	501.8	175.4	227.3	224.1	109.7	213.9	251.4	270.7	322.9	500.0	37.4	131.3	158.0	166.1	244.7	42.0	176.2	83.3	50.0	118.7	259.0	148.7	72.4	177.5	124.3	227.2	87.1	201.1	76.8	213.9	90.6	153.5	185.1	224.0	133.9	299.5	176.4	116.5	153.2	159.6	92.6	275.2	293.3	97.1	137.7	245.3	113.3	115.5	279.3	233.9	166.4	247.9	50.5	130.8	210.8	166.8	139.5	152.2	18.6	16.3	3.8	13.8	20.6	21.1	16.7	21.0	17.1	20.1	13.6	22.1	19.3	4.4	23.0	23.6	8.9	20.1	18.3	16.0	20.2	26.6	21.1	17.1	18.0	21.0	17.3	22.8	21.1	17.0	29.1	16.4	6.4	26.8	8.1	20.3	30.2	25.8	29.5	31.3	14.9	17.4	15.9	26.6	24.3	22.4	27.6	10.4	71.8	15.7	7.4	13.7	32.2	95.9	14.7	19.4	22.9	5.4	40.4	20.9	26.6	61.2	24.6	13.7	17.8	4.5	35.1	19.2	26.7	29.7	15.2	24.4	11.8	20.3	17.9	21.9	57.8	25.4	17.9	26.6	9.4	28.0	22.6	7.2	17.1	41.7	26.7	10.0	31.6	26.7	28.8	9.9	21.6	21.7	15.5	39.5	19.3	22.1	164.0	121.5	36.7	34.5	72.7	17.5	31.1	23.7	22.2
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 58.9;granulocytes: 113.5;Hepatic stellate cells: 53.2;Sertoli cells: 59.2;Skeletal myocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 13.2;eosinophil: 22.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 22.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 220.0;BJ hTERT+: 149.5;GAMG: 142.1;HHSteC: 338.7;HSkMC: 216.4;hTERT-RPE1: 153.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	NA	NA	270000	22000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear bodies"	"HPA076624: AB_2686810"	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	67.4	37.5	27.5	24.5	32.9	18.4	46.4	36.9	25.8	25.0	32.9	26.8	13.3	21.1	5.2	15.6	28.5	31.9	29.0	24.5	30.9	17.3	16.4	47.6	28.2	42.3	32.6	22.1	17.5	10.5	8.7	41.2	36.1	21.4	16.2	1.5	18.9	16.6	11.4	19.4	26.7	17.6	36.0	48.0	22.0	3.7	32.2	13.5	22.2	11.3	12.2	42.0	29.6	46.5	9.3	29.3	14.7	5.7	220.0	138.3	5.7	36.0	149.5	25.9	23.9	1.3	4.5	0.2	47.0	80.1	142.1	6.8	5.7	11.0	9.4	99.5	5.3	10.9	17.3	10.3	338.7	0.0	13.7	216.4	3.2	57.5	33.0	153.1	5.4	2.8	2.9	5.5	31.2	0.5	0.3	1.8	5.3	2.4	3.1	1.0	8.4	0.9	10.9	7.9	0.5	1.6	9.7	2.6	12.6	16.7	2.3	1.0	19.2	27.8	10.5	123.7	22.1	2.8	1.1	0.3	70.7	0.1	106.6	13.2	0.0	22.3	0.3	0.0	0.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.2	27.5	32.9	36.9	25.8	24.5	30.9	42.3	32.6	36.1	36.0	32.2	46.5	30.6	9.6	35.5	11.8	2.3	7.4	5.1	7.9	13.1	0.3	10.0	9.3	3.2	14.3	5.3	3.7	0.0	0.8	2.0	0.6	0.0	40.4	0.4	20.6	9.3	21.6	7.8	11.1	0.3	2.3	0.5	58.9	4.6	24.8	113.5	0.3	53.2	3.0	9.2	0.0	1.0	0.8	0.0	3.5	13.1	0.3	25.1	8.2	10.6	28.1	1.6	1.8	0.0	3.0	17.5	9.3	1.6	8.6	1.9	8.0	1.2	0.9	1.1	0.2	59.2	94.4	37.1	0.6	0.7	5.6	5.5	0.8	20.9	0.7	1.0	2.6
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073789-132076170	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lung: 2.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 11.4;Basal respiratory cells: 11.3;dendritic cells: 17.7;Ductal cells: 18.3;Pancreatic endocrine cells: 24.9;T-cells: 28.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"NK-cell: 6.2"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 6.2"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 91.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"	NA	NA	23900		"Cluster 15: NK-cells - Transcription"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA057404: AB_2683428, HPA062006: AB_2684654"	"unprognostic (7.29e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.09e-2)"		"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.68e-3)"		"unprognostic (1.87e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-2)"	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	2.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	9.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	91.3	0.1	5.1	0.0	7.4	0.0	1.5	0.0	5.3	0.2	0.0	6.8	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	20.8	13.8	2.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.3	3.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	11.4	0.0	0.3	1.5	0.1	11.3	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	17.7	0.1	0.0	18.3	0.0	0.3	0.2	4.8	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.7	1.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.6	0.0	28.6	0.0	0.0	1.1
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 130.9;dendritic cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	21.4	19.9	23.4	89.1	26.2	50.6	19.4	26.5	26.7	26.8	18.2	33.6	36.7	22.4	8.0	98.5	20.0	22.9	29.3	22.5	23.9	21.3	48.8	32.0	169.3	31.0	29.8	19.0	17.2	15.8	21.1	17.6	31.6	24.8	19.5	6.9	31.6	14.1	14.8	36.7	59.9	18.7	29.1	127.9	30.0	19.2	28.2	68.5	19.5	15.8	106.3	33.0	32.8	28.4	62.2	85.6	41.2	68.1	38.5	29.2	35.3	40.7	38.8	75.7	53.6	78.9	56.0	275.7	52.6	37.0	70.2	62.9	87.2	82.1	21.2	134.7	107.8	233.8	29.5	80.2	53.3	123.6	285.1	41.7	39.6	54.0	48.1	37.9	58.1	127.5	68.7	93.1	45.7	104.6	89.7	72.7	51.2	55.7	60.6	98.0	35.4	201.9	34.9	135.6	68.1	47.2	52.8	109.5	72.3	26.2	75.5	179.5	50.7	91.1	47.8	72.5	71.7	49.6	108.7	283.8	47.1	232.5	63.1	88.7	68.0	176.1	74.3	146.8	63.4	95.6	63.6	73.9	76.6	113.6	48.3	57.0	130.8	58.6	169.8	44.3	106.2	79.5	23.4	26.2	26.5	26.7	22.5	23.9	31.0	29.8	31.6	29.1	28.2	28.4	21.3	3.2	9.2	8.5	130.9	9.3	8.2	7.6	13.1	16.6	16.7	17.1	11.5	12.8	9.3	9.2	6.2	7.5	99.1	40.6	1.9	9.3	15.8	10.0	15.1	15.3	9.5	29.2	5.3	14.0	13.7	11.3	27.0	15.3	26.6	19.0	12.5	34.3	50.7	28.6	10.0	23.2	6.1	91.2	44.9	3.3	9.0	85.1	8.8	23.4	86.9	6.4	90.6	3.5	4.7	21.2	18.4	8.2	56.7	13.9	27.5	8.0	9.3	5.1	6.6	6.9	18.1	5.7	12.5	49.4	9.1	5.6	90.3	21.5	27.5	14.9
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492982-149551471	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 847.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB016680: AB_1614518, HPA051334: AB_2681446"	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	77.0	67.6	49.0	67.3	53.9	210.8	97.8	60.0	52.7	67.9	61.5	83.2	56.6	73.7	60.2	142.4	56.6	79.7	87.6	48.6	55.9	50.3	68.2	69.6	60.0	61.3	56.4	53.2	55.0	99.4	48.8	71.7	56.6	88.3	68.2	57.6	71.3	69.2	104.1	121.4	63.1	82.9	57.9	60.7	73.5	45.6	57.8	81.0	76.9	59.5	81.8	94.8	82.3	66.3	154.4	106.4	151.0	144.1	143.6	191.4	185.0	189.7	176.8	146.0	153.5	194.1	187.0	71.6	221.3	183.3	140.7	153.9	101.2	292.5	184.1	124.6	78.0	96.9	96.6	87.8	143.1	163.9	148.4	158.5	313.4	148.1	269.0	163.9	184.7	137.2	102.2	116.0	140.7	104.4	152.2	66.6	71.4	167.6	247.3	129.0	96.1	98.9	112.3	248.3	123.5	110.5	151.1	193.3	200.8	135.6	194.1	134.4	164.6	168.6	83.6	118.2	197.1	117.0	149.2	100.6	169.2	95.6	216.9	106.0	72.6	66.6	47.5	68.9	51.6	50.2	58.1	49.7	80.0	39.9	61.4	55.2	61.1	63.7	67.8	47.4	76.7	94.7	49.0	53.9	60.0	52.7	48.6	55.9	61.3	56.4	56.6	57.9	57.8	66.3	169.7	147.4	176.7	137.1	101.8	684.5	583.1	270.0	187.8	135.8	257.0	158.4	63.5	90.1	298.1	115.8	64.6	171.2	135.6	126.8	92.0	167.1	95.7	195.8	193.5	191.1	129.9	146.7	108.4	184.1	223.7	159.8	124.4	285.2	117.6	114.0	216.4	108.9	136.1	151.4	115.4	141.9	154.6	167.8	311.5	87.5	104.1	183.8	152.9	119.0	156.6	156.9	108.1	168.4	198.1	197.2	113.9	111.7	105.4	368.6	120.4	102.8	276.7	109.6	157.8	190.2	216.1	181.9	88.9	272.4	847.7	350.9	133.5	177.0	115.7	485.2
CSNK1A1L	MGC33182	ENSG00000180138	"Casein kinase 1 alpha 1 like"	Q8N752	13	37103259-37105664	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 30.0;Late spermatids: 23.0;Spermatocytes: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	33	"neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 7.6"	"Not detected"	"Not detected"											HPA051334			Uncertain	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA051334: AB_2681446"	"unprognostic (1.23e-2)"		"unprognostic (1.59e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.40e-2)"		"unprognostic (5.40e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.38e-1)"		0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	7.6	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	1.8	3.5	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	30.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	23.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.6	2.2	16.1	1.2	0.0	2.7	0.3	0.0	0.0	0.1	1.7
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 312.5;Late spermatids: 775.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	46.7	57.0	36.9	28.9	36.9	25.9	42.3	34.4	37.9	45.3	30.3	57.1	35.1	56.6	26.7	50.8	45.3	24.8	42.4	39.0	40.2	45.5	40.9	45.3	30.8	37.2	37.6	43.1	47.5	43.1	54.2	30.2	36.3	51.8	20.0	15.1	48.6	36.8	88.9	36.4	50.9	29.0	36.3	56.3	49.3	60.7	42.6	34.0	44.7	38.7	22.8	49.0	37.0	32.9	60.3	70.9	39.5	54.7	50.8	53.9	77.7	85.1	54.4	61.0	56.8	58.6	49.4	55.0	66.3	62.5	64.8	57.1	37.4	88.3	48.9	47.0	90.5	68.5	53.4	63.7	146.9	56.9	50.4	81.9	61.5	41.6	61.3	76.0	90.0	39.5	78.5	28.4	58.5	70.6	73.7	59.3	42.2	71.3	108.6	62.6	48.7	49.7	64.8	93.4	48.5	87.4	100.4	85.5	97.7	54.3	61.5	73.0	95.6	86.9	77.3	76.2	67.0	61.0	32.1	58.4	69.5	48.1	64.7	8.8	20.8	27.4	12.3	21.3	11.8	11.1	9.6	12.1	20.1	9.0	8.1	8.7	50.4	15.3	20.3	9.6	9.2	15.4	36.9	36.9	34.4	37.9	39.0	40.2	37.2	37.6	36.3	36.3	42.6	32.9	65.8	48.1	54.3	36.6	81.1	56.6	116.0	58.3	52.9	46.5	59.8	51.2	19.7	31.5	65.7	42.3	27.1	61.8	101.0	105.2	33.2	71.6	312.5	69.6	54.0	54.2	46.2	32.4	24.4	69.6	95.2	42.8	87.1	93.2	60.1	45.3	42.5	33.6	65.3	95.9	21.2	62.8	67.1	51.5	83.8	775.6	30.1	75.7	28.4	24.4	65.8	28.7	79.3	24.6	21.2	87.7	83.2	40.3	80.9	90.8	94.3	43.8	66.6	54.4	39.5	78.6	57.5	55.1	29.6	44.2	48.3	126.6	87.6	46.7	56.7	118.6
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 280.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (2.32e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.95e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (2.08e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.16e-3)"	"prognostic unfavorable (4.67e-6)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.25e-3)"	87.1	52.8	81.1	41.2	82.6	51.6	88.3	80.8	95.1	93.6	66.0	73.0	41.4	82.7	52.5	69.0	83.3	48.7	80.9	82.9	73.7	70.2	37.4	92.2	40.3	78.9	78.6	109.5	64.9	74.1	85.1	71.2	79.5	80.3	35.5	47.3	71.6	44.9	60.5	94.8	50.9	45.3	70.2	63.6	58.0	29.5	83.2	33.3	64.4	47.2	37.8	65.7	88.4	93.9	101.5	57.4	121.6	114.7	61.5	88.3	92.1	126.9	168.6	116.7	114.3	63.9	76.7	74.2	53.0	120.7	70.7	77.9	96.1	177.9	79.2	123.0	215.2	23.9	181.2	47.4	123.7	48.3	61.9	90.2	143.8	171.7	220.3	141.0	121.1	60.6	50.9	155.0	110.8	68.4	71.1	60.9	87.2	67.3	69.1	130.8	90.1	123.4	99.0	92.4	181.6	69.3	102.9	109.3	124.7	68.0	59.5	73.0	134.3	94.0	111.3	58.7	102.1	61.2	105.2	104.5	151.0	56.9	176.3	4.8	1.6	3.6	3.0	0.8	3.8	2.1	3.4	3.0	1.8	3.1	1.9	2.5	3.8	5.7	0.5	15.9	1.6	1.2	81.1	82.6	80.8	95.1	82.9	73.7	78.9	78.6	79.5	70.2	83.2	93.9	73.4	38.5	21.7	0.0	32.3	78.6	158.8	89.1	68.9	132.6	53.7	42.4	49.8	34.3	73.9	23.9	60.5	35.2	42.3	28.4	7.9	30.8	46.0	94.3	72.5	76.4	62.8	12.6	0.0	41.8	49.2	60.8	39.8	126.5	3.8	46.6	45.0	21.3	23.1	72.3	0.0	46.0	46.8	17.6	54.1	69.1	85.4	21.8	60.5	0.0	13.3	117.9	28.8	0.0	0.0	57.5	33.1	66.2	83.5	160.5	9.0	6.5	62.8	60.7	72.3	85.7	98.0	8.0	20.0	50.3	104.7	125.5	26.0	34.9	37.6	280.8
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	36.1	32.6	20.9	38.6	23.2	34.0	35.9	28.2	29.6	36.5	29.3	48.3	39.1	35.8	26.6	50.0	39.9	31.3	54.0	25.7	21.0	41.0	31.8	31.6	41.2	20.6	21.1	41.5	46.9	59.1	21.2	42.4	21.1	35.8	40.7	32.9	41.1	37.7	110.5	34.2	40.5	39.1	18.8	30.2	49.5	65.2	22.3	51.6	39.6	86.4	46.6	47.4	28.5	27.3	209.5	170.4	152.9	96.0	61.1	103.8	103.5	117.9	116.1	125.8	139.5	178.5	120.0	179.1	74.2	90.1	179.1	147.8	162.1	167.4	187.2	62.6	57.7	247.3	44.7	177.7	102.5	228.1	51.3	99.5	173.3	105.8	316.0	122.2	139.5	146.4	248.9	112.6	123.8	64.2	262.0	73.7	227.4	173.4	97.6	149.8	140.5	140.9	112.9	128.5	163.9	132.3	97.2	184.0	174.8	120.7	120.4	83.9	142.7	136.0	118.4	90.0	178.5	120.6	311.8	174.1	65.8	119.5	138.6	40.5	23.8	28.7	18.2	32.3	22.4	23.0	18.0	17.6	31.5	22.5	17.9	17.4	14.9	25.1	33.5	25.7	20.4	20.8	20.9	23.2	28.2	29.6	25.7	21.0	20.6	21.1	21.1	18.8	22.3	27.3	50.7	64.1	84.6	51.9	46.1	41.0	40.0	43.8	45.5	49.4	42.1	36.1	59.4	41.5	75.8	44.1	31.3	42.2	50.5	43.5	41.1	68.5	135.5	67.6	77.0	44.5	35.2	59.3	65.6	50.6	54.4	46.3	40.2	75.7	63.8	108.6	27.1	31.1	33.2	60.6	69.3	41.8	46.8	39.2	30.3	140.0	41.0	45.3	14.2	51.5	61.7	38.6	37.0	73.9	73.6	66.6	34.4	36.9	49.6	57.2	43.2	68.8	65.5	27.8	52.6	43.6	56.8	94.2	68.7	52.3	50.2	61.4	38.9	81.2	40.6	59.4
CSPG4	"CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2"	ENSG00000173546	"Chondroitin sulfate proteoglycan 4"	Q6UVK1	15	75674322-75712848	"Predicted membrane proteins"	"Angiogenesis, Differentiation, Tissue remodeling"	"Developmental protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.4"	"Group enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 57.3;Sertoli cells: 118.3;Smooth muscle cells: 47.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.7;SK-MEL-30: 146.1;U-138 MG: 92.1;WM-115: 138.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		48000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoplasm	"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991"	"unprognostic (5.21e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (7.60e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (4.93e-5)"	29.6	1.8	9.0	7.3	7.1	0.0	18.5	6.6	9.3	16.0	1.8	55.4	2.8	34.5	1.4	8.3	15.0	5.6	14.6	7.5	8.2	4.9	0.9	19.4	0.4	11.7	7.8	8.9	2.1	1.2	2.2	15.5	9.7	14.4	2.2	0.1	4.7	11.2	39.6	7.8	15.3	22.7	6.7	5.6	19.1	1.3	7.7	0.6	5.6	10.0	0.3	30.3	12.6	9.8	11.9	0.1	1.0	7.1	1.6	9.8	0.1	64.7	28.6	44.4	28.8	0.1	45.0	0.0	1.5	45.4	6.2	0.6	0.1	0.3	13.6	0.6	0.2	0.0	19.2	0.0	10.0	0.0	0.1	4.8	0.1	13.5	1.5	16.5	0.0	0.0	0.1	0.1	7.6	0.1	0.0	0.2	1.2	0.0	0.3	0.1	4.0	0.1	0.0	0.0	0.1	0.2	1.7	0.1	146.1	1.2	0.9	1.2	0.1	92.1	17.9	3.6	0.8	0.0	0.2	0.0	20.3	0.5	138.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.0	7.1	6.6	9.3	7.5	8.2	11.7	7.8	9.7	6.7	7.7	9.8	4.9	0.0	0.0	1.0	0.0	2.8	0.7	4.7	0.0	1.4	0.1	0.8	11.4	0.0	0.8	1.8	0.0	0.2	0.5	0.1	0.0	0.0	0.6	0.7	0.7	2.7	0.0	0.0	0.4	0.0	0.6	5.9	1.5	0.4	0.0	1.8	1.1	0.2	1.1	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.3	0.3	12.4	3.7	0.0	0.0	0.0	57.3	0.1	0.0	0.0	0.4	0.0	4.3	0.0	0.1	1.0	0.2	118.3	3.1	47.1	0.0	1.3	0.1	1.8	0.3	0.3	0.1	0.0	0.4
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562238-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 83.2;choroid plexus: 65.2;retina: 28.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 67.6;Muller glia cells: 94.7;Oligodendrocyte precursor cells: 233.7"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.6;HEK 293: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	0.9	0.8	58.3	0.2	62.4	0.1	0.6	33.6	83.2	0.3	65.2	1.1	0.0	0.3	0.1	0.3	0.3	0.1	0.5	62.5	49.7	0.2	0.2	3.2	0.2	41.2	45.6	0.2	0.3	0.3	1.7	0.8	45.8	0.4	0.2	28.3	0.3	0.0	0.5	1.1	0.3	0.4	37.0	0.0	0.4	1.9	48.0	0.1	0.4	0.0	0.1	0.1	0.2	46.1	0.3	1.7	32.6	5.7	0.6	0.0	0.9	0.6	0.1	1.2	0.3	0.3	2.0	0.1	2.5	0.1	2.4	0.5	2.7	0.3	0.3	0.0	8.8	0.5	1.4	0.0	0.0	0.4	1.4	0.0	1.1	0.1	0.0	0.9	0.1	1.1	6.6	0.3	0.1	1.5	0.2	0.4	3.1	2.4	3.3	0.5	0.2	0.7	1.4	1.1	3.4	1.5	2.1	4.1	0.1	0.9	1.6	3.1	0.3	0.1	6.5	0.1	1.9	0.8	0.8	0.0	0.5	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	62.4	33.6	83.2	62.5	49.7	41.2	45.6	45.8	37.0	48.0	46.1	0.7	3.2	2.0	67.6	0.1	0.8	0.1	0.0	0.0	28.6	2.2	1.8	1.3	0.0	0.0	0.0	6.2	0.2	0.0	0.5	0.0	0.2	2.0	0.6	0.6	0.3	1.8	0.0	18.6	0.0	0.2	0.5	0.0	2.0	0.0	6.1	0.0	0.5	0.2	6.7	25.0	0.3	0.0	0.0	0.2	0.6	0.3	0.2	0.0	7.5	0.0	94.7	0.0	233.7	9.9	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	22.7	0.0	0.8	0.8	13.5	3.3	0.0	0.6	0.1	0.2	0.2	0.4	0.1
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66012008-66013505	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"skin 1: 761.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Club cells: 115.2;Pancreatic endocrine cells: 368.1;Respiratory ciliated cells: 404.0"	"Group enriched"	"Detected in many"	5	"thyroid cancer: 171.0;urothelial cancer: 43.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 130.2;CAPAN-2: 364.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		82000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: AB_2679158"	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	3.2	0.3	0.1	0.3	0.1	0.2	28.5	0.8	0.4	7.4	0.8	0.4	0.0	0.3	0.6	34.6	14.9	0.5	2.8	0.1	0.3	2.6	0.3	18.3	0.0	0.2	0.2	0.7	0.7	2.1	1.6	8.1	0.1	0.9	0.0	0.0	7.4	4.9	2.0	761.4	0.3	0.1	0.1	0.2	0.6	1.8	0.4	2.7	21.4	0.0	2.2	1.2	22.5	0.2	130.2	0.0	0.0	0.6	0.0	0.0	37.6	1.4	0.0	0.3	0.2	1.0	364.6	0.0	1.8	5.1	0.1	4.5	0.0	32.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.6	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.8	0.2	0.7	0.0	0.0	35.8	0.4	0.1	0.8	0.1	0.0	0.2	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.4	0.1	0.3	0.2	0.2	0.1	0.1	0.4	0.2	0.1	93.0	6.1	0.0	0.6	1.1	1.7	41.4	0.6	0.0	5.3	7.1	1.2	0.0	115.2	58.8	0.0	33.3	0.0	0.1	0.0	57.4	0.2	7.7	0.1	0.9	0.0	0.0	0.0	21.6	24.4	2.0	0.0	0.6	21.6	0.1	0.4	0.1	41.1	0.0	0.0	0.0	24.4	1.4	10.0	0.8	0.0	5.3	5.4	0.0	1.1	1.3	0.0	0.0	0.0	368.1	1.1	0.4	9.8	1.9	0.0	0.5	404.0	0.1	0.0	0.3	16.0	5.2	17.6	1.0	27.6	64.2	0.7	0.0	0.4	6.1
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325248-122341969	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5912.9;vagina: 1853.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2493.8;Club cells: 768.0;Kupffer cells: 579.4;monocytes: 1298.6;Squamous epithelial cells: 3020.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 227.7;head and neck cancer: 405.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 514.7;intermediate monocyte: 269.1;myeloid DC: 382.9;neutrophil: 245.6;non-classical monocyte: 161.7"	"Group enriched"	"Detected in all"	193	"dendritic cells: 382.9;granulocytes: 245.6;monocytes: 514.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 282.0;hTCEpi: 1218.6;THP-1: 789.0;U-698: 504.5;U-937: 250.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		28000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favorable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	30.7	4.7	0.8	27.1	0.9	297.8	56.3	1.0	3.7	961.0	1.4	3.8	1.1	2.2	10.3	5912.9	4.6	7.2	5.9	0.8	1.0	2.4	38.9	26.0	25.1	1.5	0.9	21.1	3.7	0.8	5.0	19.0	1.3	19.7	3.6	0.3	996.1	9.6	4.6	369.1	5.8	6.3	1.1	20.4	30.3	1.3	1.4	46.5	2.7	2.8	941.0	39.1	1853.3	1.6	14.6	1.3	0.2	3.2	31.5	58.0	2.9	0.6	0.8	0.0	0.0	0.0	0.0	3.2	7.6	5.9	0.5	86.9	0.0	282.0	0.0	0.3	0.2	0.7	0.0	6.8	6.8	117.6	1.9	30.5	1218.6	2.9	119.1	0.0	0.0	1.5	0.8	29.9	0.5	0.8	0.2	108.3	0.0	0.5	0.0	0.0	0.9	0.0	0.0	141.3	0.0	0.0	14.1	7.5	10.4	0.1	1.6	789.0	0.5	1.7	19.7	0.2	0.9	0.0	1.7	504.5	26.4	250.3	0.3	8.8	514.7	16.4	0.6	269.1	1.5	1.5	0.7	0.6	382.9	0.5	0.5	0.7	245.6	1.9	161.7	6.9	1.0	283.2	0.8	0.9	1.0	3.7	0.8	1.0	1.5	0.9	1.3	1.1	1.4	1.6	1.1	6.4	19.8	0.0	5.0	83.5	136.5	2493.8	117.8	0.0	7.1	119.8	0.2	2.8	768.0	0.0	0.0	230.6	7.4	3.9	0.0	2.1	0.4	0.3	0.4	3.0	0.0	3.8	0.1	22.1	17.8	13.6	12.8	0.3	13.9	0.1	6.1	96.0	134.5	0.0	0.1	0.5	179.0	579.4	90.6	2.4	10.2	243.7	8.8	0.0	1298.6	0.0	20.6	0.5	0.2	46.2	1.5	3.8	2.8	30.2	0.0	0.7	115.7	0.0	32.9	8.8	24.3	0.1	0.5	3020.6	205.0	334.2	4.9	26.1	2.0	134.1
CSTF2T	"CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64"	ENSG00000177613	"Cleavage stimulation factor subunit 2 tau variant"	Q9H0L4	10	51695486-51699595	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039216, HPA062021"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"HPA039216: AB_10795462, HPA062021: AB_2684662"	"unprognostic (2.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.96e-1)"	13.5	13.2	10.6	17.4	13.1	13.6	11.7	13.4	13.4	11.0	11.2	10.4	11.7	11.7	10.3	9.0	14.8	10.2	14.4	10.4	11.5	11.9	12.6	9.6	19.6	13.3	12.6	17.9	12.3	18.0	6.0	11.9	13.1	11.9	10.6	13.8	10.7	9.3	22.2	10.9	11.6	12.2	13.9	17.6	11.1	9.5	12.0	21.5	11.5	22.8	19.4	12.4	6.3	18.4	16.2	18.9	27.9	29.4	38.5	26.2	1.9	22.5	20.7	25.4	24.7	25.3	23.2	46.5	12.7	19.7	15.4	24.8	21.2	23.6	22.9	27.1	24.0	26.8	19.9	4.7	18.6	10.5	23.6	38.0	18.0	22.4	25.8	16.1	19.3	26.9	29.3	25.6	22.2	13.9	42.9	16.8	10.3	19.7	40.3	33.7	56.2	9.9	19.6	13.4	23.3	30.1	18.8	19.4	20.4	28.9	36.2	19.2	20.7	16.2	22.1	15.1	28.5	32.5	13.0	32.9	33.7	24.1	14.3	2.8	4.1	4.5	3.5	3.8	4.9	1.7	2.6	2.8	4.3	3.0	4.4	4.0	1.1	10.9	2.8	2.7	4.6	2.9	10.6	13.1	13.4	13.4	10.4	11.5	13.3	12.6	13.1	13.9	12.0	18.4	13.4	9.6	7.5	2.9	15.8	9.1	7.1	15.7	12.5	18.2	8.7	5.6	14.3	8.6	11.1	9.2	8.4	24.1	13.7	7.5	23.5	16.4	1.7	9.2	13.5	17.7	6.1	17.7	4.6	15.3	14.6	12.4	9.7	7.8	20.3	10.9	17.9	16.7	15.4	20.2	5.7	8.7	10.2	14.8	8.3	2.7	23.9	8.9	0.0	3.7	22.5	13.2	33.0	3.0	19.3	13.9	6.1	19.9	7.1	4.1	9.3	13.6	17.8	13.7	6.6	16.1	9.1	37.0	15.7	8.5	6.5	6.2	17.2	12.0	11.2	5.1
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 7.8"	"Group enriched"	"Detected in some"	50	"Spermatocytes: 3.5;Spermatogonia: 6.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 246.0;Karpas-707: 112.8"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	246.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	112.8	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	21.5	0.0	0.3	1.7	33.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.6	0.2	0.3	0.3	0.4	0.4	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 9.2"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 47.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 85.4;K-562: 26.9;Karpas-707: 94.7;U-266/84: 88.6"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	85.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	94.7	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.4	0.0	0.0	18.5	88.6	0.1	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	1.2	1.3	0.4	1.5	0.6	2.0	0.6	1.3	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A2	"CT45-2, CT45.2"	ENSG00000271449	"Cancer/testis antigen family 45 member A2"	Q5DJT8	X	135811668-135820012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 25: RPMI-8226 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A3	"CT45-3, CT45-4, CT45.3, CT45.4, CT45A4"	ENSG00000269096	"Cancer/testis antigen family 45 member A3"	Q8NHU0	X	135759846-135768191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 9.5"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 94.7;T-47d: 63.5;U-266/84: 308.8"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.7	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	94.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.4	0.0	0.0	2.3	0.0	0.0	0.4	308.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.7	1.1	0.8	0.8	1.2	0.8	1.0	0.6	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A5	"CT45-5, CT45.5"	ENSG00000228836	"Cancer/testis antigen family 45 member A5"	P0DMU8	X	135777130-135785298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8;pituitary gland: 1.9;testis: 3.5"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.3;Spermatogonia: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 195.1"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.0	0.0	1.9	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	9.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	6.4	0.0	0.1	2.0	195.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.2	1.0	0.5	1.2	0.6	2.8	1.7	0.3	0.6	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A6	"CT45-6, CT45.6"	ENSG00000278289	"Cancer/testis antigen family 45 member A6"	P0DMU7	X	135794685-135802787	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 1.2;testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.1;HMC-1: 3.0;Karpas-707: 2.6;RPMI-8226: 4.5;U-266/84: 13.7"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.9	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A7		ENSG00000273696	"Cancer/testis antigen family 45 member A7"	P0DMV0	X	135829247-135837268	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"U-266/84: 70.4"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	70.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A8		ENSG00000278085	"Cancer/testis antigen family 45 member A8"	P0DMV1	X	135846497-135854538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HMC-1: 115.3"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 3: HMC-1 - Innate immune response"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A9		ENSG00000270946	"Cancer/testis antigen family 45 member A9"	P0DMV2	X	135863418-135871812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 29.9;HMC-1: 111.3;U-266/84: 49.2"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.8	49.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTDNEP1	"DULLARD, HSA011916, NET56"	ENSG00000175826	"CTD nuclear envelope phosphatase 1"	O95476	17	7243591-7252491	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037439, HPA066466"	Uncertain		Approved	"Lipid droplets"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Lipid droplets"		"HPA037439: AB_10601264, HPA066466: AB_2732745"	"unprognostic (7.11e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (6.45e-4)"	"unprognostic (3.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.90e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.37e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.02e-2)"	99.7	94.2	53.0	41.4	52.5	48.8	91.4	49.2	55.1	102.4	51.2	89.8	36.4	97.6	37.1	105.2	88.2	32.1	119.0	49.9	49.0	85.5	69.1	91.6	45.9	55.9	52.7	103.4	98.5	44.4	83.8	41.1	51.2	81.8	46.7	29.7	82.6	33.6	410.0	114.7	93.8	45.0	50.5	115.9	95.4	66.5	55.8	56.2	81.2	179.2	61.8	88.2	87.0	52.8	86.2	123.9	68.4	73.7	105.0	128.0	52.5	62.4	102.8	97.4	83.1	59.6	57.7	80.6	65.6	111.5	68.6	70.5	90.8	95.4	108.6	118.5	74.6	55.2	79.7	104.1	96.5	63.3	100.3	103.4	113.8	111.9	118.3	99.9	105.2	76.2	50.9	56.3	93.3	53.4	77.3	67.0	48.3	75.7	50.9	85.3	61.3	62.6	77.9	44.1	26.3	75.5	49.8	48.9	69.8	67.6	46.3	51.5	61.6	70.9	61.3	57.5	119.4	49.2	46.0	40.6	91.5	85.8	75.1	4.2	6.3	11.0	5.5	6.7	4.4	7.8	5.2	5.9	4.6	7.4	4.0	5.9	8.4	4.1	4.5	9.7	5.7	2.3	53.0	52.5	49.2	55.1	49.9	49.0	55.9	52.7	51.2	50.5	55.8	52.8	48.0	25.6	23.2	12.7	47.1	47.2	42.4	36.1	19.9	44.8	73.9	70.1	13.1	37.1	33.5	40.5	22.9	66.1	68.3	84.5	11.7	63.7	4.8	50.0	59.9	47.2	73.7	18.5	14.7	85.2	129.9	43.5	22.4	68.5	20.3	71.3	44.6	35.6	90.6	30.3	17.0	79.6	22.4	104.4	62.2	7.9	57.8	69.8	28.4	14.0	69.2	47.9	59.8	11.6	21.9	84.5	52.1	47.0	41.3	58.3	62.8	34.8	25.8	35.4	26.3	42.5	51.4	23.7	35.5	32.5	67.1	83.2	41.3	68.3	69.6	61.8
CTDSPL2	"FLJ10523, HSPC129"	ENSG00000137770	"CTD small phosphatase like 2"	Q05D32	15	44427622-44529038	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.5;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040763, HPA062198"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA040763: AB_10960989, HPA062198: AB_2684708"	"unprognostic (6.64e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (8.36e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.16e-1)"	9.1	7.4	2.9	12.9	3.6	20.5	14.1	12.8	5.3	14.0	3.4	10.8	10.0	17.5	7.0	12.5	11.1	11.9	9.5	3.4	4.4	10.7	10.3	10.4	19.4	3.4	2.7	19.1	11.5	11.1	4.0	15.8	3.1	10.2	11.3	15.1	9.1	10.2	5.4	8.1	12.7	13.9	3.0	13.3	9.8	21.0	2.9	25.3	15.0	9.4	19.0	12.2	6.2	6.0	28.6	14.2	57.7	29.4	9.1	19.9	31.9	29.1	25.4	37.3	46.8	29.3	26.4	30.1	27.7	20.3	20.6	39.2	33.4	19.6	42.6	30.9	16.1	37.4	34.8	17.6	12.3	65.7	33.5	15.7	14.0	25.6	33.4	15.8	28.4	37.9	44.2	34.0	26.7	12.1	78.2	23.1	31.2	30.4	20.3	86.7	80.5	28.0	19.4	38.9	26.7	38.5	36.0	28.5	16.2	21.2	38.7	57.7	24.9	46.0	49.5	44.3	49.4	19.3	79.2	93.9	22.2	50.4	36.0	7.4	10.8	9.2	10.3	11.3	9.4	10.6	9.8	9.3	13.8	10.5	10.4	11.8	7.7	15.7	8.9	8.8	14.9	9.4	2.9	3.6	12.8	5.3	3.4	4.4	3.4	2.7	3.1	3.0	2.9	6.0	34.4	19.2	35.7	26.4	25.4	24.6	14.7	14.5	27.9	23.7	24.5	21.0	23.1	11.5	31.3	12.9	10.4	18.9	40.9	16.9	17.6	12.5	165.5	18.3	35.4	27.2	9.0	16.2	41.8	14.6	18.4	30.2	11.7	29.6	36.0	26.7	20.3	13.6	14.0	30.3	41.2	13.9	20.3	22.2	20.9	166.9	20.2	22.1	16.0	49.6	23.8	19.2	39.1	50.3	65.7	17.7	10.4	13.2	24.0	18.0	17.2	14.5	19.5	31.1	26.3	30.4	34.2	23.7	31.4	19.6	21.9	14.6	31.4	21.9	15.3	16.8
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 177.7;skin 1: 434.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 185.7;Suprabasal keratinocytes: 291.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067089	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA		35000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"	"Nucleoli, Vesicles"	"HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	34.4	11.1	29.7	11.2	28.2	22.4	35.2	37.3	31.2	59.2	13.1	15.0	18.8	11.8	77.4	177.7	12.5	10.3	43.8	29.5	30.0	17.6	15.7	26.4	8.7	33.8	29.0	14.6	35.9	10.9	19.7	28.2	36.4	24.5	10.2	27.5	53.1	14.1	39.0	434.9	14.9	10.9	27.1	9.3	22.8	27.0	37.5	19.6	21.0	22.3	25.1	13.3	85.1	27.3	74.8	10.9	65.9	50.4	9.8	16.2	21.1	14.4	25.2	20.9	13.3	5.4	92.6	22.9	41.0	18.7	21.6	37.3	7.7	85.9	9.6	58.0	11.9	14.9	3.4	69.3	20.3	11.3	8.4	18.2	83.5	26.7	27.0	17.7	57.2	42.4	26.8	10.5	13.0	45.6	25.3	41.6	35.0	60.0	18.7	28.4	19.3	14.7	10.7	25.2	72.1	45.4	32.9	29.4	44.4	22.3	36.3	27.2	37.7	13.4	16.4	20.4	32.2	22.9	32.5	27.0	5.0	56.6	54.5	2.6	5.2	13.8	2.6	1.8	1.6	1.7	1.3	2.1	6.4	1.5	1.3	1.2	3.7	8.6	1.2	2.0	1.3	2.6	29.7	28.2	37.3	31.2	29.5	30.0	33.8	29.0	36.4	27.1	37.5	27.3	150.6	28.9	13.9	30.0	9.6	103.1	42.3	16.1	40.5	9.0	39.9	33.3	14.0	24.3	17.0	18.4	8.4	71.3	23.5	20.5	33.2	20.9	116.3	20.0	17.9	42.7	49.1	20.0	18.0	18.7	43.2	15.7	30.1	38.5	0.0	27.2	20.0	25.6	58.0	16.8	14.1	37.5	12.2	43.0	97.4	34.8	14.9	38.3	48.0	12.2	33.6	185.7	71.1	17.1	24.1	37.6	28.3	23.0	13.3	53.5	28.6	30.5	5.2	12.8	46.0	15.0	24.5	72.1	43.6	154.0	291.5	48.4	17.2	14.3	28.6	60.5
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 372.9;granulocytes: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 308.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	26.9	16.8	20.9	27.3	22.8	41.8	23.8	21.6	24.8	23.7	23.4	31.8	21.7	27.7	31.1	23.4	25.3	19.8	32.3	22.0	22.4	22.9	46.8	25.3	39.3	22.8	22.3	27.1	17.3	19.7	18.2	22.1	21.7	23.4	23.1	18.8	18.5	30.6	33.3	25.3	25.1	30.6	21.6	54.0	34.8	43.3	22.1	40.1	17.1	20.9	41.2	25.8	20.4	23.6	66.7	60.3	56.7	44.6	40.3	32.8	89.2	41.9	43.7	98.0	86.0	224.8	52.4	73.9	59.6	42.7	94.4	69.8	77.1	98.6	105.3	36.1	38.0	243.0	33.2	110.2	41.8	77.4	308.0	35.1	58.9	55.6	54.8	34.1	59.8	103.8	66.8	29.6	53.5	54.9	127.0	101.4	51.4	74.9	85.8	87.9	109.1	56.3	42.9	55.0	45.1	53.6	72.5	102.3	75.4	52.3	50.6	61.1	44.5	97.4	58.0	64.9	68.8	34.1	46.6	85.5	68.5	48.6	52.7	267.9	77.7	103.3	51.0	103.0	49.1	88.9	49.9	53.8	110.3	83.4	49.8	53.6	16.9	79.9	109.6	86.9	66.2	71.3	20.9	22.8	21.6	24.8	22.0	22.4	22.8	22.3	21.7	21.6	22.1	23.6	28.6	28.9	26.4	21.2	40.0	22.8	32.9	40.7	13.1	26.1	13.0	13.2	39.8	17.2	34.1	18.4	18.8	147.8	40.4	21.1	37.2	34.8	372.9	24.2	24.9	32.5	20.9	43.7	31.6	34.7	69.4	28.7	48.4	21.6	263.6	34.4	44.3	45.2	49.3	18.5	35.6	27.3	42.7	36.0	35.5	131.2	34.2	44.5	26.6	14.0	89.8	32.1	40.2	30.7	39.8	31.9	21.5	33.4	21.6	22.3	34.7	43.1	26.1	25.8	19.7	25.4	48.0	79.4	45.2	10.7	22.4	52.9	38.8	23.7	24.2	20.6
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979688-41012565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	Yes		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol	"Actin filaments"	"CAB017111: , HPA051322: AB_2681441"	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	9.1	8.1	4.8	11.1	4.7	6.8	6.7	4.0	5.8	9.3	7.9	8.7	4.4	23.6	5.7	14.9	11.1	10.6	5.3	4.9	5.3	12.4	73.4	7.6	12.4	4.6	4.9	3.4	4.7	47.6	0.0	7.8	5.8	13.5	12.0	2.4	50.6	24.8	7.7	4.6	8.4	51.9	4.7	5.0	4.1	14.7	4.9	17.3	4.8	7.6	17.8	17.7	0.3	5.0	77.8	68.5	95.3	60.5	22.9	30.9	138.5	138.8	57.0	141.2	92.0	131.5	66.6	149.8	55.6	61.7	39.4	38.6	91.5	97.0	139.5	66.5	78.0	87.3	72.3	43.3	87.8	128.0	56.8	34.0	49.2	148.5	103.0	23.0	64.1	102.2	84.7	51.5	99.4	42.9	125.0	38.1	126.8	66.4	81.3	100.9	120.0	93.7	71.4	69.4	118.4	61.7	79.2	77.7	33.9	90.8	30.1	152.9	53.5	78.2	119.6	61.7	167.2	36.8	50.8	134.5	59.8	84.5	97.4	0.0	3.5	0.0	3.6	6.5	5.7	5.2	4.1	4.3	11.0	4.0	3.7	6.1	0.0	6.9	5.9	11.9	6.3	3.4	4.8	4.7	4.0	5.8	4.9	5.3	4.6	4.9	5.8	4.7	4.9	5.0	5.4	6.4	18.4	4.9	10.9	8.0	14.3	9.1	9.6	12.5	4.6	4.7	5.7	21.5	7.0	5.5	6.2	15.4	26.4	2.2	1.9	19.2	32.4	4.7	10.8	8.5	3.0	22.5	14.1	17.2	26.4	8.7	7.1	7.3	1.3	15.8	2.2	29.0	11.0	11.8	18.7	3.4	6.1	2.8	6.2	27.9	10.8	6.8	1.8	7.5	8.7	5.4	7.2	7.1	10.3	19.3	1.1	24.8	15.1	19.3	25.2	12.8	2.8	4.3	39.5	9.3	17.5	11.1	40.6	11.8	7.4	5.6	9.9	20.7	5.8	7.3
CTPS2		ENSG00000047230	"CTP synthase 2"	Q9NRF8	X	16587999-16712936	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017437, HPA075930"	Approved		Approved	Mitochondria,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Mitochondria, Cytosol"		"HPA017437: AB_1847326, HPA075930: "	"unprognostic (1.40e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (6.57e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.56e-4)"	5.5	7.0	5.6	4.3	7.2	6.9	10.4	7.6	6.3	9.5	6.0	8.1	12.3	10.3	6.7	5.1	9.0	6.8	4.4	5.1	6.8	6.0	7.5	6.5	6.6	8.0	6.3	13.2	9.2	12.1	4.0	6.6	8.0	9.5	9.5	9.9	7.4	7.0	4.3	7.1	10.3	7.4	6.5	4.4	8.3	2.0	6.3	6.1	6.8	4.6	8.2	6.2	6.2	9.4	13.7	12.6	20.3	16.9	10.1	7.6	0.2	7.3	6.2	12.1	11.0	13.0	14.2	0.4	23.2	7.9	11.0	11.0	28.9	13.9	14.3	0.1	18.9	7.9	17.0	19.2	5.3	5.7	0.2	8.4	4.7	11.3	9.5	13.6	16.5	0.3	11.1	0.5	11.2	18.9	0.2	4.6	34.7	5.2	14.6	0.3	11.6	4.4	13.3	15.5	12.5	22.8	23.5	1.8	14.2	21.9	32.8	16.2	10.3	6.2	3.3	16.5	6.6	0.3	0.2	45.6	5.0	4.9	7.0	0.1	0.6	0.5	0.4	0.3	0.9	0.6	0.8	0.5	1.3	0.5	0.6	0.6	0.0	1.7	2.7	0.9	0.9	0.6	5.6	7.2	7.6	6.3	5.1	6.8	8.0	6.3	8.0	6.5	6.3	9.4	6.7	9.6	6.7	13.4	3.4	3.2	6.0	4.8	4.6	5.4	8.0	6.5	6.0	8.6	8.9	5.5	0.0	3.5	4.4	5.5	3.9	9.8	4.0	7.2	6.4	5.4	11.3	3.8	10.4	9.4	7.9	5.9	6.1	9.0	6.3	9.1	6.8	7.9	5.3	6.7	18.2	7.5	4.1	4.4	2.7	8.6	9.0	3.3	8.8	24.4	6.0	4.4	1.0	26.2	35.5	11.3	9.0	4.1	4.0	3.9	19.2	3.0	6.1	5.1	6.6	4.1	6.6	0.1	0.3	3.7	3.8	1.5	2.7	4.3	8.8	5.8
CTR9	"KIAA0155, p150TSP, SH2BP1, TSBP"	ENSG00000198730	"CTR9 homolog, Paf1/RNA polymerase II complex component"	Q6PD62	11	10751246-10801625	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 186.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061027, HPA068122"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA061027: AB_2684418, HPA068122: AB_2685959"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (3.65e-6)"	"unprognostic (6.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	15.4	20.6	10.0	21.0	10.2	23.7	18.8	9.9	11.3	19.9	13.4	16.9	16.2	22.2	48.0	17.5	16.8	15.3	17.2	10.4	10.8	22.5	25.2	17.2	26.3	10.0	12.0	22.0	13.3	30.0	12.5	20.3	10.5	17.6	18.1	29.2	18.3	16.1	17.9	19.2	16.8	16.4	9.7	22.5	17.2	27.0	10.4	30.3	23.2	15.1	26.0	21.8	11.8	11.0	40.5	30.9	43.5	41.4	93.1	37.0	21.2	43.9	29.2	34.8	36.5	51.1	83.9	36.7	23.6	36.6	42.3	40.9	54.0	36.2	56.7	56.7	64.6	186.6	31.0	29.2	29.7	74.1	98.8	34.6	28.8	22.5	30.1	32.1	40.6	34.5	77.0	43.2	42.6	18.3	47.5	28.9	36.0	48.7	38.2	43.6	52.9	25.1	29.9	54.8	19.9	47.4	39.6	38.9	31.3	41.5	34.6	32.3	40.2	29.2	30.0	51.7	24.0	23.6	59.8	39.5	31.2	49.5	30.5	54.4	15.4	31.3	20.0	17.7	26.3	16.7	21.4	19.7	18.1	17.0	20.1	19.6	11.3	26.7	18.3	9.0	19.4	15.8	10.0	10.2	9.9	11.3	10.4	10.8	10.0	12.0	10.5	9.7	10.4	11.0	51.5	57.7	48.8	14.7	49.0	87.2	46.2	29.7	64.3	34.0	30.2	31.6	49.2	31.5	41.7	25.8	56.3	37.9	42.7	30.7	19.6	26.9	28.5	34.0	38.0	37.7	26.9	25.5	16.5	24.5	24.8	36.4	15.8	52.4	85.9	33.2	28.5	38.6	29.1	63.9	21.4	45.1	32.6	32.3	23.6	13.1	33.5	36.1	12.4	15.0	31.8	31.1	29.9	20.6	18.6	26.9	17.5	31.2	37.2	26.1	22.8	18.3	33.7	45.9	26.3	47.8	33.1	100.3	71.3	51.1	81.1	45.7	48.0	56.4	25.3	31.5
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 368.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 445.6;Proximal enterocytes: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 856.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		28000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	80.4	368.3	56.8	75.3	58.1	75.6	61.9	63.6	65.6	47.6	96.0	178.6	100.9	55.1	39.0	60.4	39.3	89.7	97.2	59.7	63.8	188.1	95.7	90.9	61.6	62.6	59.1	62.2	52.9	104.4	43.8	76.4	61.4	38.5	170.4	44.0	61.3	48.4	56.0	95.2	109.2	67.3	59.4	108.5	63.3	33.5	70.2	23.0	47.4	61.7	58.8	82.8	49.2	68.4	111.9	114.1	17.6	89.2	856.5	438.6	47.0	150.3	424.0	169.6	217.5	214.4	291.8	24.1	176.2	299.9	638.1	168.6	55.9	105.6	95.7	47.6	53.6	54.3	53.4	375.9	187.3	98.0	240.9	349.0	123.6	107.9	22.5	421.9	190.1	28.2	61.0	355.1	186.9	232.1	25.8	82.4	19.4	172.6	272.1	37.8	107.3	135.7	138.2	96.7	36.9	37.8	263.2	450.3	444.4	51.5	108.5	141.8	172.5	335.0	76.2	178.9	123.7	162.1	238.5	15.7	599.3	128.6	142.4	480.7	305.9	530.5	44.9	168.8	185.5	42.0	75.6	78.3	102.4	25.7	26.6	39.8	152.4	81.2	120.1	40.6	155.4	378.1	56.8	58.1	63.6	65.6	59.7	63.8	62.6	59.1	61.4	59.4	70.2	68.4	53.7	35.3	32.6	26.1	38.2	24.2	38.9	88.8	17.6	58.4	18.4	15.9	12.6	65.8	64.1	71.7	60.5	104.1	27.5	445.6	39.2	246.0	3.3	22.3	39.5	56.0	54.0	22.1	20.4	166.4	109.2	86.8	29.6	62.4	9.5	50.8	102.1	67.9	297.1	47.1	25.2	74.5	95.6	177.1	25.1	4.8	32.9	273.1	112.1	12.2	135.6	86.6	37.0	7.1	10.2	135.0	216.0	27.4	41.9	18.6	301.8	245.8	34.2	46.1	26.3	33.7	54.5	15.3	31.9	24.0	22.9	144.1	49.1	91.3	113.9	36.2
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869533	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	443.9	304.5	65.6	399.7	71.2	87.0	249.0	65.9	77.2	583.2	101.0	312.4	120.8	379.2	116.9	421.6	368.4	230.6	447.0	64.7	95.5	420.6	497.2	428.9	289.6	100.4	90.8	169.1	135.4	79.6	156.8	253.2	107.4	255.5	159.3	33.6	437.3	156.6	237.4	184.7	260.2	316.1	91.9	521.1	194.3	33.2	204.5	60.9	1150.7	99.3	104.0	431.9	477.8	159.2	66.6	283.4	4.0	94.9	657.3	754.5	128.3	885.0	1607.5	258.4	299.5	10.3	294.4	1.5	32.2	1436.1	419.3	279.5	65.3	157.1	195.6	25.9	52.6	58.8	10.0	397.1	479.2	7.7	73.7	296.4	532.2	327.2	427.3	611.5	33.4	20.2	81.7	260.7	194.6	62.5	6.5	23.1	16.3	839.7	91.3	33.6	39.3	202.7	2.6	121.1	4.9	68.6	165.1	68.6	514.6	110.1	97.8	68.7	922.4	766.5	111.9	129.9	259.3	182.7	178.5	4.8	432.5	22.9	249.4	390.6	610.1	90.6	26.3	467.3	35.4	44.1	79.0	31.5	287.4	38.8	48.3	21.5	97.8	31.3	307.6	410.1	78.7	703.7	65.6	71.2	65.9	77.2	64.7	95.5	100.4	90.8	107.4	91.9	204.5	159.2	87.7	109.0	171.4	17.6	54.8	54.7	441.6	563.2	54.7	55.2	94.1	74.5	320.1	165.8	331.7	114.0	41.7	279.4	122.4	147.9	27.4	294.6	15.6	105.8	240.1	163.0	154.7	210.2	36.2	238.2	341.7	155.0	44.4	183.5	179.4	105.9	204.2	239.5	2744.5	58.9	42.8	94.2	158.7	1774.9	436.5	18.5	76.4	1224.3	161.9	70.3	373.1	117.4	24.7	19.1	12.9	363.9	154.0	92.9	47.3	295.5	198.6	351.8	180.8	40.0	39.5	39.4	149.9	10.8	21.0	160.3	40.5	649.6	56.0	32.1	139.6	321.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88265069-88359684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 900.7;Club cells: 471.8;Hofbauer cells: 1100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	173.2	60.7	9.9	185.1	9.6	71.7	63.4	11.1	24.9	77.9	14.2	143.1	121.0	43.9	28.5	63.3	54.0	182.0	38.5	9.5	10.1	234.7	82.0	272.6	243.7	14.0	11.9	22.1	52.2	42.4	39.3	253.3	13.3	26.0	191.5	3.7	131.6	28.9	18.8	29.6	128.8	88.9	11.5	197.2	73.6	22.8	19.5	63.7	43.6	31.9	140.6	176.3	43.3	21.3	80.3	75.9	27.6	69.9	103.7	286.1	218.4	626.5	1078.4	372.8	270.3	194.7	361.3	117.3	278.9	365.2	84.3	133.6	50.4	269.2	341.9	204.7	82.8	144.5	188.0	233.5	140.2	188.9	108.7	419.1	198.8	284.5	697.4	302.1	377.6	122.3	155.3	145.4	54.8	14.8	89.1	295.1	172.2	551.5	244.9	113.6	30.7	227.0	451.3	106.6	8.8	66.8	81.2	114.9	80.6	185.4	27.9	152.7	149.3	23.5	190.5	156.8	364.6	61.9	81.0	122.9	56.8	435.8	122.4	85.5	203.8	309.7	230.1	415.6	194.9	47.2	99.6	198.2	209.9	26.3	49.5	115.3	215.0	200.5	582.9	425.0	162.7	243.3	9.9	9.6	11.1	24.9	9.5	10.1	14.0	11.9	13.3	11.5	19.5	21.3	78.6	22.4	88.1	0.3	40.8	30.1	7.3	900.7	33.6	1.5	15.9	14.6	4.4	52.9	471.8	40.5	0.0	414.1	330.6	37.9	29.4	29.8	1.6	13.4	135.6	94.8	11.4	29.7	3.0	90.6	159.2	114.4	39.8	21.2	75.3	25.5	26.4	15.8	1100.6	0.0	8.2	19.4	158.7	344.7	200.7	7.9	198.5	391.7	48.0	61.8	185.4	0.5	299.7	13.6	0.4	44.8	72.3	25.6	78.5	8.5	20.2	166.4	93.7	0.8	59.2	4.4	150.8	3.0	11.1	43.3	27.1	227.3	170.6	286.7	44.9	16.1
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029677-97156556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 643.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 63.7;Cytotrophoblasts: 122.3;Extravillous trophoblasts: 153.0;Granulosa cells: 54.2;Syncytiotrophoblasts: 67.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.1"	"Group enriched"	"Detected in many"	8	"BEWO: 592.6;SuSa: 739.0"					"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.2	0.2	0.6	0.3	0.7	0.3	5.8	0.8	1.6	43.1	0.8	2.9	1.1	2.8	1.7	19.8	1.3	0.5	0.1	0.6	0.5	21.3	0.2	0.9	0.1	0.7	0.6	0.2	2.1	1.4	1.5	16.8	0.6	0.7	3.2	17.2	9.4	0.1	0.7	52.5	0.4	0.8	0.5	0.2	2.8	65.8	0.6	643.6	1.3	0.1	6.0	0.4	20.1	1.0	37.1	5.2	12.1	33.1	0.6	0.0	592.6	0.5	0.0	7.1	4.7	81.0	37.7	0.3	2.8	0.5	50.5	67.2	58.8	43.9	9.7	0.1	4.4	0.8	1.9	3.1	0.2	0.1	3.3	0.0	9.2	1.5	0.8	0.9	2.4	8.5	0.5	0.2	14.4	15.2	0.9	0.3	76.2	78.9	10.7	0.0	27.3	0.1	11.4	3.7	2.4	3.6	39.1	13.1	13.2	739.0	21.1	3.2	0.0	1.0	23.6	0.2	3.5	5.7	20.6	0.8	1.6	0.4	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.2	3.3	0.0	15.1	0.0	0.1	0.6	0.7	0.8	1.6	0.6	0.5	0.7	0.6	0.6	0.5	0.6	1.0	0.9	0.0	1.1	0.3	0.9	30.3	13.0	63.7	19.9	4.6	13.1	9.9	1.3	0.0	17.4	1.8	10.4	122.3	6.9	4.7	1.9	1.8	2.6	15.0	2.9	1.8	1.8	0.0	0.6	0.8	153.0	3.2	0.0	24.0	0.0	54.2	0.4	0.0	13.6	0.0	0.9	1.5	10.2	0.8	3.0	8.2	4.1	2.4	0.0	0.0	0.2	6.5	0.0	0.0	3.5	0.5	10.5	1.2	0.0	8.1	0.1	22.1	4.2	36.6	6.6	1.4	3.6	46.7	33.7	8.2	11.9	67.3	0.5	0.7	4.2	8.4
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58985686-59008238	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1078.9;Langerhans cells: 983.5;Macrophages: 652.3;monocytes: 723.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 542.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	178.1	117.8	18.9	208.8	21.8	99.8	137.0	20.5	32.0	92.1	59.6	173.8	215.4	87.3	13.4	53.1	88.9	89.4	152.6	15.3	33.9	125.6	356.4	233.3	271.5	31.6	23.5	71.0	89.4	91.8	112.5	118.7	27.9	87.8	77.1	4.1	181.0	66.3	58.7	58.5	226.0	97.9	26.2	234.4	88.2	24.6	47.2	57.1	122.3	54.6	91.3	146.3	69.0	45.4	205.4	139.8	1.1	1.1	114.2	124.2	106.5	291.0	225.4	187.4	152.3	231.6	324.6	96.5	213.9	542.1	0.5	160.1	51.4	257.5	30.2	362.1	13.6	80.3	169.0	0.8	137.3	9.0	331.0	130.9	127.8	83.1	62.4	34.8	281.3	1.1	74.0	48.7	90.0	1.1	1.3	70.6	11.5	43.5	158.2	2.9	0.4	135.7	86.3	25.5	2.7	1.7	222.4	258.4	0.8	19.5	131.9	148.4	420.5	1.4	161.8	209.0	2.0	253.7	172.0	18.2	2.8	207.9	0.4	1.2	1.5	1.6	0.6	1.4	0.4	1.1	0.6	0.4	1.1	1.4	0.7	0.8	1.6	0.5	2.9	1.8	0.3	0.7	18.9	21.8	20.5	32.0	15.3	33.9	31.6	23.5	27.9	26.2	47.2	45.4	132.1	16.0	5.3	5.9	119.8	50.3	64.5	33.8	24.5	6.7	67.4	99.6	21.7	62.9	14.1	71.7	0.0	38.2	104.8	303.6	23.5	176.0	3.5	52.9	47.7	82.2	27.1	63.3	5.3	42.4	104.8	71.5	19.4	71.3	10.8	68.4	62.8	363.0	1078.9	11.8	3.0	56.6	26.4	334.0	983.5	6.0	13.1	652.3	101.4	23.4	723.6	58.6	21.6	2.5	2.5	82.6	217.5	13.9	96.3	50.6	339.8	90.0	18.8	5.0	46.0	67.5	74.5	3.7	4.8	14.5	41.5	41.3	33.4	3.3	99.7	52.7
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 128.8;granulocytes: 139.9;Inhibitory neurons: 194.9;Oligodendrocyte precursor cells: 428.8;Oligodendrocytes: 444.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"non-classical monocyte: 7.7"	"Lineage enriched"	"Detected in single"	26	"monocytes: 7.7"	"Group enriched"	"Detected in some"	6	"HEL: 57.6;HMC-1: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: AB_2679037"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	6.9	1.8	11.4	0.7	16.7	0.0	3.8	13.0	14.7	5.7	6.8	2.4	1.6	10.6	4.8	12.1	6.0	3.5	1.8	12.7	14.8	6.4	1.8	1.8	0.2	15.7	14.7	3.1	7.8	9.3	2.9	1.7	16.3	3.4	2.4	7.9	3.4	1.8	0.5	1.8	2.4	5.2	11.9	2.2	1.3	1.0	15.1	0.7	5.5	0.9	0.9	4.2	4.2	26.1	0.0	0.9	1.6	0.0	0.0	0.0	1.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.1	8.3	0.0	0.0	0.0	2.5	57.6	0.5	0.0	0.2	0.0	74.1	0.3	0.4	0.0	0.0	1.0	1.6	0.0	0.0	0.1	1.1	0.0	0.0	0.0	10.6	0.0	0.3	0.0	0.0	0.2	10.6	0.0	6.1	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	2.6	1.0	0.1	0.0	0.7	0.0	0.2	5.0	0.0	1.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	11.4	16.7	13.0	14.7	12.7	14.8	15.7	14.7	16.3	11.9	15.1	26.1	15.6	3.2	4.8	10.1	0.0	1.9	3.4	3.7	15.9	33.6	1.9	6.7	3.6	10.0	5.6	7.3	56.3	2.8	0.3	1.8	1.9	6.3	1.8	5.1	32.5	10.2	1.8	0.0	128.8	4.2	2.1	9.1	1.1	7.4	139.9	3.8	20.0	1.1	9.2	74.0	194.9	1.1	24.4	10.1	12.3	3.3	0.9	8.0	7.2	75.9	1.3	97.2	0.0	428.8	444.2	0.6	2.1	1.2	0.3	2.1	0.3	24.3	1.4	6.6	0.0	3.3	9.6	0.6	2.1	38.8	0.3	1.1	2.7	0.2	6.8	1.4
CTTNBP2NL	DKFZp547A023	ENSG00000143079	"CTTNBP2 N-terminal like"	Q9P2B4	1	112396214-112463456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007301	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center, Cytosol"		"HPA007301: AB_1847693"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.21e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (8.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (5.12e-2)"	14.5	4.8	5.6	10.3	4.6	0.5	11.3	4.4	6.1	11.8	3.1	15.5	7.5	15.2	4.7	19.5	8.4	16.5	6.3	4.4	7.6	9.1	5.6	13.0	6.2	7.3	6.6	9.4	4.6	7.4	3.5	20.2	7.1	8.9	14.8	8.2	7.0	9.2	3.0	15.4	10.5	13.5	5.7	10.6	8.6	5.8	5.9	4.3	8.3	6.9	8.2	15.6	11.8	7.6	21.8	7.9	25.7	12.2	17.0	22.3	8.6	33.6	31.4	21.4	21.1	6.1	10.7	3.4	13.2	25.4	10.5	17.4	16.9	23.2	24.9	7.1	8.1	4.6	13.1	4.9	19.7	1.6	7.8	26.4	14.0	26.5	23.0	24.5	52.7	5.7	4.2	3.0	29.9	6.4	3.0	0.6	16.6	6.1	12.3	5.3	24.0	0.0	32.6	15.9	12.6	13.2	26.0	5.3	13.3	24.5	4.3	1.8	68.5	21.3	24.9	22.0	15.8	0.4	3.1	0.1	22.1	2.0	57.0	0.0	2.6	0.0	0.0	2.1	0.0	0.1	0.0	0.0	8.6	0.3	0.0	0.0	0.1	0.0	0.4	3.7	2.0	0.4	5.6	4.6	4.4	6.1	4.4	7.6	7.3	6.6	7.1	5.7	5.9	7.6	100.4	57.7	22.4	17.6	4.4	38.7	30.2	32.0	24.5	10.2	12.3	9.5	9.7	7.2	41.4	22.0	6.2	17.6	4.6	64.0	3.9	39.1	3.3	29.1	30.7	71.6	8.3	3.6	44.1	21.6	12.8	24.2	14.8	58.5	19.0	17.8	41.7	1.6	13.5	5.0	31.2	27.4	30.5	29.7	131.7	4.0	10.5	40.8	16.0	81.5	30.5	11.0	0.0	30.2	25.1	47.7	52.7	11.3	0.7	25.4	21.7	22.6	17.5	7.9	19.7	20.1	29.2	16.8	16.7	25.0	60.7	25.4	2.7	9.1	24.4	69.3
CTU2	"C16orf84, NCS2"	ENSG00000174177	"Cytosolic thiouridylase subunit 2"	Q2VPK5	16	88706483-88715396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041135, HPA041894"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041135: AB_10794543, HPA041894: AB_10796463"	"unprognostic (4.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	9.7	9.6	8.8	5.0	8.7	6.2	8.8	7.9	13.8	10.2	6.5	9.9	4.2	11.6	2.0	8.7	9.5	3.5	11.8	9.1	7.5	9.7	12.5	7.9	6.1	9.6	8.1	10.5	11.3	3.6	11.3	3.2	8.5	8.8	1.6	1.4	8.0	3.7	19.1	8.7	7.6	3.4	7.5	9.4	9.6	10.9	8.2	4.0	10.3	5.4	3.4	9.9	8.1	10.5	14.9	22.9	8.8	19.4	7.3	7.5	21.8	15.2	11.4	16.6	8.1	27.2	14.0	21.7	19.8	9.8	7.8	14.7	14.8	14.9	4.5	6.8	44.6	14.9	9.8	27.8	12.4	15.1	10.8	8.5	10.8	13.1	13.9	6.0	14.1	13.1	56.5	6.3	6.3	40.0	42.0	34.9	13.7	12.9	36.9	33.0	6.6	23.4	5.8	5.8	29.0	14.0	24.2	4.6	9.7	5.3	13.8	15.6	15.9	17.5	22.1	19.2	16.8	19.4	10.5	61.7	15.1	32.1	19.6	1.1	5.5	0.0	7.3	6.9	6.0	5.5	6.6	7.3	6.8	5.8	6.4	5.5	0.4	7.5	6.0	6.4	4.1	4.2	8.8	8.7	7.9	13.8	9.1	7.5	9.6	8.1	8.5	7.5	8.2	10.5	6.5	0.0	4.4	2.3	10.0	13.8	12.2	7.8	5.2	12.5	7.3	7.2	2.5	10.0	7.8	1.8	6.2	11.0	15.7	8.4	11.7	8.8	12.1	4.0	7.1	6.6	5.4	3.8	2.9	13.6	16.2	8.6	11.2	4.9	0.0	9.9	3.6	6.7	9.9	13.5	2.3	7.1	4.1	1.9	4.0	7.0	8.1	6.7	5.4	1.0	5.0	4.4	7.2	0.5	2.7	8.9	8.2	9.8	15.5	17.2	9.6	7.8	4.7	8.7	0.0	8.9	11.1	25.6	25.7	6.5	10.7	8.1	9.5	10.8	10.5	8.9
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 466.3;Late spermatids: 567.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	33.2	27.3	19.6	29.4	20.9	15.5	30.2	20.4	26.5	28.1	22.2	38.9	23.0	29.8	28.8	30.6	29.4	23.2	35.9	22.1	23.0	21.6	45.1	26.3	39.0	20.4	21.2	30.9	20.6	36.3	25.6	32.7	20.4	27.3	24.5	52.1	26.1	30.1	88.8	28.8	27.3	32.2	21.8	30.0	29.7	95.1	21.3	30.3	27.4	74.6	35.6	34.9	26.6	21.7	79.9	61.6	59.5	93.6	46.6	51.6	72.8	64.8	77.7	65.8	61.4	64.5	53.9	109.6	49.5	65.9	104.4	52.5	87.0	59.9	76.4	72.8	71.9	65.2	39.6	64.5	50.5	74.8	58.9	40.0	58.5	45.9	46.0	59.9	71.3	52.8	100.8	78.2	72.2	76.4	64.1	81.0	111.6	68.6	58.8	78.7	52.3	106.3	54.2	55.4	83.3	61.0	74.5	92.3	51.4	69.9	29.0	57.5	56.6	44.1	15.4	87.7	75.8	70.4	54.2	96.7	94.3	82.5	66.2	15.5	17.0	14.1	16.5	18.3	21.8	17.3	18.9	21.2	26.6	15.0	22.4	18.5	1.4	27.9	18.5	6.7	18.5	20.0	19.6	20.9	20.4	26.5	22.1	23.0	20.4	21.2	20.4	21.8	21.3	21.7	24.0	35.3	40.9	41.4	26.0	27.9	31.1	19.5	22.2	33.4	13.8	17.5	29.2	12.8	32.2	9.2	29.2	66.6	19.1	12.0	17.6	28.1	466.3	20.4	23.4	25.1	15.6	23.1	76.3	26.2	77.1	29.9	19.4	21.9	23.4	31.6	18.5	41.5	29.8	21.9	89.5	19.7	22.4	18.5	16.8	567.7	21.8	25.7	28.4	60.9	51.7	32.7	37.0	52.8	74.3	28.5	15.0	30.5	25.3	29.8	11.7	13.5	33.6	48.9	32.9	30.3	38.9	59.6	34.0	20.6	25.4	73.2	26.5	24.1	18.8	21.7
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182184-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	53	"Early spermatids: 513.7;Late spermatids: 1508.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	2.9	3.0	3.1	4.9	4.5	6.9	2.9	1.3	3.4	3.2	3.5	3.6	4.0	3.3	1.7	5.5	4.9	3.6	2.6	3.2	2.0	3.1	2.1	3.6	6.3	2.4	2.8	4.3	4.2	5.5	2.9	2.4	2.7	3.4	2.3	3.2	3.9	4.0	2.8	8.0	4.2	2.8	1.5	4.9	4.2	5.2	2.5	7.6	5.2	2.9	4.7	3.8	2.7	2.7	8.2	6.0	3.2	7.7	8.8	5.2	4.4	3.2	5.6	5.0	4.6	1.9	3.4	6.8	6.0	5.1	4.5	5.8	2.7	6.7	2.3	8.3	2.5	7.4	6.8	3.0	5.8	4.7	11.6	7.1	13.8	4.1	3.7	4.4	7.4	11.5	3.9	8.7	4.5	7.2	9.6	6.8	0.6	15.7	3.6	13.9	2.2	6.6	3.8	8.4	5.5	7.8	4.2	5.0	7.2	2.7	8.6	10.4	6.9	12.5	8.6	3.7	6.1	8.3	8.3	5.5	3.2	8.2	5.7	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	3.1	4.5	1.3	3.4	3.2	2.0	2.4	2.8	2.7	1.5	2.5	2.7	6.6	0.0	8.2	16.3	7.5	6.4	2.7	9.3	16.5	10.2	8.0	6.1	6.9	8.6	5.9	3.7	12.5	3.4	6.5	8.8	3.9	4.2	513.7	7.5	5.5	6.8	6.0	3.4	15.8	6.2	1.7	5.3	18.8	6.4	2.5	14.6	9.3	6.4	11.6	11.8	11.9	7.9	6.1	9.6	5.0	1508.3	11.1	8.5	3.6	9.4	6.3	9.6	5.2	11.6	11.2	6.5	2.1	8.2	4.1	2.3	8.5	6.7	8.5	10.0	13.1	6.4	3.6	14.5	10.1	14.2	5.5	2.6	7.1	5.6	7.2	2.9
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 385.5;tongue: 204.2"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	38.7	15.5	19.3	14.6	21.9	23.6	27.3	20.8	25.9	17.3	17.3	19.4	11.1	14.7	11.0	16.0	17.1	12.1	41.7	18.7	20.7	13.5	30.2	15.1	22.3	21.0	20.6	12.6	14.2	8.6	7.8	11.3	21.3	16.1	15.9	28.3	16.9	11.2	385.5	18.6	20.9	14.4	20.1	28.6	18.6	43.4	20.3	23.9	13.2	204.2	19.7	43.8	16.7	25.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	19.3	21.9	20.8	25.9	18.7	20.7	21.0	20.6	21.3	20.1	20.3	25.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CUZD1	"ERG-1, UO-44"	ENSG00000138161	"CUB and zona pellucida like domains 1"	Q86UP6	10	122832158-122846175	"Predicted membrane proteins"	"Cell adhesion, Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1631	"pancreas: 2414.2"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 266.9"	"Cancer enriched"	"Detected in some"	54	"pancreatic cancer: 32.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 1.9;U-937: 1.2"	"Not detected"	"Not detected"							"HPA068479, HPA068660, HPA074117"	Enhanced		Approved	Nucleoli,Vesicles		No	No				"Cluster 25: Pancreas - Digestion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli	Vesicles	"HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663"	"unprognostic (4.68e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.52e-5)"	"unprognostic (8.08e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.15e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.75e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.83e-4)"	0.4	0.2	0.2	0.2	0.3	0.8	0.4	0.2	0.5	0.6	0.2	0.6	0.5	0.4	0.4	0.5	0.4	0.0	0.4	0.3	0.2	0.9	0.2	0.5	0.2	0.2	0.2	1.0	2414.2	0.0	1.4	0.1	0.4	0.7	0.0	0.4	0.5	0.0	0.1	0.7	0.9	0.0	0.2	1.1	0.4	1.0	0.2	0.3	0.5	0.0	0.0	0.5	0.5	0.3	0.3	0.5	0.1	0.0	0.0	0.3	0.4	0.1	0.1	0.0	0.7	0.0	0.1	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.9	0.1	0.2	0.3	0.3	0.3	1.0	0.1	0.4	0.3	0.4	0.4	0.0	0.0	0.4	0.0	0.4	0.1	0.4	0.2	0.3	0.0	0.3	0.5	0.4	0.6	0.5	0.0	0.5	0.2	0.0	0.0	0.4	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.5	0.3	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.7	0.2	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.9	2.8	0.1	0.1	0.1	0.0	0.4	0.0	266.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.0	0.0	0.1	0.0	0.3	0.3	6.7	0.3	0.1	0.0	0.0	3.7	0.1	0.0	0.0	0.0	43.6	0.1	0.4	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.7	0.2	0.0	0.1	0.0	0.7	0.1	0.2	0.1
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated cyclophilin"	Q6UX04	5	64768930-65018750	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 255.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561"	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	13.4	13.0	13.6	13.0	14.6	20.5	13.4	16.7	18.4	12.6	10.7	14.3	9.8	15.5	12.3	11.8	11.8	11.2	18.9	13.1	15.5	14.1	10.2	10.7	15.4	14.5	13.7	18.2	9.0	16.9	8.8	14.6	14.4	13.9	15.0	14.0	10.5	12.3	22.2	11.5	10.1	14.3	13.5	12.8	11.1	17.2	14.1	21.7	13.9	26.4	16.0	13.2	11.5	15.4	32.7	21.4	37.5	69.9	31.4	38.2	41.8	33.5	27.7	36.7	38.2	36.0	40.3	48.0	57.0	35.0	41.2	20.2	39.8	60.5	66.2	40.4	32.4	36.2	35.6	30.3	48.0	38.3	23.5	25.6	45.7	46.3	58.3	32.3	39.4	53.9	35.8	30.8	36.8	32.6	53.5	34.7	30.4	16.9	25.6	49.0	50.4	50.3	35.0	28.0	44.4	19.6	40.8	16.4	39.7	35.5	35.9	55.5	32.9	21.4	37.8	34.6	54.2	23.9	33.1	46.5	40.1	65.9	38.8	13.2	13.1	9.6	13.6	13.2	16.8	17.5	15.3	17.4	16.9	13.2	16.2	16.9	2.7	20.4	10.2	13.8	18.0	10.4	13.6	14.6	16.7	18.4	13.1	15.5	14.5	13.7	14.4	13.5	14.1	15.4	24.2	9.6	26.2	64.3	26.0	16.4	27.7	37.5	13.6	31.4	17.4	20.3	63.6	18.6	23.2	14.7	14.6	44.0	16.8	11.6	21.5	44.1	255.6	21.0	27.2	27.2	29.9	37.8	114.1	33.1	54.5	25.1	13.7	20.2	19.6	40.7	16.4	11.4	33.0	20.2	110.3	17.0	40.7	17.1	15.2	57.9	38.5	22.3	14.2	61.8	33.6	34.2	36.0	103.0	103.2	40.4	16.0	36.1	21.0	22.1	13.3	24.4	28.6	51.3	32.9	31.3	33.6	74.2	28.3	20.6	20.0	30.8	26.2	30.7	28.6	23.8
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740541-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 3301.3"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 13262.1;Macrophages: 3685.4;Prostatic glandular cells: 8869.1;Urothelial cells: 13149.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"cerebral cortex: 136.1"	"Immune cell enriched"	"Detected in some"	451	"neutrophil: 483.0"	"Lineage enriched"	"Detected in single"	788	"granulocytes: 483.0"	"Group enriched"	"Detected in many"	5	"BJ hTERT+: 4072.6;GAMG: 1080.2"					"Not detected"	"Not detected"			HPA057179	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7260		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA057179: AB_2683362"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	67.9	13.5	1.8	209.9	2.8	3301.3	3.6	1.7	136.1	54.5	7.6	10.6	3.6	41.0	0.2	3.7	8.9	177.2	33.8	1.7	1.6	10.8	77.7	91.2	1.2	2.1	1.6	6.0	16.1	1.8	3.2	41.1	15.1	9.6	7.3	0.9	25.4	1.5	1.3	3.2	4.9	12.7	1.9	10.3	8.8	0.7	4.9	15.2	3.4	8.1	8.7	456.7	4.0	1.9	2.7	1.4	0.0	0.1	3.9	19.4	0.2	25.7	4072.6	35.9	117.0	0.2	13.0	0.2	547.6	1.3	1080.2	48.2	0.0	1.0	562.3	1.8	0.2	0.9	0.4	6.5	6.8	41.0	2.5	12.4	1.7	119.0	2.9	12.9	124.9	0.0	1.4	0.8	0.7	0.0	0.0	55.7	0.0	14.7	20.3	0.3	0.5	0.9	317.3	17.2	0.1	0.0	1.9	0.1	61.1	0.8	0.1	5.6	308.3	56.8	5.1	15.1	55.0	0.4	0.7	1.7	252.5	30.9	88.2	1.0	0.6	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	483.0	0.0	0.0	0.0	0.0	0.1	1.8	2.8	1.7	136.1	1.7	1.6	2.1	1.6	15.1	1.9	4.9	1.9	28.6	51.3	254.1	0.0	26.4	0.0	13262.1	0.0	164.4	0.5	40.2	15.4	23.8	127.2	426.5	0.0	0.0	4.3	17.7	14.4	0.0	1695.0	3.2	717.6	257.1	712.2	19.1	8.0	0.0	260.7	5.2	1475.1	54.0	1708.7	51.2	0.5	15.7	3.6	367.1	0.0	0.0	26.4	0.0	543.0	0.0	1.9	0.6	3685.4	0.0	0.0	1178.5	0.5	0.0	0.0	0.0	584.9	0.3	0.4	27.3	8869.1	0.9	1.0	178.6	1.1	39.5	44.3	263.0	0.3	2.5	124.9	0.0	21.3	138.8	0.0	18.5	13149.4
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137251	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.2;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	52	"neutrophil: 3273.9"	"Lineage enriched"	"Detected in many"	111	"granulocytes: 3273.9"	"Group enriched"	"Detected in some"	11	"BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1"					"Low region specificity"	"Detected in all"			"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	13.8	1.5	0.3	40.0	0.6	7.3	0.8	0.2	2.6	4.5	0.1	0.9	0.2	0.4	1.3	27.2	2.9	7.8	1.0	0.3	0.1	0.4	2.4	6.5	0.7	0.6	0.5	0.4	2.9	0.4	0.2	4.6	1.4	0.6	0.7	0.0	3.0	3.8	0.5	4.8	1.2	2.4	0.3	27.3	0.7	0.2	0.5	2.8	0.6	11.6	3.0	7.8	7.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.3	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	15.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	63.5	29.5	50.3	28.8	7.4	0.4	0.2	1.3	7.3	13.5	0.2	1.1	9.9	3273.9	6.8	3.6	25.0	0.5	17.4	0.3	0.6	0.2	2.6	0.3	0.1	0.6	0.5	1.4	0.3	0.5	0.4	0.0	0.0	10.5	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.7	12.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	6.3	3.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	1.6	0.0	0.0	2.8	0.0	1.0	3.7	0.0	40.2	0.0	0.1	0.0	2.2	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.0	11.6	0.1	0.3	4.1	0.1	0.1	1.9
CXorf58	FLJ25444	ENSG00000165182	"Chromosome X open reading frame 58"	Q96LI9	X	23908006-23939509	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	8	"testis: 3.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 33.3;Late spermatids: 6.9;Respiratory ciliated cells: 5.5;Spermatocytes: 19.7;Spermatogonia: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"GAMG: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031542, HPA031543, HPA031544"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA031542: AB_2673927, HPA031543: AB_10603789, HPA031544: AB_2673929"	"unprognostic (9.74e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.06e-3)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	3.9	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	2.0	0.2	0.0	0.2	0.4	0.0	0.5	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.9	0.2	33.3	1.6	0.1	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	1.0	0.6	0.7	0.0	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.2	5.5	2.8	0.0	0.0	0.1	19.7	8.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250846-74291973	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 889.6;liver: 2472.0"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1117.0;RT4: 513.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol		No	No		1400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750"	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	309.5	109.6	38.4	31.2	39.7	25.3	253.5	42.2	45.2	86.0	37.6	146.5	438.2	44.9	176.2	78.1	81.9	301.2	84.8	37.5	38.8	889.6	2472.0	356.6	43.7	43.1	39.7	223.9	461.3	236.0	58.5	81.8	41.9	95.9	103.4	10.3	59.1	122.8	41.4	118.4	381.7	46.7	40.8	75.6	194.8	57.9	40.0	51.6	42.5	42.1	35.2	155.5	68.3	43.5	78.8	130.8	67.4	0.6	1117.0	198.2	89.5	52.6	113.8	111.0	163.8	156.2	82.7	95.6	36.7	97.6	54.4	170.6	0.1	73.1	86.9	179.8	91.7	34.9	65.6	418.1	174.6	67.3	44.1	334.1	57.4	63.0	32.3	66.0	63.6	85.8	58.6	35.0	93.7	140.9	38.3	80.5	30.4	110.0	86.8	93.6	21.9	2.3	111.9	513.2	190.4	79.7	51.4	137.1	65.8	56.6	271.5	63.7	57.9	0.6	85.8	26.6	68.1	24.6	109.2	30.3	67.0	19.2	64.3	4.1	29.5	7.5	51.3	36.3	116.2	93.7	55.6	60.2	53.7	112.7	54.5	68.6	3.7	36.3	45.7	47.8	48.8	43.2	38.4	39.7	42.2	45.2	37.5	38.8	43.1	39.7	41.9	40.8	40.0	43.5	169.7	637.8	1371.0	11.4	76.0	98.0	82.1	368.6	50.7	9.9	345.8	213.2	90.7	836.4	1053.2	842.4	4.2	229.3	29.4	197.0	2156.1	239.4	7.5	163.1	76.6	119.9	164.2	180.0	13.1	504.6	169.8	141.4	208.9	345.6	39.9	55.0	177.4	3376.3	97.4	8.4	12.6	236.5	457.7	128.6	72.9	26.7	158.1	60.8	90.7	10.3	224.1	39.2	32.0	14.1	22.7	266.7	358.9	149.7	33.4	142.0	1856.4	3630.6	619.5	14.0	52.6	49.6	85.0	15.3	42.0	141.2	223.9	44.5	52.6	1123.6	329.9	220.7
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961873-202967275	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 605.2"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 187.2;Extravillous trophoblasts: 196.5;Syncytiotrophoblasts: 293.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 187.3;hTCEpi: 188.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	38.6	57.3	37.4	23.0	38.8	19.7	43.7	41.1	40.5	49.7	57.3	35.7	19.3	41.2	131.4	61.6	68.2	27.2	154.8	38.3	48.0	64.5	50.2	44.0	25.2	45.4	49.4	41.7	45.1	82.9	46.1	66.6	55.7	41.1	21.2	34.3	56.9	40.0	605.2	123.8	25.7	37.5	39.9	39.1	92.8	50.7	41.4	40.1	40.5	308.0	38.8	52.7	45.8	43.6	34.8	21.3	18.3	37.7	166.0	37.9	178.5	68.3	63.4	43.2	38.4	17.5	39.9	21.5	56.5	68.1	24.0	187.3	14.9	58.0	28.2	31.2	37.8	12.4	24.0	20.4	59.7	10.5	29.6	61.2	188.3	47.5	25.8	36.4	28.9	25.8	37.0	37.6	157.8	40.4	13.6	9.5	12.1	31.0	40.1	21.9	87.6	45.7	41.1	40.8	15.7	19.1	38.0	124.0	57.4	39.4	57.7	23.4	28.5	49.0	20.8	18.7	38.3	34.9	44.5	10.0	53.6	16.2	37.1	24.4	56.7	46.6	27.4	42.6	36.3	23.4	30.9	28.9	37.6	35.0	41.9	29.6	46.0	32.2	29.4	25.9	34.2	52.6	37.4	38.8	41.1	40.5	38.3	48.0	45.4	49.4	55.7	39.9	41.4	43.6	33.0	22.4	29.8	10.1	15.5	187.2	38.5	89.5	42.1	21.0	46.1	41.9	119.3	37.1	60.5	29.5	29.2	171.1	15.8	10.6	7.9	38.3	5.0	58.7	17.3	30.0	19.2	30.7	8.9	48.3	196.5	28.9	31.6	34.9	28.5	13.6	32.9	44.6	63.5	10.1	11.3	10.8	105.8	45.4	29.7	8.6	29.8	39.5	64.0	8.4	20.9	65.9	11.3	11.6	8.1	72.8	11.3	31.2	12.5	25.8	16.0	38.9	75.9	35.0	13.1	49.1	30.0	23.0	4.3	40.6	157.4	293.5	19.5	27.9	14.7	48.2
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095039-144097525	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 730.0;tongue: 724.9"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 817.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 1125.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Approved	Mitochondria		NA	NA		45000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	84.7	173.2	92.1	62.4	97.2	104.4	72.7	115.4	103.8	71.4	102.4	162.6	171.2	75.9	35.7	155.5	67.8	39.5	527.7	92.3	105.3	152.6	180.4	56.7	55.8	99.8	96.9	63.6	101.2	163.3	58.2	45.8	103.1	67.8	111.0	42.0	104.4	70.0	730.0	106.5	127.5	59.9	94.9	70.1	139.6	38.9	106.9	63.4	64.8	724.9	61.0	92.0	86.5	99.6	172.0	381.4	98.9	208.4	80.5	88.5	189.6	96.7	116.7	240.2	156.9	269.4	208.2	241.0	210.8	129.8	116.2	247.3	217.9	191.2	89.8	148.2	289.2	259.7	306.5	250.4	143.1	154.7	162.5	129.4	234.9	153.2	301.4	80.6	141.3	163.7	240.4	208.2	127.7	616.8	292.0	143.5	115.1	476.8	1125.5	253.7	132.4	422.1	199.7	273.0	263.3	117.2	267.8	365.7	200.0	54.0	302.5	233.2	108.8	152.1	321.6	169.6	299.7	229.1	179.7	183.8	193.2	261.9	198.4	185.7	340.4	95.7	131.6	360.4	139.8	208.7	108.1	141.5	444.1	180.3	104.9	134.6	32.7	187.8	278.8	251.0	158.2	397.1	92.1	97.2	115.4	103.8	92.3	105.3	99.8	96.9	103.1	94.9	106.9	99.6	77.0	19.2	29.3	23.5	94.0	156.1	191.9	394.8	62.6	113.6	110.7	102.6	402.3	181.6	156.0	79.1	81.3	263.6	61.7	516.1	817.8	239.9	81.2	59.1	68.1	88.0	146.4	130.6	14.4	289.1	257.1	102.8	144.8	60.2	59.7	89.2	62.4	239.4	246.3	87.5	21.6	390.4	272.6	104.8	139.4	88.6	88.9	101.4	179.7	12.2	208.4	115.2	92.7	12.1	17.5	290.6	332.5	90.7	149.9	237.9	570.0	468.6	86.1	100.9	72.3	109.4	250.6	83.1	116.7	212.9	163.7	236.8	63.8	197.5	602.6	258.3
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 94.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 136.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	14.3	22.0	23.9	38.8	23.5	94.3	13.6	17.9	18.2	13.0	22.3	16.3	16.1	15.1	12.1	23.3	11.0	20.5	20.1	17.3	23.3	14.2	21.0	21.5	53.4	21.3	27.8	15.4	15.2	23.0	15.4	15.4	23.6	16.3	19.3	22.0	18.9	16.0	34.3	15.2	16.2	16.8	21.6	39.0	19.9	38.3	32.7	35.6	24.9	20.5	48.4	24.1	12.9	24.2	26.9	8.3	9.4	10.6	14.3	21.0	8.7	39.1	56.7	39.9	23.4	6.9	12.5	30.7	13.7	38.3	43.4	10.3	11.3	23.7	58.7	136.6	16.6	15.5	15.3	5.8	29.1	15.4	69.5	23.0	18.6	48.1	50.1	37.7	16.3	21.3	6.6	26.1	56.4	4.0	14.4	22.3	10.1	8.5	13.3	13.4	18.8	29.4	12.9	9.1	12.0	9.2	33.1	11.2	9.8	14.3	11.0	18.9	18.6	67.2	15.4	23.4	15.9	68.0	68.4	33.2	49.3	16.7	14.7	64.6	15.2	38.3	18.1	17.7	21.8	17.2	27.1	24.5	18.3	11.1	24.4	19.4	32.3	25.7	18.8	11.0	37.3	19.5	23.9	23.5	17.9	18.2	17.3	23.3	21.3	27.8	23.6	21.6	32.7	24.2	28.8	44.8	31.8	31.6	87.7	120.1	59.5	32.2	40.9	89.2	35.5	26.0	34.4	21.5	32.9	18.4	93.8	6.8	84.1	28.3	5.9	20.0	48.2	22.5	24.9	36.0	31.1	26.1	51.9	19.1	4.4	37.3	22.4	47.1	80.5	21.4	27.8	25.5	21.5	67.3	54.7	10.7	30.5	40.0	127.6	31.3	25.4	66.4	74.7	57.1	63.7	23.3	70.0	51.8	119.2	18.0	22.4	21.1	79.7	66.4	15.4	13.9	23.3	48.3	6.6	54.2	30.5	59.2	15.2	64.3	155.6	4.1	119.5	21.3	14.8	66.7
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338601	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"placenta: 124.4"	"Cell type enriched"	"Detected in some"	10	"Syncytiotrophoblasts: 2007.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Group enriched"	"Detected in many"	4	"amygdala: 4.8;hypothalamus: 4.1;medulla oblongata: 1.4;midbrain: 2.0;thalamus: 3.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 92.8;HDLM-2: 17.5;HSkMC: 31.4;SuSa: 16.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000355, HPA051194"	Enhanced		Uncertain	Mitochondria		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria		"CAB000355: , HPA051194: AB_2681381"	"unprognostic (9.41e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.52e-5)"	"unprognostic (6.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.25e-4)"	"unprognostic (5.18e-5)"	"unprognostic (1.54e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.54e-5)"	"unprognostic (2.52e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.11e-1)"	8.3	9.0	4.8	0.4	0.6	0.2	2.1	0.1	0.5	0.6	0.0	0.2	0.7	0.3	0.0	0.1	0.3	0.5	1.2	0.3	4.1	0.1	0.1	0.7	0.0	1.4	2.0	3.2	1.3	0.2	0.0	124.4	0.7	0.6	0.1	0.6	0.9	2.7	0.6	1.8	0.2	1.3	0.2	0.6	0.2	6.5	3.7	0.2	2.4	0.3	0.0	3.5	0.5	0.7	0.1	0.0	0.0	0.0	1.7	92.8	6.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.3	0.5	0.4	0.0	0.0	0.0	0.0	17.5	0.0	0.6	0.2	8.1	0.6	0.0	0.1	31.4	0.0	0.3	4.0	0.3	0.0	0.0	0.0	0.8	0.4	0.7	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.4	0.2	16.3	0.0	0.5	0.1	0.3	0.1	0.2	0.0	3.0	1.6	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.6	0.1	0.5	0.3	4.1	1.4	2.0	0.7	0.2	3.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.0	0.1	0.0	7.9	1.5	0.0	0.0	0.0	191.3	0.0	0.0	14.0	0.0	0.3	0.0	0.0	0.9	0.0	5.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.9	12.3	0.3	0.0	0.0	2007.5	0.0	22.2	0.0	0.0
CYP20A1	CYP-M	ENSG00000119004	"Cytochrome P450 family 20 subfamily A member 1"	Q6UW02	2	203238977-203306026	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA055872, HPA058461"	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions, Actin filaments"	Nucleoplasm	"HPA055872: AB_2682951, HPA058461: AB_2683725"	"unprognostic (4.72e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.64e-3)"	"unprognostic (9.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-3)"	3.1	3.2	3.1	2.1	4.3	2.2	2.4	4.1	3.4	2.7	4.2	3.6	2.1	2.3	2.4	2.4	1.9	3.2	1.7	2.7	3.0	6.1	4.6	3.5	3.9	4.5	3.8	3.8	3.1	2.9	0.9	3.4	3.8	3.5	3.2	1.7	2.3	2.1	2.6	3.8	2.6	3.2	2.9	3.7	3.7	2.9	4.2	2.2	8.0	1.3	2.9	3.2	1.0	5.7	2.8	4.7	2.9	2.9	12.1	2.9	2.5	5.0	3.3	2.4	1.7	9.1	5.2	1.9	3.8	4.8	4.4	4.0	1.9	2.7	4.6	2.9	1.0	6.1	3.0	3.5	7.2	6.4	3.3	5.5	2.2	5.7	4.9	2.1	6.4	2.8	8.0	9.9	5.1	4.2	4.3	3.7	7.7	2.3	4.2	3.5	3.7	4.5	3.2	9.2	2.0	2.2	0.4	4.0	5.5	3.3	2.7	4.8	8.5	8.4	2.5	4.0	4.1	5.2	4.4	2.3	6.4	2.8	3.6	5.7	5.2	2.1	6.5	5.6	7.1	6.1	8.0	5.9	2.3	9.6	5.9	3.5	3.0	4.9	6.5	7.4	8.0	4.3	3.1	4.3	4.1	3.4	2.7	3.0	4.5	3.8	3.8	2.9	4.2	5.7	41.2	16.0	33.2	24.2	55.5	12.4	41.6	20.2	29.6	42.0	17.1	17.8	33.6	50.1	33.8	16.5	58.4	33.4	55.8	40.3	11.7	18.3	96.6	24.2	33.6	40.5	45.4	45.5	12.1	20.3	23.0	49.0	53.0	23.7	29.1	65.4	88.2	50.4	37.9	50.5	20.5	33.0	22.4	38.1	22.5	21.9	123.0	35.8	7.2	34.7	44.5	32.4	74.2	24.1	39.1	15.2	30.6	83.8	51.7	33.6	30.8	26.2	23.5	70.5	65.7	76.6	45.7	104.5	64.1	25.4	13.4	40.8	54.4	59.7	32.8	28.7
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153446-54173986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 18.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"A549: 411.5;Hep G2: 122.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022261, HPA063771"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.0	0.0	0.2	0.4	0.4	0.0	3.7	0.0	0.3	1.7	0.0	0.0	0.1	14.9	0.2	3.8	0.2	0.0	0.0	0.1	1.8	35.3	0.4	0.7	0.2	0.4	2.0	0.0	0.0	0.0	0.2	10.0	0.3	2.9	0.0	0.0	0.3	2.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.2	1.3	0.0	10.5	28.7	1.3	0.2	0.5	411.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.6	0.0	3.2	0.0	0.9	15.8	0.0	0.1	0.1	0.0	0.0	0.0	6.5	122.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	7.0	1.3	0.0	2.6	0.6	0.0	0.1	0.1	0.0	0.0	0.0	16.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.1	1.8	0.4	2.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	1.3	22.8	48.3	142.7	74.0	0.0	11.0	8.6	0.4	0.0	47.0	0.0	0.0	0.1	0.1	0.1	5.9	0.1	0.0	0.7	0.5	0.3	0.0	0.0	0.2	0.0	0.1	2.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	9.8	0.0	61.3	13.1	0.0	0.0	0.0	0.6	0.0	0.0	3.3	19.6	0.1	0.1	0.0	0.2	36.7
CYP26B1	P450RAI-2	ENSG00000003137	"Cytochrome P450 family 26 subfamily B member 1"	Q9NR63	2	72129238-72147862	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;skin 1: 31.4"	"Group enriched"	"Detected in many"	4	"Leydig cells: 75.8;Peritubular cells: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 9.8;HaCaT: 14.8;RH-30: 18.4;U-2 OS: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012567	Uncertain		Approved	Cytosol	"Intracellular and membrane"	No	No				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA012567: AB_1847429"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.19e-4)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.17e-4)"	"unprognostic (8.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.04e-2)"	26.2	4.3	12.0	1.9	3.3	0.1	15.0	12.3	7.0	5.0	0.4	3.2	3.7	2.5	1.5	3.9	5.5	1.1	8.5	6.7	1.3	8.8	1.0	2.7	4.9	48.0	10.4	4.5	0.6	0.8	9.3	3.3	49.9	2.6	1.2	4.2	9.9	7.3	5.9	31.4	4.7	1.6	0.0	3.5	1.2	13.8	0.7	19.3	14.4	2.3	2.9	3.2	4.2	3.5	0.6	5.9	0.0	0.1	9.8	4.0	5.9	0.9	0.1	0.2	0.2	1.8	0.5	0.0	0.5	0.7	3.0	14.8	8.5	0.0	0.1	0.0	2.7	0.0	7.0	0.9	0.2	0.0	0.3	0.0	0.5	0.0	0.3	3.0	1.1	4.0	0.6	0.1	0.9	2.9	0.0	0.1	0.0	0.1	1.0	0.1	18.4	0.0	0.0	1.3	0.6	0.1	3.0	0.0	3.5	1.2	0.3	0.9	0.0	1.6	19.3	9.0	3.0	0.1	1.2	0.0	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	3.3	12.3	7.0	6.7	1.3	48.0	10.4	49.9	0.0	0.7	3.5	2.4	0.0	0.0	2.0	1.2	14.7	1.1	0.8	0.6	0.2	2.3	0.8	1.4	4.3	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.2	4.1	0.2	0.2	19.0	1.8	5.3	5.3	0.0	0.9	15.6	0.0	0.3	0.0	1.5	34.6	0.8	0.1	0.0	0.7	0.0	0.0	6.1	19.1	9.6	75.8	0.4	7.2	0.0	0.0	7.4	0.0	2.0	0.5	0.4	1.5	229.9	0.0	0.5	0.2	0.1	0.2	0.3	0.0	5.7	20.7	1.5	3.8	1.6	9.7	0.1	0.8	7.5	0.1	0.4
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 594.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 404.3;Hofbauer cells: 148.9;Proximal enterocytes: 206.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 176.9;melanoma: 85.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 151.5;neutrophil: 126.3"	"Group enriched"	"Detected in many"	21	"granulocytes: 126.3;monocytes: 151.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 299.6;HSkMC: 54.7;RPTEC TERT1: 78.5;SK-MEL-30: 103.6;WM-115: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	23.1	50.3	45.2	15.7	59.0	1.3	21.8	57.0	59.3	27.6	75.6	27.6	77.8	19.8	11.6	11.9	34.0	19.1	30.7	42.2	49.3	46.4	594.4	71.7	24.6	63.0	56.1	32.6	8.3	18.5	29.6	6.2	62.7	41.8	20.7	22.5	40.4	29.5	37.9	17.5	81.9	13.2	50.6	13.0	13.8	12.6	58.8	23.6	12.6	49.2	28.0	24.3	23.2	69.2	0.2	0.0	2.7	0.2	4.6	3.3	0.4	1.9	11.7	3.9	7.8	13.7	0.8	0.0	4.3	7.6	0.2	0.1	0.0	0.0	1.7	1.4	1.0	0.0	0.4	299.6	16.2	0.4	0.3	54.7	0.5	0.1	0.0	12.8	5.9	0.0	0.3	0.1	8.3	0.0	0.0	0.2	2.3	0.3	0.5	0.1	2.4	0.5	78.5	0.2	0.2	0.2	0.1	0.0	103.6	2.4	1.6	2.2	5.9	0.0	0.2	0.1	6.0	0.0	0.0	0.1	0.1	0.3	42.9	0.0	151.5	0.4	0.2	17.1	0.3	0.7	0.2	0.5	6.5	0.0	0.1	0.0	126.3	0.0	1.2	0.8	0.0	44.1	45.2	59.0	57.0	59.3	42.2	49.3	63.0	56.1	62.7	50.6	58.8	69.2	10.6	3.2	28.9	33.6	0.9	5.2	52.4	8.5	21.6	15.3	12.7	18.8	5.1	17.2	11.3	3.7	27.1	0.7	0.5	37.0	9.8	12.1	1.0	12.6	4.3	10.3	24.5	8.4	2.2	12.0	0.7	35.4	2.6	14.8	2.5	1.9	19.6	404.3	148.9	10.1	3.9	20.0	4.1	18.2	5.1	1.0	47.5	104.3	49.8	15.0	92.4	28.7	0.0	26.7	108.5	9.7	44.0	26.7	0.0	43.3	206.3	76.9	21.4	14.1	0.0	12.8	7.2	0.7	0.1	3.2	3.1	1.2	2.3	1.2	30.3	20.4
CYP27C1	FLJ16008	ENSG00000186684	"Cytochrome P450 family 27 subfamily C member 1"	Q4G0S4	2	127183832-127220313	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 4.1;skin 1: 5.1"	"Cell type enhanced"	"Detected in some"		"Club cells: 5.4;Collecting duct cells: 3.7;Endometrial stromal cells: 5.8;Leydig cells: 7.5;Pancreatic endocrine cells: 7.6;Suprabasal keratinocytes: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 7.6;HDLM-2: 11.8;hTERT-RPE1: 12.5;TIME: 11.6;U-138 MG: 10.9;U-251 MG: 7.9"									"HPA062460, HPA068731"			Enhanced	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA062460: AB_2732683, HPA068731: AB_2686023"	"unprognostic (1.90e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.31e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.29e-4)"	"unprognostic (3.49e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.64e-2)"	0.6	0.5	0.8	0.4	0.2	0.3	0.3	0.8	0.7	4.1	0.6	1.2	0.3	0.6	0.4	1.6	0.6	0.7	0.9	0.5	1.0	0.2	0.2	0.2	0.3	0.6	2.4	0.2	0.2	0.0	0.1	0.1	0.4	0.9	0.3	0.1	0.3	0.7	0.4	5.1	0.6	0.2	0.3	0.2	0.3	0.3	2.7	0.0	0.1	0.1	0.8	1.8	2.5	0.8	1.3	3.4	1.9	0.1	0.1	0.0	0.1	0.4	3.2	1.8	0.8	0.1	2.8	0.1	0.1	2.0	1.3	7.6	2.7	1.4	0.6	11.8	1.4	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.1	12.5	0.4	0.3	0.0	0.2	2.1	0.2	0.3	0.1	4.0	0.0	1.0	0.1	0.2	0.0	5.9	1.0	0.1	0.7	4.9	0.0	0.0	1.5	0.1	0.2	11.6	10.9	2.0	5.3	7.9	0.1	0.1	0.0	0.1	0.1	0.9	0.5	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.8	0.2	0.8	0.7	0.5	1.0	0.6	2.4	0.4	0.3	2.7	0.8	0.2	0.0	0.6	0.0	0.2	1.8	1.2	2.1	0.0	0.0	1.5	0.3	0.5	0.0	5.4	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	5.8	0.5	0.0	0.0	0.6	0.2	0.0	2.4	0.0	0.5	0.0	0.2	0.4	0.1	0.0	0.0	0.7	0.0	2.0	0.0	1.9	0.1	7.5	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.2	7.6	0.0	0.4	0.0	1.6	0.0	0.0	0.2	0.0	0.0	1.5	1.0	0.1	0.7	0.0	7.2	0.0	0.2	0.0	0.0	2.9
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130865	"Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 320.0"	"Group enriched"	"Detected in many"	35	"Hepatocytes: 512.8;Proximal enterocytes: 465.2"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.8"					"Low region specificity"	"Detected in many"			HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.2	0.0	0.3	0.3	0.1	0.8	0.2	0.1	0.3	0.3	3.7	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.3	320.0	0.1	0.1	0.2	0.0	0.2	0.8	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.2	11.7	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.3	0.6	0.0	1.1	5.5	0.7	0.5	0.7	1.3	2.8	7.3	1.1	1.4	0.4	2.8	0.7	1.8	2.1	0.1	0.6	2.9	1.9	0.7	3.1	0.8	0.6	0.6	1.2	0.0	6.5	0.6	0.1	0.3	4.1	1.4	0.0	0.7	5.7	512.8	0.1	11.8	9.4	7.6	0.0	5.6	0.0	13.6	0.0	0.4	0.0	0.0	0.1	0.7	0.0	5.0	4.9	0.7	11.3	1.5	0.4	0.6	465.2	0.5	1.3	2.3	0.0	0.4	2.1	0.8	0.4	0.6	1.1	0.4	1.0	0.1	3.4	0.3
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	309	"liver: 10379.8"	"Cell type enriched"	"Detected in many"	58	"Hepatocytes: 6272.7"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5;myeloid DC: 6.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 6.2;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.0;HL-60: 8.9;HMC-1: 8.9;NB-4: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	2.8	2.9	5.4	0.6	5.4	0.8	3.0	9.1	7.5	4.9	3.0	5.0	1.4	4.5	8.3	16.7	5.5	2.5	2.1	5.5	5.5	9.1	10379.8	2.6	2.0	6.1	5.5	4.1	12.4	0.6	4.1	1.4	6.7	5.3	1.2	11.5	3.6	6.1	2.8	13.8	2.2	2.2	5.0	7.2	6.7	3.7	6.3	1.7	4.0	0.9	33.6	3.5	3.2	7.5	0.1	0.0	0.3	1.0	3.5	1.9	0.7	1.6	4.5	0.0	0.3	0.0	2.7	1.4	0.2	0.5	0.0	11.0	0.0	0.2	0.4	0.3	1.5	1.8	0.2	1.3	0.6	8.9	8.9	1.0	0.2	0.0	0.7	1.9	0.0	3.1	0.6	0.4	1.0	0.7	0.6	24.0	6.4	4.3	0.4	0.4	6.1	0.0	2.0	0.0	0.0	0.0	4.2	0.0	0.6	0.2	0.3	0.9	0.0	1.4	0.4	2.3	1.0	2.2	1.0	3.0	1.5	7.4	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.6	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	5.4	5.4	9.1	7.5	5.5	5.5	6.1	5.5	6.7	5.0	6.3	7.5	0.8	0.0	1.1	5.5	9.2	2.3	0.2	0.7	0.6	5.7	0.6	0.5	2.8	48.6	1.9	0.0	2.1	0.0	0.4	0.1	0.0	1.6	2.1	0.6	0.8	4.6	0.0	67.6	6.7	1.3	0.1	1.1	1.5	0.5	1.3	0.7	67.1	6272.7	0.0	8.4	5.3	0.0	0.0	108.0	2.8	2.1	1.5	0.3	0.0	1.9	0.4	0.7	0.0	2.0	2.2	3.2	0.0	2.6	0.3	0.6	0.0	0.6	2.2	5.8	0.0	0.2	0.6	4.1	4.2	2.0	7.5	0.1	5.7	0.2	0.0	0.0
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193210-41207539	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 101.3;stomach 1: 120.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.0;Gastric mucus-secreting cells: 110.6;Intestinal goblet cells: 29.2;Langerhans cells: 73.0;Proximal enterocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 24.7;myeloid DC: 84.4"	"Group enriched"	"Detected in many"	131	"dendritic cells: 84.4;monocytes: 24.7"	"Cell line enhanced"	"Detected in many"		"A549: 99.4;CACO-2: 49.8;HaCaT: 50.3;NTERA-2: 69.6;OE19: 158.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.8	1.1	1.4	6.7	1.4	1.8	0.9	3.1	1.5	2.7	1.2	26.7	101.3	0.5	0.2	14.5	6.3	5.5	0.5	1.3	4.1	1.1	1.4	7.1	1.7	6.3	10.0	0.3	0.6	0.7	1.2	1.6	6.1	1.3	18.6	0.2	5.0	0.9	0.2	3.7	65.3	1.7	2.2	6.1	120.4	0.8	3.6	3.2	0.6	0.2	13.2	3.6	4.0	2.5	3.8	99.4	0.0	0.1	0.0	0.0	4.5	0.6	0.8	1.0	0.2	49.8	13.6	0.2	10.4	0.7	0.1	50.3	16.6	25.0	0.4	0.0	0.3	12.9	5.1	19.1	19.4	0.0	0.4	0.8	1.4	1.4	0.8	0.2	0.8	4.3	5.8	0.2	0.0	2.0	0.3	0.2	69.6	158.6	12.5	0.2	0.0	0.9	1.5	20.4	0.1	0.6	9.1	0.0	0.0	27.8	12.2	4.7	10.6	0.1	4.0	1.7	0.0	0.5	0.0	0.0	0.5	2.1	0.1	0.0	24.7	0.0	0.0	5.9	0.4	0.0	0.0	0.1	84.4	0.0	0.0	0.0	0.2	0.1	3.7	3.2	0.0	11.4	1.4	1.4	3.1	1.5	1.3	4.1	6.3	10.0	6.1	2.2	3.6	2.5	0.3	0.0	6.9	1.0	0.7	2.5	2.0	18.2	23.3	0.0	0.1	0.3	1.2	0.0	7.6	1.8	0.0	24.9	0.1	31.0	0.0	0.7	0.3	7.4	0.3	0.4	0.0	0.0	0.4	1.0	1.1	0.8	110.6	0.3	1.3	0.1	0.4	0.0	14.5	0.0	0.5	29.2	0.0	5.7	73.0	0.0	0.0	16.0	0.0	1.0	7.2	0.0	0.0	0.5	0.1	23.7	22.3	0.0	0.4	0.5	50.7	0.2	10.8	0.0	0.0	0.3	0.9	0.1	0.4	4.0	2.8	10.3	0.3	0.0	14.1	0.5
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112153-92134803	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 204.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 169.7;Early spermatids: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 481.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	19.4	58.2	22.3	20.6	24.9	30.3	30.6	39.8	32.3	26.4	21.0	52.7	86.6	21.2	35.8	43.7	16.7	24.3	20.7	24.2	39.0	38.7	204.7	53.2	13.1	60.1	42.3	29.0	48.7	59.6	17.1	21.9	50.6	43.8	41.5	31.4	20.3	17.5	7.9	26.5	40.0	20.4	46.6	13.4	45.1	86.4	31.8	6.6	33.6	11.7	16.6	21.3	26.2	57.0	113.7	54.3	134.0	86.4	92.0	149.6	18.7	37.7	112.7	47.1	128.8	131.8	201.7	98.1	57.9	65.3	481.6	96.2	118.1	237.0	55.3	40.3	82.6	27.9	51.1	99.7	125.7	56.0	39.4	109.1	105.7	185.6	194.0	42.2	49.4	19.8	108.2	217.8	56.4	115.6	12.5	53.8	100.7	45.9	53.4	40.3	27.8	222.8	216.7	187.9	94.1	62.5	80.0	156.3	117.2	60.6	56.9	69.5	59.5	65.0	70.6	95.2	49.8	72.8	70.5	88.1	49.8	75.5	85.2	2.8	11.1	3.9	11.6	16.3	7.7	15.6	8.0	8.9	16.3	12.3	7.1	9.6	1.5	7.8	10.3	14.3	6.7	8.2	22.3	24.9	39.8	32.3	24.2	39.0	60.1	42.3	50.6	46.6	31.8	57.0	3.1	67.3	169.7	35.9	24.0	2.5	1.6	4.6	48.9	2.6	6.7	3.7	1.6	7.2	44.5	1.8	2.1	1.5	8.9	20.3	1.9	10.7	74.4	10.7	8.1	7.7	10.8	11.6	34.3	19.8	1.0	9.1	43.3	16.4	28.5	4.1	5.3	45.2	1.5	0.0	39.6	13.1	2.0	5.6	1.9	34.4	3.7	9.2	0.0	15.9	1.3	2.4	0.0	39.2	53.1	14.2	11.7	1.5	34.3	1.4	9.6	1.5	15.7	1.9	0.0	4.0	6.5	7.8	4.2	51.4	5.4	4.4	12.2	9.3	11.9	2.5
CYSRT1	"C9orf169, MGC59937"	ENSG00000197191	"Cysteine rich tail 1"	A8MQ03	9	137224635-137226315	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 239.5"	"Group enriched"	"Detected in some"	10	"Pancreatic endocrine cells: 58.0;Squamous epithelial cells: 66.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 23.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 25.1;CAPAN-2: 28.9;HaCaT: 33.3;HeLa: 30.6;MCF7: 49.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021883, HPA021886"	Approved		Approved	"Nuclear speckles,Vesicles,Midbody"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear speckles"	"Vesicles, Midbody"	"HPA021883: AB_1853190, HPA021886: AB_1853192"	"unprognostic (1.35e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.31e-3)"	"unprognostic (6.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.11e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	0.6	1.1	0.6	0.2	0.4	0.4	1.5	0.3	1.6	43.1	0.0	0.6	0.4	0.5	0.4	239.5	1.8	0.7	0.9	0.8	0.8	3.7	1.7	1.1	0.7	1.4	1.3	0.3	1.5	0.6	7.3	0.3	0.6	2.6	0.1	0.6	29.9	0.5	0.4	34.4	0.8	0.0	1.0	0.7	2.0	4.1	0.9	0.3	2.4	0.0	14.3	1.2	57.7	0.5	25.1	2.4	1.8	3.9	0.0	0.1	5.3	0.4	0.4	0.5	0.2	1.3	28.9	1.3	1.2	0.3	0.7	33.3	0.5	7.0	0.0	2.7	1.8	0.3	30.6	16.8	0.9	0.2	1.4	0.4	3.5	0.9	0.2	1.3	0.3	1.4	0.6	3.1	1.6	49.5	0.7	1.0	0.7	4.8	3.0	2.4	2.8	3.5	0.6	1.6	0.4	1.8	4.5	3.5	0.9	1.5	7.7	0.4	1.0	1.1	0.9	3.2	0.6	1.9	1.7	1.2	1.4	1.3	1.4	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.6	0.4	0.3	1.6	0.8	0.8	1.4	1.3	0.6	1.0	0.9	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.5	0.4	1.5	2.5	5.5	0.0	0.6	0.1	0.4	0.0	4.6	0.5	2.1	0.2	0.3	0.0	0.0	0.3	5.8	0.2	0.1	3.1	1.7	0.0	0.6	0.7	0.8	0.2	0.0	0.3	0.6	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	58.0	1.1	0.4	0.1	0.2	1.6	0.9	0.0	0.6	0.0	0.3	0.3	3.0	1.1	66.0	0.0	0.0	0.1	0.9	0.5	1.7
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315341	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.3;lymphoid tissue: 67.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 117.5;granulocytes: 57.0;Hofbauer cells: 76.8;Kupffer cells: 71.5;Langerhans cells: 87.5;Macrophages: 55.0;NK-cells: 120.5;T-cells: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 34.1;HMC-1: 141.1;THP-1: 95.2;U-266/70: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004065, HPA071573"	Approved		Supported	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA004065: , HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	21.5	8.8	4.9	67.3	4.5	58.3	5.1	4.4	8.5	5.3	6.0	10.7	8.5	4.4	1.6	6.1	4.8	16.4	5.6	4.7	5.6	4.1	5.7	18.9	57.0	8.8	7.4	3.4	2.5	2.1	2.9	28.0	7.8	3.6	10.0	0.3	7.3	4.3	2.2	2.2	15.2	12.9	6.7	59.2	11.5	2.7	9.7	25.6	3.0	5.1	40.3	23.2	2.5	9.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	9.3	0.3	0.0	2.5	0.1	0.0	0.6	0.0	5.3	0.0	9.8	0.0	0.0	0.0	34.1	141.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	23.2	0.0	0.0	0.5	13.5	0.0	0.1	1.0	1.3	0.2	19.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	95.2	0.3	0.0	0.1	0.1	0.0	28.4	4.0	4.5	18.5	11.5	0.2	15.8	62.6	87.5	55.4	102.5	39.0	30.3	30.5	44.8	47.5	31.8	30.0	38.3	199.1	45.0	129.4	113.8	30.7	76.2	4.9	4.5	4.4	8.5	4.7	5.6	8.8	7.4	7.8	6.7	9.7	9.1	1.1	3.2	8.4	0.0	37.0	2.4	0.8	0.0	0.6	0.1	0.7	1.5	2.0	0.0	1.8	0.0	0.0	0.5	117.5	0.1	0.0	0.0	0.4	0.1	0.2	2.5	0.0	2.5	0.2	0.2	0.6	1.9	2.0	0.1	57.0	0.0	2.2	1.1	76.8	0.0	0.2	0.2	0.0	71.5	87.5	0.9	0.6	55.0	7.2	24.4	42.7	0.0	120.5	0.5	0.0	0.8	0.0	0.0	25.1	0.3	0.0	0.8	0.0	0.1	0.0	0.9	1.0	0.0	0.2	0.3	2.3	1.0	43.9	0.0	0.2	0.5
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 105.6;lymphoid tissue: 114.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.4;dendritic cells: 244.3;Langerhans cells: 552.9;Macrophages: 164.0;monocytes: 490.1;NK-cells: 181.3;Plasma cells: 392.5;T-cells: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 54.6;HDLM-2: 44.3;Karpas-707: 146.4;RPMI-8226: 46.9;U-266/70: 246.5;U-266/84: 99.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA007191	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"	9.2	2.7	1.4	70.0	1.7	105.6	7.7	1.5	3.7	5.7	4.0	12.8	27.3	3.2	2.1	6.9	3.4	11.8	4.1	1.4	1.9	5.2	12.3	26.1	91.5	3.1	1.8	1.5	3.4	0.9	1.4	4.4	2.6	3.3	14.6	0.5	14.3	3.9	1.1	2.8	23.1	7.0	2.5	42.2	41.6	2.5	2.3	53.6	4.0	2.2	114.3	20.8	3.7	3.2	0.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.4	54.6	0.1	0.6	0.0	0.1	0.0	0.0	0.1	44.3	0.0	0.3	0.0	0.0	0.0	7.8	6.4	0.0	0.0	0.2	0.0	4.0	0.0	0.2	0.0	146.4	0.7	0.0	0.0	6.3	0.3	0.8	0.1	0.0	0.1	46.9	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	2.0	0.2	246.5	99.8	24.1	2.4	6.8	0.0	248.9	37.6	109.9	121.8	122.5	122.5	91.5	127.9	115.7	56.1	91.6	205.5	161.0	203.6	90.2	247.9	28.1	136.5	154.8	1.4	1.7	1.5	3.7	1.4	1.9	3.1	1.8	2.6	2.5	2.3	3.2	3.2	3.2	12.2	0.0	240.4	20.9	1.0	0.0	0.6	0.0	24.4	2.5	2.1	5.7	1.3	1.8	0.0	0.7	244.3	0.6	15.6	0.3	1.4	0.3	0.4	4.5	1.8	14.9	0.1	1.9	13.6	6.4	29.0	0.8	7.0	0.0	6.8	1.7	25.2	0.0	0.1	3.7	0.0	86.1	552.9	2.0	0.0	164.0	83.6	12.2	490.1	0.0	181.3	0.0	0.0	0.3	0.3	0.0	392.5	0.7	0.4	1.1	0.0	0.1	0.0	1.5	4.5	0.0	0.6	1.2	17.8	3.0	366.6	0.0	3.8	0.5
CZIB	"C1orf123, FLJ20580"	ENSG00000162384	"CXXC motif containing zinc binding protein"	Q9NWV4	1	53214099-53220634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 29.2;Cardiomyocytes: 45.8;Cytotrophoblasts: 60.7;Extravillous trophoblasts: 76.7;Fibroblasts: 22.2;Hofbauer cells: 66.5;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043835	Uncertain		Approved	"Vesicles,Mitotic spindle,Cytosol"		Yes	No		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Vesicles, Mitotic spindle"	"HPA043835: AB_10796797"	"unprognostic (1.09e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.27e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (6.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-1)"	55.8	35.5	56.1	22.3	58.0	21.9	49.4	57.2	74.6	53.6	56.9	66.5	22.5	57.1	39.8	32.3	52.3	30.2	52.5	57.7	56.6	39.4	43.5	33.1	30.0	57.9	56.6	47.2	25.1	34.6	28.5	30.6	57.0	41.0	34.8	21.6	24.8	45.4	76.5	26.2	31.6	59.2	57.1	32.5	40.3	31.0	57.4	36.3	35.1	65.3	29.7	57.7	37.6	59.0	32.6	34.7	44.7	41.0	101.6	129.1	39.4	47.8	50.4	47.3	50.8	29.6	27.5	50.1	39.0	58.1	45.8	12.6	27.9	46.9	57.0	65.0	47.5	51.0	24.9	45.0	100.0	59.5	32.1	84.6	50.3	50.6	53.3	71.5	78.5	61.0	53.7	13.7	60.1	54.6	73.5	55.6	74.8	39.7	54.3	52.8	56.8	39.7	55.8	32.6	37.6	36.1	45.1	40.9	47.7	72.2	29.2	59.8	49.3	54.5	31.9	38.2	47.2	19.5	30.7	57.3	43.9	58.5	42.8	60.7	56.6	58.6	50.9	72.3	46.9	46.9	49.8	53.6	68.8	45.1	55.0	54.9	22.8	59.0	60.3	46.3	68.2	51.1	56.1	58.0	57.2	74.6	57.7	56.6	57.9	56.6	57.0	57.1	57.4	59.0	29.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	60.7	8.2	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	76.7	22.2	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	46.7	1.3	0.0	0.0	0.0
D2HGDH	"D2HGD, FLJ42195, MGC25181"	ENSG00000180902	"D-2-hydroxyglutarate dehydrogenase"	Q8N465	2	241734602-241768816	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.5"	"Group enriched"	"Detected in many"	4	"B-cells: 2.5;T-cells: 1.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056216, HPA060548"	Uncertain		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA056216: AB_2683070, HPA060548: AB_2732650"	"unprognostic (2.85e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.11e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.05e-2)"	11.5	17.7	6.9	11.2	8.0	18.6	7.6	6.2	7.3	10.5	14.9	16.6	11.4	11.8	13.0	15.0	16.1	14.1	11.4	6.6	6.1	15.9	19.1	10.6	12.0	8.4	6.9	14.8	16.6	15.2	10.5	8.9	6.6	14.6	14.6	3.2	18.7	14.9	33.8	39.4	14.9	9.3	6.1	15.1	14.7	4.9	7.3	7.4	18.0	23.7	11.5	8.9	9.6	8.6	10.2	10.5	6.2	9.6	14.7	7.9	21.5	9.7	12.2	9.6	7.7	11.8	21.9	8.3	4.4	9.7	11.0	23.2	5.9	7.8	4.0	8.8	5.7	15.9	11.3	20.5	8.2	19.0	12.1	14.1	13.7	7.6	7.3	18.5	9.5	13.1	20.7	5.3	8.6	16.8	16.0	19.7	3.0	13.8	20.8	19.5	6.9	16.2	17.6	36.7	20.4	7.2	9.4	23.8	6.6	4.1	14.7	6.7	4.1	14.9	5.6	7.9	5.8	9.9	1.9	13.4	10.3	20.8	10.0	0.0	0.2	0.0	0.2	0.2	0.4	2.5	0.1	1.0	0.4	0.1	0.6	0.2	0.0	0.0	0.3	0.1	0.8	0.1	6.9	8.0	6.2	7.3	6.6	6.1	8.4	6.9	6.6	6.1	7.3	8.6	10.4	9.6	14.3	33.3	10.4	19.8	23.5	13.7	25.6	14.3	22.8	22.7	10.6	25.8	16.3	18.4	14.6	44.0	13.0	40.9	23.5	10.5	3.6	12.5	13.2	9.7	31.8	6.9	7.1	8.7	15.9	15.7	23.0	19.2	5.7	28.0	13.2	46.0	18.2	11.8	9.9	56.4	14.2	10.8	7.5	4.8	16.8	12.6	3.6	15.9	5.3	37.4	8.2	28.6	12.8	6.7	32.0	18.0	15.0	19.3	26.4	31.4	13.9	12.0	6.6	14.0	11.7	2.1	7.0	25.7	14.8	22.6	14.0	27.0	49.9	22.2
DACH1	DACH	ENSG00000276644	"Dachshund family transcription factor 1"	Q9UI36	13	71437966-71867204	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Excitatory neurons: 77.0;Horizontal cells: 87.5;Late spermatids: 103.7;Microglial cells: 143.4;Muller glia cells: 143.8;Spermatocytes: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 4.2;eosinophil: 8.4;NK-cell: 4.2;plasmacytoid DC: 6.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 6.4;granulocytes: 8.4;NK-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"AF22: 14.2;HAP1: 22.5;HEK 293: 16.8;HL-60: 37.9;NB-4: 16.7;SCLC-21H: 36.9;SH-SY5Y: 29.5;THP-1: 26.9"	"Region enriched"	"Detected in all"	5	"basal ganglia: 38.8"	"Region enriched"	"Detected in all"	5	"basal ganglia: 34.2"	"HPA012672, HPA012938, HPA073222"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear speckles"		"HPA012672: AB_1847466, HPA012938: , HPA073222: "	"unprognostic (3.16e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.17e-2)"	4.4	11.1	2.3	1.2	14.0	6.0	4.0	1.6	2.9	9.7	0.3	3.1	5.2	3.8	1.3	0.9	2.8	7.2	2.2	1.0	4.6	8.9	2.0	5.9	0.5	7.0	9.3	0.5	1.9	6.6	3.5	6.9	5.9	7.0	3.3	16.7	2.0	2.3	1.9	1.8	6.7	2.0	2.6	5.4	1.9	6.3	4.3	3.5	0.2	1.2	0.4	2.0	2.7	2.4	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	22.5	0.0	0.0	0.0	16.8	0.2	0.0	0.0	0.4	37.9	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.9	16.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	36.9	29.5	0.0	0.0	0.0	0.1	0.9	26.9	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.2	4.2	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	4.2	0.0	6.4	0.0	0.1	2.3	14.0	1.6	2.9	1.0	4.6	7.0	9.3	5.9	2.6	4.3	2.4	36.4	0.0	0.6	15.7	0.5	1.7	3.6	0.0	0.0	15.4	19.4	9.3	2.1	1.5	0.0	7.3	4.2	0.0	12.5	0.9	5.9	1.0	88.5	5.0	4.7	34.2	34.1	2.5	77.0	0.0	0.0	4.6	1.1	3.2	5.1	0.3	2.9	0.0	0.2	87.5	28.2	21.4	0.0	1.2	1.2	103.7	3.4	2.5	0.0	143.4	1.1	143.8	0.0	6.6	3.9	0.6	0.3	1.9	0.0	5.8	3.5	6.9	0.7	6.9	13.1	1.5	4.3	58.8	10.2	0.2	1.3	0.0	1.0	1.3	12.6	2.7
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	7.3	15.6	9.9	6.7	9.9	15.0	6.6	7.3	11.1	7.0	5.9	6.7	7.6	5.8	3.6	8.0	5.9	6.4	5.6	11.2	8.8	4.9	7.9	9.3	7.4	9.7	7.7	7.9	6.9	7.0	4.3	8.7	8.0	5.3	5.0	3.4	7.7	4.5	13.3	12.4	7.6	5.8	8.4	8.5	7.1	5.5	8.1	8.1	7.5	7.0	6.7	5.8	7.3	10.7	21.6	23.9	10.9	14.3	16.1	12.5	8.4	29.8	21.3	26.6	28.7	13.6	24.4	12.3	12.5	15.4	64.8	32.4	17.8	16.7	15.2	5.8	11.7	6.6	26.9	9.4	17.3	18.8	10.1	11.3	27.2	17.9	17.5	10.7	11.7	15.6	18.2	6.1	15.9	16.2	6.7	26.9	39.6	11.3	18.5	57.4	12.7	25.5	16.8	8.1	13.5	8.4	17.7	26.7	5.3	17.2	19.0	34.7	14.4	22.4	41.9	28.1	13.9	6.2	11.2	10.4	11.3	28.9	28.2	10.8	22.8	22.0	6.2	21.3	5.5	8.2	4.8	4.1	28.6	4.7	11.4	6.7	10.2	3.9	19.5	5.0	4.3	12.2	9.9	9.9	7.3	11.1	11.2	8.8	9.7	7.7	8.0	8.4	8.1	10.7	6.5	9.6	12.6	5.9	7.9	16.8	3.6	6.2	12.0	4.5	5.7	5.7	3.1	4.3	5.0	5.5	2.1	5.1	4.8	12.2	0.0	7.0	0.4	10.3	6.8	9.0	2.4	13.3	13.8	6.2	8.9	5.4	19.4	19.9	3.8	5.5	8.9	8.0	17.2	0.0	9.2	5.8	6.1	16.1	17.4	1.7	6.2	16.3	5.4	26.2	15.8	1.4	7.2	2.5	6.5	12.2	8.0	2.2	5.0	5.7	10.6	1.6	3.8	4.3	0.0	4.0	5.0	8.5	7.1	9.4	13.4	12.4	6.7	7.4	7.6	4.3
DAPK1	"DAPK, ROCO3"	ENSG00000196730	"Death associated protein kinase 1"	P53355	9	87497228-87708634	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 139.1;Excitatory neurons: 120.2;Inhibitory neurons: 155.9;Kupffer cells: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.7;eosinophil: 8.7;intermediate monocyte: 14.0;myeloid DC: 4.8;non-classical monocyte: 15.2;plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 6.2;granulocytes: 8.7;monocytes: 15.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 97.6;HUVEC TERT2: 56.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390"	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (8.31e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-3)"	22.9	5.9	12.1	11.8	16.4	5.4	5.9	2.2	20.5	9.6	12.6	27.1	10.1	7.9	18.8	5.5	15.2	28.0	5.2	22.8	7.6	22.0	27.6	37.5	12.5	7.6	7.6	46.0	29.2	6.7	23.4	27.3	13.8	5.2	9.2	11.5	13.7	8.5	1.8	5.0	14.4	9.4	7.8	22.8	19.5	8.1	8.6	41.8	9.8	2.3	6.8	14.5	3.8	7.5	0.0	47.5	22.5	15.8	0.7	0.3	35.4	3.1	4.4	18.3	20.4	6.8	0.3	0.4	4.7	1.0	0.2	43.9	13.9	1.0	7.9	0.4	11.4	23.4	6.6	23.7	19.5	0.0	97.6	1.4	7.5	3.5	1.4	28.5	56.3	6.5	17.8	9.6	15.4	1.5	7.0	0.0	25.4	44.4	0.0	2.0	19.8	0.1	50.6	47.6	10.2	11.3	0.0	4.6	20.1	32.7	0.0	15.2	0.4	0.1	0.3	0.1	0.1	36.9	8.1	0.0	0.2	6.4	3.0	1.7	6.7	8.7	0.0	14.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.1	2.0	0.1	15.2	6.2	0.0	3.0	12.1	16.4	2.2	20.5	22.8	7.6	7.6	7.6	13.8	7.8	8.6	7.5	8.8	51.3	72.2	139.1	2.7	3.6	0.8	1.2	0.6	19.4	1.3	2.3	2.4	31.5	24.3	22.0	2.1	6.8	9.5	1.1	1.9	33.8	1.8	30.2	7.9	17.3	0.0	12.8	120.2	23.0	19.0	12.3	26.5	58.6	24.1	22.1	68.9	20.8	22.7	18.5	155.9	9.3	0.0	85.7	18.3	3.1	14.9	57.1	12.4	18.7	41.2	14.6	2.1	6.6	4.7	35.8	1.9	13.5	6.2	3.2	9.6	7.0	10.2	2.9	0.0	1.5	3.9	3.4	7.2	1.6	3.1	14.2	2.8	3.4	3.7	14.9
DAW1	"FLJ25955, ODA16, WDR69"	ENSG00000123977	"Dynein assembly factor with WD repeats 1"	Q8N136	2	227871054-227924344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 25.7;fallopian tube: 32.6;testis: 51.3"	"Group enriched"	"Detected in some"	13	"Early spermatids: 106.7;Late spermatids: 215.3;Respiratory ciliated cells: 113.9;Spermatocytes: 177.1"	"Cancer enhanced"	"Detected in some"		"lung cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HUVEC TERT2: 21.8;U-2197: 40.7"	"Low region specificity"	"Detected in many"							HPA046118	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Plasma membrane"	"HPA046118: AB_10961428"		"unprognostic (1.23e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.37e-1)"		"unprognostic (1.23e-1)"	"unprognostic (5.63e-3)"	"unprognostic (2.90e-2)"	"unprognostic (9.92e-3)"		"unprognostic (1.54e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-1)"	0.6	0.0	4.3	0.1	5.3	0.3	0.4	2.9	4.7	0.7	25.7	0.2	0.0	0.1	0.3	0.5	32.6	0.3	0.5	4.5	4.5	0.2	0.4	3.0	0.2	7.3	8.8	0.1	0.0	0.2	0.2	0.8	5.5	0.0	0.0	0.7	0.1	0.0	3.6	0.2	0.0	0.1	6.8	0.2	0.1	51.3	5.4	0.4	0.1	0.0	0.2	0.1	0.0	5.4	0.8	0.0	0.1	0.0	0.3	1.2	0.6	0.8	0.4	0.9	0.6	5.4	0.5	0.2	0.0	0.2	8.8	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.7	0.0	1.0	0.7	5.8	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.1	0.3	0.1	0.2	0.4	0.1	0.8	0.0	0.0	0.2	0.0	0.5	2.2	0.2	2.0	40.7	0.0	0.0	0.1	0.3	3.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.3	2.9	4.7	4.5	4.5	7.3	8.8	5.5	6.8	5.4	5.4	0.0	0.0	1.1	0.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.7	0.0	11.5	0.0	4.2	0.2	0.0	0.0	0.0	0.2	106.7	11.2	0.0	0.2	0.0	0.0	6.2	0.0	2.8	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	8.2	0.0	0.0	215.3	3.4	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.1	3.0	0.2	2.6	0.0	0.1	0.0	0.1	113.9	0.3	0.0	0.7	2.1	177.1	4.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909553	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 15.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 468.6;Spermatocytes: 569.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042923			Supported	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA042923: AB_2678222"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	0.1	0.2	0.2	0.2	0.4	0.6	0.2	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.3	0.2	15.1	0.2	0.6	0.3	0.0	0.5	0.1	0.1	0.3	0.9	0.8	2.0	2.5	0.4	0.4	0.5	1.0	0.2	1.0	2.1	1.4	0.6	2.1	0.6	0.6	1.7	0.9	2.2	0.5	1.0	1.6	1.3	1.3	1.0	0.4	0.1	1.7	1.0	0.4	0.6	1.2	1.0	0.3	0.9	1.9	1.2	4.2	1.4	1.7	2.8	2.0	2.0	2.1	1.9	0.7	3.1	2.5	0.8	0.1	3.0	1.8	1.2	2.2	1.0	1.6	0.9	1.6	0.1	1.2	1.4	3.1	2.0	2.3	5.2	2.1	0.8	3.1	2.5	1.0	0.1	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.4	0.1	0.2	0.4	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3	13.3	3.2	12.6	5.5	38.4	15.6	16.4	10.7	12.0	6.6	13.0	16.8	3.7	2.8	7.7	9.2	12.5	19.6	59.2	9.7	3.9	8.3	468.6	12.1	23.6	11.1	14.9	40.8	14.7	14.7	36.4	12.4	14.3	17.7	31.0	19.4	6.4	6.5	16.1	3.3	9.1	20.6	16.2	9.1	15.5	116.0	15.5	20.8	12.4	2.8	11.0	2.1	24.7	6.0	6.7	14.1	8.5	9.4	48.9	18.4	4.2	5.8	10.2	16.6	13.1	9.7	11.4	569.4	74.6	20.5	12.6	9.6	44.4	13.5	22.3	11.7
DBF4B	"ASKL1, chifb, DRF1, FLJ13087, ZDBF1B"	ENSG00000161692	"DBF4 zinc finger B"	Q8NFT6	17	44708608-44752264	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Horizontal cells: 30.3;Oligodendrocytes: 30.9;Spermatocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA048465, HPA077959"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA048465: AB_2680405, HPA077959: "	"unprognostic (2.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.53e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.39e-1)"	0.9	0.7	1.1	1.2	1.1	2.0	1.3	1.2	1.8	1.5	0.5	1.9	0.6	1.9	3.5	1.4	1.8	0.7	0.8	1.1	1.0	1.6	0.6	0.8	1.5	1.1	1.0	1.7	0.9	0.8	1.7	0.9	1.1	2.3	1.2	2.9	1.1	1.3	0.6	2.0	1.5	1.5	0.8	1.6	1.3	5.1	1.2	1.9	2.7	0.4	1.3	1.6	1.3	1.2	3.7	7.7	5.7	4.2	0.5	1.1	4.9	3.9	1.7	8.1	7.9	3.3	3.1	5.5	2.1	1.3	7.2	3.6	5.0	1.7	9.3	9.2	8.2	7.0	6.2	4.3	0.2	4.8	5.9	0.5	0.6	4.4	1.4	1.8	4.1	9.3	8.9	5.6	4.4	4.0	7.1	2.9	2.5	7.7	4.0	6.2	6.6	2.3	1.8	2.2	3.1	3.4	3.8	1.2	2.9	6.1	3.9	3.1	1.8	2.8	5.2	3.6	7.2	2.6	3.5	7.2	2.1	4.1	4.3	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.1	1.1	1.1	1.2	1.8	1.1	1.0	1.1	1.0	1.1	0.8	1.2	1.2	2.1	0.0	1.1	15.0	4.0	0.6	2.6	1.2	1.2	30.0	1.5	1.3	1.1	0.0	2.1	5.5	12.5	4.2	5.8	0.6	0.0	0.3	8.1	2.0	2.2	2.8	4.2	5.5	11.4	0.8	1.4	2.3	1.5	1.1	3.8	9.6	3.3	0.3	1.4	30.3	11.0	0.3	0.0	1.3	3.1	7.4	1.2	2.5	5.4	5.6	1.4	7.2	2.1	7.5	30.9	0.2	0.2	3.0	3.4	2.0	0.7	0.5	1.9	15.7	0.0	4.5	2.0	35.7	16.5	1.9	0.1	1.4	1.4	5.3	1.1	2.3
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636363-133659329	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 272.7;brain: 236.6"	"Cell type enriched"	"Detected in some"	6	"Hepatic stellate cells: 10.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.7"	"Region enriched"	"Detected in many"	8	"pons: 236.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	346	"SH-SY5Y: 1826.4"	"Region enriched"	"Detected in some"	6	"pons and medulla: 22.1"	"Region enriched"	"Detected in single"	26	"pons: 18.5"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	2.8	272.7	0.1	1.0	0.2	0.2	0.1	0.0	0.8	0.4	0.0	0.1	0.4	0.3	0.2	0.1	0.3	0.3	0.5	0.3	0.2	1.3	36.1	0.8	2.3	9.8	29.4	0.4	4.3	0.0	1.4	1.4	236.6	0.4	0.0	0.1	0.6	0.2	0.1	0.2	0.6	0.0	0.0	0.9	0.4	0.2	0.6	0.2	0.4	0.0	0.0	0.4	1.1	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	3.2	0.9	0.1	0.0	0.0	0.3	5.2	4.7	0.0	0.0	2.1	1826.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	0.3	0.2	9.8	29.4	236.6	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0
DBNDD1	"FLJ12582, MGC3101"	ENSG00000003249	"Dysbindin domain containing 1"	Q9H9R9	16	90004871-90019890	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 92.0;skeletal muscle: 48.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 22.8;Ductal cells: 16.0;Exocrine glandular cells: 18.8;Horizontal cells: 30.3;Pancreatic endocrine cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"naive B-cell: 12.9"	"Lineage enriched"	"Detected in many"	4	"B-cells: 12.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043018	Uncertain		Approved	"Nuclear speckles,Cytosol"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear speckles"	Cytosol	"HPA043018: AB_10794921"	"unprognostic (1.07e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (2.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (5.67e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.00e-2)"	1.8	7.4	47.1	2.5	35.3	0.3	4.4	27.5	60.6	4.1	11.6	2.9	1.6	0.9	10.0	28.2	3.6	3.8	4.6	35.2	40.7	13.3	6.5	3.5	4.7	50.6	55.3	3.1	19.5	9.6	7.7	0.1	50.8	3.8	1.4	7.4	15.5	3.1	48.0	6.0	1.7	1.3	30.3	1.2	7.7	1.0	92.0	1.4	5.2	4.8	5.1	1.7	7.3	38.6	22.8	34.7	3.5	44.7	0.9	0.4	24.7	4.9	6.6	10.5	5.3	32.1	19.7	0.0	2.7	1.1	10.2	24.0	41.3	1.2	10.7	0.1	65.4	0.0	4.4	58.6	1.5	0.3	4.7	1.0	3.3	18.8	0.1	25.2	47.3	0.8	6.7	0.4	4.1	139.7	0.1	33.5	59.5	18.6	13.9	14.5	32.3	0.6	64.2	4.5	51.2	53.0	5.6	5.3	44.8	10.2	34.6	4.8	36.2	7.4	15.1	0.4	24.1	0.3	0.3	0.4	3.5	3.9	20.1	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.6	0.5	0.0	12.9	2.9	0.5	0.0	0.0	0.0	0.1	0.0	1.0	47.1	35.3	27.5	60.6	35.2	40.7	50.6	55.3	50.8	30.3	92.0	38.6	0.3	3.2	2.0	2.9	6.0	0.4	0.6	0.6	0.0	1.8	13.5	7.5	2.5	22.8	2.0	9.2	0.0	0.2	0.1	1.4	9.8	16.0	0.0	5.7	0.7	1.1	6.0	0.0	6.1	18.8	0.3	0.2	2.6	7.8	0.0	3.4	1.4	2.5	0.3	30.3	3.6	1.5	2.0	0.0	0.7	0.0	1.2	0.1	3.6	2.8	0.2	10.4	0.0	1.5	0.7	15.0	2.9	0.4	0.5	4.3	0.2	10.8	2.7	1.8	0.0	1.4	1.2	0.1	2.0	8.1	1.0	0.0	1.4	0.3	0.8	1.3
DBT	"BCKAD-E2, BCKDH-E2, BCOADC-E2"	ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	11.1	13.6	4.4	5.9	5.2	4.6	11.8	4.3	4.9	11.3	3.7	9.2	8.0	8.2	6.0	12.8	11.1	6.3	25.9	4.2	5.0	30.3	43.4	7.4	7.5	5.6	4.6	11.1	15.4	19.4	2.3	10.0	4.5	15.9	10.2	5.9	12.8	11.2	13.4	7.4	7.1	8.0	4.6	6.1	17.3	4.7	5.2	9.9	17.2	19.2	8.9	9.4	4.0	7.1	18.5	8.2	9.5	17.4	23.9	17.6	20.6	13.1	12.3	13.9	15.6	17.7	7.4	17.1	18.3	9.3	8.1	18.7	20.3	17.7	16.8	18.2	11.5	12.1	16.3	9.5	18.0	16.1	6.1	18.2	18.1	10.6	17.9	11.4	12.4	17.9	20.9	19.2	11.1	4.9	14.4	4.1	18.6	14.8	18.4	14.1	30.3	14.2	15.3	15.9	15.8	8.7	27.5	25.4	23.7	16.7	20.9	11.9	10.8	12.1	7.6	15.9	11.0	12.7	14.1	9.1	13.8	10.7	5.3	2.1	1.2	0.8	2.2	1.5	2.4	1.9	2.0	1.9	1.2	2.1	1.8	1.9	1.1	2.0	1.4	1.3	1.5	1.1	4.4	5.2	4.3	4.9	4.2	5.0	5.6	4.6	4.5	4.6	5.2	7.1	9.6	22.4	36.4	29.0	9.6	6.8	6.5	9.8	13.6	22.2	11.9	8.5	65.9	18.6	11.3	12.9	39.6	19.8	10.9	11.4	50.9	10.0	0.8	18.5	20.5	11.7	9.1	8.2	24.0	8.5	11.6	11.3	15.8	15.4	2.5	19.6	15.4	53.2	8.7	15.2	25.2	12.0	14.2	8.8	5.0	1.7	15.2	7.3	3.6	3.7	10.3	14.5	12.3	22.1	26.1	6.4	6.0	21.1	7.1	9.4	9.9	32.1	18.0	22.4	6.6	15.0	12.9	2.8	6.1	18.7	7.2	8.2	9.7	17.3	15.1	5.5
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 17.9;Granulosa cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	11.4	11.3	7.6	11.7	8.8	15.9	11.2	11.2	9.4	9.4	9.8	11.0	7.9	10.3	9.4	10.6	8.9	7.4	9.5	7.8	9.3	11.0	11.5	10.0	14.8	8.4	8.8	10.3	10.4	18.9	8.6	10.3	8.6	9.7	10.9	19.7	11.3	9.6	27.9	13.5	11.4	9.2	8.0	11.3	10.3	53.4	8.5	18.6	14.6	16.1	15.9	11.2	10.0	9.0	19.9	23.9	22.8	20.7	20.1	15.9	21.6	21.8	16.2	23.1	22.5	26.4	18.8	48.1	11.7	17.2	35.3	17.1	43.3	19.5	29.6	33.7	21.5	41.2	32.4	22.8	14.7	54.4	28.7	10.6	22.2	29.8	21.6	15.0	18.2	26.1	24.5	30.3	18.3	20.3	41.8	22.0	24.0	23.5	26.0	17.5	24.4	32.0	18.0	30.5	11.8	21.0	24.1	22.0	13.2	16.7	15.0	22.8	22.9	18.8	25.1	31.4	33.9	20.5	29.7	48.2	21.9	36.6	15.7	2.5	3.0	2.4	6.5	3.3	7.4	5.1	5.6	5.6	4.8	4.9	6.0	5.1	0.7	5.8	5.0	3.8	6.7	4.9	7.6	8.8	11.2	9.4	7.8	9.3	8.4	8.8	8.6	8.0	8.5	9.0	11.1	3.2	10.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.3	9.4	0.0	0.0	6.8	3.7	0.0	7.6	9.7	0.0	1.9	7.0	0.0	11.2	10.3	5.6	0.0	0.0	0.0	6.7	5.7	3.0	0.0	17.9	6.3	13.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.8	0.0	0.0	6.1	5.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	10.5	5.0	7.4	0.0	0.0
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262549	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	63.3	62.6	35.3	47.0	43.3	54.6	60.6	47.7	52.8	55.8	47.1	72.0	56.6	60.4	76.2	50.2	58.9	53.5	85.1	33.7	41.8	55.8	103.4	50.9	60.5	39.2	37.3	62.2	80.2	85.7	66.3	45.1	37.0	53.6	40.6	106.7	60.6	53.2	219.7	67.2	61.8	44.0	32.6	65.6	67.3	40.7	41.1	67.5	77.9	118.3	51.1	61.1	49.8	53.0	54.2	62.5	72.0	64.8	86.3	65.5	63.7	62.7	81.8	49.5	42.2	69.8	89.6	56.3	112.1	67.2	34.6	64.8	34.6	57.4	31.0	134.9	69.0	63.4	99.7	54.1	69.3	52.9	80.3	74.6	58.9	44.2	60.8	55.3	73.5	73.1	60.6	98.4	46.0	50.0	71.7	54.5	52.7	70.1	62.6	69.2	41.8	115.5	57.7	87.6	49.0	47.3	101.8	113.1	68.2	68.9	104.9	82.0	95.1	60.7	31.5	38.6	58.7	169.8	124.9	94.3	68.7	49.6	51.2	32.9	21.5	22.0	31.5	19.7	29.6	28.5	27.0	29.2	17.5	30.4	29.4	27.0	24.9	30.4	28.4	22.0	30.4	19.2	35.3	43.3	47.7	52.8	33.7	41.8	39.2	37.3	37.0	32.6	41.1	53.0	21.4	57.7	54.9	57.5	35.4	18.4	16.3	17.3	38.7	44.6	27.5	21.8	54.2	30.0	30.5	25.8	64.6	30.9	26.4	20.4	62.6	23.9	3.6	26.6	18.9	26.4	25.1	48.4	53.7	21.6	21.0	28.9	35.2	21.4	34.1	21.2	21.4	77.6	23.8	40.4	49.5	19.2	20.3	29.8	18.9	4.3	28.0	24.2	14.2	39.4	27.6	38.1	18.6	58.8	93.1	19.2	13.6	32.7	45.3	16.3	29.0	38.1	40.5	60.5	13.1	29.5	26.6	28.0	20.4	35.1	24.2	44.3	36.5	25.6	18.8	12.5
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171755-24358059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Supported	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Mitotic spindle, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.0	1.3	0.8	0.0	1.2	0.1	4.4	0.3	0.8	1.6	15.1	0.7	0.6	4.4	5.3	0.0	7.6	3.9	0.0	0.8	1.0	23.2	2.2	3.4	0.0	2.2	2.7	0.2	26.2	8.2	1.2	0.6	1.7	1.2	0.6	1.4	0.4	2.3	0.3	0.1	0.1	0.1	2.0	0.1	1.8	3.7	1.1	0.1	8.2	0.2	0.0	0.4	0.0	1.6	0.0	8.8	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	71.8	0.2	0.0	48.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.2	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.4	0.0	0.2	0.1	0.0	0.3	10.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	254.5	0.3	5.2	0.5	0.0	1.3	0.0	0.2	12.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.3	0.8	0.8	1.0	2.2	2.7	1.7	2.0	1.1	1.6	0.2	19.2	14.4	3.9	1.4	0.1	0.6	0.3	0.0	0.0	20.3	11.7	0.3	62.9	6.1	79.1	0.0	0.4	0.0	1.2	56.7	135.9	40.1	160.3	5.3	0.4	3.6	0.0	11.3	8.4	0.0	1.3	3.6	102.4	0.0	4.1	0.0	1.0	0.5	0.0	8.3	2.9	0.0	0.0	0.0	14.6	0.3	1.0	0.0	1.0	2.0	2.3	0.0	1.0	0.5	27.9	4.1	0.4	0.0	1.3	0.0	54.3	37.1	0.1	0.0	0.0	2.4	32.3	2.6	0.0	0.1	0.1	1.1	5.6	2.7	0.9
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436811-94479682	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"skin 1: 107.4"	"Cell type enriched"	"Detected in some"	23	"Melanocytes: 3552.1"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	272	"SK-MEL-30: 257.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Vesicles	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.4	0.4	0.6	0.0	1.0	0.1	3.0	0.4	0.7	0.2	0.2	0.3	0.0	0.3	0.9	0.0	0.9	0.1	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.6	0.6	0.4	0.4	0.0	1.6	0.0	0.5	0.3	0.0	0.9	1.5	0.3	0.4	107.4	0.1	0.1	0.6	0.1	0.1	0.6	0.6	0.5	0.2	0.1	0.0	0.2	0.3	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	257.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.4	0.7	0.6	0.6	0.6	0.6	0.5	0.6	0.6	0.5	0.0	0.0	0.0	23.5	0.0	152.3	0.1	0.0	0.0	1.0	0.3	0.5	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.5	0.1	1.2	0.0	0.0	16.1	0.2	0.0	1.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	25.5	23.8	0.9	0.0	3552.1	1.9	0.0	3.5	0.0	6.6	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.5	1.0	0.5	0.8	0.0	33.4	0.0	0.9	0.1	0.0	0.0
DCTN1		ENSG00000204843	"Dynactin subunit 1"	Q14203	2	74361154-74392087	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"		"Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009108, HPA034635, HPA071875"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: "	"unprognostic (1.14e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.34e-7)"	"unprognostic (5.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.12e-3)"	43.3	40.0	90.5	27.0	94.7	23.7	37.4	76.4	113.2	44.3	20.8	51.3	22.2	51.4	17.0	42.6	38.7	28.2	82.6	99.9	80.1	27.6	18.2	36.0	22.8	110.9	85.1	39.2	28.6	118.0	61.2	32.6	112.6	30.0	25.5	43.5	56.3	38.0	87.6	44.2	32.2	49.9	76.0	26.5	39.5	51.3	101.9	34.7	31.3	63.4	24.6	47.6	39.0	116.2	65.0	74.7	68.4	71.9	122.5	90.7	55.2	102.0	105.2	127.0	89.9	99.9	48.6	88.8	40.8	213.0	70.1	63.5	84.3	129.5	96.1	111.2	85.0	92.5	55.6	84.7	94.4	50.7	109.3	109.6	62.0	138.3	82.3	86.9	110.3	79.4	40.3	61.4	97.3	55.6	92.8	52.5	74.0	78.6	78.3	82.3	120.1	63.8	70.2	39.6	83.3	74.1	57.1	67.7	60.6	59.0	43.5	36.5	84.3	115.0	82.7	50.0	77.2	37.8	32.7	78.9	107.6	81.4	82.5	8.3	11.3	12.7	14.4	13.0	11.7	10.1	8.2	10.8	11.2	6.8	5.6	6.3	9.2	9.2	15.6	8.8	7.7	16.5	90.5	94.7	76.4	113.2	99.9	80.1	110.9	85.1	112.6	76.0	101.9	116.2	28.6	32.1	25.4	9.8	23.2	10.1	10.3	19.1	25.6	27.2	19.6	17.8	56.4	18.6	20.0	29.5	25.0	29.8	19.4	41.0	19.6	22.5	7.3	21.5	32.8	26.6	16.7	27.3	28.4	19.9	27.1	25.1	49.5	27.8	29.2	30.8	29.6	19.9	28.8	90.9	26.7	31.8	24.4	21.0	11.3	9.3	44.7	21.2	16.0	8.4	27.3	14.9	23.7	12.1	29.7	26.6	33.6	51.9	24.7	9.6	34.2	19.6	19.4	45.5	19.7	28.3	30.0	40.6	38.5	29.0	11.8	25.2	20.0	33.9	24.9	10.7
DCTN5	"MGC3248, p25"	ENSG00000166847	"Dynactin subunit 5"	Q9BTE1	16	23641466-23677472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042003, HPA063710"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA042003: AB_10796468, HPA063710: AB_2685101"	"unprognostic (5.90e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.36e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.55e-2)"	13.9	11.3	14.6	18.1	18.1	41.5	14.2	10.4	18.3	13.6	3.8	19.2	20.8	14.8	12.0	25.2	13.6	14.2	14.7	17.2	13.0	21.0	10.7	14.0	22.1	11.4	13.6	12.0	15.9	19.8	8.5	20.9	11.1	14.1	24.9	21.5	12.8	14.0	13.9	14.1	22.2	21.7	11.4	15.1	16.7	20.6	12.8	20.9	18.8	14.2	32.2	20.6	10.9	12.9	30.0	58.5	56.0	46.9	39.0	28.9	39.2	51.9	32.1	32.9	39.3	66.5	40.3	42.1	41.2	54.8	34.6	30.6	93.4	50.2	40.5	48.1	37.1	51.9	67.2	93.9	26.5	63.7	38.4	24.3	35.3	40.5	42.8	36.5	52.8	52.0	100.7	31.6	53.3	82.4	49.4	18.4	66.3	43.3	25.5	59.8	48.6	45.9	26.2	62.6	46.8	48.5	45.6	36.7	30.5	49.0	51.2	53.2	71.8	44.0	20.0	34.9	36.6	42.6	68.6	66.2	42.0	31.4	48.8	14.3	16.6	20.3	15.5	14.0	17.1	13.9	14.2	17.0	17.5	10.5	12.0	14.3	7.3	22.0	22.0	12.4	19.0	17.2	14.6	18.1	10.4	18.3	17.2	13.0	11.4	13.6	11.1	11.4	12.8	12.9	19.7	16.0	26.2	12.1	19.1	14.7	14.5	12.9	22.8	52.1	15.5	14.5	27.1	15.7	15.6	20.2	91.8	32.9	16.1	36.2	11.7	23.8	23.2	11.9	22.4	22.5	22.1	27.6	13.4	25.2	36.3	16.3	20.9	20.8	27.8	37.3	17.2	14.2	28.4	52.2	13.2	18.9	12.2	19.1	11.4	23.4	13.1	17.1	7.2	6.5	34.4	32.3	30.9	11.1	12.0	45.7	19.4	18.0	17.4	14.4	31.9	23.3	11.2	45.0	13.1	22.4	18.1	70.4	30.6	20.9	14.2	48.2	18.7	17.9	26.2	22.0
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;endometrium 1: 1.4;retina: 2.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 39.1;Inhibitory neurons: 90.2;Oligodendrocyte precursor cells: 49.8;Rod photoreceptor cells: 21.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 52.5;SH-SY5Y: 22.1"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 74.0"	"Region enriched"	"Detected in all"	4	"olfactory bulb: 68.6"	HPA036121	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA036121: AB_2674950"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"	0.1	0.2	2.1	0.0	2.4	0.0	1.3	0.0	2.5	0.1	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.0	1.4	2.7	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.3	0.0	0.8	0.0	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	52.5	22.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	2.5	1.4	2.7	0.2	1.3	0.8	0.0	2.4	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.6	2.2	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	39.1	0.0	0.2	6.8	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	90.2	0.2	0.0	0.0	0.4	0.5	0.0	0.0	1.8	1.9	0.0	1.6	0.0	49.8	2.3	0.1	0.0	1.5	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.2	0.0	0.0
DDA1	"C19orf58, MGC2594, PCIA1"	ENSG00000130311	"DET1 and DDB1 associated 1"	Q9BW61	19	17309518-17323298	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 416.9;Syncytiotrophoblasts: 253.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042134, HPA055272"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA042134: AB_10794169, HPA055272: AB_2682767"	"unprognostic (1.30e-1)"	"unprognostic (6.35e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	7.9	11.5	15.8	5.1	14.4	7.1	7.8	12.2	19.9	7.8	10.4	11.5	5.7	8.6	3.4	10.9	8.4	4.0	12.0	14.7	15.3	9.8	10.9	9.6	6.2	14.0	15.0	7.3	6.8	6.1	8.0	8.0	14.4	10.0	4.8	3.8	8.7	5.4	9.5	13.0	11.2	4.2	13.1	9.9	10.1	10.1	15.2	7.3	7.9	5.0	4.7	9.3	8.0	13.2	15.6	13.5	10.1	8.2	10.5	7.5	15.6	10.1	13.0	15.4	14.1	12.0	13.8	6.0	13.7	10.6	7.3	13.2	7.5	15.0	7.8	9.9	19.4	7.2	11.1	11.5	12.5	8.3	14.2	11.5	17.5	9.3	8.7	9.5	9.1	13.9	8.9	10.7	8.4	7.8	17.5	12.7	11.7	16.0	22.3	11.0	7.8	10.3	12.6	11.5	10.4	15.2	7.3	17.8	9.5	6.1	9.0	11.6	13.7	10.6	8.7	26.9	14.6	12.8	18.2	8.6	23.3	14.4	10.6	3.0	3.8	6.4	4.2	4.3	3.6	3.7	3.5	4.2	3.2	3.2	3.9	3.9	4.0	3.4	3.8	6.8	4.8	3.4	15.8	14.4	12.2	19.9	14.7	15.3	14.0	15.0	14.4	13.1	15.2	13.2	24.4	28.9	14.1	13.4	26.3	54.6	38.6	84.0	30.1	18.4	41.8	30.5	17.1	11.5	54.2	27.6	12.5	140.5	38.5	70.4	39.2	77.2	416.9	48.6	32.8	26.4	20.3	29.9	10.4	46.4	152.8	26.8	34.7	53.7	38.7	25.2	20.3	26.3	65.0	13.5	9.8	43.4	54.9	22.4	36.8	130.3	22.4	34.2	30.2	7.5	57.2	34.1	58.7	4.5	10.8	139.6	79.9	27.1	31.8	41.4	47.4	55.1	43.7	19.0	19.7	19.5	36.0	107.7	40.0	36.8	61.8	253.5	34.2	31.5	28.6	89.5
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.8;kidney: 314.9;retina: 175.6"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9"	"Group enriched"	"Detected in many"	9	"midbrain: 86.3;pons: 29.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 74.5;pons: 29.4"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		120000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.5	48.9	0.1	2.3	0.7	0.0	1.0	0.0	0.6	0.0	0.2	36.5	154.8	0.0	9.1	0.1	0.0	0.1	0.0	0.2	2.2	314.9	54.6	2.0	0.1	6.1	86.3	0.8	15.8	0.0	0.0	0.0	29.4	0.6	37.5	175.6	0.0	0.0	0.0	0.1	165.8	1.7	0.0	0.1	18.1	1.5	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	83.6	0.0	0.0	0.0	0.7	1.3	0.0	130.9	135.9	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.2	2.2	6.1	86.3	29.4	0.0	1.9	0.2	0.0	0.0	12.2	0.0	2.5	0.0	0.0	0.0	0.0	89.3	0.1	0.1	0.4	2.8	0.6	3.7	41.7	0.0	0.0	34.4	25.4	0.1	6.6	0.1	0.0	1.8	410.3	0.0	0.3	0.9	0.1	0.1	0.0	0.4	0.0	0.0	1.1	67.2	0.1	3.3	0.4	67.8	0.0	1.3	0.0	5.4	0.0	2.5	0.0	0.0	0.0	45.1	0.0	0.0	0.1	0.2	31.8	0.0	0.0	0.3	391.5	429.5	0.0	498.9	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	1.3	0.1	88.7	0.2
DDIT3	"CHOP, CHOP10, GADD153"	ENSG00000175197	"DNA damage inducible transcript 3"	P35638	12	57516588-57521737	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 170.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 784.2;hTERT-HME1: 399.9;SK-MEL-30: 409.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058416, HPA068416"	Uncertain		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA058416: AB_2683712, HPA068416: AB_2685985"	"unprognostic (1.12e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (8.55e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	65.3	66.2	90.6	16.1	97.8	196.5	64.3	97.4	145.5	51.0	92.9	52.0	20.7	39.1	109.3	31.6	41.2	32.1	85.1	89.0	99.2	106.4	81.7	55.4	18.8	95.9	98.4	57.4	37.3	80.5	81.4	37.6	97.1	45.5	26.6	123.1	43.3	25.8	44.8	48.7	28.0	29.2	95.5	34.2	44.4	40.9	106.4	17.8	182.1	55.4	17.5	56.2	49.5	129.5	17.8	16.1	10.1	34.5	90.7	61.0	53.8	48.2	106.0	70.1	65.4	57.2	45.7	25.3	46.9	14.3	186.7	21.4	38.5	7.3	72.2	21.0	15.5	19.9	19.9	42.3	784.2	31.8	29.3	175.7	152.7	118.6	399.9	81.7	16.9	26.5	86.4	94.0	31.2	10.8	21.1	41.5	19.7	37.3	37.5	11.8	220.7	22.3	25.0	22.3	20.9	15.3	14.2	16.2	409.0	37.2	34.4	82.8	9.9	47.5	20.2	45.4	42.0	164.4	60.3	26.8	57.4	29.1	85.8	121.1	17.9	48.8	25.1	16.6	22.7	48.3	17.9	23.6	12.8	44.8	34.1	31.1	170.7	35.6	19.4	15.9	23.8	18.0	90.6	97.8	97.4	145.5	89.0	99.2	95.9	98.4	97.1	95.5	106.4	129.5	237.9	19.2	55.1	17.0	96.6	56.3	176.5	93.1	177.0	114.9	86.3	265.7	177.9	37.1	56.7	22.0	91.8	42.3	101.8	265.7	115.4	43.3	9.5	111.3	39.4	62.3	230.7	12.8	9.6	16.0	17.5	115.7	74.5	82.4	204.0	26.3	27.5	20.1	45.7	55.5	14.5	218.4	101.7	30.4	81.6	6.3	28.0	81.5	88.9	6.5	8.2	156.1	17.5	14.1	23.0	33.0	300.0	38.0	43.2	115.1	61.7	61.6	38.1	160.0	13.1	56.9	122.2	77.7	15.6	91.5	45.7	107.8	89.7	37.2	127.2	65.1
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787405	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 89.8;Fibroblasts: 116.5;Leydig cells: 63.0;Peritubular cells: 88.4;Skeletal myocytes: 98.2;Smooth muscle cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 233.3;ASC TERT1: 214.4;BJ hTERT+: 163.4;fHDF/TERT166: 137.6;HSkMC: 157.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Approved	"Plasma membrane,Actin filaments"		Yes	No		770000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Actin filaments"		"HPA070112: AB_2686229"	"unprognostic (4.12e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (1.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.10e-3)"	59.8	64.3	13.2	15.8	11.3	0.3	25.2	10.4	9.2	33.7	51.5	54.7	5.8	26.2	13.2	18.1	22.4	23.8	24.1	12.6	24.5	6.4	5.4	14.5	9.1	37.0	22.1	37.4	3.7	2.5	5.4	10.6	31.7	17.3	14.1	5.1	9.8	29.2	4.9	9.7	17.6	42.8	17.8	5.8	20.4	3.9	21.0	3.3	12.9	19.3	6.9	23.2	23.6	25.2	0.3	0.0	0.2	63.2	233.3	214.4	1.0	92.2	163.4	41.5	56.8	0.0	0.2	0.0	0.1	137.6	8.9	0.1	0.3	0.4	54.0	42.9	0.3	0.0	0.4	0.1	103.9	0.2	0.2	157.0	0.4	73.1	2.2	65.8	46.0	0.4	0.6	16.8	36.9	0.1	0.0	0.3	0.4	0.1	0.3	0.1	24.1	0.7	0.2	0.2	0.3	35.4	0.2	0.1	2.9	3.6	0.2	0.3	2.1	58.5	13.8	29.1	12.6	2.6	4.0	0.1	56.3	0.1	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	11.3	10.4	9.2	12.6	24.5	37.0	22.1	31.7	17.8	21.0	25.2	23.4	3.2	2.3	53.2	2.5	12.6	3.9	0.8	1.2	3.0	6.0	15.6	31.3	1.5	1.1	0.0	0.0	0.5	1.7	3.2	0.0	0.4	8.9	5.0	89.8	22.3	1.2	0.0	13.1	1.8	0.5	116.5	2.6	8.2	1.3	16.7	30.0	3.5	1.2	0.0	26.2	1.0	0.0	1.9	19.3	7.1	63.0	3.1	23.2	29.0	0.0	16.5	2.1	6.0	5.6	1.8	4.4	88.4	5.6	5.9	1.2	2.1	2.4	3.0	39.5	98.2	78.3	1.0	0.9	2.0	8.7	1.0	2.5	34.2	0.8	4.2
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15634346	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		86000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	52.8	53.4	32.6	39.0	33.5	37.8	61.7	36.1	44.2	49.9	39.6	54.3	45.0	45.4	48.0	56.5	42.4	31.7	97.6	33.8	37.1	76.7	62.0	38.9	35.3	36.8	32.6	45.7	59.0	89.5	46.7	50.9	36.0	44.6	58.0	55.5	52.9	47.8	157.9	50.3	46.0	56.5	34.7	33.8	50.5	42.5	35.3	47.0	62.3	134.2	46.8	48.4	41.0	36.3	84.1	127.1	172.3	126.2	148.1	125.5	193.3	176.8	142.6	165.1	135.9	203.0	80.7	221.8	80.4	202.8	120.9	118.8	245.5	166.8	170.7	94.6	154.3	244.5	150.6	241.8	110.2	204.5	102.3	101.2	105.9	140.6	129.6	100.8	151.0	98.4	253.4	61.8	161.9	112.2	110.3	126.7	221.0	205.6	104.4	125.0	276.8	152.6	178.9	161.9	136.6	169.3	124.3	118.0	154.8	123.2	83.6	77.5	133.7	132.1	139.8	84.2	197.2	84.5	169.3	296.2	120.5	153.7	128.4	32.4	34.5	20.3	31.0	42.0	33.2	28.6	35.8	37.0	38.8	30.5	39.9	35.8	3.0	38.5	42.0	30.1	38.1	34.1	32.6	33.5	36.1	44.2	33.8	37.1	36.8	32.6	36.0	34.7	35.3	36.3	41.3	80.1	57.6	25.8	34.9	40.3	57.2	96.4	31.9	58.9	50.3	41.5	362.7	67.2	78.6	90.1	52.1	112.1	29.0	43.7	142.8	112.3	23.1	49.2	69.6	57.2	52.1	64.2	52.1	120.3	108.5	67.0	28.5	51.2	57.0	49.3	47.5	123.0	53.4	45.4	48.6	69.8	83.4	30.3	19.7	19.5	72.7	28.1	49.8	29.0	41.2	60.1	55.6	45.8	49.0	107.2	52.4	78.2	32.8	31.3	74.5	170.2	80.6	75.9	59.2	51.3	94.6	174.0	76.8	30.0	42.3	80.2	30.7	73.5	74.1	36.6
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073860-31104799	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	Nucleoplasm,Nucleoli		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA065197: AB_2685430"	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	5.9	6.4	6.0	10.2	6.8	29.2	7.2	6.9	7.3	10.7	7.1	9.6	8.0	7.5	4.3	9.5	8.0	5.9	5.3	6.0	6.1	9.2	9.3	6.1	13.2	6.9	6.4	11.0	17.5	5.8	9.4	5.4	6.9	10.0	10.1	6.6	8.6	5.3	10.6	16.7	13.4	3.6	6.1	13.8	9.6	8.8	6.7	24.0	8.0	6.6	11.1	6.9	9.8	6.9	36.5	35.0	42.2	34.5	5.8	11.0	58.7	21.8	10.4	25.2	28.5	44.1	58.6	49.2	23.9	10.8	23.6	35.0	31.7	28.9	21.3	43.4	66.6	47.4	71.0	25.4	2.1	37.4	35.0	11.9	13.0	32.6	24.8	16.9	12.6	55.2	26.6	103.3	17.6	30.9	64.5	60.7	84.0	39.9	19.5	55.0	53.3	66.2	13.3	38.5	30.2	21.7	23.4	33.2	10.4	65.0	27.3	25.5	8.2	22.0	42.1	42.2	40.0	39.4	29.6	95.3	24.6	32.5	20.3	0.0	1.3	0.8	2.0	1.2	1.5	2.5	1.9	1.5	1.5	2.6	2.0	2.6	0.5	2.2	4.4	2.4	2.0	1.3	6.0	6.8	6.9	7.3	6.0	6.1	6.9	6.4	6.9	6.1	6.7	6.9	10.1	3.2	9.5	1.6	9.0	6.0	4.0	6.0	2.2	9.4	8.3	7.1	2.5	4.3	6.0	0.0	14.6	7.6	8.8	7.8	0.0	2.0	1.7	5.5	8.9	5.4	0.0	15.3	2.5	3.3	7.5	5.7	9.7	7.4	5.7	15.6	6.1	7.7	5.2	8.4	3.6	6.5	10.2	4.1	5.4	1.3	7.2	4.4	7.2	3.7	3.5	2.7	4.1	1.5	1.7	3.2	2.7	4.5	17.2	6.0	2.3	1.4	6.7	25.8	0.0	4.9	4.8	5.3	18.0	5.5	6.5	2.6	8.4	4.1	9.5	5.1
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814691-117832377	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 376.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA035400: AB_10672091, HPA041056: AB_2677277"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	25.3	21.4	14.9	30.2	15.9	21.8	32.7	16.1	18.0	23.4	15.1	28.3	22.4	30.0	22.9	24.8	23.6	22.2	21.2	14.1	15.9	27.0	35.2	24.8	41.1	15.7	15.2	25.5	21.1	21.4	10.8	26.2	16.1	23.2	31.0	19.4	19.3	23.0	18.6	22.9	23.4	26.3	16.6	32.3	22.8	20.6	15.1	34.5	30.2	18.3	41.7	33.2	17.3	19.0	94.0	41.9	61.3	55.5	35.5	31.9	101.0	54.7	43.0	73.7	64.6	104.2	60.6	137.8	85.9	45.6	68.0	71.1	120.3	70.7	108.0	70.6	83.9	132.0	36.9	105.1	49.5	178.4	66.0	33.4	63.9	93.7	94.3	37.6	44.9	70.3	146.5	58.4	57.1	58.6	98.2	92.6	154.4	79.1	62.3	84.4	95.8	121.3	48.8	55.2	58.8	99.3	62.7	69.2	73.4	62.1	43.9	96.7	34.9	65.6	96.5	46.8	99.5	66.3	87.9	376.0	48.2	82.9	30.1	11.7	23.0	16.3	24.9	28.9	32.0	37.4	29.8	28.9	20.7	30.3	35.6	31.7	5.8	29.7	33.1	33.7	25.7	32.1	14.9	15.9	16.1	18.0	14.1	15.9	15.7	15.2	16.1	16.6	15.1	19.0	144.4	96.1	62.5	24.8	153.9	192.7	114.4	149.4	100.2	150.5	82.8	94.5	50.4	101.5	103.8	121.4	83.4	110.3	140.6	69.0	117.4	125.4	17.1	92.2	125.1	109.1	56.9	76.4	24.3	115.2	120.9	98.2	63.2	102.8	110.3	71.8	107.1	195.6	87.9	82.4	28.0	108.0	109.9	104.8	100.8	17.7	106.6	100.6	92.5	20.6	117.1	70.3	135.9	26.7	39.1	130.0	68.8	103.8	103.3	118.1	53.3	186.5	90.6	132.9	65.7	158.7	110.1	138.6	129.9	81.4	160.5	88.8	143.2	67.4	114.6	65.3
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829756-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		21000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: AB_2676317"	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	33.2	30.7	28.7	36.9	30.8	26.5	33.1	29.7	29.6	35.3	33.1	39.3	33.5	35.1	25.0	37.5	35.4	25.4	30.1	28.0	29.9	33.0	43.0	33.8	46.6	30.7	29.9	40.6	36.7	34.5	28.4	33.7	29.7	36.1	37.6	27.8	37.3	29.7	54.4	39.2	41.2	34.0	30.1	47.6	38.3	26.7	30.8	63.3	32.9	35.8	48.1	36.1	34.7	30.4	74.0	165.1	76.6	81.5	74.7	51.4	81.3	89.1	68.1	98.9	62.5	162.0	95.7	92.5	95.6	74.4	93.3	64.9	168.1	81.1	84.0	146.1	89.2	122.7	139.0	73.8	40.3	125.3	106.9	49.9	71.7	105.1	62.6	67.6	82.4	80.4	165.6	80.3	72.9	102.1	119.8	118.2	114.4	104.0	77.4	125.9	90.7	73.5	58.3	101.9	94.1	54.9	89.4	101.0	38.4	78.0	99.0	113.7	74.5	74.4	54.1	37.2	71.8	60.1	89.8	109.5	63.3	86.8	41.8	20.9	11.8	21.9	19.3	13.6	19.6	12.6	14.1	17.5	11.3	10.5	13.5	16.6	12.2	12.8	9.8	11.9	14.3	12.0	28.7	30.8	29.7	29.6	28.0	29.9	30.7	29.9	29.7	30.1	30.8	30.4	22.7	25.6	36.5	11.8	25.5	12.9	13.7	12.7	25.6	17.5	18.6	19.4	20.0	22.8	25.8	12.9	25.0	25.9	30.7	33.0	15.6	25.9	14.4	24.4	25.2	27.2	13.9	21.7	6.9	38.9	29.1	19.2	25.5	26.6	18.3	29.8	17.9	18.7	19.1	15.2	8.7	26.6	16.2	13.2	10.3	6.3	24.5	16.5	14.2	9.4	25.5	26.2	35.0	7.5	8.4	33.9	32.3	22.2	32.0	26.7	24.3	12.5	34.4	26.1	19.7	20.8	20.0	43.8	33.1	24.4	15.2	26.5	28.6	21.1	27.3	21.6
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68020916-68023232	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: AB_2682200"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favorable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	5.8	10.0	3.9	4.8	4.1	16.8	5.6	4.0	4.3	3.9	4.0	5.7	3.9	6.0	5.1	8.2	5.0	2.8	8.3	4.1	4.7	6.4	8.7	4.3	7.7	4.0	3.9	5.5	5.6	7.0	3.6	4.7	4.3	3.5	4.3	1.6	5.0	3.5	15.4	9.7	7.0	3.7	4.0	9.0	6.3	9.7	4.1	5.6	4.0	7.7	6.4	5.5	4.3	4.1	10.2	14.7	7.1	8.5	9.5	5.3	16.5	6.9	9.8	16.4	11.6	14.4	15.5	37.6	10.2	8.3	9.0	17.9	10.1	16.1	9.6	5.1	16.7	13.6	7.4	14.9	12.8	21.7	14.1	10.3	17.2	13.5	12.4	5.7	9.2	24.9	24.5	5.7	7.4	22.4	22.9	30.0	17.2	10.2	10.7	22.1	6.6	40.3	11.6	11.4	14.8	9.9	27.6	7.8	15.3	8.0	14.9	23.1	7.0	7.3	6.3	10.6	11.2	12.8	16.9	36.7	9.0	16.4	10.1	24.0	22.3	27.4	17.0	22.4	18.7	14.3	15.6	18.5	20.8	19.0	24.2	18.2	7.2	21.5	23.4	10.2	16.0	20.8	3.9	4.1	4.0	4.3	4.1	4.7	4.0	3.9	4.3	4.0	4.1	4.1	4.4	6.4	6.8	0.7	10.9	9.2	14.2	11.7	8.0	5.6	4.8	4.3	4.1	8.6	8.3	3.7	0.0	27.9	4.0	2.9	13.7	12.0	6.6	5.4	4.4	5.7	4.8	9.5	0.9	9.7	12.5	4.4	5.1	5.4	3.8	8.0	6.8	11.6	17.1	3.3	1.0	3.5	6.1	8.5	3.1	4.0	5.0	6.8	7.2	0.0	13.3	7.5	25.7	0.5	1.4	7.4	4.2	3.4	4.2	5.7	2.0	19.7	5.3	4.3	13.1	4.4	9.4	22.7	14.1	6.7	10.7	99.9	7.6	12.5	6.1	8.8
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3 X-linked"	O00571	X	41333348-41364472	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 887.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		260000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	164.7	123.2	28.7	113.3	29.9	146.1	99.8	31.9	37.3	102.4	38.8	85.6	80.7	123.4	39.1	107.6	108.8	111.0	96.4	27.0	36.0	110.5	130.6	103.5	118.7	33.6	29.8	108.1	76.9	133.0	52.5	107.3	34.2	68.7	75.8	81.9	72.9	64.8	126.9	91.2	81.6	145.1	32.4	103.2	84.4	43.0	30.9	169.6	104.3	112.5	111.5	153.3	97.7	34.7	230.5	225.6	236.3	122.3	273.6	211.1	136.4	150.6	239.3	167.1	132.3	238.8	141.4	2.5	103.9	185.8	212.4	149.4	292.2	235.0	248.3	130.2	232.9	132.6	237.6	152.1	140.5	253.8	236.4	159.1	150.9	278.4	270.3	204.1	258.3	131.5	258.4	134.5	158.9	157.8	163.0	83.2	212.2	121.3	114.2	187.8	223.3	182.6	143.7	279.1	147.1	220.0	352.3	184.3	194.3	248.9	158.9	172.4	224.5	159.6	166.3	178.7	188.2	153.6	194.0	215.7	161.5	156.1	151.5	50.8	39.0	30.7	23.3	35.3	33.5	21.0	23.3	26.3	34.7	13.0	25.4	25.3	54.0	30.7	39.4	11.7	24.8	37.8	28.7	29.9	31.9	37.3	27.0	36.0	33.6	29.8	34.2	32.4	30.9	34.7	466.5	86.6	150.0	66.9	280.1	264.3	160.5	63.7	191.8	77.1	295.1	237.6	158.0	81.5	96.5	58.8	131.3	94.6	415.2	231.1	43.0	64.3	370.6	261.1	237.7	238.5	183.7	113.0	43.8	85.6	95.1	191.8	178.9	290.1	165.5	180.6	144.2	174.5	123.1	60.6	47.1	161.4	71.2	208.7	269.1	887.5	66.5	319.0	128.1	47.8	112.2	90.0	79.3	44.7	63.1	114.1	156.7	62.8	241.8	145.0	234.9	87.3	102.5	127.1	72.3	351.4	210.1	30.6	57.7	212.6	333.4	172.9	342.4	144.8	129.1	225.8
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 275.5;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 31.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	29.0	26.1	2.8	15.2	2.9	96.0	20.7	5.5	31.8	0.0	6.6	25.8	12.0	0.0	26.8	18.5	0.0	18.7	19.1	2.7	5.5	23.7	22.0	27.4	9.6	2.8	3.3	0.1	14.8	12.4	25.1	22.1	3.2	33.6	24.0	23.6	18.5	31.3	19.9	20.2	25.9	0.0	2.3	26.5	19.8	70.1	3.8	0.0	22.0	28.1	23.6	22.0	0.0	4.6	0.7	28.3	0.0	0.0	0.0	0.0	20.0	69.3	49.9	35.9	44.0	0.2	0.0	153.7	0.1	69.5	0.0	0.0	0.0	0.0	63.2	38.8	0.0	156.8	0.0	46.5	34.2	0.1	0.1	37.4	43.4	0.0	0.0	0.0	0.0	15.2	0.2	0.1	43.1	0.2	61.8	0.2	27.1	0.0	0.0	0.0	18.0	28.2	38.2	41.5	44.5	0.1	0.1	0.2	51.4	43.5	0.0	36.5	49.1	55.0	0.3	0.1	45.8	78.7	133.1	112.8	6.9	0.1	0.0	1.5	3.8	3.2	4.4	3.9	4.0	3.2	3.3	3.7	4.9	2.7	3.9	3.5	3.5	3.4	2.4	1.4	3.0	3.2	2.8	2.9	5.5	31.8	2.7	5.5	2.8	3.3	3.2	2.3	3.8	4.6	0.1	48.1	75.8	10.1	58.0	94.1	92.7	37.5	89.4	53.8	0.0	0.0	26.0	10.0	41.2	9.2	41.7	38.3	13.3	5.6	5.9	13.9	275.5	0.0	0.0	56.5	16.0	24.6	19.7	0.2	18.9	63.4	56.1	0.0	92.9	0.0	42.1	9.1	20.1	42.1	15.7	9.3	10.2	64.1	127.5	575.3	38.8	58.2	26.6	5.6	27.8	53.7	26.8	4.0	5.7	5.0	8.8	39.5	54.7	70.8	10.5	13.9	101.2	49.3	19.7	56.2	39.2	67.2	70.1	43.8	80.4	37.8	66.2	0.0	8.1	75.0
DDX49	"Dbp8, FLJ10432"	ENSG00000105671	"DEAD-box helicase 49"	Q9Y6V7	19	18919705-18929189	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041870, HPA048093"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041870: AB_2677717, HPA048093: AB_2680262"	"unprognostic (3.51e-1)"	"prognostic favorable (2.01e-6)"	"unprognostic (2.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.67e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (7.44e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.24e-1)"	16.5	17.7	17.1	13.9	17.3	23.3	15.5	17.9	22.1	16.0	14.0	17.4	15.7	15.9	5.9	25.9	13.9	7.9	18.2	18.2	16.5	15.6	24.9	13.7	16.1	17.1	16.0	14.6	20.1	12.6	11.3	13.4	16.7	16.4	7.4	4.8	18.0	10.8	33.6	27.1	14.8	9.9	17.7	16.1	15.7	19.2	17.3	14.1	13.6	13.6	10.3	17.5	17.5	19.3	46.5	47.4	19.0	61.3	28.1	21.1	71.0	29.2	19.8	50.9	40.1	54.6	45.8	60.6	86.7	29.1	16.1	39.4	42.9	39.8	14.8	18.9	110.5	29.9	49.9	48.6	63.5	77.5	40.1	44.4	35.9	40.7	41.9	14.4	23.3	46.9	58.2	43.1	18.2	104.4	56.6	37.9	62.7	50.3	112.8	62.8	31.5	65.9	27.4	28.2	67.2	69.7	38.2	36.6	48.2	9.8	39.2	37.6	29.5	24.3	27.9	92.0	48.7	55.5	73.0	57.1	31.1	88.8	39.3	17.1	21.9	16.7	14.8	26.2	12.0	9.1	11.0	11.1	31.1	9.8	10.9	12.1	8.6	19.5	18.1	13.7	18.0	12.7	17.1	17.3	17.9	22.1	18.2	16.5	17.1	16.0	16.7	17.7	17.3	19.3	15.6	3.2	10.0	4.9	20.5	22.6	18.7	28.0	14.8	19.5	25.2	29.1	13.8	27.1	20.5	18.4	4.2	46.5	27.0	48.0	37.2	35.0	37.2	18.8	26.5	15.3	25.8	18.3	7.4	52.2	50.3	19.0	19.4	24.7	18.4	25.1	7.5	14.8	33.5	10.1	7.6	31.5	30.5	21.0	22.0	103.0	21.5	18.8	26.6	4.7	28.5	18.3	29.9	6.0	8.2	29.8	30.7	19.9	29.5	21.5	48.0	25.0	12.5	24.1	19.7	21.1	26.9	33.4	31.8	29.5	28.3	42.1	20.8	38.1	39.4	21.5
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64498254-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		310000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	202.9	124.0	75.2	75.7	80.0	219.5	163.4	93.4	91.3	190.4	122.8	176.8	36.1	181.7	61.9	136.9	181.2	186.4	109.8	83.6	83.8	113.6	157.5	185.9	124.7	85.5	79.7	134.2	83.3	177.7	118.9	119.4	79.0	122.8	157.7	211.7	112.0	144.8	165.7	130.6	116.3	274.6	65.4	127.5	137.1	88.7	83.2	272.5	172.8	107.5	157.5	228.2	128.9	100.2	204.7	85.5	353.1	144.4	316.2	316.7	134.1	221.4	349.8	306.9	300.3	98.2	105.3	299.7	102.0	364.8	238.1	87.1	361.6	291.5	428.2	107.7	76.0	211.2	84.5	81.6	216.6	383.9	186.3	301.4	306.8	270.2	264.1	241.5	362.2	303.6	174.3	247.3	284.0	108.7	520.4	44.8	159.5	294.5	32.0	310.1	286.7	239.1	201.8	145.6	151.0	305.7	181.5	167.6	284.0	326.5	138.5	132.1	158.2	123.0	146.3	170.0	207.3	112.2	283.9	622.0	166.6	140.5	184.2	232.6	160.6	170.0	117.2	143.3	149.8	111.5	105.4	125.4	148.5	106.3	107.6	109.4	86.6	112.2	197.1	85.5	135.9	319.9	75.2	80.0	93.4	91.3	83.6	83.8	85.5	79.7	79.0	65.4	83.2	100.2	990.8	535.2	690.9	200.8	909.4	879.5	1536.4	837.0	618.1	403.5	433.3	393.7	249.6	346.0	855.7	369.6	335.7	439.9	1284.6	521.5	334.6	476.2	603.0	1021.9	987.2	767.7	664.1	309.7	187.9	419.2	371.3	733.5	452.1	1288.8	874.3	647.9	528.7	254.3	445.8	420.6	165.7	475.9	801.5	577.8	629.4	136.9	415.4	833.2	432.2	280.1	800.2	587.1	777.5	291.6	325.7	464.2	598.6	437.8	661.5	537.7	552.6	287.5	737.9	550.4	493.0	1437.7	961.5	407.6	399.1	466.4	746.0	887.3	1043.4	745.0	424.7	1056.4
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565804-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	21.3	21.8	24.8	21.5	25.6	16.6	17.1	25.5	29.0	19.2	25.3	18.6	20.8	15.4	17.3	25.9	27.2	15.8	20.3	25.1	25.3	16.2	30.1	15.7	29.4	25.6	25.2	22.1	28.2	27.1	7.9	20.1	25.7	18.2	15.7	7.3	24.6	20.2	27.4	32.2	16.4	21.2	25.2	19.5	20.8	10.4	25.2	24.5	23.5	21.5	27.1	28.4	7.3	26.0	69.5	118.8	32.0	70.0	36.6	40.3	62.3	60.9	43.7	107.6	83.9	139.2	90.7	109.8	65.0	59.4	143.5	111.4	70.9	97.5	38.5	45.9	99.2	64.3	90.9	86.1	59.9	77.0	66.4	57.9	78.8	105.8	82.2	35.5	62.0	55.8	150.2	42.8	78.3	103.7	67.3	104.4	108.8	127.8	103.6	70.7	54.3	76.7	69.8	65.4	68.8	90.6	64.2	199.4	58.9	21.3	120.6	105.5	52.4	71.0	86.0	52.6	155.1	88.7	135.0	167.1	75.2	115.1	146.1	36.3	50.8	21.1	37.6	66.3	47.7	48.3	40.9	41.6	63.8	55.0	49.2	38.7	3.6	63.2	67.7	34.8	44.9	59.7	24.8	25.6	25.5	29.0	25.1	25.3	25.6	25.2	25.7	25.2	25.2	26.0	21.5	16.0	29.0	13.1	22.8	17.1	23.9	45.1	21.1	26.6	18.4	14.7	12.3	11.5	40.3	22.0	14.6	57.0	19.1	29.0	27.4	39.4	41.4	21.0	21.1	26.4	18.5	35.8	6.1	32.3	48.5	24.6	30.5	20.6	28.5	35.3	16.8	30.1	35.4	6.7	8.0	24.9	38.7	13.2	17.5	37.5	21.1	17.9	14.2	3.7	28.8	22.4	23.7	6.6	6.2	37.5	18.8	19.9	18.2	24.8	37.2	63.0	31.8	26.9	13.1	22.4	25.1	36.2	25.6	30.1	19.9	47.2	23.6	40.3	36.8	21.3
DDX58	"DKFZp434J1111, FLJ13599, RIG-1, RIG-I, RIG1"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455302-32526208	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 79.0;BJ hTERT+ SV40 Large T+ RasG12V: 76.0;GAMG: 22.8"									"CAB012643, HPA047193, HPA073217"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB012643: , HPA047193: AB_2679978, HPA073217: "	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	6.3	4.9	3.5	7.5	2.9	1.3	6.0	3.0	4.3	7.1	3.1	6.3	2.9	5.6	4.7	6.4	4.4	6.0	4.1	2.7	3.6	5.5	6.3	7.1	7.4	5.2	3.7	4.6	5.7	2.5	5.2	5.7	4.0	4.2	5.3	2.3	10.0	3.5	4.8	7.8	7.1	5.7	6.5	9.2	4.8	2.8	3.6	15.6	4.3	1.7	5.2	5.1	5.3	2.9	4.3	2.4	2.5	2.2	7.5	6.4	2.7	2.1	14.6	79.0	76.0	2.4	1.4	0.4	2.7	2.7	22.8	2.8	2.3	1.3	11.4	7.4	0.9	1.1	2.4	3.5	5.0	1.4	4.5	4.9	1.3	6.9	1.3	4.2	14.3	1.5	1.8	1.0	6.6	0.6	3.8	12.4	1.8	0.6	2.0	2.4	3.1	0.0	11.6	0.6	2.0	0.3	1.7	1.7	12.6	1.7	3.5	0.9	13.4	1.5	0.9	1.7	1.1	0.0	0.3	0.9	2.6	3.3	2.1	0.0	0.1	0.3	0.2	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.2	0.2	1.3	0.4	0.2	0.0	0.2	0.0	3.5	2.9	3.0	4.3	2.7	3.6	5.2	3.7	4.0	6.5	3.6	2.9	41.7	22.4	8.8	20.5	13.9	4.2	5.1	7.2	13.6	4.1	5.8	5.1	5.1	5.7	6.7	1.8	2.1	5.6	13.9	13.8	0.0	19.5	2.7	12.9	8.7	23.6	3.0	5.7	10.4	12.2	7.6	13.9	21.9	20.3	5.1	16.8	9.3	6.7	5.6	6.7	13.2	4.6	4.1	7.3	4.6	0.4	6.5	11.6	0.0	39.4	12.3	6.4	21.6	31.2	17.5	16.2	7.7	6.0	9.1	4.9	16.9	7.2	7.3	2.5	6.6	16.8	13.1	0.5	2.3	10.9	5.4	2.5	17.8	10.4	2.6	5.3
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216291-168318883	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 40.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 57.6;Gastric mucus-secreting cells: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 27.4;BJ hTERT+ SV40 Large T+ RasG12V: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	8.2	6.0	2.3	9.8	2.6	5.6	7.2	2.0	2.4	9.6	2.6	17.4	13.3	7.7	4.8	3.5	7.1	9.7	5.9	1.9	2.4	6.7	9.4	11.4	9.8	4.8	2.3	11.0	4.0	6.4	4.0	11.5	2.9	6.0	15.7	3.3	21.3	5.8	2.4	6.5	12.3	6.1	5.1	17.4	40.8	3.4	3.2	15.4	6.3	3.5	6.8	6.8	5.6	3.1	8.3	1.1	4.2	1.4	2.9	10.4	5.3	2.3	14.9	27.4	26.1	0.0	20.2	0.0	1.4	3.1	12.6	6.6	0.5	4.1	8.7	6.1	0.3	12.9	7.3	0.0	9.9	3.8	3.3	7.2	1.7	6.7	1.2	7.1	10.1	4.8	0.0	2.0	3.4	0.3	6.2	2.5	0.4	0.4	2.1	5.1	1.5	0.0	5.3	4.6	0.8	0.7	5.4	1.3	18.8	0.3	1.0	5.1	8.9	2.1	1.5	0.9	2.0	1.6	0.3	0.0	6.6	6.1	6.1	1.6	1.2	1.2	4.2	2.5	4.8	1.4	3.2	4.1	1.1	1.4	3.3	3.7	0.6	3.7	3.0	0.0	3.0	1.8	2.3	2.6	2.0	2.4	1.9	2.4	4.8	2.3	2.9	5.1	3.2	3.1	32.4	35.3	6.5	14.0	12.2	4.2	4.8	6.2	5.7	0.8	3.9	3.2	8.6	11.5	11.5	12.9	0.0	7.6	13.4	57.6	5.9	8.2	3.3	11.8	10.5	22.8	3.0	8.4	0.7	6.8	10.4	11.6	90.2	10.2	27.3	16.2	14.3	4.0	6.2	0.0	1.3	22.4	2.0	4.1	2.8	2.2	8.1	13.5	3.6	25.3	9.3	7.4	17.5	27.6	1.3	12.0	14.9	9.4	3.1	4.1	11.0	4.2	15.3	2.9	6.6	10.0	9.0	1.1	1.0	2.2	2.7	2.9	17.2	18.4	6.0	3.7
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90053633	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 290.1;liver: 272.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 399.2;Proximal tubular cells: 485.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		120000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	60.2	136.8	12.4	9.6	14.4	24.9	54.4	12.5	14.4	29.4	22.2	65.0	20.2	28.0	14.9	52.6	26.1	7.4	290.1	12.7	13.2	103.5	272.3	34.2	15.0	12.2	13.1	35.5	44.4	13.2	32.6	5.9	12.1	28.6	18.8	8.0	42.8	6.5	121.8	43.3	61.0	9.1	12.5	47.1	44.5	52.3	15.4	10.2	33.0	34.4	13.9	31.1	35.8	12.8	13.1	7.9	19.6	16.1	8.0	17.3	5.2	13.2	12.9	5.9	8.2	2.8	13.4	7.7	5.3	15.1	4.1	6.8	7.7	11.1	11.0	12.6	1.2	18.4	13.6	14.5	11.6	8.7	4.4	12.0	7.0	7.6	10.7	10.1	17.4	16.5	21.3	15.5	20.7	16.3	12.5	7.6	1.5	9.1	24.9	7.4	5.8	13.4	23.4	43.9	1.3	10.6	13.0	81.1	7.7	1.1	10.7	7.4	20.1	11.4	6.2	12.9	6.0	10.5	7.5	12.8	8.6	12.0	10.8	3.9	9.1	6.2	7.1	10.2	7.9	7.4	6.9	8.6	8.8	4.6	8.1	7.8	15.2	3.9	9.3	3.9	9.6	5.8	12.4	14.4	12.5	14.4	12.7	13.2	12.2	13.1	12.1	12.5	15.4	12.8	66.1	76.9	59.4	72.5	52.9	41.3	70.6	180.2	35.3	11.4	51.1	57.4	268.3	82.9	96.4	71.7	2.1	50.2	57.6	119.0	399.2	137.8	165.3	68.2	65.5	60.0	104.8	77.4	27.2	92.5	49.0	60.2	61.2	40.6	50.0	81.3	47.8	244.8	115.1	32.0	55.9	105.9	116.0	95.2	82.7	52.6	85.4	85.1	85.4	29.0	107.1	52.5	74.2	66.9	35.0	87.5	111.6	51.6	67.8	30.3	250.3	485.2	69.0	7.6	72.3	54.5	61.7	157.5	24.6	68.6	41.1	41.0	64.4	135.1	139.6	86.8
DECR2	"PDCR, SDR17C1"	ENSG00000242612	"2,4-dienoyl-CoA reductase 2"	Q9NUI1	16	401858-412487	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 165.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 129.2;Proximal enterocytes: 81.3;Proximal tubular cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047631			Approved	Peroxisomes,Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes	Microtubules	"HPA047631: "	"unprognostic (2.74e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.22e-3)"	13.0	34.8	5.5	1.6	5.7	5.8	11.8	5.5	8.1	9.6	5.4	18.5	20.6	10.0	2.0	12.0	9.2	2.1	12.4	6.0	6.6	35.8	165.1	6.8	1.2	5.6	5.5	8.6	21.2	1.7	8.4	2.4	5.5	11.9	2.8	0.5	9.5	7.1	32.3	10.5	17.4	1.5	5.5	6.8	13.8	11.4	6.1	1.8	6.3	7.2	1.0	10.7	8.1	6.1	2.4	22.5	3.4	14.7	4.1	6.3	7.7	7.0	5.7	6.0	6.7	16.2	16.2	6.1	12.2	7.5	3.7	3.5	2.1	6.4	1.3	12.4	5.7	2.3	10.3	37.6	17.7	4.9	11.1	9.1	4.8	4.2	5.5	6.1	6.9	9.5	4.3	7.9	5.5	27.7	3.2	10.2	8.0	9.0	7.5	5.8	1.3	12.2	6.9	6.3	4.3	8.5	11.3	15.9	8.8	1.3	21.9	10.1	10.8	5.1	5.8	7.5	5.6	6.7	7.1	2.6	7.0	10.2	16.1	0.0	3.8	0.1	2.7	5.1	1.5	1.8	1.1	1.5	5.1	1.7	2.6	1.5	0.2	2.9	2.5	7.8	0.9	2.6	5.5	5.7	5.5	8.1	6.0	6.6	5.6	5.5	5.5	5.5	6.1	6.1	9.6	12.8	16.2	5.2	4.3	3.8	7.3	5.6	10.2	2.0	14.9	15.6	8.3	20.0	7.4	20.2	0.0	34.3	5.7	53.8	39.2	37.3	2.6	7.1	8.1	9.4	12.5	29.5	2.3	38.9	7.1	9.9	38.7	9.6	12.7	15.8	7.5	129.2	12.9	3.3	2.7	30.6	6.1	7.3	5.7	6.3	6.5	6.0	5.4	0.0	10.0	7.0	5.2	3.0	2.8	25.3	37.2	6.8	3.8	6.4	81.3	159.1	7.7	3.0	0.0	7.7	8.3	3.8	6.3	12.6	6.0	12.6	3.5	25.8	38.8	5.1
DEDD2	FLAME-3	ENSG00000160570	"Death effector domain containing 2"	Q8WXF8	19	42198598-42220140	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Paneth cells: 178.2;Syncytiotrophoblasts: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043419			Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA043419: AB_10960747"	"unprognostic (1.59e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (3.26e-6)"	7.0	11.4	16.1	6.6	16.5	12.8	5.8	17.3	23.1	9.4	17.4	8.8	6.7	7.3	3.1	12.3	10.1	2.1	8.6	16.3	24.0	10.7	12.9	13.8	5.3	17.3	18.2	11.3	9.5	4.2	19.3	3.6	21.2	10.6	2.1	3.4	10.0	3.3	9.8	13.0	9.9	1.3	15.3	17.8	9.5	11.7	19.9	7.0	9.9	3.4	4.1	8.8	11.0	23.4	17.1	32.4	2.3	2.8	5.7	1.3	10.5	6.5	5.6	5.2	3.3	9.3	12.2	10.5	12.8	1.9	6.1	7.0	11.1	2.4	2.3	9.0	28.5	5.2	8.7	15.9	6.9	5.8	10.6	0.8	6.3	3.8	5.2	9.5	2.9	4.5	26.7	12.3	1.5	7.2	6.5	21.1	6.0	15.8	22.3	6.8	4.4	9.8	4.1	5.6	19.0	7.1	6.0	18.1	3.6	3.4	3.1	7.2	5.7	3.9	12.6	1.6	12.3	21.4	10.3	3.3	5.8	9.3	4.0	81.7	56.4	94.7	47.9	73.1	51.7	40.6	44.2	46.7	34.6	39.0	39.9	41.2	126.2	40.9	83.1	48.6	46.4	71.9	16.1	16.5	17.3	23.1	16.3	24.0	17.3	18.2	21.2	15.3	19.9	23.4	13.4	6.4	7.5	2.9	47.6	46.4	67.0	30.2	18.2	26.0	33.5	24.5	7.6	21.5	14.4	14.7	12.5	29.1	57.6	101.8	11.7	26.0	32.4	38.4	8.6	19.1	92.2	53.2	5.6	24.2	47.8	15.5	20.4	36.0	70.6	10.0	9.3	8.2	36.6	15.2	5.5	67.0	20.3	31.7	73.6	5.9	13.4	47.4	39.2	2.8	44.5	20.9	75.2	2.5	5.5	45.9	178.2	12.8	34.1	60.7	52.9	20.7	21.4	22.9	6.6	10.3	19.9	18.1	21.1	21.9	53.6	162.0	70.8	17.7	48.7	90.2
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	5.8	3.6	5.9	33.5	5.9	63.2	6.0	6.3	7.2	8.0	7.3	9.8	10.2	2.8	8.5	28.2	4.4	7.2	2.6	5.9	6.6	4.7	5.2	14.7	48.6	8.7	7.0	3.1	21.6	1.3	8.3	7.7	8.0	21.0	7.4	2.2	15.8	4.8	1.7	28.5	30.7	3.5	7.7	62.9	16.3	26.7	8.1	50.2	8.3	1.1	38.1	10.2	16.5	8.8	24.0	0.0	0.8	0.6	0.1	0.3	29.0	2.6	3.6	0.6	0.7	1.5	10.0	28.1	8.3	1.3	0.1	15.5	0.0	19.6	0.4	1.0	1.1	31.7	0.4	12.6	0.7	57.5	40.0	4.5	24.6	0.3	22.0	0.1	0.0	83.3	14.3	65.7	0.1	12.3	75.5	99.3	1.3	3.0	2.8	68.8	0.6	38.4	2.5	17.8	0.4	0.2	2.1	5.8	5.5	1.1	15.9	78.9	3.8	0.3	0.6	0.1	0.3	37.2	37.1	23.3	0.0	117.7	0.2	49.2	39.5	119.7	78.6	29.7	62.4	34.2	63.3	76.8	55.2	31.3	65.1	65.2	69.3	72.9	27.8	36.6	73.1	64.3	5.9	5.9	6.3	7.2	5.9	6.6	8.7	7.0	8.0	7.7	8.1	8.8	1.7	6.4	8.0	1.3	49.2	11.9	16.9	15.0	20.5	2.5	5.4	7.2	0.8	2.8	8.2	5.5	0.0	25.0	52.3	4.2	0.0	0.9	56.3	2.2	0.8	3.1	4.2	6.7	2.0	10.0	17.2	2.2	26.0	3.0	17.7	1.5	2.9	0.9	94.0	3.3	1.0	9.9	2.0	28.0	26.4	151.4	2.8	31.7	7.2	17.8	30.0	0.8	88.6	0.5	0.5	8.0	8.9	1.9	57.9	6.0	3.1	0.3	5.8	1.7	0.0	0.6	1.2	40.0	0.9	20.0	11.8	12.6	78.3	1.0	9.1	13.0
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056739	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	768	"intestine: 9759.8"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 1740.2;Undifferentiated cells: 1753.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 28.3;NB-4: 24.2;RPMI-8226: 26.6;SH-SY5Y: 19.6;U-2197: 8.5"									"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"	Yes	NA		110000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favorable (9.44e-5)"											"unprognostic (3.91e-2)"				0.3	0.4	0.1	12.7	0.1	0.2	0.5	0.1	0.5	0.0	0.1	56.6	5185.1	3.9	0.1	0.8	0.0	0.0	0.4	0.1	0.2	0.2	1.1	0.4	6.0	0.1	0.2	0.4	0.8	0.0	1.1	0.0	0.2	0.7	0.2	0.1	0.7	0.0	0.3	0.3	9759.8	0.1	0.1	0.4	0.9	0.8	0.2	0.4	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	2.5	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	325.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	399.9	0.0	0.0	0.0	1740.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	1753.0	0.0
DENND3	KIAA0870	ENSG00000105339	"DENN domain containing 3"	A2RUS2	8	141117278-141195808	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 157.0;Microglial cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 34.6;neutrophil: 39.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 39.8;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 64.6;HeLa: 89.5;U-937: 58.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024491, HPA041668"		Approved	Approved	Vesicles,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"		"HPA024491: AB_2671581, HPA041668: "	"unprognostic (2.27e-1)"	"unprognostic (9.62e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.42e-2)"	42.8	8.9	21.7	27.2	18.8	106.4	28.2	12.2	28.4	22.9	14.7	36.2	5.7	17.8	2.1	7.5	19.1	13.6	24.9	19.9	17.7	21.5	6.5	57.9	28.6	33.6	24.7	15.1	7.6	4.1	10.0	15.1	25.7	16.9	7.8	3.7	18.2	8.5	13.8	15.6	23.7	8.3	22.7	43.9	15.8	6.1	21.2	7.1	20.6	11.7	25.1	12.4	17.6	31.4	16.4	14.8	1.0	3.1	4.4	6.4	2.4	8.5	27.4	3.8	3.0	4.6	15.3	4.2	22.8	17.5	7.5	7.8	4.2	10.0	2.7	64.6	3.6	17.3	89.5	1.4	3.9	17.2	2.4	0.5	5.1	4.2	5.3	9.2	21.1	7.8	0.2	40.7	2.9	5.2	2.6	24.1	1.1	3.2	16.6	2.9	0.8	16.6	14.8	5.6	4.7	3.0	1.8	1.3	1.1	7.3	6.8	27.6	16.7	0.7	6.8	10.6	0.3	8.0	37.0	1.3	2.6	58.6	1.0	24.3	5.4	34.6	0.8	8.0	0.8	5.0	0.6	0.3	4.1	4.3	0.1	0.2	39.8	2.7	10.0	0.1	0.2	3.5	21.7	18.8	12.2	28.4	19.9	17.7	33.6	24.7	25.7	22.7	21.2	31.4	49.0	157.0	35.2	2.6	39.7	15.7	7.6	11.7	7.4	4.5	6.3	2.0	10.1	10.0	18.8	22.0	4.2	0.7	29.5	18.3	1.9	3.5	6.1	15.1	8.1	31.7	4.8	5.7	53.9	3.5	0.6	4.8	16.8	14.5	10.8	1.9	16.4	0.3	24.4	1.7	5.2	7.9	4.1	55.6	22.2	2.8	1.5	39.7	8.8	79.6	33.0	0.7	21.6	1.5	1.1	11.0	9.9	0.7	38.8	20.3	1.5	2.7	15.1	0.5	39.5	2.1	21.5	8.7	8.5	2.9	9.1	0.5	12.5	0.6	4.1	6.3
DENND4A	"IRLB, MYCPBP"	ENSG00000174485	"DENN domain containing 4A"	Q7Z401	15	65658046-65792293	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 59.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 195.4;Oligodendrocyte precursor cells: 176.5;Oligodendrocytes: 180.2;Rod photoreceptor cells: 155.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065343	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA065343: AB_2685476"	"unprognostic (1.10e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.83e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.48e-1)"	6.2	9.8	4.0	11.4	6.5	33.8	6.8	29.9	7.5	7.4	11.2	6.6	5.8	8.8	5.1	6.6	7.2	11.2	5.1	5.6	5.1	7.9	16.8	9.5	19.7	3.5	4.7	12.8	15.5	10.1	8.4	8.5	4.7	6.0	6.8	59.3	6.1	5.6	9.2	6.5	6.3	7.4	4.2	12.4	8.9	7.9	3.3	12.7	9.3	7.8	18.2	10.2	4.5	7.6	9.9	9.6	4.9	5.1	14.3	15.9	5.9	10.1	13.9	6.8	9.9	5.5	7.8	52.0	6.8	15.1	8.4	18.1	9.7	9.2	12.0	56.7	11.2	49.4	11.7	10.4	8.3	16.8	16.7	10.6	10.3	9.5	20.0	12.0	18.5	11.4	15.2	31.5	7.9	5.2	8.1	9.1	1.5	30.5	6.9	3.9	17.2	45.1	8.0	19.0	7.7	7.0	9.8	6.9	8.9	5.8	6.7	43.1	19.6	9.3	10.3	16.7	14.2	16.8	20.1	19.3	13.1	36.2	7.8	3.2	2.6	5.2	3.6	1.0	5.5	5.4	3.1	4.6	2.3	6.1	3.2	3.1	1.4	3.5	0.9	0.9	3.3	1.5	4.0	6.5	29.9	7.5	5.6	5.1	3.5	4.7	4.7	4.2	3.3	7.6	22.7	16.0	23.1	126.7	81.5	27.9	29.8	7.9	36.5	73.8	23.9	12.2	12.3	20.0	15.2	9.2	60.5	5.6	47.8	5.8	0.0	10.1	2.4	29.3	22.2	23.7	17.4	83.1	195.4	13.0	6.8	22.4	25.0	46.1	48.8	10.5	21.0	25.9	20.4	111.0	140.3	9.7	0.0	19.0	47.5	3.0	13.1	42.2	24.9	145.2	24.5	26.9	20.6	176.5	180.2	12.0	10.1	12.4	55.1	20.2	6.4	9.8	18.1	155.9	6.6	37.9	15.7	11.3	10.9	18.7	17.0	12.6	56.5	13.2	10.0	17.3
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015876-33033582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 29.0;kidney: 19.6;liver: 74.0;testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 34.8;Early spermatids: 153.3;Extravillous trophoblasts: 47.0;Proximal enterocytes: 33.2;Spermatocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 53.7;RH-30: 40.1;SiHa: 37.3;SK-MEL-30: 34.4;U-2197: 34.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.8	2.5	1.9	3.2	1.8	0.9	2.9	3.7	2.8	2.7	4.6	24.6	1.0	2.2	4.4	0.9	4.4	1.1	2.6	2.7	19.6	74.0	0.9	0.7	3.2	2.7	1.6	3.8	2.3	0.8	1.5	3.0	1.9	5.1	0.1	2.0	1.5	4.9	6.0	29.0	1.7	2.8	0.3	3.0	28.2	2.7	2.9	0.5	0.9	1.5	1.2	3.4	4.9	9.4	5.2	7.3	3.3	3.8	3.6	4.9	16.2	5.4	9.8	13.0	13.5	0.9	0.0	3.7	16.2	4.5	9.4	10.8	3.8	11.5	0.0	14.9	2.5	16.1	19.3	3.2	9.1	10.9	4.6	5.7	5.7	4.2	5.3	0.0	0.0	6.2	0.0	53.7	1.0	0.0	14.6	4.8	7.7	0.0	0.0	40.1	0.1	3.2	1.3	1.6	4.2	37.3	6.6	34.4	5.1	1.7	4.7	0.0	6.3	10.4	34.1	10.6	0.0	0.0	0.1	2.3	0.0	31.5	4.1	0.5	6.7	0.2	0.1	0.0	0.0	0.4	0.2	3.2	0.0	1.9	2.1	0.0	2.4	0.0	1.2	0.0	0.4	2.5	3.2	2.9	3.7	2.6	2.7	3.2	2.7	3.0	2.8	2.7	4.9	0.2	0.0	0.0	1.0	0.0	34.8	12.8	4.5	12.5	0.0	0.2	0.6	0.1	1.5	0.9	0.0	0.0	0.5	0.5	6.0	3.9	0.9	153.3	0.2	0.2	0.3	3.5	3.2	0.1	0.6	47.0	1.6	0.0	0.1	2.5	0.1	1.4	22.6	3.1	0.0	0.4	2.4	0.0	0.6	9.5	16.3	1.5	1.7	1.8	3.7	1.2	0.0	0.0	3.5	10.4	0.8	0.6	1.2	0.1	2.4	33.2	18.4	0.9	0.0	0.0	4.5	1.4	42.3	6.5	6.6	7.4	1.5	0.7	0.2	2.4	1.6
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050918	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.2;tongue: 122.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Glandular and luminal cells: 66.1;Oligodendrocytes: 123.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 20.3"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 20.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 105.1;RPMI-8226: 193.2;RPTEC TERT1: 149.3;U-698: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Mitochondria	"Nucleoplasm, Nuclear bodies"	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	14.4	52.8	12.0	3.0	16.7	2.0	20.7	12.6	11.9	39.2	3.8	23.3	16.9	16.5	11.1	15.2	27.1	10.8	5.1	9.7	23.2	40.0	16.3	5.3	10.1	15.8	12.5	24.7	11.9	16.9	11.4	4.9	15.3	12.1	9.9	2.0	106.3	15.6	158.2	6.6	14.5	15.5	14.8	9.5	40.0	2.9	16.3	5.1	98.0	122.3	2.9	5.6	7.0	24.2	0.1	3.5	0.3	1.1	21.0	6.2	0.3	0.1	0.3	0.6	0.5	2.4	0.4	105.1	2.3	1.2	0.3	0.3	5.4	0.2	0.4	2.3	2.7	14.2	0.9	0.6	12.8	3.0	23.7	5.5	9.5	0.8	0.6	0.1	0.0	1.8	0.1	16.9	0.3	7.1	0.1	2.5	1.3	45.5	3.7	0.4	4.9	193.2	149.3	4.1	3.2	0.7	1.7	11.0	3.2	2.8	9.6	0.5	0.0	0.4	0.9	21.4	0.5	45.4	11.4	55.2	6.5	3.9	0.6	0.0	0.9	0.0	0.2	1.7	0.8	0.1	0.4	0.7	20.3	0.1	0.8	0.6	0.3	0.4	0.2	1.0	0.4	1.0	12.0	16.7	12.6	11.9	9.7	23.2	15.8	12.5	15.3	14.8	16.3	24.2	23.1	6.4	9.3	4.9	2.9	5.2	15.4	3.8	27.3	2.1	16.5	10.4	2.4	15.7	8.4	25.8	0.0	0.6	0.8	2.7	86.1	5.7	2.2	19.0	9.7	7.5	16.7	12.4	14.5	11.8	4.1	10.0	29.6	66.1	12.0	5.4	2.5	12.7	3.3	0.0	31.0	7.7	0.0	16.0	39.5	2.2	11.8	14.9	14.2	46.9	1.5	1.2	2.1	9.5	123.9	1.1	36.5	3.4	6.4	7.1	21.0	33.6	1.1	0.7	0.0	8.1	5.7	3.6	3.8	16.5	5.5	0.4	1.3	6.0	16.5	21.9
DESI1	"D15Wsu75e, DESI-1, FAM152B, POST, PPPDE2"	ENSG00000100418	"Desumoylating isopeptidase 1"	Q6ICB0	22	41598028-41621043	"Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 761.4;Late spermatids: 415.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053415	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Cytokinetic bridge"	"HPA053415: AB_2682141"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.16e-3)"	"unprognostic (8.75e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	11.9	18.5	34.3	10.4	36.0	7.5	10.9	37.1	36.6	10.7	23.6	13.3	11.6	11.2	11.3	26.4	10.2	8.9	38.1	34.4	37.5	22.3	47.3	14.7	11.6	36.1	37.9	12.4	12.5	13.1	12.2	9.3	35.5	13.0	10.6	12.9	12.0	10.6	16.1	15.5	12.6	11.3	34.9	13.5	16.4	18.7	38.6	8.8	9.2	17.6	13.6	12.7	11.9	35.3	16.7	17.4	17.0	23.4	23.5	28.0	9.6	33.0	21.0	30.0	21.9	23.2	10.4	63.2	22.2	38.2	15.7	23.8	45.7	36.8	31.1	28.6	34.7	14.2	32.5	19.7	28.8	56.4	18.4	24.1	42.2	36.8	34.1	24.3	45.8	21.7	42.0	69.5	24.0	21.2	12.9	17.2	16.8	62.2	26.0	17.3	7.2	65.2	38.0	10.5	12.1	6.3	31.8	34.5	23.0	19.3	11.4	18.3	46.8	22.0	16.0	23.4	16.3	25.4	21.1	29.7	54.4	24.4	29.7	9.1	6.6	7.8	3.3	9.0	4.3	4.1	4.0	3.9	5.2	3.7	3.5	4.3	3.8	2.1	6.2	3.0	5.3	4.2	34.3	36.0	37.1	36.6	34.4	37.5	36.1	37.9	35.5	34.9	38.6	35.3	21.2	9.6	18.9	10.7	27.1	8.7	36.6	42.1	13.1	19.8	29.7	29.8	55.2	18.6	21.7	9.2	6.2	31.1	15.0	29.0	39.2	50.8	761.4	29.5	24.7	24.1	19.7	11.8	13.9	30.2	39.5	17.6	19.4	55.0	10.8	27.6	19.6	72.9	50.4	21.9	18.1	19.9	22.4	28.1	18.6	415.8	19.0	33.8	14.2	6.5	49.4	18.6	30.9	11.6	13.3	50.0	29.5	10.5	46.5	111.0	80.1	53.7	10.8	11.4	26.3	14.3	24.3	149.4	30.7	43.6	13.2	83.6	22.4	28.9	26.3	72.3
DET1	FLJ10103	ENSG00000140543	"DET1 partner of COP1 E3 ubiquitin ligase"	Q7L5Y6	15	88494440-88546681	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA048873: AB_2680541"	"unprognostic (9.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.67e-2)"	3.7	5.2	2.5	2.0	2.8	1.2	3.6	2.7	2.7	6.0	3.2	4.2	3.5	6.7	5.4	2.2	5.6	3.0	5.6	2.5	2.6	3.2	2.7	2.1	2.9	2.7	2.5	10.3	3.6	3.7	3.7	3.5	2.8	4.1	3.2	5.0	4.1	3.8	9.7	2.6	3.2	5.5	2.4	2.5	3.4	1.5	2.6	5.6	4.1	11.7	3.0	4.5	3.3	3.2	1.7	6.2	8.6	6.0	3.4	6.0	1.1	5.4	6.1	4.5	5.1	1.0	4.8	3.3	4.1	7.3	4.5	2.4	8.7	1.3	3.9	0.2	5.9	6.9	3.1	1.5	6.7	2.5	1.1	5.0	5.9	1.9	6.9	4.4	3.8	2.9	8.5	3.8	6.7	2.6	3.2	2.8	3.6	2.6	1.8	4.2	6.9	3.8	2.4	5.3	3.0	4.9	6.5	2.0	14.9	5.6	2.9	5.2	3.0	5.1	3.7	4.8	5.4	2.3	1.4	2.1	5.4	4.3	4.5	0.0	2.3	1.6	2.2	3.4	1.4	1.8	1.7	1.9	3.7	2.2	2.6	1.9	0.3	1.4	2.3	1.9	2.4	1.3	2.5	2.8	2.7	2.7	2.5	2.6	2.7	2.5	2.8	2.4	2.6	3.2	3.5	3.2	2.7	6.8	3.5	0.6	2.0	3.7	4.6	11.5	4.3	3.8	2.3	1.5	2.1	3.7	10.4	7.2	1.7	2.1	1.9	3.4	1.2	3.4	6.1	2.3	3.0	5.5	5.7	3.9	6.3	4.9	2.0	2.4	0.0	10.6	2.2	2.8	4.4	6.7	6.8	2.7	2.0	1.6	2.2	0.6	4.4	2.5	3.6	3.7	4.7	7.1	2.1	6.0	9.5	3.1	1.0	3.8	1.6	1.5	3.1	2.6	3.1	7.9	0.0	5.6	4.5	8.1	9.9	1.5	1.3	4.1	2.7	8.4	3.3	1.4
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 213.5;Proximal enterocytes: 700.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.4;PC-3: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Nucleoli rim,Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"	"Nucleoli, Nucleoli rim"	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	15.0	24.7	4.6	1.8	4.6	5.1	11.8	5.5	5.6	6.1	4.1	16.7	37.0	5.6	1.0	8.6	5.1	2.0	11.7	4.7	4.1	7.9	16.5	6.9	1.8	4.5	4.6	4.3	6.5	3.9	6.5	1.5	4.2	6.6	4.2	1.6	7.4	2.4	11.7	6.9	40.6	1.6	4.1	9.3	8.7	14.7	4.4	2.3	7.4	3.5	1.4	6.7	6.4	4.5	5.2	4.9	2.2	4.1	3.5	1.5	2.9	3.4	3.1	2.9	2.0	11.2	3.1	2.1	12.4	1.9	1.6	4.0	1.8	4.3	0.6	3.7	5.1	3.3	4.2	18.4	2.5	1.0	3.4	2.1	3.2	2.0	2.1	2.1	2.3	7.3	2.9	5.2	1.9	3.7	6.8	4.1	1.1	10.9	21.2	7.7	0.9	3.4	2.8	2.5	2.6	4.2	4.7	5.2	2.3	0.8	2.9	3.3	2.0	1.6	5.6	3.6	2.8	2.3	0.6	0.8	1.8	6.3	3.2	0.0	0.4	0.7	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.1	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.2	4.6	4.6	5.5	5.6	4.7	4.1	4.5	4.6	4.2	4.1	4.4	4.5	34.0	16.0	19.0	15.7	8.5	8.0	12.5	6.3	4.0	24.6	21.6	16.0	20.8	12.8	8.7	18.4	29.2	11.3	17.6	213.5	1.9	9.4	19.2	12.3	13.7	26.5	23.4	17.7	11.2	11.9	10.3	9.3	48.4	21.3	7.0	23.9	12.5	57.4	18.8	18.5	12.8	93.6	4.1	25.5	11.8	25.8	6.8	22.8	5.4	8.4	9.2	21.3	4.1	17.6	7.0	13.3	113.4	6.8	18.8	8.1	700.1	7.4	5.6	23.6	0.0	11.9	12.3	27.7	17.4	12.3	9.2	16.4	12.3	41.1	108.0	20.7
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 476.0;breast: 133.6;liver: 331.8;skin 1: 151.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"eosinophil: 137.7;neutrophil: 348.6"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 348.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 22.0"	HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	476.0	5.1	5.8	19.4	11.7	7.2	133.6	2.9	6.1	2.6	5.3	9.0	14.5	1.2	1.8	24.1	2.1	5.8	11.7	5.7	6.4	3.4	331.8	5.6	4.0	3.7	3.9	1.8	4.6	2.1	1.6	1.5	5.5	2.2	4.9	0.6	10.5	1.6	4.1	151.5	16.5	2.8	3.4	15.0	12.8	38.1	6.9	4.3	8.8	5.6	18.2	21.3	12.6	5.1	13.3	6.4	0.4	11.2	80.4	6.4	1.0	1.3	1.7	1.6	1.0	46.6	13.5	21.1	16.8	0.3	11.9	0.5	1.8	6.5	4.4	62.5	1.2	1.5	4.0	64.9	0.9	7.4	7.2	26.8	33.6	7.3	10.6	4.4	1.2	20.9	1.2	27.6	0.7	8.5	5.1	16.7	3.6	124.0	31.5	0.0	0.1	24.8	1.2	35.8	22.6	1.4	12.3	1.9	2.9	2.7	4.4	26.6	1.6	14.1	7.0	0.3	9.1	16.3	40.0	28.8	10.2	23.7	25.3	19.4	22.1	137.7	0.0	4.4	0.4	7.4	0.4	0.0	6.1	7.6	0.1	0.2	348.6	0.0	5.0	1.8	0.0	5.7	5.8	11.7	2.9	6.1	5.7	6.4	3.7	3.9	5.5	3.4	6.9	5.1	3.2	6.4	5.4	0.3	5.0	1.1	0.9	3.0	0.6	0.9	5.2	7.0	3.5	0.0	2.7	0.0	2.1	0.5	0.3	0.6	0.0	1.7	259.3	3.3	0.2	0.5	1.2	2.7	2.9	0.5	0.1	0.7	10.7	0.2	0.0	2.1	2.9	116.4	2.2	1.7	1.3	4.8	0.0	4.1	13.1	64.1	2.1	4.2	1.8	0.0	4.0	0.4	0.0	0.0	1.0	3.7	2.2	0.7	0.9	2.8	1.2	2.2	3.4	0.0	6.6	0.6	1.0	53.9	53.5	0.3	8.0	0.8	0.5	0.2	3.0	15.7
DGCR8	"C22orf12, DGCRK6, Gy1, pasha"	ENSG00000128191	"DGCR8 microprocessor complex subunit"	Q8WYQ5	22	20080232-20111877	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.3;Rod photoreceptor cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076916, HPA079351"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA076916: , HPA079351: "	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.26e-2)"	5.2	4.4	5.3	6.1	5.2	7.7	4.8	9.4	5.6	6.8	5.0	7.0	5.0	8.5	3.6	7.1	6.9	4.7	5.2	5.3	4.6	4.7	4.5	5.3	6.3	5.1	5.1	8.4	6.2	6.4	5.2	11.6	5.6	5.5	5.0	6.5	7.2	5.6	14.8	7.5	6.7	6.0	4.7	5.9	6.1	15.2	5.3	9.5	6.0	9.3	5.9	6.8	5.7	6.2	22.7	15.7	20.1	11.9	7.7	12.4	25.5	21.3	12.6	14.1	9.9	17.0	11.3	20.1	11.6	20.0	9.4	21.4	18.4	17.8	12.2	19.7	27.4	21.7	17.4	14.0	20.3	40.7	17.5	10.0	21.6	14.8	10.7	12.9	12.6	12.1	78.7	14.1	16.5	14.6	24.7	12.1	19.4	16.5	11.8	29.0	21.2	6.8	8.5	20.9	22.3	14.3	19.4	11.3	13.0	12.0	10.9	17.2	18.8	20.5	17.1	13.0	21.9	7.8	11.5	19.9	15.3	18.2	20.3	0.0	1.1	0.6	2.0	0.9	1.5	0.7	0.9	2.1	1.3	0.6	0.9	1.2	0.2	1.6	3.6	1.5	1.2	1.5	5.3	5.2	9.4	5.6	5.3	4.6	5.1	5.1	5.6	4.7	5.3	6.2	8.1	6.4	7.9	11.8	6.0	9.6	5.2	6.8	10.2	37.1	9.1	8.0	4.2	11.5	7.3	5.5	39.6	13.6	6.9	9.6	0.0	6.1	61.3	5.5	8.3	10.2	7.3	10.3	12.4	10.2	11.2	7.3	12.8	7.3	3.8	19.2	9.7	14.4	5.3	43.7	12.7	10.3	4.1	8.4	6.5	39.2	18.3	5.0	5.4	6.5	7.2	10.9	11.3	9.5	14.0	10.9	5.8	10.5	9.3	8.6	6.2	3.4	8.1	60.7	6.6	9.7	8.1	25.2	17.5	10.4	9.2	13.5	9.3	15.1	9.7	5.6
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 336.3;urinary bladder: 392.6"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 15.1;Syncytiotrophoblasts: 24.8;Theca cells: 12.6;Urothelial cells: 30.6"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 719.8;RT4: 828.1;SK-BR-3: 4047.2;U-2 OS: 1286.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	1.2	1.6	0.3	0.1	0.2	0.0	336.3	0.2	0.4	1.9	0.2	0.2	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.4	1.2	1.6	23.6	0.2	0.0	0.4	1.2	25.5	10.3	2.1	2.5	3.2	1.7	3.3	0.4	0.4	97.7	3.1	0.0	3.4	0.1	0.2	0.3	19.0	4.7	3.4	1.1	0.0	0.1	0.0	0.0	392.6	13.6	0.3	1.2	2.2	0.2	199.9	0.3	0.3	3.1	0.3	0.2	6.4	0.1	14.4	1.1	0.8	1.9	0.3	10.4	2.0	0.7	1.2	1.4	289.5	21.6	2.8	1.0	719.8	0.0	4.3	25.1	1.7	0.2	2.5	1.7	0.0	0.1	0.4	1.8	0.7	1.4	8.0	2.5	0.3	1.1	6.9	31.7	2.6	6.3	2.7	0.0	828.1	3.5	5.0	5.9	4047.2	4.9	0.7	3.9	1.0	0.0	2.4	1286.3	7.7	4.3	2.0	0.6	11.3	1.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.4	1.2	0.4	1.2	1.7	0.3	1.1	0.3	0.1	0.0	0.0	0.0	0.4	0.0	2.1	0.2	0.0	0.8	7.4	1.3	0.4	0.0	0.0	0.0	0.0	7.9	0.1	0.1	7.9	0.1	5.0	0.1	0.0	0.2	3.5	0.0	0.1	0.2	15.1	3.5	0.0	0.0	0.0	1.4	0.0	4.9	1.7	0.0	0.1	0.2	0.0	0.3	0.8	3.7	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	4.8	0.2	1.2	0.0	0.3	0.0	0.2	0.0	1.2	6.6	0.0	0.7	0.3	7.4	0.0	0.1	24.8	0.2	12.6	0.7	30.6
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12618210	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 323.7"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 409.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 86.8;MAIT T-cell: 63.1;memory CD4 T-cell: 46.9;memory CD8 T-cell: 41.0;myeloid DC: 24.0;naive CD4 T-cell: 79.2;naive CD8 T-cell: 50.1;NK-cell: 41.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 24.0;NK-cells: 41.1;T-cells: 86.8"	"Cell line enhanced"	"Detected in many"		"A549: 107.4;CAPAN-2: 206.9;hTERT-RPE1: 196.7;SK-BR-3: 104.6;WM-115: 192.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	150.9	21.6	38.3	18.6	37.8	13.8	115.8	34.8	41.1	89.8	96.3	60.8	50.2	34.6	25.3	117.1	53.9	33.5	73.2	38.0	38.0	87.8	323.7	56.4	18.0	57.2	37.8	38.8	108.4	31.3	48.8	19.6	40.1	169.6	21.2	8.6	67.0	48.2	76.2	71.9	52.5	16.8	40.6	27.0	87.1	20.2	41.3	10.4	121.2	24.7	8.9	73.0	107.0	44.2	18.1	107.4	0.1	42.7	54.9	5.0	11.9	6.2	0.3	0.2	0.4	11.8	206.9	0.1	5.2	57.7	17.6	79.9	21.4	10.6	0.2	0.1	36.3	16.5	11.3	57.3	8.5	0.3	0.3	27.9	13.5	0.3	0.5	196.7	18.0	0.7	24.3	0.3	0.3	3.0	4.4	1.0	6.8	18.5	40.3	0.5	0.1	20.2	0.1	36.6	1.3	2.0	35.0	104.6	6.6	13.2	10.3	4.8	13.5	0.5	2.2	30.3	0.4	3.3	0.2	0.2	23.9	1.4	192.8	9.2	0.8	0.1	86.8	0.5	63.1	0.6	46.9	41.0	24.0	0.7	79.2	50.1	4.7	41.1	1.1	3.0	1.4	48.2	38.3	37.8	34.8	41.1	38.0	38.0	57.2	37.8	40.1	40.6	41.3	44.2	139.5	96.1	55.9	26.8	3.4	25.6	136.0	114.8	59.2	2.0	17.5	22.6	42.3	45.8	93.4	20.2	18.8	34.4	35.5	83.8	23.5	99.3	99.6	69.8	50.2	54.1	25.1	23.6	3.7	163.1	45.0	56.4	32.1	83.7	15.8	2.6	73.5	181.3	67.1	0.0	3.3	33.0	42.7	69.6	8.4	409.5	22.7	43.6	7.2	17.8	11.5	15.3	38.1	1.0	0.6	129.6	69.5	9.8	3.5	76.2	112.6	52.9	82.8	2.4	0.0	10.5	30.8	1.9	1.4	51.7	27.0	26.3	28.3	7.9	33.0	156.8
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144119-60169856	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 615.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 840.4"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031121, HPA078401"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Mitochondria"		"HPA031121: AB_10600803, HPA078401: "	"prognostic favorable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	62.1	103.4	50.8	43.8	53.9	61.0	58.5	59.2	75.4	48.9	50.2	73.0	108.9	49.8	96.5	44.3	45.9	59.1	47.1	49.9	55.1	100.5	146.4	64.2	45.5	62.3	54.9	64.9	76.8	226.8	54.7	29.6	63.3	409.9	69.5	111.1	317.5	134.6	615.8	46.6	181.0	51.0	57.8	45.4	182.3	9.8	52.0	39.2	120.3	136.0	49.4	51.7	41.1	65.6	221.3	52.9	41.8	89.3	219.6	74.4	42.8	74.3	186.4	26.5	59.0	37.3	149.8	21.5	41.7	76.8	78.0	92.7	57.2	108.3	34.5	156.1	36.0	53.7	28.7	60.9	110.1	71.8	1.7	63.3	116.7	47.6	153.0	50.8	52.5	66.2	18.2	52.6	61.4	59.2	40.9	67.2	18.6	151.2	55.4	42.7	50.8	24.4	118.3	70.5	83.4	99.8	72.6	118.0	168.2	52.7	72.7	32.5	35.8	126.6	38.7	36.9	44.2	18.3	7.9	45.0	62.6	64.8	93.5	743.5	213.1	519.6	335.7	159.1	340.6	184.4	238.9	298.5	185.0	167.0	134.6	258.5	835.4	294.7	224.0	388.8	215.5	450.2	50.8	53.9	59.2	75.4	49.9	55.1	62.3	54.9	63.3	57.8	52.0	65.6	109.6	54.5	102.5	16.0	72.2	34.0	70.3	233.2	52.3	25.7	81.2	57.4	27.6	160.2	138.4	86.5	83.4	29.6	210.4	101.3	19.6	222.5	2.1	56.2	55.5	89.7	46.5	20.4	12.2	165.9	88.7	87.9	120.8	120.0	178.5	22.9	48.5	166.4	94.4	42.1	19.0	102.2	386.6	54.5	70.6	3.5	82.3	98.7	108.5	16.9	172.5	94.4	299.7	26.2	20.1	210.6	114.5	84.2	99.0	263.4	840.4	44.1	57.0	70.7	85.5	66.4	73.7	1.6	2.9	47.0	25.4	20.8	152.1	19.7	79.2	47.1
DHRSX	"DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6"	ENSG00000169084	"Dehydrogenase/reductase X-linked"	Q8N5I4	X	2219506-2502805	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003035, HPA075955"	Approved		Uncertain	"Mitotic spindle,Cytosol"	"Secreted to blood"	Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	"Mitotic spindle"	"HPA003035: AB_1080631, HPA075955: "	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.69e-2)"	13.1	16.2	7.0	4.8	8.2	5.2	12.2	6.7	7.7	13.3	11.9	12.7	6.5	13.0	8.0	6.0	11.0	8.8	19.9	6.1	6.8	14.7	30.6	10.3	5.6	11.5	10.1	12.6	21.9	11.5	10.6	8.2	8.4	13.2	8.3	2.2	14.7	7.0	12.4	9.0	10.8	6.9	8.5	10.1	16.5	6.4	10.9	6.1	13.3	7.0	3.9	11.2	9.3	8.2	8.1	35.7	23.9	11.0	28.8	18.0	18.5	17.8	29.9	13.3	17.9	26.9	16.8	12.6	22.6	21.5	31.4	3.9	16.4	14.3	9.4	24.1	26.1	12.2	17.9	21.2	33.8	6.6	9.5	22.3	17.7	11.6	11.4	22.7	10.9	13.9	14.0	6.1	21.7	9.2	28.5	9.7	6.9	10.6	9.9	10.4	12.4	3.5	14.5	19.3	24.3	22.9	17.0	20.3	14.2	14.8	8.7	10.8	15.6	14.5	3.6	8.4	10.6	7.1	0.1	33.2	9.7	8.7	6.7	14.9	38.3	34.6	15.1	30.6	16.0	25.0	13.5	12.7	35.1	20.1	12.3	10.6	56.4	17.7	19.5	28.3	18.2	21.0	7.0	8.2	6.7	7.7	6.1	6.8	11.5	10.1	8.4	8.5	10.9	8.2	8.7	19.2	9.3	64.3	19.2	10.6	22.9	58.0	20.5	9.5	19.3	16.9	23.4	25.8	24.4	25.8	10.4	42.9	17.0	32.9	13.7	52.3	0.6	16.1	15.9	14.8	19.2	13.7	41.2	81.2	43.5	26.9	21.4	14.4	17.8	27.1	15.0	50.6	38.4	3.3	42.7	21.4	32.6	20.8	30.7	3.0	24.2	26.3	12.4	61.8	35.9	9.4	14.4	46.3	31.9	71.0	28.8	25.2	29.1	65.3	49.2	43.7	14.8	6.2	19.7	12.0	18.3	12.0	21.2	11.3	6.5	107.3	14.0	14.6	24.1	29.2
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068954-12123221	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 129.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 227.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	10.7	8.4	8.1	6.8	10.4	3.8	8.4	12.6	8.5	8.8	11.9	10.1	7.6	6.2	6.8	7.5	6.1	5.3	13.2	7.6	8.5	42.7	129.5	5.4	8.5	9.5	8.6	10.0	18.0	12.7	5.6	7.7	9.5	12.9	10.8	7.5	13.1	5.7	18.7	5.6	6.9	5.7	8.8	7.8	10.9	4.7	9.1	10.5	11.6	23.1	9.7	6.3	6.1	11.4	27.0	20.4	29.8	23.8	18.2	10.8	35.9	13.3	8.6	23.4	20.6	13.1	15.7	19.3	4.3	8.4	10.8	37.4	31.6	10.4	26.6	10.9	14.2	10.6	7.7	10.1	17.8	4.2	3.8	13.3	7.9	13.7	5.5	9.2	13.0	23.1	16.7	15.1	6.3	52.3	14.4	7.7	16.7	24.9	4.7	24.3	9.7	16.5	15.2	6.4	7.7	34.9	26.3	46.3	15.4	31.7	102.2	15.2	5.8	7.5	5.4	15.8	9.9	13.4	10.3	12.6	9.7	7.4	12.8	23.8	6.8	15.4	4.2	9.2	4.5	13.0	3.2	2.7	11.9	9.9	3.1	4.1	19.4	14.3	17.0	17.3	5.7	4.9	8.1	10.4	12.6	8.5	7.6	8.5	9.5	8.6	9.5	8.8	9.1	11.4	6.9	12.8	38.8	21.5	21.3	5.2	6.7	5.3	10.2	13.3	13.7	8.3	31.1	28.6	7.8	16.5	10.4	35.4	23.2	14.6	19.6	10.9	3.5	8.8	17.3	8.1	11.3	21.9	12.8	11.1	25.1	8.1	21.9	20.8	8.8	45.2	11.0	227.4	10.3	26.9	17.3	18.0	4.1	15.3	10.1	4.2	12.5	13.5	5.4	17.8	13.4	10.4	8.2	15.6	20.5	12.4	9.6	12.0	22.6	9.6	9.4	62.5	5.2	19.2	13.1	10.6	7.4	6.7	3.8	16.2	6.0	13.5	8.4	21.8	16.6	7.8
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	6.6	4.2	4.2	4.5	4.9	9.8	6.0	4.4	5.2	10.1	3.1	16.7	6.2	11.2	8.0	8.1	8.5	5.6	10.2	4.5	3.9	6.0	4.8	5.3	6.7	4.1	4.3	7.9	3.7	7.0	3.8	5.2	4.1	8.1	8.6	6.0	5.1	7.2	8.2	6.9	7.9	8.1	3.8	4.8	8.0	6.6	4.2	6.4	5.1	6.3	5.4	11.9	7.0	5.1	10.3	8.4	15.9	6.6	6.0	7.8	11.3	6.0	10.3	13.5	9.9	29.1	9.0	11.4	10.4	11.4	10.4	16.0	11.0	17.5	13.2	2.9	5.2	15.4	14.3	16.7	7.2	18.4	7.7	9.0	11.3	11.7	10.9	8.3	6.1	19.4	16.0	6.5	7.2	8.2	30.0	14.0	9.1	18.5	13.5	14.5	23.2	9.5	5.0	11.8	13.9	11.1	16.4	9.6	15.4	9.9	13.3	14.7	6.0	19.1	10.6	7.8	12.6	6.5	9.2	12.3	10.9	8.2	10.4	0.0	3.0	1.2	2.9	2.7	2.9	2.5	2.4	3.1	4.0	2.9	4.5	2.4	0.6	3.9	2.4	1.4	1.7	2.9	4.2	4.9	4.4	5.2	4.5	3.9	4.1	4.3	4.1	3.8	4.2	5.1	5.4	0.0	3.7	16.0	3.8	0.5	1.4	2.2	7.4	5.1	2.3	3.0	6.7	4.3	4.8	1.8	4.2	3.7	4.1	4.2	1.9	2.4	3.7	2.5	6.6	3.8	5.4	5.5	23.5	1.1	2.4	3.8	7.7	3.2	8.2	6.1	5.7	7.0	5.0	5.0	21.5	6.3	4.1	4.7	4.0	0.8	6.2	3.3	3.6	14.0	3.6	3.3	6.2	22.6	24.8	2.0	5.8	6.4	4.9	2.7	4.6	2.2	4.3	4.7	0.0	4.7	3.9	1.9	9.4	4.5	2.0	3.0	4.5	4.9	5.4	1.1
DHX36	"DDX36, KIAA1488, MLEL1, RHAU"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324487	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 547.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035398, HPA035399"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA035398: , HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	17.7	14.4	5.6	17.3	8.6	16.3	16.4	8.9	7.3	13.9	6.3	12.0	12.6	18.3	11.6	14.8	14.4	15.5	16.9	5.6	8.1	18.6	20.0	13.7	21.7	7.0	7.5	19.0	16.0	29.1	14.9	19.0	7.2	17.3	13.7	17.0	11.7	16.4	58.9	12.0	12.8	17.1	6.9	15.2	16.0	34.4	6.9	21.7	23.1	31.6	20.5	17.2	11.0	10.0	63.8	42.6	56.6	32.7	26.1	36.3	28.1	40.6	40.5	45.2	53.5	43.7	49.7	61.3	64.0	35.8	41.7	40.1	53.8	34.4	70.6	59.3	35.6	44.5	34.8	25.0	44.2	62.7	37.4	41.3	28.5	48.6	59.1	24.5	39.4	37.3	42.6	34.3	42.2	31.0	52.2	13.7	75.4	33.6	40.5	53.4	47.6	88.8	32.1	44.4	52.7	56.1	42.3	44.4	59.7	38.3	45.5	31.5	44.9	47.1	29.6	44.6	82.1	63.6	43.9	87.5	38.1	32.2	51.1	1.2	1.5	1.8	3.7	1.5	2.3	2.6	3.2	2.5	1.3	3.1	2.9	3.1	0.6	2.6	3.5	3.3	3.1	0.6	5.6	8.6	8.9	7.3	5.6	8.1	7.0	7.5	7.2	6.9	6.9	10.0	95.6	57.7	92.9	45.4	123.6	92.9	146.6	56.6	81.4	152.2	61.8	62.6	60.8	67.2	83.5	60.7	129.3	138.0	179.3	43.8	39.2	71.2	547.0	73.4	147.9	82.0	92.0	68.5	53.5	62.8	69.9	97.6	66.8	104.2	103.8	86.7	72.8	80.5	62.0	154.8	60.2	57.4	73.2	73.7	85.2	335.5	110.6	83.0	53.4	37.5	88.5	86.4	113.3	59.3	55.4	66.5	49.9	121.5	97.6	132.2	40.4	54.4	52.3	128.6	78.9	130.6	88.8	197.4	135.1	65.3	83.1	370.1	152.0	114.2	58.1	128.4
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093613-72112912	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041347: AB_10796571, HPA041604: AB_2677577"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	25.8	18.7	22.4	22.8	24.4	39.7	23.8	22.2	24.7	25.1	25.9	24.8	19.6	25.5	10.7	24.2	23.8	15.0	27.0	21.5	21.6	19.6	24.0	23.9	27.8	23.2	23.2	30.6	20.2	22.9	19.3	18.6	22.5	20.9	16.1	13.2	21.1	14.4	39.9	27.6	27.3	17.6	22.2	30.4	22.5	21.3	23.5	24.2	22.8	21.4	23.1	23.7	22.9	25.0	38.5	55.0	39.4	21.9	33.4	25.8	51.1	33.6	32.6	49.1	37.8	66.4	37.5	50.5	29.2	50.9	27.0	48.6	46.3	45.8	38.0	25.3	50.0	38.7	48.9	92.5	30.8	46.9	66.7	35.6	41.2	66.1	47.4	25.9	42.9	35.7	58.9	22.9	30.6	112.8	43.9	53.1	49.7	23.9	30.9	55.8	27.1	49.9	24.0	35.6	35.6	38.9	43.8	20.3	24.5	22.5	36.8	38.4	49.4	46.6	40.8	34.8	37.3	56.2	47.6	96.7	43.9	32.1	37.5	7.1	6.2	7.1	11.3	8.3	9.8	8.1	6.8	8.2	6.2	6.0	7.4	7.9	6.4	8.8	5.1	5.5	8.6	5.5	22.4	24.4	22.2	24.7	21.5	21.6	23.2	23.2	22.5	22.2	23.5	25.0	22.5	25.6	34.3	13.7	24.4	12.2	11.0	9.5	20.5	30.7	12.0	13.6	8.6	20.0	22.0	14.7	16.7	15.0	33.3	28.5	0.0	14.5	9.0	19.3	23.0	22.3	30.5	16.8	6.7	20.6	14.3	17.1	28.1	23.6	43.0	24.0	15.0	13.6	14.9	30.3	6.1	24.8	6.1	15.2	13.9	11.0	28.9	20.3	8.8	5.6	16.9	17.9	19.6	8.0	11.1	23.7	17.1	25.2	22.4	12.7	21.1	8.6	19.0	35.3	19.7	25.6	19.1	25.5	17.8	18.5	12.8	20.4	28.2	20.6	23.4	12.6
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43610338	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA049285: AB_2680698"	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	20.4	18.5	25.9	18.0	25.8	55.0	20.5	24.7	36.7	22.4	22.8	21.4	17.3	19.9	26.1	26.9	16.7	16.4	21.8	25.4	24.8	20.3	18.6	20.0	23.7	25.6	25.2	17.0	17.0	27.5	20.8	20.9	25.5	21.6	23.9	16.8	20.8	20.4	22.6	33.7	20.6	23.6	23.4	25.8	19.5	24.3	25.8	35.1	19.0	19.4	29.6	23.0	21.7	25.5	29.2	81.7	43.3	52.4	42.3	42.5	24.0	30.2	62.0	64.9	61.7	37.4	28.1	40.3	27.0	59.4	46.6	38.0	65.9	53.1	74.8	40.8	51.9	33.8	61.2	56.7	35.8	59.8	49.5	21.1	44.1	53.0	58.4	31.4	57.4	52.1	38.8	35.2	51.2	32.0	75.9	52.7	35.5	35.4	31.0	46.2	82.4	40.2	44.3	60.6	37.3	56.0	33.9	18.6	27.3	50.9	44.1	58.3	40.0	50.3	26.9	36.3	45.8	27.5	36.6	44.7	41.2	36.8	41.2	30.2	17.4	20.4	16.0	25.2	14.7	12.2	12.7	15.5	17.0	11.0	10.6	11.5	21.8	11.0	26.1	10.3	12.8	11.4	25.9	25.8	24.7	36.7	25.4	24.8	25.6	25.2	25.5	23.4	25.8	25.5	17.1	6.4	15.0	6.5	18.6	11.9	7.1	12.4	12.0	16.9	16.3	13.0	13.2	7.2	19.2	22.0	18.8	9.1	23.6	13.4	13.7	16.2	19.4	18.3	26.2	17.6	26.7	13.7	10.7	17.7	8.8	14.5	14.8	23.9	14.5	15.3	16.1	14.7	11.1	6.7	10.5	15.3	10.2	14.8	11.5	10.6	12.5	18.4	17.8	14.0	24.8	10.6	21.6	9.5	15.8	21.2	16.0	10.9	20.0	9.4	10.1	12.4	13.7	19.8	19.7	20.3	14.4	27.9	16.8	17.2	13.4	21.2	20.9	11.1	10.8	14.3
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839347-182887982	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	38.7	30.5	13.6	47.4	15.8	131.4	53.2	19.0	19.7	43.7	17.0	40.2	32.6	49.4	33.0	32.2	45.9	31.1	28.5	13.1	16.0	49.9	36.9	38.6	56.9	15.2	13.6	52.8	30.5	68.2	21.1	44.6	16.3	39.6	47.1	66.5	32.5	44.3	30.3	31.1	36.3	50.8	16.6	40.9	34.5	50.4	14.6	88.7	48.0	37.7	70.2	54.0	30.0	25.5	165.7	158.8	223.0	122.3	113.7	87.8	219.2	143.5	130.3	203.6	137.0	175.8	124.2	264.3	133.7	129.6	121.7	138.8	342.6	155.2	225.7	108.3	169.5	176.4	121.0	119.6	62.5	258.3	115.0	78.6	75.8	200.4	53.4	91.6	161.7	132.9	281.8	91.9	165.1	142.3	263.6	61.1	282.8	173.9	96.8	236.0	208.0	151.0	127.0	187.8	160.0	183.2	203.2	125.0	83.2	186.4	148.4	140.9	127.6	125.3	138.8	128.9	195.9	93.6	167.2	305.0	79.0	137.0	174.5	7.7	21.3	16.1	23.4	22.5	26.2	20.5	19.8	21.1	29.9	16.6	21.6	23.7	8.0	20.0	19.7	14.2	20.1	21.2	13.6	15.8	19.0	19.7	13.1	16.0	15.2	13.6	16.3	16.6	14.6	25.5	43.6	41.7	74.1	59.1	54.5	53.7	61.2	42.7	38.7	59.6	43.3	38.9	43.9	30.0	60.8	51.5	52.1	50.9	70.2	38.6	19.6	49.0	26.8	79.2	67.4	50.7	53.8	74.5	49.4	50.8	47.5	48.0	37.8	109.8	44.9	67.7	36.0	28.0	40.8	28.6	55.5	40.9	30.5	35.4	35.1	45.8	60.3	44.7	30.2	55.3	55.9	42.7	42.2	55.3	70.3	52.3	28.0	47.0	52.4	48.3	35.4	38.0	67.7	77.1	39.5	73.9	54.1	69.9	68.2	51.7	47.2	49.5	59.2	60.9	54.4	55.4
DIDO1	"BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333"	ENSG00000101191	"Death inducer-obliterator 1"	Q9BTC0	20	62877738-62937952	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004374, HPA049904"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"CAB004374: AB_2093108, HPA049904: AB_2680944"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (9.92e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.82e-2)"	30.4	20.1	15.7	21.5	17.6	29.1	31.0	22.4	17.8	33.8	23.3	36.3	19.6	38.2	26.8	27.1	36.8	17.5	27.6	15.4	17.2	25.5	24.7	30.9	31.6	16.4	16.4	39.5	24.6	28.5	28.1	24.8	16.6	34.0	19.7	19.9	33.2	24.9	32.5	39.5	36.5	20.9	14.0	35.9	28.8	27.9	17.3	30.8	33.0	22.8	26.9	32.6	31.5	22.2	29.6	22.5	36.7	21.0	18.4	22.6	19.6	21.9	18.5	79.4	22.8	96.4	29.9	29.0	29.4	26.9	46.1	45.2	33.8	42.4	51.1	16.1	22.9	41.9	40.2	69.6	23.5	37.8	41.6	23.3	57.0	27.5	15.4	18.1	22.1	54.6	41.7	25.8	20.5	28.7	76.9	33.1	29.4	35.7	32.2	53.7	47.0	18.5	13.1	26.0	45.2	26.7	43.8	41.9	28.9	21.9	41.8	42.7	27.8	64.3	44.8	21.7	31.5	17.1	11.9	38.2	29.3	18.8	23.7	32.6	7.2	20.2	15.0	9.5	15.9	11.7	13.4	14.8	5.1	9.8	17.6	16.5	10.6	13.8	7.6	10.7	11.8	9.6	15.7	17.6	22.4	17.8	15.4	17.2	16.4	16.4	16.6	14.0	17.3	22.2	24.8	25.6	30.1	37.9	28.4	24.2	35.3	17.8	25.6	25.6	23.1	19.6	27.5	22.8	23.8	25.8	33.3	28.6	49.0	32.3	23.5	18.0	42.8	32.1	26.1	26.2	19.2	21.0	44.9	13.8	15.7	24.2	30.1	34.3	22.8	33.8	20.7	19.6	14.5	38.7	46.0	23.2	14.2	16.8	13.7	13.0	35.1	20.2	21.4	32.8	26.8	16.7	42.2	40.7	47.4	22.2	20.2	33.8	30.0	26.3	25.3	9.6	45.8	23.4	6.6	35.4	23.4	26.1	32.1	26.0	25.6	19.7	32.1	25.6	21.1	34.4
DIO3	TXDI3	ENSG00000197406	"Iodothyronine deiodinase 3"	P55073	14	101561351-101563452	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 25.0;placenta: 17.8"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 7.8;Fibroblasts: 27.9;Leydig cells: 10.8;Muller glia cells: 8.1;Peritubular cells: 7.5;Skeletal myocytes: 16.3;Syncytiotrophoblasts: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"AF22: 54.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"amygdala: 4.4;hippocampal formation: 5.6"	HPA073684			Supported	Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA073684: "	"unprognostic (4.52e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-5)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-4)"	"unprognostic (9.80e-3)"	5.0	0.4	0.5	1.8	1.2	0.0	3.2	0.2	1.2	25.0	0.2	1.7	0.0	6.5	0.6	1.8	6.7	3.0	0.6	0.6	0.2	0.3	3.9	2.6	1.3	1.3	0.3	13.6	1.5	0.0	0.7	17.8	0.3	3.2	0.4	0.7	1.7	2.2	1.6	3.5	1.7	0.9	0.4	0.6	1.6	1.3	3.3	0.2	4.1	3.0	0.1	5.2	15.4	0.4	0.0	0.2	54.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.0	1.3	0.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.2	1.2	0.6	0.2	1.3	0.3	0.3	0.4	3.3	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.6	0.4	0.0	0.0	0.0	0.0	1.9	0.0	5.9	0.0	0.6	0.3	0.4	4.9	7.8	0.0	0.0	0.1	0.0	2.5	27.9	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.0	0.0	0.7	0.6	10.8	0.1	0.0	0.0	0.6	8.1	0.0	0.0	0.0	0.9	1.1	7.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	16.3	0.7	0.1	0.2	0.2	0.1	28.3	0.2	0.1	0.3	0.4
DIP2B	"FLJ34278, KIAA1463"	ENSG00000066084	"Disco interacting protein 2 homolog B"	Q9P265	12	50504985-50748657	"Human disease related genes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.4"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 188.3;Oligodendrocyte precursor cells: 144.8;Oligodendrocytes: 634.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038472, HPA046133, HPA056045"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Endoplasmic reticulum"		"HPA038472: AB_2676033, HPA046133: AB_2679551, HPA056045: AB_2683019"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-3)"	6.6	8.7	22.8	8.9	46.0	12.1	10.5	35.0	28.2	7.1	6.9	9.5	6.2	6.2	3.4	14.6	4.3	7.0	5.7	22.5	31.0	6.0	11.3	6.7	9.9	36.1	40.0	9.3	7.6	11.0	6.1	10.3	38.0	6.5	10.7	16.4	8.5	4.1	5.1	17.3	6.5	7.1	26.4	14.9	6.9	7.6	37.0	12.9	8.2	6.3	11.7	7.3	8.8	61.4	20.0	12.0	17.9	12.6	10.0	9.7	25.0	11.3	13.1	10.6	8.0	21.8	11.0	13.4	13.4	12.4	10.9	20.5	28.8	21.1	12.6	15.9	10.7	21.3	10.1	27.6	15.7	25.7	12.4	11.0	18.1	11.8	17.1	18.6	20.4	12.0	30.3	12.5	9.4	15.7	19.9	12.9	10.2	11.4	22.0	23.4	17.6	6.4	12.0	15.5	16.9	11.8	28.3	16.4	17.3	20.6	23.0	17.7	21.6	8.6	10.1	7.9	9.3	9.0	16.0	15.4	11.9	11.7	12.0	1.0	1.2	2.7	0.4	1.4	0.6	1.4	0.9	0.3	1.4	2.2	1.6	1.3	4.9	0.5	3.9	0.4	1.0	0.7	22.8	46.0	35.0	28.2	22.5	31.0	36.1	40.0	38.0	26.4	37.0	61.4	15.4	6.4	10.5	74.1	26.3	54.9	30.2	14.7	12.5	31.5	15.0	11.4	9.0	17.2	10.5	9.2	64.6	13.3	9.2	25.2	0.0	10.9	1.4	14.3	12.9	15.5	31.3	13.7	121.1	17.4	17.6	11.2	20.4	15.1	10.8	25.0	15.0	18.2	20.4	11.8	125.3	18.3	10.2	37.4	15.7	3.3	10.2	24.5	16.0	188.3	18.7	14.4	11.3	144.8	634.8	22.0	14.0	10.1	15.4	28.1	8.4	6.7	8.8	31.9	0.0	8.0	10.0	12.4	17.7	34.6	66.9	38.0	13.3	34.3	12.4	24.4
DIPK1B	"C9orf136, FAM69B, MGC20262"	ENSG00000165716	"Divergent protein kinase domain 1B"	Q5VUD6	9	136712572-136724742	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"Adipocytes: 23.1;Cardiomyocytes: 7.3;Endothelial cells: 6.9;Extravillous trophoblasts: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.8"	"Group enriched"	"Detected in many"	9	"B-cells: 2.8;dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 56.4;HEK 293: 58.2;HUVEC TERT2: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054443			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA054443: AB_2682489"	"unprognostic (2.78e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (6.67e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.78e-1)"	17.4	4.8	21.7	3.7	20.3	9.1	14.0	25.7	26.8	14.9	18.7	12.3	5.4	16.8	2.1	4.9	16.7	5.5	35.9	20.1	20.0	17.8	11.4	16.4	5.8	23.5	21.1	11.5	14.3	12.8	25.1	18.7	24.2	13.6	0.8	5.9	9.8	3.1	8.9	11.5	7.7	3.0	17.3	8.6	6.8	15.0	24.2	1.7	16.8	3.8	1.3	8.0	7.7	19.4	3.2	11.3	25.3	21.0	0.0	0.0	19.5	2.9	0.0	0.8	0.9	27.7	6.6	9.2	56.4	0.0	7.9	13.5	11.7	0.3	0.2	8.1	58.2	13.5	4.7	5.9	0.2	7.0	9.0	0.2	0.0	0.3	0.1	10.1	65.2	19.7	14.8	4.2	0.0	14.8	10.8	28.3	36.9	12.6	9.7	49.9	1.9	26.2	1.4	3.7	38.5	38.3	1.8	8.2	27.4	8.7	18.3	21.9	33.3	5.6	18.7	5.3	6.8	12.9	3.3	8.9	3.2	6.7	10.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	2.8	0.2	0.1	0.0	0.0	0.0	1.0	0.1	0.3	21.7	20.3	25.7	26.8	20.1	20.0	23.5	21.1	24.2	17.3	24.2	19.4	23.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	6.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DISC1		ENSG00000162946	"DISC1 scaffold protein"	Q9NRI5	1	231626790-232041272	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 21.7"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 113.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"THP-1: 11.4;TIME: 8.7;WM-115: 8.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA048911			Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments, Cytosol"		"HPA048911: AB_2732549"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	2.4	1.4	5.3	3.1	5.4	2.6	1.9	3.9	5.6	2.1	2.6	1.5	1.1	1.5	0.5	1.3	1.1	2.6	9.0	4.2	4.9	1.1	1.4	1.7	2.4	6.9	5.8	4.4	0.8	1.1	1.0	7.3	6.9	1.2	1.2	21.7	2.0	0.9	1.4	1.2	1.3	1.4	5.6	2.9	1.0	0.9	7.3	3.1	1.8	1.1	1.7	1.6	1.3	7.7	0.0	0.4	4.0	0.1	0.1	0.3	2.8	1.6	3.6	4.1	3.5	1.4	0.8	0.1	4.8	1.3	1.0	0.0	0.3	0.1	3.7	2.6	1.7	2.2	0.3	4.0	0.5	3.7	5.1	2.2	0.7	1.4	1.2	2.8	3.8	2.7	0.0	1.4	4.6	0.4	1.1	5.6	2.0	0.0	1.5	2.7	1.1	0.4	0.1	0.0	0.7	2.2	1.4	0.0	2.4	1.0	0.0	11.4	8.7	2.1	2.3	1.0	0.9	0.9	0.7	0.0	1.7	5.6	8.8	0.1	0.8	0.0	0.2	0.8	0.1	0.0	0.4	0.0	1.0	0.1	0.4	0.1	0.7	0.2	0.4	0.6	0.1	0.2	5.3	5.4	3.9	5.6	4.2	4.9	6.9	5.8	6.9	5.6	7.3	7.7	6.7	0.0	1.1	0.0	2.1	0.9	0.5	0.7	3.4	23.3	2.0	1.8	7.2	0.0	1.2	3.7	8.4	8.0	2.0	0.5	0.0	0.6	16.6	3.4	2.1	6.7	0.0	2.1	0.0	1.1	0.8	3.0	0.0	4.5	7.0	8.0	10.0	0.0	11.3	0.0	0.0	0.1	0.0	13.0	12.6	23.2	0.9	13.7	3.6	0.0	5.6	2.4	2.1	0.0	0.0	2.0	0.3	1.5	2.1	0.7	0.0	0.2	2.5	113.1	0.0	4.6	2.7	1.4	1.6	0.5	1.1	2.5	5.8	8.1	0.7	0.6
DISP1	"DISPA, DKFZP434I0428, MGC13130, MGC16796"	ENSG00000154309	"Dispatched RND transporter family member 1"	Q96F81	1	222815022-223005995	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.7;Gastric mucus-secreting cells: 48.4;Inhibitory neurons: 54.4;Microglial cells: 204.2;Oligodendrocyte precursor cells: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 15.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051411	Uncertain		Approved	"Nuclear bodies"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear bodies"		"HPA051411: AB_2681475"	"unprognostic (2.10e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-1)"	"prognostic favorable (5.00e-4)"	"unprognostic (4.13e-1)"	"prognostic favorable (3.86e-5)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (4.16e-4)"	"unprognostic (9.69e-3)"	6.8	5.7	1.7	1.5	2.0	0.2	3.0	4.0	2.5	3.2	3.7	9.0	2.6	4.3	2.0	1.9	2.4	4.6	3.9	1.6	1.9	5.2	2.7	9.2	1.1	1.2	0.9	4.5	2.4	5.1	2.5	4.6	1.1	2.4	2.1	1.3	1.9	2.0	4.1	3.3	3.7	4.2	0.7	2.5	5.3	6.5	1.5	1.4	5.2	3.1	1.4	5.4	2.5	2.6	0.9	2.2	5.6	3.8	10.1	6.1	2.4	3.2	2.7	1.1	1.1	2.6	1.6	0.1	4.2	1.5	2.2	0.6	1.6	1.3	1.6	8.1	2.4	1.1	6.3	1.2	4.4	0.2	1.1	4.8	1.9	2.3	0.9	5.8	2.3	1.2	0.0	0.1	3.9	1.5	1.4	0.3	4.0	6.1	1.3	1.7	15.1	0.2	6.8	0.8	1.6	2.5	1.8	0.7	2.3	2.7	2.7	1.4	4.2	2.3	1.5	3.9	3.6	1.2	0.5	0.3	3.2	0.8	5.1	0.3	0.2	0.0	0.7	0.4	1.6	0.5	0.6	0.7	0.6	0.9	0.6	0.5	0.1	1.0	0.2	0.3	0.5	0.4	1.7	2.0	4.0	2.5	1.6	1.9	1.2	0.9	1.1	0.7	1.5	2.6	4.6	6.4	1.7	42.7	3.6	0.5	0.6	1.2	5.7	2.7	3.4	1.5	7.8	7.2	3.3	11.0	0.0	1.4	2.1	1.0	0.0	1.9	2.1	1.9	3.4	4.9	0.0	0.0	47.7	2.8	1.8	5.6	48.4	4.1	0.0	15.8	6.8	3.3	5.9	0.0	54.4	2.6	4.1	1.6	0.9	3.7	1.5	4.1	0.0	204.2	1.4	0.9	5.2	199.6	15.4	1.3	3.1	3.4	0.7	0.7	6.4	5.8	2.7	2.3	0.0	4.0	3.7	2.1	2.3	5.4	1.1	0.8	1.7	2.8	1.6	0.3
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11956207-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1224.0"	"Group enriched"	"Detected in many"	7	"Cardiomyocytes: 884.3;Muller glia cells: 1960.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 6.2;memory CD8 T-cell: 3.8"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		18000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	31.2	79.1	110.7	10.0	183.6	0.2	26.0	12.6	135.2	89.7	104.8	53.2	14.6	47.0	16.7	29.7	23.0	67.0	1224.0	147.7	80.2	17.0	5.6	123.7	8.5	95.1	54.3	38.1	18.2	34.2	38.2	25.0	46.8	59.4	13.0	204.1	30.9	78.1	7.8	29.7	24.6	43.1	83.9	33.2	31.7	30.9	99.9	4.7	16.4	18.8	5.4	40.9	48.3	121.6	1.5	13.1	18.1	0.1	15.3	29.7	0.6	418.9	643.0	182.4	205.5	9.6	3.2	0.0	44.8	614.4	96.8	64.4	1.5	181.9	69.5	0.1	0.5	0.0	1.7	0.0	113.6	0.0	0.3	45.3	60.0	61.9	151.3	370.2	195.3	0.0	0.2	0.4	256.4	0.0	0.1	0.4	8.6	0.0	0.5	0.1	1.2	0.1	62.5	0.6	0.5	53.2	2.0	0.0	0.2	47.9	0.2	0.5	349.7	107.5	82.8	11.2	110.3	0.1	0.0	0.3	18.1	0.0	103.5	0.0	0.0	0.0	0.5	0.0	6.2	0.0	0.6	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	110.7	183.6	12.6	135.2	147.7	80.2	95.1	54.3	46.8	83.9	99.9	121.6	5.8	3.2	3.0	94.3	0.1	45.6	59.5	70.3	93.4	31.6	3.2	103.2	884.3	0.0	12.8	0.0	12.5	0.5	0.4	0.0	0.0	0.8	104.3	0.7	8.4	32.9	1.8	0.0	90.4	0.2	0.8	106.1	7.1	0.6	1.3	17.0	66.8	0.4	20.4	13.5	83.7	0.1	0.0	1.3	12.5	88.5	20.5	1.4	64.0	38.4	0.0	1960.4	0.0	27.6	14.7	1.1	0.1	57.6	1.7	32.8	0.0	0.2	2.9	67.5	190.7	12.7	83.4	1.2	3.2	5.8	14.8	0.8	4.1	0.5	0.3	3.0
DLAT	"DLTA, E2, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112025408-112064404	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 89.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 100.5;Distal tubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Supported	Mitochondria		NA	NA		44000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favorable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	24.7	16.5	7.7	13.3	8.3	7.9	14.5	9.5	9.3	11.0	10.4	24.7	18.3	10.0	13.4	19.5	13.0	8.5	69.4	8.1	11.1	33.8	15.5	11.7	16.1	8.3	8.9	9.5	6.8	31.7	8.5	13.1	9.7	14.5	26.0	10.8	16.8	14.8	75.4	10.3	16.5	13.4	8.2	9.9	14.3	9.9	9.4	12.7	20.2	89.4	18.2	14.2	8.1	8.0	18.7	16.4	28.2	34.4	41.6	30.5	26.5	26.6	18.2	34.8	38.7	52.8	56.7	85.4	46.0	28.7	42.6	41.0	65.7	34.2	38.9	27.3	30.2	51.9	17.9	39.2	29.0	64.9	26.6	36.9	37.7	32.0	35.2	24.2	33.9	41.7	88.4	42.6	41.2	16.6	25.4	66.9	30.3	58.6	35.4	45.4	38.0	93.3	64.4	21.4	51.2	27.8	30.7	93.4	20.5	30.9	67.4	42.9	17.8	29.1	29.1	29.1	33.0	11.1	19.4	127.5	7.7	73.0	22.7	9.1	3.8	3.0	4.3	5.8	5.4	5.6	4.9	5.1	5.8	4.0	5.6	5.1	0.3	4.7	6.1	4.5	5.8	5.0	7.7	8.3	9.5	9.3	8.1	11.1	8.3	8.9	9.7	8.2	9.4	8.0	7.6	12.8	14.5	15.3	13.8	11.2	9.2	18.2	14.2	8.1	9.2	5.8	100.5	15.7	13.2	11.0	0.0	21.2	6.4	26.3	74.3	18.7	3.9	15.8	11.6	9.6	17.3	18.1	18.0	11.4	39.6	11.7	11.7	12.1	3.8	13.5	7.5	15.5	18.7	8.4	24.4	17.8	24.4	8.8	7.5	3.2	6.2	9.5	17.8	9.4	16.7	10.4	4.1	11.1	19.7	14.1	9.2	10.9	19.4	7.0	19.0	37.6	30.3	11.1	0.0	14.2	19.9	25.1	18.3	21.1	9.8	17.4	8.5	26.3	26.7	9.3
DLD	"DLDH, E3, GCSL, LAD, OGDC-E3"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107891162-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 357.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 356.2;Distal tubular cells: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	108.7	98.9	22.7	42.1	23.7	54.0	49.0	27.1	29.1	36.3	35.6	109.0	81.8	45.3	21.2	94.1	34.3	48.5	264.1	23.1	29.5	153.3	112.8	39.3	50.1	27.1	27.4	30.0	49.2	136.7	27.8	43.1	26.6	45.7	99.3	35.0	50.2	50.3	295.0	38.9	71.9	67.7	24.9	38.4	80.5	31.3	25.7	43.2	64.2	357.0	67.5	66.1	32.7	23.4	171.4	134.5	74.8	127.9	104.6	91.4	88.4	96.5	80.8	110.6	86.2	159.5	95.5	165.9	159.6	103.0	177.7	110.9	150.2	135.8	166.1	111.1	88.4	116.9	175.6	116.7	80.3	194.7	116.0	104.8	97.6	116.4	63.4	72.3	134.0	137.0	298.5	119.7	121.8	188.1	161.8	138.9	87.4	206.0	98.2	113.1	117.8	225.9	151.8	250.8	92.3	99.9	156.3	262.1	143.9	149.9	100.5	165.8	87.9	120.7	97.3	238.1	149.4	89.3	187.1	114.6	115.0	204.1	130.2	132.7	63.9	136.0	46.9	81.6	49.4	37.8	46.8	46.8	87.2	38.5	47.9	50.5	39.9	68.1	116.9	29.9	49.0	64.2	22.7	23.7	27.1	29.1	23.1	29.5	27.1	27.4	26.6	24.9	25.7	23.4	26.7	28.9	20.7	14.7	26.3	31.4	42.7	124.7	31.3	47.1	24.0	19.2	356.2	51.5	70.5	79.1	22.9	110.2	27.3	56.1	226.9	69.3	10.2	27.6	26.2	32.2	30.6	53.9	23.9	55.9	62.7	36.3	36.7	28.0	26.6	35.3	26.0	86.8	69.2	21.9	25.3	44.1	114.0	41.0	26.5	7.3	23.3	37.5	37.4	15.9	62.2	36.0	38.1	21.1	16.7	42.6	51.4	42.2	30.7	24.3	60.0	178.9	55.5	45.5	26.3	28.4	44.8	55.2	51.5	48.0	32.4	108.4	29.5	73.7	78.7	39.2
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 51.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.9;Excitatory neurons: 39.1;Horizontal cells: 21.9;Inhibitory neurons: 27.9;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;NTERA-2: 4.2;SCLC-21H: 12.5;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	0.3	0.4	46.9	0.5	41.2	1.1	0.2	0.0	48.2	0.2	0.0	0.3	0.2	0.3	0.0	0.1	0.3	0.1	0.1	36.0	19.1	1.3	0.1	0.2	0.3	0.0	17.8	0.1	1.1	0.2	4.8	0.0	0.0	0.2	0.0	1.8	0.2	0.2	0.1	0.2	0.5	0.0	0.0	1.9	0.3	7.5	51.6	0.3	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	8.0	0.1	0.0	1.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.3	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	12.5	2.4	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	46.9	41.2	0.0	48.2	36.0	19.1	0.0	17.8	0.0	0.0	51.6	0.0	0.2	0.0	0.0	1.0	1.8	0.3	0.9	0.8	1.8	4.1	0.7	0.8	1.0	0.0	0.1	1.8	4.2	0.1	0.9	0.8	3.9	0.4	18.9	0.2	0.1	0.4	1.2	0.0	39.1	0.6	0.2	0.4	0.0	0.1	0.0	0.3	0.4	0.1	10.1	21.9	27.9	0.4	0.0	7.1	0.6	19.3	0.9	4.1	0.0	1.9	0.7	1.5	1.0	8.0	0.7	0.2	0.0	0.0	0.8	0.2	1.3	0.8	0.0	2.2	0.0	0.7	0.4	3.4	4.9	1.1	0.3	0.0	1.3	0.1	0.9	0.6
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191608	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 29.7;lymphoid tissue: 42.0;testis: 17.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 5.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	0.8	0.3	1.4	8.1	0.9	29.7	1.4	0.4	1.8	0.8	0.6	5.5	5.0	1.3	0.1	5.2	0.4	0.8	0.2	1.0	1.7	0.2	0.7	0.7	17.9	0.7	1.0	0.2	0.1	0.2	0.0	4.1	0.8	0.2	6.7	0.1	0.8	0.1	0.1	3.1	4.6	2.7	0.3	2.6	3.0	17.4	1.1	42.0	0.4	0.0	18.7	2.0	1.5	3.8	144.8	56.8	140.6	63.7	3.3	13.4	43.8	80.3	52.7	115.3	109.3	45.9	75.8	82.1	44.2	46.9	47.4	85.6	91.5	64.0	150.5	101.9	45.7	84.4	49.9	39.3	0.4	82.7	49.3	2.8	2.2	54.8	27.0	18.9	129.0	82.5	70.5	79.8	109.3	69.2	105.0	42.7	72.6	63.3	57.3	80.8	137.9	39.0	37.9	45.2	71.7	40.7	84.8	31.7	30.8	60.6	71.6	31.6	49.6	52.4	133.3	50.6	94.6	19.4	44.9	108.9	35.9	59.6	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	1.4	0.3	0.0	0.2	0.1	0.2	1.0	0.0	0.0	5.4	0.7	1.4	0.9	0.4	1.8	1.0	1.7	0.7	1.0	0.8	0.3	1.1	3.8	0.1	0.0	0.5	0.0	4.4	1.1	0.7	3.3	0.0	0.0	1.2	0.9	0.4	0.0	1.3	0.0	0.0	11.6	1.4	3.2	0.0	0.4	19.7	7.2	2.6	2.4	0.0	92.6	0.3	0.0	23.1	4.2	7.7	4.5	0.0	15.8	3.9	0.5	10.5	0.0	0.3	3.6	8.2	4.1	1.6	6.0	0.9	3.7	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.2	1.2	22.1	0.6	0.3	0.1	1.3	0.0	6.6	0.0	3.8	68.1	31.7	11.6	0.4	1.9	4.0	0.9	6.9	1.4
DLK2	"EGFL9, MGC2487"	ENSG00000171462	"Delta like non-canonical Notch ligand 2"	Q6UY11	6	43450352-43456632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.3;prostate: 12.9;skin 1: 12.7"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 96.9;Basal respiratory cells: 56.8;Basal squamous epithelial cells: 64.3;Breast myoepithelial cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 24.1;HBEC3-KT: 13.1;hTCEpi: 38.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA061223, HPA068672, HPA070955"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: "	"unprognostic (4.65e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.68e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.80e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.27e-12)"	"unprognostic (7.71e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.43e-2)"	0.8	0.5	3.8	0.7	4.5	0.9	2.9	6.9	7.0	2.9	1.8	0.4	0.4	0.6	2.0	12.3	0.6	0.3	1.7	4.4	4.2	0.5	0.7	0.5	0.9	2.7	2.6	1.1	0.8	0.1	0.8	0.6	2.7	12.9	0.0	0.6	8.1	5.2	0.2	12.7	0.6	0.1	2.6	0.7	0.4	1.0	3.5	2.3	0.7	0.0	0.9	0.8	6.7	3.2	7.9	2.8	0.8	11.3	0.0	0.6	2.5	2.8	3.0	3.1	1.4	2.7	0.4	1.5	1.7	0.5	3.8	24.1	8.0	13.1	0.7	1.5	3.0	0.6	1.5	4.2	0.8	0.5	1.6	1.3	38.5	0.9	7.1	1.0	0.0	4.5	0.7	1.1	1.2	3.0	0.6	0.6	1.0	3.0	2.9	1.6	1.4	0.7	0.4	2.6	8.3	0.8	0.9	0.3	0.4	0.6	0.7	2.4	0.8	1.1	3.6	0.8	5.6	1.8	0.4	2.5	0.1	1.1	0.8	0.3	0.1	0.1	0.1	0.0	0.8	0.1	0.5	0.5	0.0	0.2	0.2	0.1	0.2	0.8	0.1	0.5	0.0	0.1	3.8	4.5	6.9	7.0	4.4	4.2	2.7	2.6	2.7	2.6	3.5	3.2	0.3	0.0	0.5	0.3	0.4	10.1	96.9	56.8	64.3	1.3	0.6	26.7	0.6	0.0	6.0	0.0	0.0	1.3	0.5	0.0	0.0	0.1	0.3	0.1	3.0	0.7	1.2	0.0	6.1	0.0	2.7	0.4	0.0	0.2	0.0	4.7	0.0	0.0	0.1	11.8	2.8	0.0	2.0	0.0	0.4	0.5	0.3	0.6	1.8	2.8	0.0	0.6	0.0	3.0	0.9	0.1	0.0	0.0	0.1	12.9	0.0	0.0	1.1	1.2	0.0	0.5	1.1	1.7	7.0	6.7	2.6	0.3	1.3	0.4	0.0	8.3
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 5.7;choroid plexus: 2.3;pituitary gland: 3.4;testis: 1.4"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 24.6;Spermatogonia: 39.5"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.6;naive CD8 T-cell: 1.4"	"Group enriched"	"Detected in many"	13	"B-cells: 2.6;T-cells: 1.4"	"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 83.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024559, HPA056533"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA024559: , HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.0	0.0	5.1	0.1	5.7	0.0	0.0	3.1	5.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	4.7	0.0	0.0	0.0	0.1	4.9	4.7	0.2	0.0	0.5	3.4	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.1	0.0	1.4	4.6	0.0	0.1	0.0	0.1	0.0	0.0	5.4	0.1	3.9	0.9	2.0	0.0	0.0	0.6	1.1	0.0	0.7	0.2	0.5	0.9	0.1	3.7	0.0	1.5	0.1	2.3	1.0	0.2	1.2	6.0	0.2	0.1	0.3	0.3	1.0	4.6	0.0	0.0	0.1	0.1	0.1	0.1	4.3	1.1	0.1	0.3	0.0	0.2	0.0	0.7	0.0	6.2	0.6	0.2	0.2	0.2	0.2	13.6	14.1	2.9	0.1	83.7	0.3	0.0	0.2	0.0	0.0	2.6	0.1	1.0	1.4	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.5	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	5.1	5.7	3.1	5.6	4.7	4.7	4.9	4.7	4.2	4.4	4.6	5.4	0.3	0.0	0.0	0.3	1.1	0.3	0.3	0.4	0.0	0.5	1.3	4.7	0.5	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.7	0.6	0.1	0.7	0.2	3.0	0.0	1.7	0.6	0.6	1.0	0.5	0.3	0.0	1.7	0.0	0.0	0.3	0.0	3.4	0.3	0.0	0.0	0.0	2.2	1.2	0.1	1.8	0.0	0.0	0.9	0.0	24.6	0.5	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.7	6.6	0.0	0.6	6.5	39.5	0.2	0.1	0.3	0.5	1.7	0.0	0.1
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997564-79236038	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	18	"kidney: 169.4;liver: 283.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		680000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	8.4	4.5	1.5	0.3	1.7	0.0	2.2	1.4	1.6	1.4	3.0	1.3	0.2	2.8	12.2	1.4	1.3	2.1	1.9	1.5	2.4	169.4	283.8	0.4	0.2	1.5	1.9	2.2	1.8	0.6	2.9	0.1	2.0	1.8	0.4	1.5	0.4	1.8	2.4	0.6	0.6	1.7	1.4	0.1	1.0	2.3	2.9	0.3	4.8	1.5	0.3	1.2	0.5	1.6	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.2	3.6	0.8	1.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	7.6	1.9	0.0	0.0	1.7	2.1	2.2	1.6	1.5	0.0	0.8	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	1.6	1.5	2.4	1.5	1.9	2.0	1.4	2.9	1.6	1.3	0.0	1.1	19.9	2.9	0.1	0.5	1.0	1.8	1.9	1.4	1.8	1.0	2.8	0.8	9.2	2.1	0.3	1.9	0.7	19.6	0.4	40.6	2.6	5.0	1.2	1.2	6.1	5.8	0.7	0.1	2.7	3.6	2.7	0.0	4.1	1.8	104.2	0.1	0.0	1.5	1.2	4.1	1.6	0.4	33.1	2.5	1.7	0.0	4.7	0.2	4.3	3.1	4.5	3.3	0.8	1.4	2.6	4.5	0.9	1.6	83.9	4.7	3.7	0.0	1.7	0.7	4.9	5.3	1.8	0.3	0.3	2.9	4.4	0.9	0.8
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.2;lymphoid tissue: 20.9;parathyroid gland: 46.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 115.4;Ionocytes: 46.8;Skeletal myocytes: 22.7"	"Group enriched"	"Detected in many"	4	"lung cancer: 3.0;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;RH-30: 5.0;RPMI-8226: 19.4;SK-MEL-30: 5.2;THP-1: 3.6;WM-115: 3.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"HPA003498, HPA029297"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Vesicles,Centriolar satellite"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Vesicles, Centriolar satellite"	"HPA003498: , HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	4.7	0.1	1.7	0.1	3.4	0.0	5.3	3.1	2.7	0.1	0.2	1.6	0.0	0.1	1.1	0.3	0.6	0.0	0.1	1.9	1.9	41.2	0.0	3.1	0.2	3.0	3.1	0.0	0.0	46.4	0.5	0.2	2.9	0.3	0.9	0.4	1.3	1.4	13.3	0.3	0.1	0.0	1.7	0.0	0.0	0.8	2.8	20.9	0.1	2.5	0.1	0.0	0.2	8.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.0	19.4	0.0	0.8	2.9	0.0	0.0	0.0	5.2	0.3	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.4	3.1	2.7	1.9	1.9	3.0	3.1	2.9	1.7	2.8	8.5	0.5	0.0	0.0	0.3	0.2	0.5	0.6	1.8	0.0	0.1	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.1	0.1	1.8	115.4	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	4.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	46.8	0.0	1.1	0.4	0.6	0.2	3.6	0.0	0.0	0.3	0.0	0.5	11.1	0.0	1.9	0.0	0.4	0.2	0.0	0.4	0.6	2.4	0.0	22.7	0.7	4.0	3.0	0.2	0.1	0.1	0.1	0.0	1.8	0.4
DMRTC1		ENSG00000269502	"DMRT like family C1"	Q5HYR2	X	72872025-72943814	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5;pituitary gland: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"		"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (1.83e-1)"													0.0	0.5	1.5	0.1	1.3	0.0	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.7	0.2	0.0	1.0	1.8	0.1	0.0	0.1	0.3	0.4	0.2	0.5	0.2	0.2	1.8	0.0	0.5	0.1	0.2	0.8	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.6	1.3	0.2	0.7	0.0	0.3	0.1	0.1	2.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	0.0	2.5	1.0	1.8	0.4	0.2	0.5	0.0	1.3	2.4	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;pituitary gland: 25.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.3;Microglial cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.2	3.2	17.5	0.8	17.9	0.0	0.6	11.6	22.5	1.1	10.7	1.0	0.4	1.6	6.7	0.2	2.3	0.4	0.2	18.7	19.7	1.4	0.0	0.8	1.0	13.7	14.3	8.2	3.8	1.5	25.3	0.0	13.7	2.7	0.5	9.7	0.8	1.2	0.0	0.3	1.0	0.4	11.9	1.0	1.0	8.9	20.5	1.2	3.3	0.0	1.5	0.3	0.8	16.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	17.5	17.9	11.6	22.5	18.7	19.7	13.7	14.3	13.7	11.9	20.5	16.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease variant, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 33.2;Excitatory neurons: 14.1;Inhibitory neurons: 15.5;Oligodendrocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.3	0.9	1.9	2.8	2.1	4.6	1.8	2.5	3.6	1.4	1.0	2.3	2.1	1.1	0.9	1.9	0.9	0.9	1.8	1.8	1.9	2.6	4.2	1.8	5.2	2.3	1.9	1.2	1.6	0.4	1.5	1.6	2.4	1.9	2.8	5.3	1.6	0.4	1.6	1.8	3.2	1.1	1.6	2.1	1.9	2.9	2.1	8.1	1.0	0.9	4.2	1.4	1.4	3.2	25.6	13.0	29.0	20.7	3.2	2.2	20.4	12.4	10.3	17.4	21.2	31.1	16.1	26.1	4.6	3.8	6.7	15.2	16.8	6.5	20.7	16.2	12.6	15.8	8.5	12.3	0.9	27.7	16.4	1.8	2.6	12.3	3.6	4.5	7.9	17.0	23.6	22.8	10.1	9.0	42.8	19.8	20.5	10.9	24.0	33.1	20.0	8.4	7.5	11.7	13.1	15.7	16.9	21.4	4.2	20.1	16.5	11.6	3.4	6.6	20.5	8.5	23.8	11.5	13.9	38.3	5.7	26.1	8.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	1.9	2.1	2.5	3.6	1.8	1.9	2.3	1.9	2.4	1.6	2.1	3.2	1.0	6.4	1.1	4.9	1.3	2.3	0.9	1.7	2.8	2.5	2.3	1.4	10.5	2.8	1.1	1.8	6.2	3.9	2.2	1.7	0.0	0.8	2.2	2.0	1.4	2.0	1.2	33.2	14.1	0.9	4.8	2.0	2.6	2.8	0.0	6.0	0.7	4.6	2.2	0.0	15.5	1.8	0.0	1.3	0.7	3.7	0.6	1.5	0.0	4.7	0.5	0.5	2.1	5.5	18.4	0.7	0.1	0.7	7.4	2.5	2.4	0.6	0.8	4.3	0.0	2.4	1.1	9.1	12.2	4.7	1.7	1.2	1.6	0.7	3.7	1.0
DNAAF3	"C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22"	ENSG00000167646	"Dynein axonemal assembly factor 3"	Q8N9W5	19	55158661-55166722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 40.8;testis: 65.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 395.2;Late spermatids: 722.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 26.2;HEL: 31.6;K-562: 25.3;U-937: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056220			Approved	"Nuclear bodies,Mitochondria"		No	No				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria	"Nuclear bodies"	"HPA056220: AB_2683071"	"unprognostic (1.71e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.03e-2)"	0.4	1.8	1.5	0.0	1.2	0.0	0.6	0.9	0.7	2.5	6.1	0.3	0.1	0.9	3.4	0.6	40.8	0.6	5.0	1.5	2.3	2.7	0.6	4.3	0.1	4.0	8.2	0.2	1.6	3.5	0.7	0.1	4.7	0.3	0.1	0.4	0.4	0.9	0.1	0.9	0.3	0.2	3.1	0.3	0.3	65.4	1.5	0.5	2.3	0.0	0.1	0.1	0.4	2.1	8.8	6.6	0.6	6.7	0.1	0.0	0.6	0.1	0.2	1.0	0.7	0.3	4.0	10.5	2.5	0.3	1.9	10.1	1.5	3.0	0.4	0.0	26.2	31.6	0.5	0.5	0.2	13.6	3.1	0.2	4.0	1.7	2.2	0.9	0.5	4.7	25.3	13.9	0.4	5.9	0.4	0.3	0.5	9.5	15.0	16.5	1.0	3.2	5.4	0.2	0.8	2.6	1.1	1.1	1.6	0.2	8.3	0.4	1.0	0.8	3.9	4.0	0.2	0.4	2.5	0.6	4.9	18.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	1.2	0.9	0.7	1.5	2.3	4.0	8.2	4.7	3.1	1.5	2.1	0.2	0.0	0.5	0.0	0.0	3.2	0.0	4.7	4.6	0.0	1.1	0.6	3.0	1.5	7.5	7.3	0.0	0.0	0.0	0.3	7.9	2.7	395.2	55.8	0.5	0.6	0.0	0.0	0.5	1.0	0.1	1.2	0.0	1.3	0.0	1.9	0.7	0.4	0.2	0.0	0.5	0.5	12.2	0.0	0.4	722.0	4.4	4.2	0.0	0.0	0.0	2.1	0.0	0.5	0.1	0.2	0.1	3.0	0.0	0.1	0.0	5.1	75.2	0.0	0.0	0.0	2.3	104.8	18.6	0.3	1.3	0.0	0.1	1.1	0.4	0.2
DNAJA3	"hTid-1, TID1"	ENSG00000103423	"DnaJ heat shock protein family (Hsp40) member A3"	Q96EY1	16	4425805-4456775	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016095, HPA040875, HPA044229"	Approved		Supported	Vesicles,Mitochondria		NA	NA		16000	"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Vesicles	"CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (1.79e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-1)"	18.9	44.3	15.7	11.8	16.3	6.4	18.3	17.5	18.7	19.9	15.3	25.2	17.5	18.6	6.8	27.8	18.0	8.1	43.6	16.0	16.8	26.7	65.7	15.8	13.3	16.5	16.1	20.7	26.5	23.9	20.2	12.3	17.2	18.7	12.6	8.7	20.2	12.4	90.5	22.7	21.2	10.4	16.6	19.3	23.9	23.6	17.5	11.5	18.7	48.3	11.9	23.8	20.5	16.8	26.4	53.7	16.1	33.1	20.5	18.8	34.6	34.2	22.9	45.1	36.1	40.2	38.7	50.2	32.9	20.3	31.3	38.4	55.7	39.7	24.8	42.2	35.8	25.4	48.8	40.4	50.8	47.5	24.4	22.6	46.6	40.0	66.1	20.5	20.4	36.7	63.1	39.7	27.8	60.9	39.6	33.8	35.6	48.2	43.2	51.5	27.6	92.7	32.5	28.0	43.7	17.3	38.2	77.6	62.0	13.7	46.7	38.3	22.2	35.8	24.5	80.1	44.4	38.5	56.6	69.7	17.9	45.0	39.8	1.4	5.3	3.2	10.3	8.7	12.4	12.1	9.6	9.8	7.6	10.0	12.9	10.4	0.8	11.1	6.9	5.4	10.8	10.5	15.7	16.3	17.5	18.7	16.0	16.8	16.5	16.1	17.2	16.6	17.5	16.8	10.9	12.8	8.1	11.4	23.7	15.7	18.5	12.6	25.0	23.0	14.8	10.8	36.3	14.3	13.0	25.8	10.4	42.8	8.2	17.9	45.0	21.8	62.6	8.9	13.5	13.3	17.5	18.7	19.4	12.2	34.3	13.6	18.8	10.0	12.7	17.9	8.9	46.1	16.6	23.5	20.4	17.5	16.2	10.1	7.0	30.5	19.3	10.0	21.4	6.5	15.2	18.5	16.5	10.6	15.2	13.9	15.5	22.2	19.9	28.9	21.5	25.9	9.2	23.2	13.1	14.2	14.2	50.5	33.7	23.5	16.9	28.5	17.5	29.8	32.7	16.7
DNAJB13	"RSPH16A, TSARG6"	ENSG00000187726	"DnaJ heat shock protein family (Hsp40) member B13"	P59910	11	73951026-73970366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Chaperone	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 53.2;testis: 18.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 90.6;Endometrial ciliated cells: 114.8;Late spermatids: 62.9;Respiratory ciliated cells: 104.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;Karpas-707: 2.6;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052465, HPA061330"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA052465: AB_2681842, HPA061330: AB_2732659"	"unprognostic (1.07e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.72e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.40e-2)"	0.1	0.1	1.5	1.2	1.5	4.4	0.2	1.0	1.4	5.5	12.2	0.1	0.6	2.0	5.2	0.1	53.2	2.2	0.1	2.0	1.9	1.0	0.1	3.1	2.1	4.8	5.7	0.3	0.8	0.1	1.1	0.5	3.6	0.9	0.0	0.4	0.6	2.9	0.3	0.1	2.9	0.1	4.0	1.3	0.2	18.9	2.4	0.0	0.2	0.0	0.0	0.2	0.1	1.8	0.0	0.4	0.3	0.7	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.7	0.2	0.9	2.1	0.2	0.3	0.5	0.1	0.0	0.0	2.7	0.3	1.0	0.9	0.3	0.0	0.2	0.6	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.2	2.6	0.4	0.3	0.6	0.9	0.2	0.2	1.5	0.4	1.2	1.1	4.5	0.5	0.3	1.0	0.5	2.2	0.2	0.4	0.3	0.7	0.0	0.0	0.6	0.6	0.0	2.2	2.0	1.9	0.0	0.3	0.1	0.7	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.1	1.5	1.5	1.0	1.4	2.0	1.9	4.8	5.7	3.6	4.0	2.4	1.8	0.2	3.2	0.0	2.0	0.0	0.0	1.9	11.1	0.0	0.2	0.1	0.3	0.2	0.0	7.6	1.8	0.0	0.1	0.0	0.1	0.0	1.7	90.6	114.8	2.4	0.2	0.0	0.0	0.4	0.0	0.1	0.5	0.0	13.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	10.2	0.0	0.0	62.9	1.2	0.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	1.2	0.0	1.3	1.4	1.0	104.2	0.9	0.0	1.1	3.3	19.5	1.5	0.0	0.0	0.0	0.3	0.0	0.0	1.2
DNHD1	"C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184"	ENSG00000179532	"Dynein heavy chain domain 1"	Q96M86	11	6497260-6593758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.5;Erythroid cells: 35.6;Excitatory neurons: 41.4;Inhibitory neurons: 32.8;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039698, HPA040267, HPA057639"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytokinetic bridge"		"HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.45e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-4)"	"unprognostic (8.15e-2)"	2.2	1.7	2.6	1.5	3.3	4.5	2.2	2.1	4.3	2.9	2.3	3.3	1.6	2.5	2.1	1.6	2.6	1.4	2.0	2.1	3.2	2.5	2.8	3.3	2.5	4.7	2.8	3.3	1.7	0.4	2.2	0.8	5.0	2.4	1.4	4.0	1.8	1.3	2.0	2.3	3.3	1.4	2.4	2.8	2.0	10.3	3.5	2.1	2.4	0.8	2.0	2.4	2.5	6.2	2.1	2.0	2.4	1.9	2.0	2.9	2.6	1.0	1.2	0.7	0.9	1.3	2.3	2.4	0.4	1.0	1.8	3.7	1.1	1.1	0.9	1.5	2.3	1.8	3.7	1.5	1.3	2.1	0.8	2.0	1.8	2.2	3.6	1.2	0.6	3.1	2.0	2.3	1.0	0.6	0.9	3.0	2.6	0.7	2.0	1.4	0.9	1.5	1.3	1.6	1.1	2.2	0.8	2.2	1.9	1.8	1.3	2.5	1.2	1.3	1.4	1.8	1.4	6.6	5.0	3.0	1.3	2.6	1.7	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.3	0.3	0.4	0.1	0.0	0.0	0.2	0.2	0.1	2.6	3.3	2.1	4.3	2.1	3.2	4.7	2.8	5.0	2.4	3.5	6.2	2.3	0.0	3.4	69.5	3.8	0.9	1.2	1.9	0.6	9.9	2.7	3.0	3.8	0.0	4.3	0.0	4.2	0.3	4.0	2.2	0.0	0.3	12.7	4.0	1.5	2.8	0.0	35.6	41.4	0.4	0.2	2.2	2.6	3.6	1.3	4.7	3.3	4.8	0.8	10.1	32.8	1.7	0.0	2.5	1.5	13.9	0.9	4.0	0.0	19.7	2.2	3.4	3.1	36.2	67.4	0.4	1.6	1.2	1.7	1.8	2.2	0.6	7.3	9.5	0.0	2.1	1.7	19.5	2.0	1.5	3.8	0.7	2.4	1.8	2.1	1.8
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009947	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: AB_2683640"	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.15e-4)"	13.6	6.0	3.6	5.5	3.7	10.3	10.2	6.2	5.3	15.8	8.6	17.7	22.5	9.6	12.5	10.2	11.3	11.0	7.5	4.7	4.2	20.6	13.1	8.4	4.6	3.7	3.6	11.5	17.6	31.7	3.9	10.5	3.8	8.9	20.7	15.8	8.4	12.8	13.4	27.4	27.2	8.8	3.0	7.7	23.8	6.9	5.2	20.1	8.1	11.1	5.2	19.8	17.7	3.1	25.7	20.7	18.4	29.2	32.9	27.4	4.4	45.2	43.6	21.5	20.7	14.2	38.0	26.6	18.9	34.9	11.8	19.9	21.6	26.1	29.9	1.4	6.7	3.8	23.7	10.0	17.1	2.6	1.8	13.0	5.7	26.6	23.4	75.5	52.1	8.5	3.6	0.0	44.1	3.2	4.5	5.1	17.7	18.0	12.3	5.5	18.7	1.4	36.6	21.9	3.1	4.2	7.4	1.9	5.7	25.3	1.5	2.4	63.4	16.0	15.3	13.1	29.8	2.1	1.7	36.3	15.2	8.4	12.2	0.0	0.8	0.2	0.7	1.2	0.7	1.2	0.1	0.4	0.3	1.9	0.1	0.3	0.7	2.1	1.2	0.3	0.0	0.6	3.6	3.7	6.2	5.3	4.7	4.2	3.7	3.6	3.8	3.0	5.2	3.1	6.8	9.6	11.0	11.1	14.8	35.1	7.2	5.0	5.2	6.3	9.3	6.3	6.1	12.8	11.2	12.9	35.5	7.7	4.4	36.7	3.9	7.5	1.0	27.0	11.0	12.6	3.6	0.0	15.9	14.3	1.4	17.6	26.0	43.9	2.5	4.1	11.4	12.8	4.7	13.5	24.8	25.0	6.1	10.7	9.6	3.2	13.7	20.5	3.6	23.4	3.3	4.3	0.0	10.6	2.6	19.3	23.6	9.1	6.1	4.0	36.5	3.7	19.9	26.6	0.0	4.3	6.9	4.2	9.3	9.0	45.6	3.7	4.3	15.0	28.4	21.8
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	5.6	9.0	8.9	9.8	12.6	8.7	6.2	9.3	10.7	9.1	2.4	11.3	6.7	9.3	8.7	6.0	7.5	6.3	5.9	8.8	7.9	11.3	5.3	7.3	11.1	9.0	7.6	13.0	8.3	4.2	11.5	15.7	8.6	7.2	6.6	15.4	6.2	5.9	21.0	4.9	8.9	7.1	5.2	13.4	8.5	5.2	9.4	20.6	6.9	10.2	9.0	7.3	6.2	11.3	1.6	8.1	34.6	8.3	3.8	2.7	45.2	1.9	2.2	4.7	3.8	21.1	13.2	0.0	4.7	4.7	3.5	2.2	3.8	5.2	2.8	5.7	4.3	14.7	12.8	25.4	8.8	2.9	7.6	8.2	2.6	6.0	2.2	9.1	19.5	34.0	18.0	2.9	3.5	20.6	33.7	36.5	59.6	14.3	4.2	59.5	32.5	3.8	2.9	3.4	18.6	71.5	2.7	19.6	6.2	29.5	2.1	16.2	6.8	5.4	4.7	1.0	2.5	5.6	5.1	19.6	2.2	8.4	5.5	2.8	1.0	2.1	2.7	1.7	4.0	1.3	1.7	2.4	1.3	1.6	4.6	3.9	2.5	5.5	2.7	2.3	1.9	1.2	8.9	12.6	9.3	10.7	8.8	7.9	9.0	7.6	8.6	5.2	9.4	11.3	18.5	6.4	13.1	28.1	11.0	5.2	10.2	6.6	5.7	73.3	12.1	9.8	15.8	5.7	9.9	20.2	127.2	40.6	15.3	6.3	5.9	16.9	1.6	13.3	19.1	20.5	13.1	15.8	49.4	9.8	10.7	16.4	9.7	10.7	37.4	37.3	11.0	6.4	23.2	95.9	43.2	11.4	2.0	14.2	3.9	1.9	19.3	13.7	7.2	38.4	7.4	20.6	13.4	36.7	63.4	9.3	9.4	15.4	9.8	12.4	6.2	6.6	7.3	143.5	19.7	15.1	14.3	2.8	14.6	8.1	2.6	32.2	19.6	26.1	12.1	10.2
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 5.3;Extravillous trophoblasts: 5.2;Horizontal cells: 5.0;Inhibitory neurons: 6.8;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 245.7;CACO-2: 95.8;HEL: 100.7;K-562: 98.6;NTERA-2: 333.9;SuSa: 174.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	0.8	0.6	1.2	0.8	1.5	3.6	1.3	2.4	1.6	1.3	1.0	0.7	0.8	1.0	3.1	0.8	0.7	0.8	1.0	1.2	1.6	1.7	1.2	0.7	0.9	1.4	1.3	0.8	6.0	1.1	0.6	2.0	1.3	0.8	0.7	3.0	1.2	0.6	0.5	3.8	0.8	0.9	1.0	1.0	0.9	5.8	1.4	3.7	1.7	0.2	0.9	1.3	1.1	1.4	3.9	5.3	27.0	6.2	0.5	2.1	245.7	3.5	2.4	3.6	3.8	95.8	4.3	10.0	9.7	1.7	4.3	2.2	17.6	1.7	3.0	1.2	14.0	100.7	3.3	18.5	0.9	4.6	9.7	2.3	1.9	5.5	1.1	1.8	6.6	6.2	98.6	2.7	1.4	15.7	15.6	86.1	333.9	8.8	3.2	15.4	4.5	2.3	9.1	4.2	8.6	5.7	5.9	8.5	2.5	174.4	5.8	5.5	1.6	5.5	12.3	2.8	2.6	5.9	2.8	3.8	2.6	27.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.5	2.4	1.6	1.2	1.6	1.4	1.3	1.3	1.0	1.4	1.4	1.6	0.0	1.5	3.9	0.1	0.9	0.2	0.3	0.6	2.1	1.5	1.3	1.3	0.0	0.8	0.0	2.1	5.3	0.3	0.2	0.0	1.3	0.1	0.8	0.9	1.6	0.0	4.6	1.1	0.6	5.2	1.2	0.5	2.2	0.0	1.3	0.7	0.6	0.8	5.0	6.8	0.3	0.0	0.3	0.3	1.0	0.0	0.7	0.0	1.9	0.1	0.8	0.0	1.5	1.3	1.0	0.1	0.4	1.3	0.3	0.1	1.3	0.1	2.5	6.6	0.3	0.9	0.1	2.6	0.9	1.3	4.8	0.3	0.8	0.6	0.1
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229481	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 450.0;Proximal enterocytes: 818.0;Proximal tubular cells: 1091.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 547.1;RPMI-8226: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		540000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	46.1	103.3	42.7	29.1	45.1	23.2	37.2	40.2	66.2	45.2	66.7	68.7	104.0	50.2	8.3	62.3	57.8	13.2	46.5	41.7	45.7	172.4	136.8	31.8	33.0	39.9	42.5	40.3	100.7	75.8	37.2	9.2	41.5	42.0	17.9	6.0	45.8	18.7	89.5	42.2	88.3	11.4	43.2	61.6	57.5	10.2	46.1	17.0	35.8	44.7	18.8	39.1	39.8	42.3	189.4	135.3	20.7	86.2	14.4	44.5	64.1	44.9	16.1	29.8	38.9	55.8	67.2	134.9	69.4	15.3	1.5	95.1	16.2	35.7	8.6	72.4	318.7	63.7	127.4	161.2	34.1	54.3	40.3	28.1	44.3	9.0	26.7	12.0	39.6	96.8	147.1	232.0	24.5	311.8	52.3	135.3	41.5	547.1	81.5	87.0	27.7	347.3	52.1	63.6	79.8	96.2	41.4	108.5	95.7	6.6	149.2	177.9	49.7	22.6	39.2	51.6	90.2	160.7	79.6	109.5	14.3	71.6	36.0	1.2	109.7	4.8	42.4	237.9	78.5	219.8	138.8	74.6	178.2	194.6	122.2	83.8	4.1	42.0	176.6	135.3	269.7	92.3	42.7	45.1	40.2	66.2	41.7	45.7	39.9	42.5	41.5	43.2	46.1	42.3	16.4	28.9	38.2	5.5	73.9	61.3	91.3	147.6	68.3	11.9	138.4	181.0	91.0	163.0	80.9	115.8	2.1	53.4	12.9	164.0	450.0	201.6	0.6	159.5	66.4	30.8	64.8	78.8	4.1	107.2	66.5	60.1	88.7	39.1	33.7	108.4	28.5	231.2	308.3	6.7	4.9	216.6	93.6	75.8	62.3	3.1	67.1	63.4	110.3	1.0	36.7	78.4	10.3	5.5	5.1	157.2	155.3	59.8	81.8	112.6	818.0	1091.6	260.3	23.5	0.0	39.4	57.9	8.9	38.1	131.5	73.6	32.3	44.5	82.2	288.9	101.4
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791954-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 124.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 43.3;granulocytes: 124.8;monocytes: 50.9"	"Cell line enhanced"	"Detected in all"		"PC-3: 280.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	19.9	19.4	22.8	24.7	23.2	44.1	20.0	23.3	26.1	21.0	23.9	33.2	17.5	27.2	25.0	19.5	24.7	21.7	27.3	23.1	24.2	19.2	19.3	22.3	23.7	23.2	24.3	20.6	15.8	26.1	20.8	23.1	23.4	22.0	38.7	21.7	19.4	22.8	62.0	28.2	21.0	24.4	23.4	25.3	24.6	30.4	23.8	30.1	19.6	31.0	28.0	34.0	19.3	24.4	79.8	41.6	42.1	40.2	31.7	34.1	43.7	29.2	47.1	92.7	83.4	134.8	126.1	32.8	93.2	42.9	147.1	58.4	37.3	62.8	61.1	18.0	47.2	36.0	45.2	87.2	64.4	70.0	56.7	34.4	58.0	60.8	58.2	42.4	55.1	46.9	33.9	32.6	56.0	107.5	57.9	108.2	28.7	44.8	280.7	46.0	52.3	34.4	47.4	37.9	39.5	35.6	59.7	48.2	65.2	32.7	47.6	111.4	32.6	55.4	41.1	54.0	71.0	35.5	24.8	41.0	120.5	44.8	48.1	16.7	50.9	71.0	4.1	22.0	4.2	12.0	5.5	7.0	43.3	11.1	10.1	4.7	124.8	3.3	13.6	16.6	9.3	13.5	22.8	23.2	23.3	26.1	23.1	24.2	23.2	24.3	23.4	23.4	23.8	24.4	21.2	16.0	22.9	10.1	22.0	25.5	44.8	43.1	22.2	19.8	20.3	23.0	19.9	21.5	37.1	25.8	4.2	60.7	14.3	37.2	50.9	57.6	37.9	35.1	19.4	22.6	22.2	9.7	11.2	75.4	43.0	25.7	26.5	20.6	6.3	26.4	25.0	16.6	70.8	20.2	9.5	92.7	59.0	26.3	34.7	15.7	28.3	32.4	16.0	11.2	68.3	53.1	15.5	7.5	10.6	105.0	50.5	27.1	21.9	38.2	33.3	44.2	48.0	29.7	0.0	20.8	26.5	92.9	35.4	19.4	27.6	57.7	16.3	32.9	34.8	60.7
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866284-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044502: AB_10960277, HPA053707: AB_2682236"	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	5.0	3.7	4.9	3.5	5.2	15.3	5.0	10.3	6.7	3.5	5.6	3.4	2.7	4.0	6.3	4.4	3.5	4.5	4.5	5.5	5.4	4.2	5.0	3.7	5.5	4.8	4.9	4.3	3.4	3.8	2.1	4.6	5.1	3.7	3.6	4.2	2.9	3.0	8.9	5.5	2.7	3.7	3.8	4.5	3.6	4.5	5.3	4.3	4.7	5.0	5.2	6.5	2.8	6.8	14.3	6.6	7.2	7.8	6.9	6.2	11.1	9.4	6.6	11.0	9.4	7.3	6.1	18.8	12.2	9.9	13.8	7.7	11.9	11.2	15.6	11.4	6.6	15.4	11.3	11.0	7.2	17.4	5.3	6.8	11.9	11.9	9.8	5.5	7.9	6.0	18.6	6.0	15.1	6.3	12.2	11.3	14.2	6.3	10.6	7.0	15.6	7.2	11.3	10.8	8.7	7.7	9.8	14.4	10.5	9.2	6.2	12.6	7.7	8.8	9.2	10.2	15.9	6.4	9.3	15.3	5.1	13.6	5.9	9.7	5.7	11.6	6.4	8.3	7.7	8.2	5.8	5.8	5.1	8.4	5.3	6.9	8.0	9.6	8.5	3.5	6.4	6.8	4.9	5.2	10.3	6.7	5.5	5.4	4.8	4.9	5.1	3.8	5.3	6.8	98.9	57.7	78.2	3.6	66.7	54.4	163.0	57.9	43.3	33.9	27.5	38.9	73.0	11.5	91.2	12.9	58.4	52.0	110.2	17.3	21.5	74.3	53.8	85.1	72.0	74.2	8.4	20.6	6.8	60.3	44.4	54.3	38.2	122.4	119.4	36.6	25.7	19.4	38.1	20.2	7.7	14.5	46.8	29.5	72.1	11.0	25.7	75.8	23.2	8.4	52.1	29.2	48.4	3.5	7.2	88.6	20.1	25.9	50.1	96.7	17.2	19.6	85.1	34.4	19.7	90.7	79.0	62.8	65.9	40.0	50.6	55.8	87.7	44.4	23.1	112.0
DOCK5	FLJ21034	ENSG00000147459	"Dedicator of cytokinesis 5"	Q9H7D0	8	25184689-25418082	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.0"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 789.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 30.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017719, HPA056837"	Approved		Enhanced	Cytosol		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA017719: AB_1847820, HPA056837: AB_2683253"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (8.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.18e-3)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	4.9	3.4	17.1	7.5	56.6	17.0	4.8	33.4	30.0	4.4	25.2	8.4	10.6	4.1	5.1	3.4	6.2	5.8	7.8	19.5	29.1	4.3	15.2	9.3	1.8	43.4	39.9	6.8	4.7	2.6	8.2	10.2	43.6	7.9	9.4	2.5	6.7	5.6	2.6	5.4	12.9	3.3	19.3	19.3	6.6	6.2	40.7	1.9	15.5	2.8	1.6	4.1	4.9	86.0	19.8	43.2	4.1	0.3	9.8	10.6	14.2	45.5	26.5	12.4	9.6	6.3	15.5	0.4	4.0	40.3	13.7	34.6	4.9	32.5	19.9	6.2	6.1	20.2	40.5	15.8	11.1	5.0	21.6	7.3	12.9	13.6	20.3	13.6	10.7	0.8	0.3	0.8	12.2	11.5	0.7	9.5	4.1	24.4	11.9	0.3	9.0	0.5	9.1	12.0	3.0	1.4	24.0	14.5	4.7	3.4	4.5	4.0	32.1	21.1	13.6	25.5	17.1	0.7	0.2	0.3	27.4	10.2	27.4	14.6	2.5	3.8	0.4	5.5	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.3	30.7	0.4	6.8	0.4	0.0	0.3	17.1	56.6	33.4	30.0	19.5	29.1	43.4	39.9	43.6	19.3	40.7	86.0	2.7	44.8	41.5	96.6	2.2	18.5	13.2	30.5	2.2	9.6	12.8	5.8	13.4	31.5	31.4	14.7	2.1	28.3	20.1	50.6	0.0	10.3	0.9	16.3	10.0	10.6	17.5	9.9	4.9	12.0	100.2	28.1	32.1	53.1	31.0	52.8	8.2	35.0	13.3	1.7	3.6	26.7	8.2	60.3	51.0	5.6	28.9	41.3	85.4	38.4	24.5	20.0	22.6	61.3	789.8	48.9	27.4	48.2	13.4	36.0	60.0	6.2	20.9	2.3	13.1	4.0	12.1	0.9	5.6	5.8	7.2	20.5	10.8	25.1	27.7	16.8
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490821-3500674	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	7.5	8.8	15.6	4.4	18.9	8.9	6.8	18.9	18.3	6.2	9.9	8.2	17.8	7.6	0.5	11.0	6.7	1.2	12.6	14.7	15.2	11.1	10.9	6.4	3.2	20.6	19.2	6.5	8.5	2.5	8.4	2.2	18.8	7.5	1.0	1.3	6.9	2.1	18.9	10.5	11.5	1.3	16.5	7.9	8.7	8.1	17.6	2.1	5.9	2.2	1.6	8.3	6.9	24.0	18.6	22.4	3.1	7.1	1.6	2.0	15.0	17.4	3.6	8.0	6.5	31.9	7.6	15.3	13.2	2.4	7.5	19.3	4.6	6.1	1.5	21.5	24.5	15.1	13.3	37.7	6.7	20.7	19.9	2.3	5.7	8.2	3.3	2.8	4.3	15.6	34.1	16.4	3.7	22.3	20.3	23.3	19.1	7.1	29.2	25.4	7.6	21.3	5.3	11.1	20.0	15.5	12.7	10.8	18.4	1.3	15.0	11.0	9.9	10.9	14.4	29.0	31.7	21.9	17.4	20.1	12.4	46.6	12.7	1.2	6.7	2.4	7.6	8.1	9.4	11.1	10.1	14.9	11.0	16.5	14.1	12.3	0.4	10.0	8.9	14.1	13.2	5.9	15.6	18.9	18.9	18.3	14.7	15.2	20.6	19.2	18.8	16.5	17.6	24.0	9.5	6.4	2.2	2.0	15.5	23.6	22.6	13.2	12.5	17.2	12.4	10.0	7.7	11.5	7.1	5.5	10.4	30.9	7.6	27.9	21.5	22.2	8.6	10.9	7.9	13.2	13.1	23.2	4.9	21.3	29.9	13.6	16.3	7.8	13.4	10.5	11.7	10.0	21.6	25.2	5.1	17.6	24.4	7.9	9.3	23.8	14.0	9.3	19.6	1.9	16.9	12.7	15.5	4.5	30.0	24.7	17.2	15.1	16.0	28.4	10.8	28.9	4.6	12.4	0.0	16.2	13.6	12.6	12.7	14.5	27.6	34.8	12.1	13.6	27.2	18.7
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501904-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.6;lymphoid tissue: 118.4"	"Group enriched"	"Detected in many"	5	"B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 133.6"	"Group enriched"	"Detected in many"	6	"B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0"	"Low region specificity"	"Detected in many"							HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.0	6.1	5.2	30.2	6.2	93.6	4.4	6.5	7.9	3.2	6.3	8.2	6.5	3.4	1.7	5.5	7.8	4.3	4.1	6.0	7.0	5.0	6.5	27.1	31.5	11.3	6.8	2.1	4.5	0.8	3.4	7.0	10.5	5.5	3.5	2.1	6.6	2.0	3.6	2.6	28.9	4.5	6.7	118.4	5.9	8.9	9.9	4.3	4.4	4.1	32.3	7.1	4.0	8.1	5.2	7.8	5.4	6.3	3.2	0.4	13.0	4.4	1.1	14.0	12.9	11.0	2.2	124.0	3.2	4.0	6.8	8.9	12.2	7.6	6.9	26.1	14.6	21.3	21.4	2.5	1.0	46.1	87.5	1.6	4.5	16.2	1.6	1.5	1.9	11.4	14.8	50.2	5.1	12.9	2.7	52.5	12.2	1.5	12.9	148.6	9.3	1.2	4.4	5.2	7.4	4.9	2.0	2.1	6.2	4.8	11.7	63.4	2.7	12.3	11.3	6.5	5.4	11.1	15.0	122.1	2.7	88.0	2.2	16.8	62.4	57.0	0.3	61.3	0.6	37.2	0.1	0.3	14.5	19.6	0.1	0.1	133.6	0.5	77.6	1.2	0.0	28.7	5.2	6.2	6.5	7.9	6.0	7.0	11.3	6.8	10.5	6.7	9.9	8.1	1.4	0.0	5.6	1.6	31.6	0.3	0.1	0.4	1.8	0.8	1.0	0.9	0.4	0.0	0.2	0.0	0.0	0.5	0.3	0.2	0.0	0.2	0.0	0.4	0.4	1.9	0.0	6.3	4.1	0.2	0.7	1.2	0.5	0.8	18.3	0.2	7.1	0.8	55.7	0.0	3.5	0.3	0.0	51.1	2.3	0.4	0.6	38.3	1.8	3.7	45.4	0.3	2.1	0.5	0.5	0.0	0.7	1.2	38.3	0.2	0.2	0.1	0.1	0.6	0.0	1.8	0.4	3.0	1.9	0.7	0.3	1.0	2.2	0.3	0.8	0.1
DOK4	FLJ10488	ENSG00000125170	"Docking protein 4"	Q8TEW6	16	57471922-57487327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 127.9;Paneth cells: 99.9;Proximal enterocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 94.2;CACO-2: 107.8;SH-SY5Y: 239.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008348, HPA055849"	Supported		Approved	Cytosol		NA	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA008348: , HPA055849: AB_2682942"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.18e-3)"	10.5	9.2	12.0	9.6	12.2	1.8	8.8	12.2	12.7	20.7	9.0	43.9	46.1	16.9	12.1	32.8	15.2	17.5	14.8	11.1	11.8	42.0	33.7	23.3	4.3	8.3	11.0	19.8	17.6	12.0	19.8	10.9	13.0	18.3	31.3	4.1	12.6	25.8	3.0	43.2	49.9	12.2	7.5	10.5	37.3	7.0	10.8	3.8	10.7	3.9	7.4	16.7	21.6	9.4	10.3	94.2	15.0	26.8	20.6	22.6	16.7	17.7	23.5	12.4	3.8	107.8	53.1	1.1	75.4	37.2	7.3	21.0	9.2	4.9	5.3	2.7	6.9	22.3	28.2	63.2	29.3	0.3	2.3	15.8	14.2	16.4	1.8	27.6	19.0	3.8	7.3	4.3	14.9	9.9	1.1	4.1	9.6	46.1	4.0	8.9	7.8	1.2	64.8	3.9	73.6	239.9	14.5	6.3	4.5	66.0	5.6	4.2	20.5	2.1	15.1	6.1	0.8	2.9	4.1	0.8	6.7	4.7	9.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	12.0	12.2	12.2	12.7	11.1	11.8	8.3	11.0	13.0	7.5	10.8	9.4	8.3	12.8	14.0	0.7	1.4	7.9	7.2	3.6	5.2	15.5	3.7	5.0	2.4	30.0	3.3	14.7	0.0	0.9	1.8	127.9	5.9	15.0	1.2	2.1	5.3	11.3	3.6	1.3	5.0	23.7	7.6	7.9	36.2	2.9	0.0	19.6	6.8	20.4	0.9	8.4	7.1	30.3	2.0	0.8	1.6	2.0	13.4	1.0	3.6	1.0	0.7	2.2	0.0	2.0	0.4	30.8	99.9	12.0	1.4	7.1	96.6	46.9	2.5	0.8	6.6	1.1	6.9	0.2	4.1	11.6	18.0	0.5	2.5	4.8	34.1	6.1
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463306-3501473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.9;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9"	"Group enriched"	"Detected in many"	16	"B-cells: 3.4;NK-cells: 1.9"	"Cell line enriched"	"Detected in some"	4	"MCF7: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	0.1	0.9	1.0	0.2	4.7	0.2	0.4	7.8	2.9	2.1	11.1	0.3	0.1	1.0	1.7	0.3	5.9	0.3	41.9	1.1	0.9	2.7	1.1	1.6	0.7	4.2	1.5	0.3	5.8	0.1	15.7	0.0	4.7	1.8	0.1	0.0	1.9	1.0	29.5	1.6	1.4	0.0	0.2	1.9	2.7	4.8	3.0	0.0	0.7	8.8	0.4	1.2	0.6	0.0	2.7	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.6	0.0	1.2	0.0	0.1	1.3	0.0	4.4	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	36.2	0.0	1.4	0.3	1.6	0.1	0.0	6.7	0.3	2.3	3.0	0.6	0.1	3.0	0.0	0.0	0.0	8.3	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	1.0	4.7	7.8	2.9	1.1	0.9	4.2	1.5	4.7	0.2	3.0	0.0	0.1	0.0	1.5	1.3	5.3	0.0	3.9	3.7	0.0	0.3	0.7	0.9	17.1	0.0	3.0	5.5	0.0	0.0	0.4	0.5	0.0	2.3	5.8	2.6	0.7	0.1	6.0	2.7	0.4	4.4	0.0	1.4	4.1	2.8	0.0	3.0	0.0	0.1	0.1	0.0	0.9	3.0	2.0	0.0	0.0	9.9	0.9	0.1	0.0	0.0	0.1	0.0	3.1	1.0	0.0	1.8	0.0	0.0	0.0	2.0	0.1	0.3	1.8	0.5	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.4	1.2
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	9.6	14.3	6.6	6.3	6.3	1.5	7.8	6.7	6.7	7.4	8.6	7.5	7.6	9.3	13.5	8.6	8.9	7.9	10.5	6.5	7.1	9.1	10.5	9.1	6.8	6.9	7.6	6.7	14.5	16.8	5.9	9.3	7.3	10.0	6.6	4.4	12.0	10.0	6.7	9.9	7.5	9.4	6.5	8.0	10.6	14.5	7.6	5.1	7.8	7.1	6.6	8.6	5.9	6.8	11.7	42.5	14.8	22.0	42.6	22.2	20.0	23.7	38.1	28.5	21.0	33.7	17.9	6.4	12.3	34.6	40.3	80.3	20.3	29.6	14.7	10.7	17.8	8.0	27.4	24.5	43.0	8.8	13.5	31.1	27.0	30.8	16.8	16.7	28.1	9.1	19.7	10.0	31.3	56.9	7.3	7.3	19.0	33.0	26.0	7.2	19.5	25.1	25.7	17.3	13.5	15.1	31.4	25.6	14.1	13.7	44.8	11.4	23.6	25.6	9.2	32.5	19.8	9.4	25.0	6.4	24.2	8.0	19.9	2.7	15.4	6.9	11.2	15.3	10.1	11.8	9.9	12.3	16.6	12.5	12.8	13.2	2.2	13.0	21.2	9.3	16.8	10.5	6.6	6.3	6.7	6.7	6.5	7.1	6.9	7.6	7.3	6.5	7.6	6.8	8.5	6.4	4.1	2.9	2.6	1.8	3.6	13.9	4.6	9.1	4.4	4.3	3.5	10.0	10.9	7.3	8.4	25.6	3.5	5.2	0.0	15.7	15.1	5.9	7.2	9.2	1.2	3.6	1.2	14.2	16.4	8.1	5.1	3.6	1.3	7.5	16.1	9.2	13.5	5.0	2.2	3.5	12.2	5.2	2.7	3.7	12.2	2.9	3.6	1.9	2.8	10.7	5.2	2.5	1.7	11.1	7.5	6.0	1.5	4.4	7.5	9.0	11.4	7.1	0.0	7.0	15.7	33.8	15.1	3.3	1.3	18.2	2.3	15.8	5.7	2.1
DOP1B	"C21orf5, DOPEY2, KIAA0933"	ENSG00000142197	"DOP1 leucine zipper like protein B"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.2;dendritic cells: 3.8;Extravillous trophoblasts: 11.4;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 19.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072065	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Mitochondria	"HPA072065: AB_2686486"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	3.5	1.7	2.9	5.6	4.8	24.2	5.8	19.8	8.0	4.6	0.0	15.4	12.6	2.3	3.0	11.8	4.2	4.1	4.5	3.6	1.0	3.2	9.1	4.9	4.7	3.6	1.1	1.6	4.6	30.4	2.3	3.1	4.5	12.1	15.1	1.6	19.3	3.4	15.9	7.1	11.7	3.8	0.1	5.5	20.5	3.5	2.1	6.5	4.0	13.5	6.3	4.0	5.9	3.4	25.9	5.4	4.0	6.8	4.4	8.4	38.2	12.0	14.2	16.7	10.4	3.8	2.0	4.8	1.8	9.0	12.7	5.2	7.8	2.8	13.5	8.8	7.0	11.0	1.2	1.4	3.9	10.8	5.5	2.9	5.5	10.9	2.9	10.0	7.1	11.2	3.5	7.6	5.0	29.0	8.7	11.1	3.3	30.4	5.6	15.4	2.3	23.7	8.8	10.2	10.7	6.1	8.0	35.9	10.1	5.5	13.1	13.2	12.2	6.4	1.7	8.4	9.8	5.7	15.0	2.2	9.2	23.0	3.7	1.0	3.0	6.1	2.6	2.7	1.4	7.3	1.7	1.5	1.9	10.5	1.1	0.9	4.8	1.0	2.4	5.9	1.4	1.4	2.9	4.8	19.8	8.0	3.6	1.0	3.6	1.1	4.5	0.1	2.1	3.4	2.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	11.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	0.0
DPH2	DPH2L2	ENSG00000132768	"Diphthamide biosynthesis 2"	Q9BQC3	1	43970000-43973369	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045796	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA045796: AB_2679456"	"unprognostic (2.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.17e-8)"	"unprognostic (1.38e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.37e-2)"	8.2	11.5	9.3	10.8	9.6	7.0	7.9	9.0	10.2	7.2	9.0	9.7	7.3	7.7	6.1	11.8	8.2	5.5	11.6	9.1	8.5	13.2	12.6	7.1	12.4	8.7	9.2	7.2	15.9	10.2	8.8	6.6	9.0	8.1	9.2	3.5	9.5	6.7	32.8	10.5	9.0	8.9	8.6	11.8	9.7	7.2	9.4	8.8	7.4	17.0	10.9	12.3	6.7	9.5	25.0	28.5	12.2	26.8	9.2	9.6	41.6	13.0	13.9	32.9	26.9	36.1	23.8	41.4	21.4	13.3	17.0	28.1	41.7	36.8	18.4	28.0	36.1	42.4	36.1	37.9	24.1	49.9	23.4	14.9	40.6	39.2	21.0	10.0	23.2	32.0	55.4	23.1	16.8	28.6	44.6	28.3	86.3	40.5	31.4	37.6	28.2	67.4	20.6	19.5	42.8	49.3	17.2	43.1	32.6	16.3	18.2	34.3	15.4	16.1	36.7	28.6	52.4	55.3	98.7	43.0	14.2	55.0	24.1	0.0	6.6	0.4	6.1	9.4	9.0	8.3	6.4	6.5	10.1	8.8	6.4	9.3	0.6	10.3	4.8	8.4	6.6	6.3	9.3	9.6	9.0	10.2	9.1	8.5	8.7	9.2	9.0	8.6	9.4	9.5	5.8	0.0	4.8	5.2	14.4	22.9	13.2	8.9	8.6	6.8	10.3	10.0	9.3	7.2	5.2	1.8	10.4	14.8	8.8	4.8	5.9	16.5	0.3	4.0	5.6	7.6	12.0	6.3	6.9	18.8	16.2	6.2	8.6	4.3	4.5	6.9	2.5	5.7	8.6	3.3	6.5	8.1	4.1	3.7	7.1	1.0	8.4	4.4	5.4	0.0	9.2	4.4	12.3	4.0	6.9	15.2	3.0	3.8	11.5	23.6	3.8	9.0	6.0	6.0	0.0	6.5	8.0	9.4	24.9	10.3	27.1	8.6	6.9	12.7	13.7	9.0
DPH5	CGI-30	ENSG00000117543	"Diphthamide biosynthesis 5"	Q9H2P9	1	100989623-101026088	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046439, HPA076234"	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	Nucleoli	"HPA046439: AB_2679667, HPA076234: AB_2797274"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.00e-2)"	12.5	23.2	17.2	8.4	17.8	10.7	28.8	17.3	22.5	23.2	18.3	14.6	7.1	17.2	23.8	13.7	26.2	11.6	23.5	17.4	18.7	19.5	25.3	10.1	18.1	17.8	18.0	49.8	31.4	20.0	15.5	12.3	17.8	15.0	17.5	8.8	11.9	17.1	20.8	15.0	11.2	19.7	17.6	15.4	14.1	9.8	19.0	29.0	20.7	25.0	25.4	14.7	13.3	18.0	28.1	30.1	40.1	37.0	48.3	154.7	34.9	24.9	42.9	41.0	34.5	35.3	7.7	46.0	33.2	22.2	23.1	20.0	47.5	41.1	62.6	20.0	35.8	22.1	26.7	71.4	84.1	33.4	13.8	97.1	63.9	38.8	118.6	67.4	64.8	33.4	62.6	16.7	70.3	26.3	40.7	36.7	31.5	15.2	46.4	37.8	51.1	32.6	50.0	25.7	44.2	22.2	13.7	36.2	114.0	29.6	27.3	18.3	25.1	23.0	28.7	28.8	34.4	20.0	24.1	31.9	31.5	29.6	7.9	5.7	7.5	4.6	16.1	8.9	21.7	19.2	17.9	17.7	13.6	15.1	24.0	20.9	2.7	24.7	10.6	9.8	12.8	10.2	17.2	17.8	17.3	22.5	17.4	18.7	17.8	18.0	17.8	17.6	19.0	18.0	8.1	6.4	14.6	17.0	30.3	15.8	17.0	24.2	19.9	5.3	18.7	12.3	23.8	21.5	12.7	7.3	0.0	26.2	10.1	4.7	23.5	14.0	1.8	14.2	19.6	11.2	10.2	17.7	12.0	18.4	27.8	13.5	5.6	8.2	25.4	29.0	12.1	29.3	18.9	1.7	14.6	15.0	22.4	28.4	13.1	3.0	27.1	14.0	12.4	8.4	27.7	16.5	27.8	27.2	28.3	8.9	12.9	13.9	10.3	10.8	8.1	30.9	16.8	6.5	6.6	16.6	12.5	15.7	17.6	17.0	18.0	13.0	19.4	33.4	23.7	11.3
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554444-137578925	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 189.9;Spermatogonia: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.3	3.4	2.6	3.6	4.2	9.5	4.5	4.1	15.7	3.9	13.8	2.2	12.6	7.0	9.0	14.6	2.6	9.4	3.6	3.3	10.2	10.9	9.4	4.7	3.7	3.3	12.8	20.3	6.3	13.5	3.4	4.0	15.0	4.1	2.8	9.9	5.4	8.3	11.0	12.2	4.8	3.3	15.2	12.3	9.3	3.8	5.6	12.8	2.4	5.3	11.2	11.1	5.7	4.5	5.2	8.2	7.6	6.2	5.1	10.2	5.1	5.2	9.1	7.7	11.0	5.4	10.6	9.3	5.9	4.8	9.8	10.6	10.1	8.3	9.2	13.2	4.9	6.6	3.7	7.0	10.6	9.5	5.4	7.6	5.1	9.2	6.5	14.4	7.1	9.2	5.7	7.2	15.3	8.2	9.9	10.4	19.9	13.3	13.7	3.7	7.6	6.9	4.5	10.8	7.3	8.7	7.0	5.4	5.7	7.9	9.1	6.5	6.2	5.4	7.7	9.5	3.7	9.1	12.5	3.9	6.1	6.3	9.5	5.1	6.2	4.5	4.8	6.3	5.6	7.2	6.4	5.9	4.7	5.1	4.9	1.6	4.5	4.0	8.0	5.4	4.6	3.4	3.6	4.5	4.1	3.6	3.3	3.7	3.3	4.0	3.3	3.8	5.7	21.0	6.4	11.9	21.2	17.7	16.7	9.8	18.9	8.0	18.7	14.7	20.6	15.5	2.8	11.5	1.8	50.1	22.1	22.5	7.7	3.9	10.6	3.0	11.1	17.1	13.8	6.7	5.5	17.2	9.2	14.9	14.5	13.3	10.2	10.8	26.5	8.2	6.5	11.9	16.8	21.5	11.7	6.1	6.6	7.2	7.5	16.4	8.8	8.8	15.0	9.9	15.4	23.7	16.1	28.2	11.5	10.3	15.8	24.7	18.6	7.2	5.2	14.2	58.8	19.7	13.1	16.0	189.9	100.0	11.4	18.9	12.2	18.0	19.9	15.0	11.1
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.2;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.3"	"Group enriched"	"Detected in some"	4	"HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	12.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	89.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	327.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.5	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	22.3	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.4	0.1	0.0	17.2	0.5	0.0	0.0	1.3	0.0	0.4	1.6	1.7	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.7	0.0	0.0	0.9	0.3	0.3	11.7	0.0	0.0	6.2	0.5	0.2	0.0	0.3
DPY19L2	"FLJ32949, SPATA34"	ENSG00000177990	"Dpy-19 like 2"	Q6NUT2	12	63558913-63668939	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 65.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 329.9;Excitatory neurons: 124.1;Inhibitory neurons: 137.2;Late spermatids: 363.0;Oligodendrocyte precursor cells: 124.1;Spermatocytes: 143.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 9.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA071264, HPA078305"	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Nucleoplasm	"HPA071264: AB_2686375, HPA078305: "	"unprognostic (1.97e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (4.22e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.79e-1)"	6.7	5.3	4.0	0.5	3.9	3.0	4.7	7.0	6.9	11.4	6.6	5.2	0.6	7.8	4.1	1.4	6.4	2.8	19.2	3.0	4.3	12.7	0.2	1.3	0.9	2.4	3.0	11.0	2.7	9.0	10.5	1.2	1.5	9.3	1.3	14.4	1.6	4.7	0.5	1.6	1.7	3.5	0.8	1.7	2.9	65.6	3.3	0.7	13.1	0.6	0.6	6.3	5.1	4.2	1.0	2.6	2.2	5.4	0.6	0.0	0.2	1.8	1.8	2.4	3.1	0.4	0.8	2.8	1.8	0.7	2.9	0.4	2.7	0.3	3.6	1.5	1.7	4.6	1.4	1.7	0.5	3.4	1.4	1.5	0.1	1.1	0.0	6.1	0.8	2.2	1.9	2.9	3.9	1.7	0.2	1.4	2.1	0.4	2.4	0.0	1.8	0.0	4.6	0.5	7.0	0.7	0.6	0.2	1.0	0.9	1.9	0.9	0.5	3.2	4.2	0.5	4.6	7.5	9.3	0.0	3.4	1.6	3.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	4.0	3.9	7.0	6.9	3.0	4.3	2.4	3.0	1.5	0.8	3.3	4.2	6.7	3.2	0.0	23.2	0.2	0.5	2.9	0.1	2.2	49.6	1.9	1.8	32.3	1.5	3.8	12.9	14.6	2.0	0.3	0.1	5.9	0.4	329.9	5.6	7.1	1.7	0.0	7.2	124.1	0.0	1.3	2.2	0.5	2.1	2.5	1.2	1.4	0.1	0.3	3.3	137.2	0.1	6.1	0.0	0.4	363.0	7.2	0.4	7.2	11.2	0.1	9.2	0.0	124.1	5.0	0.2	0.0	8.6	0.5	2.9	0.0	6.4	11.6	6.7	26.3	3.8	19.9	143.3	4.9	0.2	0.4	1.4	0.8	3.6	0.1	1.1
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390808-147510068	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 101.5;Cone photoreceptor cells: 331.5;Granulosa cells: 261.9;Peritubular cells: 205.7;Rod photoreceptor cells: 125.0"	"Cancer enhanced"	"Detected in all"		"glioma: 109.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 685.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Approved	Cytosol		NA	NA		740000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.23e-4)"	58.4	18.6	63.4	54.4	68.6	0.8	37.5	60.3	55.8	66.1	30.4	142.1	18.4	119.9	73.9	69.0	63.4	65.1	59.2	57.0	116.0	7.7	4.4	45.2	18.1	123.7	94.2	88.0	5.5	2.7	12.7	19.8	81.8	104.6	37.6	163.8	24.5	162.0	68.7	23.8	43.3	217.6	115.2	26.4	40.9	19.9	95.2	7.1	22.4	36.0	27.0	118.0	50.6	105.1	0.5	36.1	63.9	0.1	2.3	63.3	1.6	34.1	163.0	71.4	94.4	114.5	3.1	0.0	9.6	100.1	37.4	3.7	13.1	1.4	79.1	16.3	29.2	0.1	30.0	0.2	63.1	0.3	0.2	12.2	0.6	153.8	60.3	178.7	206.9	0.0	0.0	1.3	41.1	0.3	0.2	0.6	135.9	0.2	53.7	0.2	135.1	0.5	63.0	14.2	47.1	685.4	0.3	0.3	10.8	87.9	0.5	1.0	91.1	51.6	38.5	127.0	127.3	113.9	21.7	0.2	47.5	1.4	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	68.6	60.3	55.8	57.0	116.0	123.7	94.2	81.8	115.2	95.2	105.1	59.9	0.0	2.8	101.5	0.0	9.4	3.4	1.5	2.2	14.2	8.1	6.6	7.8	1.5	4.0	0.0	331.5	0.1	0.0	0.2	0.0	9.1	16.8	0.3	4.6	62.6	6.6	0.0	11.3	8.4	0.3	79.8	3.1	1.2	1.3	261.9	57.8	0.4	1.6	5.0	12.9	0.2	24.4	1.2	11.9	19.2	42.9	3.1	19.6	5.6	0.0	28.3	0.0	83.9	0.7	13.7	0.0	205.7	0.3	10.1	0.0	0.1	2.8	125.0	0.0	23.6	40.9	1.8	3.2	3.7	8.2	0.4	1.5	49.6	0.3	4.5
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399604-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 160.2"	"Group enriched"	"Detected in all"	5	"Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001218	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		22000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	31.4	32.6	22.6	21.4	23.9	32.3	35.1	27.0	31.6	27.3	22.8	24.7	22.6	27.8	38.7	27.4	32.7	19.5	44.6	23.7	24.6	35.9	37.9	20.9	29.2	23.9	23.7	35.0	34.1	38.4	18.6	35.7	25.0	25.0	30.0	30.1	30.5	28.8	100.5	23.7	21.3	34.1	24.5	20.1	24.2	160.2	22.7	40.4	34.5	85.1	38.3	30.8	20.6	26.4	80.3	61.3	73.9	63.3	64.4	75.2	61.5	70.2	81.7	125.7	104.4	100.3	38.3	111.2	38.6	86.9	60.3	64.5	128.5	82.8	134.4	52.0	152.0	71.9	64.9	99.6	91.4	174.2	65.1	65.6	60.9	103.7	152.9	64.6	87.5	61.6	93.9	48.1	97.2	88.0	75.7	88.4	62.1	114.0	65.9	98.7	118.9	97.3	82.1	68.6	80.8	50.4	78.5	79.8	107.2	70.8	59.7	77.2	50.6	57.7	79.3	59.1	81.3	67.2	78.5	108.6	57.0	77.7	77.4	25.0	43.3	46.0	34.3	49.7	39.6	53.6	36.6	43.0	45.2	39.4	40.5	39.8	9.8	46.7	37.5	39.6	50.9	47.0	22.6	23.9	27.0	31.6	23.7	24.6	23.9	23.7	25.0	24.5	22.7	26.4	22.0	19.2	15.4	3.9	29.4	38.6	40.8	77.2	29.6	18.7	27.2	27.2	52.4	35.8	37.6	27.6	25.0	126.4	20.6	22.5	64.6	56.4	798.4	23.7	24.4	34.4	11.4	37.8	10.3	45.4	104.5	33.2	21.4	21.1	33.7	27.1	35.7	36.9	60.4	15.2	11.2	31.0	48.8	31.1	24.0	651.5	35.8	22.9	17.8	7.5	39.2	27.6	33.0	9.5	11.1	42.7	27.0	37.2	27.1	48.7	42.9	60.3	28.7	18.4	59.2	35.4	36.1	469.3	92.1	33.1	32.1	117.1	25.5	26.2	41.0	45.3
DRG2		ENSG00000108591	"Developmentally regulated GTP binding protein 2"	P55039	17	18087892-18107970	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007716	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Vesicles, Cytosol"	Nucleoplasm	"HPA007716: AB_1078705"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (1.26e-3)"	"unprognostic (7.86e-2)"	"unprognostic (8.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	19.3	19.1	14.2	12.8	14.8	15.9	19.6	14.8	15.0	21.6	13.6	19.4	14.8	22.3	12.9	21.6	19.8	12.6	19.8	14.9	15.7	18.5	16.6	15.7	18.4	15.2	15.4	22.5	19.6	15.8	17.8	12.3	16.1	20.1	10.0	5.2	17.0	15.2	36.6	20.3	17.4	13.7	15.4	19.8	17.9	8.9	14.9	16.0	18.4	16.5	14.9	20.0	18.3	16.5	37.1	51.1	17.4	17.3	31.1	31.7	33.1	24.8	24.7	40.0	37.0	55.5	21.8	35.5	31.8	29.4	21.2	38.9	28.5	35.1	27.4	32.1	74.2	16.0	26.5	31.5	33.4	14.3	24.2	36.4	30.5	39.1	33.0	22.9	38.5	46.8	27.6	13.7	23.6	42.5	38.7	25.8	12.9	51.4	36.1	41.5	41.8	66.7	24.3	21.6	9.9	28.0	25.2	15.2	31.9	102.8	30.0	21.4	29.2	19.6	18.3	23.0	42.8	15.5	19.4	20.1	27.9	26.2	36.6	17.7	21.1	23.6	24.6	23.3	20.2	14.9	17.8	20.0	24.6	17.7	16.9	18.7	2.8	28.2	30.5	13.8	24.9	19.3	14.2	14.8	14.8	15.0	14.9	15.7	15.2	15.4	16.1	15.4	14.9	16.5	23.8	0.0	12.4	8.5	19.5	16.7	19.9	21.2	11.4	14.9	18.8	23.0	3.9	24.3	13.2	7.3	2.1	37.5	26.3	20.1	29.4	29.4	7.3	12.8	19.3	20.8	21.6	10.1	11.9	27.1	40.8	19.4	17.9	12.9	12.0	32.6	16.4	19.4	32.2	6.7	10.0	19.7	16.2	21.4	12.2	14.2	21.5	18.0	12.4	8.4	23.9	19.6	23.7	4.0	8.0	24.8	16.2	24.5	22.9	17.4	31.4	31.8	9.3	13.4	6.6	22.0	21.7	12.1	13.0	18.2	11.6	39.3	21.9	33.9	24.5	14.4
DRICH1	C22orf43	ENSG00000189269	"Aspartate rich 1"	Q6PGQ1	22	23608452-23632321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 17.0;testis: 46.4"	"Group enriched"	"Detected in some"	44	"Early spermatids: 405.5;Late spermatids: 589.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 11.1"									HPA020446			Approved	Nucleoplasm,Nucleoli		No	No				"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA020446: AB_1853151"	"unprognostic (7.48e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.22e-4)"	"unprognostic (6.46e-2)"	"unprognostic (8.35e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.73e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.08e-3)"	0.8	1.4	1.3	1.1	1.5	3.7	2.2	3.0	1.9	1.0	2.4	1.3	1.1	3.3	17.0	0.6	1.7	1.8	0.4	0.9	1.1	2.6	0.7	1.3	2.3	1.1	1.2	3.0	2.4	9.2	1.4	0.8	1.1	1.4	1.3	3.9	1.5	2.0	0.2	3.3	1.1	1.5	0.7	2.0	0.8	46.4	1.1	1.4	1.7	0.0	0.8	0.6	0.7	1.0	0.5	0.6	1.5	0.4	1.8	0.4	1.3	0.0	0.0	0.0	0.0	11.1	0.4	0.7	0.1	0.4	0.3	1.1	2.1	0.1	0.3	0.1	1.0	0.4	1.1	0.5	0.6	0.2	1.6	0.8	0.9	0.3	0.0	0.6	0.3	0.3	0.9	0.2	0.1	0.5	0.2	0.5	0.1	0.5	0.6	1.2	0.0	0.0	0.3	1.2	0.6	0.5	0.0	0.9	0.7	0.3	0.2	0.0	0.3	0.0	1.8	1.7	0.2	0.6	1.1	0.1	1.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	3.0	1.9	0.9	1.1	1.1	1.2	1.1	0.7	1.1	1.0	0.1	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.8	0.0	0.1	0.3	0.1	0.0	0.1	405.5	0.4	0.0	0.3	1.8	0.0	9.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	11.3	0.4	0.0	0.0	0.0	589.5	4.1	0.2	0.0	3.7	0.0	0.0	0.0	1.5	1.4	0.1	1.2	1.5	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	4.4	2.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847158	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.6;pituitary gland: 4.2;retina: 1.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 4376.6"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019324, HPA057493"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA019324: AB_2670118, HPA057493: "	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.0	0.0	5.4	0.0	5.8	0.0	0.1	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.6	4.2	0.0	0.1	0.0	0.0	2.3	2.8	0.0	0.1	0.0	4.2	0.7	3.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.8	0.1	6.6	5.6	4.2	2.3	2.8	3.5	2.9	4.1	4.1	0.0	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	19.6	0.0	0.4	1.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.4	0.0	0.0	1083.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	16.8	649.1	0.0	0.0	2.4	0.0	4.2	0.0	0.0	0.0	200.5	0.0	0.7	0.0	4376.6	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.0	0.1	1.7	1.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 component of MIS12 kinetochore complex"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol"	"HPA002813: AB_1078343, HPA030627: AB_2732460"	"unprognostic (3.60e-2)"	"prognostic favorable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	5.9	9.9	4.2	7.5	4.2	14.3	8.6	3.9	4.5	5.0	5.2	9.2	6.8	4.4	9.3	7.9	4.1	4.4	5.1	4.3	4.4	4.8	9.1	6.3	12.8	4.0	3.9	4.3	4.3	5.5	3.5	8.8	4.1	6.5	10.8	10.7	5.9	6.3	4.0	8.0	7.8	6.3	3.9	9.6	7.3	23.3	4.1	16.4	5.1	4.8	14.3	4.4	4.7	4.7	36.7	29.1	35.7	29.5	14.0	18.0	24.7	42.9	35.1	63.9	70.2	52.5	44.4	39.3	27.4	23.0	69.1	45.8	33.3	32.7	60.3	18.2	22.7	78.3	26.2	36.1	3.0	46.2	34.0	7.0	9.4	43.7	13.8	10.4	31.5	42.4	30.9	33.7	41.7	25.3	59.2	34.5	16.8	63.3	55.1	46.1	109.4	28.4	16.2	20.5	37.8	16.9	52.9	53.7	25.8	26.3	55.9	30.5	16.4	60.1	35.0	56.9	46.1	27.3	39.1	46.4	49.8	40.8	42.6	53.4	6.4	14.5	7.4	11.0	8.4	14.6	8.1	10.3	7.1	18.4	10.1	9.0	11.9	11.1	10.1	46.9	12.2	6.7	4.2	4.2	3.9	4.5	4.3	4.4	4.0	3.9	4.1	3.9	4.1	4.7	6.5	6.4	4.4	1.6	10.3	5.0	11.4	7.6	3.4	8.0	8.7	7.6	5.4	2.8	8.6	5.5	29.2	49.8	9.8	9.2	7.9	6.8	10.6	5.5	5.9	8.1	2.4	22.1	6.3	6.4	30.4	8.4	20.9	9.4	3.8	21.8	7.9	6.2	14.7	6.7	4.4	13.6	4.1	6.3	4.6	8.0	8.7	6.7	1.8	5.6	7.4	6.0	7.2	3.0	3.6	5.1	5.4	7.5	22.9	7.1	7.7	3.6	8.2	17.5	0.0	5.3	8.2	115.5	75.1	12.3	7.2	47.5	7.7	6.9	13.6	11.0
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 14.6;intestine: 4.7;lymphoid tissue: 14.2;placenta: 3.9;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.3;Erythroid cells: 36.2;Extravillous trophoblasts: 16.2;Spermatocytes: 53.2;Spermatogonia: 20.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028016, HPA032023, HPA032031"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	0.6	0.2	0.0	4.1	0.0	14.6	1.9	0.0	0.1	0.6	0.0	3.3	2.3	1.1	0.1	1.9	0.4	0.4	0.1	0.0	0.0	0.1	1.2	1.4	5.6	0.0	0.1	0.1	0.1	0.5	0.2	3.9	0.0	0.4	4.7	0.0	0.4	0.1	0.1	2.1	3.0	1.9	0.0	2.5	1.3	13.7	0.1	14.2	0.5	0.0	6.4	1.2	0.7	0.0	34.1	28.1	48.0	23.6	2.9	5.8	23.3	41.3	25.5	38.1	56.1	17.6	29.0	25.2	15.4	16.1	25.0	25.8	62.5	34.9	54.7	31.4	30.9	40.7	33.6	21.5	0.1	54.1	25.3	2.5	1.2	62.2	32.4	6.8	17.7	44.7	49.1	51.1	44.4	13.5	75.3	24.3	56.6	25.2	32.9	57.2	84.0	49.2	11.6	22.9	29.6	46.0	39.2	37.5	17.6	47.7	32.0	24.1	9.7	38.2	28.6	40.5	47.8	18.4	30.5	57.7	19.1	35.5	37.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.3	2.3	0.4	1.7	0.0	0.0	1.3	1.3	7.0	1.5	0.9	0.0	0.0	12.8	1.4	1.5	0.0	0.4	25.3	0.4	1.3	5.2	0.0	36.2	0.2	0.0	16.2	2.4	3.1	1.0	0.0	11.4	0.7	0.4	4.7	0.0	0.3	3.3	0.0	0.3	0.8	12.4	1.2	2.2	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.6	0.4	0.0	12.8	0.2	0.6	0.0	0.1	0.0	0.0	0.2	2.7	53.2	20.8	5.6	1.7	1.5	2.6	1.6	5.2	0.7
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522807-15663058	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 127.0"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	16.2	9.3	40.8	17.6	60.1	16.7	14.8	35.1	46.6	13.2	32.5	26.0	11.8	13.5	18.3	11.3	11.6	12.6	21.5	42.8	45.7	18.0	8.6	14.7	29.3	40.2	41.9	11.0	11.9	21.0	11.5	14.9	40.8	13.8	16.4	127.0	13.7	14.8	26.8	13.6	17.4	17.8	38.0	22.1	17.1	12.0	44.3	21.4	13.2	16.0	30.9	19.8	12.5	37.8	30.6	12.9	10.9	23.7	15.5	17.8	16.6	15.3	20.0	36.0	32.4	17.6	13.7	42.9	40.5	21.8	29.6	10.4	21.8	16.3	32.6	27.3	28.9	30.2	15.4	25.7	27.3	30.6	24.8	16.9	24.7	18.5	26.8	16.6	32.2	29.0	29.3	10.2	22.1	35.9	31.9	48.7	7.7	25.4	18.6	37.7	21.2	33.4	33.7	31.7	22.1	9.5	12.1	28.4	36.4	25.1	20.6	19.4	15.2	20.5	13.4	21.2	28.6	27.7	57.3	30.9	9.5	27.1	39.5	11.1	10.1	14.4	19.5	12.4	13.1	24.8	16.5	17.2	11.0	31.3	15.5	12.6	11.6	49.3	9.0	30.8	12.1	11.5	40.8	60.1	35.1	46.6	42.8	45.7	40.2	41.9	40.8	38.0	44.3	37.8	23.2	12.8	11.3	35.3	42.6	29.1	16.5	12.5	11.4	47.2	14.3	13.1	29.3	15.7	11.4	14.7	58.4	41.4	29.6	18.6	37.2	37.5	50.5	16.3	9.8	31.7	13.8	5.5	36.3	35.8	17.9	16.9	14.3	14.5	54.6	54.1	20.0	6.0	54.8	25.2	38.6	17.5	8.2	18.5	32.4	26.6	10.2	22.1	37.4	39.4	29.8	55.2	64.9	26.7	36.3	26.5	12.1	15.4	20.2	12.9	27.2	81.6	13.0	173.4	6.6	12.3	20.8	22.3	18.3	8.6	22.0	16.7	29.1	11.0	19.2	12.0
DTWD1	"MDS009, MGC111207"	ENSG00000104047	"DTW domain containing 1"	Q8N5C7	15	49621037-49656232	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042214	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"HPA042214: AB_2677903"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.70e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.35e-1)"	19.6	11.8	7.7	13.0	10.1	5.4	18.2	8.2	9.1	27.4	6.5	21.1	7.4	22.6	16.8	13.3	21.1	23.0	11.0	9.0	8.9	11.0	11.5	10.9	12.9	5.7	6.9	22.7	33.3	11.5	9.2	12.8	6.0	15.7	11.9	8.8	21.5	14.7	10.3	12.2	9.1	20.5	6.4	9.0	14.9	9.5	9.9	11.7	17.6	21.1	10.0	20.4	15.9	9.8	10.0	11.9	21.2	11.5	41.3	84.1	16.6	29.3	28.6	36.8	27.5	4.2	8.3	16.7	20.3	38.7	16.8	17.8	15.6	15.8	37.7	10.8	11.2	13.8	23.5	14.5	29.1	18.0	11.1	38.8	20.4	24.3	29.7	32.9	15.5	19.3	26.3	17.3	41.7	23.3	12.3	15.1	12.4	22.6	15.7	17.4	44.7	64.9	12.3	7.1	18.6	14.4	34.7	11.5	27.3	22.1	12.1	25.4	10.7	43.6	17.3	25.6	32.3	13.2	22.2	10.0	37.5	53.9	28.3	8.7	9.7	5.2	6.8	11.7	9.8	9.7	10.3	11.6	12.8	10.1	12.0	11.5	2.6	13.9	15.3	25.3	8.9	6.0	7.7	10.1	8.2	9.1	9.0	8.9	5.7	6.9	6.0	6.4	9.9	9.8	39.9	19.2	15.0	36.6	16.6	19.2	15.4	31.9	18.2	41.8	23.0	34.0	18.8	12.8	22.1	35.0	31.3	23.4	27.1	4.7	31.3	20.1	21.0	27.8	88.1	23.6	15.5	20.8	57.2	21.0	27.7	49.9	20.4	14.1	7.0	29.3	25.4	14.9	19.5	18.5	55.2	19.2	40.7	16.4	14.9	11.2	37.9	16.7	16.0	18.7	10.4	20.3	18.6	33.7	66.1	20.8	10.3	28.2	27.0	21.5	9.5	22.0	37.9	40.0	6.6	35.5	46.7	51.2	44.3	19.6	19.0	9.7	16.2	35.4	17.1	12.7
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 70.7"	"Cancer enriched"	"Detected in all"	4	"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"NK-cells: 1.0;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 84.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: AB_2684097"	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	36.6	58.2	117.1	15.8	120.2	7.2	36.4	117.5	138.2	97.6	115.0	117.4	11.5	95.5	50.7	24.2	92.0	24.5	67.6	124.5	111.4	63.8	12.3	37.2	21.2	107.8	112.1	124.3	41.9	39.4	145.1	28.1	108.6	82.1	16.8	80.8	31.4	48.2	21.0	21.1	46.2	48.5	105.3	46.0	51.0	29.0	112.6	23.6	75.9	16.6	15.5	65.0	60.7	119.0	8.8	22.7	65.9	0.1	0.0	0.1	0.4	13.8	35.4	29.7	30.0	11.8	36.5	12.3	20.5	30.0	0.3	14.2	0.0	1.7	20.9	31.1	4.1	7.1	39.4	12.5	49.4	0.0	0.1	24.5	16.7	22.8	0.3	84.4	33.6	0.1	0.0	40.9	23.1	19.2	38.4	0.3	52.1	7.2	2.0	0.0	55.1	0.7	2.8	22.7	47.7	75.5	10.9	3.1	7.0	15.8	38.4	18.9	0.1	38.6	15.3	17.9	20.2	66.2	53.6	0.2	24.8	0.1	20.6	0.0	0.0	0.0	2.5	0.0	0.6	0.1	0.9	1.2	0.1	0.1	0.8	1.6	0.0	1.0	0.0	0.3	2.2	1.2	117.1	120.2	117.5	138.2	124.5	111.4	107.8	112.1	108.6	105.3	112.6	119.0	4.9	16.0	15.6	25.8	2.9	6.2	10.0	8.7	21.1	47.8	12.2	19.9	11.0	11.5	10.5	12.9	50.1	0.5	10.6	0.5	13.7	8.2	0.9	17.8	17.4	8.5	15.6	4.4	29.9	1.9	0.3	15.1	6.1	5.5	5.7	17.2	15.0	0.6	0.6	70.7	29.3	0.9	10.2	2.0	2.1	2.8	34.2	1.6	3.6	8.4	0.8	27.4	36.0	25.1	19.0	2.6	0.0	31.6	5.8	7.1	0.0	4.6	30.9	42.0	46.0	11.5	37.5	4.6	5.7	2.8	2.8	1.2	10.4	16.8	0.7	3.5
DTYMK	"CDC8, TMPK, TYMK"	ENSG00000168393	"Deoxythymidylate kinase"	P23919	2	241675747-241686944	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 108.6;Extravillous trophoblasts: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042593, HPA042719"	Approved		Approved	Mitochondria		NA	NA		7000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA042593: AB_10959590, HPA042719: AB_10960633"	"unprognostic (1.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (7.13e-2)"	"unprognostic (6.81e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.19e-2)"	12.2	16.0	15.6	15.6	17.1	37.0	11.8	16.2	19.8	11.2	16.5	15.1	13.2	10.8	6.1	19.1	10.2	8.6	10.6	14.5	15.0	14.9	18.8	9.7	24.8	16.8	16.0	8.2	9.5	7.5	5.0	11.1	16.1	11.1	12.2	4.3	9.8	7.4	8.1	18.8	14.0	13.4	15.3	17.2	13.3	8.2	16.8	24.1	8.7	6.4	19.2	10.6	11.2	17.2	102.6	112.3	93.6	120.1	30.2	33.3	103.2	82.1	63.2	110.8	125.6	54.8	120.1	48.3	24.6	66.8	126.8	84.4	87.8	102.2	56.7	118.8	104.6	103.9	88.3	105.1	26.3	69.1	83.1	23.7	27.3	102.7	42.4	32.1	104.8	74.4	123.6	38.4	114.1	112.6	132.2	125.0	100.7	113.1	94.2	111.4	139.8	71.8	62.3	59.5	115.0	74.0	53.4	81.5	67.9	27.0	74.2	120.0	66.5	147.5	110.4	99.0	152.5	47.3	49.1	144.6	122.4	112.2	184.9	20.5	26.2	17.4	30.4	46.7	29.6	35.6	28.5	32.6	19.7	36.7	28.1	25.0	4.2	32.6	37.1	38.5	42.1	28.5	15.6	17.1	16.2	19.8	14.5	15.0	16.8	16.0	16.1	15.3	16.8	17.2	28.9	9.6	5.8	8.1	21.4	15.2	17.7	47.7	16.5	19.1	36.3	44.8	11.0	24.3	22.2	25.8	2.1	79.5	24.0	22.9	21.5	39.6	2.1	17.6	25.0	29.2	14.4	108.6	3.3	34.1	149.1	26.9	25.5	22.3	15.2	52.3	23.9	22.3	84.9	5.0	4.7	35.7	36.7	17.0	13.9	2.1	16.4	21.7	23.2	5.6	39.3	23.0	38.1	6.0	9.2	33.7	10.6	19.2	37.6	21.7	12.7	37.7	12.9	17.4	26.3	21.4	31.2	27.5	63.4	32.6	11.9	27.5	17.4	28.2	52.2	19.5
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742089	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 32.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 19.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 102.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	3.8	2.4	4.3	5.2	7.4	25.0	6.0	7.7	5.3	4.5	4.7	8.0	1.4	3.6	1.2	6.0	6.4	6.6	2.6	4.5	4.5	1.4	32.9	6.2	9.1	7.1	6.0	1.6	17.0	1.2	1.2	3.8	5.8	2.7	4.1	14.9	6.3	0.9	22.9	6.1	3.9	8.9	3.8	6.1	2.5	3.1	9.0	5.6	4.4	3.6	7.6	6.1	2.7	13.5	15.2	6.4	0.5	0.4	45.4	22.6	0.5	10.1	25.9	16.2	12.5	0.3	4.2	11.6	3.3	26.1	11.9	102.3	2.2	9.8	14.0	30.5	1.2	20.4	3.0	1.8	10.6	9.1	13.3	31.9	7.0	17.6	17.8	7.5	0.6	3.0	2.1	4.0	16.0	0.3	1.8	7.2	1.5	3.2	0.7	1.1	28.5	0.9	5.7	9.1	37.4	3.0	1.3	1.2	43.6	5.6	2.1	5.5	3.6	8.1	2.2	12.6	12.4	6.8	5.1	6.2	12.8	4.1	8.9	8.2	5.5	0.3	4.5	4.6	3.9	0.8	2.9	3.1	7.0	0.9	1.0	1.7	0.5	19.7	1.9	0.2	16.9	2.2	4.3	7.4	7.7	5.3	4.5	4.5	7.1	6.0	5.8	3.8	9.0	13.5	4.9	0.0	1.7	2.6	21.7	50.9	13.5	13.6	25.6	6.0	42.4	18.7	4.7	14.3	19.2	3.7	20.9	2.8	39.0	3.1	0.0	35.9	61.1	57.9	6.6	6.7	43.9	2.5	0.3	9.1	3.7	7.9	4.6	53.7	133.5	0.2	1.8	53.6	22.3	1.7	30.9	17.7	69.2	9.7	46.9	7.1	24.8	26.0	23.2	2.8	14.1	14.3	17.5	17.1	50.5	26.2	0.8	12.8	9.9	11.0	0.4	1.1	18.5	34.2	0.0	33.7	5.3	9.7	3.2	16.7	41.3	3.4	47.0	28.7	3.6	16.5
DUSP11	PIR1	ENSG00000144048	"Dual specificity phosphatase 11"	O75319	2	73762184-73780157	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021052			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge"		Yes	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli fibrillar center"	"Cytokinetic bridge"	"HPA021052: AB_2670577"	"unprognostic (2.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.28e-3)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (7.20e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.84e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.46e-1)"	16.0	13.3	7.9	17.1	7.7	35.2	20.4	13.4	11.2	22.4	7.6	16.0	17.3	21.2	19.3	30.5	39.0	15.9	14.2	8.1	6.9	20.2	17.9	14.3	25.3	6.1	5.7	23.5	11.0	14.7	14.0	20.5	6.1	16.5	17.4	8.3	16.0	14.4	14.3	27.6	15.3	19.6	4.8	19.0	16.3	16.8	6.5	24.8	16.5	17.8	26.1	25.2	22.4	8.3	39.4	16.7	17.6	18.6	31.2	38.7	31.2	28.2	36.7	35.8	36.4	24.2	29.1	50.6	17.7	30.6	32.1	26.7	22.0	56.8	34.3	35.2	22.9	31.2	12.0	37.3	32.7	35.5	28.0	31.6	67.3	32.1	44.1	31.1	40.4	24.2	33.6	28.6	40.2	21.3	34.3	37.6	28.4	36.7	22.7	13.6	47.3	46.0	29.3	32.1	25.9	14.1	26.1	30.6	35.7	21.0	16.4	18.6	23.1	25.4	31.4	29.5	33.7	30.7	26.2	68.1	23.5	35.5	25.3	72.5	42.2	99.5	56.3	39.3	73.5	68.3	65.8	67.4	47.3	65.9	69.4	65.5	65.2	69.8	40.6	35.7	88.6	71.7	7.9	7.7	13.4	11.2	8.1	6.9	6.1	5.7	6.1	4.8	6.5	8.3	26.5	9.6	12.0	7.5	39.5	83.2	55.1	93.0	39.3	11.0	12.9	15.1	8.6	27.1	45.7	12.9	4.2	32.8	34.8	15.5	50.9	29.6	9.1	18.0	15.7	34.6	12.0	21.0	14.9	27.3	42.0	26.5	16.3	13.6	40.7	20.5	52.1	15.3	30.7	5.0	12.7	18.0	36.7	20.2	27.1	7.0	28.9	17.0	23.2	10.3	34.8	9.8	41.2	13.0	13.8	28.2	17.8	25.6	31.8	30.0	22.8	50.4	38.2	16.6	6.6	18.2	23.1	23.8	34.6	42.8	83.0	38.6	39.8	20.7	18.8	60.9
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 123.4;Late spermatids: 344.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB034070: AB_2094867, HPA051349: AB_2681450"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	3.3	1.9	3.4	4.5	3.6	3.3	2.8	2.9	5.3	2.4	9.1	5.4	5.0	2.9	4.9	4.1	10.9	4.2	2.0	3.7	4.0	2.2	1.0	5.5	4.7	5.4	7.6	2.4	2.9	3.3	4.2	2.1	4.9	2.1	6.8	5.2	2.5	2.4	1.3	4.8	4.6	3.8	4.8	4.3	4.8	13.9	4.5	4.0	3.3	1.6	3.9	3.3	2.6	6.0	5.4	5.4	2.5	5.8	6.2	11.9	2.3	4.9	5.3	4.7	5.1	3.1	5.3	3.6	3.3	6.0	6.2	3.8	1.3	3.8	5.3	9.8	6.1	1.5	2.2	2.2	2.6	7.4	5.3	3.1	5.4	7.8	3.0	5.3	15.0	4.1	1.7	2.8	5.2	4.8	4.2	1.8	0.8	6.4	3.3	2.8	1.7	1.2	5.6	3.7	6.2	3.7	4.8	1.7	3.5	3.2	4.5	2.2	11.1	9.9	5.4	2.7	2.8	2.1	2.6	1.7	11.4	1.3	5.0	31.4	15.3	29.9	8.6	19.3	6.6	9.7	9.6	7.7	17.2	8.7	6.6	7.5	31.8	7.4	21.4	9.7	13.2	8.4	3.4	3.6	2.9	5.3	3.7	4.0	5.4	7.6	4.9	4.8	4.5	6.0	7.2	19.2	5.4	11.4	7.1	21.4	13.3	6.5	2.2	2.9	4.9	3.4	2.0	10.0	9.6	5.5	45.9	1.2	12.0	10.0	3.9	10.1	123.4	34.5	5.0	10.1	35.5	2.1	8.0	9.4	3.9	6.8	8.6	5.0	7.0	4.4	13.9	1.1	8.1	1.7	4.4	15.4	6.1	15.6	28.5	344.2	8.4	13.2	8.8	13.1	13.9	10.1	9.2	1.5	14.3	9.3	15.4	6.8	3.9	8.8	24.2	4.1	64.6	16.8	6.6	8.6	6.6	63.0	17.2	5.7	21.3	1.0	9.7	3.5	19.0	8.7
DUSP19	"DUSP17, SKRP1"	ENSG00000162999	"Dual specificity phosphatase 19"	Q8WTR2	2	183078559-183100008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.2;Endometrial ciliated cells: 17.7;Respiratory ciliated cells: 15.7;Spermatocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 1.3;basal ganglia: 2.4;cerebral cortex: 2.7;hippocampal formation: 3.8"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021501	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA021501: AB_1847892"	"unprognostic (1.24e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.80e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.75e-2)"	1.1	1.4	1.3	0.8	2.4	0.3	1.1	0.0	2.7	1.2	0.1	1.4	1.4	1.4	3.5	1.4	3.2	1.3	3.1	3.8	0.1	1.8	1.1	1.3	1.0	0.1	0.0	1.6	0.9	1.6	1.2	1.0	0.0	1.5	1.0	1.2	0.9	1.9	1.6	1.3	1.1	1.9	0.0	1.6	3.9	3.7	0.0	1.2	1.7	1.7	0.7	1.1	0.6	0.4	0.1	1.6	1.8	0.9	2.5	1.4	0.0	0.7	1.1	2.9	1.0	1.5	1.9	0.6	3.8	0.8	2.1	0.2	3.8	0.5	2.3	3.9	1.8	7.1	1.1	1.0	1.0	1.8	4.2	1.1	0.3	1.3	0.7	1.8	1.5	0.0	2.2	1.0	1.8	0.6	3.4	1.6	1.5	0.6	1.2	3.3	2.9	0.2	0.6	0.7	2.3	0.9	2.6	1.1	2.0	0.1	0.5	0.6	1.3	1.6	1.3	1.1	0.6	1.3	1.6	0.0	2.0	0.3	2.4	0.7	0.1	0.6	0.6	0.2	0.6	1.1	0.5	0.8	0.1	0.5	0.7	0.7	0.3	0.7	0.1	0.4	1.0	0.3	1.3	2.4	0.0	2.7	3.8	0.1	0.1	0.0	0.0	0.0	0.0	0.4	2.5	0.0	3.2	0.7	1.6	1.0	1.3	1.1	3.4	1.8	2.1	2.7	8.3	1.5	1.8	1.8	2.1	2.0	0.8	1.5	5.9	0.9	15.2	17.7	2.3	3.3	2.4	0.0	9.9	0.7	1.5	1.7	3.6	1.5	1.3	3.0	2.9	1.9	0.6	1.7	7.8	1.9	0.0	0.8	0.3	6.0	1.8	2.2	0.0	1.0	1.1	4.8	2.1	4.0	3.1	0.6	3.4	2.6	0.3	0.7	2.2	2.9	15.7	1.5	0.0	1.9	4.4	15.5	3.8	2.3	1.6	0.7	1.2	3.6	1.8	1.1
DUSP26	"DUSP24, MGC1136, NEAP"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591330-33600023	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 421.3;tongue: 204.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 76.8;Cardiomyocytes: 59.4;Cone photoreceptor cells: 41.7;Enteroendocrine cells: 25.7;Horizontal cells: 25.2;Rod photoreceptor cells: 75.2"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7;pancreatic cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	0.7	27.4	44.2	1.2	45.2	0.2	0.4	47.4	49.6	1.2	18.4	2.8	3.5	1.3	5.6	5.0	3.6	1.2	70.8	45.0	53.0	1.5	0.2	3.3	0.4	39.8	42.1	33.2	3.0	2.0	61.4	0.0	55.2	4.2	1.1	34.1	4.6	0.8	421.3	0.3	2.6	2.7	38.3	0.7	3.9	3.6	44.4	0.8	0.9	204.4	0.8	1.2	1.7	41.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	97.7	23.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	3.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	45.2	47.4	49.6	45.0	53.0	39.8	42.1	55.2	38.3	44.4	41.1	0.0	0.0	0.0	1.3	0.9	0.0	0.2	0.0	0.6	76.8	0.0	0.3	59.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	21.5	0.4	7.8	0.4	0.1	0.8	25.7	0.0	11.3	0.4	0.0	3.5	0.5	0.1	0.0	1.0	0.4	0.0	0.0	25.2	14.7	0.5	0.0	0.0	0.0	5.2	0.0	0.1	1.8	2.8	0.0	22.8	0.0	12.1	12.0	1.1	0.0	6.0	5.3	0.3	0.0	2.5	0.0	75.2	0.0	10.8	5.2	0.2	0.2	0.0	0.0	0.0	0.6	0.7	0.1	0.1
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240565256	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 39.7;Spermatocytes: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 8.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.5	2.4	1.6	1.3	1.7	5.4	1.7	3.0	1.8	2.2	0.5	2.5	1.1	2.1	1.7	3.1	2.6	0.8	3.4	1.3	1.7	3.2	3.2	2.2	1.9	1.7	1.2	2.2	3.0	0.9	3.9	0.6	1.4	3.5	1.0	1.2	2.8	0.8	9.8	2.0	3.6	0.6	1.1	4.7	2.7	6.2	1.5	1.1	3.5	4.0	1.5	2.3	2.2	2.0	1.0	0.8	1.1	1.4	0.7	0.4	1.3	1.0	0.6	0.8	0.5	0.5	2.4	1.7	0.6	0.6	1.3	3.1	0.9	0.3	0.7	2.2	4.0	2.1	2.2	1.3	0.5	1.6	3.7	1.0	0.9	0.6	0.6	1.6	0.4	2.3	1.6	1.9	0.7	1.1	1.7	2.5	0.9	1.4	0.9	2.3	2.4	2.1	0.6	1.6	2.8	1.5	0.9	1.1	1.3	0.7	1.2	2.2	1.0	1.9	1.6	1.3	1.0	8.2	2.1	2.8	1.2	1.0	1.5	8.9	1.1	0.5	1.2	0.7	1.4	1.0	1.2	1.3	0.6	1.8	1.4	1.2	1.9	1.5	0.7	1.9	0.9	0.9	1.6	1.7	3.0	1.8	1.3	1.7	1.7	1.2	1.4	1.1	1.5	2.0	5.7	0.0	4.5	1.3	11.4	3.7	7.7	4.7	6.2	6.7	12.3	10.0	13.8	10.0	3.8	12.9	4.2	7.8	18.4	11.0	15.6	5.1	35.2	11.2	5.5	4.1	8.4	8.8	3.8	5.8	4.8	4.3	14.8	10.2	7.0	6.2	3.3	8.6	11.5	8.4	4.9	9.8	6.1	10.0	6.1	39.7	3.1	13.6	7.2	1.9	10.5	9.9	23.7	2.5	3.6	4.4	10.4	1.5	16.8	8.0	15.7	15.6	11.7	6.8	6.6	4.1	7.2	45.8	18.7	10.7	5.4	7.0	14.9	7.6	11.2	8.7
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350684	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 32.2;stomach 1: 32.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 155.5;Ionocytes: 126.1;Pancreatic endocrine cells: 195.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 20.9"	"Immune cell enriched"	"Detected in single"	9	"T-reg: 6.7"	"Lineage enriched"	"Detected in single"	20	"T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"A549: 100.0;OE19: 91.7;SK-MEL-30: 157.2;WM-115: 122.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	15.2	5.2	2.3	5.4	1.4	6.2	23.7	5.0	9.0	6.0	0.4	1.2	1.2	4.5	0.1	2.5	1.9	11.3	2.3	20.9	1.2	2.8	0.7	5.7	2.6	1.6	1.1	0.4	32.2	0.6	5.3	7.5	1.1	5.2	1.4	5.9	16.1	10.1	4.2	5.6	2.0	1.2	0.3	1.0	32.4	2.8	2.9	4.2	1.2	0.9	2.7	13.8	2.8	1.1	38.0	100.0	57.9	2.8	7.2	0.0	4.9	7.7	42.0	22.8	10.1	1.1	18.8	0.0	20.5	3.6	16.0	12.0	0.7	25.7	13.5	1.0	1.9	0.3	3.7	0.7	0.2	0.5	47.3	4.6	16.7	7.1	42.1	49.7	18.9	0.4	0.3	4.5	46.0	42.9	0.1	7.1	10.1	91.7	60.5	1.2	1.9	8.1	52.3	19.7	0.4	32.0	10.8	49.5	157.2	1.1	10.7	1.1	53.3	16.7	0.3	0.0	5.7	11.6	1.4	0.1	50.2	8.9	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.7	0.0	2.3	1.4	5.0	9.0	20.9	1.2	1.6	1.1	1.1	0.3	2.9	1.1	11.1	0.0	2.8	0.0	33.5	12.1	98.3	27.3	4.0	43.2	80.4	62.2	2.6	51.5	51.1	0.0	12.5	3.2	24.0	1.9	0.0	74.3	7.6	64.7	13.3	16.3	97.8	0.0	3.8	78.6	40.9	9.6	121.8	155.5	6.3	0.0	21.8	0.3	25.0	43.7	8.2	8.5	126.1	4.0	102.8	25.6	0.3	47.4	65.8	0.0	75.6	0.8	0.0	1.5	0.3	195.2	0.0	0.0	31.0	30.9	0.4	0.2	43.6	3.4	13.1	18.9	17.8	1.4	8.2	2.3	11.9	17.8	115.6	0.1	4.6	102.7
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 56.9;placenta: 72.6"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 1171.5;Distal tubular cells: 727.8;Syncytiotrophoblasts: 1735.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Hep G2: 372.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.0	4.1	0.0	3.3	0.0	0.2	1.7	3.8	0.1	1.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	4.0	1.9	56.9	1.1	0.0	0.0	2.1	2.5	0.8	0.5	0.7	0.0	72.6	2.2	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	1.9	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.7	0.1	2.6	1.6	0.8	0.1	32.6	0.0	0.0	10.3	0.1	0.0	0.0	0.0	6.5	2.0	0.0	15.8	0.0	1.2	7.5	39.9	1.0	0.0	1.1	7.3	0.0	3.0	372.7	0.0	0.0	5.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	9.7	0.0	0.0	2.1	0.1	0.8	1.1	1.8	14.8	0.0	0.0	0.0	0.1	9.4	0.4	1.2	2.3	2.8	1.6	0.9	0.6	3.9	0.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.3	1.7	3.8	4.0	1.9	2.1	2.5	2.2	1.9	2.8	2.6	0.0	0.0	0.0	3.6	0.5	0.6	1.0	0.6	2.8	0.0	0.2	3.4	2.3	1.5	0.0	11.0	0.0	1171.5	0.0	0.0	727.8	0.1	0.0	0.1	0.1	3.1	0.0	0.0	0.7	0.0	84.0	6.1	0.0	0.0	0.0	3.8	0.0	0.9	84.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	3.2	0.4	0.0	0.0	0.0	0.4	0.8	8.9	0.2	0.0	1735.1	0.2	10.8	0.1	1.1
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes		31000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	73.0	65.3	54.7	61.7	58.9	162.9	76.4	57.1	77.2	90.7	60.0	69.5	29.3	76.9	49.7	72.1	77.6	33.6	68.9	53.9	59.6	67.6	53.6	58.1	97.8	58.2	55.5	86.1	53.2	48.3	80.0	45.1	58.3	77.8	47.1	49.1	66.5	48.3	57.9	71.6	66.5	40.4	57.7	82.1	61.5	57.3	57.5	111.4	89.2	53.0	87.8	69.1	78.0	63.5	196.1	60.2	143.9	137.1	98.4	104.0	85.3	202.1	128.1	182.8	224.6	69.8	131.0	539.3	106.0	112.0	149.4	262.1	152.4	138.4	177.6	383.4	157.2	442.2	151.8	96.1	54.8	469.0	202.0	64.4	92.1	123.9	65.0	117.8	123.3	316.6	244.0	297.6	136.5	79.3	422.4	548.7	90.7	197.4	114.5	338.6	313.9	570.0	120.8	130.4	207.2	210.1	150.0	119.6	184.4	145.5	169.6	368.6	103.0	190.1	183.1	228.3	269.7	238.1	534.3	532.5	143.6	789.4	213.4	32.5	50.3	46.8	52.9	53.1	68.7	94.8	94.7	84.6	74.0	90.0	97.4	64.3	30.9	60.5	68.4	85.3	94.3	71.4	54.7	58.9	57.1	77.2	53.9	59.6	58.2	55.5	58.3	57.7	57.5	63.5	153.6	54.5	38.9	39.8	126.8	179.6	212.0	222.4	131.5	48.3	158.0	205.5	120.1	95.8	118.5	104.8	14.6	221.8	103.9	62.8	203.5	94.3	36.8	67.2	123.5	123.0	96.1	418.8	36.5	46.5	286.8	147.9	76.5	86.0	84.4	118.3	101.4	77.6	174.5	82.4	32.1	98.4	105.8	87.7	112.6	31.5	184.8	92.0	154.7	23.4	89.5	106.3	95.8	23.6	45.1	45.4	58.8	177.6	192.3	133.2	27.2	256.4	59.6	40.9	157.8	167.1	154.0	508.7	270.0	206.4	168.5	97.1	124.4	82.3	195.4	181.2
DVL3	KIAA0208	ENSG00000161202	"Dishevelled segment polarity protein 3"	Q92997	3	184155377-184173614	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046486, HPA058265"	Approved		Approved	"Intermediate filaments,Midbody ring,Centrosome"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	"Midbody ring, Centrosome"	"Intermediate filaments"	"CAB046486: AB_10610845, HPA058265: AB_2683658"	"unprognostic (2.20e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (8.61e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.77e-5)"	"prognostic unfavorable (1.53e-8)"	"unprognostic (1.87e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.95e-1)"	35.2	28.1	16.4	18.7	17.4	18.6	29.8	17.4	18.9	39.0	15.9	46.0	17.2	44.7	16.1	30.3	34.5	22.6	35.0	16.4	17.1	25.7	20.0	31.7	13.9	18.1	17.3	42.0	25.6	17.9	24.4	38.3	17.6	29.1	16.1	22.8	25.6	25.8	34.9	33.8	27.1	31.7	16.6	25.6	27.9	15.1	17.0	12.4	30.0	22.3	15.9	36.6	31.6	18.3	47.9	13.6	36.4	41.4	37.5	37.8	95.0	28.4	28.9	32.7	27.6	43.6	18.3	33.6	73.3	37.0	32.4	40.8	29.6	22.2	23.4	54.0	32.2	38.1	21.3	28.2	56.6	21.2	27.8	38.4	39.9	23.4	27.3	55.9	24.6	21.6	38.9	44.2	35.5	46.5	28.3	25.2	32.8	34.6	22.1	49.9	42.7	30.0	31.7	36.2	36.3	51.0	34.9	39.8	67.4	35.8	98.7	26.8	25.0	29.5	28.5	31.0	43.8	48.3	38.8	37.0	30.0	22.4	23.6	0.1	0.6	1.3	0.6	1.0	0.8	0.7	0.4	0.7	0.6	0.5	0.5	0.3	0.9	0.4	0.3	0.8	0.2	0.4	16.4	17.4	17.4	18.9	16.4	17.1	18.1	17.3	17.6	16.6	17.0	18.3	15.9	25.6	14.1	16.6	10.8	18.7	15.7	12.9	15.9	20.1	23.5	16.5	26.9	12.8	17.2	22.0	27.1	34.4	14.6	40.8	23.5	13.3	12.8	23.2	30.9	15.9	34.3	6.9	11.4	16.6	21.6	22.6	32.6	27.7	17.1	29.7	19.2	20.5	20.3	62.2	11.8	22.3	12.2	16.2	14.4	47.5	33.5	17.4	12.4	14.0	10.8	19.7	14.4	9.0	11.5	20.7	18.9	37.2	13.9	20.8	25.2	18.3	13.4	18.5	19.7	23.6	27.1	10.6	12.4	20.4	21.7	52.1	10.3	21.9	21.5	25.7
DYNC2H1	"DHC1b, DHC2, DNCH2, DYH1B, hdhc11"	ENSG00000187240	"Dynein cytoplasmic 2 heavy chain 1"	Q8NCM8	11	103109410-103479863	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 173.7;Cone photoreceptor cells: 112.6;Endometrial ciliated cells: 124.0;Excitatory neurons: 164.7;Inhibitory neurons: 101.8;Respiratory ciliated cells: 171.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039015, HPA039016"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA039015: AB_2676309, HPA039016: AB_10673410"	"unprognostic (3.11e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (8.49e-5)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.11e-3)"	4.2	3.0	5.0	1.2	5.2	0.3	3.5	5.6	10.2	5.1	14.6	3.2	1.6	4.6	3.7	1.6	6.5	3.2	2.0	4.1	6.1	3.7	0.8	2.8	0.9	8.3	8.9	5.6	2.9	6.7	6.8	1.4	6.3	2.6	0.7	10.5	2.6	2.5	0.8	2.8	2.1	2.3	5.5	1.9	2.2	7.9	6.7	1.8	4.6	1.5	0.7	3.3	3.0	5.9	1.3	2.7	7.0	3.3	9.5	21.2	0.4	4.0	6.4	6.5	7.0	1.6	1.5	0.0	5.5	8.0	3.1	5.5	5.5	7.7	5.3	0.0	4.6	1.2	4.8	0.2	9.3	2.2	1.3	13.6	2.8	14.9	16.9	10.3	2.7	1.4	0.2	0.0	8.6	5.4	0.7	0.7	1.9	0.0	7.7	0.0	5.9	0.1	7.5	0.9	4.6	3.6	6.5	1.7	3.1	1.7	6.8	1.5	6.4	7.9	3.3	7.7	3.0	0.0	0.0	0.1	2.3	6.7	2.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	5.0	5.2	5.6	10.2	4.1	6.1	8.3	8.9	6.3	5.5	6.7	5.9	12.7	0.0	13.1	173.7	2.3	6.6	13.4	17.3	9.6	25.9	8.2	9.7	10.1	4.3	18.0	27.6	112.6	0.3	2.1	0.2	1.9	7.0	26.1	124.0	43.7	11.1	17.3	1.3	164.7	3.4	0.5	32.0	5.6	7.5	3.8	15.4	9.3	0.8	2.5	32.0	101.8	1.0	4.1	0.8	5.8	11.1	20.8	3.1	8.8	45.0	0.9	16.5	1.0	86.0	72.6	10.5	2.9	18.4	3.3	4.9	0.9	16.9	171.0	85.1	19.7	40.8	18.5	90.6	11.6	5.0	5.5	0.5	5.0	23.5	1.7	5.9
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.3;testis: 83.8"	"Group enriched"	"Detected in many"	12	"Early spermatids: 179.4;Late spermatids: 580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	9.5	19.6	4.8	2.7	4.8	4.7	10.9	4.1	6.2	12.5	4.8	12.4	5.3	11.9	7.8	11.7	13.8	3.3	20.0	4.7	3.6	16.2	7.5	8.8	4.6	3.5	3.4	11.6	10.3	6.5	31.5	2.7	3.6	13.0	2.1	4.1	14.3	3.3	131.3	14.8	10.2	2.6	1.2	14.0	12.1	83.8	3.6	5.2	16.5	49.9	2.5	11.4	10.5	3.0	0.4	9.3	8.8	6.2	4.9	4.6	0.7	2.9	1.8	2.6	2.3	0.9	3.6	1.4	11.0	3.4	0.1	3.2	1.3	2.0	2.3	5.4	7.8	0.6	5.9	0.9	4.1	0.3	1.9	6.2	1.2	0.8	2.9	8.6	0.6	3.5	1.5	2.0	0.4	4.7	2.1	0.8	2.2	2.7	2.1	1.0	0.2	0.6	5.7	2.2	12.7	14.5	4.5	4.4	0.2	4.6	4.4	0.5	4.5	1.1	2.0	1.0	0.9	3.2	1.1	1.0	7.4	0.9	0.4	0.7	1.6	1.8	3.0	1.7	3.6	2.4	2.0	3.1	1.9	1.6	1.0	1.7	2.5	3.3	1.6	4.5	2.2	1.7	4.8	4.8	4.1	6.2	4.7	3.6	3.5	3.4	3.6	1.2	3.6	3.0	6.0	0.0	0.6	6.2	10.9	3.4	3.8	8.4	10.2	15.2	9.0	6.1	6.1	7.2	3.4	16.5	20.9	2.1	21.7	10.3	9.8	13.1	179.4	15.4	6.7	7.3	20.4	19.8	4.6	4.3	1.7	5.1	7.7	10.1	1.3	11.9	12.1	3.9	5.9	10.1	6.3	9.8	10.2	8.2	3.0	580.2	7.2	4.7	5.4	7.5	5.7	8.3	10.3	5.0	3.2	9.7	9.7	5.3	5.0	4.8	11.5	17.4	10.7	13.0	0.0	11.1	4.8	30.1	13.4	6.1	2.8	1.4	10.8	20.2	7.4	3.6
DYRK4		ENSG00000010219	"Dual specificity tyrosine phosphorylation regulated kinase 4"	Q9NR20	12	4562204-4615302	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 392.2;Late spermatids: 393.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028065, HPA056073"	Enhanced		Enhanced	Vesicles		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA028065: AB_10601212, HPA056073: AB_2683028"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (1.86e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	2.1	4.2	3.9	3.4	4.2	4.6	6.4	5.1	7.6	5.9	4.2	5.4	4.6	5.0	17.0	4.0	5.0	4.4	4.7	4.2	4.4	3.5	4.2	4.7	5.9	4.4	4.5	5.1	3.0	5.0	3.6	6.8	4.8	5.0	6.2	7.7	3.7	7.2	2.2	4.9	4.0	5.1	4.1	6.2	3.2	36.7	4.8	4.3	9.1	4.1	5.4	4.7	2.0	5.7	2.0	3.2	3.9	4.3	5.8	7.1	4.7	2.4	4.8	5.4	5.9	0.6	3.2	6.1	0.3	6.9	3.7	4.2	3.0	4.5	4.2	4.7	6.8	4.2	1.0	3.6	16.4	3.7	3.3	4.9	9.6	3.8	12.4	10.1	7.8	6.5	1.8	6.7	4.9	4.3	3.5	9.1	5.3	1.0	1.8	0.7	2.8	2.6	6.7	1.9	0.0	1.5	0.5	2.4	3.3	8.4	1.9	3.3	0.5	6.3	4.9	0.6	3.1	1.9	2.6	3.8	3.3	5.8	3.3	0.3	1.7	0.8	0.5	1.3	0.6	4.4	0.8	0.9	1.6	3.0	0.8	0.9	0.0	0.7	3.5	0.8	0.7	0.8	3.9	4.2	5.1	7.6	4.2	4.4	4.4	4.5	4.8	4.1	4.8	5.7	13.0	12.8	16.2	11.1	15.8	8.9	13.2	31.2	14.8	20.7	21.2	30.4	23.8	7.2	19.9	16.5	10.4	15.7	16.7	5.2	31.3	25.1	392.2	14.0	22.5	15.5	5.4	12.2	10.3	27.1	12.0	17.3	14.3	13.3	17.7	19.0	8.2	9.8	49.7	13.5	10.4	75.4	14.2	16.1	9.3	393.1	15.2	18.7	16.0	9.4	14.5	19.4	13.4	14.1	16.1	20.1	14.2	31.6	22.9	16.4	7.3	35.6	13.9	21.7	6.6	15.2	17.6	23.7	39.0	20.4	7.5	9.9	12.7	40.6	17.3	11.8
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 95.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Endothelial cells: 43.7;Excitatory neurons: 34.7;Hepatic stellate cells: 32.2;Kupffer cells: 27.1;Oligodendrocytes: 62.7;Syncytiotrophoblasts: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.0"	"Group enriched"	"Detected in many"	5	"hTERT-RPE1: 31.9;HUVEC TERT2: 85.5;LHCN-M2: 75.3;RH-30: 78.5;TIME: 58.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	10.1	1.7	1.0	11.5	1.1	31.6	4.3	4.1	7.7	1.9	0.7	7.0	2.0	2.3	0.5	7.4	3.2	4.6	16.8	0.2	3.8	3.6	6.5	8.3	3.7	14.8	5.1	1.3	1.5	2.3	1.5	21.1	13.7	3.3	2.5	0.5	1.3	4.8	95.3	1.2	3.1	10.2	2.0	21.4	2.5	1.1	10.2	2.3	4.6	32.3	0.9	6.9	1.8	1.8	1.1	0.0	3.3	3.0	0.0	0.0	6.1	0.1	0.8	2.2	1.5	0.4	1.0	0.0	12.1	0.1	3.4	2.5	0.0	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	1.5	0.0	2.3	10.6	31.9	85.5	0.2	8.4	0.0	75.3	0.0	0.0	5.8	8.1	0.0	0.9	0.0	78.5	0.0	2.6	0.2	0.0	0.0	4.1	0.7	0.1	7.9	0.3	0.8	58.1	0.3	3.8	0.2	1.1	0.0	0.0	0.0	0.0	13.3	0.0	0.0	4.1	0.1	0.5	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	27.0	0.4	0.1	0.0	0.0	1.4	1.0	1.1	4.1	7.7	0.2	3.8	14.8	5.1	13.7	2.0	10.2	1.8	30.5	3.2	8.1	1.0	1.0	2.4	0.0	0.1	0.0	1.1	0.3	0.6	24.0	0.0	1.3	0.0	0.0	8.1	0.7	0.1	0.0	0.4	4.8	0.7	1.3	43.7	0.0	2.7	34.7	0.2	3.8	2.2	0.0	9.3	2.5	0.3	32.2	13.4	11.4	0.0	13.0	0.2	0.0	27.1	3.0	6.0	0.6	10.2	0.0	16.9	5.8	0.1	0.0	2.5	62.7	0.1	0.0	0.7	0.1	0.2	0.0	2.1	0.7	0.2	6.6	5.2	5.5	0.6	1.1	0.1	1.6	66.2	1.1	0.9	0.0	0.1
DZIP1L	"DZIP2, FLJ32844"	ENSG00000158163	"DAZ interacting zinc finger protein 1 like"	Q8IYY4	3	138061990-138115818	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 58.8;Respiratory ciliated cells: 74.0;Rod photoreceptor cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030404	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA030404: AB_10601548"	"unprognostic (3.65e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.47e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.72e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.77e-2)"	4.9	1.4	1.7	2.2	2.2	8.8	4.7	5.9	2.1	8.6	15.3	5.0	2.2	8.1	1.9	2.5	12.8	5.7	3.3	2.2	2.3	5.6	1.0	5.7	0.9	5.7	7.4	7.0	6.3	2.7	2.1	2.0	4.2	4.1	1.5	4.6	2.1	3.3	1.0	7.8	2.1	4.6	4.3	2.6	7.2	4.1	2.6	0.4	3.6	0.9	0.7	6.1	5.3	2.2	5.4	3.1	6.1	5.1	3.8	5.1	1.4	8.6	5.1	5.0	6.3	2.0	0.4	0.0	4.3	8.0	7.0	1.7	4.5	2.0	2.4	1.2	4.4	2.4	7.5	0.3	3.1	1.8	4.0	5.4	2.0	5.5	2.6	5.1	2.8	1.4	1.8	0.0	6.9	0.3	0.0	0.8	7.4	0.0	1.1	0.0	7.1	0.0	2.3	8.5	2.1	4.8	8.9	0.0	4.3	3.4	2.3	3.7	2.2	12.3	5.6	6.0	4.5	0.0	0.0	0.1	4.9	2.6	4.8	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	2.2	5.9	2.1	2.2	2.3	5.7	7.4	4.2	4.3	2.6	2.2	1.4	3.2	2.0	4.2	0.0	3.6	0.6	1.9	7.4	8.6	0.2	2.5	2.9	7.2	7.7	1.8	8.4	0.1	0.0	0.0	5.9	3.8	17.4	58.8	8.5	2.6	0.0	1.3	4.0	1.2	0.1	6.5	7.1	1.1	0.0	7.4	0.0	0.0	1.4	3.3	2.9	0.0	2.0	3.2	2.6	1.8	6.2	3.5	0.0	3.7	0.6	2.7	0.0	2.5	0.2	5.9	0.0	4.1	0.0	0.4	0.0	0.8	74.0	19.4	0.0	7.2	9.8	0.6	2.3	1.7	4.3	0.0	0.5	1.7	0.0	0.1
DZIP3	"hRUL138, PPP1R66"	ENSG00000198919	"DAZ interacting zinc finger protein 3"	Q86Y13	3	108589705-108694840	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 327.4;Respiratory ciliated cells: 218.2;Spermatocytes: 351.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035066, HPA049232"	Approved		Approved	Vesicles		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA035066: AB_10601549, HPA049232: AB_2680684"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.51e-3)"	"unprognostic (3.81e-2)"	5.2	9.7	15.6	4.9	19.4	4.0	5.3	11.8	18.6	5.3	22.6	5.1	3.0	7.9	10.1	3.9	18.7	5.9	11.7	18.8	18.5	10.9	4.3	6.5	10.2	13.3	14.9	10.5	5.3	7.8	24.5	4.9	12.4	9.7	4.7	29.8	3.6	7.0	12.4	3.7	3.9	5.2	10.4	8.3	6.6	34.6	15.5	8.5	12.8	16.2	8.0	5.2	3.4	15.0	9.8	8.2	24.8	14.7	10.7	10.8	8.6	6.1	12.2	10.1	13.9	12.1	6.8	18.0	12.8	6.6	20.9	3.5	13.7	5.3	21.0	6.6	6.1	8.1	3.4	8.5	6.3	3.3	4.5	11.8	2.8	9.4	11.4	10.2	6.4	10.9	8.0	8.7	19.6	8.6	8.2	3.5	15.5	5.0	6.2	10.4	20.5	1.8	8.4	4.7	17.0	16.2	9.8	1.0	11.1	21.6	15.1	2.8	7.6	9.0	13.7	1.8	5.3	9.6	6.0	34.7	6.8	2.7	11.3	6.5	0.5	1.2	4.1	0.8	5.0	6.3	4.2	5.1	0.5	4.6	3.6	4.8	0.1	10.6	1.5	1.5	6.0	1.5	15.6	19.4	11.8	18.6	18.8	18.5	13.3	14.9	12.4	10.4	15.5	15.0	7.3	12.8	12.8	86.8	14.8	7.5	8.6	16.3	9.1	67.8	9.6	8.3	45.0	4.3	26.6	33.1	327.4	21.9	17.1	4.1	13.7	12.9	28.4	106.1	16.0	8.7	52.8	11.1	145.2	9.0	8.8	18.2	9.2	9.2	8.8	30.9	7.5	4.4	9.4	77.4	103.4	6.9	34.6	5.7	7.5	59.9	17.4	5.7	7.2	37.5	10.5	32.9	11.3	79.4	80.6	8.9	4.6	17.7	9.0	6.9	4.5	20.6	218.2	33.7	19.7	16.6	17.7	351.3	112.5	4.4	7.4	14.8	29.4	35.4	7.4	5.6
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 11.8;skeletal muscle: 12.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	0.3	0.1	0.0	2.8	0.0	14.2	0.5	0.1	0.1	1.0	0.0	4.0	3.8	0.4	0.0	4.9	0.9	0.4	2.1	0.0	0.0	0.1	0.3	0.3	7.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	5.1	0.0	0.9	0.2	12.6	3.0	3.0	0.6	0.0	1.3	5.6	1.7	0.0	11.8	0.1	0.4	7.3	1.8	1.3	0.1	23.3	7.2	7.1	9.8	0.4	1.1	31.7	13.0	3.7	15.3	16.4	25.4	7.8	23.5	5.5	4.3	9.0	20.2	17.2	1.6	13.5	15.9	14.9	8.0	4.1	7.1	0.0	12.7	19.2	0.3	0.1	3.1	1.0	0.9	21.0	17.2	17.6	22.1	6.3	11.6	25.8	16.6	6.9	26.3	10.1	26.9	12.8	16.0	6.6	16.8	6.0	7.0	5.5	11.3	1.3	4.0	7.7	13.7	4.2	7.3	9.0	18.3	11.8	7.7	16.2	30.6	9.0	24.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.1	1.3	0.0	0.0	0.3	0.1	3.8	0.0	0.5	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.4	3.3	0.8	0.8	1.2	34.1	0.1	0.0	1.7	1.0	10.2	3.3	0.0	3.1	0.0	0.0	2.4	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.2	0.0	9.7	0.1	0.4	0.2	5.6	0.0	0.0	1.5	0.9	4.0	3.1	10.0	0.3	0.3	2.2	0.5	6.3	0.9
EARS2	"KIAA1970, MSE1, mtGlnRS"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23520754-23557731	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	3.7	7.6	3.3	1.2	3.5	1.5	4.0	2.7	4.0	2.9	3.6	3.7	1.1	3.7	3.0	5.2	3.0	1.0	5.3	3.3	3.6	4.9	9.9	3.1	1.8	3.3	2.5	3.3	5.6	4.8	3.5	2.5	2.6	3.0	2.3	1.9	4.6	1.4	4.2	5.6	2.9	2.0	1.5	3.3	4.1	3.8	3.5	2.5	4.3	3.8	2.4	3.3	3.3	3.2	2.6	8.3	2.4	4.8	2.9	3.8	3.9	3.2	3.1	3.6	2.4	5.0	2.9	4.8	2.6	3.3	1.8	2.9	9.6	6.4	4.7	2.9	7.7	2.4	5.3	7.1	2.4	3.4	2.1	3.2	4.4	2.4	4.7	4.5	1.4	5.2	7.0	2.5	2.6	5.5	2.1	2.3	7.5	4.4	2.8	4.1	4.5	8.0	5.5	3.8	5.0	4.1	2.1	5.0	2.7	6.3	5.9	3.0	2.3	3.1	2.1	3.1	3.4	5.1	3.7	3.4	4.1	4.0	4.3	0.1	0.8	0.0	1.0	1.5	1.6	0.8	1.4	1.1	1.7	1.0	1.3	1.1	0.4	1.8	1.1	1.6	1.7	1.3	3.3	3.5	2.7	4.0	3.3	3.6	3.3	2.5	2.6	1.5	3.5	3.2	1.8	9.6	5.9	5.2	3.8	2.2	4.0	4.0	4.0	3.8	6.2	4.7	11.6	2.8	2.9	3.7	2.1	15.1	2.3	2.5	5.9	7.0	2.9	3.3	4.9	3.2	5.4	9.4	8.3	3.5	12.3	4.3	4.1	3.4	5.7	6.5	3.6	11.4	7.1	8.4	7.9	4.3	2.0	3.2	2.5	2.5	2.5	3.4	5.4	3.7	5.3	2.6	4.1	4.0	4.7	3.7	1.7	1.9	8.8	4.9	1.6	8.6	5.3	3.9	0.0	2.7	3.4	5.8	9.8	6.5	3.0	11.4	3.3	12.6	6.2	3.2
EBF2	"COE2, FLJ11500"	ENSG00000221818	"EBF transcription factor 2"	Q9HAK2	8	25841725-26045413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 17.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.9;Fibroblasts: 23.2;Microglial cells: 13.1;Sertoli cells: 39.5;Smooth muscle cells: 53.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 22.7;ASC TERT1: 45.7;HSkMC: 46.9;hTEC/SVTERT24-B: 26.7;U-138 MG: 17.1;U-2197: 22.7;U-87 MG: 19.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.7;cerebellum: 3.1;hypothalamus: 2.0;midbrain: 4.4;pons and medulla: 2.8"	"Region enriched"	"Detected in many"	5	"spinal cord: 8.7"	"HPA003954, HPA055101"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA003954: , HPA055101: "	"unprognostic (3.70e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (7.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.82e-2)"	17.8	0.7	0.2	0.9	0.5	0.0	8.0	0.2	0.1	0.7	0.1	1.4	0.0	0.8	1.9	0.8	4.0	2.6	9.8	0.0	0.7	0.5	0.0	0.6	0.6	1.3	3.1	1.0	0.8	2.2	0.4	0.5	2.7	0.5	0.4	0.2	1.4	0.4	4.7	1.5	0.7	1.7	3.8	0.0	0.8	1.1	0.9	1.4	6.2	9.6	0.2	1.9	1.2	0.3	0.0	0.0	0.8	0.0	22.7	45.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	26.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	17.1	0.2	22.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.7	1.3	3.1	2.7	3.8	0.9	0.3	11.9	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.6	0.1	0.2	0.3	5.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	5.6	0.0	0.0	0.5	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	3.2	5.9	0.6	0.0	13.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	39.5	2.6	53.4	1.0	0.2	0.4	0.3	0.0	0.2	0.1	0.0	0.1
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	35.1	38.8	30.3	35.2	31.1	34.3	39.5	28.8	33.5	30.0	32.5	35.4	23.6	35.5	55.7	46.5	43.5	21.7	37.1	31.1	31.0	55.7	126.6	27.7	35.9	29.3	28.5	27.3	36.1	45.6	48.9	33.1	30.0	29.0	36.5	19.6	34.5	31.0	51.9	36.8	24.5	35.0	29.6	24.8	33.4	44.4	31.8	30.5	41.4	28.6	39.8	52.5	34.5	31.1	325.0	180.2	66.0	192.7	52.1	58.3	142.6	219.4	107.8	338.7	210.5	215.2	192.5	211.0	167.9	157.0	157.2	218.2	144.5	200.9	360.5	101.2	146.5	144.8	160.9	188.5	95.7	248.7	106.8	47.6	197.4	248.6	197.3	64.2	185.5	145.2	220.3	67.8	165.1	172.8	190.0	152.0	290.8	209.5	165.0	139.2	150.4	235.5	123.7	135.0	132.0	139.9	127.3	228.6	219.0	105.6	94.5	136.1	147.6	128.7	248.9	211.4	360.7	102.9	219.7	262.7	107.6	258.7	265.2	19.7	45.4	24.9	52.3	54.1	55.2	61.5	52.8	54.5	68.7	68.5	48.3	48.3	3.9	59.6	53.3	65.6	60.5	43.6	30.3	31.1	28.8	33.5	31.1	31.0	29.3	28.5	30.0	29.6	31.8	31.1	38.0	35.3	39.5	5.9	36.9	123.0	91.6	78.0	40.5	26.3	50.6	62.1	32.0	52.9	52.5	31.3	6.2	102.2	23.3	34.0	90.1	144.5	163.5	56.8	47.3	51.0	24.1	45.0	5.6	124.4	135.1	51.5	33.1	31.6	50.7	35.1	27.8	148.3	63.3	15.2	3.8	49.7	48.8	22.5	24.7	94.9	33.2	28.9	55.2	3.7	41.4	55.7	35.0	6.0	4.9	135.3	25.8	38.4	53.1	179.3	29.4	135.9	81.3	29.5	39.5	55.0	68.1	92.6	97.8	54.2	99.4	84.3	26.8	57.8	66.2	95.3
ECD	"GCR2, hSGT1"	ENSG00000122882	"Ecdysoneless cell cycle regulator"	O95905	10	73130155-73169055	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006465	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA006465: AB_2667595"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.55e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.84e-2)"	13.8	17.2	8.0	14.6	11.2	31.9	17.9	12.7	10.7	14.8	10.2	13.1	12.1	16.0	16.2	15.2	11.9	15.9	12.8	8.5	7.7	17.4	18.9	12.6	17.7	7.4	7.1	13.9	16.7	22.8	11.3	17.8	7.5	16.5	13.9	17.0	14.4	14.3	13.8	15.3	11.7	14.7	7.2	14.4	13.1	19.2	7.6	21.0	19.0	14.3	18.4	20.0	12.5	12.5	41.0	28.8	32.0	48.1	28.8	28.2	26.3	31.1	48.5	49.9	57.8	52.0	41.4	31.8	29.9	30.5	36.7	33.0	34.6	36.9	50.3	26.1	33.5	39.9	21.2	38.0	43.7	48.3	25.3	31.5	30.9	41.6	51.7	37.9	53.3	29.3	42.1	21.4	47.6	34.8	44.5	28.6	33.0	37.7	81.8	32.1	35.6	17.6	40.4	29.5	13.9	26.5	28.4	62.5	40.3	32.6	36.1	23.0	33.3	21.1	42.8	23.3	36.2	25.2	18.1	54.5	40.1	40.4	18.5	21.0	23.3	26.3	24.7	24.9	26.4	24.3	23.0	24.4	20.3	21.2	29.9	21.5	27.5	32.5	34.7	13.8	24.8	20.3	8.0	11.2	12.7	10.7	8.5	7.7	7.4	7.1	7.5	7.2	7.6	12.5	21.2	28.9	12.1	13.1	22.7	11.0	27.9	16.6	24.5	13.9	11.9	10.3	12.5	8.6	23.0	7.3	25.0	22.7	22.7	9.0	7.9	15.8	39.4	15.3	15.5	17.4	10.8	21.8	17.3	12.2	15.7	15.7	23.4	24.8	19.6	12.2	15.0	8.8	16.6	20.2	16.3	11.8	8.2	12.4	10.1	11.5	15.8	16.0	14.2	9.4	10.8	10.3	14.4	11.6	18.6	14.7	5.7	13.2	16.7	13.1	9.8	12.2	10.5	13.1	6.6	17.8	18.2	32.9	16.0	19.2	10.9	33.2	22.1	11.6	9.2	24.7
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487834	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 106.9;ovary: 99.7;pituitary gland: 27.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 33.5;Muller glia cells: 100.3;Peritubular cells: 21.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 106.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 44.1;HeLa: 21.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 70.7"	"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	1.8	10.0	5.2	1.0	5.5	0.0	1.7	1.2	31.6	1.0	3.4	0.8	0.1	2.2	0.0	0.4	3.5	0.5	0.2	0.5	106.9	4.1	2.5	0.4	0.3	20.9	11.3	99.7	0.7	1.2	27.6	0.3	17.1	0.4	0.0	13.4	0.6	1.5	3.0	0.6	0.4	1.4	2.4	4.5	0.9	1.9	44.2	0.2	1.4	0.0	0.4	0.4	1.1	4.5	0.0	0.1	0.1	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.4	0.0	0.2	0.0	0.6	0.0	0.0	0.0	4.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.5	1.2	31.6	0.5	106.9	20.9	11.3	17.1	2.4	44.2	4.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	33.5	0.5	0.3	1.1	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	1.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	1.5	0.1	0.0	0.0	0.0	100.3	0.0	0.0	0.0	0.1	0.0	21.1	0.0	0.0	0.0	0.1	0.0	3.7	0.0	1.0	2.3	0.5	1.6	0.0	0.0	0.0	0.1	0.6	0.0	0.1
ECH1	HPXEL	ENSG00000104823	"Enoyl-CoA hydratase 1"	Q13011	19	38815422-38831841	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 749.9;skeletal muscle: 906.9"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 796.9;Proximal tubular cells: 880.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002907, HPA005835"	Supported	Supported	Supported	Mitochondria		No	No		720000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA002907: AB_1847964, HPA005835: AB_1847965"	"unprognostic (1.91e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.73e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.54e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.74e-2)"	216.0	343.0	51.2	47.6	53.7	62.3	194.2	54.1	60.3	124.9	58.6	232.9	93.5	115.3	32.3	168.4	114.0	66.8	749.9	49.3	52.5	271.6	556.1	122.1	67.8	51.8	51.8	107.2	141.4	56.0	77.1	67.1	53.4	99.5	99.9	12.8	138.6	43.3	906.9	149.0	167.4	59.7	50.6	192.3	180.5	100.7	55.0	51.0	117.9	455.1	65.7	142.4	132.4	53.3	64.0	273.8	42.0	68.8	161.0	82.0	61.8	31.7	53.2	26.6	27.1	178.8	124.8	98.6	117.2	72.8	24.1	30.1	70.9	72.9	21.1	345.3	37.7	120.7	76.5	146.1	161.3	131.9	116.9	109.0	186.6	35.1	61.2	52.3	63.4	127.3	58.4	160.8	59.6	120.0	91.8	82.2	27.8	278.8	65.9	101.8	126.2	199.0	168.7	142.6	51.4	67.2	161.0	77.1	86.5	27.3	106.4	288.4	53.7	45.5	39.3	46.5	29.6	121.0	153.2	96.4	71.4	164.9	90.7	316.1	312.9	268.0	253.6	248.2	237.2	368.4	243.5	249.1	308.6	361.3	216.5	242.4	41.6	342.7	212.8	221.5	391.8	541.8	51.2	53.7	54.1	60.3	49.3	52.5	51.8	51.8	53.4	50.6	55.0	53.3	125.4	86.6	104.7	13.1	111.1	82.2	220.0	320.8	80.8	22.4	124.0	143.8	302.7	205.9	203.2	145.3	16.7	796.9	103.4	257.7	510.6	195.4	64.5	95.7	56.9	96.4	189.2	99.9	7.1	90.1	370.6	104.1	112.7	77.0	120.9	177.6	90.7	549.4	277.6	37.0	8.6	298.9	193.3	99.0	85.2	56.7	130.8	97.5	145.9	8.4	205.1	53.0	113.3	7.1	16.0	97.0	257.5	143.0	122.1	100.1	383.0	880.0	182.6	21.4	78.9	88.4	119.7	73.3	51.3	121.6	90.8	580.9	118.6	624.2	350.0	218.1
ECHDC1	dJ351K20.2	ENSG00000093144	"Ethylmalonyl-CoA decarboxylase 1"	Q9NTX5	6	127288712-127343609	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035445, HPA035446"	Uncertain		Approved	Vesicles		NA	NA		56000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA035445: AB_10669860, HPA035446: AB_2732468"	"unprognostic (9.57e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.89e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.99e-1)"	"unprognostic (9.97e-2)"	"unprognostic (8.21e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	92.9	29.4	21.8	36.8	24.5	16.2	37.3	26.4	28.6	36.4	32.3	58.4	46.8	21.4	23.0	33.5	23.2	27.5	42.6	22.0	27.0	92.5	93.8	56.8	41.3	28.1	24.7	21.1	27.9	26.2	14.1	36.2	28.5	33.8	53.8	30.0	46.3	28.4	39.3	22.7	40.7	33.4	24.4	28.4	37.0	18.2	24.7	41.1	38.7	52.2	42.6	43.4	23.4	32.3	58.3	45.6	64.0	59.3	92.9	87.7	54.1	92.7	112.1	78.0	99.0	79.7	43.1	87.6	77.8	88.6	88.4	46.9	0.1	69.6	98.3	52.4	43.3	116.9	58.4	128.3	82.6	158.0	63.4	99.6	81.9	73.1	61.6	70.6	71.8	63.2	147.6	51.6	105.7	55.1	105.7	73.5	52.9	29.0	55.8	49.0	78.7	72.3	142.8	70.8	73.3	71.2	52.1	1.8	131.3	48.3	1.8	182.6	75.2	47.8	76.9	121.8	104.8	65.7	141.0	116.3	87.2	136.4	114.7	19.0	71.6	24.0	23.4	57.5	24.7	28.6	19.8	22.9	66.6	29.2	23.7	24.2	28.6	15.3	43.1	50.5	22.1	43.9	21.8	24.5	26.4	28.6	22.0	27.0	28.1	24.7	28.5	24.4	24.7	32.3	37.0	96.1	114.0	32.3	59.7	26.1	42.3	94.2	35.3	26.4	30.8	28.3	60.8	32.9	102.4	31.3	31.3	106.8	49.3	35.6	127.2	76.1	64.7	47.0	48.3	32.6	13.8	22.9	47.4	79.5	85.6	45.8	38.2	40.2	43.7	32.9	26.0	68.8	85.8	28.6	41.0	35.7	59.0	48.4	38.7	24.4	32.9	55.9	35.6	40.3	55.3	33.5	47.4	55.3	95.0	54.4	41.1	31.2	48.3	31.1	74.4	230.3	47.0	42.3	26.3	55.7	33.0	27.6	28.6	34.7	22.9	65.5	46.3	88.2	56.9	52.7
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239402-2252300	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 301.3;Hepatocytes: 246.5;Proximal tubular cells: 272.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		NA	NA		7300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	51.5	57.3	35.9	12.7	39.2	19.6	52.0	38.6	45.9	46.2	61.6	74.0	59.9	44.9	10.6	57.0	50.7	11.3	189.7	32.1	38.0	123.2	235.7	37.2	13.8	39.1	37.8	38.6	74.7	43.8	50.4	14.6	35.0	56.6	15.0	12.8	78.7	24.2	220.6	49.7	58.8	9.3	37.3	35.3	69.5	18.2	42.0	13.4	105.0	87.8	9.5	50.3	43.6	36.5	29.5	68.0	25.7	107.4	9.6	13.6	96.6	29.5	19.1	23.1	33.7	120.0	88.0	42.3	71.2	17.7	16.9	71.6	29.6	27.5	3.2	74.2	157.1	12.9	61.7	151.7	87.3	38.6	6.0	25.2	63.1	18.9	41.7	16.4	23.6	1.1	71.7	87.1	8.0	119.1	4.0	57.8	60.1	46.8	68.8	134.3	27.7	207.1	45.5	32.5	88.8	56.2	70.0	131.4	92.7	12.6	84.7	67.7	19.6	18.4	68.0	19.9	33.0	95.8	61.0	72.2	23.9	35.4	26.2	1.7	3.6	1.6	1.9	3.8	3.1	4.4	2.8	1.6	3.0	4.9	3.4	2.9	2.0	3.6	2.5	3.6	4.0	0.8	35.9	39.2	38.6	45.9	32.1	38.0	39.1	37.8	35.0	37.3	42.0	36.5	47.1	3.2	28.2	13.4	28.0	21.3	115.6	11.3	21.1	53.2	77.2	95.1	92.3	94.4	15.0	77.3	43.8	179.6	20.5	151.7	301.3	35.1	10.9	128.2	54.8	28.2	45.5	61.7	4.2	36.9	80.7	33.1	33.1	122.8	5.7	62.2	34.2	246.5	47.9	21.9	6.7	105.9	20.3	31.0	23.8	5.3	24.5	29.8	39.2	4.7	17.5	89.9	5.2	13.0	10.0	33.2	91.1	24.0	36.8	72.8	176.1	272.3	14.6	77.6	0.0	73.4	42.7	6.3	19.6	32.9	22.3	109.9	21.7	50.2	104.7	110.5
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 73.3;Hepatocytes: 49.3;Leydig cells: 122.1;Peritubular cells: 69.6;Skeletal myocytes: 43.6;Smooth muscle cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 19.1;ASC TERT1: 34.5;HSkMC: 36.8;hTCEpi: 42.8;hTERT-HME1: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035347, HPA035348"	Approved		Approved	"Mitotic spindle,Centrosome,Cytosol"	"Secreted to extracellular matrix"	Yes	NA		10000000		"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Centrosome, Cytosol"	"Mitotic spindle"	"HPA035347: AB_10669856, HPA035348: "	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	122.1	14.3	5.0	2.1	5.0	0.6	34.8	6.0	4.9	43.5	8.1	6.8	9.0	40.8	23.2	9.0	30.0	31.7	31.5	4.5	11.6	28.4	81.5	22.5	8.3	5.2	10.3	91.6	6.3	9.1	6.1	3.5	5.8	21.2	7.4	0.3	7.2	22.2	7.4	9.7	14.8	27.8	4.4	0.9	4.3	16.8	8.0	5.0	11.4	24.6	7.8	13.3	11.1	12.0	0.7	0.1	0.4	0.0	19.1	34.5	1.3	0.8	1.1	0.1	0.5	0.6	0.0	0.0	0.1	1.9	0.3	0.5	0.9	0.8	0.1	4.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	36.8	42.8	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.1	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.0	6.0	4.9	4.5	11.6	5.2	10.3	5.8	4.4	8.0	12.0	12.9	0.0	2.3	5.5	0.3	11.5	0.1	0.6	0.6	3.0	0.3	1.3	5.5	1.5	2.0	0.0	2.1	0.1	0.3	0.2	0.0	0.1	5.1	0.6	18.6	5.2	0.0	0.8	3.4	0.0	16.2	73.3	0.5	0.5	0.0	18.2	2.2	49.3	0.4	0.0	2.8	0.4	0.0	1.3	15.4	8.9	122.1	1.1	5.4	17.8	0.1	0.1	0.0	0.5	2.9	0.0	0.2	69.6	1.4	0.1	11.1	9.2	3.3	2.5	26.3	43.6	50.2	0.9	0.6	0.9	9.1	0.8	0.9	13.5	0.6	0.2
ECPAS	"ECM29, FLJ22036, KIAA0368"	ENSG00000136813	"Ecm29 proteasome adaptor and scaffold"	Q5VYK3	9	111360692-111484745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021646, HPA059795"	Uncertain		Approved	Nucleoplasm		Yes	No		5400	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021646: AB_2670788, HPA059795: AB_2684127"	"unprognostic (1.64e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.05e-1)"	41.6	34.1	33.8	23.5	43.7	28.6	31.8	33.9	52.9	31.6	31.6	34.0	32.1	28.4	23.6	28.7	26.5	19.9	44.4	52.7	30.6	31.0	28.2	31.0	21.6	32.0	31.9	33.0	38.4	40.6	32.7	24.0	33.7	34.3	29.6	28.3	32.0	25.6	245.0	32.4	29.6	28.5	26.1	22.4	31.2	35.6	31.4	16.2	32.4	97.1	21.2	31.6	30.9	40.1	58.9	53.1	35.0	37.7	81.6	81.1	57.5	70.8	60.4	57.0	39.1	49.7	35.6	59.3	32.5	62.6	46.5	83.7	45.1	47.4	52.7	65.4	28.3	36.6	64.5	72.0	60.4	68.9	38.2	74.2	48.8	57.3	84.4	64.6	58.8	14.7	85.4	81.1	47.1	49.5	0.3	39.9	68.6	74.7	44.1	33.4	107.2	35.7	48.9	52.2	66.7	31.7	60.5	64.1	46.2	37.6	50.5	36.4	64.7	38.1	43.6	57.5	65.5	71.2	144.9	71.3	55.7	27.8	36.0	2.7	5.8	1.9	4.6	6.0	5.3	3.9	4.7	5.3	8.1	4.2	2.8	4.9	1.7	4.8	4.5	3.6	4.1	2.9	33.8	43.7	33.9	52.9	52.7	30.6	32.0	31.9	33.7	26.1	31.4	40.1	24.6	57.7	63.9	0.0	5.3	0.0	0.0	0.0	0.0	0.0	19.0	14.7	0.0	0.0	32.8	12.9	0.0	17.3	11.6	0.0	9.8	21.0	0.0	19.3	32.0	12.1	0.0	0.0	0.0	21.7	11.4	12.5	0.0	26.2	24.0	30.6	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	25.7	0.0	0.0	4.9	0.0	0.0	14.4	24.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	20.2	6.5	29.2	0.0	0.0
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Spermatocytes: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol		No	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.82e-6)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	3.6	3.3	2.1	8.2	1.9	19.8	7.5	3.4	3.4	8.1	1.4	11.5	9.3	4.4	1.8	8.9	3.3	5.3	3.2	2.4	1.4	4.3	2.6	5.2	10.5	2.1	1.7	1.3	2.9	3.6	1.2	8.8	2.7	3.2	15.8	12.5	5.6	2.6	2.1	7.1	7.6	7.5	0.7	4.3	9.4	15.9	2.3	23.3	3.9	2.7	11.4	6.9	4.2	3.5	192.0	133.6	103.2	54.0	10.6	21.8	51.6	81.5	67.5	121.4	116.9	74.7	196.9	47.2	122.1	48.8	116.0	81.8	84.2	53.1	164.3	67.8	46.6	29.6	70.0	38.5	4.6	46.2	32.8	7.1	9.0	72.2	73.2	34.0	53.0	68.6	31.3	67.2	97.2	67.6	47.5	34.6	84.4	156.7	72.0	33.7	101.1	60.7	92.2	43.7	68.6	44.1	104.5	117.4	42.2	51.5	195.4	34.1	46.5	58.5	55.7	79.6	174.9	32.8	47.2	88.2	51.6	39.7	78.0	6.0	2.0	0.7	1.0	1.7	1.1	1.4	1.4	0.9	1.6	1.3	0.6	0.9	6.3	0.7	0.7	1.6	2.5	0.7	2.1	1.9	3.4	3.4	2.4	1.4	2.1	1.7	2.7	0.7	2.3	3.5	6.7	6.4	3.2	4.2	3.8	19.5	4.9	6.2	9.1	3.4	10.1	6.5	3.6	5.7	5.7	3.7	64.6	12.0	2.9	10.7	0.0	9.5	3.3	20.1	6.6	7.7	4.8	25.2	6.5	9.2	14.9	6.0	17.9	20.5	0.0	17.9	5.3	2.9	7.3	0.0	2.5	13.5	10.2	4.7	6.3	2.8	0.9	5.1	7.2	15.0	2.8	3.1	2.1	3.0	4.9	20.7	3.8	1.5	9.6	12.8	1.5	3.7	11.0	16.3	0.0	2.9	5.2	42.6	30.4	16.9	12.8	3.8	4.1	3.3	13.5	8.8
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73489308-73525587	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol		NA	NA		82000000	"Cluster 30: Non-specific - Translation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	7265.1	5743.3	2531.3	4576.8	2717.1	10489.1	10504.6	2524.2	2783.1	7953.2	2902.2	6991.5	4783.5	7397.5	7203.8	6302.2	9034.9	4902.1	4074.6	2309.3	2687.4	7520.3	6459.1	4891.3	8813.5	2792.2	2572.6	12627.2	10370.0	6942.9	3776.4	5545.3	2828.4	5639.5	6936.4	2200.9	8381.0	6045.9	1682.1	7151.8	5076.6	7695.8	2980.6	5912.7	5776.4	1701.2	2687.7	8091.2	8348.4	1938.8	11294.9	6993.4	6470.3	2900.2	5218.1	8235.8	8697.0	13940.8	18183.0	32963.3	7874.7	7061.7	21384.2	10632.9	10044.2	12591.7	8020.5	20786.6	9976.7	13824.2	6089.1	5849.1	11729.0	15249.9	9969.0	3868.8	7099.6	7824.7	6142.2	13619.5	14708.8	15773.6	9201.9	26454.1	27514.4	7357.6	24803.6	17437.1	14783.4	8434.8	15242.2	7357.1	13131.5	8385.7	7184.5	17411.3	10348.2	6259.3	4400.0	14212.5	15389.7	26105.5	12201.5	14719.8	8337.9	8853.1	3931.6	10026.7	17535.8	9067.6	6928.7	24671.0	11535.0	4637.5	6195.9	3343.0	9206.4	7296.2	6913.1	5011.8	4780.9	12625.1	7404.1	2888.1	8472.3	895.8	7474.9	7600.7	14243.9	10580.7	12006.0	10174.3	8618.3	8426.8	13912.6	12049.7	681.7	9555.0	7680.9	6461.2	9278.5	26796.5	2531.3	2717.1	2524.2	2783.1	2309.3	2687.4	2792.2	2572.6	2828.4	2980.6	2687.7	2900.2	4915.6	3169.9	6059.2	107.4	11291.6	9829.9	12187.6	10417.5	11667.5	978.9	10528.4	9476.3	160.6	6258.2	5739.8	2637.3	546.3	9401.2	8653.6	2189.4	10344.0	5796.3	1373.9	4535.2	6754.2	5952.7	3862.8	6396.8	84.5	10404.1	12700.2	5756.1	4472.5	5831.2	3736.3	5732.4	6124.7	3323.0	6415.2	494.6	109.3	6969.3	3289.7	7779.7	8970.1	2325.8	8931.5	6705.0	5112.0	175.2	18016.6	3733.0	8468.7	76.9	162.0	7231.8	5821.6	7213.5	6811.7	11638.2	7494.7	14215.0	2974.6	1469.9	3536.8	7040.7	7075.1	1092.8	703.6	12784.4	10055.1	11086.8	9616.5	6982.9	8574.9	16180.0
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488013-63499239	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 1638.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 130.8;Cardiomyocytes: 125.5;Horizontal cells: 269.2;Rod photoreceptor cells: 50.9;Skeletal myocytes: 49.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 347.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 240.0;MCF7: 405.9;SCLC-21H: 187.0;T-47d: 157.2;U-2 OS: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Approved	Nucleoli,Cytosol		NA	NA		55000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	Nucleoli	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	0.9	32.7	59.3	1.4	81.3	0.0	1.7	17.1	347.2	2.8	0.0	5.1	0.7	0.3	1.1	9.7	0.4	2.4	358.0	73.4	97.3	1.3	3.0	0.8	0.6	95.0	2.9	0.5	6.5	16.2	111.5	0.0	76.3	9.6	0.4	37.2	19.5	0.8	1638.0	6.8	1.9	0.8	0.0	0.3	8.5	1.2	30.7	0.2	0.7	320.7	0.1	2.2	1.8	125.0	0.5	71.0	0.8	16.8	0.0	0.6	7.9	10.0	1.3	51.6	16.3	9.8	41.5	0.0	110.4	0.5	13.4	38.8	240.0	0.7	115.9	0.5	13.1	0.0	24.1	4.1	2.9	0.0	13.4	1.4	2.2	0.1	1.0	0.2	0.0	0.0	3.4	0.2	0.5	405.9	1.4	0.5	11.4	95.6	96.5	8.0	0.2	10.2	2.4	3.9	187.0	89.9	90.0	12.6	1.6	2.2	157.2	3.8	0.0	0.3	202.9	0.7	1.8	0.3	0.9	1.4	0.9	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	59.3	81.3	17.1	347.2	73.4	97.3	95.0	2.9	76.3	0.0	30.7	125.0	0.1	0.0	0.0	9.4	0.7	0.4	0.9	0.0	0.0	130.8	11.8	4.6	125.5	1.5	0.6	0.0	12.5	0.0	1.1	0.4	0.0	1.3	0.2	0.5	0.3	2.2	0.0	0.0	35.5	0.2	0.2	3.6	4.6	1.4	5.7	1.0	1.1	0.1	0.0	269.2	37.2	0.0	0.0	0.3	0.7	0.5	0.0	0.6	0.0	15.0	0.0	11.7	0.0	14.6	12.7	0.3	0.0	0.0	0.3	2.6	0.0	0.5	0.0	50.9	0.0	49.9	3.4	0.0	0.3	0.0	1.8	0.0	1.5	0.0	0.5	1.1
EEF1AKMT2	"C10orf138, Efm4, METTL10"	ENSG00000203791	"EEF1A lysine methyltransferase 2"	Q5JPI9	10	124748149-124791887	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Distal tubular cells: 66.5;Extravillous trophoblasts: 29.8;Proximal tubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA050138	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Vesicles, Cytosol"	"HPA050138: AB_2681030"	"unprognostic (1.64e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.75e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.04e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.09e-2)"	4.8	3.8	3.0	2.1	3.3	3.6	5.3	4.8	4.2	4.6	3.0	3.7	1.8	4.0	4.6	4.0	3.8	2.1	4.1	3.1	3.0	4.9	5.2	3.3	2.5	2.8	3.1	5.5	4.4	4.5	4.3	2.7	2.8	4.3	3.8	2.5	5.1	2.8	4.0	5.0	3.5	2.6	2.7	3.5	3.7	5.6	2.8	3.3	5.1	3.3	3.1	3.4	4.2	3.6	12.6	3.3	4.8	8.0	3.1	8.0	3.1	5.8	7.6	7.4	6.5	4.3	7.1	8.4	3.0	4.7	2.5	3.8	6.8	4.2	11.5	7.0	2.5	6.8	4.2	3.9	6.0	10.9	4.1	3.9	3.9	4.1	9.9	6.2	4.7	7.0	7.6	9.3	9.3	3.7	5.2	8.5	5.9	4.6	4.8	2.3	5.7	2.6	4.6	2.7	1.5	3.8	3.7	6.2	8.7	3.3	5.4	8.5	5.8	2.7	2.9	4.5	8.8	4.3	3.7	6.8	4.9	5.7	3.9	0.8	1.0	1.6	1.6	1.1	2.5	1.9	1.6	2.0	1.2	1.3	2.2	1.6	0.1	4.4	0.8	1.5	1.9	1.1	3.0	3.3	4.8	4.2	3.1	3.0	2.8	3.1	2.8	2.7	2.8	3.6	23.2	3.2	11.3	0.0	8.9	0.0	0.0	0.0	0.0	0.0	20.5	22.4	0.0	0.0	2.5	11.0	0.0	29.1	13.4	0.0	66.5	20.0	0.0	11.4	11.8	7.5	0.0	0.0	0.0	20.4	29.8	10.4	0.0	10.5	2.5	17.8	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	11.4	0.0	0.0	0.0	0.0	19.8	0.0	0.0	2.8	0.0	0.0	30.5	3.6	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	17.1	7.1	14.7	0.0	0.0
EEF1AKMT3	"DKFZP586D0919, FAM119B, METTL21B"	ENSG00000123427	"EEF1A lysine methyltransferase 3"	Q96AZ1	12	57771492-57782541	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 14.9;Breast myoepithelial cells: 7.6;Exocrine glandular cells: 12.7;monocytes: 8.8;Proximal tubular cells: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	7	"RH-30: 152.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043020, HPA045492"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome,Centrosome"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	"Nucleoplasm, Mitotic chromosome"	"HPA043020: AB_2678274, HPA045492: "	"unprognostic (2.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.23e-1)"	7.5	6.2	2.5	3.6	2.3	2.6	9.2	4.1	2.7	10.5	2.6	5.6	3.9	9.3	9.6	5.6	8.4	5.4	3.7	2.4	1.8	11.6	6.5	5.3	3.6	2.6	2.4	11.4	21.7	6.4	3.7	4.6	2.7	8.2	4.6	3.7	19.4	8.7	2.9	7.3	3.8	7.6	2.1	4.0	7.2	4.2	2.4	1.9	10.1	3.1	3.1	6.3	7.3	3.1	5.4	11.0	4.6	5.9	12.8	12.0	4.0	5.8	10.9	8.9	9.0	5.6	9.5	3.1	7.4	7.6	7.2	5.2	3.7	3.3	9.3	4.0	5.6	14.9	6.6	9.2	11.3	3.7	6.6	12.6	8.7	9.3	9.8	15.2	9.7	13.2	8.9	22.6	5.4	3.8	4.7	11.0	3.4	4.3	8.0	8.5	152.1	10.0	6.0	5.3	4.4	6.0	10.0	7.5	6.2	4.1	11.9	10.0	9.5	13.7	7.7	5.8	6.4	5.7	2.3	3.8	11.3	15.4	10.0	0.4	3.0	0.1	1.8	1.1	7.8	0.5	3.5	2.2	3.1	0.4	1.7	1.4	0.7	1.5	4.6	1.5	2.2	2.3	2.5	2.3	4.1	2.7	2.4	1.8	2.6	2.4	2.7	2.1	2.4	3.1	3.9	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	7.6	0.0	0.0	1.8	1.8	0.0	3.4	1.3	0.0	5.9	5.5	0.0	2.0	6.0	1.9	0.0	0.0	0.0	12.7	4.9	3.4	0.0	2.5	2.5	5.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.0	16.4	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	4.7	0.0	0.0
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985463	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		17000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (5.47e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (4.46e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.86e-2)"	1022.6	1037.0	771.8	507.3	755.2	920.3	946.7	737.2	1059.6	966.7	807.6	1122.4	821.4	887.6	563.7	1062.3	857.3	501.2	1396.6	740.9	729.1	843.2	1152.9	666.9	685.4	775.4	769.6	1627.6	3194.1	494.0	838.0	386.2	782.3	819.2	344.5	224.7	1276.4	500.3	2322.6	1142.7	798.9	385.4	758.3	721.6	1266.6	490.5	762.7	541.0	793.6	1112.4	499.0	927.8	797.7	745.1	1456.8	1018.4	579.3	1539.4	1515.6	2706.7	830.9	1110.4	1479.8	1036.7	1012.7	1618.1	652.7	3000.6	644.1	1032.3	461.1	1069.8	919.4	1719.4	544.2	755.0	1533.0	768.5	919.9	1677.0	2204.8	1668.0	1277.6	3515.5	1777.2	916.0	1404.1	1497.5	1086.6	1434.4	1526.7	2145.4	642.1	2095.7	1510.1	1266.3	1537.0	518.3	1015.7	1654.2	860.3	1938.3	871.2	1270.2	1575.4	1466.4	699.0	1377.1	2058.3	543.1	1344.7	1992.7	1321.8	738.2	765.7	1521.4	1738.7	2276.4	1644.3	1485.3	1100.4	2065.8	986.6	81.2	455.7	64.1	259.8	333.1	460.2	578.5	453.0	344.6	430.7	478.1	497.2	404.1	43.1	355.3	342.1	358.7	429.4	756.5	771.8	755.2	737.2	1059.6	740.9	729.1	775.4	769.6	782.3	758.3	762.7	745.1	323.1	221.2	392.2	24.5	1125.5	1321.1	1071.3	754.3	1269.7	212.6	981.3	694.3	627.9	597.7	448.3	255.6	77.2	958.1	535.9	556.9	986.1	716.0	799.2	318.2	675.4	568.2	744.2	934.8	23.2	1816.8	1305.0	679.7	619.3	428.5	373.4	596.1	656.8	690.6	610.1	203.6	28.9	982.1	411.0	885.4	859.5	1195.6	1008.4	514.2	645.7	36.5	907.5	429.1	614.8	27.2	42.2	868.2	815.5	832.8	992.8	1010.5	1562.7	1078.8	194.5	134.1	585.1	797.7	697.3	371.5	308.4	1343.0	1347.1	1243.1	727.1	1044.3	1168.4	1051.6
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.6;fallopian tube: 19.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 8.9"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.3	0.4	0.8	0.1	1.0	0.8	0.3	1.7	1.1	1.1	12.6	0.1	0.0	0.3	0.8	0.0	19.7	0.2	0.3	1.4	1.5	0.8	1.2	1.7	0.1	4.9	7.0	1.0	0.6	1.7	3.6	0.1	3.2	3.0	0.0	1.6	0.2	0.2	0.0	0.1	0.3	0.0	3.6	0.4	0.7	6.9	2.4	0.2	1.2	0.0	0.2	0.0	0.1	1.0	0.1	0.7	0.2	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	1.5	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.7	1.1	1.4	1.5	4.9	7.0	3.2	3.6	2.4	1.0	0.2	3.2	1.7	0.3	0.5	0.5	0.1	0.8	0.0	0.4	0.7	0.4	1.3	1.5	1.8	0.0	2.1	0.0	0.3	0.1	0.0	0.2	29.6	31.9	0.7	0.5	0.0	0.0	2.7	0.2	0.1	0.5	3.1	1.9	0.0	0.1	0.0	1.1	0.1	5.0	0.8	0.3	2.0	0.0	0.0	20.1	0.3	0.3	0.0	0.0	0.1	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.9	46.0	5.6	0.0	0.5	0.6	6.8	2.7	0.7	0.3	0.0	0.3	0.3	0.0	0.2
EFCAB6	"dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672"	ENSG00000186976	"EF-hand calcium binding domain 6"	Q5THR3	22	43528744-43812337	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.3"	"Group enriched"	"Detected in many"	8	"Early spermatids: 286.6;Late spermatids: 473.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;RPTEC TERT1: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA003098			Uncertain	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA003098: AB_1079087"	"unprognostic (1.85e-1)"	"unprognostic (8.85e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.96e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.71e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.33e-2)"	0.4	0.8	0.9	0.1	0.9	0.0	1.1	0.0	0.7	1.1	6.8	0.5	0.3	1.2	2.1	0.4	7.7	0.5	0.4	0.9	1.4	1.4	0.4	1.2	0.2	2.2	3.2	1.4	1.2	2.4	2.0	0.2	1.5	0.9	0.2	3.1	0.8	1.1	0.2	0.4	0.2	0.5	1.4	0.1	0.9	24.3	1.4	0.2	3.1	0.2	0.1	0.4	0.4	0.4	0.1	0.3	0.4	0.7	0.6	2.1	0.0	0.5	0.4	0.1	0.2	0.0	0.1	0.0	0.3	0.2	0.8	0.6	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.8	0.5	0.1	0.5	0.1	0.2	0.0	0.0	0.3	1.4	0.0	0.1	0.6	0.4	0.2	0.0	0.0	0.0	1.5	0.3	0.9	0.3	1.4	0.0	0.7	0.3	0.2	0.0	0.1	0.3	0.1	0.5	0.1	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.7	0.9	1.4	2.2	3.2	1.5	1.4	1.4	0.4	0.2	3.2	1.8	18.9	0.5	0.3	0.9	1.0	2.2	3.0	1.2	1.0	1.7	0.0	2.3	0.0	6.2	0.0	0.0	0.4	0.0	0.9	286.6	21.8	1.5	0.4	0.0	0.0	46.0	0.7	0.1	1.3	1.1	1.9	1.3	1.5	0.4	0.4	0.3	6.7	36.8	0.4	2.0	0.3	0.3	473.7	3.1	0.3	0.0	15.9	0.6	1.7	0.0	15.1	10.2	1.0	0.1	1.5	0.2	0.5	0.1	1.1	20.4	12.5	6.6	1.3	0.8	24.1	4.7	0.8	0.1	0.1	0.1	1.4	0.4	0.3
EFHD1	FLJ13612	ENSG00000115468	"EF-hand domain family member D1"	Q9BUP0	2	232606057-232682780	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 414.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 241.8;Breast myoepithelial cells: 129.0;Distal tubular cells: 393.2;Oligodendrocytes: 173.4;Sertoli cells: 197.2;Smooth muscle cells: 130.9;Syncytiotrophoblasts: 263.9"	"Cancer enriched"	"Detected in all"	5	"breast cancer: 100.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 125.8;RPTEC TERT1: 68.6;SK-BR-3: 301.8;T-47d: 236.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049331, HPA056959"	Enhanced		Supported	"Nucleoli fibrillar center,Golgi apparatus"		No	NA		14000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA049331: AB_2680716, HPA056959: AB_2683288"	"unprognostic (9.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.57e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-3)"	86.3	7.0	199.7	3.7	303.2	0.8	180.7	244.9	261.3	86.9	129.9	16.9	4.4	72.4	33.7	9.6	73.7	12.0	46.0	196.6	217.4	186.2	54.6	15.3	3.9	253.6	258.7	76.5	86.5	10.5	16.5	77.9	261.8	25.6	5.7	9.5	22.2	27.7	35.5	30.9	16.2	20.6	201.4	52.5	17.6	20.1	237.8	3.0	32.7	42.7	2.4	22.0	44.5	414.6	0.0	3.4	5.7	1.4	2.2	0.1	125.8	26.8	2.1	2.3	1.9	0.9	0.6	0.1	2.0	11.6	2.9	0.2	19.0	0.0	0.3	0.5	9.2	0.0	2.4	1.9	0.0	0.1	0.3	1.0	0.4	0.2	0.0	0.4	0.0	5.5	3.9	0.5	0.5	2.3	0.6	0.2	8.4	0.0	0.2	0.6	7.2	0.4	68.6	0.7	0.3	3.2	9.1	301.8	18.3	42.3	236.9	2.6	0.0	0.0	1.8	0.4	0.8	0.2	0.1	0.1	0.3	0.1	13.4	1.0	0.2	0.1	0.2	0.1	0.4	0.3	0.3	0.4	0.1	0.1	0.6	0.6	2.2	0.1	0.1	0.2	0.1	0.1	199.7	303.2	244.9	261.3	196.6	217.4	253.6	258.7	261.8	201.4	237.8	414.6	15.6	0.0	0.0	37.5	1.5	3.6	2.8	1.3	1.2	0.5	241.8	129.0	7.4	1.5	4.6	35.0	0.0	112.0	3.0	0.3	393.2	0.0	9.0	1.1	37.8	16.8	0.0	2.7	2.6	0.0	19.7	41.1	0.0	1.7	0.0	3.2	6.4	89.4	8.7	0.0	5.3	0.1	59.0	1.3	3.0	7.0	44.4	2.1	8.8	18.7	0.0	48.0	0.0	1.5	173.4	0.0	0.0	57.2	0.1	4.6	0.0	116.5	1.9	1.4	197.2	8.7	130.9	17.3	13.6	0.4	3.1	263.9	2.5	1.5	0.3	2.0
EFHD2	MGC4342	ENSG00000142634	"EF-hand domain family member D2"	Q96C19	1	15409888-15430339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 372.4;NK-cells: 416.1;Pancreatic endocrine cells: 481.2;Urothelial cells: 431.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 133.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 370.3"	"Low region specificity"	"Detected in all"							HPA048961	Enhanced		Approved	Cytosol		No	No		220000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA048961: AB_2680572"	"unprognostic (1.37e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (9.11e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (6.31e-9)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (2.70e-4)"	"prognostic favorable (3.60e-5)"	37.7	78.9	52.5	77.7	56.8	174.3	27.5	31.6	76.9	32.8	20.4	74.3	83.3	33.7	5.9	58.7	29.3	32.9	28.5	75.4	34.9	23.0	33.3	60.0	46.3	100.2	31.4	26.9	75.7	10.7	28.6	21.4	101.7	44.6	29.6	2.7	27.3	19.0	6.4	35.9	96.4	17.3	29.6	140.0	92.0	95.2	36.1	25.2	41.6	4.9	29.5	62.6	40.5	62.9	370.3	91.8	8.8	23.8	14.1	30.0	46.8	46.0	43.4	42.7	40.5	35.5	98.8	79.6	141.6	32.1	54.8	88.1	24.5	80.9	27.0	99.8	47.8	19.1	21.6	57.4	22.5	98.1	160.1	23.9	27.2	87.0	21.9	19.9	55.5	35.5	46.4	37.6	26.6	36.8	50.8	188.6	11.6	50.1	112.9	67.2	82.1	63.4	25.3	76.2	20.1	15.6	40.5	34.3	76.8	6.9	15.1	104.8	105.4	62.5	66.9	196.7	74.8	25.4	63.8	34.9	87.4	193.2	86.8	16.3	33.8	52.5	44.0	34.4	12.7	3.9	9.8	20.9	29.5	4.2	4.6	18.0	133.2	28.5	30.0	10.3	7.6	17.0	52.5	56.8	31.6	76.9	75.4	34.9	100.2	31.4	101.7	29.6	36.1	62.9	54.2	3.2	12.2	5.9	44.1	66.2	123.7	25.2	26.7	1.8	21.3	23.0	7.2	32.9	24.4	22.0	10.4	23.7	372.4	280.0	19.6	69.6	93.6	55.4	28.8	52.6	61.7	28.0	33.9	259.4	222.8	31.1	157.0	69.4	44.5	49.4	23.6	20.9	219.3	0.0	21.9	160.8	24.4	217.1	188.2	221.2	9.9	246.9	23.2	13.1	171.3	4.9	416.1	0.5	3.7	481.2	190.5	6.8	62.9	112.2	305.8	28.1	25.7	5.0	46.0	26.7	28.5	5.4	5.7	48.9	68.5	53.4	120.1	178.3	117.8	431.4
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1285873-1301431	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.3;liver: 12.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.5;Cardiomyocytes: 4.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 5.0;Paneth cells: 2.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5;stomach cancer: 8.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;CACO-2: 6.2;Hep G2: 13.5;NTERA-2: 6.8;OE19: 6.0;REH: 6.8;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Mitochondria, Cytosol"		"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.0	0.0	1.6	1.5	1.7	0.0	0.0	1.2	1.3	0.1	0.3	9.9	9.9	0.0	0.0	0.4	0.0	3.5	0.0	1.4	2.0	0.4	12.9	0.0	0.0	1.7	3.0	0.0	0.1	0.2	0.3	0.2	1.1	0.0	4.4	0.6	0.0	0.0	0.2	0.1	12.3	0.0	1.9	0.0	0.2	0.6	3.1	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.2	10.3	3.1	0.0	0.0	3.7	0.2	0.0	0.0	0.0	6.2	0.1	0.0	1.8	0.0	0.0	0.0	4.8	0.0	0.0	0.0	1.4	0.0	0.0	13.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.1	6.8	6.0	0.0	6.8	1.0	0.1	0.0	0.4	0.0	13.3	0.7	0.0	0.2	3.5	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.6	1.7	1.2	1.3	1.4	2.0	1.7	3.0	1.1	1.9	3.1	1.4	0.1	0.0	0.0	1.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.0	0.0	2.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.2	0.0
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356403-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol		No	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA001581: AB_2666367, HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	19.3	12.6	39.7	5.5	59.6	0.0	22.7	51.7	45.6	47.3	28.0	24.4	3.1	29.2	9.9	44.1	28.6	8.7	15.0	35.6	39.3	10.0	1.8	12.1	3.6	63.0	57.6	41.9	2.2	22.2	8.4	10.4	54.8	36.8	3.3	10.6	26.2	22.5	3.6	59.0	9.6	12.5	44.8	7.6	11.9	5.4	49.9	3.2	17.5	5.1	4.8	25.3	42.9	76.0	4.7	0.0	73.2	39.5	17.1	20.0	57.7	5.3	11.3	2.0	0.9	0.0	0.0	0.0	0.0	30.3	0.3	27.5	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	11.6	18.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	0.0	0.0	22.6	0.1	0.0	24.1	7.8	66.5	15.1	2.6	0.0	8.7	17.6	0.0	0.0	7.6	0.0	19.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	59.6	51.7	45.6	35.6	39.3	63.0	57.6	54.8	44.8	49.9	76.0	2.0	0.0	6.7	17.0	0.0	11.6	11.6	5.6	9.6	5.0	20.3	16.3	0.7	0.0	4.1	0.0	6.2	9.3	0.2	0.0	1.9	0.1	0.9	0.6	18.9	1.8	0.0	0.0	0.2	0.0	14.7	15.7	0.0	0.7	0.0	4.4	1.8	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.7	0.8	20.2	0.4	7.2	1.9	0.0	9.0	0.0	22.1	48.9	0.0	0.0	13.9	0.1	7.6	0.0	0.3	1.1	9.3	6.6	12.6	8.9	2.2	0.5	22.7	13.4	18.1	0.5	0.3	0.0	7.0
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849948-44899445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		94000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	23.6	30.7	26.7	31.3	27.2	37.4	22.4	24.6	28.0	17.6	27.9	26.5	21.6	19.4	18.8	33.1	25.0	16.3	35.3	28.0	26.3	26.1	26.2	22.6	35.5	25.6	26.1	17.6	24.0	27.9	13.2	28.6	26.4	17.8	28.8	15.5	22.5	18.6	65.8	28.5	22.8	23.5	25.1	29.8	22.5	27.5	27.3	41.0	21.2	38.3	46.5	28.8	20.3	26.6	88.7	173.6	82.8	134.9	61.9	60.9	97.1	68.7	91.4	169.6	146.0	134.6	73.9	152.1	79.0	87.1	130.3	98.6	181.5	120.2	196.2	153.9	150.8	150.9	100.9	144.5	68.2	179.9	107.5	66.5	67.4	157.2	85.0	65.2	149.1	134.8	189.6	57.8	98.0	88.2	182.3	118.6	85.7	206.8	143.1	126.1	168.1	132.0	97.0	97.8	135.7	81.1	67.7	49.5	73.9	120.6	131.6	112.2	91.4	126.5	97.4	77.7	176.3	60.2	81.4	150.0	101.6	98.4	132.0	42.7	84.3	85.9	37.2	81.6	41.7	32.3	32.9	36.1	82.8	31.3	28.8	32.2	13.0	44.2	85.0	35.5	35.2	70.7	26.7	27.2	24.6	28.0	28.0	26.3	25.6	26.1	26.4	25.1	27.3	26.6	11.3	0.0	14.0	11.1	18.1	11.7	12.2	15.1	13.6	14.7	14.1	11.8	21.1	22.8	15.3	18.4	33.3	34.5	14.0	15.6	3.9	29.4	12.5	17.8	17.9	21.4	10.8	24.8	17.5	26.7	30.9	14.0	18.3	18.8	19.7	22.6	21.8	22.4	38.5	26.9	17.2	13.4	16.2	30.1	17.5	6.5	12.8	26.2	5.4	12.2	46.7	12.0	21.6	6.0	15.5	27.7	12.0	9.1	20.3	14.5	15.9	13.2	17.4	18.0	19.7	14.8	14.8	28.2	43.3	16.0	14.6	27.2	16.3	21.4	22.2	12.5
EGR1	"AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225"	ENSG00000120738	"Early growth response 1"	P18146	5	138465479-138469303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 1113.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 133.1"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 7.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.1;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 192.0;hTCEpi: 286.6;U-266/84: 478.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019427, HPA029937, HPA029938"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259"	"unprognostic (5.47e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.74e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	565.5	354.0	7.5	135.4	15.9	176.7	173.9	133.1	70.1	302.5	10.0	246.5	54.8	197.6	13.5	370.9	911.7	345.2	258.8	20.7	30.4	173.2	149.5	173.4	145.2	9.9	13.2	974.6	137.0	93.5	243.3	54.2	12.9	309.7	161.1	56.0	140.9	84.4	66.0	363.1	107.2	474.3	4.4	77.5	254.5	26.9	10.4	301.5	584.4	354.9	19.1	191.4	115.9	19.5	21.8	0.9	45.0	67.6	119.6	192.0	5.1	36.7	22.7	48.4	39.0	26.4	18.9	1.1	5.9	80.2	165.8	10.1	2.6	74.5	22.2	1.1	3.3	3.0	11.5	7.6	15.5	8.0	57.8	15.2	286.6	43.2	9.8	37.6	4.2	53.9	112.5	26.0	14.3	108.2	3.2	34.1	4.1	80.3	0.1	0.8	6.7	4.1	36.8	13.1	56.5	6.4	44.7	120.1	106.6	43.3	1.5	6.6	1.8	17.5	22.6	8.7	14.2	60.1	478.8	8.6	20.3	103.5	5.2	0.0	2.6	0.3	0.1	3.6	0.0	0.7	0.1	0.0	0.7	0.2	0.1	0.1	7.1	0.1	1.2	0.0	0.2	0.5	7.5	15.9	133.1	70.1	20.7	30.4	9.9	13.2	12.9	4.4	10.4	19.5	920.4	275.7	485.6	6.8	116.4	181.8	719.6	207.4	816.1	43.5	550.0	459.0	652.4	420.4	124.0	29.5	64.6	159.5	46.2	645.2	7.9	255.4	1.4	356.0	836.5	383.1	960.5	27.3	20.3	101.7	110.1	989.9	736.0	645.4	354.0	274.8	347.0	183.1	131.4	3.3	2.7	747.6	93.6	218.6	109.7	3.8	164.7	300.7	106.7	20.6	8.6	191.6	0.0	1.5	2.4	135.3	380.8	53.0	67.2	405.1	224.8	5.7	127.4	101.3	223.5	1113.1	613.2	3.2	2.9	644.8	200.3	129.7	83.4	104.9	480.2	145.4
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34663288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 287.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"myeloid DC: 1.7"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.9	1.1	0.9	14.7	1.7	0.2	199.5	0.9	0.6	120.8	1.3	99.3	42.2	13.9	95.0	200.7	129.6	32.2	0.3	1.1	0.8	25.7	1.3	23.4	1.5	2.6	4.0	0.2	41.1	18.5	0.7	0.1	2.8	82.7	126.3	0.8	287.7	153.4	0.2	53.6	34.1	3.5	2.5	1.2	59.5	0.7	1.3	1.3	2.5	0.0	67.3	50.7	79.2	4.7	46.5	26.8	0.0	0.3	0.0	0.0	0.8	0.0	3.9	0.0	0.2	0.4	138.4	0.1	17.1	0.0	0.2	95.7	0.0	107.6	0.5	0.1	0.2	0.0	1.5	0.2	0.0	0.2	0.0	0.0	41.7	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.8	0.2	132.9	1.0	0.0	0.1	1.0	20.2	214.8	0.0	0.2	0.5	14.8	0.2	0.0	213.5	0.5	0.0	0.2	1.2	5.1	0.4	0.5	0.2	0.3	0.3	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.9	0.6	1.1	0.8	2.6	4.0	2.8	2.5	1.3	4.7	0.8	48.1	97.2	1.3	0.6	109.6	400.8	271.6	133.1	0.0	123.0	51.9	0.9	60.1	323.3	55.2	0.0	0.1	1.1	62.7	15.6	77.8	14.2	229.6	17.7	4.0	23.3	0.0	0.7	86.5	0.0	3.2	53.5	281.8	1.3	0.0	0.0	0.4	0.1	0.0	0.0	82.8	116.0	0.0	17.7	1.0	0.0	5.1	12.4	0.0	5.6	3.8	0.0	0.0	2.4	104.8	30.2	0.0	1.2	173.1	14.1	0.3	204.6	0.0	0.0	0.0	9.6	0.4	0.1	251.1	170.1	1.4	4.9	0.0	74.5	397.3
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618992-137870016	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 167.0;Plasma cells: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	17.7	18.3	11.0	22.3	12.0	30.5	18.2	16.0	12.3	17.0	13.8	19.3	18.8	21.5	9.7	19.1	18.1	14.0	13.5	8.6	8.3	11.0	14.4	15.8	29.6	10.7	10.2	19.9	14.9	13.8	12.9	15.0	11.1	16.2	13.1	13.7	18.4	13.9	31.4	19.3	19.6	15.1	4.4	25.9	18.2	40.5	12.7	22.9	19.6	15.0	21.2	18.3	16.2	19.9	26.7	52.3	57.4	53.2	23.9	24.6	48.1	34.5	21.4	24.7	20.2	34.7	32.5	81.6	32.7	26.0	29.9	56.2	34.8	37.8	19.2	45.3	24.7	34.4	54.2	22.4	20.9	52.9	39.5	22.6	25.9	29.9	28.9	18.1	41.3	30.1	52.6	27.5	17.9	61.9	62.5	26.3	56.0	42.1	34.8	79.3	49.5	47.2	20.7	47.7	50.6	41.1	65.4	45.4	15.3	40.6	51.1	42.0	39.0	28.9	29.5	44.8	33.2	17.2	52.0	67.0	21.3	27.6	32.0	19.5	16.2	21.2	18.0	14.3	11.3	16.4	15.6	15.6	12.9	23.0	14.9	13.5	28.8	17.3	15.6	23.3	14.2	9.7	11.0	12.0	16.0	12.3	8.6	8.3	10.7	10.2	11.1	4.4	12.7	19.9	34.3	19.2	19.2	130.6	64.9	17.5	23.4	26.9	32.5	39.7	30.5	26.7	31.5	25.8	24.7	22.0	52.1	23.8	36.9	24.4	3.9	24.1	86.8	29.3	44.8	29.9	28.1	31.7	74.4	21.0	21.8	27.6	45.3	40.6	18.9	55.8	18.9	41.7	19.7	50.5	76.4	22.2	10.2	25.8	18.1	167.0	35.8	26.9	12.4	71.2	31.2	19.7	51.5	64.3	104.0	25.4	30.3	37.6	170.6	34.9	20.7	14.3	22.6	46.8	13.1	34.7	28.5	80.4	51.9	35.3	20.2	26.5	38.9	81.3	23.8	28.8
EIF1AD	"haponin, MGC11102"	ENSG00000175376	"Eukaryotic translation initiation factor 1A domain containing"	Q8N9N8	11	65996545-66002176	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054991, HPA058735"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"	Cytosol	"HPA054991: AB_2682664, HPA058735: AB_2683802"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (1.30e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.96e-1)"	15.7	17.7	15.3	19.9	15.8	44.6	16.0	18.7	19.8	13.1	14.4	15.8	15.1	15.9	16.2	21.0	15.3	13.0	17.1	16.4	17.7	15.2	17.3	15.0	23.4	16.1	15.7	20.4	19.2	17.1	16.6	21.1	16.3	13.4	14.7	16.6	16.8	14.9	27.2	23.1	16.9	14.8	14.8	20.0	16.1	19.4	17.3	19.9	13.8	23.3	27.6	17.1	14.5	18.4	51.0	43.9	35.0	35.9	27.6	28.8	32.8	36.4	34.6	44.2	37.7	44.8	47.5	38.2	62.6	41.2	38.0	34.9	42.2	48.8	41.5	35.1	21.7	54.4	52.0	46.4	33.7	50.3	41.8	24.1	41.9	65.3	44.1	31.2	31.0	40.9	81.1	54.4	64.7	68.7	46.6	55.1	25.9	23.3	47.5	50.3	35.9	75.0	25.6	31.8	26.5	31.2	39.3	54.7	41.5	28.1	53.1	31.0	36.5	59.7	39.9	47.8	36.1	66.7	85.5	79.8	42.9	33.8	39.5	52.6	20.5	13.5	17.7	16.6	13.6	19.4	15.0	13.0	21.3	19.0	14.1	13.5	13.1	16.4	21.3	12.7	15.3	13.3	15.3	15.8	18.7	19.8	16.4	17.7	16.1	15.7	16.3	14.8	17.3	18.4	8.2	3.2	5.4	3.3	16.2	37.7	12.2	13.4	12.5	7.2	14.2	9.1	16.2	14.3	7.3	5.5	14.6	16.3	17.7	11.6	15.6	12.7	18.3	9.0	8.3	11.6	2.4	21.0	3.0	13.1	23.0	11.4	7.1	10.5	12.7	31.7	16.4	16.5	24.5	11.8	2.8	11.2	6.1	10.4	29.5	14.3	12.2	14.4	12.4	1.0	17.6	10.5	17.5	5.5	4.5	29.0	15.2	5.7	22.6	13.2	13.8	15.7	10.6	18.5	6.6	9.8	27.0	31.3	23.2	15.7	48.9	25.3	16.2	7.4	10.9	13.2
EIF2A	EIF-2A	ENSG00000144895	"Eukaryotic translation initiation factor 2A"	Q9BY44	3	150546678-150586016	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036256	Approved		Uncertain	Mitochondria,Cytosol		No	No		16000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria	Cytosol	"HPA036256: AB_10611961"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.05e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (6.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-1)"	57.0	54.0	14.5	47.8	18.5	86.8	103.4	27.2	25.4	63.9	21.9	57.8	65.5	69.7	46.9	64.7	62.7	55.8	72.3	16.6	18.4	72.2	75.2	47.7	68.4	17.1	15.3	94.9	107.2	62.8	32.8	52.4	18.5	52.8	70.8	52.3	77.2	47.0	87.3	74.0	55.3	68.4	18.1	47.4	59.7	24.3	15.1	68.7	92.1	76.7	83.4	67.5	43.4	22.8	158.0	69.4	76.6	79.9	100.8	234.3	105.0	97.3	158.0	134.1	143.0	202.5	168.9	212.0	142.4	134.3	160.1	125.1	149.9	152.9	193.5	81.3	91.6	129.4	76.1	130.9	101.1	155.0	113.0	151.4	153.6	97.2	221.9	200.7	180.3	112.3	109.8	116.5	105.5	121.3	109.6	70.6	108.4	161.3	98.7	97.5	101.1	238.8	119.9	116.9	93.7	102.1	62.6	88.0	144.5	91.6	130.9	127.3	99.9	76.3	69.3	109.2	186.6	194.9	119.6	195.0	96.4	130.5	39.5	23.6	47.2	10.4	27.9	49.5	46.1	36.2	40.6	35.7	54.2	34.7	51.5	41.6	3.7	46.1	56.9	26.5	37.0	44.4	14.5	18.5	27.2	25.4	16.6	18.4	17.1	15.3	18.5	18.1	15.1	22.8	77.7	35.3	67.1	14.4	91.4	140.1	157.3	109.8	109.3	30.6	86.0	76.5	102.4	58.6	69.2	35.0	27.1	84.1	85.7	43.1	137.0	76.1	21.5	39.6	64.3	67.5	56.8	80.3	30.4	108.3	113.6	63.8	64.7	51.4	75.5	45.0	60.0	30.6	62.4	23.5	33.1	81.7	54.9	96.4	82.8	6.6	61.5	72.7	69.4	19.7	97.4	37.2	73.2	32.6	34.7	64.0	57.7	56.4	112.1	79.6	77.0	138.4	41.7	31.2	78.9	95.4	77.9	40.4	41.9	102.3	122.9	120.3	95.0	55.1	99.0	130.4
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	"Eukaryotic translation initiation factor 2 alpha kinase 4"	Q9P2K8	15	39934115-40035591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 66.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011811	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA011811: AB_2668543"	"unprognostic (3.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.97e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.11e-3)"	20.1	14.6	21.5	12.2	22.4	18.7	17.6	27.2	23.7	14.6	16.8	15.5	11.3	30.5	15.4	16.0	16.1	17.0	17.7	21.2	22.0	13.4	21.3	16.9	16.9	20.3	20.2	17.1	14.1	17.7	24.1	19.0	20.5	19.8	12.9	13.1	13.9	11.5	18.9	19.0	11.3	15.6	18.9	15.7	15.2	8.9	22.1	13.1	21.8	11.0	11.6	17.2	12.4	28.9	37.1	17.5	30.3	46.3	49.0	81.7	28.9	51.0	58.1	40.8	40.0	25.2	15.6	19.6	25.9	69.3	54.7	38.6	41.1	61.4	56.6	92.8	20.4	41.6	30.8	30.7	42.1	25.6	27.8	65.3	41.2	39.0	69.8	57.3	58.0	40.5	31.3	18.1	81.7	12.3	21.7	34.6	18.8	32.8	38.2	25.4	42.2	33.1	51.4	24.7	16.1	24.4	36.4	22.2	32.3	29.5	30.7	43.4	61.6	54.3	40.9	27.3	33.6	24.6	47.8	6.0	38.1	34.4	77.4	11.6	10.8	8.6	6.8	14.1	5.7	7.1	7.6	7.9	17.6	9.2	8.3	8.2	3.3	8.5	20.5	66.5	5.8	4.9	21.5	22.4	27.2	23.7	21.2	22.0	20.3	20.2	20.5	18.9	22.1	28.9	47.9	16.0	31.1	28.7	29.3	12.0	27.5	17.8	43.3	29.9	45.0	45.2	32.3	32.9	21.4	16.5	12.5	37.5	32.2	21.1	13.7	23.7	1.5	19.3	52.7	35.3	14.4	37.4	42.7	25.4	34.8	36.5	23.4	27.0	24.1	35.0	22.9	27.8	30.7	28.6	53.9	25.9	12.2	33.7	55.4	4.3	42.3	52.1	32.0	29.0	41.1	30.4	16.5	30.2	26.3	47.6	16.2	39.9	115.6	30.7	6.4	18.2	12.9	23.9	46.0	43.6	35.6	8.6	29.8	47.0	14.5	15.2	18.2	64.0	29.6	18.4
EIF3A	"EIF3, eIF3-p170, eIF3-theta, EIF3S10, KIAA0139, TIF32"	ENSG00000107581	"Eukaryotic translation initiation factor 3 subunit A"	Q14152	10	119033670-119080823	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038315, HPA038316"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA038315: AB_10672588, HPA038316: AB_10673168"	"unprognostic (8.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.07e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.89e-2)"	83.0	53.2	27.5	73.7	30.9	120.7	62.5	28.4	31.8	48.8	38.0	62.9	65.8	60.1	34.9	69.3	44.8	50.1	69.0	25.7	33.7	58.1	77.9	49.5	75.1	34.8	30.0	61.7	155.1	70.2	24.4	57.0	35.4	55.5	63.9	31.6	73.3	46.3	178.2	69.9	60.0	62.8	31.6	57.4	72.8	44.8	32.4	78.3	70.3	89.8	74.6	76.4	51.8	32.4	258.5	190.9	154.0	211.6	163.6	235.0	119.4	228.9	235.9	144.0	143.7	181.2	165.5	300.2	83.2	190.3	113.3	252.0	202.5	175.7	203.5	166.1	166.3	258.3	143.6	203.2	186.2	382.3	183.9	204.6	193.0	212.7	362.8	240.7	165.7	119.8	269.7	191.9	188.7	152.5	159.4	179.8	147.8	99.4	96.3	162.1	332.1	143.7	137.0	213.9	71.6	151.3	180.2	166.9	244.9	132.0	107.2	241.1	245.6	138.7	128.0	147.1	335.8	164.9	194.0	286.9	147.2	368.2	97.6	49.0	38.2	23.9	27.4	41.8	31.7	25.6	33.1	25.2	36.1	24.7	22.6	24.7	10.0	26.6	58.1	20.5	50.9	28.3	27.5	30.9	28.4	31.8	25.7	33.7	34.8	30.0	35.4	31.6	32.4	32.4	122.1	233.9	323.8	24.5	147.3	304.2	279.1	129.0	203.7	60.1	155.8	133.7	320.7	111.5	198.5	64.4	62.6	169.1	181.1	130.2	27.4	157.2	199.4	230.3	248.6	145.3	141.2	270.0	32.7	185.4	159.5	152.5	159.0	371.8	145.4	132.6	74.3	184.5	126.3	43.7	34.9	168.2	87.5	200.3	169.0	119.1	108.7	196.5	147.7	29.0	235.9	78.2	135.9	24.6	38.9	192.8	105.4	117.8	258.6	253.6	98.5	58.7	158.3	54.1	59.2	209.7	221.6	158.0	112.9	255.3	363.8	252.3	171.1	145.0	227.7	302.3
EIF3I	"eIF3-beta, eIF3-p36, EIF3S2, TRIP-1"	ENSG00000084623	"Eukaryotic translation initiation factor 3 subunit I"	Q13347	1	32221077-32245397	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA029939, HPA029940"	Enhanced		Approved	Cytosol		NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA029939: AB_10611109, HPA029940: AB_10600878"	"unprognostic (4.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.82e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (9.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (4.81e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.47e-2)"	123.4	146.6	69.2	109.3	70.2	103.5	164.5	76.9	87.3	126.4	78.7	137.2	96.4	104.4	162.3	154.7	141.7	93.7	127.0	68.6	71.8	123.8	152.8	99.6	134.0	72.8	71.2	154.1	134.8	141.9	78.3	116.2	73.3	113.2	163.5	52.5	127.2	120.4	247.3	119.8	91.0	144.9	72.7	84.7	118.8	48.9	73.6	164.5	131.8	220.5	187.1	158.0	107.1	79.0	404.3	293.3	207.4	463.5	326.9	427.2	209.3	301.3	514.2	517.2	401.5	317.1	418.3	533.0	320.7	514.0	315.9	265.9	498.6	549.9	667.0	234.4	348.1	288.9	245.8	362.7	352.5	559.1	295.4	413.1	471.2	528.0	569.5	363.4	478.8	363.8	699.1	223.4	502.4	276.3	469.3	370.2	624.2	445.4	339.4	344.1	356.3	509.0	515.9	300.9	325.6	343.4	276.6	351.7	562.1	366.6	282.9	270.7	286.4	333.2	360.3	523.8	653.5	377.7	495.7	487.4	365.2	419.6	440.2	113.8	196.6	93.7	164.4	206.7	180.4	182.1	171.8	160.5	235.8	164.9	148.4	140.5	15.2	183.0	162.0	177.0	219.6	299.8	69.2	70.2	76.9	87.3	68.6	71.8	72.8	71.2	73.3	72.7	73.6	79.0	136.9	51.3	76.7	6.8	114.5	136.6	227.6	275.6	84.8	38.0	123.6	114.7	41.9	87.2	136.4	51.5	10.4	300.8	118.2	90.1	133.1	295.4	60.8	79.2	114.2	163.5	138.6	69.0	6.8	272.8	341.4	125.6	71.9	85.1	115.3	120.3	89.6	77.1	224.1	13.5	8.2	184.0	148.5	108.1	131.5	29.5	172.4	108.8	144.1	5.6	190.8	69.9	112.3	7.1	10.7	284.4	115.6	139.2	107.5	173.9	125.9	216.2	99.2	41.8	92.1	108.0	338.3	76.5	76.6	121.8	141.4	342.3	115.1	192.3	213.5	219.9
EIF3K	"ARG134, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001"	ENSG00000178982	"Eukaryotic translation initiation factor 3 subunit K"	Q9UBQ5	19	38619082-38636955	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045446, HPA054590"	Uncertain		Supported	Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA045446: AB_10962716, HPA054590: AB_2682534"	"unprognostic (7.07e-3)"	"prognostic favorable (1.31e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.69e-2)"	233.4	177.9	98.8	83.6	100.4	172.7	228.3	104.9	114.2	214.3	113.1	285.5	142.0	186.6	110.2	286.1	188.4	73.2	591.7	98.9	100.9	313.3	189.0	169.3	142.0	103.2	101.7	214.8	262.2	179.6	173.0	72.0	101.0	172.1	165.7	57.9	197.5	100.4	682.7	290.7	219.1	113.7	102.1	222.5	265.7	66.5	103.7	143.7	168.6	462.4	182.1	218.4	216.6	105.3	135.3	421.3	110.1	175.4	196.5	197.7	134.3	104.2	180.7	220.9	192.5	272.0	118.6	300.2	121.2	174.2	128.7	122.4	221.2	280.8	165.1	145.7	184.6	214.0	134.4	197.2	201.0	345.1	170.7	219.6	252.3	151.4	269.6	118.8	242.3	156.6	217.9	250.8	188.8	215.2	185.3	158.6	103.5	474.4	211.4	222.7	197.0	235.7	225.3	311.0	141.5	139.4	114.8	377.1	174.0	117.3	145.9	260.3	133.9	135.0	134.8	81.3	185.9	246.4	276.3	255.6	114.9	321.6	155.0	154.8	267.8	138.2	182.8	297.8	232.1	252.0	222.3	213.2	359.0	218.0	228.9	204.0	72.4	201.2	305.7	209.4	296.4	441.8	98.8	100.4	104.9	114.2	98.9	100.9	103.2	101.7	101.0	102.1	103.7	105.3	372.1	93.0	166.1	26.4	430.3	395.6	547.4	674.4	345.4	83.6	477.2	755.1	502.5	320.3	331.0	217.0	66.7	422.9	376.3	466.2	1097.6	345.5	160.6	182.0	231.8	309.3	326.1	284.2	23.8	453.2	484.8	267.7	231.9	180.6	248.2	239.0	311.7	278.6	660.9	23.5	25.0	567.7	305.2	640.7	552.1	274.4	265.3	470.7	466.0	10.3	572.6	276.9	415.1	14.6	24.7	330.2	487.2	199.7	386.6	461.9	874.5	974.2	198.3	174.9	203.8	331.4	450.3	109.0	83.4	594.2	457.0	454.1	424.0	319.1	719.5	622.7
EIF3M	"FLJ29030, GA17, hfl-B5, PCID1, TANGO7"	ENSG00000149100	"Eukaryotic translation initiation factor 3 subunit M"	Q7L2H7	11	32583798-32606264	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031063	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA031063: AB_10602128"	"unprognostic (4.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.28e-9)"	"unprognostic (5.79e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.42e-2)"	96.9	105.0	49.5	72.4	53.0	141.4	135.1	51.9	71.6	89.6	51.1	80.6	77.1	96.5	106.6	95.0	146.4	70.8	86.1	52.0	56.1	112.7	108.4	60.1	122.7	52.3	49.5	162.9	131.6	64.7	49.4	79.8	51.5	71.3	98.4	43.3	78.6	82.3	103.1	102.5	60.2	98.3	52.7	71.1	88.0	74.3	51.7	131.2	107.6	82.4	146.6	113.6	79.5	55.9	173.6	219.0	171.0	218.8	222.7	318.2	251.5	176.1	242.7	264.5	255.6	284.5	124.1	445.6	118.1	201.6	226.7	214.1	301.1	319.4	328.2	151.4	372.3	201.2	164.5	303.4	322.1	473.9	276.4	287.4	355.1	178.8	434.6	221.5	301.3	234.6	403.8	151.2	293.8	204.1	238.3	494.4	188.4	230.8	334.2	192.0	430.7	209.9	291.4	321.4	131.3	203.0	125.2	233.5	279.9	187.0	259.3	279.6	142.1	164.6	188.0	353.0	540.2	183.5	248.8	324.0	148.2	284.3	166.1	71.9	211.7	65.7	99.7	189.3	137.6	144.9	136.9	127.3	258.4	117.9	141.1	129.9	24.8	142.3	142.8	154.8	156.5	186.0	49.5	53.0	51.9	71.6	52.0	56.1	52.3	49.5	51.5	52.7	51.7	55.9	82.7	83.3	66.4	19.2	147.5	212.9	256.2	372.8	189.0	44.7	112.9	132.3	41.1	81.5	168.0	60.7	20.9	261.8	127.8	47.1	131.0	187.3	154.9	76.4	168.8	106.3	72.4	148.5	23.8	250.7	284.0	121.9	103.0	104.3	158.4	123.6	98.6	73.3	197.1	10.1	23.5	132.3	156.6	250.6	209.6	55.2	133.9	153.6	110.3	12.2	283.6	70.0	131.8	20.1	21.6	171.8	87.4	120.4	132.4	212.0	86.3	220.6	87.6	42.5	72.3	140.1	254.9	109.4	72.6	159.5	225.0	243.0	154.1	228.3	169.9	252.9
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
EIF4EBP1	"4E-BP1, PHAS-I"	ENSG00000187840	"Eukaryotic translation initiation factor 4E binding protein 1"	Q13541	8	38030534-38060365	"Cancer-related genes, Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 188.9;salivary gland: 164.2"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 730.0;Pancreatic endocrine cells: 277.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005032, CAB005039, HPA023501"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		44000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095"	"unprognostic (1.55e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.18e-3)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.72e-3)"	60.9	12.6	7.7	16.9	8.0	35.0	53.6	8.0	10.9	24.9	12.7	25.3	18.5	19.7	2.2	86.0	21.7	8.9	32.7	8.0	9.8	19.5	63.5	25.0	10.3	9.8	8.5	22.2	188.9	7.8	9.2	28.6	9.8	19.2	15.4	1.5	164.2	17.0	98.1	20.8	23.1	14.4	8.5	23.9	43.8	5.5	10.1	9.6	9.6	27.2	10.4	33.6	26.5	10.8	146.9	113.2	32.4	193.2	41.3	32.3	77.0	130.5	111.9	128.4	203.5	74.8	56.3	46.3	101.5	121.3	77.1	85.1	109.1	197.5	74.8	36.0	190.9	269.6	52.0	104.9	423.6	98.8	60.4	100.0	314.9	142.0	264.1	40.1	208.2	57.7	152.7	221.8	54.8	141.7	95.9	297.8	186.0	112.9	243.7	80.3	80.4	197.4	49.3	22.3	281.6	200.8	26.1	78.8	534.8	20.3	105.8	192.2	105.2	76.1	167.1	179.9	137.8	185.1	121.6	72.1	173.4	213.4	169.1	51.1	416.3	258.3	27.9	336.6	27.3	130.7	32.8	30.9	335.0	103.3	26.2	26.0	39.4	35.0	268.3	242.6	66.0	258.3	7.7	8.0	8.0	10.9	8.0	9.8	9.8	8.5	9.8	8.5	10.1	10.8	23.6	9.6	8.3	1.6	25.2	74.4	42.4	114.8	51.8	3.6	84.8	72.8	41.7	57.2	97.3	20.2	2.1	41.3	27.3	70.1	29.4	226.1	17.0	11.6	39.0	54.6	40.2	79.9	0.8	730.0	224.2	68.6	35.7	12.5	18.4	76.0	65.3	103.4	223.4	0.0	1.3	138.2	79.3	108.6	82.2	106.2	43.5	83.9	72.9	1.9	101.9	19.2	21.6	4.0	0.4	277.9	64.5	19.2	38.7	100.2	19.5	103.1	33.5	2.2	13.1	17.6	85.2	1.9	25.5	209.3	85.4	38.6	19.8	69.3	83.8	58.9
ELAVL1	"Hua, HUR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958573-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 227.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		230000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: AB_2679618"	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	27.5	27.7	14.5	33.1	15.6	27.8	25.0	16.0	15.7	29.4	19.5	27.9	25.2	31.6	25.9	30.0	34.3	22.4	34.0	15.3	15.9	24.8	29.0	24.2	40.2	13.7	15.6	31.8	28.4	37.5	21.4	32.7	13.8	26.9	27.2	19.0	29.6	29.4	37.7	24.9	25.1	35.9	16.2	30.1	24.6	46.1	15.1	52.7	27.9	32.2	44.1	37.4	25.2	16.6	127.5	84.1	137.9	104.5	52.9	52.7	76.5	89.5	78.4	136.9	106.3	122.4	73.2	153.2	125.5	104.0	76.9	86.0	155.2	107.9	114.8	134.9	131.8	135.5	58.9	115.7	77.4	129.9	103.1	65.8	63.6	95.7	57.7	64.8	106.2	115.6	140.7	112.6	95.7	95.8	215.3	103.7	122.1	96.4	101.6	239.0	89.6	100.9	87.5	93.9	98.0	70.8	88.9	89.1	71.7	82.6	101.8	101.4	79.7	127.3	87.3	119.2	161.8	109.8	114.7	161.9	71.3	154.2	112.2	29.9	19.7	37.2	16.4	17.2	17.0	20.8	24.0	26.3	25.0	27.7	21.8	16.6	5.3	33.1	22.1	12.5	20.9	16.3	14.5	15.6	16.0	15.7	15.3	15.9	13.7	15.6	13.8	16.2	15.1	16.6	45.7	25.6	23.1	18.6	56.0	72.4	79.5	29.0	51.2	47.2	54.9	37.2	31.3	30.0	20.7	47.8	56.3	86.8	48.1	32.9	66.5	37.1	227.7	41.6	46.5	52.2	42.0	95.7	20.3	33.8	102.3	53.1	40.2	47.2	21.0	59.5	47.2	89.2	64.2	60.6	21.5	52.9	18.3	57.5	79.2	164.1	50.4	47.3	51.6	23.4	43.9	43.4	57.7	33.7	26.9	35.3	45.7	56.8	88.7	98.2	38.3	65.8	27.3	55.7	52.6	45.5	71.0	164.7	61.2	72.0	71.0	74.8	50.9	44.7	60.2	84.6
ELF3	"EPR-1, ERT, ESE-1, ESX"	ENSG00000163435	"E74 like ETS transcription factor 3"	P78545	1	202007945-202017183	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Inflammatory response, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1599.6;Gastric mucus-secreting cells: 1390.9;Paneth cells: 1506.1;Proximal enterocytes: 1476.3;Urothelial cells: 1628.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 209.6;CAPAN-2: 296.0;OE19: 196.3;RT4: 215.3;SK-BR-3: 405.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003316, HPA003479"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA003316: AB_1078757, HPA003479: AB_1078756"	"unprognostic (9.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.05e-3)"	"unprognostic (7.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (9.92e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-3)"	1.6	0.2	0.2	12.7	0.1	0.8	79.2	0.8	0.4	55.3	0.1	161.3	142.9	12.9	4.5	237.0	35.5	77.6	5.0	0.1	0.2	66.7	79.2	59.8	0.3	0.0	0.0	1.2	120.7	8.4	3.9	6.1	0.1	58.7	127.5	1.0	147.1	14.8	0.2	14.5	145.6	7.3	0.0	0.5	122.7	0.2	0.1	1.6	6.6	0.0	16.0	165.2	93.6	0.2	56.1	209.6	0.0	0.4	0.0	0.0	63.5	0.0	7.9	0.0	0.1	47.3	296.0	0.3	24.0	0.0	1.7	53.8	0.0	0.2	0.0	6.7	0.2	0.0	38.3	9.2	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.7	0.3	0.7	3.3	196.3	17.6	0.1	0.1	3.0	78.3	215.3	0.3	0.4	2.4	405.7	0.2	9.2	28.8	0.0	0.1	0.0	0.7	0.4	0.5	1.2	3.9	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.4	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	2.7	294.9	422.9	0.0	12.2	5.1	691.3	879.7	113.8	1.5	470.3	180.3	1.5	586.2	1130.0	329.2	18.8	76.6	9.5	1599.6	41.1	792.7	0.0	812.3	90.8	16.4	452.2	2.7	0.4	641.0	122.2	15.9	1390.9	1127.5	40.6	0.2	0.4	38.6	9.3	0.0	0.2	1225.3	1102.7	2.5	2.7	0.0	0.0	18.6	8.8	0.0	15.4	2.6	1.0	0.5	0.1	512.5	1506.1	0.0	6.0	1014.2	1476.3	147.1	888.2	67.3	0.0	0.8	46.3	0.0	0.3	418.5	8.4	257.2	18.7	0.3	983.0	1628.9
ELK1		ENSG00000126767	"ETS transcription factor ELK1"	P19419	X	47635521-47650604	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 251.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003808, HPA036084, HPA064381"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250"	"unprognostic (2.25e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.67e-2)"	16.8	30.7	71.7	12.4	53.1	13.7	12.0	37.1	62.5	15.0	19.9	12.8	9.0	17.0	17.4	15.0	18.6	10.1	19.3	58.5	32.8	12.6	26.4	16.2	12.3	26.7	26.2	54.2	12.9	17.0	12.7	9.2	27.5	15.4	9.6	7.7	13.1	11.2	32.9	15.2	12.9	10.9	23.4	18.9	13.6	21.2	52.2	12.9	10.5	18.5	12.3	14.8	11.9	40.6	35.6	27.2	14.3	39.1	23.3	26.5	19.8	31.1	34.9	34.8	34.5	19.3	26.4	29.0	16.1	31.0	59.9	21.2	37.6	31.7	31.5	31.1	34.8	23.4	25.0	17.9	49.3	26.3	39.4	27.9	27.2	53.4	33.5	28.8	20.8	40.4	47.9	32.9	27.8	46.5	28.2	30.8	33.7	16.7	59.1	30.0	36.0	45.8	19.7	15.3	31.0	25.6	48.5	17.8	43.4	31.8	44.7	16.7	16.1	39.5	41.2	53.9	29.2	53.5	83.2	27.8	44.5	45.3	25.0	1.7	6.3	2.8	5.3	7.2	6.4	5.2	6.8	6.3	9.5	4.6	5.7	5.0	3.1	3.4	6.5	6.5	9.8	5.6	71.7	53.1	37.1	62.5	58.5	32.8	26.7	26.2	27.5	23.4	52.2	40.6	10.1	0.0	6.7	4.2	12.0	16.8	14.3	7.5	15.9	15.2	15.0	10.4	9.0	5.7	5.3	7.3	4.2	7.7	6.3	7.5	5.9	7.6	4.0	8.0	13.3	9.8	10.2	14.9	7.7	7.3	9.6	18.0	6.6	9.2	8.2	251.8	20.3	14.6	10.3	5.0	5.7	7.8	4.1	9.5	19.0	3.3	14.0	15.0	7.2	2.8	16.8	9.0	6.2	5.0	2.9	7.1	5.6	29.7	10.3	12.8	4.6	6.3	2.1	7.2	6.6	18.7	20.0	2.6	11.1	12.3	15.9	8.9	11.1	48.8	10.0	11.8
ELL2	MRCCAT1	ENSG00000118985	"Elongation factor for RNA polymerase II 2"	O00472	5	95885098-95961851	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 382.9;Plasma cells: 430.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 322.3;HDLM-2: 291.4;U-266/84: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013569			Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA013569: AB_2668853"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.31e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-2)"	49.0	19.5	13.5	28.6	32.3	48.3	37.3	22.9	26.8	24.0	6.8	13.5	14.5	9.1	5.7	61.2	16.0	35.6	39.9	18.4	32.0	16.5	86.8	35.8	14.6	51.1	28.5	24.8	94.3	15.6	25.1	25.3	33.7	39.1	13.1	3.7	96.5	23.0	33.5	58.9	14.5	11.4	21.3	18.0	44.3	15.2	41.4	8.1	17.1	10.7	21.8	33.2	35.7	55.8	31.7	12.3	3.8	0.5	45.0	56.1	4.6	322.3	56.2	105.4	89.7	23.7	7.2	1.4	6.7	173.7	24.6	40.0	10.0	103.5	129.3	291.4	7.6	20.5	53.5	52.3	29.0	4.5	33.3	55.1	70.1	64.0	191.4	63.2	17.0	3.8	11.5	120.3	100.6	3.3	0.1	5.6	4.9	5.0	16.8	3.1	19.2	25.3	20.3	30.0	6.4	2.1	118.6	6.2	7.3	15.1	3.6	3.7	35.5	137.6	27.4	32.0	59.4	84.0	216.0	1.5	71.9	2.1	9.4	7.0	0.8	5.7	0.6	1.0	1.0	3.5	0.8	0.9	0.4	1.7	0.6	0.5	1.8	1.6	0.8	0.3	1.1	0.6	13.5	32.3	22.9	26.8	18.4	32.0	51.1	28.5	33.7	21.3	41.4	55.8	30.9	28.9	94.9	28.1	93.2	183.2	137.3	47.1	134.9	0.6	56.0	37.6	31.6	14.3	61.5	18.4	0.0	2.0	98.6	19.4	5.9	24.6	2.5	46.2	32.4	33.4	107.8	25.7	138.6	91.9	14.8	64.4	85.6	88.6	172.4	11.2	18.5	141.1	36.7	0.0	87.5	18.1	12.2	64.4	52.0	4.3	7.8	126.5	46.2	83.4	25.3	1.2	2.1	49.8	382.9	70.8	14.7	7.2	430.1	134.7	12.7	15.8	35.2	0.5	13.1	213.2	76.8	17.2	9.2	185.8	171.5	25.9	72.4	2.4	14.3	88.8
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772605-43777315	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.7;skin 1: 25.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Gastric mucus-secreting cells: 4.6;Proximal enterocytes: 6.5;Squamous epithelial cells: 21.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 10.5;naive B-cell: 15.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 15.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 73.8;OE19: 28.5;T-47d: 39.0;U-698: 149.9"	"Region enriched"	"Detected in single"	11	"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA028938, HPA073494"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA028938: AB_10795352, HPA073494: "	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.5	0.9	1.0	9.7	1.0	0.2	5.2	1.0	1.1	1.6	4.7	8.0	14.1	0.6	1.1	4.5	3.9	0.7	0.5	1.0	1.1	1.4	0.7	1.5	49.7	1.0	1.1	1.7	0.4	1.6	0.5	3.7	1.1	2.0	12.3	0.1	2.2	1.0	0.4	25.0	12.9	1.0	1.0	1.0	1.8	16.2	1.4	1.5	0.7	1.9	57.7	0.7	0.8	1.1	2.1	0.2	0.6	1.1	4.9	1.2	0.4	0.2	1.3	2.8	3.1	0.0	1.3	73.8	0.1	1.2	0.1	13.7	1.3	0.7	1.4	1.6	7.3	0.4	2.6	4.6	1.0	0.1	0.0	1.4	12.3	0.7	0.2	0.2	1.1	0.4	0.2	0.0	0.7	4.0	1.5	1.4	0.1	28.5	2.4	0.8	0.0	0.0	1.8	0.0	9.5	0.0	1.7	21.5	0.0	0.3	39.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	149.9	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	10.5	0.6	0.1	0.0	15.9	1.1	0.2	0.0	0.1	0.0	2.2	0.6	0.6	1.0	1.0	1.0	1.1	1.0	1.1	1.0	1.1	1.1	1.0	1.4	1.1	0.1	0.0	0.0	0.0	2.2	0.4	0.1	0.2	5.2	0.0	0.7	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.3	1.2	0.0	0.1	1.8	0.4	0.1	0.2	0.0	0.4	0.1	0.7	0.0	0.5	4.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.5	0.0	0.0	0.5	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	6.5	0.1	3.1	0.0	0.0	0.2	0.4	0.2	0.2	21.0	1.0	0.3	0.1	0.1	2.3	0.2
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	242.4	134.7	51.3	74.9	67.0	114.6	199.2	74.6	79.2	48.9	49.4	40.0	28.3	39.8	49.7	28.4	46.0	51.3	37.8	50.8	65.3	38.9	108.9	68.4	106.7	80.7	69.0	32.3	15.4	24.3	28.5	40.2	74.5	128.0	18.3	36.5	24.8	103.0	9.9	32.9	47.5	52.4	67.7	56.1	22.8	82.5	65.8	107.3	45.1	19.5	102.4	67.1	27.0	98.9	137.2	98.1	168.0	309.0	436.0	250.8	71.3	155.8	174.2	123.2	171.5	87.4	154.5	154.4	110.3	163.3	193.1	78.9	168.0	142.6	183.7	131.2	117.5	153.1	85.0	122.9	239.0	122.2	107.2	233.6	109.8	123.6	153.9	124.5	139.1	301.4	194.2	87.3	90.3	14.9	364.4	107.9	91.2	5.2	73.6	139.9	115.3	54.3	232.7	80.6	155.7	107.1	129.3	66.9	135.2	108.7	152.3	112.9	133.0	134.7	118.5	242.2	208.8	72.8	72.1	116.2	70.2	173.6	97.8	47.6	49.2	183.7	34.9	34.9	56.5	88.4	58.1	42.7	77.9	101.5	27.8	26.3	261.5	36.7	45.0	20.4	110.0	50.6	51.3	67.0	74.6	79.2	50.8	65.3	80.7	69.0	74.5	67.7	65.8	98.9	48.6	80.1	50.7	75.4	118.3	52.4	108.2	36.8	44.3	11.6	177.3	70.9	23.3	21.5	40.2	12.9	2.1	25.3	55.5	2.1	15.6	34.9	94.2	37.4	53.2	54.4	25.0	77.0	25.8	36.1	58.2	54.8	3.1	66.4	99.0	28.4	39.3	88.7	35.5	8.4	29.8	1.6	16.2	57.3	114.6	181.0	20.8	55.5	48.0	39.4	53.5	83.2	39.1	49.3	111.2	27.8	1.4	32.0	45.2	169.2	21.9	48.4	58.5	6.0	65.7	27.3	77.5	27.0	18.9	35.7	60.9	31.2	97.2	60.0	4.4	73.4
EMG1	"C2F, Grcc2f, NEP1"	ENSG00000126749	"EMG1 N1-specific pseudouridine methyltransferase"	Q92979	12	6970913-6997428	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039304, HPA039666"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA039304: AB_2676432, HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	16.8	18.0	13.0	15.2	14.2	12.6	17.3	14.4	20.2	14.9	15.9	14.0	11.1	14.5	13.6	20.2	16.1	4.6	22.6	13.2	14.1	23.2	22.8	15.9	13.4	14.4	14.2	13.9	13.6	9.4	12.8	8.6	14.5	15.7	9.7	9.3	13.6	6.1	21.2	17.4	14.0	7.4	14.3	18.1	14.6	9.9	14.0	12.3	15.6	12.8	12.8	16.1	14.1	15.3	55.5	53.7	20.5	25.2	15.8	11.5	84.7	40.1	17.9	31.2	21.2	106.4	57.6	55.4	14.7	25.1	56.8	39.8	18.9	46.1	35.2	40.1	30.6	76.8	51.7	99.6	20.3	79.0	47.8	18.5	27.2	45.5	51.8	16.2	13.9	38.6	38.6	12.1	29.8	65.3	41.4	48.3	169.6	45.4	28.0	56.3	41.2	44.0	20.0	68.8	11.9	35.7	42.2	43.9	41.4	57.5	12.0	57.8	29.2	32.4	42.6	26.8	92.9	14.6	17.9	97.7	34.8	33.7	52.8	15.5	44.1	22.3	60.7	66.4	63.3	85.3	63.6	67.6	51.2	88.0	74.4	69.1	6.2	60.9	86.4	55.8	68.1	81.3	13.0	14.2	14.4	20.2	13.2	14.1	14.4	14.2	14.5	14.3	14.0	15.3	30.1	16.0	41.3	1.3	34.0	36.6	92.2	79.1	25.0	14.7	29.0	36.8	0.0	24.3	60.9	42.3	8.4	107.3	22.8	18.1	49.0	75.3	9.6	23.1	24.8	32.3	9.6	16.0	1.3	66.8	121.0	31.8	11.7	22.7	60.9	27.7	23.2	35.9	65.4	16.8	1.4	25.7	71.2	25.0	29.3	15.5	37.9	27.7	28.4	1.9	45.1	24.5	43.3	2.0	2.7	75.7	19.8	25.9	17.3	69.0	25.1	81.1	54.0	16.0	39.5	29.2	86.5	28.9	59.7	28.4	39.9	74.3	30.6	46.4	35.7	75.8
EMP1	"CL-20, TMP"	ENSG00000134531	"Epithelial membrane protein 1"	P54849	12	13196723-13219941	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2255.1;vagina: 819.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 835.5;Basal keratinocytes: 694.1;Endothelial cells: 662.2;Squamous epithelial cells: 888.5;Suprabasal keratinocytes: 687.6;Urothelial cells: 1193.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1166.6;fHDF/TERT166: 861.7;HaCaT: 766.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 4.5;spinal cord: 16.0"	HPA046912			Approved	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA046912: "	"unprognostic (1.40e-2)"	"unprognostic (7.30e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (2.98e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (9.69e-8)"	536.6	42.0	18.6	63.9	20.2	20.7	166.7	18.2	28.4	463.2	14.2	100.7	39.5	61.6	12.5	2255.1	84.8	205.8	121.8	17.7	46.5	93.9	35.1	177.9	11.4	29.5	22.9	21.8	86.8	20.6	29.9	76.9	27.2	39.6	56.4	5.5	377.8	20.3	27.0	150.9	41.8	149.2	25.1	26.2	48.5	9.2	20.8	28.4	133.5	35.6	165.4	205.7	819.5	22.1	373.5	19.4	9.1	1.9	563.2	1166.6	1.5	269.6	489.4	135.7	172.3	2.7	612.6	2.2	187.3	861.7	60.0	766.6	10.8	35.7	182.9	7.2	0.8	1.2	61.9	0.2	135.6	2.6	2.1	369.8	50.9	432.7	126.4	107.3	316.8	0.2	2.0	6.2	325.4	1.6	0.8	8.3	6.6	69.8	62.3	1.0	37.1	3.4	396.4	4.4	0.3	0.3	120.1	17.4	211.9	69.9	3.1	2.2	349.8	302.2	106.7	287.0	146.8	1.5	4.1	2.5	441.2	2.2	363.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	18.6	20.2	18.2	28.4	17.7	46.5	29.5	22.9	27.2	25.1	20.8	22.1	835.5	205.1	88.5	8.1	3.7	694.1	362.3	34.8	223.7	0.1	316.5	91.7	12.9	27.1	166.8	18.4	0.0	1.2	7.6	481.5	15.6	28.7	0.8	76.0	167.6	662.2	47.6	0.0	0.9	4.4	1.8	470.5	62.2	160.3	50.4	0.1	157.1	2.2	39.8	0.0	0.4	13.5	6.1	37.1	481.2	2.1	69.6	105.8	473.2	7.5	7.0	2.4	0.0	0.5	0.2	62.2	343.0	109.4	12.7	413.0	48.6	0.5	60.2	0.4	6.6	202.1	170.1	1.1	0.9	888.5	687.6	1.1	23.0	5.1	26.6	1193.8
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580632	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 230.6"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	56.8	9.7	15.5	12.4	15.5	0.7	49.5	14.8	17.1	51.0	18.6	48.0	15.5	25.9	45.5	152.1	35.5	17.7	64.1	13.6	15.6	20.3	83.2	230.6	5.7	16.1	16.8	54.9	13.7	32.8	13.3	23.0	16.0	38.8	34.1	2.0	39.2	17.3	22.5	140.6	28.3	22.3	15.2	16.0	39.1	7.2	18.8	5.3	27.7	25.4	32.8	39.6	72.9	15.7	28.7	39.1	15.9	18.9	35.0	30.0	31.3	40.0	36.8	23.9	35.7	128.5	98.2	0.2	12.6	48.4	17.2	123.9	41.1	49.8	31.3	0.1	26.1	0.1	76.6	72.1	6.1	0.2	0.4	18.4	13.1	31.9	3.2	5.4	10.1	0.1	9.6	2.6	66.9	268.1	0.4	0.6	18.3	46.4	9.5	7.5	18.2	61.7	5.5	182.0	22.0	25.0	49.6	256.2	15.2	45.2	156.6	6.2	5.7	75.5	32.2	25.6	22.7	0.8	1.0	0.2	33.2	0.5	75.7	1.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	1.1	0.3	0.3	0.3	0.2	0.1	15.5	15.5	14.8	17.1	13.6	15.6	16.1	16.8	16.0	15.2	18.8	15.7	239.7	4163.5	368.4	13.1	3.1	356.9	137.9	172.2	111.0	2.3	105.0	94.0	53.1	100.1	255.8	42.3	0.0	74.2	3.1	119.5	0.0	3.8	8.0	78.8	30.9	183.9	104.9	0.0	0.7	67.0	17.8	152.7	46.4	51.9	36.7	68.7	161.0	235.1	10.1	0.0	0.6	207.8	81.4	19.6	136.5	9.3	190.7	17.0	87.2	41.2	33.6	5.7	0.0	22.6	0.6	32.9	158.4	276.1	1.6	86.0	21.0	0.2	142.8	2.2	52.6	256.3	129.3	5.7	12.9	319.5	1174.3	48.0	9.3	73.3	178.5	221.4
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;kidney: 36.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 55.2;Excitatory neurons: 13.0;Proximal tubular cells: 35.7"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 3.7"	"Region enriched"	"Detected in some"	10	"cerebral cortex: 13.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;CACO-2: 3.7;HEK 293: 8.3;HMC-1: 1.6;RPTEC TERT1: 1.4;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"amygdala: 2.7;cerebral cortex: 10.5;hippocampal formation: 7.8"	"HPA006230, HPA006421"	Approved		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.1	0.1	0.0	1.3	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.8	0.0	0.7	0.1	0.0	0.0	0.0	1.3	0.0	36.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	13.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	55.2	0.0	0.1	0.0	1.2	5.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	35.7	0.0	0.0	0.0	0.0	0.0	1.5	5.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847648	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.2;skeletal muscle: 13.9;skin 1: 10.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 5.6;Fibroblasts: 4.8;Melanocytes: 12.4;Skeletal myocytes: 12.0;Smooth muscle cells: 5.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Region enriched"	"Detected in many"	6	"midbrain: 18.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;ASC TERT1: 7.2;fHDF/TERT166: 13.3;HSkMC: 13.5;PC-3: 7.8;U-138 MG: 9.9;U-2197: 11.2"	"Region enriched"	"Detected in single"	5	"midbrain: 4.9"	"Region enriched"	"Detected in some"	6	"midbrain: 23.6"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	3.5	0.2	0.1	0.0	0.1	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.7	18.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	13.9	10.4	0.0	0.0	0.5	0.0	0.0	0.1	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.5	4.0	0.2	0.6	0.2	16.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	4.7	0.5	0.6	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.3	0.0	0.0	0.0	9.9	1.0	11.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.5	0.7	18.2	3.2	0.5	1.4	0.5	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	5.6	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.4	0.1	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"brain: 19.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3.6;Glandular and luminal cells: 8.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"	"Group enriched"	"Detected in many"	6	"cerebellum: 19.2;midbrain: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.1;AN3-CA: 15.2;HAP1: 9.0;HEK 293: 25.1;SK-MEL-30: 12.9"	"Region enriched"	"Detected in some"	8	"cerebellum: 27.8"	"Region enriched"	"Detected in some"	5	"cerebellum: 52.3"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		No	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli, Nucleoli fibrillar center"	"HPA045646: AB_2679404, HPA069809: AB_2686205"	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.1	0.1	0.1	0.0	0.2	0.0	0.1	19.2	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.2	8.0	0.6	0.3	0.5	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.8	0.7	41.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.1	0.0	1.4	0.0	9.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	5.5	0.0	0.0	0.0	0.0	2.0	0.0	3.2	0.0	0.1	0.3	0.0	0.0	3.0	0.0	12.9	0.0	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	19.2	0.7	0.2	0.4	0.2	8.0	2.3	0.3	0.9	2.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.6	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.4	1.5	0.6	0.0	0.1	0.0	0.1	0.3	0.0	0.0
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815013-127854658	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 528.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 407.5;Endothelial cells: 514.4;Extravillous trophoblasts: 294.4;Hepatic stellate cells: 579.0;Leydig cells: 487.1;Peritubular cells: 1421.8;Syncytiotrophoblasts: 376.4;Theca cells: 308.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 19.9;intermediate monocyte: 28.2;myeloid DC: 10.3;NK-cell: 7.6;non-classical monocyte: 22.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 10.3;monocytes: 28.2;NK-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 263.8;HUVEC TERT2: 487.4;TIME: 1027.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"		NA	NA		280000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (6.61e-4)"	"prognostic favorable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	234.5	92.6	44.4	80.2	41.5	18.8	164.8	45.2	44.5	129.7	50.4	62.4	33.2	111.1	35.1	43.1	122.4	58.7	528.7	36.7	43.1	211.6	60.7	260.7	43.4	50.0	47.1	220.9	47.1	29.7	56.1	93.6	52.8	93.9	17.5	2.1	46.2	73.5	72.3	51.3	76.8	65.7	43.1	226.5	57.6	98.9	59.4	17.3	169.2	54.8	17.7	93.0	95.8	43.6	1.3	1.0	7.1	0.4	117.8	81.0	217.8	147.1	102.0	74.4	43.4	0.5	1.3	1.0	70.2	263.8	56.8	2.4	0.0	23.2	24.5	0.7	0.3	42.3	76.7	4.6	91.7	20.2	0.5	137.6	5.4	97.7	34.9	1.0	487.4	1.4	0.7	1.4	88.1	0.9	0.6	1.8	1.7	0.3	4.2	66.9	12.5	1.4	0.0	0.4	0.8	1.8	78.0	65.3	20.1	4.7	13.8	29.8	1027.5	248.1	13.7	164.7	0.7	5.2	1.2	0.9	67.1	52.0	83.2	0.0	19.9	0.5	1.8	28.2	0.6	0.6	3.0	3.4	10.3	1.4	1.9	3.0	0.5	7.6	22.1	3.8	1.2	8.4	44.4	41.5	45.2	44.5	36.7	43.1	50.0	47.1	52.8	43.1	59.4	43.6	407.5	3.2	16.0	2.0	9.2	12.0	2.3	2.1	2.8	2.8	9.5	9.8	28.4	18.6	2.3	3.7	4.2	30.0	8.6	0.4	0.0	10.2	8.6	7.7	67.9	514.4	2.4	49.2	0.6	1.1	294.4	85.7	3.1	8.1	15.2	0.8	579.0	9.8	132.0	0.0	0.7	1.6	0.0	65.4	29.7	51.4	487.1	56.6	24.9	78.7	36.2	2.0	4.1	1.5	1.1	1.4	0.0	1421.8	2.1	2.0	0.0	0.3	5.1	4.6	72.3	44.0	57.5	4.4	5.2	1.3	8.4	376.4	9.6	308.1	0.5	1.4
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074824-79088599	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Enhanced		Approved	Centrosome,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Centrosome	"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.73e-5)"	9.3	8.4	8.4	8.2	9.4	7.2	9.1	8.6	11.5	11.9	10.2	14.5	14.3	9.6	2.0	5.4	10.7	5.9	9.1	8.3	9.9	7.6	8.8	9.4	9.2	10.0	10.7	13.7	7.9	6.7	7.1	5.6	10.1	10.8	9.2	6.1	9.1	4.3	24.0	9.6	14.9	5.2	8.4	20.0	11.0	3.4	11.0	7.2	11.8	10.4	5.8	11.6	9.5	12.3	6.3	12.8	5.7	10.0	4.4	2.5	9.6	5.6	3.5	4.6	3.9	7.2	6.4	0.0	5.9	5.1	6.2	9.7	7.2	5.4	2.3	4.3	12.5	5.9	14.8	4.2	4.2	6.7	11.2	5.8	7.9	3.4	3.3	7.8	4.9	14.7	9.1	3.6	2.5	5.1	0.6	7.3	2.7	15.4	12.1	12.7	16.8	5.3	2.4	16.4	4.2	9.2	7.3	33.5	4.2	6.8	10.8	7.8	6.4	6.8	6.1	6.4	4.4	10.9	1.9	2.9	4.0	13.6	5.1	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.5	0.1	0.0	0.4	0.1	0.0	0.7	0.1	8.4	9.4	8.6	11.5	8.3	9.9	10.0	10.7	10.1	8.4	11.0	12.3	6.9	0.0	16.0	18.3	6.1	4.5	5.6	3.4	3.4	11.1	7.5	7.4	6.3	5.7	5.7	11.0	35.5	5.3	7.1	23.3	0.0	4.2	1.8	3.9	6.3	7.6	26.2	3.8	5.4	4.3	5.4	6.7	18.8	4.8	5.1	11.5	8.2	11.5	8.6	8.4	10.1	18.6	0.0	13.2	9.8	1.3	3.4	15.5	0.0	14.0	8.8	5.3	6.2	3.5	11.0	2.5	10.7	1.9	5.7	5.3	16.5	2.9	2.9	24.5	13.1	7.9	8.3	1.9	1.6	4.1	5.8	6.7	7.4	7.5	27.5	4.4
ENKD1	"C16orf48, DKFZP434A1319, FBB11"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.2;Endometrial ciliated cells: 38.3;Respiratory ciliated cells: 42.5;Spermatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Centrosome"	Cytosol	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favorable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	12.8	12.8	8.4	4.6	8.3	3.5	14.9	22.0	11.5	23.2	13.6	28.6	3.9	21.2	5.6	8.6	30.7	3.6	13.2	8.2	8.6	26.6	11.6	14.7	2.2	9.9	10.9	21.2	67.2	16.0	25.6	3.3	8.4	20.6	2.7	8.5	13.7	9.2	9.5	12.1	11.1	4.4	10.0	11.9	15.9	41.1	9.1	4.7	22.3	1.6	2.5	21.5	14.2	8.5	11.1	7.5	17.2	8.0	5.6	5.8	8.5	8.5	5.1	6.7	8.1	5.5	16.5	4.1	14.3	5.3	0.0	12.7	4.5	10.2	8.2	6.5	10.2	4.1	25.7	13.1	9.1	7.4	5.4	5.1	7.3	9.1	8.2	15.4	5.5	13.3	6.9	2.5	3.5	5.7	8.2	30.9	8.2	11.5	3.0	28.5	1.8	31.3	7.2	1.1	17.4	18.9	18.2	1.8	9.7	3.9	15.8	10.5	14.3	8.1	11.4	15.2	0.1	19.1	9.2	4.5	12.3	10.8	2.5	0.0	0.4	0.0	0.1	0.1	0.4	0.2	0.3	0.2	0.1	0.0	0.2	0.3	0.9	0.2	0.2	1.3	0.0	0.1	8.4	8.3	22.0	11.5	8.2	8.6	9.9	10.9	8.4	10.0	9.1	8.5	8.8	22.4	14.4	8.8	1.7	6.9	5.9	6.2	4.0	3.6	10.4	11.2	5.5	10.0	4.0	9.2	4.2	3.1	1.5	4.4	1.9	13.1	34.2	38.3	10.5	8.6	13.2	2.1	2.1	10.7	2.4	7.5	1.5	9.5	1.3	7.4	10.4	26.4	4.7	3.3	2.2	6.0	2.0	3.2	4.3	20.6	13.1	2.6	5.4	0.0	3.0	8.8	0.0	2.5	1.7	9.5	1.4	14.3	2.6	6.0	1.8	7.3	42.5	10.5	6.6	9.1	8.0	37.0	7.9	1.2	5.3	3.4	1.9	11.6	4.9	4.4
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879190	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 2259.3;Extravillous trophoblasts: 2078.5;Muller glia cells: 2624.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394, CAB080034"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		310000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , CAB080034: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	463.4	418.4	552.9	553.3	591.7	792.8	409.1	679.7	749.9	370.7	585.6	382.6	401.2	321.7	125.7	1049.4	281.6	302.0	328.2	638.1	599.6	1063.6	612.2	453.2	492.4	624.1	607.7	295.0	220.8	347.2	245.7	362.7	602.9	279.2	358.3	741.5	581.3	354.2	231.0	548.1	382.3	471.3	583.4	394.9	321.6	217.7	585.3	455.6	271.4	146.5	695.4	485.9	519.7	571.5	3637.0	3088.4	1461.8	1258.6	1194.2	1323.8	1316.6	1919.1	2110.9	4044.1	3767.4	1986.9	2041.5	2586.5	2496.8	2328.5	1651.8	1736.8	2511.5	5127.7	4081.0	1780.5	2645.9	2191.3	2848.0	2511.0	1789.6	4421.6	1290.1	1377.4	1526.1	3208.9	4825.9	3045.2	2630.1	1294.6	2444.4	982.3	2664.2	1784.1	1685.2	2354.5	1600.3	1290.4	3063.4	1712.4	2172.9	4259.0	4815.0	843.6	1961.4	1211.1	2251.0	3232.5	2407.8	1748.4	1621.8	1302.1	2424.7	2774.5	2444.5	2402.3	3328.3	2771.0	2120.4	3906.9	4313.8	3556.1	2388.6	195.9	1198.7	232.3	528.4	822.7	597.3	411.2	552.5	543.2	1216.4	386.1	443.4	466.0	230.6	635.3	830.6	336.1	700.0	2171.2	552.9	591.7	679.7	749.9	638.1	599.6	624.1	607.7	602.9	583.4	585.3	571.5	140.0	278.9	499.1	99.6	222.3	416.5	570.9	1939.8	348.8	178.2	242.7	324.6	69.6	283.1	657.4	606.9	70.9	1045.4	194.0	455.9	925.4	2259.3	281.3	205.3	227.7	314.3	189.0	145.4	32.0	1399.1	2078.5	303.5	144.8	248.4	297.2	408.6	133.5	351.7	1147.4	482.9	33.2	297.3	787.3	356.4	524.5	699.6	171.5	454.2	448.2	30.9	1558.2	2624.9	279.1	28.6	26.9	1433.6	366.9	135.1	211.0	555.7	742.2	1005.4	245.7	216.6	151.2	156.1	402.5	215.1	154.3	468.1	349.6	1001.8	285.6	609.8	528.4	444.2
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 1695.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 318.2;Cone photoreceptor cells: 312.8;Horizontal cells: 429.0;Rod photoreceptor cells: 787.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 9.9;MAIT T-cell: 11.3;memory B-cell: 6.8;memory CD4 T-cell: 13.1;memory CD8 T-cell: 11.4;naive B-cell: 4.4;naive CD4 T-cell: 8.2;naive CD8 T-cell: 8.6;neutrophil: 7.0;T-reg: 7.5"	"Group enriched"	"Detected in many"	7	"B-cells: 6.8;granulocytes: 7.0;T-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 537.4;U-87 MG: 398.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		55000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	25.6	46.7	280.8	20.0	289.7	9.6	20.2	291.2	400.7	55.9	97.5	74.0	10.2	40.1	12.6	15.3	40.2	17.9	53.7	295.0	289.4	27.8	7.7	33.8	26.3	289.4	189.9	29.7	9.0	43.6	124.4	10.4	282.2	34.9	15.5	1695.6	13.8	34.4	7.4	19.3	37.1	35.0	164.3	26.4	30.4	9.6	259.0	26.7	42.0	6.4	24.4	57.4	44.1	306.2	74.3	45.3	16.2	0.5	23.7	26.0	1.5	56.5	37.3	82.0	125.9	8.6	5.8	103.9	9.5	24.3	108.8	11.0	173.0	15.4	116.1	211.9	16.6	141.0	47.7	60.3	17.4	8.3	161.2	13.0	0.7	61.1	11.5	537.4	17.5	137.9	9.5	1.1	56.3	10.3	66.9	8.8	84.9	31.7	27.2	75.0	13.9	22.9	38.5	9.8	128.3	94.0	14.3	1.0	96.3	76.4	4.5	3.9	20.9	69.4	73.7	95.7	73.0	73.3	79.5	15.4	398.4	0.3	15.2	2.1	0.0	0.2	9.9	0.0	11.3	6.8	13.1	11.4	0.1	4.4	8.2	8.6	7.0	0.4	0.3	1.2	7.5	6.1	280.8	289.7	291.2	400.7	295.0	289.4	289.4	189.9	282.2	164.3	259.0	306.2	3.2	35.3	27.4	54.2	11.2	6.2	2.3	45.2	1.8	318.2	5.2	4.3	16.1	1.5	17.2	12.9	312.8	0.3	7.5	0.3	0.0	17.0	0.5	9.6	2.1	9.9	23.9	7.0	96.2	1.8	1.1	8.3	2.0	2.7	67.2	1.0	5.3	0.2	1.7	429.0	89.4	0.5	18.3	0.6	6.9	0.3	5.6	5.9	12.4	25.3	3.5	146.1	0.0	23.6	31.5	9.3	1.2	9.8	9.2	2.5	0.1	0.2	32.2	787.2	13.1	8.1	20.2	1.5	2.5	1.1	2.3	0.3	17.1	0.3	0.4	2.2
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	26	"skeletal muscle: 14758.3;tongue: 10771.0"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 582.2;Skeletal myocytes: 248.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 263.8;HeLa: 120.0;HMC-1: 115.1;RH-30: 170.2;RPMI-8226: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		86000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.8	5.5	3.8	15.6	3.9	20.4	8.0	7.1	4.3	6.6	5.0	8.0	20.1	7.2	7.1	173.8	7.4	2.6	499.8	3.5	3.7	10.3	108.0	8.6	13.0	4.3	5.0	6.0	5.5	4.0	7.9	6.3	4.6	47.3	3.0	5.0	116.8	3.1	14758.3	8.3	15.6	2.8	4.1	16.9	10.1	9.3	4.3	5.8	10.3	10771.0	4.9	5.6	5.0	4.9	12.0	25.5	11.3	10.7	9.1	2.2	27.6	21.0	2.7	1.5	1.3	12.8	8.1	21.9	25.8	1.9	3.5	15.4	3.8	1.9	1.0	263.8	24.3	21.9	120.0	18.9	3.7	6.8	115.1	14.4	3.8	2.1	4.1	9.8	1.4	24.8	10.2	39.0	4.9	6.6	7.9	26.5	14.8	3.3	10.6	34.6	170.2	96.9	3.1	7.9	7.1	27.1	13.6	11.4	14.7	7.6	10.2	7.0	6.5	12.1	21.3	5.4	16.0	27.6	16.8	18.2	6.7	20.8	12.2	31.4	28.5	50.4	36.8	41.5	24.8	24.5	30.8	34.4	37.6	20.1	20.0	32.2	34.4	34.9	47.6	29.9	43.2	83.6	3.8	3.9	7.1	4.3	3.5	3.7	4.3	5.0	4.6	4.1	4.3	4.9	1.2	0.0	1.8	2.3	2.7	2.0	1.2	2.1	4.0	6.6	3.0	3.0	582.2	0.0	2.2	5.5	4.2	5.4	3.2	2.9	0.0	1.5	1.8	0.9	1.6	7.3	0.0	3.8	0.2	0.8	3.8	17.3	4.6	2.2	8.2	2.4	2.2	56.2	4.5	3.3	0.2	2.2	2.0	3.5	6.7	3.7	0.3	4.3	1.8	0.0	78.3	1.9	4.1	1.0	0.5	1.8	1.9	0.4	2.3	1.2	6.6	9.5	0.3	2.5	6.6	248.4	55.8	7.9	7.5	2.1	1.8	3.3	4.5	1.1	2.6	0.8
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase 4"	A6NNW6	10	116849499-116911788	"Enzymes, Predicted intracellular proteins"	Glycolysis	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.5;choroid plexus: 4.7;fallopian tube: 5.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.3;Cone photoreceptor cells: 22.9;Early spermatids: 15.5;Endometrial ciliated cells: 15.8;Inhibitory neurons: 18.4;Late spermatids: 15.8;Oligodendrocytes: 62.4;Respiratory ciliated cells: 30.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA037937: AB_10697089, HPA037938: AB_2675746"	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.2	0.3	1.7	0.0	5.3	0.0	0.4	1.7	3.4	0.4	4.7	0.3	0.0	0.6	1.3	0.1	5.0	0.3	0.1	2.1	2.6	0.6	1.3	0.6	0.1	4.8	4.5	0.5	0.6	1.0	1.0	0.0	3.5	0.3	0.1	2.0	0.2	0.4	0.0	0.2	0.2	0.2	2.6	0.2	0.3	2.5	4.0	0.1	0.7	0.0	0.0	0.1	0.2	11.5	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	5.3	1.7	3.4	2.1	2.6	4.8	4.5	3.5	2.6	4.0	11.5	0.0	0.0	0.0	16.3	0.0	0.1	0.3	0.8	0.6	4.9	0.4	0.3	0.3	0.0	0.4	0.0	22.9	0.3	0.0	0.2	0.0	0.5	15.5	15.8	0.7	0.1	1.8	0.0	12.2	0.2	0.2	0.7	0.0	1.1	0.0	0.5	0.0	0.0	0.0	5.0	18.4	0.0	0.0	0.0	0.6	15.8	1.2	0.2	0.0	8.4	0.6	1.3	0.0	4.5	62.4	0.2	0.1	0.7	0.0	0.1	0.3	0.8	30.2	8.4	0.0	1.0	0.5	9.4	2.9	0.1	0.0	0.1	0.0	1.0	0.3	0.1
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 5"	Q9UJA9	6	46159185-46170980	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 243.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 100.1;Respiratory ciliated cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.1;HSkMC: 7.1;SuSa: 6.2;T-47d: 8.7;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		620000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.8	8.6	6.2	1.1	7.6	0.2	13.4	6.9	12.6	12.8	4.0	2.6	1.5	1.8	243.6	1.8	15.4	7.0	4.4	7.0	9.7	24.3	0.5	8.8	1.2	5.8	13.0	9.7	9.7	46.3	19.8	1.7	6.2	29.4	3.2	30.6	14.4	31.0	10.7	1.6	1.9	0.9	4.5	5.7	6.7	35.5	14.0	8.2	51.0	10.3	1.4	5.6	1.8	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.5	0.1	0.3	11.1	1.8	3.6	0.2	3.7	0.0	0.6	1.5	0.1	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.5	2.3	5.4	0.0	0.0	0.2	0.2	4.5	0.6	4.7	0.2	0.0	4.6	0.0	6.2	8.7	0.0	0.0	0.0	1.2	0.0	0.1	5.3	7.9	0.0	2.8	0.0	0.1	0.0	0.0	0.0	14.9	0.1	8.0	0.5	3.0	9.7	0.0	0.8	0.9	8.7	1.1	2.8	0.0	0.0	0.0	3.2	6.2	7.6	6.9	12.6	7.0	9.7	5.8	13.0	6.2	4.5	14.0	6.3	0.4	12.8	12.2	16.3	1.6	0.9	4.8	0.5	1.2	10.6	18.1	10.8	7.5	8.6	6.1	23.9	4.2	4.9	4.2	1.9	1.9	11.6	0.7	15.3	0.8	0.4	8.3	0.0	24.6	7.5	2.9	4.2	2.0	5.4	4.5	4.0	0.4	0.1	0.4	10.1	14.5	2.8	2.0	0.0	0.4	3.8	2.8	0.5	0.0	1.9	0.6	100.1	23.7	9.0	10.5	2.2	2.3	12.0	0.1	12.0	1.7	16.3	47.3	3.4	6.6	25.7	1.8	0.5	2.4	1.1	0.6	0.3	3.2	21.2	2.9	3.3
ENPP6	MGC33971	ENSG00000164303	"Ectonucleotide pyrophosphatase/phosphodiesterase 6"	Q6UWR7	4	184088706-184221230	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4;kidney: 30.6;ovary: 12.5"	"Cell type enhanced"	"Detected in some"		"Oligodendrocytes: 119.9;Peritubular cells: 35.3;Proximal tubular cells: 31.3;Theca cells: 23.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.2;SH-SY5Y: 3.6;U-266/70: 2.9;U-266/84: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042740, HPA069197"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		290000		"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA042740: AB_10793984, HPA069197: "	"unprognostic (4.81e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.60e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.01e-1)"	0.2	0.3	2.7	0.8	11.8	0.9	0.8	14.2	5.5	0.2	2.3	1.0	1.7	0.2	6.1	1.0	0.3	0.5	0.2	2.7	6.1	30.6	0.1	0.3	0.9	20.4	9.6	12.5	0.0	0.0	4.2	0.1	18.1	2.2	1.0	0.1	0.7	6.1	0.2	0.1	2.2	0.1	12.5	1.0	1.2	2.4	11.1	1.9	0.1	1.3	2.8	0.6	0.3	29.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.9	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	2.7	11.8	14.2	5.5	2.7	6.1	20.4	9.6	18.1	12.5	11.1	29.4	0.5	0.0	0.0	5.9	0.1	0.0	0.2	0.9	0.6	0.0	0.1	0.5	0.9	0.0	0.4	1.8	0.0	0.0	0.0	0.0	3.9	1.1	1.0	0.0	0.0	0.5	0.0	0.0	4.3	0.2	0.0	8.7	0.0	0.0	5.7	0.0	0.0	0.4	0.2	0.0	1.5	0.0	0.0	0.6	0.0	0.4	4.1	0.6	1.8	4.7	1.1	0.0	0.0	6.6	119.9	0.0	0.0	35.3	0.5	0.1	0.0	31.3	0.2	0.0	0.0	5.1	0.6	0.1	1.6	0.0	0.0	0.0	0.3	23.9	0.0	0.3
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	11	"U-698: 8664.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol		NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: AB_2681425"	"unprognostic (6.27e-2)"	"prognostic favorable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	140.5	106.6	151.2	115.1	156.7	219.8	154.9	133.6	188.2	145.2	132.6	135.9	133.6	117.8	183.3	288.0	100.5	94.9	120.2	161.6	144.1	118.8	148.8	124.0	128.4	137.2	135.6	102.4	108.5	173.0	92.0	103.7	134.2	97.7	123.9	121.8	122.9	94.6	301.0	241.3	132.7	105.8	136.9	99.7	124.1	45.2	147.4	157.8	134.4	212.3	146.7	147.0	165.6	157.0	287.1	170.8	236.9	206.9	149.7	126.8	220.7	141.0	148.4	199.9	171.7	207.3	216.6	288.9	196.8	122.1	125.1	238.3	198.5	325.4	160.1	415.1	277.4	434.3	239.6	158.2	108.3	372.1	462.6	100.5	202.0	214.1	293.6	118.8	206.2	224.8	321.7	551.8	140.9	775.5	302.3	272.6	431.2	386.2	211.1	298.6	199.9	328.0	299.2	306.0	303.8	193.3	201.6	385.6	222.1	200.8	533.9	442.9	208.2	143.9	261.9	171.8	340.3	309.4	441.4	8664.2	197.1	357.6	191.8	67.3	54.4	94.3	55.6	62.9	52.2	64.3	46.3	57.5	70.7	55.3	37.7	56.0	53.0	68.8	64.3	58.3	58.2	75.1	151.2	156.7	133.6	188.2	161.6	144.1	137.2	135.6	134.2	136.9	147.4	157.0	103.1	41.7	166.1	20.9	132.9	190.3	225.1	303.9	124.7	59.7	152.7	117.1	102.6	98.7	172.9	82.8	45.9	286.5	148.9	170.7	254.3	160.3	9.7	109.1	68.5	114.2	130.8	178.2	44.7	152.4	184.2	85.9	71.9	93.7	224.3	51.1	80.3	86.9	203.3	67.3	29.3	169.1	211.6	101.1	171.4	17.7	86.0	123.3	103.2	19.7	409.7	83.6	184.4	21.6	19.3	91.5	146.8	104.2	135.6	128.0	187.2	186.0	128.8	50.0	72.3	85.5	94.4	27.6	25.0	269.7	286.8	382.8	140.4	87.9	163.9	253.7
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
EPB41L1	"4.1N, KIAA0338"	ENSG00000088367	"Erythrocyte membrane protein band 4.1 like 1"	Q9H4G0	20	36091504-36232799	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 156.4;Inhibitory neurons: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 163.5;HaCaT: 237.9;OE19: 192.9;SK-BR-3: 185.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054104, HPA056817"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"HPA054104: AB_2682380, HPA056817: AB_2683244"	"unprognostic (2.01e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.39e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.26e-2)"	55.1	122.1	68.6	8.1	73.8	0.4	25.7	66.0	97.2	37.7	0.0	31.2	13.8	27.9	31.0	46.3	45.3	40.3	21.3	64.7	81.7	64.7	8.9	30.1	4.4	101.5	80.3	41.8	29.3	37.0	21.1	21.8	94.0	26.9	20.9	39.5	56.6	42.6	12.0	14.2	16.7	27.2	53.0	8.1	64.2	18.3	75.0	4.5	24.8	15.4	14.0	40.7	31.7	79.9	53.5	163.5	57.7	21.5	36.8	22.8	53.8	16.8	37.7	35.1	27.9	108.7	93.7	3.0	26.4	52.7	71.7	237.9	26.7	19.6	26.2	0.5	14.9	0.4	52.7	107.6	11.3	0.2	19.4	19.9	9.4	32.9	2.7	44.7	8.6	13.0	2.7	41.5	30.5	34.2	1.8	0.9	21.4	192.9	49.9	2.6	16.0	66.3	30.5	84.6	20.1	24.5	74.9	185.6	6.4	43.9	45.8	2.4	7.3	40.9	43.0	20.8	3.7	50.3	19.0	0.6	71.2	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	68.6	73.8	66.0	97.2	64.7	81.7	101.5	80.3	94.0	53.0	75.0	79.9	14.5	16.0	22.1	27.7	0.4	2.9	5.0	11.1	30.7	31.9	12.8	9.4	8.5	28.6	16.5	47.8	156.4	1.5	0.8	23.8	19.6	22.2	2.9	10.6	8.7	9.2	15.5	0.0	56.8	10.8	0.5	11.0	50.4	7.5	52.5	13.3	10.0	3.7	6.9	32.0	75.7	6.0	4.1	1.3	2.2	2.7	15.8	6.0	3.6	3.7	0.0	22.7	0.0	24.6	73.1	31.6	15.7	42.2	2.1	5.1	8.0	37.1	21.9	8.7	32.9	6.8	35.1	4.6	7.1	43.2	1.7	1.1	0.8	7.1	13.2	18.0
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 45.1;Enteroendocrine cells: 48.7;Intestinal goblet cells: 61.1;Oligodendrocytes: 76.3;Pancreatic endocrine cells: 63.7;Undifferentiated cells: 97.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 86.5;HUVEC TERT2: 74.2;TIME: 79.2;U-251 MG: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		380000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.1	1.6	2.1	9.2	3.7	0.5	1.6	4.1	4.2	2.5	0.0	22.6	21.0	1.8	1.9	0.6	4.4	3.7	3.3	2.2	4.3	3.8	0.4	1.8	2.9	5.7	4.5	10.6	3.9	6.1	2.9	4.0	4.8	1.9	23.3	2.9	1.5	3.0	0.2	0.9	21.8	3.3	5.0	2.4	1.7	1.8	5.4	1.2	7.3	0.3	1.7	4.4	1.0	8.2	43.4	17.2	17.2	27.7	1.6	1.5	0.0	10.0	0.5	27.3	5.7	6.3	16.6	0.6	20.2	4.0	86.5	39.6	10.8	52.8	7.7	0.1	4.1	0.0	1.9	0.1	16.5	0.0	4.3	5.3	17.5	48.7	0.3	25.4	74.2	2.4	1.8	0.1	5.7	6.4	1.1	0.3	4.0	49.0	11.2	5.3	18.0	0.8	14.7	4.0	18.0	19.3	17.4	0.7	0.2	1.5	1.1	0.5	79.2	11.5	29.6	29.4	69.5	0.0	0.2	0.1	21.8	0.9	0.5	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	4.1	4.2	2.2	4.3	5.7	4.5	4.8	5.0	5.4	8.2	0.4	3.2	0.0	5.5	0.3	0.8	1.7	20.5	0.0	15.4	0.1	0.1	1.3	7.2	8.6	0.0	0.0	0.5	0.1	24.3	0.0	45.1	2.6	1.0	0.8	1.2	48.7	0.0	34.1	8.0	2.8	5.0	1.1	2.4	0.0	0.5	0.4	0.4	9.6	6.7	32.3	61.1	6.1	7.6	1.4	0.8	0.9	7.2	0.0	21.5	0.7	18.4	0.0	5.5	76.3	63.7	12.6	0.7	0.3	2.3	5.5	0.2	1.7	1.8	0.0	0.6	2.1	0.5	3.5	0.0	0.4	1.1	0.3	0.2	97.2	1.1
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 387.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 263.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009729, HPA061136, HPA071503"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	57.1	75.3	63.1	27.3	61.2	22.1	53.0	30.3	82.2	51.1	14.8	73.1	88.7	47.8	9.2	80.5	48.7	14.3	148.6	65.2	31.5	85.2	137.1	50.5	19.3	37.8	38.5	76.2	104.3	22.3	51.1	17.4	31.1	64.8	16.2	8.9	50.9	20.0	156.1	71.0	80.4	11.0	27.9	72.8	152.6	80.8	40.0	11.6	49.0	35.3	11.2	50.1	54.5	47.1	95.5	128.8	31.5	64.8	35.6	33.8	64.6	69.3	39.0	48.2	48.0	54.1	58.7	58.1	46.1	55.6	42.5	71.5	27.7	52.9	17.4	20.4	263.2	42.8	67.4	65.3	48.9	27.8	39.3	43.9	45.6	41.7	30.1	34.7	46.4	40.7	64.7	48.0	32.2	53.6	44.4	45.2	72.3	71.4	179.6	29.5	42.8	103.2	36.8	55.3	45.2	109.9	64.1	68.8	48.0	21.7	51.6	95.7	78.4	133.0	63.8	48.4	101.3	52.2	50.9	41.7	97.9	55.0	67.5	1.4	1.8	2.3	0.6	2.2	0.4	1.0	0.6	0.6	1.1	0.8	0.6	0.6	2.1	0.3	3.6	1.7	0.9	1.5	63.1	61.2	30.3	82.2	65.2	31.5	37.8	38.5	31.1	27.9	40.0	47.1	62.6	3.2	20.4	9.8	44.2	31.4	29.0	25.9	44.3	33.3	32.7	25.8	15.5	55.8	17.9	44.1	66.7	46.1	28.1	227.7	119.3	57.1	63.2	39.5	37.5	46.1	45.0	35.3	7.8	88.5	80.8	37.2	145.2	45.9	10.8	87.0	83.9	106.1	62.9	28.6	7.8	115.6	22.4	136.5	21.4	169.4	47.5	55.4	23.2	6.5	40.8	33.6	28.8	4.5	8.9	106.5	167.7	53.0	57.7	37.6	387.2	81.8	20.9	41.3	13.1	41.2	34.6	50.2	62.7	46.6	27.4	52.3	26.3	48.2	132.5	39.2
ERCC3	"BTF2, RAD25, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	24.4	25.9	15.0	14.5	16.0	19.8	24.4	15.1	16.5	32.2	19.6	28.9	9.6	27.0	11.6	22.7	28.9	14.2	23.4	16.6	14.9	22.8	22.2	22.1	21.6	15.7	14.8	29.5	23.8	26.3	33.8	13.6	16.0	27.4	13.8	4.4	23.2	16.8	35.3	27.7	24.3	21.5	15.1	32.6	23.7	29.8	15.6	26.6	25.0	25.6	22.4	27.2	26.4	15.2	45.9	30.8	37.8	40.6	40.6	27.8	46.4	41.3	52.9	65.1	62.5	48.1	32.9	34.5	33.2	37.8	41.7	40.2	57.7	43.3	56.1	54.4	51.4	43.6	35.8	51.0	30.5	38.1	45.4	28.9	39.8	75.7	32.4	41.5	42.4	44.3	43.0	22.1	41.7	45.1	54.8	42.2	55.0	29.2	47.3	44.5	42.7	28.8	36.4	42.2	45.2	49.2	35.3	52.6	55.0	42.4	28.7	43.0	34.1	39.2	45.2	35.8	49.7	39.2	81.5	54.0	34.3	18.0	42.8	8.0	11.5	8.8	18.2	12.0	18.4	13.7	13.1	15.7	16.9	12.7	17.7	12.2	3.5	25.0	9.9	13.6	20.5	15.5	15.0	16.0	15.1	16.5	16.6	14.9	15.7	14.8	16.0	15.1	15.6	15.2	12.2	22.4	14.6	24.8	17.7	7.6	9.5	20.6	21.1	0.0	13.0	11.6	13.0	5.7	25.4	7.3	0.0	18.6	18.9	6.1	1.9	13.7	9.0	22.9	13.9	12.2	6.1	3.8	22.3	14.9	12.2	16.6	18.8	13.1	10.1	17.1	15.4	8.6	14.6	0.0	23.5	10.0	14.2	12.5	7.6	5.1	16.4	10.7	8.8	10.3	12.3	0.0	14.4	18.1	22.4	15.5	7.3	12.8	16.4	7.4	6.3	8.5	45.2	0.0	13.1	17.6	13.3	41.1	31.0	11.3	9.5	14.6	15.7	12.3	10.6	8.5
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"P0DP91, Q03468"	10	49454168-49539538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 53.8;hTERT-RPE1: 123.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	2.7	2.1	1.6	1.9	1.5	4.6	3.8	3.0	2.3	3.1	7.7	2.4	2.0	3.0	1.5	3.8	2.9	2.7	3.4	1.2	1.1	3.2	3.3	2.7	2.9	2.4	1.9	4.5	3.1	5.9	2.8	3.4	2.1	3.3	2.7	3.1	3.2	2.2	3.5	4.6	2.5	2.3	2.2	2.9	2.4	3.1	2.1	3.3	5.1	3.6	3.4	2.6	3.3	1.9	11.2	5.5	4.1	2.1	6.6	10.5	3.4	21.2	27.1	14.1	9.9	6.2	5.6	4.9	3.7	18.7	6.7	9.5	6.3	16.6	13.5	8.4	4.1	3.9	21.7	3.4	3.9	5.0	3.7	4.3	17.2	12.9	53.8	123.4	19.8	2.9	6.8	0.8	16.8	8.3	3.4	2.0	4.0	3.5	10.2	2.3	5.8	2.6	4.1	7.1	5.9	4.7	15.4	3.6	8.2	9.4	7.1	2.7	38.9	7.0	5.5	8.6	5.2	3.3	4.5	4.1	7.3	5.0	5.1	13.1	3.0	7.5	4.1	2.6	3.0	6.8	2.3	2.2	3.9	5.2	2.8	1.4	7.2	1.2	5.3	2.2	3.1	1.8	1.6	1.5	3.0	2.3	1.2	1.1	2.4	1.9	2.1	2.2	2.1	1.9	6.9	16.0	13.2	14.7	6.0	3.6	1.4	1.5	5.2	0.0	7.1	7.1	7.1	5.7	8.2	9.2	0.0	2.5	10.9	4.8	5.9	5.2	11.3	8.1	8.7	5.1	1.2	1.3	24.3	6.0	2.1	4.9	2.0	10.1	7.6	8.9	5.3	4.3	2.6	0.0	21.7	5.3	0.0	4.4	2.6	15.3	2.8	8.0	1.8	23.4	11.2	0.0	4.1	17.6	16.6	5.2	2.6	2.2	3.6	2.5	5.0	3.6	9.0	0.0	6.6	4.4	4.2	5.3	5.0	3.5	4.1	1.8	7.4	11.4	2.8	1.9
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239027	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2;lymphoid tissue: 3.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.4;Granulosa cells: 2.5;Spermatocytes: 2.1;Spermatogonia: 2.4;Squamous epithelial cells: 2.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: AB_2681145"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.1	0.1	0.1	1.3	0.2	3.2	0.4	0.8	0.2	0.4	0.1	0.9	0.7	0.2	0.2	1.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.1	0.0	0.3	0.1	0.0	0.1	0.5	0.1	0.1	1.1	0.5	0.3	0.0	0.1	0.6	0.6	0.3	0.0	0.5	0.7	0.8	0.2	3.6	0.1	0.0	2.7	0.2	0.4	0.6	19.0	16.3	14.6	9.3	1.0	1.7	8.0	19.8	9.1	17.0	17.7	13.3	11.6	30.5	7.3	7.2	23.0	15.2	27.8	14.8	30.1	17.5	20.2	10.5	5.5	7.9	0.0	20.7	14.2	0.2	0.9	23.7	4.4	2.8	9.6	15.1	14.1	7.3	17.6	14.8	19.8	12.1	26.6	18.3	24.8	16.4	26.2	5.4	4.4	11.5	12.0	8.6	14.7	9.8	3.6	11.8	7.5	4.6	6.0	11.4	18.3	21.8	13.1	5.7	9.4	25.9	8.1	14.1	11.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	1.7	0.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.3	0.6	0.5	1.5	0.2	0.0	0.0	1.1	0.9	0.6	0.0	0.0	0.3	0.9	0.8	0.3	0.0	3.4	0.9	0.0	1.7	0.5	0.0	0.5	0.0	2.5	0.0	0.0	1.0	0.0	0.7	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.4	2.1	2.4	2.4	0.1	0.4	0.3	0.2	0.9	0.1
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365145-74388749	"Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"bone marrow: 129.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 179.1;Kupffer cells: 133.9;Langerhans cells: 171.1;Macrophages: 570.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 270.0;CAPAN-2: 76.7;hTEC/SVTERT24-B: 83.7;U-2197: 181.4;U-87 MG: 307.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054373			Approved	Vesicles	"Secreted to blood"	NA	NA	46000			"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	4.5	0.0	0.3	10.3	0.3	129.0	2.5	0.2	0.5	1.9	0.2	2.0	0.2	0.2	0.2	12.6	0.8	5.7	0.7	0.3	0.1	0.1	0.2	2.7	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.6	0.4	0.1	3.4	0.1	1.3	0.0	0.2	9.3	1.6	3.0	0.0	0.5	0.2	0.1	0.6	0.1	0.1	0.0	1.0	4.9	4.0	0.3	1.4	41.1	0.0	0.0	3.8	6.6	0.1	9.2	270.0	2.6	1.6	32.5	76.7	0.0	44.1	0.0	20.1	2.4	0.0	59.3	2.7	0.0	0.0	1.2	1.6	1.2	1.1	0.1	0.1	3.9	20.2	83.7	43.5	0.0	0.0	0.0	0.1	0.5	0.2	0.4	0.1	0.1	0.1	0.2	0.6	0.1	0.0	0.1	0.6	1.6	0.0	0.0	27.0	0.2	0.0	0.0	0.1	0.0	0.0	1.6	0.6	181.4	0.0	0.0	0.0	0.2	307.0	0.0	0.2	0.4	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.3	0.1	0.2	0.1	0.4	0.0	0.6	0.3	4.9	6.4	7.2	0.0	5.7	5.4	5.6	179.1	4.0	0.0	24.4	2.3	18.2	5.7	82.4	0.0	0.0	0.4	2.2	56.3	0.0	1.8	3.7	2.4	0.7	2.5	3.6	17.0	0.1	0.2	0.7	4.4	0.5	3.9	7.0	0.1	0.4	1.9	26.8	0.0	1.8	38.2	16.2	133.9	171.1	1.0	0.3	570.7	7.2	0.0	23.2	0.0	0.0	0.0	0.0	0.8	27.1	0.0	11.7	2.5	32.4	0.2	41.9	0.0	0.0	2.5	3.1	0.5	0.3	3.8	9.2	0.7	3.3	0.2	33.1	7.4
ERI3	"FLJ22943, PINT1, PRNPIP"	ENSG00000117419	"ERI1 exoribonuclease family member 3"	O43414	1	44221070-44355260	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 943.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027147, HPA029895"	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA027147: AB_1855725, HPA029895: AB_2673239"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (5.94e-2)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.70e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-3)"	31.1	34.8	105.3	15.5	105.9	24.6	30.5	92.0	140.3	30.1	92.2	34.4	20.6	33.3	34.2	27.9	37.2	20.5	51.7	111.9	98.7	59.8	41.8	25.6	19.3	99.4	108.1	32.4	35.0	45.2	45.1	23.3	122.2	38.8	23.2	22.4	27.8	25.2	77.2	36.1	22.7	28.6	97.2	26.4	28.9	63.3	105.7	24.1	31.2	60.2	20.4	32.2	27.2	103.4	73.6	56.5	69.3	77.7	44.9	55.5	46.0	44.0	61.4	82.1	75.1	37.8	78.3	52.3	76.4	58.7	42.2	41.2	62.6	80.6	55.9	56.9	115.8	60.0	90.2	52.0	67.9	59.3	32.8	57.9	76.9	66.2	91.3	61.0	57.3	59.5	56.4	43.9	55.2	51.2	68.7	57.0	82.2	72.2	83.7	62.6	62.4	75.3	65.2	38.9	120.5	54.9	52.5	71.3	87.7	55.1	46.6	50.1	34.1	54.3	56.5	60.7	72.0	37.7	50.1	56.4	67.7	52.4	70.4	17.6	25.8	15.8	25.5	36.4	27.2	30.8	21.1	24.5	40.3	30.9	24.8	26.0	2.4	26.1	37.3	30.3	29.4	26.2	105.3	105.9	92.0	140.3	111.9	98.7	99.4	108.1	122.2	97.2	105.7	103.4	35.4	25.6	16.5	74.4	26.2	31.6	36.5	64.7	27.3	22.6	36.2	51.3	15.1	15.7	26.2	29.5	2.1	93.2	19.3	31.2	97.8	56.9	202.7	35.3	30.7	27.4	118.3	26.5	36.7	62.5	85.9	39.8	25.0	23.1	15.2	62.8	18.9	22.3	45.0	25.2	34.0	99.1	46.8	19.2	27.2	943.6	36.4	20.1	48.0	38.4	27.9	42.6	15.5	66.4	54.5	37.7	22.2	36.5	28.3	51.0	17.0	167.3	20.4	16.4	6.6	28.5	52.0	68.0	51.4	29.4	34.5	61.6	20.2	54.0	37.1	30.7
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318631-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 498.6;choroid plexus: 136.2"	"Cell type enriched"	"Detected in some"	51	"Oligodendrocytes: 290.9"	"Cancer enriched"	"Detected in some"	4	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HAP1: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	0.7	0.2	212.4	2.3	342.3	18.8	0.5	312.8	386.9	0.5	136.2	0.7	0.5	0.4	0.1	0.4	0.4	0.8	0.3	208.7	266.4	0.5	0.5	2.4	3.3	408.3	313.2	0.2	0.3	0.0	0.4	0.1	391.8	0.3	0.9	0.6	1.7	0.3	0.4	0.7	3.8	0.3	266.5	4.7	1.3	0.5	300.8	1.6	0.4	0.0	3.0	0.7	0.3	498.6	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.3	0.0	1.9	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	3.5	0.4	0.2	0.7	2.3	0.2	0.1	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.5	0.0	0.1	0.0	0.3	0.6	1.2	0.0	0.2	0.1	0.3	0.6	3.4	2.5	0.6	1.7	0.9	0.9	0.5	0.3	0.3	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.3	0.3	0.6	0.5	0.2	0.3	0.2	0.1	212.4	342.3	312.8	386.9	208.7	266.4	408.3	313.2	391.8	266.5	300.8	498.6	0.1	0.0	1.3	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.8	0.2	0.0	1.2	0.9	0.1	0.0	2.2	0.0	1.9	1.1	0.0	3.1	2.0	290.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0
ERRFI1	"GENE-33, MIG-6, RALT"	ENSG00000116285	"ERBB receptor feedback inhibitor 1"	Q9UJM3	1	8004404-8026309	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 743.8;pancreas: 678.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1242.3;Basal prostatic cells: 1428.1;Hepatocytes: 722.3;Suprabasal keratinocytes: 732.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 2.0"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 558.4;LHCN-M2: 442.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076543			Supported	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA076543: "	"unprognostic (2.13e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.03e-3)"	143.6	41.7	13.8	31.0	15.3	1.8	127.6	33.0	20.5	87.0	42.2	61.5	33.3	78.1	18.3	51.2	75.8	131.1	53.3	16.7	20.3	157.3	743.8	82.8	17.6	31.9	16.7	148.5	678.8	88.0	112.1	125.6	17.4	53.1	23.4	36.3	76.1	26.0	225.9	124.6	47.2	88.5	28.6	9.5	125.0	16.5	18.7	18.4	113.4	30.2	12.5	86.9	75.5	20.9	86.1	49.7	20.8	28.2	192.6	143.0	215.7	81.9	23.8	15.0	17.5	22.2	218.9	1.4	47.9	27.6	102.5	18.2	5.8	144.7	68.2	2.6	16.1	1.3	15.1	260.1	558.4	0.9	3.3	195.8	142.7	49.4	118.7	208.4	38.3	3.6	6.1	0.7	442.5	36.8	0.3	5.5	50.0	66.3	121.7	7.4	233.8	1.4	69.3	27.0	14.3	8.5	16.2	36.5	26.0	145.6	25.4	2.0	54.4	57.7	33.9	49.0	116.6	1.3	1.1	1.5	222.0	3.8	54.4	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.1	0.3	0.4	0.0	0.0	2.0	0.1	0.2	0.0	13.8	15.3	33.0	20.5	16.7	20.3	31.9	16.7	17.4	28.6	18.7	20.9	93.0	221.2	108.7	22.5	9.2	1242.3	1428.1	228.6	249.8	9.8	186.3	115.9	52.1	177.3	198.7	27.6	14.6	87.6	25.7	161.9	31.3	99.1	24.0	209.6	74.4	29.8	109.5	21.5	18.4	111.2	51.0	130.1	56.6	336.3	14.5	3.9	32.5	722.3	10.0	3.3	16.5	70.2	59.0	11.7	95.0	63.9	51.9	17.9	71.2	8.4	0.6	40.0	3.1	13.0	30.9	144.9	127.2	38.4	6.6	382.2	78.1	131.1	86.3	9.9	6.6	113.9	93.3	21.1	21.8	152.6	732.9	259.0	33.5	4.9	82.7	543.4
ERVV-1	"ENVV1, FLJ32214, HERV-V1"	ENSG00000269526	"Endogenous retrovirus group V member 1, envelope"	B6SEH8	19	53013921-53016122	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 16.0"	"Cell type enriched"	"Detected in some"	28	"Syncytiotrophoblasts: 260.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.6;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 7.9;SuSa: 6.2"									HPA076115			Approved	Centrosome,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Centrosome	"HPA076115: "	"unprognostic (1.04e-3)"			"unprognostic (7.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"		"unprognostic (1.67e-2)"		"unprognostic (9.92e-2)"		"unprognostic (6.75e-2)"	"unprognostic (4.34e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.35e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	260.9	0.0	0.0	0.0	0.0
ERVV-2	ENVV2	ENSG00000268964	"Endogenous retrovirus group V member 2, envelope"	B6SEH9	19	53044740-53051680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"placenta: 8.4"	"Cell type enriched"	"Detected in single"	4	"Syncytiotrophoblasts: 3.8"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 16.9;SuSa: 10.9;T-47d: 4.6;U-266/84: 2.8"									HPA076115			Approved	Centrosome,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Centrosome	"HPA076115: "				"unprognostic (3.14e-3)"		"unprognostic (2.06e-1)"				"unprognostic (1.31e-1)"			"unprognostic (4.33e-9)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.60e-4)"	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	10.9	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;intestine: 11.0;lymphoid tissue: 8.5;testis: 5.7"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	0.5	0.4	0.0	2.7	0.2	6.0	1.2	0.4	0.2	0.5	0.0	3.7	11.0	0.6	0.0	2.4	0.2	0.6	0.2	0.0	0.0	0.1	0.7	0.4	4.6	0.0	0.0	0.1	1.0	0.3	0.0	1.1	0.1	0.3	4.3	0.5	0.3	0.1	0.0	1.1	7.9	0.7	0.0	0.8	2.5	5.7	0.0	8.5	0.3	0.2	5.7	0.8	0.5	0.2	54.6	39.9	17.9	22.0	2.3	3.9	10.2	31.6	12.9	27.8	32.5	14.2	10.7	21.0	16.6	8.3	24.7	29.2	22.0	8.5	43.6	15.8	9.2	24.4	16.2	15.3	0.3	12.5	21.4	0.7	0.9	17.0	4.2	3.0	11.6	15.2	20.0	30.0	17.7	10.5	49.8	5.9	12.2	29.9	13.4	21.7	53.0	14.8	9.6	31.9	8.0	11.7	15.5	19.6	7.9	6.5	13.2	14.1	5.2	17.9	37.0	36.2	25.7	4.0	11.1	25.2	10.2	20.5	25.2	0.0	0.2	0.1	0.0	0.4	0.0	0.4	0.2	0.2	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	1.3	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	4.7	0.0	2.4	2.3	0.6	2.1	1.8	1.2	1.5	1.7	1.2	0.0	3.3	0.0	4.2	4.6	1.3	8.2	0.0	0.4	5.4	1.3	2.6	1.0	1.2	44.6	0.3	0.0	6.6	3.2	5.6	3.1	1.3	11.4	1.4	1.5	5.4	0.0	0.4	4.4	2.0	2.5	3.5	0.8	1.8	3.2	0.0	1.0	0.5	0.1	4.1	1.0	0.9	0.1	1.5	0.0	11.5	0.6	15.1	0.1	1.6	2.0	6.6	0.8	2.3	62.0	80.0	6.8	0.6	1.0	3.1	1.8	8.0	1.4
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 569.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	123.8	87.5	83.0	73.0	85.5	95.1	146.7	86.3	110.8	141.0	87.7	125.7	106.7	129.7	160.1	93.6	121.8	96.4	151.5	84.3	98.6	194.4	277.2	92.3	93.5	87.3	85.6	179.0	67.3	109.9	81.5	81.9	89.7	112.5	135.0	122.0	92.8	140.3	149.8	83.3	93.4	166.2	94.3	63.9	83.0	54.2	82.4	155.7	155.0	179.0	110.3	104.9	96.2	100.0	138.4	77.9	229.8	160.4	264.5	441.9	62.5	190.8	280.9	264.7	204.6	131.6	162.8	156.5	56.9	233.3	194.0	137.1	256.8	227.2	333.0	180.4	270.4	200.3	70.7	208.6	220.5	400.1	82.2	304.6	207.0	167.9	229.4	316.2	253.2	260.3	200.3	40.7	433.5	135.1	352.7	260.0	59.8	175.2	148.8	277.1	133.6	106.2	378.4	55.4	115.0	130.1	85.0	72.6	160.3	157.6	137.1	223.0	169.2	94.4	113.0	187.5	181.8	27.6	63.5	135.7	205.3	223.2	131.2	35.0	129.4	55.7	48.5	113.6	80.9	104.1	97.6	76.3	142.8	83.4	114.1	90.5	15.0	109.3	106.1	170.7	90.6	100.3	83.0	85.5	86.3	110.8	84.3	98.6	87.3	85.6	89.7	94.3	82.4	100.0	139.0	54.5	56.8	37.5	77.2	134.1	227.4	300.5	148.0	51.5	114.1	123.2	99.2	167.3	111.7	154.5	41.7	160.4	51.2	59.1	360.0	168.0	135.5	102.2	120.6	112.5	108.8	99.5	22.7	103.2	141.0	162.9	51.0	80.7	96.4	71.1	132.1	154.7	227.5	21.9	19.3	114.6	175.0	140.2	148.0	34.8	267.8	108.2	165.4	25.3	144.3	199.5	36.0	23.6	36.2	85.4	92.3	211.4	35.9	99.1	137.1	569.1	94.2	77.3	151.2	196.0	484.2	61.6	46.3	120.6	129.3	74.4	78.2	151.2	199.8	143.6
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	Actin-binding	"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 129.1;retina: 117.8;testis: 145.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 13.4;thalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"HPA028674, HPA060220"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	5.7	0.4	2.6	1.0	28.0	9.2	13.4	1.0	30.3	0.2	28.2	90.4	2.4	39.9	34.3	18.6	0.3	0.9	0.4	1.7	63.4	129.1	3.2	0.3	0.6	1.3	0.4	0.9	26.8	42.1	0.9	1.1	10.0	6.8	117.8	9.4	6.2	0.8	91.7	89.5	0.8	0.3	0.9	2.7	145.3	6.1	1.6	0.4	0.0	1.7	1.3	22.3	0.5	14.1	0.7	0.6	0.1	0.0	0.0	48.9	0.0	0.0	0.2	0.0	29.9	1.5	0.5	6.5	0.0	0.1	32.6	2.3	0.1	0.0	2.0	0.7	0.4	0.7	81.5	0.0	0.6	2.7	0.1	0.6	0.0	0.0	0.0	0.0	1.0	17.6	0.0	0.0	28.2	0.2	1.0	0.6	3.8	12.2	0.0	0.4	10.9	0.2	0.1	21.0	0.7	3.7	160.1	5.0	0.3	53.6	7.4	15.6	0.1	0.8	0.6	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	13.4	1.0	0.4	1.7	0.6	1.3	1.1	0.3	6.1	0.5	0.2	0.0	0.6	0.0	0.8	7.8	2.4	4.5	12.5	5.6	10.7	3.9	1.4	11.5	3.8	9.2	68.8	3.0	0.2	175.5	13.7	0.2	137.5	19.1	0.9	0.8	6.0	8.2	0.2	3.1	0.5	0.3	5.6	12.4	0.0	0.0	3.9	109.4	0.2	0.0	0.2	36.3	8.2	3.2	0.9	461.6	3.7	1.5	0.0	0.0	0.0	272.5	0.0	0.0	0.1	0.1	186.3	2.2	0.0	1.6	512.1	102.2	9.0	72.5	0.0	0.0	0.2	12.3	3.9	17.6	22.7	6.6	1.5	0.0	35.3	2.9
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305497-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 159.2;Hepatocytes: 266.3;Proximal enterocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053785, HPA077297"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: AB_2682260, HPA077297: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	27.3	35.5	25.5	15.8	29.8	16.3	23.6	36.4	31.4	17.5	33.6	67.6	81.8	15.5	4.7	62.7	14.6	10.2	154.9	23.5	31.6	70.3	91.5	30.9	11.0	30.9	31.7	8.1	56.3	23.9	15.9	15.4	29.8	26.4	22.9	5.1	48.5	12.6	195.3	35.9	65.4	7.1	26.6	32.0	52.4	8.4	37.5	8.4	28.3	88.8	12.4	31.0	28.8	23.7	25.9	40.2	9.8	23.6	13.0	12.7	54.2	25.0	11.9	9.2	9.0	37.4	30.3	34.9	45.1	12.8	23.7	66.0	16.9	33.0	3.5	23.0	21.0	22.9	51.7	30.1	18.0	39.3	55.3	17.4	49.8	20.7	27.0	12.8	12.8	18.1	37.9	18.7	15.3	57.9	19.4	55.9	27.9	30.4	74.4	20.4	19.7	79.6	31.1	52.4	20.6	26.2	12.8	81.2	83.8	5.5	25.8	38.2	28.9	16.6	20.4	47.4	25.6	28.6	25.5	23.6	26.9	38.2	13.4	0.2	2.9	4.8	2.7	5.4	2.6	1.7	2.3	1.9	2.7	2.3	2.3	3.3	5.3	1.8	5.1	2.1	3.6	1.7	25.5	29.8	36.4	31.4	23.5	31.6	30.9	31.7	29.8	26.6	37.5	23.7	20.8	9.6	22.7	21.2	14.7	18.6	41.0	29.7	18.8	28.8	30.9	24.3	9.2	100.1	21.3	20.2	33.3	103.8	20.9	159.2	54.8	51.3	3.4	18.7	17.4	15.3	37.8	19.4	13.6	80.2	61.3	12.4	39.8	20.3	7.6	9.3	35.0	266.3	33.6	33.7	16.6	82.5	28.5	82.7	11.7	1.1	6.5	22.2	17.8	11.2	28.8	20.1	27.8	9.0	6.4	81.1	103.1	12.0	8.2	42.8	199.7	82.2	19.8	20.4	13.1	18.7	21.7	3.5	7.1	26.3	18.5	134.2	14.5	22.2	113.7	65.0
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 36.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 13.7;Early spermatids: 14.1;Horizontal cells: 55.5;Late spermatids: 37.6;Rod photoreceptor cells: 40.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;K-562: 5.0;U-266/70: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA074772			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA074772: "	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.9	0.3	0.6	6.6	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	36.5	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.1	2.4	1.2	0.9	0.1	0.0	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.2	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.2	2.3	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.3	0.6	1.5	1.2	0.7	0.6	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.4	5.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	13.7	0.0	14.1	0.0	0.0	0.8	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	2.0	0.0	0.0	0.0	0.0	37.6	0.0	0.1	0.0	3.7	0.0	4.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.3	0.0	0.1	0.8	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ESRRG	"ERR-gamma, ERRg, NR3B3"	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.6;parathyroid gland: 46.3;retina: 36.1;stomach 1: 35.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 330.7;Excitatory neurons: 415.2;Inhibitory neurons: 495.5;Oligodendrocyte precursor cells: 391.6;Oligodendrocytes: 218.7;Syncytiotrophoblasts: 214.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 23.0;SH-SY5Y: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm		No	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.4	6.4	1.1	0.2	3.1	0.0	3.6	16.9	12.3	1.5	7.4	0.5	5.3	0.4	0.9	1.6	2.5	0.7	10.6	4.4	2.3	29.0	0.7	0.5	0.2	45.4	4.9	0.7	5.7	46.3	1.5	10.6	49.6	3.1	0.3	36.1	16.0	0.7	5.8	0.8	5.0	0.2	1.6	1.1	35.1	1.1	3.5	0.6	5.9	10.2	0.3	0.7	0.2	6.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.0	0.2	0.0	0.0	23.0	3.4	2.5	8.1	42.4	0.0	0.4	0.0	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	3.1	16.9	12.3	4.4	2.3	45.4	4.9	49.6	1.6	3.5	6.1	0.2	0.0	1.8	330.7	0.2	0.3	3.8	0.6	0.6	29.5	9.5	5.2	51.2	10.0	1.8	23.9	58.4	35.4	0.0	0.0	54.8	5.0	5.1	15.9	2.0	1.3	8.3	0.0	415.2	2.4	4.7	3.0	70.3	3.5	0.0	0.5	1.1	0.6	4.8	48.8	495.5	1.7	14.2	0.3	0.4	8.1	0.3	0.5	8.8	36.5	0.0	13.3	0.0	391.6	218.7	0.4	1.3	0.7	0.1	4.9	16.3	29.0	16.0	41.3	0.0	10.3	0.4	1.6	0.3	0.8	0.3	214.9	0.3	1.1	2.6	1.7
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein subunit alpha"	P13804	15	76215353-76311472	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 389.7;tongue: 493.5"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 402.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria		NA	NA		680000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	93.0	112.3	33.8	55.0	36.0	63.0	70.4	36.0	54.6	38.7	40.3	131.4	135.6	27.0	30.6	85.1	30.1	44.7	243.0	34.2	37.6	180.0	389.7	39.0	60.9	35.6	35.7	25.6	81.6	71.0	13.9	70.9	36.0	42.2	123.5	34.3	49.3	38.2	300.8	40.1	116.3	65.7	35.5	38.8	67.7	28.4	38.2	54.5	38.7	493.5	65.9	74.0	33.1	36.9	122.4	196.7	128.2	134.8	141.7	149.1	201.0	144.4	166.2	183.0	162.8	175.3	221.3	203.5	141.3	144.3	138.5	304.6	502.7	200.2	211.9	245.8	98.0	222.2	131.4	205.2	114.7	214.5	158.7	112.7	185.9	93.1	153.5	100.0	187.8	64.7	214.1	205.2	190.3	191.2	44.9	178.2	99.9	225.3	58.4	192.8	158.6	272.8	202.1	386.9	133.3	67.2	218.2	492.2	205.0	294.4	254.1	223.4	111.4	178.2	119.5	157.0	177.4	99.0	221.0	255.9	127.8	281.1	128.5	50.0	120.3	82.7	65.4	110.3	61.7	77.3	60.6	67.6	159.4	67.3	48.8	60.1	30.2	122.9	96.1	63.4	95.8	141.9	33.8	36.0	36.0	54.6	34.2	37.6	35.6	35.7	36.0	35.5	38.2	36.9	65.7	57.7	41.6	45.1	54.3	53.4	110.8	151.5	44.9	13.1	47.2	46.4	352.9	65.8	84.5	36.8	22.9	277.4	61.1	250.9	209.4	106.5	11.7	29.5	45.1	51.8	65.4	117.8	26.0	84.1	180.8	66.8	90.2	37.0	38.6	53.1	48.9	348.8	132.3	53.8	31.5	141.6	89.5	79.0	84.5	7.9	59.4	103.0	56.9	28.1	129.0	26.7	85.5	37.2	46.9	92.1	176.2	58.3	87.8	92.4	231.1	402.9	50.2	20.4	46.0	44.0	113.7	66.4	40.5	79.5	57.1	300.2	55.5	123.4	187.3	162.0
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1 persulfide dioxygenase"	O95571	19	43506719-43527230	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 256.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1037.7;Paneth cells: 788.4;Proximal enterocytes: 376.3;Undifferentiated cells: 447.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 222.6;OE19: 360.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	24.4	27.9	16.1	34.8	17.0	45.8	26.7	16.5	17.3	28.7	15.8	256.1	85.5	18.3	29.8	81.0	20.6	21.0	18.8	15.6	17.4	40.4	52.7	30.5	23.4	17.3	17.2	13.5	28.9	16.1	19.1	26.3	16.6	27.1	226.6	3.2	40.1	18.5	22.8	27.2	77.0	35.6	17.1	27.8	37.8	3.0	18.2	19.8	24.1	21.9	41.7	34.4	39.1	17.2	54.1	68.9	14.1	49.6	75.1	50.9	5.5	82.1	222.6	69.8	71.1	21.1	54.3	0.2	60.0	79.8	22.2	42.9	20.6	123.4	19.6	26.2	6.2	13.8	29.7	59.2	34.0	19.3	18.4	52.2	95.1	26.9	76.0	92.2	52.0	49.8	9.0	87.6	35.1	35.7	22.2	18.9	3.8	360.5	32.9	26.6	6.1	12.0	153.0	110.9	0.2	16.6	20.8	74.8	50.6	23.6	22.4	34.3	41.6	10.9	46.9	13.1	15.3	23.1	20.2	1.4	48.4	83.8	57.7	24.2	63.3	1.6	41.1	34.5	48.3	20.5	47.6	39.4	95.8	7.5	36.4	35.0	2.1	29.3	22.8	17.9	50.4	40.2	16.1	17.0	16.5	17.3	15.6	17.4	17.3	17.2	16.6	17.1	18.2	17.2	32.0	22.4	23.4	3.9	25.5	34.5	82.2	242.5	57.5	9.8	85.8	95.2	9.8	47.1	84.5	55.2	0.0	191.6	38.0	1037.7	54.8	71.7	0.9	31.0	41.2	44.9	63.7	17.4	6.2	63.6	95.7	42.1	53.5	68.2	38.0	12.6	42.1	89.2	115.1	5.0	6.8	324.2	79.3	105.0	78.5	2.1	17.7	74.6	80.0	3.7	78.5	11.7	63.8	4.0	5.6	102.7	788.4	16.1	34.9	75.0	376.3	136.4	23.1	5.8	19.7	32.0	45.1	2.1	6.2	82.8	23.2	92.5	50.4	15.8	447.5	146.5
ETNK1	"EKI, EKI1"	ENSG00000139163	"Ethanolamine kinase 1"	Q9HBU6	12	22625075-22690665	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 299.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010712, HPA029407"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA010712: AB_2668349, HPA029407: AB_2673026"	"unprognostic (2.06e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.98e-3)"	"unprognostic (8.30e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.53e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.75e-4)"	10.1	14.4	13.7	14.5	15.2	12.2	13.7	9.0	15.9	10.8	16.4	27.2	23.3	10.2	19.6	10.8	10.1	14.0	7.3	14.7	28.1	18.4	18.2	12.6	17.4	12.0	14.2	11.7	10.7	10.8	13.7	11.3	15.8	10.9	15.3	18.2	12.4	6.2	6.2	15.3	15.5	7.6	11.1	16.7	45.0	17.8	19.3	23.1	14.5	5.6	14.3	10.8	9.5	17.5	14.8	27.9	30.4	27.5	21.2	21.3	21.7	15.6	12.2	17.4	16.0	20.6	33.3	41.1	14.7	11.6	16.5	10.7	27.1	7.6	28.2	36.8	23.7	34.7	11.5	18.9	20.6	33.9	29.4	13.7	7.2	21.9	17.4	25.8	20.3	15.7	41.8	17.2	22.3	7.7	38.8	67.1	59.3	17.9	20.1	32.7	28.1	32.9	25.6	16.5	9.8	17.8	18.9	13.9	27.1	41.1	24.1	32.1	17.5	12.2	19.9	18.6	25.0	12.9	18.1	46.8	16.2	21.0	23.9	44.0	14.3	15.9	15.4	22.0	15.2	22.2	16.4	14.4	14.1	15.3	17.7	17.7	14.6	17.7	23.4	12.6	20.5	19.2	13.7	15.2	9.0	15.9	14.7	28.1	12.0	14.2	15.8	11.1	19.3	17.5	33.6	48.1	32.2	48.0	55.9	144.3	75.7	34.7	64.9	41.0	56.8	42.2	10.1	45.8	43.8	44.1	50.1	30.1	57.6	116.1	27.4	30.7	299.0	64.2	49.1	34.8	108.3	48.8	104.4	44.5	24.2	38.2	230.4	51.4	34.8	40.9	28.2	41.5	42.9	26.9	104.3	60.7	46.8	88.3	60.0	43.5	24.2	57.0	67.6	84.3	39.1	17.7	43.3	121.2	152.9	39.5	62.9	21.4	63.7	73.8	57.7	33.2	81.6	39.5	39.5	23.3	38.9	49.1	18.5	51.9	170.2	75.4	49.0	41.5	47.8	90.3
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742048-108763054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.6;liver: 191.1"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 219.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Supported		Approved	Nucleoplasm		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	0.3	5.5	155.6	0.1	155.6	0.0	0.1	98.4	144.3	0.1	47.4	0.0	0.2	0.3	0.0	0.1	0.0	0.2	10.6	124.4	145.8	9.1	191.1	0.1	0.0	100.7	118.1	0.1	0.0	2.9	1.9	0.0	110.3	0.0	0.0	1.7	34.4	0.1	2.4	0.0	0.0	0.0	101.2	0.7	18.3	0.5	119.8	0.1	1.1	1.5	0.0	0.0	0.0	101.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.6	155.6	98.4	144.3	124.4	145.8	100.7	118.1	110.3	101.2	119.8	101.3	0.0	0.0	0.0	219.4	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.4	0.0	0.0	0.7	26.8	0.0	0.0	0.6	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	7.5	0.0	8.5	0.0	1.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 328.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 352.9;JURKAT: 362.3;U-698: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	101.2	19.2	11.7	145.7	10.4	35.3	65.4	9.8	14.1	35.9	8.9	31.2	26.9	36.5	9.3	21.8	20.2	62.5	43.0	8.9	11.3	30.4	47.6	76.2	277.1	13.1	14.7	27.0	20.1	28.4	7.8	56.3	13.4	17.1	31.4	1.8	16.5	20.7	25.6	18.1	49.3	38.1	11.6	185.8	46.1	8.0	15.2	328.8	39.8	42.3	250.2	67.9	19.2	11.3	87.7	15.7	72.8	0.3	30.7	49.3	0.2	65.7	140.2	80.9	77.3	5.1	91.7	312.1	65.7	109.5	184.7	29.8	7.0	190.0	169.0	66.6	1.1	352.9	6.4	0.3	82.2	36.7	4.0	97.2	15.0	69.6	252.2	46.1	67.9	362.3	0.6	63.3	98.1	0.0	185.7	27.4	27.0	7.9	55.0	50.4	118.7	24.5	64.2	95.6	0.9	5.0	34.5	0.7	73.6	48.5	0.3	17.7	126.1	180.5	57.1	35.5	109.1	46.7	8.9	462.5	32.2	68.0	162.1	51.2	0.1	6.6	20.4	0.3	28.9	12.3	27.0	25.0	0.2	9.2	32.5	26.1	1.1	27.8	1.0	6.2	33.3	9.5	11.7	10.4	9.8	14.1	8.9	11.3	13.1	14.7	13.4	11.6	15.2	11.3	263.1	25.6	26.5	2.9	125.6	114.8	41.0	12.4	1.8	0.0	8.2	7.2	9.0	4.3	24.3	11.0	0.0	0.2	378.9	13.1	0.0	31.9	6.2	26.3	51.0	190.4	15.5	13.7	2.0	22.6	0.5	45.5	17.3	66.2	19.6	1.3	213.8	5.4	7.3	0.0	25.6	15.0	10.2	18.3	48.2	1.5	14.0	12.5	69.4	65.6	16.8	0.2	399.6	55.3	9.5	99.3	6.6	15.4	129.6	26.8	2.2	4.6	5.9	0.2	105.2	55.5	76.6	0.7	1.8	1.5	63.2	0.4	323.2	40.4	5.8	32.6
ETV1	ER81	ENSG00000006468	"ETS variant transcription factor 1"	P50549	7	13891229-13991425	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 119.9;salivary gland: 91.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 137.7;Astrocytes: 67.3;Cardiomyocytes: 87.7;Enteroendocrine cells: 198.1;Excitatory neurons: 66.9;Oligodendrocyte precursor cells: 135.7"	"Cancer enhanced"	"Detected in all"		"glioma: 22.5"	"Group enriched"	"Detected in all"	5	"cerebellum: 119.9;thalamus: 32.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 67.8;hTERT-RPE1: 76.2;SCLC-21H: 79.3;U-87 MG: 157.2;WM-115: 78.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 200.7"	"HPA068389, HPA077249"		Supported	Approved	Nucleoplasm		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA068389: , HPA077249: AB_2686829"	"unprognostic (2.45e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.64e-7)"	"unprognostic (7.08e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	4.9	23.0	13.6	1.9	10.9	0.2	8.2	119.9	12.1	2.3	0.1	4.1	2.2	4.4	2.3	2.7	1.5	17.3	35.6	14.6	5.6	3.2	3.9	28.7	1.4	4.6	14.0	1.4	3.1	11.5	7.4	3.5	9.0	5.5	4.3	4.5	91.6	12.6	0.8	1.9	3.5	3.5	3.1	9.1	2.6	8.9	32.8	4.7	12.2	2.5	1.9	2.7	1.5	8.1	0.1	4.9	35.5	67.8	12.1	35.4	0.1	3.2	12.1	2.0	8.0	0.0	16.6	0.0	3.6	5.6	9.8	0.4	1.5	3.8	4.3	0.9	1.6	2.1	3.1	0.0	7.1	12.3	4.5	10.7	0.0	23.3	1.9	76.2	15.3	1.1	11.0	0.6	14.6	0.0	0.1	0.0	53.2	2.1	36.5	0.0	21.5	2.9	23.7	0.4	79.3	15.6	0.0	1.2	19.6	12.2	1.2	0.5	8.6	7.0	2.2	13.8	13.4	12.2	4.1	0.0	157.2	0.8	78.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	13.6	10.9	119.9	12.1	14.6	5.6	4.6	14.0	9.0	3.1	32.8	8.1	16.0	19.2	137.7	67.3	0.0	1.0	2.8	0.9	13.6	4.9	5.8	23.6	87.7	28.6	0.7	3.7	0.0	0.6	0.1	0.8	5.9	3.6	25.4	1.3	3.9	11.1	198.1	0.8	66.9	0.9	0.4	17.7	1.1	2.0	2.5	0.2	2.9	13.1	3.4	5.0	45.3	2.4	0.0	7.2	1.6	8.7	1.5	0.7	12.4	28.1	0.0	12.6	0.0	135.7	4.3	0.9	0.1	34.6	1.2	0.6	0.0	3.0	1.4	0.6	19.7	17.4	12.6	1.2	2.1	3.1	1.3	0.3	2.2	9.7	1.2	0.3
ETV3	PE-1	ENSG00000117036	"ETS variant transcription factor 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 361.2;monocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004794, HPA073211"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA004794: AB_1078761, HPA073211: "	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	13.7	7.7	6.6	11.1	6.6	24.0	12.1	7.9	20.1	8.3	5.3	8.7	15.1	9.3	7.5	15.6	7.8	12.7	7.4	8.3	8.1	6.6	6.6	12.6	10.1	7.7	6.5	11.5	6.4	23.9	5.0	12.8	7.0	10.2	9.5	5.7	9.2	8.5	9.4	31.5	14.6	10.1	7.1	10.0	10.0	9.4	7.4	10.8	7.9	8.8	12.5	17.6	11.4	7.1	11.9	11.4	11.6	10.1	17.3	11.3	9.9	10.9	11.4	10.5	9.7	12.2	11.6	14.2	13.4	13.4	5.6	18.0	12.8	16.7	13.8	31.0	8.1	11.9	12.2	6.7	10.3	19.0	18.1	12.5	19.2	15.7	13.3	8.5	11.1	8.8	13.9	10.2	12.0	15.7	5.8	10.7	38.6	16.9	8.7	8.7	13.8	16.3	8.1	43.9	9.8	19.0	11.9	28.1	29.5	20.7	14.4	20.7	18.8	13.5	11.9	13.2	13.7	24.6	13.5	16.7	15.5	10.9	45.2	6.3	4.6	3.3	4.5	4.2	6.2	2.1	3.9	4.5	4.5	2.4	3.9	3.5	5.4	4.2	4.2	1.2	3.3	2.6	6.6	6.6	7.9	20.1	8.3	8.1	7.7	6.5	7.0	7.1	7.4	7.1	22.9	35.3	16.2	3.6	20.4	70.4	18.4	20.2	71.7	2.3	18.2	14.4	9.4	5.7	24.3	12.9	10.4	7.5	37.2	22.1	0.0	6.4	9.4	18.1	18.0	19.4	10.7	5.9	8.1	6.3	9.0	16.3	15.3	29.5	22.2	6.4	15.4	8.3	8.7	1.7	6.9	12.5	10.2	13.2	361.2	7.3	4.1	69.0	16.0	5.6	97.0	3.9	10.3	6.0	4.4	10.4	13.4	4.5	25.3	16.5	16.0	3.2	29.7	6.3	13.1	16.4	15.4	10.2	9.4	64.2	78.7	14.9	40.4	6.0	14.4	51.4
ETV4	"E1A-F, E1AF, PEA3"	ENSG00000175832	"ETS variant transcription factor 4"	P43268	17	43527844-43579620	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 23.3;Cholangiocytes: 17.2;Distal tubular cells: 17.6;Enteroendocrine cells: 14.9;Extravillous trophoblasts: 19.8;Syncytiotrophoblasts: 14.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 80.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 177.7;Hep G2: 173.0;SK-MEL-30: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005768	Approved		Supported	"Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli rim"	"Mitotic chromosome"	"HPA005768: AB_1848294"	"unprognostic (2.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.58e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.08e-2)"	"prognostic favorable (7.60e-4)"	"unprognostic (1.69e-1)"	0.5	2.4	1.2	1.0	1.6	0.0	7.0	0.8	2.2	3.6	0.0	2.0	6.1	2.4	1.0	9.2	2.5	6.4	3.1	1.3	0.8	5.4	1.2	2.2	0.6	1.0	0.9	0.4	7.8	7.9	14.7	5.2	1.4	4.5	1.7	3.0	4.6	3.6	1.3	6.4	4.2	1.4	0.3	0.4	3.8	1.2	0.7	0.3	6.9	2.5	4.8	2.1	5.3	0.9	24.5	67.0	80.4	177.7	3.1	20.1	17.9	7.9	21.1	14.9	15.2	38.1	33.9	0.1	4.3	4.1	36.6	43.6	2.7	40.2	13.2	0.8	0.5	2.3	10.7	173.0	4.3	47.0	20.9	3.6	1.4	56.8	35.0	16.8	32.1	0.3	48.9	0.1	31.0	9.8	0.2	82.9	116.9	123.1	110.9	99.8	9.8	58.9	33.0	17.3	0.1	71.4	2.1	4.5	197.0	43.8	0.8	13.9	15.1	10.6	52.0	15.7	22.1	7.3	47.8	0.1	18.9	8.9	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.8	2.2	1.3	0.8	1.0	0.9	1.4	0.3	0.7	0.9	0.2	0.0	0.0	1.3	0.0	1.9	2.5	3.6	23.3	3.2	10.4	12.3	1.1	17.2	2.4	0.0	0.0	2.3	0.1	1.1	17.6	6.5	3.1	0.7	0.3	1.5	14.9	0.0	1.6	1.0	19.8	1.9	3.1	1.6	0.0	0.2	0.7	0.0	0.8	0.0	1.0	4.0	2.0	0.3	0.3	6.0	0.3	0.2	3.6	1.0	0.0	10.9	0.0	1.0	0.0	3.7	3.3	0.4	0.0	0.9	1.9	0.1	1.0	0.3	0.0	2.1	1.7	0.0	1.3	3.6	1.1	14.9	0.3	0.1	7.7	4.3
EVC2	LBN	ENSG00000173040	"EvC ciliary complex subunit 2"	Q86UK5	4	5542772-5709548	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.6;Basal squamous epithelial cells: 12.0;Fibroblasts: 8.9;Leydig cells: 11.5;Skeletal myocytes: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.7;HHSteC: 13.0;hTERT-HME1: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040910, HPA048122"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Microtubules, Cytokinetic bridge"	"Nucleoplasm, Cytosol"	"HPA040910: AB_2677195, HPA048122: AB_2680272"	"unprognostic (6.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.57e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (1.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.61e-2)"	"unprognostic (6.29e-5)"	4.8	0.7	1.3	1.5	1.4	0.1	3.6	1.2	1.1	6.0	2.3	3.7	0.6	4.7	1.7	2.2	4.7	2.7	3.1	1.3	1.4	2.6	0.7	2.1	1.9	1.6	1.5	7.8	1.7	3.1	1.1	1.3	1.2	3.2	0.6	0.3	2.8	2.0	1.1	3.8	2.0	2.3	1.4	1.0	2.1	1.6	1.5	1.0	3.8	1.9	1.7	4.1	4.4	1.3	0.0	2.7	0.0	6.6	8.4	9.3	0.0	4.1	9.7	3.6	6.0	0.0	0.0	5.2	0.0	3.3	2.0	2.8	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	5.9	4.6	4.6	10.6	0.0	3.9	0.0	0.0	0.2	5.3	0.0	0.0	0.0	3.9	0.0	0.0	8.6	8.2	0.0	0.4	0.0	0.4	0.6	0.0	0.0	0.0	1.6	0.0	0.5	6.7	0.0	0.0	2.4	0.0	4.1	4.7	1.2	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	1.4	1.2	1.1	1.3	1.4	1.6	1.5	1.2	1.4	1.5	1.3	0.6	0.0	0.5	17.6	0.8	2.2	4.9	2.3	12.0	0.0	0.9	2.2	1.0	1.5	1.3	0.0	0.0	8.3	1.7	0.0	0.0	1.9	2.2	0.7	5.6	1.2	0.0	0.4	0.3	0.5	0.3	8.9	0.5	1.7	2.5	4.7	1.4	0.1	0.5	0.0	0.3	0.0	0.0	0.3	1.2	0.9	11.5	0.8	0.0	6.5	0.0	1.9	1.0	1.0	0.3	0.6	0.0	7.9	1.7	2.8	0.0	0.9	1.0	0.1	0.0	14.7	3.2	1.8	2.1	4.4	0.9	1.4	2.8	3.4	0.0	1.4
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim"		No	No		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli rim"	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	84.8	102.2	63.2	93.2	64.7	172.3	80.3	70.3	69.5	87.9	61.2	90.5	88.0	105.1	61.9	99.0	86.0	56.1	101.7	64.7	63.7	88.0	85.0	76.8	120.1	67.4	64.7	86.8	79.1	98.0	64.1	70.2	63.6	78.4	84.4	111.2	76.5	77.3	140.0	88.0	92.6	86.9	59.7	101.0	84.3	135.5	63.9	183.0	77.2	79.9	126.8	88.1	86.2	71.8	307.7	239.7	327.6	249.1	166.0	136.0	218.2	188.1	301.3	309.9	264.5	270.3	154.5	428.0	114.1	294.3	234.9	238.9	471.5	392.6	313.7	287.5	341.6	323.9	218.8	262.7	246.5	499.5	219.3	211.1	162.5	259.1	413.0	152.2	244.2	201.1	248.3	186.0	233.8	310.6	505.9	185.8	221.1	261.4	182.8	348.1	317.2	253.3	288.0	328.2	261.4	247.7	236.3	258.5	195.9	216.2	170.9	261.0	246.3	184.4	198.2	115.1	272.3	236.2	205.5	387.4	169.9	220.6	224.4	203.9	201.1	182.6	195.2	283.5	199.5	169.4	181.3	194.4	227.5	191.3	175.8	170.9	148.1	216.9	293.0	122.0	244.0	314.2	63.2	64.7	70.3	69.5	64.7	63.7	67.4	64.7	63.6	59.7	63.9	71.8	77.5	102.5	106.8	68.6	130.8	69.5	145.2	153.2	108.1	72.4	63.8	46.6	68.0	87.2	127.2	64.4	75.0	141.0	91.3	92.4	66.5	121.7	165.4	96.3	88.1	88.3	80.9	102.0	55.8	107.6	133.5	85.4	117.2	115.2	121.0	88.5	71.7	71.7	99.3	82.4	60.8	110.9	136.3	69.7	94.0	32.7	61.5	91.9	81.8	47.8	110.9	72.8	122.6	49.8	67.6	116.5	106.4	62.1	156.6	97.4	79.4	72.6	128.9	84.9	52.6	93.1	141.4	209.6	107.5	105.5	58.5	152.4	121.4	84.9	110.2	115.1
EXOC3	"SEC6L1, Sec6p"	ENSG00000180104	"Exocyst complex component 3"	O60645	5	443175-471937	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037880			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA037880: AB_2675716"	"unprognostic (2.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.82e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.70e-1)"	27.1	22.0	16.7	20.3	19.1	24.3	25.5	20.9	18.7	27.0	18.5	38.1	20.8	29.1	10.7	36.4	25.6	19.3	28.6	19.0	19.0	22.7	21.8	22.3	23.6	18.5	18.4	26.1	31.7	22.1	26.0	18.5	19.8	24.6	14.4	8.0	26.7	20.3	78.8	34.4	27.0	19.0	16.6	26.5	32.9	35.6	18.2	22.9	25.0	41.2	20.1	31.4	27.6	20.3	33.5	55.3	18.2	40.9	30.6	26.3	45.2	29.1	29.9	28.6	34.5	28.0	48.0	28.4	44.2	36.6	35.3	37.2	14.7	25.2	20.9	105.8	25.7	30.6	114.0	21.3	28.6	46.0	73.9	26.8	18.4	32.1	28.0	30.0	32.5	18.3	23.6	18.1	22.5	39.7	33.2	54.8	15.1	20.5	33.0	27.0	20.9	36.5	24.1	41.4	18.2	23.2	72.5	40.5	28.8	17.7	54.8	52.5	24.5	28.3	34.6	22.0	23.8	30.3	23.6	20.2	29.8	55.1	26.2	10.4	10.5	61.0	11.2	12.4	9.8	6.0	8.8	9.1	6.6	6.4	11.1	10.2	14.8	19.4	9.1	4.8	12.4	7.1	16.7	19.1	20.9	18.7	19.0	19.0	18.5	18.4	19.8	16.6	18.2	20.3	15.5	22.4	29.1	15.0	14.1	42.8	16.3	18.6	20.5	14.0	18.1	16.5	31.4	14.3	21.1	14.7	35.5	25.3	15.6	28.9	27.4	27.3	31.8	16.4	16.2	17.1	5.4	14.7	12.6	30.2	24.2	16.6	23.4	17.0	22.9	27.7	13.9	16.9	24.0	63.9	11.2	20.3	18.3	26.9	23.8	65.3	20.2	24.6	26.6	10.3	25.2	17.0	13.4	10.6	16.7	26.4	23.1	17.0	18.6	18.0	25.5	23.1	29.3	20.2	19.7	19.1	24.8	33.9	29.7	29.4	53.8	34.1	22.7	21.1	23.5	24.6
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099869	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.33e-1)"	31.8	21.4	18.3	25.9	18.4	39.4	30.8	23.1	22.2	32.5	14.7	27.6	20.7	28.7	23.9	27.3	26.4	19.2	20.3	17.7	15.9	21.8	20.0	24.3	31.1	17.2	15.2	35.8	24.0	25.2	26.1	26.1	16.6	25.3	27.6	35.4	25.4	21.0	33.3	37.0	26.1	27.5	13.7	27.4	26.1	23.4	17.9	32.7	23.3	22.6	34.2	24.6	28.4	19.1	66.4	41.5	84.9	33.0	44.3	48.7	48.5	63.8	46.8	109.8	99.1	61.6	94.1	66.3	40.3	61.0	48.8	64.2	95.0	71.2	100.1	74.9	95.0	96.5	80.5	63.2	43.4	79.5	73.7	38.4	60.2	108.1	63.1	40.9	69.4	58.0	103.2	59.3	61.4	37.4	78.5	73.1	56.5	50.3	49.1	79.8	72.2	58.1	64.8	33.3	54.5	53.3	68.8	58.9	77.0	59.4	51.5	72.1	63.6	58.2	60.4	53.0	76.2	35.7	60.0	130.0	59.4	116.2	71.5	57.7	32.0	26.6	36.2	41.5	43.0	36.4	37.7	36.7	37.9	36.5	31.9	35.4	6.2	49.3	51.2	19.3	39.4	43.3	18.3	18.4	23.1	22.2	17.7	15.9	17.2	15.2	16.6	13.7	17.9	19.1	18.4	28.9	18.3	17.0	26.1	13.3	14.3	19.8	26.2	14.9	11.0	23.6	6.4	12.8	29.2	5.5	47.9	26.5	18.8	16.4	9.8	25.0	16.4	14.3	21.0	20.1	9.0	28.0	20.3	31.9	34.3	17.2	31.1	19.2	20.2	26.2	13.9	11.1	24.7	21.9	24.3	16.5	22.4	15.1	14.1	7.1	29.5	18.7	12.4	9.4	24.0	6.1	28.8	30.2	15.2	30.2	9.4	23.0	26.8	8.5	12.7	8.8	27.3	34.8	13.1	18.4	17.6	21.9	20.8	28.7	13.4	22.7	21.2	19.7	20.1	10.0
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease variant, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	9.1	8.2	8.6	13.8	8.7	9.9	12.6	8.9	11.1	8.9	8.6	10.3	7.7	12.8	6.8	10.0	12.8	5.6	8.8	8.9	8.9	9.7	13.0	6.7	13.0	8.5	8.6	14.8	9.9	11.5	3.2	9.2	8.4	9.3	11.9	10.6	7.1	9.0	15.0	8.4	8.3	12.9	8.9	8.3	8.2	4.1	8.6	14.6	8.4	12.0	15.8	10.1	8.6	9.3	39.9	79.7	46.6	41.2	16.8	18.9	34.0	58.6	28.1	57.4	44.1	64.4	33.7	79.0	31.2	31.8	62.9	71.0	75.8	58.8	62.9	46.9	36.7	63.1	75.2	45.3	31.3	96.7	39.9	24.0	21.7	80.8	94.1	21.1	41.6	52.3	70.1	33.1	41.0	70.3	68.2	27.3	57.8	109.3	51.0	52.3	85.8	85.5	27.5	36.4	28.6	31.8	68.3	51.4	31.1	32.8	53.5	34.1	25.5	56.1	43.5	50.2	83.3	16.8	71.4	117.2	40.0	55.0	44.7	1.7	7.3	6.0	10.0	8.3	10.6	11.6	10.2	8.9	10.4	10.0	11.1	9.4	1.6	16.5	5.7	7.1	10.1	7.7	8.6	8.7	8.9	11.1	8.9	8.9	8.5	8.6	8.4	8.9	8.6	9.3	7.6	6.4	20.5	3.6	13.5	10.6	12.6	7.7	8.0	12.4	6.1	8.3	8.7	4.3	5.7	3.7	6.2	19.1	10.6	6.0	5.9	13.4	1.4	3.8	11.4	8.0	1.2	23.5	5.3	11.3	22.8	9.8	5.1	4.5	12.7	14.0	7.1	10.7	12.8	5.0	5.2	7.9	4.1	2.5	5.7	1.7	8.4	7.8	7.2	1.9	5.4	14.7	13.4	4.5	4.0	8.3	2.7	7.9	13.7	14.2	5.0	10.4	6.7	15.0	6.6	11.7	10.2	5.8	10.9	10.6	8.4	8.3	10.1	11.9	10.0	8.1
EXOSC8	"bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p"	ENSG00000120699	"Exosome component 8"	Q96B26	13	36998816-37009614	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034240, HPA039702, HPA043942, HPA075230"	Uncertain		Supported	"Nucleoli fibrillar center,Mitotic chromosome,Vesicles"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitotic chromosome, Vesicles"		"CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: AB_2678742, HPA075230: "	"unprognostic (8.67e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (8.39e-7)"	"unprognostic (9.58e-3)"	"unprognostic (7.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.51e-1)"	15.0	14.2	16.6	19.1	17.6	27.5	18.8	17.9	24.3	16.8	16.6	17.0	12.6	14.2	14.4	18.2	16.8	8.4	19.4	16.9	17.8	17.9	19.8	13.5	21.2	17.5	17.1	16.4	13.9	11.6	10.8	15.6	18.1	14.2	19.0	15.3	11.3	13.2	24.2	16.6	14.0	16.6	17.3	17.5	15.3	27.8	17.0	31.5	12.3	24.8	25.1	16.2	14.7	19.7	47.5	33.5	97.7	66.4	28.4	30.1	73.8	68.9	48.8	93.2	74.2	72.7	93.6	65.1	29.8	38.2	91.4	64.7	92.7	67.1	111.5	96.3	73.9	174.8	34.2	87.4	37.0	148.3	58.9	17.4	51.3	62.6	100.2	24.1	72.8	93.6	86.6	41.3	66.4	59.1	78.6	116.6	101.4	113.2	44.0	48.5	98.6	53.5	51.1	30.8	23.8	46.1	38.1	44.5	65.3	51.1	35.4	117.6	37.2	35.5	49.1	42.9	95.5	23.3	29.4	135.7	56.0	104.1	66.8	28.9	29.8	23.5	42.8	39.6	44.8	66.0	54.1	50.5	33.9	57.2	67.1	62.7	6.0	46.2	41.7	54.8	54.6	52.4	16.6	17.6	17.9	24.3	16.9	17.8	17.5	17.1	18.1	17.3	17.0	19.7	43.5	32.1	38.9	15.7	40.1	36.1	51.6	109.6	25.0	20.8	25.0	50.0	50.2	18.6	69.5	11.0	8.4	86.8	46.8	13.1	56.7	58.1	115.7	21.5	31.4	39.4	13.2	57.9	7.0	52.1	92.3	41.8	19.4	20.6	103.6	46.2	18.5	17.4	46.8	28.6	8.6	19.1	79.3	13.6	34.2	54.6	40.7	26.0	26.6	10.3	32.6	27.1	35.0	17.1	22.0	36.1	16.4	36.5	38.8	29.0	18.0	26.6	53.4	32.0	26.3	38.8	52.1	163.3	85.9	29.0	36.2	67.0	38.7	42.7	30.2	37.7
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 55.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Basal prostatic cells: 47.5;Basal respiratory cells: 50.4;Endometrial ciliated cells: 43.7;Glandular and luminal cells: 53.8;Oligodendrocyte precursor cells: 48.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 40.1;SCLC-21H: 58.3;U-266/70: 110.9;U-266/84: 139.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	12.0	1.5	12.3	2.4	14.1	0.0	11.0	15.6	12.3	55.6	11.2	9.3	0.3	17.2	3.7	34.2	34.0	1.8	5.0	10.7	11.8	4.7	2.1	2.2	0.8	14.6	14.4	0.7	1.9	9.4	5.3	6.3	13.7	23.6	3.1	1.2	31.2	9.3	2.5	5.3	1.1	1.8	11.8	0.6	8.9	5.6	13.4	18.8	14.6	3.4	6.6	4.9	16.5	11.0	0.2	4.4	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	2.5	1.9	0.3	40.1	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.1	0.3	2.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	7.7	0.1	0.0	0.6	0.1	0.0	0.1	0.8	0.5	0.0	0.0	58.3	0.0	0.0	24.8	0.0	3.0	5.3	0.2	0.0	0.0	4.5	0.3	8.8	110.9	139.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	14.1	15.6	12.3	10.7	11.8	14.6	14.4	13.7	11.8	13.4	11.0	0.4	0.0	0.0	153.8	0.9	0.6	47.5	50.4	14.8	0.4	7.8	7.6	0.5	2.8	33.0	0.0	6.2	27.7	0.0	2.5	0.0	0.9	0.2	43.7	3.9	0.6	1.2	0.0	1.5	0.0	3.0	4.8	9.2	53.8	1.3	9.8	0.4	3.3	7.4	0.0	5.1	0.6	34.6	0.0	0.4	0.3	0.0	1.1	3.6	13.1	2.6	0.0	0.0	48.7	1.0	1.1	1.7	0.7	3.4	10.9	0.0	6.3	22.2	0.4	0.0	0.3	2.8	0.2	7.4	16.0	0.3	10.8	0.6	4.2	3.6	34.6
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 80.2;Oligodendrocytes: 80.5;Spermatocytes: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	4.7	4.8	7.4	8.2	7.0	5.2	7.1	8.8	7.9	7.4	9.6	5.7	5.9	6.1	6.4	9.9	6.2	4.3	6.4	6.5	7.6	11.6	6.0	5.9	9.4	7.1	7.1	6.4	6.5	8.3	7.6	7.7	7.2	6.1	6.2	10.5	5.6	5.4	7.1	9.0	6.3	5.5	6.4	7.2	5.5	11.4	7.6	9.4	9.3	8.3	14.4	7.1	6.1	7.9	16.3	6.6	13.1	9.7	14.9	11.6	7.3	11.8	11.0	13.2	12.9	6.4	9.5	25.5	12.3	7.8	4.9	15.3	24.4	9.5	15.6	13.4	13.5	28.2	14.4	11.6	8.8	27.9	25.2	7.0	8.3	14.6	9.7	11.3	17.0	9.0	26.9	9.6	11.9	7.0	18.0	18.5	27.5	12.6	8.6	13.2	24.9	16.8	15.3	8.8	14.9	8.2	12.6	7.6	11.0	10.5	6.2	7.3	16.6	15.9	8.4	15.1	9.4	13.9	15.2	22.0	11.5	26.7	7.0	5.7	6.8	7.3	7.5	6.9	6.7	5.2	5.8	5.4	8.3	4.6	4.9	5.6	6.4	7.1	6.1	5.1	5.4	1.9	7.4	7.0	8.8	7.9	6.5	7.6	7.1	7.1	7.2	6.4	7.6	7.9	12.6	9.6	10.8	46.4	17.5	17.8	11.3	10.0	9.6	18.3	12.0	7.1	9.2	12.8	7.9	25.8	16.7	13.0	10.6	8.2	15.6	13.5	80.2	13.6	13.2	12.9	20.4	9.9	66.0	8.9	14.4	11.6	16.8	15.3	12.0	15.8	14.6	8.7	9.7	18.5	58.8	9.1	12.2	13.3	46.1	39.1	10.2	14.6	12.4	39.4	12.9	8.1	10.3	45.2	80.5	14.5	10.9	6.0	13.7	12.0	13.8	18.0	5.7	20.6	13.1	11.1	8.4	98.7	50.6	10.7	22.9	10.9	15.8	9.6	10.5	11.7
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532128	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.6;tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.1	2.5	2.6	0.1	1.9	0.0	0.4	2.2	1.9	2.6	13.3	0.2	0.2	0.5	1.2	0.4	7.4	0.5	5.8	2.3	1.2	5.0	0.0	1.8	0.1	5.6	7.9	1.2	0.2	0.0	0.8	0.0	4.5	5.7	0.2	0.1	0.2	11.8	27.6	0.0	0.1	0.3	4.5	0.4	0.4	3.0	3.3	6.6	2.1	21.3	0.5	2.2	2.3	4.9	0.0	25.4	2.4	0.0	0.0	0.0	0.0	0.0	20.4	0.5	2.9	0.1	0.1	0.1	19.6	0.0	25.6	0.0	15.4	6.7	0.0	0.0	20.2	2.8	74.3	0.0	0.6	0.0	6.8	5.1	0.0	14.4	4.5	3.4	0.0	0.0	0.0	10.7	8.1	0.0	0.0	0.0	0.0	0.3	1.6	0.3	23.8	0.0	0.0	3.9	3.7	4.1	0.2	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	18.4	7.2	3.4	0.0	24.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	2.2	1.9	2.3	1.2	5.6	7.9	4.5	4.5	3.3	4.9	0.3	12.8	1.8	2.6	0.0	0.1	0.1	13.3	0.0	0.0	0.0	0.0	14.4	0.0	6.7	46.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.1	0.1	0.5	1.8	0.0	4.8	0.2	0.0	2.9	0.0	0.1	0.0	1.5	0.4	0.1	0.0	0.0	139.0	0.0	8.2	1.0	0.0	2.6	0.6	0.2	0.0	2.8	7.2	0.0	0.0	1.5	79.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.8	0.0	0.0	26.2	3.3	7.9	7.1	0.0	0.0	0.0	0.1	1.5	0.0	0.2
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.9;lymphoid tissue: 43.0;testis: 27.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 109.3;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009589, HPA029131"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB009589: , HPA029131: AB_2672920"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	1.5	1.5	1.1	10.1	1.1	47.9	2.7	2.0	1.3	2.7	1.5	7.0	6.4	2.0	1.2	10.8	1.1	1.9	1.2	1.1	1.1	2.1	3.3	2.3	22.1	1.2	1.2	1.6	3.7	1.3	0.5	4.8	1.2	1.3	8.2	3.3	2.8	0.2	2.9	10.7	6.9	2.8	1.0	5.6	4.0	27.8	1.5	43.0	1.3	1.9	21.1	3.5	3.8	1.2	65.6	30.1	99.7	66.9	3.1	5.1	54.6	49.7	19.9	39.9	40.2	45.6	73.2	114.3	23.5	18.7	36.3	39.0	52.1	17.1	50.6	164.9	51.8	48.9	38.4	35.5	8.0	110.1	38.5	4.3	9.6	29.9	15.9	12.1	24.0	108.9	105.9	73.6	36.2	74.0	215.7	91.7	79.6	57.0	39.9	131.3	56.0	70.9	18.6	31.0	95.1	60.3	62.3	46.8	16.5	25.3	34.3	46.7	14.8	42.4	19.8	85.2	90.4	65.7	76.6	115.3	38.6	74.2	84.9	0.4	1.7	1.1	1.2	1.2	0.9	1.1	2.6	2.2	3.8	0.6	1.4	0.9	0.1	7.2	3.6	0.8	8.3	1.2	1.1	1.1	2.0	1.3	1.1	1.1	1.2	1.2	1.2	1.0	1.5	1.2	14.4	0.0	6.7	1.3	14.5	26.5	6.7	6.3	10.2	6.0	15.1	12.2	6.1	2.8	7.1	7.3	35.5	28.8	35.9	14.7	3.9	9.5	109.3	16.3	17.0	9.4	9.0	57.0	6.2	8.5	32.2	9.9	15.8	24.2	21.6	45.9	3.3	2.2	11.9	15.2	9.2	20.5	6.1	9.0	33.6	27.7	3.1	19.1	14.2	14.0	14.9	2.6	12.3	16.6	7.0	12.4	10.5	0.7	37.4	4.8	6.8	1.2	9.7	21.3	6.6	13.8	24.1	142.2	58.2	35.8	29.0	30.5	25.7	4.7	22.1	5.9
EZHIP	"CATACOMB, CXorf67"	ENSG00000187690	"EZH inhibitory protein"	Q86X51	X	51406948-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 5.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 2.3;Extravillous trophoblasts: 2.5;Syncytiotrophoblasts: 1.9"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	45	"U-2 OS: 32.8"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.6	0.6	0.2	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	1.4	0.2	0.0	0.1	0.0	0.5	0.3	0.4	0.1	0.0	1.0	0.9	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	5.9	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.6	0.6	0.2	1.4	0.5	0.3	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819368	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		42000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	88.2	186.6	100.7	98.4	99.5	135.2	59.8	86.0	96.8	77.1	224.4	133.5	158.8	35.6	78.4	260.3	114.6	116.1	116.3	96.2	95.6	159.1	57.9	173.2	185.6	97.6	105.3	44.7	112.6	447.4	42.8	233.0	91.7	81.4	103.6	10.7	89.9	72.2	46.9	187.8	257.1	36.6	99.3	75.6	273.7	55.9	98.9	108.8	126.1	25.5	216.3	219.0	98.6	91.1	668.3	355.4	86.5	125.0	9.3	10.3	502.7	204.7	67.1	225.7	189.2	420.9	357.7	667.1	197.2	235.2	108.5	497.7	172.2	228.0	259.5	235.3	111.2	14.0	204.9	187.5	223.2	167.7	98.9	16.6	172.9	212.9	205.1	191.4	150.2	90.8	134.9	316.7	132.3	175.9	239.3	199.6	144.5	180.6	117.6	176.9	40.7	152.5	462.1	198.6	156.3	127.2	358.5	507.7	37.9	391.5	124.1	218.5	195.3	72.6	233.4	101.1	319.9	216.5	212.8	566.9	45.4	84.9	88.5	177.2	83.4	103.7	195.9	190.8	233.2	466.5	205.6	245.1	181.9	389.7	108.6	146.3	36.2	133.6	202.9	84.5	385.7	298.2	100.7	99.5	86.0	96.8	96.2	95.6	97.6	105.3	91.7	99.3	98.9	91.1	47.4	951.9	547.8	111.3	799.6	614.7	809.5	202.4	247.0	11.2	240.4	144.4	311.0	154.4	726.2	156.3	0.0	406.1	372.4	806.8	97.8	302.3	10.2	782.9	75.4	71.0	159.9	46.5	0.4	256.1	560.3	213.1	500.5	844.5	119.0	40.8	25.4	37.5	113.3	0.0	0.5	415.3	179.0	79.1	820.5	32.8	135.5	297.5	321.9	12.2	110.5	35.7	62.8	2.0	0.7	618.3	631.2	294.2	564.9	416.7	694.2	238.1	1248.4	5.1	249.8	205.5	136.3	52.5	61.7	430.4	726.5	1243.4	483.8	102.3	312.9	1142.8
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 59.4;stomach 1: 44.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.9;Distal enterocytes: 124.7;Gastric mucus-secreting cells: 74.5;Glandular and luminal cells: 74.7;Paneth cells: 86.1;Suprabasal keratinocytes: 168.4;Urothelial cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 42.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 126.0;RPTEC TERT1: 205.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	1.0	1.3	0.8	6.2	0.9	1.7	8.0	0.5	0.8	3.6	8.9	59.4	45.8	2.9	4.8	8.2	8.2	29.9	4.6	0.5	0.8	31.8	7.1	4.1	1.4	1.7	2.2	0.5	23.6	5.2	1.5	3.9	1.4	5.0	53.0	2.6	8.9	11.5	0.3	37.5	41.0	2.7	1.0	3.8	44.0	0.6	0.9	1.1	8.3	0.2	1.6	27.5	5.8	0.8	32.7	52.1	4.3	0.2	1.5	4.0	33.1	1.6	17.1	0.9	2.7	45.0	81.8	0.0	69.5	3.7	78.1	54.4	27.1	24.0	1.5	0.1	26.8	0.8	1.0	32.8	10.6	0.0	0.3	5.5	67.3	8.0	49.8	8.0	84.9	7.8	0.4	0.0	0.1	17.6	3.8	0.1	5.7	17.9	126.0	0.1	0.0	0.8	205.9	58.5	2.1	0.4	12.3	12.6	0.3	48.5	5.3	0.3	57.1	0.1	31.8	0.1	0.3	4.8	1.0	0.1	18.7	0.0	1.4	11.9	10.0	1.8	0.4	3.2	2.1	0.5	3.8	1.9	4.7	0.1	3.4	2.1	42.0	0.7	0.5	0.5	1.0	4.0	0.8	0.9	0.5	0.8	0.5	0.8	1.7	2.2	1.4	1.0	0.9	0.8	0.3	9.6	3.7	0.0	0.9	109.9	17.8	4.5	10.8	0.5	10.5	6.3	0.3	32.9	12.7	31.3	0.0	5.4	0.2	124.7	1.9	28.0	0.0	40.9	5.1	1.2	13.1	2.5	0.2	15.0	7.9	2.9	74.5	74.7	2.5	1.0	1.1	9.6	0.9	0.0	1.4	50.8	4.1	1.9	3.8	0.0	0.0	2.1	1.8	1.0	2.6	0.0	0.0	0.0	0.0	44.7	86.1	0.0	0.1	34.1	62.9	19.3	25.0	2.0	0.0	0.4	2.8	0.9	1.3	37.0	168.4	2.1	2.1	0.1	50.7	116.0
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529173-94541759	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 902.0;Exocrine glandular cells: 464.1;Pancreatic endocrine cells: 1755.7;Peritubular cells: 530.7;Urothelial cells: 497.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 1062.0;HaCaT: 490.7;HBEC3-KT: 1270.5;U-2197: 473.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	118.2	21.3	53.1	28.8	69.9	4.1	70.1	53.2	74.4	48.0	44.1	52.2	36.8	61.1	44.2	41.3	89.9	59.6	36.8	54.0	62.7	18.0	5.1	59.8	12.9	77.7	62.6	114.8	96.5	17.2	81.2	133.4	57.1	56.8	42.1	72.6	93.3	60.4	7.6	56.0	47.3	10.7	60.8	7.2	42.6	34.6	62.0	5.6	62.6	9.9	14.9	65.4	73.0	55.4	1062.0	1.8	2.2	0.5	108.0	53.1	57.2	147.0	87.6	155.4	167.9	18.6	220.6	0.0	73.3	183.5	33.4	490.7	13.2	1270.5	254.4	0.9	1.6	0.0	35.0	3.3	35.9	0.7	0.6	91.9	28.2	73.8	356.5	293.7	1.1	1.1	0.9	0.8	110.0	1.8	1.5	22.3	9.8	6.8	2.2	1.2	10.3	0.5	19.8	3.2	1.3	2.6	117.4	48.3	3.6	29.6	1.3	13.9	0.3	93.7	2.5	473.0	44.6	0.9	1.3	0.9	71.9	5.7	3.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	53.1	69.9	53.2	74.4	54.0	62.7	77.7	62.6	57.1	60.8	62.0	55.4	9.4	131.4	243.3	196.6	0.7	16.3	902.0	359.6	2.2	3.6	29.6	20.4	26.4	18.6	380.3	14.7	0.0	16.5	0.6	20.9	0.0	133.5	8.6	61.3	125.0	13.2	13.1	0.0	0.4	464.1	6.0	125.3	23.0	123.0	2.5	38.1	7.5	0.4	6.1	3.3	4.6	70.3	65.1	2.8	5.2	14.5	281.1	9.1	3.6	45.9	2.1	340.6	0.0	15.6	1.2	1755.7	15.5	530.7	1.2	121.6	10.1	0.4	92.0	16.1	6.6	39.3	76.7	1.7	4.4	6.4	7.5	7.7	7.3	7.9	14.3	497.9
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128062	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"intestine: 5501.2;liver: 13065.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 122.1;Hep G2: 393.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		45000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		6.7	0.8	0.6	160.2	0.6	0.0	10.7	0.5	1.8	0.7	0.4	5501.2	4751.8	13.0	0.0	2.6	3.9	0.5	0.8	0.6	0.7	727.6	13065.3	0.9	3.7	0.6	0.5	0.9	1.0	0.3	0.8	0.7	0.5	2.6	3416.4	0.1	0.5	8.4	0.9	0.5	4727.6	230.4	0.5	2.8	15.8	1.1	0.6	0.1	0.5	0.4	0.1	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	122.1	0.0	1.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	393.9	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	33.0	0.5	0.0	0.0	0.3	6.4	37.4	0.0	0.5	3.6	24.7	2.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	11.8	0.7	0.4	0.1	2.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.8	0.6	0.7	0.6	0.5	0.5	0.5	0.6	0.7	0.0	0.0	0.0	0.3	42.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	120.1	0.0	60.7	0.0	0.2	0.0	12424.2	156.5	0.0	0.0	0.0	0.0	7.5	261.9	149.7	0.1	0.0	1.2	0.1	2.6	0.0	129.2	0.0	105.3	7459.2	1.5	0.0	0.1	1061.1	0.0	166.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3975.2	0.0	0.0	0.1	15929.5	2014.4	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	1.4	29.3	0.0	1708.4	0.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322138	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"intestine: 550.0"	"Cell type enriched"	"Detected in some"	10	"Proximal enterocytes: 5965.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 1.6;neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		61000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.2	0.1	0.1	3.1	0.1	0.9	0.0	0.6	0.2	0.0	0.4	28.2	291.0	0.3	0.1	0.1	0.2	0.1	0.6	0.2	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.3	0.0	0.0	0.1	0.4	550.0	1.9	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.3	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.6	0.4	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.2	4.2	0.4	0.1	0.3	0.3	0.0	0.1	0.1	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.8	0.0	0.0	0.0	242.0	0.0	0.0	0.0	1.4	0.1	0.1	1.2	0.0	0.0	0.2	0.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	570.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	383.1	0.0	0.0	0.0	5965.8	17.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	222.5	0.0
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779716-122784074	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 366.1;choroid plexus: 164.8;retina: 175.3;tongue: 199.3"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 1407.3"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 105.5;U-251 MG: 28.8;WM-115: 63.7"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 1195.2"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	1.9	0.4	184.8	0.1	210.5	0.3	38.0	228.1	366.1	1.2	164.8	0.7	0.1	0.1	0.2	0.8	0.1	0.1	0.3	198.7	176.2	0.8	0.3	0.0	0.1	188.0	175.5	0.1	0.1	0.0	8.0	0.4	171.2	0.3	0.1	175.3	8.8	3.9	8.8	41.8	0.1	0.0	170.8	0.0	0.4	0.2	174.0	1.8	0.0	199.3	0.1	0.2	0.4	182.9	0.0	0.1	105.5	0.0	0.0	0.0	3.8	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.1	0.2	0.1	0.2	0.0	0.1	28.8	0.0	0.0	0.0	1.2	0.1	63.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	184.8	210.5	228.1	366.1	198.7	176.2	188.0	175.5	171.2	170.8	174.0	182.9	0.1	0.0	0.0	14.0	0.0	12.2	0.3	0.0	0.0	11.6	44.5	38.9	1.3	0.0	0.0	0.0	12.5	4.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.9	0.0	228.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	30.2	0.0	0.0	1407.3	0.0	41.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	48.0	0.0	0.5	0.3	0.0	0.3	0.0	18.9	7.1	0.3	0.0	0.0	0.0
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960267	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 202.4;Excitatory neurons: 296.7;Inhibitory neurons: 278.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 269.9;Oligodendrocytes: 424.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Supported	Nucleoplasm		NA	NA		12000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	18.2	16.8	21.0	9.2	22.0	21.0	18.5	21.8	27.5	18.9	18.7	23.7	12.4	18.2	11.7	23.1	15.7	8.7	34.9	22.3	22.1	21.5	23.6	14.9	13.1	21.5	21.5	19.9	26.2	23.2	20.6	10.6	22.0	18.5	12.7	19.6	18.1	16.3	67.9	28.1	16.4	13.4	21.8	14.0	18.2	47.8	21.2	22.2	18.3	37.6	14.1	21.4	18.7	25.9	37.4	27.1	23.1	39.3	22.4	21.1	33.9	35.5	32.1	53.9	48.8	30.4	26.0	59.9	25.7	30.5	47.5	27.2	37.3	33.1	45.9	40.1	33.5	49.9	33.5	31.6	36.4	54.3	28.5	19.8	29.4	57.0	69.4	27.8	29.5	44.5	58.9	0.2	28.1	15.0	56.6	43.0	30.6	49.3	19.2	52.1	50.7	0.0	54.9	33.1	0.3	28.6	32.3	64.9	56.4	32.0	20.4	64.1	18.2	30.4	37.3	37.8	0.2	45.1	50.6	69.3	0.0	77.6	35.7	1.1	2.1	4.9	4.0	2.7	5.5	2.5	3.6	4.0	3.6	4.2	4.3	2.8	0.7	4.3	3.5	2.9	6.1	1.6	21.0	22.0	21.8	27.5	22.3	22.1	21.5	21.5	22.0	21.8	21.2	25.9	17.9	6.4	18.2	202.4	26.9	21.4	38.5	27.8	33.6	19.9	16.9	16.9	43.9	11.5	27.2	16.5	27.1	14.2	18.0	13.1	29.4	8.8	75.1	15.1	15.6	14.2	11.4	44.6	296.7	11.6	28.2	16.0	29.0	16.9	5.7	19.2	10.4	18.2	11.4	16.8	278.9	17.8	6.1	13.6	18.0	117.2	11.1	15.4	16.0	177.1	8.9	20.0	15.5	269.9	424.4	8.5	9.7	10.9	35.4	18.3	20.0	28.3	32.7	33.0	6.6	26.2	20.3	36.9	15.6	37.9	28.1	15.3	27.9	19.6	21.6	34.1
FAM110A	"bA371L19.3, C20orf55"	ENSG00000125898	"Family with sequence similarity 110 member A"	Q9BQ89	20	833715-857463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 71.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 71.7;Extravillous trophoblasts: 138.2;Langerhans cells: 74.2;Macrophages: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 543.5;eosinophil: 163.4;intermediate monocyte: 160.6;non-classical monocyte: 248.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 543.5;monocytes: 248.6"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 84.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034110, HPA069240"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB034110: AB_1562838, HPA069240: AB_2686103"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (9.64e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.42e-3)"	"unprognostic (4.21e-3)"	4.2	5.5	4.2	5.9	5.2	8.8	9.0	3.1	3.6	10.1	3.9	5.5	10.0	2.5	4.7	39.3	2.5	2.3	4.0	2.8	3.4	8.8	3.6	12.3	6.7	5.5	5.3	2.8	5.5	11.0	7.9	6.6	5.6	19.3	3.2	1.2	18.4	3.6	4.0	71.2	9.7	1.1	3.3	23.4	6.1	3.7	6.6	6.9	7.6	0.6	7.8	9.2	18.4	3.6	27.7	7.3	4.1	7.6	4.4	1.9	27.8	8.5	4.7	5.3	4.7	16.0	16.9	8.9	3.7	5.3	7.6	43.7	3.3	22.2	4.4	7.3	2.3	18.6	4.9	4.2	2.0	5.1	6.3	1.2	27.1	7.3	7.1	1.6	3.6	8.1	10.2	21.5	4.9	16.4	14.3	13.8	5.3	17.7	12.3	14.1	7.0	11.7	4.1	19.6	7.7	9.1	7.4	84.0	3.8	1.7	34.9	7.5	4.8	12.6	9.1	11.5	9.6	7.8	7.3	3.8	2.0	13.2	9.2	543.5	28.3	163.4	13.2	160.6	11.7	7.0	23.7	27.2	36.2	11.7	28.1	27.9	15.3	6.9	248.6	3.9	43.0	24.2	4.2	5.2	3.1	3.6	2.8	3.4	5.5	5.3	5.6	3.3	6.6	3.6	3.5	0.0	7.0	0.0	18.5	32.6	17.0	31.6	71.7	0.3	26.7	20.1	2.9	7.2	15.7	11.0	0.0	41.5	24.3	5.1	1.9	10.1	9.9	3.0	1.7	8.0	10.8	16.2	0.5	6.0	138.2	3.6	5.1	5.2	51.5	1.4	17.2	0.7	20.0	5.0	0.4	8.8	16.2	36.7	74.2	24.3	3.4	70.0	7.2	1.9	29.9	0.3	25.7	0.5	0.1	13.4	7.8	1.9	3.5	20.9	16.1	2.4	7.4	2.6	6.6	1.1	4.3	3.4	4.9	57.7	36.8	31.3	26.1	14.2	10.4	24.6
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127412	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 12.8;Erythroid cells: 9.1;Plasma cells: 8.8;Squamous epithelial cells: 7.1;Undifferentiated cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.3;naive B-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	0.9	0.5	0.5	5.9	0.6	4.8	2.7	2.8	1.8	1.0	0.1	5.6	3.4	1.0	0.5	3.4	0.5	0.8	0.3	0.6	1.1	0.4	2.5	1.1	12.3	0.5	1.0	0.2	0.6	0.9	0.0	1.7	0.7	1.0	5.8	1.3	0.8	0.4	0.4	4.4	4.0	2.0	0.1	1.8	3.2	0.8	0.6	18.0	0.9	0.1	13.3	1.7	1.0	2.1	72.6	18.5	26.6	0.4	2.7	4.9	0.3	53.5	26.7	31.2	46.1	38.7	28.0	89.8	35.4	15.7	26.3	54.7	39.5	36.2	55.2	46.8	9.5	9.8	32.3	16.9	0.1	0.3	11.1	1.2	1.2	30.3	2.4	6.0	16.9	24.1	2.8	81.9	37.2	27.3	57.7	0.6	0.3	43.2	21.0	60.1	39.7	34.7	16.8	61.2	5.2	16.9	44.4	50.8	8.7	9.7	56.2	5.0	9.4	24.1	52.4	73.5	49.6	62.6	48.4	0.6	35.0	0.4	35.4	0.2	0.1	0.1	0.1	0.0	0.1	3.3	0.2	0.3	0.1	2.6	0.1	0.1	1.6	0.0	0.1	0.1	0.7	0.1	0.5	0.6	2.8	1.8	0.6	1.1	0.5	1.0	0.7	0.1	0.6	2.1	0.7	0.0	0.0	0.0	12.8	4.2	2.2	4.2	1.8	0.0	2.5	4.2	0.3	0.0	1.4	0.0	0.0	1.1	1.4	4.0	0.0	0.8	0.0	0.9	1.6	1.2	0.0	9.1	0.0	0.0	0.4	1.5	3.6	1.9	0.0	6.3	0.0	0.2	3.9	0.0	0.0	4.4	2.0	0.3	1.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	1.3	0.0	8.8	0.7	0.5	0.1	1.6	0.0	0.0	1.3	1.8	0.1	1.0	7.1	2.7	0.1	3.2	1.1	10.4	1.6
FAM114A1	Noxp20	ENSG00000197712	"Family with sequence similarity 114 member A1"	Q8IWE2	4	38867677-38945739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 2.4;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 204.7;BJ hTERT+: 244.1;fHDF/TERT166: 273.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067948, HPA069104, HPA069701"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		96000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175"	"unprognostic (2.13e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.40e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.63e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-3)"	28.4	48.1	7.9	23.6	11.8	2.0	20.2	7.8	9.2	48.4	23.7	34.6	22.9	29.2	17.8	35.1	19.5	36.4	23.7	9.9	11.4	11.8	54.2	21.2	8.9	13.7	12.5	41.5	25.6	22.4	18.5	35.6	11.2	35.5	33.7	3.1	61.2	27.8	16.6	15.6	24.4	61.7	9.0	8.8	34.4	12.5	12.1	4.3	17.6	22.7	19.5	35.6	26.4	13.4	43.5	30.7	18.5	21.9	197.4	204.7	6.1	167.9	244.1	69.7	105.8	8.1	33.0	0.0	23.0	273.8	118.8	11.9	0.1	53.7	80.1	0.2	4.6	3.1	30.3	40.6	70.6	0.1	5.8	122.1	17.0	101.2	23.3	157.2	101.4	0.1	3.4	0.2	102.9	11.0	0.1	2.3	3.8	18.3	15.6	0.8	90.9	3.2	23.4	8.7	0.7	9.4	33.8	0.7	33.8	42.8	20.8	3.8	156.3	75.4	34.8	95.3	39.5	0.7	0.2	0.3	123.3	3.3	63.0	0.6	3.2	0.0	0.1	3.6	0.0	0.4	0.1	0.1	2.6	0.1	0.1	0.1	2.4	0.0	1.4	0.3	0.0	0.9	7.9	11.8	7.8	9.2	9.9	11.4	13.7	12.5	11.2	9.0	12.1	13.4	28.1	16.0	13.2	5.9	2.2	12.2	47.4	43.7	15.4	0.3	29.9	21.2	17.2	14.3	56.0	7.3	0.0	2.2	0.2	46.8	9.8	45.6	1.0	17.5	88.6	35.2	15.7	3.6	1.0	61.0	47.0	94.9	35.7	39.1	1.3	30.4	31.1	68.3	16.1	0.0	1.8	78.7	83.4	7.2	15.0	6.3	110.9	8.7	21.4	17.8	6.4	12.2	0.0	14.6	31.0	47.6	41.6	116.2	8.5	92.6	39.0	11.7	47.8	1.2	19.7	49.4	44.3	1.2	5.5	23.6	10.2	3.4	3.1	94.1	32.0	82.7
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202634969-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 45.8;Inhibitory neurons: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: AB_2672760"	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	3.1	7.5	5.1	4.5	5.4	2.9	3.3	7.0	7.1	2.7	0.7	4.9	4.3	2.9	2.9	5.4	3.8	3.0	1.8	5.0	6.3	4.9	1.9	2.9	7.2	3.1	3.8	5.1	4.6	7.3	3.5	6.9	3.6	5.1	4.7	2.6	3.3	3.0	1.5	5.0	3.7	2.0	3.3	5.4	4.1	5.8	6.4	9.6	2.8	1.8	7.4	3.8	3.2	4.1	2.0	2.4	10.5	7.2	3.5	1.9	10.2	0.6	0.9	0.6	1.1	3.1	4.2	8.2	6.5	1.2	1.6	1.9	9.0	4.6	1.7	0.2	7.2	6.9	4.3	11.6	2.8	5.9	3.0	2.6	6.3	1.3	1.9	4.7	2.8	10.8	10.1	1.6	0.6	3.9	16.1	12.1	10.7	5.8	4.5	12.5	2.1	9.8	5.5	5.2	17.7	15.4	8.0	5.3	3.9	8.7	2.2	8.1	1.7	1.2	2.4	1.9	1.1	5.9	3.6	10.8	2.4	4.5	1.3	0.4	3.9	1.5	1.3	8.2	3.4	8.1	3.0	2.7	4.5	7.7	8.2	5.7	2.2	4.4	9.1	1.5	1.2	3.1	5.1	5.4	7.0	7.1	5.0	6.3	3.1	3.8	3.6	3.3	6.4	4.1	9.7	3.2	7.5	13.1	21.5	17.2	2.9	3.0	12.0	4.9	8.1	4.3	4.9	12.8	2.6	18.4	4.2	8.4	8.8	11.7	0.0	10.2	2.2	8.6	6.5	4.9	25.8	3.0	45.8	6.4	6.3	6.1	7.1	10.1	5.7	15.3	8.2	2.2	2.8	6.7	49.7	11.8	2.0	27.4	13.9	1.4	13.1	17.1	3.6	23.4	17.1	1.7	3.1	29.1	29.4	5.8	9.7	23.7	5.2	6.7	4.9	5.9	3.0	2.7	6.6	2.0	4.1	5.0	16.3	29.2	19.9	2.7	10.1	11.1	13.8	6.0
FAM122A	"C9orf42, MGC17347"	ENSG00000187866	"Family with sequence similarity 122A"	Q96E09	9	68780065-68785566	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056646	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA056646: AB_2683202"	"unprognostic (1.88e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.18e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.58e-3)"	"prognostic favorable (1.34e-5)"	"unprognostic (9.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.89e-2)"	9.9	9.3	4.6	5.8	4.9	5.3	9.7	8.2	6.3	9.7	15.0	7.9	4.4	9.3	6.7	8.3	8.5	5.6	9.0	5.4	5.4	9.7	9.9	6.8	7.4	5.1	5.4	10.5	8.9	11.0	6.8	10.2	5.1	7.7	6.5	6.8	8.2	8.4	8.9	7.6	7.4	7.8	4.4	8.3	7.4	4.9	5.0	6.5	8.5	8.6	7.2	7.2	8.0	5.0	5.2	3.4	4.8	4.1	15.9	10.3	6.4	7.3	6.9	6.3	5.0	1.2	2.5	11.0	3.5	7.7	4.5	9.6	5.3	4.9	7.8	11.9	5.6	6.1	6.0	4.4	9.7	11.2	4.1	8.4	11.0	5.8	4.5	7.1	6.3	7.8	6.5	12.1	6.8	2.9	6.3	2.9	6.0	12.4	6.2	7.6	6.6	3.4	5.7	4.3	7.6	3.4	5.4	4.5	3.8	6.6	2.7	4.8	8.0	5.8	4.2	11.0	5.5	14.2	6.1	4.4	6.3	6.9	6.7	1.9	2.0	1.5	1.7	1.9	1.4	1.5	1.7	1.8	2.2	2.5	3.5	2.0	1.1	1.8	1.9	2.6	2.0	1.0	4.6	4.9	8.2	6.3	5.4	5.4	5.1	5.4	5.1	4.4	5.0	5.0	10.0	3.2	9.8	0.0	19.6	23.6	18.7	13.3	20.5	18.8	18.2	17.0	15.9	10.0	13.1	5.5	16.7	28.2	11.8	11.3	66.5	18.3	32.0	10.4	20.2	17.2	18.0	27.0	0.0	13.8	17.0	13.9	14.3	8.1	17.7	12.7	17.2	18.6	21.6	8.4	0.0	17.0	10.2	22.3	17.0	15.4	15.2	15.0	14.2	0.0	16.8	38.3	24.7	0.0	0.0	12.9	15.8	17.0	18.3	11.9	11.1	27.2	23.0	19.8	46.0	18.8	43.9	52.4	21.3	19.5	23.7	30.6	16.8	23.1	15.3	17.8
FAM131A	"C3orf40, MGC21688"	ENSG00000175182	"Family with sequence similarity 131 member A"	Q6UXB0	3	184335926-184348421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042800	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli rim"	"Mitotic chromosome"	"HPA042800: AB_10797023"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.28e-2)"	15.6	22.7	42.8	5.4	51.1	3.2	13.5	25.0	57.6	17.3	20.5	26.4	7.5	19.1	5.0	13.2	20.6	10.2	29.6	68.2	39.2	13.3	5.5	16.9	4.4	29.5	27.5	24.1	13.7	14.5	54.8	5.8	29.9	17.0	3.7	4.8	10.8	12.3	17.3	30.1	13.8	10.0	22.5	10.7	16.6	16.4	38.8	3.1	12.8	18.0	2.9	17.1	15.2	40.1	14.5	6.1	9.5	16.3	12.1	10.2	8.8	6.5	13.7	9.6	7.5	4.7	5.1	2.1	25.9	6.0	20.7	13.5	0.0	11.8	5.8	15.7	16.0	0.1	9.4	10.2	12.4	0.3	10.8	7.3	1.9	8.4	19.2	9.2	19.4	9.7	3.2	2.1	3.3	11.3	5.6	0.3	16.1	8.7	11.8	10.4	4.0	14.0	9.8	0.5	28.2	29.3	4.1	10.5	14.7	5.9	31.9	3.3	20.2	12.1	9.3	9.9	20.0	22.9	15.4	1.5	38.5	2.1	8.3	1.5	3.8	4.8	1.1	4.9	1.2	1.4	0.8	1.1	4.2	1.4	0.9	1.1	8.3	1.2	2.7	1.7	1.7	2.2	42.8	51.1	25.0	57.6	68.2	39.2	29.5	27.5	29.9	22.5	38.8	40.1	15.5	6.4	5.0	13.7	5.5	11.1	20.0	6.1	5.7	24.0	8.0	11.0	7.6	14.3	4.1	14.7	14.6	9.0	4.6	11.6	1.9	6.0	4.4	6.5	10.5	11.5	9.6	6.1	30.8	3.5	3.5	9.7	5.1	11.0	7.0	55.9	13.6	1.4	7.9	23.5	16.6	7.5	6.1	5.7	14.2	2.5	18.6	7.7	1.8	11.2	9.6	13.1	6.2	6.6	11.9	10.7	9.6	20.7	2.5	15.2	15.7	3.4	15.8	15.9	6.6	13.0	14.4	12.9	7.1	3.5	14.6	33.2	5.0	20.0	8.7	15.9
FAM133A	"CT115, FLJ37659, RP1-32F7.2"	ENSG00000179083	"Family with sequence similarity 133 member A"	Q8N9E0	X	93674013-93712274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.5;choroid plexus: 3.3;testis: 7.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.6;Early spermatids: 18.8;Excitatory neurons: 13.1;Horizontal cells: 20.2;Inhibitory neurons: 24.0;Late spermatids: 28.6;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 15.6;Spermatocytes: 26.4;Spermatogonia: 39.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 14.5;Karpas-707: 46.0;U-2197: 23.9;U-266/70: 35.7;U-266/84: 82.6"					"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Uncertain	Nucleoplasm,Nucleoli		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.67e-3)"	"unprognostic (4.45e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.22e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.12e-4)"	"unprognostic (1.67e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-3)"	0.0	1.2	5.2	0.0	5.2	0.0	0.2	4.3	9.5	0.5	3.3	0.1	0.0	0.3	0.2	0.0	0.3	0.1	0.9	4.7	6.3	0.0	0.0	0.0	0.0	4.6	5.6	0.4	0.0	0.0	2.2	0.0	5.8	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	4.5	0.0	0.0	7.6	5.8	0.0	0.2	0.0	0.0	0.0	0.1	4.7	0.3	2.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.8	46.0	0.0	0.0	0.0	0.0	1.1	0.0	11.6	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.3	0.0	0.0	0.0	0.9	1.1	23.9	1.0	35.7	82.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.2	4.3	9.5	4.7	6.3	4.6	5.6	5.8	4.5	5.8	4.7	0.1	0.0	0.0	3.6	0.0	0.6	0.0	0.0	0.0	13.6	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.8	0.0	0.4	0.1	0.0	0.0	13.1	0.0	0.1	0.5	0.0	0.0	0.0	3.0	0.7	0.0	0.0	20.2	24.0	0.0	0.0	0.0	0.3	28.6	1.2	0.1	0.0	1.0	0.0	2.9	0.0	22.6	15.6	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.2	26.4	39.0	0.0	0.1	0.0	0.1	3.7	0.0	0.0
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560758-92590393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	14.4	13.7	21.5	12.7	23.5	35.5	16.2	25.6	43.1	15.8	20.5	13.6	13.4	14.3	22.4	13.6	13.2	9.8	11.1	21.5	20.6	13.0	16.6	11.1	16.6	22.1	21.8	16.7	15.8	11.8	12.5	10.6	23.1	13.7	11.9	9.5	13.2	11.1	16.2	14.4	13.2	10.8	21.1	14.0	13.1	8.2	23.3	17.3	14.0	15.1	14.6	13.6	14.3	26.8	24.5	12.1	34.5	55.4	20.8	22.8	20.0	29.1	29.9	26.4	32.5	21.1	27.6	43.5	26.5	19.0	22.7	19.9	28.5	17.5	40.0	22.4	37.5	35.2	20.6	43.9	20.5	36.8	27.6	14.6	17.8	20.4	24.5	21.0	16.1	31.6	46.0	50.4	29.9	30.8	58.8	59.2	50.0	22.6	16.8	42.9	36.9	34.0	26.7	27.5	35.1	31.7	26.3	29.3	32.1	32.9	27.7	26.6	19.8	28.7	46.6	37.4	30.5	12.1	14.4	76.3	18.8	48.5	39.6	15.9	13.8	14.0	12.7	15.0	18.5	30.3	16.4	17.2	13.7	23.4	19.5	17.3	5.8	15.2	11.4	31.2	21.0	7.7	21.5	23.5	25.6	43.1	21.5	20.6	22.1	21.8	23.1	21.1	23.3	26.8	157.6	57.7	64.3	23.8	146.2	114.3	196.1	130.7	84.2	83.7	120.3	113.2	27.8	184.5	87.9	88.3	75.0	61.7	258.3	126.9	99.7	93.3	47.8	174.1	167.5	89.3	137.3	119.5	28.0	87.0	62.0	99.6	59.1	294.0	87.0	76.3	109.9	120.9	72.4	55.5	27.1	118.7	95.6	121.2	155.1	19.2	102.6	116.5	76.5	27.2	112.5	104.8	121.5	27.6	57.8	89.2	122.3	88.8	139.3	126.1	84.2	98.1	55.1	73.8	52.6	207.3	107.0	100.9	115.7	75.4	104.8	70.6	151.7	78.5	113.3	137.9
FAM161B	"C14orf44, FLJ31697"	ENSG00000156050	"FAM161 centrosomal protein B"	Q96MY7	14	73931501-73950414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 62.9;Late spermatids: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019125	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA019125: AB_1845570"	"unprognostic (1.50e-1)"	"unprognostic (9.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (6.78e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.60e-1)"	2.7	8.7	6.6	1.7	6.6	1.2	4.8	5.8	8.2	5.3	3.4	3.9	3.3	5.2	4.3	4.1	5.5	2.7	5.4	6.4	5.9	7.2	5.1	2.8	1.8	6.8	5.7	12.8	2.2	4.3	7.6	2.4	7.1	6.0	2.7	10.1	2.8	5.2	7.9	2.1	3.3	3.4	5.5	3.1	3.3	18.8	6.1	1.9	4.2	4.8	1.8	5.5	3.8	6.6	2.1	1.6	2.2	3.4	4.7	3.5	2.0	3.6	2.8	6.0	5.8	1.5	2.6	3.3	2.3	4.2	2.5	3.9	0.9	1.7	4.1	9.2	1.8	1.6	1.6	1.7	4.0	1.1	2.3	2.6	3.4	6.1	2.2	4.4	2.7	3.4	1.0	1.6	4.3	3.3	3.1	4.2	0.5	1.4	3.5	2.1	2.9	1.3	3.1	3.1	2.7	2.5	5.1	2.3	3.1	1.6	8.1	1.5	2.9	12.4	5.6	3.1	2.2	3.3	2.2	2.1	6.3	1.9	2.2	3.2	1.3	1.9	1.1	0.3	1.3	0.7	1.2	1.7	0.2	0.9	0.6	0.4	0.4	1.3	0.4	0.3	0.7	0.9	6.6	6.6	5.8	8.2	6.4	5.9	6.8	5.7	7.1	5.5	6.1	6.6	3.5	3.2	4.8	4.9	3.0	0.6	2.1	1.0	3.4	8.9	3.7	3.8	3.4	0.0	3.2	1.8	4.2	1.5	1.9	3.5	0.0	1.0	62.9	5.9	3.9	2.2	0.0	1.7	7.3	1.6	1.1	4.6	7.1	4.5	0.0	5.0	2.5	0.7	2.9	3.3	8.6	4.1	2.0	1.2	0.7	142.7	3.4	1.4	1.8	2.8	2.2	8.0	6.2	5.5	2.9	1.2	0.8	9.4	1.4	0.8	4.3	4.2	9.4	16.7	6.6	5.2	4.2	11.0	6.1	0.6	0.9	2.2	3.3	9.6	1.4	0.9
FAM167B	"C1orf90, DIORA-2, MGC10820"	ENSG00000183615	"Family with sequence similarity 167 member B"	Q9BTA0	1	32247222-32248856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 44.0"	"Group enriched"	"Detected in many"	14	"Adipocytes: 68.5;Endothelial cells: 102.5;Hepatic stellate cells: 200.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 46.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.6;EFO-21: 12.0;SK-MEL-30: 30.9;U-2197: 29.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA029398, HPA062074"	Uncertain		Approved	"Actin filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"		"HPA029398: AB_10602807, HPA062074: AB_2684677"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.03e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-3)"	"unprognostic (7.44e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.04e-2)"	"unprognostic (5.08e-2)"	19.9	19.7	4.3	4.1	3.8	0.2	10.0	3.8	6.3	14.3	4.3	7.4	2.8	12.9	0.5	4.0	10.3	4.2	11.0	3.8	4.5	44.0	10.7	20.5	2.7	4.5	4.1	4.1	8.4	4.3	14.4	4.2	4.5	16.5	2.1	1.4	4.7	5.9	3.0	2.4	8.1	5.8	4.4	1.9	7.5	0.9	5.1	0.8	19.9	1.1	1.5	13.2	7.7	4.3	0.9	1.8	0.6	0.0	1.2	1.1	0.0	4.3	9.6	1.9	2.7	0.1	0.9	0.2	12.0	7.3	2.2	1.4	0.3	0.0	0.6	0.1	0.0	0.0	4.6	0.5	0.4	0.0	0.1	1.0	0.7	1.4	0.4	2.6	3.5	0.6	0.0	0.1	0.2	0.6	0.2	0.0	0.3	0.2	4.1	0.9	0.0	1.2	1.2	0.4	1.8	0.4	2.8	0.2	30.9	0.8	0.5	0.1	3.2	0.8	0.9	29.9	0.1	0.1	0.3	0.7	0.3	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	1.7	0.2	4.3	3.8	3.8	6.3	3.8	4.5	4.5	4.1	4.5	4.4	5.1	4.3	68.5	0.0	1.1	0.3	3.2	0.3	0.5	0.2	0.0	0.4	2.8	2.8	0.4	0.0	0.1	5.5	0.0	0.1	2.7	1.3	0.0	0.5	0.0	1.3	3.5	102.5	0.0	8.0	0.0	0.8	0.2	3.7	1.5	1.0	0.0	0.2	200.3	1.7	0.6	0.0	0.1	1.3	0.0	8.5	2.2	0.0	2.8	1.4	1.8	2.8	0.0	0.0	2.1	0.5	0.4	0.2	1.2	1.2	0.6	0.6	0.0	0.1	1.3	0.5	0.0	0.6	1.6	0.0	0.3	0.3	1.0	0.3	2.1	0.9	0.7	0.3
FAM174B	"LOC400451, MGC102891"	ENSG00000185442	"Family with sequence similarity 174 member B"	Q3ZCQ3	15	92617448-92809884	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Intestinal goblet cells: 60.9;Late spermatids: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.5;granulocytes: 2.9;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 74.3;MCF7: 91.8;OE19: 76.3;RPMI-8226: 109.6;RT4: 221.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015306	Approved		Approved	"Intermediate filaments"		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Intermediate filaments"		"HPA015306: AB_2669182"	"unprognostic (3.00e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (9.03e-5)"	"unprognostic (4.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.23e-3)"	"unprognostic (7.67e-3)"	"unprognostic (5.05e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-2)"	5.6	5.6	13.8	5.9	13.2	1.1	27.2	9.7	14.6	16.9	9.1	10.7	6.3	8.2	7.2	8.4	24.0	6.1	10.5	13.9	14.5	5.3	6.9	21.0	8.5	14.0	16.0	16.2	76.6	2.9	26.5	6.7	14.6	32.2	15.2	6.4	52.5	16.2	16.2	8.4	8.5	4.9	7.8	4.0	35.0	17.9	14.9	8.0	37.2	15.9	7.4	26.3	6.6	19.5	0.3	12.2	8.0	2.4	0.0	0.2	1.0	4.6	21.8	0.2	0.0	74.3	8.6	1.2	20.6	0.6	5.8	0.4	13.9	0.5	0.0	0.5	6.5	0.7	1.4	1.0	1.3	1.1	3.2	1.0	0.3	0.2	0.2	0.5	10.5	6.8	1.2	54.7	12.2	91.8	2.7	0.1	39.2	76.3	0.0	8.9	22.5	109.6	5.4	221.3	4.9	3.9	6.4	42.7	14.3	22.7	33.8	7.9	0.0	0.0	1.6	0.3	10.3	1.7	17.2	2.6	0.2	0.8	5.3	0.9	0.6	0.8	0.1	0.7	0.2	0.3	1.8	0.0	0.5	0.3	2.0	2.6	2.9	0.7	0.0	3.5	8.9	0.6	13.8	13.2	9.7	14.6	13.9	14.5	14.0	16.0	14.6	7.8	14.9	19.5	8.5	105.8	22.2	13.7	1.7	2.3	14.7	1.7	5.7	7.0	26.3	11.3	5.2	5.7	12.6	7.3	8.4	1.4	2.3	3.7	7.9	5.5	22.6	17.8	4.2	10.3	42.1	0.8	24.0	14.6	21.2	4.9	19.4	23.4	18.4	1.3	22.1	7.0	5.4	11.8	24.4	60.9	24.4	3.8	4.8	57.8	5.9	4.9	12.4	22.5	0.4	3.9	0.0	17.1	44.8	19.1	1.6	1.9	6.6	24.2	3.0	1.5	14.5	3.7	0.0	7.7	3.7	1.0	5.0	3.9	3.0	0.7	3.4	1.8	5.5	24.3
FAM186A	LOC121006	ENSG00000185958	"Family with sequence similarity 186 member A"	A6NE01	12	50326230-50396622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 14.2"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 521.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047128, HPA064735"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA047128: AB_10967726, HPA064735: "	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.65e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.22e-3)"	0.1	0.3	0.2	0.2	0.4	0.5	0.1	0.6	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.2	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.2	0.3	0.0	0.9	0.0	0.1	0.3	0.1	0.7	0.2	0.0	1.1	0.3	0.2	0.0	0.0	0.3	0.1	14.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	521.1	0.1	0.2	0.1	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	64.7	0.6	0.1	0.0	2.8	0.0	0.6	0.0	1.5	3.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM210B	"C20orf108, dJ1167H4.1, DKFZP434A1114"	ENSG00000124098	"Family with sequence similarity 210 member B"	Q96KR6	20	56358974-56368663	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 449.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 299.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042652	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"		"HPA042652: AB_2678098"	"unprognostic (3.29e-1)"	"prognostic favorable (5.44e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.34e-2)"	"unprognostic (9.45e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (1.44e-10)"	"unprognostic (1.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.00e-1)"	38.2	87.6	32.1	13.9	34.1	85.2	62.0	30.0	33.6	43.7	37.7	39.8	24.7	36.5	45.7	31.1	40.1	40.6	43.9	33.9	32.6	34.6	100.3	28.2	13.9	29.6	33.8	108.9	41.5	32.7	28.1	36.7	29.9	66.8	30.6	30.0	54.9	58.7	75.2	36.5	23.3	34.2	29.6	19.6	34.2	14.1	35.9	20.6	28.4	102.2	20.0	32.5	32.7	29.1	19.9	7.5	29.3	71.6	83.2	93.4	57.1	23.8	53.4	42.6	48.7	13.9	9.6	1.6	12.1	40.9	24.6	56.2	15.9	68.7	71.0	2.9	24.9	12.2	16.9	132.0	54.4	1.3	7.4	80.2	75.2	24.1	34.0	49.3	69.4	10.2	93.6	12.7	52.7	20.6	10.4	5.4	24.9	29.0	46.7	0.1	60.4	15.9	21.9	22.9	40.4	72.9	57.9	124.6	299.1	62.3	55.0	11.1	48.4	37.8	25.2	61.0	14.7	9.9	10.9	0.4	30.0	7.7	25.2	2.3	2.3	6.9	1.7	3.3	1.3	1.1	1.9	2.3	1.7	1.3	2.0	1.9	1.0	1.4	1.5	1.5	2.3	1.0	32.1	34.1	30.0	33.6	33.9	32.6	29.6	33.8	29.9	29.6	35.9	29.1	30.3	16.0	29.3	4.2	7.4	24.9	85.4	28.2	70.6	10.3	57.5	98.8	56.8	54.3	19.3	16.5	39.6	77.7	13.5	23.8	64.6	27.9	1.0	41.4	49.0	28.8	50.9	449.3	5.7	19.5	26.3	46.1	44.9	37.4	19.1	47.5	46.1	154.5	28.0	1.7	6.6	28.6	20.3	44.1	21.2	4.7	66.8	26.2	37.4	5.6	36.6	27.8	14.4	4.0	8.4	35.7	15.3	155.7	9.4	48.7	34.1	46.1	15.6	19.2	19.7	28.1	37.1	1.1	9.4	68.6	32.5	41.9	14.6	123.4	33.4	56.3
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109713825-109770495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Early spermatids: 29.1;Horizontal cells: 77.4;Oligodendrocytes: 78.5;Rod photoreceptor cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 116.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA075616"	Uncertain		Approved	"Golgi apparatus,Cell Junctions,Midbody ring"		Yes	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Cell Junctions, Midbody ring"	"HPA040181: AB_10796448, HPA075616: "	"unprognostic (8.59e-3)"	"prognostic favorable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	0.7	19.0	23.7	0.7	45.2	0.6	1.2	36.7	34.2	0.6	5.6	1.9	4.8	0.3	0.8	2.3	0.4	0.8	8.9	20.0	27.6	10.6	4.0	2.1	0.4	41.2	43.1	13.4	3.9	0.7	22.4	0.1	37.7	1.8	1.0	22.1	3.4	0.5	4.3	3.2	2.2	0.4	29.0	6.2	7.2	23.4	48.4	0.4	0.7	0.6	0.6	0.9	1.8	65.6	2.0	3.1	1.6	3.7	1.0	0.0	1.1	0.6	0.3	1.6	0.2	28.1	0.5	0.3	2.2	0.8	1.7	1.2	1.9	0.1	0.6	16.8	4.0	3.5	0.9	6.5	0.2	2.8	3.6	0.2	0.2	0.3	0.0	0.4	0.1	2.0	1.2	0.6	0.3	11.5	0.7	3.6	3.0	3.3	5.3	2.3	8.0	1.2	3.5	1.5	19.2	116.4	2.5	3.7	8.2	0.5	4.5	3.0	0.2	0.5	3.2	1.3	2.4	2.9	4.0	2.4	0.3	2.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	45.2	36.7	34.2	20.0	27.6	41.2	43.1	37.7	29.0	48.4	65.6	2.1	0.0	0.0	2.3	3.6	2.2	0.9	0.1	3.4	23.4	7.4	6.1	8.1	1.5	0.8	1.8	33.3	0.3	10.4	1.2	7.9	1.7	29.1	1.2	0.5	1.3	7.7	0.0	1.3	0.8	0.2	1.5	1.5	1.8	0.0	0.7	0.7	1.3	0.3	77.4	6.7	5.8	0.0	0.0	2.1	13.4	1.2	1.9	7.2	0.0	0.1	11.2	0.0	9.5	78.5	1.1	0.2	0.4	1.3	1.7	0.9	0.7	0.6	50.3	0.0	2.6	1.5	1.1	5.7	3.3	1.8	0.8	3.7	6.0	1.6	0.4
FAM240C		ENSG00000216921	"Family with sequence similarity 240 member C"	A0A1B0GVR7	2	241893988-241902551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"tongue: 225.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.5;REH: 2.4;SCLC-21H: 1.6"									HPA073342			Approved	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"		Nucleoplasm		"HPA073342: "	"unprognostic (9.31e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.75e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.29e-1)"	3.5	0.7	5.9	0.1	6.9	0.3	3.9	6.4	8.2	1.4	5.6	0.2	0.2	1.9	0.0	4.0	1.7	0.1	1.3	5.4	5.9	0.1	0.2	0.1	0.4	6.2	6.4	1.6	36.8	0.5	0.4	0.2	6.4	3.5	0.0	0.6	5.4	3.9	10.2	3.1	0.2	0.1	5.6	0.3	0.4	1.3	6.3	3.4	6.9	225.1	0.2	0.4	1.0	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.2	0.0	0.7	0.5	0.0	0.2	0.0	0.0	2.4	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.9	6.4	8.2	5.4	5.9	6.2	6.4	6.4	5.6	6.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"FAM3 metabolism regulating signaling molecule A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"	"Secreted to blood"	Yes	No		15000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"CAB025016: , HPA035268: , HPA056991: AB_2683303"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	28.4	37.3	43.5	11.3	49.1	11.3	27.6	50.8	51.3	44.6	38.8	35.3	28.0	36.0	7.7	41.3	38.9	8.4	58.7	40.6	45.8	38.6	63.1	26.8	9.4	52.2	47.6	51.5	52.0	14.8	40.9	10.1	47.8	39.1	6.8	6.1	28.5	12.7	36.8	31.1	33.8	7.4	46.9	28.2	36.1	10.0	46.4	12.1	39.9	13.7	5.5	35.8	35.3	58.1	44.4	41.1	10.3	34.5	30.3	15.4	28.8	22.3	15.1	14.8	17.6	19.1	26.2	28.5	109.2	36.8	29.0	31.6	16.2	19.3	3.6	23.4	21.7	11.2	36.9	13.8	47.2	7.6	17.6	19.0	17.5	30.7	21.4	17.7	10.5	18.1	21.6	20.5	17.3	46.3	14.2	32.7	4.6	47.8	52.4	17.3	10.4	79.6	16.6	18.0	20.4	15.6	10.3	24.4	37.3	7.4	18.7	11.8	12.0	19.9	12.0	54.7	30.6	77.6	46.5	36.0	36.4	19.6	20.8	23.4	10.8	15.2	13.4	12.7	13.2	6.1	8.6	9.6	11.0	8.7	10.0	12.0	5.8	10.6	11.3	14.6	9.1	10.1	43.5	49.1	50.8	51.3	40.6	45.8	52.2	47.6	47.8	46.9	46.4	58.1	23.5	12.8	16.7	13.1	16.9	16.3	23.4	29.2	22.8	25.4	21.9	24.9	21.9	22.8	16.3	22.0	14.6	47.0	19.3	60.2	27.4	27.6	1.0	13.4	18.3	18.3	17.5	29.9	7.1	42.5	50.0	28.4	50.0	15.0	5.7	34.8	23.6	30.3	29.8	21.9	9.4	58.9	18.3	16.4	15.3	2.8	33.5	18.0	33.8	6.5	17.6	28.9	24.7	11.1	14.3	28.2	57.5	29.3	32.5	28.7	116.2	33.1	12.7	20.4	6.6	26.7	24.5	5.2	10.1	32.1	21.2	71.3	19.3	23.7	39.7	22.9
FAM43A	FLJ90022	ENSG00000185112	"Family with sequence similarity 43 member A"	Q8N2R8	3	194685883-194689037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 89.2;Endothelial cells: 102.4;Extravillous trophoblasts: 83.3;Hepatic stellate cells: 97.1;NK-cells: 75.2;Syncytiotrophoblasts: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 123.7;NB-4: 72.8;PC-3: 56.9;TIME: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048345	Uncertain		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA048345: AB_2680367"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.71e-3)"	"unprognostic (5.13e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-3)"	"prognostic unfavorable (9.96e-4)"	25.2	4.8	8.3	5.1	5.6	3.7	15.7	6.9	14.1	16.1	4.0	15.7	1.4	13.0	1.2	15.4	15.1	4.0	30.3	11.7	6.5	41.4	5.8	9.7	10.0	33.2	9.6	4.5	3.0	1.4	8.7	11.2	34.8	22.1	2.3	0.8	8.0	2.7	6.0	25.2	11.6	3.7	7.3	54.9	8.3	4.4	8.3	1.3	8.0	4.0	6.3	17.2	25.1	6.9	0.3	1.8	1.4	1.1	23.3	11.4	10.4	3.8	8.6	0.1	0.0	0.8	0.3	1.3	37.4	11.6	8.5	3.8	2.3	1.0	0.1	0.9	6.4	4.7	10.8	1.3	1.8	1.2	13.5	3.0	4.8	0.5	0.1	0.6	123.7	0.2	2.8	2.5	0.3	1.9	0.0	72.8	6.0	12.8	56.9	6.0	0.4	0.6	0.1	0.2	35.6	3.0	2.4	2.3	7.5	2.4	1.5	15.7	66.3	1.2	1.9	1.6	0.8	0.2	1.5	3.5	0.7	34.3	24.0	2.2	0.6	1.3	0.5	0.5	0.7	1.2	0.3	0.5	0.8	2.5	0.0	0.2	0.9	1.6	0.5	4.5	0.2	0.3	8.3	5.6	6.9	14.1	11.7	6.5	33.2	9.6	34.8	7.3	8.3	6.9	89.2	0.0	2.5	0.0	26.7	4.0	21.4	6.7	4.6	16.0	10.6	7.0	35.1	0.0	4.0	1.8	8.4	21.1	38.3	39.6	7.9	7.8	0.3	3.2	19.5	102.4	6.6	0.4	3.5	1.8	83.3	30.1	8.6	4.0	15.2	3.8	97.1	1.4	6.0	0.0	7.3	8.0	24.4	13.1	3.9	1.3	16.4	9.3	12.4	28.1	7.7	2.2	75.2	0.0	2.6	7.0	19.1	9.8	8.5	20.3	1.0	0.4	1.4	2.8	26.3	5.2	20.8	0.6	14.2	6.5	4.0	162.4	16.0	3.0	11.0	12.6
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849373-3851320	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.3;MCF7: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064111, HPA067817"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Midbody"		Yes	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Midbody"	"HPA064111: AB_2685191, HPA067817: AB_2685904"	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	6.9	9.1	11.7	3.7	14.3	1.8	7.0	12.3	15.1	8.3	8.5	10.2	6.6	9.7	3.9	6.6	8.8	3.7	18.0	12.5	13.6	9.8	12.9	5.3	5.1	11.7	11.1	9.3	9.2	4.2	10.4	1.7	11.5	6.4	1.4	5.5	10.2	5.8	32.1	7.1	6.5	2.8	11.2	7.1	8.1	14.0	13.0	3.9	9.8	8.8	3.5	9.7	6.3	12.6	6.6	8.7	0.1	0.0	4.9	4.7	0.4	7.6	3.7	5.1	6.5	0.0	11.7	7.0	8.0	5.5	2.0	4.9	0.0	3.0	3.8	88.3	4.6	0.0	21.1	0.0	5.2	0.0	0.1	5.2	6.0	4.0	1.1	1.6	5.1	0.0	0.0	0.0	4.6	27.5	0.0	9.8	1.9	4.0	4.1	0.0	0.0	0.0	2.5	0.0	11.8	10.3	12.4	7.7	0.4	0.0	8.4	7.8	7.2	0.0	0.9	10.1	0.0	0.0	19.7	0.0	2.7	0.6	14.1	5.7	7.9	4.4	11.3	10.8	26.7	25.0	21.8	14.6	10.5	20.8	17.7	11.2	3.3	33.8	17.7	17.3	36.0	9.0	11.7	14.3	12.3	15.1	12.5	13.6	11.7	11.1	11.5	11.2	13.0	12.6	11.4	16.0	7.0	2.6	8.3	6.4	5.7	10.2	15.4	18.1	8.7	13.5	19.8	17.2	8.3	12.9	4.2	4.2	9.3	2.3	33.2	13.5	31.5	6.8	5.0	6.7	1.2	6.7	2.5	11.1	6.9	8.0	7.1	3.3	3.8	7.5	11.0	21.6	10.1	15.2	2.6	3.5	8.2	6.8	4.7	28.8	8.4	5.6	12.4	1.0	8.7	20.9	4.1	1.0	4.6	8.5	5.1	10.9	6.9	3.3	7.4	36.9	6.8	16.0	0.0	13.0	8.4	38.3	43.9	12.5	6.7	1.0	6.1	7.8	3.8	2.1
FAM71F1	"FAM137A, NYD-SP18"	ENSG00000135248	"Family with sequence similarity 71 member F1"	Q96KD3	7	128709061-128731743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"testis: 93.9"	"Group enriched"	"Detected in some"	93	"Early spermatids: 1122.8;Late spermatids: 2008.1"	"Cancer enriched"	"Detected in single"	23	"testis cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"NTERA-2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020636			Uncertain	Cytosol		No	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA020636: AB_1854739"	"unprognostic (3.09e-2)"	"unprognostic (3.39e-3)"		"unprognostic (6.03e-2)"	"unprognostic (5.25e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-6)"	"unprognostic (6.97e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.99e-1)"	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.4	0.9	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.4	0.0	0.1	0.0	0.6	1.0	0.0	0.1	0.0	0.5	0.0	0.8	0.2	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	93.9	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	1.4	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.4	0.9	0.7	0.6	0.6	1.0	0.8	0.5	1.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	1122.8	0.2	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	2008.1	12.8	0.7	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.8	0.1	16.7	6.8	0.0	0.1	1.2	0.0	0.5	0.0	0.0
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725961-27763116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.5;Late spermatids: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: AB_2686867"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	21.0	5.8	5.9	8.5	6.5	13.7	11.7	8.3	8.9	9.3	10.1	10.1	8.7	12.9	10.0	11.7	9.7	10.8	10.1	5.5	7.4	11.6	12.0	10.5	10.7	6.9	5.7	9.6	11.3	13.7	7.8	11.1	6.5	10.0	13.4	15.4	7.9	10.4	40.4	12.0	8.8	10.3	4.5	11.0	11.7	18.6	6.9	8.0	15.9	12.8	10.9	7.1	8.0	12.3	10.0	7.8	8.8	9.1	10.9	9.4	15.9	9.1	9.5	13.1	12.9	9.1	13.0	18.1	5.9	10.2	12.5	12.8	11.2	10.1	10.2	9.4	8.2	5.6	11.7	10.7	8.7	8.9	8.4	9.7	10.8	14.6	14.5	6.7	6.7	9.5	10.9	16.5	9.6	9.5	21.4	8.3	13.9	9.6	7.8	12.8	10.4	10.3	10.6	14.1	12.7	5.7	10.5	11.1	11.3	10.7	7.8	3.5	7.3	15.5	6.7	18.1	6.4	14.9	17.7	14.6	9.7	11.5	6.7	9.8	8.8	11.0	10.4	9.4	11.3	9.2	10.8	10.2	8.1	9.7	10.1	11.2	6.1	9.4	10.1	11.3	8.9	5.3	5.9	6.5	8.3	8.9	5.5	7.4	6.9	5.7	6.5	4.5	6.9	12.3	20.0	28.9	17.0	9.4	20.3	19.1	9.4	8.1	23.3	28.5	14.8	12.1	15.9	14.3	8.8	23.9	27.1	31.3	26.7	12.1	21.5	11.7	131.5	19.6	19.6	14.8	4.2	13.5	15.9	9.7	11.5	26.0	17.3	13.9	11.4	8.5	22.1	18.4	11.8	28.6	15.2	10.4	6.1	15.8	25.2	110.7	16.8	15.2	39.2	13.1	11.4	19.1	16.5	5.0	11.6	9.6	9.1	37.2	10.9	5.4	10.3	20.1	25.3	39.6	19.7	25.4	27.6	35.3	55.4	17.3	27.0	45.4	18.9	11.0	9.2	5.3
FAM76B	MGC33371	ENSG00000077458	"Family with sequence similarity 76 member B"	Q5HYJ3	11	95768953-95790409	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 261.6;Late spermatids: 372.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036608	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036608: AB_2675215"	"unprognostic (8.17e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-3)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.72e-4)"	5.8	5.0	1.1	12.5	1.6	39.5	5.2	4.2	2.3	4.2	1.7	4.9	9.2	6.8	1.6	4.0	3.9	5.3	4.0	1.2	1.0	3.1	8.2	5.0	17.1	1.9	1.8	5.5	6.1	3.7	2.3	6.7	1.8	4.7	5.1	5.3	4.7	3.3	3.9	5.8	6.4	4.5	1.1	8.4	5.9	17.7	1.8	14.2	5.5	3.7	17.6	4.9	3.7	3.4	8.0	6.0	22.1	12.0	3.6	3.6	18.4	13.4	6.4	9.6	11.0	22.4	15.3	29.8	16.5	6.4	12.5	15.0	13.1	4.5	10.1	16.1	9.5	35.0	10.9	11.8	9.2	25.0	19.3	4.7	7.3	11.1	9.9	6.3	9.3	17.5	21.1	16.1	5.5	5.8	28.0	29.9	12.3	8.5	5.4	30.0	16.5	17.7	7.3	8.8	9.3	26.3	16.3	9.1	10.1	7.4	12.1	10.9	9.5	13.4	14.1	15.8	12.3	8.8	19.7	45.5	3.2	23.8	19.2	0.1	1.9	3.5	3.3	2.0	2.7	1.8	3.0	3.4	1.3	1.5	2.7	4.1	5.7	3.3	1.9	4.8	5.2	1.8	1.1	1.6	4.2	2.3	1.2	1.0	1.9	1.8	1.8	1.1	1.8	3.4	27.9	6.4	16.5	14.7	41.5	13.8	12.5	8.4	22.8	16.1	17.0	16.4	12.9	8.6	14.0	5.5	27.1	8.5	28.9	10.5	0.0	7.7	261.6	23.2	23.4	19.2	20.4	34.1	18.7	7.5	10.1	14.9	15.3	18.3	10.8	21.0	15.4	19.8	8.3	11.8	15.9	14.0	4.1	18.0	18.0	372.1	17.1	20.0	16.0	13.1	17.7	12.4	19.6	16.6	30.1	9.1	16.0	15.4	16.2	12.5	10.3	2.4	12.3	15.1	26.3	17.6	21.3	31.8	20.9	14.4	16.1	7.7	26.4	15.0	10.8	10.7
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 84.7;intestine: 83.1;smooth muscle: 95.3"	"Group enriched"	"Detected in many"	4	"Basal squamous epithelial cells: 44.9;Erythroid cells: 72.6;Extravillous trophoblasts: 67.5;Squamous epithelial cells: 71.7;Syncytiotrophoblasts: 152.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.1;NK-cells: 1.1;T-cells: 2.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Mitotic spindle"	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA049333: AB_2680717, HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.44e-6)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	1.6	1.8	0.8	7.2	1.6	23.3	1.1	0.9	1.4	4.1	0.2	83.1	8.4	1.0	1.6	84.7	1.0	13.6	1.0	0.9	0.5	5.7	3.7	5.2	4.5	0.5	0.4	0.5	0.4	0.2	0.4	3.4	0.5	16.2	8.6	0.2	7.8	1.7	0.2	10.2	34.7	95.3	0.5	1.9	44.9	5.0	0.5	6.6	1.0	0.2	12.2	27.0	17.1	0.9	112.2	67.3	52.0	44.0	5.8	6.5	93.6	49.3	30.2	94.7	57.4	103.4	49.7	28.3	47.6	32.1	73.4	93.1	71.8	83.9	87.9	9.4	28.6	32.6	50.7	75.2	4.7	14.6	16.5	3.3	4.2	54.6	31.4	11.4	52.7	12.3	29.6	39.5	54.4	59.7	22.7	21.3	43.2	64.4	85.1	21.8	96.0	15.6	27.6	28.0	24.3	40.2	143.0	117.4	20.6	48.1	73.6	14.9	25.4	62.4	76.4	71.6	110.1	12.0	19.6	29.0	28.1	21.2	46.7	0.0	0.0	0.0	0.2	0.1	0.9	0.6	1.0	1.1	0.0	1.1	1.1	1.4	0.0	1.1	0.1	0.0	2.0	0.5	0.8	1.6	0.9	1.4	0.9	0.5	0.5	0.4	0.5	0.5	0.5	0.9	3.9	0.0	1.3	0.3	2.3	2.3	5.8	7.0	44.9	0.0	2.8	9.0	0.8	1.5	18.0	0.0	0.0	17.3	6.3	6.5	0.0	0.1	0.5	1.1	1.6	2.2	1.8	72.6	3.7	0.0	67.5	2.7	18.3	2.1	0.0	8.2	1.8	5.7	4.8	0.0	1.2	6.0	4.1	1.6	0.5	0.6	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	6.0	0.0	12.5	1.6	1.7	8.3	4.5	0.0	19.7	0.3	4.0	15.7	18.3	71.7	1.8	152.6	5.2	0.3	10.2	4.1
FAM83E	FLJ20200	ENSG00000105523	"Family with sequence similarity 83 member E"	Q2M2I3	19	48599961-48615076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.7;salivary gland: 28.5;stomach 1: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 22.8;Early spermatids: 26.0;Gastric mucus-secreting cells: 74.9;Intestinal goblet cells: 26.9;Paneth cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.9;OE19: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049305, HPA075968"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Vesicles	"HPA049305: AB_2680705, HPA075968: "	"unprognostic (1.36e-1)"	"unprognostic (9.81e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.00e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.05e-8)"	"unprognostic (5.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.90e-3)"	0.1	0.1	0.2	3.7	0.3	0.4	1.4	0.8	0.5	10.6	0.2	32.7	30.0	1.1	0.1	7.0	3.9	6.4	0.2	0.3	0.2	0.8	0.3	8.0	0.2	0.1	0.1	0.0	1.2	0.0	0.2	0.6	0.2	3.2	16.6	0.2	28.5	0.4	2.7	1.9	30.0	1.0	0.0	0.2	37.4	2.2	0.2	0.1	0.1	0.0	1.3	1.2	4.1	0.5	0.4	0.4	0.0	0.7	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.3	2.9	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.4	0.1	0.1	0.3	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.8	1.1	9.4	0.9	0.2	0.1	0.3	0.0	0.2	0.5	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.2	0.5	0.1	0.1	0.2	0.1	1.0	0.1	0.2	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.8	0.5	0.3	0.2	0.1	0.1	0.2	0.0	0.2	0.5	0.0	9.6	13.4	1.3	0.4	0.0	1.4	0.8	0.6	0.0	1.8	0.8	2.1	8.6	6.5	1.8	0.0	0.1	0.3	22.8	0.0	0.1	26.0	4.8	0.5	0.2	5.4	0.0	0.3	1.1	0.1	0.2	74.9	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	26.9	2.0	0.0	0.0	9.3	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	1.6	16.5	0.0	0.4	3.3	12.7	0.0	5.1	0.0	0.0	0.2	0.2	0.8	0.5	2.3	0.0	0.1	0.3	0.1	12.8	6.9
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (5.53e-4)"	10.6	9.6	14.5	5.5	13.9	8.7	12.3	12.3	17.6	14.8	7.2	14.6	13.8	10.7	2.6	17.7	12.3	5.3	11.6	13.8	11.7	12.2	13.3	9.1	6.2	18.9	11.6	12.5	18.6	8.4	11.6	2.3	13.5	13.4	4.7	1.7	13.9	5.8	3.3	25.2	15.4	3.3	12.7	11.8	14.4	9.0	14.4	4.7	11.4	2.5	3.8	12.7	14.6	14.3	15.6	16.3	1.9	9.4	2.0	6.8	8.2	8.8	7.3	8.5	8.9	2.8	11.0	13.9	9.7	5.2	3.0	7.5	3.7	6.3	1.4	22.6	7.6	4.6	2.9	6.5	9.0	3.9	8.1	6.6	13.0	4.3	7.8	4.7	5.0	22.5	12.9	15.0	5.1	17.2	5.9	3.1	1.4	25.5	17.5	11.6	3.9	8.4	10.4	8.0	3.3	9.6	8.8	15.6	5.6	0.9	11.8	12.3	6.7	3.8	10.4	11.9	10.7	16.1	8.8	6.1	9.9	9.2	6.2	0.0	1.9	10.8	2.4	2.7	3.2	2.0	4.2	3.4	2.6	6.5	3.3	2.6	1.7	3.0	2.7	1.0	3.9	1.4	14.5	13.9	12.3	17.6	13.8	11.7	18.9	11.6	13.5	12.7	14.4	14.3	19.8	9.6	8.9	3.6	17.5	21.5	22.3	23.7	14.8	15.1	21.1	26.3	5.4	10.0	21.2	23.9	12.5	11.8	22.1	41.4	21.5	22.2	6.4	18.2	9.1	12.0	25.7	9.7	11.7	32.9	10.9	13.9	17.9	18.0	15.2	8.6	11.4	12.5	11.0	11.8	9.5	32.4	22.4	13.2	18.2	2.4	18.6	14.3	23.2	2.8	14.4	14.6	34.0	5.5	8.5	23.8	42.8	18.4	12.7	12.2	100.4	22.6	22.4	12.5	13.1	13.5	13.8	37.4	37.4	22.3	29.8	6.2	21.8	12.9	34.8	23.4
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30890559-30943108	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: AB_2680311"	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	6.2	8.5	9.3	0.9	9.5	0.5	6.7	9.4	9.7	10.1	9.3	10.7	0.9	9.2	6.6	6.5	9.0	1.2	8.8	8.9	9.5	9.5	9.6	5.5	0.8	9.7	9.8	11.8	12.7	5.9	11.4	3.0	10.0	11.5	2.0	2.7	9.8	1.4	18.7	10.8	7.3	2.4	9.5	6.8	8.6	8.9	9.9	4.4	10.0	7.3	0.7	9.3	9.7	10.0	5.2	9.9	3.6	1.9	12.4	9.3	0.8	4.4	2.1	4.7	5.0	4.5	1.7	0.6	7.6	3.6	7.4	9.2	4.7	9.4	5.0	4.2	1.4	1.3	5.5	1.9	4.8	1.2	1.9	2.8	7.3	3.0	7.3	7.2	3.4	5.7	4.7	6.1	4.7	0.6	8.6	3.1	2.2	11.5	2.8	7.0	12.0	2.3	6.7	2.3	4.5	4.6	9.2	5.6	3.0	8.8	4.4	3.3	3.3	9.4	3.0	5.0	3.4	7.4	8.7	1.1	4.1	1.9	1.1	0.0	0.1	0.0	1.4	0.3	2.0	1.2	1.2	0.7	0.9	1.5	1.8	1.1	0.0	1.8	4.3	1.1	1.4	0.7	9.3	9.5	9.4	9.7	8.9	9.5	9.7	9.8	10.0	9.5	9.9	10.0	9.1	16.0	8.4	21.2	5.4	4.1	5.8	4.9	9.6	17.0	11.2	9.8	17.0	0.0	10.7	9.2	20.9	6.5	3.5	7.6	9.8	4.5	11.9	10.2	12.9	8.8	7.8	6.9	23.7	2.9	2.2	8.4	8.6	9.0	8.8	15.5	6.8	13.4	3.7	26.9	25.5	11.0	8.2	5.4	2.5	7.1	10.5	3.9	5.4	15.0	3.4	14.9	7.2	13.6	44.2	3.6	6.4	6.8	7.0	6.0	4.2	8.0	13.6	23.5	6.6	9.4	7.6	20.9	16.4	7.2	2.4	4.1	5.3	9.2	10.3	3.7
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"FA complementation group D2"	Q9BXW9	3	10026414-10101932	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 120.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	1.1	0.7	2.7	7.7	2.1	17.8	3.4	1.6	5.3	1.5	1.1	4.0	3.2	2.0	0.7	2.5	2.6	2.0	0.5	3.4	1.6	0.9	1.1	1.9	12.2	3.9	1.4	3.6	0.8	0.8	0.5	4.7	3.0	1.9	6.4	3.1	4.9	1.0	4.8	4.5	4.0	2.0	2.4	6.4	3.5	11.8	2.3	9.8	1.9	0.4	13.0	2.3	1.3	5.1	24.1	25.4	46.5	13.2	2.4	3.5	120.7	22.0	9.8	31.3	25.4	18.8	23.0	46.7	9.8	7.0	25.1	20.2	48.8	16.7	31.0	22.6	33.0	63.6	39.6	17.9	0.4	48.1	37.9	1.2	2.6	34.1	18.4	4.2	18.4	39.3	39.6	51.6	23.1	27.2	40.6	17.9	56.1	18.1	17.6	43.4	37.7	32.5	10.3	26.7	13.0	25.3	26.4	20.1	8.3	33.5	31.0	29.4	10.6	24.6	28.4	15.1	31.5	21.7	46.4	77.2	14.1	47.7	43.2	2.7	0.6	1.9	0.6	0.5	0.6	2.4	0.9	0.5	0.4	3.2	1.1	0.9	1.5	1.0	1.4	1.8	1.5	0.5	2.7	2.1	1.6	5.3	3.4	1.6	3.9	1.4	3.0	2.4	2.3	5.1	0.7	0.0	0.5	0.7	12.5	4.6	3.5	2.9	2.8	3.1	4.5	2.7	2.0	1.5	1.9	1.8	10.4	12.7	5.6	3.1	0.0	1.9	5.9	2.6	1.5	2.1	1.2	25.2	3.0	3.5	15.2	2.6	2.0	3.4	1.3	11.8	3.3	1.5	5.7	0.0	2.6	3.2	6.1	3.8	7.0	8.0	2.1	3.7	3.6	1.9	4.9	0.6	1.0	1.5	2.4	1.8	3.6	1.5	8.1	2.2	0.5	0.7	2.0	5.6	19.7	2.6	2.1	62.5	30.2	4.1	2.7	7.0	5.2	1.6	7.6	3.1
FAR1	"FLJ22728, MLSTD2, SDR10E1"	ENSG00000197601	"Fatty acyl-CoA reductase 1"	Q8WVX9	11	13668668-13732346	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Cataract, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 437.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017322	Approved		Supported	Peroxisomes		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Peroxisomes		"HPA017322: AB_1848424"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	21.1	16.2	19.3	23.0	36.0	74.9	20.6	34.3	31.5	23.8	24.5	32.9	38.7	24.7	24.9	50.9	17.7	13.7	20.0	22.6	29.7	14.0	5.0	20.2	20.5	48.4	29.9	19.9	21.3	29.1	15.6	24.6	44.1	20.5	37.6	32.6	18.2	15.4	15.2	12.2	21.1	30.7	37.3	20.5	62.0	20.8	32.1	16.5	19.8	18.6	23.9	28.4	30.0	94.8	79.5	50.6	49.1	38.4	45.9	52.6	26.7	69.2	27.6	50.0	52.7	53.5	66.4	100.9	30.2	55.5	74.3	84.3	73.2	69.9	76.1	30.0	59.4	43.4	44.8	0.2	44.1	87.9	33.7	40.2	70.3	36.2	107.7	36.9	49.6	50.2	68.9	29.3	41.5	39.9	65.5	26.3	25.8	100.1	72.6	56.9	62.6	28.4	48.4	126.4	37.7	27.3	65.5	61.6	34.4	56.2	37.8	54.1	62.1	68.5	58.2	63.7	58.4	16.4	59.6	84.7	43.4	26.4	42.4	10.4	24.9	28.0	7.7	21.3	5.4	3.5	3.7	6.6	28.5	5.5	3.3	5.5	38.9	9.1	18.2	4.4	5.3	7.7	19.3	36.0	34.3	31.5	22.6	29.7	48.4	29.9	44.1	37.3	32.1	94.8	38.6	35.3	21.1	80.0	24.2	32.2	24.2	21.5	41.5	46.0	27.6	20.3	24.1	5.7	26.2	22.0	41.7	25.7	40.2	59.8	5.9	12.8	100.8	21.1	36.5	31.4	36.0	38.5	146.0	25.9	18.5	26.8	114.7	26.2	38.7	23.3	29.6	2.5	33.9	47.1	113.5	28.8	26.4	53.5	57.0	181.3	26.8	48.8	35.6	71.2	54.8	20.6	20.6	93.5	437.2	29.3	43.4	25.6	36.1	30.8	23.3	8.7	18.7	50.4	26.3	29.3	29.3	41.6	32.3	116.9	19.9	9.9	25.8	17.0	47.7	42.0
FARSA	"CML33, FARSL, FARSLA"	ENSG00000179115	"Phenylalanyl-tRNA synthetase subunit alpha"	Q9Y285	19	12922479-12934037	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001911	Enhanced		Approved	Cytosol		NA	NA		55000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA001911: AB_1848427"	"unprognostic (1.52e-1)"	"prognostic favorable (8.23e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.22e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (8.32e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.84e-2)"	26.4	32.5	30.1	29.4	32.2	31.6	25.0	28.1	40.0	21.8	19.4	29.1	26.2	24.3	12.1	39.2	24.0	16.4	37.4	33.4	32.7	29.1	40.6	20.7	36.0	32.6	31.8	23.1	36.3	30.4	32.1	22.5	33.4	25.5	17.1	14.7	30.4	21.7	57.0	33.3	26.5	17.7	24.3	32.0	30.6	22.6	30.6	33.0	25.5	30.6	25.4	30.6	25.6	31.1	135.7	125.6	49.3	106.9	33.4	31.4	88.9	93.6	60.8	133.0	103.9	154.2	56.1	148.7	147.1	54.1	53.9	101.9	121.0	108.4	48.1	87.9	183.7	117.0	106.8	124.2	108.4	227.7	147.8	43.4	78.7	102.8	82.1	43.8	73.1	148.7	179.6	30.6	56.7	181.5	273.4	283.5	154.2	83.4	210.6	139.5	51.2	191.4	70.5	78.7	153.8	141.4	64.2	109.2	69.0	23.0	85.9	137.5	71.3	108.0	47.8	165.6	180.6	199.6	186.5	156.8	97.7	203.4	114.1	66.6	111.0	86.3	87.1	119.0	108.2	88.2	85.1	81.4	120.4	94.5	85.4	82.3	7.0	118.0	92.8	97.0	87.6	130.2	30.1	32.2	28.1	40.0	33.4	32.7	32.6	31.8	33.4	24.3	30.6	31.1	15.0	9.6	21.4	9.1	24.7	25.4	28.0	63.4	20.5	25.1	18.8	18.5	25.7	14.3	35.4	23.9	10.4	87.5	17.5	26.7	58.7	55.4	5.8	16.0	18.6	20.0	22.8	61.8	12.1	46.4	78.7	18.4	27.5	15.8	23.5	26.3	21.0	25.8	62.9	18.5	12.8	32.6	69.2	23.5	21.2	9.4	19.0	19.7	33.8	1.9	45.5	23.6	25.7	8.5	7.5	47.0	26.3	13.2	40.9	32.6	30.4	55.7	22.3	17.1	6.6	16.5	24.3	20.2	41.9	26.3	29.5	96.7	22.5	28.9	44.7	26.8
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078338-82098294	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 372.8;breast: 271.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.0;Breast glandular cells: 442.9;Breast myoepithelial cells: 165.4;Hepatocytes: 244.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		3400000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	372.8	30.9	25.0	14.9	44.2	18.7	271.6	67.3	49.9	31.7	0.0	25.5	11.5	18.0	6.2	63.6	15.2	6.6	21.9	39.9	15.0	11.8	191.4	54.1	7.2	84.4	75.7	16.3	18.6	8.5	72.4	12.1	101.7	69.0	3.0	4.3	38.3	14.3	27.9	89.4	28.8	5.3	12.5	8.8	63.6	11.9	33.7	9.6	21.2	2.3	3.0	27.0	31.8	60.8	179.1	182.0	81.7	56.7	130.1	87.2	176.9	34.3	43.3	35.5	64.6	190.6	116.7	58.8	29.2	26.3	99.5	144.0	79.2	157.8	6.5	30.0	358.0	123.9	140.0	257.2	36.8	67.5	19.2	84.2	40.4	90.8	21.0	12.1	40.1	54.8	193.2	50.7	12.6	304.1	78.9	105.5	161.1	28.1	107.1	64.1	47.8	116.5	40.3	220.7	205.0	117.0	50.6	1109.2	93.6	29.5	199.4	123.4	71.1	52.3	107.0	45.2	88.4	68.5	17.1	60.6	31.2	71.1	79.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	25.0	44.2	67.3	49.9	39.9	15.0	84.4	75.7	101.7	12.5	33.7	60.8	9.6	25.6	126.0	28.4	7.4	7.8	12.7	33.2	8.0	28.7	442.9	165.4	5.9	21.5	28.4	11.0	6.2	32.0	12.8	35.7	3.9	19.2	1.5	19.6	19.8	10.8	18.1	20.6	11.9	29.2	77.7	13.4	33.6	17.1	12.7	29.9	10.8	244.1	13.9	30.3	12.5	22.3	22.4	9.8	6.2	3.4	16.4	7.0	17.8	4.7	6.2	14.1	8.2	11.6	17.6	19.1	23.6	11.3	9.7	60.4	6.5	5.9	23.7	13.1	0.0	9.0	14.9	1.8	11.7	34.1	13.8	29.6	10.6	27.9	27.4	19.6
FASTKD2	KIAA0971	ENSG00000118246	"FAST kinase domains 2"	Q9NYY8	2	206765357-206796189	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067191			Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA067191: AB_2685801"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.36e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.57e-2)"	14.4	14.0	5.2	12.4	5.9	11.4	17.3	4.8	6.2	12.8	7.5	15.0	14.9	15.8	8.8	15.9	12.9	11.5	24.9	5.7	5.3	17.4	27.2	11.8	14.3	5.8	4.5	15.7	11.6	18.4	6.9	13.0	6.5	13.3	17.0	11.2	11.2	11.1	31.5	11.8	12.5	15.7	4.4	11.2	13.3	12.0	4.9	13.1	17.8	36.6	17.2	20.4	9.6	4.8	30.2	27.0	24.7	28.1	27.2	32.7	46.2	34.3	29.0	57.3	32.4	48.3	32.0	37.4	37.5	35.5	66.7	40.0	30.7	47.4	50.4	11.7	19.8	29.4	25.6	46.6	33.1	64.3	26.5	35.2	48.8	43.8	47.2	29.1	39.3	27.2	56.4	18.6	42.8	25.3	27.3	27.4	44.0	28.2	51.2	23.7	38.1	38.8	39.4	49.7	36.0	22.9	26.6	44.7	41.3	36.8	20.9	33.4	30.8	35.0	31.5	24.4	36.3	18.5	32.9	48.0	40.6	29.2	29.5	9.6	21.4	5.2	19.2	21.4	21.5	20.1	21.3	20.2	31.0	17.3	28.0	25.2	1.4	31.2	16.5	14.6	18.7	20.5	5.2	5.9	4.8	6.2	5.7	5.3	5.8	4.5	6.5	4.4	4.9	4.8	17.8	28.9	11.4	19.6	20.3	23.7	33.7	28.8	32.5	18.9	11.1	12.2	23.2	7.2	22.8	12.9	22.9	28.2	15.1	6.7	9.8	19.2	30.9	14.5	23.1	14.6	7.3	11.6	41.9	15.1	22.4	21.2	27.5	14.9	5.1	17.5	9.3	17.6	14.8	6.7	40.3	10.5	12.2	7.9	9.4	8.0	9.6	10.8	5.4	25.3	12.9	9.3	8.2	26.2	23.2	12.1	8.2	13.9	20.0	13.7	8.8	12.7	15.9	22.8	13.1	19.3	17.4	37.5	12.8	24.5	21.5	25.7	18.4	18.6	13.1	22.6
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120630-65122177	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059015	Supported		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No			"Cluster 30: Non-specific - Translation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: AB_2683881"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	817.0	787.0	976.0	655.4	1009.0	1898.7	878.5	956.5	1212.5	1024.2	887.1	905.9	604.0	780.6	535.3	720.0	907.5	590.1	862.2	928.0	953.5	632.1	756.3	614.0	1342.5	982.1	958.7	1403.7	1167.7	395.0	521.6	482.7	989.8	649.3	438.8	228.2	854.7	532.3	1191.2	905.1	712.9	441.6	1010.2	784.5	796.3	336.6	1011.9	843.5	619.9	642.1	818.5	796.7	794.0	1017.9	1305.1	1040.6	658.8	1067.9	766.4	1142.2	1033.3	727.3	887.7	1327.5	832.4	1258.7	1232.1	1782.0	1782.3	744.2	701.5	1101.2	821.5	1287.2	419.3	1075.4	1494.0	1428.1	907.1	1607.8	1612.2	1546.9	1184.9	1583.3	1944.0	1106.3	1286.5	842.2	998.5	1416.3	1334.4	1578.6	644.9	2003.0	1579.6	2925.2	1850.4	1007.2	2027.5	1464.8	622.2	2980.1	1036.0	744.3	1054.4	949.2	663.8	1490.6	2131.0	399.1	1393.3	1829.5	771.2	868.6	954.8	1327.5	1150.0	1629.0	1943.6	2802.6	1042.6	1285.4	979.3	2638.2	2997.4	1808.3	2906.6	2694.0	3986.3	7025.5	4689.8	3729.6	3181.0	6502.9	5484.9	4364.5	1905.5	2994.7	2398.9	4141.8	3794.9	10270.4	976.0	1009.0	956.5	1212.5	928.0	953.5	982.1	958.7	989.8	1010.2	1011.9	1017.9	2252.8	641.0	1035.7	17.6	3768.6	3773.3	3059.7	1883.6	2632.2	351.8	3483.5	5942.5	507.2	1712.8	1280.4	958.2	196.0	2277.7	2670.7	1454.5	2050.4	1540.6	875.1	954.7	1569.4	1671.7	1226.4	1786.0	15.9	2689.2	2487.3	1531.1	923.5	1298.4	1370.0	1483.3	1755.9	2176.7	2188.0	190.1	18.2	2143.3	907.3	2643.8	3977.8	2397.4	2285.9	2349.4	2123.8	16.9	3121.9	935.5	2472.7	15.6	40.8	2042.7	2666.5	1229.2	2317.3	3295.5	2501.4	2615.9	826.4	513.6	1117.5	2227.4	2678.6	654.4	590.6	2506.0	4195.9	2793.0	2897.4	1470.6	2184.8	3518.0
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 324.4;kidney: 297.8;liver: 893.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 500.4;Macrophages: 238.6;Proximal enterocytes: 1095.0;Proximal tubular cells: 864.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 404.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HaCaT: 75.2;MCF7: 243.4;OE19: 54.5;RT4: 157.0;U-698: 170.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		21000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	13.7	27.4	1.6	12.7	1.8	15.0	41.4	1.8	5.7	19.9	2.6	29.8	324.4	3.6	15.8	2.7	7.1	34.4	2.9	1.5	2.2	297.8	893.2	165.9	6.8	3.6	2.6	1.1	41.4	107.9	8.6	3.0	2.9	25.8	30.5	0.7	53.2	28.9	1.3	8.1	258.1	8.8	2.6	12.2	85.6	2.5	3.2	2.2	16.8	0.9	7.8	70.8	6.7	3.8	0.5	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.6	3.8	0.0	0.3	0.8	0.1	75.2	0.1	0.0	0.1	0.0	0.3	0.6	2.9	1.3	0.0	1.5	18.8	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.2	0.3	0.2	243.4	0.1	4.4	1.1	54.5	9.5	0.0	0.9	1.9	0.0	157.0	0.7	5.6	0.6	44.5	0.0	0.9	26.7	7.7	0.2	0.1	1.0	0.8	0.0	0.3	1.1	170.4	0.0	1.4	0.1	63.3	68.4	404.3	7.9	162.3	11.7	3.0	4.6	4.6	90.1	3.2	16.2	8.3	12.1	15.4	90.7	32.1	2.3	33.1	1.6	1.8	1.8	5.7	1.5	2.2	3.6	2.6	2.9	2.6	3.2	3.8	2.8	76.9	182.8	0.0	10.3	0.8	8.9	0.7	0.0	0.1	62.4	24.3	0.7	102.9	41.0	62.5	0.0	11.1	14.8	26.1	111.6	21.5	0.1	4.0	0.4	4.8	31.9	24.4	0.9	62.7	1.7	5.4	102.4	5.2	47.4	16.0	12.1	500.4	177.6	0.0	0.8	61.4	0.0	79.9	32.1	1.5	1.5	238.6	12.4	1.9	20.1	2.6	8.2	0.5	0.3	24.0	77.6	4.1	18.3	11.9	1095.0	864.1	9.1	0.2	6.6	0.6	2.0	0.6	1.3	0.8	1.0	10.1	12.1	0.5	90.4	68.1
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593824	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 753.6;tongue: 385.3"	"Group enriched"	"Detected in some"	7	"Gastric mucus-secreting cells: 11.2;Skeletal myocytes: 8.7;Spermatogonia: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;CACO-2: 2.1;HMC-1: 2.2;MCF7: 3.0;OE19: 2.9;PC-3: 2.0;SiHa: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		960000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	0.1	0.9	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.0	69.2	0.3	5.3	0.0	0.0	8.1	0.0	0.1	0.2	6.1	0.0	0.2	0.2	0.4	0.4	0.7	0.3	0.0	4.3	49.7	0.0	0.1	0.1	1.2	0.0	0.0	4.2	3.3	753.6	0.2	0.9	0.0	0.9	0.0	36.1	1.4	1.4	0.2	0.3	385.3	0.9	0.3	0.0	0.0	0.3	1.3	0.0	1.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	1.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	2.8	0.6	0.0	0.1	0.2	0.1	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	6.1	0.0	0.7	0.3	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.2	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FBXL17	"DKFZP434C1715, Fbl17, Fbx13, FBXO13"	ENSG00000145743	"F-box and leucine rich repeat protein 17"	Q9UF56	5	107859035-108382098	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Astrocytes: 270.0;Excitatory neurons: 568.2;Inhibitory neurons: 578.0;Microglial cells: 205.2;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036410, HPA036411"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA036410: AB_2675109, HPA036411: AB_10669603"	"unprognostic (8.15e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.30e-2)"	"prognostic favorable (4.60e-8)"	"unprognostic (1.86e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.35e-2)"	15.4	13.8	11.8	7.8	13.1	5.9	10.4	7.5	15.3	10.8	3.8	10.1	10.6	9.9	8.9	12.0	9.0	9.1	27.0	12.4	12.5	16.9	14.2	8.9	8.5	9.0	12.2	9.3	10.0	26.0	5.7	5.9	9.0	11.8	10.4	25.6	9.8	13.7	55.8	8.7	10.9	11.7	10.5	10.7	10.1	8.6	11.8	10.1	24.6	41.7	10.7	8.5	4.5	10.3	8.7	8.5	9.6	17.7	15.8	16.4	6.4	10.4	23.3	8.4	11.3	1.7	17.9	9.7	16.0	16.9	13.0	3.8	7.7	11.9	13.0	9.8	6.9	9.2	9.0	4.2	8.2	6.2	10.1	11.8	17.4	7.8	5.7	16.3	10.1	3.9	1.3	12.2	18.5	6.5	5.4	7.9	1.3	6.7	7.9	7.6	12.8	12.7	11.7	11.9	8.2	14.0	13.6	11.9	13.4	6.6	9.4	14.6	11.0	18.9	5.9	5.9	13.6	9.5	14.3	7.0	16.7	9.4	12.6	0.1	0.1	0.8	0.4	0.2	0.4	0.2	0.4	0.4	0.2	0.3	0.4	0.3	0.3	0.2	0.1	0.4	0.2	0.1	11.8	13.1	7.5	15.3	12.4	12.5	9.0	12.2	9.0	10.5	11.8	10.3	13.2	19.2	14.5	270.0	13.9	16.8	7.4	7.5	6.8	37.2	18.6	10.2	38.3	17.2	8.3	29.5	56.3	4.8	12.8	22.8	17.6	7.3	5.6	8.5	9.7	12.3	29.9	5.7	568.2	13.1	6.5	12.1	12.2	10.7	16.5	12.2	21.0	21.4	8.4	30.3	578.0	21.7	2.0	21.0	14.1	5.4	14.0	9.9	16.0	205.2	13.1	20.8	12.3	302.6	256.1	13.3	16.0	16.6	10.7	8.6	14.4	15.0	6.1	50.4	0.0	16.6	9.8	9.5	3.9	10.6	24.6	4.5	12.6	13.8	16.6	8.8
FBXL18	"Fbl18, FLJ11467"	ENSG00000155034	"F-box and leucine rich repeat protein 18"	Q96ME1	7	5431335-5513809	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036049			Approved	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA036049: AB_2674918"	"unprognostic (2.86e-3)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.98e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.28e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.30e-4)"	"unprognostic (1.73e-3)"	2.3	1.9	6.8	2.0	7.0	2.7	1.1	3.2	14.2	1.0	1.8	1.3	1.7	1.5	1.1	2.0	1.1	0.9	1.9	10.2	4.3	1.3	1.2	1.3	1.9	5.3	2.5	1.2	2.6	2.1	1.4	1.3	2.6	1.4	0.9	1.4	2.0	1.2	3.6	3.8	1.5	1.3	0.7	1.5	1.6	1.6	5.8	1.4	1.4	2.0	1.6	1.3	1.0	5.1	11.0	15.2	3.7	9.7	5.7	4.2	6.9	6.5	2.9	4.0	3.9	12.0	7.4	5.2	7.5	4.0	7.4	17.3	4.9	14.7	2.8	3.5	6.3	2.8	10.7	4.7	4.2	4.9	4.3	4.3	7.9	6.4	3.6	3.8	5.0	3.0	8.0	3.5	3.7	16.4	3.0	5.3	13.7	5.1	12.1	6.8	7.8	3.6	4.0	6.1	7.9	12.2	10.2	18.1	3.5	4.5	17.9	4.4	11.4	12.9	16.6	10.1	9.9	5.2	7.5	3.8	7.1	7.1	16.1	6.3	2.1	0.9	1.4	2.1	1.3	1.3	0.9	1.4	1.6	1.8	1.0	1.2	5.0	2.3	2.9	1.4	1.2	1.5	6.8	7.0	3.2	14.2	10.2	4.3	5.3	2.5	2.6	0.7	5.8	5.1	4.8	6.4	4.8	6.2	2.6	2.5	3.0	0.9	1.2	9.7	3.9	9.1	5.3	2.8	5.8	0.0	4.2	3.9	5.5	4.8	0.0	2.4	1.5	7.6	3.5	2.8	4.8	0.4	10.8	2.6	2.7	2.7	4.6	7.3	2.5	3.0	2.5	1.8	1.5	1.7	8.5	1.9	4.1	3.5	2.9	0.5	1.5	2.4	0.0	7.5	3.2	4.7	5.2	4.0	7.8	2.2	2.1	0.7	1.4	2.4	2.4	1.2	3.2	6.6	0.0	4.7	3.0	2.7	4.9	2.4	3.3	2.2	2.9	1.5	4.8	1.8
FBXL6	FBL6	ENSG00000182325	"F-box and leucine rich repeat protein 6"	Q8N531	8	144355431-144359376	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008867			Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"HPA008867: AB_2668161"	"unprognostic (2.97e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (4.49e-10)"	"unprognostic (3.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	4.6	4.8	2.3	1.4	2.3	2.0	4.9	2.5	3.2	4.3	2.5	8.0	4.6	3.5	0.6	7.2	3.1	1.0	4.1	2.3	2.2	4.6	10.8	3.9	1.8	2.5	2.4	2.1	8.1	1.6	3.8	1.8	2.4	4.2	1.8	0.5	5.1	1.6	4.2	6.6	7.8	0.7	2.4	6.8	5.5	5.2	2.6	1.5	3.3	0.3	1.2	4.6	4.3	2.3	9.0	3.0	2.1	13.3	2.7	0.7	3.8	4.4	5.1	4.5	3.1	3.2	3.9	4.1	5.3	2.2	2.2	5.8	2.4	6.1	1.0	7.6	3.0	8.2	1.6	7.9	4.0	2.1	8.4	1.2	5.5	2.5	6.6	1.2	3.7	6.7	3.8	6.6	1.7	16.7	6.0	1.9	2.6	9.8	8.3	6.7	2.4	14.0	6.0	3.0	3.1	3.0	5.1	8.0	7.7	1.2	13.2	3.7	3.3	2.2	8.1	10.8	5.4	2.5	2.1	3.0	3.4	5.1	2.9	0.0	0.1	0.6	0.4	0.4	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.3	1.6	0.7	0.0	0.0	2.3	2.3	2.5	3.2	2.3	2.2	2.5	2.4	2.4	2.4	2.6	2.3	17.9	6.4	2.0	4.6	10.1	5.7	6.0	2.1	7.4	9.9	13.2	12.8	1.1	7.2	4.6	0.0	14.6	8.3	17.3	18.2	5.9	5.2	1.9	5.2	6.8	5.9	2.4	3.0	7.4	6.2	11.6	5.2	13.7	7.8	1.3	7.7	6.8	6.7	6.9	1.7	5.6	19.4	2.0	4.7	7.6	1.6	5.3	9.0	5.4	4.7	2.6	7.9	6.2	2.0	2.7	7.5	10.8	1.9	20.1	8.2	43.7	8.1	2.0	9.0	0.0	5.1	13.6	5.0	7.8	14.8	6.7	3.8	10.7	9.9	17.3	6.3
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: AB_2677484"	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	12.8	11.5	7.3	12.9	8.4	9.8	13.9	8.1	9.9	14.1	8.2	12.5	9.6	12.5	11.1	10.5	10.0	11.5	17.4	7.0	7.7	12.9	18.0	14.5	14.6	8.0	7.6	12.3	9.5	18.5	10.2	13.8	8.0	14.6	13.0	11.0	11.5	12.0	18.7	12.2	11.6	12.3	7.5	14.4	12.5	12.4	7.8	20.2	12.2	16.8	15.6	13.8	11.2	9.9	12.6	13.2	20.1	14.7	22.1	24.6	10.4	16.1	30.7	22.4	30.5	19.6	15.1	18.2	15.5	26.2	23.6	17.2	21.2	20.3	26.8	20.1	13.6	10.8	19.0	13.3	21.9	29.6	17.0	24.0	17.1	21.6	21.1	24.0	30.7	16.6	12.2	19.1	22.3	5.1	18.8	13.8	9.4	13.9	19.8	16.6	29.3	18.4	21.7	14.5	17.9	17.3	21.4	14.2	21.2	17.1	15.0	21.2	20.2	20.4	7.3	10.8	18.2	23.3	25.1	15.3	20.3	16.6	15.8	15.1	6.1	9.1	5.0	8.0	5.5	4.9	4.7	5.0	7.5	3.8	4.8	6.2	11.2	7.7	15.2	3.7	7.4	4.9	7.3	8.4	8.1	9.9	7.0	7.7	8.0	7.6	8.0	7.5	7.8	9.9	10.6	16.0	45.7	25.1	13.8	3.3	5.5	7.4	7.4	10.3	8.5	6.7	18.7	11.5	10.6	11.0	10.4	7.5	13.4	11.3	5.9	8.8	11.2	8.9	9.9	10.8	9.6	7.2	40.2	6.7	6.8	11.8	14.8	10.4	15.8	9.6	11.4	16.9	12.6	13.5	37.4	10.1	6.1	24.9	6.4	2.9	9.0	17.8	3.6	38.4	12.3	5.9	12.3	33.2	44.4	9.9	8.9	18.4	11.0	8.6	9.3	9.3	16.4	9.0	0.0	6.9	7.8	20.6	8.6	9.2	3.8	12.3	12.1	11.2	9.0	8.7
FBXW11	"BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696"	ENSG00000072803	"F-box and WD repeat domain containing 11"	Q9UKB1	5	171861549-172006873	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072204	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA072204: AB_2686493"	"unprognostic (4.04e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.76e-1)"	19.5	20.4	33.3	13.6	38.2	8.2	17.0	34.7	41.6	19.9	27.4	14.6	12.6	22.9	12.4	24.2	27.0	17.5	36.1	38.0	35.5	23.0	20.7	17.6	16.7	33.3	34.4	25.6	29.1	33.1	14.2	13.9	33.1	19.0	16.0	37.2	13.5	20.3	34.5	13.7	13.2	26.1	34.4	18.1	20.0	14.3	37.7	17.3	21.1	35.6	22.0	19.2	15.8	42.4	35.4	35.6	52.0	45.2	39.9	40.2	26.4	37.1	51.7	45.0	54.9	36.7	23.1	32.5	44.3	46.4	72.0	22.8	37.6	56.3	74.6	42.7	37.3	26.2	35.0	28.5	35.4	29.8	36.0	28.5	38.2	36.8	59.8	48.5	38.6	27.3	16.6	31.7	55.7	26.5	20.7	15.3	19.8	20.8	39.5	30.1	43.7	22.0	34.8	29.2	21.6	37.2	32.9	27.3	70.8	38.7	34.2	31.0	33.8	44.3	22.0	27.4	37.2	31.8	38.9	22.2	31.3	27.8	34.6	25.4	7.3	7.2	5.8	5.1	6.1	8.5	4.8	5.7	7.3	8.4	4.3	5.7	7.1	14.1	5.7	8.6	5.7	6.6	33.3	38.2	34.7	41.6	38.0	35.5	33.3	34.4	33.1	34.4	37.7	42.4	35.4	25.6	21.2	75.4	52.7	19.1	15.6	21.8	32.5	43.5	26.4	22.1	59.1	42.9	20.8	27.6	8.4	8.5	49.8	25.1	43.0	33.7	32.9	42.0	47.9	26.3	28.8	27.4	86.5	36.9	7.8	24.7	38.2	51.0	20.8	25.8	29.3	43.1	12.8	35.3	85.3	21.6	20.3	29.6	25.3	34.3	29.5	26.6	12.4	62.8	24.6	63.6	16.5	75.9	94.4	54.1	14.9	28.6	36.5	30.2	21.5	52.4	17.1	34.3	46.0	28.2	33.5	34.5	16.0	28.7	23.7	12.0	28.8	17.2	15.0	32.9
FBXW5	"DKFZP434B205, Fbw5, MGC20962"	ENSG00000159069	"F-box and WD repeat domain containing 5"	Q969U6	9	136940435-136944738	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 251.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 581.9;Late spermatids: 1900.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046615	Approved		Approved	Mitochondria		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA046615: AB_10965648"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.56e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (4.74e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	54.7	58.1	27.6	23.3	23.0	28.7	47.4	23.4	32.4	36.2	23.4	73.9	42.9	44.1	9.4	70.8	33.9	17.7	117.1	34.7	23.5	54.3	132.4	37.5	22.1	27.0	27.2	29.1	75.7	19.0	41.1	15.5	28.3	56.3	13.4	3.9	54.8	26.9	188.7	42.6	59.3	17.2	24.3	47.6	65.0	251.8	33.0	24.7	42.5	66.0	17.6	59.4	41.5	23.7	39.2	65.5	14.9	36.7	36.6	23.6	85.7	40.6	27.5	27.7	15.3	42.9	48.8	27.0	46.0	42.0	21.5	48.0	13.6	35.3	4.6	35.4	47.2	22.9	88.8	46.8	40.0	34.2	55.2	26.9	31.0	25.4	21.1	21.9	28.9	19.5	46.0	42.7	21.3	98.3	26.2	36.4	26.7	48.1	70.6	28.7	22.5	46.3	24.5	37.9	30.9	30.0	49.0	52.8	54.4	5.7	60.3	52.4	55.8	39.5	35.1	75.1	35.1	33.6	45.1	17.0	55.0	29.7	30.5	62.8	62.1	88.0	97.7	74.3	75.3	39.2	73.9	83.3	59.6	31.1	32.0	53.7	32.9	55.4	61.2	98.8	96.8	72.8	27.6	23.0	23.4	32.4	34.7	23.5	27.0	27.2	28.3	24.3	33.0	23.7	61.3	19.2	45.4	13.1	40.7	28.7	44.5	129.0	26.7	29.9	50.1	48.8	86.9	50.1	72.8	23.9	16.7	68.3	108.0	336.5	74.3	111.7	581.9	29.1	27.5	53.6	67.3	36.8	15.9	148.1	132.9	38.9	98.4	38.6	28.6	116.2	46.1	113.3	88.0	60.6	15.3	153.7	65.1	62.6	49.3	1900.7	51.6	69.2	69.4	8.4	124.9	59.1	83.4	11.1	17.1	132.5	238.0	71.1	59.4	84.6	420.9	134.1	43.5	37.3	59.2	33.5	59.0	224.3	47.4	47.1	35.9	101.4	66.6	49.4	127.6	70.0
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 206.9;salivary gland: 85.4;stomach 1: 85.5;thyroid gland: 99.9"	"Cell type enriched"	"Detected in many"	9	"Intestinal goblet cells: 6081.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 63.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.6;Daudi: 1.8;JURKAT: 1.7;MOLT-4: 1.8;RH-30: 7.1"									"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Golgi apparatus, Cytokinetic bridge"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.28e-5)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.08e-1)"	5.9	10.0	5.1	14.0	7.2	0.4	3.2	4.0	8.4	56.4	15.0	206.9	68.7	1.2	0.6	4.6	9.8	49.2	2.9	5.6	6.8	11.3	1.0	1.9	0.9	20.1	10.6	3.7	4.9	0.5	3.4	2.9	11.1	3.8	67.7	0.6	85.4	1.4	0.4	14.8	148.7	2.6	5.9	1.5	85.5	2.9	14.0	1.5	99.9	0.0	0.7	3.4	1.6	12.0	0.0	4.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.1	1.8	0.6	0.1	1.5	0.3	0.1	7.1	1.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.0	0.1	5.1	7.2	4.0	8.4	5.6	6.8	20.1	10.6	11.1	5.9	14.0	12.0	0.6	3.2	5.1	2.6	4.6	3.7	1.9	15.8	1.2	1.1	1.3	3.4	2.8	70.1	60.0	25.8	0.0	0.7	1.8	622.2	0.0	5.2	7.2	4.2	0.3	26.7	81.1	0.0	0.6	0.9	0.4	1.9	552.0	4.0	15.9	0.4	0.7	1.3	44.0	0.0	0.4	6081.9	2.0	30.2	12.6	9.2	0.9	21.6	8.8	15.9	0.9	0.4	1.0	0.5	0.2	3.9	253.6	0.0	2.1	13.8	413.5	1.2	11.0	2.0	59.2	0.5	1.1	0.5	2.4	0.4	6.8	0.4	5.6	0.9	191.4	164.1
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cell line enhanced"	"Detected in some"		"HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	68.0	24.8	7.3	101.7	6.6	48.6	13.3	8.0	12.1	18.1	13.9	16.0	8.1	7.3	4.3	11.7	14.6	36.8	11.5	6.5	11.5	12.7	12.3	77.5	16.1	15.1	11.4	7.2	12.7	8.5	7.6	107.3	13.3	6.1	21.0	2.3	9.9	9.6	2.6	3.5	10.8	40.9	11.9	61.8	10.1	4.4	13.8	9.8	6.4	10.2	7.7	68.3	5.2	21.8	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	29.4	0.3	0.0	0.7	8.6	56.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	17.9	0.5	0.0	0.0	0.4	15.8	0.0	0.0	1.1	0.2	1.2	8.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	61.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.4	26.7	6.6	2.4	358.3	421.8	0.7	268.4	1.0	3.2	0.5	0.4	89.9	1.7	0.4	0.7	2322.4	0.4	232.7	3.8	0.9	170.3	7.3	6.6	8.0	12.1	6.5	11.5	15.1	11.4	13.3	11.9	13.8	21.8	2.3	22.4	49.1	0.0	8.6	8.7	0.9	0.3	1.2	0.4	1.1	3.8	1.8	2.8	12.1	0.0	0.0	1.0	3.4	0.1	9.8	0.2	38.2	0.1	0.8	15.6	0.0	3.0	0.1	0.6	1.6	8.9	1.1	0.1	30.4	0.1	3.9	2.1	178.2	0.0	0.1	0.0	0.0	159.1	336.6	66.5	1.5	305.0	17.8	12.2	97.3	0.5	7.2	1.0	0.6	0.5	0.0	0.0	4.6	0.3	0.0	9.6	3.7	0.2	6.6	1.5	6.0	0.4	0.6	0.8	7.7	1.6	4.8	0.2	0.1	0.4
FCHSD2	"KIAA0769, SH3MD3"	ENSG00000137478	"FCH and double SH3 domains 2"	O94868	11	72836745-73142318	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 219.6;Microglial cells: 387.8;Oligodendrocyte precursor cells: 471.0;Oligodendrocytes: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 164.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038545, HPA038546"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments"	"Nuclear speckles, Focal adhesion sites"	"HPA038545: AB_2676074, HPA038546: AB_10673013"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	22.2	19.2	43.3	33.4	47.9	28.6	16.8	31.5	38.7	14.9	34.6	14.5	8.9	16.0	6.9	11.7	13.8	22.6	25.5	37.0	44.5	13.0	17.6	23.9	45.2	36.6	36.4	32.3	10.4	9.9	8.1	31.2	35.4	11.6	14.4	19.6	9.3	13.8	8.8	9.0	17.7	17.2	32.5	42.3	13.1	22.6	41.3	28.5	14.9	14.7	46.1	21.6	11.7	45.0	14.2	12.3	26.0	31.3	9.8	23.9	21.8	26.7	50.6	14.8	12.0	9.6	21.0	76.3	31.3	31.0	15.6	20.0	15.3	14.1	21.0	27.2	7.0	64.2	14.3	33.4	25.7	30.6	7.6	14.6	15.6	15.1	17.7	33.4	35.7	26.7	13.7	49.6	19.5	16.1	36.4	54.7	5.5	15.6	13.8	56.4	39.8	164.1	24.8	21.4	13.1	16.9	9.6	16.2	31.9	12.2	12.4	23.7	47.9	45.9	18.5	32.9	7.5	46.8	29.4	71.2	8.4	51.4	13.8	18.3	8.4	18.7	2.8	5.1	1.9	22.2	2.8	3.2	8.1	26.9	3.2	4.1	19.9	2.0	3.0	32.3	3.2	3.6	43.3	47.9	31.5	38.7	37.0	44.5	36.6	36.4	35.4	32.5	41.3	45.0	47.3	9.6	14.0	114.9	76.7	8.5	5.2	3.6	9.1	13.5	5.9	4.7	16.0	8.6	6.1	3.7	25.0	12.4	39.4	1.9	1.9	4.1	6.2	6.6	8.3	30.2	4.8	19.4	79.4	6.2	9.2	9.4	7.7	5.4	2.5	33.6	46.1	11.3	19.9	10.1	219.6	7.7	4.1	30.8	29.9	10.0	10.8	32.8	5.4	387.8	20.6	10.6	5.2	471.0	198.1	5.3	5.7	16.6	70.1	3.8	1.8	3.5	3.9	17.0	6.6	13.0	26.1	9.6	13.0	7.1	5.8	12.0	14.9	6.0	3.7	4.8
FCSK	"FLJ39408, FUK"	ENSG00000157353	"Fucose kinase"	Q8N0W3	16	70454595-70480274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.7;Cardiomyocytes: 4.2;Cytotrophoblasts: 5.5;Extravillous trophoblasts: 3.0;Hofbauer cells: 5.0;Syncytiotrophoblasts: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041971	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA041971: AB_10795648"	"unprognostic (4.55e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.91e-4)"	"unprognostic (2.49e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.89e-2)"	"prognostic favorable (8.38e-4)"	3.9	7.2	5.4	5.4	7.1	5.0	4.9	8.2	7.7	5.6	7.5	7.5	10.1	4.9	2.4	5.6	5.5	3.8	4.3	5.3	5.0	8.9	8.2	4.8	5.4	6.4	4.6	6.6	8.3	9.1	9.8	3.6	5.7	6.3	3.9	2.9	5.9	4.4	5.5	7.2	7.4	3.1	4.5	6.4	6.6	4.5	5.7	3.8	7.9	2.3	2.8	4.8	4.8	11.1	3.4	4.6	2.5	5.8	1.5	1.8	10.0	1.8	2.8	2.2	3.0	4.2	10.0	2.3	8.8	1.7	0.7	4.8	1.8	4.7	1.6	4.4	6.5	2.9	8.9	4.5	3.7	3.8	2.3	3.0	5.4	2.1	4.4	3.3	4.3	4.6	5.9	2.6	1.8	10.3	4.6	9.2	1.6	5.5	2.7	7.0	0.6	10.4	5.9	5.5	4.0	5.3	10.1	3.7	5.3	1.9	14.8	7.5	5.0	1.8	2.4	4.0	2.2	9.5	5.1	4.8	3.3	3.8	4.2	0.2	1.9	0.8	1.9	1.0	1.6	0.8	1.9	1.9	1.1	1.5	2.6	1.2	1.6	1.2	1.2	1.3	1.4	1.2	5.4	7.1	8.2	7.7	5.3	5.0	6.4	4.6	5.7	4.5	5.7	11.1	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	5.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 355.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 927.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 1187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	73.5	188.2	48.2	66.5	50.4	69.5	68.8	60.1	58.8	63.4	51.1	88.7	167.2	57.5	73.0	142.5	57.4	39.8	72.2	49.9	64.6	78.0	355.7	86.1	76.1	71.1	62.5	45.0	75.7	67.9	40.4	72.5	77.5	56.1	102.9	45.9	82.6	42.7	60.9	107.1	81.1	66.0	53.6	59.3	81.5	42.0	55.0	72.6	46.8	66.7	102.3	47.0	76.8	55.0	293.9	156.2	561.5	204.4	128.7	467.7	199.6	136.8	268.1	213.6	344.2	255.4	677.7	222.3	323.6	120.6	506.9	319.1	338.9	1187.5	198.9	122.4	242.5	129.4	260.1	311.5	210.8	212.1	142.0	335.5	184.6	339.6	168.8	96.4	377.6	322.3	235.1	579.9	225.3	315.1	273.6	205.0	338.9	216.4	225.5	231.6	243.2	620.0	567.7	193.0	217.4	185.6	140.7	253.0	243.0	317.3	182.6	567.6	277.1	118.4	144.3	74.3	254.9	244.3	202.3	401.1	115.3	221.7	191.1	90.6	85.5	124.1	89.2	92.9	79.7	102.8	77.8	91.1	95.6	95.1	69.9	87.1	38.9	115.2	70.0	76.2	113.7	134.7	48.2	50.4	60.1	58.8	49.9	64.6	71.1	62.5	77.5	53.6	55.0	55.0	154.2	73.7	181.6	38.5	68.4	36.8	83.3	927.7	42.1	69.4	84.6	56.9	1.8	97.2	431.5	53.3	62.6	207.8	74.9	343.0	137.0	180.9	216.6	56.7	38.2	161.9	71.4	133.4	30.8	329.9	198.7	59.8	52.0	77.8	62.8	116.6	168.1	361.9	112.0	55.5	28.1	135.7	299.1	54.8	44.4	67.9	60.9	52.8	96.0	15.0	144.7	81.1	87.6	22.6	39.7	256.7	324.3	70.3	91.3	206.1	194.1	145.0	129.6	90.8	72.3	47.0	177.5	42.0	14.2	49.7	59.8	143.5	68.3	230.6	165.4	148.2
FDX1	"ADX, FDX"	ENSG00000137714	"Ferredoxin 1"	P10109	11	110429948-110464884	"Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"adrenal gland: 313.7"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1139.6;Theca cells: 745.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041630, HPA062087"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria		"HPA041630: AB_10793970, HPA062087: AB_2630366"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (3.58e-7)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.80e-1)"	9.0	313.7	6.9	6.8	7.5	12.1	8.5	7.5	8.6	7.4	8.7	12.9	22.0	6.2	8.2	9.3	5.9	9.1	16.3	6.8	7.6	29.6	44.3	10.8	7.9	7.3	7.8	5.4	13.4	9.3	6.1	17.7	7.6	8.2	10.7	5.3	8.6	26.3	20.6	6.2	18.4	6.1	7.5	6.7	13.5	7.6	7.9	12.0	20.3	18.5	7.5	10.5	5.5	8.8	10.2	7.0	10.6	11.6	10.1	17.8	23.5	9.2	11.2	8.0	13.5	24.1	16.7	23.8	26.4	11.9	14.2	11.8	12.4	13.9	10.8	22.9	15.8	12.0	12.0	14.8	17.7	12.7	18.8	31.3	11.4	7.3	17.1	13.8	16.5	16.2	12.2	34.4	17.3	11.3	18.2	28.3	9.5	19.3	13.1	26.4	10.1	22.1	17.4	18.1	14.4	7.4	17.5	19.7	12.5	12.3	11.7	8.7	9.8	8.0	9.8	9.8	9.9	7.7	6.4	71.7	6.0	25.5	10.5	1.8	4.5	2.8	3.8	3.3	4.1	9.7	5.2	5.4	5.2	7.5	6.2	4.4	0.5	3.4	4.6	4.0	7.4	2.6	6.9	7.5	7.5	8.6	6.8	7.6	7.3	7.8	7.6	7.5	7.9	8.8	53.2	19.2	38.1	15.0	68.6	68.3	104.3	45.4	42.7	33.0	40.3	37.0	57.1	102.9	28.3	80.9	8.4	174.3	65.7	109.5	244.6	71.4	53.4	49.6	35.6	36.7	47.9	28.8	22.6	144.8	169.4	48.1	61.2	42.0	45.7	36.3	45.0	192.7	113.3	42.1	25.8	56.2	34.6	58.4	68.3	11.0	46.9	77.3	69.4	15.0	57.3	42.3	50.4	22.1	19.6	78.5	76.5	45.5	102.7	114.2	183.9	338.7	18.6	17.3	26.3	50.6	43.6	48.0	67.0	75.3	97.5	1139.6	74.0	745.1	96.4	149.6
FDXR	"ADR, ADXR"	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 343.1"	"Group enriched"	"Detected in many"	7	"Granulosa cells: 329.3;Theca cells: 794.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 89.5;Hep G2: 173.5"					"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	3.9	343.1	6.9	2.4	8.4	2.2	3.8	7.8	8.1	7.8	8.6	9.7	4.6	6.7	5.1	26.0	12.9	4.1	6.0	6.6	6.7	6.5	14.9	5.3	2.9	7.6	7.9	20.5	12.9	5.9	4.1	3.0	7.5	6.7	3.2	0.5	7.1	4.4	7.7	16.4	5.6	2.3	7.4	33.9	7.6	45.6	7.0	4.7	6.0	1.7	2.5	6.2	10.5	7.5	12.5	65.6	9.6	10.8	6.8	9.1	89.5	14.8	15.9	8.6	17.1	18.3	10.8	29.6	2.6	6.2	4.8	24.9	6.9	18.4	2.5	27.9	15.2	22.6	10.6	173.5	19.0	5.0	75.1	29.2	20.3	9.1	3.1	7.0	43.9	10.9	36.1	4.8	13.4	53.4	19.7	10.6	5.5	11.8	14.5	10.6	16.4	16.2	7.1	21.0	5.2	12.1	10.0	21.7	11.2	10.9	47.4	4.7	20.5	5.9	51.9	9.4	7.4	12.7	2.3	6.5	16.1	7.7	20.6	1.7	6.0	5.0	5.6	4.5	5.0	4.8	5.1	6.8	7.3	2.4	4.4	5.4	2.0	10.3	3.4	1.4	15.4	5.2	6.9	8.4	7.8	8.1	6.6	6.7	7.6	7.9	7.5	7.4	7.0	7.5	4.0	3.2	3.9	7.5	8.2	9.7	17.8	42.6	17.1	4.9	6.6	8.4	3.8	5.7	23.3	9.2	4.2	53.2	2.8	18.6	5.9	11.1	6.5	28.2	4.3	4.6	7.1	4.0	1.4	7.9	18.9	12.9	13.7	3.5	5.7	329.3	12.5	13.9	23.1	3.3	2.2	13.1	36.7	6.2	2.7	14.9	5.9	4.6	5.4	1.0	3.9	11.4	8.2	3.0	1.3	9.0	16.9	4.5	7.1	5.2	24.9	21.7	73.6	5.1	0.0	6.2	18.3	6.3	6.1	33.7	18.2	46.1	8.6	794.1	20.3	17.4
FER	"PPP1R74, TYK3"	ENSG00000151422	"FER tyrosine kinase"	P16591	5	108747841-109196841	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"Alveolar cells type 1: 80.1;Astrocytes: 207.3;Early spermatids: 158.1;Excitatory neurons: 266.3;granulocytes: 95.5;Inhibitory neurons: 313.8;Late spermatids: 182.4;Microglial cells: 227.7;Oligodendrocyte precursor cells: 284.0;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 91.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007641, CAB022464"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"CAB022464: , HPA007641: AB_1078845"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (5.55e-4)"	"unprognostic (3.83e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-3)"	4.2	3.7	3.4	3.0	3.2	1.6	3.6	2.8	3.4	3.8	0.6	3.9	1.7	3.7	2.9	4.2	3.0	3.3	3.0	3.1	3.9	3.5	2.3	3.7	1.4	3.6	3.7	4.6	1.9	9.4	2.5	4.2	3.8	3.0	2.4	5.7	2.5	3.9	1.3	4.5	2.0	4.9	4.1	2.7	2.2	6.7	3.1	2.8	6.4	2.0	2.0	3.5	3.2	5.0	9.8	3.4	11.0	18.0	6.6	10.1	7.2	11.4	11.0	6.5	7.6	19.0	5.5	15.3	6.9	13.8	8.4	6.3	6.2	14.4	14.7	6.5	8.4	9.8	14.5	7.0	4.4	5.6	8.2	6.2	7.9	15.8	17.5	6.4	9.8	14.6	12.9	11.1	8.4	2.7	4.4	1.7	1.6	0.9	7.0	3.3	10.7	91.7	6.4	3.3	3.8	5.6	18.6	1.0	11.4	7.0	4.4	2.4	14.7	12.5	10.2	6.5	9.0	9.4	14.9	5.9	7.4	1.9	6.0	8.9	3.7	4.6	1.2	2.5	2.1	10.3	0.7	1.4	2.3	3.4	1.2	1.5	0.3	1.1	2.0	4.5	1.7	0.9	3.4	3.2	2.8	3.4	3.1	3.9	3.6	3.7	3.8	4.1	3.1	5.0	23.8	80.1	28.3	207.3	9.5	29.2	15.8	9.5	25.6	17.6	6.6	8.5	21.9	10.0	21.8	14.7	18.8	3.9	7.5	4.9	1.9	13.6	158.1	13.1	17.2	19.7	8.4	10.7	266.3	6.0	10.7	31.4	16.8	12.6	95.5	21.8	18.9	2.3	8.2	18.5	313.8	4.5	8.2	9.5	13.4	182.4	19.3	14.1	14.2	227.7	12.0	10.5	4.1	284.0	216.0	9.1	4.7	17.7	13.7	12.1	1.7	6.9	27.9	16.3	6.6	30.7	23.8	7.7	11.5	13.2	17.6	3.1	10.4	10.2	4.1	6.9
FERMT2	"KIND2, mig-2, PLEKHC1, UNC112B"	ENSG00000073712	"Fermitin family member 2"	Q96AC1	14	52857268-52952435	"Predicted intracellular proteins"	"Cell adhesion, Cell shape, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040505, HPA072965"	Uncertain		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		230000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	"Nucleoplasm, Cytosol"	"HPA040505: AB_10673300, HPA072965: "	"unprognostic (4.38e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.73e-3)"	148.4	21.2	28.7	38.8	31.6	0.5	57.6	29.0	37.3	44.7	18.0	104.3	13.1	105.1	26.3	46.8	55.7	65.7	66.9	31.0	27.4	55.4	108.3	47.9	15.3	35.7	29.1	43.6	20.6	18.4	13.1	116.5	33.5	69.1	33.3	29.5	22.6	117.9	48.8	13.4	29.3	155.6	30.6	37.6	46.4	15.5	27.6	6.9	35.9	69.6	6.6	77.7	29.1	38.1	22.8	18.9	101.6	46.8	163.7	133.7	84.6	148.4	95.2	172.3	107.9	34.1	17.6	0.1	49.4	153.1	33.8	9.6	80.1	11.1	128.3	0.2	22.6	31.9	83.1	40.3	209.6	0.4	12.6	129.4	23.5	95.3	125.4	78.5	91.2	16.8	0.6	153.4	131.7	28.0	7.7	0.5	64.3	0.2	51.3	3.9	103.8	0.4	60.9	20.6	6.2	130.5	157.8	35.0	37.7	103.3	30.1	1.1	115.2	134.5	92.4	108.2	56.0	22.6	29.4	0.6	30.9	0.2	33.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	31.6	29.0	37.3	31.0	27.4	35.7	29.1	33.5	30.6	27.6	38.1	152.7	76.9	42.0	116.5	1.0	18.6	150.6	15.5	13.6	39.5	33.8	41.4	65.8	24.3	25.6	40.5	37.5	74.8	2.3	0.2	31.3	48.5	68.2	20.1	141.7	110.4	0.0	2.7	13.7	33.2	178.1	103.9	3.6	40.2	58.3	31.6	110.3	82.3	10.4	15.2	16.1	0.5	4.1	8.9	19.5	27.9	74.9	4.4	46.2	29.0	4.8	52.3	1.0	41.2	92.0	27.6	0.1	174.9	4.5	40.0	0.0	44.7	10.1	56.0	151.2	83.4	174.1	4.1	16.2	2.2	8.1	102.6	7.9	12.3	0.4	37.0
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223891	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.6;lymphoid tissue: 130.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.3;granulocytes: 96.4;Hofbauer cells: 193.1;Kupffer cells: 95.8;Langerhans cells: 88.0;Macrophages: 232.9;monocytes: 142.9;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 306.9;HL-60: 135.9;HMC-1: 314.2;Karpas-707: 127.6;MOLT-4: 121.8;NB-4: 174.1;U-937: 138.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065231			Approved	Vesicles		NA	NA		160000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA065231: AB_2685439"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	25.1	14.5	9.4	63.3	11.6	180.6	13.0	11.2	18.1	8.5	12.2	17.3	22.0	8.4	0.7	6.4	13.6	15.6	12.0	9.8	11.6	11.1	12.5	46.2	89.2	17.9	12.2	5.1	7.0	1.3	5.9	15.0	13.2	8.2	8.1	0.6	10.7	4.4	6.0	7.1	34.1	9.4	13.3	130.1	29.6	4.5	17.1	48.7	10.0	4.6	41.8	19.8	7.3	15.3	1.2	1.6	0.5	0.9	0.3	0.8	2.0	1.4	0.2	0.4	0.3	2.6	2.3	32.6	3.2	6.3	0.7	2.4	1.0	0.5	0.5	83.9	0.6	306.9	1.6	0.1	10.8	135.9	314.2	1.2	1.1	5.2	0.0	0.5	81.2	77.0	7.3	127.6	8.6	3.5	121.8	174.1	1.2	1.0	2.3	72.4	8.8	0.7	0.3	0.7	1.9	0.5	0.7	4.5	1.7	0.7	2.0	92.6	7.8	1.1	2.5	1.9	0.9	1.5	3.3	59.4	19.5	138.9	86.6	204.1	207.0	236.5	120.0	192.6	114.9	54.5	94.1	112.0	162.0	53.1	60.9	80.6	184.6	102.4	151.2	195.7	120.9	292.6	9.4	11.6	11.2	18.1	9.8	11.6	17.9	12.2	13.2	13.3	17.1	15.3	3.8	9.6	14.7	0.7	52.1	4.7	0.9	0.3	3.4	0.5	3.3	5.2	2.4	4.3	3.9	0.0	0.0	1.2	118.3	6.1	0.0	0.8	0.4	4.3	5.6	7.9	0.0	62.5	1.2	2.4	1.4	5.4	19.9	7.3	96.4	0.4	19.6	1.4	193.1	0.0	1.5	32.1	0.0	95.8	88.0	0.9	0.9	232.9	17.8	5.6	142.9	0.3	93.7	1.0	1.5	4.3	10.9	2.6	35.2	0.9	8.2	0.4	1.0	0.3	6.6	13.7	6.6	1.2	0.8	1.9	4.5	2.6	78.5	1.4	15.0	0.7
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 234.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 47.2"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035132, HPA035133"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	47500000000	3600000000		"Cluster 62: Liver - Hemostasis"		"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA035132: AB_10601650, HPA035133: "		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.6	0.0	0.1	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.4	234.6	0.0	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.8	0.0	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.9	0.0	5.3	0.2	0.2	0.1	0.0	2.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.7	47.2	0.0	0.0	0.0	0.2	0.0	2.9	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301303-122310691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 126.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 5.1;Spermatocytes: 5.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 126.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 152.1;SCLC-21H: 66.0"	"Region enriched"	"Detected in some"	11	"hypothalamus: 11.7"	"Region enriched"	"Detected in single"	14	"hypothalamus: 7.4"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	24.8	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.5	126.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	152.1	3.8	2.7	0.0	0.0	0.0	0.0	0.2	66.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	7.2	0.3	0.0	0.1	2.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.2	1.8	0.6	24.8	0.3	2.6	0.5	0.2	126.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	388	"liver: 18396.9"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 17365.8"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 429.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			2.1	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.6	0.6	0.7	0.9	13.2	1.2	0.0	0.0	18.8	18396.9	5.3	0.1	0.0	0.0	0.7	18.8	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.5	0.0	0.5	0.6	0.9	0.0	0.0	9.9	47.4	3.7	0.0	0.1	0.4	0.0	0.1	0.6	0.7	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	2.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	429.3	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.5	6.1	0.0	0.0	0.5	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	1.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	414.6	3.2	0.0	0.0	0.0	0.0	0.0	1.9	38.6	28.3	0.1	0.2	8.1	0.0	205.9	0.0	1.8	0.1	0.1	1.1	1.3	0.0	0.0	238.8	17365.8	0.1	0.0	0.0	0.0	0.0	328.3	0.0	46.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	1.2	0.0	0.0	0.0	2.3	9.5	0.0	0.0	0.0	0.1	17.4	0.7	0.0	0.0	0.1	17.6	0.0	0.0	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	373	"liver: 17944.9"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 17273.6"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 249.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		110000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			2.0	0.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	1.3	0.0	0.5	0.0	0.6	0.3	0.6	0.8	0.4	1.4	0.0	0.0	48.0	17944.9	0.5	0.1	0.0	0.0	0.6	3.3	0.0	0.5	1.0	0.0	0.4	0.0	0.0	0.4	0.0	0.5	0.5	1.2	0.0	0.0	12.1	6.8	0.5	0.0	0.3	0.4	0.0	0.1	0.5	0.7	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.2	0.1	249.9	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.9	0.0	2.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	39.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	251.6	0.0	3.7	0.0	0.0	0.0	0.0	1.9	10.6	0.5	0.6	0.8	13.1	1.8	302.1	0.0	3.8	0.2	0.0	0.0	5.9	0.0	0.0	318.1	17273.6	0.3	0.0	0.0	0.0	0.0	421.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.7	0.0	0.0	0.0
FGD4	"CMT4H, frabin, FRABP, ZFYVE6"	ENSG00000139132	"FYVE, RhoGEF and PH domain containing 4"	Q96M96	12	32399558-32646050	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 232.5;Early spermatids: 196.3;Late spermatids: 250.1;Microglial cells: 203.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 14.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;granulocytes: 8.4;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039235	Approved		Approved	"Actin filaments"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Actin filaments"		"HPA039235: AB_10673420"	"unprognostic (6.73e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.16e-5)"	"unprognostic (9.50e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.41e-3)"	12.6	4.3	8.1	5.6	10.3	12.1	8.0	11.4	6.7	6.1	13.8	9.4	8.8	2.3	2.9	7.4	4.9	10.3	5.3	7.4	10.3	10.8	17.7	8.1	1.8	12.3	10.1	24.6	9.4	14.8	3.1	10.4	12.4	4.6	10.1	23.6	6.7	4.0	10.8	7.4	8.2	3.4	9.2	5.2	28.9	12.1	9.5	1.7	6.3	10.8	2.7	4.0	5.9	13.7	5.4	2.6	6.6	2.0	24.1	14.8	8.1	4.5	22.5	1.2	0.4	8.1	8.3	0.8	2.5	0.3	2.8	5.1	5.3	7.5	0.7	0.7	2.6	4.7	2.7	2.5	4.3	0.9	0.0	8.8	10.3	6.0	12.9	3.3	11.6	1.1	0.5	5.4	15.6	1.9	0.0	1.7	17.4	5.3	0.2	0.4	6.9	16.2	8.0	5.3	7.2	8.5	4.7	4.4	6.6	11.8	7.0	0.3	13.1	0.1	1.5	18.8	0.7	1.9	4.6	2.9	0.0	2.8	5.2	3.6	3.8	8.4	0.2	5.7	0.2	0.6	0.3	0.2	3.6	1.4	0.2	0.3	5.5	0.7	5.1	0.4	0.2	1.3	8.1	10.3	11.4	6.7	7.4	10.3	12.3	10.1	12.4	9.2	9.5	13.7	84.3	48.1	31.4	232.5	5.6	8.4	11.3	12.1	8.6	23.8	10.7	7.5	19.2	54.3	18.3	22.0	118.9	1.3	0.5	57.8	13.7	16.8	196.3	36.0	8.1	24.8	19.2	4.4	40.5	20.7	16.8	19.9	78.5	65.7	2.5	34.1	9.3	37.7	11.8	70.7	55.1	31.2	26.4	71.7	22.3	250.1	4.7	92.9	14.2	203.3	39.9	79.3	1.0	25.1	95.1	33.5	29.3	1.5	16.4	16.4	54.8	15.0	15.3	114.5	52.6	16.5	41.3	10.4	7.4	25.0	12.6	1.4	3.1	25.6	30.5	20.2
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	330	"liver: 16556.3"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 10221.7"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"Hep G2: 735.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	73000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	1.7	34.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.0	0.4	0.0	0.4	0.2	0.6	0.7	25.0	1.2	0.0	0.0	8.8	16556.3	50.2	0.1	0.0	0.0	1.4	15.8	0.0	0.4	6.3	0.0	0.4	0.0	0.0	0.4	0.3	0.4	0.5	0.6	0.0	0.0	9.1	8.7	3.0	0.1	0.3	0.4	0.0	0.0	0.5	0.6	0.1	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.5	0.4	735.3	0.2	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.3	6.4	0.0	0.0	0.6	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.1	0.1	1.7	0.0	3.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	19.2	214.4	0.0	31.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	633.4	2.5	0.0	0.0	0.0	0.0	0.1	0.0	21.9	4.3	0.0	0.1	9.2	0.0	157.7	0.0	48.5	0.2	0.5	0.0	0.1	11.4	1.1	202.4	10221.7	0.2	0.0	0.0	0.0	0.0	289.5	0.0	0.5	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	161.8	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.4	17.3	0.2	0.0	0.0
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 77.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 191.7;Cholangiocytes: 343.1;Hepatocytes: 142.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.9;RH-30: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054971, HPA075137"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Nuclear bodies"	"HPA054971: , HPA075137: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.2	14.6	10.5	2.0	12.8	2.3	6.6	21.8	10.2	6.3	4.5	7.1	7.1	4.7	36.5	5.5	9.9	5.4	11.3	7.4	12.1	19.1	77.1	4.7	3.3	12.9	13.4	4.8	12.0	10.5	9.7	3.0	12.9	7.8	6.7	9.6	7.5	10.3	41.8	5.7	8.1	4.2	9.3	2.8	6.1	4.2	16.5	4.1	7.7	17.1	3.6	7.0	5.2	12.7	4.8	1.4	9.2	3.9	4.7	16.6	0.8	4.1	6.8	2.3	3.4	0.0	3.8	5.4	13.0	11.0	4.1	2.0	1.6	11.9	4.9	42.9	1.1	3.8	2.9	8.6	12.3	2.3	2.4	23.2	10.2	5.0	7.9	10.0	4.6	6.0	2.7	3.4	15.3	5.2	3.0	3.2	5.8	13.0	5.3	6.5	28.3	2.1	12.9	8.8	7.2	3.2	5.6	3.3	12.0	8.0	2.8	2.3	4.7	4.0	2.6	4.7	2.8	7.5	2.9	4.6	12.9	9.2	3.8	1.5	1.3	1.4	3.0	1.3	2.7	5.1	1.4	3.8	2.2	3.6	2.7	4.3	2.2	2.9	3.4	1.1	2.8	1.8	10.5	12.8	21.8	10.2	7.4	12.1	12.9	13.4	12.9	9.3	16.5	12.7	3.7	54.5	191.7	83.2	7.9	20.9	23.8	45.2	14.2	10.1	33.1	66.9	29.9	343.1	40.4	12.9	12.5	9.3	3.7	4.2	17.6	62.6	14.0	33.2	7.5	6.9	2.4	12.2	20.4	42.5	4.5	7.6	7.1	20.4	10.1	5.3	5.3	142.3	11.4	8.4	33.7	11.3	22.4	8.8	7.6	11.4	1.8	6.7	35.6	17.8	11.2	12.2	3.1	39.2	36.0	17.7	7.7	3.0	3.4	19.1	14.9	47.9	91.2	16.4	0.0	31.4	8.9	4.6	11.5	13.5	31.5	4.5	5.1	5.9	17.1	35.5
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"heart muscle: 1421.4;ovary: 535.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1077.5;Extravillous trophoblasts: 585.9;Granulosa cells: 851.4;Leydig cells: 567.0;Peritubular cells: 1049.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 5.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.7;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 534.6;RPTEC TERT1: 489.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"		NA	Yes		14000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments, Focal adhesion sites"		"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	68.3	70.2	10.4	28.9	13.2	17.0	65.4	7.6	18.2	101.9	15.0	75.2	48.5	105.1	33.8	55.4	55.8	81.5	1421.4	18.9	7.4	55.2	22.1	17.5	17.2	6.7	7.2	535.4	9.1	8.2	29.3	79.3	7.0	88.8	56.8	8.5	45.3	63.8	67.5	44.2	50.4	91.5	7.5	20.1	94.9	50.9	7.9	22.8	41.3	118.6	13.9	105.5	47.2	12.2	156.8	36.1	20.9	0.8	65.2	81.7	196.4	289.3	75.9	182.2	216.7	65.6	237.6	0.4	23.7	353.6	223.8	47.7	31.4	262.4	204.2	6.5	23.9	108.7	42.9	49.0	257.6	0.4	23.5	171.7	142.2	286.0	188.1	360.8	374.4	18.0	29.0	8.9	534.6	5.6	25.8	1.0	44.1	108.3	113.2	0.4	31.6	4.3	489.8	108.4	1.0	6.9	109.2	48.1	76.9	20.5	60.7	3.9	183.1	130.4	134.1	146.4	236.0	3.3	0.6	0.7	208.1	0.6	138.5	5.7	0.4	0.4	1.1	0.2	0.7	0.6	0.9	2.0	0.4	0.5	0.7	1.5	2.2	0.7	0.2	0.6	2.7	1.5	10.4	13.2	7.6	18.2	18.9	7.4	6.7	7.2	7.0	7.5	7.9	12.2	15.7	9.6	5.1	0.7	1.0	468.5	1077.5	342.5	389.9	9.5	59.8	126.2	362.1	15.7	91.0	29.5	2.1	220.4	1.7	212.6	3.9	100.7	5.7	44.8	40.4	27.4	58.2	63.5	46.3	117.9	585.9	96.1	186.1	32.5	10.2	851.4	17.2	9.2	25.3	0.0	4.9	169.8	73.2	0.6	31.8	17.3	567.0	10.4	23.2	25.3	2.7	1.6	0.0	0.5	1.6	234.5	258.2	1049.0	6.7	198.2	51.7	28.1	19.1	13.0	216.9	60.6	171.0	9.1	17.7	124.5	296.9	178.7	7.7	193.5	55.8	536.2
FIG4	"ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3"	ENSG00000112367	"FIG4 phosphoinositide 5-phosphatase"	Q92562	6	109690609-109878098	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.5;Oligodendrocyte precursor cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017823, HPA068859"	Approved		Supported	"Vesicles,Lipid droplets"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Lipid droplets"		"CAB017823: , HPA068859: AB_2686049"	"prognostic unfavorable (5.91e-4)"	"unprognostic (4.12e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.44e-3)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.00e-2)"	9.3	10.2	5.5	7.1	7.2	5.6	8.1	5.9	7.7	8.2	12.9	10.1	5.0	8.5	7.8	9.4	7.2	7.6	7.7	6.0	8.8	9.5	6.1	13.4	10.1	6.4	7.3	8.2	7.5	17.4	11.9	8.8	8.9	7.7	9.5	10.8	10.7	7.8	10.6	7.6	9.1	10.3	5.6	13.8	8.7	8.2	6.1	12.3	9.3	8.3	10.1	9.2	8.4	7.0	8.3	8.4	11.7	14.9	11.8	17.2	7.8	9.9	14.1	8.3	23.2	4.6	7.2	23.2	5.8	18.9	14.9	5.2	12.6	8.5	20.7	13.3	16.5	10.9	5.9	5.5	11.4	9.5	10.0	8.8	9.9	12.8	10.6	22.8	18.3	13.9	6.8	8.8	12.7	6.8	12.0	8.4	5.9	12.0	4.7	7.9	6.1	7.3	13.3	18.4	12.8	11.7	7.1	10.7	21.1	15.6	6.0	23.1	11.2	4.2	3.8	5.4	9.5	3.4	2.6	7.9	27.3	8.5	4.6	15.4	24.9	14.2	8.8	24.5	7.7	18.9	6.3	8.5	19.2	21.2	7.5	7.5	7.4	10.0	15.2	8.1	9.4	11.7	5.5	7.2	5.9	7.7	6.0	8.8	6.4	7.3	8.9	5.6	6.1	7.0	4.9	16.0	9.0	24.5	15.7	4.6	7.1	7.3	5.2	8.8	5.4	3.3	6.7	2.8	6.9	9.2	2.1	13.4	9.5	7.0	5.9	9.8	18.0	7.5	5.3	5.2	10.2	3.0	49.5	11.4	7.0	6.0	8.2	7.9	8.8	8.6	7.1	4.1	23.3	1.7	32.4	8.6	8.2	19.2	6.8	17.7	3.4	17.3	8.8	29.0	16.4	8.5	11.3	46.8	37.4	7.6	6.3	6.8	6.5	4.0	6.3	8.2	9.1	7.6	0.0	5.1	6.6	5.5	12.1	8.3	4.4	12.3	9.3	5.6	6.4	8.9
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 53.8;skeletal muscle: 35.8;tongue: 48.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.9;HUVEC TERT2: 1.7;RPTEC TERT1: 1.9;U-266/70: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"		No	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	6.8	1.5	1.5	2.9	1.8	0.2	2.4	0.1	2.5	1.8	0.7	11.7	1.8	8.5	0.9	9.5	4.8	5.7	53.8	4.1	0.5	1.8	3.2	7.6	1.2	0.2	0.5	1.3	1.4	12.4	1.4	5.1	0.3	3.9	3.3	0.4	1.2	3.4	35.8	0.6	2.6	13.2	0.5	0.3	3.2	2.1	0.8	1.1	2.3	48.9	0.9	10.9	1.6	1.5	0.0	1.3	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.7	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	1.5	1.8	0.1	2.5	4.1	0.5	0.2	0.5	0.3	0.5	0.8	1.5	82.1	128.2	82.6	5.9	0.5	0.6	0.5	2.8	0.0	3.5	0.5	0.8	582.5	0.0	9.1	0.0	0.0	0.8	0.5	0.1	1.9	0.1	54.2	18.2	1.7	45.9	0.0	2.7	9.7	0.4	0.3	60.3	0.0	19.2	1.3	1.7	72.1	0.7	1.3	0.0	12.8	0.1	8.2	1.9	1.2	17.6	2.5	1.8	1.8	5.6	0.0	2.5	1.0	6.0	10.0	0.0	0.0	4.5	0.0	0.8	0.4	0.1	62.4	3.5	92.1	70.2	114.2	7.1	7.9	0.7	0.9	0.8	1.8	11.9	0.1	0.4
FKBP2	"FKBP-13, FKBP13, PPIase"	ENSG00000173486	"FKBP prolyl isomerase 2"	P26885	11	64241003-64244132	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 929.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB025561, HPA049405"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	No	No		510000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"CAB025561: , HPA049405: AB_2680749"	"unprognostic (4.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.66e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.57e-2)"	64.7	127.6	185.1	77.5	187.6	50.1	58.3	192.7	234.7	113.1	210.8	105.7	136.3	81.1	397.7	68.4	94.4	77.2	117.4	185.0	196.9	122.7	197.3	62.7	70.7	199.9	199.6	75.3	280.1	160.4	200.9	73.1	197.7	92.5	84.2	37.1	208.9	146.7	33.3	60.9	107.3	72.6	183.4	67.5	113.4	74.7	194.3	59.0	187.6	48.4	70.4	85.7	61.6	196.0	101.2	144.8	82.8	165.9	178.5	98.2	94.6	132.9	146.4	108.8	101.4	148.1	257.0	80.8	195.4	186.5	148.2	134.7	70.5	121.0	51.3	101.4	54.5	90.0	196.5	158.3	231.6	74.5	125.5	116.0	169.3	145.4	163.5	156.9	86.9	76.6	61.0	253.6	138.1	186.7	85.1	112.6	92.6	211.1	130.0	70.8	70.9	299.2	198.9	120.7	110.0	91.3	85.4	263.2	147.9	59.5	98.1	69.5	68.9	123.8	100.9	182.8	72.6	128.5	48.6	69.0	156.7	80.6	142.8	276.8	173.1	25.9	178.9	191.2	230.8	170.1	139.2	176.4	172.2	165.0	90.4	131.5	68.6	162.9	162.7	929.1	55.9	126.7	185.1	187.6	192.7	234.7	185.0	196.9	199.9	199.6	197.7	183.4	194.3	196.0	129.5	147.4	168.0	20.9	179.7	164.4	251.0	447.2	125.2	86.4	205.0	185.4	134.7	275.9	270.6	389.9	22.9	279.8	174.4	534.1	412.8	270.8	126.4	212.5	206.3	138.6	342.6	41.4	11.3	254.2	386.9	167.0	179.4	258.5	144.0	146.5	148.5	754.4	228.4	32.0	14.8	508.2	305.2	100.1	201.7	99.0	230.2	140.7	300.6	16.9	151.7	181.7	111.2	11.1	20.6	292.2	424.7	255.1	765.2	315.5	594.7	792.2	241.9	83.3	184.1	138.4	221.3	327.1	282.1	136.6	168.1	620.5	123.6	138.8	339.4	312.0
FKBP3	"FKBP-25, FKBP25"	ENSG00000100442	"FKBP prolyl isomerase 3"	Q00688	14	45115599-45135319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 424.4;tongue: 372.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 377.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol		NA	NA		1300000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	40.9	46.8	100.3	35.8	102.3	38.4	50.0	110.1	122.1	38.1	91.8	49.4	44.7	31.4	64.8	54.7	31.4	29.8	109.5	101.9	100.6	66.5	69.7	27.6	53.7	100.7	99.3	35.3	32.8	55.5	56.6	46.9	100.1	57.7	49.1	82.3	37.1	37.9	424.4	38.3	47.8	39.2	99.8	39.9	38.0	52.9	101.4	59.6	40.1	372.0	57.7	43.3	38.6	105.8	161.0	175.3	249.0	132.4	109.0	117.8	98.3	96.2	110.3	149.3	163.5	154.8	134.1	85.1	98.9	110.0	84.1	130.0	188.4	124.8	211.7	123.7	111.0	69.8	138.8	202.6	107.1	122.2	72.8	112.0	127.5	87.2	80.1	136.8	198.0	131.9	102.9	62.1	179.9	196.9	197.5	163.0	126.7	178.3	164.5	187.0	183.7	102.9	242.2	183.7	151.2	59.2	154.8	94.5	156.0	186.4	222.6	89.9	128.7	113.0	195.6	59.9	75.1	104.0	198.8	132.5	68.3	83.0	108.1	23.4	22.4	22.1	18.7	27.3	22.8	29.7	25.0	25.7	33.3	21.8	23.4	26.7	3.6	24.2	29.4	43.0	30.8	20.2	100.3	102.3	110.1	122.1	101.9	100.6	100.7	99.3	100.1	99.8	101.4	105.8	48.3	41.7	46.6	25.8	45.3	47.8	94.4	205.5	45.5	79.3	39.9	46.7	202.5	48.6	101.4	93.8	10.4	320.9	51.2	56.4	252.4	131.1	212.7	55.0	83.3	58.5	56.1	50.9	49.7	73.0	135.4	70.0	36.7	68.1	53.7	75.6	38.2	91.1	131.1	40.4	44.5	71.2	124.1	39.9	43.0	377.4	80.8	53.7	69.4	17.8	110.7	80.7	50.4	21.1	34.3	88.4	53.7	97.8	58.0	76.4	91.8	220.1	73.5	67.4	105.2	71.3	118.5	154.0	111.2	65.0	47.9	165.0	48.8	84.1	96.1	77.6
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FKBP prolyl isomerase 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 892.7;tongue: 925.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 759.3;ASC TERT1: 468.5;HHSteC: 593.0;HSkMC: 718.3;hTCEpi: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	400.1	92.3	18.2	70.1	26.8	26.6	160.4	19.7	32.1	86.4	20.2	110.9	11.3	97.5	63.0	130.6	104.6	78.9	93.7	16.8	20.7	108.8	144.5	92.7	166.7	22.7	23.8	122.1	200.4	227.0	52.9	28.5	23.5	85.0	37.1	25.6	61.0	49.8	892.7	114.0	135.7	81.8	17.0	105.6	129.0	41.4	22.1	229.4	97.2	925.1	80.3	108.9	109.1	26.2	40.0	17.1	73.1	109.7	759.3	468.5	1.2	21.2	1.0	13.6	31.0	29.7	6.9	195.3	19.5	4.1	11.8	0.6	44.1	93.2	32.0	77.7	41.6	84.0	14.1	41.7	593.0	53.3	8.3	718.3	368.6	23.7	220.5	14.8	80.1	38.8	91.3	77.1	144.3	25.3	222.5	99.6	18.9	8.7	12.3	97.7	19.1	95.4	60.2	23.7	27.7	16.8	17.3	19.8	4.2	15.9	108.4	62.2	178.7	19.3	17.3	2.8	29.7	34.9	42.9	243.5	6.6	102.3	7.6	57.6	105.0	70.0	64.4	92.3	78.0	9.7	90.6	68.5	107.5	12.5	133.4	96.7	85.1	45.2	46.8	32.0	37.2	158.5	18.2	26.8	19.7	32.1	16.8	20.7	22.7	23.8	23.5	17.0	22.1	26.2	180.2	12.8	11.3	23.2	42.9	17.6	59.2	20.1	37.0	1.9	32.0	20.8	131.8	74.4	14.2	5.5	0.0	1.2	102.0	14.3	23.5	0.6	9.8	55.7	76.1	57.9	20.9	102.2	25.9	7.9	0.8	97.5	18.8	79.2	38.5	54.7	117.1	225.6	35.1	0.0	2.8	35.5	34.6	384.2	44.8	22.0	160.9	192.2	7.2	66.5	110.3	4.6	44.3	16.6	26.3	2.9	19.3	218.6	66.4	49.9	157.0	27.4	18.2	22.6	144.7	188.1	106.8	14.9	19.1	37.5	21.3	0.4	128.7	2.8	39.5	22.2
FKBP7	FKBP23	ENSG00000079150	"FKBP prolyl isomerase 7"	Q9Y680	2	178463664-178478600	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.1;Endometrial stromal cells: 54.8;Fibroblasts: 67.6;Leydig cells: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 155.0;ASC TERT1: 96.7;fHDF/TERT166: 60.9;HSkMC: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.3	5.4	1.5	3.9	1.6	1.4	11.9	2.6	2.8	23.1	1.5	8.3	2.8	27.8	11.3	5.9	15.1	15.4	12.3	1.6	1.8	5.2	8.3	7.8	2.9	1.6	1.5	50.0	2.8	2.7	5.0	13.0	1.5	9.3	6.2	2.1	5.0	13.3	3.8	4.2	4.4	19.2	1.2	3.0	5.4	4.4	1.5	2.5	6.6	6.5	2.8	11.6	10.2	2.1	0.2	1.9	18.5	27.8	155.0	96.7	1.7	33.3	55.0	5.9	19.0	0.3	1.9	5.4	7.3	60.9	5.5	0.3	7.1	2.8	10.3	4.5	3.9	5.7	7.3	5.5	23.7	3.5	3.8	64.7	1.4	24.0	3.4	44.2	19.8	6.6	2.5	3.4	25.2	0.3	6.1	6.0	3.6	3.5	2.9	7.8	31.9	7.7	8.4	0.6	9.7	32.0	7.0	0.2	6.2	12.7	0.5	6.8	18.2	11.0	6.8	12.8	3.2	6.3	7.2	2.6	19.9	8.7	24.3	0.0	0.4	0.0	1.0	0.7	1.2	1.1	0.9	0.7	2.6	0.7	0.9	1.0	0.0	0.6	0.0	2.1	1.1	0.4	1.5	1.6	2.6	2.8	1.6	1.8	1.6	1.5	1.5	1.2	1.5	2.1	16.2	6.4	4.1	2.9	5.4	7.0	9.3	19.6	7.4	4.2	6.7	13.6	16.1	2.8	5.2	7.3	0.0	7.6	2.7	0.7	1.9	10.9	149.1	3.4	54.8	19.3	1.2	4.2	1.6	8.4	22.4	67.6	4.1	3.5	14.0	19.0	15.7	11.9	5.8	5.0	3.7	5.6	14.2	4.4	13.6	27.1	64.0	3.8	17.8	4.7	1.6	4.2	1.0	7.1	4.2	3.9	0.7	48.5	10.3	3.4	0.4	3.7	2.1	3.6	6.6	31.1	37.7	8.5	5.1	3.7	5.8	5.1	5.5	30.4	3.1	4.1
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FKBP prolyl isomerase 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 719.1;Late spermatids: 1236.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 93.4;neutrophil: 78.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"		NA	NA		10000	"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: AB_2679244"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	206.9	161.5	426.8	79.8	423.7	272.9	197.3	359.7	645.5	235.3	332.7	311.1	85.5	188.6	59.0	238.3	198.1	85.5	244.3	427.4	395.7	194.8	233.7	187.6	97.9	427.6	405.1	263.6	167.2	109.1	312.3	91.2	406.1	249.4	33.6	51.4	200.0	115.3	202.7	185.9	159.2	62.5	381.7	193.6	189.3	378.4	423.4	86.2	205.9	105.5	52.7	228.3	222.4	437.8	196.3	139.0	106.0	201.7	106.2	165.6	266.8	155.0	163.1	116.5	160.2	133.3	259.1	111.6	245.0	191.7	77.7	104.4	65.0	216.5	31.4	136.6	316.5	105.3	175.4	162.3	183.3	105.5	220.6	217.3	204.8	104.0	65.4	216.1	121.9	213.2	222.4	254.8	102.1	329.1	190.4	313.1	216.3	174.6	200.2	197.8	88.4	387.3	154.9	126.6	117.1	213.2	108.8	87.7	197.5	77.8	104.5	299.4	143.2	143.2	130.3	282.1	120.0	194.6	118.2	130.8	321.5	166.7	130.8	18.1	14.7	93.4	14.2	15.5	13.3	10.2	14.6	16.3	11.1	9.8	11.1	12.6	78.0	8.8	19.0	11.3	15.8	30.1	426.8	423.7	359.7	645.5	427.4	395.7	427.6	405.1	406.1	381.7	423.4	437.8	115.9	9.6	1.1	35.3	115.1	95.3	164.1	118.4	68.3	64.8	110.9	107.4	2.0	115.8	58.0	101.2	14.6	246.4	107.0	287.7	248.4	178.4	412.3	65.6	59.2	92.3	205.9	719.1	32.0	126.9	234.8	126.5	80.5	64.6	52.8	125.0	99.6	66.4	237.3	99.3	33.2	156.8	126.1	184.1	145.0	1236.4	203.8	152.1	202.7	8.4	221.9	149.0	183.4	12.5	32.8	166.9	283.4	165.5	127.2	139.4	339.3	290.4	51.9	56.4	98.6	95.7	129.9	193.5	212.4	96.5	117.9	312.9	145.0	121.7	158.3	158.0
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FKBP prolyl isomerase 9"	O95302	7	32957404-33006930	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 108.6;Fibroblasts: 89.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 379.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"	No	No		63000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: AB_2682761"	"unprognostic (1.23e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (5.80e-4)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavorable (7.02e-6)"	80.7	44.8	23.9	16.8	24.0	2.3	59.1	26.5	25.3	65.9	28.1	44.8	19.7	55.7	22.4	35.6	50.6	44.4	77.1	21.4	32.1	38.2	21.1	49.6	13.6	28.9	30.2	46.3	40.8	25.1	34.8	77.4	29.3	42.3	45.3	11.7	36.0	52.1	35.0	64.4	31.0	74.4	28.0	23.7	41.0	11.4	34.2	8.2	40.8	49.7	15.8	43.3	52.2	27.9	38.9	71.4	27.6	113.4	254.1	290.2	36.4	202.6	209.9	65.5	103.9	31.6	89.2	0.2	80.7	379.5	105.1	73.3	40.8	100.0	75.2	0.1	11.9	6.6	72.3	31.6	105.6	0.4	10.8	191.8	59.6	59.0	56.9	156.3	83.9	0.1	15.0	7.7	137.3	37.1	0.2	19.4	5.8	76.6	37.3	0.3	73.7	0.3	73.0	13.0	25.7	62.4	115.6	58.4	73.4	69.6	41.1	18.7	112.8	107.0	99.8	67.4	46.8	23.9	48.9	0.2	104.4	0.3	218.5	0.9	2.2	0.5	0.0	1.6	0.0	0.2	0.0	0.0	0.8	0.1	0.1	0.0	4.0	0.1	0.4	0.1	0.0	0.6	23.9	24.0	26.5	25.3	21.4	32.1	28.9	30.2	29.3	28.0	34.2	27.9	108.6	12.8	21.7	22.9	0.6	34.3	12.7	31.4	10.2	8.2	15.7	16.5	46.1	17.2	10.3	18.4	10.4	18.8	0.6	23.2	5.9	19.5	0.5	22.6	25.8	80.1	12.2	1.7	9.8	41.5	27.7	89.1	17.9	23.0	5.7	81.0	60.0	18.0	7.6	11.8	10.2	25.4	10.2	8.6	23.5	3.2	36.7	5.4	60.5	15.0	2.9	30.5	0.0	8.5	8.8	36.5	22.1	55.3	4.4	8.1	18.8	8.1	11.0	5.2	46.0	21.2	45.8	1.0	1.3	12.1	28.6	13.1	3.1	12.3	27.7	10.5
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FKBP prolyl isomerase like"	Q9UIM3	6	32128707-32130288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 51.2;Squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.3	4.2	2.9	2.0	2.5	2.8	4.0	2.2	3.2	3.8	2.2	4.1	1.6	3.1	6.1	10.7	4.3	1.6	2.9	2.6	2.4	4.0	5.2	3.2	3.1	2.9	2.4	3.2	5.5	4.0	2.9	1.7	2.6	3.2	3.4	1.8	6.4	1.1	4.5	9.8	3.6	3.6	2.1	4.7	6.1	6.2	2.5	5.5	5.6	4.4	1.1	2.9	5.1	3.6	0.0	0.9	8.1	13.8	11.6	8.2	3.4	5.4	6.1	10.0	9.7	17.5	7.3	0.0	1.8	9.3	13.1	4.2	11.3	10.5	6.9	0.0	13.7	0.0	11.9	10.2	6.5	0.0	6.6	8.0	5.6	19.3	6.1	7.3	10.6	15.8	11.9	15.0	10.2	6.0	6.9	5.9	6.0	16.1	3.0	0.0	5.0	13.6	10.4	1.5	15.3	1.0	5.5	9.6	10.2	2.4	16.8	11.8	4.7	14.3	4.1	7.5	13.3	7.7	1.5	5.7	5.6	7.1	9.1	6.6	1.8	0.5	0.7	2.5	0.7	2.1	1.1	1.3	1.9	0.5	1.0	1.0	2.6	3.4	0.8	1.6	0.3	1.5	2.9	2.5	2.2	3.2	2.6	2.4	2.9	2.4	2.6	2.1	2.5	3.6	8.8	6.4	5.9	0.3	7.8	11.2	4.7	6.7	51.2	2.9	11.5	8.5	2.0	7.2	6.2	1.8	0.0	9.9	6.1	9.3	5.9	8.1	4.2	11.6	6.1	9.6	6.0	19.8	0.7	6.7	13.3	5.6	6.1	8.1	2.5	12.4	5.0	3.3	5.0	10.1	0.6	7.0	8.2	2.8	8.8	5.5	2.8	4.2	7.2	1.0	3.7	7.3	3.1	0.0	0.5	6.0	6.2	3.4	7.7	5.2	10.3	9.9	3.2	4.9	0.0	5.4	17.4	11.1	8.8	34.1	10.2	14.1	6.8	14.9	6.5	4.1
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	10.2	1.9	3.7	10.9	2.3	12.2	6.0	2.1	2.8	5.7	1.2	3.7	3.2	4.6	1.1	2.8	2.7	6.1	6.2	1.8	2.9	2.1	2.8	10.8	12.3	4.7	2.7	1.2	1.7	3.5	0.7	12.5	4.3	1.9	2.9	0.5	2.2	2.2	2.8	1.7	4.0	5.9	3.5	35.8	4.3	0.9	3.9	17.2	2.9	6.6	10.4	6.7	1.9	2.8	0.2	0.0	5.6	0.0	0.8	1.0	0.1	3.3	9.2	3.8	3.1	0.0	0.0	18.5	31.7	11.1	1.1	0.1	0.8	13.5	4.1	9.0	0.2	113.9	0.5	0.0	6.0	13.7	14.6	0.8	1.1	7.7	17.3	11.1	60.5	25.6	0.0	23.3	0.8	0.0	13.3	8.1	1.8	0.0	3.1	49.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	20.4	63.0	0.7	0.0	0.2	3.5	7.3	16.4	16.6	0.1	31.8	5.2	34.5	15.5	24.5	10.1	15.3	11.9	6.8	8.9	8.2	19.1	6.0	3.7	8.2	11.8	12.3	19.1	3.3	11.1	20.1	3.7	2.3	2.1	2.8	1.8	2.9	4.7	2.7	4.3	3.5	3.9	2.8	53.4	6.4	5.3	0.3	65.7	5.1	0.3	1.7	2.2	0.0	0.7	1.3	5.5	5.7	0.1	1.8	0.0	0.4	43.1	0.0	0.0	0.0	0.5	0.4	0.6	84.2	0.0	23.4	0.3	0.0	0.4	5.9	2.0	0.3	22.8	0.0	64.6	1.3	43.2	0.0	1.5	0.1	0.0	86.4	24.7	0.5	1.8	60.3	7.2	231.4	68.4	0.1	93.7	4.0	0.7	0.0	0.0	0.7	56.9	0.3	0.0	0.4	0.8	0.4	6.6	2.1	3.1	0.2	0.1	0.6	4.1	0.3	52.8	0.9	0.2	0.4
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322985-14337614	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 156.5;Basal prostatic cells: 168.3;Club cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 27.5;hTCEpi: 51.3;RPTEC TERT1: 17.3;WM-115: 62.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	5.0	3.7	2.3	0.8	3.0	0.0	2.3	6.4	5.3	3.2	0.9	1.6	11.8	2.3	3.1	1.6	2.4	5.0	0.6	5.3	1.3	23.2	7.0	17.7	0.1	0.0	1.3	10.6	1.2	8.2	1.0	1.8	0.8	8.2	0.8	1.6	1.2	14.0	2.0	6.3	2.3	1.4	0.6	0.7	9.7	1.2	2.3	7.3	5.2	0.7	0.3	7.9	2.1	1.8	0.0	12.2	27.5	0.0	0.0	0.0	0.0	2.7	0.8	0.1	0.0	15.3	5.6	0.0	0.9	0.6	0.0	8.0	0.0	8.3	0.1	0.0	1.8	0.0	0.4	0.3	2.4	0.0	0.0	4.6	51.3	0.0	9.7	0.0	0.1	0.2	0.0	0.2	5.3	0.4	3.7	0.0	8.9	6.2	0.1	0.1	0.2	0.0	17.3	3.6	0.5	5.7	0.0	0.0	9.2	15.5	0.5	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.0	0.0	0.2	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	6.4	5.3	5.3	1.3	0.0	1.3	0.8	0.6	2.3	1.8	0.3	218.0	156.5	2.3	0.5	8.7	168.3	26.1	55.8	23.9	4.4	6.5	1.2	24.3	73.1	22.0	6.2	0.5	0.0	2.2	13.7	23.6	0.2	0.7	1.7	1.9	11.3	0.0	27.2	14.9	0.0	8.7	37.8	0.7	5.1	5.0	2.9	8.5	0.2	6.7	39.3	2.5	2.0	0.3	0.7	0.5	3.7	1.3	5.4	1.9	1.6	0.6	0.0	26.2	3.9	10.0	3.0	0.4	0.1	24.9	3.5	49.2	13.4	3.3	0.0	25.0	1.8	0.0	0.1	5.9	16.6	0.0	0.8	1.4	1.5	18.3
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related receptor tyrosine kinase 1"	P17948	13	28300346-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 432.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 411.6;Endothelial cells: 263.1;Extravillous trophoblasts: 815.4;Hepatic stellate cells: 234.9;Microglial cells: 433.8;Syncytiotrophoblasts: 1127.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 71.8;BJ hTERT+: 57.2;HMC-1: 349.2;HUVEC TERT2: 64.9;WM-115: 127.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	87000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	47.6	9.6	37.6	9.1	36.2	1.1	31.2	37.0	43.0	16.4	24.6	9.4	7.5	17.2	3.7	5.9	11.7	16.6	46.0	33.3	39.8	34.9	18.2	25.8	5.3	44.6	40.0	4.4	12.7	30.5	9.0	432.4	50.1	13.9	6.1	52.5	7.0	11.0	19.9	5.9	9.3	17.4	33.4	18.6	10.9	17.4	59.6	3.6	48.9	38.8	5.7	14.0	9.5	38.7	0.1	0.0	0.0	0.6	0.6	0.9	0.3	71.8	57.2	25.8	14.9	0.0	0.2	0.1	0.1	9.6	0.0	0.3	6.7	0.0	45.4	0.0	2.0	0.2	0.1	0.0	0.1	0.0	349.2	0.6	0.0	0.1	1.0	0.1	64.9	6.1	1.7	0.3	0.0	0.3	4.5	3.7	37.5	0.0	0.1	2.9	0.0	0.1	0.1	0.1	8.1	0.6	0.0	0.1	0.2	44.4	0.3	0.2	6.3	0.2	1.2	0.1	0.1	2.1	1.0	0.2	0.4	0.3	127.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	37.6	36.2	37.0	43.0	33.3	39.8	44.6	40.0	50.1	33.4	59.6	38.7	411.6	0.0	6.0	2.0	4.7	4.1	0.7	0.2	3.4	17.8	1.2	1.5	26.5	2.8	2.9	0.0	4.2	197.2	1.4	0.1	1.9	0.6	157.2	0.5	1.5	263.1	0.0	0.0	0.9	0.0	815.4	32.1	0.5	2.1	1.3	0.1	234.9	6.9	30.8	1.7	14.5	0.0	0.0	12.5	23.6	173.8	18.6	15.3	0.0	433.8	0.0	153.2	0.0	9.5	2.0	0.0	0.0	48.5	4.1	1.3	0.0	0.1	1.8	9.7	92.1	11.4	30.1	14.6	4.6	1.0	4.8	1127.1	2.8	1.5	0.0	1.1
FMO5		ENSG00000131781	"Flavin containing dimethylaniline monoxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 683.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 64.2;Cholangiocytes: 133.0;Hepatocytes: 265.4;Proximal enterocytes: 108.8;Proximal tubular cells: 69.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	3.1	5.7	2.0	5.1	2.9	2.0	46.1	3.9	2.8	7.8	0.5	41.3	71.3	2.8	6.9	1.2	3.6	15.8	3.1	2.1	2.4	51.5	683.3	27.1	4.0	4.2	2.9	4.1	48.1	68.3	6.7	2.4	4.8	9.7	46.6	0.9	32.7	4.0	0.8	11.6	73.9	3.5	3.2	4.0	120.1	5.2	3.1	1.1	2.0	1.4	2.5	3.9	1.5	5.6	0.1	1.1	0.6	0.1	2.8	0.8	0.9	0.7	0.5	0.3	0.8	0.7	2.4	0.4	0.8	0.8	0.2	0.4	0.0	0.0	0.0	1.4	0.2	1.6	0.1	41.7	0.9	1.4	9.0	1.3	0.2	0.4	0.0	0.4	0.6	0.2	0.1	0.1	1.5	1.4	0.2	0.7	2.8	5.3	0.8	0.4	0.5	0.4	3.4	0.6	0.5	0.3	0.9	2.8	1.3	1.3	2.1	10.4	1.1	0.0	0.3	0.9	0.0	0.3	0.0	0.3	1.1	0.5	0.3	7.0	12.9	4.1	2.0	5.9	0.3	4.7	0.5	0.6	5.4	8.5	0.3	1.3	1.3	1.2	1.8	2.5	1.6	3.9	2.0	2.9	3.9	2.8	2.1	2.4	4.2	2.9	4.8	3.2	3.1	5.6	2.8	9.6	64.2	11.1	6.4	1.7	3.9	0.9	1.8	2.0	17.5	6.7	1.9	133.0	10.4	14.7	0.0	1.5	1.7	60.8	7.9	7.5	7.7	2.5	1.8	2.7	6.7	4.8	8.2	5.9	1.1	2.9	24.5	6.1	5.7	9.8	5.0	265.4	4.0	3.3	6.4	34.4	4.1	10.0	2.3	4.5	2.8	4.6	28.4	10.3	5.3	0.2	4.1	10.1	17.5	7.0	29.0	1.5	0.4	5.6	108.8	69.2	18.1	1.3	0.0	2.2	1.0	5.9	0.9	1.3	1.6	1.4	2.6	6.6	20.7	6.4
FMR1	"FMRP, FRAXA, MGC87458, POF, POF1"	ENSG00000102081	"FMRP translational regulator 1"	Q06787	X	147911919-147951125	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012444, HPA050118, HPA056084"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB012444: AB_732400, HPA050118: AB_2681023, HPA056084: AB_2683033"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.98e-2)"	18.1	16.5	22.3	20.6	24.1	43.5	18.3	29.6	29.2	18.8	16.1	19.1	17.5	27.3	41.0	17.0	22.8	15.9	20.1	21.7	21.0	34.0	39.6	20.1	22.7	21.9	21.1	27.7	13.3	29.6	13.5	31.2	21.3	16.5	18.9	27.6	14.1	21.4	9.5	23.2	19.7	21.1	22.7	27.7	17.8	19.6	22.9	24.6	30.6	11.6	21.7	16.7	14.7	23.4	44.9	39.6	41.2	27.2	24.4	19.4	31.9	23.8	24.9	37.6	66.4	43.5	42.1	89.5	93.5	29.8	43.3	74.4	65.8	30.2	42.0	34.9	45.2	25.3	71.3	41.4	24.0	28.3	15.1	21.2	16.2	31.6	28.8	22.6	31.8	24.4	15.9	57.7	32.7	59.0	32.0	20.3	18.2	30.9	21.8	34.7	116.8	37.6	43.2	119.3	35.1	23.3	26.8	24.4	35.7	55.4	21.8	24.9	30.4	30.5	25.5	37.7	60.0	61.1	65.5	94.5	27.4	46.9	16.3	2.0	1.3	3.4	2.7	1.6	3.5	2.6	1.8	3.1	1.7	2.4	2.3	2.7	3.5	2.5	1.6	1.3	2.4	1.3	22.3	24.1	29.6	29.2	21.7	21.0	21.9	21.1	21.3	22.7	22.9	23.4	35.3	57.7	26.6	26.8	22.1	31.4	16.0	12.6	21.1	37.5	20.7	17.4	43.2	14.3	23.9	22.0	12.5	37.2	37.1	27.2	19.6	14.7	1.0	36.4	42.5	27.2	14.9	10.7	33.3	9.8	43.5	27.2	17.9	49.3	19.7	36.8	17.5	37.5	15.4	70.7	32.2	13.8	18.3	25.4	15.7	3.0	30.1	23.7	35.6	29.0	16.8	40.0	11.3	28.6	33.9	13.5	18.1	29.7	20.3	22.7	20.7	42.6	23.4	30.0	6.6	37.2	33.3	14.9	20.9	28.1	32.4	40.8	24.1	39.4	16.9	34.7
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735615-82751196	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 79.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 90.1;Proximal tubular cells: 167.2;Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 34.3;Hep G2: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		180000		"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	14.4	47.3	47.4	2.9	64.3	12.0	8.4	64.4	56.6	10.4	36.8	15.5	22.4	9.4	7.0	4.6	12.5	6.9	47.5	46.5	54.3	49.6	48.1	7.8	2.4	63.3	56.8	22.3	18.1	21.9	22.4	5.3	62.7	12.5	9.5	13.8	28.5	12.1	23.5	5.3	14.5	6.6	49.4	4.6	17.4	5.2	55.6	1.0	10.2	10.9	2.3	8.8	7.9	79.8	1.3	16.1	4.4	23.2	6.9	5.7	2.9	2.9	2.2	5.4	2.7	21.0	3.3	0.2	3.9	2.6	4.5	0.6	34.3	2.5	2.0	1.0	2.4	12.5	12.9	66.2	18.8	0.3	10.1	4.9	9.0	2.1	0.0	5.7	10.6	1.0	22.4	0.6	1.1	1.8	0.2	0.2	2.9	7.6	13.0	2.1	0.3	0.1	11.5	4.5	7.0	22.7	5.3	1.2	15.8	3.8	15.4	4.5	2.5	0.4	1.6	5.6	4.3	1.2	0.3	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	64.3	64.4	56.6	46.5	54.3	63.3	56.8	62.7	49.4	55.6	79.8	3.9	3.2	2.0	8.8	1.9	1.5	3.7	1.5	14.8	41.9	4.5	3.7	5.8	4.3	2.5	31.3	47.9	11.7	2.6	5.7	90.1	3.2	0.2	11.6	3.0	5.2	5.4	49.2	10.2	1.2	2.6	8.6	47.9	25.9	1.3	6.9	4.2	5.4	8.2	32.0	13.0	10.4	6.1	1.0	3.4	0.4	5.3	5.7	12.4	5.6	1.2	36.2	1.0	6.0	17.1	1.7	7.3	3.0	9.1	3.9	28.2	167.2	2.5	72.9	0.0	6.1	9.8	0.8	4.1	12.8	1.8	8.3	3.1	18.6	9.5	3.5
FOLR1	"FOLR, FRα"	ENSG00000110195	"Folate receptor alpha"	P15328	11	72189558-72196323	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 480.2;fallopian tube: 187.2;lung: 193.5;salivary gland: 219.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 496.8;Alveolar cells type 2: 213.3;Breast glandular cells: 211.3;Club cells: 276.3;Collecting duct cells: 318.2;Cytotrophoblasts: 462.2;Proximal tubular cells: 366.0;Syncytiotrophoblasts: 259.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 444.2;RPTEC TERT1: 476.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA	448000	140000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.1	1.7	2.7	0.2	1.8	0.1	28.3	11.8	1.8	123.5	480.2	0.5	0.3	1.9	7.6	3.4	187.2	2.4	0.6	14.1	4.1	153.0	0.2	193.5	0.0	5.7	7.8	0.7	7.1	17.5	8.1	36.2	3.8	1.5	0.4	0.5	219.5	15.2	0.1	2.5	0.4	0.2	3.2	0.2	33.0	0.2	7.7	0.2	45.9	0.0	0.4	0.1	0.1	2.7	0.2	0.2	0.0	0.2	0.0	0.0	64.7	0.1	0.1	0.1	0.1	44.5	46.0	0.0	45.5	0.8	0.0	0.9	2.4	2.1	0.2	0.1	1.4	1.0	444.2	1.3	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.5	0.1	0.1	2.2	0.7	0.0	0.5	15.1	0.0	476.5	0.0	0.1	3.0	1.4	7.1	0.1	38.5	65.7	0.5	0.0	0.0	8.4	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.8	11.8	1.8	14.1	4.1	5.7	7.8	3.8	3.2	7.7	2.7	1.0	496.8	213.3	0.0	1.3	0.9	7.9	80.3	0.0	0.0	211.3	62.9	0.2	34.3	276.3	318.2	0.0	462.2	1.1	0.0	133.1	14.3	0.1	33.6	2.3	3.4	1.8	0.0	0.0	1.4	110.9	4.3	9.7	33.7	5.1	0.0	0.0	0.0	29.5	0.0	0.0	0.1	87.5	0.0	0.4	0.0	0.6	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	6.3	0.0	366.0	149.1	0.1	0.0	0.1	6.3	0.0	0.5	3.2	0.1	259.0	2.2	0.3	0.3	10.4
FOS	"AP-1, c-fos"	ENSG00000170345	"Fos proto-oncogene, AP-1 transcription factor subunit"	P01100	14	75278826-75282230	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 504.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 504.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 453.1;OE19: 170.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 80.9;spinal cord: 235.3"	HPA018531	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018531: AB_1846576"	"unprognostic (1.18e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.55e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-2)"	1136.1	735.7	62.9	576.0	87.2	2270.6	477.4	184.8	113.1	700.5	111.5	479.5	235.3	410.4	58.4	1250.8	1777.3	1160.0	513.1	58.9	190.7	266.1	308.8	486.9	449.9	145.1	84.0	1188.7	298.4	264.7	452.3	417.4	92.0	791.1	627.4	233.3	555.6	462.3	99.1	1645.4	584.5	964.3	100.6	178.0	525.6	87.2	104.4	424.2	1007.6	1014.2	26.8	946.5	346.6	121.7	2.2	1.4	7.1	10.4	59.9	18.3	42.1	6.4	2.4	4.5	3.2	4.4	12.6	0.6	1.8	43.5	42.6	3.0	3.6	74.7	1.1	1.2	1.1	1.0	21.9	1.9	27.6	2.6	42.8	44.3	453.1	3.9	27.4	6.2	2.7	9.2	2.0	19.7	1.2	26.1	0.9	12.9	7.4	170.9	2.5	2.0	1.4	23.8	18.8	20.4	52.4	3.6	9.8	85.9	39.8	21.8	1.4	9.2	6.3	0.4	5.7	3.7	2.0	52.4	61.2	9.6	2.9	8.0	5.7	38.3	81.0	89.5	0.3	20.1	0.4	0.3	0.2	0.7	69.6	0.2	0.2	0.1	504.8	4.6	2.5	1.5	0.4	27.7	62.9	87.2	184.8	113.1	58.9	190.7	145.1	84.0	92.0	100.6	104.4	121.7	3911.0	1102.6	1859.4	137.1	1015.9	859.7	1644.7	1577.5	4336.7	106.1	3184.1	2874.6	1027.6	1416.9	752.7	191.3	129.3	1506.7	1323.5	1648.6	17.6	690.9	17.4	1834.4	3720.3	1624.0	1628.0	290.5	4.9	528.1	2694.6	4146.8	2049.5	3656.5	1630.6	751.3	1317.2	207.2	1693.8	35.3	3.0	1967.2	793.5	2600.2	1540.4	53.5	943.8	2910.7	855.6	58.1	269.5	1119.5	10.3	6.0	1.8	383.5	1507.8	178.3	1256.1	1115.7	1675.1	20.0	354.4	406.9	1209.6	3390.9	2705.7	10.0	10.5	2438.0	1092.4	2283.3	1497.0	417.4	1366.2	298.4
FOSB	"AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291"	ENSG00000125740	"FosB proto-oncogene, AP-1 transcription factor subunit"	P53539	19	45467995-45475179	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 45.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010267, HPA054663"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB010267: AB_640583, HPA054663: AB_2682562"	"unprognostic (7.22e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.72e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.04e-2)"	394.7	121.6	2.1	118.4	5.5	433.8	91.7	35.7	45.6	150.3	4.8	37.6	24.8	46.6	3.9	187.7	404.1	347.1	48.9	11.1	7.8	34.7	85.5	113.5	67.7	1.5	1.6	274.4	126.3	46.2	27.3	57.8	1.5	118.5	78.4	10.7	76.8	29.6	3.3	267.8	63.1	353.7	0.8	21.8	104.4	8.8	1.2	152.2	316.0	81.3	1.6	213.9	11.0	3.8	0.4	0.6	0.1	0.3	1.2	0.3	1.8	2.3	1.0	0.7	0.7	0.5	1.0	2.0	0.4	1.5	11.4	0.8	0.5	1.6	0.5	0.3	0.7	0.6	0.8	0.4	0.8	1.1	13.3	0.5	8.1	1.7	1.9	0.4	0.9	2.3	0.8	6.8	0.2	0.2	0.2	1.2	0.4	1.0	0.4	0.5	0.1	1.4	0.6	1.3	3.1	0.4	1.4	9.6	1.2	1.9	0.5	0.8	0.1	0.5	0.6	1.1	0.7	5.1	0.8	0.5	1.1	0.8	1.3	0.9	1.2	1.0	0.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.1	2.1	5.5	35.7	45.6	11.1	7.8	1.5	1.6	1.5	0.8	1.2	3.8	1048.7	685.9	761.3	2.6	445.7	380.5	533.4	162.4	865.6	50.6	1627.1	1523.2	177.8	370.3	174.4	11.0	135.5	237.5	359.6	551.1	1.9	145.5	10.1	667.9	1204.4	442.6	877.0	68.6	1.3	74.2	301.9	788.2	911.3	1541.3	830.4	239.3	393.7	77.9	210.3	8.4	0.3	898.4	42.7	345.2	353.4	11.3	240.2	797.3	172.5	1.0	16.3	186.1	1.0	0.0	0.3	111.6	457.3	59.5	503.4	307.3	417.8	2.7	111.5	217.6	302.4	2234.0	608.8	3.3	4.5	476.3	380.9	396.9	481.8	174.2	616.5	208.5
FOSL2	"FLJ23306, FRA2"	ENSG00000075426	"FOS like 2, AP-1 transcription factor subunit"	P15408	2	28392448-28417317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 287.6;Langerhans cells: 319.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 36.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004817, CAB013460, HPA061417"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.41e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.79e-2)"	149.4	169.7	18.8	67.6	18.4	232.1	78.6	18.8	31.8	83.0	17.4	64.3	30.2	77.8	7.0	129.5	85.7	79.6	75.1	34.7	32.2	65.8	30.9	83.4	9.1	36.0	19.3	133.5	37.2	7.5	46.6	46.9	18.8	53.8	40.2	10.7	47.4	26.7	101.7	103.4	52.2	81.5	18.2	32.7	76.6	7.3	23.5	17.2	35.2	33.9	16.6	82.3	112.1	15.0	45.0	30.2	2.0	23.2	23.9	41.6	62.0	37.7	38.0	58.8	51.1	35.9	34.6	0.2	53.9	48.6	59.6	42.0	2.5	49.7	52.6	10.6	3.1	4.6	59.3	6.3	37.3	7.9	18.9	66.9	123.3	69.0	60.5	49.5	31.2	1.5	0.6	12.5	39.7	7.3	0.7	24.3	3.6	45.2	14.8	1.8	57.4	4.3	94.3	152.5	15.7	2.3	61.0	35.2	10.9	16.8	3.8	35.5	93.8	122.8	81.9	72.3	55.2	19.1	7.6	0.2	81.5	43.3	21.6	17.2	9.9	8.7	7.7	7.3	7.4	0.0	1.6	3.8	3.9	0.0	0.4	2.5	36.6	4.6	6.4	1.3	1.2	5.1	18.8	18.4	18.8	31.8	34.7	32.2	36.0	19.3	18.8	18.2	23.5	15.0	183.1	32.1	50.9	4.6	20.2	143.1	86.3	85.8	90.0	0.8	76.4	41.7	27.9	70.1	59.7	167.3	0.0	27.4	287.6	140.6	19.6	58.5	1.3	115.7	88.0	111.0	28.1	4.4	11.9	59.8	148.3	79.7	115.7	193.6	108.3	68.1	56.7	16.5	37.4	0.0	8.1	65.2	40.7	58.0	319.8	4.3	22.4	181.2	85.4	15.0	62.8	2.3	53.5	0.5	0.6	54.1	91.5	24.5	67.0	82.2	124.8	35.1	38.2	1.4	26.3	93.8	122.3	1.6	2.5	157.6	150.7	50.2	142.4	23.6	57.6	152.8
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86566829-86569728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.6"	"Group enriched"	"Detected in some"	4	"Peritubular cells: 30.9;Sertoli cells: 19.7;Smooth muscle cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.2;HUVEC TERT2: 19.5;LHCN-M2: 31.2;TIME: 36.0;U-138 MG: 18.4;U-2197: 31.5;U-87 MG: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"spinal cord: 42.7"	HPA056302			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA056302: AB_2683093"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	2.4	1.5	0.5	0.3	1.1	0.0	1.8	0.9	1.6	2.2	3.2	0.5	0.1	0.8	0.6	0.5	2.0	1.3	5.6	0.4	0.4	5.4	0.1	2.1	0.4	0.5	0.5	1.1	0.2	0.1	2.4	0.1	0.5	1.0	0.1	0.1	2.4	0.6	0.7	0.8	0.4	0.4	0.7	0.0	0.4	1.9	0.7	0.1	2.0	0.5	0.1	0.8	1.5	0.3	0.0	0.0	0.0	0.0	5.8	7.8	0.0	11.3	14.3	8.0	1.5	0.0	0.0	0.0	1.5	1.4	11.2	0.0	0.2	3.3	7.0	0.0	0.6	0.0	7.9	0.0	2.7	0.0	0.0	1.3	3.4	25.2	7.9	14.5	19.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.7	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	5.9	0.0	0.0	36.0	18.4	0.0	31.5	0.0	0.0	0.0	0.0	24.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.9	1.6	0.4	0.4	0.5	0.5	0.5	0.7	0.7	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.8	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	1.5	0.1	1.8	1.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	30.9	1.2	0.8	0.0	0.0	0.0	0.1	19.7	0.6	33.2	0.2	5.0	0.5	0.0	0.0	0.0	0.0	0.1	1.4
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Cell type enriched"	"Detected in some"	11	"monocytes: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.5"									"HPA012836, HPA069839"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA012836: AB_2105429, HPA069839: "	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.5	0.1	0.3	0.4	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312098-1314758	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 107.2;urinary bladder: 53.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 60.4;Basal respiratory cells: 24.9;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 67.2;Suprabasal keratinocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 39.0;HaCaT: 44.7;Hep G2: 93.8;OE19: 117.1;RT4: 38.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059700			Supported	Nucleoplasm		Yes	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA059700: AB_2684107"	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favorable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.3	0.0	6.9	0.2	5.2	0.0	1.4	7.1	7.1	6.7	3.8	0.8	10.4	0.9	0.3	11.3	3.9	5.4	0.0	4.7	5.1	9.8	6.4	4.0	0.0	5.6	6.0	0.0	6.5	0.1	2.5	1.1	6.0	8.9	0.4	0.1	30.4	1.1	0.2	25.7	0.6	0.0	5.3	0.0	107.2	0.2	7.5	0.6	3.6	0.6	8.0	53.5	16.9	4.7	16.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.1	0.1	39.0	22.6	0.0	0.7	0.0	0.1	44.7	0.0	1.7	0.0	0.0	1.1	0.0	8.2	93.8	0.0	0.0	2.4	0.0	16.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	117.1	0.8	0.0	0.0	0.0	0.4	38.2	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	5.2	7.1	7.1	4.7	5.1	5.6	6.0	6.0	5.3	7.5	4.7	0.3	16.0	10.6	0.0	0.0	60.4	3.2	24.9	6.8	0.0	5.3	5.1	0.8	0.0	16.8	40.5	0.0	0.0	0.0	0.0	1.9	3.0	0.0	5.2	3.0	0.4	0.0	0.0	1.2	13.4	0.0	1.4	67.2	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	2.9	0.0	0.0	0.7	1.8	15.9	0.0	0.0	0.0	0.0	0.5	11.8	0.0	0.0	0.2	0.6	0.0	6.2	5.0	0.0	0.0	0.0	1.6	0.0	0.0	22.2	45.5	0.0	0.3	0.0	0.0	3.9
FP565260.1		ENSG00000275464	"Periodic tryptophan protein 2 homolog"		21	5130871-5154658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 102.4"									HPA024573	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	9.2	9.2	6.4	9.9	8.8	12.1	7.4	7.2	8.0	5.9	4.9	8.5	9.1	6.8	1.7	8.3	7.8	7.3	7.5	7.1	6.8	9.0	6.8	7.1	13.4	7.6	7.2	6.7	7.7	6.5	6.0	7.9	9.1	6.5	8.4	3.5	6.7	4.7	10.1	8.6	8.2	7.3	6.8	11.5	7.6	7.1	7.2	6.7	6.6	3.2	5.3	11.4	7.1	13.7	32.0	24.0	15.4	24.2	6.6	5.0	9.1	0.2	0.0	0.1	0.1	0.4	20.1	0.3	14.1	10.5	20.8	21.0	42.9	19.0	0.0	7.4	15.1	102.4	12.4	11.9	10.4	47.6	29.1	17.8	22.5	25.5	20.1	5.0	20.1	16.5	56.8	11.6	6.6	28.4	34.4	33.1	60.4	36.5	29.3	54.0	14.2	28.8	13.5	25.3	16.6	27.3	25.5	38.4	14.9	4.2	31.5	24.9	10.2	12.0	29.7	0.3	32.9	13.9	16.0	63.5	20.4	62.3	16.7	3.3	7.3	6.9	18.5	12.6	21.2	11.0	11.3	13.5	8.7	11.2	11.1	15.2	4.1	9.9	18.2	5.5	8.5	11.6	6.4	8.8	7.2	8.0	7.1	6.8	7.6	7.2	9.1	6.8	7.2	13.7	0.9	0.0	9.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	1.9	0.0	0.0	2.5	0.0	0.0	2.7	1.1	0.8	0.0	9.3	0.0	0.8	1.1	0.9	0.0	0.0	0.0	8.0	1.4	0.9	0.0	0.9	5.1	0.6	0.0	0.0	6.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.3	1.2	0.4	0.9	0.0
FRAT2		ENSG00000181274	"FRAT regulator of WNT signaling pathway 2"	O75474	10	97332497-97334729	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 15.0;neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 58.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.3	3.6	7.2	10.4	7.1	31.0	8.0	7.7	7.4	6.0	9.8	17.1	25.1	4.1	6.2	14.4	7.1	4.0	6.0	6.3	6.8	7.8	18.3	9.7	8.7	7.7	7.6	2.8	14.0	5.2	3.0	7.4	6.8	7.9	15.5	3.3	15.1	4.3	10.1	20.4	15.9	4.1	7.0	28.9	13.2	14.6	7.5	8.9	5.3	9.1	10.8	6.7	8.1	6.0	10.9	4.3	6.9	31.2	4.9	4.0	25.7	2.4	8.9	3.7	3.7	6.8	12.5	13.3	8.4	2.5	2.2	20.3	18.3	9.5	2.9	20.0	28.0	17.9	9.2	15.0	2.8	28.9	20.6	3.2	20.0	3.6	11.4	7.9	9.3	11.7	15.8	4.2	1.8	17.9	12.6	36.5	42.9	36.2	17.5	12.8	2.9	19.1	8.9	9.8	12.5	10.2	3.1	19.1	12.6	28.0	28.8	44.8	4.2	2.2	2.7	1.7	6.4	11.4	12.5	6.6	2.6	49.3	0.8	8.3	7.2	15.0	1.1	4.8	0.6	1.1	1.3	1.8	3.8	3.2	2.2	1.3	58.2	1.6	7.9	1.0	0.7	2.3	7.2	7.1	7.7	7.4	6.3	6.8	7.7	7.6	6.8	7.0	7.5	6.0	18.2	0.0	3.9	2.9	15.7	31.7	25.3	6.6	46.1	19.7	24.7	19.6	6.4	20.0	5.0	14.7	4.2	6.1	26.1	31.0	11.7	2.2	40.7	39.6	9.7	10.3	13.8	14.5	2.0	5.3	18.5	6.4	37.2	46.3	1.3	16.7	8.6	11.3	8.6	11.8	2.8	30.6	4.1	28.3	9.0	42.3	2.1	25.2	10.6	7.5	24.7	5.0	14.4	2.0	1.1	3.4	21.6	2.6	8.4	30.0	13.5	3.7	4.5	18.1	0.0	14.9	8.7	2.3	4.4	37.7	52.7	7.8	18.8	20.1	31.6	32.3
FRYL	"AF4p12, DKFZp686E205, KIAA0826, MOR2"	ENSG00000075539	"FRY like transcription coactivator"	O94915	4	48497357-48780322	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.5"	"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 1148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031106, HPA031107"	Supported		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA031106: AB_10600660, HPA031107: AB_10600536"	"unprognostic (7.50e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.22e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	8.8	5.4	12.2	13.2	43.5	15.0	7.9	26.6	22.6	8.4	0.8	37.9	10.4	8.4	3.7	6.6	6.1	8.3	8.6	12.1	19.9	8.4	5.7	9.7	13.4	34.8	23.4	7.9	5.6	20.3	2.7	10.5	31.2	6.5	36.7	29.2	6.8	6.6	4.5	10.2	12.8	9.2	22.2	10.8	10.7	6.3	25.7	16.7	7.9	12.0	13.1	10.2	3.4	81.5	19.7	11.6	26.8	16.4	11.3	16.1	14.5	18.1	17.4	17.6	21.2	9.4	14.7	25.0	14.3	19.3	32.9	11.8	17.8	28.1	37.9	14.3	6.1	45.6	11.3	4.3	7.0	31.6	16.8	11.6	10.5	24.0	24.9	16.4	26.4	21.3	14.8	9.2	22.9	9.6	34.5	10.9	4.6	8.9	9.8	25.4	35.0	4.7	15.7	20.8	23.1	9.9	17.7	5.2	9.9	12.8	6.8	19.6	40.3	19.8	25.5	10.1	35.3	12.4	17.5	22.1	16.6	20.6	19.8	13.5	0.9	1.8	2.0	1.4	1.6	1.5	1.8	1.7	1.0	1.2	2.0	1.9	2.8	2.7	1.0	1.7	1.3	0.7	12.2	43.5	26.6	22.6	12.1	19.9	34.8	23.4	31.2	22.2	25.7	81.5	87.1	38.5	33.1	92.1	50.1	47.3	24.3	32.0	38.7	45.3	23.7	17.0	33.5	18.6	28.9	16.5	135.5	23.6	59.9	122.8	3.9	13.8	11.6	48.2	29.0	74.8	79.5	80.6	110.1	11.6	21.5	23.7	128.4	56.8	46.9	25.6	48.9	15.2	19.4	47.1	172.5	195.1	38.7	30.1	34.0	3.9	17.1	40.1	26.6	214.5	35.1	32.8	63.8	146.8	1148.7	28.8	87.3	18.4	38.6	43.4	50.4	8.4	21.0	105.6	19.7	31.2	37.3	12.8	10.9	37.3	49.3	10.8	54.4	15.6	93.9	53.3
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480626-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.7"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 700.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 351.1;HaCaT: 292.3;HBEC3-KT: 191.3;HMC-1: 206.5;PC-3: 558.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA016612, CAB026025"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1800000	"Cluster 32: T-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"CAB026025: , HPA016612: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	26.1	6.2	0.8	3.0	0.5	0.4	15.2	0.4	0.7	7.7	0.7	9.8	1.8	4.2	3.7	6.5	11.8	7.2	9.4	2.0	2.0	2.9	68.7	8.2	1.6	1.8	1.0	9.9	2.6	0.5	5.9	24.1	0.9	15.5	3.0	0.3	11.3	10.8	9.2	18.0	8.8	4.7	0.5	0.3	11.1	5.0	1.1	2.3	4.0	7.7	12.9	40.4	7.5	0.7	20.0	1.8	33.7	0.0	38.6	13.5	55.4	76.3	351.1	46.4	45.4	0.3	0.2	0.0	0.6	19.9	2.3	292.3	0.0	191.3	32.7	0.8	0.2	4.0	1.7	31.3	20.4	0.3	206.5	31.0	0.5	84.5	55.0	31.3	40.0	0.0	0.0	0.6	29.7	0.1	0.1	1.6	52.1	0.0	558.2	4.2	43.6	0.0	0.0	31.9	0.5	0.1	3.1	0.2	2.0	83.9	0.3	0.3	0.2	124.1	35.3	13.2	11.1	0.4	0.1	0.1	14.8	4.1	116.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.4	0.7	2.0	2.0	1.8	1.0	0.9	0.5	1.1	0.7	5.2	0.0	1.1	0.0	1.0	20.0	31.5	64.4	13.1	0.0	0.9	23.4	11.4	0.0	8.3	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.4	0.1	3.4	2.9	0.0	0.0	0.1	4.6	14.8	107.7	3.6	0.1	0.0	700.1	1.1	57.2	1.8	0.0	0.7	0.0	2.0	0.8	16.4	1.5	3.1	1.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	11.3	0.2	37.1	0.0	0.1	1.6	0.0	13.1	29.6	33.3	0.3	12.2	4.0	4.7	6.0	2.0	0.3	0.0	51.8
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 939.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 131.5;Early spermatids: 104.7;Hepatocytes: 444.9;Late spermatids: 124.3;Proximal tubular cells: 395.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 92.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		1600000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.4	1.7	5.4	0.2	6.8	0.0	0.4	3.6	8.4	1.3	3.0	1.3	1.3	1.2	0.4	0.3	0.9	0.1	1.6	4.9	4.7	155.7	939.8	0.2	0.2	4.6	3.9	3.0	4.0	0.0	3.4	0.0	5.6	4.2	0.0	0.0	0.2	0.6	0.4	0.3	1.7	0.0	3.5	0.5	0.5	13.9	4.4	0.0	0.9	0.0	0.0	1.3	1.0	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.0	92.9	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.5	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.4	6.8	3.6	8.4	4.9	4.7	4.6	3.9	5.6	3.5	4.4	5.5	0.0	0.0	0.0	1.0	8.1	0.1	0.0	0.0	0.0	1.3	0.2	0.5	1.5	131.5	0.0	9.2	0.0	0.0	0.1	0.0	46.9	0.0	104.7	0.1	0.4	1.8	0.0	61.5	10.5	0.0	0.0	0.6	0.0	0.2	0.0	0.6	30.4	444.9	0.1	3.3	5.9	0.1	0.0	28.9	0.0	124.3	3.1	1.6	0.0	1.0	0.0	0.2	0.0	1.0	18.5	0.0	0.1	2.6	0.0	0.5	0.3	395.1	0.0	0.4	0.0	0.2	0.5	39.2	17.9	0.2	0.4	0.0	3.6	0.1	0.2	0.1
FTO	"ALKBH9, KIAA1752, MGC5149"	ENSG00000140718	"FTO alpha-ketoglutarate dependent dioxygenase"	Q9C0B1	16	53701692-54158512	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.3;Excitatory neurons: 226.1;Inhibitory neurons: 240.7;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 282.5;Respiratory ciliated cells: 182.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017123, HPA041086, HPA068695"	Enhanced		Supported	Vesicles,Cytosol		No	No		540000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Vesicles	"CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117"	"unprognostic (9.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.11e-3)"	24.4	33.6	31.8	12.5	36.6	8.2	36.3	30.1	37.7	25.8	31.0	22.2	7.7	26.9	21.4	17.2	25.3	21.6	27.1	35.2	39.5	25.0	17.4	36.8	15.0	29.2	31.3	27.2	20.7	40.6	26.2	20.1	31.9	20.0	14.1	38.4	18.9	23.9	33.1	21.4	12.5	29.9	30.5	16.4	15.0	8.3	33.8	17.0	27.5	23.0	14.8	21.9	18.5	43.9	15.1	26.8	35.0	35.9	67.3	50.4	11.5	35.6	32.2	29.3	8.5	16.8	19.3	34.4	38.2	46.3	16.6	21.7	32.4	34.9	42.5	16.0	25.5	15.5	33.6	31.7	46.2	12.5	17.1	55.9	36.5	26.6	32.5	36.6	44.1	25.1	15.2	8.4	48.1	11.8	28.0	19.2	18.1	15.5	17.5	42.2	52.9	32.3	44.6	12.3	43.0	29.7	40.4	23.6	10.8	33.7	31.1	29.3	42.4	36.4	23.9	19.8	22.1	15.9	13.9	35.0	33.9	22.9	28.7	14.9	17.9	9.7	25.6	22.7	32.4	17.6	24.4	25.9	23.8	17.4	22.5	24.4	2.9	26.4	16.5	9.5	26.6	23.1	31.8	36.6	30.1	37.7	35.2	39.5	29.2	31.3	31.9	30.5	33.8	43.9	15.1	80.1	62.0	173.3	10.3	12.4	10.0	8.6	13.6	22.8	69.1	39.5	22.3	15.7	54.4	7.3	12.5	9.3	10.2	4.8	7.9	9.0	39.1	11.0	18.3	17.4	6.6	9.7	226.1	5.7	7.4	23.1	9.7	9.9	25.9	16.8	11.0	13.8	9.2	16.8	240.7	6.6	10.2	9.0	13.2	69.9	14.3	11.8	10.6	134.0	5.5	19.6	10.3	210.6	282.5	5.5	5.0	15.1	18.7	6.0	4.5	15.8	182.7	14.1	13.1	21.6	16.8	3.5	3.4	11.0	9.1	5.1	12.9	17.8	6.3	7.9
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA 2'-O-methyltransferase 3"	Q8IY81	17	63819433-63830012	"Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA055544: AB_2682843, HPA062628: AB_2684813"	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.7	20.7	11.8	18.2	12.4	15.8	18.0	12.3	12.7	20.4	12.0	20.5	14.2	20.2	17.2	19.0	18.8	15.1	20.8	11.3	12.0	23.3	18.8	14.8	20.9	12.6	12.1	22.3	15.7	20.6	12.4	13.1	12.5	18.7	18.0	8.8	17.7	18.1	28.8	23.9	18.4	22.6	12.3	21.0	17.8	15.2	12.3	21.0	17.2	14.6	23.8	20.1	18.7	12.7	63.0	97.0	36.8	52.5	57.9	49.5	57.0	61.4	44.7	68.8	54.2	81.4	40.9	83.4	24.7	36.2	36.0	42.6	69.3	58.4	87.8	14.4	69.2	75.0	68.6	76.6	42.2	95.9	52.5	35.1	45.3	106.9	51.2	34.9	58.2	50.2	75.9	33.1	46.5	105.5	84.9	31.1	99.4	70.2	97.7	74.6	100.9	58.6	44.8	56.3	33.9	132.5	72.3	60.9	43.1	72.7	58.0	31.8	52.7	50.9	71.6	57.4	115.1	79.5	120.9	81.4	45.6	62.6	50.3	4.5	11.4	7.0	11.0	13.0	14.5	9.6	11.6	14.5	13.6	8.6	9.2	11.5	2.5	13.9	10.1	10.3	15.1	10.0	11.8	12.4	12.3	12.7	11.3	12.0	12.6	12.1	12.5	12.3	12.3	12.7	16.2	32.1	30.2	4.2	17.3	13.8	13.6	16.1	26.7	6.6	10.6	12.6	27.7	18.6	25.7	14.7	10.4	16.0	19.4	15.7	13.7	28.0	8.8	23.5	27.5	25.1	12.7	20.8	2.0	33.8	17.0	18.4	11.2	24.1	24.1	17.5	14.3	19.9	14.2	3.3	2.0	12.0	16.2	13.8	9.3	17.8	24.2	16.3	8.8	1.9	19.3	16.0	15.5	1.5	3.8	30.6	14.0	19.2	18.6	10.6	15.5	29.8	24.3	9.3	46.0	21.0	20.5	11.7	15.7	20.8	12.8	16.3	18.6	15.7	21.1	9.5
FUT4	"CD15, ELFT, FCT3A, FUC-TIV"	ENSG00000196371	"Fucosyltransferase 4"	P22083	11	94543840-94549898	"Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 100.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 22.8;Ductal cells: 19.3;Gastric mucus-secreting cells: 21.9;Intestinal goblet cells: 23.7;Pancreatic endocrine cells: 22.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 11.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 37.4;NB-4: 24.2;THP-1: 46.6;U-937: 32.9"	"Low region specificity"	"Detected in single"							"CAB000014, CAB016129"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles		"CAB000014: , CAB016129: AB_626918"	"unprognostic (6.36e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (7.26e-2)"	"unprognostic (4.14e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.10e-3)"	3.7	1.2	1.3	4.7	1.1	100.8	2.5	1.2	1.4	2.3	0.2	9.2	12.3	2.8	1.2	1.8	2.1	3.7	1.7	1.6	1.1	1.9	1.5	2.1	3.7	1.3	1.0	2.9	6.7	0.5	1.3	3.1	1.3	1.6	8.7	1.6	6.8	2.2	0.9	0.8	10.8	2.5	1.6	3.6	10.8	1.3	1.4	3.7	1.2	1.1	2.8	2.1	1.3	1.9	2.9	1.4	1.7	0.0	5.3	4.8	8.9	2.6	1.3	2.3	2.5	12.5	4.0	0.0	6.1	4.4	1.2	1.4	2.9	0.3	2.1	19.1	2.9	9.4	2.2	0.3	2.7	37.4	8.0	4.1	0.1	2.9	0.0	0.5	3.6	8.3	9.7	0.0	2.7	1.4	7.9	24.2	3.4	11.6	3.4	6.9	0.0	0.0	2.4	1.9	2.4	0.9	1.5	3.7	1.5	5.1	2.1	46.6	3.3	1.8	4.9	0.0	1.0	1.1	0.6	0.0	1.6	32.9	1.1	0.5	0.8	0.7	0.2	0.4	0.1	0.1	0.2	0.3	0.4	0.1	0.2	0.1	0.3	0.2	1.2	0.5	0.5	0.2	1.3	1.1	1.2	1.4	1.6	1.1	1.3	1.0	1.3	1.6	1.4	1.9	2.9	0.0	0.0	1.3	1.8	1.7	3.0	0.9	1.2	1.0	1.8	1.8	0.9	22.8	1.9	1.8	4.2	15.6	2.6	12.1	0.0	19.3	0.3	1.1	2.8	2.3	10.2	3.4	1.5	17.9	3.2	6.0	21.9	3.3	0.0	2.6	3.9	1.0	9.0	0.0	1.9	23.7	0.0	12.9	3.5	0.8	4.4	5.2	3.6	3.7	13.6	0.4	0.0	3.0	3.4	22.5	5.8	1.2	0.5	2.9	11.6	2.4	1.7	7.9	0.0	3.1	2.6	1.7	3.5	2.1	0.6	2.2	3.1	2.0	17.9	1.4
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830408-5839722	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.4;kidney: 36.1;salivary gland: 45.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"Hep G2: 10.5;RPMI-8226: 4.0"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		51000	"Cluster 10: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favorable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.1	0.0	0.1	2.6	0.1	0.4	1.7	0.2	0.1	17.3	0.4	17.3	28.6	0.3	0.0	79.4	0.6	9.3	0.0	0.1	0.1	36.1	12.4	0.2	0.1	0.1	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.2	11.6	2.0	45.7	2.5	0.0	0.1	27.0	0.4	0.1	0.1	4.8	0.2	0.1	0.0	0.0	0.0	6.7	0.0	26.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.2	10.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.7	4.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.5	0.0	0.7	0.0	0.4	3.5	0.0	0.4	3.7	1.9	0.3	18.6	15.7	1.8	0.0	0.2	0.3	35.6	3.9	6.8	0.3	0.6	0.7	0.3	4.9	0.0	0.1	0.4	0.1	0.3	0.0	0.7	0.0	0.2	0.7	5.1	0.1	0.0	0.1	39.4	8.2	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.5	0.1	2.7	21.5	0.0	0.0	0.2	101.4	45.3	6.4	11.5	0.0	0.3	0.7	1.0	0.6	3.6	0.1	0.0	0.5	0.1	29.0	1.7
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015974-96215612	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 18.9;stomach 1: 23.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	0.0	0.4	10.5	0.0	12.6	0.0	0.6	14.5	11.7	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	11.8	13.6	0.2	0.0	0.0	0.0	3.4	18.9	0.0	4.8	0.0	0.4	0.4	3.2	0.2	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	5.5	0.0	23.2	0.0	15.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	6.5	6.3	0.1	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	12.6	14.5	11.7	11.8	13.6	3.4	18.9	3.2	5.5	15.3	6.4	0.0	0.0	0.0	776.4	0.2	0.0	0.6	0.0	0.0	4.2	1.4	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.1	1.3	0.0	0.0	333.5	2.0	0.0	0.1	56.1	1.4	0.0	0.4	0.0	0.0	0.1	0.0	238.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.2	0.0	168.9	224.7	0.5	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2
FUZ	"CPLANE3, FLJ22688, Fy"	ENSG00000010361	"Fuzzy planar cell polarity protein"	Q9BT04	19	49806866-49817376	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 78.7"	"Group enriched"	"Detected in many"	18	"Early spermatids: 1243.5;Late spermatids: 2329.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041779, HPA042196"	Approved		Approved	Cytosol		No	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041779: AB_10793974, HPA042196: AB_10797383"	"unprognostic (2.40e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.70e-1)"	9.3	17.6	17.3	2.8	21.0	6.2	9.3	18.8	20.8	11.2	19.7	12.1	4.2	11.1	7.3	6.8	19.5	5.2	13.6	16.4	16.8	16.8	7.1	7.7	4.6	19.9	19.1	15.4	12.3	7.1	12.5	4.0	18.2	11.2	1.9	4.9	7.5	7.3	20.4	6.6	6.9	4.1	19.5	8.8	10.2	78.7	18.7	6.0	11.5	12.4	2.2	9.0	8.2	20.4	0.1	10.6	9.5	12.2	8.9	9.5	2.7	5.2	5.4	7.9	11.0	0.9	17.2	3.1	10.6	4.9	2.5	4.3	2.7	9.2	3.5	11.7	20.5	13.0	7.6	0.0	10.1	7.6	7.0	10.1	6.3	16.1	4.0	6.2	7.5	18.6	3.0	8.7	4.1	0.5	14.1	15.4	15.7	8.4	6.3	24.4	7.7	7.4	9.7	2.7	26.5	31.0	1.0	10.8	17.9	3.7	6.2	4.7	3.7	6.6	5.9	1.9	1.9	24.9	26.5	8.4	7.6	0.2	8.4	7.0	4.6	17.7	4.9	2.2	4.1	5.3	3.1	4.2	3.8	6.0	3.8	4.3	10.6	3.8	1.6	15.0	3.8	2.6	17.3	21.0	18.8	20.8	16.4	16.8	19.9	19.1	18.2	19.5	18.7	20.4	9.2	0.0	2.8	6.2	8.4	3.8	19.3	10.1	8.6	7.2	14.5	14.6	3.9	17.2	7.3	7.3	4.2	17.5	12.2	1.9	66.5	15.3	1243.5	61.6	8.0	6.5	2.4	19.3	2.7	5.1	12.1	11.1	6.1	8.1	10.2	11.5	13.6	5.8	13.2	10.1	3.0	3.5	12.2	7.1	7.6	2329.6	27.7	6.7	0.0	2.8	7.9	26.1	5.2	2.0	9.9	4.5	6.1	17.7	10.9	8.0	7.3	86.1	35.4	11.3	0.0	17.1	9.9	95.3	13.5	5.0	4.1	12.0	6.4	13.7	5.5	14.1
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035751-69079076	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	10.3	20.1	8.9	7.8	9.2	29.1	10.1	9.7	8.9	9.3	11.7	10.4	7.4	12.1	12.1	9.5	10.2	5.3	27.0	9.0	10.4	12.9	46.3	7.1	9.8	9.8	10.2	17.6	15.1	22.2	8.1	9.1	9.8	10.2	12.3	4.1	11.7	13.6	25.5	5.2	7.7	13.3	9.5	12.6	10.1	10.7	9.9	5.4	10.4	19.8	10.4	12.3	7.9	10.4	27.0	22.1	34.2	17.0	15.7	23.1	34.3	18.6	16.3	28.0	21.2	11.8	16.6	45.9	14.0	19.5	28.8	28.6	41.8	42.6	34.9	53.9	47.5	66.2	14.1	87.2	26.7	48.7	27.7	25.7	33.7	27.8	29.9	9.6	37.7	28.0	50.3	43.9	26.1	25.6	14.0	21.0	47.5	53.1	42.8	32.7	24.0	32.0	32.2	21.5	26.9	12.1	19.2	12.5	20.7	24.3	14.1	14.4	22.7	18.0	32.0	24.1	27.6	11.6	11.4	27.8	8.5	39.7	18.5	8.1	39.9	0.4	48.6	45.4	37.5	36.3	48.0	48.4	42.8	22.7	61.6	59.8	1.9	60.8	36.2	33.2	43.3	49.5	8.9	9.2	9.7	8.9	9.0	10.4	9.8	10.2	9.8	9.5	9.9	10.4	11.0	3.2	11.5	13.1	19.9	9.7	19.8	36.6	14.8	6.8	16.9	20.8	38.2	10.0	10.5	14.7	4.2	39.9	14.9	4.9	21.5	17.5	2.4	11.7	22.5	16.9	7.2	56.1	14.2	14.7	22.3	14.7	14.3	8.7	7.0	15.4	11.0	69.0	33.4	0.0	18.6	15.3	18.3	22.1	16.1	6.3	15.8	13.9	17.8	9.4	18.3	7.6	28.8	6.6	10.8	15.0	3.7	13.2	42.0	17.1	5.8	27.2	7.4	1.6	13.1	10.1	19.8	5.1	32.3	29.8	8.1	14.6	17.1	27.9	17.5	14.1
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 382.6;dendritic cells: 291.6;NK-cells: 228.6;Oligodendrocyte precursor cells: 342.8;Proximal tubular cells: 212.2;T-cells: 275.8"	"Cancer enhanced"	"Detected in all"		"glioma: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	16	"NK-cells: 69.0;T-cells: 174.8"	"Cell line enhanced"	"Detected in many"		"U-2197: 538.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		820000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	76.6	10.8	117.1	52.4	106.4	32.3	46.8	83.8	104.3	45.5	33.3	32.9	16.4	45.6	33.8	16.0	51.4	32.1	40.5	102.1	121.5	23.9	20.4	63.5	108.9	136.3	104.9	28.8	8.5	18.7	22.9	29.7	107.0	17.6	15.6	26.9	12.9	12.5	12.3	41.5	47.1	38.0	109.9	71.9	29.3	16.5	105.7	86.1	45.7	18.3	67.6	48.4	33.4	109.8	10.4	1.5	178.6	30.2	133.4	81.4	3.2	29.1	90.8	24.2	42.9	1.3	1.6	21.0	18.3	56.1	21.0	1.3	25.8	39.9	46.8	0.7	66.5	57.0	13.6	2.7	78.7	19.5	19.0	78.8	59.1	90.5	76.8	62.9	99.5	99.6	4.9	140.3	86.8	1.5	92.7	17.9	26.0	3.3	18.0	29.1	24.0	1.4	0.0	9.1	124.6	50.7	5.7	2.4	124.7	39.6	1.3	57.0	63.9	72.3	13.5	538.7	18.5	20.0	19.7	32.5	136.0	44.3	128.9	1.1	6.4	0.2	137.0	5.6	174.8	4.8	83.9	152.7	7.4	6.4	27.9	72.3	3.0	69.0	4.2	4.3	79.2	51.5	117.1	106.4	83.8	104.3	102.1	121.5	136.3	104.9	107.0	109.9	105.7	109.8	87.8	0.0	8.3	382.6	26.0	17.1	2.5	0.6	1.8	57.2	2.9	6.9	11.3	14.3	2.1	7.3	0.0	2.7	291.6	1.2	17.6	9.3	3.7	5.6	51.7	70.3	13.2	20.9	118.7	1.0	2.4	61.9	17.9	4.9	52.0	20.9	76.4	60.3	3.0	47.1	127.6	3.8	2.0	35.8	96.1	3.2	26.4	42.7	37.4	88.1	64.5	89.1	228.6	342.8	162.3	9.7	0.1	7.2	96.2	3.9	17.7	212.2	4.4	8.3	13.1	48.8	32.9	3.9	8.6	0.7	13.4	52.0	275.8	71.1	2.9	1.1
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA067052: AB_2685771"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	56.7	97.2	64.8	22.5	67.8	16.0	55.6	70.5	79.3	47.6	88.8	42.1	28.7	55.4	63.9	37.1	45.6	23.9	61.9	65.3	77.5	75.2	26.4	42.9	19.3	74.9	86.9	44.3	56.5	66.7	95.1	25.8	96.1	59.5	18.2	17.1	48.7	40.6	54.3	26.8	39.6	23.0	67.9	45.2	51.4	55.1	72.7	15.2	71.1	26.4	12.0	48.7	37.7	72.4	40.0	231.7	73.7	128.5	77.9	58.3	55.3	45.0	86.9	96.2	64.4	97.1	62.3	88.9	62.8	95.1	65.4	67.4	53.5	92.1	44.5	46.4	86.0	49.3	142.5	182.4	84.1	46.1	59.8	77.3	44.3	93.1	62.3	59.6	79.3	35.9	51.5	109.6	72.5	112.1	22.4	71.4	99.3	48.7	133.5	45.6	48.4	207.5	137.6	93.6	92.7	83.0	49.1	57.4	59.3	82.9	158.6	45.1	87.6	98.8	53.1	26.8	63.5	74.0	56.2	26.1	110.3	38.2	128.9	3.0	33.1	7.9	9.9	43.4	12.1	12.1	8.0	9.1	54.2	13.9	9.7	12.9	1.4	17.5	26.3	74.5	8.5	16.9	64.8	67.8	70.5	79.3	65.3	77.5	74.9	86.9	96.1	67.9	72.7	72.4	22.3	3.2	12.9	5.2	10.4	2.5	17.3	31.8	8.0	10.5	20.7	21.5	6.4	21.5	25.2	40.5	12.5	64.3	17.1	12.4	13.7	59.3	5.0	18.9	22.1	26.0	22.9	9.7	2.8	49.4	41.1	25.0	16.8	20.1	18.3	20.2	18.5	7.1	58.7	5.0	4.5	14.1	24.4	21.6	12.2	6.2	20.2	20.9	14.2	0.0	21.8	30.7	10.3	8.0	5.5	33.6	13.6	23.0	27.2	19.5	20.5	36.0	24.6	8.3	13.1	15.3	21.4	31.5	26.7	14.3	2.6	42.5	7.0	43.9	19.7	17.2
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 412.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 412.7"	"Cell line enhanced"	"Detected in all"		"A549: 2333.8;MCF7: 883.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		No	No		2400000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	40.7	39.1	19.9	30.2	21.8	105.9	31.9	20.5	28.3	20.6	20.0	13.9	13.1	21.6	13.3	54.3	19.3	46.5	14.3	21.3	22.7	12.7	6.5	29.4	28.9	25.4	22.2	24.1	13.0	9.6	27.5	13.7	24.5	12.2	13.1	26.1	21.2	14.4	4.2	21.3	12.4	25.6	19.7	26.9	18.1	54.0	26.1	26.2	45.9	5.1	37.2	33.8	22.4	21.9	168.5	2333.8	49.7	189.7	207.2	281.7	43.5	116.0	341.7	120.0	205.8	111.2	61.9	110.9	174.1	274.3	475.9	146.3	79.3	202.5	60.3	111.4	55.0	116.8	517.2	244.6	401.6	117.8	373.5	136.6	58.5	233.9	49.8	185.6	252.5	79.8	69.6	46.3	218.4	883.9	77.5	93.0	35.3	549.5	172.2	74.9	28.4	120.5	357.1	210.9	49.6	62.0	115.9	444.5	99.9	65.0	67.1	99.4	289.8	73.1	250.0	102.5	181.8	58.2	80.0	189.8	200.6	77.5	150.9	166.1	84.9	412.7	50.3	72.1	32.1	16.0	13.7	36.7	40.1	17.0	16.5	28.2	137.4	69.3	63.5	18.9	18.7	72.8	19.9	21.8	20.5	28.3	21.3	22.7	25.4	22.2	24.5	19.7	26.1	21.9	7.9	0.0	17.0	4.6	21.5	12.5	24.3	46.6	8.6	6.2	14.6	8.6	1.1	14.3	22.9	11.0	18.8	29.6	58.9	25.5	29.4	39.3	10.3	7.7	13.7	13.2	9.5	37.7	2.9	29.3	41.2	19.6	23.4	10.7	37.5	26.1	18.2	1.6	45.6	33.7	2.3	11.5	24.4	58.2	26.0	20.8	26.1	56.6	19.6	5.6	112.3	13.6	83.4	3.5	3.7	31.0	11.4	16.1	21.6	23.9	18.5	18.3	10.9	32.5	6.6	7.5	23.6	10.9	32.8	34.4	13.8	36.3	33.8	11.6	13.5	30.5
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor subunit alpha1"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 55.1;retina: 17.8"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 198.0;Excitatory neurons: 220.5;Inhibitory neurons: 215.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA029363, HPA055746"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"CAB022502: , HPA029363: , HPA055746: AB_2682904"					"unprognostic (2.58e-2)"						"unprognostic (4.78e-3)"	"unprognostic (1.84e-1)"		"unprognostic (3.31e-1)"		"unprognostic (2.43e-1)"		0.0	1.2	6.7	0.0	11.1	0.0	0.0	24.8	55.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	14.3	0.6	0.0	0.0	0.2	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	11.1	24.8	55.1	7.7	21.7	0.0	0.0	0.0	0.0	14.3	24.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	198.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	220.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	215.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	17.8	0.0	3.5	0.0	8.0	16.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor subunit alpha2"	P47869	4	46243548-46475230	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.5;epididymis: 8.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 425.4;Excitatory neurons: 156.2;Inhibitory neurons: 111.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6;glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"U-2 OS: 4.2;U-87 MG: 2.1;WM-115: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029363, CAB079061"		Supported	Uncertain	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"CAB079061: , HPA029363: "	"unprognostic (2.03e-2)"		"unprognostic (2.77e-1)"	"unprognostic (2.45e-4)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	1.2	0.3	20.2	0.4	29.9	0.2	1.3	2.6	31.5	0.5	0.0	3.0	0.9	0.4	8.8	0.7	0.0	0.5	0.2	29.4	16.0	6.3	0.4	0.1	0.3	0.3	1.9	0.7	0.1	0.0	0.5	0.4	0.0	0.1	2.1	2.4	0.2	0.7	0.1	0.2	6.0	0.2	1.3	1.2	0.5	0.5	13.8	0.4	0.1	0.1	0.4	0.2	0.7	8.8	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	4.2	0.2	0.0	0.2	0.6	0.0	2.1	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	29.9	2.6	31.5	29.4	16.0	0.3	1.9	0.0	1.3	13.8	8.8	4.9	0.0	0.0	425.4	0.0	0.1	0.0	0.0	1.2	15.3	0.2	0.0	0.6	0.0	0.0	40.5	4.2	0.0	0.0	23.1	3.9	0.0	9.1	1.2	31.7	1.0	31.8	0.0	156.2	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	111.6	3.4	0.0	0.0	0.0	17.1	0.6	0.1	1.8	16.9	0.0	0.2	0.0	13.0	5.5	0.0	4.7	0.0	0.0	0.0	38.1	0.1	0.0	1.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.0	2.7	0.0
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor subunit alpha3"	P34903	X	152166234-152451315	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.5;choroid plexus: 16.3;retina: 9.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 70.3;Hofbauer cells: 16.2;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;HMC-1: 8.4;Karpas-707: 14.4;PC-3: 8.4;U-266/70: 7.7;U-266/84: 13.6;U-87 MG: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.0	0.0	10.0	0.0	13.7	0.0	0.0	0.0	13.2	0.9	16.3	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	9.6	15.5	0.0	0.0	0.0	0.0	0.9	4.0	0.0	0.0	0.0	0.6	2.9	3.0	0.1	0.0	9.0	0.1	0.6	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.7	11.2	0.0	0.0	0.0	0.1	0.4	0.2	2.7	0.0	0.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	14.4	0.0	0.0	0.0	0.0	2.6	6.4	8.4	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	5.3	0.4	0.3	0.1	1.3	0.1	5.3	7.0	0.3	1.6	7.7	13.6	0.0	8.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.7	0.0	13.2	9.6	15.5	0.9	4.0	3.0	0.6	11.2	2.7	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	2.1	3.2	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.0	0.0	70.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	1.7	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	3.0	0.0	58.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	1.2	0.9	0.0	1.9	0.0	0.0	0.0	0.5
GABRA5		ENSG00000186297	"Gamma-aminobutyric acid type A receptor subunit alpha5"	P31644	15	26866911-26949208	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 111.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 27.6;Inhibitory neurons: 14.1"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Group enriched"	"Detected in many"	4	"amygdala: 52.0;basal ganglia: 73.5;cerebral cortex: 98.6;hippocampal formation: 111.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A549: 35.3;HAP1: 12.0;NTERA-2: 16.2;U-2 OS: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029363, HPA077031, CAB079022"		Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"CAB079022: , HPA029363: , HPA077031: AB_2686825"	"unprognostic (6.33e-2)"			"unprognostic (8.94e-3)"	"unprognostic (1.04e-1)"			"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.57e-1)"		"unprognostic (7.63e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	52.0	0.1	73.5	0.0	0.0	0.0	98.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.5	111.0	7.2	0.1	0.1	0.0	0.0	0.0	3.0	0.0	0.1	0.7	0.5	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.7	12.0	9.0	0.1	0.1	0.3	0.0	0.0	19.6	0.0	35.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	12.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.1	0.2	1.8	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	73.5	0.0	98.6	111.0	7.2	0.0	3.0	0.0	0.0	12.0	19.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.8	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GADD45GIP1	"CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6"	ENSG00000179271	"GADD45G interacting protein 1"	Q8TAE8	19	12953119-12957223	"Predicted intracellular proteins, Ribosomal proteins"	"Cell cycle, Host-virus interaction"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055205, HPA065048, HPA071910"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: "	"unprognostic (5.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-1)"	32.0	46.3	28.9	14.0	28.8	20.6	29.9	28.7	41.3	32.0	27.2	39.0	12.4	34.4	7.7	41.8	30.7	7.5	75.7	28.4	31.0	42.0	52.2	25.2	13.5	31.1	33.1	28.7	39.0	11.6	34.6	11.0	30.6	37.1	4.8	7.4	28.9	9.5	80.1	31.4	25.4	6.8	28.5	32.5	33.1	22.7	30.4	8.8	30.9	23.1	6.5	36.3	28.4	29.9	68.7	56.9	23.5	33.2	16.1	20.8	32.7	49.4	24.5	48.2	39.5	79.1	27.1	49.1	79.8	29.8	34.7	47.0	28.9	48.2	12.4	32.1	140.5	34.9	78.6	90.2	39.2	58.2	51.3	24.7	38.4	33.6	27.5	25.7	28.3	46.1	53.6	18.8	30.3	100.6	93.2	122.8	65.0	44.0	176.7	68.1	23.7	79.2	38.1	39.9	71.9	65.7	36.8	49.3	60.4	11.6	38.4	54.7	46.4	93.0	32.9	81.7	92.3	73.4	55.1	52.0	64.5	72.7	54.8	13.4	35.6	12.6	33.3	34.6	33.1	102.5	51.3	53.1	43.6	84.1	55.1	40.0	2.1	39.9	29.9	41.4	46.9	29.5	28.9	28.8	28.7	41.3	28.4	31.0	31.1	33.1	30.6	28.5	30.4	29.9	111.9	41.7	51.6	6.5	132.4	145.4	189.2	198.9	83.6	59.9	127.0	141.1	157.0	114.4	123.4	138.0	22.9	321.9	101.5	232.1	401.1	265.8	41.8	166.8	139.9	151.8	139.1	159.3	6.1	381.7	355.8	138.3	88.2	130.6	73.6	158.1	146.7	288.8	245.5	37.0	8.1	205.7	101.7	132.9	228.9	56.0	191.3	106.0	179.7	8.4	253.1	103.9	95.8	7.1	14.7	311.5	138.3	170.4	142.4	247.0	215.9	616.7	160.6	88.8	190.7	141.0	164.4	85.4	129.4	153.3	160.8	204.3	105.6	235.8	258.9	171.0
GALNT14	"FLJ12691, GalNac-T10, GalNac-T14"	ENSG00000158089	"Polypeptide N-acetylgalactosaminyltransferase 14"	Q96FL9	2	30910467-31155202	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 21.6;Excitatory neurons: 29.1;Inhibitory neurons: 79.2;Proximal enterocytes: 21.9;Proximal tubular cells: 45.5"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	8	"neutrophil: 8.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"A549: 28.6;RPMI-8226: 32.3;RPTEC TERT1: 41.3;RT4: 35.3;SCLC-21H: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030138			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		27000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA030138: AB_2673332"	"unprognostic (5.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.51e-3)"	1.2	1.5	3.9	1.0	10.6	5.9	0.8	2.0	4.5	1.3	3.6	0.3	0.5	0.3	0.3	11.8	1.2	2.2	0.3	2.9	3.2	41.3	1.3	0.6	2.2	1.7	6.7	0.1	3.1	4.0	5.9	0.0	0.8	1.6	0.1	0.6	1.2	0.0	0.1	2.1	3.3	0.7	1.8	2.4	0.5	2.5	10.9	0.4	0.9	0.4	4.8	2.3	1.3	3.3	23.6	28.6	0.0	0.0	0.0	0.0	0.0	7.9	4.1	4.9	0.6	0.0	0.0	22.1	7.8	0.4	0.0	0.0	1.0	1.0	0.8	0.6	2.8	12.1	0.0	0.0	0.0	18.2	0.0	0.1	4.5	0.0	17.0	0.2	0.0	0.6	0.0	19.0	0.0	10.7	0.1	0.0	12.6	0.0	0.0	15.5	0.0	32.3	41.3	35.3	24.4	18.3	0.0	0.0	0.1	4.4	0.1	0.0	0.0	0.0	19.6	0.0	0.5	1.9	6.2	0.1	0.0	11.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	3.9	10.6	2.0	4.5	2.9	3.2	1.7	6.7	0.8	1.8	10.9	3.3	2.2	0.0	0.0	1.0	1.4	2.8	4.1	5.3	21.6	0.3	0.6	2.4	1.1	0.0	6.2	9.2	0.0	0.0	0.0	0.3	13.7	2.9	5.7	0.0	0.1	1.2	0.0	0.0	29.1	0.4	0.0	1.1	0.5	0.4	0.0	0.0	8.2	0.2	0.1	0.0	79.2	0.9	2.0	0.6	0.3	12.0	0.0	0.4	0.0	2.8	0.0	0.2	0.0	4.0	8.7	2.6	0.0	0.0	3.1	14.2	21.9	45.5	1.1	0.4	6.6	0.4	2.2	3.4	6.9	9.2	0.9	0.0	0.4	0.2	1.8	5.1
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257705-157318491	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.5;lung: 10.2;stomach 1: 12.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 157.0;Distal enterocytes: 48.3;Intestinal goblet cells: 75.5;Pancreatic endocrine cells: 53.5;Prostatic glandular cells: 40.1;Urothelial cells: 115.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 4.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 45.3;BJ: 29.8;BJ hTERT+: 53.5;fHDF/TERT166: 64.5;HaCaT: 51.8;K-562: 30.7;LHCN-M2: 52.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA		1300000		"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Cytosol"	"Nucleoli, Vesicles"	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.1	0.0	0.0	0.7	0.0	0.6	1.1	4.0	0.3	1.1	5.2	10.6	2.2	0.1	0.1	4.5	0.0	2.7	0.4	0.4	0.0	0.0	0.0	10.2	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.2	0.7	13.5	0.1	8.2	0.1	0.0	0.3	4.1	0.4	0.0	0.1	12.8	0.1	0.1	0.1	0.1	0.1	1.7	4.5	4.6	0.2	45.3	4.8	0.0	0.0	2.0	17.0	0.0	29.8	53.5	0.5	1.1	1.9	24.4	0.0	0.1	64.5	0.0	51.8	0.9	10.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	0.2	0.0	0.9	0.0	0.0	0.0	30.7	0.0	52.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	25.4	0.3	0.6	0.1	0.0	0.1	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.3	0.4	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.1	157.0	36.1	0.0	0.1	0.8	13.3	20.2	6.2	0.0	0.5	2.8	0.5	2.8	32.9	0.0	0.0	0.0	0.2	48.3	0.0	1.2	6.9	1.2	0.0	0.6	2.4	5.2	0.8	3.2	0.0	2.1	35.7	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	75.5	6.1	0.0	0.7	0.5	0.0	0.3	3.6	0.0	1.6	0.0	0.0	0.0	0.1	53.5	26.4	0.0	1.4	40.1	3.1	0.2	10.0	0.0	0.0	0.5	1.2	2.6	0.5	4.5	0.1	0.0	0.3	0.0	22.7	115.1
GAP43	"B-50, GAP-43, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623510-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 277.0"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 270.2"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	0.6	6.3	131.6	7.5	149.2	0.0	0.9	36.3	277.0	0.6	0.0	10.5	2.5	0.2	0.1	1.1	0.2	4.7	4.3	149.9	187.2	0.2	0.2	0.3	0.2	55.6	156.5	0.2	0.8	0.0	10.0	1.7	113.3	0.9	4.8	8.0	2.1	0.3	0.3	0.5	5.5	4.3	28.5	0.0	2.9	0.4	150.7	0.1	0.2	0.6	0.4	1.3	1.9	121.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.5	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	39.6	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	18.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	131.6	149.2	36.3	277.0	149.9	187.2	55.6	156.5	113.3	28.5	150.7	121.0	0.1	0.0	0.0	20.9	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.8	5.1	0.0	0.0	270.2	0.0	0.1	4.5	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	62.5	0.0	0.0	0.0	1.2	1.8	0.0	0.0	1.8	29.0	0.0	1.4	0.0	40.2	20.2	0.8	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.5	0.0	2.0	1.1	0.9	1.7	0.0	0.1	0.0	0.1	0.3	0.0	0.0
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6534512-6538374	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Immunity, Innate immunity, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 27580.7;tongue: 18892.5"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 10357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"CAB005197, CAB016392, HPA040067, HPA061280, CAB079968"	Supported		Enhanced	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		1400000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, CAB079968: , HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	1219.9	1815.8	2605.9	1191.3	2589.5	4608.5	1042.3	2869.0	3067.8	1163.8	2419.2	1720.0	1480.8	1080.9	769.9	2973.8	1042.8	1161.3	5572.8	2630.1	2880.0	2323.2	2557.9	1137.9	1388.3	2845.2	2861.3	1087.0	652.0	1616.0	1338.7	1190.6	2828.4	1241.0	1586.6	2386.8	1835.8	1238.7	27580.7	1775.5	1457.5	1424.4	2670.8	1208.5	1215.5	693.0	2985.1	1570.9	1022.1	18892.5	1861.0	1889.0	1672.9	2741.6	6063.0	10247.9	3109.5	4709.2	3026.2	5018.7	6516.0	4716.2	7218.1	7172.8	7491.2	7211.3	4091.6	7540.8	878.2	5947.4	4904.2	3359.8	3372.7	10829.1	5432.4	6263.1	3229.5	4224.9	5857.5	6279.2	3890.9	6710.2	3046.1	4089.0	3521.7	6553.0	7609.7	15565.8	7762.7	5052.4	2215.9	1484.1	8670.0	11849.8	7303.1	3247.3	10995.7	7254.7	3950.7	5849.8	5505.7	3512.8	7909.6	7115.9	2088.3	3331.0	4243.1	10206.4	5984.0	8874.7	1657.2	4311.2	4794.3	5049.0	5907.2	2717.1	7931.5	3178.4	2544.6	9374.4	10632.2	4050.5	8040.5	2575.4	4295.8	737.9	1325.8	2011.2	1171.4	1046.9	1364.8	1333.1	3253.6	652.5	757.6	886.9	1981.4	1227.8	1900.6	474.6	2126.1	6812.0	2605.9	2589.5	2869.0	3067.8	2630.1	2880.0	2845.2	2861.3	2828.4	2670.8	2985.1	2741.6	1036.7	237.2	259.5	228.2	1086.9	1818.8	2223.4	7367.5	4070.9	1157.6	1794.6	3689.2	40.4	1263.9	2213.7	1022.5	417.0	4237.7	1032.7	2579.6	3463.0	5198.9	759.8	770.1	702.4	1597.4	1324.3	1180.6	112.1	3794.5	10357.8	1127.1	1068.8	1021.8	562.3	2063.7	1242.9	1742.3	3895.3	2348.7	145.8	2351.2	2543.1	2586.7	2494.4	2257.7	889.4	2134.0	4220.8	86.2	3422.3	6177.9	1045.4	98.5	196.2	5681.8	3001.4	1026.9	2668.2	1714.0	5714.0	7286.7	864.3	1435.2	1150.4	1744.7	2827.8	429.9	476.2	3605.2	1600.7	4694.0	1514.9	1839.0	3140.9	2882.4
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533455-35545319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"testis: 269.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 8717.5"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		7500000	"Cluster 52: Eosinophils - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	1.2	2.7	0.4	4.1	1.3	2.4	0.2	1.2	1.3	0.0	0.1	0.6	3.3	2.7	0.0	3.0	1.9	3.6	4.0	0.2	0.5	0.9	0.3	1.9	6.5	0.3	0.4	3.4	5.2	0.0	0.1	1.1	0.4	2.0	0.0	3.5	5.1	0.0	1.6	13.9	3.2	0.0	0.1	5.2	2.4	269.8	0.8	0.0	11.4	0.0	0.0	1.5	0.1	1.5	6.5	22.4	6.4	9.6	0.0	0.0	5.4	1.9	0.0	0.0	0.0	13.8	10.4	10.7	2.9	0.0	2.6	7.6	0.0	0.0	0.0	10.5	11.2	7.1	16.7	7.1	0.1	6.4	8.3	0.0	0.0	0.0	0.0	3.9	0.0	10.3	17.6	6.0	0.0	19.6	2.5	3.0	8.6	4.1	3.1	7.6	4.3	8.3	0.0	6.1	11.3	5.1	2.4	5.7	7.0	4.3	4.8	2.7	2.1	7.2	7.9	1.8	2.7	16.9	4.8	6.2	3.9	11.4	2.6	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.4	1.3	1.2	1.3	0.2	0.5	0.3	0.4	0.4	0.1	0.8	1.5	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1915.7	0.0	0.0	1.6	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.4	8717.5	24.8	2.4	44.4	0.0	0.2	0.0	0.0	1.0	0.5	0.0	0.0	28.6	0.0	0.0	0.0	0.1	0.0	0.0	26.3	0.0	0.1	33.4	18.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.1;Excitatory neurons: 178.4;Inhibitory neurons: 184.7;Microglial cells: 48.7;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 165.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 5.3;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	3.1	6.0	5.7	0.3	5.7	0.0	4.4	11.6	6.0	6.0	2.0	2.9	1.8	7.4	5.2	4.4	5.4	3.7	11.3	6.9	5.2	2.1	1.8	2.4	1.3	4.7	4.5	4.5	2.1	6.6	2.0	1.4	5.8	6.2	1.9	1.3	5.0	4.0	1.5	2.8	1.8	6.7	4.6	1.8	1.8	2.9	4.2	0.6	5.7	1.8	1.3	4.6	3.3	11.2	0.5	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	1.0	1.2	0.3	0.0	1.0	0.1	0.4	0.6	1.8	0.0	0.1	0.0	0.8	0.0	1.9	1.2	0.4	0.4	0.1	0.1	1.5	0.0	0.0	1.5	0.7	1.9	0.8	0.7	0.1	0.5	0.0	0.3	0.4	5.3	1.6	0.1	1.1	3.4	1.9	2.5	1.2	3.9	0.8	2.7	0.4	0.6	0.9	0.0	0.0	0.2	1.0	0.0	0.4	2.3	2.4	1.0	0.4	0.5	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	5.7	5.7	11.6	6.0	6.9	5.2	4.7	4.5	5.8	4.6	4.2	11.2	1.3	0.0	0.0	77.1	0.5	2.7	1.7	0.4	2.8	8.0	3.1	4.3	6.8	4.3	2.0	3.7	0.0	0.6	0.2	0.9	1.9	0.3	2.2	1.0	21.1	1.5	1.2	0.4	178.4	0.6	0.1	4.8	5.6	1.2	0.0	2.4	1.8	2.5	0.8	1.7	184.7	0.8	0.0	1.3	1.9	1.0	7.5	1.3	1.8	48.7	0.0	4.0	0.0	45.2	165.3	0.4	1.6	3.4	0.5	3.3	0.6	1.8	0.1	1.0	0.0	7.1	4.0	3.5	3.9	2.7	2.0	0.3	0.7	1.0	0.8	1.2
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol		NA	NA		300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (5.05e-5)"	"prognostic unfavorable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.1	20.3	9.2	24.2	12.2	18.8	24.3	11.3	11.9	16.4	10.1	23.2	22.1	18.3	17.1	24.8	21.8	15.9	20.7	8.6	10.5	21.0	29.7	16.0	30.3	11.0	10.3	19.0	22.3	19.9	12.8	26.1	11.7	17.0	29.1	20.9	16.8	16.7	29.1	17.4	19.4	26.3	11.3	20.0	19.7	29.3	10.9	34.4	20.8	21.9	38.6	32.2	16.5	14.0	132.2	61.5	90.3	98.8	61.1	64.2	100.3	82.6	70.8	96.8	101.5	117.7	108.9	174.8	48.5	55.6	124.9	67.9	189.0	130.4	138.3	91.3	111.7	265.2	68.5	78.6	85.2	148.6	66.3	57.3	86.5	113.3	162.5	48.1	91.5	138.4	312.4	108.5	84.9	63.6	158.2	100.0	194.4	186.3	71.8	131.1	166.6	246.7	74.7	69.4	93.1	84.1	116.9	89.1	107.1	81.0	113.0	93.9	68.7	64.9	76.9	56.1	90.9	106.8	159.6	193.0	67.1	171.3	96.2	9.0	24.0	16.3	25.9	33.9	31.4	29.7	25.2	27.1	31.6	24.5	26.4	26.2	10.6	43.9	30.6	23.2	34.1	22.8	9.2	12.2	11.3	11.9	8.6	10.5	11.0	10.3	11.7	11.3	10.9	14.0	21.1	19.2	19.8	17.3	30.1	46.0	50.3	34.1	38.1	18.5	18.6	17.3	19.3	11.5	28.0	14.7	35.5	41.2	21.8	12.4	23.5	28.4	21.7	23.3	36.9	21.9	13.1	40.3	19.1	24.2	37.4	27.2	21.4	23.4	7.6	31.8	16.1	18.0	23.6	5.0	21.1	17.1	22.4	17.0	12.0	6.6	17.4	17.0	12.4	10.3	19.8	13.3	22.6	17.6	19.3	31.5	12.7	18.0	22.7	54.3	16.4	14.3	17.8	28.5	13.1	23.0	23.9	57.2	27.6	34.4	45.9	25.6	21.2	55.0	24.1	46.6
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625509-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 39.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 39.8;Excitatory neurons: 114.9;Inhibitory neurons: 141.9;Oligodendrocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Hep G2: 43.2;JURKAT: 24.0;Karpas-707: 85.2;SCLC-21H: 24.8;U-266/84: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favorable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.4	0.8	2.1	0.3	1.9	0.1	0.8	4.5	5.4	0.9	0.0	0.7	1.8	0.8	0.0	0.7	1.2	1.6	3.5	0.7	2.2	5.4	39.7	1.0	1.0	6.2	7.5	2.0	9.6	0.1	2.5	0.4	6.3	1.0	0.4	2.2	1.5	0.6	4.6	0.8	1.6	0.3	3.3	1.3	2.6	0.8	6.1	8.2	0.8	1.8	0.7	1.0	0.7	6.1	0.0	0.1	1.7	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.7	0.4	0.2	0.0	43.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.3	0.0	24.0	1.6	85.2	0.0	0.4	0.3	0.1	0.3	2.4	0.0	0.9	0.5	4.4	0.0	1.1	24.8	1.3	0.0	0.0	0.5	0.2	0.1	0.0	1.8	0.0	0.4	1.1	0.0	1.1	30.7	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	1.9	4.5	5.4	0.7	2.2	6.2	7.5	6.3	3.3	6.1	6.1	0.1	0.0	0.0	39.8	0.4	0.1	0.4	0.1	0.6	1.9	0.4	0.1	12.7	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.3	1.3	0.1	0.4	0.0	0.0	114.9	3.3	0.0	1.0	3.1	0.7	0.0	0.2	0.7	22.9	0.0	0.0	141.9	0.6	0.0	0.0	0.0	5.4	0.6	0.0	0.0	9.4	0.2	0.2	0.0	18.6	83.9	1.6	1.4	0.0	0.5	0.1	0.1	3.2	4.0	1.2	0.0	0.3	0.8	0.4	1.1	0.6	0.0	0.0	0.4	0.1	0.9	0.3
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910606-10198606	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.6;Fibroblasts: 79.6;Inhibitory neurons: 76.6;Late spermatids: 73.4;Oligodendrocytes: 163.3"	"Group enriched"	"Detected in all"	4	"glioma: 15.7;melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 26.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 17.1;monocytes: 26.2"	"Cell line enriched"	"Detected in many"	9	"WM-115: 533.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: AB_2685319"	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (6.89e-4)"	27.3	8.5	34.9	23.7	68.9	31.1	15.3	75.4	79.8	29.9	0.0	26.3	7.3	13.3	4.3	23.8	17.8	16.3	46.1	61.9	8.4	1.7	2.3	17.1	9.1	23.4	24.1	7.8	3.4	1.1	2.6	16.2	15.8	8.5	12.0	30.1	7.8	10.8	5.8	33.7	11.9	24.0	14.3	16.1	8.9	17.4	32.9	9.3	4.6	6.8	10.3	18.3	19.5	85.3	0.1	0.5	0.6	1.0	16.5	22.5	0.3	0.8	0.0	2.6	1.1	0.1	0.2	6.6	1.9	6.6	0.3	0.3	0.0	0.0	1.6	0.0	1.5	0.0	1.3	0.7	5.3	1.8	48.7	4.3	0.3	5.1	0.1	0.0	0.0	42.7	0.0	0.6	0.0	0.0	54.3	15.4	2.6	2.1	0.0	14.3	0.1	49.6	0.0	0.2	0.1	3.0	0.2	0.2	60.1	21.0	2.8	24.7	0.0	0.2	3.4	0.1	0.1	0.4	0.0	0.0	0.4	35.1	533.8	0.6	26.2	17.1	2.8	6.9	0.9	0.5	0.3	1.4	5.3	0.6	0.2	1.4	16.4	4.5	4.9	1.0	0.0	7.7	34.9	68.9	75.4	79.8	61.9	8.4	23.4	24.1	15.8	14.3	32.9	85.3	2.9	0.0	4.2	6.8	3.3	8.3	4.5	1.5	1.2	34.6	1.6	2.3	13.3	0.0	1.1	5.5	27.1	1.0	14.5	0.0	0.0	1.0	62.3	17.7	12.8	5.7	0.0	0.4	133.6	0.0	1.8	79.6	0.0	26.3	17.2	7.9	5.0	0.9	39.2	0.0	76.6	0.0	0.0	66.7	32.2	73.4	10.2	54.3	33.8	52.5	57.2	9.5	18.6	11.1	163.3	0.2	0.0	1.9	5.5	2.0	0.0	0.1	16.3	31.7	0.0	67.0	7.1	1.6	6.7	1.0	16.6	1.9	7.4	0.2	0.0	4.9
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169589-22202528	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.8;ovary: 73.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.6;Gastric mucus-secreting cells: 100.9;Granulosa cells: 52.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;CACO-2: 69.7;hTERT-RPE1: 25.5;OE19: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavorable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	22.2	57.8	0.0	2.5	0.2	0.0	3.8	0.0	0.3	4.9	2.8	11.4	22.8	19.8	1.2	0.8	28.9	11.1	43.9	0.1	0.0	3.0	12.6	14.8	1.9	0.1	0.0	73.0	22.7	0.3	0.6	6.5	0.0	5.5	11.0	0.1	0.8	0.7	0.8	1.5	20.7	9.5	0.2	15.0	49.6	6.3	0.1	0.4	5.3	0.6	0.2	23.0	3.2	0.0	10.1	1.4	0.0	0.0	2.1	1.0	54.8	0.3	0.4	0.8	1.0	69.7	3.8	0.0	3.2	1.2	3.4	10.8	0.4	4.5	1.4	0.0	13.6	0.0	4.3	6.1	14.3	0.6	0.6	0.4	8.9	12.1	9.1	25.5	9.5	0.0	0.5	0.0	0.0	1.5	0.0	0.2	0.1	37.6	9.8	0.0	1.1	0.2	0.4	2.8	0.9	0.1	10.7	6.1	3.0	2.7	1.7	0.0	0.7	1.4	1.6	11.4	1.7	0.0	0.0	0.0	6.2	0.3	9.9	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	7.3	44.8	30.2	0.0	0.0	0.9	4.0	4.6	1.8	0.0	3.4	2.7	97.6	30.0	6.1	0.0	0.0	0.9	0.9	50.0	0.0	28.4	44.7	6.3	6.3	11.5	26.0	2.7	0.1	19.6	11.2	24.4	100.9	16.6	5.1	52.9	28.5	11.1	1.6	0.0	0.1	45.8	2.0	0.6	0.9	8.8	3.4	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	36.8	27.7	10.1	0.2	4.1	43.3	0.0	3.9	0.0	32.9	0.4	8.6	1.4	1.4	0.9	0.9	1.9	1.3	11.4	47.2	2.9
GATAD1	"FLJ22489, ODAG, RG083M05.2"	ENSG00000157259	"GATA zinc finger domain containing 1"	Q8WUU5	7	92447482-92460075	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 234.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006105, HPA072785"			Enhanced	Nucleoplasm		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006105: AB_1078956, HPA072785: AB_2686556"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-3)"	"unprognostic (6.43e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.98e-3)"	22.7	22.1	9.5	7.3	12.8	6.2	22.2	10.1	10.9	26.8	9.7	22.3	11.2	21.4	18.3	14.6	26.5	11.8	16.2	9.6	10.5	21.4	20.1	20.1	8.7	12.1	11.5	33.6	29.4	15.5	23.1	12.4	12.4	23.9	11.3	13.2	18.4	12.4	10.8	14.0	18.6	11.7	10.4	20.2	21.6	10.2	12.0	6.7	26.0	5.7	7.3	22.0	20.2	16.0	12.3	7.5	15.3	16.1	19.7	22.4	12.1	11.9	17.8	12.4	16.9	8.5	18.5	9.1	15.9	8.9	28.9	14.3	10.7	8.1	13.0	15.8	11.3	11.6	8.0	11.6	27.4	14.1	30.0	16.8	19.3	9.5	27.4	22.3	14.2	6.6	24.2	19.0	13.8	17.7	5.5	20.2	20.8	19.9	14.4	7.2	18.1	12.1	13.6	13.4	13.4	21.4	15.7	16.5	23.7	19.0	9.2	18.8	13.0	19.7	14.9	30.0	15.5	15.2	5.5	10.0	16.6	9.0	27.6	2.9	1.1	1.2	0.7	0.7	0.7	0.9	0.5	0.5	0.6	1.4	0.6	0.9	1.0	0.9	0.8	1.2	0.6	0.4	9.5	12.8	10.1	10.9	9.6	10.5	12.1	11.5	12.4	10.4	12.0	16.0	59.0	48.1	64.6	98.9	26.5	13.3	37.8	14.6	26.7	79.0	33.3	35.1	16.3	24.3	26.6	47.8	70.9	25.7	28.8	30.2	3.9	22.4	3.8	46.7	48.3	34.7	16.8	24.6	77.8	22.0	23.4	38.1	30.5	51.6	53.2	115.1	37.1	21.7	24.6	62.2	70.4	33.3	2.0	30.8	23.7	5.0	45.4	40.2	21.4	54.4	25.8	65.3	32.0	108.6	234.9	27.0	30.7	35.0	13.6	45.9	33.2	18.2	36.1	114.1	19.7	54.3	36.7	14.1	10.4	23.6	17.8	20.7	24.7	56.0	31.9	35.7
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2099.3;liver: 2804.2;pancreas: 2935.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.4	21.4	133.9	12.4	138.4	1.8	25.4	152.5	216.5	9.9	94.3	19.6	175.5	8.4	10.5	25.1	11.6	47.7	57.2	131.1	140.9	2099.3	2804.2	7.3	18.4	148.0	135.4	165.2	2935.3	2.7	8.3	74.7	153.4	12.4	11.5	7.5	57.5	15.1	142.5	137.6	110.2	14.5	149.2	33.6	99.2	78.2	140.4	12.6	63.0	46.9	29.7	18.0	15.5	181.2	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	133.9	138.4	152.5	216.5	131.1	140.9	148.0	135.4	153.4	149.2	140.4	181.2	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GBX2		ENSG00000168505	"Gastrulation brain homeobox 2"	P52951	2	236165236-236168386	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	58	"brain: 14.3"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 2.8"	"Group enriched"	"Detected in some"	6	"glioma: 1.7;testis cancer: 6.6"	"Region enhanced"	"Detected in many"		"thalamus: 14.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.5;BEWO: 8.3;PC-3: 14.2;TIME: 7.7"	"Region enhanced"	"Detected in single"		"thalamus: 1.3"	"Group enriched"	"Detected in some"	4	"midbrain: 2.5;pons: 2.7;thalamus: 6.4"	HPA067809			Approved	Nucleoplasm		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA067809: AB_2685900"	"unprognostic (5.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.55e-4)"	"unprognostic (8.69e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.39e-4)"	0.0	0.0	1.5	0.0	1.8	0.0	0.0	2.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	4.9	5.3	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	14.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.6	0.9	47.5	1.8	0.0	0.0	8.3	0.7	0.0	1.3	0.0	1.1	0.0	0.0	0.9	0.0	1.4	0.0	0.4	0.1	0.3	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	3.9	0.0	3.4	0.0	0.6	1.2	0.0	0.4	1.2	0.0	14.2	0.0	5.1	0.0	0.4	0.0	0.6	0.3	1.6	0.0	0.5	1.5	0.0	0.0	7.7	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.8	2.0	1.2	0.4	2.7	4.9	5.3	3.6	3.0	14.3	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 140.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Hepatocytes: 66.1;Proximal tubular cells: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020460, HPA063924"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548, HPA063924: "	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	6.6	15.7	25.1	3.2	24.8	14.1	6.5	26.2	33.3	6.3	22.5	7.3	4.9	7.8	3.0	17.0	6.0	5.0	43.4	26.1	25.0	13.0	53.3	5.6	2.8	25.9	27.4	9.0	140.2	6.0	9.7	2.7	27.8	22.8	4.9	2.2	13.3	6.8	19.5	8.1	5.4	4.2	24.4	1.5	13.2	10.3	27.9	4.3	16.0	19.1	3.1	7.1	7.0	24.6	18.7	4.7	11.9	68.2	24.0	19.4	8.4	25.9	26.9	19.2	16.3	10.5	2.1	5.8	11.8	11.7	11.3	10.6	11.9	18.3	4.3	2.6	21.9	12.9	15.0	42.5	39.0	23.0	16.4	22.8	10.9	12.7	27.7	6.2	16.0	23.0	33.2	6.6	9.2	16.2	24.3	42.3	5.0	28.8	19.0	25.2	2.5	34.4	24.6	14.3	24.5	16.7	20.0	32.3	13.9	4.2	25.8	11.1	11.8	19.3	10.6	12.9	9.2	21.9	11.5	12.1	13.3	21.1	20.5	0.1	0.6	0.4	0.7	0.7	0.3	0.1	1.6	0.5	1.3	0.0	3.5	1.4	0.3	1.3	0.4	1.3	1.7	1.4	25.1	24.8	26.2	33.3	26.1	25.0	25.9	27.4	27.8	24.4	27.9	24.6	3.5	6.4	15.4	9.8	2.8	7.8	18.5	11.2	12.5	8.9	18.6	17.4	54.6	11.5	9.4	11.0	4.2	15.7	0.7	13.1	80.3	7.2	4.1	9.9	8.1	5.5	2.4	22.7	5.0	10.3	19.6	9.8	15.3	16.7	8.9	17.6	5.0	66.1	4.7	8.4	4.7	32.3	8.2	2.9	1.3	7.7	3.7	2.1	21.4	1.0	1.0	25.1	1.0	6.6	4.1	5.4	8.7	9.8	2.0	19.1	8.6	163.8	6.4	2.2	6.6	4.8	30.1	12.6	33.2	19.6	6.0	27.8	3.0	27.8	24.0	14.4
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142882-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"pancreas: 1943.6"	"Cell type enriched"	"Detected in some"	23	"Enteroendocrine cells: 5457.0"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Region enriched"	"Detected in single"	55	"medulla oblongata: 6.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 133.4;U-2 OS: 186.8;U-698: 44.5"	"Region enriched"	"Detected in single"	10	"pons and medulla: 3.5"	"Region enriched"	"Detected in some"	5	"spinal cord: 13.7"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	127000	420000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				20.3	0.1	0.0	3.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	84.4	3.4	0.6	0.0	5.3	0.0	4.1	2.5	0.0	0.0	41.9	0.0	0.2	3.5	6.2	0.0	0.1	1943.6	0.0	0.0	0.1	0.1	0.8	151.9	0.0	0.3	0.0	0.0	37.2	130.2	0.8	0.0	0.2	41.2	0.0	0.0	0.4	0.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	186.8	0.2	12.1	0.0	5.6	44.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.2	0.0	0.0	0.3	0.1	5457.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	230.9	8.5	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.9	0.0
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902826	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease variant, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;liver: 36.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 212.5;Hepatocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	2.4	6.0	2.1	8.1	3.0	31.4	1.8	1.1	2.0	0.4	1.5	2.4	9.4	0.4	0.2	3.5	1.2	0.4	1.9	1.9	4.8	4.6	36.7	4.1	7.0	3.5	16.1	0.5	2.6	0.9	1.8	0.3	8.4	1.5	2.4	0.1	1.7	1.0	0.4	2.2	7.5	1.1	2.4	6.9	2.8	1.2	7.8	3.8	0.8	0.2	2.0	3.3	1.4	2.0	4.7	0.6	1.3	7.1	0.0	0.0	23.5	0.0	2.0	2.4	2.9	1.4	1.0	25.0	6.9	0.2	5.8	4.0	4.9	1.5	0.1	10.9	5.2	0.6	0.3	3.1	8.4	0.0	1.9	0.3	0.7	1.2	0.1	0.0	0.7	23.0	2.8	0.0	0.0	5.0	15.1	0.3	0.4	6.5	8.2	9.6	2.8	0.0	2.9	1.6	11.6	50.9	3.3	2.4	1.6	0.4	2.9	1.5	0.3	0.1	4.0	9.9	3.8	10.5	8.4	7.8	3.1	8.4	0.0	0.0	2.6	0.2	2.8	5.3	2.1	0.7	1.0	1.5	2.8	1.9	2.5	1.3	0.3	1.8	11.1	0.1	2.1	1.2	2.1	3.0	1.1	2.0	1.9	4.8	3.5	16.1	8.4	2.4	7.8	2.0	19.2	3.2	4.8	0.7	33.4	74.6	30.9	23.6	17.6	0.0	19.4	13.2	6.5	4.3	13.6	5.5	2.1	1.9	50.9	21.8	7.9	8.7	0.5	16.8	5.8	19.8	212.5	10.1	3.8	9.4	44.3	15.3	43.8	29.3	0.0	0.3	6.8	94.6	6.1	0.0	5.9	22.7	4.1	28.0	33.3	0.6	0.3	55.8	10.6	15.9	29.5	0.7	29.9	0.5	0.8	11.0	13.6	4.9	14.4	20.5	17.1	48.6	6.9	0.4	0.0	12.5	7.5	2.2	6.7	20.8	76.1	4.2	41.8	11.9	12.2	39.0
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 220.7;Urothelial cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 205.4;Hep G2: 178.2;OE19: 287.5;RT4: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	26.7	18.3	18.5	16.6	24.9	37.8	27.2	18.1	23.3	9.5	14.1	22.8	41.9	19.2	10.8	37.0	62.9	32.1	16.4	16.8	18.9	34.1	152.1	10.9	26.2	18.4	19.7	8.5	15.9	18.3	4.8	9.1	20.4	26.9	26.0	14.4	13.1	15.8	11.4	18.8	32.2	16.0	18.2	39.1	32.9	11.3	22.5	13.7	30.0	14.5	24.0	63.7	14.5	36.0	31.3	205.4	16.5	39.1	19.4	8.6	22.1	15.5	24.9	11.4	13.3	30.5	70.7	59.1	28.7	14.1	86.9	43.3	50.7	112.5	15.3	46.9	31.4	39.6	38.3	178.2	22.1	52.8	23.5	13.5	46.6	12.8	56.8	15.0	17.7	50.9	22.4	18.2	5.6	32.9	45.5	20.9	30.6	287.5	19.2	14.9	10.2	52.1	37.0	189.8	47.5	23.3	25.9	40.9	27.8	23.8	28.2	24.6	24.6	10.2	35.5	26.0	23.4	24.1	39.9	34.0	25.6	37.0	17.5	1.2	0.5	0.3	0.5	0.9	0.4	0.8	0.5	1.1	2.3	0.5	0.3	0.6	0.2	4.2	1.0	1.6	0.9	0.3	18.5	24.9	18.1	23.3	16.8	18.9	18.4	19.7	20.4	18.2	22.5	36.0	17.1	0.0	2.4	36.9	12.7	34.8	61.6	56.6	47.3	14.4	23.7	13.6	20.9	38.6	47.4	0.0	25.0	6.4	22.9	22.1	11.7	14.6	2.2	34.8	14.9	14.1	220.7	113.2	22.4	12.8	8.6	13.6	43.8	69.8	2.5	50.9	10.4	118.5	22.7	8.4	30.4	19.4	40.7	87.2	10.9	1.5	6.5	32.1	8.8	24.4	10.6	12.5	17.5	30.2	84.1	15.9	13.2	9.4	10.4	88.3	18.2	27.1	66.5	5.0	13.1	14.0	13.5	3.1	9.2	72.6	24.9	7.8	14.9	26.6	14.8	144.8
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885199-93909456	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 48.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 207.9;Erythroid cells: 301.9;Prostatic glandular cells: 762.3;Urothelial cells: 374.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	12.2	13.1	5.4	6.6	4.7	15.0	6.6	5.1	5.4	4.5	5.6	6.2	19.2	3.6	4.0	6.6	14.3	14.1	4.7	4.7	7.5	11.3	48.5	5.9	4.6	6.4	6.9	2.8	7.7	6.7	3.4	10.3	7.1	5.6	5.5	3.6	4.5	5.9	16.0	3.0	12.7	3.6	5.1	6.8	5.7	3.2	5.7	5.0	16.8	11.8	10.1	6.9	3.7	6.1	37.7	58.6	6.4	12.6	20.9	13.0	24.4	43.7	27.3	32.8	24.3	9.9	21.7	14.2	84.8	28.8	106.7	37.3	9.6	18.0	26.2	38.6	12.7	98.9	37.4	42.8	39.1	36.8	15.2	16.1	6.7	67.0	10.7	13.2	36.4	16.0	40.0	20.5	24.0	7.3	26.8	8.5	21.5	36.0	27.4	12.3	19.0	20.9	23.6	43.4	14.8	6.1	41.3	32.2	15.4	71.8	7.2	22.7	38.4	34.1	20.1	64.5	66.7	18.1	25.0	14.7	28.2	20.4	12.2	2.1	0.3	0.7	2.6	0.2	1.5	1.3	2.5	3.4	0.3	2.0	1.5	1.6	1.5	2.3	0.3	1.0	0.7	0.7	5.4	4.7	5.1	5.4	4.7	7.5	6.4	6.9	7.1	5.1	5.7	6.1	28.7	41.7	19.1	16.0	14.6	11.5	207.9	33.2	24.5	24.8	24.2	34.2	16.4	61.5	29.0	29.5	6.2	63.5	39.3	21.7	25.4	25.1	3.9	66.3	27.6	55.5	52.5	301.9	32.0	12.3	19.6	44.5	15.8	50.1	19.7	17.3	31.4	102.4	19.9	33.7	30.7	19.9	22.4	20.7	51.4	4.0	21.5	32.0	8.8	15.0	9.3	21.2	34.0	11.1	11.6	24.2	8.0	12.4	21.6	762.3	47.2	65.1	64.3	13.1	0.0	48.4	37.1	32.0	36.7	33.5	9.2	45.0	34.1	26.5	17.8	374.9
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2 (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4"	"Region enriched"	"Detected in all"	4	"basal ganglia: 61.1"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		750000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	0.6	0.3	0.7	1.0	0.6	0.3	10.1	2.5	1.1	4.2	4.5	3.6	5.2	1.4	0.2	1.4	0.8	1.5	6.6	0.8	1.1	5.7	5.1	3.9	1.8	1.2	1.0	0.3	1.3	0.4	1.4	2.6	1.4	13.5	2.0	0.3	4.2	0.3	0.7	1.4	5.8	1.6	0.9	1.5	5.9	2.5	0.9	0.5	1.2	1.8	2.4	1.0	0.7	1.0	6.3	4.9	1.5	4.8	0.0	0.0	9.6	0.0	4.1	1.1	0.5	11.0	5.2	3.5	44.2	0.0	3.2	0.3	0.4	5.1	2.9	3.1	1.8	0.5	2.6	19.7	0.0	1.7	4.7	0.0	0.0	0.5	0.0	2.4	9.1	0.0	0.4	0.0	0.4	0.0	0.0	4.0	4.4	0.0	3.6	0.2	3.8	6.0	16.0	2.9	4.0	1.2	0.0	14.4	17.1	21.4	0.3	0.8	6.4	0.8	0.5	0.0	5.0	0.1	0.0	2.4	0.8	0.3	2.3	1.9	1.1	0.5	0.1	0.8	0.0	0.7	0.1	0.1	0.8	0.4	0.1	0.2	0.1	0.2	0.2	0.2	0.0	0.3	0.7	0.6	2.5	1.1	0.8	1.1	1.2	1.0	1.4	0.9	0.9	1.0	1.4	76.9	32.4	1.0	9.5	4.6	6.6	15.5	9.6	5.1	30.5	16.1	18.4	2.8	28.6	7.3	0.0	27.9	6.4	15.5	11.7	2.9	4.3	79.1	5.5	11.0	2.4	25.9	0.7	24.7	2.1	2.0	16.8	105.5	2.5	0.0	12.8	32.0	15.8	3.3	11.8	5.6	6.1	7.7	9.4	8.2	0.3	7.8	49.8	52.5	11.1	2.4	0.0	18.6	1.1	12.0	11.9	0.0	1.0	16.6	44.3	13.4	27.9	0.6	0.0	0.7	2.2	6.2	27.6	11.2	1.7	10.9	3.1	0.0	16.3	8.1
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 75.5;intestine: 142.9;salivary gland: 55.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.2	0.7	0.2	11.9	0.2	0.5	0.4	0.6	0.4	19.2	0.2	142.9	97.5	2.0	0.0	15.8	4.2	75.5	0.1	0.2	0.1	17.9	0.4	0.7	0.9	0.1	0.4	0.1	2.1	0.9	0.1	0.1	0.2	1.2	123.2	0.1	55.8	0.3	0.2	0.3	123.3	4.6	0.0	0.1	25.8	4.3	0.2	1.3	2.1	0.0	10.6	9.1	29.9	0.4	0.1	147.4	0.0	0.2	0.0	1.0	0.2	0.1	7.7	0.0	0.0	6.3	6.0	0.6	24.6	0.0	9.5	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.5	30.3	0.0	0.2	0.2	0.3	3.5	0.7	0.0	0.1	0.0	0.2	0.0	0.4	1.4	0.6	0.1	0.2	0.2	75.9	0.3	0.4	0.0	0.6	10.2	1.2	0.2	0.2	0.0	0.2	0.4	0.1	0.1	0.0	0.1	0.2	0.4	7.3	0.1	0.2	0.5	0.8	8.9	0.3	0.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.1	0.0	0.2	0.2	0.6	0.4	0.2	0.1	0.1	0.4	0.2	0.0	0.2	0.4	0.0	0.0	2.2	0.0	1.0	0.0	18.3	8.9	0.0	0.0	0.5	0.0	0.7	11.5	40.5	104.8	0.0	0.0	0.1	360.1	0.0	92.6	9.8	23.3	8.6	0.3	7.8	0.0	0.0	14.9	0.0	0.2	27.5	75.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	26.9	8.2	0.6	0.0	19.2	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.4	163.2	0.0	0.1	8.0	85.5	4.4	9.8	0.0	6.6	0.6	1.5	3.0	0.3	1.4	0.0	0.0	0.8	0.0	48.5	52.4
GCNT4	"C2GNT3, LINC01336"	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4"	Q9P109	5	75025346-75052558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.0;lymphoid tissue: 15.4;stomach 1: 18.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"amygdala: 1.1;basal ganglia: 1.8;cerebral cortex: 3.3;hippocampal formation: 2.1;white matter: 1.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 22.4"	"Group enriched"	"Detected in many"	53	"granulocytes: 22.4;T-cells: 18.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 37.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.9	0.8	1.1	2.9	1.8	0.7	1.3	0.0	3.3	1.4	0.0	1.4	24.0	1.2	1.9	2.2	2.1	5.3	0.4	2.1	0.0	4.1	1.1	1.7	4.4	0.0	0.0	1.0	4.6	9.6	0.2	6.3	0.0	1.7	1.3	0.1	0.5	4.8	1.0	2.1	20.2	2.3	0.0	1.7	18.5	1.6	0.0	15.4	0.5	1.4	3.0	4.1	1.8	1.4	0.3	0.2	1.4	2.3	2.5	0.8	0.1	2.8	7.2	1.5	1.2	3.7	0.2	0.0	0.4	2.2	0.8	1.0	1.4	2.5	0.3	0.0	0.1	1.2	0.3	0.3	1.1	0.0	0.0	0.4	3.9	0.1	0.5	0.0	0.0	2.2	0.0	0.5	0.2	0.0	2.1	0.1	0.6	8.0	0.0	0.0	0.0	3.6	0.3	37.1	0.0	0.1	0.3	0.0	0.1	7.0	0.0	0.0	0.0	0.8	0.2	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	22.4	0.0	0.0	1.2	0.0	5.0	0.0	11.4	3.7	0.0	0.0	11.1	8.1	0.2	0.3	0.2	0.1	18.2	2.3	1.1	1.8	0.0	3.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.2	5.0	0.7	0.3	0.6	8.7	0.5	0.0	0.0	0.9	2.3	0.5	32.9	2.7	12.9	0.0	39.6	0.8	4.9	9.8	7.1	0.1	11.9	2.4	1.8	0.0	0.0	1.3	4.4	0.9	2.5	14.8	16.7	7.6	2.0	3.3	0.7	2.3	0.0	0.0	2.7	0.0	0.3	0.0	0.3	4.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	6.9	2.6	0.5	3.0	28.0	0.7	0.6	0.0	6.6	1.6	2.5	0.2	1.7	0.6	0.1	24.4	3.7	0.0	4.4	4.2
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4;prostate: 5.5"	"Cell type enriched"	"Detected in some"	24	"granulocytes: 223.3"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.4"	"Immune cell enriched"	"Detected in single"	661	"basophil: 227.7"	"Lineage enriched"	"Detected in single"	661	"granulocytes: 227.7"	"Group enriched"	"Detected in some"	71	"HEL: 151.8;HMC-1: 564.8"					"Low region specificity"	"Detected in all"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA027507: AB_10600756, HPA027510: AB_2672309"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	0.5	0.2	0.4	0.8	0.4	1.8	1.0	6.4	0.7	0.7	0.4	1.2	1.5	0.8	0.5	1.1	0.3	1.4	0.2	0.3	0.4	0.1	0.2	2.1	0.3	0.4	0.3	0.1	0.4	0.1	0.0	0.3	1.2	5.5	1.5	1.2	0.3	0.4	0.2	0.7	1.4	0.6	0.1	0.4	0.9	3.4	0.4	0.7	0.3	0.7	0.2	0.7	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.8	0.2	0.1	0.0	0.1	151.8	0.2	0.0	0.0	0.3	564.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.3	0.3	5.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.4	0.0	0.0	0.3	0.2	0.0	2.3	0.1	0.4	227.7	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.4	6.4	0.7	0.3	0.4	0.4	0.3	1.2	0.1	0.4	1.2	0.0	0.0	4.4	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.9	0.0	9.1	0.0	0.1	0.6	0.0	5.0	0.4	0.0	0.0	0.3	0.0	0.0	223.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.3	1.7	0.0	0.6	0.0	1.4	0.1	0.0	0.2
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.7;intestine: 94.8;kidney: 42.9;liver: 60.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1500000	"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.3	2.7	57.0	1.2	66.9	0.4	0.2	19.8	79.7	1.6	23.2	10.4	94.3	3.7	0.4	0.4	8.5	15.9	0.1	62.3	52.3	42.9	60.3	0.2	0.4	19.9	26.1	0.2	2.7	8.5	2.8	2.9	25.8	0.1	9.9	0.1	0.0	6.7	1.6	2.2	94.8	0.4	20.5	0.1	3.4	1.2	60.5	0.6	0.1	0.4	4.7	4.0	0.2	42.3	34.4	4.5	0.1	0.1	0.0	0.0	0.8	0.3	24.9	0.0	0.0	3.2	19.3	0.0	127.9	0.0	0.2	2.9	0.2	0.0	0.0	0.4	0.1	0.0	46.4	0.2	0.0	0.1	0.1	0.2	62.3	0.0	0.6	0.1	0.0	0.0	9.6	0.1	0.0	0.2	0.2	0.3	0.2	157.0	0.0	0.0	0.1	1.1	1.1	7.9	0.2	0.6	2.5	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.1	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.0	57.0	66.9	19.8	79.7	62.3	52.3	19.9	26.1	25.8	20.5	60.5	42.3	0.0	0.0	0.5	3.9	1.9	0.0	0.7	19.0	0.0	0.0	0.0	0.0	0.8	14.3	24.7	0.0	0.0	0.2	0.0	65.5	3.9	11.7	1.2	112.3	7.4	0.4	4.8	0.0	109.3	10.7	1.9	0.3	12.2	171.1	0.0	0.0	1.1	56.9	0.2	0.0	22.8	22.1	2.0	1.9	0.4	0.6	0.3	1.2	0.0	5.6	0.6	0.0	0.0	5.0	3.8	6.7	83.7	0.0	0.1	0.8	321.3	98.2	58.6	0.0	0.0	0.8	3.0	1.4	4.7	0.0	0.1	1.9	1.2	0.2	16.1	2.2
GDAP2	"dJ776P7.1, FLJ20142, MACROD3"	ENSG00000196505	"Ganglioside induced differentiation associated protein 2"	Q9NXN4	1	117863485-117929621	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046185	Approved		Approved	"Endoplasmic reticulum"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA046185: AB_10960897"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.68e-1)"	3.0	2.4	2.3	3.2	2.1	8.0	3.2	3.6	2.7	3.4	3.4	3.8	4.0	2.8	4.0	3.1	2.4	3.2	2.5	2.0	2.3	4.8	5.1	3.4	3.6	2.1	2.6	2.4	4.5	4.9	2.3	4.1	2.4	3.4	4.4	2.9	3.0	3.3	1.8	2.9	4.7	3.0	2.4	4.2	4.4	4.8	2.7	4.1	4.6	2.1	4.4	4.5	3.1	2.9	9.2	5.1	6.1	5.1	6.5	3.1	9.0	5.2	6.8	10.3	9.9	5.4	6.2	3.6	6.2	7.1	7.8	5.3	8.1	6.8	12.6	7.2	4.7	5.4	6.7	5.9	7.7	6.8	6.6	2.5	8.5	12.9	9.9	4.7	6.9	8.1	5.7	7.6	8.6	9.6	6.0	5.5	10.6	6.9	8.8	3.2	16.7	5.3	5.8	9.1	4.6	5.1	6.3	10.7	8.2	18.3	3.7	6.8	4.3	7.3	8.5	8.5	7.1	7.9	6.1	5.1	9.4	4.8	9.1	11.4	6.7	12.6	2.4	7.2	3.8	2.3	2.7	2.9	6.5	2.2	2.4	2.3	6.5	4.1	7.6	1.5	3.6	3.2	2.3	2.1	3.6	2.7	2.0	2.3	2.1	2.6	2.4	2.4	2.7	2.9	9.2	9.6	8.6	27.7	13.5	13.5	6.5	8.1	8.6	13.1	8.1	5.5	7.8	8.6	10.8	3.7	18.8	12.4	11.6	13.4	7.9	10.6	21.2	12.8	9.0	7.6	4.2	13.9	36.7	6.2	11.4	7.7	18.3	11.5	0.0	10.4	6.4	9.0	13.8	15.2	39.1	14.0	14.2	17.2	15.8	5.7	5.9	20.0	10.6	34.7	16.2	9.2	8.2	31.7	35.8	10.7	7.5	7.2	21.0	9.8	17.8	10.2	10.5	13.7	0.0	8.6	10.2	28.4	14.5	14.3	13.8	21.1	13.8	6.7	8.3	9.6
GDE1	MIR16	ENSG00000006007	"Glycerophosphodiester phosphodiesterase 1"	Q9NZC3	16	19501693-19522123	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 270.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077420			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA077420: "	"unprognostic (1.69e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (7.52e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.60e-3)"	"unprognostic (9.92e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (8.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	28.9	25.9	42.9	15.6	46.3	27.8	21.1	42.9	49.9	21.9	40.4	44.9	30.0	20.0	27.5	22.4	16.9	18.4	52.8	45.7	45.5	27.6	25.4	29.3	11.7	44.5	47.7	12.8	28.5	76.8	19.2	20.5	43.3	26.7	41.6	19.8	28.3	30.3	62.9	26.4	27.7	26.5	42.8	13.5	34.3	14.1	48.8	16.8	20.3	64.4	15.3	30.2	16.6	47.4	38.6	46.2	25.0	29.4	115.3	43.3	34.7	38.3	66.9	30.0	37.1	26.6	67.4	29.2	48.1	57.2	32.8	31.8	35.2	46.6	36.9	31.7	52.8	24.2	41.4	57.2	69.1	32.7	21.5	44.9	73.1	32.2	37.4	54.5	40.6	36.3	13.7	29.1	33.2	70.3	28.3	29.1	29.1	59.9	34.2	40.2	45.7	41.7	72.9	59.7	28.9	25.8	37.0	44.5	37.9	38.5	45.8	37.8	42.7	25.3	22.3	33.9	24.6	27.0	27.4	19.9	38.5	47.2	23.1	52.0	19.3	11.2	8.9	17.7	11.5	7.2	10.4	10.4	12.4	6.1	5.5	8.5	34.0	6.6	22.7	7.5	12.7	8.2	42.9	46.3	42.9	49.9	45.7	45.5	44.5	47.7	43.3	42.8	48.8	47.4	12.2	38.5	86.8	7.2	18.9	23.5	30.3	56.2	22.8	15.4	38.3	22.4	66.8	34.3	56.0	9.2	27.1	80.4	23.2	123.1	23.5	97.0	35.1	26.9	23.8	17.7	33.5	100.8	12.0	163.9	78.6	27.3	24.5	21.5	3.8	36.4	20.7	23.9	60.8	32.0	15.9	57.5	61.1	48.2	22.9	61.2	28.6	32.3	24.9	8.4	38.2	22.3	24.7	9.5	25.0	77.4	97.6	38.0	19.6	100.5	101.7	45.9	39.7	29.6	13.1	16.7	24.9	87.1	59.6	31.9	29.5	270.4	22.0	45.9	85.3	79.2
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300197-47313577	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.6;retina: 18.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 20.9;Cone photoreceptor cells: 16.7;Fibroblasts: 25.7;Rod photoreceptor cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 13.5;MOLT-4: 3.0;SH-SY5Y: 5.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 42.5"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	12.4	3.2	5.4	0.3	5.4	0.0	9.7	5.1	4.0	2.6	0.6	2.5	0.0	4.2	0.2	2.4	1.6	2.2	4.4	5.9	3.3	0.1	0.1	19.6	0.8	2.6	5.8	0.3	13.3	0.0	0.7	0.0	1.4	2.2	0.3	18.4	8.8	0.2	2.2	3.1	0.6	0.4	2.5	0.1	1.8	7.1	5.5	0.4	9.7	10.4	1.0	1.3	1.7	3.7	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.4	5.1	4.0	5.9	3.3	2.6	5.8	1.4	2.5	5.5	3.7	2.4	0.0	0.6	0.0	0.0	0.4	0.1	0.0	0.0	20.9	0.1	0.0	0.8	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.2	25.7	0.0	0.0	1.3	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.0	2.6	0.7	0.9	0.2	1.8	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.6	1.6	0.4	1.3	0.0	0.9	0.0	0.4	0.0	0.0	0.0
GDF11	"BMP-11, BMP11"	ENSG00000135414	"Growth differentiation factor 11"	O95390	12	55743122-55757264	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 76.6;Cone photoreceptor cells: 77.2;Horizontal cells: 57.2;Rod photoreceptor cells: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 127.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060985, HPA069609"	Approved		Approved	Vesicles	"Secreted to blood"	No	No	46400	340000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA060985: AB_2684403, HPA069609: AB_2686159"	"unprognostic (5.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.48e-2)"	3.6	4.0	22.5	3.7	17.5	1.8	2.3	16.4	17.8	6.8	15.9	5.4	1.6	7.6	2.0	2.4	5.0	4.6	7.5	18.1	18.5	3.0	1.3	3.6	2.8	22.0	26.6	5.7	2.9	2.9	4.7	2.0	20.9	6.0	1.6	21.6	4.8	9.4	1.8	1.5	3.7	4.6	18.3	5.6	2.7	1.1	22.3	4.6	3.6	2.0	1.8	5.9	3.4	17.7	4.9	7.6	32.8	18.6	24.4	17.8	8.2	10.1	9.5	12.5	10.7	26.0	2.1	9.5	13.0	10.5	5.9	4.6	25.0	18.0	4.3	18.2	22.7	11.7	12.3	4.1	4.9	9.8	127.7	17.2	1.0	18.3	5.2	14.0	16.4	12.7	13.2	30.1	16.0	9.2	16.0	8.5	26.4	0.3	18.9	25.1	8.9	5.9	7.7	6.6	22.2	13.6	6.2	2.8	2.6	13.3	10.7	10.7	10.1	15.0	22.9	11.9	7.4	8.1	2.6	4.9	8.0	9.7	10.8	0.2	0.2	0.5	1.2	0.1	1.0	0.7	0.7	0.7	0.2	0.7	0.6	0.8	0.3	0.2	0.4	0.7	0.5	0.1	22.5	17.5	16.4	17.8	18.1	18.5	22.0	26.6	20.9	18.3	22.3	17.7	8.4	0.0	1.1	19.2	10.9	0.5	9.8	0.6	4.0	76.6	6.3	6.6	25.6	1.5	0.9	0.0	77.2	3.6	16.6	1.5	0.0	5.0	0.6	9.9	35.2	8.0	10.7	11.1	4.3	1.4	5.3	13.3	3.1	18.0	5.7	7.6	6.4	0.2	1.6	57.2	10.8	1.9	0.0	1.9	0.7	0.8	9.0	4.4	3.6	1.9	4.1	30.6	22.6	17.1	3.2	3.3	4.1	5.7	4.1	9.8	3.4	0.5	0.1	53.1	13.1	31.1	18.1	2.9	4.1	3.0	0.9	4.7	18.9	7.2	2.2	6.2
GDI1	"FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4"	ENSG00000203879	"GDP dissociation inhibitor 1"	P31150	X	154436913-154443467	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 438.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012979, HPA049290, HPA057668"	Enhanced		Approved	Cytosol		NA	NA		31000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB012979: AB_2533970, HPA049290: AB_2680700, HPA057668: AB_2683498"	"prognostic unfavorable (6.84e-4)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.72e-1)"	77.3	85.9	351.5	54.9	381.7	41.2	67.4	309.6	438.5	99.7	214.0	91.8	36.7	92.2	46.2	57.5	94.6	47.3	99.1	391.8	349.9	74.4	53.9	90.1	53.9	344.5	312.7	120.0	54.7	63.4	176.0	60.4	349.5	74.9	41.7	130.9	49.7	69.5	62.9	61.6	67.5	78.9	311.4	89.4	68.5	54.1	330.6	58.7	63.0	70.8	51.1	89.2	81.2	366.2	100.2	88.9	195.9	164.6	77.7	91.4	64.5	149.6	91.1	140.4	146.0	52.6	51.1	79.5	149.3	139.4	213.2	79.7	172.7	83.9	96.5	147.5	93.8	25.0	142.6	35.5	113.5	24.6	90.5	94.7	101.3	163.4	99.6	154.6	92.4	95.7	31.1	120.5	169.4	99.2	77.9	62.1	53.0	106.1	168.8	77.6	51.6	45.0	98.8	46.5	272.5	210.3	67.6	86.1	109.0	150.3	50.9	42.5	110.4	131.9	116.8	138.4	212.0	182.1	202.0	128.3	140.7	54.5	162.5	23.7	8.4	26.9	12.1	12.6	18.0	9.9	13.0	12.0	7.0	10.1	10.0	10.1	30.0	8.7	21.3	12.1	16.2	7.3	351.5	381.7	309.6	438.5	391.8	349.9	344.5	312.7	349.5	311.4	330.6	366.2	39.3	16.0	27.4	30.3	35.9	27.1	24.8	48.3	33.6	71.3	24.1	25.7	62.6	24.3	29.0	27.6	25.0	22.7	27.0	31.4	31.3	39.4	2.9	33.1	41.1	35.3	90.8	9.2	48.8	31.3	39.3	37.5	37.8	34.3	33.7	29.7	30.4	17.7	36.3	60.6	43.2	24.8	65.1	35.9	40.9	6.0	37.6	35.5	17.8	22.5	59.0	37.7	19.6	33.2	46.4	50.2	25.9	39.9	35.7	27.4	24.3	25.5	46.8	37.1	52.6	29.5	49.8	33.9	66.6	20.7	30.3	49.5	43.2	22.0	15.0	26.2
GDI2	RABGDIB	ENSG00000057608	"GDP dissociation inhibitor 2"	P50395	10	5765223-5842132	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049290, HPA057668"	Supported		Approved	Cytosol		NA	NA		53000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA049290: AB_2680700, HPA057668: AB_2683498"	"unprognostic (1.08e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.26e-4)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.56e-7)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	125.1	111.5	62.4	151.6	70.0	126.6	138.1	76.0	90.3	120.6	66.8	152.9	175.4	96.3	115.3	131.1	96.8	112.6	86.8	59.3	70.7	146.0	241.1	98.3	217.5	85.8	72.7	116.9	165.1	91.3	59.6	135.5	82.6	88.8	160.7	69.1	97.7	92.2	107.0	107.6	160.2	124.1	80.9	138.7	108.6	74.3	65.1	149.1	114.1	99.7	239.2	145.5	81.7	95.4	343.4	245.8	341.1	241.2	298.2	347.5	191.4	325.0	170.8	287.3	312.0	351.8	287.3	553.2	198.2	340.5	88.1	320.8	368.3	289.3	288.0	212.2	174.7	380.0	152.0	428.4	276.9	252.1	230.7	292.6	235.8	249.6	148.9	324.0	400.6	340.1	398.5	203.4	331.6	291.1	390.9	208.0	242.5	355.1	159.3	466.7	181.9	389.8	330.7	250.1	138.0	210.0	257.5	468.5	358.3	289.9	382.3	299.0	342.0	142.3	243.4	420.3	282.2	180.0	314.8	526.5	212.0	275.5	130.0	154.9	280.8	169.0	109.9	347.8	136.4	210.7	136.9	121.6	329.1	204.2	124.8	119.3	138.4	177.5	445.1	146.1	181.5	416.8	62.4	70.0	76.0	90.3	59.3	70.7	85.8	72.7	82.6	80.9	65.1	95.4	101.5	25.6	83.8	31.0	208.1	161.7	131.3	144.8	145.7	37.1	124.5	81.8	76.6	107.2	109.0	57.0	18.8	252.1	148.5	156.6	133.1	185.7	29.5	69.1	138.0	125.4	118.4	177.1	27.7	212.2	312.0	151.5	109.6	84.3	132.5	121.7	121.3	145.9	284.5	92.5	32.1	184.7	91.6	354.2	302.8	40.4	152.2	255.7	149.4	36.5	485.8	75.0	97.9	34.7	49.2	158.1	141.9	141.8	151.3	129.2	271.0	194.1	63.0	36.8	111.7	96.1	125.8	126.2	119.3	177.6	165.1	247.4	120.1	136.9	213.5	131.9
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113537	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 447.4"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 32.1;MCF7: 50.6;OE19: 53.3;SK-BR-3: 165.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	7.1	2.4	6.1	6.0	6.1	1.8	5.4	6.8	11.4	18.7	5.9	25.9	8.4	5.3	9.3	45.6	5.7	2.5	5.2	6.0	6.1	17.9	2.1	6.4	4.2	7.5	6.1	6.8	2.2	0.4	4.8	11.4	8.0	5.7	17.2	6.5	9.0	2.2	2.1	11.0	10.2	5.2	6.3	9.0	18.8	1.8	6.1	4.1	4.7	0.9	20.9	5.4	19.1	6.8	21.8	0.3	5.2	1.5	1.6	5.5	5.5	0.6	1.3	1.8	1.7	1.0	15.2	0.6	2.9	1.5	0.6	1.8	1.6	0.5	1.8	2.5	4.0	0.2	1.0	32.1	1.0	0.7	1.3	0.2	1.6	4.5	0.3	4.1	5.1	4.2	1.0	2.3	2.2	50.6	1.5	2.0	2.6	53.3	0.6	6.3	1.4	7.1	2.6	7.4	1.1	2.2	0.2	165.0	0.5	1.6	3.0	2.7	2.7	0.9	1.1	1.9	1.8	2.7	0.9	1.5	4.2	2.7	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.1	0.0	6.1	6.1	6.8	11.4	6.0	6.1	7.5	6.1	8.0	6.3	6.1	6.8	5.9	6.4	1.1	1.6	1.0	1.3	0.9	4.4	1.2	1.6	4.1	3.0	1.5	0.0	22.2	5.5	0.0	24.2	1.2	98.2	5.9	0.9	67.8	2.6	3.8	4.3	3.5	0.0	0.6	1.3	71.9	2.1	30.1	4.1	0.0	2.0	3.9	0.3	3.1	1.7	0.8	34.2	6.1	1.9	1.0	447.4	3.4	1.4	1.8	1.9	1.2	0.6	0.0	1.5	1.2	19.2	36.7	3.0	0.1	1.1	46.0	100.6	9.0	1.7	6.6	0.6	2.7	1.4	1.3	5.1	2.0	9.3	1.9	1.3	13.9	4.8
GDPD5	"GDE2, PP1665"	ENSG00000158555	"Glycerophosphodiester phosphodiesterase domain containing 5"	Q8WTR4	11	75434640-75525941	"Enzymes, Predicted membrane proteins"	Neurogenesis	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 116.6;retina: 83.5"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 60.9;Cone photoreceptor cells: 148.0;Early spermatids: 52.1;Late spermatids: 178.0;Rod photoreceptor cells: 88.4;Syncytiotrophoblasts: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.7;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 32.8;fHDF/TERT166: 32.4;HDLM-2: 66.9;U-2 OS: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065257, HPA066762, HPA069281"	Uncertain		Approved	"Golgi apparatus"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.12e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.59e-9)"	"unprognostic (8.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.65e-1)"	31.0	8.7	19.5	4.8	22.1	12.8	24.6	17.4	12.9	12.4	6.0	7.3	2.7	17.9	1.8	3.3	10.3	4.3	9.5	10.5	14.5	7.8	8.1	15.2	6.7	14.2	27.0	7.3	38.1	0.8	19.1	14.0	10.2	11.5	1.6	83.5	21.3	5.3	13.1	7.4	10.0	6.5	7.4	116.6	4.8	38.9	42.1	3.1	7.7	8.7	4.7	12.6	9.9	12.4	2.1	7.5	3.2	3.7	2.2	1.1	11.1	2.3	3.1	1.1	0.7	10.0	4.4	14.2	32.8	32.4	8.1	4.7	4.0	3.8	0.6	66.9	3.1	2.6	11.7	21.2	3.2	1.6	10.7	2.4	2.0	0.8	1.6	3.2	26.7	12.7	4.7	6.3	1.5	4.5	3.9	7.1	5.7	3.7	10.6	4.5	0.9	3.9	0.9	3.6	1.7	1.2	4.8	18.3	9.3	4.1	2.7	6.3	7.9	7.5	30.4	5.8	2.6	1.6	0.3	2.8	1.7	8.5	0.8	7.7	0.8	0.5	1.2	0.3	1.7	0.6	1.3	0.9	0.2	0.2	0.7	0.9	0.1	0.0	0.0	0.7	2.0	0.5	19.5	22.1	17.4	12.9	10.5	14.5	14.2	27.0	10.2	7.4	42.1	12.4	4.2	6.4	0.0	1.6	5.4	1.0	0.3	0.7	0.6	60.9	3.6	3.4	3.0	1.5	1.3	0.0	148.0	3.2	9.1	0.5	0.0	4.2	52.1	1.0	10.4	7.0	0.0	8.2	5.0	9.3	1.5	6.6	1.1	1.5	4.5	1.6	20.7	2.4	1.9	5.0	15.8	0.7	0.0	2.8	3.7	178.0	5.9	3.1	5.4	8.4	4.9	8.9	1.0	1.0	0.8	4.7	0.3	2.6	5.0	0.8	0.3	0.1	0.8	88.4	0.0	4.6	1.9	12.9	8.2	0.1	1.1	46.0	7.0	0.9	2.0	0.6
GET3	"ARSA-I, ASNA1, TRC40"	ENSG00000198356	"Guided entry of tail-anchored proteins factor 3, ATPase"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 106.6;Extravillous trophoblasts: 80.7;Hofbauer cells: 142.4;Syncytiotrophoblasts: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		37000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	47.5	61.6	56.4	39.4	58.2	66.2	46.5	59.0	72.8	48.4	62.4	43.0	39.9	49.8	41.0	58.1	47.0	39.3	62.0	59.6	58.4	61.6	38.4	40.8	48.3	55.4	57.3	41.9	48.2	73.3	48.2	28.0	57.9	34.3	28.7	36.4	47.3	31.4	67.6	59.1	38.7	33.9	55.9	43.4	50.9	60.2	58.9	46.9	56.3	58.6	38.1	46.3	43.3	57.3	143.7	116.5	60.7	132.3	118.6	72.4	74.6	72.4	99.7	137.5	107.6	90.3	69.6	64.8	111.0	95.4	157.5	75.2	84.5	97.6	65.4	100.9	132.7	54.3	82.4	105.3	125.8	83.5	104.9	83.6	84.1	111.3	66.1	89.2	99.4	75.9	71.3	86.8	109.5	320.4	112.9	68.1	154.6	92.0	215.6	82.2	93.6	128.4	130.2	120.7	111.6	95.5	97.3	131.3	119.8	51.5	108.2	80.5	85.5	193.3	65.4	217.1	172.4	153.9	279.4	61.7	136.2	137.0	109.0	33.6	44.3	26.3	24.8	34.3	21.2	20.3	22.0	22.2	44.8	17.0	15.7	19.5	15.6	16.7	42.9	29.4	34.2	35.8	56.4	58.2	59.0	72.8	59.6	58.4	55.4	57.3	57.9	55.9	58.9	57.3	14.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	106.6	13.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	80.7	12.5	0.0	0.0	0.0	0.0	0.0	0.0	142.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	110.7	1.7	0.0	0.0	0.0
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Guided entry of tail-anchored proteins factor 4"	Q7L5D6	7	876554-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	25.0	98.0	28.9	12.5	33.7	31.6	26.8	29.7	37.0	28.1	19.1	33.5	20.8	25.5	21.1	43.7	32.1	11.4	33.1	28.8	31.1	68.8	98.4	25.5	15.8	36.1	33.4	34.3	46.1	13.7	70.7	20.5	36.0	37.8	8.8	16.4	28.8	12.3	56.3	46.9	33.6	7.7	29.1	37.5	41.5	79.0	34.0	14.4	34.3	21.9	10.4	31.3	28.9	45.6	78.8	38.1	25.8	38.4	13.2	9.1	81.7	21.2	14.9	26.5	26.6	103.4	95.1	28.5	21.7	12.4	73.7	48.7	29.3	23.3	11.5	11.6	50.9	15.8	31.5	59.5	29.1	27.1	28.1	13.8	27.6	23.4	15.1	19.9	21.1	32.5	103.6	25.7	15.2	59.7	20.8	65.2	93.3	46.1	56.0	43.0	4.5	30.8	23.8	45.4	46.7	50.5	19.5	71.2	32.2	31.5	54.2	47.8	21.4	19.6	43.6	45.7	29.5	38.5	25.9	37.5	20.1	46.2	50.3	22.3	28.5	32.4	23.9	27.6	23.3	24.3	26.4	24.1	29.4	24.5	25.2	27.0	21.9	27.7	35.3	33.3	26.9	24.8	28.9	33.7	29.7	37.0	28.8	31.1	36.1	33.4	36.0	29.1	34.0	45.6	0.3	0.0	3.1	14.7	10.6	1.0	0.3	0.2	14.8	0.8	1.1	0.9	0.6	0.0	2.2	0.0	4.2	1.1	0.7	2.3	0.0	0.9	4.0	2.0	1.1	1.5	0.0	9.2	9.1	0.7	0.7	3.8	36.7	2.8	1.3	1.2	0.0	0.4	0.6	8.4	9.1	2.8	0.0	0.6	0.8	2.7	0.0	6.1	0.0	4.7	0.5	0.2	0.0	10.1	15.8	0.8	1.0	0.0	37.2	0.4	3.6	1.1	2.1	1.4	0.0	0.8	1.8	0.6	1.1	23.5	1.0	1.6	9.9	0.8	1.7	0.8
GFAP	FLJ45472	ENSG00000131095	"Glial fibrillary acidic protein"	P14136	17	44903159-44916937	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 13076.3"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 381.9"	"Cancer enriched"	"Detected in some"	368	"glioma: 2468.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.2;NK-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000039, HPA056030, HPA063513"	Enhanced	Supported	Supported	"Intermediate filaments"		No	No		170000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Intermediate filaments"		"CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027"	"unprognostic (1.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.12e-5)"	"unprognostic (4.08e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.35e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.75e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	1.9	1.8	5096.2	2.2	5407.4	14.1	3.5	5902.8	4887.4	1.9	2342.2	1.4	0.4	0.9	1.5	3.7	2.2	1.6	8.2	5059.3	9869.7	2.1	1.7	1.3	1.9	13076.3	9001.4	2.1	1.5	1.6	33.9	0.7	9204.1	1.3	1.0	117.7	1.9	1.0	2.1	2.6	0.7	0.9	10040.2	1.5	1.5	1.4	8068.5	0.4	1.7	0.3	1.1	1.4	0.9	10496.9	1.0	0.7	1.2	2.3	0.0	0.4	0.2	1.0	1.2	1.5	1.2	1.3	1.5	2.2	1.9	0.5	0.9	2.7	1.4	0.4	1.8	3.0	1.1	1.4	2.1	0.9	0.0	0.2	2.2	0.1	0.8	1.0	0.0	1.7	0.0	2.3	0.7	5.3	0.8	1.3	1.9	2.6	1.6	0.1	3.3	0.7	0.7	1.2	0.7	0.6	1.6	1.8	0.1	1.7	0.2	1.0	1.2	1.2	0.7	1.2	0.9	1.1	2.0	0.7	1.6	1.6	6.1	2.0	2.7	1.5	0.8	0.3	0.3	0.6	0.2	0.2	0.2	0.4	0.1	0.5	0.3	0.4	6.2	1.7	0.5	0.5	0.2	0.2	5096.2	5407.4	5902.8	4887.4	5059.3	9869.7	13076.3	9001.4	9204.1	10040.2	8068.5	10496.9	0.0	0.0	0.0	381.9	0.1	0.0	0.1	0.0	0.0	0.8	1.3	0.6	5.2	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.8	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.7	0.0	53.5	0.0	10.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.4	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"bone marrow: 39.0"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 99.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	20	"basophil: 195.6;eosinophil: 395.8"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 395.8"	"Group enriched"	"Detected in some"	5	"HEL: 168.9;HMC-1: 104.6;K-562: 53.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004420, HPA006291"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.3	0.1	39.0	0.0	0.2	0.2	0.0	0.2	0.5	0.9	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.2	1.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.0	0.1	0.1	0.4	0.5	1.0	0.1	0.1	1.8	0.3	2.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.9	0.3	23.8	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	168.9	0.2	0.1	0.0	0.1	104.6	0.0	1.4	0.0	0.2	0.0	0.0	0.0	53.0	0.2	0.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	195.6	0.3	395.8	0.1	1.9	0.1	0.1	0.1	0.0	1.9	0.2	0.5	0.1	3.9	0.5	15.1	1.0	0.0	12.5	0.0	0.1	0.2	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.0	0.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.1	0.8	0.0	0.1	3.8	0.0	0.3	0.4	1.2	99.1	0.4	0.0	0.2	0.3	0.0	0.1	14.5	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.0	12.9	0.0	15.8	0.0	0.0	0.6	0.0	0.0	0.5	0.2	0.0	24.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.3	0.2	1.0	0.6	0.1
GFM2	"EF-G2mt, EFG2, FLJ21661"	ENSG00000164347	"GTP dependent ribosome recycling factor mitochondrial 2"	Q969S9	5	74721206-74767147	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036863, HPA069871"	Uncertain		Approved	"Nucleoplasm,Midbody ring,Mitochondria"		Yes	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Nucleoplasm, Midbody ring"	"HPA036863: AB_2675354, HPA069871: "	"unprognostic (2.58e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (9.55e-2)"	"unprognostic (4.15e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.82e-2)"	9.6	18.1	9.7	10.2	10.5	15.0	14.1	10.2	14.5	10.7	16.1	13.9	9.3	11.1	17.4	11.9	23.4	9.0	33.3	10.8	10.7	23.3	34.0	9.0	12.2	9.5	9.1	11.4	10.0	30.4	10.7	13.5	10.0	13.0	15.8	16.8	13.4	11.2	30.6	11.3	10.8	10.8	9.4	8.5	17.9	15.8	10.2	17.2	13.1	38.5	15.5	12.9	7.0	11.1	39.5	34.3	27.2	52.2	20.3	27.1	28.2	41.5	24.7	41.5	44.1	36.4	24.9	39.7	44.9	21.9	65.7	32.1	55.0	59.6	54.8	34.8	35.5	22.9	31.7	27.0	27.1	23.6	26.0	32.1	26.3	33.6	40.5	29.8	30.3	39.4	40.7	32.9	48.5	23.3	32.1	15.1	11.4	14.8	29.7	41.1	43.5	49.3	32.0	24.7	46.6	24.8	46.3	38.1	44.3	30.1	33.0	44.0	24.0	16.2	27.8	20.5	27.2	19.0	38.3	40.1	24.1	34.2	24.6	22.8	6.9	9.2	6.7	7.2	6.6	8.3	5.5	7.5	6.7	7.2	7.5	7.3	3.5	16.0	11.8	4.4	7.0	5.2	9.7	10.5	10.2	14.5	10.8	10.7	9.5	9.1	10.0	9.4	10.2	11.1	6.4	12.8	12.9	19.9	8.5	6.0	7.1	13.0	8.6	9.1	7.7	6.9	11.0	7.2	12.5	7.3	6.2	20.1	7.5	8.9	21.5	9.5	11.5	42.4	9.2	6.4	5.4	17.9	35.7	5.3	15.9	6.3	15.3	13.7	2.5	10.4	5.3	22.4	9.9	16.8	34.1	9.7	30.5	8.5	2.4	2.6	7.2	6.8	8.8	13.1	17.9	13.0	7.2	34.2	29.1	9.8	9.9	7.5	11.4	4.6	8.5	11.2	61.5	9.6	0.0	5.6	7.8	15.2	11.7	10.0	7.0	16.0	7.3	11.1	10.0	7.5
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.9;Cardiomyocytes: 108.2;Excitatory neurons: 133.2;Inhibitory neurons: 106.2;NK-cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.5;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.5;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEL: 30.5;HMC-1: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	10.5	2.0	14.3	2.8	21.6	12.7	9.6	11.2	26.1	5.0	0.0	6.2	1.8	3.6	0.8	8.6	4.4	4.3	16.7	24.5	3.7	2.3	7.2	9.7	4.3	3.0	1.5	1.5	1.5	1.7	3.5	3.9	2.3	4.0	2.8	2.1	3.6	1.4	12.0	5.5	6.5	4.9	0.6	8.8	7.9	0.6	2.5	3.0	2.7	9.7	4.2	6.2	5.8	16.9	12.5	1.3	1.0	2.1	1.7	1.8	1.3	1.0	0.5	0.7	0.4	0.4	0.9	16.8	16.6	1.2	1.0	10.9	3.4	5.4	0.7	1.2	6.0	30.5	7.2	6.6	2.4	9.0	46.3	0.9	4.1	1.6	4.5	2.6	9.5	4.5	0.9	1.5	1.3	4.1	2.0	5.2	1.8	4.3	3.3	6.9	2.1	8.8	0.6	2.4	5.5	1.0	4.0	0.7	4.0	2.1	0.9	0.9	12.2	1.6	3.2	3.5	5.6	13.4	8.3	19.8	1.4	5.3	0.4	0.2	0.4	15.5	1.5	0.9	0.2	2.7	0.2	0.7	0.2	1.9	0.1	0.5	0.3	13.1	0.9	0.1	0.1	1.0	14.3	21.6	11.2	26.1	24.5	3.7	3.0	1.5	2.3	0.6	2.5	16.9	100.9	0.0	1.8	33.0	14.3	20.3	4.9	14.5	19.9	43.8	7.4	3.7	108.2	10.0	14.4	0.0	0.0	1.5	46.1	18.2	0.0	5.3	0.1	3.8	1.0	49.0	8.4	31.2	133.2	3.1	34.7	9.1	2.0	8.0	4.5	0.2	51.4	19.5	2.5	1.7	106.2	11.2	8.2	15.7	31.3	0.3	2.5	21.4	12.4	42.2	4.7	2.1	142.2	58.8	56.6	30.5	31.7	1.2	14.5	3.1	10.6	0.3	13.6	2.7	13.1	19.9	17.5	0.0	3.3	34.6	22.4	0.7	23.4	1.0	4.4	4.7
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319780-69387250	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 184.2;Intestinal goblet cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA		93000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	"Nucleoli fibrillar center"	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favorable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	31.2	17.9	6.6	21.5	6.5	15.0	22.4	5.5	7.1	37.8	31.5	74.3	38.4	15.6	41.6	16.4	24.3	32.5	24.8	7.0	11.0	21.6	23.1	17.0	10.6	4.9	10.5	12.0	33.7	26.2	18.9	36.0	10.8	36.7	76.6	10.4	42.4	25.9	10.2	6.0	41.2	23.2	5.3	9.5	64.3	46.6	8.0	10.2	91.8	13.9	15.9	21.8	9.2	6.8	46.6	42.7	34.7	20.9	107.7	75.8	73.5	97.1	94.5	44.7	59.3	109.5	50.5	31.7	31.9	92.9	61.4	22.6	47.1	28.6	73.6	38.4	18.4	38.2	25.0	94.5	123.0	27.9	17.9	47.8	132.5	88.7	158.8	55.5	43.4	29.8	34.8	58.3	85.2	30.9	31.3	22.9	37.0	116.7	27.4	28.2	79.1	18.3	70.6	42.0	25.2	11.9	35.2	52.4	93.7	73.5	22.7	17.2	61.8	37.2	62.3	64.6	47.5	39.5	32.2	25.4	65.7	18.3	46.9	9.2	3.5	4.9	7.5	4.3	7.0	6.4	6.5	8.3	4.7	3.6	6.3	6.2	1.2	5.2	5.2	4.4	5.0	4.2	6.6	6.5	5.5	7.1	7.0	11.0	4.9	10.5	10.8	5.3	8.0	6.8	14.6	51.3	49.5	15.7	29.8	28.4	21.6	31.7	26.7	13.7	50.6	16.5	43.1	42.9	54.5	44.1	12.5	28.6	30.3	184.2	17.6	34.1	123.9	54.4	54.1	17.2	75.1	3.8	49.2	89.5	70.3	37.6	110.1	60.0	24.1	19.2	17.9	53.6	17.0	6.7	56.3	244.0	16.2	10.0	31.4	23.7	23.3	16.0	53.4	27.2	28.1	10.6	13.4	42.7	43.8	66.0	83.3	28.2	82.1	72.3	62.5	30.0	89.7	14.0	19.7	21.6	41.8	134.1	45.3	20.3	21.0	34.3	33.4	15.7	135.3	56.3
GFUS	"FX, P35B, SDR4E1, TSTA3"	ENSG00000104522	"GDP-L-fucose synthase"	Q13630	8	143612618-143618048	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 32.1;Cytotrophoblasts: 82.1;Extravillous trophoblasts: 156.4;Hofbauer cells: 69.9;Syncytiotrophoblasts: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		850000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	36.3	37.2	21.6	27.7	21.1	52.3	34.0	21.4	25.9	28.6	21.7	45.9	69.2	24.8	19.2	88.7	24.0	29.3	32.1	20.7	21.3	37.5	86.6	28.4	29.1	23.5	21.9	19.0	99.5	22.8	44.0	24.4	22.8	45.0	37.6	6.5	70.9	24.2	30.2	81.5	52.4	19.4	20.2	35.7	111.4	49.4	21.0	26.6	32.1	18.4	27.1	31.0	36.0	22.5	85.6	67.1	29.2	99.7	28.6	26.1	54.1	70.3	73.0	50.2	38.1	78.5	94.3	37.5	64.6	52.5	21.2	60.6	47.8	100.8	23.2	101.7	53.8	58.7	103.0	93.4	57.2	42.2	67.1	30.3	47.4	31.7	127.3	42.2	84.3	61.9	66.4	57.0	41.2	267.5	39.8	53.2	45.8	267.7	87.1	47.1	26.3	122.3	106.1	94.8	67.3	45.9	53.3	100.2	73.0	23.0	133.5	58.8	75.5	34.8	132.0	35.1	67.6	34.1	30.2	29.0	52.8	91.6	54.7	34.9	27.4	42.9	40.3	38.5	43.0	35.2	43.1	46.8	30.1	40.1	31.5	38.5	31.0	63.6	33.8	54.5	57.5	45.7	21.6	21.1	21.4	25.9	20.7	21.3	23.5	21.9	22.8	20.2	21.0	22.5	32.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	82.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	156.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	87.7	1.7	0.0	0.0	0.0
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 212.7;Late spermatids: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029472, HPA050727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA029472: AB_10696206, HPA050727: "	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.0	23.5	20.4	17.3	21.4	7.8	34.1	23.0	27.6	24.5	18.5	24.8	21.2	23.3	30.4	22.4	21.2	20.0	23.5	21.1	22.5	27.8	21.7	20.1	21.3	21.8	20.6	23.3	16.4	21.1	17.6	19.2	22.3	29.4	23.9	38.8	31.2	19.7	29.8	20.3	20.6	25.7	22.3	20.5	20.4	48.2	20.9	27.6	27.4	28.9	21.9	23.6	17.0	25.7	41.3	22.3	54.5	41.5	41.7	59.9	20.5	36.2	50.7	23.6	33.1	17.5	64.5	28.1	51.3	40.6	38.1	33.5	29.4	37.8	31.2	28.8	54.4	24.0	19.7	29.9	46.9	30.0	19.7	39.3	66.5	32.2	43.0	41.8	42.5	46.2	58.5	24.7	31.5	24.6	37.0	35.7	46.4	109.9	11.5	22.6	17.3	32.6	66.2	22.4	43.3	59.8	27.3	61.5	54.7	20.1	76.7	46.5	35.9	27.9	20.8	47.6	34.7	42.0	55.8	34.3	35.4	33.3	51.4	43.7	31.0	48.5	31.5	37.3	32.1	38.6	39.5	33.8	30.4	32.8	36.2	33.4	27.8	31.9	54.2	25.2	42.5	36.8	20.4	21.4	23.0	27.6	21.1	22.5	21.8	20.6	22.3	22.3	20.9	25.7	18.3	32.1	34.5	16.3	27.2	39.9	60.4	64.6	27.9	32.1	29.1	22.4	24.5	17.2	39.5	20.2	43.8	30.7	24.1	21.4	72.4	37.5	212.7	16.8	15.1	29.4	17.4	12.0	26.5	28.3	43.7	31.0	14.3	12.9	24.6	16.4	28.9	13.0	26.8	48.8	25.7	26.1	69.2	26.9	49.0	290.7	35.8	24.3	67.6	20.6	36.7	55.4	36.0	15.6	23.2	31.8	23.3	35.0	8.5	65.6	29.3	61.3	30.4	51.2	26.3	26.1	32.5	111.6	50.0	18.7	40.6	47.1	33.0	30.9	22.7	55.9
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 174.8;liver: 115.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 37.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	3.3	2.4	5.5	6.4	6.7	12.0	24.7	7.0	7.5	28.7	5.1	20.3	84.7	3.0	72.0	3.3	3.3	47.1	7.2	5.1	5.1	174.8	115.7	42.6	5.4	7.2	6.6	3.2	63.1	0.2	5.5	2.4	7.8	48.8	11.0	1.6	9.9	21.6	1.9	4.1	80.4	2.2	5.9	13.3	31.3	18.4	7.1	6.5	15.9	0.4	6.2	5.7	4.3	9.2	1.0	79.7	1.0	0.3	0.0	0.5	2.2	0.5	1.7	0.8	1.0	11.7	18.3	1.0	16.2	0.1	14.8	11.0	6.2	0.8	0.5	103.6	12.3	0.6	40.8	64.3	5.5	1.5	33.2	2.1	0.9	2.5	1.7	1.4	0.5	19.0	8.4	165.8	1.0	1.7	1.6	52.4	6.4	169.5	0.7	0.7	6.8	210.3	203.2	2.9	0.5	1.2	0.4	33.3	0.8	22.2	32.4	39.6	6.4	10.6	9.3	46.6	0.9	48.2	18.4	0.7	19.0	58.7	0.5	4.8	12.3	0.2	1.0	6.0	2.9	2.2	5.0	2.4	6.5	0.2	0.6	1.4	15.9	4.9	4.0	0.1	6.5	5.6	5.5	6.7	7.0	7.5	5.1	5.1	7.2	6.6	7.8	5.9	7.1	9.2	0.2	80.1	22.8	3.3	2.8	0.8	0.1	0.3	4.6	0.5	5.9	2.3	0.7	48.6	4.9	1.8	0.0	1.4	0.7	54.1	1.9	82.6	1.8	1.2	0.6	0.7	1.2	5.3	4.4	8.1	0.4	3.9	15.3	5.1	5.7	0.1	1.8	40.8	4.9	0.0	4.1	4.4	4.1	2.5	1.7	6.7	0.0	2.9	1.8	1.0	5.8	2.5	0.0	1.5	5.7	20.9	20.1	0.4	12.8	2.0	111.7	62.9	1.6	0.1	0.0	0.1	1.0	0.6	0.8	0.4	0.4	0.8	4.0	0.0	6.5	0.1
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 8.7;thyroid gland: 8.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.2;Early spermatids: 5.6;Late spermatids: 18.7;Proximal tubular cells: 3.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;HeLa: 3.5;Karpas-707: 1.3;U-2197: 8.9"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.7	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.1	1.5	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.2	1.0	0.1	0.0	8.5	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.3	0.3	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	3.2	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872856	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 60.9;Inhibitory neurons: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1900000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	13.2	13.8	37.0	11.8	35.8	5.5	15.4	43.4	43.8	25.6	53.2	19.1	16.0	19.3	29.1	10.1	21.1	18.2	22.3	38.6	33.3	24.9	16.8	14.4	18.2	34.3	28.9	24.1	27.1	22.9	40.5	13.7	33.6	24.8	14.9	22.7	30.8	22.6	67.5	17.9	20.1	14.9	22.5	15.4	22.1	10.1	32.0	15.8	28.8	13.8	13.6	19.7	18.0	35.4	5.2	7.7	38.5	39.5	29.7	26.4	34.2	21.7	21.9	17.5	26.0	40.6	25.5	0.0	25.1	17.1	17.8	3.6	16.8	9.5	11.5	1.8	29.9	15.9	16.0	21.3	26.5	0.8	24.9	38.5	10.6	19.7	9.1	52.2	1.5	20.3	12.0	2.8	12.2	9.1	4.2	8.1	8.9	9.1	3.8	0.1	26.3	25.9	25.3	7.7	22.4	26.1	11.2	17.6	28.2	14.4	13.5	14.2	0.6	59.8	23.6	5.7	12.6	29.6	4.2	1.9	70.4	1.5	22.4	1.4	2.8	1.5	6.9	2.0	2.0	6.1	5.8	2.6	2.5	5.4	11.5	8.2	0.3	3.0	0.7	1.4	5.1	1.8	37.0	35.8	43.4	43.8	38.6	33.3	34.3	28.9	33.6	22.5	32.0	35.4	2.0	3.2	2.7	23.2	6.4	7.4	18.1	14.8	9.1	40.2	9.6	5.8	1.9	32.9	11.1	18.4	12.5	24.2	2.2	14.2	0.0	16.1	3.2	3.3	7.6	2.1	10.8	1.7	60.9	5.6	12.3	14.0	23.4	4.5	2.5	9.0	1.4	12.1	4.5	40.4	58.0	15.2	38.7	3.2	4.4	1.8	12.5	3.2	10.6	17.8	2.8	9.7	4.1	31.2	25.5	6.3	17.8	7.9	1.9	9.3	11.9	6.1	7.2	19.3	6.6	16.0	9.4	13.9	15.5	5.7	4.3	16.8	7.2	17.0	17.9	13.9
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423439-42721878	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.7;liver: 213.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 53.3;Hepatocytes: 141.3;Inhibitory neurons: 115.7;Oligodendrocyte precursor cells: 181.0"	"Group enriched"	"Detected in many"	4	"breast cancer: 2.8;liver cancer: 7.6;prostate cancer: 8.1;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 21.2;T-47d: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	2200000	24000000		"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	84.7	5.6	1.8	1.7	2.1	0.2	30.1	1.7	1.7	5.2	2.3	5.8	1.1	4.5	4.6	3.9	5.4	5.2	8.9	1.8	5.6	11.8	213.3	4.0	1.3	1.0	2.0	7.5	2.1	5.5	1.2	4.8	1.4	11.1	5.7	0.4	3.7	4.7	45.7	5.6	4.3	4.0	1.1	4.0	6.1	1.7	3.4	2.3	4.6	11.6	0.9	5.0	5.8	1.4	0.0	0.0	0.6	5.0	3.3	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.3	4.3	0.0	0.0	2.6	0.0	0.1	0.0	0.6	0.0	0.0	21.2	7.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.3	0.1	3.5	0.6	56.0	0.1	3.0	4.8	2.1	2.6	0.5	0.5	0.0	0.0	0.5	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.7	1.7	1.8	5.6	1.0	2.0	1.4	1.1	3.4	1.4	17.2	0.0	0.5	14.7	0.4	4.7	4.5	17.8	10.2	0.6	9.7	16.0	18.6	1.5	1.9	1.8	0.0	17.4	0.5	2.8	1.9	0.0	5.1	0.5	9.4	4.8	3.0	5.3	53.3	0.2	2.2	23.8	0.5	0.3	0.0	1.1	6.1	141.3	1.9	0.0	115.7	1.9	0.0	3.0	1.8	2.8	18.6	0.7	1.8	36.5	0.0	0.7	0.0	181.0	3.6	0.2	1.7	12.0	0.0	5.2	0.0	9.6	0.6	0.4	13.1	18.7	15.1	0.7	0.3	2.9	3.7	40.2	0.5	49.4	2.2	0.9
GINS2	"Pfs2, PSF2"	ENSG00000131153	"GINS complex subunit 2"	Q9Y248	16	85676198-85690073	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 163.5;Spermatogonia: 148.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 271.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA057285	Uncertain		Approved	Nucleoplasm		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA057285: AB_2683398"	"unprognostic (3.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.70e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.60e-1)"	1.0	0.9	3.0	5.4	2.8	14.7	3.7	3.0	3.7	1.7	2.2	6.4	4.6	1.6	1.3	4.7	1.1	0.4	0.6	4.5	2.2	0.7	3.0	0.8	9.0	2.3	2.4	1.4	0.9	2.6	0.8	3.0	2.3	1.5	7.0	11.1	1.3	0.8	2.7	3.2	5.3	1.6	2.3	3.0	2.2	9.6	2.3	10.2	1.8	1.0	11.0	1.4	2.1	2.6	50.7	36.2	69.0	28.9	2.0	6.7	18.3	33.8	13.7	49.8	30.5	48.2	32.9	60.0	18.1	12.0	26.0	38.0	73.7	28.1	47.9	20.8	63.9	29.2	25.7	54.6	0.3	20.6	15.6	1.8	3.4	30.0	11.5	6.1	21.6	47.5	82.4	13.8	28.9	107.1	72.7	77.8	38.8	45.0	27.3	100.7	41.5	33.1	16.4	20.9	94.2	30.0	49.4	10.0	10.0	27.3	100.0	28.2	12.8	32.1	42.5	30.6	39.5	25.6	48.3	271.9	18.7	43.4	37.2	0.7	0.2	1.1	1.0	1.0	0.1	1.0	3.3	2.3	1.3	0.7	1.6	1.1	0.9	3.2	2.8	0.8	8.5	1.7	3.0	2.8	3.0	3.7	4.5	2.2	2.3	2.4	2.3	2.3	2.3	2.6	0.6	3.2	0.0	0.7	8.5	9.2	7.4	9.5	4.0	20.3	13.1	18.5	1.0	0.0	3.8	3.7	2.1	35.3	3.1	11.9	3.9	8.2	9.8	1.5	3.3	2.4	3.0	43.3	0.5	1.5	31.8	7.2	5.6	2.7	1.3	21.6	0.0	2.1	23.8	8.4	0.4	14.9	4.1	1.3	6.6	29.4	1.2	3.3	0.0	0.0	1.1	5.6	0.0	1.0	0.6	2.0	4.5	1.9	43.1	2.6	2.4	0.7	1.7	7.5	19.7	4.2	7.9	163.5	148.4	13.8	3.8	12.7	4.2	2.2	33.6	7.4
GINS3	"FLJ13912, PSF3"	ENSG00000181938	"GINS complex subunit 3"	Q9BRX5	16	58295080-58406147	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 146.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041216, HPA048209"	Uncertain		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041216: AB_10794989, HPA048209: AB_2680314"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.34e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.14e-7)"	"unprognostic (9.76e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.07e-2)"	4.3	7.4	2.0	4.2	4.2	8.4	3.7	3.7	2.6	3.7	2.2	5.8	3.2	2.8	3.7	9.1	2.4	1.5	6.2	2.4	2.5	2.5	2.6	2.1	7.8	3.0	3.5	1.3	1.7	3.7	2.0	3.7	2.7	2.2	4.2	1.8	3.4	4.6	1.8	4.5	2.8	3.8	2.8	5.4	2.6	6.8	3.2	8.8	1.9	4.9	8.0	3.0	6.7	2.7	20.2	22.4	26.5	14.3	2.9	3.7	13.3	22.4	9.8	35.4	26.8	16.9	20.2	35.0	17.5	7.6	26.3	18.7	24.5	18.8	39.6	19.5	30.4	20.4	12.0	20.5	1.6	26.1	33.7	4.2	3.5	18.4	6.3	7.9	24.4	28.9	33.5	14.4	15.0	20.9	48.1	24.2	24.5	17.2	45.3	82.6	29.4	44.4	12.8	12.6	30.3	20.1	37.3	24.3	12.8	10.6	12.9	21.4	10.4	23.5	27.8	14.2	28.4	14.3	20.2	146.3	16.2	26.1	29.3	0.1	1.8	0.1	1.9	1.6	1.5	2.5	1.6	2.9	4.1	4.4	1.5	2.5	0.4	4.1	1.0	8.2	2.4	1.5	2.0	4.2	3.7	2.6	2.4	2.5	3.0	3.5	2.7	2.8	3.2	2.7	3.9	0.0	2.6	9.1	3.2	1.8	4.9	2.7	4.0	1.5	2.0	1.7	4.1	0.0	1.4	0.0	2.1	9.1	4.5	1.6	0.0	3.7	20.7	1.8	2.1	4.3	0.0	12.4	0.6	2.0	7.6	2.5	1.5	7.9	1.3	6.9	3.6	0.8	2.8	5.0	0.2	0.9	0.0	1.6	1.1	9.2	1.5	1.9	1.8	2.8	2.6	1.8	2.1	5.0	1.2	1.9	0.3	1.2	6.2	1.7	0.2	0.5	1.1	1.8	6.6	1.6	3.0	4.6	8.7	13.0	2.4	3.1	2.4	3.2	2.8	4.9
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573475-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 97.8;Late spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"		NA	NA		36000	"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	30.2	13.5	79.4	18.0	89.3	14.4	29.9	29.1	122.3	22.0	14.9	20.5	17.9	20.9	7.6	28.6	22.5	15.5	28.9	101.2	38.0	18.4	7.6	34.8	21.3	42.5	45.3	21.3	21.9	18.0	23.7	21.1	39.7	21.3	10.1	12.1	19.0	14.4	31.9	34.2	20.5	12.9	31.7	22.3	19.1	88.8	51.8	23.1	23.2	18.5	15.2	21.6	23.6	62.1	49.7	80.9	39.1	69.9	30.4	19.1	45.3	23.9	23.4	28.2	25.1	33.1	18.0	37.3	37.3	31.5	50.5	79.5	41.6	61.4	14.4	48.3	49.7	26.9	39.8	29.8	37.0	34.4	21.3	23.4	69.2	32.4	50.5	40.0	53.0	48.6	22.3	31.2	20.5	50.9	109.0	45.7	29.2	49.9	19.2	81.7	52.3	55.6	25.8	26.7	82.0	70.0	33.8	77.2	117.7	27.9	38.0	45.0	66.2	26.7	38.2	59.3	49.0	25.8	39.3	41.5	43.9	29.0	45.9	0.1	1.6	1.4	1.9	2.5	0.9	0.7	1.9	2.1	2.2	0.6	1.6	1.1	0.5	2.4	1.8	1.8	1.3	1.8	79.4	89.3	29.1	122.3	101.2	38.0	42.5	45.3	39.7	31.7	51.8	62.1	54.6	3.2	1.5	21.9	9.5	27.1	6.7	9.2	10.2	15.5	12.6	16.3	8.7	4.3	4.9	5.5	10.4	5.1	17.3	19.2	1.9	7.5	97.8	9.4	16.8	30.8	14.9	1.7	16.8	9.4	8.0	9.7	11.2	10.5	1.3	17.9	22.5	4.0	8.3	11.8	14.1	13.8	8.2	9.5	18.9	99.2	14.3	10.6	8.8	15.9	7.4	13.3	9.2	12.5	16.9	9.5	11.5	10.5	8.7	13.4	17.2	6.1	9.8	10.2	13.1	17.3	9.5	30.5	11.5	14.4	28.1	3.6	12.4	8.6	14.6	8.3
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149930-228159826	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 51.3"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 12.5;Oligodendrocytes: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.4;SCLC-21H: 2.9;TIME: 2.7"	"Region enhanced"	"Detected in all"		"white matter: 105.5"	"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.9	0.9	13.6	0.6	31.2	0.2	1.7	39.0	20.2	4.2	5.2	5.8	0.2	4.7	0.9	1.4	5.4	0.7	1.7	13.9	19.5	1.3	0.5	2.9	0.6	43.9	31.6	3.8	0.5	0.7	1.4	0.5	38.1	3.0	0.3	0.5	0.8	1.7	0.8	1.7	1.7	1.8	28.1	1.4	2.4	1.2	27.6	0.4	2.0	0.8	0.3	4.2	3.5	51.3	0.2	0.2	0.1	0.3	0.8	0.4	1.0	0.8	0.2	0.3	0.4	0.5	0.7	0.1	5.4	1.5	0.4	0.5	0.2	0.2	0.1	0.2	0.9	0.2	1.4	1.2	1.4	0.0	0.0	0.2	0.1	0.5	0.3	0.7	0.1	1.0	0.6	0.1	0.2	0.3	1.1	0.3	0.3	0.0	1.1	0.2	0.1	0.0	0.4	0.0	2.9	1.7	0.2	0.0	0.2	0.1	0.1	0.2	2.7	0.7	2.1	2.5	0.9	0.1	0.4	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.6	31.2	39.0	20.2	13.9	19.5	43.9	31.6	38.1	28.1	27.6	51.3	2.8	0.0	0.6	0.7	0.2	3.4	1.3	0.6	1.8	2.6	1.3	0.6	1.8	0.0	0.0	0.0	12.5	0.0	0.4	0.2	0.0	0.1	0.2	1.0	1.1	4.3	0.0	0.0	0.8	0.5	0.0	2.2	0.0	1.6	0.0	0.3	3.6	0.0	0.1	3.3	1.1	0.3	0.0	0.6	3.8	0.0	2.5	1.3	1.8	0.0	0.0	0.3	0.0	0.0	26.9	1.1	0.0	4.1	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.6	1.8	0.0	0.0	0.5	1.7	0.0	0.8	0.6	0.3	1.0
GLCCI1	"FAM117C, GIG18, TSSN1"	ENSG00000106415	"Glucocorticoid induced 1"	Q86VQ1	7	7968796-8094272	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.7"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 193.3;Inhibitory neurons: 149.3;Oligodendrocyte precursor cells: 276.5;Plasma cells: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.7;U-266/70: 86.8;U-698: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001674, HPA005987"	Approved		Approved	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli		"HPA001674: AB_1078971, HPA005987: AB_1078970"	"unprognostic (6.12e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.20e-3)"	4.4	3.5	0.7	7.1	4.4	7.4	3.2	6.0	7.4	4.3	0.0	4.5	5.2	2.5	1.0	2.0	2.0	3.4	1.2	0.7	3.1	3.1	3.4	8.9	12.2	0.9	0.8	4.2	1.1	4.9	2.1	3.8	0.8	2.7	4.0	7.4	3.8	1.6	2.1	4.0	3.8	2.2	0.0	7.1	5.3	10.9	2.4	33.7	16.7	1.6	14.8	4.4	1.4	5.7	5.3	0.8	8.4	2.1	2.5	3.6	1.7	4.4	6.1	2.5	2.4	2.7	1.7	14.3	1.0	3.6	4.3	0.8	7.7	2.3	3.3	7.2	6.0	4.3	10.1	1.9	4.1	6.8	6.0	1.7	2.8	1.7	5.6	4.2	2.3	5.3	15.7	37.7	4.5	3.0	3.1	6.7	20.9	2.3	5.2	15.3	6.3	7.7	2.5	6.0	13.8	26.9	6.7	8.2	0.5	22.3	9.8	17.5	1.9	4.6	2.0	4.1	2.3	86.8	29.8	40.4	4.8	7.0	3.5	2.0	0.0	0.7	1.1	0.1	1.0	0.7	1.1	0.8	0.0	1.4	0.6	0.7	0.5	2.1	0.0	1.0	2.0	0.2	0.7	4.4	6.0	7.4	0.7	3.1	0.9	0.8	0.8	0.0	2.4	5.7	7.2	83.3	49.5	98.9	28.5	10.3	8.2	4.3	5.7	63.4	13.3	11.2	6.9	1.5	21.6	7.3	43.8	11.6	50.2	3.6	1.9	1.2	87.6	9.5	12.8	4.0	19.3	6.9	193.3	1.6	11.4	8.0	4.6	10.2	5.7	41.5	6.4	9.2	13.5	8.4	149.3	7.6	8.2	2.7	4.6	20.5	8.1	9.4	8.8	112.4	3.1	19.4	71.1	276.5	73.2	3.4	2.6	11.3	132.0	19.6	2.4	2.0	15.4	21.5	6.6	6.6	9.8	76.0	36.0	8.1	13.1	28.7	36.1	8.5	4.3	13.6
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 10.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Fibroblasts: 10.4;Leydig cells: 25.1;Peritubular cells: 30.9;Skeletal myocytes: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.1;hTEC/SVTERT24-B: 13.1;U-2 OS: 17.9;WM-115: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	1.6	1.0	1.9	0.9	2.2	0.0	1.4	1.4	1.3	4.3	0.6	3.4	0.4	4.7	1.2	0.8	2.8	2.1	2.3	1.1	1.9	1.4	0.4	2.0	0.3	2.1	2.1	10.9	0.3	0.1	1.8	0.8	1.8	2.9	0.6	0.0	1.4	1.1	0.9	2.7	1.6	1.9	1.6	0.8	1.6	2.4	1.8	1.3	1.0	0.4	0.3	3.1	2.4	0.9	0.0	10.3	20.1	5.5	3.2	4.0	0.0	5.8	1.8	2.4	2.4	0.0	0.5	0.0	0.9	5.2	0.9	0.3	4.3	0.2	1.9	0.0	2.1	0.4	6.1	0.2	3.8	0.0	1.2	2.3	0.0	13.1	0.0	2.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	1.6	4.3	0.1	2.2	3.5	0.0	0.0	2.0	2.1	3.8	0.0	0.2	4.3	0.1	0.0	5.1	0.0	17.9	2.5	0.0	0.0	0.1	0.0	7.4	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.2	1.4	1.3	1.1	1.9	2.1	2.1	1.8	1.6	1.8	0.9	0.3	0.0	0.0	39.5	0.0	2.0	0.1	0.5	0.6	0.0	0.1	0.9	1.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.3	6.1	0.5	0.0	0.0	0.7	0.2	0.1	10.4	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.5	2.1	25.1	0.1	0.0	2.8	0.0	0.0	1.0	3.0	0.3	1.0	0.0	30.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.0	3.4	0.1	3.6	0.1	1.7	0.0	0.0	7.9	0.0	0.1
GLI3	"ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV"	ENSG00000106571	"GLI family zinc finger 3"	P10071	7	41960949-42264100	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"Astrocytes: 301.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 47.1;WM-115: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005534	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA005534: AB_1078973"	"unprognostic (2.53e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.48e-5)"	"unprognostic (9.13e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.00e-2)"	6.1	1.9	9.2	3.6	8.8	0.1	8.9	1.0	5.4	7.2	0.0	11.6	1.2	11.8	2.7	3.7	8.2	3.8	1.6	6.3	5.5	1.7	0.3	3.4	0.9	1.7	10.4	13.2	0.7	0.5	1.1	11.9	3.0	5.5	2.9	1.8	2.8	8.2	1.1	8.3	3.4	10.7	0.5	1.1	2.6	1.7	14.4	3.0	4.6	2.3	1.7	4.8	7.3	2.3	0.0	0.0	47.1	0.4	16.9	23.6	3.5	3.1	9.0	9.3	12.8	0.0	0.0	0.0	1.7	22.1	22.7	10.1	8.7	8.9	10.8	0.0	7.0	0.0	6.0	0.0	9.0	0.0	0.1	21.0	12.9	10.6	6.8	5.7	10.6	5.4	0.0	0.2	5.6	5.6	0.4	0.0	20.9	0.0	21.2	12.4	0.1	1.4	0.2	6.4	1.5	0.0	6.3	7.0	4.1	23.8	8.0	0.1	11.3	13.6	18.8	16.0	6.0	0.1	0.0	0.0	7.3	0.2	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.8	1.0	5.4	6.3	5.5	1.7	10.4	3.0	0.5	14.4	2.3	2.9	0.0	7.7	301.3	0.2	23.5	7.2	8.5	31.9	1.6	20.5	27.1	1.8	0.0	2.3	1.8	0.0	21.1	0.5	0.0	0.0	0.0	16.6	2.4	12.6	3.4	0.0	0.0	0.8	0.0	13.6	25.9	0.0	4.6	1.3	10.5	3.9	0.0	3.3	0.0	3.6	0.1	6.1	0.3	6.3	5.4	19.3	0.4	8.8	22.5	0.0	13.6	0.0	8.5	0.7	0.1	0.0	3.4	1.2	6.6	0.0	3.8	1.5	1.1	13.1	17.0	12.1	0.3	2.2	7.9	15.5	34.2	0.7	5.2	0.1	5.0
GLI4	"HKR4, ZNF928"	ENSG00000250571	"GLI family zinc finger 4"	P10075	8	143267433-143276931	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023131	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytokinetic bridge"		"HPA023131: AB_2671080"	"unprognostic (4.98e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.45e-3)"	"unprognostic (5.03e-1)"	"unprognostic (6.88e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.71e-3)"	11.6	6.6	8.8	4.7	8.2	5.8	10.7	8.3	15.4	12.3	3.3	10.8	6.4	10.3	2.1	12.8	10.2	2.7	13.0	9.6	7.1	13.7	12.0	6.9	5.6	7.4	6.8	13.4	12.6	4.6	9.3	2.0	7.5	13.4	3.7	2.5	9.2	3.9	9.2	12.9	10.4	1.8	5.1	11.6	11.5	10.4	7.5	5.5	10.1	2.0	4.8	11.3	11.1	7.2	6.7	13.5	6.2	9.9	9.9	4.1	7.0	3.9	2.3	2.9	3.5	3.9	19.1	8.7	7.2	6.5	4.2	8.7	3.4	4.3	1.9	15.3	10.3	13.4	7.1	4.6	7.1	4.2	4.3	12.9	2.3	4.0	8.5	6.7	6.4	13.2	7.2	14.1	8.0	18.5	19.7	3.5	5.8	12.8	19.0	11.9	2.9	8.8	7.0	15.0	6.0	7.0	11.7	5.0	8.2	5.7	22.1	1.9	3.6	4.3	12.1	6.2	4.1	18.6	9.7	7.0	7.0	8.0	7.3	0.0	0.3	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.3	0.6	0.2	0.3	1.1	0.0	1.1	0.6	0.2	8.8	8.2	8.3	15.4	9.6	7.1	7.4	6.8	7.5	5.1	7.5	7.2	9.5	0.0	0.0	13.1	11.2	7.4	12.7	1.3	13.6	14.6	10.9	12.2	2.0	12.8	1.1	12.9	20.9	5.0	20.6	15.4	25.4	2.6	6.3	8.2	10.6	6.8	11.5	5.9	7.2	4.0	4.5	9.5	11.7	7.3	4.5	15.8	8.9	7.7	7.2	6.7	8.4	7.6	2.0	10.1	5.7	4.3	16.1	9.9	8.8	12.2	6.9	11.9	13.4	4.5	15.5	3.6	17.9	16.6	8.8	9.4	16.4	20.1	2.3	11.9	6.6	11.2	10.6	13.4	14.7	15.8	10.7	2.9	11.9	14.6	13.7	9.9
GLIS2	NPHP7	ENSG00000126603	"GLIS family zinc finger 2"	Q9BZE0	16	4314761-4339597	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 22.1;Peritubular cells: 33.8;Proximal tubular cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062755, HPA065406"			Enhanced	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA062755: , HPA065406: "	"unprognostic (2.86e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.59e-5)"	"unprognostic (3.76e-1)"	"unprognostic (5.15e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.59e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.40e-3)"	16.3	23.4	4.4	2.5	4.1	0.1	11.4	5.2	3.9	22.3	3.3	19.2	1.5	20.9	0.7	4.9	17.3	5.6	30.9	3.1	3.8	41.5	3.2	30.6	1.6	5.6	5.6	27.5	13.2	2.3	18.9	4.4	4.3	21.7	0.4	0.7	9.8	4.0	3.0	7.1	7.4	3.3	4.4	4.5	11.9	5.3	5.5	0.2	19.4	0.4	0.5	20.2	11.4	2.5	6.1	12.3	2.0	4.8	1.5	7.2	4.3	6.1	5.3	2.3	1.6	3.2	5.1	0.0	10.8	6.0	2.2	3.7	1.2	5.6	0.1	8.9	0.3	0.0	10.9	1.9	6.9	0.0	0.9	4.1	1.2	1.9	0.9	2.6	1.9	0.1	0.5	2.0	1.3	4.0	0.0	1.2	4.6	0.7	2.2	11.7	2.6	6.7	0.4	0.0	0.9	4.6	6.1	2.9	1.7	0.6	8.2	1.0	3.2	3.2	6.0	36.8	1.9	1.4	0.9	1.5	1.4	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	4.1	5.2	3.9	3.1	3.8	5.6	5.6	4.3	4.4	5.5	2.5	4.8	16.0	9.8	8.5	0.0	5.6	5.4	8.7	1.8	10.6	3.5	2.4	5.9	15.7	5.6	12.9	4.2	0.9	0.1	0.0	19.6	11.8	0.2	1.8	9.0	6.9	0.0	0.0	2.1	8.3	0.9	18.3	0.5	2.1	0.0	2.6	6.8	0.7	0.4	6.7	3.2	0.2	2.0	0.3	6.1	0.9	22.1	0.8	3.6	5.6	1.0	10.4	0.0	4.0	1.3	10.3	0.0	33.8	0.0	5.1	0.0	21.7	3.1	7.3	0.0	8.2	14.6	0.2	3.4	0.7	2.8	1.1	0.7	0.1	0.0	2.8
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703145	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 2571.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	55.4	62.3	69.4	38.9	74.1	31.6	74.2	74.6	83.4	55.9	77.2	51.8	116.3	57.8	110.9	60.0	72.3	41.4	88.9	72.6	76.2	87.2	157.7	66.6	48.4	73.7	72.8	82.8	42.1	106.1	23.2	64.1	75.1	171.4	52.3	100.3	43.2	62.1	154.2	66.6	67.7	61.8	77.9	48.2	48.5	27.9	72.9	50.0	54.8	128.8	60.3	52.4	51.6	77.1	201.6	92.0	257.4	256.7	119.2	213.9	227.0	171.1	161.4	235.4	243.0	224.4	75.3	222.5	132.2	137.5	280.1	129.5	222.5	221.1	295.8	203.8	343.0	329.4	105.7	211.3	178.5	126.7	2571.5	183.9	133.5	223.7	159.0	153.2	258.5	154.9	264.7	143.6	223.3	170.6	199.5	160.5	185.5	179.2	176.7	171.0	311.1	145.8	217.8	149.9	199.3	201.3	120.6	165.4	329.8	175.9	192.4	628.3	107.6	182.0	167.1	159.8	275.9	112.7	227.0	608.6	66.1	322.7	299.6	23.7	20.7	15.3	35.5	33.4	48.0	51.9	35.3	36.7	39.0	51.4	32.7	34.9	2.7	23.5	26.9	60.4	34.1	33.3	69.4	74.1	74.6	83.4	72.6	76.2	73.7	72.8	75.1	77.9	72.9	77.1	69.2	131.4	174.4	26.1	86.3	64.6	112.6	88.2	37.0	56.1	67.7	55.8	133.2	58.6	84.5	90.1	20.9	102.7	68.3	34.1	248.4	132.1	4.5	76.2	58.8	74.3	36.5	83.5	23.9	73.3	323.0	86.0	53.0	67.5	71.4	78.7	161.0	114.0	78.8	69.0	21.9	39.3	99.7	125.7	72.8	6.5	83.9	70.0	104.9	17.8	92.6	190.3	49.4	25.1	24.8	77.3	36.0	109.9	86.4	178.8	103.2	132.2	80.7	65.5	46.0	62.0	70.9	15.0	16.1	77.2	88.2	73.2	62.4	123.7	63.4	130.2
GLOD4	"C17orf25, CGI-150, HC71"	ENSG00000167699	"Glyoxalase domain containing 4"	Q9HC38	17	757097-783390	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021623, HPA023246, HPA023248"	Enhanced		Approved	Cytosol		NA	NA		3500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"	42.5	46.8	27.4	33.5	31.0	22.5	34.5	25.4	33.3	28.4	33.4	71.3	80.5	31.6	33.6	42.9	44.9	32.6	37.3	30.6	36.4	75.7	67.7	31.5	46.9	27.8	27.9	39.9	40.5	37.6	23.2	36.7	28.8	37.8	48.3	25.6	39.5	27.3	39.8	44.3	72.7	31.9	28.3	36.8	85.3	19.4	35.3	35.2	47.4	23.0	40.0	41.5	22.4	27.5	121.1	106.8	120.9	67.1	52.0	51.5	73.8	94.4	57.6	75.0	56.7	87.4	84.0	142.9	100.2	42.8	69.7	85.5	106.6	60.1	78.0	105.4	91.2	69.0	55.7	115.5	51.6	72.1	87.5	36.2	81.9	75.5	66.0	47.7	70.4	116.9	115.1	90.4	80.2	73.9	124.1	55.3	88.7	118.8	36.3	122.7	49.0	65.9	74.5	81.2	54.8	91.8	74.8	53.6	124.6	75.3	66.6	75.2	92.2	71.0	56.8	99.9	120.4	50.3	100.0	89.1	83.6	79.5	75.9	26.1	51.8	48.7	68.1	64.1	73.2	70.0	81.0	82.2	45.9	75.4	68.9	75.7	7.1	64.0	70.4	47.2	99.1	75.9	27.4	31.0	25.4	33.3	30.6	36.4	27.8	27.9	28.8	28.3	35.3	27.5	52.2	57.7	35.2	11.4	48.5	47.9	40.4	91.1	40.5	39.6	39.2	36.3	30.9	54.3	70.4	101.2	29.2	104.5	43.2	39.3	178.1	77.3	34.0	44.0	34.3	43.8	28.9	54.7	12.7	57.4	85.9	41.5	71.4	40.8	40.4	42.1	31.1	58.8	82.3	13.5	13.6	52.0	97.6	30.1	26.5	63.3	38.8	40.8	67.6	7.5	61.7	39.8	44.3	10.1	13.2	58.7	52.0	46.6	27.5	39.4	110.5	186.1	66.8	38.7	46.0	30.3	45.8	23.5	32.9	53.6	54.8	69.1	53.3	57.2	63.7	39.3
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880821-190965552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 391.8;Excitatory neurons: 427.1;Proximal tubular cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 907.3;RPTEC TERT1: 419.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		92000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	37.0	77.4	38.5	45.7	50.5	28.7	32.0	40.5	74.6	31.0	35.6	32.0	92.2	28.8	26.6	16.8	25.1	41.8	34.7	55.5	35.9	316.8	11.7	55.6	68.0	44.7	19.8	28.9	36.9	62.0	19.9	35.8	52.5	20.8	30.1	81.8	20.4	31.2	15.8	28.5	103.4	36.9	12.0	49.3	18.7	16.2	24.1	41.7	35.7	23.6	57.9	36.5	23.6	44.8	43.6	47.2	32.4	43.1	99.7	68.9	84.0	126.8	95.7	90.6	103.1	58.1	42.1	88.5	907.3	269.3	46.1	55.6	58.0	50.0	131.5	219.8	37.7	147.3	69.1	72.2	90.8	87.2	66.5	62.9	51.0	71.2	48.4	90.1	119.3	36.7	69.3	175.2	203.3	22.8	59.2	83.7	86.9	25.7	76.7	74.2	83.7	77.4	419.2	78.9	44.9	46.8	172.8	37.9	169.2	115.1	14.9	53.0	85.3	129.4	94.5	65.9	156.8	56.2	138.9	122.1	46.7	70.6	105.5	6.4	1.0	1.9	3.7	1.5	6.5	3.4	4.4	4.8	1.6	3.8	4.5	5.5	2.1	2.8	1.1	3.6	4.1	1.1	38.5	50.5	40.5	74.6	55.5	35.9	44.7	19.8	52.5	12.0	24.1	44.8	81.0	189.1	122.5	61.0	89.3	174.5	44.7	15.6	60.9	93.5	51.8	49.5	38.2	35.8	28.4	391.8	210.6	4.4	128.0	100.6	50.9	21.4	6.6	33.7	66.8	68.3	59.2	17.9	427.1	24.5	15.6	66.0	46.4	97.9	36.8	48.2	63.5	4.3	29.1	26.9	270.5	36.7	14.2	31.2	230.0	7.3	28.6	84.3	88.9	143.4	68.4	11.9	55.6	163.3	146.9	29.8	92.9	43.2	118.4	70.1	165.9	539.1	17.0	111.9	19.7	71.6	76.0	11.3	12.9	61.7	162.8	4.0	114.0	97.8	43.6	56.7
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988987-104064183	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	16.9	10.9	4.2	5.2	4.9	1.5	19.5	2.6	5.1	29.6	11.2	17.6	5.8	27.4	21.6	7.5	22.3	35.8	15.4	4.8	3.7	4.3	2.7	10.2	6.0	2.9	3.1	41.6	4.5	6.6	9.6	9.4	3.1	13.3	11.4	1.0	7.7	16.0	3.2	4.1	7.7	21.8	2.8	1.6	8.4	6.8	3.7	2.2	26.3	11.5	5.8	20.8	18.9	4.4	0.3	0.6	0.7	22.2	28.3	69.3	0.5	32.0	89.4	8.3	10.5	0.4	0.2	0.9	1.8	37.5	0.4	0.1	0.4	11.9	7.0	1.6	10.0	0.6	11.2	0.2	12.7	0.9	0.5	63.2	0.7	10.0	13.8	51.9	4.4	0.6	0.4	1.3	36.5	0.3	0.8	0.5	2.7	0.1	6.7	1.0	33.6	0.2	45.5	0.4	1.3	1.7	33.5	0.8	0.4	2.4	6.0	0.5	0.7	13.2	6.2	1.3	1.9	3.9	0.8	0.3	1.0	0.7	1.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	4.9	2.6	5.1	4.8	3.7	2.9	3.1	3.1	2.8	3.7	4.4	8.0	0.0	4.6	2.9	0.3	2.8	4.2	2.4	0.0	0.8	1.0	26.3	3.9	1.5	0.1	0.0	2.1	4.1	0.4	0.0	0.0	0.1	41.2	0.6	8.3	7.5	1.8	0.0	10.2	0.0	0.8	55.9	1.1	0.4	0.0	0.1	20.7	0.3	0.6	0.0	10.5	1.3	0.0	0.6	2.8	11.5	55.9	0.4	3.6	4.7	0.6	0.5	0.0	1.0	2.6	0.3	0.0	51.9	1.2	1.4	0.0	0.0	0.1	0.5	6.6	25.2	18.0	1.1	1.1	0.2	2.4	1.4	0.6	10.7	0.0	0.1
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050202-87094843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 816.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.1;Hepatocytes: 402.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 555.0"	"Low region specificity"	"Detected in all"							"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		23000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	70.1	93.0	217.2	44.8	219.0	29.2	96.4	180.4	216.8	50.2	135.8	63.4	80.9	48.1	30.0	77.0	47.4	53.3	75.6	193.3	223.2	249.2	816.4	57.7	42.9	220.9	222.9	71.6	66.2	39.0	37.1	58.8	202.3	110.5	61.5	90.2	55.6	53.2	51.1	84.2	88.6	53.3	223.2	46.4	57.0	22.3	254.6	44.8	68.1	64.4	59.2	68.1	55.6	202.3	127.1	100.3	77.1	131.5	143.0	174.5	84.0	97.7	167.8	92.4	100.5	233.0	120.6	141.5	77.8	143.4	53.0	194.7	101.4	98.5	98.0	102.7	79.8	69.0	55.9	555.0	318.1	163.2	95.5	121.3	181.5	103.2	304.9	140.3	112.0	109.3	70.7	124.0	101.0	92.1	148.1	145.7	88.2	136.9	79.8	110.4	98.3	93.1	267.4	101.8	39.7	73.9	87.8	68.8	126.1	73.9	94.3	112.8	112.4	47.8	42.5	98.2	101.0	73.6	81.4	167.5	115.3	182.8	29.3	9.1	14.2	9.7	8.3	11.1	10.3	9.8	11.2	10.1	15.9	11.3	9.9	8.0	1.2	13.6	16.0	5.9	12.6	6.5	217.2	219.0	180.4	216.8	193.3	223.2	220.9	222.9	202.3	223.2	254.6	202.3	49.3	22.4	23.9	294.1	56.6	106.0	57.5	32.2	105.3	22.5	83.3	38.2	60.2	57.2	47.3	60.7	37.5	95.7	45.6	56.1	156.5	32.5	14.2	37.3	44.0	54.1	39.4	52.6	35.8	33.8	63.8	89.0	86.2	59.7	43.2	33.6	50.7	402.3	69.1	15.2	38.0	49.5	36.7	74.1	184.5	26.0	88.0	81.4	104.9	42.2	50.6	140.0	39.1	48.7	42.9	50.2	38.3	90.7	75.7	103.4	124.2	175.5	21.6	68.9	65.7	41.3	55.9	11.4	8.6	189.5	122.3	47.6	84.6	70.9	49.6	107.3
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047610-121050094	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"liver: 3.9;testis: 15.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.6;Cytotrophoblasts: 4.6;Early spermatids: 2.6;Hepatocytes: 4.6;Proximal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;K-562: 4.3;OE19: 2.1;SK-MEL-30: 5.5;THP-1: 2.7;WM-115: 6.0"									"HPA042492, HPA044839, HPA061369"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	1.7	1.7	0.0	0.1	0.3	0.0	1.2	0.0	0.8	0.4	0.5	0.5	0.0	0.4	1.7	0.5	0.4	0.4	0.9	0.4	0.0	1.6	3.9	0.5	0.1	0.0	0.0	0.4	1.0	0.5	0.4	0.8	0.0	0.4	0.0	0.1	0.6	0.2	0.5	0.6	0.4	0.1	0.0	0.1	0.6	15.4	0.1	0.0	0.4	0.1	0.1	0.4	0.4	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.8	0.0	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.1	1.2	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.8	0.0	0.0	2.3	0.1	0.0	0.5	0.0	0.6	0.0	0.4	0.1	2.6	0.0	0.0	0.0	2.1	4.6	0.1	0.1	1.9	0.2	2.6	0.6	0.8	0.9	0.0	0.0	1.2	0.4	0.5	0.8	0.0	0.5	0.0	0.1	0.0	4.6	0.5	0.0	0.4	0.1	0.0	1.2	0.3	2.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.2	3.3	0.0	0.1	0.0	0.9	0.4	1.2	1.0	0.1	0.1	2.5	0.3	0.7	0.2	0.3
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182378098-182392206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1443.6"	"Group enriched"	"Detected in all"	4	"Late spermatids: 8544.2;Muller glia cells: 6247.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 365.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 656.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 656.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1150.8;ASC TERT1: 807.6;HSkMC: 702.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	753.5	76.0	694.3	156.9	746.5	232.9	573.5	717.5	1237.1	161.4	583.2	157.8	24.4	116.7	115.7	218.7	224.3	105.4	129.7	676.6	764.7	65.3	280.7	221.7	75.2	891.0	783.7	303.0	204.7	32.3	70.5	176.6	767.0	103.4	92.5	891.1	233.5	96.0	1443.6	231.4	148.2	124.1	725.0	216.4	648.2	87.1	811.4	97.0	257.4	472.0	103.2	185.5	292.0	810.4	26.4	10.8	117.2	0.2	1150.8	807.6	86.0	44.1	141.7	25.9	23.4	64.1	26.7	22.4	46.3	85.5	23.8	59.3	51.8	309.4	21.5	61.2	143.3	296.5	47.6	124.8	61.1	132.6	227.2	702.1	363.3	32.9	384.6	39.1	52.8	71.7	254.3	13.3	92.6	15.0	208.2	126.5	87.3	36.8	55.0	74.3	31.3	38.6	45.8	114.0	79.7	52.5	12.4	157.3	17.4	93.3	153.1	165.9	39.7	0.9	1.9	0.8	10.1	4.8	3.4	0.4	22.3	73.9	5.0	396.5	153.4	409.4	42.3	145.8	17.6	11.5	29.9	35.5	80.0	17.8	15.3	25.3	656.8	27.2	130.5	43.7	13.0	172.0	694.3	746.5	717.5	1237.1	676.6	764.7	891.0	783.7	767.0	725.0	811.4	810.4	127.8	125.0	173.8	599.4	37.6	134.7	533.8	1190.7	260.0	105.6	166.6	99.1	216.2	171.6	855.3	82.8	52.1	161.7	113.4	118.3	74.3	124.2	1491.3	140.2	150.0	191.5	325.9	319.7	3.4	116.6	65.9	404.4	388.4	124.6	786.3	88.0	152.8	597.1	798.0	43.7	22.0	256.7	451.6	907.2	614.1	8544.2	487.4	687.4	136.9	74.9	112.7	6247.0	42.2	38.2	330.0	108.1	105.3	375.0	38.7	421.0	10.3	46.6	569.9	176.0	92.1	481.5	218.5	48.2	63.6	186.5	128.3	235.3	108.6	53.3	173.3	1420.5
GMNN	Gem	ENSG00000112312	"Geminin DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 231.4"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 184.8;Paneth cells: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 25: Pancreas - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	10.1	7.7	16.9	17.2	18.2	68.9	24.2	19.5	23.7	11.1	13.5	41.6	17.8	10.6	5.8	16.6	16.5	7.9	8.0	14.7	20.2	24.6	18.2	8.9	30.4	17.0	20.2	14.6	231.4	8.4	11.1	16.5	17.8	41.5	44.4	16.3	8.7	24.9	7.4	40.3	16.1	12.5	16.4	19.1	22.6	37.4	19.8	37.4	10.8	14.3	23.7	28.4	13.9	15.5	110.9	64.2	159.2	66.2	22.2	23.5	106.0	106.0	55.9	124.4	135.5	125.1	38.8	110.1	131.3	34.4	91.3	63.3	139.4	78.1	133.0	41.2	145.4	151.5	109.3	207.4	20.7	119.1	53.1	19.1	25.1	75.9	29.5	25.8	62.2	84.6	193.9	56.9	88.9	86.3	224.9	128.2	87.3	89.6	50.2	128.9	124.4	141.2	53.5	94.6	127.3	78.3	47.5	77.4	95.2	89.1	81.3	72.0	30.9	75.7	76.8	88.3	182.6	62.8	207.6	210.3	23.1	220.9	111.2	5.5	5.2	17.1	4.4	6.9	5.6	9.2	8.5	6.9	7.6	4.6	6.1	6.9	3.0	5.9	5.0	9.4	15.9	5.6	16.9	18.2	19.5	23.7	14.7	20.2	17.0	20.2	17.8	16.4	19.8	15.5	24.0	6.4	15.6	8.8	17.0	33.0	28.4	57.4	18.8	9.5	51.0	52.5	12.1	18.6	68.1	44.1	2.1	83.2	19.9	72.6	9.8	113.6	94.8	84.8	30.6	18.4	25.9	66.2	3.5	112.3	136.3	17.7	12.2	184.8	13.3	36.4	13.9	17.4	54.0	11.8	5.3	66.3	10.2	10.7	13.2	28.0	9.6	15.2	23.2	5.6	12.6	30.9	6.2	5.5	3.2	31.8	300.5	10.9	41.6	25.6	20.8	20.6	25.2	13.7	19.7	8.0	21.9	158.8	58.8	26.8	63.5	48.7	19.1	30.4	156.5	30.1
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Approved		Approved	Nucleoplasm,Nucleoli		No	No		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032"	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	45.0	92.1	24.5	19.7	25.7	19.3	44.3	25.8	30.2	44.7	28.2	44.2	30.9	38.2	29.9	38.7	44.9	32.0	39.6	24.8	25.7	70.1	56.0	38.8	26.9	26.2	25.6	51.2	49.0	67.7	48.1	22.7	26.8	41.7	25.5	18.8	41.8	26.3	40.6	35.2	45.8	21.2	26.0	55.9	50.7	21.9	26.1	28.4	58.4	19.8	27.3	43.1	40.3	26.2	27.1	34.2	29.0	26.7	50.9	74.7	40.0	32.1	59.2	47.3	55.7	38.8	24.6	34.7	22.5	49.8	25.5	43.6	42.4	69.2	69.5	19.0	25.5	24.3	25.0	159.1	46.8	53.7	51.4	72.2	54.9	23.6	47.7	61.1	69.7	52.3	12.5	33.3	46.6	51.8	50.1	57.1	34.3	39.5	37.3	33.5	24.2	22.6	69.1	52.7	22.0	36.2	16.9	45.8	52.6	39.5	38.6	41.1	36.2	23.0	15.8	32.0	20.6	59.4	63.1	21.8	16.6	38.9	20.2	24.3	34.2	15.0	19.7	27.5	21.6	13.7	21.5	23.7	35.9	15.9	19.3	20.2	56.0	14.9	27.9	15.8	31.5	26.5	24.5	25.7	25.8	30.2	24.8	25.7	26.2	25.6	26.8	26.0	26.1	26.2	25.2	25.6	18.7	10.7	23.2	11.0	44.5	49.9	27.3	19.6	24.8	32.9	12.5	38.6	35.7	53.3	4.2	67.2	22.6	35.6	101.8	43.6	18.3	29.6	16.6	26.3	10.3	20.6	7.8	33.0	48.5	18.8	17.9	20.0	31.7	29.7	16.8	24.8	50.0	18.5	8.0	19.8	30.5	46.6	14.6	10.5	28.9	32.5	21.4	9.4	32.1	43.3	25.7	7.5	11.7	33.7	32.1	25.2	21.2	19.0	50.2	123.1	43.2	19.7	26.3	16.0	24.5	19.8	10.3	20.7	10.7	49.3	24.6	51.3	28.4	30.5
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870650-155944020	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 100.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 272.7;Late spermatids: 193.6;Spermatocytes: 171.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol		No	No		50000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046630: AB_2679727"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	18.8	20.7	7.2	20.0	7.7	44.6	24.1	22.7	11.0	21.2	7.9	19.7	15.8	20.6	16.0	22.1	17.1	14.0	17.9	6.8	8.5	15.9	22.6	18.2	27.0	7.8	6.8	17.0	26.4	23.1	11.5	20.8	8.3	17.4	22.5	10.1	20.9	17.5	20.0	25.0	16.7	23.4	6.3	19.2	18.0	100.3	8.0	32.3	20.3	16.7	29.4	23.3	19.9	8.8	241.0	93.1	123.0	101.1	49.0	77.0	118.9	99.8	91.6	128.2	128.8	170.5	156.2	171.7	116.1	77.1	98.1	114.6	105.7	104.2	175.0	101.1	81.8	183.2	63.7	92.8	55.9	188.5	68.7	57.3	62.9	99.4	150.5	68.2	79.9	91.3	131.7	63.8	96.8	160.1	153.9	99.4	118.5	130.4	68.3	149.2	145.8	207.5	66.3	103.5	73.3	68.0	111.0	156.0	101.8	83.9	163.6	122.3	56.9	84.4	68.5	121.0	204.3	88.8	58.5	288.5	84.8	137.4	77.0	23.7	16.1	11.5	24.7	20.2	29.1	16.0	23.6	22.3	26.1	11.6	23.3	22.3	2.2	29.3	29.5	14.2	27.1	17.5	7.2	7.7	22.7	11.0	6.8	8.5	7.8	6.8	8.3	6.3	8.0	8.8	23.8	19.2	20.2	19.6	21.5	39.9	47.4	43.9	22.8	22.0	19.5	18.5	16.4	15.7	28.4	7.3	2.1	44.1	21.6	8.3	25.4	33.8	272.7	14.3	37.5	29.9	7.2	68.5	40.9	29.5	56.2	32.4	19.9	18.4	28.6	34.0	22.1	11.6	29.9	21.9	41.6	19.7	26.4	18.5	27.1	193.6	23.0	25.2	23.2	22.5	31.7	17.8	30.9	30.2	31.6	21.3	11.9	24.8	21.9	50.6	17.8	22.8	17.3	8.7	19.7	28.6	65.2	171.2	65.5	29.0	38.2	30.8	30.4	63.2	26.8	42.4
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595937	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"		"HPA027163: AB_10601655, HPA060026: AB_2684191"	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	27.8	22.4	11.1	24.8	12.1	49.9	30.4	12.5	13.5	21.7	13.1	22.8	17.8	22.8	24.4	26.4	20.1	19.4	21.6	10.9	12.1	19.2	31.6	22.7	26.5	13.0	12.0	20.4	20.8	20.9	19.3	23.5	12.7	18.2	25.5	11.7	23.2	14.2	50.6	29.5	18.7	24.4	12.1	19.6	21.9	30.2	13.5	26.1	16.0	29.0	32.7	35.2	21.2	14.1	66.5	33.5	63.9	66.4	49.8	57.1	102.9	98.6	68.5	89.3	90.4	92.6	75.2	107.8	62.7	73.5	50.8	60.6	105.1	80.5	121.1	62.6	83.5	108.4	66.4	74.5	66.5	143.3	73.7	36.2	72.6	122.4	144.3	42.7	65.2	47.1	146.8	74.6	87.3	58.2	77.7	85.9	165.8	48.2	65.9	81.8	114.7	121.8	75.0	70.7	76.9	71.1	74.2	73.4	73.1	93.8	52.7	82.5	53.0	59.1	83.9	127.2	138.6	69.9	67.8	185.8	68.3	113.2	77.3	23.2	28.1	24.4	22.5	36.3	26.0	28.1	21.0	24.6	39.8	21.1	21.9	21.2	2.8	33.5	35.3	29.0	28.2	21.7	11.1	12.1	12.5	13.5	10.9	12.1	13.0	12.0	12.7	12.1	13.5	14.1	18.5	16.0	48.1	6.5	29.7	63.3	84.3	37.2	27.3	8.8	17.5	14.5	21.9	12.8	63.3	7.3	10.4	37.2	27.8	18.2	27.4	52.9	54.0	27.2	31.0	28.1	17.3	17.7	6.4	62.3	49.4	40.8	23.9	29.7	48.1	29.5	11.0	18.3	32.0	6.7	5.3	27.3	24.4	17.9	29.6	13.5	23.9	27.7	8.8	8.4	31.7	21.1	25.7	3.5	5.7	51.5	21.9	19.2	32.4	68.3	15.7	18.8	54.4	9.6	0.0	44.8	34.8	46.7	45.6	29.5	52.8	46.1	28.3	20.6	27.5	56.5
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"	"Nuclear bodies, Mitotic chromosome"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (6.11e-4)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	47.2	47.1	17.1	42.1	17.0	27.4	68.8	18.4	24.4	38.8	18.7	40.0	38.8	33.8	25.6	65.0	28.2	28.0	29.6	17.9	19.4	33.4	50.3	29.7	51.5	17.9	17.7	35.8	60.7	27.1	35.9	36.4	17.8	46.7	46.0	16.0	46.4	26.3	78.2	39.1	29.6	32.2	16.9	34.0	41.0	26.8	17.9	35.9	28.6	42.9	64.9	92.3	41.3	19.1	110.4	79.1	114.4	125.3	105.6	105.1	178.1	133.0	101.5	135.4	100.6	121.3	80.8	255.4	42.2	100.1	104.6	78.2	189.1	125.1	180.5	156.3	134.6	196.8	139.0	189.3	218.1	283.7	138.0	96.1	216.5	147.8	224.1	90.3	107.8	99.7	214.8	136.2	93.8	77.7	170.6	162.1	195.6	153.4	151.2	99.3	93.0	315.0	108.9	153.9	81.4	105.6	82.1	190.5	193.6	101.7	74.7	155.8	86.6	92.8	100.0	139.2	281.7	147.6	252.0	387.0	96.9	203.5	148.4	1.2	15.2	3.3	19.9	16.7	34.1	28.7	26.8	24.1	26.1	23.9	30.4	29.4	1.8	26.1	12.9	40.7	18.8	20.2	17.1	17.0	18.4	24.4	17.9	19.4	17.9	17.7	17.8	16.9	17.9	19.1	34.6	22.4	48.2	5.2	84.3	163.7	146.0	111.9	77.4	19.0	72.6	46.4	51.3	25.8	144.9	12.9	10.4	73.2	78.5	42.8	41.1	105.1	54.4	44.7	76.5	53.4	47.8	51.5	11.6	104.6	117.5	92.9	47.9	53.0	63.1	47.5	23.2	41.9	40.9	21.9	11.1	71.7	67.1	24.2	77.6	28.2	51.9	43.0	78.2	5.6	59.5	17.7	38.1	7.1	9.4	99.9	34.4	34.3	122.3	126.1	19.1	47.2	56.5	14.8	6.6	106.2	79.1	37.9	74.4	59.4	153.7	90.3	63.0	74.5	85.8	135.7
GNPTAB	"GNPTA, KIAA1208, MGC4170"	ENSG00000111670	"N-acetylglucosamine-1-phosphate transferase subunits alpha and beta"	Q3T906	12	101745499-101830959	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cancer-related genes, Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014558, HPA042343"	Approved		Supported	"Golgi apparatus"		NA	NA		160000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA014558: AB_2732409, HPA042343: "	"unprognostic (6.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.71e-3)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.98e-2)"	11.9	7.9	18.8	16.2	22.2	23.9	16.4	14.4	20.0	17.4	2.7	29.6	14.2	11.8	6.2	15.6	8.8	14.8	21.5	22.7	10.8	14.5	9.4	27.0	20.6	8.5	11.1	7.2	11.3	23.0	8.4	14.8	9.7	20.1	30.3	13.0	54.3	13.0	16.4	25.1	16.2	15.9	8.9	19.0	21.3	10.4	12.4	34.1	13.9	25.9	17.8	19.3	12.0	13.3	18.2	17.5	6.4	10.9	52.3	24.8	19.6	25.4	52.3	24.7	32.2	13.5	12.4	38.1	17.9	35.1	20.1	23.2	29.8	32.8	38.4	18.1	15.6	16.3	15.4	19.3	9.7	15.0	31.7	19.3	17.7	23.5	13.8	61.4	44.0	30.0	25.9	11.0	23.4	27.8	45.6	21.0	22.0	22.6	12.5	10.6	32.6	51.2	39.5	46.8	13.6	11.2	42.3	29.7	60.7	23.5	30.6	9.8	43.6	23.1	12.5	19.6	14.4	30.0	32.9	21.5	26.4	21.8	14.6	8.6	3.8	4.4	18.8	3.6	6.2	3.0	4.0	10.3	7.1	4.9	5.1	7.9	1.4	17.0	4.6	6.9	3.3	3.7	18.8	22.2	14.4	20.0	22.7	10.8	8.5	11.1	9.7	8.9	12.4	13.3	25.3	60.9	65.0	35.9	42.1	16.8	32.9	16.2	17.1	23.6	25.2	18.9	43.5	18.6	27.8	22.0	25.0	25.7	107.3	68.3	7.9	10.3	0.6	25.3	23.7	21.1	18.0	19.5	84.5	15.1	15.0	18.9	33.1	61.6	122.8	24.6	10.4	9.7	46.7	8.4	83.8	29.6	24.4	46.7	17.6	3.8	17.1	41.2	42.7	30.0	43.5	26.9	192.6	135.2	19.8	15.7	129.3	12.8	63.9	28.1	17.7	13.8	10.0	37.0	0.0	18.6	14.9	12.4	33.0	26.7	14.3	8.8	63.4	30.6	49.7	46.5
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878275-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174"	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	8.7	9.4	5.4	8.7	7.0	5.9	7.8	5.8	6.3	8.0	7.1	10.8	10.1	8.8	5.9	9.9	7.7	7.6	10.2	5.1	5.9	6.8	9.5	7.5	7.6	6.1	6.4	8.0	10.8	9.1	8.0	5.6	6.9	8.3	9.3	37.7	8.4	8.3	13.2	10.8	9.6	8.6	6.1	8.5	8.7	15.2	6.8	5.3	8.2	9.6	7.4	10.4	8.1	9.0	8.4	14.7	8.6	9.1	14.7	13.0	11.0	13.5	14.3	14.0	10.2	9.7	9.6	5.6	6.5	15.0	10.8	21.2	7.1	11.4	10.2	8.0	7.0	5.9	20.5	12.9	16.9	7.1	13.7	8.8	8.1	13.5	16.3	9.9	12.7	7.0	9.8	9.4	10.0	17.5	5.1	8.0	3.2	19.7	13.5	3.2	12.7	12.3	7.0	11.3	5.0	9.5	16.2	13.0	8.5	7.6	25.1	5.0	14.8	13.0	7.2	16.8	12.6	11.4	19.6	6.5	16.3	7.4	13.8	8.1	3.4	4.3	4.2	3.5	3.4	3.0	2.6	4.5	3.3	3.5	2.7	2.5	7.6	3.2	2.8	4.6	2.7	1.3	5.4	7.0	5.8	6.3	5.1	5.9	6.1	6.4	6.9	6.1	6.8	9.0	11.8	6.4	14.4	32.3	8.1	2.0	4.2	5.8	6.2	16.3	10.2	10.2	21.0	7.2	10.8	5.5	64.6	6.8	11.5	11.7	3.9	9.5	16.2	10.4	13.6	10.0	5.4	5.0	31.7	8.9	4.9	7.8	10.7	8.8	15.8	14.6	10.8	14.8	6.6	18.5	31.4	9.7	12.2	7.3	4.2	9.8	5.9	9.3	8.8	20.6	10.1	15.2	9.2	27.2	34.3	9.0	2.7	9.1	11.1	4.5	7.8	6.1	17.8	38.0	6.6	15.4	12.3	50.1	21.4	11.0	4.3	8.6	9.1	10.9	8.8	4.0
GOLGA6A	"GLP, GOLGA6"	ENSG00000159289	"Golgin A6 family member A"	Q9NYA3	15	74069857-74082550	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"liver: 4.1;testis: 15.1"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 47.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"									"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "					"unprognostic (1.68e-1)"		"unprognostic (2.09e-2)"			"unprognostic (9.50e-2)"				"unprognostic (9.67e-2)"	"unprognostic (6.70e-2)"			0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	15.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6B		ENSG00000215186	"Golgin A6 family member B"	A6NDN3	15	72654738-72666394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"liver: 3.5;testis: 7.2"	"Group enriched"	"Detected in some"	4	"Astrocytes: 3.9;Early spermatids: 8.6;Excitatory neurons: 2.7;Inhibitory neurons: 2.7;Oligodendrocytes: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "					"unprognostic (5.47e-3)"		"unprognostic (1.88e-2)"			"unprognostic (2.07e-1)"				"unprognostic (2.01e-1)"	"unprognostic (2.03e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6C		ENSG00000167195	"Golgin A6 family member C"	A6NDK9	15	75258599-75270199	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 9.9"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (6.53e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GOLGA6D		ENSG00000140478	"Golgin A6 family member D"	P0CG33	15	75282835-75295807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 12.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (7.95e-3)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0
GOLGA8A	"CFAP286, FAP286, GM88, GOLGIN-67"	ENSG00000175265	"Golgin A8 family member A"	A7E2F4	15	34379068-34437466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 211.5;Oligodendrocyte precursor cells: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.0;HeLa: 80.1"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (4.80e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.58e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.68e-6)"	24.5	18.6	16.1	10.4	11.7	7.9	32.4	18.5	21.4	56.3	11.0	32.7	10.5	31.6	31.8	31.2	37.6	7.3	23.6	13.1	10.0	33.2	6.8	22.4	14.0	17.8	8.8	62.5	22.9	6.3	22.8	2.2	11.9	37.8	2.2	26.4	26.8	10.2	7.6	36.8	38.2	3.2	7.0	48.1	30.3	40.0	12.8	1.2	56.8	1.0	2.1	33.0	40.2	12.2	2.4	13.4	3.7	12.5	0.1	0.0	2.8	20.3	0.1	3.4	1.5	23.3	0.0	0.1	3.6	2.4	6.9	21.7	9.5	6.8	5.3	20.1	7.6	48.0	80.1	15.0	1.3	18.4	12.6	0.0	19.5	2.3	0.5	2.3	0.3	7.0	46.0	40.0	9.2	4.3	4.7	34.6	6.9	6.4	7.2	19.6	11.2	16.2	7.7	13.8	17.1	8.2	13.6	9.2	2.2	0.1	3.6	11.4	10.5	15.7	3.5	0.0	3.6	37.5	13.4	5.5	4.7	38.9	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.1	11.7	18.5	21.4	13.1	10.0	17.8	8.8	11.9	7.0	12.8	12.2	37.3	211.5	71.6	82.9	16.1	26.1	10.9	13.4	7.4	95.3	36.1	41.9	35.0	5.7	127.6	1.8	100.1	2.9	21.1	6.5	0.0	4.2	37.5	17.6	83.9	18.4	16.1	2.5	114.4	2.6	5.0	17.4	13.7	52.3	13.9	39.3	14.6	1.5	2.4	84.1	91.8	11.9	14.2	6.8	20.1	8.4	31.4	8.5	23.2	38.4	1.7	14.8	6.2	146.8	62.5	4.7	6.9	21.1	19.3	8.5	6.6	0.9	52.0	117.6	0.0	26.7	22.4	33.0	23.5	7.8	21.6	3.3	32.9	39.9	11.7	9.4
GOLGA8B		ENSG00000215252	"Golgin A8 family member B"	A8MQT2	15	34525207-34588503	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 228.4"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 14.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (2.12e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.90e-3)"	"unprognostic (9.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (2.14e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.79e-4)"	16.5	28.8	10.9	7.2	11.0	18.4	20.8	13.8	15.0	28.7	10.8	18.6	0.9	16.8	11.9	10.0	27.9	6.9	15.5	11.0	11.1	41.1	41.8	23.8	19.6	11.2	10.9	55.6	228.4	0.7	60.6	3.0	10.9	37.8	1.4	8.0	18.1	10.6	10.1	13.4	25.2	2.0	10.9	38.5	28.7	43.2	11.1	2.8	113.8	1.3	7.4	19.7	13.4	11.2	2.6	2.8	0.3	5.3	2.8	5.4	7.3	2.3	0.7	2.5	4.0	2.8	3.5	0.0	4.7	2.5	0.3	2.1	0.9	2.4	1.9	3.6	8.4	0.4	20.4	16.2	3.9	2.3	2.5	7.8	3.3	1.5	4.5	2.7	2.6	4.0	0.9	0.2	2.3	1.2	1.2	24.5	3.2	5.0	4.6	0.1	0.0	0.4	2.2	4.9	3.8	5.8	1.3	0.4	3.2	3.9	2.2	4.8	0.0	3.7	8.8	1.1	4.0	1.8	1.7	3.9	1.2	1.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	11.0	13.8	15.0	11.0	11.1	11.2	10.9	10.9	10.9	11.1	11.2	19.0	192.3	66.5	95.0	34.8	21.9	8.8	10.9	33.0	53.6	30.9	34.3	37.4	20.0	74.7	31.3	73.0	7.6	30.6	2.8	1.9	9.2	53.8	17.3	27.1	11.0	7.2	13.0	133.4	13.0	5.4	12.7	20.4	24.5	9.5	36.4	11.0	28.7	1.5	45.4	126.1	10.1	12.2	6.6	9.9	10.8	39.4	5.0	21.4	12.2	6.4	9.3	32.0	112.1	24.2	16.8	4.9	37.6	45.1	7.6	7.1	5.8	39.9	67.8	13.1	13.5	13.8	48.9	28.4	10.0	14.8	2.9	49.8	22.0	9.4	6.6
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	15.5	14.2	14.6	15.8	14.9	7.1	20.2	15.6	18.0	23.4	11.0	18.7	12.2	23.5	18.0	12.1	17.4	16.3	22.1	15.9	13.3	14.5	16.4	13.6	19.9	12.5	12.5	25.6	12.7	22.1	16.1	19.9	13.1	16.2	20.3	13.5	14.3	17.3	15.8	18.7	15.0	18.4	13.6	16.9	14.9	17.7	12.6	21.0	23.9	17.4	17.2	15.1	14.7	16.8	14.1	15.0	19.1	25.6	40.1	47.9	30.3	57.1	41.7	30.6	31.5	23.1	15.5	42.2	24.3	32.4	60.4	31.2	37.2	27.6	42.8	21.2	20.8	38.7	39.9	37.5	42.4	52.2	24.8	57.4	74.9	22.8	65.7	60.6	26.5	29.0	36.7	16.8	62.2	12.9	21.8	40.3	16.5	24.0	16.0	33.0	37.0	30.8	23.3	12.9	26.7	21.0	57.6	19.7	15.8	36.3	14.3	49.7	31.8	2.2	27.9	28.5	62.6	29.9	28.8	35.4	37.9	43.4	23.9	10.5	4.2	3.2	6.7	3.9	9.3	7.9	7.1	7.1	5.5	7.7	8.2	8.5	2.9	9.2	4.7	9.2	7.7	4.1	14.6	14.9	15.6	18.0	15.9	13.3	12.5	12.5	13.1	13.6	12.6	16.8	43.2	22.4	22.7	46.4	33.4	46.7	25.1	63.9	46.7	59.2	47.0	67.3	46.2	34.3	32.2	20.2	22.9	77.0	28.6	40.4	27.4	27.9	35.1	30.4	77.4	38.1	33.6	26.5	52.9	25.6	62.4	48.3	30.1	30.6	31.1	50.4	35.0	38.7	38.5	74.0	46.2	65.2	24.4	24.2	22.9	13.7	42.3	27.0	28.4	32.8	24.1	39.3	35.0	73.9	64.5	21.1	40.9	42.2	38.7	40.3	20.9	27.1	35.3	35.9	32.9	50.0	44.3	115.6	51.4	36.7	59.8	52.3	38.7	43.3	37.7	27.3
GPAA1	"GAA1, hGAA1"	ENSG00000197858	"Glycosylphosphatidylinositol anchor attachment 1"	O43292	8	144082590-144086216	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 275.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077224	Approved		Approved	"Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"	"Centrosome, Mitochondria"	"HPA077224: "	"unprognostic (2.53e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	47.0	75.5	35.7	21.2	37.5	48.2	46.7	39.9	43.6	52.2	62.3	46.1	35.8	56.9	18.8	51.7	45.9	25.0	72.1	35.9	35.6	61.9	69.9	42.6	23.4	41.9	37.4	49.9	66.2	47.5	37.2	20.0	40.7	50.9	13.1	11.4	60.5	40.5	71.7	47.1	46.8	18.8	40.1	48.4	55.8	40.9	38.1	18.6	60.1	28.4	12.9	43.0	42.8	47.6	67.3	117.2	26.9	84.7	60.8	51.5	92.8	68.5	66.5	55.8	57.4	49.0	108.9	36.6	94.1	73.9	26.4	82.5	17.9	67.2	8.1	60.4	59.0	58.0	53.1	36.3	58.6	28.5	83.2	56.8	61.6	56.9	39.4	45.0	46.4	61.5	42.1	125.7	54.1	237.6	55.9	26.5	27.2	79.3	275.8	38.1	34.2	176.9	48.4	46.8	45.7	63.2	88.8	112.4	51.1	14.7	73.2	79.3	31.6	51.8	88.6	29.5	77.2	70.0	57.5	24.9	91.2	34.8	72.0	35.7	64.4	59.0	84.2	78.1	57.2	37.4	41.7	66.7	59.6	40.1	40.6	57.7	14.8	69.1	91.9	107.1	40.1	76.7	35.7	37.5	39.9	43.6	35.9	35.6	41.9	37.4	40.7	40.1	38.1	47.6	41.0	38.5	40.0	13.7	46.7	28.8	54.9	84.6	37.0	60.8	74.9	59.9	42.7	55.8	58.0	44.1	64.6	123.4	72.5	100.2	25.4	125.8	5.7	30.8	30.7	37.3	56.9	48.0	12.8	89.9	152.9	57.1	56.6	37.3	64.8	45.1	42.5	74.9	86.6	55.5	14.6	52.6	79.3	53.6	25.6	10.9	40.4	41.2	72.9	6.5	57.4	98.0	98.9	15.6	20.4	76.0	91.0	37.6	85.5	58.0	155.1	90.3	46.8	73.2	59.2	50.8	50.5	194.8	109.9	55.9	22.3	109.3	38.9	66.5	85.3	48.1
GPALPP1	"AD029, bA245H20.2, KIAA1704, LSR7"	ENSG00000133114	"GPALPP motifs containing 1"	Q8IXQ4	13	44989529-45037669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038966, HPA058739"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim"	Nucleoplasm	"HPA038966: AB_10672656, HPA058739: AB_2683804"	"unprognostic (4.99e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.94e-2)"	6.2	6.6	2.4	3.2	2.2	6.5	5.3	4.8	3.2	6.9	0.7	6.1	3.0	6.7	3.0	5.8	6.1	2.1	5.5	2.3	2.2	6.9	5.0	5.2	4.3	1.0	1.6	8.0	4.9	1.8	6.0	3.6	1.2	5.7	2.9	5.6	5.3	2.5	4.3	4.5	5.2	2.6	0.3	5.6	5.6	5.3	1.6	3.2	6.1	1.8	3.6	6.5	6.4	3.3	4.7	3.8	6.2	4.6	2.6	5.3	6.3	6.1	3.8	6.1	5.8	7.8	9.1	10.9	4.3	4.1	5.8	9.6	6.6	5.1	5.7	9.2	9.2	8.1	6.3	5.4	3.9	10.9	4.5	3.3	2.9	4.8	3.2	3.7	4.9	8.5	7.2	2.4	4.0	5.5	11.0	9.3	5.7	11.9	4.4	11.0	5.3	4.5	3.5	4.6	3.2	5.1	5.8	4.0	3.5	4.5	4.0	11.0	7.9	4.0	3.3	4.6	5.1	4.0	4.0	11.5	4.1	6.7	5.2	2.4	3.9	6.7	4.0	3.1	3.2	4.8	4.1	2.7	4.4	6.2	4.7	4.2	2.9	4.0	3.3	5.7	3.1	2.5	2.4	2.2	4.8	3.2	2.3	2.2	1.0	1.6	1.2	0.3	1.6	3.3	18.5	32.1	34.2	26.1	19.1	7.1	15.6	11.6	15.4	24.4	13.7	13.6	16.2	15.7	22.3	23.9	18.8	27.9	19.6	6.8	23.5	13.0	7.0	15.2	26.1	17.3	18.0	14.7	65.0	13.3	13.1	19.0	9.2	17.2	21.5	27.7	16.8	17.3	15.5	23.5	57.3	11.3	12.2	14.2	7.6	5.1	26.8	12.9	12.4	24.4	15.6	18.5	29.9	53.3	42.6	11.4	11.1	26.7	10.5	10.0	10.7	21.0	22.3	26.1	26.3	20.1	23.1	48.7	26.7	16.7	9.2	18.2	16.2	22.9	12.6	11.8
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.0;Late spermatids: 1127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		86000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	196.9	283.2	83.4	74.5	101.9	222.8	129.0	67.7	130.5	95.0	84.8	162.9	113.7	92.4	27.2	197.8	88.8	87.1	407.2	108.5	73.6	196.8	222.6	91.2	66.4	73.5	58.5	97.0	84.2	166.3	147.2	47.5	69.3	94.4	84.3	156.1	105.1	61.0	416.6	120.1	126.5	78.4	34.0	102.2	122.5	95.9	83.2	50.1	100.8	374.6	76.0	147.9	121.5	95.8	572.9	596.1	58.7	433.3	167.5	121.9	134.1	183.4	132.4	206.3	253.7	314.9	169.6	303.5	311.4	177.9	149.1	343.7	337.7	437.0	259.4	461.0	105.1	382.1	252.3	310.8	108.4	517.6	259.3	173.7	136.6	289.0	132.7	273.3	209.3	230.5	210.3	261.8	140.2	319.2	245.5	133.5	158.0	421.3	174.6	242.7	149.1	649.4	254.1	275.4	304.9	185.8	331.9	634.3	131.7	100.5	144.4	161.7	171.9	80.8	185.5	256.7	312.8	535.5	383.7	318.4	287.4	372.3	170.6	188.8	93.2	331.3	80.4	141.2	99.1	59.9	73.7	93.1	101.0	50.5	61.8	72.8	7.4	58.0	180.3	31.6	83.4	123.4	83.4	101.9	67.7	130.5	108.5	73.6	73.5	58.5	69.3	34.0	83.2	95.8	34.2	28.9	40.0	98.9	43.8	25.9	30.1	104.5	42.7	98.8	34.1	27.2	232.5	42.9	51.4	57.0	75.0	44.5	41.6	76.7	115.4	101.7	331.0	35.9	41.2	38.0	63.7	46.7	121.8	66.9	69.2	47.1	109.1	58.0	23.4	36.1	42.8	89.5	89.6	237.2	127.2	75.8	50.8	52.9	40.5	1127.2	37.0	58.1	35.6	17.8	44.4	32.6	23.7	43.7	87.7	77.6	39.4	30.5	77.1	31.5	111.8	103.0	33.1	68.3	19.7	44.3	65.0	7.8	22.3	139.1	32.8	39.3	64.3	74.8	126.9	37.2
GPKOW	"GPATC5, GPATCH5, Mos2, Spp2, T54"	ENSG00000068394	"G-patch domain and KOW motifs"	Q92917	X	49113407-49123735	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000287, HPA001894"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000287: AB_1079015, HPA001894: AB_1079014"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	17.6	15.9	21.5	11.7	22.6	16.1	16.4	22.7	21.8	14.7	14.0	17.0	14.3	16.9	11.8	14.7	15.1	10.3	18.6	19.8	21.2	15.5	14.5	13.8	14.9	24.2	23.6	13.6	12.1	19.0	17.2	13.8	23.9	12.7	12.6	11.9	13.8	16.5	34.8	20.4	14.1	13.8	22.4	15.4	15.5	7.2	25.2	17.7	13.4	25.4	14.4	16.2	14.2	24.4	36.5	38.1	24.9	20.9	21.6	18.6	27.0	23.1	25.9	36.0	38.0	27.9	35.5	15.2	17.4	28.6	36.8	25.2	27.9	27.3	23.4	32.2	29.8	15.8	31.4	19.9	25.8	18.9	32.1	20.4	34.3	28.8	29.2	21.1	27.4	30.0	19.8	23.1	23.8	59.5	26.0	31.5	17.6	19.5	30.0	32.2	27.4	41.5	18.5	45.8	20.8	24.1	26.9	25.2	25.4	26.1	48.5	24.5	30.7	20.7	31.2	30.4	22.1	35.4	26.1	20.7	26.7	31.1	32.7	26.2	22.3	28.9	37.2	31.4	30.3	20.5	28.6	27.8	22.6	34.8	24.3	22.4	17.3	25.0	35.9	20.8	31.1	20.2	21.5	22.6	22.7	21.8	19.8	21.2	24.2	23.6	23.9	22.4	25.2	24.4	10.9	19.2	11.0	7.2	10.5	8.0	14.1	21.8	4.6	14.8	6.4	5.5	13.1	21.5	19.1	7.3	4.2	28.4	16.3	16.2	15.6	26.2	1.1	15.6	10.0	13.4	7.8	22.5	2.8	25.2	20.5	11.7	14.3	10.6	11.4	10.4	11.7	14.5	16.7	5.0	2.8	12.1	18.3	10.9	9.3	1.7	15.5	8.7	5.4	2.8	13.2	20.9	28.8	2.0	3.9	25.6	23.2	15.1	9.4	9.4	19.5	20.5	12.7	13.4	39.5	12.9	13.0	9.9	18.4	6.1	9.9	43.8	16.7	10.6	11.0	12.8
GPN3	"ATPBD1C, MGC14560"	ENSG00000111231	"GPN-loop GTPase 3"	Q9UHW5	12	110452486-110469268	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039764, HPA047793"	Uncertain		Approved	"Nuclear speckles,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA039764: AB_2676669, HPA047793: AB_2680157"	"unprognostic (1.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.82e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (3.98e-5)"	"unprognostic (5.50e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (5.81e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.27e-1)"	25.6	18.9	10.4	16.3	11.7	15.4	24.4	12.9	12.9	15.7	11.6	15.6	8.1	17.8	15.2	16.3	18.5	13.8	34.2	10.0	11.0	31.4	32.1	16.9	22.9	12.2	11.2	23.3	19.9	29.2	11.1	21.3	12.8	22.2	13.1	23.4	24.2	18.0	47.9	11.1	10.6	19.5	13.0	16.2	15.6	41.3	10.9	18.1	21.2	51.1	18.1	17.6	13.8	14.9	42.3	65.8	43.2	42.8	47.5	30.1	57.6	57.1	34.1	62.2	50.3	59.7	24.6	81.5	38.5	31.0	46.0	37.9	54.2	50.5	83.9	46.9	50.6	47.7	33.8	50.5	33.2	75.2	42.2	32.2	31.4	61.1	39.5	34.9	45.6	67.0	82.1	17.9	44.3	28.2	69.8	142.8	53.4	58.6	64.8	23.5	59.9	62.2	39.3	37.8	34.7	34.8	57.7	39.0	49.9	55.0	66.7	87.7	25.4	51.6	38.0	51.3	66.6	24.7	68.0	85.1	38.2	68.5	60.3	41.0	54.4	79.4	30.0	71.9	32.8	46.5	32.0	34.2	51.1	47.9	40.5	26.9	27.4	28.4	75.3	62.5	30.1	41.6	10.4	11.7	12.9	12.9	10.0	11.0	12.2	11.2	12.8	13.0	10.9	14.9	23.8	25.6	34.5	3.3	24.5	29.8	49.3	57.9	15.9	18.8	28.8	32.5	43.8	20.0	36.0	33.1	14.6	62.4	26.6	3.8	107.6	30.4	111.1	24.9	24.6	20.8	8.3	26.9	4.3	21.3	74.0	25.4	8.2	21.5	31.0	18.6	18.2	38.1	94.7	21.9	5.6	9.1	40.7	19.1	17.7	22.6	19.9	33.2	16.0	14.0	39.6	25.7	19.6	3.5	6.4	22.4	11.0	23.7	20.9	55.5	5.3	72.1	34.2	33.0	26.3	31.0	35.3	187.2	77.6	20.8	25.4	46.7	19.2	22.1	13.7	40.2
GPR108	LUSTR2	ENSG00000125734	"G protein-coupled receptor 108"	Q9NPR9	19	6729914-6737603	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041924, HPA041951, HPA063863"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"	Vesicles	"HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.04e-7)"	"unprognostic (1.58e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (8.68e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.13e-3)"	29.9	45.2	26.9	18.8	29.3	26.2	32.7	29.7	27.2	36.8	29.9	39.9	32.9	31.6	31.6	39.6	40.1	32.2	22.5	24.2	29.4	42.1	34.4	32.4	23.2	28.9	28.1	34.5	46.7	49.0	23.2	22.2	27.5	34.4	28.1	27.8	57.5	40.2	18.4	31.2	36.6	26.3	27.7	33.3	35.8	25.5	29.1	23.5	41.3	20.5	27.8	31.0	32.9	27.8	33.5	35.9	21.7	42.6	83.0	44.8	24.4	25.6	77.0	34.7	36.7	22.2	37.5	15.8	46.4	52.4	41.6	28.1	24.7	53.3	17.8	64.1	28.4	25.7	37.7	29.6	81.3	16.7	33.7	48.7	100.2	33.5	67.2	45.9	41.3	37.9	26.4	102.7	35.6	23.3	29.5	24.0	15.6	60.2	31.5	23.7	24.7	61.0	72.7	32.6	0.2	23.4	25.9	41.8	38.7	18.4	39.9	40.0	34.4	19.7	12.5	63.2	27.6	66.2	39.3	11.4	68.0	52.9	21.7	79.3	116.1	123.0	82.6	109.7	75.2	48.2	65.2	70.4	84.6	49.9	45.9	52.8	178.4	80.9	130.5	30.0	81.2	132.7	26.9	29.3	29.7	27.2	24.2	29.4	28.9	28.1	27.5	27.7	29.1	27.8	40.8	9.6	14.5	12.7	26.3	26.5	43.7	107.4	21.1	28.3	42.7	33.0	8.0	45.8	59.7	36.8	22.9	58.7	31.1	76.4	37.2	87.7	38.0	30.8	23.6	32.7	21.7	6.9	5.4	110.1	37.2	27.4	39.3	44.1	26.0	15.0	40.7	26.7	57.1	21.9	6.0	57.6	81.4	30.3	46.7	94.9	23.6	42.4	30.2	5.6	50.3	46.0	42.2	7.5	9.6	83.3	83.7	18.4	27.8	29.1	121.2	55.0	39.8	43.0	39.5	22.2	26.4	34.3	19.9	27.2	31.8	58.6	38.9	28.3	47.1	36.1
GPR148	PGR6	ENSG00000173302	"G protein-coupled receptor 148"	Q8TDV2	2	130729070-130730336	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046655, HPA060527"	Uncertain		Supported	"Plasma membrane"		NA	NA							"Plasma membrane"		"HPA046655: , HPA060527: AB_2684307"											"unprognostic (7.16e-4)"				"unprognostic (3.38e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.2	0.3	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037995-170085392	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.9;parathyroid gland: 216.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 194.8;Proximal enterocytes: 362.1;Proximal tubular cells: 151.4;Rod photoreceptor cells: 153.2;Undifferentiated cells: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 123.9;SK-BR-3: 95.8;THP-1: 197.2;U-266/70: 206.2;U-266/84: 127.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006970	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.61e-4)"	12.2	1.7	0.7	15.9	1.0	107.9	22.5	1.0	1.6	11.2	0.9	72.0	73.8	5.8	57.9	2.9	5.4	18.6	1.0	0.6	0.7	59.8	4.1	15.0	27.9	1.4	0.9	0.6	18.4	216.6	1.4	4.1	1.1	26.7	72.6	104.7	19.3	6.3	1.3	1.2	98.6	4.4	0.8	25.2	43.0	5.2	0.9	9.5	6.7	2.7	30.4	26.8	1.0	1.2	64.2	1.5	0.3	0.5	0.3	0.4	15.6	0.4	0.5	0.4	1.9	11.7	8.1	29.4	12.9	0.6	4.0	0.7	8.8	0.5	1.0	45.9	17.7	19.1	1.0	24.3	0.2	38.2	24.8	0.2	0.9	2.0	2.3	2.8	1.4	13.7	6.4	73.9	0.4	41.5	2.9	8.4	10.3	39.1	2.4	5.3	1.1	123.9	32.3	86.8	6.1	1.8	0.8	95.8	4.5	8.2	55.9	197.2	1.9	0.2	0.4	7.1	4.8	206.2	127.9	51.4	0.8	40.3	2.8	2.9	1.1	9.3	0.5	0.4	1.0	8.0	1.0	0.4	2.4	12.3	3.0	1.1	11.3	0.4	0.2	3.2	0.3	1.2	0.7	1.0	1.0	1.6	0.6	0.7	1.4	0.9	1.1	0.8	0.9	1.2	35.2	9.6	51.1	0.7	25.9	0.4	3.2	4.1	0.0	9.5	48.5	18.3	1.0	28.6	22.7	62.5	39.6	3.1	11.6	88.9	54.8	10.3	33.7	20.6	4.4	8.7	194.8	0.4	1.5	72.0	21.1	1.0	50.0	54.0	1.3	0.1	20.0	0.9	7.4	15.2	0.6	133.9	18.3	11.7	11.2	36.3	0.6	17.0	28.4	7.5	62.3	16.6	0.0	1.0	0.9	60.3	118.6	0.4	56.8	25.4	362.1	151.4	27.9	153.2	0.0	0.8	1.4	7.4	13.1	0.9	0.9	27.2	4.2	1.2	199.7	35.5
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 41.5;smooth muscle: 27.6"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 158.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		Yes	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	3.5	1.1	3.8	5.3	2.8	0.2	2.7	3.3	4.0	6.7	1.1	8.4	1.5	41.5	3.6	9.8	10.7	5.6	3.1	3.8	2.4	1.4	0.4	4.2	0.9	3.7	9.4	7.3	11.7	5.4	1.7	2.2	3.8	9.5	3.2	2.1	1.8	11.8	1.0	2.1	3.3	27.6	2.8	2.0	2.9	1.7	4.1	2.0	1.7	1.9	1.3	4.6	5.4	2.7	11.7	7.1	28.0	18.1	6.6	11.7	0.0	11.1	11.9	9.2	9.7	44.9	1.8	0.0	6.0	16.6	17.2	33.9	6.9	10.7	5.3	4.4	8.8	4.2	5.8	0.1	2.8	1.2	2.8	4.2	6.9	7.9	12.7	21.3	18.7	3.6	3.9	0.1	14.2	1.0	1.3	0.2	11.5	19.4	11.0	3.4	12.1	0.0	4.9	3.1	5.7	24.6	12.0	0.4	32.2	10.6	6.3	1.4	25.4	18.9	9.7	25.6	12.7	0.0	0.0	0.0	5.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	2.8	3.3	4.0	3.8	2.4	3.7	9.4	3.8	2.8	4.1	2.7	5.8	3.2	1.1	13.7	0.1	2.2	5.7	2.5	5.2	2.2	2.2	4.2	3.6	0.0	1.4	0.0	0.0	0.5	0.0	2.8	0.0	4.1	0.4	1.3	19.4	9.1	0.0	0.0	10.8	8.0	0.4	12.3	1.1	1.8	0.0	15.3	8.9	0.1	0.8	158.2	10.9	1.5	0.0	2.5	6.3	0.9	7.5	2.0	1.8	3.7	1.1	3.2	0.0	9.5	0.4	2.6	2.4	17.0	0.0	10.9	0.0	0.1	1.1	2.1	19.7	8.8	15.1	0.3	3.3	2.7	1.4	0.4	1.0	0.7	2.5	2.7
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124743885-124765792	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 109.5;retina: 39.0"	"Group enriched"	"Detected in many"	8	"Muller glia cells: 616.6;Oligodendrocytes: 324.9"	"Group enriched"	"Detected in many"	4	"glioma: 19.2;liver cancer: 5.7;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 7.5;fHDF/TERT166: 17.7;hTCEpi: 7.7;SK-BR-3: 6.8;SuSa: 8.0;TIME: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		900000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	0.5	0.1	28.3	0.1	65.3	0.0	0.5	53.8	43.4	0.3	5.2	0.6	0.0	1.6	0.2	3.7	0.6	0.2	0.1	31.2	40.4	0.3	10.0	0.2	0.1	62.8	56.3	0.0	1.5	0.1	0.2	5.1	62.5	0.5	0.3	39.0	0.9	0.5	0.6	2.3	0.6	1.2	45.2	2.1	1.3	10.6	47.8	0.0	0.0	0.1	0.0	1.4	0.6	109.5	0.1	1.4	7.5	0.0	0.0	0.0	2.1	0.5	1.9	1.9	0.4	0.3	0.7	0.0	0.0	17.7	0.2	0.1	2.2	0.0	0.4	0.3	1.0	0.1	4.4	0.0	2.2	0.0	0.3	0.0	7.7	0.0	0.1	0.0	3.6	0.0	0.0	3.4	0.0	0.4	0.0	0.0	1.1	0.0	3.5	0.0	0.0	0.0	0.0	0.1	1.7	2.7	0.0	6.8	2.6	8.0	1.7	0.0	12.7	1.5	0.6	0.0	0.0	1.1	0.0	0.0	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	65.3	53.8	43.4	31.2	40.4	62.8	56.3	62.5	45.2	47.8	109.5	0.1	0.0	0.0	5.9	0.0	4.6	0.5	4.4	6.8	55.8	4.6	3.0	0.6	7.2	1.8	1.8	6.2	10.1	0.0	0.1	0.0	5.1	0.4	2.0	0.4	0.7	0.0	0.0	6.0	0.6	19.7	1.9	0.0	3.4	0.0	0.3	0.4	22.4	1.2	18.5	1.1	1.1	2.0	0.3	0.7	1.7	2.8	0.2	3.6	1.0	0.6	616.6	0.0	1.5	324.9	0.4	0.2	0.7	0.0	3.2	0.0	0.0	1.4	22.5	0.0	4.8	0.7	0.6	2.2	4.6	10.2	3.0	0.5	0.1	0.0	0.4
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176584-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 17.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 5.0;SuSa: 4.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 14.4;white matter: 5.0"	"Region enriched"	"Detected in single"	10	"hypothalamus: 4.8"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"		"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	17.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.6	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR65	"hTDAG8, TDAG8"	ENSG00000140030	"G protein-coupled receptor 65"	Q8IYL9	14	88005135-88014811	"G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.6;lymphoid tissue: 9.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 256.1;granulocytes: 317.8;Kupffer cells: 112.5;monocytes: 90.9;NK-cells: 319.3;T-cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;HEL: 6.2;HL-60: 7.5;HMC-1: 9.0;RH-30: 11.5"	"Not detected"	"Not detected"							"HPA072624, HPA077397"	Enhanced		Approved	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Nucleoli, Cytosol"	"HPA072624: , HPA077397: "	"unprognostic (8.56e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.80e-1)"	2.0	1.1	0.5	9.1	0.6	12.6	0.9	0.5	0.8	1.1	0.6	1.2	1.6	0.7	0.4	0.9	0.7	2.8	0.6	0.4	1.0	0.8	2.7	4.3	8.8	1.9	1.0	0.3	0.4	0.4	0.4	1.7	1.6	0.8	1.5	0.1	0.7	0.5	0.2	0.3	2.4	2.3	1.0	9.6	1.6	0.6	1.2	4.2	0.4	0.5	6.6	3.4	0.5	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.2	7.5	9.0	0.3	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	39.0	19.8	43.6	33.8	28.4	62.4	9.3	16.9	26.2	13.0	8.1	8.6	19.4	15.2	49.1	32.1	5.9	9.0	24.5	0.5	0.6	0.5	0.8	0.4	1.0	1.9	1.0	1.6	1.0	1.2	2.3	2.9	3.2	21.6	0.3	77.8	4.2	0.5	0.0	0.0	0.2	1.9	3.2	0.4	7.2	1.3	0.0	0.0	0.2	256.1	0.5	0.0	0.0	9.1	0.2	0.4	2.1	0.0	6.6	0.0	0.0	0.3	2.3	6.6	0.5	317.8	0.0	3.9	1.4	62.8	0.0	0.0	0.6	0.0	112.5	73.1	1.4	0.6	88.6	3.6	4.7	90.9	0.0	319.3	0.0	0.1	0.0	0.0	0.0	25.6	0.2	0.1	0.3	0.7	0.2	0.0	0.9	2.0	0.1	0.1	0.7	5.3	0.4	192.8	0.9	0.4	0.2
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316820	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 32.8;vagina: 23.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 139.2;Basal respiratory cells: 150.0;Suprabasal keratinocytes: 68.2;Syncytiotrophoblasts: 205.0;Urothelial cells: 211.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 110.8;CAPAN-2: 40.8;HaCaT: 90.6;HBEC3-KT: 116.7;hTCEpi: 152.8;hTERT-HME1: 62.2;RT4: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.1	0.8	10.0	2.9	0.0	0.0	0.0	3.2	35.9	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	9.6	0.0	4.3	0.0	0.0	13.7	5.5	0.1	32.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	3.5	0.0	0.0	12.4	13.2	23.8	0.4	110.8	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.2	0.0	40.8	0.0	0.0	0.0	0.6	90.6	0.0	116.7	1.1	0.0	0.1	0.0	1.1	0.0	0.8	0.0	0.0	0.0	152.8	0.1	62.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.1	6.1	0.0	0.0	0.0	3.8	46.7	0.0	0.0	19.0	0.5	0.0	3.1	0.4	0.1	0.0	0.0	10.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.1	1.0	0.0	59.3	139.2	150.0	46.7	0.0	2.8	1.8	0.1	0.0	49.9	3.7	0.0	59.0	0.4	0.0	0.0	1.2	0.7	3.3	0.0	1.5	0.0	0.0	1.1	0.7	8.7	1.1	0.0	2.4	1.3	0.0	0.0	0.0	4.2	0.0	0.4	0.0	28.5	0.0	3.6	0.1	0.0	0.6	10.6	0.0	0.0	0.0	0.0	1.0	0.0	12.9	0.0	0.0	0.0	60.6	0.0	0.1	19.6	0.0	0.0	0.0	4.1	0.0	0.0	52.7	68.2	205.0	0.9	0.0	0.0	211.4
GPRASP1	"GASP, GASP1"	ENSG00000198932	"G protein-coupled receptor associated sorting protein 1"	Q5JY77	X	102651092-102659083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.6;Cardiomyocytes: 28.6;Cone photoreceptor cells: 37.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.5;REH: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000161, HPA031061"	Approved		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA000161: AB_2247872, HPA031061: AB_2673718"	"unprognostic (3.92e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.42e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (1.77e-5)"	"unprognostic (3.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.23e-2)"	8.6	22.6	25.1	5.4	23.9	3.8	9.9	19.8	31.2	32.4	2.7	23.3	2.4	25.5	10.7	4.4	26.7	7.6	17.7	22.8	33.2	10.3	2.9	7.2	9.4	16.6	17.8	53.4	5.6	17.3	43.5	2.9	18.6	20.4	4.5	29.9	8.7	17.7	6.1	5.2	12.4	15.3	12.8	11.3	9.6	5.3	23.6	6.8	26.1	4.2	7.6	18.6	16.9	20.2	0.2	0.5	1.7	1.1	1.7	1.7	1.0	1.8	0.1	2.7	4.5	0.2	0.3	0.0	0.4	3.8	0.3	0.5	0.5	0.1	3.9	0.0	0.2	0.1	0.6	0.5	1.4	0.2	0.2	2.2	0.7	3.3	0.3	0.4	0.2	1.8	0.3	0.1	4.3	0.4	3.7	0.1	1.2	0.3	0.6	5.6	1.7	0.0	0.2	0.4	1.7	2.7	0.6	0.2	0.5	1.4	0.2	0.9	0.5	0.8	1.0	0.5	0.3	0.3	0.5	0.0	0.4	0.2	1.1	0.0	0.0	0.0	0.5	0.0	1.3	0.2	1.1	0.4	0.0	0.7	2.3	2.3	0.0	0.1	0.0	0.3	0.8	0.5	25.1	23.9	19.8	31.2	22.8	33.2	16.6	17.8	18.6	12.8	23.6	20.2	5.1	0.0	3.6	0.0	4.4	3.6	4.1	0.8	1.8	42.6	1.8	3.0	28.6	1.5	3.5	5.5	37.5	0.4	3.5	0.1	0.0	0.2	0.3	0.6	6.5	7.3	6.0	0.4	0.0	0.2	0.2	9.9	1.1	0.7	2.5	13.9	7.1	0.7	0.3	6.7	0.0	0.7	0.0	0.3	2.0	1.7	15.2	1.3	1.8	0.0	0.5	12.9	3.1	0.0	0.0	0.6	0.1	15.4	2.2	3.8	0.4	1.7	1.2	18.8	6.6	16.9	8.5	7.0	2.4	0.4	0.9	0.1	7.3	6.5	0.8	1.6
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 10.5;skin 1: 17.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0"	"Low region specificity"	"Detected in many"							"HPA038129, HPA070760"	Approved		Approved	"Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA038129: AB_2675846, HPA070760: "	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.1	0.0	1.7	0.6	1.6	0.0	0.9	5.9	2.1	0.9	0.4	6.2	3.6	0.0	0.0	4.4	0.3	0.2	0.0	0.6	6.7	5.7	0.3	10.5	0.0	5.5	4.9	0.1	5.7	2.1	4.2	0.0	5.7	1.9	3.4	0.1	2.8	1.1	0.1	17.4	8.0	0.1	1.8	0.0	5.1	3.0	9.7	0.0	3.4	0.0	0.5	0.6	2.0	1.0	10.2	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.7	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.0	1.7	0.3	0.3	0.1	3.7	12.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.9	2.1	0.6	6.7	5.5	4.9	5.7	1.8	9.7	1.0	0.0	19.2	3.7	0.0	0.0	1.7	2.8	1.9	2.8	0.3	1.4	1.0	0.2	7.2	2.1	3.7	0.0	0.0	0.0	30.4	0.0	11.3	9.3	0.0	0.0	0.1	6.6	0.0	0.7	20.2	0.0	0.1	3.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	30.8	0.0	0.0	0.3	20.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	13.1	0.4	0.0	2.1	21.7	4.0	1.8	0.1	0.0	0.0	0.2	2.9	0.8	2.4	6.1	0.0	0.1	0.0	7.3	1.3
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236383-89307800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 78.7;Macrophages: 53.9;Sertoli cells: 78.9;T-cells: 76.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 102.6;RPMI-8226: 27.7;SCLC-21H: 27.2;U-266/70: 15.9;U-266/84: 13.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.2"					"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli	Nucleoplasm	"HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902"	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	2.7	1.2	4.1	9.0	9.5	7.8	1.4	17.8	3.1	2.2	0.9	5.3	6.2	1.4	0.7	0.9	0.9	3.5	4.0	2.2	7.3	3.9	2.0	6.9	10.2	4.3	6.5	3.2	5.1	0.6	2.9	1.0	4.5	0.8	7.1	3.5	1.5	0.6	1.0	0.6	5.3	1.4	4.1	7.1	3.6	0.4	5.0	2.8	1.3	3.2	7.9	2.7	1.0	5.9	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.8	0.1	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	102.6	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.7	0.0	27.7	0.3	0.1	27.2	0.6	0.0	0.1	1.1	1.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	15.9	13.2	0.1	0.5	0.0	0.0	0.0	0.3	0.0	2.8	1.0	3.8	0.2	2.7	2.2	0.9	0.0	1.1	1.1	0.0	1.9	1.5	0.0	3.4	1.0	4.1	9.5	17.8	3.1	2.2	7.3	4.3	6.5	4.5	4.1	5.0	5.9	11.1	0.0	22.6	10.1	6.7	1.1	0.9	0.1	0.0	12.2	1.6	1.7	20.3	8.6	5.0	3.7	0.0	0.2	51.2	17.4	1.9	2.0	0.2	5.8	3.4	11.7	78.7	6.5	21.7	9.4	0.1	3.0	15.8	15.0	7.6	12.2	1.8	0.4	18.7	26.9	32.7	38.0	0.0	28.2	29.0	0.0	0.3	53.9	1.8	41.2	7.4	1.0	23.7	26.2	0.5	1.3	11.0	1.2	48.6	0.3	16.3	1.9	0.7	10.8	78.9	3.3	32.7	0.1	0.8	0.3	1.0	0.3	76.9	0.7	26.2	0.5
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884362-46931289	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 267.4;skeletal muscle: 176.4;tongue: 184.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 64.3;Hepatocytes: 123.9;Syncytiotrophoblasts: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 159.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	56.8	10.4	51.6	4.0	49.9	3.8	17.0	49.1	56.9	5.2	38.4	7.7	1.7	3.7	31.4	77.8	7.6	9.8	7.9	51.3	45.7	23.5	103.7	2.1	4.3	69.8	45.9	2.3	267.4	8.3	13.0	3.1	63.9	24.2	4.9	6.9	48.8	10.9	176.4	37.8	3.9	3.1	60.2	2.3	58.6	15.0	54.9	7.7	7.6	184.5	13.4	2.7	7.7	64.5	42.6	19.0	23.8	90.6	32.7	7.0	43.1	28.9	10.9	30.7	19.2	65.3	17.6	29.9	24.7	20.7	15.6	33.6	43.3	42.8	20.4	14.0	21.1	10.5	10.8	159.9	22.4	75.6	9.5	15.2	37.0	30.0	46.3	20.3	15.1	56.1	8.7	23.3	10.3	75.8	15.1	62.9	25.3	52.2	54.2	0.3	26.3	71.1	12.4	21.0	73.7	37.7	14.9	76.4	39.0	9.4	19.6	67.6	11.3	21.1	40.9	14.2	23.4	110.2	36.9	87.1	32.6	48.3	11.7	0.4	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	51.6	49.9	49.1	56.9	51.3	45.7	69.8	45.9	63.9	60.2	54.9	64.5	1.3	6.4	3.4	54.9	4.8	15.9	4.9	6.8	64.3	14.5	6.7	8.4	14.9	8.6	9.1	18.4	22.9	9.2	0.3	10.2	11.7	7.0	9.6	12.2	7.2	2.3	13.1	5.2	16.7	30.2	44.8	7.5	37.2	37.5	3.8	14.9	5.0	123.9	3.8	6.7	18.8	13.4	6.1	3.2	7.3	22.9	4.7	2.3	8.8	1.0	1.1	42.5	1.0	13.6	26.0	25.6	5.2	15.4	7.9	12.4	2.0	38.6	5.4	5.9	0.0	5.2	3.6	2.5	17.3	53.1	16.3	83.3	1.4	2.6	6.3	4.2
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160167-55167297	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 62.7;Extravillous trophoblasts: 218.9;Fibroblasts: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 254.4;fHDF/TERT166: 246.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036720	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA036720: AB_2675269"	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (5.13e-9)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	13.3	6.1	1.2	12.5	1.2	0.1	12.6	1.2	1.6	37.1	6.9	7.3	2.9	21.1	21.9	6.2	14.3	17.0	11.2	1.0	1.7	6.5	2.2	6.9	3.8	1.5	1.1	27.3	4.6	9.3	2.4	39.7	1.4	10.2	8.4	1.3	7.2	15.8	1.5	5.0	4.1	27.2	1.5	4.0	5.6	5.6	1.2	1.3	22.3	6.3	3.0	17.8	9.8	3.6	37.2	39.0	75.3	77.0	180.7	223.9	36.6	179.8	254.4	97.0	192.7	3.2	82.1	0.0	199.0	246.4	86.5	28.2	46.0	51.5	131.5	0.5	17.3	2.1	49.1	6.9	64.4	0.0	0.0	157.5	60.8	68.3	35.5	126.5	122.7	0.0	1.1	0.1	137.4	14.4	0.0	0.0	32.6	1.0	42.8	0.1	40.2	0.0	65.9	1.3	0.1	1.4	56.6	4.6	68.0	80.8	56.6	3.4	102.7	63.6	65.6	84.5	102.3	0.1	0.5	0.5	103.0	0.1	118.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.2	1.6	1.0	1.7	1.5	1.1	1.4	1.5	1.2	3.6	10.9	0.0	1.1	0.3	0.3	7.1	6.0	38.3	9.1	0.2	8.9	6.1	4.3	0.0	33.3	25.8	0.0	49.5	0.2	0.5	5.9	13.7	0.4	6.5	62.7	18.6	0.0	0.0	0.1	38.8	218.9	76.6	2.6	4.9	4.5	30.9	19.2	0.2	10.2	0.0	0.1	4.7	4.1	0.0	6.9	0.6	51.3	1.1	24.9	5.6	1.1	7.9	0.0	0.0	0.1	15.8	0.3	39.9	1.4	2.6	0.1	0.5	36.5	0.3	13.1	20.1	38.2	0.1	0.4	3.1	6.1	13.3	1.8	29.9	0.9	2.4
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2 related adaptor protein 2"	O75791	22	39901084-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 184.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 32.6;granulocytes: 146.9;Macrophages: 82.0;NK-cells: 59.8;T-cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 58.2"	"Group enriched"	"Detected in some"	4	"HEL: 45.7;JURKAT: 175.8;K-562: 44.8;MOLT-4: 122.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.2	0.7	0.2	7.9	0.2	10.3	2.0	0.2	0.3	1.5	0.5	2.2	3.6	0.8	0.5	1.2	0.7	2.6	1.1	0.2	0.3	0.6	1.2	4.4	15.7	0.6	0.3	0.2	0.4	0.1	0.3	0.6	0.5	1.6	2.3	0.3	1.7	0.7	0.4	1.1	4.5	0.9	0.5	9.3	3.8	1.9	0.4	184.8	0.8	0.5	12.9	3.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	45.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.2	0.3	0.0	175.8	44.8	0.0	0.0	0.0	122.8	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	6.3	0.7	0.1	51.4	0.3	38.2	3.1	37.5	56.2	1.2	5.2	31.3	58.2	6.6	5.4	0.3	0.8	35.0	74.9	0.2	0.2	0.2	0.3	0.2	0.3	0.6	0.3	0.5	0.5	0.4	0.7	1.1	0.0	6.7	0.3	8.2	1.7	0.0	0.0	0.0	0.6	1.1	0.8	1.0	2.8	0.0	0.0	0.0	0.0	18.3	0.1	0.0	0.4	4.8	0.3	0.1	0.8	1.2	32.6	1.3	0.2	0.0	0.6	0.0	0.1	146.9	0.2	2.5	2.3	0.2	0.0	1.2	0.6	0.0	1.9	4.6	2.9	0.3	82.0	1.8	1.0	6.8	0.3	59.8	2.5	1.0	0.0	0.3	0.4	6.3	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.9	4.4	2.1	0.1	1.1	0.1	57.1	0.0	0.1	0.3
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.2;kidney: 61.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.1;Basal squamous epithelial cells: 104.7;Prostatic glandular cells: 79.0;Squamous epithelial cells: 124.7;Syncytiotrophoblasts: 98.6;Urothelial cells: 79.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"OE19: 1706.0"	"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Low region specificity"	"Detected in many"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	5.9	0.1	0.0	0.7	0.4	0.0	14.2	5.6	0.4	13.5	4.5	8.1	11.8	3.3	3.8	60.2	22.3	9.5	1.2	0.2	0.0	61.5	11.1	10.6	0.1	0.0	0.4	1.0	32.7	11.4	6.9	11.9	0.5	14.5	10.0	0.1	25.2	11.6	0.3	39.9	10.8	1.0	0.0	0.5	16.9	1.2	0.1	1.1	6.6	0.1	8.7	7.5	26.2	0.3	12.6	14.4	0.0	0.0	0.0	0.0	19.1	0.0	0.8	0.1	0.5	44.7	24.3	0.0	4.2	0.4	0.9	24.1	0.0	16.1	0.0	0.0	2.1	0.0	6.4	38.5	0.0	0.0	0.0	0.0	15.1	0.2	3.7	2.5	0.1	0.0	0.0	0.0	0.0	11.5	0.2	0.1	4.9	1706.0	3.4	0.1	0.0	18.6	18.5	14.0	9.5	0.1	18.4	370.7	0.1	17.3	14.0	0.0	0.0	0.0	1.1	0.2	0.0	0.2	0.1	1.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.6	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.5	22.4	15.1	0.0	0.9	38.2	77.1	20.0	104.7	0.2	48.2	30.5	2.5	17.2	18.2	22.0	0.0	35.7	0.7	25.6	9.8	35.6	0.0	30.2	5.3	2.6	14.4	0.0	0.3	19.4	27.4	3.1	27.0	41.8	1.3	0.5	0.4	5.1	2.8	0.0	0.0	19.7	40.7	0.0	2.3	0.0	2.8	1.3	5.4	0.0	1.6	0.4	0.0	0.0	0.0	26.7	26.0	1.2	0.3	79.0	28.3	13.8	20.9	0.1	0.0	0.9	2.1	0.4	0.3	124.7	41.9	98.6	1.4	0.0	21.1	79.7
GRID2IP		ENSG00000215045	"Grid2 interacting protein"	A4D2P6	7	6497462-6551436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"brain: 31.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.8;Inhibitory neurons: 2.9;Oligodendrocyte precursor cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"thalamus: 31.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"REH: 3.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 22.4;thalamus: 7.2"	"Low region specificity"	"Detected in all"			HPA045381			Approved	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA045381: AB_10962495"	"unprognostic (1.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.19e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.17e-1)"	0.0	0.4	6.7	0.1	6.2	0.2	0.2	10.7	1.4	0.1	0.0	0.3	0.4	0.1	0.0	0.3	0.2	0.1	0.1	0.1	7.9	0.2	0.0	0.2	0.1	2.4	9.8	0.1	0.5	0.5	0.9	0.0	1.9	0.5	0.1	0.5	0.4	0.3	0.0	0.7	0.3	0.0	0.0	0.3	0.4	0.3	31.9	0.2	0.3	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.3	0.0	3.6	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	6.2	10.7	1.4	0.1	7.9	2.4	9.8	1.9	0.0	31.9	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.6	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.5	0.1	0.0	0.1	0.0	0.4	2.8	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.5	1.3	0.1	0.0	0.0	0.3	0.2	0.4	0.1	0.0	1.0	0.0	0.0	0.1	0.8	0.2	1.2	0.0	0.0	0.1	0.9	0.1	0.2
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;testis: 32.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Bipolar cells: 23.0;Excitatory neurons: 32.4;Horizontal cells: 18.5;Inhibitory neurons: 31.1;Oligodendrocyte precursor cells: 31.7;Rod photoreceptor cells: 21.2"	"Group enriched"	"Detected in many"	5	"glioma: 15.4;ovarian cancer: 6.6;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.7;hTERT-RPE1: 21.2;NTERA-2: 13.1;REH: 37.5;SCLC-21H: 10.3;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.6	4.0	20.0	1.7	17.3	3.0	1.2	6.2	26.7	5.3	0.1	16.4	0.7	7.3	1.8	1.6	6.8	1.9	4.9	36.5	15.5	7.0	0.3	0.5	0.7	3.6	4.8	3.6	2.7	14.8	18.3	0.0	7.0	6.2	1.0	12.5	0.7	6.5	0.5	0.9	3.4	5.2	3.0	1.3	5.3	32.9	14.6	0.9	11.3	0.7	0.6	5.0	2.7	6.6	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.3	13.7	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	21.2	0.0	0.6	0.1	0.6	0.0	0.2	0.2	0.0	13.1	0.1	0.0	37.5	0.0	0.1	5.8	0.1	10.3	22.7	0.1	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	17.3	6.2	26.7	36.5	15.5	3.6	4.8	7.0	3.0	14.6	6.6	0.2	0.0	0.0	17.9	0.1	0.4	0.1	0.0	0.0	23.0	0.2	0.8	3.1	0.0	0.0	1.8	2.1	0.0	0.0	0.1	0.0	0.8	1.6	0.2	0.2	0.4	0.0	0.0	32.4	0.0	0.0	0.6	0.0	0.3	4.5	7.2	0.0	0.0	0.0	18.5	31.1	0.0	0.0	0.0	0.0	2.3	0.9	0.1	0.0	2.8	0.0	9.1	0.0	31.7	0.9	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	21.2	0.0	4.9	1.7	4.2	2.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1
GRPR	"BB2, BB2R"	ENSG00000126010	"Gastrin releasing peptide receptor"	P30550	X	16123565-16153518	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"pancreas: 20.3"	"Cell type enriched"	"Detected in single"	15	"Inhibitory neurons: 6.3"	"Cancer enriched"	"Detected in some"	4	"breast cancer: 6.6"	"Region enhanced"	"Detected in some"		"hypothalamus: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"PC-3: 29.2;T-47d: 38.2;U-138 MG: 51.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in all"			HPA069604			Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA069604: AB_2686158"	"unprognostic (3.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.86e-2)"	0.1	0.1	0.1	0.2	0.2	0.1	1.9	0.0	0.3	0.3	0.1	0.4	0.1	0.5	1.9	0.0	0.1	0.1	0.2	0.2	1.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	20.3	0.2	0.0	0.1	0.2	0.5	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.8	1.1	0.1	1.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.3	0.0	0.9	0.1	4.0	1.6	0.4	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.5	0.0	0.0	0.0	0.5	0.0	29.2	0.0	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.1	0.1	1.5	38.2	0.1	0.2	51.5	1.9	0.0	1.6	0.3	0.2	0.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.2	1.6	0.3	0.0	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445841-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.0	13.7	6.3	14.0	5.8	14.0	14.4	7.0	6.9	13.7	7.2	11.5	13.1	16.1	4.2	18.2	13.0	8.6	13.6	6.2	6.7	13.0	16.3	10.9	16.0	6.9	7.4	13.7	18.6	13.0	8.6	11.4	7.4	12.2	6.5	3.7	12.7	8.9	28.4	17.5	10.9	8.6	5.6	14.1	13.8	7.4	8.7	11.5	11.8	14.5	10.6	14.6	13.5	7.3	58.3	148.9	25.0	47.3	20.2	19.8	21.6	44.9	20.8	62.2	51.8	84.0	42.4	83.4	37.8	28.7	35.0	48.8	62.7	67.9	24.9	63.8	86.5	78.2	48.6	60.4	23.0	71.9	47.8	23.8	37.0	58.9	29.4	14.3	31.5	43.8	107.3	50.1	27.0	59.1	75.1	180.1	68.1	63.8	43.2	92.9	28.3	58.5	26.4	70.4	56.2	32.1	51.3	71.0	22.4	15.4	34.6	36.5	35.2	57.9	49.1	25.9	107.1	50.6	126.8	78.3	19.7	64.8	69.0	0.3	24.8	3.3	41.5	40.7	46.4	44.4	37.1	41.0	40.9	44.8	42.6	40.3	2.0	41.6	32.4	29.7	36.3	37.4	6.3	5.8	7.0	6.9	6.2	6.7	6.9	7.4	7.4	5.6	8.7	7.3	17.3	3.2	17.5	1.0	26.8	46.3	31.7	18.6	23.3	13.4	16.0	13.7	7.1	14.3	14.3	12.9	0.0	41.4	15.1	14.4	23.5	29.0	3.8	13.1	20.5	19.1	19.2	28.8	1.6	18.2	39.7	18.1	13.3	14.3	19.7	16.8	13.6	18.5	24.4	21.9	3.9	14.5	14.2	11.1	14.3	19.4	17.1	11.4	28.4	2.8	25.3	6.1	19.6	3.0	2.6	22.4	6.5	12.4	28.5	24.2	6.8	18.8	16.8	15.7	19.7	22.7	20.4	9.4	34.3	20.5	40.6	35.0	17.9	26.3	17.1	24.0
GSK3B		ENSG00000082701	"Glycogen synthase kinase 3 beta"	P49841	3	119821321-120094994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 218.7;Inhibitory neurons: 246.3;Microglial cells: 197.7;Oligodendrocyte precursor cells: 241.8;Oligodendrocytes: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016263, HPA028017"	Approved		Supported	Nucleoplasm		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB016263: AB_2279451, HPA028017: AB_10600708"	"unprognostic (1.09e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (3.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.79e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.16e-1)"	11.0	13.6	9.2	11.7	9.5	15.1	11.2	16.6	16.9	10.0	0.0	11.7	12.3	10.3	11.1	13.8	10.1	11.1	18.2	8.2	13.8	12.0	14.8	13.9	10.4	15.2	15.3	9.3	10.7	17.3	7.1	16.3	16.5	10.0	12.4	23.6	13.2	9.3	17.5	16.3	15.3	13.3	4.9	12.9	12.6	23.1	9.6	20.0	15.1	18.0	11.7	12.0	9.5	12.5	59.3	22.7	46.8	25.5	31.9	29.5	50.3	36.6	57.6	28.3	29.3	25.9	23.8	24.1	19.1	43.0	33.8	46.0	22.2	59.1	45.8	15.5	6.6	42.2	18.4	16.6	35.6	31.6	49.9	34.3	39.5	27.0	56.8	27.3	31.5	29.3	13.6	34.6	40.5	25.1	44.0	10.7	25.2	23.3	28.3	16.9	41.0	22.2	25.1	45.3	37.1	22.6	38.5	29.0	44.1	41.1	30.9	27.0	40.0	45.5	55.1	12.7	20.6	31.9	35.2	44.8	29.4	22.0	33.9	1.0	1.8	6.3	0.7	1.6	1.2	0.5	1.0	1.7	1.4	0.7	0.9	0.8	6.6	0.5	2.1	1.1	1.2	0.8	9.2	9.5	16.6	16.9	8.2	13.8	15.2	15.3	16.5	4.9	9.6	12.5	39.3	32.1	26.7	113.6	28.3	50.9	37.8	22.2	46.1	63.2	21.9	17.0	39.7	20.0	21.4	18.4	60.5	27.0	29.0	37.3	11.7	26.9	138.2	25.2	31.6	31.5	26.9	15.4	218.7	32.0	49.3	25.1	46.4	32.5	17.2	18.1	25.0	22.9	21.5	143.0	246.3	22.3	20.3	27.3	29.2	48.1	13.1	33.4	35.6	197.7	35.5	31.6	22.6	241.8	202.5	49.0	23.4	19.9	29.0	28.7	35.8	17.3	16.3	42.4	13.1	24.4	38.2	38.8	29.3	50.8	41.1	43.0	36.4	32.7	25.9	41.6
GSKIP	C14orf129	ENSG00000100744	"GSK3B interacting protein"	Q9P0R6	14	96363452-96387288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 166.1;Early spermatids: 384.9;Late spermatids: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043054, HPA046782"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus, Vesicles"	Nucleoli	"HPA043054: AB_2678293, HPA046782: AB_2679803"	"unprognostic (3.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	11.4	13.1	13.6	17.5	16.7	16.2	13.2	14.7	16.7	10.4	10.9	60.4	48.3	10.6	11.3	41.0	10.9	14.2	11.0	15.7	14.8	16.4	23.3	9.7	19.6	12.9	12.0	6.7	9.9	9.5	8.1	13.8	13.3	13.9	54.6	67.8	12.1	9.9	12.7	14.5	56.6	15.9	13.9	11.8	23.3	48.7	13.7	11.1	10.3	10.6	22.4	21.1	16.2	14.9	21.9	30.5	33.6	23.1	25.2	29.1	56.6	39.7	30.7	26.2	28.8	22.7	36.6	20.9	23.6	30.4	15.9	23.8	22.1	24.2	37.9	49.9	21.1	8.8	16.1	17.5	23.4	23.1	14.5	23.2	37.7	33.1	32.7	20.1	34.6	23.5	19.2	18.7	33.6	53.5	17.0	18.6	37.3	33.9	38.3	16.7	31.4	19.3	61.5	79.9	11.8	38.4	44.8	41.6	34.9	33.7	31.9	14.3	37.8	12.0	15.1	25.6	12.8	21.7	67.0	17.8	30.6	16.4	19.6	64.4	20.9	47.0	27.7	24.3	42.8	38.3	37.6	32.4	21.2	33.1	37.0	34.5	40.9	37.5	33.6	17.9	66.6	28.6	13.6	16.7	14.7	16.7	15.7	14.8	12.9	12.0	13.3	13.9	13.7	14.9	12.6	12.8	7.4	5.9	24.8	45.2	24.2	27.6	19.9	26.8	18.4	14.5	18.9	14.3	21.7	20.2	41.7	42.7	17.9	166.1	72.4	34.1	384.9	32.3	11.1	17.4	28.1	24.0	14.3	39.4	43.3	12.1	41.8	32.2	19.7	6.6	17.9	17.3	23.6	23.5	10.8	73.0	52.9	19.8	19.6	321.7	8.1	16.8	19.6	5.6	25.2	22.3	16.5	10.6	17.9	39.9	102.9	7.9	22.6	37.4	81.8	47.4	28.6	104.0	19.7	6.5	16.5	40.0	34.1	35.7	65.9	119.6	24.4	7.9	69.1	43.7
GSPT1	"eRF3a, ETF3A, GST1"	ENSG00000103342	"G1 to S phase transition 1"	P15170	16	11868128-11916082	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052488, HPA074588"	Approved		Approved	Vesicles,Cytosol		NA	NA		210000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Vesicles	"HPA052488: AB_2681849, HPA074588: "	"unprognostic (4.13e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-3)"	"unprognostic (3.13e-2)"	60.8	57.5	22.3	49.5	24.7	76.3	46.0	24.4	33.3	42.0	27.4	56.0	33.8	34.5	46.6	67.9	30.1	35.2	53.4	23.9	24.5	53.6	76.3	47.7	55.4	25.0	23.1	33.3	62.2	62.7	27.5	50.0	26.2	47.8	59.6	35.3	41.0	41.8	127.0	43.5	34.3	46.9	25.0	40.2	49.8	68.7	23.1	56.3	57.7	97.8	82.0	85.7	39.6	29.3	220.1	212.9	116.1	161.0	164.2	169.3	167.5	238.0	245.9	187.1	185.4	153.1	197.8	295.7	303.9	207.5	130.1	164.3	297.8	220.3	312.9	142.4	153.6	202.0	163.1	325.5	137.9	258.7	103.5	133.5	170.0	212.0	288.3	122.4	210.4	146.2	331.7	148.7	220.0	211.2	219.8	134.0	232.9	163.0	120.1	256.4	200.5	345.6	184.7	189.3	186.4	99.6	342.0	256.3	144.2	164.3	222.4	122.6	163.3	206.8	129.5	151.5	190.3	146.6	233.2	253.8	145.4	258.1	128.5	1.4	5.8	7.7	6.3	11.1	8.8	7.9	8.1	7.7	7.0	6.5	8.2	8.1	1.9	7.2	9.9	3.8	10.5	4.3	22.3	24.7	24.4	33.3	23.9	24.5	25.0	23.1	26.2	25.0	23.1	29.3	69.4	76.9	160.2	39.5	92.3	242.2	232.0	47.1	170.8	47.7	95.0	61.6	123.4	57.2	69.1	86.5	50.1	76.1	94.5	88.1	103.7	58.9	94.9	109.0	95.6	74.4	66.6	328.5	61.6	63.4	118.3	77.2	81.1	153.9	24.7	93.2	43.5	77.9	75.2	52.2	47.0	107.2	32.6	60.8	116.3	51.6	47.8	80.9	64.0	35.6	50.1	43.6	25.7	38.7	42.9	73.0	66.9	47.4	166.2	271.0	38.3	120.3	52.7	41.5	59.2	94.6	123.0	138.3	83.5	198.5	257.7	102.1	132.1	128.1	114.1	270.4
GSPT2	"eRF3b, FLJ10441"	ENSG00000189369	"G1 to S phase transition 2"	Q8IYD1	X	51743442-51746232	"Predicted intracellular proteins"	"Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 95.5;Late spermatids: 189.0;Muller glia cells: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 47.6;PC-3: 53.8;SuSa: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044769, HPA074588"	Approved		Enhanced	Cytosol		NA	NA		130000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA044769: AB_10963577, HPA074588: "	"unprognostic (8.55e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.39e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.07e-1)"	6.2	6.5	6.8	5.8	7.1	2.8	6.2	5.6	7.5	4.4	5.3	5.0	3.2	5.4	7.5	2.7	5.6	5.1	6.8	6.9	10.7	6.3	11.2	5.5	9.2	5.1	7.1	9.9	4.8	6.1	6.5	2.4	6.1	6.8	3.5	7.7	6.3	6.1	5.9	2.7	5.0	5.3	5.3	5.8	3.9	13.3	9.5	10.4	6.0	5.3	8.6	4.8	2.3	4.7	0.0	9.9	19.7	0.0	13.6	11.8	0.0	11.3	1.9	8.0	10.0	6.3	10.0	29.3	0.0	9.7	24.6	3.2	0.0	5.3	9.1	0.0	12.7	0.4	0.0	0.0	10.1	0.0	12.3	15.7	2.5	7.0	7.1	13.6	11.7	13.4	7.9	2.2	14.2	0.0	2.6	1.8	47.6	0.0	53.8	14.0	18.6	0.0	14.5	10.6	0.0	16.6	0.0	0.0	10.5	38.9	0.0	9.5	7.5	7.9	16.0	7.4	7.5	0.0	17.3	0.0	10.5	1.9	8.9	2.9	2.5	1.6	4.5	3.6	4.5	7.9	3.9	4.3	8.2	8.1	6.3	5.5	0.3	6.5	2.7	6.9	5.6	3.6	6.8	7.1	5.6	7.5	6.9	10.7	5.1	7.1	6.1	5.3	9.5	4.7	6.4	12.8	11.8	3.6	10.1	1.8	5.3	8.9	3.4	17.0	4.2	7.0	17.9	14.3	8.0	14.7	8.4	9.6	11.5	2.0	5.9	14.2	95.5	1.4	10.7	8.3	3.0	4.2	3.9	8.7	4.3	11.2	3.1	1.3	10.8	6.3	6.1	20.3	6.2	11.8	4.3	3.5	2.0	7.6	2.1	189.0	12.8	4.9	3.6	1.9	9.8	61.4	14.4	3.5	2.6	5.6	5.5	18.8	7.6	6.5	0.8	11.5	10.0	10.4	26.3	8.2	7.6	11.6	10.4	2.5	1.4	3.4	7.5	15.7	3.2	3.9
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678066-30727846	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		81000000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.6	23.3	12.3	18.7	11.1	25.9	11.0	10.6	11.7	28.5	25.8	42.5	54.3	16.0	21.6	37.3	21.6	30.5	25.4	12.9	12.5	45.3	35.8	17.4	23.6	9.5	14.2	23.1	26.5	82.3	14.8	23.5	12.0	35.3	46.6	12.8	25.8	29.4	28.9	12.8	50.8	17.9	10.7	22.1	41.8	11.6	17.6	26.7	16.9	21.3	24.0	22.5	27.7	11.2	49.4	197.8	35.9	40.1	35.8	38.3	29.1	23.4	46.8	31.8	36.7	66.0	31.3	95.8	94.8	32.0	96.1	59.2	62.3	51.1	33.1	22.6	40.7	104.6	67.0	197.8	88.4	38.6	159.7	72.6	28.5	48.9	20.9	33.5	43.3	57.3	73.2	55.1	67.9	44.1	147.1	32.0	65.4	191.9	31.5	43.8	41.9	59.3	56.0	124.3	28.2	31.8	31.2	87.8	58.8	40.7	37.5	32.6	63.8	21.0	34.7	37.3	35.2	20.2	29.4	70.0	51.9	51.8	62.4	32.3	5.9	15.0	5.0	5.4	8.8	3.6	4.5	5.4	6.0	2.3	2.8	3.7	8.2	3.6	7.9	3.9	4.5	3.1	12.3	11.1	10.6	11.7	12.9	12.5	9.5	14.2	12.0	10.7	17.6	11.2	8.2	3.2	20.8	12.7	13.7	4.2	15.2	9.4	52.3	6.7	6.7	5.0	26.8	30.0	15.0	12.9	16.7	17.0	20.3	61.8	9.8	11.4	8.4	61.4	13.4	9.9	34.1	28.6	18.1	19.8	6.3	10.0	33.1	41.3	6.3	64.3	12.1	43.4	18.2	3.3	27.4	51.7	8.2	40.5	5.8	18.9	7.2	22.1	8.8	11.2	20.6	12.6	17.5	12.5	10.0	15.2	32.0	10.9	15.6	27.5	75.7	19.0	11.7	8.0	6.6	7.0	8.6	1.2	3.4	39.6	5.4	6.4	17.3	17.2	47.5	33.5
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928432-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 164.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm		NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (2.90e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.64e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.31e-6)"	"unprognostic (3.35e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.52e-1)"	18.8	46.9	24.2	17.7	25.6	27.1	23.8	21.4	26.2	21.1	24.6	41.1	30.4	17.4	67.7	43.4	26.9	17.9	24.8	25.4	25.3	42.7	44.8	21.7	15.9	23.7	25.1	14.3	15.7	27.7	26.4	19.8	25.5	34.2	40.6	15.7	28.9	18.6	20.4	34.6	28.4	19.1	22.9	23.7	28.5	23.7	25.9	21.5	23.2	16.9	18.5	22.9	26.1	25.4	63.7	75.7	36.2	51.2	41.4	42.8	51.5	52.9	48.7	81.6	67.1	139.9	75.5	44.8	68.6	54.9	78.7	58.7	53.6	134.8	68.5	20.9	30.4	176.1	46.8	140.1	58.1	44.8	59.5	45.3	141.8	77.0	128.8	36.3	58.4	59.5	87.1	35.7	100.6	70.1	72.5	63.5	21.4	83.2	96.0	64.8	72.7	106.9	117.7	63.9	71.0	41.3	93.6	86.5	70.9	19.7	106.5	40.5	46.7	93.1	52.5	61.7	46.5	35.7	35.9	49.1	79.4	48.6	56.7	17.5	36.2	8.7	30.4	39.2	27.6	12.8	24.0	31.4	43.6	8.7	27.7	23.7	8.4	29.3	36.6	23.9	32.6	29.0	24.2	25.6	21.4	26.2	25.4	25.3	23.7	25.1	25.5	22.9	25.9	25.4	10.6	19.2	10.5	13.4	9.9	26.3	32.5	72.4	38.7	23.0	32.8	20.8	17.1	27.1	38.1	25.8	10.4	79.4	19.1	58.1	25.4	51.6	55.6	14.8	18.2	16.1	23.4	26.9	12.2	47.2	52.5	19.3	37.2	16.4	17.7	80.1	10.0	27.3	59.9	35.3	13.8	50.6	48.8	17.2	17.3	164.1	10.2	26.8	16.0	5.6	31.0	29.6	19.6	10.1	9.9	39.8	40.1	18.4	19.6	21.4	33.8	121.5	18.1	16.9	26.3	12.0	21.0	14.7	18.9	38.1	24.2	49.0	20.6	52.1	77.7	33.0
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791371-52803860	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 916.5;kidney: 943.1;liver: 2610.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 555.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 263.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.5	916.5	0.0	2.5	0.0	0.0	4.2	0.0	0.2	2.0	0.0	7.3	672.0	0.4	7.0	5.3	86.1	119.5	0.2	0.0	0.0	943.1	2610.5	12.2	0.5	0.0	0.0	78.9	148.6	0.0	0.2	0.5	0.0	18.7	8.1	0.0	21.5	0.6	0.1	1.2	674.6	0.3	0.0	0.2	135.5	336.8	0.3	0.1	0.1	0.0	11.5	2.2	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.1	263.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.2	1.5	2.1	0.3	0.0	0.0	1.1	0.0	0.2	0.5	0.5	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.4	7.7	0.0	13.5	0.0	5.0	35.7	0.0	0.0	7.0	1.5	0.0	453.2	159.9	73.5	0.0	0.1	0.1	5.8	536.1	71.3	11.8	0.4	0.1	3.1	3.0	45.5	0.0	1652.6	0.2	7.3	116.7	0.5	2.5	3177.1	26.4	1013.9	0.1	0.0	0.0	165.6	42.7	31.5	0.0	43.0	65.6	25.3	0.0	0.0	13.3	0.0	1.0	0.0	0.1	629.1	187.4	4.5	0.2	27.6	4294.8	3190.6	533.5	0.0	0.0	0.0	98.6	36.8	3.4	6.8	0.0	0.5	10.4	4578.2	295.3	58.7
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750087-52763475	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 696.0;liver: 2058.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 201.6;Distal tubular cells: 213.2;Exocrine glandular cells: 239.6;Pancreatic endocrine cells: 334.7;Proximal enterocytes: 367.0;Proximal tubular cells: 1186.6;Respiratory ciliated cells: 435.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 25.9;Hep G2: 20.0"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.4	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	149.5	0.0	0.7	0.1	2.5	109.4	0.0	0.0	0.0	696.0	2058.5	4.8	0.1	0.0	0.0	0.2	299.2	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.5	0.0	0.0	0.0	115.5	0.0	0.0	0.0	11.7	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.0	20.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.3	0.6	0.5	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	1.7	0.0	0.2	1.5	0.0	0.0	0.1	0.1	0.0	201.6	31.1	16.5	0.0	0.0	0.0	0.1	213.2	8.1	6.9	0.0	0.0	0.6	0.0	0.0	0.0	239.6	0.2	0.5	7.7	0.0	0.0	37.2	0.7	124.2	0.1	0.0	0.0	13.7	2.0	2.2	0.0	14.6	1.2	5.1	0.0	0.0	5.2	0.0	0.0	0.0	0.1	334.7	18.8	0.4	0.0	3.9	367.0	1186.6	435.5	0.0	0.0	0.0	1.5	1.9	0.7	0.0	0.0	0.0	2.6	10.4	30.1	1.3
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909698	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 67.3;fallopian tube: 65.4;placenta: 22.7;skin 1: 26.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 194.9;Syncytiotrophoblasts: 515.3;Theca cells: 91.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.5;testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.0	67.3	0.0	0.1	0.1	0.0	1.8	0.0	0.0	1.1	0.5	0.0	0.3	0.8	0.8	0.0	65.4	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.5	0.9	0.1	2.9	0.0	22.7	0.0	0.1	0.0	0.0	0.3	0.2	0.0	26.0	0.4	0.1	0.0	0.0	2.4	11.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	6.2	0.0	0.0	194.9	0.0	0.0	0.0	0.0	1.3	47.0	0.5	0.5	0.0	0.0	0.0	0.0	7.5	1.1	0.0	0.7	1.3	7.4	0.0	0.4	15.7	0.0	0.0	0.0	2.0	0.0	0.4	2.1	1.5	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	24.8	0.0	0.0	0.0	0.8	0.5	0.5	0.0	9.8	515.3	0.1	91.3	0.0	0.0
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52840843	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"Smooth muscle cells: 23.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA						"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.2	0.4	0.0	0.0	0.0	23.6	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006311, HPA022904"	Supported		Supported	Peroxisomes		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favorable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	150.9	180.9	77.5	135.9	82.5	187.0	159.1	82.7	89.2	154.5	141.0	217.9	317.2	95.2	110.7	154.0	144.7	140.6	271.7	75.7	82.7	257.2	449.3	125.1	185.0	85.2	84.0	71.1	138.0	308.2	79.7	104.2	85.3	111.4	230.8	26.9	213.0	96.4	238.6	132.6	277.1	106.6	79.8	236.5	163.4	85.1	83.3	96.2	160.1	324.1	183.7	129.5	112.4	88.6	150.7	106.1	14.7	130.1	224.2	319.7	68.8	87.0	148.4	76.3	150.8	64.5	375.2	85.4	120.8	126.7	114.5	222.4	57.5	136.2	66.0	165.0	62.3	69.6	80.9	102.9	154.1	84.7	108.4	290.4	164.3	88.0	62.0	113.1	205.3	109.5	99.3	100.9	207.2	116.2	87.3	152.9	34.7	291.3	158.6	73.9	2.4	169.6	266.1	81.6	59.7	81.4	159.4	256.3	137.4	88.3	123.6	117.0	122.2	41.0	37.7	108.5	75.2	171.0	86.5	20.0	148.5	336.0	86.6	351.1	537.1	210.7	298.5	597.9	289.7	254.5	554.6	386.4	445.2	183.2	281.3	274.6	165.0	188.3	641.7	187.0	800.5	917.1	77.5	82.5	82.7	89.2	75.7	82.7	85.2	84.0	85.3	79.8	83.3	88.6	181.9	70.5	95.6	17.0	134.1	114.2	174.9	244.0	118.4	11.6	181.9	198.2	172.9	211.6	219.5	121.4	12.5	295.3	151.4	301.6	291.6	160.5	561.3	102.7	95.8	117.0	153.6	63.3	25.8	120.3	132.0	96.4	185.5	92.9	145.1	47.4	155.3	322.1	304.2	8.4	28.8	252.8	154.6	288.3	174.1	1160.2	72.7	195.8	151.2	16.9	228.5	85.9	194.7	16.6	14.3	104.5	505.2	50.8	130.0	82.9	670.0	620.2	154.0	15.4	85.5	65.9	121.7	6.9	10.3	166.3	116.4	183.7	250.7	150.7	366.5	218.9
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 479.1;liver: 609.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.8;Cardiomyocytes: 6.0;Club cells: 6.7;Hepatocytes: 5.5;Kupffer cells: 7.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Region enriched"	"Detected in all"	18	"cerebral cortex: 479.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 87.0;HeLa: 96.1;HHSteC: 78.6;hTEC/SVTERT24-B: 73.0;HUVEC TERT2: 62.4;MOLT-4: 115.4;U-266/84: 64.4"	"Low region specificity"	"Detected in all"							"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	55.5	155.7	26.1	17.4	26.4	9.7	56.9	24.9	479.1	61.5	26.9	39.1	27.9	38.1	69.6	152.3	45.8	29.4	30.5	25.9	25.8	37.3	609.6	28.2	1.8	25.5	26.3	178.4	66.8	48.7	33.5	8.7	26.1	47.0	22.4	10.2	43.8	128.6	69.3	73.5	47.3	64.3	25.0	63.6	59.5	57.0	26.6	33.5	27.7	0.0	17.9	127.0	135.2	25.3	0.3	0.6	0.3	1.3	0.0	0.0	0.5	0.0	0.3	0.2	0.4	1.0	7.0	26.9	0.1	41.6	0.0	1.3	0.1	0.6	0.7	0.1	0.4	87.0	96.1	1.7	78.6	0.0	0.7	0.1	0.1	73.0	0.3	48.1	62.4	50.1	0.0	56.8	2.5	0.0	115.4	0.7	54.6	0.1	0.0	0.4	0.6	11.1	9.0	0.1	5.3	0.7	0.0	0.3	0.5	2.6	1.1	44.5	0.2	35.5	2.0	0.9	0.1	45.1	64.4	3.7	30.7	1.1	2.0	2.2	26.1	32.2	28.8	39.1	31.0	30.8	31.4	28.5	77.8	32.5	33.1	32.6	2.0	30.1	17.4	41.1	38.9	28.5	26.1	26.4	24.9	479.1	25.9	25.8	25.5	26.3	26.1	25.0	26.6	25.3	0.3	9.6	6.8	0.0	0.2	1.8	0.6	2.0	0.0	0.1	2.7	1.9	6.0	2.8	6.7	0.0	0.0	0.0	0.8	0.4	0.0	1.2	0.0	0.9	1.9	0.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	2.5	0.0	5.0	5.5	0.1	0.0	0.0	0.3	0.0	7.1	2.2	0.4	3.7	0.5	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.6	0.1	2.2	0.0	0.1	1.9	0.0	5.1	0.0	0.0	0.3	1.4	0.5	0.4	0.0	1.6	0.0	0.8	0.0	0.2	1.8
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 61.0;Plasma cells: 28.4;Squamous epithelial cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 116.0;HSkMC: 115.6"	"Low region specificity"	"Detected in all"							"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		1200000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	73.7	84.4	92.3	11.9	109.9	10.7	81.2	86.7	104.6	165.9	111.5	115.2	26.3	70.6	43.7	61.6	102.7	22.0	99.7	93.5	104.7	86.8	35.6	45.2	14.3	94.3	97.1	240.9	54.5	53.6	113.7	9.3	91.9	159.0	17.7	25.1	55.2	80.7	218.4	88.2	65.5	34.2	93.9	52.6	88.3	41.9	105.2	15.9	97.9	108.4	12.6	108.3	144.5	90.6	0.0	3.5	37.8	38.9	44.0	116.0	7.2	24.5	42.6	22.1	28.0	6.7	0.0	0.7	25.5	61.1	18.0	0.2	3.1	0.2	28.6	1.5	0.8	14.0	0.4	9.3	29.6	1.1	25.2	115.6	1.0	32.7	0.0	58.5	16.1	11.6	4.2	0.7	48.5	0.3	19.5	24.6	6.7	0.7	32.4	23.8	0.1	0.2	6.6	0.5	8.1	18.7	0.0	1.0	13.0	21.7	38.6	7.0	0.2	24.3	1.2	35.3	1.9	11.9	19.0	1.3	36.7	0.5	0.3	1.8	3.8	29.6	3.1	6.3	3.1	8.8	8.8	3.4	23.0	6.2	34.4	15.1	2.2	18.0	4.1	29.8	9.4	10.8	92.3	109.9	86.7	104.6	93.5	104.7	94.3	97.1	91.9	93.9	105.2	90.6	2.0	0.0	4.8	16.0	4.5	4.8	2.4	0.9	20.5	1.5	4.5	4.3	61.0	2.8	11.5	3.7	0.0	0.5	6.1	0.4	0.0	0.2	1.9	2.8	10.3	5.8	0.0	10.9	1.5	0.0	0.2	19.2	14.8	2.7	2.5	4.4	1.8	0.8	1.5	3.3	2.6	1.3	2.0	0.8	2.3	10.4	15.5	3.4	5.4	11.2	0.7	7.2	8.2	12.5	0.7	0.1	0.0	10.5	28.4	0.8	0.4	1.2	9.9	0.3	6.6	5.6	13.6	0.3	0.8	27.0	2.8	0.5	5.1	4.0	0.7	1.6
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656099-109674836	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 149.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 382.8;Proximal tubular cells: 109.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"eosinophil: 351.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 351.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"prognostic favorable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	22.3	31.1	19.7	15.3	23.7	5.9	22.5	19.1	23.8	24.5	40.0	45.4	149.5	22.6	24.3	31.3	22.2	17.8	33.5	19.2	19.9	45.9	41.2	14.6	11.8	20.7	20.9	42.9	21.2	57.8	18.6	7.6	20.2	25.8	38.5	12.5	21.2	41.0	92.4	20.6	99.4	25.7	21.1	30.2	28.8	15.1	20.1	9.9	27.7	45.5	15.6	36.8	28.8	20.2	13.5	6.0	10.5	78.9	23.0	35.1	13.4	4.3	34.1	9.8	12.8	43.3	1.5	12.5	16.1	19.1	19.3	13.6	27.1	14.4	6.2	18.9	0.0	27.4	23.5	38.8	37.1	9.5	31.8	22.3	14.0	12.6	0.0	27.5	8.1	31.7	12.8	18.4	6.9	12.7	8.1	41.9	8.2	56.3	31.9	16.9	5.8	18.5	38.8	9.6	7.4	17.6	0.2	68.2	54.9	7.8	18.6	20.1	3.6	11.4	44.0	12.5	6.3	27.0	51.4	1.1	37.1	13.9	32.5	11.9	14.5	351.7	12.2	14.5	7.4	17.0	9.3	14.1	37.8	14.9	8.9	10.7	1.8	12.8	3.6	12.6	14.1	12.6	19.7	23.7	19.1	23.8	19.2	19.9	20.7	20.9	20.2	21.1	20.1	20.2	6.9	9.6	2.7	11.4	9.9	18.1	27.3	17.9	18.8	6.2	14.7	19.0	30.2	21.5	9.5	31.3	0.0	21.0	13.9	53.0	101.8	45.9	3.0	4.5	10.8	8.6	7.2	4.2	3.3	57.7	18.6	22.9	13.3	5.4	21.0	13.3	14.3	35.7	35.6	5.0	3.3	45.9	6.1	17.2	26.0	6.4	30.1	14.9	40.9	2.8	14.8	23.9	17.5	5.0	3.4	35.4	38.6	24.8	13.3	6.7	382.8	109.8	7.5	5.4	32.9	15.3	23.2	7.0	7.3	23.0	15.3	8.8	11.2	12.6	96.7	26.9
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109711780-109775428	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 929.9"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 59.0;Leydig cells: 143.5;Muller glia cells: 213.3;Peritubular cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.9"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 21.6;HHSteC: 10.3;HSkMC: 10.9"									"HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 5: Breast - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	21.7	6.4	60.3	4.6	65.3	0.5	929.9	60.4	71.1	72.5	62.9	13.9	2.3	35.1	32.9	11.6	62.0	25.8	17.0	61.4	54.5	5.5	3.9	18.0	5.0	57.2	55.4	213.9	4.7	0.2	9.4	0.8	56.7	27.9	7.8	12.4	7.9	32.6	3.9	12.2	10.3	26.5	60.1	7.7	13.2	11.4	53.5	6.4	9.1	14.0	6.5	27.9	47.6	58.6	0.0	0.0	0.0	0.0	1.7	1.6	0.4	1.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	21.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	10.3	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.6	0.0	3.9	0.9	0.7	60.3	65.3	60.4	71.1	61.4	54.5	57.2	55.4	56.7	60.1	53.5	58.6	2.5	0.0	0.5	32.3	0.0	6.6	0.9	0.2	0.0	2.0	0.5	0.8	0.9	1.5	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	9.0	0.3	12.3	2.2	0.0	2.1	0.1	0.0	0.1	59.0	1.1	0.3	0.0	0.6	5.7	0.0	0.3	0.0	0.5	0.1	0.0	0.6	9.3	15.1	143.5	0.6	10.6	1.9	0.0	213.3	0.0	2.0	0.3	0.0	0.0	127.2	0.1	0.1	0.1	0.0	0.0	6.8	26.3	2.3	9.4	2.0	1.8	1.0	6.5	0.0	2.8	2.4	0.1	0.6
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583742-67586656	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2087.9"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 4033.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 4998.3;OE19: 7810.3"	"Low region specificity"	"Detected in all"							"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol		No	No		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	290.5	276.2	346.8	232.1	370.3	601.3	288.7	358.9	425.7	641.9	695.8	329.6	394.6	331.9	280.3	2087.9	647.5	435.8	367.2	341.4	381.9	567.7	45.1	468.3	321.8	375.7	379.2	306.9	340.9	737.4	320.2	326.9	378.5	291.7	197.1	137.9	541.2	780.4	355.0	731.4	321.7	214.2	367.0	257.2	535.5	45.8	378.1	296.9	579.0	312.5	380.8	526.5	946.2	377.7	1202.5	1599.4	763.7	1198.9	577.8	645.2	705.3	511.3	678.1	761.2	589.3	2956.3	1225.0	3.3	1144.7	813.5	683.7	1707.8	2073.9	2248.5	214.4	848.0	765.3	59.9	1107.6	0.5	852.2	400.3	667.6	807.2	4998.3	609.9	583.3	560.9	1160.2	847.2	1318.2	321.8	605.7	4.3	918.2	1100.6	1475.2	7810.3	681.3	844.8	129.6	3.8	1236.8	3.6	260.6	754.3	719.1	230.9	2394.0	598.2	3.6	656.3	634.5	351.6	883.8	740.6	378.6	200.0	1353.9	447.1	400.0	652.4	747.8	56.0	3145.4	246.6	720.0	2470.8	271.9	509.2	322.4	597.7	3582.7	476.3	267.8	466.5	130.5	1443.8	1608.5	1435.1	363.3	3948.4	346.8	370.3	358.9	425.7	341.4	381.9	375.7	379.2	378.5	367.0	378.1	377.7	466.7	1153.8	872.3	25.5	296.8	865.6	1914.8	3813.8	767.2	170.0	628.7	838.3	297.3	987.9	2763.5	1230.4	33.3	2116.8	372.4	655.0	1805.9	1811.9	4.9	1381.0	589.0	431.4	368.2	166.3	6.8	1444.4	1703.9	710.5	781.9	1020.9	269.9	795.0	382.3	10.5	861.2	70.7	10.1	992.4	1930.7	597.9	1090.3	25.5	572.3	703.5	1531.5	27.2	2166.5	558.5	459.3	17.6	38.4	1412.1	948.9	400.2	591.6	2266.2	844.4	3495.5	3715.4	274.4	361.6	401.3	941.7	4.8	54.9	4033.7	1061.7	1645.5	342.5	527.8	1118.5	3418.6
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B"	P0CG30	22	23957414-23961195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 81.8;breast: 307.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Hepatocytes: 27.6;Muller glia cells: 20.9;Peritubular cells: 28.6;Skeletal myocytes: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 57.0;HHSteC: 81.9;SK-MEL-30: 60.3;T-47d: 64.8"									HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol		No	No				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favorable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	12.3	81.8	21.6	4.3	21.5	0.0	307.9	21.4	27.0	16.6	19.5	17.2	1.4	15.5	12.0	24.7	16.1	5.5	23.9	20.8	22.7	15.2	39.5	18.5	1.8	22.2	22.2	22.6	26.1	6.4	26.0	4.4	22.2	40.6	1.9	3.8	12.5	10.4	16.4	47.8	8.3	11.8	21.0	10.2	23.8	5.5	24.3	1.8	18.6	41.0	1.6	12.1	14.0	21.1	17.0	0.8	0.0	57.0	1.0	1.1	2.4	8.0	4.7	11.5	11.9	24.8	0.2	0.0	12.9	20.2	29.7	24.5	0.0	25.5	5.2	0.0	2.2	0.9	33.6	4.0	81.9	0.1	9.1	33.4	4.0	33.2	6.7	32.6	9.6	0.0	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.9	12.5	0.0	42.4	0.1	26.0	0.0	1.1	23.8	8.2	0.2	60.3	0.2	64.8	0.9	32.0	9.9	6.5	1.3	6.4	0.0	0.0	0.1	6.1	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	21.5	21.4	27.0	20.8	22.7	22.2	22.2	22.2	21.0	24.3	21.1	8.1	3.2	3.6	1.3	0.9	0.0	8.6	0.0	2.8	3.9	9.4	17.9	0.2	7.2	1.3	0.0	0.0	1.6	0.1	0.0	29.4	7.9	0.6	1.3	11.8	7.1	1.2	5.3	2.4	9.1	3.5	7.6	1.1	2.9	1.3	2.2	18.5	27.6	10.5	0.0	2.1	0.4	0.0	3.8	0.0	1.5	9.9	1.5	0.0	0.0	3.2	20.9	0.0	2.0	0.7	4.2	0.0	28.6	0.7	7.9	0.0	5.7	0.0	2.8	6.6	26.7	9.6	0.4	0.7	0.9	0.0	1.8	0.2	0.4	0.1	3.8
GSX1	"Gsh-1, GSH1"	ENSG00000169840	"GS homeobox 1"	Q9H4S2	13	27792483-27794768	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	41	"brain: 7.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	29	"glioma: 3.9"	"Region enriched"	"Detected in some"	4	"hypothalamus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA047096			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA047096: AB_2679929"					"unprognostic (1.62e-1)"													0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.3	0.3	7.5	0.4	0.2	0.2	0.2	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852633-88891944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"HPA061626: AB_2684570"	"prognostic favorable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	25.3	26.4	14.8	18.8	15.7	62.2	28.3	16.4	24.0	22.9	17.7	22.6	17.9	21.8	30.3	26.3	22.7	23.8	15.7	15.5	16.5	22.9	32.6	22.0	28.9	15.5	15.9	26.3	23.3	22.7	20.3	25.2	15.7	18.1	23.1	17.9	22.9	16.3	23.1	28.3	23.9	20.7	16.2	28.7	23.0	16.3	15.1	40.2	21.2	18.5	31.3	31.5	23.7	17.0	40.0	13.6	34.6	18.8	49.8	34.4	42.9	32.1	39.4	44.1	46.4	17.9	24.3	45.5	37.8	28.0	53.3	22.0	36.8	32.1	38.3	42.8	34.3	48.6	21.2	32.1	31.9	56.8	28.7	30.0	32.1	38.2	21.7	33.4	25.1	41.1	43.1	33.6	47.0	12.6	54.9	46.7	28.8	35.4	29.3	34.4	46.8	34.2	47.0	47.2	26.7	22.4	28.5	35.4	57.8	30.7	15.9	51.1	22.3	19.2	24.0	35.0	38.8	35.1	29.9	62.6	12.8	48.8	16.7	91.2	49.3	82.1	45.9	57.1	53.2	57.8	52.1	50.5	62.5	48.2	62.9	53.9	99.7	54.9	60.4	40.5	70.1	50.9	14.8	15.7	16.4	24.0	15.5	16.5	15.5	15.9	15.7	16.2	15.1	17.0	106.6	6.4	29.7	13.7	114.9	46.3	75.4	63.3	58.6	14.6	39.7	104.9	12.3	21.5	45.6	11.0	2.1	74.0	122.3	39.1	39.2	49.2	22.9	53.9	28.4	30.3	20.3	51.1	22.7	38.6	60.0	53.0	41.8	29.8	48.9	30.2	16.8	17.6	40.5	18.5	21.4	30.5	52.9	32.3	42.5	7.9	36.4	93.4	28.4	22.5	40.3	30.7	33.0	18.1	25.2	49.9	70.5	29.3	74.3	27.8	26.9	47.4	55.2	18.5	13.1	86.6	65.0	24.2	29.0	40.1	50.0	150.1	122.8	34.5	22.7	79.4
GTF2H3	"BTF2, P34, TFIIH"	ENSG00000111358	"General transcription factor IIH subunit 3"	Q13889	12	123633739-123662604	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004844, HPA053562"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA004844: AB_2667265, HPA053562: AB_2682191"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.68e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.80e-2)"	10.4	9.0	6.1	12.9	6.0	11.2	15.6	5.8	6.9	11.7	5.0	14.0	10.5	12.9	8.9	15.4	15.0	9.7	10.7	5.8	5.2	11.2	14.1	9.7	16.6	5.9	6.3	11.2	5.6	11.7	5.9	12.9	6.4	13.0	16.2	10.1	7.3	11.3	13.8	12.8	10.6	14.2	5.8	10.4	11.7	12.2	6.2	16.0	13.4	11.1	16.1	11.4	8.2	7.1	42.0	21.7	27.6	35.5	33.3	37.1	38.9	31.2	38.2	47.1	31.6	23.2	21.1	48.4	37.4	43.0	18.8	27.8	46.2	56.4	56.2	41.4	32.5	39.7	19.3	33.3	46.8	80.9	25.3	39.7	42.2	38.2	85.9	35.3	34.2	59.4	60.4	15.7	42.9	27.4	40.5	27.2	35.6	29.6	39.9	41.3	42.1	27.4	24.1	40.1	24.8	21.8	41.1	19.8	32.1	30.1	55.4	48.1	22.9	29.3	22.3	45.9	50.7	28.8	42.3	47.6	33.7	40.5	34.3	11.4	4.6	6.0	7.6	6.9	7.6	5.9	6.1	8.1	7.0	5.7	8.7	8.0	0.6	10.7	7.0	5.9	6.7	4.1	6.1	6.0	5.8	6.9	5.8	5.2	5.9	6.3	6.4	5.8	6.2	7.1	20.8	22.4	24.3	23.5	19.2	11.7	12.3	20.9	27.9	16.2	12.6	15.2	7.4	12.8	22.3	12.9	10.4	26.3	13.8	8.4	3.9	12.9	8.6	18.3	24.7	11.1	6.7	21.6	26.6	11.0	23.4	17.1	16.8	16.7	24.1	19.9	12.1	16.9	17.2	16.8	27.8	12.3	6.1	12.3	7.9	4.3	11.8	15.3	1.8	10.3	16.1	21.9	7.2	15.6	23.1	10.8	10.8	11.3	17.1	10.5	6.1	15.8	20.7	13.7	13.1	18.8	15.2	32.6	27.1	25.7	13.2	23.7	14.5	36.2	15.7	10.4
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Inhibitory neurons: 42.1;Rod photoreceptor cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	6.0	12.6	7.0	3.4	7.0	0.5	6.9	7.2	8.1	16.8	14.0	15.1	7.7	11.3	8.6	26.7	8.8	5.7	11.6	6.0	8.4	18.6	4.6	11.7	1.0	9.2	8.9	10.5	10.0	18.9	27.6	5.8	9.0	13.3	5.6	36.7	17.3	8.2	68.1	22.4	6.7	8.4	6.7	2.0	13.9	5.0	10.1	3.4	17.4	29.7	5.4	15.0	19.8	10.2	21.2	12.9	28.1	30.8	22.2	10.8	0.2	8.8	23.7	17.1	17.7	21.7	30.1	5.4	6.5	18.1	41.7	11.6	22.6	10.2	12.6	0.2	13.0	1.1	43.1	26.1	71.2	0.2	0.7	14.7	42.1	12.0	48.9	39.7	8.9	10.4	15.5	0.1	19.2	26.1	2.7	18.9	22.6	25.7	12.8	28.1	16.4	20.0	32.7	14.6	23.1	30.5	21.7	39.0	19.9	14.2	23.4	21.2	4.6	17.5	16.9	11.4	20.5	1.1	3.4	8.9	6.7	0.3	14.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	7.0	7.0	7.2	8.1	6.0	8.4	9.2	8.9	9.0	6.7	10.1	10.2	0.9	9.6	8.2	48.3	0.1	7.9	9.9	10.5	9.6	30.8	5.6	4.1	10.4	12.8	6.8	9.2	33.3	1.4	1.5	4.5	11.7	7.6	1.6	11.5	8.0	4.1	4.2	0.8	24.6	9.2	1.8	5.6	6.1	17.0	2.5	8.0	2.9	3.1	2.6	21.9	42.1	3.6	8.2	1.2	5.7	0.3	4.1	2.5	7.2	14.0	0.7	5.9	1.0	25.6	24.9	11.6	3.2	5.7	0.0	17.8	3.6	17.4	12.7	41.1	0.0	19.0	5.7	0.1	3.7	18.2	6.7	2.9	1.1	2.4	7.4	15.8
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	4.9	4.4	4.3	4.6	5.0	6.9	8.4	9.2	4.3	7.3	3.6	5.3	3.9	6.6	5.5	6.7	6.6	5.2	5.8	4.5	5.2	6.0	5.3	5.7	5.0	3.4	4.8	10.3	6.1	9.4	3.2	6.4	3.7	6.2	5.4	5.5	7.3	5.7	5.8	9.8	3.6	6.2	3.6	4.5	5.8	8.3	5.6	8.1	9.5	8.0	6.6	5.0	3.8	3.8	15.2	21.7	25.8	22.5	12.3	14.4	20.0	15.1	18.4	19.6	14.4	25.4	10.9	22.7	9.8	18.6	18.1	33.8	39.8	23.6	21.1	15.4	19.1	19.0	28.9	10.8	12.8	28.6	12.4	11.4	17.6	20.4	26.1	11.6	16.8	15.1	32.7	11.4	14.0	24.6	17.8	13.3	33.1	22.2	21.4	17.6	31.1	20.6	14.3	12.5	36.3	24.6	25.9	25.8	15.9	15.8	35.4	12.1	17.8	32.9	18.7	15.1	21.6	4.9	12.3	25.1	13.5	17.8	20.7	0.0	0.3	0.2	0.5	0.3	0.4	0.5	0.4	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.2	0.5	0.4	0.2	4.3	5.0	9.2	4.3	4.5	5.2	3.4	4.8	3.7	3.6	5.6	3.8	9.9	19.2	11.5	2.3	7.8	30.7	6.9	6.9	21.6	15.5	19.1	14.7	14.6	1.5	6.7	3.7	14.6	7.5	9.0	6.6	7.9	8.3	6.5	21.5	26.2	11.6	13.1	8.2	3.2	6.3	7.5	13.0	8.6	17.7	1.3	17.1	10.0	8.6	6.3	20.2	3.1	8.1	10.2	7.6	9.3	3.7	19.0	6.3	3.6	1.9	7.1	11.9	7.2	1.0	2.1	5.8	7.0	19.2	10.7	11.6	3.8	6.6	16.2	16.9	0.0	18.8	10.9	16.7	13.8	22.1	40.1	6.4	8.8	18.2	9.0	6.4
GTPBP4	"CRFG, FLJ10686, FLJ10690, NGB, NOG1"	ENSG00000107937	"GTP binding protein 4"	Q9BZE4	10	988434-1019932	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039618, HPA056468"	Uncertain		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"HPA039618: AB_10795292, HPA056468: AB_2683141"	"unprognostic (2.11e-3)"	"unprognostic (3.10e-3)"	"unprognostic (7.77e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (8.85e-12)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.67e-2)"	15.6	19.6	8.0	12.6	8.5	26.9	12.8	8.6	8.7	8.4	9.4	9.5	8.6	11.0	8.8	11.4	9.2	7.9	11.1	8.8	9.5	9.4	10.9	8.5	13.9	9.1	9.4	9.8	11.9	10.3	7.8	10.2	9.1	9.0	10.8	8.9	7.8	8.4	26.6	9.5	8.2	12.2	9.5	9.4	9.2	21.0	9.4	12.0	9.8	14.8	15.6	18.3	8.7	10.1	57.0	49.4	37.1	34.9	27.9	31.1	27.3	52.3	18.8	62.6	53.3	73.2	43.3	87.0	15.2	45.5	21.3	43.6	77.4	52.0	71.2	41.8	50.9	94.7	35.3	45.4	44.5	41.3	47.1	43.1	42.7	72.7	51.6	25.5	34.7	62.9	98.3	33.5	60.1	57.0	62.0	40.3	56.2	77.9	33.8	59.3	35.5	57.6	37.9	37.4	19.3	57.3	37.3	44.7	66.3	36.7	61.8	42.3	32.4	30.3	16.4	71.5	65.2	45.0	86.9	103.5	33.9	43.5	24.9	18.2	9.6	3.6	12.4	16.2	14.3	12.0	11.7	12.6	12.9	11.2	12.7	12.5	1.5	18.4	13.3	8.6	16.6	8.9	8.0	8.5	8.6	8.7	8.8	9.5	9.1	9.4	9.1	9.5	9.4	10.1	36.2	57.7	74.3	5.9	41.8	62.7	100.0	52.8	35.3	26.1	28.1	27.4	32.6	21.5	83.5	29.5	18.8	50.3	37.4	18.4	33.2	57.7	70.9	46.8	51.9	49.2	22.1	37.4	9.3	44.1	54.9	48.9	33.6	78.8	66.9	40.1	20.0	27.5	34.7	23.5	8.9	29.9	40.7	26.0	24.4	20.9	24.8	33.1	23.2	8.4	39.5	26.5	22.6	6.0	10.2	72.2	17.3	29.3	37.0	84.7	10.6	25.6	55.8	32.7	19.7	58.5	51.4	88.7	84.9	47.0	67.2	95.4	37.5	57.7	32.6	102.6
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990984-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 79.8;Spermatocytes: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA034831: AB_10671506, HPA058631: AB_2683783"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	5.3	5.7	3.6	6.1	4.3	8.4	5.6	4.6	4.9	4.6	4.6	6.0	6.6	5.6	3.7	7.4	4.4	5.2	11.9	3.9	3.9	7.3	5.9	4.3	11.2	4.3	3.8	6.7	6.8	8.9	4.5	6.1	4.2	5.7	7.1	4.2	6.5	3.7	20.0	4.8	6.0	5.5	4.4	4.9	7.5	14.4	3.9	9.7	10.1	18.3	8.1	5.9	4.7	6.4	25.5	10.8	15.7	16.5	9.2	15.6	11.5	17.9	14.7	17.0	20.5	18.6	10.4	16.8	9.7	10.0	14.2	17.1	21.0	17.1	23.5	7.0	13.4	46.5	11.4	11.6	8.4	28.9	10.5	11.9	11.9	9.6	7.0	19.2	16.1	19.9	16.4	19.5	18.0	8.8	18.5	14.4	32.8	13.2	20.8	16.1	14.7	10.4	14.4	16.3	17.5	18.2	14.2	11.3	25.7	13.7	12.3	19.6	9.8	12.7	19.4	4.5	16.0	13.1	17.4	24.0	12.7	23.6	14.0	7.9	4.3	2.9	6.4	3.0	5.7	4.2	7.8	6.3	8.1	3.6	9.9	6.5	0.7	8.7	2.7	3.7	5.4	4.5	3.6	4.3	4.6	4.9	3.9	3.9	4.3	3.8	4.2	4.4	3.9	6.4	13.1	16.0	15.4	2.9	16.9	13.5	15.9	28.8	8.0	11.5	12.9	12.4	25.8	10.0	19.5	5.5	6.2	28.3	27.1	10.4	23.5	16.3	79.8	17.7	12.9	11.6	10.2	22.7	5.5	18.3	25.1	13.3	12.8	18.3	19.7	20.0	17.9	7.7	22.7	10.1	6.3	10.3	28.5	16.7	14.8	35.5	11.8	13.6	10.6	4.7	18.3	10.4	13.4	7.1	6.9	16.5	12.2	5.7	17.1	12.8	17.7	29.6	16.0	14.0	0.0	17.4	15.8	79.7	28.1	16.1	12.1	15.2	22.5	34.9	12.0	18.9
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296870-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 52.2;Extravillous trophoblasts: 31.2;Granulosa cells: 27.1;Spermatocytes: 73.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"		Yes	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.90e-10)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	0.6	0.6	0.2	5.1	0.2	11.2	0.5	0.5	0.3	0.7	0.2	2.4	4.1	0.8	0.0	3.6	0.2	0.5	0.3	0.2	0.3	0.3	0.4	0.6	9.2	0.4	0.3	0.2	0.2	0.1	0.1	2.6	0.4	0.2	2.6	0.1	0.7	0.1	0.1	2.5	2.9	1.2	0.1	2.4	1.9	7.2	0.5	19.6	0.2	0.2	8.7	1.0	1.2	0.4	59.5	27.6	53.2	42.2	1.1	3.0	25.5	50.3	23.5	71.7	58.8	29.3	21.9	55.7	13.0	19.4	32.8	30.3	48.0	12.7	45.7	33.7	52.0	37.4	38.9	22.8	0.1	67.5	43.8	0.6	1.0	30.9	15.6	7.5	31.2	39.7	29.0	67.8	43.4	33.1	60.9	33.0	37.2	24.2	30.7	59.6	59.7	36.3	11.7	10.7	27.5	37.5	48.1	30.7	21.5	23.8	26.2	25.8	25.1	40.6	75.8	33.4	53.7	38.6	19.7	56.3	25.8	32.2	60.5	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.4	0.3	0.2	0.2	0.2	0.5	0.3	0.2	0.3	0.4	0.3	0.4	0.1	0.5	0.4	1.1	0.0	0.0	0.7	7.0	2.8	1.1	2.1	0.6	0.7	2.8	3.4	1.6	0.0	0.5	0.0	0.0	19.2	6.8	7.6	0.0	0.9	5.6	2.1	4.7	3.9	1.2	52.2	0.3	0.2	31.2	5.1	16.8	4.3	0.0	27.1	6.4	1.2	19.9	0.0	0.5	9.4	2.0	7.5	4.0	3.9	0.3	4.7	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.8	0.2	0.7	19.1	1.8	0.5	0.5	0.2	0.3	6.6	2.6	5.4	73.6	27.8	11.7	2.6	1.5	5.0	1.2	13.8	1.6
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 213.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	28.4	18.2	11.0	22.3	12.3	84.2	80.9	12.0	16.1	26.7	14.3	38.2	36.1	26.2	41.8	16.4	24.6	27.6	19.6	10.7	11.5	25.1	104.0	35.7	25.6	13.2	12.2	19.9	33.6	30.3	12.6	48.2	13.2	20.2	41.9	9.7	32.9	21.2	10.9	18.8	29.8	19.1	11.9	34.0	38.1	19.5	13.0	22.7	27.7	14.4	24.0	27.3	15.4	13.5	67.0	26.5	25.2	56.3	80.9	49.1	35.3	21.3	56.8	45.0	42.1	37.0	67.8	30.9	32.3	26.8	24.1	27.5	16.5	25.1	26.8	27.3	34.1	41.5	40.9	27.3	39.7	89.6	67.1	33.4	26.7	26.3	33.3	54.5	39.3	18.0	63.2	213.5	30.5	50.3	34.2	92.0	17.9	103.0	21.0	34.4	55.9	172.4	29.4	42.8	36.2	32.7	55.6	129.1	72.3	29.9	71.1	88.8	28.5	55.3	49.3	21.8	53.6	119.6	151.9	50.0	41.0	116.3	68.3	26.0	80.1	65.7	32.0	103.0	28.4	27.7	24.7	28.4	80.5	22.6	16.8	19.5	13.2	46.6	93.5	34.2	34.5	51.4	11.0	12.3	12.0	16.1	10.7	11.5	13.2	12.2	13.2	11.9	13.0	13.5	53.1	51.3	58.7	10.1	33.0	18.0	32.0	51.9	29.0	12.2	26.1	19.9	12.2	48.6	48.9	29.5	8.4	81.9	32.6	52.2	5.9	41.1	59.1	28.9	26.5	39.7	43.0	47.1	12.3	30.3	61.2	49.5	49.5	49.4	36.8	38.3	37.9	72.7	126.4	16.8	10.6	51.6	30.5	88.1	33.2	46.7	43.2	78.0	39.2	14.0	44.8	28.0	20.6	8.5	14.2	29.4	49.5	28.6	87.5	25.3	50.6	26.8	43.2	20.1	26.3	27.1	26.0	49.6	31.0	16.0	14.8	66.9	32.2	24.4	44.3	29.6
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888046-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Endometrial stromal cells: 45.4;Fibroblasts: 23.0;Late spermatids: 27.1;Oligodendrocytes: 61.3;Skeletal myocytes: 40.0;Theca cells: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 22.3;JURKAT: 22.1;MOLT-4: 36.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	6.0	3.8	2.6	5.2	5.3	1.8	4.0	4.3	3.2	5.7	2.6	3.7	0.6	5.6	2.5	3.2	5.1	10.1	13.6	2.0	2.4	0.9	0.3	3.8	1.5	6.2	5.8	16.5	4.2	2.4	1.9	4.0	4.1	3.3	2.0	0.4	5.3	4.0	0.8	1.7	1.2	5.5	5.3	0.7	1.3	5.8	4.6	6.7	8.8	1.5	1.0	5.7	3.6	6.9	0.2	1.8	0.1	11.2	9.9	19.3	1.7	1.8	4.2	4.0	9.8	0.5	1.2	0.0	3.1	4.9	22.3	0.1	1.0	2.2	3.8	0.0	1.3	0.0	7.2	12.4	12.6	4.9	0.0	18.8	1.1	9.7	1.6	6.0	0.0	22.1	5.8	0.1	2.4	2.7	36.5	0.1	6.6	0.1	2.2	0.2	9.5	0.0	1.3	1.7	1.1	5.0	9.8	0.5	1.3	2.0	3.7	1.5	0.1	4.3	13.5	13.3	6.5	1.0	0.1	0.2	11.1	2.3	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.3	0.0	2.6	5.3	4.3	3.2	2.0	2.4	6.2	5.8	4.1	5.3	4.6	6.9	1.6	3.2	2.6	7.2	0.1	1.9	1.9	5.3	0.0	0.6	1.5	7.6	14.6	2.8	2.3	0.0	0.0	0.2	1.5	1.4	0.0	0.1	47.9	5.7	45.4	0.6	3.5	0.0	8.3	1.1	0.3	23.0	0.0	7.5	0.0	8.0	0.7	0.0	0.4	0.0	9.0	2.9	0.0	0.0	4.0	27.1	8.1	0.5	0.0	12.2	0.0	2.5	0.0	3.0	61.3	0.8	0.4	7.2	0.0	2.0	0.6	0.5	2.1	0.4	0.0	40.0	3.9	2.5	4.2	0.2	0.4	0.8	0.4	22.9	1.6	0.4
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828822-2882820	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adipose tissue: 156.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7;Enteroendocrine cells: 20.4;Granulosa cells: 10.2;Hepatocytes: 20.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 39.1;CACO-2: 30.4;Hep G2: 32.6;NTERA-2: 38.4;SK-MEL-30: 87.6;SuSa: 59.0"					"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favorable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	156.3	2.2	10.3	1.9	10.8	0.2	38.9	18.4	8.8	3.0	8.5	3.9	1.5	6.6	1.0	0.9	5.1	2.2	1.4	11.2	18.9	2.0	18.5	0.5	0.6	29.4	24.5	2.5	5.4	1.0	0.8	2.1	27.3	4.0	2.8	1.4	4.7	6.6	0.3	1.9	2.1	3.7	36.0	0.3	4.5	0.9	13.7	0.4	1.7	0.5	0.3	3.7	2.0	35.4	0.1	11.5	39.1	0.2	20.5	0.0	28.5	2.0	6.3	6.1	8.2	30.4	0.6	0.0	3.1	5.2	6.6	0.0	22.5	0.5	6.8	0.2	6.3	0.1	0.7	32.6	6.7	0.0	8.9	8.1	0.4	1.0	0.0	0.2	0.0	0.0	0.3	0.1	6.6	1.9	0.0	1.0	38.4	0.4	0.2	6.1	13.0	0.0	0.0	0.1	0.0	0.7	0.1	0.3	87.6	59.0	4.1	25.4	0.0	0.0	6.7	3.8	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.3	10.8	18.4	8.8	11.2	18.9	29.4	24.5	27.3	36.0	13.7	35.4	0.3	0.0	0.0	10.7	0.2	0.4	1.1	0.5	0.0	1.2	2.1	0.8	1.2	4.3	0.2	0.0	4.2	6.0	0.0	1.2	5.9	1.0	0.4	3.8	1.0	0.3	20.4	0.0	5.9	4.0	7.9	1.6	4.6	0.7	0.0	10.2	0.0	20.2	1.1	0.0	4.9	1.7	0.0	1.0	0.0	0.5	0.6	0.1	3.6	0.0	0.0	1.6	0.0	0.5	0.1	2.1	0.6	3.0	0.0	1.0	0.4	2.4	1.1	0.1	0.0	0.3	1.2	0.3	1.5	0.0	0.3	2.3	0.0	3.2	3.5	0.7
H1-0	"H1.0, H1F0, H1FV"	ENSG00000189060	"H1.0 linker histone"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 660.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 51.4;Cytotrophoblasts: 42.9;Extravillous trophoblasts: 125.7;Hofbauer cells: 73.2;Syncytiotrophoblasts: 219.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.1;granulocytes: 17.1;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"OE19: 662.8;U-2 OS: 823.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"		Yes	No		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favorable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	89.8	53.5	56.6	36.7	55.4	660.5	121.4	72.5	64.1	218.3	42.5	146.2	129.9	168.2	43.5	230.6	119.7	56.3	86.5	55.4	67.1	292.8	179.3	72.4	24.4	58.4	54.2	120.7	125.9	93.2	58.2	80.0	57.7	151.7	120.0	39.9	155.3	40.2	216.2	228.6	137.1	97.7	52.6	36.7	131.2	42.4	58.3	136.2	93.9	93.5	46.6	85.6	194.9	55.8	159.6	67.9	206.0	91.8	53.4	48.4	291.6	126.9	262.3	362.6	512.6	278.1	247.3	0.2	31.1	106.3	84.1	303.8	0.0	87.2	256.0	0.9	15.3	268.2	25.3	187.4	185.8	0.1	0.7	45.4	152.4	182.3	203.2	4.0	97.8	60.4	0.1	0.5	28.5	263.3	45.4	26.5	80.2	662.8	329.9	74.6	122.6	56.1	58.0	42.7	47.3	263.9	349.9	235.4	473.9	91.8	184.2	167.1	65.4	27.4	823.3	122.7	25.9	0.7	18.5	1.2	33.5	95.9	80.3	17.1	9.9	15.7	0.1	11.7	0.1	0.0	1.0	0.2	8.1	0.1	2.8	0.4	5.4	0.1	10.3	7.4	0.2	6.9	56.6	55.4	72.5	64.1	55.4	67.1	58.4	54.2	57.7	52.6	58.3	55.8	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	42.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	125.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0
H1-1	"H1.1, H1a, H1F1, HIST1H1A"	ENSG00000124610	"H1.1 linker histone, cluster member"	Q02539	6	26017032-26017787	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 1.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 3.3;Cytotrophoblasts: 1.2;Extravillous trophoblasts: 4.2;Hofbauer cells: 2.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Not detected"	"Not detected"							"HPA043753, HPA056830"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA043753: AB_2678654, HPA056830: "		"unprognostic (3.80e-1)"					"unprognostic (1.82e-1)"			"unprognostic (1.15e-1)"				"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.05e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.0	0.4	0.2	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0
H1-2	"H1.2, H1c, H1F2, H1s-1, HIST1H1C"	ENSG00000187837	"H1.2 linker histone, cluster member"	P16403	6	26055740-26056470	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 49.3;Cytotrophoblasts: 42.7;Extravillous trophoblasts: 68.1;Hofbauer cells: 75.5;Syncytiotrophoblasts: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 258.6;eosinophil: 458.7;neutrophil: 229.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 458.7"	"Cell line enhanced"	"Detected in many"		"K-562: 334.2;SiHa: 311.1;U-2 OS: 601.6;U-266/70: 673.7;U-266/84: 661.8"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		5500000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	72.2	47.6	67.1	27.2	55.3	229.5	71.7	148.8	64.2	116.1	84.5	54.5	33.6	14.6	42.0	70.3	41.3	18.9	154.7	51.1	60.1	236.3	130.0	60.5	31.5	64.6	70.4	89.4	60.5	8.7	15.2	43.8	56.7	132.9	44.2	22.0	39.8	16.4	227.4	65.0	42.8	7.9	57.4	56.6	73.4	26.8	71.4	62.0	59.7	99.1	27.8	29.5	90.6	76.7	39.9	27.5	20.5	21.9	49.9	10.0	0.7	19.5	30.8	87.9	92.6	14.9	28.1	3.1	109.6	25.6	32.8	17.3	6.4	15.0	24.3	38.7	23.4	16.5	27.8	17.5	14.7	7.8	38.4	70.4	19.9	11.5	19.2	27.3	13.8	17.6	334.2	243.3	43.7	17.3	20.8	18.3	11.5	96.3	41.4	10.8	9.5	129.1	52.8	28.1	52.6	17.9	311.1	53.0	22.0	19.1	65.8	12.5	6.8	41.1	601.6	12.5	9.0	673.7	661.8	31.3	29.9	253.6	14.4	258.6	14.3	458.7	19.3	14.2	24.4	57.7	31.9	21.4	30.5	76.8	29.4	23.1	229.3	20.2	18.9	31.6	48.3	22.1	67.1	55.3	148.8	64.2	51.1	60.1	64.6	70.4	56.7	57.4	71.4	76.7	14.9	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	0.0	0.0	42.7	29.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	68.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	298.4	4.5	0.0	0.0	0.0
H2AC1	"bA317E16.2, H2AFR, HIST1H2AA"	ENSG00000164508	"H2A clustered histone 1"	Q96QV6	6	25726063-25726562	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"			Nucleoplasm		"HPA041189: AB_2677357"													"unprognostic (4.53e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC11	"H2A.1b, H2A/p, H2AFP, HIST1H2AG, pH2A/f"	ENSG00000196787	"H2A clustered histone 11"	P0C0S8	6	27133042-27135291	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 2.8;testis: 3.1"	"Group enriched"	"Detected in some"	10	"Cardiomyocytes: 1.2;Cytotrophoblasts: 2.0;dendritic cells: 1.5;Extravillous trophoblasts: 3.1;Hofbauer cells: 2.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5"	"Group enriched"	"Detected in many"	5	"B-cells: 2.8;granulocytes: 9.5;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"K-562: 15.5;SiHa: 17.3;U-266/84: 48.8"					"Low region specificity"	"Detected in many"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.86e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.54e-2)"	0.3	0.3	0.7	0.3	0.9	2.4	2.8	0.5	0.7	0.5	0.7	0.9	1.3	0.1	0.6	0.6	0.2	0.3	0.2	0.6	1.0	0.2	0.5	0.3	1.0	1.5	1.4	0.1	0.2	0.0	0.1	0.4	1.4	0.7	0.7	0.1	0.1	0.4	0.2	0.2	1.1	0.2	1.2	0.9	0.5	3.1	1.7	1.9	0.3	0.3	0.4	0.4	0.4	1.7	2.1	2.8	2.3	2.0	7.1	1.5	1.5	0.7	1.1	2.4	0.3	1.2	2.1	0.7	3.0	0.9	2.3	4.2	2.8	1.2	1.6	3.7	1.6	1.1	5.2	0.0	1.5	1.1	2.2	2.7	0.5	0.7	0.8	1.2	0.8	2.0	15.5	6.9	0.1	2.7	2.9	1.8	1.3	3.1	1.9	1.9	2.3	8.0	0.4	0.5	9.0	2.1	17.3	2.7	1.0	1.1	0.0	0.7	0.9	2.6	5.8	2.1	1.1	12.4	48.8	4.9	0.5	1.7	1.6	9.5	0.3	0.6	0.4	0.2	0.9	2.3	1.7	1.1	0.5	2.8	1.4	1.3	2.3	0.9	0.6	1.0	2.9	5.3	0.7	0.9	0.5	0.7	0.6	1.0	1.5	1.4	1.4	1.2	1.7	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0
H2AC12	"dJ86C11.1, H2A/S, H2AFALii, HIST1H2AH"	ENSG00000274997	"H2A clustered histone 12"	Q96KK5	6	27147106-27147562	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.8;brain: 2.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.6;Extravillous trophoblasts: 2.3;Hofbauer cells: 1.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.4;MOLT-4: 6.2;NB-4: 6.9"									"CAB004030, HPA041189"	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB004030: AB_2118804, HPA041189: AB_2677357"	"unprognostic (4.07e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.35e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"		"unprognostic (9.74e-3)"	"unprognostic (1.87e-1)"		"unprognostic (1.26e-4)"	0.2	0.1	0.5	0.0	0.9	8.8	0.3	0.7	0.5	0.2	0.8	0.7	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.9	0.0	0.1	0.2	1.1	1.6	1.3	0.1	0.1	0.1	0.0	0.3	1.8	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.1	0.1	1.8	0.6	0.2	1.6	2.0	1.5	0.1	0.0	0.2	0.2	0.2	2.8	1.7	2.0	0.7	3.0	0.0	0.0	0.4	0.2	0.3	0.3	0.0	2.0	0.6	2.7	0.6	0.0	0.3	0.2	0.6	0.0	0.0	1.4	5.4	3.0	2.5	0.0	0.0	2.1	1.1	0.0	0.0	0.7	0.0	0.0	0.5	1.1	3.1	1.7	0.5	0.3	6.2	6.9	2.1	0.6	0.7	2.2	1.9	3.2	0.0	0.2	1.5	0.4	0.9	0.3	0.2	0.0	0.6	1.0	0.0	0.6	1.7	0.1	1.8	1.8	2.0	4.0	0.8	2.8	0.6	0.0	0.8	0.0	2.2	2.3	1.0	3.3	4.1	3.8	2.0	11.9	2.1	1.5	0.0	5.1	1.4	1.4	0.7	2.0	0.5	0.9	0.7	0.5	0.3	0.9	1.6	1.3	1.8	1.8	2.0	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
H2AC13	"H2A/c, H2AFC, HIST1H2AI"	ENSG00000196747	"H2A clustered histone 13"	P0C0S8	6	27808199-27808701	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.2;brain: 4.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 42.1;U-266/84: 118.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (6.82e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.54e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.50e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.24e-2)"	0.3	0.1	1.0	0.2	0.5	5.2	0.1	0.6	0.6	0.3	2.8	2.5	0.9	0.0	0.1	0.7	0.4	0.3	0.1	0.4	1.2	0.1	0.2	0.5	1.5	1.7	1.8	0.4	0.0	0.7	0.0	0.7	1.6	0.2	2.2	0.0	0.1	0.0	0.0	0.2	1.1	0.1	1.6	1.1	0.9	0.5	2.5	2.5	0.1	0.0	0.6	0.4	0.5	4.2	2.4	8.5	2.0	1.4	0.9	0.5	0.8	1.6	0.3	2.7	2.0	2.8	1.5	2.4	5.1	0.7	1.5	1.8	0.0	1.5	1.2	8.6	11.0	3.7	12.6	8.0	0.9	0.9	1.9	3.7	0.6	0.8	0.2	2.3	0.6	3.0	42.1	9.9	0.0	11.8	6.5	7.0	2.2	7.2	3.2	3.4	0.0	16.6	3.0	1.6	11.7	2.3	23.6	3.4	0.8	0.7	14.2	1.1	0.4	1.2	4.6	1.0	1.0	9.1	118.9	5.0	1.1	9.8	0.7	0.0	0.2	1.5	0.3	0.3	0.3	0.8	1.4	0.3	1.1	1.1	0.3	0.2	2.1	1.0	0.3	1.0	1.8	1.0	1.0	0.5	0.6	0.6	0.4	1.2	1.7	1.8	1.6	1.6	2.5	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H2AC14	"H2A/E, H2AFE, HIST1H2AJ"	ENSG00000276368	"H2A clustered histone 14"	Q99878	6	27814302-27814777	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 7.2"	"Cell type enhanced"	"Detected in single"		"Extravillous trophoblasts: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 6.9;Karpas-707: 9.8;MCF7: 11.5"					"Low region specificity"	"Detected in many"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (8.95e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.43e-1)"		"unprognostic (9.35e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.88e-2)"	0.1	0.0	0.2	0.3	0.4	7.2	0.0	0.5	0.7	0.5	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.1	0.1	1.0	1.7	0.0	0.0	0.1	0.2	0.1	0.8	3.5	0.0	0.9	0.0	0.0	0.0	0.7	1.0	0.8	0.7	1.8	1.4	0.1	3.1	0.3	0.5	0.1	1.0	0.0	0.8	0.4	1.4	0.3	4.6	0.7	6.9	0.2	0.0	1.7	0.0	0.2	0.5	0.2	0.0	1.0	1.6	0.0	9.8	0.2	11.5	5.0	4.6	1.4	1.5	2.4	4.6	0.0	1.4	0.1	1.9	0.3	0.8	0.8	1.0	0.3	0.2	0.3	3.4	0.0	0.0	1.6	0.3	0.1	4.8	3.1	2.9	0.8	3.2	2.2	0.0	0.0	0.0	0.2	0.2	0.4	0.3	1.3	1.3	1.1	1.3	0.4	0.1	1.1	0.1	0.1	0.1	2.8	1.7	0.2	0.4	0.5	0.7	0.2	0.4	0.7	0.5	1.3	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0
H2AC15	"H2A/d, H2AFD, HIST1H2AK"	ENSG00000275221	"H2A clustered histone 15"	P0C0S8	6	27837880-27838375	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"dendritic cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.3;SCLC-21H: 3.5;U-266/84: 3.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"																		0.4	1.0	0.9	0.4	0.9	1.0	0.4	2.7	1.3	0.9	2.5	0.4	0.1	0.5	1.7	0.3	1.2	1.0	1.7	0.9	1.8	0.9	0.6	0.8	1.2	1.9	1.5	2.0	0.6	0.4	1.3	0.3	2.0	1.2	0.4	0.2	0.4	0.3	0.8	0.2	0.6	0.0	2.2	0.8	0.4	2.6	2.2	1.2	1.3	0.4	0.2	0.4	0.7	3.9	0.0	1.3	0.1	1.7	0.3	0.0	0.0	0.1	0.0	0.3	0.0	1.1	0.0	0.6	0.1	0.2	0.1	1.4	0.5	0.0	0.3	0.4	0.1	0.4	3.3	0.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.3	0.4	0.0	0.2	0.0	1.1	0.6	0.2	0.1	0.3	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.4	0.1	0.0	1.2	3.9	0.3	0.0	0.0	0.1	0.0	0.1	0.0	1.4	0.0	1.3	4.1	1.7	1.5	0.0	3.2	2.5	1.8	0.0	0.9	0.4	0.7	1.3	2.6	0.9	0.9	2.7	1.3	0.9	1.8	1.9	1.5	2.0	2.2	2.2	3.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0
H2AC16	"dJ193B12.9, H2A/i, H2AFI, HIST1H2AL"	ENSG00000276903	"H2A clustered histone 16"	P0C0S8	6	27865317-27865798	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.6;brain: 2.5"	"Cell type enhanced"	"Detected in single"		"Extravillous trophoblasts: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.8;MOLT-4: 5.2"					"Low region specificity"	"Detected in single"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"		"unprognostic (2.41e-2)"	"unprognostic (2.12e-1)"		"unprognostic (6.21e-2)"	0.1	0.1	0.5	0.1	0.3	7.6	0.2	0.6	0.4	0.0	1.0	0.2	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.3	1.0	0.1	0.1	0.4	0.4	1.5	1.3	0.0	0.0	0.3	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	1.2	0.7	0.2	0.3	1.7	0.5	0.0	0.1	0.1	0.0	0.2	2.5	2.8	1.2	0.8	0.0	0.0	0.0	0.5	0.9	0.5	1.5	1.4	0.0	0.7	2.0	0.8	0.2	0.8	0.8	0.0	0.2	1.0	1.9	4.8	0.6	0.2	0.5	0.0	0.4	1.1	0.0	0.0	0.4	0.2	0.0	0.0	1.1	4.5	3.3	0.2	3.0	5.2	3.9	1.6	1.5	0.6	2.6	0.0	0.2	0.3	2.0	1.6	1.4	1.0	0.1	0.4	0.1	0.7	1.1	0.0	0.1	0.0	1.0	1.7	3.7	0.0	4.0	0.8	3.1	0.7	2.0	1.4	1.1	0.1	1.3	0.0	2.4	1.2	1.3	3.6	5.9	0.4	0.7	6.1	0.0	2.9	2.6	1.1	0.7	0.5	0.3	0.6	0.4	0.3	1.0	1.5	1.3	1.5	1.2	1.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H2AC17	"H2A.1, H2A/n, H2AFN, HIST1H2AM"	ENSG00000278677	"H2A clustered histone 17"	P0C0S8	6	27892699-27893185	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2;brain: 5.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.2;Syncytiotrophoblasts: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 63.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 28.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (6.05e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.24e-1)"	"unprognostic (8.85e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.30e-1)"	0.4	0.4	1.3	0.2	0.9	3.2	0.3	1.2	1.1	0.5	2.5	0.8	0.7	0.3	0.2	0.9	0.0	0.0	0.2	0.5	1.5	0.2	0.5	0.6	1.5	3.3	3.2	0.0	0.3	0.3	0.0	0.9	3.2	0.6	0.6	0.0	0.3	0.0	0.2	0.4	0.8	0.0	2.7	1.2	0.4	0.9	2.4	2.1	0.7	0.0	0.4	0.3	0.7	5.8	3.7	2.6	2.3	5.4	0.3	0.2	4.8	1.2	0.6	2.4	3.1	0.9	1.6	5.8	4.3	0.7	2.9	2.2	2.3	1.6	1.9	4.6	1.3	2.9	3.5	3.9	0.0	2.1	2.4	1.8	0.0	1.7	0.0	0.2	2.3	4.2	12.5	8.0	0.4	6.8	12.6	8.9	4.2	2.1	1.2	7.7	3.6	11.9	1.2	0.9	8.9	1.6	6.5	0.6	0.9	1.2	5.4	1.7	0.0	1.1	0.2	1.2	2.0	9.0	28.9	14.2	1.5	9.7	1.0	63.8	5.0	21.1	10.0	6.0	5.9	13.5	8.8	8.6	18.3	15.3	3.5	4.2	16.7	8.5	10.5	22.5	13.4	9.7	1.3	0.9	1.2	1.1	0.5	1.5	3.3	3.2	3.2	2.7	2.4	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0
H2AC18	"H2A.2, H2A/q, H2AFO, HIST2H2AA, HIST2H2AA3"	ENSG00000203812	"H2A clustered histone 18"	Q6FI13	1	149842188-149842736	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.5;Hofbauer cells: 1.0;Syncytiotrophoblasts: 2.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 116.8;U-266/70: 472.4;U-266/84: 300.7"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.41e-2)"				"unprognostic (3.79e-1)"					"unprognostic (1.53e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.20e-1)"				73.9	37.8	7.8	16.5	7.1	175.8	47.2	8.4	18.6	121.9	51.9	46.1	11.4	13.9	7.7	79.5	50.5	14.6	59.9	8.5	19.9	88.7	74.7	152.6	12.7	21.6	12.9	54.6	24.0	0.1	31.4	21.8	14.1	200.5	3.4	0.0	46.9	6.5	42.7	116.2	31.7	5.5	14.0	127.6	59.8	117.5	13.7	15.1	31.1	3.8	2.3	42.7	135.9	11.4	14.7	0.0	1.1	0.0	11.1	7.8	0.0	29.8	12.3	17.3	14.5	0.3	7.3	7.5	20.5	11.7	0.7	4.6	1.6	5.5	2.0	15.3	0.0	3.7	31.7	8.8	11.4	0.0	7.9	55.0	9.9	4.2	4.8	0.0	4.5	0.0	43.6	116.8	6.0	21.6	0.0	28.9	0.0	30.1	31.4	6.1	0.0	47.8	7.4	11.8	2.7	1.2	50.4	10.1	1.6	0.0	41.2	12.8	10.1	7.8	58.3	1.5	2.6	472.4	300.7	11.5	26.3	59.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.1	8.4	18.6	8.5	19.9	21.6	12.9	14.1	14.0	13.7	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0
H2AC19	"H2A/r, HIST2H2AA4"	ENSG00000272196	"H2A clustered histone 19"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 26.6"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 1820.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 1820.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 98.8;U-266/70: 270.8;U-266/84: 249.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				63.3	27.8	32.4	10.1	36.7	20.9	40.2	57.3	31.8	111.3	43.3	39.5	10.8	10.0	0.0	66.7	45.2	6.9	34.4	31.6	38.9	52.0	58.3	140.4	3.8	43.5	36.7	53.3	13.7	3.0	27.2	4.7	42.4	156.3	1.0	6.1	41.1	0.0	30.3	102.5	31.9	0.0	45.7	124.6	64.4	109.9	32.3	9.6	29.1	2.6	1.4	47.4	124.3	50.6	14.9	41.0	4.2	9.4	0.0	0.0	12.9	31.6	0.0	0.0	0.0	26.4	13.9	0.0	36.4	0.0	10.0	23.0	0.0	0.0	0.0	20.4	53.9	5.4	35.5	15.5	0.0	5.2	27.4	0.0	0.0	0.0	0.0	9.7	0.0	18.7	32.9	61.2	0.0	85.0	18.5	5.6	15.7	75.7	31.8	14.3	6.4	20.1	0.0	5.9	37.8	16.1	98.8	21.2	9.1	5.3	38.5	8.9	0.0	6.9	71.4	14.1	4.5	270.8	249.5	20.8	0.0	26.9	11.6	314.7	206.9	388.5	34.8	121.2	35.8	72.9	30.4	32.6	135.6	93.1	22.8	21.6	1820.8	41.6	151.6	193.3	48.3	215.9	32.4	36.7	57.3	31.8	31.6	38.9	43.5	36.7	42.4	45.7	32.3	50.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0
H2AC20	"H2A, H2A/q, H2AFQ, HIST2H2AC"	ENSG00000184260	"H2A clustered histone 20"	Q16777	1	149886918-149887411	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.3;brain: 27.2;choroid plexus: 20.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.7;dendritic cells: 8.1;Extravillous trophoblasts: 18.2;Hofbauer cells: 9.7;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 60.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.50e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (1.20e-10)"	"unprognostic (1.42e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.86e-5)"	3.8	3.6	15.5	0.8	20.6	25.3	3.5	24.0	14.0	5.4	20.0	3.1	0.2	2.0	0.0	2.2	2.7	0.4	2.6	10.0	27.2	2.3	2.6	4.7	0.5	19.8	13.1	4.3	2.4	0.1	3.0	0.5	16.7	3.2	0.1	0.5	1.4	0.1	0.7	4.5	3.3	0.4	19.9	5.2	2.5	1.2	18.2	1.6	1.8	0.0	0.1	2.5	4.1	18.2	3.9	4.2	5.0	15.7	0.0	0.7	7.8	1.2	0.9	2.4	3.3	2.5	1.1	8.0	0.2	0.2	0.5	2.0	0.3	1.6	0.0	0.7	5.7	1.9	1.6	12.2	0.0	4.7	4.6	0.9	0.2	0.2	0.5	0.1	1.6	2.0	1.7	10.0	0.5	60.6	5.7	5.4	6.7	4.5	10.0	1.8	2.2	1.4	1.0	2.4	1.8	7.5	3.2	1.2	3.8	0.4	0.6	4.4	1.5	1.1	10.9	1.9	2.9	5.5	4.0	4.2	2.9	6.3	2.3	47.2	33.8	19.0	22.9	22.6	20.2	13.1	20.1	18.5	17.7	33.1	14.0	14.8	98.4	19.1	25.6	24.9	16.3	22.6	15.5	20.6	24.0	14.0	10.0	27.2	19.8	13.1	16.7	19.9	18.2	18.2	2.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.7	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	18.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.8	1.5	0.0	0.0	0.0
H2AC21	HIST2H2AB	ENSG00000184270	"H2A clustered histone 21"	Q8IUE6	1	149887469-149887965	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 15.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.3;NB-4: 1.9;U-266/70: 1.6;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011483, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011483: AB_732909, HPA041189: AB_2677357"	"unprognostic (6.31e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"		"unprognostic (9.97e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.36e-2)"	0.2	0.1	3.3	0.0	4.6	3.4	0.3	15.3	3.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	3.0	0.1	0.1	0.2	0.0	0.5	1.3	0.3	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.2	0.6	0.5	0.0	1.5	0.3	0.1	0.1	2.3	0.3	0.1	0.0	0.0	0.1	0.2	3.7	0.5	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.3	0.4	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.7	0.2	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.2	0.0	3.3	1.9	0.4	0.3	0.5	0.7	0.2	0.7	0.0	0.1	0.6	0.4	0.8	0.0	0.1	0.0	0.2	1.4	0.0	0.3	1.2	0.0	0.3	1.6	1.9	0.5	0.6	0.1	0.2	1.5	1.9	0.8	2.2	1.7	2.0	3.7	3.7	3.3	2.1	6.6	2.3	2.5	9.8	3.6	2.0	4.0	2.0	0.5	3.3	4.6	15.3	3.0	1.7	3.0	0.5	1.3	1.0	1.5	2.3	3.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
H2AC4	"H2A/m, H2AFM, HIST1H2AB"	ENSG00000278463	"H2A clustered histone 4"	P04908	6	26033092-26033618	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.5;brain: 2.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.7;U-2 OS: 1.4"	"Not detected"	"Not detected"							HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.53e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.04e-3)"		"unprognostic (3.28e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.47e-3)"	0.2	0.0	0.5	0.0	0.4	1.5	0.0	2.0	0.5	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.1	0.7	1.9	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.6	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.3	0.9	0.5	0.2	2.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.4	0.7	0.7	1.2	0.0	1.0	0.4	0.2	0.5	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.1	1.4	0.1	0.1	0.6	0.9	0.0	0.2	1.2	0.1	0.0	0.0	1.0	0.1	0.4	0.0	1.5	0.4	0.6	0.5	0.7	0.1	0.2	0.2	0.5	0.0	0.0	0.2	0.0	0.5	0.4	2.0	0.5	0.6	0.6	0.8	1.2	0.7	0.3	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
H2AC6	"H2AFL, HIST1H2AC"	ENSG00000180573	"H2A clustered histone 6"	Q93077	6	26124145-26139116	"Cancer-related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.9;Cardiomyocytes: 23.3;Cytotrophoblasts: 14.3;Extravillous trophoblasts: 28.5;Hofbauer cells: 16.2;Syncytiotrophoblasts: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1552.9"	"Lineage enriched"	"Detected in all"	14	"granulocytes: 1552.9"	"Cell line enhanced"	"Detected in many"		"U-266/84: 61.0"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.89e-3)"	14.0	12.7	26.8	5.0	39.2	12.9	10.7	38.1	38.5	21.6	24.1	13.1	11.5	4.7	11.3	28.1	10.8	10.3	11.2	34.5	41.7	21.5	30.2	22.9	5.5	37.9	34.4	12.7	7.2	0.9	10.5	5.2	33.9	26.0	5.3	3.9	10.8	2.1	20.2	16.7	13.2	2.1	52.1	21.2	13.8	4.7	30.6	18.1	12.7	4.7	2.0	12.0	28.6	65.4	13.2	30.7	0.1	0.0	14.4	8.8	1.5	8.4	2.4	4.0	4.1	10.3	3.7	0.0	36.8	4.2	1.8	4.0	0.0	0.8	2.7	18.4	3.5	1.8	21.5	3.8	10.8	0.7	8.8	26.5	4.5	1.4	4.5	10.9	1.4	0.7	23.1	11.9	3.9	20.0	2.9	3.4	1.3	10.4	13.9	2.3	0.2	25.6	13.2	8.7	3.2	3.2	29.5	4.0	13.4	7.1	33.3	2.4	3.2	6.9	20.5	3.6	1.7	32.7	61.0	4.7	2.0	28.4	1.1	440.2	31.9	324.6	28.0	24.6	25.7	61.7	29.7	19.4	28.3	109.5	34.9	19.6	1552.9	33.7	65.6	79.9	33.8	662.0	26.8	39.2	38.1	38.5	34.5	41.7	37.9	34.4	33.9	52.1	30.6	65.4	10.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	14.3	7.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	28.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	75.9	1.1	0.0	0.0	0.0
H2AC7	"H2A.3, H2A/g, H2AFG, HIST1H2AD"	ENSG00000196866	"H2A clustered histone 7"	P20671	6	26198784-26199293	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 17.5;U-266/84: 6.3"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.10e-9)"	"unprognostic (2.00e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	0.7	0.2	0.4	0.3	1.7	2.9	0.6	4.1	2.1	3.3	3.6	0.5	0.0	0.1	0.0	2.5	0.6	0.3	0.4	1.0	1.9	0.6	1.2	2.1	0.5	3.1	1.7	0.7	0.1	0.0	0.3	0.2	2.1	2.1	0.1	0.0	0.5	0.0	0.0	1.1	0.5	0.0	3.9	1.2	0.6	0.3	3.0	1.8	0.3	0.0	0.3	0.3	2.8	6.8	1.1	0.0	0.2	0.2	0.0	0.0	0.2	0.7	0.1	1.1	0.0	1.3	0.4	0.7	1.2	0.2	0.1	0.3	0.0	0.1	0.2	0.0	1.0	0.3	1.4	1.3	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.7	2.5	1.3	0.0	0.0	3.7	1.5	1.1	0.0	1.1	1.0	0.4	0.9	0.4	0.1	1.4	0.2	0.6	0.8	0.1	0.0	1.4	0.3	0.0	1.1	3.1	0.0	1.0	17.5	6.3	2.2	1.0	1.3	0.4	2.3	0.3	3.8	1.3	1.9	1.3	2.7	2.0	4.0	1.1	7.6	1.9	1.9	17.9	1.8	2.2	6.2	2.7	0.8	0.4	1.7	4.1	2.1	1.0	1.9	3.1	1.7	2.1	3.9	3.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC8	"H2A.1, H2A/a, H2AFA, HIST1H2AE"	ENSG00000277075	"H2A clustered histone 8"	P04908	6	26216975-26217483	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.2;breast: 40.7"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 6.5;Extravillous trophoblasts: 5.5;Hofbauer cells: 18.0;Syncytiotrophoblasts: 13.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.9"	"Group enriched"	"Detected in all"	5	"cerebellum: 41.2;white matter: 17.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.0"									"CAB012242, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012242: AB_470265, HPA041189: AB_2677357"	"unprognostic (4.26e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.36e-2)"	4.3	2.4	2.1	1.6	5.6	19.3	40.7	41.2	6.0	14.7	4.6	7.9	3.6	1.6	16.7	8.6	7.8	1.8	4.2	5.1	3.7	11.6	5.7	7.9	2.9	2.3	1.1	6.8	1.0	0.4	3.4	1.6	3.7	32.9	2.1	1.5	4.7	1.2	0.2	16.5	4.6	0.6	1.7	9.5	5.2	4.3	3.3	9.4	5.8	0.1	0.8	2.2	17.4	17.5	4.1	0.0	3.0	0.0	4.9	0.9	0.8	1.3	2.0	4.3	2.9	2.0	3.3	0.2	10.8	0.4	3.9	3.4	1.5	2.0	1.7	4.5	3.7	2.7	5.9	2.6	0.9	0.3	4.1	8.4	0.9	1.8	0.2	1.2	2.1	0.8	11.4	2.9	0.4	7.5	9.3	7.9	3.5	14.1	3.7	7.3	2.4	14.7	1.8	2.3	11.9	5.0	10.9	3.7	2.4	2.0	14.9	4.1	0.0	0.2	0.8	1.8	1.8	37.0	0.0	0.0	1.5	5.5	2.7	18.2	2.2	8.2	2.8	2.6	4.1	4.7	3.3	4.6	5.9	6.0	1.7	2.3	10.1	4.5	1.6	17.6	4.4	10.4	2.1	5.6	41.2	6.0	5.1	3.7	2.3	1.1	3.7	1.7	3.3	17.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.2	0.0	0.0	0.0
H2AJ	"FLJ10903, H2AFJ, MGC921"	ENSG00000246705	"H2A.J histone"	Q9BTM1	12	14774383-14778002	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 565.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 58.1;Cytotrophoblasts: 130.2;dendritic cells: 56.4;Extravillous trophoblasts: 124.3;Fibroblasts: 59.5;Hofbauer cells: 241.2;Syncytiotrophoblasts: 160.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 151.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 256.2;MCF7: 338.4;RT4: 239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.38e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.66e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.87e-3)"	236.7	186.0	29.1	33.8	34.1	60.4	223.6	33.7	40.9	123.7	37.9	126.6	55.4	105.6	20.9	155.7	106.6	36.0	125.5	27.7	31.3	115.7	82.7	129.6	29.6	37.1	32.5	63.6	182.3	21.1	34.2	57.7	35.7	275.8	29.3	5.3	166.8	35.0	91.4	198.4	85.2	25.1	33.4	94.8	111.1	565.0	33.1	34.2	85.0	24.8	18.2	122.8	124.9	38.7	107.9	256.2	10.0	0.0	112.2	73.8	163.2	78.9	43.4	31.3	30.4	50.9	172.4	0.1	48.7	38.6	0.2	100.7	6.2	60.1	8.5	5.7	4.6	4.3	92.6	43.8	160.5	0.1	39.0	97.0	64.5	43.3	40.0	12.7	63.0	0.0	0.1	0.1	15.9	338.4	0.7	28.7	16.0	77.8	58.0	42.4	0.0	21.0	51.0	239.0	3.0	1.0	99.8	122.3	0.4	34.6	187.0	32.6	63.1	0.3	29.6	46.2	15.6	25.0	39.4	0.4	8.6	0.3	25.4	84.0	127.6	29.3	51.3	76.4	46.3	16.8	49.6	38.0	117.2	21.7	34.9	38.2	46.6	61.2	69.4	58.2	78.1	72.1	29.1	34.1	33.7	40.9	27.7	31.3	37.1	32.5	35.7	33.4	33.1	38.7	58.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	130.2	56.4	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	124.3	59.5	0.0	0.0	0.0	0.0	0.0	0.0	241.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	0.0	0.0	160.3	6.5	0.0	0.0	0.0
H2AW	"HIST3H2A, MGC3165"	ENSG00000181218	"H2A.W histone"	Q7L7L0	1	228456979-228457873	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.2;Cytotrophoblasts: 14.1;dendritic cells: 13.8;Extravillous trophoblasts: 10.8;Hofbauer cells: 28.4;Syncytiotrophoblasts: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 29.7;U-266/70: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (3.65e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.76e-2)"	6.0	35.9	6.3	0.8	6.1	5.9	6.8	13.4	6.9	27.9	9.9	5.9	3.2	5.4	1.6	19.2	7.2	1.2	17.8	5.8	6.7	4.4	1.1	4.4	1.2	5.0	4.9	14.1	3.9	3.7	12.9	1.0	5.3	11.1	0.9	4.9	10.3	0.4	1.0	18.0	5.5	0.3	5.0	13.0	6.3	5.8	6.9	1.8	2.1	0.7	0.9	5.4	24.2	5.5	5.9	3.1	4.0	5.6	3.3	3.3	4.8	2.9	2.8	8.2	5.7	3.1	4.8	2.7	3.4	0.6	0.0	14.3	2.9	1.4	1.9	4.2	29.7	4.2	4.0	0.0	7.6	3.0	8.1	7.3	8.4	1.5	3.5	3.3	3.5	5.4	15.0	0.0	0.0	8.4	3.9	0.0	6.2	3.5	7.5	0.0	0.0	22.9	1.4	3.5	24.7	17.4	10.2	8.9	20.7	0.6	15.7	2.2	1.3	0.0	0.1	11.0	2.6	29.4	22.4	0.0	2.9	3.0	2.1	4.4	1.4	0.0	5.8	2.8	4.3	2.7	5.5	4.3	3.0	2.1	4.2	4.1	0.6	6.5	7.0	0.5	10.4	3.4	6.3	6.1	13.4	6.9	5.8	6.7	5.0	4.9	5.3	5.0	6.9	5.5	0.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	14.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.8	2.6	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	53.8	2.4	0.0	0.0	0.0
H2AX	H2AFX	ENSG00000188486	"H2A.X variant histone"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		Yes	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	13.2	20.7	35.2	12.6	37.8	24.9	8.0	39.0	42.2	13.3	20.6	18.6	13.3	14.0	2.1	43.6	13.1	3.1	13.4	33.7	32.3	17.0	13.9	14.3	16.0	43.9	38.9	18.7	11.6	3.4	24.3	11.0	37.8	15.7	4.3	6.6	11.4	4.7	12.4	18.1	18.8	3.5	38.0	24.0	16.1	15.4	37.8	30.5	10.4	3.6	12.0	11.8	15.7	51.8	132.1	77.9	120.3	72.3	10.9	7.9	126.4	146.0	44.0	80.3	70.4	124.0	55.1	89.7	85.9	34.0	60.5	134.0	57.5	41.7	21.5	133.4	161.0	182.2	20.7	129.8	11.4	90.5	108.9	6.7	9.0	34.2	21.0	13.1	40.7	115.4	149.9	143.1	38.9	335.6	207.8	269.9	87.5	60.0	162.6	200.7	141.6	42.7	37.5	56.3	127.6	152.0	116.0	66.6	20.6	20.6	99.8	68.2	50.9	77.7	204.2	63.8	110.2	38.7	40.8	92.3	17.9	145.2	155.0	3.8	1.3	4.2	1.6	0.6	0.8	0.9	1.7	1.7	1.8	0.8	1.1	1.0	0.6	2.2	0.8	0.8	1.6	1.2	35.2	37.8	39.0	42.2	33.7	32.3	43.9	38.9	37.8	38.0	37.8	51.8	43.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	83.2	34.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	106.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	64.2	7.2	0.0	0.0	0.0
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728094-104859919	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Excitatory neurons: 118.8;Inhibitory neurons: 84.2;Microglial cells: 45.9;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: AB_2679524"	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.75e-1)"	3.7	3.2	2.7	2.2	4.4	2.9	3.1	5.0	4.8	3.9	0.4	2.6	2.1	3.9	1.1	5.3	3.3	3.1	3.3	3.1	2.5	6.2	1.6	3.6	2.2	1.9	2.6	3.8	1.9	7.2	1.5	30.6	2.3	3.7	1.8	11.5	2.9	4.1	2.2	2.5	2.1	4.0	1.4	2.5	2.4	10.4	3.1	3.9	4.5	4.1	2.4	3.3	2.9	5.8	3.9	2.7	11.3	14.3	6.6	8.8	13.3	7.7	11.9	4.8	7.2	2.5	2.3	2.2	3.4	5.9	8.1	2.6	2.8	5.3	10.0	9.1	7.2	7.7	2.5	3.4	6.6	6.8	2.5	5.9	4.7	6.2	5.2	6.3	8.0	9.2	7.6	2.4	9.6	2.8	5.1	4.1	5.0	2.9	2.6	8.0	12.8	0.9	3.8	6.6	6.1	9.1	4.2	4.3	2.3	7.3	2.7	9.2	8.5	3.9	3.2	10.5	7.4	3.5	4.1	7.6	4.0	6.4	7.1	0.0	0.6	0.7	1.2	1.0	1.3	0.9	1.1	1.1	0.6	0.8	1.2	0.9	0.1	0.8	0.5	0.8	0.4	0.5	2.7	4.4	5.0	4.8	3.1	2.5	1.9	2.6	2.3	1.4	3.1	5.8	11.6	3.2	1.1	42.4	5.1	4.7	2.3	2.3	5.2	11.6	5.3	3.7	6.7	1.5	3.9	5.5	45.9	10.6	4.1	1.5	1.9	1.6	6.2	2.7	6.2	12.9	1.8	3.0	118.8	1.5	5.4	7.1	5.6	3.4	1.3	7.1	4.2	2.6	5.7	16.8	84.2	2.0	0.0	4.1	2.4	4.6	6.2	3.5	1.8	45.9	4.3	6.1	8.2	64.3	74.6	1.4	2.9	3.8	3.7	1.6	3.8	5.7	2.6	31.7	6.6	6.4	6.6	13.2	3.5	5.3	4.7	6.3	6.2	2.9	1.9	1.9
HACL1	"2-HPCL, HPCL, PHYH2"	ENSG00000131373	"2-hydroxyacyl-CoA lyase 1"	Q9UJ83	3	15560699-15601852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 117.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 117.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035496, HPA035497, HPA073760"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633"	"unprognostic (6.64e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (5.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.62e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.07e-2)"	14.4	12.0	7.5	8.2	7.8	11.6	14.6	10.4	10.5	9.1	7.9	10.0	56.6	8.3	16.6	7.5	10.8	8.8	11.0	7.6	7.0	26.0	51.8	9.7	14.1	7.4	7.2	7.5	15.2	20.0	7.8	7.8	7.0	10.8	12.0	12.2	9.1	9.1	17.6	10.6	27.7	9.5	7.4	11.4	13.2	26.7	6.8	13.9	20.4	10.6	14.5	10.3	6.4	10.0	15.1	28.6	8.2	30.7	13.4	12.4	82.3	14.2	22.0	26.6	26.3	27.3	14.3	14.6	9.7	18.7	10.5	10.4	18.7	25.3	23.8	13.6	36.4	25.4	17.7	24.7	20.3	30.5	23.1	13.7	16.2	37.9	16.6	8.3	31.4	18.3	24.0	21.2	22.9	28.7	14.0	12.6	19.7	19.7	29.7	14.4	21.5	19.6	26.4	20.2	9.6	12.3	22.4	19.0	25.2	12.8	8.5	25.4	22.5	14.1	14.6	17.4	24.7	27.2	50.9	28.5	27.1	26.4	17.2	117.3	16.0	18.3	14.4	20.1	21.2	15.4	15.5	18.0	16.0	21.2	14.8	16.1	3.4	24.1	24.2	10.2	19.8	13.0	7.5	7.8	10.4	10.5	7.6	7.0	7.4	7.2	7.0	7.4	6.8	10.0	12.4	9.6	17.3	34.9	22.1	10.3	12.0	13.5	20.5	19.3	9.1	10.2	6.4	14.3	15.6	11.0	29.2	27.2	15.7	6.1	13.7	16.0	66.6	12.6	6.0	12.3	9.1	8.2	67.4	25.2	18.0	12.0	11.2	5.4	13.3	12.7	8.9	24.3	13.2	13.5	55.8	7.5	10.2	9.3	8.1	56.8	23.3	8.8	12.4	25.3	19.3	24.8	8.2	40.7	38.8	14.5	11.2	15.4	21.4	9.0	41.9	39.7	29.8	38.3	6.6	9.0	11.2	51.1	24.4	8.6	7.1	18.9	19.4	15.1	10.6	7.9
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035174	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Oxidoreductase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 280.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 272.4;Proximal enterocytes: 383.0;Proximal tubular cells: 318.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Enhanced		Supported	Mitochondria		No	Yes		1000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	143.0	54.1	23.2	20.9	23.8	27.4	74.9	24.6	26.3	37.9	33.5	101.2	84.4	49.8	24.9	34.2	56.2	24.0	175.6	22.9	27.2	140.2	225.5	22.8	22.2	24.7	26.3	54.3	42.1	40.2	18.0	13.7	26.0	35.4	90.8	10.4	55.9	42.4	249.7	28.0	89.1	72.7	26.0	18.0	60.7	27.9	24.9	76.0	37.7	280.3	28.5	34.1	28.7	28.0	32.2	27.9	64.3	46.2	149.2	48.2	27.0	43.1	68.5	49.6	48.9	21.2	60.9	185.0	23.5	38.8	34.6	42.0	85.5	64.5	55.5	49.6	37.2	39.9	50.5	48.9	24.3	88.2	17.0	50.4	34.1	35.1	32.3	41.4	34.4	127.1	53.1	98.7	57.3	58.9	163.6	36.7	29.0	147.8	30.1	113.5	84.3	89.2	54.5	129.4	73.2	43.1	41.1	161.9	45.6	37.0	77.4	70.8	20.6	35.5	18.9	48.5	26.7	52.1	63.3	80.6	47.0	60.2	27.0	0.0	11.1	11.4	17.2	14.2	22.1	31.4	19.5	20.7	36.8	27.1	22.4	22.2	1.2	36.7	20.1	41.7	17.7	16.3	23.2	23.8	24.6	26.3	22.9	27.2	24.7	26.3	26.0	26.0	24.9	28.0	17.3	28.9	33.8	11.1	25.7	15.6	54.2	65.8	41.5	6.9	46.5	56.1	225.6	52.9	48.1	35.0	4.2	41.0	18.3	164.7	160.4	43.3	196.8	41.4	22.6	17.5	32.4	65.6	15.1	32.2	44.7	28.2	52.5	26.1	10.8	63.9	21.0	272.4	116.5	6.7	18.9	93.3	36.7	37.8	11.8	108.5	46.3	25.3	21.4	12.2	15.3	26.8	8.2	9.5	9.9	23.0	100.8	35.3	32.0	33.9	383.0	318.8	70.8	6.8	39.5	21.7	38.2	22.4	20.3	64.0	18.2	17.0	19.6	66.3	194.2	49.1
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290465	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 793.3;skeletal muscle: 950.6;tongue: 1097.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1167.5;Distal tubular cells: 520.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		61000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	127.0	224.7	120.6	51.1	135.4	58.8	91.3	146.4	138.1	65.2	128.0	110.7	224.2	55.9	73.7	101.3	68.8	64.3	793.3	109.0	138.1	231.4	324.8	64.7	54.9	135.9	141.6	78.4	83.7	209.5	48.1	65.6	139.6	77.1	113.2	63.0	104.8	75.0	950.6	74.4	184.4	79.0	141.4	75.8	109.0	67.1	143.3	53.1	90.8	1097.1	62.5	89.2	64.1	152.8	108.2	83.2	56.6	102.2	342.1	190.1	57.9	89.0	134.6	89.0	86.8	100.5	101.7	53.9	60.8	145.3	100.1	82.8	95.2	124.8	109.2	121.1	83.1	123.6	44.9	194.2	145.9	100.6	90.0	183.7	201.6	92.7	149.0	151.0	168.2	81.0	105.2	83.9	189.5	78.0	57.1	190.7	39.8	160.2	89.0	61.7	188.3	103.2	183.3	148.9	27.2	93.7	151.7	169.8	239.5	68.5	105.4	177.9	118.0	83.5	86.9	79.3	65.1	62.6	101.1	94.7	95.5	158.4	84.4	95.7	168.1	66.4	45.2	150.3	57.6	65.5	61.3	56.6	154.2	49.7	55.8	51.3	72.7	88.2	123.3	51.8	94.7	135.6	120.6	135.4	146.4	138.1	109.0	138.1	135.9	141.6	139.6	141.4	143.3	152.8	106.5	48.1	36.5	63.0	48.3	62.1	136.5	183.3	49.5	29.3	49.5	52.3	1167.5	104.4	107.7	97.5	56.3	227.9	42.4	129.5	520.4	124.0	93.4	59.5	49.0	75.2	74.9	85.2	32.7	57.2	75.2	79.5	53.0	60.2	62.8	94.2	69.9	277.6	139.6	13.5	33.0	93.4	114.0	98.1	67.4	99.7	56.5	78.1	88.9	27.2	110.2	65.0	32.0	35.2	47.5	58.4	134.8	62.8	37.1	60.5	376.0	321.1	73.5	80.0	72.3	72.9	80.7	120.4	49.4	53.8	54.7	186.6	45.2	194.0	113.5	110.3
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2078998-2242276	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040649, HPA048190"	Approved		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	9.6	8.6	3.5	7.5	3.5	27.5	8.9	9.0	4.6	8.1	1.9	8.3	6.5	7.3	4.9	8.0	7.2	4.2	5.8	3.4	3.2	6.2	7.4	9.0	10.2	3.4	3.4	7.3	10.5	4.0	5.6	6.5	3.3	8.5	5.3	5.8	8.5	4.5	7.4	8.9	9.2	4.7	2.3	12.0	9.0	10.7	3.4	8.6	7.4	4.6	8.3	7.1	7.7	4.3	9.8	4.7	14.2	13.0	5.5	8.5	12.8	14.3	6.0	12.7	10.6	9.5	12.5	18.9	6.5	5.7	14.3	9.3	11.9	7.2	15.9	6.8	6.9	12.5	13.1	7.0	4.5	11.6	11.2	4.3	10.2	11.0	5.8	6.6	10.3	8.8	22.0	21.2	12.5	5.4	19.6	19.5	11.2	8.5	12.3	13.9	12.4	10.4	6.3	6.7	18.4	10.0	10.1	7.6	8.4	10.5	15.7	7.8	8.5	18.1	7.8	11.1	17.0	11.2	10.6	16.9	8.8	16.8	12.0	9.6	4.2	12.2	7.9	5.8	10.1	5.5	8.2	8.9	3.8	9.1	9.5	8.9	4.7	10.7	6.9	6.8	12.0	6.6	3.5	3.5	9.0	4.6	3.4	3.2	3.4	3.4	3.3	2.3	3.4	4.3	15.5	3.2	4.8	0.0	15.8	12.6	5.0	6.4	15.4	11.9	9.3	8.8	5.8	7.2	10.3	3.7	12.5	7.3	24.0	3.9	1.9	7.4	11.8	8.9	11.8	9.4	7.2	23.1	0.0	5.7	11.7	9.6	4.6	8.3	13.3	12.1	6.8	3.7	7.2	25.2	0.0	6.4	12.2	5.4	9.3	6.4	9.9	10.4	12.4	0.0	7.9	6.5	16.5	0.0	0.0	5.3	1.8	8.6	22.5	5.1	5.8	2.6	5.4	12.5	0.0	12.3	17.7	34.4	25.3	10.5	7.7	5.1	26.5	10.1	5.8	3.0
HAUS6	"dgt6, FAM29A, FLJ20060, KIAA1574"	ENSG00000147874	"HAUS augmin like complex subunit 6"	Q7Z4H7	9	19053141-19102904	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 124.9;Spermatocytes: 68.9;Spermatogonia: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 215.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020960, HPA020965"	Approved		Approved	"Nuclear speckles,Centriolar satellite,Cytosol"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centriolar satellite, Cytosol"	"Nuclear speckles"	"HPA020960: AB_1848393, HPA020965: AB_1848394"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (6.04e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.03e-1)"	5.3	6.5	5.2	7.9	7.3	17.0	9.2	8.9	7.4	5.4	4.2	5.8	4.0	7.1	6.2	5.2	4.7	5.1	5.2	5.1	6.2	4.1	6.9	4.7	11.4	6.4	6.2	8.2	3.9	6.1	3.0	6.9	6.6	5.6	6.2	9.1	4.5	5.6	4.4	8.1	5.2	7.2	6.1	6.9	4.3	24.0	6.1	15.1	5.3	7.2	10.7	6.2	4.2	9.3	34.7	23.7	46.4	36.3	17.4	20.9	25.1	36.5	25.5	32.7	49.9	12.2	15.4	40.5	13.1	21.1	25.0	14.2	43.3	21.3	50.4	36.8	20.9	215.8	42.1	27.8	11.6	29.0	46.7	13.0	21.5	30.9	66.9	16.9	24.0	40.4	29.8	25.7	37.8	11.3	56.6	49.1	49.9	19.4	23.2	43.3	31.8	16.4	18.0	19.8	27.1	37.3	16.4	15.0	23.6	29.5	11.6	36.1	24.1	29.3	17.7	25.5	42.2	10.2	24.0	39.7	27.3	24.0	13.0	9.8	1.5	1.6	2.8	1.5	3.9	2.3	2.8	3.6	1.5	2.3	3.3	2.9	2.3	5.0	1.4	1.8	3.7	1.7	5.2	7.3	8.9	7.4	5.1	6.2	6.4	6.2	6.6	6.1	6.1	9.3	15.9	19.2	12.5	7.8	14.3	9.7	12.6	8.7	9.1	11.8	9.4	9.3	8.4	5.7	7.2	9.2	10.4	10.5	21.9	5.6	0.0	9.8	124.9	11.8	14.4	11.6	2.4	34.1	10.3	6.1	15.3	9.5	5.6	15.3	11.4	23.8	3.9	6.8	8.2	11.8	10.2	4.6	2.0	5.8	7.7	28.2	11.8	14.5	8.8	10.3	8.2	13.5	12.3	7.1	16.8	9.0	3.4	8.2	17.3	14.6	4.5	3.2	3.6	9.7	6.6	16.2	10.1	68.9	56.0	9.1	8.1	4.9	18.2	11.0	9.4	9.4
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	142728-154503	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.9;testis: 7.3"	"Group enriched"	"Detected in some"	4	"Erythroid cells: 82.9;Hofbauer cells: 192.0;Late spermatids: 275.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	80	"K-562: 2189.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		80000000		"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA063268: , HPA064073: , HPA071726: AB_2732184"					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.6	0.0	0.5	0.0	0.4	3.9	0.6	0.2	0.8	0.5	0.8	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.5	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.6	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.1	7.3	0.2	0.0	0.1	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	27.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2189.0	0.2	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.4	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.5	0.7	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	40.0	0.0	0.1	3.7	0.0	82.9	0.5	0.0	42.4	1.8	0.0	0.0	0.0	0.1	0.4	0.0	192.0	0.0	0.3	0.0	0.0	0.3	0.3	275.5	0.6	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	6.6	1.9	4.8	1.3	1.8	0.0	0.1	10.4	0.1	0.0	0.1	0.0
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123086	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavorable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	13.9	16.1	6.2	13.7	6.7	20.5	12.6	7.0	8.4	8.4	8.4	21.6	23.1	9.6	7.6	19.3	8.5	10.8	39.0	7.4	6.8	17.6	22.9	11.5	15.6	6.7	6.2	8.3	9.9	25.1	8.3	13.1	6.4	9.5	21.6	13.5	15.2	10.0	64.4	17.6	20.2	12.5	6.2	14.5	15.3	10.2	6.7	13.0	10.8	57.0	17.1	22.3	11.6	6.1	54.3	60.5	31.8	28.5	25.6	25.2	29.2	52.0	43.0	67.8	57.5	70.7	38.5	34.3	26.3	46.1	80.8	49.8	63.2	51.8	70.5	30.8	48.0	34.1	80.8	38.6	47.3	40.9	39.4	24.2	37.4	67.9	46.5	37.9	49.1	26.1	63.1	41.1	46.3	72.5	28.0	31.4	51.5	36.6	70.1	27.3	59.9	65.4	44.0	44.8	20.9	24.2	54.8	58.7	38.2	66.7	45.6	27.1	48.7	42.4	23.6	110.4	47.0	26.9	29.0	47.8	35.5	28.8	42.7	25.6	47.8	30.1	20.2	66.4	19.0	39.0	19.6	18.2	62.2	34.7	17.1	22.1	13.1	19.1	57.4	56.2	23.5	19.0	6.2	6.7	7.0	8.4	7.4	6.8	6.7	6.2	6.4	6.2	6.7	6.1	15.5	6.4	4.8	2.3	20.8	54.8	53.2	57.0	22.8	5.3	16.1	13.7	49.3	17.2	33.3	16.5	0.0	32.9	12.4	44.6	50.9	34.9	13.7	19.0	10.4	21.0	10.8	32.8	3.8	29.3	37.9	17.1	12.8	16.7	13.3	10.4	15.7	18.5	41.8	8.4	4.5	19.2	67.1	21.0	44.1	2.3	13.4	23.5	24.9	1.9	27.9	13.0	7.2	2.0	2.7	68.4	31.9	10.5	18.4	63.5	46.4	36.0	28.9	7.1	6.6	12.5	20.1	24.4	28.4	21.8	46.0	40.9	12.0	15.6	30.2	88.6
HCFC1R1	"FLJ20568, HPIP"	ENSG00000103145	"Host cell factor C1 regulator 1"	Q9NWW0	16	3022625-3024286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 511.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 396.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 376.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059647	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059647: AB_2684094"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.03e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.23e-1)"	82.6	98.5	174.5	20.9	178.9	17.9	74.8	164.1	248.1	124.9	129.3	131.5	30.4	140.6	29.2	59.0	81.7	43.1	138.7	172.0	182.0	180.5	48.2	72.0	24.2	181.5	182.7	86.7	44.0	40.9	97.7	32.1	185.2	102.8	18.8	21.6	50.6	87.4	511.6	76.3	53.1	47.5	154.0	45.9	65.6	36.6	181.0	17.0	68.0	196.2	18.3	85.2	103.0	174.1	59.6	175.6	32.5	38.1	123.0	160.9	33.4	26.0	115.0	57.8	161.2	37.9	75.8	49.2	66.1	108.3	52.8	81.0	32.7	121.5	26.3	62.7	88.4	21.3	132.2	65.5	105.2	37.3	39.5	205.7	73.9	62.1	63.4	376.5	81.5	33.0	30.4	81.6	63.3	63.0	20.1	53.0	70.5	34.7	36.5	70.1	31.3	124.6	209.4	13.7	57.3	48.4	54.7	70.7	78.5	77.5	48.6	28.1	35.5	98.4	256.8	85.8	50.7	53.0	59.1	40.7	42.9	22.1	23.8	5.3	36.3	16.3	20.1	28.2	19.3	23.2	25.5	21.7	44.9	21.7	18.5	22.9	8.0	25.8	26.5	22.1	36.7	17.9	174.5	178.9	164.1	248.1	172.0	182.0	181.5	182.7	185.2	154.0	181.0	174.1	51.3	57.7	15.0	17.9	30.7	85.4	58.0	123.7	92.2	29.3	45.2	80.0	45.8	47.1	37.4	198.6	6.2	116.2	23.7	53.7	240.7	49.7	5.2	38.0	56.0	38.3	43.7	37.0	19.3	26.5	120.7	98.4	34.1	45.3	40.0	26.1	60.3	45.9	117.9	20.2	19.8	40.9	40.7	57.5	57.0	15.8	96.3	42.2	64.0	13.1	51.0	52.6	39.1	6.6	19.0	26.7	55.4	178.3	35.0	37.8	114.2	396.2	28.4	28.1	124.9	39.7	149.2	15.2	44.3	69.5	65.8	53.9	35.0	26.7	45.9	41.3
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 153.6;lymphoid tissue: 300.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 175.7;Kupffer cells: 666.3;Macrophages: 269.0;monocytes: 245.7;NK-cells: 216.3;T-cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 265.6;HMC-1: 362.3;RPMI-8226: 256.5;THP-1: 262.8;U-266/70: 361.6;U-698: 371.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		870000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	67.0	32.9	14.6	147.2	14.7	153.6	25.5	15.4	18.7	20.7	15.8	29.2	21.2	13.7	6.4	15.7	21.5	37.8	18.4	14.3	17.0	21.5	39.1	52.7	207.6	21.6	17.5	9.4	11.9	7.7	14.6	51.4	20.8	15.8	31.4	2.3	16.0	11.1	7.3	11.1	68.7	34.6	18.5	300.3	27.1	4.5	18.2	140.3	15.4	18.8	242.8	53.0	13.7	23.0	0.8	0.0	0.2	0.1	20.9	11.5	5.7	4.1	4.0	0.8	1.6	0.1	0.0	265.6	124.6	0.0	0.2	0.3	6.9	9.9	1.1	120.6	0.0	172.6	0.0	0.0	11.6	192.4	362.3	2.2	0.5	0.0	1.5	0.0	153.4	106.2	35.1	235.9	0.0	0.0	137.9	162.9	0.3	0.2	4.5	137.1	0.2	256.5	0.0	68.0	0.3	0.2	0.2	0.4	0.6	0.6	0.1	262.8	203.5	0.0	2.0	0.3	0.9	361.6	118.1	371.5	1.9	181.5	0.2	357.3	713.1	1180.9	405.3	870.4	333.0	345.7	334.2	376.8	636.2	313.1	279.3	326.2	1619.2	280.0	997.1	197.4	494.2	1427.9	14.6	14.7	15.4	18.7	14.3	17.0	21.6	17.5	20.8	18.5	18.2	23.0	23.0	9.6	31.8	1.0	175.7	3.2	1.0	7.8	0.6	0.5	2.7	5.1	2.3	4.3	13.1	0.0	0.0	122.4	139.5	0.8	0.0	0.3	1.1	8.8	1.6	23.3	0.0	50.5	1.4	0.2	60.0	7.0	8.6	3.1	73.4	0.7	27.8	7.7	126.9	0.0	0.7	0.4	4.1	666.3	105.8	1.5	3.4	269.0	19.6	26.2	245.7	0.4	216.3	0.5	0.3	0.2	0.2	1.2	148.6	0.4	0.1	0.9	24.7	0.8	13.1	3.7	6.7	0.6	0.6	1.3	4.4	145.4	181.4	2.4	0.5	2.2
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 58.2"	"Group enriched"	"Detected in many"	4	"Astrocytes: 62.0;Early spermatids: 69.9;Excitatory neurons: 118.1;Inhibitory neurons: 84.9;Late spermatids: 59.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 85.5;Oligodendrocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 32.0;neutrophil: 47.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 47.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 49.1;MOLT-4: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	4.4	6.3	9.3	5.0	12.0	17.0	3.8	0.6	13.4	7.5	0.1	29.0	2.7	9.1	2.5	8.0	6.7	7.1	5.2	9.0	6.5	3.7	2.4	3.9	3.5	9.9	6.1	7.5	3.7	2.7	6.5	1.5	11.2	5.6	3.4	2.4	3.3	5.9	58.2	5.9	7.2	6.2	2.3	5.6	7.2	9.2	6.7	9.7	4.2	35.6	2.5	10.0	4.5	10.1	3.2	5.8	4.1	6.1	4.5	3.9	5.9	3.0	2.3	2.3	1.7	2.9	7.5	2.0	1.9	3.4	3.6	3.4	4.0	2.0	1.4	12.8	1.8	3.1	5.1	5.8	3.8	5.5	4.6	4.4	2.6	4.6	3.3	2.3	2.4	49.1	3.7	4.5	2.7	4.7	48.1	10.7	4.0	6.0	2.8	7.6	7.2	4.0	5.3	4.4	4.6	6.4	5.3	2.5	16.2	2.6	1.0	17.9	1.9	5.0	0.4	6.8	4.6	3.3	3.2	3.1	6.9	6.9	7.4	32.0	10.2	2.3	1.0	3.3	1.2	0.2	1.1	1.0	1.0	0.1	0.5	0.5	47.7	3.2	1.7	0.6	1.7	1.1	9.3	12.0	0.6	13.4	9.0	6.5	9.9	6.1	11.2	2.3	6.7	10.1	8.6	3.2	7.4	62.0	5.2	7.9	2.9	3.0	8.6	12.2	6.2	4.8	13.3	7.2	2.9	11.0	2.1	1.5	12.8	4.1	0.0	2.8	69.9	7.0	15.1	7.1	6.0	6.1	118.1	2.2	1.7	14.0	7.7	7.4	2.5	6.6	11.7	6.7	3.2	16.8	84.9	5.2	2.0	17.2	10.0	59.0	11.8	10.3	5.4	38.4	14.9	8.6	15.5	85.5	124.0	1.9	1.6	12.4	7.0	6.4	5.0	1.6	2.6	7.1	0.0	18.7	6.5	2.8	3.3	11.1	9.7	1.4	12.2	4.9	6.4	2.7
HDDC3	"MESH1, MGC45386"	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929968-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	13.0	13.1	15.5	7.9	15.1	10.4	9.2	15.0	20.0	6.5	13.9	11.2	10.3	4.3	8.2	5.9	10.4	4.6	13.3	15.1	14.8	12.1	11.4	6.4	8.2	15.1	14.8	6.5	20.0	15.7	8.0	7.0	14.7	7.0	9.1	7.1	20.7	5.8	13.3	7.7	11.9	3.9	15.3	9.3	9.7	4.5	16.1	7.4	9.8	14.6	9.2	5.5	5.5	15.7	12.7	15.7	5.3	6.4	11.8	11.8	9.0	8.5	11.4	7.7	11.5	7.7	25.5	24.2	8.5	7.0	6.1	19.3	11.1	19.3	6.3	30.4	24.4	30.5	6.0	17.7	23.9	11.6	14.1	10.5	30.1	13.9	24.8	12.2	17.0	19.5	24.6	20.7	6.9	19.1	16.1	10.0	4.3	47.2	15.6	13.2	2.1	38.2	15.8	13.2	13.3	8.5	7.1	19.2	21.4	11.0	29.2	30.5	9.8	4.7	10.5	8.1	10.9	33.5	41.4	16.7	17.5	22.4	14.3	10.1	20.1	8.5	23.3	27.4	30.1	35.1	30.0	26.3	27.4	31.4	34.6	25.5	4.7	31.5	26.7	44.0	31.9	25.6	15.5	15.1	15.0	20.0	15.1	14.8	15.1	14.8	14.7	15.3	16.1	15.7	42.8	28.9	7.4	5.9	23.5	5.6	14.1	22.5	6.8	13.8	27.8	30.1	1.1	44.3	21.6	16.5	4.2	48.2	19.1	18.1	76.3	42.3	4.6	18.8	12.4	19.0	19.9	34.3	4.8	56.5	33.0	12.7	13.7	18.6	7.0	14.3	15.7	41.4	45.9	15.2	5.2	32.9	12.2	15.1	10.9	4.3	14.3	19.6	14.2	1.9	36.3	39.9	34.0	1.0	3.9	28.4	30.2	11.7	31.7	14.7	59.7	71.5	20.6	38.8	6.6	13.2	11.5	29.6	38.4	17.2	8.4	24.2	21.4	21.7	33.0	13.5
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472297-4502208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 37.0;Endometrial stromal cells: 31.0;Extravillous trophoblasts: 30.1;Granulosa cells: 44.7;Theca cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	27.2	29.0	24.8	16.5	25.5	14.4	28.1	24.2	32.3	42.9	17.8	40.4	15.7	39.3	9.6	29.4	35.6	10.0	32.0	27.4	20.5	31.2	31.3	25.4	17.7	22.9	22.2	49.5	26.9	12.5	38.3	15.0	22.0	36.4	7.6	10.8	26.0	18.6	67.8	29.3	27.0	12.6	19.7	33.4	28.1	74.6	22.2	18.6	29.3	19.1	11.8	34.2	34.8	24.6	71.6	41.2	70.1	65.5	29.9	30.3	49.0	56.2	30.1	60.4	53.3	47.5	30.4	62.6	32.1	41.6	31.8	40.2	46.9	51.1	35.2	70.4	74.7	38.6	32.4	63.5	38.5	38.3	52.8	43.5	27.4	41.6	20.2	42.8	55.9	57.8	45.1	76.3	29.6	50.6	86.9	76.4	80.2	28.5	73.3	85.4	57.6	40.6	38.0	35.8	77.0	76.1	54.7	31.0	47.2	38.1	30.6	60.2	74.8	38.0	51.7	72.3	54.1	94.1	52.9	43.6	53.2	60.8	41.1	0.0	0.9	1.7	0.6	0.6	0.1	0.5	0.7	0.5	0.7	5.6	1.1	0.4	0.2	1.3	0.3	1.0	1.0	0.5	24.8	25.5	24.2	32.3	27.4	20.5	22.9	22.2	22.0	19.7	22.2	24.6	25.5	6.4	5.4	0.0	2.3	0.0	0.0	0.0	0.0	0.0	13.3	15.2	0.0	0.0	5.0	12.9	0.0	37.0	14.3	0.0	19.6	26.4	0.0	26.9	31.0	9.8	0.0	0.0	0.0	19.8	30.1	13.9	0.0	19.8	1.3	44.7	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.3	0.0	0.0	23.6	9.5	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	15.2	7.1	42.7	0.0	0.0
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604516	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"		NA	NA		470000	"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: AB_2679863, HPA062200: AB_2684709"	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	8.5	5.6	3.3	11.1	4.1	12.7	9.8	4.6	4.0	6.8	3.3	6.2	5.6	8.7	6.5	7.3	7.0	5.5	4.4	3.5	3.7	5.4	5.5	5.2	12.9	3.7	3.3	9.4	8.7	7.9	3.4	7.7	3.8	6.2	7.5	4.8	6.2	6.4	6.6	10.4	6.2	8.0	3.7	8.5	6.2	14.4	4.2	10.1	7.9	5.7	13.5	10.8	6.7	6.5	35.2	41.4	21.2	32.3	29.1	32.5	47.4	27.7	17.8	31.2	27.7	41.8	29.0	57.3	30.4	25.8	19.3	41.5	48.7	29.7	42.0	29.0	56.0	40.7	28.3	36.1	26.1	73.5	25.2	26.7	26.2	47.2	40.5	14.9	36.3	25.9	93.8	18.8	31.5	18.8	35.1	20.1	84.9	44.8	16.9	38.6	30.6	53.8	19.9	34.9	19.9	44.1	33.5	23.7	28.3	14.1	28.2	27.2	34.7	31.2	29.5	40.6	69.4	35.4	47.2	65.5	27.8	40.2	47.4	1.6	3.3	1.0	6.0	4.2	5.6	9.1	5.9	6.6	4.0	6.5	8.1	7.8	0.4	5.7	4.2	5.2	5.3	2.3	3.3	4.1	4.6	4.0	3.5	3.7	3.7	3.3	3.8	3.7	4.2	6.5	13.3	3.2	12.8	19.6	21.8	19.8	16.3	8.3	26.2	12.4	9.8	7.6	4.2	7.2	11.7	5.5	18.8	8.1	15.0	3.6	3.9	8.9	10.5	8.4	26.3	12.4	4.2	12.6	35.1	8.5	10.8	15.2	8.6	11.3	32.9	23.4	10.4	9.7	7.5	6.7	30.4	6.2	4.1	11.3	7.5	2.7	14.0	11.7	1.8	26.2	9.6	3.0	9.2	36.2	34.1	12.0	4.3	10.1	19.0	15.7	3.3	5.6	11.5	9.6	0.0	19.4	11.8	29.3	30.1	19.3	16.9	4.9	18.1	15.6	11.1	12.0
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065970-50107272	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	7.1	8.2	3.8	9.0	3.7	5.6	5.3	4.6	4.2	5.1	4.3	7.0	4.9	5.0	4.5	8.0	4.8	4.2	6.4	3.7	3.6	6.7	10.2	6.3	6.6	4.2	3.2	3.3	8.0	4.8	6.5	5.8	3.4	4.9	6.3	4.8	6.0	3.4	12.0	6.3	7.0	5.3	3.2	12.6	6.6	5.8	3.8	4.6	3.7	6.2	6.2	5.1	5.1	3.9	13.0	12.8	11.8	18.6	7.0	9.6	12.6	15.5	10.1	15.0	6.0	15.9	9.4	24.4	10.9	14.7	5.6	15.1	14.1	11.3	17.2	6.1	15.4	12.1	9.0	20.4	10.2	21.1	23.5	7.5	7.8	10.4	6.2	6.6	12.2	12.6	15.5	3.9	14.9	7.8	16.2	26.4	13.8	15.5	13.1	17.6	15.8	19.8	8.4	10.4	15.1	8.0	14.8	18.9	10.0	8.8	8.5	15.4	16.1	12.0	8.0	9.1	11.8	9.8	8.0	21.3	11.7	20.9	12.0	0.5	2.4	0.5	0.9	2.8	1.0	0.6	0.5	1.0	1.7	0.8	0.8	0.9	0.5	0.7	2.6	1.5	0.9	1.0	3.8	3.7	4.6	4.2	3.7	3.6	4.2	3.2	3.4	3.2	3.8	3.9	4.2	3.2	5.8	7.8	4.6	3.2	1.4	1.5	3.4	7.8	3.1	2.0	6.0	2.8	1.8	1.8	16.7	3.5	7.1	3.3	7.9	2.4	10.7	3.7	6.8	4.6	3.5	3.8	21.2	3.1	3.6	4.7	7.7	3.8	1.3	6.5	1.8	9.6	9.4	1.7	16.7	3.2	4.1	22.2	4.7	18.3	3.4	13.9	1.8	7.5	13.3	2.4	3.1	20.1	12.8	2.9	2.5	2.2	7.2	1.9	4.7	4.1	2.8	8.1	0.0	2.5	4.2	5.3	4.8	7.6	1.7	1.0	5.8	6.7	5.8	1.5
HEG1	"HEG, KIAA1237"	ENSG00000173706	"Heart development protein with EGF like domains 1"	Q9ULI3	3	124965710-125055997	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 90.1;Cardiomyocytes: 90.5;Cone photoreceptor cells: 264.8;Endothelial cells: 121.5;Hepatic stellate cells: 130.3;Microglial cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 174.1;HHSteC: 241.5;hTERT-RPE1: 351.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010952, HPA011559"	Approved		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		510000000	"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA010952: AB_2668389, HPA011559: AB_1850580"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.11e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.16e-4)"	30.1	9.9	19.3	19.2	23.2	1.9	14.8	27.0	15.0	20.8	28.3	11.9	8.0	19.2	6.2	16.1	13.2	38.9	67.3	14.3	22.7	15.2	7.5	55.1	16.5	32.0	28.1	12.4	31.6	16.1	3.6	33.4	28.6	13.9	12.2	46.8	7.7	14.6	14.3	5.2	9.4	25.4	27.3	17.9	9.8	13.5	30.3	8.6	52.2	24.2	15.7	30.0	10.1	30.6	7.0	7.1	54.7	4.2	73.2	58.7	21.1	64.9	90.1	72.6	83.5	58.5	1.0	2.8	43.8	174.1	52.3	15.3	7.4	31.6	97.9	6.5	3.7	1.3	42.3	8.4	241.5	1.8	80.6	77.8	10.1	87.4	21.5	351.3	69.3	5.0	0.1	1.0	25.7	1.3	2.8	0.1	10.1	0.1	5.5	4.8	41.0	0.2	14.6	1.2	1.0	5.6	134.8	10.6	6.4	55.1	24.2	4.3	93.9	37.7	41.3	150.5	29.1	6.9	19.7	0.4	76.8	6.5	82.4	1.1	0.1	0.0	1.9	1.7	1.1	0.5	0.6	1.7	0.4	0.3	1.2	0.8	0.0	3.9	1.9	0.4	0.2	0.5	19.3	23.2	27.0	15.0	14.3	22.7	32.0	28.1	28.6	27.3	30.3	30.6	90.1	86.6	5.8	28.7	4.9	5.0	8.0	25.4	6.8	6.1	2.4	5.7	90.5	7.2	6.5	27.6	264.8	1.8	19.2	0.5	0.0	32.0	7.0	4.0	20.1	121.5	0.0	6.1	0.9	6.4	65.3	44.8	1.1	2.2	26.6	24.9	130.3	3.5	6.8	1.7	14.9	0.5	4.1	18.4	7.3	9.4	5.0	7.1	7.2	92.8	4.0	6.0	35.0	13.0	57.6	6.4	0.1	13.9	8.6	5.2	0.8	1.3	1.0	66.8	0.0	24.0	28.7	1.0	1.1	2.7	4.4	3.3	14.2	3.1	0.1	1.3
HELB		ENSG00000127311	"DNA helicase B"	Q8NG08	12	66302493-66343643	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 32.8;T-cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;HDLM-2: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052461			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Plasma membrane"		"HPA052461: "	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.06e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-6)"	"unprognostic (3.97e-3)"	"unprognostic (9.19e-4)"	"unprognostic (1.93e-1)"	"unprognostic (9.50e-3)"	0.8	0.3	0.1	0.4	0.1	1.0	0.7	0.1	0.3	0.5	0.2	0.7	0.0	0.4	0.0	0.6	0.5	0.1	0.4	0.1	0.1	0.7	1.2	1.1	0.5	0.4	0.2	0.8	0.9	0.1	1.2	0.0	0.3	0.8	0.1	0.1	0.8	0.0	0.2	0.5	1.2	0.1	0.2	1.8	0.8	0.4	0.3	0.4	0.7	0.0	0.3	0.5	0.6	0.4	0.4	2.7	0.2	0.6	0.1	0.1	0.5	0.6	0.1	0.6	1.2	0.6	1.5	1.0	0.9	0.1	0.9	0.8	0.5	0.2	0.3	2.6	0.2	0.8	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.2	0.1	1.3	0.6	1.1	0.4	1.1	0.0	0.2	0.0	1.1	0.5	0.2	1.0	0.2	0.0	0.0	0.1	0.3	1.7	0.2	0.4	0.4	0.3	1.7	0.2	0.2	0.5	0.3	0.5	1.2	1.0	0.5	0.1	0.9	0.4	4.5	0.8	5.8	2.6	0.5	4.2	0.4	4.9	3.9	1.7	0.7	5.1	4.1	0.7	3.5	0.2	0.6	5.6	1.0	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.2	0.3	0.2	0.3	0.4	14.7	0.0	7.5	1.3	14.0	0.6	2.5	0.6	10.8	3.2	10.3	9.8	4.0	0.0	6.6	0.0	12.5	3.0	32.8	4.3	1.9	1.7	0.5	12.6	11.5	9.9	4.8	6.1	7.7	1.1	2.5	5.7	11.7	20.9	2.5	10.3	4.6	2.8	3.3	13.5	5.2	5.6	2.0	5.5	3.3	0.8	3.4	10.3	3.6	20.6	8.0	2.4	14.4	0.0	16.2	2.4	3.0	0.7	21.7	5.8	5.9	3.2	3.4	6.5	0.0	11.3	8.0	1.2	1.5	5.2	1.7	2.5	43.5	9.2	6.4	1.8
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Developmental protein, Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 182.0;Spermatogonia: 173.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Region enhanced"	"Detected in many"		"cerebellum: 5.5"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 36.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.1	1.2	0.8	6.4	0.3	16.3	3.0	5.5	1.2	3.2	1.3	4.3	2.9	2.9	1.4	5.9	1.7	2.0	0.7	0.4	1.3	2.5	1.8	1.7	12.4	0.8	0.8	2.6	1.2	1.4	3.0	4.1	1.0	2.1	5.1	1.1	1.9	1.0	0.3	5.3	3.9	2.2	0.9	4.3	3.7	12.8	0.9	15.9	1.1	0.2	12.6	3.6	3.2	1.5	57.7	55.4	70.6	90.1	2.9	6.4	37.4	42.9	27.8	34.4	54.6	70.3	45.5	70.0	16.7	15.5	29.1	56.3	40.9	34.9	50.7	68.5	45.5	37.3	56.3	58.0	1.7	71.2	31.6	3.6	2.0	42.1	20.0	9.4	24.0	46.0	20.7	43.5	43.1	54.9	75.2	35.6	73.4	42.3	24.1	70.3	62.1	16.3	24.2	72.2	28.4	22.8	50.3	14.5	7.8	59.0	60.9	23.1	17.2	38.4	19.4	35.4	52.4	22.3	47.6	74.5	19.0	42.8	17.9	0.3	0.7	0.0	7.0	1.5	2.4	18.8	11.4	9.4	2.3	23.2	5.2	7.7	1.0	10.2	1.0	36.8	19.7	2.3	0.8	0.3	5.5	1.2	0.4	1.3	0.8	0.8	1.0	0.9	0.9	1.5	4.7	9.6	3.9	0.0	19.7	21.5	11.5	12.6	13.1	16.4	10.0	15.0	1.0	12.8	12.6	22.0	0.0	46.3	13.2	26.2	3.9	9.0	2.0	9.3	16.4	8.1	10.8	50.5	3.3	6.2	43.4	13.0	17.9	16.3	5.7	60.6	5.7	3.6	15.1	6.7	5.4	17.8	8.2	2.2	10.3	5.3	9.0	7.3	1.8	9.4	5.7	4.3	1.0	4.5	6.6	4.7	1.8	5.7	37.5	3.7	1.7	1.6	6.3	11.4	19.7	10.5	16.4	182.0	173.9	22.9	9.9	11.1	15.7	16.5	30.9	11.7
HEMGN	"CT155, EDAG, NDR"	ENSG00000136929	Hemogen	Q9BXL5	9	97926791-97944856	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 246.7"	"Group enriched"	"Detected in some"	27	"Early spermatids: 1329.5;Erythroid cells: 1206.7;Late spermatids: 1439.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.1"	"Group enriched"	"Detected in many"	28	"granulocytes: 2.2;NK-cells: 2.0;T-cells: 5.1"	"Cell line enriched"	"Detected in some"	5	"K-562: 290.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019572, HPA019604, HPA019606"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591"	"unprognostic (1.94e-1)"				"unprognostic (3.15e-3)"			"unprognostic (2.50e-2)"		"unprognostic (9.00e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-4)"	"unprognostic (2.77e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.25e-1)"		0.1	0.0	0.1	0.8	0.1	246.7	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.6	0.9	1.5	0.4	0.0	0.0	0.2	0.0	0.1	5.9	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.1	0.0	0.0	3.2	0.2	50.5	0.1	12.6	0.2	0.1	1.5	0.1	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.3	64.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.2	290.9	0.3	0.0	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.2	0.0	1.5	0.5	1.8	0.0	0.0	0.1	2.2	0.1	0.0	0.2	0.0	0.5	0.0	1.5	0.7	0.1	0.0	5.1	2.1	0.6	2.0	0.0	0.0	0.9	2.7	0.1	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.2	0.4	0.1	0.0	0.0	1329.5	0.2	0.0	0.5	0.0	1206.7	0.4	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.7	0.7	1.0	0.0	0.2	0.0	0.0	1.6	0.0	1439.7	5.9	47.4	1.8	0.0	2.1	0.0	4.1	0.0	0.1	0.0	0.0	4.1	0.5	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.1	10.0	4.4	0.0	0.0	0.5	2.3	0.0	0.0	0.0
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188534-93226469	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 96.2"	"Group enriched"	"Detected in some"	11	"Enteroendocrine cells: 218.2;Intestinal goblet cells: 387.5;Ionocytes: 349.9;Paneth cells: 318.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.4;pancreatic cancer: 10.7;renal cancer: 10.6;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SCLC-21H: 172.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		210000		"Cluster 9: Intestine - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.1	0.0	2.3	0.0	2.5	8.9	0.0	0.1	0.0	0.0	64.3	30.1	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	15.2	0.0	0.1	0.0	0.1	0.1	0.0	4.3	0.4	7.3	0.2	0.0	0.8	96.2	0.0	2.6	1.4	0.0	0.0	48.0	1.5	0.1	0.1	10.1	3.2	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	172.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.4	0.3	1.1	0.7	0.0	0.0	15.1	6.6	0.2	0.0	0.9	5.5	0.0	0.0	0.0	17.2	9.8	0.1	2.5	0.0	0.0	0.1	218.2	18.7	0.5	0.0	0.0	0.1	27.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.6	387.5	349.9	0.0	0.0	2.4	0.0	0.0	7.2	1.0	0.0	0.0	0.0	0.0	2.2	0.0	318.1	0.0	0.1	0.9	11.5	0.0	0.3	0.0	0.0	0.0	0.1	5.6	1.2	0.0	0.1	0.1	0.1	0.0	19.7	0.3
HEPN1		ENSG00000221932	"Hepatocellular carcinoma, down-regulated 1"	Q6WQI6	11	124919244-124920677	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 11.4;brain: 37.3;liver: 20.9"	"Group enriched"	"Detected in some"	23	"Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	287	"Hep G2: 55.5"									"HPA043768, HPA063054"	Uncertain		Approved	"Golgi apparatus"		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Golgi apparatus"		"HPA043768: AB_2678662, HPA063054: AB_2684932"																		11.4	0.2	6.1	0.1	23.1	0.0	8.3	0.3	9.4	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.6	5.0	6.1	0.2	20.9	0.1	0.1	37.3	10.3	0.1	0.2	0.0	2.4	0.0	13.5	0.8	0.0	2.2	0.4	0.0	0.2	0.3	0.7	0.0	5.1	0.1	0.5	0.5	19.0	0.0	0.2	0.0	0.0	0.2	0.5	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	23.1	0.3	9.4	5.0	6.1	37.3	10.3	13.5	5.1	19.0	17.9	0.2	0.0	0.0	94.3	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	3.1	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.5	0.6	0.0	0.0	1.9	0.0	29.1	0.0	49.3	114.6	0.0	0.0	1.2	0.0	0.1	0.0	2.2	0.0	1.9	0.0	0.1	0.1	1.8	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 201.4;fHDF/TERT166: 226.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: AB_2686247"	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	13.9	19.6	18.2	14.4	18.9	10.9	14.3	19.5	23.5	15.2	15.3	14.1	13.8	14.9	14.0	14.5	13.4	13.3	13.6	20.6	22.4	13.7	16.6	13.9	21.0	19.4	19.7	15.3	11.1	12.0	14.1	16.5	19.4	12.2	15.9	13.9	11.5	11.4	13.5	13.4	14.6	15.6	18.1	18.2	11.6	14.2	21.1	15.2	13.1	12.3	19.4	16.2	14.3	26.7	75.4	30.4	16.7	28.5	47.5	63.9	15.5	201.4	125.5	75.5	47.6	17.5	35.3	29.7	14.3	226.7	40.6	40.9	21.1	28.9	102.0	17.6	9.2	13.7	51.3	12.2	22.6	17.3	21.3	30.2	33.8	39.3	34.4	89.1	47.5	15.0	14.9	14.3	117.4	35.2	11.3	19.9	9.9	15.8	49.0	15.3	7.6	8.2	32.3	23.7	8.7	9.4	66.1	26.4	26.5	37.6	15.4	20.1	65.0	38.2	17.5	94.7	31.9	8.7	11.2	17.8	67.7	32.3	13.6	10.8	5.0	6.6	3.9	4.1	5.0	3.4	4.1	4.5	5.7	3.4	4.1	4.2	6.7	5.2	4.1	1.6	5.6	3.7	18.2	18.9	19.5	23.5	20.6	22.4	19.4	19.7	19.4	18.1	21.1	26.7	29.8	48.1	29.3	127.0	41.0	50.3	33.7	27.2	26.2	50.1	29.1	16.6	23.0	14.3	24.1	18.4	43.8	29.3	38.7	78.7	7.9	19.5	66.4	44.3	45.4	30.9	22.1	32.4	170.2	12.2	40.8	30.3	34.1	70.9	30.4	31.3	28.5	24.5	23.6	53.8	148.8	29.9	26.4	42.9	23.3	47.4	26.8	30.9	17.8	149.9	36.0	18.9	40.2	174.9	209.2	38.6	52.3	19.2	17.4	42.6	37.8	24.9	25.5	45.8	6.6	33.2	28.1	25.2	12.4	23.4	60.9	15.6	40.9	38.5	21.9	48.5
HERPUD2	FLJ22313	ENSG00000122557	"HERPUD family member 2"	Q9BSE4	7	35632659-35697459	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 329.7;Late spermatids: 660.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015630, HPA076087"	Approved		Approved	"Nucleoli,Nucleoli rim"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"		"HPA015630: AB_1850609, HPA076087: AB_2686774"	"unprognostic (1.85e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	17.4	13.6	17.1	19.7	19.8	33.6	14.7	18.6	19.1	17.3	19.4	16.2	15.9	21.0	15.0	21.2	16.6	19.3	16.6	16.4	16.2	16.1	23.5	21.1	21.5	17.9	17.3	32.6	28.9	14.3	10.3	17.7	17.2	15.1	16.8	23.0	14.8	12.8	16.4	23.1	16.8	17.9	16.5	24.3	17.1	26.0	18.2	18.0	23.3	14.4	19.8	18.3	16.0	21.2	36.4	13.1	25.5	28.2	34.0	26.7	18.0	25.4	31.3	14.6	16.9	15.3	39.3	28.2	35.0	28.9	58.4	41.7	12.7	16.8	22.4	17.0	16.3	18.5	17.1	12.6	29.3	17.2	20.9	31.5	31.4	18.1	29.6	32.9	24.8	32.9	28.2	34.8	27.3	19.3	21.1	31.3	19.5	23.8	15.9	22.6	34.0	20.0	20.4	16.4	23.8	37.9	35.3	30.5	23.0	42.2	31.5	25.0	28.9	26.1	29.4	24.5	19.9	45.0	57.4	28.0	24.9	27.9	48.0	8.8	7.4	23.2	11.0	8.4	12.6	4.8	9.7	12.0	6.3	7.0	6.1	8.6	12.4	13.7	11.3	3.8	10.1	5.7	17.1	19.8	18.6	19.1	16.4	16.2	17.9	17.3	17.2	16.5	18.2	21.2	30.8	25.6	17.1	66.6	48.1	16.8	17.0	9.0	20.5	14.1	12.0	12.7	12.8	20.0	11.8	5.5	8.4	17.6	57.4	19.8	17.6	25.0	329.7	20.5	19.3	21.5	14.3	27.4	25.8	28.9	25.0	23.2	24.5	25.5	36.8	24.4	24.3	21.8	17.5	11.8	44.2	11.8	12.2	25.1	20.0	660.5	27.4	27.3	23.2	31.9	28.5	24.0	40.2	37.2	34.7	34.7	16.0	25.2	42.8	17.9	24.3	12.7	11.1	13.9	13.1	26.5	26.6	45.0	18.7	19.9	15.8	31.1	83.2	16.6	14.2	20.3
HES1	"bHLHb39, FLJ20408, HES-1, HRY"	ENSG00000114315	"Hes family bHLH transcription factor 1"	Q14469	3	194136148-194138732	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 850.6;Muller glia cells: 1146.0;Paneth cells: 1137.2;Undifferentiated cells: 882.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"eosinophil: 15.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 94.1;OE19: 95.8;SK-BR-3: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066929			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA066929: AB_2732753"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.04e-5)"	64.2	32.2	13.6	7.9	14.9	0.9	87.0	12.5	15.0	66.0	11.8	44.1	31.2	22.5	9.0	127.8	22.4	17.7	65.6	14.7	16.8	87.3	68.7	47.1	7.0	15.3	17.4	25.3	34.8	22.6	42.7	27.5	13.5	90.1	35.7	66.5	79.9	31.5	69.9	184.5	23.9	9.8	13.5	23.4	42.1	12.8	14.5	11.9	93.2	22.4	11.8	59.8	136.6	11.6	9.3	2.6	20.8	27.1	6.1	0.0	5.2	4.3	12.2	0.9	0.5	36.4	26.1	1.3	74.6	1.6	12.6	51.4	3.9	24.2	0.3	7.7	44.0	33.1	3.5	9.4	0.1	0.2	30.1	2.2	94.1	0.8	10.9	14.3	28.6	1.7	16.1	1.2	0.0	43.9	47.5	45.7	19.4	95.8	17.8	0.1	1.5	1.0	28.0	71.2	1.2	1.6	21.0	78.9	38.9	23.6	22.2	2.6	22.3	2.3	21.8	0.3	31.3	0.2	0.1	0.2	1.6	0.1	43.7	0.0	0.0	15.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	13.6	14.9	12.5	15.0	14.7	16.8	15.3	17.4	13.5	13.5	14.5	11.6	684.0	25.6	96.0	70.2	54.2	122.9	498.5	736.7	159.4	15.9	352.0	164.1	128.8	517.6	355.1	196.8	16.7	41.1	4.7	696.8	189.8	268.9	2.2	231.9	37.6	401.8	160.1	19.2	1.2	199.1	6.0	274.1	105.0	257.4	303.4	16.1	850.6	163.1	24.4	10.1	0.4	579.7	213.6	95.3	76.2	8.7	58.7	74.6	80.0	5.6	22.8	1146.0	0.0	4.5	0.1	227.1	1137.2	18.8	5.0	231.1	297.5	126.6	190.2	54.9	164.3	76.8	291.7	1.2	13.2	367.8	296.5	209.2	24.1	31.4	882.7	358.1
HES5	bHLHb38	ENSG00000197921	"Hes family bHLH transcription factor 5"	Q5TA89	1	2528745-2530263	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 18.7;skin 1: 4.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 24.8;Astrocytes: 53.5;Muller glia cells: 113.4;Oligodendrocyte precursor cells: 15.6"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.8"	"Group enriched"	"Detected in many"	4	"amygdala: 10.3;basal ganglia: 14.2;cerebral cortex: 5.1;hypothalamus: 12.4;thalamus: 18.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA065458, HPA076164"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		No	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA065458: AB_2685492, HPA076164: AB_2732303"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.60e-4)"	"unprognostic (1.76e-4)"	"unprognostic (1.60e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (9.95e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-1)"	0.5	0.0	10.3	0.0	14.2	0.0	0.3	0.7	5.1	0.4	0.0	0.5	0.0	0.2	0.0	0.8	0.2	0.0	2.5	2.8	12.4	0.1	0.3	0.3	0.0	1.1	0.9	0.1	0.0	0.0	2.5	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.1	4.8	0.2	0.0	0.4	0.2	0.1	0.9	18.7	0.0	0.5	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	14.2	0.7	5.1	2.8	12.4	1.1	0.9	1.0	0.4	18.7	0.0	24.8	0.0	0.0	53.5	0.2	0.1	0.3	0.2	1.8	2.9	1.1	2.8	1.4	0.0	0.3	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	5.4	0.8	5.1	0.0	0.0	0.7	0.0	0.0	0.3	0.0	8.9	0.0	0.1	0.0	0.0	0.0	3.3	0.8	4.9	0.0	0.0	0.8	0.0	0.0	0.3	0.0	1.9	0.0	113.4	0.0	15.6	0.3	0.0	2.9	0.0	0.0	0.5	0.1	0.0	0.0	7.7	0.0	1.0	6.2	0.0	0.4	6.2	1.4	0.0	0.5	0.0	3.0	0.2
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120592-8124106	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.1"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 3.6;Smooth muscle cells: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.0;Daudi: 6.0;HAP1: 8.3;HDLM-2: 6.5;HeLa: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA				"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA072105: AB_2686488"	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.3	0.1	0.2	0.0	0.2	0.0	0.3	1.7	1.6	0.7	0.0	0.3	0.0	0.7	0.0	0.3	0.5	0.1	0.9	0.5	0.2	2.1	0.0	0.9	0.1	0.2	0.0	0.9	0.1	0.4	0.4	0.6	0.2	0.4	0.0	0.5	0.6	0.0	0.2	0.5	0.2	0.0	0.3	0.4	0.2	1.1	0.2	0.0	0.5	0.0	0.1	0.2	0.7	0.4	6.0	0.4	0.5	1.8	0.1	0.2	0.2	0.3	0.5	0.5	2.2	0.1	0.3	6.0	0.1	0.0	1.0	0.7	8.3	0.7	0.0	6.5	3.9	0.2	13.9	0.1	0.7	0.7	0.8	0.1	1.1	1.8	4.4	1.0	0.1	1.0	0.2	2.9	0.2	0.1	0.1	0.3	0.2	0.5	1.5	0.6	0.3	1.2	0.2	0.0	0.3	2.9	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	1.3	1.4	2.1	3.9	0.9	0.4	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.7	1.6	0.5	0.2	0.2	0.0	0.2	0.3	0.2	0.4	0.9	0.0	0.0	1.0	0.2	2.2	1.0	0.3	1.2	2.3	2.3	1.7	1.3	0.0	0.1	1.8	0.0	0.0	0.8	0.2	0.0	0.1	1.7	0.2	0.1	1.7	0.0	0.0	1.1	0.0	0.0	1.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.3	1.8	0.0	0.0	0.5	3.6	0.0	0.6	0.9	0.0	1.0	0.0	0.0	0.0	0.4	0.1	1.6	0.0	0.1	0.2	0.7	0.0	1.5	5.9	0.1	0.6	1.0	1.6	0.3	0.3	0.0	0.2	0.2
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340924-72376420	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 234.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	49.8	56.1	18.3	37.6	21.1	110.0	58.5	20.4	21.6	73.8	28.5	55.1	49.8	42.6	164.6	24.8	47.8	76.7	54.3	19.9	20.1	90.1	79.4	84.2	54.2	23.0	21.3	39.3	30.6	54.0	26.3	102.0	24.6	45.3	67.0	32.1	45.0	53.3	22.1	21.8	41.2	59.5	21.7	54.7	45.1	35.6	27.0	38.1	76.5	33.2	42.4	71.6	19.7	29.9	39.8	66.4	27.8	53.8	223.6	253.1	39.7	54.8	274.1	115.3	182.8	34.6	282.7	32.9	50.9	110.0	59.9	77.1	74.5	34.6	72.5	26.5	30.0	41.4	60.4	60.9	172.9	99.9	113.1	216.7	101.3	50.4	89.3	210.3	107.4	48.4	65.1	197.6	156.0	33.9	21.7	50.0	16.0	128.9	0.3	22.3	60.6	75.3	129.1	61.6	23.8	26.4	136.5	126.6	307.3	56.1	23.4	123.9	54.1	171.9	70.7	160.1	59.3	104.7	151.8	33.4	62.1	130.4	85.3	24.2	84.6	60.1	43.8	35.7	38.7	41.1	28.8	38.9	98.0	38.0	22.5	33.2	8.1	51.3	13.3	37.3	28.2	63.0	18.3	21.1	20.4	21.6	19.9	20.1	23.0	21.3	24.6	21.7	27.0	29.9	68.9	64.1	62.4	19.9	46.3	22.2	33.3	94.3	19.4	42.4	28.6	30.4	26.9	30.0	68.0	66.2	106.3	150.2	54.2	36.6	60.7	88.3	20.6	27.2	30.2	50.8	47.2	19.1	22.7	38.0	68.0	78.7	42.8	40.6	29.9	49.9	43.5	42.9	234.3	26.9	24.7	46.3	81.4	92.8	75.0	13.7	74.3	118.1	94.3	24.4	60.3	38.4	82.4	20.6	26.7	39.1	74.6	44.8	37.7	33.0	68.5	66.7	37.5	56.9	46.0	24.5	31.7	24.3	32.3	13.5	15.6	157.6	36.7	45.2	50.6	27.5
HEXIM1	"CLP-1, EDG1, HIS1, MAQ1"	ENSG00000186834	"HEXIM P-TEFb complex subunit 1"	O94992	17	45148475-45152099	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 467.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008926, CAB011625"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB011625: AB_2233058, HPA008926: AB_1079048"	"unprognostic (2.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.26e-2)"	16.8	32.6	16.3	13.2	15.4	36.3	17.0	16.2	16.5	17.2	16.5	22.5	17.7	19.6	15.9	24.2	21.3	14.3	15.0	14.8	16.8	21.1	26.8	17.3	12.8	17.0	19.1	14.4	19.7	14.1	19.2	25.2	16.0	24.2	10.2	9.0	19.2	19.8	33.2	22.6	24.9	13.0	17.7	25.6	23.1	21.6	19.7	15.4	20.1	21.6	12.4	19.7	17.6	14.2	35.7	111.1	22.8	33.0	36.7	19.6	55.3	30.9	27.8	25.0	27.8	52.6	49.3	15.5	93.1	32.7	12.1	28.2	13.8	30.4	20.0	32.2	32.9	48.2	65.8	65.0	32.0	30.3	61.4	23.0	25.5	18.6	8.1	62.6	12.7	26.8	21.5	36.6	19.0	47.8	31.9	34.9	20.9	32.9	33.4	13.1	19.9	19.2	66.5	62.1	12.2	9.2	46.6	52.0	52.2	23.0	54.2	23.5	24.3	25.1	34.6	14.6	58.5	33.1	11.4	10.0	23.0	28.1	29.1	16.2	4.0	6.8	4.2	6.1	2.4	3.0	4.2	3.7	3.3	3.2	3.7	3.9	10.0	3.7	7.3	3.4	3.8	2.2	16.3	15.4	16.2	16.5	14.8	16.8	17.0	19.1	16.0	17.7	19.7	14.2	210.3	73.7	111.8	7.2	76.1	84.5	75.0	57.7	157.1	25.1	127.0	215.9	59.7	87.2	60.5	25.8	22.9	134.8	114.3	250.4	7.9	35.0	2.2	88.8	66.1	91.3	52.8	82.1	10.7	23.6	70.1	99.2	94.3	137.9	125.9	16.5	42.5	40.5	42.1	15.2	12.9	122.0	54.9	33.9	83.2	3.0	35.1	83.0	53.4	9.4	38.4	27.7	28.8	7.1	8.2	25.3	127.1	43.6	44.1	52.1	184.9	53.8	45.7	24.8	26.3	249.2	128.2	2.6	7.9	126.7	71.5	467.5	111.1	16.9	92.2	34.4
HEY2	"bHLHb32, HERP1, HESR2"	ENSG00000135547	"Hes related family bHLH transcription factor with YRPW motif 2"	Q9UBP5	6	125747664-125761269	"Predicted intracellular proteins, Transcription factors, Transporters"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 30.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 49.9;Endometrial ciliated cells: 46.1;Granulosa cells: 73.9;Late spermatids: 80.6;Sertoli cells: 52.6;Smooth muscle cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HEK 293: 7.1;SK-MEL-30: 6.6;TIME: 14.8;U-266/70: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030205, HPA074851"	Approved		Approved	"Nuclear bodies,Aggresome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	Aggresome	"HPA030205: AB_10600712, HPA074851: AB_2686718"	"unprognostic (5.10e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.10e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.19e-1)"	6.5	0.9	8.8	1.0	12.0	0.1	5.7	9.4	7.6	8.0	3.0	2.5	1.3	7.5	16.4	1.8	13.5	1.7	30.7	7.2	10.4	3.1	5.3	3.2	0.5	12.7	10.0	7.1	3.3	2.6	5.5	3.7	10.6	2.1	1.3	5.7	2.0	2.7	16.2	2.4	2.1	1.7	14.1	1.9	2.0	6.6	11.8	0.7	3.1	4.9	0.6	2.7	4.7	12.2	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.5	7.1	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.6	0.0	0.4	0.0	0.0	3.2	0.0	0.3	0.5	0.6	0.9	0.0	0.1	2.3	0.0	0.0	0.0	6.6	3.2	1.9	0.0	14.8	0.3	0.0	0.1	0.8	17.6	0.3	0.1	0.6	0.0	2.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	12.0	9.4	7.6	7.2	10.4	12.7	10.0	10.6	14.1	11.8	12.2	2.8	3.2	1.1	12.4	0.7	3.8	0.5	8.7	3.4	0.4	9.8	5.7	21.5	0.0	2.7	0.0	8.4	0.0	1.4	0.1	9.8	0.1	49.9	46.1	4.2	6.0	0.0	2.7	0.1	1.8	0.1	3.3	1.1	36.8	0.0	73.9	1.8	8.0	0.1	1.7	0.4	0.0	2.0	0.8	3.0	80.6	6.5	0.6	3.6	5.6	0.0	34.8	3.1	2.5	23.4	1.1	0.1	23.3	3.1	0.3	0.0	6.4	5.4	5.2	52.6	17.5	41.8	16.2	15.1	7.7	2.0	0.0	2.0	2.8	0.1	0.3
HFE	"HFE1, HLA-H"	ENSG00000010704	"Homeostatic iron regulator"	Q30201	6	26087281-26098343	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 39.2;T-47d: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: AB_2682163"	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	9.6	7.9	1.3	5.3	2.1	0.6	7.8	1.4	1.9	6.7	9.3	5.8	5.9	4.9	12.4	4.8	4.5	8.1	3.7	1.5	1.5	6.7	15.4	7.5	3.6	2.4	1.7	7.3	6.3	15.4	1.2	6.1	2.2	6.8	6.9	1.3	6.9	9.6	2.3	2.8	5.0	6.0	1.7	8.6	8.3	1.7	1.9	1.7	9.9	3.0	3.1	7.4	3.2	2.8	17.2	39.2	0.7	18.6	27.3	21.1	0.1	12.2	28.5	15.1	23.6	3.3	34.3	1.8	32.4	20.2	22.9	10.7	0.0	14.2	19.1	4.6	0.2	0.5	8.1	2.6	5.6	0.0	0.7	21.6	4.0	16.7	1.4	13.2	10.4	0.0	0.7	0.4	13.0	7.2	0.1	0.2	0.9	8.1	0.0	2.3	0.0	0.3	12.5	11.5	0.1	0.1	7.3	0.0	10.2	0.3	54.0	1.9	8.2	10.6	1.1	10.7	10.6	0.2	0.4	0.2	15.9	0.2	23.5	1.3	10.7	0.0	1.5	10.4	1.2	3.3	1.6	2.1	4.7	1.3	0.4	1.0	1.9	0.2	9.2	0.3	0.3	3.8	1.3	2.1	1.4	1.9	1.5	1.5	2.4	1.7	2.2	1.7	1.9	2.8	3.9	3.2	5.1	1.0	1.7	1.7	2.6	3.7	6.2	1.0	3.7	2.2	3.2	2.8	6.7	5.5	2.1	1.7	0.5	3.8	0.0	4.1	0.1	1.8	2.3	3.4	1.8	2.7	0.1	3.4	0.8	4.6	8.2	1.5	2.5	3.0	6.8	12.2	11.1	0.0	0.1	4.0	4.1	25.4	7.6	0.2	3.7	7.4	0.0	2.8	3.8	2.9	2.1	0.0	3.3	2.4	0.9	6.0	0.3	2.6	2.9	2.7	5.9	1.7	0.0	5.7	2.4	0.2	1.1	3.4	3.4	1.8	1.0	2.8	3.3	1.9
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628172-120682269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"kidney: 200.3;liver: 752.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 119.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.4	0.3	0.4	2.5	1.9	0.5	12.5	0.6	0.8	27.4	1.5	16.7	31.6	3.1	13.0	0.4	4.2	61.7	0.3	0.5	0.4	200.3	752.6	0.8	0.4	0.4	0.4	0.2	31.2	7.0	0.2	0.2	0.4	44.5	20.3	0.7	4.2	4.2	0.1	0.9	25.6	0.5	0.4	0.6	25.5	0.1	0.5	0.7	55.1	0.2	0.1	0.2	0.1	0.6	0.0	12.3	4.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	55.8	10.7	0.1	82.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	186.6	0.0	0.4	1.0	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.5	0.0	0.0	0.2	0.3	328.0	0.0	0.1	0.3	0.1	212.2	0.0	0.2	0.2	0.2	0.9	0.0	0.0	0.2	1.0	0.6	0.1	0.9	0.2	0.1	0.0	0.3	0.5	0.2	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.4	1.9	0.6	0.8	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.6	0.1	0.0	2.0	0.3	5.9	0.0	0.4	0.6	0.0	0.3	7.5	1.7	0.3	81.5	4.9	27.6	2.1	0.0	0.3	18.5	103.7	7.2	0.2	113.9	17.1	1.2	43.8	24.0	3.2	17.8	0.0	0.4	19.4	127.8	1.3	0.0	16.4	534.7	0.2	0.0	0.6	16.0	2.0	16.1	0.0	0.0	0.0	21.3	0.0	1.9	2.0	4.2	0.0	0.0	0.5	12.1	35.6	0.0	0.0	12.9	54.6	477.5	4.1	0.2	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	3.8	0.4	9.1	0.4
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548104	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.8;thyroid gland: 2.0"	"Group enriched"	"Detected in some"	9	"Early spermatids: 16.7;Late spermatids: 25.5;Spermatocytes: 13.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 18.7;Hep G2: 5.7;RH-30: 21.3;SuSa: 7.8;U-87 MG: 10.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"	No	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA059673: AB_2684100"	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.1	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	18.7	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.9	5.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.1	0.3	0.0	21.3	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	7.8	0.0	0.0	0.0	1.0	0.3	0.0	0.2	0.0	0.1	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	25.5	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	13.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 subunit alpha inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.6;tongue: 40.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458"	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	6.5	8.1	6.9	7.8	6.5	6.2	6.5	6.1	7.3	6.2	5.7	7.5	7.2	7.3	7.2	7.5	6.8	6.3	12.3	6.6	6.0	7.5	5.4	5.7	7.8	6.7	7.5	10.3	8.1	12.1	6.5	6.0	6.5	7.5	6.6	9.8	6.5	8.3	41.6	10.1	7.2	7.4	6.0	6.8	6.5	13.9	7.0	9.3	5.5	40.8	9.6	7.1	5.4	6.5	13.8	14.4	19.0	19.1	28.8	11.9	16.3	14.4	34.4	20.9	24.5	22.3	11.5	14.8	12.8	21.7	15.4	15.9	16.9	13.0	22.6	16.5	10.2	14.2	12.8	17.2	14.9	17.1	17.9	11.7	12.9	20.4	22.2	29.4	11.9	19.5	6.3	8.1	23.9	14.4	18.3	11.2	6.2	11.6	6.9	13.2	23.4	7.2	14.6	18.2	7.2	11.9	12.4	7.6	13.7	15.8	25.7	9.2	10.1	10.6	13.8	10.6	14.7	10.9	11.8	11.1	17.6	13.8	8.1	13.7	7.6	15.3	7.7	10.7	7.7	7.9	8.0	7.3	7.2	6.4	7.6	7.8	8.0	9.1	13.0	2.6	9.8	8.4	6.9	6.5	6.1	7.3	6.6	6.0	6.7	7.5	6.5	6.0	7.0	6.5	7.9	0.0	6.5	11.8	16.7	11.0	11.5	16.4	13.1	17.9	12.3	8.9	40.7	14.3	11.7	11.0	16.7	27.8	16.5	15.5	9.8	17.3	21.5	9.0	11.3	12.1	13.2	16.0	12.2	13.9	17.6	10.9	11.2	8.7	6.3	20.0	8.2	10.9	14.3	25.2	11.2	12.0	8.2	18.5	6.8	49.3	11.1	10.1	3.6	11.2	23.4	15.0	27.8	11.1	12.8	17.7	11.3	12.0	11.2	11.4	20.1	20.5	11.6	23.1	6.6	12.0	16.1	48.2	26.6	11.4	11.6	32.7	14.0	14.8	13.3	10.3
HIGD1B	"CLST11240, CLST11240-15"	ENSG00000131097	"HIG1 hypoxia inducible domain family member 1B"	Q9P298	17	44846353-44850476	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.6;choroid plexus: 65.0;placenta: 105.2"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 762.6;Smooth muscle cells: 209.3"	"Cancer enhanced"	"Detected in all"		"glioma: 9.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA079501			Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA079501: "	"unprognostic (6.85e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.19e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.52e-2)"	11.7	0.5	71.0	0.7	71.0	0.5	8.8	70.3	114.6	8.3	65.0	3.7	2.1	9.9	11.6	5.0	5.3	11.3	46.4	68.8	71.4	11.5	0.6	38.6	2.6	71.4	70.9	2.9	3.1	8.0	1.4	105.2	72.4	9.5	1.1	2.3	1.4	6.4	14.5	2.0	4.3	11.3	68.9	0.1	3.7	1.5	73.0	1.8	5.0	30.8	1.4	4.3	4.4	69.1	0.2	0.6	0.0	0.7	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.3	0.2	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.7	0.1	0.8	0.5	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.7	0.5	0.0	0.3	0.7	0.7	0.4	0.3	0.3	0.8	0.4	1.0	0.0	0.5	0.7	0.3	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.6	0.2	0.4	0.5	0.4	1.2	0.6	0.5	1.1	0.7	1.7	0.6	0.2	1.2	1.0	0.4	0.2	0.7	0.9	1.2	0.3	0.9	0.7	0.0	0.7	0.1	0.3	0.8	0.5	71.0	71.0	70.3	114.6	68.8	71.4	71.4	70.9	72.4	68.9	73.0	69.1	88.9	0.0	0.5	0.0	0.3	3.4	0.6	0.3	0.0	0.5	1.2	2.8	11.0	0.0	1.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.7	70.2	0.0	0.0	0.7	0.0	0.2	4.4	0.0	0.3	0.0	0.0	0.7	0.1	0.8	1.7	0.6	0.0	0.0	0.0	3.9	0.6	0.3	1.6	0.0	2.8	0.0	1.0	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	762.6	9.5	209.3	0.0	0.3	0.7	2.4	0.3	0.8	32.3	0.0	0.7
HIKESHI	"C11orf73, HSPC138, HSPC179, OPI10"	ENSG00000149196	"Heat shock protein nuclear import factor hikeshi"	Q53FT3	11	86302211-86345943	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Extravillous trophoblasts: 146.2;Hofbauer cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012708, HPA035063, HPA035064"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441"	"unprognostic (1.10e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.01e-12)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.71e-1)"	34.7	27.0	46.1	17.8	46.7	19.0	31.4	47.8	71.5	33.9	44.5	40.8	10.4	32.3	24.7	33.4	31.0	15.0	57.1	46.1	47.2	17.0	24.7	23.9	26.0	46.6	46.0	37.5	22.8	22.9	31.5	28.3	47.1	24.5	19.1	32.5	19.8	28.6	59.9	29.5	20.8	31.1	49.1	28.5	23.5	19.0	47.1	32.9	17.7	57.8	30.8	32.8	31.8	50.9	28.6	30.5	72.7	40.5	59.9	74.2	38.2	43.2	52.0	44.2	52.6	90.8	77.8	29.0	96.9	57.4	83.9	59.9	54.2	95.1	47.0	62.0	47.6	47.0	47.5	68.2	80.8	58.0	36.8	52.7	94.9	52.8	62.5	56.9	85.9	54.7	51.1	64.6	91.5	78.0	69.6	136.7	59.5	186.3	20.1	53.0	35.7	65.4	77.2	53.2	44.8	38.7	53.8	39.8	31.1	72.7	64.1	38.5	44.2	52.1	36.4	105.8	32.7	27.7	68.3	57.6	26.6	54.4	52.6	47.8	53.4	44.4	48.6	52.5	54.3	61.8	59.1	53.6	68.9	52.9	51.1	52.3	11.2	57.9	53.9	53.7	84.5	43.2	46.1	46.7	47.8	71.5	46.1	47.2	46.6	46.0	47.1	49.1	47.1	50.9	59.9	38.5	32.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	53.4	81.3	0.0	0.0	14.9	27.6	0.0	129.6	28.7	0.0	41.1	76.1	0.0	41.4	60.4	28.7	0.0	0.0	0.0	66.3	146.2	30.2	0.0	36.8	22.7	52.1	0.0	0.0	94.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	50.1	0.0	0.0	0.0	0.0	49.8	0.0	0.0	4.1	0.0	0.0	43.2	27.7	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	77.6	18.1	59.3	0.0	0.0
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 633.9;Hepatocytes: 457.4;Proximal tubular cells: 578.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		110000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020961: AB_1850715, HPA059109: AB_2683906"	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	50.8	79.5	41.7	15.5	43.9	27.0	48.5	44.9	46.8	23.2	40.3	42.6	34.9	25.9	48.6	27.5	29.9	14.9	87.4	39.8	43.1	91.1	169.2	30.2	21.0	43.8	42.5	19.2	65.9	72.6	41.2	17.6	42.0	33.9	34.2	20.4	39.7	26.1	80.1	33.4	34.2	20.1	43.9	33.8	56.9	29.8	47.3	38.8	38.4	85.5	23.8	30.6	24.2	44.0	30.3	76.1	47.1	45.6	29.0	24.3	33.2	27.8	39.2	42.3	46.1	49.9	31.1	39.9	31.7	25.3	59.8	29.3	21.2	40.9	44.1	87.8	40.7	42.2	64.1	45.8	68.1	25.1	40.0	27.3	36.8	40.2	64.8	16.7	33.2	91.4	25.5	117.4	34.0	60.3	61.3	31.3	21.4	70.0	138.7	60.8	33.1	53.6	61.5	21.5	38.4	46.4	36.0	42.7	49.6	27.5	45.9	44.6	16.5	22.0	37.7	30.4	35.7	107.0	127.3	57.4	49.8	32.2	36.2	41.0	77.5	4.7	68.9	58.5	62.4	98.9	73.7	69.8	113.4	96.7	56.4	58.6	7.6	66.8	56.9	246.1	107.3	81.2	41.7	43.9	44.9	46.8	39.8	43.1	43.8	42.5	42.0	43.9	47.3	44.0	49.3	22.4	17.5	5.2	57.9	45.4	63.4	137.6	49.5	39.8	99.1	105.8	115.1	130.1	68.3	80.9	20.9	154.9	69.3	148.2	633.9	115.5	67.3	83.9	28.6	47.8	96.0	100.8	1.7	172.1	71.7	53.2	52.5	44.6	18.4	43.5	63.1	457.4	113.9	20.2	2.5	127.4	126.1	61.1	51.4	128.0	40.4	47.7	120.9	1.9	74.1	123.7	87.6	1.5	4.5	85.6	157.5	44.8	77.7	40.7	181.4	578.1	105.1	45.5	46.0	54.2	72.6	38.4	77.4	64.7	45.9	56.8	51.0	85.1	126.7	84.8
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777998	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"brain: 397.5"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 463.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 27.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favorable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.8	9.2	253.4	6.9	359.7	15.0	10.3	124.8	187.0	4.3	39.4	6.6	7.4	6.0	4.1	9.2	8.8	4.7	30.3	146.3	235.5	25.5	14.9	10.7	4.1	253.8	268.7	5.5	11.5	11.5	8.9	10.1	192.5	9.3	4.8	27.8	12.1	5.7	23.5	3.0	6.3	3.9	187.4	6.9	14.5	1.9	318.3	6.9	9.3	17.0	4.2	6.0	5.2	397.5	11.7	51.4	23.2	14.3	55.2	39.4	2.7	6.4	6.3	7.0	7.3	3.8	6.3	0.0	14.3	12.1	43.2	0.6	10.7	16.6	17.5	120.9	4.3	53.7	8.7	18.4	31.0	14.9	14.0	60.3	10.5	32.4	47.9	16.5	17.6	10.0	31.7	14.4	54.3	8.9	18.9	10.6	5.9	6.6	34.3	22.1	12.7	1.6	31.5	2.0	14.1	12.9	14.4	0.5	7.0	4.3	7.9	6.0	59.5	24.5	11.6	28.5	31.4	68.7	44.3	10.2	49.4	7.7	13.4	27.5	1.3	3.5	0.2	1.1	0.3	0.6	0.5	0.2	0.6	0.5	1.6	0.5	1.7	0.2	4.1	0.2	0.1	0.7	253.4	359.7	124.8	187.0	146.3	235.5	253.8	268.7	192.5	187.4	318.3	397.5	107.8	16.0	31.2	82.6	45.8	9.3	30.6	24.9	16.5	116.0	65.6	32.6	213.9	55.8	35.6	64.4	152.2	8.8	72.0	38.4	35.2	32.5	3.1	39.1	12.2	80.3	67.2	18.5	17.8	67.0	1.5	28.1	70.8	41.7	44.9	24.3	151.0	145.2	15.7	222.1	36.3	32.2	63.1	119.5	10.9	4.0	13.1	53.2	44.4	49.6	47.6	78.0	95.8	145.3	463.7	63.4	24.6	18.8	97.9	118.9	22.5	75.0	48.7	62.9	46.0	96.6	60.8	2.7	4.8	42.5	9.5	9.6	30.5	20.1	29.3	43.9
HIPK3	"DYRK6, FIST3, PKY, YAK1"	ENSG00000110422	"Homeodomain interacting protein kinase 3"	Q9H422	11	33256672-33357023	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028069	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nuclear bodies"	"HPA028069: AB_10601815"	"unprognostic (2.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-3)"	"unprognostic (7.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	57.8	21.5	29.5	25.3	31.5	23.3	35.1	32.9	23.4	27.6	75.9	30.7	16.7	33.1	24.2	30.9	31.7	30.6	53.7	19.9	42.1	38.2	29.8	26.9	22.8	35.5	36.2	27.2	25.8	46.7	12.8	34.7	27.8	23.3	20.6	22.4	22.9	26.1	69.0	22.3	20.2	39.3	34.2	30.6	22.1	18.9	43.1	25.5	33.7	85.3	24.7	32.3	22.4	33.0	19.3	18.0	13.4	15.1	60.5	37.9	12.9	20.0	23.1	15.9	13.3	19.9	13.8	20.7	16.3	24.4	8.0	24.3	10.2	22.2	22.1	30.8	15.8	21.0	20.3	15.2	25.0	22.9	12.8	35.8	42.8	6.1	17.7	16.5	19.4	14.8	6.4	40.4	26.0	10.1	19.2	15.8	3.4	17.3	11.1	25.4	47.3	19.9	26.4	29.4	2.0	11.3	27.1	30.7	18.7	14.2	34.6	41.2	25.8	24.8	16.9	28.9	14.6	21.7	37.2	21.4	11.9	23.5	23.7	10.6	12.7	6.1	4.0	9.4	5.0	2.8	3.6	4.3	14.0	3.3	3.2	4.0	21.1	4.4	11.1	1.7	4.0	5.0	29.5	31.5	32.9	23.4	19.9	42.1	35.5	36.2	27.8	34.2	43.1	33.0	122.2	12.8	44.7	46.0	29.6	66.5	42.8	21.3	39.3	16.2	35.8	25.8	159.9	37.1	32.9	33.1	18.8	18.6	31.2	32.7	5.9	13.0	21.8	76.5	80.5	96.5	37.1	20.6	44.9	24.9	13.4	59.2	23.0	49.0	14.5	24.3	57.5	53.2	30.7	32.0	48.0	28.4	12.2	102.0	76.0	26.1	42.9	68.1	58.7	73.1	69.1	16.2	25.7	45.8	69.1	21.5	21.1	37.6	24.9	52.6	40.7	35.0	65.4	24.9	52.6	83.4	56.4	10.7	8.1	33.4	75.0	15.5	29.8	12.5	25.2	51.2
HIRIP3		ENSG00000149929	"HIRA interacting protein 3"	Q9BW71	16	29992330-29996074	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 129.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051897, HPA063205"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051897: AB_2681655, HPA063205: AB_2684963"	"unprognostic (6.99e-2)"	"prognostic favorable (2.74e-5)"	"unprognostic (4.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (8.53e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.35e-2)"	12.3	11.6	24.4	9.0	25.5	15.8	11.8	23.9	24.7	13.3	19.0	16.0	8.3	13.5	10.6	9.6	12.2	7.1	19.2	22.9	23.8	12.6	14.9	11.6	13.1	25.5	24.6	16.8	11.0	15.6	14.5	6.8	25.4	11.9	7.3	20.1	11.1	12.8	33.5	14.6	10.9	8.6	24.1	12.9	10.6	38.7	24.4	25.6	11.7	21.7	12.3	14.2	11.5	25.7	27.4	27.7	44.2	28.5	13.9	14.8	13.4	20.9	16.1	21.2	18.2	24.8	26.8	52.7	42.5	13.7	15.3	19.0	28.8	26.6	15.8	47.8	28.1	56.7	36.2	26.9	11.5	50.3	42.4	7.4	19.4	20.9	32.3	12.4	13.4	50.6	27.2	57.0	12.9	20.0	66.1	26.3	13.0	17.8	15.5	65.9	52.6	52.5	14.9	12.2	28.6	34.7	21.7	16.3	14.5	11.3	24.2	30.6	15.4	28.4	21.8	20.3	20.5	37.1	31.0	31.4	26.8	43.2	38.1	4.6	7.5	15.0	16.7	12.0	11.4	19.1	18.6	15.3	6.3	14.6	19.3	17.9	3.4	14.3	20.8	19.1	22.9	10.8	24.4	25.5	23.9	24.7	22.9	23.8	25.5	24.6	25.4	24.1	24.4	25.7	19.1	67.3	26.3	2.0	14.9	12.7	17.1	11.2	14.8	36.4	14.6	19.6	30.4	10.0	15.8	9.2	14.6	30.6	18.7	12.5	29.4	10.5	27.6	12.6	10.9	15.4	9.6	27.0	2.1	12.1	28.9	14.6	4.6	10.9	31.0	12.1	10.8	16.7	18.7	15.2	2.7	10.8	14.2	8.2	11.9	12.0	20.5	9.8	5.4	1.0	8.8	37.3	32.0	3.5	4.7	6.3	11.4	22.6	22.0	6.7	25.6	19.9	19.9	49.4	13.1	14.7	18.6	129.5	46.2	10.2	11.4	11.5	20.9	12.1	14.0	8.3
HIVEP1	"CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A"	ENSG00000095951	"HIVEP zinc finger 1"	P15822	6	12008762-12164999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050724, HPA067457"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Mitochondria, Cytosol"	"HPA050724: AB_2616457, HPA067457: "	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.65e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.38e-1)"	7.2	2.3	0.8	8.0	3.0	16.7	5.5	0.7	3.0	7.4	6.5	6.4	5.0	5.9	4.5	7.4	6.1	7.3	3.8	2.2	0.8	4.5	11.7	6.3	8.0	1.3	2.8	6.5	6.7	10.5	3.3	4.9	0.5	6.9	6.6	5.8	4.8	5.8	2.8	5.7	5.2	6.2	0.0	6.0	4.9	4.8	1.2	9.1	4.9	6.2	8.3	9.3	3.3	1.6	8.1	5.9	7.5	4.2	5.8	7.3	7.2	6.4	5.5	5.2	5.7	3.8	4.2	6.7	13.6	7.8	12.4	7.6	7.4	9.2	7.1	14.6	4.3	3.1	5.6	3.7	4.7	3.7	2.5	5.1	9.0	10.6	16.3	11.0	15.5	4.6	32.9	7.5	11.5	6.0	5.9	3.3	6.4	2.8	2.7	3.2	9.8	10.7	3.1	8.7	7.1	5.2	15.9	12.8	4.3	16.6	7.6	4.7	25.2	13.0	5.8	12.3	7.4	30.0	27.3	12.0	4.0	4.8	5.5	2.4	1.8	2.1	1.2	2.0	0.9	3.1	2.0	0.8	1.2	4.8	3.4	2.1	11.7	3.3	5.2	9.0	4.4	0.7	0.8	3.0	0.7	3.0	2.2	0.8	1.3	2.8	0.5	0.0	1.2	1.6	40.2	28.9	16.9	74.7	35.6	32.2	25.4	7.4	30.7	20.4	12.3	10.9	10.4	17.2	17.6	7.3	12.5	3.4	18.7	17.5	3.9	5.6	2.5	37.7	16.4	20.3	10.8	6.5	94.6	7.2	1.8	25.2	22.4	51.0	7.6	7.0	6.4	12.3	5.9	21.9	68.3	14.4	4.1	9.6	47.9	1.8	3.7	23.1	19.6	44.0	29.6	13.1	5.2	59.3	25.0	11.5	10.3	4.5	33.6	25.2	6.7	2.5	16.7	9.7	0.0	21.0	17.1	3.9	3.5	18.7	33.4	5.2	18.8	6.6	8.6	23.7
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.4;Erythroid cells: 38.3;Extravillous trophoblasts: 16.1;Granulosa cells: 14.8;Spermatocytes: 37.5;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	0.6	0.6	0.0	5.5	0.1	47.4	1.1	0.1	0.2	0.8	0.1	3.9	4.1	0.9	0.2	5.6	0.3	0.5	0.3	0.1	0.1	0.4	0.8	1.4	12.6	0.1	0.3	0.2	0.2	0.1	0.1	3.0	0.1	0.4	5.2	0.1	1.0	0.1	0.2	3.6	3.8	1.9	0.0	4.1	2.4	11.1	0.3	30.4	0.3	0.0	12.0	1.4	2.0	0.2	54.5	73.6	68.4	32.7	2.6	5.4	42.8	79.5	37.9	55.2	59.9	51.3	57.6	17.1	9.0	31.4	98.0	61.7	54.9	40.9	72.6	40.0	21.6	65.5	61.4	50.9	0.3	54.1	43.2	1.8	1.5	45.1	30.9	15.7	35.5	51.3	56.6	40.8	103.0	55.3	76.4	59.7	58.9	42.2	49.1	58.4	103.0	30.3	28.6	32.3	39.4	24.7	45.8	34.2	31.7	31.0	25.7	42.1	26.0	59.6	64.6	44.3	87.2	38.6	32.7	67.9	35.7	39.3	151.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.5	0.0	2.9	1.3	0.5	1.9	0.0	0.0	0.7	0.5	1.2	0.0	2.1	0.0	0.0	8.2	0.5	5.6	0.0	0.2	17.4	0.3	1.3	1.1	0.0	38.3	0.0	0.0	16.1	2.0	5.1	1.3	0.0	14.8	2.2	0.3	7.1	0.0	0.0	3.5	0.0	3.0	2.9	9.0	0.6	3.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	11.4	1.0	0.5	0.1	0.1	0.0	0.0	0.1	1.9	37.5	16.3	8.9	0.9	1.5	2.3	0.3	7.6	0.9
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220332-69267552	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.5;retina: 46.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 31.5;Distal enterocytes: 29.0;Ductal cells: 32.6;Endometrial ciliated cells: 50.0;Glandular and luminal cells: 55.2;Muller glia cells: 126.9;Proximal enterocytes: 56.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 3.1;naive CD4 T-cell: 5.8;naive CD8 T-cell: 2.3;T-reg: 5.4"	"Lineage enriched"	"Detected in single"	23	"T-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;CACO-2: 57.5;CAPAN-2: 111.4;EFO-21: 33.9;GAMG: 45.4;Hep G2: 33.6;RPTEC TERT1: 81.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 11.9"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	1.1	2.7	1.3	0.0	0.0	1.4	1.0	1.1	1.4	6.8	53.5	0.9	0.0	0.1	4.6	6.8	0.0	1.0	1.1	13.3	4.6	1.5	1.0	1.3	2.1	0.0	6.2	0.0	0.3	0.0	1.7	0.0	4.2	46.8	0.1	0.0	0.0	0.1	48.0	0.5	1.4	0.3	1.1	1.0	1.0	5.2	9.3	0.0	0.2	0.0	0.1	1.2	1.2	40.1	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.1	57.5	111.4	0.0	33.9	0.3	45.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	33.6	2.7	0.0	0.0	0.0	0.3	0.4	3.2	0.6	0.0	11.3	0.0	0.0	0.7	0.1	0.2	0.1	0.0	11.9	1.3	0.0	1.2	0.1	81.9	0.1	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.4	1.6	0.2	0.8	0.0	0.1	0.0	8.1	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.5	0.0	3.1	1.0	0.0	0.0	5.8	2.3	0.0	0.2	0.0	0.0	5.4	1.0	1.1	1.3	1.4	1.0	1.0	1.1	1.3	2.1	1.7	1.4	1.0	1.2	0.0	3.2	4.8	11.8	0.7	0.0	0.0	0.3	0.0	1.9	0.0	0.0	1.0	31.5	1.0	16.5	0.0	0.0	0.2	29.0	1.9	32.6	0.6	50.0	4.5	0.5	0.0	0.0	0.4	7.3	0.0	0.2	1.5	55.2	0.0	0.0	0.0	0.4	0.1	3.3	0.5	5.6	0.0	0.3	0.0	0.2	0.3	0.4	0.0	0.0	0.0	126.9	0.0	0.0	0.5	25.5	12.7	0.0	0.3	0.0	56.3	15.7	0.3	5.1	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	1.3	0.1	5.6	0.3
HLF	MGC33822	ENSG00000108924	"HLF transcription factor, PAR bZIP family member"	Q16534	17	55264960-55325187	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 122.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 120.7;Excitatory neurons: 77.5;Hepatocytes: 156.8;Horizontal cells: 92.5;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 53.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 163.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA068156: AB_2685963, HPA071210: AB_2686361"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	15.1	21.5	9.8	1.9	23.1	0.4	15.4	0.0	53.3	14.4	0.0	18.0	1.4	14.4	11.0	26.3	12.2	7.8	24.1	17.6	0.0	12.7	122.4	13.4	2.2	0.0	0.6	50.0	2.9	4.0	9.9	1.0	0.0	13.2	3.4	43.2	24.1	12.4	7.7	16.7	4.3	12.3	0.0	8.2	6.1	4.1	3.9	3.4	34.3	9.9	7.7	12.3	7.8	17.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.9	0.5	0.0	0.0	0.0	0.4	0.2	0.0	27.3	0.7	0.0	0.1	163.0	0.1	0.9	0.2	0.1	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.6	1.1	0.0	0.1	0.0	2.4	0.0	0.4	0.4	13.0	0.1	11.1	0.6	0.0	7.2	0.2	0.0	0.2	0.0	0.1	0.8	0.2	0.6	0.5	5.1	4.9	0.0	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.8	23.1	0.0	53.3	17.6	0.0	0.0	0.6	0.0	0.0	3.9	17.2	13.8	3.2	42.8	22.2	0.4	22.3	4.4	1.4	56.9	120.7	5.9	16.4	38.6	12.8	6.3	7.3	10.4	0.1	0.5	0.0	11.7	1.9	1.3	0.1	6.2	19.7	3.0	0.8	77.5	0.9	0.0	17.6	0.0	0.6	0.0	0.5	6.1	156.8	0.1	92.5	36.6	0.6	0.0	3.5	4.0	4.7	28.3	0.7	10.6	74.0	0.1	60.7	0.0	24.6	6.9	0.4	0.0	39.1	1.5	1.3	2.8	23.3	1.0	15.0	13.1	4.5	7.4	0.4	5.0	33.7	27.6	1.2	3.8	0.5	0.4	0.4
HMBOX1	"FLJ21616, HNF1LA, HOT1, PBHNF"	ENSG00000147421	"Homeobox containing 1"	Q6NT76	8	28890395-29064764	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.0"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 125.7;Oligodendrocyte precursor cells: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055855, HPA058586, CAB070418"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764"	"unprognostic (2.68e-3)"	"unprognostic (2.30e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-1)"	4.6	6.7	7.6	5.1	11.9	10.8	4.2	10.6	5.7	3.7	1.7	3.8	3.1	4.4	3.0	3.2	3.7	4.2	4.5	5.3	17.9	4.3	4.2	4.6	5.3	15.0	20.0	6.1	3.3	5.0	1.8	6.8	15.6	2.9	3.9	6.2	3.1	2.5	2.8	4.4	4.3	5.2	10.4	5.7	4.3	7.6	11.6	4.9	6.2	3.7	5.9	3.8	2.4	12.9	6.2	6.8	7.1	8.2	6.5	6.7	6.0	2.6	3.5	4.0	4.3	3.1	3.9	15.1	6.3	4.5	6.0	5.3	14.4	5.3	5.6	5.5	2.4	15.6	13.8	4.2	5.3	5.4	10.2	3.3	7.5	5.3	10.1	4.9	9.1	9.0	22.7	14.4	5.7	3.8	9.9	2.7	5.0	6.6	1.6	8.1	7.1	3.4	2.8	11.5	3.0	9.2	5.1	3.9	5.4	5.9	3.9	4.8	13.0	3.6	16.8	3.9	3.8	4.4	4.8	5.9	4.6	6.5	5.4	3.2	2.4	1.1	1.9	2.6	2.7	3.4	1.9	1.8	2.5	2.6	2.4	2.4	1.4	1.2	4.7	1.9	0.8	1.4	7.6	11.9	10.6	5.7	5.3	17.9	15.0	20.0	15.6	10.4	11.6	12.9	25.5	16.0	18.1	125.7	30.3	16.7	15.8	18.1	15.9	24.4	15.3	10.5	23.6	20.0	14.0	29.5	39.6	12.9	18.7	16.2	15.6	8.3	93.0	15.0	21.2	34.2	17.4	19.6	90.1	14.4	14.1	19.2	11.2	29.4	17.1	36.7	68.6	13.7	10.3	30.3	109.8	12.9	22.4	19.8	36.4	31.5	35.8	20.1	16.0	91.8	21.4	28.3	26.8	118.1	111.8	14.1	11.3	31.6	14.4	21.0	20.4	8.8	14.3	31.6	19.7	34.6	17.3	43.6	15.2	10.1	19.7	19.2	22.8	19.5	14.7	22.6
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 170.8"	"Cell type enriched"	"Detected in many"	15	"Erythroid cells: 935.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: AB_2681206"	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	10.3	15.9	9.3	9.3	10.4	170.8	9.4	11.5	10.4	7.9	10.1	13.7	12.5	10.2	11.9	14.4	7.7	4.0	17.3	9.1	10.0	12.3	22.8	8.8	9.2	10.7	10.2	3.8	16.2	9.2	8.5	10.6	10.6	8.6	14.9	5.9	9.9	8.6	30.4	10.5	10.1	10.5	10.4	15.2	11.7	5.7	10.7	7.6	8.9	23.9	11.9	9.6	8.0	12.6	40.0	59.9	27.7	47.5	21.6	27.2	41.7	31.1	34.8	45.0	38.2	74.4	60.2	59.4	68.3	40.1	42.0	53.7	41.6	60.1	28.2	42.0	42.4	97.2	22.5	55.0	40.8	37.6	31.2	29.8	38.0	71.5	53.1	18.7	21.5	55.9	154.6	25.7	35.9	158.4	36.3	72.6	32.1	72.8	36.5	41.9	27.8	59.5	45.3	36.2	31.1	41.4	24.6	38.4	29.3	19.3	64.7	52.3	20.0	33.0	25.5	32.9	36.0	14.2	16.7	36.6	22.7	47.4	40.0	48.5	38.5	4.4	13.6	35.2	17.8	21.4	12.5	15.1	52.8	24.4	19.7	14.7	1.3	11.5	22.2	35.1	14.2	26.6	9.3	10.4	11.5	10.4	9.1	10.0	10.7	10.2	10.6	10.4	10.7	12.6	5.2	9.6	9.0	4.2	12.1	7.9	11.0	26.7	13.6	5.6	14.5	16.8	13.7	18.6	12.8	11.0	27.1	57.8	12.1	12.4	19.6	25.6	1.7	5.8	10.4	6.2	13.2	935.9	3.8	31.2	61.1	9.0	5.6	5.8	2.5	6.3	4.6	23.7	29.1	10.1	5.7	19.1	14.2	13.0	10.4	3.0	5.9	9.5	14.2	1.9	15.3	7.5	8.2	4.5	8.6	23.3	13.0	8.6	25.0	14.5	9.2	24.5	13.6	25.9	0.0	8.6	11.7	1.7	32.0	18.8	8.1	23.3	6.1	16.7	31.0	10.5
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 275.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032200, HPA065612, HPA068442"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		72000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	28.1	9.0	22.1	79.6	20.9	184.0	27.4	17.8	27.3	93.3	2.6	59.9	118.7	22.8	16.7	275.1	41.0	39.2	35.8	24.1	23.3	89.2	20.0	46.5	139.3	24.3	19.1	4.7	31.9	15.0	15.4	82.4	21.1	27.7	57.2	32.2	69.7	12.6	119.7	141.6	103.6	9.7	15.4	68.7	73.3	80.1	22.9	156.0	31.5	35.1	154.7	100.1	109.6	25.2	1418.7	547.0	274.2	192.9	124.8	916.6	1193.8	556.0	628.8	421.5	233.4	361.3	960.0	658.9	273.1	229.1	264.0	294.7	326.2	991.8	332.3	146.0	228.2	202.6	177.1	488.2	263.7	732.1	227.3	396.1	109.4	765.1	395.8	1083.8	1290.0	369.3	832.0	32.9	596.0	143.0	650.0	898.8	1340.9	697.5	950.3	947.6	6.2	728.0	286.6	128.4	477.0	202.5	59.3	278.3	533.3	430.2	112.2	775.8	1132.1	218.5	691.2	321.3	528.0	260.5	444.5	867.4	461.2	301.7	1115.0	18.7	26.6	35.5	24.4	26.8	32.2	63.5	45.0	39.0	79.6	39.5	52.0	42.9	6.7	20.1	26.5	86.6	55.8	30.7	22.1	20.9	17.8	27.3	24.1	23.3	24.3	19.1	21.1	15.4	22.9	25.2	11.0	28.9	21.7	2.3	117.8	432.3	947.5	181.3	109.8	29.0	88.8	47.4	30.8	28.6	106.1	40.5	4.2	894.3	70.3	173.5	46.9	755.3	7.2	50.5	14.6	113.9	117.0	268.3	5.4	277.5	799.8	72.0	79.5	115.3	66.7	8.3	18.2	12.3	377.2	11.8	5.7	226.4	97.6	74.0	149.9	24.5	5.6	94.3	90.7	1.0	74.3	44.1	33.0	4.5	2.7	1838.5	249.1	2.6	198.2	1483.3	174.5	15.8	21.7	41.9	0.0	18.6	77.7	40.2	417.6	224.7	361.4	822.8	66.6	0.9	364.3	1681.0
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824460-65966291	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;testis: 3.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 16.0;Early spermatids: 18.4;Glandular and luminal cells: 17.3;Granulosa cells: 29.7;Pancreatic endocrine cells: 19.9;Smooth muscle cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 324.4;hTERT-RPE1: 232.6;SuSa: 216.1"									"CAB017809, HPA039076"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB017809: , HPA039076: AB_2676335"	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.86e-4)"	0.4	0.0	0.3	0.3	0.2	4.9	0.2	0.7	0.5	1.1	0.0	2.1	1.3	0.4	0.0	0.3	1.2	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.6	0.9	0.0	0.4	0.2	0.2	0.0	2.4	0.5	0.1	0.1	1.5	0.4	1.0	0.1	0.1	0.1	1.1	3.8	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.4	47.9	21.4	324.4	45.8	15.0	82.0	0.1	148.5	68.5	26.0	25.8	28.1	19.8	0.0	92.3	7.0	120.0	20.5	54.2	129.3	123.8	0.2	56.2	0.2	0.7	169.3	8.4	4.7	0.4	62.7	8.0	55.2	98.4	232.6	105.0	0.2	0.1	0.6	149.9	0.2	0.4	27.8	190.3	4.6	89.2	12.7	16.1	0.1	68.9	0.3	0.0	0.0	0.1	0.1	85.0	216.1	0.5	0.7	120.8	89.5	26.9	71.2	45.3	0.2	0.2	0.4	112.0	0.3	21.4	1.4	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.6	0.1	0.0	0.0	0.3	0.2	0.7	0.5	0.2	0.1	0.4	0.2	0.2	0.1	0.2	0.4	0.0	0.0	1.1	5.9	0.2	0.0	3.6	16.0	2.8	0.0	0.1	0.1	1.7	0.0	3.0	0.0	0.0	0.8	0.0	5.0	0.0	2.5	18.4	10.4	0.8	0.6	0.0	7.4	0.8	0.8	0.5	2.3	3.1	17.3	0.0	29.7	0.7	0.0	9.0	0.0	0.9	5.1	4.1	0.0	0.0	9.0	0.3	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.9	19.9	4.5	0.0	0.4	5.5	4.0	0.3	7.3	0.0	0.0	1.1	33.7	13.5	0.6	0.3	0.1	0.8	0.3	0.3	8.4	1.1
HMGB1	"DKFZp686A04236, HMG1, HMG3, SBP-1"	ENSG00000189403	"High mobility group box 1"	P09429	13	30456704-30617597	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003506, CAB005873, HPA073663"	Supported		Supported	Nucleoplasm	"Secreted to blood"	NA	NA		2800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB005873: AB_444360, HPA003506: AB_1079070, HPA073663: "	"unprognostic (9.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.28e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.97e-2)"	312.0	224.3	266.2	355.1	282.2	1021.3	318.2	267.6	362.4	319.0	227.0	327.8	281.9	363.6	270.1	297.0	265.5	227.0	242.2	250.1	282.9	243.7	360.8	242.2	664.8	281.5	273.3	254.9	189.3	226.1	163.3	252.1	286.2	265.9	381.2	174.8	224.5	280.1	388.5	244.2	309.2	319.5	277.7	284.9	269.0	153.9	269.9	900.3	267.4	364.7	738.9	282.7	274.1	308.2	816.7	617.4	1402.5	1054.0	384.5	380.1	551.4	1012.6	547.9	957.3	643.5	983.6	1328.6	1639.3	515.5	924.0	880.6	886.5	1484.7	817.4	1639.6	869.6	622.4	1727.4	455.4	913.5	210.3	2513.6	1009.8	253.4	426.0	713.3	656.6	497.8	1302.2	1350.8	1167.9	571.7	855.6	1508.3	3224.3	2682.1	1184.3	1424.3	683.7	2673.3	1927.8	965.8	908.1	792.8	1264.0	1139.8	928.6	682.0	541.0	672.3	668.5	1857.9	814.7	637.2	921.8	689.7	1197.1	513.9	714.8	3508.3	261.1	1634.0	1369.3	1036.6	503.7	926.1	467.3	410.9	522.1	582.6	532.3	530.7	520.1	590.7	477.4	459.7	631.7	615.4	411.0	512.5	702.6	1072.0	266.2	282.2	267.6	362.4	250.1	282.9	281.5	273.3	286.2	277.7	269.9	308.2	948.9	458.3	496.6	188.4	920.7	791.1	986.7	942.7	752.4	414.3	471.9	630.0	172.5	561.9	561.3	603.2	131.3	998.9	759.9	408.1	766.9	941.3	113.4	611.2	1040.2	766.0	423.0	1808.9	58.5	967.2	1441.4	676.5	486.3	728.3	546.8	772.2	589.0	749.5	728.8	196.9	47.2	675.6	710.1	549.9	884.4	107.2	720.1	694.2	674.1	81.5	578.7	609.9	879.5	99.5	149.3	1212.3	554.8	666.9	1252.9	811.2	506.7	827.5	418.7	252.8	650.8	588.9	1005.9	549.1	1211.0	1045.8	691.9	465.7	797.9	515.7	839.1	867.9
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43287470-43313512	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 390.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 511.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 797.7;GAMG: 523.5;HBEC3-KT: 467.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		470000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	19.2	55.2	25.2	27.2	32.9	15.8	40.1	23.0	38.6	56.4	16.8	50.2	93.6	19.8	36.1	137.5	12.4	23.3	16.1	36.1	44.6	32.8	390.2	51.4	21.5	46.5	34.7	21.6	26.6	31.7	15.0	22.5	47.2	40.5	45.4	34.2	53.2	15.7	17.8	85.9	47.2	19.9	24.7	14.8	43.4	33.2	35.3	19.1	23.6	16.7	31.5	18.3	69.5	30.4	103.4	48.8	797.7	93.0	45.8	178.4	54.1	16.2	63.8	22.8	45.2	86.6	146.6	108.4	35.6	23.3	523.5	80.2	199.7	467.2	24.1	23.5	240.7	40.1	45.3	119.3	71.3	88.0	28.0	98.5	56.2	119.5	47.9	14.0	23.7	98.4	73.1	291.7	19.4	48.9	81.3	111.9	143.1	41.7	25.9	57.5	111.9	121.8	357.7	158.2	68.2	33.0	83.6	41.4	25.9	114.5	63.6	116.7	28.3	17.1	85.7	18.0	15.5	38.8	64.0	148.3	15.0	106.2	15.5	3.3	1.8	1.9	2.4	3.3	2.4	3.8	2.6	3.4	3.5	2.9	2.2	3.1	3.0	3.2	3.6	2.9	2.6	1.6	25.2	32.9	23.0	38.6	36.1	44.6	46.5	34.7	47.2	24.7	35.3	30.4	27.8	67.3	172.6	70.5	44.8	108.3	42.3	93.8	68.3	43.6	46.3	30.0	8.9	47.1	79.2	47.8	52.1	22.3	43.3	211.2	13.7	43.0	9.0	47.1	20.2	31.3	92.1	22.3	44.9	59.8	41.1	32.3	100.4	98.6	58.5	56.6	22.1	511.7	25.5	48.8	42.6	101.9	75.3	21.9	38.2	3.2	12.8	27.5	26.6	15.0	49.1	26.4	14.4	53.3	41.8	50.4	132.3	14.3	38.1	149.2	56.8	21.4	51.1	50.1	0.0	40.1	32.8	20.0	8.7	197.9	236.4	44.5	36.4	129.4	62.9	74.5
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119748002-119768905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 2434.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 327.2;Hepatocytes: 1118.3;Intestinal goblet cells: 226.8;Paneth cells: 177.7;Undifferentiated cells: 282.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 113.6;RT4: 201.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027423, HPA027442, CAB032906"	Enhanced		Approved	Mitochondria		NA	NA		830000		"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	1.0	0.3	0.0	7.3	0.0	0.0	222.4	0.0	0.0	0.1	5.2	366.7	165.6	1.4	0.4	4.3	0.4	4.3	36.6	0.0	0.1	64.9	2434.1	2.2	0.1	0.0	0.1	0.1	20.1	0.1	0.1	0.4	0.0	34.0	228.0	0.1	50.8	0.6	6.9	14.2	151.8	23.7	0.0	0.6	101.2	35.6	0.0	0.4	0.6	3.1	0.0	36.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	113.6	0.1	0.2	0.7	0.7	0.0	201.6	0.1	0.8	0.6	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	10.8	0.0	2.4	0.1	3.7	0.0	1.2	0.0	18.8	5.6	8.7	42.9	0.1	31.3	0.0	0.8	0.0	327.2	0.0	0.0	1.9	0.6	0.1	1.1	73.1	24.0	0.0	0.0	0.2	0.2	66.8	1.4	4.5	19.5	16.4	1118.3	0.2	0.0	0.0	226.8	0.0	26.1	0.7	3.9	1.5	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	177.7	0.0	0.0	6.3	12.4	0.9	0.0	0.0	6.6	0.0	0.1	0.4	0.5	1.9	0.3	9.4	2.2	0.1	282.3	26.5
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472440-26476642	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		640000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: AB_2686835"	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	216.3	225.6	180.2	254.5	187.3	1137.3	234.8	179.6	251.3	328.1	162.5	280.3	176.3	283.8	359.3	291.1	293.4	142.9	192.5	170.6	183.1	259.7	212.9	259.2	436.5	185.1	178.8	394.6	252.5	160.4	328.7	214.9	188.4	281.6	301.1	285.0	217.1	162.8	251.8	242.8	270.0	235.8	188.7	324.3	224.7	160.4	175.8	916.1	306.1	133.5	534.0	245.1	250.7	211.6	1074.5	304.8	1192.5	496.5	112.0	251.6	390.8	517.2	331.2	1089.4	835.7	305.8	1073.1	1107.2	443.1	482.3	338.4	627.8	1564.6	565.6	1001.7	684.2	906.7	1222.2	401.5	360.2	197.7	2793.6	738.7	254.9	303.4	602.1	369.1	245.1	541.7	866.8	964.3	643.0	623.0	690.8	1906.1	1363.3	922.7	1463.0	619.6	1384.3	1598.6	776.5	380.3	278.6	1064.5	641.1	1384.3	498.7	651.4	304.9	759.0	1508.9	322.3	536.9	920.4	977.1	943.6	641.2	899.2	1266.9	338.9	2989.0	1056.9	331.8	530.8	1430.5	279.2	622.3	267.3	532.2	379.7	343.3	531.5	505.6	412.4	337.7	462.4	355.5	690.4	704.7	746.7	1084.6	180.2	187.3	179.6	251.3	170.6	183.1	185.1	178.8	188.4	188.7	175.8	211.6	128.7	342.9	394.4	28.1	459.3	288.6	323.8	383.2	211.1	180.2	353.0	241.3	93.4	221.6	314.8	261.1	141.8	898.7	325.2	227.2	371.7	218.4	204.3	328.9	291.1	190.3	576.9	980.4	14.4	268.7	606.4	435.4	263.5	278.1	383.0	375.0	185.6	147.5	763.0	94.2	22.2	564.5	193.3	434.3	467.9	53.5	185.8	477.5	227.7	15.0	655.6	376.0	399.6	15.1	36.9	93.7	304.4	151.9	669.5	250.4	238.0	320.4	495.6	370.2	124.9	249.0	325.7	306.4	412.0	585.8	213.4	923.4	369.5	351.9	613.2	314.0
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113699-81201913	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 107.4"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.6;Karpas-707: 298.5"	"Low region specificity"	"Detected in all"							"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		41000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	13.2	24.6	31.6	6.1	31.8	34.0	14.5	28.8	60.6	12.7	27.7	16.6	23.0	17.2	65.2	14.8	17.5	11.0	10.2	29.3	32.3	27.6	23.0	8.7	5.3	35.3	32.5	20.4	12.7	20.3	29.7	4.8	32.6	15.4	16.3	7.3	13.0	19.4	9.4	12.0	21.5	10.8	32.1	12.9	13.8	107.4	32.7	30.7	17.9	8.7	6.6	12.1	11.6	33.1	1.1	9.6	26.4	130.0	22.2	6.8	5.5	7.4	11.5	2.2	3.2	3.1	49.6	209.6	22.7	3.1	2.1	8.9	158.6	19.2	4.8	123.5	62.9	87.6	97.0	1.6	2.6	147.9	83.1	5.6	4.9	8.1	7.9	7.3	10.4	132.2	118.2	298.5	13.3	4.4	135.2	51.8	117.9	29.5	34.5	5.1	110.1	98.3	32.0	3.5	1.1	3.1	0.9	2.9	9.1	22.6	16.3	34.6	12.2	4.2	33.5	20.4	28.5	20.7	9.4	33.8	12.4	57.5	7.4	1.3	3.1	1.2	7.5	1.6	6.6	3.8	4.4	4.0	5.2	6.0	8.7	7.6	1.4	3.4	2.2	10.0	1.7	2.9	31.6	31.8	28.8	60.6	29.3	32.3	35.3	32.5	32.6	32.1	32.7	33.1	18.1	9.6	16.4	19.9	9.0	15.9	27.6	12.8	17.6	3.5	18.9	17.5	11.1	27.1	16.2	46.0	0.0	0.6	6.4	22.7	68.4	12.8	24.5	44.0	11.0	18.1	17.4	64.8	11.6	18.7	0.4	15.4	16.8	31.1	13.3	39.4	22.1	87.2	15.7	1.7	16.5	34.2	28.5	11.3	10.8	79.7	29.5	10.2	8.8	13.1	2.9	25.8	7.2	25.6	8.5	7.1	19.6	41.0	9.6	15.0	27.4	113.6	55.9	1.7	46.0	13.3	19.6	18.9	8.7	32.8	14.9	0.4	8.3	31.0	45.0	24.4
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491941	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.6;lymphoid tissue: 27.3;testis: 27.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.2;Erythroid cells: 133.3;Extravillous trophoblasts: 55.1;Late spermatids: 60.9;Spermatocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (5.52e-4)"	"prognostic unfavorable (1.93e-7)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	0.8	0.7	0.2	10.1	0.3	20.6	2.1	0.3	0.4	1.1	0.1	6.6	7.4	0.8	0.2	4.0	0.5	0.9	0.8	0.2	0.2	0.7	1.7	0.9	18.1	0.5	0.3	0.2	0.3	0.9	0.2	6.2	0.4	0.5	8.8	0.8	0.8	0.2	1.2	4.2	6.5	2.9	0.3	2.9	3.6	27.5	0.7	27.3	0.7	0.4	17.7	2.2	1.4	0.5	77.0	47.2	94.5	50.8	5.0	9.0	70.3	71.4	34.9	88.0	78.9	96.8	145.1	127.5	66.0	22.2	118.5	86.3	112.4	69.0	148.6	116.1	34.4	76.7	32.3	48.4	1.4	68.7	67.3	2.4	4.1	82.8	64.0	14.7	50.6	85.7	73.2	101.0	93.2	28.5	72.3	38.8	81.9	51.2	51.6	78.0	126.3	63.9	34.8	20.4	78.8	43.8	106.3	32.8	38.6	45.1	97.3	54.5	32.9	63.2	52.4	50.6	97.2	53.7	96.3	102.4	41.4	104.2	61.1	0.2	0.2	0.0	0.1	0.1	0.3	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.6	1.5	0.2	0.2	0.3	0.3	0.4	0.2	0.2	0.5	0.3	0.4	0.3	0.7	0.5	0.4	0.0	1.1	1.3	6.0	2.5	1.8	4.5	2.8	0.6	3.2	3.7	2.5	4.3	3.2	0.0	0.0	37.3	2.3	5.3	0.0	0.8	86.2	3.8	3.1	3.1	1.2	133.3	0.6	0.2	55.1	4.6	11.7	5.7	0.0	21.6	5.3	3.8	22.2	0.0	0.4	7.8	6.1	8.8	2.7	60.9	2.1	7.6	0.0	0.0	2.3	0.1	1.0	0.5	1.2	0.2	0.3	0.7	22.9	1.5	1.3	2.6	2.8	1.0	6.6	0.6	3.8	100.9	23.3	14.1	1.4	4.5	5.2	1.6	15.6	3.0
HMOX2	HO-2	ENSG00000103415	"Heme oxygenase 2"	P30519	16	4474690-4510347	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 515.3;Late spermatids: 2001.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025464, HPA040611"	Supported		Approved	Vesicles,Cytosol		NA	NA		12000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 43: Testis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"CAB025464: , HPA040611: AB_10961034"	"unprognostic (3.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (2.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (9.87e-2)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.51e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.64e-1)"	63.0	51.3	43.7	23.2	51.9	18.3	55.7	56.9	55.2	47.1	36.2	41.0	34.8	35.8	22.5	84.5	35.9	26.9	149.9	47.7	50.0	71.2	109.5	46.6	33.2	55.8	49.2	25.6	39.7	38.6	43.8	17.9	57.1	34.5	25.1	22.5	44.1	14.1	37.9	44.4	42.6	22.7	44.7	67.8	100.2	152.2	54.3	24.3	41.9	32.3	36.3	33.2	49.0	53.5	82.9	38.2	20.5	45.6	65.8	31.5	33.8	53.9	26.5	48.3	43.7	48.3	55.5	36.9	64.0	55.7	34.6	51.5	75.4	126.9	48.4	51.5	48.4	27.5	35.2	63.3	43.7	56.8	44.4	48.7	41.7	55.7	37.6	37.9	83.7	46.9	44.7	18.1	44.5	114.3	48.7	58.4	34.2	81.1	35.7	54.3	33.7	84.4	72.3	51.8	34.4	19.4	43.1	95.1	66.4	33.9	58.2	36.3	91.7	25.7	39.9	120.3	30.1	24.3	30.0	78.0	16.5	52.5	35.2	87.6	37.1	252.6	166.3	46.5	142.1	69.8	153.8	168.5	73.6	66.8	145.5	151.6	125.1	99.0	35.7	39.2	155.4	142.3	43.7	51.9	56.9	55.2	47.7	50.0	55.8	49.2	57.1	44.7	54.3	53.5	33.8	35.3	41.5	7.8	37.2	54.8	35.7	73.5	19.4	29.3	26.4	29.1	70.6	32.9	54.5	36.8	20.9	75.3	59.8	70.7	129.1	79.7	515.3	38.6	30.9	53.4	31.8	14.3	23.0	90.7	69.6	39.4	89.7	53.3	19.7	38.8	75.0	93.0	67.2	28.6	21.6	37.6	85.5	23.9	52.9	2001.6	45.4	30.6	62.2	5.6	29.3	53.9	141.1	9.5	32.9	114.9	70.7	56.1	47.1	37.7	110.8	239.3	39.9	27.8	72.3	14.6	58.0	199.7	149.8	28.2	51.6	38.4	88.3	47.4	48.9	28.7
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135970-123139423	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 6.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.1;HEL: 6.1;HeLa: 7.0;K-562: 17.9;NB-4: 13.4;SiHa: 7.0;THP-1: 5.7"	"Region enriched"	"Detected in single"	4	"hypothalamus: 1.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 1.4;hypothalamus: 4.8"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Centriolar satellite"	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				0.9	0.1	0.4	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.1	0.0	0.0	0.1	1.3	6.9	0.0	0.1	0.0	0.2	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	8.1	0.0	0.0	0.7	0.4	6.1	7.0	0.2	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	17.9	0.1	0.0	0.0	0.0	13.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	7.0	0.0	0.1	0.0	0.0	5.7	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.6	0.3	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.3	0.9	0.4	0.2	0.4	0.2	0.1	0.4	0.1	0.3	0.1	0.1	6.5	1.3	6.9	2.4	0.1	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.4;kidney: 43.3;liver: 117.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2;liver cancer: 38.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.1	0.1	5.9	0.2	0.1	0.1	0.2	0.2	0.0	8.4	58.6	102.4	0.1	0.0	0.1	1.0	5.9	0.0	0.4	0.0	43.3	117.1	0.1	0.1	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	44.1	0.1	0.0	0.1	0.2	0.0	82.6	1.8	0.0	0.0	22.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.4	6.0	0.1	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	114.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	42.2	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	35.8	0.0	12.9	0.0	0.0	0.0	232.6	15.6	7.8	4.0	2.5	0.1	0.4	35.9	2.7	0.5	22.1	0.0	0.1	38.2	0.1	4.5	0.0	3.6	186.8	0.0	0.0	0.3	69.8	0.0	5.3	0.0	18.7	0.3	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	21.0	120.0	0.4	0.1	0.3	153.9	170.1	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.8	136.1	0.2
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566834	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 114.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.0	0.2	2.5	0.5	0.0	1.0	0.2	0.3	2.3	0.1	20.6	100.5	0.4	1.2	0.3	1.0	12.1	0.0	0.3	0.3	17.4	12.9	0.2	0.1	0.4	0.5	0.0	5.6	0.0	0.0	0.1	0.3	0.6	19.6	0.0	0.4	0.4	0.0	0.0	114.6	0.9	0.4	0.1	8.1	3.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.1	4.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.1	0.0	2.2	0.0	1.8	0.0	2.0	0.0	0.0	0.0	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	10.0	4.8	0.0	0.0	0.3	2.7	0.1	0.3	1.6	0.3	0.1	0.0	0.2	0.2	5.5	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.3	0.3	0.3	0.4	0.5	0.3	0.4	0.3	0.3	0.0	0.0	1.1	39.8	0.5	0.0	0.6	0.4	2.2	0.0	1.3	0.5	0.2	17.2	1.5	3.7	0.0	0.0	0.0	51.0	5.9	3.2	3.1	3.6	0.2	0.0	16.3	0.0	0.5	4.3	0.0	0.1	8.2	3.2	0.0	0.0	0.0	10.7	0.0	0.0	0.6	32.3	2.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.6	5.6	54.3	0.0	0.0	1.6	165.3	18.5	8.1	0.0	0.0	0.1	0.4	4.8	0.0	0.4	0.0	0.0	0.2	0.0	36.9	2.9
HNRNPA0	HNRPA0	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754363	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm		No	No		150000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: AB_2684004"	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	21.9	23.8	11.1	14.5	10.9	32.1	19.2	14.8	12.1	22.3	8.3	19.0	13.7	28.5	10.7	20.1	23.2	10.2	18.1	10.8	13.4	14.8	14.8	19.1	15.7	10.9	10.4	30.3	17.5	12.3	15.5	15.6	10.9	15.2	10.7	10.9	14.5	11.9	18.1	19.8	19.1	16.1	10.2	18.0	19.4	12.9	12.6	28.7	17.6	12.8	14.6	19.1	19.1	11.8	36.9	36.2	68.6	69.7	33.1	20.9	70.3	27.6	22.7	24.2	27.8	67.8	28.3	66.3	38.9	23.7	26.6	33.1	37.4	42.8	29.4	33.6	52.1	42.9	22.5	41.6	30.4	39.8	43.9	34.0	29.6	19.2	22.0	26.6	34.0	59.0	35.7	43.2	24.7	47.8	75.0	53.2	53.7	17.3	26.1	88.6	50.0	33.8	24.2	41.7	86.6	70.5	35.6	24.5	49.1	74.8	31.1	45.6	33.4	38.6	32.8	21.6	53.3	43.4	37.6	46.8	25.0	45.4	38.9	2.7	1.4	4.6	2.9	2.1	3.4	2.1	2.8	3.0	2.3	2.5	3.0	3.2	1.3	4.4	2.5	3.2	1.7	1.1	11.1	10.9	14.8	12.1	10.8	13.4	10.9	10.4	10.9	10.2	12.6	11.8	151.5	86.6	53.6	7.2	251.2	550.9	436.4	290.2	390.9	85.1	197.5	136.1	36.1	155.8	138.6	101.2	37.5	347.9	234.6	88.8	172.1	257.5	25.5	108.6	172.1	204.4	236.4	179.6	11.3	146.5	478.1	237.2	141.7	126.8	95.8	162.4	192.1	77.0	191.7	84.1	11.5	181.2	229.9	142.3	416.4	44.9	157.8	142.4	281.1	11.2	228.6	137.1	213.1	15.6	16.8	201.6	157.2	150.8	138.9	313.1	147.3	146.9	65.3	62.9	85.5	271.8	221.9	144.0	72.8	247.6	484.3	365.7	267.5	155.8	242.0	401.0
HNRNPH1	"hnRNPH, HNRPH1"	ENSG00000169045	"Heterogeneous nuclear ribonucleoprotein H1"	P31943	5	179614178-179634784	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, HPA016884, CAB032820"	Supported		Enhanced	Nucleoplasm		NA	NA		2800000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (9.01e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.85e-4)"	"prognostic unfavorable (3.29e-7)"	"unprognostic (7.99e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.72e-3)"	115.8	108.5	83.6	103.2	88.9	242.9	90.4	100.4	99.6	134.4	95.6	109.5	73.3	120.3	67.9	112.7	109.5	71.4	93.0	84.6	88.2	159.3	137.1	102.5	175.0	86.2	86.0	148.4	123.5	99.2	95.5	91.3	86.1	117.5	79.2	162.9	92.5	84.1	142.1	110.5	137.4	102.9	82.8	209.3	105.0	121.2	88.1	210.8	130.8	84.3	166.6	115.6	112.0	88.6	425.0	432.1	496.0	291.0	155.8	135.0	391.5	227.3	188.7	472.0	271.1	519.4	222.0	618.0	205.4	235.2	297.1	227.0	517.8	345.3	552.9	582.8	322.2	335.5	497.3	528.4	196.1	426.0	295.5	104.7	249.1	379.8	230.0	182.6	247.1	293.8	494.4	281.7	279.8	338.5	724.8	371.1	534.9	249.0	226.8	660.7	507.2	368.3	180.4	485.0	431.5	364.3	410.7	232.7	421.8	344.6	275.7	567.1	250.5	415.3	304.2	184.8	556.0	252.0	674.2	723.6	213.0	405.1	501.6	55.7	44.8	46.5	61.4	73.2	82.6	63.4	65.8	66.4	67.9	52.1	81.5	86.8	9.1	62.9	57.6	87.3	83.1	38.9	83.6	88.9	100.4	99.6	84.6	88.2	86.2	86.0	86.1	82.8	88.1	88.6	374.3	115.4	238.0	80.6	263.0	775.3	182.3	89.2	202.1	118.0	332.7	242.1	136.4	165.8	125.5	156.3	131.3	158.3	419.8	183.0	78.2	97.1	151.3	178.7	246.3	237.8	255.2	189.8	81.8	124.1	181.8	241.7	128.0	258.9	247.3	178.6	189.5	225.3	108.2	70.7	85.8	213.7	81.4	186.2	621.4	86.6	111.6	224.0	334.4	104.9	148.3	93.4	110.2	148.8	121.8	105.2	153.0	117.4	269.3	200.4	142.7	75.4	95.9	166.0	184.1	306.3	253.2	189.1	120.6	181.0	718.0	192.5	311.9	87.4	266.4	191.5
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408222-101414133	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 302.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	60.1	70.3	53.5	63.0	57.7	78.0	72.3	53.6	69.6	59.2	58.4	57.2	60.1	61.6	66.1	55.5	55.2	48.7	59.1	57.4	56.8	79.0	77.7	57.4	58.3	56.1	55.5	53.0	42.7	124.0	52.8	71.8	55.6	63.1	60.9	79.4	45.6	72.7	90.4	63.8	59.7	68.7	55.7	59.5	49.0	25.6	55.0	73.0	63.1	77.8	73.2	71.9	47.2	59.8	105.0	72.1	137.8	83.2	119.4	104.0	66.0	87.3	123.5	82.0	166.6	62.1	91.9	107.9	86.6	125.5	112.3	93.8	160.6	122.5	111.9	104.9	78.0	80.1	173.7	84.8	102.2	100.4	74.7	106.1	111.0	80.8	79.3	98.5	113.5	58.1	82.9	150.6	126.8	136.9	83.3	88.7	86.6	171.7	69.7	76.9	146.2	105.1	177.8	140.7	63.1	114.6	130.0	61.3	104.5	97.3	78.9	94.7	122.0	45.0	81.4	129.7	36.2	49.8	76.9	75.0	93.2	114.6	57.5	138.8	104.6	165.1	59.2	112.3	62.9	56.7	56.6	59.3	99.4	54.5	58.7	61.3	247.6	79.5	114.5	41.9	57.4	92.2	53.5	57.7	53.6	69.6	57.4	56.8	56.1	55.5	55.6	55.7	55.0	59.8	46.3	28.9	61.2	0.0	47.7	70.9	94.1	119.0	21.1	40.5	42.6	24.9	48.1	45.8	88.5	90.1	12.5	137.7	37.5	52.0	99.7	99.1	3.2	41.4	35.6	56.1	60.6	41.0	0.0	73.4	65.0	49.0	28.1	44.6	82.4	26.2	52.1	85.3	84.3	16.8	0.0	45.7	83.4	75.4	75.8	6.1	55.3	66.0	69.4	0.0	97.8	44.1	55.6	0.0	0.0	64.5	65.8	59.0	24.6	45.3	58.4	146.2	75.0	34.1	78.9	57.2	64.6	17.6	33.1	28.2	72.0	302.5	42.0	44.3	46.0	64.5
HNRNPLL	HNRPLL	ENSG00000143889	"Heterogeneous nuclear ribonucleoprotein L like"	Q8WVV9	2	38561969-38603586	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 155.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046084	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA046084: AB_10960895"	"unprognostic (2.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-2)"	16.0	16.4	16.3	12.5	20.7	51.7	14.7	19.3	21.3	16.2	12.9	16.1	15.5	18.2	13.9	10.2	16.7	14.1	12.8	28.6	8.3	11.1	10.8	16.4	12.5	5.9	8.1	16.9	15.9	16.8	9.2	13.1	7.2	13.9	11.8	26.6	12.8	15.0	13.8	11.4	12.7	12.8	7.8	12.0	15.7	22.6	9.3	31.0	17.7	11.9	9.6	15.2	12.8	15.8	36.7	16.9	48.2	28.4	22.9	21.6	30.1	33.8	27.5	28.8	24.1	19.0	20.7	0.5	29.5	30.4	30.9	23.0	30.7	25.4	29.6	54.6	26.8	26.7	32.3	48.6	21.6	49.9	26.4	16.9	19.6	24.0	26.5	28.5	30.6	23.9	45.9	79.7	34.3	17.2	54.9	27.2	48.4	35.2	30.6	10.6	33.9	18.1	25.0	47.2	32.9	36.9	29.8	25.8	26.0	26.7	21.8	21.6	32.0	21.5	32.1	23.8	28.1	43.4	46.9	0.3	18.5	12.2	26.8	10.6	6.3	9.7	10.3	3.2	17.9	0.4	24.2	18.9	12.0	1.9	7.2	4.6	4.2	6.8	1.2	0.2	38.5	5.8	16.3	20.7	19.3	21.3	28.6	8.3	5.9	8.1	7.2	7.8	9.3	15.8	17.0	19.2	23.4	26.8	5.5	28.7	35.2	16.5	33.0	13.3	18.0	15.2	18.8	8.6	18.8	27.6	8.4	26.2	6.4	13.9	19.6	22.4	155.6	18.1	18.8	20.1	14.4	22.5	68.6	24.3	28.9	26.0	32.1	11.6	9.5	26.3	22.5	7.4	24.4	6.7	40.1	15.4	6.1	15.0	90.2	48.7	27.7	23.1	39.2	37.5	24.5	22.3	2.1	48.7	28.4	21.2	14.2	52.3	23.0	23.6	16.6	18.6	14.5	11.7	39.5	22.6	28.4	91.1	28.8	19.4	21.3	22.2	48.0	22.3	18.8	21.4
HOMER1	"HOMER-1B, SYN47, Ves-1"	ENSG00000152413	"Homer scaffold protein 1"	Q86YM7	5	79372636-79514134	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;skeletal muscle: 34.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 440.0;Inhibitory neurons: 112.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004437, HPA036521, HPA036522"	Enhanced	Supported	Approved	Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171"	"unprognostic (2.80e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.83e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.86e-3)"	2.8	1.3	2.1	2.3	14.0	0.3	2.5	10.6	27.6	3.9	0.0	1.2	0.7	6.7	4.1	4.6	1.7	6.8	20.5	17.9	5.6	5.8	1.7	5.1	1.1	0.0	3.3	3.8	2.2	4.1	2.3	5.4	2.2	1.7	1.0	5.8	1.2	1.7	34.0	2.4	0.8	4.7	0.6	0.8	2.0	5.3	7.4	1.3	15.0	12.9	1.4	8.0	1.7	15.1	14.6	9.8	14.5	23.1	5.4	3.6	33.5	9.0	7.2	9.0	9.6	15.5	9.9	0.2	26.9	7.8	16.2	7.7	18.2	24.5	15.4	2.2	14.3	17.3	3.9	15.7	8.8	8.3	5.4	5.8	15.4	8.1	22.4	3.6	4.3	26.4	21.7	9.3	11.7	20.4	34.8	5.7	24.5	5.2	8.4	22.4	23.8	22.2	9.6	22.3	14.7	8.8	17.2	12.0	9.3	16.0	16.5	7.2	0.7	6.6	16.7	8.0	16.1	4.5	10.8	8.5	18.8	3.3	13.0	0.0	0.0	0.0	0.4	0.0	0.2	0.4	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	2.1	14.0	10.6	27.6	17.9	5.6	0.0	3.3	2.2	0.6	7.4	15.1	4.3	51.3	9.6	21.9	12.1	64.2	28.0	8.5	20.5	24.4	25.6	18.2	95.2	7.2	12.1	16.5	27.1	58.4	20.3	4.3	11.7	4.8	4.7	30.6	24.9	9.5	11.4	0.4	440.0	4.3	44.8	19.3	5.6	39.9	5.7	16.9	4.6	6.9	11.9	52.2	112.1	7.5	10.2	9.6	29.7	5.5	5.6	13.9	21.4	31.9	3.0	4.4	8.2	86.0	19.3	5.5	2.7	8.6	8.9	23.3	3.1	7.0	10.8	8.1	13.1	29.7	19.3	6.9	10.3	23.9	54.8	84.4	9.8	10.2	3.0	25.2
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720895	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 117.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 727.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 5.6;HeLa: 4.9;hTCEpi: 19.4;SiHa: 6.1;SuSa: 6.5;THP-1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.2	0.0	0.1	0.5	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.4	0.1	0.4	0.0	0.0	6.8	0.2	0.1	0.0	0.9	0.1	117.8	0.2	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.1	0.0	0.1	4.9	0.0	0.0	0.1	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.1	6.5	0.0	11.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	5.4	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.4	0.0	0.3	0.0	0.1	88.3	0.5	0.1	0.5	0.0	0.0	2.7	0.0	2.1	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.8	0.0	2.0	0.0	0.0	1.3	0.9	35.1	5.3	0.8	0.0	1.0	1.5	0.0	0.0	1.0	0.1	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.5	0.0	32.9	0.0	0.4	727.7	163.5	0.0	9.2	2.2	0.0	0.3	0.2	0.1
HORMAD2	"CT46.2, MGC26710"	ENSG00000176635	"HORMA domain containing 2"	Q8N7B1	22	30080464-30177075	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 22.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 52.8;Spermatocytes: 133.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003074, HPA043880"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA003074: AB_1850916, HPA043880: "					"unprognostic (1.43e-1)"		"unprognostic (6.77e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.36e-2)"			"unprognostic (8.19e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"		0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.9	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.2	0.0	133.0	12.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181157-27185232	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 44.8;endometrium 1: 96.7;smooth muscle: 41.2"	"Cell type enriched"	"Detected in some"	19	"Endometrial stromal cells: 116.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.5;HEK 293: 44.0;THP-1: 34.7;U-937: 43.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"spinal cord: 3.5"	"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	3.5	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	44.8	0.0	23.1	0.0	96.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	10.0	0.0	14.7	3.9	0.0	0.1	9.6	7.9	1.5	0.2	41.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	17.0	10.4	0.0	4.8	0.3	0.0	13.1	15.2	11.1	0.0	26.8	32.5	18.9	13.8	0.3	1.7	0.0	6.1	23.5	0.1	3.2	16.3	0.0	14.7	1.6	44.0	5.7	11.2	0.7	0.9	12.5	1.7	6.5	0.6	0.1	0.0	0.0	14.1	1.1	0.4	0.0	2.2	0.4	0.0	9.4	0.0	4.4	13.1	0.7	0.0	0.3	9.6	8.1	5.6	0.0	6.7	0.0	2.0	3.6	1.2	34.7	0.0	0.2	12.9	3.2	1.5	0.0	0.0	0.0	0.2	43.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.3	1.1	5.9	0.0	0.8	4.0	116.8	1.3	5.3	0.0	0.0	0.0	0.1	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.8	0.2	0.2	0.0	0.0	0.0	0.9	5.8	1.2	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.3
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200091	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 23.1;placenta: 17.1;prostate: 22.3;seminal vesicle: 23.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 41.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 26.9;HEK 293: 37.3;PC-3: 18.4;RT4: 42.1;THP-1: 18.2;U-937: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		Yes	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.1	0.0	9.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	22.3	11.9	0.0	0.0	23.3	2.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	14.1	0.0	2.2	1.6	0.0	2.5	0.2	0.0	0.1	13.2	14.4	5.1	3.3	2.8	0.2	0.0	1.6	6.2	0.7	0.0	26.9	0.0	4.3	0.0	37.3	1.9	6.9	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	8.7	0.0	11.8	18.4	2.7	0.6	0.0	0.1	42.1	0.7	0.0	3.3	0.0	0.3	2.0	0.0	18.2	0.0	0.5	4.5	0.3	0.1	0.0	0.0	0.0	0.0	20.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.6	0.1	4.0	1.1	8.4	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.5	0.0	0.0	0.1	0.1	0.1	0.0	10.3	3.1
HOXA2	HOX1K	ENSG00000105996	"Homeobox A2"	O43364	7	27100354-27102686	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 3.8;Enteroendocrine cells: 4.8;Hepatic stellate cells: 6.4;Squamous epithelial cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"medulla oblongata: 4.5;pons: 3.3;spinal cord: 4.7;white matter: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 14.5;HaCaT: 6.2;RPTEC TERT1: 4.9"	"Region enriched"	"Detected in single"	36	"pons and medulla: 5.8"	"Group enriched"	"Detected in some"	17	"medulla oblongata: 4.2;pons: 1.1;spinal cord: 3.0"	HPA078220			Approved	Nucleoplasm,Vesicles		Yes	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA078220: AB_2686880"	"unprognostic (7.30e-2)"	"unprognostic (4.90e-4)"	"unprognostic (2.81e-1)"	"unprognostic (7.43e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.98e-9)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-2)"	1.9	1.0	0.0	0.6	0.0	0.0	1.6	0.0	0.0	1.6	0.0	3.3	0.9	2.0	5.1	2.3	4.1	1.0	0.2	0.0	0.0	4.4	0.2	1.7	0.2	4.5	0.2	0.6	0.3	5.7	0.0	0.0	3.3	1.7	1.8	0.0	0.0	2.1	0.7	1.6	2.6	0.9	4.7	1.2	2.2	0.1	0.1	1.8	0.8	3.0	0.6	2.0	0.9	4.3	1.1	0.6	4.0	14.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	3.4	0.1	1.5	0.1	1.8	6.2	0.2	0.0	0.0	0.0	2.0	0.0	0.1	0.2	1.8	0.1	0.3	0.8	0.0	3.1	3.1	0.0	2.5	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.9	1.0	0.7	0.0	4.9	0.5	0.9	0.0	0.2	0.0	0.9	0.2	0.0	0.0	2.5	0.0	0.2	1.1	0.5	0.0	0.0	0.1	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	3.3	4.7	0.1	4.3	1.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	23.3	0.0	1.2	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.1	1.3	2.5	4.8	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	6.4	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	1.1	0.5	0.0	0.0	0.0	1.0	1.9	0.0	0.0	6.3	0.3	0.0	0.1	0.0	1.7	0.7
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162438-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Endometrial stromal cells: 31.1;Enteroendocrine cells: 39.4;Proximal tubular cells: 75.1;Suprabasal keratinocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 6.7;myeloid DC: 5.6;NK-cell: 11.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.6;granulocytes: 6.7;NK-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 124.4;PC-3: 43.9;RPTEC TERT1: 42.0;SCLC-21H: 113.4;U-937: 42.3"	"Not detected"	"Not detected"							"HPA061982, HPA076200"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA061982: AB_2684651, HPA076200: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	4.7	5.9	0.0	2.8	0.0	2.5	6.9	0.0	0.2	12.7	0.0	22.0	0.0	17.0	5.6	1.0	19.6	0.0	0.0	0.0	0.0	28.4	0.0	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.1	14.1	3.9	0.0	0.0	4.5	16.1	25.7	14.8	1.9	0.2	0.9	0.2	0.0	0.0	1.9	0.1	0.0	0.0	16.8	13.8	0.2	37.7	0.0	0.0	18.4	6.0	4.4	0.0	14.6	11.7	1.2	1.2	2.4	1.4	0.3	1.4	7.9	0.0	34.7	23.5	0.0	1.2	0.0	124.4	0.3	1.1	0.0	0.6	0.0	0.5	6.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	43.9	8.1	0.0	0.0	42.0	0.7	113.4	0.0	15.6	0.0	0.3	0.6	0.0	31.3	1.4	0.0	11.4	14.0	0.2	0.0	0.0	0.0	0.0	42.3	0.0	6.7	0.8	0.0	1.3	0.2	0.2	0.1	0.0	0.1	5.6	0.9	0.2	0.0	0.8	11.5	0.3	1.8	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	6.2	0.0	0.0	0.0	2.0	25.1	14.9	0.0	3.4	0.0	12.2	14.7	0.5	0.0	0.0	18.4	0.0	0.2	2.9	10.5	54.8	0.0	0.0	1.0	31.1	4.3	39.4	16.6	0.0	0.0	0.3	4.8	0.0	0.6	0.0	0.0	0.7	0.0	0.3	0.0	0.0	21.7	0.0	3.4	4.2	0.0	0.0	1.9	5.4	0.0	0.8	0.0	2.1	0.0	0.0	0.0	20.2	0.0	0.9	19.4	13.3	75.1	0.0	0.0	0.0	3.0	4.6	0.0	1.0	2.6	27.6	0.3	2.2	0.3	21.4	14.2
HOXB13		ENSG00000159184	"Homeobox B13"	Q92826	17	48724763-48728750	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 41.1;prostate: 82.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 144.7;Enteroendocrine cells: 195.2;Intestinal goblet cells: 77.0;Paneth cells: 71.3;Prostatic glandular cells: 61.9;Undifferentiated cells: 81.6"	"Cancer enriched"	"Detected in many"	17	"prostate cancer: 187.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	13	"PC-3: 173.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004438, HPA062852, HPA065019"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.73e-11)"	"unprognostic (1.39e-2)"	"unprognostic (4.50e-2)"		"unprognostic (1.12e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	82.3	41.1	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	4.6	0.0	1.9	6.0	0.0	13.2	0.0	0.0	0.5	0.6	0.0	0.2	0.0	2.5	3.0	0.0	3.0	0.0	1.4	0.0	8.7	0.0	0.1	1.0	4.2	2.5	1.5	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.7	0.0	0.0	0.3	0.0	2.2	173.0	0.0	1.4	0.1	0.0	0.4	0.0	0.0	2.7	0.0	4.4	0.5	0.0	0.5	0.0	0.5	4.7	4.7	1.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	144.7	0.0	0.0	0.6	0.0	0.0	0.2	195.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	77.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.3	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.1	0.2	0.1	81.6	14.6
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621156-48626358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 87.9;intestine: 26.3;kidney: 22.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal enterocytes: 30.4;Distal tubular cells: 39.2;Enteroendocrine cells: 176.7;Intestinal goblet cells: 40.7;Undifferentiated cells: 45.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 56.0;endometrial cancer: 26.4"	"Region enhanced"	"Detected in single"		"spinal cord: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 339.3;HEK 293: 126.4;HMC-1: 127.7;K-562: 145.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	69	"spinal cord: 6.8"	HPA004928			Supported	Nucleoplasm		NA	No				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA004928: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	1.0	0.0	4.6	0.0	0.0	0.5	0.0	0.0	11.4	0.0	26.3	0.0	0.9	87.9	0.0	0.3	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.6	0.0	0.4	22.3	0.0	0.0	15.8	0.1	0.1	13.4	1.3	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.7	18.0	5.8	0.0	32.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.6	7.0	0.1	34.6	0.9	3.9	0.1	5.5	0.0	0.0	339.3	126.4	59.1	2.3	0.0	2.3	1.1	127.7	0.1	0.2	0.1	3.3	9.8	0.0	2.7	145.7	0.1	5.5	0.3	0.0	0.4	0.0	8.0	5.4	0.3	21.9	1.9	57.1	0.2	0.0	0.0	4.4	0.0	37.4	0.5	0.6	0.3	0.4	0.1	32.1	0.2	10.4	0.2	0.4	0.2	0.1	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.7	3.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	58.8	0.0	0.0	0.5	30.4	39.2	0.0	0.1	5.5	0.4	3.0	176.7	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	0.0	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.3	0.0	0.0	0.3	6.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.0	0.4	0.0	45.5	0.2
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.1;ovary: 26.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 17.6;Fibroblasts: 14.0;Granulosa cells: 13.2;Leydig cells: 22.4;Peritubular cells: 15.1;Skeletal myocytes: 13.5;Spermatocytes: 34.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"medulla oblongata: 4.1;pons: 4.3;spinal cord: 3.1;white matter: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 94.4;fHDF/TERT166: 47.9;HDLM-2: 80.6"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	32	"spinal cord: 9.7"	HPA054981			Supported	Nucleoplasm,Cytosol		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	18.9	14.8	0.0	1.1	0.0	0.0	13.4	0.0	0.1	1.1	0.0	1.0	0.3	5.3	19.3	2.9	27.1	0.1	0.6	0.0	0.1	17.8	0.0	0.7	4.3	4.1	0.2	26.2	0.4	0.3	0.0	5.7	4.3	1.3	0.2	0.5	0.2	0.5	17.3	13.3	11.4	8.8	3.1	0.2	0.7	3.5	0.1	0.1	1.0	0.0	0.0	1.3	1.5	1.5	6.6	4.5	0.0	94.4	34.1	32.0	1.0	4.9	4.7	7.9	7.1	4.1	7.4	3.0	6.3	47.9	2.3	10.7	3.8	0.5	6.7	80.6	27.3	5.2	14.6	0.0	3.8	0.5	12.0	30.7	5.0	15.7	5.6	0.0	0.3	0.3	3.5	0.0	27.4	1.5	0.0	3.3	0.0	0.8	4.1	0.0	3.6	0.0	24.1	0.2	0.0	11.8	7.3	7.0	21.7	8.2	16.6	1.3	0.0	9.7	21.1	10.7	7.0	0.7	0.9	0.2	3.7	0.8	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	0.2	4.3	3.1	0.1	1.5	3.9	0.0	0.0	0.0	0.3	6.2	0.0	0.0	9.1	0.0	3.2	5.8	0.6	0.0	0.0	3.7	0.0	0.4	0.2	0.0	17.6	0.0	1.6	0.0	0.6	1.1	0.0	0.0	0.0	0.0	3.0	14.0	0.0	0.0	0.0	13.2	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	1.8	1.0	22.4	0.4	12.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.8	9.6	0.0	2.1	6.6	13.5	11.8	34.0	2.7	5.1	4.0	0.3	0.4	7.4	0.2	0.0
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119937	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.6;endometrium 1: 35.9;vagina: 25.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.0;Collecting duct cells: 14.7;Distal enterocytes: 10.6;Distal tubular cells: 15.6;Endometrial stromal cells: 25.3;Endothelial cells: 13.5;Enteroendocrine cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HEK 293: 40.3;RPTEC TERT1: 32.3;SCLC-21H: 11.8;SiHa: 18.4;U-251 MG: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	66	"spinal cord: 6.6"	HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		No	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA065871: AB_2685573"	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	2.0	0.1	0.0	0.5	0.0	0.0	2.6	0.0	0.0	20.6	0.0	18.7	0.0	35.9	0.5	0.5	4.1	0.1	0.0	0.0	0.0	19.9	0.0	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	16.8	5.8	0.0	0.1	6.7	0.1	1.5	0.1	18.1	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.2	2.2	25.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.2	6.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.1	12.0	0.0	0.0	0.5	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.9	0.0	32.3	0.0	11.8	3.1	18.4	0.0	0.1	2.2	0.0	0.0	2.7	0.0	2.1	1.0	14.4	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.0	0.0	0.0	0.0	0.0	0.9	6.2	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	14.7	0.0	0.0	0.1	10.6	15.6	0.0	0.0	1.2	25.3	13.5	24.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.8	0.2	1.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	1.1	0.0	0.2	0.0	4.4	2.9
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326895-45328679	"Human disease related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Gastric mucus-secreting cells: 8.2;Undifferentiated cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 111.7;HL-60: 34.2;NB-4: 42.8;SK-BR-3: 72.5"	"Low region specificity"	"Detected in many"							"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.4	0.2	1.0	1.3	1.3	1.8	0.4	3.1	1.0	1.2	0.0	3.7	2.4	0.6	0.0	2.2	0.6	0.0	0.3	0.9	0.9	0.6	0.1	0.3	1.0	1.3	1.2	0.6	0.3	0.0	0.3	2.1	1.3	0.6	2.8	0.4	1.0	0.2	1.6	0.8	2.5	0.3	0.8	1.8	3.4	0.3	1.3	1.2	0.6	0.6	0.9	0.5	1.1	1.3	0.1	1.1	0.5	0.1	0.1	0.4	111.7	1.5	0.0	2.0	0.4	28.7	7.7	5.8	0.3	1.5	0.0	7.0	0.0	0.4	0.7	0.2	0.3	0.6	13.4	0.0	0.7	34.2	0.9	1.1	0.2	1.2	0.0	0.1	2.2	0.2	0.0	5.2	0.2	14.6	22.1	42.8	0.5	23.0	0.0	6.6	0.1	19.4	0.4	0.4	22.2	1.5	14.6	72.5	11.4	1.6	0.2	6.3	1.0	0.0	0.3	1.3	0.0	0.9	0.6	21.3	0.1	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.2	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.1	1.0	1.3	3.1	1.0	0.9	0.9	1.3	1.2	1.3	0.8	1.3	1.3	0.1	0.0	0.0	2.9	1.0	0.1	2.3	0.5	1.2	0.2	0.7	1.0	0.4	0.0	0.1	0.0	0.0	29.1	0.3	3.0	3.9	0.4	0.2	0.1	1.5	0.7	1.2	4.2	0.0	0.0	5.8	0.8	8.2	0.2	0.0	0.9	0.4	0.1	2.5	0.0	0.2	3.3	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	1.9	0.0	5.2	2.2	0.4	0.3	0.0	0.4	0.0	0.6	0.8	0.0	1.9	2.1	1.1	5.1	0.4	1.2	7.6	1.5
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729470-169757944	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 71.0;Distal tubular cells: 92.0;Extravillous trophoblasts: 61.2;Granulosa cells: 56.4;Hofbauer cells: 56.3;Proximal tubular cells: 63.9;Theca cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (5.63e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	19.3	18.6	18.6	16.4	19.9	16.8	21.2	19.6	26.0	19.6	22.0	22.0	12.2	23.3	24.8	15.7	17.1	13.1	22.5	19.2	19.7	18.1	22.1	14.3	21.1	20.2	19.3	22.7	14.4	16.0	19.5	16.8	20.9	17.3	17.7	21.3	13.2	15.7	21.3	19.6	12.8	24.8	19.6	17.5	15.8	14.1	19.6	26.9	18.8	20.9	21.1	16.8	16.8	22.2	33.7	21.0	71.2	37.7	42.6	52.4	30.3	59.9	58.8	72.8	76.7	14.3	35.5	17.5	15.7	39.2	53.3	14.7	49.5	43.6	76.7	55.1	33.7	57.0	30.0	20.5	29.9	48.7	20.1	34.1	43.2	47.1	14.5	44.1	64.1	59.1	43.7	66.2	64.4	27.3	102.7	42.4	29.2	32.2	27.0	44.7	33.8	21.2	41.9	21.9	17.2	63.1	39.7	17.2	56.3	49.1	34.0	43.1	31.3	24.8	39.2	58.4	54.3	31.3	49.8	52.4	68.3	47.0	40.3	19.3	20.0	22.4	28.7	24.0	34.6	22.0	33.0	35.1	26.1	18.1	32.1	33.3	5.3	25.4	23.7	17.9	38.1	21.9	18.6	19.9	19.6	26.0	19.2	19.7	20.2	19.3	20.9	19.6	19.6	22.2	41.6	44.8	26.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	19.9	29.6	0.0	0.0	17.3	27.6	0.0	71.0	14.3	0.0	92.0	45.7	0.0	31.9	36.9	20.1	0.0	0.0	0.0	46.3	61.2	26.1	0.0	21.9	17.7	56.4	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	31.1	0.0	0.0	1.6	0.0	0.0	63.9	15.3	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.3	10.5	56.0	0.0	0.0
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490175-174523154	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 235.0;urinary bladder: 376.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 123.7;T-reg: 45.0"	"Group enriched"	"Detected in many"	73	"granulocytes: 123.7;T-cells: 45.0"	"Cell line enhanced"	"Detected in many"		"A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA		20000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	9.2	16.5	1.0	11.4	0.7	2.7	159.9	0.5	1.2	32.2	8.7	60.9	152.2	45.5	36.5	81.6	13.4	24.9	1.6	1.2	2.8	60.2	210.8	91.0	5.5	1.4	2.0	1.1	2.6	85.3	2.1	99.1	1.0	10.2	57.4	1.0	7.7	4.0	2.5	39.8	117.3	63.7	0.8	10.3	235.0	1.6	2.2	12.2	1.7	3.0	26.6	376.0	83.0	0.7	0.0	157.8	0.0	0.0	110.6	5.4	0.4	0.0	0.0	0.0	0.4	45.1	0.2	0.1	0.0	0.0	0.2	14.2	16.0	0.0	0.0	0.3	2.9	355.0	10.8	0.3	0.0	2.1	0.9	5.6	2.6	0.0	0.1	0.1	0.0	22.6	0.2	0.0	0.0	0.3	1.2	0.3	1.4	102.1	7.4	16.3	0.3	1.3	36.2	565.7	0.9	0.4	0.0	1.3	3.5	121.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	28.4	0.0	0.1	0.3	0.2	0.0	123.7	0.3	16.6	9.9	0.0	15.6	0.4	5.2	4.5	0.7	0.2	1.6	4.0	1.3	1.1	0.0	0.0	45.0	3.0	1.0	0.7	0.5	1.2	1.2	2.8	1.4	2.0	1.0	0.8	2.2	0.7	3.4	16.0	33.0	0.0	4.3	17.3	80.8	6.9	45.5	3.3	14.5	6.7	0.8	35.8	23.6	22.0	0.0	48.5	38.5	457.8	21.5	7.4	1.4	5.7	5.4	18.2	8.4	17.2	0.8	94.5	701.7	25.3	196.7	36.4	864.5	1.5	13.9	245.7	21.4	0.0	9.7	60.7	0.0	14.8	19.5	0.5	19.9	29.2	76.5	5.6	2.9	0.0	10.3	0.0	4.1	42.4	254.7	0.0	50.2	76.8	500.6	131.1	4.4	0.8	0.0	2.4	3.7	0.5	1.0	53.4	22.4	56.6	42.7	65.0	58.9	922.8
HPS3	"BLOC2S1, SUTAL"	ENSG00000163755	"HPS3 biogenesis of lysosomal organelles complex 2 subunit 1"	Q969F9	3	149129638-149173732	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 115.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046281, HPA052778"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Plasma membrane"		"HPA046281: AB_10961641, HPA052778: AB_2681943"	"unprognostic (1.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.06e-2)"	7.6	9.2	4.2	11.4	4.7	5.6	7.9	4.8	4.2	7.5	8.3	7.5	11.0	9.9	4.9	5.6	8.6	9.0	5.0	3.7	6.0	12.0	8.0	9.7	17.6	6.7	5.6	14.0	6.7	5.7	3.7	10.6	6.8	9.3	9.1	9.6	6.6	8.5	2.8	4.7	10.8	10.3	5.6	16.0	9.2	6.9	5.2	16.8	8.8	3.9	16.4	8.4	5.2	8.5	49.1	26.5	15.7	16.3	21.4	27.4	11.7	19.7	38.4	25.3	32.4	9.1	31.8	12.4	23.8	23.7	115.3	16.5	17.4	13.4	32.4	30.6	13.9	5.8	11.8	9.9	19.1	15.7	9.1	18.0	13.5	24.4	10.0	51.6	26.2	20.2	6.5	29.4	32.5	30.3	11.3	22.1	37.7	26.3	21.1	13.4	10.3	33.7	13.9	24.1	4.7	12.4	16.8	17.7	35.9	33.4	19.2	20.5	13.2	25.2	4.5	26.0	29.0	24.0	10.0	30.6	37.7	30.1	6.3	20.7	12.5	12.1	12.0	15.2	14.5	15.4	10.9	12.9	19.5	12.2	8.4	10.9	5.7	9.8	10.3	11.0	10.7	10.9	4.2	4.7	4.8	4.2	3.7	6.0	6.7	5.6	6.8	5.6	5.2	8.5	9.9	12.8	19.5	17.6	28.6	3.7	3.9	11.5	6.8	6.7	9.1	7.4	2.5	5.7	22.9	7.3	2.1	21.0	24.3	8.0	5.9	10.7	3.0	10.6	11.6	9.9	9.0	7.4	13.3	18.1	14.6	10.8	16.8	10.4	15.2	18.0	17.5	6.9	19.8	3.3	16.5	8.8	14.2	29.3	23.8	4.8	11.5	33.1	14.2	38.4	14.4	25.1	19.6	19.1	27.3	12.9	4.9	30.1	15.4	6.8	13.6	22.8	20.7	5.2	0.0	7.4	8.4	4.4	8.4	8.7	5.3	14.1	18.9	5.4	7.5	5.1
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 16.4;Kupffer cells: 41.5;Macrophages: 20.2;monocytes: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.2;neutrophil: 18.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.5;monocytes: 27.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.8;OE19: 40.1;TIME: 25.8"	"Region enhanced"	"Detected in some"		"olfactory bulb: 3.7"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		6500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	3.4	4.5	0.8	6.6	0.9	2.3	1.0	0.6	1.7	2.4	0.4	5.9	2.1	2.7	0.2	9.9	3.9	2.7	0.8	0.9	0.9	1.6	2.4	3.2	4.5	1.8	1.0	4.5	0.8	5.6	1.2	2.1	1.3	0.6	6.4	0.2	9.7	0.6	0.3	5.3	2.8	1.9	1.8	6.0	2.0	5.7	2.7	2.0	0.7	0.3	3.9	3.0	3.3	3.6	13.5	0.6	0.1	1.7	3.2	0.9	0.1	1.5	8.2	3.6	16.5	0.0	11.0	0.4	2.3	4.2	20.8	12.3	16.8	2.5	6.5	1.4	1.7	4.2	9.0	0.2	1.4	2.5	8.4	1.8	5.1	2.4	15.4	1.4	18.1	2.4	0.1	39.8	1.5	2.8	0.2	0.3	0.7	40.1	2.6	0.0	0.4	0.6	10.2	0.3	9.3	0.0	17.7	9.8	1.4	2.6	1.5	3.8	25.8	1.5	4.6	1.4	1.7	0.5	6.2	0.2	9.9	11.4	2.7	0.4	27.2	0.0	1.4	10.1	1.0	0.2	2.7	1.0	3.0	0.3	1.7	1.6	18.5	2.3	1.5	0.1	5.2	7.9	0.8	0.9	0.6	1.7	0.9	0.9	1.8	1.0	1.3	1.8	2.7	3.6	0.3	6.4	4.4	0.0	0.7	3.4	3.0	3.3	2.8	0.0	0.3	0.5	0.6	0.0	5.6	1.8	0.0	0.5	2.4	10.1	0.0	1.9	0.6	2.3	3.7	1.0	6.6	2.7	0.8	1.3	2.9	1.4	4.1	13.2	0.0	0.4	2.9	0.6	16.4	0.0	3.8	2.8	0.0	41.5	3.0	0.3	0.6	20.2	0.0	7.5	33.9	0.0	3.1	0.0	0.1	1.1	6.7	0.0	0.7	1.7	4.1	0.0	2.8	0.0	0.0	0.1	1.2	0.2	1.0	4.0	3.7	1.5	6.2	1.4	4.6	3.7
HRNR	"FLG3, S100A16, S100a18"	ENSG00000197915	Hornerin	Q86YZ3	1	152212076-152224193	"Plasma proteins, Predicted intracellular proteins"	Keratinization	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 1.0;Horizontal cells: 1.7;Rod photoreceptor cells: 3.5"	"Cancer enriched"	"Detected in single"	4	"melanoma: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.9"	"Not detected"	"Not detected"							HPA031469	Uncertain		Approved	Mitochondria		No	No		180000000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA031469: AB_10603771"	"unprognostic (1.34e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.72e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.64e-2)"	0.1	0.2	0.9	0.0	0.4	0.0	0.1	0.0	0.6	0.2	0.3	0.1	0.0	0.2	0.0	0.5	0.2	0.0	0.2	0.4	1.9	0.3	0.1	0.1	0.0	1.8	0.7	0.4	0.4	0.0	0.2	0.0	1.1	0.2	0.0	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.3	0.1	0.1	0.4	0.7	0.0	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.4	0.0	0.6	0.4	1.9	1.8	0.7	1.1	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
HS1BP3	HS1-BP3,FLJ14249	ENSG00000118960	"HCLS1 binding protein 3"	Q53T59	2	20560448-20651130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035050	Approved		Approved	Nucleoli,Cytosol		No	No		54000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA035050: AB_10601816"	"unprognostic (4.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (2.06e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-1)"	18.5	31.0	16.4	10.0	20.6	13.7	15.9	17.9	19.6	21.5	19.4	33.6	13.1	22.2	13.3	18.6	19.4	16.4	23.3	16.9	17.5	24.8	57.4	18.5	9.2	20.4	19.3	17.5	14.5	13.1	16.3	15.5	19.4	26.7	12.6	3.7	16.7	17.5	13.0	23.3	17.7	21.1	15.8	18.4	22.0	13.8	21.3	7.4	17.8	10.1	7.6	29.2	17.8	23.3	20.3	23.1	11.5	14.1	58.8	39.2	22.7	7.6	34.9	17.7	23.0	18.2	24.0	13.5	5.9	11.1	80.1	12.5	23.1	24.0	8.6	17.4	19.1	7.2	11.3	61.2	54.8	5.5	30.5	42.1	53.8	20.0	36.5	20.7	34.1	11.9	4.7	28.3	20.5	17.4	2.5	9.3	9.6	29.9	16.4	13.3	23.3	13.4	39.0	24.4	10.9	16.7	5.4	23.4	45.0	23.2	14.6	11.2	21.7	17.3	18.5	27.0	11.7	19.9	24.5	12.9	37.3	25.8	18.7	17.9	14.7	14.5	6.0	13.9	4.2	6.8	3.6	4.7	9.9	4.3	3.0	3.3	17.7	3.8	18.3	3.6	3.4	8.6	16.4	20.6	17.9	19.6	16.9	17.5	20.4	19.3	19.4	15.8	21.3	23.3	17.6	6.4	17.9	3.3	8.2	4.5	7.4	5.6	2.2	4.0	6.2	8.0	6.2	8.6	10.9	7.3	0.0	9.8	6.5	12.5	17.6	21.4	20.8	9.3	9.4	8.4	6.7	7.0	2.6	14.9	17.8	9.7	8.2	12.5	2.5	8.5	11.0	9.2	30.7	15.2	2.5	7.3	12.2	20.1	5.5	42.7	8.4	13.9	14.2	4.7	13.1	8.9	15.5	3.0	5.4	9.7	11.9	10.5	4.9	5.2	21.6	28.2	10.4	5.3	0.0	7.1	17.1	16.7	10.5	5.8	5.3	17.5	6.3	7.8	7.7	4.5
HS2ST1	KIAA0448	ENSG00000153936	"Heparan sulfate 2-O-sulfotransferase 1"	Q7LGA3	1	86914635-87109982	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.9;Excitatory neurons: 126.1;Inhibitory neurons: 130.1;Oligodendrocyte precursor cells: 95.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043069, HPA043603, HPA075001"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.58e-2)"	8.0	25.7	11.5	9.4	13.8	3.8	8.1	8.0	12.2	10.5	13.2	9.3	9.7	9.1	9.9	7.0	6.7	10.6	7.0	11.9	11.4	13.8	17.2	8.2	11.8	10.1	11.0	12.7	10.1	13.4	6.6	8.3	8.1	9.5	9.0	19.3	6.7	9.9	4.4	8.2	9.3	7.8	8.8	12.7	8.3	9.3	12.2	10.6	12.9	4.7	11.6	9.4	5.9	8.4	24.4	20.4	59.0	38.5	31.9	92.3	20.4	23.3	30.5	19.2	21.2	78.1	30.6	53.3	22.1	16.4	33.2	14.5	27.2	19.5	30.8	42.1	22.2	64.0	21.0	63.0	13.4	33.6	31.0	38.2	17.0	31.0	25.6	30.4	28.8	29.7	44.6	27.4	28.1	8.6	33.8	20.2	19.8	26.5	12.9	41.2	55.7	11.6	23.5	50.3	12.6	19.0	30.6	26.2	27.2	15.2	17.2	15.2	25.7	24.0	29.8	42.2	29.7	25.1	19.9	49.7	14.8	23.6	25.0	6.2	1.1	1.0	1.3	0.6	1.6	1.1	1.5	1.5	0.7	2.8	1.4	0.9	1.2	1.1	2.8	0.7	0.9	1.0	11.5	13.8	8.0	12.2	11.9	11.4	10.1	11.0	8.1	8.8	12.2	8.4	13.0	16.0	12.4	160.9	14.2	16.6	8.6	9.3	19.9	10.9	11.9	7.6	12.8	14.3	15.2	20.2	4.2	8.2	5.7	13.5	13.7	18.2	5.5	7.1	23.6	13.8	23.4	12.2	126.1	11.5	9.3	16.9	11.2	8.0	19.0	74.2	18.2	28.9	37.7	8.4	130.1	12.5	18.3	12.8	13.5	3.8	6.8	15.3	12.4	53.4	8.2	28.8	5.2	95.0	54.5	11.3	7.7	20.3	24.0	7.3	17.6	18.3	11.2	17.7	0.0	21.1	16.8	10.1	15.0	12.8	15.8	4.4	12.9	77.4	13.5	7.1
HS6ST1	HS6ST	ENSG00000136720	"Heparan sulfate 6-O-sulfotransferase 1"	O60243	2	128236716-128318868	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 75.4;Granulosa cells: 285.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"EFO-21: 131.2;HMC-1: 206.6;SCLC-21H: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044586			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		72000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA044586: AB_10963057"	"unprognostic (9.94e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.94e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	16.2	63.4	36.2	8.8	33.8	5.1	16.1	24.4	45.5	15.5	10.9	15.4	8.7	12.3	6.1	34.1	17.5	21.0	19.0	35.4	26.5	71.4	46.8	17.0	8.4	32.1	34.7	26.4	30.8	8.8	15.2	12.0	33.6	28.2	6.9	26.4	26.0	22.8	36.2	26.5	15.1	6.4	31.2	32.1	12.7	25.0	39.9	14.5	14.2	18.7	7.4	19.4	23.1	28.9	12.5	17.4	46.0	26.5	17.5	32.5	24.7	15.1	19.1	14.8	8.1	9.0	8.0	11.9	131.2	19.4	6.9	32.5	17.5	29.1	5.5	19.9	18.1	10.5	6.4	87.9	21.1	18.4	206.6	43.9	33.9	11.9	3.6	4.9	8.0	31.8	6.7	12.1	5.4	25.7	49.6	81.0	55.3	4.7	10.7	16.1	12.6	61.9	13.4	36.3	112.9	28.4	12.1	30.1	6.7	30.6	12.2	6.9	9.6	13.1	28.9	49.1	12.3	7.2	7.6	2.7	7.9	13.0	9.7	3.0	0.7	0.6	1.0	0.4	0.1	0.7	0.4	0.6	0.5	0.7	0.4	0.4	0.2	0.2	1.5	2.3	0.2	0.6	36.2	33.8	24.4	45.5	35.4	26.5	32.1	34.7	33.6	31.2	39.9	28.9	9.5	25.6	8.9	20.9	4.9	16.2	11.2	16.1	14.8	9.4	15.1	12.8	7.3	10.0	10.3	75.4	31.3	9.7	7.3	22.3	5.9	15.4	0.9	22.9	11.5	12.6	3.0	6.9	24.2	5.8	36.9	12.6	4.1	39.7	57.0	285.6	30.0	23.8	10.7	21.9	20.3	6.5	8.2	14.2	9.2	3.3	11.8	9.1	7.2	5.6	6.7	8.2	1.0	6.6	10.4	6.6	12.0	17.0	3.2	9.7	6.9	3.3	8.7	32.8	6.6	7.6	9.4	1.1	3.1	18.3	17.0	23.3	3.5	27.1	3.7	8.9
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090107-96839562	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5"	"Group enriched"	"Detected in some"	27	"Excitatory neurons: 1308.8;Inhibitory neurons: 893.1;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RT4: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA		24000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: AB_2732374"	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	1.4	4.2	1.4	0.2	3.5	0.0	0.3	0.0	9.0	1.8	0.0	0.2	0.4	2.1	2.1	0.4	0.5	0.2	0.9	12.5	7.3	0.8	0.0	0.0	0.0	0.1	5.2	0.1	2.2	2.1	1.9	0.0	0.3	0.2	0.1	2.2	0.0	0.2	1.1	0.5	0.4	1.5	0.3	0.0	0.9	0.3	6.1	0.0	2.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	17.3	0.9	0.7	0.1	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.5	0.0	9.0	12.5	7.3	0.1	5.2	0.3	0.3	6.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.6	0.1	0.0	0.0	1308.8	0.6	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	3.3	893.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	38.4	0.0	0.9	0.0	968.6	16.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	1.8	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 249.9;kidney: 335.2;salivary gland: 260.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 191.3;Distal enterocytes: 476.1;Intestinal goblet cells: 288.8;Paneth cells: 226.2;Proximal enterocytes: 270.2;Syncytiotrophoblasts: 114.5;Undifferentiated cells: 170.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 62.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.4;OE19: 29.0;RPMI-8226: 13.9;RT4: 13.9;SCLC-21H: 14.9;SK-BR-3: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	2.1	5.4	1.6	13.4	4.6	0.1	14.0	2.8	2.8	15.5	0.7	249.9	40.0	11.8	4.0	10.9	10.4	6.8	1.9	1.6	1.3	335.2	5.5	3.2	1.0	2.7	1.3	9.3	7.4	3.6	0.5	13.0	3.3	12.9	102.2	0.0	260.2	6.2	0.9	66.1	141.8	18.3	1.5	7.0	9.8	2.5	2.0	0.4	11.1	0.2	0.9	5.3	23.6	2.4	3.6	1.1	0.4	1.4	0.1	1.7	3.6	0.0	0.0	0.1	0.1	6.1	1.3	0.0	2.7	0.1	0.1	7.8	5.1	0.5	0.0	0.0	1.8	0.0	0.7	6.6	0.6	0.7	0.0	1.7	3.0	0.3	0.1	0.0	0.0	4.6	0.4	0.0	0.0	3.8	0.2	0.2	11.4	29.0	1.0	0.0	0.2	13.9	0.5	13.9	14.9	1.0	0.8	13.4	0.6	1.3	6.5	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.6	2.8	2.8	1.6	1.3	2.7	1.3	3.3	1.5	2.0	2.4	0.7	0.0	0.5	0.0	1.1	1.5	7.2	1.3	1.2	0.0	4.8	2.2	0.5	30.0	2.3	191.3	0.0	1.2	0.3	476.1	45.0	2.1	0.2	17.4	25.2	0.5	26.9	0.0	1.1	3.0	0.7	7.1	7.1	43.5	8.9	43.4	1.1	1.2	1.4	0.0	0.8	288.8	4.1	0.3	0.5	0.5	25.4	0.7	1.8	0.0	0.0	0.0	0.0	0.5	0.3	0.6	226.2	6.8	0.2	13.5	270.2	16.3	0.4	0.0	13.1	0.3	3.9	0.2	1.6	3.5	3.4	114.5	1.2	16.7	170.9	10.5
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 429.0;liver: 217.9;placenta: 381.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 155.8;Distal enterocytes: 203.4;Hepatocytes: 121.9;Paneth cells: 284.2;Proximal enterocytes: 390.7"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.9;pancreatic cancer: 6.5;stomach cancer: 4.2;urothelial cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 57.9;Hep G2: 47.5;hTERT-HME1: 27.1;OE19: 87.1;RT4: 96.8;TIME: 54.0"	"Group enriched"	"Detected in some"	5	"midbrain: 2.2;pons and medulla: 3.4"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	1.6	0.0	0.4	4.2	0.2	0.7	26.4	0.9	0.4	4.3	0.2	74.8	429.0	1.2	0.1	9.6	0.1	21.1	0.2	0.3	0.2	9.6	217.9	2.3	0.3	0.1	0.0	0.3	23.2	0.0	1.2	381.8	0.1	2.0	56.9	17.4	22.1	0.2	0.1	4.2	188.6	2.4	0.0	0.2	20.1	0.3	0.1	0.4	0.1	0.0	3.4	78.6	1.4	0.3	0.4	0.1	0.4	0.0	0.0	0.7	0.7	0.2	57.9	0.0	0.0	10.9	1.7	0.1	11.4	0.0	0.1	0.4	0.0	2.4	0.0	0.1	0.1	0.3	0.3	47.5	0.4	0.3	0.3	0.0	3.1	0.0	27.1	0.6	0.9	0.1	0.1	0.4	8.6	0.1	0.0	0.9	0.2	87.1	21.4	0.1	0.2	1.3	1.0	96.8	0.4	1.5	0.0	2.7	0.2	0.0	0.1	0.1	54.0	0.6	0.5	0.3	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.9	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.3	1.0	3.2	3.9	0.3	0.7	0.4	2.7	16.4	2.2	0.5	45.7	12.3	0.6	155.8	21.4	0.0	0.0	2.7	0.3	203.4	0.0	73.6	0.5	5.9	5.4	21.3	3.0	2.7	0.1	6.0	1.8	38.3	15.3	41.3	0.0	0.0	2.5	121.9	3.5	0.0	0.1	26.3	6.1	3.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	45.1	0.0	0.0	0.1	20.1	284.2	0.0	0.1	2.7	390.7	1.4	5.6	0.7	0.0	0.4	2.0	0.0	0.1	0.8	1.1	6.4	0.7	0.0	47.1	14.8
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 77.7"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 140.8;Syncytiotrophoblasts: 502.0"	"Cancer enriched"	"Detected in single"	4	"urothelial cancer: 1.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.0;cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 64.1;SuSa: 26.5"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		Yes	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	1.2	0.2	0.0	1.0	0.0	1.5	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	77.7	0.0	0.1	0.5	0.0	0.1	0.0	0.1	4.5	8.7	0.5	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.0	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	7.0	0.7	0.8	26.5	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	140.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	502.0	0.0	0.1	1.0	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"adrenal gland: 2174.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 40.6;Proximal enterocytes: 38.8;Theca cells: 68.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.4"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		Yes	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.2	2174.8	0.3	2.1	0.8	0.0	0.1	0.0	0.7	0.2	0.0	7.7	0.0	0.2	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.9	1.0	0.5	0.0	0.0	0.0	0.9	0.5	0.0	0.1	3.6	0.1	0.4	1.0	0.0	1.0	0.0	0.1	0.2	38.7	0.1	0.0	0.2	0.3	2.9	0.2	0.5	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	3.5	0.0	0.0	0.0	40.6	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	38.8	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	68.9	1.7	0.0
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989147	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 42.5;Hepatocytes: 68.9;Hofbauer cells: 53.9;Proximal enterocytes: 45.3;Proximal tubular cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"basophil: 61.8;eosinophil: 27.3"	"Lineage enriched"	"Detected in many"	38	"granulocytes: 61.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 91.0;Hep G2: 66.2;HMC-1: 98.1;U-2197: 96.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Approved		Enhanced	"Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	27.3	25.7	5.7	10.9	6.2	4.4	17.1	14.7	9.1	8.5	3.5	15.9	19.5	9.5	2.1	12.3	9.4	11.5	11.7	5.9	5.9	27.7	136.5	11.2	8.4	6.3	5.4	8.6	25.6	8.0	5.4	4.5	6.6	8.2	5.8	1.6	10.0	4.5	7.0	18.5	18.4	9.8	5.6	16.3	11.1	6.0	7.1	2.8	6.3	4.5	5.5	13.9	8.7	6.9	20.3	23.2	2.4	11.5	7.9	28.5	1.4	24.8	38.7	4.8	10.0	1.7	34.4	1.2	8.1	30.3	0.8	6.1	2.2	3.6	2.4	91.0	5.4	1.6	18.6	66.2	7.4	0.5	98.1	13.7	6.0	23.1	4.6	11.2	2.2	1.2	4.9	1.0	18.3	43.6	0.6	14.4	1.9	8.5	3.2	2.5	7.8	22.3	15.1	1.3	8.4	4.1	3.2	15.9	2.2	1.1	31.1	1.6	11.5	10.0	2.8	96.1	2.7	1.6	15.4	1.1	39.1	2.5	0.8	61.8	1.4	27.3	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.2	0.0	0.1	1.2	0.5	0.0	0.6	0.0	0.7	5.7	6.2	14.7	9.1	5.9	5.9	6.3	5.4	6.6	5.6	7.1	6.9	7.6	3.2	4.2	3.3	1.2	7.9	2.6	4.1	4.0	0.7	13.6	9.8	1.7	27.1	2.2	14.7	0.0	2.0	0.5	10.8	15.6	42.5	37.5	1.9	7.1	11.1	7.8	4.8	0.2	30.3	3.5	26.0	8.2	4.2	9.5	9.0	6.8	68.9	53.9	1.7	0.4	11.4	6.1	7.3	15.9	2.2	6.5	11.4	14.2	0.0	12.8	2.1	0.0	0.5	1.2	20.7	14.0	5.3	1.9	1.8	45.3	46.7	1.3	0.5	13.1	9.4	6.3	0.8	1.2	4.9	12.6	1.4	1.7	6.5	23.5	2.8
HSDL1	SDR12C3	ENSG00000103160	"Hydroxysteroid dehydrogenase like 1"	Q3SXM5	16	84122141-84145192	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 45.4;Rod photoreceptor cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045745			Supported	"Vesicles,Intermediate filaments,Mitochondria"		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	"Vesicles, Intermediate filaments"	"HPA045745: AB_2679440"	"unprognostic (2.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.66e-1)"	"prognostic favorable (4.20e-7)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.14e-2)"	7.5	15.4	14.3	7.1	14.6	4.4	11.9	10.9	13.0	10.6	10.7	7.4	6.2	13.2	10.5	7.8	12.6	7.1	15.7	14.0	18.3	10.8	5.1	9.1	9.0	15.0	14.8	22.0	4.9	15.1	11.9	9.1	18.6	9.8	6.9	34.3	7.3	11.1	20.7	8.0	5.7	10.8	9.5	8.0	6.4	13.2	17.0	14.1	26.8	30.5	9.2	7.3	7.1	10.2	11.1	12.6	57.4	19.8	20.7	14.5	14.6	13.8	13.1	17.0	8.9	14.5	18.8	22.7	24.7	12.4	18.8	7.6	31.1	12.1	26.9	4.9	18.9	10.9	7.9	32.5	21.0	17.1	19.2	11.0	20.0	24.1	15.4	21.9	20.9	30.6	23.0	28.2	34.3	27.3	37.8	17.4	29.5	6.4	13.3	36.7	20.4	8.4	16.6	12.0	27.1	20.2	35.0	5.6	39.0	28.5	34.4	10.2	17.5	19.2	22.9	13.9	11.3	44.1	38.1	36.9	22.8	12.3	18.2	21.2	5.0	11.1	3.8	3.4	5.0	5.0	4.1	4.6	2.8	7.5	5.3	5.6	5.5	4.3	6.3	0.0	5.4	4.4	14.3	14.6	10.9	13.0	14.0	18.3	15.0	14.8	18.6	9.5	17.0	10.2	8.9	12.8	16.4	7.8	8.2	4.8	4.6	6.4	8.6	20.2	10.2	8.3	16.7	1.5	8.6	3.7	14.6	6.9	4.4	3.7	5.9	7.9	38.5	11.4	10.5	7.7	9.5	5.7	12.4	6.7	6.6	7.7	3.6	11.0	1.3	38.6	9.3	4.1	12.2	45.4	15.8	3.7	4.1	6.9	3.5	12.2	5.9	10.4	5.4	11.2	6.1	28.4	5.2	15.6	13.0	6.8	2.5	10.1	10.1	5.2	3.9	8.0	13.7	44.2	0.0	8.0	7.8	35.8	30.1	8.8	7.0	8.8	6.6	12.7	4.5	4.8
HSF2		ENSG00000025156	"Heat shock transcription factor 2"	Q03933	6	122399551-122433119	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.1;Spermatocytes: 73.8;Spermatogonia: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016067, HPA031455"	Approved		Supported	Nucleoplasm		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB016067: AB_627754, HPA031455: AB_10670702"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (3.40e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (9.27e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	9.5	15.2	12.2	7.9	12.3	29.6	12.7	15.0	13.5	13.1	15.9	11.6	6.9	14.5	10.3	8.2	11.9	7.5	23.3	11.5	12.6	6.8	5.5	8.8	12.7	10.5	10.9	14.6	6.4	14.0	10.6	8.2	11.3	11.1	6.9	44.5	8.5	12.7	48.6	12.7	9.1	14.0	10.7	9.2	9.4	37.9	13.0	17.9	8.8	64.3	12.5	9.6	9.0	13.1	8.5	8.7	44.5	35.8	19.6	15.6	12.2	14.6	35.5	26.9	41.6	13.0	7.0	32.2	12.4	18.9	30.2	10.5	30.1	14.4	37.4	32.7	36.4	31.8	8.6	27.1	19.9	23.5	15.4	20.0	21.6	22.3	25.2	24.9	16.4	28.8	34.0	15.5	25.6	11.5	38.8	30.9	13.6	12.2	12.3	35.6	18.0	10.3	20.5	9.7	46.5	31.5	15.1	12.5	14.5	32.5	10.8	25.5	10.4	14.3	16.2	16.1	22.6	22.1	22.7	41.4	15.5	15.3	18.9	6.9	3.9	6.1	11.7	4.7	12.6	9.2	11.0	10.3	5.5	7.0	27.9	22.0	0.6	11.0	6.8	3.8	13.2	11.4	12.2	12.3	15.0	13.5	11.5	12.6	10.5	10.9	11.3	10.7	13.0	13.1	10.6	19.2	10.3	17.0	11.9	31.7	11.4	8.1	27.3	21.8	12.1	10.9	36.6	4.3	11.1	0.0	27.1	15.5	14.4	1.9	11.7	7.7	97.1	21.3	14.6	10.3	6.6	16.2	26.6	4.2	7.4	16.2	10.2	9.6	8.8	19.4	6.1	4.9	7.9	21.9	29.4	6.1	24.4	4.8	7.8	21.3	10.2	6.0	19.6	14.0	2.9	15.2	7.2	24.1	23.5	4.8	5.2	9.8	7.9	8.7	3.2	7.5	23.3	34.2	26.3	14.9	12.1	73.8	97.0	16.1	25.7	3.1	20.5	39.6	5.4	6.4
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080742-102139699	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 2527.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 12150.7;Urothelial cells: 5781.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol		NA	NA		71000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB002058: "	"prognostic unfavorable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	362.9	439.5	1188.2	299.3	1221.3	459.2	438.6	1272.5	2527.6	282.1	1284.0	289.7	191.3	239.6	318.6	262.0	560.3	363.7	460.6	1213.8	1334.7	452.4	380.5	376.1	321.9	1283.8	1324.0	350.4	273.5	421.8	355.5	420.6	1351.6	348.4	311.1	1127.6	371.1	319.5	405.8	224.8	244.2	306.2	1216.2	217.6	297.5	541.9	1274.3	404.8	223.3	434.9	376.7	406.5	232.8	1639.1	1348.6	1832.2	1142.0	794.2	678.0	567.7	1512.1	1466.0	709.0	1779.5	994.1	1123.6	1245.6	1671.5	1323.1	960.7	1164.7	1471.2	3319.0	1452.5	3215.8	1227.4	1091.9	1291.8	1029.3	1444.3	334.9	1936.9	950.0	539.4	604.6	1140.3	416.2	1107.1	998.6	1764.9	1818.9	838.8	1634.1	1850.8	2087.7	891.1	1191.0	2500.5	1709.3	1968.2	1550.2	715.1	1030.3	1738.2	1497.0	1077.2	1860.4	1389.6	848.2	1903.9	1790.2	765.2	708.2	1234.6	786.5	1860.0	2826.4	783.5	2534.1	2402.7	1167.3	1182.5	1521.0	184.4	87.6	112.1	195.4	128.5	254.9	128.4	162.4	202.2	104.9	127.8	119.2	174.8	57.5	252.6	124.9	208.0	177.8	113.5	1188.2	1221.3	1272.5	2527.6	1213.8	1334.7	1283.8	1324.0	1351.6	1216.2	1274.3	1639.1	1571.4	1137.8	696.7	255.6	934.0	1340.7	12150.7	814.1	748.4	1185.6	1215.2	1173.1	2257.3	684.9	1020.6	513.1	2103.8	1415.1	1091.2	905.8	342.4	1210.5	662.9	2972.0	1350.8	1163.8	947.3	1502.3	158.9	867.6	1909.7	1632.5	788.5	2209.5	916.4	1026.8	341.3	554.4	1348.0	723.5	216.2	992.2	703.9	618.8	3110.7	442.6	732.0	2305.3	1300.2	267.0	773.6	1548.1	356.3	96.5	435.3	779.9	1021.6	722.9	1227.4	3791.1	552.2	896.4	2827.3	3623.6	618.0	1112.4	1974.9	3800.9	2142.4	830.1	1113.7	2050.2	3196.2	972.6	1028.8	5781.1
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815543-31817946	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 7514.5;Langerhans cells: 2690.4;Urothelial cells: 3444.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	64	"cerebral cortex: 403.6"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;monocytes: 3.6;T-cells: 3.0"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 4450.4"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	Yes		47000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"	Cytosol	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	640.5	350.5	3.5	12.7	3.8	0.0	167.2	6.3	403.6	414.1	3.4	497.7	0.0	209.7	15.9	452.9	194.6	5.9	927.7	4.3	3.7	745.9	1116.2	1055.0	9.1	5.4	5.1	369.7	308.2	1.1	474.3	12.0	4.0	427.7	4.2	6.5	111.5	0.5	294.4	257.3	174.4	2.2	3.8	451.9	483.2	98.0	3.7	2.5	340.2	0.3	2.3	569.2	553.7	6.1	0.2	524.1	0.0	0.1	20.1	14.4	0.0	0.3	0.0	0.0	0.0	1.6	0.7	0.0	122.9	28.7	0.0	0.4	0.0	34.1	0.0	6.9	4450.4	0.0	1.7	3.1	0.0	1.1	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.4	0.0	0.5	0.7	0.0	0.0	16.6	5.3	0.0	0.1	4.1	0.0	49.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	2.3	3.2	1.1	3.6	0.7	0.6	1.6	1.4	0.3	0.2	0.7	0.6	6.8	0.8	2.0	0.3	3.0	0.4	3.5	3.8	6.3	403.6	4.3	3.7	5.4	5.1	4.0	3.8	3.7	6.1	1537.0	147.4	97.0	427.4	312.4	362.4	7514.5	125.5	968.7	305.3	782.0	844.3	1010.7	81.5	109.3	126.9	379.5	43.2	148.1	634.6	41.1	86.8	81.0	534.7	488.1	1049.0	469.2	64.0	9.7	21.6	154.1	1208.6	592.8	753.4	445.4	18.1	123.5	95.2	270.4	205.3	11.4	560.1	114.0	319.0	2690.4	49.5	603.0	1715.2	839.6	398.2	126.6	768.2	15.5	17.1	207.0	39.5	668.8	160.6	1173.3	1404.1	68.4	72.9	177.2	690.2	151.2	443.4	1802.0	65.4	148.8	1105.8	336.3	104.3	1382.2	285.6	454.9	3444.4
HSPA1B	HSP70-2	ENSG00000204388	"Heat shock protein family A (Hsp70) member 1B"	P0DMV9	6	31827738-31830254	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 3007.4;Urothelial cells: 1619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 204.3"									"CAB008640, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes				"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"	Nucleoplasm	"CAB008640: AB_1617331, HPA052504: AB_2681854"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.69e-2)"	"unprognostic (5.99e-2)"	526.3	340.1	0.7	0.4	1.3	0.0	126.0	1.6	5.6	475.3	0.6	361.2	0.0	154.0	9.1	375.2	231.5	2.3	718.3	1.1	1.9	555.5	685.4	845.3	0.0	0.8	1.0	682.2	336.5	3.3	438.2	0.0	1.2	303.6	0.5	2.6	94.8	0.3	159.9	299.0	139.1	0.0	0.4	274.7	372.0	93.8	1.5	0.0	289.9	0.0	0.0	415.3	503.3	1.2	0.4	24.1	0.4	0.2	1.1	0.0	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.0	8.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	15.4	0.0	0.5	2.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	204.3	0.0	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	1.6	0.0	0.0	0.3	3.2	0.0	0.4	41.5	0.4	0.4	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.3	1.6	5.6	1.1	1.9	0.8	1.0	1.2	0.4	1.5	1.2	563.2	112.2	75.0	140.7	242.7	239.2	3007.4	63.2	630.0	44.6	509.4	403.9	512.3	40.0	73.7	69.9	131.3	82.7	82.8	542.8	19.6	45.5	1.9	434.9	380.2	446.2	318.6	57.9	2.7	15.6	140.8	585.8	595.8	710.4	346.8	14.1	25.7	17.7	142.0	47.1	2.8	426.3	61.1	84.4	1140.4	9.8	220.6	627.1	642.1	126.5	17.7	192.4	1.0	5.5	61.8	21.4	524.1	54.9	967.0	584.2	159.1	38.3	75.0	144.2	105.2	226.4	846.5	15.2	46.4	904.0	221.9	259.7	604.6	116.7	400.5	1619.4
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815283	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"testis: 63.2"	"Group enriched"	"Detected in many"	22	"Early spermatids: 212.5;Late spermatids: 560.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;EFO-21: 1.5;HEK 293: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		53000000		"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: AB_2681854"	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	1.2	1.4	0.0	0.0	0.2	0.1	0.9	1.4	0.3	1.5	0.0	1.8	0.1	1.8	0.0	0.6	2.4	0.0	1.4	0.1	0.2	1.5	1.2	1.3	0.0	0.2	0.2	2.2	0.9	0.0	1.7	0.0	0.3	1.1	0.0	0.1	1.0	0.0	3.9	1.0	1.5	0.0	0.2	2.4	1.3	63.2	0.4	0.0	1.5	0.1	0.0	1.6	1.1	0.6	0.1	1.1	0.1	0.4	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.4	0.4	0.1	0.0	0.1	0.3	4.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.4	0.6	4.2	0.0	1.1	2.9	3.5	0.9	1.3	0.4	2.2	2.6	1.9	2.0	4.5	0.0	0.9	0.0	8.4	0.6	1.4	1.4	0.0	0.7	212.5	2.0	0.7	2.2	1.8	3.2	0.6	0.2	0.6	1.3	0.0	1.3	0.0	0.9	1.8	1.1	1.3	3.3	0.8	1.4	0.0	4.4	2.5	560.9	5.0	2.1	5.4	2.8	4.1	3.6	1.0	0.5	2.0	0.4	1.4	2.2	1.9	0.9	0.9	0.6	2.2	2.8	0.0	0.8	2.9	17.0	8.7	1.7	0.1	0.4	3.8	0.9	1.5	0.3
HSPA2		ENSG00000126803	"Heat shock protein family A (Hsp70) member 2"	P54652	14	64535905-64546173	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 320.2;skeletal muscle: 170.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 342.0;Distal tubular cells: 238.7;Extravillous trophoblasts: 509.9;Spermatocytes: 578.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 75.4;BEWO: 114.4;BJ hTERT+: 99.0;CAPAN-2: 52.9;SCLC-21H: 101.4"	"Low region specificity"	"Detected in all"							"HPA000798, HPA052504"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA		63000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA000798: AB_1079090, HPA052504: AB_2681854"	"prognostic favorable (1.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	9.8	6.5	83.9	7.5	161.2	0.7	6.4	148.0	116.3	12.5	84.2	94.1	5.5	51.6	18.6	42.3	17.0	5.3	39.7	88.5	96.0	73.0	4.2	14.2	3.8	170.1	122.9	5.6	8.8	7.8	15.2	61.5	174.9	10.8	9.5	1.2	16.4	4.5	170.4	31.7	29.6	28.7	128.5	20.2	18.5	121.0	125.3	3.0	2.7	60.6	5.0	42.9	16.0	320.2	30.4	75.4	11.4	0.2	8.1	0.7	114.4	42.3	99.0	16.6	27.3	2.9	52.9	7.4	16.8	46.4	3.6	33.6	0.0	2.2	10.1	4.3	5.8	0.1	4.0	0.2	7.9	0.2	10.0	3.7	1.7	2.4	0.1	4.1	1.1	0.5	0.0	6.0	8.4	13.5	0.5	0.4	8.4	11.7	9.1	6.0	0.0	0.1	26.1	4.6	101.4	5.8	1.8	3.7	0.1	3.9	2.9	3.1	1.6	0.3	0.2	3.7	0.2	7.6	0.2	0.2	9.2	0.1	11.4	0.3	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.2	0.0	0.1	0.1	0.1	0.6	0.2	0.1	0.0	1.0	0.1	83.9	161.2	148.0	116.3	88.5	96.0	170.1	122.9	174.9	128.5	125.3	320.2	74.7	0.0	5.2	18.6	21.1	54.0	31.2	35.1	342.0	1.9	37.5	57.1	39.1	5.7	8.8	132.4	0.0	42.5	30.8	29.2	238.7	8.3	35.7	56.4	63.8	59.6	28.1	0.0	0.5	5.6	509.9	40.7	83.6	54.5	13.3	1.4	32.2	0.8	15.7	0.0	1.1	63.4	24.4	3.1	25.7	27.3	8.7	24.0	30.2	6.5	0.0	14.2	0.0	2.5	157.4	5.5	15.6	7.5	7.1	7.5	8.5	1.5	4.6	2.4	26.3	48.6	66.2	578.6	77.1	175.8	42.3	75.9	29.8	4.5	12.9	11.3
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133052013-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	31.3	36.9	33.8	41.0	37.2	35.6	26.9	38.1	63.7	26.6	52.0	31.8	26.6	27.5	29.3	62.0	26.8	27.8	50.8	39.8	43.8	44.3	47.2	26.3	47.4	37.6	41.0	21.3	29.7	43.5	24.0	37.7	45.0	26.3	34.7	104.0	27.9	26.9	57.7	26.1	26.0	35.3	38.4	28.7	26.6	62.8	40.3	40.2	39.7	41.7	60.9	48.4	23.7	48.2	160.8	215.8	147.6	241.7	137.5	114.6	267.3	171.0	127.8	162.1	199.2	408.0	163.2	264.4	175.2	165.8	382.6	138.9	259.4	282.9	232.7	122.9	148.3	195.4	136.5	225.7	109.6	122.6	163.8	115.1	117.3	209.7	136.3	92.9	157.2	126.5	207.9	79.6	179.8	141.4	173.5	91.0	202.4	123.8	98.7	156.6	180.4	140.2	146.7	207.4	117.0	96.0	163.4	84.4	234.6	273.5	124.3	118.5	139.0	146.8	210.8	127.1	206.1	90.7	215.2	199.9	125.5	198.7	149.2	29.5	22.6	24.9	18.1	35.8	21.5	34.2	16.6	19.0	27.7	42.0	17.1	16.2	14.7	22.9	27.1	10.5	18.0	18.5	33.8	37.2	38.1	63.7	39.8	43.8	37.6	41.0	45.0	38.4	40.3	48.2	30.5	64.1	47.0	12.4	74.8	41.8	116.8	25.5	52.9	58.9	30.3	26.8	113.1	28.6	47.3	22.0	54.2	67.3	38.5	42.9	27.4	48.4	68.7	54.7	48.5	40.8	47.2	46.9	24.2	49.9	66.1	45.3	38.2	46.1	54.6	66.9	19.6	32.9	64.3	35.3	24.8	34.4	36.7	28.2	40.9	31.9	23.3	50.7	30.2	21.5	55.0	60.1	22.6	18.6	24.2	50.1	24.9	25.9	66.5	61.5	27.7	49.7	60.7	152.4	26.3	41.8	85.1	107.4	101.0	71.7	41.8	87.2	58.2	68.0	39.4	69.7
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526894	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 242.2;lung: 94.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 335.3;Langerhans cells: 478.8;Macrophages: 213.7;Prostatic glandular cells: 180.1;Smooth muscle cells: 235.6;T-cells: 391.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebral cortex: 242.2"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 317.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 317.9"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 50.7"					"Low region specificity"	"Detected in all"			"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	26.2	15.7	11.3	9.9	16.3	3.6	3.6	22.1	242.2	2.9	24.7	9.3	1.7	1.7	0.7	7.3	3.8	8.7	31.7	12.9	12.4	27.2	33.0	94.4	2.3	15.1	12.4	46.8	5.9	1.1	23.8	20.5	28.7	3.3	1.7	1.8	3.3	5.0	3.8	8.4	5.1	2.3	13.8	63.5	34.5	2.4	15.5	1.3	12.8	3.6	1.7	18.5	10.9	20.1	0.8	1.5	0.0	0.3	0.0	1.1	1.0	0.6	0.5	0.2	0.4	0.5	0.7	0.2	2.2	0.2	0.8	0.4	0.5	0.4	0.3	0.5	0.1	0.3	1.4	0.0	0.0	0.1	3.3	0.2	1.0	0.5	0.0	0.0	0.0	0.2	0.6	50.7	0.0	0.0	0.3	1.3	0.1	0.3	5.4	0.0	0.1	0.7	0.0	0.3	0.1	0.0	0.2	0.9	3.1	0.1	0.4	0.7	0.2	0.1	0.5	0.4	3.6	6.9	0.4	0.0	1.3	1.3	2.3	6.5	35.1	13.4	6.4	44.1	1.0	0.2	0.7	3.4	12.2	0.0	0.0	1.6	317.9	8.3	37.7	0.2	0.0	11.8	11.3	16.3	22.1	242.2	12.9	12.4	15.1	12.4	28.7	13.8	15.5	20.1	14.0	9.6	9.3	0.3	23.8	29.3	335.3	4.4	5.2	42.5	8.7	36.2	11.1	0.0	12.2	5.5	127.2	1.8	12.8	25.3	0.0	0.4	3.2	16.2	16.4	36.7	71.0	24.0	0.0	0.0	11.2	98.8	30.1	26.2	2.5	0.0	3.9	0.3	76.0	10.1	0.0	71.0	4.1	47.8	478.8	1.1	5.6	213.7	103.2	1.0	15.8	36.1	5.2	0.0	0.1	0.3	16.5	0.0	104.1	180.1	0.0	1.5	17.1	36.9	0.0	11.1	235.6	2.9	0.6	16.5	21.7	18.3	391.3	3.6	67.3	92.7
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Hydrolase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 2455.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	Yes		140000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: AB_2681854"	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	539.8	604.9	456.3	542.1	498.1	442.4	448.9	591.6	887.9	326.6	571.4	435.8	506.9	367.3	614.7	554.2	498.5	508.6	892.4	535.1	614.9	850.5	763.2	480.1	685.0	564.8	564.2	421.4	1238.1	593.8	501.9	487.1	620.0	411.2	525.8	531.5	404.1	439.8	1519.0	224.4	453.5	508.4	554.2	520.3	676.7	395.0	559.8	628.6	422.6	1508.5	879.6	866.0	302.4	656.8	1369.6	2077.3	1370.5	1176.5	1259.4	1337.4	1775.6	2730.9	1550.4	3373.2	2004.8	3151.7	1787.3	2318.5	1614.6	1591.9	2337.3	1835.9	4091.6	1027.2	3323.5	1955.4	605.9	2570.4	881.5	1532.0	347.5	2418.0	1757.1	721.8	1594.5	1045.0	320.7	1753.4	1845.6	321.7	2727.8	1147.0	2704.5	1235.5	2507.0	1761.3	2063.2	3463.3	1874.0	2214.4	962.2	1281.3	1665.1	1008.4	1371.8	1023.9	1980.4	2110.5	763.6	1491.1	1837.1	901.9	1767.0	1621.1	1246.1	1404.5	2402.7	740.6	1985.0	1890.9	1791.1	3316.9	1970.0	517.7	592.3	587.8	1245.4	1159.8	1499.6	1009.2	1441.8	1366.1	656.1	752.2	1367.5	1326.5	201.8	1110.7	1255.0	465.5	1761.7	3439.4	456.3	498.1	591.6	887.9	535.1	614.9	564.8	564.2	620.0	554.2	559.8	656.8	795.5	192.3	228.2	72.5	576.3	282.3	2455.6	315.3	507.6	206.7	454.5	380.1	396.3	278.8	352.8	130.6	127.2	926.1	740.3	513.1	528.3	589.0	49.8	404.1	380.1	512.8	519.8	551.7	33.4	628.8	1032.6	609.7	366.0	366.5	434.8	633.8	249.9	223.9	810.9	181.7	45.6	511.1	303.2	359.8	1060.8	58.2	222.4	590.6	528.3	35.6	530.9	307.4	639.5	28.1	50.3	513.8	552.1	270.0	573.6	779.5	823.0	1002.2	465.7	278.1	243.3	416.3	893.1	248.9	419.2	590.6	284.6	1512.1	1123.5	430.3	632.0	1171.5
HSPA9	"GRP75, HSPA9B, mot-2, mthsp75, PBP74"	ENSG00000113013	"Heat shock protein family A (Hsp70) member 9"	P38646	5	138553756-138575675	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000898, CAB005219"	Supported		Supported	Mitochondria		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB005219: AB_647720, HPA000898: AB_1079032"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.29e-1)"	88.6	226.3	10.3	51.5	15.1	98.8	72.4	25.4	26.0	60.3	28.8	80.3	61.2	67.0	33.9	87.8	56.5	38.3	179.5	10.9	19.6	112.1	194.2	62.5	43.6	19.6	20.7	80.0	79.8	169.4	71.4	46.5	23.8	56.4	56.5	48.8	78.9	46.7	288.9	77.5	64.3	44.2	21.6	54.7	91.8	50.1	17.8	44.6	91.3	193.6	55.7	73.8	65.6	29.1	196.0	276.6	111.4	231.0	138.1	94.3	274.7	198.3	196.7	255.4	268.6	579.4	194.4	419.3	263.7	150.8	382.0	158.6	334.0	314.1	298.2	219.7	177.9	230.5	209.0	270.4	360.4	229.0	201.3	142.6	317.7	299.5	494.8	78.7	128.0	167.8	280.4	297.5	134.7	220.6	206.7	82.9	182.5	191.6	173.3	252.1	188.8	302.4	192.8	267.4	150.1	112.4	242.5	338.5	630.7	269.0	230.5	200.5	117.7	204.1	126.5	174.9	313.5	324.6	300.5	378.6	249.6	301.4	202.6	11.8	31.3	10.7	39.8	34.9	46.2	31.7	30.6	36.8	42.0	22.4	34.1	33.9	4.3	28.3	38.8	17.9	31.3	53.6	10.3	15.1	25.4	26.0	10.9	19.6	19.6	20.7	23.8	21.6	17.8	29.1	63.0	99.3	123.8	43.1	101.7	87.8	228.6	157.2	84.8	88.2	83.4	63.8	337.3	70.1	153.8	99.3	83.4	194.7	114.7	80.8	223.0	151.4	12.1	90.1	98.4	83.1	73.0	75.1	41.1	106.1	132.9	109.6	73.9	126.6	167.8	86.1	43.5	175.9	133.9	99.3	48.4	95.4	148.5	54.1	76.4	12.6	67.4	100.1	83.6	25.3	92.3	92.5	43.3	27.6	43.3	93.8	66.0	72.6	102.3	131.1	85.8	231.3	119.7	89.3	46.0	134.3	136.2	52.5	91.4	93.2	73.9	175.5	130.7	157.9	150.7	141.2
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754566-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 2969.8;tongue: 1759.1"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		310000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610"	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.43e-6)"	650.0	414.0	37.3	45.4	40.6	0.4	394.9	32.5	49.2	581.9	26.1	699.9	28.1	565.1	101.6	112.3	495.1	97.9	1463.9	30.0	43.6	69.0	42.3	126.6	5.7	76.7	48.5	455.2	50.5	4.2	17.5	40.2	73.7	271.2	44.0	21.1	115.9	194.7	2969.8	39.1	180.0	278.2	50.8	15.7	362.1	60.6	53.8	6.2	99.5	1759.1	2.7	537.3	290.6	49.3	0.6	0.7	2.1	2.5	1774.3	742.0	1.2	83.0	1.3	4.9	9.3	1.1	0.4	0.7	0.6	252.4	0.0	0.2	0.4	0.7	3.9	0.9	0.5	0.4	1.3	0.5	599.9	0.2	0.9	700.3	0.0	19.1	0.9	2.2	5.4	0.3	0.5	1.0	0.2	0.3	0.4	1.9	1.2	2.3	0.6	1.5	0.5	0.7	0.0	0.1	0.8	0.7	0.1	0.2	0.7	0.3	0.3	0.5	0.1	153.2	0.9	17.3	0.6	1.0	2.8	0.3	20.5	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	40.6	32.5	49.2	30.0	43.6	76.7	48.5	73.7	50.8	53.8	49.3	11.1	3.2	0.6	1.6	0.1	1.8	0.4	0.0	3.4	7.8	0.5	0.5	29.7	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	0.1	27.0	4.9	165.7	3.6	0.0	5.2	0.2	0.0	2.5	125.2	4.1	3.5	0.0	3.6	17.5	0.3	5.0	0.0	0.5	0.0	0.0	0.3	3.6	18.9	271.8	2.7	1.8	0.0	0.6	44.5	0.0	0.0	0.1	0.2	0.0	220.4	0.1	0.4	0.0	0.4	0.0	2.8	26.3	38.0	102.6	2.3	1.4	1.9	2.0	4.8	1.8	311.0	0.0	0.5
HSPBP1	FES1	ENSG00000133265	"HSPA (Hsp70) binding protein 1"	Q9NZL4	19	55262223-55280381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 270.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005865, HPA070398, HPA071444"	Supported		Approved	Vesicles,Centrosome,Cytosol		NA	NA		19000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Vesicles, Centrosome"	"CAB005865: AB_304116, HPA070398: , HPA071444: AB_2686396"	"unprognostic (3.07e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.20e-3)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.14e-2)"	24.6	29.0	41.4	14.5	50.8	16.6	25.4	41.4	60.5	29.8	34.1	34.9	15.7	39.3	5.2	42.1	38.4	6.2	46.9	41.9	40.3	38.8	37.9	23.9	12.3	40.3	41.8	34.3	27.4	18.9	26.8	8.3	38.6	29.3	6.7	7.3	25.2	10.4	46.9	33.7	24.0	8.0	39.2	21.0	28.9	32.5	39.6	9.6	27.1	16.9	8.1	33.3	29.7	39.5	86.9	150.0	27.1	38.6	15.3	14.3	78.8	44.3	17.8	45.0	38.3	85.5	57.7	56.1	42.1	24.3	27.0	59.0	33.1	43.9	11.6	48.4	270.8	74.9	48.2	79.7	34.1	72.3	38.1	18.5	39.4	44.6	20.9	19.4	22.5	46.5	61.6	31.1	15.8	80.3	65.4	64.2	95.6	75.2	125.8	63.7	41.7	121.0	30.4	54.8	71.0	108.0	54.2	54.2	46.9	14.4	41.7	56.4	29.8	50.3	55.0	29.4	83.1	48.4	126.9	60.0	57.6	62.6	56.6	2.0	25.7	7.2	39.1	45.4	40.9	53.9	42.2	44.7	52.9	64.3	42.1	41.1	1.7	44.2	39.6	29.3	43.3	25.1	41.4	50.8	41.4	60.5	41.9	40.3	40.3	41.8	38.6	39.2	39.6	39.5	11.8	9.6	11.5	5.5	15.6	26.8	39.7	55.5	29.6	15.9	20.1	20.8	13.2	34.3	35.1	35.0	6.2	48.0	11.6	46.4	72.4	62.5	13.4	69.4	15.2	18.5	22.6	18.1	8.6	46.1	57.0	22.0	25.5	13.4	10.8	20.0	10.4	23.9	39.1	13.5	11.6	31.7	44.7	11.3	13.7	16.0	19.6	11.9	17.8	3.7	28.2	14.9	21.6	6.0	7.3	42.6	44.4	17.7	27.3	29.5	25.5	62.5	119.8	14.8	26.3	24.2	31.9	39.0	28.8	27.9	29.5	37.5	17.1	16.6	58.9	35.2
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134973-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 1251.1"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1316.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 1251.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	Yes		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	52.2	42.1	175.9	23.5	193.6	20.7	27.9	175.2	1251.1	25.0	182.5	29.3	11.3	25.9	37.6	35.8	54.8	32.3	57.3	184.9	189.3	73.5	47.6	66.6	34.9	172.7	180.7	56.3	28.6	30.3	63.8	37.8	180.9	28.4	25.3	26.7	20.1	29.3	36.6	21.7	20.4	28.0	177.2	32.3	53.1	67.8	190.2	37.4	32.2	32.6	45.1	58.8	35.4	227.4	69.9	130.7	105.1	10.2	99.1	56.0	70.0	117.8	104.6	179.0	82.8	154.9	105.4	179.6	71.9	82.4	253.7	131.2	411.7	104.8	229.2	141.6	51.7	155.7	69.3	137.2	32.3	109.1	118.8	35.5	236.5	119.6	68.3	93.0	105.4	62.0	132.7	27.8	127.4	94.7	158.1	124.2	150.3	338.6	96.6	122.5	85.8	58.9	135.0	83.5	108.5	90.1	107.4	104.0	56.6	160.6	35.0	104.7	64.4	61.3	77.4	89.2	132.4	21.8	76.0	150.6	51.0	129.8	104.7	1.4	5.0	2.7	7.6	12.2	9.4	11.1	9.7	11.8	8.4	10.6	14.7	13.8	0.5	16.7	19.6	6.6	7.0	7.7	175.9	193.6	175.2	1251.1	184.9	189.3	172.7	180.7	180.9	177.2	190.2	227.4	171.1	131.4	87.7	36.6	130.8	214.6	1316.2	44.7	175.2	38.7	152.2	143.3	163.6	40.0	123.3	46.0	417.0	23.2	78.9	153.2	29.4	49.8	100.0	346.1	140.1	132.3	227.7	58.9	121.0	35.9	64.2	249.6	94.3	250.6	248.6	61.7	26.4	25.7	90.6	30.3	77.7	159.0	65.1	38.6	452.1	36.5	33.8	281.3	163.7	55.3	42.6	28.2	26.8	30.7	53.2	45.5	154.0	39.1	142.0	426.3	18.2	31.6	290.5	79.0	39.5	98.1	153.1	161.3	164.6	151.1	143.3	42.5	363.8	58.5	166.1	511.8
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43450989-43453989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 232.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 97.7;HUVEC TERT2: 106.7;U-251 MG: 99.2;WM-115: 105.5"					"Low region specificity"	"Detected in all"			HPA040092	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favorable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.72e-5)"	31.7	22.8	28.1	9.3	29.2	12.1	19.3	29.6	36.3	23.4	27.9	21.3	44.1	23.3	15.4	15.0	24.2	18.7	20.8	27.0	31.2	29.5	44.6	23.0	11.3	30.9	28.9	42.1	53.7	25.2	14.6	10.5	30.9	19.8	12.3	4.1	35.3	47.0	20.8	16.2	34.4	13.2	30.0	12.2	23.9	3.9	28.4	8.8	19.1	10.2	9.2	17.4	15.3	32.4	58.7	7.3	2.2	3.5	9.8	15.1	0.2	48.4	35.7	52.6	34.3	24.2	97.7	0.0	4.1	29.7	25.1	10.9	0.0	45.8	21.6	15.2	20.5	10.2	25.0	0.0	58.8	0.0	0.0	9.4	12.4	64.0	0.0	56.3	106.7	0.5	1.2	0.0	34.5	1.2	9.6	8.8	11.1	5.6	15.5	46.0	0.0	0.3	37.5	2.2	27.2	20.3	56.0	30.4	13.2	8.7	9.2	72.0	59.5	3.7	0.0	12.4	99.2	0.0	0.0	0.0	4.1	13.4	105.5	10.6	1.7	3.7	4.2	1.3	5.5	4.3	7.1	3.3	5.8	5.3	6.6	2.0	0.1	7.5	1.8	29.9	0.7	4.0	28.1	29.2	29.6	36.3	27.0	31.2	30.9	28.9	30.9	30.0	28.4	32.4	29.8	19.2	64.4	5.9	16.1	28.0	45.2	22.8	51.8	16.9	41.0	65.3	0.4	65.8	23.0	57.0	10.4	18.6	19.2	56.6	45.0	106.7	1.2	9.9	23.6	23.2	69.5	21.5	1.4	86.1	115.9	45.7	25.5	18.7	43.2	33.5	25.0	59.0	29.8	8.4	1.9	89.1	16.2	8.5	31.0	4.5	31.7	23.5	40.9	1.9	15.8	45.0	8.2	4.5	4.8	109.6	97.0	30.5	41.7	33.7	232.5	146.9	12.4	16.7	26.3	31.3	58.2	1.4	3.0	27.3	22.0	12.0	12.3	49.8	47.6	38.4
IARS1	"IARS, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase 1"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 47.6;Cytotrophoblasts: 29.8;Extravillous trophoblasts: 31.7;Hofbauer cells: 17.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	22.2	24.3	6.3	28.8	5.8	13.2	27.4	8.8	11.5	26.4	10.7	29.1	17.9	32.5	15.1	31.8	27.7	16.1	32.2	6.8	10.7	28.4	19.6	18.9	28.3	5.9	7.3	20.4	40.1	52.3	11.7	27.7	8.6	27.7	33.3	25.2	25.5	31.6	43.1	21.7	16.2	42.6	3.6	19.7	31.4	20.0	5.2	27.5	64.6	47.2	37.6	28.2	11.7	6.9	150.7	154.9	83.3	132.2	110.5	142.2	126.8	156.4	146.2	118.8	138.5	52.2	99.0	216.0	54.9	231.4	130.5	194.9	254.4	197.9	149.3	126.1	97.9	135.3	128.3	62.8	235.6	181.3	90.6	134.1	194.9	208.9	348.9	78.3	123.6	230.1	229.2	189.8	145.0	79.3	173.2	31.6	139.7	294.5	143.3	116.2	129.3	103.0	72.9	72.6	110.2	91.5	118.2	117.0	128.8	87.8	95.2	94.4	101.3	89.5	104.6	149.3	119.1	134.8	156.4	99.5	218.7	133.3	173.3	2.8	5.9	0.7	11.9	7.0	16.4	13.9	11.8	11.9	12.7	9.7	12.8	12.7	0.5	19.5	6.3	4.8	10.9	9.0	6.3	5.8	8.8	11.5	6.8	10.7	5.9	7.3	8.6	3.6	5.2	6.9	7.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	29.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	31.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	17.4	1.1	0.0	0.0	0.0
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094132-220148041	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		35000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	55.8	49.8	19.9	33.3	21.1	18.3	41.8	23.5	25.4	35.3	37.8	54.2	43.4	31.8	31.4	47.9	41.4	30.5	60.0	20.0	21.8	65.5	83.8	31.0	38.8	22.7	22.2	39.0	33.6	80.5	16.0	40.7	25.0	36.1	54.8	34.8	40.0	37.5	92.9	40.5	40.4	39.4	21.6	28.4	39.1	30.1	22.3	31.8	39.7	85.7	43.1	35.6	30.0	22.9	137.2	125.6	70.7	69.9	104.2	104.4	169.6	81.4	86.9	87.9	70.7	121.7	138.8	125.6	107.1	101.4	68.0	129.3	99.0	101.5	100.9	87.5	119.3	62.6	94.6	137.8	64.6	100.4	64.9	76.0	101.3	95.4	97.6	84.7	86.9	79.9	156.9	70.7	116.7	75.9	79.8	72.0	92.1	106.2	82.1	69.5	140.7	202.2	126.2	90.4	38.0	106.6	123.2	188.2	130.3	80.6	218.5	111.9	89.8	86.1	71.6	117.0	138.4	60.0	98.9	90.8	91.3	77.3	97.6	33.8	24.6	22.8	23.0	27.7	30.8	23.6	24.9	30.3	29.2	18.3	27.8	25.6	4.7	28.3	22.3	10.6	29.9	26.7	19.9	21.1	23.5	25.4	20.0	21.8	22.7	22.2	25.0	21.6	22.3	22.9	66.4	35.3	38.0	15.7	30.7	20.1	28.6	44.1	34.7	28.6	40.1	39.4	144.3	22.8	42.9	29.5	25.0	79.0	31.5	54.2	11.7	47.7	20.0	63.8	48.3	43.7	36.2	29.6	17.3	65.4	55.5	37.0	32.1	44.3	19.6	41.3	37.5	99.6	45.9	20.2	22.7	55.4	28.5	51.0	11.2	6.8	37.3	35.9	19.6	15.0	46.1	34.6	27.8	16.6	31.5	67.4	44.9	42.5	33.1	34.1	38.4	36.1	62.0	35.5	46.0	46.3	39.0	44.6	44.1	63.5	26.6	71.7	31.0	54.4	69.9	27.6
ICA1	"ICA69, ICAp69"	ENSG00000003147	"Islet cell autoantigen 1"	Q05084	7	8113184-8262687	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 594.7;Late spermatids: 867.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"T-reg: 29.9"	"Lineage enriched"	"Detected in many"	9	"T-cells: 29.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.1;MCF7: 42.5;OE19: 48.4;RT4: 49.4;SCLC-21H: 66.1;SH-SY5Y: 105.8;SK-BR-3: 52.1;T-47d: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017646, HPA061452"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 25: Pancreas - Digestion"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Vesicles, Cytosol"		"HPA017646: AB_1851382, HPA061452: AB_2684525"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.83e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.23e-8)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.08e-2)"	15.8	10.4	11.3	5.7	16.2	23.8	21.1	21.5	21.8	16.4	1.2	22.8	13.6	6.8	13.6	9.5	13.7	11.1	44.3	13.4	9.3	16.0	8.8	11.2	13.5	8.0	9.5	1.7	62.7	20.9	19.8	8.2	9.3	22.1	23.5	2.9	37.1	4.9	2.8	12.8	17.8	5.6	5.1	12.4	30.5	24.2	13.3	5.0	14.1	3.3	9.6	13.8	7.4	15.3	0.0	1.5	1.7	0.2	0.2	0.0	4.2	0.0	0.0	0.6	0.2	1.0	47.1	0.3	5.2	0.1	0.9	0.0	0.8	1.9	0.0	0.0	6.8	9.1	0.9	0.0	0.4	9.1	1.8	0.0	3.0	0.0	0.0	0.5	31.5	8.2	26.4	0.0	0.0	42.5	0.4	0.0	9.9	48.4	0.4	0.0	0.0	19.5	19.0	49.4	66.1	105.8	0.0	52.1	0.7	11.6	43.4	14.3	19.8	0.0	0.9	0.2	1.0	14.1	7.5	0.0	0.0	6.9	10.3	1.0	2.4	0.2	0.3	0.8	0.6	0.4	5.4	0.4	2.4	0.7	0.3	0.2	3.4	0.9	0.4	0.6	29.9	1.3	11.3	16.2	21.5	21.8	13.4	9.3	8.0	9.5	9.3	5.1	13.3	15.3	73.4	28.9	24.4	6.5	1.6	20.5	16.2	7.1	9.1	10.4	42.8	28.7	43.2	22.8	20.1	22.0	6.2	2.7	2.1	28.2	43.0	38.4	594.7	34.2	5.8	44.1	77.2	16.4	132.1	74.8	0.8	4.5	56.1	65.4	8.2	11.2	42.1	1.3	23.9	0.0	138.0	80.5	44.7	8.1	9.3	867.0	7.5	9.6	14.2	60.0	6.3	0.8	3.1	49.3	3.9	59.8	53.1	3.0	1.7	53.8	23.8	8.3	17.8	1.7	6.6	1.2	5.6	13.9	9.6	18.4	8.9	2.2	9.5	4.7	41.8	42.7
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 219.3;urinary bladder: 215.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 612.2;Alveolar cells type 2: 561.6;Endothelial cells: 240.8;Langerhans cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 158.3;Karpas-707: 459.7;RPMI-8226: 148.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA	87900000	2200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favorable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	87.9	23.6	9.1	44.6	9.6	117.1	32.4	7.9	12.0	11.2	9.9	17.7	16.8	23.9	3.5	11.0	26.2	56.4	39.1	8.8	9.9	43.9	67.1	219.3	38.3	12.3	8.7	13.0	11.1	8.3	9.3	27.8	10.2	22.2	18.1	10.5	18.0	6.3	15.1	17.9	22.6	23.4	10.0	55.9	21.5	5.6	15.4	28.4	30.8	12.8	32.9	215.3	12.5	10.2	46.3	0.5	7.9	0.2	2.0	4.4	9.7	8.6	91.6	21.8	62.0	14.0	49.8	39.6	130.3	3.8	99.3	8.9	1.7	0.4	45.6	123.8	0.1	3.8	1.4	62.0	158.3	1.3	23.9	55.7	4.0	13.7	20.3	2.0	10.7	4.9	15.0	459.7	1.5	3.3	0.5	34.9	3.1	0.5	24.7	1.0	0.2	148.5	36.8	0.3	0.3	1.1	61.2	3.3	94.5	3.7	6.9	2.8	34.3	22.3	1.9	12.3	0.8	137.4	142.7	25.5	35.1	26.3	32.6	5.0	28.3	5.2	5.3	25.8	9.8	3.8	4.0	6.3	24.7	1.5	1.9	3.8	40.8	15.2	17.0	14.1	6.1	20.8	9.1	9.6	7.9	12.0	8.8	9.9	12.3	8.7	10.2	10.0	15.4	10.2	150.3	612.2	561.6	0.3	31.7	85.3	22.2	62.6	28.5	0.0	50.2	24.9	1.1	21.5	133.5	3.7	0.0	1.1	28.9	2.9	0.0	176.8	2.0	14.1	15.5	240.8	2.4	1.3	0.5	98.7	3.3	136.6	13.7	29.8	139.8	0.1	48.2	12.1	86.7	0.0	0.4	0.7	32.6	53.6	232.6	1.3	4.7	168.3	76.5	7.5	101.9	4.6	5.2	0.5	0.2	113.7	0.3	1.5	57.6	27.1	0.3	15.0	83.2	0.4	6.6	38.2	57.6	0.8	1.6	4.3	69.3	1.2	28.8	0.5	1.6	14.1
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1667.3;Basal respiratory cells: 1443.4;Hepatic stellate cells: 2131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 509.6;HaCaT: 500.2;Hep G2: 425.3;PC-3: 515.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740"	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	242.2	88.5	53.0	20.2	43.1	9.0	141.3	50.1	57.1	125.7	60.9	136.7	78.4	116.0	4.7	340.4	146.3	35.0	291.9	45.3	56.8	218.1	154.1	204.7	14.0	69.3	56.0	66.8	42.4	8.1	167.8	45.7	62.3	202.5	26.4	5.1	58.5	149.6	53.8	129.6	154.3	12.2	53.3	79.7	162.5	16.4	79.1	5.9	266.8	37.8	6.2	351.1	206.9	47.1	76.1	245.3	2.7	49.3	31.2	14.1	187.6	314.1	12.6	56.9	6.2	130.5	111.4	0.6	509.6	84.3	67.2	500.2	40.1	17.9	8.6	6.2	25.6	41.5	229.2	425.3	42.3	0.9	2.2	57.4	69.7	0.3	4.3	93.5	35.0	27.6	94.0	2.3	110.4	99.8	11.4	1.8	172.7	336.5	515.3	0.9	200.8	4.2	11.1	206.1	93.5	87.4	261.3	91.9	2.4	128.8	57.0	7.6	188.5	151.3	300.0	49.0	216.1	5.6	6.3	5.2	176.2	39.5	21.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	0.1	53.0	43.1	50.1	57.1	45.3	56.8	69.3	56.0	62.3	53.3	79.1	47.1	1667.3	237.2	171.7	88.2	25.1	102.3	992.2	1443.4	406.3	2.7	98.6	114.3	35.1	112.9	685.1	228.1	4.2	129.9	46.3	594.3	37.2	584.1	5.7	794.1	450.1	907.7	572.7	49.9	0.6	535.5	493.7	195.3	675.3	707.6	22.2	8.9	2131.4	109.1	25.6	0.0	0.5	557.4	321.4	72.2	52.4	8.7	28.6	38.9	90.7	92.8	8.2	85.0	1.0	4.0	0.3	257.4	924.9	0.4	26.7	519.7	579.8	7.1	168.1	8.3	13.1	229.7	206.1	3.2	53.7	455.8	87.9	89.1	39.8	15.9	389.1	591.6
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1"	O75874	2	208236229-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 536.3"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 768.1;RT4: 524.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		16000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	150.8	230.8	24.0	37.5	23.9	10.7	63.0	24.6	30.9	67.9	40.8	124.9	179.4	22.9	164.9	92.2	36.6	69.5	25.3	23.5	26.1	122.0	536.3	49.8	33.3	26.4	25.7	84.4	39.9	42.0	16.7	82.5	25.9	214.6	131.2	35.0	59.3	79.1	25.7	23.6	117.4	43.8	25.5	40.1	113.6	57.0	30.0	21.8	45.5	28.1	29.8	153.1	39.9	30.6	66.5	109.6	152.5	63.3	275.1	191.4	86.7	26.3	122.3	44.2	107.3	176.1	159.1	13.1	168.8	84.4	181.6	101.4	112.4	130.7	43.0	8.8	41.7	56.7	87.3	768.1	367.3	37.0	54.7	169.5	278.0	102.7	74.2	69.8	126.1	37.2	58.1	44.5	68.9	42.8	26.3	66.2	284.5	479.7	43.9	25.2	54.8	37.8	206.3	524.0	25.9	45.2	100.5	99.7	351.7	161.2	37.9	111.0	81.1	45.2	44.1	65.3	29.6	20.8	34.5	16.9	148.2	226.7	37.0	12.4	70.1	11.0	9.1	32.3	10.6	10.6	8.2	10.9	50.9	10.1	6.7	7.8	13.8	17.2	15.5	18.8	15.1	29.9	24.0	23.9	24.6	30.9	23.5	26.1	26.4	25.7	25.9	25.5	30.0	30.6	13.9	12.8	49.5	39.2	20.2	12.4	18.8	60.5	52.3	19.5	61.8	31.5	21.8	45.8	69.1	29.5	25.0	320.2	23.7	106.8	21.5	31.1	13.8	31.0	23.4	22.0	58.4	30.3	16.6	86.5	178.8	29.6	76.0	108.8	14.0	257.5	39.7	328.2	175.3	11.8	16.2	98.4	57.0	130.2	23.8	11.2	24.5	71.7	26.6	19.7	47.8	25.4	18.6	66.4	20.0	44.8	55.5	29.3	13.7	53.2	181.2	108.5	21.9	56.6	13.1	7.8	23.6	8.0	26.2	82.4	14.9	95.6	19.8	127.1	129.3	46.7
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha"	P50213	15	78131498-78171945	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 144.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	22.6	25.1	11.5	19.9	12.6	9.7	9.6	17.0	14.7	12.4	21.4	26.2	36.6	13.7	7.8	17.0	11.0	9.0	62.5	14.8	13.2	16.8	14.2	11.9	17.1	13.0	13.1	10.8	13.0	54.7	6.9	12.1	15.2	13.9	26.7	26.2	16.2	16.1	79.4	15.8	36.0	17.1	10.1	15.3	11.9	16.9	14.3	35.0	11.2	99.7	24.8	17.7	11.1	14.8	43.8	58.5	10.4	36.5	25.5	26.1	22.6	50.8	24.5	40.6	30.5	41.6	25.8	91.6	36.8	29.9	59.9	64.2	98.2	39.3	37.0	40.7	32.2	35.7	62.4	19.2	21.8	69.8	48.8	19.9	23.6	39.4	41.2	19.3	25.7	32.0	46.4	35.9	26.0	41.4	51.4	17.4	12.9	25.2	21.8	29.3	44.4	28.1	33.4	58.3	41.4	15.8	58.2	82.1	47.1	19.1	32.7	37.4	26.4	47.6	43.9	63.1	83.1	41.5	99.9	48.8	33.2	64.9	37.7	16.9	27.9	8.3	15.1	52.9	16.4	27.7	14.7	13.5	43.5	32.6	15.2	16.4	15.5	17.3	54.8	144.4	17.7	23.2	11.5	12.6	17.0	14.7	14.8	13.2	13.0	13.1	15.2	10.1	14.3	14.8	18.0	9.6	16.5	22.9	30.6	56.0	58.7	51.4	33.0	35.1	10.9	12.6	17.5	14.3	22.6	25.8	37.5	38.3	63.0	69.0	82.2	26.1	52.2	19.9	13.4	17.5	19.2	9.4	45.9	17.9	40.4	21.2	11.7	9.2	27.3	14.5	10.8	22.4	26.5	26.9	53.3	37.6	69.2	24.9	28.6	23.4	20.8	26.4	26.6	12.2	16.0	29.3	12.3	19.6	17.9	21.5	37.9	23.7	33.2	40.6	49.6	48.1	38.2	34.6	13.1	23.8	25.5	45.7	26.2	28.4	41.2	68.4	17.7	37.2	56.0	42.0
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria		NA	NA		8300	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favorable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	55.6	61.3	51.8	33.4	53.0	57.9	54.7	60.8	57.9	56.6	49.4	70.8	73.9	57.3	35.9	62.4	49.8	29.6	185.8	53.8	56.3	71.0	60.5	43.9	41.9	58.0	54.0	57.7	46.0	75.3	36.8	41.1	60.0	45.7	59.7	46.1	49.1	43.1	204.0	61.9	59.9	44.7	50.6	53.1	63.7	36.6	56.6	59.5	49.4	236.6	56.5	55.5	53.4	56.0	111.6	147.4	66.0	57.9	71.3	55.9	76.0	58.2	74.0	134.5	106.7	191.4	113.4	124.5	52.2	80.4	123.7	152.7	122.9	189.0	122.6	34.7	96.7	151.2	58.4	200.6	69.7	166.5	31.8	74.4	71.5	125.9	65.7	59.2	80.4	105.6	194.9	67.7	83.0	61.1	146.1	190.4	128.3	113.4	137.9	117.7	120.2	140.2	77.7	102.5	118.5	85.5	71.9	235.0	127.3	50.8	118.1	73.0	72.4	104.2	65.4	35.8	136.3	91.2	225.3	129.8	49.1	169.9	101.2	76.0	111.7	72.2	84.9	120.8	64.5	96.3	72.8	77.7	131.9	84.6	84.6	73.1	31.4	84.8	110.9	61.2	108.1	102.1	51.8	53.0	60.8	57.9	53.8	56.3	58.0	54.0	60.0	50.6	56.6	56.0	50.7	38.5	28.2	10.4	52.1	56.7	60.2	103.8	48.9	37.9	38.5	38.2	186.0	52.9	49.5	23.9	33.3	133.9	71.3	81.7	156.5	88.5	59.3	28.2	36.0	53.7	50.7	41.6	7.0	102.1	86.3	49.2	37.2	35.9	48.2	54.1	41.7	55.4	97.6	13.5	7.6	68.4	71.2	57.7	60.9	115.1	45.1	51.7	69.4	10.3	78.7	49.3	56.7	6.6	8.9	70.8	72.5	47.4	38.1	37.5	121.7	174.9	33.4	33.4	78.9	50.0	64.1	52.8	55.3	48.4	60.0	108.5	49.1	63.4	113.7	54.3
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 284.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	52.0	67.1	45.5	38.5	50.0	60.3	49.9	47.8	61.3	44.1	46.5	57.2	52.3	50.7	23.5	50.2	44.8	35.0	91.9	54.9	48.8	68.5	49.2	42.0	40.3	50.5	45.7	49.3	48.3	45.5	47.9	28.3	52.3	43.8	34.6	24.4	51.7	39.9	100.5	51.7	54.7	34.5	43.9	51.8	52.2	32.1	49.1	35.2	48.0	82.9	34.9	44.3	43.2	47.2	94.9	90.0	47.3	65.9	74.4	59.4	62.0	47.3	64.1	80.5	84.3	76.0	66.5	121.4	80.2	74.7	68.2	67.2	72.6	69.2	30.0	38.9	101.7	43.0	118.9	59.0	85.5	61.6	87.5	76.1	48.0	64.4	69.4	50.4	65.3	50.3	24.7	60.4	64.7	138.5	72.0	76.0	21.6	84.2	118.0	62.7	43.3	105.8	94.4	61.1	59.5	42.8	30.2	96.3	48.0	20.8	39.6	51.9	56.0	49.9	34.1	76.8	112.5	89.0	22.6	152.1	81.8	75.8	57.6	178.1	159.3	165.8	71.8	163.9	68.0	68.5	73.2	71.2	163.1	78.9	57.9	63.7	57.8	86.5	169.6	101.3	107.5	140.1	45.5	50.0	47.8	61.3	54.9	48.8	50.5	45.7	52.3	43.9	49.1	47.2	44.4	35.3	33.8	5.5	49.2	80.9	67.5	103.9	37.5	34.9	48.4	57.9	55.1	50.1	55.0	51.5	29.2	99.8	48.2	145.0	207.4	93.4	132.0	42.2	39.4	44.6	62.3	41.4	5.6	90.5	98.7	48.2	47.9	39.8	93.8	43.6	43.2	35.4	131.0	18.5	6.4	107.0	79.3	98.0	77.0	284.2	53.4	75.6	67.6	3.7	116.4	50.8	64.9	3.0	5.0	73.5	133.8	58.6	49.7	35.6	222.4	253.1	50.7	49.3	52.6	47.4	68.2	15.9	18.3	50.3	77.4	110.8	55.2	103.0	112.7	64.2
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928790	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.7;placenta: 110.9"	"Cell type enriched"	"Detected in many"	11	"monocytes: 2612.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"eosinophil: 465.0"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 465.0"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 61.8"	"Region enriched"	"Detected in many"	12	"basal ganglia: 34.1"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	9.8	0.7	0.6	40.5	0.4	0.7	2.0	0.4	0.8	7.2	1.0	5.3	10.3	10.2	1.2	1.3	2.6	6.2	1.8	0.4	0.6	1.7	2.4	25.9	58.7	0.7	0.3	1.2	1.2	0.2	0.1	110.9	0.5	2.0	8.2	1.3	1.9	3.0	8.1	1.3	8.4	2.4	0.4	23.0	5.8	1.1	0.8	31.2	4.0	0.6	31.5	9.1	0.5	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	7.6	4.8	0.3	0.8	0.0	61.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.1	0.2	0.2	0.0	0.3	0.0	32.5	1.3	465.0	0.1	1.4	0.1	0.2	0.1	0.0	26.4	0.3	0.1	0.2	4.9	0.1	0.1	0.3	0.1	1.2	0.6	0.4	0.4	0.8	0.4	0.6	0.7	0.3	0.5	0.4	0.8	0.6	24.9	0.0	0.5	0.7	4.4	0.4	0.2	18.3	0.0	0.0	0.5	0.1	0.3	0.0	76.0	0.0	0.0	0.0	0.3	8.3	0.0	4.4	3.7	70.1	23.0	6.9	0.0	0.0	0.2	8.1	0.0	0.3	0.0	223.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	2.0	3.7	28.1	1.8	0.0	13.6	0.0	0.0	2612.3	3.0	0.0	0.0	0.1	0.4	0.0	0.4	2.4	0.5	0.0	0.0	33.3	0.2	0.0	1.2	8.4	0.0	0.1	0.1	0.6	0.0	1.3	0.0	1.3	2.0
IDO2	INDOL1	ENSG00000188676	"Indoleamine 2,3-dioxygenase 2"	Q6ZQW0	8	39934614-40016391	"Metabolic proteins, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"liver: 5.4;placenta: 4.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 21.0;Endometrial ciliated cells: 18.4;Glandular and luminal cells: 51.3;Late spermatids: 6.9;monocytes: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054911			Approved	Cytosol		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"		"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA054911: "	"unprognostic (2.00e-3)"	"unprognostic (2.34e-5)"	"unprognostic (2.22e-3)"	"unprognostic (4.41e-3)"	"unprognostic (5.37e-2)"	"unprognostic (3.69e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.47e-7)"	"unprognostic (3.25e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.1	21.0	18.4	4.4	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	51.3	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.0	0.0	0.0	1.9	6.9	0.3	0.8	0.0	0.0	14.6	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.1
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA002134, CAB016293, HPA073514"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099, HPA073514: "	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	95.7	37.9	13.5	114.5	17.5	35.5	72.8	14.3	14.1	56.8	9.1	38.3	23.8	76.5	22.7	63.6	54.2	100.6	35.0	13.7	20.3	30.1	27.7	68.2	140.6	29.9	22.7	76.8	16.7	9.7	9.3	66.7	27.0	26.5	45.0	7.7	63.7	32.0	16.8	58.8	47.9	87.3	23.6	107.8	30.7	18.8	23.8	116.8	37.4	32.6	133.1	113.6	52.8	26.2	43.5	3.2	14.4	0.6	97.4	319.5	0.4	89.9	238.0	245.7	324.2	0.0	54.1	251.7	75.4	55.3	79.2	122.2	2.2	91.1	97.7	78.4	1.1	64.9	17.2	0.1	181.8	22.8	4.2	302.4	159.5	126.5	177.8	117.8	262.8	218.1	1.4	179.4	138.6	0.0	302.2	21.1	38.4	0.0	32.5	140.6	91.4	295.0	34.4	16.1	6.6	0.1	117.7	1.0	259.5	56.9	0.4	26.3	150.2	63.1	29.7	179.9	38.2	165.8	82.8	235.5	181.2	72.7	155.7	9.1	67.7	0.4	57.5	66.4	51.9	88.4	54.3	59.4	68.3	94.6	33.9	43.3	164.4	91.6	65.3	51.1	82.1	63.8	13.5	17.5	14.3	14.1	13.7	20.3	29.9	22.7	27.0	23.6	23.8	26.2	378.4	38.5	54.6	4.2	217.8	95.0	110.7	197.6	174.8	0.4	47.8	43.8	10.7	37.1	130.7	42.3	0.0	3.4	278.3	7.9	1.9	38.0	4.9	41.9	219.1	286.8	12.1	38.7	1.3	47.8	2.9	207.8	9.7	68.0	138.3	27.7	137.4	3.0	214.2	0.0	2.2	19.9	79.3	163.8	135.0	9.8	117.4	187.2	83.6	116.2	202.4	30.8	329.6	37.2	20.7	47.1	23.5	53.0	143.3	32.6	7.9	4.9	76.6	1.4	85.5	185.3	132.7	2.4	13.2	92.6	68.2	3.3	219.2	70.6	26.4	107.5
IFI27L2	"FAM14A, TLH29"	ENSG00000119632	"Interferon alpha inducible protein 27 like 2"	Q9H2X8	14	94127779-94130253	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 446.8"									HPA049588			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Nucleoli	"HPA049588: "	"unprognostic (9.70e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.76e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.52e-2)"	47.8	114.5	148.9	42.4	157.0	46.6	43.1	159.2	207.3	76.4	142.8	57.3	22.5	51.5	14.5	73.9	54.1	46.4	108.2	149.3	169.0	68.2	10.2	60.0	57.9	162.6	152.7	78.8	27.8	55.0	83.3	10.7	162.3	35.8	20.4	51.6	26.7	21.6	8.8	52.5	52.8	25.6	160.9	72.2	35.5	31.1	160.1	46.9	35.1	9.9	50.5	41.6	72.1	171.9	61.5	39.3	10.8	90.8	70.1	166.5	7.6	118.1	129.9	92.3	99.6	12.1	28.0	29.0	128.3	134.2	59.1	81.6	8.8	150.5	36.8	185.4	3.0	44.0	41.0	4.6	98.5	53.2	116.7	163.1	55.8	50.5	39.0	162.6	49.1	108.5	3.8	446.8	107.5	128.3	32.3	33.9	16.4	41.9	49.2	1.9	40.2	42.2	137.8	25.2	24.1	28.7	3.8	0.0	78.4	22.9	146.4	87.6	65.9	61.5	35.0	79.5	30.1	171.8	164.4	10.4	201.7	124.1	39.2	167.4	238.3	48.0	153.4	167.9	99.4	214.2	140.6	168.4	184.2	201.3	104.2	134.9	37.6	44.3	121.5	153.5	203.5	217.4	148.9	157.0	159.2	207.3	149.3	169.0	162.6	152.7	162.3	160.9	160.1	171.9	86.5	38.5	50.9	10.1	71.8	92.8	73.1	218.3	111.0	27.2	47.9	103.6	162.8	50.1	55.8	178.4	20.9	2.3	79.3	58.2	178.1	159.2	8.2	78.1	113.7	70.1	99.6	20.6	1.6	29.1	2.7	133.0	43.8	11.6	90.7	64.8	121.1	4.2	190.8	23.5	3.6	193.8	57.0	163.7	107.6	31.1	183.0	119.1	236.5	0.0	134.7	181.0	137.0	5.5	13.9	68.1	150.2	115.5	104.4	23.7	125.6	113.3	61.8	113.3	124.9	70.4	87.7	8.3	22.1	105.2	66.9	2.9	92.2	92.7	82.8	55.9
IFIT1	"G10P1, GARG-16, IFI56, IFNAI1"	ENSG00000185745	"Interferon induced protein with tetratricopeptide repeats 1"	P09914	10	89392546-89406487	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 63.3;Distal tubular cells: 64.6;Muller glia cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 66.7"	"Group enriched"	"Detected in all"	8	"granulocytes: 66.7;monocytes: 21.7"	"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 325.3;BJ hTERT+ SV40 Large T+ RasG12V: 318.1"									"CAB045980, HPA053890, HPA055380"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB045980: AB_11125836, HPA053890: , HPA055380: AB_2682800"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.35e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.82e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.75e-3)"	"unprognostic (6.40e-3)"	17.5	38.0	12.6	4.5	12.4	9.9	14.3	15.2	17.8	17.2	13.0	14.6	3.9	6.9	6.6	5.0	9.5	13.8	22.7	12.4	12.7	23.7	24.9	14.1	3.4	15.1	14.2	9.1	6.1	11.9	20.3	9.9	13.5	6.7	5.0	8.0	42.0	6.2	17.4	4.9	7.5	7.9	29.4	18.7	6.9	5.4	13.9	13.3	9.1	20.6	2.4	7.6	9.4	14.4	10.0	1.2	2.6	17.2	8.1	16.5	0.2	11.7	68.9	325.3	318.1	1.0	10.4	0.7	3.8	14.6	63.4	8.2	1.0	1.0	15.6	0.6	1.1	1.7	8.4	0.9	9.2	1.4	1.7	13.5	0.3	6.2	0.1	6.4	0.4	1.7	0.2	7.7	3.5	0.3	2.3	6.8	0.3	0.1	6.3	3.1	0.8	2.0	7.9	1.2	0.1	0.6	3.1	2.4	69.6	2.4	1.3	1.5	0.5	1.7	1.9	2.5	1.4	1.0	1.3	0.6	2.2	2.3	0.9	9.9	12.6	15.4	1.6	15.6	2.9	3.0	4.1	2.9	3.7	3.2	5.7	3.5	66.7	1.9	21.7	0.2	4.9	6.6	12.6	12.4	15.2	17.8	12.4	12.7	15.1	14.2	13.5	29.4	13.9	14.4	63.3	35.3	5.8	7.2	2.5	2.9	3.3	12.9	3.4	26.4	2.4	5.2	19.1	4.3	7.6	9.2	18.8	4.8	4.7	6.3	64.6	12.6	0.4	21.1	3.2	41.4	0.0	4.0	13.8	5.1	20.8	22.8	0.5	7.2	2.5	11.0	9.3	12.1	36.9	32.0	13.3	1.4	4.1	14.5	3.3	3.0	19.3	13.3	1.8	16.9	13.5	77.9	1.0	12.1	14.4	3.6	4.7	43.6	0.7	1.1	9.8	26.7	17.8	13.4	39.5	18.1	11.4	0.5	3.0	1.0	1.7	1.4	3.1	15.4	0.2	1.2
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422887-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 64.2;neutrophil: 112.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 112.3"	"Low cell line specificity"	"Detected in all"											"HPA024122, HPA072413"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA024122: AB_1851452, HPA072413: "	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	35.2	24.6	11.2	6.5	14.4	57.7	32.3	13.2	16.2	23.0	31.7	30.3	8.1	20.8	4.8	24.0	25.4	4.6	30.9	13.9	19.0	21.3	27.3	40.1	3.9	11.0	13.2	31.3	102.9	9.8	31.2	7.9	13.0	28.1	5.5	13.4	25.7	6.4	58.9	21.9	22.2	10.2	11.7	19.9	38.3	24.5	13.1	4.5	25.6	3.1	3.9	24.1	25.8	19.6	22.1	26.8	25.9	21.7	44.4	28.2	25.0	23.8	26.6	36.0	29.6	42.7	21.1	12.2	52.9	18.8	64.6	15.0	21.5	29.2	46.9	17.1	31.7	13.8	46.1	37.9	61.5	19.9	9.5	24.7	43.4	39.7	47.1	18.9	18.3	22.2	46.5	17.4	14.2	35.7	24.1	20.1	51.8	26.9	30.1	24.6	9.2	22.9	6.0	6.1	37.9	18.9	28.0	15.5	61.2	57.7	9.8	15.2	12.6	45.8	10.4	35.0	68.5	27.2	34.8	37.1	12.9	43.6	63.8	19.8	7.6	64.2	7.2	6.5	6.2	8.7	7.7	7.9	6.6	7.2	6.8	7.0	112.3	8.0	6.4	4.6	8.6	5.2	11.2	14.4	13.2	16.2	13.9	19.0	11.0	13.2	13.0	11.7	13.1	19.6	179.3	32.1	31.4	39.2	110.6	197.3	159.3	55.6	259.6	50.3	141.7	142.6	60.6	37.1	55.0	18.4	89.6	66.5	130.9	276.0	17.6	49.6	43.9	123.2	159.7	96.8	138.2	24.6	36.1	56.5	84.2	135.5	162.6	190.1	74.4	51.3	52.8	21.7	126.1	21.9	24.4	183.5	54.9	96.9	153.4	10.1	36.7	141.8	103.2	44.0	55.8	32.4	20.6	24.1	42.6	55.1	287.8	41.0	104.6	143.9	226.9	13.3	34.1	86.8	39.5	138.9	172.7	25.5	14.5	135.1	126.0	151.7	129.8	53.4	180.0	154.4
IFT57	"ESRRBL1, FLJ10147, HIPPI, MHS4R2"	ENSG00000114446	"Intraflagellar transport 57"	Q9NWB7	3	108160812-108222435	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding	Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 1675.3;Late spermatids: 2795.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 41.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035514, HPA035515"	Supported		Approved	"Nuclear speckles,Mitochondria,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 34: Spermatids - Unknown function"	"Nuclear speckles"	"Mitochondria, Cytosol"	"HPA035514: AB_10601757, HPA035515: AB_10696505"	"unprognostic (1.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (2.98e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.59e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (5.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.12e-2)"	8.9	15.3	11.6	8.6	11.7	13.2	13.1	10.2	15.5	11.7	14.8	13.3	6.0	13.3	45.1	8.5	32.0	13.4	10.4	11.4	11.5	21.3	4.5	40.7	17.3	12.0	12.2	14.0	13.8	23.0	16.3	7.8	11.6	27.5	14.6	24.0	9.1	17.5	4.2	8.6	9.0	10.6	11.9	12.1	9.8	42.8	12.0	8.2	26.1	4.4	16.4	13.9	8.3	11.8	35.5	17.2	12.8	23.1	26.1	26.9	7.1	10.6	25.8	15.3	13.6	12.4	6.1	39.5	13.3	17.8	22.0	13.9	11.5	17.8	25.8	6.2	12.2	13.6	8.0	3.3	19.4	28.5	30.2	16.3	16.1	19.9	34.2	24.4	17.5	6.6	6.4	6.9	17.8	18.9	9.5	25.8	13.6	2.7	21.0	6.1	11.5	6.3	31.6	12.3	21.1	14.7	15.9	5.2	9.9	7.1	11.0	8.3	7.5	19.6	10.2	10.5	12.6	8.1	6.2	20.7	28.4	2.7	7.3	0.2	3.5	3.1	3.6	6.5	5.8	41.9	7.4	4.5	10.2	34.9	6.2	3.7	1.8	6.8	12.8	2.0	5.1	4.9	11.6	11.7	10.2	15.5	11.4	11.5	12.0	12.2	11.6	11.9	12.0	11.8	36.6	471.1	291.2	18.6	98.4	41.0	114.1	72.9	34.7	25.6	42.2	50.9	33.8	58.6	201.9	51.5	68.8	22.3	16.9	51.1	117.4	158.8	1675.3	266.3	57.8	38.2	57.2	13.7	52.6	134.1	19.3	78.9	25.5	37.0	44.3	57.1	25.7	5.9	14.5	28.6	20.3	35.7	42.7	8.1	27.7	2795.4	65.3	19.3	46.2	4.7	13.1	56.8	8.2	13.0	13.5	79.4	36.6	64.3	40.2	151.4	24.3	124.5	528.7	72.7	52.6	61.7	61.3	242.2	43.6	25.4	37.2	14.9	30.2	104.9	52.3	93.0
IFT81	"CDV-1R, CDV1, MGC4027"	ENSG00000122970	"Intraflagellar transport 81"	Q8WYA0	12	110124335-110218793	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 79.1;Respiratory ciliated cells: 148.2;Spermatocytes: 179.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019087, HPA020051"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Centrosome	"HPA019087: AB_1851462, HPA020051: AB_1851465"	"unprognostic (2.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.45e-1)"	5.9	9.0	5.0	4.6	5.0	1.5	8.8	7.5	6.0	15.6	10.8	13.6	2.7	14.5	18.5	5.9	18.3	8.5	7.6	5.2	6.0	9.4	4.1	8.3	3.0	7.2	7.0	14.5	5.2	16.5	15.2	5.0	4.4	12.3	5.7	23.0	9.3	14.3	6.8	5.7	5.2	8.5	5.1	4.0	7.4	31.8	5.3	5.8	13.8	6.7	2.9	11.5	9.7	4.1	14.1	26.2	53.0	22.7	9.6	19.6	4.0	8.8	13.5	18.7	16.0	5.1	7.8	4.6	4.8	17.0	13.2	12.2	19.7	10.4	24.1	5.9	10.8	9.7	15.4	8.4	8.3	6.0	4.5	14.1	11.6	17.7	4.5	45.2	11.8	9.0	12.0	2.5	17.3	3.0	12.3	10.1	26.2	8.1	8.6	14.4	13.9	6.2	23.2	9.4	32.8	36.2	24.1	5.0	36.8	14.7	26.9	9.1	8.0	10.5	5.4	8.8	8.4	7.9	8.0	6.3	25.3	7.6	12.2	0.0	0.3	0.1	0.2	0.2	0.5	0.4	0.5	0.2	1.0	0.4	0.4	0.1	0.8	0.7	0.3	1.0	0.2	0.3	5.0	5.0	7.5	6.0	5.2	6.0	7.2	7.0	4.4	5.1	5.3	4.1	5.2	12.8	20.1	26.4	2.4	6.1	12.9	20.3	11.4	16.4	8.6	11.6	22.1	8.6	26.0	14.7	41.7	2.5	0.6	2.3	15.6	10.9	51.8	79.1	36.1	6.0	21.6	2.5	30.1	4.0	1.6	14.9	8.2	11.9	3.8	16.8	4.6	4.8	2.6	25.2	31.8	4.3	18.3	1.3	1.4	18.1	14.0	2.5	35.6	11.2	2.1	19.1	1.0	41.2	14.5	5.7	1.9	27.8	1.9	3.6	0.9	10.5	148.2	37.7	6.6	14.4	25.6	179.0	46.0	7.4	6.5	1.0	1.5	36.3	3.5	4.8
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888360-45893660	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 1198.4"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 994.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	25000000		"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	2.6	0.1	0.2	0.0	0.2	0.0	2.4	0.2	0.3	0.3	0.1	0.0	0.3	79.6	0.1	0.0	4.1	0.3	0.5	0.2	0.3	1.6	1198.4	0.1	0.1	0.8	0.3	46.3	0.5	0.0	0.5	204.5	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.1	0.1	0.3	1.1	0.3	0.0	0.0	0.0	0.2	0.2	0.2	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.3	1.4	0.1	1.6	0.3	0.0	0.0	0.7	0.0	0.0	0.3	0.5	54.7	0.3	1.1	0.1	0.1	0.7	11.3	0.1	0.6	0.3	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.3	0.0	2.2	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.9	0.0	0.0	0.0	0.2	145.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.8	0.3	0.9	0.2	0.3	0.2	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	5.7	1.0	35.8	0.7	0.0	0.0	0.9	0.0	0.0	0.0	11.0	0.1	4.7	94.3	0.9	3.5	10.7	0.1	0.0	1.6	1.8	0.0	15.9	0.0	2.1	6.8	994.8	1.7	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.1	0.5	0.0	0.0	3.4	0.8	0.0	0.0	0.0
IGFN1	"DKFZp434B1231, EEF1A2BP1"	ENSG00000163395	"Immunoglobulin like and fibronectin type III domain containing 1"	Q86VF2	1	201190824-201228952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 186.3"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 103.8"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 8.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"HeLa: 76.6"	"Group enriched"	"Detected in many"	7	"amygdala: 3.3;basal ganglia: 1.2;cerebral cortex: 2.9;hippocampal formation: 1.9"	"Low region specificity"	"Detected in some"			HPA050415	Enhanced		Approved	"Midbody ring"		Yes	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"	"Midbody ring"		"HPA050415: AB_2681120"	"unprognostic (2.09e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.27e-8)"	"unprognostic (3.55e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.0	0.3	0.9	0.6	0.1	0.0	10.4	15.1	0.0	0.9	0.2	0.3	1.2	0.6	0.1	0.1	0.5	0.1	0.1	0.2	0.2	7.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.3	186.3	0.3	0.0	0.8	0.0	0.0	0.1	2.5	0.4	0.0	14.6	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	76.6	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	4.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.2	0.6	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.1	0.0	0.0	0.1	1.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	22.1	0.4	1.8	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	103.8	0.7	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757718-39864312	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 12.1;lymphoid tissue: 41.0"	"Group enriched"	"Detected in many"	4	"B-cells: 108.1;dendritic cells: 76.5;granulocytes: 47.9;NK-cells: 121.5;Plasma cells: 80.2;T-cells: 99.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.2;T-cells: 28.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.0;Karpas-707: 35.6;U-266/70: 41.7;U-266/84: 50.0;U-698: 108.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA024377, HPA073266"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favorable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.0	0.8	0.3	18.8	0.2	5.9	1.8	0.7	0.6	1.5	0.6	3.3	3.5	1.0	0.7	1.5	0.7	3.0	0.5	0.7	0.1	0.6	2.0	3.1	36.5	0.5	0.1	0.7	0.4	0.1	0.2	0.3	0.4	1.0	3.1	0.3	2.2	0.3	0.5	0.9	12.1	0.8	0.1	22.3	6.2	1.6	0.4	23.0	0.9	0.3	41.0	4.5	0.7	1.0	0.2	0.2	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.3	69.0	0.1	0.0	0.1	0.3	0.1	0.2	0.0	15.6	0.3	4.2	0.4	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.1	1.8	35.6	0.0	0.2	6.2	2.4	0.2	3.9	0.1	0.3	0.2	12.7	0.0	4.2	0.4	0.2	1.2	0.5	0.1	0.1	0.2	0.8	0.3	0.3	0.5	0.2	0.1	41.7	50.0	108.1	0.1	0.2	0.1	1.0	0.2	0.8	26.3	0.1	28.8	13.2	11.0	20.3	0.1	11.9	4.5	12.2	1.1	4.5	0.3	0.6	18.9	8.7	0.3	0.2	0.7	0.6	0.7	0.1	0.5	0.1	0.4	0.1	0.4	1.0	1.1	9.6	21.8	0.3	108.1	0.1	2.2	0.0	0.0	1.7	1.2	0.9	4.0	1.5	5.6	1.8	0.0	0.1	76.5	0.2	0.0	0.1	12.8	1.9	0.9	2.4	0.0	4.0	0.6	0.0	0.4	2.3	3.1	3.9	47.9	0.4	4.2	1.2	0.1	0.0	0.4	0.1	0.0	6.3	0.0	11.8	0.0	4.4	0.0	2.8	3.3	0.2	121.5	0.0	0.1	1.2	0.1	0.0	80.2	1.8	0.0	0.3	0.7	1.7	0.0	4.0	1.2	6.3	2.3	0.6	0.1	0.3	99.9	0.1	0.0	1.6
IL10RA	"CD210, CD210a, CDW210A, HIL-10R, IL10R"	ENSG00000110324	"Interleukin 10 receptor subunit alpha"	Q13651	11	117986370-118003037	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 63.6;lymphoid tissue: 73.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.5;Extravillous trophoblasts: 93.0;Kupffer cells: 190.7;Langerhans cells: 145.0;Macrophages: 128.6;monocytes: 175.7;NK-cells: 110.2;Plasma cells: 129.5;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.5;HDLM-2: 76.6;Karpas-707: 27.7;RPMI-8226: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065647, HPA069086"			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"HPA065647: , HPA069086: "	"unprognostic (1.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.27e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.70e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.82e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-1)"	13.9	8.9	4.7	39.8	4.9	63.6	6.1	4.4	7.0	5.6	4.9	12.0	8.0	3.5	2.7	6.4	5.2	17.9	5.3	4.2	5.9	4.1	13.1	23.8	51.7	6.9	5.1	3.1	2.4	2.6	3.6	14.2	5.5	4.7	14.5	0.5	5.2	3.2	1.7	3.2	24.8	10.4	6.0	73.7	9.2	1.9	5.3	16.9	4.2	3.3	32.4	20.7	3.7	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	0.2	0.0	0.7	0.0	0.5	0.0	0.0	76.6	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.6	27.7	0.0	0.0	0.4	6.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	5.6	1.0	8.0	0.0	11.4	0.0	3.3	48.9	2.4	52.8	68.6	38.3	12.6	51.0	62.1	44.7	6.2	17.9	33.3	3.4	70.2	58.6	17.3	88.7	84.1	4.7	4.9	4.4	7.0	4.2	5.9	6.9	5.1	5.5	6.0	5.3	7.5	2.2	6.4	16.0	0.3	52.8	5.7	0.4	0.0	5.7	0.1	1.0	1.9	2.7	0.0	1.3	0.0	0.0	1.3	87.5	0.5	0.0	0.2	0.1	0.4	0.5	4.9	0.0	9.3	0.8	0.8	93.0	2.3	6.6	0.7	12.6	0.0	3.6	1.4	60.4	0.0	1.2	0.0	0.0	190.7	145.0	0.5	0.3	128.6	17.8	22.5	175.7	0.4	110.2	0.0	0.6	0.1	0.1	0.0	129.5	0.0	0.0	1.0	1.5	0.1	0.0	1.6	2.7	0.1	0.3	1.2	4.1	3.3	105.5	0.0	0.7	0.4
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 24.2;lymphoid tissue: 18.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.7;granulocytes: 111.2;Langerhans cells: 25.4;NK-cells: 42.2;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HHSteC: 35.4;U-937: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007615	Approved		Approved	Mitochondria		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	8.2	2.3	1.3	5.6	1.4	2.4	5.4	1.2	1.9	4.5	1.6	4.0	4.1	3.1	1.6	2.2	3.7	2.9	4.5	1.0	2.4	4.4	6.6	24.2	4.1	1.5	1.3	1.1	1.3	3.2	1.7	6.9	1.8	3.3	1.0	0.2	2.2	5.7	0.9	2.6	8.8	0.7	1.3	18.5	4.3	0.5	2.0	2.0	2.1	1.1	2.2	4.0	2.8	1.3	1.8	0.6	0.0	0.0	1.3	0.8	2.3	0.0	1.1	0.1	0.5	0.0	0.8	0.0	0.1	0.0	3.4	0.9	0.0	2.4	0.0	27.4	1.2	2.1	0.5	0.1	35.4	8.8	10.1	7.8	1.9	3.1	5.4	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.4	1.1	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.8	0.9	0.5	3.2	0.6	0.0	0.0	0.0	0.1	52.0	3.6	10.0	0.0	4.8	6.2	0.1	16.3	0.1	3.6	4.7	3.6	0.2	0.6	1.4	6.7	45.6	0.0	10.4	4.1	1.9	1.3	1.4	1.2	1.9	1.0	2.4	1.5	1.3	1.8	1.3	2.0	1.3	10.2	0.0	8.5	0.3	2.7	0.8	1.1	1.1	0.6	0.0	0.3	0.3	3.9	0.0	2.3	1.8	0.0	0.0	44.7	0.3	1.9	0.9	0.1	1.0	4.1	7.4	0.0	3.6	0.2	0.6	1.0	3.1	5.1	1.1	111.2	0.0	10.0	7.6	0.1	0.0	1.0	0.1	0.0	2.4	25.4	0.1	0.3	16.5	3.6	12.2	1.0	0.2	42.2	1.5	0.0	1.1	0.4	0.0	10.3	1.0	0.1	0.9	3.8	0.2	6.6	0.9	1.4	0.4	1.3	0.3	1.0	0.0	25.4	0.1	0.4	0.9
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 110.7;skin 1: 163.3;vagina: 66.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 36.8;Basal respiratory cells: 115.8;Basal squamous epithelial cells: 60.9;Club cells: 43.0;Early spermatids: 57.0;Late spermatids: 28.8;Squamous epithelial cells: 56.5;Suprabasal keratinocytes: 38.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 86.0;HBEC3-KT: 140.0;HHSteC: 91.8;hTCEpi: 555.6;hTERT-HME1: 102.6"	"Not detected"	"Not detected"							HPA063914			Approved	Vesicles,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Cytosol	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	2.3	0.2	0.1	0.0	0.2	0.0	10.3	0.1	0.6	24.3	0.1	0.6	0.0	0.2	0.0	110.7	0.4	0.0	0.6	0.1	0.1	0.2	5.4	0.5	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.4	0.2	2.2	0.5	0.0	13.6	0.2	1.0	163.3	0.4	0.0	0.1	0.3	0.5	3.7	0.2	2.0	0.5	0.9	9.5	1.3	66.2	0.2	27.2	0.0	0.1	0.4	15.4	64.9	2.6	0.6	1.8	0.3	1.2	2.7	3.4	0.2	14.9	9.7	1.0	86.0	0.0	140.0	0.7	0.4	0.0	0.3	19.5	0.0	91.8	0.2	0.2	11.5	555.6	4.5	102.6	0.7	0.1	0.1	0.3	0.1	0.0	0.0	0.6	0.0	0.4	2.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	54.6	0.0	2.8	4.7	0.5	0.9	0.0	0.2	1.8	0.5	0.5	0.1	0.2	0.2	8.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.7	0.0	0.0	0.7	0.0	36.8	1.7	115.8	60.9	0.0	0.3	0.5	0.4	0.0	43.0	0.0	0.0	1.7	0.8	0.8	0.0	0.9	57.0	0.7	0.4	0.9	0.0	0.0	1.0	0.2	1.4	3.9	0.0	0.8	0.0	0.2	0.0	2.2	0.4	0.0	1.2	0.7	10.2	0.3	6.6	28.8	0.3	0.6	3.6	1.0	1.7	0.0	1.0	1.0	0.2	1.0	0.1	0.7	0.4	1.3	0.2	0.3	5.5	0.0	0.0	0.6	3.6	1.7	1.9	56.5	38.1	1.6	0.6	0.2	0.5	5.3
IL27RA	"CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1"	ENSG00000104998	"Interleukin 27 receptor subunit alpha"	Q6UWB1	19	14031762-14053218	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 49.1;dendritic cells: 56.6;Kupffer cells: 41.1;Langerhans cells: 44.2;NK-cells: 69.0;T-cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA073441			Approved	Vesicles		NA	NA		4900000	"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA073441: "	"prognostic favorable (1.74e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (2.58e-10)"	"unprognostic (5.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.87e-3)"	7.8	1.7	2.4	8.7	2.3	2.7	6.5	2.2	2.7	2.7	2.2	3.1	2.3	2.4	0.7	2.6	3.3	2.3	7.7	2.8	2.9	6.1	1.5	8.0	12.6	2.5	2.5	1.0	2.8	5.6	0.8	1.3	2.7	3.6	2.1	0.2	3.0	1.2	2.0	2.2	8.1	1.9	2.5	14.7	2.8	2.0	3.1	11.1	4.0	2.4	16.5	3.9	2.8	2.4	7.7	3.3	3.2	4.4	0.2	1.6	1.3	3.5	7.3	6.3	9.0	1.6	6.1	0.1	3.6	3.1	2.9	1.4	5.1	2.1	4.8	14.8	3.5	18.6	0.7	2.7	0.5	9.0	0.2	1.6	0.8	3.0	0.6	5.1	2.5	4.6	13.1	13.5	0.3	10.7	6.8	19.5	4.2	4.5	2.2	5.8	1.9	7.1	3.9	1.8	2.8	1.5	4.5	0.3	5.2	1.7	5.6	5.4	4.0	0.6	7.7	6.4	3.8	13.9	7.2	6.7	0.6	18.2	4.2	7.9	22.5	0.6	24.3	18.4	21.4	15.6	24.0	20.2	20.7	12.8	26.1	20.6	1.6	22.9	9.5	7.6	23.1	21.4	2.4	2.3	2.2	2.7	2.8	2.9	2.5	2.5	2.7	2.5	3.1	2.4	30.4	0.0	10.0	0.0	49.1	1.9	13.3	8.5	3.4	0.3	14.0	11.9	5.4	5.7	5.7	3.7	0.0	0.6	56.6	0.7	0.0	10.7	0.4	1.9	1.2	22.8	2.4	7.2	2.4	2.7	1.4	4.0	3.6	1.5	17.7	1.4	22.9	0.7	21.4	1.7	2.1	0.9	4.1	41.1	44.2	0.5	3.4	32.8	5.4	1.0	22.8	0.3	69.0	1.0	0.6	3.8	0.8	3.4	26.0	12.4	0.0	0.9	2.0	0.0	0.0	1.9	2.2	0.1	11.5	2.6	1.3	0.1	63.5	0.4	2.4	3.5
IL33	"C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV"	ENSG00000137033	"Interleukin 33"	O95760	9	6215786-6257983	"Predicted intracellular proteins, Predicted secreted proteins"	Transcription	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 120.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 141.8;Fibroblasts: 87.5;Hepatic stellate cells: 499.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 53.6;U-2197: 162.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007057, HPA022899, HPA024426"	Supported		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"CAB007057: , HPA022899: , HPA024426: AB_1845820"	"prognostic favorable (4.42e-4)"	"unprognostic (8.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.85e-3)"	38.7	16.7	9.2	44.6	9.3	0.2	27.2	7.0	12.1	56.2	6.4	24.8	8.8	50.0	15.9	24.5	25.9	33.4	40.9	8.5	10.8	5.0	36.7	53.0	47.1	7.8	8.3	5.0	3.4	3.7	5.7	61.1	7.1	30.0	19.4	2.0	18.9	31.5	6.1	44.0	15.6	50.8	8.3	20.5	33.6	5.8	10.8	13.1	12.6	13.8	43.0	120.7	21.2	8.6	0.0	0.0	0.0	0.0	0.3	1.4	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.1	16.9	0.3	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.7	0.3	0.4	53.6	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	162.9	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	9.3	7.0	12.1	8.5	10.8	7.8	8.3	7.1	8.3	10.8	8.6	63.5	6.4	7.2	39.5	1.0	24.2	17.0	73.9	27.3	0.0	9.4	4.1	5.8	4.3	77.8	0.0	0.0	0.0	0.1	2.2	0.0	3.0	0.5	12.4	7.1	141.8	10.7	8.0	0.2	7.9	0.0	87.5	48.4	20.6	1.3	0.0	499.4	5.0	0.1	0.0	0.1	0.2	2.0	20.8	10.2	1.6	20.5	1.7	1.8	1.0	0.0	9.5	0.0	0.5	0.1	12.1	0.2	12.4	0.2	5.2	0.0	0.0	62.1	0.1	0.0	65.5	11.5	0.0	0.4	3.3	48.4	0.1	1.2	0.1	1.1	4.9
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 136.8"	"Cell type enriched"	"Detected in some"	26	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.7;PC-3: 5.9;RT4: 3.2"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	76700		"Cluster 48: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"		"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.1	0.0	0.0	0.2	0.0	0.2	16.7	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.1	0.4	136.8	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.1	0.2	2.7	0.2	0.2	0.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.4	0.8	0.1	0.0	1.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.2	0.2	5.9	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	73.2	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.8	0.0	0.1	0.0	0.0	0.0
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 18.3;testis: 26.8"	"Group enriched"	"Detected in many"	5	"Langerhans cells: 295.1;monocytes: 682.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 35.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 103.4"	"Group enriched"	"Detected in many"	6	"monocytes: 36.8;T-cells: 103.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 34.3;HDLM-2: 62.4;Karpas-707: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	1.6	0.6	0.4	18.3	0.6	4.2	0.9	0.8	0.6	1.1	0.7	1.7	4.1	1.6	0.2	0.6	3.9	2.0	0.5	0.6	0.5	4.8	1.2	2.4	9.3	1.7	0.9	0.4	0.7	0.2	0.6	1.9	1.8	0.8	1.4	0.1	0.9	0.5	0.3	1.3	2.7	1.5	1.0	4.1	3.1	26.8	1.2	3.4	0.5	0.2	6.7	4.5	0.5	2.3	1.0	1.2	0.8	0.7	0.0	0.8	0.3	0.5	2.0	1.4	2.1	0.7	1.9	3.5	34.3	0.4	2.9	0.5	0.4	0.0	0.2	62.4	0.2	1.6	0.1	0.5	0.1	1.2	12.3	1.0	0.4	0.6	0.1	0.4	2.6	0.4	0.4	47.3	0.1	0.4	0.7	2.1	0.4	0.9	0.1	1.0	0.9	3.6	2.5	3.2	0.7	0.8	0.5	0.9	0.5	0.2	0.4	2.8	2.9	7.1	1.0	0.1	1.0	4.1	9.7	2.0	1.0	0.5	0.7	0.3	22.0	0.3	6.4	36.8	103.4	0.4	13.2	11.5	11.6	0.2	0.3	0.1	0.5	1.3	5.3	1.3	0.7	8.8	0.4	0.6	0.8	0.6	0.6	0.5	1.7	0.9	1.8	1.0	1.2	2.3	0.8	0.0	0.0	0.0	3.6	9.7	0.6	9.8	0.0	0.1	1.2	1.3	0.5	0.0	5.5	3.7	0.0	0.4	1.0	0.2	0.0	3.5	75.4	2.9	0.6	6.7	0.0	0.0	0.4	4.0	0.7	1.3	0.5	2.1	1.3	0.1	1.1	0.2	97.4	0.0	0.4	0.3	6.1	3.0	295.1	18.4	0.3	38.8	3.6	1.9	682.5	0.1	1.0	0.0	0.4	0.5	0.1	0.4	0.7	1.4	0.3	2.7	1.6	0.2	0.0	0.2	2.5	45.2	3.6	0.4	8.2	0.8	6.3	0.0	0.2	2.1
IL7R	"CD127, IL7RA"	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 183.7"	"Group enriched"	"Detected in many"	4	"monocytes: 271.8;T-cells: 973.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 102.1;MAIT T-cell: 369.5;memory CD4 T-cell: 213.8;memory CD8 T-cell: 151.1;naive CD4 T-cell: 179.5;naive CD8 T-cell: 124.6;NK-cell: 113.2"	"Group enriched"	"Detected in all"	33	"NK-cells: 113.2;T-cells: 369.5"	"Cell line enhanced"	"Detected in many"		"BJ: 99.8;BJ hTERT+ SV40 Large T+: 87.7;fHDF/TERT166: 187.7;HBF TERT88: 168.3;REH: 406.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010215, HPA067550"			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		610000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"		"CAB010215: AB_673727, HPA067550: "	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"	11.2	14.4	1.5	137.6	1.8	14.0	20.4	7.4	2.7	12.0	1.0	17.3	15.0	3.9	1.6	11.0	5.7	32.4	2.2	2.0	2.5	4.5	12.5	63.9	139.4	1.8	0.5	2.2	5.3	0.8	1.7	2.9	1.6	8.7	20.4	0.9	3.3	3.1	4.1	3.8	56.8	5.6	0.6	70.1	34.1	4.7	4.4	183.7	7.6	1.7	123.0	48.0	7.1	6.2	0.6	0.4	0.7	0.4	0.7	0.6	0.6	99.8	50.6	87.7	51.3	0.5	0.6	9.6	0.3	187.7	15.9	16.0	0.2	6.0	168.3	8.6	1.1	3.2	10.3	0.0	1.5	0.6	7.2	1.6	0.0	18.7	4.3	2.4	2.6	0.7	0.7	0.9	71.3	0.2	2.3	1.0	0.3	0.3	4.6	406.2	5.2	0.6	0.0	5.3	0.4	0.2	15.9	1.7	0.2	0.3	0.6	0.4	7.0	34.5	58.4	14.8	13.4	0.6	0.2	10.4	17.4	9.2	27.8	4.3	1.6	1.0	102.1	1.2	369.5	1.5	213.8	151.1	0.7	2.1	179.5	124.6	7.3	113.2	1.5	1.8	39.7	87.7	1.5	1.8	7.4	2.7	2.0	2.5	1.8	0.5	1.6	0.6	4.4	6.2	8.9	16.0	16.0	0.0	47.4	11.6	2.7	0.0	5.2	0.0	8.6	6.1	4.9	0.0	2.5	0.0	0.0	0.2	136.0	0.6	0.0	1.0	0.1	1.1	0.4	13.2	0.0	16.4	0.0	2.0	0.2	11.6	53.5	1.2	19.6	0.2	13.2	4.4	10.6	0.0	0.0	0.5	0.0	10.6	98.5	0.8	0.0	58.8	21.4	2.8	271.8	0.0	11.3	0.0	0.0	0.1	1.4	0.0	93.5	1.4	0.0	0.8	5.8	0.0	0.0	5.5	7.9	0.2	0.1	1.5	10.4	0.3	973.8	0.4	0.4	3.5
ILF2	NF45	ENSG00000143621	"Interleukin enhancer binding factor 2"	Q12905	1	153661788-153671028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007484	Supported		Supported	Nucleoplasm		No	No		3400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA007484: AB_1079137"	"unprognostic (1.97e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-3)"	"unprognostic (9.70e-2)"	"prognostic unfavorable (5.71e-8)"	"unprognostic (2.64e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.61e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.09e-1)"	81.4	84.2	42.3	81.5	44.1	158.1	100.7	45.9	51.1	75.4	51.2	80.5	57.4	75.6	85.7	99.1	77.5	61.0	71.3	43.5	47.9	97.6	69.0	76.1	97.7	44.8	44.9	75.4	79.7	101.7	75.3	86.1	46.1	63.5	91.3	43.4	84.3	61.2	114.6	90.0	63.3	79.2	46.8	78.1	76.9	101.2	44.6	189.7	88.7	85.9	132.4	105.8	69.5	50.6	323.3	244.7	420.1	297.8	173.1	162.4	336.2	233.5	263.6	411.9	294.5	362.1	254.3	441.5	349.5	233.6	198.8	239.3	508.8	248.3	394.6	242.0	328.9	330.5	182.2	310.0	158.6	521.0	234.7	149.6	139.7	314.4	339.1	171.7	389.3	256.0	423.5	203.4	347.2	424.3	702.8	215.4	607.5	468.5	366.2	502.1	367.2	418.3	194.8	304.0	379.5	350.2	272.3	336.1	272.3	392.0	367.2	442.7	239.5	210.7	266.4	191.6	391.8	348.6	522.6	882.9	177.2	314.1	327.2	168.7	158.1	118.1	147.4	156.0	188.0	198.7	169.8	160.3	219.2	165.0	190.7	164.8	14.8	218.5	129.7	212.2	212.6	357.3	42.3	44.1	45.9	51.1	43.5	47.9	44.8	44.9	46.1	46.8	44.6	50.6	101.4	57.7	68.5	6.8	102.1	197.9	220.9	238.0	129.7	38.0	113.5	112.1	62.2	70.1	130.4	38.6	27.1	215.3	99.0	54.2	131.0	209.9	73.9	81.6	84.4	114.0	106.8	113.0	9.4	156.4	259.3	110.8	50.4	103.0	94.4	107.0	49.2	31.5	124.8	28.6	10.5	87.2	164.8	54.9	117.4	33.1	60.0	74.0	112.1	9.4	112.9	82.8	61.8	10.6	17.1	145.4	63.5	65.8	125.4	139.9	45.5	201.6	80.7	36.3	65.7	102.4	124.2	360.3	159.9	119.1	158.8	260.4	101.4	144.9	110.9	181.0
ILF3	"DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1600000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	49.2	58.5	31.6	79.4	31.5	179.5	49.8	44.2	37.5	60.8	38.5	56.0	52.0	64.5	40.9	60.4	61.1	31.9	49.0	31.4	37.9	43.1	32.1	50.5	82.9	30.6	32.8	76.5	52.6	55.5	53.8	47.8	29.7	52.4	44.8	69.5	54.0	48.8	83.6	58.7	56.1	49.8	29.4	61.7	47.8	78.9	35.4	97.3	61.6	58.2	72.3	56.1	52.1	42.8	285.9	226.7	359.5	330.9	76.5	104.0	208.9	178.1	149.6	291.8	226.5	261.8	160.8	353.2	172.1	160.8	178.0	248.9	392.5	240.7	260.9	227.2	349.5	459.3	206.9	247.5	109.2	334.8	219.5	99.0	105.0	232.1	257.4	111.1	253.1	201.7	400.0	269.4	172.3	233.8	558.1	534.0	433.3	149.2	246.2	405.2	342.2	244.2	116.3	297.1	395.1	286.7	229.0	179.4	131.6	161.6	152.2	212.0	205.2	237.6	224.2	249.3	356.5	228.9	339.7	431.4	132.8	351.6	262.2	20.2	18.1	10.2	24.4	14.1	20.6	19.3	20.2	22.3	22.8	22.9	19.5	20.2	2.7	21.3	21.2	25.1	20.6	11.8	31.6	31.5	44.2	37.5	31.4	37.9	30.6	32.8	29.7	29.4	35.4	42.8	63.6	99.3	133.9	34.3	106.2	86.2	110.0	64.2	104.7	95.4	77.5	64.3	69.7	60.1	98.8	42.3	85.5	90.0	100.0	78.4	27.4	89.0	21.2	89.8	105.7	77.4	114.0	124.3	24.4	80.4	111.1	94.8	101.9	121.4	96.8	145.9	36.8	47.9	71.4	94.2	34.0	85.6	50.8	55.0	68.3	21.0	76.4	75.8	39.2	24.4	66.0	69.2	92.7	31.7	28.9	88.2	55.6	62.4	124.9	144.6	38.8	47.2	82.9	103.6	32.9	100.3	80.1	137.2	120.6	113.8	77.0	70.9	103.5	140.8	111.7	94.9
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		30000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	108.0	77.2	49.8	85.1	52.4	43.7	91.8	51.7	50.6	151.6	55.0	398.2	66.4	359.1	81.8	115.5	164.2	88.0	175.9	47.4	50.7	78.8	65.9	107.9	72.4	51.8	50.6	101.0	89.3	73.2	47.1	98.8	50.9	182.7	116.8	28.3	69.5	412.2	90.8	61.5	117.4	364.7	51.1	95.5	149.7	26.5	53.7	45.8	72.0	92.0	70.5	226.7	118.8	51.9	127.8	94.4	148.9	51.8	224.8	159.4	67.2	182.2	360.0	211.9	256.0	102.7	145.7	47.0	47.0	304.1	206.9	99.5	84.4	155.6	213.0	83.5	74.3	69.1	84.9	82.8	150.8	55.9	74.7	153.2	72.8	143.8	108.9	217.7	206.9	40.5	63.7	55.0	282.8	97.1	49.4	97.4	94.3	107.5	110.8	51.0	77.8	50.5	160.3	100.8	25.6	57.4	86.0	118.4	103.6	144.0	82.2	62.2	238.8	263.9	118.0	111.1	90.7	38.9	25.9	67.1	195.6	82.8	125.3	314.9	260.0	417.6	127.3	258.1	124.9	96.9	114.4	122.3	242.7	92.9	70.2	88.5	165.5	257.8	254.8	98.5	142.8	402.8	49.8	52.4	51.7	50.6	47.4	50.7	51.8	50.6	50.9	51.1	53.7	51.9	79.5	44.8	17.9	24.2	33.6	50.5	73.7	100.6	24.5	21.5	43.1	68.2	0.5	70.1	49.7	57.0	8.4	119.8	46.0	71.9	58.7	136.1	64.6	33.2	78.1	69.4	37.9	53.7	14.6	125.0	177.7	83.2	50.4	52.5	30.4	41.6	76.4	31.4	127.4	8.4	17.1	50.1	69.2	51.5	97.7	143.7	71.4	115.9	85.4	30.9	143.0	54.3	77.2	15.6	15.3	117.1	60.0	147.4	35.1	42.0	74.5	98.6	31.0	32.9	157.8	53.3	165.8	31.7	17.1	32.3	43.2	110.0	49.3	65.0	50.1	43.9
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP U3 small nucleolar ribonucleoprotein 3"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Nucleoli"		"HPA060955: AB_2684397, HPA061177: AB_2684445"	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	45.8	61.8	37.1	26.4	38.7	29.3	43.9	39.3	49.1	36.9	46.6	43.4	36.6	30.1	30.4	79.8	32.7	14.2	53.1	38.3	41.6	49.6	90.4	33.9	34.9	38.7	36.7	33.3	50.6	23.2	40.1	21.1	39.5	39.7	24.4	17.8	44.8	22.2	71.5	71.6	51.6	14.0	40.0	63.0	50.9	16.8	38.7	34.7	36.1	33.1	38.4	35.1	47.4	41.2	75.1	82.9	39.5	68.8	68.6	39.0	58.5	61.6	48.8	49.3	56.6	64.1	64.3	88.7	65.5	32.2	54.5	121.7	131.1	100.0	43.4	67.2	157.3	93.6	64.9	112.8	50.6	95.9	62.5	36.1	81.0	39.8	48.8	36.6	32.8	71.3	122.8	70.4	45.4	89.9	76.3	232.9	106.4	75.7	86.4	82.1	48.4	98.3	68.1	100.2	67.1	69.4	52.2	89.8	119.4	56.8	78.5	87.9	37.6	64.0	51.9	46.4	84.6	95.4	188.5	100.3	70.7	153.2	43.0	80.6	109.0	85.2	137.4	87.3	148.8	143.2	131.5	133.8	117.4	127.3	150.7	144.3	13.7	126.4	87.4	119.3	140.9	192.2	37.1	38.7	39.3	49.1	38.3	41.6	38.7	36.7	39.5	40.0	38.7	41.2	85.9	38.5	41.6	6.5	81.4	228.5	93.1	177.0	149.7	22.4	72.1	79.4	12.1	77.2	89.7	40.5	14.6	106.8	79.0	47.5	144.8	105.2	1.6	71.7	54.9	74.0	43.9	56.8	6.8	105.9	106.5	63.0	78.0	70.9	48.7	50.8	76.4	114.1	94.2	21.9	7.1	71.2	93.6	54.3	106.6	6.6	60.9	51.0	97.8	8.4	118.0	58.2	152.4	6.0	10.2	113.7	56.0	44.0	66.5	107.0	113.8	209.5	65.2	23.7	26.3	46.1	50.7	13.9	38.2	144.4	237.4	54.9	83.3	77.2	98.8	86.9
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030877	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 359.1;skeletal muscle: 257.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 440.3;Extravillous trophoblasts: 272.2;Proximal tubular cells: 498.6;Squamous epithelial cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 26.0;neutrophil: 31.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 9.0;granulocytes: 31.3;monocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 258.2;OE19: 299.8;SiHa: 155.1"	"Low region specificity"	"Detected in all"							HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	19.8	11.1	2.5	12.3	3.2	31.5	14.8	1.8	4.4	31.0	5.3	50.0	22.4	16.2	1.7	131.2	16.3	19.9	29.5	2.5	2.4	129.4	47.4	23.2	5.7	2.2	2.4	7.8	359.1	5.3	11.1	22.0	2.1	13.7	30.7	0.8	31.0	5.9	257.1	150.0	29.2	15.6	2.3	19.0	53.7	2.9	2.6	5.0	17.4	89.8	7.3	61.0	50.8	2.3	29.3	41.7	11.3	20.4	14.1	10.5	258.2	7.2	18.4	2.9	4.2	35.4	21.7	6.1	17.4	10.1	24.1	19.8	13.2	6.9	0.8	33.5	22.5	0.0	56.0	30.6	8.3	47.5	2.3	23.9	36.3	10.0	5.2	8.5	3.9	30.7	7.4	0.0	10.7	31.8	19.4	27.1	40.5	299.8	42.7	36.0	29.6	28.6	122.1	15.6	15.0	0.3	155.1	35.8	16.2	14.5	33.3	58.5	0.0	5.6	11.5	73.7	7.3	24.5	66.3	17.9	24.0	31.7	9.6	9.4	11.4	26.0	0.7	8.7	0.3	1.5	0.7	0.2	9.0	0.3	0.3	0.5	31.3	0.1	5.8	6.7	1.1	3.1	2.5	3.2	1.8	4.4	2.5	2.4	2.2	2.4	2.1	2.3	2.6	2.3	9.2	19.2	32.7	17.6	7.8	105.5	22.7	32.1	159.4	0.7	16.8	20.2	11.6	72.9	16.1	22.0	0.0	52.5	5.8	72.9	440.3	83.4	2.8	5.7	20.2	6.9	17.5	15.3	4.7	110.6	272.2	16.1	65.2	30.4	2.5	13.4	10.0	66.8	42.5	0.0	1.8	90.2	65.1	37.7	17.0	7.1	4.7	34.2	14.2	5.6	25.5	22.3	2.1	0.5	0.5	56.1	50.1	3.8	8.6	42.9	36.9	498.6	12.3	1.0	105.2	16.0	27.6	0.8	10.1	202.1	141.4	106.3	6.1	14.0	84.4	52.8
IMPDH1	"LCA11, RP10, sWSS2608"	ENSG00000106348	"Inosine monophosphate dehydrogenase 1"	P20839	7	128392277-128410252	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"Disease variant, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 106.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 165.8;Cone photoreceptor cells: 141.8;Horizontal cells: 121.1;Rod photoreceptor cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 89.1;eosinophil: 89.1;intermediate monocyte: 104.5;myeloid DC: 59.9;neutrophil: 197.5;non-classical monocyte: 135.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 59.9;granulocytes: 197.5;monocytes: 135.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 374.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001400	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA		17000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol	"Rods & Rings"	"HPA001400: AB_1079139"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.23e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.31e-5)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.24e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (1.78e-12)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.72e-5)"	54.8	15.9	19.2	33.8	18.5	44.1	38.7	15.7	23.7	18.5	12.7	24.8	8.3	15.1	2.5	30.0	17.7	11.9	23.7	18.1	17.8	15.8	5.7	31.7	25.5	26.3	18.7	20.5	30.1	5.3	26.7	11.4	25.6	27.8	9.8	106.2	29.5	13.1	4.7	23.2	19.1	19.6	17.1	55.9	48.9	16.5	20.0	8.4	11.5	6.2	15.9	29.4	20.4	17.1	111.5	93.2	13.8	102.8	56.5	40.7	38.8	74.1	46.4	61.9	40.1	68.3	35.0	70.8	24.7	111.1	64.4	83.3	78.6	104.1	30.9	25.8	87.1	46.4	66.8	49.1	51.4	62.1	21.1	49.4	49.5	63.2	62.5	29.2	74.5	42.0	46.9	51.8	21.0	76.1	44.1	164.9	77.4	87.7	108.0	51.9	25.2	150.8	27.5	35.1	58.3	55.6	48.0	374.6	68.3	8.6	42.7	119.7	68.5	103.6	37.7	55.0	53.6	38.5	38.3	90.6	53.0	134.0	64.6	11.2	89.1	89.1	22.7	104.5	24.4	15.5	17.9	20.2	59.9	8.9	10.3	12.7	197.5	11.7	135.9	6.0	21.5	58.3	19.2	18.5	15.7	23.7	18.1	17.8	26.3	18.7	25.6	17.1	20.0	17.1	66.8	0.0	11.2	4.6	13.5	8.8	9.3	13.6	9.6	165.8	12.8	9.9	5.1	2.8	8.6	5.5	141.8	3.3	11.1	6.3	5.9	8.1	0.5	4.0	10.9	20.3	9.6	9.7	8.2	17.8	21.3	15.1	44.9	6.5	21.0	46.0	13.6	1.0	46.1	121.1	11.2	10.1	28.5	58.5	21.7	2.0	4.7	38.2	16.0	3.7	65.3	27.3	24.7	2.0	1.5	10.9	3.1	6.8	29.6	21.5	0.8	1.1	7.4	205.5	0.0	9.0	17.3	2.9	16.9	15.8	7.4	2.3	20.4	18.6	11.9	10.3
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029447	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001400, CAB020717"	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA		340000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.47e-2)"	109.1	89.3	42.1	68.0	43.0	105.3	188.6	44.2	41.6	169.6	37.3	100.8	75.3	113.5	48.2	169.0	199.3	64.9	70.0	39.5	45.2	67.5	63.5	83.3	78.7	46.9	43.2	331.0	313.9	55.7	65.0	81.0	46.6	97.6	121.2	22.0	87.9	66.4	272.8	180.0	74.1	100.9	45.1	68.6	93.4	36.1	43.8	95.9	75.1	124.4	122.0	119.7	137.5	48.9	271.8	150.6	201.6	211.3	309.2	558.4	200.6	180.8	298.2	425.5	361.0	265.8	235.2	485.7	128.2	220.7	119.5	183.1	433.6	369.8	371.1	119.9	135.3	362.2	205.0	257.8	264.4	388.4	139.0	497.7	403.1	414.6	756.5	331.8	313.5	337.7	221.7	266.2	354.1	213.4	327.0	258.9	269.0	255.4	300.2	143.5	218.4	487.9	251.7	166.2	130.2	128.9	198.1	216.5	341.3	170.2	277.3	166.1	151.4	181.0	347.7	449.5	468.8	253.3	193.3	227.3	214.1	421.9	188.1	21.8	27.8	10.7	43.6	46.8	81.9	79.7	58.4	47.7	51.1	79.6	84.9	71.6	10.9	60.5	41.6	38.0	40.2	45.2	42.1	43.0	44.2	41.6	39.5	45.2	46.9	43.2	46.6	45.1	43.8	48.9	40.5	64.1	60.9	3.9	92.2	202.7	255.0	253.8	229.9	16.1	202.7	231.8	32.3	74.4	122.4	36.8	14.6	327.3	34.5	51.1	80.3	133.6	2.7	49.0	120.5	60.9	60.7	112.5	2.9	187.1	280.6	104.4	70.3	51.2	66.1	98.0	52.8	24.9	95.3	15.2	4.1	124.4	114.0	55.9	105.4	6.7	123.3	50.0	88.9	1.0	67.3	26.5	24.7	4.0	5.2	108.8	70.8	71.1	64.6	160.1	47.4	92.0	53.7	15.8	39.5	149.4	215.1	22.6	62.5	195.7	195.6	314.0	52.3	166.8	266.5	157.2
INCA1		ENSG00000196388	"Inhibitor of CDK, cyclin A1 interacting protein 1"	Q0VD86	17	4988130-4997610	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 47.8"	"Group enriched"	"Detected in many"	19	"Early spermatids: 130.0;Late spermatids: 306.6;Spermatocytes: 211.3;Spermatogonia: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044359, HPA052401"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA044359: AB_10794289, HPA052401: AB_2681816"	"unprognostic (1.78e-2)"	"unprognostic (9.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-2)"	"prognostic favorable (3.61e-5)"	"unprognostic (3.14e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	2.9	3.7	3.2	6.3	3.4	1.6	2.1	4.3	4.2	3.6	2.0	3.3	10.8	5.2	0.8	5.1	3.2	7.1	6.6	3.0	3.8	4.0	3.8	4.6	8.5	4.3	3.4	8.1	3.9	1.6	2.2	3.0	4.5	4.5	1.2	4.4	5.7	1.7	10.6	8.0	7.9	2.2	3.6	7.3	5.0	47.8	4.3	0.4	8.0	4.8	0.4	2.7	2.4	3.9	5.0	5.6	3.9	3.7	2.6	1.0	4.7	5.3	0.5	1.4	1.5	4.0	5.9	23.9	3.5	1.4	4.6	14.0	0.7	0.3	0.8	10.0	5.9	5.2	7.6	2.7	1.8	0.8	12.2	1.5	0.0	0.8	0.4	8.5	0.5	8.4	6.6	10.9	1.0	2.6	7.4	1.7	1.7	2.3	1.5	9.0	2.0	2.2	0.9	1.6	11.7	3.5	2.6	3.4	3.1	4.1	7.0	1.1	10.8	4.9	1.8	4.7	4.1	1.8	1.0	1.1	4.8	12.6	2.5	0.2	0.8	0.0	0.2	1.5	0.6	0.4	0.4	0.5	0.3	0.2	0.7	0.6	0.2	0.0	1.2	0.4	0.2	0.2	3.2	3.4	4.3	4.2	3.0	3.8	4.3	3.4	4.5	3.6	4.3	3.9	1.0	0.0	1.1	1.0	0.6	1.1	1.5	1.2	0.6	0.5	0.9	0.8	1.0	1.5	1.2	3.7	2.1	0.6	0.1	9.3	0.0	0.7	130.0	0.6	0.8	1.3	0.0	2.7	0.8	1.6	0.7	1.3	1.5	0.6	4.5	2.5	0.7	1.4	1.2	0.0	0.9	2.0	2.0	0.0	1.5	306.6	7.2	1.1	1.8	1.0	0.7	6.1	0.0	1.0	1.1	1.2	9.3	1.2	0.1	0.4	5.2	2.2	1.5	0.8	6.6	2.0	1.9	211.3	87.1	0.3	0.9	0.8	0.2	0.7	2.9	0.8
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123998-62153169	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.9"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"basophil: 1.2;NK-cell: 1.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;NK-cells: 1.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279"	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	3.1	2.5	2.7	7.5	1.1	20.9	2.8	6.2	3.0	4.6	0.0	4.8	6.8	3.0	8.1	14.0	3.5	2.2	2.8	2.9	0.5	2.4	1.9	3.0	11.6	1.6	0.8	3.8	3.1	3.1	1.5	4.1	1.3	2.5	3.6	3.4	6.1	2.9	4.2	7.9	5.7	3.4	0.1	5.5	4.5	6.4	0.5	17.8	5.1	3.4	8.2	2.8	5.5	1.2	74.3	69.4	51.6	45.5	6.8	8.4	28.1	47.6	21.2	44.4	28.3	37.0	50.7	70.0	36.2	16.0	46.2	72.6	52.2	28.4	31.8	60.5	36.6	45.7	68.0	29.6	2.7	53.5	62.1	4.3	6.5	41.3	23.6	6.8	25.8	50.2	48.8	57.6	25.3	59.7	85.0	43.3	56.2	28.0	34.4	79.3	66.4	53.4	12.0	35.8	40.1	42.2	46.8	30.8	27.9	19.8	48.2	19.4	28.5	41.8	51.9	59.8	50.0	29.7	48.3	75.8	23.5	34.7	50.6	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.7	1.1	6.2	3.0	2.9	0.5	1.6	0.8	1.3	0.1	0.5	1.2	1.2	3.2	2.3	1.3	3.4	5.6	0.8	1.0	2.8	2.4	1.1	0.6	1.3	0.0	3.7	0.0	0.0	4.2	4.2	5.4	0.0	1.9	1.0	2.0	2.1	1.5	0.0	10.9	3.3	2.5	7.1	1.9	9.2	2.7	3.8	5.7	0.0	0.7	4.2	0.0	2.5	3.4	0.0	0.9	1.6	0.5	2.8	3.3	3.6	1.0	5.0	1.5	3.1	2.0	1.5	2.2	1.6	1.5	10.9	1.2	1.3	0.3	2.6	2.3	0.0	1.9	4.3	6.5	7.8	15.1	3.3	2.2	3.7	1.9	4.8	1.1
ING4	"my036, p29ING4"	ENSG00000111653	"Inhibitor of growth family member 4"	Q9UNL4	12	6650301-6663142	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Chromatin regulator"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031817, HPA057338"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA031817: AB_2674056, HPA057338: AB_2683412"	"unprognostic (2.95e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.65e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.42e-2)"	22.9	26.4	43.8	15.5	44.5	11.6	27.9	45.8	51.7	34.9	40.7	33.7	17.9	27.4	30.7	22.8	27.4	18.1	23.9	44.0	43.9	29.7	25.7	18.6	27.6	44.9	44.0	31.3	19.7	32.0	27.7	21.6	44.8	33.0	21.8	22.3	25.9	23.1	19.3	31.0	26.7	22.5	44.8	37.7	26.9	20.4	44.7	38.5	34.9	23.8	24.5	29.5	27.2	49.3	9.2	12.3	35.8	17.0	27.3	26.9	22.9	12.0	19.4	19.6	23.4	5.6	41.1	15.9	7.8	16.8	15.6	14.3	17.8	14.1	21.7	31.1	26.4	22.9	22.5	11.5	16.0	9.1	10.4	27.3	32.3	10.4	13.3	63.4	29.8	30.6	10.9	8.9	19.0	6.6	33.2	13.9	52.8	20.3	11.7	30.9	18.8	17.0	24.7	10.4	14.7	38.3	18.6	6.2	23.2	51.5	8.2	25.0	22.7	8.1	16.1	9.1	7.9	10.7	15.6	21.6	21.6	14.0	8.3	32.2	31.1	26.8	33.5	43.5	31.2	30.9	27.8	28.7	34.3	48.2	37.9	32.9	20.1	38.0	51.0	26.5	30.9	37.9	43.8	44.5	45.8	51.7	44.0	43.9	44.9	44.0	44.8	44.8	44.7	49.3	20.5	22.4	19.0	15.0	26.8	8.2	11.1	19.1	13.6	31.2	22.2	27.6	10.9	17.2	17.9	18.4	18.8	43.3	37.0	14.4	29.4	25.0	2.0	17.1	21.6	22.4	25.2	18.1	23.1	8.1	11.7	21.8	10.2	14.8	27.9	40.7	20.0	8.9	24.6	35.3	23.0	18.6	30.5	16.6	12.4	6.7	34.5	27.0	10.6	13.1	32.6	34.6	52.5	18.6	20.7	11.9	16.9	37.6	11.7	11.8	21.3	24.4	12.5	26.4	32.9	13.6	21.2	20.7	19.1	9.9	10.1	30.6	22.3	31.8	14.6	9.7
INHA		ENSG00000123999	"Inhibin subunit alpha"	P05111	2	219569162-219575711	"Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 75.6;ovary: 104.4;testis: 95.3"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 254.3;Syncytiotrophoblasts: 331.0;Theca cells: 75.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;HEL: 4.5;SK-BR-3: 9.9;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB000047, HPA019141, HPA048834"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Golgi apparatus"	"CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: "	"unprognostic (8.90e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.61e-3)"	"unprognostic (4.15e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (4.85e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	1.2	75.6	3.4	0.2	3.7	0.1	1.4	2.7	4.8	2.0	2.2	0.9	0.2	2.0	2.2	0.8	3.0	0.4	16.3	3.5	3.2	3.1	0.7	0.8	0.1	3.4	2.9	104.4	12.3	0.7	6.6	11.3	3.5	3.1	0.0	1.9	1.5	1.1	0.8	2.1	0.4	0.4	2.5	0.4	0.7	95.3	3.4	0.0	3.3	0.0	0.0	1.0	1.8	3.0	0.4	0.2	0.0	1.9	0.6	0.1	3.5	0.3	0.2	0.5	0.2	0.3	3.2	0.0	0.2	0.7	0.5	2.0	0.2	0.5	0.0	0.0	0.6	4.5	1.8	2.4	0.3	0.0	0.0	0.6	0.8	0.0	0.5	1.4	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.1	1.2	0.1	0.9	0.1	0.2	0.0	0.5	0.2	0.3	0.8	1.1	9.9	0.3	4.9	0.5	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	2.7	4.8	3.5	3.2	3.4	2.9	3.5	2.5	3.4	3.0	0.1	0.0	0.0	5.9	0.0	0.0	0.1	0.8	0.0	2.7	0.3	0.3	2.2	0.0	0.1	7.3	2.1	11.8	0.0	0.0	0.0	2.8	0.8	0.5	0.5	0.2	0.0	0.0	5.9	8.9	35.5	1.2	0.0	0.5	0.0	254.3	0.7	0.1	2.6	6.7	6.9	0.0	0.0	0.3	0.0	5.0	4.1	0.2	0.0	0.0	0.0	3.7	0.0	1.0	0.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	1.5	3.4	0.6	0.0	0.0	331.0	0.0	75.6	0.0	0.0
INO80B	"hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4"	ENSG00000115274	"INO80 complex subunit B"	Q9C086	2	74455087-74457944	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 28.0;Suprabasal keratinocytes: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA070644, HPA078274"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nucleoli, Nuclear bodies"	"HPA070644: AB_2732159, HPA078274: "	"prognostic favorable (2.89e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.56e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-3)"	26.3	30.5	18.9	18.0	20.7	20.6	29.1	17.2	27.6	38.1	15.7	24.1	19.4	30.4	17.1	31.1	31.5	15.1	20.1	19.6	17.5	27.4	32.1	25.9	18.9	18.4	17.1	48.1	41.9	19.6	42.0	11.6	19.2	34.7	12.3	18.7	29.9	17.9	30.1	40.8	23.9	14.8	14.2	24.5	32.7	31.0	16.7	12.8	39.3	9.1	20.1	27.1	32.2	20.9	27.8	29.0	11.0	14.2	21.0	29.6	28.2	25.7	23.0	19.4	16.3	19.9	34.4	46.7	32.2	18.8	18.2	29.1	9.1	20.4	15.8	42.5	28.8	35.9	14.5	20.5	22.4	33.9	17.2	29.5	35.0	27.8	31.2	48.4	26.2	27.4	20.7	18.5	16.5	32.7	44.3	47.7	7.7	20.2	39.7	26.3	34.9	47.4	23.5	18.9	16.7	31.8	13.5	37.3	15.4	12.1	16.1	11.6	22.1	17.7	27.9	29.7	20.0	65.8	48.4	16.9	33.3	21.3	18.9	3.2	2.5	1.0	1.2	1.9	1.6	2.6	1.4	0.7	1.6	2.1	1.2	1.1	3.2	2.1	1.7	3.2	2.2	0.9	18.9	20.7	17.2	27.6	19.6	17.5	18.4	17.1	19.2	14.2	16.7	20.9	4.4	0.0	2.2	0.0	5.4	28.0	2.8	8.5	2.2	14.0	11.3	6.0	0.9	4.3	6.8	3.7	12.5	4.3	7.1	5.8	0.0	15.9	3.0	6.5	5.7	5.4	4.8	9.3	0.0	27.0	4.7	3.4	2.6	3.8	5.7	2.4	6.8	10.8	5.6	13.5	0.0	7.9	12.2	9.7	21.0	6.5	3.1	4.3	5.4	0.0	12.5	4.7	9.2	0.0	0.0	17.4	3.3	3.0	5.1	2.2	11.6	6.5	12.3	15.0	0.0	2.1	4.9	5.6	1.9	3.3	31.7	5.3	7.5	2.2	6.7	2.0
INO80E	"CCDC95, FLJ90652"	ENSG00000169592	"INO80 complex subunit E"	Q8NBZ0	16	29995715-30005793	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043146	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli rim"	"HPA043146: AB_10794923"	"unprognostic (5.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.38e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-3)"	25.9	22.7	36.6	22.1	39.0	33.1	26.4	38.8	43.1	31.6	29.1	35.3	19.9	30.8	29.2	29.7	40.8	24.8	25.3	35.7	36.3	21.9	26.4	28.7	32.9	40.3	38.9	38.0	25.5	39.9	23.2	24.8	38.0	24.1	36.5	13.4	32.4	34.7	30.9	27.6	24.0	40.3	37.1	26.5	24.8	27.8	38.3	42.5	33.3	29.7	46.8	30.8	25.5	42.5	79.1	95.1	59.6	88.0	54.0	45.6	55.0	66.9	75.2	95.4	93.8	54.7	85.7	101.6	100.4	75.3	63.0	52.9	73.8	109.8	80.0	106.7	88.8	50.2	57.7	79.0	63.5	66.4	59.5	53.5	89.1	112.1	87.6	54.9	115.4	137.5	64.4	55.6	89.9	114.7	142.0	87.2	120.3	55.4	55.1	176.9	72.6	104.7	73.2	39.5	90.8	111.3	36.8	65.1	83.7	48.9	80.8	53.0	62.5	68.0	48.3	58.7	84.6	58.9	120.2	92.9	77.3	96.2	97.9	1.5	6.1	5.1	4.3	4.1	3.6	4.5	3.4	5.0	4.9	3.3	3.2	3.3	3.0	3.5	6.8	5.1	5.2	21.4	36.6	39.0	38.8	43.1	35.7	36.3	40.3	38.9	38.0	37.1	38.3	42.5	32.8	38.5	19.6	15.0	27.6	14.8	19.1	34.0	37.0	15.1	23.5	22.6	0.8	22.8	24.1	20.2	20.9	36.9	27.6	32.9	33.2	29.3	1.9	17.1	13.3	25.4	35.2	14.9	6.6	39.3	40.1	20.2	45.9	19.2	15.8	16.4	23.9	18.9	27.8	8.4	6.9	28.4	32.6	22.4	15.0	5.2	26.1	24.0	19.6	14.0	25.2	20.4	29.9	9.0	14.4	38.0	39.7	27.8	35.2	12.4	48.2	29.8	19.7	20.9	26.3	17.3	23.1	44.4	23.3	33.6	17.2	18.1	30.9	13.9	31.6	12.4
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 50.8;lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.5;dendritic cells: 95.8;Kupffer cells: 65.6;Microglial cells: 181.8;NK-cells: 193.6;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 44.7;HEL: 94.6;HMC-1: 94.8;hTCEpi: 87.1;NB-4: 89.4;THP-1: 62.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016300, HPA070455"	Enhanced		Supported	Cytosol		No	No		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	15.5	5.8	6.7	19.8	7.3	32.7	11.4	7.6	6.5	9.2	6.7	9.5	3.7	6.3	2.8	7.5	9.2	6.0	8.2	6.0	8.5	9.5	6.5	25.2	34.1	10.8	9.4	3.2	3.1	1.2	6.9	8.4	11.2	11.8	4.7	0.3	26.3	2.9	3.9	7.9	50.8	3.5	9.3	99.4	6.3	3.5	10.4	14.5	7.8	1.7	31.9	9.8	8.4	10.3	0.1	0.1	0.6	0.0	0.0	0.2	4.8	0.1	0.2	0.1	0.0	0.0	1.2	17.9	0.0	0.0	0.0	0.1	0.0	44.7	0.1	15.4	0.2	94.6	0.1	9.0	0.7	28.7	94.8	1.6	87.1	0.3	9.6	0.3	12.7	2.6	0.4	8.0	0.4	0.0	13.2	89.4	2.9	0.0	0.1	27.5	0.1	6.5	0.1	5.5	0.1	0.1	0.0	1.7	0.0	11.1	0.0	62.9	10.7	0.0	1.5	0.0	0.0	0.2	5.2	26.7	0.1	36.5	0.2	13.2	10.8	11.4	16.0	15.8	10.9	14.0	7.1	12.0	12.3	12.6	5.8	8.4	10.3	12.5	20.0	6.1	10.5	17.9	6.7	7.3	7.6	6.5	6.0	8.5	10.8	9.4	11.2	9.3	10.4	10.3	18.1	3.2	15.5	3.3	94.5	1.7	1.6	5.4	9.1	0.5	3.2	5.8	3.6	4.3	5.2	3.7	0.0	0.6	95.8	1.1	0.0	0.5	13.0	0.8	0.3	20.8	0.0	35.7	2.6	0.5	0.8	1.7	2.0	0.5	15.2	0.1	15.0	2.2	29.2	0.0	1.1	0.2	0.0	65.6	17.1	13.4	0.0	51.5	0.0	181.8	51.4	0.0	193.6	4.0	1.8	0.4	2.5	1.2	34.0	0.6	0.1	0.4	5.7	0.0	0.0	2.0	1.7	0.5	1.0	3.1	1.1	1.1	60.6	0.1	0.5	1.5
INPP5F	"hSac2, KIAA0966, SAC2"	ENSG00000198825	"Inositol polyphosphate-5-phosphatase F"	Q9Y2H2	10	119726042-119829147	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.3"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 79.5;Inhibitory neurons: 130.5;Late spermatids: 88.6;Oligodendrocytes: 70.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 91.4;SK-MEL-30: 149.0;SuSa: 181.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042605			Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA042605: AB_10793886"	"unprognostic (2.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.21e-2)"	9.9	16.8	53.8	9.9	49.4	4.7	7.6	45.3	63.9	15.7	10.1	15.5	4.6	15.4	22.8	9.3	8.3	6.9	5.9	50.6	135.3	10.5	3.2	9.1	10.7	71.2	57.3	12.3	6.7	7.4	57.1	10.9	75.0	10.9	8.0	32.9	10.8	10.0	11.0	13.7	9.5	13.2	50.3	7.5	8.6	14.8	62.7	7.0	10.5	3.8	13.0	9.2	12.5	55.2	13.5	8.2	91.4	14.3	6.9	10.6	8.5	18.4	9.3	8.4	8.4	12.0	15.2	8.3	7.6	19.7	10.6	14.4	7.9	9.8	11.9	6.0	10.3	6.5	3.9	11.0	13.5	4.4	19.0	9.7	8.6	14.2	13.5	15.7	23.2	6.1	5.7	13.8	20.8	7.0	5.5	15.7	9.2	9.9	12.0	7.0	18.8	2.3	12.5	5.3	6.5	70.2	19.8	7.2	149.0	181.5	4.3	3.4	19.6	9.9	12.2	11.0	17.5	15.2	7.7	4.5	11.0	12.8	32.3	0.9	3.4	1.3	1.0	3.0	1.3	6.7	2.2	1.3	6.2	9.1	2.2	1.1	0.8	3.4	3.6	1.4	5.3	1.9	53.8	49.4	45.3	63.9	50.6	135.3	71.2	57.3	75.0	50.3	62.7	55.2	7.8	6.4	4.8	52.5	21.5	9.1	11.7	7.5	10.2	24.2	6.9	9.5	5.4	1.5	7.8	12.9	16.7	9.3	7.9	15.1	11.7	3.6	58.7	4.3	18.3	8.6	1.2	5.2	79.5	4.5	10.6	7.9	5.1	6.9	2.5	9.7	4.2	3.5	9.9	42.1	130.5	5.6	10.2	6.0	27.8	88.6	5.3	13.1	19.6	34.7	16.3	21.7	6.2	52.8	70.5	6.8	6.6	3.8	4.7	8.2	6.5	24.7	4.0	21.6	6.6	7.8	13.8	22.4	41.0	13.1	10.4	13.3	7.7	19.3	6.5	13.1
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239147	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 344.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	45.2	56.4	39.0	34.4	43.4	51.3	44.7	41.3	40.5	63.8	47.3	87.5	35.9	56.1	18.2	34.6	61.3	33.7	73.6	33.2	42.5	60.0	36.6	61.8	36.8	53.9	43.2	68.6	55.7	36.4	60.5	39.7	45.8	68.7	23.3	14.9	53.8	39.5	116.6	31.4	57.1	33.4	45.0	66.1	60.8	24.2	48.8	19.3	67.7	43.0	23.2	59.9	43.4	41.2	28.7	62.1	71.5	49.8	35.4	41.1	122.5	118.9	61.2	80.6	49.6	84.3	72.2	79.5	125.6	101.7	57.8	106.7	60.4	37.6	28.0	101.9	59.1	84.8	344.5	31.9	68.1	56.1	176.7	58.2	39.1	78.0	31.4	100.5	44.2	29.3	59.7	34.7	45.1	78.8	42.1	224.9	67.7	20.7	93.7	185.0	161.0	18.2	94.8	48.6	33.8	48.6	133.9	85.1	182.8	36.6	88.8	106.0	74.5	86.4	96.7	129.9	43.1	94.5	17.5	80.1	24.7	51.7	47.2	2.5	3.5	3.3	1.9	2.0	1.7	0.9	1.6	1.3	2.4	1.0	1.1	1.6	2.3	2.2	3.6	1.8	1.5	1.8	39.0	43.4	41.3	40.5	33.2	42.5	53.9	43.2	45.8	45.0	48.8	41.2	13.9	3.2	12.8	47.0	8.1	7.1	4.9	10.8	14.2	1.7	20.3	17.3	13.6	11.5	11.7	12.9	27.1	27.9	9.1	28.3	1.9	11.6	1.5	14.6	16.3	11.2	22.7	5.7	2.6	12.5	15.4	10.8	24.5	25.5	7.6	21.0	8.9	12.5	21.7	10.1	2.2	16.4	18.3	27.6	16.2	2.1	9.9	29.8	10.6	18.7	17.6	16.8	14.4	15.1	6.1	14.9	17.5	13.9	7.8	7.8	15.2	16.2	10.2	17.2	6.6	12.9	14.5	1.4	4.9	6.7	4.8	32.4	11.6	10.1	21.8	5.4
INSM2	"IA-6, Mlt1"	ENSG00000168348	"INSM transcriptional repressor 2"	Q96T92	14	35534164-35537054	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.6;retina: 2.7"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 7.2;Spermatocytes: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	134	"SH-SY5Y: 114.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Low region specificity"	"Detected in some"			"HPA044885, HPA051925"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA044885: AB_10794779, HPA051925: AB_2681664"	"unprognostic (9.88e-2)"	"unprognostic (8.74e-2)"			"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"		"unprognostic (3.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-3)"		"unprognostic (7.51e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.36e-3)"	"unprognostic (5.00e-1)"	0.0	0.3	0.9	0.0	1.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.6	0.0	0.0	0.0	0.0	1.9	0.8	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	114.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	2.2	0.9	3.6	1.9	0.8	2.1	0.3	1.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.4	0.0	0.0	0.0	2.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.1	4.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
INSYN1	"C15orf59, LOC388135, MGC131524"	ENSG00000205363	"Inhibitory synaptic factor 1"	Q2T9L4	15	73735458-73753351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.6;heart muscle: 48.5"	"Cell type enriched"	"Detected in single"	24	"Cardiomyocytes: 14.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;fHDF/TERT166: 5.8;HEK 293: 3.9;NTERA-2: 3.4;SK-BR-3: 4.7;U-2 OS: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol		No	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	3.5	2.6	32.6	0.9	30.1	0.1	1.9	27.2	42.8	7.9	1.6	6.6	0.8	4.2	3.4	12.0	7.8	1.9	48.5	38.9	28.8	15.5	0.4	2.7	0.2	26.9	56.6	13.5	1.4	2.9	5.2	0.5	27.7	10.6	0.6	3.9	3.3	11.0	4.6	13.3	2.4	3.2	22.8	0.7	3.7	4.5	46.3	0.2	2.1	2.6	0.9	6.4	16.9	34.7	0.0	0.0	1.8	1.2	8.7	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.8	1.0	2.1	1.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.4	4.7	0.4	1.3	2.0	0.1	0.0	1.3	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.6	30.1	27.2	42.8	38.9	28.8	26.9	56.6	27.7	22.8	46.3	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INTS14	"C15orf44, DKFZP564O1664, VWA9"	ENSG00000138614	"Integrator complex subunit 14"	Q96SY0	15	65578753-65611289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040255, HPA040651"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"Nuclear membrane"	"HPA040255: AB_10805710, HPA040651: AB_10796559"	"unprognostic (2.92e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.30e-1)"	12.5	15.8	13.2	14.2	15.8	18.0	22.3	14.7	16.6	20.9	18.2	21.8	14.1	18.1	27.4	16.1	24.2	19.6	13.4	13.5	14.8	21.3	21.1	15.6	22.7	14.5	14.9	18.4	17.7	22.9	16.3	19.2	14.6	19.1	23.6	13.1	16.2	19.8	9.9	18.0	17.2	18.8	14.8	18.9	18.1	18.9	15.8	25.4	23.2	13.6	24.3	23.6	13.6	17.7	26.4	46.7	46.1	36.8	25.2	31.4	29.5	28.4	36.5	46.4	42.5	42.2	61.2	42.9	38.9	35.6	38.5	52.0	99.4	47.6	40.5	37.8	60.2	37.5	32.2	46.4	50.0	38.7	46.2	30.6	46.9	35.1	53.7	34.1	50.8	64.8	52.2	24.3	33.4	41.7	44.3	41.2	33.8	66.2	25.6	37.5	38.8	49.0	36.7	48.6	33.1	26.3	34.2	34.5	49.5	39.2	32.3	44.0	25.2	31.8	33.2	28.8	45.6	23.9	48.4	58.1	32.1	70.0	38.1	25.7	11.0	6.2	19.8	12.7	22.3	19.3	20.3	22.6	19.8	14.8	21.1	19.2	1.2	23.8	9.5	17.9	30.8	16.6	13.2	15.8	14.7	16.6	13.5	14.8	14.5	14.9	14.6	14.8	15.8	17.7	12.2	22.4	10.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	13.0	11.0	0.0	0.0	5.6	12.9	0.0	40.5	7.7	0.0	21.5	18.2	0.0	12.8	11.8	6.8	0.0	0.0	0.0	15.4	30.5	6.7	0.0	12.6	7.6	22.5	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	9.3	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.5	0.0	0.0	15.1	10.9	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	49.8	4.8	24.0	0.0	0.0
INTS7	"C1orf73, DKFZP434B168, INT7"	ENSG00000143493	"Integrator complex subunit 7"	Q9NVH2	1	211940399-212035557	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 35.6;Oligodendrocytes: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072611			Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"		"HPA072611: AB_2732204"	"unprognostic (1.25e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.37e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.44e-2)"	5.5	5.1	5.4	6.3	7.1	7.9	6.7	5.8	8.5	5.1	5.3	6.3	5.8	4.6	6.6	8.2	4.5	4.5	4.7	5.3	5.7	4.4	11.1	5.1	9.1	6.0	6.1	4.3	4.7	2.7	5.6	5.8	6.8	5.5	7.6	7.8	4.2	3.1	5.4	7.6	5.4	7.1	5.5	6.0	5.3	21.4	5.7	13.6	6.6	8.5	10.2	6.4	5.5	9.0	31.1	27.2	21.4	17.1	15.3	16.7	25.7	24.9	15.8	29.2	36.8	25.8	26.4	36.0	13.1	18.1	22.7	27.9	32.2	20.0	24.2	34.8	27.5	31.3	27.9	19.0	16.6	56.3	27.9	14.9	24.1	46.8	35.4	13.8	17.7	19.5	46.8	31.2	24.3	18.1	45.6	16.1	39.2	21.3	26.8	27.9	39.7	53.0	16.9	23.2	36.1	28.2	32.4	34.7	20.6	24.7	28.9	26.7	12.6	23.7	25.5	22.0	37.5	13.5	24.3	42.8	21.0	22.8	27.2	12.6	7.3	6.1	8.7	7.5	7.3	9.4	8.7	10.4	10.9	10.9	5.2	6.4	0.8	22.2	10.0	7.6	15.0	7.6	5.4	7.1	5.8	8.5	5.3	5.7	6.0	6.1	6.8	5.5	5.7	9.0	2.4	0.0	12.0	9.1	7.3	9.9	8.2	4.6	10.8	8.5	5.9	3.7	4.9	5.7	4.6	3.7	4.2	10.5	6.9	6.7	1.9	5.1	35.0	5.1	4.9	4.6	1.2	11.6	20.4	7.0	7.9	5.7	6.6	4.5	4.5	8.1	4.6	10.8	5.5	5.0	24.5	5.6	6.1	4.7	5.1	35.6	5.0	3.8	1.8	19.7	6.2	4.2	10.3	34.7	46.6	5.5	1.9	6.8	9.1	4.2	4.4	3.3	6.2	5.6	0.0	5.4	4.5	31.5	18.8	9.9	11.9	6.8	6.7	17.7	8.3	3.9
INTS8	"C8orf52, FLJ20530, INT8, MGC131633"	ENSG00000164941	"Integrator complex subunit 8"	Q75QN2	8	94813311-94881746	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057299	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA057299: AB_2683403"	"unprognostic (1.08e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.07e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.24e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-2)"	8.8	7.5	4.4	13.9	4.8	15.5	8.1	8.3	6.4	14.5	6.9	12.8	7.8	13.2	4.2	10.5	9.5	7.3	10.2	4.8	6.4	6.4	8.9	7.5	17.4	5.7	4.4	11.4	13.5	10.1	8.3	9.4	4.6	10.4	14.8	10.3	11.0	8.7	12.6	10.3	10.6	13.6	4.0	9.9	10.6	30.6	6.3	20.6	8.8	12.0	13.6	10.4	10.4	6.1	52.4	31.9	49.2	43.4	17.7	41.7	25.5	27.5	26.0	35.7	33.0	22.5	38.0	52.3	25.2	20.7	44.3	31.5	61.3	29.2	47.6	58.1	28.8	45.7	19.3	22.1	21.1	24.6	31.7	17.1	13.5	34.7	29.6	40.8	40.1	35.1	44.4	38.9	22.0	34.5	53.7	20.4	28.1	114.9	55.8	42.7	19.7	29.0	30.0	26.6	34.6	18.4	26.8	7.7	24.1	40.3	37.3	31.6	28.1	16.1	18.9	31.1	25.1	22.0	43.0	45.2	21.6	49.4	32.2	2.1	9.6	15.1	4.6	6.8	7.5	13.4	10.8	11.8	9.3	10.4	11.0	6.5	9.3	9.6	6.6	5.5	10.0	4.5	4.4	4.8	8.3	6.4	4.8	6.4	5.7	4.4	4.6	4.0	6.3	6.1	11.0	16.0	8.6	16.6	19.4	5.9	11.6	9.1	9.6	13.7	6.1	4.6	8.3	5.7	11.6	7.3	33.3	10.0	9.7	10.3	3.9	8.3	36.0	15.0	12.1	11.8	18.0	17.7	44.8	13.4	12.9	10.8	8.6	6.1	12.7	15.2	8.9	5.5	9.5	28.6	40.9	11.8	8.2	11.6	6.6	6.4	16.1	14.0	7.2	25.3	21.6	8.0	16.5	33.2	31.2	10.9	14.6	16.1	18.0	8.8	9.5	5.1	19.7	18.9	6.6	10.6	13.1	54.7	32.5	9.0	7.0	8.5	14.2	11.0	11.1	8.1
INTS9	"CPSF2L, FLJ10871, RC-74"	ENSG00000104299	"Integrator complex subunit 9"	Q9NV88	8	28767661-28890242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 29.5;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051615, HPA066822"			Enhanced	Nucleoplasm		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051615: AB_2681552, HPA066822: AB_2685729"	"unprognostic (2.19e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.91e-3)"	"prognostic favorable (7.71e-4)"	"unprognostic (3.64e-2)"	"unprognostic (5.01e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (1.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	8.6	22.0	7.9	11.1	8.9	6.8	8.3	8.7	9.4	9.1	10.5	8.8	6.9	9.2	11.3	11.1	9.7	6.7	12.2	7.9	8.6	10.7	5.9	8.8	14.6	8.5	8.8	8.2	9.7	9.5	12.5	7.9	8.6	9.1	9.3	10.5	8.9	7.2	11.6	9.9	9.6	9.0	8.6	15.7	9.4	12.8	8.9	17.5	10.6	6.9	17.9	11.0	8.7	9.4	24.7	17.0	20.1	21.4	24.3	11.3	8.8	11.1	15.1	19.0	20.9	11.9	13.4	24.4	15.2	11.4	17.0	20.1	39.2	22.7	26.1	10.3	16.1	24.4	9.5	21.0	17.6	12.3	18.2	13.0	16.0	22.9	16.3	10.2	23.8	34.5	52.2	13.7	12.8	13.5	57.5	22.3	27.4	28.8	10.9	36.5	23.3	12.8	13.4	16.8	14.4	26.4	11.5	14.8	20.5	16.0	14.4	13.8	14.1	10.9	27.6	18.7	14.2	7.0	5.3	29.8	16.8	20.3	15.8	17.0	20.6	19.0	17.3	23.0	16.1	18.0	15.1	19.3	29.1	19.5	13.4	14.5	8.3	25.1	17.4	15.4	20.3	12.0	7.9	8.9	8.7	9.4	7.9	8.6	8.5	8.8	8.6	8.6	8.9	9.4	3.6	6.4	4.2	28.7	10.9	2.3	2.4	4.7	1.8	2.1	2.7	2.3	5.8	5.7	3.7	3.7	6.2	7.7	6.1	2.8	1.9	3.7	8.3	4.8	6.2	4.6	6.0	4.2	29.5	5.1	4.8	4.7	9.2	5.9	0.0	6.7	3.9	2.5	7.5	1.7	31.3	3.6	4.1	3.8	6.1	4.1	7.8	4.1	3.6	23.4	5.4	2.4	4.1	32.2	39.9	4.9	1.7	4.5	4.3	1.9	3.3	4.3	3.4	6.1	0.0	4.2	4.0	5.1	3.5	7.7	3.0	4.8	5.4	11.2	3.5	1.7
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721662-33746905	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 308.1;tongue: 83.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cardiomyocytes: 11.2;Hepatocytes: 8.9;Horizontal cells: 10.1;Oligodendrocytes: 15.3;Proximal tubular cells: 8.2;Skeletal myocytes: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 21.9;HSkMC: 7.9;LHCN-M2: 36.2;RH-30: 15.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	1.4	0.7	4.8	0.4	15.5	0.0	1.3	12.2	9.5	1.9	5.7	6.8	0.4	3.8	0.1	6.5	1.2	0.1	29.6	5.9	8.8	6.0	18.8	5.2	0.1	14.7	13.1	0.5	0.6	0.0	0.5	4.7	15.0	5.3	0.6	0.9	2.7	1.6	308.1	0.7	2.3	1.8	7.0	3.3	1.6	0.2	12.4	0.5	12.9	83.3	0.0	2.4	1.9	27.1	0.1	0.0	0.5	0.0	0.0	0.1	3.6	0.1	0.4	0.3	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	21.9	0.0	0.1	7.9	1.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.5	5.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	15.5	12.2	9.5	5.9	8.8	14.7	13.1	15.0	7.0	12.4	27.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	8.5	0.4	0.4	11.2	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.2	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.0	8.9	0.3	10.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.0	0.4	6.6	51.7	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2
IPO4	"FLJ23338, Imp4"	ENSG00000196497	"Importin 4"	Q8TEX9	14	24180219-24188869	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 40.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 80.5;Late spermatids: 118.0;Spermatocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039043, HPA064572"	Uncertain		Approved	Cytosol		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA039043: AB_10673233, HPA064572: AB_2685291"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (9.45e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (8.59e-4)"	"unprognostic (5.45e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.15e-2)"	8.9	13.2	1.6	4.7	1.4	4.2	8.0	1.5	1.6	6.9	4.4	7.2	3.2	7.7	2.0	14.0	8.0	1.1	7.8	1.3	2.1	14.1	14.7	6.7	2.8	1.6	1.4	6.9	27.7	2.6	9.4	2.5	1.8	6.8	1.4	0.3	8.7	3.6	21.0	10.7	5.9	1.9	1.4	7.3	8.6	40.4	1.6	2.1	7.0	1.0	1.8	8.7	7.0	2.0	21.9	49.2	6.0	36.0	4.1	8.6	28.4	14.8	6.3	23.5	12.5	39.2	22.4	31.3	16.1	10.6	12.2	25.6	20.4	28.8	2.6	12.1	29.8	20.4	18.6	77.0	8.7	45.4	18.1	7.5	12.3	24.3	6.0	5.3	11.8	15.8	37.5	8.5	15.0	76.6	21.8	21.2	29.1	28.5	41.7	24.4	17.3	23.2	12.6	25.7	29.3	21.1	19.7	31.8	13.9	2.9	27.1	14.7	12.4	22.9	30.8	21.0	32.4	19.8	27.1	34.2	10.8	19.3	31.8	0.0	1.1	0.4	3.3	1.9	3.8	1.8	2.8	2.7	2.4	2.6	2.3	2.9	0.0	2.7	2.4	3.2	1.7	1.9	1.6	1.4	1.5	1.6	1.3	2.1	1.6	1.4	1.8	1.4	1.6	2.0	3.5	0.0	7.9	0.7	4.9	5.9	3.8	5.0	4.6	0.8	11.1	9.7	1.6	8.6	8.7	5.5	4.2	12.1	5.5	3.1	0.0	13.3	80.5	8.3	3.9	5.6	4.2	3.4	1.3	11.0	11.1	4.5	1.1	5.0	0.0	3.1	2.9	5.8	7.9	1.7	1.1	5.9	2.0	2.2	2.6	118.0	5.0	1.3	0.0	0.0	1.7	1.6	2.1	1.0	0.8	6.8	2.5	5.7	2.9	6.1	0.7	11.7	15.1	2.7	6.6	7.0	4.7	52.1	18.8	3.9	6.3	5.9	3.1	6.1	10.4	2.7
IPPK	"C9orf12, FLJ13163, INSP5K2, IP5K, IPK1"	ENSG00000127080	"Inositol-pentakisphosphate 2-kinase"	Q9H8X2	9	92613183-92670131	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 31.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020603	Uncertain		Approved	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA020603: AB_1851853"	"unprognostic (3.51e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.26e-9)"	"unprognostic (1.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.28e-4)"	5.4	6.9	5.2	4.5	5.7	8.5	6.4	7.5	6.4	9.1	3.9	4.1	3.2	5.2	4.8	31.6	5.4	4.6	7.8	6.9	4.7	4.4	5.3	4.7	5.7	5.5	5.1	5.4	3.6	8.5	8.1	5.5	5.7	4.2	4.4	5.7	8.8	2.8	7.6	29.8	4.2	5.4	5.0	5.4	4.6	11.6	5.6	5.9	4.6	6.1	8.7	5.7	15.5	5.6	19.3	10.1	9.2	8.0	11.1	8.2	30.4	13.5	8.5	13.6	7.8	6.3	7.4	11.9	6.6	18.9	12.0	27.1	16.4	18.9	11.3	14.9	10.4	9.8	21.9	9.9	7.8	16.7	11.2	8.1	18.4	16.3	12.7	12.4	10.3	9.8	13.5	14.1	13.6	26.3	9.6	7.7	15.8	21.2	14.9	8.5	9.8	4.9	8.0	11.5	19.1	11.2	10.9	44.9	7.8	8.9	10.6	4.2	19.7	10.0	11.3	28.2	14.4	13.0	16.2	6.5	13.0	7.5	9.9	0.0	1.4	3.4	3.6	1.8	4.1	2.4	3.0	3.1	2.1	2.2	2.3	2.6	2.1	0.8	1.9	2.3	4.6	1.9	5.2	5.7	7.5	6.4	6.9	4.7	5.5	5.1	5.7	5.0	5.6	5.6	6.8	3.2	3.4	10.1	4.8	25.4	6.4	7.6	16.5	7.5	6.0	4.7	0.4	1.5	5.1	1.8	6.2	10.8	4.6	5.0	5.9	6.2	11.0	8.3	5.3	6.8	6.7	6.1	23.8	8.0	13.8	4.1	7.1	10.2	0.0	3.6	10.0	3.1	5.1	15.2	23.7	3.5	6.1	7.5	4.6	33.7	3.1	5.3	3.6	7.5	2.8	4.9	8.2	20.6	23.3	9.1	1.4	3.0	6.0	6.4	2.6	3.6	2.6	4.6	6.6	3.9	3.5	20.0	19.4	25.5	29.5	22.8	6.0	4.4	3.7	10.5
IQCB1	"KIAA0036, NPHP5, SLSN5"	ENSG00000173226	"IQ motif containing B1"	Q15051	3	121769761-121835079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding	"Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 155.3;Spermatogonia: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 131.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042028	Approved	Approved	Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA042028: AB_2677806"	"unprognostic (3.82e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (3.08e-5)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-3)"	11.6	11.2	9.6	14.7	10.0	20.4	23.1	11.0	10.5	15.7	10.8	13.0	12.0	15.5	19.7	12.5	16.6	12.1	9.7	10.1	10.1	12.2	8.9	12.3	24.3	9.7	9.5	17.9	18.3	13.9	15.3	11.5	9.5	15.9	16.2	18.9	15.6	15.5	11.4	15.5	14.1	11.8	9.7	18.3	12.3	28.9	10.4	22.1	10.5	5.7	25.7	14.2	13.7	11.0	38.3	10.1	48.9	55.5	7.5	11.6	57.2	17.4	10.8	19.7	23.8	33.6	18.1	76.8	23.9	10.1	30.2	28.7	30.5	14.5	29.3	15.1	23.8	51.2	22.2	28.7	20.0	64.1	14.8	7.4	27.2	13.7	30.3	10.2	15.2	32.4	31.0	27.9	22.3	19.3	41.7	44.5	40.1	22.6	18.1	40.4	23.4	24.9	11.4	16.9	26.0	20.9	17.3	12.2	31.3	16.0	10.8	49.4	12.9	18.5	22.4	9.1	23.4	66.4	44.9	131.2	17.9	29.0	17.1	3.2	6.6	11.7	7.2	12.3	10.5	22.8	9.8	9.0	9.6	21.6	11.5	7.2	2.8	12.2	14.1	8.7	11.7	6.4	9.6	10.0	11.0	10.5	10.1	10.1	9.7	9.5	9.5	9.7	10.4	11.0	15.8	6.4	15.0	48.3	28.4	18.9	19.2	20.0	19.9	15.2	19.6	17.3	8.4	11.5	26.5	11.0	27.1	26.6	21.9	7.7	3.9	11.1	3.7	31.1	12.7	11.2	7.2	21.5	60.1	12.9	8.2	15.4	11.7	12.6	8.8	21.9	6.8	6.2	10.5	13.5	66.8	8.6	20.3	9.8	14.1	7.4	15.5	11.3	14.2	51.5	15.8	12.8	17.5	49.3	59.5	13.9	8.2	13.5	45.2	15.7	7.9	7.5	69.2	27.7	13.1	17.8	15.9	155.3	96.5	16.2	20.6	14.1	19.9	8.4	11.9	16.3
IQCE	KIAA1023	ENSG00000106012	"IQ motif containing E"	Q6IPM2	7	2558972-2614733	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 410.0;Late spermatids: 419.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.6;granulocytes: 4.6;monocytes: 1.2"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019515	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA019515: AB_1851855"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.91e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.56e-3)"	"unprognostic (3.13e-2)"	4.5	6.6	19.3	6.5	16.7	5.6	6.2	9.6	19.3	7.5	22.5	9.4	12.0	8.3	10.3	5.3	14.6	7.2	6.6	17.3	16.3	6.6	3.3	7.5	4.3	16.5	18.6	7.7	7.6	11.0	14.4	3.5	11.3	7.8	8.7	9.8	9.1	9.3	4.9	7.3	10.1	6.6	13.3	4.6	9.6	31.7	18.6	4.3	10.5	5.5	3.5	5.7	4.3	15.1	35.5	18.2	7.0	23.0	9.2	13.4	13.2	7.2	11.7	8.8	9.4	9.5	19.6	2.5	8.0	16.7	19.7	17.9	5.1	7.4	8.9	6.3	10.9	4.9	21.9	2.6	6.8	12.8	6.4	5.8	13.5	8.3	9.9	10.4	10.3	8.9	15.4	4.5	11.8	35.8	5.2	8.6	6.6	15.7	12.4	4.9	8.4	8.8	10.1	15.9	15.7	18.7	8.2	33.9	7.1	4.9	41.5	17.1	10.3	7.6	15.7	30.2	12.2	4.9	8.0	0.5	15.3	8.5	22.1	0.8	0.8	2.3	0.6	1.2	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.6	4.6	0.2	0.4	2.6	0.2	0.2	19.3	16.7	9.6	19.3	17.3	16.3	16.5	18.6	11.3	13.3	18.6	15.1	4.8	12.8	14.3	14.4	2.1	5.5	5.7	5.3	6.2	8.9	12.3	7.9	9.1	14.3	11.4	12.9	60.5	4.1	13.8	27.4	17.6	20.6	410.0	44.8	15.3	5.7	8.4	1.7	16.6	19.7	10.0	7.0	24.5	9.4	1.3	7.6	6.4	2.8	10.1	20.2	17.4	12.3	12.2	8.1	5.3	419.3	14.0	9.3	0.0	3.7	12.0	14.9	12.3	4.5	4.2	24.1	18.9	15.4	8.0	5.4	12.1	9.5	58.7	36.7	19.7	7.8	6.6	40.9	43.8	3.5	4.3	1.9	4.9	11.2	12.4	4.0
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 11.2;Late spermatids: 26.6;Undifferentiated cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	0.7	0.7	0.2	2.2	0.4	15.5	0.6	0.0	0.6	1.1	0.2	4.1	6.6	0.5	1.1	5.2	0.2	0.7	0.4	0.5	0.1	0.6	0.6	1.6	1.6	0.9	0.4	0.1	0.2	0.1	0.1	2.8	0.9	0.4	5.0	0.0	1.0	0.1	0.3	3.7	5.7	2.9	0.0	0.8	4.6	3.8	0.6	3.4	0.2	0.0	2.2	0.9	2.1	0.4	59.2	28.4	25.6	18.1	1.6	4.0	12.4	43.1	28.3	41.0	36.6	32.4	52.5	5.2	15.6	25.2	21.6	54.6	17.5	22.1	36.3	0.1	15.7	7.8	62.6	16.1	0.2	9.7	0.1	1.2	2.5	34.3	50.0	10.0	24.1	12.5	16.1	8.1	30.2	31.2	5.7	13.7	18.6	57.7	28.0	18.9	28.8	6.1	10.4	20.3	16.3	25.2	38.7	44.9	14.9	29.8	35.8	25.6	16.8	36.8	43.7	30.4	51.4	4.0	2.1	2.4	12.4	15.1	42.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.4	0.0	0.6	0.5	0.1	0.9	0.4	0.9	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.4	0.6	0.0	1.4	1.3	1.0	2.8	0.1	0.0	0.0	2.2	0.1	3.9	0.0	0.3	6.5	0.5	0.7	0.6	1.2	6.5	0.7	0.0	3.6	0.9	11.2	1.4	0.0	4.4	2.5	0.4	3.9	0.0	0.2	3.7	0.0	1.3	6.1	26.6	0.3	1.9	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	0.4	0.8	0.4	0.0	0.0	0.0	0.0	1.4	6.4	2.6	3.6	1.0	0.8	0.2	0.3	7.4	0.4
IQSEC2	"BRAG1, IQ-ArfGEF, KIAA0522, MRX1, MRX18, MRX78"	ENSG00000124313	"IQ motif and Sec7 domain ArfGEF 2"	Q5JU85	X	53225828-53321350	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 58.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.0;Late spermatids: 41.6;Proximal enterocytes: 42.1;Proximal tubular cells: 52.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 10.4;plasmacytoid DC: 10.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 10.6;monocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"A549: 47.3;GAMG: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003973, HPA076533"			Approved	"Vesicles,Lipid droplets"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Lipid droplets"		"HPA003973: AB_2280343, HPA076533: "	"unprognostic (1.85e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.66e-3)"	"unprognostic (6.02e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.38e-4)"	10.8	18.8	18.3	5.8	22.4	2.4	9.9	9.8	32.3	9.7	0.0	14.9	12.5	12.0	4.4	9.5	10.7	6.1	11.2	35.8	0.0	19.4	1.9	8.7	2.8	2.4	0.1	7.6	9.0	14.1	10.9	3.8	2.8	12.0	7.1	3.0	14.9	8.8	58.7	8.9	14.2	7.3	0.3	5.3	10.4	9.9	0.2	3.4	9.7	34.0	3.4	12.1	9.8	14.2	4.8	47.3	1.8	4.4	6.5	13.1	5.3	7.7	13.4	6.2	10.9	1.2	18.2	0.3	12.4	18.3	58.5	6.4	1.7	7.7	4.4	4.8	8.3	5.4	20.8	1.3	14.2	0.2	2.8	9.8	11.8	16.1	9.0	14.4	8.5	0.1	17.3	5.3	12.4	11.2	0.0	1.0	14.6	14.2	21.0	3.5	3.7	6.0	9.0	10.1	1.9	1.8	18.0	11.0	7.5	8.3	15.7	2.3	9.5	5.6	10.6	3.1	3.5	1.5	0.2	0.2	34.6	3.5	3.1	0.1	10.4	0.5	0.0	3.7	0.1	0.2	0.0	0.0	5.4	0.1	0.1	0.0	0.6	0.0	2.0	10.6	0.0	2.3	18.3	22.4	9.8	32.3	35.8	0.0	2.4	0.1	2.8	0.3	0.2	14.2	8.4	6.4	5.9	15.0	1.4	4.0	6.7	11.5	7.4	1.5	12.2	9.5	4.0	12.8	9.3	14.7	0.0	8.0	2.0	21.1	21.5	5.2	18.0	5.4	3.5	6.2	3.6	0.8	54.0	7.1	6.5	6.6	8.2	4.7	3.8	9.1	6.4	0.9	14.7	0.0	25.7	9.7	8.2	12.0	5.0	41.6	1.5	14.1	10.6	17.8	11.9	5.0	0.0	9.5	2.5	5.5	12.6	2.2	1.0	7.0	42.1	52.4	7.6	0.1	0.0	2.7	8.4	0.8	1.5	9.3	3.8	4.5	1.5	2.5	10.7	14.6
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452193-123535077	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 33.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 283.9;Endometrial ciliated cells: 82.6;Late spermatids: 157.5;Respiratory ciliated cells: 88.2;Spermatocytes: 116.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nucleoplasm,Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	"Nucleoplasm, Intermediate filaments, Cytosol"	"HPA049626: AB_2732554"	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.1	0.6	0.2	0.0	0.4	0.0	0.5	1.7	0.9	0.8	3.9	0.1	0.0	0.7	1.1	0.0	5.0	0.8	0.1	0.2	0.5	3.0	0.0	0.8	0.0	1.8	2.0	0.2	0.3	1.7	1.0	0.1	1.3	0.5	0.0	1.1	0.2	0.6	0.1	0.1	0.0	0.2	1.0	0.0	0.1	33.4	0.6	0.0	3.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.7	0.9	0.2	0.5	1.8	2.0	1.3	1.0	0.6	0.4	1.1	6.4	0.5	19.6	0.0	0.5	0.7	3.8	0.0	2.5	1.9	1.8	1.8	0.0	11.4	18.4	4.2	0.4	0.1	0.1	1.9	1.1	283.9	82.6	3.2	0.9	1.8	0.0	12.0	0.4	0.3	1.1	0.0	1.7	1.3	0.3	0.7	0.0	0.1	3.3	8.6	0.2	8.2	0.0	0.3	157.5	2.5	0.4	0.0	4.7	0.3	1.8	0.0	5.0	2.6	0.2	0.0	3.0	0.0	0.5	0.0	5.7	88.2	9.0	6.6	0.7	2.7	116.2	6.0	0.2	0.1	0.7	0.3	2.9	0.0	0.3
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010506-154019902	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: AB_2682501"	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	48.6	61.2	24.4	37.6	25.3	82.4	40.7	23.6	34.9	29.0	20.0	41.4	43.3	31.8	7.7	69.1	28.8	20.2	34.4	22.3	26.5	44.2	64.7	48.9	33.7	38.1	30.0	28.9	84.9	12.4	37.5	17.8	30.8	46.1	15.0	4.5	41.6	21.0	92.5	44.3	51.1	16.4	29.6	69.9	41.9	20.8	34.3	19.4	24.5	16.8	24.0	47.7	36.5	29.4	467.2	178.9	24.5	201.2	48.4	38.5	108.3	68.8	64.5	104.0	96.0	142.3	199.4	200.8	371.4	73.6	157.6	124.3	57.6	112.4	39.8	156.7	173.4	73.3	158.6	85.7	110.8	174.2	118.7	53.2	96.1	99.0	107.8	53.2	62.8	39.6	130.9	220.3	73.3	171.4	70.8	152.1	60.9	148.4	353.5	181.6	126.4	334.7	68.5	86.3	137.4	98.7	82.2	88.6	135.2	9.5	34.3	179.2	86.4	123.8	194.6	284.6	424.2	274.8	190.6	358.2	179.6	205.1	130.8	1.3	7.2	6.2	5.3	9.2	4.7	6.5	4.3	4.4	4.8	7.9	2.5	4.7	5.2	5.4	7.5	10.9	2.3	3.3	24.4	25.3	23.6	34.9	22.3	26.5	38.1	30.0	30.8	29.6	34.3	29.4	20.2	0.0	13.3	5.9	29.7	13.4	14.5	10.9	5.2	9.1	23.9	19.0	9.3	18.6	16.0	11.0	6.2	11.4	33.0	41.4	7.9	40.5	0.9	9.8	13.5	18.1	20.4	18.1	9.7	113.6	20.9	15.2	18.3	17.3	12.7	25.5	13.2	35.9	57.2	16.8	8.9	27.2	0.0	51.4	24.7	3.8	18.0	43.0	14.2	11.2	24.2	21.8	13.4	4.5	6.6	75.0	28.6	21.4	33.5	30.0	39.4	19.6	10.0	5.3	0.0	14.5	14.9	1.6	8.1	15.1	13.1	12.3	19.6	18.4	39.4	25.3
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66189195-66254622	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"			Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.3;Kupffer cells: 123.0;Macrophages: 126.3;Microglial cells: 114.3;monocytes: 96.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.7;classical monocyte: 23.4;intermediate monocyte: 24.2;myeloid DC: 11.5;neutrophil: 12.9;non-classical monocyte: 42.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 11.5;granulocytes: 12.9;monocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;ASC TERT1: 21.1;HEL: 22.9;HL-60: 30.8;NB-4: 25.1;THP-1: 37.3;U-937: 26.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	18.7	3.8	3.7	12.4	4.1	78.1	11.6	4.1	7.5	9.3	5.4	4.6	1.3	4.0	3.0	3.8	8.0	6.9	7.9	3.2	4.7	3.5	2.8	19.0	4.1	5.6	5.7	3.2	2.5	0.9	8.9	6.8	6.5	5.3	2.8	0.4	6.2	5.6	2.6	3.4	5.6	5.4	5.0	27.5	6.9	1.8	5.6	2.7	5.0	4.6	3.9	8.4	6.6	5.1	0.0	0.0	0.4	0.0	25.9	21.1	0.0	2.9	0.0	1.5	2.3	0.0	2.2	0.0	1.4	5.3	0.0	0.0	3.2	0.0	1.3	0.0	0.0	22.9	1.4	0.0	13.4	30.8	4.0	13.5	0.1	1.2	0.0	0.0	7.6	0.0	0.0	0.0	1.0	0.0	0.0	25.1	1.3	0.0	0.0	0.0	6.4	0.0	0.1	3.3	0.1	0.0	11.6	0.0	1.2	0.1	0.1	37.3	8.2	0.0	0.0	0.0	0.0	0.9	0.2	2.2	0.0	26.8	0.0	12.7	23.4	4.3	0.0	24.2	0.0	0.1	0.0	0.0	11.5	0.7	0.0	0.0	12.9	1.8	42.0	0.1	0.6	7.3	3.7	4.1	4.1	7.5	3.2	4.7	5.6	5.7	6.5	5.0	5.6	5.1	83.3	9.6	19.4	1.3	2.3	1.5	4.8	27.5	6.2	0.3	2.5	1.8	2.8	0.0	46.9	3.7	0.0	0.2	14.8	0.5	0.0	0.6	6.4	0.5	7.5	38.5	0.0	9.7	0.4	1.2	0.4	22.3	18.3	0.5	27.3	0.5	36.4	1.2	9.4	0.0	5.6	1.1	36.7	123.0	12.1	5.3	7.2	126.3	5.4	114.3	96.9	0.2	3.1	2.0	0.6	4.9	0.1	11.3	9.1	1.6	0.0	0.2	35.1	0.1	0.0	18.1	10.2	0.8	1.8	1.2	1.3	0.3	3.5	12.5	0.7	2.5
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785617-209806175	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 95.4;skin 1: 114.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 387.2;Basal prostatic cells: 253.9;Basal squamous epithelial cells: 217.9;Squamous epithelial cells: 251.9;Suprabasal keratinocytes: 552.4;Urothelial cells: 290.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 10.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 61.9;HaCaT: 210.7;HBEC3-KT: 80.5;hTCEpi: 170.1;hTERT-HME1: 82.2;RT4: 78.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.6	11.4	1.6	3.2	1.5	2.8	35.9	10.9	1.8	21.6	5.2	27.1	26.9	5.9	49.3	95.4	21.7	10.8	29.7	1.7	1.4	17.0	33.3	8.8	0.9	1.9	2.9	1.9	19.7	26.4	6.5	20.4	1.9	32.4	31.5	2.4	39.0	26.4	0.5	114.0	25.0	2.0	2.1	2.1	24.8	2.9	2.3	20.3	17.1	2.7	23.0	40.5	46.8	1.2	61.9	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.5	0.1	0.3	13.6	20.7	0.0	0.1	0.1	0.0	210.7	0.0	80.5	0.0	0.0	1.3	0.1	0.2	0.0	0.2	0.0	0.2	0.1	170.1	0.1	82.2	0.0	3.7	0.0	0.1	0.2	0.0	8.3	0.0	0.3	1.2	17.0	0.2	0.0	0.0	0.3	7.7	78.8	18.7	6.1	1.4	34.1	1.9	3.8	24.1	0.3	0.0	0.0	0.1	0.0	0.3	0.8	15.8	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.2	1.6	1.5	10.9	1.8	1.7	1.4	1.9	2.9	1.9	2.1	2.3	1.2	1.9	16.0	10.4	0.3	1.0	387.2	253.9	154.0	217.9	0.1	47.2	33.3	26.0	32.9	70.4	35.0	0.0	94.2	1.3	95.5	27.4	36.7	1.1	120.2	9.5	6.0	59.9	0.4	0.0	19.2	25.4	4.5	53.0	121.7	2.5	0.0	1.1	35.9	8.3	0.0	0.1	74.9	38.7	1.0	30.1	0.7	0.6	2.3	35.6	1.9	1.0	6.5	0.0	0.0	0.0	49.2	43.8	0.0	2.5	153.9	49.5	11.9	82.1	0.6	0.0	0.4	7.4	8.2	3.7	251.9	552.4	161.6	2.5	0.7	44.5	290.3
IRF7		ENSG00000185507	"Interferon regulatory factor 7"	Q92985	11	612553-615983	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.2;lymphoid tissue: 33.2"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 576.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	12	"plasmacytoid DC: 596.9"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 596.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 9.6;Karpas-707: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017694, HPA052757"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017694: AB_2280489, HPA052757: AB_2681937"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-10)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.71e-2)"	10.4	2.6	1.3	1.6	1.6	1.6	7.5	1.5	2.1	11.2	2.2	8.8	0.0	3.4	0.0	12.7	4.7	2.2	7.9	1.2	1.6	15.6	38.2	14.4	0.9	2.7	1.6	4.7	5.9	0.2	6.2	0.7	2.4	9.2	0.3	0.3	8.8	0.8	11.3	7.8	15.3	0.9	1.3	33.2	8.6	1.9	1.6	1.4	10.7	1.3	2.2	5.1	7.3	1.6	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.4	3.9	15.5	9.6	2.2	0.1	0.0	3.7	0.6	3.7	0.5	0.2	0.1	1.0	0.2	0.0	0.1	0.0	0.2	0.8	0.0	0.0	1.6	0.6	0.0	0.6	0.7	0.1	1.9	0.0	6.5	0.1	0.0	0.7	0.0	0.0	3.1	1.3	0.1	0.2	0.0	0.2	0.1	3.1	0.0	0.6	1.8	0.4	0.3	0.0	1.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.7	20.4	30.6	8.1	46.1	7.8	16.5	6.7	7.0	24.3	20.8	7.5	8.5	12.9	18.7	49.5	596.9	13.5	19.7	1.3	1.6	1.5	2.1	1.2	1.6	2.7	1.6	2.4	1.3	1.6	1.6	65.0	16.0	19.0	2.9	59.2	34.4	32.3	19.6	18.8	0.4	27.7	20.2	4.3	18.6	18.2	20.2	0.0	6.1	576.1	70.1	9.8	29.9	5.9	20.1	6.3	33.0	26.3	4.8	0.0	16.9	39.0	19.3	40.8	21.2	31.7	20.1	17.9	31.7	37.3	0.0	0.1	42.5	22.4	23.2	65.4	28.9	12.2	67.4	37.4	3.7	65.2	2.7	40.2	1.0	1.3	29.9	73.8	4.9	65.1	24.8	37.6	6.3	25.5	4.6	13.1	8.8	19.8	0.4	5.9	8.0	28.4	24.1	42.7	4.6	18.9	34.6
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85899162-85922606	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 85.5;lymphoid tissue: 244.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 225.8;dendritic cells: 492.3;Kupffer cells: 105.1;Langerhans cells: 366.0;Macrophages: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 2477.4"	"Lineage enriched"	"Detected in all"	7	"dendritic cells: 2477.4"	"Group enriched"	"Detected in some"	4	"Daudi: 240.7;THP-1: 382.3;U-698: 928.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	25.9	7.6	4.7	81.4	5.6	85.5	9.3	7.0	6.2	5.6	5.4	27.1	47.1	8.0	3.1	6.7	6.5	19.7	3.8	6.3	5.4	6.1	36.9	27.4	244.1	9.5	8.5	2.5	3.4	1.7	1.7	10.1	10.0	7.7	33.5	0.8	7.1	8.9	2.0	5.0	56.2	13.5	11.3	137.3	22.9	4.8	12.6	61.5	4.1	1.7	224.9	21.8	1.6	14.0	0.9	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	26.0	0.0	240.7	1.5	0.0	0.0	0.1	1.4	0.0	0.2	0.2	2.7	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.5	0.0	0.0	0.6	21.3	0.2	20.6	0.0	7.5	1.1	27.2	0.0	0.0	0.1	0.1	1.0	0.0	0.2	1.4	0.0	382.3	0.6	0.0	10.9	0.2	0.9	0.3	0.3	928.2	0.0	128.4	0.0	9.1	137.1	3.4	3.3	134.3	4.5	347.0	1.8	2.1	291.2	361.3	3.5	2.8	8.4	111.5	97.3	2477.4	0.7	150.1	4.7	5.6	7.0	6.2	6.3	5.4	9.5	8.5	10.0	11.3	12.6	14.0	3.7	0.0	4.2	0.0	225.8	10.5	0.8	0.0	0.6	0.0	2.4	3.4	1.5	2.8	1.3	0.0	0.0	0.8	492.3	13.0	1.9	0.5	1.5	7.3	7.6	7.6	28.7	7.4	0.6	1.4	5.7	10.8	15.3	12.5	2.5	0.4	1.8	6.5	64.1	0.0	0.2	11.8	0.0	105.1	366.0	4.6	0.3	122.2	44.4	33.7	35.3	0.4	23.7	1.0	0.4	0.1	10.7	0.0	14.1	2.3	34.2	3.5	0.0	0.2	6.6	0.7	6.7	0.7	6.7	0.4	9.2	1.1	23.1	48.8	25.6	2.5
IRS1	HIRS-1	ENSG00000169047	"Insulin receptor substrate 1"	P35568	2	226731312-226799820	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 75.4;Theca cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005261, HPA046433"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005261: AB_649615, HPA046433: AB_2732524"	"unprognostic (2.20e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.55e-3)"	7.6	9.7	1.7	2.9	1.6	0.5	11.7	5.2	3.1	14.7	1.8	10.3	3.9	17.4	1.9	3.6	15.0	5.6	5.0	1.6	1.0	3.4	10.5	5.0	1.7	1.8	1.6	20.9	3.5	3.3	1.5	9.5	1.2	7.8	2.7	1.5	3.0	7.0	28.0	5.2	5.1	10.3	2.0	2.0	5.3	0.8	1.6	8.1	20.0	2.9	1.3	11.6	6.6	1.5	5.7	26.0	18.6	0.7	25.0	14.8	0.0	15.6	12.2	20.4	13.0	15.0	14.4	2.3	2.5	10.6	14.0	10.0	1.2	15.0	11.5	5.9	1.0	0.1	1.7	7.1	12.5	0.5	0.1	20.7	8.1	16.1	14.5	12.3	0.0	2.3	3.0	22.7	14.0	22.6	4.9	6.6	7.5	3.6	14.3	1.1	24.1	0.1	9.3	18.9	3.2	0.5	5.0	3.6	8.4	14.9	13.7	0.3	1.3	26.8	24.2	20.9	15.1	10.6	4.6	3.4	26.5	0.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.2	3.1	1.6	1.0	1.8	1.6	1.2	2.0	1.6	1.5	1.7	19.2	4.6	5.9	2.7	35.4	31.9	29.7	19.4	19.3	36.9	28.1	13.4	14.3	12.8	0.0	0.0	6.4	0.0	13.2	17.6	15.4	1.6	22.1	28.4	2.1	2.4	0.0	17.3	11.4	0.6	28.3	2.0	24.3	0.0	75.4	1.8	57.4	1.7	20.2	31.3	6.5	24.4	1.3	4.6	1.8	22.7	3.6	16.0	15.0	0.8	8.4	0.0	26.7	1.7	11.1	8.2	14.7	9.5	14.5	23.4	3.0	8.1	1.7	13.1	9.5	22.8	1.0	1.2	4.2	23.7	18.3	1.2	110.3	7.7	22.8
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752695-109786583	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.1;LHCN-M2: 36.9;SH-SY5Y: 40.2;THP-1: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Aggresome	"CAB016944: , HPA054664: AB_2682563"	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	26.2	16.5	22.2	5.9	21.8	51.3	18.9	12.1	28.4	10.7	3.9	11.3	4.4	13.0	6.3	4.2	7.7	4.0	13.0	32.2	22.9	3.5	22.1	11.1	2.3	29.4	24.5	18.6	4.3	3.6	19.1	6.7	24.8	13.3	3.4	6.0	11.6	6.1	21.4	15.5	6.0	4.7	13.6	5.4	7.8	3.0	25.2	2.3	5.5	7.7	2.2	7.1	8.6	20.1	5.8	6.6	4.2	0.0	34.5	6.9	2.3	6.3	7.4	3.8	3.1	0.6	7.0	0.0	3.9	4.5	5.4	2.6	2.2	5.6	4.7	2.3	29.5	2.8	9.3	0.0	34.8	10.7	3.3	14.5	29.6	1.1	38.1	24.5	1.4	0.5	1.9	0.0	36.9	3.0	0.1	31.1	4.5	3.2	1.4	13.1	3.8	2.8	10.6	1.5	6.1	40.2	3.3	0.1	27.2	3.5	0.8	62.8	0.1	7.8	0.0	0.5	8.5	0.0	3.1	2.1	5.8	10.2	13.7	1.5	0.6	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.3	0.0	0.2	0.0	0.2	0.1	22.2	21.8	12.1	28.4	32.2	22.9	29.4	24.5	24.8	13.6	25.2	20.1	13.7	32.1	33.8	53.8	31.1	113.9	48.0	100.2	81.4	25.8	68.9	98.4	72.3	60.1	79.5	31.3	114.7	20.3	40.0	71.2	5.9	36.4	47.6	81.6	110.6	13.4	122.6	34.5	51.3	3.1	11.1	52.0	28.1	188.5	25.3	25.8	20.0	142.9	24.1	25.2	42.2	42.0	52.9	143.5	24.4	12.3	37.3	131.2	129.9	29.0	59.3	32.4	17.5	46.3	34.8	30.8	44.4	20.3	7.9	76.8	77.3	3.9	40.3	30.6	26.3	57.1	44.0	21.2	10.2	74.6	126.2	30.6	37.5	63.1	42.7	53.6
IRX5	IRX-2a	ENSG00000176842	"Iroquois homeobox 5"	P78411	16	54930865-54934485	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Vision"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.0;skin 1: 16.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 40.3;Breast myoepithelial cells: 55.5;Granulosa cells: 43.8;Muller glia cells: 43.1;Squamous epithelial cells: 33.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.1;T-47d: 36.6;THP-1: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047130			Approved	"Nuclear speckles,Microtubules,Cytosol"		No	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"	"Microtubules, Cytosol"	"HPA047130: AB_10962983"	"unprognostic (2.63e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.38e-3)"	"prognostic favorable (4.59e-4)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.28e-2)"	1.7	0.6	1.3	0.0	1.5	0.0	14.0	4.1	0.4	1.8	0.3	0.2	0.0	0.1	0.0	7.2	0.2	0.1	9.8	0.3	1.9	6.9	0.0	6.4	0.0	3.6	4.1	0.3	0.1	0.3	0.4	0.0	3.1	3.4	0.0	1.3	10.2	0.2	1.4	16.9	0.0	0.0	3.6	0.0	2.6	0.7	4.6	0.3	0.1	1.1	0.0	0.6	5.9	3.5	0.8	0.5	8.6	3.2	3.1	0.6	0.4	3.3	8.2	1.1	0.8	1.9	0.8	0.0	0.7	4.5	0.3	8.4	3.0	3.6	0.6	6.0	4.1	0.9	3.4	0.0	0.1	2.0	3.3	0.8	15.1	5.4	2.3	1.5	0.0	4.8	0.5	0.0	6.2	3.3	9.6	12.3	0.1	1.3	2.4	5.0	4.4	0.5	27.1	0.2	2.9	3.0	1.4	7.3	3.9	0.0	36.6	20.2	0.5	5.9	0.2	4.2	1.3	3.6	2.3	2.9	9.6	3.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	4.1	0.4	0.3	1.9	3.6	4.1	3.1	3.6	4.6	3.5	2.4	9.6	21.9	0.0	0.1	8.3	9.7	6.7	15.9	8.6	40.3	55.5	11.1	0.0	15.4	0.0	0.0	0.2	1.0	0.2	0.0	0.3	1.0	9.6	1.2	1.6	0.0	0.0	0.0	0.6	0.0	5.3	7.7	12.2	0.0	43.8	0.0	0.0	0.2	1.7	0.0	0.8	4.1	0.0	2.7	2.4	0.0	0.6	5.4	0.0	0.0	43.1	0.0	0.0	0.0	2.9	0.3	0.0	0.3	4.8	0.0	1.5	13.0	1.9	0.0	8.3	5.2	0.7	2.8	33.9	8.0	0.0	0.4	0.0	0.5	8.5
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55324203-55330756	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.8;heart muscle: 9.8;skin 1: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.5;Collecting duct cells: 5.5;Hofbauer cells: 4.7;Late spermatids: 5.1;Melanocytes: 3.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HEK 293: 1.9;RPTEC TERT1: 7.1;SK-MEL-30: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Mitochondria"		"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	9.8	0.1	0.2	0.0	0.6	0.0	4.8	1.1	0.3	2.3	0.0	0.2	0.0	0.2	0.0	0.5	0.1	0.1	9.8	0.0	1.1	2.7	0.0	1.8	0.1	0.5	0.8	0.2	0.1	1.7	0.2	0.1	0.6	0.2	0.0	1.6	1.9	0.0	2.8	8.9	0.3	0.1	0.2	1.3	0.0	0.4	0.6	2.2	0.6	1.3	1.1	0.0	0.5	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.1	0.0	1.1	4.8	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	1.1	0.3	0.0	1.1	0.5	0.8	0.6	0.2	0.6	0.2	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.5	0.0	7.5	0.4	0.6	1.3	0.0	1.2	5.5	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.8	0.0	0.6	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.7	5.1	0.0	0.1	3.6	0.0	0.6	1.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.3	0.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0
ISOC1	CGI-111	ENSG00000066583	"Isochorismatase domain containing 1"	Q96CN7	5	129094749-129114028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 156.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070307			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA		1900000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum, Vesicles"		"HPA070307: AB_2686249"	"unprognostic (1.67e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.42e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.18e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.32e-2)"	27.8	28.0	11.9	12.8	12.2	12.6	25.5	11.9	13.7	57.2	11.4	19.6	32.1	102.7	21.0	22.1	27.2	15.6	65.7	11.1	16.0	33.6	100.2	14.0	14.6	15.9	16.4	17.1	19.9	15.7	20.5	15.3	13.8	19.7	21.7	14.8	28.4	8.9	17.1	23.5	28.3	64.9	13.8	10.0	20.4	11.1	15.2	18.9	13.3	16.4	16.8	21.3	19.2	15.2	27.7	21.4	21.7	33.5	35.0	18.5	95.7	11.7	10.0	13.1	23.1	75.5	38.2	19.6	28.3	6.9	40.0	14.7	46.5	35.2	24.2	107.5	52.8	39.0	20.9	55.7	24.7	15.6	13.6	12.2	10.5	20.5	17.7	9.4	31.6	30.6	43.0	33.2	11.6	110.2	29.2	25.3	33.5	26.4	57.8	41.5	63.2	19.3	32.9	55.4	36.6	156.9	33.7	42.3	21.6	19.7	34.9	13.0	13.4	14.8	28.1	11.9	38.3	27.5	22.9	32.7	16.5	48.4	17.0	64.0	25.2	38.0	54.0	25.0	61.4	47.7	50.3	57.7	31.5	49.4	43.9	51.8	30.9	61.4	25.3	29.0	69.0	48.9	11.9	12.2	11.9	13.7	11.1	16.0	15.9	16.4	13.8	13.8	15.2	15.2	58.1	12.8	17.2	6.5	18.9	131.8	42.4	28.5	88.2	12.4	33.6	19.8	70.6	34.3	19.3	20.2	10.4	74.7	26.3	19.9	125.2	22.2	1.6	23.5	30.1	16.9	31.8	21.0	1.7	28.1	71.8	33.9	17.3	24.9	18.4	51.0	5.3	84.7	23.9	0.0	5.6	26.6	30.5	8.8	41.0	4.2	13.7	14.3	28.4	4.7	18.9	52.9	18.6	6.0	9.2	16.3	29.8	19.2	36.9	38.5	45.7	96.2	10.6	6.5	0.0	33.7	15.9	6.5	38.1	53.7	84.1	50.9	26.4	79.3	32.8	37.8
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363241-34540748	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 139.7;Oligodendrocytes: 260.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607"	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	19.5	16.2	13.7	18.1	27.1	27.3	20.0	19.6	17.7	24.5	17.7	21.6	20.2	19.4	16.6	42.8	15.7	17.0	20.2	14.7	15.9	23.3	55.6	18.7	21.4	19.8	20.0	18.8	16.5	23.1	7.8	25.6	21.0	19.6	23.5	25.6	18.7	19.9	17.2	14.0	20.9	21.5	15.9	20.4	20.9	38.5	20.2	23.2	26.3	21.7	25.7	30.6	14.8	45.7	55.5	34.6	35.2	25.9	38.3	57.4	42.7	43.5	52.0	56.2	54.0	101.5	83.8	26.7	42.1	55.6	73.9	66.2	54.9	92.3	66.2	20.8	17.9	78.3	28.2	59.3	43.9	32.6	34.4	31.7	46.2	44.4	72.2	49.8	41.7	40.6	45.5	45.7	46.2	26.5	49.2	18.8	16.9	35.6	44.2	40.9	76.3	63.6	34.7	91.2	21.4	16.4	82.0	32.7	51.0	33.9	38.3	31.1	39.5	61.5	36.0	42.8	33.3	36.2	40.5	40.0	41.0	21.6	38.0	4.6	6.7	7.0	12.0	7.0	12.5	9.2	4.2	6.1	4.9	7.8	3.7	5.7	20.2	7.6	4.9	14.3	5.8	4.3	13.7	27.1	19.6	17.7	14.7	15.9	19.8	20.0	21.0	15.9	20.2	45.7	26.1	12.8	21.8	56.5	33.1	15.0	23.9	11.7	25.6	19.5	15.1	8.5	25.0	12.8	25.6	31.3	25.0	17.5	46.1	28.8	5.9	12.8	59.0	26.5	34.6	20.7	12.0	26.5	85.0	16.3	21.2	24.2	33.1	36.1	19.0	17.9	18.2	53.0	15.8	15.2	72.3	16.9	10.2	24.3	26.7	139.7	22.4	31.4	26.6	68.4	30.0	38.2	43.3	79.4	260.0	22.6	23.7	15.4	50.3	25.8	21.1	26.8	23.5	26.0	13.1	21.4	22.0	40.6	25.5	30.4	16.2	46.9	30.8	12.3	11.9	40.6
ITGA2	CD49B	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989340-53094779	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 406.2;Oligodendrocytes: 370.9;Pancreatic endocrine cells: 558.7;Prostatic glandular cells: 299.3;Urothelial cells: 363.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 91.4;HaCaT: 92.5;hTERT-RPE1: 83.2;HUVEC TERT2: 83.5;TIME: 71.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		43000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.4	12.8	2.4	4.9	6.7	0.4	7.8	4.4	3.7	5.0	0.9	6.1	7.7	4.9	7.4	11.0	2.6	9.0	1.1	2.4	4.2	9.8	0.5	12.5	0.9	4.8	4.9	1.0	1.6	9.3	1.2	4.8	5.4	6.6	5.9	2.4	10.4	11.1	0.5	17.1	7.7	2.4	3.3	6.8	7.5	0.4	4.8	4.3	2.3	0.7	4.6	15.6	8.0	12.9	60.4	15.4	1.3	0.8	3.9	7.1	4.5	60.2	91.4	2.2	3.6	29.0	41.8	0.1	9.8	25.4	33.5	92.5	4.9	67.1	8.5	0.0	4.4	4.3	3.7	17.5	13.3	0.7	1.3	2.9	11.4	59.2	10.5	83.2	83.5	3.1	0.1	0.2	1.6	11.4	0.6	0.1	3.7	15.7	29.6	0.0	0.4	0.1	18.9	32.0	0.6	3.2	3.2	4.1	6.1	2.3	9.6	0.2	71.2	10.8	6.3	1.7	12.1	0.0	0.1	0.1	64.0	0.0	48.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	6.7	4.4	3.7	2.4	4.2	4.8	4.9	5.4	3.3	4.8	12.9	7.4	57.7	13.7	9.1	0.6	151.0	406.2	141.3	56.9	2.7	24.4	39.0	1.3	15.7	133.2	53.3	4.2	1.9	0.9	23.2	9.8	144.0	0.1	20.3	5.0	39.0	13.8	0.0	0.5	169.3	2.2	11.6	13.3	90.6	1.3	45.4	5.3	0.2	0.3	0.0	0.9	37.8	20.3	0.0	6.1	0.2	1.2	2.5	12.4	14.0	1.1	14.7	0.0	0.0	370.9	558.7	20.3	0.0	2.6	299.3	20.6	3.8	103.6	4.3	0.0	4.4	12.1	0.0	1.3	57.0	37.2	0.4	5.8	23.7	30.9	363.9
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 111.9;Exocrine glandular cells: 105.1;Pancreatic endocrine cells: 245.6;Urothelial cells: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 647.2;hTERT-RPE1: 572.8;RPTEC TERT1: 562.0;U-87 MG: 920.8;WM-115: 570.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"		NA	NA		170000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (3.24e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (9.51e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.28e-3)"	"unprognostic (2.76e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.35e-2)"	17.5	29.8	5.3	9.9	5.4	0.4	17.3	6.0	6.1	14.8	5.2	25.4	30.4	21.3	11.7	24.1	24.5	17.9	13.2	5.0	10.9	68.9	2.2	65.8	3.0	7.5	6.6	12.8	15.9	17.7	21.1	26.7	11.9	19.5	15.5	4.4	19.4	15.7	9.0	30.8	26.7	15.6	4.2	11.1	24.5	2.1	7.8	5.9	43.5	4.1	6.2	46.7	17.1	4.0	181.8	234.9	1.4	7.5	4.3	17.5	37.3	83.4	177.9	123.1	93.2	5.3	276.2	0.4	507.9	59.5	400.4	126.8	2.2	647.2	73.9	22.9	3.5	0.1	56.8	1.6	105.1	0.3	5.0	21.6	313.5	123.2	540.7	572.8	91.6	9.1	0.1	2.6	236.0	52.9	0.7	0.5	5.5	81.2	141.0	0.4	12.1	13.7	562.0	311.1	9.7	3.9	89.8	12.2	205.0	56.2	21.1	2.4	200.8	541.8	169.4	5.6	329.5	8.1	14.2	5.9	920.8	1.9	570.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	5.4	6.0	6.1	5.0	10.9	7.5	6.6	11.9	4.2	7.8	4.0	8.5	54.5	30.1	3.6	3.4	57.4	63.5	63.5	48.3	18.0	17.1	32.0	5.3	27.1	26.2	77.3	25.0	2.8	1.3	91.2	0.0	111.9	0.5	26.4	3.1	14.7	14.5	0.0	24.3	105.1	3.2	5.3	47.4	20.7	3.8	3.4	8.9	0.3	1.1	3.3	20.0	25.1	16.2	1.2	8.2	0.6	1.8	2.0	17.8	8.4	4.3	3.1	2.1	3.0	0.8	245.6	26.7	4.1	4.5	72.6	69.6	4.4	21.7	16.2	13.1	5.6	23.4	0.5	1.6	17.0	23.2	1.8	3.8	0.9	44.7	104.2
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 376.2;lymphoid tissue: 175.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 417.6;Hofbauer cells: 652.4;Kupffer cells: 485.9;Langerhans cells: 259.1;Macrophages: 527.4;monocytes: 463.8;NK-cells: 959.9;T-cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"THP-1: 812.4;U-937: 615.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		3300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	54.5	23.2	8.2	175.2	9.5	376.2	15.4	13.1	9.3	15.5	11.7	25.2	23.8	8.5	2.8	16.2	17.0	36.4	11.8	7.7	14.2	8.4	23.4	78.0	169.1	29.5	19.9	7.2	11.3	5.1	4.6	44.4	28.1	8.8	13.9	1.1	19.5	9.2	6.8	9.3	32.8	46.4	23.9	137.2	29.1	5.9	26.2	87.2	7.3	7.6	68.4	46.3	5.9	50.4	1.9	4.8	0.0	0.0	0.0	0.3	1.7	0.0	2.7	0.1	0.0	0.4	0.4	17.9	128.1	0.2	0.6	0.5	0.0	0.2	0.0	1.5	1.4	18.2	0.0	3.2	0.1	106.6	27.5	1.6	0.1	0.5	0.3	0.1	0.3	58.0	0.7	1.4	7.0	4.0	117.8	126.1	0.4	0.4	2.4	1.5	23.2	64.6	4.7	0.0	0.6	1.3	3.4	2.5	1.7	0.0	0.4	812.4	2.5	0.2	6.6	0.4	3.7	0.8	5.9	2.9	0.1	615.0	0.9	186.6	1848.8	1224.1	726.7	1144.9	326.6	86.1	349.7	506.5	1031.4	115.2	233.1	396.5	1386.1	585.5	1183.5	165.5	288.0	3034.2	8.2	9.5	13.1	9.3	7.7	14.2	29.5	19.9	28.1	23.9	26.2	50.4	7.1	16.0	29.6	0.3	81.7	5.5	0.5	9.6	0.6	0.0	4.1	6.5	4.0	14.3	18.6	5.5	0.0	4.0	417.6	0.3	0.0	3.4	1.0	0.6	0.5	16.8	0.0	19.6	0.5	0.4	4.8	5.3	2.6	0.7	24.1	8.2	9.7	8.6	652.4	0.0	0.3	0.2	2.0	485.9	259.1	2.8	0.6	527.4	5.4	27.2	463.8	0.4	959.9	0.0	0.2	0.6	0.1	1.5	50.5	0.6	1.8	4.2	3.6	0.8	6.6	2.1	3.2	0.2	1.0	0.9	5.1	5.6	254.5	0.0	0.3	0.7
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 459.9;hTERT-RPE1: 508.7;WM-115: 477.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"		NA	NA		64000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	102.7	32.5	24.4	26.0	33.4	3.3	71.3	32.6	20.3	84.7	71.0	48.1	33.1	75.9	16.4	54.9	33.2	71.7	68.8	24.6	28.7	48.6	51.4	53.9	6.0	38.2	32.9	28.0	23.1	21.8	20.5	82.3	35.4	37.3	24.9	14.3	49.6	46.9	30.0	88.9	32.5	60.1	32.3	41.0	29.7	13.5	32.5	12.2	34.3	33.7	9.9	40.3	70.0	35.8	189.1	459.9	32.4	82.7	296.6	84.2	166.3	197.5	120.0	35.9	57.6	92.6	240.3	0.8	93.5	336.3	177.0	148.0	29.5	102.7	31.2	2.0	20.1	66.3	69.5	98.0	51.0	0.4	116.8	51.2	23.2	91.1	46.9	508.7	121.2	0.2	60.7	98.1	122.7	190.0	0.8	1.1	145.8	105.1	50.4	0.4	52.2	71.8	98.8	41.2	0.9	67.5	146.6	214.5	165.7	56.4	121.9	4.2	318.2	134.9	200.7	118.5	103.7	16.6	18.4	1.3	141.3	0.8	477.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	2.5	24.4	33.4	32.6	20.3	24.6	28.7	38.2	32.9	35.4	32.3	32.5	35.8	50.4	6.4	6.7	55.5	1.0	17.2	23.1	18.8	6.2	8.1	20.6	27.2	28.9	42.9	10.0	29.5	4.2	68.5	0.6	34.9	11.7	38.3	10.7	22.0	21.4	27.5	3.5	2.7	0.9	18.8	7.4	52.1	11.2	13.4	0.0	135.9	31.1	39.1	72.3	35.3	18.1	12.9	2.0	36.8	17.5	4.1	20.2	28.5	10.6	60.9	0.4	50.2	0.0	16.6	12.5	70.4	27.0	16.6	0.6	24.9	21.0	10.7	6.2	14.9	39.5	31.3	52.1	2.6	7.0	15.6	22.3	55.1	1.7	1.0	16.3	14.8
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191323-53207282	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 45.1;dendritic cells: 62.3;NK-cells: 134.9;Plasma cells: 115.9;T-cells: 62.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	99	"Karpas-707: 4821.4;RPMI-8226: 3980.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042277			Approved	"Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"	1.6	1.4	1.7	20.0	1.8	15.5	1.9	1.7	2.2	2.7	2.0	9.7	11.7	1.6	2.8	6.4	2.9	3.9	0.8	1.5	2.0	4.7	5.3	6.6	29.2	2.3	1.8	0.7	1.2	0.7	1.3	0.5	2.0	1.7	9.5	1.0	4.1	2.3	0.7	11.9	17.3	2.4	1.9	30.0	8.2	0.6	2.8	8.6	3.1	0.6	26.5	6.2	2.9	2.1	0.1	0.0	0.0	0.3	0.1	0.7	1.4	0.5	0.0	0.0	0.5	0.0	2.1	44.5	0.8	0.0	0.0	9.4	0.0	0.3	0.0	16.5	0.0	1.5	0.0	0.0	0.0	1.0	18.5	1.0	1.8	0.2	0.1	0.6	0.0	2.2	0.4	4821.4	0.0	1.6	0.9	7.0	0.3	41.7	0.1	1.8	0.0	3980.8	0.0	1.2	1.9	0.6	0.1	1.8	0.5	0.0	0.8	10.4	0.0	0.3	0.6	0.9	0.0	8.9	17.9	3.8	3.8	2.6	1.6	80.7	5.6	97.7	52.0	1.4	38.2	28.1	51.8	63.0	44.5	29.8	44.5	44.4	1.5	23.7	0.4	11.9	71.8	17.3	1.7	1.8	1.7	2.2	1.5	2.0	2.3	1.8	2.0	1.9	2.8	2.1	1.0	3.2	5.5	1.3	45.1	2.2	0.3	1.7	3.4	0.1	1.3	1.0	0.5	2.8	1.3	7.3	4.2	0.1	62.3	0.6	7.9	0.3	0.0	1.2	0.4	0.9	0.0	2.1	0.0	0.5	0.1	1.3	2.6	2.4	29.2	0.1	0.4	2.2	13.3	0.0	0.1	0.5	0.0	3.7	10.3	0.3	0.0	17.3	7.2	1.9	13.3	7.0	134.9	0.0	0.5	0.9	1.7	0.0	115.9	0.2	0.0	7.6	0.2	0.8	0.0	1.0	8.2	0.2	1.4	3.3	3.7	0.1	62.5	0.1	1.2	1.4
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703316-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	668	"liver: 2156.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 489.6"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	453	"Hep G2: 1103.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		32000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.1	0.2	0.3	0.1	1.1	0.1	3.0	1.6	3.2	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.1	0.6	1.0	0.8	2156.1	0.6	0.1	0.6	0.5	0.0	0.2	0.0	1.7	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.8	0.4	0.0	0.0	0.9	0.3	0.5	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	1103.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.4	0.0	0.1	0.7	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	1.6	3.2	0.6	1.0	0.6	0.5	0.6	0.9	0.9	0.7	0.1	0.0	2.2	0.7	1.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.4	117.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.1	0.0	0.0	0.6	0.0	2.7	3.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	8.2	489.6	0.1	0.0	1.4	0.0	0.0	9.4	0.0	2.1	0.0	0.0	0.0	18.7	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255185	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 57.9"	"Group enriched"	"Detected in some"	6	"dendritic cells: 51.7;granulocytes: 31.8;NK-cells: 42.2;Plasma cells: 34.0;T-cells: 115.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	23	"gdT-cell: 39.6;MAIT T-cell: 26.4;memory CD4 T-cell: 55.6;memory CD8 T-cell: 54.9;naive CD4 T-cell: 78.2;naive CD8 T-cell: 65.0;NK-cell: 29.3;T-reg: 73.2"	"Group enriched"	"Detected in many"	23	"NK-cells: 29.3;T-cells: 78.2"	"Group enriched"	"Detected in some"	10	"JURKAT: 62.2;MOLT-4: 23.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043670			Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA043670: "	"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"	1.0	0.3	0.0	15.9	0.0	3.7	0.9	0.0	0.0	1.0	0.0	1.4	0.7	0.4	0.0	1.4	0.4	4.2	0.2	0.0	0.0	0.3	1.6	3.1	29.3	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	1.5	0.0	0.3	0.1	0.0	0.2	4.0	0.5	0.0	10.5	3.1	0.5	0.0	57.9	0.5	0.0	24.6	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	3.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	62.2	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	39.6	0.0	26.4	0.0	55.6	54.9	0.1	0.0	78.2	65.0	1.3	29.3	2.3	0.1	73.2	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.0	4.0	2.7	0.6	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.6	1.8	0.0	0.1	51.7	0.1	0.0	0.1	8.5	0.2	0.3	0.8	0.0	1.7	0.2	0.0	0.0	1.1	7.7	0.4	31.8	0.1	1.8	1.0	0.0	0.0	0.2	0.0	0.0	1.6	5.1	6.7	0.0	2.9	1.8	1.0	2.8	0.0	42.2	0.0	0.1	0.0	0.0	0.0	34.0	0.3	0.0	0.4	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.2	3.4	0.1	115.7	0.0	0.1	0.6
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	26.2	37.1	16.7	21.2	17.5	26.4	25.0	16.9	20.0	24.8	18.2	25.3	27.0	24.0	13.0	43.9	29.9	16.7	20.8	18.2	16.8	34.2	28.2	22.4	27.6	17.0	16.5	21.2	21.9	24.2	13.0	19.8	17.0	20.3	19.2	6.9	26.4	16.1	26.5	33.6	23.2	18.5	17.3	27.0	27.1	12.3	18.0	24.8	33.5	15.1	21.4	24.1	25.7	18.5	118.2	91.1	44.0	49.1	29.7	42.7	30.9	50.9	72.4	65.9	58.8	75.0	106.6	52.5	46.9	48.7	65.7	101.9	62.3	79.8	46.6	32.9	91.6	123.9	39.1	117.6	55.5	54.5	41.4	41.5	60.3	64.4	40.9	28.6	52.5	39.5	88.7	34.2	62.6	55.2	66.0	156.5	77.2	132.1	89.6	61.4	60.7	135.0	96.7	39.2	67.4	80.9	41.4	154.0	106.3	19.3	60.1	94.2	37.9	76.5	42.4	51.7	116.0	52.0	68.4	94.2	32.9	102.8	83.0	32.8	61.5	22.9	47.7	78.2	41.7	48.9	43.6	49.0	74.5	50.2	32.4	39.5	3.4	64.5	56.9	70.7	61.0	48.0	16.7	17.5	16.9	20.0	18.2	16.8	17.0	16.5	17.0	17.3	18.0	18.5	29.4	22.4	47.0	15.3	38.0	40.1	50.5	93.2	56.9	20.4	48.8	58.3	9.8	34.3	59.3	44.1	14.6	74.4	45.9	37.5	58.7	104.2	2.7	51.8	64.4	29.4	27.5	24.6	12.0	105.1	128.2	41.8	48.4	60.9	42.5	49.7	29.3	32.1	116.6	5.0	9.2	53.1	54.9	42.4	54.0	3.7	31.1	49.0	40.9	5.6	90.3	21.0	41.2	14.1	21.5	102.2	59.9	22.2	34.5	53.5	51.6	94.5	37.9	24.5	19.7	35.4	45.0	16.8	17.6	58.8	49.2	56.2	47.2	53.3	79.9	66.0
ITPK1		ENSG00000100605	"Inositol-tetrakisphosphate 1-kinase"	Q13572	14	92936914-93116320	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Isomerase, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 42.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.9;monocytes: 25.9"	"Cell line enhanced"	"Detected in all"		"WM-115: 110.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055230	Approved		Approved	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA055230: AB_2682748"	"unprognostic (1.93e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.56e-4)"	"unprognostic (4.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.20e-1)"	"unprognostic (7.25e-3)"	60.0	27.2	88.3	15.5	105.9	17.3	45.3	84.7	92.7	57.0	57.2	60.1	44.4	66.8	11.6	24.8	30.3	19.4	59.2	92.5	80.7	35.6	48.3	31.6	9.0	90.2	95.8	27.1	30.7	14.8	20.6	6.8	83.0	38.8	16.4	9.3	21.0	21.7	40.9	22.2	58.5	23.4	83.2	38.1	34.2	29.5	100.4	6.9	25.4	16.1	6.6	62.5	35.0	100.7	28.1	56.6	10.3	26.3	22.5	12.6	27.8	11.8	17.5	22.9	13.8	32.8	48.9	17.7	57.4	18.6	8.7	32.5	29.6	50.3	7.2	65.9	13.1	39.2	14.6	28.5	16.8	17.9	41.5	8.2	29.5	11.6	26.3	9.9	22.8	18.0	21.9	19.8	11.3	74.6	15.5	25.5	22.0	36.4	25.5	29.1	15.1	26.3	15.5	46.3	28.0	35.5	29.6	59.0	49.5	7.8	79.5	21.7	18.0	15.9	17.3	27.0	18.9	19.3	19.1	11.4	14.6	13.8	110.8	5.3	9.8	18.2	3.2	15.4	1.9	3.3	2.0	2.1	7.0	1.0	1.2	2.2	42.9	2.4	25.9	3.5	3.0	5.1	88.3	105.9	84.7	92.7	92.5	80.7	90.2	95.8	83.0	83.2	100.4	100.7	11.8	12.8	11.1	32.0	10.8	7.4	7.5	8.3	2.8	10.2	11.8	7.6	24.3	17.2	5.1	29.5	18.8	9.7	12.9	73.5	13.7	19.2	12.7	18.1	12.5	12.4	28.8	5.9	45.1	27.3	10.0	8.9	13.3	21.2	16.5	9.2	13.9	31.3	19.4	6.7	21.6	24.8	4.1	44.7	11.8	30.3	14.9	30.5	26.6	16.9	23.2	17.2	18.6	31.7	46.5	44.6	38.7	48.2	13.2	15.2	106.6	23.0	3.3	13.7	19.7	7.4	17.8	4.3	14.3	7.0	4.4	6.8	12.7	10.3	34.5	11.0
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;intestine: 18.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 51.4;Early spermatids: 45.4;Gastric mucus-secreting cells: 34.1;Late spermatids: 166.4;Proximal enterocytes: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.6;OE19: 18.2"	"Low region specificity"	"Detected in all"							HPA040454	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Plasma membrane"	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.2	7.3	21.4	0.7	26.7	0.4	0.2	13.8	36.5	1.3	10.9	10.7	17.6	0.3	0.1	0.3	0.5	0.2	2.6	28.7	12.4	0.2	1.7	0.5	0.1	10.9	12.0	0.3	1.9	2.0	0.4	0.3	11.6	0.8	2.7	0.3	1.4	0.3	4.4	0.4	18.1	0.3	11.3	0.2	10.9	10.4	12.1	0.0	0.2	0.0	0.0	0.6	0.9	20.4	7.1	1.9	0.3	7.9	0.0	2.5	14.3	4.3	3.4	2.8	2.9	16.3	0.3	0.0	3.5	0.4	6.3	0.8	3.4	0.3	0.2	6.6	4.3	9.9	4.7	33.6	12.6	3.4	0.5	0.2	0.2	2.7	0.8	1.6	0.2	1.3	12.9	1.9	1.0	4.7	0.3	6.5	0.9	18.2	5.6	1.7	1.4	0.6	0.3	0.4	0.7	1.5	3.2	0.0	0.3	0.0	0.9	5.0	0.3	6.9	7.1	7.7	11.8	1.0	10.8	0.0	12.6	13.2	2.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.4	26.7	13.8	36.5	28.7	12.4	10.9	12.0	11.6	11.3	12.1	20.4	0.1	0.0	0.0	3.3	0.5	0.1	0.3	0.1	0.0	0.0	0.3	0.0	1.4	0.0	0.1	0.0	0.0	0.6	0.1	51.4	0.0	0.1	45.4	0.3	2.4	0.5	0.0	0.8	23.7	0.7	0.5	0.3	34.1	0.3	0.0	1.0	0.4	0.3	0.2	0.0	0.8	12.0	0.0	0.0	0.0	166.4	2.5	0.4	0.0	1.9	0.0	7.9	0.0	1.5	2.9	0.8	16.1	1.5	0.1	0.1	35.8	0.1	0.1	0.2	6.6	0.3	0.5	14.4	4.9	0.0	0.0	0.1	0.4	0.1	18.7	0.2
ITPKB	"IP3-3KB, IP3KB"	ENSG00000143772	"Inositol-trisphosphate 3-kinase B"	P27987	1	226631690-226739323	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 211.8;choroid plexus: 123.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.5;Astrocytes: 225.3;Microglial cells: 58.1;Oligodendrocytes: 110.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030273, HPA072923"	Enhanced		Approved	Nucleoplasm		NA	NA		39000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA030273: AB_10601127, HPA072923: AB_2686558"	"unprognostic (4.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.24e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.87e-2)"	29.6	4.5	148.6	15.6	205.6	19.0	19.6	152.0	104.8	28.0	123.3	45.3	6.6	48.8	17.0	14.0	27.0	10.0	16.2	109.0	149.5	15.1	3.2	22.5	29.0	211.8	188.0	9.5	5.8	7.1	6.8	15.9	169.1	14.5	6.7	0.6	30.2	22.7	12.4	19.4	24.9	31.7	154.6	23.5	21.2	3.7	207.6	33.2	8.3	12.3	20.3	38.6	15.6	133.7	4.7	5.0	7.9	9.1	6.1	3.9	2.1	1.2	5.5	2.5	5.7	0.7	5.8	21.6	7.4	1.2	0.5	6.8	10.1	4.1	1.2	3.0	6.9	9.6	5.5	0.0	2.3	8.8	16.4	4.4	5.9	2.8	2.5	6.9	17.2	10.8	0.1	2.9	0.3	4.5	16.7	12.1	17.3	3.5	8.0	6.4	14.2	4.8	18.2	7.5	4.6	6.0	3.8	2.8	47.2	7.7	11.7	10.1	12.0	3.2	2.4	2.9	7.6	0.2	8.0	25.8	0.8	8.0	12.1	0.9	0.9	5.4	2.6	1.3	2.3	1.2	3.2	2.7	0.6	1.8	4.7	3.5	3.4	2.1	2.5	0.5	1.9	2.0	148.6	205.6	152.0	104.8	109.0	149.5	211.8	188.0	169.1	154.6	207.6	133.7	70.5	0.0	7.4	225.3	16.0	12.2	4.8	3.1	7.4	0.3	7.0	5.3	8.5	1.5	4.5	7.3	0.0	0.6	28.9	1.2	3.9	2.2	2.8	4.7	6.8	42.2	4.2	5.2	2.4	2.4	2.3	8.9	3.6	4.5	10.1	21.8	27.8	1.0	19.8	0.0	6.9	2.8	2.0	16.0	38.0	22.9	7.2	14.4	19.6	58.1	10.2	1.2	28.8	10.6	110.6	2.7	3.7	9.4	11.8	5.1	2.0	0.6	2.6	0.1	0.0	5.9	16.3	0.9	4.7	5.3	10.1	0.4	35.2	3.7	3.1	2.7
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717112-40740860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 96.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 151.4;Glandular and luminal cells: 139.3;Squamous epithelial cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA050760: AB_2681227, HPA053003: AB_2682011"	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	45.3	13.9	11.2	10.8	9.6	3.5	29.4	9.4	10.7	32.6	11.6	16.8	11.7	18.6	4.7	96.7	25.0	23.0	19.3	10.0	10.7	18.8	17.7	41.8	6.0	15.0	11.5	12.9	22.8	10.3	22.0	10.3	11.6	27.1	6.8	5.5	31.1	10.5	18.4	51.0	16.9	16.3	10.8	14.5	26.3	6.0	15.2	8.7	17.2	8.9	13.9	22.4	42.0	9.3	12.9	12.0	7.3	11.5	32.2	27.8	11.6	7.5	15.7	7.6	6.7	17.3	13.1	3.5	8.5	9.7	5.7	13.3	7.3	32.6	3.1	6.7	7.5	2.7	4.5	12.3	31.8	3.0	3.6	38.8	46.4	7.2	26.5	10.3	18.9	5.0	10.6	6.1	7.5	15.7	4.4	4.5	3.7	29.4	5.4	4.7	3.6	4.9	12.0	21.5	5.2	6.5	7.6	30.5	7.2	8.4	14.1	7.6	12.2	4.9	7.3	3.3	5.1	3.5	0.9	3.7	7.6	3.1	5.4	0.9	0.7	0.4	0.8	0.3	0.3	0.3	0.6	0.4	0.3	0.7	0.4	0.5	0.3	0.2	0.5	0.5	0.6	0.4	11.2	9.6	9.4	10.7	10.0	10.7	15.0	11.5	11.6	10.8	15.2	9.3	75.4	86.6	35.2	6.5	2.7	60.4	72.4	17.4	39.9	10.0	88.4	44.4	4.1	7.2	29.7	3.7	0.0	7.7	2.8	57.7	1.9	13.9	2.1	67.5	23.2	26.4	16.7	3.2	7.4	12.3	5.5	20.1	151.4	139.3	3.8	4.3	25.7	6.8	2.9	5.0	6.0	27.2	2.0	7.8	9.6	2.2	11.8	6.8	19.6	6.5	3.1	3.7	3.1	9.0	3.5	23.2	50.8	7.5	1.2	65.3	28.7	4.4	29.4	6.2	0.0	7.1	10.1	1.9	2.0	160.8	53.4	16.8	5.2	4.6	18.0	98.6
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493345-4847840	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 290.2;Inhibitory neurons: 183.1;Microglial cells: 84.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Immune cell enhanced"	"Detected in many"		"naive B-cell: 13.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.4;HEL: 41.1;HeLa: 74.9;HMC-1: 40.0;U-87 MG: 56.7"	"Region enhanced"	"Detected in all"		"cerebellum: 697.2"	"Region enhanced"	"Detected in all"		"cerebellum: 208.8"	"HPA014765, HPA016487"	Approved		Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.40e-1)"	10.6	12.0	1.8	11.8	12.0	7.2	17.3	49.9	20.1	11.5	15.6	19.5	4.5	36.5	10.0	10.6	27.1	14.1	10.1	5.9	0.0	13.9	3.9	13.7	11.2	0.0	0.5	25.3	6.7	45.3	16.0	8.0	0.0	21.7	6.3	3.9	16.1	27.9	3.0	5.0	11.5	24.5	0.0	9.2	11.1	4.5	0.0	10.3	31.7	5.3	10.5	27.9	11.8	6.1	0.4	4.1	1.0	3.0	27.7	1.9	11.8	0.9	0.5	1.3	0.8	1.3	1.2	14.5	0.6	1.9	6.5	0.1	2.2	2.6	2.1	76.4	3.2	41.1	74.9	3.5	27.4	17.7	40.0	9.2	4.0	5.8	1.1	7.6	7.2	8.4	7.9	13.9	3.7	1.8	7.2	3.0	2.1	0.5	9.7	4.2	1.0	1.1	1.7	5.5	0.7	19.5	5.4	4.3	4.3	0.9	2.6	20.6	13.5	1.8	4.3	3.7	2.3	17.7	12.0	9.6	56.7	17.0	2.7	5.8	2.0	1.5	2.3	0.9	1.7	6.7	1.6	1.6	2.2	13.4	2.7	1.6	1.8	1.8	0.9	4.7	1.4	1.1	1.8	12.0	49.9	20.1	5.9	0.0	0.0	0.5	0.0	0.0	0.0	6.1	30.1	0.0	31.4	24.8	49.7	3.8	6.1	6.3	11.4	4.0	40.0	29.7	8.0	2.8	11.2	9.2	0.0	0.5	17.8	0.3	3.9	2.4	5.4	9.1	11.9	31.2	3.5	8.4	290.2	5.1	0.5	21.5	20.4	12.7	26.5	22.6	36.0	2.0	4.7	1.7	183.1	1.3	2.0	12.9	17.4	7.9	30.1	23.9	7.2	84.3	14.2	4.3	6.2	25.1	12.7	1.5	1.2	52.6	8.8	5.4	0.3	3.9	13.1	1.5	39.5	8.8	28.2	1.5	2.9	4.9	3.1	1.0	25.7	22.0	0.8	3.3
ITPR3	IP3R3	ENSG00000096433	"Inositol 1,4,5-trisphosphate receptor type 3"	Q14573	6	33620365-33696574	"Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.0;Gastric mucus-secreting cells: 127.4;Late spermatids: 220.4;Pancreatic endocrine cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 164.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003915, HPA064704"	Approved		Uncertain	Vesicles		No	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA003915: AB_1851845, HPA064704: "	"unprognostic (2.57e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.08e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-2)"	16.3	11.4	5.5	17.0	5.0	6.1	14.6	3.8	5.3	18.0	3.7	26.2	29.1	8.5	13.1	18.1	14.0	15.3	15.0	3.8	3.9	16.4	2.2	30.6	20.4	5.6	5.0	13.5	11.3	2.8	7.4	4.3	5.2	13.9	18.4	0.8	18.5	11.2	4.5	58.9	35.1	4.7	4.7	39.8	41.5	15.4	7.0	14.3	54.0	5.1	21.0	12.1	24.0	3.9	73.7	34.0	6.3	0.3	6.2	19.3	40.9	24.8	62.8	30.5	27.4	46.7	55.9	62.6	26.1	17.9	76.1	70.9	28.6	66.7	15.7	36.8	24.0	0.1	102.6	52.0	14.1	11.3	7.9	14.0	59.2	76.7	164.7	66.5	52.1	24.5	25.0	19.7	33.3	35.0	19.0	6.4	6.2	55.8	49.4	29.0	0.1	37.1	107.6	50.9	57.3	2.1	42.8	61.6	60.2	6.9	21.2	5.9	71.8	41.1	20.1	53.1	55.2	13.5	14.3	29.4	32.8	16.6	24.1	0.8	0.0	0.0	0.8	0.0	0.6	0.4	0.4	0.5	0.0	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.7	0.2	5.5	5.0	3.8	5.3	3.8	3.9	5.6	5.0	5.2	4.7	7.0	3.9	12.4	48.1	58.9	0.3	13.5	26.5	10.9	27.9	18.2	1.5	9.3	9.9	2.7	12.8	20.2	31.3	0.0	0.3	10.9	52.9	0.0	28.4	123.0	19.1	9.1	18.2	23.9	6.6	1.1	30.2	6.3	9.2	127.4	43.1	0.0	0.2	12.5	0.4	0.5	0.0	1.6	41.6	10.2	0.6	6.9	220.4	23.3	2.6	12.4	23.4	3.2	0.4	4.1	0.5	0.4	89.7	41.6	13.9	18.7	20.5	45.9	0.2	12.1	1.2	6.6	3.9	3.3	1.6	3.2	14.5	25.4	0.5	13.1	5.8	35.6	20.7
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405485-40435947	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.0;Theca cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	25.8	80.5	35.1	14.5	40.8	15.9	45.3	35.6	40.8	29.4	39.5	31.6	24.3	26.4	29.0	16.0	35.0	21.5	61.7	34.0	41.5	59.1	145.4	24.3	19.6	40.2	38.8	43.3	27.4	39.2	58.3	15.3	37.5	42.1	27.2	13.0	31.8	36.8	55.7	8.6	26.8	23.8	37.9	27.9	46.7	25.0	44.5	16.8	119.2	55.4	19.5	31.1	20.8	45.3	20.9	11.9	22.9	38.9	35.9	32.9	1.0	27.6	32.7	39.4	24.0	36.5	16.0	0.8	57.7	43.4	32.6	20.8	45.9	46.6	30.1	36.4	34.0	52.1	36.2	38.9	64.6	22.0	48.5	45.3	18.5	23.5	55.3	46.3	38.8	60.4	2.5	2.4	42.1	27.1	27.3	38.9	17.8	1.3	33.0	41.2	32.6	27.9	45.2	51.6	37.3	21.5	38.2	83.4	18.7	21.5	69.0	117.6	27.6	29.9	20.2	23.6	24.9	54.5	38.5	1.0	30.9	22.8	28.4	17.0	24.8	36.7	33.3	36.1	31.0	27.5	18.5	26.6	58.8	27.6	18.5	26.7	2.3	39.4	73.1	89.2	26.9	24.3	35.1	40.8	35.6	40.8	34.0	41.5	40.2	38.8	37.5	37.9	44.5	45.3	13.1	28.9	54.5	27.4	19.0	2.3	21.0	17.3	13.1	26.0	27.5	22.2	88.0	45.8	29.9	44.1	14.6	20.3	34.0	17.9	95.9	19.7	5.4	21.4	31.0	18.6	19.7	21.3	15.3	14.9	7.3	20.2	29.6	19.9	34.7	46.5	21.4	135.0	28.1	16.8	16.6	24.4	14.2	18.3	6.2	7.4	20.5	18.6	5.4	21.5	28.8	26.0	26.8	25.1	21.4	14.8	9.4	24.8	10.0	16.6	22.0	97.3	29.3	19.9	19.7	25.0	18.2	16.1	3.7	17.4	0.6	9.9	18.0	105.7	35.4	11.9
IVL		ENSG00000163207	Involucrin	P07476	1	152908546-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 162.3;esophagus: 298.3;salivary gland: 94.5;skin 1: 160.9;vagina: 235.2"	"Cell type enhanced"	"Detected in some"		"Club cells: 10.4;Squamous epithelial cells: 30.8;Suprabasal keratinocytes: 71.0;Urothelial cells: 13.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"HaCaT: 292.9;RT4: 76.9;SK-BR-3: 86.3"					"Not detected"	"Not detected"			"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		NA	NA		4700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	162.3	0.0	0.0	0.0	0.0	18.2	298.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	94.5	0.1	0.4	160.9	0.1	0.0	0.0	0.1	0.2	0.1	0.0	3.5	0.1	0.0	36.9	17.4	235.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	292.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	0.0	86.3	0.0	0.2	3.6	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	3.1	3.5	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.6	0.0	0.0	30.8	71.0	0.0	0.1	0.0	0.0	13.3
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.4;Inhibitory neurons: 122.3;Microglial cells: 106.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 132.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 132.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 42.2;HDLM-2: 75.0;HEL: 154.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	15.6	7.6	3.2	19.2	3.7	21.7	8.9	6.3	9.1	8.5	1.1	6.7	6.5	11.3	8.6	8.8	8.0	10.5	24.5	2.7	3.1	6.8	4.5	10.9	18.2	3.3	1.8	11.5	3.8	6.5	2.9	11.0	2.0	6.8	6.5	12.8	4.0	6.2	9.8	11.2	7.7	9.5	3.5	17.6	13.4	9.8	1.7	7.5	4.8	8.9	12.7	11.7	9.1	3.9	6.8	3.7	3.7	6.3	42.2	12.4	1.1	9.1	8.6	7.2	4.6	1.2	2.0	0.3	2.1	5.4	5.4	2.3	4.4	5.1	4.9	75.0	1.4	154.7	7.6	1.7	10.0	10.5	7.1	9.5	2.1	2.8	4.5	7.6	6.6	5.1	10.9	17.4	11.6	2.2	2.9	12.8	3.3	3.3	4.3	5.1	8.2	2.2	4.7	3.5	4.2	2.4	2.6	3.5	2.8	3.6	2.0	15.4	13.1	10.2	3.6	10.7	6.4	3.1	6.4	1.5	13.6	4.7	5.3	132.5	20.5	38.2	5.6	20.1	4.5	5.6	4.1	3.1	26.5	4.9	2.2	2.8	19.2	9.6	16.4	9.7	4.5	7.7	3.2	3.7	6.3	9.1	2.7	3.1	3.3	1.8	2.0	3.5	1.7	3.9	14.3	16.0	7.9	31.6	12.9	9.7	3.3	4.9	10.8	8.0	5.2	3.4	30.0	0.0	6.7	7.3	8.4	1.9	13.9	11.7	1.9	3.3	8.6	5.1	11.2	9.4	3.0	19.8	93.4	3.9	0.9	8.9	38.7	5.6	14.0	11.4	4.6	1.9	14.2	8.4	122.3	4.5	0.0	33.6	28.8	7.1	23.6	38.9	5.4	106.8	49.5	12.6	8.2	69.9	42.3	7.0	20.9	33.4	10.7	3.0	3.9	3.3	7.1	11.2	0.0	9.7	12.5	15.0	5.5	11.6	8.4	3.4	10.4	5.1	4.1	4.5
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.3;lymphoid tissue: 68.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3529.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 28.0"					"Region enriched"	"Detected in many"	11	"cerebellum: 58.0"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	13.9	4.5	0.9	68.7	1.0	20.9	5.6	2.4	2.1	5.6	2.3	16.8	17.8	3.5	1.5	8.5	4.3	20.4	3.2	0.7	0.9	3.4	9.8	43.3	31.1	1.3	0.9	1.8	2.9	1.0	1.6	7.8	1.0	4.4	22.7	0.3	2.9	3.6	1.2	4.6	32.1	15.3	1.0	60.0	9.4	1.5	1.0	24.3	2.9	7.8	31.6	24.9	3.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	3.1	0.4	3.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	137.4	1023.8	3529.6	60.1	616.5	386.5	7.1	107.4	113.7	1017.6	2.9	124.7	103.1	2121.1	24.3	310.3	765.1	191.3	844.1	0.9	1.0	2.4	2.1	0.7	0.9	1.3	0.9	1.0	1.0	1.0	1.1	1.2	6.4	34.2	0.0	6.9	0.0	0.2	0.0	0.0	0.3	0.9	1.3	0.0	2.8	5.6	1.8	0.0	0.3	136.9	0.9	0.0	0.1	1.0	0.4	0.2	1.3	0.0	5.0	0.0	0.4	0.4	1.8	2.6	0.6	15.2	0.0	5.7	2.8	31.0	0.0	0.0	0.2	0.0	125.8	0.0	1.1	0.0	166.6	0.0	0.0	204.7	0.0	9.2	0.0	0.0	0.1	0.1	0.0	6.3	0.1	0.6	0.8	2.2	0.2	0.0	0.4	0.5	2.2	5.9	0.2	0.0	0.4	56.0	0.0	0.1	0.2
JMJD1C	"DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8"	ENSG00000171988	"Jumonji domain containing 1C"	Q15652	10	63167221-63521850	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 590.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 49.7"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 14.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056175, HPA066195"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA056175: AB_2683057, HPA066195: AB_2685634"	"unprognostic (7.72e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.13e-1)"	16.3	12.5	3.7	18.9	5.4	40.2	22.3	49.7	6.6	19.9	6.4	11.3	16.9	24.0	11.3	12.8	12.5	24.6	12.1	4.0	4.5	15.6	22.3	16.0	22.1	5.0	5.0	24.7	13.1	21.9	6.8	14.4	6.2	14.1	12.3	41.4	13.1	11.5	11.0	11.1	18.9	15.6	3.1	20.9	14.5	15.7	4.8	20.4	20.8	13.8	21.3	16.0	9.4	7.7	23.2	11.5	26.5	20.4	13.8	25.2	9.3	15.8	32.5	13.9	19.0	19.8	24.2	31.3	9.4	14.9	12.6	18.6	7.6	15.2	24.7	8.5	9.6	11.9	11.9	14.4	16.8	25.8	4.3	25.3	15.3	24.7	71.3	31.5	25.4	22.0	21.4	23.0	33.1	6.2	19.8	13.8	28.3	5.2	40.0	34.0	57.5	15.0	14.1	16.5	14.4	23.5	23.8	14.7	22.8	19.3	14.6	46.0	30.6	12.9	18.1	11.3	20.0	20.4	17.4	29.1	15.7	15.1	11.7	0.6	2.7	3.2	1.8	1.8	2.7	4.4	1.9	1.9	2.3	4.2	2.7	2.3	14.1	1.7	1.6	4.0	1.8	1.1	3.7	5.4	49.7	6.6	4.0	4.5	5.0	5.0	6.2	3.1	4.8	7.7	256.1	112.2	93.3	214.5	184.4	151.9	369.2	46.6	93.9	88.7	106.7	92.7	69.4	55.8	96.9	55.2	152.2	34.7	117.4	80.7	13.7	63.3	38.3	155.8	179.7	176.7	86.0	75.3	590.1	47.0	27.7	141.1	119.8	210.1	93.1	79.1	118.2	37.2	57.9	117.8	416.5	66.8	38.7	89.8	185.0	42.3	103.8	206.8	76.5	355.1	96.6	61.2	58.7	419.2	378.8	76.7	88.4	89.5	124.8	161.0	90.6	32.4	104.1	170.9	72.3	214.4	112.6	158.6	146.5	56.4	134.0	33.2	145.6	76.0	52.3	286.7
JMJD6	"KIAA0585, PTDSR, PTDSR1"	ENSG00000070495	"Jumonji domain containing 6, arginine demethylase and lysine hydroxylase"	Q6NYC1	17	76712832-76726799	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 121.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004548, HPA059156"	Supported		Supported	Nucleoplasm		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004548: AB_628185, HPA059156: AB_2683934"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (5.71e-4)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (7.59e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.82e-1)"	30.3	27.0	14.2	17.0	16.3	121.7	19.6	19.2	29.5	20.2	15.3	32.3	15.4	19.4	7.4	18.8	22.4	18.7	41.2	14.3	16.5	18.3	18.5	26.8	15.7	16.2	16.2	27.6	18.0	11.0	22.4	16.2	16.2	19.9	10.3	29.5	15.2	10.7	38.2	15.6	18.4	16.0	14.6	21.1	24.4	17.8	16.9	13.4	16.6	28.1	12.8	23.9	20.4	20.8	39.0	53.3	18.0	23.5	22.6	19.4	17.6	34.7	26.8	49.6	47.6	53.6	18.7	25.3	14.9	37.6	72.6	28.8	57.3	17.3	47.2	18.6	45.9	37.3	37.5	54.4	36.8	19.7	55.0	23.9	26.8	54.2	18.2	31.6	41.6	13.8	57.1	45.2	37.0	24.4	34.7	28.4	15.9	37.3	62.4	27.1	33.6	39.2	16.6	12.1	31.1	31.1	30.2	43.7	43.7	30.4	39.5	28.6	27.7	56.7	33.3	29.9	65.8	50.6	28.8	23.4	55.7	17.4	32.5	50.8	28.6	40.2	24.7	37.8	24.0	20.5	28.4	28.2	25.9	13.0	23.3	22.2	23.3	14.6	39.4	22.4	31.0	20.1	14.2	16.3	19.2	29.5	14.3	16.5	16.2	16.2	16.2	14.6	16.9	20.8	44.1	25.6	22.9	9.1	29.3	83.2	79.9	46.1	67.2	16.5	30.8	42.8	30.5	14.3	29.2	9.2	50.1	29.0	96.5	33.1	17.6	28.1	30.3	39.1	29.6	36.0	39.4	13.0	6.6	27.4	52.9	37.9	33.1	58.6	65.2	18.6	28.2	10.2	32.7	6.7	7.4	32.0	24.4	19.5	79.2	12.5	16.1	52.4	58.7	3.7	26.9	11.8	21.6	7.1	7.9	29.6	32.1	17.7	50.0	38.5	40.8	7.9	20.5	35.4	13.1	32.7	69.2	59.6	27.2	48.8	73.6	30.5	80.4	29.9	31.3	60.2
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 59.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.1;Excitatory neurons: 33.2;Horizontal cells: 50.5;Inhibitory neurons: 28.7;Late spermatids: 14.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Group enriched"	"Detected in all"	5	"amygdala: 17.1;basal ganglia: 24.6;cerebral cortex: 59.1;hippocampal formation: 42.7;white matter: 20.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.7;SH-SY5Y: 7.2;SiHa: 5.0;U-2 OS: 22.5"	"Low region specificity"	"Detected in all"							HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	0.2	1.3	17.1	0.2	24.6	0.0	0.1	1.1	59.1	0.7	0.0	1.1	0.1	0.2	0.0	0.6	0.4	0.0	0.1	42.7	5.6	0.0	0.1	0.1	0.0	6.4	5.8	0.1	0.3	0.0	14.1	0.0	1.1	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.5	0.0	1.1	0.1	0.5	1.4	1.1	0.0	0.1	0.0	0.0	0.1	0.3	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.9	0.0	1.2	0.0	0.0	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.2	5.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	24.6	1.1	59.1	42.7	5.6	6.4	5.8	1.1	1.1	1.1	20.6	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	24.4	0.0	0.0	3.7	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	0.0	41.1	0.0	0.0	0.8	0.0	0.0	33.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.1	50.5	28.7	0.0	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.0	1.3	0.0	10.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.2	0.1	1.1	3.7	0.0	0.0	0.1	0.1	0.5	0.0	0.1
JRK	"jerky, JH8"	ENSG00000234616	"Jrk helix-turn-helix protein"	O75564	8	142657460-142681968	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052675			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA052675: AB_2681910"	"unprognostic (3.65e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.58e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.69e-2)"	3.7	4.5	5.9	4.1	6.1	2.1	4.0	7.9	7.4	7.4	4.0	5.9	3.0	6.7	3.4	4.9	5.5	2.5	5.9	5.8	4.7	7.9	4.0	3.9	5.4	6.2	5.2	8.5	5.4	4.6	6.4	3.0	5.5	6.2	2.8	3.8	4.7	4.0	7.5	6.0	5.3	3.7	4.3	7.2	5.7	6.6	6.2	5.1	6.9	4.7	5.9	5.7	4.7	6.8	6.5	6.9	8.0	6.4	7.6	10.8	4.8	10.4	4.2	11.9	6.8	6.3	13.1	11.0	4.1	8.2	8.2	8.7	7.0	6.2	6.0	8.5	12.0	11.2	25.3	7.2	3.1	8.6	7.5	7.2	5.4	7.6	4.3	6.0	6.8	13.1	12.0	4.8	10.1	11.1	10.1	4.8	6.8	4.6	9.6	13.1	5.0	6.2	4.1	11.1	14.5	9.6	18.1	7.3	4.3	5.0	7.3	5.2	8.1	9.1	19.5	9.1	5.5	6.3	7.6	6.3	6.9	10.7	9.0	1.0	0.7	0.9	0.9	0.5	0.5	0.4	1.0	0.9	0.7	1.2	1.3	1.0	0.8	0.6	0.2	0.6	0.6	0.4	5.9	6.1	7.9	7.4	5.8	4.7	6.2	5.2	5.5	4.3	6.2	6.8	3.5	6.4	1.1	8.5	4.8	0.0	2.5	0.0	2.2	14.7	4.5	3.3	11.5	4.3	0.6	7.3	20.9	4.4	8.6	3.2	3.9	2.8	1.9	1.4	4.9	6.5	9.1	12.0	11.3	2.5	2.7	3.7	6.6	2.1	1.3	15.5	8.2	2.6	3.0	10.1	11.0	3.1	0.0	6.6	0.0	2.2	11.5	3.4	0.0	8.4	4.5	4.4	12.3	9.5	9.5	5.6	1.4	11.7	4.3	3.7	2.7	2.7	0.7	10.0	0.0	5.8	4.8	9.1	19.4	3.2	0.0	2.2	2.5	6.8	4.2	4.5
JRKL	HHMJG	ENSG00000183340	"JRK like"	Q9Y4A0	11	96389989-96507574	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.1;Late spermatids: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046184, HPA060341"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge"	"HPA046184: AB_10963576, HPA060341: AB_2732646"	"unprognostic (4.59e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	"unprognostic (4.94e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.57e-3)"	7.4	6.2	4.2	7.6	4.4	1.7	8.8	4.5	4.9	9.8	4.3	7.1	7.2	8.4	7.4	5.9	10.1	6.6	6.1	4.0	5.3	6.7	4.2	6.2	9.3	4.7	4.7	13.2	5.1	6.9	4.1	8.4	4.8	8.4	9.0	11.1	8.8	6.9	4.1	7.8	8.4	6.9	4.4	7.5	8.6	11.7	4.7	9.6	9.6	4.4	9.2	6.8	6.0	5.3	9.4	5.8	11.8	8.9	23.1	25.7	8.6	15.6	10.5	10.9	14.2	9.8	22.2	12.8	22.3	14.4	13.9	14.5	5.9	10.6	12.6	13.9	5.5	11.9	17.0	7.5	18.7	6.8	7.4	12.2	16.3	15.8	19.6	20.3	10.0	14.5	6.4	5.5	17.9	1.9	8.8	19.8	1.8	16.7	7.9	8.9	11.5	10.5	13.5	9.7	4.7	8.6	9.1	6.2	7.1	11.0	7.6	9.1	12.4	21.1	9.4	18.6	6.4	4.7	10.9	7.5	9.8	10.9	9.2	3.3	2.6	2.6	1.6	2.1	2.3	2.2	2.6	2.0	2.6	1.6	3.2	2.9	0.9	1.8	2.5	4.1	1.3	1.6	4.2	4.4	4.5	4.9	4.0	5.3	4.7	4.7	4.8	4.4	4.7	5.3	6.2	9.6	5.8	4.2	5.0	4.7	10.3	6.6	2.8	7.4	7.6	8.9	6.8	15.7	12.0	0.0	4.2	6.0	11.7	9.0	1.9	11.5	171.1	9.9	13.6	5.8	6.0	4.8	3.4	5.1	5.0	9.9	7.1	6.8	3.8	5.0	6.4	2.2	5.0	8.4	3.0	10.5	4.1	7.2	5.2	49.3	8.4	6.0	1.8	1.0	6.9	5.2	6.2	3.5	8.2	8.2	4.5	9.4	2.4	8.4	7.6	6.1	25.3	12.3	0.0	6.0	9.6	9.9	4.9	5.3	6.0	4.0	4.8	7.5	9.7	8.4
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58776845-58784048	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 295.6"	"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA031174, HPA059474"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030"	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"	331.1	92.7	34.4	36.3	37.0	129.1	308.2	41.6	38.1	172.0	28.0	154.7	34.7	116.4	15.8	100.2	314.1	89.6	158.4	39.1	37.2	94.0	205.2	202.8	52.1	32.7	30.7	197.0	192.2	59.8	75.0	40.1	30.5	153.4	55.0	29.7	154.5	71.7	114.3	286.6	79.1	113.3	34.3	62.0	239.5	20.2	33.8	71.5	189.5	158.8	5.4	156.4	164.5	36.9	49.8	2.8	22.4	2.6	35.3	40.0	0.2	69.4	27.0	57.1	34.3	10.1	3.5	1.7	23.8	57.4	133.6	12.9	2.0	27.7	40.6	29.8	128.9	0.5	1.9	16.9	29.4	5.3	10.2	42.0	74.0	78.1	34.0	27.7	47.2	2.4	15.6	29.6	24.9	8.0	2.5	32.5	13.5	34.6	32.2	1.1	295.6	7.0	60.7	5.8	43.7	12.8	49.9	62.3	26.4	24.5	17.2	3.0	61.6	127.5	37.3	35.3	96.8	37.9	9.8	4.4	133.9	8.4	35.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	34.4	37.0	41.6	38.1	39.1	37.2	32.7	30.7	30.5	34.3	33.8	36.9	2721.4	538.5	543.8	187.7	1018.8	1235.5	2850.5	772.6	2825.1	103.4	1647.1	2067.3	1487.5	1315.4	449.3	104.8	262.7	675.8	651.1	1653.6	50.9	987.0	49.3	1337.1	2845.2	1443.8	1497.4	174.3	12.2	516.4	93.9	2730.7	2663.1	1822.2	541.9	333.4	737.2	158.6	650.5	87.5	4.9	1909.1	836.2	584.9	632.0	48.2	1227.4	1034.9	757.7	65.6	140.1	1234.2	8.2	17.6	10.0	562.8	1529.6	258.8	1540.3	1489.1	1654.1	48.6	216.3	453.5	1538.3	1892.9	2392.5	17.4	20.9	2146.3	964.4	415.6	1065.5	846.5	1199.5	545.7
JUND	AP-1	ENSG00000130522	"JunD proto-oncogene, AP-1 transcription factor subunit"	P17535	19	18279694-18281622	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 2129.8;dendritic cells: 1844.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005268, HPA063029"	Supported		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB005268: AB_2130177, HPA063029: AB_2684925"	"prognostic favorable (6.15e-5)"	"unprognostic (4.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.99e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.49e-1)"	296.3	189.3	190.3	38.9	201.6	429.1	257.3	172.1	208.5	159.7	153.1	185.2	62.9	186.6	37.5	118.3	291.4	30.0	210.6	187.5	192.5	148.8	211.8	227.3	28.8	261.3	213.2	424.2	178.4	40.4	256.4	45.1	180.9	159.1	33.0	25.7	112.7	33.8	81.0	287.7	161.3	57.5	182.5	100.5	201.4	97.4	180.4	58.2	154.8	37.1	15.9	129.5	147.7	263.8	84.2	35.3	33.3	37.9	25.9	28.8	150.5	35.0	40.8	19.2	25.4	38.3	72.9	42.1	39.4	34.8	31.1	46.1	8.2	8.3	9.5	84.6	75.9	62.7	30.3	84.9	58.6	29.5	81.4	27.8	33.7	20.0	25.9	44.5	15.3	18.8	86.5	119.8	5.2	113.6	89.9	92.5	69.7	22.7	50.6	32.7	20.9	94.0	27.8	13.1	184.2	75.1	41.7	45.4	122.0	37.5	38.6	43.9	54.7	11.8	54.8	74.4	20.9	171.3	73.8	36.3	41.5	44.7	27.9	10.5	6.5	6.8	4.9	8.2	3.8	8.4	6.4	4.5	4.9	8.7	4.5	5.0	19.7	4.8	8.3	11.3	5.7	2.4	190.3	201.6	172.1	208.5	187.5	192.5	261.3	213.2	180.9	182.5	180.4	263.8	2129.8	179.5	386.7	104.5	1176.8	317.1	400.4	76.0	188.4	129.8	1147.5	1419.1	158.8	291.7	84.4	257.5	79.2	78.5	1844.7	810.5	31.3	96.5	80.8	1026.0	1289.3	468.1	568.8	78.3	51.6	140.8	112.9	950.9	336.4	1561.4	257.7	514.1	338.4	436.1	100.1	139.7	41.0	569.6	67.1	332.7	506.0	59.2	123.3	847.7	249.1	65.6	91.7	625.2	27.8	44.7	132.0	154.4	464.2	88.8	734.5	253.6	538.1	65.4	90.4	174.3	131.5	1064.7	798.4	11.8	22.7	172.0	394.1	164.3	1158.2	448.7	297.4	232.7
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.3"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 1434.2;Inhibitory neurons: 480.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 57.4;HEL: 35.3;OE19: 20.1;SH-SY5Y: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		83000	"Cluster 35: T-regs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	9.4	6.3	15.0	2.2	23.4	0.3	6.7	0.0	31.3	9.1	4.9	2.0	2.5	7.7	1.9	9.5	4.6	2.9	12.8	21.3	3.4	3.8	5.8	4.4	0.9	0.0	6.6	3.1	8.8	3.5	4.1	4.2	0.0	2.8	1.8	4.5	2.8	4.9	27.2	2.0	2.0	6.2	0.0	8.5	12.1	2.6	10.7	0.5	5.1	19.3	1.6	2.6	6.0	20.9	0.7	1.1	6.2	1.3	0.9	0.2	8.1	2.5	1.5	2.4	1.1	57.4	4.5	0.2	0.8	6.4	3.9	0.4	1.4	0.0	2.0	0.0	0.7	35.3	0.4	8.9	0.1	0.0	0.0	0.4	0.0	0.5	0.1	2.6	2.9	0.1	8.3	0.2	0.7	4.2	0.0	0.0	3.5	20.1	5.4	1.8	2.8	0.0	0.2	0.5	2.1	15.9	0.7	0.5	0.5	6.0	1.2	0.1	14.4	7.0	2.8	1.0	1.1	0.0	0.6	0.0	0.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	1.6	0.4	15.0	23.4	0.0	31.3	21.3	3.4	0.0	6.6	0.0	0.0	10.7	20.9	56.2	3.2	3.9	191.3	0.6	1.7	1.5	0.3	0.6	61.2	6.1	7.1	32.1	18.6	0.5	16.5	6.2	8.0	2.5	40.5	1.9	5.0	57.0	15.0	18.8	23.2	9.6	5.3	1434.2	8.4	1.7	5.9	29.0	7.4	3.8	4.4	45.3	21.7	1.0	0.0	480.8	16.4	0.0	1.6	1.1	64.0	3.7	5.3	3.6	48.7	0.0	4.7	8.2	162.3	63.1	4.4	21.0	33.1	0.3	2.6	34.8	3.6	8.4	2.7	19.7	8.8	21.8	5.2	2.6	4.9	1.1	14.2	1.0	17.5	12.3	1.6
KANSL1	"CENP-36, DKFZP727C091, KIAA1267, MSL1v1, NSL1"	ENSG00000120071	"KAT8 regulatory NSL complex subunit 1"	Q7Z3B3	17	46029916-46225389	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 334.6;Inhibitory neurons: 326.7;Microglial cells: 327.9;Oligodendrocyte precursor cells: 313.6;Oligodendrocytes: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006874, HPA007208"	Approved		Supported	Nucleoplasm		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006874: AB_1852393, HPA007208: AB_1852395"	"unprognostic (2.46e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (1.54e-2)"	"unprognostic (9.28e-2)"	"unprognostic (7.79e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-2)"	12.3	9.2	3.7	7.6	4.4	12.9	11.3	13.8	6.7	14.2	2.1	11.7	4.2	15.3	9.1	12.9	11.7	4.1	7.3	4.1	4.0	8.4	5.8	9.4	7.6	4.2	4.7	15.2	12.4	11.9	9.0	7.2	5.4	9.1	8.4	9.4	11.1	4.5	16.4	17.2	12.0	9.8	3.6	9.2	10.0	17.5	4.8	16.9	12.0	9.0	9.7	12.7	13.1	5.8	3.1	2.4	11.2	5.1	2.5	4.0	7.0	3.0	5.8	5.4	6.4	11.6	0.9	11.8	4.9	12.5	16.2	6.7	22.6	8.1	10.7	14.9	11.3	1.6	5.8	14.3	17.3	1.3	4.3	4.1	17.2	12.2	19.6	7.6	13.4	18.6	5.1	12.3	12.1	4.5	42.5	2.9	3.4	2.8	14.1	24.3	21.9	20.2	8.3	7.4	5.7	13.8	15.3	0.5	9.8	29.8	17.4	21.5	11.8	23.2	13.5	9.0	3.2	20.6	15.2	17.6	6.4	6.4	16.2	0.0	0.1	0.3	0.2	0.1	0.2	0.4	0.3	0.5	0.0	0.1	0.3	0.2	0.3	0.3	0.1	0.2	0.3	0.2	3.7	4.4	13.8	6.7	4.1	4.0	4.2	4.7	5.4	3.6	4.8	5.8	53.4	32.1	36.7	226.9	47.7	27.1	19.7	22.4	42.7	68.1	57.4	39.5	13.2	20.0	18.2	47.8	102.2	15.0	95.5	35.0	1.9	37.1	162.9	58.2	80.2	40.9	31.8	22.1	334.6	25.4	20.4	33.3	33.1	85.9	24.1	111.4	30.4	25.3	21.1	69.0	326.7	29.2	28.5	41.7	25.3	136.6	34.8	38.1	21.4	327.9	52.3	23.6	60.8	313.6	346.4	40.8	27.2	30.1	60.1	33.7	28.9	12.7	18.9	78.5	26.3	42.0	43.7	29.4	50.9	48.9	30.1	14.6	70.6	71.6	27.2	32.7
KANSL3	"FLJ10081, KIAA1310, NSL3, Rcd1"	ENSG00000114982	"KAT8 regulatory NSL complex subunit 3"	Q9P2N6	2	96593170-96642787	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035017, HPA035018"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"HPA035017: AB_2674414, HPA035018: AB_10601763"	"unprognostic (2.19e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-3)"	"unprognostic (4.99e-3)"	11.8	9.9	1.9	8.6	2.4	14.9	12.3	1.6	3.1	13.7	8.1	11.8	7.2	15.0	7.7	8.9	12.5	6.9	10.7	2.9	2.6	8.8	6.4	9.9	8.2	2.1	2.9	15.1	9.8	15.1	8.8	9.0	2.3	11.2	6.9	6.3	12.5	14.7	33.9	10.8	12.0	10.6	3.3	10.1	9.8	12.8	3.3	13.1	12.9	21.1	8.9	13.0	10.8	2.3	13.1	7.9	26.0	19.4	10.6	6.4	11.4	9.7	15.2	20.1	21.4	15.1	7.8	18.1	14.6	16.2	14.7	8.2	18.8	9.4	17.5	12.8	14.8	26.0	8.1	16.2	15.0	17.4	9.0	15.0	5.8	12.8	11.4	12.0	11.0	21.0	18.6	12.8	12.8	6.9	32.3	13.5	12.5	6.7	12.8	26.2	16.5	10.6	12.4	12.7	26.8	16.9	12.3	11.8	11.8	14.7	11.4	5.5	15.9	13.5	11.8	9.8	8.9	10.1	6.7	15.7	7.0	19.9	12.2	2.4	1.3	0.5	2.8	1.5	2.1	1.6	1.7	2.9	0.7	1.5	1.2	2.3	0.2	3.1	1.3	0.7	1.1	1.7	1.9	2.4	1.6	3.1	2.9	2.6	2.1	2.9	2.3	3.3	3.3	2.3	11.6	44.8	30.8	29.0	10.5	4.6	9.9	8.1	9.1	15.0	14.8	12.2	23.8	10.0	18.8	11.0	43.8	8.1	10.0	15.0	3.9	10.5	13.4	13.0	13.7	12.1	13.1	6.7	35.6	9.6	4.3	12.7	17.3	13.5	18.3	33.1	15.7	12.7	8.1	15.2	36.2	18.4	10.2	12.5	5.6	28.6	9.9	11.2	7.2	16.9	13.7	10.2	9.2	29.7	37.3	13.2	7.9	12.8	10.6	10.3	10.7	5.8	13.1	29.5	13.1	16.0	13.6	23.3	9.7	11.3	6.5	11.1	14.2	18.3	15.6	10.1
KARS1	"DFNB89, KARS, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase 1"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 90.7;Cytotrophoblasts: 122.7;Extravillous trophoblasts: 143.3;Hofbauer cells: 89.5;Syncytiotrophoblasts: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		82000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	68.5	49.6	45.5	71.6	47.3	86.1	83.0	46.9	63.2	60.3	50.6	75.8	62.4	53.9	75.1	72.5	69.5	50.4	96.0	45.6	48.3	72.2	76.8	53.1	88.3	46.9	47.5	74.9	86.5	76.7	51.5	62.2	46.8	55.2	85.6	69.6	79.6	60.6	213.4	67.3	62.6	69.6	46.8	57.6	66.2	98.9	47.4	96.6	65.3	186.8	107.8	92.1	55.0	48.1	164.2	187.0	133.5	185.4	140.1	140.3	262.4	135.0	164.9	290.2	217.0	332.8	209.0	292.4	145.4	180.8	138.4	229.4	272.0	246.7	314.4	86.0	139.8	161.4	153.1	348.5	255.8	245.5	174.1	166.4	173.8	257.4	414.6	147.7	240.0	253.5	273.4	68.5	222.5	378.0	254.1	262.2	284.3	238.4	135.9	329.2	120.0	358.4	235.4	136.3	200.2	162.9	339.5	122.8	152.2	144.8	166.1	229.2	133.8	159.8	164.9	123.6	196.7	145.1	178.6	696.6	139.5	206.5	199.7	88.6	112.7	130.0	110.7	155.7	202.6	109.5	137.1	132.0	135.7	91.6	126.6	117.1	24.9	127.6	163.1	85.7	155.5	160.5	45.5	47.3	46.9	63.2	45.6	48.3	46.9	47.5	46.8	46.8	47.4	48.1	14.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	0.0	0.0	0.0	0.0	122.7	10.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	143.3	14.4	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	110.0	2.1	0.0	0.0	0.0
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040446-20154404	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 165.2;Oligodendrocyte precursor cells: 418.2;Oligodendrocytes: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	17.9	9.9	38.7	15.4	46.5	48.0	10.3	39.1	40.3	14.9	33.8	13.8	17.7	12.3	8.1	27.4	11.7	12.6	35.9	34.4	42.2	16.6	39.3	16.2	22.4	41.7	44.9	27.7	18.7	51.0	10.2	13.7	43.0	14.5	12.5	33.9	37.6	13.0	60.2	14.3	21.5	13.6	37.1	19.8	13.9	2.7	42.2	23.6	14.4	56.1	20.1	11.9	15.1	45.1	2.7	6.9	3.8	6.2	15.1	14.2	8.8	8.8	13.0	9.1	13.3	2.1	4.5	24.0	3.6	16.7	11.5	2.0	9.4	2.8	7.6	21.8	9.0	21.0	10.7	0.7	7.1	3.2	26.2	6.1	5.0	7.9	5.1	16.0	8.8	5.8	13.7	32.9	13.0	3.3	7.0	6.4	1.6	6.7	6.8	9.1	7.1	5.1	12.4	14.2	1.9	4.1	4.9	7.9	30.5	5.9	8.2	14.2	8.5	15.3	6.1	5.8	10.1	12.3	27.6	5.7	13.9	13.8	33.0	0.6	0.4	1.3	1.5	0.7	1.5	0.4	1.3	1.1	0.4	0.8	0.4	0.8	2.4	0.5	0.5	1.2	2.2	0.3	38.7	46.5	39.1	40.3	34.4	42.2	41.7	44.9	43.0	37.1	42.2	45.1	15.5	32.1	20.8	165.2	11.9	8.5	11.3	2.2	3.4	14.6	5.5	5.0	64.1	4.3	10.4	5.5	4.2	7.3	19.5	16.6	11.7	3.8	3.8	6.4	5.7	14.6	11.5	52.2	22.4	4.4	1.1	11.7	3.6	13.1	10.8	12.3	20.7	33.6	7.7	15.2	32.1	7.3	4.1	22.8	23.3	1.8	6.5	16.0	17.8	52.5	11.1	14.8	14.4	418.2	175.4	3.3	2.4	5.3	19.9	7.1	24.7	6.2	12.7	11.9	6.6	25.2	9.0	0.8	1.4	10.0	12.9	9.9	23.5	2.9	3.8	8.0
KAT5	"cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5"	ENSG00000172977	"Lysine acetyltransferase 5"	Q92993	11	65711996-65719604	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016953, HPA074328"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Vesicles, Cytosol"	"HPA016953: AB_1851277, HPA074328: "	"unprognostic (2.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.10e-13)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-2)"	31.6	30.0	38.7	23.8	41.0	52.9	32.1	41.7	48.8	39.5	38.6	43.6	21.6	45.1	33.7	34.9	44.9	20.5	32.4	37.9	38.9	32.9	26.3	29.5	28.0	40.0	39.5	39.2	32.7	45.6	33.7	29.9	41.2	33.1	27.0	31.0	29.6	36.3	42.8	47.6	32.2	35.2	40.0	34.3	35.9	45.2	39.9	39.3	38.2	34.6	30.2	39.5	34.8	43.8	37.2	44.1	40.1	29.6	31.3	32.7	41.1	26.7	43.6	44.0	38.0	32.6	42.2	34.3	36.2	47.4	47.5	30.8	50.8	45.1	26.4	44.4	32.5	50.6	36.3	38.9	44.6	55.7	56.4	35.2	49.7	28.9	59.0	33.7	28.1	39.1	52.5	51.1	42.0	68.2	45.7	62.3	33.9	26.8	28.4	38.2	26.5	63.3	40.6	56.2	37.1	38.9	25.4	46.5	51.2	20.8	45.9	34.2	36.3	33.9	30.4	27.6	28.0	38.7	43.7	50.4	29.7	27.0	29.3	42.7	33.6	58.8	33.4	32.0	29.6	28.2	28.8	34.2	34.1	30.4	36.5	29.8	34.8	35.8	34.6	20.9	31.0	36.4	38.7	41.0	41.7	48.8	37.9	38.9	40.0	39.5	41.2	40.0	39.9	43.8	17.6	12.8	17.5	10.7	26.0	21.2	44.2	60.2	17.6	44.9	17.3	15.0	1.0	25.8	33.8	29.5	31.3	51.3	25.6	27.1	35.2	42.2	11.1	20.2	14.2	18.7	30.4	12.4	7.5	51.5	42.6	21.1	20.4	19.8	33.7	27.0	18.2	10.9	36.3	38.7	8.7	25.1	42.7	17.6	15.2	11.1	28.0	20.4	42.7	3.7	38.8	40.3	33.0	7.1	13.8	39.4	30.6	38.7	10.4	24.2	23.3	32.6	30.0	44.8	46.0	27.6	27.0	61.1	27.8	14.6	21.3	102.5	21.6	29.2	26.2	31.0
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 416.6;Late spermatids: 194.2;Spermatocytes: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.9	8.2	7.2	10.3	8.4	19.2	12.6	9.6	9.1	13.3	12.3	13.1	8.5	13.3	9.8	12.5	11.8	9.7	11.6	7.0	7.9	13.2	9.0	11.2	14.1	8.2	7.9	19.5	9.5	7.3	7.4	12.7	8.4	9.9	9.9	16.8	9.7	10.9	23.0	12.3	10.0	12.4	7.9	11.8	10.1	45.1	7.8	17.0	11.2	14.3	15.8	12.0	12.7	9.6	22.5	8.3	18.6	42.1	22.9	32.7	28.9	28.7	24.3	29.4	37.2	17.9	11.4	33.7	16.9	28.4	20.4	17.1	34.5	18.5	37.8	30.4	33.8	42.7	17.6	27.9	31.0	60.0	16.4	22.8	22.5	33.3	27.3	27.3	27.8	44.4	46.1	20.7	26.2	32.0	41.2	40.4	19.1	26.2	15.1	30.5	33.3	15.2	21.6	11.6	13.7	20.7	48.9	15.0	22.2	24.3	14.4	61.6	23.7	14.6	23.4	39.2	33.9	20.4	20.3	43.9	19.8	42.7	26.4	39.8	20.4	29.1	25.9	28.5	22.2	27.7	25.2	25.8	26.1	18.3	21.4	20.9	8.7	18.2	25.6	22.3	34.0	20.5	7.2	8.4	9.6	9.1	7.0	7.9	8.2	7.9	8.4	7.9	7.8	9.6	27.6	16.0	11.3	11.8	20.2	29.3	35.7	23.0	12.5	9.1	17.3	26.9	15.5	10.0	15.0	14.7	29.2	23.6	31.4	12.1	17.6	19.5	416.6	23.2	21.6	19.3	6.0	27.4	8.6	12.4	19.4	25.9	11.7	19.3	20.3	23.9	10.0	7.7	17.4	13.5	9.4	9.7	24.4	12.5	19.4	194.2	21.1	17.3	10.6	7.5	22.1	12.2	27.8	13.6	16.3	15.9	12.5	16.6	9.0	19.4	9.7	20.9	23.8	36.1	6.6	40.0	28.5	109.3	58.8	17.7	28.7	25.6	25.6	17.7	12.1	15.4
KATNAL1	MGC2599	ENSG00000102781	"Katanin catalytic subunit A1 like 1"	Q9BW62	13	30202630-30307551	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 144.3;Excitatory neurons: 80.6;Oligodendrocytes: 78.5;Spermatocytes: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 63.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046205			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046205: AB_10965325"	"unprognostic (3.34e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.83e-3)"	8.7	3.8	7.0	5.0	8.8	6.5	4.7	7.5	8.9	9.7	0.0	8.7	1.4	9.3	2.7	5.8	4.8	3.8	17.9	8.0	8.1	4.0	3.9	4.9	6.5	7.2	6.4	4.2	1.9	2.2	2.9	3.0	7.0	4.5	4.1	7.9	2.2	5.9	5.1	2.6	2.8	15.0	7.5	3.3	2.8	20.8	8.4	9.2	3.0	6.6	7.1	5.0	5.2	11.8	11.7	9.6	16.5	8.8	12.3	26.0	0.4	47.5	15.2	24.9	19.4	1.9	11.6	18.8	5.5	63.7	31.3	3.2	11.8	12.2	37.5	16.3	4.4	13.4	11.2	4.4	6.5	6.7	8.7	10.1	6.0	28.0	6.8	23.3	26.4	10.2	7.3	8.1	30.8	2.4	15.2	6.1	7.1	0.2	6.1	16.8	19.4	1.9	8.8	0.8	6.8	14.3	12.6	2.6	9.0	13.6	4.1	4.1	24.2	21.8	32.7	12.1	19.3	4.2	8.2	25.8	8.7	6.5	32.1	1.5	0.7	2.9	4.4	0.4	2.1	1.9	3.4	4.4	1.9	4.5	0.8	1.8	0.2	7.7	0.9	5.5	5.8	1.2	7.0	8.8	7.5	8.9	8.0	8.1	7.2	6.4	7.0	7.5	8.4	11.8	12.9	9.6	1.8	30.3	7.2	5.9	3.9	4.7	6.2	10.2	4.0	5.6	41.4	2.8	2.3	5.5	27.1	0.4	6.6	0.3	3.9	6.5	144.3	10.3	26.5	9.3	10.2	16.4	80.6	1.5	0.8	12.3	1.5	3.6	10.1	10.3	7.9	10.6	2.9	21.9	34.5	1.0	0.0	2.8	8.9	50.7	9.0	5.9	17.8	21.5	21.9	9.6	13.4	29.1	78.5	5.7	0.0	5.3	6.4	1.9	0.3	8.4	14.7	18.7	6.6	11.9	13.7	59.0	24.6	5.2	5.7	0.3	9.8	19.2	0.7	1.7
KATNAL2	"DKFZP667C165, MGC33211"	ENSG00000167216	"Katanin catalytic subunit A1 like 2"	Q8IYT4	18	46917492-47102243	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.2;Early spermatids: 91.8;Inhibitory neurons: 41.8;Late spermatids: 71.4;Oligodendrocytes: 38.7;Spermatocytes: 58.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.5;Daudi: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040712, HPA042029"	Approved		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Intermediate filaments"		"HPA040712: AB_2677092, HPA042029: AB_2677807"	"unprognostic (3.40e-1)"	"unprognostic (7.75e-2)"	"unprognostic (9.00e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.52e-6)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.24e-7)"	"unprognostic (1.64e-1)"	"unprognostic (7.14e-4)"	"unprognostic (1.06e-3)"	"unprognostic (1.61e-1)"	5.3	3.4	9.6	1.8	11.1	2.7	4.0	14.4	14.7	3.4	23.1	2.6	1.4	2.3	5.5	2.6	7.1	4.4	4.4	9.1	9.2	10.4	6.9	3.3	3.2	10.6	11.5	3.3	2.9	18.0	8.0	1.7	11.2	4.3	2.5	10.8	4.4	2.7	6.1	7.4	2.2	1.8	8.6	3.7	2.2	15.5	10.3	1.9	17.5	2.9	2.1	2.3	3.1	12.9	2.7	5.7	3.5	21.5	7.1	7.9	1.6	2.4	2.1	1.9	2.5	0.2	7.5	28.2	2.2	4.2	2.6	0.9	6.9	0.7	1.6	2.6	3.7	1.3	2.0	0.4	2.8	1.7	2.4	16.5	2.6	3.5	0.9	4.9	0.7	12.8	1.0	2.3	11.5	2.7	1.9	3.7	7.6	4.0	3.9	7.8	1.5	0.1	6.4	0.4	7.6	8.8	2.7	0.5	1.0	11.9	15.5	16.7	1.5	7.1	0.7	2.7	1.7	1.8	1.5	19.7	3.7	18.0	13.4	0.1	0.1	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.0	0.6	0.3	0.3	0.2	0.1	0.2	0.1	0.0	0.0	9.6	11.1	14.4	14.7	9.1	9.2	10.6	11.5	11.2	8.6	10.3	12.9	3.7	0.0	1.1	84.2	1.0	1.5	3.0	2.9	8.0	9.9	1.6	1.3	2.9	1.5	5.2	3.7	6.2	0.0	0.2	2.5	13.7	0.9	91.8	22.6	6.2	2.5	0.0	1.7	28.2	0.2	0.0	3.1	3.6	1.6	0.0	3.9	2.2	4.2	3.6	11.8	41.8	0.7	2.0	1.9	0.9	71.4	1.5	1.5	3.6	18.7	0.9	2.6	0.0	26.7	38.7	0.2	0.3	2.2	0.4	1.0	0.2	12.1	35.2	2.3	0.0	7.5	1.9	58.7	4.6	2.8	1.1	0.1	0.6	2.6	2.3	1.9
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 128.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 128.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: AB_2684796"	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	22.0	12.1	16.3	22.9	16.6	16.3	20.8	25.0	20.8	22.5	22.4	19.9	15.9	20.7	19.0	39.9	16.8	15.9	13.4	15.8	14.9	17.0	17.6	18.4	17.6	15.0	13.8	14.4	14.0	14.5	12.1	32.4	16.0	16.9	21.2	31.2	14.6	13.6	13.2	31.4	15.7	25.4	12.9	18.6	17.7	18.0	18.2	15.2	12.5	13.0	20.3	17.8	27.7	25.3	37.1	31.5	49.7	33.4	39.5	39.0	37.0	49.6	30.0	38.7	38.4	17.8	19.9	17.6	31.2	32.2	54.5	47.5	24.9	28.5	45.8	36.9	12.6	31.8	34.6	21.6	27.0	33.9	33.1	23.6	40.8	26.1	51.3	39.7	70.6	45.4	34.3	36.7	53.1	17.6	21.4	27.4	35.8	47.4	25.0	32.3	30.3	16.1	35.9	49.5	28.1	24.8	30.1	21.9	14.7	49.2	27.0	38.8	40.4	51.9	26.7	46.8	39.7	21.5	32.5	37.1	46.5	35.7	38.9	62.8	18.2	29.7	18.4	17.3	23.3	23.9	19.6	18.8	20.7	25.6	21.5	19.2	128.5	13.2	11.5	28.4	17.9	12.0	16.3	16.6	25.0	20.8	15.8	14.9	15.0	13.8	16.0	12.9	18.2	25.3	59.7	38.5	25.2	83.9	41.7	41.3	65.2	60.5	34.7	57.0	42.1	43.1	12.8	24.3	51.6	25.8	52.1	58.6	42.3	30.6	33.2	59.1	75.4	40.5	53.3	47.0	23.9	39.8	104.3	54.5	86.2	38.8	39.3	50.8	44.9	68.7	37.9	20.8	39.1	67.3	96.7	35.6	52.9	27.6	48.8	59.2	31.7	36.2	32.0	64.6	49.9	53.1	27.8	86.0	114.4	105.3	37.4	33.1	41.1	116.8	21.4	41.6	49.6	44.7	59.2	52.2	45.3	47.8	44.3	45.0	54.3	179.5	39.7	31.6	39.1	132.6
KCNA10	Kv1.8	ENSG00000143105	"Potassium voltage-gated channel subfamily A member 10"	Q16322	1	110517217-110519175	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015061, CAB022564"			Uncertain	Nucleoplasm,Cytosol		No	NA							"Nucleoplasm, Cytosol"		"CAB022564: , HPA015061: AB_1855573"														"unprognostic (2.96e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537225-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;lymphoid tissue: 2.3;retina: 4.6"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 264.8;Excitatory neurons: 279.1;Inhibitory neurons: 241.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;HDLM-2: 1.4;HEK 293: 3.4;SCLC-21H: 2.7"					"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.1	0.4	1.7	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	2.4	2.2	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.5	0.0	1.1	0.0	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.3	0.0	1.3	2.3	0.4	0.3	1.5	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.0	1.4	2.4	2.2	1.0	2.6	0.4	1.3	1.5	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	17.4	0.0	0.0	0.3	0.0	0.0	1.8	264.8	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	17.9	0.0	279.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	241.2	0.6	0.0	0.0	0.0	6.8	1.2	0.0	0.0	3.7	0.0	0.7	0.0	11.6	4.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.1	0.1	0.4	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971844	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 3.5;Peritubular cells: 3.8;Rod photoreceptor cells: 3.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 10.6;NB-4: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (6.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.19e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.41e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.30e-11)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.22e-3)"	3.8	0.9	2.8	1.5	2.8	2.7	1.8	5.5	2.7	2.7	0.1	2.0	0.8	3.6	1.4	1.1	5.4	2.4	2.3	2.9	3.0	1.7	1.4	2.6	1.3	3.6	2.9	2.7	1.1	0.4	2.3	1.0	3.9	2.3	0.8	6.1	0.9	2.1	0.5	1.3	2.2	2.5	3.3	3.3	1.8	1.5	3.2	0.7	1.8	0.4	1.4	2.3	2.3	3.8	0.3	1.6	0.7	3.9	5.1	4.1	1.3	0.8	3.3	2.3	1.5	1.1	0.5	1.3	2.8	2.6	0.6	0.5	0.6	0.3	2.2	2.3	2.7	1.2	1.8	0.1	1.9	0.3	2.5	10.6	1.4	4.2	0.4	3.7	0.8	1.9	0.9	3.0	1.7	3.1	0.4	9.2	2.1	0.2	0.6	1.1	0.7	1.3	2.6	1.3	0.4	1.8	0.7	0.0	1.8	7.9	1.7	1.3	2.0	0.5	2.1	0.5	0.2	2.5	3.5	3.2	1.4	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.8	2.8	5.5	2.7	2.9	3.0	3.6	2.9	3.9	3.3	3.2	3.8	0.9	0.0	1.1	1.0	0.4	0.8	0.0	0.4	0.0	0.2	0.3	0.3	0.8	0.0	0.2	1.8	0.0	0.1	0.4	0.3	1.9	0.2	0.1	0.2	1.0	0.6	3.5	0.0	0.7	0.0	0.1	1.2	0.5	0.5	0.0	1.7	1.1	0.0	0.1	0.0	1.1	0.3	0.0	0.6	0.0	0.2	1.8	0.4	0.0	1.0	0.1	0.4	0.0	2.0	0.1	0.1	0.0	3.8	0.1	0.2	0.2	0.1	0.3	3.0	0.0	0.1	0.6	0.6	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2
KCNH5	"eag2, H-EAG2, hEAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699464-63102037	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 8.5;retina: 4.5"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 62.2;Excitatory neurons: 185.0;Inhibitory neurons: 74.4;Oligodendrocyte precursor cells: 65.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;RT4: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.2	1.0	2.4	0.0	2.1	0.0	0.0	0.0	5.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	2.9	3.3	0.0	0.0	0.0	0.3	0.2	3.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	5.9	4.5	1.8	2.9	3.3	3.0	0.8	8.5	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	62.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.8	0.1	0.2	0.2	0.0	0.0	185.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	74.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	0.0	0.5	0.0	65.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.6	0.0	0.0	0.1	1.6	1.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium inwardly rectifying channel subfamily J member 12"	Q14500	17	21376357-21419870	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 25.5;skeletal muscle: 69.1;tongue: 25.7"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 89.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;HeLa: 3.9;PC-3: 4.3;SCLC-21H: 4.8;SiHa: 2.5;SuSa: 5.2;U-2197: 4.2"									HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.3	1.1	2.9	0.6	2.2	0.4	0.8	25.5	3.3	1.2	0.0	0.9	0.1	0.5	0.6	1.4	2.1	0.4	6.4	1.5	2.9	1.3	0.1	1.9	0.1	4.0	6.0	0.4	0.2	5.5	0.8	0.4	3.1	0.6	0.3	1.3	0.7	0.6	69.1	3.6	0.4	0.6	1.1	1.2	1.1	0.8	10.8	0.1	1.1	25.7	1.0	0.7	0.5	1.4	0.0	0.7	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	4.3	0.0	0.6	1.1	0.0	0.0	4.8	0.2	2.5	0.0	1.1	5.2	0.0	0.0	2.0	0.0	0.3	4.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.2	25.5	3.3	1.5	2.9	4.0	6.0	3.1	1.1	10.8	1.4	1.4	0.0	0.0	0.7	0.0	1.5	0.0	2.3	0.0	2.9	0.0	0.3	14.3	0.0	1.2	1.8	0.0	0.0	0.1	1.1	1.9	0.0	0.5	0.4	0.5	3.4	1.2	0.0	2.8	0.0	0.0	3.4	0.5	1.8	0.0	0.0	6.8	0.1	0.2	89.2	5.7	1.4	4.1	0.0	1.2	0.5	7.5	0.1	0.0	2.8	0.0	10.2	0.0	0.0	0.2	0.0	0.5	4.1	0.0	0.2	0.0	0.8	0.1	1.5	0.0	3.0	0.7	0.6	2.5	0.0	2.3	0.1	0.5	0.0	1.8	0.2
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium inwardly rectifying channel subfamily J member 13"	O60928	2	232765802-232776565	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 159.5;intestine: 91.3"	"Group enriched"	"Detected in some"	4	"Muller glia cells: 54.8;Proximal enterocytes: 217.4;Undifferentiated cells: 68.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Group enriched"	"Detected in many"	4	"cerebellum: 7.3;hippocampal formation: 8.0;thalamus: 5.3;white matter: 3.4"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.1	0.1	0.4	0.0	1.3	0.4	0.1	7.3	1.1	0.1	159.5	0.1	7.9	0.1	0.3	0.1	0.0	2.2	0.1	8.0	0.4	3.3	0.2	0.1	0.2	1.3	0.8	0.2	0.8	15.8	0.2	0.0	1.3	0.1	0.0	13.7	0.2	1.1	0.1	3.2	91.3	0.1	0.4	0.1	2.3	0.5	5.3	0.1	7.0	0.0	0.0	0.1	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.3	0.0	0.2	0.2	0.1	0.0	1.9	0.3	0.3	0.3	0.0	0.4	0.2	0.6	0.2	0.1	0.3	0.7	0.3	0.3	0.4	0.4	0.3	1.0	0.0	0.4	1.3	7.3	1.1	8.0	0.4	1.3	0.8	1.3	0.4	5.3	3.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.5	0.5	0.0	0.0	1.8	0.0	0.0	0.2	0.1	1.9	0.0	3.0	0.7	0.3	0.2	0.0	0.0	1.1	1.3	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	25.7	0.0	0.0	0.0	0.6	0.0	0.1	21.4	0.0	0.0	54.8	0.0	1.5	2.0	0.0	8.8	0.0	0.0	0.1	217.4	0.2	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	68.1	0.0
KCNJ18	"KIR2.6, TTPP2"	ENSG00000260458	"Potassium inwardly rectifying channel subfamily J member 18"	B7U540	17	21692523-21704612	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 7.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8;head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027021	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"		"unprognostic (2.41e-1)"				"unprognostic (3.90e-5)"			"unprognostic (2.56e-1)"						"unprognostic (1.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium inwardly rectifying channel subfamily J member 3"	P48549	2	154697855-154858354	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 309.6;Horizontal cells: 124.5;Inhibitory neurons: 431.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;SH-SY5Y: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024231, HPA064138"	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Plasma membrane"	"HPA024231: AB_1855558, HPA064138: "	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.5	1.4	5.7	0.1	8.7	0.1	0.3	32.7	17.0	1.6	4.7	0.8	10.7	0.1	1.1	0.1	0.4	1.3	15.1	14.6	3.7	10.5	3.1	0.2	0.0	2.2	4.3	0.1	2.1	10.4	6.8	0.0	2.4	6.5	0.8	5.0	0.0	11.3	5.3	0.1	9.5	0.2	1.6	0.4	0.7	0.4	4.1	0.0	0.1	0.2	0.0	0.4	0.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.1	5.7	8.7	32.7	17.0	14.6	3.7	2.2	4.3	2.4	1.6	4.1	6.4	0.3	0.0	0.0	38.8	0.0	0.8	5.3	0.0	0.0	10.9	3.7	1.7	49.0	5.7	0.0	20.2	14.6	0.0	0.0	0.1	5.9	0.1	0.3	0.0	0.0	1.3	31.1	0.0	309.6	3.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.3	0.1	124.5	431.3	7.0	0.0	0.0	2.1	0.0	6.2	0.6	1.8	5.6	0.0	0.7	0.0	32.6	6.8	0.0	1.2	4.1	0.0	6.1	16.2	8.7	0.0	3.9	0.0	8.0	1.6	0.4	0.3	0.0	1.8	0.0	0.8	1.9	8.4	4.7
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.7;thyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.8"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 83.8"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.5	0.3	0.3	0.4	0.4	1.2	0.8	0.3	0.6	0.7	0.2	0.6	1.9	1.2	0.0	0.3	0.8	2.5	5.8	0.2	0.3	0.1	4.0	7.7	0.7	0.4	0.5	0.2	3.9	0.1	1.8	4.0	0.3	0.6	0.5	0.0	0.7	0.2	0.1	0.1	1.1	1.0	0.2	0.7	2.9	0.2	0.5	1.3	6.5	0.5	1.1	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	63.8	0.0	0.3	0.3	0.4	0.3	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.5	0.3	0.0	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	7.9	0.0	1.8	1.1	0.1	6.3	0.0	0.7	0.2	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.9	0.0	17.8	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"brain: 92.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 12.8;Langerhans cells: 19.8;Skeletal myocytes: 6.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Group enriched"	"Detected in many"	7	"amygdala: 34.8;basal ganglia: 30.6;cerebral cortex: 67.2;hippocampal formation: 92.2;white matter: 30.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"REH: 155.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments, Cytosol"		"HPA065938: AB_2685582"	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.3	0.2	34.8	0.4	30.6	0.1	0.2	0.0	67.2	0.9	0.0	0.3	0.1	0.6	0.1	0.2	0.1	0.1	1.1	92.2	0.0	0.2	0.0	0.1	0.1	4.4	0.0	1.8	0.1	1.6	1.0	0.0	6.8	0.6	0.0	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	2.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	30.6	0.1	0.6	0.2	6.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.5	0.2	5.3	0.0	0.2	0.2	2.5	5.0	0.3	0.1	0.0	0.0	12.8	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.4	0.0	0.0	1.8	0.0	0.1	155.3	0.0	0.2	0.0	0.0	0.2	8.6	0.0	0.0	0.1	0.4	0.3	0.2	0.1	0.0	4.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	30.6	0.0	67.2	92.2	0.0	4.4	0.0	6.8	0.0	0.0	30.6	0.4	0.0	0.0	3.6	1.1	2.5	3.7	0.0	0.0	2.3	0.2	0.3	0.8	0.0	0.7	0.0	2.1	0.1	1.5	0.2	0.0	0.0	0.2	1.3	1.5	1.9	0.0	0.0	12.8	0.0	0.2	2.6	0.0	1.9	0.0	3.6	0.4	0.2	0.1	0.0	4.4	0.0	0.0	0.3	19.8	0.4	0.9	2.1	5.4	1.9	2.2	1.4	1.0	3.0	0.7	0.2	0.0	1.9	0.7	2.8	0.0	0.2	0.0	1.0	0.0	6.8	1.8	0.6	4.0	0.0	3.8	0.1	1.5	2.2	0.0	1.8
KCTD1	C18orf5	ENSG00000134504	"Potassium channel tetramerization domain containing 1"	Q719H9	18	26454910-26657401	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 106.4;Distal tubular cells: 117.4;Excitatory neurons: 283.7;Squamous epithelial cells: 109.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 106.6;HaCaT: 113.5;hTCEpi: 100.6;RPTEC TERT1: 97.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057808, HPA062486"			Approved	"Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite"		Yes	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytokinetic bridge, Centriolar satellite"	"HPA057808: , HPA062486: "	"unprognostic (1.15e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.35e-4)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (3.65e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.60e-8)"	"unprognostic (3.87e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.02e-2)"	7.8	16.5	21.7	2.7	41.5	0.6	32.4	14.0	44.3	19.2	9.5	9.7	4.1	14.2	22.6	50.6	50.2	8.4	23.8	31.2	10.3	28.8	3.5	5.5	2.7	9.8	13.6	15.1	7.4	12.0	10.8	11.4	9.2	21.6	10.6	18.4	19.9	22.6	5.1	61.1	3.7	12.5	10.2	3.9	10.3	5.9	13.7	17.6	19.9	6.9	14.3	13.0	36.9	29.6	17.5	55.1	106.6	11.6	61.8	9.7	13.4	14.3	21.5	22.0	21.9	5.1	19.1	2.9	52.2	30.5	18.0	113.5	20.5	30.6	20.6	2.2	8.7	3.1	10.2	8.2	11.1	1.7	4.7	16.7	100.6	6.2	41.4	28.0	21.0	24.1	1.3	1.2	16.0	24.5	16.3	5.2	10.5	57.1	27.1	8.5	5.7	2.3	97.8	25.2	10.3	40.5	20.7	27.5	8.7	61.3	24.1	4.0	11.7	24.4	6.8	4.8	15.0	4.8	4.1	0.4	8.7	11.0	36.8	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	41.5	14.0	44.3	31.2	10.3	9.8	13.6	9.2	10.2	13.7	29.6	3.0	3.2	4.1	80.0	0.7	31.7	55.9	17.2	106.4	5.0	27.3	29.7	13.9	8.6	15.0	25.8	8.4	45.5	0.8	6.2	117.4	8.3	28.0	47.0	7.8	2.9	1.2	0.8	283.7	3.6	7.6	5.5	7.1	42.4	0.0	66.3	2.5	1.7	4.4	21.9	66.1	4.3	20.3	0.8	1.7	12.0	5.3	1.2	23.2	16.9	0.4	21.4	1.0	81.4	42.1	11.8	2.4	3.0	6.6	36.4	0.4	10.7	29.3	5.9	0.0	2.7	6.2	1.8	5.1	109.0	44.5	33.2	1.0	6.3	4.0	51.2
KCTD13	"FKSG86, PDIP1, POLDIP1"	ENSG00000174943	"Potassium channel tetramerization domain containing 13"	Q8WZ19	16	29905012-29926236	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Autism, Autism spectrum disorder, Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.5;testis: 36.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043524	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA043524: AB_2678528"	"unprognostic (6.97e-2)"	"unprognostic (9.06e-3)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.49e-3)"	6.0	7.5	27.3	7.8	28.7	8.5	5.4	17.6	37.5	5.0	17.4	6.3	7.3	5.1	9.9	5.9	8.3	7.8	4.4	36.9	24.5	3.9	3.5	4.5	9.8	19.5	21.3	7.5	7.5	7.9	3.6	4.5	19.6	6.7	6.5	9.4	6.5	8.0	2.7	12.2	7.0	5.2	20.5	7.6	5.8	36.3	23.0	9.6	5.7	2.4	7.1	6.0	2.7	28.8	9.7	12.4	6.2	15.5	10.0	8.1	12.5	5.8	7.2	5.7	8.9	3.5	12.6	17.4	11.3	8.5	9.6	14.4	6.8	5.5	4.4	26.5	17.0	3.7	7.1	6.0	13.7	9.2	15.9	10.2	15.3	11.6	8.7	6.1	4.7	19.9	9.1	14.8	7.9	28.1	18.7	14.2	3.6	5.0	6.0	13.9	4.5	9.0	7.8	9.1	15.5	15.4	2.4	7.0	31.7	5.8	10.1	7.2	10.0	5.0	5.1	15.3	10.6	12.4	5.3	3.9	12.0	10.4	14.4	7.2	3.3	8.0	2.9	2.6	3.0	3.0	5.4	5.0	3.5	2.4	5.0	4.7	11.1	3.1	4.4	3.8	4.4	1.9	27.3	28.7	17.6	37.5	36.9	24.5	19.5	21.3	19.6	20.5	23.0	28.8	7.1	0.0	9.7	20.9	10.6	6.0	5.7	10.4	12.5	9.9	8.5	8.0	3.4	5.7	5.8	0.0	8.4	5.3	7.9	5.2	3.9	6.9	17.9	9.1	6.8	4.7	7.7	3.0	15.4	4.2	5.1	6.5	4.6	8.7	2.5	10.9	6.4	2.4	7.6	5.0	20.5	7.2	10.2	4.4	5.6	9.0	6.2	6.3	8.8	12.2	5.7	5.0	11.3	17.6	28.9	11.0	7.4	6.4	3.6	8.7	6.5	2.9	6.3	6.5	0.0	5.0	7.8	20.6	26.5	12.4	9.1	6.7	10.6	5.8	6.1	7.0
KCTD9	"BTBD27, FLJ20038"	ENSG00000104756	"Potassium channel tetramerization domain containing 9"	Q7L273	8	25427847-25458476	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042468, HPA047902"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA042468: , HPA047902: AB_2680205"	"unprognostic (4.18e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (7.88e-4)"	"unprognostic (7.04e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.97e-3)"	18.4	8.2	4.9	11.5	5.8	21.5	22.3	7.9	6.5	15.4	8.6	21.1	19.6	11.3	13.0	23.8	14.6	13.3	38.3	5.5	5.9	12.8	10.8	13.4	12.2	9.1	7.7	14.2	11.2	11.0	9.8	12.0	10.0	17.4	22.6	12.9	17.5	15.6	29.5	19.0	17.7	14.5	7.8	9.4	12.8	12.9	6.9	14.7	13.7	36.7	14.4	15.6	18.7	6.9	46.4	32.4	34.5	11.9	44.0	58.0	28.2	68.6	61.4	44.1	44.5	23.4	33.2	30.1	28.6	69.0	62.3	30.3	30.6	32.3	52.9	15.4	18.2	35.3	30.2	21.7	53.2	12.3	25.1	44.8	38.5	40.2	33.2	26.9	37.8	29.6	37.8	23.0	50.7	12.4	48.2	21.6	16.8	35.8	17.0	18.6	39.8	11.2	45.0	26.1	8.8	11.4	52.7	23.1	35.8	30.8	17.8	14.2	42.2	48.5	28.2	94.1	37.6	6.6	12.9	39.1	33.9	21.8	35.8	0.7	0.5	1.2	1.0	0.7	1.0	0.6	1.0	1.0	0.3	0.3	0.6	0.9	0.5	0.2	0.9	1.0	1.1	0.4	4.9	5.8	7.9	6.5	5.5	5.9	9.1	7.7	10.0	7.8	6.9	6.9	19.5	32.1	18.5	18.6	8.9	74.4	36.4	26.0	31.9	13.7	20.4	12.7	61.1	5.7	24.2	27.6	25.0	9.4	23.3	53.8	13.7	17.6	6.5	12.8	12.7	16.8	10.2	20.2	14.3	27.2	17.6	32.5	8.2	17.9	20.3	10.9	12.5	9.0	9.3	3.3	12.9	16.0	18.3	9.3	18.5	5.2	30.7	12.9	30.2	36.5	8.5	8.1	18.6	17.1	13.6	36.6	21.6	55.7	17.1	52.6	25.8	10.4	17.4	19.6	6.6	21.6	26.2	35.6	26.4	41.6	54.7	11.2	19.8	14.4	17.7	46.0
KDELR3		ENSG00000100196	"KDEL endoplasmic reticulum protein retention receptor 3"	O43731	22	38468078-38483447	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 73.2;Fibroblasts: 54.7;Intestinal goblet cells: 70.6;Proximal enterocytes: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 267.0;BJ: 180.5;BJ hTERT+: 182.0;fHDF/TERT166: 289.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043477, HPA076405"	Uncertain		Supported	"Endoplasmic reticulum"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA043477: AB_10962952, HPA076405: AB_2686797"	"unprognostic (1.76e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.05e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.07e-2)"	13.4	4.4	0.9	7.6	1.3	2.0	12.2	2.9	2.1	31.1	8.7	18.1	15.4	7.5	29.5	4.8	7.4	19.6	15.7	1.3	0.9	8.5	12.6	10.3	3.2	1.5	1.7	3.5	15.9	12.1	14.2	16.0	1.1	19.7	22.5	3.1	34.4	10.9	2.1	4.1	18.5	15.5	1.3	2.5	35.0	3.9	1.1	1.7	6.3	3.7	7.2	12.5	4.4	1.5	35.8	11.1	8.7	37.2	142.7	267.0	6.4	180.5	182.0	42.7	105.3	22.1	45.1	0.3	38.2	289.3	15.2	5.1	8.9	10.7	51.0	0.4	21.8	2.5	8.7	55.2	62.9	0.4	24.1	99.9	8.0	53.9	5.7	60.1	52.4	0.3	9.0	0.1	70.7	56.8	0.1	1.3	2.1	150.2	33.2	0.2	2.4	11.8	51.5	4.8	0.7	4.6	46.7	2.7	22.9	3.6	13.3	2.4	41.5	45.8	29.0	160.3	18.0	1.7	0.6	0.2	73.5	0.1	65.0	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.2	0.1	0.0	0.1	0.2	0.2	0.2	0.0	0.0	1.6	0.2	0.1	0.9	1.3	2.9	2.1	1.3	0.9	1.5	1.7	1.1	1.3	1.1	1.5	14.5	0.0	4.8	0.3	4.5	7.6	5.7	7.5	1.2	1.3	10.0	4.2	2.5	8.6	10.0	14.7	2.1	5.1	0.3	9.1	7.9	19.0	0.2	8.0	19.4	10.2	4.9	0.8	0.7	31.6	73.2	54.7	24.5	11.0	1.3	6.9	14.6	5.3	4.7	0.0	0.5	70.6	0.0	0.9	14.5	0.6	32.6	1.1	16.0	1.9	1.0	6.3	0.0	0.0	0.4	31.5	4.9	16.1	12.8	16.3	40.1	0.8	9.2	1.4	0.0	1.7	20.5	0.5	2.4	1.6	7.1	8.2	2.3	4.2	11.1	7.8
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153598	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.1;dendritic cells: 1.7;granulocytes: 4.7"	"Cell line enhanced"	"Detected in all"		"T-47d: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071568			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA071568: "	"prognostic favorable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.74e-4)"	"prognostic favorable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"	12.4	19.4	7.8	8.9	9.4	13.5	16.8	15.8	10.0	23.4	5.1	14.7	6.6	18.4	6.7	17.0	20.2	4.7	16.0	9.3	5.3	10.4	21.2	12.5	11.7	9.2	7.3	17.8	13.7	6.6	18.4	9.5	7.5	25.6	2.9	14.7	14.1	7.4	32.2	21.7	13.8	4.9	4.7	22.1	12.6	16.1	8.8	8.8	29.4	8.3	7.2	13.4	18.2	11.9	16.1	5.5	12.8	15.4	7.3	7.2	25.7	7.9	5.8	6.8	8.5	9.6	4.4	22.4	8.2	9.1	5.5	8.9	7.8	9.3	4.2	10.1	19.9	7.5	9.9	8.0	13.6	7.6	16.7	11.2	9.9	5.6	4.7	12.3	9.3	12.4	18.7	13.3	6.2	8.3	8.8	11.5	11.3	5.8	13.6	14.7	9.7	19.0	6.8	10.5	23.7	18.1	10.3	11.2	12.5	12.3	61.5	19.7	13.5	10.1	5.7	12.5	8.0	36.5	16.4	17.1	20.0	15.1	6.0	1.5	0.6	1.9	0.3	0.2	0.2	4.2	0.2	0.2	0.3	5.1	0.4	0.5	4.7	0.8	0.3	1.7	0.4	0.3	7.8	9.4	15.8	10.0	9.3	5.3	9.2	7.3	7.5	4.7	8.8	11.9	15.3	6.4	10.4	18.9	73.2	7.4	14.1	10.8	7.4	72.5	36.1	22.2	15.3	10.0	9.4	7.3	98.0	25.7	25.5	15.3	7.9	10.5	17.0	25.4	18.7	16.4	8.4	9.4	33.6	7.6	26.2	14.6	26.5	30.2	8.2	34.3	15.4	30.9	9.0	74.0	30.6	16.7	16.2	14.2	7.8	12.1	18.3	15.8	10.6	27.2	17.0	23.5	19.6	29.7	28.7	18.0	14.1	23.3	23.9	19.3	7.4	6.6	11.7	69.2	6.6	23.1	13.7	25.2	9.1	14.1	15.3	24.1	13.9	29.7	9.5	12.9
KDM6A	UTX	ENSG00000147050	"Lysine demethylase 6A"	O15550	X	44873188-45112779	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 116.2;Oligodendrocyte precursor cells: 118.1;Oligodendrocytes: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000568, HPA001165, HPA002111"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704"	"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.16e-2)"	9.6	8.0	6.7	4.5	7.6	19.4	10.6	7.2	10.6	15.7	6.5	9.1	6.2	14.0	5.1	11.1	14.0	3.4	6.6	6.8	6.9	6.8	10.4	10.8	8.0	7.3	6.8	17.2	10.8	6.4	8.6	3.9	7.3	7.7	4.1	3.8	10.5	3.1	10.4	18.4	13.0	4.1	7.1	14.1	12.5	12.2	7.0	12.9	9.4	6.1	5.3	9.8	15.2	9.9	7.3	5.8	7.0	9.3	5.0	6.8	15.7	4.9	4.2	4.0	4.1	10.4	5.2	4.6	3.2	3.5	10.1	13.9	6.5	5.4	3.9	7.6	10.8	2.4	4.5	5.2	3.7	2.6	13.2	2.6	6.4	8.2	6.6	5.1	4.2	5.3	6.4	10.1	2.4	6.0	6.9	13.6	6.8	4.2	7.4	6.4	7.1	1.4	3.8	9.2	6.2	4.4	18.2	6.8	10.7	14.1	8.5	0.0	3.0	5.4	5.2	5.2	3.6	5.5	8.8	5.6	4.0	3.3	3.3	7.3	1.7	1.5	1.9	3.5	2.1	1.9	2.5	2.8	3.1	1.2	2.5	2.4	2.8	2.8	3.0	1.7	2.2	2.0	6.7	7.6	7.2	10.6	6.8	6.9	7.3	6.8	7.3	7.1	7.0	9.9	23.2	6.4	10.6	92.1	26.0	26.1	14.3	9.4	38.1	7.7	16.8	12.1	12.8	12.8	10.9	7.3	14.6	4.5	26.1	24.6	0.0	8.4	1.5	26.4	25.5	13.1	13.1	16.8	88.3	7.5	7.9	14.2	23.0	39.7	2.5	27.3	6.4	17.6	7.0	25.2	74.0	14.0	6.1	9.1	13.8	2.0	6.5	19.9	10.6	116.2	12.6	6.8	6.2	118.1	264.6	9.1	17.4	7.2	31.4	14.2	22.6	3.7	8.9	9.7	6.6	20.9	17.0	14.1	12.5	29.3	26.3	10.9	27.4	10.6	13.1	17.1
KDM7A	"JHDM1D, KIAA1718"	ENSG00000006459	"Lysine demethylase 7A"	Q6ZMT4	7	140084746-140176983	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012114	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA012114: AB_1852429"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"	6.6	2.1	2.1	6.9	1.6	16.4	4.7	3.8	3.9	9.5	1.5	8.4	8.2	6.6	1.4	7.0	2.9	4.5	4.1	2.7	1.6	3.6	6.7	4.8	7.0	2.5	2.5	2.1	4.5	4.1	1.3	9.1	2.8	3.3	9.3	5.8	5.1	2.1	12.6	7.5	8.3	4.4	2.4	5.6	9.3	7.7	3.7	6.7	2.8	13.2	8.0	5.7	3.7	3.0	0.8	0.4	2.7	2.8	2.4	2.3	5.4	1.2	1.7	0.4	0.5	0.2	0.4	1.9	1.9	1.3	1.4	1.0	3.7	2.3	0.8	10.8	2.3	0.1	0.4	5.1	2.5	1.8	1.9	2.4	5.1	1.4	8.0	1.3	2.6	5.0	6.1	8.2	0.5	0.8	3.6	3.1	4.3	6.3	1.5	3.8	0.2	4.0	0.9	1.2	4.7	5.8	2.8	6.5	2.7	4.3	8.8	0.7	4.6	0.5	1.0	1.7	0.8	2.9	0.4	6.2	1.5	5.0	1.0	0.6	0.8	0.3	0.3	0.4	0.3	0.5	0.5	0.5	1.1	1.1	0.5	0.3	2.2	0.6	0.2	0.4	0.4	0.3	2.1	1.6	3.8	3.9	2.7	1.6	2.5	2.5	2.8	2.4	3.7	3.0	34.4	16.0	25.5	25.5	30.6	49.8	44.8	17.7	8.0	11.8	11.1	7.4	14.6	8.6	30.1	16.5	27.1	12.3	17.8	36.7	1.9	7.2	5.2	17.0	18.2	23.8	52.7	32.4	35.3	9.4	2.8	20.0	30.5	28.7	8.2	12.2	18.5	18.5	10.7	6.7	34.8	38.0	12.2	31.4	86.7	4.9	7.8	35.4	3.6	96.5	34.7	4.3	10.3	35.7	36.0	12.2	28.7	4.1	11.8	35.3	26.9	3.3	33.3	9.2	6.6	14.9	17.8	31.2	14.3	12.3	46.5	37.9	18.5	3.4	27.2	50.0
KEL	"CD238, ECE3"	ENSG00000197993	"Kell metallo-endopeptidase (Kell blood group)"	P23276	7	142941114-142962363	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 56.3;testis: 32.3"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 79.7;Oligodendrocytes: 30.1;Squamous epithelial cells: 16.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"HEL: 31.7;K-562: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064442			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	1.8	0.8	2.7	56.3	0.3	1.7	2.2	0.9	1.4	0.1	0.0	0.2	0.0	0.8	0.5	0.0	0.3	2.0	1.5	0.6	0.3	0.5	10.6	2.5	2.2	0.2	0.2	0.0	0.2	0.4	2.4	0.3	0.0	0.1	0.6	0.1	0.2	0.1	0.9	0.0	1.9	4.9	0.2	32.3	2.4	1.3	0.3	0.0	6.7	0.1	0.4	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	31.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.5	0.1	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.2	0.0	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	1.7	2.2	2.0	1.5	2.5	2.2	2.4	1.9	2.4	2.8	0.2	0.0	0.0	0.3	0.0	0.0	1.3	0.2	4.0	0.0	0.3	0.1	0.4	0.0	1.4	3.7	0.0	0.1	0.1	0.0	1.9	0.3	2.4	0.2	0.1	0.1	0.0	79.7	3.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	3.1	0.0	1.4	0.2	16.8	0.0	0.1	0.0	0.0	0.0	0.9
KHDRBS3	"Etle, etoile, SALP, SLM-2, SLM2, T-STAR"	ENSG00000131773	"KH RNA binding domain containing, signal transduction associated 3"	O75525	8	135457456-135656722	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 157.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 364.5;Excitatory neurons: 828.6;Inhibitory neurons: 190.8;Microglial cells: 227.7;Oligodendrocyte precursor cells: 578.6;Spermatocytes: 276.1"	"Cancer enhanced"	"Detected in all"		"glioma: 9.0"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 27.9;cerebral cortex: 50.9;hippocampal formation: 29.8;white matter: 41.1"	"Immune cell enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 87.8;RPTEC TERT1: 76.0;WM-115: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000275, HPA000500, HPA000981"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.16e-6)"	"unprognostic (6.63e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.33e-3)"	16.8	16.4	21.4	5.6	27.9	2.6	11.5	0.0	50.9	17.0	0.0	12.5	4.1	6.8	22.8	6.2	6.5	11.5	10.3	29.8	0.6	19.3	12.3	8.8	3.0	7.5	1.4	9.3	9.2	7.6	6.8	2.0	0.4	8.4	8.9	21.1	11.0	12.3	32.6	6.4	5.9	8.7	0.0	2.8	6.9	157.7	5.7	9.2	5.6	31.2	4.2	10.6	9.0	41.1	0.5	1.8	30.9	1.7	6.5	12.0	12.4	20.7	28.6	19.2	9.8	11.1	4.4	0.1	10.9	19.8	0.3	2.7	19.5	20.9	26.0	4.4	33.6	0.1	11.2	22.9	5.0	5.8	69.8	2.6	2.8	10.5	16.1	23.2	15.9	36.7	2.6	51.0	34.5	7.5	2.2	1.2	6.3	16.9	34.0	87.8	42.0	22.6	76.0	0.6	39.5	33.4	1.5	4.4	22.6	19.4	1.4	1.8	1.3	23.6	40.7	0.4	45.2	17.9	0.0	0.1	14.3	0.0	85.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	27.9	0.0	50.9	29.8	0.6	7.5	1.4	0.4	0.0	5.7	41.1	15.4	28.9	5.3	20.2	3.1	15.0	14.7	2.3	2.8	160.9	23.8	10.8	12.3	2.8	4.8	7.3	0.0	0.6	0.6	7.0	25.4	14.6	364.5	24.2	21.1	13.7	23.4	0.8	828.6	22.9	1.2	37.2	2.0	40.7	4.5	4.0	5.0	21.8	0.8	6.7	190.8	8.7	10.2	3.5	10.9	142.4	16.1	5.2	14.2	227.7	1.6	7.0	0.0	578.6	34.9	19.8	2.5	8.6	1.1	19.3	2.1	29.0	2.9	16.1	0.0	57.9	34.5	276.1	33.1	3.4	9.2	1.4	2.1	12.7	6.6	12.6
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 121.2;kidney: 104.4;liver: 180.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	4.2	3.0	4.3	1.7	2.0	7.1	5.9	2.6	1.2	4.2	112.4	3.8	0.6	2.4	4.3	1.3	1.4	4.8	3.9	104.4	180.5	1.6	1.9	5.4	4.0	3.6	9.4	2.6	1.4	0.5	5.5	1.6	1.2	1.5	4.4	1.4	3.8	2.4	121.2	1.9	3.6	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.3	4.7	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	4.2	4.3	7.1	5.9	4.8	3.9	5.4	4.0	5.5	3.6	3.8	4.7	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
KIAA0100	"BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488"	ENSG00000007202	KIAA0100	Q14667	17	28614446-28645454	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042781	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted to blood"	No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cytosol"		"HPA042781: AB_10797020"	"unprognostic (1.91e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.24e-3)"	"unprognostic (7.58e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	36.1	30.7	22.4	28.5	20.7	31.5	30.6	18.2	23.5	22.7	31.7	30.8	19.7	23.1	25.7	31.3	29.2	20.5	24.2	24.4	21.3	43.0	18.6	30.7	28.4	29.9	24.4	23.9	24.4	51.8	25.2	29.6	29.3	27.1	34.8	27.5	28.9	27.1	51.9	31.8	26.7	35.3	20.2	28.8	23.3	24.9	26.5	32.3	35.4	42.5	34.9	30.3	16.0	20.6	66.5	123.8	61.4	58.8	109.3	64.8	44.8	60.9	80.1	72.3	67.6	85.9	29.4	92.0	71.2	111.2	75.3	86.2	91.4	89.6	87.1	102.8	88.7	73.2	95.9	47.2	47.0	129.1	121.3	66.5	68.2	98.0	74.1	56.1	104.9	64.1	70.6	29.0	66.8	94.4	94.5	61.1	26.9	119.0	46.6	71.7	69.0	60.0	43.4	116.9	60.2	46.5	76.8	205.5	50.7	76.0	123.2	88.6	98.1	55.0	60.4	74.5	116.2	27.2	33.8	58.0	62.8	81.7	65.4	0.3	1.1	1.5	1.2	1.0	1.2	1.1	0.5	1.0	1.3	0.6	0.6	0.7	0.7	0.8	1.2	2.9	0.7	0.7	22.4	20.7	18.2	23.5	24.4	21.3	29.9	24.4	29.3	20.2	26.5	20.6	21.5	16.0	17.8	15.0	16.5	10.3	8.9	8.7	15.4	31.7	19.3	14.7	30.2	14.3	13.0	12.9	29.2	15.3	34.4	30.5	5.9	9.9	19.4	20.4	16.1	16.4	12.1	14.1	19.1	11.0	9.4	14.1	21.4	16.4	8.2	20.4	18.5	30.5	10.6	28.6	18.3	16.4	8.2	31.5	18.6	23.2	9.3	19.9	10.6	14.0	25.3	14.3	21.6	11.6	12.7	9.8	12.1	6.4	17.1	15.8	17.9	15.1	15.1	22.5	0.0	20.3	20.1	30.5	28.1	22.9	11.1	45.6	17.0	24.2	22.6	11.7
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646191	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.3;pituitary gland: 4.1"	"Group enriched"	"Detected in some"	8	"Astrocytes: 119.5;Early spermatids: 65.6;Excitatory neurons: 129.2;Inhibitory neurons: 72.7;Late spermatids: 96.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;A549: 2.0;GAMG: 2.1;HDLM-2: 2.4;HeLa: 1.9;SCLC-21H: 3.8;U-266/84: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.0	0.4	10.0	0.2	10.3	0.0	0.1	4.3	10.4	0.1	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.2	0.0	9.2	5.8	0.0	0.0	0.6	0.0	7.2	7.4	0.0	1.4	0.1	4.1	0.0	7.6	0.4	0.4	1.2	0.2	0.0	0.0	0.7	0.2	0.1	2.7	0.2	0.8	1.1	12.3	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.0	2.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.6	0.9	0.0	2.1	0.8	0.3	0.0	0.0	2.4	1.0	0.0	1.9	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.1	3.8	0.2	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.4	0.3	3.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	10.0	10.3	4.3	10.4	9.2	5.8	7.2	7.4	7.6	2.7	12.3	4.8	0.1	3.2	0.5	119.5	0.6	0.0	0.0	0.5	0.0	3.6	0.1	0.1	1.4	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.4	65.6	2.6	0.1	0.0	10.2	0.0	129.2	0.0	0.0	0.3	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	72.7	0.8	0.0	0.0	0.0	96.8	0.6	0.2	0.0	5.6	0.6	0.3	0.0	5.0	3.1	0.3	0.1	0.7	0.0	0.2	0.0	0.1	10.9	0.9	0.0	0.1	0.0	1.2	1.5	0.0	0.0	0.7	0.1	0.1	0.3	0.3
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324152-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.9;Endometrial ciliated cells: 41.8;Late spermatids: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: AB_2670571, HPA061066: AB_2684423"	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.1	8.1	5.3	0.7	5.8	2.4	3.7	14.2	5.2	2.3	10.5	2.5	1.8	3.0	6.2	2.3	5.8	3.1	1.7	5.3	8.7	9.2	5.5	3.0	0.2	4.1	5.0	8.6	9.1	11.6	6.3	1.2	3.9	2.9	1.3	15.0	2.8	2.6	1.5	5.8	1.1	2.9	3.7	0.6	11.1	22.3	6.0	3.2	3.6	1.4	0.4	1.3	1.1	5.0	10.7	6.3	13.2	12.4	0.4	0.3	2.9	2.8	3.3	6.5	7.5	2.8	5.5	0.1	3.0	0.7	11.0	6.1	18.1	5.6	5.4	0.9	10.1	0.2	9.7	2.5	2.3	1.9	0.4	1.5	9.5	6.0	7.0	7.7	0.2	5.8	4.4	0.2	0.6	3.8	6.0	4.0	0.6	2.6	1.5	2.2	0.5	0.0	13.8	1.3	38.1	13.6	4.8	12.5	4.0	9.0	11.8	1.5	0.0	0.8	3.2	1.8	4.2	6.2	14.6	0.1	2.4	0.5	2.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	5.8	14.2	5.2	5.3	8.7	4.1	5.0	3.9	3.7	6.0	5.0	1.5	6.4	2.7	7.5	1.4	9.7	5.1	3.5	17.6	17.8	13.3	8.1	3.7	5.7	3.7	3.7	27.1	2.3	0.9	0.9	5.9	5.0	87.9	41.8	2.2	1.6	8.4	0.8	22.4	2.9	1.2	2.1	11.2	13.3	1.3	8.3	0.4	5.6	0.5	11.8	25.9	1.5	0.0	0.0	0.4	65.4	2.8	0.4	3.6	1.0	0.1	5.7	0.0	12.1	13.1	3.9	1.7	0.4	3.2	3.0	0.2	10.0	25.9	16.3	6.6	5.7	2.1	28.8	11.9	4.7	8.7	0.7	1.2	7.6	1.6	2.0
KIAA0930	"bK268H5.C22.1, C22orf9"	ENSG00000100364	KIAA0930	Q6ICG6	22	45192244-45240894	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 211.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 132.2;Excitatory neurons: 139.6;Oligodendrocytes: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 11.0;eosinophil: 8.6;intermediate monocyte: 13.9;myeloid DC: 12.1;non-classical monocyte: 17.3;plasmacytoid DC: 10.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 12.1;granulocytes: 8.6;monocytes: 17.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 327.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038091	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Mitochondria"	Nucleoplasm	"HPA038091: AB_10675627"	"unprognostic (4.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (6.90e-8)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavorable (8.95e-7)"	"unprognostic (6.89e-3)"	"unprognostic (5.32e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.15e-1)"	33.9	58.3	195.7	27.7	209.3	24.7	25.9	163.3	211.9	46.0	130.3	29.4	14.6	24.0	40.4	34.5	18.2	16.0	18.1	184.1	189.1	23.8	48.4	24.8	29.0	182.8	192.6	13.6	20.1	18.5	19.2	12.0	179.8	29.1	11.2	3.5	26.7	24.7	33.8	64.0	21.4	15.2	170.4	38.7	18.6	26.2	193.6	20.4	18.4	13.1	22.3	44.0	35.6	210.3	49.6	31.5	19.1	38.3	64.1	30.2	19.2	26.9	26.8	28.2	24.1	29.5	26.5	33.2	39.2	42.8	22.5	54.5	29.5	118.6	10.7	35.6	46.4	0.1	42.0	34.3	25.7	89.4	19.7	17.1	59.2	27.3	45.3	21.5	26.8	23.9	11.7	53.1	17.4	56.9	40.0	82.8	18.9	35.8	26.5	48.1	12.9	110.7	42.6	29.7	15.9	28.4	42.5	57.6	75.5	36.8	28.1	327.8	36.5	29.0	50.6	39.7	15.7	44.9	32.9	32.1	34.0	133.7	30.3	0.8	11.0	8.6	2.3	13.9	1.6	2.3	0.9	2.6	12.1	1.8	0.9	1.6	2.5	1.9	17.3	10.0	2.0	3.7	195.7	209.3	163.3	211.9	184.1	189.1	182.8	192.6	179.8	170.4	193.6	210.3	11.4	6.4	8.8	132.2	9.9	52.8	18.6	22.7	6.8	7.3	13.9	13.5	11.5	12.8	11.8	18.4	6.2	2.0	24.9	16.2	0.0	18.6	2.9	11.6	9.3	9.7	10.7	23.1	139.6	20.7	6.5	32.7	4.6	19.5	2.5	3.8	17.5	23.3	67.5	5.0	56.7	10.0	14.2	71.1	50.0	10.8	10.8	59.8	44.4	24.4	68.5	6.5	13.4	16.1	152.9	18.0	13.7	14.7	11.2	25.6	15.7	13.8	9.3	5.9	0.0	10.2	10.9	7.5	4.4	15.2	57.3	2.7	9.3	5.3	12.8	23.1
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	9.2	7.4	3.6	4.9	4.5	4.4	8.2	3.9	4.7	7.7	2.1	8.9	4.5	10.4	3.5	6.5	7.8	5.4	9.8	3.4	4.0	7.0	4.9	5.7	6.4	4.4	4.3	11.0	7.5	8.1	4.7	6.4	4.4	9.0	5.1	5.8	7.0	6.2	17.4	7.0	6.5	7.4	3.7	6.4	7.0	3.1	4.1	9.2	8.4	9.0	7.2	8.1	6.5	6.0	8.3	5.3	14.7	10.2	9.8	15.1	7.3	9.3	13.1	11.7	11.9	5.3	7.2	20.2	6.9	9.8	5.6	5.6	17.5	9.9	15.4	11.2	5.9	14.7	9.6	6.5	6.7	18.6	9.9	10.9	11.7	12.0	11.3	13.0	9.9	12.3	21.2	10.8	11.6	4.7	20.9	13.1	13.9	8.7	6.8	8.5	14.0	11.5	7.5	7.0	7.3	12.5	10.9	8.3	7.5	9.8	13.9	15.8	11.5	6.5	5.8	17.2	10.7	6.9	21.1	12.1	12.0	17.8	9.7	2.6	2.3	4.0	2.8	2.5	2.4	2.5	2.4	2.2	2.2	2.3	2.5	2.4	2.3	3.1	3.8	1.5	2.1	1.9	3.6	4.5	3.9	4.7	3.4	4.0	4.4	4.3	4.4	3.7	4.1	6.0	35.8	38.5	39.4	5.9	32.9	34.5	31.6	44.1	25.0	20.0	24.5	24.0	28.4	32.9	43.6	23.9	8.4	40.6	32.5	18.8	68.4	45.5	245.7	29.0	32.4	34.6	15.6	27.3	5.4	62.6	55.8	28.9	18.3	29.3	38.6	17.6	37.1	26.4	35.0	15.2	6.0	24.6	26.4	42.9	27.3	84.4	37.6	30.3	14.2	5.6	37.7	44.8	41.2	5.5	10.1	48.9	24.0	49.2	19.1	51.0	23.5	45.2	30.5	14.0	0.0	43.3	28.3	53.8	40.5	22.3	27.8	57.2	35.3	25.7	25.7	46.7
KIAA1586		ENSG00000168116	KIAA1586	Q9HCI6	6	57046532-57055239	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.0;Erythroid cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036370	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA036370: AB_10672219"	"unprognostic (7.17e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.64e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.07e-1)"	4.1	4.8	2.0	3.6	2.4	8.6	5.4	9.4	3.7	4.6	0.0	2.9	2.1	6.1	3.7	3.3	2.8	4.6	3.5	2.3	3.0	3.6	4.9	2.7	4.6	2.9	2.4	7.6	2.8	5.2	3.7	9.4	2.8	5.2	2.6	4.0	2.7	3.6	1.6	2.5	2.4	4.4	1.4	4.5	2.1	8.0	2.8	5.9	5.7	3.4	3.9	4.8	2.6	2.6	8.6	3.5	21.9	25.1	8.5	13.7	12.0	14.1	11.6	12.0	14.4	5.9	2.7	3.4	11.4	10.4	10.6	4.2	16.7	8.3	16.4	10.7	12.7	35.9	8.0	13.3	11.1	29.0	12.7	10.1	5.9	10.6	11.7	8.5	11.5	9.1	49.9	2.7	14.4	6.8	14.0	17.5	14.2	3.0	5.0	12.8	16.0	8.4	8.0	17.6	18.5	16.8	9.3	3.0	10.6	15.1	7.2	26.0	9.4	18.6	7.7	17.9	10.2	10.9	15.4	16.8	11.5	21.0	7.7	0.2	2.5	2.0	2.3	2.0	2.7	3.7	3.4	3.0	3.9	3.1	4.2	3.6	0.1	5.3	2.0	4.0	4.4	1.9	2.0	2.4	9.4	3.7	2.3	3.0	2.9	2.4	2.8	1.4	2.8	2.6	15.4	9.6	6.3	10.4	8.8	10.5	4.5	13.0	13.1	15.4	7.4	11.7	23.1	1.5	7.8	7.3	2.1	43.3	11.7	1.0	11.7	7.0	87.0	4.6	29.6	12.5	5.4	74.9	32.4	5.4	33.2	21.4	3.1	3.2	13.3	30.5	8.2	4.0	12.5	10.1	32.7	2.4	6.1	6.6	7.1	21.9	12.8	8.9	3.6	12.2	9.7	9.6	15.5	23.6	24.4	2.8	0.9	14.7	13.0	2.3	0.7	14.6	8.4	8.2	19.7	19.5	17.6	23.4	17.9	8.7	4.4	10.7	10.6	29.5	3.2	1.6
KIAA2026	FLJ20375	ENSG00000183354	KIAA2026	Q5HYC2	9	5881596-6008482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002109	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytosol"	Nucleoplasm	"HPA002109: AB_1078071"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.41e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (8.34e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	6.8	5.1	13.5	5.6	17.2	6.4	6.2	24.1	11.7	7.8	25.1	6.4	4.8	7.9	5.8	6.1	6.4	5.7	5.7	9.9	12.1	6.1	4.9	5.9	6.7	11.6	13.3	10.2	5.2	8.6	6.2	6.9	11.9	6.2	5.0	10.4	6.1	5.4	9.5	8.2	5.6	6.3	10.3	8.1	6.5	11.5	12.6	8.3	8.4	9.5	5.9	6.2	7.1	17.0	7.1	3.5	7.2	4.6	5.4	8.5	3.2	4.6	6.8	4.4	4.0	2.3	4.0	8.8	1.7	5.8	5.5	3.5	4.2	3.9	6.5	19.2	3.0	26.5	8.4	3.7	4.2	9.4	11.6	5.3	5.0	3.9	6.4	8.3	6.9	5.7	2.8	16.2	5.5	2.2	5.1	17.2	4.0	4.1	2.8	5.3	4.6	4.5	4.8	4.9	9.3	5.3	4.3	4.0	3.7	4.9	4.1	12.6	7.8	8.4	4.7	4.2	5.3	11.1	9.5	8.8	4.3	4.3	2.3	5.0	2.3	7.0	4.2	1.9	4.8	5.9	4.1	3.8	0.9	3.8	4.5	4.8	6.0	4.8	4.5	2.9	2.6	0.8	13.5	17.2	24.1	11.7	9.9	12.1	11.6	13.3	11.9	10.3	12.6	17.0	47.8	44.8	34.0	99.9	40.3	44.6	29.9	21.4	37.5	89.0	33.5	25.5	53.7	42.9	22.1	38.6	79.2	17.1	51.9	31.0	7.9	18.2	33.0	28.3	40.9	39.7	38.5	18.7	97.8	13.4	10.6	33.2	31.1	46.7	20.2	43.5	29.3	18.7	16.9	45.4	119.1	34.7	16.2	25.5	28.8	17.2	70.5	31.9	23.2	113.4	55.1	47.7	95.8	116.1	170.1	18.4	29.1	76.3	35.4	34.4	30.1	11.9	18.2	81.5	46.0	45.8	40.1	127.7	121.2	38.3	52.4	30.0	45.1	38.7	28.5	42.0
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92574105-92655395	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.4;lymphoid tissue: 37.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	1.1	0.7	0.5	8.5	0.7	19.4	2.5	0.4	0.6	1.4	0.5	6.3	5.5	1.8	1.0	6.7	1.0	1.2	0.6	0.5	0.5	1.0	1.1	1.3	17.5	0.6	0.6	0.6	0.5	0.7	0.3	3.9	0.6	1.0	7.4	0.8	1.3	0.7	0.2	6.0	5.3	2.5	0.5	2.9	3.9	11.6	0.4	37.9	1.6	0.3	18.5	2.3	2.3	0.6	103.1	45.2	100.6	94.5	7.3	10.5	24.2	72.6	62.8	78.8	78.1	39.6	67.2	111.1	36.5	34.4	32.9	72.0	72.1	36.5	92.4	68.3	41.3	70.5	41.4	42.4	1.4	116.0	63.0	3.6	3.3	61.4	55.9	18.3	50.0	46.1	51.2	126.4	61.1	41.4	99.3	65.8	40.3	42.5	30.7	106.6	98.8	40.2	21.0	30.1	30.0	42.9	56.4	25.9	29.2	34.1	67.9	37.6	28.6	35.7	51.3	37.1	96.9	35.4	58.3	113.4	29.5	82.3	50.3	0.8	0.0	0.1	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.1	0.2	0.2	1.0	0.1	0.1	1.1	0.2	0.5	0.7	0.4	0.6	0.5	0.5	0.6	0.6	0.6	0.5	0.4	0.6	0.4	0.0	2.0	1.3	3.5	2.9	1.1	1.6	3.4	1.0	1.8	1.8	1.7	1.5	2.5	1.8	0.0	6.7	2.3	2.9	1.9	0.5	16.3	3.4	4.3	2.0	0.0	39.1	2.1	0.6	11.4	4.7	9.2	4.9	0.0	20.7	2.2	0.4	8.2	0.0	1.8	4.3	4.1	4.6	3.4	4.4	0.9	4.0	0.0	0.0	1.0	0.7	2.1	2.5	1.1	0.2	0.4	0.7	15.2	0.8	0.5	0.6	3.7	0.4	0.0	1.7	3.7	38.0	23.4	12.6	3.3	1.5	4.5	2.5	8.0	1.7
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.1;Granulosa cells: 13.2;Spermatocytes: 22.8;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"		Yes	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.2	0.2	0.1	2.0	0.0	6.5	0.3	0.2	0.3	0.2	0.1	0.9	1.2	0.3	0.0	1.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.2	3.2	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.2	0.1	0.1	0.0	0.0	1.0	1.1	0.6	0.0	0.6	0.6	2.5	0.1	10.9	0.1	0.0	3.2	0.4	0.3	0.1	29.7	17.3	26.8	15.0	0.8	3.0	14.8	20.0	11.7	18.7	16.8	10.5	15.1	18.0	7.0	9.6	11.6	23.0	21.6	13.3	26.7	22.1	11.3	28.8	24.8	10.3	0.1	45.5	15.7	0.6	0.6	20.9	17.8	4.0	13.5	26.3	44.0	22.6	23.5	12.1	26.9	14.2	22.6	8.7	15.0	24.3	35.4	22.8	6.3	8.3	12.7	14.0	28.3	9.5	11.0	19.8	12.9	11.6	11.1	14.7	17.3	16.2	35.3	8.2	8.9	25.8	8.6	24.0	30.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.0	1.9	2.4	1.0	1.1	0.6	2.3	1.5	1.9	0.8	0.0	0.9	0.0	2.1	4.2	0.6	2.5	0.0	0.2	4.1	3.7	2.2	1.6	0.0	27.1	1.1	0.0	7.7	3.3	10.2	5.0	2.5	13.2	2.5	0.9	5.4	0.0	0.9	5.2	0.0	2.9	1.9	2.5	0.6	2.3	0.0	0.0	0.4	0.5	0.0	0.5	0.8	0.3	0.0	0.7	11.3	1.2	0.2	0.1	1.4	0.8	6.6	1.4	2.1	22.8	16.3	8.3	0.9	1.4	2.3	0.7	4.3	1.9
KIF18A	"DKFZP434G2226, PPP1R99"	ENSG00000121621	"Kinesin family member 18A"	Q8NI77	11	28020619-28108156	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 8.2;lymphoid tissue: 9.6;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.1;Spermatocytes: 78.7;Spermatogonia: 28.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.1;memory B-cell: 1.0;NK-cell: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039312, HPA039484"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Cytokinetic bridge"		"HPA039312: AB_10794087, HPA039484: AB_10795252"	"unprognostic (3.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.09e-3)"	"unprognostic (3.80e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.72e-4)"	"unprognostic (4.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.50e-1)"	0.2	0.1	0.0	1.9	0.1	8.2	0.7	0.0	0.1	0.7	0.1	1.6	1.5	0.5	0.3	1.4	0.3	0.5	0.0	0.1	0.1	0.3	0.3	1.0	4.7	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.1	0.3	2.0	0.6	0.3	0.4	0.2	1.2	1.4	0.8	0.1	0.7	0.6	13.7	0.2	9.6	1.1	0.1	4.6	0.7	0.5	0.1	27.9	27.4	27.2	19.0	0.9	3.7	9.1	28.3	13.2	44.2	46.0	9.2	11.0	23.3	10.0	14.7	24.1	27.2	23.4	11.1	61.4	23.4	14.2	15.2	17.8	11.8	2.1	22.6	13.4	6.8	1.4	15.5	18.1	7.8	17.2	19.0	24.6	20.0	25.2	14.8	23.1	16.7	13.4	18.0	11.1	17.8	65.0	11.6	12.5	8.0	16.3	12.6	23.7	11.1	7.8	16.5	23.8	6.9	10.1	35.0	27.2	33.2	37.4	7.9	19.8	23.4	21.0	16.5	25.2	4.1	0.0	0.3	0.1	0.2	0.3	1.0	0.4	0.2	0.3	0.4	0.3	0.1	0.0	1.4	0.0	0.3	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.2	3.2	0.0	0.0	4.7	2.3	1.3	1.4	1.2	0.3	1.3	2.9	0.5	0.0	2.2	0.0	6.2	4.6	2.8	1.9	0.0	0.6	43.1	3.4	2.5	1.1	1.8	15.4	0.2	0.9	7.1	5.4	1.5	3.4	4.5	9.7	1.4	0.0	2.2	0.0	0.1	1.9	0.0	1.6	1.4	8.7	0.6	1.4	0.0	1.0	1.1	0.7	1.0	0.5	0.9	0.5	0.1	0.4	5.1	0.2	0.2	0.6	1.7	1.9	0.0	2.5	1.9	78.7	28.3	4.3	1.0	1.6	3.9	2.7	3.6	0.5
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947773	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.4	0.4	0.3	3.8	0.4	12.7	0.2	0.7	0.3	0.9	0.3	2.0	2.7	0.4	0.0	5.1	0.2	0.4	0.3	0.3	0.4	0.2	0.4	0.8	5.7	0.5	1.1	0.1	0.1	0.0	0.1	1.9	0.6	0.2	1.7	0.1	0.7	0.0	0.4	3.0	2.5	1.1	0.3	2.9	1.5	2.9	0.6	14.4	0.2	0.0	4.7	0.6	1.6	0.5	31.5	41.7	35.3	32.8	0.8	3.0	28.1	25.8	10.3	34.6	26.9	34.0	27.4	28.3	10.9	10.8	21.5	34.0	25.1	11.3	17.9	56.6	36.4	35.4	51.7	22.1	0.0	30.0	30.2	0.7	0.6	29.7	12.2	4.7	17.9	29.2	28.1	48.0	18.2	25.9	60.0	31.1	25.4	30.4	28.9	43.5	51.8	19.2	5.8	16.7	26.2	24.7	18.0	16.1	9.8	17.0	30.2	21.6	11.2	49.9	48.0	28.8	56.8	15.1	15.7	34.4	16.3	22.9	33.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.7	0.3	0.3	0.4	0.5	1.1	0.6	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.2	0.0	0.5	0.5	0.4	2.6	0.0	0.0	0.0	0.0	2.4	0.4	1.9	0.0	0.0	0.0	0.3	0.8	0.6	0.0	9.0	0.3	0.0	3.8	1.4	1.5	0.5	0.0	5.9	0.4	0.3	2.3	0.0	0.3	1.6	0.0	2.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	7.1	0.1	0.1	0.0	0.0	2.1	0.2	0.3	0.0	0.0	0.3	0.0	0.2	0.8	1.1	2.9	2.5	0.4	0.8	1.3	0.3	3.2	0.3
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701590-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.2;lymphoid tissue: 9.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 89.2;Spermatocytes: 165.4;Spermatogonia: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050214	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA050214: AB_2681053"	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	1.3	0.7	0.3	4.5	1.0	10.2	2.5	2.4	0.4	1.5	0.1	3.2	3.6	2.3	0.4	3.3	1.2	1.3	0.9	0.3	0.3	1.3	1.3	1.5	8.0	0.5	0.3	2.7	0.7	1.1	0.2	2.4	0.6	1.3	4.0	1.1	1.0	0.9	0.4	2.5	3.4	2.2	0.4	3.3	2.5	6.9	0.6	9.8	1.8	0.7	7.5	1.6	0.7	0.6	84.8	17.0	24.3	21.7	4.7	8.0	20.2	33.8	30.9	34.8	36.3	22.6	38.1	32.5	10.4	17.3	13.0	41.8	27.3	18.9	46.4	39.5	18.6	33.1	30.5	19.5	1.4	57.1	26.3	3.4	2.8	33.7	33.9	12.2	22.8	17.0	32.2	36.5	31.3	14.6	33.6	10.8	25.0	13.8	16.1	23.1	47.8	14.3	10.7	11.2	7.7	13.9	24.4	11.0	12.2	17.3	28.5	16.3	17.9	22.2	22.1	29.1	55.3	10.1	29.5	43.2	21.1	49.4	16.8	13.1	2.4	4.2	5.5	4.1	6.8	13.0	7.4	6.1	1.3	16.0	8.6	8.0	0.2	3.0	4.5	5.2	9.5	2.2	0.3	1.0	2.4	0.4	0.3	0.3	0.5	0.3	0.6	0.4	0.6	0.6	11.5	3.2	13.5	2.3	36.4	17.7	6.2	20.8	6.8	14.3	8.3	8.5	8.7	1.5	10.7	0.0	10.4	21.4	32.3	8.8	3.9	6.9	13.1	10.6	13.2	11.0	1.2	89.2	8.1	4.7	38.1	13.2	14.8	12.9	44.4	37.2	9.3	4.4	20.7	13.5	9.5	8.6	16.2	21.0	17.9	10.5	8.1	17.1	5.4	23.4	11.3	7.5	24.7	9.0	9.1	4.1	5.7	8.6	51.4	3.7	8.9	3.2	6.6	9.8	6.6	16.9	17.1	165.4	96.7	26.1	14.1	5.2	34.2	12.9	25.5	5.2
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	1.6	0.8	16.1	9.4	16.4	34.1	1.3	0.0	16.5	0.9	0.0	2.4	2.0	0.7	0.4	0.8	1.2	2.1	0.7	21.6	8.3	0.9	1.5	4.8	12.9	5.9	5.7	0.7	0.8	6.0	0.6	0.9	6.5	0.8	1.8	21.4	1.4	0.7	0.3	0.7	6.7	0.8	1.5	12.3	2.5	13.7	9.5	11.8	1.0	0.4	8.0	2.3	0.8	7.9	1.3	1.5	11.8	0.5	0.0	0.0	3.0	0.1	0.0	0.3	0.1	0.7	0.4	39.1	0.5	0.0	3.4	0.3	1.2	0.3	0.4	1.9	0.4	9.7	0.2	0.2	1.0	29.4	41.0	1.0	4.1	0.4	0.7	0.0	1.5	78.8	4.6	49.6	0.0	0.2	24.5	11.2	5.2	3.9	0.0	8.4	0.1	43.8	0.2	0.0	7.2	1.0	0.6	0.5	0.6	2.1	0.2	8.9	2.8	0.0	3.3	0.0	0.2	90.2	44.7	19.3	3.9	12.8	0.3	6.0	0.0	0.6	0.8	0.2	0.9	0.4	0.6	0.8	0.1	0.3	0.5	0.6	1.0	1.3	0.3	0.1	0.6	0.4	16.1	16.4	0.0	16.5	21.6	8.3	5.9	5.7	6.5	1.5	9.5	7.9	1.5	0.0	3.8	22.5	11.0	1.0	0.5	0.2	0.0	25.7	0.4	0.8	1.5	0.0	0.1	1.8	58.4	0.0	17.4	1.2	0.0	0.5	20.4	0.1	0.2	1.8	0.0	4.8	15.6	1.6	0.1	0.6	1.1	0.4	6.3	0.5	1.4	0.3	1.7	1.7	11.8	1.4	0.0	4.4	3.1	82.1	0.9	5.3	0.0	8.4	2.7	20.0	13.4	14.6	4.0	2.4	0.3	0.0	12.0	0.4	0.2	0.0	0.1	26.1	6.6	0.6	1.1	1.9	3.7	0.1	1.0	0.0	18.0	0.1	1.1	2.0
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	13	"granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.0	1.5	0.3	5.7	0.2	21.6	1.4	0.2	0.3	1.5	1.4	4.1	3.9	2.0	0.1	5.3	0.9	1.3	0.6	0.3	0.2	4.6	0.5	1.5	7.9	0.2	0.3	0.7	0.5	0.4	0.1	6.4	0.3	0.9	5.0	0.2	1.1	1.2	0.1	3.7	3.8	4.2	0.2	2.2	2.0	10.6	0.3	15.9	0.3	0.2	9.8	1.8	2.1	0.2	100.7	81.5	64.2	59.0	3.7	7.3	36.3	105.3	57.0	154.8	120.6	50.2	72.4	56.8	31.4	53.1	78.6	110.5	121.6	39.5	158.7	52.9	60.2	55.3	78.8	30.7	2.1	55.6	48.3	3.3	4.2	71.8	60.5	19.4	52.0	46.9	36.0	70.2	95.4	44.1	31.2	28.2	71.6	35.5	33.2	37.0	133.8	31.2	39.3	49.7	32.5	25.3	120.4	51.9	44.9	74.5	50.6	25.3	34.5	90.0	120.8	62.0	157.6	26.3	74.3	48.4	31.5	72.2	78.0	0.0	1.2	4.6	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.4	0.0	0.5	0.0	2.3	1.9	3.7	4.2	0.0	0.2	1.8	2.8	0.8	5.7	4.7	7.3	2.1	24.2	1.4	3.3	3.9	1.8	13.3	13.1	3.6	2.2	1.8	42.3	1.8	0.0	32.4	5.8	3.6	8.7	2.5	22.4	3.9	0.3	8.1	0.0	1.0	3.1	0.0	2.8	3.4	4.8	0.9	3.2	0.0	1.0	8.1	0.2	0.0	0.0	0.2	0.4	0.4	1.9	6.8	1.6	0.8	0.9	3.6	0.1	6.6	0.4	8.2	70.8	20.9	11.3	1.0	2.5	4.2	3.6	8.6	3.3
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62391025	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome		Yes	No		300000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: AB_2667215, HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.9	7.7	15.6	23.2	20.7	12.8	10.8	15.5	17.7	19.5	0.0	13.8	11.5	12.0	6.3	12.5	17.6	12.9	6.2	17.4	23.0	8.0	5.3	9.8	32.8	17.9	17.5	12.9	10.2	12.3	8.5	16.9	18.4	9.9	14.7	42.7	6.9	11.4	4.8	5.9	15.9	13.1	14.6	18.4	9.6	49.1	16.1	43.6	12.6	6.8	28.9	20.2	7.2	28.0	47.3	46.9	81.4	67.3	28.8	39.6	65.2	51.2	38.5	54.6	67.5	53.1	49.6	111.9	53.3	41.9	67.2	29.1	61.3	37.7	72.5	116.8	44.2	113.8	41.2	27.8	34.7	65.3	42.9	30.5	26.6	50.1	47.5	33.1	49.1	66.5	86.6	66.7	46.9	36.1	104.4	33.1	42.6	12.0	31.9	78.3	59.6	65.3	25.4	55.4	68.0	55.9	67.0	27.9	34.7	55.3	37.6	38.5	39.8	31.9	52.2	40.5	51.3	64.8	94.9	114.1	36.4	74.5	39.8	10.4	4.6	4.7	29.2	5.0	35.3	13.5	29.8	32.7	6.2	10.5	26.3	29.0	7.8	23.2	3.3	9.6	42.3	17.7	15.6	20.7	15.5	17.7	17.4	23.0	17.9	17.5	18.4	14.6	16.1	28.0	30.8	16.0	14.1	54.5	44.1	16.8	41.4	20.1	39.3	45.5	17.9	23.9	9.4	4.3	20.5	20.2	104.3	20.3	73.4	23.1	13.7	37.5	113.8	103.3	47.2	21.4	21.0	42.3	56.7	30.9	22.6	28.2	20.4	43.4	17.7	25.6	19.6	4.4	15.4	52.2	64.5	7.9	14.2	12.9	22.1	130.7	13.1	83.6	12.4	26.2	104.9	28.0	76.2	119.6	156.0	26.6	26.1	13.2	47.8	42.7	13.5	18.7	49.2	92.9	26.3	33.1	25.4	118.9	42.8	34.3	9.5	43.9	77.9	48.9	11.0	56.1
KIF2B		ENSG00000141200	"Kinesin family member 2B"	Q8N4N8	17	53822927-53825193	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	508	"testis: 75.3"	"Group enriched"	"Detected in some"	68	"Early spermatids: 744.0;Late spermatids: 623.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023081, HPA023103, HPA024795"	Uncertain		Supported	"Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Nucleoli	"HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	744.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	623.2	6.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	10.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.7	0.8	0.7	7.0	0.7	33.0	1.6	2.3	0.7	1.8	1.1	6.2	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.6	1.1	0.8	0.7	1.3	16.4	1.1	0.9	0.6	0.5	1.3	0.4	5.4	1.4	0.8	7.6	0.8	1.3	0.7	0.9	6.0	5.1	3.2	0.9	3.7	3.5	76.5	0.8	37.4	1.1	0.7	19.2	2.1	2.7	0.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	0.7	0.7	2.3	0.7	0.6	1.1	1.1	0.9	1.4	0.9	0.8	0.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290104-70420886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.6;Erythroid cells: 29.5;Extravillous trophoblasts: 11.5;Granulosa cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.3	0.3	0.3	3.2	0.2	11.2	0.7	0.1	0.3	0.6	0.3	3.7	3.1	0.8	0.0	3.6	1.5	0.5	0.2	0.2	0.5	0.2	0.5	0.5	5.5	0.9	0.7	0.1	0.1	0.1	0.5	2.3	0.6	0.1	4.5	0.6	0.5	0.1	0.1	2.2	3.3	1.3	0.7	2.4	1.7	1.5	0.6	12.6	0.2	0.0	6.6	0.9	1.1	0.2	60.2	41.1	61.0	30.1	2.9	5.1	24.0	44.7	23.8	59.7	51.6	46.7	34.3	36.7	27.4	22.1	46.2	35.1	66.6	24.2	66.8	42.5	33.4	41.7	50.1	33.4	0.7	46.7	27.8	1.7	1.5	49.6	28.2	7.3	37.0	27.7	53.8	79.1	57.0	38.7	43.0	23.1	61.7	63.8	43.2	47.1	82.2	34.6	14.5	23.4	40.1	33.5	72.9	30.5	18.6	30.6	24.5	18.1	26.0	39.3	50.6	42.6	54.1	22.6	41.7	52.0	20.8	50.4	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.1	0.3	0.2	0.5	0.9	0.7	0.6	0.7	0.6	0.2	0.1	0.0	0.5	1.3	1.3	1.8	0.3	1.4	0.6	0.2	1.1	0.8	0.4	1.5	0.2	0.0	0.0	7.0	0.9	2.2	0.0	0.0	0.4	18.6	1.5	1.3	1.2	29.5	1.9	0.0	11.5	2.1	3.1	1.6	0.0	12.2	1.1	0.1	5.3	0.0	1.9	4.6	2.0	1.3	0.7	0.8	0.0	1.4	0.0	0.0	0.2	3.1	0.0	2.0	0.7	0.1	0.1	0.0	8.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	2.9	8.7	5.4	7.2	0.3	1.8	1.8	1.3	6.6	0.5
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018141	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 3.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Early spermatids: 5.4;Late spermatids: 4.3;Spermatocytes: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57546026-57586633	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease variant, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"brain: 1628.2;choroid plexus: 951.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.7;Early spermatids: 12.2;Endometrial stromal cells: 12.9;Excitatory neurons: 28.4;Horizontal cells: 26.9;Inhibitory neurons: 21.7;Late spermatids: 15.2;Rod photoreceptor cells: 11.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.2;K-562: 15.3;NTERA-2: 17.7;SCLC-21H: 34.4;U-87 MG: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: AB_2686601"	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	0.4	10.6	1198.6	4.6	1243.7	4.2	0.5	1056.4	1628.2	2.5	951.3	4.5	3.6	3.8	1.4	1.4	0.6	0.7	0.6	1242.7	1056.4	0.8	0.2	0.8	0.7	1103.5	1046.7	0.6	2.6	9.0	21.3	0.1	1113.3	0.9	1.9	48.0	1.1	0.6	0.3	1.1	2.5	2.0	1002.7	0.8	1.3	4.8	1052.3	0.1	2.3	0.1	0.4	0.5	1.5	1313.2	0.5	0.1	7.2	5.7	0.0	0.0	0.6	1.4	1.3	2.2	3.5	1.2	0.2	3.2	0.4	1.9	1.3	0.8	3.8	0.1	2.5	33.2	4.1	0.5	1.8	7.0	1.9	1.5	1.3	1.0	0.4	1.6	0.1	0.5	0.5	2.8	15.3	9.4	0.0	0.6	0.8	0.0	17.7	0.0	0.0	0.5	0.2	0.3	1.1	0.5	34.4	9.1	0.0	1.6	0.0	2.0	0.9	0.2	0.9	0.6	5.3	1.1	2.1	5.3	7.7	1.9	14.5	0.1	0.6	0.2	0.4	0.1	1.0	0.5	1.6	0.7	0.7	1.2	0.3	0.5	0.9	2.2	1.1	0.3	1.1	0.3	1.0	0.4	1198.6	1243.7	1056.4	1628.2	1242.7	1056.4	1103.5	1046.7	1113.3	1002.7	1052.3	1313.2	0.1	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	40.7	0.1	0.9	2.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	12.2	0.5	12.9	0.7	0.0	0.4	28.4	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	26.9	21.7	0.2	0.0	0.0	0.2	15.2	0.0	0.1	0.0	0.0	0.0	6.4	0.0	8.5	3.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.7	3.3	7.9	0.0	0.1	0.0	0.3	0.0	0.1	0.1
KIF5C		ENSG00000168280	"Kinesin family member 5C"	O60282	2	148875227-149026759	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 252.2;Early spermatids: 568.4;Excitatory neurons: 267.2;Inhibitory neurons: 249.1;Late spermatids: 702.5;Oligodendrocytes: 270.7"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7;prostate cancer: 19.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035210, HPA062272"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA035210: AB_10671931, HPA062272: AB_2732678"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.70e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.55e-6)"	"unprognostic (8.34e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.46e-2)"	0.5	5.1	41.3	0.6	17.6	0.0	0.5	13.9	65.2	1.4	0.0	1.1	0.3	0.5	3.7	0.1	0.9	0.1	0.6	28.9	13.7	0.2	0.0	0.2	0.3	15.4	9.0	1.6	2.3	0.3	5.5	0.0	24.6	10.4	0.6	7.8	0.2	2.8	0.3	0.3	0.8	0.4	16.3	0.2	0.6	12.1	49.8	0.1	1.3	0.9	0.2	0.6	1.4	32.0	0.0	0.0	17.8	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.2	0.0	0.7	0.0	0.2	5.4	0.0	14.1	0.0	1.3	13.7	3.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.7	0.0	0.7	0.0	0.1	0.0	0.8	0.0	0.0	22.4	0.0	9.2	0.0	0.1	0.1	0.0	3.6	117.1	27.1	0.2	0.5	0.2	2.8	0.0	0.0	0.0	0.0	3.3	0.0	3.7	3.0	0.4	0.0	8.8	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	17.6	13.9	65.2	28.9	13.7	15.4	9.0	24.6	16.3	49.8	32.0	1.8	0.0	0.0	33.6	2.4	1.3	6.1	0.1	2.2	252.2	8.0	3.7	14.9	4.3	0.0	18.4	108.4	0.0	0.8	1.1	0.0	0.3	568.4	0.9	1.6	6.1	129.7	0.0	267.2	0.0	0.1	4.9	2.0	0.2	0.0	1.1	0.7	0.0	0.2	99.3	249.1	2.7	4.1	0.3	1.9	702.5	8.1	0.8	5.4	10.3	0.8	8.5	2.1	125.2	270.7	0.9	3.4	12.8	1.7	35.8	0.1	0.1	0.0	15.1	6.6	1.6	9.1	15.8	10.7	0.2	0.4	0.0	11.9	0.3	4.9	2.3
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 114.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 20.3;NK-cells: 13.1"	"Group enriched"	"Detected in many"	13	"HEL: 247.2;HMC-1: 496.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		49000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	6.6	1.8	8.2	5.3	6.3	6.4	114.9	21.4	6.5	17.6	5.1	13.5	9.2	9.6	5.9	13.0	2.9	20.3	3.4	23.9	5.1	12.4	0.8	21.8	3.4	6.8	12.3	45.0	2.6	1.7	1.9	10.0	8.8	5.6	16.0	3.2	21.4	8.7	1.1	24.5	13.4	10.1	5.9	5.0	17.4	6.2	16.7	3.1	47.1	6.9	6.2	14.5	4.9	5.1	0.0	0.0	3.9	0.0	0.7	0.3	0.0	3.3	4.6	12.6	15.8	0.0	0.0	0.0	0.0	7.3	0.6	0.3	2.6	0.0	10.8	0.0	5.9	247.2	0.0	0.0	0.0	0.0	496.2	0.0	0.0	0.0	0.0	0.0	28.4	4.3	3.5	0.5	0.0	0.0	1.4	2.5	6.9	0.0	0.0	0.8	0.0	0.0	0.0	24.2	6.0	2.1	0.0	0.0	0.0	14.1	0.0	2.6	0.3	0.5	0.0	4.9	0.1	0.4	0.0	0.0	0.5	0.9	0.6	20.3	0.0	12.8	0.1	0.0	2.3	0.0	0.4	0.9	2.3	0.0	0.0	0.0	1.0	13.1	1.4	0.1	0.0	0.2	8.2	6.3	21.4	6.5	23.9	5.1	6.8	12.3	8.8	5.9	16.7	5.1	7.3	6.4	21.9	9.8	1.0	14.3	0.9	0.4	2.2	4.5	83.1	59.2	0.7	4.3	3.6	3.7	0.0	0.1	5.2	0.4	3.9	1.0	0.0	0.2	0.7	9.2	5.4	15.5	0.9	0.0	0.1	2.8	8.6	0.7	529.3	0.5	1.8	0.0	0.3	0.0	111.2	0.5	101.7	0.3	4.2	0.4	1.2	1.6	211.7	14.0	0.2	2.4	0.0	16.1	3.7	0.0	0.1	0.0	3.2	0.5	0.0	0.8	0.1	0.2	0.0	0.7	0.8	0.1	12.3	2.2	3.8	0.3	8.8	63.7	0.6	0.3
KLF11	"MODY7, TIEG2, Tieg3"	ENSG00000172059	"Kruppel like factor 11"	O14901	2	10042849-10054836	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.0;Suprabasal keratinocytes: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058276			Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Focal adhesion sites, Cytosol"	"HPA058276: AB_2683664"	"unprognostic (9.66e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.63e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.24e-2)"	27.7	15.6	4.0	7.6	3.2	27.8	22.3	8.3	3.9	13.5	4.1	17.9	7.5	20.0	9.7	13.2	13.7	18.1	19.1	2.9	3.9	15.7	35.2	22.4	9.3	3.7	3.3	23.9	54.2	18.3	2.5	19.5	3.4	10.1	9.3	3.0	15.9	14.8	12.1	26.9	8.7	16.8	3.2	18.8	12.4	30.0	3.5	4.0	16.5	27.3	5.5	12.6	13.1	5.1	6.9	3.3	7.8	0.7	5.3	9.4	18.8	7.9	7.9	4.4	4.6	7.8	15.8	0.0	13.9	9.6	17.9	1.6	6.8	6.1	2.9	47.6	5.2	3.5	9.7	1.6	5.2	14.6	22.1	14.7	22.3	8.4	2.3	11.4	3.9	1.3	9.7	30.8	4.6	8.2	0.0	2.7	12.5	5.6	6.7	7.8	0.2	13.6	10.8	8.5	10.0	6.2	12.0	24.5	23.4	12.2	5.7	19.6	11.2	19.3	15.9	14.7	2.6	27.9	36.0	18.7	5.0	3.8	10.4	0.0	8.2	2.0	2.6	12.3	0.8	3.2	1.8	1.9	7.3	2.9	0.5	1.1	0.2	6.6	14.8	0.3	3.0	5.4	4.0	3.2	8.3	3.9	2.9	3.9	3.7	3.3	3.4	3.2	3.5	5.1	58.8	6.4	4.6	0.3	12.5	60.5	17.7	5.5	25.6	6.2	14.3	13.2	3.5	10.0	6.1	7.3	6.2	3.2	10.1	2.5	29.4	8.2	135.0	9.1	21.5	33.3	7.1	4.6	1.7	8.5	4.2	17.5	9.7	26.6	8.2	15.5	37.5	38.1	12.5	3.3	1.4	7.0	16.2	32.4	42.4	25.9	14.6	22.0	30.2	1.0	16.6	2.2	3.1	0.5	0.3	8.9	1.5	16.6	5.3	15.0	6.1	8.4	4.3	5.8	32.9	10.4	35.7	13.8	39.0	13.1	86.2	8.2	10.8	11.2	7.8	11.7
KLF2	LKLF	ENSG00000127528	"Kruppel like factor 2"	Q9Y5W3	19	16324826-16328685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1043.3;B-cells: 691.8;dendritic cells: 542.9;Endothelial cells: 511.8;Gastric mucus-secreting cells: 561.7;NK-cells: 466.5;Plasma cells: 806.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 26.8;TIME: 67.8;U-266/70: 45.6;U-266/84: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055964	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA055964: AB_2682989"	"unprognostic (3.22e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.56e-2)"	153.7	27.1	25.0	61.6	23.2	90.0	108.4	15.4	18.5	59.2	10.9	55.2	9.6	61.5	2.5	32.2	105.9	14.7	118.4	13.6	17.9	41.6	13.4	110.8	45.4	27.3	34.1	152.6	12.5	5.6	28.8	22.4	24.2	41.8	5.0	0.6	35.7	6.8	52.0	65.5	44.6	19.5	14.1	70.9	73.1	18.3	27.9	13.0	53.5	20.5	8.3	86.9	63.8	15.5	7.5	1.8	0.1	1.6	0.4	1.0	2.9	16.6	1.8	5.5	1.8	0.1	24.0	0.7	3.7	6.7	0.9	2.5	0.5	0.0	1.5	0.6	2.0	0.0	1.4	0.2	4.2	0.0	12.1	1.2	0.2	1.4	0.3	7.1	10.9	14.7	0.5	15.4	2.4	0.4	1.5	3.2	0.2	7.3	2.2	0.5	4.3	26.8	0.2	0.3	0.5	0.2	0.9	12.3	10.4	0.1	0.5	8.6	67.8	12.9	9.4	1.0	23.8	45.6	49.3	1.6	5.7	0.0	5.8	63.2	8.3	25.1	42.7	32.9	34.9	44.7	56.6	43.9	3.3	47.5	53.5	44.4	79.5	28.7	29.1	0.6	59.4	20.5	25.0	23.2	15.4	18.5	13.6	17.9	27.3	34.1	24.2	14.1	27.9	15.5	1043.3	35.3	60.0	1.0	691.8	23.8	25.9	7.4	30.1	5.8	69.6	51.8	47.9	31.5	9.0	3.7	8.4	4.5	542.9	151.7	0.0	10.3	2.3	53.8	31.1	511.8	46.4	35.0	0.8	6.0	7.6	350.6	561.7	20.4	33.6	8.1	393.3	10.6	91.3	0.0	1.9	110.5	2.0	242.4	58.5	6.3	89.5	272.9	64.0	48.7	74.1	7.6	466.5	0.5	0.3	64.3	61.3	73.0	806.5	10.7	4.8	1.9	18.2	8.8	65.7	460.9	235.3	0.8	2.9	22.1	26.3	6.6	417.8	57.9	33.7	12.9
KLF4	"EZF, GKLF"	ENSG00000136826	"Kruppel like factor 4"	O43474	9	107484852-107490482	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 254.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1054.7;Basal squamous epithelial cells: 832.1;Distal enterocytes: 789.2;Intestinal goblet cells: 710.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.0;non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.2;hTCEpi: 84.4;hTERT-HME1: 54.5;OE19: 47.2;U-2197: 111.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002926	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA002926: AB_1852541"	"unprognostic (2.06e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.93e-5)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.32e-2)"	73.5	23.9	5.1	21.0	4.7	50.5	63.7	4.0	7.8	53.2	4.6	87.3	28.4	16.0	5.6	102.1	43.0	44.3	31.0	3.7	5.1	6.2	12.4	44.8	5.6	5.0	4.7	29.0	7.0	5.7	4.9	32.4	5.0	16.7	96.0	0.8	27.5	7.6	14.2	254.7	40.5	40.6	4.1	24.1	58.0	17.8	6.0	17.0	25.2	23.2	14.5	43.9	58.9	4.0	13.3	3.9	0.6	0.1	16.6	39.2	5.2	4.4	27.6	6.7	8.1	1.0	18.0	0.0	0.6	6.9	23.7	8.7	6.1	3.9	3.0	0.0	2.2	0.0	7.5	0.3	21.6	0.0	0.0	5.0	84.4	14.0	54.5	1.5	0.6	0.2	0.6	0.0	4.1	7.3	0.0	1.4	4.1	47.2	25.2	0.3	1.6	0.2	2.3	3.7	0.4	0.2	4.0	11.8	15.2	12.7	1.3	5.4	3.5	3.6	0.1	111.5	2.1	0.2	0.1	0.0	3.4	2.6	6.8	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	1.0	0.2	0.0	0.1	5.1	4.7	4.0	7.8	3.7	5.1	5.0	4.7	5.0	4.1	6.0	4.0	1054.7	12.8	41.1	0.3	32.2	436.0	284.3	143.0	832.1	0.5	206.7	205.0	70.3	35.8	71.5	1.8	8.4	49.1	15.0	789.2	1.9	24.4	263.1	154.1	216.0	336.6	123.8	4.8	0.0	38.7	75.5	463.2	537.2	297.4	54.7	4.7	216.0	4.6	89.9	0.0	0.2	710.9	83.4	232.9	282.0	163.0	143.8	401.0	206.3	16.9	36.8	2.0	0.0	0.0	0.0	49.3	540.9	60.5	38.3	187.3	198.0	2.1	46.4	2.0	39.5	463.7	130.0	21.6	15.9	639.9	674.0	107.9	26.8	63.5	332.6	236.8
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 436.6"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 2075.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Supported	Nucleoplasm,Nucleoli,Vesicles,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: AB_2686157"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	211.3	46.9	19.0	122.1	18.0	436.6	129.7	19.2	22.4	95.4	21.9	92.1	55.4	98.1	17.7	165.5	77.2	181.9	49.7	18.0	19.2	64.1	141.8	117.0	65.4	29.4	20.1	47.3	118.3	31.8	12.0	98.2	25.2	32.8	99.6	18.4	73.8	33.7	84.9	197.1	106.0	208.2	22.7	64.3	73.2	14.6	23.0	56.8	193.9	41.3	45.0	136.3	92.7	25.0	55.0	14.7	27.2	9.0	155.1	154.3	17.1	91.7	46.5	95.9	64.8	38.0	71.4	15.6	20.8	100.0	74.5	32.7	17.0	84.9	79.5	76.6	10.2	2.2	17.5	35.8	66.4	10.3	51.5	51.4	158.2	68.6	129.3	34.2	99.3	10.1	17.5	117.9	123.6	4.0	19.4	15.9	10.2	29.2	26.0	12.6	28.2	55.5	94.1	53.4	12.0	11.5	22.5	64.0	142.8	73.5	32.0	8.6	130.9	128.7	17.8	76.9	43.0	22.6	78.1	28.6	34.7	13.7	40.8	318.8	85.2	234.1	129.8	74.2	115.9	81.1	147.4	131.5	67.6	70.9	44.9	69.0	391.6	72.5	104.6	152.8	120.6	148.7	19.0	18.0	19.2	22.4	18.0	19.2	29.4	20.1	25.2	22.7	23.0	25.0	511.0	1246.8	489.4	14.0	716.9	585.5	1298.4	625.8	1227.0	39.6	985.9	630.0	63.6	544.7	451.9	138.0	33.3	163.1	518.3	1507.0	21.5	808.6	58.0	1065.6	618.9	469.9	397.3	77.9	18.5	553.0	473.8	545.5	1120.3	1905.9	626.7	195.9	248.4	309.9	583.6	37.0	10.0	746.7	429.3	968.7	885.1	53.2	130.5	992.1	483.8	58.1	609.8	42.9	150.4	7.5	4.3	857.9	949.9	133.9	1172.5	600.2	1009.9	97.4	342.0	90.1	138.1	194.8	441.8	9.0	19.4	2075.6	628.2	195.9	920.5	67.1	542.0	572.5
KLHDC1	MST025	ENSG00000197776	"Kelch domain containing 1"	Q8N7A1	14	49693105-49753150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Excitatory neurons: 41.7;Inhibitory neurons: 51.1;Microglial cells: 49.6;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 90.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;ASC TERT1: 5.3;HSkMC: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020461	Approved		Supported	Cytosol		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA020461: AB_1852556"	"unprognostic (2.97e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (1.94e-4)"	"unprognostic (3.42e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	5.2	4.2	3.3	2.3	5.1	1.4	4.8	4.5	6.0	6.2	1.5	5.5	1.9	6.0	5.7	2.2	5.8	3.1	4.6	2.8	5.4	3.1	3.5	3.1	3.6	5.0	4.2	9.3	3.8	4.1	6.2	2.6	4.3	4.6	2.3	6.0	3.3	4.3	7.2	5.1	3.8	3.5	3.1	3.8	3.9	4.8	4.0	1.9	5.6	4.7	2.6	4.4	4.8	7.4	0.7	0.3	0.6	0.3	5.7	5.3	0.0	1.5	2.1	0.5	0.3	0.0	1.8	0.3	0.3	0.6	0.5	0.5	0.1	0.0	0.4	1.5	0.5	0.2	0.1	0.0	2.9	0.1	0.7	4.5	0.2	0.2	0.2	2.9	1.2	1.0	0.3	0.0	2.2	0.2	0.4	0.8	0.0	0.2	0.2	0.4	0.5	0.0	1.1	0.2	0.2	1.5	0.2	0.0	0.6	0.7	0.6	1.2	1.7	1.3	1.4	0.5	0.1	0.5	0.0	0.4	1.2	0.2	0.7	0.5	0.4	1.0	0.7	0.8	1.4	1.2	1.0	0.9	0.4	0.8	1.7	1.4	0.0	0.6	0.4	1.4	0.3	0.7	3.3	5.1	4.5	6.0	2.8	5.4	5.0	4.2	4.3	3.1	4.0	7.4	7.6	22.4	6.5	46.4	6.1	3.6	3.4	1.5	4.0	10.4	3.3	2.3	10.1	5.7	5.7	0.0	4.2	1.5	2.7	1.7	9.8	0.8	2.1	3.5	5.4	5.7	1.8	5.2	41.7	0.8	0.8	7.3	2.6	1.9	1.3	4.5	4.6	3.2	2.6	13.5	51.1	2.4	2.0	2.2	3.3	3.3	18.0	2.9	5.4	49.6	2.2	15.0	4.1	45.2	90.5	0.4	2.7	10.1	2.9	1.6	4.2	2.5	3.1	15.8	0.0	9.5	6.1	17.9	7.6	1.3	3.3	0.3	3.7	4.2	1.2	1.8
KLHDC8B	MGC35097	ENSG00000185909	"Kelch domain containing 8B"	Q8IXV7	3	49171598-49176486	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 128.7"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 60.7;Sertoli cells: 98.6;Theca cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 28.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 28.8;monocytes: 8.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008463, HPA014467"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA008463: AB_1852563, HPA014467: AB_1852565"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.66e-1)"	"unprognostic (5.03e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (1.47e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	29.1	128.7	13.5	5.6	14.0	6.1	24.9	9.4	14.8	20.2	24.8	56.1	7.2	26.2	10.6	31.1	26.5	16.7	70.5	12.4	21.2	16.3	12.6	17.3	9.9	12.4	14.2	70.1	9.4	10.4	10.1	12.3	16.1	16.9	3.6	2.3	14.1	13.5	29.6	28.1	14.0	14.2	11.6	13.2	16.7	15.5	19.1	4.3	26.6	13.4	6.8	29.4	22.5	10.3	2.5	5.5	22.4	11.4	13.5	8.0	6.9	8.4	4.7	8.2	6.6	3.6	7.4	0.0	4.6	14.0	2.3	0.1	5.6	5.1	2.1	4.6	1.5	15.1	15.2	9.6	25.6	0.0	8.5	13.3	23.9	10.6	0.8	18.4	21.2	5.3	23.7	0.2	6.3	0.7	1.6	16.7	7.4	1.3	13.1	2.3	2.1	0.7	6.1	1.3	0.9	25.2	6.7	0.2	17.0	4.7	6.8	7.3	9.3	6.2	17.1	11.2	2.6	2.1	0.7	0.3	4.5	0.0	3.1	0.0	5.4	28.8	1.0	8.0	0.4	0.0	0.5	0.7	0.5	0.1	1.8	1.0	9.7	0.0	8.3	0.8	0.2	2.4	13.5	14.0	9.4	14.8	12.4	21.2	12.4	14.2	16.1	11.6	19.1	10.3	14.1	9.6	10.9	5.9	0.9	7.6	11.5	16.4	10.8	2.2	10.8	9.0	60.7	11.5	14.3	7.3	2.1	10.9	2.4	1.0	17.6	14.3	7.2	6.8	6.9	20.5	6.7	6.5	3.8	5.9	8.5	22.3	2.6	3.3	1.3	7.7	37.1	7.5	41.7	0.0	4.6	3.0	18.3	12.0	2.2	7.7	15.2	10.5	12.4	6.5	2.5	29.4	0.0	3.5	0.7	8.6	1.7	14.3	0.6	8.3	0.7	13.4	4.0	2.7	98.6	28.3	31.1	9.2	8.6	15.5	9.8	49.8	1.5	55.5	1.7	7.9
KLHDC9	KARCA1	ENSG00000162755	"Kelch domain containing 9"	Q8NEP7	1	161098361-161100346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 29.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 424.7;Late spermatids: 448.2;Spermatocytes: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HDLM-2: 1.5;HEK 293: 1.8;MCF7: 1.4;T-47d: 1.4;U-266/70: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043197			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA043197: AB_2678359"	"unprognostic (1.79e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.31e-2)"	"prognostic favorable (4.20e-6)"	"unprognostic (1.81e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	0.4	3.0	1.3	0.1	1.8	0.0	0.7	1.0	2.9	1.1	2.1	1.4	0.2	1.4	0.5	0.5	2.2	0.0	0.9	1.7	2.2	4.7	1.9	0.8	0.0	1.7	1.8	1.0	2.4	1.1	4.6	0.0	1.6	1.7	0.2	0.4	1.0	0.4	0.7	0.3	0.8	0.0	1.2	0.3	1.3	29.0	2.4	0.0	2.4	0.1	0.1	1.0	0.5	0.9	0.1	1.1	0.4	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	1.5	1.8	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.2	0.9	1.0	0.0	0.7	0.2	0.0	1.0	0.4	0.0	0.4	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	1.0	2.9	1.7	2.2	1.7	1.8	1.6	1.2	2.4	0.9	2.4	0.0	6.7	8.8	1.5	0.9	11.7	11.5	0.6	13.7	15.3	16.3	9.3	14.3	11.7	29.5	2.1	2.3	0.4	7.6	56.7	10.2	424.7	57.5	2.8	3.4	5.4	0.0	8.9	5.5	3.6	3.2	3.1	10.3	1.3	1.6	3.9	9.5	0.6	3.3	6.8	10.6	16.2	0.6	0.7	448.2	8.1	0.9	7.2	2.8	0.6	35.1	1.0	6.0	1.7	3.9	8.2	8.2	2.1	6.4	2.5	47.8	77.8	20.0	13.1	2.8	4.4	198.1	15.6	2.6	0.9	0.8	1.2	1.7	8.7	8.2
KLHL11	FLJ10572	ENSG00000178502	"Kelch like family member 11"	Q9NVR0	17	41848518-41865423	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 108.3;Late spermatids: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023021, HPA052403, HPA054269"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432"	"unprognostic (9.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.82e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.07e-2)"	2.0	2.5	7.5	2.0	6.9	9.1	3.6	8.7	8.2	2.2	1.6	2.0	1.7	2.8	4.0	1.8	2.5	1.6	2.0	9.7	7.6	2.6	2.5	2.3	2.8	6.8	6.3	3.9	3.0	4.6	0.8	2.0	7.4	2.9	1.8	7.1	2.2	2.7	4.3	3.2	1.7	1.8	5.1	2.8	2.2	9.7	7.5	2.7	4.5	1.9	2.8	1.6	0.8	7.0	3.3	5.6	3.9	10.3	5.3	2.8	6.8	3.1	2.9	3.3	3.1	5.2	2.5	10.7	3.4	3.8	3.0	9.3	10.1	4.4	6.0	4.1	4.5	3.8	8.2	7.1	4.9	4.7	4.1	3.4	4.0	4.4	8.3	3.4	3.4	5.3	3.4	9.1	4.3	4.2	7.1	4.9	3.4	2.9	1.8	6.1	9.5	7.7	3.7	5.7	9.8	4.8	5.4	24.9	4.2	3.8	10.9	3.8	5.3	5.1	6.9	4.9	6.2	5.6	5.1	7.9	5.4	4.9	4.8	0.2	0.5	0.3	0.5	0.7	0.8	0.6	0.6	0.6	0.5	0.8	0.7	0.6	0.2	0.4	0.4	0.3	0.4	0.4	7.5	6.9	8.7	8.2	9.7	7.6	6.8	6.3	7.4	5.1	7.5	7.0	1.2	0.0	0.5	6.8	4.5	0.5	1.4	0.2	14.8	3.8	0.9	1.8	0.2	0.0	1.5	0.0	4.2	0.4	3.6	0.3	0.0	0.4	108.3	1.6	3.4	1.5	0.0	3.0	16.6	0.2	0.4	3.0	10.7	1.9	0.0	1.1	0.0	0.0	0.3	8.4	18.0	0.7	0.0	0.0	1.0	41.8	0.3	1.5	1.8	4.7	0.9	1.8	1.0	11.1	13.9	0.5	0.1	0.0	5.8	0.9	0.9	0.2	0.0	3.6	6.6	2.2	3.2	5.5	2.1	5.5	0.3	0.4	4.6	0.9	0.6	0.9
KLHL22	"FLJ14360, KELCHL"	ENSG00000099910	"Kelch like family member 22"	Q53GT1	22	20441519-20495844	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 41.1;Excitatory neurons: 42.9;Inhibitory neurons: 51.1;Oligodendrocyte precursor cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040766			Supported	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA040766: AB_2732488"	"unprognostic (4.15e-1)"	"unprognostic (9.34e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.88e-6)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.99e-2)"	"prognostic favorable (3.85e-6)"	"unprognostic (3.94e-2)"	"prognostic favorable (1.34e-8)"	"unprognostic (3.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.08e-2)"	13.7	14.2	24.1	10.2	23.0	11.3	11.9	25.9	25.1	20.5	18.2	16.6	7.7	20.4	17.2	8.0	17.9	13.6	14.2	22.9	21.4	15.6	10.8	11.8	17.6	18.0	18.1	22.3	16.5	22.9	19.6	11.6	18.7	18.7	10.6	15.3	14.0	18.0	22.1	11.7	10.4	21.7	14.8	15.6	12.2	10.2	23.1	8.0	20.8	18.0	20.7	13.4	10.9	21.2	17.1	16.5	37.5	29.9	30.6	35.5	9.0	21.4	37.6	21.0	23.6	8.2	6.4	11.9	7.0	37.3	16.9	21.3	25.6	9.2	18.1	25.9	15.1	12.6	17.4	8.3	30.6	2.6	11.7	26.9	14.2	19.3	12.4	26.8	31.3	9.1	32.7	11.4	20.7	25.9	2.5	15.6	6.3	14.1	11.4	23.5	13.8	0.5	12.3	19.9	19.9	20.3	23.0	16.9	15.8	12.3	15.7	9.3	14.2	25.1	12.2	17.5	8.9	6.4	7.4	7.9	13.5	11.1	16.6	8.9	4.6	19.3	8.1	6.3	6.4	8.3	10.2	7.5	15.5	6.2	7.7	8.3	10.6	16.6	8.3	5.6	19.2	6.5	24.1	23.0	25.9	25.1	22.9	21.4	18.0	18.1	18.7	14.8	23.1	21.2	4.6	0.0	3.7	41.1	8.2	1.7	2.8	8.4	4.0	11.7	4.3	5.2	4.8	10.0	5.3	9.2	4.2	17.9	5.2	2.9	3.9	8.4	0.8	3.2	7.1	4.8	3.0	1.3	42.9	2.6	6.6	9.2	5.1	3.9	5.1	14.2	4.2	6.3	7.9	13.5	51.1	5.2	12.2	5.7	4.9	1.8	12.2	4.8	1.8	16.9	4.2	13.9	7.2	41.2	26.8	5.6	3.5	19.9	5.4	3.9	3.0	10.9	4.3	6.7	6.6	4.7	5.3	17.3	15.4	2.8	1.4	13.4	7.8	17.7	3.8	1.8
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 56.7;skeletal muscle: 268.3;tongue: 76.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;SK-BR-3: 2.8;U-2197: 4.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.2	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.2	0.1	0.9	0.1	1.3	0.0	2.5	0.7	0.7	56.7	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.1	1.3	0.0	1.5	0.0	0.8	0.1	0.0	0.7	0.1	268.3	0.2	0.2	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	76.9	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.9	0.0	0.5	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526258	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	42	"skeletal muscle: 5038.6;tongue: 3473.7"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 108.1;Skeletal myocytes: 251.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HSkMC: 21.6;LHCN-M2: 35.4;RH-30: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	1.5	0.5	1.7	0.2	1.4	0.0	2.0	3.1	1.8	1.0	1.4	1.4	0.1	0.8	1.5	75.1	1.2	6.7	100.3	1.2	1.6	0.8	0.9	2.7	0.3	0.9	2.5	1.1	1.1	0.5	5.8	0.1	1.5	50.0	0.3	16.1	52.1	0.7	5038.6	4.6	0.8	0.6	0.9	0.8	1.3	2.6	5.1	1.7	2.2	3473.7	0.3	5.9	0.9	1.4	0.0	0.1	0.0	0.6	0.4	2.7	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.2	0.2	0.0	21.6	0.5	0.3	0.0	0.2	0.1	0.2	0.1	0.0	35.4	0.1	0.1	0.2	0.0	0.0	0.2	0.0	55.9	0.0	0.2	0.1	0.7	0.1	0.1	0.0	1.5	0.1	0.0	0.1	0.0	0.4	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	3.1	1.8	1.2	1.6	0.9	2.5	1.5	0.9	5.1	1.4	0.0	0.0	0.5	1.3	0.0	0.1	0.5	0.1	0.0	2.4	0.2	0.1	108.1	0.0	2.0	0.0	8.4	0.0	0.0	0.1	0.0	0.5	5.8	1.3	0.2	1.0	1.2	0.0	4.1	0.5	0.0	6.4	0.0	0.1	0.0	0.2	0.4	0.2	0.2	0.0	4.6	0.1	0.0	0.3	0.0	2.9	0.9	0.8	0.0	3.7	0.0	0.7	0.0	1.5	2.3	0.7	0.1	1.2	0.0	0.3	0.0	0.3	4.1	5.8	0.0	251.8	1.8	4.1	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.1
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487551-183555706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 31.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 35.7;Endometrial ciliated cells: 28.3;granulocytes: 51.1;Hofbauer cells: 24.1;Macrophages: 33.3;Plasma cells: 63.6;Respiratory ciliated cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.3;HEL: 26.6;HMC-1: 26.7;U-266/70: 82.1;U-266/84: 45.5;U-698: 121.3"	"Low region specificity"	"Detected in all"							HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	1.5	0.7	0.7	11.8	0.8	3.5	0.9	1.0	1.0	0.8	0.7	2.5	2.5	0.6	0.2	0.6	4.8	2.1	0.7	0.6	1.4	0.4	1.0	4.2	29.3	2.6	1.4	0.3	0.6	0.2	0.2	1.9	2.0	0.5	2.3	0.1	1.3	0.1	0.2	0.1	4.8	0.7	1.5	6.3	4.1	0.2	3.1	10.0	0.6	0.3	31.0	1.8	0.3	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	26.6	0.0	0.0	0.0	7.3	26.7	0.0	0.0	0.0	0.0	0.0	4.6	0.5	0.4	18.4	0.0	0.0	8.8	4.1	0.0	0.0	0.0	14.8	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.5	0.0	0.1	0.0	0.1	82.1	45.5	121.3	0.0	8.0	0.0	7.8	2.8	11.8	0.6	2.2	0.7	3.6	2.4	1.0	2.0	2.4	2.9	1.8	2.4	2.2	2.7	4.6	4.2	2.6	0.7	0.8	1.0	1.0	0.6	1.4	2.6	1.4	2.0	1.5	3.1	3.7	4.0	6.4	6.5	0.7	35.7	1.1	1.7	0.6	0.6	0.6	0.3	0.4	4.8	0.0	5.4	0.0	2.1	0.2	16.6	0.2	0.0	0.1	2.0	28.3	0.5	4.6	0.0	7.6	0.3	0.0	0.3	1.7	2.0	0.8	51.1	8.1	1.1	0.2	24.1	0.0	0.3	0.0	0.0	20.7	22.4	0.8	0.3	33.3	8.8	14.0	10.1	0.3	5.2	1.0	0.3	0.0	0.1	0.0	63.6	1.2	0.0	0.4	24.4	0.7	0.0	1.8	1.5	0.3	0.4	0.1	0.6	0.5	16.8	0.0	0.2	1.2
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 253.0;esophagus: 94.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 23.9;Breast myoepithelial cells: 16.1;Collecting duct cells: 11.0;Oligodendrocytes: 87.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 575.5;CAPAN-2: 1346.5"	"Region enhanced"	"Detected in all"		"pons and medulla: 167.8"	"Region enhanced"	"Detected in many"		"spinal cord: 371.7"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		10000000		"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.2	0.0	71.8	0.0	135.8	0.0	7.2	170.8	119.8	53.1	45.6	0.1	0.2	1.5	0.4	94.2	28.9	3.5	0.0	72.9	94.3	20.4	0.0	0.0	0.0	213.8	130.8	0.8	0.0	0.0	0.7	0.0	182.1	0.1	0.0	0.0	15.8	2.2	0.0	9.9	0.0	0.0	123.6	5.8	0.1	0.9	118.1	1.5	0.0	0.0	36.4	0.0	27.4	253.0	575.5	0.0	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.7	1346.5	0.0	8.1	0.0	0.6	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	131.0	2.2	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	5.6	18.2	1.0	1.9	0.0	1.1	46.3	0.0	1.3	0.0	0.4	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.8	135.8	170.8	119.8	72.9	94.3	213.8	130.8	182.1	123.6	118.1	253.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	0.0	23.9	16.1	0.3	0.0	1.7	11.0	0.0	0.1	0.4	0.0	0.0	0.1	2.3	0.6	7.5	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	87.9	7.8	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	1.6	0.0	0.3	0.1	0.0	0.0	2.4
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976468-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 94.7;skin 1: 201.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Basal keratinocytes: 5.0;Basal squamous epithelial cells: 4.6;Breast glandular cells: 9.4;Breast myoepithelial cells: 10.4;Squamous epithelial cells: 5.9;Suprabasal keratinocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.0;CAPAN-2: 8.0;HaCaT: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		3700000	"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	7.1	0.1	8.4	0.1	9.2	0.3	11.2	0.9	7.4	19.7	1.0	0.1	0.5	0.7	0.2	94.7	16.3	1.3	0.2	6.5	1.4	12.1	0.1	3.1	0.0	4.3	1.4	0.1	0.1	0.3	0.7	0.0	4.9	0.1	0.0	0.1	21.6	0.2	1.0	201.2	0.0	0.2	2.1	0.8	0.3	0.3	7.4	0.9	0.2	0.0	10.9	0.0	30.9	3.0	5.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.8	8.0	0.0	1.1	0.0	0.1	31.7	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	8.4	9.2	0.9	7.4	6.5	1.4	4.3	1.4	4.9	2.1	7.4	3.0	0.0	6.4	1.1	0.0	0.0	5.0	0.1	0.5	4.6	0.0	9.4	10.4	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	5.9	10.7	0.0	0.1	0.0	0.1	2.7
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859158-87863533	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 5.7;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 5.0;Karpas-707: 5.1"									HPA074502			Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA074502: AB_2686695"	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.0	0.7	1.0	0.6	0.7	0.5	0.6	1.5	1.6	0.7	0.6	0.9	0.4	0.5	1.0	0.4	1.4	0.4	0.5	0.7	0.9	0.9	0.9	0.4	0.8	0.5	0.6	0.4	0.2	0.5	0.5	0.6	0.6	0.4	0.8	1.0	0.3	0.5	4.5	0.4	0.4	0.5	0.3	0.8	0.6	1.0	0.6	1.0	0.7	0.5	0.8	0.3	0.3	1.5	0.8	1.0	1.1	0.7	0.5	0.3	0.8	0.7	0.9	0.5	0.7	0.6	2.6	2.0	0.3	0.2	0.5	0.9	0.7	0.8	0.4	0.5	0.3	0.7	1.5	0.6	0.6	1.4	0.5	0.6	0.8	0.7	0.8	0.9	0.3	5.0	0.4	5.1	0.5	1.8	4.1	1.6	0.4	0.6	0.5	2.6	0.1	2.6	0.4	0.8	0.4	1.0	0.9	0.6	0.1	0.7	1.6	1.2	0.3	0.5	0.3	0.9	0.3	2.9	3.3	2.9	0.9	2.9	0.6	1.6	0.3	0.6	0.2	0.5	0.4	0.4	0.3	0.3	0.3	0.5	0.4	0.3	2.5	0.6	0.8	0.5	0.2	0.2	1.0	0.7	1.5	1.6	0.7	0.9	0.5	0.6	0.6	0.3	0.6	1.5	0.6	0.0	0.0	0.3	0.5	0.1	0.3	0.2	0.6	1.7	1.0	1.3	2.7	1.5	1.3	0.0	0.0	0.7	2.0	3.0	0.0	0.2	3.9	0.8	0.9	0.6	0.0	0.8	0.4	0.2	0.4	1.1	3.6	0.4	5.7	0.3	0.7	0.4	0.3	3.3	0.5	1.8	0.0	1.3	0.0	2.0	0.0	0.6	0.0	0.0	0.3	1.6	0.0	0.0	0.1	0.3	2.5	0.0	0.2	0.3	1.8	1.9	2.3	1.0	6.6	1.1	2.9	0.3	1.2	0.6	0.4	0.5	0.7	0.3	1.3	0.2
KLRC1	"CD159a, NKG2, NKG2-A, NKG2-B"	ENSG00000134545	"Killer cell lectin like receptor C1"	P26715	12	10442264-10454685	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.7"	"Group enriched"	"Detected in some"	8	"dendritic cells: 104.2;NK-cells: 254.3;T-cells: 100.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 229.2;NK-cell: 367.6"	"Group enriched"	"Detected in many"	46	"NK-cells: 367.6;T-cells: 229.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 5.6;Karpas-707: 1.9"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (8.17e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.58e-7)"	"unprognostic (3.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-3)"	0.7	0.5	0.8	2.2	0.8	5.3	2.0	0.6	1.4	0.7	0.4	1.8	1.4	3.1	1.5	1.4	0.9	2.0	0.7	1.0	1.6	0.3	1.8	3.3	3.1	1.4	1.4	0.7	0.8	0.3	0.3	2.2	1.0	0.7	2.0	1.2	1.2	0.4	0.4	1.0	2.6	0.9	1.2	6.7	4.3	0.9	1.8	1.1	0.7	0.0	2.5	1.0	0.6	2.0	0.2	0.8	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.4	0.8	0.0	0.6	0.1	0.0	0.2	1.6	0.1	0.3	1.4	0.5	0.4	0.2	1.0	5.6	0.0	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	0.4	0.3	0.6	1.9	0.4	0.0	0.1	1.4	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.4	0.0	0.1	1.7	0.1	0.0	1.3	0.2	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.4	0.0	1.9	0.3	0.2	229.2	0.3	29.1	0.6	0.1	40.1	0.3	0.2	0.3	33.2	6.4	367.6	0.6	0.4	0.1	28.6	0.8	0.8	0.6	1.4	1.0	1.6	1.4	1.4	1.0	1.2	1.8	2.0	1.2	0.0	0.6	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.9	1.3	0.5	1.5	0.0	0.0	0.0	0.1	104.2	0.8	0.0	0.1	1.3	0.3	0.4	0.4	1.8	11.2	0.2	0.0	0.0	0.6	3.1	0.4	0.0	0.0	3.9	0.9	0.1	1.7	0.1	2.8	0.0	4.0	0.4	0.4	0.6	2.0	5.4	0.0	1.4	0.0	254.3	1.0	0.0	0.0	1.2	1.2	17.6	0.1	0.6	0.6	0.0	2.0	0.0	0.1	0.8	1.1	0.6	0.5	0.1	0.1	100.2	0.0	0.5	0.4
KLRC2	"CD159c, NKG2-C"	ENSG00000205809	"Killer cell lectin like receptor C2"	P26717	12	10426854-10442300	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.4;lymphoid tissue: 5.8"	"Group enriched"	"Detected in some"	6	"dendritic cells: 111.5;Oligodendrocyte precursor cells: 32.6;T-cells: 49.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 24.6;NK-cell: 84.5"	"Group enriched"	"Detected in many"	103	"NK-cells: 84.5;T-cells: 24.6"	"Cell line enhanced"	"Detected in some"		"GAMG: 19.1;HEL: 5.8;HeLa: 17.5;HSkMC: 4.1"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (9.05e-4)"	"unprognostic (2.54e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-9)"	"unprognostic (8.10e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.31e-3)"	0.4	0.1	3.9	0.4	3.8	2.2	0.8	3.6	9.4	0.3	2.8	1.3	0.7	0.9	0.0	0.5	0.5	1.1	0.1	3.7	4.1	0.1	0.8	1.0	1.1	4.2	4.2	1.0	0.2	0.0	0.1	0.4	4.1	0.3	0.8	0.3	0.3	0.2	0.0	0.1	1.1	0.0	4.2	5.8	2.3	0.4	3.9	0.3	0.3	0.0	1.3	0.4	0.3	4.7	0.0	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	19.1	0.0	0.0	2.2	0.0	0.0	0.0	5.8	17.5	0.3	0.0	0.6	0.0	4.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.1	1.2	0.1	0.4	0.0	0.0	0.0	0.0	0.6	2.8	0.1	0.1	0.0	0.0	0.0	24.6	0.0	0.6	0.0	0.0	11.0	0.0	0.0	0.1	9.2	0.5	84.5	0.1	0.0	0.0	4.6	3.9	3.8	3.6	9.4	3.7	4.1	4.2	4.2	4.1	4.2	3.9	4.7	0.5	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.3	1.2	0.0	0.6	0.0	0.0	0.0	111.5	0.2	0.0	0.2	0.0	0.1	0.1	0.1	9.6	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	9.2	32.6	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	49.9	1.7	0.3	0.2
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412315-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	4	"dendritic cells: 19.2;Oligodendrocyte precursor cells: 36.2;T-cells: 15.9"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 63.1"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 63.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.4;GAMG: 2.8;HEL: 1.3;HeLa: 7.0;HSkMC: 1.2;SuSa: 1.3;U-698: 1.9"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"		0.2	0.1	1.3	0.3	1.4	1.9	0.1	0.7	2.1	0.1	0.2	0.5	0.8	0.5	0.1	0.2	0.2	0.6	0.0	1.3	1.7	0.1	0.5	0.6	1.7	1.7	1.1	0.1	0.1	0.0	0.0	0.1	1.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.3	0.1	1.3	4.0	0.6	0.2	1.3	0.4	0.1	0.0	0.8	0.1	0.1	2.1	0.0	0.0	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.0	0.0	1.3	7.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	7.0	0.0	0.0	0.1	8.7	0.6	63.1	0.0	0.0	0.0	3.6	1.3	1.4	0.7	2.1	1.3	1.7	1.7	1.1	1.2	1.3	1.3	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	0.1	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	1.0	36.2	2.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.1
KLRG1	"2F1, CLEC15A, MAFA, MAFA-L"	ENSG00000139187	"Killer cell lectin like receptor G1"	Q96E93	12	8950044-9010760	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 93.7;granulocytes: 118.9;NK-cells: 164.8;T-cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 390.9;MAIT T-cell: 461.3"	"Lineage enriched"	"Detected in all"	22	"T-cells: 461.3"	"Cell line enhanced"	"Detected in many"		"HEL: 25.1;NTERA-2: 22.1;U-937: 17.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051403, HPA076494"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA051403: , HPA076494: AB_2686800"	"unprognostic (1.54e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.86e-2)"	4.1	1.7	2.4	3.8	2.6	3.0	2.5	4.3	2.9	1.3	1.4	1.5	1.0	1.2	2.1	1.0	1.0	3.3	2.0	2.1	3.2	1.4	3.0	2.2	10.4	2.5	3.4	1.0	0.5	0.4	1.1	0.6	2.3	1.1	1.9	1.3	1.6	0.7	1.7	1.0	2.2	1.6	1.7	8.8	1.6	1.1	2.6	2.5	1.0	1.8	5.0	2.4	0.8	3.8	0.2	3.1	1.6	2.3	3.0	0.7	1.4	0.5	0.3	0.4	1.1	1.1	1.1	4.9	0.1	0.4	2.1	0.2	3.3	0.5	0.4	3.6	1.9	25.1	0.4	1.6	0.8	1.1	1.6	1.4	0.4	0.5	0.0	0.4	7.6	2.5	1.4	0.4	0.2	0.7	1.0	2.0	22.1	1.0	1.7	1.2	1.0	0.0	0.5	0.4	0.4	4.4	1.1	0.5	1.6	4.3	0.3	1.7	0.8	0.7	1.0	0.6	1.4	1.4	4.1	2.6	1.8	17.3	0.2	17.5	2.6	1.5	390.9	2.9	461.3	4.2	85.1	237.7	8.2	5.0	23.5	147.7	5.7	20.9	5.4	3.9	8.7	99.7	2.4	2.6	4.3	2.9	2.1	3.2	2.5	3.4	2.3	1.7	2.6	3.8	12.7	0.0	4.3	2.9	4.7	0.4	0.4	0.0	4.0	5.0	1.0	0.9	2.8	1.5	0.1	0.0	8.4	1.0	93.7	0.1	1.9	0.7	1.6	0.8	0.6	2.9	1.2	24.6	3.8	0.2	0.5	1.3	0.5	0.5	118.9	0.9	25.7	2.0	3.4	5.0	3.6	0.1	0.0	9.1	1.4	3.1	0.6	3.7	1.8	2.8	5.4	1.8	164.8	9.5	6.2	0.3	0.1	0.0	16.9	0.2	0.3	3.1	0.1	3.9	0.0	2.1	1.0	7.8	7.3	1.3	0.0	0.3	109.3	0.7	0.6	0.1
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436641	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 363.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	12.7	11.2	16.7	7.3	25.7	16.4	12.9	16.7	15.7	15.3	5.5	13.1	5.7	14.3	13.7	14.1	11.9	7.7	10.2	13.0	18.9	8.9	10.4	12.7	8.1	25.3	19.4	16.8	18.5	12.4	12.1	10.3	20.6	9.3	7.6	21.7	14.2	9.0	25.9	17.6	12.8	7.5	12.2	12.2	15.2	13.4	19.1	16.1	14.6	16.9	9.5	11.3	12.7	28.6	13.4	6.1	11.6	11.7	19.0	13.9	10.2	4.7	6.4	5.0	5.5	10.9	4.7	22.4	8.9	11.3	9.2	5.2	14.3	7.5	9.2	12.7	6.5	14.0	7.3	4.5	8.9	22.9	12.8	6.6	9.1	7.1	8.2	7.2	8.4	9.7	22.5	15.0	11.7	12.7	14.8	11.1	6.8	8.5	7.9	9.5	12.3	8.4	5.8	10.9	19.6	12.8	13.4	15.8	6.3	10.6	4.6	15.7	12.8	8.0	4.4	9.0	8.9	15.3	7.7	22.4	10.7	14.7	8.4	6.1	3.0	4.4	1.9	2.7	1.6	6.9	2.0	1.5	1.4	3.9	1.9	1.4	15.2	2.2	2.6	3.7	1.3	0.8	16.7	25.7	16.7	15.7	13.0	18.9	25.3	19.4	20.6	12.2	19.1	28.6	62.4	76.9	71.9	292.8	75.0	89.1	38.3	31.5	62.0	89.0	59.6	35.2	65.8	44.3	72.4	46.0	173.0	38.0	61.9	61.7	5.9	37.6	32.1	94.4	92.1	58.9	67.9	55.5	180.7	33.1	51.7	58.3	89.2	200.5	65.2	52.8	56.7	46.0	33.7	80.8	172.2	53.5	42.7	54.7	79.6	17.3	67.4	90.5	42.7	202.4	77.1	57.7	59.8	299.6	363.2	37.6	49.0	60.2	90.3	53.6	36.3	14.7	46.9	73.0	26.3	83.0	55.5	42.3	33.9	80.9	96.3	127.2	76.8	54.8	39.1	61.4
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018978-49060794	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	19.9	21.9	14.0	17.0	14.4	62.1	20.3	14.7	18.1	20.2	3.8	21.3	13.2	26.9	14.4	25.5	24.1	11.7	23.7	12.1	9.1	18.2	20.5	25.1	17.5	9.3	8.2	25.3	33.2	22.9	25.4	16.2	8.6	19.2	14.7	48.0	22.1	16.2	44.9	30.4	27.9	15.5	3.1	36.6	25.5	23.6	12.7	29.0	26.5	21.9	17.2	19.4	19.4	13.4	32.3	31.9	31.0	24.7	29.3	20.4	32.6	17.3	17.1	20.3	10.9	54.8	14.1	33.4	21.2	23.9	14.0	21.5	38.1	19.9	17.7	22.4	26.7	47.2	37.7	29.9	20.5	59.1	43.2	18.4	25.8	30.7	32.0	27.3	31.8	33.2	55.1	19.2	23.7	37.4	26.8	48.0	29.9	45.4	25.0	37.4	22.4	12.0	18.1	37.2	24.6	21.2	28.1	25.5	19.5	26.1	24.0	44.1	49.8	15.5	30.7	14.5	30.5	24.8	20.9	31.7	17.1	28.0	12.5	0.5	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.5	0.5	0.0	0.2	0.0	0.1	14.0	14.4	14.7	18.1	12.1	9.1	9.3	8.2	8.6	3.1	12.7	13.4	12.9	9.6	19.1	17.6	13.3	14.0	7.8	8.1	14.2	26.8	12.1	7.1	7.8	12.8	10.9	18.4	52.1	8.2	15.3	12.3	1.9	6.3	2.8	10.7	12.7	13.2	13.1	16.0	17.4	6.0	6.0	8.8	24.5	13.1	8.2	23.3	17.9	13.0	9.8	21.9	16.5	10.0	6.1	15.7	18.4	2.4	9.6	15.4	10.6	15.0	14.9	6.4	17.5	12.5	19.8	8.8	9.5	10.9	10.1	11.0	13.3	4.5	9.0	38.4	6.6	14.4	12.5	6.5	3.8	18.9	17.6	11.4	15.3	10.8	10.3	9.6
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E (inactive)"	Q8IZD2	7	105014190-105115019	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	23.0	16.4	17.6	28.8	23.6	69.9	22.5	53.6	26.1	28.9	11.6	29.0	22.7	33.4	22.1	22.7	24.8	24.5	21.1	16.9	25.9	18.7	16.4	27.9	31.4	19.0	19.2	43.8	22.8	23.1	11.5	26.8	17.7	24.9	28.5	40.5	25.5	23.0	15.0	30.3	22.3	26.8	14.4	33.4	26.7	18.6	17.1	35.6	27.4	22.9	33.0	27.9	14.3	34.4	35.7	24.8	49.3	43.5	29.3	34.5	12.3	24.3	38.2	21.0	25.5	19.0	30.1	28.8	24.7	30.0	27.7	26.2	27.1	25.7	35.0	45.8	17.4	27.0	31.6	19.2	28.1	39.7	34.8	24.2	23.3	28.6	30.6	38.6	40.2	32.3	39.9	76.9	28.7	26.5	62.1	35.0	17.9	19.1	19.1	53.4	30.3	33.5	23.0	34.5	28.8	36.1	35.7	32.3	20.2	32.8	13.6	23.5	47.2	50.0	33.1	57.5	26.4	61.6	50.8	63.5	34.3	29.5	36.3	246.8	73.2	173.1	118.3	56.2	114.6	153.9	109.7	103.0	53.8	152.0	106.0	100.0	290.3	89.9	94.4	103.2	101.5	71.7	17.6	23.6	53.6	26.1	16.9	25.9	19.0	19.2	17.7	14.4	17.1	34.4	169.3	141.1	158.4	108.4	283.5	146.6	115.5	119.2	118.4	236.4	93.4	81.5	102.9	85.8	124.6	115.8	252.3	40.5	278.0	138.0	35.2	82.2	27.0	77.8	89.3	205.6	100.0	90.5	160.2	68.1	50.4	128.8	91.7	112.4	247.9	78.2	119.2	33.6	60.4	185.1	148.9	96.4	89.5	91.8	348.4	27.3	141.1	152.2	140.5	148.9	147.5	104.1	255.4	189.0	236.2	80.7	102.9	131.7	223.1	149.7	82.6	32.4	78.3	297.5	124.9	136.7	168.3	100.0	76.4	86.1	134.7	65.3	278.3	58.2	115.4	159.9
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409353	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA064495: AB_2685273"	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	13.7	10.1	22.6	15.3	22.1	39.2	13.1	20.8	23.2	22.2	18.7	17.7	12.8	21.3	12.9	40.7	21.7	13.6	17.0	22.2	20.6	13.7	14.0	15.5	15.4	22.4	22.7	12.0	19.7	11.4	10.7	16.5	22.9	30.2	14.4	11.7	24.0	19.7	24.4	28.1	15.6	16.7	21.4	16.8	16.9	7.9	23.3	17.9	25.7	15.3	16.6	16.6	25.7	23.9	37.3	24.3	27.8	43.5	18.1	30.9	40.1	57.4	26.3	32.0	26.9	28.8	21.9	84.9	33.1	37.5	11.7	35.8	41.6	21.7	33.3	39.3	45.0	68.8	26.4	15.2	26.5	54.8	18.8	15.1	27.1	34.7	32.8	30.2	26.2	36.4	136.8	38.1	27.5	29.9	58.1	84.9	13.8	34.6	29.0	70.4	22.1	24.1	22.8	43.4	37.9	30.9	51.3	28.3	28.6	23.6	39.6	75.3	32.4	35.2	26.0	42.3	42.3	23.0	25.9	75.9	24.6	29.6	29.9	2.3	1.2	4.3	1.3	2.1	2.7	1.7	1.6	2.1	1.0	1.1	0.9	1.1	1.8	2.3	2.1	2.0	1.5	0.3	22.6	22.1	20.8	23.2	22.2	20.6	22.4	22.7	22.9	21.4	23.3	23.9	34.5	12.8	14.5	0.0	12.7	0.0	17.6	0.0	20.5	20.8	32.0	27.3	0.0	7.2	6.8	27.6	6.2	15.1	22.4	10.4	7.9	9.2	10.1	46.8	43.8	20.7	4.9	62.1	0.0	9.4	16.6	14.7	15.8	41.1	2.5	21.3	30.4	19.5	17.7	3.3	0.0	22.2	0.0	16.8	0.0	3.2	16.1	19.6	0.0	0.0	3.4	28.7	7.2	0.0	0.0	13.6	9.6	42.9	15.9	24.1	14.3	13.1	11.7	17.9	6.6	23.2	19.7	9.7	10.2	38.8	0.0	14.2	14.5	18.4	12.7	22.5
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.2	0.1	0.1	1.9	0.0	5.3	0.3	0.2	0.2	0.2	0.2	1.3	1.6	0.3	0.2	1.0	0.1	0.3	0.1	0.1	0.1	0.5	0.7	0.4	3.6	0.1	0.3	0.0	0.0	0.3	0.0	1.3	0.1	0.1	1.4	0.2	0.2	0.0	0.0	0.8	1.7	0.7	0.0	0.6	0.9	16.9	0.3	7.4	0.3	0.1	3.4	0.5	0.2	0.1	19.1	9.3	18.0	13.8	0.5	2.6	8.6	20.5	8.1	16.0	13.1	11.6	7.2	11.9	6.1	9.3	12.0	21.9	17.6	9.7	16.3	21.4	5.0	35.5	15.5	3.9	0.0	26.2	17.8	0.5	0.4	10.8	6.4	2.1	13.8	20.9	22.9	19.2	18.3	6.1	23.5	6.1	9.4	11.3	9.5	21.2	25.8	5.9	2.6	15.6	15.9	7.7	17.7	10.6	2.1	5.9	11.1	9.0	13.1	18.7	16.3	21.9	11.7	7.5	27.9	22.3	7.6	18.5	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.8	1.8	0.0	8.5	2.6	0.0	1.9	0.2	0.0	3.5	3.5	1.9	0.0	0.0	0.0	0.6	11.3	4.2	0.0	2.9	0.0	22.8	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	11.5	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.7	1.9	1.7	0.0	0.0
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin (SPAG5) binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.6;thyroid gland: 53.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 328.2;Late spermatids: 600.1;Spermatocytes: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	8.0	6.2	6.3	8.1	7.1	14.1	14.3	7.7	8.6	5.1	4.5	7.9	9.2	6.4	12.3	9.1	5.7	4.4	7.4	7.2	6.2	7.2	12.0	5.8	14.5	6.2	6.2	5.1	5.0	8.4	5.6	10.7	6.5	6.8	10.4	9.0	10.3	7.2	12.2	6.7	6.2	10.2	5.9	7.1	10.2	63.6	6.1	25.6	53.1	12.4	16.1	5.6	5.6	7.7	103.4	47.5	92.7	61.0	20.1	30.9	48.1	69.9	54.0	141.0	123.3	102.6	44.2	39.7	34.8	47.3	112.1	115.7	100.0	64.8	126.5	70.8	48.8	117.7	107.4	65.2	18.9	63.8	58.6	16.1	36.5	71.3	70.6	34.5	80.3	97.6	86.3	66.8	120.0	52.2	55.6	51.2	58.6	87.7	71.2	56.4	69.7	45.7	49.7	42.3	89.9	62.5	58.3	63.3	15.1	55.8	66.5	45.3	41.6	67.5	68.8	69.7	98.3	56.5	98.6	70.5	41.8	84.0	56.5	13.2	17.6	17.4	7.9	24.3	6.8	9.5	5.7	7.0	18.4	11.2	5.4	5.5	9.7	9.8	47.8	12.7	9.4	7.1	6.3	7.1	7.7	8.6	7.2	6.2	6.2	6.2	6.5	5.9	6.1	7.7	2.4	9.6	1.1	2.6	4.1	2.2	2.9	7.6	3.4	8.2	4.2	3.4	7.3	1.5	5.4	0.0	8.4	25.2	2.5	1.9	3.9	8.5	328.2	5.9	4.9	3.7	2.4	34.3	5.1	9.3	40.8	5.2	5.6	4.4	1.3	16.9	3.6	8.0	21.6	5.0	4.9	5.3	14.2	9.8	2.0	600.1	9.0	8.2	3.6	4.7	8.0	8.5	6.2	2.0	4.3	12.3	0.5	7.2	12.6	4.9	2.8	5.8	7.2	8.5	0.0	3.7	6.5	145.7	19.2	7.0	1.4	21.1	5.1	8.5	6.4	3.0
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035636-68047364	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	25.9	15.9	18.9	45.2	19.3	99.2	15.2	18.7	23.3	17.4	15.7	30.7	26.1	17.6	25.7	41.4	10.8	19.4	23.9	20.8	24.7	16.2	23.1	17.9	72.1	19.1	20.5	6.5	10.0	10.6	15.6	43.8	22.2	8.2	35.8	22.2	15.4	11.6	14.8	21.0	23.3	34.6	20.5	28.3	19.0	209.1	20.0	94.7	10.9	16.7	104.9	38.6	17.7	22.7	556.0	712.3	667.1	264.4	95.7	93.9	421.1	467.9	372.9	758.1	587.9	499.5	250.4	514.4	146.7	273.4	375.1	297.4	753.8	359.4	870.7	203.8	437.5	446.5	311.7	482.7	101.9	387.6	294.3	58.1	69.3	426.0	267.2	105.8	746.8	211.0	360.8	346.0	686.1	517.3	484.4	249.8	451.4	455.2	365.8	271.5	605.1	280.6	304.0	250.0	262.2	286.3	269.5	839.1	291.9	609.6	495.6	196.9	288.6	416.7	506.2	290.6	647.3	291.5	451.9	504.7	203.0	334.9	458.0	30.1	31.0	12.7	24.1	46.5	19.2	45.8	18.8	27.3	56.2	39.6	13.3	21.5	0.9	43.9	39.6	41.4	37.7	31.3	18.9	19.3	18.7	23.3	20.8	24.7	19.1	20.5	22.2	20.5	20.0	22.7	41.0	12.8	31.0	6.2	49.4	109.7	32.2	73.7	43.3	20.1	39.8	45.5	13.8	7.2	39.7	18.4	8.4	128.3	96.4	27.7	15.6	31.4	863.9	70.8	55.1	48.6	42.9	70.9	8.5	25.5	279.7	64.9	31.1	68.0	44.4	68.2	21.8	17.2	126.0	32.0	7.3	27.6	97.6	42.9	132.1	266.6	19.3	60.0	53.4	3.7	72.1	31.2	18.6	6.6	5.9	20.7	11.9	14.7	60.3	27.6	9.3	31.2	22.7	20.0	32.9	52.4	74.1	552.9	185.2	61.3	88.5	118.9	79.8	28.0	49.3	24.2
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	57.6	44.9	31.6	74.4	33.6	35.9	53.4	34.7	32.2	49.9	30.5	55.3	35.9	47.5	29.5	66.0	49.6	47.2	53.6	31.2	37.1	48.8	50.6	42.6	81.7	38.2	39.8	64.3	38.1	56.3	28.1	55.4	37.1	44.4	63.6	49.0	39.2	45.7	91.0	38.7	38.8	66.6	37.2	54.0	43.3	100.9	33.9	117.3	57.4	88.3	108.7	79.6	40.5	47.3	273.2	485.0	324.6	259.1	152.8	265.8	271.6	345.4	307.0	441.6	339.3	853.2	161.5	385.8	210.4	343.8	301.8	186.3	607.2	316.3	691.1	212.1	344.7	421.2	408.7	241.6	148.4	485.5	238.9	209.6	140.5	511.7	509.2	202.3	305.8	203.0	461.3	237.5	349.4	288.8	464.9	97.2	270.6	199.4	300.2	250.1	563.3	216.4	156.2	444.2	267.5	240.5	233.3	121.7	176.6	388.4	253.9	157.6	248.7	463.9	264.7	252.8	412.9	258.8	373.0	542.6	216.1	224.2	325.8	3.1	2.9	6.1	4.1	3.6	5.8	4.0	4.7	5.1	1.8	4.0	4.5	4.3	12.2	3.5	4.4	3.0	3.4	2.4	31.6	33.6	34.7	32.2	31.2	37.1	38.2	39.8	37.1	37.2	33.9	47.3	76.8	128.2	71.9	42.7	138.3	125.7	101.1	67.8	165.0	96.5	110.8	89.5	132.7	88.6	75.2	44.1	68.8	132.7	93.9	69.5	41.1	117.1	55.8	71.2	123.1	110.5	123.8	148.7	51.4	119.5	147.5	102.9	72.4	106.3	76.1	147.2	128.8	97.5	124.1	80.8	48.2	82.2	44.7	115.0	91.6	41.7	96.9	102.7	60.5	30.9	152.8	83.4	80.3	39.2	58.2	147.0	69.8	121.5	163.4	149.7	49.2	48.0	60.6	90.2	98.6	107.0	104.6	291.6	186.0	163.9	143.5	158.2	108.1	138.8	128.4	128.1
KREMEN1	"KREMEN, KRM1"	ENSG00000183762	"Kringle containing transmembrane protein 1"	Q96MU8	22	29073035-29168333	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 59.1;Skeletal myocytes: 82.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.3;neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 34.7;U-2197: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058513			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		1100000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA058513: AB_2683739"																		7.3	13.5	10.3	9.5	22.3	4.1	7.6	7.4	10.8	9.1	5.6	13.1	6.6	6.7	8.7	37.2	10.9	4.0	22.7	12.7	7.6	9.0	2.4	11.9	2.9	8.2	9.8	22.2	4.6	48.2	6.5	6.1	8.0	9.1	11.3	4.0	28.3	9.8	28.7	36.3	11.1	6.2	5.6	9.1	9.4	12.5	12.9	22.4	9.5	42.6	16.4	9.2	13.7	8.3	5.2	3.6	11.8	6.2	3.9	11.9	9.9	1.4	12.0	3.8	5.7	16.5	2.4	0.1	4.5	5.6	9.6	24.7	24.6	9.9	4.1	6.2	15.5	1.4	1.7	15.6	4.1	0.1	1.3	11.4	19.7	4.3	2.4	1.6	0.6	10.1	5.4	0.3	4.8	4.4	0.1	1.7	0.5	34.0	2.5	0.8	34.7	0.3	4.1	9.7	23.6	13.1	14.2	5.0	18.3	3.9	18.5	0.9	0.4	15.7	4.8	59.3	1.7	1.2	0.4	0.2	10.0	2.2	18.5	1.3	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	4.6	0.3	0.2	0.6	0.1	0.1	10.3	22.3	7.4	10.8	12.7	7.6	8.2	9.8	8.0	5.6	12.9	8.3	2.0	16.0	18.4	59.1	0.3	15.3	14.0	14.1	7.4	4.4	5.7	6.1	23.9	14.3	18.3	7.3	0.0	15.5	0.3	3.9	1.9	5.4	3.2	6.2	19.7	3.9	0.0	17.2	10.3	4.2	1.8	24.4	8.6	8.0	19.0	5.9	5.3	2.6	2.6	0.0	2.7	19.4	4.1	24.1	6.8	10.8	17.7	2.5	0.0	15.9	2.7	22.2	2.1	10.6	6.3	3.0	9.5	10.5	0.1	10.9	2.2	4.7	18.4	3.4	13.1	82.2	7.9	8.1	6.0	26.3	19.5	5.3	2.3	33.5	10.2	10.5
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2964216-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 4.1;skin 1: 7.7"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 14.1;Basal squamous epithelial cells: 23.3;Intestinal goblet cells: 14.0;Rod photoreceptor cells: 10.9;Spermatocytes: 9.7;Spermatogonia: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 29.3;MCF7: 15.0;RPMI-8226: 28.8;T-47d: 14.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoli		"HPA003223: AB_1079217"	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.1	0.1	0.7	0.3	0.7	0.7	0.1	0.0	0.6	1.5	0.0	0.3	0.1	0.1	0.1	2.0	0.3	0.1	0.0	1.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.0	4.1	0.4	0.0	0.3	7.7	0.6	0.0	0.0	0.2	0.2	1.7	0.0	2.1	0.0	0.0	0.8	0.0	0.5	0.1	1.8	1.1	0.4	10.2	0.0	0.0	1.5	0.6	0.0	0.0	0.0	4.2	1.5	7.8	2.1	0.0	1.1	8.6	1.3	0.7	0.0	1.1	1.2	0.5	2.9	2.6	0.0	0.6	29.3	0.2	0.0	0.0	0.1	0.9	0.0	0.8	3.3	2.9	0.0	15.0	1.8	3.5	2.9	3.0	2.2	4.7	11.8	28.8	0.1	0.3	2.9	1.8	2.0	4.7	5.2	0.4	14.9	2.8	0.2	0.9	12.2	1.0	0.7	5.3	1.3	4.7	0.4	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.7	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.4	14.1	0.9	0.3	23.3	0.4	1.0	0.9	0.9	0.0	0.0	0.0	6.2	0.2	0.0	1.1	0.0	0.1	0.7	0.4	0.1	0.1	0.0	0.0	0.4	2.7	1.8	0.1	0.0	0.9	4.5	0.0	0.0	0.0	0.1	0.0	0.1	14.0	0.0	0.0	0.6	0.6	0.0	0.2	3.6	0.0	0.1	0.5	0.0	0.0	0.0	0.2	1.3	0.0	0.1	2.1	0.5	0.0	0.0	10.9	0.0	0.0	0.3	9.7	18.0	1.2	5.5	0.1	0.6	0.0	0.5	0.4
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553085-10566031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 177.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA043110: AB_2678321, HPA043574: AB_2678561"	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	12.3	11.5	10.6	20.0	11.3	17.1	12.6	11.0	11.8	16.6	11.6	14.3	10.0	13.8	7.6	16.8	14.4	7.1	12.1	10.2	12.0	12.7	13.6	11.2	22.3	11.3	11.0	14.8	15.6	10.3	13.4	8.7	11.1	15.6	7.5	33.8	13.0	8.7	22.3	20.9	17.4	7.3	10.3	22.3	12.5	16.1	11.2	30.6	14.6	9.7	15.1	15.9	15.9	11.9	37.7	17.6	23.6	35.0	13.2	14.3	16.6	34.0	16.1	21.6	20.2	27.1	13.6	55.7	39.2	14.1	18.4	29.1	30.3	27.3	23.9	60.2	67.1	177.2	39.6	18.1	23.4	69.6	61.7	17.7	21.7	31.8	31.4	18.4	13.9	33.2	50.4	56.4	18.7	33.5	72.7	104.3	38.2	30.3	45.0	30.0	30.7	28.4	18.1	32.6	39.2	18.2	40.2	23.4	25.7	20.7	29.5	50.0	16.8	27.9	23.0	74.4	71.9	38.7	48.5	39.7	23.2	56.3	41.6	2.2	4.9	2.9	11.9	5.7	11.0	7.4	7.9	9.7	6.8	8.3	8.7	9.5	0.8	10.3	3.0	16.0	6.5	4.8	10.6	11.3	11.0	11.8	10.2	12.0	11.3	11.0	11.1	10.3	11.2	11.9	8.9	16.0	25.5	6.2	20.4	13.5	11.4	12.2	40.9	15.4	6.4	9.5	8.6	8.6	17.5	14.7	39.6	11.4	15.0	9.5	1.9	8.5	4.6	9.0	17.6	11.0	9.6	26.1	4.0	7.5	8.9	11.0	16.3	10.4	19.6	12.3	10.4	9.0	8.0	11.8	3.7	10.1	8.2	12.5	6.1	5.8	8.4	10.5	8.8	5.6	9.2	11.6	24.7	6.0	7.7	5.6	7.6	9.1	17.4	10.8	9.0	5.0	16.0	55.0	0.0	13.5	9.3	25.3	16.8	28.1	13.8	4.5	26.8	9.0	12.7	8.2
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1 small subunit processome component homolog"	Q13601	12	75490863-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	15.2	14.2	6.5	15.6	7.0	43.9	16.7	9.3	10.4	11.6	7.6	12.5	12.1	15.0	9.0	16.0	9.8	10.0	11.8	6.9	8.2	16.2	20.4	11.5	19.0	6.6	7.3	15.0	10.7	20.3	8.0	14.5	7.0	13.2	10.9	16.0	19.3	9.8	23.5	12.7	10.3	10.9	7.4	12.6	12.7	12.0	7.5	17.9	14.9	22.7	18.0	15.9	9.8	8.2	59.4	48.1	29.2	27.1	21.8	20.1	54.1	51.0	31.7	38.5	24.8	35.7	30.7	62.2	40.3	23.9	39.0	30.5	39.1	43.0	42.4	52.0	39.9	60.9	25.0	41.8	26.4	107.0	37.1	21.3	35.8	44.8	41.7	39.1	26.6	57.4	67.7	19.8	38.2	39.2	63.1	30.8	43.6	32.4	42.4	49.9	56.1	37.4	42.6	73.6	35.4	29.6	48.0	33.7	59.5	27.9	56.2	42.9	34.4	36.2	24.1	37.7	53.2	38.8	52.3	39.0	19.6	37.0	66.2	13.3	3.2	13.2	13.1	6.5	16.4	23.0	18.3	15.0	5.5	20.6	18.6	17.9	1.5	12.9	5.5	15.3	18.2	7.6	6.5	7.0	9.3	10.4	6.9	8.2	6.6	7.3	7.0	7.4	7.5	8.2	62.9	70.5	49.2	13.4	64.0	49.1	104.3	70.3	48.9	56.4	41.1	50.5	25.6	24.3	55.7	40.5	33.3	68.5	86.4	18.7	58.7	50.9	5.4	52.5	63.8	46.7	18.0	55.8	25.3	49.0	55.7	48.2	21.4	62.6	38.0	41.3	31.1	40.9	29.5	74.0	24.3	25.7	46.8	24.2	21.3	7.6	52.5	30.0	12.4	6.5	42.4	66.4	66.9	19.1	16.3	42.8	28.1	53.4	37.9	45.6	19.2	47.0	42.3	55.5	13.1	79.2	50.2	72.6	61.1	46.8	44.3	70.5	65.4	59.6	29.3	63.2
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40925.1;vagina: 13409.3"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 16844.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	93	"A-431: 2462.5;HaCaT: 1626.2"									"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		680000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	7.7	7.5	0.0	0.0	0.1	6.8	5.1	0.0	0.0	6884.6	0.0	5.6	0.1	10.2	0.0	40925.1	7.0	8.8	9.2	0.0	0.1	5.6	12.8	6.0	0.3	0.0	0.0	9.9	17.2	0.0	26.9	0.0	0.0	115.2	0.0	0.0	6881.1	3.8	9.8	20.5	8.5	14.2	0.0	7.7	31.3	6.9	0.0	13.6	6.1	0.0	1855.2	924.7	13409.3	0.0	2462.5	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.6	0.8	7.1	0.6	0.0	0.0	1626.2	0.0	0.4	0.0	1.4	0.0	4.5	21.8	0.0	0.0	1.7	1.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	5.4	1.2	0.0	1.3	0.1	0.1	0.1	14.8	0.3	0.2	1.2	0.3	0.0	10.7	0.0	0.0	1.9	2.0	7.7	0.0	2.3	6.4	5.1	0.0	0.4	0.0	6.6	0.3	6.3	5.8	1.9	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.0	1.1	0.0	0.9	2.8	545.6	17.1	146.8	0.0	2.3	4.6	0.6	1.5	94.5	0.0	0.0	0.1	0.2	0.6	0.0	0.0	1.2	2.7	0.2	11.4	1.2	5.5	0.0	0.0	0.5	12.6	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	8.2	0.0	0.0	3.2	55.9	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.7	286.6	27.1	227.9	0.1	0.1	3.3	0.0	0.0	0.0	16.9	0.2	0.6	16844.0	1.6	0.4	8.8	0.0	0.4	3645.4
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586895	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 6940.5"	"Group enriched"	"Detected in many"	9	"Basal keratinocytes: 35588.3;Suprabasal keratinocytes: 11677.1"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 5910.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4065.2;HBEC3-KT: 2003.9;hTCEpi: 2448.6;hTERT-HME1: 794.2;U-2197: 696.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"spinal cord: 36.3"	"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		1600000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favorable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	15.8	1.2	0.0	0.0	0.0	2.7	332.7	0.0	0.0	412.0	0.0	1.7	0.0	0.9	0.0	1304.2	1.7	0.0	3.5	0.0	0.0	0.8	2.5	1.7	0.0	0.0	0.0	1.3	2.9	0.0	4.3	2.2	0.1	29.1	0.0	0.0	702.1	3.8	15.9	6940.5	2.1	0.1	0.0	0.9	1.7	1.5	0.0	186.7	2.3	0.0	262.3	0.7	846.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.7	0.0	4065.2	0.0	2003.9	0.2	0.0	0.0	0.1	1.6	0.0	0.1	0.2	2.5	0.1	2448.6	3.0	794.2	0.0	0.1	0.0	0.5	3.6	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.6	0.0	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.4	0.0	0.3	9.1	1.7	696.0	0.0	0.9	0.0	0.0	3.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.5	35588.3	1072.7	181.5	2407.4	0.0	103.5	740.9	0.3	0.0	6.0	0.0	0.0	17.9	3.2	7.3	0.0	0.1	0.0	0.1	0.0	129.0	0.0	0.0	0.0	0.0	127.0	116.5	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.4	0.0	0.0	1833.4	0.0	0.0	9.3	1990.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.5	0.0	9.9	702.0	96.8	0.0	2.3	0.0	0.0	0.0	96.3	0.0	0.1	83.2	11677.1	2.5	62.1	0.1	2.3	100.0
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513745-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 419.1;esophagus: 1156.7;skin 1: 1319.5;vagina: 423.3"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 2789.9;Basal squamous epithelial cells: 8290.4;Squamous epithelial cells: 4637.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"HaCaT: 1156.8;hTCEpi: 1001.5"	"Region enhanced"	"Detected in single"		"white matter: 1.9"	"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		No	No		480000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favorable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	4.7	0.3	0.1	0.2	0.0	0.7	419.1	0.0	0.1	148.2	0.2	1.1	1.5	0.3	2.2	1156.7	32.4	2.8	0.7	0.1	0.0	0.3	0.6	4.3	0.0	0.1	0.1	0.4	1.4	0.0	1.2	0.3	0.1	182.8	1.6	0.0	140.0	4.1	0.7	1319.5	2.3	0.1	0.0	0.3	1.6	8.0	0.1	93.7	0.5	0.0	77.6	9.5	423.3	0.1	56.4	7.4	0.0	0.0	0.0	0.0	0.7	5.3	1.3	0.3	0.2	5.9	20.2	0.0	1.8	0.6	14.0	1156.8	0.0	41.8	0.2	0.6	0.0	0.0	7.7	1.9	0.0	0.1	4.7	0.0	1001.5	2.2	6.9	2.7	3.4	0.0	0.3	0.5	0.2	3.5	0.1	0.5	0.0	3.9	6.2	0.0	0.0	104.9	3.3	5.9	2.6	0.1	1.1	15.0	1.2	0.3	20.3	0.0	18.6	0.3	2.8	0.3	2.2	0.1	0.1	0.0	8.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	6.1	12.8	10.3	0.0	2.7	1309.8	2789.9	1190.9	8290.4	0.6	577.7	670.3	0.8	5.7	287.5	1.8	0.0	0.7	16.9	18.3	1.9	8.5	117.6	4.1	0.7	22.9	4.8	0.0	0.1	7.5	7.7	21.7	4.6	8.2	2.5	0.0	0.0	0.0	0.4	0.0	0.1	10.3	189.2	0.0	61.7	44.4	1.5	17.2	320.2	0.0	0.0	0.2	0.0	0.0	0.1	14.1	10.5	0.4	88.7	872.9	8.6	0.1	57.7	0.6	0.0	0.4	32.1	0.6	0.8	4637.9	193.6	1.2	21.6	0.1	7.2	906.0
KRT16	NEPPK	ENSG00000186832	"Keratin 16"	P08779	17	41609778-41615899	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 307.2;esophagus: 1025.8;skin 1: 360.7;vagina: 489.4"	"Group enriched"	"Detected in many"	6	"Basal keratinocytes: 906.1;Basal prostatic cells: 596.6;Suprabasal keratinocytes: 1348.4;Urothelial cells: 506.9"	"Group enriched"	"Detected in many"	7	"cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.9;hippocampal formation: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 816.8"	"Not detected"	"Not detected"							"CAB000136, HPA000539"	Approved		Approved	"Intermediate filaments"		NA	NA		1700000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"CAB000136: , HPA000539: "	"unprognostic (3.95e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (8.23e-2)"	"unprognostic (6.53e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.61e-2)"	7.1	1.4	0.2	0.1	0.3	0.3	17.4	3.9	0.6	307.2	0.0	0.2	0.0	1.0	0.0	1025.8	0.7	2.4	0.5	1.0	0.0	0.8	0.4	0.2	0.1	0.0	0.0	0.3	0.7	0.0	1.4	0.1	0.1	6.3	0.0	0.0	180.6	37.7	0.5	360.7	0.2	0.1	0.0	0.2	0.6	2.6	0.0	16.9	0.3	0.0	112.1	5.5	489.4	0.4	20.0	1.7	0.0	0.0	0.2	0.0	0.2	1.5	0.4	0.5	0.2	0.3	4.9	0.1	2.9	0.1	0.2	24.8	0.0	5.6	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	816.8	0.3	17.6	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.0	0.3	0.0	127.1	0.7	0.0	0.2	98.1	0.8	6.2	0.0	0.0	57.1	1.5	0.0	0.9	0.0	0.0	0.2	0.0	1.6	4.5	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	3.9	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	906.1	596.6	70.1	16.5	0.0	37.8	27.1	0.1	0.0	94.6	1.8	0.0	0.1	0.6	0.0	0.0	1.0	0.0	2.6	0.6	9.2	0.0	0.0	0.0	5.8	3.2	11.5	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	94.1	0.0	0.3	1.1	64.0	0.0	0.0	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.0	127.3	0.0	0.0	17.1	0.0	0.0	0.0	9.3	0.0	0.3	88.1	1348.4	0.1	3.4	0.0	0.0	506.9
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619442-41624842	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 382.1;skin 1: 949.4;urinary bladder: 632.2"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 13196.1;Prostatic glandular cells: 5931.6;Urothelial cells: 8499.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"hTCEpi: 20287.9;SiHa: 8539.7"	"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"		Yes	No		610000000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204"	"prognostic favorable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	5.1	0.4	4.9	0.8	5.3	2.8	382.1	3.5	5.8	102.2	3.5	2.0	0.8	4.3	14.1	320.4	6.9	1.9	2.7	6.3	3.3	3.1	0.6	9.8	0.3	3.5	3.4	0.9	2.6	0.5	6.6	7.0	3.5	132.4	0.3	0.3	263.2	116.1	0.9	949.4	0.6	1.0	3.4	0.4	2.3	4.5	3.3	142.7	1.6	0.0	97.8	632.2	212.3	4.7	212.5	0.2	0.0	0.0	0.8	0.9	48.8	1.9	0.4	2.8	2.7	16.8	1.9	1.0	14.7	0.2	0.4	2101.7	0.1	2129.1	1.9	0.3	1.6	2.0	910.8	2.0	0.5	1.9	2.2	0.4	20287.9	1.3	1539.9	0.0	1.0	0.0	1.0	1.5	0.4	0.7	0.7	0.3	0.4	237.2	0.0	0.7	3.1	1.7	0.8	770.5	0.3	0.2	8539.7	3.8	0.9	4.8	0.3	1.4	0.8	0.0	401.5	0.2	1.0	0.9	0.4	3.1	1.4	77.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.3	3.5	5.8	6.3	3.3	3.5	3.4	3.5	3.4	3.3	4.7	5.6	22.4	7.2	0.3	0.5	139.6	13196.1	338.0	327.8	0.2	158.4	792.8	0.1	0.0	415.8	36.8	0.0	21.5	3.8	0.9	0.0	567.7	0.4	116.9	13.5	54.5	1.8	0.0	3.2	202.1	148.5	87.9	0.0	134.1	3.8	0.0	0.0	0.0	3.8	20.2	0.5	0.6	36.7	0.0	14.1	1.6	2.1	37.5	10.6	3.7	6.7	0.0	0.0	0.5	1.4	1754.5	2.5	212.5	0.0	5931.6	0.1	0.4	100.1	0.0	0.0	0.9	101.0	0.3	0.4	48.2	124.3	5.7	60.8	3.1	0.8	8499.3
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 889.0;salivary gland: 810.7;urinary bladder: 781.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 7444.0;Club cells: 5055.9;Ductal cells: 4717.9;Extravillous trophoblasts: 6919.3;Pancreatic endocrine cells: 7374.9;Proximal enterocytes: 8623.3;Urothelial cells: 5959.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1945.3;HBEC3-KT: 2945.0;MCF7: 2220.9;RT4: 3146.7;SK-BR-3: 5446.1;T-47d: 3674.2"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"		NA	NA		300000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Intermediate filaments"		"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	89.3	18.7	2.0	61.7	2.4	0.3	403.3	7.9	2.5	250.0	1.6	525.7	348.3	57.9	72.0	889.0	176.1	298.6	13.5	1.5	1.7	141.8	7.7	204.1	0.4	1.6	2.9	74.4	48.8	14.3	15.6	175.1	2.2	208.3	359.2	0.1	810.7	194.2	1.3	141.9	776.1	46.5	1.4	1.2	631.5	3.4	1.8	127.8	28.3	1.6	98.3	781.4	317.0	1.8	2.6	343.4	0.0	6.3	0.7	1.8	1169.3	412.1	0.5	12.8	2.9	992.6	1945.3	0.4	393.3	199.0	1.5	1044.6	0.1	2945.0	2.5	0.8	10.4	0.2	213.4	692.3	30.3	0.0	82.0	0.7	524.9	9.0	0.4	0.2	26.2	0.0	148.4	2.5	0.1	2220.9	5.9	3.0	18.5	1323.5	492.7	2.9	0.1	5.8	1335.4	3146.7	40.0	1.7	3.3	5446.1	0.1	266.5	3674.2	0.3	1.7	3.6	6.1	7.7	0.7	1.1	0.8	2.0	1.5	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	2.4	7.9	2.5	1.5	1.7	1.6	2.9	2.2	1.4	1.8	1.8	10.5	673.1	185.5	0.0	17.8	5.2	4317.3	7444.0	1715.8	0.0	1393.0	867.5	2.9	662.0	5055.9	892.0	0.0	1160.8	20.5	3599.6	1.9	4717.9	0.1	737.2	102.8	41.9	362.5	0.0	0.1	2589.9	6919.3	171.8	1571.4	1010.7	94.6	1.0	1.1	0.7	179.0	0.0	0.1	1382.4	2720.0	2.6	2.5	2.6	37.9	25.5	190.3	1.0	30.0	0.8	0.0	0.0	0.0	7374.9	3399.6	88.8	19.9	2228.8	8623.3	26.7	1954.3	0.0	0.0	0.0	240.0	1.1	1.6	1302.6	1.1	2127.5	36.1	4.8	1619.0	5959.8
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703752	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 178.0;lymphoid tissue: 76.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.0;Fibroblasts: 4.6;Leydig cells: 3.1;Syncytiotrophoblasts: 4.0"	"Group enriched"	"Detected in some"	4	"cervical cancer: 9.6;head and neck cancer: 15.0;urothelial cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 7.0"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Low region specificity"	"Detected in some"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"		No	NA		300000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.3	0.0	8.0	0.0	0.1	16.7	178.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	5.8	0.2	2.2	1.6	0.0	0.0	0.3	0.5	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	76.3	2.6	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"esophagus: 19735.6"	"Cell type enriched"	"Detected in some"	18	"Squamous epithelial cells: 5828.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HaCaT: 734.9;SK-BR-3: 361.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		NA	NA		600000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.26e-4)"	1.5	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	513.5	0.0	1.1	0.0	1.2	0.0	19735.6	9.5	3.1	7.2	0.0	0.0	0.9	2.6	17.3	0.0	0.0	0.0	1.8	2.8	0.0	8.9	0.0	0.0	4.3	0.0	0.0	2124.1	0.0	2.6	3.9	1.7	0.9	0.0	1.5	8.6	0.8	0.0	2.0	1.0	0.1	1418.0	4.4	1040.2	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.8	0.0	0.1	0.0	734.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.5	1.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	1.4	0.0	0.2	0.0	15.5	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	361.6	0.0	0.0	2.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	1.0	0.9	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	3.3	0.0	0.0	0.0	6.5	36.9	23.3	0.0	0.5	2.9	0.5	0.0	308.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.5	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	6.9	0.0	0.1	53.7	0.0	0.0	0.0	5.3	0.0	0.1	5828.7	0.0	0.0	2.0	0.0	0.0	54.4
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520530	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 5865.0;skin 1: 5885.4;vagina: 2150.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 5870.1;Basal prostatic cells: 1037.6;Basal squamous epithelial cells: 1571.3;Squamous epithelial cells: 4370.9;Suprabasal keratinocytes: 2020.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1863.2;head and neck cancer: 3340.4"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	326	"plasmacytoid DC: 32.6"	"Lineage enriched"	"Detected in single"	326	"dendritic cells: 32.6"	"Group enriched"	"Detected in some"	7	"HaCaT: 3368.0;HBEC3-KT: 5990.5;hTCEpi: 13326.8"					"Region enriched"	"Detected in many"	8	"spinal cord: 36.4"	"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		3600000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	10.0	1.7	0.2	1.8	0.8	4.6	252.5	0.7	0.5	826.2	58.9	1.9	0.0	2.0	97.2	5865.0	12.5	2.0	3.8	1.7	0.0	1.3	3.5	6.4	3.0	0.1	0.0	2.2	4.7	0.1	8.2	2.0	0.1	125.8	0.0	0.0	880.3	100.0	9.9	5885.4	1.8	0.6	0.1	1.7	5.0	2.1	0.6	527.1	3.0	0.3	648.6	93.2	2150.9	0.4	50.6	0.0	0.0	0.0	2.3	0.2	0.8	0.0	0.0	0.0	0.0	1.0	0.3	2.4	0.5	0.2	0.0	3368.0	0.2	5990.5	0.2	0.0	0.0	0.2	0.1	0.0	0.6	1.4	2.8	0.3	13326.8	0.6	1049.7	0.0	0.8	0.0	1.8	4.0	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.2	1.0	1.2	0.8	0.9	0.0	0.1	1.2	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.5	0.2	10.1	1.0	0.9	4.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.1	0.2	0.8	0.7	0.5	1.7	0.0	0.1	0.0	0.1	0.1	0.6	0.4	1.7	0.0	1.1	0.0	0.4	5870.1	1037.6	627.1	1571.3	0.0	43.6	226.2	0.5	0.0	180.7	0.0	0.0	0.0	39.8	0.0	0.0	0.5	0.8	31.3	1.2	26.4	0.0	0.0	0.5	0.0	0.0	29.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	273.6	0.1	0.6	7.3	286.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	22.2	789.7	0.0	0.1	34.8	0.0	0.0	0.2	33.4	0.0	0.0	4370.9	2020.2	0.0	17.8	0.0	0.1	459.8
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487176-52493257	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Allergen, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 2523.3;esophagus: 7338.5;vagina: 4945.4"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 674.0;Club cells: 200.5;Squamous epithelial cells: 876.0;Suprabasal keratinocytes: 151.4;Urothelial cells: 306.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 9761.7"									"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		NA	NA		4500000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavorable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	3.1	1.5	0.0	1.9	0.0	0.1	6.9	0.0	0.0	2523.3	0.0	1.2	0.0	1.3	0.0	7338.5	9.1	0.9	1.8	0.0	0.0	1.1	2.6	3.4	0.0	0.0	0.0	2.3	3.3	0.0	3.1	8.8	0.0	5.0	0.0	0.0	1025.5	0.0	1.9	480.0	1.3	0.4	0.0	1.4	4.9	1.0	0.0	33.6	1.5	0.0	628.6	19.7	4945.4	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.9	0.0	0.0	1143.8	0.0	2414.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.5	0.6	0.3	9761.7	0.2	306.7	0.0	0.3	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	14.0	0.3	0.1	0.5	0.0	0.3	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.2	0.2	0.4	0.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.5	79.0	674.0	12.0	0.0	0.6	1.7	0.0	0.0	200.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	2.6	0.2	0.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	5.5	0.0	0.0	0.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	100.4	0.0	0.0	24.5	0.0	0.0	0.0	11.8	0.0	0.0	876.0	151.4	0.0	1.7	0.0	0.1	306.8
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 228.2;esophagus: 934.5;skin 1: 285.1;vagina: 229.6"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 217.5"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 1424.3;melanoma: 472.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 148.7"									"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440"	"prognostic favorable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavorable (9.52e-4)"	0.9	0.2	0.0	2.0	0.0	0.1	16.2	0.0	0.0	228.2	0.0	0.5	0.0	0.1	0.0	934.5	0.2	0.2	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	168.6	0.0	0.3	285.1	0.2	0.0	0.0	0.1	0.7	0.2	0.0	2.1	0.1	0.0	74.3	0.2	229.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	27.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.7	1.1	0.0	0.1	13.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	20.6	1.8	40.4	0.0	0.0	28.7	16.8	0.1	0.0	16.3	0.0	0.0	0.0	0.9	0.3	0.0	46.2	1.8	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	1.7	1.3	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	5.6	0.0	0.0	2.8	0.0	0.0	0.0	1.4	0.0	0.2	217.5	32.7	0.0	0.3	0.0	0.6	5.9
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 211.7;esophagus: 799.4;vagina: 333.5"	"Cell type enriched"	"Detected in some"	60	"Squamous epithelial cells: 234.3"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 564.7;melanoma: 242.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 94.1"									"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavorable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	211.7	0.0	0.1	0.0	0.1	0.0	799.4	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	144.3	0.0	0.1	24.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.1	0.0	9.5	0.1	333.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	94.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.2	1.3	2.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	234.3	2.4	0.0	0.0	0.0	0.2	3.9
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 905.8;thyroid gland: 593.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1756.7;Ductal cells: 2931.3;Exocrine glandular cells: 2143.5;Extravillous trophoblasts: 4196.1;Pancreatic endocrine cells: 6163.7;Prostatic glandular cells: 2386.6;Urothelial cells: 1900.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A549: 2418.2;BEWO: 2737.9;HBEC3-KT: 6225.3;hTERT-HME1: 2433.8;RT4: 7463.2;SiHa: 5833.6;SK-BR-3: 3363.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315, CAB079970"	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA		1300000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Intermediate filaments"	Cytosol	"CAB000028: AB_2134589, CAB079970: , HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (9.42e-5)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	27.1	0.7	0.0	1.4	0.0	0.3	272.9	0.0	0.2	48.4	0.0	1.6	0.4	12.9	15.2	91.7	75.9	82.4	5.6	0.0	0.0	147.5	14.2	325.2	1.7	0.2	0.0	2.4	57.4	5.6	12.0	265.1	0.2	58.1	0.7	0.3	905.8	213.2	1.7	78.3	1.3	0.4	0.1	0.8	17.8	0.8	0.1	3.3	593.0	2.0	6.7	389.8	20.1	0.4	4.9	2418.2	0.6	1.7	2.8	0.0	2737.9	509.6	0.6	261.3	23.6	7.6	1683.1	0.3	1.4	176.3	0.8	1871.6	0.2	6225.3	13.3	3.0	0.0	2.2	1179.8	8.0	57.4	1.5	1.5	1.3	380.7	1.3	2433.8	1.0	267.4	0.0	0.7	2.2	0.1	13.7	1.8	3.7	7.6	1.1	2.6	2.0	4.8	38.6	1520.5	7463.2	3.5	2.4	5833.6	3363.4	0.0	27.5	130.3	0.0	2028.2	1.9	3.7	2.4	1.1	1.8	0.4	2.0	2.0	1.6	1.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	8.1	653.9	109.4	0.0	2.5	3.6	1172.6	173.6	8.0	0.0	451.3	426.3	0.8	724.9	684.8	360.5	0.0	1756.7	8.9	2.2	135.0	2931.3	16.1	106.2	20.4	30.6	6.6	0.0	0.1	2143.5	4196.1	29.9	14.3	253.2	3.8	0.1	4.2	2.9	189.9	0.0	0.0	3.5	954.2	3.4	4.6	140.0	3.7	11.0	131.6	0.0	35.6	0.0	0.0	0.0	0.0	6163.7	0.3	0.4	1.4	2386.6	0.2	8.5	249.2	0.0	0.0	7.6	72.1	0.6	1.3	35.3	2.3	1442.5	9.2	0.0	4.4	1900.8
KRT74	"K6IRS4, KRT5C, KRT6IRS4"	ENSG00000170484	"Keratin 74"	Q7RTS7	12	52565782-52573843	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 5.6;skin 1: 16.3"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA040655, HPA048596"	Enhanced		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA		130000000		"Cluster 61: Skin - Cornification"		"Cluster 31: Spermatids - Spermatogenesis"	"Intermediate filaments"	"Nucleoli, Cytosol"	"HPA040655: , HPA048596: AB_2680457"		"unprognostic (6.75e-3)"		"unprognostic (3.93e-1)"		"unprognostic (1.60e-1)"		"unprognostic (2.49e-2)"		"unprognostic (9.46e-2)"		"unprognostic (2.29e-1)"			"unprognostic (8.54e-2)"		"unprognostic (1.02e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192014	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 219.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 25.9;Ductal cells: 63.0;Endometrial ciliated cells: 33.0;Glandular and luminal cells: 33.5;Pancreatic endocrine cells: 48.4;Suprabasal keratinocytes: 37.4;Syncytiotrophoblasts: 58.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 202.5;MCF7: 287.3;SK-BR-3: 127.7;U-2 OS: 174.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"		No	No		230000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Intermediate filaments"		"HPA077836: AB_2686857, HPA077918: AB_2686871"	"prognostic unfavorable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.4	5.3	0.0	0.3	0.0	0.1	8.7	0.3	0.6	18.5	0.0	0.1	0.5	1.2	0.9	51.0	3.4	2.7	0.3	0.1	0.0	2.7	0.7	3.4	0.0	0.0	0.0	0.2	11.6	7.0	0.4	7.3	0.0	1.5	0.1	0.5	24.8	3.4	1.3	219.1	0.3	0.1	0.0	0.1	0.5	0.3	0.0	0.8	0.8	0.0	41.1	9.9	36.5	0.0	202.5	66.7	0.0	0.0	0.0	0.0	54.2	2.9	1.8	15.3	4.6	4.5	85.9	0.0	94.4	2.3	99.4	98.5	0.0	1.3	5.3	0.4	0.0	0.0	99.4	2.4	10.1	0.1	0.1	1.1	11.9	3.5	23.0	70.2	23.2	0.0	0.0	0.1	5.4	287.3	0.2	0.1	0.4	58.5	10.1	0.2	79.4	3.0	87.1	35.7	24.5	1.3	50.1	127.7	1.2	5.6	24.1	1.0	13.5	0.3	174.4	0.2	71.6	0.1	0.3	0.5	18.0	7.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	6.2	3.9	4.4	0.0	0.0	14.7	4.6	0.4	10.0	9.4	11.0	0.0	25.9	0.1	0.3	0.0	63.0	0.9	33.0	3.7	0.5	0.0	0.0	0.1	20.4	3.4	0.4	0.0	33.5	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.1	12.2	0.0	1.6	0.5	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	4.8	0.1	1.8	21.7	0.0	0.0	0.4	2.2	0.1	0.0	2.9	37.4	58.3	0.3	0.3	0.3	8.5
KYAT1	"CCBL1, GTK, KATI"	ENSG00000171097	"Kynurenine aminotransferase 1"	Q16773	9	128832942-128882494	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"Granulosa cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021176, HPA021177, HPA027736"	Approved		Supported	Cytosol		NA	NA		22000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"	"unprognostic (6.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	3.5	4.7	12.3	3.6	13.3	2.3	4.0	13.0	15.5	7.2	10.6	4.7	2.5	5.8	2.9	5.3	6.4	2.7	10.3	12.1	11.8	7.8	12.7	3.6	5.0	13.2	12.3	6.2	3.1	5.5	8.7	2.5	12.8	7.4	1.3	7.5	4.2	4.3	12.6	7.7	4.2	3.1	12.3	5.4	4.9	5.6	12.9	8.9	6.1	8.7	4.8	7.2	6.7	18.0	4.8	9.8	9.3	10.6	6.9	11.4	3.0	5.5	8.0	6.2	8.0	3.9	9.7	8.3	2.9	4.6	7.0	14.9	13.9	11.1	9.3	10.0	7.3	5.7	27.7	9.6	7.7	5.0	1.9	4.5	7.1	7.1	7.7	21.8	11.3	22.7	8.2	9.0	8.5	3.1	14.0	3.4	15.2	18.3	7.6	16.4	6.4	18.9	8.7	1.7	10.5	7.4	9.9	2.9	6.2	12.8	6.6	1.6	7.0	4.6	7.9	7.1	5.0	15.2	11.0	11.6	9.6	8.3	3.2	0.1	1.4	2.9	5.1	1.8	4.5	7.7	5.7	6.0	5.5	3.3	5.9	6.7	0.9	3.3	2.9	2.4	7.0	3.3	12.3	13.3	13.0	15.5	12.1	11.8	13.2	12.3	12.8	12.3	12.9	18.0	2.6	0.0	1.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.0	0.6	0.0	0.0	5.0	0.9	0.0	3.9	1.6	0.0	2.6	3.3	0.7	0.0	0.0	0.0	0.2	2.4	0.7	0.0	4.2	0.0	45.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	7.3	2.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	1.3	1.3	0.0	0.0
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.7;Exocrine glandular cells: 38.2;Extravillous trophoblasts: 39.9;Proximal tubular cells: 35.6;Syncytiotrophoblasts: 83.5;Theca cells: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	19.3	22.5	8.3	16.0	9.3	13.4	29.8	10.0	12.2	18.0	12.3	19.9	22.6	21.3	21.7	26.5	18.3	20.0	11.3	9.4	9.5	30.5	27.4	15.4	22.1	8.5	9.5	25.7	30.0	33.4	15.2	22.7	9.2	21.1	21.7	11.0	20.5	22.1	10.6	18.8	17.4	15.7	8.7	17.6	22.7	9.9	8.7	21.6	26.2	10.0	23.7	24.6	14.9	8.9	55.1	11.1	52.2	18.0	19.1	51.2	46.4	31.7	57.2	39.8	49.4	15.6	18.9	35.6	23.8	23.8	27.3	15.7	15.6	25.6	57.7	22.7	21.3	32.4	9.8	26.8	61.8	45.6	8.5	44.9	25.2	29.0	50.1	26.8	37.0	41.0	41.5	19.0	37.9	17.8	48.0	21.6	31.0	42.5	10.3	49.3	36.2	19.2	87.0	49.2	38.9	45.6	44.4	60.0	29.1	31.8	33.3	13.9	27.7	17.5	11.4	55.5	23.1	23.7	13.6	23.6	8.4	19.5	14.7	8.3	12.1	7.5	8.0	7.7	11.1	8.6	10.6	9.5	16.3	8.9	10.6	9.3	8.8	11.3	10.2	5.9	16.3	8.3	8.3	9.3	10.0	12.2	9.4	9.5	8.5	9.5	9.2	8.7	8.7	8.9	10.6	12.8	11.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	16.0	13.7	0.0	0.0	8.1	12.9	0.0	70.7	13.1	0.0	25.4	34.4	0.0	12.7	14.1	4.6	0.0	0.0	0.0	38.2	39.9	10.1	0.0	14.3	5.1	17.5	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	1.8	0.0	0.0	35.6	3.6	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	83.5	7.6	43.3	0.0	0.0
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877657-143055833	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.4;urinary bladder: 51.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 136.1;Club cells: 109.6;Ionocytes: 114.0;Langerhans cells: 190.5;Macrophages: 122.9;monocytes: 248.0;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"classical monocyte: 109.4;intermediate monocyte: 142.7;memory B-cell: 73.6;myeloid DC: 111.2;naive B-cell: 51.3;non-classical monocyte: 123.4;plasmacytoid DC: 77.7"	"Group enriched"	"Detected in many"	19	"B-cells: 73.6;dendritic cells: 111.2;monocytes: 142.7"	"Cell line enhanced"	"Detected in many"		"A549: 185.2;GAMG: 298.5;HeLa: 195.5;Hep G2: 128.3;hTEC/SVTERT24-B: 106.5;U-87 MG: 314.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		590000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	5.2	4.0	2.4	24.4	2.1	10.8	30.8	2.7	4.5	4.0	3.6	2.4	1.1	2.5	1.3	6.7	1.2	9.8	1.2	2.0	1.6	18.6	88.4	13.5	15.0	2.8	1.7	0.4	0.9	0.8	1.2	7.3	3.3	0.9	2.9	1.5	1.8	0.7	0.7	1.3	3.0	4.8	0.5	8.9	5.8	16.6	6.6	3.9	2.3	0.3	28.9	51.5	3.4	2.1	0.2	185.2	0.3	0.4	0.4	0.6	0.5	0.4	5.1	0.2	0.2	3.3	2.7	11.9	0.5	0.1	298.5	0.7	0.1	0.2	0.2	0.6	0.2	4.3	195.5	128.3	2.4	0.4	0.8	17.3	15.0	106.5	0.6	0.2	0.2	0.3	0.5	1.1	1.7	96.7	0.2	11.8	0.7	0.2	0.9	0.2	0.9	0.4	3.2	96.0	0.5	0.3	102.2	15.2	1.0	1.0	50.9	26.5	1.5	5.9	0.5	89.1	0.3	0.7	0.3	0.3	314.5	22.2	0.6	0.7	109.4	2.4	0.5	142.7	0.4	73.6	0.6	0.3	111.2	51.3	0.5	0.3	5.8	1.8	123.4	77.7	0.6	49.2	2.4	2.1	2.7	4.5	2.0	1.6	2.8	1.7	3.3	0.5	6.6	2.1	3.0	3.2	2.7	0.7	46.8	4.0	0.5	136.1	0.0	0.5	5.8	0.9	1.6	7.2	109.6	3.7	4.2	3.3	16.1	0.7	5.9	14.5	46.3	1.5	1.1	5.1	0.0	2.5	1.3	9.5	2.3	1.8	20.4	15.7	0.0	0.0	2.5	49.1	38.8	10.1	0.9	0.0	114.0	64.7	190.5	42.8	1.8	122.9	1.8	29.0	248.0	0.2	1.0	0.5	0.8	59.6	1.1	0.4	5.1	1.1	0.0	44.4	21.1	0.6	6.6	0.5	3.9	47.8	8.0	1.5	3.1	104.7	2.2	0.1	1.0	22.6
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886173	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;intestine: 48.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 84.6;Excitatory neurons: 23.7;Horizontal cells: 33.7;Inhibitory neurons: 23.3;Melanocytes: 44.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 372.4;BJ hTERT+ SV40 Large T+ RasG12V: 200.8;HeLa: 258.1;RH-30: 162.6;RPTEC TERT1: 218.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	3.5	27.2	20.4	7.6	23.0	0.5	2.1	23.0	42.8	8.4	0.0	48.5	4.2	2.4	2.1	4.4	3.4	2.4	12.1	12.6	42.4	18.5	0.9	0.6	3.2	9.0	2.5	1.3	2.2	0.1	14.4	0.6	6.1	8.3	4.7	15.7	4.8	9.0	0.9	9.2	13.0	5.4	0.0	0.9	11.3	0.8	3.2	0.7	2.5	2.1	1.8	6.1	9.6	13.2	95.2	7.2	27.6	0.2	0.0	0.0	11.8	131.6	372.4	123.6	200.8	37.8	1.0	0.0	121.8	0.9	103.2	3.9	3.5	2.3	64.1	0.3	1.0	0.0	258.1	6.1	0.4	0.3	20.4	0.9	1.6	18.7	12.9	0.2	0.1	0.1	0.3	0.3	0.6	127.9	0.4	2.6	6.5	0.4	4.7	0.2	162.6	0.9	218.4	1.9	81.4	53.0	73.4	64.2	54.1	61.0	6.7	1.7	0.3	0.1	52.6	5.8	63.7	1.1	1.6	1.0	0.9	1.1	105.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	23.0	23.0	42.8	12.6	42.4	9.0	2.5	6.1	0.0	3.2	13.2	0.4	0.0	0.0	2.6	1.3	1.1	0.1	0.6	3.4	11.6	0.0	0.4	1.2	0.0	0.0	84.6	4.2	0.3	0.1	0.0	0.0	0.5	0.0	0.3	0.1	1.9	0.0	0.0	23.7	0.0	0.2	1.3	0.0	0.6	0.0	0.0	1.4	0.0	0.1	33.7	23.3	0.0	0.0	0.0	1.1	0.0	0.9	0.3	44.4	5.6	0.0	1.5	0.0	1.5	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	10.4	0.0	2.2	0.6	0.4	0.1	0.0	1.3	0.1	1.5	0.0	0.0	0.1
L3MBTL1	"dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3"	ENSG00000185513	"L3MBTL histone methyl-lysine binding protein 1"	Q9Y468	20	43489442-43550954	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 31.2;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 5.1"									HPA059648			Supported	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.65e-4)"	"unprognostic (6.02e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-4)"	2.7	4.8	8.6	0.8	8.5	0.8	3.9	6.4	10.2	6.4	6.1	6.1	1.1	5.0	2.0	4.2	6.9	0.6	3.9	8.0	9.4	5.9	2.0	3.0	0.8	8.0	8.8	7.5	3.3	1.1	16.7	0.6	8.7	6.4	0.7	3.4	4.6	1.7	5.1	3.9	4.8	0.8	6.1	5.5	3.9	10.1	10.8	0.8	6.9	1.1	0.5	4.8	6.4	7.6	0.1	0.1	1.6	0.9	0.1	0.0	2.6	0.2	0.3	0.5	0.4	0.2	1.7	0.9	0.4	0.9	0.5	1.1	0.0	0.4	0.3	0.0	1.1	0.3	1.4	2.1	0.3	0.0	0.3	0.3	0.6	0.1	0.0	2.9	0.3	0.9	0.6	0.2	0.1	0.3	0.4	1.2	1.0	0.7	1.4	0.6	0.2	0.5	1.2	0.4	0.4	1.3	0.5	0.5	0.1	5.1	0.6	1.7	0.6	0.2	1.1	0.0	0.4	1.0	0.4	0.3	1.5	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.2	8.6	8.5	6.4	10.2	8.0	9.4	8.0	8.8	8.7	6.1	10.8	7.6	1.2	3.2	3.2	16.0	3.3	0.9	2.0	1.9	8.0	17.2	2.7	2.8	1.9	1.5	4.2	5.5	14.6	2.1	5.2	0.9	1.9	1.3	2.0	2.4	2.6	2.2	1.2	1.7	12.4	0.2	3.3	1.9	2.0	1.8	5.1	8.3	1.8	0.6	1.4	6.7	24.4	2.1	4.1	1.6	1.8	2.8	5.0	2.0	3.6	4.7	1.0	4.7	4.1	31.2	25.4	0.8	1.9	6.0	1.7	2.5	3.1	0.7	6.6	10.8	0.0	4.2	2.8	13.9	12.3	1.5	1.1	1.9	2.3	4.6	1.8	1.4
LACTBL1		ENSG00000215906	"Lactamase beta like 1"	A8MY62	1	22953043-22965338	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 3.0"	"Cell type enriched"	"Detected in single"	10	"Bipolar cells: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066810			Approved	"Nuclear bodies"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"		"HPA066810: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183245127	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 39.3"	"Cell type enriched"	"Detected in many"	5	"Pancreatic endocrine cells: 1531.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 574.7;CAPAN-2: 501.6;HBEC3-KT: 2492.2;hTERT-HME1: 1487.5;RPTEC TERT1: 579.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, HPA046539, CAB078165"	Enhanced		Uncertain	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	No	No		130000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum, Golgi apparatus"		"CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689, HPA046539: "	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	3.5	0.1	0.2	16.2	1.9	0.1	20.9	2.6	0.6	15.1	0.2	12.1	2.6	12.3	2.1	7.7	34.9	13.0	3.0	0.2	0.2	13.8	0.7	24.9	8.0	0.0	0.1	1.0	3.3	0.0	4.2	10.9	0.1	5.4	12.9	0.1	12.9	6.1	1.7	17.5	15.0	3.3	0.0	0.9	14.9	2.8	0.1	11.3	18.5	2.3	12.3	39.3	6.3	0.2	574.7	25.4	0.0	0.7	4.9	11.9	40.2	4.3	4.7	2.1	0.7	41.4	501.6	0.0	207.9	1.4	16.4	252.4	0.1	2492.2	2.7	0.7	0.2	0.0	0.5	0.1	1.2	0.0	0.2	6.1	189.7	6.0	1487.5	2.3	32.6	0.0	0.0	0.2	2.5	1.1	0.0	0.1	4.5	206.7	35.2	0.1	1.2	0.0	579.4	147.1	30.5	0.1	14.7	0.4	0.9	14.9	2.0	2.7	3.8	2.2	30.2	15.0	7.8	0.9	0.7	0.7	4.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	2.6	0.6	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.5	218.0	17.8	0.0	0.2	86.3	227.1	232.7	105.3	0.0	8.2	26.2	2.3	10.0	56.8	23.9	0.0	30.7	0.4	74.4	0.0	183.4	19.6	68.9	3.6	7.8	9.0	0.0	0.4	94.0	11.7	17.2	59.7	97.4	0.0	0.0	0.0	0.0	2.5	0.0	0.3	34.1	14.2	0.0	4.9	11.8	3.4	3.1	8.8	1.0	2.6	0.0	0.0	0.0	0.3	1531.1	91.2	0.4	0.3	302.0	16.7	0.2	69.3	0.0	0.0	3.4	9.6	3.6	1.0	60.3	29.7	83.3	5.3	0.1	15.3	169.9
LAMP5	"BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46"	ENSG00000125869	"Lysosomal associated membrane protein family member 5"	Q9UJQ1	20	9514358-9530524	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.6;retina: 29.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 78.4;Granulosa cells: 22.2;Horizontal cells: 60.6;Inhibitory neurons: 38.9;Theca cells: 23.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"plasmacytoid DC: 141.3"	"Lineage enriched"	"Detected in many"	31	"dendritic cells: 141.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 469.4;SH-SY5Y: 86.4;THP-1: 169.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004802, HPA070765"	Enhanced		Uncertain	"Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Mitotic spindle, Centriolar satellite"	"HPA004802: AB_10603682, HPA070765: AB_2686309"	"unprognostic (2.78e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.73e-4)"	"unprognostic (5.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (6.46e-6)"	"unprognostic (5.12e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.49e-3)"	0.5	4.3	41.7	1.5	96.6	2.3	0.9	11.0	51.8	8.8	3.7	2.2	1.2	4.8	6.3	0.4	10.6	3.1	0.4	39.1	14.3	0.8	0.2	0.9	5.7	47.7	10.1	21.9	1.2	0.7	6.3	0.1	43.7	2.3	1.2	29.6	1.1	3.8	0.1	0.7	1.3	3.9	29.1	1.8	1.4	0.9	35.3	1.4	0.9	0.2	5.2	0.7	1.2	13.6	0.1	0.2	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	469.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	86.4	0.0	0.0	0.1	0.4	0.0	169.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	21.1	0.3	4.2	1.7	0.0	0.0	0.3	0.2	4.5	0.0	0.1	9.5	0.5	0.0	0.0	0.4	0.0	0.0	141.3	0.0	2.4	41.7	96.6	11.0	51.8	39.1	14.3	47.7	10.1	43.7	29.1	35.3	13.6	0.5	0.0	1.1	6.2	3.4	0.1	0.0	0.0	0.0	12.3	0.3	4.3	0.3	0.0	0.0	0.0	8.4	0.0	78.4	0.0	0.0	0.8	5.4	0.2	0.7	0.8	0.0	0.0	10.0	0.0	0.0	8.4	0.0	0.7	0.0	22.2	0.0	0.0	1.3	60.6	38.9	0.0	0.0	0.6	0.8	7.5	0.6	3.5	3.6	4.7	5.4	3.9	0.0	13.0	1.5	0.4	0.0	0.0	5.5	0.5	0.0	0.0	0.0	5.7	0.0	0.3	13.9	0.6	1.1	0.0	0.0	0.0	0.9	23.2	0.1	0.0
LAMTOR2	"ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3"	ENSG00000116586	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2"	Q9Y2Q5	1	156054782-156058506	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 627.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004126	Approved		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"		"HPA004126: AB_1849916"	"unprognostic (2.09e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.35e-1)"	64.3	84.4	81.9	41.6	81.4	57.1	57.7	83.9	98.9	44.8	83.0	62.0	51.5	42.3	76.7	75.2	52.1	43.8	96.1	81.6	84.7	91.0	164.3	53.8	56.3	81.6	82.5	26.7	87.8	74.4	44.6	37.5	82.0	50.9	56.5	18.0	59.3	44.0	88.6	57.8	53.7	48.9	82.2	65.7	78.1	26.6	85.8	56.1	44.7	70.2	52.0	53.6	46.7	85.8	63.9	142.3	65.4	90.9	131.9	106.7	72.3	55.7	94.4	68.8	78.1	65.9	106.1	94.0	94.4	108.7	60.0	91.5	67.7	151.1	38.7	78.4	103.0	54.9	96.2	88.6	104.4	78.0	86.5	126.1	93.4	73.1	93.3	94.4	142.6	137.3	50.8	68.1	100.9	128.7	80.6	111.4	69.4	250.9	212.1	67.5	48.7	138.7	152.5	93.2	25.3	145.3	70.4	195.1	116.3	104.1	136.5	227.9	96.6	57.5	52.4	83.4	53.0	101.6	166.5	56.2	102.2	87.3	62.9	281.8	465.8	376.2	172.2	446.9	169.8	290.6	188.2	188.7	537.2	249.4	142.6	152.8	231.8	207.0	363.2	284.1	298.3	389.7	81.9	81.4	83.9	98.9	81.6	84.7	81.6	82.5	82.0	82.2	85.8	85.8	102.5	57.7	46.5	3.6	64.5	48.4	59.5	190.3	43.3	29.4	129.9	123.2	113.5	114.4	120.2	108.5	6.2	146.3	73.9	247.5	387.4	193.0	44.5	113.2	78.7	92.6	126.1	48.0	4.5	179.3	203.1	67.5	68.3	105.0	107.3	56.7	86.7	322.1	416.1	6.7	5.4	164.7	197.4	188.9	150.1	89.0	47.2	165.0	158.3	5.6	297.4	92.8	94.7	4.5	5.8	183.2	267.4	50.8	76.8	80.2	317.8	627.2	144.1	30.5	32.9	38.9	124.6	25.5	33.9	99.4	80.0	77.2	64.2	83.3	166.9	97.7
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577198-17607972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 230.6;Hofbauer cells: 262.1;Proximal tubular cells: 274.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		3500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	92.8	52.6	33.0	131.4	34.8	59.2	60.3	39.0	42.9	30.7	31.4	60.3	78.3	34.4	25.4	44.6	45.4	67.3	65.0	31.8	36.3	106.3	190.4	100.6	150.4	46.3	37.7	24.0	30.9	61.0	22.1	70.9	42.2	36.7	62.0	20.0	67.7	31.0	68.1	40.3	61.3	76.2	45.6	94.1	55.3	43.8	41.9	56.8	46.4	63.8	94.3	82.8	25.3	42.9	51.7	44.4	41.6	39.4	80.5	97.9	0.4	79.6	89.1	282.3	340.3	81.4	96.1	202.0	51.7	61.6	167.9	31.3	157.7	56.3	106.7	77.7	45.2	112.1	47.3	107.6	94.1	102.3	69.2	100.0	35.3	92.7	48.6	32.3	99.7	52.2	110.6	139.9	67.6	55.6	91.9	139.5	87.1	96.3	83.9	139.8	39.8	102.7	73.5	59.6	61.4	50.2	72.9	44.4	161.1	57.3	37.9	39.1	65.2	71.3	48.5	76.1	140.6	127.7	208.8	172.7	96.3	167.2	70.8	43.1	200.6	44.7	33.7	210.0	31.0	32.7	31.2	36.3	204.6	23.5	26.7	28.3	28.1	54.0	158.1	116.6	60.2	135.8	33.0	34.8	39.0	42.9	31.8	36.3	46.3	37.7	42.2	45.6	41.9	42.9	230.6	28.9	49.6	10.7	34.4	22.0	26.1	60.1	21.6	8.1	53.5	41.7	48.9	18.6	44.1	27.6	2.1	35.9	68.3	44.2	117.4	68.6	100.5	67.3	45.7	129.7	16.3	31.7	6.4	109.2	54.7	42.0	29.6	40.7	64.1	29.4	71.0	95.5	262.1	6.7	9.6	35.6	42.7	92.1	50.5	31.7	23.0	141.9	42.7	18.7	195.0	103.8	28.8	9.5	21.2	53.3	31.8	35.0	71.2	26.9	52.4	274.0	92.5	15.4	32.9	31.3	57.8	95.7	13.7	32.5	22.9	55.7	42.4	80.7	45.6	27.1
LARP6	"acheron, FLJ11196"	ENSG00000166173	"La ribonucleoprotein 6, translational regulator"	Q9BRS8	15	70829130-70854157	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 429.0;Late spermatids: 259.8;Spermatocytes: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 232.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020338, HPA049029"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Microtubules	"Cytokinetic bridge"	"HPA020338: AB_1844500, HPA049029: AB_2680604"	"unprognostic (1.35e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.63e-3)"	"unprognostic (2.96e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (4.51e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.43e-1)"	51.4	9.8	42.8	6.5	69.8	0.1	44.0	56.9	65.5	27.5	22.8	18.5	2.1	22.8	28.4	7.9	29.0	10.9	43.4	44.5	52.0	27.9	10.6	17.9	2.3	57.8	56.6	30.4	10.9	19.6	23.6	7.7	56.4	26.1	4.0	11.8	19.5	14.1	17.6	14.0	10.3	12.1	46.8	2.6	26.9	9.6	55.9	5.1	40.8	26.1	1.5	21.1	31.0	90.4	42.3	44.2	14.1	28.3	70.2	77.9	0.1	127.7	99.0	67.4	71.2	12.9	12.0	0.0	50.9	69.9	65.4	22.7	32.0	11.2	66.4	0.4	78.3	0.2	37.6	12.0	127.1	0.2	0.2	49.0	45.6	67.9	107.5	70.6	22.2	15.4	0.1	0.6	30.4	7.3	0.3	0.3	14.9	0.0	113.9	0.2	50.6	0.3	22.0	35.9	8.4	18.5	42.5	0.5	93.1	21.7	2.3	2.4	29.6	27.4	109.6	232.0	107.5	0.2	0.3	0.4	116.9	0.0	14.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	42.8	69.8	56.9	65.5	44.5	52.0	57.8	56.6	56.4	46.8	55.9	90.4	32.3	0.0	1.1	2.9	0.1	18.1	47.7	20.4	9.6	41.4	15.4	18.3	22.2	24.3	11.8	12.9	2.1	0.5	1.0	0.3	54.8	59.4	429.0	24.6	31.8	24.5	12.0	0.0	10.8	25.1	0.8	87.5	4.1	8.4	0.0	7.5	11.4	15.3	1.2	25.2	11.8	1.5	10.2	0.6	13.3	259.8	73.3	3.2	19.6	7.5	0.1	28.5	0.0	5.5	105.9	62.9	0.0	45.9	0.5	61.9	0.0	100.9	16.8	4.8	19.7	28.3	34.8	166.8	11.0	1.4	8.9	0.4	1.9	5.3	0.6	37.7
LARS1	"FLJ10595, FLJ21788, HSPC192, LARS, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase 1"	Q9P2J5	5	146110566-146182696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.8;Cardiomyocytes: 135.7;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 40.3;Hofbauer cells: 36.7;Smooth muscle cells: 22.7;Syncytiotrophoblasts: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: AB_2677185"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.96e-2)"	35.4	37.0	40.0	26.6	42.0	20.2	46.3	42.8	48.9	33.9	44.0	34.4	18.4	33.9	35.4	35.0	34.8	18.7	38.5	40.4	44.3	34.6	25.6	26.4	29.7	42.3	42.9	37.2	49.7	34.7	37.0	22.2	41.8	35.6	34.8	34.7	40.0	28.3	70.6	31.7	28.1	33.4	43.1	35.7	29.8	23.9	43.2	32.7	34.7	58.8	34.8	35.6	30.9	46.2	56.1	59.5	65.9	125.9	88.0	95.7	102.5	45.5	57.8	71.4	92.4	66.1	59.8	67.8	32.7	91.2	72.6	52.9	107.2	116.5	106.4	45.2	88.2	65.5	76.0	58.5	122.7	101.4	51.9	83.7	153.6	92.0	173.3	73.2	87.7	108.0	67.4	121.3	83.4	56.9	102.8	116.1	126.8	63.8	86.8	75.0	62.0	101.9	73.6	44.1	77.7	97.3	50.2	111.6	221.2	76.6	103.1	159.3	63.4	61.2	44.3	56.7	89.4	79.3	82.3	86.3	89.8	164.1	79.1	1.1	11.8	5.4	14.5	19.2	19.6	18.9	16.6	14.9	21.2	15.5	21.2	21.9	0.7	19.2	16.7	16.6	19.6	14.9	40.0	42.0	42.8	48.9	40.4	44.3	42.3	42.9	41.8	43.1	43.2	46.2	26.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.7	0.0	0.0	0.0	0.0	39.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	40.3	16.6	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	33.0	2.8	0.0	0.0	0.0
LATS2		ENSG00000150457	"Large tumor suppressor kinase 2"	Q9NRM7	13	20973036-21061586	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA039191: AB_2676385, HPA049037: AB_2680609"	"unprognostic (2.77e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-1)"	"unprognostic (6.57e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-2)"	19.8	12.2	3.9	7.3	4.3	15.1	12.4	4.8	3.7	10.1	7.7	13.1	2.9	12.2	3.0	11.5	9.7	15.1	11.5	5.3	3.3	9.9	9.8	12.4	5.3	5.4	4.6	11.0	10.2	4.3	2.3	13.9	4.5	9.8	4.3	1.3	6.1	8.8	16.7	7.7	6.2	13.1	4.1	11.2	7.8	14.6	5.1	2.4	13.5	13.3	3.3	14.2	8.9	4.7	6.8	7.4	16.0	9.7	18.4	24.1	14.6	22.1	22.8	22.5	19.2	21.1	10.0	0.0	10.5	33.8	8.8	9.6	9.5	10.1	33.1	3.8	2.5	12.4	9.4	16.0	28.6	3.4	4.2	36.0	18.1	14.9	9.9	11.3	32.0	2.8	2.3	0.5	28.9	11.7	0.4	11.6	3.8	7.0	3.5	2.9	28.5	0.0	16.3	3.1	0.3	0.0	17.4	11.3	23.9	13.9	9.8	6.4	40.6	23.8	15.9	17.7	14.1	2.9	1.7	0.0	5.7	3.8	18.6	0.1	0.5	0.5	0.4	0.4	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.9	0.4	0.2	0.0	0.0	0.1	3.9	4.3	4.8	3.7	5.3	3.3	5.4	4.6	4.5	4.1	5.1	4.7	36.6	41.7	9.9	12.1	2.8	32.9	14.7	8.5	21.6	0.4	12.5	11.0	24.3	15.7	10.5	5.5	0.0	24.8	21.0	6.5	3.9	10.1	139.4	40.3	30.4	35.1	0.0	8.2	0.6	7.3	8.9	37.2	8.6	62.1	5.1	9.8	44.6	19.6	9.9	0.0	0.6	1.9	6.1	17.9	49.3	13.7	25.4	26.0	17.8	21.5	11.0	4.9	13.4	2.0	8.8	18.6	2.8	34.6	8.9	21.7	0.6	9.5	11.6	1.0	6.6	32.3	30.0	8.8	14.5	9.9	25.3	48.0	8.1	7.9	1.5	15.2
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 26.5"	"Cell type enriched"	"Detected in single"	5	"Skeletal myocytes: 3.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 1.9;medulla oblongata: 3.5;pons: 2.5;spinal cord: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 3.4;RH-30: 4.3;SCLC-21H: 9.1"	"Group enriched"	"Detected in some"	24	"cerebellum: 1.6;pons and medulla: 3.0"	"Group enriched"	"Detected in some"	18	"cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0"	"HPA002016, HPA002086, CAB079927"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.5	0.4	2.5	4.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LBX2		ENSG00000179528	"Ladybird homeobox 2"	Q6XYB7	2	74497517-74503316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 5.3;liver: 8.7;stomach 1: 3.2"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 3.7;Proximal tubular cells: 7.5;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.5;Hep G2: 22.1;SK-MEL-30: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.9;olfactory bulb: 1.0"	HPA044257	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Midbody	"HPA044257: AB_2678880"	"unprognostic (5.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.35e-5)"	"unprognostic (8.22e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.43e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	1.3	0.3	0.3	0.4	0.3	0.4	0.6	0.9	0.4	0.4	0.0	1.1	5.3	0.3	0.2	0.2	0.2	0.4	0.3	0.1	0.2	1.3	8.7	0.5	0.4	0.5	0.2	0.1	0.7	0.1	0.0	0.5	0.5	0.3	0.1	0.1	0.5	0.3	0.4	0.9	4.8	0.2	0.1	1.1	3.2	0.1	0.4	0.0	0.3	0.0	0.1	0.3	0.2	1.3	4.4	1.6	0.0	0.1	2.0	1.5	7.1	0.3	0.2	0.4	0.4	10.5	6.2	0.2	1.7	0.8	0.6	1.7	0.0	0.3	0.0	9.0	1.8	4.7	0.7	22.1	1.4	0.3	3.0	1.9	1.6	1.6	0.3	0.2	1.8	0.1	3.1	2.2	0.3	2.3	0.1	0.7	0.4	1.7	0.2	0.4	0.4	0.2	0.2	1.4	0.2	1.1	2.6	0.4	10.1	0.1	0.2	0.3	4.1	1.5	6.6	8.1	0.2	2.9	2.3	0.2	1.5	0.8	4.8	0.5	1.5	0.1	0.3	0.8	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.2	0.6	1.1	2.2	0.2	0.0	0.7	0.3	0.3	0.9	0.4	0.1	0.2	0.5	0.2	0.5	0.1	0.4	1.3	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.7	0.5	0.7	1.5	0.5	1.8	0.0	0.3	0.5	0.9	0.0	0.6	0.0	0.4	0.5	1.0	2.4	0.4	0.0	0.6	0.5	1.3	1.1	0.2	0.0	0.0	1.4	3.7	1.1	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	2.4	7.5	0.7	0.0	6.6	0.0	0.9	0.4	0.1	0.3	0.1	0.5	0.5	0.2	1.0	0.1
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.3;Inhibitory neurons: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	4.2	4.9	6.1	5.0	6.7	9.9	5.3	10.8	9.3	6.7	3.4	7.8	12.3	7.2	9.8	5.1	6.1	6.2	11.3	5.3	7.8	9.5	8.6	5.1	5.4	2.9	3.3	4.9	5.9	6.3	3.2	4.3	3.1	7.8	7.9	10.6	4.6	7.0	9.6	6.6	9.5	8.7	0.8	5.3	5.3	8.3	7.0	6.4	10.9	4.1	5.4	4.9	3.7	10.2	16.9	21.6	11.3	19.3	2.6	5.7	16.3	11.8	11.7	12.3	10.3	21.8	19.0	10.5	10.7	18.4	15.2	18.3	38.8	16.0	12.1	13.6	13.0	19.4	12.8	21.6	12.0	28.1	14.3	4.6	12.4	13.0	18.0	8.0	8.7	6.0	18.3	9.5	9.6	12.8	16.1	16.5	12.5	13.6	12.4	15.6	22.9	21.8	9.7	24.7	13.1	20.5	26.4	17.4	15.7	7.7	12.6	9.5	10.0	22.1	18.2	12.4	18.9	7.0	16.2	23.2	22.7	20.1	17.3	15.9	2.3	5.0	5.2	3.8	6.2	7.5	8.3	6.7	2.8	9.7	11.7	11.5	7.2	4.6	3.6	2.0	4.2	3.0	6.1	6.7	10.8	9.3	5.3	7.8	2.9	3.3	3.1	0.8	7.0	10.2	6.5	9.6	6.9	27.1	11.4	7.1	5.0	8.4	6.8	15.5	6.9	5.3	20.1	18.6	8.7	14.7	27.1	5.2	6.7	10.4	0.0	7.7	3.9	12.0	7.0	7.7	13.1	10.3	67.3	16.4	5.3	6.7	3.1	9.4	3.8	11.6	8.6	21.5	6.1	15.2	86.8	14.3	0.0	5.7	3.9	1.4	5.6	3.4	5.4	45.0	2.4	7.9	5.2	50.8	37.3	12.9	8.6	9.1	5.2	5.4	21.4	12.1	16.6	18.2	6.6	10.9	16.3	13.9	21.0	7.9	6.7	1.9	9.1	10.9	17.0	4.7
LCMT1	"CGI-68, PPMT1"	ENSG00000205629	"Leucine carboxyl methyltransferase 1"	Q9UIC8	16	25111731-25178231	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041559, HPA043530"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA041559: AB_2677548, HPA043530: AB_2678532"	"unprognostic (9.08e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.41e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-3)"	"unprognostic (6.71e-2)"	17.5	27.3	41.5	13.3	43.2	19.9	22.5	41.1	44.5	23.9	36.5	22.0	16.8	21.2	31.1	22.8	20.5	13.6	36.1	45.1	42.8	26.9	10.9	14.9	16.7	39.9	39.0	28.1	47.2	32.0	32.9	24.1	42.4	20.8	21.3	21.8	21.2	21.3	52.3	28.2	17.1	18.5	40.2	16.2	22.5	35.4	43.4	21.3	18.6	36.2	20.2	18.1	20.6	43.0	40.3	36.3	33.9	47.2	30.2	42.9	34.9	24.7	40.5	35.7	45.9	46.4	35.7	24.4	34.1	37.6	44.2	20.1	35.9	34.3	47.9	24.9	53.3	13.5	35.4	77.3	67.9	32.0	20.9	48.7	37.7	39.9	41.4	51.3	32.3	54.0	21.5	31.2	39.5	102.3	37.9	60.6	52.1	25.3	37.0	44.3	30.9	47.7	40.7	27.9	55.5	34.1	29.0	45.8	58.2	39.9	46.0	14.9	19.1	34.6	24.3	23.4	25.0	39.8	43.9	25.8	42.3	27.5	26.6	33.4	36.5	46.2	39.4	33.5	43.3	42.0	47.8	42.1	35.0	31.6	42.8	39.2	14.6	33.6	37.6	18.1	82.9	42.2	41.5	43.2	41.1	44.5	45.1	42.8	39.9	39.0	42.4	40.2	43.4	43.0	21.0	16.0	19.8	15.3	23.5	24.1	31.1	55.6	33.6	25.7	39.3	42.0	34.8	15.7	29.6	33.1	2.1	164.5	20.9	60.5	49.0	51.7	76.5	22.7	31.4	22.7	51.4	29.5	29.0	66.7	69.4	29.1	20.9	20.2	9.5	197.7	23.2	9.5	46.8	23.5	30.1	46.9	38.7	33.9	20.0	137.5	26.1	27.0	33.8	17.8	31.3	32.0	32.0	28.1	31.7	46.7	45.1	24.0	28.9	34.6	79.4	90.0	30.0	26.1	26.3	22.9	67.7	67.3	52.9	35.6	31.8	163.8	29.6	78.7	43.7	34.7
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 709.0;epididymis: 402.7;lymphoid tissue: 605.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.4;granulocytes: 309.1;Hofbauer cells: 264.4;Kupffer cells: 401.2;Langerhans cells: 337.6;Late spermatids: 290.9;Macrophages: 466.1;monocytes: 535.7;NK-cells: 471.7;T-cells: 375.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 875.8;HDLM-2: 799.3;HL-60: 850.7;HMC-1: 861.7;JURKAT: 792.7;NB-4: 789.2;THP-1: 840.5;U-698: 1105.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		1800000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	85.9	31.1	11.3	396.9	13.1	709.0	43.9	13.9	30.9	28.5	16.8	54.7	42.4	27.4	402.7	29.5	21.5	76.4	14.5	11.3	14.2	13.1	89.0	173.8	563.5	19.7	18.9	10.0	12.2	12.6	4.3	67.2	21.3	184.5	71.2	4.9	44.4	24.3	7.1	40.6	62.3	60.4	18.6	375.2	53.2	33.2	24.8	499.8	23.6	17.8	605.1	133.0	7.7	29.9	36.1	0.2	1.9	0.0	0.0	0.0	409.8	0.1	1.2	3.9	2.9	237.4	1.4	875.8	179.5	0.0	249.1	1.7	0.1	0.6	3.9	799.3	202.9	187.6	0.4	1.1	0.9	850.7	861.7	2.3	0.1	1.4	1.2	0.3	0.0	792.7	100.4	569.7	0.0	2.8	624.8	789.2	1.0	0.4	8.2	451.6	1.6	638.2	0.0	233.8	2.8	7.5	1.9	91.8	6.4	25.0	6.4	840.5	3.1	22.0	13.6	1.5	25.5	135.3	292.5	1105.7	17.0	530.9	3.6	1007.3	1559.5	810.8	915.7	1806.2	822.0	342.3	539.6	761.2	1134.5	251.6	330.2	560.5	1908.6	650.6	1826.1	297.5	598.1	3644.2	11.3	13.1	13.9	30.9	11.3	14.2	19.7	18.9	21.3	18.6	24.8	29.9	7.4	32.1	73.2	0.3	185.2	12.0	1.2	0.0	1.8	0.4	10.3	11.7	4.2	5.7	18.0	3.7	0.0	9.8	438.4	0.2	0.0	16.9	113.1	4.7	42.8	9.6	1.2	63.9	0.5	16.3	68.3	10.9	19.9	7.0	309.1	0.7	12.5	24.0	264.4	0.0	0.5	0.5	0.0	401.2	337.6	290.9	1.2	466.1	23.2	17.8	535.7	23.7	471.7	0.5	1.5	6.8	2.4	1.9	102.4	42.0	0.1	1.5	13.8	1.2	0.0	3.1	6.2	2.7	1.6	2.2	11.8	13.5	375.3	0.5	0.4	4.0
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.5;Endothelial cells: 194.4;Excitatory neurons: 1314.4;Hepatic stellate cells: 364.8;Inhibitory neurons: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AF22: 18.3;fHDF/TERT166: 19.0;HAP1: 34.4;HUVEC TERT2: 65.3;TIME: 17.1;U-138 MG: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	58.9	15.5	13.7	8.0	19.8	0.4	52.2	3.3	45.9	43.5	7.6	12.7	6.5	65.5	23.4	15.8	28.0	31.2	33.7	23.3	7.3	28.0	26.0	58.2	11.5	4.4	10.9	18.2	7.6	17.0	9.0	58.8	4.7	18.0	8.5	5.3	10.8	13.7	14.0	9.4	12.8	53.8	7.1	50.4	11.5	5.0	7.9	8.3	31.3	24.3	4.8	22.5	22.8	19.7	0.0	0.0	18.3	0.1	10.5	16.9	0.0	10.2	8.0	1.2	2.7	0.0	0.0	0.0	0.0	19.0	0.0	0.0	34.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	9.5	0.0	12.5	0.0	2.7	65.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.7	0.0	0.1	8.8	0.0	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.0	4.9	0.0	0.0	17.1	25.7	0.1	1.2	0.0	8.3	0.1	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.2	13.7	19.8	3.3	45.9	23.3	7.3	4.4	10.9	4.7	7.1	7.9	19.7	236.5	0.0	5.5	44.7	1.5	8.7	0.3	0.0	2.8	27.1	1.7	2.2	8.7	2.8	0.0	0.0	0.0	0.2	6.8	0.0	0.0	4.4	1.3	1.4	36.5	194.4	0.0	8.0	1314.4	0.2	0.2	44.4	4.1	1.1	5.7	0.1	364.8	3.1	0.4	0.0	196.5	0.0	0.0	16.4	13.2	2.6	38.2	1.4	8.8	117.1	0.0	10.4	3.1	120.6	36.7	0.2	0.0	50.4	0.0	0.3	0.0	0.1	0.7	2.1	6.6	2.8	19.3	0.2	0.7	1.3	6.8	0.1	4.9	39.7	0.0	0.5
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394560-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2198.1;Basal respiratory cells: 2133.0;Extravillous trophoblasts: 2086.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		170000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	444.5	358.1	64.3	139.5	68.4	184.6	330.4	54.0	72.1	203.1	58.4	278.5	158.1	151.1	43.8	450.6	189.2	75.5	361.2	68.4	73.7	440.2	729.2	242.0	97.2	73.6	74.9	149.7	171.5	26.6	95.9	113.9	94.9	170.1	117.4	443.8	267.5	81.8	947.5	468.6	296.6	124.2	58.5	185.3	181.1	95.2	67.4	115.3	180.8	500.3	146.5	266.2	314.4	65.9	1261.4	730.9	28.4	415.2	599.8	399.3	400.6	1186.1	1148.5	936.9	1366.4	324.5	196.6	909.3	380.3	1110.8	727.1	979.2	716.1	1715.1	2082.2	331.3	422.6	329.6	629.4	588.5	148.9	811.2	235.8	411.1	760.3	380.3	373.7	1670.8	550.8	292.3	462.8	431.7	1127.7	319.4	674.8	509.3	182.7	413.2	849.4	432.0	298.0	768.0	1546.6	284.5	220.5	279.3	642.7	518.6	230.8	431.4	241.7	192.9	546.9	1228.3	455.3	1094.7	14.3	348.0	545.1	899.4	1767.1	415.0	434.1	98.4	147.1	79.7	93.8	165.0	105.2	70.4	122.1	99.6	202.1	54.4	78.1	81.0	47.1	91.3	169.3	68.0	140.8	237.6	64.3	68.4	54.0	72.1	68.4	73.7	73.6	74.9	94.9	58.5	67.4	65.9	421.7	73.7	201.6	21.5	220.8	2198.1	475.6	2133.0	523.0	464.2	213.6	229.5	241.8	175.8	837.3	309.0	146.0	509.8	427.2	696.1	434.3	1293.9	204.4	180.0	317.4	492.8	45.6	123.2	38.7	1532.3	2086.2	544.4	163.6	485.8	262.9	205.3	205.6	514.4	659.3	514.8	33.5	285.1	649.0	224.4	1155.1	129.6	287.7	373.9	1177.5	20.6	973.4	444.2	170.0	9.5	12.6	1771.4	590.3	205.0	376.0	546.8	1765.0	682.5	178.1	481.4	190.7	251.6	706.3	195.5	44.0	422.9	1723.2	501.7	410.9	196.2	362.1	530.8
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1947.7;kidney: 1726.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 2502.3;Cytotrophoblasts: 1693.0;Distal tubular cells: 3306.5;Proximal tubular cells: 3483.9;Syncytiotrophoblasts: 1639.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 6021.8"									"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		560000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	549.9	424.8	509.1	259.2	528.2	352.8	321.1	593.7	617.0	238.6	549.8	320.2	84.4	273.1	169.0	166.6	252.9	232.9	1947.7	484.1	581.9	1726.6	70.5	220.4	425.8	564.4	575.4	472.4	370.3	447.3	161.3	298.2	556.2	240.9	277.0	290.0	162.3	287.2	309.4	81.4	171.3	309.7	537.8	182.0	459.1	119.5	582.5	534.5	348.5	950.4	449.4	417.9	171.2	517.8	647.2	1697.3	1457.5	966.0	1021.7	1126.6	1689.4	879.8	873.0	1201.5	1179.4	2712.9	3.6	2268.6	561.5	597.3	1170.1	315.8	2031.4	1631.4	1518.4	586.5	1413.1	2339.5	1619.0	3.0	975.0	2212.8	967.9	1300.5	572.1	1056.8	1423.4	1416.9	1395.2	1610.8	1304.6	332.6	1342.7	3.2	1895.9	2665.6	4216.4	1051.1	727.7	1681.3	2032.0	1838.7	6021.8	2832.7	467.2	1077.8	403.6	618.1	1586.1	3842.2	5.3	1704.6	548.3	803.7	1048.1	578.5	1684.5	291.0	420.9	2953.4	891.8	1037.5	978.2	540.8	201.9	25.1	346.8	124.7	583.1	349.4	1341.5	723.8	367.2	250.9	1722.4	1124.1	31.7	459.0	95.2	427.7	1405.8	1431.2	509.1	528.2	593.7	617.0	484.1	581.9	564.4	575.4	556.2	537.8	582.5	517.8	89.8	141.1	316.4	68.2	242.2	73.0	439.5	1103.1	221.4	151.5	332.4	325.0	2502.3	298.8	433.9	474.5	68.8	1693.0	208.0	69.6	3306.5	18.4	10.5	224.3	325.0	227.3	92.4	361.2	39.4	314.9	870.1	299.4	222.8	309.4	268.6	412.6	155.7	11.2	612.9	141.3	55.6	152.2	956.2	189.8	104.3	34.3	274.6	174.8	179.7	33.7	197.3	277.6	159.6	47.7	40.3	99.7	84.3	415.2	303.1	310.6	0.2	3483.9	363.0	118.1	236.7	195.2	363.7	21.5	124.3	216.3	64.2	1639.5	398.1	1105.3	257.0	344.9
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116780	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.6;liver: 135.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 37.3;Distal enterocytes: 80.2;Distal tubular cells: 37.2;Hepatocytes: 88.6;Proximal tubular cells: 118.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 11.1"	"Group enriched"	"Detected in many"	45	"granulocytes: 11.1;monocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 11.4;HMC-1: 14.4;T-47d: 29.1;U-266/70: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol		No	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	24.9	14.4	17.7	2.1	19.7	0.7	11.7	20.5	22.6	5.4	34.1	27.2	8.8	3.5	1.1	10.8	5.5	3.0	85.6	16.1	18.9	36.1	135.5	4.9	0.8	20.8	20.2	16.4	18.7	17.0	11.8	0.7	22.4	8.1	9.7	1.3	21.3	3.2	68.7	5.8	5.7	1.2	17.0	1.1	23.1	1.7	19.3	0.5	10.6	52.7	0.6	2.6	3.7	17.5	0.7	2.1	0.0	0.2	1.6	1.4	6.1	0.2	0.1	0.2	0.2	2.8	2.6	0.1	2.1	0.9	1.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.8	11.4	2.6	0.0	14.4	2.0	0.3	0.0	0.0	0.6	0.1	0.4	0.7	2.5	0.0	5.3	0.1	0.8	1.4	2.7	1.3	0.0	0.0	7.8	1.4	0.1	0.0	0.0	0.2	5.2	0.3	0.7	29.1	3.3	0.0	0.0	0.2	0.0	0.0	11.5	0.6	0.0	1.9	0.1	0.0	11.1	2.2	0.6	0.0	3.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	17.7	19.7	20.5	22.6	16.1	18.9	20.8	20.2	22.4	17.0	19.3	17.5	1.6	0.0	6.7	7.8	1.0	0.6	1.8	2.2	0.6	0.5	6.5	2.4	37.3	11.5	2.3	11.0	0.0	2.1	0.1	80.2	37.2	2.3	0.4	2.2	0.3	1.7	3.0	2.7	1.0	6.2	1.2	2.3	32.6	3.8	10.2	2.1	4.2	88.6	7.2	1.7	1.4	11.0	0.0	6.0	1.0	0.6	0.0	3.0	5.4	1.9	2.0	12.0	0.0	1.0	3.2	3.0	28.3	0.0	0.8	2.1	2.4	118.1	2.0	1.4	0.0	4.1	1.3	0.0	0.7	3.6	0.3	3.1	1.0	1.8	15.7	1.5
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 349.2"	"Cell type enhanced"	"Detected in many"		"Melanocytes: 33.8;Microglial cells: 145.2;T-cells: 70.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 142.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 142.6"	"Group enriched"	"Detected in many"	5	"JURKAT: 579.6;MOLT-4: 569.0;REH: 454.8"	"Region enhanced"	"Detected in all"		"thalamus: 22.6"	"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	1.0	12.7	10.7	13.8	7.6	11.6	2.0	6.1	7.9	4.2	14.3	1.5	0.7	8.0	4.8	3.2	5.1	3.9	0.2	5.7	9.9	2.5	0.3	3.3	31.3	8.9	11.2	1.1	0.1	0.3	1.0	11.0	9.4	3.7	1.4	0.5	1.0	1.0	0.1	2.8	4.1	3.9	5.9	9.8	1.5	12.3	18.2	349.2	3.0	0.1	22.8	5.5	3.0	5.5	0.1	0.0	8.0	0.0	0.0	0.0	0.0	0.2	7.2	1.8	4.7	27.1	0.0	0.0	0.1	0.0	2.5	0.2	7.9	0.0	3.7	0.3	17.6	6.9	0.0	0.0	0.0	23.6	2.9	0.4	0.4	0.0	0.7	3.5	0.0	579.6	14.2	0.0	2.6	1.0	569.0	0.0	1.7	6.3	1.4	454.8	9.1	0.2	2.4	1.3	3.0	5.2	0.0	0.5	83.8	6.7	2.4	0.2	0.0	11.9	10.3	0.0	15.3	38.3	17.0	100.9	7.8	0.0	48.4	0.3	0.2	0.0	8.2	0.0	1.6	0.6	68.3	29.9	0.1	0.9	142.6	102.2	1.9	32.9	0.3	0.5	97.7	36.8	10.7	7.6	6.1	7.9	5.7	9.9	8.9	11.2	9.4	5.9	18.2	5.5	1.4	3.2	1.9	2.0	4.4	3.3	1.4	1.0	24.5	0.1	0.4	5.0	1.6	0.0	0.7	0.0	0.0	0.1	6.2	0.0	13.7	0.0	4.2	5.8	22.3	22.0	0.0	9.2	0.2	0.0	0.2	2.1	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	4.1	0.3	1.4	7.9	0.6	2.0	33.8	145.2	3.5	0.6	10.3	0.5	0.6	0.1	0.0	0.0	5.4	1.8	0.0	0.5	2.3	0.3	0.0	0.6	9.0	16.1	6.6	11.3	1.3	0.4	70.3	0.0	0.9	0.4
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"		3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.8;Late spermatids: 47.7;Respiratory ciliated cells: 28.0;Spermatocytes: 65.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.3;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	0.9	1.0	0.7	0.3	1.0	0.2	1.6	0.9	0.7	0.5	1.9	0.6	1.0	0.7	3.4	0.3	3.8	0.4	0.9	0.9	1.1	1.4	0.7	0.6	1.0	1.9	1.7	0.9	1.0	1.5	1.5	0.2	1.5	0.9	0.6	1.8	0.6	0.6	0.2	0.4	0.6	0.4	1.6	0.5	0.9	12.8	1.1	0.7	2.3	0.2	0.4	0.5	0.2	1.0	3.3	1.2	0.0	0.7	0.4	0.2	0.1	0.1	0.5	0.6	0.5	0.1	1.7	0.0	0.9	0.4	1.2	1.2	0.0	0.3	1.3	0.5	0.3	1.0	0.1	0.0	0.0	1.0	0.2	1.5	0.8	0.1	0.9	0.3	0.3	0.0	0.7	0.6	1.2	1.2	0.0	0.7	1.0	0.9	0.7	0.0	0.8	0.8	1.0	0.2	1.9	0.7	1.0	0.7	0.0	0.2	2.2	1.8	0.0	0.1	0.3	0.2	0.5	2.9	0.5	0.0	0.5	0.7	1.0	0.6	0.0	0.0	0.2	0.0	0.4	0.8	0.4	0.0	0.3	0.9	0.4	0.2	0.0	0.7	0.0	0.5	0.6	0.1	0.7	1.0	0.9	0.7	0.9	1.1	1.9	1.7	1.5	1.6	1.1	1.0	0.5	0.0	1.1	19.9	6.3	1.3	1.1	1.4	2.8	1.2	2.7	3.9	1.5	1.5	2.8	3.7	2.1	0.3	0.7	1.5	3.9	0.7	96.8	20.7	1.4	0.6	0.0	2.1	6.5	1.6	0.1	1.1	9.7	2.8	1.3	1.4	0.0	1.8	0.2	3.3	11.8	0.9	0.0	1.6	1.3	47.7	1.5	1.8	1.8	3.7	1.1	1.7	0.0	8.0	8.0	1.0	0.6	1.9	2.5	0.7	1.2	5.4	28.0	4.8	0.0	0.6	1.4	65.2	4.3	2.2	0.9	0.1	2.3	1.1	0.9	0.8
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971778	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"granulocytes: 272.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.2	11.4	8.1	13.8	8.8	9.0	15.5	14.7	12.9	11.6	6.4	17.0	13.3	10.4	10.0	19.8	8.7	13.2	8.1	8.0	10.0	13.7	22.2	9.7	18.0	8.0	8.1	8.5	8.1	18.8	9.1	12.1	7.7	12.3	19.2	12.0	18.5	8.6	13.9	20.8	14.5	11.7	6.9	10.5	13.2	9.3	8.3	22.1	11.1	11.7	17.9	19.3	14.0	10.0	28.0	63.9	40.3	32.6	40.7	35.0	28.8	44.4	36.6	37.3	33.9	44.3	17.9	56.2	25.3	45.8	41.3	53.2	54.2	39.6	35.8	37.5	24.5	88.5	50.6	78.5	32.0	80.7	118.2	37.9	30.5	29.2	37.6	35.2	37.0	46.5	54.6	30.1	44.9	118.7	43.0	61.1	17.4	82.6	27.0	47.6	69.7	58.9	32.8	77.0	28.5	43.4	33.9	51.5	36.5	43.8	42.8	72.6	44.4	36.8	25.5	34.3	53.7	23.4	78.2	50.7	32.2	113.1	40.0	11.5	14.5	15.7	27.4	23.3	25.7	18.7	27.2	22.3	23.8	16.4	27.9	25.2	3.3	30.9	26.0	17.8	31.7	16.3	8.1	8.8	14.7	12.9	8.0	10.0	8.0	8.1	7.7	6.9	8.3	10.0	16.2	35.3	24.6	10.1	15.2	26.1	16.8	33.4	18.2	38.2	11.8	10.2	21.2	17.2	37.0	7.3	10.4	24.9	24.8	24.6	15.6	26.3	2.4	19.5	38.8	18.0	7.7	12.4	16.5	24.2	26.7	19.9	15.8	29.8	272.8	16.2	10.0	18.0	19.5	26.9	16.9	17.9	26.4	14.8	6.0	2.7	8.1	13.0	3.6	5.6	12.8	23.1	22.6	13.0	13.3	18.2	14.7	13.5	11.0	9.0	20.5	23.3	31.4	23.2	6.6	18.5	29.3	21.5	11.0	19.5	24.7	17.6	25.0	23.8	17.0	21.2
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.2;hTERT-HME1: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 24.0"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	1.2	1.0	3.4	1.1	3.6	5.3	0.7	5.7	4.9	1.6	2.9	0.7	0.8	1.4	1.1	1.1	1.4	1.2	0.8	3.2	2.8	2.3	0.7	2.0	1.3	2.3	2.9	2.1	0.7	1.6	1.3	1.8	3.1	1.1	0.8	4.2	0.4	0.8	0.2	1.1	0.5	0.6	2.0	1.6	2.7	23.8	2.6	2.4	1.0	0.3	1.4	1.9	0.6	4.2	21.2	4.5	3.0	2.9	2.3	7.0	2.5	7.5	9.2	10.6	6.2	1.5	8.3	2.8	16.5	1.5	3.1	2.2	5.9	25.2	11.7	1.2	2.9	3.2	2.3	4.2	2.7	0.7	2.8	1.7	7.2	11.7	26.9	5.9	10.7	3.4	2.6	3.9	9.3	4.2	7.5	1.8	0.8	1.6	18.2	2.9	4.8	1.6	16.8	1.1	2.4	2.3	2.5	0.4	0.9	1.8	2.4	1.2	20.0	3.3	22.5	7.4	1.7	2.6	1.6	2.0	5.6	3.3	2.5	1.3	4.1	0.7	0.9	1.6	2.0	1.5	0.9	1.5	1.7	1.8	1.7	1.7	21.5	1.4	5.0	0.7	5.2	1.3	3.4	3.6	5.7	4.9	3.2	2.8	2.3	2.9	3.1	2.0	2.6	4.2	3.0	3.2	6.4	2.3	10.3	0.5	13.9	7.6	6.8	6.6	2.1	3.3	1.8	4.3	3.2	5.5	6.2	2.6	10.1	1.4	1.9	4.0	76.9	21.8	7.1	4.2	0.0	0.8	3.6	20.5	7.9	5.0	16.8	20.5	9.5	1.1	1.4	0.0	1.4	6.7	7.3	1.9	2.0	2.2	2.3	57.6	2.1	3.6	1.8	1.0	2.0	3.6	1.0	1.5	1.6	48.6	0.1	1.5	4.5	2.9	0.3	3.0	4.9	8.4	0.0	4.5	3.3	54.8	3.3	2.5	0.9	8.1	9.1	1.5	1.3	4.5
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 74.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		880000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	"Nuclear membrane"	"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	16.7	6.5	23.3	17.3	25.9	9.8	13.7	29.3	22.4	9.9	11.1	23.1	15.5	9.4	2.2	11.4	6.1	11.8	13.1	17.4	30.1	9.0	2.5	14.4	18.6	34.1	35.6	1.8	74.4	3.0	3.7	6.5	24.8	17.1	12.0	3.0	33.4	4.6	4.6	58.2	17.2	5.8	25.0	20.9	37.8	4.2	38.1	5.8	6.7	3.6	10.8	12.2	13.8	23.6	1.5	14.3	18.4	2.5	2.0	1.7	1.2	5.4	2.8	4.7	5.9	6.0	37.7	1.1	16.7	14.8	8.1	27.1	2.9	5.1	2.3	8.6	0.6	4.3	7.7	3.2	0.1	6.2	7.7	3.3	12.6	7.8	0.8	3.2	1.9	0.3	0.7	0.2	3.6	34.5	0.1	8.7	22.4	46.4	10.3	1.8	46.0	2.9	1.8	4.5	16.9	4.2	6.2	1.4	0.3	4.7	10.2	7.3	4.5	10.5	49.7	0.4	15.4	0.2	0.0	1.4	11.8	16.4	2.0	6.3	5.3	12.7	1.8	6.9	2.0	1.1	1.7	0.9	2.3	2.0	1.8	1.8	2.8	1.3	6.6	0.6	4.2	1.7	23.3	25.9	29.3	22.4	17.4	30.1	34.1	35.6	24.8	25.0	38.1	23.6	23.3	6.4	6.0	18.9	15.6	6.8	2.5	10.6	3.4	8.5	5.3	12.4	3.6	5.7	2.8	0.0	0.0	0.1	40.3	23.1	0.0	1.2	0.1	2.4	8.5	16.0	87.4	2.7	0.0	6.4	0.3	5.7	30.5	1.2	17.7	0.1	13.9	0.6	7.0	0.0	0.1	34.5	6.1	30.4	13.8	0.5	1.8	30.6	3.6	11.2	38.2	31.3	19.6	1.5	0.1	21.7	3.1	0.0	12.6	2.2	8.8	0.4	1.2	0.8	0.0	0.6	5.0	0.3	3.1	0.6	4.0	0.0	15.9	0.5	15.3	0.7
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675636-37679802	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3949.7;Langerhans cells: 4906.5;monocytes: 7118.4;Smooth muscle cells: 4703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 1649.6"	"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	No	Yes	10000000	20000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (5.10e-4)"	1921.2	778.5	482.4	523.8	520.7	324.7	1490.9	613.5	695.3	1805.7	465.2	1634.7	197.7	2270.1	196.8	387.4	1147.0	556.0	1397.4	457.7	549.0	362.4	277.4	920.2	176.7	694.5	576.1	1440.2	155.5	188.1	254.8	426.1	661.5	903.0	207.2	39.5	397.5	756.3	1172.9	472.8	475.3	1353.4	593.8	460.7	582.7	244.9	624.9	153.9	290.9	691.9	116.9	1059.7	1156.4	782.4	2850.9	1664.3	36.5	1440.9	3314.6	6505.1	32.7	6450.7	7619.4	4761.9	4716.9	189.6	368.3	3.3	649.1	6661.4	1609.2	296.3	58.8	4309.2	1663.3	2917.2	30.9	251.3	1606.3	791.1	2155.3	145.1	3167.7	4031.7	294.2	3785.7	1609.9	4271.1	5325.7	1.7	186.6	1163.4	3771.1	1287.6	5.2	2038.4	14.3	629.6	3914.9	5.4	2388.6	799.7	2000.0	6.4	5.5	843.4	1287.4	224.3	1644.5	66.7	1187.2	1689.0	7122.0	6224.0	3070.2	2788.9	3349.3	701.8	530.6	13.6	7291.9	762.0	2535.9	1086.5	3047.4	110.2	766.5	2320.4	113.6	567.7	694.9	754.2	3653.1	287.5	114.3	478.1	122.2	415.4	2556.7	899.2	1514.7	4667.0	482.4	520.7	613.5	695.3	457.7	549.0	694.5	576.1	661.5	593.8	624.9	782.4	1505.8	166.7	90.4	12.7	294.3	730.3	144.0	2796.6	49.5	10.0	144.2	477.9	986.3	74.4	213.4	163.7	6.2	88.0	466.5	49.9	17.6	690.2	30.9	183.0	3011.6	1063.6	3.0	74.9	7.5	90.4	1573.3	2540.4	28.1	230.3	540.0	172.2	653.2	614.1	3949.7	8.4	5.4	8.4	339.7	2159.0	4906.5	106.4	975.5	1700.0	2856.6	15.9	7118.4	278.0	588.1	4.0	17.1	233.5	6.1	1300.7	590.9	118.8	0.5	28.7	109.8	45.4	1650.1	1873.6	4703.8	33.8	13.1	18.2	588.0	151.5	767.5	197.2	11.6	57.0
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570248-37582616	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 335.5;intestine: 198.0;kidney: 153.0;pancreas: 211.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 779.2;Distal enterocytes: 695.4;Langerhans cells: 982.8;Proximal enterocytes: 2724.7;Proximal tubular cells: 1764.8;Undifferentiated cells: 749.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	27	"classical monocyte: 1464.7;intermediate monocyte: 553.8;myeloid DC: 1207.2"	"Group enriched"	"Detected in all"	50	"dendritic cells: 1207.2;monocytes: 1464.7"	"Group enriched"	"Detected in many"	4	"CACO-2: 109.4;Hep G2: 62.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	7.5	1.4	0.6	23.5	1.4	19.2	5.4	0.2	1.1	1.8	0.2	55.0	41.2	3.6	1.0	5.2	4.4	335.5	1.6	0.5	1.0	153.0	5.0	8.6	60.7	1.6	1.2	0.9	211.5	0.2	0.1	1.7	1.4	2.2	81.1	0.1	2.1	0.7	1.9	9.9	198.0	5.2	0.4	59.2	10.7	0.6	1.1	41.3	1.0	0.7	64.0	8.2	0.5	3.4	2.8	1.5	0.9	1.0	0.0	0.0	1.1	1.7	0.0	0.0	0.0	109.4	0.1	0.4	0.3	0.0	0.3	1.7	0.0	0.0	0.0	0.2	1.1	0.0	0.0	62.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	2.8	0.0	1.0	0.4	21.2	0.3	0.0	0.9	1.3	0.0	0.0	0.0	0.3	1.7	1.9	2.4	0.5	1.6	1.7	6.4	2.0	1.0	4.3	0.8	0.0	0.2	0.3	2.7	0.2	1.3	7.7	1464.7	8.7	1.8	553.8	3.3	9.9	1.8	2.1	1207.2	2.3	2.3	1.9	26.8	2.3	39.7	9.6	3.0	981.5	0.6	1.4	0.2	1.1	0.5	1.0	1.6	1.2	1.4	0.4	1.1	3.4	1.6	6.4	3.9	0.0	16.4	17.1	0.1	0.5	0.0	0.0	13.2	7.5	0.3	779.2	1.4	29.5	0.0	0.2	7.0	695.4	127.2	26.3	0.1	0.1	0.3	2.3	73.7	4.8	0.1	206.7	0.3	3.2	5.6	0.2	2.5	0.0	0.7	1.9	26.4	0.0	0.1	413.0	0.0	100.8	982.8	0.3	0.6	150.8	24.9	0.0	164.8	0.0	4.1	0.0	0.1	291.6	331.6	0.0	0.9	0.3	2724.7	1764.8	2.1	0.0	0.0	0.3	2.3	0.0	0.4	0.1	12.4	0.3	8.6	0.0	749.3	0.3
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 1194.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 4097.0;Paneth cells: 3445.9;Proximal enterocytes: 4397.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 651.4;intermediate monocyte: 544.6;myeloid DC: 397.8;non-classical monocyte: 441.2;T-reg: 251.9"	"Group enriched"	"Detected in all"	13	"dendritic cells: 397.8;monocytes: 651.4;T-cells: 251.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1169.3;CAPAN-2: 968.0;OE19: 1613.0;SK-MEL-30: 2329.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003162, CAB005191, HPA076528"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1900000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937, HPA076528: "	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	404.5	72.0	111.4	219.8	111.8	346.9	323.1	110.7	148.1	331.4	104.3	1194.1	691.9	162.3	53.8	437.8	223.1	273.0	246.2	110.3	109.4	120.0	27.3	356.1	84.5	118.6	111.9	251.4	79.9	19.8	60.6	141.2	108.6	143.1	875.4	68.3	358.6	177.4	78.6	473.1	853.4	158.8	110.4	61.9	340.7	63.5	125.2	53.0	72.3	105.6	114.1	300.8	273.5	114.0	298.6	96.5	3.3	2.5	581.2	1169.3	344.9	226.7	496.2	64.0	113.2	225.4	968.0	0.7	121.3	272.8	114.6	289.0	6.1	245.4	37.5	357.1	4.4	1.0	104.7	103.8	446.8	1.0	1.1	363.4	375.2	73.9	152.8	145.1	101.5	0.7	1.4	283.1	148.8	218.5	1.3	74.4	5.6	1613.0	271.1	0.7	11.3	22.4	604.8	434.2	7.8	22.6	529.0	0.9	2329.1	16.2	242.8	31.4	180.5	297.8	41.5	112.0	4.4	154.0	535.6	2.8	426.8	18.6	31.8	18.5	651.4	32.4	15.7	544.6	99.7	11.5	58.4	44.2	397.8	4.7	2.5	8.3	28.7	24.2	441.2	9.6	251.9	449.6	111.4	111.8	110.7	148.1	110.3	109.4	118.6	111.9	108.6	110.4	125.2	114.0	1157.4	721.1	359.8	33.3	42.0	631.3	624.1	1278.9	241.9	2.9	307.3	478.7	218.2	258.7	1463.3	119.5	0.0	766.1	38.8	4097.0	673.1	605.9	21.7	636.2	742.7	397.8	173.4	578.1	0.2	1057.8	1051.7	666.3	281.4	846.8	580.5	6.3	64.6	2.3	1137.4	1.7	0.5	1733.8	1778.1	287.8	844.6	44.4	555.7	651.2	848.4	14.0	639.1	300.1	9.2	2.0	0.3	1289.6	3445.9	384.0	77.4	708.4	4397.2	81.3	1506.5	14.7	144.7	220.2	521.0	11.5	6.6	524.8	797.6	483.8	119.5	2.9	1880.1	1139.7
LHFPL3	LHFPL4	ENSG00000187416	"LHFPL tetraspan subfamily member 3"	Q86UP9	7	104328700-104907232	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 30.5;retina: 23.6"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocyte precursor cells: 4790.3"	"Cancer enriched"	"Detected in some"	12	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.6;SH-SY5Y: 2.1;SK-BR-3: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069691			Approved	Vesicles		No	NA				"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA069691: AB_2686171"		"unprognostic (1.20e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.59e-3)"	"unprognostic (5.03e-2)"			"unprognostic (2.27e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.96e-2)"	"unprognostic (5.81e-2)"	"unprognostic (5.99e-3)"	"unprognostic (8.50e-3)"	"unprognostic (3.07e-1)"		"unprognostic (1.33e-1)"	0.0	0.1	20.2	0.1	10.8	0.0	0.0	13.1	7.4	3.3	0.0	0.7	1.4	0.6	0.0	0.0	0.3	0.0	0.0	5.4	15.5	1.4	0.0	1.5	0.0	7.3	14.2	0.1	0.9	0.0	0.0	0.0	7.5	0.2	0.1	23.6	0.0	0.0	0.0	0.2	1.2	0.0	10.2	0.4	0.3	0.1	30.5	0.0	0.0	0.0	0.1	0.0	0.2	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	10.8	13.1	7.4	5.4	15.5	7.3	14.2	7.5	10.2	30.5	9.5	0.0	0.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	7.7	0.1	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	245.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	1.3	0.0	4790.3	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35797206-35845397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.8;epididymis: 12.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.5;Excitatory neurons: 8.0;Glandular and luminal cells: 2.8;Inhibitory neurons: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029421, HPA055110"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA029421: , HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.9	1.1	4.1	2.7	4.6	18.8	0.8	4.8	5.6	0.3	0.3	0.9	3.0	1.5	12.4	1.3	0.6	1.7	0.7	3.6	2.6	0.6	0.8	1.0	2.8	0.0	0.3	1.1	5.6	0.3	0.5	1.3	0.2	1.0	0.7	8.2	2.4	0.4	1.4	7.6	2.5	0.3	0.0	2.2	1.7	1.5	1.9	0.5	1.4	0.2	0.6	0.6	0.0	2.7	2.3	1.5	3.0	3.1	0.2	0.6	4.6	1.6	0.3	0.1	0.4	2.7	2.0	3.6	1.2	0.6	1.9	2.9	0.2	0.8	0.3	1.6	2.6	3.2	5.3	4.0	0.0	3.4	2.2	0.5	0.3	0.3	0.4	2.1	0.2	3.6	3.1	5.1	0.9	1.9	2.5	6.2	2.6	0.7	1.5	2.2	1.1	2.0	0.7	5.6	3.4	1.9	1.6	2.3	1.0	2.9	2.4	1.9	2.6	3.1	1.7	2.5	2.4	3.2	3.0	3.1	1.1	3.6	1.6	2.9	0.6	0.5	0.3	0.3	0.3	0.5	0.3	0.3	0.1	0.9	0.4	0.5	3.3	0.6	0.4	0.7	0.4	0.1	4.1	4.6	4.8	5.6	3.6	2.6	0.0	0.3	0.2	0.0	1.9	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.7	0.3	0.0	0.4	8.0	0.2	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"kidney: 10.7"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 361.7"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 8.1;testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 19.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 15.7"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.5	0.2	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	42.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	361.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.0	0.0	1.6	0.0	0.0	0.2	1.1	2.3	0.0	0.0	0.4	0.3	0.0	0.2	0.0
LHX5		ENSG00000089116	"LIM homeobox 5"	Q9H2C1	12	113462033-113472280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 5.0"	"Cell type enhanced"	"Detected in single"		"Basal respiratory cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053908			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA053908: AB_2682304"		"unprognostic (5.20e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-2)"		"unprognostic (1.06e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.56e-1)"			"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.54e-3)"	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.0	1.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.7	0.1	0.0	1.9	5.0	1.5	1.7	1.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.2;salivary gland: 2.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 1.2;Late spermatids: 1.4;Spermatocytes: 3.3;Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 6.2;hypothalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 25.6;U-266/70: 8.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 9.7"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	1.3	1.7	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.3	0.0	0.0	8.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	6.2	0.0	6.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39459004-39485109	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.0;Late spermatids: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	5.4	7.5	5.9	3.0	6.5	6.6	5.7	7.6	9.8	5.1	5.9	6.4	5.5	4.6	5.3	6.7	6.1	3.6	11.1	6.2	6.7	8.7	8.6	2.9	5.1	6.3	6.4	10.0	6.8	6.5	4.0	3.3	6.8	4.1	6.4	5.4	4.3	3.1	27.2	5.7	5.2	5.2	5.5	3.6	6.3	9.8	6.2	4.3	4.2	21.0	4.2	5.8	4.7	8.3	5.7	4.5	5.4	5.2	11.5	11.4	4.8	6.6	3.7	6.1	4.1	6.8	7.8	20.8	7.3	2.5	15.2	4.9	15.9	9.1	8.0	2.4	4.0	8.8	2.3	7.0	10.4	19.1	5.5	10.8	14.6	7.1	22.4	13.4	7.0	12.7	21.1	5.2	7.5	3.6	10.9	24.9	7.3	15.3	14.2	9.1	15.2	12.9	7.1	2.9	6.0	4.8	3.8	4.9	22.5	7.6	5.6	8.8	2.6	4.7	10.6	6.3	15.5	9.9	15.8	14.3	7.2	22.2	4.0	2.5	6.4	3.9	5.7	7.6	12.7	10.0	8.1	8.0	6.2	7.6	16.2	11.6	3.4	7.7	5.6	5.5	5.7	4.7	5.9	6.5	7.6	9.8	6.2	6.7	6.3	6.4	6.8	5.5	6.2	8.3	11.0	9.6	12.6	14.0	12.9	9.7	11.6	17.4	12.0	25.8	15.7	17.3	20.1	17.2	12.7	18.4	10.4	24.0	22.6	12.9	21.5	13.2	86.0	11.2	15.8	10.3	18.1	12.4	11.9	6.4	18.2	10.4	9.2	10.3	17.7	19.0	11.4	19.0	17.5	10.1	18.8	13.5	18.3	13.5	7.8	100.1	10.2	11.4	1.8	6.5	17.6	15.4	16.5	14.6	22.9	10.3	10.1	12.4	5.8	6.6	18.3	32.6	14.1	26.7	0.0	10.8	20.5	64.9	25.1	13.7	9.2	9.6	14.2	19.0	18.4	8.8
LIG1		ENSG00000105486	"DNA ligase 1"	P18858	19	48115445-48170603	"Enzymes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037015, HPA041431, HPA048071"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248"	"unprognostic (1.83e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.45e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.47e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.10e-3)"	"prognostic unfavorable (5.75e-5)"	"unprognostic (3.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	2.8	3.2	3.3	9.0	3.2	34.5	3.6	3.6	3.5	5.5	2.3	6.8	8.6	4.0	2.5	7.4	5.9	2.3	1.6	2.9	3.2	2.9	4.0	3.4	15.6	4.4	2.9	6.0	7.0	4.2	4.8	5.1	4.5	4.0	4.2	2.7	4.8	3.0	3.8	10.4	9.6	2.2	2.6	6.0	5.2	8.2	3.1	20.7	5.1	1.0	9.7	3.5	5.0	3.9	43.4	64.1	57.1	37.6	2.6	4.2	41.7	27.0	19.1	44.1	47.2	35.0	42.9	83.7	15.3	11.2	11.9	30.1	24.7	26.7	16.9	45.2	48.8	56.4	38.7	47.5	1.0	63.0	43.7	5.7	2.5	23.0	3.4	5.0	24.0	51.0	46.3	29.8	23.3	44.0	107.3	123.7	33.6	46.7	15.9	84.1	48.4	43.6	12.3	64.8	36.3	36.5	32.3	33.6	10.1	12.5	22.7	44.5	22.6	31.7	54.3	23.9	40.3	29.3	49.0	83.1	12.7	38.0	33.3	0.0	1.6	2.6	7.8	6.8	7.7	10.9	8.8	8.3	1.6	10.0	11.5	8.2	1.3	12.1	3.3	1.5	10.9	5.7	3.3	3.2	3.6	3.5	2.9	3.2	4.4	2.9	4.5	2.6	3.1	3.9	3.9	3.2	13.6	5.9	16.1	8.3	9.5	8.7	24.5	21.5	7.8	12.3	3.9	7.2	10.3	3.7	10.4	31.1	9.6	10.2	7.9	5.8	19.3	12.0	5.1	8.3	0.0	36.2	4.2	5.2	35.8	6.8	5.1	8.3	6.3	23.1	5.0	5.3	16.4	8.4	5.6	10.0	6.1	3.5	6.8	8.5	2.1	6.6	3.6	3.7	7.2	10.9	11.3	3.5	8.4	3.0	4.4	1.9	23.0	2.8	7.6	4.7	19.5	11.3	13.1	4.5	6.5	13.5	26.1	15.9	9.1	10.0	13.9	6.0	15.3	8.7
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 27.6;Horizontal cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 136.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	11.1	10.5	31.1	18.7	32.7	6.8	9.4	28.3	77.9	21.4	0.2	8.9	6.6	13.1	3.5	11.3	7.3	10.1	9.4	35.0	43.8	10.8	4.6	13.2	23.5	75.5	40.0	13.2	11.4	5.8	13.9	7.3	73.0	12.3	4.1	4.0	17.9	8.2	23.7	11.4	12.1	7.1	31.8	22.3	9.2	15.6	59.1	8.1	11.2	7.8	18.2	13.1	14.7	38.3	47.4	37.2	27.2	45.4	35.1	47.0	20.0	28.8	27.3	22.6	25.4	21.3	45.6	30.2	12.7	35.5	76.9	28.1	10.1	17.8	8.6	53.7	18.6	23.2	13.1	24.6	40.5	17.2	81.4	46.8	15.6	18.5	9.6	68.3	34.4	20.9	15.1	9.0	28.8	41.4	14.8	31.4	52.1	16.6	23.7	21.1	43.3	18.2	26.5	10.1	10.7	25.2	18.6	43.7	23.5	29.7	13.9	15.4	41.1	36.0	33.7	94.5	47.7	10.2	12.5	54.9	136.5	12.4	25.2	0.1	6.1	3.5	1.8	6.0	1.4	3.4	0.4	1.2	7.0	1.7	0.1	0.5	0.5	5.8	3.8	0.7	0.3	3.3	31.1	32.7	28.3	77.9	35.0	43.8	75.5	40.0	73.0	31.8	59.1	38.3	2.9	3.2	2.7	7.5	14.4	2.9	5.2	6.6	1.8	6.6	7.7	6.9	3.4	7.2	3.8	1.8	2.1	2.5	11.9	2.9	0.0	6.6	1.2	2.7	9.7	4.1	2.4	0.4	15.4	6.5	6.3	9.2	3.1	5.1	5.7	27.6	3.3	2.1	25.0	35.3	20.8	2.7	0.0	13.5	10.8	2.2	7.2	15.6	3.6	6.5	14.9	3.5	22.6	6.6	2.4	13.5	2.3	6.0	10.0	9.0	0.3	2.8	3.1	3.3	0.0	5.3	4.5	3.4	11.5	1.8	3.1	3.7	11.1	6.9	2.4	7.2
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 115.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 40.0;neutrophil: 96.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 96.9"	"Cell line enhanced"	"Detected in all"		"BEWO: 135.5;hTCEpi: 251.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	20.1	14.4	25.5	39.8	27.3	53.8	30.9	25.8	22.1	26.4	32.6	34.0	21.2	17.0	7.7	71.8	34.2	21.3	14.3	20.8	27.7	27.7	33.0	46.8	23.2	37.8	34.2	21.6	28.8	27.0	21.9	48.0	32.8	36.7	34.7	25.5	50.7	19.1	18.8	71.5	29.3	15.9	32.7	37.5	30.0	19.2	33.6	21.3	42.0	9.2	17.8	25.7	45.3	33.1	26.6	4.4	17.9	10.0	7.6	8.8	135.5	17.2	8.0	16.9	14.2	22.7	12.2	25.8	29.9	26.0	8.1	52.6	20.9	90.3	10.6	19.1	22.8	18.8	21.1	24.7	11.4	35.1	33.1	14.3	251.5	13.7	41.0	114.5	43.6	20.6	10.7	18.2	23.3	20.9	21.5	12.0	16.7	68.3	6.7	28.1	30.0	14.3	19.6	62.3	22.8	20.4	13.0	82.1	35.1	54.8	68.7	13.9	26.6	15.1	23.5	8.3	16.3	10.0	16.2	22.4	9.6	16.4	6.6	5.8	5.1	40.0	3.1	3.5	5.9	2.0	5.7	4.3	1.9	2.4	5.6	4.4	96.9	6.7	1.4	4.4	15.2	4.4	25.5	27.3	25.8	22.1	20.8	27.7	37.8	34.2	32.8	32.7	33.6	33.1	19.5	32.1	17.9	16.3	5.2	35.9	37.7	24.8	59.2	9.4	18.0	23.2	25.1	10.0	32.6	5.5	20.9	69.8	15.3	39.3	3.9	13.0	1.4	49.6	19.2	22.4	13.2	10.3	6.4	45.0	52.4	7.6	48.9	41.6	23.5	8.6	14.3	7.1	18.2	3.3	11.3	42.8	18.3	8.9	8.2	1.6	4.4	13.8	3.6	16.9	5.4	16.6	2.1	2.5	15.5	25.9	21.2	4.5	6.2	27.1	12.0	10.5	36.3	22.8	19.7	7.5	17.2	15.6	18.4	46.1	39.1	115.5	9.3	7.1	51.7	29.9
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410817-26429728	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 5.2"	"Group enriched"	"Detected in some"	43	"Early spermatids: 35.2;Late spermatids: 69.5"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 861.2;SuSa: 300.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.1	0.3	0.0	0.4	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	5.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.3	0.5	0.0	0.0	62.7	0.1	0.0	0.0	0.0	2.0	0.5	0.0	0.1	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	861.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	300.9	27.2	0.2	0.1	0.4	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.2	1.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	69.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	1.1	0.4	1.2	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.2
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 398.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 123.6;monocytes: 355.1"	"Cell line enhanced"	"Detected in many"		"A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		280000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	76.0	46.3	43.5	66.7	65.2	39.8	47.8	64.1	74.4	54.0	39.0	67.7	167.6	38.8	21.7	28.6	37.8	83.5	24.2	43.5	53.1	44.9	218.9	169.5	159.3	74.7	55.5	32.7	21.4	68.9	12.7	79.1	82.2	30.7	72.0	12.6	22.5	33.8	11.8	18.7	227.5	47.7	65.4	398.4	34.3	13.4	57.0	44.5	31.6	22.5	45.5	58.4	19.3	115.5	354.4	49.4	30.7	367.8	343.5	450.8	10.0	171.4	194.8	65.5	121.5	18.6	176.6	63.9	34.0	264.4	73.7	338.7	13.8	92.8	53.6	86.1	34.7	25.1	19.1	81.5	87.6	48.8	48.9	190.4	69.2	72.9	40.6	88.2	14.9	45.4	0.3	108.5	58.3	28.2	45.7	34.6	22.7	62.4	60.0	26.4	39.0	60.5	69.2	50.9	10.5	21.8	41.4	49.9	133.9	20.4	64.4	65.8	26.2	58.8	15.5	132.1	44.6	60.0	65.7	25.8	71.4	112.9	82.1	4.2	167.3	16.9	40.0	355.1	40.6	31.9	35.8	38.8	123.6	33.4	36.7	40.4	7.1	29.8	198.5	25.0	38.2	159.6	43.5	65.2	64.1	74.4	43.5	53.1	74.7	55.5	82.2	65.4	57.0	115.5	75.5	41.7	33.8	11.1	35.9	17.7	30.3	58.1	25.6	5.4	16.1	14.1	9.6	45.8	31.9	33.1	0.0	34.8	31.4	2.8	21.5	35.1	6.8	11.4	20.4	56.7	21.8	27.4	34.4	36.2	32.9	34.6	21.4	15.5	28.5	10.8	54.7	66.7	515.0	16.8	15.1	8.9	40.7	714.8	69.0	2.7	11.5	303.1	48.0	30.0	71.7	33.1	29.9	15.1	143.0	19.3	12.0	21.8	15.4	11.3	161.0	14.0	28.8	2.2	6.6	19.7	21.0	5.1	13.8	31.9	12.5	20.0	33.1	17.6	9.1	24.0
LIPI	"CT17, LPDL, mPA-PLA1beta, PLA1C, PRED5"	ENSG00000188992	"Lipase I"	Q6XZB0	21	14108813-14210955	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"epididymis: 421.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1.7;Excitatory neurons: 1.5;Inhibitory neurons: 2.0;Microglial cells: 1.9;Oligodendrocyte precursor cells: 2.0"	"Cancer enriched"	"Detected in single"	6	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049665			Supported	"Plasma membrane"	"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA049665: "	"unprognostic (2.60e-2)"	"unprognostic (3.49e-1)"		"unprognostic (1.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.64e-13)"	"unprognostic (2.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.5	421.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.6	0.1	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 32.4;retina: 42.6"	"Cell type enriched"	"Detected in some"	13	"Muller glia cells: 289.4"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Group enriched"	"Detected in some"	13	"RPTEC TERT1: 53.5;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: AB_2683715"	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	0.0	0.3	24.0	0.2	22.3	0.3	0.0	24.7	16.2	0.0	7.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	26.6	30.7	3.1	0.0	0.0	0.5	31.1	32.4	0.0	0.0	0.0	1.5	0.4	24.7	1.5	0.3	42.6	0.0	5.8	0.0	0.1	0.2	0.2	32.2	0.1	0.4	0.1	26.1	0.0	4.6	0.0	0.0	0.0	0.0	29.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.1	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.0	22.3	24.7	16.2	26.6	30.7	31.1	32.4	24.7	32.2	26.1	29.1	0.0	0.0	0.0	21.2	1.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.7	0.0	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.3	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	289.4	0.0	0.5	1.4	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LKAAEAR1	C20orf201	ENSG00000171695	"LKAAEAR motif containing 1"	Q8TD35	20	64083380-64084359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 32.3"	"Group enriched"	"Detected in some"	14	"Early spermatids: 496.7;Late spermatids: 694.8"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 0.8;glioma: 1.2;ovarian cancer: 1.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 8.6;non-classical monocyte: 13.5"	"Lineage enriched"	"Detected in many"	13	"monocytes: 13.5"	"Group enriched"	"Detected in some"	4	"REH: 5.6;SCLC-21H: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA056463			Approved	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA056463: AB_2683139"	"unprognostic (5.47e-3)"	"unprognostic (1.18e-1)"		"unprognostic (1.20e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.78e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.16e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.30e-2)"	0.1	0.1	1.6	0.0	0.9	0.1	0.1	0.3	1.9	0.2	0.0	0.0	0.1	0.1	0.0	0.0	2.6	0.0	0.2	1.1	1.6	0.0	0.0	0.6	0.0	1.1	1.6	0.0	0.2	0.0	0.7	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.0	32.3	1.7	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.4	0.2	0.0	0.9	5.6	0.0	0.1	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.1	8.6	0.6	0.1	0.6	0.1	1.0	0.0	0.7	0.2	0.0	0.0	13.5	0.2	0.0	0.9	1.6	0.9	0.3	1.9	1.1	1.6	1.1	1.6	1.0	0.6	1.7	0.5	0.5	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	1.1	0.6	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	496.7	40.3	1.3	0.5	0.0	0.8	1.1	0.0	0.0	0.6	0.0	0.5	0.0	0.1	1.4	0.1	1.6	0.0	0.9	0.0	0.0	1.8	0.0	694.8	3.7	2.2	0.0	0.0	1.4	0.7	0.0	1.0	0.5	0.1	0.0	3.0	0.4	0.2	0.0	0.2	0.0	1.0	13.1	0.3	0.4	24.0	6.6	0.1	0.0	0.1	0.8	0.1	0.0	0.2
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501807-8574668	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 573.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 20.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 20.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No		6600	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	131.4	14.3	9.5	45.6	9.5	0.1	97.5	13.5	10.8	27.2	38.8	18.1	9.0	90.3	18.4	36.1	57.8	67.2	90.6	14.0	9.7	33.0	9.7	131.7	17.3	14.0	11.0	65.8	37.7	30.0	8.7	54.5	12.1	34.8	7.0	15.2	42.2	16.8	573.4	28.8	20.1	63.3	13.2	55.6	46.4	11.3	12.6	4.7	18.5	260.9	10.2	110.6	31.5	14.8	9.4	52.0	8.6	6.6	62.0	34.6	8.9	37.9	19.4	20.5	50.0	38.8	11.5	0.0	4.2	44.2	8.8	0.8	4.9	9.9	8.4	16.0	3.6	11.6	3.5	7.6	88.9	0.0	1.1	124.9	0.2	93.8	0.7	11.9	10.1	0.0	0.0	0.0	26.8	6.7	0.0	0.1	16.8	12.0	2.3	0.2	28.2	0.1	19.1	3.6	0.3	21.3	6.4	31.1	20.6	23.9	40.7	0.1	5.0	20.4	40.3	83.0	25.9	5.1	6.2	2.6	4.1	2.9	27.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	2.9	0.6	3.3	0.3	0.0	0.1	0.0	0.0	0.0	1.0	20.5	0.3	9.5	9.5	13.5	10.8	14.0	9.7	14.0	11.0	12.1	13.2	12.6	14.8	287.6	9.6	10.7	2.0	2.1	31.6	42.1	7.4	9.6	13.0	20.4	17.0	14.7	14.3	13.5	5.5	10.4	3.9	1.7	1.4	3.9	122.0	1.1	9.6	77.7	161.9	12.1	0.0	0.8	48.5	4.2	64.5	7.1	4.8	10.2	44.2	30.7	12.6	3.4	97.6	1.2	2.4	4.1	0.8	47.0	2.3	11.5	3.2	53.4	29.0	9.0	38.9	1.0	4.0	8.7	114.1	0.9	32.4	8.0	8.4	0.3	45.5	12.0	8.0	0.0	57.0	112.9	6.4	9.1	29.0	27.1	4.4	5.3	21.5	4.7	7.5
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328880-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial stromal cells: 508.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 586.8;T-47d: 373.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	49.0	16.3	102.1	28.6	116.5	21.9	34.7	79.8	173.7	51.7	70.8	44.7	26.7	43.2	39.4	50.9	32.4	45.5	42.2	117.4	82.9	42.7	33.3	38.2	29.5	82.1	78.9	39.6	25.5	22.9	31.6	63.9	80.1	56.4	31.6	34.5	87.4	81.0	47.6	39.7	43.1	30.3	79.4	38.7	90.7	28.0	83.2	23.5	33.8	25.5	87.8	38.8	54.0	100.6	55.1	42.3	32.3	586.8	96.6	113.9	81.8	48.4	38.3	44.9	49.8	104.3	34.0	127.5	60.3	57.2	72.4	44.7	13.1	33.8	44.5	68.6	32.4	116.5	87.2	32.3	92.9	63.6	151.2	60.2	76.4	70.0	39.8	80.9	30.8	48.7	26.8	109.8	24.5	22.3	1.8	41.3	118.1	58.6	39.3	72.8	45.0	28.5	56.1	206.7	26.5	1.7	195.3	28.7	149.6	61.1	373.3	171.8	20.1	208.9	39.0	50.6	161.7	99.7	70.6	28.8	26.1	13.8	30.7	30.5	9.1	19.5	7.8	11.6	9.0	10.1	6.9	8.0	6.9	6.9	1.8	4.4	15.0	22.4	11.5	10.3	2.1	5.1	102.1	116.5	79.8	173.7	117.4	82.9	82.1	78.9	80.1	79.4	83.2	100.6	103.5	44.8	24.1	50.9	88.6	98.4	49.3	105.6	245.3	226.2	170.0	191.5	72.4	153.0	78.1	36.8	73.0	322.8	116.5	50.0	62.6	74.2	2.1	106.5	508.1	65.6	31.1	48.1	204.4	127.6	363.3	149.0	159.6	131.5	307.4	19.5	78.1	85.7	74.0	111.0	37.5	80.6	14.2	138.4	73.2	7.5	95.1	76.1	65.8	22.5	74.6	82.7	83.4	52.8	25.8	107.2	29.9	235.5	174.6	49.3	90.3	56.8	31.0	35.9	32.9	80.6	175.5	4.4	97.9	200.3	92.9	256.0	77.9	61.7	64.9	37.5
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896456-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 513.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Leydig cells: 125.6;Peritubular cells: 275.3;Rod photoreceptor cells: 70.2;Sertoli cells: 197.2;Smooth muscle cells: 224.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.8;BJ: 21.3;BJ hTERT+: 34.4;fHDF/TERT166: 17.4;HSkMC: 14.5;hTERT-RPE1: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	157.7	52.5	7.8	28.5	9.7	0.0	75.4	5.7	9.1	161.9	5.5	513.9	25.1	309.5	49.7	135.8	194.7	85.5	31.7	6.2	8.0	11.8	5.1	44.3	7.3	13.6	6.5	72.2	8.4	18.2	5.8	35.3	6.8	165.2	46.9	48.0	21.2	242.5	137.5	43.2	115.5	206.6	5.4	18.5	218.6	17.9	9.1	2.5	39.8	45.7	1.6	368.7	111.9	7.2	0.0	0.1	0.4	1.2	15.8	2.0	1.3	21.3	34.4	1.3	1.5	0.1	0.2	0.0	0.7	17.4	0.2	0.3	0.5	0.0	0.4	0.0	1.4	0.0	0.1	0.0	1.5	0.1	0.1	14.5	0.0	1.0	0.0	54.4	0.1	0.0	0.2	0.2	0.7	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.4	0.1	0.3	0.0	0.5	0.4	9.5	0.7	0.0	0.0	0.1	0.8	0.3	0.0	0.7	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	9.7	5.7	9.1	6.2	8.0	13.6	6.5	6.8	5.4	9.1	7.2	16.1	0.0	1.1	8.5	0.3	1.3	1.0	0.3	0.0	4.8	1.6	40.8	25.1	0.0	0.0	0.0	135.5	1.7	0.0	0.1	0.0	0.0	2.1	2.6	64.5	5.8	0.0	0.0	0.5	0.6	0.3	20.4	0.5	1.2	0.0	0.7	9.3	0.4	1.0	3.3	1.0	0.0	0.0	0.0	2.3	8.2	125.6	0.9	3.6	3.7	0.0	7.3	0.0	4.0	1.0	0.0	0.0	275.3	0.0	0.9	0.0	0.1	0.9	70.2	197.2	5.2	224.3	1.2	0.5	0.8	2.3	1.2	1.3	2.1	0.0	0.4
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126613928-126701032	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;salivary gland: 18.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.3"	"Region enhanced"	"Detected in many"		"midbrain: 5.0"	"HPA073716, HPA075656"			Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA073716: AB_2686630, HPA075656: "	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	0.6	0.0	0.1	0.0	0.1	0.1	4.1	0.1	5.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	1.0	3.6	0.0	0.1	0.0	3.8	9.2	0.0	0.2	1.1	0.2	0.0	3.3	0.0	0.0	0.0	18.5	0.0	0.1	2.1	0.1	0.0	6.8	0.0	0.1	1.4	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.2	0.6	0.3	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.3	0.0	2.5	0.6	3.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	10.4	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.2	0.1	8.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.6	1.0	1.0	3.8	9.2	3.3	6.8	2.6	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.6	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 196.2"	"Cell type enhanced"	"Detected in all"		"Theca cells: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No		7900	"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	30.4	196.2	31.5	22.2	32.7	23.7	27.2	34.6	42.8	24.4	39.9	27.9	22.6	25.2	14.1	27.7	22.6	15.4	76.0	30.8	35.7	43.2	79.1	25.6	24.1	37.6	35.8	26.6	38.2	35.2	41.5	18.5	37.9	26.4	13.2	13.0	30.8	16.6	69.3	28.9	25.5	14.7	30.8	29.5	33.7	24.2	37.2	17.5	34.6	40.7	14.5	28.2	22.4	33.0	108.4	111.0	35.6	114.0	41.4	29.2	110.4	67.2	52.7	71.0	86.0	96.3	37.7	134.3	91.4	70.6	68.0	45.0	92.1	81.1	34.2	80.0	78.0	74.5	97.5	127.6	190.4	169.7	74.9	55.0	114.6	67.5	132.6	34.1	57.5	183.9	200.9	259.4	33.0	71.8	85.5	101.6	127.6	43.6	143.1	89.4	50.9	146.6	39.3	63.9	94.2	94.1	59.4	85.2	242.2	24.9	50.3	211.9	41.2	36.0	39.2	100.7	99.2	272.3	182.6	121.4	161.7	185.0	66.2	4.5	2.4	0.5	3.4	3.7	2.3	4.0	3.1	3.4	2.6	3.7	3.8	2.6	0.3	2.7	1.5	3.9	2.7	1.7	31.5	32.7	34.6	42.8	30.8	35.7	37.6	35.8	37.9	30.8	37.2	33.0	12.6	6.4	13.1	18.3	14.1	8.3	11.1	14.9	11.4	26.9	14.2	12.7	19.8	15.7	14.3	27.6	6.2	28.8	8.4	40.1	46.9	33.9	6.5	24.0	16.3	15.3	11.4	17.1	13.5	28.0	31.9	13.3	29.6	25.6	5.7	51.1	11.4	47.0	30.8	21.9	17.4	26.4	22.4	14.6	8.6	6.3	12.8	16.4	14.2	9.4	17.8	24.9	8.2	10.6	15.7	26.0	16.8	17.3	17.6	16.8	27.5	50.2	17.0	26.5	19.7	17.9	24.7	12.0	14.4	11.0	10.7	35.0	10.7	85.0	35.1	11.4
LOXHD1	"DFNB77, FLJ32670, LH2D1"	ENSG00000167210	"Lipoxygenase homology domains 1"	Q8IVV2	18	46476972-46657220	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 7.2;kidney: 6.9;testis: 23.0"	"Group enriched"	"Detected in some"	70	"Early spermatids: 199.3;Late spermatids: 439.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077128			Approved	"Plasma membrane"		NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA077128: "	"unprognostic (6.95e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.75e-4)"	"unprognostic (9.53e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.48e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.66e-3)"	2.3	0.0	0.5	0.0	3.4	2.8	0.6	0.0	2.1	0.0	0.1	0.1	0.0	0.1	7.2	0.0	1.7	0.2	0.9	0.3	0.0	6.9	0.0	1.0	0.0	0.0	0.1	0.1	0.2	0.2	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.1	0.0	0.0	0.8	0.1	23.0	0.3	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	3.4	0.0	2.1	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.9	1.2	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	199.3	0.0	0.1	0.9	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	439.4	1.8	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	4.5	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 92.3;Extravillous trophoblasts: 145.8;Fibroblasts: 76.0;Smooth muscle cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.4"	"Lineage enriched"	"Detected in single"	34	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"BJ: 66.5;BJ hTERT+: 75.2;hTERT-RPE1: 73.7;U-87 MG: 61.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		280000	"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: AB_2685050"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	12.4	3.1	1.4	5.4	0.8	0.8	6.8	0.2	1.4	12.7	12.3	10.2	1.9	16.0	1.4	4.7	8.3	5.0	27.9	1.7	1.9	8.7	1.5	10.1	4.4	1.4	1.7	8.0	3.3	2.2	9.2	8.0	1.1	15.3	1.4	0.0	7.6	11.9	3.8	6.4	5.6	4.9	0.8	3.2	7.8	2.4	1.9	0.9	5.2	1.9	2.3	16.6	14.8	0.6	3.3	0.0	0.9	0.0	45.6	54.8	2.2	66.5	75.2	27.6	48.7	1.3	1.7	0.0	12.1	49.1	6.9	19.9	0.3	0.2	6.5	0.0	4.3	0.2	2.0	0.3	6.2	0.0	0.1	45.0	0.0	20.8	0.2	73.7	1.0	1.2	0.0	0.3	33.3	2.4	0.4	1.3	6.3	4.4	45.1	0.0	38.7	0.6	2.5	12.0	5.5	0.0	2.0	0.4	0.0	6.5	0.4	0.0	4.9	53.8	47.0	42.8	25.8	0.2	0.0	0.0	61.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.9	0.0	1.3	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	3.4	0.2	1.4	0.8	0.2	1.4	1.7	1.9	1.4	1.7	1.1	0.8	1.9	0.6	4.1	0.0	0.6	3.3	0.1	5.9	7.6	6.0	4.0	0.9	2.3	4.8	92.3	2.8	0.9	9.2	0.0	2.2	0.6	0.1	3.9	5.2	1.7	9.2	8.0	4.1	3.5	0.0	0.5	1.3	145.8	76.0	8.6	9.3	1.3	5.5	12.1	0.1	6.6	0.0	0.4	0.6	2.0	0.0	6.2	1.3	9.9	0.9	10.6	0.0	0.1	6.4	0.0	1.5	0.3	12.2	0.1	21.1	0.1	4.8	0.4	2.5	1.2	0.4	0.0	6.0	32.7	8.9	4.9	2.4	3.4	5.1	3.4	0.3	1.1	5.0
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23296897-23425328	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 26.9;Endometrial stromal cells: 26.9;Endothelial cells: 33.1;Extravillous trophoblasts: 22.0;Fibroblasts: 22.9;Hepatic stellate cells: 19.6;Sertoli cells: 26.3;Smooth muscle cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 935.5;BJ hTERT+ SV40 Large T+ RasG12V: 517.3;fHDF/TERT166: 602.7;TIME: 510.7;U-87 MG: 905.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	30.4	3.3	1.9	15.9	2.7	1.2	18.8	4.7	3.0	10.6	0.8	25.3	9.3	12.0	0.9	3.8	4.9	8.0	10.7	1.8	3.2	6.1	3.9	8.3	11.7	7.7	8.1	12.9	6.5	2.5	2.6	36.2	7.0	7.5	5.4	3.0	4.1	13.0	4.5	5.4	10.3	41.3	4.5	5.0	9.0	2.3	4.5	1.8	5.2	2.6	9.5	12.0	7.3	3.7	58.2	147.7	42.7	35.8	112.4	183.8	19.4	935.5	295.9	415.6	517.3	1.1	4.4	10.7	7.5	602.7	193.2	47.6	2.1	79.0	215.3	1.8	8.5	0.9	19.4	1.0	226.8	0.5	3.8	164.6	3.9	155.0	20.8	274.0	350.7	2.4	0.5	2.0	138.1	32.3	0.6	1.4	29.1	0.4	24.5	1.9	36.7	0.4	120.1	0.3	0.9	13.7	122.9	6.1	8.6	131.3	0.8	1.2	510.7	384.6	103.3	163.8	127.3	4.1	0.8	29.9	905.4	1.4	413.5	0.1	0.2	0.8	0.4	0.1	0.2	0.4	0.1	0.3	0.1	0.1	0.2	0.6	0.3	0.1	0.2	0.2	0.1	0.2	1.9	2.7	4.7	3.0	1.8	3.2	7.7	8.1	7.0	4.5	4.5	3.7	12.9	0.0	3.0	6.8	0.6	2.5	0.3	26.9	0.6	1.5	0.6	9.7	2.6	1.5	4.1	0.0	0.0	2.7	0.4	0.0	0.0	1.9	0.6	1.7	26.9	33.1	0.0	0.0	8.1	1.5	22.0	22.9	1.5	2.1	0.0	2.0	19.6	0.2	1.3	1.7	3.2	0.1	0.0	0.3	5.7	0.4	0.9	0.9	3.6	6.5	0.0	1.2	0.0	7.1	11.9	2.3	0.1	0.4	0.9	0.6	0.2	0.2	1.6	3.2	26.3	2.7	48.1	1.3	1.6	0.5	3.1	1.0	1.0	3.1	0.4	0.2
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013144	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 154.4;Granulosa cells: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	9.7	9.3	17.9	21.2	19.9	19.8	9.8	14.6	17.4	9.7	16.6	13.9	62.8	9.8	6.7	10.0	9.5	25.7	7.2	16.1	24.2	26.4	165.8	21.2	24.3	22.7	22.0	13.2	16.4	13.5	10.9	15.7	24.2	9.0	12.5	10.7	7.4	8.0	2.7	3.6	39.9	9.6	15.6	20.3	28.1	22.0	28.8	18.9	12.1	3.0	19.2	9.9	6.0	14.3	8.7	12.0	17.1	6.6	31.7	27.4	10.5	17.4	22.8	18.9	16.9	16.7	7.1	5.4	10.8	30.2	30.2	0.2	13.8	6.3	13.2	11.2	2.7	13.3	10.0	19.4	27.2	11.2	17.0	27.4	4.6	18.5	17.2	28.2	23.4	14.8	12.8	3.5	28.2	7.2	15.0	12.0	5.7	13.7	13.1	26.7	14.0	23.2	17.6	20.0	14.4	10.2	18.4	9.1	6.8	10.7	0.0	18.0	31.2	25.3	28.7	31.7	14.6	5.0	7.9	12.3	22.1	12.2	8.1	8.7	2.4	7.8	11.8	1.5	12.1	1.0	9.2	7.2	1.0	1.7	9.1	6.3	23.4	12.5	0.8	1.5	9.2	3.2	17.9	19.9	14.6	17.4	16.1	24.2	22.7	22.0	24.2	15.6	28.8	14.3	17.7	67.3	44.0	55.2	20.4	5.6	9.8	8.5	5.7	35.7	12.1	11.2	11.2	154.4	23.9	38.6	14.6	25.2	41.9	45.3	17.6	11.8	3.3	48.2	33.3	18.9	14.9	138.1	26.3	19.0	11.3	25.4	103.0	64.4	12.6	323.0	19.2	131.1	23.1	116.1	65.6	36.8	16.2	26.8	8.9	11.0	22.7	31.1	8.8	79.6	31.2	16.7	59.8	37.7	21.0	22.2	21.6	31.2	16.1	21.2	92.4	54.9	17.1	16.7	6.6	16.6	20.1	26.5	73.0	0.6	2.0	49.5	58.9	20.3	14.0	14.1
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 118.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 75.9;dendritic cells: 80.7;Langerhans cells: 154.6;Macrophages: 81.7;Plasma cells: 82.2;T-cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 200.7;HMC-1: 329.3;Karpas-707: 285.0;U-2197: 199.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	10.4	8.3	7.5	48.3	8.2	10.2	10.2	7.8	11.8	7.9	4.5	14.5	10.9	7.4	11.9	5.2	7.6	15.1	5.3	7.1	7.8	10.6	14.0	33.5	87.1	9.1	8.8	9.5	8.6	6.5	7.2	5.2	10.2	9.4	19.6	7.0	11.0	7.1	3.8	5.9	26.2	9.7	8.6	44.1	13.0	10.2	10.0	103.3	10.2	5.1	118.5	32.4	6.0	10.9	1.7	2.1	2.0	3.9	7.4	9.3	1.4	50.5	200.7	12.4	22.0	0.4	5.1	149.8	2.0	61.9	9.2	2.0	1.7	137.7	51.4	65.4	0.9	6.8	1.3	1.0	12.8	41.1	329.3	7.2	3.2	170.8	22.0	12.0	80.9	90.0	1.9	285.0	101.5	1.1	144.8	51.6	1.6	2.3	45.8	2.1	2.5	129.2	8.3	71.2	1.0	1.6	2.2	3.2	20.1	2.8	2.7	11.7	79.8	30.8	9.5	199.5	45.9	18.4	18.9	146.5	71.6	36.8	71.6	6.3	74.3	12.2	101.3	41.8	148.9	71.9	102.9	117.6	137.5	46.2	79.6	95.9	14.1	79.2	22.2	124.4	152.1	98.8	7.5	8.2	7.8	11.8	7.1	7.8	9.1	8.8	10.2	8.6	10.0	10.9	4.1	0.0	6.7	22.9	75.9	9.7	6.6	7.2	3.4	4.1	4.0	4.7	2.3	4.3	2.8	0.0	4.2	2.8	80.7	4.2	3.9	2.5	23.0	2.8	1.9	5.9	6.1	13.3	18.2	5.6	1.3	6.6	13.3	2.3	51.5	5.4	2.5	7.6	44.0	1.7	19.8	3.1	6.1	63.7	154.6	8.7	1.8	81.7	19.6	30.0	52.9	2.8	49.4	11.6	27.3	4.1	5.2	3.8	82.2	3.6	6.9	5.7	4.3	4.4	6.6	3.6	3.8	9.2	4.2	2.6	9.7	2.5	90.3	2.9	5.2	27.6
LRATD1	"FAM84A, FLJ35392, NSE1"	ENSG00000162981	"LRAT domain containing 1"	Q96KN4	2	14632700-14650814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.2;intestine: 41.0"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 162.2;Syncytiotrophoblasts: 207.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 35.0"	"Group enriched"	"Detected in many"	7	"amygdala: 19.7;basal ganglia: 10.8;cerebral cortex: 18.1;hippocampal formation: 13.0;white matter: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.4;hTCEpi: 18.0;RT4: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047703	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA047703: AB_2680123"	"unprognostic (1.05e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.36e-1)"	0.5	1.4	19.7	4.9	10.8	0.0	2.4	0.0	18.1	10.6	0.0	41.0	26.3	2.7	32.2	28.6	2.9	3.4	2.1	13.0	2.0	4.0	1.4	3.0	0.2	0.0	0.2	8.2	3.2	5.2	3.3	5.3	0.0	13.6	36.2	0.9	13.9	2.0	0.9	18.5	25.3	2.8	0.0	0.2	3.0	12.3	1.4	1.3	2.2	0.1	1.4	14.8	16.6	6.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	2.5	0.6	0.5	0.0	0.3	0.0	0.0	0.3	0.0	9.4	1.0	4.2	1.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	18.0	0.0	5.9	0.2	0.0	0.0	0.0	0.0	1.3	7.8	0.0	0.2	0.8	0.0	4.0	0.0	0.0	0.1	6.9	49.3	4.3	2.0	0.0	1.8	0.0	0.3	0.0	0.0	2.9	8.2	0.7	0.0	3.2	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	10.8	0.0	18.1	13.0	2.0	0.0	0.2	0.0	0.0	1.4	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	162.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	22.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	207.8	0.0	0.0	0.0	0.0
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 139.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 38.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 38.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA012380: AB_1853260, HPA017299: AB_2669576"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	13.1	10.2	7.7	12.0	11.9	8.0	11.4	18.7	9.1	16.2	7.3	16.3	7.0	15.5	7.7	10.7	13.7	10.2	14.6	7.7	12.5	8.2	10.3	11.9	17.0	9.8	8.1	18.8	9.5	12.2	12.3	10.1	8.5	13.9	10.2	19.2	12.0	12.1	19.3	10.8	12.8	14.8	6.0	13.9	11.2	13.1	10.1	15.5	9.7	11.5	18.7	14.8	13.8	15.7	30.5	10.0	28.8	17.5	28.9	35.2	11.0	21.5	25.6	25.3	31.5	26.0	15.5	16.1	33.5	24.9	40.7	19.1	25.7	21.2	34.5	13.3	14.4	29.8	16.2	19.2	18.9	21.4	19.3	25.0	10.9	24.7	31.9	23.0	30.7	14.7	18.1	27.5	23.4	25.1	15.9	7.8	19.3	15.8	22.3	16.0	17.6	10.6	11.3	19.4	14.2	14.4	28.5	18.5	20.1	26.4	39.0	17.1	30.1	19.4	12.0	24.4	22.2	24.5	26.9	15.2	19.8	28.0	20.3	38.9	4.7	10.1	7.4	6.9	6.0	9.3	5.8	6.3	4.1	6.6	5.3	7.5	2.3	7.1	6.9	3.5	6.1	5.4	7.7	11.9	18.7	9.1	7.7	12.5	9.8	8.1	8.5	6.0	10.1	15.7	19.2	32.1	27.0	64.6	29.7	10.6	18.1	11.4	8.0	56.0	11.6	8.5	15.4	14.3	17.0	9.2	56.3	8.5	25.8	10.4	1.9	10.1	12.8	12.2	22.9	20.8	6.0	11.1	69.8	9.9	6.6	23.8	10.7	16.4	11.4	23.0	34.6	14.2	9.0	38.7	86.1	11.0	8.2	17.6	17.9	9.6	25.1	14.6	17.8	66.5	30.8	19.8	27.8	102.1	139.2	14.1	9.5	28.6	15.1	15.9	7.1	5.2	15.1	43.1	19.7	31.7	22.8	18.0	17.2	9.4	10.5	6.0	19.9	17.0	11.0	14.7
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536402-4540036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 944.2"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 793.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 285.2"	"Lineage enriched"	"Detected in many"	44	"granulocytes: 285.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.4;SK-BR-3: 15.7;THP-1: 26.2;U-937: 48.7"	"Low region specificity"	"Detected in single"							"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	21000000000	42000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.60e-2)"	7.2	4.5	0.6	17.8	0.5	31.4	4.3	1.2	2.6	8.7	1.1	7.3	6.7	1.9	5.9	22.7	10.0	15.5	1.2	0.6	0.6	9.8	944.2	7.8	0.8	0.7	0.7	1.5	44.1	0.1	1.6	1.9	1.9	4.4	4.7	0.1	20.9	6.2	1.0	4.8	3.3	2.2	0.5	16.2	13.6	0.3	0.9	1.2	1.3	1.4	6.5	13.3	3.8	0.9	10.8	0.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	1.0	8.0	3.6	13.3	0.0	0.5	1.4	0.0	1.7	0.1	13.4	0.4	0.3	0.2	15.4	0.0	0.4	13.9	4.1	0.0	0.0	0.0	0.0	0.1	0.0	9.6	0.2	0.0	0.6	0.0	11.3	0.2	8.2	0.0	0.1	0.3	11.3	1.0	2.0	0.0	0.0	0.1	15.7	0.1	1.3	4.8	26.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	48.7	0.0	2.4	6.4	15.0	0.1	2.0	0.1	0.4	0.3	0.1	1.6	0.4	0.1	0.1	285.2	0.2	1.3	0.2	1.1	2.2	0.6	0.5	1.2	2.6	0.6	0.6	0.7	0.7	1.9	0.5	0.9	0.9	13.4	12.8	54.3	0.0	3.3	8.0	33.1	56.8	18.2	0.1	14.2	2.5	0.5	60.1	50.2	14.7	0.0	0.8	0.5	44.7	1.9	112.7	0.0	38.0	1.8	24.7	4.9	13.2	0.0	64.1	12.4	3.0	31.6	17.3	12.0	0.2	38.2	793.0	6.7	1.7	0.0	26.3	32.6	19.9	5.0	0.0	0.0	14.7	1.8	0.0	7.3	0.1	0.0	0.0	0.0	40.6	11.9	0.0	1.7	4.5	10.8	4.9	76.1	0.1	0.0	2.3	3.3	0.0	0.2	9.0	5.8	1.4	1.9	3.4	27.6	30.2
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947190-110963965	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"	6.6	9.4	8.7	10.3	9.1	5.5	11.4	10.7	18.5	6.2	8.5	6.5	6.0	6.8	19.8	5.6	8.1	5.0	14.5	9.2	10.3	7.9	13.2	6.8	16.0	8.4	8.7	15.5	6.1	6.5	7.7	10.0	8.7	8.2	6.4	21.5	7.2	5.4	18.2	9.3	6.0	4.7	8.7	13.0	7.1	25.7	9.5	13.3	10.9	17.3	17.4	7.6	4.5	10.0	33.2	14.4	26.8	18.4	12.3	19.8	30.2	19.9	22.7	33.8	27.2	36.4	40.4	25.2	27.5	15.1	36.5	21.0	12.9	12.0	40.6	45.9	15.2	27.9	14.3	37.4	35.8	52.7	32.5	12.5	32.3	23.5	41.0	14.4	18.6	26.4	88.3	111.5	23.2	11.1	5.4	41.4	40.0	20.1	32.6	35.0	43.4	30.5	8.8	17.0	22.3	24.4	0.1	33.8	59.1	16.3	28.0	83.6	13.5	30.0	1.0	35.4	16.3	51.7	19.4	46.9	17.1	59.2	53.6	24.8	8.3	18.6	21.0	9.4	26.6	29.9	16.6	22.1	16.8	22.7	18.1	24.8	31.4	28.2	13.0	15.0	16.9	12.8	8.7	9.1	10.7	18.5	9.2	10.3	8.4	8.7	8.7	8.7	9.5	10.0	22.5	12.8	8.4	11.8	39.4	14.4	48.4	21.0	19.9	22.4	27.9	35.1	27.8	8.6	17.0	9.2	18.8	19.5	21.9	15.5	15.6	18.8	15.3	15.9	15.2	21.5	11.3	24.8	17.9	19.9	32.3	16.5	23.0	18.5	8.2	11.2	17.5	31.8	13.9	15.2	16.5	13.2	18.3	10.7	53.1	11.4	15.8	23.2	32.0	3.7	20.1	28.6	49.4	4.0	16.1	23.4	12.9	13.9	28.4	56.8	10.0	11.8	22.3	35.1	13.1	20.0	19.0	49.9	54.8	25.1	17.6	37.8	31.5	21.4	11.3	50.9
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362534	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.5;kidney: 34.8;parathyroid gland: 44.7;retina: 29.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Cytotrophoblasts: 63.2;Oligodendrocytes: 300.1;Proximal tubular cells: 283.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 29.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 39.4;CACO-2: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA		74000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.5	0.0	5.5	0.0	23.4	0.1	9.6	18.9	13.5	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.2	7.5	14.6	34.8	0.3	1.2	0.0	30.5	17.5	0.0	0.0	44.7	0.1	7.5	31.9	0.0	0.0	29.3	0.9	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.0	0.2	18.7	0.0	17.3	0.0	0.0	0.0	0.0	70.5	0.0	0.0	39.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	23.4	18.9	13.5	7.5	14.6	30.5	17.5	31.9	14.5	18.7	70.5	0.2	6.4	43.7	1.0	3.0	0.3	0.2	0.0	0.0	2.8	22.9	15.1	2.1	2.8	2.5	3.7	87.6	63.2	0.2	0.0	17.6	0.0	3.1	0.1	0.1	0.5	0.0	0.0	1.8	0.0	2.2	1.8	0.0	0.1	2.5	0.0	0.0	0.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	2.5	0.0	1.9	0.0	33.1	0.0	1.5	300.1	0.0	0.0	0.0	0.0	0.0	0.0	283.9	2.2	19.5	0.0	0.0	0.3	0.1	0.8	0.0	0.0	23.1	1.7	0.0	0.0	0.2
LRPPRC	"GP130, LRP130, LSFC"	ENSG00000138095	"Leucine rich pentatricopeptide repeat containing"	P42704	2	43886224-43995989	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033786, HPA036408, HPA036409"	Enhanced		Enhanced	Mitochondria		No	No		210000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (1.68e-1)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (2.31e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.68e-2)"	"prognostic favorable (6.65e-6)"	"unprognostic (9.07e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.00e-2)"	32.2	33.2	30.1	23.8	31.3	49.6	41.6	39.3	35.4	23.9	49.2	50.6	33.4	32.5	28.4	28.4	27.6	18.2	47.0	30.8	31.8	63.5	48.3	19.6	31.2	33.0	30.4	34.1	30.4	48.7	19.2	27.2	35.2	27.7	48.9	40.4	27.8	25.3	100.9	30.2	30.3	27.6	30.2	24.3	27.1	33.2	32.1	29.3	31.2	93.5	31.7	27.0	22.5	36.3	127.8	101.9	62.3	80.0	58.1	79.9	108.0	82.7	59.4	88.0	67.3	164.4	65.7	181.7	78.4	50.8	58.8	105.2	118.8	86.3	116.8	110.2	75.2	164.2	76.5	217.9	85.5	239.9	71.4	77.3	73.8	81.6	130.4	49.2	71.2	53.6	246.5	71.5	75.8	68.5	126.8	273.7	104.0	123.8	71.8	139.7	140.7	147.6	95.3	115.3	111.0	107.3	93.6	120.6	154.5	79.2	90.1	140.6	62.6	63.2	86.4	66.9	89.2	72.5	87.4	156.2	60.0	144.1	55.6	10.5	16.5	2.9	13.3	16.2	25.5	22.5	18.0	17.9	23.5	24.5	24.8	21.9	1.2	20.3	18.9	9.6	16.3	20.2	30.1	31.3	39.3	35.4	30.8	31.8	33.0	30.4	35.2	30.2	32.1	36.3	29.2	22.4	34.1	56.8	46.2	46.3	27.2	34.6	46.1	66.4	37.6	30.4	97.2	32.9	35.4	46.0	31.3	37.1	22.5	33.1	21.5	25.6	5.3	31.2	48.2	30.4	27.5	58.4	91.6	17.7	23.6	32.4	40.2	40.1	29.2	51.0	22.1	55.1	25.2	65.6	96.5	49.2	20.3	38.8	25.9	6.3	25.1	28.9	21.4	38.4	36.8	24.5	23.7	55.3	94.9	20.0	33.0	23.7	34.4	31.9	36.6	62.3	25.8	57.0	13.1	45.8	32.6	27.2	33.3	53.9	44.3	33.2	32.2	63.7	76.0	31.9
LRR1	"LRR-1, MGC20689, PPIL5"	ENSG00000165501	"Leucine rich repeat protein 1"	Q96L50	14	49598761-49614672	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.5;Spermatocytes: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA065703, HPA069364"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065703: AB_2685537, HPA069364: AB_2686129"	"unprognostic (2.73e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (7.34e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.90e-7)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.04e-2)"	5.7	5.5	1.6	9.1	1.7	22.6	5.6	1.7	2.1	3.0	1.6	12.2	9.6	3.7	2.4	6.7	3.3	3.6	3.2	1.5	1.6	3.1	6.1	4.2	14.0	1.8	1.7	2.4	4.3	2.9	1.2	4.0	1.8	3.2	10.0	3.2	4.1	3.4	4.0	4.7	10.1	6.1	1.7	7.5	4.6	29.1	1.8	23.2	3.4	4.8	13.3	5.4	3.5	1.9	66.5	39.3	34.2	38.4	15.1	10.6	38.2	35.0	30.8	72.5	68.7	38.4	49.1	60.9	25.1	22.9	23.2	41.7	42.2	29.8	64.1	56.5	31.3	27.4	29.4	24.6	8.5	64.5	34.2	6.9	11.3	33.9	19.4	9.2	35.8	49.2	29.3	45.4	49.2	55.2	87.2	60.1	22.5	31.7	53.0	54.8	56.2	41.4	25.4	27.1	36.9	21.7	33.1	35.3	25.4	12.1	49.9	49.6	13.1	50.6	83.1	24.8	44.4	23.6	35.9	69.0	23.6	47.7	42.9	22.4	14.2	25.4	10.1	22.7	13.5	16.1	13.3	14.8	15.0	12.6	10.8	12.3	8.2	11.1	16.9	17.7	15.7	10.5	1.6	1.7	1.7	2.1	1.5	1.6	1.8	1.7	1.8	1.7	1.8	1.9	6.4	3.2	6.5	2.0	12.1	15.6	5.7	12.0	4.6	3.8	6.5	5.6	3.6	5.7	9.3	3.7	2.1	12.6	9.2	11.8	1.9	16.8	129.5	3.4	5.3	8.9	4.8	48.4	0.9	22.7	34.2	7.8	6.6	2.9	14.5	9.5	6.8	6.6	21.6	1.7	1.1	11.0	12.2	10.4	19.2	41.6	7.5	11.5	10.6	2.8	16.7	8.1	13.4	1.0	2.0	14.1	3.7	3.4	31.3	11.2	8.7	7.5	4.3	5.2	6.6	5.5	8.0	151.7	14.0	8.8	14.9	7.7	10.5	7.5	14.5	7.0
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508749-61511018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 42.4;fallopian tube: 28.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 49.3;Muller glia cells: 9.5;Respiratory ciliated cells: 37.2;Sertoli cells: 19.7;Smooth muscle cells: 20.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 42.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 9.7;RH-30: 10.5;SCLC-21H: 5.4"	"Region enriched"	"Detected in many"	7	"basal ganglia: 222.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 30.9;hippocampal formation: 24.2"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	3.7	0.9	11.1	0.4	42.4	0.0	2.9	0.5	11.2	5.9	3.6	2.2	0.3	4.9	1.9	0.5	28.7	0.3	1.7	13.5	5.2	2.2	0.1	4.9	0.0	4.0	4.0	2.3	1.3	2.2	33.7	0.5	2.1	1.6	0.3	0.1	1.3	0.5	0.7	0.9	1.4	1.6	3.1	0.4	2.9	5.9	7.9	2.7	1.6	0.9	0.0	1.1	2.5	3.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	5.4	0.5	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	42.4	0.5	11.2	13.5	5.2	4.0	4.0	2.1	3.1	7.9	3.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.6	0.4	1.1	0.0	3.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	3.2	49.3	0.5	0.4	4.2	0.0	1.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	6.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	37.2	0.2	19.7	0.7	20.6	0.8	1.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191495-196334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 34.0;skeletal muscle: 113.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.6"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 43.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Cytosol"		"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.0	0.0	0.2	0.0	0.5	0.3	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	34.0	0.0	0.8	0.1	0.0	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.9	0.4	0.0	113.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.4	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	4.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	10.1	43.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.5	0.9	0.3	0.0	0.8	0.6	0.5	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC17	"H_RG318M05.3, P37NB"	ENSG00000128606	"Leucine rich repeat containing 17"	Q8N6Y2	7	102913000-102945111	"Predicted secreted proteins"	Osteogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 76.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 31.3;Granulosa cells: 68.6;Leydig cells: 101.9;Peritubular cells: 31.6;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	94	"eosinophil: 9.9"	"Lineage enriched"	"Detected in single"	94	"granulocytes: 9.9"	"Cell line enriched"	"Detected in many"	5	"LHCN-M2: 1237.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073458			Approved	"Vesicles,Cytokinetic bridge"	"Secreted in other tissues"	Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Cytokinetic bridge"	"HPA073458: "	"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (8.57e-3)"	"unprognostic (4.48e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.30e-4)"	8.1	2.4	1.6	1.1	1.7	0.2	12.9	1.6	2.4	22.5	1.7	2.7	1.6	15.7	12.1	6.0	17.3	27.4	13.2	1.7	1.6	2.8	3.5	3.2	2.1	1.6	1.7	76.2	2.3	2.0	2.4	0.6	1.5	5.6	3.3	1.8	2.7	3.2	2.1	3.0	2.3	6.0	1.6	3.3	6.9	5.0	2.3	6.2	3.8	2.8	1.0	4.4	5.8	1.6	0.0	0.0	58.8	0.5	6.0	29.4	0.1	1.6	18.2	0.6	2.8	0.0	0.2	0.0	3.4	1.5	7.3	0.1	0.0	0.0	4.3	0.0	1.4	0.1	0.0	0.1	8.3	0.5	0.2	28.1	0.7	21.5	0.0	141.1	140.9	0.6	0.0	0.1	1237.5	0.0	0.1	0.4	3.1	0.1	0.1	0.1	244.0	0.2	0.2	0.1	1.3	1.3	0.1	0.0	0.1	0.1	0.0	1.7	11.8	0.2	1.5	15.2	2.3	1.1	0.4	0.0	0.3	0.0	0.3	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.7	1.6	2.4	1.7	1.6	1.6	1.7	1.5	1.6	2.3	1.6	3.6	0.0	1.1	4.6	0.2	0.9	0.2	0.9	0.0	3.7	0.7	0.8	1.1	0.0	0.5	1.8	2.1	0.3	0.3	0.0	0.0	1.7	3.5	2.7	15.3	4.4	0.0	0.0	6.9	0.4	0.2	31.3	1.1	4.6	1.3	68.6	6.1	0.5	0.4	0.0	8.7	0.1	2.0	0.0	2.7	2.9	101.9	0.5	5.4	10.3	0.6	0.6	0.0	2.5	5.3	0.2	0.3	31.6	0.0	0.3	0.1	0.3	0.1	2.2	65.7	16.1	17.8	0.6	0.5	0.4	0.6	0.0	0.9	6.6	0.2	0.2
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 305.6;tongue: 125.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 31.0;Early spermatids: 25.4;Hepatocytes: 17.5;Late spermatids: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA039630: AB_10795467"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	2.8	5.9	17.1	2.6	17.7	3.3	2.3	13.6	21.5	15.1	10.0	14.1	2.7	6.5	3.1	14.7	4.3	3.1	40.7	18.3	14.8	3.7	32.0	4.5	3.1	17.3	15.5	4.3	3.4	3.2	13.2	1.4	18.1	4.6	4.0	4.4	6.3	4.2	305.6	3.5	4.1	6.9	14.4	3.3	5.0	12.5	18.0	7.3	4.4	125.0	5.3	6.2	19.9	17.5	26.1	18.1	16.2	29.7	9.3	6.5	0.1	4.0	14.5	9.2	8.6	17.2	27.7	5.9	13.2	2.4	31.1	9.8	14.3	18.1	8.1	14.7	3.6	3.2	4.6	53.3	8.6	8.2	2.7	2.6	7.0	11.3	5.4	11.2	18.7	34.6	4.0	7.6	8.4	3.6	31.0	8.4	5.3	26.0	46.3	23.8	8.2	14.8	15.1	2.7	32.4	16.2	2.0	2.5	10.9	4.1	3.4	9.2	10.6	6.3	64.7	10.7	8.9	13.6	22.3	9.3	12.6	32.7	1.7	0.0	0.2	0.0	0.4	0.3	0.4	0.1	0.3	0.4	0.6	0.0	1.0	0.4	0.0	0.4	0.1	0.1	0.0	0.3	17.1	17.7	13.6	21.5	18.3	14.8	17.3	15.5	18.1	14.4	18.0	17.5	1.9	0.0	4.6	9.4	1.1	1.5	0.5	0.6	0.0	8.5	1.5	0.6	31.0	2.8	1.3	0.0	4.2	0.1	0.8	0.8	0.0	3.9	25.4	1.1	1.3	2.4	5.4	1.7	10.0	4.7	0.2	2.8	1.5	0.7	0.0	2.5	2.2	17.5	0.5	1.7	10.1	2.0	0.0	0.6	0.7	50.1	3.1	0.8	1.8	1.9	1.2	7.5	1.0	6.6	3.9	5.8	3.1	1.5	1.7	0.8	0.3	1.6	0.6	2.0	0.0	5.2	1.9	8.5	4.8	0.1	0.6	0.0	1.3	1.8	2.1	0.6
LRRC28	"FLJ34269, FLJ45242, MGC24976"	ENSG00000168904	"Leucine rich repeat containing 28"	Q86X40	15	99251362-99390729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 159.2;Excitatory neurons: 127.4;Late spermatids: 406.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039378, HPA040784, HPA066130"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Mitochondria"	"HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623"	"unprognostic (4.84e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.82e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.41e-1)"	8.1	7.8	4.4	4.4	5.1	8.6	6.4	4.5	5.8	6.1	4.3	8.0	16.9	5.8	7.4	9.7	4.8	9.1	9.7	5.3	3.9	19.4	47.1	5.3	6.9	3.7	3.5	4.9	19.5	9.4	4.1	6.1	3.5	5.3	9.7	6.8	6.1	6.6	18.3	10.4	16.5	7.9	3.3	4.9	8.2	28.5	3.9	22.6	6.6	18.4	9.4	6.5	6.3	4.4	4.0	9.8	9.5	12.3	13.2	18.7	4.0	4.2	11.9	7.1	8.3	7.4	8.6	8.2	7.6	10.1	8.7	8.8	7.0	13.5	10.3	5.0	10.2	5.5	4.0	7.7	11.7	5.5	8.6	11.1	18.2	6.7	13.4	16.0	22.7	13.0	4.9	8.1	14.9	8.0	15.2	8.9	4.0	31.2	3.7	9.3	8.0	7.6	15.1	12.8	4.3	5.5	10.1	5.4	16.4	14.4	8.4	10.2	8.3	7.0	4.8	5.4	8.4	15.9	24.1	5.1	8.8	5.4	13.3	23.4	9.3	32.0	7.2	7.8	5.8	6.2	6.7	7.7	8.4	5.8	6.2	5.4	5.0	5.1	8.0	6.9	10.4	6.1	4.4	5.1	4.5	5.8	5.3	3.9	3.7	3.5	3.5	3.3	3.9	4.4	13.2	16.0	4.1	29.0	13.5	13.8	14.5	14.5	12.5	19.9	8.9	12.4	13.4	12.8	11.0	11.0	22.9	17.5	11.4	18.6	27.4	12.7	159.2	7.4	8.4	11.9	9.1	12.4	127.4	29.5	22.6	8.5	15.8	6.5	2.5	15.0	12.8	37.0	19.3	21.9	86.8	16.0	20.3	19.8	20.1	406.4	12.8	15.3	14.2	37.5	19.1	14.4	14.4	63.3	63.0	14.8	24.2	8.6	14.7	8.4	72.3	74.1	10.1	19.8	0.0	10.7	11.7	77.1	39.0	15.1	15.8	13.0	11.3	18.0	19.5	15.4
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 62.1;SK-MEL-30: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	5.5	21.5	6.8	6.4	5.0	16.1	0.5	1.8	7.7	1.3	0.1	20.2	47.4	4.0	0.2	2.1	1.3	3.1	2.4	6.8	6.5	2.0	0.6	4.6	5.6	4.1	6.7	4.4	7.0	4.7	3.1	3.4	5.1	1.9	9.0	2.3	1.3	1.1	2.9	2.2	44.0	2.3	3.4	21.5	7.4	10.6	5.1	0.5	4.9	0.6	1.6	1.5	0.5	5.3	8.9	6.3	7.6	6.0	0.2	0.2	1.3	2.4	0.4	1.8	1.5	7.9	2.6	0.6	6.6	0.2	3.7	3.7	0.2	0.0	0.0	3.4	6.5	62.1	3.9	0.0	0.3	1.5	7.3	0.0	0.0	0.4	0.0	3.2	2.3	9.4	3.9	1.7	0.1	12.8	15.3	6.7	1.7	20.3	0.7	5.8	5.5	0.8	0.4	1.8	16.6	4.6	0.6	1.8	21.7	3.3	1.4	1.4	0.0	2.2	10.5	6.7	11.9	12.2	2.6	2.0	0.8	5.1	7.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.7	0.3	0.4	1.0	0.0	0.0	0.4	6.8	5.0	1.8	7.7	6.8	6.5	4.1	6.7	5.1	3.4	5.1	5.3	40.5	41.7	69.7	10.7	21.6	0.0	9.6	0.0	2.2	9.1	24.9	13.3	0.7	14.3	19.8	1.8	6.2	16.1	24.8	52.5	19.6	3.9	7.1	30.0	61.0	14.7	24.7	9.7	5.3	7.1	20.4	30.5	2.0	58.7	29.7	25.0	11.0	10.0	12.0	3.3	3.6	52.2	0.0	13.9	0.0	8.0	16.4	22.9	0.0	1.0	7.7	21.3	2.1	4.0	4.2	6.2	36.0	11.3	12.0	8.7	65.4	19.4	8.7	18.2	13.1	22.9	19.4	8.0	6.5	1.1	0.0	16.7	18.6	66.3	66.0	7.5
LRRC8C	AD158	ENSG00000171488	"Leucine rich repeat containing 8 VRAC subunit C"	Q8TDW0	1	89633072-89769903	"Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 73.5;Excitatory neurons: 73.6;Inhibitory neurons: 99.2;Microglial cells: 185.5;Oligodendrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.9;monocytes: 6.6;T-cells: 11.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029347	Uncertain		Approved	"Golgi apparatus"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 28: Placenta - Pregnancy"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA029347: AB_10601544"	"unprognostic (2.61e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.76e-3)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.78e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.38e-2)"	14.3	7.6	3.8	9.0	4.5	8.0	7.7	4.5	5.8	3.2	11.4	3.2	3.2	7.3	1.9	2.9	2.8	6.6	6.2	4.1	4.1	2.5	3.3	7.7	12.2	4.6	5.0	5.3	1.8	2.8	2.3	6.6	5.1	2.3	3.7	1.6	2.0	2.0	2.7	6.0	3.8	15.8	4.8	9.2	2.9	4.0	4.7	5.6	3.5	8.0	7.7	6.2	2.0	6.0	0.3	3.8	3.0	2.7	9.1	10.2	1.4	19.3	21.6	8.7	8.0	0.0	1.3	6.0	5.3	8.5	14.9	13.1	10.1	29.0	20.9	14.8	6.1	5.7	2.9	0.3	7.4	26.6	1.9	4.4	5.8	18.8	10.0	5.8	35.6	9.2	3.9	7.9	7.5	0.7	3.9	26.2	3.3	0.1	7.8	26.5	1.4	2.0	1.8	3.2	2.3	10.7	7.1	0.7	16.2	4.7	0.2	41.3	29.9	15.3	7.3	5.3	14.9	2.9	2.6	3.1	4.7	19.6	2.6	0.4	6.0	0.0	3.8	5.2	3.3	0.7	6.1	5.1	8.9	0.5	4.8	4.5	0.8	2.0	6.6	0.7	11.3	3.2	3.8	4.5	4.5	5.8	4.1	4.1	4.6	5.0	5.1	4.8	4.7	6.0	73.5	3.2	3.6	31.3	7.6	45.4	3.8	5.6	3.4	2.3	1.7	2.9	6.3	2.8	2.7	0.0	0.0	0.1	24.6	0.3	0.0	1.7	36.3	0.2	1.9	47.3	1.2	4.8	73.6	2.4	1.1	8.7	2.6	0.6	0.0	58.5	28.9	0.1	13.6	1.7	99.2	0.3	2.0	29.5	36.9	21.3	0.0	27.8	26.6	185.5	21.3	0.5	13.4	22.1	85.2	12.8	1.9	0.7	20.8	2.1	0.3	0.6	2.9	1.2	0.0	2.2	24.2	3.9	2.0	1.3	44.9	0.3	27.1	3.4	0.3	2.5
LRRN4	"C20orf75, dJ1056H1.1, NLRR4"	ENSG00000125872	"Leucine rich repeat neuronal 4"	Q8WUT4	20	6040546-6054060	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.3;lung: 9.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 3.9;Collecting duct cells: 1.8;Ductal cells: 3.8;Proximal tubular cells: 2.4"	"Group enriched"	"Detected in many"	7	"lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"RPTEC TERT1: 79.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA075974			Uncertain	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		73000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA075974: AB_2686770"	"unprognostic (6.16e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.40e-3)"	"unprognostic (9.04e-3)"	"unprognostic (5.95e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.84e-3)"	8.3	0.0	0.3	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.2	0.6	2.2	0.1	9.7	0.0	0.2	0.2	0.4	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	1.4	0.0	3.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	79.6	0.0	0.3	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	1.0	0.2	0.6	0.2	0.2	0.0	0.1	0.7	0.0	0.0	9.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926036-67101551	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.6;brain: 4.8;ovary: 2.7;pituitary gland: 3.4"	"Group enriched"	"Detected in some"	22	"Early spermatids: 164.0;Excitatory neurons: 485.6;Inhibitory neurons: 577.7;Late spermatids: 178.7;Oligodendrocyte precursor cells: 601.7;Oligodendrocytes: 253.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;HAP1: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.1	2.6	2.7	0.0	3.1	0.0	0.0	1.0	4.8	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.9	0.7	0.0	0.0	0.2	0.0	0.0	0.6	2.7	1.0	0.0	3.4	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.1	1.0	4.8	3.9	0.7	0.0	0.6	0.0	0.1	1.0	3.4	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.0	0.0	0.2	0.2	0.0	0.0	485.6	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	577.7	0.0	0.0	0.0	0.0	178.7	8.7	0.1	0.0	8.4	0.0	0.4	0.0	601.7	253.5	0.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.3	2.5	1.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0
LRSAM1	"CMT2P, FLJ31641, RIFLE, TAL"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451489-127503499	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Excitatory neurons: 28.6;Inhibitory neurons: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	7.2	9.8	8.6	3.4	8.6	2.0	7.3	7.3	12.5	10.7	5.2	16.5	3.4	9.0	5.9	8.7	7.8	3.9	17.3	8.8	8.8	9.0	8.8	7.4	4.5	11.1	7.6	10.7	5.7	6.9	9.0	3.4	11.4	9.1	2.6	2.3	7.5	5.6	13.5	21.2	9.1	5.0	7.0	9.5	9.5	4.3	7.9	3.4	8.8	7.2	3.2	12.3	10.2	9.0	5.7	10.8	4.8	10.7	9.8	9.1	8.3	5.3	8.1	10.0	7.6	8.9	5.9	9.8	5.9	9.9	3.6	18.7	7.8	13.3	3.8	11.5	5.3	5.2	9.0	10.2	9.4	6.2	7.3	6.1	7.9	6.1	12.2	10.7	11.2	7.6	4.8	7.6	4.5	17.6	3.9	4.5	4.7	17.4	9.3	7.1	5.6	18.4	11.5	5.1	9.8	9.2	4.1	12.6	8.8	4.3	26.5	3.2	10.2	4.6	5.6	4.2	2.5	6.2	7.9	1.1	9.1	4.5	2.6	18.5	4.8	21.3	3.7	6.5	4.7	3.7	2.8	3.5	6.1	2.7	1.1	1.4	4.0	1.3	6.8	3.6	2.3	3.8	8.6	8.6	7.3	12.5	8.8	8.8	11.1	7.6	11.4	7.0	7.9	9.0	5.3	9.6	3.9	32.0	5.1	1.1	3.1	2.9	4.6	6.7	5.2	5.0	20.4	4.3	7.3	0.0	6.2	5.0	5.3	6.0	5.9	7.1	0.6	3.6	4.7	4.8	1.2	2.5	28.6	1.4	2.1	4.9	12.2	4.6	9.5	6.6	3.3	7.1	6.3	11.8	26.9	5.8	14.2	5.6	3.7	1.2	2.8	7.4	3.6	10.3	7.4	4.7	3.1	18.1	21.0	4.7	5.0	5.3	3.9	5.0	6.6	5.8	6.0	5.2	0.0	5.1	6.0	5.7	3.6	5.8	2.7	7.0	5.6	3.9	4.8	3.3
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640791-194672463	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	14.9	12.8	13.2	15.8	13.8	28.1	15.8	13.9	15.9	12.8	14.0	15.1	17.2	15.2	19.8	15.9	14.5	12.6	14.0	13.1	14.5	16.6	21.7	12.8	18.7	14.7	16.4	14.2	15.5	16.8	11.1	17.2	15.8	14.6	18.1	14.0	13.8	13.9	23.0	19.3	14.9	14.5	14.0	15.4	13.6	14.4	14.4	17.2	15.5	18.9	21.3	18.2	14.3	15.4	55.6	36.0	21.2	35.3	32.3	17.8	43.1	31.0	30.1	42.9	37.6	47.9	25.1	43.1	93.5	29.4	75.5	39.5	68.2	35.0	52.1	56.3	32.5	46.8	38.4	27.6	22.9	51.1	42.4	17.3	31.5	44.4	41.7	16.0	47.1	29.4	39.5	46.2	36.0	76.6	46.3	30.8	57.7	73.5	65.6	56.2	35.0	49.3	23.7	46.9	40.5	27.9	39.9	38.2	40.0	39.7	90.3	32.9	36.5	32.4	37.3	46.2	66.6	50.6	71.1	97.7	26.2	64.7	52.4	3.5	10.1	13.6	15.3	13.2	17.1	16.6	12.5	13.9	17.2	14.3	14.4	12.9	1.3	21.0	8.9	9.0	15.4	10.6	13.2	13.8	13.9	15.9	13.1	14.5	14.7	16.4	15.8	14.0	14.4	15.4	25.0	19.2	29.6	10.4	22.5	16.2	13.4	8.9	25.0	18.3	12.1	11.9	17.2	18.6	27.9	9.2	12.5	25.1	21.2	14.0	5.9	23.3	12.0	22.1	24.5	23.7	7.8	16.2	10.5	22.4	19.4	17.7	21.9	24.0	53.7	21.9	11.7	14.0	13.0	15.2	8.3	14.2	12.2	4.4	10.2	8.9	15.5	15.5	12.4	8.4	14.0	18.2	12.3	12.5	12.2	19.7	8.0	14.7	23.8	11.5	10.8	9.7	34.3	18.6	19.7	22.1	14.6	26.4	35.7	30.5	16.1	28.5	24.0	23.2	17.6	9.0
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000753-96043520	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 207.2;Kupffer cells: 255.8;monocytes: 245.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		86000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	40.2	66.9	24.6	64.5	25.5	180.4	53.6	29.4	30.6	55.6	33.8	48.2	78.1	51.1	38.4	110.1	61.7	40.3	35.5	25.0	27.8	58.1	43.9	190.8	64.1	26.3	25.4	110.5	54.9	53.3	37.4	27.4	26.0	41.1	49.6	36.9	41.2	40.9	45.0	67.8	60.5	58.3	25.7	57.8	46.6	19.9	28.1	49.2	49.4	45.0	96.4	51.9	52.7	33.0	85.2	90.4	123.5	73.4	104.2	115.1	53.8	33.7	101.8	67.5	78.1	66.6	72.0	190.0	42.0	51.9	52.8	108.3	103.4	140.1	92.3	63.3	97.0	68.5	54.3	81.8	61.8	35.7	39.4	110.1	118.4	91.9	114.5	305.3	134.9	101.1	42.9	32.5	98.7	59.2	96.7	115.0	145.8	100.7	115.5	88.9	90.5	109.7	125.7	107.7	63.9	75.5	64.2	80.4	78.3	95.1	98.7	44.7	49.0	28.3	47.6	40.2	38.2	42.8	79.4	85.4	19.1	66.2	22.3	4.4	662.9	17.7	33.4	699.2	63.4	126.1	46.6	43.4	282.3	157.5	65.0	50.5	46.0	120.4	638.8	70.4	51.2	591.5	24.6	25.5	29.4	30.6	25.0	27.8	26.3	25.4	26.0	25.7	28.1	33.0	32.8	38.5	135.0	15.3	82.8	51.9	64.8	96.6	52.3	21.4	41.8	41.1	25.3	25.8	110.2	38.6	33.3	29.3	47.9	17.6	74.3	42.9	74.3	18.4	20.8	38.2	21.6	50.5	21.3	28.0	28.2	29.7	38.2	27.3	7.6	31.5	57.8	21.7	207.2	11.8	18.5	40.4	40.7	255.8	76.6	16.4	36.7	183.3	21.4	10.3	245.5	35.5	26.8	19.6	17.5	20.8	27.1	41.0	40.1	35.4	73.2	69.3	45.0	55.6	6.6	26.7	35.4	46.9	11.6	108.0	74.9	20.8	39.1	32.9	70.4	49.7
LXN		ENSG00000079257	Latexin	Q9BS40	3	158645822-158672648	"Predicted intracellular proteins"	"Inflammatory response"	"Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 97.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 123.0;Respiratory ciliated cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"hTERT-RPE1: 1196.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014179, CAB025128"	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		4700000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB025128: , HPA014179: AB_1853404"	"unprognostic (4.46e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (8.45e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.84e-2)"	59.0	47.0	3.7	21.5	6.4	27.1	22.4	7.3	4.4	20.3	14.1	42.0	30.3	13.7	23.7	9.9	34.3	40.5	23.1	4.5	5.4	21.6	5.6	26.3	18.6	3.9	4.3	49.7	14.1	14.0	16.0	22.0	4.1	36.9	44.0	3.6	42.4	17.9	5.4	12.4	26.1	22.9	3.6	10.2	15.0	4.5	6.2	13.8	18.3	7.8	14.3	97.7	14.4	4.2	0.1	40.7	3.1	0.5	17.0	58.2	3.4	31.3	80.4	7.6	15.2	0.1	91.3	0.3	28.2	8.7	0.2	14.1	8.1	12.7	11.2	0.1	40.2	19.6	33.0	0.4	19.5	5.0	0.5	131.5	2.3	14.5	2.4	1196.4	296.5	0.1	0.3	0.9	0.0	167.0	2.1	0.0	3.6	7.3	10.5	5.5	0.0	40.0	27.6	113.4	5.1	0.1	0.0	42.5	10.4	9.4	0.3	0.1	42.8	0.3	0.3	42.3	0.1	0.6	0.0	0.2	14.8	1.6	0.5	28.8	5.8	8.6	5.6	5.8	5.8	10.3	11.7	9.3	7.3	6.9	12.9	7.2	36.7	9.8	3.6	7.6	29.8	6.5	3.7	6.4	7.3	4.4	4.5	5.4	3.9	4.3	4.1	3.6	6.2	4.2	71.0	16.0	9.2	0.3	4.4	5.6	84.1	27.0	4.6	0.3	17.3	21.2	3.8	11.5	38.7	16.5	4.2	13.4	5.5	34.1	15.6	18.5	3.9	20.7	16.5	88.5	35.2	86.3	0.5	26.4	16.2	28.8	6.1	7.6	123.0	3.6	77.8	0.8	22.9	0.0	0.3	73.1	22.4	6.3	18.1	7.9	8.4	8.0	19.6	4.7	17.7	8.9	6.2	0.0	0.3	15.1	58.4	2.6	2.8	49.8	48.6	15.5	120.3	1.2	13.1	1.3	29.4	0.9	10.8	8.6	8.2	4.0	6.5	5.9	30.8	77.0
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 244.0;dendritic cells: 36.2;Melanocytes: 71.2;Plasma cells: 102.5;T-cells: 44.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.3;JURKAT: 14.1;Karpas-707: 28.0;U-266/70: 70.7;U-266/84: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050917	Approved		Approved	"Plasma membrane,Centriolar satellite"		NA	NA		43000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Centriolar satellite"	"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"	2.4	0.9	0.1	13.7	0.2	11.5	2.0	0.1	0.2	0.8	0.2	3.9	4.0	0.6	0.4	0.9	0.9	2.5	0.5	0.1	0.2	1.1	2.3	3.8	30.2	0.3	0.2	0.6	0.2	0.0	0.2	0.3	0.2	1.1	3.8	0.0	7.1	0.4	0.3	0.8	12.0	0.5	0.3	26.7	6.0	0.2	0.2	25.5	1.4	0.2	31.1	3.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	28.0	0.0	0.0	2.3	0.5	0.1	0.8	0.0	1.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	70.7	29.3	0.3	0.0	4.0	0.0	1.2	0.8	0.4	112.9	1.1	113.5	56.1	97.6	109.8	5.2	52.8	109.6	112.3	2.4	22.2	0.8	72.8	80.3	53.5	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.0	1.8	0.3	244.0	1.0	0.5	0.1	0.0	0.0	0.4	0.8	0.9	0.0	0.0	0.0	0.0	0.1	36.2	0.1	0.0	0.0	0.1	0.1	0.1	0.7	1.2	28.0	0.1	0.2	0.0	1.4	0.5	0.1	0.0	0.0	1.8	0.4	1.9	0.0	0.1	0.0	0.0	3.2	31.9	0.0	0.0	6.3	71.2	1.9	2.1	0.0	22.6	0.0	0.1	0.1	0.0	0.0	102.5	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.1	0.5	1.0	0.1	44.8	0.0	0.3	0.3
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43785874-43827206	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.0;Late spermatids: 81.8;Melanocytes: 17.8;Syncytiotrophoblasts: 21.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.0;HaCaT: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA042511: AB_10794279, HPA054670: AB_2682567"	"unprognostic (4.27e-3)"	"prognostic favorable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.1	0.6	2.6	1.4	2.5	0.1	2.9	1.8	6.0	9.3	0.0	2.3	0.1	0.9	1.4	11.4	0.8	1.1	1.5	3.0	2.9	3.0	0.4	4.0	0.7	6.8	3.2	0.4	0.3	0.6	1.6	1.0	6.6	1.3	0.8	2.0	3.1	0.8	0.2	50.6	1.2	1.1	1.7	4.8	1.0	3.8	4.1	0.9	1.4	0.4	1.7	1.9	9.0	4.1	3.5	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.5	0.6	0.4	1.2	0.2	0.7	0.4	1.4	5.2	0.0	0.7	0.3	0.6	0.0	0.1	0.4	0.0	1.5	0.1	0.0	1.7	1.5	0.2	0.7	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.3	1.9	1.2	0.0	0.0	0.0	0.3	0.6	0.2	0.1	0.7	0.7	0.0	1.1	0.4	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.1	2.6	2.5	1.8	6.0	3.0	2.9	6.8	3.2	6.6	1.7	4.1	4.1	0.5	0.0	0.0	4.6	0.0	3.6	2.6	1.6	4.0	1.4	1.8	1.5	0.7	0.0	0.4	0.0	0.0	1.6	0.1	3.7	3.9	0.6	33.0	0.2	0.1	3.1	0.0	0.0	7.7	0.9	8.4	1.2	0.0	0.2	0.0	0.5	0.7	0.0	2.4	0.0	8.8	1.9	0.0	0.6	0.8	81.8	0.3	0.5	17.8	1.0	0.0	0.9	0.0	9.5	7.8	0.3	2.3	1.2	0.0	1.4	0.2	0.0	1.4	0.9	0.0	1.0	0.2	9.9	2.6	3.7	2.8	21.6	0.1	0.1	0.8	6.2
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 188.1;Late spermatids: 464.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 154.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 154.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Midbody	"HPA059840: AB_2684137"	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favorable (9.50e-4)"	37.8	31.1	26.7	16.4	27.2	24.2	30.0	28.7	31.4	30.4	31.6	32.0	13.8	27.6	35.2	18.7	34.4	16.2	50.8	27.1	28.3	51.8	95.8	18.8	24.2	28.1	27.7	34.0	27.3	33.5	21.2	13.6	28.7	29.1	20.4	26.5	16.2	26.8	42.3	19.2	18.0	22.6	27.3	16.9	27.9	37.6	27.7	25.1	22.8	34.1	21.9	34.8	23.0	28.5	33.2	29.7	30.3	25.9	74.1	64.0	9.6	27.9	39.3	14.8	21.7	42.8	39.2	22.6	92.2	31.5	21.6	21.6	14.1	25.5	25.6	41.6	19.8	10.1	8.3	112.1	56.6	35.9	20.4	45.0	24.5	40.0	98.6	41.4	58.5	37.3	23.2	39.6	59.0	43.5	39.1	26.3	34.3	46.5	17.2	47.8	18.4	30.8	56.3	15.1	29.8	27.7	16.6	26.3	45.1	18.5	27.5	19.5	16.0	21.4	15.8	35.1	19.6	35.1	51.2	38.5	59.7	35.6	20.1	154.9	16.7	59.3	19.7	21.8	28.2	29.5	29.8	24.2	14.3	24.8	24.3	24.1	63.8	22.1	25.9	17.9	33.0	24.5	26.7	27.2	28.7	31.4	27.1	28.3	28.1	27.7	28.7	27.3	27.7	28.5	32.5	19.2	18.9	9.1	29.9	21.0	57.6	26.8	25.6	28.9	41.2	39.4	55.1	27.1	17.2	23.9	14.6	29.1	24.6	9.6	76.3	41.3	188.1	24.2	12.9	35.8	30.0	8.4	10.6	44.2	10.6	30.8	21.9	15.9	15.8	20.5	15.0	53.9	16.5	15.2	14.1	15.0	28.5	16.4	14.5	464.6	28.9	16.2	17.8	4.7	45.7	48.0	22.6	9.5	11.2	30.2	14.6	38.0	15.8	41.6	19.2	125.4	25.4	34.0	13.1	25.8	26.3	112.5	27.5	18.2	20.9	14.9	22.9	16.3	24.5	56.7
LYSMD4	FLJ33008	ENSG00000183060	"LysM domain containing 4"	Q5XG99	15	99715697-99733561	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029152, HPA059824"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Actin filaments"	"HPA029152: AB_10602033, HPA059824: AB_2684135"	"unprognostic (2.43e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.30e-1)"	7.1	5.5	6.3	1.7	6.8	3.1	6.7	6.3	7.1	8.4	6.2	9.7	4.8	9.4	3.4	11.1	8.1	1.5	20.2	6.4	6.0	11.8	11.8	7.6	2.3	5.9	6.4	8.9	8.0	5.7	7.1	2.8	6.2	9.5	3.2	5.2	9.5	4.2	10.3	16.7	7.9	3.8	5.9	8.0	7.8	7.7	7.0	3.9	5.0	5.9	3.8	7.9	9.4	6.8	3.5	3.3	6.5	3.8	7.1	6.4	3.9	3.9	2.7	3.3	4.8	8.2	3.0	3.8	2.3	3.6	5.8	10.1	5.1	6.3	3.8	0.8	9.2	2.5	7.2	5.7	4.1	1.8	4.6	3.7	9.2	3.0	3.6	2.0	4.5	10.9	6.2	4.8	2.2	4.1	4.8	5.1	4.3	9.7	3.7	3.4	4.6	1.9	5.9	9.0	3.7	3.3	7.2	2.2	3.9	8.3	1.5	3.5	5.8	2.7	7.3	3.7	1.7	6.3	9.1	3.1	3.5	4.5	2.9	0.0	1.3	5.3	2.1	1.9	1.7	1.0	3.0	2.6	0.6	1.7	3.5	1.6	0.4	0.7	2.7	3.0	3.2	2.4	6.3	6.8	6.3	7.1	6.4	6.0	5.9	6.4	6.2	5.9	7.0	6.8	7.0	6.4	3.3	4.6	2.5	8.7	8.1	4.6	8.0	8.0	3.5	6.3	12.8	7.2	3.9	3.7	10.4	2.6	4.9	4.4	1.9	4.1	7.3	1.3	3.0	4.8	3.0	6.1	9.8	9.7	2.0	6.8	3.6	1.7	0.0	2.9	3.9	3.4	4.3	10.1	11.4	6.2	6.1	2.2	3.7	8.1	5.3	3.9	1.8	8.4	8.1	11.6	3.1	6.0	7.4	7.2	3.0	6.8	3.9	2.1	3.9	5.3	2.5	10.0	13.1	3.9	5.7	12.7	11.3	8.1	9.1	1.4	2.9	2.2	2.6	3.5
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Phagocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.3;retina: 27.9"	"Cell type enhanced"	"Detected in all"		"monocytes: 277.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;SK-MEL-30: 27.1;THP-1: 99.5;U-937: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: AB_2682129, HPA055725: AB_2682898"	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	5.2	2.7	2.0	8.5	2.7	31.3	6.4	10.1	3.3	7.1	9.1	4.5	3.0	4.3	2.7	4.2	3.9	5.1	2.2	2.0	2.5	3.6	5.5	5.5	7.5	2.2	2.6	4.5	2.2	6.2	1.8	4.6	2.5	3.4	4.3	27.9	4.3	3.3	1.7	9.7	3.3	4.4	1.1	10.8	7.7	6.1	3.3	25.7	6.4	3.8	6.5	5.7	5.2	3.4	8.6	1.9	0.9	2.0	12.7	14.4	1.3	3.1	12.5	3.3	3.1	0.0	2.3	1.1	1.2	6.8	7.7	4.1	1.2	1.6	2.9	30.8	2.7	2.8	1.9	0.6	2.3	4.2	3.7	4.8	7.8	4.0	10.0	4.8	2.8	1.3	0.2	1.7	2.6	0.4	5.3	8.7	0.2	1.6	0.9	0.4	1.2	0.0	9.2	9.2	5.4	1.1	3.4	0.2	27.1	1.0	1.2	99.5	5.8	2.4	1.1	2.8	2.8	2.1	0.1	0.2	4.1	38.0	7.0	0.4	2.9	5.7	0.6	3.4	0.8	1.0	0.2	0.7	1.7	1.4	0.2	0.4	12.2	1.7	6.1	0.2	0.2	0.7	2.0	2.7	10.1	3.3	2.0	2.5	2.2	2.6	2.5	1.1	3.3	3.4	66.3	19.2	41.1	71.2	70.9	71.0	89.8	14.6	18.8	67.4	17.6	15.6	11.6	15.7	28.4	11.0	93.8	6.7	77.3	25.0	11.7	6.6	24.6	22.6	23.8	51.2	9.6	21.0	151.5	12.3	5.0	27.0	41.3	22.4	112.5	9.4	26.0	15.4	31.9	52.2	155.9	14.3	28.5	65.6	81.3	17.7	28.0	111.4	120.9	159.3	277.4	25.6	88.6	112.1	81.6	39.6	24.2	21.8	37.3	56.0	12.7	10.9	26.7	162.5	13.1	31.2	22.7	93.3	28.0	18.7	65.1	8.8	71.3	13.6	7.6	98.5
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 304.7;Spermatocytes: 191.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: AB_2683779"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	20.6	18.1	20.2	18.8	24.4	19.4	25.5	24.8	23.4	24.3	16.2	28.5	29.0	25.9	16.2	22.9	23.7	18.1	29.6	19.8	21.2	28.9	30.4	17.0	21.9	24.0	24.1	35.0	13.4	29.2	12.3	22.3	24.2	21.9	27.6	25.9	20.9	19.8	27.3	20.1	27.1	24.8	24.2	15.8	16.7	66.9	21.6	30.0	24.6	27.5	23.8	18.1	15.3	28.4	43.0	27.8	52.5	37.2	32.0	51.9	23.3	38.1	32.1	52.8	50.9	34.6	73.4	51.6	42.3	48.1	33.3	31.9	49.7	55.1	78.7	48.5	33.5	75.7	34.9	57.9	30.7	69.7	37.5	34.3	77.0	74.1	69.2	37.6	41.8	67.4	95.6	28.7	49.1	30.5	57.3	33.8	26.6	53.7	44.5	60.7	69.4	41.9	28.5	19.2	26.1	41.2	46.6	20.2	91.2	49.9	33.5	35.1	38.6	36.5	49.6	52.4	40.8	23.2	57.5	87.4	37.3	101.7	49.6	34.9	25.1	40.3	20.5	29.5	17.8	18.4	20.6	20.1	24.8	20.4	20.1	21.2	25.6	23.2	33.2	38.0	29.3	17.5	20.2	24.4	24.8	23.4	19.8	21.2	24.0	24.1	24.2	24.2	21.6	28.4	34.3	6.4	17.3	6.8	20.7	12.7	21.9	24.1	17.6	12.0	22.6	27.3	57.4	10.0	15.9	7.3	6.2	26.9	26.9	25.9	49.0	27.0	304.7	34.7	36.4	19.9	9.1	24.0	11.1	21.2	45.7	27.8	13.3	27.0	30.4	27.2	14.3	23.9	42.7	42.1	14.8	18.1	10.2	22.6	15.7	91.6	26.4	34.9	14.2	14.0	36.8	45.6	20.6	13.6	23.8	22.6	27.8	27.4	22.4	27.6	41.7	53.0	27.4	18.0	19.7	26.6	31.1	191.3	86.2	29.2	16.8	34.5	26.8	21.4	22.5	21.6
LZTR1	"BTBD29, LZTR-1"	ENSG00000099949	"Leucine zipper like transcription regulator 1"	Q8N653	22	20982269-20999032	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067852, HPA068772, HPA071248"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.25e-2)"	18.4	15.2	9.0	8.9	9.7	6.0	17.3	8.9	10.1	20.1	7.2	20.1	9.9	23.3	4.4	12.6	18.5	9.4	13.4	9.1	9.1	15.8	12.0	16.0	7.3	10.3	9.5	19.5	12.4	11.5	24.7	9.8	10.8	16.2	6.4	3.4	13.0	8.6	14.7	13.6	15.9	11.3	8.1	18.3	13.9	8.2	8.9	6.5	18.8	8.0	5.7	18.1	15.8	9.3	10.3	8.4	12.2	15.0	27.6	18.9	9.6	20.8	14.6	11.6	15.8	4.9	4.2	11.0	7.6	23.4	10.7	13.7	9.3	17.1	4.7	20.5	21.0	11.8	11.8	7.4	14.6	6.4	14.9	17.5	8.5	14.7	10.6	18.4	22.9	10.0	49.8	18.5	13.4	6.3	11.5	6.0	3.8	12.6	9.1	13.4	17.8	4.4	9.2	13.9	11.9	17.9	11.3	19.5	12.4	7.4	9.1	11.7	20.6	27.0	13.3	12.3	11.5	8.0	7.4	3.2	12.2	6.2	13.5	0.0	0.5	0.0	0.7	0.7	0.4	0.4	0.3	0.8	0.4	0.1	0.4	0.3	0.0	0.3	1.0	0.3	0.1	0.5	9.0	9.7	8.9	10.1	9.1	9.1	10.3	9.5	10.8	8.1	8.9	9.3	12.4	12.8	8.6	20.5	7.9	2.2	1.8	3.7	4.0	9.5	7.5	7.6	11.7	5.7	5.2	9.2	6.2	4.1	11.9	10.7	1.9	7.0	0.9	5.5	12.7	10.1	9.1	2.5	14.2	4.9	4.0	10.9	11.2	8.4	5.7	14.7	12.1	8.5	7.7	3.3	13.2	10.0	6.1	8.8	3.5	1.6	8.7	7.1	7.2	14.0	5.0	5.6	5.2	8.0	17.6	6.1	8.9	9.8	9.2	2.3	7.0	7.6	7.3	9.8	0.0	7.0	11.6	4.5	1.5	5.9	3.7	3.6	7.7	10.1	6.7	1.4
LZTS2	"KIAA1813, LAPSER1"	ENSG00000107816	"Leucine zipper tumor suppressor 2"	Q9BRK4	10	100996618-101007836	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044956	Approved		Approved	"Plasma membrane,Cytosol"		No	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA044956: AB_10795989"	"unprognostic (1.42e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.76e-3)"	69.9	66.0	46.8	14.9	65.5	14.4	63.3	58.0	54.1	74.3	25.8	96.3	17.5	90.3	17.7	41.0	69.2	19.8	58.9	41.2	45.8	51.8	18.0	57.1	12.1	63.7	64.3	78.6	29.5	29.1	43.6	28.5	58.5	69.5	8.9	5.9	44.3	40.6	37.8	48.9	43.0	26.6	49.0	44.4	54.9	36.2	64.1	10.8	57.6	18.0	8.1	84.1	54.4	78.9	32.9	43.1	34.6	59.7	45.0	36.3	70.8	38.7	72.8	31.9	36.0	50.5	26.6	13.1	35.1	52.5	23.0	54.6	21.5	28.2	7.8	12.8	31.9	12.1	46.4	66.3	63.6	6.4	15.2	66.1	20.2	25.1	30.1	67.3	32.8	15.6	38.7	7.3	28.7	31.6	5.8	15.8	38.8	12.6	35.2	74.7	101.3	13.5	24.4	39.3	8.4	62.8	26.3	11.9	99.9	18.6	61.0	51.6	42.1	37.9	42.6	40.5	20.7	14.0	10.2	3.3	64.0	17.7	19.4	0.0	0.7	0.4	2.7	0.4	3.7	2.3	3.4	3.0	1.1	2.9	3.5	3.0	0.3	2.9	0.1	1.8	3.0	1.5	46.8	65.5	58.0	54.1	41.2	45.8	63.7	64.3	58.5	49.0	64.1	78.9	34.7	16.0	10.5	20.2	5.3	13.4	9.0	12.4	19.4	14.4	21.7	20.3	5.2	11.5	9.4	5.5	6.2	18.6	1.9	8.0	7.9	19.1	6.8	7.9	20.5	22.9	16.7	5.0	6.8	12.6	13.2	21.8	14.8	13.0	1.3	38.9	18.5	2.6	22.2	18.5	7.7	17.8	16.2	7.2	9.2	4.1	25.7	8.4	16.0	13.1	4.8	18.9	4.1	9.0	70.3	13.3	7.9	29.3	5.4	18.1	6.5	8.3	6.1	4.0	26.3	21.1	40.7	3.8	15.0	10.8	12.1	47.1	6.0	26.9	15.1	9.7
MACC1	"7A5, SH3BP4L"	ENSG00000183742	"MET transcriptional regulator MACC1"	Q6ZN28	7	20134655-20217404	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.7"	"Cell type enhanced"	"Detected in many"		"Club cells: 102.4;Glandular and luminal cells: 100.5;Pancreatic endocrine cells: 136.4;Respiratory ciliated cells: 93.4;Urothelial cells: 238.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 98.0;CAPAN-2: 22.2;HaCaT: 66.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020081, HPA020103, HPA029476, CAB068194"	Supported		Approved	Mitochondria		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB068194: AB_2665682, HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136"	"unprognostic (1.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.71e-9)"	"unprognostic (4.49e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.93e-3)"	0.6	2.3	1.4	1.3	0.6	1.0	4.3	1.0	1.4	2.9	0.0	2.7	9.8	0.8	0.7	8.8	0.9	2.9	0.2	1.0	0.3	6.6	0.4	5.4	0.9	1.1	0.7	0.1	3.3	0.4	0.3	0.2	1.4	1.0	3.2	0.6	5.6	2.6	0.1	2.9	11.7	0.3	0.2	0.8	4.9	0.5	0.9	0.6	1.1	0.0	3.5	3.9	3.0	1.3	98.0	0.4	0.4	0.0	0.1	0.2	0.9	0.1	0.0	0.0	0.0	21.6	22.2	13.8	1.0	0.0	0.1	66.9	0.2	0.9	0.0	0.1	0.4	13.0	0.3	0.0	0.0	5.5	0.4	0.0	0.7	0.0	0.1	0.2	0.1	0.3	14.2	6.5	0.1	8.1	0.0	1.4	1.0	19.1	0.1	0.0	0.6	10.5	16.5	6.7	0.3	0.5	0.0	7.5	0.1	0.4	3.9	0.2	0.4	0.2	0.2	0.1	0.2	20.1	1.0	5.0	0.1	0.7	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.1	1.4	0.6	1.0	1.4	1.0	0.3	1.1	0.7	1.4	0.2	0.9	1.3	4.1	70.5	57.4	0.7	6.5	2.8	75.8	11.3	2.8	3.3	22.2	7.5	0.6	24.3	102.4	40.5	2.1	0.8	2.2	16.9	7.9	51.4	2.9	59.6	16.3	4.1	38.7	4.2	1.0	63.8	0.2	5.7	18.3	100.5	12.6	0.4	2.2	0.8	4.4	1.7	2.9	19.5	34.6	0.9	3.8	1.2	2.1	11.0	1.8	0.0	8.4	0.3	1.0	0.0	0.9	136.4	20.4	2.6	6.3	72.8	40.2	17.5	93.4	1.3	0.0	0.8	3.6	0.4	0.6	13.2	4.0	0.3	2.9	0.3	17.5	238.8
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"Mono-ADP ribosylhydrolase 2"	A1Z1Q3	20	13995369-16053197	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 349.7;Excitatory neurons: 752.7;Inhibitory neurons: 1058.5;Oligodendrocyte precursor cells: 672.0;Oligodendrocytes: 301.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 8.9;naive B-cell: 13.2;neutrophil: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 13.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 15.5;Karpas-707: 19.1;RT4: 8.4;SCLC-21H: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	1.9	3.1	3.9	2.2	8.4	1.2	2.8	2.3	4.7	3.1	0.1	1.3	0.7	5.0	2.3	1.4	7.3	2.8	1.1	4.8	2.8	3.9	1.8	10.9	4.0	3.3	3.6	2.9	2.9	2.5	2.2	1.1	3.7	4.7	1.3	4.9	1.3	9.9	1.5	2.7	0.9	4.0	2.1	5.0	2.3	5.1	7.3	1.8	2.6	0.6	5.3	4.5	1.2	4.3	1.0	0.4	3.0	1.2	0.8	0.7	0.5	0.3	2.1	1.2	0.7	0.4	0.7	2.0	15.5	1.4	2.6	1.5	0.3	0.7	1.9	1.0	0.9	1.2	1.2	2.4	3.4	0.3	0.3	1.9	1.3	0.0	0.5	1.1	1.1	0.2	1.4	19.1	3.1	0.5	0.5	0.8	0.9	7.1	0.6	1.2	0.5	4.0	2.2	8.4	10.6	1.9	1.6	0.2	0.6	1.1	1.0	1.8	0.7	1.4	3.2	0.3	0.0	0.7	0.3	2.1	0.9	1.0	1.7	0.1	0.5	0.5	0.2	1.2	0.2	8.9	0.2	0.2	0.4	13.2	0.2	0.3	3.4	0.1	1.6	0.2	0.0	0.5	3.9	8.4	2.3	4.7	4.8	2.8	3.3	3.6	3.7	2.1	7.3	4.3	1.6	51.3	203.8	349.7	18.3	4.5	49.8	1.4	5.2	94.0	7.6	6.9	5.9	11.5	37.5	12.9	39.6	7.1	0.1	1.8	9.8	11.9	35.4	8.6	2.5	3.0	1.2	0.4	752.7	1.6	0.4	4.6	9.2	6.7	1.3	7.6	7.1	4.8	0.9	8.4	1058.5	4.5	0.0	0.3	2.1	62.2	3.4	0.9	3.6	87.1	0.0	10.2	0.0	672.0	301.4	6.6	1.7	17.7	2.8	6.2	2.4	8.6	9.8	20.3	6.6	2.1	6.0	23.7	18.8	5.8	6.7	2.1	0.9	13.2	2.8	5.4
MACROH2A1	"H2AFY, macroH2A1.2"	ENSG00000113648	"MacroH2A.1 histone"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 67.2;Cytotrophoblasts: 151.6;Extravillous trophoblasts: 148.8;Hofbauer cells: 419.5;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm		NA	NA		2700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357, HPA050962: AB_2681292"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	64.4	58.7	44.3	97.0	45.2	247.8	55.6	46.8	49.0	59.4	52.2	111.5	115.0	48.0	49.1	146.1	61.5	70.6	56.4	45.6	51.7	52.7	50.4	72.7	126.0	45.0	48.5	39.3	31.2	85.6	57.2	78.7	49.2	54.1	118.7	114.1	64.6	36.3	90.8	95.7	117.4	61.4	47.7	75.1	81.3	26.0	48.3	219.4	53.2	73.4	130.9	99.6	76.2	51.6	303.5	208.8	314.9	217.5	144.5	85.6	282.8	124.2	133.1	215.8	151.8	331.3	295.6	356.5	206.5	101.2	182.8	200.7	239.2	526.1	160.8	194.4	237.7	426.3	227.7	226.0	105.7	205.0	179.7	91.3	140.0	180.5	192.3	132.0	140.6	239.0	150.9	142.4	124.4	264.5	594.1	388.7	123.7	359.4	110.5	528.3	179.2	252.5	270.7	339.4	441.1	277.6	241.8	232.2	204.4	164.2	275.8	558.0	114.7	188.1	158.2	140.1	259.1	67.9	296.2	334.5	157.0	455.0	135.5	16.1	178.7	84.3	40.3	122.6	34.0	47.2	51.1	49.8	203.0	67.8	49.2	40.4	93.2	87.8	80.1	147.2	65.3	138.4	44.3	45.2	46.8	49.0	45.6	51.7	45.0	48.5	49.2	47.7	48.3	51.6	57.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	151.6	38.3	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	148.8	30.4	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	183.5	5.8	0.0	0.0	0.0
MACROH2A2	H2AFY2	ENSG00000099284	"MacroH2A.2 histone"	Q9P0M6	10	70052544-70112282	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.1;Fibroblasts: 1.7;Hofbauer cells: 4.9;Syncytiotrophoblasts: 1.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 12.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 173.9;AN3-CA: 111.5;SCLC-21H: 137.0;SH-SY5Y: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035865, HPA041189"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA035865: AB_10672099, HPA041189: AB_2677357"	"unprognostic (1.62e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.17e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.66e-2)"	3.8	3.2	5.3	5.6	4.5	1.9	10.2	7.3	6.3	14.7	3.3	10.8	9.5	18.3	11.6	17.4	16.5	8.7	13.5	4.1	4.9	15.2	5.2	5.6	4.9	3.8	3.9	13.3	7.8	14.9	14.0	2.1	3.7	13.1	10.5	3.2	10.9	14.4	6.5	10.7	10.1	15.3	3.6	2.7	8.6	11.8	4.2	7.4	10.2	8.6	7.2	13.2	11.8	4.4	4.7	31.1	173.9	111.5	2.5	5.1	0.1	8.6	0.3	16.2	11.0	0.5	55.8	0.0	23.5	2.8	9.1	27.4	15.3	44.8	5.1	81.1	63.4	0.0	0.2	59.1	11.2	1.9	0.8	8.1	30.4	6.4	8.5	23.4	0.0	6.3	0.1	0.6	15.7	37.5	0.2	0.9	74.8	0.2	44.9	0.4	0.5	0.6	30.7	34.0	137.0	132.4	28.6	0.2	0.0	35.2	41.5	20.3	0.0	0.3	32.3	12.4	6.2	0.4	0.1	0.3	0.0	0.2	0.3	1.6	2.4	0.8	0.6	5.4	1.1	0.3	0.9	0.8	12.6	0.3	0.8	0.9	1.4	1.1	3.0	0.2	0.5	1.6	5.3	4.5	7.3	6.3	4.1	4.9	3.8	3.9	3.7	3.6	4.2	4.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640941	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: AB_2672752"	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	13.3	16.2	13.6	14.1	13.8	53.5	17.3	14.1	15.8	14.6	15.4	25.9	23.6	12.4	17.3	17.6	16.7	14.4	25.4	14.3	14.9	17.5	21.9	14.9	21.7	13.8	13.2	13.0	16.7	21.1	12.6	14.0	14.2	14.4	27.7	15.2	22.8	13.5	28.5	13.2	18.8	14.5	13.6	17.4	19.3	20.4	14.3	29.3	15.6	44.6	26.6	21.4	10.6	13.8	53.9	24.4	37.7	42.2	32.1	34.7	22.7	31.7	50.9	68.5	63.8	50.3	21.4	41.6	17.6	37.3	62.2	34.4	59.2	43.9	52.6	38.5	46.0	51.5	26.1	43.8	34.6	30.6	29.9	35.3	53.0	51.1	31.0	34.5	52.2	32.8	67.2	21.8	48.4	50.6	27.4	56.5	23.3	221.1	31.3	31.3	29.3	39.4	48.9	42.5	44.7	45.3	22.8	34.5	152.2	28.6	40.6	80.3	28.7	36.5	30.7	24.4	51.3	27.7	25.8	99.0	33.2	51.3	41.0	105.4	41.4	49.4	46.3	42.8	46.5	52.6	54.7	51.4	52.7	47.9	56.5	51.2	35.2	55.6	41.3	34.9	78.9	43.6	13.6	13.8	14.1	15.8	14.3	14.9	13.8	13.2	14.2	13.6	14.3	13.8	11.6	25.6	12.7	3.3	18.2	14.4	20.5	44.9	17.6	12.8	11.6	9.3	10.8	15.7	32.5	3.7	12.5	21.1	11.1	30.7	27.4	28.0	47.0	13.2	8.6	12.5	17.4	20.6	3.0	21.2	21.5	12.0	14.3	10.8	31.6	7.8	11.4	12.7	17.6	10.1	3.2	17.1	32.6	10.4	8.6	36.5	12.2	19.6	28.4	1.9	17.3	13.9	11.3	3.0	5.0	24.7	29.5	12.0	11.1	11.5	28.2	21.2	21.1	15.1	26.3	8.3	13.4	26.4	18.3	12.6	9.7	6.2	14.8	11.9	23.4	27.2
MAEA	"EMP, GID9, HLC-10, p44EMLP"	ENSG00000090316	"Macrophage erythroblast attacher, E3 ubiquitin ligase"	Q7L5Y9	4	1289887-1340147	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036886, HPA058185"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA036886: , HPA058185: AB_2683633"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.94e-3)"	"unprognostic (4.65e-3)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.51e-2)"	28.5	44.2	21.9	23.5	21.3	18.3	28.8	19.8	24.0	32.6	25.9	39.7	33.5	34.4	10.9	46.7	29.2	17.5	38.6	21.1	27.2	40.9	32.3	24.0	24.3	25.7	23.0	34.9	35.4	30.7	38.9	17.2	26.3	29.2	14.2	8.8	35.7	21.5	37.1	41.2	35.7	14.9	18.1	40.0	37.1	26.8	23.2	20.7	33.9	19.2	15.7	30.7	33.5	20.0	58.1	66.9	47.6	47.7	31.5	31.1	61.4	57.4	30.6	47.1	42.2	70.5	73.5	52.5	43.6	42.4	85.5	42.0	46.1	72.2	19.1	42.4	52.2	49.2	74.1	68.1	37.1	55.8	50.9	38.8	38.6	37.8	23.6	31.8	38.0	50.4	70.4	41.6	41.3	61.5	84.2	86.5	62.2	63.4	72.9	81.0	38.1	47.8	50.3	68.2	84.7	57.8	51.1	39.3	41.5	26.3	71.5	48.4	52.8	85.9	36.0	39.0	96.1	50.5	83.4	58.1	59.0	51.3	48.2	74.9	49.9	70.9	59.2	52.6	83.5	47.6	47.1	56.4	47.1	38.1	41.4	42.5	117.9	45.5	77.3	33.0	59.8	59.1	21.9	21.3	19.8	24.0	21.1	27.2	25.7	23.0	26.3	18.1	23.2	20.0	22.0	19.2	25.0	28.4	21.6	18.7	15.7	33.9	8.0	28.1	22.5	25.3	35.5	14.3	24.3	16.5	20.9	48.2	29.7	41.2	46.9	43.4	8.0	21.9	25.2	24.4	20.4	26.3	19.6	30.3	46.4	25.0	25.5	25.0	10.8	30.4	19.6	15.0	39.6	21.9	23.2	33.1	30.5	29.2	15.9	9.8	35.4	23.2	28.4	14.0	46.3	22.3	28.8	22.6	20.0	40.3	31.3	37.2	23.5	22.7	30.4	36.4	17.9	19.1	13.1	24.9	27.9	36.6	44.0	19.3	19.9	95.2	29.7	59.6	38.1	21.8
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689236	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 273.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 264.0;Hofbauer cells: 377.6;Kupffer cells: 672.8;Macrophages: 456.7;Squamous epithelial cells: 361.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 88.3;non-classical monocyte: 121.4"	"Lineage enriched"	"Detected in many"	15	"monocytes: 121.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 28.6;hTCEpi: 61.2;SCLC-21H: 16.7;SiHa: 15.6;U-138 MG: 16.4;U-2197: 24.4;U-87 MG: 16.0"	"Low region specificity"	"Detected in many"							HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	35.3	13.8	4.8	37.3	4.9	59.2	27.3	4.4	10.5	16.5	6.9	9.5	7.8	9.3	5.4	33.0	11.3	24.4	10.7	3.7	5.7	17.5	29.3	20.9	27.8	14.3	6.3	6.8	15.8	273.1	3.1	13.2	7.2	8.3	7.2	0.6	18.3	4.7	15.8	85.3	13.2	14.2	9.0	96.3	11.0	3.9	13.1	6.7	50.1	16.7	12.7	13.9	21.9	15.8	0.0	0.0	0.0	2.6	1.5	0.2	0.4	0.3	0.1	0.3	0.1	0.4	0.2	0.0	1.9	0.4	0.0	3.8	0.0	0.0	0.0	0.0	1.4	0.0	1.2	0.2	0.9	0.0	0.1	28.6	61.2	0.2	2.1	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.3	7.4	2.6	6.2	0.0	0.0	0.0	0.0	0.5	0.4	16.7	1.4	15.6	1.5	3.9	5.4	1.5	0.3	0.5	16.4	0.3	24.4	0.0	0.0	0.0	0.0	16.0	0.6	0.0	0.4	24.3	0.0	0.0	88.3	0.0	0.0	0.0	0.1	7.9	0.1	0.0	0.0	2.1	0.0	121.4	0.1	0.0	10.6	4.8	4.9	4.4	10.5	3.7	5.7	14.3	6.3	7.2	9.0	13.1	15.8	70.0	22.4	37.9	1.6	7.8	68.6	50.5	17.1	264.0	12.0	112.2	217.8	208.9	7.2	16.8	51.5	25.0	9.8	7.6	117.1	1.9	2.3	0.8	15.7	64.4	39.1	57.7	4.0	0.8	3.4	2.8	172.7	49.5	27.6	10.8	0.9	34.6	36.1	377.6	3.3	25.4	50.7	6.1	672.8	91.7	2.8	29.5	456.7	21.4	6.5	65.3	21.9	3.1	2.0	1.3	4.9	30.9	24.5	5.6	29.7	89.5	1.3	2.4	8.3	13.1	160.6	102.4	0.8	1.7	361.5	88.2	12.4	9.5	114.6	39.0	19.2
MAFF	hMafF	ENSG00000185022	"MAF bZIP transcription factor F"	Q9ULX9	22	38200767-38216507	"Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 682.0;Syncytiotrophoblasts: 479.1;Urothelial cells: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 23.9;neutrophil: 8.7;NK-cell: 21.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 23.9;NK-cells: 21.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 79.2;SK-MEL-30: 104.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 5.6"	"CAB025341, HPA055371"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Mitochondria	"CAB025341: , HPA055371: AB_2682797"	"prognostic favorable (4.32e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.42e-3)"	"unprognostic (7.83e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-2)"	102.9	22.8	9.4	12.9	9.0	36.2	69.9	9.3	10.7	37.4	9.4	26.6	8.1	28.8	2.1	53.4	64.2	41.4	53.8	8.2	11.9	32.0	30.8	59.2	4.7	14.5	10.0	53.9	19.7	5.3	19.5	34.5	13.4	39.5	10.3	19.6	28.6	5.5	73.3	45.7	19.6	23.2	10.5	9.3	45.4	3.0	14.1	7.4	25.0	6.9	11.3	53.8	41.4	16.6	20.8	3.3	4.4	6.6	6.9	21.3	20.6	41.4	54.2	19.8	21.0	6.1	16.0	0.7	3.9	16.9	29.5	13.5	1.1	15.7	33.2	3.9	0.6	2.1	2.1	5.2	18.0	1.3	7.1	9.3	25.7	79.2	43.6	17.6	42.1	1.9	4.2	18.6	15.6	4.9	0.8	5.2	3.3	22.0	16.8	1.4	3.8	4.3	19.9	30.6	2.2	3.7	6.1	15.4	104.9	10.7	3.3	1.5	57.9	24.7	19.2	18.8	13.7	7.2	8.0	0.7	37.4	1.4	15.9	23.9	0.4	0.3	2.9	0.7	2.8	0.8	1.7	2.1	1.4	0.5	2.1	1.6	8.7	21.1	3.5	0.2	0.7	1.8	9.4	9.0	9.3	10.7	8.2	11.9	14.5	10.0	13.4	10.5	14.1	16.6	215.4	54.5	43.4	1.0	19.3	125.9	344.1	56.8	169.0	2.9	302.9	214.1	18.6	67.2	49.5	11.0	0.0	37.8	112.5	134.2	7.9	49.9	0.5	284.7	149.3	97.3	104.8	5.7	0.8	24.2	77.5	134.7	132.5	682.0	22.2	11.5	22.1	8.2	26.0	0.0	1.6	112.5	34.6	14.0	131.1	0.4	9.9	113.5	58.7	1.0	10.2	36.0	17.5	1.5	1.3	76.0	181.0	3.8	25.8	258.4	67.6	3.7	37.9	3.6	19.7	265.2	153.1	2.4	1.0	139.5	103.1	479.1	59.0	8.4	75.5	409.2
MAFIP	"FLJ00219, FLJ35473, FLJ39633, MIP, pp5644, TEKT4P4"	ENSG00000274847	"MAFF interacting protein (pseudogene)"		Unmapped	53594-115055	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.0;Endometrial ciliated cells: 3.9;Endometrial stromal cells: 3.8;Glandular and luminal cells: 5.2;Proximal tubular cells: 3.3"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA053929			Uncertain	"Intermediate filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"		"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Intermediate filaments"		"HPA053929: AB_2682314"																		3.8	5.5	6.3	1.5	6.6	0.9	1.1	6.9	8.2	1.6	6.4	1.2	1.6	1.5	0.8	2.7	1.9	2.3	2.0	6.6	6.7	2.0	1.8	1.9	3.7	7.2	6.5	3.6	2.7	1.5		1.4	7.1	2.3	0.5	1.4	4.1	1.4	1.8	0.7	2.3	2.1	6.9	3.2	0.8	1.2	6.6	0.4	1.5	1.8	1.3	1.9		7.2	0.0	2.9	0.0	0.9	0.0	0.0	2.0	3.9	1.7	1.1	1.6	6.5	7.5	0.0	6.4	5.1	3.0	0.9	2.3	3.7	0.5	0.0	2.5	1.7	3.0	6.0	0.1	0.0	5.7	0.6	5.7	2.0	0.0	4.7	3.8	0.0	7.6	1.8	2.4	7.8	6.0	0.7	0.0	3.5	1.1	0.0	3.6	1.3	4.1	0.5	1.9	4.2	0.0	2.3	3.6	0.7	5.7	0.1	8.6	2.1	3.4	0.9	2.7	5.6	2.1	0.0	8.7	0.0	1.2	2.1	1.5	1.2	1.3	2.1	0.9	2.1	1.2	1.1	2.5	2.3	1.6	1.6	0.1	1.9	0.9	5.0	2.0	1.4	6.3	6.6	6.9	8.2	6.6	6.7	7.2	6.5	7.1	6.9	6.6	7.2	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.4	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.7	0.0	3.9	3.8	1.2	0.0	0.0	0.0	1.1	0.7	1.1	0.0	5.2	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.0	0.0
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530702-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026820: , HPA060841: AB_2684377"	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	40.9	31.0	37.0	13.0	34.8	19.5	34.4	26.8	34.8	30.9	38.2	61.1	18.2	34.7	1.8	30.1	33.6	11.6	80.5	26.8	28.0	50.3	32.8	60.0	9.4	35.5	33.3	21.7	39.7	4.2	25.6	25.4	32.2	49.2	4.7	2.4	25.6	10.7	78.6	38.6	31.1	6.7	30.2	21.0	37.2	9.7	35.6	22.9	27.3	13.1	4.9	39.4	35.7	43.2	50.0	35.0	1.2	5.2	3.9	4.8	26.2	32.3	18.3	7.7	5.4	25.2	13.4	11.6	11.7	8.2	51.8	38.1	2.9	9.2	3.3	17.9	25.2	6.8	50.8	18.7	8.7	16.2	20.7	4.8	11.8	12.9	9.6	9.5	7.1	35.7	17.8	6.2	3.6	32.7	18.2	57.6	11.2	12.2	35.2	27.1	1.2	19.5	7.3	20.2	14.8	5.4	19.5	56.4	14.6	7.5	22.0	21.3	16.8	11.8	82.3	59.5	17.9	11.8	3.9	19.8	15.5	22.0	17.1	0.5	0.4	1.2	0.6	0.2	0.6	0.3	0.3	0.7	0.2	0.5	0.7	0.5	0.6	0.5	0.5	1.5	0.7	0.4	37.0	34.8	26.8	34.8	26.8	28.0	35.5	33.3	32.2	30.2	35.6	43.2	33.0	41.7	17.6	2.0	8.8	63.9	52.2	21.3	37.0	2.2	33.7	20.2	2.8	11.5	25.7	31.3	2.1	11.0	13.2	45.8	1.9	15.2	2.9	57.3	13.3	24.6	23.2	8.2	8.8	14.9	9.0	16.6	20.4	94.3	9.5	6.6	9.7	14.8	10.9	11.8	3.7	24.4	16.2	13.2	27.9	6.0	4.7	18.0	19.6	9.4	8.7	7.1	8.2	0.5	3.1	46.2	38.9	3.0	6.0	60.8	27.4	2.5	29.6	1.6	13.1	33.2	27.1	0.9	4.0	25.8	57.7	78.0	11.0	2.0	19.8	73.5
MAGEA9	"CT1.9, MAGE9, MGC8421"	ENSG00000123584	"MAGE family member A9"	P43362	X	149781930-149787737	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	38	"testis: 3.7"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 2.3;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"U-266/70: 45.2;U-266/84: 32.9"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA9B		ENSG00000267978	"MAGE family member A9B"	P43362	X	149581653-149587453	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"testis: 10.0"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 39.6;Spermatogonia: 16.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"OE19: 82.4;RT4: 131.1;U-266/70: 55.1;U-266/84: 73.7"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "															"unprognostic (6.12e-3)"		"unprognostic (3.26e-1)"	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.0	0.1	82.4	0.0	0.2	0.0	6.3	0.0	131.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	55.1	73.7	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	39.6	16.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909374	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 7.3"	"Group enriched"	"Detected in some"	9	"Sertoli cells: 6.6;Spermatocytes: 17.1;Spermatogonia: 13.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 54.3;Karpas-707: 51.6;U-2 OS: 33.8;U-2197: 65.4;U-266/70: 46.5;U-266/84: 44.4"									"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.6	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.1	33.8	65.4	0.1	46.5	44.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	17.1	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEC2	"CT10, HCA587, MAGE-C2, MAGEE1"	ENSG00000046774	"MAGE family member C2"	Q9UBF1	X	142202342-142205290	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 19.6"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 84.6;Spermatogonia: 91.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 19.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 87.3;U-266/84: 99.8"									HPA062230	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA062230: AB_2684718"					"unprognostic (1.25e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.82e-1)"						"unprognostic (1.04e-1)"		"unprognostic (4.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.9	3.7	0.0	0.0	0.0	0.2	5.7	0.9	11.3	0.0	0.1	99.8	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	84.6	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816015	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Granulosa cells: 1684.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No		120000	"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	81.6	125.1	102.3	52.8	97.8	31.8	162.6	104.9	112.2	174.5	111.7	106.8	54.3	134.3	101.9	67.4	149.0	94.3	142.2	95.5	121.9	141.0	57.5	85.9	48.0	125.4	118.4	255.9	75.5	148.0	195.3	177.1	128.8	208.8	53.5	74.4	103.3	169.9	88.9	60.5	62.5	140.6	108.5	60.8	77.6	63.1	110.1	68.8	149.2	91.4	46.2	111.7	95.7	108.9	34.0	61.4	373.7	111.0	171.6	229.5	66.8	137.9	243.7	106.4	187.5	62.3	84.4	47.1	361.2	279.0	88.5	45.2	106.5	104.2	76.1	84.5	87.0	100.0	68.6	122.1	145.5	25.4	71.8	310.4	43.0	109.3	55.5	223.6	209.9	55.2	24.5	55.7	207.6	94.0	57.0	41.9	134.7	59.1	72.4	37.4	132.9	68.2	148.5	25.3	56.6	149.5	54.7	62.4	330.6	437.5	263.1	42.9	185.0	90.4	141.3	135.9	39.5	35.7	32.7	34.5	132.0	66.7	477.6	178.5	31.9	132.1	119.1	80.0	91.7	59.2	98.1	112.1	41.1	63.9	97.3	112.0	11.8	108.6	140.8	25.8	108.9	127.4	102.3	97.8	104.9	112.2	95.5	121.9	125.4	118.4	128.8	108.5	110.1	108.9	77.9	44.8	42.8	17.6	37.4	42.4	96.4	198.6	43.3	69.8	123.3	97.8	60.5	44.3	175.4	77.3	29.2	231.5	36.9	11.9	246.5	107.4	3.4	42.4	96.8	116.4	58.3	10.3	12.9	53.7	133.7	151.7	20.9	57.1	102.1	1684.0	79.9	16.2	69.1	138.0	20.3	48.8	173.0	19.5	47.4	17.4	233.3	41.1	158.3	21.5	42.1	175.9	44.3	17.6	20.4	47.9	33.7	320.4	46.7	75.2	25.5	149.3	119.9	66.0	157.8	77.7	236.3	12.8	13.7	15.3	34.9	169.2	51.4	58.6	25.3	76.6
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427710-76431342	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.2;Excitatory neurons: 12.2;Horizontal cells: 28.6;Inhibitory neurons: 12.2;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.8"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favorable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	1.6	3.2	10.0	1.6	10.2	0.3	1.6	3.0	20.6	2.8	0.0	2.2	0.5	3.3	1.7	1.0	2.5	1.1	2.2	12.1	17.0	2.1	0.3	1.3	2.5	7.7	5.1	4.7	2.6	6.1	6.0	0.0	7.9	3.2	0.9	6.4	1.7	4.0	1.1	1.8	1.8	2.6	1.0	2.7	1.6	0.4	9.8	2.9	2.1	0.9	1.9	2.1	1.7	6.7	0.2	3.8	3.9	7.5	2.7	1.5	3.4	2.9	2.9	2.4	1.3	0.8	0.6	0.8	1.4	2.5	7.8	2.9	5.8	5.4	1.9	1.9	0.1	0.0	0.0	2.5	0.5	1.5	0.5	1.1	2.4	0.6	0.6	0.1	0.9	4.2	0.3	0.0	3.6	0.5	4.3	0.2	4.7	0.0	5.8	3.4	2.9	0.0	3.1	0.0	0.0	2.0	0.0	0.4	0.6	3.9	1.7	0.1	0.5	3.6	4.5	3.8	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.2	0.5	0.0	0.2	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.1	10.0	10.2	3.0	20.6	12.1	17.0	7.7	5.1	7.9	1.0	9.8	6.7	0.8	3.2	2.6	3.3	1.7	0.5	0.7	1.2	1.2	11.2	0.9	1.9	1.9	1.5	1.1	1.8	4.2	0.2	1.4	0.3	1.9	1.4	0.0	0.4	1.3	2.4	0.0	0.4	12.2	1.5	0.4	1.3	1.1	0.4	1.3	1.5	1.8	0.2	0.1	28.6	12.2	0.4	0.0	0.3	0.0	0.1	1.5	0.1	0.0	3.7	0.1	5.5	2.1	5.5	5.0	0.7	0.0	4.5	0.3	0.3	0.0	1.3	0.3	5.0	19.7	2.7	3.6	0.3	0.2	0.6	0.1	0.1	2.5	0.8	0.1	0.2
MAGIX	"FLJ21687, JM10, PDZX"	ENSG00000269313	"MAGI family member, X-linked"	Q9H6Y5	X	49162564-49168483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Hepatocytes: 35.0;Proximal tubular cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 5.5;RT4: 12.8;SK-BR-3: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007390, HPA035302"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Mitotic chromosome"	"HPA007390: , HPA035302: AB_10603015"	"unprognostic (1.11e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.64e-6)"	"unprognostic (6.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"prognostic favorable (6.91e-9)"	"unprognostic (4.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (2.10e-4)"	1.3	2.1	3.9	0.7	3.6	1.4	1.8	9.5	4.3	2.4	7.9	3.4	1.7	1.8	1.2	4.3	4.0	1.3	9.9	3.9	3.9	9.7	19.1	2.8	0.4	4.2	4.2	1.0	13.9	3.7	5.9	0.5	4.2	5.1	1.0	1.1	10.0	2.8	2.1	2.7	1.5	0.3	3.5	1.2	12.4	0.7	4.0	0.6	7.0	0.5	0.3	2.8	2.1	3.7	0.3	1.9	0.4	0.5	0.5	0.1	1.4	0.3	0.3	0.3	0.3	1.1	5.5	0.5	0.5	0.6	0.7	1.2	0.3	1.3	0.0	1.6	1.8	2.4	3.4	0.6	0.2	0.6	4.7	0.5	0.2	0.4	0.1	0.6	0.4	0.8	0.3	2.0	0.4	0.7	0.5	1.7	0.5	1.5	1.0	0.3	0.1	1.0	1.0	12.8	2.4	0.5	1.1	5.7	0.6	0.3	4.5	0.5	0.2	0.6	1.4	0.5	0.4	1.3	0.7	0.4	2.3	0.8	1.8	3.1	1.1	2.0	0.1	1.0	0.4	0.6	0.5	0.0	0.7	0.5	0.3	0.5	4.2	0.7	1.1	1.4	0.1	0.6	3.9	3.6	9.5	4.3	3.9	3.9	4.2	4.2	4.2	3.5	4.0	3.7	1.6	3.2	5.4	1.0	2.8	3.2	10.3	5.6	4.6	8.0	18.7	10.4	8.5	11.5	7.0	12.9	2.1	2.1	3.9	33.7	46.9	13.1	0.2	24.7	2.5	2.0	17.5	0.4	1.2	20.8	4.1	2.4	28.5	16.0	0.0	0.8	4.2	35.0	5.1	8.4	1.1	23.4	2.0	3.2	5.7	0.0	0.6	5.7	1.8	0.0	4.8	8.3	0.0	1.0	1.3	8.9	30.7	0.4	5.2	5.8	15.2	44.3	20.4	9.7	0.0	6.9	3.8	3.0	2.7	8.0	4.4	3.8	3.9	1.7	15.3	9.9
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671465-58754477	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: AB_2680389"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	7.1	2.5	2.9	11.2	2.8	10.5	6.3	4.8	3.6	7.7	4.2	5.1	3.6	5.4	4.2	12.5	5.1	5.8	5.4	3.1	4.1	6.7	6.9	7.3	21.1	3.2	2.6	5.3	4.0	5.3	4.7	4.0	3.0	11.5	5.5	8.7	5.8	3.8	8.3	9.4	7.7	4.2	3.0	11.5	4.6	8.2	4.1	15.6	5.3	2.8	23.1	7.1	9.6	3.6	11.4	16.0	16.8	5.2	3.1	6.7	9.2	19.7	12.1	15.7	12.6	13.8	13.5	27.0	10.3	24.0	11.1	12.0	10.8	7.6	20.8	17.0	6.8	9.7	9.0	21.8	4.0	20.1	11.4	4.0	12.2	11.8	10.4	6.6	3.4	7.7	15.3	42.3	9.6	3.3	4.7	9.7	6.3	4.1	7.1	14.8	11.5	19.7	88.9	2.8	2.5	4.5	11.7	6.0	9.3	12.0	5.1	12.2	5.7	22.6	9.1	7.1	20.8	38.5	54.4	16.3	10.6	15.6	9.9	0.3	0.5	0.2	0.7	0.7	0.6	1.1	1.4	0.8	0.7	2.1	1.0	0.8	0.3	0.5	0.5	1.3	0.8	0.4	2.9	2.8	4.8	3.6	3.1	4.1	3.2	2.6	3.0	3.0	4.1	3.6	35.0	22.4	19.2	24.2	67.8	33.0	32.3	4.8	26.2	14.7	13.6	11.0	14.4	10.0	7.0	11.0	85.5	6.2	53.2	11.1	3.9	16.6	12.7	10.4	17.5	31.1	6.7	0.8	61.3	8.5	6.0	15.7	13.7	24.7	31.7	28.1	10.4	11.1	11.8	55.5	42.9	8.6	8.2	21.0	96.5	8.0	10.2	55.9	12.4	34.7	79.5	26.2	20.6	52.3	11.9	16.2	21.9	7.2	42.2	46.6	8.0	30.7	5.8	18.1	19.7	16.1	12.9	40.1	35.6	25.4	24.7	9.0	55.2	5.7	10.7	38.1
MAMDC4	"AEGP, DKFZp434M1411, EDTB"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 30.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 22.9;Hepatocytes: 26.6;Horizontal cells: 16.8;Intestinal goblet cells: 21.8;Proximal enterocytes: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.9"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol		NA	Yes				"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB026377: , HPA059977: AB_2684186"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favorable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.7	3.2	1.6	1.6	2.0	1.4	2.4	7.2	3.1	3.9	1.5	7.3	3.9	2.5	0.3	2.8	4.5	0.7	6.1	1.4	1.3	8.3	30.7	3.6	0.9	2.1	1.9	3.1	7.4	0.6	15.0	1.0	2.2	7.7	0.8	0.7	3.3	1.0	2.5	2.0	5.8	0.5	1.1	9.7	3.9	4.3	1.7	0.6	11.4	0.9	0.2	2.6	3.1	3.3	1.5	2.5	1.3	2.6	0.5	0.1	16.9	2.5	0.3	0.3	0.5	1.9	1.4	1.3	0.6	0.6	0.7	2.1	0.3	1.2	0.0	1.9	0.9	0.8	6.1	2.2	1.0	0.1	4.6	0.8	1.5	1.2	0.5	1.3	0.7	2.3	2.6	1.1	0.2	4.0	0.9	3.5	1.3	1.0	0.7	1.5	0.4	2.3	0.8	1.3	1.5	1.9	0.5	1.2	1.1	0.8	4.0	0.8	0.7	6.8	4.2	1.4	0.4	2.8	1.6	0.4	1.5	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.0	7.2	3.1	1.4	1.3	2.1	1.9	2.2	1.1	1.7	3.3	1.0	0.0	3.4	6.8	2.0	0.8	1.0	3.9	1.2	5.9	2.4	3.6	7.9	11.5	1.8	1.8	0.0	2.5	2.6	22.9	1.9	0.8	2.2	0.6	1.1	1.5	0.0	3.2	1.1	4.8	3.9	2.4	4.1	1.4	0.0	6.7	2.5	26.6	2.6	16.8	2.1	21.8	6.1	1.9	1.2	2.7	1.8	1.6	0.0	0.0	1.7	2.9	1.0	2.5	1.9	0.9	11.3	1.5	3.0	1.4	23.4	2.5	2.9	7.6	0.0	1.0	2.4	1.6	2.1	0.9	0.4	2.3	1.8	1.8	12.4	0.6
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343195	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 690.5;Microglial cells: 579.9;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 311.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	10.9	2.7	5.8	6.3	5.5	3.1	14.2	17.2	3.9	10.6	6.9	6.1	3.0	5.4	1.8	5.5	8.0	7.7	4.4	7.1	10.6	9.9	2.4	9.8	8.7	9.0	9.0	7.9	5.9	5.9	4.0	12.2	7.4	7.4	6.2	6.8	11.0	5.7	2.0	7.9	4.8	6.5	7.0	10.3	4.8	2.3	7.5	13.7	6.5	4.8	7.0	8.8	6.5	6.6	10.7	2.0	17.8	4.7	18.1	20.7	3.8	12.1	17.9	7.8	8.1	1.3	22.1	2.3	27.7	28.1	4.1	9.6	3.6	11.7	10.7	52.8	1.3	1.4	3.7	4.1	10.5	0.1	0.0	30.4	1.1	13.9	8.2	14.3	4.5	0.3	6.1	3.2	14.0	0.9	0.2	2.9	1.9	5.5	3.3	3.7	3.4	12.3	11.6	14.8	0.1	1.6	4.5	1.9	5.0	5.7	1.7	0.5	19.7	13.6	3.2	4.7	7.7	2.2	0.4	3.3	6.5	2.0	25.6	0.1	0.6	0.0	0.8	0.3	1.3	0.9	1.6	2.1	0.6	1.2	3.2	2.2	2.6	2.4	0.4	0.5	0.6	1.2	5.8	5.5	17.2	3.9	7.1	10.6	9.0	9.0	7.4	7.0	7.5	6.6	43.5	16.0	8.6	690.5	35.4	19.5	21.5	12.6	19.9	44.1	28.6	43.1	5.3	18.6	16.6	12.9	91.8	15.4	21.8	31.0	11.7	19.3	1.4	61.6	49.4	24.0	6.7	2.7	81.6	0.4	26.0	41.6	20.9	52.3	1.3	44.0	9.3	0.4	18.6	0.0	36.8	7.6	4.1	19.2	21.2	3.0	8.7	29.3	12.4	579.9	26.0	21.9	16.5	1300.8	311.4	15.0	16.8	8.6	18.1	19.1	9.4	17.1	24.2	25.9	32.9	3.6	51.5	0.6	0.8	19.4	13.5	13.0	38.1	9.0	14.3	19.2
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177205-119349761	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 154.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		NA	NA		460000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042"	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	102.2	48.5	4.2	32.8	12.3	28.9	34.3	1.2	8.9	25.9	5.1	36.1	52.7	23.8	8.8	22.7	16.0	47.1	15.3	8.0	4.6	66.6	154.6	35.8	34.8	2.9	5.0	20.1	32.7	25.8	4.6	79.4	2.5	18.1	29.3	6.2	42.7	15.0	7.6	14.3	69.8	27.2	3.3	36.5	25.9	7.0	8.4	18.9	22.6	31.0	25.9	56.0	17.1	5.9	0.2	0.0	3.4	0.0	273.1	119.9	6.6	6.9	41.4	5.1	12.5	19.8	2.6	43.2	0.3	26.5	65.7	0.4	7.6	0.1	6.4	64.5	19.4	36.3	3.9	204.0	27.2	0.1	17.7	82.4	5.3	41.6	25.3	22.1	3.4	12.6	128.1	219.6	39.7	6.1	1.7	0.3	2.3	20.0	10.0	12.1	4.2	66.6	13.4	35.4	14.1	21.0	0.1	0.6	0.0	8.3	10.4	4.8	24.8	16.9	15.4	32.0	15.8	294.5	44.6	84.8	50.2	0.7	10.4	4.3	0.3	1.1	1.1	0.5	2.3	0.7	0.6	0.6	0.3	0.4	0.3	0.9	1.9	0.9	0.5	2.8	0.7	0.3	4.2	12.3	1.2	8.9	8.0	4.6	2.9	5.0	2.5	3.3	8.4	5.9	37.1	9.6	46.1	19.9	31.0	31.7	5.7	1.2	5.2	28.1	18.8	5.8	4.4	44.3	6.9	106.7	0.0	6.8	40.6	23.3	5.9	9.4	232.5	5.9	63.9	42.1	48.0	40.4	165.0	37.8	12.4	98.4	18.8	10.7	3.8	24.0	97.5	270.5	101.1	0.0	79.4	61.1	0.0	84.6	91.2	39.3	26.4	98.0	28.4	128.4	13.5	1.7	42.2	4.5	3.7	14.8	18.9	4.1	147.5	5.3	92.2	33.5	4.6	5.0	6.6	12.9	27.8	2.8	3.9	3.4	27.8	6.2	24.3	14.6	18.9	9.7
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Macrophages: 74.0;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;granulocytes: 16.6;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;hTCEpi: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles		NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 57: B-cells - Immune response"	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	7.1	12.4	1.9	1.5	2.4	7.0	6.4	4.7	2.2	6.5	2.2	6.7	1.6	6.1	0.2	3.8	6.3	1.3	6.6	1.1	2.1	4.8	4.7	10.5	2.1	3.8	2.9	8.8	8.3	3.0	5.0	3.7	4.7	4.3	1.1	2.7	8.9	2.0	3.0	4.5	8.5	2.4	3.0	12.0	9.1	1.6	3.5	1.2	7.1	0.1	2.0	8.1	5.8	3.7	2.9	1.4	0.6	1.6	15.5	12.1	0.9	1.1	6.9	1.8	4.1	1.7	1.0	3.6	1.4	2.7	3.9	1.0	3.0	2.2	1.1	2.2	0.7	3.0	1.1	0.7	2.7	2.8	8.2	3.7	13.7	7.6	3.4	8.9	3.0	1.2	3.6	2.0	3.4	1.4	2.0	2.3	1.3	1.9	1.1	1.9	1.6	0.6	3.4	2.3	1.4	0.5	1.4	1.9	1.5	5.4	4.5	1.8	0.2	2.0	1.3	9.3	1.2	1.3	5.8	0.5	3.1	1.5	1.6	4.0	6.8	16.6	0.4	6.1	0.7	1.7	0.0	0.7	5.3	2.1	0.4	0.6	6.1	1.8	9.1	1.2	0.5	3.1	1.9	2.4	4.7	2.2	1.1	2.1	3.8	2.9	4.7	3.0	3.5	3.7	6.4	32.1	35.6	24.5	45.4	5.9	8.4	13.2	12.0	6.2	11.6	8.1	14.6	14.3	13.5	9.2	6.2	42.3	14.3	5.1	1.9	8.1	2.8	6.9	6.9	8.1	1.8	19.7	36.4	2.7	7.3	13.8	25.5	12.8	34.8	5.5	10.4	17.7	43.6	6.7	66.5	10.5	2.0	58.5	29.6	1.6	9.0	74.0	0.0	111.5	52.8	5.2	17.5	31.2	66.8	5.5	17.3	19.9	17.5	7.5	5.2	9.8	5.8	7.5	0.0	10.8	6.7	0.2	1.4	12.6	4.5	22.6	16.9	12.6	11.2	9.7
MANEA	"FLJ12838, mandaselin"	ENSG00000172469	"Mannosidase endo-alpha"	Q5SRI9	6	95577535-95609452	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 59.8;Plasma cells: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011046, HPA011069"	Enhanced		Supported	"Golgi apparatus"		NA	NA		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA011046: AB_1079303, HPA011069: AB_1079304"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.86e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.47e-2)"	11.9	6.9	3.1	7.9	3.6	3.3	8.9	3.7	3.7	8.4	4.2	8.1	8.8	6.8	6.3	8.0	6.4	7.9	5.6	2.5	3.7	12.0	24.0	7.3	9.2	4.3	3.3	9.7	8.4	11.1	2.1	6.3	4.4	7.0	8.7	6.1	5.6	7.9	1.4	6.8	8.8	6.7	3.6	9.6	12.1	6.1	3.7	9.1	11.6	3.4	11.2	9.0	3.5	5.6	6.5	5.3	20.4	16.6	33.1	38.5	7.7	17.7	16.2	10.1	14.8	6.1	16.0	12.3	21.7	11.7	14.9	10.4	14.1	12.0	23.2	20.9	12.6	16.6	4.7	10.2	11.5	22.3	14.4	38.4	13.7	12.0	8.5	14.6	24.3	12.1	26.2	28.1	22.0	4.5	13.1	9.5	3.0	17.1	5.5	15.4	19.9	18.8	15.5	11.2	16.3	8.8	10.0	7.2	6.5	14.3	11.4	20.7	22.0	10.1	7.1	18.4	17.8	20.9	12.9	15.2	18.2	19.1	23.6	8.5	2.3	1.3	3.2	4.1	4.6	4.5	3.9	3.8	2.5	2.3	4.5	3.1	0.5	2.9	3.7	1.0	7.7	2.4	3.1	3.6	3.7	3.7	2.5	3.7	4.3	3.3	4.4	3.6	3.7	5.6	11.6	12.8	8.4	7.8	15.5	7.4	4.4	6.4	8.6	8.1	8.4	7.4	4.5	10.0	7.4	12.9	4.2	5.4	5.4	1.8	5.9	4.1	16.7	7.3	14.4	10.7	1.8	8.2	6.0	7.3	5.6	12.0	8.2	8.1	2.5	17.8	28.2	59.8	11.0	11.8	7.3	4.6	0.0	12.0	5.8	11.7	5.9	7.9	8.8	8.4	6.8	10.5	3.1	16.1	18.7	3.4	2.8	15.8	113.4	3.4	4.8	8.5	8.5	5.3	13.1	9.8	17.1	7.1	12.1	11.8	7.0	1.4	9.2	13.5	5.0	3.5
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350242	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 70.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"neutrophil: 98.3"	"Lineage enriched"	"Detected in many"	39	"granulocytes: 98.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.7;OE19: 54.3;RPTEC TERT1: 25.9"	"Low region specificity"	"Detected in all"							"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		44000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	18.9	12.1	3.4	4.3	4.1	3.5	19.5	3.9	6.5	16.9	5.0	22.9	11.7	22.1	11.5	42.3	16.6	10.2	11.2	4.1	3.0	13.2	9.7	12.3	2.3	3.2	3.3	11.3	25.2	11.3	17.9	9.5	3.2	15.1	15.8	5.4	70.0	10.8	4.0	21.7	15.2	12.1	2.6	11.3	21.5	8.4	3.8	1.4	13.8	4.4	6.4	16.3	20.6	4.0	0.3	5.7	1.8	0.1	5.6	5.5	6.2	3.9	4.6	2.0	2.5	4.8	18.2	0.0	4.2	3.9	2.1	0.8	7.1	3.3	1.5	0.0	6.9	8.3	6.4	4.2	0.9	1.4	2.3	3.5	5.3	1.3	0.9	13.8	50.7	0.1	5.6	0.1	0.6	11.0	0.0	0.6	6.5	54.3	3.0	0.2	0.0	0.1	25.9	18.8	2.6	10.3	2.1	16.9	6.0	2.8	15.4	5.0	20.5	2.8	2.3	0.7	5.5	0.4	0.2	2.8	2.0	0.0	2.1	6.6	1.2	1.0	0.1	0.9	0.0	0.2	0.3	0.0	0.6	0.4	2.5	0.4	98.3	0.6	0.4	0.1	0.0	0.6	3.4	4.1	3.9	6.5	4.1	3.0	3.2	3.3	3.2	2.6	3.8	4.0	29.0	9.6	21.2	8.8	3.3	4.0	7.1	7.2	6.2	6.1	21.2	13.5	2.6	28.6	11.9	23.9	8.4	35.4	4.5	33.6	1.9	19.0	0.9	15.1	5.2	28.8	21.7	3.6	16.6	37.9	7.4	10.4	23.0	20.5	2.5	8.6	37.1	9.8	8.0	10.1	13.5	33.4	8.2	5.5	0.7	2.2	13.7	2.0	0.0	15.0	2.7	11.4	9.2	7.5	11.4	16.3	25.2	16.6	1.0	7.4	16.7	3.0	18.1	13.1	0.0	4.8	6.5	2.1	1.5	22.1	4.7	17.0	3.0	9.7	26.5	8.8
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 230.3"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 819.8;Proximal tubular cells: 569.9;Undifferentiated cells: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 162.1;HHSteC: 302.9;HSkMC: 76.1;hTCEpi: 87.2;RT4: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Supported	Mitochondria,Cytosol		No	No				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	143.9	27.7	24.7	8.6	27.6	0.4	71.6	26.5	26.6	26.6	13.9	116.4	163.4	24.0	14.1	46.7	39.1	16.9	49.6	22.3	31.7	76.9	119.1	63.5	2.4	26.9	32.5	40.7	39.1	31.4	4.0	30.2	56.4	46.3	117.9	28.2	77.3	35.0	33.5	37.4	230.3	24.0	21.3	6.3	55.9	3.7	41.4	9.9	118.4	34.3	5.3	65.0	38.8	19.0	0.0	3.7	0.6	9.9	162.1	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	4.6	17.2	6.1	22.3	0.1	0.0	2.5	6.9	0.5	18.6	302.9	0.0	16.9	76.1	87.2	0.2	45.2	0.1	20.0	0.0	0.3	0.4	5.7	2.9	0.1	0.8	1.6	20.7	5.0	0.0	0.3	0.5	22.3	131.8	3.1	7.8	0.0	0.0	0.3	0.4	0.5	0.0	8.7	0.0	8.2	0.7	0.0	0.3	0.0	0.0	9.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	27.6	26.5	26.6	22.3	31.7	26.9	32.5	56.4	21.3	41.4	19.0	35.2	70.5	146.9	23.2	4.6	11.0	177.7	32.3	116.7	5.0	13.6	10.2	101.3	94.4	49.3	60.7	22.9	11.5	0.2	248.0	121.3	36.7	25.2	50.4	42.5	43.6	38.0	4.8	4.0	13.4	21.3	24.3	40.2	175.1	5.7	7.3	53.6	193.7	6.6	3.3	5.0	137.5	67.1	12.2	2.1	33.9	5.6	6.7	10.6	21.5	17.1	25.4	0.0	7.5	1.3	49.5	140.5	0.0	2.6	64.6	819.8	569.9	32.8	27.4	6.6	4.4	30.5	1.3	0.8	120.6	14.3	207.0	3.7	3.5	285.1	129.0
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 325.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 90.9;Horizontal cells: 299.5;Peritubular cells: 76.3"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	61	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	61	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.7;BJ hTERT+: 61.8;fHDF/TERT166: 94.0;hTEC/SVTERT24-B: 58.1;U-87 MG: 121.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol		No	No		55000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (1.09e-5)"	"prognostic unfavorable (1.66e-5)"	7.2	6.0	65.3	3.8	78.6	0.9	4.4	39.5	325.5	8.0	0.0	16.5	1.2	8.2	2.4	3.0	7.2	4.2	15.5	92.8	37.5	1.2	0.2	2.2	1.0	201.4	41.4	5.0	1.0	2.0	11.7	2.7	186.0	4.8	3.5	21.7	2.5	7.5	4.5	3.2	4.0	13.1	22.5	0.9	4.3	3.8	85.8	24.0	4.1	5.1	0.9	11.9	4.5	156.7	0.3	2.5	11.1	6.4	60.7	41.5	0.1	36.3	61.8	10.5	10.1	4.4	0.1	0.2	15.3	94.0	3.3	0.5	15.0	0.1	6.1	5.5	1.4	14.2	3.5	0.3	5.8	0.4	5.8	31.3	0.1	58.1	0.3	15.8	8.0	41.3	24.0	0.3	42.8	0.5	26.6	0.8	8.1	0.0	1.0	7.2	32.1	0.1	0.2	0.1	34.8	10.6	1.2	0.1	0.3	14.6	2.3	0.6	1.5	33.7	11.3	11.3	0.5	0.0	1.6	5.0	121.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.1	0.1	65.3	78.6	39.5	325.5	92.8	37.5	201.4	41.4	186.0	22.5	85.8	156.7	6.7	3.2	1.1	11.8	2.2	5.5	1.4	1.4	2.8	43.4	1.7	3.6	55.1	0.0	7.9	3.7	25.0	0.3	90.9	1.0	0.0	0.4	13.1	33.2	19.5	5.7	11.4	3.0	34.4	0.0	0.6	46.9	2.6	1.0	7.0	16.7	4.2	0.0	2.4	299.5	45.1	1.7	10.2	0.3	7.4	5.6	51.0	9.4	8.8	12.2	0.7	16.7	0.0	9.5	51.4	0.7	0.0	76.3	1.1	0.5	0.0	0.5	63.6	27.2	32.9	45.7	48.2	10.6	25.6	1.1	4.1	1.1	5.6	3.1	1.4	0.5
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424058-209734118	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 253.3;retina: 411.0"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 875.7;Excitatory neurons: 883.3;Inhibitory neurons: 823.6;Oligodendrocyte precursor cells: 688.6;Rod photoreceptor cells: 514.5"	"Group enriched"	"Detected in many"	4	"glioma: 30.4;thyroid cancer: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 296.9;NTERA-2: 106.7;SCLC-21H: 148.6;SH-SY5Y: 82.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012558, HPA012828"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946"	"unprognostic (2.47e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (1.98e-6)"	"unprognostic (2.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.10e-5)"	5.5	11.6	89.2	1.2	115.9	0.3	5.5	2.7	253.3	4.3	0.0	2.9	0.9	2.3	3.9	6.5	2.5	7.6	8.4	135.2	215.6	5.4	3.8	13.5	1.8	37.7	52.2	7.4	10.7	15.5	33.8	0.8	75.3	7.6	1.7	411.0	7.8	4.9	1.7	16.9	1.6	2.8	14.5	1.7	3.3	6.5	123.9	3.5	16.7	4.6	2.4	1.6	5.3	88.2	2.6	0.6	296.9	0.0	3.9	2.2	0.1	1.9	2.1	0.7	2.2	0.0	16.1	0.0	1.7	3.8	14.0	4.1	23.4	1.8	1.0	0.1	1.4	1.2	8.9	0.1	36.7	0.3	0.2	3.1	9.6	0.1	5.8	17.3	7.8	0.1	0.0	3.1	0.3	1.1	0.1	0.0	106.7	0.5	0.5	0.0	0.6	0.3	3.8	0.1	148.6	82.7	6.3	0.9	3.7	34.8	8.2	0.0	0.2	0.3	1.7	0.1	4.1	1.9	0.0	0.0	15.5	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	89.2	115.9	2.7	253.3	135.2	215.6	37.7	52.2	75.3	14.5	123.9	88.2	16.8	96.1	3.2	127.3	1.8	5.9	3.3	12.0	4.6	144.7	6.2	8.0	4.9	27.1	3.7	5.5	875.7	0.4	0.1	0.0	3.9	26.8	22.1	2.2	1.1	15.7	32.4	2.7	883.3	11.0	0.1	5.3	3.6	4.4	1.3	1.6	18.5	0.4	0.5	33.7	823.6	0.2	6.1	1.4	1.5	10.7	28.6	1.4	19.6	74.0	0.0	129.7	0.0	688.6	53.8	10.0	0.0	15.4	0.1	12.3	0.0	0.4	3.4	514.5	32.9	5.1	26.1	6.6	22.7	2.3	6.5	0.3	0.3	6.6	0.0	0.7
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	"Mitogen-activated protein kinase kinase 2"	P36507	19	4090321-4124122	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 724.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003835, HPA051993"	Supported		Supported	Cytosol		NA	NA		140000	"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB003835: AB_562312, HPA051993: AB_2681685"	"unprognostic (4.39e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (2.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (5.43e-5)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.90e-2)"	73.9	118.4	145.5	54.1	143.1	102.4	69.1	151.5	190.7	76.6	150.4	103.4	134.0	72.3	23.2	121.6	64.7	30.4	156.6	145.9	147.3	82.6	123.3	66.8	57.1	149.6	152.9	84.1	134.3	54.9	99.3	36.4	154.3	93.9	42.7	68.0	79.6	37.6	289.0	95.8	101.0	31.7	143.5	89.1	92.7	131.6	150.7	69.3	74.6	132.1	41.0	77.2	75.2	142.8	163.1	175.4	93.7	132.8	127.1	151.9	93.8	104.5	138.8	139.6	125.8	153.0	85.5	137.7	95.9	120.0	111.9	114.3	74.2	111.6	107.4	118.1	90.4	50.5	91.4	171.7	194.0	93.6	101.8	168.8	106.8	98.2	129.5	185.5	125.2	123.0	98.1	263.1	119.3	203.5	186.3	130.6	107.8	118.6	125.9	140.7	61.9	159.1	123.5	102.7	126.8	126.3	95.7	130.6	344.1	107.3	101.0	158.5	111.8	113.6	98.2	293.4	163.9	263.1	172.4	100.2	176.5	166.8	199.3	27.5	13.0	45.4	16.9	16.6	13.6	13.0	13.3	17.2	15.9	18.2	12.3	15.9	21.2	18.8	14.1	9.0	14.3	7.3	145.5	143.1	151.5	190.7	145.9	147.3	149.6	152.9	154.3	143.5	150.7	142.8	77.7	9.6	31.9	22.5	62.3	35.4	93.3	21.3	15.4	85.1	92.9	95.4	62.9	44.3	22.8	40.5	41.7	28.7	102.3	300.5	146.8	20.7	248.1	59.5	68.3	52.1	63.2	123.1	17.6	45.5	38.6	60.3	64.7	48.8	19.7	124.4	49.2	48.1	55.0	121.1	23.2	107.7	16.2	56.0	38.2	724.3	35.8	65.6	42.7	10.3	28.5	121.1	62.8	13.0	24.2	47.0	151.8	23.0	79.9	103.2	166.1	92.8	18.9	106.8	26.3	93.1	71.8	23.5	17.4	42.9	63.9	35.6	77.0	120.2	119.9	113.1
MAP3K11	"MEKK11, MLK3, PTK1, SPRK"	ENSG00000173327	"Mitogen-activated protein kinase kinase kinase 11"	Q16584	11	65597756-65615382	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010165	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite, Cytosol"		"CAB010165: AB_631936"	"unprognostic (8.36e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.27e-3)"	47.6	32.6	39.9	36.9	51.7	24.4	42.9	45.1	48.4	27.2	27.2	40.0	48.3	29.7	7.4	35.6	31.3	13.5	53.2	36.1	38.8	48.5	95.3	62.7	23.7	48.8	50.3	21.0	35.8	12.1	27.8	21.6	44.6	39.2	11.7	2.8	29.1	12.6	20.1	35.9	51.0	10.0	41.5	78.3	36.3	21.3	50.5	19.3	37.3	10.4	11.3	29.2	28.3	60.1	48.0	43.4	23.1	22.6	7.0	8.0	21.7	19.3	11.9	19.9	14.9	43.4	43.9	16.4	65.5	13.0	33.0	40.9	12.2	19.5	7.1	40.2	15.5	50.0	28.2	50.9	18.6	28.9	71.2	12.4	19.1	14.5	13.3	21.6	57.4	21.5	21.6	32.7	10.9	58.2	34.0	50.9	24.2	31.0	48.1	56.1	13.3	36.2	19.2	43.1	19.6	22.9	22.0	58.1	107.7	10.4	46.6	45.8	68.8	31.3	35.8	48.1	32.4	23.3	27.5	15.8	35.3	33.1	75.1	7.5	10.5	13.1	3.1	15.3	3.0	2.7	3.2	4.5	10.1	3.0	2.4	1.8	17.3	2.4	15.4	3.0	1.8	9.5	39.9	51.7	45.1	48.4	36.1	38.8	48.8	50.3	44.6	41.5	50.5	60.1	70.0	22.4	21.1	4.2	22.1	21.0	25.3	18.4	20.5	24.4	28.9	23.4	8.7	31.5	14.1	11.0	25.0	24.7	26.4	123.5	19.6	21.9	13.5	15.4	11.3	78.9	41.9	13.0	4.1	27.5	17.7	11.4	44.4	26.1	26.0	19.6	58.5	56.2	53.3	18.5	3.5	54.9	20.3	50.6	65.5	68.5	9.6	48.3	21.4	21.5	50.2	16.1	23.7	3.0	29.5	33.7	99.0	6.4	15.5	28.1	113.1	27.6	10.3	54.7	32.9	10.5	12.8	12.2	18.3	24.8	30.0	34.3	24.0	28.9	55.2	34.6
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557046-136792477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 88.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 383.6;Excitatory neurons: 170.4;Inhibitory neurons: 204.8;Microglial cells: 216.4;Oligodendrocyte precursor cells: 210.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"CAB007824: AB_598175, HPA063245: AB_2684969"	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	13.2	88.1	21.7	11.7	23.6	14.1	9.5	21.6	18.9	8.4	7.0	8.7	7.3	11.3	7.7	10.0	12.9	7.5	11.3	18.6	18.9	10.6	9.0	11.9	12.1	17.2	20.7	49.3	30.9	1.9	16.2	5.3	16.1	18.0	9.7	14.5	7.1	7.1	6.3	8.0	9.0	5.1	16.6	11.7	14.8	12.0	24.8	8.2	12.8	6.1	12.3	18.5	9.2	15.7	5.6	3.4	0.0	0.0	7.6	20.2	1.9	8.0	42.6	4.0	3.8	0.3	5.6	3.3	11.5	11.1	3.0	7.6	13.6	4.1	10.5	4.6	10.6	28.9	7.6	0.0	36.3	13.6	0.1	26.8	5.3	6.3	17.9	15.4	13.6	4.1	7.3	31.2	28.7	10.9	0.3	11.6	1.3	10.9	4.5	7.6	8.9	13.2	16.2	35.3	9.7	6.4	6.6	6.3	1.8	1.4	1.4	12.0	12.0	6.7	2.1	0.4	7.5	25.3	18.0	0.0	5.3	18.6	6.0	3.5	1.8	2.1	1.5	1.4	2.9	1.1	2.5	2.2	1.5	1.5	0.2	0.8	5.2	2.3	1.4	1.5	4.6	0.9	21.7	23.6	21.6	18.9	18.6	18.9	17.2	20.7	16.1	16.6	24.8	15.7	11.9	6.4	22.0	383.6	14.3	5.0	20.5	32.0	3.4	18.2	10.0	5.0	21.2	4.3	35.1	11.0	6.2	1.0	25.9	12.3	3.9	3.0	6.4	17.3	31.4	7.7	34.8	14.9	170.4	23.1	1.1	12.1	20.9	62.5	5.7	67.7	9.7	11.2	8.0	0.0	204.8	18.2	14.2	23.5	10.2	4.2	23.6	26.6	0.0	216.4	21.7	43.3	12.3	210.1	4.2	17.8	8.7	14.3	13.5	18.8	7.2	8.3	20.5	2.6	13.1	5.3	17.9	3.4	15.5	13.1	10.1	2.7	18.5	16.2	11.2	23.4
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587072	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	11.8	12.5	13.1	12.5	15.1	8.7	14.3	15.6	17.3	14.3	11.7	11.6	9.2	16.6	16.5	10.6	11.0	12.7	16.9	14.7	14.9	11.4	11.6	10.4	16.4	15.3	13.7	15.8	9.7	16.3	13.0	17.4	15.8	14.9	10.9	23.5	12.1	13.3	16.9	13.9	9.8	14.0	15.3	17.6	10.8	9.9	13.8	20.8	14.7	18.4	16.8	14.3	12.2	22.4	16.7	14.4	41.3	35.6	29.5	39.1	29.0	32.7	37.7	28.8	36.1	18.6	15.5	36.9	20.4	35.6	25.6	17.3	26.3	25.5	48.7	19.0	27.7	32.9	19.9	24.9	30.8	36.9	24.4	32.5	30.5	28.2	34.2	33.1	27.4	31.8	67.0	29.3	41.8	20.3	17.2	31.2	34.0	25.7	18.0	29.3	73.9	18.0	24.2	18.4	20.8	29.5	22.9	15.6	24.8	32.2	15.5	64.7	26.5	23.3	14.7	21.6	30.9	25.9	24.7	15.8	35.7	39.7	35.0	18.2	11.5	18.4	12.8	15.9	14.5	13.0	12.3	12.5	14.6	9.9	13.7	13.4	11.5	17.9	17.6	8.9	20.8	13.4	13.1	15.1	15.6	17.3	14.7	14.9	15.3	13.7	15.8	15.3	13.8	22.4	16.1	16.0	26.9	47.0	24.3	36.3	20.8	19.5	21.6	23.3	17.9	12.3	31.0	14.3	16.9	16.5	27.1	31.8	17.8	12.4	7.9	17.6	3.6	10.9	19.8	21.2	12.1	14.1	85.7	20.9	34.6	23.2	16.3	14.8	13.9	25.9	25.7	20.7	24.3	28.6	63.8	13.7	20.3	27.3	24.6	3.2	26.8	21.7	21.4	36.5	35.2	19.6	16.5	50.8	137.2	20.1	9.1	41.0	18.8	30.1	11.1	16.6	21.4	21.5	19.7	28.0	18.5	25.9	24.9	21.3	37.2	48.4	22.7	18.1	15.1	24.8
MAP6D1	"FLJ12748, SL21"	ENSG00000180834	"MAP6 domain containing 1"	Q9H9H5	3	183815922-183825594	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 102.6;choroid plexus: 24.9;skeletal muscle: 26.9"	"Cell type enriched"	"Detected in some"	13	"Oligodendrocytes: 101.3"	"Cancer enhanced"	"Detected in many"		"glioma: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"T-47d: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037991	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA037991: AB_10672503"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (8.81e-12)"	"unprognostic (1.08e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.72e-2)"	0.8	0.9	40.9	0.3	66.1	0.2	0.9	60.3	73.2	1.1	24.9	1.3	0.7	1.0	0.9	1.4	1.1	0.4	1.8	40.9	44.5	1.2	1.2	0.7	0.7	67.1	59.1	1.1	4.7	0.4	2.2	0.3	60.4	3.4	0.3	1.0	1.2	0.7	26.9	3.6	1.0	0.4	53.0	1.3	0.7	1.3	56.3	3.6	1.0	14.3	0.4	1.0	1.2	102.6	3.5	2.1	3.6	0.7	0.9	1.2	2.8	4.2	0.8	7.3	5.3	2.5	0.1	0.3	5.4	6.1	3.6	2.7	6.9	1.6	4.5	2.3	11.8	0.5	0.0	0.0	2.3	4.5	1.5	0.5	0.6	1.7	0.8	0.4	1.7	5.5	0.5	0.0	0.7	14.8	10.0	5.8	2.2	2.0	6.7	5.0	5.7	0.0	0.4	0.0	11.7	2.1	2.9	2.2	4.4	2.5	63.9	4.2	0.8	1.8	2.5	2.7	6.1	2.4	1.6	1.4	0.6	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	40.9	66.1	60.3	73.2	40.9	44.5	67.1	59.1	60.4	53.0	56.3	102.6	0.0	0.0	0.0	4.9	0.1	1.1	0.7	0.9	0.6	2.5	0.0	0.0	2.4	0.0	0.4	0.0	2.1	0.3	0.0	0.9	0.0	0.0	3.4	0.0	0.0	0.3	2.4	0.4	7.4	0.0	0.5	0.4	1.1	0.0	0.0	0.0	0.7	0.4	0.9	1.7	3.5	0.4	4.1	0.0	0.7	2.2	0.9	0.3	0.0	0.0	0.5	0.8	1.0	7.1	101.3	0.0	0.1	0.0	0.2	2.4	0.2	0.0	0.3	1.9	0.0	1.6	0.4	2.9	2.1	1.0	1.4	0.7	0.3	0.0	0.3	0.7
MAPK11	"p38-2, p38Beta, PRKM11, SAPK2"	ENSG00000185386	"Mitogen-activated protein kinase 11"	Q15759	22	50263713-50270767	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 70.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.5;Astrocytes: 16.6;Endothelial cells: 21.1;Excitatory neurons: 15.8;Hepatic stellate cells: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012961, HPA045069"	Approved		Approved	Mitochondria		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"CAB012961: AB_2533144, HPA045069: AB_2679207"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.02e-6)"	"unprognostic (9.84e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	27.5	6.8	52.3	7.9	56.0	1.1	24.0	48.2	70.9	15.1	40.6	7.3	1.9	15.5	5.8	9.4	16.7	8.7	18.9	55.2	49.6	18.6	4.8	16.8	9.4	48.2	47.2	12.5	5.7	5.4	28.4	8.3	48.2	18.2	2.6	8.6	7.2	7.2	6.4	7.5	8.3	9.4	47.4	16.3	10.9	6.1	50.2	3.5	11.0	5.8	6.1	11.6	12.3	51.0	2.8	6.8	7.4	27.8	9.5	14.3	0.2	10.2	7.4	6.8	2.7	2.8	5.2	0.0	8.7	9.9	11.3	6.9	4.9	4.2	0.5	13.9	3.4	10.1	10.4	0.6	10.9	2.5	15.0	19.9	12.3	1.9	0.8	7.7	15.2	10.6	8.1	26.8	6.9	12.4	0.5	9.4	0.6	8.4	7.7	26.7	0.1	9.9	10.3	0.0	6.8	18.4	9.0	3.7	7.7	0.9	12.2	7.9	24.0	20.4	16.5	1.5	3.7	1.2	3.2	11.8	10.4	2.9	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.3	56.0	48.2	70.9	55.2	49.6	48.2	47.2	48.2	47.4	50.2	51.0	29.5	0.0	1.1	16.6	2.2	1.9	1.8	3.2	8.0	3.3	1.1	1.5	6.6	1.5	1.7	0.0	6.2	0.0	1.8	0.1	1.9	1.0	4.7	0.6	1.8	21.1	0.0	0.4	15.8	0.2	0.4	2.7	0.5	1.7	0.0	0.1	20.0	2.1	0.3	0.0	3.6	0.2	2.0	1.3	2.1	9.7	3.1	0.5	5.4	13.1	0.1	5.9	0.0	1.0	0.9	0.7	0.0	2.2	1.6	2.9	0.0	1.9	1.3	11.4	0.0	0.6	1.8	1.3	3.2	1.8	1.3	0.0	3.3	0.7	0.1	1.1
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261716	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 279.7;tongue: 120.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 23.1;Astrocytes: 22.9;Endothelial cells: 15.8;Hepatic stellate cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 31.6"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	11.0	2.3	15.6	3.8	16.5	1.3	7.9	15.5	21.2	11.4	9.2	4.7	3.5	19.0	9.8	6.3	11.2	4.4	15.7	15.1	16.5	10.7	1.4	6.8	4.1	17.1	14.9	10.6	1.8	4.3	25.1	4.1	14.6	10.0	1.1	1.4	4.3	6.9	279.7	1.5	4.4	8.6	14.6	4.3	5.0	4.6	15.2	0.9	3.2	120.9	1.4	6.0	5.9	13.9	23.2	13.9	5.3	16.3	12.4	13.5	7.5	17.5	15.1	28.2	18.3	19.6	7.2	45.1	23.4	19.6	16.8	15.4	24.3	3.4	5.5	12.8	34.0	29.2	46.7	24.9	37.7	28.4	54.5	29.8	6.0	7.2	0.0	16.8	33.2	4.0	26.3	38.5	13.4	12.8	0.0	35.4	15.9	7.6	22.5	41.4	14.2	43.9	17.5	3.0	18.0	6.5	13.3	0.5	22.1	4.2	7.1	29.6	18.7	28.5	26.1	6.6	11.2	9.3	7.3	24.5	7.2	24.7	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.6	16.5	15.5	21.2	15.1	16.5	17.1	14.9	14.6	14.6	15.2	13.9	23.1	0.0	3.2	22.9	1.6	0.8	0.7	3.3	1.2	5.5	1.2	1.3	8.8	4.3	0.8	0.0	0.0	0.3	0.9	0.3	1.9	0.5	0.3	0.6	10.0	15.8	1.8	1.7	9.8	0.0	2.8	5.3	2.6	0.7	10.8	0.6	20.7	0.9	6.3	1.7	6.5	0.2	8.2	2.2	0.8	1.9	6.5	2.2	0.0	6.5	0.6	8.1	0.0	5.0	0.9	0.5	0.0	3.8	2.8	3.6	0.4	8.0	0.9	2.2	6.6	3.3	3.0	0.7	12.1	0.8	0.6	0.4	2.2	3.2	0.3	0.2
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 79.0;neutrophil: 24.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 79.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		970000	"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	29.9	26.1	15.2	31.5	16.5	89.3	23.8	19.2	17.1	30.8	19.3	26.6	27.9	37.2	15.8	32.3	25.7	23.5	25.7	17.2	18.2	23.9	41.4	28.3	28.0	11.5	11.7	22.2	18.3	20.6	19.3	44.6	12.1	19.6	29.0	14.8	21.0	24.4	33.5	34.4	26.2	39.0	13.0	44.9	22.5	9.1	18.1	38.6	31.1	31.9	33.3	32.3	29.2	13.8	49.7	26.7	28.3	44.9	60.0	59.8	62.2	50.2	64.8	58.7	60.3	67.3	24.8	40.4	49.6	54.9	28.0	34.8	47.2	43.7	60.9	47.3	37.6	94.9	37.2	53.1	33.2	60.3	54.9	43.1	40.5	42.2	40.9	47.6	67.1	67.2	52.4	49.1	40.3	21.1	62.2	62.5	17.0	29.9	26.2	71.7	45.5	37.5	38.5	67.6	21.8	17.2	46.0	33.5	50.3	34.1	40.8	99.9	47.9	52.5	29.8	33.6	47.7	24.3	59.8	39.5	23.2	112.1	43.9	79.0	10.3	6.3	4.5	7.2	5.5	3.1	4.4	5.1	8.2	5.3	4.6	4.7	24.9	6.1	10.8	4.0	5.8	5.1	15.2	16.5	19.2	17.1	17.2	18.2	11.5	11.7	12.1	13.0	18.1	13.8	24.4	32.1	13.9	37.2	22.6	15.9	11.0	13.9	28.5	18.9	14.0	11.7	25.0	14.3	18.5	18.4	31.3	45.4	26.8	29.0	1.9	13.9	3.6	18.7	25.8	22.6	16.8	47.1	104.9	11.3	18.7	25.9	21.9	30.7	21.0	17.7	28.9	52.9	25.3	11.8	79.2	25.4	10.2	51.7	24.9	5.2	24.5	38.5	10.6	52.5	58.7	10.9	39.1	46.8	69.6	22.8	16.2	26.7	27.7	10.3	33.7	17.2	20.9	22.5	13.1	20.4	15.7	9.9	8.5	27.1	19.0	23.9	28.0	12.3	18.8	10.7
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560087-50731826	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;parathyroid gland: 51.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 202.7;Excitatory neurons: 105.2;Inhibitory neurons: 58.5;Late spermatids: 66.4;Muller glia cells: 62.6"	"Cancer enriched"	"Detected in many"	4	"glioma: 15.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;HeLa: 3.3;NTERA-2: 2.2;SCLC-21H: 11.6;SH-SY5Y: 2.8;SK-MEL-30: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Golgi apparatus"	Midbody	"HPA007461: AB_1079308"	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	0.9	26.8	56.5	0.2	79.9	0.0	0.8	56.4	46.0	1.5	28.0	6.8	0.6	0.8	3.1	2.3	1.5	1.8	22.1	41.6	57.5	3.3	4.5	2.3	0.0	65.4	70.0	2.9	1.4	51.0	17.8	2.6	56.7	5.0	0.8	22.6	0.9	9.8	1.5	1.3	1.6	1.8	48.8	0.1	2.1	2.4	81.9	7.3	6.2	1.5	0.0	4.6	1.3	38.7	0.0	0.0	1.0	0.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.1	1.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.6	2.8	0.0	0.8	1.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.5	79.9	56.4	46.0	41.6	57.5	65.4	70.0	56.7	48.8	81.9	38.7	0.4	9.6	0.0	202.7	0.0	0.0	0.4	0.0	0.0	11.4	0.9	1.1	22.9	1.5	0.0	0.0	0.0	4.6	0.0	0.0	5.9	0.9	30.1	0.0	0.0	0.3	0.0	0.0	105.2	0.0	0.3	1.0	0.0	0.0	0.0	0.7	0.0	1.0	0.4	5.0	58.5	0.0	0.0	0.0	0.0	66.4	0.9	0.1	0.0	7.5	0.0	62.6	0.0	18.6	1.9	0.4	0.0	1.5	0.0	0.7	0.0	0.2	0.0	1.0	0.0	1.0	0.7	0.8	0.6	0.0	0.0	1.8	0.0	0.4	0.0	0.1
MAPK6	"ERK3, HsT17250, p97MAPK, PRKM6"	ENSG00000069956	"Mitogen-activated protein kinase 6"	Q16659	15	51952106-52067375	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 218.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005184, HPA030262, HPA047825"	Approved	Supported	Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB005184: AB_2140298, HPA030262: AB_10601868, HPA047825: "	"unprognostic (6.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.31e-2)"	10.9	7.0	8.6	12.1	11.1	32.4	13.9	14.5	13.3	15.3	7.6	20.3	17.5	16.4	10.9	28.0	8.2	17.5	7.7	10.5	10.5	15.2	35.3	8.8	10.8	10.5	10.8	6.2	8.3	11.0	8.0	12.6	10.6	10.1	18.7	17.9	15.3	8.7	27.7	23.1	24.5	13.7	9.7	8.3	16.9	29.3	10.6	14.5	13.9	32.9	13.6	27.3	21.3	12.0	27.1	36.0	69.1	26.7	21.1	34.3	50.5	38.0	38.0	34.2	40.1	43.3	15.9	38.9	26.0	48.9	50.0	37.5	53.8	72.4	46.5	24.0	16.8	58.0	20.3	68.9	50.4	43.9	118.6	36.8	130.0	41.5	106.8	36.4	32.7	26.1	76.5	64.3	44.2	61.3	30.8	34.4	24.7	33.6	17.2	26.8	44.5	62.3	32.8	112.3	33.8	31.9	30.7	24.6	56.5	94.9	22.6	64.3	32.9	40.7	43.9	26.8	51.4	33.2	104.4	47.5	50.4	62.9	51.2	1.7	2.5	0.7	1.9	2.3	2.3	2.5	2.8	2.2	2.3	1.3	2.6	1.9	0.3	3.6	1.5	1.0	4.3	1.9	8.6	11.1	14.5	13.3	10.5	10.5	10.5	10.8	10.6	9.7	10.6	12.0	31.3	28.9	31.5	24.5	24.2	111.9	123.8	50.6	24.5	55.6	39.3	19.3	21.9	25.8	43.1	16.5	16.7	16.9	15.9	110.2	17.6	35.2	147.5	61.3	75.7	28.8	31.0	17.1	29.1	50.1	39.5	39.2	35.7	126.4	137.9	19.3	17.9	59.6	28.0	33.7	31.0	42.9	42.7	41.8	66.6	218.1	22.7	50.5	30.2	17.8	15.7	32.3	11.3	28.6	63.7	69.1	46.5	23.7	35.3	89.0	110.6	60.3	42.9	23.8	19.7	24.7	33.9	72.7	81.0	49.6	110.7	33.1	23.0	13.9	28.6	174.0
MAPKAPK5	"MK5, PRAK"	ENSG00000089022	"MAPK activated protein kinase 5"	Q8IW41	12	111842228-111902222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	18.1	20.8	12.6	17.9	14.4	27.1	20.4	14.9	15.0	15.2	15.7	28.2	25.5	15.7	20.7	17.2	16.1	12.2	16.7	15.3	14.3	20.3	19.4	17.5	20.7	12.3	12.4	18.1	20.4	21.4	11.6	20.3	11.8	17.0	30.7	27.2	17.4	15.6	30.4	20.1	28.2	18.9	11.3	15.6	18.0	15.9	12.9	23.2	19.3	25.3	19.3	18.5	14.4	13.8	32.4	42.1	40.0	33.7	28.2	28.4	60.6	31.7	38.1	47.7	32.7	54.8	25.9	48.6	22.9	37.7	28.4	31.6	53.1	33.2	44.4	32.6	29.0	43.4	29.5	44.2	34.1	55.1	29.4	30.2	46.7	45.6	53.7	36.0	35.6	43.4	61.0	18.7	35.3	36.4	55.2	86.6	56.9	79.1	29.4	53.7	29.1	46.9	37.9	46.2	49.0	41.4	36.1	60.5	46.3	36.2	49.1	62.0	31.2	26.8	27.2	27.9	40.4	37.8	50.1	57.4	32.7	39.4	38.9	1.1	3.3	2.3	4.2	2.4	2.2	3.5	2.7	3.0	2.2	3.1	4.2	3.1	1.6	2.9	8.8	2.6	4.8	1.8	12.6	14.4	14.9	15.0	15.3	14.3	12.3	12.4	11.8	11.3	12.9	13.8	16.9	3.2	23.1	12.1	22.3	20.5	22.3	12.5	21.1	47.0	18.3	14.0	20.1	22.8	15.4	3.7	41.7	29.9	32.4	34.1	13.7	28.2	17.2	14.2	17.3	16.0	36.6	15.8	24.6	29.6	33.3	19.4	20.9	15.2	2.5	22.3	14.6	13.4	19.9	23.5	22.3	47.3	14.2	21.2	17.7	7.3	15.5	15.0	8.8	14.0	27.8	19.6	25.7	15.6	21.8	36.3	27.4	17.7	21.6	37.5	63.6	21.8	12.0	36.4	19.7	22.6	19.8	30.7	40.3	23.6	21.3	30.1	22.2	22.5	32.3	32.3
MAPKBP1	"KIAA0596, NPHP20"	ENSG00000137802	"Mitogen-activated protein kinase binding protein 1"	O60336	15	41774434-41827855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 204.3;Excitatory neurons: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030832, HPA030833"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA030832: AB_10601869, HPA030833: AB_2673628"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	6.2	10.5	10.9	4.6	12.4	4.4	7.7	31.1	13.7	11.1	10.1	10.2	9.6	9.9	4.5	18.6	10.4	4.6	6.4	9.9	8.5	7.1	4.1	6.0	3.9	9.0	8.0	15.1	5.5	4.2	12.7	5.4	9.0	8.9	3.6	9.0	7.5	5.9	5.1	24.2	9.9	9.0	5.3	8.0	9.3	34.4	9.1	6.3	13.4	3.7	6.8	12.2	12.0	10.2	7.4	3.8	10.0	9.5	10.9	10.8	6.9	10.1	25.5	9.1	6.6	7.6	2.7	1.8	8.1	8.3	12.5	17.2	9.8	28.5	6.5	6.7	2.7	7.3	12.8	2.6	4.7	4.7	14.5	5.6	22.3	14.3	25.9	14.8	13.4	11.9	4.6	3.4	12.9	1.5	4.0	4.2	1.1	4.3	7.6	4.3	7.2	0.7	5.3	8.1	11.3	6.3	5.7	5.9	4.5	10.2	7.1	3.7	10.6	13.0	6.2	12.4	10.0	7.3	12.7	4.3	8.7	6.3	11.0	1.1	0.4	0.3	0.8	0.1	0.6	0.4	0.4	0.3	0.5	0.4	0.6	0.5	0.1	0.6	0.5	0.1	0.2	0.5	10.9	12.4	31.1	13.7	9.9	8.5	9.0	8.0	9.0	5.3	9.1	10.2	7.1	6.4	10.3	33.0	3.5	54.7	10.0	8.6	36.5	14.5	5.4	8.9	3.4	2.8	7.3	3.7	204.3	6.8	5.6	4.0	0.0	3.0	15.7	10.9	7.1	9.5	4.8	0.8	62.2	3.7	4.4	5.8	9.2	8.9	1.3	12.2	5.3	2.6	3.9	15.2	55.1	1.7	4.1	2.5	6.1	27.1	7.2	5.0	8.8	33.7	4.2	4.4	3.1	34.7	51.9	4.6	1.8	7.9	5.1	12.5	8.1	0.5	13.0	8.9	13.1	7.8	5.7	12.7	4.2	27.7	53.6	5.3	5.8	8.0	2.5	15.2
MARCHF1	"FLJ20668, MARCH-I, MARCH1, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.6;retina: 27.5"	"Group enriched"	"Detected in some"	4	"B-cells: 21.4;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	94	"classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014600, HPA048024"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Endoplasmic reticulum, Golgi apparatus"	"HPA014600: AB_1853573, HPA048024: "	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	6.4	3.5	7.8	21.5	8.1	3.9	2.7	3.6	7.7	3.1	1.8	3.5	3.9	2.5	0.7	3.0	2.8	5.3	1.7	6.6	10.1	1.8	4.1	8.0	31.6	8.0	8.2	2.7	2.8	0.8	2.5	9.9	6.9	2.3	4.5	27.5	3.2	1.2	1.0	4.5	7.0	6.2	7.0	25.8	3.9	1.7	12.1	5.6	2.1	1.0	25.5	7.7	2.9	14.4	0.6	0.5	2.1	1.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	1.2	2.4	7.1	2.5	0.0	0.2	1.0	0.0	0.0	0.0	0.8	0.7	5.0	3.0	0.5	0.0	3.1	1.6	0.0	0.0	0.0	0.1	2.8	0.0	1.3	1.9	3.6	2.4	0.7	1.8	1.9	2.6	0.2	0.9	2.0	0.3	0.5	0.1	1.1	1.0	0.9	0.6	1.0	0.4	1.4	2.9	0.5	2.3	0.8	1.4	0.5	1.7	7.0	2.5	1.9	0.9	1.5	1.1	0.0	41.8	25.5	0.1	41.0	0.0	42.3	0.1	0.0	44.2	35.8	0.0	0.0	0.3	0.3	45.4	16.5	0.0	18.4	7.8	8.1	3.6	7.7	6.6	10.1	8.0	8.2	6.9	7.0	12.1	14.4	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 150.1;Intestinal goblet cells: 68.2;Paneth cells: 102.9;Proximal enterocytes: 199.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 21.7;BEWO: 30.9;CACO-2: 23.6;CAPAN-2: 22.5;HaCaT: 21.4;MCF7: 40.8;RT4: 18.8;SK-BR-3: 18.5;T-47d: 26.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"		No	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Intermediate filaments"	"HPA043514: AB_10959475, HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favorable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.2	0.3	0.5	3.1	0.6	0.6	6.2	1.8	0.9	4.0	6.5	23.6	31.1	1.8	7.3	4.2	4.2	4.8	0.3	1.1	0.5	12.9	5.3	2.4	0.5	0.4	0.5	0.5	17.1	12.5	1.0	5.7	0.5	6.0	18.7	2.1	11.6	2.5	0.8	3.3	33.1	0.6	0.1	0.4	2.8	0.9	0.5	0.9	3.9	0.0	1.7	3.8	2.5	0.9	21.7	0.7	0.5	0.9	0.0	0.1	30.9	0.0	0.0	0.0	0.0	23.6	22.5	0.2	2.3	0.0	0.1	21.4	1.9	10.3	0.1	0.0	12.1	0.0	0.4	6.2	0.0	0.1	0.2	0.9	12.5	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.0	40.8	0.2	0.3	3.5	13.4	0.2	0.0	0.1	8.8	0.3	18.8	3.7	0.2	0.4	18.5	0.0	2.4	26.3	0.3	0.0	0.0	0.4	0.4	0.2	0.2	0.3	0.1	0.2	0.2	0.2	1.8	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.2	1.2	0.4	0.1	0.3	0.2	0.1	0.5	0.6	1.8	0.9	1.1	0.5	0.4	0.5	0.5	0.1	0.5	0.9	0.3	9.6	8.4	0.3	0.8	7.9	28.7	9.6	22.8	7.0	25.4	10.7	0.6	40.0	17.9	9.2	0.0	36.5	1.5	150.1	1.9	29.8	4.4	14.2	1.5	1.0	61.5	0.0	0.6	33.7	2.5	1.5	6.1	19.4	0.0	3.8	0.4	9.1	3.1	0.0	0.6	68.2	14.2	1.0	1.0	3.3	0.3	1.2	0.0	0.0	0.8	1.0	0.0	0.0	0.6	26.3	102.9	0.7	0.0	38.4	199.3	27.6	17.4	19.6	0.0	4.1	1.6	9.6	5.0	19.6	3.7	4.8	1.4	0.0	61.3	44.3
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217282-187291980	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 120.0;heart muscle: 116.1;liver: 183.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 133.3;BJ hTERT+: 498.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1900000000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	6.3	3.6	9.4	1.3	9.4	0.0	2.8	12.9	7.0	120.0	4.9	57.5	1.9	88.4	3.3	11.1	17.7	5.1	116.1	10.4	27.0	4.8	183.4	6.0	1.0	19.2	16.5	2.7	0.2	0.3	1.0	9.0	15.3	46.0	5.6	0.0	2.3	52.2	37.5	6.3	7.5	44.4	22.2	0.8	1.6	0.5	14.6	0.2	3.2	18.9	4.3	9.9	61.5	32.0	0.0	0.0	0.3	0.4	15.7	17.3	0.1	133.3	498.3	1.8	0.9	0.0	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.4	12.9	7.0	10.4	27.0	19.2	16.5	15.3	22.2	14.6	32.0	1.1	0.0	1.8	28.1	0.2	2.9	0.1	0.2	0.0	0.0	0.0	0.0	38.1	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.7	30.6	2.0	0.0	0.0	0.2	0.0	0.3	16.4	0.0	0.7	0.0	0.2	23.2	65.8	0.4	0.0	0.9	0.0	0.0	1.9	3.7	7.5	2.5	0.3	1.8	1.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.7	0.1	0.1	0.0	2.4	0.0	0.0	0.0	5.4	4.5	0.0	0.0	0.2	1.7	0.1	0.5	5.1	0.0	0.1
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874952	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 37.7;pituitary gland: 23.3;retina: 15.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.7"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	0.0	2.2	6.5	0.3	12.1	0.3	0.1	7.3	37.7	0.2	0.0	1.2	0.3	0.0	0.0	0.2	0.1	0.2	0.2	8.3	2.4	0.1	0.6	0.1	0.1	11.2	1.1	0.3	0.6	0.5	23.3	0.0	9.5	0.2	0.1	15.4	0.2	0.0	0.0	3.7	0.4	0.0	0.0	0.1	0.6	5.0	1.2	0.8	0.1	0.0	0.0	0.2	0.3	3.0	3.6	1.6	1.5	23.3	0.0	0.0	1.9	0.2	0.1	0.3	0.9	0.8	1.5	5.8	2.6	0.0	3.9	0.1	6.8	0.1	0.1	4.1	4.5	0.5	5.8	2.6	0.0	1.3	1.2	0.5	0.1	0.8	0.7	1.3	0.0	15.2	5.2	3.0	0.0	0.8	2.4	0.6	6.9	0.6	7.2	15.9	4.6	8.3	0.3	0.2	40.5	20.2	0.8	1.4	4.3	1.2	3.8	2.1	0.0	2.8	4.2	3.1	0.8	16.7	14.5	3.7	5.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	6.5	12.1	7.3	37.7	8.3	2.4	11.2	1.1	9.5	0.0	1.2	3.0	0.5	0.0	2.4	7.8	0.2	0.9	1.6	0.6	0.6	24.7	0.8	2.5	1.0	0.0	0.3	0.0	43.8	0.6	0.4	0.6	0.0	0.4	14.0	0.2	0.2	1.3	0.0	0.0	64.7	0.5	0.6	1.3	0.0	0.3	1.3	0.5	1.1	0.5	0.2	15.2	70.3	0.1	0.0	1.0	1.2	8.2	0.6	0.7	5.4	6.5	0.1	3.7	0.0	22.1	3.0	0.3	2.5	1.2	0.0	1.0	0.9	0.2	1.0	20.4	0.0	2.0	0.5	8.0	5.2	0.7	1.4	0.3	1.0	0.4	0.7	1.2
MAST3	KIAA0561	ENSG00000099308	"Microtubule associated serine/threonine kinase 3"	O60307	19	18097793-18151692	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.6;Oligodendrocytes: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035061, HPA035062"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA035061: AB_10670585, HPA035062: AB_10671508"	"unprognostic (5.94e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (1.93e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-3)"	4.9	4.8	49.9	9.2	53.4	14.4	3.7	0.0	62.1	9.4	0.0	7.3	9.6	5.3	4.7	3.3	7.1	3.1	3.7	61.6	0.0	7.6	14.5	9.1	11.2	5.3	1.9	7.1	20.2	5.0	15.5	2.6	4.3	5.6	4.3	1.0	4.8	3.9	3.0	7.3	12.4	3.0	0.0	19.2	4.5	3.6	13.7	4.2	4.5	1.6	10.1	3.7	4.9	47.4	3.5	5.1	2.3	10.2	6.7	5.4	5.5	3.5	2.2	2.4	3.4	5.2	4.7	9.0	5.1	3.5	2.6	1.9	3.4	2.0	1.7	7.7	4.2	4.1	5.7	8.3	5.6	2.2	13.2	6.2	5.7	3.6	1.4	3.2	1.1	6.1	4.3	5.8	2.8	6.3	4.7	7.3	2.4	7.7	6.2	12.6	2.0	6.6	1.9	1.5	3.8	6.2	4.9	2.8	2.1	1.6	3.2	5.1	4.0	3.0	3.2	13.1	1.5	6.2	9.0	8.0	6.7	11.6	2.9	0.3	6.2	14.8	11.7	8.0	8.4	5.9	6.3	4.7	3.2	5.9	4.9	8.4	32.9	8.1	14.7	15.4	7.6	6.1	49.9	53.4	0.0	62.1	61.6	0.0	5.3	1.9	4.3	0.0	13.7	47.4	2.6	6.4	9.4	5.5	13.5	0.5	0.8	2.8	2.8	3.0	2.6	2.8	1.5	7.2	3.6	9.2	2.1	0.5	19.0	30.0	3.9	2.9	9.3	2.8	5.4	3.8	2.4	1.3	62.6	10.5	1.5	3.4	7.7	1.5	2.5	3.0	4.6	16.3	7.7	0.0	6.1	8.5	0.0	21.7	6.3	30.8	4.1	13.3	5.4	19.7	19.6	0.9	32.0	8.0	63.7	7.1	7.9	6.8	5.1	1.2	16.7	8.8	4.2	0.7	0.0	2.1	3.0	0.6	3.9	2.3	2.3	0.4	11.0	5.3	13.0	0.6
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.5;brain: 41.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 177.0;Hofbauer cells: 57.4;NK-cells: 422.2;T-cells: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 76.8"	"Group enriched"	"Detected in many"	57	"NK-cells: 76.8;T-cells: 46.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 108.3;HMC-1: 30.9;K-562: 48.9;MCF7: 34.4;NB-4: 74.8;SCLC-21H: 30.9;THP-1: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	4.7	1.3	18.3	6.6	21.3	20.5	2.5	2.9	41.9	1.1	1.6	2.1	6.6	0.9	0.1	2.1	4.0	4.4	1.4	25.9	8.7	2.4	3.2	9.9	9.4	10.4	11.0	0.7	1.2	0.7	2.7	1.0	8.8	1.3	1.1	2.2	3.2	0.7	0.8	1.9	6.2	0.8	4.7	16.5	4.0	3.1	14.1	3.8	1.6	0.2	4.0	1.6	1.1	23.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.2	1.7	0.0	1.0	10.6	13.8	0.4	0.0	0.0	18.1	12.0	1.5	2.9	0.0	108.3	30.9	0.1	0.0	0.2	0.1	0.0	0.0	1.2	48.9	0.1	0.0	34.4	0.3	74.8	8.4	9.0	0.3	0.0	0.1	0.0	0.0	0.0	30.9	0.1	0.1	0.1	0.1	0.9	0.0	27.4	3.3	0.0	0.6	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	46.2	0.0	31.3	0.0	5.7	29.3	0.8	0.9	2.7	16.4	1.0	76.8	0.2	0.3	0.4	7.6	18.3	21.3	2.9	41.9	25.9	8.7	10.4	11.0	8.8	4.7	14.1	23.6	1.4	0.0	1.1	0.3	11.1	0.4	0.1	0.0	0.0	1.4	4.9	7.2	1.3	0.0	0.0	0.0	12.5	0.3	177.0	0.3	0.0	0.0	2.0	0.2	0.5	1.9	7.1	28.6	17.7	0.0	0.5	0.8	11.7	0.5	44.5	0.1	8.6	1.1	57.4	0.0	8.3	0.3	0.0	6.0	14.6	5.1	0.0	11.5	1.8	4.7	3.0	1.3	422.2	2.0	1.6	0.0	1.1	0.0	17.1	0.1	0.3	0.2	0.7	2.0	0.0	0.5	1.2	0.4	4.5	1.3	1.1	0.3	99.7	0.0	1.1	0.0
MBD5	"FLJ11113, KIAA1461"	ENSG00000204406	"Methyl-CpG binding domain protein 5"	Q9P267	2	148021011-148516971	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 317.4;Excitatory neurons: 510.1;Inhibitory neurons: 456.0;Microglial cells: 288.6;Oligodendrocyte precursor cells: 604.2;Oligodendrocytes: 438.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035964			Supported	Nucleoplasm,Midbody		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody"		"HPA035964: AB_2674891"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.82e-1)"	2.5	3.2	3.7	2.2	4.3	2.0	2.3	7.2	5.1	3.1	0.5	5.2	1.8	3.2	1.6	2.6	2.2	3.2	2.8	3.9	3.1	3.4	2.0	2.3	2.4	2.2	2.2	3.7	1.7	4.1	3.8	3.0	2.1	3.0	1.9	5.7	1.8	2.5	2.8	1.9	2.3	2.7	2.0	2.6	2.7	3.1	3.3	4.2	3.4	3.0	2.2	3.7	2.2	4.1	1.1	1.1	4.4	4.1	3.5	3.6	2.9	4.0	3.9	3.1	2.3	2.8	2.9	1.9	0.9	3.4	1.7	0.8	3.1	5.1	4.1	1.6	1.6	3.5	2.8	1.5	2.0	0.6	0.6	2.9	4.1	4.5	3.3	5.0	4.1	2.7	1.9	3.6	4.8	2.7	1.5	2.7	2.2	2.5	1.7	1.6	1.2	0.8	3.2	3.8	2.9	3.5	3.2	1.6	3.0	3.2	2.3	3.4	2.8	3.7	1.8	0.6	1.9	2.4	1.1	1.5	4.8	1.6	3.6	0.8	0.1	0.5	0.3	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.3	0.1	0.1	3.7	4.3	7.2	5.1	3.9	3.1	2.2	2.2	2.1	2.0	3.3	4.1	27.3	16.0	13.7	317.4	23.4	3.8	11.9	4.1	10.8	24.7	16.5	15.0	10.5	11.5	14.8	12.9	37.5	7.3	23.8	5.0	3.9	18.6	94.5	14.8	25.8	15.2	11.5	36.6	510.1	15.7	9.8	15.5	12.2	18.0	3.8	35.9	15.0	8.4	7.0	13.5	456.0	4.9	6.1	16.9	3.3	37.6	18.0	15.1	0.0	288.6	13.6	8.1	24.7	604.2	438.3	20.4	4.6	10.5	22.8	7.8	9.4	14.0	8.5	17.4	6.6	16.5	16.8	15.7	9.4	10.4	3.3	8.5	27.7	23.7	5.8	12.6
MBLAC2	"DKFZp686P15118, MGC46734"	ENSG00000176055	"Metallo-beta-lactamase domain containing 2"	Q68D91	5	90458209-90474771	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037757, HPA037758"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA037757: AB_10670528, HPA037758: "	"unprognostic (6.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.96e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-2)"	2.6	3.8	4.3	3.3	4.4	1.5	5.2	4.7	5.9	4.4	1.2	3.1	3.3	5.1	3.3	3.8	3.8	2.4	2.8	4.6	4.8	5.0	6.3	2.3	4.2	3.0	5.1	8.6	3.1	8.1	2.4	2.9	3.5	4.5	3.2	3.4	4.6	3.9	2.3	5.2	3.0	3.7	3.3	3.8	2.6	3.1	6.4	4.3	5.2	2.2	3.9	2.5	2.9	4.7	6.4	2.7	4.6	5.9	6.0	8.0	5.6	5.0	4.5	4.2	4.4	2.1	4.7	14.9	2.9	4.4	5.8	6.4	6.0	7.5	6.6	8.5	4.1	6.7	4.6	4.8	6.3	6.7	2.8	7.0	9.9	3.0	11.6	4.9	5.4	7.9	10.2	8.0	7.2	3.9	6.5	9.1	3.0	1.3	13.1	6.9	7.7	20.5	6.3	2.3	7.9	9.3	4.5	6.5	12.1	2.7	5.4	4.9	6.7	5.2	3.6	6.4	6.5	5.6	6.8	6.5	4.5	13.8	7.2	0.0	0.7	0.5	1.4	1.8	1.6	1.3	1.5	1.5	1.3	2.4	2.0	1.6	0.0	1.6	0.9	0.4	0.6	1.1	4.3	4.4	4.7	5.9	4.6	4.8	3.0	5.1	3.5	3.3	6.4	4.7	3.8	3.2	3.6	2.9	4.7	2.7	1.2	2.8	8.6	8.1	4.6	5.0	4.9	2.8	1.7	1.8	8.4	3.9	3.9	1.9	1.9	1.6	0.3	2.0	5.0	4.2	4.2	6.3	14.4	1.3	3.1	3.5	3.1	2.0	0.0	5.3	3.6	5.8	2.6	3.3	16.4	2.9	4.1	5.1	1.0	0.6	4.1	2.1	1.8	6.5	2.1	5.5	3.1	8.5	15.6	1.8	1.8	5.3	2.1	1.2	3.0	5.5	2.4	6.7	0.0	4.3	4.9	2.5	6.1	7.3	3.3	0.8	3.7	12.6	3.9	0.7
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003709	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 171.1;Erythroid cells: 162.6;Excitatory neurons: 134.6;Horizontal cells: 141.3;Oligodendrocyte precursor cells: 177.4;Oligodendrocytes: 230.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 4.7;eosinophil: 1.7;neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 41.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.32e-4)"	2.2	2.1	16.4	2.4	23.6	26.9	9.0	20.5	18.4	7.7	26.2	7.6	2.4	4.6	2.7	15.8	2.9	3.6	4.6	18.9	21.9	7.0	0.8	6.7	1.9	21.8	22.2	5.8	1.4	29.3	5.4	3.2	22.4	14.4	8.5	15.6	5.7	2.3	1.1	11.6	3.7	3.9	20.6	2.4	6.1	2.1	21.9	2.4	4.5	1.1	4.8	3.8	8.4	29.3	14.0	4.2	12.7	5.4	5.6	12.5	7.3	6.5	2.4	8.5	5.6	1.1	21.9	3.9	7.5	15.9	6.8	10.5	11.4	13.5	12.6	12.3	19.0	16.7	5.9	0.0	6.9	0.0	5.0	9.1	7.8	8.1	5.6	18.5	4.5	5.5	14.4	3.0	7.5	3.6	4.9	0.3	5.0	6.4	15.8	7.4	20.0	0.1	12.6	2.0	7.6	23.0	6.9	41.1	6.6	6.2	7.7	4.8	2.5	14.7	7.7	11.6	19.0	1.1	0.4	4.3	23.3	2.4	5.1	4.7	0.4	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	4.0	0.0	0.1	0.1	0.0	0.2	16.4	23.6	20.5	18.4	18.9	21.9	21.8	22.2	22.4	20.6	21.9	29.3	7.7	19.2	12.7	171.1	1.7	3.3	4.6	33.1	0.6	20.6	18.1	12.1	12.2	7.2	54.7	40.5	8.4	3.9	1.1	28.2	5.9	5.6	9.7	3.2	19.4	13.4	37.6	162.6	134.6	1.5	1.4	12.7	21.4	2.9	8.2	14.7	4.6	0.2	1.8	141.3	107.8	59.3	32.6	1.9	17.7	12.7	5.3	5.0	14.2	33.7	29.0	98.7	0.0	177.4	230.5	88.1	42.9	7.5	0.3	19.5	1.6	10.4	45.7	8.8	6.6	10.5	15.2	12.1	24.8	24.4	5.1	1.9	2.0	1.9	12.7	66.4
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658706	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.5"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 107.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 81.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	21.3	47.6	13.4	13.5	13.7	6.0	60.0	12.4	15.5	21.3	24.9	30.5	27.2	14.4	38.9	25.4	17.2	15.2	54.9	12.0	13.1	73.3	120.5	13.4	17.8	14.8	13.4	14.2	24.6	32.8	14.1	14.2	14.8	48.2	35.9	12.2	28.2	20.6	34.4	19.8	20.7	11.7	16.3	15.6	25.8	8.6	16.0	14.2	44.6	35.4	21.5	27.0	15.0	18.4	38.5	52.4	21.4	82.5	22.4	23.0	36.9	16.4	29.4	35.7	25.7	91.1	46.9	90.4	62.8	25.9	28.0	30.8	37.8	58.8	44.3	47.6	45.6	48.2	24.7	100.5	39.2	24.4	42.8	29.5	30.1	32.6	25.8	15.8	31.7	24.9	63.2	31.6	24.9	103.0	0.3	42.9	29.0	33.2	27.2	46.3	64.5	130.9	92.5	66.9	32.9	36.7	80.1	111.8	38.8	10.1	92.7	59.6	22.7	14.4	22.1	26.1	49.9	22.4	46.2	54.6	23.7	66.3	36.6	2.0	8.4	1.9	6.5	13.5	8.5	9.7	8.4	7.4	19.4	9.9	8.3	9.1	1.3	14.7	8.1	8.1	12.1	8.3	13.4	13.7	12.4	15.5	12.0	13.1	14.8	13.4	14.8	16.3	16.0	18.4	9.1	16.0	23.6	27.4	26.8	13.3	17.5	20.2	22.2	12.6	54.9	28.3	61.5	20.0	22.3	16.5	6.2	48.5	17.6	26.3	21.5	20.6	4.3	94.0	24.0	15.1	29.5	13.9	22.2	18.2	23.0	13.1	30.1	107.0	12.7	22.7	9.7	93.1	18.0	3.3	21.6	22.8	8.2	12.1	11.2	9.8	13.7	14.0	12.4	11.2	17.9	15.4	20.6	30.2	28.0	15.3	17.0	20.3	27.2	29.6	23.6	59.1	17.7	10.8	6.6	15.2	9.0	4.2	12.0	35.9	13.8	63.6	17.9	30.9	33.9	20.9
MCEE	"GLOD2, MCE"	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 92.0;Proximal tubular cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"	No	No		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.76e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	17.8	30.0	8.9	12.3	9.7	9.1	32.7	10.5	12.5	22.1	15.4	20.1	20.1	13.1	30.5	26.3	14.8	14.2	35.9	8.9	9.4	33.7	69.8	13.7	14.7	9.5	9.1	18.5	36.1	35.6	24.1	17.6	9.9	23.9	23.9	12.3	42.8	17.8	36.5	28.4	16.9	12.2	9.7	16.0	23.5	6.0	9.4	13.3	14.1	61.7	15.5	16.5	21.9	11.7	12.1	5.2	10.6	7.6	34.3	46.6	30.2	18.5	23.3	9.2	13.9	14.7	14.8	18.7	5.5	18.5	7.0	12.5	12.4	9.6	9.5	17.1	10.7	12.7	16.3	42.5	19.5	14.5	10.3	31.3	13.5	6.2	12.3	20.5	10.6	14.6	17.1	31.9	9.1	15.5	10.9	16.9	9.6	33.1	14.6	12.8	12.3	35.2	14.8	10.4	11.9	8.8	6.9	40.1	18.1	12.1	31.7	13.4	13.7	10.6	8.3	10.9	7.5	30.7	13.1	20.0	17.5	23.7	9.9	20.3	23.2	27.6	15.4	25.6	21.9	21.6	19.3	15.5	19.9	16.7	17.6	15.0	6.1	16.5	25.3	23.9	35.3	14.6	8.9	9.7	10.5	12.5	8.9	9.4	9.5	9.1	9.9	9.7	9.4	11.7	11.1	25.6	13.4	13.7	12.8	8.5	10.5	18.4	21.6	2.6	37.5	27.3	75.2	25.8	18.2	5.5	2.1	36.2	11.2	14.0	92.0	13.3	1.1	17.2	16.2	9.0	9.0	12.0	13.3	18.4	36.8	23.3	17.3	20.2	0.0	5.2	12.8	73.0	15.1	5.0	14.5	32.5	18.3	10.4	8.7	1.0	29.2	9.4	14.2	14.0	9.1	7.3	5.2	16.1	20.8	9.6	16.2	17.7	42.0	11.0	35.0	77.1	19.4	8.6	26.3	12.7	17.9	3.7	5.1	25.6	20.9	11.4	10.1	16.9	23.0	11.9
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 65.9;lung: 74.2;lymphoid tissue: 35.1"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 147.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Group enriched"	"Detected in some"	5	"classical monocyte: 102.1;neutrophil: 45.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.9;monocytes: 102.1"	"Group enriched"	"Detected in some"	6	"THP-1: 53.7;U-937: 166.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	4.0	0.5	0.0	19.7	0.0	65.9	0.5	0.0	2.1	0.1	0.0	0.4	0.2	0.1	0.0	0.5	1.7	0.6	1.3	0.0	0.0	0.7	1.5	74.2	0.1	0.0	0.0	0.2	0.7	0.0	0.2	1.8	0.9	0.5	0.1	0.0	0.8	0.0	0.3	0.1	0.6	5.1	0.0	35.1	0.9	0.2	0.7	0.9	0.4	1.5	0.1	4.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	1.4	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	166.6	0.0	0.0	102.1	2.8	0.2	6.0	0.0	0.0	0.3	0.0	14.9	0.0	0.0	0.3	45.9	0.6	0.4	0.9	0.2	38.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.4	19.2	34.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	11.2	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	2.2	0.0	3.6	0.0	0.0	1.0	2.9	0.0	0.0	7.6	0.0	0.0	0.3	28.8	0.0	0.0	0.0	0.0	28.3	0.0	0.1	0.0	147.5	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.8	2.9	0.0	0.0	0.1
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1 apoptosis regulator, BCL2 family member"	Q07820	1	150560895-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 685.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 106.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 4726.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Enhanced		Enhanced	Mitochondria		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	297.8	149.2	72.9	264.9	75.0	685.1	175.0	77.0	84.2	143.4	85.0	137.1	99.4	98.5	41.8	199.3	190.7	278.8	139.1	65.3	81.5	125.2	404.6	237.1	161.2	86.4	77.8	105.3	161.7	89.2	82.8	146.9	79.4	96.3	120.1	90.1	124.7	56.4	153.8	189.2	133.6	171.4	80.6	171.5	167.0	41.3	91.4	128.9	133.3	160.1	157.1	302.6	124.6	75.8	140.2	74.8	131.9	73.3	262.9	262.2	175.8	164.8	174.5	173.0	139.4	91.9	112.3	184.9	102.2	120.2	80.3	187.7	101.7	203.3	166.7	154.8	68.3	76.4	109.9	106.2	204.7	130.6	151.3	147.3	221.3	170.6	330.0	159.5	192.7	49.4	168.1	225.3	234.2	160.3	64.6	80.7	242.0	122.9	131.9	94.7	111.1	85.9	195.2	103.7	95.9	134.2	125.6	135.9	232.4	191.2	100.4	195.2	251.6	109.2	119.4	55.5	212.8	310.2	409.5	4726.7	189.5	95.1	141.9	23.3	19.8	51.8	15.0	17.4	17.4	12.6	19.0	16.6	16.6	14.0	22.8	17.6	106.3	10.6	16.2	9.4	30.1	11.2	72.9	75.0	77.0	84.2	65.3	81.5	86.4	77.8	79.4	80.6	91.4	75.8	366.0	198.7	295.5	12.4	339.2	489.2	394.7	142.6	434.2	38.7	339.3	229.9	84.8	228.8	148.8	33.1	60.5	108.6	398.5	491.8	41.1	196.4	209.2	187.5	310.8	241.9	259.6	61.8	6.5	174.7	203.4	278.4	228.3	365.7	343.8	209.0	229.2	218.8	262.7	11.8	5.5	309.0	107.8	453.6	930.9	347.0	72.7	614.2	273.9	30.0	250.6	101.2	94.7	10.1	6.8	183.4	345.1	60.9	831.8	293.4	233.1	68.9	110.3	78.0	78.9	350.3	217.4	47.4	35.4	372.2	572.0	270.4	499.8	126.0	205.7	401.1
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161558-13211110	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.2;lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	1.2	0.1	0.0	3.3	0.1	9.2	0.8	0.1	0.2	0.4	0.1	1.7	1.5	0.4	0.1	1.9	0.2	0.2	0.1	0.0	0.0	0.1	0.7	0.3	4.8	0.0	0.1	0.2	0.1	0.2	0.1	2.1	0.1	0.1	2.2	0.1	0.3	0.0	0.5	1.1	1.2	0.8	0.0	1.0	0.8	1.5	0.2	8.1	0.3	0.1	4.5	0.6	0.6	0.1	38.0	42.0	48.6	36.9	1.6	2.9	21.2	38.7	5.9	42.7	44.0	41.3	26.4	56.7	17.1	9.9	15.7	43.3	69.0	22.8	39.2	29.7	32.9	70.9	17.6	27.7	0.0	36.6	30.8	0.6	0.8	43.3	4.0	3.5	14.0	45.0	85.2	37.6	23.4	34.0	87.7	15.7	28.9	36.3	10.3	68.3	43.0	34.6	9.8	13.7	9.7	36.6	31.3	22.0	5.9	25.2	27.7	24.9	8.6	27.0	50.3	41.0	42.4	11.7	49.0	74.3	17.2	39.6	21.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.9	0.3	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	1.7	0.0	0.0	0.0	1.8	1.7	0.4	0.8	0.0	0.0	0.8	0.5	2.4	0.0	0.8	0.0	0.0	11.8	0.8	2.4	0.0	0.4	1.0	0.3	1.2	1.4	0.0	23.5	0.4	0.2	20.9	1.8	1.1	1.0	0.0	7.2	0.0	0.2	5.3	0.0	0.4	1.2	2.0	0.6	0.4	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.4	15.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	6.4	15.8	12.9	3.6	0.4	3.4	1.2	0.8	3.1	0.4
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264014-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.7;Erythroid cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		150000	"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	24.3	15.9	12.8	41.5	13.6	55.5	29.1	13.7	13.7	27.5	13.4	32.9	19.6	30.8	23.8	33.4	29.2	16.4	25.4	11.9	12.7	27.5	18.8	21.4	68.8	14.1	13.6	31.9	17.0	28.9	10.8	40.0	14.1	19.7	39.3	19.3	19.2	30.7	16.0	32.2	29.3	37.0	14.5	31.3	24.1	21.1	14.0	81.1	18.3	17.7	78.5	28.1	24.5	13.9	187.9	121.7	208.0	196.9	43.9	39.4	136.1	135.8	103.7	226.6	230.3	251.6	99.2	202.8	132.5	79.7	147.8	145.4	277.4	165.9	226.9	230.0	261.4	383.6	233.2	358.2	11.8	381.7	150.8	23.7	38.1	166.6	46.2	55.6	117.3	240.4	318.1	452.9	118.3	123.8	386.9	293.5	173.1	369.8	84.8	338.3	317.0	271.2	101.1	195.8	210.3	160.5	142.2	81.1	125.3	289.4	159.7	266.9	60.5	153.5	163.6	160.8	206.4	132.9	163.5	356.4	132.2	323.8	184.0	30.5	18.3	27.3	50.0	31.3	42.8	47.7	49.9	50.3	30.0	41.2	47.6	51.2	2.6	55.0	18.3	19.0	71.6	46.9	12.8	13.6	13.7	13.7	11.9	12.7	14.1	13.6	14.1	14.5	14.0	13.9	24.3	22.4	12.3	3.3	26.4	19.2	20.0	24.9	12.5	16.1	14.1	17.1	19.9	7.2	19.2	22.0	4.2	122.7	18.6	10.9	13.7	30.9	1.1	9.6	16.7	30.9	7.3	92.6	2.5	20.2	63.6	22.3	15.8	15.1	37.4	48.3	15.0	10.5	36.0	0.0	2.1	20.4	8.2	10.1	7.5	3.6	27.1	12.1	7.2	8.4	12.5	17.8	34.0	2.5	6.1	17.3	10.5	21.1	37.6	10.9	7.3	7.5	17.0	16.0	6.6	16.8	27.9	22.5	64.0	24.5	10.1	27.4	26.0	19.0	37.1	13.9
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 153.2;Erythroid cells: 60.8;Late spermatids: 77.9;Spermatocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	6.5	8.8	4.8	21.7	4.8	63.2	16.0	5.7	5.2	7.7	1.8	17.7	13.3	6.9	4.6	22.4	9.7	5.6	14.5	5.2	3.5	8.2	9.2	6.3	38.7	3.6	4.2	7.1	5.5	7.7	4.1	18.3	3.9	5.6	21.3	12.3	8.8	4.9	13.4	24.2	16.7	9.2	4.2	8.1	10.6	41.6	4.8	47.0	6.5	15.8	41.8	11.8	10.9	5.2	184.0	139.6	188.1	83.2	20.7	36.6	102.8	122.6	99.8	178.5	190.3	156.6	181.1	229.8	70.3	72.1	119.2	143.2	278.7	128.2	199.8	64.2	190.4	371.8	133.3	169.2	5.4	189.7	82.0	20.3	24.1	147.8	54.3	28.6	72.0	136.8	216.2	167.0	129.9	155.6	435.5	141.5	241.2	246.5	54.2	266.6	159.6	139.2	64.9	168.1	209.0	97.8	325.6	133.6	46.3	117.7	154.9	110.5	45.1	138.1	125.4	144.5	131.9	54.7	104.6	347.2	114.8	185.7	131.5	2.3	1.8	1.1	4.0	3.1	2.0	3.9	3.8	5.4	3.9	1.6	3.3	2.7	0.1	4.1	3.5	1.5	10.2	3.6	4.8	4.8	5.7	5.2	5.2	3.5	3.6	4.2	3.9	4.2	4.8	5.2	3.3	0.0	6.3	3.3	6.5	21.7	11.1	9.0	13.6	12.2	9.0	7.7	25.1	1.5	8.4	5.5	10.4	36.7	5.8	12.1	3.9	8.0	153.2	11.0	7.9	6.7	6.7	60.8	5.0	6.0	40.2	10.6	11.2	13.4	1.3	24.9	2.2	3.2	12.3	16.8	5.7	13.9	4.1	2.9	6.5	77.9	5.3	7.9	3.6	1.9	2.4	7.0	3.1	4.0	2.9	4.5	4.8	3.0	22.3	7.7	5.6	3.0	13.1	16.7	0.0	9.5	11.4	65.8	39.9	19.1	19.0	29.8	9.0	11.7	26.2	9.7
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400134-35425431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		44000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	15.2	7.1	5.8	49.1	10.4	138.7	14.4	8.3	7.4	14.5	5.8	20.2	19.6	16.3	3.3	25.1	13.7	9.6	8.9	5.8	7.0	9.1	14.9	14.8	70.1	10.3	7.7	25.6	12.6	10.3	5.3	25.2	9.6	10.2	16.7	2.3	13.9	9.6	13.3	17.6	28.3	12.2	8.1	47.3	17.9	20.6	9.0	58.9	12.1	8.0	53.6	12.7	15.6	12.3	213.0	147.5	115.7	118.8	11.0	22.2	100.6	138.1	71.2	199.4	188.3	98.9	102.4	137.9	78.8	70.5	83.6	103.8	116.0	108.3	64.4	112.7	212.6	198.3	141.5	203.7	3.9	414.0	172.4	12.3	9.7	120.0	32.4	18.4	88.7	124.5	124.0	201.2	76.9	172.7	341.8	137.9	154.9	143.4	86.7	379.6	164.8	173.0	39.4	120.1	88.2	94.8	188.3	75.4	41.8	60.9	78.8	155.6	54.1	201.3	153.1	127.2	145.4	111.9	150.2	265.2	130.9	153.5	157.6	66.5	59.8	43.4	49.5	69.6	35.8	127.5	43.1	53.1	77.8	106.1	34.0	39.0	28.4	65.5	81.2	88.8	96.6	77.1	5.8	10.4	8.3	7.4	5.8	7.0	10.3	7.7	9.6	8.1	9.0	12.3	8.1	6.4	7.3	1.3	49.5	10.6	13.6	12.1	8.6	1.5	9.2	10.8	3.5	8.6	6.0	7.3	0.0	147.8	30.4	12.0	5.9	19.8	2.8	6.2	4.1	11.8	3.5	96.6	0.3	12.7	77.1	11.2	18.8	9.0	15.2	65.7	13.2	5.3	53.1	1.7	0.4	16.6	4.1	24.0	29.4	5.1	10.8	28.4	7.2	7.5	137.7	5.7	13.4	3.0	6.0	11.0	8.6	6.0	49.3	4.0	6.5	5.7	4.8	3.7	19.7	8.8	14.5	16.1	58.8	14.9	6.3	82.2	19.4	8.5	34.6	9.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876443	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Erythroid cells: 50.5;Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		33000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	10.0	5.3	4.7	20.7	5.1	35.6	11.6	6.3	6.4	10.2	3.5	12.8	11.7	10.0	5.1	11.1	7.9	6.8	5.3	5.0	5.1	6.4	9.5	7.8	34.4	4.4	4.6	11.3	3.9	4.6	3.0	12.6	4.7	6.9	15.6	3.2	6.0	8.3	8.1	10.5	13.2	11.8	4.8	9.9	8.2	14.6	5.4	48.5	4.5	7.6	38.0	9.6	8.9	5.5	104.4	62.8	133.8	85.7	28.2	36.5	52.3	73.9	55.8	84.3	93.0	129.3	77.7	181.0	52.9	54.0	36.9	60.4	136.7	67.6	89.5	93.6	94.4	179.9	85.0	40.9	13.1	218.4	76.9	21.7	8.6	61.7	18.9	16.8	58.1	139.8	130.8	147.9	62.6	106.3	268.6	159.6	120.9	91.3	62.1	131.1	159.9	165.7	42.3	90.3	83.7	71.3	97.6	45.9	47.0	95.2	53.1	135.4	29.0	58.3	48.0	63.4	56.8	87.8	153.7	234.2	81.4	163.5	70.9	9.2	1.6	1.1	8.1	4.7	7.6	6.1	11.1	9.9	5.2	4.7	9.9	12.4	0.9	9.1	4.5	10.6	16.1	6.3	4.7	5.1	6.3	6.4	5.0	5.1	4.4	4.6	4.7	4.8	5.4	5.5	6.4	0.0	2.7	3.9	10.3	6.6	4.1	5.4	7.4	3.3	4.2	5.8	4.6	2.8	5.4	3.7	0.0	40.1	28.2	3.0	0.0	7.2	3.2	2.5	8.9	8.3	2.4	50.5	3.5	6.6	28.0	13.3	9.7	7.1	9.5	27.2	8.9	3.0	24.4	3.3	3.4	11.7	0.0	4.7	3.5	2.1	9.3	9.6	5.4	3.7	3.2	2.4	4.1	2.0	2.8	3.9	4.9	17.0	27.6	1.6	2.4	0.9	3.0	0.5	0.0	7.2	10.0	26.6	40.4	10.2	4.1	10.7	22.0	9.6	15.4	2.7
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.8;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA045141, HPA066433"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	2.9	2.9	3.0	4.6	4.1	10.2	2.8	6.8	4.4	4.0	4.2	3.9	3.6	3.1	2.1	3.7	3.2	1.7	3.3	3.1	3.4	2.4	1.8	2.4	7.5	2.9	3.1	2.6	3.1	2.0	1.6	3.3	3.1	3.6	3.2	5.3	2.9	1.8	6.9	4.7	3.7	2.1	2.6	3.6	3.3	13.4	3.1	9.0	2.4	4.6	6.5	3.4	3.6	5.8	48.6	33.0	27.7	30.3	4.6	6.6	27.4	38.1	12.3	26.6	32.0	35.4	27.6	48.3	11.3	10.2	51.5	50.9	46.1	25.7	47.9	13.4	21.5	49.3	16.8	27.9	0.9	56.6	7.4	2.5	3.8	47.2	17.6	5.3	12.3	28.7	56.7	45.8	27.1	12.3	27.6	30.0	40.3	25.3	21.6	34.8	50.9	18.6	5.0	15.3	21.6	23.2	40.0	36.3	22.5	28.6	27.1	16.4	9.6	51.5	43.2	28.2	56.8	20.1	53.8	82.2	9.6	33.5	43.4	1.0	0.1	0.4	0.4	0.1	0.7	0.3	0.2	0.4	0.0	0.3	0.2	0.4	0.4	0.4	0.2	0.4	0.5	0.1	3.0	4.1	6.8	4.4	3.1	3.4	2.9	3.1	3.1	2.6	3.1	5.8	3.3	0.0	4.4	1.6	6.0	2.3	3.0	1.9	4.6	7.3	2.1	2.8	10.3	7.2	2.4	12.9	16.7	7.2	4.2	5.8	0.0	1.9	8.5	4.9	3.5	4.2	4.2	14.9	3.7	2.8	6.3	5.0	3.1	5.4	1.3	24.4	2.9	1.9	4.5	6.7	2.9	4.0	6.1	2.8	4.6	3.2	3.7	3.7	1.8	2.8	0.3	3.7	8.2	3.5	6.6	3.6	3.9	3.0	9.2	3.3	4.7	2.4	4.0	11.5	6.6	5.7	4.8	71.8	37.1	5.0	2.6	4.0	6.0	3.0	6.3	2.2
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522624-7534009	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 109.4;Kupffer cells: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 117.5;classical monocyte: 45.2;eosinophil: 105.7;intermediate monocyte: 95.5;neutrophil: 41.1;non-classical monocyte: 105.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 117.5;monocytes: 105.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	21.2	37.4	6.4	9.2	6.5	10.4	15.3	7.0	8.4	11.7	8.3	13.6	8.3	11.6	2.7	11.0	12.2	10.1	15.7	7.0	7.4	11.7	14.7	20.3	13.2	8.2	7.4	10.0	9.9	10.2	21.7	15.9	9.0	8.7	5.6	5.0	12.3	6.1	22.2	20.8	12.1	8.1	7.1	48.2	12.8	5.6	8.2	6.2	8.5	11.7	4.1	15.8	10.9	9.9	11.6	11.7	5.6	19.1	32.0	10.3	16.1	21.2	16.9	25.2	21.6	9.0	10.0	6.5	25.5	14.5	22.2	5.3	9.5	7.3	7.4	12.7	21.1	5.8	11.0	7.3	28.0	6.6	24.5	14.5	16.8	24.1	4.2	7.9	10.7	14.2	10.9	27.9	14.7	3.9	9.1	6.6	12.6	6.1	24.8	12.6	9.4	13.8	9.6	9.9	14.4	17.8	9.1	15.8	26.8	6.1	9.6	11.4	13.5	12.0	6.9	48.8	16.0	21.5	35.5	4.7	19.2	9.2	18.4	117.5	45.2	105.7	7.7	95.5	6.3	4.2	6.5	6.3	19.2	4.1	6.0	6.5	41.1	10.3	105.1	21.1	10.0	17.1	6.4	6.5	7.0	8.4	7.0	7.4	8.2	7.4	9.0	7.1	8.2	9.9	15.1	3.2	2.6	5.9	8.0	13.4	6.5	16.9	10.2	27.3	15.9	15.0	2.3	15.7	8.1	31.3	22.9	11.6	12.1	32.0	1.9	23.7	4.8	5.0	19.8	14.1	16.8	21.7	10.6	23.1	20.0	16.0	9.7	6.5	1.3	22.2	13.6	13.6	109.4	58.9	8.0	10.0	22.4	117.1	32.2	17.0	16.4	70.6	21.4	7.5	18.0	23.0	16.5	7.5	11.4	23.4	19.3	15.8	8.0	5.6	21.8	12.3	6.5	44.1	6.6	11.2	14.8	10.3	14.7	8.9	17.3	29.6	8.7	17.3	9.4	4.8
MCU	"C10orf42, CCDC109A, FLJ46135"	ENSG00000156026	"Mitochondrial calcium uniporter"	Q8NE86	10	72692131-72887694	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 53.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 68.3;Inhibitory neurons: 65.6;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016480	Approved		Supported	Mitochondria		No	No		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA016480: AB_2071893"	"unprognostic (2.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (1.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.48e-2)"	6.1	3.8	2.8	7.4	2.5	19.9	5.7	10.4	3.6	8.3	6.4	28.7	27.8	8.9	3.0	14.2	10.8	12.7	7.8	3.9	2.8	10.6	7.0	10.2	4.9	3.4	3.2	4.9	5.5	10.0	1.9	12.8	3.2	5.8	30.8	2.3	6.7	5.7	41.8	6.8	24.5	13.5	3.0	5.0	43.2	4.3	3.3	5.7	6.4	53.7	7.7	14.9	5.1	2.8	41.7	66.1	16.8	12.2	25.0	28.0	17.1	25.0	35.5	24.5	26.0	39.6	38.6	17.7	19.6	30.8	13.3	36.9	22.2	29.8	32.5	19.5	20.8	22.1	23.5	22.1	19.5	56.0	17.9	28.7	24.9	22.0	46.6	38.4	29.8	18.5	14.0	12.9	23.0	24.3	15.2	12.0	18.5	45.2	13.6	15.7	35.8	4.7	32.7	22.4	17.8	7.9	30.8	34.1	7.5	20.2	6.8	14.5	24.3	11.8	19.9	25.7	16.9	9.4	12.8	12.1	15.8	27.5	9.2	1.8	6.7	18.6	3.0	7.3	3.1	3.5	2.9	3.6	5.8	1.7	2.3	2.6	8.8	2.2	8.9	2.0	5.2	4.2	2.8	2.5	10.4	3.6	3.9	2.8	3.4	3.2	3.2	3.0	3.3	2.8	13.7	35.3	17.0	21.2	4.2	11.7	14.4	8.9	10.8	3.0	5.9	3.9	6.6	8.6	22.0	18.4	2.1	7.3	4.8	38.2	1.9	11.1	14.5	23.3	9.9	9.7	8.4	10.8	58.2	25.2	10.1	7.2	68.3	26.4	8.2	3.4	8.9	5.8	6.7	0.0	65.6	28.2	12.2	6.0	2.9	7.2	5.3	6.7	8.8	37.5	5.7	5.4	2.1	72.4	40.3	40.7	15.6	4.1	5.7	9.7	19.8	8.6	22.6	3.9	13.1	6.8	12.1	5.1	5.2	6.2	12.4	9.3	5.0	12.7	24.5	26.8
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717447	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Focal adhesion sites"	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	11.3	7.0	2.7	8.6	3.2	13.0	10.9	4.1	5.2	12.4	3.3	11.0	4.9	13.7	8.5	6.2	12.3	4.6	9.5	2.4	4.1	8.2	9.7	9.5	10.2	4.5	3.3	16.8	10.8	8.6	12.8	7.4	3.5	10.1	6.9	14.1	9.1	8.2	11.0	9.4	10.9	8.9	2.0	11.3	8.4	28.2	3.4	14.5	16.4	5.8	11.3	10.7	9.3	3.6	36.7	11.1	47.4	34.8	6.3	10.0	23.0	14.8	10.0	25.2	21.3	22.7	8.5	37.7	17.5	17.0	23.5	20.2	63.0	28.6	34.9	29.9	65.6	43.4	28.7	12.5	4.1	27.1	16.9	7.9	9.2	48.6	27.3	9.0	11.5	25.7	61.0	36.7	19.1	14.7	14.6	20.0	20.6	8.4	7.8	33.2	24.7	37.4	11.0	10.7	39.9	23.2	11.5	26.2	13.5	29.1	21.8	16.8	13.8	24.8	26.4	19.2	26.3	19.3	21.6	34.5	7.8	63.9	34.3	0.1	0.1	0.1	0.6	0.1	0.3	0.4	0.4	0.5	0.1	0.7	0.5	0.5	0.0	3.2	0.1	0.7	0.0	0.3	2.7	3.2	4.1	5.2	2.4	4.1	4.5	3.3	3.5	2.0	3.4	3.6	9.7	16.0	13.0	10.1	13.4	4.5	5.5	5.6	15.9	11.5	6.8	8.6	7.6	7.2	5.7	5.5	8.4	7.9	11.0	2.5	3.9	5.3	4.7	8.0	8.7	9.7	6.7	14.5	8.3	6.2	11.4	11.2	4.1	13.7	17.1	12.8	6.1	12.0	6.7	5.0	8.1	3.3	12.2	6.0	5.7	3.9	7.8	7.3	1.8	11.2	5.9	10.6	14.4	12.5	9.9	5.2	1.1	6.0	16.9	2.9	1.2	3.0	8.0	17.1	13.1	16.2	8.3	74.5	18.0	8.7	3.7	1.9	12.1	7.7	6.0	1.9
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 697.1;tongue: 601.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		14000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	76.9	163.4	68.0	51.4	73.6	71.9	73.9	62.1	83.9	67.4	81.3	118.7	112.7	69.2	34.7	144.9	66.8	38.0	367.5	73.5	69.9	121.7	215.5	60.7	62.4	66.7	61.4	64.1	118.3	90.5	70.7	45.2	67.0	67.3	80.3	40.2	98.8	56.8	697.1	119.5	94.4	60.0	56.3	75.6	103.2	60.2	64.1	60.4	62.3	601.9	66.2	85.6	82.4	66.6	176.5	278.4	99.2	250.7	110.3	121.2	172.0	113.9	145.8	159.4	143.2	246.2	204.7	261.3	51.1	151.1	172.6	174.4	256.3	170.0	112.7	192.1	368.3	144.6	138.7	229.9	135.2	229.3	144.6	153.7	149.7	155.2	229.3	124.9	150.9	160.5	466.3	149.4	149.7	389.6	206.4	402.1	222.8	306.6	344.3	164.3	121.7	379.9	149.9	225.5	247.4	226.9	114.6	567.5	247.0	124.9	323.4	260.0	117.7	160.0	151.6	175.5	232.7	166.5	148.1	290.8	138.6	289.1	249.1	95.4	129.9	63.3	102.4	148.8	107.1	122.2	113.7	111.2	176.0	110.2	109.0	102.6	34.0	107.4	164.2	157.2	156.6	175.8	68.0	73.6	62.1	83.9	73.5	69.9	66.7	61.4	67.0	56.3	64.1	66.6	98.8	51.3	65.9	7.8	110.2	135.9	190.8	437.9	118.4	68.0	151.8	165.5	486.2	135.8	217.3	115.8	18.8	328.1	104.9	242.3	448.0	269.8	263.7	108.0	97.9	96.8	169.7	97.2	13.0	333.1	334.0	112.6	111.1	104.8	54.5	150.9	88.5	246.6	248.1	72.3	15.0	280.6	288.9	132.6	113.5	161.5	99.4	117.6	181.5	9.4	171.4	85.7	126.7	8.0	12.8	255.0	252.1	99.3	149.8	197.3	433.3	466.3	139.0	67.3	85.5	114.7	150.9	157.8	65.3	256.6	166.1	294.8	105.4	233.4	372.7	234.7
MEAF6	"C1orf149, CENP-28, Eaf6, FLJ11730, NY-SAR-91"	ENSG00000163875	"MYST/Esa1 associated factor 6"	Q9HAF1	1	37489993-37514766	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029599			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA029599: AB_10599996"	"unprognostic (4.95e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.41e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.87e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.68e-3)"	"unprognostic (3.57e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.19e-1)"	37.9	31.4	28.8	18.7	30.5	28.4	39.0	23.9	38.5	42.3	23.5	45.2	19.7	36.7	32.0	37.3	35.6	26.9	25.8	30.5	38.4	32.9	29.5	32.9	29.0	25.9	29.6	41.7	38.9	52.4	67.6	20.9	29.8	66.5	20.3	18.8	43.1	45.1	43.3	46.5	31.8	26.4	23.8	26.7	35.5	38.8	34.2	50.5	31.0	25.1	28.0	41.6	38.7	28.1	56.3	11.2	36.0	37.5	42.3	57.9	32.8	49.0	51.8	57.4	47.4	24.0	48.2	45.9	52.4	41.8	39.0	30.4	47.6	43.0	44.5	75.8	55.6	67.4	17.6	44.5	46.1	59.4	46.2	37.6	72.0	53.7	78.5	31.2	49.5	58.7	89.1	36.4	46.2	23.4	61.9	39.5	69.7	36.4	49.3	60.4	53.4	65.0	42.7	26.6	68.2	38.9	61.8	35.2	73.3	23.0	41.1	41.3	39.4	47.3	36.1	58.5	39.4	58.1	88.0	83.7	43.4	77.8	33.4	108.4	71.1	123.0	97.7	61.3	100.3	102.2	87.6	95.8	73.4	101.8	86.0	79.7	33.3	80.3	70.3	62.3	109.9	114.4	28.8	30.5	23.9	38.5	30.5	38.4	25.9	29.6	29.8	23.8	34.2	28.1	71.4	64.1	47.2	30.0	102.9	211.8	179.3	158.5	84.2	44.0	115.7	81.8	28.1	107.2	98.1	108.5	22.9	88.6	94.0	23.0	223.0	96.0	47.0	127.2	53.3	59.4	70.2	83.5	34.1	63.0	58.3	74.2	47.9	89.7	54.3	67.5	75.3	59.9	88.9	20.2	28.9	60.3	146.5	66.3	125.5	103.2	75.8	61.5	131.6	9.4	81.4	71.2	115.4	28.6	36.9	64.2	35.8	81.6	59.4	251.4	52.8	184.2	174.7	42.5	46.0	52.4	79.2	143.7	197.5	91.8	246.6	53.8	111.6	56.5	52.3	120.4
MED26	"CRSP7, CRSP70"	ENSG00000105085	"Mediator complex subunit 26"	O95402	19	16574907-16629062	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.4;Late spermatids: 67.4;Spermatocytes: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057997, HPA071835"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA057997: AB_2732618, HPA071835: AB_2686455"	"unprognostic (2.02e-2)"	"prognostic favorable (2.46e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.98e-3)"	4.5	3.8	4.4	3.8	4.0	11.0	4.1	5.1	4.7	4.0	4.0	4.1	2.4	4.3	1.8	5.2	3.2	2.3	3.2	5.0	5.1	2.8	3.7	4.0	4.9	5.2	4.7	4.7	3.9	3.5	3.6	3.2	4.7	4.2	1.9	2.0	4.5	2.4	6.9	6.4	3.6	2.5	3.6	4.7	3.6	35.9	4.5	4.4	3.1	3.2	4.6	3.9	4.6	4.2	11.1	4.2	3.8	8.3	4.8	3.8	11.1	6.3	4.4	6.7	6.0	6.3	6.5	17.6	6.5	4.0	2.1	8.2	5.9	6.3	4.6	13.0	12.2	6.9	4.2	5.1	4.7	7.9	6.3	4.6	6.1	5.7	5.9	4.0	3.6	9.1	11.5	20.7	4.2	11.1	8.4	7.4	9.0	5.2	13.4	8.7	5.8	19.3	4.0	4.3	10.0	5.4	5.5	5.3	6.4	2.7	3.9	10.3	4.5	8.5	6.8	10.4	8.5	14.3	12.6	14.4	6.0	10.4	5.0	0.7	0.1	0.1	0.5	0.3	0.1	0.4	0.0	0.2	0.2	0.7	0.3	0.0	0.3	0.4	0.1	1.4	0.7	0.1	4.4	4.0	5.1	4.7	5.0	5.1	5.2	4.7	4.7	3.6	4.5	4.2	13.7	3.2	12.7	11.4	11.8	14.1	5.0	3.8	11.4	4.2	14.3	12.2	1.1	2.8	3.0	5.5	10.4	6.2	15.8	5.9	3.9	4.4	65.4	12.9	7.7	6.1	2.4	5.0	8.6	4.0	11.1	7.0	5.6	16.6	1.3	5.8	4.2	5.6	5.0	5.0	7.6	4.7	2.0	8.5	10.7	67.4	6.5	9.9	1.8	1.9	4.9	6.0	4.1	7.1	8.5	6.0	3.0	3.8	15.9	6.7	3.6	2.0	3.5	6.4	0.0	17.7	8.0	54.1	19.4	11.5	10.7	16.8	11.0	6.1	5.1	8.7
MED31	"CGI-125, Soh1"	ENSG00000108590	"Mediator complex subunit 31"	Q9Y3C7	17	6643311-6651634	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035947	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA035947: AB_10696646"	"unprognostic (1.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.87e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	12.1	22.4	17.2	9.3	19.3	9.9	14.4	17.2	26.4	13.2	17.6	9.6	8.7	11.2	26.5	25.0	12.8	12.5	15.6	18.3	19.7	16.6	18.2	11.0	14.8	17.1	17.8	12.8	9.7	13.1	25.3	9.7	18.6	12.5	8.5	10.8	12.8	8.9	14.4	21.1	10.3	12.4	17.5	16.5	10.9	17.5	19.4	13.7	14.7	10.6	14.7	14.2	14.4	17.1	37.7	41.2	36.4	23.2	32.5	27.4	13.1	28.8	29.5	43.6	56.6	20.6	19.2	5.0	35.6	14.3	32.3	40.5	29.2	35.7	37.7	27.1	48.9	9.3	34.5	32.3	24.4	10.5	18.8	15.2	37.8	39.6	13.4	23.2	32.8	20.0	16.5	9.4	32.2	13.7	20.2	27.4	13.0	16.9	23.5	15.0	16.2	13.6	36.7	18.4	14.5	16.0	14.8	11.8	33.1	17.2	12.3	11.5	14.8	21.3	18.6	27.1	29.2	8.5	11.9	12.8	29.4	12.4	15.4	77.7	22.6	38.6	26.0	16.4	24.7	22.7	24.2	25.7	19.9	23.7	21.5	23.1	63.3	23.7	20.0	25.6	31.2	20.2	17.2	19.3	17.2	26.4	18.3	19.7	17.1	17.8	18.6	17.5	19.4	17.1	34.1	16.0	22.9	13.4	37.0	106.9	48.3	92.3	68.3	8.4	38.0	35.3	4.8	37.1	47.6	33.1	10.4	40.8	29.1	23.1	54.8	36.4	34.2	78.8	31.9	35.7	12.6	30.5	32.7	31.5	40.3	31.5	15.3	38.6	26.6	21.4	39.3	57.1	33.7	13.5	24.6	23.1	59.0	23.9	37.9	62.5	44.4	25.1	40.9	12.2	29.3	22.9	21.6	18.1	21.9	46.4	15.3	26.4	34.4	51.0	22.4	81.8	97.2	12.8	39.5	29.7	33.7	101.9	81.3	46.6	120.2	47.9	37.5	35.6	19.3	66.6
MED7	"CRSP33, CRSP9"	ENSG00000155868	"Mediator complex subunit 7"	O43513	5	157137424-157159019	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 314.5;Late spermatids: 289.0;Spermatocytes: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067181			Supported	"Nuclear bodies"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA067181: AB_2685798"	"unprognostic (1.63e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.81e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (7.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-3)"	10.1	11.4	7.9	9.2	8.3	10.5	12.6	9.9	11.1	8.4	10.3	10.5	6.3	9.2	13.5	8.5	7.9	7.6	10.2	8.3	8.4	15.5	10.1	8.0	12.9	8.7	8.2	10.8	6.9	10.9	8.0	8.2	8.5	10.3	11.0	12.0	7.6	7.1	14.3	6.0	8.8	9.0	7.6	12.3	10.0	26.5	8.4	9.7	11.8	10.9	11.6	9.3	6.4	9.0	13.2	15.3	20.6	14.5	17.2	12.2	15.3	20.5	11.8	15.2	19.2	20.7	24.8	23.4	17.8	15.4	29.1	16.3	11.5	23.0	22.2	10.1	11.1	8.7	15.3	11.1	15.4	12.6	11.9	14.5	16.5	13.5	14.8	13.3	19.5	15.2	8.1	17.4	24.5	12.9	12.5	11.0	6.1	18.3	18.9	11.2	17.9	12.9	32.6	18.2	15.9	11.9	13.8	14.1	19.7	16.1	36.0	12.8	14.7	22.3	18.3	11.6	18.6	16.7	19.4	11.3	14.0	17.7	18.1	40.9	22.3	30.8	19.3	24.6	23.0	35.4	23.2	24.4	16.1	34.5	34.4	24.8	19.3	26.1	35.7	15.0	28.3	22.2	7.9	8.3	9.9	11.1	8.3	8.4	8.7	8.2	8.5	7.6	8.4	9.0	12.3	9.6	10.1	6.2	17.1	7.1	14.8	52.4	7.4	22.7	9.6	11.3	20.8	10.0	26.6	23.9	22.9	38.0	10.7	15.3	52.8	28.0	314.5	10.7	12.9	12.3	11.4	17.7	9.1	18.7	22.9	14.4	13.3	9.4	20.3	15.7	16.4	9.4	22.8	18.5	9.5	12.0	32.6	19.9	12.0	289.0	18.6	13.8	3.6	5.6	20.4	22.0	35.0	4.5	10.7	18.9	14.1	16.6	11.8	11.3	16.1	40.2	21.7	14.3	6.6	10.5	18.1	112.9	43.0	7.5	6.0	30.5	16.1	22.4	11.5	14.2
MED9	"FLJ10193, MED25"	ENSG00000141026	"Mediator complex subunit 9"	Q9NWA0	17	17476994-17493221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056415	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Midbody	"HPA056415: AB_2683120"	"unprognostic (1.81e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (3.96e-2)"	"prognostic favorable (2.83e-9)"	"unprognostic (2.26e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-1)"	9.3	14.9	21.6	4.9	23.0	10.6	10.3	20.6	28.0	12.4	19.2	11.3	8.2	12.1	11.9	10.2	8.6	4.6	32.7	22.5	21.0	20.4	23.6	7.3	6.8	21.8	22.1	9.4	10.0	18.3	12.8	5.7	20.6	11.8	7.4	9.9	12.9	8.5	27.3	14.2	9.4	5.8	20.9	10.4	12.4	10.9	22.3	11.6	13.8	41.5	6.7	8.8	9.4	21.8	12.0	15.0	12.7	13.7	10.0	9.0	11.0	9.6	11.9	14.5	13.0	22.0	5.9	14.7	10.8	9.9	8.8	15.3	16.3	13.2	13.5	9.6	26.3	9.0	10.0	15.9	10.8	7.2	7.5	14.6	12.3	12.2	12.5	10.8	10.0	21.3	10.7	6.7	9.7	10.1	32.7	14.9	11.7	24.8	15.4	24.8	28.7	9.8	13.0	8.4	8.2	13.0	12.6	9.8	21.7	47.6	11.6	9.3	6.8	10.6	12.3	18.6	15.3	12.4	9.9	8.2	13.3	12.5	11.5	2.6	7.0	11.8	9.3	9.5	12.3	9.9	9.7	9.7	7.7	9.1	10.2	11.4	2.3	10.7	12.4	12.5	10.2	7.8	21.6	23.0	20.6	28.0	22.5	21.0	21.8	22.1	20.6	20.9	22.3	21.8	6.0	3.2	4.4	10.1	5.8	4.6	8.9	5.5	5.2	25.9	8.2	6.7	19.6	10.0	5.0	9.2	14.6	8.6	8.1	9.1	11.7	6.6	8.7	6.0	6.3	6.0	15.7	4.2	14.4	4.5	5.8	5.6	11.7	8.8	0.0	14.5	7.5	5.5	6.1	16.8	12.9	9.6	8.2	4.4	2.8	8.9	5.6	4.0	1.8	1.9	4.7	24.1	10.3	14.1	6.5	3.3	5.7	9.4	7.2	8.4	9.5	6.1	4.0	25.0	0.0	6.0	6.9	10.9	29.9	5.6	4.8	9.6	6.6	13.4	8.1	9.0
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3487951-3611508	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 20.6;Basal keratinocytes: 18.4;Basal squamous epithelial cells: 23.3;Melanocytes: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 51.1;HeLa: 56.3;hTERT-RPE1: 69.7;U-2197: 55.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted to blood"	Yes	No		1700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Microtubules	"Cytokinetic bridge"	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	25.9	4.3	2.9	3.9	2.7	10.8	20.0	2.6	2.8	14.5	1.4	14.1	2.1	9.6	1.4	13.2	28.9	11.2	14.2	1.9	3.2	5.9	5.0	22.1	5.5	3.5	5.8	18.0	6.5	0.4	4.1	2.8	3.6	26.5	1.1	1.8	19.3	4.7	4.8	44.6	10.0	1.4	2.1	10.7	10.1	3.3	3.7	3.4	11.6	1.9	3.4	11.0	22.8	1.9	11.6	14.1	4.3	6.6	0.4	0.3	1.0	51.1	14.1	5.2	1.6	3.3	10.4	0.0	13.8	24.6	4.4	6.7	0.0	0.5	1.7	0.0	0.4	0.0	56.3	3.3	0.0	0.2	0.9	0.1	0.6	0.4	0.8	69.7	5.6	0.1	0.0	0.0	0.1	6.0	0.0	10.9	2.7	3.3	0.9	2.2	3.0	6.2	1.1	3.8	3.8	3.1	18.8	1.1	6.4	11.4	4.9	1.5	2.2	19.6	1.7	55.6	3.9	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.8	0.0	0.0	0.0	0.8	0.1	2.9	2.7	2.6	2.8	1.9	3.2	3.5	5.8	3.6	2.1	3.7	1.9	5.0	22.4	20.6	8.8	2.7	18.4	7.1	3.9	23.3	0.8	3.6	3.0	3.3	5.7	4.4	1.8	0.0	0.2	0.4	0.6	0.0	3.6	0.2	1.4	0.6	7.0	0.0	4.8	6.5	1.4	1.3	9.4	6.6	5.0	1.3	9.8	16.8	0.9	1.0	0.0	7.2	1.4	0.0	0.3	7.5	0.5	11.5	2.8	19.6	5.6	0.7	14.7	1.0	4.5	5.2	4.5	0.1	3.4	0.4	4.0	0.5	1.2	0.3	1.2	0.0	0.5	2.7	0.3	1.1	7.6	11.4	0.4	3.6	0.1	1.1	2.7
MEIS1		ENSG00000143995	"Meis homeobox 1"	O00470	2	66433452-66573869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	Transcription	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Endometrial stromal cells: 117.2;Horizontal cells: 82.4;Oligodendrocytes: 227.5;Rod photoreceptor cells: 121.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.5;HeLa: 29.3;HHSteC: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011521, HPA056000, HPA058641"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 51: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011521: AB_776272, HPA056000: AB_2683004, HPA058641: AB_2683784"	"unprognostic (6.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-2)"	21.8	52.0	7.0	12.0	10.4	2.5	13.1	33.1	8.7	89.8	4.0	72.2	5.7	84.0	23.0	23.0	82.7	15.7	13.8	4.1	8.0	9.5	3.8	34.1	2.3	14.0	10.5	43.6	45.0	6.9	1.6	15.3	18.1	33.8	12.2	43.0	39.0	35.4	5.6	11.7	19.7	50.0	11.3	18.4	31.7	2.9	8.8	4.7	5.8	3.4	6.9	39.2	55.9	19.4	0.3	1.6	12.4	2.7	16.3	10.9	1.6	17.0	43.5	14.4	15.2	1.5	12.3	0.0	4.2	13.5	0.8	2.0	7.7	7.5	14.1	0.0	6.9	20.3	29.3	3.1	31.3	0.0	5.8	9.6	8.8	6.0	2.4	11.5	6.7	3.3	1.8	0.0	0.6	0.7	1.8	0.4	0.3	1.6	1.8	0.0	3.3	3.6	1.2	4.0	3.8	26.2	3.0	1.0	1.3	9.4	1.3	2.5	2.1	3.1	4.8	2.3	4.8	3.4	1.1	0.1	2.3	18.2	0.8	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.5	1.6	0.0	1.3	0.1	2.1	7.0	10.4	33.1	8.7	4.1	8.0	14.0	10.5	18.1	11.3	8.8	19.4	0.6	0.0	0.5	55.5	0.2	3.2	11.9	10.1	15.4	19.8	2.5	1.4	18.7	1.5	8.3	0.0	110.5	5.7	0.4	2.1	0.0	21.6	10.3	36.8	117.2	4.4	1.2	5.9	6.5	17.5	1.6	19.4	7.1	27.9	0.0	0.2	16.1	1.8	2.2	82.4	5.8	0.7	10.2	1.4	1.9	14.1	34.5	10.3	3.6	15.9	0.5	21.4	1.0	54.3	227.5	20.1	67.3	28.2	0.0	2.4	0.6	3.2	6.8	121.0	19.7	6.7	12.5	2.7	2.0	17.9	2.3	1.9	2.0	6.3	1.2	18.8
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640389-43661922	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.0;breast: 26.1;heart muscle: 24.9"	"Group enriched"	"Detected in some"	9	"Adipocytes: 63.5;Endothelial cells: 41.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 17.5"	"Lineage enriched"	"Detected in single"	48	"T-cells: 17.5"	"Cell line enriched"	"Detected in some"	14	"HeLa: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	36.0	0.5	0.0	4.7	0.0	0.0	26.1	0.0	0.1	8.0	0.0	4.7	1.6	5.5	1.1	3.7	9.0	5.7	24.9	0.0	0.0	0.2	0.1	1.4	6.6	0.0	0.0	1.0	1.5	1.2	0.5	0.1	0.0	2.6	2.4	0.0	4.9	1.9	8.3	6.6	5.1	10.6	0.0	10.8	3.0	1.1	0.0	3.0	1.9	17.1	5.3	7.7	7.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	1.8	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.3	2.7	0.0	0.0	1.7	0.5	0.0	0.3	0.0	0.0	17.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	1.0	0.3	4.1	0.0	0.0	1.2	0.0	0.4	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	41.3	0.0	0.0	0.7	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	1.8	0.1	1.5	0.3	0.0	0.0
MEPCE	"BCDIN3, FLJ20257"	ENSG00000146834	"Methylphosphate capping enzyme"	Q7L2J0	7	100428790-100434118	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026384, HPA051587"	Supported		Approved	"Nucleoplasm,Cell Junctions"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Cell Junctions"	"CAB026384: , HPA051587: AB_2681544"	"unprognostic (8.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (6.01e-6)"	"unprognostic (1.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.01e-10)"	"unprognostic (9.66e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.57e-1)"	"unprognostic (9.50e-3)"	26.4	41.0	27.5	19.4	28.3	28.3	24.2	30.4	31.5	26.1	23.6	25.8	18.5	28.8	27.8	27.5	27.0	19.4	26.8	26.7	27.0	37.0	36.9	21.9	29.0	27.6	27.3	36.0	22.5	35.0	23.6	20.9	27.4	26.5	12.9	9.9	24.9	20.7	38.5	34.5	27.2	18.0	26.8	56.6	24.6	79.8	28.0	28.1	36.5	31.5	24.2	28.3	21.9	28.2	42.6	53.6	38.9	41.9	36.8	36.7	29.1	46.4	66.5	48.7	37.4	43.8	60.1	87.1	75.5	29.1	38.5	38.4	43.0	34.9	32.0	39.4	49.4	45.1	41.5	33.3	30.9	58.0	53.0	38.2	40.9	55.7	70.0	26.5	41.1	27.4	90.6	62.2	47.2	155.6	66.3	129.8	72.1	35.0	58.9	53.0	31.5	79.1	32.7	25.6	58.5	50.6	72.5	139.1	49.1	19.3	35.6	52.1	36.2	81.5	63.5	55.9	62.0	41.0	42.4	96.3	45.8	71.1	72.9	2.6	2.6	3.7	3.8	2.3	4.6	6.2	4.4	4.2	3.3	6.6	6.2	5.5	6.4	5.9	1.9	6.3	4.5	7.5	27.5	28.3	30.4	31.5	26.7	27.0	27.6	27.3	27.4	26.8	28.0	28.2	34.2	9.6	18.9	5.5	33.8	30.2	17.3	7.1	19.9	9.9	30.2	21.6	25.6	20.0	7.8	22.0	8.4	15.8	34.3	32.2	15.6	10.3	29.6	18.3	13.1	21.7	10.7	9.9	2.8	12.0	8.5	17.3	54.6	18.8	18.3	14.5	28.9	22.1	12.7	11.8	2.6	26.1	8.2	26.7	16.9	66.5	17.4	32.9	8.8	7.5	18.1	19.4	15.5	2.5	2.7	10.4	23.6	15.4	14.9	15.6	39.9	14.4	10.4	9.5	6.6	35.0	17.9	44.8	15.1	22.3	25.1	21.2	25.0	19.5	20.3	9.9
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898607-112029561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.6;Kupffer cells: 119.8;Macrophages: 46.5;Microglial cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 8.6;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	50	"monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.1;Hep G2: 39.9;HUVEC TERT2: 38.4;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		Yes	NA		65000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	59.8	22.8	13.5	28.0	1.5	15.3	18.0	29.3	12.6	44.7	10.9	12.3	11.5	26.3	8.4	15.5	12.0	7.0	22.0	22.5	11.4	21.0	13.6	13.1	23.5	22.3	12.6	9.9	21.2	15.5	20.1	22.4	14.1	7.9	16.6	6.4	16.3	3.2	6.4	14.3	14.4	18.4	30.6	13.9	17.2	30.1	6.8	10.1	4.6	8.9	13.6	9.4	22.0	1.0	1.7	7.6	17.3	0.4	0.2	12.3	0.0	0.2	1.0	1.7	35.1	2.2	0.1	8.1	0.1	7.9	0.2	10.2	0.0	1.4	1.5	5.5	7.0	0.0	39.9	0.3	0.2	1.5	0.5	0.0	8.9	0.6	4.0	38.4	1.5	2.2	3.5	2.9	1.8	0.0	9.1	4.8	1.1	6.0	2.9	2.1	3.0	19.4	23.4	0.3	7.2	0.2	0.5	3.2	2.7	0.0	0.4	5.8	1.0	3.4	0.1	0.0	3.1	4.8	0.1	0.0	1.4	0.0	0.0	0.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.0	0.2	22.8	28.0	18.0	29.3	22.0	22.5	23.5	22.3	22.4	18.4	30.1	22.0	8.8	3.2	27.7	162.6	1.7	1.7	2.9	0.3	1.8	0.6	2.1	4.3	2.7	2.8	6.4	0.0	2.1	3.3	0.4	1.2	1.9	1.1	2.3	8.0	4.7	10.2	0.0	0.4	5.0	1.0	1.1	3.2	0.5	12.1	0.0	3.8	28.5	9.2	25.5	0.0	7.0	2.0	0.0	119.8	1.8	2.7	5.0	46.5	0.0	124.6	1.5	7.7	0.0	10.6	0.6	1.2	1.9	6.8	10.8	2.9	4.4	1.9	1.5	11.3	6.6	1.5	9.2	0.6	1.5	0.6	1.3	18.9	1.3	3.5	1.9	1.6
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 4.5;prostate: 7.3;skeletal muscle: 4.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 52.2;Breast myoepithelial cells: 58.9;Distal enterocytes: 40.1;Exocrine glandular cells: 43.0;Spermatocytes: 41.5"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.5;HDLM-2: 3.1;HEK 293: 3.0;PC-3: 5.7;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Nucleoli	"HPA069981: AB_2686225"	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	4.5	1.4	2.4	0.0	2.7	0.1	3.0	1.7	3.5	0.5	0.5	1.4	0.1	0.1	0.0	0.3	0.2	0.0	1.3	2.7	2.1	0.7	0.8	0.2	0.0	1.7	1.5	0.2	1.2	0.2	1.0	0.0	1.9	7.3	0.0	0.2	2.1	0.1	4.5	0.2	0.5	0.0	1.2	0.1	0.5	1.3	2.6	0.0	0.5	0.3	0.0	0.3	0.4	2.0	3.5	1.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	1.3	0.0	0.4	0.0	0.2	0.0	0.0	3.1	3.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.1	0.5	0.8	0.0	0.0	5.7	0.1	0.0	0.8	0.0	0.0	2.6	0.1	0.7	1.1	0.8	0.0	0.0	0.4	0.0	0.0	0.2	2.0	0.6	1.3	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.7	1.7	3.5	2.7	2.1	1.7	1.5	1.9	1.2	2.6	2.0	1.7	0.0	1.1	2.6	2.9	0.3	2.8	5.1	0.6	11.6	52.2	58.9	6.3	17.2	33.9	1.8	10.4	3.0	3.2	40.1	11.7	18.6	5.3	0.3	0.3	2.1	6.1	3.0	2.8	43.0	0.2	3.5	0.5	0.9	4.5	22.1	4.2	12.8	2.0	8.4	3.0	7.4	12.2	1.6	2.1	2.1	1.2	2.5	7.2	1.0	2.1	19.2	2.1	1.5	1.7	4.8	17.9	0.0	4.6	35.7	7.2	16.2	8.7	20.6	0.0	4.0	3.7	41.5	21.7	2.0	0.3	0.3	2.2	18.0	15.5	6.2
METTL14	KIAA1627	ENSG00000145388	"Methyltransferase like 14"	Q9HCE5	4	118685392-118715433	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038002	Supported		Supported	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA038002: AB_10672401"	"unprognostic (4.48e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.76e-3)"	8.9	8.8	5.2	8.6	6.0	19.5	11.5	6.8	6.3	8.8	5.5	8.8	8.8	11.7	10.7	8.9	8.8	7.7	8.3	4.8	6.3	10.2	14.9	9.1	11.6	5.5	5.2	12.7	7.8	10.9	8.2	9.0	6.3	9.7	8.2	11.7	7.6	8.0	8.4	10.9	9.2	9.2	5.4	10.8	7.9	15.1	5.7	12.5	10.6	7.7	11.0	8.5	7.9	7.4	19.6	8.9	19.0	17.8	11.7	14.7	13.8	17.1	13.0	12.6	14.4	12.9	22.8	22.0	9.8	12.0	12.6	9.4	16.2	14.1	16.1	17.5	9.8	18.5	11.4	14.4	13.3	30.2	21.2	13.1	15.8	14.6	9.6	16.5	11.5	17.4	20.1	18.2	17.5	13.2	29.7	24.7	16.2	16.7	7.7	16.8	23.7	11.2	13.8	12.7	15.4	17.3	12.0	22.0	17.2	17.2	10.0	28.5	15.8	18.1	16.6	16.3	13.7	15.2	17.0	24.9	12.9	16.5	15.1	37.7	12.8	29.0	17.0	19.6	19.3	24.3	17.8	17.7	15.3	25.3	21.0	19.0	10.3	21.8	23.7	12.1	20.8	13.7	5.2	6.0	6.8	6.3	4.8	6.3	5.5	5.2	6.3	5.4	5.7	7.4	18.6	25.6	25.9	14.7	20.6	10.8	18.3	10.6	16.5	16.8	13.4	12.6	15.7	17.2	20.8	23.9	22.9	18.7	28.3	13.7	11.7	11.9	96.9	14.5	21.7	17.3	12.1	8.4	18.7	15.6	10.2	16.8	9.2	18.0	22.1	18.3	16.4	32.1	12.1	8.4	17.0	15.2	6.1	17.9	7.6	16.7	18.6	13.3	7.2	14.0	14.0	13.4	25.7	14.1	26.9	14.8	13.0	13.9	8.2	17.1	15.4	20.6	15.2	25.4	13.1	15.3	15.5	42.2	28.1	12.4	11.9	15.3	20.6	17.0	12.8	16.0
METTL17	"FLJ20859, METT11D1"	ENSG00000165792	"Methyltransferase like 17"	Q9H7H0	14	20989973-20997035	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002955, HPA059802"	Uncertain		Enhanced	Nucleoplasm	"Intracellular and membrane"	No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA002955: AB_2144183, HPA059802: AB_2684129"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	11.9	32.2	11.0	11.1	11.5	26.6	12.2	12.3	16.1	14.1	13.2	20.6	17.6	12.8	11.2	22.4	13.0	10.3	23.7	10.7	11.1	20.0	19.7	11.7	18.0	12.0	10.9	13.8	18.8	19.4	9.6	12.2	11.6	12.3	21.7	8.0	15.6	13.8	21.3	16.1	21.5	14.2	12.0	23.3	17.6	18.6	12.0	21.7	13.6	29.2	19.3	12.2	14.6	12.3	37.5	48.0	41.8	16.1	25.3	12.2	32.0	22.3	32.8	69.1	58.2	34.3	44.9	85.8	24.4	29.1	43.7	54.0	57.5	48.5	49.6	32.5	44.7	41.8	27.5	56.6	31.5	71.5	42.8	23.4	41.7	35.1	27.8	23.0	27.9	70.5	40.4	38.6	33.8	24.9	48.9	72.2	49.6	62.7	56.2	56.8	42.9	48.2	37.5	34.4	30.2	36.5	30.0	43.9	24.8	31.1	29.4	60.0	15.5	22.4	72.0	25.1	30.2	28.7	49.8	62.1	15.5	46.0	29.3	28.8	8.1	8.6	11.7	9.8	7.0	13.9	12.7	13.2	16.8	10.8	12.4	11.7	0.1	10.7	5.5	11.1	11.5	6.9	11.0	11.5	12.3	16.1	10.7	11.1	12.0	10.9	11.6	12.0	12.0	12.3	11.2	9.6	17.7	21.9	33.6	18.9	17.9	21.2	46.1	37.5	16.5	16.4	5.4	21.5	17.9	11.0	43.8	30.8	23.0	19.3	5.9	20.4	49.2	11.8	16.2	13.5	12.2	26.9	9.7	15.4	17.4	17.7	36.2	11.1	29.7	22.0	11.7	24.2	18.1	21.9	9.3	24.0	16.2	11.3	12.4	10.2	33.5	16.3	3.6	6.5	19.8	23.4	26.8	8.5	11.0	13.8	32.5	21.4	33.6	11.0	27.9	18.0	21.4	53.1	13.1	14.6	17.0	23.4	17.3	40.6	17.8	12.7	27.6	29.0	35.6	24.8
METTL22	"C16orf68, FLJ12433,MGC2654"	ENSG00000067365	"Methyltransferase like 22"	Q9BUU2	16	8621683-8649654	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 119.9;Late spermatids: 357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040803, HPA059882, HPA074173"	Uncertain		Supported	"Nucleoplasm,Nucleoli rim"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"	Nucleoplasm	"HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672"	"unprognostic (1.74e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.90e-2)"	4.4	5.8	9.0	5.7	10.2	7.7	4.5	16.4	13.2	6.7	9.5	5.9	4.9	5.9	6.1	5.3	5.4	4.4	9.3	8.8	9.1	5.1	6.6	4.7	6.1	12.7	10.7	6.4	6.1	3.1	5.1	5.0	13.3	7.2	4.0	10.4	4.7	5.2	20.2	8.4	4.1	4.7	9.1	4.7	5.1	13.7	12.6	4.0	5.2	5.9	5.0	5.5	5.8	12.9	4.3	8.7	9.7	9.3	3.6	9.1	8.4	7.2	3.8	8.4	9.5	8.5	9.8	6.7	6.3	6.4	3.1	7.9	6.1	11.5	5.5	9.8	8.4	6.9	17.3	24.6	10.8	7.2	5.1	9.2	8.2	9.2	10.1	5.1	6.8	9.2	9.4	6.6	6.5	15.2	7.4	17.0	5.2	1.9	8.5	11.1	7.3	13.9	4.1	4.5	11.9	7.9	6.3	7.3	4.7	5.2	8.0	5.9	5.4	10.0	8.7	8.2	3.3	8.9	5.3	10.4	3.6	9.3	4.7	1.6	2.5	2.0	0.9	1.9	0.9	0.9	0.9	1.0	2.3	0.8	1.1	0.5	9.7	1.6	2.2	1.3	1.2	1.0	9.0	10.2	16.4	13.2	8.8	9.1	12.7	10.7	13.3	9.1	12.6	12.9	5.1	9.6	5.6	8.5	7.6	3.3	6.9	7.5	8.6	13.8	5.8	6.1	18.3	4.3	6.0	0.0	4.2	12.8	2.7	4.9	11.7	9.3	119.9	3.5	6.5	7.2	7.2	18.5	13.4	9.8	9.8	7.4	9.2	3.5	8.2	11.3	5.7	7.4	29.5	1.7	14.3	7.0	2.0	31.8	9.6	357.8	10.8	27.5	1.8	12.2	17.6	4.9	11.3	12.5	13.3	8.4	6.8	13.9	7.7	11.0	8.3	8.9	3.4	11.8	0.0	9.0	8.5	39.6	15.7	7.5	2.7	13.3	6.6	7.8	6.5	8.1
METTL23	"C17orf95, LOC124512"	ENSG00000181038	"Methyltransferase like 23"	Q86XA0	17	76726830-76733936	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 182.5;Spermatocytes: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022889			Approved	Vesicles		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA022889: "	"unprognostic (5.45e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (3.93e-7)"	"unprognostic (1.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.65e-1)"	30.8	32.7	20.4	24.2	22.8	27.3	30.6	22.5	27.9	28.7	24.2	26.0	22.6	25.8	34.7	23.9	27.7	19.8	28.5	20.1	21.4	39.1	47.3	26.7	42.7	21.9	22.0	29.4	42.2	35.1	33.3	19.7	22.7	28.1	27.4	22.9	29.1	21.9	34.7	29.2	30.7	23.5	22.3	48.1	30.0	51.6	21.9	36.9	42.1	25.9	40.4	26.1	24.7	26.1	68.3	58.4	32.6	30.0	79.2	66.5	31.3	33.7	68.2	43.5	41.9	29.5	47.1	38.0	32.2	43.0	56.7	37.6	23.8	61.0	48.9	19.2	55.8	49.5	38.0	56.6	77.4	35.1	41.7	64.0	57.3	54.0	74.6	68.5	69.1	46.5	48.1	46.0	53.1	38.5	44.3	30.1	24.2	75.2	65.3	29.9	54.5	106.5	63.0	33.9	30.9	44.5	33.8	51.6	123.3	78.8	72.3	43.7	25.8	49.8	24.9	48.9	59.9	63.2	26.0	38.6	47.5	25.0	46.3	23.0	28.9	34.1	48.0	30.3	53.6	51.3	53.0	53.5	32.1	44.7	50.2	51.1	9.4	51.8	27.9	48.3	57.6	34.5	20.4	22.8	22.5	27.9	20.1	21.4	21.9	22.0	22.7	22.3	21.9	26.1	39.5	28.9	14.5	8.5	49.6	16.4	47.2	64.8	42.1	13.9	34.9	48.4	17.7	27.1	35.6	20.2	10.4	42.9	50.7	11.7	119.3	42.0	182.5	31.7	23.4	28.0	22.8	22.3	4.2	39.5	41.1	26.6	24.5	25.9	31.1	21.8	25.7	49.9	57.0	6.7	5.4	24.5	40.7	33.3	23.5	54.5	32.6	33.9	24.9	8.4	50.1	38.6	81.4	7.5	13.4	33.2	26.3	25.9	49.2	33.2	27.5	87.8	32.7	23.7	52.6	28.1	43.0	198.9	49.5	32.2	16.2	17.2	55.3	53.3	32.1	34.1
METTL27	WBSCR27	ENSG00000165171	"Methyltransferase like 27"	Q8N6F8	7	73834590-73842516	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Distal tubular cells: 29.4;Ductal cells: 16.5;Endometrial ciliated cells: 66.7;Proximal tubular cells: 68.8;Respiratory ciliated cells: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.7;RPMI-8226: 82.2;T-47d: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA074662	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA074662: "	"unprognostic (6.70e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.24e-2)"	2.6	1.5	1.8	0.4	1.4	0.2	2.9	3.4	2.2	6.4	7.9	2.9	1.9	4.1	1.1	1.6	7.2	2.0	0.7	1.6	1.5	10.7	2.0	2.6	1.2	2.3	3.0	2.7	8.9	6.7	3.1	2.0	2.0	5.2	0.7	0.4	5.1	3.3	0.6	1.8	2.6	0.7	1.7	3.1	1.5	5.2	1.5	1.0	3.9	0.1	0.3	2.5	2.8	1.5	12.8	15.5	0.1	1.2	2.3	6.6	2.5	0.1	0.2	0.5	0.4	0.8	18.7	3.1	2.8	2.6	10.7	1.2	0.0	5.0	0.2	2.1	0.1	0.1	4.7	4.8	2.6	0.0	0.1	2.6	1.1	7.8	3.8	0.8	2.9	1.0	0.3	2.6	1.8	3.6	0.1	0.0	0.3	10.2	4.0	0.9	3.4	82.2	4.1	2.4	1.3	0.5	1.7	1.3	1.4	3.5	23.0	0.7	3.4	4.9	1.2	9.4	5.1	3.5	1.3	0.0	1.0	0.1	1.5	0.0	0.6	1.3	0.0	2.2	0.0	2.1	0.3	0.0	0.9	0.6	0.7	0.5	0.6	0.0	0.5	0.7	6.3	0.2	1.8	1.4	3.4	2.2	1.6	1.5	2.3	3.0	2.0	1.7	1.5	1.5	3.8	6.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.3	0.0	0.0	2.5	20.2	0.0	5.4	0.5	0.0	29.4	16.5	0.0	66.7	5.2	1.2	0.0	0.0	0.0	2.3	2.2	2.2	0.0	6.1	2.5	0.7	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	68.8	30.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.9	0.2	0.0	0.0
METTL6	MGC24132	ENSG00000206562	"Methyltransferase like 6"	Q8TCB7	3	15381275-15440566	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 223.0;Late spermatids: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035166	Uncertain		Approved	Vesicles		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA035166: AB_10602709"	"unprognostic (2.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (3.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	7.9	7.0	13.7	7.5	13.8	5.3	9.7	13.9	15.9	9.0	6.5	6.1	6.2	8.9	8.8	8.2	9.5	6.2	7.8	14.4	13.3	6.9	6.3	6.7	9.2	11.0	10.9	12.2	6.5	9.2	8.3	9.2	11.4	8.5	7.1	13.2	5.7	9.1	7.0	8.1	5.8	10.3	11.6	7.5	7.0	18.0	14.0	10.2	9.5	7.7	10.0	7.6	6.5	16.8	13.5	21.4	23.4	20.2	21.0	23.7	59.3	24.0	24.5	28.4	29.9	12.9	17.2	22.3	16.1	22.7	24.2	11.0	23.3	20.8	30.0	15.9	25.6	21.4	20.6	19.9	39.7	20.5	18.5	21.3	25.6	34.1	17.1	22.9	26.6	22.8	22.5	22.4	28.6	28.0	22.7	17.0	23.7	14.2	25.6	17.4	29.0	22.0	17.1	18.6	10.1	18.7	20.9	19.1	19.8	16.9	27.9	17.6	18.1	22.0	14.1	22.3	22.0	24.1	43.9	26.7	23.6	19.5	21.1	7.2	8.1	12.2	9.7	10.7	9.6	7.6	9.1	9.7	9.2	9.6	9.1	10.0	4.7	11.8	10.5	12.4	9.1	6.9	13.7	13.8	13.9	15.9	14.4	13.3	11.0	10.9	11.4	11.6	14.0	16.8	5.6	3.2	5.5	20.5	6.8	4.0	8.0	13.9	10.2	17.4	5.9	6.5	5.5	1.5	7.8	9.2	6.2	9.2	5.0	1.3	5.9	10.2	223.0	5.9	10.7	7.7	1.8	6.3	37.4	13.5	21.5	8.2	4.1	5.4	5.1	14.2	5.3	2.3	9.0	20.2	38.2	2.3	4.1	4.4	4.2	121.3	9.0	6.8	5.4	9.4	8.0	11.9	13.4	17.1	22.0	9.2	2.7	9.1	10.3	5.5	4.6	4.9	9.3	15.9	6.6	8.7	8.6	31.3	17.6	6.3	2.8	11.6	8.2	11.4	3.7	5.3
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681678-55684611	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1;heart muscle: 124.2;liver: 284.3"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 83.9;Hofbauer cells: 72.7;Proximal enterocytes: 192.4;Proximal tubular cells: 55.6"	"Cancer enhanced"	"Detected in many"		"glioma: 97.9;liver cancer: 97.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.5;myeloid DC: 7.0;naive B-cell: 1.7;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	45	"B-cells: 1.7;dendritic cells: 7.0;monocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 28.4;CAPAN-2: 56.6;EFO-21: 41.3;Hep G2: 28.7;LHCN-M2: 47.0;OE19: 32.5;THP-1: 42.2;U-87 MG: 41.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038644	Enhanced		Approved	Vesicles,Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Microtubules	Vesicles	"HPA038644: AB_2676130"	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (2.43e-1)"	2.1	1.7	5.5	1.8	5.9	1.2	0.9	4.9	10.8	0.4	5.9	28.5	59.6	0.4	133.1	0.1	3.1	11.7	124.2	13.1	5.9	52.1	284.3	1.6	2.3	8.4	5.5	0.1	2.9	0.2	3.1	10.9	5.0	0.3	23.6	1.3	0.5	0.8	7.4	0.9	55.3	2.1	5.7	4.3	4.2	0.7	11.6	0.2	3.3	10.0	0.5	1.3	0.1	7.7	0.4	21.8	0.1	0.5	4.3	15.3	0.3	0.8	3.2	0.2	1.4	28.4	56.6	11.6	41.3	1.2	1.1	0.1	4.1	0.3	0.8	0.0	5.4	1.2	3.2	28.7	0.0	0.6	0.0	4.0	0.0	1.0	0.0	4.2	0.0	0.0	0.2	0.0	47.0	20.2	0.0	0.4	5.7	32.5	2.7	0.0	1.5	2.7	0.5	0.1	0.1	0.3	2.2	0.0	3.9	0.2	3.8	42.2	0.0	3.1	3.5	0.4	2.9	0.0	0.6	3.5	41.9	9.9	0.2	0.0	0.8	0.0	0.0	4.5	0.0	0.5	0.0	0.0	7.0	1.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.4	5.5	5.9	4.9	10.8	13.1	5.9	8.4	5.5	5.0	5.7	11.6	7.7	0.0	0.0	1.5	0.7	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.1	26.5	22.8	0.6	0.0	0.0	0.5	0.0	29.0	3.9	3.9	0.0	0.1	0.0	0.5	1.2	4.0	0.7	5.1	0.5	2.0	2.6	0.2	0.0	0.8	1.1	83.9	72.7	0.0	0.1	14.0	0.0	17.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	4.6	20.7	1.2	0.0	0.1	192.4	55.6	0.0	0.0	0.0	7.8	0.6	0.0	0.1	0.0	0.0	0.7	0.3	0.1	22.2	0.1
MEX3B	"DKFZp434J0617, RKHD3, RNF195"	ENSG00000183496	"Mex-3 RNA binding family member B"	Q6ZN04	15	82041778-82046119	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 14.0;testis: 46.8"	"Group enriched"	"Detected in many"	8	"Early spermatids: 204.7;Granulosa cells: 99.5;Late spermatids: 201.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 65.9;HEL: 49.2;SH-SY5Y: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041093	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA041093: AB_10793868"	"unprognostic (2.42e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.93e-8)"	"unprognostic (1.24e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.51e-2)"	2.2	0.4	1.7	1.5	1.6	2.0	1.5	2.8	2.8	14.0	0.0	3.4	0.6	6.2	0.5	0.9	1.3	2.5	2.7	1.8	0.7	0.7	0.9	1.5	2.7	0.7	0.9	5.6	0.6	0.2	0.8	2.3	0.7	2.5	0.7	0.8	2.6	3.2	1.6	1.1	1.1	1.4	0.3	1.1	1.0	46.8	1.9	6.4	0.8	2.0	1.0	1.4	4.1	1.0	0.2	2.5	17.2	65.9	1.4	2.0	4.9	2.1	1.0	3.6	3.2	0.5	0.4	3.2	1.2	3.9	1.1	0.5	8.2	0.3	2.5	0.7	5.3	49.2	2.8	2.2	2.8	0.6	15.1	1.0	1.3	2.0	4.0	8.4	7.6	6.1	2.4	0.0	6.2	1.6	8.3	4.2	22.4	0.1	0.6	11.4	10.4	1.7	0.1	0.0	13.7	26.2	3.5	0.6	2.4	4.8	0.2	0.8	6.9	9.0	10.3	5.0	3.1	6.1	3.4	3.7	2.9	5.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	2.8	2.8	1.8	0.7	0.7	0.9	0.7	0.3	1.9	1.0	3.6	0.0	0.6	0.0	1.3	2.8	0.4	1.4	5.2	3.1	6.0	8.0	4.5	1.5	0.4	0.0	2.1	11.3	1.6	0.7	0.0	0.8	204.7	1.8	13.5	5.3	1.2	7.2	2.1	0.2	8.7	8.3	0.5	1.3	1.3	99.5	2.5	0.2	1.5	0.0	3.4	1.0	0.0	1.0	9.8	201.1	6.5	5.0	7.2	1.0	0.5	5.2	0.0	4.0	1.3	0.5	0.2	4.5	0.8	0.8	0.0	0.0	0.3	2.9	6.6	1.9	16.8	2.7	18.8	5.8	2.0	2.5	2.0	1.0	1.4	0.2
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824690	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	15.9	24.0	17.5	17.6	18.0	12.9	21.4	21.3	23.2	16.6	19.7	17.1	14.5	18.8	23.4	22.2	18.4	14.9	22.1	17.7	19.3	23.7	18.1	15.2	26.6	18.3	19.3	24.8	15.3	33.2	14.5	23.2	18.7	22.8	18.1	25.0	17.0	17.7	26.3	20.5	15.0	19.1	17.7	17.1	16.8	19.3	18.5	24.4	24.7	23.2	32.4	20.6	17.5	19.1	40.1	41.0	69.4	46.0	57.9	36.3	42.7	63.1	43.8	50.3	58.2	64.1	25.6	42.8	58.7	39.4	50.9	70.8	62.5	51.7	58.9	72.9	37.6	103.7	71.6	48.5	45.4	62.3	53.2	34.1	55.3	48.0	43.3	48.0	49.8	48.3	95.8	35.7	60.9	30.0	51.1	47.0	49.2	74.2	35.4	73.9	69.6	27.6	52.0	59.0	43.8	43.0	55.6	47.0	27.0	55.2	70.7	39.5	47.4	50.6	35.8	56.3	51.7	43.5	112.2	91.8	42.5	58.4	37.9	42.5	25.5	56.9	35.3	34.8	34.7	35.0	35.1	33.6	32.6	28.3	35.7	35.0	22.6	50.5	29.1	26.8	44.1	26.3	17.5	18.0	21.3	23.2	17.7	19.3	18.3	19.3	18.7	17.7	18.5	19.1	30.4	35.3	30.2	5.2	32.8	30.3	59.6	50.1	35.9	41.8	22.4	28.8	31.0	25.8	43.2	51.5	6.2	94.6	33.2	27.4	56.7	44.2	6.2	43.1	39.9	35.6	11.3	32.0	9.0	29.4	55.0	29.8	21.4	39.4	46.3	37.6	20.7	18.8	35.4	32.0	8.6	24.4	38.7	20.7	20.5	6.3	28.0	25.5	26.6	5.6	30.6	51.5	33.0	2.0	8.2	26.8	27.1	35.7	20.6	39.3	22.1	42.9	60.0	35.2	19.7	35.9	41.7	49.7	84.8	28.1	27.7	147.4	33.6	39.4	21.3	50.6
MFF	"C2orf33, GL004"	ENSG00000168958	"Mitochondrial fission factor"	Q9GZY8	2	227325151-227357836	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 985.9;Late spermatids: 1746.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010968, HPA074625"	Enhanced		Supported	Mitochondria		No	No		62000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA010968: AB_1845714, HPA074625: AB_2686704"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.22e-1)"	52.3	58.0	61.2	29.3	66.6	48.1	46.9	67.4	71.8	49.0	63.5	60.9	41.0	46.6	37.9	48.4	49.0	31.0	66.2	60.0	67.3	68.8	44.2	38.9	39.4	66.4	61.7	51.6	57.2	60.0	42.7	33.4	66.1	42.5	40.9	80.4	43.8	47.9	100.4	44.8	40.5	42.3	67.3	38.7	49.0	199.2	63.5	51.5	37.1	86.5	44.5	50.1	45.9	74.5	71.1	60.6	72.4	100.5	92.7	88.6	95.3	69.1	93.7	82.6	88.7	66.4	49.8	40.3	80.1	76.9	87.5	57.8	121.0	88.5	112.6	86.4	97.3	85.8	144.5	165.0	122.4	84.2	73.6	79.6	113.9	79.0	84.3	109.6	72.7	91.6	76.7	117.8	75.3	72.5	88.9	127.3	98.6	76.7	62.5	79.0	91.8	78.7	124.2	66.5	76.3	70.8	153.3	68.7	106.7	59.4	44.8	82.0	49.7	80.6	67.0	119.2	78.3	95.2	69.6	81.9	106.1	73.6	111.7	118.5	66.8	133.6	65.2	74.0	69.9	84.0	67.5	63.9	72.0	77.9	70.4	60.2	65.1	67.7	70.0	71.9	97.5	76.3	61.2	66.6	67.4	71.8	60.0	67.3	66.4	61.7	66.1	67.3	63.5	74.5	40.4	32.1	46.7	53.8	74.8	48.3	62.1	70.3	90.5	33.1	54.9	64.1	79.3	44.3	57.0	60.7	31.3	95.3	49.8	46.2	127.2	95.2	985.9	36.7	40.3	45.6	32.3	73.6	95.8	94.8	89.8	67.6	42.8	52.0	22.1	66.4	43.5	56.1	78.4	40.4	97.7	60.3	61.1	61.5	56.4	1746.9	88.0	63.0	81.8	47.8	64.0	204.4	74.2	135.2	151.3	91.7	63.8	85.7	127.7	66.5	69.5	135.7	32.3	65.5	59.2	69.1	62.1	392.3	96.9	87.6	47.3	91.9	57.2	63.7	73.0	71.6
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12015211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 270.4;skeletal muscle: 310.5;tongue: 337.6"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	34.7	31.4	39.9	20.9	42.4	26.7	31.8	39.1	41.4	29.3	17.4	59.7	41.9	37.0	12.7	57.3	26.2	21.8	270.4	34.7	43.0	36.5	58.5	31.1	19.8	41.1	44.8	27.0	22.5	76.7	28.7	27.6	40.6	36.3	38.1	35.0	32.2	62.3	310.5	58.9	46.3	41.2	43.5	31.5	44.9	25.4	48.8	26.1	56.1	337.6	30.4	51.2	36.2	40.5	93.6	54.0	52.6	72.7	59.7	47.2	58.8	76.0	66.1	96.5	72.6	88.7	51.8	68.8	74.8	92.6	60.6	80.5	101.7	156.1	90.6	60.6	75.4	94.5	81.8	54.2	53.8	114.2	51.9	57.0	105.1	133.1	124.5	40.1	66.2	26.4	106.1	53.6	69.7	30.2	60.2	15.2	39.7	57.8	77.4	68.2	95.8	58.5	44.9	61.4	68.2	44.6	88.4	81.0	74.6	41.4	43.8	49.2	71.2	63.1	58.3	88.4	71.2	59.0	86.4	120.7	69.0	99.6	69.8	10.4	11.5	7.6	8.9	14.0	10.2	6.7	6.7	7.9	9.7	4.8	5.0	6.2	16.2	6.2	18.3	4.2	8.1	15.7	39.9	42.4	39.1	41.4	34.7	43.0	41.1	44.8	40.6	43.5	48.8	40.5	18.1	22.4	15.8	16.6	10.2	22.8	9.4	18.9	19.9	26.7	17.4	16.4	336.9	7.2	14.9	14.7	12.5	15.1	12.5	39.2	21.5	13.6	4.7	8.9	12.1	18.5	18.0	32.4	21.5	20.4	15.5	17.3	17.3	12.8	10.8	12.8	11.7	46.3	16.0	30.3	24.5	22.2	18.3	23.9	9.7	8.0	7.2	19.1	17.8	8.4	17.3	14.6	8.2	11.1	16.7	18.5	16.8	15.1	10.9	13.9	41.8	14.3	12.9	21.0	13.1	16.0	16.5	25.9	15.6	25.1	30.1	25.2	10.3	12.5	26.4	16.6
MFNG		ENSG00000100060	"MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	O00587	22	37469063-37486393	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.4;dendritic cells: 54.6;Endothelial cells: 37.1;Hepatic stellate cells: 53.2;Kupffer cells: 45.8;monocytes: 40.6;NK-cells: 72.1;T-cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 174.6;HEL: 143.4;HL-60: 220.9;HMC-1: 266.9;HUVEC TERT2: 232.9;TIME: 134.7;U-698: 166.8;U-937: 201.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048936, HPA056479"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		74000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA048936: AB_2680564, HPA056479: "	"unprognostic (1.21e-1)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (5.12e-4)"	"prognostic favorable (1.65e-4)"	"unprognostic (6.41e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (2.67e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	22.2	7.1	8.9	37.0	8.9	40.3	14.8	8.4	10.8	8.9	6.4	10.5	8.6	9.7	2.4	7.5	11.0	14.5	14.6	7.9	9.2	9.5	7.1	26.3	69.1	18.1	10.8	3.1	3.9	2.6	3.1	30.3	20.5	6.6	7.8	0.7	5.4	5.7	7.5	5.0	24.0	11.5	10.2	58.9	8.6	2.9	11.0	50.5	9.6	8.8	42.5	13.9	6.2	10.3	6.0	2.2	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	7.1	3.0	174.6	0.7	0.0	0.8	10.8	45.1	8.7	0.2	81.6	1.0	143.4	0.6	1.5	0.6	220.9	266.9	0.0	2.6	1.7	3.2	0.9	232.9	69.0	0.7	73.8	0.0	1.5	27.8	3.0	0.4	6.1	1.0	67.0	1.8	128.7	0.4	0.1	94.1	0.9	0.5	0.3	0.3	0.8	1.3	14.1	134.7	0.0	5.8	22.8	0.6	0.4	0.4	166.8	1.1	201.1	2.7	210.3	198.9	386.5	196.1	196.1	214.5	103.0	222.7	206.1	204.1	113.5	243.4	209.9	127.9	217.1	218.7	51.7	284.3	314.0	8.9	8.9	8.4	10.8	7.9	9.2	18.1	10.8	20.5	10.2	11.0	10.3	51.4	0.0	3.8	0.0	35.4	3.7	0.4	0.2	0.0	6.3	1.0	1.3	1.6	5.7	3.1	0.0	0.0	0.3	54.6	1.1	0.0	2.9	0.2	0.4	0.2	37.1	1.2	30.1	0.1	0.9	0.3	1.1	2.0	1.0	31.6	0.1	53.2	1.5	31.9	0.0	0.1	2.1	0.0	45.8	20.2	0.3	0.0	33.5	3.6	6.5	40.6	0.1	72.1	0.0	0.0	3.7	4.0	0.0	35.0	0.5	2.3	0.3	0.1	0.6	0.0	1.6	1.0	0.1	0.7	0.3	2.4	0.7	51.0	0.1	0.8	0.4
MFSD10	"IT10C3, TETRAN"	ENSG00000109736	"Major facilitator superfamily domain containing 10"	Q14728	4	2930561-2934834	"Predicted membrane proteins"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 251.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 275.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043209	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"	Nucleoplasm	"HPA043209: AB_2678364"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.76e-2)"	"unprognostic (9.43e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (8.32e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.00e-2)"	35.2	20.2	15.8	9.9	16.4	66.1	30.5	13.6	24.1	43.1	19.3	30.3	12.3	34.7	3.3	27.6	36.9	12.5	26.5	16.1	14.4	33.6	10.8	36.9	13.2	16.9	14.7	41.6	29.0	3.6	28.7	11.5	14.7	34.3	3.8	1.1	30.4	11.3	14.0	22.0	31.0	7.6	13.2	36.1	31.6	15.6	17.6	6.3	37.6	3.4	6.3	34.6	32.8	14.3	50.4	46.2	13.3	33.7	21.7	15.5	36.0	45.1	21.9	21.5	24.6	24.7	117.3	8.8	23.7	28.4	40.0	45.9	12.1	65.6	5.8	56.9	40.7	19.1	39.2	25.9	36.5	59.9	27.1	23.5	37.5	24.5	15.4	33.4	24.7	20.0	26.4	18.0	16.5	53.8	16.9	275.6	43.0	38.9	54.5	20.7	6.4	41.8	32.9	30.6	34.2	40.7	10.8	31.5	49.1	13.5	82.9	112.9	37.1	17.7	30.4	22.2	36.6	12.2	5.8	13.8	50.0	153.3	27.8	64.7	55.0	117.4	73.0	71.2	62.6	45.1	46.8	82.1	57.4	35.2	23.3	41.1	44.2	45.9	95.8	45.7	34.4	42.6	15.8	16.4	13.6	24.1	16.1	14.4	16.9	14.7	14.7	13.2	17.6	14.3	64.6	38.5	29.1	17.6	41.3	31.4	78.8	251.5	28.5	9.2	56.3	68.1	5.0	28.6	123.2	46.0	8.4	67.4	71.0	37.8	3.9	96.0	11.7	41.5	33.4	41.1	28.2	13.3	21.5	45.9	93.0	42.9	33.6	44.3	32.4	50.7	45.7	3.1	69.6	15.2	14.8	37.2	93.6	49.3	36.7	18.8	36.4	45.6	42.7	9.4	62.1	11.0	64.9	9.5	8.8	86.0	51.5	22.6	28.1	92.1	60.0	17.9	104.9	10.0	92.1	27.0	56.6	15.5	16.1	26.9	26.9	83.7	62.4	44.7	49.4	100.5
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266165-139280225	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 228.0;retina: 116.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 151.3;Granulosa cells: 93.5;Horizontal cells: 208.6;Muller glia cells: 508.9;Theca cells: 474.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 20.4;fHDF/TERT166: 30.7;HHSteC: 23.6;HUVEC TERT2: 61.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015994, HPA070835"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA015994: AB_2630370, HPA070835: "	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"	9.4	228.0	3.2	0.3	3.2	0.1	1.8	7.8	4.6	2.0	3.1	1.0	0.2	5.0	1.8	0.4	2.2	0.9	3.0	3.1	4.0	1.8	0.2	0.7	0.9	3.7	4.0	23.9	0.3	0.2	11.8	0.3	3.7	2.6	0.3	116.9	0.4	4.0	0.8	0.4	0.3	3.8	3.2	0.8	0.4	8.6	3.6	0.3	0.8	0.3	0.6	1.1	2.5	3.6	0.0	1.1	0.6	0.5	1.5	0.7	0.1	20.4	0.1	3.0	0.1	0.1	0.2	0.1	0.2	30.7	8.7	0.5	4.4	0.1	1.7	0.0	2.0	0.0	0.1	0.2	23.6	0.2	0.2	7.2	0.7	3.3	0.2	7.1	61.7	0.2	0.4	0.4	5.1	0.1	0.8	0.5	1.1	0.4	0.1	0.1	0.0	0.0	0.7	0.3	0.6	1.2	0.0	0.0	0.2	0.3	0.0	0.4	0.5	0.1	0.1	0.0	0.0	0.8	0.7	0.5	8.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.2	7.8	4.6	3.1	4.0	3.7	4.0	3.7	3.2	3.6	3.6	0.6	0.0	0.0	0.0	0.2	1.7	0.7	0.4	1.2	151.3	0.7	10.8	3.5	0.0	0.1	0.0	8.4	0.2	0.3	0.1	1.9	0.0	0.3	0.8	1.2	1.1	0.0	0.0	1.3	0.0	0.2	10.7	0.0	0.3	0.0	93.5	0.4	0.4	0.5	208.6	2.5	0.0	0.0	0.0	0.3	0.6	17.1	0.6	0.0	0.0	0.0	508.9	2.1	5.0	0.7	0.1	0.0	24.8	0.3	0.3	0.1	9.2	0.0	32.6	0.0	1.9	3.4	0.8	0.4	0.7	0.9	0.3	0.6	474.8	0.1	0.3
MGAT4A	"GnT-4a, GnT-Iva"	ENSG00000071073	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A"	Q9UM21	2	98619106-98731132	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 175.2;Proximal enterocytes: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 127.2;HUVEC TERT2: 48.3;JURKAT: 86.5;TIME: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007608	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA007608: AB_10602008"	"prognostic unfavorable (4.30e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.48e-8)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.04e-1)"	11.2	7.8	13.2	20.8	17.8	96.0	12.5	26.1	15.6	8.9	15.1	24.4	29.5	5.8	3.7	6.3	7.0	12.7	7.6	13.1	15.2	27.5	9.7	16.9	21.1	16.4	15.8	3.2	38.8	28.0	9.8	19.6	15.5	7.5	25.5	5.4	25.9	6.4	3.8	4.1	43.8	11.5	18.1	8.1	11.3	6.3	15.5	20.5	8.7	4.7	18.2	13.1	4.7	22.9	8.8	1.7	3.4	7.3	0.0	0.0	127.2	0.0	0.1	0.9	0.0	21.0	10.6	0.0	18.9	0.0	2.4	0.4	7.2	1.0	0.2	10.6	7.9	0.5	0.0	36.7	0.2	17.8	6.4	0.0	4.7	0.0	0.7	0.3	48.3	86.5	1.6	9.2	0.0	17.3	39.3	30.9	1.1	7.6	1.4	9.8	0.0	10.5	24.8	17.6	10.4	3.3	2.5	32.2	4.8	9.2	7.6	23.8	78.8	0.0	4.0	0.1	2.6	3.2	7.6	2.2	0.0	26.7	0.6	7.0	5.1	12.7	20.8	1.0	27.5	3.6	25.2	23.7	3.8	2.5	32.6	27.2	14.0	15.3	2.5	17.1	16.0	12.5	13.2	17.8	26.1	15.6	13.1	15.2	16.4	15.8	15.5	18.1	15.5	22.9	80.8	54.5	25.7	19.2	22.7	9.9	21.1	6.1	11.4	19.8	28.2	15.6	13.4	11.5	17.6	22.0	4.2	6.2	116.9	92.4	21.5	20.8	12.7	14.2	3.8	39.8	53.0	6.3	58.0	29.8	77.9	7.2	19.4	35.1	13.3	5.1	18.9	10.4	57.2	48.8	48.6	41.3	34.6	33.9	18.3	17.5	2.5	54.5	10.6	175.2	21.0	13.4	89.6	36.7	42.0	21.6	58.2	2.2	31.4	17.8	132.4	27.3	7.1	4.8	6.6	6.8	4.9	2.5	7.7	8.6	10.5	14.9	112.2	0.7	40.9	30.2
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B"	Q3V5L5	17	76868404-76950393	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 12.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.0;Early spermatids: 7.3;Excitatory neurons: 26.2;Inhibitory neurons: 21.9;Late spermatids: 8.1"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 12.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 32.1;SCLC-21H: 15.9;U-138 MG: 19.2;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	0.2	0.2	2.4	0.2	2.1	0.1	0.1	0.0	12.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.0	5.2	0.0	0.2	0.0	0.3	0.1	0.3	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	1.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	3.7	32.1	6.4	3.4	0.0	0.0	3.7	0.4	1.3	11.7	6.9	0.1	0.7	0.0	2.5	1.5	13.7	0.2	1.6	0.2	3.0	0.1	0.5	0.0	1.7	0.1	0.0	0.0	0.2	0.1	0.2	0.0	1.8	5.2	2.0	0.7	0.2	0.0	0.0	1.5	0.1	0.0	1.8	0.8	3.5	4.8	5.6	7.1	8.9	0.1	15.9	6.1	5.5	2.4	5.0	0.4	0.2	0.2	5.8	19.2	20.9	0.3	6.3	0.0	0.0	0.7	0.6	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	12.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.0	0.1	0.1	0.1	0.0	0.0	5.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.1	0.1	0.8	0.0	0.0	26.2	0.0	3.2	0.2	0.0	0.2	0.0	0.6	0.7	0.0	0.1	0.0	21.9	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	2.8	0.0	0.2	0.0	5.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	1.1	2.4	0.0	0.0	0.1	0.1	0.2	0.0	0.0
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1096.9;adrenal gland: 1137.3;liver: 3104.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1205.9;Club cells: 1308.7;Hepatocytes: 4345.6;Proximal tubular cells: 1265.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 170.2;myeloid DC: 123.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 123.5;monocytes: 170.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 5391.4;ASC TERT1: 2078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA		19000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	1096.9	1137.3	139.2	76.1	143.9	79.3	574.8	131.4	200.7	69.7	111.9	315.5	128.9	32.7	43.9	195.3	78.4	200.8	135.1	133.9	165.4	392.9	3104.7	177.2	3.5	156.5	155.7	11.4	131.3	0.8	52.6	14.2	166.6	161.2	212.8	7.0	155.3	55.8	25.5	88.8	119.5	44.7	146.4	7.3	131.4	20.2	147.5	14.0	272.3	43.3	7.7	267.9	114.7	132.9	1.4	495.2	115.6	139.4	5391.4	2078.4	1.5	408.5	418.5	220.6	339.1	186.0	838.6	0.4	48.5	535.8	694.2	2.4	317.0	663.5	202.9	1.1	41.4	175.7	256.6	664.8	1252.0	350.4	1.2	1375.9	714.7	671.2	710.5	540.4	393.1	0.1	126.7	0.6	486.3	101.2	0.3	137.0	987.6	0.7	391.2	0.4	69.3	229.3	503.3	982.1	21.8	17.1	645.8	411.8	17.5	630.1	442.5	190.8	248.0	226.1	30.5	447.3	541.1	0.6	1.7	1.5	748.1	538.5	7.1	11.3	170.2	1.8	0.1	26.3	0.5	1.0	0.2	0.1	123.5	0.0	0.1	0.1	5.9	0.2	5.9	34.1	1.1	55.9	139.2	143.9	131.4	200.7	133.9	165.4	156.5	155.7	166.6	146.4	147.5	132.9	39.6	266.0	651.3	130.2	14.0	25.6	130.2	1205.9	91.0	0.0	383.8	262.6	5.1	574.7	1308.7	71.7	0.0	2.9	9.8	288.1	181.9	26.9	25.4	299.9	198.2	19.6	45.6	92.8	4.4	434.1	218.1	404.5	153.9	947.9	34.1	26.3	67.5	4345.6	160.2	0.0	0.5	280.5	740.6	176.4	52.0	17.9	33.2	75.7	39.2	6.5	224.4	1.0	5.2	1.0	0.8	322.7	175.0	113.2	6.0	467.2	209.5	1265.6	526.1	1.3	0.0	11.3	124.3	0.7	2.3	510.3	17.6	7.9	22.1	152.4	534.1	883.3
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 441.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 194.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 276.3;OE19: 558.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010690, HPA010707"	Enhanced		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Endoplasmic reticulum"	"HPA010690: , HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	61.8	92.7	43.5	30.4	42.9	42.6	66.6	45.1	60.6	63.6	54.8	112.5	132.5	39.2	82.1	177.6	70.8	87.6	118.3	42.6	45.7	99.2	393.2	49.0	36.0	46.6	44.6	26.3	66.2	102.0	44.6	75.6	46.5	74.9	121.2	7.8	90.6	50.0	104.2	97.1	143.5	57.4	46.6	60.5	72.5	50.6	45.3	35.1	45.8	118.4	64.6	86.7	78.4	48.9	40.8	58.5	28.7	0.3	4.8	15.4	17.7	7.2	66.1	3.2	10.7	62.3	276.3	0.1	158.2	17.5	13.6	74.8	52.7	81.2	4.9	22.3	47.7	174.9	57.3	251.5	13.3	152.7	130.0	53.0	197.2	2.1	12.5	63.9	166.3	0.3	75.9	25.7	23.3	33.9	0.2	24.7	6.5	558.9	59.4	12.7	33.4	54.0	153.0	87.4	71.9	21.6	53.2	83.2	64.8	2.0	52.9	202.2	104.9	5.6	27.3	7.8	6.4	29.7	22.5	9.7	3.8	254.8	12.6	43.8	103.8	30.4	4.1	64.8	2.9	1.3	7.6	3.5	147.0	2.4	2.3	2.6	17.7	26.4	22.2	194.6	37.7	39.4	43.5	42.9	45.1	60.6	42.6	45.7	46.6	44.6	46.5	46.6	45.3	48.9	327.9	25.6	36.6	5.5	7.7	61.1	295.9	316.7	75.7	7.8	99.1	57.3	100.5	205.9	185.5	95.6	25.0	85.3	71.0	168.3	90.1	121.0	6.3	132.5	27.1	238.4	121.8	60.2	19.4	138.6	62.8	31.8	90.2	172.9	43.2	56.9	203.1	419.3	378.1	6.7	24.2	215.1	170.9	107.8	77.8	12.8	44.4	85.3	39.2	49.6	83.6	14.1	27.8	11.6	4.7	121.8	213.1	33.4	7.1	94.6	441.1	277.2	126.6	3.5	13.1	44.6	49.6	4.6	15.1	264.0	124.9	67.2	15.2	43.6	258.2	344.9
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA SH3 domain ER export factor 3"	Q5JRA6	1	222618097-222668007	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA055922, HPA056816"	Supported		Enhanced	Vesicles		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA055922: AB_2682971, HPA056816: AB_2683243"	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	25.6	22.0	11.0	23.4	13.1	33.2	21.4	12.9	14.9	23.9	13.2	24.3	23.9	23.7	29.2	13.7	16.0	20.6	20.6	10.9	13.6	21.1	74.5	21.5	26.9	10.8	12.3	25.4	38.7	30.1	15.2	23.1	11.7	39.3	29.5	24.4	33.2	22.1	23.7	17.4	25.9	23.8	10.7	27.3	45.0	36.5	11.5	25.7	31.7	20.5	26.2	21.0	14.1	12.8	24.8	18.8	26.5	42.5	92.8	47.1	46.5	34.8	49.4	36.2	43.1	16.6	26.2	24.0	33.0	41.8	20.5	39.9	28.5	31.3	37.8	38.1	21.6	27.7	21.5	31.5	88.6	50.7	34.7	45.2	35.0	35.9	60.8	44.8	41.4	28.9	34.8	44.4	30.7	15.9	34.3	33.8	33.2	76.8	27.5	24.4	70.8	47.8	23.1	22.8	30.4	31.3	38.6	36.2	30.4	36.2	38.2	37.5	31.7	27.5	17.9	44.5	41.3	48.4	30.9	23.8	36.7	25.4	37.5	26.8	15.6	36.5	17.6	22.4	17.7	20.7	14.7	17.5	11.7	18.6	16.4	17.8	27.1	22.5	26.0	13.2	19.2	13.5	11.0	13.1	12.9	14.9	10.9	13.6	10.8	12.3	11.7	10.7	11.5	12.8	48.5	70.5	49.6	31.3	46.9	18.7	26.8	20.4	29.0	60.9	24.3	35.3	65.0	25.8	47.1	5.5	31.3	28.6	73.8	35.2	0.0	25.1	37.0	34.9	72.5	36.4	60.4	26.3	51.4	34.8	17.0	53.0	79.5	42.0	17.7	44.2	25.4	63.3	20.4	45.4	58.0	95.3	32.6	22.0	14.0	24.9	37.0	32.9	19.6	35.6	32.1	31.8	44.3	41.2	29.1	26.4	25.8	48.9	54.4	39.0	41.3	19.4	44.7	41.5	19.7	57.9	46.6	55.7	42.1	21.9	16.1	35.8	47.8	70.2	24.6	29.4
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024561	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.5;Inhibitory neurons: 164.6;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 104.9"	"Immune cell enriched"	"Detected in some"	4	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in all"		"WM-115: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	15.9	12.0	18.3	14.9	20.3	17.3	11.2	104.9	34.5	16.5	3.6	28.1	11.0	31.0	17.0	19.6	38.6	13.4	35.6	14.3	13.7	10.9	18.8	8.3	23.0	13.2	6.4	26.5	14.0	38.5	7.2	16.7	15.6	16.4	20.6	14.1	10.9	19.8	48.2	18.9	14.5	37.3	1.9	17.8	10.7	24.4	12.7	6.0	14.7	20.8	20.3	15.9	12.0	45.9	34.0	39.6	20.2	33.7	15.6	19.2	25.6	32.6	33.1	43.6	34.5	36.1	4.8	35.1	15.5	39.3	51.2	38.7	30.1	31.9	43.0	35.6	25.2	35.9	44.6	11.9	9.6	17.1	20.2	14.4	25.9	46.9	43.7	25.2	24.9	9.7	47.6	22.8	16.9	26.6	16.9	10.7	13.0	27.3	26.4	23.2	30.3	1.9	32.1	24.8	53.5	21.1	40.6	26.0	65.2	31.5	10.8	7.0	43.9	46.0	28.4	29.7	63.6	16.4	30.2	50.8	40.0	7.7	131.6	11.1	0.0	0.1	0.3	0.0	0.6	2.5	0.3	0.3	0.0	2.6	0.2	0.1	0.1	0.9	0.0	0.2	0.7	0.2	18.3	20.3	104.9	34.5	14.3	13.7	13.2	6.4	15.6	1.9	12.7	45.9	19.6	3.2	10.2	57.1	32.1	11.2	15.2	17.9	13.1	20.9	13.7	15.5	16.5	12.8	13.2	12.9	52.1	14.1	6.2	43.5	0.0	23.9	10.5	36.4	10.2	16.4	10.2	19.3	176.5	9.8	40.3	10.5	13.3	38.8	19.0	9.7	8.9	37.3	3.1	1.7	164.6	20.8	8.2	3.2	9.6	13.9	4.1	4.2	8.8	23.4	6.0	38.2	5.2	71.9	216.0	24.6	23.6	6.4	12.5	14.4	19.8	5.5	27.8	12.2	0.0	11.0	12.1	19.8	13.8	11.2	11.8	11.2	9.1	24.2	21.5	10.1
MIDN		ENSG00000167470	Midnolin	Q504T8	19	1248553-1259140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 455.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 11.8"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 11.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042018, HPA049432"	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA042018: AB_2677800, HPA049432: AB_2680765"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.19e-2)"	71.4	61.9	25.6	25.2	25.0	82.6	42.7	24.9	32.3	48.0	16.1	53.9	22.3	34.2	6.3	99.2	64.6	31.4	72.9	21.1	32.1	46.9	50.5	67.0	19.1	44.8	30.1	61.4	37.4	8.2	81.9	15.5	29.8	39.2	12.0	12.4	46.6	11.5	141.6	79.1	52.6	12.4	29.8	50.3	56.1	19.6	32.4	19.0	35.0	17.4	15.1	42.2	55.7	23.1	14.7	31.8	53.5	25.0	11.2	19.0	39.2	25.0	14.9	12.6	8.9	41.8	16.1	23.3	26.6	18.9	6.8	29.6	16.3	26.5	4.9	32.9	30.0	32.8	21.8	33.3	22.7	33.3	46.9	29.4	24.4	15.1	14.3	19.5	20.8	27.3	42.7	24.0	13.5	58.9	44.6	13.6	117.6	28.6	21.1	68.8	15.2	10.7	23.8	17.2	42.7	55.9	52.9	50.1	33.7	27.7	20.2	37.7	26.2	22.9	25.4	106.2	27.3	22.4	13.2	32.2	43.9	14.6	79.5	1.6	1.0	1.1	1.0	1.0	0.7	0.2	0.3	0.7	0.4	0.3	0.2	0.5	11.8	1.3	1.1	0.4	0.1	0.7	25.6	25.0	24.9	32.3	21.1	32.1	44.8	30.1	29.8	29.8	32.4	23.1	330.7	38.5	60.5	17.3	101.1	98.9	128.3	114.4	175.8	53.9	290.6	224.2	84.3	117.2	86.2	134.3	31.3	15.8	184.8	455.8	19.6	125.5	34.7	220.6	84.5	186.1	164.5	19.4	8.0	155.5	47.3	84.0	132.0	294.7	61.5	60.6	197.4	80.9	77.9	21.9	5.6	219.5	59.0	100.0	134.9	33.3	49.7	150.9	42.7	24.4	49.7	77.8	96.8	32.2	10.3	259.0	306.8	33.1	69.9	190.9	242.1	35.8	109.6	35.7	39.5	219.8	142.4	3.3	12.0	227.3	148.0	81.3	122.9	33.2	167.8	190.7
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894383-23895227	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 2032.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 4974.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	No	13800000	5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	233.3	467.9	195.8	119.5	200.0	146.0	223.3	209.3	450.0	235.0	204.3	194.3	98.9	205.3	49.8	514.2	219.4	20.9	290.8	245.2	289.7	530.3	484.6	208.2	61.5	225.2	224.7	223.7	255.7	127.8	368.0	100.4	217.2	318.7	35.2	23.8	233.6	132.8	99.3	302.5	171.7	43.4	250.8	204.5	230.7	113.5	204.2	65.0	274.0	19.5	46.2	255.8	316.7	369.4	1698.3	605.3	122.2	499.0	58.9	111.3	590.7	581.2	154.7	298.9	382.1	526.4	364.4	761.3	499.8	83.1	115.2	788.1	155.0	546.8	51.5	642.2	4974.4	286.2	534.6	1126.5	225.3	1077.2	758.6	230.9	354.9	173.8	103.5	248.8	241.3	589.4	466.9	540.1	122.2	1476.0	827.0	2345.5	532.8	488.6	2365.8	1040.4	127.9	2398.8	294.7	179.6	1080.9	1290.4	380.3	531.9	1374.7	37.6	671.2	442.6	424.7	232.5	1227.9	127.3	9.9	1647.2	732.5	1020.9	967.5	484.6	477.9	484.2	543.5	443.5	872.4	579.5	1250.8	1527.9	1221.7	983.3	796.9	1378.9	1040.4	928.4	166.8	1158.9	383.3	977.1	1258.3	1803.3	195.8	200.0	209.3	450.0	245.2	289.7	225.2	224.7	217.2	250.8	204.2	369.4	161.2	157.0	199.4	21.5	433.4	672.2	295.5	1134.8	1027.2	28.3	856.0	778.2	0.3	479.0	489.1	693.4	2.1	462.7	171.3	317.9	1649.4	859.0	190.5	733.7	485.3	248.5	348.9	455.7	17.1	377.7	885.0	336.2	606.5	844.3	180.3	192.2	261.6	885.2	278.8	21.9	24.1	432.5	697.8	207.7	505.2	153.9	336.1	232.6	773.7	19.7	217.0	59.5	155.5	17.6	52.8	649.9	360.4	302.8	1337.1	269.8	476.8	2032.7	404.6	33.2	138.1	338.1	349.7	21.3	124.2	1511.3	758.8	686.0	386.3	227.6	473.0	256.1
MINDY1	"FAM63A, FLJ11280, MINDY-1"	ENSG00000143409	"MINDY lysine 48 deubiquitinase 1"	Q8N5J2	1	150996086-151008375	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Distal tubular cells: 39.2;Ductal cells: 11.6;Proximal tubular cells: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 98.4;eosinophil: 56.2;neutrophil: 85.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 98.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028351, HPA028358, HPA061086"	Approved		Enhanced	Nucleoplasm		NA	NA		220000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.43e-8)"	"unprognostic (2.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.06e-2)"	13.8	13.0	24.9	8.2	49.9	7.2	15.0	42.7	33.7	19.0	30.9	18.4	16.8	18.1	7.0	37.1	17.4	14.0	33.5	22.2	30.7	30.4	19.0	12.9	6.4	58.7	43.9	21.7	47.6	30.1	15.1	6.8	53.4	14.3	17.2	13.3	29.6	13.7	16.7	20.6	14.8	15.6	33.3	15.1	25.9	23.6	43.1	3.6	47.3	18.0	8.7	15.0	20.1	75.6	11.3	7.3	7.7	10.8	13.4	11.1	6.4	3.6	9.1	5.0	7.9	15.6	26.3	0.7	8.4	4.7	1.5	5.5	6.1	6.8	2.2	8.6	9.2	11.0	13.8	13.5	3.0	3.3	4.3	9.1	5.9	9.0	2.5	16.8	12.9	3.8	7.0	27.5	5.3	17.4	0.6	7.4	3.5	3.5	2.5	8.3	1.4	34.8	23.4	22.1	13.1	9.7	6.9	12.4	7.4	3.6	49.5	11.1	12.0	4.3	5.5	2.2	3.1	10.1	9.9	37.5	10.2	7.2	20.4	98.4	9.3	56.2	0.4	4.1	0.3	0.8	3.5	1.0	11.5	1.5	5.8	2.0	85.4	4.7	2.8	1.7	4.8	9.9	24.9	49.9	42.7	33.7	22.2	30.7	58.7	43.9	53.4	33.3	43.1	75.6	4.5	9.6	5.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.8	5.8	0.0	0.0	3.7	3.7	0.0	3.8	1.4	0.0	39.2	11.6	0.0	3.4	3.7	3.7	0.0	0.0	0.0	7.0	0.8	2.9	0.0	4.5	3.8	6.4	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	12.0	2.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.6	0.8	5.0	0.0	0.0
MINDY2	"FAM63B, KIAA1164"	ENSG00000128923	"MINDY lysine 48 deubiquitinase 2"	Q8NBR6	15	58771192-58861900	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Collecting duct cells: 82.8;Endometrial ciliated cells: 66.4;Extravillous trophoblasts: 108.7;Glandular and luminal cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 72.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051103, HPA063669"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA051103: AB_2681345, HPA063669: AB_2685082"	"unprognostic (4.71e-2)"	"unprognostic (8.92e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (3.00e-8)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.77e-2)"	9.4	5.4	9.3	5.7	9.6	3.8	6.6	15.0	10.4	7.0	8.9	5.4	3.5	7.1	4.6	7.1	6.8	6.3	10.8	8.0	11.6	10.1	3.5	7.7	4.1	10.5	11.0	6.8	3.3	7.3	4.9	9.0	10.0	8.9	3.9	16.3	4.9	6.1	3.4	7.1	3.6	8.5	9.2	6.1	4.8	3.9	11.2	5.9	9.6	8.9	3.7	8.0	5.2	10.3	10.9	5.3	7.3	4.4	10.7	19.7	11.5	9.8	20.8	3.0	4.3	8.4	5.4	5.6	10.5	11.8	5.3	10.3	13.4	7.9	4.6	5.6	4.9	7.8	5.7	7.6	6.6	5.9	6.9	8.7	12.9	3.5	8.0	11.3	7.4	5.9	13.7	6.1	7.1	1.4	7.4	4.4	15.7	1.4	2.7	3.3	21.0	6.0	8.9	12.1	6.7	4.9	7.1	10.0	17.9	15.3	3.0	12.5	8.7	4.2	3.7	72.5	4.3	5.4	8.3	5.4	9.4	9.5	10.2	3.0	0.7	1.3	1.1	0.6	2.1	0.9	1.0	1.3	0.2	1.6	0.8	1.2	1.4	0.8	1.4	1.1	0.9	0.5	9.3	9.6	15.0	10.4	8.0	11.6	10.5	11.0	10.0	9.2	11.2	10.3	65.2	147.4	39.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	43.8	44.8	0.0	0.0	18.0	82.8	0.0	65.2	27.5	0.0	46.9	44.4	0.0	66.4	46.8	19.8	0.0	0.0	0.0	21.2	108.7	21.7	0.0	73.2	11.4	11.6	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	32.4	0.0	0.0	7.5	0.0	0.0	14.2	28.4	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	53.2	11.3	17.6	0.0	0.0
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889400	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 108.0;Oligodendrocytes: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	6.3	9.6	3.7	6.2	4.3	5.3	11.1	3.2	5.0	7.5	13.4	12.9	8.8	7.2	12.4	11.5	17.3	7.7	18.4	14.4	4.0	25.4	12.0	7.1	5.1	4.0	5.0	5.4	8.2	14.6	5.4	4.7	4.6	10.9	13.1	6.1	9.7	8.7	13.9	21.4	7.6	7.8	4.0	4.3	8.6	9.8	3.7	6.0	11.1	16.9	7.8	7.7	6.4	4.9	14.6	16.1	7.8	18.4	17.4	23.4	16.6	10.3	16.0	15.1	12.7	21.7	28.1	17.0	10.2	8.4	13.3	35.8	18.1	21.6	18.8	9.9	11.5	7.4	7.0	18.8	14.3	17.5	3.9	11.6	26.4	15.7	13.9	12.7	19.2	12.7	14.5	2.7	24.0	10.8	12.6	9.8	10.8	64.8	16.1	13.8	21.0	14.8	33.7	9.6	18.2	6.1	11.0	17.8	21.8	9.8	18.3	9.7	10.7	9.2	7.6	15.3	11.2	2.6	4.0	9.1	15.9	8.8	11.7	0.0	3.0	1.3	7.4	3.7	9.3	8.7	7.1	6.8	6.5	7.2	6.7	6.7	0.0	10.3	12.0	5.5	5.2	4.0	3.7	4.3	3.2	5.0	14.4	4.0	4.0	5.0	4.6	4.0	3.7	4.9	2.5	16.0	8.6	18.9	5.9	39.9	7.7	13.8	6.2	3.6	6.2	5.8	108.0	11.5	12.6	9.2	6.2	9.8	2.4	8.2	29.4	23.4	8.2	26.0	8.5	5.4	6.0	4.6	43.8	10.6	9.3	8.0	7.1	8.5	2.5	4.2	3.6	5.9	9.7	15.2	47.5	7.1	14.2	3.5	5.0	7.4	6.8	4.3	5.4	12.2	3.4	5.5	5.2	18.1	62.8	8.6	7.0	8.6	4.9	7.5	6.6	25.6	46.3	11.4	0.0	7.3	5.7	9.7	19.0	10.1	42.3	5.1	4.0	8.9	13.6	5.6
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751112-764318	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 196.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 793.4;Intestinal goblet cells: 230.9;Paneth cells: 646.7;Proximal enterocytes: 1115.2;Undifferentiated cells: 220.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 121.4;HaCaT: 90.2;hTCEpi: 82.6;MCF7: 63.2;OE19: 76.9;SK-BR-3: 134.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"		No	No				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	1.3	0.0	0.3	12.1	0.3	0.0	0.9	0.5	0.4	4.4	0.1	95.5	171.0	0.7	0.0	0.3	9.8	11.3	0.0	0.4	0.3	8.8	0.1	9.3	0.1	0.5	0.5	0.3	1.7	0.0	8.1	1.2	0.5	5.6	48.4	0.0	1.0	0.5	0.0	0.6	196.6	3.3	0.2	0.0	22.9	0.5	0.3	0.3	0.1	0.0	0.0	9.0	0.6	0.2	30.4	121.4	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	42.1	44.2	10.8	11.5	0.0	0.1	90.2	0.0	37.7	0.0	0.0	0.1	0.0	47.0	13.3	0.0	0.0	1.9	0.0	82.6	0.3	4.5	0.0	0.0	0.0	0.0	0.4	0.2	63.2	0.1	0.7	0.1	76.9	24.6	0.2	0.4	1.0	30.1	33.7	1.4	0.4	42.9	134.3	0.1	0.1	29.3	0.0	0.0	0.0	14.8	1.8	0.2	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.4	0.4	0.3	0.5	0.5	0.5	0.2	0.3	0.2	0.1	38.5	8.0	0.3	2.9	0.1	4.5	22.5	0.0	0.0	4.7	2.3	0.5	10.0	39.7	11.0	0.0	0.6	0.0	793.4	1.9	39.9	0.6	40.5	1.5	0.8	58.0	0.0	0.2	46.0	6.0	2.4	56.6	14.3	8.9	0.0	0.0	0.0	0.1	0.0	0.3	230.9	28.5	0.0	0.0	0.9	0.0	0.6	0.0	1.0	0.6	0.0	0.0	0.0	0.2	157.7	646.7	0.0	0.1	41.6	1115.2	27.5	41.3	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.3	2.1	1.6	0.0	220.7	62.1
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227060	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 18.5"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.7;Hep G2: 9.0;SuSa: 1.9;U-698: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005662			Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.1	0.1	0.3	1.0	0.2	0.2	0.2	1.2	0.3	0.1	0.2	0.7	1.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	2.4	0.3	0.2	0.2	0.1	0.6	0.0	0.2	0.3	0.1	0.6	0.1	0.2	0.2	0.0	0.2	0.7	0.1	0.1	1.0	0.8	0.4	0.2	0.2	0.1	0.0	3.4	0.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.1	0.2	9.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	49.7	6.5	13.0	6.4	10.0	12.6	11.3	7.3	7.3	7.2	10.4	9.6	9.7	18.2	19.6	19.5	11.0	10.3	6.2	0.3	0.2	1.2	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.4	0.6	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.5	0.1	0.1	0.1	0.0	0.5	0.0	0.3	0.1	0.1	1.5	0.0	0.0	0.3	0.1	0.1	0.0	0.1
MKI67	"MIB-1, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.3;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	0.9	0.7	0.0	8.5	0.1	46.3	1.7	0.0	0.1	1.2	0.2	8.1	6.2	1.0	0.0	10.0	0.3	0.9	0.3	0.1	0.1	0.4	0.8	1.4	14.9	0.1	1.0	0.2	0.2	0.1	0.1	4.1	0.6	0.4	9.2	0.0	1.4	0.1	0.0	6.6	5.8	2.6	0.0	4.8	4.2	2.3	0.9	52.7	0.4	0.1	16.4	1.8	2.8	0.3	204.6	101.5	103.2	73.6	4.3	8.7	32.1	75.7	55.3	70.3	62.3	83.9	82.3	152.6	21.3	51.9	46.4	120.7	109.3	56.8	104.7	161.8	53.1	131.0	79.4	52.7	0.1	186.0	68.0	2.0	2.5	72.2	73.2	17.2	69.8	69.5	61.2	142.1	70.5	80.9	111.7	56.6	41.3	52.7	45.7	82.2	135.1	20.3	25.6	56.2	35.9	38.9	107.1	38.0	17.3	33.9	31.4	39.3	65.0	37.0	73.6	53.0	206.8	64.2	54.9	177.2	30.7	83.3	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.0	0.9	0.3	0.6	0.0	5.4	0.0	16.0	6.4	1.6	5.3	0.6	0.0	3.9	3.2	1.6	1.5	5.3	0.0	0.0	30.6	7.4	25.0	0.0	0.8	4.2	2.3	10.2	6.7	6.7	232.9	0.0	0.0	86.1	13.5	34.7	13.2	1.3	87.0	5.7	1.7	42.1	0.0	0.0	22.4	2.0	12.9	13.7	0.9	0.3	16.6	3.6	0.0	0.2	0.0	8.2	0.0	0.0	0.1	3.0	0.4	107.4	4.6	2.6	0.1	1.6	0.0	0.0	0.5	13.6	8.1	24.1	50.4	3.0	7.8	23.0	2.7	47.1	4.8
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAPK interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 475.7;tongue: 551.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 367.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157"	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	87.2	50.2	70.5	51.3	78.0	133.6	39.5	109.2	131.2	41.9	80.6	55.2	47.4	24.7	47.8	114.5	38.1	26.7	54.8	67.2	65.4	27.6	71.2	51.8	66.8	80.3	70.7	34.5	191.9	34.5	39.6	35.3	74.6	38.6	30.0	35.7	133.8	39.7	475.7	63.8	57.3	21.8	68.2	80.2	55.1	21.6	75.7	34.5	54.6	551.1	58.6	39.9	60.9	91.0	64.9	71.8	30.1	66.3	219.5	79.0	65.1	37.3	27.1	26.5	26.8	45.5	111.8	88.2	50.7	77.4	27.9	78.4	38.4	110.9	12.0	122.1	34.4	36.8	62.1	49.2	367.4	72.3	61.6	84.1	262.0	50.8	107.2	61.9	63.5	59.2	62.0	155.4	18.6	37.7	42.8	59.3	78.6	49.6	78.1	81.8	8.6	113.1	48.1	41.2	39.9	48.2	89.0	125.1	166.4	33.5	52.7	89.5	96.5	9.5	37.5	38.5	46.0	238.9	97.0	85.7	78.2	53.5	17.9	4.4	9.2	9.8	8.1	10.2	7.5	16.9	8.4	9.4	7.7	15.0	5.4	6.6	41.7	9.5	13.6	9.2	12.5	3.6	70.5	78.0	109.2	131.2	67.2	65.4	80.3	70.7	74.6	68.2	75.7	91.0	102.2	38.5	56.5	9.8	91.4	82.5	105.6	84.5	50.1	55.7	99.0	103.5	54.5	38.6	65.5	36.8	25.0	23.5	106.5	155.3	9.8	27.3	8.7	60.2	28.0	51.9	150.2	80.2	5.6	56.6	47.2	45.0	57.6	76.2	29.2	14.5	82.5	60.3	36.9	42.1	5.9	104.1	46.8	52.5	134.6	13.0	20.2	68.0	56.9	8.4	41.8	63.6	30.9	6.0	5.2	47.2	86.6	20.3	55.4	94.2	98.8	18.6	55.2	47.5	19.7	132.6	48.7	18.1	19.5	97.8	117.2	56.5	69.3	18.1	79.7	114.0
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453033-140479536	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 328.0;Erythroid cells: 424.2;Late spermatids: 340.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 129.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	39.5	36.8	50.9	47.9	50.7	202.6	47.8	52.6	57.1	43.0	46.6	97.9	69.2	46.7	43.3	49.0	51.3	37.5	64.6	51.0	53.7	47.9	42.7	46.9	49.7	57.6	50.7	56.5	58.1	66.8	42.3	43.0	58.9	48.6	80.1	58.6	56.5	44.4	84.0	51.7	65.8	43.5	50.2	52.7	53.9	123.2	55.6	47.1	46.9	58.5	56.4	45.7	38.9	50.9	96.5	72.3	55.6	83.1	86.5	75.5	78.2	64.6	83.3	49.8	57.2	30.0	98.8	69.4	98.4	63.4	99.2	45.7	63.2	71.2	62.8	138.0	55.6	72.1	43.5	55.9	69.4	62.5	107.1	75.4	105.1	56.2	52.8	81.9	50.8	46.9	58.0	84.8	49.1	82.6	73.4	114.2	143.3	80.7	53.6	52.4	47.4	107.6	80.8	109.2	76.6	79.1	80.8	108.5	120.6	81.6	53.3	53.5	71.9	34.9	27.4	85.8	59.8	200.2	159.2	60.9	99.3	96.1	73.3	58.6	22.5	100.4	15.4	21.3	18.0	33.6	29.5	23.0	18.0	32.9	39.9	25.5	42.5	31.1	26.5	6.0	35.3	15.3	50.9	50.7	52.6	57.1	51.0	53.7	57.6	50.7	58.9	50.2	55.6	50.9	28.4	51.3	37.2	13.4	76.8	82.1	66.6	57.1	57.5	61.5	60.9	36.2	57.7	67.2	71.1	42.3	35.5	75.8	54.0	172.1	103.7	69.8	328.0	58.4	30.6	34.2	97.3	424.2	28.9	67.8	96.6	43.3	38.7	65.7	37.4	79.5	45.7	45.0	59.5	119.5	28.0	107.7	89.5	95.9	93.3	340.6	66.5	86.3	69.4	22.5	119.0	61.4	92.7	15.1	22.1	57.6	140.3	62.4	41.8	101.2	112.4	54.4	70.0	46.4	46.0	34.7	53.3	303.0	60.1	62.4	95.5	138.0	62.9	39.6	103.5	145.9
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557057-12586208	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"Early spermatids: 572.9;Late spermatids: 774.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favorable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	16.3	11.5	15.1	10.9	15.1	3.5	13.8	16.9	17.6	15.7	13.5	16.3	13.0	16.6	12.0	17.9	14.7	11.6	32.5	15.1	17.0	16.0	15.1	13.4	14.5	15.5	15.9	21.7	24.1	23.9	12.8	16.7	16.1	12.5	13.5	11.4	14.0	14.0	32.0	14.5	12.2	18.9	16.7	10.7	13.7	56.3	16.7	21.4	21.1	24.5	17.3	15.3	14.3	17.6	20.6	18.8	24.5	17.4	45.2	44.3	40.6	30.0	35.5	41.7	34.1	19.2	18.8	26.7	16.9	37.7	18.8	10.9	38.4	33.1	37.1	30.9	29.2	40.3	19.1	31.1	51.9	38.8	14.4	46.8	30.6	47.6	30.2	34.8	34.9	39.1	39.7	30.8	37.7	25.9	51.4	17.8	16.5	21.7	40.4	45.9	26.0	32.2	30.4	24.8	14.8	26.4	28.4	12.8	30.4	17.3	29.7	38.0	31.1	23.0	23.0	28.5	43.0	26.6	62.8	60.8	28.8	49.5	41.1	20.9	17.9	32.9	20.7	16.4	26.4	21.3	21.4	22.0	19.8	16.5	22.8	20.8	13.2	27.8	23.3	15.9	24.5	20.2	15.1	15.1	16.9	17.6	15.1	17.0	15.5	15.9	16.1	16.7	16.7	17.6	15.4	19.2	9.6	9.8	13.8	9.6	9.9	13.5	10.2	13.8	8.5	8.9	14.7	1.5	14.2	5.5	4.2	19.7	20.8	7.6	19.6	16.1	572.9	9.7	13.8	14.1	2.4	5.0	15.9	16.8	19.6	11.4	5.1	10.1	19.0	17.3	7.9	5.8	15.5	11.8	15.5	10.0	6.1	7.2	9.1	774.2	20.5	9.6	16.0	6.5	20.1	19.1	20.6	14.1	11.1	16.0	10.8	20.7	14.7	9.5	12.0	11.6	14.2	13.2	13.1	11.3	17.4	66.5	38.4	8.1	9.2	16.1	15.7	23.6	10.1	9.8
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Endothelial cells: 25.9;granulocytes: 29.1;Macrophages: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	20.0	7.1	8.4	20.3	8.7	30.7	12.1	8.6	12.7	9.0	9.6	11.0	11.0	6.0	2.0	15.6	8.0	11.5	10.6	7.8	8.2	15.4	9.3	25.6	15.4	10.1	9.8	3.0	9.9	1.6	3.7	9.2	9.3	8.4	11.4	0.3	13.3	4.3	3.1	4.9	14.4	7.6	9.1	36.1	10.8	1.2	10.3	6.7	8.7	3.1	13.8	12.3	11.5	9.6	13.5	24.4	0.1	0.1	6.0	12.4	0.2	17.0	14.8	15.4	22.4	13.9	26.6	0.3	19.1	14.2	13.7	21.7	4.3	24.9	5.8	8.3	0.6	18.8	17.6	16.2	4.2	12.3	18.6	8.5	2.4	16.8	5.7	9.0	37.3	21.3	2.7	2.5	11.9	22.0	7.0	24.3	2.2	29.3	30.0	13.5	1.8	23.8	22.0	10.2	1.0	0.8	13.4	8.7	7.2	0.1	6.2	12.5	41.4	7.8	4.8	7.0	11.7	11.2	40.2	3.2	13.7	42.3	3.9	21.9	36.2	45.8	11.2	22.2	15.4	8.1	12.6	12.0	18.9	6.7	6.8	10.4	48.6	3.6	23.3	1.2	17.4	16.0	8.4	8.7	8.6	12.7	7.8	8.2	10.1	9.8	9.3	9.1	10.3	9.6	32.1	3.2	10.7	1.0	9.8	3.4	6.8	3.1	7.4	0.2	3.3	3.4	3.1	2.8	5.5	1.8	0.0	0.2	9.6	8.9	1.9	4.6	3.5	1.2	1.9	25.9	1.2	3.4	0.5	5.2	0.8	7.1	15.3	1.6	29.1	0.3	16.8	1.3	16.6	1.7	0.5	10.9	0.0	18.2	7.8	5.2	0.9	28.9	7.2	11.2	16.7	0.1	11.3	1.5	5.2	4.9	9.4	0.4	18.5	2.8	5.5	0.6	2.0	0.6	0.0	3.0	3.1	0.1	0.2	13.4	2.8	0.3	16.5	0.2	9.5	7.5
MLLT11	AF1Q	ENSG00000213190	"MLLT11 transcription factor 7 cofactor"	Q13015	1	151060397-151069544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 109.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 54.1;Early spermatids: 76.9;Excitatory neurons: 57.9;Late spermatids: 215.6"	"Cancer enriched"	"Detected in all"	4	"glioma: 29.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 216.7;EFO-21: 164.9;SH-SY5Y: 238.6;U-698: 207.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000540	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA000540: AB_2666024"	"unprognostic (2.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.25e-12)"	"unprognostic (5.66e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-3)"	5.3	19.0	59.4	4.7	61.8	2.0	2.5	41.1	109.3	4.5	8.8	7.2	1.6	10.7	1.3	4.0	6.2	6.0	38.1	66.2	80.6	3.8	2.0	3.8	2.1	63.1	50.5	8.2	3.1	16.2	10.4	1.0	66.1	4.3	3.6	35.6	3.8	1.5	11.3	2.6	4.9	13.8	29.9	4.6	5.1	2.8	49.7	20.6	3.8	10.8	2.1	4.0	3.9	57.1	6.3	31.0	216.7	34.4	3.5	5.8	1.4	11.6	15.2	13.2	24.0	3.0	12.6	10.0	164.9	10.6	35.9	4.5	54.3	13.0	7.6	65.8	14.5	28.9	17.7	0.9	6.9	0.8	1.0	9.9	1.6	73.5	2.9	42.2	100.1	43.3	30.8	2.3	43.6	1.4	106.4	19.0	95.7	0.6	4.4	99.8	28.1	0.6	25.5	1.7	132.8	238.6	0.8	1.3	6.9	142.5	5.3	2.7	65.9	27.0	29.0	9.2	24.7	2.4	3.2	207.1	70.0	0.6	51.7	1.1	0.3	1.4	5.9	0.6	2.7	2.5	3.9	6.2	0.7	1.9	5.3	9.1	1.6	4.0	0.9	1.4	4.1	3.2	59.4	61.8	41.1	109.3	66.2	80.6	63.1	50.5	66.1	29.9	49.7	57.1	1.4	0.0	1.1	11.8	4.2	3.6	5.0	14.6	4.6	54.1	2.5	4.8	10.2	1.5	2.2	3.7	8.4	2.9	15.3	0.1	17.6	3.9	76.9	0.8	11.3	5.2	10.7	6.3	57.9	1.2	2.5	17.5	2.0	0.9	4.5	4.3	4.2	0.4	6.0	37.0	40.6	0.1	16.2	6.6	14.5	215.6	2.1	12.3	5.4	10.3	33.3	20.6	19.6	16.1	14.4	3.0	0.2	3.8	4.8	1.3	0.2	2.4	0.6	26.3	0.0	3.4	30.0	8.6	12.3	2.8	3.4	7.4	9.9	3.0	0.2	4.3
MMAA	cblA	ENSG00000151611	"Metabolism of cobalamin associated A"	Q8IVH4	4	145599042-145660033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 24.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037361, HPA058187"	Supported		Supported	Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA037361: AB_10672107, HPA058187: "	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.21e-4)"	4.1	3.2	1.4	3.0	1.9	1.7	4.2	2.7	2.3	3.0	1.3	5.8	7.4	2.4	4.0	4.1	2.7	3.8	3.3	1.5	1.4	7.3	24.5	3.7	3.1	1.3	1.5	2.3	2.0	4.2	0.7	2.8	1.3	2.3	5.3	1.9	3.5	2.8	4.7	3.8	6.2	2.6	1.2	3.5	3.6	4.5	1.3	5.2	3.1	6.0	3.7	4.7	0.8	1.6	2.5	1.4	4.0	2.1	8.4	9.8	1.1	7.1	4.0	2.3	1.4	1.7	4.3	12.1	2.1	4.4	1.1	2.2	2.0	4.4	1.7	7.5	0.8	4.0	1.3	1.5	6.5	5.6	3.3	5.5	6.1	2.6	5.8	3.7	7.2	8.1	1.1	4.6	5.1	3.4	7.2	1.4	1.5	6.2	2.7	3.7	2.2	1.4	13.3	1.3	1.9	1.4	3.5	6.0	3.3	2.4	3.9	1.5	7.0	2.8	1.4	5.0	1.6	2.2	2.0	3.3	4.4	5.5	2.8	3.9	3.1	3.0	4.5	6.1	4.0	3.1	5.3	4.6	3.2	2.6	4.0	5.3	0.5	4.8	7.4	3.3	5.2	2.3	1.4	1.9	2.7	2.3	1.5	1.4	1.3	1.5	1.3	1.2	1.3	1.6	3.6	12.8	5.6	5.5	3.6	2.9	10.4	7.7	5.7	3.4	3.0	2.4	7.6	14.3	13.0	11.0	2.1	7.9	6.5	7.7	15.6	11.1	10.5	5.0	4.5	4.1	2.4	1.7	5.7	12.5	2.8	4.8	7.1	5.7	8.2	3.4	7.9	31.8	4.9	0.0	5.7	6.5	8.2	4.1	1.6	6.3	4.7	3.6	1.8	3.7	5.6	2.3	9.2	8.0	7.4	8.4	7.3	3.0	2.8	6.5	10.9	21.1	6.8	1.6	0.0	4.2	3.8	8.7	5.2	4.4	1.1	7.7	4.5	5.7	6.7	12.2
MMAB	"cblB, CFAP23"	ENSG00000139428	"Metabolism of cobalamin associated B"	Q96EY8	12	109553715-109573580	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 225.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039017	Supported		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"HPA039017: AB_10673603"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.65e-2)"	15.5	51.2	17.8	6.3	18.3	5.8	15.8	18.8	26.9	12.4	18.6	15.8	13.0	10.7	21.2	29.1	13.0	6.0	30.0	17.0	18.8	32.8	103.6	14.9	6.2	22.2	19.0	18.9	23.0	9.8	20.5	4.9	21.3	26.5	7.9	7.3	17.1	6.3	21.1	18.2	14.0	5.6	19.0	12.4	17.7	12.6	18.9	5.5	22.1	16.2	6.5	14.1	14.7	22.9	32.2	22.3	22.2	17.6	8.8	17.7	11.3	7.1	16.2	10.3	10.8	25.8	29.5	21.0	19.9	8.0	19.1	32.9	14.6	54.9	4.6	8.2	60.9	8.6	15.9	42.1	31.3	18.4	7.2	24.0	33.5	22.2	9.7	12.3	9.7	16.4	27.5	15.5	7.3	74.7	16.6	29.2	27.3	3.3	31.6	13.6	8.7	53.9	45.3	30.3	34.1	14.8	15.8	29.2	12.7	6.2	60.5	50.5	5.4	8.6	3.6	6.1	10.4	11.9	9.6	24.0	19.0	22.2	23.9	7.4	7.2	1.0	15.3	10.0	12.2	13.6	11.1	12.1	11.3	17.8	15.2	14.6	1.9	11.2	10.9	9.2	5.8	10.3	17.8	18.3	18.8	26.9	17.0	18.8	22.2	19.0	21.3	19.0	18.9	22.9	25.1	35.3	80.8	9.8	20.4	10.3	33.1	105.6	17.1	32.9	59.6	47.0	52.3	60.1	68.9	42.3	29.2	55.4	15.2	33.6	150.6	49.7	41.3	23.8	10.0	22.1	33.0	34.1	6.4	71.3	37.6	24.7	28.5	16.5	16.5	34.3	28.5	225.3	34.8	104.3	8.5	50.4	71.2	20.4	10.2	82.9	40.4	13.5	26.6	4.7	25.1	30.6	30.9	6.6	21.5	29.7	30.0	30.5	18.1	31.8	61.9	143.6	62.1	29.7	13.1	17.9	26.3	26.0	15.8	44.7	19.7	61.8	16.1	121.1	56.6	30.3
MMD	"MMA, PAQR11"	ENSG00000108960	"Monocyte to macrophage differentiation associated"	Q15546	17	55392622-55421924	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 152.2;brain: 87.5"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 56.4;Macrophages: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 110.0;HSkMC: 199.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026978			Approved	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA026978: AB_2672068"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.52e-5)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (8.07e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (3.71e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.12e-2)"	152.2	13.3	54.2	15.7	55.9	14.1	28.4	11.6	58.5	4.8	5.4	13.4	10.9	6.2	9.7	7.2	4.2	9.4	6.5	87.5	19.7	8.5	13.2	10.0	17.8	16.3	29.2	2.8	3.5	3.7	4.8	21.4	16.1	6.2	12.9	12.8	4.9	7.9	3.4	5.3	10.1	11.4	24.2	16.5	5.4	17.0	21.6	8.2	6.6	8.0	12.1	11.6	4.0	27.2	20.1	46.3	67.0	13.5	110.0	86.0	39.2	13.6	5.2	7.2	10.2	7.4	53.8	30.1	39.6	4.5	20.1	1.5	18.8	14.3	14.9	41.5	9.5	11.0	2.5	85.2	29.8	10.8	3.2	199.4	4.5	10.1	11.4	15.7	9.0	27.4	4.4	20.5	15.1	2.8	29.7	8.2	20.6	3.3	15.6	12.4	46.9	10.0	19.7	5.0	7.0	72.8	5.0	7.1	10.9	41.5	15.4	17.3	9.6	18.7	26.6	15.5	14.0	13.1	6.2	45.7	26.7	8.5	15.2	14.2	1.5	1.9	1.7	2.1	4.9	4.5	1.8	3.3	4.3	5.0	3.1	3.3	4.6	2.9	1.9	1.3	2.1	17.5	54.2	55.9	11.6	58.5	87.5	19.7	16.3	29.2	16.1	24.2	21.6	27.2	15.5	3.2	0.6	5.2	20.3	5.4	23.7	9.3	5.2	28.2	3.3	3.3	4.6	11.5	2.7	7.3	4.2	11.5	12.2	3.4	15.6	27.7	2.5	4.8	8.9	16.4	7.8	27.3	36.5	1.3	18.8	12.7	2.6	8.7	0.0	3.5	19.6	17.9	37.6	16.8	11.5	6.8	8.2	56.4	35.9	4.0	1.8	85.9	7.2	14.0	48.6	14.5	12.3	7.5	7.2	17.3	1.6	3.4	12.1	26.2	2.3	9.8	2.4	10.2	19.7	5.2	11.4	28.9	23.3	3.1	17.5	20.0	17.7	1.3	8.6	6.1
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770502-102780628	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"endometrium 1: 265.4"	"Cell type enriched"	"Detected in some"	38	"Basal respiratory cells: 3913.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 47.8;head and neck cancer: 102.2;lung cancer: 42.3"	"Region enhanced"	"Detected in single"		"thalamus: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 11.8;HUVEC TERT2: 15.1;SCLC-21H: 4.7"									CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.0	0.1	7.7	0.0	0.1	0.1	0.0	0.8	1.2	0.0	0.4	1.1	265.4	0.0	0.2	0.0	1.3	0.0	0.2	0.3	0.1	1.0	2.0	0.1	0.1	0.3	0.2	0.2	0.0	0.0	1.3	0.3	1.4	0.2	0.0	1.6	0.0	0.0	0.1	0.8	0.2	0.0	0.0	2.9	0.5	1.9	0.6	0.0	0.2	0.7	4.4	3.2	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	11.8	0.6	0.1	0.1	0.3	0.0	0.0	3.3	1.8	0.2	2.7	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.5	0.0	15.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	2.8	0.5	1.6	0.0	0.0	0.0	0.0	0.6	4.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.9	3.5	1.2	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.3	0.1	0.3	0.3	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	51.3	3913.2	0.0	0.0	0.7	0.0	0.1	0.0	85.4	29.5	0.0	0.0	0.0	0.4	0.0	34.0	6.1	6.4	2.5	9.0	0.0	0.0	0.0	14.6	0.0	6.3	0.0	12.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	9.5	1.3	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	102.5	0.1	0.0	0.0	42.5	0.0	0.1	29.3	0.0	0.0	0.0	11.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.2
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836560-22849041	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		1400000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	151.5	31.7	5.6	59.9	5.0	1.6	101.5	5.7	7.5	181.3	61.8	77.2	39.5	167.3	19.0	92.1	82.1	148.2	41.3	6.6	7.2	35.9	13.2	91.8	24.8	11.9	8.4	90.2	36.0	65.3	14.2	118.9	9.2	59.9	36.6	9.6	78.1	45.5	18.8	127.5	69.4	106.0	7.3	30.8	57.7	11.7	13.2	13.0	50.0	16.1	30.8	103.9	111.1	10.6	90.6	1.2	26.3	2.0	923.8	651.6	455.9	270.1	606.4	93.3	158.5	21.3	337.4	0.9	146.4	301.9	24.6	216.3	0.3	262.2	99.7	1.1	0.6	37.2	1.7	5.0	794.2	0.4	1.3	887.0	148.7	334.7	288.3	925.5	492.9	0.6	0.8	2.1	185.1	0.7	0.4	79.4	14.7	17.7	52.4	2.1	96.0	0.2	61.4	148.1	0.3	0.6	187.3	0.3	574.2	104.4	1.0	79.5	436.8	724.9	53.7	198.2	329.6	0.8	1.6	1.1	410.9	0.6	396.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	5.0	5.7	7.5	6.6	7.2	11.9	8.4	9.2	7.3	13.2	10.6	13.9	12.8	3.0	2.0	3.4	34.0	23.4	105.4	39.3	0.0	14.1	17.5	4.7	50.1	42.2	7.3	0.0	105.6	0.3	19.9	11.7	63.0	0.4	16.1	81.6	35.2	7.8	0.0	0.0	28.7	244.0	84.0	25.5	14.8	3.8	9.3	32.9	2.7	89.5	0.0	0.0	24.5	34.6	20.2	32.7	2.4	72.1	38.0	37.4	4.7	21.5	14.3	0.0	0.5	0.1	144.7	33.0	54.9	0.3	21.8	19.9	11.7	46.8	0.8	39.5	11.1	73.9	0.8	0.8	33.7	34.2	122.7	2.5	15.6	18.6	37.9
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226690-35276998	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Excitatory neurons: 24.6;Horizontal cells: 15.2;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.0;Proximal tubular cells: 11.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.4;testis cancer: 10.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 40.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.3;CACO-2: 56.0;EFO-21: 15.8;RPTEC TERT1: 24.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 51.5"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	3.4	1.0	6.1	0.5	5.8	0.7	0.5	40.0	8.1	0.7	3.5	0.7	2.1	1.3	0.1	0.3	2.2	0.6	0.6	6.0	5.6	7.8	0.5	4.7	0.4	4.4	5.6	0.4	5.8	0.3	3.8	0.2	5.4	1.7	0.2	2.5	0.5	4.2	0.3	1.2	1.4	2.0	2.7	0.4	0.6	0.4	7.2	0.0	0.7	0.1	0.0	0.4	0.3	4.8	0.6	36.3	0.1	0.2	0.2	0.0	1.0	1.9	2.3	3.8	2.0	56.0	9.7	0.0	15.8	2.5	1.2	0.6	8.5	0.0	1.6	0.2	0.3	1.9	1.2	0.6	0.0	0.1	0.4	0.2	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.5	0.4	0.5	0.1	0.2	13.6	0.1	2.4	0.1	0.2	0.0	24.6	0.1	14.1	9.7	2.5	0.7	0.3	2.9	0.5	0.3	0.6	7.4	17.7	1.8	0.7	0.3	0.2	0.1	1.6	0.2	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.1	5.8	40.0	8.1	6.0	5.6	4.4	5.6	5.4	2.7	7.2	4.8	0.3	16.0	1.5	5.2	0.0	0.1	0.2	0.0	0.0	3.9	0.2	0.8	0.5	8.6	1.3	1.8	0.0	0.1	0.1	0.7	5.9	8.5	0.6	0.8	0.3	1.4	0.0	0.0	24.6	0.9	0.1	0.6	0.0	0.5	0.0	0.1	0.4	0.4	0.0	15.2	38.4	0.1	0.0	0.6	0.0	0.0	0.3	0.1	1.8	10.3	0.0	0.2	0.0	12.5	12.0	1.9	0.1	0.0	0.0	0.4	2.3	11.4	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.1
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.7;Basal respiratory cells: 56.8;Distal enterocytes: 82.0;Paneth cells: 46.2;Proximal enterocytes: 47.2;Urothelial cells: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 6.3;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.8;HaCaT: 86.9;hTCEpi: 38.3;OE19: 41.7;RT4: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	14.7	2.0	18.7	0.5	18.1	0.2	8.3	12.1	18.8	4.1	11.9	17.5	1.8	5.2	2.1	13.5	6.1	1.4	3.8	16.2	15.6	1.9	0.3	14.1	0.2	15.2	17.8	1.1	0.8	0.1	1.3	2.0	12.9	5.0	10.5	3.0	2.5	3.5	1.8	23.7	10.2	4.1	14.4	1.1	8.8	22.3	19.3	0.3	5.9	2.4	3.2	16.3	7.6	13.9	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.1	1.5	0.0	0.1	86.9	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.0	4.3	0.0	0.0	1.2	38.3	0.0	3.1	0.7	0.3	0.3	0.0	0.2	0.0	0.3	0.1	0.3	0.0	41.7	0.1	0.8	0.0	0.0	0.0	15.7	0.2	0.7	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.6	0.2	1.0	0.0	0.4	6.3	3.7	0.0	0.9	0.2	0.9	0.0	0.4	18.7	18.1	12.1	18.8	16.2	15.6	15.2	17.8	12.9	14.4	19.3	13.9	31.5	28.9	26.5	47.7	0.4	38.5	5.3	56.8	21.1	2.7	1.0	1.5	1.3	7.2	15.2	7.3	0.0	0.0	0.2	82.0	0.0	1.2	6.7	0.1	0.0	16.8	3.6	0.4	2.8	0.4	0.0	4.4	12.2	0.1	0.0	0.0	17.9	0.0	0.1	1.7	4.8	32.9	2.0	0.0	1.8	13.4	1.2	0.5	3.6	10.3	0.4	9.4	1.0	1.0	0.6	16.7	46.2	3.0	0.1	8.6	47.2	0.8	4.5	0.5	6.6	0.7	5.5	1.1	3.7	34.9	33.1	0.0	1.0	0.1	21.5	43.9
MNAT1	"MAT1, RNF66"	ENSG00000020426	"MNAT1 component of CDK activating kinase"	P51948	14	60734742-60969965	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 365.2;Inhibitory neurons: 223.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000701, HPA001154, CAB004495"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212"	"unprognostic (4.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.34e-2)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.14e-3)"	21.5	20.4	25.0	9.5	26.9	14.0	25.8	27.8	31.6	21.0	16.7	18.5	8.8	18.1	18.9	16.8	24.7	14.1	21.0	25.3	26.0	27.0	23.5	14.3	13.5	22.9	22.9	22.4	14.7	55.3	22.2	16.0	22.2	20.8	12.7	29.2	25.7	15.7	79.9	13.0	10.7	19.3	21.3	11.6	16.8	12.2	27.2	26.1	18.3	65.3	17.3	19.8	16.4	28.7	203.9	38.5	47.0	33.3	53.5	58.6	51.3	73.1	78.4	87.5	70.2	30.9	69.4	48.6	53.9	53.9	47.3	63.2	53.0	84.1	124.7	61.0	55.0	32.9	36.2	45.9	66.4	77.0	16.8	36.0	60.5	56.5	62.1	84.1	84.6	69.6	49.6	45.3	98.5	69.5	48.2	48.2	25.8	38.3	85.1	49.4	127.9	30.9	102.9	94.3	41.9	28.5	56.0	46.6	71.7	54.0	72.2	37.0	64.9	66.8	70.7	31.8	55.6	19.7	17.8	70.4	53.9	12.9	49.4	12.2	6.1	22.3	14.3	8.6	14.7	26.9	15.3	15.3	11.9	19.8	17.6	17.8	0.5	34.6	10.1	46.6	13.6	6.6	25.0	26.9	27.8	31.6	25.3	26.0	22.9	22.9	22.2	21.3	27.2	28.7	30.1	32.1	25.5	91.1	31.1	24.9	59.4	88.3	23.3	43.0	28.0	35.6	58.4	22.8	50.8	29.5	31.3	50.6	51.1	6.1	80.3	35.2	6.1	85.6	34.6	28.9	17.4	14.5	365.2	44.5	36.3	33.9	25.5	60.4	32.9	23.3	18.5	23.3	20.2	23.5	223.4	13.8	52.9	6.9	10.7	6.9	30.1	13.3	14.2	119.9	12.6	50.3	44.3	196.6	148.1	59.3	9.3	30.5	30.1	48.1	4.3	74.3	81.4	59.2	52.6	77.5	52.2	50.9	41.2	26.6	18.2	36.0	35.3	26.9	16.0	44.2
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831351-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 292.9;lymphoid tissue: 107.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 219.1;Kupffer cells: 408.5;Langerhans cells: 241.7;Macrophages: 412.0;monocytes: 1118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 6012.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 6012.8"	"Group enriched"	"Detected in some"	14	"NB-4: 151.8;THP-1: 282.7;U-937: 185.5"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	24.2	14.9	2.7	82.4	2.8	292.9	6.0	2.9	4.4	6.3	3.2	6.7	3.7	4.0	1.4	7.4	5.7	26.6	4.3	2.6	3.1	3.6	11.5	47.3	15.6	5.2	4.3	2.2	4.8	3.7	1.6	20.4	4.3	3.8	7.7	12.1	5.7	3.5	3.8	5.1	7.7	20.7	5.1	107.8	4.5	5.1	4.2	14.4	3.8	19.0	14.5	23.4	1.8	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	282.7	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	185.5	0.0	155.4	1354.4	243.8	2.6	534.3	3.7	33.5	1.6	1.9	616.5	15.3	1.6	1.4	6012.8	2.8	270.6	9.6	1.5	1099.5	2.7	2.8	2.9	4.4	2.6	3.1	5.2	4.3	4.3	5.1	4.2	5.4	2.6	35.3	56.0	0.0	34.7	2.4	0.0	0.0	0.0	1.2	1.1	3.4	0.9	5.7	9.3	0.0	0.0	0.9	5.9	0.0	0.0	0.0	0.4	0.1	0.1	5.0	0.0	22.3	0.0	0.4	1.3	6.5	0.5	0.1	44.1	0.0	3.9	2.2	219.1	0.0	0.1	0.0	0.0	408.5	241.7	3.3	1.2	412.0	1.8	33.7	1118.9	136.1	26.8	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	1.7	8.0	4.8	13.1	1.5	8.2	0.9	0.3	0.4	2.3	1.0	11.7	0.0	0.0	0.1
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010663	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 7.2;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 6.6;Enteroendocrine cells: 25.1;Intestinal goblet cells: 19.7;Paneth cells: 7.0;Proximal enterocytes: 7.3;Undifferentiated cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;BEWO: 12.7;EFO-21: 16.2;HEK 293: 13.2;RPMI-8226: 37.6;SCLC-21H: 19.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	39	"spinal cord: 3.9"	HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: AB_2686437"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.3	0.6	0.0	0.0	3.7	7.2	0.0	0.0	0.2	0.0	0.8	0.0	0.5	0.2	0.1	0.0	0.0	0.0	1.3	0.3	0.0	16.3	0.0	2.6	0.0	0.9	0.3	3.0	0.0	1.1	0.0	0.0	0.1	6.1	0.0	0.8	0.0	2.2	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.4	5.8	0.0	17.2	0.0	0.0	12.7	0.0	0.0	0.1	0.0	7.6	2.5	1.4	16.2	0.0	0.5	0.3	3.0	2.3	1.3	2.2	13.2	0.0	1.5	3.6	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	6.1	5.7	2.9	0.0	10.1	0.9	0.2	0.0	1.7	1.1	0.0	2.5	37.6	6.5	0.6	19.3	0.0	2.5	2.2	0.4	0.1	5.4	4.4	0.0	0.0	0.0	0.0	0.0	5.3	2.9	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.6	0.5	0.2	1.3	0.3	0.9	0.8	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	4.4	1.3	0.1	0.0	0.1	25.1	0.0	0.0	3.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	19.7	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	3.1	7.0	0.0	0.4	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.8	0.0	0.0	0.0	0.2	0.0	13.6	0.0
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.7;Hepatocytes: 36.2;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.4;JURKAT: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	33.7	9.5	14.6	3.2	17.9	0.0	26.8	16.8	14.7	8.8	11.2	11.7	16.2	10.0	10.1	6.7	10.3	5.5	22.0	12.7	16.0	20.4	40.3	22.9	4.5	17.4	18.8	9.0	11.9	9.6	5.3	35.6	16.2	5.3	5.6	3.0	6.1	7.5	25.7	7.3	12.7	9.2	15.6	2.6	7.6	3.2	17.3	3.3	16.0	45.0	3.4	10.0	6.6	16.4	0.0	2.1	7.0	11.4	19.3	7.2	15.2	8.7	15.0	12.1	10.0	40.4	0.1	0.0	8.4	7.4	7.0	0.4	8.2	9.8	8.7	0.0	8.6	0.0	0.0	13.7	12.2	0.0	3.1	12.0	3.7	7.9	4.2	7.2	10.1	51.1	8.4	0.7	11.7	5.0	16.0	0.0	7.9	0.1	4.6	0.0	6.3	1.1	7.6	8.2	6.1	8.5	0.0	4.2	7.0	6.3	5.2	1.4	16.2	12.2	9.8	7.7	4.1	0.0	1.7	0.0	1.3	0.0	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.2	14.6	17.9	16.8	14.7	12.7	16.0	17.4	18.8	16.2	15.6	17.3	16.4	5.7	6.4	1.5	6.2	0.1	0.6	0.6	0.7	1.2	1.6	9.3	6.5	11.6	8.6	0.3	9.2	12.5	33.7	0.5	3.6	5.9	4.4	0.8	0.9	1.6	3.3	0.0	0.0	3.2	4.1	2.3	4.3	1.1	1.4	1.3	6.3	3.3	36.2	2.9	3.3	2.6	3.5	0.0	2.8	1.0	1.8	3.7	0.4	1.8	2.8	0.0	4.6	0.0	1.0	4.4	1.0	9.1	3.0	1.3	0.2	13.2	17.8	0.0	2.2	78.9	3.9	20.3	1.6	1.9	1.2	1.1	6.2	0.3	0.8	5.5	0.6
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000212	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 79.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Alveolar cells type 2: 130.4;Cytotrophoblasts: 329.8;Syncytiotrophoblasts: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	13.4	30.9	24.8	7.8	35.5	11.8	12.2	47.8	51.0	12.1	17.8	8.5	10.4	11.5	16.3	9.6	10.4	10.1	7.0	32.4	22.4	10.8	21.1	8.8	5.6	11.1	11.4	17.4	15.1	11.7	6.2	79.9	16.6	12.4	10.8	22.3	10.9	11.5	20.2	18.7	10.0	11.4	3.9	6.0	8.4	20.2	16.6	5.6	10.2	10.3	7.0	7.5	11.1	55.7	29.8	121.0	11.4	26.4	35.0	40.3	60.5	28.7	30.8	14.6	18.3	64.6	13.1	3.7	14.2	30.5	23.9	22.5	39.8	25.5	17.1	4.6	23.0	6.4	40.7	27.1	25.6	4.7	13.9	20.8	24.3	19.6	28.6	85.7	13.1	4.1	3.9	41.4	32.7	26.7	10.7	6.4	8.9	82.0	45.2	4.2	22.9	4.3	47.0	23.3	9.2	11.5	35.4	33.9	23.0	15.9	19.7	5.0	12.6	22.5	21.4	44.7	15.7	11.1	16.2	11.5	24.0	3.8	16.2	8.3	1.5	1.8	1.9	1.3	1.7	1.7	1.9	1.5	0.7	2.7	2.1	1.7	3.7	1.5	1.7	2.5	1.5	0.4	24.8	35.5	47.8	51.0	32.4	22.4	11.1	11.4	16.6	3.9	16.6	55.7	8.6	131.4	130.4	6.2	5.1	17.5	19.1	4.9	21.1	5.4	11.5	9.5	3.0	10.0	61.8	5.5	4.2	329.8	10.4	3.6	21.5	9.9	0.9	6.2	11.5	13.6	1.8	0.4	4.2	7.4	28.2	33.4	10.2	15.5	66.3	10.3	7.5	24.0	23.4	1.7	6.5	10.5	6.1	2.1	5.0	1.8	11.1	8.2	12.4	3.7	0.3	6.7	3.1	15.1	8.7	7.5	6.7	11.7	5.8	16.4	4.4	12.7	62.2	7.2	26.3	16.9	12.0	9.9	26.6	19.7	16.1	257.8	11.9	10.1	10.1	11.8
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1472.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: AB_2680325"	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	16.7	36.6	14.9	5.6	14.1	13.8	16.8	12.6	19.0	22.1	11.2	17.2	6.8	18.7	3.1	33.5	16.2	8.3	15.1	13.4	14.0	21.0	38.9	13.6	8.0	15.5	13.6	19.2	18.4	7.8	15.6	4.1	13.7	18.1	3.0	2.1	19.6	7.0	10.7	41.8	12.8	5.1	13.3	16.3	19.6	57.9	14.4	7.1	14.9	5.4	5.3	17.4	23.4	13.3	12.6	16.2	13.0	22.9	6.6	4.9	9.3	9.3	10.7	9.3	9.3	15.4	16.1	7.7	20.2	8.3	13.3	9.5	7.5	12.9	1.7	20.4	9.9	8.0	12.1	23.2	8.5	6.1	30.0	13.8	10.8	7.9	4.6	8.2	15.8	12.7	19.2	15.4	9.4	35.9	17.4	47.4	11.9	16.0	24.9	16.4	13.6	18.9	14.8	17.9	7.1	42.8	17.5	26.3	9.8	5.3	16.2	18.3	19.0	18.5	28.3	38.2	9.2	12.2	12.4	5.5	18.3	69.5	22.7	38.7	29.1	40.3	31.3	22.7	36.9	21.7	36.0	36.7	31.7	22.4	21.3	22.2	21.3	37.5	15.9	21.1	57.2	14.8	14.9	14.1	12.6	19.0	13.4	14.0	15.5	13.6	13.7	13.3	14.4	13.3	18.5	9.6	7.0	4.6	10.9	12.1	20.0	31.0	21.1	5.7	28.0	25.8	3.6	21.5	16.9	20.2	6.2	6.6	19.8	9.3	43.0	43.2	324.0	15.7	12.8	16.4	21.6	21.7	4.7	42.8	26.3	16.4	12.8	11.2	3.8	11.5	23.6	31.3	29.8	6.7	7.6	14.2	22.4	25.1	14.8	1472.9	27.7	15.6	26.6	1.9	17.4	19.0	25.7	8.5	4.9	43.9	17.3	21.8	7.8	16.2	15.1	48.7	15.9	4.0	13.1	10.7	17.5	20.3	31.1	26.7	19.6	6.2	24.4	16.7	17.0	25.3
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401475	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 64.2;smooth muscle: 78.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Basal squamous epithelial cells: 153.1;Early spermatids: 70.2;Endometrial stromal cells: 57.8;Excitatory neurons: 36.0;Oligodendrocyte precursor cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 3.1;naive B-cell: 1.7;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in many"	41	"B-cells: 3.1;dendritic cells: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.8;ASC TERT1: 131.7;BJ: 106.1;fHDF/TERT166: 196.5;HBF TERT88: 120.6;U-2197: 310.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035740	Approved		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	2.8	36.5	18.0	5.7	10.6	0.1	2.5	3.1	11.7	25.7	3.5	13.4	5.2	64.2	11.0	23.5	3.4	28.7	5.4	10.9	4.0	37.0	1.8	25.3	6.2	3.5	3.8	0.8	2.2	0.5	4.5	1.4	3.9	32.0	8.8	5.0	12.2	39.6	0.3	14.4	7.5	78.6	3.6	4.7	5.2	1.8	6.7	2.1	1.8	0.5	15.6	19.1	12.8	10.8	0.1	0.9	4.1	0.0	164.8	131.7	0.2	106.1	71.0	37.7	65.8	0.2	1.2	0.4	0.1	196.5	30.9	0.1	1.4	0.5	120.6	0.0	19.3	0.0	0.1	0.0	1.5	0.1	0.1	31.8	0.0	76.6	2.5	46.6	0.0	0.0	0.0	7.8	22.4	0.0	0.1	0.2	3.5	0.0	0.7	1.1	0.4	0.2	46.3	0.4	2.8	0.2	0.0	0.4	2.4	9.6	0.1	5.9	0.5	17.4	15.9	310.0	56.1	4.1	0.0	0.0	43.9	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	18.0	10.6	3.1	11.7	10.9	4.0	3.5	3.8	3.9	3.6	6.7	10.8	0.4	0.0	1.3	92.7	5.4	28.0	0.4	0.1	153.1	0.3	0.4	0.6	0.7	0.0	2.5	1.8	0.0	0.9	2.7	0.0	0.0	0.6	70.2	1.0	57.8	0.6	0.0	0.0	36.0	0.0	1.5	23.9	0.5	1.2	3.8	0.0	0.0	0.0	0.4	0.0	8.6	0.0	0.0	0.3	4.7	11.8	0.3	0.3	7.2	4.7	0.0	16.4	0.0	33.7	1.1	0.4	0.0	0.4	9.5	1.5	0.0	0.3	0.0	0.8	0.0	6.2	3.3	0.5	0.8	14.6	6.8	0.0	0.5	0.1	0.1	0.0
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 739.7;tongue: 559.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 950.0;Distal tubular cells: 1721.8;Proximal tubular cells: 573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	61.7	39.6	105.9	33.4	119.5	57.0	52.8	129.7	153.1	52.4	108.0	97.7	84.8	35.7	44.8	71.5	34.7	41.7	739.7	101.2	127.8	259.9	411.2	44.6	44.3	119.2	123.9	43.4	66.0	141.8	38.1	23.7	119.5	43.5	89.9	57.3	87.7	42.3	319.4	40.9	63.8	38.5	117.1	35.0	96.1	22.2	121.5	48.6	82.9	559.2	44.2	47.4	34.9	132.4	25.6	7.5	31.3	107.7	88.4	49.8	45.2	29.1	47.1	45.1	43.9	38.8	17.9	53.6	50.9	45.4	36.1	24.5	47.0	36.7	31.9	36.1	79.0	27.5	35.4	132.6	36.6	104.9	34.1	40.0	51.0	36.8	26.7	13.7	36.9	80.8	94.2	84.1	28.6	40.5	73.1	193.7	16.1	148.0	35.5	39.1	51.7	134.9	85.4	20.5	96.7	85.7	33.6	145.8	34.0	25.9	34.5	154.3	25.3	25.7	26.8	91.6	30.0	55.8	42.2	46.3	23.5	127.0	42.1	60.7	60.0	90.1	41.7	98.3	39.4	33.1	48.5	45.1	72.2	25.4	44.7	43.3	54.6	40.5	128.5	43.0	69.1	49.8	105.9	119.5	129.7	153.1	101.2	127.8	119.2	123.9	119.5	117.1	121.5	132.4	56.1	118.6	48.0	64.6	51.7	45.6	44.2	83.6	29.0	61.1	74.2	79.1	950.0	187.3	67.6	106.7	10.4	22.0	54.2	219.1	1721.8	89.3	66.8	73.7	50.7	51.7	37.2	72.6	49.0	140.3	78.3	74.1	63.7	93.2	71.0	28.0	47.5	391.0	121.4	48.8	74.7	122.1	166.8	89.6	81.7	10.2	66.5	80.3	129.9	20.6	104.7	199.9	58.7	32.2	108.0	65.2	125.0	89.9	114.5	32.0	162.0	573.6	46.3	66.7	92.1	76.9	80.4	163.2	79.6	67.3	55.8	24.4	58.4	39.9	146.7	53.6
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130632-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947"	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	22.6	18.4	15.2	20.4	16.4	26.5	25.0	17.7	21.4	19.9	15.4	17.6	17.7	22.1	27.5	28.6	16.6	18.4	23.2	15.3	17.7	17.8	30.8	16.9	25.2	17.1	17.0	25.9	19.7	22.9	15.8	20.3	17.0	24.6	19.1	15.1	21.0	16.7	33.1	26.7	15.5	16.8	15.6	19.6	17.8	15.4	16.3	22.5	21.7	24.0	27.5	23.8	18.1	17.6	45.8	33.7	42.7	51.3	39.1	36.7	58.3	49.8	39.6	40.6	29.7	60.7	32.9	64.3	30.5	35.3	31.0	41.1	54.8	35.3	54.1	44.7	43.2	77.3	26.3	139.1	34.1	101.0	58.2	32.0	44.4	33.4	44.4	27.4	34.8	39.1	113.5	49.1	41.0	49.1	81.6	101.5	71.0	63.5	38.1	66.6	66.7	75.4	33.1	49.0	51.8	40.0	33.6	75.0	49.9	36.1	38.2	44.5	36.0	47.2	51.1	45.3	64.0	41.0	50.6	104.1	40.5	82.8	49.1	17.6	12.4	9.8	15.2	17.8	20.2	18.0	19.6	18.8	15.3	15.0	21.4	19.2	1.9	17.1	26.1	16.3	18.3	11.3	15.2	16.4	17.7	21.4	15.3	17.7	17.1	17.0	17.0	15.6	16.3	17.6	38.6	35.3	55.5	8.1	36.8	33.4	42.7	37.8	30.7	37.2	26.0	36.8	44.5	30.0	53.0	18.4	4.2	50.5	47.7	17.9	25.4	47.8	6.0	40.4	52.4	40.4	18.0	26.9	9.8	41.8	48.1	43.2	19.9	65.4	48.1	31.2	21.8	33.2	27.2	18.5	11.4	21.6	26.4	17.7	20.8	6.3	48.7	19.0	12.4	15.0	39.2	25.5	47.4	12.1	15.9	33.1	15.0	43.6	25.6	40.6	14.2	22.7	29.2	53.2	39.5	62.2	49.1	70.2	84.5	35.6	33.5	32.4	39.9	42.8	28.2	31.9
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170224	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	19.8	21.3	26.7	25.5	26.8	20.0	72.5	29.6	32.8	23.6	19.1	22.7	13.8	25.8	22.4	36.2	15.9	16.5	13.9	26.7	28.3	17.8	15.9	18.7	24.7	22.1	24.7	13.4	9.0	16.2	21.3	24.4	23.1	15.3	24.9	31.6	26.0	13.0	18.0	40.1	15.9	22.8	21.7	16.7	15.7	14.1	27.5	20.7	11.6	17.5	26.2	34.7	21.0	28.4	67.8	36.2	79.0	38.9	37.7	52.7	43.5	71.1	84.7	60.6	29.3	58.5	38.4	55.2	42.0	39.2	44.7	69.2	76.2	73.6	80.8	41.3	49.9	44.5	31.2	106.5	37.5	111.9	65.9	33.6	64.7	36.2	102.8	30.5	70.6	75.7	106.2	15.3	93.4	54.8	86.5	131.2	72.4	83.4	49.5	105.5	36.6	36.5	55.3	69.8	54.1	23.3	119.6	52.5	53.6	32.4	92.2	68.6	56.0	56.5	56.3	50.2	51.3	22.4	58.0	217.9	51.0	89.9	73.2	26.1	38.3	36.9	38.2	46.5	48.5	35.6	38.7	39.9	44.9	29.2	41.1	38.8	4.9	33.1	33.8	27.2	44.3	28.3	26.7	26.8	29.6	32.8	26.7	28.3	22.1	24.7	23.1	21.7	27.5	28.4	13.2	19.2	38.3	20.5	22.9	38.7	40.3	123.9	19.4	14.5	74.3	50.0	31.5	14.3	66.2	20.2	10.4	56.9	23.0	21.7	50.9	45.2	6.5	13.9	18.5	19.3	9.0	23.1	38.5	28.1	46.1	31.4	15.8	22.0	18.3	21.9	20.0	19.0	49.6	20.2	35.6	20.7	40.7	29.1	42.7	7.5	11.1	55.9	32.0	12.2	56.0	61.1	34.0	29.7	17.1	56.4	28.4	10.1	22.3	38.6	12.2	46.5	32.7	24.5	19.7	15.4	30.1	36.9	57.5	30.6	54.0	32.8	27.4	26.3	34.0	48.1
MPND	FLJ14981	ENSG00000008382	"MPN domain containing"	Q8N594	19	4343527-4360086	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 84.7;Paneth cells: 42.7;Proximal enterocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043274, HPA045475"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli rim"	Nucleoplasm	"HPA043274: AB_2678403, HPA045475: AB_2679339"	"unprognostic (3.16e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.85e-2)"	"prognostic favorable (6.12e-4)"	"unprognostic (8.60e-2)"	"unprognostic (5.37e-3)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.04e-2)"	10.5	21.9	22.6	9.3	22.4	15.8	10.7	27.1	35.0	13.2	20.8	25.4	30.6	11.9	8.6	18.1	11.5	9.5	22.4	23.1	20.5	22.7	46.5	12.6	11.7	22.7	20.7	13.0	24.4	15.4	11.0	6.9	23.3	19.0	16.2	4.0	17.2	9.6	23.2	15.6	19.8	6.5	19.4	15.2	20.1	6.6	20.6	10.2	13.3	14.4	7.1	15.2	12.7	25.0	16.0	13.2	21.3	24.6	13.1	6.1	21.7	7.6	7.2	6.2	7.6	25.6	8.1	14.4	23.3	9.9	18.2	16.1	9.8	13.2	3.4	16.4	21.5	11.0	18.4	37.4	10.0	14.9	19.1	9.4	9.4	6.8	7.1	9.3	18.9	37.4	6.0	36.4	7.8	41.8	35.4	12.6	9.8	26.5	18.2	28.8	6.5	21.0	15.5	25.4	23.7	24.3	13.5	19.4	9.9	12.1	13.0	18.1	7.3	9.8	10.4	60.4	15.4	30.1	20.1	9.7	10.9	8.3	11.5	9.3	3.1	1.5	1.3	3.7	2.1	1.0	1.6	1.9	2.9	1.6	1.0	1.1	0.8	1.7	1.8	2.9	3.7	1.3	22.6	22.4	27.1	35.0	23.1	20.5	22.7	20.7	23.3	19.4	20.6	25.0	6.1	0.0	3.7	1.6	5.1	5.4	8.4	1.4	3.4	8.2	9.5	8.5	13.9	11.5	2.7	11.0	2.1	13.6	9.8	84.7	0.0	4.1	0.8	8.0	6.1	6.0	16.7	2.5	2.6	5.1	11.9	5.2	9.2	8.9	4.5	7.8	5.7	23.5	14.8	6.7	2.4	31.2	2.0	26.0	9.6	3.9	6.2	14.4	3.6	1.9	8.8	8.6	21.6	3.5	2.1	4.3	42.7	3.8	7.7	6.9	50.7	15.0	2.3	5.6	6.6	6.1	11.7	0.2	7.6	7.8	8.4	10.4	6.3	9.1	34.6	9.6
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269855-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"bone marrow: 4023.1"	"Cell type enriched"	"Detected in some"	30	"Erythroid cells: 87.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"HL-60: 3517.4;NB-4: 4589.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.5	0.4	0.8	0.6	0.6	4023.1	0.3	0.6	1.1	0.0	0.3	0.2	0.0	0.2	1.1	0.1	0.1	0.3	1.1	0.8	0.7	0.2	1.8	8.4	1.7	0.9	1.0	0.1	0.1	0.0	1.5	1.4	0.9	0.2	0.2	0.4	66.3	0.1	1.1	4.3	0.2	0.3	0.8	21.7	0.1	0.4	0.8	10.9	0.3	0.3	0.2	0.5	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3517.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4589.9	0.0	0.0	0.0	5.3	3.2	0.6	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	4.0	0.0	0.0	6.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.1	7.5	0.8	0.6	0.6	1.1	0.8	0.7	0.9	1.0	0.9	0.8	0.8	0.7	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.9	0.0	0.5	0.1	0.0	0.1	0.0	87.4	0.3	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.7	0.3	0.9	0.0	0.2	0.0	0.0	1.2	0.0	1.3	0.0	2.9	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.3	0.1	0.0	0.1	0.6	0.0	0.0	0.0
MPP1	"DXS552E, PEMP"	ENSG00000130830	"Membrane palmitoylated protein 1"	Q00013	X	154778684-154821007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 410.9;Erythroid cells: 393.8;Hofbauer cells: 291.9;Macrophages: 155.9;Syncytiotrophoblasts: 454.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 215.7;neutrophil: 202.1"	"Group enriched"	"Detected in all"	8	"dendritic cells: 57.7;granulocytes: 215.7;monocytes: 98.8"	"Cell line enhanced"	"Detected in many"		"HEL: 218.0;REH: 136.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076675	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		650000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"HPA076675: "	"unprognostic (2.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.60e-6)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.67e-3)"	24.1	27.2	21.0	27.1	22.0	116.8	16.5	26.2	29.7	11.6	18.6	17.2	59.4	13.4	5.3	10.5	15.7	24.3	26.0	22.5	25.2	42.9	37.5	28.3	24.9	28.3	21.9	10.6	34.6	30.7	9.7	86.5	30.7	15.5	17.6	10.6	23.7	18.1	29.2	10.2	47.3	19.7	22.5	40.9	11.8	7.1	27.3	72.8	14.0	27.2	12.5	21.3	10.0	28.2	41.4	8.3	18.7	18.7	19.0	20.1	59.5	15.3	23.3	25.3	30.8	23.7	3.7	32.8	29.3	17.1	67.9	4.6	21.6	6.9	19.9	34.9	38.0	218.0	5.7	25.3	28.6	44.4	121.4	19.4	9.0	28.2	7.0	25.9	58.5	42.1	96.1	5.3	28.7	0.2	102.6	60.3	1.9	3.8	28.2	136.0	4.8	15.5	14.8	3.3	4.7	7.5	12.7	1.2	13.3	18.5	3.2	25.8	26.6	23.2	12.5	51.8	41.7	36.6	52.9	12.5	32.7	61.7	11.1	49.7	95.6	215.7	5.1	76.6	6.0	7.8	5.9	5.7	57.7	2.7	15.4	7.9	202.1	10.1	98.8	15.5	3.5	79.1	21.0	22.0	26.2	29.7	22.5	25.2	28.3	21.9	30.7	22.5	27.3	28.2	18.3	3.2	11.2	8.1	6.3	8.7	4.8	0.2	8.0	10.2	7.1	5.1	17.0	41.5	6.2	7.3	4.2	410.9	6.9	16.3	21.5	11.7	0.6	3.5	5.7	18.9	11.5	393.8	16.1	2.8	27.0	11.4	1.1	6.4	90.6	9.6	11.7	10.6	291.9	16.8	17.1	4.4	0.0	104.7	30.2	2.4	8.7	155.9	10.6	15.9	52.5	15.4	9.2	6.0	5.9	3.7	4.1	13.2	8.1	3.1	57.4	66.3	2.2	8.2	0.0	8.6	10.3	0.7	6.8	6.4	6.0	454.4	9.9	14.5	5.8	1.2
MPP2	"DKFZp761D0712, DLG2"	ENSG00000108852	"Membrane palmitoylated protein 2"	Q14168	17	43875357-43909711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 91.0;Early spermatids: 69.6;Horizontal cells: 35.3;Oligodendrocytes: 59.6;Spermatogonia: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026486, HPA073483"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 56: Bipolar cells - Visual perception"	"Mitochondria, Cytosol"		"HPA026486: AB_1854085, HPA073483: "	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (4.37e-2)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.89e-4)"	2.5	3.8	22.2	1.3	25.7	0.5	3.3	25.0	27.0	5.3	7.3	9.4	1.1	5.6	26.0	3.0	5.0	2.2	8.9	23.3	24.2	1.6	0.2	1.4	0.5	30.0	27.1	3.2	3.4	15.8	13.7	2.5	26.5	7.5	1.2	15.7	1.4	8.7	1.0	1.8	2.5	5.0	24.7	0.7	3.7	16.9	28.0	0.7	3.5	1.5	0.6	6.7	4.4	41.6	7.2	10.5	11.0	15.7	1.4	1.0	6.0	2.5	0.3	9.9	9.0	3.7	4.7	10.4	5.7	2.5	12.2	2.9	15.1	6.0	7.0	0.0	11.5	0.9	9.2	0.2	0.3	0.0	2.9	1.5	0.5	6.8	0.1	5.4	0.7	16.6	3.9	0.0	2.5	2.8	1.5	0.8	19.7	0.8	6.4	7.4	15.5	0.7	0.2	0.2	11.6	10.7	3.0	1.0	4.1	9.8	24.5	4.9	0.1	10.5	13.2	4.0	4.5	3.4	7.4	0.0	15.8	6.9	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	22.2	25.7	25.0	27.0	23.3	24.2	30.0	27.1	26.5	24.7	28.0	41.6	2.1	0.0	0.0	11.1	0.0	0.4	1.4	1.0	0.0	91.0	0.5	2.9	10.5	0.0	0.0	0.0	2.1	5.8	0.1	0.1	0.0	0.7	69.6	0.1	0.4	1.4	0.0	0.0	20.4	0.4	0.4	2.7	0.0	0.1	0.0	1.2	0.0	0.0	0.7	35.3	19.0	0.0	0.0	0.0	0.4	21.1	3.7	0.2	0.0	1.9	0.0	16.1	0.0	13.6	59.6	0.5	0.0	5.7	0.1	0.0	0.0	0.1	0.0	7.1	0.0	1.5	1.9	23.2	31.4	0.2	0.1	2.7	0.3	0.1	0.0	0.0
MPP4	DLG6	ENSG00000082126	"Membrane palmitoylated protein 4"	Q96JB8	2	201644870-201698694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	194	"retina: 286.2"	"Group enriched"	"Detected in some"	36	"Cone photoreceptor cells: 1586.7;Rod photoreceptor cells: 808.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 22.2;hTEC/SVTERT24-B: 21.0;LHCN-M2: 85.8;TIME: 16.4;U-87 MG: 21.3"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	HPA057393			Supported	"Actin filaments,Cytosol"		No	No				"Cluster 79: Retina - Phototransduction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Actin filaments"	"HPA057393: AB_2732612"	"unprognostic (1.42e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.33e-16)"	"unprognostic (1.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	0.1	0.5	0.3	0.1	0.3	0.0	0.1	1.3	0.4	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.0	286.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	1.4	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.1	6.6	0.0	11.2	2.7	6.6	6.7	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.8	22.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.7	0.0	21.0	0.1	3.2	12.3	0.1	0.0	0.0	85.8	0.0	0.0	0.0	0.6	0.0	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	16.4	8.4	2.6	2.0	7.8	0.0	0.0	0.0	21.3	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.3	0.4	0.4	0.2	0.6	0.1	0.2	0.1	0.1	0.3	0.7	3.2	8.6	0.3	0.0	0.4	0.0	0.2	0.0	20.0	0.4	0.0	0.2	1.5	6.2	1.8	1586.7	0.1	0.2	0.0	0.0	0.2	2.8	0.4	0.4	2.6	0.0	0.0	7.3	0.2	0.1	0.6	0.0	0.1	3.8	0.1	0.0	0.1	0.1	18.5	2.8	0.0	0.0	0.3	0.9	2.5	0.0	0.4	1.8	0.0	0.1	33.0	1.0	2.0	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.1	6.7	808.3	0.0	1.4	1.1	0.1	0.4	0.0	0.4	0.0	0.3	0.1	0.2	0.0
MPP7	FLJ32798	ENSG00000150054	"Membrane palmitoylated protein 7"	Q5T2T1	10	28050993-28334486	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.3;Excitatory neurons: 76.7;Suprabasal keratinocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 4.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.3;CACO-2: 45.2;CAPAN-2: 27.9;T-47d: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037597, HPA037598"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	Nucleoplasm	"HPA037597: AB_2675569, HPA037598: AB_10696941"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.64e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.79e-14)"	"unprognostic (2.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	3.8	2.7	0.1	5.7	1.0	8.8	9.7	4.7	2.2	6.4	0.1	10.7	6.0	5.1	1.9	37.1	11.8	6.4	6.6	0.4	0.0	12.2	1.9	10.1	2.6	0.0	0.0	3.4	12.1	11.8	2.2	11.7	0.1	8.0	9.3	9.7	7.6	4.8	13.8	24.8	7.2	8.7	0.0	2.4	8.8	9.0	0.0	3.2	14.4	14.3	6.9	9.7	9.6	1.1	5.9	0.1	0.6	0.0	0.1	0.1	23.3	1.2	0.9	4.7	7.4	45.2	27.9	0.0	0.3	3.4	3.4	10.4	3.9	7.5	10.9	0.0	7.5	0.0	1.3	2.8	0.0	0.0	0.0	0.3	11.6	0.7	0.4	0.0	0.0	2.2	1.1	0.0	6.2	10.9	2.3	0.0	1.4	8.9	2.1	1.2	13.3	0.0	0.4	19.0	1.1	0.0	2.3	11.3	0.0	3.6	89.3	1.1	0.0	1.8	12.5	0.0	1.0	0.2	0.0	0.1	0.1	10.7	0.0	0.0	7.7	9.0	3.8	2.5	5.6	0.6	4.2	2.6	7.8	0.5	7.9	5.7	3.1	5.0	1.5	0.1	1.1	5.1	0.1	1.0	4.7	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.1	1.6	44.8	48.3	10.4	5.5	23.1	10.9	9.5	7.4	1.1	14.7	8.6	12.1	10.0	24.3	14.7	16.7	50.0	9.8	15.3	9.8	5.5	82.3	9.3	0.6	11.7	6.7	4.2	76.7	12.9	3.5	2.6	11.2	6.6	1.3	0.7	2.9	3.2	5.4	3.3	30.3	10.4	8.2	4.7	5.3	20.3	0.9	8.1	7.2	12.2	16.2	24.0	4.1	4.5	2.5	6.6	7.8	0.4	5.1	7.5	12.1	9.5	19.3	8.5	0.0	1.5	7.6	5.4	9.5	48.0	61.1	46.5	16.3	0.1	11.3	17.4
MPPED2	"239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638"	ENSG00000066382	"Metallophosphoesterase domain containing 2"	Q15777	11	30384493-30586872	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.5;thyroid gland: 24.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 155.7;Cone photoreceptor cells: 285.7;Excitatory neurons: 108.1;Horizontal cells: 82.4;Oligodendrocyte precursor cells: 345.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 21.6;HAP1: 12.2;JURKAT: 10.9;RT4: 9.0;SH-SY5Y: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062575			Approved	Nucleoli,Vesicles,Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Vesicles, Mitochondria"	"HPA062575: AB_2684797"	"unprognostic (9.60e-3)"	"unprognostic (6.12e-3)"	"unprognostic (3.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-4)"	"unprognostic (6.82e-2)"	"unprognostic (2.47e-7)"	"unprognostic (3.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.57e-2)"	2.0	5.2	6.3	0.5	13.3	0.3	4.1	4.7	10.5	24.5	0.9	4.9	0.7	6.4	5.6	0.9	8.9	1.0	3.7	11.9	13.0	9.6	0.4	0.4	0.2	19.6	10.3	0.5	1.6	3.2	11.0	1.6	11.7	12.6	0.6	16.0	10.3	7.4	5.1	0.7	1.0	3.6	4.9	2.3	1.7	1.7	9.5	3.6	24.6	1.5	0.3	3.3	5.1	6.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	12.2	0.0	0.0	0.0	2.6	0.0	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.9	0.0	0.3	3.5	0.1	0.1	0.0	3.4	0.2	0.0	9.0	0.1	6.5	0.0	0.0	3.6	1.3	1.8	0.0	0.1	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.2	0.1	0.4	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.1	6.3	13.3	4.7	10.5	11.9	13.0	19.6	10.3	11.7	4.9	9.5	6.8	3.1	0.0	2.2	155.7	1.8	1.0	51.7	2.6	2.8	26.7	3.6	5.2	5.2	0.0	1.0	46.0	285.7	0.3	0.5	0.1	25.4	4.2	2.1	35.6	1.5	6.3	0.0	1.3	108.1	0.0	0.2	2.6	0.0	13.8	5.1	12.1	0.7	0.2	4.1	82.4	56.0	0.3	2.0	22.5	3.6	1.6	0.3	2.7	5.4	13.1	0.5	44.0	0.0	345.8	7.9	0.1	0.1	3.4	0.5	19.3	0.0	3.1	3.0	18.5	0.0	1.2	7.1	0.1	2.1	1.5	1.1	0.5	0.8	0.4	0.0	28.4
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029821	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 390.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 553.6;Hepatocytes: 578.6;Paneth cells: 621.4;Proximal enterocytes: 1322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	58.0	57.3	25.3	10.0	32.3	36.5	51.0	29.0	31.0	40.9	29.8	102.4	106.5	34.7	0.6	91.5	42.9	16.6	64.2	22.9	23.4	71.4	390.7	43.5	8.8	34.0	27.5	81.7	106.4	4.8	14.7	9.1	29.7	45.3	17.0	0.5	43.5	9.6	89.7	82.3	93.0	7.0	26.0	22.1	70.3	51.7	31.4	4.5	24.8	23.1	6.0	48.3	62.3	35.1	44.0	50.4	24.2	50.0	27.8	17.2	38.1	23.4	20.6	24.8	33.2	48.6	18.9	68.7	33.0	16.7	16.7	29.9	20.9	33.8	3.6	41.4	119.2	26.5	21.3	115.6	87.5	29.0	35.6	30.0	64.2	16.1	15.1	22.8	50.6	33.1	48.0	19.3	7.0	33.8	2.6	97.5	45.7	56.7	52.2	73.6	28.8	51.9	25.5	14.0	12.4	92.9	15.6	23.9	46.6	12.2	26.0	45.6	39.8	21.3	60.1	23.9	16.0	33.3	16.8	21.0	7.7	34.7	11.1	48.5	71.9	54.7	31.0	27.5	42.4	24.9	20.1	26.4	104.0	25.0	2.7	10.4	21.9	87.8	12.7	16.3	44.3	35.4	25.3	32.3	29.0	31.0	22.9	23.4	34.0	27.5	29.7	26.0	31.4	35.1	21.3	35.3	61.9	14.7	25.1	81.6	80.4	120.3	70.6	4.5	81.4	83.4	29.4	243.1	70.0	60.7	0.0	61.9	20.3	553.6	133.1	146.4	191.1	38.5	46.8	42.6	108.6	122.6	1.1	148.3	119.1	52.8	87.1	72.5	17.2	140.3	108.5	578.6	77.5	3.3	1.9	363.1	85.5	84.6	77.6	115.1	91.0	62.7	58.7	3.7	60.7	24.8	56.7	4.5	14.9	117.9	621.4	84.7	65.7	77.7	1322.1	469.8	13.4	2.8	46.0	34.4	36.0	101.3	11.5	133.7	152.9	50.1	26.6	57.7	397.5	110.6
MRAS	"M-RAs, R-RAS3, RRAS3"	ENSG00000158186	"Muscle RAS oncogene homolog"	O14807	3	138347648-138405534	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 202.3;heart muscle: 132.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"non-classical monocyte: 25.0"	"Lineage enriched"	"Detected in many"	9	"monocytes: 25.0"	"Cell line enhanced"	"Detected in many"		"BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042728	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"HPA042728: AB_10796582"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.69e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.23e-2)"	91.9	67.7	112.7	10.8	130.6	1.7	46.7	118.2	105.5	17.3	48.9	24.2	3.3	28.7	7.1	7.9	26.4	12.0	132.9	105.6	132.8	22.9	5.5	18.4	5.2	126.1	135.9	48.6	5.7	8.2	17.7	10.6	112.9	15.3	4.1	15.9	13.4	15.0	80.4	12.2	8.7	23.2	110.3	12.2	12.0	9.6	202.3	4.9	26.4	48.0	3.3	29.1	12.1	97.8	0.8	7.9	15.8	24.5	59.6	29.2	40.0	92.9	16.0	7.3	8.2	3.3	3.1	0.3	113.7	70.4	18.6	0.1	9.0	1.8	6.1	7.7	3.1	0.5	4.8	20.1	15.9	0.0	1.9	41.5	5.9	0.7	1.4	13.6	1.3	0.0	10.7	0.8	31.4	3.7	0.0	20.4	19.1	0.0	2.7	1.1	33.8	0.2	30.4	2.0	18.6	42.0	62.8	0.7	45.9	10.9	16.1	37.7	0.6	23.7	25.3	24.3	2.4	0.1	1.0	1.2	21.4	0.1	11.4	0.2	2.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.8	25.0	0.1	0.0	0.8	112.7	130.6	118.2	105.5	105.6	132.8	126.1	135.9	112.9	110.3	202.3	97.8	8.9	9.6	1.5	54.2	0.8	2.2	3.0	3.4	1.2	5.6	28.8	34.8	121.7	2.8	3.5	9.2	10.4	20.1	0.2	0.0	58.7	8.6	11.6	1.0	21.4	14.5	1.8	0.0	25.5	3.2	3.2	23.0	2.0	1.5	6.3	35.2	12.8	1.6	26.3	28.6	20.6	0.0	2.0	15.1	18.4	40.0	23.3	18.2	28.4	20.6	12.2	24.3	0.0	28.6	11.0	3.8	0.0	34.3	0.1	3.3	0.0	27.5	1.3	9.6	6.6	20.8	18.9	7.3	18.6	0.4	1.0	14.4	0.8	59.1	0.0	0.6
MRFAP1	"PAM14, PGR1"	ENSG00000179010	"Morf4 family associated protein 1"	Q9Y605	4	6640091-6642745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB042447, HPA056367"	Approved		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB042447: AB_2145271, HPA056367: AB_2683107"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.90e-7)"	"unprognostic (1.24e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	227.9	291.8	348.2	126.4	355.0	108.2	209.1	360.6	382.1	222.2	330.6	254.2	147.1	254.8	207.9	189.0	221.4	134.3	260.4	335.9	359.7	266.1	245.3	203.4	114.8	409.8	362.8	243.2	156.1	260.7	262.1	194.2	367.5	193.0	132.7	165.7	164.8	207.0	372.3	179.8	163.4	215.1	358.3	181.3	196.1	154.7	359.7	131.0	177.7	308.2	132.8	220.3	194.6	389.3	344.4	371.8	311.7	360.9	373.9	336.6	245.7	444.2	407.3	401.1	398.9	368.7	362.7	214.4	333.0	411.9	455.0	192.2	425.4	462.3	482.5	85.4	306.6	319.6	430.5	405.8	349.7	241.6	151.2	351.0	416.2	369.2	371.6	380.2	452.2	185.9	427.9	136.4	401.2	432.5	182.2	565.1	387.7	297.6	472.6	233.6	564.5	182.3	490.3	255.6	488.0	381.6	287.7	204.2	429.7	270.4	569.8	291.2	408.6	350.3	235.2	262.6	592.2	196.8	266.4	351.5	362.5	507.6	347.7	202.0	186.2	163.2	126.9	154.0	127.9	89.4	125.3	127.0	177.8	94.8	127.8	126.3	198.6	137.1	153.1	143.8	147.1	196.4	348.2	355.0	360.6	382.1	335.9	359.7	409.8	362.8	367.5	358.3	359.7	389.3	141.8	160.3	158.9	14.4	84.7	188.5	262.6	155.6	130.9	113.9	148.6	155.2	227.0	163.0	124.4	88.3	16.7	547.5	103.7	83.8	219.2	241.8	43.1	161.8	184.2	196.4	178.1	123.1	18.7	204.2	312.7	197.2	69.8	166.8	150.4	141.4	171.4	179.7	200.4	111.0	20.9	129.7	130.2	144.4	114.1	65.1	314.0	106.8	126.3	12.2	158.5	270.7	113.3	12.5	33.7	189.0	121.3	304.6	61.1	257.3	168.0	252.6	126.0	111.5	216.9	230.7	197.7	349.3	211.8	126.3	173.8	322.2	121.4	337.1	138.3	236.7
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764522-13774282	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No		880000	"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: AB_2678141"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	15.8	19.2	7.9	9.0	8.2	9.5	18.5	9.3	8.5	24.8	7.0	17.3	9.6	21.6	4.1	20.5	21.8	5.3	12.9	7.6	7.5	22.3	23.8	15.8	10.5	8.9	7.7	24.4	19.6	7.8	18.0	11.9	8.7	19.3	6.4	5.3	20.5	8.8	11.6	26.0	21.1	5.2	7.1	23.1	18.3	3.6	8.4	7.8	23.0	4.4	8.7	17.6	22.4	10.9	14.7	9.3	5.5	13.1	6.1	9.5	13.0	17.9	9.3	13.8	12.4	9.9	11.5	7.9	6.5	6.6	7.3	25.4	24.5	15.5	10.8	12.6	39.3	6.6	18.5	12.0	4.7	20.3	14.8	9.9	9.4	7.1	6.0	14.3	13.7	7.9	11.6	0.6	7.4	18.7	21.9	14.3	9.1	6.0	27.2	20.5	7.6	17.4	8.1	11.4	10.4	9.9	6.6	13.9	14.5	7.7	11.1	8.2	8.2	8.2	7.6	29.3	8.8	11.0	11.3	2.4	6.8	22.5	9.7	3.4	1.8	0.7	1.7	1.7	1.8	1.5	1.7	2.2	1.4	1.6	1.3	1.1	1.6	1.8	1.1	2.7	1.5	1.3	7.9	8.2	9.3	8.5	7.6	7.5	8.9	7.7	8.7	7.1	8.4	10.9	9.2	9.6	19.8	15.0	10.8	11.1	8.9	10.8	6.8	4.3	9.0	8.4	0.9	8.6	13.4	16.5	8.4	13.2	17.2	8.1	5.9	9.2	0.7	11.5	14.4	13.8	9.1	13.3	22.3	12.7	8.7	12.3	14.3	14.2	13.3	9.9	12.8	10.0	7.2	1.7	19.6	9.3	6.1	7.2	8.4	1.7	17.4	7.4	1.8	9.4	10.5	5.0	17.5	18.1	15.2	6.8	11.0	15.1	13.3	4.7	16.5	10.5	19.2	9.3	26.3	10.8	13.3	0.3	4.5	13.3	11.4	5.3	16.0	22.2	9.8	6.8
MRM3	"FLJ10581, HC90, RMTL1, RNMTL1"	ENSG00000171861	"Mitochondrial rRNA methyltransferase 3"	Q9HC36	17	782353-792509	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 27.1;Distal tubular cells: 19.6;Ductal cells: 18.9;Exocrine glandular cells: 18.4;Extravillous trophoblasts: 24.6;Proximal tubular cells: 20.0;Syncytiotrophoblasts: 19.6;Theca cells: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022534, HPA023031, HPA023292"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388"	"unprognostic (1.66e-1)"	"unprognostic (5.83e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (3.82e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.42e-2)"	9.3	12.9	7.9	6.8	8.4	17.6	8.7	9.9	9.2	6.7	9.7	9.7	7.8	7.6	5.2	11.6	8.0	4.8	17.3	8.2	7.9	9.7	20.5	6.0	10.4	8.2	8.7	8.7	19.6	9.1	6.2	6.9	8.6	7.5	7.5	4.3	9.5	6.0	29.4	14.7	8.2	6.6	7.7	9.9	13.0	18.6	8.6	8.3	7.0	18.7	9.3	8.6	7.2	8.3	26.4	53.9	11.3	19.8	16.2	13.8	22.5	13.6	12.8	27.3	22.8	31.8	12.0	47.3	14.1	10.6	13.1	21.7	33.0	12.0	24.8	16.2	55.9	18.3	30.6	27.9	16.7	15.8	16.0	16.7	16.2	29.0	23.9	13.6	20.7	28.3	31.3	20.1	14.5	28.5	27.5	20.8	16.9	19.3	28.2	33.1	7.9	25.3	18.2	14.2	15.1	17.6	19.8	16.6	26.5	9.0	20.6	14.2	16.6	14.6	11.2	21.0	38.3	8.0	11.8	18.9	18.3	22.1	20.0	12.5	24.6	14.7	25.0	20.6	27.0	38.2	27.1	30.8	25.8	38.4	32.8	28.4	1.8	32.7	21.1	20.8	31.9	26.8	7.9	8.4	9.9	9.2	8.2	7.9	8.2	8.7	8.6	7.7	8.6	8.3	11.3	6.4	1.1	0.0	4.2	0.0	0.0	0.0	0.0	0.0	9.8	10.4	0.0	0.0	1.3	5.5	0.0	27.1	7.6	0.0	19.6	18.9	0.0	8.3	8.0	5.1	0.0	0.0	0.0	18.4	24.6	4.1	0.0	8.8	3.8	15.6	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.5	0.0	0.0	20.0	0.7	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	19.6	4.4	28.9	0.0	0.0
MRPL23	"L23MRP, RPL23L"	ENSG00000214026	"Mitochondrial ribosomal protein L23"	Q16540	11	1947278-1984522	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 342.1"									HPA050406	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"	"unprognostic (5.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.33e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.08e-2)"	67.5	123.1	18.3	16.4	19.2	42.4	66.3	19.4	26.0	64.2	20.3	74.8	27.1	54.0	14.3	125.9	57.8	10.9	128.4	18.8	20.1	96.6	140.1	67.4	26.7	19.7	18.7	90.8	118.0	23.5	92.3	8.5	19.6	71.8	19.1	7.0	90.4	14.6	159.5	124.0	67.1	13.1	19.3	81.7	94.3	27.1	19.0	17.7	71.5	39.6	23.9	59.7	70.9	20.5	69.3	74.9	39.7	49.2	15.9	44.0	67.4	20.9	28.0	31.8	23.4	4.8	79.2	72.9	43.6	44.4	44.5	70.6	64.5	88.8	15.0	75.4	342.1	28.1	24.5	98.2	41.7	65.2	40.8	34.9	34.0	22.0	6.4	37.3	23.0	38.3	24.9	34.6	46.5	71.4	57.9	55.8	64.1	58.5	71.9	77.7	27.2	92.0	28.4	25.0	86.5	81.6	25.0	56.2	45.6	22.0	1.4	78.1	30.8	43.6	32.4	11.0	44.0	58.4	47.7	68.7	68.2	56.0	0.1	2.7	18.5	16.8	8.0	14.5	6.4	36.4	11.8	9.4	23.9	34.6	25.7	8.1	1.0	8.3	10.4	10.6	20.0	5.2	18.3	19.2	19.4	26.0	18.8	20.1	19.7	18.7	19.6	19.3	19.0	20.5	33.9	12.8	6.3	17.0	79.1	186.3	69.9	154.6	19.4	7.0	105.4	111.6	69.7	95.8	88.7	38.6	0.0	125.3	43.6	298.1	123.3	126.6	10.2	57.9	29.1	37.5	136.2	117.8	9.4	232.6	224.4	43.3	54.6	40.2	96.6	54.7	57.8	178.9	178.5	5.0	9.9	258.7	99.7	163.9	214.3	18.5	23.0	78.4	200.9	3.7	133.6	30.6	63.8	7.5	12.2	171.1	273.6	36.5	76.8	61.9	175.4	245.0	98.7	11.7	39.5	33.5	69.2	24.4	39.8	47.5	258.7	90.6	50.2	67.0	256.1	82.8
MRPL28	"MAAT1, p15"	ENSG00000086504	"Mitochondrial ribosomal protein L28"	Q13084	16	366969-371289	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030594, CAB033542, HPA055589"	Supported		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855"	"unprognostic (2.39e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.45e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.56e-2)"	43.3	63.2	43.2	25.8	46.6	43.7	43.6	41.6	55.9	40.8	39.9	48.9	31.4	47.0	20.6	58.0	39.4	23.3	101.0	46.9	42.7	74.9	79.9	38.7	30.4	41.2	41.7	36.4	32.2	46.6	44.0	21.1	42.5	45.3	18.1	20.4	37.9	23.8	87.6	45.9	43.0	25.8	41.2	52.2	43.8	85.2	42.2	36.8	44.2	59.3	27.1	43.1	42.3	43.9	72.8	135.8	68.3	82.9	37.9	48.6	90.1	82.6	107.3	147.2	143.2	175.4	95.9	105.5	88.6	85.0	75.3	87.6	107.8	172.6	78.2	95.4	211.8	78.7	110.0	149.2	123.9	98.1	96.1	73.8	84.6	136.3	110.5	69.0	109.5	99.5	143.8	75.6	93.0	249.0	152.9	98.2	109.1	72.3	82.5	181.7	85.2	149.1	121.4	41.3	115.2	102.4	102.5	100.3	84.6	66.4	131.1	92.4	85.5	86.0	118.6	70.8	92.4	111.1	100.3	143.0	60.0	68.4	140.8	95.4	105.7	122.1	71.0	107.2	59.1	93.3	62.0	68.9	96.6	105.0	43.0	54.7	120.5	79.3	115.1	119.0	125.8	97.9	43.2	46.6	41.6	55.9	46.9	42.7	41.2	41.7	42.5	41.2	42.2	43.9	44.2	38.5	34.1	8.5	43.6	34.7	50.4	134.5	25.6	34.8	35.6	36.4	55.4	40.0	69.0	69.9	8.4	87.0	46.8	70.2	193.7	112.5	97.7	35.3	30.0	44.9	64.1	51.3	5.8	111.9	108.0	41.2	37.2	31.2	26.6	57.2	47.2	66.6	99.7	28.6	5.0	54.6	77.3	66.5	36.1	232.6	38.2	47.8	71.2	2.8	136.1	56.1	45.3	3.0	5.4	107.0	76.5	38.4	47.2	46.7	106.3	180.0	55.4	42.5	39.5	31.0	61.9	122.2	50.5	38.9	32.4	45.8	37.1	86.6	65.8	52.9
MRPL36	"BRIP1, L36mt, MRP-L36, PRPL36, RPMJ"	ENSG00000171421	"Mitochondrial ribosomal protein L36"	Q9P0J6	5	1798385-1801366	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 472.3;Late spermatids: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047238	Approved		Supported	"Nuclear bodies,Mitochondria"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies, Mitochondria"		"HPA047238: AB_10965331"	"unprognostic (2.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (8.53e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	46.2	60.4	35.6	24.7	36.9	19.2	42.1	40.9	44.2	31.5	36.3	49.6	27.9	38.6	26.3	51.1	32.3	22.0	77.3	36.6	38.4	70.4	76.1	28.6	30.1	37.8	36.9	35.1	44.4	34.6	29.1	21.8	38.4	44.0	20.0	22.6	36.5	21.6	140.2	39.3	33.7	26.9	38.3	34.3	44.9	97.4	38.3	29.1	27.4	86.1	25.9	38.8	34.2	38.3	93.3	134.9	61.7	116.9	111.3	91.2	80.9	79.4	69.4	92.7	88.2	98.4	73.4	124.2	140.2	85.7	136.1	99.1	139.9	130.9	66.8	136.1	155.8	60.2	285.1	158.4	142.0	78.9	45.5	80.9	98.9	103.6	133.4	80.8	91.1	72.3	93.4	77.9	133.6	169.4	93.2	177.5	60.1	102.2	164.0	73.8	46.0	149.6	84.6	74.9	68.5	46.8	172.6	133.1	89.8	56.3	78.2	84.5	55.5	79.9	87.1	54.7	89.4	74.0	100.3	167.4	100.4	144.5	111.3	88.4	103.2	68.6	90.6	104.8	109.6	132.6	101.5	111.1	127.3	103.3	89.1	106.3	29.7	101.7	92.9	476.0	143.0	142.0	35.6	36.9	40.9	44.2	36.6	38.4	37.8	36.9	38.4	38.3	38.3	38.3	52.6	32.1	29.0	6.8	37.6	106.0	108.8	150.2	89.4	23.0	61.5	93.2	163.1	50.1	83.6	58.8	6.2	93.4	66.0	47.3	307.2	84.1	472.3	45.4	63.9	63.7	26.4	50.9	7.9	75.0	74.0	62.7	35.2	33.1	27.9	46.2	35.7	118.2	88.2	15.2	7.9	53.8	107.8	43.0	52.4	471.3	74.9	32.0	60.5	2.8	62.5	76.0	70.0	7.1	9.6	92.1	58.7	59.8	45.6	148.8	79.2	199.6	63.2	31.2	65.7	51.1	68.6	188.6	76.2	92.4	124.9	87.4	37.3	79.8	65.7	112.6
MRPL37	"MRP-L2, RPML2"	ENSG00000116221	"Mitochondrial ribosomal protein L37"	Q9BZE1	1	54184041-54225464	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025767, HPA025826, HPA025951"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107"	"unprognostic (2.00e-1)"	"unprognostic (6.81e-2)"	"prognostic favorable (6.99e-4)"	"unprognostic (1.71e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.67e-3)"	44.7	73.8	28.6	32.4	30.6	67.4	41.5	35.5	37.2	36.1	42.7	50.7	51.5	34.7	26.9	65.8	38.2	25.5	86.3	31.5	29.8	55.4	108.1	30.2	41.1	32.5	30.3	41.0	67.7	47.2	20.8	31.5	33.2	33.8	53.5	21.8	41.3	29.8	167.9	56.2	41.0	41.6	27.4	34.6	49.2	31.4	30.8	41.2	28.5	154.2	51.3	37.9	40.5	28.7	168.3	94.9	84.6	114.5	83.4	110.9	150.5	111.2	103.5	194.0	167.7	190.7	75.4	226.1	98.2	125.3	184.8	131.6	168.2	164.6	150.6	111.1	211.7	194.8	186.9	194.8	142.9	233.3	87.1	123.2	138.7	201.8	156.5	108.7	176.1	174.2	219.2	66.1	140.2	123.3	161.7	226.4	173.5	134.4	208.2	175.3	171.7	191.6	110.8	123.4	166.3	77.6	153.8	261.4	214.0	110.6	113.2	260.7	88.5	123.6	112.2	157.7	227.1	83.1	126.0	175.5	161.1	234.2	119.9	53.0	103.4	45.4	67.5	91.8	79.1	120.4	81.9	76.1	120.4	105.1	82.0	72.8	5.6	94.0	88.7	101.5	116.4	126.6	28.6	30.6	35.5	37.2	31.5	29.8	32.5	30.3	33.2	27.4	30.8	28.7	24.0	22.4	18.7	3.9	33.4	34.7	43.8	84.6	45.5	8.9	46.3	57.0	71.3	55.8	43.1	18.4	2.1	118.0	15.5	36.6	80.3	81.2	31.0	25.7	23.2	30.3	33.1	103.3	7.5	96.3	145.8	37.3	41.8	33.1	14.5	40.6	37.5	156.5	87.0	6.7	8.4	53.0	52.9	43.6	25.6	57.5	26.1	30.9	23.2	4.7	53.1	9.2	24.7	4.5	5.4	69.0	41.1	28.6	72.2	54.2	73.8	105.2	29.4	8.7	13.1	28.8	34.3	23.6	50.4	79.6	37.4	73.9	24.5	57.2	86.0	55.2
MRPL52		ENSG00000172590	"Mitochondrial ribosomal protein L52"	Q86TS9	14	22829879-22835037	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 549.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012319	Approved		Supported	Nucleoplasm,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA012319: AB_1854118"	"unprognostic (8.98e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.41e-1)"	76.5	105.6	106.9	53.7	109.6	51.9	72.4	113.6	130.8	66.5	109.4	88.3	70.0	72.8	30.8	141.6	61.0	20.6	193.7	107.7	110.4	130.8	154.2	73.5	41.7	113.4	109.8	59.9	108.7	70.6	70.1	32.9	113.6	83.5	33.9	15.2	79.6	35.6	155.2	96.6	77.7	25.6	111.5	96.3	113.4	67.7	112.0	62.0	83.2	55.4	41.3	85.0	78.2	112.9	237.5	181.4	97.4	121.4	59.3	69.1	236.8	161.2	115.0	140.8	133.4	224.1	321.9	178.8	172.5	111.3	143.4	210.8	79.8	223.4	105.6	190.8	132.6	133.6	65.6	518.5	180.3	211.9	183.6	104.8	150.4	182.7	154.5	111.2	226.6	222.7	139.4	172.8	104.6	329.2	172.5	320.0	180.1	292.5	397.5	210.2	121.5	210.4	149.9	138.7	96.8	125.1	124.5	120.6	178.3	68.9	116.0	198.9	176.5	146.4	172.0	185.1	249.2	169.4	219.1	228.0	133.3	143.3	239.6	101.5	111.2	60.2	74.5	128.9	69.5	140.9	82.2	68.2	159.1	111.6	75.9	74.2	19.1	74.5	96.4	131.3	100.7	98.5	106.9	109.6	113.6	130.8	107.7	110.4	113.4	109.8	113.6	111.5	112.0	112.9	105.5	73.7	85.4	5.2	132.5	121.2	88.0	169.2	98.4	23.2	131.2	145.2	103.4	167.3	118.0	136.1	18.8	177.3	82.5	220.9	277.8	245.2	72.4	106.5	89.8	104.4	138.0	112.5	5.7	314.5	287.7	65.8	165.1	116.3	123.0	70.5	106.4	291.0	236.2	20.2	6.2	268.0	107.8	140.2	125.1	58.3	55.9	120.1	124.5	6.5	221.5	80.4	107.1	5.5	9.1	396.9	215.6	49.2	156.4	111.8	313.7	549.8	99.9	33.7	65.7	70.7	147.7	135.4	105.3	190.8	149.2	126.0	85.0	80.3	233.8	98.8
MRPL54		ENSG00000183617	"Mitochondrial ribosomal protein L54"	Q6P161	19	3762682-3768575	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042117, HPA046767"	Uncertain		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA042117: AB_2677856, HPA046767: AB_2679795"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.54e-3)"	56.1	85.5	68.9	41.0	69.0	109.0	54.8	70.6	80.0	47.0	70.5	54.9	53.8	49.8	36.3	58.4	57.8	34.6	78.6	67.5	70.4	78.7	122.9	43.1	63.5	69.5	68.4	46.9	87.8	71.3	64.0	31.4	69.8	57.9	44.0	38.1	71.9	37.1	57.8	55.9	48.8	37.6	69.8	54.4	70.7	54.4	70.1	63.4	57.8	57.8	50.5	50.4	43.8	72.0	115.1	64.4	58.4	57.6	34.2	54.6	49.6	53.8	69.0	126.8	108.5	55.7	39.8	82.1	54.4	66.8	47.6	71.3	77.6	70.9	53.8	53.0	118.4	41.8	33.6	72.0	89.1	89.7	95.0	64.2	121.3	53.2	92.7	49.0	105.8	56.4	80.2	157.1	67.3	77.9	81.1	94.5	77.8	79.8	46.9	69.4	33.2	122.8	97.8	57.9	81.6	67.6	43.8	103.4	83.4	27.8	69.7	126.6	75.5	79.5	45.8	136.5	117.2	95.4	140.5	82.4	78.6	142.3	60.6	96.9	121.2	81.9	103.4	132.8	96.0	139.1	112.5	122.3	134.7	125.8	107.6	99.1	35.3	133.0	133.7	122.7	168.4	144.1	68.9	69.0	70.6	80.0	67.5	70.4	69.5	68.4	69.8	69.8	70.1	72.0	61.1	76.9	79.3	5.5	101.2	49.1	91.9	111.1	63.2	55.6	89.2	98.8	55.2	91.5	91.7	79.1	18.8	134.4	69.7	183.5	358.1	112.7	94.2	90.1	54.7	60.5	105.4	63.1	3.6	193.6	125.7	62.8	90.7	78.8	106.5	47.6	62.4	249.8	157.7	38.7	4.7	234.8	79.3	115.3	65.4	63.0	56.2	90.9	71.2	2.8	120.7	105.1	106.1	2.0	10.1	128.7	185.4	44.8	123.2	116.2	234.4	427.8	76.0	90.9	26.3	65.7	64.4	113.4	47.1	106.7	57.3	176.9	94.6	109.3	171.5	118.2
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 60.1;Distal tubular cells: 56.7;Ductal cells: 50.9;Exocrine glandular cells: 60.3;Hofbauer cells: 48.1;Pancreatic endocrine cells: 53.7;Proximal tubular cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003634, HPA076987"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nucleoplasm, Plasma membrane"	"HPA003634: AB_1851388, HPA076987: "	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	22.7	36.3	22.1	18.0	22.8	22.8	24.6	24.4	23.0	17.1	31.9	25.9	19.1	19.4	18.2	32.1	17.5	13.1	49.1	21.9	23.6	34.7	47.2	16.3	24.4	23.4	22.6	14.2	27.4	25.0	14.0	19.3	23.4	18.6	22.8	11.2	21.8	18.6	79.0	28.4	21.7	18.8	23.3	21.6	26.0	10.5	22.9	18.3	18.7	50.3	23.8	24.5	19.9	24.5	81.1	111.4	36.5	42.1	38.3	37.9	50.5	46.7	50.7	95.7	80.7	86.3	49.5	56.0	37.3	46.8	58.9	56.3	75.6	80.7	100.2	28.1	87.7	43.8	50.5	72.2	72.5	92.5	28.8	40.9	37.8	63.3	101.0	32.3	73.8	57.0	71.7	39.9	54.8	100.9	80.7	63.4	27.5	125.3	147.1	41.2	64.8	81.2	71.1	58.5	33.5	64.1	40.3	72.5	92.9	46.7	97.5	75.6	31.6	50.8	56.0	54.3	89.7	41.0	34.8	63.2	58.5	102.5	43.5	26.6	41.2	21.4	30.8	40.9	27.1	33.8	38.0	31.4	55.3	29.3	27.8	31.1	4.0	42.2	36.1	37.2	67.2	42.5	22.1	22.8	24.4	23.0	21.9	23.6	23.4	22.6	23.4	23.3	22.9	24.5	18.8	32.1	8.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	22.5	32.8	0.0	0.0	8.1	25.8	0.0	60.1	11.4	0.0	56.7	50.9	0.0	29.3	18.3	8.4	0.0	0.0	0.0	60.3	40.5	8.9	0.0	19.0	1.3	22.3	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.8	0.0	0.0	121.1	21.1	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	29.1	7.4	43.5	0.0	0.0
MRPS27	KIAA0264	ENSG00000113048	"Mitochondrial ribosomal protein S27"	Q92552	5	72219403-72320646	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071751	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Nucleoli	"HPA071751: AB_2686442"	"unprognostic (3.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.07e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.95e-2)"	25.5	36.1	23.8	21.8	25.3	18.9	31.8	23.6	27.8	27.0	33.8	26.2	20.4	25.8	27.6	32.4	31.3	19.0	55.5	25.0	23.1	30.5	38.5	17.5	36.9	24.6	24.1	39.5	27.1	32.7	20.9	21.2	24.6	25.2	31.5	17.7	22.4	30.3	58.7	31.7	22.0	26.9	24.5	25.9	25.7	15.1	25.0	30.7	35.6	89.1	41.9	29.7	26.0	24.1	49.7	65.2	56.8	94.4	73.1	93.5	73.0	46.7	66.4	86.9	69.7	81.9	68.5	128.2	63.8	54.8	94.9	54.0	111.8	166.1	93.6	48.6	69.2	66.0	71.3	91.1	72.7	58.4	49.0	88.1	68.7	91.3	101.5	79.0	94.2	92.2	67.2	37.5	73.0	59.7	87.8	70.4	65.7	35.8	40.4	92.0	94.4	131.5	80.7	52.4	87.5	46.7	78.5	63.8	58.5	52.2	97.8	69.9	54.1	35.3	51.8	50.3	85.2	37.7	61.0	89.1	60.9	94.6	57.0	15.5	23.4	8.1	24.9	27.5	37.1	36.1	30.6	30.4	44.2	32.1	35.2	37.9	3.2	43.3	23.0	16.6	34.6	31.5	23.8	25.3	23.6	27.8	25.0	23.1	24.6	24.1	24.6	24.5	25.0	24.1	13.9	9.6	11.7	32.7	27.6	20.4	22.3	21.6	23.3	11.4	26.5	22.2	101.9	7.2	15.6	11.0	16.7	41.5	18.6	9.1	25.4	20.5	2.2	16.1	21.8	17.2	16.2	36.8	43.9	17.3	48.2	18.8	17.9	12.1	7.6	29.3	15.7	34.8	24.8	10.1	38.4	21.0	8.2	28.6	13.3	4.4	19.0	15.0	10.6	30.0	31.4	15.3	17.5	38.7	51.1	14.9	15.3	25.2	16.8	13.5	10.7	28.8	12.6	13.2	13.1	18.2	17.6	10.3	18.7	32.3	17.6	28.9	21.2	30.4	31.4	14.8
MRPS35	"MDS023, MRPS28"	ENSG00000061794	"Mitochondrial ribosomal protein S35"	P82673	12	27710822-27756295	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 242.6;Proximal tubular cells: 231.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038513	Supported		Approved	Mitochondria,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA038513: AB_10794084"	"prognostic unfavorable (9.41e-4)"	"unprognostic (8.35e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.51e-5)"	"unprognostic (4.63e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	27.3	42.1	25.0	26.8	26.1	31.2	42.7	26.7	33.4	23.8	28.0	59.2	52.6	25.8	29.4	35.8	29.4	24.1	62.2	26.0	27.2	78.6	77.7	21.6	31.9	25.7	26.0	26.2	27.8	46.9	14.0	29.1	26.5	31.5	61.1	18.4	29.6	24.1	83.3	23.5	46.4	29.8	26.7	21.0	43.9	18.0	26.4	28.3	44.2	72.5	32.1	35.3	20.4	27.9	95.0	102.1	42.4	65.1	58.9	71.8	156.0	61.4	52.6	84.4	76.2	125.0	132.4	88.2	87.5	63.3	65.5	70.0	88.0	77.9	99.1	74.2	82.8	100.2	39.2	103.7	58.5	138.1	51.1	61.4	95.1	71.1	143.2	77.3	69.6	73.0	110.1	58.6	77.9	57.9	96.7	227.0	158.9	231.8	147.7	101.1	109.8	145.3	130.8	77.3	24.0	48.5	84.4	131.0	106.1	93.9	133.6	108.2	54.5	51.4	54.9	117.8	111.4	22.8	36.9	186.8	68.6	104.5	68.5	11.0	21.5	7.8	15.1	38.3	24.1	20.7	18.9	18.7	30.5	19.7	22.3	20.4	1.2	25.9	46.4	14.4	26.4	23.8	25.0	26.1	26.7	33.4	26.0	27.2	25.7	26.0	26.5	26.7	26.4	27.9	25.0	73.7	40.3	13.4	38.2	47.3	42.3	65.0	46.1	20.8	49.8	43.8	94.8	50.1	55.4	51.5	4.2	104.0	21.2	51.8	242.6	92.0	12.6	42.0	42.4	30.1	60.3	26.3	28.0	59.2	113.4	35.9	72.4	40.0	54.5	34.5	18.9	67.1	73.1	18.5	28.0	81.2	40.7	38.4	28.8	9.1	25.4	42.9	42.7	8.4	64.7	27.1	34.0	19.6	25.4	62.2	52.3	24.5	32.1	55.4	63.6	231.4	70.2	18.0	26.3	35.8	39.8	23.9	27.2	68.7	52.1	61.7	34.8	83.8	116.5	46.1
MRPS5	"MRP-S5, S5mt"	ENSG00000144029	"Mitochondrial ribosomal protein S5"	P82675	2	95085369-95149434	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055765	Approved		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA055765: AB_2682911"	"unprognostic (1.18e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (7.98e-7)"	"unprognostic (7.51e-3)"	"unprognostic (6.30e-3)"	"prognostic unfavorable (7.73e-5)"	"unprognostic (8.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.25e-1)"	26.0	33.6	5.6	3.8	5.7	7.6	22.3	6.9	7.1	24.4	6.3	34.5	6.9	24.1	4.7	34.5	24.3	3.6	53.6	5.7	5.6	34.6	53.6	24.3	5.5	5.7	5.5	24.9	24.1	6.8	19.9	3.7	5.8	18.5	6.9	5.0	24.7	2.9	71.2	19.4	26.8	5.1	5.1	25.0	30.1	19.5	5.8	6.2	23.8	13.7	5.4	23.7	24.8	6.3	18.8	14.8	8.1	7.8	8.6	10.6	15.3	9.5	4.2	7.1	7.6	28.7	12.9	18.4	7.5	8.4	17.1	11.3	14.0	11.8	13.8	13.0	11.2	11.6	12.3	22.8	11.6	16.5	7.3	10.5	9.3	12.0	12.5	9.0	12.3	10.4	18.0	7.8	10.4	15.1	18.6	17.8	9.0	16.5	13.5	10.5	8.0	21.3	17.4	18.5	12.4	7.8	8.2	17.2	17.6	12.8	7.4	16.0	9.5	10.6	12.9	15.1	15.5	7.6	8.9	14.0	8.8	16.3	9.6	2.5	5.4	3.8	3.6	7.2	4.4	4.5	4.8	4.2	4.8	3.3	4.2	4.4	2.2	3.6	7.4	3.3	5.9	4.2	5.6	5.7	6.9	7.1	5.7	5.6	5.7	5.5	5.8	5.1	5.8	6.3	46.3	80.1	84.6	33.3	52.3	34.8	59.1	112.5	56.9	52.8	42.1	40.5	130.2	58.6	74.4	66.2	50.1	81.8	51.2	68.3	185.9	74.8	68.3	48.5	69.9	48.1	59.4	79.3	31.8	55.4	83.8	53.9	51.0	43.0	40.4	90.7	50.3	129.8	74.1	47.1	29.3	65.0	109.9	51.8	41.2	48.9	51.3	55.3	44.4	7.5	61.5	29.7	44.3	30.7	40.3	50.2	44.2	53.4	69.7	68.1	87.3	131.8	72.3	69.0	39.5	52.2	59.5	80.9	99.1	78.7	32.0	39.4	57.4	60.7	104.5	48.2
MRPS7	"MRP-S, RP-S7, RPMS7"	ENSG00000125445	"Mitochondrial ribosomal protein S7"	Q9Y2R9	17	75261674-75266376	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 454.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022522, HPA023007"	Supported		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA022522: AB_1854131, HPA023007: AB_1854132"	"unprognostic (1.24e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (5.82e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.05e-3)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.95e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.15e-1)"	44.3	58.4	55.5	38.1	55.9	32.9	41.2	60.0	61.9	28.7	59.0	49.9	48.9	28.3	24.4	58.5	39.2	27.1	129.0	55.1	59.3	66.1	64.6	32.4	41.3	57.2	57.5	29.2	39.0	76.6	36.0	40.8	57.6	34.1	48.2	47.3	41.1	35.7	201.3	32.6	40.0	33.8	57.8	39.5	47.5	29.9	59.8	33.6	35.9	212.3	43.6	42.6	35.0	56.3	113.8	188.6	78.8	57.6	63.9	35.7	139.4	73.3	60.9	137.4	101.1	209.8	93.5	96.4	66.4	79.8	91.4	104.5	122.3	135.8	82.2	50.8	173.5	131.8	133.6	201.3	62.5	134.3	69.6	60.0	131.8	108.6	109.6	69.2	177.3	117.8	130.1	93.3	91.1	203.5	151.8	104.7	85.4	157.7	176.2	100.7	229.5	145.2	128.4	124.6	135.8	122.8	93.8	249.9	150.0	83.9	188.4	108.7	72.2	124.0	125.3	68.2	155.7	97.9	61.5	106.6	89.5	88.3	96.9	43.2	155.1	48.2	115.7	161.6	124.2	140.2	112.0	126.0	172.0	128.1	128.6	120.7	11.0	130.5	138.5	164.9	141.6	236.0	55.5	55.9	60.0	61.9	55.1	59.3	57.2	57.5	57.6	57.8	59.8	56.3	44.1	51.3	48.3	12.1	69.3	39.5	75.1	148.1	37.0	65.8	56.5	63.0	77.8	70.1	74.3	57.0	98.0	192.9	63.3	94.1	230.9	112.9	139.2	50.9	43.2	55.6	47.5	61.4	11.8	104.1	175.3	50.2	55.5	43.5	39.3	68.6	45.3	91.7	148.8	47.1	14.0	84.3	77.3	60.0	35.6	454.3	48.4	52.6	42.7	3.7	107.0	85.6	73.2	9.5	11.3	89.8	69.3	39.9	87.7	85.3	129.2	219.3	81.0	114.4	59.2	40.8	73.0	60.5	68.5	68.5	41.9	137.9	53.8	110.0	133.8	77.4
MRPS9	"MRP-S9, RPMS9, S9mt"	ENSG00000135972	"Mitochondrial ribosomal protein S9"	P82933	2	105038069-105099960	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043476, HPA048479"	Supported		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA043476: AB_2678498, HPA048479: AB_2680412"	"unprognostic (8.10e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-3)"	"unprognostic (5.25e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	17.2	33.5	21.4	17.9	22.7	24.6	23.3	24.1	26.5	18.3	25.7	29.8	29.5	20.7	19.2	23.8	24.2	13.4	64.1	21.4	23.3	32.7	31.8	15.4	24.7	24.0	22.8	30.8	24.2	32.8	19.6	12.9	24.3	23.4	33.3	22.3	23.3	21.6	98.6	21.9	23.4	19.8	22.7	18.5	25.9	33.5	22.8	30.8	21.4	97.0	27.1	20.2	17.9	25.1	68.2	28.9	59.4	55.1	30.6	31.5	69.6	42.6	40.6	66.2	59.2	155.0	46.4	70.6	41.1	33.9	68.9	59.8	118.0	62.1	69.9	44.0	77.5	69.7	42.4	94.4	51.0	52.2	29.9	37.9	41.5	54.6	45.4	38.3	51.6	84.8	101.5	35.9	45.7	54.9	70.6	68.6	93.9	57.4	62.6	88.9	50.9	98.3	83.2	47.3	51.4	30.9	49.4	71.5	59.9	58.0	58.9	52.2	34.0	38.8	78.2	38.9	46.6	32.6	41.5	56.3	33.6	79.1	33.3	21.7	23.8	10.1	39.3	31.5	43.3	44.4	43.0	41.7	43.0	35.3	42.9	42.4	2.8	46.0	39.9	32.1	49.9	31.7	21.4	22.7	24.1	26.5	21.4	23.3	24.0	22.8	24.3	22.7	22.8	25.1	18.2	22.4	28.2	28.1	21.0	19.5	25.3	56.4	22.2	24.7	15.4	22.2	110.2	22.8	30.4	22.0	12.5	39.9	29.1	17.7	107.6	40.7	51.7	35.9	18.6	22.5	19.7	47.5	43.4	42.7	40.7	21.2	18.8	12.9	22.8	34.6	18.2	31.2	28.8	8.4	54.2	27.9	24.4	15.2	9.9	14.6	23.9	15.9	30.2	17.8	26.2	21.2	29.9	49.3	69.4	22.6	18.3	27.1	25.0	17.4	23.1	72.3	42.1	32.0	39.5	24.8	28.1	112.8	40.7	23.4	13.2	20.4	25.2	62.9	40.5	19.0
MRRF	RRF	ENSG00000148187	"Mitochondrial ribosome recycling factor"	Q96E11	9	122264603-122331337	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 210.0;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047177, HPA049987"	Supported		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Microtubules, Cytokinetic bridge"		"HPA047177: AB_2679970, HPA049987: AB_2680984"	"unprognostic (8.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.01e-2)"	"prognostic favorable (2.14e-8)"	"unprognostic (3.89e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.02e-2)"	"unprognostic (8.88e-3)"	18.9	19.3	10.4	12.1	10.7	14.2	19.3	11.7	13.3	13.9	15.3	25.1	23.7	10.1	13.1	25.5	11.4	8.8	28.2	10.6	11.3	23.4	24.3	13.3	14.0	11.4	10.9	11.3	18.3	23.2	12.5	9.0	11.3	14.7	28.6	14.5	15.3	10.6	40.6	22.1	18.5	10.1	10.6	15.6	14.4	18.1	11.3	13.8	16.3	32.1	20.4	16.9	16.4	11.5	34.7	45.8	25.6	43.0	35.7	32.5	48.7	33.7	43.0	44.5	26.0	55.0	40.6	75.0	16.7	27.0	35.5	99.3	74.1	78.8	36.3	25.2	30.3	25.6	53.4	30.5	23.6	72.3	32.7	30.5	52.7	40.0	70.8	22.4	50.4	29.6	44.2	27.8	45.1	55.1	36.2	23.6	30.0	86.0	45.7	26.8	48.8	79.7	76.6	34.8	30.3	19.9	36.2	58.3	27.9	24.3	62.8	18.2	27.1	19.5	29.6	51.0	42.0	19.1	50.1	33.0	36.8	42.4	22.8	4.7	17.5	6.0	13.3	29.0	14.2	15.6	13.3	12.5	29.8	12.7	13.8	16.5	2.0	22.9	31.3	12.9	16.3	11.1	10.4	10.7	11.7	13.3	10.6	11.3	11.4	10.9	11.3	10.6	11.3	11.5	22.7	3.2	9.1	21.9	18.8	15.4	22.1	30.3	26.2	13.2	20.1	17.3	21.8	18.6	17.8	14.7	12.5	29.0	10.8	21.4	35.2	36.0	210.0	16.2	15.7	22.5	7.8	29.3	28.6	29.5	49.2	11.1	23.9	12.1	24.7	14.5	14.3	19.2	30.4	5.0	39.1	22.0	18.3	17.0	16.5	191.7	9.6	16.0	14.2	20.6	18.3	6.3	11.3	22.1	31.0	24.0	20.6	7.5	19.4	18.1	41.2	37.3	16.2	23.5	19.7	15.1	11.7	30.2	16.6	32.5	22.4	37.1	12.3	31.1	33.9	22.7
MRTFA	"BSAC, KIAA1438, MAL, MKL, MKL1, MRTF-A"	ENSG00000196588	"Myocardin related transcription factor A"	Q969V6	22	40410281-40636719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Actin-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.5;Cardiomyocytes: 8.7;Cytotrophoblasts: 8.9;Extravillous trophoblasts: 8.7;Fibroblasts: 4.3;Hofbauer cells: 12.7;Syncytiotrophoblasts: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 189.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 93.1;granulocytes: 189.4;monocytes: 58.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030782	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA030782: AB_10600930"	"unprognostic (7.90e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (9.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.98e-1)"	21.1	15.4	15.8	27.3	18.0	80.7	19.9	10.9	22.8	25.5	12.3	20.8	11.7	33.1	7.3	16.6	22.6	11.7	21.3	20.2	10.0	14.6	12.3	24.5	27.5	9.3	8.7	20.9	16.1	8.9	13.8	18.3	7.9	19.4	8.8	11.1	18.2	15.2	19.1	24.4	18.6	16.3	6.7	29.7	19.1	35.9	9.5	21.7	22.1	8.0	22.8	22.0	19.6	15.3	26.5	33.9	14.5	17.5	21.6	15.9	27.8	25.6	16.6	23.1	22.8	19.1	7.9	27.2	10.2	27.0	20.3	35.5	12.7	31.9	13.8	32.0	29.2	46.3	39.9	24.7	17.8	53.5	79.8	15.5	36.7	22.4	15.1	17.5	18.3	15.0	12.9	12.3	11.5	25.3	20.7	57.4	11.7	14.2	12.1	35.4	17.5	16.4	16.9	22.1	8.7	8.7	43.7	19.4	13.8	18.3	16.0	59.0	27.8	14.7	38.7	21.4	20.9	16.1	16.5	39.1	12.1	25.6	26.5	49.0	53.5	189.4	18.5	43.7	16.9	13.0	15.8	13.6	64.3	18.6	21.1	18.1	57.2	16.8	58.8	93.1	22.0	34.2	15.8	18.0	10.9	22.8	20.2	10.0	9.3	8.7	7.9	6.7	9.5	15.3	4.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	7.8	0.6	0.0	0.0	0.0
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251805-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	18.9	18.5	17.0	16.8	17.1	13.4	20.2	14.8	17.9	13.0	13.7	13.5	16.8	15.8	12.9	23.7	17.6	8.9	14.4	17.4	16.1	17.9	20.3	11.1	20.0	15.8	16.0	17.0	23.4	12.5	8.9	12.1	16.1	12.9	16.5	7.2	12.3	10.5	22.7	17.4	19.5	16.7	15.4	13.8	15.5	14.0	16.1	14.8	11.1	11.4	22.8	21.4	14.1	16.4	90.9	65.9	51.1	67.0	24.2	38.6	44.7	69.0	38.9	116.7	76.1	92.9	92.0	133.6	56.7	60.5	50.4	70.1	142.7	104.6	114.0	47.4	109.6	98.4	55.4	80.8	30.3	133.4	38.7	34.0	69.8	131.6	69.6	31.7	66.1	59.0	151.1	42.3	68.9	68.0	106.3	96.5	65.0	95.6	95.4	99.3	62.7	100.5	64.8	31.3	82.9	59.2	54.0	73.0	75.4	37.6	50.8	76.5	44.2	61.9	77.5	97.6	118.0	33.8	64.3	178.2	61.2	172.4	102.5	1.4	11.6	1.3	11.4	12.7	22.9	23.1	13.7	15.9	17.6	19.7	18.4	16.7	1.4	16.6	10.2	19.7	10.6	11.4	17.0	17.1	14.8	17.9	17.4	16.1	15.8	16.0	16.1	15.4	16.1	16.4	30.0	6.4	14.5	6.2	31.2	37.3	59.1	45.8	42.7	20.4	23.6	37.7	10.3	38.6	26.4	7.3	10.4	50.4	14.9	15.7	41.1	61.8	23.3	19.1	46.8	32.1	21.6	31.3	8.4	55.0	69.9	29.5	19.4	21.1	26.0	36.8	15.4	16.3	47.1	15.2	7.3	25.4	36.7	13.3	18.2	36.5	23.0	21.0	19.6	1.9	32.0	25.7	16.5	4.5	4.3	57.5	17.0	20.3	29.0	57.4	6.0	37.9	15.8	16.4	19.7	44.8	35.9	55.6	49.7	48.2	33.5	26.0	18.6	58.1	34.8	36.7
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 673.3"	"Cell type enriched"	"Detected in some"	35	"B-cells: 970.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 625.4;naive B-cell: 627.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 627.0"	"Group enriched"	"Detected in some"	26	"Daudi: 731.3;U-698: 364.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	3.6	0.4	0.0	149.7	0.0	19.1	0.8	0.0	0.1	0.5	0.1	9.0	3.0	2.2	1.0	4.2	0.5	8.4	1.8	0.0	0.1	3.4	2.1	4.0	500.4	0.2	0.0	0.3	0.2	7.3	0.3	0.9	0.1	5.1	10.6	0.0	8.9	0.3	0.8	0.1	123.5	1.2	0.1	253.8	18.4	1.2	0.1	50.6	6.7	0.1	673.3	16.3	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	731.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.5	0.2	0.0	0.1	0.0	364.1	0.0	0.2	0.0	0.8	0.5	0.3	2.4	0.1	3.7	625.4	2.8	5.5	0.5	627.0	0.5	2.1	2.0	6.5	0.6	0.5	0.8	32.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	3.8	0.0	970.5	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	4.5	0.7	0.1	0.3	0.0	7.0	0.0	0.0	0.1	1.8	2.0	0.1	2.5	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.0	0.6	0.3	2.0	0.0	4.6	7.2	0.0	2.5	0.0	2.1	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.1	0.8	0.1	0.0	27.3	0.7	0.2	0.0
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.1	7.5	8.3	12.8	10.5	15.7	15.7	14.6	10.6	9.7	12.2	11.9	7.8	11.7	14.0	9.5	12.4	5.8	10.1	9.6	9.0	8.2	6.7	8.1	23.7	8.6	8.0	8.7	6.5	14.8	6.2	11.6	9.5	8.6	15.0	34.9	8.5	7.7	7.1	11.1	9.3	8.8	8.5	10.8	8.1	16.2	7.9	32.6	15.8	7.2	25.0	7.9	6.4	8.9	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	8.3	10.5	14.6	10.6	9.6	9.0	8.6	8.0	9.5	8.5	7.9	8.9	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5;choroid plexus: 1.1;pituitary gland: 1.5;placenta: 1.2"	"Group enriched"	"Detected in some"	50	"Early spermatids: 96.3;Late spermatids: 216.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 85.7;PC-3: 108.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in other tissues"	No	No		30000	"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	Vesicles	Cytosol	"HPA055174: AB_2682726"																		0.2	0.0	0.6	0.2	0.3	0.0	0.1	0.4	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.2	1.5	0.4	0.0	0.0	0.0	1.5	1.2	0.9	0.0	0.1	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.6	0.3	0.4	0.8	0.3	0.3	1.5	0.4	0.9	0.6	0.3	0.4	1.3	0.0	1.1	0.0	1.1	0.4	1.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	1.4	96.3	0.6	0.1	3.1	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.2	0.0	0.5	2.5	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.8	216.6	0.3	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.1	0.7	0.1	1.5	0.0	0.4	0.2	0.5	0.0	0.0	0.1	0.8	0.5	0.0	0.1	0.3	0.2	0.1	0.3	1.3
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054292-10428891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 86.0;liver: 64.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 625.8;Inhibitory neurons: 318.6;Oligodendrocyte precursor cells: 268.9;Proximal tubular cells: 666.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 28.4"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.3"	"Low region specificity"	"Detected in all"							"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		55000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"	"Plasma membrane, Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	17.0	20.4	2.2	1.1	3.0	13.5	16.1	28.4	5.4	9.1	0.0	13.9	1.1	10.7	0.1	11.6	7.4	0.4	29.0	3.8	0.0	86.0	64.0	12.2	0.6	0.0	0.4	6.4	14.5	0.7	9.2	0.8	1.8	9.2	0.6	0.6	10.5	1.0	14.5	9.5	20.1	0.8	0.0	18.6	14.2	15.2	0.3	1.5	9.6	1.3	0.6	11.6	8.2	2.8	0.1	0.9	1.3	4.3	1.2	1.4	0.5	2.5	0.2	0.3	1.7	0.6	2.1	0.0	0.6	2.5	5.8	2.3	0.4	0.1	1.3	0.2	0.0	0.3	1.5	2.2	4.3	0.8	12.3	0.4	3.2	0.3	0.0	1.4	0.6	0.3	0.4	0.2	4.9	0.1	0.0	0.3	0.6	3.3	0.8	1.6	1.3	2.0	1.1	1.1	2.5	1.5	4.6	0.2	0.5	0.4	2.3	2.8	2.6	1.7	2.0	0.4	1.2	0.2	0.1	0.7	4.8	0.8	3.1	0.5	1.9	5.6	0.4	1.2	0.3	0.6	0.4	0.3	1.2	0.1	0.3	0.2	2.2	0.7	0.9	0.2	0.3	0.2	2.2	3.0	28.4	5.4	3.8	0.0	0.0	0.4	1.8	0.0	0.3	2.8	44.1	0.0	7.4	152.8	21.4	16.4	29.3	10.8	14.2	10.1	21.2	21.8	21.6	25.8	7.2	25.8	31.3	7.7	12.4	26.4	92.0	32.3	80.6	13.6	8.7	30.3	9.6	3.4	625.8	47.1	4.6	13.1	14.8	11.8	80.7	13.7	19.6	97.2	47.0	16.8	318.6	20.8	4.1	33.6	48.3	167.9	9.3	38.0	30.2	85.3	22.3	14.6	11.3	268.9	60.7	51.1	37.8	9.8	16.2	33.8	195.5	666.1	5.6	6.2	13.1	11.3	16.9	39.3	26.5	20.1	14.1	8.3	18.0	14.1	24.5	31.1
MSS51	"FLJ39565, ZMYND17"	ENSG00000166343	"MSS51 mitochondrial translational activator"	Q4VC12	10	73423579-73433561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 261.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.3;Excitatory neurons: 11.9;Inhibitory neurons: 9.7;Oligodendrocyte precursor cells: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038564			Uncertain	Vesicles,Cytosol		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Cytosol	"HPA038564: AB_10674687"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.50e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-7)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-2)"	1.9	1.5	1.5	1.5	1.8	1.6	1.7	4.3	2.0	3.2	1.6	2.3	1.2	2.1	1.7	1.4	2.2	1.2	10.9	1.5	0.6	1.7	1.6	2.2	1.8	0.2	0.3	3.0	1.9	56.2	2.3	0.6	0.2	2.5	1.3	2.5	1.7	0.8	261.3	3.7	2.7	1.1	0.0	3.9	1.8	1.4	0.7	1.5	1.5	5.9	1.5	2.2	2.2	1.3	0.9	0.6	1.5	2.7	2.1	2.8	1.2	0.7	0.5	0.3	0.6	0.3	0.7	2.1	0.2	0.7	0.1	1.1	1.0	0.2	0.8	1.1	0.9	1.7	1.3	0.5	0.7	1.1	1.7	2.4	0.7	0.6	1.7	2.1	0.2	0.8	0.6	1.0	1.2	0.2	0.9	1.6	0.4	0.5	0.7	0.5	4.1	0.1	0.8	0.9	0.3	0.8	0.5	1.0	0.9	1.4	0.9	0.9	1.3	1.2	0.7	0.4	1.7	0.6	2.1	1.1	0.5	1.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.8	4.3	2.0	1.5	0.6	0.2	0.3	0.2	0.0	0.7	1.3	0.9	0.0	3.6	4.6	1.0	0.5	0.1	0.6	0.0	1.4	0.4	0.5	5.3	0.0	0.2	0.0	0.0	0.3	0.4	0.4	0.0	0.4	0.3	0.4	0.7	1.2	0.0	1.3	11.9	0.4	0.2	0.8	1.1	0.8	5.1	1.8	1.4	0.2	0.2	0.0	9.7	0.4	0.0	0.8	0.6	0.3	3.1	0.5	0.0	4.7	1.1	0.5	1.0	6.0	3.4	0.2	3.9	1.5	0.4	0.5	0.6	0.2	0.3	1.2	0.0	4.0	0.6	0.7	0.3	0.0	0.0	0.1	1.1	1.4	0.6	0.2
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Deafness, Disease variant, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 222644.8;heart muscle: 255389.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107039.5;Hepatocytes: 59794.3;Proximal enterocytes: 98329.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 54167.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	22006.8	46968.9	171347.0	8727.7	151652.8	11321.8	17952.5	132201.9	222644.8	10440.9	179120.2	42606.0	27505.7	11582.9	14226.0	20791.8	10700.5	11452.7	255389.3	151507.6	137459.2	63061.8	96575.5	12744.7	9111.4	176794.8	152802.2	8124.5	19467.4	41236.2	7420.2	10527.8	168465.9	12427.0	28389.7	12503.0	23260.1	17753.2	147209.5	26849.0	35366.3	13146.2	138626.1	16284.7	44852.9	10932.5	176888.2	7461.1	14056.3	184587.7	8381.2	17415.3	10559.7	131378.4	5837.6	8554.3	11384.1	12431.0	25510.2	11563.1	12037.2	12867.2	4284.9	3189.4	5257.4	10383.6	18320.5	15138.9	6040.7	9857.6	3118.2	21430.9	1326.6	11407.4	4515.1	7226.0	8040.6	9130.6	54167.9	19725.4	3521.2	5336.1	11055.5	13603.9	11589.8	3149.9	6917.5	14668.4	3902.1	8485.5	5916.3	10551.1	9525.6	14037.0	4378.4	23591.9	2905.0	7814.2	6900.5	5664.0	3401.6	9177.9	15910.6	15016.1	5414.7	7189.1	4466.7	17018.9	8305.7	13626.1	9809.7	17703.3	15637.8	12617.8	8438.9	12565.9	6642.1	4951.2	5072.9	3542.6	6235.7	13711.8	6294.4	5305.8	9759.2	3824.6	3085.1	4907.9	3420.5	5374.6	3047.3	3425.6	3444.6	5567.3	3080.8	3911.2	1900.4	3759.1	5775.1	4847.5	2947.7	3929.0	171347.0	151652.8	132201.9	222644.8	151507.6	137459.2	176794.8	152802.2	168465.9	138626.1	176888.2	131378.4	3924.0	2900.6	3897.1	0.0	13282.9	9769.7	9713.9	22625.0	20857.7	0.0	12033.2	11841.6	107039.5	30777.5	16135.4	19596.3	0.0	0.0	9288.4	40726.1	4255.4	7191.4	1555.3	13044.7	9033.9	7847.9	7514.7	45610.3	0.0	5089.4	0.0	6305.3	19235.7	25645.6	3832.6	20400.0	25951.4	59794.3	0.0	0.0	0.0	24302.1	19071.0	45533.4	7744.0	7398.4	11696.4	12124.7	6894.2	0.0	15180.0	0.0	8901.3	0.0	0.0	6410.5	23865.9	8490.1	13829.3	9441.3	98329.8	33652.6	10474.0	0.0	13614.6	11019.8	9403.5	12096.5	14338.7	27110.9	11475.1	0.0	11502.4	15179.6	27138.6	21770.7
MT-CYB	"COB, CYTB, MTCYB, UQCR3"	ENSG00000198727	"Mitochondrially encoded cytochrome b"	P00156	MT	14747-15887	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Cataract, Deafness, Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 130283.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 87067.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 14365.7;HeLa: 18945.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032215, HPA068400, HPA074796"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: "	"unprognostic (4.50e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.50e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (1.63e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.54e-2)"	17885.7	25075.8	39972.4	2636.6	41108.8	2926.5	15122.5	36592.4	54341.4	6621.5	47885.4	19364.4	8941.2	7119.4	6555.4	10592.2	7498.6	3433.7	130283.4	39044.7	39534.1	60620.7	59133.6	6549.1	2529.8	46506.6	40032.7	6068.7	15418.7	9106.2	11552.0	5320.4	42841.1	15142.5	8793.2	8513.5	12205.1	7331.2	52625.7	13392.0	17520.7	5804.8	34579.6	7362.7	25263.2	7372.2	41908.6	1737.2	9758.2	63751.5	3582.0	12844.4	7620.0	35340.5	2322.4	3039.1	3687.6	3950.3	14365.7	2287.8	2963.8	2587.3	1076.5	668.0	1136.3	3013.8	4943.2	5840.7	1240.7	3087.3	794.6	7063.3	556.2	3180.7	1613.0	2880.4	2458.9	3277.0	18945.0	5461.7	2697.8	1862.5	3828.3	4981.3	4631.2	1257.6	2679.7	4457.1	1715.5	2341.4	1709.0	3565.6	3417.2	6354.8	1735.3	3789.4	824.1	2230.7	2036.7	2028.2	1449.8	3681.4	5134.1	5275.9	1308.0	2302.7	1802.1	3352.1	2587.4	5497.2	4911.1	6332.5	5398.3	2302.7	2984.2	4256.3	2037.2	972.6	1390.1	2557.4	1385.7	2822.6	1485.0	8811.6	3750.4	4806.7	1834.1	1738.1	2355.1	2806.2	2123.9	2376.2	1485.5	3034.9	2241.0	2781.9	2755.9	1680.5	1944.8	1468.0	1511.0	1612.6	39972.4	41108.8	36592.4	54341.4	39044.7	39534.1	46506.6	40032.7	42841.1	34579.6	41908.6	35340.5	3091.7	1185.9	1390.0	0.0	5710.5	3319.9	7605.2	9945.0	8512.3	0.0	4026.8	5510.1	87067.0	11564.1	5338.9	7470.6	0.0	0.0	3723.1	10971.1	2163.9	2555.0	789.7	9063.7	5550.2	5673.6	2863.2	16130.5	0.0	3523.1	0.0	4692.6	4895.1	15794.2	1889.0	16261.2	9871.2	17132.6	0.0	0.0	0.0	9502.4	5486.9	14290.0	2254.1	3983.1	7943.2	4269.6	2612.9	0.0	4118.1	0.0	2612.8	0.0	0.0	2977.1	8823.6	5402.0	5725.9	4425.8	25108.7	14736.3	4210.2	0.0	5798.2	9579.6	5914.9	4807.6	4136.3	9142.3	3422.9	0.0	5502.2	11093.2	10319.6	9796.7
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 132930.7;heart muscle: 145078.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 30444.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 50775.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075648			Approved	Centrosome,Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Centrosome	"HPA075648: AB_2686760"	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	20104.7	29874.0	85794.9	4122.5	86270.4	3115.3	14930.3	82985.5	132930.7	6880.0	93989.2	20616.6	9025.8	7679.7	5976.7	10820.3	7752.4	4365.8	145078.7	84214.9	90415.7	46912.7	74928.5	8462.2	2787.1	92948.1	87984.2	6729.2	16038.2	20410.6	9234.3	5840.3	89012.2	16438.2	14044.5	15747.5	12913.6	12715.8	58998.5	13345.9	17015.9	6979.3	79192.1	7285.6	28192.3	9561.4	87700.1	4435.4	11270.7	103082.4	4852.1	15113.7	7437.4	83632.8	4598.0	4121.5	7308.1	7468.2	25088.0	5217.1	3223.3	9523.0	2384.3	1468.4	2651.9	6894.3	4080.7	11229.9	3809.7	6497.0	2387.4	8496.5	1155.8	10210.3	2895.1	4454.2	4711.8	8095.9	50775.4	13024.1	3671.8	8429.4	6965.0	9229.0	10159.4	2792.9	9675.2	10923.1	2983.6	5697.7	4556.7	7771.2	5412.1	8124.5	3199.8	10639.4	1846.3	4811.8	4953.4	1842.5	3155.8	5025.1	7636.0	9464.9	2208.4	2971.3	4666.2	7283.7	3197.8	15599.0	5199.9	10420.1	9592.2	3792.1	4708.5	5630.1	3738.0	6985.1	3552.9	6053.5	2725.1	11018.8	1816.1	16170.2	4327.0	8286.8	2536.0	2849.6	3435.6	4233.2	2723.9	2939.9	2282.7	4618.7	3206.8	4006.1	2010.3	2906.4	2817.9	2884.1	2096.4	2551.4	85794.9	86270.4	82985.5	132930.7	84214.9	90415.7	92948.1	87984.2	89012.2	79192.1	87700.1	83632.8	503.6	224.4	217.6	0.0	2303.6	228.5	254.2	170.4	5991.6	0.0	764.0	886.3	30444.3	1464.1	438.4	323.7	0.0	0.0	449.8	1428.3	90.1	152.9	52.8	870.1	618.8	942.3	256.6	3302.0	0.0	342.2	0.0	1129.2	5335.9	1186.3	479.3	1394.0	1520.3	4413.7	0.0	0.0	0.0	727.8	99.7	1977.9	193.5	286.1	417.2	1043.8	256.1	0.0	312.9	0.0	133.9	0.0	0.0	284.5	867.0	230.9	4395.8	129.7	1228.2	589.4	582.7	0.0	348.4	711.2	1052.8	247.0	207.4	5256.4	242.2	0.0	1387.0	308.6	573.4	207.9
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802636-21937651	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046915, CAB080036, CAB080037"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3000000	"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB080036: AB_11128130, CAB080037: AB_11129069, HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	5.9	6.5	4.1	5.4	4.8	5.8	8.5	4.2	5.7	7.8	7.6	6.7	4.8	8.8	7.1	8.8	7.1	4.9	7.0	3.8	4.0	6.9	10.9	5.8	6.3	5.0	4.5	12.1	6.6	8.4	2.8	8.9	5.1	7.2	8.0	3.9	6.5	7.0	4.5	7.0	5.9	9.0	4.0	7.3	7.2	2.9	5.4	6.8	7.2	5.4	7.3	10.1	7.4	6.0	30.4	1.0	23.0	19.0	19.4	19.0	28.3	42.3	21.0	21.9	24.3	21.7	14.6	15.3	13.4	21.1	16.3	15.2	24.4	59.5	36.8	0.3	19.8	0.3	56.8	28.8	18.6	24.5	26.3	23.5	0.1	38.6	42.6	24.4	22.6	0.5	0.3	20.1	21.9	3.1	26.8	0.7	27.5	14.7	35.2	0.4	18.0	26.0	18.3	0.4	14.4	15.3	14.4	17.1	21.1	17.9	10.9	0.6	23.8	0.3	15.7	0.2	34.4	13.7	25.5	30.0	0.2	24.3	12.0	1.2	5.6	0.2	3.6	4.5	6.1	5.9	5.3	4.2	6.9	8.4	4.6	4.2	0.7	6.7	2.9	6.3	3.2	2.7	4.1	4.8	4.2	5.7	3.8	4.0	5.0	4.5	5.1	4.0	5.4	6.0	18.8	22.4	19.8	26.1	16.3	14.1	58.4	22.4	16.5	0.0	20.2	23.9	22.4	24.3	27.9	14.7	0.0	52.3	11.4	6.8	15.6	38.6	77.9	28.8	28.5	14.9	9.6	19.1	14.8	28.0	80.0	18.7	15.3	40.6	10.8	30.0	17.5	22.2	27.1	0.0	9.1	14.3	30.5	25.5	11.1	14.8	14.9	15.1	10.6	48.7	15.0	0.0	10.3	40.7	32.9	41.5	6.8	14.7	13.7	45.0	9.2	19.5	19.1	0.0	13.1	20.6	23.1	1.3	13.9	35.1	13.1	22.6	15.1	33.0	20.7	62.9
MTBP		ENSG00000172167	"MDM2 binding protein"	Q96DY7	8	120445400-120542133	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Excitatory neurons: 14.7;Oligodendrocytes: 16.1;Spermatocytes: 16.2;Spermatogonia: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA025694, HPA050594"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA025694: AB_1854169, HPA050594: AB_2681185"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.40e-3)"	"unprognostic (2.77e-6)"	"unprognostic (3.99e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.20e-10)"	"unprognostic (3.41e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.86e-2)"	1.3	1.1	1.0	2.5	1.2	4.0	2.6	3.6	1.7	1.6	0.7	1.7	1.5	2.1	2.4	1.4	1.7	1.2	0.6	1.0	0.9	1.0	0.8	1.3	4.3	1.0	1.0	2.4	0.9	1.0	0.8	2.1	1.2	1.5	2.6	4.3	1.1	1.0	0.7	3.0	1.3	2.0	0.9	1.8	1.1	5.0	1.1	4.6	0.8	0.8	4.0	1.0	1.3	1.4	15.3	4.5	14.6	6.0	2.1	3.5	7.1	11.4	6.5	16.4	21.0	4.9	8.3	13.8	11.2	3.8	4.9	13.0	13.9	6.8	20.3	11.5	10.6	11.6	6.7	5.6	1.1	12.4	8.6	1.3	2.9	12.7	8.1	2.5	7.3	12.6	7.6	10.2	9.7	6.9	19.8	7.6	6.5	12.0	9.0	11.3	15.0	9.8	3.9	5.3	7.4	8.6	7.7	44.8	7.0	7.9	8.5	8.9	4.5	7.0	12.7	9.0	18.6	3.9	8.9	8.0	6.6	15.1	8.3	0.0	0.1	0.1	0.3	0.6	0.5	0.7	0.5	0.7	0.2	0.5	0.8	0.7	0.0	0.5	0.3	0.0	0.7	0.3	1.0	1.2	3.6	1.7	1.0	0.9	1.0	1.0	1.2	0.9	1.1	1.4	1.6	0.0	1.5	7.5	2.9	0.8	1.7	1.5	1.8	0.0	1.4	1.3	1.1	0.0	1.1	1.8	0.0	2.3	2.5	0.5	0.0	0.9	0.8	1.3	2.6	1.1	0.0	12.8	14.7	1.8	3.0	2.5	2.6	1.5	2.5	5.0	1.8	0.9	1.6	0.0	9.1	0.9	0.0	0.3	1.8	0.4	1.5	1.7	1.8	3.7	1.0	0.0	2.1	9.0	16.1	0.6	0.1	1.2	2.3	1.2	0.3	0.3	2.4	0.0	0.0	5.6	2.6	16.2	10.2	1.4	0.6	0.7	3.3	1.5	0.8	0.8
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	15.4	15.7	8.7	22.7	10.6	23.8	21.8	17.5	14.5	21.8	6.7	18.2	16.1	25.3	16.1	19.4	19.0	14.2	17.3	9.1	10.3	15.7	20.4	17.0	38.8	9.1	8.3	27.9	17.5	16.2	15.3	14.2	9.6	33.8	19.9	29.4	19.8	18.1	54.4	17.6	22.0	20.1	6.4	22.0	18.3	10.2	9.1	25.1	34.7	41.8	30.8	14.8	16.0	12.7	17.2	14.9	29.7	16.4	38.2	17.5	22.1	27.4	31.5	25.8	36.0	10.5	23.2	24.7	10.0	31.0	30.8	17.6	41.0	38.5	33.8	35.4	28.9	32.2	30.5	46.5	25.5	40.2	23.3	29.0	37.8	30.2	35.6	32.8	30.2	32.4	29.4	10.5	31.9	24.0	28.2	26.4	33.7	35.5	25.8	27.7	33.1	14.1	24.8	31.5	26.2	22.9	20.3	26.8	20.7	19.5	19.6	19.4	39.3	23.4	23.0	27.3	25.7	28.0	7.9	61.2	19.8	24.1	21.4	8.3	10.8	24.9	18.6	10.5	22.7	32.3	29.1	26.8	12.3	31.8	46.0	36.7	3.4	18.1	8.7	9.1	32.5	22.1	8.7	10.6	17.5	14.5	9.1	10.3	9.1	8.3	9.6	6.4	9.1	12.7	20.7	12.8	27.7	40.8	45.6	0.0	20.3	0.0	15.9	0.0	19.8	23.9	19.8	27.1	13.0	20.2	0.0	30.2	34.1	12.1	41.1	24.1	49.2	11.7	19.1	22.4	10.9	22.9	31.2	24.6	28.2	18.6	14.3	12.0	11.4	37.9	20.0	30.6	24.8	0.0	28.8	20.7	0.0	24.5	0.0	61.0	23.3	17.0	0.0	25.3	31.6	0.0	42.2	33.2	39.8	23.7	20.7	26.4	44.8	22.0	43.4	51.4	17.5	0.0	39.5	22.7	18.4	59.0	34.3	23.4	0.0	23.7	37.0	42.9	17.2	17.1
MTMR10	FLJ20313	ENSG00000166912	"Myotubularin related protein 10"	Q9NXD2	15	30938941-30991628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Oligodendrocytes: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006081	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA006081: AB_2667508"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (7.77e-12)"	"unprognostic (9.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-1)"	18.6	9.5	29.3	10.7	46.9	18.7	10.3	49.4	33.3	11.2	24.8	9.9	12.8	9.4	9.4	20.9	7.5	9.6	12.7	28.0	36.3	30.6	24.2	13.6	12.0	57.6	48.5	11.5	12.4	21.3	1.9	25.9	56.5	11.0	10.3	12.1	14.9	11.4	29.4	11.2	11.6	10.0	45.3	15.1	13.0	8.5	40.8	16.7	14.2	24.0	10.6	10.1	5.4	63.3	8.1	9.0	8.2	5.2	17.7	9.6	7.2	11.9	23.9	9.4	9.4	5.9	3.5	3.9	15.5	15.5	9.1	11.5	6.5	7.0	8.9	12.5	2.1	5.5	6.2	10.4	10.3	8.9	12.2	13.2	5.4	6.1	6.7	10.8	23.7	10.9	4.9	9.2	8.9	2.3	9.3	5.6	4.7	9.7	4.3	6.7	6.7	19.5	35.6	12.7	3.0	7.8	5.4	6.3	2.4	10.4	4.2	16.4	10.9	10.6	8.0	5.6	6.8	9.4	7.8	9.0	6.7	4.7	13.4	3.7	3.2	3.1	0.7	4.0	0.8	1.9	0.8	0.6	3.1	2.8	1.2	1.2	13.5	1.4	7.4	3.7	1.2	1.7	29.3	46.9	49.4	33.3	28.0	36.3	57.6	48.5	56.5	45.3	40.8	63.3	15.8	25.6	15.2	86.2	11.3	8.9	4.3	3.3	8.0	0.0	6.7	4.6	24.1	10.0	7.0	33.1	0.0	19.3	12.9	12.7	1.9	3.4	13.6	10.1	9.6	16.8	6.0	5.2	15.4	3.8	3.1	8.6	13.3	19.7	17.1	9.4	11.4	33.9	11.8	0.0	13.6	7.7	2.0	24.9	16.2	24.9	10.5	19.0	8.8	55.3	13.8	0.0	3.1	25.6	149.3	5.6	9.2	7.5	8.0	6.7	14.4	18.6	4.7	0.0	0.0	10.6	8.9	11.1	8.9	33.6	11.1	38.4	6.8	6.7	8.2	8.7
MTPAP	"FLJ10486, PAPD1, SPAX4, TENT6"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.8"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA038620: AB_10673015, HPA058232: AB_2683646"	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	8.9	7.4	4.9	10.3	4.8	36.8	9.7	12.6	6.7	6.1	3.1	9.6	10.6	9.0	6.2	8.3	6.6	5.2	8.8	4.8	4.3	9.6	10.6	6.3	10.7	3.4	3.5	8.2	10.0	8.4	2.7	9.6	3.9	7.2	11.0	7.1	8.0	4.9	13.2	8.4	9.0	9.1	3.2	9.3	7.1	5.1	3.6	9.2	10.2	12.0	10.3	8.1	5.2	6.2	26.0	25.3	15.8	23.0	15.2	14.2	20.6	17.6	6.2	17.7	18.4	27.0	35.4	36.9	12.3	11.7	16.3	29.7	31.1	20.7	21.6	18.7	24.0	37.3	23.7	27.5	16.0	24.6	28.2	14.3	19.0	19.9	11.7	9.8	19.6	34.0	41.2	28.1	13.5	21.8	29.8	21.8	10.8	19.5	13.3	29.6	27.9	34.4	16.2	17.1	25.9	20.8	16.0	16.4	24.7	14.8	15.8	15.6	18.7	18.4	23.8	26.0	19.8	6.2	16.3	50.8	15.9	44.5	6.6	27.4	25.2	27.3	21.7	35.0	23.0	20.8	20.4	21.1	33.0	17.1	21.6	22.0	4.2	25.1	27.9	17.3	23.1	13.1	4.9	4.8	12.6	6.7	4.8	4.3	3.4	3.5	3.9	3.2	3.6	6.2	12.2	9.6	7.4	9.1	11.2	25.2	13.9	7.4	4.6	0.0	9.8	9.8	16.7	15.7	9.2	3.7	0.0	13.1	13.9	8.1	19.6	9.6	240.7	9.9	14.8	12.9	4.2	16.6	12.7	9.1	12.0	12.7	7.7	12.5	5.1	18.8	12.5	14.6	14.7	0.0	14.5	15.6	6.1	15.8	13.6	34.3	12.2	10.8	8.8	8.4	14.8	0.0	5.2	4.5	14.4	8.9	5.2	16.6	5.3	14.1	8.7	14.2	8.6	0.0	13.1	14.7	10.8	25.3	19.5	11.4	24.9	11.5	8.8	12.6	18.4	16.6
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795260-236921278	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 100.0;Glandular and luminal cells: 130.9;Inhibitory neurons: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044474, HPA054915"	Approved		Supported	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA044474: AB_10966696, HPA054915: AB_2732589"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (8.10e-2)"	9.1	6.6	4.3	6.9	5.4	4.6	8.0	5.2	5.4	10.1	6.5	11.1	4.8	10.2	10.5	5.0	11.9	8.9	15.0	4.9	4.6	12.7	6.0	7.1	8.1	6.7	5.3	14.6	13.0	20.2	6.4	11.6	6.9	7.6	5.0	5.6	6.4	9.1	16.6	9.3	7.1	8.7	4.8	9.4	9.0	9.0	4.8	10.0	13.4	18.1	7.0	10.3	7.6	6.5	17.6	11.0	13.0	8.8	22.6	20.3	15.3	14.9	14.8	18.8	19.0	12.6	12.5	40.0	13.2	16.6	8.7	10.6	18.4	13.1	20.4	19.8	13.7	23.7	14.2	18.3	15.1	37.2	13.3	28.9	7.0	22.9	17.9	11.5	22.3	19.8	33.1	16.4	13.1	10.1	19.6	10.3	16.2	12.9	5.4	20.9	24.8	24.2	11.2	21.3	11.1	27.8	17.7	11.9	14.8	9.3	16.7	13.0	28.8	24.1	9.1	19.6	18.8	34.4	12.3	22.7	17.2	21.1	26.2	0.6	0.5	1.5	1.1	0.8	2.3	0.7	1.4	1.4	0.7	0.8	1.4	1.5	0.0	0.9	0.5	0.5	0.9	0.9	4.3	5.4	5.2	5.4	4.9	4.6	6.7	5.3	6.9	4.8	4.8	6.5	23.0	57.7	35.0	53.8	25.8	8.2	8.3	8.3	17.1	0.0	10.7	11.9	100.0	20.0	10.9	40.5	0.0	24.2	25.9	3.4	1.9	13.8	9.8	57.5	80.1	21.4	8.4	23.5	87.7	14.8	9.2	22.8	15.8	130.9	30.4	35.0	15.4	10.8	14.4	0.0	106.8	7.7	4.1	16.6	6.8	6.2	23.9	17.1	10.6	47.8	15.3	0.0	19.6	62.8	73.6	12.3	8.0	33.1	20.3	14.9	9.7	9.1	13.3	0.0	6.6	39.4	23.2	17.2	22.0	11.5	5.1	22.6	26.1	40.2	12.0	6.4
MTUS1	"ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1"	ENSG00000129422	"Microtubule associated scaffold protein 1"	Q9ULD2	8	17643795-17800917	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 408.9;Alveolar cells type 2: 281.0;Oligodendrocytes: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A549: 115.7;AN3-CA: 100.1;HUVEC TERT2: 296.8;SK-MEL-30: 84.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067903, HPA069795"			Enhanced	Nucleoli,Microtubules		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli, Microtubules"		"HPA067903: AB_2685921, HPA069795: AB_2686198"	"unprognostic (3.20e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (2.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (3.33e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.43e-1)"	52.9	39.0	65.6	13.4	100.4	0.3	45.0	97.4	81.7	34.5	59.3	36.6	32.6	31.4	22.6	38.0	28.7	37.9	85.6	66.0	76.9	26.2	56.8	40.4	9.0	106.4	90.8	51.4	98.2	65.2	22.9	70.0	104.2	31.9	39.1	56.9	49.9	24.7	106.2	26.0	33.4	38.2	75.7	16.1	42.2	12.2	87.6	22.8	27.3	167.4	14.5	35.8	31.0	151.1	21.9	115.7	18.5	100.1	0.1	0.6	33.2	1.1	7.8	0.6	2.3	8.7	7.8	2.8	8.5	0.0	4.8	22.2	30.8	10.9	1.1	15.8	13.2	0.0	19.2	55.8	6.6	0.0	0.4	9.1	16.4	2.4	33.3	0.0	296.8	7.7	0.0	43.3	0.1	5.7	4.4	5.7	26.5	44.1	2.9	0.1	17.0	11.5	5.9	44.4	9.2	2.2	14.8	26.6	84.7	11.0	19.2	0.3	61.4	0.1	24.0	0.1	0.2	5.9	3.5	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.4	65.6	100.4	97.4	81.7	66.0	76.9	106.4	90.8	104.2	75.7	87.6	151.1	408.9	70.5	281.0	139.1	2.9	21.0	56.4	38.9	58.1	0.0	42.7	31.6	141.6	55.8	88.4	20.2	0.0	23.8	1.6	58.5	11.7	50.1	18.5	71.4	53.8	154.5	15.0	0.0	6.1	174.2	40.0	83.8	94.8	144.2	9.5	7.6	29.3	71.2	58.2	0.0	81.8	47.3	22.4	4.1	16.1	24.5	76.4	9.0	28.4	174.3	2.7	0.0	2.1	39.2	469.2	56.5	19.1	57.2	15.3	77.9	52.4	10.4	49.4	0.0	19.7	69.7	60.1	2.4	8.3	45.3	20.3	54.0	7.1	79.8	49.3	81.3
MTUS2	"CAZIP, ICIS, KIAA0774, TIP150"	ENSG00000132938	"Microtubule associated scaffold protein 2"	Q5JR59	13	28820339-29505947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 50.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 548.4;Inhibitory neurons: 671.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 13.2;HeLa: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031473, HPA031474, HPA031475"	Enhanced		Supported	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Microtubules, Cytokinetic bridge"		"HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442"	"unprognostic (1.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.62e-2)"	0.2	0.2	0.4	0.1	1.7	0.1	0.1	1.2	9.7	0.6	1.8	0.9	0.1	1.5	0.0	0.3	0.8	0.1	50.2	1.0	0.0	0.1	0.9	0.1	0.6	0.0	0.1	7.5	4.8	0.0	6.1	0.0	0.0	0.3	0.2	4.6	1.0	0.1	0.1	0.2	0.4	1.2	2.2	0.5	1.3	1.2	1.0	0.2	0.5	0.1	0.1	1.3	0.2	2.4	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	13.2	0.4	0.0	0.0	0.0	0.5	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.0	0.0	2.3	1.6	0.1	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.7	1.2	9.7	1.0	0.0	0.0	0.1	0.0	2.2	1.0	2.4	0.1	0.0	0.5	10.4	0.1	0.5	0.7	0.1	0.0	0.0	0.3	0.4	145.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.4	0.3	1.0	0.7	0.0	0.8	548.4	0.6	0.0	5.9	0.0	1.1	0.0	1.2	0.4	0.5	0.1	0.0	671.8	0.7	0.0	0.0	0.8	3.3	0.9	0.2	1.8	15.0	0.1	0.0	0.0	18.1	16.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	3.6	0.0	0.0	1.6	1.0	0.1	4.1	1.8	0.1	0.3	0.3	19.6	0.0	1.1
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"salivary gland: 2621.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 443.2;Distal enterocytes: 158.4;Intestinal goblet cells: 210.1;Undifferentiated cells: 183.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"OE19: 113.9;PC-3: 120.0"	"Not detected"	"Not detected"							"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		1300000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.7	0.2	2.0	0.1	0.0	1.3	0.0	0.4	229.4	0.0	58.0	0.1	0.3	0.0	101.0	1.1	221.3	0.1	0.0	0.0	0.1	2.4	7.5	0.0	0.1	0.0	0.1	9.8	0.0	0.4	0.0	0.0	0.6	17.1	0.0	2621.9	0.0	0.3	0.4	2.6	0.6	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.2	0.0	113.9	120.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	2.3	0.0	0.0	6.7	0.6	0.0	6.4	4.3	12.4	443.2	64.0	0.0	0.0	0.1	0.0	158.4	0.0	0.9	0.0	1.4	0.8	0.9	24.5	0.0	0.1	0.0	0.1	1.1	12.8	7.2	4.5	0.0	0.0	1.2	0.2	0.0	0.0	210.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	53.4	0.0	1.4	1.3	0.1	0.2	24.5	0.0	0.0	0.0	3.0	0.0	0.5	1.6	0.0	0.1	0.7	0.1	183.1	1.1
MX1	"IFI-78K, lncMX1-215, MxA"	ENSG00000157601	"MX dynamin like GTPase 1"	P20591	21	41420020-41470071	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 127.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.8;Extravillous trophoblasts: 77.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 820.2;BJ hTERT+ SV40 Large T+ RasG12V: 734.3;Karpas-707: 160.6;SK-MEL-30: 259.3"					"Low region specificity"	"Detected in all"			"HPA030917, HPA030918, HPA049724"	Approved	Approved	Supported	"Nuclear membrane,Cytosol"		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Cytosol"		"HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862"	"unprognostic (3.62e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (9.95e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.81e-1)"	25.6	14.9	17.5	29.0	18.9	51.7	23.8	19.4	18.2	37.7	14.4	19.7	30.7	15.9	20.5	42.4	25.2	37.7	22.7	14.3	27.8	27.5	25.3	31.7	38.8	35.9	22.5	27.0	13.1	15.3	30.3	20.7	30.2	15.1	11.6	4.3	127.0	16.4	7.6	11.6	28.8	24.4	62.5	75.3	35.3	8.6	23.2	65.0	26.6	9.7	36.8	29.7	24.4	21.5	16.4	0.5	0.7	1.2	0.6	6.8	0.2	1.0	25.6	820.2	734.3	5.3	33.6	0.2	6.5	2.7	7.8	1.6	0.3	0.8	15.9	4.2	0.2	0.9	2.3	1.9	7.3	0.4	0.4	7.4	2.3	48.8	1.1	0.4	2.8	2.7	0.0	160.6	0.4	1.3	14.5	1.8	2.6	0.5	8.3	12.6	0.1	26.4	3.3	9.9	0.7	0.3	1.1	1.3	259.3	0.1	10.6	6.7	1.7	0.8	0.7	0.1	0.7	35.9	37.6	1.0	0.9	2.2	1.8	31.6	45.0	25.6	17.9	47.6	25.8	38.6	27.3	21.9	31.0	36.7	23.3	16.9	64.7	18.9	44.5	44.7	51.9	35.0	17.5	18.9	19.4	18.2	14.3	27.8	35.9	22.5	30.2	62.5	23.2	21.5	101.8	32.1	25.3	2.6	41.9	6.4	17.6	13.0	15.9	3.7	8.0	8.9	8.8	11.5	22.4	23.9	0.0	3.2	47.2	10.1	19.6	38.6	0.7	16.0	11.1	66.8	0.0	2.1	7.7	56.1	77.3	21.5	34.1	15.9	1.3	38.1	20.3	5.8	53.3	1.7	7.1	16.7	2.0	20.8	16.2	1.2	10.8	50.9	19.6	24.4	32.0	6.8	11.3	2.5	1.2	38.8	4.3	16.6	28.7	9.9	29.2	5.0	32.1	2.4	0.0	7.7	17.8	0.4	4.0	32.6	3.4	4.1	28.3	13.4	7.5	34.2
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 264.7;Oligodendrocytes: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 108.2;SK-MEL-30: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229"	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavorable (9.17e-4)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	34.0	32.7	86.8	13.2	98.0	68.0	45.1	92.9	106.1	38.8	67.0	55.9	24.4	45.6	36.2	52.3	42.4	32.8	63.2	84.9	91.1	39.2	51.1	26.4	13.8	93.9	91.8	81.4	44.7	50.6	22.1	28.5	94.7	41.0	35.0	80.2	80.1	52.1	47.3	47.6	29.6	29.8	89.3	14.8	28.0	23.3	94.9	31.2	54.5	53.2	12.3	34.6	41.2	110.8	18.2	8.3	18.0	39.6	30.7	21.4	7.4	11.1	39.2	7.1	23.1	3.2	33.5	24.6	17.6	20.0	11.3	24.3	23.5	27.8	20.0	13.5	30.9	7.3	15.7	14.5	19.5	14.3	14.4	21.7	96.0	12.4	55.2	108.2	7.1	17.5	26.9	54.9	11.3	12.3	10.1	26.1	7.7	31.0	21.2	6.1	26.0	39.9	22.8	1.6	34.3	52.4	11.1	7.3	167.1	23.3	9.9	42.2	7.7	13.5	21.0	13.6	5.6	44.6	26.1	10.0	34.3	46.1	12.7	1.8	2.7	9.7	2.7	2.3	5.1	3.9	5.1	2.8	1.6	3.6	7.7	1.9	5.6	1.4	5.0	1.7	4.8	2.0	86.8	98.0	92.9	106.1	84.9	91.1	93.9	91.8	94.7	89.3	94.9	110.8	28.9	16.0	16.8	139.1	27.9	58.0	57.9	22.8	51.2	49.9	67.2	66.8	80.2	41.5	27.6	33.1	47.9	5.4	23.0	160.7	46.9	19.3	5.1	29.1	36.4	34.1	16.9	264.7	60.8	14.8	20.1	36.0	15.8	37.3	3.8	19.1	27.8	56.6	11.1	52.2	102.5	20.1	18.3	24.1	20.5	8.8	45.1	22.6	104.9	30.9	29.9	144.2	9.2	131.7	214.9	10.4	52.5	55.7	22.5	73.4	57.0	67.1	25.3	46.0	46.0	69.6	63.0	23.8	28.2	37.4	67.3	9.7	36.9	27.4	16.6	36.9
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.3	0.5	1.6	5.3	1.7	35.2	20.1	0.0	0.7	1.6	0.4	25.3	10.9	1.0	0.1	3.0	8.4	0.9	0.1	0.3	0.2	0.1	0.4	2.0	6.3	0.9	1.0	0.0	0.3	3.6	0.0	0.4	0.6	1.4	26.5	0.3	0.6	0.9	0.1	3.0	9.4	1.4	0.2	1.2	2.0	0.7	0.3	66.1	0.1	0.0	7.0	1.1	1.3	0.1	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.6	1.7	0.0	0.7	0.3	0.2	0.9	1.0	0.6	0.2	0.3	0.1	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555386	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No		47000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	12.3	11.0	3.8	13.4	3.8	11.4	15.9	1.3	7.6	13.3	0.8	11.9	9.6	14.6	4.6	17.0	15.2	6.2	11.0	5.0	4.2	9.8	10.8	11.4	13.8	5.2	4.9	14.1	24.4	6.7	12.7	5.2	3.5	17.1	5.1	3.8	18.9	10.1	27.9	22.0	12.9	7.3	2.1	14.0	12.4	8.1	3.4	7.4	11.2	8.0	8.7	14.9	13.8	3.8	60.1	90.0	11.9	56.2	15.4	17.1	40.8	39.8	17.5	39.5	30.8	67.1	24.4	80.4	47.2	23.9	19.8	74.2	50.1	61.3	19.0	40.3	133.8	38.8	58.3	62.2	25.2	45.5	34.7	25.7	34.6	58.8	29.1	11.0	26.6	45.0	64.2	37.1	18.2	51.4	54.2	19.5	56.0	19.1	48.0	69.8	19.7	54.0	9.8	45.5	25.5	48.5	40.8	29.7	28.2	8.6	27.5	19.1	34.3	35.1	31.5	32.7	118.6	32.1	26.5	34.4	32.5	53.9	45.3	0.0	1.9	0.3	2.8	1.6	3.4	2.9	2.3	3.1	2.9	1.7	2.5	2.8	0.1	2.4	3.4	2.1	1.0	2.7	3.8	3.8	1.3	7.6	5.0	4.2	5.2	4.9	3.5	2.1	3.4	3.8	13.4	9.6	14.5	4.6	13.1	12.9	6.8	7.1	12.0	8.2	12.9	14.4	4.1	8.6	13.3	3.7	12.5	2.9	5.8	9.2	0.0	7.7	0.5	6.7	15.3	17.0	11.4	7.2	11.3	12.7	5.4	10.2	10.7	8.5	5.1	12.2	8.6	7.8	6.5	10.1	6.1	8.0	4.1	4.5	6.8	0.6	5.6	6.3	3.6	7.5	3.8	3.8	6.2	3.5	6.5	8.2	4.5	12.0	13.7	13.9	4.6	3.2	12.2	6.2	6.6	10.8	12.9	2.6	11.1	12.8	11.9	1.1	9.7	13.8	12.4	6.2
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;lymphoid tissue: 55.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.2	0.1	91.8	1.6	0.1	0.2	1.1	0.2	8.6	7.0	1.4	0.1	10.1	0.4	1.0	0.4	0.1	0.1	0.6	1.1	1.8	55.5	0.1	0.1	0.3	11.2	0.1	0.2	5.7	0.1	0.5	6.9	0.0	1.6	0.2	0.1	4.2	7.8	2.1	0.1	27.8	6.1	15.6	0.4	33.3	0.5	0.0	53.5	3.5	2.5	0.1	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
MYCBP	AMY-1	ENSG00000214114	"MYC binding protein"	Q99417	1	38862493-38873368	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 106.0;Respiratory ciliated cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041188, HPA078331"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (2.42e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (7.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.34e-3)"	"unprognostic (5.81e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.41e-2)"	11.5	11.0	2.6	16.9	3.4	16.1	18.7	3.4	4.3	12.5	3.7	22.6	16.3	9.6	17.4	23.1	27.1	11.3	8.4	2.4	2.9	18.0	11.5	12.4	16.3	5.6	7.4	6.7	16.1	18.6	8.7	19.3	4.5	14.9	22.5	8.6	16.8	16.1	12.1	13.2	21.6	11.7	2.7	11.2	16.1	15.5	3.2	12.6	18.5	5.6	17.9	16.8	11.7	5.6	51.3	22.5	18.0	13.0	10.7	18.4	74.4	38.9	12.9	38.6	29.7	27.8	56.5	42.1	43.3	18.3	6.5	35.8	29.1	51.9	46.0	52.3	49.7	44.1	29.5	26.7	2.8	107.7	38.9	16.4	38.9	32.3	20.3	14.7	28.3	45.6	64.1	35.8	41.4	31.3	35.1	54.9	47.3	75.3	53.4	33.4	54.4	58.0	50.3	40.6	34.9	23.5	37.0	47.5	25.7	42.4	33.5	52.6	23.2	20.4	33.5	31.2	45.6	25.3	48.7	45.1	20.5	63.9	26.0	51.6	32.8	85.2	18.8	39.7	21.6	22.0	22.1	22.5	40.9	17.7	18.8	21.4	64.4	27.2	38.0	54.3	33.8	22.6	2.6	3.4	3.4	4.3	2.4	2.9	5.6	7.4	4.5	2.7	3.2	5.6	9.2	9.6	13.1	0.0	18.7	10.6	15.7	31.8	22.2	0.7	25.9	14.1	7.9	20.0	37.5	27.6	0.0	106.0	26.7	35.1	64.6	27.0	68.3	84.1	11.4	11.8	9.6	38.7	0.0	27.2	86.2	9.5	21.9	17.9	26.1	9.3	8.9	15.3	21.0	10.1	0.0	25.2	26.4	15.0	14.8	25.2	7.2	20.5	19.6	0.0	31.0	5.5	18.6	0.0	0.0	29.7	40.2	9.1	69.6	18.2	31.2	50.3	142.2	5.0	6.6	6.7	14.8	29.9	64.5	53.4	17.8	88.1	19.3	14.0	31.5	22.4
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 67.8;skin 1: 41.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.9;Hepatocytes: 24.3;Intestinal goblet cells: 25.0;monocytes: 27.4;Squamous epithelial cells: 34.2;Urothelial cells: 27.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 17.3;intermediate monocyte: 8.2;myeloid DC: 18.7;plasmacytoid DC: 22.8"	"Group enriched"	"Detected in many"	72	"dendritic cells: 22.8;monocytes: 17.3"	"Group enriched"	"Detected in many"	7	"U-266/70: 444.0;U-266/84: 364.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Mitotic chromosome"	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.8	0.3	1.8	4.7	2.0	0.6	3.3	1.2	2.0	5.2	1.8	6.1	4.8	0.9	7.2	22.1	3.1	1.5	0.5	2.2	1.7	1.5	11.4	3.3	6.4	1.5	1.5	0.3	67.8	0.3	2.9	6.7	1.6	4.2	6.7	0.2	6.4	7.5	0.5	41.5	5.7	1.1	1.9	7.6	6.2	1.3	2.0	6.5	5.3	0.5	9.5	15.9	12.8	1.6	1.2	0.4	14.4	3.5	0.2	0.1	31.8	0.5	0.2	1.0	0.7	0.4	0.8	2.2	1.4	0.1	0.4	3.3	10.4	2.7	0.8	2.0	4.9	0.5	0.3	0.5	0.4	0.3	7.5	1.0	12.1	0.4	1.3	0.2	1.2	5.4	3.2	0.4	0.6	1.2	0.2	0.3	13.4	2.2	0.4	1.3	15.5	2.9	1.1	58.0	2.5	3.1	1.4	2.1	0.8	5.5	3.7	18.7	0.0	0.0	4.6	6.2	0.5	444.0	364.6	1.0	0.1	2.3	0.3	0.0	17.3	0.0	0.0	8.2	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.2	0.0	3.4	22.8	0.0	6.7	1.8	2.0	1.2	2.0	2.2	1.7	1.5	1.5	1.6	1.9	2.0	1.6	0.4	0.0	1.1	0.0	0.8	6.6	10.0	2.1	13.1	0.4	3.8	6.0	3.7	0.0	5.5	9.2	0.0	34.9	20.1	13.4	0.0	1.5	0.1	5.1	0.6	0.5	17.3	0.0	0.2	5.8	15.4	0.9	5.1	6.3	0.0	0.0	1.4	24.3	5.1	0.0	0.3	25.0	8.2	8.3	13.1	0.4	0.0	10.6	1.8	0.0	27.4	0.8	0.0	1.0	0.0	2.9	6.5	0.0	3.6	5.3	6.4	0.1	4.9	0.1	0.0	1.4	0.7	0.0	1.2	34.2	11.8	17.5	0.3	0.0	10.8	27.1
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474207-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 171.9;Excitatory neurons: 221.3;Inhibitory neurons: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		28000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	27.3	16.9	12.6	6.1	18.9	13.4	14.7	7.0	29.0	19.6	12.6	12.2	2.3	27.8	16.8	6.6	25.2	26.1	38.9	17.9	8.0	32.5	18.9	66.9	6.5	9.6	7.3	25.9	9.8	13.8	17.7	53.4	9.6	17.7	3.8	22.5	6.6	26.6	4.9	7.9	5.8	22.1	0.5	4.6	9.5	7.4	11.0	5.8	13.6	8.2	4.0	10.5	10.3	13.2	54.1	35.1	216.3	72.7	27.7	33.1	97.1	44.2	39.7	52.2	55.8	94.5	8.0	0.5	28.6	43.9	28.4	5.2	108.7	53.0	58.1	1.2	88.3	62.3	21.7	83.0	64.7	5.4	4.2	47.3	18.9	67.7	26.1	32.1	85.3	70.9	88.1	0.2	32.9	21.6	67.2	1.7	102.1	3.6	7.7	105.9	64.2	0.2	59.1	22.3	17.7	96.8	69.2	3.4	68.1	165.0	18.3	3.6	2.8	48.7	35.6	0.3	38.5	8.3	10.8	13.4	0.3	5.0	111.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	12.6	18.9	7.0	29.0	17.9	8.0	9.6	7.3	9.6	0.5	11.0	13.2	43.0	22.4	14.1	43.1	1.1	4.7	9.5	11.2	9.6	37.1	18.7	16.4	33.5	12.8	11.5	101.2	50.1	171.9	1.0	0.8	17.6	13.7	49.1	28.1	37.6	30.6	2.4	43.5	221.3	1.7	88.6	58.0	3.1	28.5	1.3	41.6	55.6	15.3	15.8	35.3	151.1	1.9	6.1	2.7	3.7	28.6	3.7	1.3	1.8	15.9	0.7	25.9	2.1	96.5	15.5	1.9	0.7	39.9	0.6	7.6	0.0	14.0	21.7	39.4	0.0	12.4	23.6	15.6	27.8	9.5	4.0	76.5	2.0	28.0	2.2	4.4
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281280-36387967	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 1343.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Nuclear bodies,Plasma membrane,Actin filaments,Cytosol"		No	No		410000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments"	"Nuclear bodies, Cytosol"	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	295.9	95.5	42.3	181.1	42.1	245.9	231.5	40.6	54.7	181.2	65.5	192.6	107.0	356.4	39.3	153.8	182.2	134.5	161.1	50.8	39.4	140.7	101.6	286.2	161.7	52.7	51.7	121.1	160.3	55.0	52.6	166.5	48.1	131.8	89.8	9.7	177.2	98.4	84.0	160.6	163.5	174.1	48.8	232.5	135.8	38.2	52.1	125.1	141.2	46.3	104.1	168.8	166.8	48.2	612.2	277.0	86.2	74.2	156.8	195.1	437.3	398.4	507.5	554.6	413.2	302.1	170.3	156.9	230.1	666.1	265.0	412.7	125.2	779.4	559.6	356.1	120.9	302.6	294.3	259.9	481.1	346.9	463.8	233.0	234.7	751.9	626.4	540.3	461.8	113.2	67.3	205.8	448.9	161.9	124.4	204.0	51.7	171.1	169.2	233.3	267.3	146.7	314.5	581.5	129.6	53.0	559.7	217.0	251.6	218.5	162.4	177.1	1343.7	1222.6	370.3	237.5	731.5	135.2	114.7	129.0	463.2	172.3	363.1	72.6	25.2	64.7	32.4	19.8	28.4	13.4	23.5	26.4	17.2	11.9	18.3	20.4	41.2	9.0	26.5	8.0	26.3	54.5	42.3	42.1	40.6	54.7	50.8	39.4	52.7	51.7	48.1	48.8	52.1	48.2	303.9	118.6	87.1	12.7	108.4	144.0	182.4	123.1	72.8	2.6	90.5	89.4	62.6	80.1	89.7	92.0	2.1	87.0	151.7	359.8	7.9	309.4	35.8	89.7	121.6	258.7	73.8	51.9	42.5	245.8	193.1	82.9	123.8	194.7	93.1	117.1	132.8	102.8	100.4	82.4	6.7	131.0	59.0	119.6	124.2	37.4	68.0	168.8	85.4	61.8	196.6	11.9	137.0	7.5	33.3	344.6	186.8	211.4	125.9	184.4	159.8	27.5	51.5	5.3	203.8	39.9	275.2	6.9	10.4	133.6	135.1	46.4	213.2	141.3	139.5	134.3
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216926-44218234	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 7.7;breast: 6.9;pancreas: 5.6;stomach 1: 2.3"	"Group enriched"	"Detected in some"	4	"Adipocytes: 5.5;Distal tubular cells: 3.9;Exocrine glandular cells: 2.2;Extravillous trophoblasts: 1.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	106	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	106	"dendritic cells: 10.6"	"Cell line enriched"	"Detected in some"	31	"RH-30: 134.6"	"Not detected"	"Not detected"							HPA051451	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Mitochondria, Cytosol"	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	7.7	0.1	0.0	0.2	0.0	0.0	6.9	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.5	1.0	0.0	0.0	0.7	0.1	0.4	0.6	0.1	0.0	0.1	5.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.1	0.0	0.4	0.9	0.5	0.1	0.0	0.8	2.3	0.4	0.0	0.8	0.4	0.2	0.3	0.5	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	134.6	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.2	1.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MYO15B	MYO15BP	ENSG00000266714	"Myosin XVB"	Q96JP2	17	75588058-75626849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 179.2"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 275.4;Paneth cells: 294.2;Proximal enterocytes: 127.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 46.4;HEL: 17.7;HMC-1: 24.9;THP-1: 37.7"	"Not detected"	"Not detected"							"HPA022857, HPA023105"			Approved	Cytosol		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA022857: AB_1848813, HPA023105: AB_1859526"	"prognostic favorable (9.34e-4)"	"unprognostic (7.55e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.59e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.90e-5)"	40.0	17.3	34.7	17.3	39.2	57.0	38.1	33.7	45.1	74.7	29.6	53.6	179.2	46.1	7.5	18.6	65.6	25.8	44.4	32.0	34.0	76.0	29.8	55.1	19.2	39.9	36.8	87.1	20.5	4.7	28.9	15.0	40.1	56.5	21.5	9.9	23.6	14.0	13.2	15.9	149.0	9.8	35.5	108.2	25.7	20.9	36.7	17.7	65.8	8.0	7.2	29.0	44.0	46.1	0.6	46.4	0.3	1.2	0.3	0.1	0.7	0.0	0.0	0.0	0.0	5.8	13.6	0.1	1.5	0.0	0.6	0.5	0.0	0.0	0.0	0.6	2.8	17.7	9.5	11.6	1.3	0.0	24.9	0.8	0.8	0.0	0.1	0.8	0.3	7.3	1.2	5.1	0.0	5.0	0.4	7.8	0.7	12.3	11.2	12.7	0.3	2.1	0.3	1.0	1.3	3.2	0.3	0.5	1.5	1.4	3.5	37.7	0.1	0.3	1.2	0.2	0.0	1.7	0.2	0.2	0.7	8.9	0.6	1.3	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.0	0.4	0.2	0.0	0.1	34.7	39.2	33.7	45.1	32.0	34.0	39.9	36.8	40.1	35.5	36.7	46.1	13.7	0.0	3.3	44.7	8.4	2.4	2.4	2.0	8.0	4.5	4.0	2.7	7.5	11.5	2.4	9.2	16.7	0.1	11.9	275.4	1.9	1.6	0.7	11.6	8.9	14.6	31.7	9.2	1.1	1.5	0.1	7.1	52.0	8.1	14.0	13.6	21.0	2.1	5.5	1.7	1.4	40.3	12.2	10.0	12.6	2.7	5.6	17.5	3.6	42.2	6.9	4.9	12.3	32.6	46.6	8.8	294.2	4.9	1.4	1.9	127.5	14.4	8.0	13.5	6.6	7.1	8.4	3.3	6.8	2.2	3.0	0.1	6.2	4.7	20.1	1.8
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979088	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.6;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.3;Langerhans cells: 65.1;Macrophages: 74.2;monocytes: 392.2;NK-cells: 252.4;T-cells: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.6;HEL: 64.1;HL-60: 39.9;JURKAT: 85.9;MOLT-4: 97.3;NB-4: 52.1;THP-1: 68.6;U-937: 57.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.2	0.8	0.4	16.6	0.3	43.6	1.0	0.3	0.6	0.8	0.3	2.0	3.3	0.7	0.3	1.5	1.2	3.5	0.9	0.3	1.0	0.9	1.3	12.0	25.1	1.4	0.7	0.3	0.7	0.1	0.5	1.2	0.6	1.1	1.8	0.0	2.3	0.7	0.3	0.9	7.8	2.8	0.6	19.0	3.3	0.4	1.6	27.2	1.6	0.4	14.8	6.1	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	52.6	0.0	64.1	2.7	0.0	0.0	39.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	97.3	52.1	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	57.3	0.0	41.5	58.3	18.5	61.5	95.5	38.4	27.7	40.5	55.6	42.7	18.9	14.1	29.6	6.0	23.9	129.8	4.5	79.9	79.9	0.4	0.3	0.3	0.6	0.3	1.0	1.4	0.7	0.6	0.6	1.6	0.8	0.9	3.2	7.7	0.0	55.7	2.8	0.4	0.0	0.0	0.2	1.2	1.3	1.1	1.5	1.3	0.0	0.0	0.2	81.3	0.2	0.0	0.3	0.6	0.3	0.5	1.0	0.0	6.3	0.1	1.1	0.3	2.3	2.0	0.6	30.4	0.4	2.2	1.4	10.5	3.3	0.0	0.2	0.0	58.7	65.1	1.6	0.0	74.2	3.6	0.0	392.2	0.3	252.4	0.5	0.0	0.2	0.1	0.4	33.4	0.4	0.0	0.6	0.7	0.2	6.6	2.0	1.4	3.8	1.2	0.2	1.7	0.1	87.1	1.2	0.1	0.2
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934229-26212532	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 15.5;testis: 5.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3"	"Not detected"	"Not detected"							"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.4	0.0	1.8	0.1	0.1	0.0	0.8	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.6	0.3	0.0	0.1	0.0	0.6	0.5	0.0	0.7	0.0	0.5	0.0	0.5	0.1	0.3	15.5	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.2	5.2	0.3	0.2	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.8	0.1	0.6	0.6	0.5	0.5	0.2	0.3	0.3	0.2	0.0	0.5	2.0	0.1	1.8	0.3	0.0	0.0	0.9	0.6	0.3	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.9	0.8	156.6	0.6	0.1	0.3	1.8	0.0	2.2	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.4	0.0	0.0	0.0	58.2	1.2	0.1	0.0	1.9	0.0	74.8	0.0	1.0	0.4	0.2	0.0	1.2	0.0	0.3	0.0	1.0	0.0	3.9	0.0	0.0	2.4	31.7	14.2	2.4	1.0	0.0	0.0	0.0	0.4	0.3
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.9;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"RT4: 103.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	9.9	9.5	18.6	7.1	29.3	0.3	28.3	22.6	32.0	18.5	32.6	22.1	33.0	7.6	22.9	32.0	11.5	27.0	5.3	19.6	19.5	51.4	15.2	23.2	4.7	23.7	24.4	4.7	21.6	40.4	14.5	7.6	24.3	17.2	19.2	49.0	25.9	19.9	3.4	16.8	33.9	5.7	16.0	7.6	27.6	14.6	23.9	5.1	15.9	3.1	12.8	24.0	15.8	34.6	52.2	13.0	12.3	8.9	29.7	23.7	42.6	20.7	23.6	12.3	18.3	22.2	44.2	0.1	16.1	25.7	14.0	40.0	15.3	29.2	18.6	17.0	30.3	17.4	5.6	14.1	25.0	0.0	22.2	17.5	21.6	19.3	14.5	24.0	43.3	7.9	22.4	7.2	15.4	48.3	0.2	0.8	7.7	44.1	3.8	0.7	29.1	1.6	51.1	103.6	26.8	14.8	5.6	46.6	6.8	28.3	16.5	35.8	59.4	13.7	9.3	0.6	20.0	13.2	16.1	0.3	10.9	0.2	5.3	0.2	0.1	0.1	5.5	0.0	3.0	0.2	1.8	3.1	0.0	0.1	0.4	3.0	0.6	2.9	0.1	0.1	0.2	0.8	18.6	29.3	22.6	32.0	19.6	19.5	23.7	24.4	24.3	16.0	23.9	34.6	74.8	141.1	207.0	286.3	4.7	30.1	87.5	49.2	18.2	83.6	99.6	35.9	8.1	38.6	91.3	150.8	120.9	32.0	14.7	112.2	54.8	128.9	7.0	86.9	26.9	57.2	85.0	0.0	147.8	120.3	23.8	30.5	91.7	169.2	26.0	81.0	37.9	33.8	6.3	95.9	167.2	76.4	116.0	2.9	6.1	9.6	30.1	6.7	30.2	105.9	2.7	307.3	12.3	179.4	409.1	197.0	99.7	43.2	11.4	165.9	105.7	97.6	109.5	188.4	13.1	26.5	32.7	14.4	32.1	28.3	34.1	78.4	13.4	191.8	77.5	199.7
MYOD1	"bHLHc1, MYF3, MYOD, PUM"	ENSG00000129152	"Myogenic differentiation 1"	P15172	11	17719571-17722136	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 36.1"	"Group enriched"	"Detected in some"	9	"Skeletal myocytes: 10.0;Spermatogonia: 3.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 461.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA055436, HPA078647"			Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA055436: , HPA078647: "						"unprognostic (1.07e-3)"				"unprognostic (2.10e-1)"					"unprognostic (1.01e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	461.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083129-203086012	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"skeletal muscle: 101.0;tongue: 46.7"	"Cell type enriched"	"Detected in single"	36	"Skeletal myocytes: 11.0"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	222	"HSkMC: 29.6;RH-30: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA028336			Supported	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA028336: AB_2672562"	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.2	0.0	0.2	4.1	0.0	101.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.6	0.0	46.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.0	0.4	0.2	2.5	0.4	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 222.5;skeletal muscle: 321.5;tongue: 255.9"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 198.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 4.6;Hep G2: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		Yes	No		830000		"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles	"Golgi apparatus, Cytokinetic bridge"	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	0.4	0.2	0.0	0.2	0.0	0.0	0.7	0.3	0.1	0.2	0.0	0.6	1.1	0.3	0.0	6.0	0.9	0.4	222.5	0.1	0.1	31.4	0.2	0.3	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.1	4.5	0.7	1.2	7.1	0.0	321.5	2.2	5.2	0.2	0.0	0.0	0.2	9.0	0.0	1.7	0.3	255.9	0.1	0.1	0.4	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.3	0.0	1.9	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	18.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.2	0.1	1.0	0.2	0.5	0.6	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.6	0.2	0.1	0.6	0.0	0.1	0.6	198.3	0.0	0.0	3.7	0.0	0.0	0.1	3.6	1.9	0.1	16.2	0.4	0.0	1.6	1.2	0.0	0.4	0.4	0.0	6.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.7	10.3	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.5	2.4	0.0	0.0	0.2	13.0	33.2	0.0	2.5	6.6	10.0	1.3	0.0	0.2	0.0	0.6	0.0	0.3	2.3	2.2	0.3
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 64.1;skeletal muscle: 283.6;tongue: 172.8"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 114.2"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 39.8;fHDF/TERT166: 112.3;HBF TERT88: 25.6;LHCN-M2: 47.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	0.1	0.3	0.2	0.2	0.1	0.6	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.2	0.0	0.1	64.1	0.8	0.8	0.0	0.0	0.0	0.2	0.6	0.2	0.1	0.6	0.0	0.0	0.1	0.1	1.7	0.1	1.7	2.7	0.0	283.6	0.1	0.1	0.2	0.0	0.1	0.8	0.9	0.0	0.1	0.0	172.8	0.0	0.1	0.0	0.3	2.9	1.3	0.0	0.0	0.7	4.1	0.1	39.8	19.7	14.4	5.4	0.0	0.1	0.1	0.0	112.3	20.5	0.7	0.0	0.2	25.6	0.4	0.0	0.0	14.6	0.0	0.3	0.0	0.1	1.6	0.0	7.9	0.9	3.6	0.4	0.0	0.0	0.2	47.6	8.6	0.0	0.1	0.0	0.0	1.3	0.0	2.2	0.0	0.1	0.1	0.1	0.0	5.7	0.9	0.2	0.1	0.0	0.0	1.1	0.7	0.2	4.1	0.1	0.1	0.0	0.0	4.6	0.1	4.2	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.8	0.8	0.6	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.2	0.0	114.2	0.0	0.0	0.0	25.0	0.0	0.0	1.8	0.0	0.0	1.0	1.5	0.1	0.7	0.0	0.0	0.5	0.2	0.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.1
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58643440-58700077	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	11.2	7.5	4.0	4.4	3.9	12.5	12.0	4.3	5.9	11.9	4.2	11.8	5.4	10.6	6.2	10.0	10.2	3.1	10.5	4.1	3.9	7.2	8.0	10.1	6.3	3.9	3.7	13.2	12.1	5.9	8.7	4.4	3.9	9.6	4.4	8.4	11.8	4.1	10.0	10.5	12.6	3.6	3.7	11.4	9.9	4.4	3.9	5.3	11.5	3.1	4.9	9.3	11.1	4.4	10.1	2.6	5.0	6.7	6.0	7.2	10.5	5.9	5.6	5.1	3.9	5.3	4.2	10.3	1.8	3.8	4.8	7.4	7.7	2.1	11.0	6.2	4.3	11.3	2.1	5.1	7.4	19.6	9.7	5.4	5.9	7.5	3.8	6.1	1.2	4.2	12.6	6.3	6.8	2.6	7.8	16.3	11.4	3.5	3.5	7.3	16.4	6.1	4.6	3.8	5.8	6.6	4.4	9.4	13.9	9.0	3.1	10.6	4.9	9.3	4.6	6.4	11.3	10.8	5.8	13.9	5.8	13.7	11.6	0.9	0.3	0.1	0.3	0.4	0.2	0.4	0.3	0.3	0.1	0.3	0.5	0.4	1.0	0.1	0.5	0.4	0.4	0.1	4.0	3.9	4.3	5.9	4.1	3.9	3.9	3.7	3.9	3.7	3.9	4.4	36.5	22.4	33.7	47.7	26.0	19.1	22.8	13.5	30.7	19.5	25.6	21.0	28.2	10.0	35.1	11.0	25.0	8.4	36.6	22.1	15.6	8.8	3.9	22.1	34.8	25.4	16.2	14.1	87.4	9.4	5.7	20.8	19.9	36.9	56.3	30.1	23.9	16.3	11.3	18.5	58.2	17.0	24.4	13.9	14.2	6.3	12.8	22.2	8.8	35.6	21.3	12.7	22.6	58.3	106.9	12.7	13.1	17.3	29.5	19.3	19.2	8.8	21.2	27.8	26.3	28.8	21.5	15.5	20.6	25.0	18.5	11.4	30.8	22.0	18.5	26.4
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.6;retina: 8.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 31.9;Cone photoreceptor cells: 60.5;Horizontal cells: 26.9;Oligodendrocyte precursor cells: 112.1;Rod photoreceptor cells: 29.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.6;SCLC-21H: 23.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.5"	HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.2	3.5	5.8	0.2	3.8	1.1	0.1	24.6	4.3	0.0	0.0	0.2	0.8	0.1	0.2	0.0	0.2	0.1	0.1	3.8	6.6	0.1	0.1	0.1	0.1	5.0	5.6	0.1	0.6	0.3	5.5	0.1	5.2	0.1	0.2	8.3	0.0	0.1	0.0	0.1	0.2	0.1	2.7	0.2	0.6	0.7	5.9	0.1	0.6	0.0	0.1	0.1	0.0	3.6	0.0	0.1	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.7	0.3	0.1	0.3	0.0	2.4	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.2	1.7	0.0	0.1	1.8	0.1	0.9	0.0	0.5	7.6	0.2	0.2	0.0	0.1	23.1	6.0	0.0	0.2	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	2.2	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.8	24.6	4.3	3.8	6.6	5.0	5.6	5.2	2.7	5.9	3.6	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	31.9	0.1	0.0	1.2	4.3	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.4	2.4	2.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.5	26.9	5.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	5.0	0.0	112.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	29.0	0.0	0.4	0.1	1.6	8.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0
MZB1	"HSPC190, MEDA-7, MGC29506, PACAP, pERp1"	ENSG00000170476	"Marginal zone B and B1 cell specific protein"	Q8WU39	5	139387467-139390081	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 89.8;lymphoid tissue: 272.2"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 4000.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 160.4;plasmacytoid DC: 569.3"	"Group enriched"	"Detected in many"	116	"B-cells: 160.4;dendritic cells: 569.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 581.5;RPMI-8226: 2193.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043745, HPA052694"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		350000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA043745: AB_10960359, HPA052694: AB_2681919"	"unprognostic (4.97e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.27e-4)"	"unprognostic (2.21e-2)"	"prognostic favorable (4.60e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.45e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.15e-8)"	"unprognostic (7.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	4.4	9.1	0.0	87.4	0.1	33.0	21.0	0.0	0.7	18.3	0.2	70.1	89.8	1.8	0.4	10.1	5.7	14.3	2.3	0.0	0.0	5.9	5.8	15.9	123.2	0.1	0.0	4.9	1.3	0.0	0.7	0.0	0.1	5.1	39.9	0.0	56.7	4.9	0.1	0.4	47.8	2.1	0.4	272.2	66.6	2.4	0.1	147.3	9.1	0.0	117.8	58.7	3.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	256.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	144.6	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	128.5	0.5	581.5	0.0	0.0	227.8	2.2	0.0	0.0	0.0	90.1	0.3	2193.9	0.0	0.0	0.3	0.8	0.0	11.4	0.0	0.0	3.1	0.1	0.6	0.0	1.8	0.1	0.0	262.0	16.7	223.0	0.1	0.4	0.0	0.0	0.1	0.1	1.5	0.1	3.0	160.4	0.6	1.1	0.5	75.6	0.1	0.2	3.1	2.7	0.0	569.3	0.2	26.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.3	0.4	6.4	10.1	0.0	665.7	2.5	1.3	0.1	0.0	0.0	3.7	3.2	1.1	4.3	2.0	0.0	0.0	0.1	235.0	0.9	0.0	0.1	0.1	1.8	0.4	2.0	1.2	49.3	0.0	0.0	0.1	2.0	6.1	0.4	2.5	0.1	11.4	14.0	0.1	0.0	0.0	1.1	0.0	7.1	3.4	1.1	0.0	4.7	540.7	0.0	1.0	0.0	4.1	0.0	0.0	0.1	0.4	0.0	4000.1	3.0	1.2	1.9	1.2	0.0	0.0	1.7	2.1	0.1	0.1	0.4	2.4	2.2	100.7	0.5	9.7	0.4
N4BP1		ENSG00000102921	"NEDD4 binding protein 1"	O75113	16	48538726-48620148	"Predicted intracellular proteins"	"Immunity, Innate immunity"	"Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 134.6;Glandular and luminal cells: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040849, HPA041080"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040849: AB_10794866, HPA041080: AB_10794186"	"unprognostic (1.07e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.03e-8)"	"unprognostic (9.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.36e-2)"	9.3	6.7	8.0	7.3	7.8	10.3	9.0	9.7	8.0	10.2	7.9	8.8	5.9	8.6	8.3	18.9	8.4	6.3	7.9	7.6	11.0	7.4	7.0	14.7	7.5	8.5	7.8	9.7	7.6	11.4	9.1	7.5	8.2	8.8	6.3	6.9	10.7	6.4	10.5	19.9	9.3	6.3	7.1	10.9	9.2	4.7	10.7	10.3	8.3	7.9	9.0	8.1	11.3	8.4	7.1	11.8	8.3	8.5	11.4	9.0	6.9	6.5	9.9	12.4	6.3	9.3	5.8	7.9	5.9	10.0	5.5	14.4	7.5	10.3	6.8	4.9	6.2	4.1	4.7	8.3	11.1	6.2	10.8	13.0	15.5	4.4	6.4	9.1	6.3	8.1	6.4	8.2	7.5	4.0	7.4	11.2	6.6	7.3	6.7	11.1	13.5	12.4	6.2	11.9	9.3	6.6	5.5	10.0	9.2	8.6	4.2	8.5	9.3	6.3	5.6	3.5	3.9	12.2	7.8	12.0	7.3	4.9	5.6	0.9	1.3	1.8	1.0	1.2	1.3	0.9	1.3	1.6	0.8	0.6	1.1	1.1	8.4	0.4	0.9	1.0	1.0	0.6	8.0	7.8	9.7	8.0	7.6	11.0	8.5	7.8	8.2	7.1	10.7	8.4	41.2	134.6	32.7	28.4	15.3	20.0	21.6	32.4	19.4	24.1	21.3	21.2	15.1	22.8	25.8	7.3	16.7	13.4	53.8	35.4	5.9	8.4	6.4	36.8	35.8	25.7	9.6	6.5	47.5	13.2	10.5	20.1	30.5	113.8	12.6	23.1	24.3	13.4	19.5	26.9	50.1	21.2	6.1	25.9	40.3	3.7	16.1	36.5	5.4	58.1	31.9	15.3	21.6	38.7	54.8	26.7	21.6	20.7	30.2	30.6	16.1	9.4	18.4	23.0	0.0	26.3	17.6	12.6	24.4	26.8	22.7	28.5	36.5	23.8	13.4	47.5
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056850-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	1.0	0.7	1.4	2.5	1.2	4.1	2.9	1.8	1.6	2.5	1.7	2.2	2.4	3.4	1.9	1.8	1.8	1.6	1.1	0.7	4.2	1.5	5.8	1.6	3.6	2.1	1.7	3.0	4.2	1.4	1.2	3.6	0.7	2.4	2.2	2.2	3.5	0.9	0.7	1.9	2.2	0.8	1.4	1.9	1.9	1.8	4.0	11.3	3.5	1.0	4.1	2.1	1.4	0.5	2.0	2.0	12.0	1.9	0.8	3.8	9.5	2.2	2.5	1.3	2.7	3.9	4.0	10.7	4.3	2.1	2.2	1.5	7.7	2.4	3.0	3.4	2.3	4.8	1.5	1.8	1.9	13.0	11.2	4.3	3.3	2.1	4.6	0.4	3.3	10.0	10.8	4.5	2.5	1.9	26.8	6.4	6.0	1.6	1.7	15.4	14.1	2.5	1.0	4.7	4.7	8.3	2.2	1.6	2.1	7.8	1.5	3.8	4.5	1.5	7.3	0.9	1.7	7.4	8.0	7.3	1.4	4.8	3.0	5.1	0.8	0.4	1.7	0.9	1.8	1.2	2.3	1.3	1.4	1.7	3.4	1.9	0.2	8.2	0.9	6.5	1.1	0.9	1.4	1.2	1.8	1.6	0.7	4.2	2.1	1.7	0.7	1.4	4.0	0.5	9.6	22.4	24.4	19.2	18.2	12.0	14.3	5.1	18.8	33.0	12.3	11.2	12.3	11.5	13.2	22.0	27.1	44.2	36.7	9.0	0.0	6.0	4.7	17.6	15.1	11.4	19.3	22.5	16.5	12.6	12.9	15.5	12.2	20.7	5.1	36.1	6.8	20.7	12.4	72.3	47.2	17.1	10.2	16.3	24.6	4.3	9.9	24.0	7.2	36.5	17.9	12.4	27.8	44.2	3.1	11.4	10.8	3.8	36.0	12.4	7.3	3.6	8.7	22.6	13.1	17.9	6.3	22.0	24.3	13.0	13.1	27.0	28.4	30.4	8.5	9.2
N6AMT1	"C21orf127, HEMK2, KMT9, MTQ2, N6AMT, PRED28, PrmC"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957"	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	2.4	5.0	4.9	2.5	5.6	0.9	5.0	4.8	5.3	6.2	4.8	3.4	3.2	6.4	6.1	2.5	4.7	2.8	5.3	4.5	5.3	4.9	2.8	2.5	3.4	5.7	5.0	7.9	2.9	5.7	4.4	6.4	5.6	4.6	3.4	8.4	3.1	4.0	6.1	3.8	2.8	3.5	4.7	3.6	3.1	3.7	5.0	2.2	5.3	5.6	3.3	3.9	4.1	8.8	2.8	2.5	6.2	8.6	5.1	5.6	4.8	6.1	2.5	3.5	2.0	3.2	5.0	3.1	3.0	3.3	6.2	3.3	5.4	3.0	4.3	4.0	4.1	6.7	4.2	4.0	4.5	4.0	2.5	2.9	6.4	3.5	2.4	6.3	2.6	3.8	8.4	5.5	7.3	2.9	1.9	3.2	7.9	6.0	3.5	2.8	5.9	2.4	6.0	4.1	4.7	6.6	5.5	1.9	2.3	5.6	2.7	3.5	5.4	2.9	5.2	5.4	3.7	3.3	4.0	1.7	4.6	10.4	5.5	0.3	0.4	0.6	0.5	0.7	0.6	0.7	1.0	0.7	0.6	0.6	1.4	1.0	0.1	1.4	0.5	0.5	0.4	0.5	4.9	5.6	4.8	5.3	4.5	5.3	5.7	5.0	5.6	4.7	5.0	8.8	7.8	3.2	5.4	5.2	7.1	1.9	5.8	10.3	1.8	10.8	6.3	6.5	17.0	7.2	8.7	12.9	8.4	18.3	4.0	1.5	7.9	11.0	2.9	10.7	9.6	6.9	0.0	13.0	4.6	6.4	12.2	7.9	8.6	4.2	1.3	15.1	5.3	3.5	7.2	10.1	5.1	3.0	10.2	1.3	0.9	4.5	9.6	2.6	1.8	1.0	2.7	11.1	4.1	6.6	15.1	7.7	4.3	10.1	1.2	4.5	2.5	9.3	15.8	10.5	0.0	7.7	8.9	4.5	10.5	4.2	3.7	14.9	5.1	20.1	3.1	4.8
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N-alpha-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929225-153935080	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: AB_2673579"	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	38.4	39.5	19.6	17.2	20.1	13.2	34.6	20.4	27.2	26.5	19.2	34.1	15.3	32.3	15.1	40.5	24.4	10.3	56.3	20.0	21.8	34.1	35.9	26.0	19.7	20.8	20.3	23.8	45.8	13.7	22.5	12.5	20.8	27.6	10.2	7.3	25.3	12.2	98.4	30.9	24.9	18.1	20.4	28.8	35.9	9.1	21.2	10.2	21.7	24.9	15.3	35.9	26.8	20.4	133.4	136.0	25.8	83.0	36.7	36.9	71.2	46.3	28.6	63.8	57.0	88.5	41.0	102.0	147.6	38.7	79.2	63.0	57.9	56.8	23.9	42.1	255.2	36.8	85.8	91.3	49.1	71.4	76.8	28.8	62.2	57.9	59.1	30.7	72.0	39.2	75.1	41.5	41.6	172.8	115.0	106.4	42.9	124.4	189.0	90.1	65.7	111.5	47.7	59.7	54.0	65.7	18.7	71.0	113.7	23.9	38.4	58.8	41.1	25.6	88.5	89.5	142.0	86.3	107.2	196.0	34.7	91.0	75.5	35.3	53.1	81.3	60.0	65.3	78.1	75.2	63.4	65.6	69.4	77.7	37.4	56.7	49.8	64.7	76.0	75.9	102.9	70.6	19.6	20.1	20.4	27.2	20.0	21.8	20.8	20.3	20.8	20.4	21.2	20.4	126.9	9.6	30.2	27.1	76.0	70.1	66.1	90.6	68.3	29.5	82.6	113.8	45.1	47.1	52.8	38.6	12.5	125.9	77.0	94.5	95.9	121.1	2.9	46.0	60.7	98.7	58.1	78.9	18.6	149.9	179.0	57.3	76.5	43.4	67.9	64.2	77.8	78.7	123.1	37.0	14.6	92.2	54.9	66.5	96.0	12.5	46.6	66.4	119.2	9.4	84.8	37.9	85.5	14.1	19.1	144.6	75.2	46.6	104.3	136.9	91.5	197.0	40.2	30.4	65.7	56.6	98.3	7.6	33.1	120.7	90.5	108.8	74.8	97.7	110.3	85.9
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N-alpha-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326061	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 2.6;placenta: 4.2;testis: 6.2"	"Group enriched"	"Detected in some"	12	"Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.6	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.0	4.2	0.3	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.0	32.9	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.6	0.1	0.1	0.2	0.5	0.4	0.3	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	15.9	0.0	0.0	13.3	0.0	0.0	0.0	0.0
NAA15	"FLJ13340, NARG1, NATH, TBDN100"	ENSG00000164134	"N-alpha-acetyltransferase 15, NatA auxiliary subunit"	Q9BXJ9	4	139301505-139420033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023589, HPA050661"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		140000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nuclear bodies"	"HPA023589: AB_1854311, HPA050661: AB_2681208"	"unprognostic (6.25e-3)"	"unprognostic (5.95e-2)"	"unprognostic (7.80e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.16e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.58e-1)"	9.1	8.9	6.5	11.4	7.3	16.4	9.9	12.4	8.3	7.3	7.3	8.4	7.6	8.9	6.0	12.5	7.1	7.0	10.0	6.5	6.7	7.5	10.9	6.4	14.5	7.3	6.8	7.9	7.8	9.7	5.8	10.6	7.7	8.3	9.1	9.2	6.2	7.2	17.0	9.3	7.0	8.7	6.9	8.5	7.9	13.1	6.9	13.4	9.0	16.3	15.5	14.5	7.7	10.5	44.7	32.1	30.4	49.2	21.7	26.4	37.3	42.2	27.6	39.9	30.6	45.3	38.2	91.1	25.3	35.0	34.6	28.1	80.5	51.7	57.2	42.8	29.6	49.0	29.6	29.8	23.0	90.5	30.5	18.7	31.0	50.4	39.1	21.1	40.5	35.2	92.1	38.7	42.9	35.6	86.8	26.8	50.7	83.4	25.0	53.4	40.9	47.0	31.8	37.2	39.3	30.8	28.2	45.7	28.8	30.6	27.8	35.2	35.0	38.3	27.0	36.7	48.7	46.5	89.0	88.7	32.9	64.6	37.4	4.2	3.4	1.1	5.0	3.9	5.9	4.8	5.3	5.9	4.7	5.3	5.1	5.8	2.6	4.5	3.9	4.0	5.5	2.1	6.5	7.3	12.4	8.3	6.5	6.7	7.3	6.8	7.7	6.9	6.9	10.5	28.4	48.1	33.8	28.4	39.7	93.4	69.6	20.7	29.0	34.0	28.1	15.7	46.9	22.8	32.3	20.2	20.9	39.9	22.8	14.4	15.6	28.1	9.0	40.3	38.9	31.5	15.6	34.5	44.0	19.5	50.8	32.9	21.4	40.5	34.8	35.7	16.8	28.1	32.5	40.4	45.9	20.8	18.3	24.1	35.0	11.3	25.4	27.8	28.4	29.0	26.6	27.7	32.0	42.3	57.6	26.5	16.2	29.0	23.4	53.8	10.2	16.4	34.0	36.3	32.9	69.0	47.4	90.0	59.7	44.0	99.3	41.7	31.7	32.1	32.5	70.2
NAA20	"dJ1002M8.1, NAT3, NAT5"	ENSG00000173418	"N-alpha-acetyltransferase 20, NatB catalytic subunit"	P61599	20	20017310-20033655	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 399.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063344			Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA063344: AB_2684991"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	50.4	53.3	38.9	34.8	40.6	46.5	65.3	41.6	51.6	40.8	54.0	41.9	27.9	41.7	54.2	113.5	41.6	32.6	61.7	40.2	42.9	85.2	82.5	40.2	37.3	40.9	41.3	33.0	62.7	103.9	26.7	53.0	41.9	43.5	42.8	49.6	47.1	46.9	84.9	38.2	33.9	46.2	42.3	31.8	42.1	66.6	41.5	37.1	59.7	73.6	51.0	51.3	44.1	44.5	212.7	139.9	50.1	69.4	95.0	116.6	67.7	149.2	100.3	132.1	123.8	67.0	137.7	108.4	80.6	113.6	125.5	156.3	85.8	233.2	153.2	51.4	75.7	79.4	49.6	132.6	141.2	102.2	65.9	122.4	182.1	132.8	153.9	93.2	139.7	80.4	126.7	115.7	157.6	177.2	128.6	149.9	37.9	181.5	180.7	69.8	191.9	148.3	190.0	70.4	84.1	62.2	81.9	254.1	170.7	42.5	145.4	171.1	113.7	106.6	75.4	137.8	153.8	130.0	171.9	116.9	66.5	76.2	76.7	39.7	86.2	70.1	55.5	97.5	83.6	63.3	65.9	65.4	92.9	56.6	63.5	75.0	12.5	70.3	81.8	77.7	75.6	100.6	38.9	40.6	41.6	51.6	40.2	42.9	40.9	41.3	41.9	42.3	41.5	44.5	60.5	67.3	42.2	17.0	44.9	108.7	113.6	312.4	45.5	52.9	62.9	75.2	73.1	77.2	147.8	104.8	25.0	111.8	51.4	32.6	230.9	194.0	399.9	99.5	87.6	77.4	41.3	28.8	18.0	169.0	102.2	66.4	31.1	75.8	51.3	46.5	50.3	72.9	255.9	69.0	22.7	43.8	164.8	66.8	56.1	60.5	69.9	68.6	71.2	31.9	100.1	91.5	58.7	16.1	25.2	198.0	37.1	74.9	44.2	184.5	45.7	242.6	199.9	60.7	39.5	75.8	90.8	354.2	58.3	122.5	118.8	85.5	40.8	99.5	54.2	141.7
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N-alpha-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112108796	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	5.5	6.1	4.6	6.0	5.0	9.8	6.8	6.4	8.1	6.8	8.5	6.8	3.9	5.5	4.3	7.6	5.8	3.7	5.6	5.3	5.1	4.6	5.6	4.9	6.6	5.6	4.7	7.0	6.9	5.9	4.3	5.3	7.7	5.4	4.2	14.8	4.9	4.4	14.9	7.5	4.8	5.4	3.6	5.3	4.9	5.1	4.9	6.0	5.7	9.9	6.9	6.4	6.7	8.0	16.7	16.1	14.8	11.9	8.1	14.0	17.9	15.3	12.4	18.3	12.4	16.2	8.6	28.9	14.4	12.3	10.5	19.2	32.8	13.0	25.1	16.6	22.9	23.6	15.9	15.0	13.2	34.0	13.7	12.1	15.9	21.3	21.8	15.5	16.1	12.6	35.3	3.7	16.7	13.5	19.6	24.9	22.1	34.2	18.6	21.5	15.2	19.7	14.0	27.0	19.1	10.5	16.9	19.8	15.0	14.0	19.3	13.4	13.7	15.2	13.6	17.0	21.3	15.0	30.4	33.0	19.4	14.7	15.5	0.0	1.7	0.5	2.4	1.9	3.7	2.5	3.0	2.3	3.5	2.8	4.2	4.1	0.0	1.6	2.5	3.7	2.5	1.6	4.6	5.0	6.4	8.1	5.3	5.1	5.6	4.7	7.7	3.6	4.9	8.0	16.1	9.6	16.2	44.1	23.3	66.7	34.5	17.1	22.8	38.9	18.9	12.4	23.5	12.8	26.5	7.3	146.0	25.6	20.4	10.1	3.9	15.3	26.5	15.1	23.9	17.4	16.2	17.0	71.6	19.4	21.6	17.8	15.8	14.8	20.3	20.7	15.4	19.4	14.0	23.5	68.0	11.9	28.5	15.4	25.2	8.6	17.4	16.5	16.0	30.0	83.8	13.0	12.3	48.2	109.6	17.4	7.5	12.8	15.7	61.5	7.4	4.7	25.0	67.7	6.6	28.7	22.7	31.5	29.5	28.5	70.2	22.6	15.3	20.0	14.7	48.1
NAA38	"LSMD1, MGC14151, PFAAP2"	ENSG00000183011	"N-alpha-acetyltransferase 38, NatC auxiliary subunit"	Q9BRA0	17	7856685-7885238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059189			Supported	Nucleoplasm	"Intracellular and membrane"	No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA059189: "	"unprognostic (6.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.75e-2)"	72.1	102.2	137.4	33.3	142.4	76.0	67.3	143.6	188.0	58.3	135.3	77.4	30.8	54.9	30.9	65.8	57.4	29.1	99.7	139.4	139.3	87.6	67.8	50.7	45.7	137.7	137.3	45.3	60.1	76.6	73.0	22.6	137.9	71.5	27.0	29.4	56.2	31.8	130.4	59.5	49.2	24.5	138.1	72.6	65.9	97.8	142.5	45.2	60.1	93.4	31.4	60.0	55.5	142.0	131.4	234.9	129.4	132.9	70.8	78.3	44.8	59.7	68.4	108.3	89.9	89.0	54.6	89.6	98.5	63.6	69.2	105.4	69.8	110.3	26.8	134.1	318.2	137.3	279.7	131.0	68.4	38.6	101.9	114.3	60.4	71.0	46.3	74.5	105.9	201.9	29.1	95.3	63.6	157.3	140.0	91.6	29.2	98.9	271.5	142.0	59.6	59.4	101.0	72.6	57.6	110.5	46.6	111.1	87.3	18.7	68.8	100.0	57.6	72.2	52.0	59.0	170.8	39.1	43.8	34.8	121.5	159.1	72.2	313.1	275.2	196.9	176.1	244.0	163.4	273.8	186.3	181.9	332.4	234.2	167.1	173.6	201.1	152.9	239.8	304.0	215.3	299.0	137.4	142.4	143.6	188.0	139.4	139.3	137.7	137.3	137.9	138.1	142.5	142.0	263.1	76.9	140.5	16.3	117.8	94.1	85.8	171.8	144.5	98.5	218.1	305.4	344.3	128.7	107.7	253.8	50.1	160.2	107.4	227.2	518.5	100.6	646.3	189.4	104.9	183.6	226.6	201.2	18.3	158.4	128.0	102.6	80.5	133.1	100.1	131.1	213.5	381.3	210.5	40.4	21.7	211.2	146.5	222.8	96.8	1601.4	116.8	149.9	76.5	14.0	195.2	221.6	182.3	34.7	13.3	134.0	161.6	113.2	161.7	86.8	184.1	468.0	107.1	126.5	111.7	70.2	109.8	120.5	132.4	182.1	99.4	91.9	103.5	175.3	289.5	129.3
NAA40	"FLJ13848, NAT11"	ENSG00000110583	"N-alpha-acetyltransferase 40, NatD catalytic subunit"	Q86UY6	11	63938959-63957319	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 102.6;Late spermatids: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037816, HPA056142"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA037816: AB_10672289, HPA056142: "	"unprognostic (3.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.29e-3)"	"unprognostic (3.42e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.25e-2)"	3.3	8.9	5.1	3.9	5.1	2.5	4.4	4.5	5.7	4.0	5.7	5.2	5.7	3.0	3.3	6.7	6.8	3.6	9.5	5.3	4.9	9.1	3.8	3.6	7.5	5.6	5.3	2.7	6.5	15.1	10.4	6.7	5.2	4.2	4.7	7.2	6.6	4.0	4.7	2.7	5.7	3.1	5.0	8.8	4.8	15.3	5.2	10.0	6.1	8.5	7.3	4.2	3.6	5.0	15.5	17.3	21.7	11.8	6.0	5.9	13.8	11.3	12.0	27.3	19.1	14.8	19.3	9.5	13.6	10.2	18.9	13.7	18.3	8.2	20.1	12.5	11.2	13.0	11.1	16.9	7.9	20.9	10.8	6.0	7.4	17.0	4.6	10.6	18.0	16.1	22.4	6.9	12.9	11.8	22.3	16.3	20.2	14.3	11.8	21.9	19.5	12.1	18.5	11.8	28.7	15.1	17.7	15.2	9.2	15.8	25.1	9.2	11.6	15.1	18.3	8.9	9.3	8.3	5.6	16.5	9.2	8.9	11.9	2.3	0.5	2.7	6.9	0.4	2.4	2.7	1.8	3.3	2.7	2.4	1.1	2.6	0.1	5.2	0.2	3.5	0.5	2.3	5.1	5.1	4.5	5.7	5.3	4.9	5.6	5.3	5.2	5.0	5.2	5.0	4.3	3.2	4.8	12.1	8.1	2.8	2.0	4.5	10.8	30.9	11.5	7.0	14.8	5.7	9.4	18.4	33.3	9.6	12.1	13.6	0.0	5.7	46.3	20.0	7.4	7.6	17.5	7.4	14.3	5.4	12.8	4.8	6.1	8.5	1.3	14.3	9.7	5.2	9.5	102.6	15.6	6.1	10.2	10.3	5.3	130.5	4.7	7.3	1.8	15.0	4.4	8.6	17.5	11.6	10.1	5.9	3.5	7.2	12.2	2.1	10.6	4.1	22.5	23.9	0.0	4.3	4.4	27.4	16.5	6.5	2.8	4.1	8.9	10.4	7.3	1.8
NACAD	KIAA0363	ENSG00000136274	"NAC alpha domain containing"	O15069	7	45080437-45088969	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 84.2;pituitary gland: 24.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 32.0;Oligodendrocytes: 23.1;Peritubular cells: 12.0"	"Group enriched"	"Detected in many"	7	"glioma: 12.1;testis cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 33.4;SCLC-21H: 25.6;SH-SY5Y: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020981, HPA079208"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Nucleoplasm	"HPA020981: AB_2670549, HPA079208: "	"unprognostic (5.54e-6)"	"unprognostic (1.89e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.72e-3)"	"unprognostic (2.72e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	3.3	5.2	23.4	1.2	50.2	0.1	3.2	54.2	42.1	6.2	0.0	8.3	0.7	7.9	0.8	2.0	5.5	1.8	4.5	26.3	34.6	2.1	0.2	2.5	0.7	58.9	48.3	8.9	1.0	0.8	24.3	1.9	58.6	4.3	0.8	3.7	1.7	3.0	1.2	1.7	3.0	4.3	32.7	1.6	3.9	3.7	57.4	0.3	1.3	1.0	0.3	5.0	4.6	84.2	0.0	0.0	2.5	0.1	1.6	0.7	0.1	2.9	3.5	7.7	4.8	0.2	0.1	0.0	2.2	5.1	33.4	0.2	2.2	1.9	2.7	0.0	0.8	0.0	1.7	0.0	1.8	0.0	0.0	1.6	0.0	3.3	0.3	4.1	2.4	0.0	0.0	3.5	2.0	0.0	0.0	0.0	2.3	0.0	2.2	0.0	0.9	0.0	0.3	0.0	25.6	17.7	0.0	0.1	0.1	6.7	0.0	0.1	0.9	0.0	0.0	0.2	0.5	1.8	1.0	0.0	1.5	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.4	50.2	54.2	42.1	26.3	34.6	58.9	48.3	58.6	32.7	57.4	84.2	0.3	0.0	0.0	6.8	0.0	0.6	3.5	0.9	1.2	5.5	0.4	1.8	6.0	0.0	0.2	1.8	0.0	0.1	0.4	0.1	0.0	0.6	2.9	0.5	3.1	0.9	1.2	0.0	4.4	0.2	0.1	3.9	1.1	1.2	1.3	3.9	0.7	0.0	0.1	32.0	5.2	0.0	0.0	0.0	0.0	4.9	6.8	0.7	1.8	1.9	1.0	2.7	0.0	3.0	23.1	0.1	0.0	12.0	0.1	2.3	0.0	0.4	0.8	2.8	6.6	5.3	4.2	1.5	1.4	0.2	0.1	0.1	0.3	9.6	0.1	0.9
NADK	FLJ13052	ENSG00000008130	"NAD kinase"	O95544	1	1751232-1780457	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 506.2"	"Group enriched"	"Detected in all"	7	"granulocytes: 506.2;monocytes: 162.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048909, HPA053368"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Vesicles	"HPA048909: AB_2680553, HPA053368: AB_2682130"	"unprognostic (1.29e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.03e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	53.6	81.8	24.8	37.5	26.6	100.7	44.7	22.1	29.0	28.6	27.8	45.1	38.0	30.9	13.3	29.9	36.1	23.3	28.7	24.1	24.3	30.2	134.0	40.3	41.2	25.4	24.6	37.2	38.9	17.2	26.4	26.0	25.0	32.9	25.4	10.9	40.2	17.4	19.6	28.3	43.3	19.8	24.5	93.1	43.2	27.5	26.5	16.4	31.7	19.2	26.6	32.3	27.1	23.8	41.6	39.3	34.4	50.7	47.8	34.5	44.2	40.9	35.5	45.6	40.3	42.1	74.2	54.5	30.4	30.5	14.7	34.6	37.3	32.5	20.3	53.5	59.1	44.7	65.0	73.6	46.2	63.4	72.1	40.6	28.9	28.4	40.3	24.8	44.9	42.6	55.9	75.8	34.4	47.4	48.1	54.8	23.5	69.4	43.8	60.4	29.4	113.1	39.7	33.9	46.2	35.2	45.8	99.2	43.7	20.3	34.2	43.6	43.8	33.1	23.7	34.6	37.5	67.1	32.7	121.8	32.7	69.3	17.6	84.2	141.3	329.7	7.4	158.6	8.8	10.8	4.3	5.9	45.9	12.1	2.8	4.1	506.2	3.8	162.6	37.9	7.0	82.9	24.8	26.6	22.1	29.0	24.1	24.3	25.4	24.6	25.0	24.5	26.5	23.8	29.0	12.8	30.7	14.4	27.2	9.8	15.7	11.2	13.6	7.9	21.4	17.9	6.8	25.8	21.6	14.7	16.7	24.5	46.8	57.8	15.6	19.1	14.9	18.7	22.2	20.8	22.8	15.8	10.2	29.4	26.3	18.7	52.0	22.8	2.5	21.2	22.5	94.3	36.6	6.7	10.4	38.7	16.2	58.4	13.7	26.7	37.6	45.0	8.8	9.4	67.3	5.7	27.8	10.6	11.1	28.7	34.6	34.6	26.0	34.7	28.6	24.3	13.5	17.7	13.1	12.6	18.2	12.4	22.4	19.5	12.8	42.8	15.4	44.2	31.0	27.5
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004622-44009068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 15.9;liver: 48.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 21.7;Proximal enterocytes: 44.2;Proximal tubular cells: 20.7;Spermatocytes: 16.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;HHSteC: 5.2;TIME: 7.1;U-87 MG: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.9	0.7	2.0	0.5	1.2	0.0	1.4	0.9	2.0	0.8	0.0	2.4	15.9	0.8	1.8	1.4	0.7	0.4	1.2	1.0	3.5	4.9	48.2	1.9	0.3	2.0	1.4	0.6	0.3	3.3	0.5	0.1	2.2	1.1	0.5	0.0	1.0	1.4	0.2	1.0	13.6	0.1	1.3	0.4	0.4	0.6	3.6	0.1	4.4	0.2	0.1	0.4	1.0	1.0	2.9	0.1	0.0	0.4	0.0	5.5	0.1	0.5	0.1	0.1	0.2	1.7	0.7	0.0	1.1	0.0	0.1	1.3	0.1	1.5	0.3	0.2	0.7	0.1	0.2	2.2	5.2	0.0	0.0	3.2	0.0	0.7	0.0	0.6	1.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.7	0.0	0.3	0.0	0.1	0.0	2.1	0.0	0.9	0.0	0.0	0.2	0.2	0.0	7.1	2.5	0.7	0.2	0.6	0.1	0.1	0.1	10.0	0.0	0.3	0.8	0.5	0.7	0.9	0.4	0.7	0.3	0.6	0.8	0.5	0.3	0.3	0.4	0.3	0.2	0.8	0.1	0.5	0.3	2.0	1.2	0.9	2.0	1.0	3.5	2.0	1.4	2.2	1.3	3.6	1.0	1.8	3.2	4.2	0.0	0.9	1.5	0.9	1.9	6.8	0.4	3.5	4.8	2.6	2.8	2.9	12.9	0.0	0.9	1.1	10.5	7.9	1.9	5.8	0.5	0.2	2.3	7.2	0.0	0.0	4.2	1.9	0.9	2.0	0.2	0.0	0.3	0.7	21.7	1.1	0.0	0.3	3.8	4.1	1.9	5.3	5.3	1.5	2.1	0.0	1.0	6.1	1.0	3.1	0.0	0.0	5.1	11.1	0.7	0.0	0.6	44.2	20.7	1.1	0.5	0.0	0.2	0.9	16.0	2.5	1.0	0.9	0.4	1.4	0.7	6.6	0.6
NANOG	"FLJ12581, FLJ40451"	ENSG00000111704	"Nanog homeobox"	Q9H9S0	12	7787794-7799146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 8.4;Spermatocytes: 5.5"	"Cancer enriched"	"Detected in single"	1164	"testis cancer: 58.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 125.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB019380, HPA072117"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"CAB019380: , HPA072117: "	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"		"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.46e-2)"		"unprognostic (6.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.51e-7)"	"unprognostic (3.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.85e-2)"	0.0	0.1	0.3	0.1	0.7	0.4	0.1	1.9	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.4	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	125.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.5	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.7	0.3	0.2	1.7	0.1	0.0	0.3	0.7	1.9	0.4	0.3	0.1	0.3	0.1	0.3	0.1	0.4	0.7	0.4	0.0	0.0	0.0	0.2	1.7	1.8	0.8	0.0	2.2	0.3	0.1	0.8	0.0	0.3	0.0	8.4	1.6	1.4	0.1	0.0	0.4	1.0	0.3	0.5	0.6	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.3	0.0	2.1	0.7	0.6	0.5	0.0	0.0	0.3	2.0	0.3	0.0	0.3	1.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.4	1.5	0.0	0.9	0.0	0.3	0.9	1.0	0.0	1.7	0.4	5.5	0.6	0.0	0.6	0.7	0.7	0.7	0.4	1.8
NANOGP8		ENSG00000255192	"Nanog homeobox retrogene P8"	Q6NSW7	15	35083410-35085295	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	415	"testis cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	69	"NTERA-2: 33.2;SuSa: 11.6"									HPA072117			Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 5: NTERA-2 - Transcription"		Nucleoplasm	Vesicles	"HPA072117: "										"unprognostic (1.58e-1)"			"unprognostic (9.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"			0.1	0.1	0.7	0.0	3.7	0.2	0.1	2.1	1.8	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.7	1.2	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	3.7	2.1	1.8	0.2	0.5	0.3	0.2	0.4	0.2	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056732-98083077	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		410000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	39.4	28.9	16.2	49.3	15.0	67.8	36.5	13.8	18.2	49.9	29.8	133.5	52.2	28.5	33.5	51.4	29.4	34.2	46.3	15.1	17.0	32.8	67.0	45.9	59.5	16.2	17.2	26.2	67.6	20.4	42.5	31.7	18.4	106.4	129.2	8.3	120.0	19.7	34.2	29.2	47.8	29.0	15.1	53.3	76.1	27.2	17.2	18.8	27.3	17.4	60.5	47.5	41.5	17.2	387.9	111.8	32.5	94.5	64.0	68.8	70.5	120.9	93.7	96.3	78.3	134.8	53.6	118.1	57.2	133.3	101.9	134.1	61.0	103.6	80.0	95.7	91.0	70.3	128.4	271.9	176.3	80.3	55.3	58.4	69.1	102.9	116.4	111.8	104.3	57.9	129.9	119.8	71.2	265.0	54.1	114.9	56.2	277.5	143.3	103.4	89.0	121.5	78.2	116.6	65.7	34.4	77.8	414.4	107.2	35.8	137.6	85.3	274.2	74.8	72.5	193.4	125.8	110.7	99.3	45.7	88.4	95.9	59.6	30.9	190.9	29.5	34.9	237.6	53.4	55.6	45.5	36.8	194.7	54.9	48.8	33.7	77.4	38.9	217.0	178.8	58.3	91.4	16.2	15.0	13.8	18.2	15.1	17.0	16.2	17.2	18.4	15.1	17.2	17.2	46.7	28.9	54.9	3.6	57.0	70.1	134.0	183.0	30.7	11.4	61.6	45.5	25.3	42.9	206.3	22.0	18.8	86.7	50.2	234.3	70.5	49.4	42.8	63.4	37.9	63.4	64.9	18.7	6.7	100.7	159.2	50.6	99.4	55.8	43.8	29.5	34.2	33.6	160.0	10.1	7.2	362.7	95.6	67.7	107.6	71.5	32.3	89.8	129.9	6.5	53.1	14.1	14.4	2.0	3.1	70.9	181.0	26.4	141.1	213.6	66.5	68.3	204.5	8.0	13.1	32.9	91.3	10.5	21.9	42.0	61.7	150.8	50.6	44.6	260.1	223.3
NAP1L4	NAP2	ENSG00000205531	"Nucleosome assembly protein 1 like 4"	Q99733	11	2944431-2992377	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011567	Approved		Supported	Nucleoplasm		NA	NA		3100000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011567: AB_776638"	"unprognostic (1.61e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (8.99e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.54e-1)"	39.6	43.5	44.3	36.1	59.2	50.3	41.3	53.0	178.1	46.7	70.3	60.3	20.1	45.4	17.3	79.6	41.2	32.5	111.4	41.3	52.1	63.7	56.2	40.5	65.7	57.2	53.8	42.9	38.0	63.5	61.4	36.8	60.2	51.9	34.2	38.6	66.4	32.1	146.1	49.0	53.8	39.1	52.2	59.0	56.6	87.4	56.4	78.8	44.6	110.7	75.8	61.9	52.1	72.2	82.8	59.9	81.7	65.7	83.9	92.4	37.7	159.8	104.1	145.4	132.5	129.7	208.4	149.5	95.3	98.0	15.1	140.0	21.9	136.3	166.8	159.2	57.5	106.7	151.4	168.2	57.7	93.0	110.5	77.8	65.1	78.6	59.1	12.0	88.9	77.6	139.3	150.7	128.0	74.5	206.4	4.2	199.8	98.9	75.2	101.4	98.1	117.0	12.2	131.7	121.4	104.3	80.5	118.1	78.3	82.5	7.3	7.4	67.8	112.5	104.4	152.4	13.8	79.3	136.5	201.5	8.4	66.0	75.3	67.5	22.9	32.6	42.3	24.0	39.9	24.7	51.9	53.0	27.2	28.4	45.7	52.1	14.5	57.6	30.4	25.0	70.5	48.0	44.3	59.2	53.0	178.1	41.3	52.1	57.2	53.8	60.2	52.2	56.4	72.2	53.6	44.8	49.8	56.2	64.3	70.1	67.4	76.9	83.1	80.4	54.6	48.3	200.4	42.9	69.0	75.4	45.9	103.8	99.4	37.2	97.8	78.7	97.0	107.7	65.9	55.4	45.4	168.7	36.9	50.4	109.2	56.6	54.0	91.1	74.6	100.6	43.5	50.0	47.3	65.6	56.6	41.4	67.1	30.8	44.7	142.6	48.1	49.7	35.6	38.4	65.3	67.5	95.8	60.8	125.3	74.1	26.8	50.0	100.7	76.1	39.8	76.9	92.6	68.1	46.0	58.8	64.7	166.1	129.0	102.3	66.9	91.3	123.8	79.7	55.1	83.7
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435968-78574874	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	7.3	11.9	10.7	6.8	12.3	6.2	11.1	12.4	13.3	9.6	19.8	11.3	10.3	9.1	11.2	8.1	9.9	7.0	11.7	10.4	11.7	19.0	23.5	7.6	9.6	11.7	13.9	11.4	10.6	11.4	7.6	8.0	13.1	10.8	10.9	13.4	10.7	7.3	23.5	7.2	9.7	7.4	11.3	7.4	9.9	7.5	11.4	11.7	11.5	19.6	9.7	8.7	8.1	12.3	16.7	22.8	23.5	15.4	16.1	13.5	19.5	13.5	13.1	20.6	16.9	39.4	17.4	40.9	34.1	8.7	19.8	21.5	39.9	26.3	28.3	27.0	21.3	28.9	17.3	33.7	13.3	31.3	10.1	9.4	16.8	18.1	32.0	18.3	17.9	33.7	44.5	11.0	23.1	19.4	32.7	50.3	25.6	67.3	27.3	33.6	38.2	55.5	27.2	23.0	27.8	17.5	20.1	25.4	35.5	25.1	24.1	12.3	10.9	27.7	32.8	32.0	23.1	18.1	33.1	91.1	5.4	27.7	19.2	9.5	9.3	4.4	11.1	10.4	13.8	17.6	12.8	12.5	16.6	15.0	18.5	16.7	2.0	20.3	12.8	12.7	10.5	10.3	10.7	12.3	12.4	13.3	10.4	11.7	11.7	13.9	13.1	11.3	11.4	12.3	5.8	19.2	26.4	27.7	14.5	13.5	14.2	12.0	12.5	5.2	9.4	6.5	8.8	5.7	10.3	5.5	2.1	20.0	4.4	4.0	29.4	9.5	13.1	10.1	7.4	6.6	12.0	9.2	34.7	7.3	23.6	9.0	10.2	9.0	8.2	14.0	2.5	19.8	12.4	0.0	45.1	8.3	22.4	6.3	11.6	5.4	7.8	6.3	17.8	45.0	2.9	6.3	4.1	42.7	47.7	7.5	9.9	4.9	14.6	17.5	7.0	28.9	10.2	9.0	6.6	7.5	8.8	8.6	19.5	12.0	13.8	15.3	7.8	9.0	14.6	10.7
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105617-34147670	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	20.6	24.2	16.0	17.3	15.4	20.4	19.6	14.7	17.4	20.1	14.0	17.0	10.2	20.0	13.7	25.7	19.2	9.4	18.4	15.1	15.4	19.5	22.3	14.9	23.4	14.3	13.6	23.1	25.3	16.8	17.5	15.1	14.7	19.4	15.5	16.3	16.7	12.2	24.8	28.9	17.5	15.5	12.6	22.8	18.7	22.0	15.6	19.4	17.2	12.5	27.5	20.3	20.5	16.9	40.0	55.5	29.3	62.0	34.2	30.2	33.6	38.8	28.5	48.4	38.4	62.6	22.6	127.6	28.3	33.0	41.8	59.5	110.5	59.4	59.5	35.9	70.2	58.0	44.5	58.9	31.0	147.3	40.7	31.1	40.0	31.5	88.3	22.8	37.4	60.6	128.6	43.5	40.8	76.0	120.5	65.7	41.9	69.3	65.7	89.3	98.0	53.7	27.8	68.5	43.1	32.6	52.3	54.9	23.6	28.2	55.0	41.0	30.5	42.8	34.0	63.7	72.8	47.0	61.0	120.3	43.3	60.0	43.4	0.7	8.3	2.8	11.7	13.7	15.5	12.2	12.6	13.4	15.5	10.6	12.7	13.2	0.9	15.0	12.9	11.6	12.0	9.1	16.0	15.4	14.7	17.4	15.1	15.4	14.3	13.6	14.7	12.6	15.6	16.9	8.5	6.4	20.7	10.4	12.7	12.2	11.3	6.9	12.5	12.2	8.8	10.2	12.6	7.2	15.1	14.7	12.5	18.1	8.0	5.8	5.9	9.2	6.1	10.1	18.3	10.9	7.2	21.0	22.8	9.6	13.4	14.5	5.6	12.2	5.1	17.3	5.7	7.5	12.0	11.8	21.7	8.9	4.1	5.5	4.4	3.4	9.3	8.5	1.8	6.5	12.9	5.3	7.2	11.6	16.0	8.7	3.5	13.2	9.8	14.8	3.7	5.8	10.6	11.0	13.1	19.6	8.4	20.5	21.6	13.1	13.8	14.4	11.0	19.7	14.3	7.6
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591756-156609507	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"	"Lipid transport, Transport"	Isomerase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 136.7;Distal tubular cells: 201.5;Ductal cells: 112.8;Exocrine glandular cells: 100.1;Proximal tubular cells: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		3300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	47.1	74.8	61.0	20.9	63.7	22.2	47.9	66.1	69.6	56.8	71.1	62.9	45.5	68.8	88.7	58.0	59.5	26.5	111.1	60.9	64.3	83.8	86.5	43.6	27.0	62.7	64.8	46.5	69.7	104.7	70.0	23.7	61.8	62.5	41.6	17.4	53.9	48.3	71.8	55.8	48.3	39.7	64.7	43.2	67.5	40.8	63.5	30.6	59.8	68.2	34.3	55.0	47.8	70.5	114.2	155.4	43.9	84.4	64.0	43.8	55.5	29.5	62.3	69.5	72.6	130.6	76.8	62.4	113.4	52.5	55.9	111.1	49.4	99.0	47.5	81.2	98.5	58.1	76.2	86.1	75.1	60.0	60.9	44.2	123.7	87.9	81.9	53.4	95.4	104.7	54.7	70.1	71.6	209.6	83.3	98.0	43.1	158.1	118.2	87.7	40.2	212.6	93.0	93.6	114.7	102.9	90.4	172.4	141.6	66.4	178.3	117.5	51.1	45.1	64.8	64.6	70.6	180.1	110.3	53.0	63.1	37.0	70.4	25.4	96.3	52.9	121.2	111.3	121.3	236.2	109.4	124.3	89.1	186.5	122.8	114.9	11.4	141.3	89.1	225.7	110.1	186.6	61.0	63.7	66.1	69.6	60.9	64.3	62.7	64.8	61.8	64.7	63.5	70.5	29.5	41.7	32.9	0.0	14.8	0.0	0.0	0.0	0.0	0.0	87.5	96.0	0.0	0.0	23.5	68.0	0.0	136.7	28.7	0.0	201.5	112.8	0.0	27.3	29.9	18.4	0.0	0.0	0.0	100.1	43.1	27.2	0.0	32.0	5.1	53.5	0.0	0.0	92.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	40.8	0.0	0.0	0.0	0.0	91.0	0.0	0.0	6.2	0.0	0.0	219.6	11.7	0.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	81.3	13.4	48.1	0.0	0.0
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998409-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 12.0;brain: 26.0"	"Group enriched"	"Detected in some"	19	"Astrocytes: 713.0;Excitatory neurons: 866.5;Inhibitory neurons: 909.2;Oligodendrocyte precursor cells: 1729.1;Oligodendrocytes: 1526.6"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.6;glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"		No	No		120000000		"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: AB_2673650"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	0.7	12.0	14.1	0.9	19.0	0.0	1.6	8.4	17.5	1.6	0.0	2.0	0.2	1.0	0.5	0.5	0.6	1.2	2.0	21.3	22.7	0.2	6.7	2.8	0.1	8.6	14.4	0.3	0.2	0.6	0.8	0.5	8.8	0.9	1.0	1.2	0.7	1.0	0.4	0.8	0.7	1.4	8.8	0.8	0.6	6.3	26.0	0.1	0.3	0.8	0.2	0.6	1.2	21.6	0.0	0.0	0.5	0.0	4.6	4.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.5	1.3	0.0	2.2	0.0	0.1	11.3	0.0	3.5	0.0	0.4	0.0	0.0	11.4	2.4	0.2	15.4	0.2	0.0	0.4	0.0	0.0	1.0	0.0	4.7	0.0	0.0	0.0	5.3	0.0	0.8	0.6	0.1	92.1	7.2	0.0	1.3	0.9	0.1	0.0	0.6	0.0	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	19.0	8.4	17.5	21.3	22.7	8.6	14.4	8.8	8.8	26.0	21.6	0.4	3.2	1.3	713.0	0.1	0.5	0.3	0.0	0.0	1.0	2.0	1.4	1.8	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	57.6	0.3	6.1	0.4	0.0	0.0	866.5	0.0	0.4	4.8	0.0	0.2	0.0	0.2	2.2	0.0	0.3	0.0	909.2	0.0	0.0	0.0	0.3	24.7	0.9	0.1	1.8	30.9	0.0	1.0	0.0	1729.1	1526.6	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.1	0.0	2.4	1.6	3.7	9.6	0.1	0.1	0.3	0.2	1.9	0.0	0.2
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631169-158704804	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.91e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	3.7	2.5	2.0	8.8	2.2	24.4	5.4	2.5	2.1	4.0	1.3	6.9	4.4	4.3	2.1	6.9	3.0	2.9	2.9	2.2	2.1	2.6	4.1	3.1	12.4	2.0	1.7	3.1	2.2	4.6	3.5	5.9	2.1	2.8	7.6	2.8	3.5	2.8	3.4	6.8	5.8	4.8	1.6	4.6	5.6	14.8	1.8	27.9	3.2	4.1	13.8	4.0	3.9	2.4	103.9	53.7	64.1	41.8	9.5	15.4	25.3	74.3	47.4	89.0	99.0	48.5	52.0	64.0	45.0	30.3	95.1	51.7	53.7	33.8	117.2	68.4	40.4	57.2	64.8	38.8	4.2	72.2	62.3	6.8	3.7	73.1	21.0	16.2	50.4	72.9	71.9	91.6	82.8	111.4	119.2	48.8	63.7	58.8	43.3	69.7	67.8	60.6	22.6	45.9	69.6	54.5	91.6	35.0	20.2	40.4	31.4	46.5	25.9	60.6	45.9	166.2	120.6	61.3	48.2	77.2	64.6	89.6	118.5	5.9	0.9	1.1	5.2	1.2	7.5	1.6	5.2	3.6	2.3	1.0	1.6	1.8	0.7	5.2	5.1	1.1	7.2	2.2	2.0	2.2	2.5	2.1	2.2	2.1	2.0	1.7	2.1	1.6	1.8	2.4	3.6	6.4	1.5	3.9	4.1	4.0	2.1	2.8	1.8	3.9	3.7	3.3	4.8	2.8	4.6	1.8	0.0	6.7	5.1	3.4	0.0	2.3	15.1	4.0	4.6	4.3	0.0	19.6	10.7	3.3	10.4	4.5	4.1	5.9	1.3	12.6	2.9	2.6	7.3	8.4	7.2	2.9	2.0	3.8	5.2	7.2	2.8	4.4	1.8	3.7	2.7	2.1	2.1	10.1	10.7	2.3	0.4	4.1	11.0	1.1	0.3	1.3	6.0	2.8	6.6	4.3	5.7	48.2	18.5	6.1	2.0	2.6	4.9	5.0	5.7	3.0
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335766-96377091	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.2;lymphoid tissue: 37.4;testis: 35.4"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 26.3;Spermatocytes: 89.3;Spermatogonia: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.8;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (9.53e-6)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.2	0.7	0.3	9.9	0.4	35.2	1.8	0.9	0.9	1.3	0.1	7.7	5.6	0.9	0.2	6.3	0.5	1.6	0.4	0.3	0.2	0.4	1.0	1.1	20.3	0.1	0.0	0.3	0.3	0.5	0.2	5.2	0.3	0.4	9.3	1.8	1.5	0.2	0.3	4.7	6.2	2.8	0.0	3.7	3.6	35.4	0.1	37.4	0.4	0.1	22.0	2.6	2.0	0.3	134.1	52.0	115.1	60.6	3.9	6.1	80.8	58.7	40.3	115.1	118.4	93.5	71.5	121.0	41.8	26.6	106.2	57.2	100.2	39.6	117.2	110.0	63.4	123.7	49.3	74.5	0.7	112.2	101.3	1.8	4.2	89.1	35.9	10.2	46.6	89.7	89.5	88.8	53.0	59.5	183.8	104.2	85.9	57.6	56.6	133.4	106.7	95.5	23.6	49.6	71.2	52.3	34.8	46.5	19.9	42.4	36.6	80.0	24.1	83.5	126.3	76.9	101.9	44.4	70.1	134.0	33.7	111.5	95.3	3.8	0.0	0.2	0.8	0.9	0.1	0.9	1.2	1.0	0.4	0.9	0.0	0.4	0.3	0.1	0.0	0.0	6.2	0.5	0.3	0.4	0.9	0.9	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	4.9	0.0	0.0	0.0	3.5	0.6	0.7	1.9	1.2	0.4	1.0	0.8	0.5	0.0	1.6	0.0	8.4	9.4	2.0	2.1	0.0	0.5	5.9	1.7	0.9	1.8	0.0	16.4	0.4	0.0	16.3	1.8	4.1	1.2	1.3	5.5	1.4	0.4	8.5	0.0	0.3	2.8	0.0	3.8	3.7	4.9	0.9	2.2	1.8	0.0	0.2	8.5	0.0	0.5	1.0	0.2	0.1	0.4	26.3	0.7	0.4	0.0	1.6	2.3	0.0	0.2	3.5	89.3	29.4	8.8	0.9	1.9	5.1	0.6	5.7	1.1
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508224-50524780	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge"	"HPA067932: AB_2685926, HPA069056: AB_2686076"	"unprognostic (2.01e-1)"	"prognostic favorable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	25.7	21.9	32.9	24.5	33.6	78.8	26.9	32.7	39.2	31.8	25.4	29.3	17.7	29.8	12.4	30.3	30.0	13.0	36.7	32.0	30.9	26.6	27.6	28.2	27.6	32.6	29.0	37.6	40.7	16.7	38.6	17.1	28.7	28.4	11.7	15.5	25.7	16.6	30.7	32.6	28.4	14.7	27.5	33.2	30.2	52.3	28.5	29.6	28.9	19.3	20.2	25.9	26.9	33.5	60.7	32.1	53.8	57.1	15.8	18.4	71.6	45.8	31.6	81.8	89.5	67.2	41.4	68.8	25.5	32.9	45.5	47.1	49.0	44.2	23.5	40.3	82.8	39.8	86.7	63.6	19.1	90.3	69.5	16.1	27.6	64.4	22.2	12.2	26.2	59.4	51.5	132.5	33.4	83.9	61.7	109.9	39.3	34.9	37.9	103.3	71.0	77.2	23.8	40.6	35.6	47.5	36.7	55.4	44.3	16.5	37.5	86.7	17.6	64.2	80.5	54.4	72.3	67.7	45.8	110.1	48.8	45.7	62.3	11.9	9.8	18.2	18.7	11.6	22.9	16.0	19.4	19.1	8.0	14.2	19.9	17.3	11.4	13.9	14.4	11.8	19.3	15.5	32.9	33.6	32.7	39.2	32.0	30.9	32.6	29.0	28.7	27.5	28.5	33.5	10.1	22.4	24.5	12.1	15.9	18.9	23.8	17.5	6.2	18.3	11.5	12.6	19.6	15.7	10.4	9.2	4.2	36.3	15.5	24.6	15.6	16.6	36.8	8.5	7.5	12.9	13.1	31.5	8.6	23.5	55.1	13.8	14.8	14.5	17.1	16.3	8.9	10.6	19.3	8.4	8.8	18.8	6.1	7.9	16.3	111.5	17.4	9.2	12.4	3.7	16.2	14.7	18.6	3.0	8.2	17.3	13.5	17.3	26.6	15.2	18.4	9.5	5.9	16.1	19.7	17.8	16.9	36.2	39.7	10.9	18.5	31.5	15.9	7.6	22.6	18.2
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942594	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	38.3	44.0	40.3	38.7	41.4	17.2	36.0	39.7	46.6	34.5	38.6	35.4	29.4	32.6	41.1	29.0	30.1	28.8	31.3	41.5	45.8	41.7	30.1	27.1	43.5	42.7	42.1	35.7	25.7	38.2	26.0	33.9	42.3	36.4	35.2	46.2	24.4	35.5	38.6	27.2	27.8	33.8	43.6	34.2	29.6	25.8	43.8	49.9	37.7	38.6	42.2	45.6	26.1	43.1	144.3	44.6	105.5	131.8	118.6	102.8	74.1	106.1	80.9	66.4	69.7	99.5	51.2	97.0	229.7	76.3	85.4	84.6	136.1	113.0	104.7	50.8	85.0	125.2	55.3	87.5	103.9	146.4	85.3	84.1	101.2	48.7	134.1	99.5	104.3	103.2	71.6	99.7	113.7	165.5	111.3	88.4	134.5	137.2	139.5	86.9	78.6	92.9	99.3	101.9	57.3	153.1	63.8	126.4	189.4	85.4	279.1	112.4	97.5	67.1	71.4	85.0	193.0	155.6	149.4	162.1	93.8	162.5	103.2	9.9	37.7	20.9	37.5	44.5	56.6	53.2	46.2	44.8	40.1	43.5	52.8	48.1	4.0	43.1	47.0	32.2	45.0	40.4	40.3	41.4	39.7	46.6	41.5	45.8	42.7	42.1	42.3	43.6	43.8	43.1	38.5	25.6	43.5	9.1	71.1	52.5	83.6	55.9	36.5	55.7	48.9	36.8	40.5	25.8	51.6	42.3	58.4	59.1	58.9	44.0	97.8	64.3	116.2	39.5	66.6	50.2	45.0	35.1	12.8	49.8	81.8	47.1	30.5	35.9	52.6	54.7	30.0	31.1	65.4	45.4	14.0	44.9	54.9	54.1	60.7	66.2	37.6	38.6	32.0	2.8	68.2	91.0	51.5	10.6	10.4	69.1	45.9	51.6	42.0	81.9	37.0	82.5	44.6	60.3	26.3	40.9	51.3	52.9	59.5	33.5	44.8	53.2	49.8	58.8	52.1	84.2
NCEH1	"AADACL1, KIAA1363, NCEH"	ENSG00000144959	"Neutral cholesterol ester hydrolase 1"	Q6PIU2	3	172630249-172711218	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.2;Pancreatic endocrine cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 287.7;LHCN-M2: 133.1;U-251 MG: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026888, HPA043873"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	No	No			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA026888: AB_10601557, HPA043873: "	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.88e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (5.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.28e-1)"	3.8	16.2	8.7	8.7	15.8	8.3	5.6	2.3	27.5	4.3	0.0	11.6	4.2	4.6	3.2	3.9	3.4	6.9	14.2	12.5	4.3	21.5	4.9	19.9	14.3	9.3	4.9	1.5	4.7	8.0	3.2	6.7	9.6	6.7	12.0	19.6	10.3	4.4	6.1	1.4	4.8	3.4	3.5	11.2	12.8	1.6	7.8	4.9	4.5	7.4	11.2	8.5	2.1	6.9	98.1	55.3	1.9	3.0	3.3	3.4	7.8	71.8	47.5	46.5	27.2	14.0	287.7	8.1	105.4	43.4	44.4	19.2	2.0	35.1	107.0	27.1	4.5	5.6	8.5	10.8	3.9	14.8	19.9	1.7	3.5	32.3	47.5	43.6	31.5	4.4	1.4	6.9	133.1	8.0	2.5	5.1	2.6	27.4	43.5	2.3	5.2	10.0	83.0	12.6	1.6	0.8	43.6	45.2	9.6	3.1	15.4	6.8	86.9	71.3	10.7	34.1	132.0	8.2	16.4	6.8	53.3	14.1	55.4	6.8	17.9	0.7	2.6	11.6	1.7	3.3	1.6	1.9	12.8	2.2	1.6	2.0	0.6	3.4	7.8	0.7	1.7	6.4	8.7	15.8	2.3	27.5	12.5	4.3	9.3	4.9	9.6	3.5	7.8	6.9	6.6	48.1	17.9	35.9	6.6	6.8	18.3	5.2	1.8	14.8	11.5	3.7	31.6	22.8	20.1	16.5	22.9	9.0	4.7	43.0	3.9	64.1	7.5	41.2	6.4	8.5	7.8	50.5	83.2	31.0	5.2	6.6	25.0	64.1	5.1	5.5	6.8	2.4	49.7	5.0	68.2	11.5	4.1	42.8	15.2	4.1	0.9	32.8	5.4	22.5	12.2	5.4	3.1	15.6	5.4	72.9	13.0	2.6	2.9	30.6	7.3	24.6	27.4	20.5	6.6	8.6	7.0	0.0	1.1	4.3	3.4	10.5	4.6	9.3	7.8	27.3
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	212.0	192.8	128.8	226.0	146.3	301.4	228.7	129.1	139.6	180.0	114.1	183.6	160.7	205.2	150.2	228.8	173.2	132.2	164.3	115.9	152.3	166.2	218.5	147.4	289.7	148.8	141.5	258.2	209.0	258.9	115.9	203.4	140.4	155.4	219.2	147.1	157.0	160.9	350.9	197.1	157.4	201.0	137.9	176.3	164.7	126.2	142.1	347.0	198.4	228.2	329.0	271.1	169.1	143.9	718.3	691.8	715.7	640.1	485.7	592.0	823.0	790.4	497.2	690.8	628.2	1227.4	521.4	1083.7	608.6	651.0	892.6	719.5	1614.4	1059.9	1284.7	554.6	644.0	1587.3	605.9	1749.5	544.0	1930.4	632.7	513.5	613.2	872.3	1019.6	394.9	834.2	770.5	1745.4	378.6	760.5	1176.4	1443.2	1086.7	1202.0	728.7	435.9	1290.8	1452.0	918.4	583.8	959.9	749.0	502.0	555.8	704.5	706.9	625.7	476.8	985.3	686.3	611.4	626.7	714.5	1063.7	624.3	554.5	1885.9	467.2	1173.1	685.2	27.3	95.6	62.5	136.5	100.3	152.8	113.5	118.4	121.9	130.6	111.9	130.3	114.2	16.8	177.8	121.7	102.0	102.3	151.0	128.8	146.3	129.1	139.6	115.9	152.3	148.8	141.5	140.4	137.9	142.1	143.9	286.2	291.7	411.7	8.1	468.9	459.9	633.8	241.0	644.9	145.0	315.2	303.8	320.9	147.3	401.6	195.0	47.9	386.9	596.2	215.0	230.9	294.4	20.6	348.7	669.8	291.1	200.0	419.2	9.3	254.4	444.6	370.9	292.0	421.8	451.7	262.7	130.6	242.0	239.5	80.8	10.4	319.6	156.6	133.7	231.1	32.2	217.2	281.8	165.4	10.3	268.9	199.6	346.1	14.1	14.9	268.0	153.9	159.9	543.5	651.1	120.1	277.6	250.3	141.0	151.2	548.9	442.0	433.3	532.4	707.9	441.4	379.0	454.0	442.6	380.6	449.1
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 467.5;Excitatory neurons: 313.0;Inhibitory neurons: 421.8;Microglial cells: 341.9;Oligodendrocyte precursor cells: 459.4;Oligodendrocytes: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	16.6	15.1	24.0	13.3	25.4	17.3	17.3	24.6	28.2	18.6	13.6	15.9	20.9	19.0	12.8	17.6	15.7	14.0	15.3	29.6	19.5	18.9	15.0	16.0	15.3	17.7	19.2	26.6	17.4	30.0	16.6	17.1	16.0	15.2	16.6	47.3	16.0	20.2	33.4	15.7	18.9	19.0	19.5	16.3	12.5	19.9	21.8	26.1	11.8	36.1	16.3	14.9	15.5	22.3	14.1	10.3	17.7	9.2	19.2	17.3	26.9	7.4	14.7	9.1	8.1	9.6	5.9	10.2	3.1	13.5	17.4	3.4	10.7	6.3	9.8	48.6	15.5	36.5	4.1	4.1	12.0	16.9	29.1	27.9	9.4	8.8	7.1	11.3	9.4	12.9	22.6	16.5	14.0	9.4	15.1	6.0	8.5	8.2	6.8	11.8	81.5	5.1	9.9	18.9	16.2	12.8	17.1	10.2	7.4	9.3	12.3	8.6	10.2	15.2	11.9	10.5	7.5	18.8	17.5	17.2	8.6	10.5	7.7	10.6	3.3	7.0	3.4	2.6	3.8	1.6	3.0	3.8	2.5	2.4	2.9	3.5	13.8	3.5	2.9	5.2	3.7	2.0	24.0	25.4	24.6	28.2	29.6	19.5	17.7	19.2	16.0	19.5	21.8	22.3	41.0	38.5	31.5	467.5	16.7	30.5	11.6	7.8	14.2	96.5	32.3	26.7	41.9	17.2	22.8	14.7	52.1	13.1	47.0	39.0	7.9	16.5	29.7	14.6	37.6	34.9	25.2	29.9	313.0	26.6	18.1	39.8	19.9	28.4	20.2	52.9	36.8	22.8	17.9	62.2	421.8	20.7	20.3	29.8	30.3	7.4	47.2	37.7	19.6	341.9	34.7	66.7	78.2	459.4	305.8	20.1	33.5	43.2	14.3	15.7	30.4	12.5	16.9	71.6	39.5	116.9	34.4	37.7	37.6	16.6	31.0	5.3	33.4	27.2	24.1	21.7
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
NDFIP2	"KIAA1165, N4wbp5a"	ENSG00000102471	"Nedd4 family interacting protein 2"	Q9NV92	13	79481124-79556075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 342.7;Late spermatids: 290.4;Suprabasal keratinocytes: 367.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 12.1;eosinophil: 22.7;naive CD4 T-cell: 5.6"	"Group enriched"	"Detected in many"	16	"granulocytes: 22.7;T-cells: 5.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009160	Uncertain		Supported	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"HPA009160: AB_1079456"	"unprognostic (2.56e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.95e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.02e-1)"	13.9	19.2	17.0	11.4	20.9	2.6	22.7	10.0	25.2	15.5	7.0	42.7	52.7	10.1	22.5	54.4	17.1	20.1	26.0	27.1	8.1	45.9	46.3	17.7	13.0	10.1	7.3	7.0	31.8	29.6	6.4	31.9	12.3	22.7	47.0	21.7	21.4	15.6	30.9	71.3	64.3	9.1	10.6	11.7	25.9	18.1	9.2	16.0	19.3	19.9	19.6	35.6	25.2	21.5	134.6	22.6	23.2	29.4	27.7	50.3	43.6	48.5	66.9	50.1	83.0	49.9	146.1	5.6	32.6	64.0	28.5	178.2	20.5	84.9	75.3	69.7	57.1	6.2	66.5	27.1	50.5	106.2	17.8	40.4	109.3	33.4	52.7	55.8	24.1	10.4	27.5	10.0	56.8	19.3	8.7	24.1	17.1	109.7	22.7	0.5	45.7	25.2	123.1	76.7	23.3	33.4	54.9	52.4	40.0	37.8	43.8	88.2	20.4	16.0	20.4	31.1	32.8	37.6	44.2	21.1	65.6	0.5	65.6	12.1	0.0	22.7	3.2	0.0	2.7	0.2	2.8	2.6	0.0	0.6	5.6	3.1	0.1	0.8	0.0	0.2	3.2	2.4	17.0	20.9	10.0	25.2	27.1	8.1	10.1	7.3	12.3	10.6	9.2	21.5	17.5	41.7	28.9	26.4	4.4	342.7	137.0	180.6	118.4	30.9	32.7	18.8	29.4	57.2	93.2	47.8	6.2	112.6	6.9	161.0	23.5	85.6	271.2	51.5	17.2	22.0	69.4	4.2	189.0	72.2	152.7	33.2	31.1	49.8	88.2	11.5	20.7	69.2	14.4	16.8	44.2	88.1	95.6	17.0	23.5	290.4	17.4	4.0	33.8	27.2	2.7	22.8	5.2	42.3	100.3	101.7	96.7	12.8	13.8	105.6	204.3	104.6	112.6	15.5	13.1	22.2	24.0	56.5	45.1	102.2	367.7	109.7	24.9	35.2	73.3	145.5
NDP	"EVR2, norrin"	ENSG00000124479	"Norrin cystine knot growth factor NDP"	Q00604	X	43948776-43973395	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8;ovary: 46.2"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 181.3;Muller glia cells: 105.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"U-87 MG: 72.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.5	0.0	31.5	0.0	33.4	0.0	3.3	30.9	35.8	20.9	22.4	0.2	0.1	15.4	22.0	0.0	20.8	0.4	0.3	31.5	29.6	0.1	0.0	0.0	0.2	30.1	33.2	46.2	0.0	0.2	0.1	4.0	31.6	7.1	0.2	19.2	0.1	13.1	0.0	0.6	0.2	11.4	32.4	0.1	0.3	1.0	34.2	0.0	0.2	0.0	0.2	0.5	2.3	32.4	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.1	1.9	0.0	0.0	0.0	1.8	0.0	4.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	2.2	0.0	0.0	0.0	72.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	33.4	30.9	35.8	31.5	29.6	30.1	33.2	31.6	32.4	34.2	32.4	0.0	0.0	0.0	29.0	0.0	0.1	0.0	1.2	0.0	0.6	1.3	0.1	0.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	9.1	17.7	0.2	0.0	0.0	4.2	0.0	0.3	0.9	0.0	17.0	0.0	181.3	0.0	0.0	0.1	0.0	0.8	0.0	2.0	0.0	0.0	0.7	13.4	0.6	0.0	0.0	0.0	105.5	0.0	1.5	9.5	1.2	0.0	9.8	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	5.4	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.7;granulocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 110.2"									HPA051515	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA051515: AB_2681517"	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	14.9	16.7	11.6	19.6	11.6	53.6	13.3	15.7	14.2	15.7	10.6	13.6	10.7	15.7	11.6	16.8	15.0	15.1	11.4	11.6	11.7	14.4	10.9	17.0	24.6	12.6	11.4	15.8	14.1	18.4	15.8	12.5	11.2	15.6	12.1	14.9	17.7	14.2	8.9	18.8	17.4	15.8	10.4	35.3	13.6	13.6	12.5	31.9	13.3	8.5	23.9	15.3	15.4	11.5	10.0	7.9	16.7	26.2	20.9	23.0	9.1	12.3	24.5	13.4	13.3	4.6	12.4	9.5	7.1	21.8	13.6	11.6	8.1	11.8	9.6	23.4	8.5	9.3	7.0	7.3	36.7	11.8	110.2	22.9	14.5	21.4	22.4	41.1	17.5	17.9	9.2	33.8	16.6	8.1	12.7	13.4	4.5	6.4	36.4	8.5	8.2	5.9	11.5	7.2	5.5	9.0	9.9	23.5	7.5	11.3	18.6	18.6	29.5	6.3	7.8	9.1	8.4	17.4	8.0	11.8	7.2	17.0	5.5	0.7	2.7	1.1	2.7	1.9	3.1	1.2	2.3	2.3	2.0	1.3	2.6	3.4	2.8	1.1	1.7	3.4	1.6	1.8	11.6	11.6	15.7	14.2	11.6	11.7	12.6	11.4	11.2	10.4	12.5	11.5	1.5	0.0	3.0	13.7	5.4	1.3	0.8	0.6	1.2	0.7	4.1	2.3	1.8	0.0	1.8	0.0	0.0	1.4	3.6	4.7	0.0	5.4	7.5	0.8	1.2	1.1	2.4	7.8	7.5	9.6	1.5	1.9	4.6	0.7	14.5	0.3	1.4	4.2	5.2	1.7	7.6	2.6	2.0	8.5	3.1	10.4	0.0	10.8	1.8	2.8	5.4	0.8	0.0	5.0	5.0	7.0	3.2	0.0	10.6	1.3	2.4	7.4	2.7	0.8	0.0	1.4	1.5	2.3	1.7	4.7	1.6	6.2	5.3	0.3	2.2	1.9
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871832-119876662	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3202.9;Distal tubular cells: 2191.3;Proximal tubular cells: 1764.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029768, HPA054359"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Mitochondria	"HPA029768: AB_2673192, HPA054359: AB_2682461"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	260.4	276.7	541.8	179.3	547.2	316.3	275.0	560.4	746.6	226.5	637.9	467.4	387.4	132.4	323.9	145.0	193.2	133.0	983.7	539.2	555.3	495.1	449.6	153.8	186.7	549.0	541.6	149.3	228.5	773.9	121.4	171.4	551.2	185.8	371.3	398.6	280.0	240.2	1381.0	90.8	334.6	180.7	545.6	169.4	297.4	65.8	551.2	273.2	173.3	1367.9	219.4	228.5	90.5	549.6	436.8	561.9	342.0	365.6	466.3	317.8	423.6	346.6	395.9	297.8	368.1	326.5	377.8	385.1	509.4	431.0	514.7	416.5	555.7	392.8	354.6	492.2	751.7	380.6	1110.1	750.5	357.0	575.9	387.2	485.4	577.0	296.5	232.5	413.2	389.1	372.4	230.9	553.4	435.6	965.3	412.5	563.2	489.1	1214.3	988.4	405.3	315.2	1169.8	887.0	765.2	255.9	319.8	714.9	871.1	479.6	476.5	224.2	653.8	395.1	209.4	198.2	422.7	672.5	469.4	798.3	524.9	377.5	719.5	262.1	1064.7	680.6	822.0	486.1	726.1	468.4	560.6	540.8	516.7	745.6	447.7	435.9	523.1	851.5	468.5	815.5	809.1	675.4	780.5	541.8	547.2	560.4	746.6	539.2	555.3	549.0	541.6	551.2	545.6	551.2	549.6	251.9	160.3	188.6	10.7	261.6	213.7	251.4	991.0	194.1	156.2	268.0	322.7	3202.9	511.9	445.8	562.8	79.2	396.5	273.9	1264.2	2191.3	503.6	34.2	332.0	237.9	228.9	459.0	272.3	12.3	512.5	416.1	266.9	322.1	348.9	210.3	177.5	260.3	1022.5	661.7	82.4	14.8	907.2	581.8	413.5	350.6	43.8	294.5	329.3	570.9	14.0	492.3	364.2	277.1	8.0	16.5	506.4	1024.5	285.1	389.2	228.8	1546.3	1764.0	443.2	231.2	216.9	208.4	289.9	50.8	105.2	394.3	249.3	380.6	255.7	126.7	887.7	339.3
NDUFA11	B14.7	ENSG00000174886	"NADH:ubiquinone oxidoreductase subunit A11"	Q86Y39	19	5891276-5904006	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA072209			Uncertain	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA072209: AB_2686495"	"unprognostic (2.24e-1)"	"prognostic favorable (4.54e-5)"	"unprognostic (8.20e-3)"	"prognostic favorable (3.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.95e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.16e-3)"	199.0	429.8	203.3	93.4	207.7	158.1	188.9	226.1	305.6	202.1	205.3	312.2	124.9	219.6	53.1	283.4	201.5	106.6	687.5	206.8	223.5	290.2	380.5	155.1	145.3	212.7	213.8	200.7	205.7	138.7	205.9	96.9	215.7	228.3	56.1	31.7	231.2	105.4	425.5	187.6	185.6	89.4	218.3	196.4	250.4	96.3	218.8	120.7	188.9	330.6	62.7	209.4	215.5	225.2	315.2	227.6	168.7	273.1	138.9	231.5	191.2	209.8	243.9	369.4	341.5	271.9	155.5	300.4	320.0	209.6	163.9	195.4	118.6	250.8	85.7	271.2	466.9	124.4	194.5	434.4	374.3	188.8	174.4	317.3	221.9	219.9	106.6	147.6	250.7	284.5	257.3	316.4	192.4	228.2	484.1	325.0	249.9	249.1	609.2	325.0	214.2	427.9	238.3	194.9	236.2	254.3	163.5	254.3	381.5	72.9	196.1	395.0	224.9	202.8	194.7	410.1	340.1	493.5	460.1	400.6	341.0	443.1	263.7	421.2	526.8	313.4	313.2	440.5	323.9	394.4	341.2	314.6	461.1	343.7	321.0	281.1	239.0	303.9	387.8	550.1	474.0	870.2	203.3	207.7	226.1	305.6	206.8	223.5	212.7	213.8	215.7	218.3	218.8	225.2	189.9	144.2	198.0	22.5	179.2	205.6	236.8	306.8	99.6	60.1	279.3	430.3	436.9	267.4	202.9	292.4	25.0	585.4	164.2	429.9	841.2	286.0	157.4	199.8	146.9	175.6	351.5	208.9	12.9	301.6	595.6	224.3	114.7	137.6	213.0	135.5	272.7	735.4	423.7	50.5	16.6	477.0	207.5	347.7	234.1	452.4	194.8	197.7	286.4	14.0	403.3	198.0	220.4	5.5	31.2	287.1	446.6	167.3	208.5	283.5	606.9	1107.9	176.7	89.6	118.3	174.3	210.0	97.2	91.8	162.5	243.5	593.4	156.9	159.0	451.1	241.3
NDUFA12	"B17.2, DAP13"	ENSG00000184752	"NADH:ubiquinone oxidoreductase subunit A12"	Q9UI09	12	94897055-95003748	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 558.6;tongue: 563.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039903	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Cytosol	"HPA039903: AB_10795516"	"unprognostic (2.76e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.27e-2)"	100.2	94.1	158.6	73.9	162.8	93.2	77.1	168.9	228.1	67.8	159.8	148.6	109.3	66.8	87.1	89.8	77.8	52.9	361.8	161.3	172.6	133.8	143.7	70.3	92.5	166.4	162.1	64.7	59.6	159.5	73.5	79.5	164.1	74.7	143.9	106.8	75.3	77.8	558.6	74.2	101.5	98.4	162.6	97.6	87.7	58.9	165.1	108.9	89.6	563.1	122.0	81.0	73.0	161.1	255.3	281.1	223.6	160.8	183.3	171.8	165.8	118.8	178.5	258.5	234.6	347.6	125.8	293.7	68.8	187.6	141.1	188.2	236.1	278.4	296.7	254.8	282.9	241.2	218.6	358.8	186.3	344.0	285.3	183.0	352.4	215.7	266.9	270.4	222.2	246.0	235.2	130.4	260.8	381.1	238.6	533.6	167.0	313.7	484.0	179.9	189.4	335.2	262.5	393.9	213.2	128.5	201.3	287.3	164.6	193.9	287.2	226.9	243.5	134.1	134.0	195.0	204.2	207.5	349.9	443.7	80.6	293.6	211.2	643.9	420.5	228.2	354.8	512.5	336.4	482.8	479.5	429.9	576.2	415.5	631.9	455.9	62.0	464.6	506.6	355.5	570.8	814.8	158.6	162.8	168.9	228.1	161.3	172.6	166.4	162.1	164.1	162.6	165.1	161.1	213.5	73.7	68.4	26.8	81.3	108.6	163.9	364.5	71.2	67.4	87.9	171.7	2159.0	135.8	168.3	108.5	64.6	254.0	127.9	172.0	620.3	162.0	240.0	110.3	98.9	206.0	85.3	86.5	19.6	163.9	254.5	172.6	67.2	100.7	58.3	103.5	109.2	149.1	192.3	37.0	29.0	171.8	244.1	103.6	161.9	122.1	97.6	111.1	160.1	13.1	203.5	141.6	199.8	20.6	22.3	234.6	228.8	133.5	98.8	123.8	229.9	338.3	134.7	130.5	105.2	120.8	291.2	156.3	109.8	127.9	127.7	209.6	120.2	181.9	219.2	182.0
NDUFA4	"CI-9k, COXFA4, MLRQ"	ENSG00000189043	"NDUFA4 mitochondrial complex associated"	O00483	7	10931943-10940153	"Disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 513.5;skeletal muscle: 525.0;tongue: 652.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 4615.5;Distal tubular cells: 3960.0;Proximal tubular cells: 3331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055323, HPA078265"	Approved		Supported	Mitochondria		NA	NA		50000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	78.6	90.1	188.7	40.8	196.2	67.5	76.0	192.9	263.4	54.7	192.8	84.1	74.2	74.2	81.1	66.9	69.5	36.2	513.5	201.9	205.0	156.6	140.3	62.8	42.5	194.4	189.6	60.1	61.3	251.9	23.3	31.6	197.6	66.0	56.6	128.4	108.6	84.4	525.0	58.3	58.8	60.9	194.1	59.6	107.0	24.3	194.3	64.0	66.3	652.5	46.1	73.7	54.1	200.1	55.3	90.9	155.0	176.8	84.0	78.4	70.3	68.2	63.2	61.3	53.6	115.2	144.7	104.6	63.0	96.7	168.0	94.1	102.1	79.4	66.5	52.2	74.0	88.2	93.4	108.6	73.2	123.3	84.3	84.8	78.4	75.4	66.0	116.7	86.6	92.7	133.2	139.0	129.8	103.8	56.2	109.3	169.2	364.2	181.6	74.7	108.6	118.6	158.0	115.4	95.2	99.7	106.9	303.7	64.7	210.3	191.6	149.6	76.8	73.3	102.0	107.0	115.0	84.6	115.8	120.5	101.3	130.8	232.5	236.7	110.2	160.6	74.3	135.8	88.3	95.7	103.3	93.9	138.9	74.6	106.1	93.3	25.3	79.4	146.4	131.2	131.6	192.8	188.7	196.2	192.9	263.4	201.9	205.0	194.4	189.6	197.6	194.1	194.3	200.1	422.2	490.4	470.7	52.9	366.9	407.1	605.8	1642.7	307.9	521.0	742.3	936.0	4615.5	843.6	879.3	952.7	266.9	875.9	357.5	543.8	3960.0	865.1	160.6	626.2	471.6	447.0	209.7	358.3	54.1	955.5	763.9	557.9	404.7	477.7	576.4	507.5	656.1	1887.5	964.5	158.2	72.7	780.8	1373.2	589.0	589.8	106.8	493.6	517.6	916.0	49.6	596.6	721.5	374.9	36.7	57.9	776.6	626.7	784.3	467.9	696.6	596.2	3331.1	803.0	666.0	335.2	546.5	846.5	172.7	295.5	581.7	482.9	658.8	389.1	443.5	712.4	803.2
NDUFA4L2	"COXFA4L2, FLJ26118, NUOMS"	ENSG00000185633	"NDUFA4 mitochondrial complex associated like 2"	Q9NRX3	12	57234903-57240715	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 304.9"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 627.0;Sertoli cells: 1130.7;Smooth muscle cells: 525.6"	"Cancer enriched"	"Detected in all"	5	"renal cancer: 356.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"AN3-CA: 133.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055323, HPA078265"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.23e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.67e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.10e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.74e-2)"	85.6	14.0	41.6	6.8	40.1	0.2	55.1	41.4	61.5	109.3	36.8	17.4	5.8	20.7	2.4	304.9	15.5	17.1	180.1	40.3	41.1	47.6	20.9	62.6	5.8	43.0	42.7	14.0	14.5	12.1	30.9	71.7	48.8	27.3	1.9	29.4	55.8	9.8	43.8	206.9	14.2	7.5	38.9	74.1	18.0	8.7	43.5	3.2	54.5	29.2	4.8	27.7	183.5	45.4	0.9	1.3	0.3	133.9	5.4	3.1	0.4	2.1	1.5	0.6	1.3	0.0	1.5	5.5	5.6	2.1	0.1	1.2	0.7	1.0	0.0	3.0	0.2	0.6	0.3	0.1	18.6	4.1	2.0	12.0	2.5	0.2	4.7	0.9	0.0	7.6	0.5	7.2	0.4	2.7	1.1	0.2	0.3	0.6	2.4	2.1	1.0	11.0	0.1	0.1	7.1	2.5	0.2	0.3	4.7	0.1	1.5	14.5	0.6	1.2	0.1	1.1	0.7	10.0	3.5	2.5	4.9	9.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	41.6	40.1	41.4	61.5	40.3	41.1	43.0	42.7	48.8	38.9	43.5	45.4	156.0	0.0	0.5	2.6	2.6	151.2	0.9	89.2	6.8	30.6	2.6	5.8	1.2	0.0	24.8	0.0	18.8	1.0	0.9	0.1	0.0	1.6	1.7	0.4	3.0	91.8	0.0	0.0	2.2	0.0	1.5	21.5	4.6	0.3	8.9	0.1	2.9	1.3	1.9	11.8	3.0	0.2	54.9	0.0	28.9	3.0	3.1	2.0	30.2	18.7	1.0	627.0	0.0	0.5	0.4	4.7	0.0	2.2	1.4	2.0	0.1	0.3	6.2	25.7	1130.7	13.0	525.6	12.3	5.5	20.3	161.4	1.1	1.9	2.5	0.2	1.4
NDUFA8	"MGC793, PGIV"	ENSG00000119421	"NADH:ubiquinone oxidoreductase subunit A8"	P51970	9	122144058-122159779	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 380.1;tongue: 363.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 579.5;Distal tubular cells: 614.3;Early spermatids: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041510, HPA041600"	Enhanced		Supported	Mitochondria		NA	NA		25000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041510: AB_10794379, HPA041600: AB_10796778"	"unprognostic (2.90e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (4.17e-6)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	54.2	74.2	139.4	33.9	146.0	28.6	53.9	146.0	159.3	44.8	142.6	101.4	65.8	46.6	86.8	57.1	62.3	39.3	380.1	144.7	148.4	97.9	81.5	37.0	43.0	141.4	139.7	35.7	46.1	137.4	56.9	48.2	141.6	57.9	88.2	72.0	72.3	61.9	259.1	44.2	53.6	73.9	138.7	41.4	75.3	95.5	145.8	48.6	53.3	363.3	56.2	57.8	40.9	141.7	84.8	154.1	99.5	132.0	105.7	96.4	123.3	96.0	114.1	130.0	108.5	197.0	81.9	123.1	92.6	113.6	234.6	206.8	191.3	208.7	127.0	121.5	132.6	96.9	254.2	172.6	113.3	172.7	95.5	106.1	200.3	130.0	82.9	118.1	189.1	134.8	151.0	89.6	150.3	215.6	108.1	112.1	91.2	377.1	293.1	85.0	156.7	179.4	189.4	116.0	172.1	67.6	151.0	176.7	122.6	100.9	187.6	82.1	123.2	71.2	70.9	135.2	109.3	100.1	176.1	123.8	148.0	110.7	120.2	17.4	82.1	66.8	78.3	100.9	76.2	88.0	71.3	77.3	109.2	92.8	76.0	80.3	13.7	79.0	88.7	114.2	91.9	74.7	139.4	146.0	146.0	159.3	144.7	148.4	141.4	139.7	141.6	138.7	145.8	141.7	70.6	28.9	40.4	16.3	38.6	48.3	73.8	298.1	43.9	47.2	61.0	73.5	579.5	48.6	128.0	82.8	29.2	130.5	34.1	87.3	614.3	103.8	499.0	80.1	52.4	98.5	77.4	100.6	19.4	101.6	113.1	70.3	47.9	52.9	20.3	68.5	60.7	110.9	124.4	45.4	26.0	105.7	185.1	40.5	42.0	121.1	56.5	48.8	94.3	18.7	72.9	91.3	65.9	14.1	17.9	100.8	80.3	75.2	56.9	91.1	163.4	249.8	113.0	59.0	26.3	52.5	114.8	294.9	116.2	67.0	56.8	126.6	36.6	104.4	136.3	86.4
NDUFA9	"CI-39k, COQ11, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 617.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042268, HPA073212"	Supported		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (5.75e-4)"	19.6	29.2	25.6	14.8	26.5	35.3	19.1	29.1	38.5	18.4	29.5	41.1	30.6	20.4	14.7	30.9	17.5	6.1	116.7	26.1	25.7	43.4	49.4	18.0	11.8	26.0	25.5	14.7	24.2	34.2	21.9	10.2	26.7	21.4	31.2	20.1	24.3	11.1	110.3	24.1	31.0	12.7	25.7	23.7	31.6	14.3	26.4	18.1	19.3	110.6	14.5	21.2	19.8	27.0	29.8	52.5	25.3	33.9	18.3	18.1	73.1	22.1	22.4	41.9	31.6	114.4	58.0	33.2	11.6	24.2	47.5	48.9	37.1	32.9	27.0	64.8	65.3	32.5	51.0	88.1	40.0	48.0	33.8	23.3	31.2	28.7	38.6	26.0	32.0	46.8	23.1	60.8	31.5	57.6	48.5	55.1	65.5	55.6	43.2	67.4	37.5	34.5	59.2	66.6	18.2	20.6	27.9	74.4	41.9	54.4	15.4	45.4	22.2	31.8	64.7	29.3	52.3	11.9	15.1	57.1	33.2	29.4	35.7	75.9	134.3	53.3	99.2	165.1	102.1	148.3	102.4	109.3	161.9	110.0	88.9	91.1	11.8	107.5	133.5	168.0	143.6	265.0	25.6	26.5	29.1	38.5	26.1	25.7	26.0	25.5	26.7	25.7	26.4	27.0	37.5	28.9	32.1	26.1	45.2	48.6	63.7	199.3	21.6	48.6	40.1	37.0	185.1	45.8	99.4	64.4	58.4	111.1	45.7	89.4	166.3	130.0	112.2	29.3	29.6	46.4	47.4	36.0	21.0	131.3	118.7	38.5	35.2	26.0	57.7	36.6	34.6	78.5	114.7	33.7	26.3	125.4	140.4	35.6	31.8	617.2	28.3	41.8	55.2	15.9	60.0	48.2	49.4	27.2	20.1	108.0	83.5	36.9	50.8	40.5	108.5	163.2	74.9	67.8	19.7	32.0	54.8	30.6	31.3	38.5	47.2	99.9	43.4	66.3	147.7	69.4
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581014-23596316	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 588.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054364, HPA076020"	Approved		Supported	Nucleoplasm,Mitochondria		No	No		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA054364: AB_2682463, HPA076020: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	89.7	127.1	104.3	49.6	106.8	60.4	81.0	114.8	157.6	64.0	117.4	123.0	102.9	68.8	50.1	98.8	66.5	32.0	588.8	107.1	113.5	132.9	165.8	61.9	52.2	110.4	105.6	54.3	84.5	110.4	94.2	47.5	112.0	63.5	89.0	91.9	75.7	58.6	425.0	71.9	90.1	51.1	107.5	72.1	109.6	61.7	108.2	60.2	66.0	432.0	59.2	79.8	70.7	106.9	172.8	125.6	151.8	136.8	107.5	116.0	212.9	129.4	96.8	129.2	105.7	110.1	135.8	284.0	206.6	94.7	158.2	138.6	271.2	155.4	102.6	161.8	312.6	151.8	203.0	507.0	112.2	284.8	121.0	108.0	212.6	95.2	102.2	120.0	167.0	249.5	326.6	139.6	142.7	262.1	221.6	431.9	394.7	254.5	288.5	299.5	171.0	389.3	120.2	140.6	209.8	163.1	144.6	260.8	258.2	167.2	211.2	235.0	131.1	116.5	122.4	113.4	180.5	175.2	283.2	321.9	130.2	228.7	134.9	77.1	179.9	80.0	127.0	222.8	142.3	171.7	150.7	143.4	239.4	151.6	139.0	145.8	37.9	117.8	175.8	268.1	177.6	204.7	104.3	106.8	114.8	157.6	107.1	113.5	110.4	105.6	112.0	107.5	108.2	106.9	136.2	99.3	99.7	9.8	96.1	122.1	142.9	416.9	79.6	91.1	131.7	191.5	1366.5	105.8	200.3	112.2	45.9	290.9	101.3	210.9	708.3	187.3	129.5	185.5	113.2	129.4	202.4	125.1	13.1	210.2	312.2	153.3	119.3	110.8	84.9	124.4	93.9	300.6	263.2	52.2	14.3	253.5	321.4	109.0	89.1	39.6	96.9	114.3	156.5	5.6	179.6	165.0	109.2	7.5	13.2	227.1	174.8	121.5	166.9	180.3	316.8	611.4	261.6	127.6	92.1	134.0	261.9	142.9	118.8	181.5	142.2	224.5	94.5	256.6	360.0	190.7
NDUFB2	"AGGG, CI-AGGG"	ENSG00000090266	"NADH:ubiquinone oxidoreductase subunit B2"	O95178	7	140690777-140722790	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3191.4;Distal tubular cells: 1997.6;Proximal tubular cells: 2437.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051377	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA051377: AB_2681460"	"unprognostic (1.17e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (7.60e-7)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	187.2	225.3	347.4	123.4	363.9	143.1	159.9	377.3	441.6	142.0	374.0	239.9	166.0	153.4	171.5	196.9	129.6	141.8	847.4	343.6	369.1	420.0	281.2	140.1	164.8	359.0	355.8	108.0	159.4	362.6	182.3	105.9	361.1	152.0	183.0	175.9	197.6	152.3	834.7	152.0	161.1	154.8	369.8	155.1	216.4	125.5	378.3	162.3	350.5	913.1	134.0	186.6	145.5	377.6	322.5	497.0	182.1	400.9	291.9	297.5	259.9	227.0	207.6	241.4	229.1	389.7	317.3	243.1	331.7	289.9	441.7	155.4	167.0	333.4	194.1	399.5	556.9	179.1	442.3	461.3	230.0	279.2	231.0	331.6	287.5	227.0	138.2	201.3	368.1	338.8	311.2	289.9	343.2	945.8	448.2	719.4	424.0	670.0	585.0	251.1	174.6	569.4	492.0	634.2	369.0	359.3	310.4	513.8	281.0	205.7	222.9	315.7	295.2	307.0	179.2	365.6	401.5	267.6	567.2	457.2	469.0	447.7	395.8	713.9	1045.5	503.4	779.4	1117.0	673.3	1009.8	755.0	768.2	1161.9	787.8	800.5	793.7	85.6	823.9	1037.9	926.9	772.0	1795.1	347.4	363.9	377.3	441.6	343.6	369.1	359.0	355.8	361.1	369.8	378.3	377.6	262.7	189.1	238.4	25.5	191.1	226.5	289.3	693.4	128.1	181.9	458.3	514.8	3191.4	351.8	398.1	673.1	98.0	555.4	275.3	776.2	1997.6	373.9	901.2	294.2	298.4	283.6	428.7	143.7	19.9	314.4	466.6	327.2	307.3	366.3	280.6	212.8	205.6	1079.3	710.8	139.7	22.7	576.3	687.7	280.3	337.3	246.9	222.7	336.5	434.0	13.1	356.7	367.2	465.5	19.6	42.3	279.4	647.9	243.8	210.7	440.1	867.3	2437.9	370.2	284.1	197.2	199.2	372.0	77.0	208.6	321.9	280.6	515.0	241.7	288.6	669.6	435.8
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596328-120602507	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 945.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1493.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051739, HPA064441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"HPA051739: AB_2681585, HPA064441: "	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.79e-4)"	148.6	338.4	159.7	90.3	169.1	112.4	145.1	175.9	203.2	126.2	173.2	170.0	147.8	117.9	133.8	159.5	113.0	85.7	619.5	163.5	178.4	232.4	187.4	102.9	93.8	168.3	163.0	119.8	137.4	260.3	170.2	76.8	168.6	118.1	148.7	100.2	148.4	117.4	945.3	144.5	135.6	103.4	170.7	112.1	162.3	106.5	161.7	125.6	113.1	562.2	114.2	133.5	142.1	172.8	294.8	204.3	246.7	248.5	151.0	181.4	199.2	157.0	212.1	205.4	224.5	200.9	219.8	147.8	311.6	177.8	255.6	272.5	191.3	202.7	155.7	227.5	212.6	226.1	205.7	208.1	90.4	202.7	256.8	161.3	268.5	98.9	125.8	246.0	258.5	271.7	138.5	219.2	220.9	224.1	398.6	294.8	193.9	478.9	554.7	228.8	141.0	325.8	337.3	177.9	273.8	283.4	186.5	205.7	360.0	162.0	348.0	319.9	199.8	179.0	233.2	76.9	226.5	263.2	260.1	454.3	283.6	279.8	250.8	205.0	164.8	197.2	156.0	229.5	162.2	231.6	215.2	176.8	213.9	176.3	182.2	181.8	101.6	152.7	238.2	267.9	300.6	205.7	159.7	169.1	175.9	203.2	163.5	178.4	168.3	163.0	168.6	170.7	161.7	172.8	274.1	163.5	162.6	36.9	167.0	222.3	289.0	612.6	190.6	137.8	290.1	351.3	1493.1	311.7	348.3	320.0	58.4	366.0	158.1	472.4	1226.7	556.7	999.2	259.9	188.9	235.7	298.7	196.9	22.6	620.9	421.0	213.7	175.3	293.5	174.8	139.4	183.5	513.9	330.3	84.1	22.0	526.3	451.6	240.2	247.9	164.6	275.2	196.2	434.0	15.9	339.2	340.7	186.4	13.0	31.2	567.9	581.8	277.2	283.2	243.2	613.4	1225.1	266.2	168.4	256.4	208.1	259.0	418.9	87.5	288.4	251.5	352.4	168.1	271.3	462.8	344.0
NDUFB6	"B17, CI"	ENSG00000165264	"NADH:ubiquinone oxidoreductase subunit B6"	O95139	9	32553001-32573184	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 583.9;Distal tubular cells: 534.1;Early spermatids: 889.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044001, HPA053334"	Supported		Enhanced	Mitochondria		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA044001: AB_10959448, HPA053334: AB_2682116"	"unprognostic (4.09e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.47e-10)"	"unprognostic (2.70e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	38.6	50.8	42.7	30.7	45.3	31.0	35.9	47.1	48.1	34.1	42.8	41.8	44.6	38.1	26.8	43.8	36.0	17.6	144.9	44.5	46.5	73.6	66.7	30.5	26.9	44.5	42.9	29.7	31.0	41.8	40.3	22.5	44.6	28.5	29.1	30.7	37.0	22.0	168.0	28.2	43.6	26.7	45.9	28.8	43.5	53.5	44.3	28.7	33.2	101.8	24.5	34.1	33.4	47.1	106.4	63.7	69.6	80.1	46.7	43.0	44.5	69.5	56.5	62.8	68.8	62.8	46.5	78.4	70.5	48.2	65.1	58.8	66.5	76.8	47.0	108.6	106.0	187.2	88.8	65.9	45.2	94.4	46.3	44.8	36.7	56.8	42.9	47.5	57.6	118.4	61.0	86.1	71.9	61.2	128.1	221.2	73.6	90.7	140.1	86.7	58.4	73.1	72.0	39.3	69.7	78.4	80.2	91.1	50.7	52.0	86.3	72.0	51.4	67.9	103.8	75.7	103.8	38.0	77.0	131.5	113.7	65.6	32.7	126.3	97.6	136.1	76.9	94.3	74.5	106.0	81.4	80.0	108.8	89.0	82.3	87.4	302.1	91.9	116.3	152.7	112.4	110.2	42.7	45.3	47.1	48.1	44.5	46.5	44.5	42.9	44.6	45.9	44.3	47.1	69.5	125.0	111.6	15.3	76.2	94.2	106.2	222.9	90.0	44.1	64.6	72.6	583.9	101.5	141.4	108.5	6.2	191.8	69.4	115.8	534.1	172.5	889.5	106.9	86.1	101.0	64.6	196.7	21.8	166.7	143.0	109.5	83.6	86.4	90.5	64.3	74.3	182.2	160.8	18.5	23.8	152.5	209.5	55.0	96.4	146.9	91.6	78.4	160.1	3.7	108.6	115.3	90.6	18.1	21.3	144.4	124.9	89.9	165.7	80.0	201.0	520.3	152.3	56.5	105.2	94.8	151.3	182.0	125.9	139.7	96.7	104.1	81.0	95.6	167.3	103.8
NDUFB9	"B22, LYRM3, UQOR22"	ENSG00000147684	"NADH:ubiquinone oxidoreductase subunit B9"	Q9Y6M9	8	124539101-124580648	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1314.9;tongue: 1486.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 2950.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042768	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA042768: AB_10797508"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.64e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (9.54e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.74e-1)"	155.6	158.2	259.0	78.5	263.8	265.2	157.8	281.1	381.2	109.7	245.0	226.4	184.6	129.5	147.4	209.2	126.0	70.4	789.5	257.6	288.7	324.9	325.0	122.9	96.5	279.3	277.8	107.1	209.4	282.9	124.0	81.2	281.5	117.8	191.0	135.8	210.9	115.1	1314.9	149.3	162.9	111.1	253.4	116.8	241.2	204.7	286.2	102.8	154.2	1486.4	104.1	139.9	124.7	274.1	348.2	316.8	236.1	321.2	240.6	204.2	196.0	165.2	189.3	297.4	222.4	417.7	327.6	341.0	421.0	193.6	153.9	385.5	347.3	266.7	279.9	395.8	464.8	831.3	199.6	505.9	320.8	261.8	218.2	239.6	382.1	271.9	587.9	160.1	275.9	241.1	523.7	277.6	243.4	1089.0	415.8	522.7	237.5	1247.0	692.7	276.3	179.9	468.0	400.0	288.8	326.6	255.0	362.4	2950.7	382.8	141.1	407.3	348.2	219.7	172.5	444.1	162.9	399.5	354.8	517.7	392.5	298.6	515.4	233.1	302.2	253.1	136.2	210.5	179.2	209.6	260.9	275.8	237.1	247.5	201.4	269.1	223.9	49.2	188.9	136.1	183.1	346.0	345.8	259.0	263.8	281.1	381.2	257.6	288.7	279.3	277.8	281.5	253.4	286.2	274.1	169.0	125.0	124.8	7.8	147.7	217.8	277.5	448.3	178.7	77.4	247.3	313.0	1005.6	260.2	267.3	286.9	98.0	494.6	119.9	525.0	800.3	338.0	389.8	120.7	100.6	164.1	233.7	227.6	10.5	405.7	296.0	187.9	169.7	109.2	139.4	149.9	167.4	517.7	380.6	37.0	14.9	421.0	488.3	206.0	137.6	865.4	158.8	183.0	247.3	15.9	226.3	144.1	171.0	7.1	18.2	378.1	450.0	152.7	169.1	290.3	584.6	789.7	208.6	91.1	170.9	221.2	511.8	317.6	264.8	377.0	188.4	523.0	155.6	216.0	521.7	315.8
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 83.5;skeletal muscle: 268.3;tongue: 158.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1840.3;Distal tubular cells: 1136.7;Proximal tubular cells: 1449.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044556, HPA062427"	Enhanced		Approved	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA044556: AB_10794402, HPA062427: "	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (7.25e-4)"	9.5	15.3	19.9	8.0	20.4	9.1	11.0	22.4	28.6	7.4	21.3	18.6	23.8	8.1	14.3	10.5	10.5	5.4	83.5	19.6	20.8	26.7	24.1	8.8	10.1	20.3	21.0	10.0	14.8	22.9	15.8	5.9	21.6	9.7	19.0	23.5	18.9	14.4	268.3	13.2	18.6	7.4	19.5	10.4	17.0	12.7	20.5	8.6	14.8	158.5	11.0	8.6	7.9	22.4	21.4	5.9	19.2	30.8	17.7	22.7	20.5	20.1	13.1	11.1	10.4	13.1	23.7	7.7	7.7	15.5	14.9	10.5	38.6	18.2	15.0	13.0	13.5	11.9	13.5	23.0	18.1	11.2	10.1	24.5	18.2	14.4	21.6	16.8	17.5	17.8	25.3	33.8	11.0	17.8	17.8	32.1	16.3	44.1	11.7	14.9	10.6	52.6	24.6	14.2	14.6	14.7	13.8	23.2	10.5	15.6	23.7	23.2	8.1	24.2	6.4	13.0	13.5	23.2	49.5	18.5	18.9	26.7	13.8	26.2	10.1	13.1	8.5	10.3	11.6	7.1	11.7	11.5	8.9	15.9	10.5	11.4	3.0	10.1	14.2	16.2	18.2	10.8	19.9	20.4	22.4	28.6	19.6	20.8	20.3	21.0	21.6	19.5	20.5	22.4	201.8	89.8	145.7	15.7	95.8	140.2	173.3	402.7	185.0	120.4	240.3	349.6	1840.3	221.6	240.1	439.6	33.3	147.4	71.7	343.0	1136.7	270.3	409.9	333.5	115.5	162.7	221.4	175.2	10.9	336.9	166.2	176.9	158.0	196.8	73.3	151.2	133.5	432.9	225.1	119.5	14.3	340.5	276.7	102.0	65.7	70.9	169.3	115.6	266.8	6.5	185.5	446.6	79.3	8.0	13.3	265.3	355.8	206.5	155.6	173.7	471.7	1449.6	297.1	139.1	98.6	159.3	184.4	439.0	197.4	290.1	179.3	118.1	83.5	224.7	343.7	176.0
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214723	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 464.8;tongue: 633.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		NA	NA		25000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	60.2	98.2	38.7	37.4	41.6	39.5	49.6	46.4	48.8	40.2	76.6	96.5	102.4	41.4	33.4	62.0	52.5	36.8	273.7	40.5	47.5	137.0	177.4	48.5	42.4	49.5	40.7	51.6	47.7	156.5	35.8	41.6	53.1	45.7	101.8	36.2	53.5	49.0	464.8	51.4	81.5	58.6	41.6	43.6	73.3	29.5	47.9	48.3	45.0	633.7	60.1	57.5	40.0	49.2	101.8	129.4	95.2	104.0	115.1	102.8	77.0	85.7	105.8	139.6	107.5	143.9	98.5	108.4	168.1	113.0	81.3	135.9	129.1	131.8	122.1	84.2	108.0	105.9	109.5	136.5	117.7	116.0	105.3	147.2	112.3	121.1	137.2	96.8	160.5	115.4	139.9	72.7	132.5	93.5	81.7	58.4	175.3	288.5	116.5	72.0	83.3	172.0	157.8	109.4	97.2	152.0	93.0	237.0	151.5	116.4	221.7	342.2	108.6	84.5	66.3	65.5	123.7	125.2	172.0	95.1	123.6	109.3	105.4	150.0	159.3	85.7	82.0	193.2	82.6	81.4	86.6	86.3	217.8	68.4	86.6	88.1	86.7	93.5	190.7	128.7	130.8	167.5	38.7	41.6	46.4	48.8	40.5	47.5	49.5	40.7	53.1	41.6	47.9	49.2	70.5	35.3	45.7	30.7	47.1	38.9	52.4	277.8	52.9	74.6	58.9	50.7	232.6	74.4	148.4	77.3	31.3	146.8	47.6	187.5	332.6	184.3	11.3	43.5	57.0	67.5	72.0	78.9	28.0	143.2	111.3	69.7	80.5	41.3	69.7	99.7	65.7	206.5	150.5	92.5	30.1	122.6	242.1	87.8	42.0	7.8	43.5	66.5	83.6	14.0	97.9	57.0	35.0	18.1	48.3	147.7	105.1	33.4	49.5	25.6	221.9	345.5	103.0	57.3	46.0	41.9	176.6	42.0	27.5	68.8	43.3	158.4	50.0	192.0	172.5	57.5
NDUFS4	"AQDQ, CI-18"	ENSG00000164258	"NADH:ubiquinone oxidoreductase subunit S4"	O43181	5	53560633-53683338	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 397.4"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 553.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003884	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA003884: AB_1079465"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.44e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.73e-3)"	"unprognostic (6.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.11e-1)"	"prognostic favorable (3.85e-6)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	94.2	80.6	71.3	37.0	71.8	50.9	99.9	75.1	101.8	82.0	70.6	93.2	83.6	65.0	68.6	80.6	69.5	50.2	190.5	70.3	78.3	137.2	147.9	55.7	45.7	72.3	70.4	101.7	45.4	125.8	58.2	63.0	73.8	65.9	89.6	59.1	63.6	73.6	346.2	76.7	71.9	72.2	75.3	42.9	80.7	37.9	75.1	59.8	74.0	397.4	60.7	71.3	73.0	77.7	118.8	102.9	200.5	119.1	133.9	192.7	167.9	140.7	136.6	153.0	185.8	126.7	151.4	83.9	180.2	121.1	146.3	85.3	72.0	167.9	175.4	77.4	137.2	57.8	97.1	115.6	142.4	141.0	95.8	161.2	190.2	105.8	184.8	167.7	135.1	93.4	50.2	88.5	141.9	110.5	106.7	116.9	60.9	45.3	115.1	126.4	113.1	166.2	165.1	113.0	92.7	99.5	96.4	92.5	175.2	106.8	148.2	145.2	104.4	93.6	98.9	68.7	186.9	67.6	91.5	102.1	99.7	202.7	137.3	19.4	83.9	7.9	49.1	101.8	55.3	72.7	61.9	58.0	121.6	50.3	68.2	70.0	6.8	79.4	108.3	93.8	72.4	68.2	71.3	71.8	75.1	101.8	70.3	78.3	72.3	70.4	73.8	75.3	75.1	77.7	62.1	38.5	56.6	49.0	52.6	125.8	150.4	382.0	56.3	44.8	100.0	119.1	328.4	82.9	170.6	84.6	41.7	168.4	43.2	124.5	553.7	174.1	61.5	65.5	87.7	84.6	90.4	47.1	55.9	167.3	163.3	113.1	47.9	68.7	76.0	146.9	99.2	137.8	144.3	30.3	73.2	135.3	215.7	76.4	127.3	61.5	157.5	70.4	117.4	38.4	161.4	113.6	63.8	52.8	68.4	179.4	153.4	152.7	38.4	95.3	188.7	425.9	112.2	76.0	124.9	145.1	173.4	76.8	75.0	79.3	101.4	179.9	50.0	96.4	171.2	158.2
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67605653-67612554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 526.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 482.4;Proximal tubular cells: 499.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Enhanced		Supported	Mitochondria,Cytosol		No	No		37000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: AB_2686732"	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	95.0	126.5	87.6	52.5	93.7	72.5	90.9	105.6	107.1	93.9	104.8	142.3	124.5	85.2	33.8	114.0	84.6	47.1	400.2	91.6	97.0	188.4	187.0	77.1	66.7	103.3	91.5	101.9	117.2	169.8	84.5	46.7	110.4	77.4	73.7	81.6	90.2	73.2	526.2	117.7	96.6	51.1	86.9	98.8	132.0	76.0	104.9	51.6	107.6	440.5	62.8	88.1	88.6	99.9	132.9	133.6	68.8	141.3	85.6	83.4	130.6	84.1	76.4	122.2	82.6	256.8	155.3	241.9	167.3	69.2	99.7	176.8	146.1	126.4	38.4	125.2	114.9	100.0	189.1	127.9	119.0	136.9	106.9	126.7	119.0	100.4	88.0	76.9	109.3	173.9	180.9	192.6	75.8	190.2	163.1	268.0	68.5	295.3	168.8	184.5	135.8	399.1	99.3	95.3	109.9	104.6	104.3	347.4	275.3	46.0	177.4	138.0	90.7	118.9	88.8	172.3	87.5	187.7	116.8	122.6	138.0	144.6	117.7	39.0	72.8	38.1	65.1	83.4	71.6	59.8	55.0	63.2	110.7	60.1	50.2	63.7	13.1	104.0	51.2	73.0	78.1	77.0	87.6	93.7	105.6	107.1	91.6	97.0	103.3	91.5	110.4	86.9	104.9	99.9	54.6	60.9	75.0	33.3	76.2	80.3	95.9	187.6	77.4	68.7	82.1	94.4	482.4	61.5	120.7	86.5	50.1	203.5	72.8	235.7	397.2	114.9	74.0	43.1	47.5	56.7	98.5	85.0	32.9	112.1	158.8	82.4	137.1	55.2	61.4	99.6	56.4	136.2	136.5	63.9	36.5	155.9	152.5	68.8	81.4	222.7	65.6	68.4	113.8	13.1	81.0	89.3	60.8	19.1	34.6	70.1	122.8	59.0	146.6	55.0	199.4	499.2	80.3	78.5	46.0	90.8	136.9	100.7	83.3	127.0	80.6	189.1	79.3	145.9	274.8	111.7
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 606.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003404, HPA077896"	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No		7600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA003404: AB_1079466, HPA077896: AB_2686866"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	97.4	171.6	94.3	69.2	97.4	149.8	101.7	106.8	139.7	63.9	106.0	124.2	102.3	69.7	91.1	142.6	64.0	68.7	419.3	96.7	106.0	180.7	404.2	88.6	105.0	105.9	104.4	52.4	111.6	136.7	72.1	73.7	105.9	88.5	119.8	129.9	97.4	72.4	606.9	94.7	100.5	80.6	103.7	86.4	133.8	79.6	102.7	90.2	72.7	538.3	105.1	122.1	76.5	104.6	136.5	139.8	159.1	148.4	116.6	164.0	133.4	165.4	266.5	217.7	205.5	265.1	109.4	209.4	149.5	158.6	200.3	66.9	157.5	175.5	208.8	104.6	136.6	133.0	135.3	364.8	133.6	373.8	159.2	139.2	144.3	134.9	146.2	156.8	239.3	184.3	216.5	644.0	204.6	171.6	263.5	328.9	131.4	750.5	172.3	124.5	118.2	794.2	354.3	218.7	167.0	122.3	164.6	188.0	220.3	113.6	174.2	282.8	145.8	273.4	194.3	198.8	223.0	180.4	292.3	237.1	195.4	166.0	181.0	250.8	161.8	194.2	118.1	196.1	148.3	237.6	176.9	140.5	237.9	201.1	153.5	142.7	76.0	124.2	187.9	315.1	231.9	231.8	94.3	97.4	106.8	139.7	96.7	106.0	105.9	104.4	105.9	103.7	102.7	104.6	107.3	80.1	145.8	17.6	143.1	148.0	319.0	629.4	159.4	101.2	165.0	167.3	69.9	178.7	339.5	150.8	87.6	344.1	146.6	211.0	876.5	415.2	271.5	160.3	108.2	117.3	106.5	165.4	32.9	531.4	323.3	122.0	144.3	183.9	120.3	109.7	96.4	351.5	313.5	94.2	37.3	201.7	480.1	115.7	267.1	186.2	122.1	170.2	231.3	17.8	293.2	167.1	96.8	32.2	46.5	530.3	201.2	102.0	244.9	554.3	349.9	810.6	293.4	184.2	105.2	124.0	196.3	217.4	175.0	226.5	147.6	289.4	165.7	266.7	227.3	469.0
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 770.8;Early spermatids: 502.9;Late spermatids: 1712.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	20.5	18.1	9.2	3.2	9.3	6.8	17.5	9.5	8.9	16.6	7.5	24.2	5.1	19.1	7.9	18.9	17.3	2.4	47.2	7.6	8.0	18.0	26.9	13.7	3.1	9.5	9.7	19.1	24.0	7.5	16.6	3.0	9.2	16.3	4.1	7.7	17.3	4.0	88.0	19.0	16.1	3.6	8.4	17.0	19.7	20.9	9.2	2.5	14.9	21.1	3.2	18.4	15.9	10.1	3.3	4.9	9.1	8.1	7.9	5.0	10.4	6.6	4.2	5.2	3.4	10.6	6.2	4.9	4.2	4.1	11.7	5.4	8.8	8.1	3.5	2.8	7.4	20.1	8.7	9.0	9.4	6.0	7.8	8.0	8.2	6.9	12.0	4.2	6.1	5.6	13.5	7.3	5.6	10.5	3.7	6.2	10.2	15.7	6.9	4.6	5.3	12.3	9.5	7.5	5.8	4.7	9.0	10.3	4.8	4.4	10.2	4.6	8.9	3.2	3.0	4.4	4.8	12.1	7.1	3.5	5.7	7.7	4.6	3.1	5.7	3.8	2.8	7.1	2.4	2.9	2.4	2.2	5.0	3.5	2.9	2.8	3.3	4.4	6.6	4.4	2.7	2.8	9.2	9.3	9.5	8.9	7.6	8.0	9.5	9.7	9.2	8.4	9.2	10.1	42.8	54.5	46.7	14.4	36.5	19.9	53.7	97.7	24.5	81.2	64.9	65.7	770.8	92.9	58.6	90.1	68.8	57.5	32.5	89.3	230.9	86.5	502.9	84.5	64.9	48.1	78.3	112.4	19.4	101.5	59.5	57.2	55.5	56.9	31.6	45.5	68.2	334.5	114.4	57.2	22.1	114.8	87.5	88.3	38.1	1712.0	66.5	62.3	37.4	17.8	86.4	88.7	49.4	15.6	19.5	98.6	80.9	62.4	39.0	109.3	176.4	372.6	85.9	104.7	72.3	54.0	66.1	243.5	77.1	50.0	23.4	89.9	29.9	83.8	95.4	65.3
NECAP2	FLJ10420	ENSG00000157191	"NECAP endocytosis associated 2"	Q9NVZ3	1	16440721-16460078	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 314.8;monocytes: 202.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028077	Approved		Approved	"Endoplasmic reticulum"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"HPA028077: AB_10601273"	"unprognostic (6.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.38e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.58e-2)"	38.1	37.9	28.4	51.7	31.0	29.0	34.3	30.7	32.8	31.6	29.5	30.9	23.4	22.8	19.2	43.5	32.8	30.5	22.2	27.0	30.4	33.2	31.7	51.7	77.6	34.6	29.5	36.8	22.1	23.7	19.8	59.9	31.5	25.4	29.5	14.2	26.6	21.0	8.6	45.7	32.0	30.2	32.0	73.3	30.5	33.7	32.5	55.9	25.7	12.8	63.3	44.4	31.1	32.7	54.1	29.2	30.5	36.0	60.6	65.0	17.9	59.6	83.3	76.8	67.9	32.1	87.1	47.8	70.4	111.2	35.4	35.8	43.1	60.3	63.9	100.0	44.3	46.7	33.4	44.6	78.9	59.8	41.7	73.0	61.6	54.7	44.9	66.2	129.1	54.4	67.0	153.7	69.1	35.3	55.8	63.3	26.6	41.1	41.9	61.2	27.0	79.6	76.9	30.5	19.1	48.6	46.4	27.1	61.9	45.1	30.9	66.1	148.0	49.2	26.8	57.4	41.1	72.5	74.5	47.9	41.6	85.7	49.0	90.2	173.1	112.3	96.1	241.2	95.6	108.8	165.8	114.5	120.1	98.8	168.2	106.6	68.2	121.6	274.7	71.0	214.7	269.9	28.4	31.0	30.7	32.8	27.0	30.4	34.6	29.5	31.5	32.0	32.5	32.7	53.6	22.4	25.0	10.1	47.6	52.3	34.1	60.4	27.3	25.7	37.9	35.1	7.0	22.8	32.2	20.2	314.8	49.0	42.5	34.6	23.5	71.3	61.1	27.0	29.5	67.8	18.7	40.8	7.0	54.2	62.0	33.3	23.9	27.6	27.8	33.0	96.4	11.0	125.7	15.2	7.7	31.8	36.7	94.5	81.8	34.3	29.8	60.5	24.9	7.5	202.0	23.8	55.6	11.6	11.4	121.9	45.8	33.8	24.3	46.6	30.8	22.8	37.4	54.3	39.5	14.7	27.2	26.8	27.4	33.3	56.0	49.4	59.4	72.7	24.0	58.8
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070998-161089558	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.9;skin 1: 113.6;vagina: 57.3"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 384.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 56.5;HaCaT: 37.0;MCF7: 24.0;OE19: 24.6;SK-BR-3: 47.8;T-47d: 31.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	No	No		170000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.4	0.1	0.1	0.5	0.1	0.7	13.7	0.3	0.2	26.5	0.0	1.5	0.7	1.2	6.9	98.9	2.9	3.8	0.1	0.1	0.0	3.1	0.1	3.5	0.1	0.1	0.1	0.0	4.5	0.4	0.6	12.2	0.1	9.4	1.7	0.1	33.6	4.3	0.6	113.6	0.6	0.1	0.0	0.0	8.8	0.6	0.3	0.8	0.2	0.0	14.5	16.8	57.3	0.4	10.9	0.4	0.0	0.1	0.0	0.1	56.5	0.1	0.1	0.1	0.2	0.0	14.6	0.0	0.2	0.0	0.1	37.0	0.0	1.2	0.2	0.0	0.5	0.0	0.8	11.1	0.0	0.1	0.7	0.0	14.6	3.0	3.6	0.1	0.0	0.0	0.0	0.1	0.1	24.0	0.1	0.1	0.1	24.6	0.0	0.0	0.0	0.1	0.0	17.5	0.0	0.2	0.2	47.8	0.0	6.4	31.1	0.0	0.0	0.1	2.4	0.5	0.2	0.2	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.2	6.4	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.6	17.8	0.0	0.0	8.1	16.5	0.0	39.4	0.4	0.0	0.0	41.7	0.0	28.1	2.9	0.6	0.0	0.0	0.0	30.0	67.1	1.2	0.0	43.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	67.1	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	384.2	0.4	0.1	0.0	0.0
NEDD8	Nedd-8	ENSG00000129559	"NEDD8 ubiquitin like modifier"	Q15843	14	24216857-24232367	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		990000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644"	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	169.0	224.3	156.9	71.5	162.3	91.0	156.7	158.6	219.1	152.4	152.5	172.9	55.9	147.6	132.6	202.1	131.3	51.0	299.8	163.1	168.6	195.8	175.7	147.7	81.2	163.7	158.7	138.1	110.9	289.1	143.9	84.3	162.4	133.7	88.7	74.6	139.3	85.5	294.3	182.2	128.8	97.7	157.5	164.6	146.8	77.9	162.1	125.7	132.8	197.1	113.1	152.0	157.5	162.0	166.9	292.7	223.8	159.9	255.2	223.2	165.6	218.7	237.4	259.5	237.5	204.6	196.1	142.1	126.9	317.1	212.3	169.2	230.8	349.5	365.6	201.9	139.7	150.2	272.9	710.7	220.8	251.8	151.6	237.0	231.8	217.2	172.0	239.1	317.3	162.3	139.3	161.5	409.4	380.3	203.4	241.1	166.1	303.7	335.8	141.3	176.9	146.1	302.7	322.1	96.7	221.7	188.3	192.6	168.4	229.5	117.6	199.2	230.3	145.4	144.9	184.9	198.5	187.9	322.7	210.6	102.6	146.2	139.6	461.6	277.3	459.9	214.7	302.8	235.5	311.9	246.0	241.0	276.3	273.4	229.8	233.1	299.8	233.7	310.5	369.7	327.3	526.6	156.9	162.3	158.6	219.1	163.1	168.6	163.7	158.7	162.4	157.5	162.1	162.0	276.4	144.2	156.8	0.0	182.1	277.9	227.5	644.7	166.8	101.0	263.4	301.5	464.7	215.9	301.5	310.8	47.9	525.7	237.0	267.8	594.8	344.9	72.6	201.8	189.4	259.5	212.4	220.7	0.0	406.9	625.0	246.0	108.1	195.4	218.6	228.7	222.0	431.5	576.3	106.0	0.0	286.4	362.2	288.7	345.5	77.3	272.1	255.4	268.6	0.0	394.0	275.0	346.1	0.0	0.0	449.8	311.5	275.7	161.3	254.4	340.2	845.8	279.7	95.9	210.4	178.7	318.4	150.0	196.9	252.1	386.6	419.5	216.0	289.8	291.8	275.5
NEFL	"CMT1F, CMT2E, NF68, NFL, PPP1R110"	ENSG00000277586	"Neurofilament light"	P07196	8	24950955-24956721	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 675.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 32.7;Distal tubular cells: 103.7;Enteroendocrine cells: 33.3;Excitatory neurons: 64.6;Horizontal cells: 30.3;Rod photoreceptor cells: 110.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2"	"Lineage enriched"	"Detected in single"	113	"T-cells: 11.2"	"Group enriched"	"Detected in some"	4	"HEK 293: 456.2;PC-3: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014850, HPA015021"	Enhanced	Supported	Approved	"Nucleoplasm,Intermediate filaments,Midbody"		Yes	NA		200000	"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Intermediate filaments"	Midbody	"HPA014850: AB_1854397, HPA015021: AB_2669135"	"unprognostic (7.63e-2)"	"unprognostic (1.36e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (5.76e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.17e-3)"	0.1	18.0	35.4	1.3	36.7	0.0	0.0	103.6	675.9	2.0	0.0	2.5	0.6	0.1	0.3	5.4	1.3	0.1	0.1	50.9	75.6	5.0	0.0	0.0	0.1	425.7	41.1	0.2	0.2	0.1	4.0	0.0	231.3	1.8	1.5	89.5	0.0	15.6	0.0	0.9	1.9	1.1	33.9	0.2	0.8	1.7	216.1	12.7	0.7	0.1	0.3	0.0	1.4	184.0	0.0	0.6	68.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.6	0.0	0.0	456.2	0.0	0.0	0.0	21.6	0.0	1.0	8.3	2.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	18.8	0.0	145.4	0.0	0.0	0.0	31.7	4.2	30.9	31.6	11.2	0.0	1.9	2.2	0.0	0.0	0.0	2.2	31.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	1.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.2	1.5	35.4	36.7	103.6	675.9	50.9	75.6	425.7	41.1	231.3	33.9	216.1	184.0	0.1	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.6	32.7	0.0	0.0	3.2	0.0	0.0	0.0	8.4	0.0	0.1	0.1	103.7	0.1	0.4	0.1	0.3	3.7	33.3	0.0	64.6	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	30.3	29.1	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	27.2	0.1	27.8	0.0	14.6	18.4	0.0	0.1	9.4	0.0	0.0	0.0	0.2	0.0	110.0	0.0	0.1	0.2	0.0	13.2	1.5	0.0	0.0	1.6	1.4	0.0	0.0
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913758-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 689.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.6;Excitatory neurons: 46.6;Late spermatids: 114.6;Rod photoreceptor cells: 69.1;Spermatocytes: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	25	"HEK 293: 3890.8"									"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"		Yes	NA		220000		"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	0.3	19.5	61.1	0.9	27.9	0.0	0.1	150.0	689.9	9.6	0.0	2.8	0.1	4.0	0.0	4.0	5.3	0.2	0.2	57.7	54.0	1.9	0.1	0.2	0.1	610.3	89.1	1.7	2.0	0.0	17.9	0.2	487.1	1.5	0.7	90.8	0.3	27.6	1.7	0.6	1.3	2.5	86.8	0.1	0.9	18.9	430.5	1.7	0.1	0.7	0.5	0.4	6.5	203.6	0.0	0.0	154.3	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3890.8	0.0	0.0	0.0	79.4	0.0	0.1	2.4	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.2	5.9	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	3.7	32.6	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.1	27.9	150.0	689.9	57.7	54.0	610.3	89.1	487.1	86.8	430.5	203.6	3.1	0.0	0.0	12.4	0.0	1.3	0.2	0.1	9.1	30.9	1.1	21.2	2.4	0.0	0.6	0.0	6.2	0.0	3.2	0.1	0.0	0.1	92.6	0.7	19.5	2.9	3.5	0.0	46.6	0.2	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	20.2	17.5	0.0	0.0	0.0	0.7	114.6	0.9	0.7	1.8	13.1	0.0	22.8	0.0	9.5	13.6	0.0	0.0	4.5	0.4	0.3	0.0	0.4	0.0	69.1	0.0	3.3	5.7	43.8	1.0	14.0	0.3	0.0	4.1	0.0	0.1	0.4
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395943-72282539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 29.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 1968.8;Inhibitory neurons: 1254.4;Oligodendrocyte precursor cells: 726.3;Oligodendrocytes: 442.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.7;TIME: 28.5;U-2 OS: 22.9;U-251 MG: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"		NA	NA		380000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	16.5	5.8	12.8	3.6	15.9	1.2	5.9	4.4	15.7	7.1	0.0	17.5	2.7	5.2	4.1	10.5	7.2	10.7	11.2	15.1	9.1	6.8	0.3	5.5	1.6	1.9	5.6	6.0	4.5	0.7	3.9	2.9	2.7	7.3	7.8	29.8	2.4	5.4	3.3	5.8	5.1	6.4	3.7	0.6	7.4	3.2	12.4	5.6	3.5	5.1	0.8	13.3	6.6	6.5	0.4	0.1	0.8	0.2	26.7	21.0	0.2	19.4	7.2	10.4	12.7	0.1	0.2	0.3	0.1	21.5	0.2	0.6	0.0	0.0	22.4	0.2	0.1	0.1	3.4	0.1	2.2	0.2	0.4	10.2	0.1	8.9	1.5	15.4	12.5	0.3	0.1	0.8	19.5	0.1	0.2	0.2	3.2	0.3	11.0	13.7	20.4	0.3	1.7	0.3	1.5	1.7	6.8	0.1	0.0	0.4	0.1	0.3	28.5	2.3	22.9	0.9	24.5	0.4	0.2	0.1	5.2	13.0	8.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	12.8	15.9	4.4	15.7	15.1	9.1	1.9	5.6	2.7	3.7	12.4	6.5	6.0	0.0	0.5	170.7	0.0	5.0	0.6	0.1	0.0	51.4	0.2	0.5	4.2	1.5	2.5	0.0	27.1	0.0	4.4	0.1	0.0	2.4	6.2	0.1	1.3	2.6	0.0	0.8	1968.8	0.0	0.0	88.7	0.5	0.1	0.0	0.2	0.0	0.0	0.2	1.7	1254.4	0.6	0.0	0.0	16.7	12.5	210.3	2.4	8.8	58.1	3.1	12.2	0.0	726.3	442.7	0.5	0.0	44.8	0.5	1.3	0.0	1.5	7.1	58.7	32.9	8.3	8.5	0.7	2.5	0.3	3.4	0.0	1.1	0.2	0.1	0.7
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156994-198322420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 172.6;Oligodendrocyte precursor cells: 131.2;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 554.5;fHDF/TERT166: 753.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	63.8	49.9	48.3	29.3	58.7	11.1	27.7	45.9	53.3	26.1	35.7	30.0	21.1	26.6	19.7	31.2	22.3	27.2	140.4	39.5	56.1	29.3	30.0	41.6	30.8	61.1	51.3	29.6	20.3	25.1	12.3	42.1	60.0	27.1	23.3	19.6	22.3	36.5	56.6	14.9	25.3	32.2	59.7	32.1	20.1	13.7	49.1	27.7	26.8	63.7	23.6	30.9	20.1	64.2	47.8	12.3	14.8	6.0	37.5	42.6	17.4	554.5	227.6	218.7	102.9	23.0	46.2	17.1	39.4	753.3	12.6	29.0	22.7	30.3	220.8	56.0	32.7	23.6	48.7	9.6	45.3	40.2	46.3	26.7	25.3	144.8	43.5	82.2	42.4	140.0	18.8	41.2	102.3	15.1	34.7	23.4	8.4	37.5	9.9	18.5	36.5	30.7	37.3	24.5	9.5	17.0	92.1	53.0	63.5	20.6	38.8	36.0	95.7	61.8	52.0	178.6	58.9	29.3	28.5	11.8	26.9	36.3	48.7	1.8	2.2	3.3	2.9	1.8	12.8	1.4	3.2	4.1	2.0	1.9	2.7	3.1	6.0	3.6	1.6	1.3	6.0	1.4	48.3	58.7	45.9	53.3	39.5	56.1	61.1	51.3	60.0	59.7	49.1	64.2	34.3	28.9	30.7	78.0	32.4	51.4	15.0	10.2	33.6	8.2	22.8	18.2	172.6	10.0	18.7	18.4	14.6	15.0	32.9	25.8	11.7	10.6	2.8	21.6	20.9	29.3	19.8	32.6	17.0	19.6	15.9	30.0	18.8	19.6	8.8	11.8	40.4	23.5	17.5	3.3	34.6	19.5	8.2	49.5	51.6	3.3	29.2	35.5	30.2	124.6	29.0	11.4	15.5	131.2	153.5	50.1	19.3	38.4	28.5	30.6	25.1	16.6	27.9	24.2	19.7	28.1	35.9	7.7	6.0	29.2	49.2	64.3	41.6	28.7	15.6	33.1
NEK8	NPHP9	ENSG00000160602	"NIMA related kinase 8"	Q86SG6	17	28725897-28743455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040661, HPA040679"	Approved		Approved	"Nuclear speckles,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Microtubules	"Nuclear speckles, Mitotic spindle"	"HPA040661: AB_10794065, HPA040679: AB_10796226"	"unprognostic (2.63e-1)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (6.25e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.67e-3)"	1.5	3.1	1.7	3.3	1.9	1.7	2.4	1.4	1.9	2.5	3.8	2.4	3.0	1.5	3.2	2.5	3.9	2.0	1.0	1.4	1.6	9.1	5.2	3.3	5.8	2.0	1.7	1.9	4.5	2.9	4.4	2.6	1.7	4.0	2.2	0.6	3.7	2.6	0.5	3.1	4.2	1.2	1.6	5.8	3.4	3.8	1.9	2.7	7.2	0.4	5.0	2.6	2.2	2.3	2.1	3.4	3.5	2.8	1.9	2.1	10.9	0.9	2.1	1.3	1.7	5.4	5.0	13.1	3.5	2.8	2.5	3.8	5.2	4.8	1.3	3.5	6.4	2.9	5.8	10.1	3.3	1.8	3.7	4.8	1.8	2.5	5.8	1.8	0.9	1.9	4.3	1.3	1.5	4.7	1.9	3.4	3.3	3.7	1.0	4.9	2.3	5.9	7.0	5.7	6.4	1.5	3.0	6.3	1.6	4.7	9.3	2.4	0.8	1.3	2.2	1.6	1.0	1.5	1.8	8.9	2.0	1.6	3.1	3.3	0.9	1.2	0.7	0.5	0.8	2.8	0.6	0.7	0.1	4.2	0.7	1.0	0.4	1.3	1.1	14.8	0.5	0.8	1.7	1.9	1.4	1.9	1.4	1.6	2.0	1.7	1.7	1.6	1.9	2.3	2.7	9.6	19.3	3.9	22.9	2.8	9.2	8.3	7.4	2.8	10.1	14.1	1.7	12.8	11.6	25.8	8.4	17.6	19.1	14.9	7.9	5.8	9.5	12.8	6.0	2.9	10.3	7.0	0.7	6.0	9.2	3.9	6.1	15.2	26.6	3.2	3.3	9.4	3.9	1.7	0.5	14.4	10.2	5.0	2.7	2.0	3.4	4.4	3.6	2.8	4.0	2.6	3.1	1.5	1.6	3.9	17.2	2.6	7.2	8.6	13.4	4.3	14.3	1.8	0.0	11.7	3.0	19.9	11.4	8.8	1.6	11.1	4.9	7.8	15.9	4.2
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002444-113019861	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	6.7	6.7	4.7	7.0	5.4	10.6	8.8	6.9	6.5	6.5	6.3	7.0	7.1	8.4	10.3	6.0	6.5	7.4	8.4	5.2	4.9	6.3	5.9	6.4	12.3	5.8	5.3	8.1	8.2	6.9	6.6	6.7	5.6	6.6	5.4	11.7	6.9	6.1	18.7	10.8	7.0	5.8	5.1	8.8	8.3	11.3	5.3	9.4	11.5	7.7	7.8	6.7	5.3	7.9	13.6	10.9	17.3	13.0	5.5	10.1	9.2	12.6	8.1	6.9	4.7	10.1	8.5	17.6	6.6	4.3	9.6	13.7	12.7	5.8	9.4	3.5	8.0	27.3	10.0	7.5	10.0	17.4	9.4	15.7	10.0	5.5	14.2	18.8	6.1	17.2	9.5	13.5	5.2	8.6	15.1	10.3	18.1	12.0	14.0	12.1	13.7	9.3	7.8	11.2	11.9	17.3	7.3	9.1	21.4	12.7	10.4	14.7	12.4	9.4	9.3	3.6	9.1	13.3	11.2	20.6	15.2	13.6	7.0	1.9	1.3	1.6	2.2	1.6	2.3	1.8	2.6	1.9	1.8	1.4	3.2	3.2	0.8	4.3	0.7	1.3	1.2	1.4	4.7	5.4	6.9	6.5	5.2	4.9	5.8	5.3	5.6	5.1	5.3	7.9	16.3	9.6	12.8	0.0	7.6	0.0	0.0	0.0	0.0	0.0	17.4	16.9	0.0	0.0	10.5	18.4	0.0	18.4	23.4	0.0	17.6	14.1	0.0	11.9	20.7	6.3	0.0	0.0	0.0	12.6	15.5	9.3	0.0	16.1	17.7	24.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	4.5	0.0	0.0	14.8	8.7	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	20.4	9.1	33.9	0.0	0.0
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677407	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 161.6"	"Group enriched"	"Detected in many"	4	"Adipocytes: 102.2;Cardiomyocytes: 279.9;Endothelial cells: 105.5;Sertoli cells: 105.2;Smooth muscle cells: 70.5"	"Cancer enhanced"	"Detected in all"		"glioma: 147.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 627.3;HUVEC TERT2: 321.5;LHCN-M2: 512.6;RH-30: 518.3;SuSa: 340.7;WM-115: 247.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"		No	No		100000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	40.0	8.5	24.4	13.8	24.8	0.0	28.2	27.2	22.7	27.1	16.5	16.8	5.3	41.1	12.9	8.2	30.3	11.3	161.6	21.1	26.5	35.2	4.8	42.1	4.8	32.8	27.1	10.1	5.6	10.4	12.8	16.7	25.8	21.2	6.6	8.2	9.7	36.1	55.7	8.6	12.5	30.3	30.0	49.1	10.8	6.2	26.4	2.7	19.9	47.3	2.3	24.2	19.0	30.9	0.2	2.5	627.3	134.7	1.3	33.4	0.6	154.7	120.7	2.3	3.4	102.5	1.9	0.6	35.8	14.9	0.1	2.8	63.9	0.0	1.8	0.0	1.1	0.9	9.7	47.3	5.5	0.3	37.1	28.5	0.0	5.7	0.0	5.3	321.5	0.1	4.9	0.2	512.6	4.3	0.0	0.3	102.3	6.0	88.1	0.7	518.3	0.4	0.6	0.0	1.6	100.4	3.6	4.5	124.9	340.7	1.3	0.9	235.1	0.8	34.5	4.1	8.8	0.2	24.0	0.2	13.4	0.1	247.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	24.8	27.2	22.7	21.1	26.5	32.8	27.1	25.8	30.0	26.4	30.9	102.2	0.0	4.4	0.0	0.7	2.4	0.4	0.2	0.6	0.5	9.4	32.9	279.9	0.0	0.6	18.4	0.0	0.2	1.0	0.6	0.0	2.1	0.4	2.1	31.9	105.5	0.0	0.0	0.3	0.0	1.9	29.4	0.5	2.7	0.0	0.2	26.7	0.1	1.8	0.0	0.6	0.2	0.0	0.8	3.1	0.1	8.1	1.7	1.8	12.2	1.0	17.4	0.0	3.0	2.2	0.3	0.1	4.1	0.1	0.5	0.0	0.1	0.0	1.5	105.2	10.9	70.5	0.5	5.0	1.2	2.4	0.1	1.1	1.4	0.3	0.5
NET1	"ARHGEF8, NET1A"	ENSG00000173848	"Neuroepithelial cell transforming 1"	Q7Z628	10	5412557-5459056	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 252.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020068	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA020068: AB_2670348"	"unprognostic (1.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (8.27e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.46e-1)"	48.8	10.8	35.5	23.4	34.2	40.5	52.8	38.5	57.6	43.7	52.8	92.2	56.2	41.8	56.2	68.4	46.2	35.9	13.2	30.2	32.4	49.3	45.1	22.2	26.7	41.8	37.2	28.5	37.9	5.4	10.6	65.7	43.8	41.3	88.2	6.5	93.1	24.3	25.0	39.8	74.7	36.9	37.5	8.1	77.8	14.4	41.1	30.4	26.2	28.0	33.0	60.8	59.3	40.1	115.9	67.7	45.2	51.0	26.8	11.9	252.9	69.1	37.6	53.4	50.4	36.4	215.2	40.6	27.7	42.4	11.4	185.5	54.9	104.3	63.9	38.1	38.5	77.5	22.9	84.0	7.2	21.5	31.1	18.2	61.0	54.0	12.3	47.6	31.1	42.6	138.5	64.4	30.0	54.3	74.3	30.6	61.5	158.6	51.0	45.0	85.0	32.4	33.4	57.6	38.5	20.6	60.7	110.9	20.3	76.2	36.7	65.3	29.5	20.3	30.9	30.7	56.0	39.3	23.1	53.4	18.1	33.1	43.4	2.0	0.6	1.4	0.6	1.0	0.0	1.4	1.2	0.4	4.9	0.6	8.7	1.7	0.1	0.8	0.4	2.0	4.0	2.2	35.5	34.2	38.5	57.6	30.2	32.4	41.8	37.2	43.8	37.5	41.1	40.1	18.4	32.1	55.8	2.6	12.7	40.3	127.2	49.0	103.0	11.0	52.6	28.3	12.1	41.5	84.3	12.9	4.2	110.2	8.4	242.2	5.9	13.1	2.4	97.7	30.6	42.7	80.8	54.1	5.1	24.4	109.1	33.2	107.0	131.4	15.2	16.9	12.5	55.7	14.5	3.3	7.7	145.3	34.6	10.5	59.8	2.4	21.8	31.2	35.6	44.0	48.7	3.8	0.0	8.5	5.7	62.1	148.3	87.6	39.2	67.8	123.6	29.2	85.7	3.5	111.7	183.0	185.0	26.3	16.0	158.1	32.4	117.5	9.3	2.9	145.0	186.5
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988279-75018893	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	3.2	12.7	8.1	6.4	9.7	23.7	6.5	5.1	10.8	3.8	2.9	4.2	4.3	4.9	5.2	2.6	4.2	4.5	6.2	5.3	5.0	5.1	8.2	5.1	8.3	4.1	4.0	8.0	6.1	10.4	5.7	3.9	5.4	11.5	6.4	10.4	4.2	3.2	26.4	8.0	4.3	4.8	1.1	6.2	4.8	13.9	5.1	12.3	8.1	22.6	7.8	3.5	2.5	7.5	9.1	8.2	6.7	11.7	5.2	4.4	7.1	8.7	5.7	9.4	7.7	24.3	7.2	25.7	8.5	7.2	12.9	8.1	16.1	11.4	14.7	13.2	7.9	21.8	14.4	10.8	5.6	34.7	19.3	5.5	9.4	9.9	15.0	6.5	7.2	37.3	35.1	17.5	11.2	9.7	33.1	16.8	8.0	18.5	10.3	27.0	17.5	22.2	12.8	9.3	12.0	7.2	13.7	8.4	37.0	8.0	18.9	8.2	10.4	11.6	11.7	8.0	9.1	15.5	15.8	51.8	3.6	17.2	9.8	1.2	2.6	2.4	1.5	1.4	1.1	1.0	1.2	1.5	1.5	1.2	1.2	1.5	1.5	0.5	1.8	1.1	0.9	0.9	8.1	9.7	5.1	10.8	5.3	5.0	4.1	4.0	5.4	1.1	5.1	7.5	1.4	3.2	4.6	4.6	5.3	0.5	2.0	0.4	0.6	8.6	3.5	3.9	7.7	2.8	2.7	1.8	62.6	2.1	4.1	1.0	0.0	1.2	9.2	2.2	2.3	2.3	7.2	5.0	12.5	3.1	1.4	2.1	3.1	2.7	1.3	3.7	3.6	6.9	5.4	11.8	10.3	2.9	2.0	10.1	1.1	7.6	1.5	6.2	0.0	8.4	6.8	3.4	3.1	9.5	9.9	2.6	1.0	1.9	5.8	3.0	1.6	3.7	1.6	6.4	0.0	5.8	1.8	32.0	2.2	1.6	0.6	1.4	3.9	3.8	2.8	0.6
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925472	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast glandular cells: 1.4;Club cells: 2.5;Hofbauer cells: 1.3;Respiratory ciliated cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HAP1: 3.7;Karpas-707: 5.9;SiHa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: AB_2665984"	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.1	0.9	3.0	0.1	3.1	0.0	0.3	1.0	2.5	0.4	0.0	0.8	0.1	0.5	0.2	0.3	0.3	0.1	0.0	2.6	6.7	0.7	0.0	0.1	0.1	0.3	0.7	0.4	1.5	1.8	1.7	0.1	0.5	0.9	0.3	1.0	0.4	0.6	0.0	0.3	0.4	0.7	0.2	0.1	0.6	0.2	4.8	0.0	0.4	0.1	0.1	0.2	0.2	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.9	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.1	1.0	2.5	2.6	6.7	0.3	0.7	0.5	0.2	4.8	0.7	0.3	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NF1		ENSG00000196712	"Neurofibromin 1"	P21359	17	31094927-31382116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 254.0;Excitatory neurons: 325.3;Inhibitory neurons: 412.5;Oligodendrocyte precursor cells: 428.2;Oligodendrocytes: 317.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045502	Uncertain		Approved	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA045502: AB_2679352"	"unprognostic (6.69e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-1)"	7.4	8.4	8.9	7.1	10.7	3.4	11.5	13.2	12.2	10.0	1.6	8.5	6.8	10.2	10.0	6.1	9.0	8.0	11.3	9.7	11.7	12.0	9.4	7.3	7.7	11.7	9.2	13.5	10.4	15.9	7.8	12.4	9.1	9.5	8.8	20.9	9.1	9.5	8.1	7.4	7.5	8.7	8.2	7.1	8.2	10.0	11.8	13.5	19.5	10.6	7.8	10.4	6.8	14.4	15.8	20.3	24.2	13.1	20.1	25.8	12.2	13.4	24.1	19.5	21.8	18.4	10.5	15.2	3.8	25.1	22.9	26.8	22.2	18.7	32.6	7.5	14.1	13.4	18.8	9.5	14.2	24.4	10.6	20.7	11.8	20.8	25.1	21.8	9.5	15.7	19.8	14.8	18.8	12.4	20.4	8.8	7.1	9.7	6.8	15.8	36.8	12.3	14.7	22.5	10.0	14.9	25.4	8.3	13.8	16.8	25.0	15.3	14.1	15.3	21.5	18.8	5.1	13.2	6.9	16.3	12.6	10.0	16.2	4.4	0.3	0.6	1.5	0.1	1.0	1.4	2.8	2.5	0.4	1.2	2.0	2.0	0.7	0.7	0.3	0.4	5.9	0.6	8.9	10.7	13.2	12.2	9.7	11.7	11.7	9.2	9.1	8.2	11.8	14.4	30.9	32.1	31.1	254.0	18.3	38.6	48.1	38.9	31.9	62.7	33.7	24.9	43.9	41.5	29.8	40.5	137.6	57.5	23.8	37.8	23.5	27.1	210.4	27.4	39.4	35.8	19.8	9.7	325.3	22.5	26.6	39.1	39.3	45.8	10.8	44.0	33.2	35.7	22.5	70.7	412.5	24.3	38.7	27.6	34.1	94.6	37.3	28.2	21.4	215.5	20.9	47.5	21.6	428.2	317.4	33.3	43.0	50.4	30.8	54.2	32.1	28.6	36.9	62.8	46.0	51.9	43.3	30.5	28.7	19.8	34.0	49.3	19.8	36.1	27.4	64.5
NFAM1	CNAIP	ENSG00000235568	"NFAT activating protein with ITAM motif 1"	Q8NET5	22	42380407-42432403	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.9;lymphoid tissue: 19.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 11.4;Hofbauer cells: 17.0;Kupffer cells: 53.9;Macrophages: 27.2;monocytes: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 90.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 90.4;monocytes: 48.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 37.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031812	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA031812: AB_10603121"	"unprognostic (9.77e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	6.3	1.9	1.5	12.4	1.9	30.9	1.1	1.5	2.2	1.8	2.0	1.5	1.3	0.6	0.6	1.3	2.0	2.3	1.3	1.8	2.4	1.2	2.3	7.5	5.5	3.1	2.2	0.3	0.8	0.3	0.6	2.9	2.9	0.9	1.2	0.1	0.8	1.4	0.4	1.4	2.3	2.9	2.3	19.9	1.1	0.7	2.9	2.1	0.7	1.5	2.1	3.1	0.7	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	5.8	0.0	0.0	0.1	0.0	0.4	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.3	48.2	2.8	0.1	32.5	0.2	0.0	0.1	0.0	16.5	0.1	0.0	0.0	90.4	0.0	31.1	0.3	0.0	25.4	1.5	1.9	1.5	2.2	1.8	2.4	3.1	2.2	2.9	2.3	2.9	3.0	0.4	0.0	3.7	0.0	0.5	0.9	0.7	0.9	0.6	0.2	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.8	0.4	0.2	0.5	1.2	0.0	0.7	0.2	0.1	0.5	0.0	0.3	11.4	0.0	0.7	0.6	17.0	0.0	0.6	0.0	0.0	53.9	8.2	5.6	0.3	27.2	0.0	8.4	44.6	0.0	0.0	2.0	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.5	0.5	0.8	0.7	0.0	1.0	0.3	1.3	0.4	0.0	0.5
NFAT5	"KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP"	ENSG00000102908	"Nuclear factor of activated T cells 5"	O94916	16	69565094-69704666	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 281.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057304, HPA069711"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA057304: AB_2683407, HPA069711: AB_2686180"	"unprognostic (2.71e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.42e-2)"	2.3	3.1	0.6	2.8	1.2	5.6	2.1	0.5	3.7	3.7	0.0	2.0	0.7	3.3	0.7	2.9	1.9	1.5	2.0	1.4	2.2	2.6	2.3	3.1	1.1	0.0	0.6	2.5	1.6	4.0	2.0	4.2	0.0	2.3	1.5	4.2	3.7	2.4	2.7	3.5	1.9	1.8	0.0	2.5	2.3	1.4	3.0	2.2	3.6	4.8	1.4	2.7	3.1	0.0	8.4	10.1	4.8	5.0	5.8	6.0	6.4	7.2	8.6	6.6	4.2	4.5	4.2	4.5	5.8	5.8	3.4	7.3	3.9	3.1	4.2	2.9	3.2	2.6	2.8	6.2	3.4	3.5	5.5	3.5	1.1	6.4	5.9	5.4	5.5	2.3	7.2	1.1	3.3	3.2	2.8	1.7	2.5	1.1	2.5	4.5	2.2	1.7	2.5	8.0	3.1	0.9	22.2	1.3	2.6	4.1	3.3	1.3	13.1	5.7	5.6	4.8	2.2	4.6	4.9	7.3	5.1	3.4	3.6	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.2	0.1	0.0	0.9	0.0	0.2	0.5	0.1	0.0	0.6	1.2	0.5	3.7	1.4	2.2	0.0	0.6	0.0	0.0	3.0	0.0	65.0	48.1	49.7	236.7	55.7	148.1	94.8	42.5	155.4	51.8	61.6	42.9	9.2	30.0	43.3	145.3	85.5	60.6	69.4	27.8	5.9	17.8	7.2	93.7	87.8	93.6	24.5	27.3	281.8	12.7	15.9	60.9	38.2	158.3	19.7	31.0	52.8	28.3	17.6	60.6	189.3	29.1	28.5	21.7	169.5	6.9	59.4	58.2	58.7	172.4	37.4	45.7	36.0	177.4	167.2	23.7	29.3	54.9	50.2	83.1	24.7	14.6	31.8	62.4	26.3	72.0	51.4	84.5	48.8	77.9	140.1	50.9	57.4	43.1	20.8	105.7
NFATC4	NFAT3	ENSG00000100968	"Nuclear factor of activated T cells 4"	Q14934	14	24365673-24379604	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.8;Endometrial stromal cells: 28.3;Fibroblasts: 22.8;Sertoli cells: 26.3;Smooth muscle cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.8;BJ hTERT+: 49.5;hTERT-RPE1: 42.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA031641, CAB032859, HPA076526"	Uncertain		Supported	"Nuclear speckles,Cytosol"		No	No				"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles, Cytosol"		"CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805"	"unprognostic (3.51e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (1.81e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-2)"	48.4	54.9	9.1	6.0	9.4	0.6	47.2	8.6	10.5	126.0	9.0	71.9	4.5	82.1	13.7	22.2	82.6	17.8	30.2	9.0	9.3	35.5	5.6	30.2	4.8	10.3	9.4	142.7	13.8	9.0	37.9	18.2	8.8	51.5	5.0	2.8	20.5	16.2	9.0	25.0	29.9	18.8	8.2	17.7	35.5	42.7	9.7	1.7	50.4	2.5	3.6	66.2	65.9	8.5	0.0	0.1	17.8	0.0	25.4	36.8	0.1	17.3	49.5	23.0	20.0	0.0	14.6	14.9	0.5	25.0	1.6	0.0	7.1	0.3	13.9	0.0	0.6	11.3	20.6	0.0	12.3	0.0	0.0	26.8	0.3	13.9	0.1	42.5	18.2	4.7	3.7	0.0	4.5	0.8	0.0	1.7	2.3	1.0	0.1	1.1	1.6	2.0	0.0	0.2	2.9	11.9	0.0	3.3	5.7	8.7	10.3	4.5	10.3	21.3	4.4	20.5	0.0	10.4	1.6	11.0	4.4	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	9.4	8.6	10.5	9.0	9.3	10.3	9.4	8.8	8.2	9.7	8.5	4.1	3.2	8.1	58.8	1.1	4.5	0.9	1.9	0.6	1.3	3.3	2.8	7.8	0.0	4.8	0.0	0.0	0.6	0.0	0.8	0.0	2.8	4.4	2.5	28.3	4.6	7.7	0.0	0.1	0.2	0.6	22.8	3.6	6.4	0.0	4.1	1.4	0.2	0.6	0.0	0.2	3.4	10.2	0.0	6.8	6.5	17.4	0.4	7.2	13.1	0.0	7.6	0.0	1.0	0.2	0.6	0.3	7.5	0.2	0.8	0.4	0.2	2.1	1.5	26.3	4.3	27.1	12.5	2.9	1.0	3.4	0.5	0.9	6.0	1.6	2.3
NFRKB	"DKFZp547B2013, INO80G"	ENSG00000170322	"Nuclear factor related to kappaB binding protein"	Q6P4R8	11	129863636-129895590	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007082, HPA007128"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA007082: AB_1079481, HPA007128: AB_1079482"	"unprognostic (1.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.15e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.93e-2)"	9.8	9.0	7.2	10.8	9.9	22.7	11.0	9.7	7.3	15.0	9.1	11.8	13.1	15.6	17.5	13.2	17.9	9.9	7.5	8.3	6.5	10.6	11.8	10.8	14.5	4.9	5.5	20.6	13.9	10.5	11.7	13.1	5.5	12.4	10.1	9.8	14.3	13.3	15.4	21.9	12.4	13.5	4.5	11.2	11.2	20.3	7.2	15.0	20.0	9.7	13.4	12.6	13.8	6.7	17.9	16.8	37.4	20.3	15.6	15.4	23.5	12.2	11.0	14.2	13.9	52.6	30.1	42.6	32.5	9.4	20.8	44.8	36.5	23.8	13.2	16.9	31.9	84.2	32.8	22.2	11.4	21.7	27.3	9.9	25.9	23.3	24.3	16.3	24.9	28.1	49.9	31.5	14.4	16.2	18.6	37.1	19.1	26.2	39.1	27.2	16.3	19.6	17.7	55.6	19.0	20.0	27.4	26.7	7.3	27.5	62.3	19.9	19.7	21.1	20.6	15.6	15.4	10.0	13.3	39.0	8.8	41.9	18.5	6.6	5.1	6.3	6.0	5.8	6.3	3.3	6.1	5.1	5.1	3.9	5.0	4.2	6.0	2.4	5.2	4.5	4.4	4.5	7.2	9.9	9.7	7.3	8.3	6.5	4.9	5.5	5.5	4.5	7.2	6.7	6.2	9.6	15.0	17.0	10.0	29.3	16.8	17.5	18.8	10.2	12.1	10.0	7.6	20.0	17.0	7.3	10.4	19.2	7.8	9.5	7.9	11.9	14.8	12.9	14.4	9.5	8.5	9.4	13.1	10.0	15.6	9.7	6.1	17.8	10.8	14.1	8.9	10.9	10.4	8.4	10.7	9.7	8.2	7.7	6.2	7.1	14.6	8.4	14.2	9.4	12.4	9.7	12.3	12.1	7.7	10.9	8.0	10.5	10.5	15.4	15.6	8.1	12.9	11.1	32.9	10.8	14.2	43.0	49.0	10.7	35.2	23.3	13.1	9.4	12.2	17.9
NFYB	"CBF-A, HAP3, NF-YB"	ENSG00000120837	"Nuclear transcription factor Y subunit beta"	P25208	12	104117086-104138241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Syncytiotrophoblasts: 433.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004211, HPA065646"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004211: AB_628018, HPA065646: "	"unprognostic (5.82e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.62e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.81e-3)"	32.9	40.8	34.0	15.2	34.3	14.7	27.2	30.5	50.8	28.6	26.8	60.4	15.0	30.5	33.1	16.1	30.1	18.5	37.4	31.0	31.2	24.0	30.6	29.0	24.7	32.9	34.0	23.2	21.3	21.7	17.4	23.6	32.0	39.0	18.4	21.2	20.6	67.9	36.2	18.4	21.7	21.1	34.7	19.4	26.3	22.6	32.1	26.3	22.7	36.3	22.8	38.1	23.9	36.2	30.1	25.3	55.3	35.7	34.2	35.6	48.6	31.5	27.2	37.2	25.6	21.2	14.0	44.4	15.1	30.3	22.9	22.0	46.5	20.9	37.4	28.9	14.7	27.4	31.0	19.7	31.0	35.0	17.6	49.3	25.6	14.5	25.5	62.0	24.0	40.1	27.1	16.2	31.6	29.6	53.2	40.5	52.8	22.1	26.0	43.5	30.9	18.8	27.3	25.3	31.3	26.2	58.0	132.5	19.3	36.8	53.1	42.9	15.2	21.3	13.1	17.5	24.0	28.5	29.5	42.0	12.5	23.7	22.8	18.0	5.7	18.5	12.1	7.8	16.6	12.3	12.1	12.5	5.7	8.5	13.0	13.7	7.2	13.5	9.0	5.0	16.9	9.1	34.0	34.3	30.5	50.8	31.0	31.2	32.9	34.0	32.0	34.7	32.1	36.2	42.5	54.5	26.7	8.8	21.1	37.3	106.8	42.9	15.9	22.7	24.3	31.8	39.5	12.8	30.3	18.4	4.2	58.8	24.5	13.3	37.2	24.2	6.2	20.4	36.4	36.5	12.0	39.4	13.1	18.3	86.3	43.0	11.2	17.5	21.5	30.8	77.1	31.2	23.1	15.2	13.7	15.4	30.5	14.4	29.8	5.4	34.2	19.2	28.4	8.4	20.2	43.3	22.6	11.1	25.3	27.3	16.9	30.5	17.1	54.5	12.6	42.5	26.7	27.2	19.7	35.4	40.0	90.0	32.4	18.0	37.1	433.2	25.6	18.8	18.3	55.7
NGDN	"C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD"	ENSG00000129460	Neuroguidin	Q8NEJ9	14	23469689-23509862	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000944	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA000944: AB_1079483"	"unprognostic (2.63e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.70e-1)"	32.2	26.4	25.6	23.3	28.4	64.4	40.3	30.5	37.7	30.5	25.0	30.1	23.4	34.7	32.5	26.2	32.0	17.6	23.7	25.9	26.6	31.3	32.9	24.2	35.3	27.1	27.0	39.6	25.7	33.3	20.8	29.2	27.7	24.8	29.0	25.2	24.6	26.6	53.4	35.2	26.8	31.4	27.7	28.6	27.0	28.6	26.9	37.5	28.4	39.2	36.8	32.3	27.7	31.7	37.6	73.1	54.5	51.5	52.0	37.3	72.1	48.6	50.7	101.3	81.4	72.1	66.8	92.6	35.0	44.7	71.1	63.7	109.0	60.1	118.7	61.8	57.3	83.2	44.1	229.3	70.5	110.4	56.9	46.5	75.0	79.9	94.4	39.6	52.2	69.5	93.6	64.1	50.4	88.8	82.3	86.0	69.5	84.8	97.1	67.1	65.6	47.9	65.7	70.4	55.6	62.8	57.6	68.3	83.8	55.0	42.2	70.4	39.8	47.8	57.3	45.1	71.3	79.4	148.7	133.3	20.6	56.1	52.2	67.0	62.3	58.5	88.0	71.8	93.5	129.0	94.6	89.9	74.8	107.7	121.3	95.5	19.1	109.5	71.7	79.1	116.1	93.3	25.6	28.4	30.5	37.7	25.9	26.6	27.1	27.0	27.7	27.7	26.9	31.7	33.8	35.3	29.2	2.9	52.1	70.6	63.8	78.2	72.8	23.2	25.5	31.2	20.2	21.5	46.8	27.6	16.7	59.3	45.3	19.9	33.2	38.6	7.2	24.3	25.9	36.5	24.6	35.1	7.5	36.0	43.3	34.4	16.3	27.5	45.0	23.2	25.4	21.4	29.8	25.2	6.8	22.7	28.5	19.2	39.0	6.9	35.1	21.1	32.0	9.4	34.3	26.8	46.4	4.0	11.0	31.1	22.8	28.2	30.4	42.9	25.8	35.5	36.6	28.6	19.7	51.5	36.0	68.7	64.2	39.6	67.6	57.2	47.6	20.5	27.2	49.5
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90275778	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 385.3;skeletal muscle: 376.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	61.0	91.8	322.8	32.9	334.0	31.7	61.4	312.4	385.3	68.8	312.1	47.0	39.7	63.4	98.3	51.7	65.3	47.1	133.0	332.8	329.8	71.7	59.1	50.3	31.8	316.3	322.1	67.8	46.4	87.6	3.0	46.4	318.1	80.1	51.1	157.0	46.3	88.9	376.8	32.6	35.6	74.6	324.8	37.0	41.5	54.2	334.5	39.6	74.0	291.8	37.4	69.2	2.7	320.9	62.1	127.8	151.7	99.7	138.4	63.9	70.4	100.7	88.4	110.5	94.0	133.2	90.5	38.4	113.8	108.9	110.2	118.2	120.3	64.7	121.5	42.6	104.6	61.0	88.4	110.6	117.7	44.5	36.1	83.4	183.3	60.8	132.9	83.7	79.5	45.7	105.0	64.7	112.8	106.5	35.9	53.5	152.7	198.8	55.0	65.6	72.8	63.1	109.8	168.3	145.8	117.0	107.1	90.1	239.1	149.1	141.9	82.6	64.6	138.3	92.3	85.7	161.7	96.9	268.2	66.4	76.8	90.1	106.4	66.4	62.1	99.0	87.2	65.2	109.9	107.7	106.1	101.9	59.2	105.7	122.6	106.8	23.4	86.7	76.0	62.8	133.5	108.0	322.8	334.0	312.4	385.3	332.8	329.8	316.3	322.1	318.1	324.8	334.5	320.9	10.8	19.2	27.4	21.5	26.2	7.1	10.6	3.7	75.1	10.4	9.1	5.8	10.1	1.5	21.6	5.5	10.4	5.9	5.0	12.1	5.9	33.6	1.9	16.2	14.6	15.8	26.5	12.0	58.3	23.4	4.5	23.0	30.1	9.4	20.3	5.5	7.5	3.8	4.2	16.8	54.0	14.4	4.1	3.8	3.6	4.0	9.0	8.4	8.8	16.9	11.6	15.1	0.0	12.5	22.2	29.9	20.0	8.6	25.0	9.2	12.6	7.8	59.8	11.2	13.1	10.5	19.6	5.2	4.3	55.2	5.1	6.7	19.9	5.7	15.4	8.7
NHLH2	"bHLHa34, HEN2, NSCL2"	ENSG00000177551	"Nescient helix-loop-helix 2"	Q02577	1	115836377-115843917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 7.4;esophagus: 2.3;retina: 2.1;skin 1: 3.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 14.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 7.9;Spermatocytes: 5.1;Squamous epithelial cells: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 58.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055238	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear bodies"	Nucleoplasm	"HPA055238: AB_2682752"	"unprognostic (2.20e-2)"	"unprognostic (2.28e-1)"		"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.11e-2)"	"unprognostic (5.26e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.25e-1)"	0.0	0.0	2.0	0.0	1.4	0.0	0.1	5.9	2.1	0.3	0.2	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	3.2	4.0	0.0	0.0	0.2	0.0	3.8	5.1	0.0	0.0	0.0	0.2	0.0	7.4	0.2	0.0	2.1	0.4	0.1	0.2	3.3	0.0	0.0	2.5	0.0	0.2	0.4	6.7	0.0	0.0	0.0	0.0	0.0	0.7	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	5.9	2.1	3.2	4.0	3.8	5.1	7.4	2.5	6.7	3.0	0.0	0.0	0.0	0.3	0.0	2.8	2.8	3.3	14.8	3.9	0.0	0.6	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	1.8	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	4.5	7.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.4	0.0	3.5	0.3	5.1	3.4	7.0	2.3	0.0	0.0	0.0	0.0	0.4
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736911	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	29.3	24.8	18.1	31.9	18.6	31.5	37.3	18.7	21.8	25.4	17.9	24.8	25.1	28.5	21.9	34.6	27.5	25.1	22.9	19.3	18.7	25.7	34.1	17.9	47.2	18.5	17.8	36.5	32.6	17.9	16.7	25.6	18.4	24.6	25.6	23.0	17.9	17.8	38.3	34.5	20.1	24.8	19.1	22.3	22.5	21.8	18.3	32.9	25.2	18.3	42.4	43.3	24.5	20.1	118.4	37.6	68.8	68.3	57.9	80.6	90.2	90.6	75.2	105.0	113.2	105.9	55.0	152.4	111.4	66.9	93.1	72.9	149.4	116.4	153.4	101.3	85.7	155.0	44.5	92.9	82.6	141.1	81.7	80.6	126.7	137.4	184.4	48.7	75.9	60.3	174.5	73.9	90.5	58.2	109.5	140.9	175.3	132.4	122.5	102.5	80.7	191.2	92.1	72.4	88.1	91.8	56.6	105.1	200.7	62.2	52.0	123.1	45.7	72.8	123.5	85.6	129.3	87.5	150.6	182.1	55.7	143.9	101.5	41.8	54.2	28.8	59.2	65.3	83.4	73.6	72.3	68.6	72.1	74.8	84.5	79.4	4.0	81.5	62.5	64.0	68.9	75.1	18.1	18.6	18.7	21.8	19.3	18.7	18.5	17.8	18.4	19.1	18.3	20.1	51.1	44.8	25.9	8.1	56.3	98.4	128.9	87.0	81.4	25.8	51.2	88.8	21.5	24.3	62.2	14.7	12.5	74.9	62.7	18.9	46.9	64.2	23.7	43.8	126.9	47.7	28.1	41.8	8.2	45.2	90.6	68.7	32.6	39.9	54.5	47.9	26.0	33.2	54.4	13.5	7.2	41.3	42.7	34.5	32.8	8.0	57.5	39.0	23.2	10.3	59.1	48.0	54.6	13.0	8.0	51.5	28.4	45.1	33.3	107.0	18.4	58.4	41.9	45.8	39.5	72.7	54.3	81.1	83.9	79.3	101.4	48.8	52.5	97.7	60.5	125.2
NINL	"KIAA0980, NLP"	ENSG00000101004	"Ninein like"	Q9Y2I6	20	25452697-25585531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 42.4;Granulosa cells: 29.6;Inhibitory neurons: 32.6;Oligodendrocyte precursor cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 37.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000686	Uncertain		Uncertain	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytokinetic bridge, Cytosol"		"HPA000686: AB_1079193"	"unprognostic (7.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.39e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (3.95e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.26e-2)"	4.0	8.6	4.9	2.0	5.9	0.6	4.0	10.4	6.1	10.1	8.8	9.8	3.2	7.2	7.2	5.8	5.2	3.3	4.0	4.4	6.9	15.1	8.1	4.1	2.2	7.9	7.1	18.9	5.4	8.2	9.9	1.5	7.0	8.8	2.1	4.7	4.4	3.7	4.5	2.4	3.9	3.5	5.5	4.9	6.3	7.7	6.5	15.7	10.2	1.2	2.2	3.6	8.5	6.8	1.0	10.8	23.0	15.1	2.6	7.5	7.1	3.6	3.1	3.1	4.4	2.8	7.5	0.6	5.0	5.6	7.6	0.8	3.4	0.7	2.6	0.5	4.7	1.6	5.0	37.5	5.4	0.6	0.1	9.2	0.7	3.6	0.0	8.8	6.8	17.8	1.9	0.3	3.8	9.6	21.7	0.7	6.5	0.1	1.1	0.5	17.9	0.8	1.5	1.3	22.7	16.0	8.2	3.0	9.1	18.3	4.9	6.4	0.3	0.1	8.6	0.1	0.2	2.3	4.4	0.1	0.2	0.6	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.9	10.4	6.1	4.4	6.9	7.9	7.1	7.0	5.5	6.5	6.8	1.2	0.0	14.6	42.4	0.8	2.0	4.9	2.5	5.7	3.0	2.8	3.3	6.5	12.8	4.8	7.3	25.0	2.8	0.6	0.4	0.0	5.6	0.6	4.2	7.3	2.3	6.1	0.0	7.4	1.2	1.3	8.7	4.6	3.4	0.0	29.6	8.9	8.4	2.3	8.4	32.6	2.3	8.2	0.3	2.0	2.7	13.1	0.8	0.0	12.2	0.0	3.2	2.1	47.3	19.4	2.8	1.5	12.4	0.9	4.5	0.7	8.8	13.7	1.9	6.6	10.8	4.7	2.5	5.0	4.3	0.9	1.5	1.1	21.0	2.5	1.9
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL cohesin loading factor"	Q6KC79	5	36876769-37066413	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: AB_2683650"	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	11.5	9.4	5.6	14.7	8.6	25.1	13.5	12.0	7.3	12.9	7.8	12.2	10.0	13.4	6.6	11.4	10.5	11.1	7.7	5.3	5.9	11.6	12.7	11.9	16.5	7.3	6.6	17.6	13.1	19.6	5.0	13.9	8.2	11.1	12.2	22.4	11.2	10.7	9.5	14.2	13.2	12.4	6.3	15.3	13.4	14.2	6.9	29.8	17.2	14.3	16.7	12.6	7.5	11.1	22.5	13.1	33.3	15.6	20.7	22.3	24.4	17.6	19.3	18.9	15.7	18.2	22.6	33.5	11.3	21.6	22.2	19.2	28.9	15.9	27.0	27.9	14.7	40.9	57.4	13.3	14.0	48.4	26.4	16.5	19.3	21.3	28.1	18.1	24.0	20.8	39.3	24.5	17.9	10.8	33.8	18.1	16.0	12.9	11.3	28.2	51.9	13.0	13.1	31.4	24.5	17.2	84.6	22.5	18.0	26.2	23.0	27.3	26.3	24.9	27.1	21.0	13.3	17.7	25.5	39.1	13.6	32.4	19.1	10.9	2.9	4.3	3.2	2.2	3.0	2.8	2.7	2.9	2.3	3.1	2.9	3.3	7.7	2.8	3.3	3.4	2.1	1.6	5.6	8.6	12.0	7.3	5.3	5.9	7.3	6.6	8.2	6.3	6.9	11.1	80.6	131.4	108.6	169.8	84.8	48.4	66.2	34.2	58.1	62.6	43.6	49.4	87.0	38.6	63.3	33.1	77.2	44.1	107.1	45.9	5.9	55.5	13.4	72.9	75.7	74.1	41.5	85.4	179.2	46.7	34.1	64.3	61.2	91.7	84.0	77.7	44.6	28.2	37.1	40.4	165.5	46.3	38.7	51.8	46.6	15.1	66.5	86.7	24.9	236.1	103.3	49.2	97.9	229.2	303.7	55.0	48.6	56.4	84.5	66.4	45.2	12.2	65.2	72.8	52.6	102.9	80.1	185.8	133.6	58.2	47.0	75.9	92.0	73.8	42.9	88.0
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600655-42648735	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: AB_2681540"	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.01e-4)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.05e-5)"	17.4	19.2	16.4	17.6	18.7	46.5	19.3	22.3	17.1	28.4	17.9	17.7	13.2	18.4	22.4	17.0	23.0	11.4	17.8	15.0	20.3	18.2	21.1	23.9	22.1	20.5	16.4	29.0	22.1	10.6	36.5	11.1	17.6	23.2	13.4	41.3	17.5	10.5	19.5	32.6	25.4	10.7	14.0	36.7	16.3	18.0	18.2	15.4	25.4	10.4	20.0	18.3	22.6	27.8	15.1	7.7	32.3	15.6	16.6	19.3	14.9	22.8	6.8	9.9	12.9	14.7	13.3	25.9	10.7	9.1	9.0	12.6	16.1	8.4	19.2	11.0	13.1	31.4	30.5	24.6	7.3	25.4	19.9	9.6	12.2	18.4	10.5	19.1	17.4	7.1	30.3	20.2	18.6	6.9	17.8	35.5	23.1	7.6	12.3	17.3	12.0	10.5	15.7	12.7	9.4	8.5	24.1	11.1	4.8	16.3	17.5	17.8	28.0	18.0	13.1	21.4	23.2	17.2	21.7	17.7	10.1	30.0	11.3	7.8	3.6	7.5	5.7	4.6	5.3	5.5	5.6	4.9	2.9	5.3	5.6	4.9	5.3	7.0	6.8	5.1	5.3	2.3	16.4	18.7	22.3	17.1	15.0	20.3	20.5	16.4	17.6	14.0	18.2	27.8	221.8	109.0	141.4	169.4	129.5	59.0	60.3	57.8	66.0	200.0	76.3	69.8	68.7	65.8	73.2	88.3	246.0	72.5	156.0	60.3	17.6	47.3	23.9	114.4	125.5	166.2	71.8	76.6	143.5	38.8	51.1	83.3	86.6	132.4	96.8	210.0	110.7	58.6	45.9	132.9	170.0	70.2	61.1	53.8	70.2	21.8	167.7	78.9	51.6	194.9	97.4	101.9	163.7	180.0	267.2	47.6	59.2	134.3	131.3	77.5	106.8	17.0	53.3	279.9	92.1	103.5	88.9	246.2	186.1	42.4	57.3	31.3	164.4	104.5	75.0	54.2
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 78.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 154.3;Early spermatids: 261.1;Excitatory neurons: 315.5;Late spermatids: 355.3;Oligodendrocytes: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	45	"basophil: 29.9"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	8.2	36.6	16.7	8.6	27.6	9.9	9.4	5.7	41.9	7.9	1.0	9.0	10.3	7.0	11.2	5.5	6.4	8.7	11.5	28.5	9.2	16.6	11.1	9.1	16.4	11.9	10.4	5.0	14.3	28.2	11.1	12.2	8.4	8.2	9.2	78.6	7.4	10.8	6.6	5.9	10.2	5.9	6.5	12.2	8.9	22.0	12.2	13.2	16.8	6.7	15.4	10.1	4.5	30.1	9.5	11.6	28.4	9.7	6.1	7.6	12.1	9.6	10.9	16.9	13.1	59.4	9.1	13.6	13.8	8.4	20.2	8.6	19.6	18.7	19.3	29.7	12.2	52.2	11.2	9.9	10.3	11.6	51.0	9.6	11.9	10.4	12.5	16.0	20.4	36.3	20.1	15.9	16.4	11.6	28.8	13.4	10.4	20.1	5.5	23.8	17.2	10.0	32.0	12.2	19.6	7.2	14.4	14.4	62.4	32.2	22.0	18.2	19.2	11.7	14.1	9.0	19.5	17.6	17.9	13.1	11.6	12.6	13.0	29.9	0.3	0.3	0.5	0.4	0.2	0.6	0.5	0.6	0.3	0.3	0.3	0.6	0.2	0.2	0.5	0.5	0.5	0.3	16.7	27.6	5.7	41.9	28.5	9.2	11.9	10.4	8.4	6.5	12.2	30.1	17.8	22.4	6.0	57.8	7.8	5.4	3.8	3.0	5.7	94.4	8.7	5.0	27.4	5.7	5.3	33.1	154.3	3.7	4.3	11.4	1.9	3.9	261.1	8.9	5.8	15.0	28.2	11.8	315.5	6.4	3.5	4.8	5.1	11.9	24.1	17.6	9.3	9.4	8.8	37.0	98.2	10.0	2.0	16.9	6.0	355.3	5.6	11.3	16.0	103.0	7.9	11.2	6.2	104.5	366.6	5.7	8.1	2.6	6.4	5.4	5.1	8.4	9.5	89.9	13.1	5.0	6.9	37.1	11.8	4.1	4.8	6.4	5.5	6.7	10.3	6.6
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722205-65871725	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.8;Excitatory neurons: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.6;intermediate monocyte: 3.4;myeloid DC: 2.2;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.2;monocytes: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		64000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	2.2	1.0	3.8	2.4	3.9	1.5	3.7	2.9	5.3	1.8	1.6	3.6	1.1	2.7	2.4	2.5	1.5	1.2	2.6	3.8	3.6	3.9	9.9	1.7	1.7	3.9	3.4	1.8	2.5	1.5	0.9	2.4	4.0	2.6	3.2	2.5	1.9	1.1	8.9	2.8	2.7	2.7	3.3	1.3	4.0	1.1	3.9	0.9	2.7	6.5	2.0	2.7	1.5	4.8	13.3	12.5	7.2	12.0	9.0	15.3	14.5	13.1	5.5	7.6	8.2	7.2	7.7	18.8	16.1	15.8	15.1	10.3	9.5	20.2	13.1	5.6	6.4	5.2	8.7	18.5	7.7	12.0	3.0	11.7	10.8	10.5	12.4	6.3	21.7	8.3	11.4	3.9	16.5	10.2	8.3	10.8	22.2	6.7	3.6	9.6	15.3	29.9	12.6	5.9	22.3	11.5	10.6	10.7	11.0	19.4	12.9	14.1	12.5	5.0	5.9	7.4	10.0	3.3	7.1	8.2	7.7	23.2	7.7	0.1	2.6	0.1	0.1	3.4	0.1	0.4	0.2	0.1	2.2	0.4	0.3	0.2	0.3	0.5	2.3	0.1	0.0	1.0	3.8	3.9	2.9	5.3	3.8	3.6	3.9	3.4	4.0	3.3	3.9	4.8	5.9	6.4	2.8	19.6	4.0	5.7	9.0	6.2	8.6	2.4	10.1	8.9	14.5	7.2	8.5	12.9	4.2	5.3	0.6	52.8	5.9	17.8	0.3	7.4	12.9	8.3	1.8	9.0	58.9	14.5	14.0	7.1	20.4	20.9	15.2	16.2	4.6	32.4	28.8	5.0	32.2	5.8	6.1	22.9	8.9	0.4	4.4	13.5	1.8	5.6	17.9	13.1	2.1	22.6	44.5	30.2	35.9	2.2	4.9	16.5	32.3	22.4	3.1	4.7	0.0	19.7	8.1	2.1	5.2	15.3	5.3	2.9	2.3	15.8	8.2	6.1
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.5;lymphoid tissue: 13.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 10.3;dendritic cells: 18.8;NK-cells: 37.0;T-cells: 23.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.8;HEL: 8.7;HL-60: 18.6;HMC-1: 9.0;JURKAT: 9.2;NB-4: 19.7;U-698: 28.9;U-937: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	1.0	0.8	0.3	7.8	0.4	4.1	0.7	0.8	0.7	0.9	1.0	1.5	1.7	0.9	0.4	0.8	1.2	1.4	1.5	0.3	0.0	1.3	1.1	2.4	13.6	0.3	0.3	0.7	0.5	0.2	0.9	0.9	0.1	1.1	1.2	1.1	1.1	0.3	1.1	0.5	6.5	0.5	0.0	11.8	2.1	0.9	0.3	11.3	1.5	0.9	11.1	1.5	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	8.8	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.2	8.7	0.1	0.0	0.0	18.6	9.0	0.0	0.0	0.0	0.0	0.5	0.2	9.2	0.2	0.0	0.0	0.4	7.7	19.7	0.0	0.0	0.1	5.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.1	4.9	0.5	0.3	0.1	0.2	0.1	0.4	0.2	28.9	0.2	13.6	0.1	2.9	0.0	0.0	2.3	0.0	2.1	0.8	1.7	2.2	0.0	0.6	1.4	1.5	0.0	2.6	0.0	0.0	2.0	2.1	0.3	0.4	0.8	0.7	0.3	0.0	0.3	0.3	0.1	0.0	0.3	0.1	1.7	3.2	0.0	1.0	10.3	0.0	0.3	0.0	0.0	1.6	0.4	0.3	4.6	1.5	0.6	1.8	4.2	0.0	18.8	0.0	0.0	0.0	4.0	1.3	0.8	2.3	0.0	6.5	3.8	0.0	0.0	0.5	1.5	0.7	2.5	0.2	3.9	0.1	0.1	0.0	3.7	0.0	0.0	1.0	0.0	1.3	0.0	1.1	0.0	1.9	1.3	0.3	37.0	1.0	0.6	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.7	5.1	0.0	0.9	0.7	0.5	0.3	0.0	0.0	0.0	23.8	0.1	0.0	0.3
NLRC4	"CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf"	ENSG00000091106	"NLR family CARD domain containing 4"	Q9NPP4	2	32224453-32265732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.3;lung: 6.2;lymphoid tissue: 11.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 11.9;Kupffer cells: 21.0;Macrophages: 14.5;Microglial cells: 10.3;monocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"classical monocyte: 49.3;intermediate monocyte: 56.9;myeloid DC: 32.2;neutrophil: 24.6;non-classical monocyte: 44.2"	"Group enriched"	"Detected in many"	32	"dendritic cells: 32.2;granulocytes: 24.6;monocytes: 56.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.1"	"Not detected"	"Not detected"							"HPA006592, HPA075894"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA006592: AB_2667620, HPA075894: "	"unprognostic (7.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.33e-2)"	"unprognostic (6.03e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.63e-1)"	3.4	1.4	0.4	8.7	0.5	8.3	0.7	0.4	0.8	0.6	0.6	0.9	0.9	0.4	0.0	0.6	0.8	1.4	1.2	0.4	0.4	0.5	1.6	6.2	2.3	0.6	0.5	0.3	0.8	0.1	0.6	2.1	0.6	0.4	0.8	0.6	0.5	0.2	1.0	0.3	1.3	2.3	0.5	11.4	0.6	0.4	0.9	0.7	0.4	0.3	1.2	2.0	0.3	0.8	0.1	0.2	0.3	0.7	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.3	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.3	0.5	0.1	0.4	0.0	3.1	0.5	0.0	0.3	0.0	1.4	0.4	0.0	0.1	0.3	0.2	0.0	0.0	0.2	1.4	0.1	0.2	0.2	0.1	0.4	0.5	0.0	0.3	0.3	0.7	0.2	0.2	1.2	0.5	0.1	1.4	0.1	0.3	0.3	0.2	0.4	0.3	0.8	1.2	0.4	1.3	0.4	0.5	49.3	5.8	0.1	56.9	0.4	0.6	0.0	0.0	32.2	1.1	0.0	0.1	24.6	0.3	44.2	0.4	0.2	18.6	0.4	0.5	0.4	0.8	0.4	0.4	0.6	0.5	0.6	0.5	0.9	0.8	0.2	0.0	1.8	1.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	4.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	1.1	0.0	11.9	0.0	3.3	0.0	0.0	21.0	1.0	0.0	0.0	14.5	0.0	10.3	18.4	0.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.0
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 918.0;Gastric mucus-secreting cells: 438.3;Plasma cells: 778.5;Squamous epithelial cells: 1490.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	503.5	428.3	308.0	259.5	319.0	329.4	489.1	328.0	379.9	439.2	431.1	409.2	335.1	383.4	236.1	610.6	350.6	187.0	403.9	313.7	338.6	478.1	428.4	339.6	288.9	326.6	320.7	500.1	632.0	201.8	234.9	204.8	321.3	367.7	330.4	63.3	432.4	247.5	545.7	540.3	307.6	286.2	326.8	336.0	403.5	77.8	333.3	190.0	305.3	353.7	289.1	463.5	464.2	333.4	1638.6	2233.9	466.1	913.7	969.3	1399.2	1449.2	1091.7	954.0	1404.8	1053.5	1789.7	792.3	1314.3	1662.9	913.0	706.6	956.2	947.3	1273.3	1035.7	1604.8	3283.2	1120.3	1345.8	2513.4	1116.1	1736.0	760.5	1324.1	1420.0	901.9	1466.4	914.6	860.9	856.5	1541.7	773.7	956.1	2741.9	931.3	2144.8	831.4	2974.6	3364.2	875.9	1731.8	2157.2	1417.9	1800.2	1160.6	641.9	674.1	1472.7	1583.0	806.1	1201.7	1268.5	1013.5	1462.8	1158.2	1135.2	1774.8	1520.9	2176.6	1558.1	815.1	919.1	819.2	66.8	243.4	14.0	166.7	325.5	235.6	338.9	211.9	183.3	439.5	259.2	153.5	170.0	13.8	251.6	282.5	478.1	211.2	298.2	308.0	319.0	328.0	379.9	313.7	338.6	326.6	320.7	321.3	326.8	333.3	333.4	9.7	28.9	67.2	0.0	146.8	14.5	8.3	10.8	918.0	0.9	41.6	35.9	0.0	22.8	85.7	5.5	0.0	10.0	10.1	7.1	37.2	47.4	0.6	16.4	34.3	60.9	14.6	298.2	0.0	34.5	27.8	99.0	438.3	21.3	42.9	6.8	22.9	37.6	16.4	0.0	0.0	19.3	8.2	34.8	17.4	2.1	25.7	136.7	10.6	0.0	55.5	0.4	2.1	0.0	0.0	40.7	15.6	12.8	778.5	7.6	11.7	33.8	63.6	0.8	6.6	10.2	43.3	0.6	5.6	1490.1	14.9	8.8	87.0	6.8	25.0	11.0
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 250.5;Erythroid cells: 311.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 14: REH - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	89.3	136.1	78.3	26.2	75.6	127.7	72.9	73.5	101.5	88.1	77.3	192.9	21.9	79.5	55.7	50.1	89.1	41.2	101.2	76.4	81.7	60.4	175.2	48.3	21.1	88.6	77.9	86.8	43.7	56.7	64.3	30.8	79.8	143.7	23.5	11.1	70.4	81.9	34.7	31.4	59.7	51.9	78.6	43.8	97.7	44.7	80.3	29.3	51.6	27.2	15.8	145.6	64.3	73.6	1.0	305.4	265.6	366.7	104.0	181.0	59.5	143.6	170.4	211.8	180.6	205.4	176.2	3.0	105.8	230.2	76.9	3.9	145.0	153.9	62.0	126.5	218.7	151.9	40.2	279.9	195.7	111.0	53.1	234.7	79.8	130.5	12.8	152.2	137.6	210.7	159.6	25.8	160.4	255.4	98.5	139.2	271.8	76.1	67.8	485.8	59.3	79.0	150.6	1.2	77.7	419.2	36.8	2.7	139.9	97.2	178.3	257.5	174.0	149.7	216.8	101.8	36.8	2.7	2.0	83.1	65.8	19.8	177.2	12.9	13.3	39.8	14.9	11.9	12.7	27.6	14.4	16.3	17.6	29.9	26.0	13.4	4.2	2.5	10.6	58.3	0.9	10.7	78.3	75.6	73.5	101.5	76.4	81.7	88.6	77.9	79.8	78.6	80.3	73.6	52.2	0.0	13.9	18.6	40.6	32.2	56.3	49.0	40.9	15.2	116.6	135.8	44.5	52.9	25.1	58.8	2.1	71.7	45.7	19.3	250.5	116.5	5.0	30.8	113.3	55.3	45.1	311.8	16.8	40.3	26.1	87.3	29.6	59.8	29.9	199.9	55.6	132.2	131.2	8.4	21.1	38.6	26.4	46.5	68.6	21.6	89.2	35.4	62.2	10.3	46.5	45.9	19.6	10.1	3.6	58.3	23.8	94.8	34.5	121.8	9.0	75.5	7.9	5.6	52.6	40.1	105.8	1.7	32.7	38.6	24.6	21.8	26.2	89.4	54.9	60.9
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115175-138139443	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 37.2;testis: 53.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 704.9;Endometrial ciliated cells: 205.8;Late spermatids: 256.5;Respiratory ciliated cells: 431.9;Spermatocytes: 326.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.4	6.5	9.7	0.5	10.5	0.0	4.5	9.2	11.7	8.6	18.6	2.1	0.2	4.9	23.1	1.0	37.2	8.7	3.6	10.5	9.2	20.5	0.5	4.5	0.4	10.5	12.3	5.3	4.4	24.3	8.9	0.1	12.1	5.0	1.1	12.9	3.7	4.5	0.4	0.3	0.6	3.1	9.6	0.2	2.8	53.3	11.0	0.7	12.4	0.6	0.2	2.1	0.6	8.9	0.0	0.0	3.9	4.3	0.0	0.0	0.0	0.7	0.4	0.7	0.3	0.1	1.8	0.0	1.1	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	2.1	0.0	0.9	0.0	3.8	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	29.9	0.0	6.7	2.5	0.0	0.8	4.9	1.7	0.5	1.6	0.0	0.7	0.0	0.0	0.9	0.4	0.8	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.5	9.2	11.7	10.5	9.2	10.5	12.3	12.1	9.6	11.0	8.9	1.0	6.4	7.5	26.8	0.3	0.6	8.5	41.1	0.0	11.7	9.0	7.9	4.3	8.6	38.1	33.1	14.6	0.5	0.1	0.3	86.1	23.8	704.9	205.8	9.2	3.5	5.4	0.0	57.9	4.0	0.0	4.2	2.6	12.7	0.0	7.7	3.6	0.6	0.1	6.7	42.2	3.3	44.7	0.0	0.3	256.5	9.0	1.4	10.6	3.7	0.6	19.1	0.0	11.1	8.1	4.2	0.3	13.9	0.0	4.8	0.2	92.3	431.9	25.8	0.0	0.5	12.6	326.8	24.7	0.0	0.3	0.0	0.8	10.9	1.7	5.9
NME9	"NM23-H9, TXL-2, TXNDC6"	ENSG00000181322	"NME/NM23 family member 9"	Q86XW9	3	138261437-138329886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 14.6;fallopian tube: 17.6"	"Group enriched"	"Detected in some"	6	"Astrocytes: 27.4;Endometrial ciliated cells: 20.0;Excitatory neurons: 26.6;Inhibitory neurons: 17.9;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 36.6;Respiratory ciliated cells: 48.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020943, HPA040000, HPA043881"	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Centriolar satellite"	"CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712"	"unprognostic (2.71e-5)"	"unprognostic (1.68e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.17e-3)"	0.7	0.7	4.1	0.4	4.0	2.9	0.7	8.8	5.5	1.1	14.6	0.6	0.2	0.6	0.7	0.4	17.6	0.4	0.5	3.4	4.1	1.0	0.4	2.2	0.3	6.9	7.0	0.7	1.3	0.9	3.7	0.2	4.2	0.8	0.0	7.4	1.6	0.7	2.7	0.8	0.8	0.2	5.2	0.5	0.6	4.3	5.0	0.5	1.1	0.0	0.2	0.5	0.5	4.4	0.3	0.2	0.4	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.7	0.8	0.1	0.0	1.0	1.7	0.3	0.0	0.0	0.0	0.7	0.0	0.7	0.2	0.4	0.0	0.1	0.1	1.0	0.2	0.1	0.3	0.3	0.0	0.3	0.5	0.9	0.9	0.2	0.6	0.1	0.1	0.3	0.3	0.0	1.1	0.3	0.2	0.3	0.1	0.3	0.4	0.4	0.2	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.4	0.1	0.1	0.1	0.0	0.2	0.2	0.0	4.1	4.0	8.8	5.5	3.4	4.1	6.9	7.0	4.2	5.2	5.0	4.4	0.2	0.0	0.5	27.4	0.0	0.0	0.2	1.1	0.0	1.5	0.1	0.0	1.5	2.8	2.3	1.8	0.0	0.1	0.0	0.0	0.0	0.2	3.1	20.0	0.2	0.3	0.0	0.0	26.6	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.4	0.0	0.0	3.3	17.9	0.0	0.0	0.3	0.0	1.4	0.3	0.0	0.0	1.0	0.0	2.7	0.0	67.8	36.6	0.0	0.0	0.0	0.3	0.2	0.0	0.5	48.4	2.3	0.0	0.5	0.7	5.0	0.7	0.0	0.0	0.3	0.2	0.4	0.0	0.1
NMNAT2	"C1orf15, KIAA0479, PNAT2"	ENSG00000157064	"Nicotinamide nucleotide adenylyltransferase 2"	Q9BZQ4	1	183248237-183418380	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.5;heart muscle: 18.3;pituitary gland: 18.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.3;Excitatory neurons: 195.5;Inhibitory neurons: 265.4;Oligodendrocyte precursor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 26.2;SCLC-21H: 80.6;SuSa: 25.1;U-2197: 45.8;U-87 MG: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015708, HPA061714"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015708: , HPA061714: AB_2732669"	"unprognostic (3.70e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.02e-1)"	8.5	5.9	13.1	0.8	14.8	0.0	5.1	17.2	45.5	2.1	0.0	2.3	0.4	1.2	1.4	0.8	2.3	2.8	18.3	15.6	21.4	0.4	0.0	0.7	0.6	0.7	0.8	0.4	1.7	0.2	18.4	0.9	6.7	0.2	0.9	6.5	0.5	2.5	0.5	0.9	0.9	1.5	0.0	0.1	1.1	8.9	0.8	0.5	6.0	1.4	0.6	0.7	0.8	10.0	1.4	0.5	5.5	0.0	3.1	12.5	4.6	3.4	8.9	1.8	0.6	2.7	5.4	0.0	14.2	0.8	1.5	2.2	0.2	0.1	3.3	0.0	0.1	0.0	2.2	0.0	0.5	0.0	0.1	26.2	1.1	2.1	0.5	11.1	0.5	0.0	0.0	0.1	2.1	0.1	0.0	0.5	9.7	0.1	5.4	0.0	0.2	0.0	5.9	4.5	80.6	6.2	0.7	0.3	0.0	25.1	0.7	1.5	3.0	2.5	0.9	45.8	3.3	0.6	0.0	0.0	35.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	14.8	17.2	45.5	15.6	21.4	0.7	0.8	6.7	0.0	0.8	10.0	21.4	0.0	1.5	3.9	0.0	0.8	0.2	0.6	0.6	12.1	0.2	0.1	35.2	0.0	2.0	0.0	0.0	0.7	0.1	0.1	0.0	0.2	54.3	2.7	0.3	5.2	0.0	0.0	195.5	0.0	12.9	5.7	0.0	7.4	0.0	0.2	0.0	0.0	0.7	20.2	265.4	0.0	4.1	1.0	0.0	42.3	0.0	0.5	1.8	11.2	0.0	0.3	0.0	98.5	6.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	3.4	2.9	19.7	0.3	12.0	0.4	0.2	0.1	0.3	1.4	0.2	0.0	0.0	0.0
NMRK1	"bA235O14.2, C9orf95, FLJ20559, NRK1"	ENSG00000106733	"Nicotinamide riboside kinase 1"	Q9NWW6	9	75060573-75088217	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 68.6;Karpas-707: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049795	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA049795: AB_2680886"	"unprognostic (1.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (3.70e-6)"	"unprognostic (3.56e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.64e-2)"	22.1	11.5	14.6	14.3	15.0	12.6	20.2	17.0	18.9	21.8	15.4	15.3	17.8	11.2	18.5	39.5	16.4	14.1	15.5	15.2	15.4	32.5	53.7	21.7	17.5	14.9	14.8	22.7	45.1	64.1	19.8	14.8	15.2	23.7	13.0	8.8	31.2	13.6	27.2	23.2	22.4	8.8	14.8	31.1	26.0	9.7	14.4	17.3	25.6	13.4	20.0	18.8	25.6	15.2	11.7	2.7	3.2	7.9	21.4	28.0	18.1	17.0	22.4	3.5	5.8	0.1	29.8	6.8	10.0	13.8	7.2	18.5	3.8	9.4	10.0	68.6	3.5	5.1	5.6	5.7	20.3	4.8	0.8	22.5	23.5	6.3	11.8	20.8	25.1	10.8	0.5	79.0	24.6	8.4	4.3	4.3	3.9	40.2	10.0	1.6	29.7	42.1	28.9	19.5	2.2	0.5	7.3	6.4	9.0	19.2	18.4	4.5	20.6	13.5	2.9	12.9	4.6	37.5	31.4	4.1	23.1	4.9	13.8	16.4	5.4	9.3	25.1	5.1	30.5	13.4	43.7	29.2	6.1	9.1	39.4	30.2	9.8	17.2	14.5	17.2	31.6	18.1	14.6	15.0	17.0	18.9	15.2	15.4	14.9	14.8	15.2	14.8	14.4	15.2	42.2	38.5	21.7	11.8	22.6	21.0	36.4	38.2	38.7	8.4	33.4	37.5	15.5	21.5	27.9	23.9	8.4	53.3	43.7	32.8	52.8	30.5	17.8	42.4	16.8	33.4	4.2	10.3	26.2	35.5	75.7	22.7	49.5	37.4	1.3	8.3	55.3	45.2	62.4	11.8	20.6	34.8	22.4	32.5	9.6	30.8	23.6	22.9	26.6	14.0	67.6	15.2	43.3	13.6	23.9	21.5	26.1	12.4	68.8	23.4	83.8	92.1	30.5	8.3	13.1	24.5	15.0	10.7	8.3	50.9	27.0	45.6	48.8	22.2	25.0	32.6
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	44957992-45109016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 344.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		94000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane"	"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.3	31.8	36.2	22.3	37.7	19.5	25.8	30.3	43.4	24.7	27.9	27.8	23.6	26.4	15.7	28.8	27.7	20.3	28.3	38.8	36.4	27.3	39.5	26.5	33.6	35.4	33.7	26.3	22.2	37.8	23.3	36.6	35.0	24.5	29.2	25.7	32.1	27.6	44.6	23.9	26.4	32.9	33.9	28.4	24.5	24.9	37.2	35.2	30.7	47.6	39.5	33.0	23.5	34.9	51.5	88.8	53.7	42.3	82.9	75.0	60.6	41.4	87.6	115.9	101.0	83.9	57.0	54.0	86.2	80.4	78.4	51.5	94.5	92.3	132.9	117.9	73.3	49.0	60.7	84.4	53.7	71.0	62.6	66.4	64.1	79.1	69.2	64.1	87.1	60.9	81.8	38.1	63.1	49.2	76.2	31.7	42.4	151.5	87.8	57.5	67.2	52.2	73.6	78.8	39.2	32.9	33.0	30.2	38.0	112.8	73.1	46.0	50.1	69.9	49.5	55.8	68.1	41.4	61.0	69.9	64.5	44.5	56.4	34.9	49.4	20.0	23.8	33.3	19.9	42.3	19.9	20.1	26.2	31.0	23.7	18.8	26.5	21.1	27.6	115.5	25.7	11.8	36.2	37.7	30.3	43.4	38.8	36.4	35.4	33.7	35.0	33.9	37.2	34.9	50.1	38.5	29.5	49.3	53.8	13.9	15.4	48.8	24.5	97.8	74.1	57.1	46.5	97.2	33.6	69.9	116.7	73.7	87.5	48.7	78.2	69.4	31.1	51.5	63.1	46.4	50.9	72.0	30.3	71.2	61.9	39.6	21.9	62.3	22.8	28.1	85.3	344.4	47.6	129.5	30.7	43.0	28.5	86.5	15.9	12.2	55.0	34.6	10.6	18.7	97.9	41.5	59.8	20.1	19.3	67.9	52.0	51.1	31.0	15.3	84.1	108.1	24.0	123.5	59.2	16.1	46.3	67.6	35.5	20.5	14.1	81.8	40.1	25.4	68.6	18.6
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313536	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 388.9"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 3913.2;Skeletal myocytes: 1639.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 204.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		410000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	130.9	11.4	1.0	25.2	1.1	0.9	91.9	1.4	1.5	36.0	1.9	37.1	1.5	31.0	2.8	15.4	55.0	43.1	35.5	1.3	1.4	24.1	388.9	64.6	9.6	3.9	1.6	21.3	11.4	1.6	10.6	23.8	2.2	31.9	8.7	0.3	21.1	3.1	73.1	49.3	32.2	30.1	1.7	36.7	30.1	2.2	1.2	2.7	33.0	5.3	8.8	48.6	33.9	3.1	0.2	17.6	0.3	18.6	92.0	118.3	0.1	21.2	58.7	35.2	69.2	0.0	17.5	0.2	58.1	45.1	4.2	0.2	0.0	8.0	34.1	0.2	0.0	0.2	16.7	0.0	123.3	0.2	0.0	255.3	89.4	24.1	37.3	29.8	50.1	0.1	0.3	0.2	144.1	0.1	0.1	0.2	0.1	0.0	0.5	0.2	79.0	0.0	479.6	0.1	0.2	0.2	97.7	0.1	0.3	5.3	0.0	0.2	37.4	18.3	34.3	23.8	3.1	0.3	0.3	0.4	6.4	0.3	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	1.1	1.4	1.5	1.3	1.4	3.9	1.6	2.2	1.7	1.2	3.1	411.8	44.8	411.3	1.0	11.2	103.6	13.2	16.5	2.2	1.9	38.5	73.9	4.7	75.8	13.3	80.9	0.0	1.0	1.6	0.0	9.8	238.3	0.3	19.0	89.9	190.0	5.3	147.2	1.3	157.0	2.5	452.2	5.1	80.5	13.9	0.5	195.2	3913.2	28.4	0.0	1.6	0.0	0.0	126.8	142.1	1.6	74.3	9.2	96.0	1.9	5.7	0.0	0.0	0.0	0.2	323.1	0.0	13.2	1.5	10.8	0.0	99.2	11.9	0.2	0.0	1639.1	154.3	0.3	0.8	1.9	92.1	2.2	20.1	0.0	0.0	3.1
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 239.1;tongue: 384.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 344.3;Hepatocytes: 314.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004829, CAB004975"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Cytosol	"CAB004975: AB_425908, HPA004829: AB_1079495"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	26.0	16.5	12.8	11.8	16.0	15.0	13.7	11.2	21.7	16.4	34.9	25.9	17.2	11.0	16.7	16.8	10.7	15.0	137.7	16.1	11.5	57.0	116.4	13.2	16.5	10.3	12.0	10.1	17.8	55.6	9.6	12.7	9.5	18.3	27.8	12.9	26.6	18.2	239.1	10.4	16.1	20.6	9.3	11.5	31.2	6.2	15.8	26.8	31.1	384.0	17.2	17.3	9.3	15.1	15.4	12.6	30.5	59.6	44.0	50.3	9.9	17.5	39.8	24.8	20.8	19.0	30.4	18.5	21.5	43.9	22.3	16.6	120.5	5.4	27.4	31.1	33.6	24.0	70.7	23.8	27.5	50.2	43.1	37.9	17.5	16.3	18.6	42.6	56.3	22.7	21.4	81.3	60.0	15.1	55.8	35.8	6.4	0.1	15.2	54.7	73.8	70.8	58.0	15.5	44.2	37.7	62.9	1.4	46.7	6.9	47.7	58.3	23.2	29.5	28.3	12.0	8.3	36.1	45.1	26.5	7.1	68.8	22.1	12.5	18.2	16.0	16.7	23.0	17.1	12.0	17.1	15.5	32.0	12.0	15.5	14.7	2.9	23.2	24.7	9.1	22.2	19.3	12.8	16.0	11.2	21.7	16.1	11.5	10.3	12.0	9.5	9.3	15.8	15.1	12.0	54.5	37.8	60.7	19.6	11.5	9.5	19.0	13.1	17.9	9.6	6.3	344.3	38.6	27.0	27.6	35.5	8.7	20.4	34.4	27.4	14.4	16.7	18.5	16.6	19.2	19.9	34.9	124.8	10.7	2.3	27.2	23.9	25.1	25.2	26.8	21.0	314.3	25.0	6.7	110.6	22.6	20.3	40.6	11.9	4.6	14.9	19.8	14.2	45.9	25.9	12.5	35.0	77.9	63.4	9.5	16.7	19.2	20.0	11.7	23.6	21.7	18.1	12.8	0.0	14.0	20.1	4.0	1.4	17.6	8.1	2.1	20.9	18.8	28.9	9.9
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944203-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044258: AB_10961284, HPA062195: AB_2684707"	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	26.7	23.6	17.1	23.0	17.1	30.1	26.4	16.8	21.2	29.5	14.3	28.0	17.9	30.3	10.3	47.3	27.7	14.1	32.8	18.1	18.5	27.1	33.7	23.6	23.1	18.5	17.0	26.0	35.6	21.2	24.4	15.8	19.5	26.8	11.6	9.6	26.5	16.0	73.0	45.0	25.2	15.0	15.1	28.0	28.4	36.0	17.6	20.1	24.3	26.4	15.9	32.7	31.7	18.5	112.8	110.4	19.8	129.5	34.5	31.0	70.2	82.3	38.9	114.4	62.1	148.5	110.5	126.3	113.3	56.0	94.0	102.2	147.6	122.8	49.2	79.2	161.5	67.0	141.2	132.0	77.4	151.1	63.8	50.3	35.0	125.3	84.3	35.3	56.4	44.6	190.8	58.2	51.6	182.1	98.7	92.6	112.0	82.3	128.8	120.0	81.5	155.9	53.6	47.4	136.0	133.0	109.3	166.3	105.1	30.3	74.8	81.1	64.1	68.3	95.9	75.2	143.0	97.6	112.5	225.7	84.3	209.1	57.7	21.3	30.9	22.2	23.9	46.4	31.3	23.9	23.3	23.4	36.8	19.3	23.3	18.6	2.8	34.5	57.5	23.6	19.9	31.7	17.1	17.1	16.8	21.2	18.1	18.5	18.5	17.0	19.5	15.1	17.6	18.5	21.5	16.0	23.1	12.4	42.7	69.3	90.8	42.9	47.8	54.6	33.4	34.7	4.5	28.6	29.8	36.8	62.6	63.7	24.7	27.4	17.6	49.9	10.2	34.8	40.9	27.8	30.0	23.8	12.6	46.2	65.5	29.9	28.1	36.9	13.9	36.4	24.7	24.0	39.6	45.4	12.4	27.6	36.7	24.6	29.2	10.3	29.5	24.4	24.9	12.2	35.7	20.6	60.8	9.5	10.6	39.2	21.4	21.4	42.6	71.9	22.9	19.6	27.1	77.0	32.9	41.2	34.6	43.0	83.9	47.4	82.0	58.8	36.6	51.8	53.1	69.3
NOC4L	"MGC3162, NET49, Noc4, UTP19"	ENSG00000184967	"Nucleolar complex associated 4 homolog"	Q9BVI4	12	132144457-132152473	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.6;Late spermatids: 80.3;Spermatogonia: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053424			Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA053424: AB_2682147"	"unprognostic (9.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.79e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	12.6	11.5	2.0	3.3	2.0	6.1	12.8	1.9	3.1	13.1	1.5	11.1	4.2	12.6	1.6	13.8	11.9	1.9	10.8	2.6	2.2	13.2	13.4	10.5	3.6	2.4	1.9	14.4	13.6	2.4	11.3	2.7	2.1	11.1	1.8	0.8	11.5	2.2	24.3	15.6	11.3	1.8	1.5	13.5	12.3	33.2	2.0	3.5	11.7	3.2	2.3	11.4	11.2	2.7	14.4	26.0	5.7	9.0	2.8	3.0	29.0	9.7	5.0	12.0	6.5	21.4	6.7	21.8	10.4	5.0	7.1	12.7	10.2	10.7	2.5	8.7	28.3	14.7	8.8	14.4	7.6	17.3	16.5	4.3	7.2	9.2	7.3	4.5	8.3	16.8	25.4	4.9	4.8	17.1	16.6	40.6	16.7	8.6	20.7	21.2	6.3	19.5	6.3	10.6	13.9	11.0	8.2	11.1	7.5	3.3	15.6	10.7	11.1	7.0	17.7	11.3	16.5	12.4	8.2	19.1	10.6	14.8	15.0	1.6	8.4	4.3	7.5	11.7	7.2	9.1	6.9	7.5	11.1	10.7	5.9	5.7	1.2	5.8	9.1	13.1	6.2	5.9	2.0	2.0	1.9	3.1	2.6	2.2	2.4	1.9	2.1	1.5	2.0	2.7	10.9	9.6	9.1	2.3	15.5	22.3	15.6	20.6	12.0	8.2	11.5	12.1	8.0	20.0	12.4	3.7	0.0	32.3	15.5	15.6	7.9	35.5	72.6	12.1	8.4	13.6	7.3	7.8	2.2	32.9	33.9	14.6	15.3	11.1	15.9	15.8	10.4	11.6	24.9	8.4	2.0	14.5	24.4	11.0	15.8	80.3	14.6	13.2	14.2	1.9	14.5	8.3	6.2	1.5	3.1	28.0	11.2	7.9	12.0	15.4	19.2	21.7	6.2	6.2	19.7	14.2	15.0	37.1	77.1	11.2	21.6	30.5	13.6	24.4	22.7	15.0
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	1.5	0.5	0.5	5.9	0.2	13.6	1.5	0.2	1.0	5.6	0.7	0.9	1.5	0.6	0.3	11.7	0.9	1.3	0.7	0.2	0.4	0.6	1.7	4.3	2.7	1.0	0.9	0.4	0.3	0.2	0.4	1.2	0.7	0.9	0.9	0.0	4.3	0.4	0.6	14.4	1.3	1.8	0.7	4.4	1.4	0.5	1.4	0.8	0.4	0.3	2.3	1.6	12.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.0	5.8	7.3	0.0	0.0	0.0	0.0	0.0	15.9	7.2	0.0	0.3	0.1	0.0	3.0	23.0	6.0	0.4	13.1	0.7	0.1	1.3	1.4	21.3	0.0	0.1	0.5	10.5	3.4	9.0	1.0	0.9	11.1	0.5	0.2	0.2	1.0	0.2	0.4	1.0	0.9	0.7	0.7	1.4	0.8	0.2	0.0	3.7	0.0	1.9	5.9	0.3	1.2	0.0	0.0	1.4	1.1	0.4	1.5	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	5.6	0.8	0.6	1.2	0.8	0.1	0.0	0.0	0.4	0.0	8.3	1.3	0.5	0.0	0.5	2.5	0.0	0.1	0.0	2.0	9.0	22.5	0.0	0.0	15.2	1.8	1.9	15.6	0.0	1.0	0.0	0.2	0.0	0.0	0.4	4.3	0.4	0.0	0.1	1.0	0.0	0.0	0.1	0.4	0.1	0.4	6.1	15.5	0.3	2.3	0.1	0.1	0.3
NOL12	"MGC3731, Nop25, RRP17"	ENSG00000273899	"Nucleolar protein 12"	Q9UGY1	22	37681673-37693476	"Predicted intracellular proteins"		"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003547	Uncertain		Approved	"Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Mitotic chromosome"	"Nucleoplasm, Vesicles"	"HPA003547: AB_10602012"	"unprognostic (3.37e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (2.65e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.23e-3)"	"prognostic favorable (9.41e-4)"	"unprognostic (9.96e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.56e-6)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (3.24e-4)"	17.1	29.2	11.3	15.1	12.7	28.7	17.5	12.1	18.0	20.5	9.6	21.3	14.9	15.5	7.9	35.1	16.2	9.0	18.6	11.8	12.3	22.0	16.2	14.3	20.9	12.3	11.8	18.5	17.5	11.5	16.5	8.1	12.1	19.8	9.5	4.9	20.5	4.4	12.6	22.7	19.5	6.6	11.2	26.5	18.8	10.4	11.8	16.1	23.1	8.2	12.6	17.1	23.3	12.9	38.3	33.5	24.4	29.5	8.1	7.8	32.2	17.1	7.7	7.4	8.4	20.0	15.7	30.2	9.8	6.2	8.1	41.4	11.6	50.0	2.2	34.4	51.9	26.3	28.9	43.6	21.3	59.3	38.2	9.6	12.4	31.2	11.7	10.0	15.3	16.7	19.8	26.9	6.8	32.3	36.4	48.0	29.5	16.6	46.7	48.5	16.7	24.7	18.2	10.1	19.2	40.3	22.1	19.5	30.8	2.7	26.9	31.0	22.9	34.2	32.5	24.8	34.5	24.0	29.9	41.0	33.3	46.2	40.0	57.3	24.4	26.9	15.1	28.4	11.7	14.1	14.8	13.6	17.6	15.8	14.8	12.6	53.1	16.7	33.8	13.6	22.3	11.9	11.3	12.7	12.1	18.0	11.8	12.3	12.3	11.8	12.1	11.2	11.8	12.9	10.9	3.2	15.3	4.9	15.3	39.0	13.7	33.0	25.0	11.0	10.2	7.7	3.5	7.2	20.3	14.7	6.2	19.4	11.0	35.6	3.9	25.7	105.7	5.4	5.0	12.9	12.6	8.8	11.4	29.1	16.2	10.2	15.8	4.7	15.2	9.7	10.8	6.2	13.9	28.6	10.9	24.8	20.3	10.7	21.8	48.3	9.9	12.7	21.4	2.8	17.7	13.8	18.6	5.5	8.2	22.4	39.9	11.3	14.0	8.6	27.4	7.8	15.9	8.3	13.1	10.0	10.6	14.5	25.9	45.4	39.8	19.8	14.3	9.7	24.1	14.5
NOL3	"ARC, CARD2, MYP, NOP30"	ENSG00000140939	"Nucleolar protein 3"	O60936	16	67170154-67175735	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009208	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"CAB009208: AB_634091"	"unprognostic (2.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (5.74e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.48e-2)"	34.4	77.5	36.1	3.8	37.1	0.7	35.4	36.7	36.2	37.1	30.7	32.5	6.7	27.8	11.4	48.6	35.4	10.2	99.3	32.9	35.0	33.0	52.0	28.9	3.1	43.9	36.2	29.3	50.6	37.7	60.2	11.6	39.6	70.1	7.6	28.6	51.1	13.8	142.2	79.2	18.1	8.0	35.4	15.9	28.2	7.6	36.9	2.8	35.6	97.5	4.1	38.7	39.8	38.1	14.9	23.9	3.9	22.1	19.2	14.5	22.0	11.8	12.5	12.6	7.4	5.2	38.2	0.3	38.0	13.8	3.3	24.3	5.4	18.3	3.0	13.4	8.3	0.6	19.8	7.8	12.0	1.3	2.9	8.9	33.1	9.9	7.0	35.9	5.3	5.2	5.5	15.3	24.0	38.7	0.3	1.9	3.7	13.5	58.1	13.3	8.3	29.8	21.5	4.5	31.1	16.6	49.5	35.3	5.7	5.1	75.5	4.0	12.4	16.5	14.1	16.3	10.3	22.1	7.5	4.2	46.4	3.7	5.7	0.0	3.5	0.0	0.1	0.3	0.0	0.0	1.7	0.1	1.1	0.0	0.0	0.2	0.8	0.4	0.1	1.1	0.0	1.3	36.1	37.1	36.7	36.2	32.9	35.0	43.9	36.2	39.6	35.4	36.9	38.1	5.1	28.9	33.6	19.2	2.7	13.8	27.6	70.6	21.6	18.5	29.3	32.6	51.2	35.8	28.8	3.7	16.7	8.1	0.8	18.2	15.6	61.3	1.2	8.6	14.0	10.1	22.3	0.0	5.0	34.7	11.3	13.8	11.2	16.4	2.5	7.6	13.2	30.9	11.4	55.5	7.6	23.7	38.7	4.1	4.5	0.7	25.1	3.4	21.4	4.7	14.6	36.3	1.0	4.0	11.3	44.2	11.4	30.1	10.4	28.5	15.5	26.2	21.3	47.9	13.1	38.7	32.3	0.3	1.2	16.4	19.7	11.1	3.2	3.6	16.4	31.6
NOL4	"CT125, HRIHFB2255, NOLP"	ENSG00000101746	"Nucleolar protein 4"	O94818	18	33851100-34224952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 11.8;pituitary gland: 8.0;retina: 6.3;testis: 12.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 133.9;Early spermatids: 268.1;Excitatory neurons: 195.6;Inhibitory neurons: 207.7;Late spermatids: 95.7;Oligodendrocyte precursor cells: 326.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 36.0;SH-SY5Y: 9.5;U-698: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046740			Supported	Nucleoplasm		No	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA046740: AB_10960527"	"unprognostic (7.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.43e-7)"	"unprognostic (5.76e-2)"		"unprognostic (1.56e-2)"	"unprognostic (7.19e-2)"		"unprognostic (3.45e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.77e-2)"	"unprognostic (7.71e-2)"	0.0	1.8	6.1	0.1	7.2	0.0	0.1	7.6	7.8	0.5	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.1	8.2	11.6	0.7	2.2	0.2	0.2	0.8	4.1	0.0	1.7	0.0	8.0	0.0	1.0	0.3	0.7	6.3	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.7	12.6	11.8	0.0	1.6	0.0	0.2	0.5	0.0	3.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.2	0.1	0.0	0.0	0.0	36.0	9.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	7.2	7.6	7.8	8.2	11.6	0.8	4.1	1.0	2.5	11.8	3.4	0.0	0.0	0.0	133.9	0.0	0.0	0.0	0.0	0.0	17.0	0.5	1.0	0.6	0.0	0.0	0.0	2.1	0.2	0.0	0.4	1.9	0.0	268.1	0.0	0.0	0.5	73.8	0.0	195.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.1	32.0	207.7	0.2	0.0	0.0	0.0	95.7	2.5	0.1	0.0	22.5	0.0	11.6	0.0	326.8	4.5	0.1	0.1	2.2	0.0	0.0	0.0	5.3	0.0	2.1	0.0	0.0	0.0	10.9	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615335-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	44.3	43.9	29.5	21.7	30.8	29.5	42.0	32.2	34.0	37.5	28.2	44.8	26.8	37.7	23.4	38.2	35.5	16.6	48.2	28.7	31.1	58.5	37.9	32.2	25.8	30.9	31.4	40.7	48.9	40.2	35.9	21.1	31.0	35.1	19.8	16.6	38.0	19.2	44.5	36.9	36.4	16.0	30.8	37.8	37.9	41.7	30.7	15.2	37.1	17.1	20.3	41.4	34.9	33.8	71.7	37.2	31.7	42.7	26.9	26.1	74.4	71.8	29.3	48.4	44.4	60.0	24.9	97.8	137.4	34.4	57.7	46.5	46.9	42.4	47.8	57.5	105.0	91.2	36.3	104.0	45.4	112.0	61.4	25.5	41.5	42.5	24.2	29.8	33.6	45.5	135.7	22.2	44.7	38.1	70.6	147.6	42.1	37.0	74.1	74.4	46.8	140.5	57.9	21.7	92.5	60.3	40.9	88.0	94.9	36.2	53.6	42.8	65.7	48.0	51.9	57.8	108.3	66.2	123.2	100.2	30.7	70.7	75.6	34.5	59.6	82.1	59.2	76.4	68.2	104.0	84.7	71.4	73.2	87.8	90.7	69.0	27.4	61.9	82.9	91.4	96.0	67.9	29.5	30.8	32.2	34.0	28.7	31.1	30.9	31.4	31.0	30.8	30.7	33.8	103.1	93.0	73.5	10.4	112.5	90.8	117.3	151.0	50.1	62.1	78.9	97.0	214.9	68.6	112.0	57.0	22.9	137.4	71.5	72.7	123.3	188.7	202.3	105.8	95.0	109.2	37.1	89.4	14.0	261.2	153.8	90.9	58.1	91.6	90.6	67.0	61.1	61.8	115.1	48.8	17.1	97.8	130.2	52.6	81.8	38.9	82.6	78.5	101.4	8.4	119.7	124.2	78.2	13.6	19.0	175.0	94.3	79.4	138.8	121.7	81.2	163.6	135.6	61.7	65.7	92.5	119.4	186.3	112.9	70.8	90.5	155.3	99.5	99.2	91.0	117.2
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Mitotic chromosome"	"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	8.6	5.8	4.2	8.0	5.8	6.8	10.0	5.0	5.3	8.2	5.2	8.6	6.0	9.8	7.4	8.7	7.4	6.5	6.8	4.1	5.3	7.2	5.5	6.9	12.0	5.6	5.4	11.2	7.1	12.6	3.2	7.6	5.6	7.4	8.3	5.8	7.8	8.5	6.3	7.2	5.9	9.9	4.6	9.8	6.2	6.1	6.0	12.6	10.5	6.2	12.6	8.6	5.1	7.1	18.9	27.1	13.4	24.2	28.5	24.3	19.8	19.7	14.9	20.9	18.7	11.2	18.5	54.2	16.3	20.1	33.8	39.9	43.5	25.8	22.3	36.3	21.4	37.1	25.9	22.4	20.3	63.2	30.5	24.0	23.5	22.0	31.6	16.7	23.7	16.3	60.7	17.1	22.5	29.7	42.7	24.8	21.4	28.4	26.8	29.8	37.9	23.0	10.6	13.4	23.0	12.3	25.3	25.1	18.0	17.3	9.5	21.2	24.9	18.3	14.0	26.7	25.0	17.7	37.5	26.7	18.5	37.4	26.6	18.9	8.3	11.3	11.4	10.8	15.8	13.0	11.3	11.8	12.1	12.9	13.3	11.7	3.1	13.2	15.7	10.2	13.8	7.1	4.2	5.8	5.0	5.3	4.1	5.3	5.6	5.4	5.6	4.6	6.0	7.1	25.4	19.2	33.4	15.7	33.8	13.0	18.4	15.3	21.1	17.9	14.7	20.6	28.4	14.3	19.8	11.0	10.4	19.5	37.7	10.1	15.6	23.5	13.9	17.9	46.2	23.9	9.0	37.6	12.1	12.9	20.1	25.8	23.9	20.8	52.4	30.6	16.1	11.5	26.5	28.6	12.5	16.9	6.1	17.7	12.1	9.4	32.0	23.9	10.6	18.7	34.5	12.4	43.3	15.6	25.9	16.1	11.2	23.7	36.5	23.3	10.3	15.8	21.2	17.7	6.6	29.3	21.5	73.3	50.2	25.4	15.9	14.6	30.1	33.4	20.3	12.2
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554513	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoli	"Intermediate filaments"	"HPA036347: AB_2675076"	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	3.8	4.6	4.5	3.5	5.0	7.5	3.7	4.9	5.6	4.7	1.9	5.0	2.4	5.0	3.6	4.7	4.3	2.3	4.5	6.2	4.2	4.4	5.3	3.2	5.2	3.3	3.8	4.8	6.0	3.4	4.0	3.0	3.8	4.1	3.1	4.3	3.6	3.1	7.0	6.0	4.8	3.9	2.7	8.8	4.5	3.7	4.6	3.8	3.4	4.5	5.1	4.5	3.8	4.0	6.4	9.1	5.0	15.2	6.6	4.0	5.4	6.3	4.1	6.4	6.8	12.6	8.6	17.9	7.3	7.1	5.5	8.3	10.2	8.6	10.9	7.3	5.5	12.2	14.7	9.9	6.6	10.4	6.4	5.8	2.6	13.6	11.8	3.7	7.6	7.8	14.3	7.3	6.6	11.2	10.2	9.2	6.9	5.0	8.7	12.7	11.7	8.3	5.1	5.8	9.7	4.4	9.7	12.1	8.1	5.1	7.9	4.8	10.0	10.1	8.1	7.2	10.6	6.1	6.2	31.9	9.4	11.4	4.9	3.5	1.9	1.6	3.1	1.9	3.2	2.9	4.5	2.9	1.3	3.7	4.6	3.8	1.2	1.7	3.2	3.5	3.2	1.2	4.5	5.0	4.9	5.6	6.2	4.2	3.3	3.8	3.8	2.7	4.6	4.0	15.0	19.2	19.5	9.4	16.2	15.4	6.9	6.9	10.8	17.1	9.8	13.2	15.0	11.5	7.4	7.3	14.6	14.8	17.3	6.7	15.6	8.9	6.0	13.7	19.7	15.2	6.7	11.6	18.9	8.6	12.6	15.3	11.7	15.6	5.1	18.3	14.3	13.2	9.1	10.1	18.5	10.9	4.1	13.8	7.3	17.0	9.6	8.6	1.8	10.3	13.4	8.1	12.3	13.0	20.1	9.0	6.2	12.8	17.9	7.3	7.6	10.7	9.0	18.2	0.0	22.6	12.7	11.7	21.5	16.0	14.8	12.7	17.3	19.1	13.2	7.3
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71254814-71301522	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"		NA	NA		450000	"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	106.4	147.2	58.6	96.4	57.7	115.3	109.2	71.5	64.9	116.8	64.4	101.3	86.2	130.2	107.9	111.9	115.4	100.7	81.2	55.3	69.9	103.3	121.5	103.2	136.5	60.3	61.5	197.9	164.8	114.8	97.1	99.1	60.5	97.0	101.2	70.2	106.8	89.6	99.1	112.2	102.0	113.5	59.2	109.5	114.3	55.2	68.5	255.5	116.0	86.1	165.2	116.8	102.6	61.0	421.2	539.7	595.3	344.4	251.2	238.5	345.3	330.9	319.2	459.3	388.5	413.4	312.9	481.4	379.9	320.5	309.7	310.5	949.5	299.4	488.1	383.9	605.7	394.8	498.4	398.0	212.3	547.7	338.7	272.0	206.0	473.1	305.7	370.5	382.0	342.1	535.3	509.0	406.2	413.9	756.0	466.8	771.3	433.9	365.2	660.0	657.3	414.0	345.9	426.1	431.7	519.4	467.8	299.1	392.5	354.9	271.4	354.0	343.9	268.0	438.6	402.9	400.1	297.3	503.2	516.0	216.8	627.1	433.8	107.5	117.3	91.1	107.9	120.0	119.9	107.4	107.9	106.4	118.7	107.2	115.1	115.6	50.8	119.6	140.7	101.1	128.0	178.1	58.6	57.7	71.5	64.9	55.3	69.9	60.3	61.5	60.5	59.2	68.5	61.0	72.9	76.9	81.1	16.3	97.2	126.3	99.9	105.8	116.7	62.3	111.4	83.6	63.5	90.1	99.8	44.1	41.7	132.3	103.6	52.0	56.7	147.8	11.8	81.6	137.8	95.4	139.8	144.6	16.2	111.4	179.9	93.9	71.4	104.8	88.0	135.9	83.9	128.3	112.6	53.8	20.7	105.6	95.6	153.2	107.7	15.9	106.6	95.0	56.9	13.1	132.0	84.8	96.8	19.6	22.8	110.7	75.4	127.9	115.2	94.9	89.0	121.0	71.1	50.3	65.7	78.7	127.8	45.7	66.5	137.3	122.3	130.1	108.5	163.7	117.2	103.0
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040119	Supported		Enhanced	Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	28.4	22.6	14.6	22.6	15.1	34.6	19.8	15.2	18.5	20.5	14.7	20.8	14.2	20.8	10.2	28.6	21.2	10.9	18.8	15.0	15.1	21.7	26.7	20.6	28.3	14.9	14.6	20.2	21.6	9.9	21.2	12.2	15.0	25.0	14.2	6.6	19.2	8.6	42.2	25.7	24.5	14.7	14.4	32.3	20.6	23.1	15.3	22.8	23.5	12.2	28.7	21.7	21.0	15.4	69.0	107.2	29.5	101.8	37.4	32.1	159.8	61.4	40.4	71.8	61.6	130.5	69.0	144.7	16.7	30.8	75.5	84.9	113.9	69.6	68.0	175.3	105.2	143.7	110.8	78.5	49.0	141.2	79.9	33.0	67.3	87.9	135.8	31.3	50.2	76.9	102.7	22.8	58.1	83.7	77.1	124.7	247.6	93.6	59.9	108.4	84.1	72.8	53.1	92.1	22.7	44.5	94.1	102.5	50.2	116.2	17.1	70.4	47.6	49.1	64.1	63.7	143.2	31.2	49.7	217.9	45.0	81.3	88.6	2.4	14.0	1.5	23.6	19.5	32.7	21.0	22.4	27.1	28.7	15.8	27.2	28.2	5.1	22.2	19.0	24.8	16.8	19.9	14.6	15.1	15.2	18.5	15.0	15.1	14.9	14.6	15.0	14.4	15.3	15.4	3.9	12.8	6.8	7.8	20.5	23.8	17.7	12.9	47.8	5.8	6.0	4.4	6.8	5.7	6.4	3.7	2.1	12.6	6.6	13.1	1.9	12.0	17.9	4.2	4.4	11.4	7.2	19.4	9.1	11.8	13.4	10.3	26.0	4.3	7.6	1.4	7.9	8.3	11.8	6.7	7.3	11.1	16.2	7.7	15.7	7.3	9.3	11.7	8.8	2.8	7.7	3.0	18.6	5.5	5.7	13.5	5.3	4.9	19.2	19.2	2.1	1.3	5.2	2.9	13.1	22.7	9.7	11.3	21.4	43.4	21.3	7.3	16.2	1.2	16.4	16.7
NOP53	"GLTSCR2, PICT-1, PICT1"	ENSG00000105373	"NOP53 ribosome biogenesis factor"	Q9NZM5	19	47745546-47757058	"Predicted intracellular proteins"	"Host-virus interaction, Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 605.5;Breast myoepithelial cells: 415.5;Cytotrophoblasts: 454.3;Exocrine glandular cells: 989.2;Extravillous trophoblasts: 570.3;Syncytiotrophoblasts: 506.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 311.8;NK-cells: 96.7;T-cells: 244.1"	"Cell line enhanced"	"Detected in all"		"NB-4: 1305.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018999, HPA049600"	Approved		Supported	Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli		"HPA018999: AB_1849733, HPA049600: AB_2680831"	"unprognostic (2.08e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	400.7	245.3	101.7	175.2	105.0	242.1	420.4	97.4	125.9	589.9	106.6	440.5	185.0	405.7	77.3	320.0	424.5	39.4	273.8	93.6	99.7	259.3	224.7	219.1	213.6	114.7	103.5	790.1	1016.5	123.0	201.7	78.4	105.4	386.3	64.1	70.2	397.0	104.5	308.6	635.8	333.6	60.1	108.4	358.9	445.3	116.5	107.3	225.3	302.8	110.0	128.3	411.8	422.5	105.6	99.7	103.0	90.7	214.6	110.6	184.2	176.8	60.6	110.5	57.8	85.3	95.5	194.8	440.3	87.0	71.2	44.2	139.8	52.9	88.8	30.2	133.0	177.8	142.6	85.1	113.5	163.0	207.4	271.6	162.5	198.9	50.8	136.1	188.0	92.3	183.1	176.8	206.5	52.3	86.9	577.2	1305.4	209.4	173.4	60.0	380.4	160.8	209.8	112.6	151.9	96.8	340.9	50.6	330.7	330.0	65.8	156.2	493.7	114.4	56.4	150.2	49.2	125.8	306.3	290.6	120.9	71.2	145.4	92.4	21.5	23.3	26.3	55.3	35.3	74.5	311.8	108.2	96.0	33.1	238.5	244.1	108.6	3.3	96.7	25.1	41.6	120.0	15.8	101.7	105.0	97.4	125.9	93.6	99.7	114.7	103.5	105.4	108.4	107.3	105.6	229.4	41.7	120.7	0.0	210.4	0.0	0.0	0.0	0.0	0.0	605.5	415.5	0.0	0.0	69.3	104.8	0.0	454.3	224.1	0.0	266.1	266.5	0.0	100.6	156.9	94.5	0.0	0.0	0.0	989.2	570.3	107.2	0.0	115.5	68.1	268.3	0.0	0.0	259.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.1	0.0	0.0	269.8	0.0	0.0	0.0	0.0	348.1	0.0	0.0	61.8	0.0	0.0	369.7	18.2	0.0	0.0	0.0	108.6	0.0	0.0	0.0	0.0	506.8	131.3	226.3	0.0	0.0
NOP9	C14orf21	ENSG00000196943	"NOP9 nucleolar protein"	Q86U38	14	24299850-24309124	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000850			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA000850: AB_1078287"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (9.39e-6)"	"unprognostic (7.03e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	9.9	13.0	6.3	5.5	6.7	7.0	9.3	6.2	6.1	8.6	4.6	11.1	7.8	9.9	3.5	16.1	9.5	3.3	13.2	5.8	6.3	8.6	13.8	8.7	6.2	6.7	6.5	11.7	12.6	6.7	7.9	4.1	6.4	9.0	5.5	7.4	10.6	4.4	27.2	12.6	11.4	4.9	6.9	17.3	10.6	7.7	6.8	5.9	8.6	11.2	6.7	9.8	9.3	6.3	6.5	12.8	10.2	12.8	8.7	7.3	9.8	11.4	8.5	13.2	10.2	9.7	11.3	16.7	6.3	10.5	10.7	16.6	20.4	14.2	13.7	10.6	7.8	12.3	18.3	22.4	7.0	28.4	13.5	7.4	10.9	9.7	8.9	7.0	12.4	9.3	10.6	8.0	9.3	11.3	13.2	10.7	4.6	22.9	16.2	16.0	6.1	10.6	8.1	14.8	10.2	7.8	16.1	18.4	3.5	7.3	6.9	7.4	12.8	8.7	7.2	6.9	10.9	11.1	10.6	12.2	4.8	12.7	7.1	0.3	0.6	0.5	0.4	0.7	0.4	0.3	0.3	0.2	0.5	0.4	0.2	0.2	0.1	0.1	1.2	0.3	0.3	0.4	6.3	6.7	6.2	6.1	5.8	6.3	6.7	6.5	6.4	6.9	6.8	6.3	4.0	3.2	3.3	2.6	6.2	12.5	3.2	4.9	6.2	8.1	5.3	3.9	1.2	7.2	8.5	9.2	8.4	6.3	6.7	15.2	0.0	7.3	3.1	5.2	4.8	5.6	10.7	9.9	3.6	10.3	5.8	4.5	6.1	5.0	1.3	9.6	6.1	18.1	7.3	6.7	4.3	7.6	0.0	10.7	6.3	1.3	6.5	5.8	0.0	1.0	7.6	5.5	2.1	3.0	5.0	11.6	8.5	4.5	5.5	5.2	12.5	6.6	7.7	8.0	6.6	5.4	5.4	4.6	5.7	8.1	13.5	6.4	4.9	5.5	14.3	4.6
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"placenta: 135.7"	"Cell type enriched"	"Detected in some"	45	"Extravillous trophoblasts: 1002.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 48.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 428.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		1900000		"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.0	0.1	1.6	0.0	1.9	0.0	0.2	0.6	1.8	0.2	0.1	0.0	1.1	2.1	0.3	0.3	0.4	0.2	0.3	1.0	1.0	1.2	10.0	2.2	0.0	1.7	2.7	0.1	0.4	0.9	0.2	135.7	1.3	0.3	0.0	0.0	0.6	0.1	8.2	2.2	0.3	0.1	0.9	0.2	2.1	2.8	1.3	0.0	0.0	0.5	0.0	1.4	0.2	0.8	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	10.0	0.4	0.0	1.8	0.3	0.2	0.4	2.4	0.0	0.0	0.1	1.1	2.2	2.8	428.6	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.2	11.2	0.0	0.0	0.6	0.0	0.2	0.1	67.9	0.4	0.0	0.2	0.1	0.0	0.2	15.7	1.6	4.2	1.7	6.2	2.3	0.1	4.9	0.0	0.5	6.3	0.0	0.2	0.1	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.6	1.8	1.0	1.0	1.7	2.7	1.3	0.9	1.3	0.8	0.0	0.0	3.7	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.6	1.3	1.2	0.0	0.0	0.0	0.0	10.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.6	0.0	1002.5	1.2	1.5	0.3	0.0	0.1	0.0	3.6	18.4	0.0	1.1	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.5	12.7	0.0	0.0	22.0	0.1	0.0	0.3	0.0
NOVA2	"ANOVA, NOVA-2, NOVA3"	ENSG00000104967	"NOVA alternative splicing regulator 2"	Q9UNW9	19	45933734-45974044	"Human disease related genes, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 39.4;Bipolar cells: 56.7;Endothelial cells: 32.0;Excitatory neurons: 21.8;Hepatic stellate cells: 42.5;Horizontal cells: 21.9;Inhibitory neurons: 20.9"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HDLM-2: 11.0;HUVEC TERT2: 16.9;SH-SY5Y: 5.6;TIME: 25.8;U-2 OS: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045607	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"HPA045607: AB_10962628"	"unprognostic (9.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.42e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.31e-2)"	6.7	1.9	12.4	0.7	15.1	0.0	5.7	0.5	16.7	3.2	0.0	1.8	0.6	3.4	0.6	1.4	2.9	1.4	6.7	16.0	5.8	4.7	1.0	9.3	0.5	4.6	3.0	1.2	1.1	1.0	6.2	3.9	3.6	2.3	0.5	5.6	1.1	0.8	2.3	1.1	1.7	2.0	0.6	1.5	1.5	2.0	4.6	0.4	4.5	2.5	0.2	2.5	2.0	9.8	0.0	0.1	9.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	1.3	0.0	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	5.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	15.1	0.5	16.7	16.0	5.8	4.6	3.0	3.6	0.6	4.6	9.8	39.4	0.0	0.0	5.9	0.1	0.6	0.2	0.0	0.6	56.7	0.1	0.5	3.4	1.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.1	32.0	0.0	0.0	21.8	0.2	0.0	1.2	0.0	0.1	0.0	0.1	42.5	0.5	0.1	21.9	20.9	0.0	0.0	1.6	1.5	3.5	0.0	0.1	0.0	9.4	0.0	1.3	0.0	11.6	9.5	0.2	0.0	0.4	1.2	0.3	0.0	0.0	0.0	3.3	0.0	0.6	0.6	2.4	2.3	0.3	0.1	0.0	0.5	0.4	0.0	0.3
NOXRED1	"C14orf148, FLJ32809"	ENSG00000165555	"NADP dependent oxidoreductase domain containing 1"	Q6NXP6	14	77394021-77423517	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 5.9;testis: 6.9"	"Group enriched"	"Detected in some"	25	"Early spermatids: 137.8;Late spermatids: 125.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA055658, HPA060408"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 34: Spermatids - Unknown function"	Vesicles	"Plasma membrane"	"HPA055658: AB_2682878, HPA060408: "	"unprognostic (1.92e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.49e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.07e-3)"	0.2	0.6	0.5	0.1	0.6	0.2	0.5	0.2	0.5	0.2	1.7	0.5	0.5	0.5	0.5	0.3	0.5	0.6	0.1	0.5	0.6	0.5	0.3	0.3	0.6	0.8	1.0	0.3	0.4	0.2	0.7	0.3	0.7	0.3	0.5	5.9	0.2	0.4	0.1	1.1	0.3	0.4	0.9	0.5	0.2	6.9	0.5	0.5	0.9	0.0	0.4	0.2	0.2	0.7	0.3	0.7	0.3	0.4	0.1	0.7	0.5	0.3	0.5	0.3	0.2	0.4	0.3	0.7	0.1	0.6	0.1	0.2	0.1	0.1	0.4	0.3	0.2	0.4	0.0	0.7	0.2	0.1	0.6	0.4	0.9	0.3	0.5	0.4	0.2	0.8	0.1	0.5	0.1	0.8	0.2	0.2	0.0	0.2	0.6	0.2	0.1	0.0	0.3	0.1	0.7	0.5	0.4	0.1	0.1	0.7	0.7	0.4	0.9	0.2	0.2	0.4	0.1	0.7	0.7	0.4	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.2	0.5	0.5	0.6	0.8	1.0	0.7	0.9	0.5	0.7	0.2	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.0	4.2	0.0	0.0	0.3	0.0	0.0	137.8	0.6	0.1	0.2	1.8	0.0	4.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.0	3.0	0.0	0.0	0.3	0.2	125.8	0.9	0.3	0.0	0.0	0.0	0.4	0.0	3.0	4.4	0.1	0.0	1.2	0.1	0.1	0.3	0.1	0.2	1.5	0.0	0.0	0.1	4.1	2.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47624665	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol		No	No		3000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA021453: AB_2670709, HPA045649: AB_2679406"	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	32.2	50.0	30.6	19.4	34.8	7.3	30.1	30.7	41.1	41.5	26.1	38.6	20.3	32.0	11.1	92.2	32.6	22.2	30.6	32.9	30.3	30.9	23.8	30.5	18.4	35.7	34.2	39.9	34.2	30.1	26.7	27.3	35.7	27.9	27.4	21.0	44.4	20.6	114.5	47.3	37.1	33.7	26.1	31.9	33.4	19.2	34.2	26.4	26.8	86.6	27.5	34.8	58.2	30.5	105.7	81.7	67.3	49.4	92.1	81.9	147.5	47.5	63.9	70.4	66.5	55.7	100.6	68.4	76.1	69.2	70.1	62.0	83.7	44.8	108.7	31.5	73.2	76.5	62.3	59.2	48.3	48.8	46.6	61.5	41.1	52.7	26.8	99.2	77.5	20.1	72.5	30.7	109.9	37.2	66.0	34.7	47.8	74.4	68.0	50.5	107.2	60.1	82.6	81.0	59.7	46.0	59.1	34.9	44.7	122.0	256.3	35.5	88.6	44.1	35.2	72.5	34.9	63.7	81.1	39.9	64.8	25.3	33.5	14.2	9.9	12.4	8.8	7.9	9.6	7.7	7.2	9.2	9.7	6.9	6.3	7.8	28.4	8.8	9.1	10.1	8.8	6.3	30.6	34.8	30.7	41.1	32.9	30.3	35.7	34.2	35.7	26.1	34.2	30.5	32.0	83.3	59.1	68.6	44.7	77.9	68.9	40.2	109.8	144.6	76.6	33.8	60.3	55.8	53.6	42.3	268.9	81.2	35.6	87.0	27.4	69.3	34.2	95.2	80.9	45.4	44.3	44.6	98.0	54.4	74.4	66.0	58.1	158.1	41.7	62.7	45.7	32.5	40.5	112.7	95.3	44.1	38.7	51.0	62.1	50.8	52.8	45.4	58.7	37.5	51.5	38.7	38.1	69.4	74.9	103.4	61.6	50.0	52.5	106.2	58.7	46.5	63.8	153.3	78.9	53.8	53.5	52.0	28.6	101.6	102.6	104.7	40.4	45.9	51.5	195.2
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.2;Cone photoreceptor cells: 33.3;Excitatory neurons: 47.1;Inhibitory neurons: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.7;hippocampal formation: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: AB_2685505"	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	2.7	2.2	1.0	2.3	0.8	3.7	2.7	0.0	2.7	2.9	2.5	2.2	2.1	2.8	2.3	2.0	7.9	2.1	1.9	3.1	0.0	2.2	1.3	3.0	2.3	0.0	0.0	2.9	2.4	2.7	7.8	1.6	0.0	2.2	1.2	2.4	2.2	2.3	2.2	4.9	2.1	2.2	0.0	2.2	2.0	5.3	0.0	2.5	6.7	1.9	1.1	2.1	2.5	0.0	7.8	4.8	5.4	4.3	4.7	6.8	4.1	3.9	3.9	5.3	4.2	4.1	6.5	4.0	9.6	4.6	3.6	7.4	2.7	6.6	2.7	5.1	7.3	3.4	8.1	4.1	3.7	6.5	5.1	5.6	3.2	6.3	3.9	3.4	3.8	9.4	6.2	4.1	2.4	5.9	8.3	7.1	1.0	4.0	5.5	7.1	3.4	6.5	2.6	1.0	17.0	5.5	6.1	4.5	6.5	2.3	6.0	7.2	3.7	7.6	3.2	13.0	4.8	5.0	7.0	4.2	3.4	8.3	2.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	1.0	0.8	0.0	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	24.2	1.3	4.0	1.2	1.8	3.4	7.3	3.0	3.6	3.1	4.3	3.9	3.7	33.3	0.6	2.2	2.1	1.9	1.6	2.0	10.2	3.3	2.9	3.6	3.2	47.1	1.8	0.5	3.5	4.1	3.0	0.0	4.0	1.8	1.5	2.0	5.0	30.8	2.2	2.0	3.5	3.7	1.4	4.1	2.4	10.6	14.0	1.8	6.3	2.1	10.6	17.3	2.1	2.2	2.2	2.6	1.8	1.1	1.9	10.9	18.2	6.6	1.6	2.7	11.6	6.5	1.9	5.3	1.1	1.7	4.0	1.7	1.1
NPM1	"B23, NPM"	ENSG00000181163	"Nucleophosmin 1"	P06748	5	171387116-171411810	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011384, CAB012983"	Supported		Enhanced	"Nucleoplasm,Nucleoli rim"		NA	Yes		2000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoli rim"	Nucleoplasm	"CAB012983: AB_2533084, HPA011384: AB_1854692"	"unprognostic (1.84e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (7.48e-4)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (1.86e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.24e-2)"	515.1	370.6	180.7	468.4	190.3	789.2	597.1	188.6	233.5	759.2	195.9	486.6	347.1	656.6	421.5	623.0	596.1	355.4	336.7	169.0	210.7	375.3	370.3	364.5	777.0	196.2	188.6	1384.6	810.6	278.0	314.4	423.7	207.5	386.2	421.2	161.3	385.2	318.5	450.9	386.6	374.1	436.0	213.9	358.1	467.8	284.7	202.6	683.3	510.1	282.4	761.7	524.9	565.4	204.5	2476.2	1522.7	1864.0	2663.1	1073.3	1915.6	2736.9	2111.3	1826.0	2678.1	2387.2	3640.2	1622.2	6243.9	1683.2	1194.5	1927.6	1386.6	2552.2	4639.2	3423.4	2027.9	2027.3	2149.1	1361.9	2740.2	1593.2	4556.3	1790.7	1732.2	1559.7	1845.8	3572.3	2184.3	2019.4	1460.9	2712.8	1406.5	1945.5	2826.5	3071.1	3087.4	2400.7	1280.7	1857.2	2695.2	2051.7	3241.9	2306.9	1583.1	1433.8	1167.4	1210.6	2084.4	4091.0	1288.7	2513.8	2000.7	1289.5	916.7	2114.4	1082.5	3705.3	1161.5	2139.6	3702.2	1403.3	3561.5	1897.0	153.6	287.1	92.3	443.1	311.4	834.2	847.9	832.8	654.3	564.2	634.9	1189.9	973.4	38.0	656.2	264.4	516.8	782.6	1076.1	180.7	190.3	188.6	233.5	169.0	210.7	196.2	188.6	207.5	213.9	202.6	204.5	462.2	346.1	461.1	12.4	911.0	1400.1	1224.1	1692.5	993.1	177.2	779.0	1045.4	243.5	514.8	764.5	323.7	43.8	1647.8	615.9	175.3	743.4	1073.6	135.8	466.3	707.3	568.2	362.1	865.5	15.6	919.2	2021.0	685.9	489.8	544.6	443.8	688.8	383.8	254.1	1071.0	127.9	20.3	656.0	679.5	629.2	817.6	98.6	974.9	557.2	610.1	19.7	862.8	339.2	476.8	14.6	21.2	922.5	370.1	649.9	671.6	1051.5	404.2	911.0	357.4	144.1	433.9	617.8	1074.1	855.7	578.6	907.2	1019.1	1538.8	865.1	1019.5	866.2	967.3
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.0;parathyroid gland: 39.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.6	18.4	11.0	0.1	16.9	1.2	2.1	7.4	40.0	4.9	2.2	1.1	2.2	5.0	0.9	1.0	3.2	1.9	2.3	12.4	9.2	6.6	1.6	1.8	0.6	7.5	7.6	1.5	11.0	39.2	18.5	0.5	10.0	6.6	1.0	5.7	2.7	1.4	0.3	2.2	1.2	3.6	2.3	12.5	1.9	5.1	7.1	2.9	25.3	0.3	0.4	2.0	2.3	13.5	3.9	0.5	0.2	0.2	0.9	0.0	1.5	0.5	0.5	2.4	4.9	1.6	3.6	0.0	1.1	0.0	0.2	17.7	0.5	0.0	1.4	0.1	0.5	14.5	1.0	32.4	3.1	1.9	1.3	0.5	2.3	0.0	0.3	3.7	0.0	9.5	0.5	0.0	0.1	0.0	0.2	3.9	0.7	6.4	0.4	0.3	1.4	0.8	5.6	0.1	3.8	0.2	0.0	0.1	4.6	0.0	0.7	11.2	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	11.0	16.9	7.4	40.0	12.4	9.2	7.5	7.6	10.0	2.3	7.1	13.5	0.1	0.0	1.1	1.0	0.7	0.1	9.7	3.7	0.6	29.4	3.1	5.2	2.1	5.7	8.8	0.0	20.9	0.1	0.5	0.6	3.9	9.4	15.1	1.1	0.3	0.6	11.4	0.4	21.3	8.0	0.2	1.7	1.5	1.1	0.0	1.4	2.5	0.5	4.6	6.7	21.9	2.1	2.0	0.0	0.3	14.4	0.6	0.9	10.6	1.9	1.0	0.9	0.0	2.5	1.6	4.3	0.8	0.4	0.6	3.4	0.5	14.6	7.7	4.2	0.0	0.4	1.6	0.5	0.9	1.1	1.1	0.3	2.7	7.6	1.2	5.8
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726668	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 522.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 539.8;Respiratory ciliated cells: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 2434.0;OE19: 4177.0;SiHa: 2756.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Supported	Cytosol		NA	NA		490000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	100.9	95.1	88.9	20.7	97.2	0.8	264.8	88.1	165.6	24.3	113.4	85.6	106.8	16.1	27.2	162.2	29.3	183.1	24.3	86.7	95.0	93.9	5.6	36.5	4.8	83.5	86.2	8.9	9.2	19.5	15.3	12.0	85.9	20.7	74.0	21.4	47.7	25.1	34.2	11.7	56.1	35.0	83.0	22.8	522.7	6.4	93.6	4.3	112.7	27.0	16.5	79.0	34.2	86.8	224.2	2434.0	203.4	901.3	473.1	682.7	77.5	363.1	632.7	363.9	547.0	302.0	1395.7	7.1	433.1	1850.6	634.3	232.1	79.1	410.3	185.2	91.3	3.3	10.9	564.4	2169.9	631.7	53.8	170.6	166.2	246.8	642.8	74.4	537.9	903.9	18.5	95.3	16.3	1914.1	725.9	11.6	98.7	107.0	4177.0	237.1	18.9	44.0	101.6	708.3	781.5	73.0	17.2	2756.6	384.8	1690.4	226.6	631.3	173.1	626.5	368.8	155.8	140.0	297.1	12.7	53.1	11.2	470.2	29.1	1864.0	1.1	3.9	0.3	6.3	0.4	3.1	5.7	7.3	8.3	3.8	2.4	2.2	5.3	0.9	18.7	0.4	1.3	15.6	5.1	88.9	97.2	88.1	165.6	86.7	95.0	83.5	86.2	85.9	83.0	93.6	86.8	88.5	25.6	14.6	8.8	2.9	5.2	26.4	185.5	32.5	10.0	31.1	30.5	4.8	138.7	90.9	42.3	4.2	1.7	3.5	165.7	146.8	25.6	0.4	117.2	11.7	81.0	20.4	1.3	1.9	147.5	4.3	32.9	539.8	65.7	19.7	10.1	28.5	2.6	15.2	3.3	1.6	81.7	107.8	3.5	7.6	1.2	25.1	10.9	17.8	4.7	128.5	10.6	7.2	0.0	5.0	75.1	59.4	12.0	2.3	22.6	62.9	44.3	471.3	15.1	6.6	21.1	72.1	0.3	1.3	128.3	4.5	1.9	5.6	17.3	51.5	40.6
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309390	"Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 32.7;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 5.4;Ionocytes: 8.2;monocytes: 2.6;Oligodendrocyte precursor cells: 10.6;Theca cells: 4.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 62.5;RT4: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: AB_2732673, HPA067207: AB_2732761"		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.2	32.7	1.4	0.0	1.3	0.0	0.2	1.0	1.5	2.4	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	1.4	1.3	3.6	2.1	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.7	19.3	5.9	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	62.5	0.0	0.0	2.3	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	8.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	1.0	1.5	1.3	1.8	1.4	1.3	1.3	1.2	5.9	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	8.2	0.0	0.0	1.9	1.2	0.1	1.8	0.0	2.6	0.0	0.0	10.6	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.8	0.0	0.1	0.0	0.0	4.9	0.0	0.1
NR1D1	"ear-1, hRev, Rev-ErbAalpha, REVERBA, REVERBalpha, THRA1, THRAL"	ENSG00000126368	"Nuclear receptor subfamily 1 group D member 1"	P20393	17	40092793-40100589	"Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 325.5"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 95.5;Suprabasal keratinocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.5"	"Group enriched"	"Detected in many"	6	"monocytes: 5.5;T-cells: 18.5"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007935	Uncertain		Supported	"Nuclear bodies"		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies"		"HPA007935: AB_10601277"	"unprognostic (1.38e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.73e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.34e-1)"	72.3	53.7	23.5	6.3	27.0	5.4	63.1	52.9	49.7	109.6	10.6	53.3	14.3	35.8	4.5	42.5	27.7	7.1	60.8	24.9	17.2	38.0	43.2	49.2	9.3	18.1	20.9	71.3	24.3	9.0	32.0	6.0	15.9	40.5	4.0	50.4	52.9	16.3	99.0	325.5	23.0	7.5	12.9	11.6	31.5	12.5	34.0	6.3	32.1	38.1	5.4	42.5	96.5	25.2	5.5	7.8	1.6	6.2	9.0	6.2	2.2	11.9	19.5	3.9	4.9	5.1	19.5	6.7	6.9	13.8	12.9	15.4	4.1	18.0	2.9	5.6	4.1	4.8	7.9	13.5	14.6	7.2	6.9	13.5	12.8	13.3	28.2	12.6	4.9	7.7	7.2	60.6	3.8	3.8	10.7	6.1	3.0	10.8	12.3	7.5	2.2	20.7	5.4	4.9	5.1	2.9	7.6	9.7	12.4	2.7	4.6	5.8	4.7	17.2	16.7	14.1	9.5	21.5	35.7	2.6	23.4	4.0	13.6	0.0	0.5	0.0	4.4	2.0	18.5	1.7	5.5	6.4	1.1	2.1	4.8	3.5	0.2	1.0	5.5	1.4	8.0	1.8	23.5	27.0	52.9	49.7	24.9	17.2	18.1	20.9	15.9	12.9	34.0	25.2	16.4	3.2	2.0	17.3	5.7	64.5	47.5	20.5	67.2	71.4	9.4	15.1	5.7	8.6	11.9	1.8	4.2	2.6	4.9	26.0	7.9	16.1	2.3	25.4	30.6	18.6	8.3	3.6	7.1	11.8	1.2	26.5	31.1	64.2	2.5	2.7	6.8	31.8	2.5	42.1	6.2	7.2	8.2	3.4	19.4	1.5	21.8	7.7	19.6	8.4	1.2	39.0	5.2	5.0	1.2	26.0	14.7	38.7	10.5	35.4	58.8	7.9	5.0	29.7	6.6	9.6	19.4	2.0	11.1	95.5	81.1	2.3	11.9	13.7	6.0	28.7
NR2E1	"TLL, TLX, XTLL"	ENSG00000112333	"Nuclear receptor subfamily 2 group E member 1"	Q9Y466	6	108166022-108188805	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	57	"brain: 19.7;choroid plexus: 14.3;retina: 30.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.2;Inhibitory neurons: 8.5;Muller glia cells: 44.9;Oligodendrocyte precursor cells: 4.5"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;GAMG: 1.4;HEK 293: 1.0;U-251 MG: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036954, HPA055642"	Uncertain		Approved	"Nuclear bodies"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear bodies"		"HPA036954: AB_10670958, HPA055642: AB_2682871"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"			"unprognostic (1.77e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.00e-1)"	"unprognostic (1.78e-2)"		"unprognostic (7.31e-2)"	"unprognostic (8.64e-2)"	"unprognostic (9.59e-8)"	"unprognostic (2.87e-1)"	"unprognostic (2.49e-1)"		"unprognostic (3.07e-1)"	0.0	0.3	16.9	0.0	19.7	0.0	0.0	7.3	18.6	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	14.3	0.1	0.0	0.0	0.0	7.4	13.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	30.6	0.1	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	19.7	7.3	18.6	16.6	14.3	7.4	13.0	7.8	7.2	16.4	12.9	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 411.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	35.3	11.8	15.2	22.6	18.1	49.4	25.5	34.0	24.7	19.7	18.2	13.7	19.2	18.8	13.6	25.7	18.8	21.1	24.2	14.9	25.0	19.2	39.8	31.9	25.6	18.1	14.9	21.1	14.7	33.8	16.2	46.9	16.1	19.7	14.5	9.5	16.1	20.0	45.0	20.4	18.0	23.8	15.0	24.5	16.0	11.1	21.6	40.0	25.6	40.1	27.3	18.2	16.0	28.5	30.4	60.6	4.4	0.1	38.2	42.3	5.2	46.5	55.3	39.3	45.1	4.5	39.7	26.8	20.8	68.6	46.0	28.1	0.3	36.6	48.3	15.2	21.0	6.9	77.0	13.5	35.7	28.1	20.6	30.8	46.3	64.7	62.5	49.0	15.0	12.1	10.3	98.8	35.1	10.9	16.7	20.0	11.9	5.1	13.0	6.0	41.4	58.0	11.5	2.1	8.0	6.1	81.3	11.7	19.4	4.9	5.3	39.8	35.8	94.7	18.7	45.7	35.9	20.1	19.7	41.5	49.7	28.5	33.6	67.4	21.3	38.9	18.3	24.2	15.1	15.9	18.6	17.9	28.5	22.3	17.8	17.2	68.4	23.1	23.6	25.9	12.8	17.3	15.2	18.1	34.0	24.7	14.9	25.0	18.1	14.9	16.1	15.0	21.6	28.5	152.3	67.3	69.1	71.2	134.1	58.8	35.9	37.9	79.6	13.1	39.0	55.8	43.4	57.2	41.2	25.8	16.7	48.9	158.3	22.9	17.6	30.8	165.6	8.1	30.1	82.3	28.1	55.9	411.4	33.3	39.5	112.2	23.9	10.4	89.3	7.5	63.5	193.9	53.2	37.0	169.5	4.1	10.2	66.3	99.2	144.1	63.0	97.4	53.4	241.7	87.6	34.6	83.4	240.3	237.5	35.9	17.9	71.5	115.1	46.2	25.3	67.9	37.9	65.0	151.2	181.9	105.0	24.5	40.1	57.4	56.3	36.5	204.5	12.6	12.9	14.3
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507420	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 188.3;lymphoid tissue: 142.8"	"Group enriched"	"Detected in some"	8	"Granulosa cells: 47.9;Theca cells: 180.1"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Region enriched"	"Detected in some"	9	"thalamus: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 82.9;Hep G2: 59.2;K-562: 20.6"	"Region enriched"	"Detected in single"	52	"hypothalamus: 5.2"	"Region enriched"	"Detected in single"	8	"hypothalamus: 1.2"	HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.1	188.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.1	0.0	0.0	35.8	0.0	0.0	21.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	142.8	0.1	14.1	18.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	59.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.3	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	180.1	0.0	0.0
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588714-113664070	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 2363.9;tongue: 1144.8"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 534.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037953, HPA037954, HPA075074"	Enhanced		Approved	"Vesicles,Intermediate filaments,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"	"Vesicles, Cytosol"	"HPA037953: AB_2675755, HPA037954: AB_10672394, HPA075074: "	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		0.3	0.1	0.1	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	24.8	0.0	0.2	428.6	0.2	0.0	0.1	0.5	0.4	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.0	20.4	1.0	0.0	22.1	0.0	2363.9	0.8	0.1	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.4	1144.8	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	534.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.1	0.0	3.7	0.0	0.0	0.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	4.8	0.0	0.0	0.3	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	57.3	3.3	1.0	2.3	0.0	0.1	0.0	0.2	0.0	0.5	0.0
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.5;Excitatory neurons: 89.9;Inhibitory neurons: 136.6;Oligodendrocyte precursor cells: 142.2;Oligodendrocytes: 50.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;HDLM-2: 4.0;Karpas-707: 4.4;PC-3: 11.1;RPTEC TERT1: 5.8;SCLC-21H: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted in other tissues"	No	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: AB_2680226"	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	2.3	3.4	2.9	0.5	2.8	0.0	3.3	8.5	3.1	5.8	0.0	2.1	0.2	1.2	1.1	1.6	3.3	1.2	1.2	2.0	2.4	0.8	0.1	0.4	0.8	3.2	2.6	7.5	2.7	8.1	3.5	0.3	3.0	3.1	0.1	1.3	6.5	1.9	5.0	3.6	0.7	0.3	1.5	1.7	0.8	2.1	2.6	0.5	0.7	0.1	0.4	3.1	1.8	2.3	0.0	1.6	0.1	6.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.3	0.0	2.8	2.1	0.3	0.1	0.1	4.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.1	0.1	0.0	4.4	0.0	0.2	0.0	0.0	0.1	0.0	11.1	0.1	0.0	0.0	5.8	1.5	4.2	2.5	0.0	2.7	2.6	0.0	0.0	0.0	0.1	1.9	0.3	0.0	1.3	0.8	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.8	8.5	3.1	2.0	2.4	3.2	2.6	3.0	1.5	2.6	2.3	15.9	0.0	0.0	71.5	1.6	2.8	9.7	0.9	29.0	16.6	4.0	16.0	2.2	0.0	0.5	1.8	0.0	0.1	3.2	0.1	1.9	0.4	0.6	2.6	8.2	2.6	0.0	0.0	89.9	2.2	0.0	2.7	0.5	0.4	0.0	1.3	1.8	0.0	0.1	6.7	136.6	0.1	0.0	0.3	1.3	0.6	9.6	0.6	3.6	8.4	0.3	11.2	5.2	142.2	50.8	0.5	0.0	10.1	2.7	2.6	0.0	1.7	1.0	1.0	6.6	10.9	2.2	2.7	9.4	1.0	0.3	0.0	2.8	4.0	0.1	6.2
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Rod photoreceptor cells: 8.8;Sertoli cells: 26.3;Smooth muscle cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	3.9	7.7	3.6	12.4	4.0	5.1	23.4	10.2	7.0	4.8	5.3	2.4	7.4	7.2	2.4	4.8	5.9	5.2	5.8	10.6	12.0	1.6	1.8	4.1	12.4	10.0	8.4	3.0	0.6	2.8	2.6	12.9	4.1	3.0	3.9	3.6	4.9	4.9	2.6	4.7	4.9	8.1	9.1	3.6	2.1	12.0	3.0	5.5	7.5	2.6	4.3	4.7	13.3	0.4	0.9	1.5	0.8	0.0	0.0	1.8	1.1	0.0	0.0	0.0	2.3	1.1	1.2	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.9	1.3	2.0	2.9	0.2	0.0	2.4	1.4	0.0	0.0	0.0	0.0	2.2	0.0	1.3	1.1	2.7	0.0	1.0	1.5	1.2	1.5	0.9	0.4	0.9	1.6	0.7	0.0	1.5	1.1	1.7	0.8	1.2	0.3	2.7	0.8	0.4	1.2	0.6	0.7	0.9	1.6	0.4	0.1	1.8	1.5	1.1	0.8	3.7	0.3	0.1	0.5	0.2	0.3	0.7	0.4	0.5	0.2	0.6	0.8	0.3	0.1	0.4	0.1	0.3	0.1	0.1	7.7	12.4	23.4	10.2	5.8	10.6	12.4	10.0	12.9	8.1	12.0	13.3	0.6	0.0	1.1	0.0	0.2	0.1	0.5	0.0	0.0	5.0	0.1	0.9	1.3	0.0	0.0	1.8	6.2	0.3	0.3	0.0	0.0	0.0	1.6	0.2	0.9	0.6	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.4	0.0	0.1	3.3	3.3	0.0	0.0	0.6	0.3	1.8	0.3	0.5	0.0	2.8	0.0	0.6	3.1	0.5	4.9	0.0	0.0	5.3	0.0	0.3	0.0	0.2	0.0	8.8	26.3	0.5	23.1	0.1	0.3	0.1	0.1	0.0	1.1	0.4	0.0	0.1
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 78.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 134.4;Hepatic stellate cells: 137.8;Hofbauer cells: 141.3;Langerhans cells: 129.8;monocytes: 224.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 123.6;HUVEC TERT2: 105.7;TIME: 106.3;U-251 MG: 217.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039980, HPA054974"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA		29000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA039980: AB_10795517, HPA054974: AB_2682657"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (7.80e-5)"	18.8	22.2	18.0	17.8	13.8	4.6	12.6	9.3	11.7	18.8	7.0	78.7	5.3	51.8	3.7	13.3	21.1	31.1	6.3	21.7	42.5	4.9	9.6	24.3	8.2	30.4	23.9	46.8	1.9	2.5	9.6	47.0	19.6	13.0	10.5	3.6	3.3	30.9	2.3	4.8	14.9	54.8	13.2	7.5	25.9	1.4	33.9	6.1	10.8	3.4	4.5	38.3	15.9	12.4	2.5	50.4	32.2	0.2	30.1	9.6	9.3	8.5	14.8	10.0	9.5	48.0	123.6	0.0	11.9	25.3	20.5	19.2	1.5	15.9	16.8	0.1	6.8	0.5	2.4	0.4	80.7	0.0	2.1	68.5	12.2	14.4	12.3	64.5	105.7	0.2	0.2	0.1	6.8	0.2	0.0	0.0	41.5	0.1	9.2	0.2	2.0	12.0	21.7	0.0	29.0	1.0	1.1	0.3	75.4	84.9	0.1	0.8	106.3	43.1	0.4	11.3	217.0	0.0	0.2	3.2	96.9	0.3	88.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	13.8	9.3	11.7	21.7	42.5	30.4	23.9	19.6	13.2	33.9	12.4	88.7	89.8	57.5	2.0	3.8	19.4	19.5	30.8	97.9	36.5	1.3	11.3	4.5	5.7	53.2	1.8	0.0	89.7	0.1	0.6	0.0	6.4	6.3	8.8	8.1	134.4	1.2	2.7	4.1	3.8	8.7	47.0	1.5	13.2	3.8	2.7	137.8	1.8	141.3	0.0	9.4	1.1	4.1	28.0	129.8	18.9	2.8	53.7	19.6	53.4	224.8	4.8	0.0	4.0	8.1	53.2	0.0	4.9	0.2	9.1	0.0	0.6	48.1	2.7	0.0	4.6	32.2	1.4	1.4	17.8	12.6	25.7	2.4	48.1	0.4	51.5
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918503-51225575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 145.0"	"Group enriched"	"Detected in many"	5	"Astrocytes: 4025.1;Excitatory neurons: 3206.3;Inhibitory neurons: 2116.2;Oligodendrocyte precursor cells: 4897.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA071400: AB_2732180"	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	1.1	2.0	40.9	1.1	60.9	0.3	0.8	145.0	74.4	2.2	0.0	11.3	0.9	1.1	3.0	2.0	0.8	1.2	5.2	62.7	16.8	0.4	0.5	0.4	0.3	0.0	2.2	0.9	1.4	0.0	6.0	0.0	7.2	2.8	2.6	7.2	2.4	8.4	0.2	0.9	2.6	1.0	4.7	0.2	2.3	5.6	15.7	1.2	0.6	0.8	0.2	2.3	3.1	22.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	31.3	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	3.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	40.9	60.9	145.0	74.4	62.7	16.8	0.0	2.2	7.2	4.7	15.7	22.0	0.1	0.0	0.0	4025.1	0.0	0.0	0.3	0.0	3.4	116.0	3.1	3.7	19.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.1	201.6	0.1	2.8	1.0	1.8	0.0	3206.3	0.0	0.0	2.3	0.0	0.1	0.0	0.2	3.3	0.2	0.1	77.4	2116.2	0.0	0.0	0.0	0.6	103.4	2.5	0.6	1.8	174.3	0.0	22.7	0.0	4897.8	678.0	0.2	0.0	0.7	1.4	0.5	0.0	0.2	0.0	9.7	0.0	2.5	1.3	13.3	5.8	0.6	0.1	0.3	0.1	0.1	0.0	0.1
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2 ribosome biogenesis factor"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	32.0	36.5	17.1	33.2	18.9	39.3	28.7	19.3	22.2	43.7	15.6	36.4	30.4	29.9	25.0	26.7	35.0	12.2	28.3	17.4	19.0	30.9	26.6	20.3	36.9	19.1	17.9	60.4	37.7	20.6	28.1	17.3	19.2	28.5	22.8	22.6	28.1	11.5	67.9	22.2	26.0	16.9	19.9	25.8	31.2	31.8	18.2	23.5	22.1	19.0	32.0	35.9	30.6	20.4	65.2	35.4	42.5	57.6	26.6	48.9	64.8	45.8	24.5	29.5	24.9	61.2	62.3	53.0	94.0	27.3	70.2	39.6	34.6	51.9	41.9	36.1	53.7	27.9	65.8	68.3	24.8	47.9	61.7	32.4	48.2	39.8	29.6	46.5	25.5	47.3	28.0	42.8	32.2	50.1	81.4	120.4	28.3	27.8	29.9	58.4	49.8	100.5	37.7	70.9	45.3	58.5	27.8	52.8	135.7	32.6	49.5	135.8	28.0	22.0	67.4	41.8	133.3	42.7	61.1	90.0	54.6	84.3	33.3	9.3	12.1	7.5	16.3	20.6	23.5	27.1	24.6	24.7	18.5	19.5	28.7	29.8	2.2	21.4	15.9	17.2	26.4	10.3	17.1	18.9	19.3	22.2	17.4	19.0	19.1	17.9	19.2	19.9	18.2	20.4	125.8	80.1	95.9	6.5	237.4	94.1	162.1	95.9	215.1	34.6	164.2	218.3	83.7	140.2	94.5	62.5	14.6	142.3	183.7	122.9	150.6	143.1	418.6	145.2	303.6	101.1	139.6	129.2	13.1	237.9	196.2	107.6	112.1	192.8	119.2	165.4	129.2	207.7	137.4	50.5	13.2	234.6	52.9	233.2	100.2	159.1	278.4	161.9	83.6	7.5	229.6	85.8	188.4	10.1	13.4	181.2	147.9	171.5	139.4	144.4	147.5	281.7	55.9	37.7	138.1	132.8	138.0	250.2	96.3	171.7	86.0	135.4	176.1	176.8	246.1	192.5
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871393-1982207	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 20.3;Granulosa cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	10.1	8.4	12.7	16.5	13.0	54.9	9.9	23.6	15.2	9.4	0.8	19.6	18.6	10.7	7.3	13.6	8.4	8.3	15.8	11.8	11.5	9.8	8.3	12.6	25.4	9.8	8.6	7.7	13.5	12.0	13.8	12.2	12.0	9.7	22.5	28.5	11.6	8.4	16.7	11.6	18.3	12.4	4.4	14.1	12.5	37.2	12.6	59.8	17.4	13.7	24.3	9.7	9.2	14.9	124.0	58.6	168.3	71.2	17.5	26.5	44.2	98.2	85.4	115.2	128.8	44.6	141.4	117.5	31.4	78.0	158.5	50.2	114.4	74.3	195.0	58.3	47.7	151.3	81.7	25.5	18.6	89.5	74.9	9.9	19.8	101.2	89.9	60.1	92.2	123.4	81.7	132.2	95.8	42.1	243.3	99.7	68.8	60.1	77.1	137.8	106.7	42.9	45.4	57.4	115.6	82.7	78.4	29.2	31.7	71.4	68.9	52.2	64.9	109.0	87.4	72.8	188.1	54.1	72.9	113.7	66.0	81.9	108.0	4.0	1.1	1.3	1.0	0.8	1.1	0.9	1.5	1.2	1.2	1.7	1.1	0.8	3.4	1.2	0.5	2.1	2.9	0.7	12.7	13.0	23.6	15.2	11.8	11.5	9.8	8.6	12.0	4.4	12.6	14.9	12.6	12.8	18.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	15.3	9.1	0.0	0.0	8.1	12.9	0.0	15.7	7.2	0.0	3.9	10.4	0.0	13.0	11.7	6.3	0.0	0.0	0.0	7.1	10.0	6.0	0.0	20.3	2.5	69.3	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	11.4	0.0	0.0	4.9	0.0	0.0	4.0	7.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	3.4	5.2	3.7	0.0	0.0
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 53.0;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	24.0	38.8	13.2	10.2	12.6	8.9	20.2	14.2	13.3	20.3	13.7	13.9	17.6	13.6	44.5	51.7	14.9	7.9	22.4	13.7	14.3	14.9	50.4	12.9	9.1	16.8	15.4	10.3	10.6	12.9	8.8	10.3	18.5	14.8	13.5	10.4	16.7	21.3	10.1	22.6	24.2	12.5	13.4	9.5	13.8	8.9	15.2	9.9	13.3	10.9	18.1	12.1	24.1	15.1	135.6	48.9	65.5	33.8	54.9	41.5	36.2	26.3	35.2	46.9	59.3	68.5	71.7	67.0	86.0	35.9	174.2	67.6	85.5	122.1	41.3	22.0	49.5	27.9	44.7	70.3	39.8	27.6	21.1	51.1	46.3	92.2	23.0	20.2	44.2	28.7	46.4	29.1	36.1	60.1	27.3	35.8	26.0	67.4	58.1	19.9	47.4	54.6	98.9	55.7	23.4	26.5	23.4	34.6	28.4	44.9	23.1	35.0	38.7	21.6	35.4	52.3	51.0	40.9	29.4	114.9	40.0	42.4	20.8	21.0	19.6	18.7	16.3	18.7	16.4	19.1	16.1	14.1	19.4	15.1	11.6	12.7	2.2	19.7	14.2	17.4	20.4	15.2	13.2	12.6	14.2	13.3	13.7	14.3	16.8	15.4	18.5	13.4	15.2	15.1	7.1	12.8	16.7	5.9	6.3	10.8	12.8	53.0	10.8	4.3	11.7	6.1	25.0	15.7	29.0	12.9	0.0	21.5	6.1	9.6	9.8	20.1	13.3	15.5	6.6	9.2	6.0	13.0	2.2	20.3	22.0	9.0	8.2	15.5	8.2	14.0	7.5	55.0	18.6	1.7	2.2	10.2	26.4	8.7	9.6	8.0	8.4	7.9	5.4	1.0	11.0	10.6	7.2	2.5	5.7	21.4	11.9	9.1	11.3	10.4	25.2	16.5	25.4	6.2	0.0	5.9	12.5	3.7	7.8	19.4	12.1	18.6	5.3	25.1	11.2	16.4
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 276.3;Inhibitory neurons: 284.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	13.5	20.2	29.9	8.0	28.8	5.7	12.5	7.7	58.7	14.1	0.0	18.3	4.9	11.8	7.3	21.6	9.7	8.0	11.3	39.2	28.6	12.9	13.7	11.6	9.6	36.8	14.3	7.0	22.9	15.3	43.1	7.7	36.6	12.4	13.9	63.0	18.4	5.8	38.9	16.5	16.1	6.4	4.1	14.9	15.6	16.7	15.6	7.9	11.9	13.5	10.0	13.2	14.3	21.1	11.7	25.4	16.6	1.2	9.6	13.4	13.5	15.6	18.2	14.7	14.3	17.5	0.1	28.5	27.3	34.8	15.3	2.0	18.9	5.8	23.9	10.1	24.6	1.0	17.4	24.2	14.3	0.8	6.1	12.3	7.8	29.8	12.3	7.8	23.4	7.0	19.4	15.0	32.9	22.8	19.4	7.5	9.4	36.0	29.9	13.7	16.1	26.7	16.7	24.0	15.2	17.2	23.1	0.1	11.1	17.5	28.5	35.1	19.3	41.2	14.4	22.0	23.7	32.0	19.9	16.4	11.5	15.2	29.7	9.3	11.5	6.6	6.1	9.8	6.7	5.4	6.2	8.1	12.6	6.1	5.1	6.1	4.8	5.9	10.8	5.0	9.4	7.5	29.9	28.8	7.7	58.7	39.2	28.6	36.8	14.3	36.6	4.1	15.6	21.1	16.3	9.6	11.3	54.9	28.2	4.0	3.6	6.7	6.2	106.6	14.0	10.0	8.1	7.2	10.9	22.0	87.6	13.0	18.8	32.3	11.7	12.4	45.2	8.3	19.7	11.5	30.5	8.6	276.3	16.2	14.4	10.9	13.7	11.2	9.5	8.2	11.0	19.3	18.8	43.7	284.7	26.3	24.4	29.9	10.9	45.8	5.9	20.5	10.6	69.3	35.4	24.5	8.2	98.5	71.8	13.7	17.4	8.6	21.7	9.0	18.5	14.7	8.7	89.9	0.0	10.6	12.9	40.6	31.4	9.5	5.7	18.5	14.8	18.3	20.6	8.6
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1900000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	22.8	37.7	38.3	13.5	39.5	27.8	21.5	37.0	45.9	23.2	41.6	23.0	14.9	22.5	26.8	28.5	26.1	13.5	29.1	39.7	38.6	21.4	26.3	18.0	15.2	39.0	39.0	25.7	15.5	23.9	14.1	21.1	39.8	20.9	18.4	22.6	19.3	26.4	69.0	36.6	17.6	22.9	36.4	19.8	18.0	14.8	38.6	21.0	20.0	43.3	18.6	22.4	21.6	39.7	55.6	64.4	35.9	32.0	30.5	31.4	28.7	21.0	41.8	57.7	41.3	53.9	43.1	31.6	16.6	47.8	47.2	50.4	25.9	70.3	40.8	12.3	25.1	29.8	10.3	61.4	33.8	30.7	16.4	23.5	33.3	55.3	20.3	30.8	46.8	23.4	42.5	26.5	36.2	29.1	31.4	54.7	40.7	42.5	65.4	14.7	41.1	29.8	68.6	37.1	20.5	23.4	29.6	59.8	26.7	18.8	36.5	22.0	37.8	38.7	29.4	23.9	40.2	21.9	41.8	24.7	28.9	43.0	29.3	31.4	21.3	80.3	20.0	26.6	19.7	35.0	21.2	19.5	29.7	36.0	23.4	20.7	69.1	16.7	28.1	23.1	28.2	25.5	38.3	39.5	37.0	45.9	39.7	38.6	39.0	39.0	39.8	36.4	38.6	39.7	34.6	22.4	23.2	17.3	36.1	89.2	63.5	106.3	44.3	60.2	28.6	26.0	35.4	24.3	57.8	31.3	22.9	150.7	29.7	68.2	56.7	104.7	23.0	51.0	29.6	44.3	43.6	41.0	24.0	94.5	146.0	41.1	30.5	54.9	40.5	49.1	31.1	42.2	81.1	70.7	24.8	42.5	61.1	43.7	43.6	38.8	39.1	43.8	42.7	14.0	52.9	61.7	32.0	17.6	31.2	123.4	65.7	46.3	41.8	76.0	66.4	73.8	43.2	44.5	78.9	44.2	64.7	106.1	103.2	55.1	75.7	151.6	31.6	48.9	44.0	88.5
NSG2	"CALY3, HMP19"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045706-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 198.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	59	"SCLC-21H: 39.5;SH-SY5Y: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA046531: AB_2732528, HPA056191: AB_2683062"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	0.5	33.3	115.8	2.6	198.5	0.0	0.1	43.8	152.8	0.0	1.7	6.9	2.3	0.0	0.4	0.1	0.0	0.3	1.0	125.2	171.9	0.7	0.4	0.3	0.0	54.5	82.1	0.1	0.9	0.0	7.0	0.0	101.1	0.2	3.9	39.2	0.1	0.1	0.3	0.1	3.8	1.8	52.4	0.2	3.0	14.7	100.3	0.0	0.6	0.0	0.0	0.1	1.2	47.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	64.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.8	198.5	43.8	152.8	125.2	171.9	54.5	82.1	101.1	52.4	100.3	47.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase 5"	Q96P11	7	73302516-73308826	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	13.9	11.6	9.8	9.7	11.3	33.4	14.1	11.7	12.9	15.3	9.1	18.6	8.9	18.7	3.2	17.7	15.5	4.2	17.7	9.8	10.9	17.4	16.2	12.1	14.2	12.8	10.8	13.0	24.0	6.6	12.8	6.1	11.7	15.5	4.3	3.2	14.6	6.3	37.9	19.7	17.7	6.2	11.6	24.4	16.3	20.7	11.0	13.0	13.6	8.1	9.4	18.6	14.7	13.3	34.7	46.4	12.3	29.3	4.8	6.3	48.4	15.3	9.1	23.6	25.3	63.0	24.3	55.3	10.6	7.7	34.6	28.9	23.7	15.2	8.1	36.6	57.0	20.7	35.8	36.4	20.0	45.9	26.0	8.3	25.7	20.0	17.3	5.2	3.1	40.4	71.0	12.7	10.8	83.2	39.3	91.6	52.1	24.9	34.9	48.9	9.5	79.8	10.1	17.1	33.2	54.6	27.9	72.5	36.4	12.8	47.9	37.1	5.3	0.2	34.8	34.7	11.1	49.6	73.8	80.8	0.5	65.6	2.5	23.7	21.5	24.0	19.6	19.6	15.7	32.2	22.3	20.4	25.0	46.2	31.0	26.5	27.4	26.8	14.8	31.5	26.9	23.2	9.8	11.3	11.7	12.9	9.8	10.9	12.8	10.8	11.7	11.6	11.0	13.3	11.1	6.4	7.4	14.4	38.2	17.0	20.0	32.8	14.8	27.5	23.0	25.0	20.4	27.1	21.3	36.8	12.5	37.7	27.3	18.3	37.2	35.8	17.4	18.1	12.7	8.9	3.6	19.1	9.2	33.0	48.9	17.2	21.4	15.5	26.6	50.5	5.3	21.0	36.6	32.0	9.3	18.3	26.4	21.0	10.8	21.6	29.2	20.2	21.4	3.7	39.9	13.2	36.0	10.1	12.1	29.1	20.5	20.7	24.9	12.6	28.4	25.1	21.8	23.1	6.6	20.8	16.8	64.2	56.7	15.1	21.3	21.8	24.9	16.2	23.1	14.3
NSUN7	FLJ14001	ENSG00000179299	"NOP2/Sun RNA methyltransferase family member 7"	Q8NE18	4	40749925-40811184	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.5;Late spermatids: 75.6;Respiratory ciliated cells: 36.4;Spermatocytes: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.6;CAPAN-2: 5.5;Karpas-707: 4.0;MCF7: 2.6;SuSa: 3.0;T-47d: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA020653	Uncertain		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA020653: AB_1848710"	"unprognostic (2.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.76e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-2)"	0.6	0.9	0.6	1.0	0.6	0.6	3.8	0.4	0.4	2.5	7.2	2.8	1.7	2.2	2.7	1.8	6.8	1.2	2.1	0.5	1.5	4.7	0.4	3.3	0.3	1.8	2.4	2.3	7.2	3.3	3.6	1.3	1.5	4.5	2.4	0.7	4.8	1.5	0.0	1.5	2.1	1.2	1.2	2.7	3.2	16.5	2.0	0.3	4.7	0.2	0.3	1.3	1.2	0.8	2.6	0.1	1.2	0.0	0.0	0.0	1.7	0.0	0.2	0.1	0.1	1.0	5.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.6	0.1	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.4	0.7	0.6	1.5	0.3	1.7	0.0	3.0	3.9	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	0.4	0.5	1.5	1.8	2.4	1.5	1.2	2.0	0.8	0.1	9.6	7.8	3.6	4.3	1.1	3.1	1.5	2.2	0.1	8.6	7.1	3.5	0.0	10.5	9.2	0.0	9.2	0.1	2.7	9.8	5.8	47.5	20.7	0.9	0.6	8.3	0.4	0.7	5.4	3.6	1.2	4.6	5.4	0.0	8.5	0.7	0.2	3.8	0.0	0.9	7.1	4.1	0.8	0.4	75.6	1.5	2.2	0.0	8.4	1.0	2.1	0.0	18.1	1.3	4.7	2.7	0.0	0.3	4.5	2.2	5.5	36.4	0.1	0.0	0.4	0.8	38.9	11.4	8.2	1.0	4.5	0.7	3.4	7.7	5.7
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014114-33062797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 191.0;Paneth cells: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010520, HPA010630, HPA029058"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.4	14.3	11.4	26.1	11.4	32.6	21.3	15.2	15.6	12.6	10.8	51.9	40.0	16.9	14.3	18.6	15.9	23.4	16.6	11.5	11.5	22.4	11.8	17.6	30.8	11.1	11.8	13.4	21.4	9.7	7.5	16.3	11.5	12.3	51.0	20.4	9.7	10.0	87.4	28.7	37.3	13.2	12.7	22.9	27.0	9.5	12.0	22.5	17.1	51.0	45.8	23.8	14.4	13.1	42.2	27.6	25.2	29.6	21.2	16.1	20.3	44.8	30.5	29.2	38.9	19.9	115.1	100.4	27.7	29.6	48.3	63.8	28.3	30.8	40.4	16.2	36.2	54.7	36.5	28.7	23.3	55.6	36.9	21.7	23.8	35.9	63.0	16.4	22.2	33.2	43.3	24.8	37.3	29.9	25.0	87.8	27.8	47.1	31.2	25.9	22.9	60.0	87.8	39.8	28.1	37.0	31.1	52.4	66.6	24.5	35.2	33.5	19.8	25.1	20.9	42.6	55.7	50.6	69.0	54.8	20.6	34.9	42.5	112.5	25.9	82.5	26.6	32.7	30.6	64.0	34.2	30.8	22.1	63.6	34.5	29.1	103.8	28.2	39.2	20.6	56.2	37.9	11.4	11.4	15.2	15.6	11.5	11.5	11.1	11.8	11.5	12.7	12.0	13.1	39.1	22.4	13.7	30.7	85.1	46.8	40.9	85.3	47.8	23.9	22.6	18.9	16.9	32.9	40.4	16.5	41.7	36.9	42.5	191.0	29.4	34.4	5.7	40.9	21.0	40.8	119.6	127.1	45.3	79.0	31.6	35.2	42.8	21.4	17.7	38.3	30.0	18.9	25.0	1.7	49.4	98.9	40.7	31.2	23.5	5.0	33.8	111.4	26.6	29.0	37.0	23.4	55.6	48.2	52.4	48.3	186.6	22.2	43.8	45.7	91.8	84.8	53.7	27.1	13.1	30.7	24.9	46.4	24.0	35.5	38.9	28.3	53.7	23.3	71.0	65.9
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841234	"Metabolic proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 80.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 41.2;Excitatory neurons: 36.6;Oligodendrocyte precursor cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Mitochondria	Cytosol	"HPA041634: AB_10795597"	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.11e-4)"	2.9	4.0	14.2	1.9	12.0	17.5	3.3	0.0	13.3	9.3	0.0	80.5	1.0	23.1	5.0	5.2	3.7	1.4	1.9	23.3	7.8	2.0	5.0	2.8	1.3	1.5	1.8	2.9	3.5	0.8	4.5	1.5	1.4	7.5	7.7	2.3	4.1	5.4	7.8	2.5	4.7	6.8	1.2	1.6	6.6	3.1	8.9	0.6	1.9	3.3	1.2	21.7	5.7	4.8	3.6	6.5	3.6	4.2	5.1	4.0	6.8	5.9	3.5	4.1	2.6	4.4	0.9	6.1	1.1	7.0	4.5	4.1	5.2	11.7	5.9	4.5	4.2	7.6	2.5	5.2	2.8	4.1	1.9	3.5	2.5	5.3	22.7	8.3	2.4	3.0	12.2	3.0	9.2	3.3	3.6	6.6	4.5	5.2	6.9	4.9	6.3	2.3	6.5	2.4	4.9	2.0	4.9	5.4	7.1	3.3	3.1	3.8	3.2	4.0	4.8	5.5	11.9	2.7	3.5	4.4	3.8	6.2	6.0	0.4	0.5	0.0	0.6	0.6	1.2	1.3	0.9	0.5	1.5	1.4	0.7	0.6	0.9	0.6	0.4	1.9	0.2	0.3	14.2	12.0	0.0	13.3	23.3	7.8	1.5	1.8	1.4	1.2	8.9	4.8	1.4	0.0	2.3	3.9	2.7	4.5	21.9	3.0	21.6	2.0	5.6	7.4	3.8	2.8	2.1	1.8	0.0	5.2	2.7	5.8	0.0	2.1	12.1	14.0	11.9	1.7	41.2	1.3	36.6	2.0	4.7	3.8	7.7	19.4	0.0	3.7	0.7	5.3	1.8	10.1	24.4	11.4	10.2	4.1	6.5	10.5	5.0	2.8	0.0	6.5	2.9	0.8	1.0	29.1	2.7	2.7	2.2	8.2	2.7	13.0	1.1	2.1	6.9	5.0	0.0	5.6	5.7	0.4	3.1	9.0	4.4	4.1	2.5	4.1	9.2	9.8
NTAN1		ENSG00000157045	"N-terminal asparagine amidase"	Q96AB6	16	15037854-15056079	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 17.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 18.5;REH: 9.2;U-266/84: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051418			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA051418: "	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (4.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	38.6	10.2	3.6	0.5	3.9	2.2	28.1	3.8	8.9	25.3	2.1	30.3	0.1	20.7	1.4	19.4	18.8	1.2	19.3	3.4	3.7	15.9	15.2	21.6	0.7	3.8	4.1	19.7	11.0	0.5	6.5	0.4	4.1	20.2	0.3	1.3	15.8	0.4	24.5	21.6	15.6	0.8	2.9	20.5	17.9	20.3	3.7	0.8	13.5	0.6	0.4	27.8	21.8	3.5	3.6	0.0	1.8	0.7	1.2	0.6	0.6	6.2	2.6	1.0	2.8	0.0	0.0	3.2	2.5	4.7	1.7	0.1	0.9	0.7	0.9	5.0	5.9	0.3	0.0	0.0	1.1	1.7	4.3	0.8	0.4	3.4	1.5	1.5	1.3	2.6	0.5	3.2	0.9	0.3	5.3	18.5	1.1	0.0	0.2	9.2	0.1	1.3	1.2	0.0	0.7	2.1	0.0	0.1	1.5	0.4	0.0	0.6	4.1	1.1	3.8	1.1	1.1	4.2	10.1	2.5	1.5	1.3	2.2	4.9	1.3	17.5	2.8	1.7	3.0	4.2	3.4	2.6	1.9	3.8	3.9	1.3	1.6	3.8	2.0	5.7	5.9	3.1	3.6	3.9	3.8	8.9	3.4	3.7	3.8	4.1	4.1	2.9	3.7	3.5	79.7	3.2	3.9	7.8	24.7	33.6	16.4	24.1	7.4	6.1	20.2	33.4	3.2	12.8	13.8	18.4	10.4	77.4	30.4	25.1	45.0	49.3	48.9	8.8	29.3	55.0	6.7	25.3	12.6	23.6	23.8	51.3	8.2	12.7	8.8	22.0	62.8	23.0	116.6	25.2	15.6	7.2	30.5	75.0	48.3	32.4	83.0	53.9	58.7	12.2	46.0	15.2	37.0	3.0	6.6	56.9	14.6	75.2	37.6	21.2	9.6	38.6	6.0	9.4	39.5	20.8	52.3	33.3	30.7	16.0	21.7	56.9	25.6	23.5	13.5	23.9
NTAQ1	"C8orf32, FLJ10204, WDYHV1"	ENSG00000156795	"N-terminal glutamine amidase 1"	Q96HA8	8	123416726-123470028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 21.9;Cytotrophoblasts: 13.9;Extravillous trophoblasts: 23.0;Hofbauer cells: 13.2;Syncytiotrophoblasts: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: AB_2682228"	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	7.1	10.9	16.2	5.1	16.7	5.9	13.5	16.3	24.0	12.8	15.5	7.5	4.3	8.1	8.9	6.9	7.5	6.7	20.1	14.8	17.8	13.0	6.8	6.8	7.4	17.0	17.9	18.2	9.6	11.0	10.5	6.8	17.4	10.2	7.9	14.9	6.9	8.8	16.0	7.7	4.4	9.5	15.8	5.2	8.5	12.7	20.0	7.1	12.8	17.6	10.1	8.8	7.2	17.7	26.6	26.9	39.2	18.1	15.3	40.9	14.5	19.1	21.3	23.4	26.1	15.8	17.8	19.7	19.8	23.8	32.7	12.8	25.8	29.7	31.4	53.1	15.8	25.6	13.2	22.4	21.2	12.7	10.9	24.1	16.0	29.3	32.8	27.1	22.6	41.2	18.8	29.0	33.5	84.3	30.2	14.4	12.3	65.6	20.5	13.5	20.0	20.4	31.1	22.6	18.6	34.1	20.7	109.0	35.8	44.5	17.6	12.2	9.8	26.5	46.2	19.7	26.4	17.4	38.1	24.1	18.8	14.1	19.1	16.3	5.7	2.1	6.2	8.7	7.4	5.0	7.3	7.7	9.0	4.1	6.2	6.9	1.5	16.0	3.8	5.2	10.6	4.6	16.2	16.7	16.3	24.0	14.8	17.8	17.0	17.9	17.4	15.8	20.0	17.7	5.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	13.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	23.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	10.0	0.3	0.0	0.0	0.0
NTPCR	"C1orf57, HCR-NTPase, MGC13186, THEP1"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA028125: AB_10601091, HPA054304: AB_2682443"	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	3.0	4.0	8.9	2.0	9.3	0.8	3.6	8.3	9.6	5.0	10.9	4.5	2.0	4.2	3.8	3.2	4.7	3.2	4.5	9.0	10.3	3.6	2.8	3.4	2.9	11.4	9.3	5.3	5.9	5.3	4.2	2.5	12.0	4.1	4.3	8.0	3.3	4.0	13.5	4.3	3.9	4.1	9.8	3.4	3.0	2.2	10.0	3.6	4.4	11.8	2.7	3.8	4.2	9.1	2.0	4.9	5.4	2.7	4.0	5.2	0.1	1.3	4.3	4.0	5.5	3.5	2.3	3.1	2.9	2.7	2.2	2.6	3.7	5.0	4.4	2.3	6.9	0.9	3.4	4.5	4.1	1.7	1.8	6.9	9.4	3.9	3.9	4.0	3.3	5.8	2.8	4.6	4.8	1.5	4.4	4.4	5.4	4.0	5.7	2.9	3.5	4.6	5.9	2.4	4.7	7.8	1.9	1.6	1.9	4.0	4.0	3.8	2.5	3.3	2.7	3.6	3.7	5.2	4.6	3.5	3.9	4.1	4.9	0.3	0.5	0.2	0.6	0.6	0.7	0.5	0.9	0.3	0.4	0.6	1.2	1.0	0.9	0.5	0.5	0.1	1.1	0.4	8.9	9.3	8.3	9.6	9.0	10.3	11.4	9.3	12.0	9.8	10.0	9.1	45.5	19.2	21.1	24.8	16.9	19.4	37.3	85.3	24.5	15.8	31.5	34.8	63.9	38.6	36.3	25.8	27.1	68.9	16.1	37.3	93.9	62.2	47.7	27.3	29.4	29.1	25.8	15.8	16.1	64.5	59.1	33.1	16.3	27.7	16.5	44.9	23.9	34.3	42.3	10.1	16.1	50.0	75.3	22.8	17.3	27.3	20.2	21.2	23.2	15.0	30.1	41.0	47.4	16.1	20.8	46.5	31.2	30.5	12.2	40.1	66.0	82.0	27.2	21.8	13.1	21.3	27.7	86.5	40.4	40.1	23.9	28.0	16.5	67.9	66.5	41.6
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 7.0;brain: 21.7"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 22.8;granulocytes: 55.9;Horizontal cells: 57.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 7.6;medulla oblongata: 19.8;pons: 21.7"	"Immune cell enriched"	"Detected in single"	116	"basophil: 94.5"	"Lineage enriched"	"Detected in single"	768	"granulocytes: 94.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 82.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.4"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.1"	"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		79000	"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	0.8	7.0	0.7	0.4	1.8	0.7	0.2	1.8	7.6	0.7	0.7	0.8	0.5	1.0	0.0	0.1	0.5	0.4	1.0	0.3	2.8	3.0	0.0	0.5	0.1	19.8	1.5	0.1	0.2	0.0	0.7	0.2	21.7	1.4	0.0	1.9	0.5	0.3	0.4	0.1	0.3	0.6	0.2	0.1	0.5	1.6	0.4	0.3	0.2	0.2	0.0	0.3	0.5	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	11.9	0.0	14.0	0.0	0.0	0.0	0.0	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	1.6	0.0	0.2	0.0	2.4	0.2	0.0	1.5	2.5	0.0	0.2	0.0	0.5	1.5	18.2	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	1.1	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.1	94.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.7	1.8	1.8	7.6	0.3	2.8	19.8	1.5	21.7	0.2	0.4	0.6	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	4.2	0.7	0.0	0.0	4.3	0.0	0.1	55.9	0.0	0.0	0.0	0.1	57.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.9	3.2	2.7	0.0	0.1	0.0	1.0	0.1	0.0	0.0
NUAK1	"ARK5, KIAA0537"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063345-106138954	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 111.7;Excitatory neurons: 150.5;Hepatic stellate cells: 136.3;Microglial cells: 93.7;Oligodendrocytes: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 58.0;EFO-21: 55.1;RH-30: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	17.5	3.6	12.6	2.3	17.5	0.6	12.1	9.4	25.4	9.8	0.0	4.1	2.2	9.5	3.1	3.5	9.0	4.9	18.8	17.4	5.6	4.2	4.0	9.3	3.2	6.1	5.9	6.1	3.2	17.5	2.7	4.5	8.3	6.0	3.9	5.4	3.4	6.0	20.6	20.8	4.3	10.2	5.5	0.8	3.8	2.6	5.5	3.3	4.3	17.2	2.3	4.8	8.1	31.8	13.0	8.3	58.0	0.6	23.7	2.5	27.0	14.2	9.5	9.9	8.0	4.3	2.1	0.0	55.1	27.4	5.0	11.9	12.6	11.2	4.8	0.2	3.4	0.0	9.7	4.7	5.0	0.1	0.1	11.0	8.1	6.0	1.7	19.2	21.2	0.1	0.0	40.3	7.8	1.3	0.2	0.6	11.1	0.2	3.3	0.1	77.7	10.5	6.6	13.3	6.8	0.4	6.9	1.9	0.5	37.2	2.9	0.4	16.6	9.4	29.7	3.3	17.0	0.0	0.0	0.7	2.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	17.5	9.4	25.4	17.4	5.6	6.1	5.9	8.3	5.5	5.5	31.8	56.4	0.0	2.4	15.7	0.6	13.5	32.9	29.8	10.2	32.3	2.1	4.2	48.9	10.0	7.2	7.3	0.0	0.8	13.5	0.9	3.9	6.2	0.4	5.1	6.6	111.7	0.0	5.3	150.5	9.6	5.2	17.9	2.0	3.8	0.0	2.9	136.3	12.1	8.0	40.4	55.4	2.3	12.2	8.4	8.8	2.6	4.1	1.3	10.6	93.7	0.6	1.9	1.0	15.6	73.5	18.4	0.5	3.0	3.2	10.6	0.2	1.8	2.2	2.9	0.0	7.1	26.4	1.0	5.5	2.5	15.9	0.3	2.7	0.4	0.8	5.2
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302063-205321745	"Enzymes, Metabolic proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.7;vagina: 45.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 46.9;Endometrial ciliated cells: 45.3;Glandular and luminal cells: 52.4;Intestinal goblet cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 120.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.1;RPMI-8226: 36.1;RPTEC TERT1: 40.9;SuSa: 45.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	2.1	3.7	1.3	7.7	1.9	11.4	0.9	4.6	1.7	31.0	3.2	8.0	16.5	1.6	1.3	56.7	4.0	1.7	1.2	1.2	1.3	28.2	5.1	10.3	11.5	2.1	1.8	1.3	16.0	0.8	3.0	4.4	2.0	1.9	8.8	0.5	15.1	1.6	0.7	22.4	12.5	1.2	1.4	13.1	2.5	3.7	2.2	3.9	16.1	1.1	8.0	3.1	45.3	4.1	4.3	23.1	13.7	0.6	0.3	0.6	44.1	5.5	5.7	14.7	5.9	24.4	0.8	7.0	3.2	1.5	24.1	8.3	3.2	8.3	6.3	0.0	0.4	0.0	1.4	4.2	9.3	0.0	0.1	2.6	6.1	8.6	5.0	3.3	0.7	0.0	0.9	1.7	2.8	1.0	0.0	0.1	8.9	3.1	0.7	0.0	1.0	36.1	40.9	0.1	2.1	0.2	1.6	6.5	0.7	45.6	6.6	0.1	1.7	5.3	2.5	0.6	8.7	12.1	2.0	4.4	0.8	0.0	2.1	11.2	16.5	40.1	10.3	11.8	7.6	37.9	12.7	12.3	10.4	39.3	27.9	21.9	120.4	17.5	13.1	4.1	8.1	17.4	1.3	1.9	4.6	1.7	1.2	1.3	2.1	1.8	2.0	1.4	2.2	4.1	2.0	6.4	6.8	0.3	28.0	1.1	3.2	3.7	13.1	1.1	1.9	2.2	2.7	20.0	2.9	33.1	0.0	9.2	7.1	34.9	5.9	46.9	2.0	45.3	7.5	5.9	10.8	2.7	0.1	1.8	29.1	3.7	7.7	52.4	0.0	2.4	0.7	2.6	4.7	0.0	0.4	43.0	18.3	12.3	11.1	2.1	0.0	8.9	7.2	3.7	38.5	1.3	18.6	0.5	3.5	6.9	7.8	0.0	18.5	2.5	18.3	17.2	7.7	0.5	6.6	2.4	5.5	0.9	1.1	21.5	5.4	4.1	5.7	0.5	22.0	0.5
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341772-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.4;monocytes: 559.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"		"HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217"	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	36.7	33.2	23.5	47.0	24.3	30.7	31.3	24.5	23.0	32.5	23.2	36.0	62.1	32.7	18.1	27.7	31.6	33.8	33.6	21.1	24.1	28.9	35.5	36.4	62.8	25.9	24.8	35.2	40.1	40.7	25.8	30.7	25.3	31.4	30.2	31.7	41.8	28.5	52.8	29.3	56.9	21.1	24.2	54.7	36.6	52.0	24.5	46.2	47.3	32.4	40.6	30.2	28.0	26.7	78.0	34.8	45.9	26.9	47.0	56.6	38.7	61.2	55.8	45.5	52.2	34.2	67.3	84.5	78.5	38.8	58.3	38.0	27.9	40.0	29.2	74.2	46.4	30.8	32.1	21.9	65.2	72.0	38.0	36.4	46.4	32.9	31.3	56.4	30.6	41.4	81.5	2.5	37.3	42.0	126.9	55.0	73.0	79.4	45.6	69.4	47.9	12.8	33.3	37.9	42.9	71.8	116.3	48.7	60.4	31.7	33.9	40.6	62.7	38.2	13.7	51.8	58.9	78.5	64.0	73.7	77.9	60.6	64.4	18.2	20.5	28.5	25.9	27.1	30.8	26.9	22.6	26.6	18.1	26.0	24.5	23.5	37.6	33.6	34.9	25.2	19.8	23.8	23.5	24.3	24.5	23.0	21.1	24.1	25.9	24.8	25.3	24.2	24.5	26.7	61.0	73.7	66.4	14.0	52.7	24.9	33.8	36.4	39.9	38.4	31.0	32.3	57.4	34.3	51.4	25.8	12.5	49.3	91.8	53.4	60.7	52.1	249.4	59.5	46.5	45.8	29.3	17.1	13.6	69.8	43.0	42.3	29.0	47.9	72.2	45.1	33.2	40.5	30.0	48.8	19.4	40.9	18.3	37.1	45.8	34.2	44.1	46.7	16.0	18.7	559.4	57.7	74.2	11.1	23.0	52.3	20.5	41.0	22.3	48.7	56.5	37.8	55.7	41.4	26.3	39.5	43.3	160.4	12.5	25.8	29.0	50.1	60.0	40.2	26.0	33.1
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712822-205750182	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	63.3	57.2	88.6	43.3	98.3	33.4	72.8	86.2	102.7	70.8	53.7	52.5	29.5	83.4	62.0	54.4	71.8	46.7	98.3	80.7	88.8	70.4	104.2	48.7	61.2	93.8	87.8	108.9	41.2	96.1	39.0	49.6	94.1	71.7	48.1	81.4	46.8	71.1	113.7	51.4	33.2	69.8	94.6	56.5	43.0	25.8	87.9	97.4	98.1	101.6	60.7	47.8	45.2	115.8	223.5	134.6	354.2	140.8	96.0	131.7	166.1	157.3	161.3	215.6	172.6	74.4	250.0	246.1	89.0	154.2	68.2	160.0	272.6	131.9	245.7	118.6	135.8	160.3	113.2	81.8	70.6	255.0	54.9	105.1	116.9	128.6	221.7	115.6	171.4	156.3	261.9	76.7	170.7	258.1	233.2	128.0	363.0	88.9	99.4	239.1	436.4	141.1	121.4	135.4	146.9	270.9	232.2	183.3	127.5	272.4	280.3	189.9	172.8	164.5	144.8	190.0	282.8	69.9	88.0	192.6	112.8	140.5	226.2	5.6	3.2	3.9	9.1	4.9	8.8	5.6	8.3	8.0	4.6	6.9	10.1	10.7	0.6	10.7	4.2	7.3	5.5	3.8	88.6	98.3	86.2	102.7	80.7	88.8	93.8	87.8	94.1	94.6	87.9	115.8	258.4	214.7	283.4	73.4	179.5	258.1	277.4	212.9	282.9	356.2	221.2	229.7	412.4	318.8	241.8	303.5	73.0	301.5	174.5	125.5	385.4	202.5	61.3	227.0	410.3	254.5	179.0	324.2	85.9	171.5	381.3	356.5	131.0	299.5	215.4	329.0	258.5	668.2	264.1	316.3	88.7	219.2	116.0	216.8	266.4	52.6	512.0	164.0	174.3	71.2	162.1	546.9	195.7	56.8	126.2	117.2	113.2	485.2	128.2	295.3	49.4	384.5	187.8	200.2	315.5	458.0	358.1	70.0	104.1	321.4	243.9	177.2	190.5	443.9	265.1	220.8
NUDCD2	"DKFZp686E10109, NudCL2"	ENSG00000170584	"NudC domain containing 2"	Q8WVJ2	5	163446526-163460102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037384, HPA037385"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA037384: AB_2675447, HPA037385: AB_10673630"	"unprognostic (3.96e-1)"	"unprognostic (3.69e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.85e-2)"	13.9	11.8	11.1	13.2	13.2	11.7	11.2	13.2	14.0	8.1	10.2	11.2	14.5	10.2	6.4	12.8	9.7	5.7	8.3	11.0	11.4	11.7	15.3	8.7	15.1	12.8	12.6	8.9	15.4	6.8	9.3	10.3	13.7	8.9	6.1	7.3	14.0	3.6	20.9	10.7	13.3	6.3	12.8	12.8	11.8	10.4	12.5	8.1	9.4	5.0	9.8	9.2	10.3	17.7	62.3	32.3	23.5	37.1	14.1	10.4	31.3	24.6	7.0	8.7	13.9	28.6	46.3	35.5	57.5	4.0	39.8	30.6	12.6	13.9	10.7	70.6	36.6	32.4	42.0	26.4	15.3	37.3	35.3	3.8	7.7	8.4	12.1	12.3	9.8	39.1	35.1	42.6	8.9	25.2	55.1	80.9	25.8	18.4	35.2	45.7	39.2	63.0	8.0	14.3	59.6	33.6	38.7	24.7	66.3	13.8	47.2	37.8	21.9	29.4	43.8	32.6	56.7	35.0	63.8	61.5	34.2	63.2	31.4	49.9	48.3	32.5	60.2	59.8	76.5	91.7	84.0	71.8	68.0	68.0	88.7	79.0	6.2	83.8	51.5	81.1	83.5	69.1	11.1	13.2	13.2	14.0	11.0	11.4	12.8	12.6	13.7	12.8	12.5	17.7	58.0	28.9	23.8	9.1	47.5	59.4	54.9	92.6	42.7	30.7	70.4	88.6	43.1	35.8	53.1	38.6	22.9	118.7	43.8	25.4	148.7	63.6	95.1	57.6	44.1	47.4	43.8	78.4	18.8	64.0	55.8	48.6	32.1	38.3	31.6	35.7	36.0	55.1	69.8	10.1	14.0	45.3	87.5	41.8	42.7	24.5	51.6	35.7	49.8	11.2	46.4	51.4	52.5	11.1	36.0	59.9	33.6	51.1	55.5	95.2	31.5	112.5	65.1	38.2	39.5	51.3	46.5	87.6	44.2	56.0	67.6	56.8	48.3	64.8	68.6	59.3
NUDT1	MTH1	ENSG00000106268	"Nudix hydrolase 1"	P36639	7	2242226-2251146	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012636	Approved		Supported	Cytosol		No	No		21000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA012636: AB_1854696"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.15e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.29e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.70e-1)"	19.1	8.0	13.7	23.8	16.6	77.6	15.0	14.6	18.0	16.9	10.9	19.1	16.2	12.4	5.4	29.1	12.0	10.5	18.7	15.4	13.6	8.9	6.3	12.4	37.1	16.1	14.1	9.3	9.1	3.2	4.4	10.5	15.6	11.3	11.0	4.3	12.4	7.0	21.3	33.8	16.8	9.2	15.0	23.6	12.2	65.5	14.5	59.4	7.6	13.5	31.5	14.6	18.5	17.9	98.4	155.2	83.3	111.0	30.0	41.3	61.0	42.3	36.5	57.0	65.8	84.2	72.1	102.8	33.7	47.0	115.5	117.1	63.8	64.3	33.1	46.2	109.4	80.6	136.3	72.7	7.2	63.2	78.0	27.4	16.7	82.3	29.0	18.6	31.0	147.1	65.0	111.6	64.5	250.2	119.1	245.3	179.5	48.5	94.7	163.5	123.4	86.4	31.7	54.9	83.5	115.6	43.7	126.9	20.8	59.8	83.9	165.8	29.1	54.2	205.1	126.8	102.3	85.2	70.6	108.9	54.6	155.1	199.8	31.5	60.2	44.4	42.8	78.6	34.3	71.0	49.6	45.6	94.3	65.1	48.9	42.3	16.2	39.4	66.8	211.5	75.5	45.7	13.7	16.6	14.6	18.0	15.4	13.6	16.1	14.1	15.6	15.0	14.5	17.9	13.0	6.4	7.5	1.0	34.2	40.1	26.5	22.6	14.8	11.2	25.3	39.0	16.8	10.0	13.7	11.0	4.2	38.5	46.1	39.6	19.6	24.3	54.7	14.9	24.3	12.8	7.8	111.7	0.5	37.4	80.0	29.6	13.7	10.7	61.0	32.4	7.9	5.2	89.4	0.0	0.5	35.7	32.6	46.2	86.7	121.2	22.1	52.6	46.2	0.0	47.1	27.4	47.4	1.0	4.3	20.4	18.4	18.8	33.1	21.5	17.3	14.1	13.0	7.9	32.9	27.5	32.4	70.2	54.8	41.0	37.1	23.7	37.3	13.7	45.1	27.3
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 176.1;Proximal enterocytes: 206.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	16.5	23.9	17.4	3.5	20.1	2.1	19.3	19.9	28.4	9.0	27.5	14.5	12.5	6.4	3.5	17.5	8.9	6.4	27.5	19.9	21.5	28.8	19.5	20.1	5.9	19.0	17.4	6.4	40.4	16.0	61.1	3.2	19.1	18.6	2.9	4.7	17.2	2.9	31.6	14.1	16.3	1.8	17.9	12.5	17.6	13.9	17.2	3.6	22.1	12.7	2.1	8.4	11.3	21.1	18.1	24.2	2.1	9.4	2.8	3.3	38.1	5.0	6.5	8.0	11.5	17.5	18.7	1.3	24.4	2.6	17.8	22.7	1.1	13.6	0.7	9.5	17.7	4.0	10.4	12.2	19.9	4.8	46.7	4.7	16.7	1.9	1.4	3.4	15.9	8.8	6.4	2.9	2.8	52.5	0.6	0.0	12.6	42.7	33.5	9.4	21.9	10.8	8.8	51.2	32.8	4.8	9.0	0.2	21.7	3.9	18.8	23.1	38.3	13.2	5.8	9.5	5.1	1.4	1.0	2.2	19.4	5.5	4.9	6.2	40.5	1.2	12.6	40.8	7.5	12.8	9.6	8.0	33.5	10.2	9.4	10.8	1.3	15.2	68.6	17.0	6.0	19.2	17.4	20.1	19.9	28.4	19.9	21.5	19.0	17.4	19.1	17.9	17.2	21.1	66.1	12.8	28.5	5.2	12.4	38.9	101.7	123.4	52.9	12.1	46.8	78.5	54.5	40.0	41.2	35.0	18.8	44.7	16.1	88.2	176.1	94.1	3.1	59.3	8.0	61.6	37.3	10.1	5.9	30.8	18.2	14.7	30.5	31.0	38.8	11.9	27.1	28.0	137.0	35.3	3.0	62.6	73.2	27.4	27.1	9.8	11.5	33.9	46.2	12.2	35.6	38.3	22.6	0.5	5.8	51.2	132.4	3.8	7.7	51.9	206.9	169.1	65.7	19.1	0.0	39.0	11.4	12.4	48.5	30.4	19.0	38.2	26.8	5.2	75.4	82.2
NUDT15	"FLJ10956, MTH2"	ENSG00000136159	"Nudix hydrolase 15"	Q9NV35	13	48037726-48047221	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038968, HPA038969"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA038968: AB_10697402, HPA038969: AB_2676295"	"unprognostic (9.48e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.64e-2)"	"unprognostic (9.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.47e-3)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-3)"	12.2	13.0	7.1	10.1	7.2	18.0	16.4	8.6	8.3	12.9	6.9	20.2	20.8	9.7	13.8	16.3	11.6	9.0	11.0	6.9	8.5	17.2	14.1	9.2	7.5	7.2	7.7	8.6	9.4	8.2	9.4	12.6	7.8	15.1	22.1	10.3	12.1	10.0	11.9	8.7	16.3	10.5	6.8	5.5	13.0	10.7	7.6	10.7	13.4	18.7	10.3	12.9	10.3	7.8	47.5	28.4	52.4	23.1	21.2	30.3	37.8	37.7	35.8	41.3	39.7	42.1	45.2	34.6	20.7	30.3	36.7	54.3	51.3	56.1	63.4	18.3	41.8	34.1	28.0	46.2	19.8	52.0	31.2	20.9	35.3	33.3	46.7	18.4	45.3	34.5	30.7	13.5	67.2	23.2	40.5	48.4	83.0	72.8	32.2	27.6	33.8	22.7	46.2	35.8	31.4	33.1	25.6	43.8	30.3	44.7	22.5	38.7	23.0	28.5	34.7	36.2	53.3	6.9	12.5	43.6	14.8	40.1	47.4	1.6	4.8	3.5	2.9	6.9	2.9	3.1	4.6	3.6	4.9	2.6	5.3	5.8	1.0	2.8	4.8	3.7	3.4	2.7	7.1	7.2	8.6	8.3	6.9	8.5	7.2	7.7	7.8	6.8	7.6	7.8	12.0	12.8	15.7	0.7	14.7	16.6	34.6	18.1	19.9	9.2	14.0	11.6	12.5	12.8	20.7	7.3	2.1	36.2	12.6	30.4	49.0	17.3	16.7	45.7	20.4	15.1	8.4	10.5	3.9	17.6	79.4	12.8	18.3	39.5	9.5	8.7	7.5	17.4	16.8	38.7	3.1	23.5	26.4	7.8	10.5	9.3	16.8	11.4	10.6	1.9	10.3	10.8	6.2	0.5	3.0	16.4	18.3	12.4	16.8	41.9	18.9	40.8	13.6	9.0	0.0	9.5	17.1	8.9	34.4	34.9	20.5	38.0	13.2	15.3	31.9	42.0
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 179.8;Proximal enterocytes: 334.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 41.7;eosinophil: 47.0;intermediate monocyte: 54.6;myeloid DC: 32.4;neutrophil: 34.0;non-classical monocyte: 63.4"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.4;granulocytes: 47.0;monocytes: 63.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA		38000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	30.6	19.0	39.3	15.2	40.1	10.4	22.9	35.9	49.3	17.1	28.6	25.6	22.2	19.4	11.0	11.1	22.7	9.8	32.9	34.1	38.3	27.7	33.8	26.2	12.3	40.7	39.6	25.2	14.7	48.6	15.8	8.1	40.9	17.8	19.5	18.8	16.1	13.6	24.7	11.6	57.6	12.6	41.7	36.0	21.3	12.2	41.2	6.7	24.4	24.5	10.1	20.9	14.0	40.8	20.8	10.8	17.5	9.2	34.3	31.0	8.1	16.5	15.1	10.9	11.3	16.8	9.0	3.4	14.1	15.4	21.5	14.8	15.7	10.4	17.3	10.4	11.5	8.7	15.3	16.4	22.0	14.9	15.4	27.8	9.0	7.2	19.5	9.7	17.2	0.0	10.2	17.4	10.7	21.5	0.0	4.0	13.6	20.6	16.0	11.6	12.6	26.1	10.8	16.6	8.6	15.0	9.9	9.9	15.6	14.7	21.6	11.7	17.1	17.7	7.6	32.8	13.0	17.1	18.1	0.5	11.5	11.2	10.0	7.2	41.7	47.0	6.0	54.6	6.2	11.2	6.0	5.5	32.4	10.5	5.3	5.4	34.0	9.8	63.4	4.3	10.7	17.4	39.3	40.1	35.9	49.3	34.1	38.3	40.7	39.6	40.9	41.7	41.2	40.8	56.1	16.0	41.1	4.6	13.0	8.4	12.3	21.1	10.8	22.8	22.2	20.2	85.2	44.3	23.9	20.2	8.4	21.0	11.5	58.8	68.4	24.7	77.8	27.2	25.5	33.0	25.3	17.9	5.6	36.9	26.1	27.8	36.2	33.1	19.6	23.0	78.1	107.5	65.1	43.7	3.0	74.7	18.3	179.8	25.3	37.5	26.4	73.6	17.8	3.7	64.6	14.2	17.5	3.0	4.6	31.1	66.7	39.5	14.3	19.5	334.3	109.4	19.8	19.2	26.3	22.1	30.7	28.2	6.3	15.4	5.4	7.3	15.1	68.2	48.5	16.0
NUDT16L1	"SDOS, TIRR"	ENSG00000168101	"Nudix hydrolase 16 like 1"	Q9BRJ7	16	4693694-4695859	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044186, HPA063605"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA044186: AB_10968571, HPA063605: AB_2685058"	"unprognostic (1.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (6.81e-2)"	"prognostic favorable (1.02e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.81e-3)"	19.7	46.4	43.1	12.0	44.8	22.2	21.5	43.6	52.5	23.1	45.6	28.5	21.7	21.4	15.3	28.9	23.4	8.4	58.2	44.1	42.0	43.4	64.1	17.2	17.9	45.3	43.2	22.7	24.6	20.4	39.9	8.0	41.9	34.8	11.9	14.5	26.6	14.7	25.0	25.2	29.2	8.5	43.3	33.7	30.1	22.8	44.3	18.2	30.8	16.9	13.1	22.7	21.8	45.7	14.7	23.8	21.2	28.7	15.7	12.1	19.4	17.2	12.9	20.4	12.8	26.9	11.6	15.2	24.4	20.7	10.3	16.8	23.1	23.4	9.5	22.6	38.9	16.8	21.1	32.8	17.0	24.4	19.2	18.7	21.3	17.2	10.7	13.9	15.1	22.6	31.2	18.5	20.1	57.3	36.8	36.0	33.6	24.4	27.0	50.9	22.4	24.2	24.8	18.0	41.8	31.5	25.1	25.9	11.7	16.5	38.4	56.4	20.0	16.7	25.3	39.8	15.9	32.1	20.5	26.1	10.4	32.3	34.8	56.6	54.3	96.2	52.6	48.2	63.1	60.7	63.4	62.8	50.2	65.3	74.0	63.5	68.2	63.9	53.5	83.6	78.3	98.1	43.1	44.8	43.6	52.5	44.1	42.0	45.3	43.2	41.9	43.3	44.3	45.7	23.3	16.0	22.4	14.4	32.6	14.0	19.7	37.4	27.9	52.1	36.0	36.2	52.6	24.3	28.0	42.3	10.4	53.8	43.6	47.7	109.5	28.7	5.2	28.7	33.6	21.4	43.1	23.1	10.2	30.9	31.8	24.0	30.5	29.0	27.9	31.7	17.9	41.8	40.9	47.1	11.8	51.7	89.5	18.3	18.7	8.7	31.4	20.8	30.2	3.7	43.3	83.5	34.0	9.5	15.0	30.0	48.5	50.0	33.0	17.9	77.8	98.2	20.1	58.3	46.0	14.2	22.8	14.8	34.7	24.9	16.6	49.1	43.6	58.0	51.4	17.6
NUDT19	RP2	ENSG00000213965	"Nudix hydrolase 19"	A8MXV4	19	32691961-32713796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042761			Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA042761: "	"unprognostic (1.20e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.61e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.35e-4)"	5.1	11.7	4.0	4.1	4.1	8.4	4.6	3.9	4.5	3.9	9.4	6.9	7.1	3.6	5.4	11.1	3.6	2.9	10.6	4.1	5.1	6.3	6.9	6.4	5.8	4.6	4.3	3.7	8.4	7.1	4.0	4.5	4.8	7.5	7.3	8.3	6.9	3.5	23.9	8.9	6.2	4.3	4.3	5.2	8.1	2.8	4.6	3.1	3.6	13.0	5.1	6.3	5.6	4.6	21.5	24.7	2.7	24.0	8.1	10.5	0.2	11.9	4.4	8.7	8.2	14.0	11.6	0.1	14.0	13.8	6.7	13.7	16.7	13.9	11.4	24.8	10.0	27.7	9.3	5.0	11.2	20.9	8.2	8.5	18.1	7.4	17.8	10.1	13.0	4.2	21.6	15.3	15.9	14.3	0.1	19.3	2.9	5.9	11.5	0.1	5.2	12.1	14.4	15.7	10.7	15.4	21.2	17.7	15.9	4.7	9.8	25.4	10.4	11.9	7.7	12.0	21.5	17.8	16.3	6.9	14.4	20.0	11.2	11.1	26.5	15.4	18.2	36.7	20.0	13.0	18.9	22.6	19.5	9.4	14.9	20.4	5.1	32.2	42.4	15.9	23.6	11.9	4.0	4.1	3.9	4.5	4.1	5.1	4.6	4.3	4.8	4.3	4.6	4.6	5.9	12.8	14.5	7.5	6.4	21.9	9.4	4.6	8.0	14.5	12.0	6.6	22.8	2.8	6.2	7.3	12.5	11.0	9.1	10.6	27.4	2.9	7.7	8.5	9.3	7.3	12.1	10.3	5.9	11.5	11.5	6.6	3.1	10.7	1.3	11.3	13.2	12.5	14.3	3.3	6.7	12.7	8.2	17.6	11.6	3.7	4.1	10.2	12.4	4.7	10.7	4.6	4.1	6.6	7.4	12.0	13.1	9.4	4.1	12.0	15.7	18.8	6.5	30.4	0.0	6.9	7.4	1.6	2.2	9.9	31.5	7.8	9.1	22.3	18.4	10.6
NUDT2	APAH1	ENSG00000164978	"Nudix hydrolase 2"	P50583	9	34329506-34343711	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004684, HPA044903, HPA058623, HPA067639"	Uncertain		Approved	Nucleoplasm		NA	NA		65000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877"	"unprognostic (2.74e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.91e-1)"	21.7	32.0	36.6	10.6	37.9	14.9	26.0	37.4	47.3	26.4	33.6	29.0	16.3	22.3	35.8	26.0	25.2	13.9	28.2	35.8	37.5	23.9	27.0	13.6	17.3	37.5	37.0	34.8	34.5	19.4	30.8	18.1	37.1	26.8	19.0	20.8	21.1	15.6	44.0	25.7	18.6	18.4	38.1	20.2	25.5	16.2	37.4	23.7	7.1	15.0	18.0	28.4	22.6	40.4	59.3	24.2	30.8	10.9	20.7	37.7	22.0	28.1	62.7	31.8	33.0	16.5	27.4	16.7	22.8	35.0	12.2	25.4	28.1	68.7	32.1	61.7	24.8	35.2	44.6	31.4	61.1	28.1	13.9	38.5	45.1	41.4	77.0	43.3	66.2	55.9	10.3	64.7	46.9	36.8	29.1	26.1	19.4	26.8	67.7	36.7	19.2	41.7	31.3	19.2	6.3	24.9	45.1	16.9	27.3	27.4	14.0	29.5	43.2	27.1	24.4	18.0	29.8	14.9	25.7	28.8	33.9	26.0	35.4	20.8	16.2	13.0	14.7	14.6	20.6	22.6	23.9	19.0	20.7	22.2	27.2	23.8	5.8	19.9	15.1	19.1	27.1	15.7	36.6	37.9	37.4	47.3	35.8	37.5	37.5	37.0	37.1	38.1	37.4	40.4	26.3	3.2	4.1	9.1	17.0	28.2	20.5	44.6	14.2	13.6	39.1	53.1	24.9	37.1	20.6	16.5	6.2	39.0	16.7	20.2	88.0	26.7	11.4	20.2	18.5	24.7	22.2	21.0	6.9	40.0	37.8	21.5	13.7	11.5	13.3	21.6	28.5	36.2	36.9	8.4	7.7	34.7	14.2	31.1	23.0	26.8	27.4	20.3	23.2	11.2	25.8	25.9	18.6	12.5	19.0	32.6	26.5	19.2	31.8	18.5	28.7	65.4	25.4	16.5	26.3	21.0	23.9	39.7	19.2	25.0	31.5	18.9	17.8	35.0	30.0	23.6
NUDT22	MGC13045	ENSG00000149761	"Nudix hydrolase 22"	Q9BRQ3	11	64225941-64230686	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039334, HPA053464"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA039334: AB_10795174, HPA053464: AB_2682160"	"unprognostic (2.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.61e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.76e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.54e-2)"	21.0	34.7	12.2	12.6	13.2	16.2	21.7	14.0	18.1	19.1	15.4	39.2	30.2	18.5	4.6	34.2	18.5	9.0	52.0	12.2	14.0	43.8	48.8	22.0	17.3	14.1	13.3	15.7	45.4	14.1	24.9	10.3	13.0	26.1	8.3	1.1	30.6	14.8	42.4	27.2	36.3	6.0	13.4	41.9	38.1	10.8	14.8	12.9	31.6	19.7	10.4	26.0	21.5	12.7	35.5	22.7	5.4	22.6	8.1	9.7	20.1	15.0	15.1	10.3	9.5	14.8	29.1	16.6	38.4	14.6	15.5	36.1	3.2	23.0	1.3	21.6	9.2	22.6	15.6	15.4	24.2	14.9	35.5	15.2	16.9	10.8	11.7	7.9	16.9	19.5	11.1	17.7	12.2	53.1	20.4	27.1	8.5	21.5	47.0	25.1	9.2	62.4	17.9	19.4	12.6	19.9	12.8	47.8	58.8	2.1	48.9	16.3	15.9	17.0	16.2	54.5	12.6	66.2	28.5	10.6	58.7	17.0	20.4	40.6	69.1	52.5	53.4	88.7	48.1	63.4	47.0	52.8	72.7	77.3	40.8	44.7	42.7	52.1	86.2	121.4	64.9	52.1	12.2	13.2	14.0	18.1	12.2	14.0	14.1	13.3	13.0	13.4	14.8	12.7	18.8	3.2	14.6	5.5	42.6	12.0	28.9	78.8	19.4	14.7	34.6	30.1	3.7	48.6	36.6	40.5	12.5	107.9	51.5	94.1	164.4	61.8	15.5	19.0	27.2	20.3	37.2	14.5	4.8	87.4	50.9	20.1	47.4	27.8	15.2	15.5	23.2	54.3	57.7	30.3	5.6	98.1	61.1	50.1	21.8	9.6	20.2	40.0	33.8	4.7	70.8	26.5	49.4	1.5	3.5	68.0	93.0	19.5	65.8	33.6	133.5	144.8	13.6	18.0	13.1	20.2	45.0	6.6	8.2	34.3	17.5	67.5	37.5	43.6	73.6	33.0
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422573-87459455	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 160.7"	"Low region specificity"	"Detected in all"							"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9900	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	23.6	36.1	20.8	16.2	21.4	6.7	19.7	25.5	38.5	27.6	39.1	27.0	42.6	24.8	32.2	19.6	24.9	16.2	28.8	21.9	24.7	40.4	46.6	23.0	13.7	21.0	20.5	26.7	67.6	55.3	29.1	19.9	21.9	30.4	27.1	20.1	28.1	23.8	42.1	16.6	40.3	23.8	19.6	14.7	22.3	22.5	22.1	13.4	28.8	45.0	14.8	22.4	24.3	26.0	30.8	25.6	34.0	19.8	67.6	39.6	26.0	59.8	35.6	21.3	21.1	17.1	53.1	47.6	58.9	47.6	41.0	21.1	32.1	38.1	33.2	34.5	24.0	13.4	34.5	31.8	42.4	25.6	21.2	41.5	52.4	25.6	22.6	45.5	41.6	13.7	40.3	30.0	38.7	33.4	39.1	23.2	29.1	68.5	12.0	45.0	31.8	27.0	160.7	24.2	41.3	28.7	37.6	63.0	30.8	44.5	36.8	38.2	43.7	34.7	34.3	25.8	27.8	21.5	18.7	37.9	51.3	21.9	48.2	1.6	17.9	5.9	19.1	21.2	18.2	22.2	18.5	19.5	21.4	18.8	22.5	26.0	1.8	15.6	24.0	20.6	19.0	16.0	20.8	21.4	25.5	38.5	21.9	24.7	21.0	20.5	21.9	19.6	22.1	26.0	32.6	67.3	44.8	20.2	14.9	9.9	40.4	45.0	9.6	15.3	11.3	13.1	40.9	30.0	55.0	23.9	27.1	33.2	13.1	21.0	41.1	44.7	28.6	26.0	26.2	25.8	16.8	6.7	21.7	36.5	32.5	29.4	8.6	27.0	20.8	23.3	18.2	47.5	33.2	6.7	24.0	18.0	40.7	12.7	11.0	11.5	25.4	14.7	10.6	20.6	16.4	26.8	8.2	18.6	24.8	29.4	37.0	26.7	15.8	32.9	55.7	56.2	41.0	18.6	26.3	36.9	23.7	44.5	23.6	15.7	9.5	37.6	12.1	29.8	24.9	27.3
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2 component of NDC80 kinetochore complex"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 28.4;lymphoid tissue: 26.0;testis: 53.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	0.8	0.6	0.5	6.9	0.8	28.4	1.2	0.5	0.8	1.0	0.4	4.2	4.3	1.1	0.3	5.8	0.4	1.0	0.3	0.6	0.6	0.3	0.7	0.9	18.2	0.9	0.8	0.4	0.2	0.6	0.2	4.7	0.9	0.4	5.3	1.5	0.9	0.3	0.1	4.1	4.3	2.3	0.7	3.6	2.6	53.5	0.8	26.0	0.5	0.2	16.7	1.8	1.8	1.0	90.8	30.8	80.5	33.9	2.5	8.1	43.6	55.9	39.3	88.9	77.3	23.7	77.7	77.4	45.5	22.6	37.0	51.6	49.6	21.0	111.5	81.4	35.6	30.3	34.8	34.4	0.3	53.0	60.2	1.0	2.0	45.0	31.6	16.8	41.1	74.5	58.1	103.9	85.0	17.6	97.3	70.6	43.9	66.1	47.0	65.0	70.3	68.4	25.3	12.4	59.9	68.9	29.9	32.2	30.6	49.7	49.3	109.5	29.4	65.9	73.8	50.1	115.1	73.9	111.5	148.9	22.0	42.9	74.7	1.4	0.1	1.3	1.2	0.0	0.5	0.6	1.8	1.2	0.2	0.7	1.2	1.0	0.4	1.8	0.1	0.3	4.3	0.4	0.5	0.8	0.5	0.8	0.6	0.6	0.9	0.8	0.9	0.7	0.8	1.0	0.5	0.0	0.5	1.3	5.3	5.9	1.9	4.2	1.2	1.2	1.3	2.7	0.9	0.0	3.3	0.0	0.0	21.7	3.6	2.6	0.0	0.8	17.7	2.5	2.5	1.8	0.0	60.8	1.1	0.2	29.7	3.4	5.6	3.0	4.5	18.3	3.3	0.4	14.0	0.0	1.4	3.3	0.0	5.2	3.6	21.4	2.5	3.1	0.0	1.0	0.9	2.0	6.2	0.5	3.6	0.2	0.1	2.2	17.8	0.8	0.9	0.2	0.7	2.3	6.6	0.9	4.2	208.2	40.3	10.6	2.4	4.0	5.0	1.7	9.0	3.8
NUFIP1	"NUFIP, Rsa1"	ENSG00000083635	"Nuclear FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989471	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	3.2	3.7	3.2	2.8	3.4	7.9	4.6	2.9	4.6	3.6	2.1	2.6	2.8	4.5	5.5	3.3	3.5	2.4	2.5	3.3	3.0	4.0	4.1	2.3	3.7	2.6	3.2	4.3	3.8	4.0	1.8	3.0	2.9	3.4	3.0	2.6	3.3	3.2	4.8	3.4	2.4	4.0	2.9	3.0	2.8	5.5	3.1	3.6	3.9	3.9	3.8	4.2	2.6	3.9	7.4	5.7	9.5	7.9	6.4	6.6	11.3	8.6	7.4	15.6	9.9	15.6	11.5	21.5	7.0	8.0	9.4	11.3	17.9	12.2	20.2	6.6	14.0	16.4	3.7	14.0	10.5	21.3	6.4	6.9	11.0	10.5	15.8	6.0	7.9	10.9	13.3	3.5	11.1	8.5	17.8	13.4	22.5	19.5	9.3	17.3	9.0	13.1	9.5	6.3	5.2	11.5	7.3	9.9	9.6	8.9	7.5	11.8	6.0	7.9	6.8	10.3	11.9	4.8	7.9	26.7	8.9	14.8	11.4	0.0	2.6	0.8	2.5	2.6	4.7	4.0	2.9	2.8	3.4	4.1	4.5	3.4	0.2	5.9	1.8	4.5	1.7	1.8	3.2	3.4	2.9	4.6	3.3	3.0	2.6	3.2	2.9	2.9	3.1	3.9	11.3	6.4	12.2	6.2	10.5	15.4	11.8	16.7	23.9	7.8	9.8	16.3	4.5	4.3	15.4	5.5	12.5	15.7	11.7	4.2	17.6	14.0	37.2	14.0	21.7	10.9	5.4	14.5	19.2	16.7	15.9	11.9	7.7	18.6	17.7	14.1	7.1	9.7	10.8	8.4	16.9	5.3	12.2	3.4	5.5	63.2	10.8	7.9	8.8	7.5	6.9	9.7	7.2	16.6	14.4	10.8	1.6	11.3	5.0	8.6	3.2	14.8	6.6	6.8	6.6	20.3	15.6	27.1	31.6	14.3	16.6	8.8	9.9	15.7	8.4	7.1
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Spermatocytes: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	13.1	15.5	9.5	16.2	10.9	21.4	11.9	13.1	10.0	15.6	10.0	14.8	7.5	13.1	8.0	23.7	11.9	9.4	13.6	9.0	9.7	10.4	9.9	16.7	18.0	11.4	11.1	11.4	12.0	13.1	14.9	11.8	11.8	13.5	11.5	13.7	13.9	9.8	15.7	21.4	13.4	13.9	9.3	16.8	13.6	56.6	10.9	27.3	12.6	10.3	20.4	16.1	15.6	11.7	33.6	62.6	50.8	69.7	37.7	37.2	45.4	45.9	35.9	82.1	54.4	76.3	26.2	58.2	16.7	50.7	52.9	96.6	115.2	56.8	61.0	47.1	55.5	51.9	113.3	60.8	23.9	89.6	50.2	26.0	26.3	86.5	43.8	24.1	47.8	74.1	116.0	40.3	58.8	84.6	77.3	36.5	68.2	63.8	59.4	69.9	109.8	59.2	25.5	37.3	71.2	34.3	118.8	44.7	17.1	37.2	49.3	32.7	39.0	67.7	48.2	69.2	83.5	34.1	67.9	76.9	39.5	56.3	51.2	8.2	4.8	1.7	7.5	8.9	9.7	4.9	6.4	7.4	6.8	4.3	6.4	7.0	0.6	5.4	5.2	2.9	8.3	6.8	9.5	10.9	13.1	10.0	9.0	9.7	11.4	11.1	11.8	9.3	10.9	11.7	9.6	0.0	12.6	15.7	10.4	6.5	6.6	6.4	5.7	16.2	7.6	7.6	3.5	10.0	5.9	5.5	45.9	8.0	8.6	6.0	1.9	6.1	14.5	7.9	13.2	9.4	9.1	8.6	11.3	6.5	6.5	9.5	9.7	12.2	6.3	24.0	11.0	5.0	8.4	20.2	13.1	7.2	6.1	4.7	6.1	5.7	9.6	8.1	1.8	12.2	5.3	6.8	9.2	12.5	13.0	9.0	2.3	11.7	8.3	10.1	3.3	2.5	6.3	24.4	26.3	18.2	7.1	52.9	37.8	13.6	11.2	8.6	9.4	12.5	7.4	8.2
NUP210L		ENSG00000143552	"Nucleoporin 210 like"	Q5VU65	1	153992685-154155116	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 26.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 20.3;Inhibitory neurons: 8.4;Late spermatids: 8.5;Oligodendrocytes: 19.2;Spermatocytes: 28.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"MCF7: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047195, HPA064245, HPA066707"	Enhanced		Approved	"Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"		"HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.51e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.35e-10)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.09e-2)"	0.1	0.0	0.2	0.0	0.7	0.1	0.0	2.4	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.7	0.6	0.1	0.1	0.0	0.3	0.0	0.8	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	26.6	0.5	0.0	0.2	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.8	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.7	2.4	0.9	0.4	0.3	0.7	0.6	0.8	0.3	0.5	2.3	0.6	0.0	0.0	6.2	0.5	0.3	0.1	0.1	0.0	0.0	0.3	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	20.3	0.7	0.6	0.9	0.0	0.4	7.0	0.2	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.0	0.2	0.0	8.4	0.1	0.0	0.0	0.6	8.5	0.9	0.8	0.0	2.8	0.0	0.0	0.0	4.5	19.2	0.0	0.0	1.2	1.7	0.1	0.0	0.1	0.1	0.0	6.6	1.8	0.3	28.2	5.1	0.3	0.6	0.0	0.4	0.1	0.1	0.3
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 151.6;Late spermatids: 424.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	7.7	8.9	5.9	6.9	7.3	4.6	13.1	8.9	7.8	8.5	5.0	7.6	6.3	8.1	7.7	8.7	8.9	6.9	6.2	6.1	5.9	10.2	14.4	5.9	9.1	5.5	5.9	10.4	10.2	8.9	6.3	7.8	5.5	7.8	9.1	9.0	8.4	7.0	7.4	9.0	6.5	8.9	6.6	5.7	7.2	24.2	5.5	10.4	8.2	8.7	11.0	9.2	8.0	6.4	19.7	19.7	32.5	20.5	11.8	11.5	23.2	23.0	18.8	35.3	33.5	37.6	24.7	34.6	22.0	12.4	40.9	17.4	45.4	26.7	57.8	29.6	27.8	32.6	16.4	43.9	8.2	23.6	21.8	8.2	13.8	29.9	28.9	7.9	20.8	20.5	28.7	25.3	27.8	23.7	28.7	29.1	57.9	31.6	61.9	34.3	25.2	25.0	34.0	24.7	29.4	20.3	21.6	26.6	26.0	24.4	17.0	16.2	10.6	28.6	19.7	23.3	26.5	16.4	38.3	37.9	19.3	16.8	39.2	0.0	4.1	1.4	4.9	5.5	8.6	7.2	6.3	6.0	3.2	6.5	7.5	6.7	0.2	5.6	6.6	3.1	6.7	4.1	5.9	7.3	8.9	7.8	6.1	5.9	5.5	5.9	5.5	6.6	5.5	6.4	9.6	9.6	6.8	6.5	10.3	26.0	20.7	17.5	12.5	10.8	9.3	8.9	4.7	14.3	13.8	16.5	18.8	23.6	8.5	3.3	11.7	15.5	151.6	5.3	8.1	10.2	3.6	12.6	11.5	12.7	20.2	10.8	5.1	6.4	8.2	8.1	12.8	12.6	8.4	6.7	12.0	7.5	16.2	4.4	9.9	424.7	9.6	3.6	21.4	2.8	5.0	11.4	7.2	17.1	12.8	11.1	5.1	8.2	7.5	12.8	4.2	14.5	6.9	19.1	13.1	18.7	11.6	39.8	21.1	11.3	27.4	9.4	11.5	9.0	9.6	11.2
NUP42	"CG1, H_RG271G13.9, hCG1, NLP_1, NUPL2"	ENSG00000136243	"Nucleoporin 42"	O15504	7	23181841-23201011	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;Cardiomyocytes: 20.3;Cytotrophoblasts: 17.1;dendritic cells: 10.5;Extravillous trophoblasts: 11.6;Hofbauer cells: 28.1;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049036, HPA057251"			Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA049036: , HPA057251: "	"unprognostic (3.81e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-2)"	10.8	14.7	12.9	10.8	8.8	20.6	11.4	21.2	13.8	11.2	18.0	11.1	14.9	14.2	15.1	13.6	12.9	13.1	19.7	11.2	10.4	15.1	13.9	10.0	21.6	11.6	9.9	12.0	6.2	17.1	6.4	8.6	8.9	12.1	14.3	8.2	10.7	10.1	11.6	16.4	12.4	15.0	3.6	15.8	11.6	18.9	10.7	19.4	14.4	9.0	18.3	13.2	7.7	22.6	31.1	14.0	21.5	44.5	21.3	25.0	17.8	23.1	16.6	25.2	26.4	21.2	31.9	52.4	22.0	16.1	54.1	41.6	37.9	17.2	32.6	15.9	39.0	32.0	36.5	21.7	24.6	67.4	47.1	11.6	25.5	21.8	14.5	20.4	29.0	22.0	58.9	31.4	25.5	7.7	32.5	54.6	45.1	38.4	21.9	31.6	19.0	40.5	27.1	21.6	33.2	31.2	22.9	14.0	44.9	41.2	17.0	86.3	21.6	16.5	21.8	28.3	39.7	44.9	64.8	52.3	17.6	46.7	44.4	33.2	10.3	8.1	11.0	10.1	10.7	18.8	12.8	12.1	15.0	13.6	10.6	12.7	8.0	17.8	9.3	14.4	16.2	11.1	12.9	8.8	21.2	13.8	11.2	10.4	11.6	9.9	8.9	3.6	10.7	22.6	7.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	17.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	11.6	5.2	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	6.6	1.3	0.0	0.0	0.0
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	20.9	12.9	15.2	18.6	15.7	20.8	20.0	21.8	17.0	21.5	15.4	18.7	15.8	20.8	16.1	20.5	20.9	11.6	16.4	15.6	14.7	18.9	22.1	18.7	26.5	15.8	15.1	20.8	18.7	12.1	12.7	19.0	16.0	18.9	21.0	11.2	16.7	14.3	16.7	23.9	20.5	19.6	14.9	25.3	16.9	22.2	15.3	33.2	18.0	14.1	27.0	17.9	19.5	17.0	66.5	74.0	53.4	37.3	20.3	31.5	74.0	47.3	37.4	108.5	101.7	63.2	61.4	61.1	26.6	41.1	70.5	55.9	88.8	50.6	96.1	19.3	70.1	51.0	83.3	56.3	16.6	52.8	40.7	30.3	30.5	76.1	32.8	24.9	84.7	49.0	63.3	38.1	53.8	73.0	100.2	64.8	40.0	82.2	67.4	68.9	115.1	55.5	42.1	47.5	40.6	38.5	58.2	73.7	42.5	59.4	83.3	59.1	30.8	80.2	74.4	52.5	76.3	23.6	21.0	79.2	41.4	47.3	50.6	8.1	24.9	21.5	16.1	22.6	22.9	16.1	17.5	15.9	20.5	21.5	17.0	12.8	8.2	16.7	16.5	22.5	16.6	17.3	15.2	15.7	21.8	17.0	15.6	14.7	15.8	15.1	16.0	14.9	15.3	17.0	13.2	6.4	12.5	7.2	13.9	6.1	8.9	19.1	6.2	7.8	10.3	7.5	9.0	8.6	15.0	7.3	10.4	23.0	11.7	9.1	7.9	16.0	3.7	11.1	13.6	15.0	7.7	16.2	13.5	19.4	22.1	13.8	9.7	10.3	11.4	13.0	21.0	23.1	23.0	6.7	9.9	11.0	16.2	13.3	7.2	3.9	14.3	13.7	8.8	10.3	15.8	4.8	22.6	3.5	10.6	18.3	7.5	9.8	8.6	7.9	8.8	11.7	11.8	8.8	32.9	7.9	19.2	24.9	29.3	7.3	7.1	12.7	10.9	7.4	13.3	8.0
NUSAP1	"ANKT, BM037, FLJ13421, LNP, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41320794-41381050	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 88.6;lymphoid tissue: 101.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 266.7;Extravillous trophoblasts: 121.2;Granulosa cells: 93.3;Spermatocytes: 99.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 10.7;T-reg: 7.7"	"Group enriched"	"Detected in many"	15	"granulocytes: 10.7;T-cells: 7.7"	"Low cell line specificity"	"Detected in many"											"HPA042904, HPA074847"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	1.8	14.1	0.2	7.8	0.2	88.6	1.5	0.3	0.4	3.6	0.3	6.1	7.0	1.1	0.1	17.7	1.1	1.0	1.1	0.2	0.2	2.6	5.0	3.8	28.7	0.3	0.4	4.4	1.3	0.0	0.6	6.5	0.3	1.1	8.0	0.1	3.6	0.6	5.4	9.4	7.4	2.7	0.2	7.8	4.5	10.9	0.3	101.5	0.9	0.1	31.5	1.9	6.4	0.3	146.0	38.3	165.1	64.6	3.5	5.9	37.0	107.4	74.6	138.9	130.6	58.4	67.0	63.5	42.5	44.4	99.1	107.6	104.2	46.2	132.4	98.5	62.3	149.6	102.0	50.7	0.2	67.3	57.2	0.9	1.3	69.1	37.3	21.7	72.0	104.2	70.1	237.5	105.7	30.7	147.5	82.2	59.8	139.8	55.0	136.5	156.5	67.5	42.4	29.3	85.7	55.2	129.8	88.5	25.7	46.0	106.2	76.1	33.7	89.9	104.8	101.5	206.2	81.3	145.8	200.5	42.1	163.6	171.2	10.7	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.5	0.3	0.6	0.0	0.3	0.2	0.4	0.0	0.3	7.7	0.5	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.4	0.3	0.2	0.3	0.3	1.9	0.0	1.5	1.3	14.2	38.5	10.3	21.2	31.9	0.9	9.9	13.7	1.1	17.2	5.0	0.0	0.0	72.2	13.4	14.4	3.9	2.3	33.2	10.7	11.6	7.3	3.0	266.7	1.4	0.5	121.2	14.6	25.5	21.8	7.0	93.3	10.8	3.9	36.7	0.0	1.5	15.5	24.4	13.8	22.7	14.6	0.3	17.5	3.6	1.9	6.1	1.9	4.1	1.0	1.3	1.5	0.4	1.9	57.2	5.3	2.6	5.4	1.1	1.0	0.0	2.8	12.1	99.6	59.9	69.5	24.9	19.3	22.9	38.8	30.0	10.3
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88534033-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.4;Endometrial ciliated cells: 39.1;Glandular and luminal cells: 13.9;Granulosa cells: 13.2;Proximal tubular cells: 18.6;Theca cells: 12.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 7.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045526	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA045526: AB_10961044"	"prognostic favorable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	6.5	0.7	4.3	1.2	3.4	4.2	2.8	6.0	5.5	4.0	1.8	0.5	0.9	2.0	1.3	0.4	4.3	1.0	0.7	3.4	3.4	2.3	4.5	0.7	0.9	0.7	1.2	1.1	0.4	0.3	0.1	0.6	1.4	0.9	0.4	4.8	1.6	0.7	1.3	1.5	0.9	0.4	0.4	1.1	0.8	1.3	3.6	0.5	1.3	0.1	0.5	0.4	0.3	5.1	1.5	2.6	1.0	1.0	0.1	0.7	0.7	2.6	0.7	0.3	0.5	0.6	1.0	0.6	1.1	0.3	0.7	1.3	0.4	0.1	0.9	0.4	0.8	1.3	4.0	1.0	0.4	0.7	1.1	0.5	0.2	0.3	0.2	0.4	0.0	0.9	0.9	2.7	0.7	0.7	0.7	1.2	1.4	0.5	0.7	0.5	0.5	0.9	10.4	0.8	0.6	0.4	1.6	0.8	0.5	0.7	1.2	0.6	0.9	0.9	1.9	1.5	0.6	0.9	0.8	0.7	0.7	0.9	0.7	2.1	0.3	0.8	0.6	0.1	0.6	0.2	0.3	0.7	0.0	0.3	0.6	0.7	0.8	0.5	0.1	0.3	0.6	0.3	4.3	3.4	6.0	5.5	3.4	3.4	0.7	1.2	1.4	0.4	3.6	5.1	0.2	0.0	0.0	1.3	0.1	0.0	1.9	0.7	1.2	0.2	7.5	3.2	0.3	4.3	0.1	1.8	0.0	0.2	0.0	0.0	1.9	0.8	11.4	39.1	4.3	0.8	0.0	0.0	1.2	0.2	1.3	0.8	0.0	13.9	0.0	13.2	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	4.4	0.9	0.2	0.0	0.0	0.0	0.5	0.0	1.0	0.7	0.2	0.0	2.2	0.1	0.4	0.0	18.6	0.2	0.8	0.0	0.3	1.3	0.4	1.6	0.0	0.1	1.1	0.3	12.7	0.0	2.2
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938051-112976460	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 15.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 202.5;BJ hTERT+ SV40 Large T+ RasG12V: 224.5;GAMG: 89.8;RT4: 62.6"	"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No		21000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	8.1	4.1	3.2	11.5	3.1	20.9	6.0	2.3	2.5	11.0	1.1	7.1	7.1	3.9	1.5	15.8	5.2	11.3	7.0	2.2	2.4	5.6	4.4	12.6	6.0	8.7	3.6	3.8	3.8	3.2	3.5	11.1	6.4	3.4	6.2	0.6	27.7	2.7	3.0	5.4	6.5	9.3	11.8	17.9	11.0	2.3	4.1	16.1	4.1	5.9	6.4	14.4	7.8	3.0	23.2	34.4	0.3	5.5	1.0	4.6	2.1	2.6	25.3	202.5	224.5	24.1	20.5	0.7	7.3	8.1	89.8	15.7	3.3	22.7	11.2	9.7	1.2	15.9	16.3	4.0	3.9	4.5	6.6	0.9	7.2	32.8	1.3	4.0	11.7	3.9	0.5	3.1	2.0	13.3	8.0	2.7	1.4	33.7	22.8	13.5	11.6	0.1	7.0	62.6	0.6	0.1	19.8	5.5	14.8	0.2	25.7	1.1	9.5	4.6	4.0	5.5	6.5	0.8	21.0	0.2	4.9	12.9	16.7	1.0	7.8	0.8	1.4	7.4	1.7	2.3	2.0	2.3	4.1	1.0	1.8	1.7	9.7	2.7	15.3	0.3	2.6	3.5	3.2	3.1	2.3	2.5	2.2	2.4	8.7	3.6	6.4	11.8	4.1	3.0	19.9	3.2	3.9	0.7	3.8	3.4	5.6	13.5	5.2	0.4	3.1	2.7	1.7	0.0	5.1	3.7	0.0	5.4	1.8	14.7	3.9	11.2	5.9	1.8	4.1	20.8	1.8	0.8	0.3	9.8	20.9	5.5	16.3	5.6	1.3	21.9	9.3	1.7	18.7	0.0	0.4	6.8	8.2	5.8	7.0	10.8	10.2	16.7	1.8	5.6	30.2	3.0	8.2	3.5	0.0	21.2	8.2	15.1	1.4	11.8	4.5	2.0	2.3	0.5	0.0	2.5	5.0	0.8	0.7	14.4	4.7	1.9	6.5	9.2	5.4	26.8
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 781.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	60.0	119.6	69.4	40.8	71.2	106.4	150.1	74.6	97.4	99.7	75.4	75.6	750.0	82.5	63.7	105.0	56.0	68.7	52.3	71.2	78.7	114.6	162.5	42.7	38.1	76.5	72.0	77.0	36.1	46.1	53.5	65.0	85.2	74.3	67.2	51.1	225.4	94.6	58.2	71.6	781.8	97.8	73.6	34.1	70.1	56.2	73.3	30.2	67.7	60.0	69.1	58.9	63.8	81.7	241.5	42.8	27.5	98.7	272.4	260.8	93.4	142.2	288.0	124.2	135.2	110.5	30.8	0.5	101.0	241.8	118.0	249.4	126.5	265.7	134.0	42.4	174.9	268.1	28.1	82.7	139.9	0.4	169.3	172.1	134.5	111.9	129.5	204.9	147.1	48.4	470.8	50.0	175.5	62.6	72.1	15.3	55.1	73.2	59.6	66.3	104.5	65.3	119.8	3.9	57.3	60.9	89.7	235.1	209.5	156.6	78.6	65.8	114.3	70.5	65.3	117.9	90.2	42.4	47.6	64.6	97.4	72.0	34.4	38.0	39.6	36.0	28.8	35.3	31.2	15.2	24.0	30.5	44.3	16.2	29.5	29.8	40.0	16.9	37.2	9.4	24.6	29.6	69.4	71.2	74.6	97.4	71.2	78.7	76.5	72.0	85.2	73.6	73.3	81.7	49.0	19.2	49.7	37.9	44.7	151.3	144.0	362.8	185.5	35.2	154.2	163.7	21.8	18.6	182.7	35.0	27.1	120.8	80.3	38.2	90.1	34.6	30.4	37.0	90.4	37.7	43.1	317.0	31.8	13.4	90.5	124.2	55.5	40.6	43.8	32.2	37.5	152.2	66.2	43.7	33.4	104.1	197.4	31.8	68.1	15.2	104.1	56.7	85.4	17.8	34.8	37.4	18.6	22.1	41.9	12.6	74.6	120.0	32.9	82.6	1222.6	196.4	76.4	24.4	78.9	106.1	115.1	46.3	33.2	161.8	126.0	48.2	65.0	92.4	214.5	82.2
OAZ3		ENSG00000143450	"Ornithine decarboxylase antizyme 3"	Q9UMX2	1	151762899-151771334	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"testis: 244.7"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 12007.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 3.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030136, HPA045808"			Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA030136: AB_2673331, HPA045808: "	"unprognostic (2.12e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.05e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.36e-2)"	1.5	1.6	2.3	1.6	2.3	0.6	2.4	4.2	2.7	0.6	1.5	1.3	0.7	0.5	2.6	1.7	0.9	0.8	1.1	2.6	2.3	1.6	2.8	1.4	1.5	2.7	2.2	0.3	2.1	4.3	2.7	0.6	2.8	15.3	1.6	2.7	8.2	1.3	2.9	1.2	1.2	0.5	1.9	1.3	1.4	244.7	2.3	0.6	3.3	0.9	0.6	1.1	1.0	2.3	0.9	1.8	1.0	2.5	0.8	2.4	2.3	1.9	0.4	1.7	0.7	1.0	2.3	0.8	1.5	0.6	1.2	0.9	1.0	1.7	0.5	5.8	5.3	0.8	3.2	1.5	1.0	0.4	0.9	3.8	1.0	1.9	2.3	1.1	2.6	2.3	1.2	2.8	1.9	7.7	0.7	1.3	2.5	3.6	1.9	0.4	0.8	1.3	0.3	2.3	1.2	2.8	0.8	3.7	3.6	2.3	8.2	2.1	2.3	1.0	0.5	1.9	1.0	4.0	7.5	2.0	1.3	1.2	2.7	0.6	0.8	0.1	0.3	0.4	0.3	0.3	0.3	0.6	1.0	0.2	0.3	0.6	0.4	0.7	1.5	0.3	0.7	0.4	2.3	2.3	4.2	2.7	2.6	2.3	2.7	2.2	2.8	1.9	2.3	2.3	2.3	0.0	1.7	0.3	0.3	0.8	2.6	1.8	1.8	0.5	16.0	6.2	1.4	0.0	2.2	0.0	2.1	1.7	0.9	4.2	1.9	2.4	2386.5	3.4	0.6	5.3	3.6	0.4	0.4	3.1	3.0	1.0	1.5	1.5	1.3	0.5	1.8	3.1	4.8	0.0	0.3	7.4	2.0	4.2	1.6	12007.9	46.0	5.1	1.8	0.0	1.8	1.7	0.0	0.0	0.3	3.3	4.9	42.5	1.6	20.4	5.7	7.4	3.2	1.6	0.0	0.4	0.8	67.6	31.8	1.2	0.6	1.5	0.6	1.4	2.7	3.2
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 155.4"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 1277.4;Proximal enterocytes: 702.0;Proximal tubular cells: 1384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 325.2;U-251 MG: 399.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	9.2	20.4	14.1	22.1	13.1	16.3	23.4	10.3	15.3	19.8	14.1	54.7	122.3	20.7	46.9	25.8	22.4	32.4	14.3	17.8	15.6	155.4	129.5	19.0	34.6	13.1	13.2	8.7	26.9	44.4	33.6	8.6	11.7	23.8	49.9	26.9	40.2	29.2	4.4	20.0	88.4	15.0	11.6	12.6	85.0	6.3	13.7	53.6	37.4	3.9	40.3	28.1	12.0	12.7	208.9	108.5	1.6	0.0	0.0	0.0	2.7	53.3	23.9	28.4	26.9	0.0	249.4	35.7	230.1	30.5	248.0	65.5	29.7	325.2	29.1	83.8	22.6	0.1	78.6	0.1	25.6	101.7	0.3	14.7	150.8	0.1	61.1	81.4	115.5	140.2	0.1	17.6	30.3	78.3	172.2	70.2	102.5	234.2	145.2	38.5	0.1	59.4	288.7	135.0	230.3	69.5	75.4	25.5	5.4	0.8	26.2	25.2	195.6	0.2	215.1	1.2	399.5	49.5	59.6	113.3	163.0	0.3	0.4	208.4	3.5	69.1	101.6	1.5	136.9	168.0	191.0	147.3	18.1	156.7	247.2	165.0	11.2	156.0	1.3	122.4	338.7	137.7	14.1	13.1	10.3	15.3	17.8	15.6	13.1	13.2	11.7	11.6	13.7	12.7	135.9	28.9	70.6	2.0	102.5	109.0	146.6	401.4	81.4	17.6	152.7	190.6	39.2	194.5	224.2	176.6	29.2	46.2	66.3	359.7	217.2	510.5	1.4	197.5	22.9	103.3	306.4	38.9	10.1	570.2	11.4	14.9	157.5	190.8	36.8	75.3	31.1	193.9	44.3	1.7	11.6	301.3	341.8	6.4	27.0	2.5	5.0	21.7	65.8	5.6	15.9	49.9	82.4	2.5	1.8	1277.4	311.6	21.4	53.5	180.1	702.0	1384.9	171.4	77.6	0.0	3.7	41.8	2.6	3.2	105.2	131.4	15.3	129.8	52.1	188.6	239.2
ODF3L2	"C19orf19, FLJ40059"	ENSG00000181781	"Outer dense fiber of sperm tails 3 like 2"	Q3SX64	19	463346-474983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 8.2;testis: 23.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 1184.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA067065, HPA067973"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA067065: , HPA067973: AB_2685937"	"unprognostic (3.75e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.02e-5)"	"unprognostic (3.13e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.99e-1)"	0.3	0.3	0.7	0.0	0.7	0.0	0.3	0.4	0.9	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.5	0.5	0.2	0.3	0.2	0.0	0.7	0.6	0.1	0.1	0.0	0.1	0.2	0.7	0.2	0.0	0.1	0.0	0.0	8.2	0.1	0.2	0.0	0.5	0.7	0.1	23.4	0.8	0.0	0.3	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.4	0.9	0.5	0.5	0.7	0.6	0.7	0.5	0.8	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.8	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1184.9	8.4	0.6	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	7.6	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
OGDH	"E1k, KGD1, OGDC-E1, OGDH2"	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 324.0;skeletal muscle: 363.6;tongue: 374.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	64.9	67.4	35.0	39.2	39.4	32.1	32.0	42.8	45.4	33.8	119.6	56.3	95.6	40.9	16.6	61.6	34.0	26.9	324.0	34.4	50.6	89.7	39.8	43.4	40.0	44.6	44.4	24.8	27.5	99.9	34.9	33.1	44.2	37.9	41.5	25.9	43.0	46.9	363.6	56.4	87.5	51.0	35.7	39.0	52.5	36.2	43.6	32.1	54.9	374.7	41.5	42.5	37.7	35.6	35.8	73.5	42.2	66.0	63.4	69.8	41.9	54.2	51.3	59.5	50.9	67.2	71.7	156.0	63.0	79.2	119.2	108.2	85.7	81.4	58.4	92.0	22.8	47.4	140.6	33.5	32.8	59.4	51.2	66.0	60.5	85.4	60.9	43.0	82.4	50.7	55.8	45.4	63.7	50.1	59.2	34.1	39.8	97.7	81.8	55.9	30.1	175.9	68.5	104.4	73.2	35.0	78.8	107.6	34.4	75.8	64.2	58.7	66.4	43.4	38.5	76.3	64.0	40.9	84.0	85.9	78.4	65.7	80.4	9.9	21.8	12.6	17.9	28.5	19.5	11.1	20.7	18.1	22.0	9.3	8.5	10.8	12.2	19.3	35.4	10.8	42.1	23.2	35.0	39.4	42.8	45.4	34.4	50.6	44.6	44.4	44.2	35.7	43.6	35.6	19.6	6.4	22.5	49.3	23.1	19.5	12.3	15.9	22.8	21.4	14.4	18.2	114.3	12.8	14.2	47.8	18.8	24.0	20.0	64.5	31.3	14.9	51.0	26.1	15.6	16.0	23.4	32.0	43.3	16.9	16.4	20.6	35.2	38.9	21.5	15.5	17.9	22.6	33.8	62.2	53.1	32.6	12.2	24.5	43.4	24.5	11.8	33.8	21.4	29.0	22.7	14.3	16.5	22.1	36.6	20.9	38.0	17.3	27.8	16.4	82.0	51.8	17.0	24.0	19.7	24.7	20.2	10.6	19.9	28.1	26.3	36.7	27.7	30.3	33.5	18.1
OGFOD1	"FLJ10826, KIAA1612, TPA1"	ENSG00000087263	"2-oxoglutarate and iron dependent oxygenase domain containing 1"	Q8N543	16	56451521-56479104	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003215, HPA003722"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	Cytosol	"HPA003215: AB_1078881, HPA003722: "	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (6.65e-4)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.49e-2)"	"unprognostic (7.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-2)"	9.6	12.3	5.2	8.8	6.5	3.9	9.5	5.5	7.3	10.4	4.1	7.7	8.8	9.8	7.6	19.4	10.6	6.7	14.5	5.3	7.2	9.3	9.1	8.0	8.9	6.5	6.3	8.1	5.7	12.0	6.1	9.2	6.5	8.4	9.6	9.6	6.4	9.5	31.5	6.3	5.1	16.7	5.1	7.5	6.1	9.5	6.3	10.5	10.2	23.5	14.5	9.1	5.7	9.0	25.4	27.4	25.7	32.5	28.6	34.5	26.0	39.1	29.9	52.4	38.5	34.5	16.5	44.7	19.0	29.3	21.7	34.9	57.2	25.5	57.3	14.1	29.6	32.4	21.6	32.8	21.4	34.9	36.2	23.2	29.0	38.7	31.2	23.1	45.3	29.3	44.3	8.2	46.2	15.6	27.4	19.2	45.0	19.8	47.2	51.2	41.0	51.9	22.9	16.7	20.4	24.1	46.3	29.0	25.2	26.9	26.4	30.1	28.9	28.1	23.2	22.9	36.7	18.0	37.1	67.5	22.9	26.5	22.7	13.4	4.6	4.5	7.7	6.4	10.1	7.1	9.5	9.4	6.4	5.6	10.7	8.4	1.5	8.5	8.6	6.8	9.0	5.9	5.2	6.5	5.5	7.3	5.3	7.2	6.5	6.3	6.5	5.1	6.3	9.0	8.9	3.2	16.0	9.8	14.1	17.7	13.8	11.2	17.6	11.3	13.1	10.7	21.4	20.0	15.0	9.2	10.4	18.3	11.7	5.8	25.4	13.7	22.2	11.6	20.0	12.2	2.4	19.6	14.4	14.1	20.5	22.3	12.2	19.1	45.7	13.0	9.7	17.6	12.0	13.5	16.6	7.9	4.1	6.9	10.2	15.6	12.2	10.9	10.6	4.7	16.1	13.6	10.3	9.0	14.5	17.4	5.5	15.8	16.1	11.0	4.6	13.8	8.0	15.2	13.1	16.7	19.0	26.0	29.6	21.2	18.9	11.6	18.4	19.1	10.6	9.0
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533104-71575892	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	59.3	55.9	39.7	38.3	42.4	61.5	62.7	43.3	51.6	72.7	40.1	62.5	30.6	56.0	62.2	52.8	76.4	26.4	55.5	43.9	35.5	61.6	45.8	70.7	71.9	36.1	35.8	85.5	102.4	24.3	46.9	26.4	37.9	75.4	39.6	36.9	64.1	27.1	62.8	68.6	86.4	24.5	36.1	122.8	67.4	19.0	36.2	57.2	70.7	39.2	57.8	55.7	67.4	44.3	40.5	37.0	47.1	41.5	49.6	45.6	31.6	30.3	54.3	32.1	49.1	39.3	45.4	47.9	20.7	37.3	33.3	49.1	52.0	29.5	39.4	41.1	53.4	30.4	98.6	28.5	37.6	62.9	48.1	43.6	59.2	35.1	65.7	55.5	30.5	100.7	31.1	160.4	31.1	34.3	48.9	75.2	31.6	35.5	49.8	47.8	52.7	62.1	50.0	45.9	24.1	21.2	46.9	30.9	30.2	35.5	22.8	42.4	35.5	34.6	27.9	36.6	17.9	43.5	33.5	56.5	24.4	65.0	21.6	2.8	4.6	2.0	7.5	5.7	6.8	7.4	6.3	6.2	6.1	6.2	7.2	7.4	1.9	10.4	5.7	6.2	6.2	5.6	39.7	42.4	43.3	51.6	43.9	35.5	36.1	35.8	37.9	36.1	36.2	44.3	31.1	35.3	85.2	52.9	67.2	88.1	37.9	23.5	58.6	26.5	49.6	34.0	42.8	20.0	31.1	49.7	8.4	15.8	130.7	31.1	9.8	14.4	2.4	32.1	49.8	39.8	34.9	51.3	110.7	14.4	8.5	47.5	54.6	53.3	27.8	26.4	45.7	27.5	16.1	40.4	94.6	37.3	22.4	60.9	69.7	4.8	53.4	45.8	35.6	71.2	51.6	11.3	51.5	92.0	97.9	17.6	34.9	29.7	147.2	53.8	34.8	15.1	28.0	21.8	32.9	44.8	42.2	2.5	6.1	63.3	84.1	10.9	82.1	62.0	34.0	50.8
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028813-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1296.1;pancreas: 671.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 497.1;Exocrine glandular cells: 900.9;Intestinal goblet cells: 791.9;Pancreatic endocrine cells: 933.7;Paneth cells: 556.9;Undifferentiated cells: 2419.9;Urothelial cells: 1989.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;BJ hTERT+: 18.8;HaCaT: 26.4;OE19: 10.4;RPMI-8226: 6.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted to digestive system"	Yes	NA		9300		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	1.9	0.1	0.2	195.4	0.5	126.0	6.8	0.1	0.5	7.9	0.2	451.6	1211.9	5.5	3.5	0.8	8.3	10.4	0.8	0.2	0.4	26.9	0.9	3.8	1.4	0.1	0.2	0.2	671.4	0.0	0.5	0.6	0.2	92.4	568.7	0.4	16.2	0.9	0.6	0.4	1296.1	52.6	0.2	18.0	16.1	0.3	0.2	4.2	0.4	2.1	0.2	127.0	285.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	5.4	2.4	18.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	26.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	10.4	0.0	0.0	0.8	6.2	0.2	0.0	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.9	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.5	0.2	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.3	3.8	0.1	168.5	0.3	0.0	0.0	9.8	2.5	0.5	0.0	11.9	139.8	0.0	0.0	0.0	98.7	1.9	497.1	0.2	13.5	0.5	1.4	92.3	0.8	1.0	900.9	0.0	1.5	0.0	17.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	791.9	2.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	10.3	4.0	0.0	0.0	0.2	933.7	556.9	0.0	0.4	209.4	300.6	0.0	0.5	0.2	0.0	2.1	9.2	0.0	0.1	0.0	0.0	0.0	3.1	0.2	2419.9	1989.0
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023869	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.5;Hofbauer cells: 38.4;Skeletal myocytes: 175.5;Smooth muscle cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 6.7;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	11	"monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.7;HSkMC: 113.3;RH-30: 88.5"	"Group enriched"	"Detected in all"	4	"hippocampal formation: 41.0;white matter: 11.9"	"Low region specificity"	"Detected in all"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA		12000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA054136: AB_2682397, HPA062739: AB_2684858"	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	23.4	6.9	4.2	19.2	7.5	0.4	14.7	2.4	5.6	16.8	6.0	18.3	2.1	16.2	5.0	3.9	11.4	48.3	6.6	5.7	3.4	3.1	0.8	15.3	14.0	3.7	4.0	4.2	1.4	3.5	2.8	40.6	4.7	5.3	2.9	0.2	10.4	6.9	10.2	10.1	5.5	22.0	3.0	10.2	3.3	15.9	9.8	3.7	20.8	6.5	11.2	16.8	7.3	4.2	0.1	0.4	6.6	2.2	21.0	39.7	0.0	2.3	10.6	4.3	11.8	0.0	0.2	0.0	0.3	25.7	4.3	0.0	0.6	0.1	2.5	0.0	0.8	0.5	0.2	0.0	0.3	0.1	0.8	113.3	0.0	5.3	0.0	2.1	0.7	0.0	0.0	1.0	19.3	0.1	0.1	0.2	2.1	0.0	1.0	0.2	88.5	8.9	1.6	0.1	0.8	0.3	9.1	0.0	0.6	19.6	0.0	0.1	0.1	2.7	0.7	4.0	3.6	0.0	0.1	0.0	25.1	2.7	1.3	0.0	0.4	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.2	4.2	7.5	2.4	5.6	5.7	3.4	3.7	4.0	4.7	3.0	9.8	4.2	4.1	0.0	0.6	0.0	0.2	3.3	0.1	0.1	0.0	0.1	0.4	1.0	3.0	1.5	0.7	1.8	0.0	0.3	0.1	0.0	0.0	0.0	122.5	1.2	24.9	1.7	0.0	0.4	2.8	0.0	0.3	21.9	0.0	0.7	1.3	1.1	1.1	0.2	38.4	0.0	0.9	0.1	0.0	31.1	9.0	12.9	20.8	16.6	1.8	8.4	0.9	0.8	0.0	0.0	2.9	0.0	0.0	29.3	0.1	0.1	0.0	0.1	0.1	0.1	6.6	175.5	57.2	8.8	1.7	0.1	2.3	0.3	0.6	16.4	0.0	0.0
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 136.6;Fibroblasts: 246.9;Leydig cells: 73.3;Theca cells: 126.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 577.3;ASC TERT1: 312.6;BJ hTERT+: 374.8;HSkMC: 581.6;LHCN-M2: 602.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		3000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA027991: AB_2732440"	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	85.6	42.6	5.7	24.9	7.4	0.9	89.7	7.2	12.4	170.6	8.2	71.9	15.1	124.7	42.6	26.6	96.3	95.0	56.6	5.4	6.7	34.1	36.3	55.4	12.0	9.8	7.7	177.4	35.2	9.9	17.9	111.8	8.6	42.9	34.5	0.2	16.7	73.8	10.3	37.6	32.3	94.6	9.2	9.9	48.4	9.3	9.7	8.9	21.8	38.2	14.9	71.1	98.8	11.2	0.0	19.7	9.7	0.1	577.3	312.6	0.6	77.1	374.8	26.5	85.3	25.2	0.2	0.0	4.1	222.4	0.2	0.0	3.2	0.3	4.0	0.0	0.0	0.0	0.1	19.3	149.6	0.2	0.0	581.6	0.0	37.2	0.5	10.7	2.1	0.0	0.0	0.1	602.3	0.3	0.2	0.4	45.8	0.0	0.7	0.1	142.6	0.3	0.0	0.0	0.3	5.4	0.1	0.2	10.5	143.3	224.6	0.9	1.8	14.9	27.6	5.9	0.0	0.2	0.1	0.0	7.3	0.0	94.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	7.4	7.2	12.4	5.4	6.7	9.8	7.7	8.6	9.2	9.7	11.2	13.6	0.0	3.7	0.0	0.4	13.0	0.2	0.0	0.6	0.0	2.1	2.9	1.4	4.3	0.8	1.8	0.0	6.8	1.1	0.2	0.0	0.8	2.9	6.2	136.6	9.5	6.0	0.0	0.0	0.0	4.9	246.9	5.6	3.5	1.3	0.3	45.7	0.5	33.3	0.0	0.0	0.6	0.0	5.9	22.7	1.7	73.3	15.5	12.4	16.9	0.6	0.0	0.0	0.0	0.1	0.3	0.1	33.1	0.2	0.7	0.0	0.5	0.0	0.1	0.0	44.8	28.0	0.3	0.4	1.2	11.5	12.4	2.6	126.1	0.2	0.2
ONECUT3		ENSG00000205922	"One cut homeobox 3"	O60422	19	1753506-1780988	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 2.1;stomach 1: 4.3"	"Group enriched"	"Detected in some"	28	"Cardiomyocytes: 89.7;Horizontal cells: 312.9"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HaCaT: 8.1;OE19: 10.9;PC-3: 18.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059936			Supported	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA059936: AB_2684172"	"unprognostic (9.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.08e-10)"	"unprognostic (1.18e-1)"	"unprognostic (9.86e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.21e-2)"	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.2	0.2	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	4.3	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.9	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.2	1.1	0.7	0.5	0.6	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.0	0.2	0.5	89.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.9	0.2	0.4	2.9	0.0	0.0	0.1	0.2	0.0	1.3	7.1	0.8	0.0	0.0	0.0	0.1	0.1	312.9	0.1	1.3	0.0	0.0	0.8	1.5	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	6.4	0.0	0.4	0.0	0.4	0.2	0.0	0.0	2.6	0.0	0.4	2.1	3.2	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.5
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772485-128775794	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"retina: 41.0"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"LHCN-M2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	41.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORC6	ORC6L	ENSG00000091651	"Origin recognition complex subunit 6"	Q9Y5N6	16	46689643-46698394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.3;lymphoid tissue: 7.4;testis: 9.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 56.7;Spermatocytes: 102.6;Spermatogonia: 108.9;Theca cells: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016330, HPA072587"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB016330: AB_670295, HPA072587: AB_2686537"	"unprognostic (3.47e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.15e-6)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (3.53e-4)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.50e-4)"	"unprognostic (3.97e-2)"	"unprognostic (3.90e-14)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.98e-2)"	0.3	0.7	2.0	2.2	1.6	10.3	0.6	1.5	1.9	0.7	1.0	1.7	1.5	0.8	1.1	4.1	0.4	0.6	1.5	1.9	1.8	0.4	0.9	0.6	7.4	1.5	1.9	0.4	0.3	0.7	0.6	3.3	1.7	0.3	1.9	0.3	0.7	0.2	0.1	1.1	1.5	1.0	1.6	2.4	0.8	9.6	1.8	6.2	0.5	0.3	7.3	1.2	1.3	1.8	28.6	27.4	43.7	33.9	5.4	6.8	31.6	54.2	20.2	59.3	30.9	39.3	18.0	35.6	27.1	10.5	29.1	29.9	57.9	15.1	50.4	17.2	46.4	27.9	13.2	40.1	6.6	46.5	23.7	1.8	2.6	32.4	17.1	9.3	20.0	30.1	36.0	17.4	35.9	26.9	65.6	60.7	48.1	20.7	76.0	78.6	80.6	35.8	14.9	9.8	52.2	30.4	24.5	29.8	18.1	34.9	15.6	37.9	11.6	53.7	34.6	33.6	51.8	12.5	18.9	123.2	22.2	29.5	40.1	0.0	0.3	0.3	0.9	0.7	0.4	0.7	0.5	0.5	0.6	1.4	0.8	0.3	0.0	0.8	0.8	1.0	1.2	0.7	2.0	1.6	1.5	1.9	1.9	1.8	1.5	1.9	1.7	1.6	1.8	1.8	1.6	3.2	14.5	1.0	8.8	6.6	2.2	3.6	8.6	6.6	4.1	5.8	3.7	1.5	6.3	5.5	4.2	39.3	6.0	9.5	1.9	2.5	13.2	6.5	7.5	4.3	1.8	45.4	6.3	0.7	40.9	8.0	7.1	9.4	1.3	56.7	0.7	9.9	15.7	11.8	2.7	12.4	6.1	3.8	11.9	8.9	2.8	7.7	33.8	2.8	1.2	2.5	2.1	0.0	2.0	2.1	1.4	3.4	18.5	2.6	2.3	1.0	10.7	10.2	0.0	5.1	7.3	102.6	108.9	16.9	6.0	10.9	7.5	47.5	14.4	2.7
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteoclastogenesis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Melanocytes: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		210000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.1	19.1	4.7	17.9	5.2	5.7	9.8	5.1	5.8	10.4	33.1	12.2	7.9	13.7	9.0	12.7	9.5	12.5	19.2	5.3	9.2	15.6	13.1	16.2	14.7	6.0	7.6	7.5	5.8	15.3	8.3	14.1	7.9	13.8	11.1	17.6	8.9	16.7	11.8	9.8	9.0	23.3	5.3	18.3	8.5	10.1	7.4	13.7	10.7	11.5	13.5	16.9	7.0	8.3	6.0	17.2	20.1	29.4	59.0	19.0	28.6	42.8	42.7	30.7	50.4	10.0	9.8	13.7	34.4	30.0	82.5	11.1	20.2	14.6	47.0	31.6	15.7	28.9	10.9	12.8	45.6	32.1	64.6	28.1	35.7	37.7	30.0	28.2	15.8	15.2	23.3	48.7	50.3	8.4	7.1	7.3	8.0	7.1	13.0	11.4	29.1	7.5	22.0	15.7	2.2	11.8	34.7	8.7	79.9	26.6	10.0	45.8	19.3	26.7	9.8	59.7	61.4	18.6	34.4	11.9	78.9	21.3	60.3	31.4	20.2	22.8	20.3	29.4	21.5	14.7	16.9	22.3	17.8	8.6	15.6	19.8	29.8	22.0	43.5	12.9	22.6	27.0	4.7	5.2	5.1	5.8	5.3	9.2	6.0	7.6	7.9	5.3	7.4	8.3	28.5	9.6	19.0	26.4	26.0	46.7	19.8	11.7	21.6	28.3	10.0	7.0	24.8	12.8	9.4	12.9	10.4	21.7	32.3	21.9	1.9	12.4	12.0	7.5	15.7	20.7	4.2	4.6	36.6	22.9	33.9	24.4	15.8	9.6	24.1	6.9	26.7	13.2	52.8	28.6	40.1	5.8	6.1	46.5	29.5	5.4	14.3	43.1	151.2	20.6	25.6	23.7	40.2	21.1	36.6	16.8	17.0	28.6	25.0	17.9	7.6	25.5	9.8	17.5	26.3	18.5	29.6	28.0	18.7	12.4	31.1	61.2	29.5	23.7	3.3	16.0
OTC	OTCase	ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352586-38421446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	124	"intestine: 112.4;liver: 377.8"	"Group enriched"	"Detected in some"	5	"Hepatic stellate cells: 38.9;Hepatocytes: 99.6;Proximal enterocytes: 82.0;Undifferentiated cells: 25.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		2200000		"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			1.2	0.0	0.2	0.5	0.3	0.0	0.2	0.3	0.4	0.4	0.1	5.0	112.4	0.7	0.0	0.4	0.5	0.4	0.3	0.2	0.3	0.1	377.8	0.9	0.1	0.3	0.3	0.1	1.7	0.0	0.0	0.0	0.4	0.0	2.5	0.1	0.1	0.1	0.0	0.0	87.4	0.5	0.3	0.0	1.9	0.4	0.3	0.0	0.3	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	7.4	0.1	0.0	1.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	38.9	99.6	0.0	0.0	0.5	8.3	0.0	3.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	82.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.3	0.0	25.3	0.0
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74922950-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 20.1"	"Cell type enriched"	"Detected in some"	20	"Paneth cells: 627.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"HDLM-2: 10.1"	"Region enriched"	"Detected in some"	12	"olfactory bulb: 12.7"	"Low region specificity"	"Detected in many"			"HPA024524, HPA053090"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.2	1.4	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	30.0	0.0	0.0	9.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	627.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	0.0
OTP		ENSG00000171540	"Orthopedia homeobox"	Q5XKR4	5	77628712-77638713	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"brain: 28.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Sertoli cells: 6.6;Spermatocytes: 2.2;Spermatogonia: 1.5"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"hypothalamus: 20.0"	"Region enhanced"	"Detected in some"		"hypothalamus: 15.5"	HPA059342	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies"	"HPA059342: AB_2732635"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-2)"		"unprognostic (6.25e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.16e-1)"		"unprognostic (7.77e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.39e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.76e-14)"	"unprognostic (3.38e-2)"	"unprognostic (1.84e-1)"		"unprognostic (9.49e-3)"	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.1	0.0	9.2	1.7	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.4	0.0	28.7	9.2	1.7	6.6	0.8	8.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	2.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTUD7B	"CEZANNE, ZA20D1"	ENSG00000264522	"OTU deubiquitinase 7B"	Q6GQQ9	1	149937812-150010726	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3;Oligodendrocytes: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027045, HPA076357"	Supported		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA027045: AB_1854847, HPA076357: "	"unprognostic (2.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.46e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (4.90e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.58e-2)"	11.7	7.7	21.0	3.8	39.2	1.1	7.8	28.7	18.5	9.9	6.8	7.6	6.2	10.5	3.8	7.7	9.3	4.8	7.1	15.3	22.1	5.6	10.7	7.3	1.9	41.4	37.2	10.9	6.1	10.9	3.4	7.1	35.5	6.6	7.1	10.1	7.8	7.5	18.6	5.8	6.2	10.8	27.9	3.6	6.7	12.7	31.7	2.1	6.7	16.2	3.2	6.3	5.2	43.0	17.2	13.5	9.3	15.6	12.0	11.1	8.8	11.8	17.3	14.0	9.6	10.0	13.6	0.2	7.5	21.7	6.3	13.4	13.2	13.1	14.6	16.5	6.7	6.6	18.9	6.8	12.8	7.6	6.9	12.4	9.9	23.7	20.6	10.9	11.5	2.0	18.4	18.1	10.1	17.5	1.3	2.1	11.9	12.8	13.1	1.8	12.9	4.4	5.4	23.2	6.0	11.4	20.8	15.2	18.5	12.1	12.6	4.0	13.9	14.4	13.2	9.8	14.0	19.1	20.0	2.0	12.8	2.2	24.1	2.0	0.0	0.4	0.7	0.0	0.5	0.1	0.3	0.4	0.0	0.1	0.2	0.3	0.3	0.4	0.0	0.1	0.1	0.0	21.0	39.2	28.7	18.5	15.3	22.1	41.4	37.2	35.5	27.9	31.7	43.0	10.2	35.3	11.7	56.8	3.0	15.9	22.7	8.7	13.1	28.0	18.3	9.3	22.2	12.8	15.3	11.0	106.3	23.5	5.1	41.1	7.9	14.5	63.4	21.8	17.8	16.7	17.4	14.9	20.6	11.1	11.6	14.8	21.4	40.2	0.0	22.0	20.3	33.0	3.1	23.5	24.6	15.8	8.2	0.8	5.9	79.4	14.6	2.4	37.4	22.5	4.3	23.6	15.5	33.2	176.8	20.6	21.3	23.0	4.7	20.2	17.1	11.5	17.4	66.9	0.0	19.8	17.9	11.1	7.2	11.8	16.6	21.2	7.5	11.1	11.1	34.0
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56816693	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"choroid plexus: 108.8;retina: 279.9"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 170.6;Cone photoreceptor cells: 168.9;Rod photoreceptor cells: 202.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 249.6;hTERT-RPE1: 57.0;NTERA-2: 199.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.0	0.0	4.1	0.0	1.3	0.0	0.0	8.5	0.5	0.0	108.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	2.6	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	2.5	0.0	2.0	0.0	0.0	279.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.8	0.0	0.0	0.8	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	249.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.3	8.5	0.5	5.9	2.6	0.2	8.7	2.0	0.1	12.8	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.6	0.0	0.0	0.3	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787063-65797214	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 57.2;skin 1: 51.0;testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 113.2;Squamous epithelial cells: 130.8;Syncytiotrophoblasts: 348.9;Urothelial cells: 114.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 52.2;CACO-2: 13.6;HaCaT: 31.4;MCF7: 12.6;RT4: 31.2;SK-BR-3: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003984	Uncertain		Approved	Nucleoplasm		Yes	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.1	0.0	0.0	1.0	0.1	0.1	2.8	0.2	0.1	13.6	0.0	10.3	15.5	0.5	0.1	57.2	0.6	0.9	0.0	0.1	0.0	7.4	0.2	0.3	0.0	0.0	0.0	0.0	9.1	15.0	0.1	6.9	0.0	1.4	8.3	0.1	8.8	1.0	0.1	51.0	9.1	0.3	0.0	0.1	1.6	35.5	0.0	0.4	1.3	0.0	5.5	27.4	21.3	0.1	19.0	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.0	0.0	0.0	13.6	5.0	0.0	0.1	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	9.7	0.1	0.3	0.0	0.1	1.4	31.2	0.2	0.1	0.0	24.0	0.2	5.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.3	2.3	26.6	62.6	14.5	54.1	0.0	59.4	25.4	0.5	7.2	13.0	3.7	0.0	19.5	1.3	57.6	0.0	2.5	81.9	76.2	11.7	1.8	31.6	0.0	0.1	3.8	14.0	0.9	0.0	113.2	2.5	0.0	0.0	0.1	2.1	0.0	0.1	54.9	20.3	0.0	1.4	87.2	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	44.5	1.9	3.0	34.1	39.1	6.7	11.3	0.0	0.0	0.0	1.1	83.9	4.8	130.8	57.4	348.9	1.7	0.0	52.0	114.9
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 245.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 243.7;Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 238.7;SiHa: 319.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		440000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	52.7	15.8	30.4	16.6	34.9	13.3	18.5	23.9	32.7	13.5	15.9	19.2	8.3	14.9	17.6	26.8	12.4	15.2	245.9	36.2	27.1	53.1	1.3	8.0	21.7	19.5	21.4	13.8	5.3	48.6	14.7	5.0	20.0	25.5	21.1	23.6	18.9	29.8	28.5	23.1	12.8	36.6	19.3	11.0	34.2	13.2	25.7	76.8	27.3	42.6	25.9	15.1	13.8	24.5	35.3	1.6	27.9	33.6	84.7	45.0	0.1	62.1	38.9	50.3	30.4	5.7	23.5	91.2	15.0	47.5	25.8	20.5	77.5	55.9	58.5	78.5	9.1	63.9	238.7	11.9	36.8	125.8	20.9	42.7	15.3	49.3	82.2	24.6	46.4	81.6	13.3	114.0	58.1	4.5	105.5	6.1	6.4	0.0	24.5	82.8	78.9	68.7	41.7	2.9	27.9	28.8	319.5	0.3	38.3	2.5	0.4	27.4	28.3	39.7	51.9	68.6	50.6	18.6	16.5	3.6	59.9	90.9	30.9	1.4	1.4	4.7	11.6	1.5	13.8	10.0	11.5	12.7	6.3	7.5	13.6	10.9	0.4	11.3	2.5	2.4	21.5	6.6	30.4	34.9	23.9	32.7	36.2	27.1	19.5	21.4	20.0	19.3	25.7	24.5	8.4	6.4	9.2	37.5	19.2	14.8	11.7	12.4	17.6	14.1	18.8	14.2	243.7	7.2	14.3	11.0	2.1	7.0	18.3	5.0	187.9	5.4	19.1	11.7	18.8	9.8	13.2	23.1	71.5	0.7	11.9	21.3	20.4	31.2	9.5	8.7	6.8	0.3	38.2	13.5	84.2	18.6	12.2	1.3	7.0	8.6	6.2	5.2	16.0	26.2	4.4	11.8	10.3	66.4	46.8	4.8	5.3	7.5	31.3	12.1	2.9	27.4	5.6	21.6	13.1	9.7	24.6	35.6	19.7	27.6	21.6	6.8	26.6	8.6	18.1	9.0
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.5;Spermatocytes: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.1	11.0	3.1	5.5	3.4	4.0	9.3	3.5	4.6	4.9	5.3	11.1	9.4	4.6	13.9	8.5	6.8	3.9	12.9	3.3	3.6	13.7	22.0	4.9	7.9	3.3	3.3	4.9	10.5	10.0	5.8	5.9	3.4	5.9	12.3	10.2	10.1	5.9	14.6	7.7	7.8	5.2	3.5	7.9	8.2	11.7	3.5	7.1	8.6	15.6	8.8	5.5	5.3	3.4	11.0	18.1	3.8	10.5	10.7	11.6	10.9	8.6	12.4	15.8	11.2	13.8	12.9	20.4	11.5	8.0	9.2	11.3	15.7	16.6	14.9	12.3	16.0	22.5	15.2	16.9	13.1	18.4	13.7	11.0	20.4	12.7	13.3	10.3	13.8	18.9	23.5	16.0	13.7	16.6	13.6	14.4	0.7	8.8	20.6	17.8	9.9	33.7	23.3	6.8	5.4	9.7	13.8	23.6	18.3	6.0	25.5	16.9	8.5	10.0	11.9	13.1	12.7	15.1	18.8	6.6	13.9	16.0	10.4	2.1	5.1	3.7	8.6	6.0	10.1	7.9	8.8	10.8	8.4	8.9	10.2	10.7	0.8	11.4	6.8	8.8	6.0	6.3	3.1	3.4	3.5	4.6	3.3	3.6	3.3	3.3	3.4	3.5	3.5	3.4	5.9	0.0	9.4	3.9	9.3	3.1	5.9	23.0	4.0	6.5	8.7	13.2	13.3	10.0	12.0	11.0	4.2	19.5	7.1	5.4	11.7	13.5	59.5	7.8	7.2	4.9	2.4	2.1	4.5	6.8	16.9	5.9	4.6	6.4	10.1	13.0	7.5	17.4	8.5	5.0	5.1	9.8	14.2	3.8	3.2	15.1	7.2	6.8	5.4	1.0	5.2	9.1	6.2	3.5	3.8	7.5	8.9	4.1	7.8	6.5	10.6	18.4	9.2	7.4	0.0	5.3	5.8	48.0	12.6	7.2	4.4	14.1	5.9	19.2	8.8	3.6
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	22	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 28.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Vesicles, Cytosol"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	4.9	41.6	2.8	4.9	3.1	1.0	6.5	3.0	3.1	17.0	1.8	24.0	2.7	17.6	18.5	11.0	8.0	4.8	8.8	3.3	4.8	51.3	7.0	28.7	2.4	7.6	4.7	16.1	3.6	2.3	8.2	9.2	6.7	37.6	10.4	19.3	4.9	26.5	1.2	17.8	6.7	32.4	5.2	54.8	23.9	4.2	4.9	5.2	3.0	1.7	2.0	11.9	19.9	8.3	46.9	18.2	35.1	0.2	0.6	1.4	42.1	48.7	19.3	7.8	12.6	15.0	18.0	0.1	27.1	8.6	120.2	109.9	0.1	65.3	16.3	0.4	6.2	0.1	12.1	0.3	35.4	0.2	0.3	16.9	21.4	15.2	5.4	73.5	1.4	0.1	0.1	0.4	12.3	1.1	0.1	0.4	11.0	31.3	3.7	0.1	7.1	2.8	109.8	77.5	2.5	0.3	66.1	3.7	29.3	51.1	0.1	0.7	24.4	45.9	16.8	0.4	8.9	3.4	0.2	0.5	10.6	0.2	60.2	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.1	0.0	28.9	0.0	0.2	2.8	3.1	3.0	3.1	3.3	4.8	7.6	4.7	6.7	5.2	4.9	8.3	5.7	48.1	80.3	19.2	1.0	0.0	7.7	0.0	13.6	2.3	1.6	9.9	1.0	2.8	3.1	44.1	4.2	42.0	9.5	19.8	5.9	4.7	19.6	2.0	27.3	10.5	0.0	2.7	55.6	0.8	14.7	10.3	8.6	1.5	1.3	124.1	32.5	0.8	11.4	10.1	60.4	0.5	0.0	3.2	0.0	14.9	4.7	5.6	0.0	91.8	0.8	44.5	0.0	43.7	4.4	30.6	1.9	0.0	0.2	15.1	0.0	26.2	0.0	1.2	0.0	10.9	45.2	0.5	0.9	13.5	0.0	38.6	0.7	74.3	2.1	3.9
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132190147-132295315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 115.6;Endometrial stromal cells: 96.9;Skeletal myocytes: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 324.2;U-87 MG: 323.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		13000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum, Vesicles"		"CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.12e-4)"	17.4	11.7	11.9	16.1	12.1	2.4	12.3	11.4	28.4	29.5	42.2	28.7	22.6	31.1	76.7	19.6	29.6	19.9	40.6	14.4	17.2	80.0	10.5	31.5	2.5	11.4	14.3	8.6	70.7	10.9	19.9	35.1	19.1	10.8	32.7	7.8	32.5	17.1	13.0	16.7	26.8	52.6	10.0	8.7	20.5	9.7	16.8	11.3	20.7	22.9	8.3	22.9	22.3	12.2	57.0	34.9	11.2	57.2	149.2	173.7	61.1	261.9	223.7	108.9	265.0	78.9	50.3	1.5	71.8	283.3	120.5	70.2	33.2	136.5	172.7	41.5	11.9	0.6	48.1	49.0	324.2	0.0	33.9	104.6	193.1	128.8	117.4	162.7	59.1	0.1	21.2	3.6	134.0	23.2	0.2	0.5	3.0	53.7	27.2	0.9	3.6	9.8	31.1	11.0	5.4	15.8	67.7	22.3	47.9	84.1	28.4	3.7	88.9	171.7	63.5	51.0	57.1	24.4	28.1	11.8	323.4	0.4	48.3	0.0	0.4	0.0	0.8	0.3	0.7	0.0	0.4	0.1	0.2	0.0	0.0	0.1	1.0	0.9	0.0	0.3	0.0	0.2	11.9	12.1	11.4	28.4	14.4	17.2	11.4	14.3	19.1	10.0	16.8	12.2	13.0	35.3	10.3	7.5	1.1	16.8	43.6	115.6	23.9	11.6	9.5	9.5	13.3	8.6	36.9	11.0	22.9	2.6	0.3	43.2	5.9	68.3	1.4	26.7	96.9	12.2	15.0	0.0	7.7	71.8	70.2	61.6	12.8	28.0	5.7	11.1	9.3	7.8	7.6	0.0	7.7	18.6	32.6	1.3	5.5	2.0	8.1	4.4	30.2	2.8	2.6	6.8	0.0	1.5	1.2	81.9	41.0	5.3	3.0	19.6	41.4	44.6	71.9	5.2	26.3	109.4	47.6	23.0	29.1	6.8	9.8	7.5	4.8	10.4	13.8	15.3
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860856	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1856.8;pancreas: 2446.9"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1077.9;Extravillous trophoblasts: 1349.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	No		110000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	266.5	507.8	34.6	209.8	35.7	517.1	225.5	39.1	35.7	272.0	59.6	258.4	640.2	206.5	133.0	618.7	183.4	202.0	318.4	31.7	50.2	270.7	1856.8	301.3	104.0	48.9	37.1	187.8	2446.9	144.3	330.0	334.3	40.8	335.8	173.6	23.3	948.1	184.2	328.5	370.4	554.7	179.8	39.8	428.6	539.2	68.8	58.7	89.3	244.8	150.8	137.9	233.7	322.9	43.7	690.3	580.7	236.8	687.5	813.4	726.7	593.6	1038.5	1081.1	741.9	934.5	550.4	576.9	264.4	501.8	1120.2	407.5	464.1	248.8	647.4	254.1	145.8	320.5	355.2	362.9	953.6	1010.8	1146.4	613.4	618.8	494.8	478.2	596.7	843.0	1250.1	182.1	273.6	978.2	559.5	566.4	260.5	723.2	157.7	791.0	463.8	261.8	342.5	614.0	453.2	492.8	248.7	301.1	586.1	1693.1	808.1	289.6	855.3	1601.2	644.1	980.5	503.1	574.3	586.6	743.5	407.9	204.8	1372.0	591.3	825.4	198.3	268.1	163.0	202.6	154.4	209.8	83.9	138.9	165.7	174.7	68.1	74.9	114.6	72.9	157.0	115.3	311.5	105.6	372.4	34.6	35.7	39.1	35.7	31.7	50.2	48.9	37.1	40.8	39.8	58.7	43.7	122.3	102.5	162.1	23.2	151.4	120.1	163.6	371.0	140.6	59.2	283.0	170.8	24.1	247.4	211.7	112.2	33.3	790.2	208.9	420.7	41.1	671.9	43.5	78.4	196.8	153.9	199.9	140.9	15.3	1077.9	1349.1	272.5	388.9	209.1	99.1	210.4	190.2	840.7	435.9	62.2	16.2	610.9	189.2	186.9	125.5	64.9	141.4	180.3	136.9	20.6	263.3	122.7	230.7	13.6	19.6	575.2	465.6	112.1	664.3	310.6	914.2	105.0	91.3	54.3	157.8	103.4	226.7	83.4	94.1	302.3	144.6	1001.2	138.8	378.4	475.4	220.8
PAFAH1B3		ENSG00000079462	"Platelet activating factor acetylhydrolase 1b catalytic subunit 3"	Q15102	19	42297033-42303546	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035639	Uncertain		Approved	"Intermediate filaments"		NA	NA		290000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"		"HPA035639: AB_10670163"	"unprognostic (3.19e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.80e-3)"	8.3	23.5	34.7	12.4	35.4	27.9	13.7	36.5	44.1	18.9	31.3	16.8	12.4	13.8	12.9	28.1	14.8	10.8	4.6	35.1	39.9	21.8	7.9	9.2	17.0	32.2	33.1	18.3	18.1	13.8	21.2	5.9	34.4	15.2	12.1	13.0	17.0	6.3	13.5	13.6	14.7	7.5	32.0	16.0	15.9	23.7	42.9	37.6	9.3	5.2	18.3	14.1	16.6	32.5	111.9	200.2	127.5	135.8	2.6	6.7	38.1	27.9	39.2	91.9	94.4	67.7	94.7	70.0	34.8	35.0	63.7	37.1	58.9	75.2	38.3	105.7	77.0	85.8	52.7	91.8	19.3	54.4	90.3	19.9	33.9	56.5	26.3	50.7	41.3	152.5	58.5	81.9	67.9	162.5	124.2	42.4	70.3	138.3	0.2	90.0	47.9	62.0	76.4	117.7	144.8	109.9	44.6	89.4	47.0	40.4	111.4	62.1	22.3	74.8	98.5	6.7	77.3	38.0	84.9	60.6	41.3	87.4	65.8	23.2	27.5	15.7	23.4	22.3	31.2	38.3	32.8	26.7	51.1	48.2	43.3	30.6	3.4	18.2	12.0	27.8	58.1	21.0	34.7	35.4	36.5	44.1	35.1	39.9	32.2	33.1	34.4	32.0	42.9	32.5	18.8	16.0	11.2	3.6	26.1	28.2	45.7	82.7	46.1	26.5	67.9	83.2	2.3	30.0	41.6	33.1	14.6	38.6	13.2	39.1	80.3	112.9	16.7	30.4	12.4	24.4	58.9	53.0	3.0	55.3	44.9	21.7	38.7	33.1	27.9	71.4	17.9	10.3	62.7	11.8	5.4	54.0	87.5	28.2	33.5	27.0	13.7	21.8	46.2	1.0	18.2	33.7	11.3	3.0	3.6	81.5	36.1	9.1	37.3	31.0	30.9	63.7	35.0	19.8	0.0	3.6	52.6	5.6	188.8	59.0	17.8	13.5	24.6	46.2	74.3	58.9
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836889-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Phenylalanine catabolism"	"Allosteric enzyme, Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 496.6;liver: 1408.4"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 250.2;Hepatocytes: 807.7;Proximal tubular cells: 344.4"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"Hep G2: 238.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		No	NA		40000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.2	6.4	2.1	0.0	1.9	0.0	0.2	1.8	3.4	0.1	1.1	0.3	0.1	0.1	0.5	0.0	0.1	79.4	0.0	2.2	2.3	496.6	1408.4	0.0	0.1	2.8	2.3	0.1	9.2	0.8	3.0	0.0	2.3	1.5	0.0	2.4	0.1	0.1	0.0	0.0	0.1	0.0	2.6	0.3	0.4	3.3	2.5	0.7	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	238.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.2	1.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.9	1.8	3.4	2.2	2.3	2.8	2.3	2.3	2.6	2.5	2.8	0.0	0.0	0.0	1.0	2.7	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.5	250.2	0.0	5.5	0.0	0.0	0.0	0.0	21.5	2.4	66.8	0.0	0.1	1.1	1.8	21.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	807.7	0.0	3.3	2.3	0.0	0.0	22.2	0.0	15.7	0.6	1.8	0.0	0.0	0.0	0.6	0.0	4.5	0.0	0.0	0.0	1.2	0.0	0.4	0.0	344.4	0.0	0.2	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.1
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 157.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		490000	"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	24.5	40.2	22.7	40.1	26.7	46.8	54.6	28.3	25.0	29.3	21.6	42.8	32.1	29.7	22.1	36.3	35.4	17.8	19.7	20.3	27.8	42.7	109.7	14.1	51.3	26.0	30.1	30.7	21.7	39.5	17.7	45.9	26.1	31.0	54.7	30.4	26.4	25.8	32.4	37.6	30.8	35.7	25.6	18.3	20.7	29.5	26.8	56.4	32.4	24.1	64.5	37.4	25.4	27.2	239.3	175.3	354.3	220.6	74.3	166.1	304.0	201.7	145.1	282.5	276.0	280.5	275.7	548.0	228.3	136.0	154.1	143.6	565.5	293.0	480.8	110.4	198.8	298.7	259.5	313.4	141.8	537.1	127.6	141.9	207.9	301.0	225.0	155.7	235.4	308.6	524.7	198.5	246.8	159.3	621.5	267.2	407.5	454.8	216.5	496.2	151.7	361.5	268.4	164.5	378.8	226.4	198.6	273.7	124.3	287.2	181.2	169.8	127.7	222.6	290.1	221.8	419.0	139.1	128.2	571.1	234.8	385.2	251.0	6.0	5.2	0.4	5.2	8.7	15.0	17.8	14.4	9.2	15.3	11.0	17.4	15.5	1.1	15.9	6.9	17.0	11.2	8.7	22.7	26.7	28.3	25.0	20.3	27.8	26.0	30.1	26.1	25.6	26.8	27.2	16.4	22.4	22.9	17.0	35.7	56.6	71.9	66.0	54.1	27.4	35.8	37.5	23.3	50.1	32.3	33.1	6.2	134.4	15.3	20.5	37.2	45.0	69.4	15.2	49.1	25.1	24.7	80.8	9.1	26.3	157.5	34.2	15.3	23.3	21.0	69.1	13.2	78.7	51.5	28.6	14.6	41.0	34.6	16.1	17.2	10.6	29.8	16.1	17.8	6.5	20.2	14.0	6.2	13.0	12.2	27.4	18.6	23.3	48.1	81.7	15.9	47.7	17.9	24.6	0.0	31.3	29.2	40.0	50.3	53.1	50.4	54.6	16.8	66.4	69.7	48.9
PAIP1		ENSG00000172239	"Poly(A) binding protein interacting protein 1"	Q9H074	5	43526267-43557758	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073653, HPA076187"	Approved		Enhanced	"Plasma membrane,Cytosol"		No	No		60000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"HPA073653: AB_2732234, HPA076187: AB_2686784"	"unprognostic (4.70e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	69.5	54.3	47.8	36.6	50.8	56.6	67.4	52.0	64.2	65.1	52.0	57.1	43.3	61.6	57.3	52.0	51.2	53.3	92.5	51.2	52.0	78.0	90.9	50.3	39.4	49.5	49.5	53.7	54.8	74.3	29.3	68.1	50.8	69.1	54.8	95.2	51.3	68.5	155.3	31.1	40.2	65.3	54.3	34.2	46.9	83.6	49.0	47.6	73.6	122.9	45.3	70.1	39.9	56.5	94.5	82.2	158.0	153.7	161.8	127.1	129.1	81.2	180.0	151.5	130.9	77.2	112.8	62.5	136.9	115.5	227.3	60.4	249.3	98.0	153.5	52.2	96.7	49.2	157.1	122.6	142.3	74.2	74.3	135.8	186.1	102.5	191.7	153.1	146.8	45.9	115.9	82.1	153.0	101.7	82.4	101.8	78.5	89.4	104.8	63.8	119.2	88.1	188.8	114.3	89.4	135.3	260.3	99.2	190.0	144.0	141.4	106.3	82.4	136.6	112.5	68.8	103.7	61.7	112.6	94.3	79.7	113.1	120.4	40.4	24.1	46.2	18.9	20.7	25.2	26.4	23.2	26.2	23.7	26.7	28.9	23.2	8.6	24.9	22.5	66.8	23.0	22.1	47.8	50.8	52.0	64.2	51.2	52.0	49.5	49.5	50.8	54.3	49.0	56.5	66.4	32.1	52.2	15.0	39.4	73.3	74.0	78.5	52.3	48.8	78.8	53.1	122.4	78.6	52.7	44.1	20.9	76.3	66.0	33.1	158.5	120.3	182.6	73.8	56.4	71.2	44.9	54.9	30.0	91.6	89.2	64.2	39.3	55.9	24.6	47.4	50.0	49.2	59.4	35.3	25.3	52.1	103.7	40.9	39.7	58.0	76.4	42.0	83.6	20.6	53.8	86.6	24.7	26.7	35.1	116.4	43.8	66.5	43.3	106.4	45.1	148.8	40.9	67.7	26.3	70.2	71.4	171.2	76.6	56.0	66.3	68.1	35.1	49.7	47.7	84.3
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537370-9839076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 12.0;retina: 4.7"	"Group enriched"	"Detected in some"	4	"Breast myoepithelial cells: 6.5;Glandular and luminal cells: 2.0;Granulosa cells: 5.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 4.6;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.0	1.9	3.6	0.0	4.8	0.0	0.4	12.0	8.4	0.1	0.0	0.0	0.0	0.2	0.6	0.2	0.0	1.2	0.0	5.5	0.7	0.2	0.7	0.0	0.0	0.3	1.4	0.0	1.3	0.0	1.2	0.0	0.4	0.4	0.0	4.7	0.3	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.2	2.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.8	12.0	8.4	5.5	0.7	0.3	1.4	0.4	0.2	2.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497052-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 527.9;Cardiomyocytes: 591.7;Peritubular cells: 399.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 304.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Mitochondria,Cytosol"		No	No		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	"Plasma membrane, Mitochondria, Cytosol"	"CAB070159: AB_1726016, HPA035905: AB_2674854"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.28e-4)"	65.0	35.5	31.7	49.7	27.3	0.9	43.6	11.1	19.9	146.1	0.0	303.3	29.0	301.5	21.9	122.6	118.4	71.0	180.4	27.9	36.2	42.1	12.4	71.7	16.9	29.8	25.9	62.1	13.2	55.6	11.3	62.1	25.1	137.0	74.9	12.8	40.8	205.7	127.7	34.7	64.1	303.1	21.4	60.5	94.8	35.1	24.7	23.3	38.7	47.3	16.6	280.2	85.3	22.7	82.1	39.6	87.9	53.4	77.2	83.9	123.6	53.7	137.6	47.2	66.7	1.1	4.6	36.6	14.4	23.7	29.0	17.0	54.1	138.8	60.5	73.9	16.6	0.8	112.5	10.4	135.5	0.4	1.0	132.8	84.4	85.5	125.4	115.0	20.8	19.7	0.1	0.5	304.5	3.8	23.8	1.4	24.9	20.8	24.1	8.3	81.4	0.8	5.3	16.4	9.0	46.4	102.8	8.1	7.3	151.2	48.6	0.5	64.4	50.3	192.1	20.7	90.1	47.8	0.7	1.7	41.6	1.0	14.2	13.7	3.1	0.0	4.6	1.8	0.2	0.1	0.5	2.4	2.1	0.1	0.6	1.6	0.7	0.6	1.2	0.2	0.8	1.8	31.7	27.3	11.1	19.9	27.9	36.2	29.8	25.9	25.1	21.4	24.7	22.7	22.7	32.1	9.4	167.8	1.5	93.6	527.9	56.8	76.8	6.0	46.0	107.9	591.7	20.0	58.7	44.1	18.8	52.1	8.1	20.9	1.9	27.6	133.1	52.8	181.2	27.7	44.8	0.8	27.8	51.3	115.6	130.5	59.7	51.0	52.6	21.0	47.8	11.2	24.5	26.9	108.4	30.7	18.3	28.9	23.8	146.4	130.1	36.7	23.2	16.9	52.9	55.1	17.5	182.4	6.5	83.0	18.6	399.4	2.6	167.6	9.8	23.4	85.2	4.0	177.5	115.4	227.8	81.0	7.6	34.1	49.3	22.3	9.2	13.4	29.3	113.0
PALM2AKAP2	PALM2-AKAP2	ENSG00000157654	"PALM2 and AKAP2 fusion"	"Q8IXS6, Q9Y2D5"	9	109498325-110172512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 10.6;naive B-cell: 10.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	97.0	13.5	21.8	37.3	21.1	9.9	17.5	6.9	22.7	28.5	0.0	17.4	14.8	28.8	8.5	26.5	14.7	37.4	93.8	15.7	18.5	30.8	38.2	69.1	32.2	18.1	26.6	9.3	13.1	14.0	0.1	97.9	20.3	14.9	18.1	3.3	38.0	25.1	17.0	10.1	13.3	48.5	10.5	38.4	18.5	4.6	38.8	45.4	25.6	24.3	31.7	43.0	0.4	26.3	20.6	7.7	112.5	0.1	110.8	93.0	33.4	116.0	141.3	101.6	93.4	134.6	17.9	92.1	30.6	129.6	146.2	28.9	9.5	98.8	185.4	68.9	12.5	9.2	30.4	11.0	75.9	12.4	256.2	109.8	24.7	183.3	280.4	62.5	150.9	14.5	0.3	76.2	204.7	1.2	61.9	31.1	47.2	9.1	62.6	5.5	98.2	25.3	72.4	2.8	25.2	1.5	10.3	9.5	26.4	87.8	4.1	22.2	240.0	94.0	77.9	137.5	108.8	52.5	89.1	52.5	81.4	51.3	73.9	2.9	0.1	1.3	1.0	0.2	0.2	10.6	1.2	1.4	1.2	10.3	0.7	0.8	0.5	2.2	0.0	2.4	3.9	1.4	21.8	21.1	6.9	22.7	15.7	18.5	18.1	26.6	20.3	10.5	38.8	26.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929887	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	13.0	12.3	14.5	16.8	13.7	20.9	12.2	15.3	15.9	11.9	14.1	11.4	8.4	11.0	11.3	20.0	16.3	12.1	8.7	15.5	13.5	15.7	18.3	14.1	18.5	12.7	14.1	12.9	10.3	10.9	8.9	15.3	13.3	12.0	14.2	10.3	11.9	10.7	9.6	11.7	11.6	13.7	12.7	14.9	9.1	25.9	13.9	16.8	15.4	11.2	22.0	15.6	9.9	12.4	39.3	29.4	33.7	18.6	39.3	32.6	15.0	25.6	34.2	38.3	48.3	40.8	25.4	34.6	10.6	34.9	70.2	34.9	34.7	57.3	49.3	8.8	9.8	47.4	22.7	80.2	33.3	33.6	15.9	28.7	26.4	39.7	28.7	17.0	36.0	23.3	34.7	30.5	42.5	11.7	30.0	30.3	28.8	22.9	19.5	20.3	46.0	22.4	26.2	45.7	36.2	16.7	30.0	44.3	78.1	32.6	23.6	28.1	24.6	47.7	17.8	60.7	43.3	14.0	50.8	23.3	15.0	30.7	34.2	3.0	10.5	3.4	3.6	11.1	3.5	3.8	3.7	3.4	8.5	4.5	4.1	3.4	5.9	6.8	9.4	3.0	5.9	4.0	14.5	13.7	15.3	15.9	15.5	13.5	12.7	14.1	13.3	12.7	13.9	12.4	23.8	19.2	11.7	23.8	29.2	25.5	17.5	12.0	41.5	22.0	15.8	17.3	9.8	7.2	13.4	14.7	25.0	29.4	38.6	14.4	23.5	19.4	83.1	24.1	20.6	26.7	20.3	42.7	28.6	17.8	36.0	21.1	24.5	24.1	7.6	20.1	26.0	14.0	33.8	35.3	25.3	12.7	10.2	52.8	37.9	17.3	21.1	34.3	19.6	29.0	55.0	14.1	35.0	23.1	17.7	15.9	12.8	22.6	33.2	20.9	15.1	20.6	20.2	21.1	6.6	14.1	23.1	54.6	25.9	37.7	24.3	18.6	31.6	21.2	15.0	20.0
PANK4	FLJ10782	ENSG00000157881	"Pantothenate kinase 4 (inactive)"	Q9NVE7	1	2508537-2526597	"Metabolic proteins, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011723, HPA012036, HPA027961"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042"	"unprognostic (1.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.57e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-2)"	10.1	11.0	1.0	2.7	1.7	4.7	9.7	1.0	5.1	10.9	2.1	13.9	4.1	11.4	0.0	9.1	10.0	0.0	21.8	1.3	1.0	11.0	12.7	11.9	2.7	1.1	1.4	9.4	8.7	1.2	13.6	2.5	1.2	10.3	2.7	5.6	10.0	1.7	32.8	12.6	11.6	1.8	1.2	13.7	11.5	8.9	1.3	2.8	11.5	20.5	2.6	12.5	10.4	1.2	2.2	6.3	4.9	13.8	9.4	5.2	4.5	0.0	1.7	0.1	2.2	12.6	18.5	2.2	0.7	4.3	8.1	4.6	0.2	7.8	5.5	0.0	12.3	7.4	1.6	5.7	0.7	5.7	0.1	8.0	7.0	11.6	2.3	0.6	5.6	2.7	0.1	14.9	0.7	5.5	11.8	7.7	0.0	3.1	12.5	13.4	0.7	5.3	0.0	3.8	10.8	6.1	0.5	10.7	11.9	3.2	5.4	0.0	1.1	15.1	2.3	5.0	5.7	4.6	0.3	4.7	6.9	7.3	3.6	0.5	0.0	1.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	1.0	1.7	1.0	5.1	1.3	1.0	1.1	1.4	1.2	1.2	1.3	1.2	4.7	6.4	5.1	7.5	6.1	4.1	5.6	7.4	6.2	7.2	3.7	2.4	23.3	2.8	6.4	3.7	10.4	7.8	5.9	7.9	7.9	5.7	1.4	3.8	4.2	5.4	3.0	11.6	6.1	6.9	5.0	6.4	4.6	5.0	1.3	5.3	3.6	7.9	5.3	3.3	6.4	4.5	6.1	5.0	3.0	0.6	5.9	5.0	5.4	1.9	7.4	4.6	11.3	5.5	3.5	5.3	8.8	9.1	7.1	4.0	4.7	4.8	3.1	13.9	19.7	2.6	6.3	6.3	6.1	3.9	4.4	9.7	8.9	3.2	5.9	4.2
PAPOLA	PAP	ENSG00000090060	"Poly(A) polymerase alpha"	P51003	14	96501433-96567111	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1036.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001788	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001788: AB_1079564"	"unprognostic (3.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.05e-1)"	52.6	60.5	62.7	66.6	65.1	96.9	62.7	71.7	87.4	61.7	70.1	70.5	57.1	68.5	72.5	59.6	57.9	56.1	61.0	59.9	64.4	60.7	81.6	50.0	77.8	63.0	61.7	76.1	71.6	73.2	53.0	85.3	64.3	54.2	71.8	92.4	63.8	54.0	46.7	57.9	67.6	61.6	62.8	69.3	65.9	75.8	62.1	93.0	68.9	56.4	82.8	66.4	53.5	80.7	126.6	119.4	150.5	152.6	107.2	119.4	331.6	112.9	120.4	132.1	125.8	132.9	125.6	170.9	125.3	134.1	115.2	104.4	50.1	156.9	235.0	141.1	81.1	131.9	88.9	138.5	110.6	166.2	133.4	110.6	134.1	148.0	131.1	127.8	150.5	79.5	128.2	146.5	128.9	184.6	140.5	91.1	102.9	205.0	135.3	146.7	183.5	98.7	132.0	192.7	154.0	102.0	151.4	115.8	111.6	167.9	165.3	158.3	119.0	91.3	72.6	104.1	140.7	114.3	186.7	138.6	144.5	137.5	158.9	73.5	32.0	56.1	23.8	39.3	29.0	38.9	30.2	34.2	38.8	42.7	35.3	33.9	41.3	41.3	37.7	25.1	32.7	36.6	62.7	65.1	71.7	87.4	59.9	64.4	63.0	61.7	64.3	62.8	62.1	80.7	126.3	80.1	122.4	64.6	171.4	229.7	406.3	196.6	126.9	78.2	140.0	101.6	157.2	88.6	160.1	84.6	95.9	346.2	139.6	124.1	183.9	121.4	634.7	326.1	145.4	150.7	117.2	126.8	87.9	137.0	440.7	129.9	95.3	371.7	136.4	113.8	85.6	112.3	155.6	63.9	111.5	154.9	168.9	141.3	239.4	275.3	96.3	153.2	168.9	104.9	171.8	93.4	135.9	105.1	115.2	129.6	118.9	80.5	197.4	373.0	122.5	136.5	253.1	107.2	105.2	131.6	185.0	256.8	203.0	146.0	247.6	1036.0	167.8	131.2	166.1	540.3
PAPOLG	FLJ12972	ENSG00000115421	"Poly(A) polymerase gamma"	Q9BWT3	2	60756253-60802086	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017795, HPA035349, HPA035350"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.72e-4)"	"unprognostic (2.49e-1)"	"unprognostic (6.97e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.62e-2)"	3.7	3.0	2.2	2.2	2.3	1.4	3.4	3.2	3.1	4.2	1.7	3.2	1.3	4.1	1.2	3.5	3.2	1.4	3.1	2.3	2.3	2.5	2.3	3.2	3.0	2.5	2.1	4.9	3.5	1.7	3.1	2.0	2.5	2.6	1.5	4.0	3.8	1.2	4.2	3.7	3.6	1.5	1.9	4.1	3.4	3.5	2.6	3.7	6.2	1.7	2.5	3.2	4.1	3.0	1.8	1.5	3.4	2.0	3.1	3.7	2.4	1.5	1.9	1.4	1.2	2.4	1.3	2.6	1.7	1.3	1.4	2.8	3.7	1.8	2.3	4.0	2.1	4.0	1.7	1.7	1.9	4.4	2.4	2.2	2.5	1.7	3.7	2.9	2.6	2.6	3.2	1.9	1.4	1.4	5.0	3.6	5.3	2.9	1.1	3.4	4.9	2.7	1.9	1.4	1.6	2.4	2.2	2.7	1.9	3.2	1.3	2.7	2.4	1.8	1.8	1.3	1.7	2.4	1.5	5.4	2.2	4.8	1.4	3.7	0.8	1.5	1.3	1.0	1.7	1.1	1.2	1.2	0.7	1.4	1.7	1.5	2.2	1.4	1.2	0.8	2.2	0.8	2.2	2.3	3.2	3.1	2.3	2.3	2.5	2.1	2.5	1.9	2.6	3.0	11.5	12.8	12.2	13.1	13.9	12.5	13.5	4.6	12.0	6.8	8.4	8.6	7.9	7.2	8.8	9.2	25.0	6.0	21.0	6.9	3.9	4.8	4.7	6.1	13.2	10.9	2.4	13.3	29.5	4.3	4.6	11.0	6.6	6.6	13.3	14.6	11.7	5.0	7.4	5.0	24.8	5.7	10.2	10.4	22.7	4.3	7.5	17.8	12.4	25.3	12.0	5.1	8.2	19.1	22.1	4.9	6.0	8.6	12.7	15.4	4.3	3.5	7.1	10.3	26.3	9.3	11.3	30.3	17.3	13.2	15.9	8.8	20.8	10.6	4.0	16.2
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720234	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 444.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 321.8;eosinophil: 359.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 359.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		13000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	26.3	14.2	36.8	30.8	43.9	26.0	49.9	46.4	50.0	49.6	26.5	20.4	16.0	47.1	43.0	36.2	48.4	26.4	15.9	41.9	40.8	31.7	10.3	44.4	32.9	53.2	41.4	29.2	49.3	26.9	15.8	17.2	51.8	41.1	24.7	22.3	66.0	25.9	6.1	49.7	15.8	33.6	51.1	17.4	62.8	17.0	41.8	35.4	20.3	9.9	51.7	31.7	23.7	66.3	33.6	29.7	49.1	62.1	59.1	74.0	39.6	42.4	77.2	39.4	53.1	45.7	46.7	51.3	26.0	76.1	30.4	40.7	46.8	81.6	50.5	124.2	35.5	60.4	62.6	103.0	32.3	93.0	99.8	61.7	41.2	45.7	37.1	95.2	88.7	63.9	13.6	97.0	111.6	50.7	77.3	28.2	52.6	35.3	33.1	62.4	78.0	15.0	59.6	45.6	55.5	81.4	42.9	63.3	51.9	61.9	37.9	14.1	52.9	49.3	51.0	33.6	35.4	76.9	57.2	48.7	60.1	69.3	79.2	321.8	49.9	359.8	15.6	56.2	18.8	44.8	21.2	18.0	51.4	26.4	13.2	14.9	55.5	27.6	60.8	9.8	39.9	36.7	36.8	43.9	46.4	50.0	41.9	40.8	53.2	41.4	51.8	51.1	41.8	66.3	19.7	96.1	20.2	41.4	25.4	32.0	36.3	73.2	33.6	19.9	48.4	41.5	7.4	50.1	92.3	57.0	10.4	20.6	7.0	10.5	17.6	36.8	6.2	124.2	84.6	25.1	23.4	15.3	112.2	44.7	48.7	35.2	62.2	444.3	42.5	25.0	20.3	10.2	55.1	30.3	64.7	17.5	32.6	46.5	27.8	6.7	18.0	53.5	60.5	29.0	37.4	35.0	10.3	100.0	150.3	33.6	9.1	25.6	86.4	29.1	6.9	28.8	110.0	13.3	26.3	45.2	29.1	19.6	14.7	62.9	40.9	8.9	22.2	19.2	14.8	29.4
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 135.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 240.4;Distal enterocytes: 202.4;Hepatocytes: 111.5;Proximal enterocytes: 181.3;Theca cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.0;myeloid DC: 2.1;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.1;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"BJ: 189.8;fHDF/TERT166: 473.2;HHSteC: 196.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No		16000	"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	33.3	135.2	6.3	26.6	7.0	2.0	20.9	6.2	9.5	17.8	6.2	79.9	29.5	8.5	3.1	10.2	12.4	20.7	11.6	5.8	6.2	23.8	77.0	70.4	11.0	6.9	6.6	27.5	26.1	2.1	3.0	58.5	7.5	6.7	64.3	2.3	16.4	3.4	4.7	3.5	61.8	16.7	6.8	8.5	9.2	11.7	8.0	3.0	21.3	8.7	14.8	16.6	11.5	7.2	19.9	20.0	6.4	0.3	129.4	164.8	0.3	189.8	157.7	110.4	79.9	1.0	4.1	0.1	9.8	473.2	3.5	8.5	13.9	13.3	125.2	0.2	10.0	8.8	13.4	0.1	196.5	0.2	3.8	58.7	0.3	63.7	5.2	135.6	94.2	1.4	0.0	89.4	79.2	74.1	0.1	0.7	7.4	4.8	24.1	0.4	0.1	0.4	117.5	8.7	0.9	1.6	92.5	3.3	1.1	12.6	13.5	5.3	120.0	38.2	22.5	131.5	13.9	0.3	1.0	0.3	18.3	0.2	0.2	0.0	1.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	7.7	0.0	0.0	0.8	6.3	7.0	6.2	9.5	5.8	6.2	6.9	6.6	7.5	6.8	8.0	7.2	49.5	240.4	38.2	3.6	2.6	2.3	0.9	18.0	1.8	0.2	11.5	4.7	4.4	8.6	13.8	9.2	0.0	0.5	0.8	202.4	13.7	6.4	1.2	2.6	18.7	23.2	12.6	5.2	22.2	30.2	0.8	36.1	15.3	11.6	0.0	20.3	36.0	111.5	11.5	0.0	27.6	26.5	4.1	29.8	50.7	0.8	17.4	51.0	1.8	30.0	5.2	1.3	0.0	21.6	1.0	19.4	46.1	5.3	3.1	2.1	181.3	9.8	3.4	0.0	13.1	1.0	20.4	1.2	0.7	1.1	1.3	1.4	1.7	96.4	74.3	1.1
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 455.4;Inhibitory neurons: 147.0;Microglial cells: 193.0;Oligodendrocyte precursor cells: 367.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 9.6"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		21000	"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cell Junctions"		"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavorable (4.41e-4)"	13.1	15.9	19.6	4.8	17.0	0.5	21.5	10.9	12.4	25.9	16.0	30.4	10.6	20.7	12.2	47.8	20.6	14.9	14.6	17.8	20.6	25.1	22.1	15.2	2.6	15.7	22.1	38.5	34.2	20.7	7.3	21.7	15.9	17.0	21.7	13.6	20.1	23.9	40.5	52.1	13.4	21.8	16.0	4.2	17.7	14.0	24.0	13.5	15.2	30.9	12.4	21.3	30.8	13.9	50.6	121.1	40.1	28.6	28.5	24.2	59.1	22.2	25.4	37.3	40.0	44.3	43.3	0.3	31.4	44.6	30.4	35.8	34.7	56.7	46.1	0.4	26.8	0.0	14.9	44.1	36.2	5.7	0.1	28.7	54.9	50.9	38.1	35.9	23.3	32.4	34.7	14.9	44.8	35.4	59.3	4.2	18.0	32.7	41.4	44.9	39.0	21.9	80.9	38.4	20.1	20.9	26.8	37.3	42.9	49.6	21.1	6.7	28.4	18.7	56.1	35.5	24.2	13.2	17.1	0.1	21.0	0.2	22.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	19.6	17.0	10.9	12.4	17.8	20.6	15.7	22.1	15.9	16.0	24.0	13.9	6.4	35.3	35.3	455.4	0.2	34.0	42.3	19.8	19.9	8.7	17.1	24.9	39.0	21.5	24.3	14.7	29.2	24.9	0.2	25.6	0.0	34.1	19.9	22.3	29.9	9.4	24.0	2.7	5.4	36.4	25.0	22.3	13.3	33.4	1.3	33.1	8.9	24.8	3.4	11.8	147.0	30.1	14.2	0.6	4.7	20.3	30.4	7.7	5.4	193.0	0.8	28.8	1.0	367.9	13.9	38.8	23.8	38.4	1.4	31.4	13.7	25.6	29.3	19.7	26.3	23.4	26.1	6.2	27.6	40.4	61.5	40.1	1.5	32.1	22.0	47.2
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662774	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 42.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 266.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.9;RPMI-8226: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favorable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	3.2	8.0	25.1	2.4	24.8	1.3	2.8	32.4	38.5	2.1	19.3	7.7	1.1	2.6	2.1	2.0	2.7	1.9	4.2	28.1	22.3	8.8	6.5	3.1	3.1	25.3	22.8	3.9	27.9	6.6	30.2	0.7	26.8	3.6	1.0	2.7	2.7	2.7	8.7	1.8	4.1	1.6	21.9	4.8	5.9	42.9	25.8	3.4	2.4	5.3	2.2	3.7	1.7	25.4	8.9	9.4	2.6	23.5	1.7	0.4	4.7	0.2	1.1	3.4	3.2	4.7	3.6	14.8	4.3	0.3	1.2	7.0	5.2	1.1	0.7	6.9	5.0	6.0	4.1	5.5	2.4	2.5	13.5	0.1	0.5	3.2	1.3	2.1	1.7	21.7	0.6	3.4	0.6	8.7	15.6	3.2	3.3	12.0	6.0	27.9	1.7	24.5	8.8	5.1	21.8	11.7	1.4	3.2	3.7	0.7	19.9	0.9	1.4	0.3	0.8	2.1	4.6	3.5	12.1	13.5	2.6	5.3	1.0	2.1	0.9	0.4	4.3	0.6	7.8	10.9	5.9	5.4	1.1	8.3	2.8	2.2	3.4	1.3	0.1	5.1	6.3	2.0	25.1	24.8	32.4	38.5	28.1	22.3	25.3	22.8	26.8	21.9	25.8	25.4	4.4	3.2	5.8	2.0	17.0	0.9	2.2	1.6	1.2	11.1	7.7	6.7	1.7	10.0	2.6	20.2	4.2	5.7	8.2	3.5	33.2	7.2	61.0	4.1	0.5	3.2	34.0	4.0	7.2	15.0	0.4	3.3	6.1	2.7	5.7	5.2	3.9	4.6	4.3	32.0	7.3	3.3	0.0	4.1	5.7	266.5	3.7	4.7	5.4	3.7	2.2	19.1	1.0	2.0	2.2	6.0	2.1	1.5	12.1	2.1	2.9	16.3	3.4	10.1	0.0	8.0	9.7	5.5	3.9	1.4	1.6	2.9	15.0	1.9	4.7	2.4
PARP1	"ADPRT, ARTD1, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360210-226408154	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		150000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	32.0	26.4	33.9	63.9	41.9	29.4	29.5	46.2	33.2	26.2	20.6	43.5	29.3	30.2	19.8	31.3	28.9	20.4	55.1	30.3	36.2	22.4	37.1	27.4	125.5	48.4	39.7	27.5	50.8	94.7	38.0	58.2	47.7	40.7	37.2	44.9	28.9	46.4	94.5	21.1	36.8	45.6	41.9	57.7	29.6	40.5	40.9	64.6	28.4	70.2	150.8	38.7	24.6	58.1	182.4	108.9	295.4	209.3	75.9	61.3	137.1	101.3	119.1	178.2	144.9	175.4	98.1	559.3	147.2	80.9	77.9	135.1	411.6	132.4	144.4	204.1	396.6	216.2	135.9	114.5	44.6	372.2	93.3	61.7	50.5	144.2	101.3	49.3	140.5	132.2	346.9	291.8	94.1	99.6	114.7	110.0	476.2	290.5	165.1	334.2	484.5	533.4	76.4	144.5	264.0	229.2	165.2	190.3	100.1	205.3	159.6	225.8	99.3	93.3	140.9	120.6	235.1	110.9	151.8	472.6	78.2	125.7	214.3	11.1	11.7	12.3	31.2	20.5	45.3	72.2	37.3	36.7	28.2	69.9	28.2	32.5	2.2	22.0	42.3	16.2	49.3	25.7	33.9	41.9	46.2	33.2	30.3	36.2	48.4	39.7	47.7	41.9	40.9	58.1	33.4	54.5	73.6	13.7	169.1	72.3	83.9	56.4	51.2	96.1	58.8	43.3	115.0	44.3	69.8	57.0	141.8	469.2	53.8	27.7	72.4	88.9	34.1	53.3	66.5	62.0	75.0	100.5	16.5	107.0	111.7	49.8	37.8	55.2	122.1	116.2	34.2	69.4	139.6	90.9	17.5	50.0	57.0	47.8	35.7	20.5	40.0	48.3	62.2	16.9	76.9	80.1	95.8	10.1	31.9	48.5	24.2	35.0	186.9	82.8	25.6	48.5	56.4	118.1	46.0	58.7	48.0	88.8	199.6	77.2	48.2	137.6	85.0	103.5	61.9	41.7
PARP10	"ARTD10, FLJ14464"	ENSG00000178685	"Poly(ADP-ribose) polymerase family member 10"	Q53GL7	8	143977153-144012772	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA028122, HPA052427"	Approved		Supported	"Nucleoli rim,Golgi apparatus,Cytosol"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA028122: AB_10601979, HPA052427: AB_2681828"	"unprognostic (9.80e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.63e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.30e-3)"	25.2	34.9	10.0	36.3	10.6	23.7	24.6	9.8	13.2	31.8	10.4	33.2	28.4	29.1	3.7	21.5	35.7	9.9	13.8	9.0	10.4	38.4	39.7	34.7	35.8	16.0	11.0	40.6	21.7	6.2	26.0	10.2	12.5	35.7	4.9	6.4	38.3	16.6	18.3	23.1	35.4	7.3	13.3	61.2	25.6	35.4	12.3	34.2	29.4	4.5	10.6	17.8	25.1	11.9	17.8	1.8	1.2	3.3	8.4	7.3	9.3	3.0	3.7	18.7	21.0	0.9	29.6	21.9	39.8	9.2	21.4	6.7	0.4	10.1	0.8	49.5	0.1	24.1	10.8	11.0	7.8	9.5	27.7	4.7	9.9	9.3	3.8	2.1	2.9	30.6	0.4	16.9	3.7	21.4	33.4	16.5	1.0	0.2	13.9	30.8	3.5	29.4	7.7	21.6	1.0	1.1	19.8	2.0	38.8	0.4	22.0	13.9	13.1	9.6	14.2	16.4	10.9	28.4	18.3	5.1	13.9	31.6	5.3	0.0	2.4	3.6	4.4	2.8	2.7	1.1	2.1	3.6	2.3	2.0	1.5	2.4	1.0	1.8	2.8	16.5	1.5	3.5	10.0	10.6	9.8	13.2	9.0	10.4	16.0	11.0	12.5	13.3	12.3	11.9	22.3	3.2	5.2	10.4	19.1	7.6	8.2	10.7	17.6	5.7	12.3	16.0	3.2	7.2	6.3	9.2	14.6	2.2	42.2	20.5	1.9	9.2	6.2	12.0	12.7	10.7	19.2	5.7	0.4	5.6	4.0	12.7	23.9	13.3	19.1	25.9	9.3	21.1	12.0	0.0	0.6	17.3	6.1	16.6	6.8	7.9	15.8	21.4	7.2	12.2	25.8	13.4	34.0	4.5	1.0	6.5	13.8	11.3	15.2	4.5	22.0	25.1	6.7	20.4	6.6	11.7	13.4	19.6	9.1	10.4	4.7	1.4	27.0	17.7	16.4	4.0
PARP12	"ARTD12, FLJ22693, PARP-12, ZC3H1, ZC3HDC1"	ENSG00000059378	"Poly(ADP-ribose) polymerase family member 12"	Q9H0J9	7	140023749-140062951	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003584, HPA063872"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA003584: AB_1079568, HPA063872: AB_2685139"	"unprognostic (1.46e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (3.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.01e-2)"	6.4	4.7	4.1	12.3	4.3	15.8	6.6	3.6	5.3	4.0	5.2	12.1	18.3	7.6	9.6	4.8	8.1	9.3	5.9	3.6	4.2	5.0	7.8	15.4	13.4	8.3	4.4	6.3	9.2	10.2	2.3	9.9	5.4	7.0	11.6	1.8	17.2	4.8	2.9	15.0	18.1	7.9	6.3	17.1	13.1	10.4	4.9	10.7	5.8	2.5	9.5	8.7	2.4	5.0	20.8	7.6	0.6	0.8	2.4	5.7	15.1	4.7	10.4	36.3	42.5	4.9	12.6	8.6	11.5	3.9	28.0	9.3	5.4	17.6	6.0	33.4	8.7	9.2	4.9	6.8	15.2	2.4	6.2	5.7	6.7	12.7	15.5	9.9	28.2	10.4	19.0	6.0	2.7	8.4	25.7	14.3	1.3	10.7	18.0	15.2	0.0	2.7	7.1	7.9	4.6	0.0	14.2	7.7	11.2	0.7	9.2	5.6	31.0	4.3	10.2	0.3	14.5	0.5	1.5	2.0	7.9	12.2	5.2	1.2	3.0	4.3	1.5	5.5	1.3	1.7	2.1	1.6	2.1	2.4	0.9	0.7	1.0	2.5	6.4	0.2	5.8	1.2	4.1	4.3	3.6	5.3	3.6	4.2	8.3	4.4	5.4	6.3	4.9	5.0	24.1	6.4	10.6	2.6	17.9	6.5	7.2	4.4	8.0	2.9	6.2	5.5	5.4	7.2	5.8	11.0	2.1	6.0	13.0	48.9	1.9	13.9	0.7	7.0	6.4	18.1	24.0	4.8	1.2	26.0	19.1	6.9	18.3	6.3	19.7	38.2	7.9	10.9	24.2	0.0	2.6	19.4	4.1	13.6	9.7	0.9	7.2	20.5	7.2	26.2	17.5	2.9	11.3	9.5	3.1	35.2	37.0	7.2	8.3	12.4	44.2	6.9	9.0	2.5	0.0	7.3	7.9	35.0	15.6	8.7	9.9	2.1	15.6	8.4	11.6	10.6
PARP14	"ARTD8, KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680839-122730840	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 74.7;BJ hTERT+ SV40 Large T+ RasG12V: 113.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	14.0	12.6	4.3	24.3	5.1	20.1	11.3	3.6	2.7	11.4	5.5	11.5	15.3	8.2	2.4	9.0	10.7	15.2	11.1	2.8	5.1	14.9	24.5	33.5	24.0	15.1	5.9	9.2	7.8	7.3	7.6	17.8	8.6	13.0	8.7	1.1	11.7	7.2	5.0	5.3	17.5	10.2	10.9	37.4	11.7	2.2	8.9	15.4	14.7	8.3	26.8	13.7	9.4	7.8	15.6	13.0	8.0	8.3	9.1	26.2	0.0	6.1	40.1	74.7	113.1	6.9	28.7	0.0	24.2	13.4	41.8	11.5	11.9	11.6	15.0	24.0	1.5	14.6	5.8	8.7	20.4	6.4	6.8	14.7	4.7	13.0	4.8	16.4	32.2	12.3	7.0	22.7	2.1	7.9	24.8	1.5	1.1	2.1	11.1	34.2	8.3	4.3	9.5	16.2	0.6	0.0	15.3	3.1	14.1	0.8	5.7	9.3	22.0	4.0	9.4	2.3	5.5	8.7	1.6	2.7	12.0	13.8	7.2	13.1	10.8	5.8	8.6	13.7	7.2	12.8	4.5	5.6	5.6	20.3	3.6	4.1	29.5	9.5	14.7	0.7	9.9	4.3	4.3	5.1	3.6	2.7	2.8	5.1	15.1	5.9	8.6	10.9	8.9	7.8	111.5	246.8	98.4	17.3	115.3	16.8	17.0	35.9	13.1	2.1	19.6	15.6	14.6	24.3	65.9	25.8	4.2	14.1	64.9	43.0	3.9	36.0	0.3	118.8	59.8	94.7	10.7	18.5	0.5	41.2	28.4	37.2	24.5	149.8	32.2	69.6	67.1	32.5	36.5	0.0	3.0	18.2	26.4	61.6	39.9	2.1	28.0	83.9	16.0	124.6	132.2	15.1	58.7	47.3	1.1	44.0	20.2	17.3	50.9	31.8	29.5	11.5	73.0	1.0	13.1	32.7	30.3	1.9	1.1	13.7	10.5	4.8	51.4	42.8	16.0	25.9
PARP3	"ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	16.0	33.4	12.7	9.9	13.5	3.1	15.3	12.9	14.6	9.6	14.4	17.1	28.1	11.4	5.9	10.4	11.2	11.3	13.6	11.6	14.2	21.2	29.2	13.4	10.9	13.8	14.9	8.9	4.4	35.8	10.9	5.9	13.7	14.6	10.2	4.7	14.5	15.5	15.8	7.5	25.2	9.3	12.9	14.8	16.4	5.4	14.9	8.2	19.6	17.6	8.0	15.4	10.8	12.4	10.0	6.6	2.0	17.3	17.8	30.0	4.8	15.4	29.0	23.1	24.9	3.9	28.1	14.1	4.5	29.4	12.6	1.6	5.0	14.5	9.1	34.8	1.2	7.8	15.1	13.2	18.8	5.3	10.9	24.4	12.4	16.2	9.1	35.7	10.8	10.2	3.5	14.7	19.9	3.4	4.6	12.5	2.4	4.2	16.4	7.3	2.8	13.9	14.0	13.5	2.0	6.4	16.3	4.8	10.7	1.4	6.5	5.9	24.0	42.5	9.9	7.4	10.4	22.5	26.0	6.0	27.2	14.4	13.6	0.0	1.6	1.2	2.4	3.0	2.2	6.3	2.6	1.8	2.6	2.5	3.6	3.5	0.1	5.7	1.6	0.9	3.2	1.8	12.7	13.5	12.9	14.6	11.6	14.2	13.8	14.9	13.7	12.9	14.9	12.4	5.3	6.4	10.0	6.2	8.1	2.7	10.6	15.9	21.1	2.0	8.6	8.9	7.4	8.6	8.6	0.0	0.0	0.6	2.1	13.1	7.9	9.7	7.8	2.4	3.8	5.3	3.0	1.7	2.6	6.3	0.4	4.7	17.3	2.7	4.5	0.8	2.5	9.5	3.7	0.0	3.0	11.3	6.1	3.2	2.2	15.3	4.7	3.7	7.2	3.7	5.0	3.8	0.0	1.0	1.8	11.5	6.5	1.5	4.9	4.3	33.4	20.6	9.5	2.1	6.6	4.1	5.7	3.4	3.3	7.8	1.4	0.5	5.9	1.6	13.8	9.3
PARP4	"ADPRTL1, ARTD4, p193, VAULT3, VPARP, VWA5C"	ENSG00000102699	"Poly(ADP-ribose) polymerase family member 4"	Q9UKK3	13	24420931-24512778	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Ribonucleoprotein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011739	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA011739: AB_1854986"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.21e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.84e-3)"	18.6	22.8	8.4	24.2	11.9	22.1	16.7	11.2	8.2	24.3	12.1	38.7	38.9	17.9	18.0	22.0	21.1	29.5	12.7	7.5	10.4	26.9	24.9	28.7	23.6	15.6	11.3	18.6	14.8	18.5	5.8	15.9	15.2	13.1	39.5	8.3	16.8	18.6	6.4	11.0	39.1	19.5	11.3	26.3	34.4	9.0	11.8	21.6	21.2	11.3	25.2	28.3	14.0	15.6	42.9	37.7	18.1	32.7	48.7	68.8	15.3	48.7	63.5	41.8	37.1	15.5	108.5	32.0	47.3	44.5	46.3	48.5	27.2	49.4	34.1	73.7	19.0	45.9	33.0	35.9	27.8	59.3	43.3	39.9	16.3	34.6	18.3	81.4	69.7	24.5	13.2	13.8	50.2	19.9	37.6	28.5	20.5	100.6	45.9	35.0	33.8	45.0	77.6	86.7	16.4	20.9	35.7	14.2	33.5	23.4	7.1	48.2	99.7	18.9	19.8	24.4	50.4	15.6	19.3	41.4	34.3	30.6	42.1	50.0	21.1	45.9	20.4	25.7	20.4	14.2	16.8	20.5	27.9	8.0	12.2	14.8	24.0	21.1	34.6	10.4	21.9	20.1	8.4	11.9	11.2	8.2	7.5	10.4	15.6	11.3	15.2	11.3	11.8	15.6	20.5	51.3	51.8	21.2	20.5	2.8	6.9	29.2	6.2	6.3	10.2	5.8	17.6	17.2	52.6	25.8	2.1	5.0	33.8	74.2	5.9	26.1	5.4	35.9	19.4	19.8	4.9	13.9	1.5	22.5	8.9	18.3	42.8	50.9	99.2	30.7	31.1	16.0	17.7	1.7	2.1	27.0	18.3	23.4	6.9	4.7	11.8	35.3	8.8	36.5	37.1	6.7	36.0	21.1	40.8	30.9	53.8	8.2	27.0	10.6	59.7	18.2	69.7	7.4	6.6	12.2	10.4	2.5	8.9	13.5	3.8	1.9	28.9	24.1	30.8	20.5
PARP6	"ARTD17, pART17"	ENSG00000137817	"Poly(ADP-ribose) polymerase family member 6"	Q2NL67	15	72241181-72272999	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026991	Approved		Approved	"Plasma membrane"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA026991: AB_1854989"	"unprognostic (3.88e-2)"	"prognostic favorable (3.17e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.36e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (8.02e-8)"	"unprognostic (6.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"	20.0	20.9	63.2	14.6	64.8	30.5	20.0	62.2	84.6	22.2	61.2	28.7	15.3	24.5	24.0	17.7	22.6	21.3	19.6	64.5	57.7	23.8	15.5	19.7	19.4	55.7	55.9	29.2	32.5	12.6	49.7	18.3	55.3	25.1	14.8	52.9	23.2	17.3	34.8	23.0	21.7	20.2	51.0	20.6	24.2	34.5	57.1	21.0	30.2	21.2	17.4	22.7	19.1	64.9	15.9	27.6	29.0	37.8	30.5	25.2	23.7	13.8	19.9	21.8	31.1	18.5	28.2	22.3	8.4	20.3	31.4	20.9	32.4	18.1	12.4	26.5	30.6	31.7	55.0	0.2	25.4	16.7	30.1	32.6	43.5	20.1	55.2	33.7	14.6	35.6	16.6	24.3	17.5	28.4	14.4	28.7	14.2	13.2	0.0	26.7	20.8	17.2	19.9	30.4	81.4	43.1	22.6	17.8	37.0	38.2	22.8	18.8	14.0	26.7	24.7	35.7	20.7	27.9	27.7	23.2	19.1	31.4	19.1	1.1	3.6	8.2	2.3	3.1	1.6	2.4	1.7	2.5	2.6	2.3	2.6	2.0	3.6	3.0	3.5	2.2	2.9	2.1	63.2	64.8	62.2	84.6	64.5	57.7	55.7	55.9	55.3	51.0	57.1	64.9	11.5	22.4	21.2	54.9	15.3	14.4	9.6	6.9	31.3	16.4	13.0	13.7	20.9	2.8	12.9	9.2	20.9	7.3	12.0	8.0	7.9	9.7	61.4	8.0	10.3	11.1	17.4	4.6	19.7	12.7	5.3	13.9	21.4	10.0	15.8	17.3	6.4	6.1	8.9	18.5	20.5	6.5	6.1	14.8	11.1	178.1	12.5	14.0	16.0	20.6	9.3	8.8	6.2	27.2	54.6	9.2	9.0	9.8	12.3	9.0	17.7	12.3	5.8	15.5	6.6	13.7	12.5	44.3	12.6	19.3	15.8	6.4	13.3	8.6	7.5	9.3
PARP8	"ARTD16, FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846519	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 124.9;Excitatory neurons: 197.9;Inhibitory neurons: 139.3;Microglial cells: 112.4;Oligodendrocyte precursor cells: 158.3;T-cells: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: AB_2680667"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (1.12e-4)"	11.7	13.1	4.6	26.8	8.8	78.2	9.2	0.0	7.9	8.3	0.3	8.8	14.5	6.6	4.2	7.7	9.9	25.7	6.9	14.7	12.6	7.0	8.0	19.8	42.0	3.4	4.5	11.6	12.2	13.8	4.9	12.4	0.1	11.3	9.3	4.6	10.3	7.4	4.8	7.6	15.0	8.4	2.7	43.6	20.2	9.1	7.7	19.2	43.1	2.1	22.5	14.5	5.4	2.0	24.8	0.1	12.2	18.8	3.2	5.7	18.0	4.3	15.7	4.1	12.0	0.9	33.5	14.8	16.9	0.5	43.3	12.4	2.1	13.1	10.0	20.2	15.9	10.6	9.2	1.1	6.3	28.1	0.2	6.8	10.9	8.5	6.0	24.6	0.2	23.1	1.6	9.1	5.9	8.8	31.8	32.5	12.3	0.4	6.0	15.4	24.0	17.1	7.6	12.8	13.0	19.0	13.8	21.6	3.7	17.6	1.0	91.2	0.0	1.0	15.4	1.2	12.6	6.9	0.2	29.5	13.8	7.6	17.7	27.4	13.7	31.9	43.6	4.0	70.6	13.4	34.3	50.5	9.2	16.7	20.9	34.9	28.6	39.5	2.9	4.2	22.5	22.7	4.6	8.8	0.0	7.9	14.7	12.6	3.4	4.5	0.1	2.7	7.7	2.0	6.2	32.1	21.1	29.4	51.7	8.0	5.2	12.7	26.2	13.6	10.4	6.5	5.6	14.3	19.1	22.0	0.0	22.5	124.9	17.2	7.9	14.2	28.7	11.8	8.4	3.9	15.0	7.4	197.9	10.2	6.4	13.4	46.9	10.6	14.5	12.6	6.8	5.0	14.3	6.7	139.3	4.2	8.2	26.1	16.9	15.3	1.2	27.1	8.8	112.4	43.4	0.7	93.7	158.3	7.3	18.7	8.4	3.0	65.0	7.7	8.2	4.3	25.6	2.1	6.6	12.3	13.0	12.8	6.0	14.3	4.0	24.8	157.3	6.5	9.6	13.7
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764523	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 9.8;Early spermatids: 11.0;Spermatocytes: 10.5;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	1.3	2.9	2.5	1.9	3.0	0.2	2.7	2.8	3.1	2.7	3.0	4.0	2.7	2.5	3.2	2.7	4.4	1.6	3.0	2.6	2.6	4.2	3.4	1.4	2.0	2.5	2.7	4.8	2.3	4.7	2.1	2.5	2.7	2.3	3.6	2.0	3.3	2.8	4.4	2.9	2.1	2.0	2.7	1.8	2.5	4.8	2.7	2.6	2.9	5.5	2.4	2.1	2.0	3.0	4.4	7.2	4.6	6.0	5.5	4.6	10.3	3.7	4.5	6.4	4.6	8.3	2.8	7.7	5.6	3.3	9.3	6.9	8.3	5.8	4.7	5.0	7.5	7.4	4.0	6.2	8.5	4.3	2.5	5.0	8.8	8.3	7.4	5.5	4.8	8.4	13.2	1.0	4.9	4.6	6.1	5.7	10.6	8.3	9.1	4.6	9.0	9.0	5.4	3.2	4.7	4.8	5.3	6.9	9.7	8.7	3.9	5.5	2.6	4.8	4.9	6.8	4.7	7.3	6.6	3.0	3.6	5.1	2.8	1.2	5.3	4.5	4.8	7.7	5.9	4.9	5.3	5.3	7.3	5.5	7.8	5.3	0.5	7.4	10.7	5.9	8.2	5.0	2.5	3.0	2.8	3.1	2.6	2.6	2.5	2.7	2.7	2.7	2.7	3.0	0.6	0.0	1.1	0.3	1.0	0.6	0.9	2.0	1.8	2.6	1.3	1.9	1.5	2.8	1.8	0.0	0.0	7.0	0.2	2.4	9.8	4.5	11.0	1.1	1.4	0.8	0.0	0.0	0.9	2.8	3.9	1.3	1.5	0.6	0.0	2.9	0.0	2.3	3.1	5.0	1.1	2.8	0.0	1.2	0.3	6.8	3.7	0.8	0.0	2.8	1.1	3.2	0.0	0.5	1.6	1.9	1.5	3.0	0.3	1.8	1.5	6.5	1.0	1.9	0.0	1.3	1.1	10.5	11.5	2.0	1.0	3.3	0.7	5.1	3.5	0.8
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ crumbs cell polarity complex component"	Q8NI35	1	61742477-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 86.6;Alveolar cells type 2: 60.6;Club cells: 39.0;Collecting duct cells: 57.0;Endometrial ciliated cells: 55.7;Glandular and luminal cells: 98.3;Pancreatic endocrine cells: 47.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 75.0"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 36.3;RPTEC TERT1: 30.3;RT4: 33.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 72.3"	"HPA066352, HPA066960, HPA069079"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"	"Centriolar satellite, Cytosol"	"HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079"	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	3.4	7.2	6.8	3.6	5.4	3.5	18.1	75.0	5.3	8.4	25.3	12.2	8.9	5.8	26.5	19.3	8.3	7.1	45.2	3.8	9.2	27.5	12.4	10.0	2.9	12.8	9.0	6.8	12.4	20.0	10.9	3.5	14.2	12.3	11.1	15.8	20.0	7.9	45.4	22.4	9.3	3.5	11.5	3.1	10.2	5.1	9.1	4.0	13.1	16.1	6.2	7.9	13.2	9.5	36.3	7.0	2.3	3.2	1.3	3.3	29.5	2.1	2.8	2.2	3.0	12.5	13.2	0.2	9.1	4.4	18.7	21.1	5.1	18.9	3.8	3.5	8.8	0.2	10.4	11.3	2.9	0.1	0.2	1.2	19.7	3.7	8.0	5.3	1.2	0.0	0.0	0.0	1.9	12.6	0.1	0.1	12.0	16.4	1.9	0.1	2.8	5.2	30.3	33.4	6.1	2.0	8.8	29.4	7.7	23.7	23.7	0.3	0.3	1.8	4.3	0.2	4.2	1.4	2.7	4.8	1.7	0.0	0.5	0.4	0.0	7.2	1.2	0.1	2.3	1.2	2.0	1.7	0.0	1.1	2.6	1.7	0.6	2.6	0.1	0.2	1.9	0.6	6.8	5.4	75.0	5.3	3.8	9.2	12.8	9.0	14.2	11.5	9.1	9.5	6.4	86.6	60.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	35.0	29.8	0.0	0.0	39.0	57.0	0.0	4.3	3.8	0.0	5.9	37.6	0.0	55.7	8.6	1.6	0.0	0.0	0.0	26.4	0.7	5.5	0.0	98.3	1.3	14.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	2.7	0.0	0.0	35.7	27.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	26.4	10.3	1.7	0.0	0.0
PATZ1	"dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG"	ENSG00000100105	"POZ/BTB and AT hook containing zinc finger 1"	Q9HBE1	22	31325804-31346346	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047893, HPA048315"	Approved		Supported	Nucleoplasm		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA047893: AB_2680201, HPA048315: AB_2680353"	"unprognostic (3.25e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-3)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (9.22e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.79e-6)"	10.2	10.5	16.0	11.4	18.1	15.8	12.1	16.4	16.1	14.5	11.1	14.8	9.9	18.7	14.2	6.1	22.2	9.3	10.8	14.7	16.0	11.6	11.8	11.2	20.3	18.4	16.7	27.3	13.5	21.0	10.5	9.3	17.6	13.1	6.9	14.9	18.7	17.0	10.5	7.9	12.7	12.2	17.1	15.7	11.1	8.1	16.4	24.0	19.3	8.5	14.8	15.7	9.7	20.4	19.0	23.3	46.7	27.7	12.1	11.1	24.5	5.7	14.2	22.6	20.6	16.5	17.7	40.1	20.1	10.6	7.9	14.5	32.0	17.3	11.5	23.7	29.5	16.9	16.7	33.8	19.7	57.4	21.9	17.4	20.5	14.4	16.0	17.8	18.0	19.4	7.3	15.7	14.6	57.7	37.1	39.3	31.4	34.4	27.1	61.9	19.9	13.3	15.3	39.4	60.8	48.7	14.2	17.1	31.4	15.4	33.8	36.2	12.8	15.1	28.3	9.5	19.5	20.3	14.4	36.5	6.3	7.5	26.3	0.0	1.0	2.8	1.8	0.6	1.8	2.5	1.3	2.3	1.4	1.8	2.9	2.2	0.4	2.1	0.3	4.0	2.2	1.2	16.0	18.1	16.4	16.1	14.7	16.0	18.4	16.7	17.6	17.1	16.4	20.4	6.6	3.2	14.9	11.4	12.8	1.7	7.1	7.6	8.0	16.8	22.0	16.0	13.7	17.2	11.7	20.2	8.4	5.2	17.0	3.3	19.6	14.3	0.6	14.9	8.8	7.6	20.4	8.0	2.4	6.2	2.0	6.4	5.6	16.7	6.3	19.3	7.1	16.2	9.4	21.9	5.0	9.7	20.3	8.1	2.6	1.7	9.6	6.6	3.6	7.5	7.7	14.4	12.3	11.1	8.8	6.4	6.0	8.6	5.5	7.4	5.0	7.1	10.5	14.3	6.6	7.1	8.5	0.7	8.1	2.3	1.6	0.8	10.4	8.4	11.8	7.3
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735396-100829944	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 29.6;kidney: 85.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0"	"Group enriched"	"Detected in some"	9	"cerebellum: 1.3;pons and medulla: 3.4"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305"	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.4	5.4	0.2	0.0	0.0	1.8	29.6	0.0	8.4	0.0	0.0	0.5	0.4	85.3	0.1	0.0	0.0	6.8	1.6	0.2	0.4	5.9	0.8	0.0	3.3	0.2	0.0	1.2	0.0	11.5	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.6	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	16.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.4	0.5	0.4	6.8	1.6	3.3	6.3	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	5.9	0.0	0.0	145.3	0.0	0.0	0.0	0.0	49.0	0.0	9.4	129.5	14.8	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	246.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.5	0.0	1.1	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.5	0.0	0.0	0.6	1.1	1.2	0.0	0.0	0.0	1.2	0.0	0.1	0.0
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	24.3	32.1	16.5	11.8	22.3	3.1	36.1	10.7	18.0	88.3	1.9	52.3	22.4	136.8	21.6	30.1	74.6	37.6	24.0	15.3	14.1	29.4	7.7	20.7	4.5	8.8	32.7	52.1	48.1	29.5	14.3	19.5	6.7	38.0	19.8	17.1	43.8	53.8	36.3	10.2	19.9	125.2	13.7	10.2	21.9	6.8	12.6	10.9	35.1	26.5	8.1	40.2	41.5	12.1	2.9	74.4	82.4	19.1	50.8	23.3	3.4	25.2	20.9	8.4	6.1	14.2	11.8	0.0	5.5	47.8	4.3	22.8	31.7	8.1	3.6	3.1	31.3	93.0	56.5	0.3	34.7	0.0	22.2	24.4	0.0	5.4	2.1	19.2	0.3	0.0	0.2	0.0	2.2	47.1	0.2	0.6	111.5	3.8	4.5	0.0	21.6	27.0	6.3	44.1	2.5	39.6	27.8	186.1	0.1	71.4	73.2	0.0	0.5	3.7	8.6	24.2	8.1	8.5	61.2	0.1	0.4	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	16.5	22.3	10.7	18.0	15.3	14.1	8.8	32.7	6.7	13.7	12.6	12.1	28.6	22.4	18.6	382.3	2.8	22.8	115.0	39.8	70.6	39.9	129.9	87.8	50.0	98.7	25.3	33.1	110.5	101.3	1.5	29.2	33.2	47.9	91.3	47.7	144.3	47.0	90.9	30.3	475.9	68.7	7.3	126.7	32.1	38.5	71.7	57.6	68.9	18.7	9.7	5.0	405.0	38.2	50.8	1.9	17.5	124.4	63.6	12.1	16.0	125.5	1.6	33.5	1.0	327.2	227.4	31.7	72.5	103.8	2.8	41.5	40.4	57.9	37.3	30.6	39.5	142.0	70.9	2.3	17.5	83.6	28.1	104.7	7.6	168.0	43.7	75.9
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 153.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 13.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 90.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 167.4"	"Group enriched"	"Detected in all"	5	"basal ganglia: 46.3;olfactory bulb: 161.9"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	10.9	56.0	10.4	12.9	14.6	6.9	10.0	17.4	13.2	27.2	7.0	47.9	6.8	9.8	20.0	11.8	14.2	22.5	38.0	7.2	15.0	7.1	18.1	13.0	8.0	19.7	21.0	58.2	18.8	153.1	12.6	6.7	19.4	30.9	13.7	28.0	11.8	28.0	8.5	19.4	14.3	22.6	18.8	12.8	21.5	8.2	15.3	16.7	35.1	5.7	6.9	20.7	21.9	21.7	11.6	11.0	50.0	43.1	13.1	19.1	8.5	29.9	16.8	19.2	14.5	14.3	21.1	11.3	3.6	22.1	20.8	8.5	28.3	12.3	38.3	12.4	20.5	9.7	7.9	5.8	17.2	9.6	15.5	9.5	13.7	14.5	10.0	45.3	23.1	7.2	0.4	10.3	43.5	5.9	10.0	4.9	35.8	14.2	7.4	18.9	73.3	1.5	15.6	6.4	25.9	45.1	20.2	3.8	9.4	18.8	15.7	90.1	26.6	40.0	10.2	23.8	57.1	7.2	12.8	11.5	19.7	15.2	20.6	2.3	1.7	2.2	0.8	1.4	0.9	1.0	0.9	0.7	1.9	1.5	1.7	0.7	1.4	3.2	1.3	13.9	0.8	1.0	10.4	14.6	17.4	13.2	7.2	15.0	19.7	21.0	19.4	18.8	15.3	21.7	7.3	9.6	16.7	17.9	10.0	22.7	10.3	3.0	6.8	7.5	11.5	8.3	60.3	2.8	8.6	12.9	37.5	0.6	20.7	1.3	7.9	13.5	15.2	1.1	14.0	11.9	11.5	6.3	44.3	2.5	0.9	23.4	5.6	1.5	16.5	9.4	9.7	12.6	15.3	42.1	19.3	5.7	6.1	29.0	23.7	11.4	19.9	22.9	7.2	91.8	13.6	11.5	6.2	136.2	192.2	3.1	12.1	11.3	3.8	13.0	0.9	2.8	8.5	43.1	0.0	5.3	13.0	33.7	16.0	10.4	26.3	0.4	10.5	8.7	3.4	8.7
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848417-66958386	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 201.9;Late spermatids: 53.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	60.9	23.7	35.7	2.9	35.5	3.5	28.4	36.6	35.8	3.7	17.5	4.7	6.5	3.8	1.8	9.3	3.2	2.8	4.3	32.4	41.0	23.3	148.0	2.6	1.3	43.4	40.1	5.1	4.9	18.2	8.6	4.4	37.6	7.2	2.8	2.4	35.3	9.3	12.1	4.7	7.7	1.4	37.8	1.5	9.1	10.7	49.0	2.0	4.6	6.6	2.0	2.9	4.4	37.0	6.1	19.3	6.5	17.2	25.4	8.9	6.6	3.4	15.5	6.9	7.5	8.8	6.0	0.0	7.4	6.0	9.6	6.8	7.7	39.5	1.5	2.8	11.0	10.3	57.4	41.2	21.0	0.1	10.8	40.2	10.1	5.8	12.4	4.4	5.7	14.3	17.4	0.0	2.1	44.6	9.2	4.6	12.0	15.1	16.2	8.3	13.0	3.2	5.7	1.9	15.2	21.0	33.6	18.0	15.5	4.8	14.6	2.7	6.3	7.8	6.6	8.8	4.7	3.5	4.8	0.1	7.7	5.7	6.7	0.0	1.3	0.0	0.5	0.3	0.5	0.0	0.1	0.5	0.9	0.2	0.9	0.5	0.1	0.1	0.1	0.3	0.5	0.7	35.7	35.5	36.6	35.8	32.4	41.0	43.4	40.1	37.6	37.8	49.0	37.0	0.9	0.0	3.0	26.4	1.4	1.3	1.6	9.1	2.8	5.6	4.8	5.8	4.4	11.5	3.0	3.7	2.1	17.4	0.6	27.6	1.9	3.1	18.4	2.3	7.1	1.5	9.0	28.0	18.5	1.8	4.2	3.2	5.6	3.0	8.9	16.0	4.6	201.9	12.3	0.0	18.6	5.0	0.0	7.0	1.8	53.2	0.6	1.8	5.4	7.5	18.9	9.4	2.1	10.1	16.7	2.3	8.5	4.1	0.1	3.1	23.6	39.0	1.5	4.8	0.0	2.2	2.2	11.2	4.7	4.1	0.6	25.4	1.2	6.0	6.4	1.3
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 429.5"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 453.9;Hepatocytes: 603.7;Proximal tubular cells: 877.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 527.8;Hep G2: 527.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	77.3	102.9	115.0	31.0	111.8	21.8	67.9	111.9	140.7	58.0	114.1	83.9	54.4	48.2	91.2	54.3	111.5	47.4	152.3	109.3	136.9	165.1	429.5	57.9	31.1	125.4	138.5	64.2	174.9	135.1	61.5	33.4	139.4	73.8	88.3	48.6	49.9	78.4	109.7	25.7	64.0	75.6	119.7	25.6	84.8	20.0	131.8	25.8	86.3	109.1	35.8	69.3	39.2	118.9	158.3	374.3	21.4	223.8	80.9	76.0	29.4	50.0	84.5	77.7	61.6	527.8	270.3	32.2	141.4	56.3	57.9	101.7	138.9	81.3	53.2	86.2	251.9	28.6	57.5	527.1	84.9	28.5	99.2	74.1	88.5	76.5	35.8	114.1	212.3	19.9	57.1	2.8	55.2	270.2	3.5	94.7	30.1	420.5	346.0	15.1	29.7	103.6	328.6	164.7	94.0	158.8	41.5	277.1	111.5	59.9	81.1	53.8	86.2	12.7	102.9	18.9	123.8	1.1	6.7	1.1	68.3	93.1	19.5	0.2	24.8	8.7	19.6	47.1	15.3	25.7	25.8	28.3	49.6	10.9	8.4	17.1	1.6	19.6	34.4	35.8	41.1	18.7	115.0	111.8	111.9	140.7	109.3	136.9	125.4	138.5	139.4	119.7	131.8	118.9	25.5	41.7	91.5	8.5	25.9	49.8	169.1	88.2	103.0	39.0	197.9	249.6	151.5	138.7	86.0	187.6	6.2	124.6	18.5	113.8	453.9	185.0	2.3	138.7	49.3	40.8	176.4	36.2	4.9	169.9	81.6	82.2	86.6	175.3	31.1	64.6	37.9	603.7	180.3	35.3	8.5	313.3	65.1	79.9	55.7	11.2	67.4	73.1	78.2	5.6	68.0	153.0	22.6	9.0	4.6	154.8	164.7	95.5	35.1	212.7	232.1	877.7	78.4	33.2	85.5	57.2	63.3	4.4	12.3	147.8	45.7	77.6	32.6	95.9	230.2	187.5
PCBP1	"hnRNP-E1, hnRNP-X, HNRPE1, HNRPX"	ENSG00000169564	"Poly(rC) binding protein 1"	Q15365	2	70087477-70089203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037113, HPA043803, HPA068497"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		No	No		1600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Cytoplasmic bodies"	"CAB037113: AB_1840915, HPA043803: AB_2678676, HPA068497: AB_2685996"	"unprognostic (1.63e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.08e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	278.3	276.3	145.5	199.8	155.0	390.0	240.4	168.5	203.5	209.3	159.1	259.9	172.8	253.9	142.6	278.4	193.8	134.9	223.2	142.1	155.6	218.1	304.3	233.6	227.1	163.7	146.9	186.0	249.9	174.6	140.2	194.8	159.2	143.9	125.8	90.5	185.0	139.5	782.3	216.6	203.1	172.4	163.8	241.3	214.5	95.2	150.4	301.0	170.8	308.3	209.6	233.8	206.0	190.9	384.9	387.5	327.1	257.5	345.1	262.4	525.9	280.5	257.2	272.0	227.0	453.0	250.6	522.9	140.9	320.7	293.7	334.7	388.4	408.6	276.5	376.2	299.9	419.2	219.5	701.3	388.0	350.8	385.8	230.3	261.6	224.5	310.5	203.4	350.7	138.9	437.2	375.6	346.2	475.7	454.7	524.7	331.5	361.1	253.2	362.9	358.0	527.1	375.5	389.6	309.7	249.1	230.3	465.8	342.1	229.8	277.6	314.2	325.1	253.5	317.6	217.6	359.4	495.7	551.2	531.7	268.6	480.4	319.5	42.6	89.7	141.5	80.3	92.5	73.8	41.1	62.1	69.3	82.9	36.4	62.8	71.2	138.2	95.4	80.5	58.9	81.7	100.5	145.5	155.0	168.5	203.5	142.1	155.6	163.7	146.9	159.2	163.8	150.4	190.9	241.0	153.8	132.7	27.4	312.7	484.0	296.0	192.1	196.9	64.9	270.8	212.6	0.6	208.8	134.5	196.8	22.9	372.4	208.7	401.7	272.0	196.0	34.4	187.6	220.8	242.8	178.6	485.3	19.1	199.2	470.1	196.9	227.9	284.8	114.2	129.6	227.0	392.7	385.7	58.9	18.0	239.8	138.4	509.2	795.9	34.4	186.1	382.4	300.6	30.0	422.9	122.3	347.1	14.1	49.1	211.7	311.7	186.5	357.1	278.5	338.4	481.0	128.6	56.1	170.9	222.9	241.9	131.0	65.5	267.0	545.8	703.4	291.2	148.4	232.9	366.6
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.6;retina: 81.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 159.4;Cone photoreceptor cells: 50.1;Horizontal cells: 116.1;Late spermatids: 79.8;Muller glia cells: 49.3;Rod photoreceptor cells: 83.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.0;HDLM-2: 56.9;HSkMC: 40.8;SH-SY5Y: 46.9;U-87 MG: 25.0;U-937: 31.3"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 229.1"					"HPA030247, HPA073145"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244, HPA073145: "	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	7.3	7.1	8.9	7.5	6.8	8.9	4.5	34.6	11.9	8.2	2.8	13.7	1.7	8.7	7.5	1.4	5.3	2.6	3.4	13.5	8.1	4.8	1.3	2.8	3.3	32.3	12.0	3.9	2.7	0.1	22.6	1.2	31.3	2.3	1.6	81.5	1.8	0.8	0.4	2.1	8.7	7.8	8.9	10.0	4.7	14.8	17.9	18.9	1.0	1.7	2.9	4.1	2.8	9.5	0.0	0.0	0.5	0.0	13.7	29.0	0.2	1.8	0.4	3.1	1.4	0.0	0.0	0.0	0.7	8.2	3.9	0.1	1.7	0.0	0.5	56.9	0.2	0.0	0.0	0.0	13.7	0.0	0.0	40.8	0.2	0.5	0.8	0.0	0.0	2.0	0.0	0.2	1.8	0.7	16.5	3.3	0.8	0.1	2.8	0.0	0.1	2.4	0.0	0.0	4.9	46.9	1.2	0.0	0.0	1.3	0.0	8.7	0.0	0.0	0.1	12.3	0.0	0.7	3.1	0.0	25.0	31.3	1.1	2.1	0.2	3.0	0.7	0.1	0.1	1.3	0.4	0.0	0.0	1.4	0.7	0.1	0.7	0.3	0.1	0.0	0.4	0.2	8.9	6.8	34.6	11.9	13.5	8.1	32.3	12.0	31.3	8.9	17.9	9.5	0.6	0.0	0.0	2.3	6.2	0.3	0.1	0.3	0.0	159.4	0.1	0.5	3.6	0.0	0.7	1.8	50.1	0.1	0.3	0.0	0.0	0.1	36.5	0.2	8.9	2.2	3.0	0.0	3.8	0.2	0.1	2.3	0.5	0.3	0.0	0.2	2.2	0.0	0.4	116.1	4.6	0.1	0.0	0.0	0.7	79.8	8.4	0.9	3.6	1.0	0.0	49.3	0.0	0.5	5.5	0.9	0.1	12.8	4.1	1.3	0.0	0.4	0.0	83.1	0.0	1.1	3.9	34.1	21.2	0.0	0.0	0.0	2.5	0.2	0.2	0.5
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase subunit alpha"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 152.8;Excitatory neurons: 152.8;Inhibitory neurons: 166.5;Microglial cells: 217.4;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 182.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 167.0;SCLC-21H: 91.1;U-937: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		NA	NA		290000	"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	35.4	56.3	29.0	12.4	29.8	6.2	25.8	55.5	34.6	22.3	44.4	37.5	13.2	14.9	218.2	19.4	17.4	11.6	35.4	28.6	26.3	111.7	104.3	12.0	8.0	28.9	27.4	19.9	27.6	25.7	12.3	21.3	31.1	25.9	27.6	25.2	26.9	16.9	17.6	18.6	18.0	13.7	30.3	17.2	40.9	9.2	33.9	11.4	20.4	27.2	6.4	21.3	17.5	38.7	10.6	18.5	29.8	9.9	27.9	24.2	16.6	10.2	15.4	9.5	9.0	23.0	13.9	0.8	15.2	10.1	12.0	11.8	9.1	14.1	15.6	17.5	10.1	24.6	12.7	49.7	15.4	1.2	11.3	22.4	15.2	8.8	14.6	23.0	19.6	13.0	9.8	13.4	17.1	11.6	2.6	54.8	18.6	37.2	8.1	21.4	12.9	17.3	167.0	20.5	91.1	10.9	7.0	38.4	17.9	31.9	27.9	43.1	14.3	9.6	8.0	6.7	7.3	13.1	12.9	0.4	18.4	131.6	6.9	1.6	9.1	1.7	4.5	11.2	5.9	3.6	2.8	4.2	13.5	2.3	3.9	4.9	1.1	8.7	12.3	1.1	6.5	5.2	29.0	29.8	55.5	34.6	28.6	26.3	28.9	27.4	31.1	30.3	33.9	38.7	11.3	3.2	8.7	152.8	6.6	1.9	29.1	12.7	8.6	15.5	13.5	8.8	10.5	52.9	14.8	20.2	29.2	25.7	4.3	20.7	99.7	19.7	17.6	76.5	22.4	12.0	3.6	3.4	152.8	8.4	6.9	12.9	12.2	72.9	14.0	20.7	12.1	48.8	11.8	28.6	166.5	12.4	12.2	14.2	2.2	12.0	8.7	8.2	5.4	217.4	6.0	11.5	10.3	200.6	182.5	5.8	17.5	13.5	9.4	11.2	13.2	86.9	13.2	31.7	13.1	12.3	10.1	7.2	6.2	10.6	3.8	30.2	6.4	17.6	27.6	19.2
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149294-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.4;placenta: 25.9;prostate: 10.6;seminal vesicle: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.1;Endometrial ciliated cells: 26.5;Excitatory neurons: 64.9;Glandular and luminal cells: 29.1;Inhibitory neurons: 57.7;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 59.6"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.5;HUVEC TERT2: 27.4;MOLT-4: 24.1;TIME: 55.4;U-138 MG: 14.5;U-251 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA		88000		"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: AB_2686605"	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	0.5	5.1	20.5	0.2	35.4	0.0	0.1	0.9	23.9	1.5	0.0	0.5	0.1	1.6	0.5	0.3	1.2	0.5	1.2	19.6	15.2	2.1	0.1	0.7	0.0	7.7	24.9	2.3	0.2	0.0	1.4	25.9	11.3	10.6	0.2	3.0	0.5	17.3	0.0	0.0	0.4	0.7	3.7	0.0	0.4	1.4	16.8	0.1	0.5	0.0	0.0	1.8	2.8	19.1	0.0	0.7	8.7	0.0	0.3	0.0	0.0	8.6	4.6	0.7	0.4	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.9	0.0	4.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	11.5	27.4	0.0	0.3	0.0	4.2	0.0	24.1	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.3	55.4	14.5	0.0	0.1	12.9	0.0	0.0	0.0	1.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	35.4	0.9	23.9	19.6	15.2	7.7	24.9	11.3	3.7	16.8	19.1	1.4	0.0	0.6	58.1	0.0	0.1	0.5	0.1	1.2	15.0	1.2	2.7	2.3	0.0	0.7	0.0	0.0	0.8	0.0	0.9	1.9	0.0	5.6	26.5	4.6	4.0	0.0	0.0	64.9	0.0	0.9	15.5	0.0	29.1	0.0	5.0	0.0	0.0	1.8	0.0	57.7	0.2	0.0	0.0	0.0	1.7	0.0	0.5	0.0	6.5	0.0	8.6	0.0	46.8	59.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.1	2.7	0.0	4.3	11.5	17.4	0.9	0.0	0.3	2.9	0.2	3.9	0.1	0.4
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.2"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		5900000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	22.2	5.2	2.6	7.9	3.0	0.1	13.5	2.8	3.2	25.3	2.6	12.2	9.3	30.4	11.2	6.4	11.7	22.5	6.5	2.5	4.8	7.1	2.1	7.2	1.7	4.1	5.8	21.0	1.5	2.0	2.4	44.2	3.8	17.5	13.8	2.1	6.5	13.5	2.6	4.1	8.7	18.4	3.2	6.4	6.7	4.5	3.9	3.6	5.1	23.2	1.4	10.8	8.4	3.0	0.0	0.3	148.2	0.0	175.0	190.8	0.1	27.4	86.8	5.0	7.7	0.3	0.0	0.0	0.1	143.3	0.4	0.4	34.2	0.7	2.6	0.2	1.0	0.0	0.0	0.0	129.4	0.0	0.1	195.9	0.3	9.4	3.8	4.7	1.0	0.7	0.0	0.6	2.8	0.0	3.9	0.1	0.3	0.0	2.7	11.7	4.1	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.2	38.3	0.9	0.0	0.0	69.3	4.2	13.9	0.5	0.2	0.0	0.0	3.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	2.8	3.2	2.5	4.8	4.1	5.8	3.8	3.2	3.9	3.0	3.4	0.0	0.5	1.3	0.0	4.1	0.4	0.1	2.2	2.5	1.1	1.7	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	1.9	72.3	3.0	0.0	0.0	0.2	0.0	0.3	56.3	0.0	1.7	0.0	6.4	2.5	0.0	3.1	0.0	9.0	0.0	0.0	0.0	7.8	1.3	37.9	0.9	1.8	10.3	0.0	6.8	0.0	0.0	0.6	0.0	0.0	58.6	0.1	0.0	0.0	0.1	0.0	0.2	19.7	6.6	25.5	0.6	0.1	1.2	2.6	0.8	0.7	18.5	0.0	0.1
PCDH20	"FLJ22218, PCDH13"	ENSG00000280165	"Protocadherin 20"	Q8N6Y1	13	61409685-61415522	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0;smooth muscle: 9.0"	"Cell type enhanced"	"Detected in some"		"Club cells: 6.2;Excitatory neurons: 8.2;Inhibitory neurons: 7.9;Intestinal goblet cells: 5.3;Ionocytes: 6.1;Oligodendrocyte precursor cells: 32.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"RPTEC TERT1: 51.3"									HPA062669			Approved	"Vesicles,Cytokinetic bridge"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles	"Cytokinetic bridge"	"HPA062669: AB_2732687"	"unprognostic (2.40e-1)"		"unprognostic (1.80e-1)"		"unprognostic (2.45e-1)"		"unprognostic (7.83e-2)"	"unprognostic (6.79e-4)"			"unprognostic (2.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.34e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.12e-1)"		0.5	1.1	3.0	0.3	4.4	0.0	0.9	1.0	11.2	2.3	0.0	3.1	0.9	3.1	2.6	0.7	0.5	0.6	3.5	18.0	3.7	0.8	1.3	3.3	0.0	1.5	4.6	0.3	0.1	0.0	0.5	0.4	1.3	1.0	1.7	0.0	0.7	1.0	0.4	1.0	1.0	9.0	2.3	1.2	1.0	0.1	2.8	0.8	0.2	0.7	0.0	0.6	0.5	2.3	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	51.3	0.0	0.7	1.9	0.0	3.6	0.5	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	4.4	1.0	11.2	18.0	3.7	1.5	4.6	1.3	2.3	2.8	2.3	0.0	3.2	0.5	2.3	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	8.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.9	5.3	6.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	32.6	1.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.2
PCDHA12	PCDH-ALPHA12	ENSG00000251664	"Protocadherin alpha 12"	Q9UN75	5	140875302-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 28.9;Alveolar cells type 2: 5.1;Bipolar cells: 11.4;Cone photoreceptor cells: 6.2;Horizontal cells: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 3.9;cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.1;hTCEpi: 3.4;PC-3: 5.1;RT4: 5.2;SH-SY5Y: 2.1"									HPA035812	Approved		Approved	"Plasma membrane,Cytosol"		No	No				"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA035812: AB_2674796"	"unprognostic (3.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.74e-2)"			"unprognostic (2.24e-2)"		"unprognostic (2.08e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.18e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.97e-2)"	0.3	0.3	0.4	0.0	0.5	0.0	0.2	3.9	1.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.7	0.0	0.3	0.1	0.6	0.1	1.5	0.0	0.3	0.1	0.0	0.7	0.0	0.8	0.0	0.4	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	7.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.6	1.7	5.1	0.0	0.0	0.0	0.1	5.2	0.2	2.1	0.0	0.6	0.0	0.3	1.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	3.9	1.1	0.3	0.1	0.3	0.1	0.4	0.1	0.0	0.5	0.2	28.9	5.1	0.0	0.0	0.0	0.0	0.8	0.0	11.4	0.8	1.3	0.4	4.3	1.9	1.8	6.2	0.0	0.0	0.1	0.0	0.7	1.3	0.8	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.8	0.0	0.1	1.4	0.1	0.0	5.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.1	0.0	0.2	1.3	3.6	0.0	0.2	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PCDHAC1		ENSG00000248383	"Protocadherin alpha subfamily C, 1"	Q9H158	5	140926299-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 29.8"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;EFO-21: 2.5;hTCEpi: 5.9;PC-3: 4.2;SCLC-21H: 2.9"	"Low region specificity"	"Detected in all"							HPA052775			Approved	Nucleoplasm,Nucleoli,Vesicles		No	No				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"	Vesicles	"HPA052775: AB_2681942"	"unprognostic (2.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.29e-2)"	0.4	0.4	0.6	0.5	0.7	0.0	0.1	4.5	1.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.0	0.0	0.5	0.5	0.2	0.1	0.7	1.2	2.0	3.1	0.0	1.2	29.8	0.7	0.0	2.3	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.7	0.7	0.0	0.9	0.0	0.6	0.0	0.0	0.6	0.0	5.7	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.2	0.0	0.0	0.0	0.1	0.3	2.9	1.7	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	4.5	1.0	0.5	0.5	2.0	3.1	2.3	0.0	0.7	0.6	0.1	6.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.2	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHB14	PCDH-BETA14	ENSG00000120327	"Protocadherin beta 14"	Q9Y5E9	5	141223343-141227759	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 15.1;Early spermatids: 8.1;Horizontal cells: 13.5;Peritubular cells: 8.6;Spermatocytes: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.4;SiHa: 12.0;U-2197: 8.5"	"Low region specificity"	"Detected in all"							"HPA007692, HPA045248"	Uncertain		Approved	Vesicles		NA	NA		39000		"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA007692: AB_2667896, HPA045248: AB_10959599"	"unprognostic (2.57e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.90e-2)"	3.1	2.8	2.3	0.8	3.2	0.1	3.5	2.1	4.0	6.0	0.0	4.6	0.3	7.0	2.4	2.0	4.3	1.9	4.4	2.6	1.3	2.1	1.2	3.0	0.4	1.5	2.3	4.7	4.0	3.6	6.2	1.1	0.7	3.1	0.9	2.3	3.6	1.9	1.6	4.4	1.6	2.6	1.6	2.0	1.9	2.5	3.1	0.4	2.2	1.5	0.3	3.5	3.5	3.3	0.0	0.0	3.3	6.3	5.4	6.4	0.4	0.5	5.5	0.5	1.7	0.1	1.0	0.3	4.5	1.5	2.9	0.3	0.7	1.0	0.5	0.0	0.1	0.0	1.3	0.1	0.2	0.3	0.2	1.2	4.7	0.1	0.2	4.8	0.6	0.2	0.0	5.8	2.3	0.5	0.4	0.0	0.4	0.0	1.1	3.8	4.1	0.0	0.1	0.2	7.6	14.4	12.0	0.3	1.3	0.5	6.1	0.5	1.7	2.2	1.9	8.5	2.2	0.0	0.1	0.1	4.5	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.2	2.1	4.0	2.6	1.3	1.5	2.3	0.7	1.6	3.1	3.3	4.1	0.0	4.8	0.0	0.0	0.4	1.1	3.1	0.0	15.1	1.6	2.4	3.3	0.0	3.1	1.8	0.0	0.0	0.2	0.3	0.0	0.9	8.1	0.8	6.3	3.9	3.5	0.0	0.0	2.4	0.0	5.0	0.0	0.9	0.0	1.3	3.3	1.3	0.1	13.5	0.0	0.6	4.1	0.0	0.7	2.1	3.4	0.3	0.0	0.0	0.0	6.8	0.0	0.0	0.0	2.2	0.5	8.6	0.0	0.5	0.0	0.8	0.6	1.3	0.0	6.3	3.9	8.0	0.1	0.7	2.8	0.0	0.2	2.5	0.3	0.7
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 2.4;Cardiomyocytes: 1.8;Horizontal cells: 3.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.5;T-47d: 7.3;WM-115: 3.3"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 37: Myocytes - Muscle contraction"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	0.3	0.2	1.1	0.2	2.3	0.2	0.2	3.2	2.0	0.5	0.0	0.5	0.2	0.6	0.9	0.2	0.4	0.1	1.2	2.2	0.9	0.2	0.1	0.3	0.1	1.5	1.4	0.6	0.5	0.5	0.9	0.5	0.9	0.3	0.2	1.0	0.2	0.2	0.7	0.3	0.1	0.4	1.7	0.2	0.1	0.7	1.4	0.1	0.2	0.4	0.1	0.4	0.3	1.3	0.0	0.2	0.3	1.1	0.7	1.3	0.1	1.1	0.7	0.3	0.6	0.3	0.1	0.2	1.8	0.7	0.5	0.1	0.1	0.2	0.7	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.1	1.1	0.3	0.0	0.4	2.1	0.0	0.1	0.1	0.5	4.5	0.0	0.1	0.5	0.1	0.0	0.2	2.0	1.6	0.2	0.2	0.2	1.0	1.3	0.1	0.6	1.1	0.3	7.3	0.2	0.5	2.0	0.3	1.0	0.2	0.1	0.6	0.1	2.4	0.1	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	2.3	3.2	2.0	2.2	0.9	1.5	1.4	0.9	1.7	1.4	1.3	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.7;Cone photoreceptor cells: 16.7;Horizontal cells: 23.5;Skeletal myocytes: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 14.6;HSkMC: 16.1;T-47d: 19.7;U-2197: 11.6"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	1.6	1.6	3.5	0.4	3.2	0.1	1.1	4.1	2.4	1.3	0.8	1.0	0.8	1.3	0.7	1.7	1.3	1.4	1.0	2.7	3.8	0.5	1.5	1.3	0.4	3.3	3.1	1.3	0.6	2.1	0.8	3.6	3.4	1.4	0.9	2.5	1.8	1.8	1.1	2.0	1.0	1.1	4.2	0.9	2.0	0.5	3.9	0.4	2.1	0.3	0.5	0.8	1.3	3.8	0.0	0.0	14.6	7.5	6.3	2.7	6.9	2.6	0.1	3.6	5.6	0.3	0.9	0.8	9.6	3.7	0.2	0.4	3.5	2.4	2.8	0.9	0.1	0.0	0.3	0.0	2.5	1.5	0.3	16.1	0.4	2.4	1.0	0.4	1.4	0.3	0.0	0.1	9.0	0.1	0.1	0.4	1.4	0.0	0.1	0.2	1.2	0.0	2.4	0.1	2.0	0.7	0.4	0.1	0.4	3.5	19.7	1.9	3.3	6.7	0.4	11.6	0.1	0.2	1.2	0.1	3.4	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	3.2	4.1	2.4	2.7	3.8	3.3	3.1	3.4	4.2	3.9	3.8	5.8	0.0	2.0	0.0	0.9	0.1	2.3	0.6	1.2	27.7	2.2	2.2	3.4	1.5	1.6	1.8	16.7	2.1	1.3	0.7	0.0	1.0	0.0	1.3	7.7	4.8	1.2	0.4	0.0	1.4	1.3	4.8	1.5	2.0	1.3	1.0	4.6	1.7	1.0	23.5	0.0	1.6	0.0	0.0	0.0	0.2	3.4	0.7	1.8	0.0	0.0	5.7	0.0	0.0	0.0	3.1	0.4	2.2	0.5	2.8	0.4	0.5	0.0	6.7	6.6	14.9	3.7	0.4	0.7	1.2	0.4	0.4	0.5	3.0	1.3	1.5
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512975	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Bipolar cells: 2.5;Hepatic stellate cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;ASC TERT1: 25.9;GAMG: 47.4;hTERT-RPE1: 69.8;WM-115: 43.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	0.8	0.7	1.4	0.7	1.8	0.0	0.6	5.1	1.3	0.8	0.7	1.0	0.2	0.7	0.3	0.7	0.9	0.5	1.6	2.1	2.3	0.5	0.4	0.6	0.4	1.8	1.2	1.1	0.5	0.3	0.6	2.2	2.1	0.5	0.3	3.1	0.7	0.7	1.1	1.7	0.4	0.8	2.4	0.3	0.4	0.8	1.9	0.3	0.8	0.5	0.3	0.6	0.8	2.9	0.0	0.0	0.7	2.4	24.3	25.9	0.9	5.5	10.6	4.2	6.6	0.1	0.2	0.6	9.1	5.6	47.4	3.7	0.1	0.6	6.6	0.2	2.4	0.1	0.1	0.0	4.0	0.4	0.0	19.0	0.3	7.4	0.1	69.8	6.5	1.2	0.0	0.1	0.1	0.0	0.0	0.3	2.9	0.0	0.1	17.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	9.9	0.5	3.2	7.9	0.8	0.1	0.6	0.1	0.0	0.4	0.0	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	1.8	5.1	1.3	2.1	2.3	1.8	1.2	2.1	2.4	1.9	2.9	0.5	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.1	0.5	0.8	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.1	0.0	0.2	1.1	0.0	0.4	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.6	0.3	0.1	0.1	0.7	0.0	0.1	0.0	0.2	0.1	0.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430507-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.2;Bipolar cells: 3.8;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.3;Endothelial cells: 2.2;Fibroblasts: 3.2;Skeletal myocytes: 2.0"	"Group enriched"	"Detected in many"	5	"glioma: 1.7;melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 9.3;BJ hTERT+: 15.4;fHDF/TERT166: 23.3;HHSteC: 7.2;HSkMC: 16.5;TIME: 7.5"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		21000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	3.0	4.3	5.3	0.8	6.8	0.0	1.5	5.5	3.7	2.0	0.8	1.3	0.2	2.6	0.4	1.0	1.9	3.9	4.2	5.1	8.4	1.0	0.7	3.1	0.4	10.0	4.2	1.9	1.1	0.3	1.4	2.2	4.5	1.0	0.3	1.4	0.9	1.5	1.3	1.7	0.8	1.7	5.5	1.2	1.0	0.3	5.2	0.9	1.6	1.1	0.4	1.2	2.0	4.6	0.0	0.0	0.1	1.9	0.8	1.4	0.1	9.3	15.4	0.0	0.0	0.0	0.0	0.5	0.0	23.3	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.0	16.5	0.0	4.5	0.0	0.0	5.4	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	2.6	7.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	6.8	5.5	3.7	5.1	8.4	10.0	4.2	4.5	5.5	5.2	4.6	2.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.8	0.2	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	2.2	0.0	0.0	0.0	0.2	0.0	3.2	1.1	0.1	0.0	0.1	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.7	0.0	2.0	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 3.2;Cardiomyocytes: 1.8;Fibroblasts: 1.5;Leydig cells: 1.2;Peritubular cells: 2.6;Skeletal myocytes: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;BJ: 3.9;fHDF/TERT166: 4.4;HSkMC: 3.4;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480"	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	2.2	1.6	1.8	0.7	1.4	0.0	1.9	2.7	2.5	3.0	0.7	1.5	0.1	2.9	1.9	0.8	3.1	1.4	4.9	2.9	1.5	1.1	0.7	2.0	0.2	3.8	3.2	6.3	1.8	3.8	2.6	0.7	2.6	1.9	0.3	2.3	1.2	2.2	1.0	1.0	0.6	2.1	3.5	0.6	0.9	2.3	2.6	0.8	1.6	1.1	0.2	1.4	1.7	2.2	0.0	0.7	0.3	0.2	2.8	6.4	0.0	3.9	1.3	0.3	0.5	0.0	0.0	0.1	0.4	4.4	0.5	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.4	0.1	0.0	0.2	3.9	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.5	0.0	0.2	0.5	0.0	2.3	0.1	0.3	0.4	0.0	2.3	0.6	0.3	0.2	0.0	0.0	0.3	0.0	1.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.4	2.7	2.5	2.9	1.5	3.8	3.2	2.6	3.5	2.6	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.2	0.3	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.1	0.9	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.5	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.4;Cardiomyocytes: 1.6;Endometrial stromal cells: 1.9;Fibroblasts: 1.3;Horizontal cells: 3.3;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 7.1;BJ: 2.3;EFO-21: 5.7"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	1.2	1.2	2.6	0.2	1.7	0.0	0.9	2.2	2.6	1.6	0.1	0.7	0.0	1.4	0.9	0.2	1.2	0.9	3.7	2.5	1.8	0.5	0.6	0.9	0.0	3.8	2.9	2.5	0.9	0.6	1.2	1.7	2.2	0.7	0.2	1.8	0.7	0.8	0.8	0.5	0.2	0.9	3.4	0.2	0.4	1.5	2.9	0.2	0.8	0.9	0.1	0.8	0.9	2.5	0.0	0.0	7.1	0.0	0.0	0.9	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	5.7	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.7	2.2	2.6	2.5	1.8	3.8	2.9	2.2	3.4	2.9	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.1	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.9	0.1	0.5	0.0	0.0	0.1	0.0	0.4	0.0	0.0
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355021-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Skeletal myocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.4;BJ: 4.3;HSkMC: 4.3;HUVEC TERT2: 4.3;U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	1.7	1.3	1.6	0.4	1.8	0.0	0.9	3.7	1.7	1.3	0.0	0.9	0.2	1.6	0.8	0.4	0.9	0.8	1.5	2.9	1.5	0.4	0.3	1.0	0.1	2.1	2.4	1.6	2.1	2.3	1.0	0.8	1.7	1.1	0.3	1.5	0.8	1.1	0.7	0.5	0.3	1.5	2.0	0.3	0.4	0.7	2.1	0.2	0.7	1.0	0.1	0.7	0.8	2.5	0.0	0.1	0.8	0.4	3.3	7.4	0.0	4.3	3.4	0.2	0.8	0.0	0.1	0.7	1.4	3.7	1.3	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.3	4.3	0.1	0.0	0.0	2.6	4.3	0.0	0.1	0.2	1.8	0.6	0.2	0.2	0.1	0.0	0.2	0.3	1.2	0.1	0.2	0.0	0.6	1.3	0.2	0.2	0.9	0.3	1.6	0.0	2.8	1.8	0.5	2.4	0.3	0.1	0.2	0.1	6.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.8	3.7	1.7	2.9	1.5	2.1	2.4	1.7	2.0	2.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 4.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.5;Endometrial stromal cells: 9.2;Horizontal cells: 10.1;Sertoli cells: 6.6;Skeletal myocytes: 5.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 15.8;ASC TERT1: 6.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	1.0	0.6	1.0	0.3	1.6	0.1	1.2	4.9	1.1	2.5	0.0	1.1	0.1	2.0	0.6	0.8	1.4	1.1	1.9	1.2	1.2	0.3	0.2	1.1	0.2	2.2	2.1	2.0	0.6	0.6	0.9	0.6	1.0	1.4	0.3	1.2	0.8	0.9	0.6	0.7	0.4	1.0	1.2	0.2	0.5	0.3	1.2	0.3	0.5	0.7	0.1	1.0	1.3	2.0	0.0	0.4	0.2	0.1	15.8	6.2	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.8	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.5	0.6	0.3	0.5	0.6	0.1	0.0	0.3	0.8	0.6	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.2	1.4	0.0	0.9	0.5	0.1	0.9	0.6	0.1	0.9	0.1	0.3	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	1.0	1.6	4.9	1.1	1.2	1.2	2.2	2.1	1.0	1.2	1.2	2.0	1.8	0.0	1.1	0.0	0.2	0.1	0.8	0.1	0.6	11.5	0.3	0.4	2.6	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.4	9.2	1.9	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.2	1.3	0.6	1.4	0.3	0.1	10.1	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.5	0.0	0.1	0.1	1.3	6.6	5.7	1.7	0.0	0.3	0.3	0.0	0.0	0.6	0.9	0.0	0.4
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373891-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.6;Cardiomyocytes: 5.0;Endometrial stromal cells: 4.6;Hepatic stellate cells: 3.6;Skeletal myocytes: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.6;T-47d: 5.6;WM-115: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	1.4	1.1	1.6	0.7	1.8	0.1	1.3	7.2	1.6	2.7	0.0	2.0	0.2	3.2	1.4	0.8	2.0	1.1	2.7	1.7	1.8	0.8	0.5	1.5	0.4	1.8	1.7	3.5	1.2	1.1	1.8	2.3	0.9	1.2	0.4	2.0	1.5	1.6	0.9	1.5	0.8	2.0	0.8	0.9	0.7	0.8	2.0	0.5	1.2	1.0	0.4	1.6	1.5	1.9	0.0	0.3	2.7	0.4	1.3	4.7	0.1	2.1	0.7	1.1	1.1	0.0	0.1	2.0	2.6	3.3	1.0	0.4	0.1	0.4	0.7	0.0	0.2	0.0	0.3	0.2	0.7	0.1	0.1	4.9	0.3	0.2	0.1	1.0	1.6	0.1	0.2	1.1	0.3	0.4	0.7	1.7	0.3	0.0	0.1	1.4	0.4	0.0	0.3	0.1	9.6	0.7	0.1	0.3	0.6	0.6	5.6	0.1	4.8	0.7	0.3	0.7	0.7	0.4	1.7	0.4	0.8	0.7	12.2	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.6	1.8	7.2	1.6	1.7	1.8	1.8	1.7	0.9	0.8	2.0	1.9	2.8	0.0	2.2	0.0	0.4	0.0	0.8	0.0	0.0	10.6	0.3	1.0	5.0	1.5	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.5	0.4	4.6	1.8	0.0	0.4	0.0	1.5	0.1	2.2	0.0	0.4	0.0	0.6	3.6	0.7	0.1	1.7	0.0	0.2	0.0	0.3	0.0	0.3	1.2	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.1	2.2	1.6	0.4	0.0	0.3	0.7	0.9	0.0	5.2	1.9	0.3	0.3	0.5	0.0	0.3	0.2	0.5	0.2	0.2
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.3;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.2;Skeletal myocytes: 2.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.3;BJ hTERT+: 20.8;hTERT-RPE1: 10.9;SH-SY5Y: 18.6;T-47d: 8.1"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	0.5	0.4	1.0	0.2	0.9	0.0	0.6	5.9	1.0	1.2	0.0	1.1	0.1	1.3	1.1	0.5	1.0	0.4	1.5	1.1	0.6	0.6	0.4	0.7	0.1	1.5	1.2	1.5	0.7	2.2	0.8	1.3	0.9	0.9	0.3	1.6	0.8	0.8	0.7	1.0	0.4	0.8	1.0	0.4	0.3	0.5	1.3	0.2	1.9	0.5	0.1	0.9	0.7	1.5	0.0	1.6	2.3	0.0	6.6	11.3	0.0	3.3	20.8	4.2	6.1	0.0	0.0	0.5	5.2	0.7	0.2	0.2	0.0	0.1	3.4	0.0	0.3	0.0	0.4	0.2	1.1	0.0	0.0	5.0	0.1	0.0	0.7	10.9	1.7	0.0	0.0	0.1	0.1	0.1	0.6	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.4	18.6	0.0	0.1	0.1	3.7	8.1	0.0	6.7	0.1	0.1	3.1	0.1	0.1	1.9	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	5.9	1.0	1.1	0.6	1.5	1.2	0.9	1.0	1.3	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.3	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.0	2.8	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.3
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.4;Cardiomyocytes: 3.5;Horizontal cells: 3.3;Skeletal myocytes: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.1	0.1	0.6	0.1	0.6	0.4	0.1	3.9	0.8	0.2	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.5	0.8	0.5	0.0	0.1	0.1	0.1	1.1	0.7	0.3	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.5	0.1	0.0	0.3	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.9	0.1	0.4	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.2	0.6	0.1	0.6	0.4	0.4	0.1	0.0	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.6	0.2	0.4	0.6	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.6	0.6	3.9	0.8	0.8	0.5	1.1	0.7	0.7	0.3	0.9	1.2	1.2	0.0	0.6	0.0	0.1	0.0	0.9	0.0	0.0	11.4	0.3	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	2.1	1.2	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.3	0.4	0.7	0.1	3.3	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.2	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.1	0.1	1.5	0.0	0.7	0.0	0.2	0.0	1.7	0.0	5.2	0.9	0.7	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.5
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.5;Cardiomyocytes: 1.3;Endometrial stromal cells: 1.5;Horizontal cells: 3.3;Skeletal myocytes: 2.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.6;HSkMC: 4.0;hTERT-RPE1: 16.9;TIME: 4.6;U-87 MG: 5.1"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	1.8	1.6	3.3	0.7	3.5	0.1	1.3	6.6	3.2	2.0	0.4	1.2	0.5	2.5	1.1	1.4	1.9	2.0	1.1	3.7	2.6	0.8	0.4	1.5	0.5	3.6	3.4	2.8	0.8	1.1	0.9	1.0	3.8	1.5	0.7	4.4	1.1	2.2	0.8	1.7	0.6	1.8	3.7	1.1	0.8	0.4	3.6	0.5	1.4	1.2	0.7	1.2	1.4	5.7	0.0	0.1	0.6	1.6	0.1	0.2	0.2	0.7	0.0	0.6	0.6	0.2	0.4	1.3	3.6	2.0	0.3	0.1	0.1	0.2	0.7	0.0	0.3	0.0	0.1	0.0	1.1	0.0	0.2	4.0	0.1	0.4	0.3	16.9	1.0	0.0	0.1	0.2	0.3	0.3	0.1	0.5	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.4	0.9	0.4	4.6	0.3	0.3	0.1	2.5	0.2	0.0	0.0	5.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.5	6.6	3.2	3.7	2.6	3.6	3.4	3.8	3.7	3.6	5.7	0.6	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.6	4.5	0.2	0.3	1.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.4	0.2	0.1	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	2.3	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.1
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.7;Late spermatids: 7.6;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.9;ASC TERT1: 6.6;hTERT-RPE1: 7.1;T-47d: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"		Yes	No				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	0.6	0.7	1.8	0.1	1.2	0.0	0.5	2.1	1.6	0.6	0.0	0.3	0.0	1.2	0.4	0.3	0.4	0.5	0.5	2.9	1.6	0.4	0.1	0.6	0.0	1.9	3.3	1.4	0.8	2.3	1.0	0.2	2.4	0.6	0.1	1.6	0.3	0.9	0.2	0.2	0.1	0.9	2.4	0.1	0.1	0.4	1.8	0.0	0.6	0.3	0.0	0.3	0.3	3.5	0.1	1.9	1.6	0.0	12.9	6.6	0.1	1.2	3.2	0.5	0.7	0.2	0.5	0.5	4.2	0.5	3.1	0.6	0.3	0.2	0.4	0.0	0.8	0.0	0.2	1.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	7.1	0.1	0.0	0.2	0.2	3.0	1.7	0.4	0.3	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.0	1.0	0.7	0.0	0.8	0.1	1.2	8.6	0.0	1.0	0.2	1.3	1.1	0.0	0.0	2.4	0.3	2.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.2	2.1	1.6	2.9	1.6	1.9	3.3	2.4	2.4	1.8	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.2;Cardiomyocytes: 1.4;Endometrial stromal cells: 1.0;Fibroblasts: 1.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.5;ASC TERT1: 9.8;LHCN-M2: 8.2;REH: 7.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350"	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	1.5	1.0	2.6	0.6	3.6	0.1	1.1	6.3	2.8	2.1	0.0	1.1	0.2	3.0	0.9	0.9	1.6	1.9	1.8	3.1	3.2	0.7	0.7	1.7	0.3	3.7	3.3	2.8	0.8	1.2	0.9	1.1	3.6	1.3	0.8	1.6	0.8	1.2	0.8	0.8	0.5	1.5	3.0	0.6	0.6	0.5	2.2	0.4	0.7	0.9	0.3	0.9	1.1	5.5	0.1	0.3	2.0	0.2	13.5	9.8	0.1	2.1	2.9	0.6	3.2	0.0	0.3	3.7	1.0	1.7	7.1	0.5	0.4	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.5	0.2	0.2	2.5	0.5	0.2	0.1	4.7	1.7	0.1	0.2	1.2	8.2	0.5	2.9	0.7	0.1	0.9	0.9	7.8	2.6	0.2	0.2	0.3	1.5	1.6	0.2	0.4	0.4	1.5	3.0	0.2	5.9	2.9	0.6	4.4	3.9	0.2	2.2	0.6	3.1	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.6	6.3	2.8	3.1	3.2	3.7	3.3	3.6	3.0	2.2	5.5	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.6	2.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370242-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.4;ASC TERT1: 8.4;fHDF/TERT166: 3.5;TIME: 5.5"									"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802"	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	0.7	0.3	0.4	0.2	0.8	0.0	0.5	3.8	0.8	0.8	0.0	0.8	0.0	1.0	0.6	0.3	0.7	0.4	1.2	0.9	0.5	0.3	0.2	0.5	0.2	1.3	1.4	1.2	0.7	1.1	0.7	0.4	0.6	0.4	0.3	0.8	0.8	0.4	0.5	0.6	0.3	0.7	0.6	0.4	0.4	0.4	0.8	0.3	0.6	0.5	0.2	0.6	0.6	1.4	0.0	0.6	0.4	0.3	10.4	8.4	0.2	1.2	2.0	0.7	0.8	0.0	0.0	1.8	0.3	3.5	0.6	0.5	0.0	0.2	0.5	0.0	0.2	0.0	0.2	0.1	0.4	0.1	0.0	2.1	0.4	0.2	0.1	0.2	1.0	0.0	0.2	0.8	0.2	0.4	0.6	0.9	0.1	0.0	0.1	1.5	0.6	0.0	0.2	0.1	2.4	0.5	0.0	0.0	0.2	0.3	0.6	0.0	5.5	0.5	0.1	0.5	0.6	0.2	1.8	0.2	0.4	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	3.8	0.8	0.9	0.5	1.3	1.4	0.6	0.6	0.8	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.3;SuSa: 15.5;TIME: 22.7"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	1.3	1.1	1.3	0.4	1.5	0.0	0.9	4.4	1.4	1.5	1.8	1.1	0.2	1.6	1.5	0.7	1.3	0.5	1.5	2.0	3.2	1.4	1.6	1.1	0.1	2.0	2.0	2.4	1.0	1.9	1.2	3.0	1.5	1.2	0.4	1.4	1.6	1.4	1.0	1.7	0.5	1.0	1.4	0.4	0.4	0.5	2.5	0.7	1.7	0.8	0.2	1.0	1.1	1.5	0.0	1.1	11.1	0.1	6.9	8.5	1.3	10.8	43.3	4.4	3.0	0.0	0.0	0.4	8.3	0.3	0.2	3.3	0.0	0.0	4.6	0.0	0.0	0.0	0.2	2.4	2.8	0.0	0.0	8.4	0.1	4.1	0.0	0.1	6.7	0.0	0.4	0.1	0.0	0.0	1.1	0.2	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	15.5	5.6	4.2	22.7	6.0	1.8	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	1.5	4.4	1.4	2.0	3.2	2.0	2.0	1.5	1.4	2.5	1.5	0.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 1.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.3;ASC TERT1: 49.6;BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.8	2.7	3.6	1.1	3.6	0.0	1.8	5.8	3.1	2.0	3.3	1.7	0.7	3.1	2.0	1.9	2.8	1.6	2.9	3.9	6.4	2.2	2.1	2.7	0.4	5.1	4.7	5.7	3.8	20.3	1.7	4.8	5.4	3.0	0.9	3.1	4.7	3.9	2.1	3.8	0.8	2.8	5.3	1.3	1.5	1.9	4.9	1.3	4.5	1.9	0.8	1.9	2.1	6.1	0.0	2.4	0.3	0.0	66.3	49.6	1.3	18.3	0.0	29.2	32.5	2.9	10.0	10.6	23.4	20.5	0.0	13.9	0.0	7.6	16.4	0.0	3.1	0.0	0.0	0.1	6.9	0.0	6.5	17.6	1.5	1.7	9.4	12.6	9.0	0.0	0.2	0.0	1.0	8.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.0	0.1	0.0	0.1	0.0	2.0	19.1	0.1	9.2	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.6	5.8	3.1	3.9	6.4	5.1	4.7	5.4	5.3	4.9	6.1	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.2	1.5	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.8	0.5	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.9;Cone photoreceptor cells: 6.2;Horizontal cells: 10.1;Skeletal myocytes: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.0;EFO-21: 5.4;HSkMC: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	3.1	3.1	3.0	0.9	3.6	0.4	2.2	5.0	2.4	2.9	2.9	2.4	0.5	3.2	2.0	1.2	2.9	1.7	2.4	2.5	3.5	1.1	1.3	2.0	0.7	3.6	3.5	6.0	1.2	2.8	1.8	3.1	3.2	1.4	0.7	2.8	2.2	2.4	2.9	2.1	1.0	1.9	3.3	1.5	1.1	0.6	3.7	0.6	2.6	1.5	0.6	1.8	2.3	3.9	0.0	0.1	16.0	0.1	0.5	0.6	0.8	1.4	0.0	0.4	0.9	0.2	0.2	1.4	5.4	0.9	0.2	0.3	0.0	0.3	1.0	0.0	0.3	0.0	0.2	0.1	1.3	0.1	0.1	3.6	1.8	0.8	0.1	0.1	0.5	0.3	0.1	0.2	0.1	0.3	0.1	1.1	0.6	0.0	0.0	0.2	0.0	0.1	2.5	0.2	0.2	0.3	0.0	0.1	0.1	0.4	1.2	0.3	2.6	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	3.0	3.6	5.0	2.4	2.5	3.5	3.6	3.5	3.2	3.3	3.7	3.9	3.6	3.2	0.5	0.0	1.0	0.0	1.5	0.0	0.0	6.9	0.6	0.4	3.9	0.0	1.3	0.0	6.2	0.2	0.6	0.4	0.0	0.7	0.0	0.6	3.8	2.6	0.0	0.0	0.0	1.2	0.1	3.3	1.1	0.5	0.0	0.4	1.4	0.7	0.3	10.1	0.0	0.4	0.0	0.0	0.0	0.2	1.8	0.2	0.0	0.0	0.1	2.7	0.0	0.0	0.0	2.0	0.1	1.2	1.5	0.8	0.1	0.3	0.7	2.5	0.0	5.2	3.2	0.2	0.5	0.3	0.1	0.1	0.7	0.8	0.4	0.8
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 7.9;Fibroblasts: 3.4;Horizontal cells: 3.3;Skeletal myocytes: 5.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"AN3-CA: 86.7;HSkMC: 26.7;hTERT-RPE1: 72.4"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	5.2	4.6	4.6	1.8	4.7	0.1	4.2	10.8	3.5	4.9	5.0	5.0	0.9	5.7	2.2	3.0	4.4	4.4	4.3	4.5	7.0	2.4	1.5	5.8	1.2	6.0	6.0	8.1	1.7	4.3	2.2	5.5	5.3	3.8	1.7	5.8	3.7	5.5	3.0	3.3	2.1	5.1	7.7	2.7	2.4	1.9	5.0	1.5	4.0	4.1	0.9	3.3	3.8	7.3	0.0	0.0	2.9	86.7	1.9	0.3	0.9	5.7	0.7	2.1	4.3	0.1	5.3	0.7	4.6	11.7	0.8	1.4	0.2	1.0	2.0	0.1	0.6	0.0	0.2	0.0	6.4	0.5	0.1	26.7	0.7	1.7	0.9	72.4	4.6	0.2	0.0	0.0	0.3	0.0	0.0	0.1	1.0	0.0	0.6	10.1	1.9	0.0	0.2	0.0	9.3	12.8	0.2	0.0	0.0	1.0	1.0	0.9	11.5	10.3	0.2	0.9	0.1	0.1	0.2	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	4.7	10.8	3.5	4.5	7.0	6.0	6.0	5.3	7.7	5.0	7.3	2.2	3.2	1.3	0.0	0.3	0.4	0.8	0.0	0.0	7.9	0.3	0.5	1.4	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.0	0.2	0.1	0.4	2.1	2.2	0.0	0.0	0.0	0.5	0.1	3.4	0.0	0.3	1.3	0.5	0.4	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.0	1.9	0.1	0.4	0.0	0.3	0.0	0.7	0.0	5.9	2.2	0.0	0.1	0.5	0.4	0.0	0.0	1.2	0.1	0.2
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 31.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.1;Horizontal cells: 3.3"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 9.1;SCLC-21H: 7.3;SH-SY5Y: 14.2;SuSa: 10.0"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.2	1.1	17.3	0.1	12.2	0.0	0.2	19.3	14.6	0.3	0.1	0.6	0.0	0.4	0.2	0.2	0.3	0.2	2.2	12.7	13.9	0.1	0.1	0.4	0.1	12.9	21.9	0.3	0.3	0.0	1.1	0.1	10.3	0.2	0.1	6.6	0.3	0.1	0.7	0.5	0.1	0.2	22.4	0.1	0.2	0.9	14.3	0.0	0.1	0.3	0.2	0.2	0.3	31.4	0.0	0.0	0.9	0.2	0.2	0.7	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.8	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	1.3	0.0	0.0	9.1	0.5	0.0	0.0	0.1	7.3	14.2	0.1	0.0	0.1	10.0	0.1	0.3	0.1	0.8	0.1	0.2	0.6	0.2	0.0	0.2	0.6	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	12.2	19.3	14.6	12.7	13.9	12.9	21.9	10.3	22.4	14.3	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489081-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 28.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 4.6;SuSa: 7.4;U-138 MG: 14.4;U-251 MG: 6.5;U-87 MG: 8.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA076140"	Supported		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"		"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	0.3	0.5	5.6	0.1	8.6	0.0	0.3	0.0	11.7	0.8	0.0	1.3	0.0	1.2	0.2	0.3	0.7	0.2	5.3	28.4	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.7	0.4	0.0	1.2	0.1	0.0	0.5	0.0	1.2	0.4	0.5	1.2	0.5	0.2	0.7	0.0	0.1	0.3	0.6	0.3	0.1	0.2	0.2	0.0	0.5	0.6	0.0	0.0	0.0	0.3	0.3	0.3	1.5	0.1	0.8	0.5	0.4	0.5	0.0	0.0	0.4	1.4	2.2	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	4.6	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	7.4	0.1	0.2	0.1	14.4	0.2	0.2	6.5	0.0	0.0	0.0	8.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.6	0.0	11.7	28.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCIF1	"bA465L10.1, C20orf67, CAPAM, PPP1R121"	ENSG00000100982	"Phosphorylated CTD interacting factor 1"	Q9H4Z3	20	45934683-45948023	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: AB_2680801"	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	28.7	28.0	20.7	18.6	23.0	33.9	28.7	30.2	24.2	36.1	17.6	30.7	16.5	39.7	10.8	24.4	35.3	16.3	31.9	20.4	20.2	23.4	19.5	28.2	27.3	22.7	21.6	41.7	29.5	22.8	26.0	17.0	22.1	26.2	11.7	15.9	23.6	21.3	41.7	36.7	27.2	21.3	20.9	34.7	25.4	18.1	21.7	34.4	32.0	27.6	19.6	28.6	29.3	24.9	21.2	29.0	22.0	27.2	15.3	18.2	24.2	8.3	25.1	24.9	24.2	49.3	27.7	22.7	27.4	22.6	28.7	23.4	15.8	29.0	10.8	14.1	11.4	29.1	23.1	33.4	28.2	26.4	28.1	25.5	29.9	15.3	24.5	22.3	21.0	37.1	20.8	30.9	17.9	44.6	52.3	48.3	7.8	25.5	24.9	32.2	20.4	28.0	20.1	21.8	30.2	30.0	31.5	29.5	16.1	11.6	31.0	30.7	18.1	30.7	24.1	27.3	16.8	35.4	22.1	21.0	37.7	23.8	18.2	75.5	47.5	80.2	54.5	47.2	43.0	51.6	47.3	50.2	50.3	56.2	48.6	43.0	74.6	74.3	48.0	40.4	54.4	64.0	20.7	23.0	30.2	24.2	20.4	20.2	22.7	21.6	22.1	20.9	21.7	24.9	19.7	3.2	14.2	4.6	33.7	8.7	26.4	7.9	26.2	9.9	17.0	19.7	21.9	20.0	7.1	11.0	2.1	19.5	32.4	14.6	15.6	21.4	9.6	13.3	10.7	16.1	26.5	25.4	2.5	38.6	22.6	15.4	17.3	13.5	14.5	14.9	9.7	12.4	16.9	13.5	3.6	14.0	4.1	16.0	8.7	8.1	11.5	21.5	17.8	1.0	24.9	12.0	33.0	3.0	3.9	28.3	13.1	12.8	35.5	25.4	14.8	23.2	11.0	13.4	0.0	20.2	19.3	14.4	11.9	23.8	10.7	27.8	30.8	15.1	12.0	38.8
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1022.2;Late spermatids: 428.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol		No	No		4100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavorable (4.02e-7)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.88e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (6.38e-4)"	48.7	43.2	77.5	32.8	85.1	75.9	46.2	70.2	107.1	46.4	56.4	45.5	36.6	38.8	48.5	45.3	39.2	28.4	121.7	87.5	84.8	51.1	73.8	37.9	41.4	80.3	73.0	39.3	38.1	46.3	43.3	42.9	86.2	52.1	43.1	55.8	39.8	50.1	211.9	44.6	34.6	48.9	71.1	34.5	37.8	76.7	72.3	57.4	49.0	163.3	46.7	40.7	38.0	79.2	87.3	68.4	70.4	88.6	152.1	125.9	77.6	140.7	82.9	114.7	143.4	200.1	65.4	117.9	113.0	127.5	126.5	106.6	123.9	143.6	159.9	79.2	180.0	175.5	122.2	192.1	99.2	203.7	197.7	62.8	105.2	128.5	138.5	80.7	107.6	89.8	256.5	107.7	142.3	258.9	98.5	150.4	56.5	84.7	78.6	83.4	89.7	82.6	108.9	62.4	137.5	52.4	111.2	173.9	97.7	82.5	107.8	146.1	83.3	67.2	80.7	124.7	151.2	64.1	109.9	115.4	103.6	135.8	137.7	162.9	193.2	178.0	93.0	182.4	94.7	105.0	93.7	102.8	176.0	81.5	86.5	98.0	101.6	108.5	185.7	79.9	129.2	204.1	77.5	85.1	70.2	107.1	87.5	84.8	80.3	73.0	86.2	71.1	72.3	79.2	57.0	54.5	41.4	21.2	62.6	175.1	74.4	204.4	56.3	72.6	48.0	40.6	154.1	60.1	96.4	79.1	37.5	169.3	66.8	56.6	78.2	113.5	1022.2	51.9	58.4	69.8	55.2	170.1	77.0	110.7	214.0	79.2	26.0	48.8	107.7	38.8	53.9	115.6	119.1	65.6	52.8	72.9	187.2	78.7	127.5	428.1	71.7	78.2	138.7	31.9	143.7	121.2	74.2	30.7	72.2	106.6	57.9	73.7	71.8	67.8	65.1	89.3	106.2	66.3	111.7	64.0	110.4	224.9	96.3	60.7	157.6	148.3	83.0	55.0	58.7	59.1
PCMTD2	"C20orf36, FLJ10883"	ENSG00000203880	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2"	Q9NV79	20	64255695-64287821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 180.5"	"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 138.2;Rod photoreceptor cells: 181.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057849	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria	Nucleoplasm	"HPA057849: AB_2683544"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.05e-3)"	31.4	33.6	27.2	22.9	31.0	17.8	37.5	40.2	40.7	36.7	28.3	25.3	23.3	39.2	49.2	22.8	29.0	32.5	42.5	27.1	30.5	34.2	32.1	24.0	41.6	27.1	25.9	57.0	27.0	27.7	31.8	41.2	25.3	29.5	20.3	180.5	32.3	18.3	44.6	66.0	25.0	19.0	24.9	36.3	21.7	24.7	28.4	39.5	27.1	32.9	29.6	20.6	28.1	38.9	22.9	8.5	32.0	25.0	30.1	37.1	30.1	13.6	15.1	19.7	12.0	19.4	35.9	33.8	23.5	16.6	15.6	27.6	17.6	22.4	26.5	7.4	23.0	16.4	42.1	32.9	25.3	16.9	24.0	52.7	30.5	10.4	17.9	35.1	29.1	34.0	30.4	29.8	16.3	14.8	39.8	56.7	23.5	31.6	31.7	32.6	12.6	41.1	30.0	26.1	50.0	58.9	26.1	30.1	37.2	49.4	32.2	34.1	21.2	29.4	10.3	18.9	11.3	35.8	31.3	32.9	19.5	17.9	16.1	10.1	7.9	9.4	9.4	5.4	11.2	10.2	14.0	10.7	9.0	10.7	19.2	14.2	10.2	17.4	5.3	5.4	22.6	9.8	27.2	31.0	40.2	40.7	27.1	30.5	27.1	25.9	25.3	24.9	28.4	38.9	40.8	22.4	26.9	25.8	21.0	20.4	15.6	10.2	31.3	118.5	27.5	18.0	67.4	28.6	17.5	29.5	93.8	33.7	21.9	6.7	23.5	8.4	13.2	21.3	23.2	36.6	22.8	35.3	34.8	9.1	7.0	34.8	17.9	26.4	12.7	33.5	45.0	36.7	14.4	37.0	29.5	15.9	14.2	28.8	10.7	9.5	42.9	17.3	48.0	21.5	19.2	61.3	20.6	138.2	64.6	9.9	15.7	30.9	20.2	14.6	12.0	23.3	24.3	181.9	26.3	25.0	27.7	51.7	37.7	24.9	21.3	21.9	21.6	63.1	15.2	11.3
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease variant, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 383.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm		No	Yes		170000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	31.2	47.2	23.2	85.2	26.0	383.2	51.0	26.8	29.7	41.5	26.8	89.0	70.7	38.1	30.9	81.2	39.1	34.8	30.6	23.0	24.4	43.7	55.3	37.5	168.8	25.1	24.0	37.7	32.8	42.4	25.1	69.8	26.0	32.2	93.7	94.1	40.3	38.3	27.9	62.8	72.9	47.9	26.8	54.0	53.9	62.3	23.3	219.9	42.0	26.8	137.3	51.0	42.3	30.0	769.1	591.4	585.0	253.7	136.1	126.6	409.5	491.6	288.3	453.7	640.0	465.3	594.2	773.4	155.7	177.5	395.2	558.8	350.7	594.4	413.2	231.7	386.8	543.7	207.8	1098.3	57.8	753.7	233.0	92.6	138.2	387.2	91.7	95.3	263.3	503.6	493.9	631.2	449.7	278.3	1450.6	829.3	439.9	592.0	322.9	787.9	514.1	622.5	208.5	441.1	500.8	339.4	345.1	524.6	351.9	213.9	371.2	378.0	177.2	324.3	373.3	461.5	572.0	317.2	981.6	1313.9	145.9	707.4	426.2	5.0	23.2	18.5	36.5	23.3	45.7	33.5	45.7	37.1	32.6	29.2	41.6	37.3	7.7	43.6	24.7	29.9	48.1	36.7	23.2	26.0	26.8	29.7	23.0	24.4	25.1	24.0	26.0	26.8	23.3	30.0	32.4	44.8	26.0	2.9	40.6	67.7	44.4	121.4	44.3	42.1	27.5	45.2	14.5	21.5	60.5	58.8	27.1	171.5	44.3	42.9	60.7	51.6	176.0	30.2	21.4	34.8	19.9	189.0	4.3	39.6	175.6	38.7	21.9	27.7	22.7	53.1	29.6	27.1	96.7	32.0	5.9	53.9	75.3	24.2	33.4	109.1	36.1	32.7	37.4	3.7	47.6	74.0	23.7	4.0	13.5	28.3	20.3	40.3	56.6	23.3	33.3	46.1	44.1	97.1	52.6	29.2	46.1	149.1	101.1	65.5	49.7	66.4	48.6	29.6	84.5	40.4
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574180-101594465	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No		38000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	47.0	47.6	42.6	43.5	45.3	58.7	53.5	48.6	69.1	48.2	54.5	47.8	38.8	53.8	52.6	48.1	43.8	41.0	57.7	43.1	50.6	51.9	49.6	41.0	57.3	43.7	43.9	69.7	33.3	50.0	39.3	50.5	44.0	47.6	45.2	58.3	42.5	49.1	66.5	39.0	36.1	53.4	45.8	39.8	34.8	28.4	45.8	58.0	49.8	66.4	57.5	50.7	40.0	52.9	135.0	71.1	105.2	82.9	96.1	136.8	113.4	90.0	126.3	94.1	105.1	85.8	73.1	139.4	66.5	100.0	92.8	71.4	138.0	119.6	196.9	102.6	76.6	151.1	84.9	103.4	73.6	141.1	72.1	82.4	115.5	78.0	109.6	134.8	129.6	64.1	143.7	82.6	117.2	55.8	123.8	120.2	162.4	110.8	113.9	71.8	93.2	110.0	123.7	76.7	136.1	108.0	83.4	82.0	132.6	119.3	76.7	105.4	81.5	86.5	113.8	44.1	97.1	62.1	100.2	174.0	84.1	150.9	107.4	58.3	22.4	38.6	22.1	27.0	29.1	29.8	28.9	26.9	23.9	24.1	29.1	27.3	20.2	36.4	36.0	18.9	35.9	40.9	42.6	45.3	48.6	69.1	43.1	50.6	43.7	43.9	44.0	45.8	45.8	52.9	94.9	60.9	101.4	25.5	124.2	232.6	235.2	171.7	126.9	89.5	90.3	65.8	111.5	75.8	106.2	64.4	39.6	120.3	75.0	46.6	266.1	130.3	30.1	89.1	80.4	111.0	81.9	195.9	50.4	95.0	205.7	126.9	55.5	114.6	102.6	53.8	90.3	51.7	90.3	97.6	51.3	70.8	187.2	87.3	242.1	15.0	130.8	105.0	250.8	39.4	131.0	128.4	102.0	36.2	49.1	111.2	51.6	134.6	77.8	207.5	72.2	182.6	85.8	90.5	131.5	110.8	170.3	105.7	70.1	100.6	238.5	235.9	125.1	60.9	78.8	196.3
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602363-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 81.1"	"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	101.5	45.5	2.4	51.5	3.8	0.6	72.6	3.5	10.2	162.8	4.6	30.5	7.8	81.7	11.0	26.9	80.6	112.5	110.8	2.3	2.5	21.9	59.7	72.4	41.3	3.0	2.4	47.7	20.6	10.3	31.2	59.5	2.9	45.5	16.7	0.2	24.9	33.5	16.9	45.0	21.6	59.9	3.1	13.8	22.9	13.7	3.6	10.5	49.1	32.7	17.4	86.4	86.7	2.5	0.2	0.5	2.2	3.0	321.5	879.0	2.4	355.5	663.0	161.1	142.7	14.5	0.8	1.1	1.2	404.5	0.5	0.2	0.0	1.2	15.9	2.5	2.5	0.3	6.1	19.8	82.1	0.1	3.5	973.2	0.3	86.3	0.6	0.4	0.1	1.7	8.3	2.0	0.7	2.1	0.6	3.3	72.2	0.0	4.2	1.0	1.5	0.8	0.4	0.6	1.1	689.9	0.2	2.4	1.6	8.2	2.0	0.0	3.5	391.8	107.6	1213.4	0.2	0.4	0.5	0.1	136.6	1.2	68.2	0.0	0.0	0.4	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	2.4	3.8	3.5	10.2	2.3	2.5	3.0	2.4	2.9	3.1	3.6	2.5	33.6	9.6	2.8	2.3	2.5	40.0	3.3	4.2	6.8	4.3	6.6	11.3	16.3	4.3	5.5	5.5	0.0	13.3	4.5	0.8	27.4	6.4	14.8	15.1	491.6	17.2	1.8	5.7	0.5	5.1	11.2	439.9	7.1	11.0	1.3	0.7	33.9	44.8	20.8	16.8	2.5	0.9	6.1	1.9	53.6	27.6	140.5	5.5	32.0	9.4	0.8	12.1	6.2	1.5	0.2	4.1	1.3	50.4	2.1	2.2	0.1	2.5	6.8	2.0	32.9	14.2	442.2	32.8	21.0	3.6	33.1	25.2	9.4	22.6	0.7	3.0
PCP2	"GPSM4, MGC41903"	ENSG00000174788	"Purkinje cell protein 2"	Q8IVA1	19	7631611-7633719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.4;retina: 33.3;testis: 112.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4139.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 53.4;white matter: 16.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 8.4;Karpas-707: 4.2;NB-4: 17.7"	"Region enriched"	"Detected in many"	44	"cerebellum: 2160.4"	"Region enriched"	"Detected in all"	28	"cerebellum: 552.9"	HPA057428			Approved	"Nuclear speckles,Vesicles"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"	Vesicles	"HPA057428: AB_2683436"	"prognostic favorable (7.93e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.79e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.70e-2)"	"prognostic favorable (2.76e-5)"	0.4	1.6	0.4	1.1	0.6	3.7	5.5	53.4	2.3	2.1	0.0	0.6	1.4	0.9	3.3	2.0	2.4	2.3	2.2	0.5	0.0	8.0	3.7	2.2	3.0	0.1	3.5	0.1	5.4	1.1	1.4	0.4	5.5	5.9	0.3	33.3	16.3	1.9	0.2	7.0	1.6	0.0	0.1	3.0	3.1	112.4	0.0	3.1	5.7	0.0	1.4	0.9	1.6	16.8	1.8	0.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	1.6	0.7	1.1	0.0	0.0	1.3	0.0	0.2	0.0	0.8	0.6	2.6	2.8	0.1	0.0	0.3	8.4	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	4.2	0.0	0.3	0.3	17.7	0.4	0.3	0.0	0.8	0.2	0.7	0.8	0.1	0.1	0.0	1.4	1.4	0.0	0.4	3.7	3.4	0.2	0.0	0.5	0.4	0.0	1.4	0.7	0.2	0.0	2.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.1	0.1	0.2	0.3	0.2	0.3	0.8	0.2	0.0	0.6	0.0	1.7	0.4	0.6	53.4	2.3	0.5	0.0	0.1	3.5	5.5	0.1	0.0	16.8	0.1	0.0	2.3	0.0	0.2	0.8	1.1	1.4	0.0	734.7	7.7	5.8	0.0	2.8	1.8	5.5	22.9	0.2	2.7	0.7	9.8	0.8	836.5	1.0	0.1	2.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.5	1.3	1.3	0.0	0.5	0.4	23.5	0.0	0.4	0.0	0.8	1.3	4139.3	10.5	7.1	1.8	1.0	1.5	40.7	2.1	0.0	0.0	0.4	0.1	13.2	0.3	1.0	1.3	0.5	0.4	100.3	19.7	0.0	0.1	14.5	9.0	0.0	1.1	0.0	1.0	0.0	0.6	0.6
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	31.4	24.4	15.2	30.0	16.0	45.3	21.0	16.6	15.8	16.7	17.8	25.7	60.3	19.1	13.9	31.0	15.6	20.7	46.4	15.5	21.1	18.3	20.7	22.5	22.9	18.8	18.0	15.8	16.8	22.7	12.9	20.1	18.5	16.6	22.9	14.4	19.3	18.6	73.8	43.0	49.1	23.0	17.5	25.9	24.2	22.4	18.1	18.1	17.2	42.1	26.8	21.0	19.8	17.1	92.6	36.6	25.8	37.2	52.2	53.9	37.0	68.2	47.1	59.2	51.8	92.3	32.8	23.9	215.2	78.1	60.2	71.4	40.5	52.1	50.4	42.1	28.6	68.6	40.6	39.5	45.2	34.3	56.7	47.4	40.0	55.9	39.6	35.4	63.0	21.0	38.3	53.3	58.1	79.6	19.9	17.3	21.4	55.7	53.0	34.5	31.0	37.5	35.7	53.6	25.4	18.3	44.5	79.5	44.2	32.8	114.1	37.2	88.5	45.5	25.2	61.8	92.7	45.8	101.1	44.1	69.6	43.8	56.9	9.6	9.2	10.4	8.8	9.3	7.5	7.2	6.5	9.7	9.1	6.3	4.2	6.3	21.0	9.4	11.0	5.9	14.9	5.2	15.2	16.0	16.6	15.8	15.5	21.1	18.8	18.0	18.5	17.5	18.1	17.1	24.7	16.0	25.7	15.3	19.9	14.5	9.4	19.7	14.2	15.9	14.1	9.4	70.1	20.0	17.5	14.7	25.0	11.9	27.3	36.4	13.7	24.8	76.3	17.8	22.9	23.2	22.1	12.2	20.4	22.9	17.7	17.0	23.4	15.6	20.8	16.1	26.7	35.6	37.4	8.4	22.7	24.2	6.1	34.6	27.1	67.6	19.9	33.9	19.6	20.6	39.4	13.1	39.1	16.1	17.6	24.6	21.1	28.2	27.2	12.0	67.2	23.2	33.9	12.8	26.3	15.0	19.0	46.0	13.2	30.0	21.5	18.6	25.6	25.5	23.8	12.2
PDCD2	"RP8, ZMYND7"	ENSG00000071994	"Programmed cell death 2"	Q16342	6	170575295-170584692	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026713, HPA075534"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Cytokinetic bridge"	"HPA026713: AB_1855103, HPA075534: AB_2686754"	"unprognostic (3.80e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	26.3	25.6	18.9	30.0	19.1	35.4	43.0	20.2	23.7	27.1	18.4	31.1	32.4	25.9	39.9	32.6	33.7	23.4	22.8	19.3	20.2	33.2	32.7	23.4	43.2	19.2	20.0	29.8	45.4	29.6	16.9	28.4	19.3	25.9	38.4	17.7	31.7	30.3	36.4	25.8	25.9	28.7	19.0	27.5	30.6	19.9	19.5	42.3	34.6	27.0	50.6	32.8	21.6	19.3	50.5	36.2	53.8	126.7	75.8	82.6	59.3	58.6	66.7	67.9	75.3	65.2	43.1	90.6	46.6	64.8	90.8	70.5	116.5	97.1	98.9	74.7	127.2	128.6	46.2	119.3	91.9	161.6	83.3	75.6	93.4	86.2	138.7	71.2	95.8	123.9	260.3	57.7	84.1	109.5	113.0	116.6	77.5	161.6	54.9	79.4	41.5	117.8	103.7	29.3	98.4	102.4	66.7	107.8	71.6	58.1	54.8	162.8	73.0	33.3	71.4	80.1	105.1	76.5	96.4	97.9	62.1	154.9	87.0	4.1	12.4	11.5	14.1	12.0	16.5	14.2	15.9	14.9	17.3	13.8	15.5	14.8	5.3	18.8	15.2	15.9	20.3	12.0	18.9	19.1	20.2	23.7	19.3	20.2	19.2	20.0	19.3	19.0	19.5	19.3	47.2	12.8	15.3	9.4	54.1	49.5	76.4	14.6	40.5	36.9	58.0	59.7	27.4	52.9	14.0	29.5	12.5	63.9	82.2	29.2	78.2	55.3	17.0	36.1	38.5	38.8	47.2	64.1	13.2	74.1	71.6	32.2	32.1	33.5	15.9	59.8	44.6	28.2	49.2	16.8	12.7	44.0	22.4	41.9	33.2	15.0	49.0	40.9	35.6	8.4	62.8	34.7	84.5	8.0	12.4	58.6	36.4	40.6	58.0	103.9	47.8	83.6	16.0	35.3	19.7	43.8	55.5	33.0	85.8	58.7	46.0	46.7	60.7	60.8	68.0	84.1
PDCD6	"ALG-2, PEF1B"	ENSG00000249915	"Programmed cell death 6"	O75340	5	271621-314974	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047221			Supported	Nucleoplasm,Cytosol		No	No		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA047221: "	"unprognostic (1.32e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.47e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (2.19e-4)"	63.3	108.3	89.0	48.7	90.4	42.1	74.8	95.4	102.6	73.4	88.1	83.0	71.6	63.4	98.2	134.8	64.8	48.4	53.5	91.1	92.9	114.6	85.0	53.1	59.9	92.2	88.9	61.7	65.5	77.3	76.4	61.4	90.5	64.3	85.4	29.6	73.9	54.4	42.3	72.7	71.8	52.8	94.9	77.0	69.0	50.3	90.3	81.2	72.8	27.3	74.5	72.7	86.9	100.1	151.8	208.6	88.4	133.5	156.1	141.9	185.6	115.5	151.9	144.2	134.6	147.3	186.4	119.6	283.2	155.4	187.2	112.9	137.3	288.2	116.0	409.9	170.9	105.9	508.7	194.0	193.3	155.7	129.5	128.1	175.0	117.4	208.9	148.3	137.9	81.2	136.8	90.3	130.7	237.7	125.7	270.1	95.6	183.8	295.1	102.0	83.8	171.5	344.7	192.6	86.3	117.5	297.2	309.4	224.7	91.9	215.1	210.7	108.5	94.0	76.9	82.8	100.0	121.4	163.4	141.8	138.9	198.9	128.9	172.8	209.7	284.4	158.2	206.0	199.7	251.9	196.4	179.6	229.3	224.6	217.8	175.5	231.0	260.7	206.6	183.2	236.7	356.2	89.0	90.4	95.4	102.6	91.1	92.9	92.2	88.9	90.5	94.9	90.3	100.1	134.6	64.1	57.4	9.4	99.5	82.1	129.6	250.6	85.4	47.9	140.1	182.1	50.4	78.6	146.7	103.0	37.5	239.1	104.4	146.4	252.4	172.0	55.4	130.9	91.6	110.7	79.7	83.9	10.7	129.1	321.6	104.3	68.8	99.9	82.5	101.3	69.9	77.7	140.4	63.9	11.3	187.5	219.7	84.1	75.5	55.5	117.4	90.0	124.5	10.3	175.3	136.8	137.0	5.5	11.0	164.0	136.7	116.6	57.7	170.7	175.6	205.1	181.9	42.0	85.5	85.3	109.5	100.8	137.8	123.8	92.5	356.7	92.6	173.3	192.3	176.6
PDCL2	GCPHLP	ENSG00000163440	"Phosducin like 2"	Q8N4E4	4	55556519-55592245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 65.1"	"Group enriched"	"Detected in some"	19	"Early spermatids: 1285.9;Late spermatids: 634.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0;testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;HaCaT: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048260, HPA072384"	Enhanced		Approved	Microtubules,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Microtubules	Centrosome	"HPA048260: AB_2680333, HPA072384: "		"unprognostic (5.93e-3)"		"unprognostic (1.19e-7)"		"unprognostic (1.04e-1)"				"unprognostic (3.01e-3)"				"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.41e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	65.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1285.9	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	634.7	7.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	13.1	0.0	0.1	40.4	50.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562993-100576739	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favorable (4.23e-4)"	20.8	22.0	19.1	27.1	21.6	22.9	23.0	21.6	24.3	18.9	16.6	27.3	17.0	24.1	37.2	36.8	22.5	21.3	30.6	18.4	21.3	28.4	18.5	18.4	25.3	21.8	24.7	21.1	11.4	23.4	10.5	23.4	21.7	27.0	28.9	21.1	16.9	23.2	58.8	36.8	17.3	38.6	20.8	17.0	17.6	22.8	22.1	22.4	21.4	34.3	34.0	33.1	17.5	22.2	41.8	58.7	59.9	52.2	19.3	27.4	67.5	51.3	32.5	92.9	58.1	74.2	25.5	68.6	74.0	62.3	122.3	34.2	76.0	50.2	74.0	110.6	65.8	72.0	31.8	89.7	50.8	77.3	73.2	29.8	92.0	82.0	52.3	24.2	58.9	52.8	61.1	43.8	70.7	74.6	75.8	117.7	77.9	45.6	86.6	72.5	63.2	48.0	58.2	98.7	55.9	49.6	41.0	54.7	59.0	48.6	42.3	53.0	45.8	56.4	60.1	44.8	72.2	26.4	54.1	68.3	34.4	90.5	45.7	82.3	64.8	80.2	63.1	124.4	72.8	92.5	95.0	70.4	114.9	78.1	97.7	75.4	7.0	93.9	161.7	64.0	113.6	87.3	19.1	21.6	21.6	24.3	18.4	21.3	21.8	24.7	21.7	20.8	22.1	22.2	37.4	19.2	25.2	1.6	39.5	65.6	36.6	79.2	52.9	13.0	24.8	36.2	40.9	18.6	46.1	14.7	6.2	70.8	61.5	16.0	60.7	50.6	37.0	38.9	26.6	30.2	19.8	21.7	2.3	39.1	51.2	22.6	19.4	34.6	92.9	25.4	12.5	17.0	59.7	11.8	2.0	24.0	89.5	17.8	80.7	14.3	14.6	54.4	35.6	3.7	104.3	19.7	40.2	2.0	4.5	31.8	18.6	33.4	27.7	33.2	19.7	77.9	28.1	16.5	52.6	23.8	54.1	5.5	66.9	63.2	57.5	52.4	91.8	24.5	31.3	32.4
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20368537-20688583	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.2;Bipolar cells: 38.4;Cardiomyocytes: 131.3;Horizontal cells: 52.2;Inhibitory neurons: 78.8;Smooth muscle cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.6;HEL: 15.3;HeLa: 42.5;HUVEC TERT2: 7.4;SH-SY5Y: 17.9;U-138 MG: 11.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 18.8"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"		NA	NA		37000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	6.5	1.0	1.6	3.1	1.3	0.2	3.8	3.1	1.3	6.7	1.8	15.0	1.9	4.2	1.4	2.2	4.1	4.7	43.4	1.3	1.5	3.3	1.3	3.9	1.0	1.9	2.3	3.4	6.2	0.6	2.1	11.3	1.2	5.4	7.6	5.7	2.7	3.5	2.2	1.3	9.6	5.2	1.6	2.2	5.1	0.4	2.5	0.6	2.8	1.8	0.5	2.5	3.1	1.4	0.0	0.2	8.6	0.0	1.9	1.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.3	42.5	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.1	0.0	0.0	0.0	2.7	0.0	0.1	17.9	0.0	0.0	0.1	3.3	0.0	0.0	0.3	11.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	3.1	1.3	1.3	1.5	1.9	2.3	1.2	1.6	2.5	1.4	2.7	0.0	0.0	98.2	0.0	0.3	0.2	0.0	0.6	38.4	0.2	0.3	131.3	4.3	0.6	0.0	0.0	0.0	0.0	28.4	0.0	5.8	0.7	0.5	1.6	3.9	4.2	0.0	4.1	0.5	0.0	11.3	0.0	1.4	17.1	0.0	2.2	0.0	0.7	52.2	78.8	7.0	0.0	0.0	0.7	0.6	1.5	3.1	1.8	27.2	0.5	4.4	0.0	27.6	3.9	0.4	26.9	0.7	0.0	0.5	33.4	3.1	0.0	2.8	6.6	3.6	49.9	0.3	0.9	0.9	0.3	0.0	0.6	0.5	16.4	0.2
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469630	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 190.8;Late spermatids: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.5;NB-4: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	13.7	5.6	10.9	5.9	12.5	5.4	9.7	3.0	32.3	12.4	0.0	11.0	2.7	9.8	1.4	4.1	7.5	6.6	12.5	11.8	7.9	7.0	2.5	13.0	3.2	21.9	7.1	1.5	12.7	22.2	3.9	6.5	20.8	8.4	4.0	5.3	9.8	4.8	37.9	5.4	6.5	6.2	1.1	8.2	12.9	24.5	13.0	1.6	11.0	16.9	2.6	8.2	8.2	15.7	0.1	2.5	0.5	6.7	18.7	11.1	3.7	5.6	11.1	0.7	1.9	6.0	5.4	2.6	16.1	14.6	0.4	0.6	3.9	0.7	0.4	6.7	5.5	23.7	8.1	6.7	12.3	3.9	36.5	8.3	0.8	6.2	0.0	0.7	5.3	2.1	18.9	5.5	4.0	1.7	2.3	43.3	2.9	6.7	4.7	15.6	3.7	20.3	0.9	1.4	4.2	1.5	0.4	0.2	6.2	1.0	0.8	7.8	11.2	8.3	10.5	5.7	3.7	10.9	0.9	12.4	3.5	0.3	6.7	4.1	1.7	3.4	0.8	2.5	0.4	0.1	0.3	1.1	2.0	0.0	0.0	0.4	0.1	3.0	2.7	0.1	0.7	1.1	10.9	12.5	3.0	32.3	11.8	7.9	21.9	7.1	20.8	1.1	13.0	15.7	9.4	3.2	11.6	6.2	10.8	10.1	2.6	2.5	1.8	25.6	6.4	4.3	7.7	8.6	5.5	9.2	0.0	0.5	58.9	7.1	0.0	3.1	48.9	2.1	20.7	8.6	0.0	1.7	39.4	12.9	4.8	12.1	7.1	3.6	31.8	0.3	10.4	0.9	10.2	55.5	43.5	5.1	6.1	22.1	190.8	197.0	17.4	53.9	14.2	12.2	15.4	1.2	22.6	12.5	1.5	12.3	3.8	18.0	27.0	3.0	0.1	0.2	6.9	3.6	6.6	9.0	10.2	8.6	8.5	0.5	8.1	0.4	37.0	1.0	6.8	1.3
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 255.9;Gastric mucus-secreting cells: 141.2;Paneth cells: 251.4;Proximal enterocytes: 73.0;Skeletal myocytes: 106.5;Undifferentiated cells: 103.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.2;cerebral cortex: 1.1"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Hep G2: 2.0;U-87 MG: 4.4"									"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	1.4	0.6	0.2	0.1	1.2	0.5	0.7	0.0	1.1	3.2	0.0	4.3	0.7	3.4	3.4	0.7	3.0	1.1	4.4	0.2	0.0	4.8	1.3	3.4	0.2	0.0	0.0	1.8	0.7	0.2	2.8	3.7	0.0	2.3	0.6	0.2	0.5	2.7	8.3	0.3	2.4	1.8	0.0	2.1	3.8	2.5	0.0	0.0	1.1	21.3	0.1	1.0	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.2	0.3	0.0	1.2	0.0	0.2	0.0	0.1	0.4	0.9	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.7	0.2	0.2	0.0	0.1	0.0	0.3	0.0	0.6	0.3	0.1	4.4	0.1	0.0	1.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.0	0.2	1.2	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.2	10.6	2.0	0.8	5.5	5.8	8.6	5.2	3.9	0.2	0.4	35.3	4.3	22.4	0.0	6.2	2.1	0.0	255.9	0.0	0.0	32.9	0.1	0.1	4.6	7.2	0.0	8.2	0.0	4.3	6.3	141.2	0.1	4.5	0.0	1.1	0.3	0.5	0.0	2.1	55.2	4.1	1.4	4.5	38.4	0.6	2.1	1.8	0.0	0.4	1.9	1.0	0.5	0.9	0.0	251.4	4.1	1.6	1.8	73.0	0.0	9.4	3.0	46.0	106.5	17.2	1.9	2.2	28.6	3.8	1.1	1.2	0.0	103.3	17.3
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851701-136195574	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 346.4;Excitatory neurons: 136.7;Inhibitory neurons: 166.0;Oligodendrocyte precursor cells: 343.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;ASC TERT1: 10.2;EFO-21: 16.2;HeLa: 9.6;HSkMC: 22.4;HUVEC TERT2: 10.8;U-2197: 11.4"	"Region enriched"	"Detected in all"	5	"basal ganglia: 125.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.2	2.3	6.5	2.2	22.1	0.1	2.6	3.6	8.1	3.9	2.8	2.5	1.9	7.8	2.2	1.3	2.8	3.4	6.6	2.6	8.7	5.5	3.7	1.7	1.5	6.2	11.6	13.0	0.8	6.2	4.8	1.0	6.0	4.3	2.7	2.4	2.9	10.3	4.7	0.8	2.2	7.6	4.6	1.1	3.6	1.5	15.8	3.8	4.7	8.9	0.8	6.0	3.6	2.8	0.0	5.7	0.2	0.0	8.7	10.2	0.1	0.5	2.9	2.1	1.1	0.0	0.1	0.1	16.2	3.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	9.6	0.0	3.7	0.1	0.0	22.4	0.0	4.2	0.0	0.9	10.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.8	0.7	3.9	3.7	0.1	0.2	0.0	0.0	1.8	0.0	2.3	0.0	11.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.8	1.3	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.1	6.5	22.1	3.6	8.1	2.6	8.7	6.2	11.6	6.0	4.6	15.8	2.8	8.3	0.0	0.5	346.4	11.9	0.4	0.3	0.5	0.0	4.4	0.9	0.4	8.4	2.8	0.2	22.0	0.0	0.1	0.7	0.1	0.0	0.2	0.5	3.1	1.4	23.1	7.3	0.8	136.7	1.6	0.0	9.8	4.6	2.1	10.2	31.1	35.3	3.8	0.3	6.7	166.0	0.0	0.0	1.9	4.8	0.9	12.2	3.2	0.0	70.3	0.7	11.5	0.0	343.8	10.4	0.1	0.0	7.9	0.2	0.4	0.0	1.6	1.6	0.9	13.1	30.6	9.1	0.3	0.1	0.2	1.4	0.0	2.9	4.4	0.0	0.3
PDE9A		ENSG00000160191	"Phosphodiesterase 9A"	O76083	21	42653621-42775509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 74.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 90.8;Paneth cells: 105.3;Proximal enterocytes: 233.5"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 31.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 29.7;EFO-21: 30.0;MCF7: 23.2;NB-4: 34.7;NTERA-2: 41.2;SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011380, HPA011978"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA011380: AB_1855132, HPA011978: "	"unprognostic (5.75e-2)"	"unprognostic (9.92e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.79e-1)"	9.4	11.1	12.3	3.9	15.1	0.5	10.8	14.0	12.9	7.2	8.6	74.7	2.9	5.1	19.4	3.7	10.6	6.8	4.3	10.6	12.6	29.8	4.2	4.9	4.8	12.4	14.4	3.5	4.1	6.5	9.9	10.3	12.7	38.5	16.4	10.7	12.7	15.8	2.4	7.0	47.3	8.8	11.0	18.3	13.4	1.9	15.0	7.8	6.5	4.8	3.1	18.9	6.2	12.0	0.0	2.8	29.7	3.7	0.0	0.8	0.5	0.0	0.0	0.0	0.0	3.2	18.2	0.0	30.0	0.0	2.2	0.0	2.7	9.8	0.0	0.0	10.4	0.0	0.0	6.4	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	23.2	1.5	34.7	41.2	14.6	0.0	0.0	0.0	1.2	20.4	7.6	22.5	13.5	5.2	0.0	0.5	7.0	0.2	19.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.2	3.1	0.6	0.4	0.9	0.0	0.4	1.0	0.3	12.3	15.1	14.0	12.9	10.6	12.6	12.4	14.4	12.7	11.0	15.0	12.0	18.6	3.2	5.0	43.4	1.6	1.0	10.9	4.2	6.2	26.4	13.4	12.6	1.6	5.7	2.4	18.4	0.0	0.0	1.0	90.8	29.4	7.3	0.6	18.1	8.5	11.9	13.1	3.2	5.6	2.4	0.1	5.9	1.5	26.8	1.3	6.1	5.7	0.9	7.5	35.3	10.8	25.8	8.2	1.3	0.8	2.2	11.8	1.6	28.4	31.9	1.1	11.0	0.0	29.1	16.6	5.3	105.3	6.0	0.2	28.1	233.5	8.9	1.3	2.8	13.1	0.5	6.4	0.4	2.3	0.5	0.6	0.4	3.8	16.9	24.4	15.0
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69326913-69330588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.0;Erythroid cells: 4.6;Gastric mucus-secreting cells: 8.6;Plasma cells: 14.7;Squamous epithelial cells: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	5.9	8.7	1.0	0.9	1.3	1.4	5.5	1.9	1.8	4.4	1.5	5.6	2.1	5.8	0.4	10.2	4.7	0.5	5.3	2.2	0.8	19.0	27.8	4.4	1.1	1.4	0.8	3.1	8.8	1.6	4.3	0.6	1.0	5.0	0.8	0.3	7.2	0.6	12.4	7.7	5.2	0.4	0.8	5.1	5.6	4.8	0.9	0.6	5.9	0.8	0.7	4.8	4.8	1.5	6.3	4.8	1.3	4.1	1.1	0.8	7.7	6.0	1.0	2.9	2.4	8.6	5.7	13.1	6.2	1.6	2.2	11.5	1.8	2.1	1.3	3.5	23.3	6.6	5.3	12.6	1.8	10.8	5.7	1.7	4.3	2.5	1.2	0.8	1.5	7.2	16.1	2.4	1.9	7.6	9.2	8.3	6.4	2.6	7.1	20.8	2.1	11.0	2.2	5.4	9.3	7.1	10.8	2.9	5.2	0.3	11.0	3.3	4.6	3.9	6.4	5.8	6.8	12.1	9.4	15.2	3.1	6.9	5.9	1.4	0.7	1.0	0.4	0.3	0.9	1.2	1.0	1.2	0.6	4.1	1.5	0.7	0.0	0.4	0.4	1.3	0.9	0.3	1.0	1.3	1.9	1.8	2.2	0.8	1.4	0.8	1.0	0.8	0.9	1.5	0.2	3.2	0.0	0.0	3.0	0.0	0.1	0.0	8.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.5	0.3	0.6	0.0	4.6	0.0	0.2	0.3	1.2	8.6	0.5	0.0	0.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	14.7	0.1	0.4	1.1	0.0	0.0	0.0	0.1	0.8	0.2	0.1	17.7	0.4	0.3	1.4	0.1	0.0	0.1
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 subunit alpha 1"	P08559	X	19343893-19361718	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 508.8;tongue: 770.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 479.9;Distal tubular cells: 354.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favorable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	93.0	69.0	62.1	37.9	66.9	88.1	63.1	66.2	91.5	55.9	84.4	112.6	87.0	53.1	78.9	76.8	49.1	29.3	508.8	68.2	67.0	174.1	118.3	47.2	36.6	64.5	62.7	50.6	83.4	161.0	48.7	43.1	65.0	48.4	104.4	90.1	109.7	63.4	459.0	60.9	82.1	51.8	59.6	49.3	121.8	24.0	67.4	52.3	64.5	770.2	59.1	61.7	56.1	71.1	124.9	151.4	107.9	114.2	102.3	77.7	131.6	83.8	74.6	170.2	130.7	216.6	78.2	212.2	60.6	102.0	226.7	159.0	334.2	145.8	178.1	70.1	186.1	104.8	264.0	194.2	107.8	170.3	82.8	100.9	132.8	157.3	154.4	85.6	105.3	129.8	94.2	87.2	120.7	164.5	142.7	173.5	110.0	227.4	261.7	145.2	180.9	260.3	298.0	125.1	59.7	62.6	134.1	167.8	158.1	229.8	177.1	118.1	65.4	87.6	78.6	240.9	108.6	73.3	82.0	140.5	82.4	117.2	77.4	99.9	87.4	65.3	72.3	119.9	88.9	103.4	69.4	79.5	115.7	82.1	67.7	72.0	15.5	98.1	109.1	76.9	84.4	89.6	62.1	66.9	66.2	91.5	68.2	67.0	64.5	62.7	65.0	59.6	67.4	71.1	34.1	44.8	44.4	18.6	30.7	29.8	59.7	135.4	25.0	59.0	37.0	29.3	479.9	87.2	74.8	152.6	33.3	105.0	32.5	73.0	354.1	88.8	2.5	41.2	33.7	36.8	41.9	55.8	21.2	59.8	120.7	49.2	49.5	36.9	42.6	39.7	18.2	76.3	73.2	25.2	24.6	64.4	71.2	26.8	30.5	4.1	35.4	32.5	56.9	9.4	40.8	49.0	26.8	13.0	11.5	47.4	52.5	40.6	43.3	47.1	88.6	213.7	33.1	69.1	32.9	37.5	51.7	51.1	25.3	45.2	33.4	133.4	31.6	25.4	130.3	55.8
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 subunit alpha 2"	P29803	4	95840093-95841464	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	602	"testis: 60.2"	"Group enriched"	"Detected in some"	71	"Early spermatids: 426.6;Late spermatids: 288.3;Spermatocytes: 229.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.3	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	229.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 subunit beta"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 299.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		61000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	59.9	76.5	48.7	42.2	50.2	25.7	42.9	53.9	62.7	43.3	63.6	56.8	42.5	38.5	44.6	57.4	37.7	35.9	175.0	49.7	52.3	100.8	110.7	36.4	53.1	51.7	49.4	26.5	36.4	88.8	44.1	57.0	51.5	48.5	60.4	30.7	45.9	52.1	272.6	36.8	37.6	63.8	51.6	42.8	53.9	42.3	53.1	53.1	40.8	299.4	56.0	49.7	35.9	54.3	66.5	90.9	92.3	69.8	91.7	111.1	110.4	81.6	101.3	117.9	120.6	165.1	62.6	140.3	44.9	103.8	109.0	37.6	113.2	74.9	90.0	81.7	83.0	125.4	163.7	126.0	92.5	103.0	67.9	97.9	67.7	95.5	55.8	137.5	103.1	114.2	65.9	61.5	129.5	63.1	98.2	107.8	127.2	69.2	101.3	46.3	71.8	136.1	188.1	89.1	63.7	70.2	75.6	107.2	85.4	131.3	159.0	108.7	76.3	62.9	83.7	66.8	94.2	85.2	129.9	99.2	96.2	120.8	60.7	57.8	98.9	98.7	83.2	115.1	87.9	102.2	81.7	80.5	141.1	103.4	90.9	82.4	19.6	129.4	109.7	94.7	113.2	124.1	48.7	50.2	53.9	62.7	49.7	52.3	51.7	49.4	51.5	51.6	53.1	54.3	57.8	60.9	34.5	5.9	45.3	27.9	40.7	142.0	26.7	31.8	29.4	31.6	300.6	48.6	96.0	35.0	25.0	174.1	35.3	41.0	230.9	95.9	76.3	37.0	37.3	58.0	58.0	22.5	10.9	72.2	101.6	54.1	29.6	34.2	39.3	48.5	46.1	76.1	84.6	57.2	13.3	50.4	162.8	37.9	26.6	16.9	60.3	37.2	56.9	9.4	76.5	61.7	70.0	9.0	13.6	55.9	43.0	51.1	38.8	19.1	45.8	146.8	70.7	45.9	65.7	30.8	72.3	98.2	88.3	42.8	29.8	157.2	44.7	224.4	53.0	37.7
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746410-43773278	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1048.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		200000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	17.0	16.6	7.5	16.5	8.0	27.1	15.6	9.2	7.6	24.7	13.9	20.6	23.6	16.4	44.7	18.9	15.4	13.5	17.3	7.7	9.8	15.3	34.5	16.8	18.7	9.3	8.2	16.5	36.0	22.6	16.2	23.8	9.1	25.2	22.5	8.4	21.6	19.1	7.6	17.3	21.4	17.0	9.0	12.5	20.4	10.8	9.3	9.6	56.0	4.1	12.3	15.6	15.2	9.8	29.4	11.9	24.6	55.1	48.9	51.9	70.8	58.6	62.1	46.0	56.7	33.6	32.1	33.8	37.4	72.9	30.8	47.8	31.8	61.5	39.7	24.3	44.7	47.2	17.6	30.9	80.1	26.0	33.8	33.6	49.8	35.0	58.5	54.0	81.3	11.1	27.7	17.4	45.5	11.1	9.1	30.4	24.4	48.5	44.0	17.9	36.7	26.2	39.3	26.0	22.9	25.4	48.7	49.0	19.4	25.0	33.1	28.1	50.9	37.7	18.9	29.7	29.1	7.1	8.6	33.9	48.1	41.2	28.8	11.6	8.8	13.3	12.1	9.2	12.8	5.4	6.8	9.5	8.3	6.1	6.0	7.1	2.4	12.7	9.9	17.6	5.8	15.8	7.5	8.0	9.2	7.6	7.7	9.8	9.3	8.2	9.1	9.0	9.3	9.8	224.9	192.3	183.9	31.6	177.8	192.2	313.7	665.2	114.4	56.5	137.9	95.5	58.3	124.4	427.7	167.3	41.7	655.2	319.6	228.7	70.5	401.2	24.3	178.8	300.3	223.7	186.1	95.3	29.2	390.4	807.8	350.7	261.0	328.5	261.6	255.1	233.1	342.2	426.0	70.7	38.3	523.1	231.9	157.3	292.2	26.7	253.5	246.5	243.7	36.5	258.0	128.3	279.1	29.7	38.8	279.9	196.8	276.8	341.1	286.5	234.3	129.1	245.6	61.9	124.9	138.4	389.7	186.4	147.6	138.9	148.5	1048.8	237.8	390.8	335.4	291.7
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 216.2;tongue: 285.0"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 123.0;Proximal tubular cells: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	40.8	63.8	49.9	8.7	51.2	5.0	26.4	65.7	58.2	30.5	37.1	42.7	28.1	29.4	124.4	21.8	24.3	18.0	116.6	50.6	41.8	62.7	50.8	15.3	10.1	40.8	44.0	48.2	44.3	40.7	17.0	14.7	41.8	23.5	21.5	14.7	25.7	27.4	216.2	26.0	32.5	25.7	40.8	18.4	33.7	13.7	44.6	12.6	27.3	285.0	9.2	30.9	22.2	44.6	12.4	17.5	20.6	18.5	21.2	16.5	2.2	13.2	19.3	19.3	18.5	1.7	13.2	15.5	21.7	37.0	13.0	6.4	13.7	5.3	18.8	30.6	19.3	14.0	17.1	13.2	11.3	0.0	15.0	33.6	19.6	12.5	0.9	33.7	17.2	20.0	5.7	15.0	11.0	15.8	11.8	0.0	4.5	37.2	17.1	17.5	45.8	21.1	10.4	10.4	13.8	20.7	18.7	5.9	9.0	25.0	35.0	13.7	8.8	22.5	18.4	16.0	10.1	29.4	29.9	8.2	33.3	4.9	15.4	14.3	16.2	8.9	16.2	12.9	12.8	12.9	14.8	18.0	18.4	13.8	17.2	18.0	2.6	22.9	14.1	25.8	22.4	17.4	49.9	51.2	65.7	58.2	50.6	41.8	40.8	44.0	41.8	40.8	44.6	44.6	17.9	9.6	10.3	18.3	12.1	15.2	12.3	12.4	17.6	19.0	16.0	26.8	5.4	12.8	11.7	20.2	6.2	19.6	16.7	38.6	58.7	11.7	8.8	6.5	12.1	11.8	13.8	10.8	18.6	9.1	3.6	17.7	13.7	7.8	1.3	19.0	18.2	52.0	19.9	43.7	15.6	50.2	16.2	13.6	9.1	18.9	24.2	12.0	24.9	8.4	14.5	37.3	7.2	6.0	11.3	6.2	55.2	52.6	25.9	6.7	123.0	131.9	6.5	11.0	19.7	15.0	20.5	3.3	11.7	14.6	18.8	7.9	12.9	29.0	36.9	11.3
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465270-24550466	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.6;Excitatory neurons: 92.8;Inhibitory neurons: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	4.4	2.0	4.4	5.6	6.2	8.9	8.8	1.4	7.5	3.5	2.5	6.1	8.2	2.8	10.9	3.9	5.9	3.2	7.4	13.2	4.7	8.8	4.7	5.0	7.9	2.6	4.2	4.8	2.9	6.7	5.8	4.1	2.4	4.6	5.3	6.0	11.1	2.9	1.4	6.8	8.3	4.5	0.9	7.7	6.9	11.6	9.1	6.3	2.3	1.8	8.0	4.2	4.1	4.2	11.5	5.2	4.2	8.0	0.2	0.0	5.0	3.4	2.4	4.1	6.9	0.5	13.9	10.4	2.3	0.8	11.6	2.1	12.3	8.4	10.4	9.7	6.0	5.3	6.1	3.3	1.4	4.6	5.8	0.9	3.6	1.1	1.2	0.5	6.8	10.9	0.9	16.5	0.5	20.9	9.4	6.0	8.1	12.2	5.6	5.0	8.0	17.3	4.1	21.4	2.6	4.0	17.9	8.0	5.5	7.3	9.6	1.9	0.1	3.3	3.6	5.8	4.2	11.0	8.9	12.9	8.7	7.7	6.4	13.3	15.4	37.9	11.8	19.6	16.5	7.5	9.1	10.3	12.2	7.3	7.6	8.6	57.6	13.3	18.8	3.5	8.3	12.4	4.4	6.2	1.4	7.5	13.2	4.7	2.6	4.2	2.4	0.9	9.1	4.2	3.9	3.2	2.0	19.6	15.2	4.6	9.5	13.5	30.1	3.5	11.1	8.1	6.6	1.5	5.2	1.8	0.0	5.5	16.6	4.2	3.9	4.3	71.6	2.1	2.9	3.8	4.2	14.3	92.8	5.1	32.1	4.9	5.6	2.8	5.7	4.9	5.3	5.3	15.0	8.4	78.0	2.9	10.2	19.8	7.4	35.9	3.7	17.4	16.0	35.6	10.3	3.7	25.7	19.6	14.0	2.1	0.3	5.7	19.0	5.9	13.3	14.2	2.4	3.5	0.0	2.0	10.6	10.2	8.3	6.8	4.4	17.8	18.2	9.7	4.1	8.4
PDLIM2		ENSG00000120913	"PDZ and LIM domain 2"	Q96JY6	8	22578279-22598025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 793.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"white matter: 429.2"	"Low region specificity"	"Detected in many"			HPA003880	Approved		Supported	"Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Actin filaments, Focal adhesion sites"		"HPA003880: AB_1855149"	"unprognostic (1.04e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-3)"	"unprognostic (9.33e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.37e-7)"	"unprognostic (6.14e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.08e-3)"	66.0	31.6	40.6	31.9	42.2	23.7	51.0	51.0	56.6	85.1	42.6	86.9	60.9	80.2	9.8	131.4	56.0	52.8	51.4	36.9	43.9	77.7	59.4	88.8	54.4	56.6	52.9	49.6	53.7	9.8	35.3	40.5	59.4	45.5	11.2	2.0	48.6	30.9	201.9	153.1	64.3	23.2	49.9	232.0	38.8	12.2	49.9	20.4	27.4	60.9	24.4	57.5	91.7	54.8	90.3	54.5	36.2	63.9	69.9	118.5	40.9	139.1	102.4	97.6	98.5	62.4	14.7	36.9	38.4	126.4	18.1	44.7	20.5	95.0	19.0	0.1	14.1	11.6	35.2	46.1	88.2	13.0	85.9	127.2	11.6	48.2	13.2	76.8	54.2	20.2	3.3	23.4	67.4	46.5	16.7	15.4	29.8	37.8	5.5	13.3	6.9	3.9	17.3	18.3	11.3	26.9	29.1	78.1	128.7	21.3	27.5	25.8	68.2	105.7	108.6	127.9	64.8	0.4	0.8	12.5	109.0	51.3	79.6	78.2	48.0	162.3	47.0	64.4	42.2	25.0	35.5	46.9	38.4	27.6	23.8	35.4	101.6	28.1	63.8	24.7	40.7	34.6	40.6	42.2	51.0	56.6	36.9	43.9	56.6	52.9	59.4	49.9	49.9	54.8	85.8	76.9	13.1	5.5	45.0	95.1	12.9	48.1	39.9	3.0	34.0	42.5	10.2	18.6	34.2	18.4	0.0	73.1	70.9	92.0	15.6	24.9	1.0	8.8	94.0	48.7	1.2	10.5	3.2	26.1	115.1	98.9	7.7	13.8	27.3	25.7	86.4	49.4	59.0	3.3	2.3	12.6	20.3	59.1	73.8	3.4	132.0	37.9	48.0	8.4	42.5	33.1	122.6	7.1	3.9	93.2	126.1	218.2	6.8	52.7	217.6	146.3	5.2	3.6	59.2	27.1	108.3	0.7	6.3	39.7	100.7	793.0	71.6	21.0	15.0	30.6
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 80.0;Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 14.2;basal ganglia: 20.1;cerebral cortex: 41.7;hippocampal formation: 23.4;white matter: 18.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 117.8;hTERT-RPE1: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	10.6	62.6	14.2	10.5	20.1	14.4	16.1	0.0	41.7	14.2	1.2	8.9	7.2	15.5	17.0	14.2	12.2	19.4	49.2	23.4	0.0	12.8	4.2	12.6	12.9	0.0	2.3	19.3	19.9	29.9	5.4	13.8	0.0	10.3	12.4	14.1	11.7	9.4	72.9	4.3	7.6	11.2	0.0	13.2	11.7	26.7	3.0	11.6	18.8	16.9	12.4	14.0	6.8	18.5	25.7	12.0	25.9	10.9	21.0	37.9	8.6	19.3	21.7	22.1	25.8	12.7	90.3	13.9	63.8	30.8	117.8	54.4	11.0	16.1	32.8	1.5	5.6	6.6	15.7	4.5	23.9	3.3	9.0	24.5	31.5	37.7	59.8	117.1	50.9	12.4	2.4	22.8	27.6	6.0	20.3	10.3	12.1	26.8	15.4	4.8	15.5	2.6	15.3	17.0	2.4	11.4	12.7	1.4	61.8	20.9	4.0	3.9	90.9	27.5	17.2	63.8	23.3	12.6	5.8	12.1	34.2	11.7	25.1	6.4	27.9	14.5	9.2	25.3	8.9	15.6	15.1	12.0	22.5	17.9	8.9	7.8	3.1	5.4	41.1	3.7	34.9	18.0	14.2	20.1	0.0	41.7	23.4	0.0	0.0	2.3	0.0	0.0	3.0	18.5	10.7	12.8	7.8	15.0	18.0	13.0	12.7	36.3	68.9	38.3	11.6	7.0	80.0	14.3	35.6	16.5	8.4	4.3	13.7	27.5	5.9	33.3	144.2	33.3	14.9	15.0	10.2	1.3	73.6	14.0	3.9	20.8	16.3	70.2	6.3	3.7	12.5	3.3	6.3	10.1	23.4	5.5	10.2	19.2	19.1	28.1	11.5	19.9	10.6	19.7	22.4	18.8	10.3	13.0	8.5	24.5	9.6	13.5	8.1	15.6	4.9	11.4	30.5	11.5	6.6	35.4	13.1	10.1	11.4	26.5	10.9	4.4	19.3	7.1	10.7	23.9
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 135.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Basal respiratory cells: 98.5;Fibroblasts: 123.1;monocytes: 116.3;Muller glia cells: 97.7;Peritubular cells: 62.8"	"Group enriched"	"Detected in many"	4	"glioma: 83.2;head and neck cancer: 40.2;testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 149.5;EFO-21: 356.4;HAP1: 253.3;HHSteC: 216.0;NTERA-2: 116.0;SuSa: 119.0;TIME: 242.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	61.5	3.3	8.9	55.9	9.3	0.0	20.9	13.7	8.1	43.1	23.5	16.6	3.8	25.9	11.3	15.8	33.4	42.1	20.3	8.0	14.6	3.4	0.6	32.4	9.8	24.9	15.6	29.4	6.4	1.1	3.3	135.6	19.1	14.0	10.6	22.7	9.1	14.1	30.0	20.0	15.9	34.5	16.4	0.3	24.7	4.5	22.5	10.3	6.2	11.3	18.5	96.1	25.2	21.2	0.1	0.0	149.5	0.1	0.5	0.0	0.1	2.4	0.1	0.0	0.0	0.0	0.1	0.2	356.4	9.0	0.1	0.7	253.3	44.7	0.0	1.0	46.1	0.1	0.0	0.0	216.0	0.0	0.2	29.5	82.9	18.6	21.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	116.0	0.0	0.6	0.3	0.2	0.1	0.0	4.0	0.1	0.1	0.2	0.0	0.3	119.0	0.1	0.6	242.2	41.8	34.6	0.6	0.1	0.1	0.3	1.0	88.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.9	9.3	13.7	8.1	8.0	14.6	24.9	15.6	19.1	16.4	22.5	21.2	2.4	105.8	11.2	3.9	0.2	14.5	30.4	98.5	14.8	1.4	0.5	19.9	8.4	2.8	18.8	0.0	4.2	2.0	0.1	0.0	0.0	0.5	0.7	1.6	37.6	22.4	0.0	0.0	2.6	0.0	2.1	123.1	0.0	2.8	1.3	3.4	6.4	0.0	6.5	0.0	3.5	0.0	8.2	0.0	14.0	1.8	20.2	5.3	7.2	5.6	116.3	97.7	0.0	19.6	0.2	0.4	0.0	62.8	0.0	15.8	0.0	0.0	5.4	3.4	0.0	17.0	8.4	1.0	8.2	3.9	7.0	2.9	1.3	0.9	0.0	3.4
PDSS2	"bA59I9.3, C6orf210, COQ1B"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152562-107459564	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 82.4;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	7.9	17.9	4.6	6.3	5.2	9.0	8.1	6.1	5.7	9.2	6.8	12.4	9.3	6.8	6.5	8.6	8.6	8.7	13.9	4.6	5.2	21.6	27.1	8.0	7.6	4.9	4.7	9.1	8.4	13.2	8.5	6.8	5.0	14.6	13.2	6.0	15.3	7.4	12.5	6.3	9.6	8.5	4.7	6.7	9.6	7.7	5.3	8.1	13.3	13.7	7.1	7.6	6.1	6.1	7.6	10.0	8.3	13.2	14.2	18.0	19.2	13.1	16.5	12.4	11.8	10.0	10.8	14.4	11.7	14.7	13.1	10.2	20.3	16.5	16.7	9.1	9.8	14.4	11.4	16.9	15.0	18.5	11.1	13.5	19.1	19.5	15.3	10.8	13.1	16.5	20.7	19.0	12.2	9.3	5.4	19.7	5.3	17.3	12.7	9.7	7.4	11.7	15.2	10.2	8.2	7.1	9.0	15.4	19.7	9.0	12.7	22.3	8.3	8.8	5.2	12.4	11.4	5.3	6.8	11.3	16.3	27.4	16.3	3.2	5.1	2.8	3.7	5.9	5.9	4.7	3.8	4.7	7.0	5.5	5.0	4.8	0.6	3.6	9.9	3.3	5.5	3.4	4.6	5.2	6.1	5.7	4.6	5.2	4.9	4.7	5.0	4.7	5.3	6.1	11.4	16.0	19.1	64.9	12.3	4.2	13.8	11.7	13.6	8.2	9.7	8.3	17.4	12.8	13.9	14.7	2.1	26.9	8.3	15.1	35.2	12.7	37.3	16.3	9.3	8.4	10.3	8.0	53.5	14.5	17.3	9.5	8.2	10.9	14.0	11.9	7.5	32.6	11.8	6.7	67.3	15.3	14.2	9.8	5.1	12.7	5.3	10.2	7.2	82.4	8.5	11.8	6.2	72.9	74.5	13.7	14.4	9.4	13.0	12.2	14.2	40.8	21.0	11.5	26.3	8.7	7.9	21.7	11.5	14.3	5.8	11.9	9.8	13.4	17.0	12.5
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920000-27926313	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 41.8;pancreas: 13.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	41.8	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	13.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.0	2.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	15.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	13.8	0.0	0.0	9.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0
PDZD2	"KIAA0300, PDZK3"	ENSG00000133401	"PDZ domain containing 2"	O15018	5	31639131-32110932	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 232.9;Excitatory neurons: 313.2;Oligodendrocyte precursor cells: 745.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 24.8;cerebral cortex: 15.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.1;EFO-21: 4.5;SiHa: 11.6;SK-BR-3: 10.6;T-47d: 5.5"	"Low region specificity"	"Detected in all"							"CAB020784, HPA036503, HPA036504, HPA064387, HPA076072"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB020784: , HPA036503: AB_2675161, HPA036504: , HPA064387: AB_2685252, HPA076072: "	"unprognostic (3.65e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.42e-5)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.79e-1)"	16.5	0.9	4.5	0.7	24.8	0.1	5.0	0.7	15.7	2.2	10.6	1.4	0.5	2.5	1.9	5.3	2.2	0.9	18.8	4.7	0.3	8.2	0.1	9.0	0.3	4.5	4.3	14.4	1.2	0.6	1.8	10.9	1.0	1.5	0.7	14.8	1.6	1.9	2.5	10.1	0.6	2.4	0.3	0.2	1.7	5.6	4.1	2.6	1.0	4.8	1.7	0.6	2.1	0.0	0.1	0.0	3.1	0.1	0.0	0.0	8.1	0.0	0.0	0.6	0.5	0.0	0.0	0.0	4.5	0.0	1.2	4.3	1.7	0.9	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	2.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	3.5	0.0	0.1	0.7	11.6	10.6	0.0	2.6	5.5	0.0	0.0	0.0	2.2	0.0	0.5	0.0	0.0	2.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	24.8	0.7	15.7	4.7	0.3	4.5	4.3	1.0	0.3	4.1	0.0	26.2	44.8	38.6	39.2	0.2	16.8	4.4	14.0	13.6	7.0	10.6	6.9	53.9	0.0	9.3	5.5	98.0	25.5	1.9	0.1	0.0	0.2	232.9	9.7	16.9	14.7	0.0	1.3	313.2	0.2	3.4	8.6	7.7	33.2	1.3	18.7	5.7	0.2	2.2	15.2	113.2	0.0	4.1	0.3	3.1	55.2	7.5	1.0	7.2	87.1	0.2	6.4	0.0	745.0	104.7	3.5	0.0	10.5	0.1	3.5	0.0	8.2	2.8	62.1	46.0	7.3	13.4	12.3	3.8	15.1	18.5	21.1	1.3	46.8	0.0	1.8
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 595.8"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 280.0;Proximal tubular cells: 1113.8"	"Group enriched"	"Detected in many"	4	"liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 14.7"	"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.2"	"Group enriched"	"Detected in many"	4	"RPTEC TERT1: 250.0;T-47d: 653.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.6	3.5	0.7	0.5	0.9	0.6	19.6	14.7	2.0	2.4	1.9	4.7	74.8	0.7	15.8	0.2	1.0	22.0	0.4	1.0	0.5	595.8	128.1	0.3	0.7	1.4	0.8	0.3	16.6	0.0	0.6	0.5	1.8	0.3	8.2	3.0	0.4	0.8	0.3	2.6	124.9	0.8	0.4	0.7	2.8	0.6	0.8	0.3	0.3	0.1	0.2	0.2	0.3	1.5	7.6	1.2	0.8	0.8	0.3	0.4	3.0	1.2	0.3	0.2	1.0	106.6	1.0	0.7	1.3	5.9	0.5	3.4	0.2	0.6	0.6	10.3	2.0	0.9	2.8	45.7	0.0	1.1	0.9	0.3	0.7	0.4	0.2	0.8	0.0	0.4	0.8	1.6	0.8	6.0	0.7	1.4	1.2	1.5	3.6	0.4	7.3	1.6	250.0	0.3	0.6	6.7	1.7	1.8	0.2	6.4	653.8	0.9	0.5	1.3	1.3	0.9	1.1	8.8	1.2	0.6	1.0	0.6	0.5	0.1	0.1	0.0	0.7	0.1	0.2	0.6	0.2	0.8	0.0	0.4	0.2	0.3	0.1	4.2	0.0	0.5	0.0	0.3	0.7	0.9	14.7	2.0	1.0	0.5	1.4	0.8	1.8	0.4	0.8	1.5	0.2	0.0	0.0	2.0	4.1	0.1	0.0	0.1	0.0	0.4	20.2	3.3	0.5	72.9	0.0	57.0	0.0	0.0	0.9	27.4	138.9	1.2	8.6	1.1	0.5	0.4	6.6	0.0	2.8	2.0	0.1	0.5	0.5	4.9	0.0	0.2	1.1	47.9	0.2	0.0	1.9	7.8	0.0	0.9	0.3	9.0	0.0	4.9	0.0	1.9	0.0	0.3	2.1	3.0	0.7	1.5	7.4	0.0	0.0	0.1	280.0	1113.8	0.1	0.5	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.1	4.1	4.3	6.5	0.1
PDZRN3	"KIAA1095, LNX3, SEMACAP3, SEMCAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382431-73624941	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 256.0;Excitatory neurons: 183.1;Inhibitory neurons: 258.3;Microglial cells: 329.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AF22: 32.1;ASC diff: 57.0;ASC TERT1: 29.6;BJ hTERT+: 42.0;HSkMC: 41.4;U-87 MG: 30.4"	"Group enriched"	"Detected in many"	4	"amygdala: 15.1;basal ganglia: 8.1;cerebral cortex: 19.5;hippocampal formation: 16.1;white matter: 7.2"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	29.9	35.7	14.9	10.2	16.3	0.0	24.0	8.5	20.9	45.2	58.0	84.0	9.2	64.1	24.5	27.8	26.7	27.4	48.0	16.7	10.6	10.7	2.1	14.9	4.5	13.0	11.8	69.4	6.9	0.8	4.6	17.5	11.0	31.7	13.9	6.3	20.9	29.0	91.8	17.3	24.4	38.4	13.1	2.4	38.7	6.4	17.1	2.9	3.6	22.4	1.4	46.7	32.0	13.2	0.0	0.0	32.1	0.1	57.0	29.6	0.1	16.9	42.0	5.0	3.2	16.2	0.0	0.1	0.1	22.8	0.8	0.0	0.0	0.0	4.8	0.0	2.2	0.0	0.0	0.0	9.5	0.0	0.1	41.4	0.0	13.8	0.1	6.0	0.0	0.0	0.0	0.0	4.9	2.1	0.0	0.2	4.6	0.0	0.2	0.0	8.4	0.1	0.0	0.0	3.7	10.5	0.0	7.8	12.7	9.2	4.5	0.0	0.0	20.6	1.5	23.6	2.2	0.7	0.0	0.2	30.4	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	14.9	16.3	8.5	20.9	16.7	10.6	13.0	11.8	11.0	13.1	17.1	13.2	5.9	0.0	0.0	256.0	0.5	2.4	9.7	0.0	1.8	19.3	7.5	7.6	65.0	0.0	0.0	5.5	6.2	0.5	2.7	1.0	1.9	0.0	0.4	2.1	45.2	2.3	21.1	0.0	183.1	0.4	0.5	25.2	2.0	3.3	0.0	35.0	0.0	0.0	0.8	0.0	258.3	9.1	0.0	0.0	2.9	1.3	23.3	0.7	16.0	329.8	0.0	22.5	0.0	21.6	5.5	0.3	0.9	28.2	0.1	10.9	0.1	7.1	0.0	1.9	0.0	4.6	19.6	0.5	6.2	2.9	1.8	0.8	0.5	12.4	3.9	6.3
PDZRN4	"DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4"	ENSG00000165966	"PDZ domain containing ring finger 4"	Q6ZMN7	12	41188320-41574745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 10.9;seminal vesicle: 17.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 371.6;Inhibitory neurons: 125.6;Oligodendrocyte precursor cells: 561.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"U-266/70: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042101	Enhanced		Approved	Mitochondria		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA042101: AB_2732496"	"unprognostic (6.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.41e-3)"	1.2	0.9	1.5	1.1	2.5	0.0	1.9	0.1	2.3	2.2	0.0	10.9	0.8	0.9	2.2	3.8	2.2	1.7	0.4	1.5	0.9	0.5	0.6	0.3	0.0	1.3	3.3	1.9	0.4	0.1	0.4	4.0	2.2	6.6	3.1	1.0	0.3	17.8	0.3	0.5	2.9	2.5	1.3	0.2	3.3	2.4	1.4	0.0	0.3	1.9	0.3	3.9	2.6	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.5	0.1	2.3	1.5	0.9	1.3	3.3	2.2	1.3	1.4	1.9	0.1	0.0	0.0	37.5	0.3	0.8	0.0	0.0	2.8	9.8	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.3	0.0	0.0	371.6	0.0	0.2	17.3	1.1	0.0	0.0	19.8	1.4	0.0	0.4	0.0	125.6	0.0	0.0	0.0	0.3	1.6	28.0	0.2	0.0	5.6	0.0	0.4	0.0	561.9	13.7	0.0	0.0	56.4	1.2	0.1	0.0	0.0	0.7	1.1	0.0	0.1	5.7	0.1	0.2	0.8	0.6	0.4	0.0	34.1	0.0	0.1
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		62000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	19.0	5.0	2.5	2.3	3.0	2.3	12.9	1.2	4.1	12.3	2.0	4.5	1.6	10.0	1.1	2.6	9.1	7.4	8.7	1.2	1.7	4.8	2.1	11.8	3.8	2.0	2.3	9.1	2.3	1.7	3.4	11.7	2.3	4.7	0.9	0.4	2.9	3.7	5.7	4.2	4.1	4.6	1.1	7.0	3.7	3.0	2.9	1.4	9.7	7.6	1.1	6.0	7.3	1.4	0.5	2.9	0.8	0.0	0.0	3.7	0.1	11.7	19.5	4.8	2.8	0.3	0.5	0.0	0.6	8.7	0.4	0.2	0.0	29.9	1.3	0.2	0.0	14.8	0.7	0.8	21.6	0.1	0.0	11.3	0.1	6.5	1.5	1.0	52.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	6.9	0.0	0.0	85.2	0.1	6.4	2.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	3.0	1.2	4.1	1.2	1.7	2.0	2.3	2.3	1.1	2.9	1.4	44.6	0.0	3.2	0.0	0.4	0.9	0.1	0.7	1.2	2.4	0.6	1.3	7.5	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.2	0.2	2.5	30.6	1.8	5.7	0.0	0.4	0.1	10.1	1.5	0.4	1.3	0.1	40.0	0.4	0.5	0.0	0.0	2.3	0.0	1.6	1.5	3.5	44.4	3.0	5.4	12.2	0.4	0.2	0.0	0.0	0.0	1.2	0.0	35.7	0.0	0.2	0.0	0.1	0.2	0.2	26.3	1.7	34.2	1.5	1.5	0.2	1.1	0.3	0.3	1.1	0.3	0.2
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 172.1;brain: 348.9;placenta: 467.0"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 2015.8;Syncytiotrophoblasts: 2856.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 773.3;HAP1: 1015.3;Hep G2: 805.0;SCLC-21H: 488.6"	"Region enhanced"	"Detected in all"		"hypothalamus: 110.7"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	3.2	172.1	101.2	2.6	111.9	0.9	24.6	43.7	46.4	7.5	0.0	5.5	0.8	5.6	1.9	2.3	10.0	3.2	1.6	43.5	331.8	7.3	2.4	15.4	5.1	55.2	122.0	65.1	11.4	2.1	88.3	467.0	136.0	2.7	2.0	23.0	9.1	2.6	2.2	0.6	1.5	3.9	32.2	2.0	2.8	41.1	348.9	13.2	11.4	3.3	3.2	3.6	1.6	23.0	22.8	111.6	773.3	329.0	16.0	28.5	45.0	60.7	35.3	42.8	57.3	187.6	37.0	2.5	2.2	70.2	87.5	6.9	1015.3	43.1	58.9	2.9	107.0	0.1	121.8	805.0	12.0	129.6	0.2	63.9	13.9	105.7	73.0	37.1	25.8	0.0	0.5	243.7	84.5	5.8	0.5	0.1	355.4	19.1	70.5	48.5	247.6	67.4	194.3	83.2	488.6	28.2	0.4	16.9	59.9	192.8	105.8	0.3	0.0	33.7	2.0	4.2	46.9	65.2	46.4	97.1	76.3	0.1	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	101.2	111.9	43.7	46.4	43.5	331.8	55.2	122.0	136.0	32.2	348.9	23.0	4.0	153.8	82.4	11.4	37.1	0.8	9.1	2.5	0.6	87.5	49.4	74.3	42.8	5.7	69.8	16.5	8.4	2015.8	3.3	0.9	64.6	18.1	4.5	9.7	3.0	8.4	60.4	0.0	15.8	5.3	205.1	45.3	2.0	15.4	2.5	24.2	4.2	4.7	175.8	37.0	21.9	0.6	8.2	0.0	0.6	18.9	9.0	1.7	14.2	4.7	0.0	109.0	0.0	10.1	12.8	5.2	0.0	4.1	1.5	9.6	0.0	22.0	8.9	29.7	6.6	173.1	23.0	52.9	51.5	2.5	0.9	2856.1	2.6	68.9	0.7	0.6
PEG3	"KIAA0287, ZKSCAN22, ZNF904, ZSCAN24"	ENSG00000198300	"Paternally expressed 3"	Q9GZU2	19	56810077-56840728	"Predicted intracellular proteins, Transcription factors"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 76.9;brain: 218.4;choroid plexus: 177.0;ovary: 260.1;placenta: 135.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 345.8;Granulosa cells: 224.1;Horizontal cells: 148.0;Syncytiotrophoblasts: 477.1;Theca cells: 395.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 103.6;Hep G2: 218.1;RH-30: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026070	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA026070: AB_10603328"	"unprognostic (1.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.48e-5)"	"unprognostic (6.92e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.68e-3)"	2.4	76.9	76.5	1.5	56.5	0.1	10.9	4.4	41.2	8.7	177.0	5.1	0.6	22.8	5.8	2.2	12.9	1.9	3.5	28.7	218.4	3.4	4.5	1.8	0.5	51.9	105.8	260.1	2.5	9.9	28.8	135.1	95.6	3.0	1.7	17.9	5.4	4.9	0.7	1.5	1.4	9.2	27.4	0.8	2.1	33.6	130.4	1.0	5.7	1.8	6.2	3.5	3.3	42.8	0.0	0.0	4.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	218.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.6	0.0	71.7	0.1	0.1	0.1	0.2	6.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	76.5	56.5	4.4	41.2	28.7	218.4	51.9	105.8	95.6	27.4	130.4	42.8	4.1	0.0	4.6	0.0	0.2	4.8	1.9	0.0	4.0	31.0	10.9	17.8	17.2	1.5	1.8	1.8	8.4	345.8	1.6	0.0	1.9	0.9	32.0	1.3	35.0	3.5	0.0	0.0	0.0	0.0	45.4	56.9	0.0	1.6	0.0	224.1	4.6	4.3	34.3	148.0	0.0	0.0	0.0	0.6	1.7	19.4	58.7	1.2	14.2	0.0	0.0	17.0	0.0	0.0	0.0	0.3	0.0	109.9	0.0	2.0	0.0	1.1	2.2	13.7	13.1	29.5	17.0	53.0	36.2	2.0	2.6	477.1	0.2	395.9	0.0	0.7
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144420	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 228.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 224.1;Plasma cells: 318.8;Squamous epithelial cells: 208.0;Suprabasal keratinocytes: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 76.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 76.9;monocytes: 23.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 58.8;U-698: 146.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Approved		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	27.6	7.9	10.2	28.1	14.4	228.5	25.7	11.9	13.5	17.9	9.2	18.6	17.6	17.3	8.6	42.9	12.7	26.1	11.8	13.8	11.2	10.6	13.5	31.0	24.7	12.2	11.2	5.5	9.3	37.9	15.8	15.6	12.2	8.9	20.1	5.1	18.9	7.7	7.1	29.7	23.2	13.9	12.6	21.8	18.1	10.7	10.9	28.3	9.7	10.0	29.0	22.4	23.7	15.6	3.6	2.8	36.5	24.6	4.2	3.2	8.3	4.8	5.4	4.3	6.8	58.8	4.1	48.3	11.3	1.7	1.6	5.8	11.1	10.5	8.6	12.2	8.9	4.4	1.7	9.5	12.4	4.8	8.3	4.2	8.1	6.4	21.6	4.5	24.3	18.2	2.7	11.7	3.7	0.3	10.6	6.9	23.8	11.1	1.7	13.2	12.6	28.1	17.7	10.8	16.7	23.3	3.6	5.5	12.9	11.3	3.0	3.3	17.5	4.0	5.7	4.0	7.1	27.0	2.8	146.7	2.1	4.3	10.9	15.0	15.6	15.0	0.9	14.1	1.7	8.5	4.8	1.9	5.4	6.6	5.6	2.5	76.9	3.0	23.2	0.5	11.6	6.6	10.2	14.4	11.9	13.5	13.8	11.2	12.2	11.2	12.2	12.6	10.9	15.6	94.5	28.9	49.2	4.6	84.4	224.1	74.6	48.2	105.9	1.7	60.9	50.3	5.7	15.7	52.0	5.5	0.0	1.7	16.9	57.9	1.9	5.3	10.6	34.6	26.4	52.1	25.7	3.4	23.4	26.7	8.6	24.5	75.4	58.7	15.2	6.3	37.5	7.5	22.8	3.3	19.1	23.4	30.5	67.6	103.7	11.2	1.5	107.0	112.1	119.9	30.6	5.5	3.1	82.9	67.9	20.9	45.9	1.9	318.8	44.7	32.7	9.6	43.6	2.0	0.0	10.1	51.9	8.4	9.6	208.0	217.5	4.0	49.4	3.2	32.4	145.8
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301524	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.3;Microglial cells: 100.2;Oligodendrocyte precursor cells: 150.8;Oligodendrocytes: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.3;JURKAT: 43.8;MOLT-4: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	11.6	3.0	8.1	4.3	7.8	18.6	7.7	27.9	5.9	6.7	5.4	7.0	11.0	6.7	2.5	4.4	6.3	10.0	2.9	5.6	6.6	9.2	2.8	6.7	4.0	8.8	10.9	15.0	28.6	1.9	2.7	3.1	9.3	4.7	3.9	15.1	7.7	3.5	2.4	5.9	9.2	3.3	8.0	6.8	14.4	10.0	10.4	19.1	4.1	3.8	2.0	10.6	5.7	9.2	0.1	3.1	8.8	0.0	4.8	7.2	0.2	1.2	4.2	0.9	0.1	0.2	0.7	0.2	4.2	2.5	0.0	0.9	6.9	0.0	0.4	2.3	2.4	7.9	13.0	0.0	4.1	1.1	33.3	4.5	0.4	0.0	0.0	4.8	1.6	43.8	6.0	0.1	0.9	0.0	39.5	0.4	14.5	0.1	1.2	19.2	0.5	1.8	3.6	15.4	17.5	0.0	0.8	0.1	10.2	5.5	0.0	6.3	0.5	2.6	4.4	0.8	4.4	0.7	0.1	1.0	4.6	5.4	2.6	0.9	1.9	2.4	0.3	1.0	0.5	0.1	0.3	0.2	1.3	0.4	0.2	0.1	5.6	0.3	0.8	0.3	0.0	0.7	8.1	7.8	27.9	5.9	5.6	6.6	8.8	10.9	9.3	8.0	10.4	9.2	13.9	0.0	10.0	114.3	7.7	14.3	10.4	1.7	9.6	30.7	7.1	7.7	2.7	8.6	6.7	12.9	29.2	0.1	11.8	15.0	3.9	5.9	3.7	23.7	14.5	18.0	7.2	5.5	13.5	14.1	0.1	13.5	34.1	21.2	5.7	5.7	17.5	1.0	1.2	21.9	22.1	7.9	2.0	19.7	14.0	5.7	17.1	20.3	17.8	100.2	22.9	9.7	10.3	150.8	77.5	9.1	6.0	18.0	5.6	7.8	12.4	10.1	8.8	19.7	13.1	5.4	22.0	2.0	24.0	4.7	18.3	0.1	6.2	5.6	3.1	12.6
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 209.5;kidney: 277.7"	"Group enriched"	"Detected in all"	4	"Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		860000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	53.2	56.0	28.5	26.9	35.5	14.3	43.6	35.6	30.5	36.9	33.5	44.2	180.5	49.7	9.9	42.8	34.2	31.2	24.3	28.7	30.9	277.7	117.8	38.1	30.7	36.2	30.8	35.9	27.1	29.3	42.5	21.9	36.3	23.6	14.8	11.8	33.6	22.9	35.6	43.1	209.5	24.5	34.6	38.2	33.6	18.3	33.4	20.8	37.0	23.2	21.3	40.1	28.2	43.4	43.2	118.7	26.4	53.1	114.9	44.9	80.6	37.4	65.3	45.6	52.7	104.7	34.2	18.8	53.5	73.2	33.9	11.2	39.5	28.5	23.4	51.3	50.4	107.7	24.6	108.3	91.6	29.6	128.8	63.6	29.0	38.2	18.3	27.8	56.4	34.4	22.7	49.4	44.2	54.3	19.0	11.7	46.2	79.6	48.8	45.3	41.0	51.2	39.4	108.8	40.3	106.4	64.2	31.3	62.5	18.2	25.1	36.3	56.6	48.3	46.6	62.3	41.8	45.2	59.1	13.1	49.5	48.2	65.8	113.7	117.2	8.3	75.5	123.6	65.5	49.6	74.0	69.8	100.6	50.5	47.1	55.6	6.1	55.6	92.5	31.0	76.1	119.6	28.5	35.5	35.6	30.5	28.7	30.9	36.2	30.8	36.3	34.6	33.4	43.4	56.9	22.4	27.4	11.4	29.0	19.4	32.9	36.0	11.4	33.3	16.2	24.4	13.3	52.9	23.8	73.5	4.2	21.4	32.6	17.6	197.6	77.2	8.0	15.0	20.1	50.7	17.3	25.4	19.9	44.2	67.3	38.6	18.3	13.0	57.6	41.9	52.8	180.3	227.2	62.2	14.9	35.6	30.5	59.7	40.9	13.2	49.4	75.3	67.6	15.9	102.2	73.6	34.0	21.6	24.3	33.8	79.3	60.5	31.5	22.9	833.0	1278.3	27.1	33.7	39.5	37.0	43.1	10.2	44.5	34.3	20.3	30.4	33.7	48.7	44.6	22.2
PER2	KIAA0347	ENSG00000132326	"Period circadian regulator 2"	O15055	2	238244044-238290102	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053136, HPA060510"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA053136: , HPA060510: AB_2684298"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.22e-2)"	12.2	3.3	4.7	5.0	5.2	8.4	14.2	7.2	5.8	11.9	2.4	7.6	5.1	10.2	5.7	13.6	7.9	12.3	5.7	5.7	5.1	3.9	12.4	7.1	4.7	5.2	5.7	7.8	14.4	4.2	9.0	2.9	4.4	9.3	6.2	5.1	14.1	8.9	11.4	17.0	8.0	4.9	5.4	4.8	13.4	11.8	4.7	4.1	8.8	7.6	6.2	8.7	8.2	4.7	1.6	11.7	2.4	4.2	0.1	1.2	8.2	1.1	4.1	1.5	1.4	1.8	5.8	10.3	1.2	2.7	1.5	8.6	2.4	3.5	2.2	2.9	1.7	9.1	6.2	8.2	2.0	13.8	9.2	1.6	8.3	1.8	6.1	1.5	0.8	4.2	4.5	6.3	1.3	7.7	6.9	15.2	3.5	7.6	2.3	16.5	5.5	3.3	1.5	3.3	9.7	1.2	2.9	6.3	1.8	0.7	5.9	8.5	2.1	3.6	4.2	2.8	4.1	7.1	1.8	12.3	6.7	5.9	4.5	2.1	1.2	0.3	1.0	2.2	1.6	1.5	1.6	1.2	1.4	1.5	1.5	1.6	1.0	1.2	2.1	1.8	1.2	0.3	4.7	5.2	7.2	5.8	5.7	5.1	5.2	5.7	4.4	5.4	4.7	4.7	24.9	16.0	30.1	18.6	9.9	73.9	61.7	21.3	38.1	20.6	67.8	33.8	5.7	31.5	46.9	27.6	2.1	9.2	27.0	22.5	7.9	7.5	9.6	69.7	30.1	15.6	24.6	6.9	20.9	10.4	6.3	39.8	52.5	86.1	9.5	3.3	11.4	35.8	3.9	11.8	13.9	35.1	18.3	10.1	25.3	4.7	11.1	12.4	24.9	5.6	5.3	13.5	2.1	9.0	7.2	7.6	35.3	18.4	10.9	15.0	10.9	5.5	44.2	7.8	6.6	110.1	32.2	31.3	17.0	38.4	85.4	13.0	13.6	3.7	36.9	33.9
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	33.3	41.0	26.3	29.2	28.6	35.5	32.2	26.7	30.5	31.8	27.1	29.6	21.7	35.5	21.2	43.6	29.4	20.2	28.8	26.9	26.2	38.7	48.2	26.2	32.3	27.1	27.2	34.2	57.3	30.1	21.8	21.5	27.6	32.9	19.6	9.2	29.3	21.5	48.8	45.3	28.2	22.5	25.8	34.4	35.7	40.0	27.0	23.8	27.1	20.0	27.3	35.0	31.9	30.0	132.2	146.6	53.0	113.7	59.9	58.4	81.6	84.7	69.6	141.6	110.0	170.6	55.2	177.2	74.4	97.0	110.3	89.4	163.9	153.5	103.1	76.4	159.8	85.9	80.8	149.0	149.3	209.6	86.8	82.7	94.7	148.3	147.3	68.3	93.0	62.4	144.6	69.9	87.7	164.3	102.6	209.8	103.1	128.3	106.7	129.0	91.7	173.3	78.9	88.7	91.4	94.6	84.2	94.6	117.8	42.0	66.8	106.1	74.2	165.9	126.1	85.3	145.1	88.1	81.0	178.6	116.2	94.9	109.0	7.5	24.9	6.4	18.9	29.8	23.2	20.2	17.4	18.1	26.8	20.0	19.4	18.0	0.9	20.0	22.3	23.2	14.3	29.3	26.3	28.6	26.7	30.5	26.9	26.2	27.1	27.2	27.6	25.8	27.0	30.0	23.6	3.2	18.9	4.9	17.4	22.6	23.4	32.7	22.2	6.5	14.1	12.2	3.8	24.3	22.1	25.8	8.4	34.9	7.8	19.6	25.4	48.0	44.4	11.7	13.8	23.2	23.4	24.6	4.3	43.9	40.0	15.4	22.4	10.6	18.3	24.4	27.8	22.8	38.4	3.3	4.3	22.4	22.4	27.8	12.6	14.3	19.9	21.2	21.4	2.8	29.0	13.5	16.5	6.6	5.1	38.7	16.2	20.3	28.3	26.4	31.3	55.1	24.6	8.9	19.7	23.2	20.7	28.7	20.9	25.9	22.9	28.5	13.5	19.9	29.7	15.1
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 1570.1;tongue: 1393.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 345.9;Horizontal cells: 121.1;Muller glia cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		410000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	18.7	54.2	50.4	11.0	50.9	8.0	15.0	58.1	59.3	28.2	50.1	34.2	10.4	36.1	14.3	38.6	29.2	15.9	298.6	49.4	63.3	46.0	8.4	14.9	8.0	54.5	51.1	45.1	10.9	136.2	36.5	12.0	58.7	29.0	16.1	85.5	29.2	39.0	1570.1	14.4	16.0	35.1	46.1	11.8	23.0	50.7	62.1	9.3	21.5	1393.9	10.2	27.7	19.2	43.4	32.9	30.6	98.4	87.5	97.2	72.5	20.2	85.4	80.2	77.1	54.4	76.3	40.5	192.9	69.6	44.1	44.9	36.0	90.1	91.2	70.9	5.5	43.9	54.7	64.7	1.9	54.3	2.9	30.9	102.1	50.4	69.2	107.3	125.1	85.9	3.7	64.6	91.7	71.5	25.8	69.5	5.1	67.7	36.0	93.9	115.7	55.7	141.3	48.4	32.5	111.5	82.6	51.0	75.9	86.5	78.7	80.3	11.2	75.8	34.0	46.5	49.5	72.1	52.8	145.3	106.4	62.4	6.8	28.5	0.3	2.9	7.8	2.1	2.5	0.9	8.8	3.5	2.1	5.6	8.3	4.3	2.4	0.7	2.1	2.1	0.9	3.5	3.1	50.4	50.9	58.1	59.3	49.4	63.3	54.5	51.1	58.7	46.1	62.1	43.4	8.6	16.0	8.4	30.3	6.9	7.4	21.7	22.1	15.9	43.3	5.6	9.1	345.9	12.8	10.8	22.0	43.8	2.8	0.9	3.4	66.5	10.6	43.1	5.5	18.0	17.3	9.1	8.6	23.2	2.5	3.8	27.1	6.6	2.4	1.3	17.3	13.9	2.7	4.1	121.1	30.0	9.1	34.6	3.8	3.7	27.0	30.7	4.3	55.2	3.7	11.3	125.7	4.1	15.6	3.4	3.5	1.9	47.8	4.6	7.9	2.7	30.6	11.2	51.1	26.3	37.6	24.5	52.1	14.4	9.2	5.3	2.5	3.3	24.0	10.1	9.7
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137718	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 277.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 459.8;Late spermatids: 516.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol		No	No		1900000	"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018257: AB_10960391, HPA056484: AB_2683147"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.55e-4)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	35.0	11.5	41.6	41.5	39.3	14.4	23.5	13.8	49.9	26.3	61.7	43.8	48.8	55.5	5.6	67.1	34.9	34.1	128.6	60.4	65.0	44.6	4.7	19.1	32.5	30.7	50.9	19.1	15.9	15.2	29.9	15.5	58.0	35.6	30.7	277.0	39.8	62.0	70.4	40.3	59.6	44.1	8.3	19.1	36.8	141.1	47.0	29.7	38.5	21.0	21.2	64.7	42.8	31.7	314.8	420.2	25.9	0.6	26.8	56.9	336.9	187.2	66.6	186.2	222.8	444.5	320.4	37.0	147.8	134.9	174.9	243.0	141.7	292.3	173.1	102.1	111.0	132.0	189.1	24.2	65.2	53.7	203.4	27.0	61.2	190.0	96.0	273.7	367.8	153.7	37.0	1.3	195.7	239.8	182.5	44.4	42.9	133.9	149.3	138.8	46.9	150.1	185.7	115.9	69.5	64.7	133.7	111.0	172.0	307.8	93.7	80.3	449.2	124.6	65.3	380.5	199.3	195.4	200.1	135.7	331.0	98.0	78.5	30.8	8.5	2.9	26.8	4.2	21.2	13.7	26.2	25.0	14.5	15.3	9.6	15.4	1.3	26.7	1.6	22.5	37.6	16.5	41.6	39.3	13.8	49.9	60.4	65.0	30.7	50.9	58.0	8.3	47.0	31.7	30.5	3.2	7.0	128.6	14.8	28.7	58.5	96.8	14.8	40.4	10.3	7.7	147.4	8.6	57.9	64.4	54.2	7.8	16.3	72.6	43.0	115.7	459.8	41.2	9.0	36.0	37.2	10.3	49.4	10.8	205.8	25.9	35.7	63.8	55.9	25.8	14.6	0.7	33.9	42.1	25.9	23.1	124.1	7.6	31.4	516.3	7.5	14.3	19.6	15.0	15.4	113.1	16.5	16.1	6.7	116.8	57.2	6.8	14.2	80.9	53.2	5.9	62.6	133.4	13.1	43.2	34.6	149.4	3.5	25.1	22.6	26.5	28.8	11.2	28.9	64.2
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426191-97433444	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 791.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Supported	Nucleoplasm		NA	NA		120000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	149.0	294.7	228.7	153.6	249.7	180.0	122.1	252.9	265.0	184.3	275.1	162.9	151.5	153.7	98.6	436.7	117.2	106.6	275.7	256.1	266.0	167.6	182.5	121.7	165.7	241.7	242.7	133.3	81.8	191.3	150.8	156.6	280.9	107.3	141.9	420.7	164.7	156.5	56.5	206.9	141.4	177.9	228.3	139.6	133.2	87.5	278.8	124.9	86.9	70.2	229.7	186.6	233.3	224.7	1160.6	538.9	364.0	697.9	336.7	307.7	494.1	722.4	938.4	830.2	1148.3	589.4	335.4	609.1	482.7	619.2	333.4	706.8	639.8	1051.4	998.1	567.2	611.7	393.6	386.4	667.5	248.4	570.0	503.9	303.2	422.5	552.7	408.7	1118.9	610.8	447.2	262.0	334.0	884.8	478.3	514.7	697.8	559.0	331.8	637.8	384.2	333.6	484.0	646.0	431.1	79.1	370.1	388.6	229.2	381.2	564.9	625.0	472.9	463.8	441.5	385.2	394.8	844.0	499.0	593.1	556.1	1023.3	937.5	209.3	242.5	433.5	572.7	217.0	366.6	192.3	134.8	183.8	216.9	309.7	114.7	117.5	164.9	312.6	149.4	422.7	110.5	265.6	580.2	228.7	249.7	252.9	265.0	256.1	266.0	241.7	242.7	280.9	228.3	278.8	224.7	92.9	44.8	44.4	23.8	122.2	187.0	173.1	394.2	124.1	403.5	77.8	76.7	22.9	85.8	140.8	106.7	77.2	495.8	122.3	233.9	358.1	321.8	15.1	50.2	113.7	145.9	48.1	71.1	29.4	205.8	791.9	146.0	68.8	72.0	103.4	109.5	96.8	193.7	395.1	387.0	35.7	116.7	152.5	170.0	129.1	27.0	149.5	174.6	131.6	16.9	376.9	404.4	174.0	14.1	19.9	295.7	132.9	234.3	254.9	175.2	283.0	274.8	72.1	300.5	203.8	73.1	199.9	38.0	114.7	253.3	204.7	372.6	138.0	257.8	176.4	269.6
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 1132.9;skeletal muscle: 4350.5;tongue: 1754.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 539.1;Late spermatids: 1891.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		38000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		4.1	3.7	32.9	0.1	37.7	0.1	2.9	40.9	43.1	2.8	28.9	2.1	2.0	1.8	0.7	58.9	2.3	2.4	1132.9	29.3	45.0	10.6	1.8	2.0	0.3	33.8	39.8	2.0	2.1	4.0	13.5	0.1	46.0	16.5	0.3	4.3	33.6	0.6	4350.5	1.8	1.3	0.5	30.8	1.2	1.7	193.9	46.8	23.9	5.1	1754.5	0.5	0.7	1.9	39.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	65.8	7.0	0.0	0.3	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	32.9	37.7	40.9	43.1	29.3	45.0	33.8	39.8	46.0	30.8	46.8	39.8	0.7	0.0	0.0	6.8	1.2	1.1	0.3	0.1	0.6	15.6	0.2	0.6	0.0	0.0	0.3	0.0	10.4	0.0	0.0	0.2	80.3	0.1	539.1	4.0	0.4	1.5	22.9	0.0	0.1	0.5	0.0	0.6	1.5	5.6	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.4	4.1	0.3	1.4	1891.7	7.8	1.5	1.8	1.9	0.0	5.6	0.0	1.0	0.5	0.3	1.2	6.0	1.4	0.2	0.4	9.2	0.1	4.6	26.3	78.3	18.6	187.6	7.0	0.2	0.6	0.0	0.6	0.1	0.2	0.5
PGAM4	"dJ1000K24.1, PGAM-B, PGAM1, PGAM3"	ENSG00000226784	"Phosphoglycerate mutase family member 4"	Q8N0Y7	X	77967949-77969638	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 2.3;Basal respiratory cells: 1.6;Langerhans cells: 1.5;Melanocytes: 3.6;Suprabasal keratinocytes: 2.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 1.3"									"HPA042528, HPA060483"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"		"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"unprognostic (3.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.52e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-3)"	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	1.3	0.4	0.1	0.4	0.0	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.8	1.0	0.3	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.0	0.6	0.2	0.1	0.5	0.2	0.2	0.2	0.0	0.2	0.4	0.4	1.0	0.5	0.4	0.3	1.0	0.7	0.1	0.5	1.0	1.5	0.5	1.0	0.4	0.3	0.5	0.5	0.8	0.3	0.3	0.5	0.6	0.4	1.1	0.2	0.9	1.7	0.1	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.1	0.1	0.0	0.0	0.0
PGAP6	"M83, TMEM6, TMEM8, TMEM8A"	ENSG00000129925	"Post-glycosylphosphatidylinositol attachment to proteins 6"	Q9HCN3	16	370788-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 63.7;Hofbauer cells: 29.2;Syncytiotrophoblasts: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 36.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 129.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	23.5	25.5	13.5	18.0	15.1	30.0	20.1	11.8	17.7	17.7	14.5	39.6	31.4	19.2	24.8	31.9	17.7	16.4	37.7	12.8	11.0	59.4	57.6	36.2	17.0	14.6	12.6	12.2	102.8	19.3	28.8	34.8	13.5	30.3	10.3	5.6	40.8	12.5	36.1	11.3	38.5	8.8	11.9	36.0	53.9	63.3	16.0	11.7	28.0	10.1	7.9	23.4	14.3	14.6	12.7	32.8	18.4	33.9	24.7	22.1	36.7	35.5	36.6	17.7	25.3	129.2	57.9	13.4	47.1	34.5	27.3	17.8	8.4	39.2	4.9	38.5	31.1	22.1	23.1	74.8	56.9	16.9	40.4	25.7	11.6	27.4	7.9	18.0	41.4	14.8	36.2	20.1	22.6	78.2	23.9	33.2	29.2	20.1	12.9	51.0	21.0	31.2	28.8	32.0	21.9	25.2	19.8	19.7	106.3	9.6	35.7	33.4	61.1	50.2	53.6	35.2	19.2	40.3	21.6	27.0	25.5	17.8	32.5	7.1	7.6	10.1	10.7	8.6	8.3	2.5	8.1	8.3	3.9	2.6	10.7	8.0	36.0	1.5	6.1	4.2	6.6	5.7	13.5	15.1	11.8	17.7	12.8	11.0	14.6	12.6	13.5	11.9	16.0	14.6	11.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	63.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	7.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	100.2	1.4	0.0	0.0	0.0
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420511	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 400.2;esophagus: 572.4"	"Cell type enhanced"	"Detected in all"		"monocytes: 214.9;Squamous epithelial cells: 496.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1060.2;classical monocyte: 321.0;eosinophil: 1074.7;neutrophil: 332.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 1074.7;monocytes: 321.0"	"Cell line enhanced"	"Detected in all"		"A549: 1445.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		41000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	115.8	51.0	49.5	59.8	49.2	400.2	89.0	52.9	49.3	75.9	52.5	52.9	91.6	23.1	41.9	572.4	30.0	94.2	34.3	47.4	54.3	53.2	81.3	88.5	38.1	57.0	54.6	35.7	32.0	52.7	43.8	47.4	55.4	30.4	46.3	49.1	133.7	22.9	34.7	50.0	70.7	35.0	49.7	110.4	61.4	68.3	59.2	53.6	71.8	28.2	73.8	61.8	126.9	52.0	191.5	1445.2	319.3	340.6	445.4	274.0	71.8	124.8	185.9	144.4	195.3	219.2	190.4	163.5	151.0	109.2	202.4	148.0	225.6	192.1	96.4	127.5	199.9	227.8	264.3	452.1	136.3	390.9	249.7	196.5	92.2	229.4	55.5	186.9	344.0	223.0	305.3	145.7	183.5	202.5	321.4	179.4	194.7	221.0	109.1	252.7	298.1	312.2	199.6	105.5	178.0	154.1	99.1	153.5	137.5	196.7	173.3	308.5	369.3	81.1	149.6	98.3	134.5	111.6	256.0	323.5	175.1	393.9	73.6	1060.2	321.0	1074.7	23.2	137.7	26.5	33.1	21.4	20.8	144.6	23.3	21.1	22.3	332.6	19.7	105.6	98.7	23.1	225.0	49.5	49.2	52.9	49.3	47.4	54.3	57.0	54.6	55.4	49.7	59.2	52.0	7.4	19.2	35.0	11.8	24.9	13.0	30.8	78.0	70.6	7.8	30.4	18.5	11.0	50.1	73.2	20.2	18.8	134.6	29.8	24.3	52.8	52.1	10.9	17.8	18.6	22.6	23.4	55.7	8.6	40.3	40.7	37.5	41.8	24.5	25.9	53.9	16.1	66.2	134.6	1.7	12.6	30.2	59.0	163.8	30.9	13.4	17.1	150.9	17.8	4.7	214.9	16.5	10.3	13.6	9.0	38.7	26.7	10.5	41.9	43.5	66.6	55.1	46.2	20.2	19.7	23.4	21.5	41.5	38.4	496.0	16.6	81.3	19.4	27.3	51.7	76.1
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955626	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.5;thyroid gland: 52.5"	"Group enriched"	"Detected in many"	11	"Extravillous trophoblasts: 1604.4;Syncytiotrophoblasts: 2122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"BEWO: 422.4;HUVEC TERT2: 199.1"	"Low region specificity"	"Detected in all"							HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	No	No	20800		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	11.8	4.9	7.4	7.8	7.6	0.1	11.3	7.3	11.7	22.4	20.2	7.0	2.4	7.6	1.4	10.0	21.8	5.9	18.8	8.7	20.6	8.1	6.0	7.2	6.4	9.5	15.7	6.4	4.9	8.4	5.5	50.5	9.3	19.3	2.0	1.2	10.5	10.3	9.9	15.7	12.5	7.8	7.0	3.3	4.8	3.2	8.6	3.9	52.5	5.9	3.3	13.6	14.8	7.8	1.4	1.5	1.3	1.3	2.0	0.2	422.4	4.0	3.6	1.8	2.2	10.9	0.6	0.3	9.1	2.8	0.2	0.5	1.8	19.2	1.6	0.2	2.4	0.0	0.1	11.3	1.5	0.2	11.0	4.7	4.5	7.5	1.8	0.5	199.1	0.0	0.0	0.1	55.6	0.9	0.0	0.5	2.1	0.1	3.4	0.2	51.3	0.0	0.5	1.0	31.0	17.0	0.0	0.8	7.7	25.0	0.1	0.5	40.6	0.3	10.2	0.1	17.0	0.4	0.2	0.7	6.3	0.5	0.5	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	7.4	7.6	7.3	11.7	8.7	20.6	9.5	15.7	9.3	7.0	8.6	7.8	32.4	9.6	4.6	1.0	1.0	24.6	10.3	111.4	34.7	1.3	8.9	16.0	3.6	0.0	26.0	0.0	14.6	83.8	2.4	2.0	0.0	2.7	0.1	1.1	3.3	169.4	7.1	2.7	0.1	0.5	1604.4	30.8	1.1	0.8	6.3	0.2	5.3	0.3	37.4	0.0	0.2	2.1	18.3	0.6	8.9	0.8	13.1	2.1	21.4	0.0	0.0	1.9	0.0	0.0	0.2	0.5	1.2	19.5	0.2	3.2	0.6	1.1	12.1	7.8	105.2	7.1	86.4	0.2	6.8	8.1	19.6	2122.6	3.0	3.0	2.3	5.8
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289126-296107	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 657.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 160.3;Alveolar cells type 2: 81.8;Breast glandular cells: 35.1;Club cells: 31.6;Collecting duct cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 132.8;U-266/70: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA039383: AB_10796225, HPA058829: AB_2683830"	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.12e-4)"	25.3	5.6	5.8	41.6	5.8	16.3	41.9	5.5	25.6	56.0	6.8	25.2	50.5	21.6	32.7	14.1	34.6	18.9	18.8	5.4	5.8	116.4	77.8	67.0	63.5	6.9	6.4	8.7	657.7	2.9	12.5	7.3	8.2	34.6	6.3	0.6	36.2	46.1	4.5	8.6	103.0	3.0	5.7	101.9	18.5	6.3	7.1	37.4	74.4	3.2	17.6	21.5	22.6	6.3	5.4	5.8	10.5	11.7	4.2	3.7	8.2	4.2	3.4	2.4	2.1	5.0	15.0	0.0	5.3	5.1	5.1	3.3	0.9	1.9	0.3	13.3	4.0	2.5	4.2	6.8	5.3	0.3	22.8	13.8	1.5	0.9	0.7	8.9	8.1	132.8	10.5	15.9	1.3	7.7	24.0	12.1	8.3	1.8	1.0	21.5	2.1	7.8	5.6	1.8	0.1	2.4	1.5	7.8	7.2	4.6	5.7	2.9	7.5	4.9	7.0	1.5	0.5	34.8	1.0	6.0	0.8	4.3	5.8	1.2	0.7	1.0	6.1	3.2	5.1	1.5	1.0	3.3	0.5	1.5	2.1	4.5	3.7	5.6	2.5	2.0	0.1	2.2	5.8	5.8	5.5	25.6	5.4	5.8	6.9	6.4	8.2	5.7	7.1	6.3	17.8	160.3	81.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	35.1	26.8	0.0	0.0	31.6	33.1	0.0	0.3	29.8	0.0	0.0	4.9	0.0	12.5	12.0	4.5	0.0	0.0	0.0	8.3	3.3	4.2	0.0	17.6	6.3	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	16.1	0.0	0.0	2.9	10.2	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	14.4	0.9	0.0	0.0
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593411-63660245	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 1559.1;tongue: 788.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 238.4;Extravillous trophoblasts: 185.9;Hepatocytes: 214.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Supported	Cytosol		NA	NA		21000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	113.7	70.8	31.6	20.7	34.7	21.5	57.4	34.3	38.4	33.9	53.1	58.9	60.8	22.9	19.2	49.3	17.0	30.3	178.9	31.4	34.0	52.2	279.8	42.6	14.7	44.7	34.1	51.0	112.2	65.3	31.8	26.9	32.7	46.6	49.9	22.6	41.8	49.7	1559.1	30.6	55.1	41.4	31.9	14.7	30.6	11.1	36.5	14.3	27.5	788.0	19.4	38.4	22.1	30.2	113.4	47.0	17.3	57.0	111.0	81.4	138.6	45.7	61.8	48.9	79.0	38.8	51.3	35.8	93.2	71.2	107.4	26.5	24.0	96.3	55.9	44.0	32.1	75.3	72.6	40.3	91.6	66.8	4.3	103.4	60.7	57.1	88.5	129.8	29.6	36.3	0.1	46.3	78.8	6.9	19.6	36.7	78.3	3.4	73.9	26.8	80.0	11.8	70.0	35.3	10.4	66.7	100.0	103.0	157.4	78.6	32.4	25.2	3.1	71.6	36.0	64.0	39.4	29.1	45.5	57.8	117.0	58.0	31.5	46.0	33.2	49.2	40.5	22.4	32.7	22.4	23.5	31.0	48.4	11.8	21.0	24.7	38.7	43.9	21.2	13.9	20.4	35.4	31.6	34.7	34.3	38.4	31.4	34.0	44.7	34.1	32.7	31.9	36.5	30.2	8.4	93.0	29.4	48.3	16.9	17.8	29.0	58.8	47.8	9.2	33.8	21.8	139.2	48.6	24.2	16.5	10.4	76.6	14.2	81.8	88.0	55.9	32.0	8.2	12.1	12.7	13.1	5.7	17.9	238.4	185.9	37.0	27.0	13.5	5.1	134.3	15.0	214.4	24.6	0.0	26.3	47.5	20.3	17.0	10.8	8.5	22.1	13.5	26.6	4.7	32.8	75.8	29.9	32.2	9.8	70.5	31.6	38.0	40.4	29.2	90.2	74.8	17.0	11.4	13.1	53.4	25.5	5.6	10.1	57.3	18.2	58.8	19.0	20.2	81.5	19.0
PGM2L1	"BM32A, FLJ32029"	ENSG00000165434	"Phosphoglucomutase 2 like 1"	Q6PCE3	11	74330316-74398433	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 90.1;Exocrine glandular cells: 124.5;Pancreatic endocrine cells: 140.1;Respiratory ciliated cells: 95.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 16.6;LHCN-M2: 19.9;RH-30: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056995, HPA060948"	Enhanced		Approved	Mitochondria		No	No		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Mitochondria		"HPA056995: AB_2683305, HPA060948: AB_2684394"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.28e-3)"	"unprognostic (8.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.16e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.03e-2)"	1.9	2.6	17.6	3.7	22.1	3.2	1.9	0.0	21.5	4.9	0.0	3.2	1.3	4.4	0.8	1.0	3.2	3.3	1.1	23.1	16.2	1.6	1.0	1.8	3.0	1.9	4.5	0.9	3.1	0.7	3.9	1.1	2.2	2.9	3.5	2.6	2.6	1.3	5.9	0.7	1.5	4.0	0.3	1.5	2.1	1.3	5.7	8.1	2.7	11.1	2.7	6.4	1.9	7.8	2.7	3.8	14.5	2.7	4.3	1.9	0.4	3.5	2.6	3.0	3.3	1.4	6.8	0.3	8.5	2.3	5.3	1.3	2.9	0.7	2.8	1.1	1.5	2.1	2.0	1.1	0.5	2.4	3.2	1.0	0.7	6.8	1.2	3.2	16.6	5.0	2.8	1.8	19.9	0.3	9.9	2.1	2.9	2.0	3.3	3.1	18.9	0.1	7.8	0.5	0.7	2.9	5.7	1.3	2.6	3.9	0.2	0.4	14.0	6.6	6.0	2.7	3.7	2.4	3.8	0.3	0.6	3.4	1.6	1.2	0.3	0.5	0.9	0.3	1.3	1.1	1.6	1.1	0.2	0.8	1.5	0.8	0.3	1.4	0.2	0.8	3.9	0.5	17.6	22.1	0.0	21.5	23.1	16.2	1.9	4.5	2.2	0.3	5.7	7.8	19.6	6.4	6.4	8.5	20.9	7.6	41.2	14.3	10.8	23.9	26.5	19.4	7.3	17.2	30.2	9.2	16.7	0.6	17.6	13.8	5.9	37.4	14.1	28.1	23.5	32.1	11.9	47.5	90.1	124.5	5.3	21.0	7.1	25.5	8.2	16.1	29.3	1.0	5.4	8.4	64.8	16.2	18.3	23.0	21.6	3.6	2.5	9.9	16.0	20.6	4.6	4.4	12.3	14.6	7.1	140.1	9.3	3.8	13.4	50.4	4.2	5.3	95.4	11.0	26.3	21.3	16.7	34.2	21.2	9.0	5.3	0.1	25.0	8.8	20.9	55.6
PGM5	PGMRP	ENSG00000154330	"Phosphoglucomutase 5"	Q15124	9	68328308-68531061	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell adhesion, Glucose metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 269.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107.2;Endothelial cells: 36.6;Hepatic stellate cells: 39.3;Microglial cells: 124.6;Sertoli cells: 52.6;Smooth muscle cells: 35.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	48	"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.8"	"Group enriched"	"Detected in some"	5	"hTERT-RPE1: 28.7;PC-3: 56.5;RH-30: 38.8;SK-BR-3: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034397, HPA046329, HPA067102"	Enhanced		Uncertain	Cytosol		NA	NA		450000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758"	"unprognostic (3.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.28e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.83e-5)"	"unprognostic (3.04e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.73e-2)"	28.9	61.0	3.7	12.6	4.1	0.0	21.0	5.8	3.8	51.7	3.3	269.4	15.4	154.0	40.8	98.6	96.5	19.6	126.1	3.1	4.1	11.5	5.1	14.6	5.8	4.6	4.0	19.8	2.7	5.0	4.3	5.8	4.3	159.0	34.2	8.0	6.7	214.0	37.5	11.1	72.0	132.5	4.7	10.8	65.2	3.0	4.6	2.9	13.1	30.5	2.9	216.7	40.6	4.6	0.2	0.2	0.0	0.0	0.7	0.0	0.3	8.2	6.3	3.8	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	9.2	0.0	9.4	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.1	0.0	4.1	0.1	0.7	0.0	0.0	56.5	0.0	38.8	1.8	1.5	0.0	0.0	0.2	0.1	47.8	2.8	1.2	0.0	0.0	0.1	0.0	5.7	0.3	0.3	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	3.7	4.1	5.8	3.8	3.1	4.1	4.6	4.0	4.3	4.7	4.6	4.6	21.6	0.0	1.7	0.7	0.2	2.3	5.6	0.0	0.6	25.3	0.2	1.5	107.2	2.8	1.8	12.9	4.2	0.0	0.1	0.1	1.9	0.1	1.8	3.7	2.8	36.6	0.0	4.0	1.4	0.0	0.2	12.4	0.0	1.1	0.0	18.7	39.3	0.1	0.1	0.0	1.7	2.7	0.0	4.0	2.8	0.5	8.1	2.1	3.6	124.6	1.0	8.3	0.0	1.0	2.3	0.1	0.1	4.9	0.0	2.1	0.8	1.2	0.8	1.9	52.6	1.7	35.9	0.1	0.2	0.4	2.4	0.0	0.6	30.0	1.6	1.5
PHC3	"EDR3, FLJ12729, FLJ12967, HPH3"	ENSG00000173889	"Polyhomeotic homolog 3"	Q8NDX5	3	170086732-170181749	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 156.5;Rod photoreceptor cells: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039162, HPA062031"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA039162: AB_10671038, HPA062031: AB_2684666"	"unprognostic (4.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.76e-2)"	9.1	7.4	3.7	12.7	9.1	50.8	10.5	29.3	8.9	9.0	6.3	10.5	11.2	12.2	8.1	12.4	10.2	12.9	8.1	2.0	14.3	9.7	8.7	9.7	18.1	6.5	2.9	14.9	11.3	15.1	5.4	8.4	7.8	11.6	11.3	42.0	8.9	8.6	8.7	8.5	12.3	13.5	0.0	13.9	11.8	11.5	5.5	16.8	16.6	14.0	14.1	11.8	7.4	14.0	35.0	32.3	6.9	11.6	19.2	19.4	12.8	14.6	16.5	14.8	18.2	21.6	17.0	16.5	34.8	20.5	19.7	17.1	15.3	14.1	26.6	38.3	14.2	28.5	30.2	10.0	11.3	35.4	14.8	14.0	8.1	22.1	31.0	10.9	11.1	12.7	6.9	45.0	14.6	32.3	16.2	7.4	7.2	11.3	11.9	12.0	29.5	24.0	7.4	38.7	7.5	4.6	48.1	29.8	9.8	4.5	34.6	27.0	22.3	20.5	12.1	17.1	25.4	43.0	37.6	48.1	12.8	13.1	12.6	9.5	7.0	25.7	16.2	11.2	13.8	16.8	15.2	14.1	7.8	21.6	15.6	13.8	10.2	13.3	7.3	26.0	20.2	7.5	3.7	9.1	29.3	8.9	2.0	14.3	6.5	2.9	7.8	0.0	5.5	14.0	26.8	22.4	31.9	77.4	46.2	14.1	16.9	16.1	19.9	36.3	16.4	12.1	22.7	18.6	18.7	27.6	60.5	15.5	45.9	11.1	0.0	8.9	5.5	18.7	34.5	21.3	7.8	28.8	108.2	7.5	9.6	25.1	25.0	19.0	12.7	35.9	19.6	17.8	11.1	53.8	103.2	14.1	16.2	21.6	22.6	3.8	29.5	22.5	19.6	105.9	25.5	21.9	32.0	103.0	156.5	10.4	16.7	27.8	45.6	22.8	16.4	10.7	24.1	126.2	6.6	29.8	26.4	21.0	19.3	17.8	15.9	18.3	40.4	25.7	14.4	19.6
PHF21A	"BHC80, BM-006, KIAA1696"	ENSG00000135365	"PHD finger protein 21A"	Q96BD5	11	45929319-46121454	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 172.4;Excitatory neurons: 171.0;Inhibitory neurons: 140.0;Microglial cells: 138.7;Oligodendrocyte precursor cells: 250.3;Oligodendrocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 34.9;neutrophil: 31.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 34.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023253, HPA023580"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA023253: , HPA023580: AB_10962727"	"unprognostic (5.30e-3)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (2.59e-8)"	"unprognostic (1.89e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.21e-1)"	13.1	17.4	18.5	20.5	25.1	28.8	11.0	39.1	23.8	12.9	5.4	18.5	7.0	17.2	10.7	11.4	12.9	12.6	17.4	13.2	20.7	7.9	8.0	17.3	16.8	17.0	17.9	24.1	8.6	16.5	12.8	13.1	15.8	12.1	9.5	16.7	9.9	11.3	15.3	13.5	10.4	16.7	12.0	17.4	10.0	23.7	26.8	17.8	12.8	12.8	14.8	14.0	11.6	27.3	7.3	19.1	36.8	35.6	14.8	22.5	4.9	14.6	25.4	12.3	20.5	3.7	11.2	30.4	10.3	14.2	19.3	8.2	22.0	9.4	12.4	34.0	15.3	17.2	19.9	7.7	17.6	12.5	25.9	20.6	21.3	7.1	20.2	30.2	18.4	21.1	21.0	48.2	14.5	6.9	13.6	20.6	31.9	9.3	11.3	22.8	18.2	10.4	12.6	12.2	24.1	31.7	21.6	10.9	16.0	23.6	19.7	23.5	18.8	20.2	16.3	16.9	12.0	52.5	46.2	20.8	16.1	13.6	16.3	34.9	7.8	4.1	6.1	3.9	5.1	5.0	4.7	5.4	4.3	4.2	2.8	4.8	31.3	5.6	7.2	2.9	6.0	4.1	18.5	25.1	39.1	23.8	13.2	20.7	17.0	17.9	15.8	12.0	26.8	27.3	13.9	12.8	17.7	172.4	25.2	10.3	8.8	11.2	22.2	25.5	11.8	12.1	25.7	10.0	10.5	3.7	27.1	4.3	26.1	4.8	1.9	10.0	9.0	10.3	26.8	15.0	23.4	18.7	171.0	6.3	3.4	18.3	12.8	11.1	16.5	30.1	12.5	5.5	10.0	15.2	140.0	6.8	4.1	25.4	12.4	8.2	26.1	23.9	10.6	138.7	35.6	7.9	37.0	250.3	231.3	5.5	6.5	14.7	21.8	7.6	5.6	3.9	15.4	23.3	13.1	18.6	18.8	16.9	16.9	19.0	8.8	4.2	19.5	19.2	6.2	5.7
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744218	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 135.0;Exocrine glandular cells: 136.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 25.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 975.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	51.4	3.0	113.6	9.4	125.3	11.4	30.1	130.7	125.9	46.1	89.1	27.2	7.6	25.4	79.6	56.6	49.3	7.6	22.4	108.8	128.8	40.9	126.0	18.0	14.9	121.8	113.9	46.1	171.1	103.9	23.7	13.2	122.4	52.6	7.0	7.5	156.2	33.5	2.6	92.5	13.3	15.0	117.0	6.5	41.7	40.3	115.8	34.0	29.5	4.3	13.3	35.8	62.9	153.6	156.8	35.2	148.0	444.6	64.9	82.8	286.1	101.0	209.3	132.9	257.6	195.7	28.6	0.1	58.1	270.5	16.6	205.6	216.8	224.6	83.9	1.1	162.1	29.1	151.3	153.3	135.7	214.3	1.7	147.6	338.6	146.8	142.2	83.0	100.1	519.7	71.4	443.9	66.8	380.9	222.8	90.1	440.0	93.3	274.6	228.0	181.1	24.8	9.6	120.4	160.8	146.0	65.9	63.9	975.9	103.9	164.8	505.7	0.9	38.3	172.1	207.3	134.8	294.0	79.9	246.1	456.9	328.2	302.7	5.3	1.1	0.2	4.7	0.3	0.2	11.1	2.4	8.2	5.3	4.0	13.0	25.2	2.2	1.8	0.3	2.6	4.5	6.3	113.6	125.3	130.7	125.9	108.8	128.8	121.8	113.9	122.4	117.0	115.8	153.6	5.3	3.2	12.6	31.6	10.0	51.9	118.1	24.2	42.7	0.7	29.7	38.0	2.1	128.7	12.5	20.2	2.1	49.9	2.2	1.6	135.0	60.2	51.2	15.6	3.8	6.9	1.8	5.5	0.3	136.1	54.0	58.7	8.6	12.2	5.7	30.9	3.6	96.1	9.2	0.0	0.6	3.6	18.3	2.2	4.3	116.9	67.7	6.5	56.9	2.8	11.0	82.4	0.0	14.1	32.3	35.6	2.0	127.9	27.4	62.1	0.2	118.4	24.7	3.4	13.1	11.2	48.8	20.0	19.4	57.5	77.1	25.3	5.9	71.4	3.2	56.8
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Muscle protein"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"parathyroid gland: 32.0;skeletal muscle: 102.6;tongue: 89.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001081, HPA075355"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA001081: AB_1079607, HPA075355: "	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	3.2	17.7	6.9	1.0	11.4	0.7	4.8	8.9	5.7	2.6	17.0	4.0	1.1	3.3	6.5	5.6	3.8	3.2	7.5	6.0	8.7	2.7	2.3	2.1	1.1	8.8	11.9	8.3	7.6	32.0	9.8	1.8	9.1	6.0	3.3	3.9	7.1	6.4	102.6	3.4	2.1	3.4	7.9	3.4	6.9	2.1	10.4	4.0	6.9	89.2	1.4	4.8	3.5	6.7	15.3	21.2	1.2	12.4	7.2	6.8	12.9	2.8	2.6	0.5	0.1	6.2	13.3	0.0	8.2	0.3	15.1	5.9	24.9	10.3	0.8	39.2	25.1	7.0	17.4	5.7	7.5	0.0	0.0	9.1	10.0	2.4	16.7	12.5	14.5	12.7	11.0	0.0	13.6	11.0	11.1	0.7	16.5	25.2	28.0	0.0	0.0	0.0	3.7	7.2	12.9	15.3	13.4	17.3	0.2	15.4	6.2	0.6	7.5	0.0	6.2	2.7	7.3	17.1	17.1	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	11.4	8.9	5.7	6.0	8.7	8.8	11.9	9.1	7.9	10.4	6.7	5.8	0.0	3.7	85.2	0.5	2.4	6.5	2.3	4.0	2.4	5.2	3.7	6.6	1.5	3.5	11.0	8.4	1.0	0.1	0.8	0.0	1.6	0.4	4.8	1.4	3.5	2.4	4.0	5.3	2.7	1.1	2.5	3.6	2.9	6.3	3.4	5.7	1.9	1.6	3.3	16.0	1.8	4.1	10.4	0.7	0.1	3.1	0.6	1.8	6.5	0.0	1.5	0.0	18.6	0.5	5.4	0.4	8.6	1.3	9.0	0.4	1.6	6.6	3.3	0.0	7.1	1.9	0.4	1.0	5.6	3.4	0.5	0.3	1.9	2.6	8.9
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.0;retina: 32.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 104.3;Distal enterocytes: 75.5;Excitatory neurons: 69.5;Proximal enterocytes: 73.7;Rod photoreceptor cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	4.2	2.8	6.6	2.8	7.5	6.5	2.7	5.8	7.4	3.5	0.1	11.7	11.1	3.7	2.9	1.4	3.2	2.4	2.8	7.8	4.8	3.4	3.0	3.1	3.5	4.6	3.9	4.2	3.1	4.5	4.0	2.7	4.7	2.7	12.2	32.2	1.7	3.4	1.9	1.8	22.0	4.5	0.6	2.5	2.4	6.8	5.3	1.9	6.6	2.6	3.2	3.3	2.4	5.1	6.0	7.8	8.3	9.3	6.5	7.8	4.8	8.8	8.0	12.5	10.1	7.2	1.9	11.8	3.4	14.6	9.0	12.4	12.1	4.5	16.1	4.2	6.5	3.3	7.3	4.8	5.1	2.9	5.0	5.8	2.5	17.7	5.7	5.2	4.7	4.1	3.0	3.2	8.7	12.7	3.9	2.3	6.5	1.9	2.1	6.3	7.3	3.9	5.9	4.5	7.2	3.8	18.9	5.1	3.1	6.4	6.3	1.6	6.5	12.5	9.0	5.3	7.4	7.1	5.4	11.9	7.7	2.3	2.8	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.7	0.1	0.5	0.3	0.1	6.6	7.5	5.8	7.4	7.8	4.8	4.6	3.9	4.7	0.6	5.3	5.1	4.0	9.6	2.2	26.1	7.4	9.3	5.1	3.5	7.4	20.6	6.9	5.6	3.3	0.0	3.6	3.7	104.3	4.3	3.8	75.5	0.0	2.7	12.0	2.9	6.1	5.3	6.0	22.9	69.5	2.3	0.4	7.7	1.1	5.1	10.2	11.3	2.9	4.1	1.5	23.5	45.9	6.7	4.1	7.0	12.7	6.3	5.3	2.7	14.2	10.3	3.2	6.5	1.0	30.7	32.7	2.5	31.4	5.3	4.0	8.2	73.7	5.1	3.1	68.6	6.6	7.8	7.9	31.6	20.4	1.9	9.1	1.4	4.9	1.7	9.2	2.2
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase 1"	Q8TCT1	17	49223366-49230787	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 103.0"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1499.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	160	"eosinophil: 171.1;neutrophil: 426.7"	"Lineage enriched"	"Detected in many"	228	"granulocytes: 426.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;EFO-21: 3.2;HDLM-2: 4.1;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065025			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	1.5	3.4	3.4	19.0	0.5	6.3	3.9	0.4	0.6	0.7	2.9	0.7	0.2	1.0	1.3	2.2	1.8	1.8	7.3	1.3	1.0	2.3	1.6	8.8	6.2	0.3	1.2	0.2	0.6	6.4	7.4	0.8	0.0	0.7	1.2	0.3	3.4	1.3	3.0	0.4	6.9	14.2	0.9	103.0	5.5	0.3	0.7	3.2	0.2	0.9	0.5	6.1	0.0	1.0	0.0	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.1	1.5	0.0	5.7	3.2	0.0	2.1	0.0	0.9	0.3	0.1	4.1	0.1	0.7	0.7	0.2	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.7	1.2	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.1	0.1	2.2	0.3	1.7	1.1	0.0	0.1	0.2	0.3	1.5	2.0	0.1	0.2	0.6	171.1	0.4	1.5	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.2	426.7	0.5	1.8	0.0	0.1	1.1	1.5	3.4	6.3	3.9	1.8	7.3	8.8	6.2	7.4	6.9	5.5	6.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	205.8	0.0	0.0	1.4	0.0	8.6	0.7	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.4	0.0	2.6	0.0	1.4	0.0	0.0	0.3	0.0	1499.6	7.8	0.6	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	11.2	4.5	0.0	0.0	237.6	0.1	0.0	0.1	0.1
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2A"	O14813	11	72239077-72245664	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 19.9;brain: 18.3"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in some"	9	"pons: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	226	"SH-SY5Y: 569.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA053810, HPA065621, HPA078004"	Enhanced		Supported	Nucleoplasm		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367"			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.3	19.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	0.0	0.2	0.0	0.5	0.0	18.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.3	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	569.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	18.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHOX2B	"NBPhox, PMX2B"	ENSG00000109132	"Paired like homeobox 2B"	Q99453	4	41744082-41748725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 8.6;brain: 15.2"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"medulla oblongata: 10.1;pons: 15.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	89	"SH-SY5Y: 132.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.6"	"Group enriched"	"Detected in some"	18	"medulla oblongata: 1.4;pons: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	0.0	0.1	0.0	0.0	0.0	15.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	15.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 953.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		590000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	71.5	109.2	196.7	54.5	200.5	64.6	62.4	206.2	245.6	76.0	192.2	74.0	54.0	44.7	103.0	70.6	99.3	62.0	267.2	192.3	203.3	82.6	47.9	57.3	57.4	199.3	191.9	65.0	153.4	160.9	85.2	49.8	200.3	89.2	50.5	26.3	144.0	86.6	432.6	45.8	62.9	78.1	198.8	41.6	61.5	56.9	199.1	68.5	86.7	441.5	40.0	71.8	41.4	216.2	53.6	452.5	225.6	199.1	153.4	266.0	412.8	147.6	170.8	158.8	138.6	165.7	138.0	145.1	142.8	168.6	180.0	155.0	51.2	293.9	50.2	116.9	132.5	45.4	276.8	380.3	177.5	82.6	176.4	322.8	248.7	91.8	109.5	145.8	218.8	93.1	102.9	129.7	257.2	328.2	156.9	176.7	216.0	372.5	206.6	106.5	106.6	196.7	255.6	113.3	137.6	132.8	146.7	155.8	75.1	107.0	127.2	226.4	177.0	390.6	130.8	91.5	166.5	60.5	93.4	94.0	174.3	59.7	235.8	38.2	290.0	31.0	197.6	318.4	170.7	241.3	173.9	184.6	321.8	178.9	126.0	175.8	13.7	196.7	231.7	425.4	223.6	324.1	196.7	200.5	206.2	245.6	192.3	203.3	199.3	191.9	200.3	198.8	199.1	216.2	125.7	96.1	159.8	24.8	111.8	150.3	187.7	659.2	204.9	43.9	223.1	317.7	384.8	178.7	326.5	217.0	22.9	322.1	111.8	337.1	747.4	196.1	271.3	122.2	168.1	111.9	265.1	80.2	8.1	252.4	489.5	213.1	140.6	170.3	123.5	367.4	83.6	201.9	286.5	67.3	12.5	370.9	309.3	97.2	197.1	953.5	205.0	133.6	334.4	5.6	273.2	194.7	146.2	10.6	25.0	185.3	359.8	223.4	187.8	257.5	540.1	817.4	250.6	77.7	85.5	137.1	249.6	141.8	143.8	140.3	161.8	264.1	106.4	352.5	336.0	199.5
PHTF1	PHTF	ENSG00000116793	"Putative homeodomain transcription factor 1"	Q9UMS5	1	113696831-113759489	"Plasma proteins, Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 198.5;Excitatory neurons: 93.4;Inhibitory neurons: 102.6;Late spermatids: 124.5;Spermatocytes: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059486			Approved	"Nucleoli,Nuclear bodies"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	Nucleoli	"HPA059486: "	"unprognostic (1.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	5.8	8.0	7.8	6.5	7.7	18.7	3.9	15.5	8.5	5.1	18.9	4.8	3.5	5.0	7.2	2.5	10.5	6.9	5.6	7.4	9.2	8.6	8.1	8.1	5.6	7.7	7.7	3.0	6.8	11.5	12.1	6.8	9.1	4.3	4.9	14.2	4.0	5.1	4.6	1.8	4.1	6.6	6.2	8.6	6.7	30.4	8.0	3.3	4.7	2.9	6.3	6.3	3.0	7.3	28.5	14.7	40.5	21.5	20.1	18.0	9.4	25.6	34.0	22.3	36.4	16.0	22.3	8.1	35.3	17.8	16.6	15.3	15.6	10.2	25.7	33.8	15.5	19.6	30.0	18.5	16.4	24.4	26.7	15.0	2.7	29.9	6.6	32.3	41.9	0.0	12.0	36.1	27.4	41.9	0.3	23.6	32.4	10.6	21.3	25.5	60.8	16.3	35.9	12.3	27.7	26.0	28.7	13.9	16.1	20.9	5.6	19.6	44.4	17.5	23.8	32.6	25.2	48.9	53.5	14.8	43.0	20.8	48.6	1.4	1.2	2.5	1.3	0.7	1.1	1.7	1.6	1.6	2.1	0.7	0.0	1.2	2.8	2.2	0.9	1.5	2.9	0.9	7.8	7.7	15.5	8.5	7.4	9.2	7.7	7.7	9.1	6.2	8.0	7.3	12.5	6.4	10.5	34.3	16.7	2.4	6.8	7.9	6.8	30.1	8.7	6.0	8.5	14.3	10.0	5.5	54.2	19.9	22.9	4.7	9.8	12.6	198.5	51.7	18.7	19.7	19.2	12.0	93.4	20.9	10.1	10.8	15.8	9.6	21.5	13.6	10.0	9.0	12.6	28.6	102.6	3.1	18.3	13.4	19.2	124.5	8.1	18.0	5.4	21.5	11.0	6.6	18.6	25.1	13.6	19.6	1.2	9.1	31.0	8.3	1.4	5.9	58.7	43.9	0.0	13.5	12.2	130.8	41.3	6.1	1.7	26.4	23.1	16.9	4.6	7.7
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219703-22232101	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 14.8;Excitatory neurons: 48.5;Inhibitory neurons: 15.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3;thyroid cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.3;SH-SY5Y: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 101.1;basal ganglia: 300.5;cerebellum: 251.7;cerebral cortex: 256.5;hippocampal formation: 296.8"	"HPA068030, HPA069318"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA068030: AB_2685944, HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	11.3	33.1	106.0	1.5	183.9	0.0	9.3	98.1	217.1	11.6	0.0	14.1	1.3	14.5	2.8	9.8	25.6	6.7	5.2	210.3	21.9	9.4	0.7	2.5	0.2	63.7	11.5	7.1	1.6	0.2	35.7	2.5	58.1	11.9	0.6	2.2	1.8	5.9	0.9	55.8	5.1	8.1	2.0	11.5	3.7	10.7	30.7	0.2	3.9	0.3	0.2	12.1	15.1	137.4	0.6	1.6	0.3	0.0	0.2	0.5	0.8	0.2	0.9	0.2	0.2	0.1	1.4	0.0	1.5	0.5	1.0	2.6	0.0	0.4	0.0	0.0	0.1	0.0	3.0	1.0	1.1	0.0	0.0	0.6	0.0	0.6	0.0	2.5	1.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.2	9.3	0.0	0.0	2.9	3.5	2.0	0.0	2.4	0.2	0.0	0.2	0.7	0.0	1.4	1.1	0.5	0.6	0.1	0.0	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.0	183.9	98.1	217.1	210.3	21.9	63.7	11.5	58.1	2.0	30.7	137.4	1.1	0.0	0.0	7.2	0.0	18.9	5.5	5.6	14.8	1.5	0.7	1.3	1.4	1.5	1.9	3.7	0.0	0.1	0.1	0.2	0.0	0.2	0.8	0.4	3.6	1.5	0.0	0.0	48.5	2.1	0.4	5.6	0.5	0.2	0.0	0.0	1.4	1.0	0.2	0.0	15.4	0.7	0.0	0.0	1.4	1.8	3.1	0.1	1.8	5.6	0.0	0.6	0.0	7.5	5.8	0.8	0.0	3.8	0.0	1.3	2.6	3.5	0.3	1.1	0.0	0.2	8.0	0.4	0.4	8.2	10.9	2.2	0.2	0.1	0.1	5.0
PHYKPL	"AGXT2L2, MGC15875"	ENSG00000175309	"5-phosphohydroxy-L-lysine phospho-lyase"	Q8IUZ5	5	178208471-178232802	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036461, HPA063608"	Approved		Approved	Mitochondria		Yes	No		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA036461: AB_10670717, HPA063608: AB_2685059"	"unprognostic (3.29e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (3.82e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-3)"	23.2	10.6	7.4	16.4	8.2	14.9	14.0	6.8	8.6	12.3	8.3	23.9	20.7	14.3	15.8	11.1	13.9	14.4	15.5	6.7	8.3	17.5	42.2	15.8	24.5	11.4	8.3	12.5	15.6	13.7	5.2	16.3	10.0	13.7	30.8	3.4	13.8	12.0	19.6	10.7	24.8	18.5	7.6	17.2	15.5	5.9	9.5	25.1	19.7	18.7	23.6	13.7	9.6	11.7	9.6	3.8	9.0	3.6	21.6	17.4	13.9	5.6	6.2	7.6	11.8	9.7	11.7	13.0	18.4	17.6	9.7	6.2	7.7	14.3	8.5	24.0	8.7	15.6	18.0	7.1	35.1	9.2	11.4	19.6	15.0	9.3	22.4	14.9	24.9	18.6	11.8	26.7	11.3	13.1	13.1	5.5	1.9	11.5	12.4	9.1	4.3	25.0	13.4	8.3	5.7	5.4	9.2	5.2	9.4	10.2	5.5	7.4	9.9	7.8	7.0	5.1	6.2	18.8	5.5	7.2	2.2	9.2	5.2	16.7	41.7	36.9	20.3	46.8	20.4	28.4	22.2	22.9	53.4	26.3	27.3	22.2	9.2	23.7	47.2	70.9	28.6	33.2	7.4	8.2	6.8	8.6	6.7	8.3	11.4	8.3	10.0	7.6	9.5	11.7	23.1	19.2	14.3	31.6	63.0	10.7	43.1	16.1	25.0	21.9	17.2	14.5	17.4	37.1	13.0	23.9	25.0	18.4	72.5	96.1	19.6	24.6	21.7	13.2	27.7	26.2	19.2	30.7	20.7	18.6	20.2	33.4	76.9	13.8	12.7	38.4	31.1	30.1	31.7	15.2	17.9	40.8	6.1	37.1	22.9	55.3	42.6	43.3	24.9	36.5	61.1	25.0	70.0	29.1	45.2	15.1	64.5	25.2	51.4	30.3	119.2	43.1	13.6	26.4	13.1	34.5	23.6	37.2	25.9	14.6	10.4	22.0	58.9	36.3	39.2	36.6
PIAS2	"ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4"	ENSG00000078043	"Protein inhibitor of activated STAT 2"	O75928	18	46803218-46920160	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 521.4;Late spermatids: 519.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068792	Enhanced		Supported	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068792: AB_2686037"	"unprognostic (9.59e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.71e-1)"	4.8	5.4	7.3	4.1	8.1	7.4	5.1	16.9	9.8	4.9	6.4	4.9	2.8	5.0	7.5	3.7	4.5	4.6	6.8	8.7	6.2	6.4	5.9	4.3	6.2	4.7	6.9	5.0	4.2	11.8	5.6	3.9	5.4	6.5	7.0	10.9	5.5	4.4	16.1	7.7	4.2	4.7	3.7	6.0	4.5	67.2	7.9	4.6	8.2	10.2	5.2	4.1	4.4	8.0	13.7	5.5	6.1	8.7	6.0	7.5	2.9	7.0	5.6	6.0	5.5	6.5	5.1	13.7	3.7	5.3	6.1	4.5	12.3	7.5	8.5	6.6	4.6	8.5	5.4	7.7	5.9	14.3	5.8	7.7	4.5	5.3	5.6	9.7	5.5	11.9	6.4	3.5	12.0	7.4	8.2	8.3	6.7	2.5	3.5	15.0	13.1	0.1	5.5	10.4	11.7	9.0	6.4	4.1	4.7	6.8	6.1	6.3	6.9	12.8	5.5	4.5	5.3	10.1	5.4	17.7	9.5	15.1	12.8	0.7	1.7	1.2	2.0	1.3	1.3	1.6	1.8	2.4	2.0	3.0	2.5	2.1	1.0	1.9	1.3	2.1	1.9	0.8	7.3	8.1	16.9	9.8	8.7	6.2	4.7	6.9	5.4	3.7	7.9	8.0	26.3	19.2	21.9	60.4	25.0	20.6	19.9	15.2	23.9	57.7	21.8	13.2	30.7	12.8	12.6	25.8	89.6	2.6	32.8	18.1	19.6	13.5	521.4	16.6	25.4	26.0	28.5	16.6	137.9	8.9	2.3	20.6	19.4	15.9	14.5	48.4	34.2	22.3	28.1	32.0	134.9	18.0	16.2	50.3	15.7	519.5	33.5	24.2	12.4	73.1	34.7	21.9	40.2	133.7	94.0	7.9	17.1	35.0	30.3	28.4	11.8	23.1	13.9	36.0	6.6	42.5	18.2	238.7	72.4	24.7	15.3	1.4	19.2	35.6	25.5	18.0
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007736-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 103.7;Late spermatids: 264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010598, HPA076008"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA010598: AB_1079616, HPA076008: "	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	8.0	10.7	9.2	6.0	11.8	4.7	9.0	11.6	11.4	11.0	3.8	15.4	6.6	10.5	2.3	11.1	8.8	2.9	10.1	8.5	7.4	8.7	15.5	7.9	5.6	12.2	11.5	10.6	13.9	3.5	10.4	5.3	10.3	11.4	2.4	3.7	9.8	3.9	10.6	12.7	9.9	3.8	8.5	11.6	12.1	37.2	10.4	5.9	7.5	4.8	4.0	10.4	9.7	17.4	15.1	10.6	9.7	9.3	4.7	4.2	15.4	9.0	4.9	9.2	8.4	16.7	6.8	11.4	7.9	4.8	10.1	15.5	10.0	7.1	4.0	18.5	15.8	8.2	7.8	13.1	9.6	12.0	13.8	4.9	7.8	8.3	5.1	5.1	11.1	11.6	15.5	15.2	4.5	15.5	21.9	13.9	21.6	7.3	9.7	19.3	9.9	15.0	6.1	8.3	17.8	19.8	12.8	12.4	10.3	7.3	11.5	11.0	8.2	9.2	13.2	19.4	14.2	28.3	22.8	14.4	7.7	14.6	11.5	10.5	13.2	19.8	15.2	15.3	10.8	16.1	10.8	14.0	11.0	14.6	9.3	10.6	15.8	17.1	19.5	11.0	13.0	10.3	9.2	11.8	11.6	11.4	8.5	7.4	12.2	11.5	10.3	8.5	10.4	17.4	12.8	3.2	15.0	15.0	10.1	18.4	8.4	15.8	7.4	18.8	14.5	11.2	3.6	11.5	11.5	9.2	12.5	24.3	12.3	13.2	7.9	17.1	103.7	13.9	10.7	12.3	22.1	9.9	7.3	17.6	16.9	9.1	11.7	12.4	7.0	15.2	11.4	12.3	14.6	26.9	5.7	15.6	20.3	8.3	9.2	264.3	14.0	10.6	7.2	2.8	12.8	11.3	10.3	6.6	18.0	13.5	7.8	18.4	12.0	11.9	14.0	12.5	15.6	23.1	6.6	8.1	9.3	69.1	42.1	7.4	15.5	36.4	10.1	13.3	12.4	9.0
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.3;Erythroid cells: 17.7;Granulosa cells: 15.1;NK-cells: 15.5;Theca cells: 18.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	0.7	1.0	0.8	2.6	0.8	3.8	0.4	0.7	1.3	0.9	0.7	2.4	1.9	0.8	0.1	3.1	0.7	0.8	0.9	0.7	1.2	0.6	0.6	1.0	4.6	1.4	1.0	0.4	0.2	0.2	0.5	0.9	1.1	1.7	1.0	0.1	0.6	0.7	0.3	1.0	2.6	1.2	0.9	4.8	1.8	2.5	1.2	3.6	0.5	0.1	3.3	1.5	1.4	0.8	7.7	8.7	21.1	8.6	3.7	4.3	7.8	7.4	3.9	7.3	5.6	14.0	12.6	9.3	3.0	3.6	6.8	20.9	21.8	6.2	2.7	14.8	8.0	10.8	28.5	10.2	1.9	4.3	8.4	2.5	0.0	3.2	2.6	1.8	7.5	13.6	7.2	18.0	7.0	6.7	4.7	17.9	17.2	9.7	6.0	9.7	7.0	13.0	4.1	4.3	8.7	5.6	5.7	6.3	3.3	9.2	7.0	4.7	5.2	4.4	22.6	7.0	14.0	14.3	14.3	9.0	4.2	18.8	6.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.8	0.7	1.3	0.7	1.2	1.4	1.0	1.1	0.9	1.2	0.8	1.2	0.0	1.1	3.6	6.5	1.9	0.8	0.6	0.0	0.5	0.6	0.6	1.9	0.0	0.1	0.0	0.0	5.1	7.5	3.2	0.0	0.0	21.3	0.4	4.4	2.3	0.0	17.7	2.6	0.0	6.5	5.6	3.6	0.7	0.0	15.1	5.3	0.5	5.8	0.0	1.0	2.4	0.0	5.1	2.0	2.3	1.5	4.5	0.0	1.9	0.1	0.8	15.5	3.5	0.1	0.2	0.1	2.2	9.7	1.1	0.2	0.1	0.1	1.2	6.6	4.2	3.5	0.8	2.0	1.6	1.0	1.1	7.5	18.3	6.2	1.3
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.57e-4)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	9.6	8.6	8.0	6.3	8.4	5.6	10.1	9.7	10.4	8.6	8.5	8.8	10.6	8.3	11.8	8.1	8.9	6.1	5.6	7.8	8.5	9.0	14.3	7.7	7.8	7.8	7.8	10.4	10.2	6.1	10.4	6.3	8.2	9.8	8.4	6.3	8.2	6.1	5.3	11.4	10.1	5.9	7.6	7.8	10.5	8.7	8.2	6.4	10.1	3.3	8.3	7.8	8.1	9.4	12.5	16.3	11.4	9.3	16.0	15.2	4.6	6.3	8.0	10.8	19.5	17.2	15.4	6.6	13.7	6.7	6.9	17.4	14.7	8.2	15.0	13.1	38.3	12.3	13.6	21.9	17.3	5.0	7.4	12.5	20.3	19.1	22.0	10.9	13.0	20.1	14.6	7.3	8.6	11.1	9.3	11.6	4.5	25.2	8.3	9.0	9.7	15.6	12.3	6.6	6.0	8.5	6.7	4.9	14.6	29.9	5.4	4.5	7.6	9.1	6.0	6.6	19.8	5.5	0.2	10.3	12.2	12.5	6.2	0.0	2.7	4.7	4.6	2.6	4.1	3.7	6.3	3.7	2.0	2.8	6.4	5.5	0.0	4.8	1.8	5.3	5.4	2.5	8.0	8.4	9.7	10.4	7.8	8.5	7.8	7.8	8.2	7.6	8.2	9.4	8.5	9.6	21.0	19.2	10.0	4.5	9.2	9.1	11.4	11.5	9.8	9.8	2.4	7.2	13.0	12.9	10.4	15.6	9.3	7.3	5.9	6.3	3.0	7.7	11.4	6.6	7.8	11.6	46.7	7.5	8.0	8.8	11.7	6.9	5.1	14.0	5.0	10.5	5.2	6.7	45.3	11.2	10.2	3.5	4.3	2.9	7.8	5.9	3.6	26.2	3.6	5.2	9.2	24.6	34.9	9.4	9.7	11.3	12.2	8.3	9.8	5.9	10.6	12.2	0.0	9.1	7.3	16.1	8.3	7.5	6.0	9.6	11.8	9.4	12.6	10.4
PIGP	"DCRC, DSCR5, DSRC"	ENSG00000185808	"Phosphatidylinositol glycan anchor biosynthesis class P"	P57054	21	37062846-37073170	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026921	Uncertain		Approved	Vesicles		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA026921: AB_1847874"	"unprognostic (4.47e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.55e-2)"	33.9	41.3	18.7	12.5	20.2	9.1	35.4	22.4	24.7	22.9	24.8	24.2	19.0	18.3	107.2	16.8	25.7	22.5	40.1	18.1	22.8	35.9	54.7	21.6	16.6	22.8	21.6	27.9	41.4	51.9	38.0	20.9	22.6	33.7	27.4	28.6	32.2	26.7	44.0	12.4	15.5	17.1	22.1	14.9	22.8	36.5	20.0	22.0	36.3	42.8	19.7	26.2	13.2	25.4	25.9	11.5	23.7	14.8	41.5	28.6	16.9	21.9	38.7	18.6	21.1	15.4	53.7	37.1	45.7	32.0	81.4	19.4	22.7	25.5	18.5	37.4	36.1	86.2	13.8	21.3	26.3	26.9	16.6	26.5	47.2	33.4	43.0	42.2	35.1	80.5	50.7	61.8	38.5	16.5	32.9	25.5	19.6	76.8	27.9	31.0	12.1	37.0	48.2	13.3	49.2	29.8	61.4	43.0	81.8	33.6	35.2	53.2	18.3	12.9	6.6	14.8	19.3	81.1	96.5	42.0	38.1	30.5	43.4	0.4	13.5	3.7	19.6	20.3	24.8	34.2	25.1	21.6	20.9	28.1	33.3	29.0	1.9	16.8	22.6	30.9	20.6	15.6	18.7	20.2	22.4	24.7	18.1	22.8	22.8	21.6	22.6	22.1	20.0	25.4	37.4	28.9	41.8	9.8	37.0	33.0	58.9	88.9	35.3	21.2	74.1	86.4	82.4	42.9	65.1	44.1	10.4	60.7	29.4	21.6	90.1	61.8	79.3	67.0	35.9	31.3	44.9	25.7	6.9	71.3	52.4	48.9	30.1	49.3	15.9	32.2	35.3	79.8	66.7	16.8	8.7	63.9	65.1	57.6	39.9	75.6	69.0	44.1	37.4	2.8	50.2	37.0	23.7	7.5	18.2	57.7	50.3	35.0	54.3	45.6	52.3	97.1	86.9	33.6	65.7	32.7	44.6	350.8	177.5	44.2	26.3	52.3	31.7	62.6	53.1	63.7
PIGW	"FLJ37433, Gwt1"	ENSG00000277161	"Phosphatidylinositol glycan anchor biosynthesis class W"	Q7Z7B1	17	36534987-36539310	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023499			Approved	"Plasma membrane"		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"		"HPA023499: "	"unprognostic (4.96e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.14e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.88e-1)"	4.5	3.8	1.0	3.9	1.1	2.7	3.9	1.4	1.5	3.2	1.8	4.3	2.6	4.2	2.0	7.4	3.4	1.9	3.7	1.0	1.5	6.5	6.5	3.7	3.8	1.5	1.2	2.5	4.7	2.6	4.0	2.0	1.5	3.3	3.6	1.8	5.0	1.3	8.2	5.8	4.3	2.6	1.1	4.4	4.5	2.8	1.4	2.1	4.1	3.4	3.5	3.6	4.3	1.3	10.8	15.2	9.0	9.2	4.9	4.2	15.0	11.6	6.2	12.2	9.3	11.7	12.2	19.9	3.8	7.9	14.9	15.7	16.5	8.0	16.1	11.3	23.3	14.7	7.3	11.0	3.8	32.2	17.2	5.2	9.6	12.5	5.4	2.5	7.9	6.3	26.9	9.5	8.9	10.1	16.4	11.2	16.5	7.5	13.0	15.3	24.0	18.8	7.6	11.6	20.7	16.7	21.0	8.6	9.3	8.4	27.8	4.7	10.4	21.7	29.1	20.8	26.1	8.8	32.8	22.0	5.2	18.0	19.6	0.8	1.7	0.3	2.0	2.7	2.8	1.5	2.6	2.1	3.5	2.9	3.2	3.1	0.4	2.6	3.5	2.1	1.6	2.2	1.0	1.1	1.4	1.5	1.0	1.5	1.5	1.2	1.5	1.1	1.4	1.3	3.6	3.2	3.1	1.6	4.6	3.4	9.5	4.6	12.5	2.2	4.3	2.9	1.6	10.0	4.2	0.0	0.0	6.1	5.4	2.9	7.9	6.8	0.2	2.4	3.6	4.7	1.2	12.6	2.0	6.4	6.7	3.8	5.1	2.7	0.0	2.3	1.1	6.0	4.5	3.3	2.6	4.0	0.0	3.3	2.2	0.6	2.8	3.5	0.0	0.0	3.1	4.2	1.0	1.5	2.5	7.1	3.6	2.2	4.9	10.2	1.0	4.9	2.8	3.1	0.0	3.7	3.6	3.4	7.4	9.4	6.8	4.1	3.1	3.5	5.6	5.3
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593315-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 83.2;lymphoid tissue: 62.3;salivary gland: 73.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;Hepatocytes: 70.7;Kupffer cells: 127.0;Macrophages: 89.8;Microglial cells: 60.9;monocytes: 57.4;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 44.7;memory B-cell: 48.3;naive B-cell: 44.5;non-classical monocyte: 123.0"	"Group enriched"	"Detected in all"	6	"B-cells: 48.3;monocytes: 123.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;NB-4: 62.1;REH: 183.5;THP-1: 92.9;U-698: 114.7;U-937: 95.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	8.1	4.5	2.1	51.1	2.0	47.5	4.7	2.4	3.2	2.8	2.7	7.3	6.8	2.1	1.7	2.4	2.2	24.8	2.5	1.9	2.9	11.8	83.2	16.7	61.2	6.5	4.6	6.0	22.8	2.0	1.4	14.1	5.3	2.8	8.6	3.1	73.6	2.4	0.7	1.0	7.7	8.3	4.7	62.3	6.9	3.0	5.7	8.7	4.1	3.1	57.8	15.2	0.6	7.6	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.2	2.8	1.5	85.3	8.5	0.0	1.3	0.1	17.7	0.0	0.6	48.0	3.0	13.0	0.0	1.7	0.1	36.1	6.7	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.9	0.1	0.1	0.4	1.1	62.1	0.8	24.3	1.0	183.5	4.3	20.0	0.2	0.1	3.6	2.0	0.2	0.2	1.1	0.3	0.2	92.9	0.0	0.0	2.8	0.1	0.7	0.7	0.2	114.7	0.0	95.2	0.0	6.1	16.0	10.5	13.3	44.7	4.7	48.3	0.3	4.1	12.9	44.5	0.1	3.3	13.5	14.0	123.0	11.3	0.5	14.4	2.1	2.0	2.4	3.2	1.9	2.9	6.5	4.6	5.3	4.7	5.7	7.6	0.5	3.2	3.9	1.3	53.7	1.5	0.1	0.1	0.6	0.6	2.2	2.3	2.6	32.9	2.2	1.8	2.1	0.5	41.5	8.1	1.9	40.0	4.3	0.3	0.1	1.8	1.8	10.3	0.8	29.1	0.9	0.7	0.0	0.2	14.0	0.2	5.7	70.7	47.7	0.0	0.8	2.8	4.1	127.0	32.5	1.0	1.2	89.8	5.4	60.9	57.4	0.2	58.7	1.0	0.3	16.4	21.2	2.2	9.4	0.4	1.6	18.3	1.1	3.4	0.0	0.6	0.8	0.8	0.2	0.3	1.1	2.3	18.3	0.4	3.8	0.3
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.5	13.7	16.3	12.3	25.9	9.4	15.9	22.5	14.6	16.1	17.4	13.2	14.9	18.0	15.7	15.4	14.5	19.0	12.4	10.5	14.0	23.5	15.5	16.6	11.3	16.6	16.1	14.1	12.3	43.6	10.3	23.1	17.0	16.4	13.0	22.4	11.8	14.8	6.4	12.3	11.8	18.3	13.8	13.0	18.0	19.3	19.6	9.4	30.7	12.1	10.9	14.9	12.0	15.8	53.8	24.1	39.6	24.8	28.0	28.3	35.3	33.2	35.7	23.9	33.2	58.9	6.0	15.6	16.2	28.6	39.1	34.8	31.9	25.4	42.1	13.5	27.6	9.8	28.4	23.3	30.6	12.3	14.9	22.2	17.5	23.6	45.8	22.2	57.7	9.9	23.4	14.7	18.6	16.6	6.6	7.7	22.6	30.1	18.5	6.9	41.1	11.0	29.6	47.0	23.2	20.5	50.6	21.4	23.2	33.0	12.7	12.3	72.5	19.1	27.4	50.1	20.4	5.9	14.1	12.8	22.8	11.3	22.6	1.7	1.5	1.1	1.7	1.0	1.1	1.4	1.3	1.3	2.1	1.5	1.7	1.0	2.3	1.8	3.2	1.4	0.9	0.6	16.3	25.9	22.5	14.6	10.5	14.0	16.6	16.1	17.0	13.8	19.6	15.8	93.2	76.9	62.0	217.4	25.0	35.3	26.1	18.7	24.5	49.1	34.7	25.0	29.7	25.8	33.1	36.8	70.9	29.6	29.5	22.6	19.6	19.8	35.9	51.8	35.1	87.6	28.7	11.2	57.0	25.1	17.9	28.6	45.3	72.4	32.2	22.8	106.7	32.4	19.2	35.3	81.1	23.5	18.3	46.3	33.1	18.6	25.7	27.0	19.6	69.3	19.6	73.0	17.5	62.8	79.4	26.1	13.1	31.2	29.9	42.7	15.2	22.4	26.4	40.4	39.5	33.7	35.1	52.6	26.8	23.5	34.0	143.5	25.3	25.1	20.7	37.3
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Lipid metabolism, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 126.7;Inhibitory neurons: 122.0;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Mitochondria	"CAB017804: , HPA009985: AB_1079610"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-2)"	14.7	7.9	3.1	8.1	3.7	12.4	8.5	9.7	8.3	8.7	0.3	6.7	4.2	8.3	4.8	7.9	5.7	8.4	9.5	3.7	3.6	8.2	7.1	7.9	9.2	5.1	4.2	10.3	4.3	11.5	3.4	11.1	5.1	7.3	5.8	12.4	4.5	7.1	7.1	5.5	5.3	8.9	2.3	8.8	5.8	6.1	3.7	13.7	7.9	13.0	9.2	8.6	5.8	6.4	19.9	6.5	9.6	9.2	22.7	27.7	6.5	10.8	16.5	10.9	16.0	5.1	13.0	16.1	21.7	10.8	14.1	5.9	8.4	9.8	16.5	32.0	6.2	22.4	5.2	4.4	10.7	13.1	12.6	16.8	10.6	12.4	15.0	13.4	15.8	12.9	10.6	17.3	18.9	6.9	10.9	8.5	8.0	8.8	7.8	13.9	10.0	16.7	8.5	10.0	5.2	9.9	13.1	10.8	16.1	9.1	19.0	11.1	21.1	10.4	6.5	18.1	13.3	9.3	13.8	29.0	11.3	9.6	5.4	1.3	1.2	0.4	1.2	1.0	0.8	1.5	0.8	0.6	0.8	1.6	1.0	0.8	2.2	0.7	0.9	0.9	0.8	0.3	3.1	3.7	9.7	8.3	3.7	3.6	5.1	4.2	5.1	2.3	3.7	6.4	31.3	32.1	26.8	60.7	28.3	14.7	17.9	11.2	2.2	27.9	14.4	15.2	18.5	5.7	15.9	7.3	31.3	10.2	17.9	8.7	1.9	10.7	2.0	14.1	21.7	25.6	2.4	9.2	126.7	13.9	6.1	23.5	8.6	21.6	31.6	19.9	33.5	21.9	11.1	38.7	122.0	10.3	14.2	23.5	24.3	3.4	32.6	20.9	14.2	75.9	24.5	17.4	18.6	130.2	84.2	16.9	10.8	39.5	15.1	34.6	9.5	14.8	20.1	27.1	26.3	25.7	28.6	11.8	10.2	9.8	14.9	8.8	19.9	19.6	9.2	32.0
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652698-138834928	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 115.2;HMC-1: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	11.6	7.4	4.3	12.4	5.0	23.7	11.9	8.6	8.6	12.4	14.4	17.8	17.8	8.2	7.0	18.0	12.1	10.3	15.8	5.4	4.4	26.4	11.0	11.2	12.3	5.1	3.3	9.2	22.3	19.3	2.7	18.6	6.1	15.0	18.1	23.0	19.8	12.0	19.5	23.7	17.9	9.1	3.5	10.8	13.0	8.0	4.0	17.0	43.2	13.2	13.2	9.9	5.4	7.9	64.1	21.9	11.7	9.4	10.6	13.0	79.2	14.2	14.5	15.1	16.7	26.0	25.2	25.0	38.0	13.7	29.1	27.5	15.1	24.1	27.3	31.8	12.5	115.2	14.8	17.3	11.8	30.1	185.1	12.4	17.6	10.2	21.9	26.4	21.5	12.3	43.0	19.0	18.1	28.6	17.8	20.7	16.6	49.2	19.5	11.5	12.2	19.6	24.5	35.5	9.8	7.4	37.6	18.0	56.2	34.7	44.8	73.0	20.3	8.4	11.7	21.2	21.1	30.3	22.1	23.7	22.8	27.7	14.0	4.4	5.1	6.9	2.4	2.8	1.6	2.8	2.8	1.8	5.9	2.6	3.5	2.4	6.4	0.8	2.8	1.0	1.5	2.0	4.3	5.0	8.6	8.6	5.4	4.4	5.1	3.3	6.1	3.5	4.0	7.9	19.7	9.6	21.3	40.1	12.1	19.1	18.7	12.5	14.2	16.2	13.1	7.7	37.3	12.8	18.3	18.4	25.0	35.5	6.9	30.3	5.9	11.1	1.1	18.3	4.0	13.9	16.3	8.0	96.5	19.4	61.1	7.3	21.4	18.8	14.5	6.7	9.7	19.1	14.4	21.9	92.4	17.1	4.1	33.3	23.1	1.7	3.7	28.1	7.2	37.5	29.5	8.9	11.3	48.2	88.2	20.0	25.9	6.8	10.2	25.8	21.9	23.4	17.4	19.5	6.6	8.6	5.9	16.0	19.9	22.1	23.3	47.9	11.6	4.2	15.1	17.5
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651731-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 60.9;lymphoid tissue: 50.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.0;granulocytes: 25.3;Kupffer cells: 35.2;Microglial cells: 29.0;NK-cells: 29.9;T-cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 153.3;NB-4: 65.9;REH: 68.9;THP-1: 65.4;U-937: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	7.2	3.1	6.8	33.4	6.3	60.9	3.9	6.1	7.5	6.2	6.4	5.4	5.2	4.9	1.7	4.9	6.1	7.0	3.3	7.0	5.3	6.4	3.5	12.0	46.9	7.3	6.6	7.0	3.0	2.9	2.8	4.2	7.8	4.6	3.4	0.6	5.1	2.7	1.2	3.0	17.2	4.7	6.6	50.4	5.7	4.0	9.3	24.3	5.5	3.5	32.0	7.4	5.1	8.5	8.1	5.2	0.4	1.4	1.3	1.1	0.7	12.1	24.5	26.0	21.1	0.3	3.3	21.5	4.9	9.8	12.4	2.4	2.0	11.0	16.2	153.3	0.4	2.4	1.3	9.0	5.1	56.0	18.7	4.3	4.5	29.2	9.8	11.4	3.8	14.9	8.0	0.1	15.0	0.6	5.4	65.9	2.2	0.3	1.4	68.9	13.0	0.7	10.9	0.0	1.7	1.5	2.7	4.9	11.9	6.8	0.8	65.4	9.8	7.7	7.9	0.2	11.5	4.9	4.9	30.1	16.7	78.6	4.4	18.0	23.5	40.2	21.6	23.0	22.6	12.8	16.3	19.9	22.5	13.6	20.9	23.1	63.2	25.9	29.2	25.7	13.3	38.3	6.8	6.3	6.1	7.5	7.0	5.3	7.3	6.6	7.8	6.6	9.3	8.5	1.7	9.6	13.4	2.0	22.2	1.5	2.2	1.8	4.0	0.7	2.0	1.7	3.1	0.0	1.1	0.0	2.1	0.3	44.0	0.1	1.9	3.9	3.0	2.0	1.7	2.7	0.0	10.3	6.7	2.0	0.5	2.9	0.0	1.0	25.3	4.2	3.6	0.0	14.7	0.0	13.4	0.1	0.0	35.2	6.0	2.8	1.2	23.1	3.6	29.0	19.3	2.5	29.9	1.0	1.1	11.3	0.0	1.5	8.2	4.1	0.2	3.8	3.3	1.3	6.6	2.0	4.7	1.5	3.4	2.9	1.1	0.3	37.1	1.5	0.2	2.1
PIK3R1	"GRB1, p85, p85-ALPHA"	ENSG00000145675	"Phosphoinositide-3-kinase regulatory subunit 1"	P27986	5	68215756-68301821	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Protein transport, Stress response, Transport"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 410.2;Endometrial stromal cells: 479.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 265.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001216, CAB004268"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB004268: AB_628126, HPA001216: AB_1079612"	"unprognostic (5.74e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (8.09e-4)"	"unprognostic (3.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.59e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.54e-1)"	60.6	27.3	13.6	27.8	33.3	126.4	92.1	12.5	40.8	51.2	0.6	38.2	17.2	65.8	45.0	43.2	69.0	35.0	72.3	29.9	13.0	35.9	100.8	26.7	28.5	11.2	22.1	53.3	13.4	40.2	7.3	32.4	12.0	26.7	22.2	59.9	64.5	31.9	63.5	28.7	24.5	74.8	9.9	38.1	18.3	8.6	20.3	46.5	20.6	33.9	23.7	27.0	31.7	36.0	4.3	8.2	23.8	71.4	265.5	76.9	10.4	23.2	10.6	8.8	9.4	20.4	7.4	21.8	38.5	32.0	4.3	10.2	6.7	46.9	11.0	90.6	8.9	26.1	6.5	17.0	89.2	27.0	20.1	81.9	104.2	16.1	83.6	4.1	11.7	25.0	4.1	16.1	8.1	11.3	65.7	10.5	6.9	14.7	4.3	61.1	11.3	17.0	11.5	47.9	4.7	21.3	4.0	6.3	15.0	13.7	34.3	19.0	14.0	10.3	10.4	17.3	14.8	18.0	29.2	25.2	11.1	32.9	7.8	22.0	1.7	8.8	11.5	2.4	16.6	1.7	14.9	11.1	3.0	3.9	18.6	14.1	2.2	11.7	6.5	1.2	12.3	5.5	13.6	33.3	12.5	40.8	29.9	13.0	11.2	22.1	12.0	9.9	20.3	36.0	47.7	51.3	24.8	112.3	47.7	14.4	23.5	30.8	175.2	46.0	61.4	168.4	263.0	38.6	19.3	5.5	25.0	13.4	410.2	28.4	72.4	15.8	12.6	38.7	479.9	39.0	9.6	43.5	232.8	9.5	18.5	151.0	43.8	93.2	68.9	110.4	31.1	198.3	30.7	48.8	82.7	32.6	28.5	69.2	24.7	11.9	172.1	68.8	33.8	117.1	37.6	194.1	137.0	281.5	199.9	12.3	19.8	122.2	173.2	8.4	24.3	39.1	8.7	89.4	19.7	127.2	76.5	1.7	4.5	37.2	10.2	10.0	309.9	45.4	36.5	8.1
PIK3R4	"p150, VPS15"	ENSG00000196455	"Phosphoinositide-3-kinase regulatory subunit 4"	Q99570	3	130678934-130746829	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036032, HPA036033"	Approved		Approved	Vesicles,Microtubules		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: AB_2674911"	"unprognostic (7.50e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (8.25e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	8.8	8.5	3.7	7.8	4.2	8.9	10.0	5.2	4.9	9.4	5.6	8.2	7.5	10.1	7.9	8.0	9.1	7.2	7.6	4.1	4.5	10.5	21.2	9.6	9.4	3.2	3.6	12.4	6.9	17.6	6.1	9.7	3.8	9.8	8.1	16.5	7.6	9.6	7.3	7.8	8.0	10.4	3.8	10.0	7.5	11.4	3.2	11.4	13.1	8.6	10.4	9.0	6.5	7.1	20.7	12.9	18.5	13.4	26.6	21.1	12.8	15.0	17.9	20.2	23.3	16.7	17.1	24.2	18.4	15.2	16.1	28.7	30.7	23.3	31.6	14.7	11.3	19.7	13.8	11.7	12.2	30.3	9.5	14.7	16.4	21.7	13.6	12.6	19.0	13.8	23.3	11.9	18.1	18.1	24.9	9.2	23.3	18.6	12.4	17.2	21.4	21.9	13.2	16.7	17.0	12.4	21.6	13.4	15.3	21.5	18.6	13.1	15.2	15.5	13.3	17.6	12.2	13.8	13.5	31.2	17.0	11.3	14.7	9.7	5.3	7.0	6.3	6.0	9.3	5.6	5.7	4.7	6.9	3.5	6.6	6.0	4.4	8.5	6.6	2.4	6.8	5.3	3.7	4.2	5.2	4.9	4.1	4.5	3.2	3.6	3.8	3.8	3.2	7.1	8.3	6.4	8.7	18.6	8.8	3.8	3.9	5.7	10.8	8.1	5.7	4.7	7.7	8.6	9.6	11.0	14.6	5.6	7.2	5.5	1.9	5.0	4.4	8.9	7.5	8.9	3.0	9.2	28.5	5.8	3.4	6.9	13.3	9.9	9.5	9.5	7.5	18.2	5.9	5.0	30.3	6.8	8.2	6.4	2.6	3.1	9.6	7.3	5.4	20.6	7.1	9.0	6.2	22.1	32.9	6.6	4.3	11.7	6.9	4.8	6.2	4.2	12.6	12.6	6.6	8.9	6.2	17.0	13.9	9.5	4.4	4.2	7.5	9.6	6.1	3.4
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 87.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 29.9;Kupffer cells: 35.7;Langerhans cells: 40.5;Macrophages: 36.8;Microglial cells: 79.6;NK-cells: 32.0;Plasma cells: 24.7;T-cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 39.2;HMC-1: 5.7;JURKAT: 13.7;U-937: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Centriolar satellite"	"HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	6.5	3.6	1.4	19.7	1.3	87.4	2.7	1.3	7.5	2.1	1.6	3.3	3.3	1.4	0.8	2.5	3.0	6.6	1.8	1.3	1.7	1.4	2.9	14.1	13.7	4.0	2.7	0.8	1.3	0.8	0.8	3.1	3.6	1.5	2.6	0.0	2.1	1.0	0.7	1.5	9.5	3.9	2.8	22.4	3.6	2.2	6.8	12.3	1.7	0.9	8.9	6.5	1.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.4	1.5	0.0	0.0	0.0	0.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.3	1.5	2.5	0.6	0.0	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	9.5	16.1	5.7	18.1	14.3	11.8	4.3	10.1	15.6	11.5	5.7	7.5	12.0	34.4	8.6	19.0	9.0	13.2	16.2	1.4	1.3	1.3	7.5	1.3	1.7	4.0	2.7	3.6	2.8	6.8	5.4	0.2	0.0	6.1	0.7	11.7	1.0	0.0	0.0	0.0	0.0	0.2	0.3	2.1	1.5	0.0	0.0	0.0	0.1	29.9	0.0	0.0	0.1	4.5	0.1	0.1	0.7	0.0	4.0	0.3	0.0	0.3	0.5	1.5	0.1	5.1	0.0	1.4	0.4	18.3	0.0	0.5	0.0	0.0	35.7	40.5	12.2	0.3	36.8	1.8	79.6	19.8	0.0	32.0	1.0	0.3	0.0	0.0	0.0	24.7	0.1	0.0	0.2	0.0	0.0	0.0	0.4	1.4	0.6	0.4	0.1	0.9	0.4	25.7	0.0	0.0	0.0
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.3;intestine: 87.6;lymphoid tissue: 163.9"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 738.8"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"HDLM-2: 567.6;Karpas-707: 675.0;RPMI-8226: 703.9;U-266/70: 1218.7;U-266/84: 1160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favorable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	7.9	7.1	10.9	85.4	11.4	102.3	8.8	9.6	12.3	6.1	11.1	40.8	87.6	5.1	10.1	8.2	11.9	16.7	5.2	15.4	12.4	9.8	10.4	23.5	114.3	9.7	10.7	10.3	4.7	3.8	10.1	4.9	11.7	7.4	50.9	5.6	36.4	7.3	2.5	6.3	46.4	6.9	10.3	163.9	45.1	10.1	13.5	45.5	10.1	2.7	104.7	45.6	6.4	8.8	17.5	14.8	8.0	15.4	2.8	2.0	11.7	10.5	13.1	14.8	13.2	13.3	12.9	74.5	4.8	5.3	5.6	10.6	25.1	10.0	14.1	567.6	19.6	90.8	15.0	13.9	6.2	21.7	58.7	5.9	8.4	15.3	9.2	12.1	5.5	9.8	97.8	675.0	8.4	12.6	8.4	45.2	165.2	6.1	22.7	9.9	5.4	703.9	14.9	2.6	5.4	7.8	11.5	8.0	8.3	36.9	19.3	29.8	3.6	3.5	2.5	3.1	10.6	1218.7	1160.5	144.1	14.0	19.0	3.7	279.1	8.2	77.7	60.4	9.7	102.3	124.8	165.9	85.6	13.2	73.5	172.4	113.3	195.5	92.7	17.4	15.2	331.9	79.0	10.9	11.4	9.6	12.3	15.4	12.4	9.7	10.7	11.7	10.3	13.5	8.8	2.9	12.8	36.0	1.0	161.6	20.3	9.0	7.1	45.5	2.6	16.2	4.7	3.5	2.8	9.9	3.7	2.1	5.8	46.8	5.7	3.9	3.3	1.9	15.6	1.0	5.3	13.1	49.9	2.3	3.5	9.1	5.1	10.7	3.9	23.4	1.3	4.2	6.3	7.2	11.8	2.2	7.5	18.3	7.5	123.1	1.8	1.8	19.8	94.3	0.0	99.5	2.2	38.1	0.5	1.0	2.0	3.7	4.1	738.8	4.6	4.1	6.8	16.3	2.1	0.0	3.8	6.2	2.2	1.6	15.7	13.8	2.5	97.1	8.6	11.8	3.4
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960768-49964072	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 408.4;Syncytiotrophoblasts: 389.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 20.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 163.3;SK-BR-3: 144.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA068758: AB_2686026"	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	97.8	48.4	25.9	31.3	31.3	114.3	80.2	32.8	38.1	49.2	26.9	55.1	23.8	40.8	12.7	80.8	54.0	25.8	68.7	25.2	32.6	113.3	92.9	107.1	28.2	40.6	36.1	35.7	73.1	21.6	51.3	21.3	38.0	87.3	10.4	3.1	93.5	22.6	112.0	116.4	51.6	9.9	30.3	80.7	118.1	33.9	35.2	19.0	54.9	35.0	13.0	71.0	68.6	39.9	26.8	17.7	11.6	21.9	9.0	6.7	65.5	16.5	26.7	19.4	14.0	29.5	22.3	47.3	20.1	4.6	39.1	22.5	22.3	12.6	6.9	35.8	92.1	19.5	46.3	36.0	41.8	42.5	36.0	12.8	41.0	11.9	20.2	10.5	63.5	31.7	27.0	163.3	5.9	60.6	21.7	76.4	24.2	28.1	27.8	100.3	19.2	57.6	10.6	20.3	41.1	28.6	32.2	144.7	109.2	10.7	19.0	56.4	16.8	12.1	51.5	19.8	27.1	82.2	56.9	41.4	30.1	24.1	33.2	0.0	4.0	0.1	2.2	4.1	2.5	4.3	5.0	4.4	3.1	7.5	4.8	1.9	20.7	1.7	5.2	7.0	5.8	2.7	25.9	31.3	32.8	38.1	25.2	32.6	40.6	36.1	38.0	30.3	35.2	39.9	120.2	64.1	85.9	6.5	107.7	227.3	236.8	79.1	96.8	31.5	99.2	67.3	32.8	121.5	72.8	80.9	2.1	56.9	79.5	57.9	84.1	50.9	5.1	114.2	76.3	167.7	97.7	10.8	10.2	54.5	346.5	69.0	202.3	170.5	69.3	16.8	98.6	45.9	69.7	62.2	6.7	101.7	81.4	41.1	408.4	4.8	32.3	134.8	108.5	6.5	35.8	14.0	11.3	6.6	20.5	71.0	94.6	11.3	95.1	298.4	58.1	88.5	40.9	16.5	26.3	39.4	57.3	26.1	37.7	95.3	204.7	389.9	90.4	11.6	79.0	266.0
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444441-6451469	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.9"	"Group enriched"	"Detected in some"	6	"Fibroblasts: 5.5;Granulosa cells: 21.5;Hofbauer cells: 7.2;Smooth muscle cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 161.8"	"Region enhanced"	"Detected in many"		"white matter: 5.7"	"Low region specificity"	"Detected in single"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043783: AB_2678669, HPA049934: AB_2680959"	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	0.5	2.5	0.3	1.3	0.0	2.5	0.8	1.1	0.4	0.9	0.0	3.3	3.0	0.8	0.0	3.3	0.3	0.7	0.3	0.1	0.1	0.3	0.3	0.7	1.5	0.2	0.0	0.8	0.2	0.1	0.1	0.6	0.0	0.3	4.1	0.4	0.7	0.1	0.0	2.7	3.1	2.0	0.0	6.0	1.2	0.3	0.1	13.9	0.4	0.0	2.1	1.3	1.3	0.2	42.1	54.1	161.8	73.1	1.5	4.5	12.6	47.9	29.8	78.6	52.5	32.8	17.9	0.0	18.8	39.8	39.9	29.9	82.6	21.6	41.9	64.6	33.9	0.1	33.8	41.2	0.2	1.7	48.9	2.4	1.5	32.2	12.4	8.0	24.8	36.8	10.1	23.0	49.9	30.5	9.2	0.5	70.9	34.0	37.8	74.9	64.8	29.6	12.9	6.4	36.5	51.3	41.7	42.5	39.1	20.4	19.9	4.0	11.9	59.9	48.4	36.0	80.7	8.2	31.5	0.2	23.6	20.4	94.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.2	1.0	0.1	0.0	0.3	0.3	0.3	0.0	1.1	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.4	1.2	0.6	0.0	0.0	0.0	0.0	0.6	5.5	0.0	0.7	1.3	21.5	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.0	0.0
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.1	14.8	23.5	10.4	24.0	8.7	16.9	25.2	36.3	15.2	24.0	16.2	11.5	14.7	21.5	14.4	12.9	7.3	19.0	23.6	24.8	19.7	28.6	10.6	10.5	24.4	24.2	16.1	13.1	20.4	13.9	11.8	24.2	15.6	12.7	18.3	16.1	10.1	19.4	10.6	12.7	10.8	24.0	13.9	15.8	5.7	23.8	17.5	16.5	20.4	11.1	13.2	14.9	25.4	36.8	41.2	42.5	29.9	28.1	23.4	23.1	24.6	26.8	28.7	29.1	20.8	26.4	11.2	68.6	25.2	39.2	25.8	38.6	43.0	35.6	26.9	83.3	18.8	51.1	55.3	14.9	29.9	14.8	15.7	22.5	32.0	11.1	32.4	29.1	32.5	32.1	46.6	20.4	43.4	25.3	49.9	30.3	42.4	36.7	25.8	34.7	32.3	37.1	24.7	27.0	48.1	28.5	13.3	27.0	32.0	20.3	25.9	30.7	13.4	19.9	36.8	17.7	15.4	18.5	17.9	38.5	28.3	14.7	42.7	37.1	40.6	41.8	41.1	41.7	49.2	43.7	40.3	38.0	45.6	44.1	44.8	15.7	41.1	39.4	44.6	58.1	39.6	23.5	24.0	25.2	36.3	23.6	24.8	24.4	24.2	24.2	24.0	23.8	25.4	68.3	67.3	48.2	14.0	44.4	43.2	63.3	167.9	36.5	26.7	67.2	94.5	84.9	78.6	89.4	119.5	8.4	162.8	44.5	99.2	181.9	125.0	13.5	78.6	66.7	71.5	92.7	71.7	17.8	117.9	89.0	59.9	45.3	56.6	57.6	46.3	92.4	288.5	110.3	28.6	17.8	93.7	128.1	72.9	44.9	9.3	74.6	50.7	60.5	7.5	69.6	90.7	80.3	16.6	27.3	136.3	114.9	81.3	38.7	51.5	162.0	296.1	95.9	42.9	85.5	65.9	94.6	19.6	42.6	51.3	46.9	120.7	44.8	53.9	88.5	54.8
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700468	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"U-2197: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	22.1	15.6	30.7	11.5	36.6	3.4	19.2	19.4	66.4	24.0	0.0	62.2	8.6	44.9	7.6	20.3	29.8	8.2	32.2	40.2	5.0	15.8	8.7	22.6	6.5	13.3	7.7	22.2	18.0	10.7	20.6	11.2	12.9	33.9	4.5	13.2	18.1	25.1	17.7	16.0	24.1	16.0	0.0	22.4	29.7	61.4	19.5	5.3	21.1	4.8	4.2	39.4	24.7	33.2	18.9	18.0	13.4	18.0	25.5	21.0	20.3	36.1	22.4	15.2	12.3	16.1	5.2	7.8	13.6	39.0	16.5	16.4	6.5	11.7	6.2	28.7	11.9	9.0	15.0	13.1	22.0	9.4	26.7	23.7	9.9	12.4	4.1	9.9	25.6	11.5	14.1	13.5	14.4	15.7	11.2	6.6	14.4	6.8	24.6	21.4	7.2	11.2	11.5	15.9	13.7	12.0	18.7	10.1	11.1	16.6	7.9	14.1	57.3	21.3	11.8	75.1	17.0	16.0	14.3	3.5	27.6	19.2	15.0	1.0	0.7	0.0	0.7	0.5	0.2	0.6	0.5	0.4	0.8	0.3	0.2	0.4	0.5	0.5	0.8	0.5	0.4	0.6	30.7	36.6	19.4	66.4	40.2	5.0	13.3	7.7	12.9	0.0	19.5	33.2	20.3	6.4	5.0	8.8	6.2	5.4	3.0	6.1	7.4	56.8	9.6	6.6	7.5	7.2	3.0	16.5	37.5	7.8	10.6	12.2	1.9	7.9	11.6	6.4	29.0	22.1	8.4	2.1	30.6	7.1	7.4	10.7	7.1	11.6	1.3	10.7	16.1	4.0	15.7	30.3	17.9	9.7	6.1	19.6	13.2	24.0	14.9	15.5	5.4	22.5	15.0	14.3	11.3	9.0	6.8	12.1	13.2	24.0	5.7	4.4	7.2	6.4	4.1	26.8	13.1	8.4	10.4	18.6	11.8	7.8	6.8	16.4	8.0	11.9	7.2	5.3
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027734-135034813	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 711.6;vagina: 199.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 121.0;Basal squamous epithelial cells: 409.2;Squamous epithelial cells: 1069.0;Urothelial cells: 257.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 141.4;HeLa: 108.9;K-562: 112.1;T-47d: 157.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA008743	Approved		Approved	Nucleoli		Yes	No				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli		"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	1.5	1.9	0.7	7.7	0.6	0.3	0.6	0.9	0.7	83.5	4.7	11.4	12.1	0.8	0.0	711.6	0.5	1.1	0.2	0.9	1.1	0.1	0.3	0.4	0.1	0.8	0.9	0.6	0.4	0.0	164.7	2.7	0.7	20.1	2.0	0.1	137.5	0.0	14.1	2.0	7.9	0.4	0.5	0.2	41.9	2.2	0.7	0.0	0.2	20.1	12.6	85.0	199.0	0.8	57.5	36.9	0.0	44.7	1.4	0.9	13.4	9.6	14.6	5.1	2.3	141.4	32.5	59.9	17.6	0.9	12.6	17.6	6.4	25.5	0.3	0.7	48.2	13.4	108.9	38.4	15.6	5.8	0.1	1.4	18.4	0.0	4.9	0.3	0.1	10.1	112.1	0.2	1.9	18.4	0.6	12.3	0.1	4.8	31.8	18.5	1.1	1.2	0.6	17.9	20.2	0.1	48.4	24.1	0.0	0.5	157.5	4.2	1.5	6.1	13.4	3.5	17.0	0.1	0.2	40.7	8.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.9	0.7	0.9	1.1	0.8	0.9	0.7	0.5	0.7	0.8	0.1	0.0	0.0	0.0	0.2	1.3	121.0	12.8	409.2	1.0	2.5	2.7	2.3	1.5	8.6	0.0	0.0	0.8	0.0	4.2	0.0	0.2	4.2	0.3	0.6	1.2	0.0	50.8	0.0	0.4	2.1	28.8	0.5	0.2	0.0	2.7	0.0	0.0	0.9	0.0	0.0	2.4	6.1	0.0	0.3	5.7	0.3	1.0	0.0	0.0	0.0	0.4	1.0	0.0	0.1	16.9	3.4	0.0	3.1	101.6	0.3	0.2	6.1	1.8	0.0	2.1	4.5	2.2	5.6	1069.0	6.8	7.7	0.9	0.7	2.5	257.3
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334713-109409974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: AB_2683485"	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	59.3	67.9	63.3	44.4	72.9	87.9	57.0	44.9	89.8	68.9	22.1	56.1	33.4	74.5	62.2	50.8	46.2	48.3	65.8	78.6	77.0	61.1	77.3	51.4	41.4	52.6	52.1	87.8	38.8	88.1	36.8	58.2	56.2	78.4	52.5	64.2	49.2	91.9	39.0	30.6	40.6	77.1	58.9	54.7	33.1	47.0	58.6	53.8	92.1	54.2	44.6	53.7	36.9	68.9	36.0	24.6	96.2	74.6	93.4	101.3	52.4	57.9	86.5	44.6	72.6	22.9	47.6	46.0	78.1	111.8	71.8	20.5	57.0	71.3	81.1	39.5	21.7	53.5	47.4	31.1	66.2	40.2	75.8	70.4	58.1	59.7	85.1	80.0	72.4	40.8	37.2	84.0	73.0	21.9	48.8	36.9	19.2	21.9	16.3	31.1	84.6	77.5	69.5	31.9	18.4	47.1	59.8	21.5	70.5	64.2	48.6	58.7	84.6	63.4	30.7	58.8	27.5	56.4	51.6	53.5	66.8	54.8	42.6	32.9	19.2	29.3	14.4	19.7	14.4	16.5	14.1	13.4	19.3	11.7	18.0	13.4	49.0	17.8	27.7	8.0	20.5	18.5	63.3	72.9	44.9	89.8	78.6	77.0	52.6	52.1	56.2	58.9	58.6	68.9	85.2	67.3	58.4	71.2	76.9	63.5	56.2	59.8	58.1	102.1	53.0	58.5	127.5	51.5	51.7	57.0	62.6	24.1	78.2	85.9	49.0	40.8	22.5	42.8	97.5	70.3	67.6	32.1	159.0	33.3	31.0	86.7	32.1	68.2	47.5	99.3	70.6	94.8	54.5	77.4	126.0	53.1	36.7	91.5	78.5	20.7	85.1	77.1	60.5	66.5	73.4	93.0	68.0	60.8	111.6	30.9	30.4	92.6	72.0	59.2	46.8	58.7	48.4	91.3	78.9	105.0	110.1	73.4	42.9	43.7	58.2	26.3	68.7	61.6	39.3	44.0
PJVK	DFNB59	ENSG00000204311	Pejvakin	Q0ZLH3	2	178451346-178462102	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 20.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 9.1;Distal tubular cells: 3.9;Granulosa cells: 6.1;Theca cells: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.8"	"Cell line enhanced"	"Detected in many"		"SuSa: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042621			Approved	Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042621: AB_10797503"	"unprognostic (4.01e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.06e-3)"	3.0	1.8	6.9	1.3	7.2	1.4	4.8	6.9	10.7	2.7	6.9	1.9	1.2	3.9	7.3	1.2	2.8	2.9	1.4	7.0	7.0	3.2	2.8	1.5	1.9	7.6	7.3	7.1	1.3	1.1	4.1	1.2	7.5	2.8	1.2	6.4	2.7	3.0	3.5	4.2	1.4	2.0	7.3	1.4	1.2	20.7	7.1	1.2	2.5	0.9	1.7	1.9	1.4	7.7	0.2	1.8	2.3	1.9	3.0	3.1	1.2	1.5	1.4	1.2	2.0	0.7	3.1	2.1	1.5	0.9	1.0	0.9	1.7	1.0	0.9	0.7	0.6	0.7	2.9	0.4	3.0	0.6	0.2	3.2	2.2	1.4	3.2	3.8	1.5	4.1	0.4	1.3	1.5	0.5	2.1	1.3	2.8	0.2	0.8	2.7	1.7	1.3	2.0	1.0	1.6	1.3	0.5	0.3	0.6	6.8	0.7	0.7	1.0	1.5	0.6	0.4	0.1	4.3	2.8	0.7	0.7	1.1	0.6	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.0	0.5	0.5	0.3	0.4	0.2	0.0	2.8	0.0	0.0	6.9	7.2	6.9	10.7	7.0	7.0	7.6	7.3	7.5	7.3	7.1	7.7	1.6	6.4	9.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	2.4	0.0	0.0	1.8	1.8	0.0	1.1	0.5	0.0	3.9	1.4	0.0	1.8	2.6	0.4	0.0	0.0	0.0	0.9	0.5	1.4	0.0	1.6	0.0	6.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	4.7	0.0	0.0
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 233.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 370.6;naive B-cell: 377.4"	"Lineage enriched"	"Detected in all"	11	"B-cells: 377.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 540.5;HSkMC: 211.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: AB_2685091"	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	90.3	76.6	77.4	59.0	80.0	20.7	74.2	70.9	95.6	105.2	78.0	189.1	30.3	111.4	37.8	76.4	101.7	73.8	289.9	82.7	82.5	104.5	44.5	162.9	49.4	80.9	77.0	57.5	32.3	66.8	69.1	82.3	72.5	102.4	31.5	26.9	45.9	75.3	104.8	31.4	72.2	92.6	73.1	42.7	81.8	68.3	83.4	19.3	68.4	91.1	46.7	169.0	68.9	73.4	27.8	27.9	44.7	28.8	67.0	135.7	6.2	66.0	540.5	73.6	55.4	64.7	12.5	108.3	52.7	58.5	61.2	10.6	9.0	14.4	23.9	54.8	16.3	16.7	4.1	45.7	61.7	2.1	1.1	211.7	28.5	35.8	7.9	36.4	167.5	29.3	13.4	2.6	6.8	35.0	17.2	27.5	23.7	0.2	39.4	2.8	1.2	2.6	40.7	5.5	18.0	58.7	16.9	7.9	45.6	19.3	21.0	13.6	108.5	99.9	44.2	44.8	32.3	13.9	41.9	76.3	49.5	1.9	43.8	2.9	1.8	0.7	1.5	1.7	1.3	370.6	1.9	1.8	9.1	377.4	5.4	8.8	2.2	4.4	1.6	35.8	1.0	17.8	77.4	80.0	70.9	95.6	82.7	82.5	80.9	77.0	72.5	73.1	83.4	73.4	93.3	9.6	6.1	26.8	82.9	25.2	14.4	20.3	10.2	24.6	37.6	45.1	233.6	24.3	15.7	46.0	20.9	15.1	6.2	44.2	127.2	70.6	110.1	104.2	91.5	122.3	44.2	34.9	65.9	30.8	17.8	93.2	5.1	18.5	47.5	27.8	65.0	37.8	8.2	10.1	42.7	15.7	32.6	3.8	20.4	40.1	73.0	14.2	49.8	22.5	8.1	94.1	3.1	25.6	25.4	39.1	46.9	61.3	11.8	11.6	19.3	156.6	78.3	28.7	118.3	19.5	153.0	155.9	27.4	5.3	30.0	36.7	8.5	80.8	29.1	10.2
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 19.6;kidney: 25.1;liver: 92.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 22.1;Hepatocytes: 16.3;Late spermatids: 23.0;Proximal enterocytes: 14.8;Proximal tubular cells: 48.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"K-562: 107.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	Cytosol		No	NA		5200000		"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.0	0.0	0.0	0.0	0.1	19.6	0.0	0.7	0.1	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	25.1	92.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.2	7.2	0.0	0.0	0.1	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.5	0.2	0.2	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1.5	0.0	1.8	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.2	0.3	0.1	0.0	22.1	1.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.7	16.3	0.2	0.0	1.2	0.9	0.0	0.0	0.0	23.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	14.8	48.9	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 4207.6;tongue: 2900.8"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 2065.2;Late spermatids: 1763.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		310000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	190.5	600.9	539.0	341.4	552.3	439.0	190.5	586.8	629.9	406.8	755.0	225.0	170.8	202.8	205.7	658.3	240.0	212.0	779.6	549.1	561.6	549.5	32.2	236.9	284.1	640.0	559.1	169.4	112.6	269.6	224.1	168.6	636.2	252.6	206.2	1266.7	389.8	291.6	4207.6	350.5	218.0	298.9	522.3	239.2	228.6	235.1	677.1	203.5	174.6	2900.8	429.2	578.5	374.9	530.6	1584.6	3937.1	788.9	938.8	914.3	1009.4	638.7	1684.6	3878.2	2619.1	2623.6	1094.4	1931.2	1184.5	1627.3	3157.6	1937.8	2253.9	2480.9	3383.2	2051.7	2134.0	1126.5	727.7	1809.1	929.7	637.1	955.2	1525.1	926.4	1559.2	2025.1	810.9	3403.0	1558.6	587.3	182.8	933.3	4267.0	965.1	359.4	419.6	966.2	2438.6	1433.3	1046.5	2560.0	2301.7	3557.2	1973.8	804.4	871.5	2226.3	1344.7	1755.4	1291.4	932.0	675.7	1247.3	3003.7	1622.0	2928.7	3110.3	1170.0	1762.1	1037.2	3720.5	1534.4	3002.3	131.9	836.3	138.6	192.6	466.7	187.9	205.2	254.1	190.4	685.6	142.9	215.8	162.5	100.7	108.4	380.1	140.5	334.0	1261.7	539.0	552.3	586.8	629.9	549.1	561.6	640.0	559.1	636.2	522.3	677.1	530.6	95.9	118.6	88.1	107.7	169.6	565.5	708.9	2065.2	307.9	480.7	157.8	174.7	313.2	87.2	759.4	829.4	369.1	566.1	100.2	358.9	802.2	1395.6	315.0	169.2	77.3	207.7	282.2	44.8	90.2	597.0	1416.7	220.1	138.1	188.0	206.7	144.0	73.2	4.3	750.0	1065.0	97.6	166.8	925.7	297.7	532.9	1763.1	157.2	558.8	355.8	38.4	1255.0	784.1	78.2	53.3	33.4	1213.2	264.5	268.1	209.9	431.4	389.1	208.7	396.9	708.6	124.9	160.9	398.2	43.4	98.6	341.6	389.0	575.7	192.7	157.4	380.7	860.7
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	"Protein kinase N1"	Q16512	19	14433053-14471867	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 102.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003982, CAB010278"	Approved		Approved	"Plasma membrane,Cytokinetic bridge"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Cytokinetic bridge"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	"unprognostic (3.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.24e-2)"	59.2	45.1	47.1	40.4	50.3	66.8	49.0	44.6	52.4	46.6	44.2	72.4	14.5	61.0	13.6	16.2	48.7	23.9	89.0	40.9	46.3	43.1	25.0	71.1	49.4	53.6	48.4	38.7	52.5	32.8	44.9	33.3	49.8	43.8	9.3	11.5	41.3	30.6	81.7	20.1	45.2	33.0	49.8	90.4	51.4	50.2	49.2	35.6	39.6	53.8	25.8	60.3	32.8	48.5	152.8	88.9	32.3	67.8	51.3	59.8	53.0	53.5	63.5	55.2	52.5	34.9	84.2	144.4	135.0	92.2	68.9	34.4	52.1	23.8	21.2	117.6	67.7	172.8	55.4	75.2	169.1	68.2	103.9	43.3	17.0	33.5	52.2	62.5	129.8	74.9	78.0	96.7	41.4	62.5	104.1	63.2	59.2	54.7	100.0	138.5	43.9	104.7	27.3	24.2	117.3	166.0	33.2	41.7	88.9	15.5	37.8	117.7	196.6	108.8	46.1	133.2	82.8	126.5	123.6	78.9	71.5	135.7	87.4	27.6	27.9	40.6	30.4	38.5	23.3	15.9	20.5	21.1	26.8	16.9	18.6	21.0	32.6	22.1	52.3	17.0	25.7	29.0	47.1	50.3	44.6	52.4	40.9	46.3	53.6	48.4	49.8	49.8	49.2	48.5	78.1	3.2	2.2	17.3	35.3	3.7	6.4	1.9	1.8	37.2	17.6	14.7	4.0	27.1	3.1	35.0	16.7	2.8	77.9	4.9	1.9	28.2	4.9	27.0	25.4	49.4	40.2	17.7	3.6	30.1	14.5	20.8	30.1	20.7	2.5	80.9	53.2	11.3	59.8	48.8	8.6	10.9	8.2	69.0	17.0	8.4	19.9	56.2	17.8	17.8	48.2	61.2	102.0	7.5	11.9	64.2	10.6	23.0	27.1	12.7	1.1	15.2	12.4	29.2	26.3	21.7	29.2	9.3	42.2	1.3	2.7	3.7	55.5	34.3	4.8	4.9
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 80.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 80.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	19.3	16.5	9.3	17.6	14.2	48.7	24.1	20.7	10.9	16.4	17.0	23.9	30.5	23.6	25.0	24.7	18.1	17.1	14.1	9.5	9.7	16.9	20.5	20.4	18.2	12.3	10.4	31.2	15.5	22.3	10.1	24.7	12.7	20.3	30.0	26.7	16.3	15.4	9.8	20.3	30.8	18.5	10.1	19.0	20.9	10.5	12.6	17.8	26.1	13.4	17.4	21.3	15.4	17.6	61.1	23.8	45.2	27.3	29.8	33.6	29.6	35.3	32.2	38.5	39.8	25.3	42.5	23.9	41.0	33.6	47.3	46.7	44.7	26.6	52.4	8.6	33.0	17.7	49.3	21.4	26.2	17.6	5.1	27.7	27.1	30.2	36.3	30.6	44.7	18.6	29.9	16.8	42.2	12.2	20.5	15.2	22.8	23.1	27.1	19.3	68.8	9.8	34.3	117.9	22.0	14.5	52.7	29.8	45.7	33.9	22.5	15.7	42.2	32.5	29.2	42.1	37.2	9.2	8.6	16.6	13.6	17.1	12.6	15.3	9.9	16.6	5.7	5.9	5.1	8.0	5.1	5.3	5.0	9.3	6.6	5.6	80.5	3.5	8.0	8.6	4.6	2.7	9.3	14.2	20.7	10.9	9.5	9.7	12.3	10.4	12.7	10.1	12.6	17.6	104.7	41.7	57.8	102.5	52.5	48.4	44.3	33.3	75.1	85.4	60.2	67.9	50.8	38.6	47.9	69.9	89.6	42.9	48.1	101.5	11.7	61.2	2.6	63.7	68.7	59.5	44.3	57.7	134.2	60.7	33.1	53.1	85.6	84.6	15.8	107.0	47.5	39.4	24.2	65.6	130.8	64.3	32.6	35.8	27.9	6.6	54.3	44.9	32.0	178.0	57.3	50.5	22.6	117.1	146.4	77.6	98.1	48.2	54.8	64.7	84.0	26.7	49.1	150.5	39.5	62.8	55.5	43.6	34.6	83.0	52.4	37.4	44.8	90.2	65.0	124.2
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	3.6	3.3	2.6	2.0	5.8	0.0	1.2	1.4	12.7	3.2	8.1	2.8	0.9	3.3	2.7	1.4	6.1	1.8	7.3	4.8	0.6	3.0	0.5	10.0	1.4	3.0	0.3	14.9	3.9	0.9	5.6	8.4	1.3	6.3	1.4	2.8	2.5	5.1	15.0	2.4	1.7	2.6	2.6	2.3	2.3	4.8	0.8	3.1	12.1	36.3	1.1	3.1	2.7	3.1	0.0	0.0	39.1	9.6	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	11.6	0.3	0.0	0.0	3.9	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	6.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.8	1.4	12.7	4.8	0.6	3.0	0.3	1.3	2.6	0.8	3.1	0.6	0.0	0.0	31.3	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	1.4	46.8	0.0	1.1	0.5	0.0	0.0	132.9	0.2	0.0	3.1	0.0	0.0	0.0	12.2	1.8	0.0	0.3	8.4	137.4	0.0	0.0	0.0	0.3	9.6	5.0	0.0	8.8	22.5	0.0	2.9	0.0	85.5	3.8	0.1	0.0	17.7	0.0	1.9	0.0	0.1	0.0	0.3	6.6	8.8	2.9	1.2	0.4	0.0	0.4	0.1	0.0	6.9	0.0	0.0
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094562	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 19.1;skin 1: 16.1;vagina: 22.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Glandular and luminal cells: 1.1;Ionocytes: 2.0;Prostatic glandular cells: 3.0;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 2.0;melanoma: 1.8;prostate cancer: 1.3;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RPMI-8226: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074206			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA074206: "	"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.3	5.2	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	19.1	0.0	0.2	0.8	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.4	22.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	15.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.4
PLAAT1	"A-C1, H-REV107, HRASLS, HRASLS1, PLA/AT1, PLAAT-1"	ENSG00000127252	"Phospholipase A and acyltransferase 1"	Q9HDD0	3	193241128-193277738	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 90.1;testis: 73.6;tongue: 44.5"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 12.5"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 12.9;NTERA-2: 11.0;PC-3: 23.8;RH-30: 10.7;SCLC-21H: 22.0;U-2 OS: 13.3;U-251 MG: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"	Cytosol	"HPA051179: AB_2681375"	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.9	2.5	4.6	0.2	4.9	0.1	1.8	3.5	6.0	0.4	0.8	0.6	0.0	0.9	5.9	6.5	0.5	0.2	9.3	5.1	6.0	0.7	0.1	0.2	0.0	4.5	4.3	0.2	1.4	2.1	2.2	0.1	4.2	0.1	0.1	9.0	2.0	0.7	90.1	3.3	0.3	1.3	2.3	0.2	0.8	73.6	3.9	2.2	7.0	44.5	0.3	0.3	0.4	4.5	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.4	0.0	0.1	0.0	0.2	0.0	5.3	0.0	12.9	0.4	0.6	0.0	5.6	6.9	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.4	23.8	0.0	10.7	0.0	3.7	0.0	22.0	4.1	1.5	3.3	0.0	2.1	6.5	0.1	0.1	0.0	13.3	0.0	18.6	0.1	0.0	0.0	7.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	4.6	4.9	3.5	6.0	5.1	6.0	4.5	4.3	4.2	2.3	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
PLAAT5	"HRASLS5, HRLP5, iNAT, PLAAT-5"	ENSG00000168004	"Phospholipase A and acyltransferase 5"	Q96KN8	11	63461404-63491194	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adipose tissue: 16.5;pancreas: 13.6;testis: 53.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Syncytiotrophoblasts: 1.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	64	"basophil: 5.4;eosinophil: 16.4"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 16.4"	"Group enriched"	"Detected in some"	5	"HAP1: 11.4;NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042493			Uncertain	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA042493: AB_10797499"	"unprognostic (3.16e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.83e-3)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (7.11e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.57e-3)"	"unprognostic (4.50e-4)"	16.5	0.2	1.2	0.3	0.9	0.1	3.3	0.7	0.8	0.1	0.0	0.7	0.2	0.5	0.2	0.8	0.9	0.6	0.6	1.0	1.3	0.1	0.0	0.6	0.1	1.5	0.5	0.6	13.6	0.0	0.0	0.0	1.0	0.4	0.2	0.5	0.8	1.3	0.1	0.2	0.3	1.4	1.1	0.1	0.5	53.4	0.8	0.0	0.1	0.1	0.0	0.5	0.1	3.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.7	0.8	1.0	1.3	1.5	0.5	1.0	1.1	0.8	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta associated 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 365.9;esophagus: 92.0;intestine: 236.0;lymphoid tissue: 155.1;stomach 1: 117.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1118.2;Distal enterocytes: 1514.4;Extravillous trophoblasts: 572.2;NK-cells: 1103.0;Paneth cells: 865.7;Respiratory ciliated cells: 549.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 2310.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 183.2;CAPAN-2: 510.7;HL-60: 329.1;NB-4: 160.1;RPMI-8226: 238.2;THP-1: 187.8;U-937: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	9.2	2.0	1.8	81.3	2.0	365.9	3.8	2.8	2.4	32.8	1.4	236.0	78.9	2.7	1.2	92.0	18.7	6.5	2.8	1.5	1.7	2.6	35.4	41.2	93.8	7.8	2.7	1.0	1.6	0.5	2.0	33.7	5.5	3.7	163.3	1.1	6.6	2.3	2.0	1.0	88.5	18.5	2.3	155.1	117.5	0.8	2.4	40.5	2.6	0.8	137.5	11.0	5.8	3.7	183.2	1.3	0.5	1.1	0.0	0.2	28.6	4.6	1.1	11.1	13.7	3.5	510.7	30.7	1.5	52.3	17.0	18.7	3.2	1.4	41.6	0.2	0.6	0.8	33.4	15.2	1.8	329.1	1.7	0.9	3.6	1.8	2.4	0.3	0.8	16.0	0.4	2.6	29.5	0.8	62.6	160.1	1.0	14.4	0.9	8.0	10.6	238.2	0.9	5.4	25.8	0.5	1.2	29.1	0.6	9.0	1.6	187.8	1.3	1.1	31.7	0.9	0.9	1.8	0.4	81.7	2.3	149.7	0.2	49.2	139.2	95.9	392.1	635.8	299.4	523.8	185.1	229.2	129.5	481.1	225.9	263.4	29.7	1053.3	358.9	2310.7	13.8	577.1	1.8	2.0	2.8	2.4	1.5	1.7	7.8	2.7	5.5	2.3	2.4	3.7	4.3	195.5	39.2	0.3	247.4	0.4	1.7	77.3	0.0	0.3	0.9	1.4	0.5	2.8	119.1	0.0	0.0	18.5	1118.2	1514.4	0.0	0.3	0.5	45.6	1.1	95.0	86.8	58.4	0.1	3.6	572.2	3.1	119.8	2.9	26.6	0.6	141.0	8.4	21.7	1.7	0.1	231.2	67.1	384.5	7.4	0.6	0.0	213.3	7.2	1.0	157.3	1.2	1103.0	0.0	0.2	99.0	865.7	0.0	35.7	1.1	374.4	1.4	549.6	0.3	6.6	0.7	8.0	0.2	0.8	10.1	0.1	14.2	150.6	0.1	104.2	9.0
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 252.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 99.0;RH-30: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: AB_2682893"	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.94e-6)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	37.7	74.8	4.1	18.5	5.2	21.7	29.6	1.9	7.0	31.4	5.8	28.8	9.6	29.5	9.0	32.9	20.8	26.9	26.4	3.8	2.9	17.0	3.6	26.7	12.1	3.6	4.1	36.5	27.7	9.5	81.6	252.3	3.9	26.0	21.3	1.6	30.1	12.1	12.2	61.9	20.6	19.7	3.2	15.6	26.9	8.7	6.0	6.6	13.8	22.3	12.1	39.6	34.4	4.0	0.2	5.0	99.0	0.1	39.4	78.0	0.3	32.9	21.6	16.1	33.5	0.3	6.0	2.7	16.0	30.4	4.0	0.0	0.8	12.0	32.2	3.1	4.4	45.2	58.7	0.9	13.9	40.9	8.9	60.5	4.6	15.8	13.8	23.4	33.5	16.1	4.4	0.8	18.0	6.2	16.9	19.8	17.2	0.0	3.7	20.7	94.1	0.1	33.1	1.1	8.7	10.3	51.0	0.1	0.1	29.6	0.1	50.1	19.8	0.2	35.2	77.7	36.4	9.1	9.0	0.6	25.3	16.6	2.0	4.9	12.0	25.1	1.4	9.1	1.4	3.7	1.3	1.9	14.9	5.8	0.9	1.5	21.7	2.2	2.9	6.7	2.0	3.8	4.1	5.2	1.9	7.0	3.8	2.9	3.6	4.1	3.9	3.2	6.0	4.0	19.5	51.3	51.0	28.4	15.2	21.7	14.6	5.3	34.1	2.1	16.8	14.0	8.4	5.7	12.6	5.5	0.0	4.6	19.0	16.1	7.9	11.8	1.8	8.6	91.9	23.8	16.7	19.3	60.3	11.3	15.0	143.6	11.7	13.0	18.4	38.7	8.6	0.2	20.3	8.4	76.6	33.6	18.3	26.8	27.8	5.5	138.5	26.8	8.8	49.6	37.6	0.9	2.1	10.6	5.5	13.0	22.5	97.0	5.7	52.0	4.3	15.3	4.4	0.4	13.1	61.7	31.1	0.9	1.0	24.1	43.3	9.9	10.0	205.8	28.5	19.7
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607855-218637184	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 166.0;skeletal muscle: 114.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 139.9;Cone photoreceptor cells: 246.0;Rod photoreceptor cells: 176.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009914, HPA038139, HPA038140"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Endoplasmic reticulum, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.5	2.7	4.5	0.2	4.4	0.0	1.3	4.5	7.2	1.4	3.5	15.6	0.6	0.6	0.3	4.8	0.6	0.4	1.1	4.5	4.6	10.7	0.6	0.6	0.1	5.6	5.1	0.7	0.5	1.7	9.6	0.2	4.9	4.4	1.7	166.0	2.3	0.3	114.0	1.0	3.3	1.3	4.2	0.3	6.9	9.8	5.0	0.1	1.6	30.4	0.1	20.5	2.0	4.7	0.0	0.9	1.2	0.0	0.3	1.2	1.1	0.0	2.5	0.4	1.3	0.0	0.1	0.0	1.5	0.4	0.4	0.1	0.0	1.5	0.3	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	2.8	0.1	1.9	0.5	4.2	2.8	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.1	4.3	0.0	1.8	20.2	0.3	0.1	0.1	0.2	2.1	0.0	4.5	0.1	0.0	0.2	0.2	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	4.4	4.5	7.2	4.5	4.6	5.6	5.1	4.9	4.2	5.0	4.7	0.3	0.0	1.1	7.8	0.1	0.5	0.3	0.9	3.4	139.9	1.5	0.9	1.0	0.0	0.1	0.0	246.0	0.1	0.1	0.0	0.0	0.1	21.4	0.6	0.4	1.5	0.0	0.0	6.7	0.0	13.5	0.7	0.0	1.0	0.0	0.1	0.7	0.0	0.6	8.4	4.9	0.1	0.0	0.0	0.4	33.8	0.3	0.2	0.0	0.0	0.1	9.1	0.0	2.0	2.3	0.7	0.0	0.0	0.0	0.1	0.0	2.2	0.2	176.9	0.0	6.1	1.8	3.6	1.2	0.6	0.1	0.8	0.1	0.0	0.1	0.2
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.7;MAIT T-cell: 6.4;memory CD4 T-cell: 4.1;memory CD8 T-cell: 3.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 4.3;NK-cell: 3.4;T-reg: 3.8"	"Group enriched"	"Detected in many"	9	"NK-cells: 3.4;T-cells: 6.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246"	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	33.3	22.4	36.2	21.7	37.3	10.0	31.8	43.8	41.3	42.5	27.8	25.2	17.8	36.1	13.7	18.9	31.9	19.9	31.9	35.6	32.9	23.2	9.7	32.4	36.4	34.8	36.2	42.6	11.4	13.3	21.6	23.8	34.2	30.2	13.7	10.9	20.2	20.5	18.5	31.5	28.8	22.9	32.0	30.0	19.4	26.3	39.5	60.5	45.0	20.3	24.0	30.4	32.0	38.6	16.6	20.8	97.2	71.6	38.0	26.5	30.9	26.7	34.1	52.4	44.3	50.1	5.4	37.0	31.9	29.1	55.0	30.2	42.7	47.8	30.4	10.5	22.7	2.6	36.4	59.6	28.9	14.7	9.7	34.1	26.3	38.8	30.0	47.2	59.4	77.3	28.0	23.6	48.0	123.8	90.7	11.5	36.2	21.3	37.6	71.1	70.8	18.2	28.7	30.1	34.4	65.7	47.8	22.1	48.4	54.1	25.8	17.0	64.6	124.4	40.3	40.2	32.9	26.1	12.4	30.3	29.7	15.6	52.9	0.0	0.0	0.0	4.7	0.0	6.4	0.2	4.1	3.9	0.0	0.5	4.3	4.3	0.0	3.4	0.0	0.0	3.8	3.0	36.2	37.3	43.8	41.3	35.6	32.9	34.8	36.2	34.2	32.0	39.5	38.6	33.4	16.0	7.0	69.2	5.1	5.6	1.8	5.3	14.8	4.3	4.7	5.8	9.6	1.5	3.8	3.7	10.4	1.9	7.4	9.4	0.0	3.3	7.0	5.4	16.9	24.2	1.8	2.1	9.7	1.6	2.0	11.5	10.2	10.3	1.3	19.8	11.7	3.1	4.0	3.3	9.1	9.5	4.1	2.9	4.3	7.2	15.2	1.7	3.6	16.9	1.2	6.7	2.1	13.0	16.4	3.3	4.8	18.4	6.3	2.3	7.8	3.0	1.8	5.1	13.1	8.5	10.2	15.9	13.0	6.1	7.0	0.8	17.0	5.7	6.4	0.9
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	9.0	4.2	69.4	33.0	141.3	30.3	8.5	706.3	105.2	5.0	347.5	8.6	17.3	8.6	22.5	4.6	5.5	13.4	4.3	40.1	122.6	23.4	14.3	9.4	66.8	301.3	122.7	1.6	3.9	2.8	1.2	8.2	207.3	2.8	7.0	0.5	7.1	3.4	1.9	4.0	19.4	8.8	241.5	34.8	8.7	2.0	283.3	10.0	6.9	3.6	72.0	10.1	3.9	437.2	1.4	3.2	0.6	2.9	0.2	0.2	4.0	0.3	0.4	2.3	0.8	0.9	8.1	183.3	30.1	0.2	7.4	4.2	4.0	0.5	1.4	1.4	2.1	22.1	0.4	0.3	1.2	22.3	84.2	0.3	1.8	1.3	1.0	0.3	4.2	8.1	2.5	15.0	0.4	5.7	2.6	55.5	3.1	2.3	1.3	75.1	0.1	23.7	0.5	3.9	1.4	0.4	5.0	1.6	1.5	3.9	3.3	67.7	1.1	0.4	3.2	0.4	0.6	35.2	61.4	403.4	0.3	30.0	1.6	9.4	12.1	76.2	1.9	16.1	0.9	51.1	0.6	2.9	10.7	49.6	0.8	1.9	65.7	41.3	36.8	7.0	0.5	6.9	69.4	141.3	706.3	105.2	40.1	122.6	301.3	122.7	207.3	241.5	283.3	437.2	187.0	12.8	54.0	0.0	138.3	2.9	1.6	2.3	1.8	224.8	139.5	113.0	7.2	28.6	13.1	16.5	104.3	13.6	94.0	0.4	13.7	2.6	20.5	65.5	88.0	61.7	21.5	23.2	0.7	0.0	2.2	30.6	16.8	86.6	40.4	29.0	37.1	43.2	27.7	101.0	0.8	2.7	65.1	47.4	9.4	30.7	11.1	46.7	8.8	95.5	21.8	221.7	47.4	2.0	1.3	0.1	9.8	4.9	138.6	3.5	5.5	5.9	6.9	196.2	6.6	28.0	51.9	4.8	2.9	3.0	2.3	11.1	48.2	8.7	1.9	6.5
PLCXD3		ENSG00000182836	"Phosphatidylinositol specific phospholipase C X domain containing 3"	Q63HM9	5	41306952-41510628	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;heart muscle: 33.2;ovary: 22.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 138.2;Endometrial stromal cells: 58.7;Enteroendocrine cells: 42.4;Inhibitory neurons: 163.5;Microglial cells: 52.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.5;PC-3: 7.5;SH-SY5Y: 34.3;TIME: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046849	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA046849: AB_2679838"	"unprognostic (1.71e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.12e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.15e-3)"	"unprognostic (5.91e-5)"	"unprognostic (5.11e-2)"	"unprognostic (6.75e-2)"	3.9	12.7	4.5	0.5	4.1	0.0	2.4	17.8	4.2	2.9	1.1	0.9	0.5	1.1	0.9	0.6	3.4	2.4	33.2	3.4	9.5	5.9	1.6	1.8	1.6	8.2	10.4	22.5	3.6	0.3	5.3	0.1	16.0	1.0	0.6	0.7	0.4	1.0	0.5	0.7	1.2	1.2	7.7	0.2	5.0	0.4	12.1	0.5	1.5	0.7	0.2	1.4	4.0	6.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.8	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.4	34.3	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	4.1	17.8	4.2	3.4	9.5	8.2	10.4	16.0	7.7	12.1	6.3	8.7	0.0	0.0	7.5	0.1	0.1	0.1	0.0	0.0	0.7	0.1	0.0	138.2	5.7	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.3	0.9	1.7	58.7	13.6	42.4	5.3	27.8	0.0	2.0	10.3	0.0	1.1	0.0	33.4	33.2	0.4	0.1	1.7	163.5	2.2	0.0	0.6	0.3	4.4	7.8	0.2	0.0	52.5	0.0	0.4	0.0	7.5	1.3	0.9	0.0	0.4	0.0	0.3	0.1	10.4	0.0	0.2	6.6	0.2	2.9	0.2	0.0	0.2	0.0	0.1	0.3	9.7	0.1	0.1
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600404-171810950	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 86.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 519.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004527, HPA042396, HPA066938"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.8	26.4	9.2	6.6	24.7	7.8	7.5	18.4	13.6	10.4	4.5	14.6	46.9	6.2	2.8	33.0	6.4	86.8	24.4	10.5	14.3	12.0	33.7	4.7	9.1	24.8	22.0	24.2	21.2	1.6	2.3	10.7	23.5	3.4	14.7	0.5	13.8	6.0	2.5	29.2	43.9	4.8	14.7	15.7	8.2	5.0	19.0	4.1	3.7	6.8	10.8	5.1	12.4	41.4	4.5	7.2	3.7	1.4	11.2	12.6	7.7	2.3	9.9	3.5	4.3	1.1	6.4	0.0	17.0	0.9	24.0	15.2	0.6	2.0	5.7	3.6	3.2	4.2	11.5	26.1	4.9	7.3	18.9	4.9	10.9	4.2	2.0	10.0	57.5	1.2	2.8	0.0	0.9	1.3	0.0	6.4	0.8	11.9	5.1	0.2	1.5	0.1	8.9	1.8	0.1	0.1	7.9	4.7	31.1	5.1	9.0	9.7	50.7	1.5	5.7	4.0	2.5	9.6	8.2	0.1	6.7	8.6	1.9	8.3	1.8	2.3	0.3	1.1	2.6	0.0	0.2	0.6	0.6	0.0	0.0	0.1	1.0	2.2	0.4	0.0	0.8	0.6	9.2	24.7	18.4	13.6	10.5	14.3	24.8	22.0	23.5	14.7	19.0	41.4	7.7	0.0	4.7	2.0	0.9	7.1	3.4	11.0	10.8	0.4	4.9	5.6	33.6	57.2	11.1	1.8	0.0	3.0	1.9	37.5	3.9	8.4	13.1	1.0	4.8	7.4	4.2	6.3	8.9	3.4	3.7	15.7	27.0	1.3	27.9	10.4	6.4	15.9	20.0	0.0	12.1	23.6	6.1	13.2	2.4	9.5	10.5	10.2	12.4	98.4	5.4	0.0	1.0	12.5	519.6	2.4	18.3	4.5	3.4	0.7	38.3	48.0	9.9	0.1	19.7	3.8	8.4	6.1	5.3	93.5	34.9	2.3	2.3	12.1	17.8	4.7
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524697	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 16.2;choroid plexus: 52.8"	"Group enriched"	"Detected in some"	6	"Inhibitory neurons: 319.5;Oligodendrocyte precursor cells: 127.6;Oligodendrocytes: 226.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	5	"cerebellum: 16.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.0;AF22: 10.3;HDLM-2: 5.3;SH-SY5Y: 2.9;U-2 OS: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol		No	No				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Vesicles, Cytosol"	"HPA028389: AB_10602145, HPA050367: AB_2681105"	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	0.4	1.7	1.7	0.0	2.9	0.0	0.4	16.2	2.5	0.6	52.8	0.2	0.0	1.1	0.2	0.4	1.1	0.1	0.1	3.4	2.5	0.4	0.0	0.2	1.1	2.9	2.6	2.1	1.0	0.2	2.4	0.4	2.8	0.8	0.1	0.3	0.7	3.0	0.2	0.1	0.1	0.9	2.0	0.7	0.3	1.5	2.2	0.4	0.2	0.0	0.4	0.1	0.3	2.7	0.0	3.0	10.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.9	16.2	2.5	3.4	2.5	2.9	2.6	2.8	2.0	2.2	2.7	0.1	0.0	0.0	7.8	0.2	0.1	0.0	0.0	1.2	0.5	0.0	1.7	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	9.1	2.9	0.6	0.3	0.0	0.0	35.5	0.0	0.0	3.1	0.0	8.2	0.0	0.7	0.0	0.0	0.0	3.3	319.5	0.2	0.0	0.0	0.0	21.0	5.0	0.1	0.0	5.6	0.0	0.4	0.0	127.6	226.8	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.2	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.1
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 53.4;Smooth muscle cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 63.4;BJ hTERT+ SV40 Large T+ RasG12V: 49.5;SK-MEL-30: 77.0"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"spinal cord: 45.0"	"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: AB_2678249, HPA048473: AB_2680409"	"prognostic favorable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	34.0	24.6	8.8	12.1	8.8	0.7	31.7	8.0	9.5	28.7	10.9	43.0	5.6	34.6	5.0	14.3	30.5	11.1	41.4	8.7	10.6	32.4	32.8	25.7	5.8	16.9	14.7	47.5	13.2	9.5	29.9	5.6	10.4	28.3	3.9	2.5	15.1	8.4	19.3	17.2	16.0	10.7	10.8	16.2	21.1	11.0	12.4	5.5	31.0	13.1	3.3	34.4	21.7	10.3	9.0	0.5	9.9	63.4	14.2	41.7	8.0	7.0	24.7	26.8	49.5	5.9	2.5	0.4	11.8	9.8	10.4	2.7	3.5	3.6	4.2	0.0	3.4	2.3	1.7	6.6	11.0	0.0	14.2	21.5	2.2	15.6	1.0	11.1	8.0	11.2	9.5	5.3	7.4	5.4	3.2	0.5	1.5	6.0	0.8	0.3	31.5	0.6	8.3	0.1	0.0	11.0	3.0	2.6	77.0	2.5	3.9	3.0	1.3	8.5	6.8	11.2	1.8	28.3	25.4	5.3	10.2	0.7	23.0	0.0	0.3	0.9	1.8	0.3	1.3	1.7	1.7	1.1	0.1	3.9	2.8	2.6	0.1	0.8	0.3	1.2	0.6	0.9	8.8	8.8	8.0	9.5	8.7	10.6	16.9	14.7	10.4	10.8	12.4	10.3	6.4	0.0	18.7	2.3	1.4	9.6	31.3	17.6	12.0	0.7	11.4	18.3	37.1	17.2	27.2	7.3	0.0	3.3	2.9	3.2	1.9	23.3	0.8	11.6	34.1	7.0	1.2	3.2	0.4	5.1	6.8	41.7	7.7	11.6	0.0	18.8	6.4	13.3	2.9	0.0	0.5	2.5	4.1	0.8	9.2	2.0	41.3	1.9	12.4	1.9	1.3	9.9	2.1	0.5	0.2	6.9	0.5	53.4	0.7	29.8	0.7	14.6	20.5	1.0	6.6	33.0	48.4	4.0	3.7	5.7	9.8	2.9	2.4	16.0	3.3	21.4
PLEKHA6	"KIAA0969, PEPP3"	ENSG00000143850	"Pleckstrin homology domain containing A6"	Q9Y2H5	1	204218853-204377665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.0;Distal enterocytes: 66.6;Excitatory neurons: 102.6;Inhibitory neurons: 62.5;Oligodendrocyte precursor cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 60.3;BEWO: 94.6;CAPAN-2: 79.2;OE19: 80.9;RT4: 66.4;SK-BR-3: 58.4;T-47d: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028152, HPA028157, HPA054311"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Vesicles	"HPA028152: AB_10601048, HPA028157: , HPA054311: AB_2682446"	"unprognostic (9.81e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.57e-4)"	5.1	6.6	20.4	6.0	21.6	0.4	13.7	20.9	34.4	4.1	9.1	32.2	25.5	4.8	12.9	17.2	9.3	13.2	20.8	19.6	18.7	27.4	27.5	3.2	0.6	23.1	24.3	4.6	10.2	5.7	31.1	8.8	23.3	13.8	29.3	11.4	9.0	13.9	6.0	4.0	29.5	3.8	17.9	3.1	39.7	5.4	34.6	1.0	4.0	2.4	2.4	12.7	7.5	24.1	60.3	36.8	23.7	0.1	0.3	0.6	94.6	2.1	6.6	0.2	0.3	17.8	79.2	0.3	17.3	1.4	0.3	6.7	0.3	6.5	0.3	0.2	3.8	0.2	15.2	25.7	3.5	0.0	0.1	1.0	19.6	0.0	5.0	7.2	10.4	0.8	0.1	0.2	23.9	26.7	0.1	0.1	7.4	80.9	44.6	0.0	0.2	0.1	23.0	66.4	4.8	48.4	26.6	58.4	0.4	4.9	55.3	0.3	0.7	0.0	1.0	0.3	0.5	0.2	0.0	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	21.6	20.9	34.4	19.6	18.7	23.1	24.3	23.3	17.9	34.6	24.1	0.2	0.0	10.9	111.0	0.3	0.1	4.2	1.9	0.6	41.6	15.7	8.1	16.6	37.1	4.5	9.2	20.9	6.6	0.5	66.6	3.9	8.4	10.4	4.0	1.3	1.2	16.8	2.7	102.6	5.1	2.4	9.0	40.8	6.2	0.0	0.3	5.0	21.4	0.8	18.5	62.5	32.7	4.1	0.6	0.7	4.0	5.3	0.7	0.0	15.0	0.1	1.2	0.0	85.5	41.8	13.3	33.2	3.8	0.1	6.9	15.2	11.7	7.2	7.1	0.0	26.4	1.1	0.6	0.2	1.4	0.6	21.6	0.6	0.1	34.5	13.7
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 91.2;Astrocytes: 98.6;Endothelial cells: 58.4;Microglial cells: 131.2;Oligodendrocytes: 168.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 23.9;naive B-cell: 22.9"	"Lineage enriched"	"Detected in single"	31	"B-cells: 23.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 26.4;Karpas-707: 23.4;U-698: 16.6"	"Region enhanced"	"Detected in all"		"thalamus: 51.3"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	15.1	1.6	9.8	9.4	12.3	2.4	13.7	15.5	8.9	7.5	3.9	5.9	4.9	5.6	10.8	9.4	8.7	7.9	6.9	5.8	8.7	7.7	4.9	10.4	14.7	19.5	16.2	3.1	2.7	6.7	3.6	14.2	18.3	2.7	5.9	4.7	3.5	4.9	3.5	7.4	6.6	5.6	18.2	31.2	4.5	6.3	19.1	22.4	5.7	5.0	13.9	9.1	5.3	21.5	0.0	0.2	17.6	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	10.1	4.4	7.2	6.8	0.0	1.6	2.5	26.4	2.4	0.0	11.4	2.9	0.4	1.4	0.0	0.0	0.0	1.9	1.1	6.7	0.0	0.2	0.0	11.0	5.9	0.0	23.4	0.0	0.3	2.3	0.1	1.3	7.0	0.7	1.2	0.0	0.0	5.1	11.9	0.5	0.1	0.1	3.1	2.2	1.9	0.0	0.1	11.2	0.1	2.4	0.0	4.9	0.0	0.0	16.6	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.7	23.9	0.4	0.6	0.0	22.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.7	9.8	12.3	15.5	8.9	5.8	8.7	19.5	16.2	18.3	18.2	19.1	21.5	91.2	0.0	6.2	98.6	50.3	4.2	0.5	5.5	2.8	0.9	2.0	3.3	2.1	1.5	6.8	7.3	0.0	5.5	0.7	7.2	3.9	2.6	3.8	20.7	6.2	58.4	5.4	5.0	12.8	1.1	1.6	11.8	7.1	19.2	0.0	7.9	35.0	4.3	0.6	0.0	5.8	8.2	8.2	5.9	3.8	1.6	0.3	2.0	5.4	131.2	4.7	11.3	0.0	14.1	168.5	9.4	12.4	0.4	5.2	1.1	3.9	3.6	9.6	0.7	0.0	2.0	3.0	0.7	1.5	6.2	3.7	2.9	5.1	1.1	5.5	3.6
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 179.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 24.0;NK-cells: 9.4;T-cells: 16.2"	"Cell line enhanced"	"Detected in many"		"A-431: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favorable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	25.2	3.5	44.0	10.7	92.5	16.3	23.4	47.2	74.1	33.9	53.0	39.0	13.0	67.5	5.0	45.8	38.1	22.6	17.2	44.5	46.7	36.0	36.3	14.3	5.6	65.8	66.3	33.8	33.0	17.0	6.8	29.3	60.9	24.2	15.5	2.9	29.2	37.5	9.7	44.9	13.2	26.4	37.9	26.6	22.3	5.7	74.1	4.6	23.7	7.4	4.9	32.2	39.1	179.2	78.4	36.5	29.8	45.3	3.1	0.0	49.0	8.7	10.4	13.8	11.0	38.9	34.3	0.0	15.3	8.6	4.8	74.6	20.3	69.7	4.7	0.2	16.7	35.1	48.3	9.2	4.0	1.3	16.1	3.9	39.6	2.9	24.4	22.9	9.1	0.3	0.0	0.4	4.6	37.5	0.1	32.0	10.0	21.2	37.0	0.4	14.7	5.5	37.0	58.0	9.9	18.0	17.7	26.7	25.1	27.5	29.0	8.0	16.6	6.0	59.8	0.3	12.3	0.1	0.2	0.1	0.6	3.7	10.7	9.0	3.0	18.2	16.2	1.5	11.1	0.0	5.0	7.3	1.0	0.0	0.5	3.6	24.0	9.4	1.0	0.0	1.7	5.3	44.0	92.5	47.2	74.1	44.5	46.7	65.8	66.3	60.9	37.9	74.1	179.2	3.1	3.2	6.2	15.0	0.7	19.4	19.4	15.1	21.6	5.5	16.0	9.8	7.8	12.8	6.0	47.8	0.0	7.9	14.5	24.7	11.7	26.7	0.9	18.6	18.5	4.0	34.7	0.4	1.0	20.6	9.5	7.4	14.3	23.6	1.3	1.9	3.6	10.1	5.5	0.0	3.2	26.9	18.3	6.5	8.0	1.5	7.5	2.7	5.4	6.5	4.6	9.1	45.3	10.6	90.9	35.3	16.7	25.6	2.8	16.1	2.3	9.5	4.0	0.8	26.3	5.1	25.3	0.2	1.6	25.6	21.5	2.6	9.0	10.5	13.2	32.2
PLEKHJ1	FLJ10297	ENSG00000104886	"Pleckstrin homology domain containing J1"	Q9NW61	19	2230084-2237704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 356.3;Proximal enterocytes: 372.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048989	Approved		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA048989: AB_2680590"	"unprognostic (5.11e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.03e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (1.10e-5)"	"prognostic favorable (6.99e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.26e-3)"	43.4	64.1	41.8	26.4	39.0	38.3	40.5	40.4	51.3	38.8	40.6	109.2	105.2	33.6	18.0	61.3	30.0	19.5	77.6	40.2	39.8	101.1	78.7	42.0	39.3	41.6	41.7	44.1	94.1	14.7	36.4	19.7	43.6	43.4	34.0	4.7	52.2	14.3	88.9	51.7	101.5	12.2	40.2	61.4	99.7	68.0	45.3	27.8	69.2	33.2	24.0	40.8	39.7	38.8	93.9	38.2	68.2	83.0	21.8	28.3	40.3	51.6	24.1	54.1	48.9	98.1	43.1	88.4	42.1	35.6	34.7	71.6	65.4	34.0	16.1	90.8	83.7	46.3	44.5	129.0	34.7	98.6	68.9	41.6	34.2	25.8	23.1	21.5	34.9	75.4	99.5	101.0	39.8	61.3	97.0	88.0	122.6	55.6	52.1	114.7	47.5	108.8	55.7	92.0	170.2	94.1	32.6	58.7	104.5	27.3	78.6	98.2	36.6	23.0	68.7	69.7	56.7	147.3	97.2	101.3	67.4	94.8	30.1	88.2	76.4	129.6	86.9	98.2	77.1	118.8	85.9	91.8	80.8	143.2	69.0	67.2	66.1	53.8	108.3	159.0	112.6	97.2	41.8	39.0	40.4	51.3	40.2	39.8	41.6	41.7	43.6	40.2	45.3	38.8	25.9	38.5	21.1	9.8	67.0	34.8	54.6	61.5	20.5	22.0	60.0	68.1	40.0	87.2	37.8	46.0	16.7	89.8	65.8	356.3	164.4	121.1	68.5	33.2	33.4	26.7	54.0	39.8	12.1	179.5	99.3	46.0	121.8	35.2	18.4	117.1	25.7	49.2	95.4	25.2	11.7	228.5	95.6	43.9	33.3	115.6	47.2	48.1	30.2	9.4	74.7	31.9	65.9	12.1	7.6	146.6	233.3	35.3	49.0	82.2	372.5	148.4	29.1	22.7	32.9	18.9	47.5	93.7	100.7	47.2	42.6	47.7	52.6	81.4	254.1	58.4
PLEKHO1	"CKIP-1, OC120"	ENSG00000023902	"Pleckstrin homology domain containing O1"	Q53GL0	1	150149183-150164720	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 202.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.9;Langerhans cells: 159.2;Late spermatids: 390.5;Macrophages: 147.9;monocytes: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061018			Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA061018: AB_2684416"	"unprognostic (1.41e-2)"	"unprognostic (7.04e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.47e-11)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.52e-2)"	27.7	43.2	49.9	53.9	50.1	17.9	22.6	52.8	61.6	32.3	45.5	202.3	17.8	50.7	5.2	17.5	43.5	20.6	59.3	49.5	47.9	15.9	8.7	34.9	49.5	49.8	48.1	28.1	5.1	4.1	14.9	15.1	48.0	45.5	11.5	4.2	11.0	16.2	39.6	11.2	58.4	40.4	48.9	59.9	55.8	83.2	48.0	33.9	13.0	15.2	26.0	97.5	23.6	48.9	14.3	3.4	46.3	36.0	14.4	12.7	3.8	24.8	32.9	31.8	28.1	1.0	0.4	0.4	4.7	28.5	23.9	1.2	23.3	1.1	10.3	86.7	12.1	2.8	1.9	8.9	27.1	20.0	77.7	18.5	1.0	39.8	6.2	30.6	30.6	38.5	5.4	35.9	43.9	6.7	76.0	40.0	43.7	0.0	6.4	68.1	25.2	16.2	5.6	4.1	28.8	46.9	2.0	0.2	18.7	22.1	2.4	19.4	43.4	20.8	24.1	21.9	30.1	14.0	0.4	9.2	83.4	0.2	8.2	2.6	25.9	0.5	5.6	24.8	6.0	20.0	8.2	5.9	20.1	17.2	5.6	4.7	30.9	4.1	23.4	27.3	6.7	9.2	49.9	50.1	52.8	61.6	49.5	47.9	49.8	48.1	48.0	48.9	48.0	48.9	23.5	35.3	8.9	32.3	65.1	21.5	92.7	2.9	4.6	7.9	11.8	17.9	36.4	2.8	2.9	0.0	0.0	1.7	97.5	0.5	1.9	8.8	245.9	17.9	50.2	58.9	17.8	4.2	13.5	7.8	3.3	29.4	4.6	22.0	5.7	24.5	42.5	1.8	107.1	8.4	24.3	0.9	10.2	85.5	159.2	390.5	17.4	147.9	24.9	21.5	151.1	34.0	23.7	9.0	1.6	10.7	0.0	24.5	23.7	50.1	0.2	0.5	1.3	6.2	72.3	7.5	105.0	122.5	17.5	2.9	14.2	1.5	45.6	8.6	0.4	23.0
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 764.9;breast: 316.5;skeletal muscle: 249.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 12.3;Astrocytes: 12.1;Cardiomyocytes: 35.9;Hepatocytes: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"ASC diff: 249.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Enhanced	"Lipid droplets,Plasma membrane,Cytosol"		NA	NA		55000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Lipid droplets"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (8.31e-4)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	764.9	3.9	8.5	6.4	9.4	2.7	316.5	8.0	5.1	8.8	2.5	70.7	2.3	28.7	2.0	9.6	18.5	8.5	112.8	5.0	6.7	7.6	87.1	3.4	0.8	9.8	9.7	21.8	24.7	0.1	4.4	0.1	7.3	13.4	3.9	0.2	22.6	15.1	249.9	16.3	18.9	20.4	8.5	4.9	25.1	2.7	11.1	0.9	4.1	163.4	0.2	34.3	7.2	7.1	0.1	0.4	0.1	0.7	249.6	1.6	8.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.4	0.0	1.2	0.1	0.0	1.8	0.0	0.6	0.3	0.0	0.1	1.4	3.6	0.1	0.1	8.1	4.7	0.0	0.4	0.1	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.2	0.3	0.1	5.7	0.3	0.0	0.2	0.0	29.7	0.1	0.4	0.3	0.0	0.0	0.1	1.3	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	9.4	8.0	5.1	5.0	6.7	9.8	9.7	7.3	8.5	11.1	7.1	12.3	0.0	7.2	12.1	0.2	0.3	1.2	0.4	0.6	0.3	0.9	3.9	35.9	7.2	2.1	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.3	1.6	0.4	1.0	0.0	0.0	0.3	1.5	0.3	1.7	3.6	0.6	0.0	1.0	7.5	30.6	0.1	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.6	0.0	0.5	0.0	0.6	0.0	4.1	0.0	0.4	0.0	0.9	0.9	0.0	6.6	5.9	1.8	0.5	0.4	0.3	0.3	0.4	0.1	0.3	0.3	1.9
PLIN5	"LSDA5, LSDP5, MLDP, OXPAT"	ENSG00000214456	"Perilipin 5"	Q00G26	19	4522531-4535224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 202.0;skeletal muscle: 149.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 47.1;Astrocytes: 53.8;Cardiomyocytes: 39.8;Hepatic stellate cells: 42.1;Hepatocytes: 140.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.9"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 13.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;BEWO: 3.2;RT4: 3.1;SH-SY5Y: 2.8;T-47d: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA077050			Supported	"Vesicles,Lipid droplets"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 15: Hepatocytes - Hemostasis"	"Vesicles, Lipid droplets"		"HPA077050: "	"prognostic favorable (7.68e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.24e-2)"	"unprognostic (6.06e-3)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"prognostic favorable (2.16e-4)"	41.9	6.4	10.8	3.5	11.2	5.2	29.3	6.9	9.6	7.5	12.8	5.4	1.5	2.7	3.9	3.4	12.6	2.0	62.7	8.5	8.1	30.1	202.0	9.3	0.5	8.4	9.2	90.8	112.2	1.5	18.9	0.2	6.9	17.6	0.6	0.9	61.0	3.9	149.2	8.0	5.3	0.5	6.8	8.2	58.9	3.3	9.4	0.4	9.8	24.7	1.0	11.2	2.7	6.4	0.2	0.1	0.5	2.3	1.7	0.1	3.2	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.4	0.3	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.7	0.2	0.1	0.6	0.1	0.4	0.4	0.3	0.3	0.1	0.1	2.1	0.2	3.1	0.3	2.8	0.2	0.4	0.0	0.2	6.3	0.4	0.3	0.3	0.3	0.2	0.2	0.3	0.1	0.1	0.2	0.6	0.1	1.9	0.4	0.8	0.3	0.3	0.2	0.3	0.2	0.2	0.1	0.4	0.3	0.3	13.9	0.6	0.3	0.3	0.1	0.1	10.8	11.2	6.9	9.6	8.5	8.1	8.4	9.2	6.9	6.8	9.4	6.4	6.0	9.6	47.1	53.8	1.6	0.5	18.4	2.3	4.0	1.2	9.2	1.9	39.8	35.8	11.5	1.8	0.0	0.4	0.1	11.9	9.8	8.7	1.5	20.8	1.4	7.4	0.0	2.7	1.1	12.3	0.5	1.3	16.3	5.1	3.8	18.7	42.1	140.5	0.5	0.0	1.8	6.9	4.1	6.9	0.5	0.3	0.3	2.5	0.0	5.6	0.1	8.1	0.0	11.1	2.0	4.8	1.3	2.6	0.5	6.6	0.5	11.1	10.4	1.2	13.1	25.8	1.8	6.2	6.6	0.5	1.0	1.4	1.1	20.5	8.8	11.5
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460139	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 380.7;Extravillous trophoblasts: 257.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"NK-cell: 9.1"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1060.6;T-47d: 396.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	24.3	8.4	25.6	7.4	35.7	9.3	40.6	6.4	31.2	37.9	16.4	11.8	9.3	29.0	9.3	35.5	21.0	32.1	54.7	44.4	10.4	15.7	31.1	32.3	7.2	8.1	12.3	19.3	23.4	5.9	6.3	47.6	8.4	17.7	14.6	2.1	42.9	10.5	7.4	47.3	12.9	26.6	7.3	83.6	10.4	38.1	11.8	7.2	18.0	13.6	7.6	29.8	32.1	16.8	131.1	115.6	38.3	3.1	19.9	31.9	15.1	27.1	44.8	86.3	49.8	8.6	112.1	0.0	176.3	95.2	208.3	159.8	1.7	61.5	75.6	0.3	3.5	0.0	50.8	9.7	106.1	0.6	3.6	18.7	82.0	33.3	90.9	1060.6	175.4	0.0	0.1	4.4	169.8	47.5	0.3	0.2	7.6	12.4	18.5	6.3	106.5	0.0	221.6	25.4	2.3	5.1	82.4	16.0	76.0	66.1	396.9	2.0	231.9	24.3	63.8	11.0	217.8	0.1	0.3	0.3	18.8	0.3	110.7	2.2	0.5	1.9	0.1	1.2	0.0	0.8	0.5	0.0	2.2	0.6	0.9	0.4	1.5	9.1	0.5	1.5	0.4	0.4	25.6	35.7	6.4	31.2	44.4	10.4	8.1	12.3	8.4	7.3	11.8	16.8	144.6	19.2	15.8	5.9	23.4	141.7	194.1	116.1	380.7	3.8	108.5	203.7	128.9	30.0	134.9	18.4	4.2	66.5	22.7	66.3	9.8	109.8	10.9	132.7	67.8	178.7	84.3	2.7	44.3	77.9	257.3	107.8	136.6	165.4	9.5	4.1	89.3	7.7	14.9	0.0	22.8	39.9	124.1	8.1	19.3	5.0	12.8	39.5	24.9	15.9	3.2	3.3	0.0	3.5	4.9	103.2	44.6	10.9	8.2	76.1	38.5	5.5	31.6	2.9	0.0	74.0	106.6	65.1	10.4	184.9	103.4	129.8	21.2	7.4	45.6	63.1
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880893-127899224	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 22.6;lymphoid tissue: 14.4;testis: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.0	1.1	0.4	4.9	0.5	22.6	2.0	0.2	0.7	0.9	0.1	3.5	2.8	1.5	0.6	3.2	1.3	1.1	0.5	0.5	0.6	0.6	0.8	0.9	7.4	0.5	0.5	1.0	0.4	0.6	0.2	3.6	0.4	0.9	4.3	2.1	0.9	0.9	0.1	2.3	2.9	1.8	0.4	1.6	2.0	22.6	0.6	14.4	0.9	0.7	7.3	1.3	1.4	0.4	26.1	12.1	44.3	22.9	1.5	4.2	20.1	24.9	17.6	32.4	33.3	17.0	26.1	34.9	9.0	13.9	26.3	16.7	31.6	19.9	49.6	27.4	13.1	31.6	20.0	16.0	0.5	45.2	35.9	1.4	2.0	29.7	13.6	5.9	25.3	26.3	37.5	45.2	27.6	18.2	69.9	20.1	20.7	26.3	13.6	36.0	30.9	12.1	10.8	16.4	24.4	20.0	15.8	14.2	7.6	18.7	11.5	19.3	11.0	25.3	24.4	17.4	31.4	23.1	27.4	49.0	13.0	33.7	28.7	0.0	0.1	0.4	0.4	0.2	0.3	0.1	0.5	0.5	0.2	0.2	0.1	0.6	0.0	0.4	0.1	0.1	1.2	0.2	0.4	0.5	0.2	0.7	0.5	0.6	0.5	0.5	0.4	0.4	0.6	0.4	1.6	0.0	0.6	0.0	1.6	1.7	0.9	1.7	1.2	1.8	1.0	0.9	0.9	0.0	0.6	1.8	0.0	6.0	1.9	2.0	0.0	0.6	65.9	4.7	1.0	1.0	2.4	19.6	0.8	0.4	12.9	1.6	4.1	2.0	1.3	7.5	0.4	0.5	3.7	0.0	0.8	3.3	6.1	1.3	0.6	87.5	2.8	1.5	0.0	1.0	1.2	1.1	1.0	1.0	1.2	0.1	0.5	0.4	8.7	0.7	0.5	0.6	3.7	0.8	0.0	0.4	3.6	53.5	13.4	6.8	0.9	3.8	2.1	0.8	4.5	1.7
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494761-56645301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.4;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4"					"Low region specificity"	"Detected in all"			HPA072751	Approved		Supported	"Golgi apparatus"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	168.4	53.0	93.9	33.6	94.2	13.1	139.8	87.3	105.9	294.6	50.7	56.7	24.0	107.2	56.2	51.3	122.5	66.3	84.6	88.3	90.6	91.4	182.0	87.0	22.4	107.5	108.1	81.9	36.8	130.2	23.1	225.5	87.7	102.8	41.8	19.0	76.2	169.7	50.9	82.1	45.8	65.6	86.8	23.3	66.0	37.3	113.2	29.8	327.6	63.0	19.9	139.2	142.8	88.6	3.3	10.8	14.1	1.5	710.0	351.8	34.5	39.3	39.7	35.5	17.4	31.8	6.2	5.2	4.6	59.3	39.4	5.9	2.1	0.8	7.4	0.0	9.4	1.3	4.4	44.5	17.3	0.1	0.0	438.1	3.0	34.2	28.6	25.1	34.1	0.4	2.9	0.1	39.0	3.2	0.1	0.5	43.3	9.2	42.6	0.1	0.1	1.7	6.1	32.6	0.4	28.1	12.4	16.1	4.2	42.6	5.2	0.0	21.6	176.2	14.4	660.4	1.8	0.0	0.0	0.0	31.0	1.7	12.7	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	93.9	94.2	87.3	105.9	88.3	90.6	107.5	108.1	87.7	86.8	113.2	88.6	148.5	25.6	18.9	0.0	7.2	0.0	19.8	0.0	35.3	3.9	12.2	31.2	0.0	44.3	13.0	22.0	0.0	127.0	1.1	8.1	21.5	21.5	7.9	13.9	139.4	148.3	2.4	8.0	0.0	9.2	9.8	392.7	5.6	16.3	3.8	8.1	779.6	132.6	38.8	0.0	0.0	8.5	0.0	35.2	0.0	28.3	1092.6	14.9	0.0	0.0	0.9	136.0	0.0	0.0	0.0	7.9	5.9	398.7	7.1	20.8	15.5	21.3	4.4	4.1	138.1	179.7	107.2	4.5	3.4	16.4	0.0	214.9	5.0	22.4	7.2	20.1
PLPP5	"DPPL1, HTPAP, PPAPDC1B"	ENSG00000147535	"Phospholipid phosphatase 5"	Q8NEB5	8	38263130-38269243	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 264.5;Prostatic glandular cells: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 80.2;memory B-cell: 211.8;naive B-cell: 305.9"	"Group enriched"	"Detected in all"	7	"B-cells: 305.9;granulocytes: 80.2"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 140.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055777			Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA055777: AB_2682915"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-3)"	"unprognostic (3.66e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (8.72e-5)"	"unprognostic (9.79e-2)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (8.33e-10)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-2)"	12.6	18.6	12.5	21.5	13.0	16.6	24.4	15.8	16.1	29.4	36.5	30.2	41.6	16.1	81.7	13.9	28.3	27.9	8.6	12.6	14.4	27.6	33.0	16.0	28.1	12.7	13.5	18.6	114.5	13.7	52.4	14.0	12.4	74.5	35.5	8.5	85.7	30.5	4.8	10.7	40.3	11.4	11.5	28.0	46.1	7.8	13.5	10.2	29.2	3.0	32.3	21.2	14.1	13.0	15.1	29.7	17.4	35.7	33.2	32.1	23.9	42.1	52.7	21.0	27.3	13.8	22.7	1.0	35.1	43.8	30.5	16.5	14.5	30.9	18.2	9.6	9.3	26.6	13.1	40.5	56.3	7.8	30.8	25.3	31.5	29.4	38.3	37.2	34.7	34.9	1.3	67.2	25.9	31.2	17.7	13.0	26.5	61.2	10.0	19.1	12.8	140.0	53.3	19.4	13.6	20.8	17.3	26.5	25.4	15.4	56.9	15.0	21.2	14.8	13.1	25.2	11.3	41.5	29.4	4.5	41.0	20.5	26.1	80.2	12.9	23.4	13.4	13.7	23.0	211.8	17.8	17.7	12.2	305.9	8.8	8.5	8.0	22.4	19.7	26.0	18.0	17.0	12.5	13.0	15.8	16.1	12.6	14.4	12.7	13.5	12.4	11.5	13.5	13.0	22.2	9.6	46.2	0.0	110.8	0.0	81.8	0.0	25.6	5.9	49.4	42.3	0.0	32.9	21.7	75.4	16.7	45.1	14.8	12.4	43.0	68.0	30.6	70.3	27.3	27.9	44.9	9.9	0.0	89.9	43.5	41.5	50.4	54.8	31.5	38.1	17.5	23.4	36.5	62.2	0.0	62.6	0.0	10.1	0.0	8.9	17.7	23.0	0.0	0.0	12.0	37.4	18.6	0.0	0.0	57.2	31.1	9.4	264.5	146.3	74.3	24.9	55.4	3.6	13.1	22.8	18.9	31.4	12.3	20.8	0.0	88.1	25.2	18.5	44.1	59.1
PLPP6	"FLJ46512, FLJ90191, PDP1, PPAPDC2"	ENSG00000205808	"Phospholipid phosphatase 6"	Q8IY26	9	4662294-4665258	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.2;Late spermatids: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HDLM-2: 99.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018096	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA018096: AB_1855609"	"unprognostic (2.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.88e-2)"	3.6	6.6	3.8	6.2	4.0	1.5	7.3	7.0	5.0	5.0	8.7	9.3	10.5	4.0	12.7	7.4	3.3	4.6	2.8	4.3	3.3	5.4	18.9	3.4	8.2	3.4	3.6	4.0	17.2	7.7	4.7	7.1	3.6	16.4	9.9	5.1	7.7	4.8	1.9	8.2	11.4	3.4	3.3	6.0	11.3	5.9	3.3	6.1	7.1	1.5	8.4	5.2	5.1	3.5	8.2	8.3	8.8	10.9	6.9	7.7	8.8	5.5	7.1	4.4	5.0	2.2	5.3	7.9	2.2	5.5	10.9	10.0	6.2	7.8	4.6	99.2	5.9	15.7	8.7	11.3	6.3	5.7	11.4	8.5	6.2	3.4	7.5	5.8	6.6	8.8	2.7	8.1	5.6	8.8	5.4	15.0	8.1	8.2	2.9	5.3	0.0	6.1	7.6	9.3	22.0	11.1	6.5	5.8	3.5	10.8	8.2	12.7	7.8	3.9	3.3	5.3	3.6	1.7	6.4	2.0	6.1	4.1	3.7	6.8	4.1	3.5	3.1	3.7	3.6	2.6	5.6	4.8	4.2	3.3	9.6	6.9	1.8	4.2	4.4	3.2	8.6	4.1	3.8	4.0	7.0	5.0	4.3	3.3	3.4	3.6	3.6	3.3	3.3	3.5	2.8	6.4	2.7	0.0	2.6	0.0	2.5	0.0	2.8	7.5	4.2	2.7	0.0	5.7	1.3	1.8	2.1	18.6	2.9	9.7	1.9	11.0	82.2	2.1	3.4	3.0	10.9	2.1	0.0	13.9	2.9	2.3	7.1	5.3	0.0	4.1	4.2	15.3	6.5	3.3	0.0	7.3	0.0	4.7	0.0	46.3	2.8	1.7	0.0	0.0	3.0	4.6	3.1	0.0	0.0	10.8	6.5	4.9	1.5	7.5	13.4	2.8	0.0	4.9	0.0	1.7	1.8	0.5	1.1	4.6	0.0	10.4	3.4	3.5	5.1	3.1
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 91.2;skeletal muscle: 210.1;tongue: 74.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 18.8;Horizontal cells: 8.4;Leydig cells: 5.0;Skeletal myocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.1;ASC diff: 11.4;ASC TERT1: 8.6;SCLC-21H: 11.3;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	4.8	9.7	10.0	1.1	11.5	0.4	4.9	16.4	13.9	6.3	1.4	9.6	0.7	6.4	0.6	2.5	5.1	2.1	91.2	10.6	9.1	4.2	0.3	2.1	0.5	11.0	10.7	8.7	2.3	1.2	4.7	0.5	11.1	4.9	0.5	4.0	3.4	2.5	210.1	1.4	3.1	2.7	8.8	2.4	3.1	5.0	11.7	0.4	1.8	74.4	0.3	6.7	4.0	11.0	0.0	0.0	2.2	11.1	11.4	8.6	2.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.3	4.5	2.4	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.6	2.8	0.0	0.0	2.9	0.0	3.1	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	11.3	8.7	0.0	0.1	0.0	0.3	0.3	2.8	0.1	0.1	0.7	0.5	0.0	0.0	0.4	0.0	1.9	0.0	1.8	0.0	2.6	0.0	0.0	1.7	0.0	0.4	0.0	0.0	2.3	0.5	0.2	0.2	0.0	1.3	1.5	1.0	0.0	0.9	10.0	11.5	16.4	13.9	10.6	9.1	11.0	10.7	11.1	8.8	11.7	11.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.0	1.8	2.1	0.1	0.1	0.0	1.9	0.0	1.4	0.1	1.7	1.4	0.0	1.3	0.0	0.6	0.7	4.1	0.0	0.1	0.0	0.8	1.1	0.0	0.5	8.4	0.0	0.0	0.0	0.3	0.0	1.7	5.0	2.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.3	0.0	3.8	0.7	0.0	0.0	2.3	0.0	3.7	0.0	7.0	3.0	0.0	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028727-101325135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;kidney: 15.6"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 37.2;Early spermatids: 12.3;Proximal tubular cells: 39.0"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 3.7;SCLC-21H: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130"	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.0	0.1	9.7	0.0	12.8	0.0	0.7	7.1	12.7	0.1	5.2	0.2	0.0	0.0	2.8	0.0	0.2	0.0	0.0	10.4	9.3	15.6	3.6	1.4	0.0	10.2	9.1	0.0	0.3	0.0	0.1	0.0	9.8	0.2	0.1	1.5	0.3	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.1	0.6	10.9	0.4	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	9.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	12.8	7.1	12.7	10.4	9.3	10.2	9.1	9.8	9.6	10.9	11.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	2.3	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	37.2	0.0	12.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	39.0	0.0	1.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.3;Alveolar cells type 1: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 3.7;plasmacytoid DC: 12.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 12.2;NK-cells: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA020433: AB_2670440, HPA076083: AB_2686773"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.72e-4)"	"prognostic unfavorable (7.04e-4)"	120.8	32.4	33.2	36.3	40.6	1.4	71.4	44.3	43.6	83.7	22.1	46.4	21.8	120.5	76.2	117.8	68.3	83.1	57.9	30.7	34.9	113.2	202.0	139.8	24.2	43.5	40.1	101.5	31.4	12.7	11.7	78.4	42.2	43.6	31.8	11.9	46.8	103.2	31.4	119.5	25.0	119.4	38.4	99.8	37.7	22.3	39.5	27.2	175.0	48.8	41.9	75.4	88.5	47.9	206.2	207.1	176.8	51.5	174.3	161.7	269.3	208.2	233.1	194.5	233.9	225.0	167.2	0.8	590.0	171.9	140.6	256.7	190.5	339.1	314.2	2.9	235.8	19.4	234.6	95.0	157.5	0.1	9.6	103.1	159.5	302.7	211.1	315.3	429.5	16.8	0.5	0.3	188.9	59.7	0.4	2.3	234.6	88.0	243.2	0.4	117.8	4.9	233.1	109.1	0.6	36.9	436.8	107.9	89.7	253.7	60.2	3.0	474.3	314.5	53.9	324.6	422.8	7.8	30.5	4.2	137.6	0.8	133.4	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.1	0.0	0.1	3.7	0.0	12.2	1.4	0.2	33.2	40.6	44.3	43.6	30.7	34.9	43.5	40.1	42.2	38.4	39.5	47.9	209.3	211.5	88.6	26.8	2.0	124.9	121.4	79.6	48.9	0.2	5.6	25.4	17.9	24.3	79.4	99.3	0.0	4.0	1.6	3.5	13.7	59.0	8.4	33.0	39.4	130.5	13.2	4.4	12.3	53.8	105.3	74.3	31.1	64.1	0.0	60.5	64.2	92.1	3.9	0.0	47.6	6.9	38.7	5.0	21.7	8.0	51.9	3.0	56.9	40.3	0.6	26.4	0.0	1.5	97.9	68.6	6.5	82.8	1.6	80.7	2.2	22.0	31.2	1.5	52.6	19.8	132.3	1.2	17.7	65.5	134.1	4.5	3.6	131.1	11.1	100.6
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544856	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Host-virus interaction"	"DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.6	23.0	11.4	86.7	12.5	64.4	45.9	12.7	17.6	25.9	11.9	65.0	39.8	28.2	31.0	47.9	40.0	66.1	24.3	12.1	13.5	71.9	49.2	49.3	40.6	17.4	14.2	34.9	38.3	16.8	15.4	56.3	15.3	23.7	59.5	9.8	49.1	49.6	10.8	13.6	45.4	41.9	16.2	64.5	44.0	17.1	14.7	30.0	27.8	17.6	39.4	68.1	29.5	14.0	106.2	41.5	26.4	12.1	40.9	65.0	40.5	32.6	88.4	319.8	418.6	34.0	88.1	8.4	75.6	20.6	245.9	86.2	21.2	32.7	56.6	32.9	21.6	66.1	12.5	25.2	292.9	40.3	35.4	106.3	53.3	36.6	182.3	52.6	49.4	19.1	44.7	104.0	66.9	41.0	30.6	16.1	25.8	71.6	37.6	27.4	28.1	2.9	95.9	29.6	16.3	0.0	42.6	20.9	569.9	35.8	20.7	46.8	30.6	26.9	22.7	59.1	55.8	79.2	15.6	0.4	27.0	29.0	23.3	41.1	157.6	44.3	20.8	159.6	30.0	25.2	13.5	18.5	105.8	19.7	9.3	13.9	100.0	57.8	94.8	28.5	8.3	79.3	11.4	12.5	12.7	17.6	12.1	13.5	17.4	14.2	15.3	16.2	14.7	14.0	191.4	35.3	43.0	12.7	28.2	37.0	106.5	92.1	26.2	0.7	36.0	22.6	7.3	124.4	110.4	95.6	0.0	53.7	25.4	134.2	74.3	291.6	2.0	56.1	24.5	135.2	33.1	18.3	7.1	217.4	114.1	74.8	47.9	58.2	28.4	60.5	100.6	29.7	139.9	0.0	9.0	71.5	79.3	86.2	162.9	6.8	114.9	185.5	48.0	35.6	72.3	64.3	32.0	7.1	0.3	157.6	110.3	45.9	18.2	79.6	40.7	75.0	133.5	1.6	39.5	63.4	59.2	1.5	2.4	21.8	28.6	44.5	25.9	42.6	69.4	211.9
PLSCR2		ENSG00000163746	"Phospholipid scramblase 2"	Q9NRY7	3	146391421-146495991	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 13.2"	"Group enriched"	"Detected in some"	30	"Early spermatids: 195.5;Late spermatids: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051352			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA051352: "	"unprognostic (1.11e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.94e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.23e-2)"	0.2	0.1	0.4	0.3	0.2	1.1	0.3	0.2	0.7	0.1	0.2	0.3	0.2	0.1	1.8	0.2	0.7	0.5	0.0	0.1	0.7	0.6	0.2	0.2	0.1	0.9	0.6	0.1	0.9	0.2	0.1	0.2	0.7	0.3	0.4	0.5	0.3	0.5	0.0	0.0	0.2	0.2	0.6	0.1	0.4	13.2	0.6	0.2	0.5	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.2	0.7	0.1	0.7	0.9	0.6	0.7	0.6	0.6	0.6	0.4	0.0	0.0	0.3	0.2	0.3	0.1	0.1	0.6	0.0	1.3	0.6	0.0	1.5	0.2	7.3	0.0	0.2	1.5	0.7	1.9	1.6	195.5	1.4	0.1	0.4	1.8	0.0	1.0	0.6	0.1	0.5	1.5	0.7	0.0	0.4	0.4	0.1	0.1	0.0	1.1	0.3	2.0	0.0	1.1	246.0	1.8	0.6	0.0	1.0	0.0	1.2	0.0	0.0	0.2	0.5	1.0	1.5	0.0	0.3	0.1	1.5	1.4	0.3	0.0	0.7	0.3	5.4	2.6	0.1	0.1	0.0	0.2	0.2	0.9	0.3
PLXDC2	"FLJ14623, TEM7R"	ENSG00000120594	"Plexin domain containing 2"	Q6UX71	10	19816239-20289856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Microglial cells: 1508.4;Oligodendrocytes: 470.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3"	"Group enriched"	"Detected in many"	13	"dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.4;U-2197: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017268, HPA070793"	Approved		Supported	"Nuclear bodies"		No	No		720000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA017268: AB_10965928, HPA070793: AB_2686313"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.66e-2)"	12.4	9.4	13.3	7.3	14.1	5.2	11.5	9.6	13.3	12.7	16.8	5.3	4.2	10.7	3.5	7.5	10.1	17.4	10.2	11.3	25.6	10.7	3.1	17.1	2.4	18.0	17.3	9.4	3.6	16.2	3.3	4.7	19.2	7.6	4.6	18.2	6.2	7.7	5.0	15.5	7.1	16.2	16.2	9.4	3.8	5.9	22.3	2.5	6.8	10.0	2.8	8.5	8.9	29.1	0.0	0.0	5.8	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.7	2.2	1.8	0.0	0.0	0.7	2.8	8.6	0.4	19.4	0.0	0.0	7.7	0.6	0.0	2.3	8.9	0.0	0.0	0.1	1.7	0.9	1.1	0.6	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.2	2.4	0.4	0.0	1.8	0.8	0.9	0.0	7.6	3.9	45.9	0.0	0.1	0.0	0.0	3.5	0.1	0.0	10.7	57.5	11.8	1.3	33.4	2.7	0.0	0.0	0.3	36.0	0.0	0.0	0.0	81.6	4.4	37.3	1.6	0.0	17.7	13.3	14.1	9.6	13.3	11.3	25.6	18.0	17.3	19.2	16.2	22.3	29.1	101.4	16.0	8.9	131.9	2.6	36.8	23.8	12.3	41.5	44.2	14.4	45.3	10.9	15.7	10.9	5.5	8.4	0.9	2.9	7.1	0.0	6.9	2.9	16.5	7.6	45.3	3.0	10.5	190.9	0.0	8.1	97.2	1.1	19.4	31.6	80.9	82.1	4.2	94.3	1.7	59.9	27.3	8.2	91.3	46.3	2.1	19.3	147.7	7.2	1508.4	94.5	25.5	5.2	158.3	470.2	1.0	16.6	57.2	3.8	5.5	16.0	22.2	3.0	73.6	19.7	110.1	12.7	1.6	1.2	35.5	38.1	1.2	4.2	71.4	8.8	11.7
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		10000000		"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	11.2	7.6	13.9	7.0	13.0	1.0	9.6	0.6	16.4	11.6	0.5	9.1	3.4	10.9	2.3	11.3	10.2	4.8	15.8	14.0	7.9	8.6	3.2	14.7	6.3	5.5	5.6	13.8	9.3	24.0	5.5	8.2	5.6	9.3	1.9	1.7	12.9	6.3	10.9	15.1	7.9	5.2	1.3	13.2	7.9	9.0	14.8	6.3	9.6	6.1	4.2	9.8	10.0	5.5	45.3	21.1	22.8	18.1	29.3	32.7	36.3	26.3	22.2	14.8	14.7	70.2	20.6	5.0	38.6	28.4	20.0	68.2	11.7	51.6	6.1	7.2	18.6	0.7	13.4	18.3	19.2	5.4	3.6	32.8	35.4	27.4	21.2	14.9	7.5	14.7	26.3	9.1	16.1	26.3	10.6	9.9	22.0	14.2	18.5	14.0	58.0	14.1	12.9	89.4	20.2	22.1	19.1	17.9	24.7	14.7	28.8	33.9	28.0	23.6	30.0	43.4	28.1	5.5	3.9	9.8	33.9	10.2	25.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.9	13.0	0.6	16.4	14.0	7.9	5.5	5.6	5.6	1.3	14.8	5.5	1.9	48.1	4.1	8.8	1.8	15.8	5.6	23.4	6.2	6.7	6.6	7.4	13.0	1.5	18.6	12.9	4.2	21.8	0.8	3.6	0.0	8.9	4.4	5.0	10.0	3.8	9.6	0.4	22.1	6.9	2.5	13.8	7.1	5.6	0.0	20.8	2.2	0.9	13.1	20.2	11.3	4.0	0.0	7.4	12.8	1.0	7.8	7.4	8.8	5.6	1.0	2.5	1.0	13.6	3.6	17.0	2.3	6.4	3.1	21.3	7.4	1.5	11.2	3.3	6.6	6.4	9.9	5.3	9.5	6.7	16.1	7.3	2.2	4.7	5.1	9.5
PMEL	"D12S53E, gp100, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"cervix: 80.5;endometrium 1: 32.2;skin 1: 115.2"	"Cell type enriched"	"Detected in many"	32	"Melanocytes: 1472.7"	"Cancer enriched"	"Detected in many"	500	"melanoma: 2481.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	68	"SK-MEL-30: 8590.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA		11000000	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA031649: AB_2673976"	"unprognostic (4.63e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.04e-1)"	3.3	0.8	0.2	0.8	0.2	1.8	8.3	0.7	0.5	80.5	0.3	1.3	1.6	32.2	1.5	0.7	1.2	1.6	0.6	0.3	0.0	2.1	5.0	0.9	5.6	0.0	0.4	4.3	2.3	1.7	0.7	2.8	0.1	0.9	1.2	0.4	3.5	0.8	0.3	115.2	2.1	3.5	0.0	0.5	1.1	4.8	0.0	0.7	1.1	0.2	2.2	1.3	4.0	0.3	14.8	1.1	5.6	0.2	83.6	0.6	126.2	0.9	0.8	1.9	2.0	12.8	6.0	2.6	6.1	0.8	0.3	2.5	0.6	1.0	1.6	3.0	2.1	2.4	2.5	0.7	0.3	1.0	1.4	0.5	1.0	1.2	0.6	1.3	1.0	1.1	0.5	1.8	0.5	2.7	0.4	1.0	17.1	2.8	0.3	1.6	3.5	1.5	1.4	2.7	0.5	2.6	0.3	2.5	8590.9	4.6	4.4	8.8	1.4	0.9	6.5	0.7	7.9	2.1	10.4	3.2	1.0	2.7	0.3	0.0	0.3	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.7	0.5	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.1	45.9	0.8	1.1	2.8	0.0	1.0	0.9	0.4	1.5	2.2	0.0	0.0	12.1	0.0	1.5	0.0	2.1	8.0	0.7	0.2	1.2	0.0	0.8	0.1	2.3	12.4	1.6	1.1	0.5	0.0	11.1	0.0	2.9	1.7	0.0	0.1	1.6	0.0	0.3	14.6	5.3	12.2	0.6	1472.7	1.0	0.6	0.2	0.0	0.0	0.1	1.0	0.6	0.7	1.2	0.5	2.4	2.8	1.0	0.0	0.0	0.2	1.7	3.9	2.6	1.0	10.2	24.9	0.4	1.3	1.6	0.4
PMF1		ENSG00000160783	"Polyamine modulated factor 1"	Q6P1K2	1	156212993-156240042	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (1.17e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.62e-2)"	39.3	39.6	33.5	29.6	35.9	73.7	42.8	35.1	39.5	47.2	33.0	38.3	30.6	42.6	24.4	50.0	34.8	26.0	69.7	33.3	34.7	56.6	62.3	38.8	46.8	37.1	34.9	42.9	39.4	56.3	34.9	29.9	36.5	47.2	26.8	16.8	42.9	27.1	113.3	54.2	36.7	28.6	35.0	52.5	43.6	15.1	34.9	45.6	50.7	89.7	39.7	39.4	41.7	38.6	68.2	82.5	86.8	66.1	16.1	33.5	67.3	34.6	48.7	91.4	75.4	101.6	95.3	62.2	73.3	44.5	31.6	44.4	88.1	57.7	47.0	44.6	104.6	46.3	59.3	91.8	33.3	65.8	61.3	30.2	57.2	41.2	43.0	36.3	69.9	44.7	69.9	70.1	45.0	138.2	69.2	84.7	151.5	99.6	72.2	75.2	46.3	123.6	97.2	50.5	79.0	99.5	57.4	65.4	45.6	63.2	106.1	79.7	40.7	39.4	50.5	44.4	69.4	52.0	58.1	123.7	31.9	63.1	55.7	18.4	85.7	40.5	43.9	60.6	39.6	54.0	43.0	41.4	70.0	45.6	41.5	42.0	59.9	49.5	55.2	95.9	75.5	77.7	33.5	35.9	35.1	39.5	33.3	34.7	37.1	34.9	36.5	35.0	34.9	38.6	25.5	19.2	25.1	0.0	38.2	49.8	87.2	108.6	3.4	12.3	39.5	33.4	11.9	51.5	57.4	75.4	12.5	136.3	63.4	21.5	176.1	98.0	5.3	22.1	26.3	41.5	49.1	13.2	0.0	99.0	115.7	34.7	8.6	36.5	45.0	50.3	47.2	56.7	80.5	8.4	0.0	46.6	61.1	40.3	43.9	6.0	39.1	34.2	85.4	0.0	59.6	71.2	43.3	0.0	0.0	81.6	52.1	28.2	11.7	51.5	44.7	120.1	15.6	28.8	26.3	36.6	35.7	14.7	33.4	7.6	51.0	157.5	47.3	66.1	52.5	83.8
PMF1-BGLAP		ENSG00000260238	"PMF1-BGLAP readthrough"		1	156212982-156243332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Proximal tubular cells: 2.5;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (8.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.65e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.85e-4)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.36e-1)"	7.0	9.0	6.8	2.2	7.1	4.6	5.0	7.6	11.5	10.8	7.3	9.5	2.8	6.7	5.1	5.2	7.3	3.6	16.2	6.8	7.3	8.6	7.6	4.9	3.4	6.8	6.7	10.0	5.7	3.8	10.3	4.7	6.8	11.0	1.6	4.9	7.7	4.1	13.3	4.3	4.6	2.9	6.8	6.5	6.5	3.5	6.9	3.0	8.7	10.0	2.5	6.8	7.2	8.4	8.9	8.4	11.6	7.8	3.0	7.4	5.2	7.8	5.0	7.5	6.0	6.6	7.9	7.7	12.8	7.0	3.1	6.0	10.8	10.1	3.5	13.4	18.4	5.3	8.5	12.5	14.5	5.3	9.3	9.7	9.3	7.0	6.2	6.9	7.3	7.0	5.4	12.4	5.0	11.1	4.7	11.3	23.7	5.9	16.1	8.7	4.5	11.4	4.8	4.2	7.9	10.3	5.2	2.0	13.6	10.0	11.8	20.9	7.9	3.7	3.8	4.6	7.0	7.4	9.4	11.5	4.7	6.9	7.5	2.3	5.7	3.1	2.8	3.9	2.9	2.7	4.6	4.3	4.2	7.7	6.2	3.6	6.4	3.0	4.3	4.4	5.6	5.7	6.8	7.1	7.6	11.5	6.8	7.3	6.8	6.7	6.8	6.8	6.9	8.4	0.6	0.0	1.5	0.3	1.3	0.0	0.5	0.1	1.8	0.0	0.5	0.4	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	3.9	0.4	0.0	0.4	1.1	0.3	0.0	1.3	0.2	0.0	0.2	1.1	0.5	0.4	0.0	0.6	0.7	0.5	0.4	0.0	0.3	0.3	0.0	0.6	0.0	0.1	1.5	0.8	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.1	0.1	0.4	2.4	0.1	0.4	2.5	1.5	0.0	6.6	0.3	0.6	0.3	0.5	2.2	0.0	1.0	1.3	0.2	0.6	0.3
PMPCA	"Alpha-MPP, CLA1, INPP5E, KIAA0123, SCAR2"	ENSG00000165688	"Peptidase, mitochondrial processing subunit alpha"	Q10713	9	136410641-136423761	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	29.2	58.1	27.0	20.6	27.6	31.4	27.1	27.0	34.6	29.2	36.8	32.2	24.8	26.8	10.4	34.5	27.5	17.9	73.2	28.0	27.3	37.3	110.8	25.4	27.1	27.1	27.6	29.3	28.8	26.9	38.8	20.8	27.9	31.8	15.3	8.8	28.4	16.1	69.2	37.6	30.6	15.3	25.6	38.2	35.3	37.8	27.9	21.4	29.4	50.0	17.0	28.0	27.8	26.7	48.7	87.7	41.8	84.5	30.8	45.0	63.2	49.3	39.6	67.2	48.9	101.1	56.5	67.4	50.5	50.3	36.2	110.2	77.9	72.0	30.0	97.2	92.8	54.6	113.2	123.6	53.9	71.7	44.9	66.3	48.9	52.6	27.0	38.2	58.0	61.2	140.2	43.4	42.6	132.1	68.1	90.1	85.4	86.2	82.2	83.0	59.1	149.9	46.3	33.9	85.4	56.1	66.6	92.9	58.6	28.6	127.6	95.5	48.2	47.8	50.7	39.8	63.8	26.2	37.4	73.5	62.9	61.3	43.9	37.4	50.5	36.5	53.2	51.9	51.4	52.5	49.0	57.2	61.7	48.8	57.9	50.2	11.9	67.2	51.5	31.4	52.7	62.2	27.0	27.6	27.0	34.6	28.0	27.3	27.1	27.6	27.9	25.6	27.9	26.7	17.3	16.0	26.7	14.7	24.2	27.5	40.2	65.0	27.9	24.7	19.3	15.2	35.9	15.7	32.8	22.0	22.9	103.1	22.5	28.0	49.0	32.9	24.6	25.6	23.5	21.7	20.8	23.5	13.8	30.7	50.4	23.7	21.9	26.2	24.7	44.2	19.6	57.2	37.8	18.5	11.4	24.2	44.7	19.2	14.6	15.8	19.0	17.4	16.0	6.5	21.0	22.9	14.4	8.5	8.0	31.6	20.9	22.6	26.6	22.6	25.6	46.9	22.6	27.4	39.5	22.4	27.9	37.7	42.4	23.2	26.9	103.8	21.7	77.0	38.6	28.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing subunit beta"	O75439	7	103297435-103329511	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		19000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	30.8	42.0	16.9	22.3	18.2	53.5	32.5	18.9	22.1	33.3	24.7	33.4	38.0	29.9	26.2	27.7	29.3	25.1	44.9	18.8	18.1	47.4	46.1	22.6	36.4	16.5	16.6	35.4	41.1	39.7	22.4	25.8	17.6	31.5	33.2	25.4	30.6	28.1	34.8	33.2	32.4	26.3	17.2	28.2	35.8	26.7	17.4	30.2	33.4	38.2	33.9	29.3	28.4	19.9	30.2	42.8	49.9	69.4	28.5	57.1	38.0	26.7	45.6	54.3	62.8	47.7	33.7	76.9	41.7	47.9	58.0	37.5	59.7	43.2	49.2	26.4	69.4	26.4	74.0	61.6	35.0	35.0	30.6	53.4	40.5	41.8	39.6	51.3	28.8	55.9	52.5	77.9	48.5	71.1	59.2	82.0	59.2	60.4	52.4	42.7	34.3	79.4	50.3	54.2	62.2	76.5	37.3	108.6	55.8	49.5	45.3	49.1	24.9	48.3	57.9	85.1	52.3	57.4	79.9	61.8	35.7	59.3	38.2	16.7	19.3	13.2	18.3	21.4	20.1	25.9	21.1	18.5	24.7	19.3	26.1	21.7	5.7	17.9	19.7	12.6	30.2	22.3	16.9	18.2	18.9	22.1	18.8	18.1	16.5	16.6	17.6	17.2	17.4	19.9	32.0	32.1	36.9	27.1	54.5	36.7	68.2	123.2	51.8	31.6	41.3	37.3	70.4	41.5	70.7	27.6	22.9	125.6	55.9	35.8	72.4	75.6	106.3	38.4	37.0	37.1	27.1	65.8	36.8	73.2	61.3	42.5	35.7	35.0	60.2	49.9	31.1	53.7	54.6	23.5	33.9	48.1	75.3	49.4	30.7	24.0	51.9	42.4	26.6	18.7	92.5	35.8	58.7	35.7	44.4	59.7	45.4	49.7	56.1	35.2	60.4	127.5	58.2	37.9	65.7	48.6	73.5	125.4	56.4	47.1	37.5	124.9	55.9	63.3	59.1	62.2
PMS1	"MLH2, PMSL1"	ENSG00000064933	"PMS1 homolog 1, mismatch repair system component"	P54277	2	189784085-189877629	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 474.4;Late spermatids: 570.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031013			Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA031013: AB_2673696"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (5.31e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.29e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.92e-2)"	"prognostic favorable (3.73e-4)"	9.2	9.0	9.6	12.0	8.2	12.1	11.6	14.7	9.7	10.8	7.6	7.7	7.4	13.3	15.7	6.3	9.7	8.3	7.0	7.8	10.0	6.3	7.7	8.0	13.7	7.5	8.2	11.9	8.3	7.3	9.8	8.7	8.7	9.5	9.1	18.4	9.9	10.2	9.4	11.5	8.4	10.2	7.2	13.2	13.0	48.4	9.5	8.0	10.6	6.6	10.7	7.4	7.5	11.4	13.8	11.8	29.9	23.8	16.1	24.3	26.6	25.3	12.3	21.2	25.4	19.6	18.1	39.7	14.0	10.6	15.1	19.2	29.9	18.7	29.5	30.3	17.4	39.5	24.1	30.3	22.5	23.3	17.3	15.6	18.4	19.3	39.7	18.8	22.4	27.6	34.0	20.8	26.1	9.7	27.6	32.2	31.6	14.1	27.6	31.9	19.5	38.8	20.9	19.6	27.8	19.3	18.5	12.5	19.6	36.2	13.4	20.1	17.3	22.8	15.4	14.7	23.2	16.6	21.9	34.4	13.1	20.4	14.7	2.9	6.4	3.7	13.6	4.2	13.3	14.4	10.1	15.5	6.4	15.9	10.6	13.0	3.0	12.0	5.2	10.0	10.8	4.8	9.6	8.2	14.7	9.7	7.8	10.0	7.5	8.2	8.7	7.2	9.5	11.4	18.5	16.0	14.4	45.1	22.7	6.9	8.9	12.9	21.6	30.8	13.7	14.6	16.3	10.0	15.8	5.5	8.4	16.4	18.7	3.6	0.0	7.6	474.4	17.3	26.6	14.8	12.0	10.9	68.6	8.0	11.7	18.5	13.7	11.7	13.3	27.7	8.2	9.6	9.2	10.1	80.2	7.3	16.2	16.0	5.1	570.1	21.8	14.9	7.2	43.1	9.8	11.2	22.6	80.9	64.8	6.4	4.3	19.5	30.1	7.5	4.9	6.1	27.0	28.0	13.1	16.3	15.0	25.3	25.9	19.3	7.0	5.2	20.9	22.2	11.1	4.3
PMS2	"H_DJ0042M02.9, HNPCC4, MLH4, PMSL2"	ENSG00000122512	"PMS1 homolog 2, mismatch repair system component"	P54278	7	5970925-6009106	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010235, HPA066490, HPA070310"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250"	"unprognostic (5.13e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.23e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-2)"	5.3	5.1	6.7	5.3	7.2	5.8	6.5	6.3	7.6	4.8	2.8	4.8	5.7	4.9	5.0	5.3	5.7	4.0	4.1	7.4	5.8	10.4	4.7	4.4	8.4	5.3	5.6	5.7	3.9	11.0	4.6	4.8	5.5	5.2	4.7	8.4	5.7	5.5	4.5	11.9	5.3	5.3	4.4	5.9	5.0	4.0	5.2	8.8	9.2	3.5	8.9	5.1	4.9	7.0	15.1	16.7	12.9	32.2	9.0	13.6	10.9	7.8	5.8	6.6	5.6	14.0	9.9	28.2	8.7	10.9	17.2	19.6	19.2	6.6	8.0	11.3	7.2	12.0	12.5	10.1	15.9	15.8	9.4	15.1	14.8	5.4	22.3	11.4	13.7	15.2	22.9	12.6	11.9	15.5	5.2	17.1	13.3	7.6	9.6	16.3	15.3	14.0	16.4	11.0	11.9	25.7	13.3	23.0	16.2	18.0	27.1	11.8	12.4	9.3	21.2	14.2	14.6	19.8	32.8	27.5	7.2	15.3	22.9	5.0	2.9	1.9	4.5	4.1	4.9	3.4	3.5	3.8	3.0	3.4	4.4	3.4	1.4	2.3	1.8	3.1	3.4	3.4	6.7	7.2	6.3	7.6	7.4	5.8	5.3	5.6	5.5	4.4	5.2	7.0	12.2	12.8	8.2	11.4	13.6	5.0	9.3	10.9	15.9	13.2	10.7	11.3	3.2	12.8	9.7	11.0	22.9	9.4	15.2	1.8	35.2	5.5	9.9	11.0	14.6	10.1	5.4	8.4	14.0	3.3	6.3	6.6	8.2	11.8	5.1	11.4	7.9	7.6	5.2	30.3	12.2	2.2	10.2	7.1	5.9	6.6	12.8	6.3	7.2	5.6	8.7	7.8	20.6	3.5	8.3	4.7	2.6	10.1	9.6	12.6	2.2	39.5	9.3	14.3	26.3	10.0	8.0	34.5	11.7	10.5	8.1	12.7	11.4	11.9	2.6	11.1
PNMA1	MA1	ENSG00000176903	"PNMA family member 1"	Q8ND90	14	73711783-73714384	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 84.2;Peritubular cells: 84.7;Spermatocytes: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA003817, HPA015007"	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Focal adhesion sites"	"HPA003817: AB_1079646, HPA015007: AB_1855502"	"unprognostic (2.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (7.49e-5)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.90e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (4.51e-5)"	35.5	30.2	75.0	20.3	80.5	8.8	20.6	55.5	85.6	37.6	34.7	56.7	13.9	46.3	54.6	23.4	38.1	24.6	23.3	77.3	90.0	27.8	4.9	15.5	16.4	62.1	62.5	53.4	9.2	8.0	53.1	21.4	62.9	48.8	16.5	59.9	10.9	89.3	12.0	9.8	24.9	52.3	66.9	19.2	26.0	71.0	78.4	19.0	18.5	10.4	12.5	41.7	26.6	70.3	48.2	42.8	72.3	54.1	53.1	56.0	29.9	49.8	27.8	44.5	32.5	40.6	29.2	1.1	33.8	60.7	42.4	31.6	56.0	29.4	45.7	45.7	34.7	27.2	35.8	30.7	56.8	15.3	41.6	49.8	35.1	53.4	33.5	87.4	68.1	28.7	23.9	29.3	61.2	117.6	30.5	37.1	21.8	24.6	149.0	47.5	45.0	1.1	58.8	1.5	85.4	65.5	87.5	19.9	40.4	43.6	97.0	25.6	66.5	89.3	71.7	54.9	41.1	25.7	42.9	14.2	88.3	21.4	30.3	2.9	1.8	4.7	8.5	3.5	5.8	2.8	10.9	8.7	3.9	3.1	10.4	10.0	1.6	5.6	5.3	0.6	14.2	7.3	75.0	80.5	55.5	85.6	77.3	90.0	62.1	62.5	62.9	66.9	78.4	70.3	13.1	6.4	3.0	21.9	8.8	3.8	6.8	5.0	6.2	48.6	7.0	7.5	19.9	2.8	4.1	14.7	12.5	7.5	10.4	6.7	15.6	10.1	84.2	32.2	30.6	13.5	18.7	3.0	31.4	6.7	11.3	20.5	14.3	10.2	16.5	16.6	20.0	1.6	15.6	58.9	28.9	5.4	14.2	6.8	25.9	57.6	32.6	18.8	19.6	12.2	14.1	65.2	10.3	17.1	21.7	30.2	1.4	84.7	10.9	7.4	1.6	26.6	23.1	49.1	72.3	31.2	44.1	87.2	44.4	4.7	3.8	6.0	20.0	43.8	2.5	3.7
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818914-825573	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 508.1;breast: 361.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	508.1	75.3	11.9	9.2	14.0	43.1	361.4	13.6	18.8	42.2	13.4	58.1	19.3	49.2	2.8	39.9	50.8	9.5	171.3	11.9	14.0	61.9	58.4	57.3	8.1	17.5	11.8	50.5	75.4	9.6	46.3	8.4	16.8	46.6	4.8	1.3	81.1	16.7	194.6	71.8	74.7	6.4	12.6	51.2	71.3	32.1	12.8	10.9	55.3	64.3	4.1	64.8	44.5	15.3	33.9	26.0	5.3	14.0	194.4	17.2	34.1	35.3	28.1	21.6	19.1	22.3	33.3	19.9	20.4	26.7	13.6	30.0	8.1	14.6	6.6	25.9	71.5	27.6	11.2	36.3	63.3	19.2	33.4	33.9	18.7	14.5	16.7	22.3	17.7	14.5	23.8	19.9	19.5	20.0	25.8	42.3	15.2	34.3	55.1	24.6	11.5	45.7	21.4	7.7	19.6	26.0	65.3	55.0	21.9	3.4	23.7	22.0	32.5	19.3	15.0	12.7	16.3	75.2	49.8	16.7	48.4	27.0	13.8	11.5	9.5	22.1	3.7	6.1	3.6	4.7	4.8	5.4	6.1	4.1	5.4	4.4	8.2	4.0	7.1	7.0	4.2	4.7	11.9	14.0	13.6	18.8	11.9	14.0	17.5	11.8	16.8	12.6	12.8	15.3	78.1	6.4	11.8	12.7	63.5	44.2	69.2	34.2	42.1	14.0	79.5	67.1	45.5	61.5	65.2	51.5	8.4	70.2	50.8	151.8	33.2	65.1	22.1	58.0	31.8	51.8	51.5	52.6	8.9	65.3	32.0	37.4	204.4	114.3	11.4	42.2	100.6	50.6	29.2	11.8	7.5	96.1	20.3	27.6	29.0	6.2	48.4	46.6	42.7	16.9	29.6	32.2	21.6	5.5	13.8	142.2	170.7	39.1	92.0	78.5	166.8	45.0	31.3	9.0	65.7	64.4	50.7	33.5	23.9	53.7	41.2	169.4	53.3	182.2	43.6	195.5
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.4;Late spermatids: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007522, HPA064773"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA007522: AB_1079649, HPA064773: "	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	17.9	27.3	18.3	26.2	23.2	26.1	16.4	14.7	31.5	20.2	12.6	25.7	26.9	20.8	5.3	20.4	16.8	13.7	20.7	21.9	16.3	25.6	21.9	40.4	19.5	23.4	20.3	18.8	16.4	15.6	32.7	13.6	25.6	21.4	8.4	10.6	15.8	12.8	33.5	17.5	29.6	14.5	10.1	41.9	19.2	36.4	23.7	10.9	22.7	19.5	8.9	24.6	17.4	23.6	32.4	80.1	14.7	36.1	25.5	37.0	34.3	42.2	41.9	31.4	28.8	18.6	43.7	27.3	69.1	55.3	19.7	40.8	13.1	39.4	16.3	68.5	29.2	17.7	41.8	13.9	29.2	20.2	53.0	31.6	22.2	41.8	23.8	49.2	62.7	31.4	14.9	36.5	28.6	15.7	22.2	26.0	16.2	15.5	71.7	17.3	9.0	31.9	27.9	31.2	19.0	32.5	34.9	15.7	45.6	20.4	14.1	27.6	67.0	38.5	22.1	53.3	44.2	42.6	30.1	12.2	64.2	23.2	36.7	15.7	11.3	37.6	5.4	20.0	5.5	6.5	3.8	5.7	12.1	4.3	3.3	4.5	3.2	7.9	35.0	3.8	6.9	8.8	18.3	23.2	14.7	31.5	21.9	16.3	23.4	20.3	25.6	10.1	23.7	23.6	12.6	6.4	12.0	16.6	11.9	4.8	4.1	9.3	8.6	12.1	10.9	8.3	10.0	15.7	10.1	33.1	27.1	18.2	14.4	48.5	1.9	15.8	73.4	8.2	7.2	13.5	17.4	25.4	14.0	7.1	15.5	7.3	14.8	10.7	12.0	19.5	13.6	20.2	27.4	21.9	16.1	14.6	10.2	68.3	16.0	106.1	9.6	42.4	8.8	15.0	23.6	9.2	21.6	9.0	16.4	9.5	17.9	7.5	8.8	4.9	67.0	12.1	14.4	16.5	0.0	7.1	7.7	60.8	10.5	8.5	5.5	12.4	15.9	10.0	20.9	3.6
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470417-108569666	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	27.8	47.3	23.6	17.9	25.1	82.9	20.2	21.6	29.6	19.4	22.1	14.1	11.8	17.9	17.7	21.1	11.6	21.4	25.3	24.0	26.5	30.0	34.6	17.5	18.0	23.5	23.3	14.7	13.9	28.4	16.5	26.6	23.4	18.0	15.1	24.4	11.9	17.7	35.9	15.0	10.7	20.9	24.9	17.7	15.6	15.5	22.9	18.6	24.3	34.7	22.1	29.1	12.7	26.5	28.6	12.8	22.1	19.7	47.7	32.7	32.4	26.6	47.2	21.6	35.8	12.4	16.0	15.9	33.1	26.4	43.4	10.6	37.9	17.1	32.6	24.2	10.1	11.0	19.3	9.1	34.8	7.6	21.7	29.8	31.7	29.2	26.9	23.4	29.5	17.7	13.0	44.5	27.2	18.9	18.0	18.3	9.8	17.9	17.8	6.5	23.3	34.3	25.9	35.9	18.3	25.3	25.8	27.4	32.7	27.7	11.6	12.6	24.2	35.1	15.7	52.8	15.0	37.4	41.5	23.9	33.4	11.4	23.2	21.9	29.8	26.2	14.6	32.8	17.8	28.6	14.2	14.6	29.2	27.3	15.4	14.7	24.5	22.9	43.4	11.6	19.1	22.9	23.6	25.1	21.6	29.6	24.0	26.5	23.5	23.3	23.4	24.9	22.9	26.5	64.5	41.7	49.3	66.3	91.3	92.9	124.0	42.2	55.2	64.0	45.7	35.9	49.7	8.6	51.2	23.9	18.8	58.0	72.7	44.3	93.9	32.0	52.3	124.9	67.3	57.1	57.1	50.7	42.4	37.8	37.5	76.6	45.3	236.1	71.7	19.0	23.2	44.3	32.2	32.0	42.9	27.8	67.1	45.5	90.0	47.4	32.0	113.8	55.2	23.4	43.5	42.9	18.6	38.2	41.3	29.6	38.6	39.5	76.8	80.1	16.7	41.0	62.0	32.5	19.7	88.9	63.9	18.6	23.1	60.5	135.7	130.2	69.1	43.7	22.9	122.7
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Hepatocytes: 53.4;Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	7.3	15.8	16.5	6.2	15.9	3.5	10.6	16.7	22.0	7.0	12.9	8.8	10.2	5.0	11.6	10.7	10.1	6.6	13.2	16.0	21.9	35.1	88.8	6.4	6.9	19.1	21.2	5.8	10.9	26.6	9.2	7.0	20.6	8.0	8.6	5.4	10.4	7.8	21.1	6.7	9.6	6.1	16.5	7.2	8.6	6.6	20.6	5.8	17.8	19.6	7.7	6.7	7.3	14.3	37.9	30.9	2.4	5.8	15.3	11.7	0.0	12.2	7.7	14.0	11.9	51.1	27.6	35.2	57.4	12.7	5.5	22.0	19.4	34.7	20.3	43.4	16.4	24.6	13.9	53.6	16.3	22.6	16.6	15.4	26.9	25.8	32.7	13.1	18.0	26.1	24.4	12.2	16.5	28.3	25.3	7.8	4.5	37.4	37.1	18.8	10.4	26.2	40.2	19.5	12.1	9.5	11.2	18.6	10.7	8.5	32.4	9.1	19.1	22.6	12.8	22.2	26.2	27.8	34.0	19.0	18.4	19.2	11.7	2.5	12.3	2.8	7.2	17.7	8.2	6.7	6.3	7.6	13.5	5.3	8.2	8.1	1.1	7.9	11.9	9.8	7.0	10.3	16.5	15.9	16.7	22.0	16.0	21.9	19.1	21.2	20.6	16.5	20.6	14.3	7.6	12.8	13.9	7.5	3.9	1.5	6.7	5.0	5.7	1.1	16.2	14.4	1.9	18.6	6.8	12.9	4.2	8.4	7.8	7.3	62.6	18.2	0.8	11.2	6.4	5.9	3.6	7.4	4.2	15.6	1.9	5.3	4.6	13.3	12.7	8.8	6.4	53.4	17.2	3.3	6.2	11.6	2.0	11.4	2.4	0.9	9.9	10.6	1.8	2.8	8.6	7.1	3.1	2.5	3.2	15.0	8.9	6.0	4.9	9.0	20.2	86.3	5.9	1.9	0.0	4.1	3.8	0.7	1.3	7.2	2.3	6.3	4.7	19.5	15.4	5.0
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634061-55693863	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease variant, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria	Cytosol	"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	6.7	5.9	5.4	4.0	7.0	7.4	5.7	6.4	7.7	5.2	6.4	5.7	3.3	6.4	4.5	4.6	5.7	3.0	6.6	4.8	6.5	5.6	5.2	5.0	4.3	6.9	6.0	4.8	7.8	4.9	5.0	2.9	7.1	4.4	5.2	5.5	5.0	3.2	11.5	5.9	5.3	4.2	5.7	6.2	5.8	3.2	6.3	3.4	5.2	5.9	3.3	5.6	4.5	9.0	9.0	4.3	6.5	2.9	4.7	7.8	8.4	12.2	7.7	19.8	13.1	13.5	4.2	17.9	5.4	5.8	6.2	7.1	8.3	10.1	9.5	6.3	16.3	10.2	5.9	7.0	11.8	25.0	6.4	8.6	6.9	8.4	7.0	4.7	6.4	7.3	11.5	4.2	8.0	4.4	15.4	17.9	15.5	9.3	8.1	15.2	10.9	16.6	8.6	5.2	15.2	9.6	4.4	14.3	17.0	5.6	3.8	11.4	6.4	4.6	3.9	4.2	13.5	18.9	1.3	3.8	9.2	21.1	8.3	3.3	3.4	4.0	4.2	2.8	2.4	3.1	1.7	4.1	1.3	5.6	3.4	3.9	3.4	2.2	2.7	4.1	1.4	2.9	5.4	7.0	6.4	7.7	4.8	6.5	6.9	6.0	7.1	5.7	6.3	9.0	25.1	48.1	57.0	23.8	21.6	24.2	23.1	17.5	29.0	41.3	12.6	11.2	25.6	15.7	46.8	20.2	58.4	19.9	14.2	7.7	9.8	18.6	25.6	27.9	28.9	24.4	10.2	17.4	48.4	16.0	23.3	25.3	14.8	14.3	58.7	21.8	11.7	14.7	15.4	30.3	48.1	12.8	26.4	12.2	17.7	4.8	17.4	26.7	16.0	17.8	16.5	23.9	13.4	34.2	97.7	15.8	11.4	18.4	23.1	26.0	7.6	19.8	38.5	58.6	26.3	31.7	22.3	43.4	20.7	25.7	20.2	12.3	24.7	58.2	18.6	17.6
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23956839-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	82.7	82.5	49.5	80.6	52.1	141.0	78.5	53.4	62.0	69.6	56.1	98.1	99.5	87.4	68.6	62.8	58.3	80.5	75.2	49.6	51.9	99.6	66.8	76.0	137.0	52.6	50.7	79.3	52.2	94.3	34.8	103.3	54.4	70.5	92.2	56.2	55.0	56.9	49.8	46.1	84.2	71.8	50.9	87.5	81.9	33.7	51.9	133.5	122.2	63.6	109.5	100.1	51.4	57.8	107.8	42.0	179.5	124.9	121.5	110.7	68.6	116.7	103.7	132.7	106.1	122.7	132.5	291.7	111.5	74.8	49.9	93.5	121.6	101.8	146.7	208.6	78.7	277.5	131.8	130.2	103.3	272.1	122.3	83.9	125.8	109.2	101.0	86.8	130.3	148.4	239.6	159.5	79.0	87.5	169.4	103.3	243.8	101.7	76.5	189.7	116.7	125.0	134.8	113.8	107.4	93.5	101.0	85.7	123.7	130.9	93.6	168.6	105.3	85.6	82.2	84.6	75.4	133.7	164.8	197.6	58.0	259.0	89.8	230.8	112.7	126.8	103.5	115.0	108.8	129.1	112.5	112.2	109.1	131.1	124.9	106.8	74.2	108.6	112.2	77.4	129.4	178.3	49.5	52.1	53.4	62.0	49.6	51.9	52.6	50.7	54.4	50.9	51.9	57.8	119.0	185.9	109.2	11.4	122.5	13.3	231.7	2.0	99.0	33.6	110.5	109.6	84.8	58.6	62.2	62.5	18.8	129.8	104.7	160.5	238.7	90.5	6.9	86.0	96.1	97.3	100.4	157.0	7.9	127.8	101.4	128.7	66.3	130.9	76.5	84.1	86.7	30.0	68.6	20.2	6.4	109.3	0.0	82.3	10.9	14.2	78.9	109.0	1.8	13.1	81.8	66.9	127.7	6.0	11.8	119.2	157.7	81.3	48.8	187.6	90.3	112.0	56.1	28.7	46.0	104.3	104.5	21.2	24.4	97.8	12.6	141.7	104.0	203.9	110.2	314.0
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418018	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 51.3;Spermatogonia: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004375: AB_675487, HPA046524: AB_2679684"	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	5.6	5.1	3.2	9.2	3.7	26.3	6.3	4.5	3.8	7.6	2.5	8.9	5.4	8.4	0.4	10.7	6.5	2.1	5.8	2.7	2.7	6.5	6.4	9.5	11.2	5.1	3.7	7.1	7.9	2.3	4.7	5.9	4.1	6.1	2.2	1.9	7.4	2.6	5.6	9.2	10.1	2.3	3.5	12.8	6.2	13.3	4.1	11.0	9.8	1.5	5.2	5.9	7.7	4.4	52.1	77.9	27.9	22.4	3.0	2.8	45.6	34.0	9.6	30.0	34.9	42.4	39.2	84.6	19.4	7.1	13.9	45.1	27.4	25.1	6.8	64.4	145.0	66.1	73.0	54.6	3.7	67.0	57.7	6.4	7.1	26.1	6.5	6.0	14.2	58.2	77.4	54.3	9.1	40.6	92.2	110.6	48.7	25.3	55.4	105.4	62.2	67.7	7.4	44.9	39.3	38.6	33.0	35.9	8.8	10.1	21.1	50.7	17.4	21.4	70.7	22.0	56.5	60.0	91.3	76.3	21.2	66.9	20.8	1.3	4.3	1.5	4.3	5.6	4.0	6.0	4.0	3.5	3.9	5.4	4.0	3.9	0.6	4.2	6.9	7.1	3.1	4.0	3.2	3.7	4.5	3.8	2.7	2.7	5.1	3.7	4.1	3.5	4.1	4.4	3.5	3.2	3.9	0.7	8.7	6.4	2.3	3.5	3.4	4.0	4.3	5.3	3.4	2.8	3.8	3.7	6.2	19.2	3.8	12.2	0.0	4.8	1.9	2.8	1.6	3.4	7.2	15.2	1.2	4.0	15.0	4.1	3.1	3.0	0.0	9.5	1.1	2.2	15.1	0.0	0.9	7.4	0.0	5.7	5.3	1.9	3.1	5.8	5.4	1.0	4.8	1.2	6.2	1.5	2.2	4.7	51.3	5.3	10.6	2.8	6.3	2.8	3.0	4.3	0.0	3.5	4.0	11.5	25.6	5.5	5.3	7.7	5.4	3.4	14.3	1.3
POLD4	"p12, POLDS"	ENSG00000175482	"DNA polymerase delta 4, accessory subunit"	Q9HCU8	11	67350772-67356972	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 272.0"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 538.2;Paneth cells: 572.5;Proximal enterocytes: 403.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 177.0"					"Low region specificity"	"Detected in all"			HPA078008			Approved	"Centriolar satellite"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite"		"HPA078008: "	"unprognostic (7.55e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.36e-2)"	80.6	78.1	9.5	60.4	9.8	37.1	66.5	8.3	19.6	60.6	9.7	110.1	86.0	53.1	5.6	118.3	47.3	19.1	98.4	8.9	8.5	106.9	272.0	73.5	83.1	12.0	11.1	48.3	104.8	4.0	39.7	17.2	11.2	87.1	14.7	3.0	72.7	9.5	91.7	56.2	118.8	9.8	8.9	111.5	81.7	27.9	11.4	8.7	49.3	9.3	25.3	82.1	75.4	10.0	48.0	125.5	2.0	13.6	14.4	27.8	7.6	58.3	12.1	8.5	6.0	21.9	147.7	126.4	177.0	16.9	31.1	64.2	0.4	39.5	1.1	53.4	7.2	29.1	29.6	29.2	31.9	10.3	142.1	31.4	19.7	15.4	13.1	42.6	25.4	19.5	27.1	42.2	14.3	79.4	13.2	22.7	10.1	94.7	83.7	21.6	23.4	34.7	19.9	33.1	1.0	13.2	29.7	21.9	95.8	6.9	51.8	37.5	82.5	28.7	20.2	75.2	19.8	52.9	19.1	72.4	95.8	24.3	34.3	129.3	147.8	258.6	63.2	192.4	59.1	333.3	72.5	65.6	143.8	354.7	78.9	71.0	143.4	50.7	376.9	101.1	115.6	128.9	9.5	9.8	8.3	19.6	8.9	8.5	12.0	11.1	11.2	8.9	11.4	10.0	8.0	19.2	44.9	12.4	115.3	43.3	3.1	152.6	47.8	2.6	14.8	8.6	2.3	12.8	86.1	7.3	6.2	8.6	15.5	538.2	15.6	144.7	7.8	4.8	7.8	19.1	83.1	26.1	6.5	188.5	10.5	25.3	180.4	11.9	68.5	5.6	22.1	40.7	31.3	3.3	4.9	226.0	105.8	31.3	92.5	18.7	6.8	66.9	60.5	34.7	114.1	4.2	36.0	5.5	12.6	220.3	572.5	3.8	66.8	4.5	403.3	30.2	18.7	4.2	6.6	5.8	26.8	4.7	3.0	96.4	68.9	12.4	49.4	2.2	130.8	4.5
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 21.0;Spermatogonia: 24.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	0.9	0.9	0.5	5.1	0.3	18.2	3.0	0.5	0.6	2.1	0.0	3.8	2.5	2.5	0.7	3.7	1.0	0.9	0.6	0.2	0.2	0.7	3.1	1.2	5.1	0.2	0.4	1.0	0.8	0.7	0.5	3.0	0.2	1.4	4.5	3.0	1.0	0.7	0.5	3.5	3.6	2.3	0.3	1.5	2.1	4.1	0.2	5.5	0.9	0.9	6.2	1.4	1.9	0.6	37.2	18.6	34.3	16.3	1.7	9.9	18.2	20.4	10.4	31.9	36.7	19.3	27.5	23.6	11.6	11.6	17.5	22.3	35.3	12.8	36.9	27.4	19.6	35.4	20.6	23.9	0.8	41.2	14.6	2.8	0.8	18.5	2.9	4.1	19.0	30.5	30.9	14.3	31.6	32.7	43.6	28.4	20.2	30.9	42.6	35.9	31.7	21.0	11.6	20.6	24.8	14.3	20.5	11.9	6.7	16.5	24.5	15.8	6.7	5.3	38.5	21.4	16.9	10.7	22.7	52.7	9.8	30.1	20.9	0.0	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.0	0.2	0.0	0.9	0.0	0.2	0.7	0.1	0.5	0.3	0.5	0.6	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	2.0	3.2	0.5	4.2	2.4	4.8	2.1	1.9	2.2	0.8	1.5	1.1	1.2	1.5	1.3	0.0	0.0	9.1	1.0	2.2	0.0	1.3	1.2	0.8	2.6	1.5	1.2	21.0	9.5	1.5	10.6	2.7	1.1	1.5	0.0	4.3	5.0	5.5	5.5	0.0	11.9	2.8	0.0	1.9	1.6	0.8	1.5	1.1	1.8	7.5	1.0	2.0	4.1	12.1	11.5	0.8	0.5	3.0	5.7	1.9	1.1	1.2	0.9	3.1	0.0	2.1	7.4	5.3	24.4	6.0	3.7	3.4	1.7	1.8	4.7	1.5
POLE3	"CHARAC17, CHRAC17, CHRAC2, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410675	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	25.4	32.9	20.3	34.9	20.9	113.5	31.7	24.7	24.2	25.8	17.3	29.6	25.4	25.2	26.0	39.7	28.2	18.0	26.4	21.2	19.7	23.6	38.1	23.7	53.6	21.9	19.6	22.6	27.4	26.7	11.2	26.6	21.5	23.0	32.8	16.4	27.2	22.8	79.1	37.3	26.3	27.8	20.8	33.0	24.9	41.1	19.8	55.1	21.8	56.4	56.7	28.5	24.8	21.5	85.0	103.3	71.2	107.6	39.8	35.3	62.5	110.3	56.0	122.1	95.6	96.5	75.0	305.5	66.9	65.0	74.5	141.4	140.3	121.4	112.0	58.8	84.7	158.9	97.7	99.5	42.4	333.5	92.2	40.5	82.2	106.3	135.5	44.3	86.0	152.7	225.7	165.6	85.9	215.1	230.6	178.4	92.1	180.7	184.8	232.4	296.3	171.8	53.4	79.8	153.8	88.7	160.2	100.0	89.4	43.0	149.7	148.1	71.3	90.0	122.3	115.2	191.2	86.0	301.5	407.4	82.2	193.5	110.1	77.4	85.4	90.4	83.8	87.0	104.2	86.3	78.9	79.8	83.3	82.4	84.8	79.3	17.5	77.4	71.6	83.6	102.0	135.2	20.3	20.9	24.7	24.2	21.2	19.7	21.9	19.6	21.5	20.8	19.8	21.5	37.2	38.5	30.2	2.0	61.4	93.8	30.8	37.0	66.0	15.0	51.9	49.9	43.6	21.5	35.8	31.3	6.2	60.7	73.9	28.9	43.0	35.7	5.1	45.4	53.7	33.9	24.6	101.6	4.7	45.4	62.5	37.6	22.4	44.1	57.5	41.4	25.7	43.1	49.3	13.5	3.9	36.9	28.5	36.5	66.4	16.4	35.8	44.7	40.9	1.9	60.3	29.9	48.4	3.5	3.6	37.6	13.9	42.5	67.8	36.0	18.3	34.4	35.5	18.3	13.1	47.9	45.7	40.2	93.1	87.6	94.9	34.9	65.5	36.3	42.5	22.6
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958643-74970128	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 110.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 47: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA054979: AB_2682661, HPA071815: AB_2686453"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	19.7	17.1	16.0	5.4	16.1	23.3	19.9	14.5	25.3	14.7	13.9	16.4	5.9	12.0	2.7	11.4	11.9	7.7	15.0	15.8	14.9	14.5	15.2	12.1	12.5	15.4	15.2	13.6	8.6	3.0	3.1	6.5	15.8	10.7	6.0	7.1	12.2	6.7	29.0	10.5	13.2	7.3	15.1	12.1	14.6	6.8	15.5	5.3	10.3	16.9	7.3	15.0	12.0	17.2	37.4	33.5	3.3	3.3	11.2	23.4	0.0	24.3	29.1	36.6	30.7	43.1	16.2	33.3	19.9	26.6	10.1	16.0	15.6	19.5	39.6	15.5	42.2	28.0	20.3	46.7	38.8	40.4	41.5	23.8	37.0	15.3	33.3	12.6	16.1	4.8	33.9	21.2	28.1	35.6	12.0	110.1	24.2	23.0	59.1	14.1	28.8	29.4	30.3	1.0	10.8	15.9	33.5	13.9	19.1	1.9	10.4	13.6	18.4	8.7	9.6	6.0	24.7	7.3	5.0	12.8	31.2	58.8	43.4	7.0	53.6	19.1	13.3	32.7	14.5	35.2	19.2	16.1	29.7	33.3	20.5	14.7	3.5	10.6	30.2	33.8	20.4	31.8	16.0	16.1	14.5	25.3	15.8	14.9	15.4	15.2	15.8	15.1	15.5	17.2	156.9	25.6	40.4	3.9	83.9	84.5	96.6	82.4	62.0	33.9	89.9	80.4	40.3	48.6	52.6	73.5	43.8	156.3	69.5	116.4	148.7	53.6	12.1	37.3	34.2	96.0	12.2	50.9	6.2	80.7	154.7	66.4	30.5	33.4	61.6	53.9	94.2	147.1	115.6	18.5	6.6	100.8	44.7	113.7	111.5	24.0	67.1	91.9	97.8	9.4	134.1	174.9	87.6	4.0	11.1	83.5	157.5	54.5	55.8	100.3	190.7	182.3	49.2	126.8	78.9	99.4	68.8	45.9	91.5	57.8	97.7	94.0	70.3	108.1	88.3	95.4
POLK	"DINB1, DINP, POLQ"	ENSG00000122008	"DNA polymerase kappa"	Q9UBT6	5	75511756-75601144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 236.8;Oligodendrocytes: 159.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012035, HPA057303, HPA068117, HPA069375"			Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131"	"unprognostic (9.66e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.02e-1)"	4.7	4.3	2.3	3.7	5.0	2.7	5.4	7.0	4.5	6.8	1.9	3.2	2.4	6.3	4.6	3.4	4.0	3.7	4.6	3.1	5.4	4.7	4.9	4.9	4.0	5.6	4.2	6.0	4.3	5.5	3.2	6.3	5.7	4.3	3.1	5.2	4.2	3.9	4.6	4.1	3.1	4.1	3.6	5.6	3.7	3.1	4.7	3.9	7.6	3.3	3.6	3.2	3.9	10.5	6.7	6.7	4.1	5.3	5.3	10.5	3.5	12.5	8.8	9.5	9.8	4.3	5.2	6.9	10.0	8.3	6.2	2.5	3.8	4.3	11.4	7.6	4.5	6.3	5.7	2.1	10.1	4.0	4.9	5.0	5.1	7.7	5.3	7.6	8.0	4.4	5.6	3.9	9.1	0.5	7.9	3.2	1.5	0.7	3.9	3.3	10.6	4.8	5.7	2.2	4.1	4.6	9.4	2.5	3.4	2.8	3.7	3.8	10.4	6.9	3.6	3.3	7.2	4.5	4.4	6.0	4.6	6.2	12.2	5.8	5.3	2.7	2.4	6.0	2.0	5.1	2.6	3.0	4.8	4.1	3.2	2.2	4.6	3.9	11.5	5.8	3.4	2.0	2.3	5.0	7.0	4.5	3.1	5.4	5.6	4.2	5.7	3.6	4.7	10.5	45.8	32.1	44.6	65.6	36.3	14.7	21.8	22.1	20.5	32.9	19.5	15.0	21.8	24.3	26.1	29.5	20.9	17.3	37.5	8.3	23.5	20.3	236.8	19.5	32.1	34.4	14.9	29.2	63.5	15.8	13.0	33.7	17.3	21.0	51.9	33.8	57.1	25.0	21.8	65.6	60.0	11.3	24.4	39.2	25.0	58.7	37.6	33.3	23.2	73.1	55.8	19.6	25.7	84.4	159.6	19.1	15.1	38.4	26.4	14.6	17.8	21.2	20.8	38.8	6.6	38.5	27.8	61.3	23.6	14.5	12.9	6.7	27.6	48.8	12.2	11.6
POLM	Tdt-N	ENSG00000122678	"DNA polymerase mu"	Q9NP87	7	44072062-44082530	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 63.0"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 63.0"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058900, HPA066007"			Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA058900: AB_2683848, HPA066007: AB_2685595"	"unprognostic (2.44e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-3)"	8.0	5.9	4.0	4.4	4.0	4.5	7.8	4.4	4.1	8.8	4.0	6.6	5.6	6.1	3.7	8.4	6.4	4.4	7.5	3.5	3.7	10.2	9.7	5.9	7.6	4.4	5.2	8.9	8.5	4.4	6.0	2.8	4.5	8.4	3.4	4.3	7.5	6.7	7.9	8.9	9.0	3.5	3.9	13.1	9.1	3.8	5.1	9.8	10.5	4.9	7.2	7.6	7.8	4.0	1.8	2.5	2.6	5.8	3.6	4.2	7.5	6.1	6.2	4.5	2.5	3.2	4.2	18.1	5.6	4.7	5.5	5.3	2.7	67.0	2.6	6.3	6.0	2.3	2.8	1.1	4.8	5.8	7.7	6.1	6.0	3.7	4.4	8.6	8.1	18.5	2.7	9.2	3.8	4.1	10.5	4.7	5.4	5.5	14.2	9.6	1.6	7.3	4.7	2.9	2.7	4.8	2.9	11.3	5.6	4.0	6.7	10.2	5.7	3.1	4.4	3.2	8.6	14.1	7.5	13.9	5.6	5.2	6.9	23.9	3.5	10.7	6.3	4.3	6.5	7.9	5.5	5.6	3.3	11.1	7.9	6.3	63.0	7.4	3.3	9.5	5.8	2.9	4.0	4.0	4.4	4.1	3.5	3.7	4.4	5.2	4.5	3.9	5.1	4.0	8.3	3.2	7.8	13.1	33.4	4.5	11.2	8.3	11.4	24.5	10.3	6.2	5.6	15.7	11.4	12.9	29.2	12.3	19.9	11.1	1.9	7.6	0.6	5.0	7.1	8.7	5.4	3.0	4.0	9.4	9.4	7.1	27.5	6.0	24.1	11.1	12.5	9.2	10.2	18.5	4.3	8.5	10.2	11.1	5.0	0.7	14.0	9.9	10.6	6.5	14.4	11.9	23.7	3.5	5.7	8.3	22.5	10.1	15.6	16.6	19.4	5.6	7.4	48.3	0.0	6.9	9.0	17.5	14.3	6.5	5.1	9.7	18.8	13.5	12.1	15.0
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	5.4	5.7	3.7	5.8	4.0	4.9	4.5	3.1	4.7	4.9	4.0	4.9	4.1	8.2	3.0	6.0	5.2	2.9	5.8	3.9	3.6	4.6	5.0	4.0	4.6	3.4	3.6	5.2	5.2	7.1	4.9	5.0	3.3	4.5	5.0	3.5	3.9	5.1	10.8	5.5	3.8	6.9	2.7	3.8	4.5	6.2	4.4	6.2	4.5	7.4	4.9	5.2	4.2	4.3	18.5	41.1	18.0	34.7	17.2	13.7	25.9	16.6	10.9	23.2	14.4	51.9	14.2	41.9	17.2	17.0	22.7	20.9	46.6	24.4	20.6	17.6	24.0	36.2	18.0	35.1	12.1	34.8	18.7	10.5	15.0	34.6	26.7	8.8	18.2	19.0	48.8	10.3	16.2	16.4	25.8	15.1	32.7	24.4	26.8	30.7	39.5	19.6	10.5	29.7	27.7	14.6	18.3	23.8	12.7	12.3	14.0	12.0	29.3	28.0	22.2	24.3	33.8	14.5	15.3	35.7	14.6	29.3	25.3	0.5	0.4	0.0	0.7	0.6	0.9	0.5	0.3	0.6	0.4	0.6	0.3	0.4	0.1	0.5	0.5	0.7	0.1	0.4	3.7	4.0	3.1	4.7	3.9	3.6	3.4	3.6	3.3	2.7	4.4	4.3	4.9	3.2	9.1	13.4	8.8	4.2	4.9	5.3	12.0	12.4	6.2	5.5	11.1	8.6	4.7	9.2	16.7	6.3	7.2	5.1	3.9	6.0	3.0	5.4	13.8	6.5	9.6	10.9	19.7	4.9	5.4	7.7	8.2	6.9	6.3	11.0	4.2	8.3	12.5	11.8	18.1	6.7	2.0	3.1	3.5	1.7	6.2	5.5	5.4	6.5	3.3	4.2	6.2	20.1	18.2	6.6	3.0	5.3	10.1	9.1	3.5	3.4	5.2	9.7	0.0	14.3	6.2	5.0	7.2	13.4	2.7	3.8	7.5	12.4	10.4	4.0
POLR1C	"AC40, RPA39, RPA40, RPA5, RPAC1, RPC40"	ENSG00000171453	"RNA polymerase I and III subunit C"	O15160	6	43509702-43562419	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 306.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031010			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA031010: AB_10603131"	"unprognostic (2.84e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (1.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	15.5	19.2	16.0	12.3	16.0	7.7	20.3	15.7	20.9	15.3	19.8	18.4	13.1	15.1	15.7	21.3	21.0	9.5	13.3	16.0	16.4	17.6	17.7	11.0	13.9	15.9	15.9	14.4	15.5	17.1	13.8	12.2	16.2	14.4	15.5	6.6	15.8	12.0	15.3	20.5	10.9	14.8	16.0	12.7	14.6	20.1	16.3	12.5	16.1	13.4	20.8	23.4	15.5	17.1	76.0	61.7	26.6	72.3	40.0	43.0	42.1	45.3	33.5	49.7	42.2	82.5	25.2	85.2	48.3	44.2	42.5	45.2	64.7	57.6	57.6	45.4	67.7	58.3	57.2	115.7	50.1	90.0	39.1	38.7	54.8	67.9	85.4	29.4	39.6	35.4	136.9	24.5	44.0	106.4	47.4	65.0	49.2	306.8	52.9	31.9	41.8	57.6	60.7	104.1	49.0	32.8	39.6	34.1	62.2	19.4	36.9	77.9	47.6	35.3	48.1	38.4	72.3	35.1	85.0	146.0	24.1	60.9	40.0	5.7	30.0	4.6	34.1	24.0	46.5	51.1	40.4	34.1	42.4	55.0	55.1	49.6	2.7	41.7	20.5	38.6	32.7	34.0	16.0	16.0	15.7	20.9	16.0	16.4	15.9	15.9	16.2	16.0	16.3	17.1	13.0	12.8	17.7	9.8	24.9	61.8	50.6	34.3	42.1	8.2	24.0	23.6	5.2	17.2	30.4	5.5	6.2	29.7	15.3	11.3	15.6	26.7	13.5	23.4	15.9	18.6	13.1	12.8	13.6	24.4	18.9	21.5	25.0	14.2	14.0	14.4	15.7	11.9	13.3	5.0	12.3	17.4	28.5	5.2	17.0	8.3	11.5	8.5	21.4	11.2	8.3	7.1	14.4	14.1	10.2	21.0	11.5	11.7	13.1	29.2	5.0	27.5	48.5	15.4	6.6	29.1	45.6	34.4	43.3	26.4	40.9	13.5	17.4	21.5	19.9	37.0
POLR2A	"POLR2, POLRA, RPB1"	ENSG00000181222	"RNA polymerase II subunit A"		17	7484366-7514616	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 2.4;lymphoid tissue: 1.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012226, CAB016388, HPA021563, HPA053012"			Enhanced	Nucleoplasm,Cytosol		NA	Yes			"Cluster 27: Non-specific - Gene expression"		"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB012226: AB_304749, CAB016388: AB_677353, HPA021563: AB_1855526, HPA053012: AB_2682017"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.43e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.70e-2)"	0.1	0.7	0.4	1.6	0.2	0.2	0.1	0.3	1.9	0.0	0.8	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.1	0.7	0.4	0.1	0.0	0.2	0.2	2.4	0.7	0.1	0.0	0.1		0.2	1.1	0.2	0.2	0.3	0.0	0.0	0.5	0.1	0.4	0.0	0.4	0.2	0.0	0.7	1.1	0.2	0.0	0.1	0.0	0.0		1.6	1.0	1.7	0.5	1.5	0.4	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.4	0.0	0.6	1.0	2.1	0.0	0.0	0.3	0.0	0.5	0.0	0.9	0.0	1.6	2.9	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	1.0	0.4	2.1	0.0	0.0	2.5	2.3	1.0	0.0	2.7	3.5	2.8	1.2	0.8	0.0	0.0	0.8	1.6	0.0	1.0	0.5	1.1	2.0	0.4	0.2	1.6	1.1	0.8	1.0	0.0	2.2	0.8	2.0	0.9	2.5	1.1	0.3	0.8	2.2	0.5	1.3	1.0	0.0	2.0	4.2	0.0	3.2	10.1	0.4	0.2	0.3	1.9	0.7	0.4	2.4	0.7	1.1	0.4	1.1	1.6	124.2	22.4	41.6	13.4	68.0	42.8	40.7	33.8	64.3	90.4	56.5	187.1	26.9	38.6	30.3	23.9	110.5	35.9	153.5	55.0	3.9	27.0	25.0	74.9	64.4	57.7	76.7	43.3	18.1	30.2	28.7	53.3	103.0	67.3	42.5	46.0	40.4	29.9	45.4	55.5	14.9	43.9	26.4	42.1	38.3	7.4	37.0	65.7	37.4	19.7	38.2	27.3	26.8	17.6	17.8	32.0	35.9	41.8	62.0	27.9	42.5	13.2	38.4	90.5	6.6	94.4	53.9	58.5	120.2	73.8	41.2	53.8	89.2	49.8	32.6	30.8
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462660-57472009	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	35.1	41.6	49.9	30.4	51.2	43.9	39.6	52.3	60.3	36.8	49.4	36.0	33.1	39.2	67.1	31.2	47.0	31.3	52.1	51.0	52.0	59.8	62.3	47.7	38.7	50.5	51.0	54.3	45.1	55.1	46.9	39.5	51.8	40.4	40.0	59.3	39.0	45.9	74.2	34.5	31.8	40.6	52.4	30.8	36.4	25.4	50.4	47.7	40.8	61.4	44.9	39.1	31.2	54.5	59.3	94.0	81.2	72.7	72.7	62.9	67.6	75.4	84.9	126.0	82.3	121.7	74.7	65.8	86.4	89.3	75.6	60.5	111.9	83.5	134.2	30.2	77.0	51.1	53.5	142.0	81.8	95.0	94.4	57.8	66.4	96.7	88.7	66.6	74.8	90.0	90.2	37.3	81.6	78.6	106.9	98.6	118.4	72.1	138.0	151.4	94.4	120.5	99.7	56.7	102.5	117.4	122.9	69.8	81.4	74.0	51.6	85.2	54.4	76.3	76.3	56.8	89.0	82.2	76.2	135.0	75.3	79.5	102.5	79.8	38.3	70.3	44.6	37.8	49.2	52.4	50.6	42.8	38.1	48.4	60.4	57.4	96.9	64.6	49.5	31.2	54.9	60.5	49.9	51.2	52.3	60.3	51.0	52.0	50.5	51.0	51.8	52.4	50.4	54.5	49.5	25.6	43.0	11.1	49.2	31.0	46.0	51.3	30.1	81.6	39.4	52.5	11.0	41.5	31.9	27.6	56.3	78.8	49.8	38.2	92.0	62.9	5.6	25.0	25.4	39.0	38.2	35.6	13.3	65.8	80.8	40.5	15.8	22.3	61.0	46.1	23.2	25.1	41.2	52.2	13.9	34.5	48.8	22.9	30.3	8.4	51.6	22.7	40.9	8.4	49.1	102.7	58.7	8.0	9.6	59.5	44.6	51.9	40.0	43.9	63.8	120.4	29.4	93.9	46.0	30.0	49.1	50.4	66.4	30.0	30.0	92.9	52.9	49.0	38.4	43.5
POLR2E	"hRPB25, hsRPB5, RPABC1, RPB5, XAP4"	ENSG00000099817	"RNA polymerase II, I and III subunit E"	P19388	19	1086574-1095380	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Host-virus interaction, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063030, HPA068992"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA063030: AB_2684926, HPA068992: AB_2686065"	"unprognostic (2.52e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (3.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.77e-2)"	30.8	16.7	25.5	16.3	22.9	15.4	18.1	23.0	28.9	13.0	16.0	18.7	13.7	12.8	14.4	22.8	17.3	7.9	14.6	25.9	23.5	23.6	41.1	17.0	18.6	28.1	24.7	14.0	13.2	20.3	12.2	10.3	28.6	12.5	19.5	17.5	14.8	12.1	16.4	16.2	17.0	16.7	23.4	19.3	15.9	13.0	26.6	13.8	17.0	22.6	26.6	14.0	11.2	24.1	33.6	30.8	41.6	33.4	55.6	34.5	19.5	24.2	34.1	39.5	23.1	36.1	11.9	27.5	10.7	72.1	6.1	26.5	79.1	26.9	73.1	29.2	23.9	36.3	36.2	33.9	22.3	54.3	26.4	25.5	17.5	27.7	51.0	40.6	36.7	14.7	42.3	31.0	44.3	27.6	30.0	17.1	33.6	23.9	23.1	31.9	40.7	27.0	39.5	38.3	21.0	23.9	40.2	27.8	17.5	37.2	29.5	24.7	49.9	19.6	21.7	36.0	28.4	47.6	70.9	50.9	32.3	34.6	23.2	24.2	50.2	29.5	25.5	33.7	26.5	18.2	23.2	26.0	44.3	19.6	18.5	18.4	25.2	28.7	38.7	31.2	24.5	38.4	25.5	22.9	23.0	28.9	25.9	23.5	28.1	24.7	28.6	23.4	26.6	24.1	67.7	32.1	63.0	8.1	80.1	104.3	83.9	152.1	59.7	55.7	80.9	82.9	78.2	60.1	79.9	55.2	41.7	234.3	67.4	103.1	174.1	156.7	21.0	64.0	64.4	77.8	70.6	77.4	13.0	141.1	264.1	95.1	66.3	57.2	71.0	74.9	68.9	96.6	259.7	55.5	13.9	91.8	107.8	93.6	221.7	37.8	69.3	103.7	99.6	6.5	361.7	78.1	103.0	4.5	10.6	162.5	84.6	62.1	93.8	111.7	163.1	188.4	72.3	48.9	26.3	50.5	96.9	125.4	82.5	104.1	109.7	234.6	73.4	110.6	130.5	106.9
POLR2L	"hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6"	ENSG00000177700	"RNA polymerase II, I and III subunit L"	P62875	11	837356-842529	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1813.6;Proximal tubular cells: 1989.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 569.0;PC-3: 706.8"	"Low region specificity"	"Detected in all"							HPA073614			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA073614: "	"unprognostic (2.65e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (5.56e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.73e-1)"	112.1	101.2	68.2	21.5	69.9	27.2	91.0	69.0	98.3	48.0	90.5	63.5	26.1	48.9	16.5	87.1	43.3	16.4	161.8	72.9	75.3	112.7	107.6	68.3	20.4	68.3	71.0	37.3	111.5	30.4	71.7	21.1	70.1	67.9	15.4	11.9	62.6	31.3	101.0	65.3	46.2	24.9	67.9	68.4	63.3	34.3	70.1	21.0	72.5	43.1	17.6	63.3	54.1	69.7	106.4	569.0	52.9	66.5	150.1	107.8	45.6	134.5	94.1	129.6	86.5	166.2	97.6	64.4	35.6	166.6	110.4	69.5	79.7	160.8	39.9	59.9	381.6	63.4	160.7	216.6	88.3	62.3	49.3	178.9	71.6	74.2	36.6	79.2	101.7	63.9	67.0	71.3	156.1	268.4	59.7	63.1	82.6	124.7	706.8	58.8	41.9	99.3	160.7	81.1	104.1	32.1	133.3	135.2	107.3	28.2	81.2	36.7	117.9	87.5	69.1	48.3	83.8	40.0	50.0	62.3	130.8	58.3	78.2	93.3	119.5	121.7	92.9	109.0	100.1	75.5	86.0	92.0	114.0	73.6	71.8	89.3	32.1	123.7	76.6	141.1	92.5	134.7	68.2	69.9	69.0	98.3	72.9	75.3	68.3	71.0	70.1	67.9	70.1	69.7	364.4	410.3	390.2	9.8	265.9	611.8	245.0	767.6	279.4	68.1	491.1	412.0	500.6	584.8	415.4	526.0	25.0	625.4	305.0	669.3	1287.4	444.0	84.2	388.4	377.2	400.3	501.7	363.4	5.0	684.1	467.7	392.3	283.4	301.7	266.2	194.4	649.6	1813.6	700.2	50.5	5.3	641.6	323.5	434.5	582.0	235.7	305.7	307.3	658.1	11.2	493.6	368.5	389.3	3.5	9.0	751.1	589.2	255.1	382.8	300.0	813.6	1989.1	329.9	82.5	157.8	195.2	340.8	182.6	268.6	459.8	696.6	449.6	286.1	284.9	553.1	289.7
POLR3B	"C128, FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357748-106510198	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	4.5	8.7	3.1	4.8	4.4	5.2	5.0	4.3	4.6	4.7	3.7	5.3	4.2	4.6	5.2	8.6	5.1	3.6	5.8	3.4	2.9	6.8	9.0	4.7	4.1	2.2	2.3	7.5	4.9	11.1	2.4	6.7	2.3	5.6	5.7	6.2	4.7	4.0	6.5	11.0	3.4	5.4	2.7	3.3	5.4	6.1	3.2	4.7	6.0	8.3	5.6	4.9	4.3	3.6	16.2	7.6	16.4	7.8	13.9	13.1	22.9	21.9	13.0	15.2	11.6	14.0	4.4	20.6	7.7	14.2	5.6	14.8	19.5	19.2	18.5	16.6	13.1	15.7	10.1	12.0	9.2	26.1	17.0	11.7	13.4	15.1	17.3	10.3	11.5	9.8	24.5	6.5	11.2	12.0	19.1	8.7	17.8	11.9	28.5	11.6	9.8	13.5	8.6	21.8	17.3	9.6	13.6	18.2	13.4	10.8	17.0	7.9	11.0	8.3	10.0	13.6	13.1	8.1	22.4	30.3	3.8	15.9	9.2	5.6	2.0	1.5	2.0	2.2	2.7	2.1	2.2	2.2	2.6	1.3	3.0	1.9	1.3	2.1	2.2	0.9	2.7	1.7	3.1	4.4	4.3	4.6	3.4	2.9	2.2	2.3	2.3	2.7	3.2	3.6	2.4	0.0	9.2	14.4	4.7	1.8	1.7	4.5	4.6	6.0	3.4	3.7	10.3	2.8	7.0	5.5	6.2	11.0	3.8	3.8	1.9	5.1	7.1	3.9	7.0	3.3	4.2	3.8	22.3	4.6	9.3	4.4	9.2	3.9	5.1	4.8	3.6	11.0	3.1	3.3	24.1	5.6	2.0	1.6	0.3	5.2	3.7	2.4	3.6	9.4	1.0	2.4	2.1	17.1	22.4	3.8	1.1	4.9	4.9	1.5	1.7	3.4	7.2	7.2	6.6	6.9	4.1	16.5	10.9	8.9	3.0	7.4	4.1	7.2	5.1	1.2
POLR3D	"BN51T, C53, RPC4, TSBN51"	ENSG00000168495	"RNA polymerase III subunit D"	P05423	8	22245133-22254601	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061331, HPA067875, HPA068461, HPA069089"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081"	"unprognostic (2.33e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.15e-6)"	"unprognostic (1.15e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.12e-4)"	15.0	11.9	3.4	4.4	3.3	6.5	10.6	3.0	3.9	14.1	3.8	11.3	2.5	10.4	3.3	15.2	11.3	4.1	14.1	3.0	3.6	11.7	10.0	11.1	4.7	3.7	3.6	14.9	17.5	4.0	13.7	6.6	3.6	12.8	4.5	4.0	10.6	3.8	32.8	11.2	8.6	5.8	3.5	11.4	10.6	19.3	3.9	3.4	10.6	8.3	4.3	15.1	14.4	4.3	5.1	10.7	11.0	7.8	10.0	16.6	11.3	18.9	9.1	10.7	8.7	10.5	3.6	27.8	10.2	12.5	8.9	9.1	16.9	9.2	11.0	6.9	9.4	20.7	10.5	11.2	13.6	5.0	9.5	13.8	12.9	13.4	21.8	13.1	8.9	14.9	28.9	9.5	8.7	7.2	22.2	10.4	18.9	13.0	9.0	14.7	12.2	18.0	6.1	6.0	7.8	24.2	8.5	5.9	17.7	11.9	5.4	8.0	13.0	9.4	9.1	18.8	11.4	17.0	22.7	18.9	9.2	10.1	14.0	0.1	1.4	0.3	1.8	1.1	2.5	2.4	2.3	2.6	1.6	2.2	3.0	1.9	0.1	2.9	1.6	3.5	1.8	1.3	3.4	3.3	3.0	3.9	3.0	3.6	3.7	3.6	3.6	3.5	3.9	4.3	15.0	9.6	6.5	4.6	15.8	19.5	43.6	21.2	13.6	12.8	15.2	14.5	10.9	4.3	13.3	11.0	16.7	16.2	18.5	6.9	11.7	20.2	42.7	11.6	37.7	15.6	21.5	10.3	2.4	11.8	33.2	21.3	12.8	14.8	18.4	18.7	11.7	3.8	13.7	3.3	2.8	19.1	12.2	8.8	8.2	40.5	15.8	8.6	8.8	1.0	13.4	4.5	14.4	2.5	3.5	22.5	6.7	12.8	20.5	52.3	6.7	12.6	11.2	12.2	19.7	22.1	21.3	44.2	52.0	12.1	19.2	27.0	15.0	25.1	12.3	41.8
POLR3E	"C37, FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335101	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	12.2	17.0	2.8	6.6	4.5	7.8	12.0	4.3	3.7	10.7	16.1	12.9	6.3	12.7	2.4	13.0	11.8	4.5	15.4	4.1	4.4	8.4	13.3	10.2	5.3	4.8	5.5	11.3	16.1	10.7	12.8	4.6	4.5	11.3	3.0	3.1	12.2	8.2	62.6	14.8	10.0	4.9	3.7	8.9	14.2	11.2	4.2	8.5	12.8	15.5	5.7	12.0	10.4	5.3	21.1	29.0	6.9	19.5	12.1	9.7	27.5	16.1	6.1	9.4	4.2	36.3	14.8	41.7	21.8	11.1	7.9	18.7	35.6	20.6	7.6	28.7	52.3	21.0	31.8	70.9	15.1	34.4	23.0	8.7	19.5	22.1	25.8	3.5	25.9	17.1	63.1	17.0	10.9	34.5	33.6	11.8	37.5	20.2	22.8	45.0	16.7	54.2	8.0	12.4	28.9	20.6	15.6	29.2	14.0	4.2	17.2	16.3	17.3	11.0	12.4	9.2	18.3	23.6	45.6	40.3	11.1	23.0	21.1	0.0	4.7	2.8	8.6	4.8	9.1	7.4	9.1	8.7	7.7	6.0	8.4	7.3	0.5	7.4	4.5	4.4	10.0	6.9	2.8	4.5	4.3	3.7	4.1	4.4	4.8	5.5	4.5	3.7	4.2	5.3	9.4	3.2	14.7	14.4	20.3	32.5	23.0	10.9	12.5	24.0	16.4	19.7	18.9	11.5	13.4	18.4	31.3	25.2	27.3	8.9	5.9	12.0	34.9	21.0	13.3	13.3	15.0	10.5	12.8	12.8	20.2	14.1	13.7	28.5	27.9	23.1	8.9	11.1	13.1	20.2	16.3	13.7	10.2	10.1	22.2	20.9	12.5	11.0	14.2	11.2	9.7	10.4	21.6	18.6	17.9	15.0	11.7	9.1	26.0	28.5	13.6	11.8	16.6	40.9	13.1	21.0	12.2	19.7	16.1	16.5	39.6	28.3	30.3	20.5	16.2	26.3
POLR3K	"C11, RPC11"	ENSG00000161980	"RNA polymerase III subunit K"	Q9Y2Y1	16	46407-53608	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 183.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005891	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA005891: AB_1079653"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.03e-3)"	"unprognostic (9.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.63e-2)"	6.9	10.4	12.5	13.1	13.0	11.6	7.0	12.3	13.5	6.4	11.0	8.1	8.3	6.8	7.3	8.7	7.4	5.2	10.3	12.6	12.8	8.2	9.0	6.5	18.4	11.8	11.9	7.1	6.9	12.3	6.1	6.7	12.5	8.0	7.6	5.1	8.4	6.8	20.5	5.3	8.5	6.7	11.5	11.9	8.4	2.6	13.6	13.1	9.5	12.6	16.3	8.8	5.8	13.2	36.1	60.9	37.7	39.4	15.2	9.4	30.3	50.2	16.0	43.4	28.7	79.4	38.2	93.1	37.1	17.7	17.3	35.0	88.5	23.0	31.0	56.5	82.1	68.2	44.5	56.6	11.6	62.1	64.3	9.2	20.4	48.3	24.3	9.9	21.7	40.9	99.0	29.0	28.4	89.9	75.1	41.2	62.3	44.8	57.4	89.9	43.7	96.7	25.0	25.7	55.1	32.5	34.7	63.2	30.8	15.9	37.2	55.2	20.9	28.1	34.5	37.8	61.6	18.5	47.5	183.8	12.1	45.1	42.5	30.5	36.3	93.2	40.4	54.7	42.1	114.6	51.3	46.5	34.4	109.9	45.8	42.6	27.7	41.2	51.8	70.2	87.6	53.1	12.5	13.0	12.3	13.5	12.6	12.8	11.8	11.9	12.5	11.5	13.6	13.2	23.3	3.2	11.3	2.0	31.8	33.3	19.9	34.4	17.6	16.4	29.7	33.8	28.9	18.6	30.3	18.4	4.2	42.5	28.2	17.6	49.0	34.0	0.7	21.6	15.6	20.0	18.0	38.3	5.1	35.0	51.1	16.9	9.2	14.9	22.2	29.7	20.7	27.5	43.7	10.1	4.6	21.8	71.2	15.1	24.3	1.8	21.1	23.2	23.2	3.7	44.1	23.5	34.0	1.0	3.4	37.0	16.2	16.6	28.1	29.6	17.1	43.4	30.6	10.8	13.1	12.0	25.2	4.5	18.9	23.4	44.2	12.9	23.1	58.8	29.3	22.1
POMT1	LGMD2K	ENSG00000130714	"Protein O-mannosyltransferase 1"	Q9Y6A1	9	131502789-131523806	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 64.5;Spermatocytes: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065252			Uncertain	"Golgi apparatus"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA065252: AB_2685445"	"unprognostic (2.00e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.76e-3)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (8.36e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-1)"	15.7	20.9	16.6	7.6	16.7	6.6	16.2	18.4	21.0	21.1	15.0	24.8	9.0	17.1	7.2	15.2	18.4	9.3	24.5	25.5	16.0	25.5	24.4	15.6	8.3	16.0	16.2	25.6	25.9	15.5	31.3	9.7	16.5	28.4	6.5	8.1	20.1	8.7	32.9	17.5	19.9	7.1	14.2	22.2	20.4	63.7	16.9	7.1	19.0	13.4	5.4	16.5	17.1	15.5	9.8	17.4	10.5	26.4	19.3	13.5	24.5	12.1	17.0	21.3	14.1	15.8	14.7	2.5	16.9	26.4	8.6	24.1	17.3	16.6	5.9	16.2	21.6	4.2	28.5	7.8	23.1	13.1	10.5	10.8	10.0	12.3	5.0	17.6	15.1	16.4	13.4	15.6	23.2	27.6	15.8	25.2	6.7	9.6	21.1	15.7	13.8	24.6	18.1	1.5	15.0	14.1	25.1	26.8	13.0	5.8	31.4	17.7	20.9	13.8	2.2	28.6	10.3	7.3	7.0	5.2	8.7	29.1	13.0	0.0	2.8	3.4	5.2	3.0	7.7	1.9	5.0	5.3	4.0	2.6	4.8	3.6	0.6	3.2	2.9	2.4	5.2	4.0	16.6	16.7	18.4	21.0	25.5	16.0	16.0	16.2	16.5	14.2	16.9	15.5	5.9	9.6	16.0	18.6	7.1	4.5	4.9	7.2	5.7	13.2	7.8	8.6	9.7	10.0	8.7	12.9	8.4	20.8	6.5	12.9	1.9	10.7	64.5	9.6	7.3	8.0	7.8	1.3	21.5	6.7	12.9	9.0	9.2	9.9	2.5	15.1	11.0	10.1	10.8	21.9	25.9	8.4	10.2	5.4	5.9	33.0	8.7	5.6	5.4	15.9	7.5	12.3	5.2	18.6	11.1	8.1	6.0	10.1	6.8	4.9	14.2	7.5	6.8	16.6	6.6	7.5	7.2	71.6	9.6	5.7	3.0	17.5	9.0	6.2	9.1	2.6
POP4	RPP29	ENSG00000105171	"POP4 homolog, ribonuclease P/MRP subunit"	O95707	19	29606283-29617237	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042748, HPA064577"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA042748: AB_10964774, HPA064577: "	"unprognostic (5.88e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.50e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.08e-3)"	11.3	13.6	8.9	5.2	9.4	6.3	10.6	10.0	9.5	8.8	8.5	11.1	4.7	9.7	3.8	13.3	7.7	2.5	14.1	9.1	9.6	13.4	14.4	8.1	5.9	10.1	9.5	7.8	9.5	3.9	8.3	3.7	9.8	8.8	2.9	3.6	10.5	3.2	18.8	11.6	10.5	3.5	9.7	11.4	11.6	12.8	9.8	5.0	9.2	4.0	4.7	9.6	9.3	10.5	44.5	61.9	5.3	5.4	7.8	3.9	26.5	42.1	4.9	9.3	9.3	28.6	10.5	35.2	72.1	7.3	10.1	20.6	10.8	10.0	5.3	79.9	65.1	42.0	19.4	18.2	7.5	51.4	21.6	4.4	8.0	7.9	4.8	5.0	8.2	18.5	34.8	8.0	8.2	36.9	29.7	8.6	10.3	13.6	39.5	19.0	44.7	18.0	5.6	17.1	15.1	16.6	44.4	15.4	18.5	5.0	15.5	12.5	30.0	13.4	40.5	23.1	37.1	30.3	59.7	44.1	17.1	24.8	13.5	73.1	39.7	40.3	35.5	52.1	26.1	48.1	34.2	37.5	39.9	36.4	27.1	32.4	23.3	36.5	43.0	33.2	53.0	45.8	8.9	9.4	10.0	9.5	9.1	9.6	10.1	9.5	9.8	9.7	9.8	10.5	26.4	22.4	20.0	4.9	29.8	12.6	20.0	61.0	15.9	16.6	18.5	21.0	26.1	27.1	29.6	33.1	8.4	53.4	25.8	29.5	80.3	59.5	18.2	29.8	21.5	27.1	17.4	21.4	4.6	78.3	45.0	22.8	17.3	22.6	26.0	22.1	25.4	40.2	62.1	11.8	4.3	27.5	46.8	26.2	18.3	15.3	16.4	27.3	24.9	0.0	57.4	34.1	52.5	4.0	5.8	66.2	26.6	28.2	33.6	20.3	39.4	72.4	38.0	15.5	26.3	18.6	27.8	71.0	15.4	21.4	16.1	47.3	27.4	31.7	26.2	19.5
PORCN	"DHOF, MG61, por, PORC, PPN"	ENSG00000102312	"Porcupine O-acyltransferase"	Q9H237	X	48508962-48520814	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 37.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 68.5;Club cells: 44.2;Pancreatic endocrine cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 176.9;LHCN-M2: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049215, HPA058413"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA049215: , HPA058413: AB_2683711"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.35e-1)"	5.2	37.3	8.7	3.3	8.3	2.9	4.7	7.0	10.6	9.1	4.5	6.3	2.3	7.1	2.1	10.8	5.8	4.6	11.5	11.2	7.0	3.7	1.5	4.6	3.6	7.1	6.6	4.3	3.5	9.8	4.7	2.4	7.2	4.5	1.6	7.4	4.9	11.6	7.6	5.9	3.7	4.6	6.2	4.5	5.2	5.1	7.7	2.3	6.3	3.5	3.3	6.2	7.1	7.8	13.1	15.6	3.8	26.6	15.9	9.4	1.6	3.7	7.7	5.8	3.9	1.8	19.7	1.1	15.9	8.3	6.5	17.3	5.5	176.9	1.8	8.3	1.8	2.2	9.0	3.8	23.4	2.0	22.5	12.2	20.6	16.8	36.0	13.5	5.3	6.4	1.0	12.1	60.8	3.7	2.0	2.8	4.9	4.0	10.4	4.0	4.6	20.5	9.8	5.1	4.2	6.5	30.8	5.9	5.9	2.5	6.7	1.0	3.3	15.0	7.8	36.4	6.8	10.4	6.3	1.5	43.0	4.9	8.7	16.9	5.5	6.8	10.8	4.9	8.5	3.2	7.1	9.0	6.8	3.5	4.7	7.1	1.1	8.4	4.3	3.6	4.9	4.7	8.7	8.3	7.0	10.6	11.2	7.0	7.1	6.6	7.2	6.2	7.7	7.8	5.4	6.4	2.8	5.2	3.8	4.0	5.3	68.5	8.0	15.4	2.9	4.6	3.4	4.3	44.2	16.5	18.8	0.3	7.3	0.8	1.9	6.9	0.2	13.4	3.5	5.7	6.0	1.3	7.8	9.9	1.3	5.0	3.6	17.8	5.7	3.9	5.0	0.7	3.5	8.4	7.6	2.9	12.2	2.7	4.5	0.1	5.6	2.5	3.6	2.8	3.1	10.1	10.3	6.0	2.8	36.4	1.8	4.1	6.3	2.5	0.2	0.7	8.7	15.5	6.6	4.0	4.8	2.9	4.9	4.2	3.8	8.2	6.9	7.5	1.5	6.6
POU2F1	"OCT1, OTF1"	ENSG00000143190	"POU class 2 homeobox 1"	P14859	1	167220876-167427345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 270.6;Excitatory neurons: 187.6;Inhibitory neurons: 184.0;Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002608, HPA058559, HPA064323"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-3)"	"unprognostic (4.26e-2)"	"unprognostic (5.67e-6)"	"unprognostic (4.47e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.17e-2)"	4.0	2.5	5.0	2.2	5.8	3.9	3.4	7.3	5.2	3.6	2.9	3.7	1.3	4.0	2.6	2.7	3.4	1.4	2.6	4.8	3.8	2.9	2.3	3.5	3.0	4.1	4.2	4.1	2.4	3.4	3.6	2.4	3.9	3.2	2.1	12.9	3.0	2.0	4.1	3.5	3.6	1.4	3.8	4.2	2.6	4.3	5.0	3.8	3.3	2.6	3.4	3.4	3.2	4.4	7.4	4.0	14.8	4.5	1.7	1.7	6.1	0.9	1.6	1.7	1.7	8.1	4.2	8.3	3.8	1.5	1.7	5.6	8.8	2.7	2.6	3.3	3.5	5.9	3.9	7.1	1.1	6.5	3.8	1.2	1.6	2.0	3.6	2.1	2.3	5.7	6.4	4.3	2.3	3.7	6.0	4.3	17.4	4.0	2.3	8.7	5.4	3.7	3.1	4.0	9.0	6.9	5.6	4.1	3.7	7.4	4.6	7.9	3.8	3.4	5.3	2.0	3.5	4.4	2.1	18.3	1.6	3.9	4.4	4.6	0.3	0.3	0.2	0.3	0.3	2.0	0.2	0.0	0.4	0.7	0.3	0.2	0.4	0.2	0.3	0.9	0.2	0.4	5.0	5.8	7.3	5.2	4.8	3.8	4.1	4.2	3.9	3.8	5.0	4.4	19.9	12.8	17.2	270.6	25.2	13.4	11.3	9.7	9.6	58.7	12.5	11.8	15.8	14.3	11.6	20.2	102.2	17.8	20.2	12.3	5.9	10.5	26.2	17.7	18.7	19.8	24.1	14.5	187.6	11.6	18.5	17.5	10.2	18.9	19.7	18.7	15.0	13.3	13.3	47.1	184.0	14.3	8.2	52.5	12.4	44.1	25.7	19.9	7.2	114.3	21.7	43.8	14.4	186.0	202.1	16.5	8.0	20.7	33.5	16.1	5.3	8.3	11.5	101.7	26.3	28.4	16.4	17.6	35.7	12.7	11.1	51.7	14.1	11.0	14.5	21.0
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 48.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.1	0.1	0.2	0.1	0.1	0.2	2.0	0.3	0.4	0.8	0.0	0.6	0.9	0.0	1.7	1.3	0.5	0.7	0.1	0.1	0.1	0.3	0.1	1.0	0.2	0.1	0.1	0.1	0.2	6.3	0.4	0.3	0.1	0.6	0.2	0.1	1.1	2.0	0.2	48.0	0.7	0.3	0.0	0.2	0.7	0.1	0.1	0.2	0.7	0.0	0.5	0.4	2.1	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	3.6	0.1	1.3	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	2.5	0.0	0.3	3.9	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	8.2	0.3	0.0	20.9	10.6	5.0	1.8	0.0	3.0	1.5	0.8	0.0	3.9	11.0	0.0	1.5	0.1	0.9	0.0	5.3	2.2	1.3	0.7	0.3	3.0	0.0	0.4	1.3	0.4	0.6	10.2	4.8	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.2	8.2	0.0	2.2	5.5	0.0	0.1	5.4	0.0	0.0	0.4	0.0	0.0	0.5	20.8	1.1	0.0	0.0	5.0	0.4	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.1	7.0	37.6	7.9	0.5	0.2	0.6	14.2
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38043829-38046793	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 10.3;skin 1: 32.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 27.3;Breast myoepithelial cells: 39.1;Cone photoreceptor cells: 22.9;Suprabasal keratinocytes: 55.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 4.4;melanoma: 4.8;testis cancer: 1.3;urothelial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.1;HDLM-2: 23.9;NTERA-2: 7.5;SCLC-21H: 5.7;SK-MEL-30: 28.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055980, HPA073824"			Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055980: AB_2682995, HPA073824: AB_2686635"	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.2	1.5	2.3	0.2	7.0	0.0	0.3	0.9	10.3	0.2	0.1	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.1	9.7	1.9	0.0	0.0	0.0	1.0	1.4	2.6	0.1	0.1	0.2	0.0	0.0	1.3	0.2	0.0	0.3	0.3	0.1	0.9	32.6	0.0	0.0	0.6	0.1	0.1	0.8	2.0	0.3	0.0	0.5	1.0	0.8	0.3	2.5	0.0	0.0	24.1	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	23.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.7	0.0	0.1	0.0	28.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.0	0.9	10.3	9.7	1.9	1.4	2.6	1.3	0.6	2.0	2.5	12.2	0.0	0.0	2.3	8.3	27.3	2.9	1.4	20.5	7.8	9.9	39.1	5.2	0.0	0.2	0.0	22.9	0.2	13.4	13.8	0.0	0.0	0.2	0.5	2.3	1.9	1.8	2.7	6.4	0.0	0.1	5.2	7.1	1.4	0.0	0.5	0.0	0.0	0.3	1.7	1.1	11.0	0.0	0.0	1.3	0.0	0.3	4.3	7.2	1.0	0.0	14.0	0.0	0.5	0.2	0.0	0.1	0.0	2.7	0.7	0.3	0.1	0.0	21.1	0.0	8.5	7.2	0.2	4.1	20.2	55.8	0.1	5.2	8.3	5.7	3.2
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104853287-104858574	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 45.6;epididymis: 32.4;kidney: 58.8;seminal vesicle: 15.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal tubular cells: 27.4;Proximal tubular cells: 13.2"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 59.6;AN3-CA: 53.9;HEK 293: 21.2;RPTEC TERT1: 57.3;SH-SY5Y: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			1.5	0.1	22.5	0.1	36.9	0.0	0.3	34.6	36.2	0.0	0.0	0.7	0.0	0.0	32.4	0.0	0.0	0.0	0.1	26.3	18.9	58.8	0.0	0.0	0.0	31.0	35.5	0.1	0.0	0.0	0.1	0.0	25.3	0.2	0.2	0.3	1.3	15.2	0.0	1.7	0.1	0.0	22.7	0.0	0.6	0.2	30.6	0.2	0.0	0.0	0.1	0.0	0.0	45.6	0.0	0.0	59.6	53.9	0.6	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	6.5	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	6.4	1.4	0.0	57.3	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	36.9	34.6	36.2	26.3	18.9	31.0	35.5	25.3	22.7	30.6	45.6	0.0	0.0	0.0	1.0	0.5	0.8	0.1	0.0	0.0	3.8	0.0	0.6	1.0	0.0	0.0	58.8	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	13.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
PPA2	FLJ20459	ENSG00000138777	"Inorganic pyrophosphatase 2"	Q9H2U2	4	105369077-105474067	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	7.4	12.8	23.8	9.0	24.6	22.0	12.0	24.3	53.7	7.4	29.5	17.4	14.2	7.4	12.5	10.8	8.4	8.0	27.5	23.7	26.3	20.7	14.8	7.5	8.3	24.4	24.3	5.8	11.8	11.7	7.7	7.4	24.5	13.3	14.0	13.6	13.8	5.7	27.6	12.2	13.8	6.8	24.0	9.9	12.6	6.3	25.4	7.0	11.5	35.5	8.7	8.1	6.7	26.6	20.6	8.5	18.5	32.3	11.3	9.1	12.9	10.2	15.7	14.6	9.9	22.2	30.4	15.6	14.5	9.7	11.3	9.5	39.2	18.7	17.0	23.6	11.8	13.5	13.7	19.9	9.3	36.7	13.6	9.7	19.6	9.9	7.9	15.4	14.6	28.4	22.3	22.0	12.5	26.2	32.5	26.6	13.9	42.4	28.3	28.2	10.9	17.9	49.7	14.7	17.8	10.7	7.8	48.9	19.0	10.7	24.8	32.1	6.9	9.2	19.2	8.9	20.0	19.0	27.3	18.4	17.5	18.6	14.1	27.0	20.9	15.4	21.0	30.1	18.6	28.5	21.7	23.7	49.9	22.6	21.1	23.9	9.5	36.4	26.4	25.9	23.4	23.5	23.8	24.6	24.3	53.7	23.7	26.3	24.4	24.3	24.5	24.0	25.4	26.6	26.7	9.6	67.3	86.2	37.6	50.0	82.4	205.0	38.1	29.7	64.8	40.9	63.3	45.8	126.2	33.1	16.7	119.0	25.9	73.3	264.1	114.0	113.7	42.3	35.3	36.3	65.7	70.2	138.2	120.1	98.5	31.1	37.2	42.3	45.6	26.4	24.3	64.2	83.5	21.9	134.6	104.6	142.4	42.9	86.1	126.4	27.7	47.1	76.5	74.9	50.5	39.2	30.9	169.9	145.7	65.0	90.4	32.4	41.9	68.1	112.2	285.4	90.7	22.6	39.5	46.3	43.6	50.8	10.8	59.1	57.7	84.7	34.3	72.1	138.0	94.6
PPAT	"GPAT, PRAT"	ENSG00000128059	"Phosphoribosyl pyrophosphate amidotransferase"	Q06203	4	56393362-56435615	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036091, HPA036092"	Approved		Approved	"Midbody ring"		Yes	No		11000	"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Midbody ring"		"HPA036091: AB_2674936, HPA036092: AB_10603132"	"unprognostic (5.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (1.38e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (1.14e-8)"	"unprognostic (6.74e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.09e-1)"	2.8	6.1	3.8	5.4	4.0	5.6	7.1	3.7	4.7	4.3	3.6	3.9	4.0	4.6	3.4	4.5	4.4	3.0	2.3	4.1	4.0	6.0	6.1	2.2	8.4	3.4	4.0	7.4	5.9	3.9	2.5	6.7	4.3	3.9	4.8	4.4	5.6	3.1	2.9	4.3	3.2	3.6	3.7	4.3	3.5	8.6	4.1	8.3	5.9	2.9	8.0	6.7	2.6	4.2	23.1	19.0	38.0	18.7	12.2	15.7	31.0	25.2	11.1	20.4	21.6	38.1	27.5	80.6	33.4	11.9	19.0	16.8	74.0	25.4	40.7	21.1	32.8	32.6	22.6	42.2	18.4	65.0	19.5	13.6	19.4	29.0	32.4	12.6	21.8	32.5	83.5	43.3	23.2	20.9	80.6	49.1	50.6	52.0	22.4	67.2	24.9	56.9	34.2	16.2	64.0	31.2	20.1	36.3	23.0	35.4	24.5	13.8	15.3	21.2	36.6	21.4	45.0	32.2	34.5	82.9	23.6	40.7	20.1	4.7	1.8	0.9	3.8	2.7	5.9	7.4	5.1	5.2	2.5	6.1	7.7	7.1	0.5	10.2	3.9	3.2	4.3	3.5	3.8	4.0	3.7	4.7	4.1	4.0	3.4	4.0	4.3	3.7	4.1	4.2	4.8	0.0	5.5	16.6	10.7	31.0	16.0	5.6	28.5	8.4	10.1	9.7	3.8	4.3	8.0	3.7	2.1	29.7	10.3	1.5	9.8	3.7	2.6	5.5	14.1	7.8	4.2	14.9	22.9	2.7	25.2	9.4	4.1	6.9	7.0	66.2	5.3	7.1	7.9	38.7	15.8	4.3	4.1	1.6	6.0	2.6	7.8	5.2	8.8	5.6	3.1	6.4	2.1	5.5	9.1	3.3	2.7	5.7	15.3	15.0	0.8	12.7	6.2	4.7	0.0	9.3	10.8	16.4	27.5	18.3	31.8	7.7	10.7	21.9	9.0	8.7
PPCS	FLJ11838	ENSG00000127125	"Phosphopantothenoylcysteine synthetase"	Q9HAB8	1	42456117-42473385	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 397.2;Proximal tubular cells: 316.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031361, HPA031363"	Approved		Approved	Mitochondria		NA	NA		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA031361: AB_10602150, HPA031363: AB_2673844"	"unprognostic (1.49e-1)"	"unprognostic (6.71e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (2.71e-1)"	"unprognostic (7.79e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.30e-2)"	51.0	62.7	28.2	34.6	29.3	27.1	65.0	29.8	34.6	44.2	36.8	63.5	58.0	35.8	71.0	48.4	31.7	43.1	42.5	28.6	32.0	88.1	99.6	39.8	43.5	30.1	28.8	30.2	66.9	59.8	27.8	38.0	29.1	52.3	58.0	22.4	59.3	44.2	45.9	47.0	56.4	29.0	31.6	42.2	64.7	15.0	29.9	27.8	64.8	40.4	38.2	43.3	40.1	32.9	83.4	34.3	17.2	28.8	52.3	55.0	72.1	40.7	43.3	49.1	44.2	30.7	93.3	22.6	80.7	46.2	30.3	48.8	11.5	62.5	40.3	66.2	35.1	39.9	34.7	31.3	72.5	39.9	69.4	48.8	98.9	35.8	62.4	58.2	48.3	29.9	16.9	17.0	50.5	47.3	20.4	40.1	22.6	70.0	49.8	22.6	18.8	45.3	106.2	70.7	23.0	25.0	47.9	113.2	129.4	50.2	56.7	167.8	31.1	28.2	41.1	42.9	46.5	58.6	37.3	17.5	12.6	44.4	61.0	298.8	231.5	325.6	114.5	245.4	135.2	171.5	141.1	128.0	195.9	182.4	149.5	132.9	159.5	185.6	237.2	135.8	160.9	262.8	28.2	29.3	29.8	34.6	28.6	32.0	30.1	28.8	29.1	31.6	29.9	32.9	61.0	57.7	84.1	5.9	62.6	23.3	42.3	99.4	42.7	12.1	91.3	100.2	104.3	84.4	90.8	64.4	6.2	172.2	52.6	129.2	397.2	96.5	3.5	66.7	43.9	48.7	31.3	29.0	7.4	136.8	131.0	52.9	61.7	59.3	57.0	52.8	44.6	120.1	107.4	11.8	7.0	124.9	103.7	84.4	44.3	4.6	60.6	76.3	81.8	6.5	127.0	64.8	79.3	8.0	8.7	98.5	125.2	63.6	41.8	51.7	159.7	316.3	63.2	28.0	26.3	26.2	48.9	10.3	20.8	66.3	36.2	134.6	62.5	103.2	101.2	60.1
PPDPF	"C20orf149, dJ697K14.9, exdpf"	ENSG00000125534	"Pancreatic progenitor cell differentiation and proliferation factor"	Q9H3Y8	20	63520765-63522206	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2997.4;Paneth cells: 2752.7;Proximal enterocytes: 2849.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"eosinophil: 26.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 26.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040929			Approved	Nucleoplasm,Nucleoli,Microtubules		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Microtubules"	Nucleoli	"HPA040929: AB_10794155"	"unprognostic (3.75e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.09e-2)"	215.1	72.2	192.7	71.1	203.3	79.6	237.4	194.7	262.1	312.4	108.7	298.3	81.3	217.8	43.8	622.2	185.6	40.8	412.9	164.7	189.8	421.8	134.9	243.4	42.2	220.9	217.1	197.5	197.9	47.1	196.8	30.3	221.9	365.0	60.6	25.6	432.4	93.4	438.3	461.5	167.1	53.4	201.1	117.0	298.8	129.3	202.5	32.1	249.8	64.2	47.3	264.0	410.7	253.9	287.2	87.8	57.9	118.5	65.4	107.9	185.4	169.1	54.1	217.5	85.2	162.8	166.3	60.7	222.8	115.2	83.2	294.3	29.5	196.0	35.5	110.5	58.5	24.8	83.0	31.9	175.3	0.2	124.3	106.5	384.9	55.3	76.4	72.7	86.5	74.9	104.5	138.9	81.1	394.9	288.7	2.7	63.3	228.1	494.5	132.0	132.2	125.7	159.8	117.4	197.1	150.9	170.3	272.6	124.4	39.1	390.7	168.8	147.3	184.1	206.9	245.8	143.5	108.9	93.3	41.1	130.7	70.9	122.6	2.3	3.0	26.0	5.7	3.6	4.7	5.0	5.1	5.4	3.4	5.8	4.3	5.2	1.2	3.0	5.7	4.0	5.7	5.7	192.7	203.3	194.7	262.1	164.7	189.8	220.9	217.1	221.9	201.1	202.5	253.9	328.1	314.1	220.3	15.7	462.8	574.5	714.7	1076.0	375.6	51.8	1282.8	1173.8	70.1	906.5	763.6	960.0	12.5	428.4	422.5	2528.3	2997.4	916.1	222.0	440.1	449.6	294.2	796.4	399.0	15.4	755.9	761.0	430.8	1120.8	520.2	337.8	293.3	376.3	224.2	600.6	50.5	12.5	1549.5	850.4	390.4	755.8	1154.3	371.9	366.4	1191.7	6.5	831.8	236.9	435.6	6.6	67.2	971.0	2752.7	288.5	280.4	1021.9	2849.8	1715.5	542.0	60.0	197.2	216.3	541.5	129.0	261.6	1559.8	932.1	414.1	541.7	158.5	1132.9	1492.7
PPEF1	"PPEF, PPP7CA"	ENSG00000086717	"Protein phosphatase with EF-hand domain 1"	O14829	X	18675909-18827921	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.8;testis: 14.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 64.0;Late spermatids: 139.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;HeLa: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034577			Uncertain	"Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Cytokinetic bridge"	"HPA034577: AB_10602817"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.10e-11)"	"unprognostic (5.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.19e-2)"	0.1	0.2	1.3	0.0	2.0	1.0	2.3	1.8	2.6	0.1	0.8	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.3	1.6	1.4	0.2	0.1	0.3	0.1	3.5	2.1	0.2	0.1	0.0	0.5	0.6	2.4	0.4	0.0	1.4	0.1	0.3	0.1	0.4	0.1	0.0	1.8	0.2	0.1	14.6	1.5	0.1	0.2	0.0	0.1	0.2	0.1	5.8	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.0	1.8	2.6	1.6	1.4	3.5	2.1	2.4	1.8	1.5	5.8	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.0	0.0	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	4.7	0.0	0.0	0.0	0.3	139.0	0.6	0.0	3.6	1.0	0.1	0.6	0.0	0.5	2.2	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	1.2	1.2	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1
PPFIA1	"LIP.1, LIPRIN"	ENSG00000131626	"PTPRF interacting protein alpha 1"	Q13136	11	70270690-70385312	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 261.2;SK-MEL-30: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017032, HPA042271"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Focal adhesion sites"	"CAB017032: , HPA042271: AB_2677923"	"unprognostic (1.89e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (7.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.14e-2)"	26.6	14.6	17.5	16.1	18.2	20.6	17.6	16.0	19.2	13.1	22.1	18.2	14.0	17.9	13.7	16.4	12.1	22.1	14.5	15.6	15.8	16.4	15.0	19.8	15.7	25.9	21.0	15.1	15.9	18.0	13.2	24.1	20.6	12.4	15.8	14.9	13.4	14.0	31.6	18.0	16.2	17.4	17.6	15.3	13.5	26.3	20.1	15.7	23.3	26.8	14.0	17.0	12.1	25.1	261.2	30.4	31.8	22.5	33.1	20.3	34.9	30.0	24.4	40.8	26.0	66.8	22.8	25.8	39.6	27.3	39.4	38.3	30.7	28.3	35.9	15.5	21.5	19.7	34.3	24.7	33.4	26.2	22.1	24.9	46.8	53.1	44.6	31.4	27.9	21.3	33.1	19.9	37.3	30.8	19.3	17.7	19.7	59.5	34.3	20.6	80.2	22.2	20.6	32.9	31.9	21.5	45.2	59.1	156.6	36.0	37.5	31.2	30.0	38.0	29.8	54.3	32.4	24.7	15.8	37.3	28.2	20.1	43.0	0.0	1.6	1.1	0.8	1.2	1.2	1.5	1.2	1.1	1.3	1.0	0.9	0.6	5.0	0.4	3.5	1.7	1.2	0.6	17.5	18.2	16.0	19.2	15.6	15.8	25.9	21.0	20.6	17.6	20.1	25.1	33.0	25.6	53.5	114.6	19.3	27.4	26.4	14.2	30.1	39.1	32.8	24.1	27.2	20.0	25.1	18.4	31.3	44.2	14.2	39.3	11.7	21.8	190.4	28.7	44.4	31.4	26.9	24.8	57.8	20.3	13.7	33.3	25.5	45.4	8.8	94.3	20.7	25.2	25.2	33.7	52.8	19.8	16.2	35.5	28.8	97.7	27.7	40.4	21.4	38.4	28.8	71.8	17.5	47.7	56.4	36.2	24.7	25.6	23.6	36.7	19.2	22.7	27.1	45.8	19.7	45.4	30.0	60.7	61.9	36.1	33.1	74.3	22.2	42.2	25.1	37.2
PPIB	"B, CYP-S1, CYPB, OI9, PPIase, SCYLP"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155740-64163134	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease variant, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1473.7;Plasma cells: 2242.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		33000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	375.5	377.5	230.7	449.5	240.3	571.9	361.9	247.9	259.2	611.5	257.2	401.0	365.0	383.9	899.0	298.8	401.5	379.2	262.0	229.7	256.9	312.3	737.4	351.1	344.5	258.1	241.4	386.2	644.2	345.4	416.8	515.2	255.1	375.7	411.3	72.3	513.1	488.6	62.2	205.5	334.3	482.4	247.0	360.5	375.0	110.0	254.9	315.6	672.8	91.1	346.4	510.9	295.6	262.6	675.6	847.9	736.7	1666.7	2577.0	1492.3	641.9	1570.3	2108.3	1248.7	1472.3	1242.6	1223.1	653.6	1227.4	2513.0	1235.3	1067.7	1384.6	1080.4	641.1	406.2	491.0	914.5	915.3	1643.7	2682.9	915.0	778.1	1374.2	1149.4	725.9	1751.3	1516.7	1539.2	301.1	645.9	2174.7	966.0	1102.6	280.6	1404.9	625.1	1879.0	529.5	520.6	784.1	3347.9	1312.7	1062.6	410.5	647.7	726.0	1224.5	1194.2	1086.0	727.6	2767.0	927.6	1213.7	975.8	679.2	1079.4	1152.5	1269.5	693.4	1129.0	1478.0	1238.2	716.7	712.5	491.7	929.6	547.3	931.8	827.8	645.0	762.4	930.9	541.4	411.3	558.0	347.5	668.1	369.3	2643.5	569.3	1512.3	230.7	240.3	247.9	259.2	229.7	256.9	258.1	241.4	255.1	247.0	254.9	262.6	389.3	125.0	209.0	16.6	375.3	160.2	426.2	614.6	234.5	34.5	264.3	303.8	0.8	270.2	328.7	272.2	31.3	625.9	560.0	271.0	90.1	665.1	19.0	295.8	910.1	285.0	297.0	172.6	10.2	566.4	1473.7	627.8	441.4	494.2	181.2	540.4	322.7	473.2	630.1	45.4	15.8	603.9	205.4	216.9	333.4	29.5	456.3	316.6	281.1	19.7	299.1	149.1	368.7	35.2	37.0	435.1	338.9	393.1	2242.6	569.3	338.6	287.4	168.2	43.7	230.1	204.3	445.6	38.4	76.6	337.0	144.8	1118.9	352.3	674.0	477.2	422.3
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709127-158723396	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		480000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	26.8	38.3	38.0	24.4	40.2	25.1	22.8	40.4	77.6	25.4	46.4	33.9	50.6	24.2	19.0	27.7	24.1	18.8	49.6	40.1	44.2	39.5	87.6	19.8	28.6	39.0	39.4	24.2	31.7	17.0	28.6	21.6	40.2	23.5	20.3	36.2	23.3	18.7	88.9	36.1	45.3	18.9	39.6	29.1	29.0	24.1	42.2	24.3	23.9	45.5	25.8	27.4	24.0	46.9	46.7	42.3	41.8	57.7	60.7	45.2	63.1	44.9	24.3	40.3	30.4	55.4	30.9	48.9	19.7	42.0	63.4	35.1	127.9	51.5	48.8	162.9	44.4	87.5	36.5	76.9	46.8	55.6	63.0	28.9	41.2	34.6	51.5	52.0	44.6	81.9	111.0	84.4	45.5	44.6	80.0	49.9	57.9	75.5	55.8	35.9	20.7	41.7	44.6	23.0	70.2	47.1	33.8	69.2	65.6	60.0	31.9	52.2	43.7	40.1	45.3	44.7	60.2	48.3	107.2	62.0	51.1	59.4	41.1	68.8	23.9	55.2	31.1	35.4	36.0	22.3	30.2	29.1	26.4	25.4	30.9	32.0	32.9	40.5	37.7	26.9	37.0	28.0	38.0	40.2	40.4	77.6	40.1	44.2	39.0	39.4	40.2	39.6	42.2	46.9	29.2	6.4	13.4	13.1	24.8	10.1	29.7	17.5	9.1	30.2	19.1	20.8	59.7	25.8	27.9	27.6	22.9	41.5	38.7	17.1	37.2	39.2	39.0	66.1	39.9	25.1	19.6	17.4	24.3	23.0	49.5	24.3	14.3	28.5	32.3	24.4	17.2	18.5	41.9	75.7	28.6	28.3	22.4	17.0	14.7	23.1	20.5	26.0	14.2	9.4	51.6	23.3	48.4	15.1	28.3	29.5	27.4	22.6	22.3	31.6	39.7	33.7	62.3	32.3	6.6	17.7	58.2	96.0	77.5	16.9	11.8	47.6	33.7	33.7	32.0	20.2
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584342-169641406	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: AB_2683445"	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.0	23.2	23.1	28.4	22.1	54.2	27.5	28.8	58.6	27.6	22.9	26.3	26.6	28.8	31.5	27.5	23.6	22.0	25.6	21.5	29.9	29.2	47.1	24.7	36.9	24.6	25.6	26.5	21.2	32.6	25.8	28.0	24.3	27.9	26.0	29.3	26.5	22.9	27.6	25.4	29.7	21.7	22.9	32.3	27.4	20.1	23.7	36.1	29.9	26.2	35.4	26.3	26.5	25.9	56.4	25.5	70.8	35.9	35.4	42.5	63.7	58.9	42.3	45.0	45.9	66.3	58.9	94.8	52.5	44.1	55.5	50.5	56.6	48.4	65.6	68.0	45.7	129.9	36.7	88.3	34.4	136.8	58.9	36.6	54.0	58.5	64.6	40.6	50.4	53.5	142.7	76.2	49.5	43.5	101.0	81.9	100.8	45.3	25.1	90.7	71.7	90.5	53.9	81.2	60.5	41.2	63.4	47.2	68.9	52.9	44.2	78.7	52.7	53.9	43.7	38.4	52.6	41.1	65.3	126.8	38.5	68.1	54.1	31.9	22.5	36.7	22.8	25.1	26.7	32.9	30.9	29.2	18.2	38.4	33.4	27.6	40.4	21.1	31.4	30.0	26.8	17.0	23.1	22.1	28.8	58.6	21.5	29.9	24.6	25.6	24.3	22.9	23.7	25.9	159.7	221.2	175.1	53.5	188.8	151.4	191.4	185.9	101.3	204.6	120.8	156.1	148.4	107.2	169.5	93.8	54.2	170.0	160.1	91.6	80.3	103.1	11.0	104.6	142.3	141.1	104.8	163.5	82.4	103.3	177.0	142.4	66.8	126.3	179.1	115.8	121.7	181.2	151.7	220.4	81.8	135.8	116.0	130.3	126.5	15.6	142.0	129.6	110.3	46.9	152.4	137.6	133.9	53.8	69.7	93.9	118.0	146.7	130.1	161.8	121.1	113.8	132.2	109.1	164.3	150.2	193.9	276.4	183.8	108.3	172.8	205.5	166.7	147.1	149.9	167.7
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36874803	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 58.7;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062916			Supported	Nucleoli		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	12.4	21.7	20.3	19.1	21.9	11.4	18.4	22.6	27.3	15.0	23.8	14.7	13.2	15.7	19.1	17.0	23.0	10.7	42.8	20.0	25.2	18.9	21.5	10.5	21.9	22.0	22.0	17.7	14.3	21.7	12.0	22.3	23.3	16.8	17.6	29.1	19.5	17.6	18.5	9.5	11.3	22.9	24.1	9.5	12.9	23.2	22.2	18.6	33.2	20.7	24.6	20.5	8.0	22.8	69.2	50.0	111.2	78.5	19.7	31.5	77.5	60.9	41.0	82.7	70.0	89.7	39.7	87.7	75.5	41.9	105.5	55.4	135.1	92.7	96.2	81.3	114.6	102.7	33.6	147.7	53.5	89.3	40.8	24.7	48.7	62.3	118.9	31.8	75.5	79.1	202.4	48.0	63.3	71.2	101.9	69.8	92.3	108.5	57.9	79.4	100.2	92.0	63.2	53.5	140.0	68.5	41.8	51.4	102.5	83.5	76.3	100.2	44.0	66.7	69.0	58.5	98.8	57.0	145.2	153.0	23.7	183.7	139.4	1.6	4.8	1.3	14.7	6.2	19.7	10.3	12.1	13.9	9.2	7.4	13.4	15.9	1.2	7.3	3.4	7.8	10.2	9.8	20.3	21.9	22.6	27.3	20.0	25.2	22.0	22.0	23.3	24.1	22.2	22.8	5.7	6.4	7.5	2.9	10.8	3.1	18.6	12.2	5.7	16.9	9.0	10.5	45.8	8.6	8.3	5.5	4.2	58.7	6.6	3.3	23.5	25.7	32.0	10.3	14.2	12.3	3.6	22.7	6.5	20.3	72.3	12.2	7.7	7.7	10.8	16.3	5.0	8.2	30.1	16.8	8.6	11.4	4.1	3.3	3.6	11.7	6.8	6.4	7.2	1.9	9.2	41.0	11.3	7.5	5.4	22.1	5.5	12.4	15.0	13.5	3.3	17.1	13.5	15.5	6.6	6.1	12.8	25.7	51.0	10.6	4.5	25.3	9.2	21.1	11.9	8.6
PPIL2	"CYC4, Cyp-60, UBOX7"	ENSG00000100023	"Peptidylprolyl isomerase like 2"	Q13356	22	21666000-21700015	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"K-562: 190.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035344, HPA055637"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA035344: AB_10672863, HPA055637: AB_2682869"	"unprognostic (1.97e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.77e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.46e-2)"	"unprognostic (5.39e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-3)"	8.9	14.2	4.7	12.8	5.7	6.3	9.5	4.0	7.0	11.6	2.1	12.1	8.1	12.0	9.3	16.4	10.7	9.5	13.9	5.8	4.8	12.6	15.0	10.1	16.4	3.5	2.9	10.7	19.2	16.4	14.3	9.1	3.9	12.4	10.6	9.0	14.7	9.5	18.8	12.3	13.3	9.9	3.6	14.0	13.9	10.1	3.1	15.8	18.8	13.0	16.4	11.7	12.1	4.8	20.4	17.1	18.1	20.1	19.2	17.6	15.8	19.3	17.9	28.0	24.5	21.3	10.3	34.0	12.7	27.2	13.9	22.9	28.6	23.6	16.2	19.2	28.2	26.7	14.2	32.4	14.7	42.5	21.5	17.4	21.2	19.4	14.0	15.1	25.1	18.5	190.3	17.9	19.6	28.6	20.5	13.7	20.2	35.7	14.9	23.7	31.1	5.7	14.2	14.1	30.8	18.4	21.2	32.7	9.7	11.3	27.1	20.3	27.5	15.8	25.1	17.5	12.7	19.2	17.5	24.7	21.6	22.6	24.9	1.5	9.7	5.1	9.6	15.3	12.2	7.2	11.5	12.6	13.7	8.3	10.5	9.4	2.3	14.1	22.6	11.9	15.6	12.1	4.7	5.7	4.0	7.0	5.8	4.8	3.5	2.9	3.9	3.6	3.1	4.8	9.8	9.6	29.5	15.0	21.5	3.2	7.9	10.9	10.8	26.3	13.4	10.2	5.7	27.1	16.6	14.7	33.3	15.8	39.4	23.9	13.7	12.8	66.8	15.4	14.8	8.0	11.4	17.7	19.9	16.7	13.3	10.3	39.3	19.5	17.1	16.6	10.4	18.9	15.3	18.5	24.2	20.6	14.2	21.0	5.3	90.9	12.2	15.5	1.8	8.4	16.6	11.5	52.5	12.5	17.4	18.5	17.4	13.5	23.8	10.9	14.2	9.1	11.9	31.4	0.0	11.2	9.4	23.6	17.3	12.3	5.7	22.2	24.5	14.8	20.8	12.6
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	13.0	16.4	15.2	19.8	14.9	35.1	25.4	17.0	22.3	15.7	13.9	19.0	14.6	20.2	28.4	18.6	22.5	13.0	18.2	14.6	16.8	18.4	21.9	15.0	32.2	15.7	15.5	35.4	12.1	14.0	14.9	17.7	16.8	15.1	19.5	25.8	17.1	18.2	18.0	18.0	18.1	12.4	15.4	17.5	19.0	21.1	15.5	30.1	20.8	11.1	32.5	16.2	12.5	18.2	19.9	18.3	53.0	23.5	42.5	90.8	17.5	32.0	35.3	37.1	37.2	13.0	37.5	19.5	32.0	35.4	41.9	24.6	19.3	38.1	33.2	41.4	43.8	84.0	48.3	90.6	21.3	79.7	39.8	32.7	37.7	30.3	47.1	62.0	25.3	38.4	67.4	46.3	46.3	32.4	61.7	67.2	32.9	19.8	28.9	23.3	30.5	29.1	49.6	30.4	22.2	21.1	31.3	29.9	51.7	62.3	24.6	36.9	34.2	51.4	28.8	31.2	26.2	45.5	51.0	94.2	39.6	36.2	33.7	36.2	17.5	19.7	17.5	16.4	25.5	35.2	20.9	17.7	30.9	26.7	25.3	27.6	4.5	31.8	23.1	25.6	30.3	14.6	15.2	14.9	17.0	22.3	14.6	16.8	15.7	15.5	16.8	15.4	15.5	18.2	12.5	0.0	11.5	16.0	33.6	31.7	43.1	71.5	37.5	12.0	23.7	28.2	18.5	15.7	30.4	16.5	10.4	50.3	24.8	9.7	56.7	26.0	44.1	16.1	21.4	16.2	9.5	25.5	19.3	16.1	51.6	22.1	16.3	13.4	26.0	17.2	13.6	19.4	47.0	3.3	18.1	25.3	48.8	32.1	59.1	9.5	36.7	26.8	28.4	9.4	30.2	23.1	37.0	15.1	19.7	18.2	18.1	28.2	24.5	15.9	25.4	59.7	28.7	11.9	19.7	18.2	39.6	45.7	22.6	34.5	46.3	30.8	31.1	8.9	29.4	35.6
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 35.6;testis: 18.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 374.4;Endometrial ciliated cells: 226.5;Late spermatids: 75.1;Respiratory ciliated cells: 228.6;Spermatocytes: 101.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;ASC diff: 9.2;ASC TERT1: 11.5;hTERT-RPE1: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.1	0.9	4.7	0.6	5.2	0.2	3.0	5.7	5.3	3.8	12.2	1.3	1.4	3.0	9.0	1.4	35.6	1.1	2.1	4.8	5.2	4.3	0.6	4.7	0.6	7.5	8.2	5.3	2.3	5.2	2.7	1.1	5.5	1.2	1.0	7.4	2.3	2.7	4.3	1.3	0.7	2.0	7.2	0.8	1.7	18.9	5.1	0.8	11.1	1.7	0.6	1.5	1.2	7.6	1.4	1.2	1.1	6.0	9.2	11.5	0.6	0.0	2.2	0.5	0.1	0.1	1.6	0.0	0.4	0.6	0.8	0.9	1.0	0.0	0.3	0.4	0.4	0.5	0.1	0.0	4.6	0.5	0.2	2.4	5.6	0.2	3.5	8.6	0.7	1.3	0.6	0.4	0.4	0.6	0.1	0.7	0.2	4.0	0.8	0.6	0.0	0.5	4.7	0.1	1.3	2.1	0.1	0.3	3.9	0.3	0.4	0.9	0.3	0.1	0.2	1.0	0.2	0.2	0.1	0.1	1.9	0.1	0.4	0.8	0.1	0.2	0.1	0.1	0.1	1.5	0.2	0.1	0.3	0.5	0.1	0.1	0.4	0.4	0.1	0.4	0.1	0.2	4.7	5.2	5.7	5.3	4.8	5.2	7.5	8.2	5.5	7.2	5.1	7.6	2.6	6.4	6.9	11.8	1.8	2.2	3.7	18.2	2.8	2.4	5.7	7.0	3.7	2.8	22.1	3.7	2.1	0.8	0.4	0.9	25.4	1.9	374.4	226.5	7.3	1.8	3.0	0.4	15.0	1.2	0.8	3.9	2.6	5.8	0.0	4.1	1.1	0.2	0.4	1.7	6.1	2.0	22.4	0.0	0.3	75.1	5.3	1.1	3.6	3.7	0.6	7.8	0.0	8.5	6.2	0.7	0.8	5.3	0.8	3.8	1.5	13.0	228.6	13.4	0.0	5.2	5.6	101.4	21.5	1.9	3.0	0.7	1.2	3.0	2.0	1.5
PPIP5K2	"CFAP160, DFNB100, HISPPD1, KIAA0433, VIP2"	ENSG00000145725	"Diphosphoinositol pentakisphosphate kinase 2"	O43314	5	103120149-103212799	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Hearing	"Kinase, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037895, HPA038442"	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA037895: AB_2675724, HPA038442: AB_10673173"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (8.80e-2)"	15.7	19.1	6.8	22.0	7.9	51.6	25.1	18.9	13.9	22.2	5.8	28.1	18.3	20.6	21.2	17.1	14.5	20.4	19.5	6.7	8.9	20.3	29.2	16.2	25.5	15.4	11.9	26.1	26.7	23.0	18.1	16.7	15.1	16.3	25.5	19.2	17.1	15.4	4.2	17.2	16.5	18.4	6.1	23.9	22.5	15.1	7.3	27.9	23.3	7.7	24.5	17.8	13.9	10.7	27.4	25.3	50.8	65.2	40.8	53.4	47.8	63.5	39.3	34.2	47.6	20.9	48.3	67.6	56.2	60.9	52.7	16.5	43.9	33.2	57.5	53.7	23.5	84.7	44.3	33.4	29.0	72.1	70.4	34.5	23.4	52.0	46.1	31.2	40.0	42.5	84.9	57.0	53.1	21.3	60.9	44.6	55.4	12.7	64.4	58.6	46.7	89.3	36.8	31.5	29.6	40.1	43.5	39.9	40.7	34.0	33.5	48.9	42.7	55.8	25.7	56.0	45.1	38.1	87.3	91.3	31.5	116.0	51.2	41.7	21.5	39.6	13.0	22.9	15.8	19.5	12.6	14.2	25.6	16.1	16.1	17.0	19.7	17.8	32.4	15.5	12.3	11.1	6.8	7.9	18.9	13.9	6.7	8.9	15.4	11.9	15.1	6.1	7.3	10.7	35.8	48.1	23.1	49.3	39.3	13.6	12.8	13.7	31.9	38.5	26.1	26.4	48.9	18.6	29.6	16.5	45.9	12.7	35.7	29.7	5.9	11.6	5.6	25.4	44.7	28.7	16.3	70.7	88.4	17.0	19.2	33.0	33.6	30.6	43.6	49.2	14.6	20.6	30.6	16.8	160.3	24.2	16.2	39.5	22.4	6.7	29.5	43.3	12.4	49.6	47.5	14.5	27.8	62.8	67.0	16.9	19.1	23.7	56.6	12.1	13.3	22.6	25.1	25.2	6.6	30.3	28.1	39.7	21.6	31.6	15.8	26.0	31.6	38.7	30.1	12.6
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 728.1;vagina: 288.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Squamous epithelial cells: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.5;HaCaT: 191.1;MCF7: 71.5;SiHa: 102.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		80000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	56.3	4.9	2.5	1.0	3.2	0.2	39.8	0.3	4.2	163.0	3.3	10.4	6.5	5.7	7.3	728.1	11.5	7.1	5.7	3.6	0.0	13.2	13.3	18.6	0.4	0.0	2.8	5.9	10.6	4.1	14.3	6.4	1.1	17.3	3.4	2.4	149.5	11.5	12.0	188.4	12.3	1.7	0.0	0.3	11.1	1.9	0.0	3.5	22.1	5.3	57.0	22.0	288.6	0.5	24.0	8.6	0.1	0.1	60.0	86.5	29.6	0.1	1.6	0.2	0.6	39.5	59.5	0.4	13.5	1.2	3.4	191.1	1.3	23.0	0.0	0.0	1.3	0.1	46.3	7.1	3.8	0.1	0.1	4.2	20.7	0.2	7.1	4.6	0.1	0.2	0.2	0.2	0.1	71.5	0.1	0.2	6.0	31.3	18.1	0.1	0.1	30.0	44.6	37.5	30.9	0.3	102.5	33.8	0.3	8.9	17.4	0.5	0.3	0.2	0.3	0.3	0.1	0.4	1.1	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.2	0.3	4.2	3.6	0.0	0.0	2.8	1.1	0.0	0.0	0.5	4.1	73.7	29.1	1.6	1.2	35.1	32.5	30.5	35.9	8.4	18.8	13.8	5.1	35.8	42.6	57.0	6.2	2.1	2.0	3.6	1.9	18.4	0.7	31.6	4.1	8.0	39.4	0.0	6.6	4.5	1.6	38.0	9.2	28.0	0.0	0.8	2.9	12.7	0.7	1.7	2.5	3.8	18.3	0.9	9.0	1.3	55.3	1.4	17.8	1.0	1.2	3.7	2.1	1.0	1.7	23.4	8.3	4.1	0.2	35.1	13.5	1.2	32.5	12.5	0.0	28.7	4.3	3.9	3.1	138.0	51.3	1.4	2.7	0.4	4.8	53.2
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	4.4	2.4	2.7	2.2	5.2	5.9	3.9	14.8	4.6	4.5	5.0	3.1	2.9	4.3	2.9	3.5	3.7	3.1	2.9	3.3	3.4	2.8	2.8	3.6	2.7	4.0	3.5	6.3	3.3	2.3	2.4	5.9	4.7	3.1	3.5	6.4	3.1	2.2	4.0	2.9	2.7	3.0	3.4	3.8	2.7	5.5	3.7	4.4	2.9	3.1	2.3	2.8	4.0	9.1	3.8	6.9	7.5	6.4	5.0	3.1	10.7	5.8	3.6	3.4	4.9	7.1	2.0	9.9	4.5	3.7	1.3	3.4	4.9	2.2	4.6	1.9	11.1	7.4	6.7	8.1	4.2	2.9	5.3	2.7	3.6	5.1	3.0	2.8	7.9	4.1	5.4	4.0	3.7	34.4	8.1	4.4	3.5	3.4	5.2	9.5	9.6	6.6	3.1	4.2	10.5	7.4	7.1	2.4	1.6	8.0	2.8	3.9	5.7	4.7	12.5	3.5	3.3	6.7	7.7	7.3	1.7	2.9	3.8	9.9	16.1	18.0	7.6	12.5	6.8	8.9	6.3	7.0	16.0	6.2	6.8	7.0	24.7	8.6	8.1	7.0	10.6	9.8	2.7	5.2	14.8	4.6	3.3	3.4	4.0	3.5	4.7	3.4	3.7	9.1	40.9	32.1	7.7	15.0	23.1	21.0	6.2	3.3	52.3	13.1	14.2	9.8	6.3	8.6	4.6	5.5	4.2	17.6	19.4	15.0	3.9	6.6	68.9	14.0	15.5	25.2	14.4	14.1	19.6	6.6	6.4	14.7	10.2	15.6	1.3	7.2	23.6	4.2	8.8	3.3	20.8	11.4	6.1	21.4	19.2	12.8	13.7	16.1	3.6	28.1	12.3	7.0	6.2	20.6	38.6	5.4	10.2	7.5	24.5	7.8	8.7	5.1	3.6	10.4	0.0	12.1	14.0	43.8	15.0	34.4	18.0	38.6	18.1	6.0	11.5	7.7
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755854-58985179	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 39.2;retina: 22.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;prostate cancer: 3.0"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 31.6;hippocampal formation: 39.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.1	5.5	5.3	0.1	4.8	0.0	0.1	1.0	31.6	0.2	0.0	0.1	0.1	0.3	0.9	0.0	1.5	0.1	1.0	39.2	7.3	0.7	1.0	0.2	0.2	1.9	4.2	0.2	0.6	0.3	1.3	0.0	3.2	1.4	0.0	22.3	0.2	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.5	6.7	8.0	0.2	0.1	0.1	0.2	0.1	0.1	2.3	0.0	0.1	12.2	0.6	0.0	0.0	0.9	0.0	0.0	0.9	1.4	0.0	0.0	8.0	0.1	0.1	2.7	0.0	19.9	0.0	0.5	0.2	5.9	0.0	0.2	0.0	1.3	0.6	2.6	0.3	1.6	0.1	0.0	0.6	0.0	4.9	2.1	0.0	0.0	3.6	9.9	0.0	3.5	0.0	1.0	0.0	1.5	0.0	0.0	0.0	9.1	18.7	0.3	0.0	1.3	0.1	0.0	8.7	0.0	0.0	2.2	0.0	2.9	0.1	0.1	5.4	0.3	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.8	1.0	31.6	39.2	7.3	1.9	4.2	3.2	0.3	8.0	2.3	0.1	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.4	3.3	0.0	1.8	0.0	31.3	0.0	0.0	0.1	0.0	0.0	30.8	3.9	0.1	0.3	3.0	0.0	220.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.4	0.1	77.4	288.4	0.0	0.0	0.3	0.0	17.6	0.0	0.1	0.0	5.6	0.0	4.2	0.0	109.1	38.4	0.0	0.2	0.4	0.0	1.3	0.0	0.1	0.0	13.8	0.0	0.0	0.5	12.1	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919425-21952848	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endothelial cells: 42.2;Hepatic stellate cells: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 28.6"	"Group enriched"	"Detected in all"	7	"dendritic cells: 8.9;granulocytes: 28.6;monocytes: 24.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 109.1;K-562: 173.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		510000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	24.1	18.1	14.9	21.6	13.9	26.8	17.6	11.6	15.7	18.5	11.8	17.1	8.9	19.9	3.8	22.1	15.0	12.2	16.8	14.5	19.4	18.4	8.0	26.1	15.2	16.8	16.4	12.5	12.3	6.4	8.5	26.6	17.3	15.8	4.2	3.7	10.9	14.3	17.0	14.8	13.8	12.1	15.3	35.8	12.0	6.3	17.1	7.8	12.4	10.5	7.8	22.0	15.9	15.4	28.9	30.1	19.0	18.6	10.4	18.1	23.9	32.1	18.9	27.7	19.0	13.8	11.3	17.3	39.0	22.7	11.8	33.9	8.3	19.9	9.8	24.7	27.1	66.8	14.5	13.2	17.1	25.0	17.4	17.1	5.9	27.1	12.6	19.6	109.1	16.9	173.4	7.2	35.9	26.2	15.0	19.3	8.0	9.2	32.7	21.9	49.0	5.2	9.4	12.1	7.7	29.6	30.4	10.0	25.7	7.4	12.5	17.2	93.1	33.1	33.4	30.5	31.1	14.1	12.2	19.6	33.5	46.7	64.7	0.0	12.8	5.9	1.7	21.0	1.0	1.1	1.1	0.9	8.9	0.9	1.0	1.3	28.6	3.1	24.4	2.2	2.4	5.4	14.9	13.9	11.6	15.7	14.5	19.4	16.8	16.4	17.3	15.3	17.1	15.4	32.1	6.4	6.0	11.8	5.5	8.2	5.2	4.9	8.6	8.3	7.4	9.9	11.9	8.6	4.1	1.8	2.1	16.6	5.1	1.4	3.9	5.2	2.0	3.0	9.4	42.2	6.0	5.5	11.6	5.1	10.0	8.4	3.1	3.8	3.8	10.4	56.4	6.5	20.6	8.4	12.7	4.2	6.1	37.0	22.0	1.5	7.2	23.4	7.2	18.7	30.9	4.1	6.2	12.5	6.8	7.4	1.1	6.8	5.0	7.4	2.6	4.4	4.0	6.5	6.6	17.2	8.2	14.2	13.1	8.5	5.7	3.0	6.4	7.1	4.5	6.6
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381195-27409591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 233.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1540.4;Late spermatids: 3492.8;Spermatocytes: 793.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	46.0	49.6	34.7	45.1	35.1	73.5	43.6	35.4	37.8	38.4	36.9	48.3	39.9	45.6	26.1	62.6	39.0	28.0	44.9	35.0	37.0	40.7	45.3	40.6	59.6	35.4	36.0	34.9	53.0	41.4	43.4	37.6	35.3	36.0	51.3	20.0	45.1	38.8	95.7	41.2	43.0	44.9	35.1	47.1	47.8	233.9	36.0	64.9	36.8	53.0	75.3	47.0	39.6	35.3	302.0	243.1	174.0	134.8	108.7	88.0	160.6	182.8	119.8	214.8	170.9	377.7	154.4	352.7	130.9	130.9	181.8	160.3	296.4	205.6	191.4	148.4	241.1	343.6	172.9	404.0	97.9	343.5	139.2	95.7	116.9	219.2	175.1	101.7	209.1	171.1	293.3	106.0	165.5	269.4	256.7	370.5	254.1	207.1	173.1	261.1	365.0	185.3	145.9	206.4	233.2	264.0	164.4	178.9	135.9	137.4	99.4	111.3	169.5	159.3	192.6	141.6	281.8	229.0	277.0	545.5	124.8	275.6	122.5	67.3	41.5	59.0	57.5	52.3	56.8	44.7	61.1	60.3	65.4	37.9	45.1	47.4	20.9	55.0	71.4	91.9	88.9	48.0	34.7	35.1	35.4	37.8	35.0	37.0	35.4	36.0	35.3	35.1	36.0	35.3	72.9	64.1	51.3	9.8	76.7	81.1	88.7	71.9	83.6	40.8	63.1	59.3	37.9	52.9	63.7	69.9	29.2	93.9	114.2	81.0	33.2	135.7	1540.4	102.7	75.8	80.8	80.7	119.6	19.5	139.3	163.8	56.6	69.3	89.8	59.1	76.1	40.4	44.7	85.4	48.8	21.1	78.9	54.9	59.7	75.7	3492.8	70.2	68.2	24.9	17.8	127.3	69.7	112.3	17.1	15.9	156.7	52.7	71.1	137.8	152.1	52.6	61.4	61.8	41.7	46.0	54.9	80.5	793.3	298.9	108.7	80.6	53.1	89.7	123.7	106.4	122.6
PPM1J	"DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ"	ENSG00000155367	"Protein phosphatase, Mg2+/Mn2+ dependent 1J"	Q5JR12	1	112709994-112715477	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 18.8;skeletal muscle: 68.4;skin 1: 18.1;testis: 63.8;tongue: 25.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 123.6;Late spermatids: 281.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 67.9"	"Lineage enriched"	"Detected in many"	15	"dendritic cells: 67.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 19.5"	"Region enriched"	"Detected in many"	7	"olfactory bulb: 27.3"	"Low region specificity"	"Detected in all"			HPA046045	Uncertain		Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA046045: AB_2679516"	"unprognostic (8.68e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.96e-4)"	1.1	2.6	6.3	1.0	6.6	0.7	2.2	5.9	6.5	2.3	3.8	1.2	0.6	1.9	18.8	4.6	2.8	1.0	8.7	5.8	5.7	7.8	0.7	1.6	3.3	5.2	7.8	2.3	1.7	5.5	2.6	0.5	4.6	3.3	0.6	6.9	2.8	2.1	68.4	18.1	1.4	1.3	4.5	1.4	1.2	63.8	9.1	2.3	3.1	25.6	2.2	1.1	4.0	3.9	2.7	0.1	1.5	1.7	0.8	1.5	1.1	0.3	0.7	0.3	1.0	1.2	0.8	0.4	0.4	0.8	0.8	4.9	1.1	4.6	0.4	0.0	2.6	0.8	0.2	0.2	0.9	0.0	0.2	1.7	3.0	0.9	4.6	1.0	2.1	0.2	1.0	0.0	1.2	2.9	0.0	0.0	1.6	1.4	2.3	0.1	0.1	0.0	2.7	0.1	0.8	0.2	0.6	4.3	1.3	2.2	19.5	0.0	1.1	0.3	2.8	0.0	0.2	0.1	0.0	0.0	2.3	0.6	2.6	0.0	0.3	0.0	0.0	1.5	0.1	0.7	0.0	0.1	7.1	0.7	0.0	0.0	0.0	0.0	4.3	67.9	0.0	0.8	6.3	6.6	5.9	6.5	5.8	5.7	5.2	7.8	4.6	4.5	9.1	3.9	1.2	0.0	0.5	0.3	2.0	2.2	4.7	8.7	10.2	5.7	4.2	4.6	5.8	0.0	2.7	1.8	10.4	1.0	41.3	0.7	9.8	3.2	123.6	3.2	0.3	1.5	0.0	0.0	1.8	4.3	1.4	1.1	1.1	0.6	0.0	5.6	0.7	0.1	0.7	0.0	1.5	0.9	2.0	1.3	11.5	281.6	3.1	2.0	0.0	0.0	1.6	25.4	0.0	0.0	0.2	2.1	2.4	2.6	0.0	6.7	0.3	0.6	1.8	9.1	6.6	1.1	2.8	2.8	16.9	3.5	2.8	0.5	0.9	3.2	0.8	2.9
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 92.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 512.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 58.0;Karpas-707: 48.6;U-698: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	5.3	8.5	23.3	14.9	26.3	9.9	14.5	22.5	31.2	19.4	22.0	5.9	4.4	32.7	7.6	11.2	21.5	8.9	92.5	26.5	23.9	17.8	7.6	9.7	25.6	19.9	22.3	32.5	11.1	12.5	9.9	9.7	22.9	16.2	6.0	14.2	11.8	7.1	14.2	2.6	10.4	26.6	22.1	18.9	8.0	19.9	27.7	15.2	7.9	11.5	25.8	8.9	11.7	33.2	4.6	1.5	5.7	10.1	8.3	10.9	2.3	7.2	13.0	23.3	27.4	11.6	1.1	58.0	7.7	4.6	11.5	0.5	17.0	5.4	9.1	44.9	7.1	10.8	5.0	10.8	6.6	14.6	5.3	7.2	2.7	14.5	12.5	4.9	4.2	25.4	15.5	48.6	7.0	6.5	20.3	7.9	3.4	3.5	2.3	10.8	9.3	21.9	8.1	2.0	4.4	3.9	4.6	0.5	5.4	9.6	23.2	3.9	0.8	8.3	4.2	2.8	4.1	15.6	15.0	48.3	9.1	11.7	14.0	24.7	9.9	8.1	39.4	12.0	51.4	102.9	37.1	39.9	18.6	113.5	36.3	44.2	3.2	27.6	3.6	131.3	46.9	24.5	23.3	26.3	22.5	31.2	26.5	23.9	19.9	22.3	22.9	22.1	27.7	33.2	20.7	48.1	12.4	105.4	124.8	9.8	15.8	5.7	29.6	109.5	42.8	25.7	512.1	8.6	13.7	49.7	18.8	11.5	153.0	0.8	156.5	7.0	7.9	9.7	37.2	27.2	9.6	34.3	89.5	6.2	3.2	42.9	8.2	20.0	19.0	32.2	24.7	30.2	28.9	85.8	145.6	16.5	4.1	14.5	16.4	10.5	23.9	27.5	21.4	40.3	75.6	21.8	80.3	100.0	54.7	4.6	9.2	31.6	82.7	32.1	8.2	47.6	19.5	14.8	26.3	38.5	36.4	38.2	22.9	71.4	5.4	2.9	70.1	45.4	4.1	6.7
PPME1	"ABDH19, PME-1"	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171267-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 432.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		45000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254"	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	14.7	25.1	16.8	10.0	18.1	16.9	14.9	8.5	21.3	17.3	7.8	15.2	11.0	16.8	29.1	20.8	24.1	14.0	21.4	18.8	19.4	18.6	10.1	13.0	9.3	12.7	14.5	18.3	15.4	62.5	14.5	14.9	17.5	23.8	15.7	23.8	20.1	24.9	29.7	28.7	11.5	21.4	9.8	8.1	13.4	31.9	13.4	18.8	23.1	24.1	14.7	22.3	13.9	14.0	50.5	62.3	42.4	45.9	45.4	36.0	41.3	71.8	48.4	134.8	103.6	139.1	32.3	26.3	47.7	55.1	73.6	79.9	63.4	50.3	123.1	36.4	23.8	38.7	66.6	64.1	96.7	28.9	33.2	34.6	41.8	69.7	32.7	54.8	39.1	37.5	93.0	22.5	236.6	34.1	38.0	36.1	34.4	71.2	50.3	39.9	432.4	39.9	56.7	33.9	57.2	49.2	85.1	38.7	108.4	46.2	72.7	29.1	23.5	52.1	67.6	51.5	55.2	41.4	54.6	46.9	39.2	26.7	43.4	1.4	8.7	11.3	10.4	10.5	13.2	7.2	13.4	12.6	11.2	8.3	13.3	10.9	4.9	13.7	9.5	11.8	10.9	9.2	16.8	18.1	8.5	21.3	18.8	19.4	12.7	14.5	17.5	9.8	13.4	14.0	16.1	28.9	12.8	28.7	10.8	20.3	24.4	30.5	23.3	31.3	18.5	17.7	18.0	7.2	28.5	35.0	37.5	14.1	11.2	15.4	17.6	16.9	51.4	44.9	32.8	15.0	25.7	96.4	65.3	13.4	38.9	19.1	23.9	24.2	8.2	21.2	10.8	9.7	13.6	33.7	59.3	13.5	34.6	6.7	14.8	13.4	13.7	11.1	3.6	20.6	10.8	15.2	16.5	35.7	40.5	16.6	12.0	25.2	8.2	19.2	10.3	11.6	40.9	18.8	6.6	19.0	33.0	61.9	45.6	21.5	24.9	15.5	12.4	18.8	13.4	17.3
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166056-161178013	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 65.9;Respiratory ciliated cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030123	Uncertain		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Vesicles, Cytosol"	"HPA030123: AB_10603987"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	9.3	17.1	24.2	3.5	24.5	25.2	10.3	25.2	38.2	14.5	24.7	12.7	3.9	10.9	8.3	8.9	22.0	4.7	13.1	24.4	24.7	15.5	11.5	8.6	5.7	25.0	25.0	13.8	10.8	7.2	13.7	6.5	24.6	13.4	3.9	12.6	8.7	7.7	7.6	11.2	8.5	6.6	25.0	13.6	10.9	6.9	24.0	5.0	11.9	5.6	5.2	11.6	9.6	25.4	10.0	8.0	12.7	8.5	10.4	9.3	3.5	5.9	5.7	7.5	10.3	10.4	9.3	7.4	14.3	5.3	4.1	6.3	9.8	8.8	7.1	4.6	20.3	9.0	18.9	23.9	8.6	3.0	4.6	7.6	11.0	6.3	9.4	9.4	14.7	7.0	22.8	11.2	5.6	9.2	12.0	8.6	8.2	11.2	18.8	13.6	8.2	16.7	15.1	4.2	9.8	14.7	6.6	10.3	12.0	14.6	19.9	9.5	5.7	6.5	7.1	6.5	7.5	19.4	15.3	10.5	6.8	6.0	4.9	6.3	7.2	5.3	10.4	7.6	7.2	9.0	7.8	7.6	10.4	8.2	6.8	6.9	2.9	12.0	5.2	6.6	16.1	7.8	24.2	24.5	25.2	38.2	24.4	24.7	25.0	25.0	24.6	25.0	24.0	25.4	10.9	3.2	13.7	10.4	9.8	12.0	8.3	16.6	9.1	18.0	12.1	14.1	10.1	4.3	15.6	7.3	22.9	21.4	10.6	3.6	21.5	9.5	9.8	39.1	5.9	8.3	6.0	65.9	5.9	5.6	9.4	9.1	5.1	4.6	6.3	12.3	8.9	6.1	9.3	15.2	7.5	7.3	26.4	4.7	8.4	12.1	10.2	8.0	1.8	5.6	8.1	10.4	8.2	9.0	8.9	6.3	3.8	6.8	16.9	3.2	6.6	17.2	84.4	20.9	6.6	9.6	15.6	12.8	9.3	7.2	14.9	10.4	10.6	11.1	7.5	6.2
PPP1R15B	FLJ14744	ENSG00000158615	"Protein phosphatase 1 regulatory subunit 15B"	Q5SWA1	1	204403381-204411817	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"		"Diabetes mellitus, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061088			Approved	"Golgi apparatus"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA061088: AB_2684426"	"unprognostic (2.91e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (9.52e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.50e-2)"	40.7	23.1	12.9	31.0	15.3	125.7	23.0	17.8	13.9	19.6	16.4	23.4	22.4	21.4	13.1	25.9	21.5	30.8	13.0	11.7	13.2	21.0	48.1	24.2	29.1	14.4	15.2	24.5	36.8	18.7	10.5	32.6	14.6	22.5	24.1	16.0	22.1	15.9	13.2	18.1	24.3	29.9	14.6	23.8	27.0	11.7	15.2	33.3	28.2	18.2	24.7	53.2	14.7	19.7	29.3	23.0	26.9	22.8	34.1	23.2	108.7	23.6	28.3	31.9	28.7	27.6	40.3	48.2	16.0	28.9	22.2	36.3	40.2	23.9	29.5	37.3	28.7	28.5	55.7	17.8	41.5	49.1	49.0	29.3	30.4	31.4	34.5	22.9	35.1	40.4	44.4	92.8	21.8	29.1	47.1	30.6	46.2	26.8	32.9	33.2	48.9	49.8	32.0	35.4	25.7	39.3	42.6	59.8	49.3	36.0	39.4	50.2	19.8	22.2	31.3	28.6	40.3	62.5	30.0	47.3	20.0	33.1	23.4	13.1	5.5	5.7	3.2	5.1	3.4	2.0	3.2	3.0	5.0	2.1	4.9	3.5	11.8	3.2	6.2	2.0	4.4	2.9	12.9	15.3	17.8	13.9	11.7	13.2	14.4	15.2	14.6	14.6	15.2	19.7	72.2	48.1	37.9	15.3	40.8	73.7	43.0	23.1	48.3	18.5	43.7	24.6	15.6	32.9	25.9	18.4	20.9	22.9	40.3	70.4	3.9	15.9	9.0	72.0	90.8	50.9	44.7	27.3	12.3	24.0	42.7	54.7	76.5	146.7	49.4	31.0	28.9	48.6	31.8	8.4	13.0	43.3	22.4	42.0	171.9	4.6	13.1	97.9	49.8	10.3	36.8	14.4	11.3	18.1	23.2	30.3	40.5	12.8	50.9	55.0	39.5	11.0	43.0	18.5	6.6	72.7	48.6	17.2	13.2	39.8	64.2	49.3	46.8	31.2	35.6	104.5
PPP1R3E	FLJ00089	ENSG00000235194	"Protein phosphatase 1 regulatory subunit 3E"	Q9H7J1	14	23295652-23302859	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 47.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 111.9;Late spermatids: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 41.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061600	Approved		Approved	"Microtubules,Mitotic spindle,Mitochondria"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Microtubules, Mitochondria"	"Mitotic spindle"	"HPA061600: AB_2684566"	"unprognostic (3.45e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.89e-5)"	"unprognostic (4.05e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.67e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.12e-2)"	"unprognostic (5.46e-2)"	5.8	8.0	15.2	5.7	17.9	3.9	6.4	17.9	23.8	10.2	9.7	7.4	6.3	6.4	10.1	6.0	9.5	3.3	6.2	15.0	15.3	11.6	11.2	5.7	9.5	18.5	16.5	12.5	10.6	5.7	19.3	2.7	19.4	12.1	5.9	47.0	8.5	6.2	14.9	10.9	13.3	3.4	13.8	15.1	9.0	14.7	17.7	8.2	14.9	5.4	8.2	7.9	8.5	23.3	1.1	3.0	3.6	2.5	6.9	2.9	1.7	1.2	2.2	2.0	1.7	1.7	5.8	11.2	0.8	1.6	2.2	7.6	2.1	1.2	2.5	4.0	2.1	2.0	6.9	4.0	1.8	2.3	4.4	2.5	4.5	1.2	6.1	3.3	0.9	6.0	1.9	9.8	1.7	2.6	2.1	3.6	0.9	3.6	2.8	3.4	2.5	7.2	1.1	2.5	4.5	1.2	1.8	1.6	1.2	1.8	1.9	0.8	1.7	2.4	1.3	4.1	0.9	41.1	4.6	5.1	1.9	4.0	1.5	0.2	0.4	0.2	0.5	1.4	0.6	1.0	0.1	0.2	0.3	0.6	0.5	0.3	0.4	0.2	1.8	0.3	0.4	0.3	15.2	17.9	17.9	23.8	15.0	15.3	18.5	16.5	19.4	13.8	17.7	23.3	5.8	3.2	4.8	30.0	25.4	5.6	9.0	5.3	11.4	59.4	7.8	11.6	8.8	7.2	5.0	20.2	37.5	8.2	12.8	8.0	5.9	2.1	111.9	3.7	6.6	7.2	8.4	7.2	25.0	3.3	2.0	6.1	20.4	4.3	3.8	9.4	7.5	7.2	7.4	32.0	33.0	7.7	4.1	9.5	9.6	62.9	27.4	9.2	10.6	15.9	8.1	20.4	26.8	16.1	56.1	2.4	11.6	25.9	11.9	6.7	19.5	9.5	4.8	38.1	13.1	3.5	5.4	36.5	13.9	8.4	9.1	5.2	15.7	7.2	9.6	8.6
PPP2R2A	"B55A, B55alpha, PR52A, PR55A, PR55alpha"	ENSG00000221914	"Protein phosphatase 2 regulatory subunit Balpha"	P63151	8	26291508-26372680	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, CAB079289"	Approved		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB079289: AB_659890, HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.16e-1)"	32.1	16.1	8.9	12.7	13.1	4.7	30.4	9.1	14.3	33.1	6.4	19.1	21.7	22.3	8.5	59.6	24.6	14.1	26.7	9.5	10.2	18.0	28.3	25.8	16.0	9.4	9.7	24.7	14.7	14.0	13.5	38.2	9.2	19.5	15.2	10.5	27.0	15.9	53.4	38.9	19.4	18.3	10.2	17.9	17.7	18.1	8.8	16.0	19.4	23.6	25.7	24.2	37.0	13.6	42.1	33.5	52.5	32.2	28.3	43.6	54.2	74.5	49.4	63.1	65.2	48.9	24.2	54.5	19.1	28.9	31.5	51.2	56.9	50.1	78.0	23.8	24.4	43.8	36.6	23.0	42.0	25.2	19.1	29.3	62.4	39.4	52.0	31.7	96.1	27.5	64.1	37.1	51.7	26.0	54.4	17.6	62.5	73.6	20.5	36.1	35.1	41.8	31.0	74.8	21.0	27.7	30.3	27.9	41.0	37.2	26.9	13.7	45.8	28.5	46.0	31.4	47.0	18.6	32.4	80.9	35.1	39.7	52.2	0.6	0.4	1.6	0.4	0.9	0.7	1.3	1.1	1.0	1.1	1.1	0.6	0.9	1.0	0.9	0.9	0.7	1.8	0.7	8.9	13.1	9.1	14.3	9.5	10.2	9.4	9.7	9.2	10.2	8.8	13.6	63.4	73.7	67.8	42.1	59.2	136.6	215.9	81.6	72.8	53.0	65.6	52.5	36.9	27.1	98.8	14.7	47.9	76.6	70.2	57.5	49.0	45.5	47.9	100.5	51.6	82.3	76.9	53.5	95.1	32.2	65.3	65.5	57.6	98.4	55.2	61.0	55.3	34.6	36.6	37.0	49.9	51.2	61.1	32.0	66.1	128.8	46.9	47.6	60.5	72.1	48.1	51.6	35.0	122.6	250.6	61.0	50.1	73.4	53.5	140.0	44.4	43.9	111.2	40.8	52.6	56.1	76.7	44.6	57.2	102.3	142.9	66.9	66.5	59.9	50.6	232.8
PPP2R2B	"B55beta, PR52B, PR55-BETA, SCA12"	ENSG00000156475	"Protein phosphatase 2 regulatory subunit Bbeta"	Q00005	5	146580742-147084784	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.1;retina: 43.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1539.0;Excitatory neurons: 846.0;Inhibitory neurons: 788.8;Late spermatids: 876.4;Oligodendrocyte precursor cells: 1035.4;Oligodendrocytes: 4480.1"	"Cancer enriched"	"Detected in some"	8	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 5.2;MAIT T-cell: 4.1;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.2;naive CD8 T-cell: 3.8;NK-cell: 2.9;T-reg: 3.4"	"Group enriched"	"Detected in many"	9	"NK-cells: 2.9;T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.2;HDLM-2: 24.2;RT4: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038118, HPA042122, HPA042770"	Approved		Uncertain	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (4.54e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.73e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.49e-8)"	"unprognostic (2.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.48e-5)"	"unprognostic (1.14e-4)"	1.3	7.8	53.9	0.9	71.4	1.9	0.8	44.7	77.1	1.2	6.0	6.5	1.0	0.4	0.5	1.3	3.6	1.8	2.5	57.8	53.9	3.7	0.7	0.8	1.7	50.7	56.3	0.4	1.9	2.8	14.8	0.7	50.4	1.9	1.9	43.0	1.0	1.0	0.3	3.4	2.2	1.3	50.7	1.8	1.1	18.9	71.6	0.8	3.1	0.3	0.8	7.5	2.0	73.9	0.2	0.0	1.3	2.0	0.2	0.0	0.4	0.7	0.3	0.7	0.2	2.3	1.9	0.2	0.2	0.1	0.0	7.2	0.5	0.4	1.8	24.2	0.4	0.4	4.8	0.6	0.4	0.1	0.4	0.2	1.2	0.0	0.4	0.8	0.3	0.7	0.7	0.5	0.9	0.3	0.2	0.1	2.3	0.0	0.9	1.6	0.2	0.0	1.9	12.5	1.3	0.2	0.3	0.0	0.3	1.4	0.7	0.0	0.4	0.1	0.3	1.7	0.6	0.1	0.4	0.2	0.9	1.9	2.0	0.5	0.0	0.0	5.2	0.0	4.1	0.1	2.4	6.2	0.0	0.0	0.6	3.8	0.1	2.9	0.1	0.0	3.4	1.4	53.9	71.4	44.7	77.1	57.8	53.9	50.7	56.3	50.4	50.7	71.6	73.9	0.5	3.2	1.8	1539.0	0.3	2.0	1.1	2.3	4.6	90.5	0.5	3.6	1.6	10.0	0.9	9.2	150.1	18.9	30.2	0.0	21.5	1.7	295.3	1.0	0.1	2.0	13.1	1.3	846.0	0.0	0.3	1.1	1.1	0.4	0.0	0.0	0.0	0.0	0.9	47.1	788.8	0.0	0.0	1.2	4.7	876.4	3.4	1.4	5.4	58.1	0.3	45.0	57.7	1035.4	4480.1	0.6	0.0	2.2	3.3	1.0	0.0	5.5	0.1	275.4	0.0	0.7	11.0	4.8	2.2	1.6	1.4	5.3	31.0	0.1	0.0	0.9
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 61.0;Early spermatids: 67.4;Excitatory neurons: 203.3;Inhibitory neurons: 82.8;Late spermatids: 182.5;Oligodendrocytes: 94.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 31.4;A549: 46.1;CAPAN-2: 28.2;GAMG: 68.4;MCF7: 36.2;PC-3: 38.9;SCLC-21H: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Approved	Cytosol		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291"	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	0.8	6.2	72.9	0.6	86.7	0.0	1.4	42.1	106.2	18.0	0.0	1.1	0.8	27.0	7.4	35.9	9.9	0.4	2.5	85.7	44.5	0.3	0.1	0.1	0.3	52.5	52.7	0.6	0.7	1.5	22.6	0.1	55.1	5.0	0.3	10.9	5.3	14.5	0.8	34.0	1.2	11.9	62.3	0.3	0.8	7.3	66.9	2.7	0.1	0.9	3.1	0.9	11.5	91.2	31.4	46.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	19.0	0.0	68.4	13.7	20.0	0.7	0.0	0.0	2.4	0.0	3.2	3.7	0.7	0.0	0.1	6.6	11.4	0.0	0.0	0.0	0.1	4.2	0.0	0.1	6.6	36.2	0.0	0.1	2.2	0.6	38.9	0.0	0.0	1.2	0.0	0.1	39.1	7.5	1.5	0.1	0.0	1.1	18.9	0.1	0.0	0.2	22.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.9	86.7	42.1	106.2	85.7	44.5	52.5	52.7	55.1	62.3	66.9	91.2	0.2	0.0	0.0	61.0	0.0	14.7	0.4	0.8	4.6	11.0	1.9	0.4	4.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	67.4	0.8	5.7	0.6	0.0	0.0	203.3	0.2	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	3.3	82.8	0.0	0.0	0.0	1.1	182.5	6.8	0.0	0.0	4.7	0.0	6.5	0.0	14.1	94.6	2.4	0.0	4.5	0.0	1.3	0.0	0.2	0.0	3.1	0.0	0.0	2.5	2.3	1.6	6.5	22.0	0.0	0.2	0.1	0.0	0.2
PPP2R2D	"B55D, B55delta, MDS026"	ENSG00000175470	"Protein phosphatase 2 regulatory subunit Bdelta"	Q66LE6	10	131901008-131959834	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042122, HPA042770"	Approved		Approved	Cytosol		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (7.75e-3)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.90e-2)"	1.5	3.0	4.5	1.2	5.4	0.0	1.4	7.0	5.8	2.1	3.8	2.8	2.1	1.6	2.0	1.6	1.6	1.6	3.3	4.9	4.1	1.8	1.6	2.3	2.4	4.1	4.1	3.6	15.9	3.2	2.3	1.9	4.1	1.8	1.9	2.8	3.3	1.9	2.8	2.7	2.4	1.3	3.6	1.8	2.1	1.3	4.6	1.7	2.2	2.9	1.5	2.3	1.9	4.9	4.4	3.8	2.4	1.8	3.3	2.6	3.4	1.5	3.1	2.9	3.1	3.1	3.6	1.8	1.0	1.8	1.8	7.9	3.2	0.7	3.1	4.5	4.2	3.0	3.7	1.8	1.1	3.2	3.4	0.9	6.7	3.2	4.5	4.6	2.0	2.6	3.9	0.8	3.2	2.1	1.5	7.3	1.5	1.5	3.4	2.0	1.6	0.5	2.3	0.6	1.9	2.6	1.9	1.6	1.8	2.5	1.4	2.4	2.8	1.6	0.7	2.3	8.1	2.8	1.6	2.3	1.4	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	5.4	7.0	5.8	4.9	4.1	4.1	4.1	4.1	3.6	4.6	4.9	26.8	19.2	14.3	22.2	20.0	37.3	37.4	6.4	20.5	55.0	25.8	23.6	36.3	14.3	10.2	9.2	10.4	10.6	36.1	27.6	19.6	9.8	12.7	21.5	24.8	19.0	10.7	18.7	43.0	17.7	13.6	21.8	19.9	32.3	6.3	33.1	13.2	23.2	14.1	52.2	37.5	18.2	8.2	12.0	17.6	6.4	17.4	23.3	12.4	26.2	10.5	28.3	18.6	29.7	38.1	16.8	18.0	20.7	20.3	39.1	20.0	29.6	5.7	32.6	26.3	29.2	23.2	14.3	20.1	18.8	34.0	11.8	24.4	39.5	19.1	39.6
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333933-386955	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 73.0;skeletal muscle: 103.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 18.5;U-698: 29.9"									HPA026606			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.90e-5)"	4.4	4.7	1.2	0.2	1.2	1.9	4.9	0.8	1.6	8.3	0.8	4.0	0.5	6.9	0.0	9.5	9.3	0.3	73.0	1.0	1.6	4.0	3.7	3.9	0.6	1.5	1.7	7.6	4.5	0.2	10.3	0.6	1.5	9.1	0.0	0.1	7.1	0.3	103.4	16.5	4.7	0.3	1.2	7.2	4.6	16.3	1.4	1.3	5.0	2.6	0.0	11.8	7.7	1.8	1.0	5.0	0.6	1.9	0.1	0.1	8.1	7.6	1.3	4.7	6.0	5.4	0.0	1.8	4.0	5.4	0.7	0.0	0.1	0.0	1.0	5.6	6.3	1.1	1.8	0.3	0.0	2.3	3.1	0.2	0.1	0.0	3.7	0.4	0.1	3.3	1.6	0.2	0.7	3.1	11.8	8.6	3.1	0.1	18.5	5.3	3.7	0.4	1.0	1.4	0.0	11.1	0.0	0.6	5.3	4.0	0.0	1.7	0.4	2.5	3.6	0.0	2.0	0.2	0.4	29.9	0.0	2.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.8	1.6	1.0	1.6	1.5	1.7	1.5	1.2	1.4	1.8	6.7	0.0	1.7	11.4	3.8	6.8	8.6	1.7	4.6	13.5	8.5	10.7	72.3	4.3	2.1	0.0	27.1	5.2	5.7	3.8	0.0	2.5	0.6	12.1	4.6	5.4	4.8	4.8	2.8	4.0	7.3	8.0	4.6	7.4	0.0	25.6	2.9	1.8	3.7	6.7	3.7	3.9	0.0	2.8	4.5	2.0	4.1	5.8	5.4	5.6	3.1	8.6	6.2	17.6	10.4	2.4	0.6	3.0	3.3	3.7	1.8	1.7	4.3	19.0	0.0	12.2	6.5	16.7	27.1	6.1	7.5	4.0	5.0	7.8	3.6	4.5
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: AB_2683831"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	19.9	15.5	23.5	23.9	25.0	42.8	17.1	24.4	41.6	18.1	23.3	18.6	21.0	16.2	16.4	12.5	14.0	18.6	22.9	23.8	25.6	14.4	16.1	17.7	31.0	25.3	24.4	15.9	10.2	17.0	17.6	18.8	25.6	17.1	20.3	15.4	13.5	14.1	24.9	7.1	22.5	21.0	24.9	24.4	16.2	71.6	24.4	26.4	12.4	25.7	25.9	22.3	10.4	27.5	41.2	21.8	41.7	33.9	32.4	54.5	29.6	33.0	32.0	41.0	48.0	18.1	32.2	47.2	13.4	33.9	15.5	17.6	20.0	13.8	60.5	47.8	19.3	26.2	11.9	65.2	43.3	51.2	51.7	41.9	14.4	29.0	19.7	24.0	55.7	26.2	25.7	46.3	57.4	28.4	46.4	43.1	37.1	27.4	24.3	50.2	27.1	32.8	15.8	24.1	39.9	37.5	41.7	27.6	57.8	19.9	17.9	57.0	47.9	41.3	17.3	36.0	34.9	44.8	52.4	92.8	22.8	47.9	48.1	66.5	41.6	86.9	23.4	52.5	27.0	31.0	24.8	29.5	36.1	33.1	22.0	26.9	76.9	33.1	42.7	16.3	40.8	34.0	23.5	25.0	24.4	41.6	23.8	25.6	25.3	24.4	25.6	24.9	24.4	27.5	35.5	16.0	24.7	32.7	40.2	11.5	23.3	31.7	9.6	15.9	18.8	14.7	26.3	17.2	25.8	20.2	4.2	19.4	48.1	29.1	33.2	31.2	489.7	23.1	28.1	33.8	31.2	69.7	28.3	36.1	26.2	26.5	19.9	21.7	33.7	31.3	34.6	22.8	61.3	8.4	30.4	26.8	32.6	49.7	36.3	233.5	28.3	42.6	28.4	24.4	71.5	28.7	46.4	36.2	58.8	49.2	22.3	30.5	37.4	24.8	37.8	43.2	25.1	21.5	32.9	24.0	43.1	239.2	58.6	19.6	13.5	34.8	45.2	36.2	24.6	30.5
PPP3CC	"CALNA3, PP2Bgamma"	ENSG00000120910	"Protein phosphatase 3 catalytic subunit gamma"	P48454	8	22440819-22541142	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.8;Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023396, CAB024950"	Approved		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"CAB024950: , HPA023396: AB_1855663"	"unprognostic (7.66e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.64e-2)"	28.5	11.9	11.8	16.5	11.8	26.5	20.8	17.7	15.3	18.1	31.1	16.6	9.1	14.5	10.6	16.9	15.6	15.7	34.5	11.3	10.8	12.9	12.4	21.5	33.0	12.1	11.0	14.0	14.3	18.4	11.7	19.3	12.2	14.4	10.3	77.9	14.0	8.2	89.4	13.6	15.4	15.5	10.0	22.4	14.6	56.0	13.1	15.0	16.6	54.2	26.9	17.0	16.4	14.8	12.2	8.8	7.7	9.4	19.8	24.4	11.2	16.5	28.9	23.9	26.5	5.1	7.5	45.7	19.7	25.6	40.0	8.4	17.9	16.5	30.5	26.3	9.5	9.8	10.5	14.7	26.8	7.1	15.6	15.0	22.3	16.2	16.5	25.6	21.1	22.0	19.6	58.8	27.2	5.7	16.8	11.7	5.6	12.5	12.0	54.0	18.1	15.2	22.4	11.3	5.4	12.7	12.3	7.4	17.4	14.4	4.9	11.8	22.8	37.1	7.9	56.7	12.9	29.3	38.5	48.3	19.6	9.3	25.1	5.4	2.7	10.7	16.6	3.2	12.7	26.3	19.0	23.6	5.1	21.3	18.1	14.9	0.6	19.2	4.7	6.2	17.2	7.1	11.8	11.8	17.7	15.3	11.3	10.8	12.1	11.0	12.2	10.0	13.1	14.8	27.2	6.4	5.1	49.6	74.7	16.6	21.3	32.6	12.0	12.8	10.0	6.0	8.0	14.3	14.0	7.3	47.9	18.0	50.3	6.7	7.9	15.0	145.8	6.5	12.7	24.2	10.3	10.8	78.9	21.0	23.8	25.1	6.6	14.6	3.8	3.9	23.6	7.8	13.1	3.3	83.6	2.5	38.7	10.8	24.6	22.6	22.4	19.3	28.4	76.8	30.4	13.1	59.8	99.5	64.8	21.1	7.4	21.4	96.8	26.3	10.6	11.6	7.8	50.5	32.9	19.5	23.3	131.8	29.6	17.1	11.4	14.1	53.4	4.8	6.3	25.5
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 189.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		42000	"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	53.7	37.7	56.1	32.4	92.9	73.6	27.1	38.0	127.3	27.3	0.0	27.6	25.7	31.0	26.1	30.0	23.3	28.0	20.6	99.0	24.2	21.4	58.2	27.7	40.2	23.5	18.4	24.9	20.7	17.0	18.3	36.6	24.9	26.3	27.8	189.9	24.9	30.1	88.8	33.6	23.9	35.3	14.4	34.2	24.8	20.6	30.0	42.6	23.8	31.0	40.5	32.9	28.6	64.5	61.5	51.7	69.7	48.4	47.4	54.3	70.5	86.3	75.9	98.8	86.8	75.9	55.4	85.7	28.7	61.4	69.5	41.8	74.4	64.8	120.0	59.4	52.9	284.0	38.3	71.1	93.1	111.9	92.2	55.1	57.6	76.9	78.0	55.9	67.2	72.2	67.8	96.8	73.2	53.8	96.1	99.4	81.9	52.0	44.4	69.1	90.6	139.9	61.7	66.1	91.4	64.2	50.4	72.3	65.9	45.0	33.9	51.8	69.5	84.6	76.5	64.2	75.1	53.8	62.6	124.7	61.3	115.2	54.0	1.5	0.5	1.3	0.2	0.3	0.5	0.2	0.3	0.1	0.5	0.3	0.3	0.5	2.7	0.3	0.6	0.7	0.3	0.4	56.1	92.9	38.0	127.3	99.0	24.2	23.5	18.4	24.9	14.4	30.0	64.5	37.0	9.6	12.7	81.6	40.4	74.8	11.6	7.0	72.8	22.2	21.0	13.1	17.9	10.0	7.7	16.5	52.1	11.7	34.0	20.5	11.7	7.1	20.0	19.9	23.0	34.0	15.1	52.8	151.2	8.7	17.2	24.2	18.8	29.1	19.7	11.2	15.4	19.2	24.7	11.8	93.1	15.6	4.1	40.0	105.1	7.7	9.9	54.7	35.6	105.9	21.2	27.8	18.6	72.9	77.5	12.9	10.6	8.6	39.2	17.3	12.6	20.1	5.8	92.7	13.1	14.4	29.8	2.9	6.1	64.0	70.5	12.0	39.9	14.2	13.2	21.3
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591604-101595021	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	161	"testis: 80.8"	"Group enriched"	"Detected in some"	38	"Early spermatids: 399.2;Late spermatids: 198.3;Spermatocytes: 600.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA047157: AB_2679960"												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	80.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.1	0.0	0.4	0.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	399.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.3	10.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.2	600.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP6R1	"KIAA1115, SAP190, SAPS1"	ENSG00000105063	"Protein phosphatase 6 regulatory subunit 1"	Q9UPN7	19	55229779-55259017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 28.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043989, HPA063681"	Approved		Enhanced	Cytosol		No	No		19000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA043989: AB_10987309, HPA063681: AB_2685087"	"unprognostic (1.15e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (2.22e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.20e-1)"	21.8	36.8	31.6	52.7	35.4	96.4	20.3	8.0	35.7	22.0	19.4	28.3	38.1	25.7	5.1	35.2	26.6	23.8	28.3	41.7	12.8	23.8	25.5	28.3	82.4	15.0	13.2	21.1	20.3	22.6	29.7	21.2	15.6	23.5	12.2	8.8	24.1	21.4	38.7	28.5	42.4	18.4	8.3	61.5	42.6	89.7	20.6	62.2	27.3	20.2	49.3	33.4	23.4	18.1	101.2	143.4	28.7	46.1	33.5	30.8	73.1	63.1	54.7	64.8	55.2	95.4	67.9	261.0	33.7	56.6	48.2	48.2	10.3	65.9	25.1	98.2	241.8	198.5	71.8	71.0	57.5	295.9	187.6	45.4	37.4	64.5	43.4	34.7	42.2	178.7	105.5	112.1	42.5	64.5	218.1	105.5	39.3	82.2	116.5	131.8	56.4	216.0	45.9	126.6	81.8	45.5	58.7	69.7	62.2	24.6	38.3	219.7	55.3	101.3	49.7	39.4	96.4	55.4	108.7	184.1	92.4	240.5	79.1	0.0	2.8	6.5	11.7	3.9	6.6	3.3	4.8	9.3	4.0	2.7	4.9	7.5	3.1	7.8	3.4	28.6	3.6	6.8	31.6	35.4	8.0	35.7	41.7	12.8	15.0	13.2	15.6	8.3	20.6	18.1	14.7	12.8	19.8	11.1	27.2	2.8	8.9	1.0	11.4	16.3	14.2	10.4	2.6	18.6	6.2	18.4	10.4	11.1	66.2	21.7	0.0	21.2	237.3	36.3	13.6	15.8	15.1	41.4	14.4	28.7	9.3	9.7	50.4	19.7	7.6	19.7	16.1	22.3	32.4	30.3	10.6	15.7	2.0	31.2	4.8	55.3	18.6	34.0	0.0	9.4	21.9	14.7	51.5	6.0	11.3	47.3	18.8	19.5	27.0	22.1	34.2	12.3	12.6	15.3	19.7	12.5	10.7	38.5	41.0	13.9	3.4	11.4	39.6	31.3	14.2	50.7
PPWD1	KIAA0073	ENSG00000113593	"Peptidylprolyl isomerase domain and WD repeat containing 1"	Q96BP3	5	65563236-65587549	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019353, HPA019360"	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA019353: AB_1855668, HPA019360: AB_1855669"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	15.0	12.1	12.3	18.2	14.6	27.6	17.2	16.5	16.4	17.3	13.4	14.7	13.4	19.0	17.8	13.5	16.1	15.7	13.5	12.4	13.2	13.0	15.5	14.9	30.0	13.6	12.8	22.9	14.0	15.5	14.7	19.6	13.4	15.0	19.2	14.7	12.7	13.7	13.2	22.2	17.1	13.2	12.9	22.6	14.4	18.1	13.0	32.9	16.3	15.6	26.0	13.7	15.2	18.5	36.5	23.6	35.1	35.2	30.6	36.9	38.8	34.5	25.3	36.5	45.5	37.8	35.4	41.5	28.5	24.3	49.1	32.3	38.4	35.5	49.8	35.7	32.3	26.0	40.0	31.1	25.9	23.9	26.4	29.2	15.3	35.5	25.5	27.0	32.3	31.6	35.3	28.8	28.8	35.8	40.0	31.6	24.7	15.2	13.3	35.4	46.7	35.1	21.2	29.5	18.1	14.8	34.8	14.5	33.1	26.8	21.5	30.8	24.9	20.2	29.2	22.4	52.9	17.1	26.3	45.5	22.3	35.8	21.4	35.0	15.1	31.6	26.1	19.3	32.0	25.8	29.1	29.9	21.2	19.1	36.1	31.0	14.3	26.5	24.0	11.8	38.1	23.4	12.3	14.6	16.5	16.4	12.4	13.2	13.6	12.8	13.4	12.9	13.0	18.5	25.1	28.9	22.4	28.1	36.0	12.4	14.9	15.4	18.2	14.2	9.1	12.8	19.8	7.2	22.1	11.0	8.4	27.7	27.0	6.9	9.8	8.7	76.8	16.4	28.7	20.7	9.6	21.5	37.2	7.7	14.4	21.1	15.8	13.8	11.4	32.6	18.9	6.0	11.8	6.7	46.8	14.9	8.2	16.4	11.9	41.7	20.2	15.2	14.2	23.4	22.6	11.8	23.7	42.3	67.1	8.9	14.7	18.8	29.4	6.6	10.0	7.9	17.8	20.9	6.6	19.9	17.8	32.5	33.7	13.2	11.8	25.2	35.4	15.8	11.4	9.0
PQBP1	"MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS"	ENSG00000102103	"Polyglutamine binding protein 1"	O60828	X	48890197-48903143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001880	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"		"HPA001880: AB_1079671"	"unprognostic (7.25e-2)"	"prognostic favorable (1.48e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.68e-7)"	"unprognostic (2.68e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-3)"	38.8	50.6	35.5	25.6	36.9	46.0	39.3	38.1	44.2	47.9	31.1	50.0	39.2	42.5	22.7	48.6	41.0	24.2	43.0	36.7	40.2	41.7	61.0	35.6	31.1	38.8	37.3	58.4	62.8	28.1	50.5	18.2	38.6	42.2	20.4	21.5	43.2	28.3	65.0	52.0	42.2	25.3	38.4	45.2	52.1	13.8	39.0	38.6	38.6	32.3	29.0	39.2	43.2	40.0	100.6	124.3	64.5	63.2	58.2	40.8	48.8	57.3	67.1	116.8	70.7	146.3	45.0	91.8	46.2	40.0	88.1	79.9	110.6	42.6	43.5	80.8	95.2	78.1	94.6	109.5	55.9	95.5	69.8	50.7	81.4	96.8	95.5	46.5	67.0	35.9	75.7	169.0	50.1	167.5	41.5	94.3	60.3	69.3	139.6	66.7	63.0	209.4	75.5	66.2	95.7	49.4	75.3	82.6	66.5	48.0	103.5	68.9	58.6	51.1	92.2	65.6	77.4	99.9	106.5	69.5	29.0	88.0	53.8	41.8	81.9	53.1	56.4	79.1	74.7	83.9	78.2	56.2	96.9	70.4	81.5	74.9	23.4	76.1	73.0	86.9	114.3	84.5	35.5	36.9	38.1	44.2	36.7	40.2	38.8	37.3	38.6	38.4	39.0	40.0	37.0	41.7	65.9	6.2	65.4	111.8	86.1	99.5	85.4	36.7	76.9	97.2	39.0	54.3	68.6	31.3	12.5	58.5	53.4	85.1	49.0	59.9	6.2	37.5	38.6	54.5	70.1	38.7	4.4	95.8	56.1	53.9	39.8	54.3	70.5	36.6	43.5	45.0	70.2	18.5	3.9	68.2	77.3	72.2	113.5	4.9	69.9	56.2	88.9	3.7	96.6	47.4	55.6	3.5	4.8	73.7	123.6	43.6	105.9	54.2	151.1	108.5	51.6	27.7	39.5	64.4	69.8	2.7	17.7	69.5	117.3	54.6	62.9	67.0	67.9	69.3
PRAME	"CT130, MAPE"	ENSG00000185686	"PRAME nuclear receptor transcriptional regulator"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 105.1"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 249.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 139.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"K-562: 834.1"					"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.2	3.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.2	0.0	3.4	10.0	0.0	0.5	0.0	0.3	0.0	0.1	1.8	0.1	0.2	0.1	0.1	0.0	4.7	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.1	105.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.9	53.3	0.0	126.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.4	0.7	3.5	88.8	0.0	0.5	0.1	4.3	0.0	0.0	61.5	14.8	36.0	21.7	0.6	0.0	2.9	172.6	0.0	0.0	0.0	0.0	0.0	0.0	14.9	834.1	15.6	0.0	8.1	0.3	0.2	0.0	27.2	3.5	5.0	0.0	0.2	0.0	0.2	1.1	185.0	0.0	0.6	0.2	0.0	27.8	24.3	5.0	0.1	159.6	0.0	0.2	3.0	14.6	1.3	0.2	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	37.8	22.3	1.1	0.3	0.0	0.0	0.0	0.0	0.9	2.0	0.0	13.0	0.0	60.9	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	41.4	5.6	0.4	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.4	6.6	0.0	2.7	41.8	249.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966040-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.9;testis: 55.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 34.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 34.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	7.4	6.2	6.4	10.0	6.1	89.9	6.4	10.3	8.4	8.1	5.0	16.3	10.6	5.7	2.3	37.6	6.0	3.0	6.9	5.6	4.9	5.6	4.8	9.0	16.9	4.8	5.2	8.1	8.9	2.6	3.6	15.3	5.2	4.9	16.5	4.9	9.5	1.5	4.1	20.1	13.0	9.4	4.9	12.5	11.7	55.0	4.2	43.0	4.3	2.3	24.9	4.8	13.7	5.6	167.9	199.9	164.8	113.6	16.8	28.7	87.5	237.8	139.3	257.2	195.3	134.6	158.5	65.5	91.4	151.9	156.9	220.9	188.8	101.2	240.6	118.7	206.4	135.6	263.5	123.5	4.1	71.4	109.0	7.7	12.8	145.8	146.9	56.6	146.4	100.5	114.0	132.4	241.1	144.4	66.9	98.5	66.6	216.4	84.9	69.7	205.1	86.3	115.3	123.6	151.2	118.9	225.4	121.9	82.7	112.3	149.1	127.1	91.2	168.2	146.0	140.5	345.1	43.5	127.7	80.0	74.5	162.0	265.3	34.4	0.6	2.9	0.6	0.1	0.4	1.1	1.3	1.3	2.4	0.5	1.2	0.4	0.4	3.0	0.3	2.6	8.0	1.0	6.4	6.1	10.3	8.4	5.6	4.9	4.8	5.2	5.2	4.9	4.2	5.6	2.5	0.0	3.1	1.3	6.8	16.6	6.6	8.0	2.2	6.4	3.4	4.3	3.2	0.0	7.6	3.7	0.0	45.5	2.8	16.5	0.0	3.2	41.5	4.5	4.0	4.7	5.4	142.9	5.0	2.9	68.3	7.2	16.3	6.8	8.9	13.2	9.3	2.1	21.5	3.3	5.2	17.0	10.2	8.7	15.0	15.4	3.7	5.2	3.6	1.9	5.5	3.8	4.1	2.0	1.7	2.3	3.2	1.9	17.5	5.9	2.0	0.1	3.2	4.6	6.6	7.4	10.9	136.4	74.2	38.0	14.2	14.6	6.8	0.4	24.1	6.7
PRDM10	"KIAA1231, MGC131802, PFM7"	ENSG00000170325	"PR/SET domain 10"	Q9NQV6	11	129899706-130002835	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Excitatory neurons: 21.3;Inhibitory neurons: 21.2;Oligodendrocytes: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026997, HPA061749"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"HPA026997: AB_1855681, HPA061749: "	"unprognostic (4.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.88e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.51e-1)"	2.8	2.4	2.5	3.1	2.5	7.9	4.2	7.4	3.3	3.2	2.8	3.4	3.4	3.0	3.3	4.0	2.6	2.8	2.0	2.9	3.4	2.2	3.5	3.0	3.9	1.8	1.8	3.4	3.1	3.4	4.6	2.6	1.9	3.4	3.9	4.7	3.1	2.5	6.7	6.2	3.7	2.5	0.9	3.1	4.0	2.4	3.3	6.7	3.0	3.8	4.0	2.6	3.4	4.0	4.7	6.1	7.7	5.1	3.4	4.1	5.1	3.9	5.0	3.2	4.1	6.2	4.8	17.8	4.5	4.6	4.4	6.1	6.4	3.2	5.2	6.6	5.5	12.3	7.5	5.0	2.2	10.9	44.8	2.9	7.1	4.8	3.1	4.9	5.7	5.0	7.0	6.6	4.7	5.2	6.7	5.7	5.9	6.3	4.4	6.5	4.8	2.9	4.7	8.0	8.3	4.3	5.7	6.4	1.7	4.3	4.5	4.8	5.7	7.2	3.4	3.8	5.1	1.7	3.0	25.1	3.2	6.1	5.9	2.4	2.2	6.0	2.6	2.5	2.6	6.8	2.1	2.2	2.1	3.6	3.1	1.4	6.3	4.4	2.7	2.1	2.9	1.4	2.5	2.5	7.4	3.3	2.9	3.4	1.8	1.8	1.9	0.9	3.3	4.0	2.7	3.2	2.7	22.5	3.2	6.1	2.6	1.8	6.8	3.7	3.5	2.2	2.7	1.5	2.0	0.0	0.0	1.5	2.5	6.3	0.0	1.2	3.0	2.9	2.7	1.8	1.8	8.6	21.3	1.1	1.2	2.7	4.6	3.2	1.3	2.7	1.1	2.3	1.6	1.7	21.2	3.1	2.0	3.1	2.9	4.1	2.5	2.8	0.0	13.1	2.1	1.0	1.0	13.6	21.6	0.9	3.2	1.9	2.4	4.6	3.1	1.0	2.3	2.7	0.0	3.9	3.4	0.8	0.8	7.2	5.1	0.5	3.5	1.7	2.7	5.8
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.1;seminal vesicle: 27.2"	"Cell type enriched"	"Detected in many"	9	"Bipolar cells: 271.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 27.3;LHCN-M2: 41.7;NB-4: 48.2;SCLC-21H: 99.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.7"	"Low region specificity"	"Detected in all"			HPA057253			Supported	"Nucleoplasm,Nuclear bodies"		No	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	Nucleoplasm	"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	4.8	2.3	5.1	5.0	10.2	4.0	4.0	0.0	17.0	11.7	0.0	11.4	1.1	9.3	1.9	1.7	5.2	1.7	1.7	13.7	0.0	1.3	0.3	1.6	5.1	0.0	0.0	5.2	0.9	0.0	5.4	4.3	0.0	26.1	1.5	24.1	1.4	27.2	2.2	2.7	5.7	3.8	0.6	1.8	5.0	1.1	0.1	0.7	1.2	0.9	2.4	10.2	9.8	3.2	2.3	0.2	0.7	0.0	2.1	7.2	0.1	5.8	20.5	2.8	3.2	0.0	2.2	0.0	0.0	7.2	1.8	0.7	0.1	2.4	12.1	8.8	1.8	0.8	0.0	0.0	4.1	9.1	2.5	4.4	0.2	11.1	3.2	27.3	0.4	2.4	0.0	3.7	41.7	0.0	4.2	48.2	0.0	0.2	17.0	1.6	0.0	0.2	1.2	0.3	99.3	13.8	0.3	0.0	0.1	0.1	0.0	4.5	8.8	7.1	1.0	5.2	0.4	1.7	0.0	0.0	17.8	4.2	1.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1	0.5	0.5	0.1	0.7	0.3	0.1	0.5	0.2	0.0	0.1	0.2	0.1	5.1	10.2	0.0	17.0	13.7	0.0	0.0	0.0	0.0	0.6	0.1	3.2	0.9	0.0	0.5	2.3	8.2	0.6	3.4	0.4	0.0	271.5	0.1	0.4	1.8	0.0	5.2	1.8	2.1	0.0	2.5	0.0	0.0	0.0	1.5	0.3	6.5	2.2	0.0	2.5	29.9	0.2	0.2	8.8	0.0	0.5	0.0	0.1	0.0	0.0	0.5	3.3	2.0	0.2	2.0	1.2	6.2	6.7	3.1	5.9	1.8	3.7	0.9	6.1	2.1	7.1	17.0	0.7	0.0	3.4	2.7	3.7	0.0	0.2	5.0	11.6	0.0	4.2	2.9	0.3	0.4	0.0	0.1	0.1	5.0	0.1	0.0	0.6
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318121-64321811	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 2430.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Supported	Mitochondria		NA	NA		6900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (2.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (1.24e-5)"	"unprognostic (8.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.03e-2)"	181.8	400.3	346.0	112.7	342.6	285.7	170.1	375.9	429.4	227.2	480.2	346.6	213.3	153.7	176.6	448.5	400.3	120.7	467.4	340.4	384.6	377.1	280.3	217.2	110.1	382.8	373.3	246.0	224.9	254.5	313.3	164.1	387.0	165.5	299.6	109.0	286.2	164.4	504.0	181.1	226.1	97.1	365.2	162.9	313.9	150.1	377.8	167.7	354.5	439.6	137.8	192.5	244.8	346.4	225.3	453.4	267.9	444.5	284.3	424.4	308.5	274.9	442.3	199.8	247.4	332.9	451.8	329.2	467.0	447.4	712.6	503.5	253.3	589.4	125.8	456.6	200.8	333.3	728.8	386.3	581.0	127.8	271.3	432.4	757.2	334.9	337.8	387.6	308.4	380.6	191.5	755.6	285.5	572.0	220.9	547.8	402.6	356.5	573.9	210.9	274.5	1178.8	760.1	442.9	224.7	424.9	230.8	506.8	818.8	254.3	370.5	283.3	298.3	281.8	258.6	326.7	123.1	383.1	490.8	392.4	340.7	253.7	223.6	703.9	465.4	630.7	251.0	432.9	218.3	393.5	229.0	205.1	369.8	409.0	224.5	225.9	802.3	368.5	399.0	487.9	297.1	639.6	346.0	342.6	375.9	429.4	340.4	384.6	382.8	373.3	387.0	365.2	377.8	346.4	213.7	266.0	463.4	17.6	182.1	326.5	760.2	1591.9	405.2	159.0	266.2	435.9	617.6	371.8	931.2	450.6	70.9	1122.2	185.8	846.1	1612.1	788.4	79.6	865.2	221.3	204.7	801.9	200.6	12.4	1039.2	1144.0	296.1	365.4	285.9	104.7	299.8	205.6	405.2	476.9	92.5	14.0	1041.6	1072.1	206.5	261.0	294.9	279.0	210.8	435.8	8.4	339.7	309.6	278.1	14.1	15.3	1487.3	641.3	226.8	288.9	401.3	922.4	1468.5	2430.7	150.3	197.2	176.2	433.1	150.2	333.9	482.8	257.7	978.9	165.2	713.3	1231.7	1077.1
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 542.1;NK-cells: 1231.7;T-cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 656.8;T-cells: 900.4"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 240.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	5.0	2.0	0.7	7.6	0.7	28.6	2.7	0.7	1.3	1.3	1.3	2.2	2.3	3.5	1.1	1.9	1.9	4.2	2.2	0.6	0.6	1.7	6.3	16.5	20.3	1.4	0.7	1.0	1.0	0.5	0.9	2.7	1.0	1.5	1.4	0.0	2.3	1.2	2.6	0.9	5.2	2.0	1.3	49.4	4.7	0.6	1.0	5.8	2.6	1.5	4.9	3.8	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	240.1	0.0	1.4	0.0	7.4	0.0	0.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	5.2	1.9	0.9	900.4	1.7	628.8	4.0	125.8	499.1	2.0	3.5	52.1	313.0	15.4	656.8	2.6	2.9	108.8	587.5	0.7	0.7	0.7	1.3	0.6	0.6	1.4	0.7	1.0	1.3	1.0	1.0	3.1	3.2	13.6	0.0	4.4	0.4	0.1	0.0	0.6	0.0	0.5	0.5	0.8	1.5	2.5	0.0	0.0	0.2	542.1	0.1	0.0	0.3	0.0	0.2	0.3	1.9	0.0	19.0	0.0	0.0	0.1	2.1	7.7	0.4	8.8	0.0	10.8	2.7	0.1	0.0	0.0	0.0	0.0	7.8	2.3	0.0	0.0	5.7	0.0	1.9	7.4	0.0	1231.7	0.0	0.1	0.0	0.0	0.0	88.5	0.1	0.1	1.6	1.5	0.0	0.0	1.1	0.8	0.0	0.0	0.5	0.9	0.7	265.4	0.0	0.1	0.0
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780782-41787452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 15.0;Basal squamous epithelial cells: 30.7;Erythroid cells: 17.7;Gastric mucus-secreting cells: 17.3;Plasma cells: 36.8;Squamous epithelial cells: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.0;HeLa: 4.6;hTERT-RPE1: 9.7"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"		Yes	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	1.8	1.2	1.3	0.3	1.2	0.1	1.9	1.3	1.2	2.2	0.0	1.6	1.1	2.4	0.0	3.8	2.3	1.0	1.9	0.7	1.0	1.3	2.0	2.1	0.1	1.1	0.7	1.3	1.2	0.4	1.0	0.6	1.0	2.3	0.5	0.6	1.7	0.4	1.6	0.8	1.2	1.5	0.3	4.5	2.6	0.8	1.0	0.0	2.5	1.5	0.3	2.6	2.9	1.3	0.2	0.6	1.3	1.2	0.0	0.0	4.0	0.1	0.1	0.0	0.0	0.7	0.9	0.4	1.5	0.0	0.1	2.1	0.0	0.1	0.0	0.3	0.3	0.2	4.6	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.5	1.2	0.2	0.0	0.6	0.0	0.7	0.2	1.8	0.2	1.3	0.3	0.0	0.2	1.4	0.1	0.4	0.0	2.4	0.2	1.2	0.6	0.7	0.6	0.4	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.3	1.2	0.7	1.0	1.1	0.7	1.0	0.3	1.0	1.3	0.0	0.0	0.0	1.6	15.0	1.5	1.4	2.4	30.7	2.3	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.7	2.6	0.0	0.0	0.3	0.0	0.0	2.8	3.5	17.7	0.2	0.0	0.0	4.8	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	1.5	0.6	1.2	8.4	0.0	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.5	2.6	36.8	1.7	2.2	0.0	0.7	4.1	0.0	1.9	3.7	1.9	1.4	49.4	2.0	0.0	10.9	0.0	3.0	1.4
PRKAA1	AMPKa1	ENSG00000132356	"Protein kinase AMP-activated catalytic subunit alpha 1"	Q13131	5	40759379-40798374	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 292.5;Late spermatids: 478.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005050, HPA035409, HPA064946"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	Cytosol	"CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390"	"unprognostic (2.07e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-2)"	33.3	21.0	7.9	27.2	9.6	52.6	30.2	10.3	11.0	26.7	12.3	30.0	35.4	26.3	18.6	20.6	21.0	33.5	20.2	6.9	11.3	32.0	49.9	27.4	29.2	11.8	9.9	19.1	23.1	32.0	9.2	21.2	12.2	31.9	34.7	19.0	27.4	24.7	16.9	23.1	30.9	26.4	10.2	27.8	33.7	41.1	10.0	21.8	32.3	19.9	23.9	28.8	17.8	10.3	28.4	28.9	22.8	30.2	55.0	57.0	21.6	47.3	48.1	34.7	30.8	27.6	35.9	16.6	21.4	48.8	45.3	22.4	21.3	43.1	64.9	49.2	19.2	33.1	66.1	22.1	45.3	31.9	33.5	52.8	20.6	46.5	47.5	38.4	52.1	21.0	15.9	46.7	52.4	13.6	29.7	24.9	9.9	28.9	34.6	24.5	48.7	24.6	53.3	47.5	19.6	19.7	83.0	54.3	28.8	12.3	28.4	26.0	56.0	62.1	33.5	36.2	39.2	18.5	15.4	19.6	38.9	67.9	33.9	17.0	6.5	12.8	8.9	7.9	11.5	8.2	8.4	8.6	6.4	7.9	10.1	9.0	15.4	10.9	9.3	1.9	11.6	6.5	7.9	9.6	10.3	11.0	6.9	11.3	11.8	9.9	12.2	10.2	10.0	10.3	47.3	41.7	26.5	19.2	34.1	24.1	24.7	40.5	15.4	20.3	36.1	17.9	18.3	42.9	43.4	47.8	35.5	13.8	45.8	44.1	7.9	27.9	292.5	19.7	35.8	42.4	21.1	25.4	24.5	44.9	13.7	36.2	36.7	20.7	18.3	17.8	37.1	83.4	20.0	15.2	30.3	28.8	42.7	25.3	28.5	478.5	30.4	24.1	35.6	24.4	40.9	15.4	44.3	30.7	43.8	36.0	32.8	25.9	23.4	33.4	33.7	35.4	42.9	27.9	0.0	22.7	43.1	82.8	17.6	19.9	32.7	18.6	44.0	19.2	36.9	35.0
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.2;tongue: 103.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044342	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA044342: AB_10966508"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.59e-3)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (6.78e-7)"	"unprognostic (4.78e-2)"	12.4	10.8	9.4	7.8	10.1	9.0	11.8	12.5	13.1	14.8	6.0	23.4	32.0	18.7	8.5	10.3	12.9	7.1	25.8	10.1	9.5	9.5	56.3	10.0	6.5	10.8	10.1	11.7	34.8	64.7	6.7	12.3	11.0	12.7	10.7	14.7	8.2	19.4	97.2	15.4	20.8	19.8	10.8	8.5	18.1	6.7	10.6	5.9	6.3	103.8	5.6	18.6	14.0	11.2	7.8	4.2	11.1	8.6	25.7	22.1	39.7	14.3	7.9	9.5	10.3	17.1	15.1	13.9	7.1	11.6	5.5	20.2	13.1	16.1	9.2	5.5	9.0	6.2	15.2	27.8	17.7	7.4	2.6	17.4	31.7	9.9	46.0	14.1	9.4	10.6	8.9	5.6	8.2	7.8	5.5	4.1	23.3	13.4	18.4	8.5	14.8	6.9	6.8	6.1	7.1	13.2	10.8	12.1	52.8	39.6	11.4	9.1	10.8	10.6	23.3	9.9	23.6	8.9	10.1	7.1	11.0	6.4	14.1	0.9	0.3	0.6	0.4	0.4	0.7	0.3	0.4	0.3	0.5	0.3	0.5	0.3	0.1	1.5	0.5	0.2	0.2	0.2	9.4	10.1	12.5	13.1	10.1	9.5	10.8	10.1	11.0	10.8	10.6	11.2	10.4	3.2	2.0	14.0	10.6	16.6	11.8	11.4	18.2	14.5	6.7	8.1	66.2	20.0	5.3	18.4	14.6	21.9	10.3	22.7	1.9	6.1	0.8	5.4	15.1	8.2	11.4	3.4	23.2	7.0	42.1	13.6	13.7	10.4	1.3	11.8	6.8	44.9	5.7	11.8	18.8	12.6	10.2	8.9	12.5	1.8	9.6	7.3	16.0	10.3	12.2	6.4	11.3	25.1	21.3	9.9	12.0	16.1	9.0	7.2	55.1	5.4	7.0	19.5	19.7	11.3	20.4	13.9	11.2	13.1	14.1	20.5	9.7	43.4	10.1	4.8
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 310.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 116.8;Theca cells: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		170000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	62.7	126.5	46.6	27.6	47.6	18.9	53.9	39.9	64.2	53.2	29.5	59.0	20.9	56.9	28.5	41.8	53.7	14.2	204.8	49.2	53.3	35.4	78.4	46.1	15.9	56.8	54.5	94.1	34.0	21.6	71.2	17.3	55.3	41.2	13.0	25.2	42.3	20.8	310.9	42.3	36.3	21.8	40.7	71.6	40.2	57.2	50.3	18.2	39.6	122.1	13.4	50.6	44.2	46.6	37.5	16.3	40.3	74.4	36.2	30.8	9.9	30.5	23.6	32.7	27.5	21.6	15.0	13.8	26.2	49.2	22.9	25.4	26.7	26.6	32.3	23.1	17.7	27.7	20.6	24.4	36.8	21.9	33.5	33.8	18.1	30.0	11.1	26.6	29.7	19.0	29.1	47.3	36.7	48.1	46.3	31.9	21.5	38.7	45.0	38.0	47.8	36.7	41.7	13.5	36.5	24.2	34.2	31.3	23.8	18.1	37.2	26.5	37.7	71.7	20.3	100.7	39.6	31.9	24.9	23.6	49.6	28.0	32.7	0.1	1.5	0.2	0.8	2.7	0.3	0.8	0.3	0.5	1.1	0.5	0.5	0.7	3.2	0.4	2.5	0.6	0.3	0.6	46.6	47.6	39.9	64.2	49.2	53.3	56.8	54.5	55.3	40.7	50.3	46.6	39.5	6.4	3.4	9.4	7.0	8.8	6.8	6.4	2.2	42.2	19.2	19.0	116.8	22.8	4.7	14.7	27.1	6.9	9.0	24.6	7.9	12.4	32.4	11.7	22.9	26.7	17.5	2.5	16.9	19.1	5.7	22.6	8.6	12.9	0.0	15.9	26.4	39.7	34.5	3.3	21.6	11.8	2.0	49.4	50.8	15.7	49.0	37.1	14.2	9.4	37.8	26.1	9.2	10.1	10.7	15.6	11.6	51.9	3.3	6.4	20.7	11.8	7.0	23.9	19.7	23.3	23.5	26.4	6.9	10.1	11.2	8.1	10.0	100.6	14.4	6.6
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 334.4;Inhibitory neurons: 348.8;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		130000	"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	16.5	47.7	79.4	26.1	101.6	16.0	17.7	70.0	113.3	19.8	0.0	55.9	10.8	19.2	38.8	17.8	10.0	26.2	23.8	100.7	107.5	23.8	20.8	15.8	41.8	53.5	44.4	17.8	27.8	23.5	24.7	11.5	65.4	30.6	51.7	71.6	83.7	27.3	4.9	4.1	12.7	28.8	59.9	36.0	34.1	8.1	91.0	63.5	25.2	13.5	36.8	27.6	7.7	110.0	8.6	16.9	26.4	31.8	29.9	26.1	12.3	41.7	31.4	20.8	19.4	0.4	7.5	45.1	28.0	32.8	38.0	5.8	12.6	13.6	22.0	44.1	6.8	99.3	21.3	3.2	29.4	39.8	2.2	15.6	6.0	20.2	11.2	30.2	97.2	16.7	3.2	25.2	34.3	1.6	51.8	21.0	26.1	0.1	11.8	39.6	41.2	27.3	50.5	30.2	8.6	33.4	23.0	8.8	25.6	19.7	8.1	8.2	86.8	28.7	22.4	29.4	31.9	18.6	24.2	45.3	13.7	41.5	36.5	56.3	7.5	16.4	59.3	10.2	47.7	35.2	43.4	52.9	19.4	28.4	65.0	69.5	3.8	73.1	16.2	11.1	44.2	66.8	79.4	101.6	70.0	113.3	100.7	107.5	53.5	44.4	65.4	59.9	91.0	110.0	9.5	0.0	1.5	118.8	56.6	5.1	7.2	3.5	11.4	44.9	11.5	9.1	44.4	21.5	5.2	14.7	35.5	1.9	103.0	115.5	33.2	6.2	2.9	11.4	27.0	13.4	21.7	52.3	334.4	11.9	1.2	17.0	16.3	14.0	58.9	15.2	28.5	17.0	27.1	47.1	348.8	58.1	4.1	62.3	24.4	3.6	14.9	51.6	16.0	95.5	14.6	35.6	96.8	302.6	499.0	20.6	42.2	21.8	53.9	10.0	4.5	25.6	6.3	34.4	13.1	14.1	20.3	13.9	8.0	8.1	2.8	0.7	87.6	11.4	51.1	9.1
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012504-69014113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	152	"testis: 24.6"	"Group enriched"	"Detected in some"	27	"Early spermatids: 71.0;Late spermatids: 88.4;Spermatocytes: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PRKCA	"PKCA, PKCα"	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302613-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 564.8;Excitatory neurons: 247.6;Inhibitory neurons: 400.0;Microglial cells: 281.1;Oligodendrocyte precursor cells: 849.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 157.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	3.1	21.1	37.0	6.9	35.0	1.8	2.3	20.8	51.4	7.5	11.8	18.5	11.9	11.7	4.8	3.2	4.6	7.5	4.4	76.8	32.8	12.8	7.3	4.5	4.9	37.3	36.1	15.7	5.1	0.9	6.3	5.0	25.3	13.0	8.6	30.1	2.3	16.9	5.8	3.0	10.6	10.7	30.1	6.5	8.4	2.6	36.9	3.1	3.2	4.3	4.6	8.9	5.6	27.3	7.3	38.0	7.7	7.8	18.2	46.0	1.0	40.8	26.4	28.8	24.3	4.5	4.6	9.6	10.9	65.9	48.1	0.9	3.9	4.8	61.9	16.4	9.3	0.0	22.2	20.2	24.9	12.2	62.8	20.2	1.8	36.0	30.5	41.8	25.0	45.6	25.8	0.2	44.8	2.3	24.9	7.4	3.1	18.9	20.2	4.5	56.5	0.2	10.2	6.4	4.6	25.6	13.5	7.7	0.4	8.0	0.8	17.0	75.1	49.6	28.6	31.4	25.8	0.1	0.0	1.2	157.6	0.1	25.1	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.8	0.4	0.3	0.0	1.2	0.7	0.0	0.0	1.1	0.4	0.1	0.3	37.0	35.0	20.8	51.4	76.8	32.8	37.3	36.1	25.3	30.1	36.9	27.3	10.0	0.0	8.4	564.8	5.7	10.6	15.0	10.3	13.6	198.3	7.9	11.2	9.8	45.8	7.2	40.5	2.1	4.1	24.6	27.1	7.9	16.1	3.2	5.5	40.1	5.6	8.4	5.7	247.6	6.8	3.4	17.5	23.9	6.3	20.3	39.9	27.8	14.7	25.4	10.1	400.0	38.4	2.0	11.9	7.6	3.0	53.4	20.9	10.6	281.1	6.8	34.3	12.3	849.0	198.3	8.8	21.0	48.5	11.8	12.8	27.0	21.3	7.0	77.1	26.3	6.5	41.4	1.3	3.9	6.1	10.4	15.2	36.9	47.1	26.4	17.2
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 128.4;Microglial cells: 267.9;NK-cells: 229.6;T-cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdT-cell: 116.5;MAIT T-cell: 91.3;memory CD4 T-cell: 88.0;memory CD8 T-cell: 137.0;naive CD4 T-cell: 106.9;naive CD8 T-cell: 105.5;NK-cell: 117.1;T-reg: 79.8"	"Group enriched"	"Detected in all"	14	"NK-cells: 117.1;T-cells: 137.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 81.8;HUVEC TERT2: 108.7;MOLT-4: 75.8;RT4: 46.4;TIME: 72.0"	"Group enriched"	"Detected in all"	6	"basal ganglia: 28.0;thalamus: 17.9"	"Low region specificity"	"Detected in all"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	26.6	7.8	21.1	21.9	30.2	24.2	21.9	12.4	15.7	20.6	9.5	8.9	9.5	14.5	10.9	30.0	13.6	19.7	19.2	13.2	13.9	14.5	10.3	35.3	55.2	19.3	21.7	5.9	8.4	14.2	15.0	32.5	19.4	15.8	8.8	3.1	28.3	11.4	14.2	23.7	16.6	18.1	18.6	38.5	9.6	7.5	29.9	65.8	21.1	18.1	38.5	25.3	21.7	15.5	18.1	6.3	0.8	4.9	2.8	0.6	81.8	0.3	1.5	0.8	0.8	1.9	10.5	0.3	12.4	0.1	1.6	12.3	0.6	13.5	1.4	2.2	7.9	0.1	2.0	0.7	1.2	0.0	2.4	2.2	13.8	0.7	9.4	1.2	108.7	35.4	0.2	0.4	6.2	32.7	75.8	0.7	1.4	12.9	8.4	6.3	3.2	0.2	0.2	46.4	3.2	5.1	2.1	16.2	10.2	14.5	15.9	1.4	72.0	2.1	14.0	2.1	0.9	1.4	0.2	0.6	3.1	1.1	3.6	0.8	3.0	2.4	116.5	1.9	91.3	2.2	88.0	137.0	9.2	1.4	106.9	105.5	5.9	117.1	1.1	3.0	79.8	84.0	21.1	30.2	12.4	15.7	13.2	13.9	19.3	21.7	19.4	18.6	29.9	15.5	59.7	6.4	11.4	2.0	6.6	18.7	16.4	8.3	15.9	0.4	15.0	9.3	9.0	10.0	15.5	0.0	0.0	27.6	128.4	0.6	3.9	6.0	32.6	10.3	2.1	70.8	11.9	18.1	1.7	6.8	21.2	5.0	7.1	20.9	1.3	15.4	68.9	2.0	6.0	0.0	3.1	2.7	2.0	14.4	6.9	6.0	1.8	15.4	16.0	267.9	8.9	7.0	229.6	4.5	1.8	5.4	4.3	6.8	26.6	14.7	4.6	1.2	9.2	0.5	0.0	4.4	5.2	0.1	2.4	18.1	26.7	48.3	130.5	1.6	1.3	26.0
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222424-170305977	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	6.7	5.0	2.0	6.9	2.4	2.6	10.4	2.0	3.2	12.7	0.3	12.4	11.6	11.0	8.2	15.1	15.9	11.4	6.9	3.4	1.1	13.5	7.3	16.6	4.6	0.4	0.2	13.6	7.0	13.0	3.1	10.9	0.5	17.3	13.1	6.2	17.5	12.7	6.2	6.9	10.8	11.0	0.2	5.2	34.5	12.5	0.9	10.9	24.5	9.8	10.4	16.1	6.2	1.1	81.6	20.2	20.0	21.6	17.3	23.9	32.2	20.4	29.9	26.4	28.3	29.7	38.6	24.7	65.3	28.8	36.4	37.3	37.9	40.0	44.8	18.2	23.5	22.9	24.3	16.6	27.9	20.9	10.0	21.8	27.5	22.6	35.1	42.8	20.9	13.3	25.8	19.8	27.4	28.0	30.5	8.5	42.3	86.4	22.1	21.8	30.7	41.2	42.3	24.4	31.5	25.8	44.1	57.7	20.0	29.5	63.0	14.5	22.4	27.5	21.1	26.0	34.3	33.9	34.9	35.2	19.8	16.4	11.0	0.0	0.6	0.4	1.1	0.6	1.7	0.9	1.5	2.0	0.8	1.2	1.6	0.9	0.3	2.6	0.5	0.8	1.1	0.7	2.0	2.4	2.0	3.2	3.4	1.1	0.4	0.2	0.5	0.2	0.9	1.1	17.6	73.7	82.1	23.2	5.8	57.1	49.5	39.8	30.7	16.4	29.0	19.7	16.2	24.3	45.3	49.7	14.6	30.2	15.0	29.0	25.4	16.5	8.4	42.0	29.7	20.5	29.3	10.5	77.2	22.0	26.6	32.2	59.7	72.3	8.8	20.4	17.5	17.7	10.0	15.2	55.2	28.3	50.8	18.6	26.8	6.8	23.3	11.6	17.8	22.5	12.7	8.8	6.2	33.2	33.5	55.2	18.6	28.6	29.4	99.4	18.7	20.4	31.9	9.4	19.7	23.7	18.7	15.8	20.6	38.5	63.6	20.7	14.8	14.3	28.5	80.1
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435284-11450968	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		55000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: AB_2677758, HPA043560: AB_2678553"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	115.3	107.6	76.4	81.2	86.7	169.6	117.6	85.1	97.6	144.0	91.4	119.7	120.0	123.0	113.0	106.5	126.2	92.0	90.4	76.4	82.0	108.8	159.9	105.5	93.3	89.9	83.9	196.9	186.2	116.3	118.3	108.8	85.9	108.5	98.9	46.6	145.9	97.8	74.8	129.3	121.7	78.5	79.6	111.2	124.9	88.5	83.3	83.9	135.5	44.9	86.2	109.9	122.6	88.8	274.8	216.7	211.6	391.5	351.2	426.4	241.5	305.5	387.6	331.5	302.7	328.3	327.5	204.4	478.1	409.2	165.4	283.4	226.3	309.6	292.1	193.3	173.5	178.0	269.4	268.8	258.0	263.0	236.4	404.5	228.6	312.5	261.4	425.6	232.8	210.1	204.8	422.4	289.0	470.1	187.9	322.1	485.0	129.7	283.3	201.8	215.3	505.6	223.2	260.1	146.9	291.5	282.3	280.4	280.5	200.8	292.5	296.7	263.6	437.1	198.2	416.0	361.0	471.9	575.3	132.3	330.1	276.8	306.5	38.8	47.2	45.1	37.9	36.2	42.6	35.9	31.8	36.4	36.1	38.7	30.2	33.1	56.3	32.8	41.2	75.7	37.5	39.5	76.4	86.7	85.1	97.6	76.4	82.0	89.9	83.9	85.9	79.6	83.3	88.8	45.2	12.8	16.9	15.3	65.1	41.8	72.2	90.0	39.9	18.2	56.9	47.5	10.5	71.4	44.9	64.4	33.3	174.9	54.6	152.0	33.2	88.7	18.1	47.4	65.0	52.0	58.8	40.6	12.3	127.5	189.1	62.6	70.3	67.2	41.9	104.5	60.3	86.4	93.4	10.1	12.5	123.2	65.1	80.0	43.4	55.9	78.6	59.3	53.4	14.0	81.4	59.8	61.8	6.0	39.0	89.0	132.8	72.6	91.4	45.9	187.8	62.7	32.7	30.2	39.5	39.8	52.0	36.8	55.2	49.5	37.8	143.5	55.5	84.2	128.2	66.6
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050411-2185395	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 708.3;Syncytiotrophoblasts: 1107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 16.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.5;OE19: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.7	11.1	23.6	4.6	25.7	2.1	5.6	58.0	41.3	4.3	0.0	13.2	29.3	2.2	7.8	16.0	9.5	4.4	9.7	23.7	10.2	16.0	11.0	31.6	8.0	18.6	8.3	2.7	12.5	14.7	17.6	43.8	19.0	8.4	11.3	14.8	10.8	3.9	0.3	13.8	28.0	1.6	5.6	10.5	8.9	31.9	7.2	3.7	21.8	0.6	7.8	5.8	8.0	24.8	14.7	9.7	3.4	17.2	0.0	0.0	44.5	1.2	0.5	11.1	0.7	23.8	31.0	0.1	27.4	3.9	9.4	25.4	20.5	25.5	7.9	1.0	21.8	0.0	15.2	33.5	3.2	0.1	11.0	0.6	14.9	0.0	8.6	0.0	0.0	4.0	6.6	0.2	0.2	17.9	0.9	0.0	6.4	41.9	22.5	0.0	0.0	5.1	18.6	16.0	24.1	18.7	11.6	27.5	5.2	28.7	17.7	4.0	0.0	0.1	13.1	0.1	0.1	6.8	1.3	0.3	1.2	0.3	16.8	0.3	0.0	16.3	0.5	0.3	2.5	0.3	0.9	0.6	0.0	0.4	0.8	0.3	1.1	0.9	0.0	0.3	0.9	0.3	23.6	25.7	58.0	41.3	23.7	10.2	18.6	8.3	19.0	5.6	7.2	24.8	0.9	121.8	72.2	2.3	6.5	13.0	11.8	11.0	10.2	27.1	11.3	11.0	1.4	5.7	21.1	7.3	4.2	118.7	7.5	48.9	7.9	12.3	224.4	14.0	4.7	6.3	10.2	6.6	39.5	10.7	66.3	3.1	17.9	11.7	8.2	12.5	10.0	16.5	14.5	62.2	35.2	25.5	10.2	0.8	2.9	708.3	9.6	4.4	7.2	2.8	4.5	19.1	8.2	13.0	41.3	14.2	45.7	8.6	7.4	19.5	78.4	24.7	22.1	25.9	0.0	0.3	4.1	28.3	28.4	13.4	13.4	1107.9	9.8	2.6	31.3	14.3
PRKX	PKX1	ENSG00000183943	"Protein kinase X-linked"	P51817	X	3604340-3713649	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 108.3;Endometrial ciliated cells: 164.0;Glandular and luminal cells: 179.5;NK-cells: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015324	Supported		Supported	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	5.5	1.6	10.0	9.8	12.9	7.7	7.9	12.6	8.8	7.8	12.7	6.5	5.1	4.6	9.6	13.9	19.4	4.4	3.7	8.3	14.3	15.6	1.8	9.0	12.8	18.1	13.8	4.0	4.4	3.1	2.0	5.3	15.8	3.8	6.1	1.7	6.1	5.9	2.2	12.0	6.3	3.7	14.5	12.4	4.0	6.8	15.3	15.4	33.8	3.2	9.9	4.5	12.4	17.1	9.1	8.3	22.4	16.7	4.2	5.6	20.5	5.3	2.1	2.6	3.5	12.4	6.1	0.7	5.3	4.3	5.4	6.2	21.1	16.1	4.5	10.2	14.7	10.0	6.7	0.2	4.4	13.0	74.7	3.8	16.8	2.8	10.3	7.1	25.7	12.3	11.8	12.7	8.6	8.0	15.0	11.7	15.0	7.0	9.4	27.7	21.5	17.2	20.6	7.6	14.9	9.6	5.6	3.6	5.5	35.1	2.8	10.3	14.2	2.2	3.8	3.7	3.6	0.3	0.7	11.6	1.3	11.6	5.8	11.0	2.0	1.2	2.3	2.4	2.4	1.6	2.4	2.2	1.6	1.5	1.9	2.1	0.5	2.4	3.2	1.9	1.8	1.2	10.0	12.9	12.6	8.8	8.3	14.3	18.1	13.8	15.8	14.5	15.3	17.1	32.0	3.2	9.4	7.8	35.5	21.4	22.3	9.7	21.6	1.8	14.4	9.1	1.6	30.0	10.1	5.5	0.0	30.8	108.3	8.8	13.7	10.8	11.9	164.0	23.8	19.7	4.8	7.2	1.3	3.1	5.8	10.4	6.1	179.5	85.1	11.8	13.2	2.3	16.9	1.7	20.2	13.5	24.4	19.4	24.1	49.2	19.9	29.0	5.4	39.4	53.4	2.2	139.0	11.1	7.0	5.6	13.1	21.8	38.2	29.0	10.7	6.1	18.0	0.6	32.9	46.4	12.4	1.3	21.6	34.1	26.9	7.8	63.5	10.6	23.6	20.4
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280841-11281330	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1099	"testis: 14115.0"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 776887.9"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.4;U-2197: 1.7"					"Not detected"	"Not detected"			"HPA055150, HPA059371"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			2.3	2.2	0.0	0.5	0.0	0.0	9.9	0.0	0.0	2.1	0.0	2.1	1.5	1.0	0.0	1.9	1.2	0.0	2.2	0.0	0.2	2.7	4.4	1.3	0.4	0.1	0.0	1.6	3.0	0.0	1.9	0.0	0.1	12.8	0.0	0.0	2.1	1.3	5.8	3.7	4.0	0.0	0.0	1.4	2.4	14115.0	0.0	0.0	4.3	0.0	0.1	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126844.3	0.0	0.0	80.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	776887.9	1855.9	161.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1689.6	0.0	0.0	0.0	0.0	0.0	0.0	1157.0	0.0	0.0	2054.0	1211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358584	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	9.7	11.9	8.1	6.2	8.3	4.7	10.5	8.4	10.2	9.8	12.0	10.8	3.2	9.4	3.3	7.5	10.7	4.3	13.2	8.3	8.3	8.6	10.2	5.9	9.4	8.9	8.4	12.1	9.7	4.8	11.1	6.3	8.8	10.5	3.0	4.6	10.0	7.0	21.8	9.8	8.8	4.5	8.3	9.7	8.8	9.8	8.4	14.4	8.6	13.5	5.8	9.7	8.3	8.4	18.1	24.7	13.2	36.1	7.1	7.0	50.8	13.8	6.8	19.5	15.6	79.4	16.1	42.4	29.8	14.0	8.4	22.6	20.4	13.8	12.6	12.7	24.5	8.6	30.8	36.8	7.8	24.3	15.8	11.3	4.9	15.2	14.0	9.3	11.8	18.7	28.1	0.8	10.3	28.2	25.8	36.3	25.3	16.5	18.8	43.7	19.3	25.7	10.7	17.7	19.8	13.2	53.5	16.2	15.7	11.9	25.2	22.2	16.0	14.7	12.9	19.9	17.6	9.6	22.5	41.6	17.1	23.4	16.8	12.3	8.2	7.1	17.4	10.6	20.2	10.9	11.6	14.9	11.8	12.8	16.7	15.4	0.8	21.4	9.5	32.9	14.7	14.3	8.1	8.3	8.4	10.2	8.3	8.3	8.9	8.4	8.8	8.3	8.4	8.4	7.1	19.2	10.6	16.6	12.1	6.9	8.9	12.8	9.1	21.2	10.8	8.8	13.3	8.6	10.0	9.2	54.2	25.4	12.6	28.3	5.9	12.3	4.4	12.9	8.7	7.6	13.2	7.8	25.0	16.1	8.4	10.5	23.4	5.9	7.0	24.9	6.8	8.4	12.2	30.3	25.9	32.4	10.2	7.7	20.6	4.3	11.8	6.2	8.8	12.2	9.1	9.7	13.4	18.6	20.4	23.6	29.8	13.2	6.9	6.7	24.7	7.7	14.5	18.2	13.1	9.9	8.6	6.9	19.3	6.1	6.0	11.6	16.5	10.0	24.1	12.7
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;liver: 86.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	1.6	10.0	11.0	1.4	21.4	0.0	1.8	24.6	18.2	1.0	0.0	2.6	2.1	1.1	1.2	0.6	2.2	1.9	15.7	23.1	12.4	4.7	86.8	1.2	2.8	18.7	17.3	7.4	15.5	0.1	4.0	0.4	13.9	0.5	2.7	21.2	0.3	0.4	3.6	0.7	2.6	0.8	10.6	7.1	2.1	5.4	30.0	0.2	7.6	2.1	0.7	1.0	0.7	38.2	0.0	0.0	0.6	0.0	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.3	0.2	2.3	0.0	0.1	0.0	1.0	0.6	0.0	31.4	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.1	3.5	2.3	5.7	0.0	0.4	0.0	0.4	0.0	1.7	2.0	1.3	0.0	15.9	2.5	0.2	0.5	2.3	77.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.2	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.4	24.6	18.2	23.1	12.4	18.7	17.3	13.9	10.6	30.0	38.2	14.3	0.0	2.3	1.3	1.9	5.9	1.1	0.3	5.7	196.4	4.8	4.7	105.9	102.9	1.3	9.2	2.1	0.0	0.1	3.2	15.6	34.7	52.7	0.1	1.0	36.5	66.9	5.3	2.9	2.7	0.1	8.7	8.6	0.3	0.0	9.3	11.0	285.9	0.9	523.3	66.8	16.5	12.2	4.4	6.6	10.4	1.2	2.2	10.6	8.4	0.0	36.0	0.0	27.2	114.0	3.4	130.6	1.2	0.1	3.9	3.3	0.4	0.9	11.7	0.0	113.6	3.7	2.9	0.4	0.4	4.5	0.0	1.9	29.6	10.5	0.9
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 147.8;parathyroid gland: 182.0"	"Group enriched"	"Detected in many"	7	"Leydig cells: 1431.5;Peritubular cells: 1995.0;Sertoli cells: 624.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051269, HPA067599, CAB070417"	Enhanced		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nuclear speckles"	"CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869"	"unprognostic (7.50e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	11.0	46.0	6.3	24.5	7.3	24.2	19.7	1.9	12.0	54.5	2.5	30.3	14.0	32.8	26.5	16.1	29.7	28.1	5.4	6.9	2.9	28.0	26.1	13.1	36.8	3.0	6.5	147.8	62.8	182.0	3.4	6.1	2.2	21.9	31.3	1.3	27.9	84.0	2.1	21.9	15.8	24.3	4.4	15.6	32.5	131.1	8.8	44.6	18.1	4.2	31.5	22.5	21.2	6.4	114.2	63.7	22.1	40.3	26.7	31.8	14.6	54.4	26.8	53.1	51.1	46.3	78.7	34.9	24.2	23.5	45.3	79.9	43.1	53.7	61.5	89.7	108.0	41.7	49.6	43.3	24.7	77.3	38.9	30.5	35.0	39.1	51.7	26.9	22.1	86.8	30.4	39.8	45.2	68.5	117.6	34.7	49.9	81.0	107.3	61.5	102.7	79.5	33.0	81.7	46.1	33.6	64.9	2.1	38.9	30.2	58.8	32.4	24.9	41.8	32.0	162.5	55.5	103.6	41.3	76.8	44.4	39.4	67.4	25.9	20.1	9.4	17.2	19.4	19.9	27.8	25.0	16.4	28.2	30.6	31.7	23.0	8.0	24.3	12.3	19.9	22.6	28.2	6.3	7.3	1.9	12.0	6.9	2.9	3.0	6.5	2.2	4.4	8.8	6.4	12.2	3.2	8.7	0.7	25.4	64.0	48.5	16.2	41.5	0.6	53.1	15.9	2.0	11.5	12.4	55.2	0.0	1.1	18.5	21.1	72.4	19.3	12.1	24.7	62.5	14.5	21.8	28.4	14.8	39.2	7.3	25.8	31.1	26.4	27.9	16.2	10.4	13.7	24.4	0.0	6.3	27.9	8.2	21.4	44.3	65.8	1431.5	20.7	40.9	3.7	18.2	1.2	18.6	3.5	5.1	24.6	17.4	1995.0	30.7	52.2	6.0	10.4	20.3	0.2	624.5	9.4	19.2	10.3	8.1	29.2	43.8	0.4	27.2	179.2	50.2	36.9
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155732-59206709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.1;lymphoid tissue: 20.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 26.3;Extravillous trophoblasts: 22.3;Granulosa cells: 14.4;Kupffer cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 9.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"		Yes	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	1.3	0.7	1.8	6.5	2.0	18.1	1.8	4.3	2.7	1.2	1.1	4.6	6.5	1.7	0.5	3.8	1.4	1.4	1.0	2.0	1.3	0.6	1.4	2.3	10.3	2.3	1.5	1.4	0.5	0.3	0.0	4.3	2.2	0.8	5.6	1.7	0.6	0.7	1.2	3.1	5.0	3.6	1.1	3.3	2.4	1.8	2.3	20.6	1.3	0.4	12.0	2.0	0.6	3.7	105.3	56.9	84.5	24.8	2.4	16.0	31.7	66.7	41.9	69.1	54.2	68.4	78.7	80.2	65.9	52.7	56.2	40.7	67.0	73.9	145.0	99.3	39.1	86.4	58.8	50.3	0.6	88.7	32.5	4.0	5.3	81.9	109.0	17.1	77.2	57.9	48.6	76.7	72.8	95.2	80.7	26.1	31.9	52.0	82.5	67.3	135.7	45.9	20.0	32.4	34.5	45.4	61.7	18.4	29.2	38.0	54.4	34.1	57.8	146.4	157.3	73.5	117.8	48.8	108.2	73.6	34.5	47.4	150.1	1.7	2.1	2.3	0.6	4.0	0.2	1.1	0.5	0.7	2.6	0.6	0.3	0.5	2.1	0.5	9.5	1.1	1.4	0.8	1.8	2.0	4.3	2.7	2.0	1.3	2.3	1.5	2.2	1.1	2.3	3.7	4.5	0.0	1.7	3.3	3.1	1.9	2.0	1.5	0.0	2.0	0.8	1.5	2.0	1.5	1.6	0.0	0.0	6.2	1.4	2.0	0.0	0.4	0.9	1.4	1.9	3.6	4.9	26.3	1.6	0.5	22.3	2.9	2.6	2.2	2.5	14.4	4.2	0.3	7.8	1.7	1.8	5.0	0.0	18.6	6.3	0.4	0.9	7.8	1.8	2.8	8.4	0.9	4.1	2.0	3.4	0.9	0.7	2.2	9.7	1.1	0.5	0.5	0.6	3.2	0.0	2.9	3.3	2.6	5.1	5.5	1.3	2.1	3.3	1.3	8.4	1.7
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 178.4;pancreas: 103.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 203.0;Distal tubular cells: 170.2;Intestinal goblet cells: 127.8;Paneth cells: 226.4;Proximal enterocytes: 263.7;Undifferentiated cells: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 205.6"	"Not detected"	"Not detected"							HPA022918	Approved		Approved	Cytosol		No	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.29e-13)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	2.2	0.1	0.0	7.9	0.1	0.1	38.8	0.2	0.2	13.4	9.5	111.2	178.4	1.4	18.3	12.9	26.5	22.0	0.4	0.8	0.0	28.0	1.9	21.7	0.2	0.1	0.0	0.3	103.9	0.8	8.5	0.0	0.0	17.7	124.3	0.0	51.8	15.8	0.1	10.0	128.5	3.3	0.0	0.0	84.4	2.5	0.0	0.4	67.8	0.0	2.0	2.7	6.7	0.1	3.8	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	8.6	5.8	0.2	0.3	0.0	0.0	20.5	0.0	0.1	0.0	0.4	0.7	0.2	0.0	2.6	0.0	0.4	0.4	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	19.7	0.4	0.4	0.0	205.6	0.7	0.3	0.0	1.4	1.1	2.6	11.7	0.5	0.0	35.7	0.0	0.0	24.1	0.0	0.1	0.3	0.0	0.7	0.1	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	22.4	19.8	0.3	0.1	0.0	2.6	2.4	0.0	0.0	16.7	8.9	0.1	80.1	19.8	16.5	0.0	0.0	0.1	203.0	170.2	35.6	5.5	9.8	0.3	0.2	31.6	0.0	0.1	36.1	0.0	0.4	55.5	3.9	0.0	0.0	0.0	0.8	0.1	0.0	0.1	127.8	24.4	0.0	0.0	9.0	1.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	226.4	0.4	0.2	15.6	263.7	30.0	19.2	0.0	0.0	0.0	1.0	11.1	0.1	7.3	0.0	0.0	0.6	0.0	100.9	9.9
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464300-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 30.4"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 171.6;Inhibitory neurons: 188.9"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.3;BJ hTERT+: 83.9;fHDF/TERT166: 102.1;HSkMC: 62.5;hTERT-RPE1: 103.0;LHCN-M2: 97.9;U-138 MG: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Midbody, Cytosol"	"HPA049254: AB_2680693"	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.0	2.8	2.0	5.2	2.1	0.2	7.9	6.1	3.5	14.9	0.0	5.1	1.7	11.8	1.5	1.8	7.0	5.7	12.7	2.2	5.1	3.0	0.9	9.8	1.1	3.4	1.8	5.6	2.0	1.1	1.7	9.7	3.2	9.3	4.5	7.0	2.6	2.4	26.4	4.0	5.0	8.2	0.7	2.5	4.0	2.4	2.3	0.7	4.4	30.4	0.9	9.5	10.0	1.4	3.7	0.0	8.0	0.0	22.2	77.3	0.0	37.0	83.9	51.5	39.1	0.0	0.2	0.0	0.0	102.1	9.3	0.0	8.1	0.9	53.8	0.0	1.9	0.0	1.2	0.0	21.5	0.2	0.1	62.5	8.9	15.4	48.0	103.0	1.7	0.0	0.1	0.1	97.9	0.0	0.0	0.0	0.9	0.0	1.4	0.0	6.2	0.0	4.3	0.0	0.3	16.1	0.1	0.0	1.1	6.1	0.1	0.1	0.5	117.9	13.3	3.8	19.4	0.3	0.0	0.0	6.7	0.2	4.1	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.3	2.0	2.1	6.1	3.5	2.2	5.1	3.4	1.8	3.2	0.7	2.3	1.4	1.4	0.0	0.0	14.0	0.4	1.3	6.2	0.0	0.0	7.5	1.5	1.9	3.2	0.0	0.0	0.0	14.6	0.1	0.1	0.0	0.0	0.1	16.8	0.9	18.9	0.8	0.0	0.0	171.6	0.0	0.0	13.5	0.0	0.8	0.0	0.2	0.4	0.0	0.5	15.2	188.9	0.0	0.0	1.8	2.7	11.6	2.8	1.0	1.8	9.4	0.1	2.6	0.0	7.5	3.9	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.7	0.0	1.4	9.6	0.9	1.4	0.5	0.6	0.5	0.4	3.1	0.0	0.7
PRR19	MGC70924	ENSG00000188368	"Proline rich 19"	A6NJB7	19	42302098-42310814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 21.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 26.7;Late spermatids: 60.1;Spermatocytes: 37.9;Spermatogonia: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA070350			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"HPA070350: AB_2686259"	"unprognostic (2.05e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.02e-2)"	"unprognostic (7.55e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.44e-5)"	"unprognostic (3.57e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-2)"	0.4	1.1	1.9	0.7	2.5	2.3	0.5	2.1	2.4	0.7	1.3	0.4	0.4	0.6	0.4	1.1	0.5	0.5	0.2	1.9	1.7	0.7	0.6	0.3	0.5	1.8	1.5	0.5	0.4	0.4	0.9	0.4	1.9	0.7	0.2	0.5	0.7	0.4	0.3	0.7	0.5	0.3	1.4	0.5	0.4	21.6	2.0	0.6	0.4	0.1	0.5	0.4	0.7	2.0	2.7	3.9	2.2	2.9	0.1	0.2	2.2	1.2	1.2	3.5	3.5	1.6	2.5	0.5	4.5	1.3	2.6	0.8	1.0	1.0	0.7	1.8	1.0	2.8	2.0	1.0	0.8	0.7	1.6	1.1	1.6	2.3	0.4	0.7	0.6	2.9	1.5	1.3	1.6	6.2	2.7	1.3	2.3	2.5	0.0	1.0	0.4	0.2	1.1	2.1	4.9	1.9	2.1	1.5	0.6	0.6	2.0	1.0	0.8	2.3	3.4	0.5	2.1	0.2	1.0	0.8	2.4	2.0	2.4	0.4	0.4	0.1	0.4	0.4	0.1	0.6	0.3	0.5	0.5	0.4	0.4	0.2	0.4	0.5	0.1	0.3	0.5	0.2	1.9	2.5	2.1	2.4	1.9	1.7	1.8	1.5	1.9	1.4	2.0	2.0	1.2	0.0	0.5	0.0	0.7	0.6	0.9	1.9	4.0	0.4	2.7	2.8	0.5	0.0	0.6	0.0	0.0	0.9	0.3	0.8	1.9	0.9	26.7	1.0	0.7	1.2	0.0	0.0	0.4	1.2	0.6	0.6	1.1	1.5	0.0	0.3	0.0	0.4	0.8	1.7	0.4	0.1	0.0	0.0	0.3	60.1	1.2	0.4	0.0	1.0	0.1	0.0	1.0	1.0	0.3	0.4	1.2	1.2	0.6	0.4	0.6	0.6	2.3	0.2	0.0	0.8	0.7	37.9	22.5	2.1	0.9	0.5	0.4	0.6	0.4	0.7
PRR23A		ENSG00000206260	"Proline rich 23A"	A6NEV1	3	139003962-139006268	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.48e-1)"			0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR23B	FLJ46116	ENSG00000184814	"Proline rich 23B"	Q6ZRT6	3	139019031-139020926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 1.3"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 6.4;Spermatogonia: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (7.57e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4
PRR23C	FLJ46210	ENSG00000233701	"Proline rich 23C"	Q6ZRP0	3	139042102-139044892	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.5;Late spermatids: 2.0;Spermatocytes: 1.6;Spermatogonia: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"			"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.00e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PRR35	C16orf11	ENSG00000161992	"Proline rich 35"	P0CG20	16	560394-565529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 46.5;kidney: 17.2"	"Cell type enriched"	"Detected in some"	9	"Collecting duct cells: 36.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	20	"cerebellum: 46.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.5"	"Not detected"	"Not detected"			HPA069297	Uncertain		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	"Cytokinetic bridge, Cytosol"	"HPA069297: AB_2686113"		"unprognostic (6.96e-2)"		"unprognostic (3.08e-2)"	"unprognostic (5.25e-1)"	"unprognostic (8.11e-2)"				"unprognostic (2.56e-1)"				"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"			0.0	0.1	0.1	0.0	0.2	0.0	0.0	46.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	17.2	0.0	0.0	0.0	0.2	1.5	0.0	1.1	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	46.5	1.8	0.3	0.1	0.2	1.5	2.3	0.3	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	1.3	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR36		ENSG00000183248	"Proline rich 36"	Q9H6K5	19	7868719-7874390	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 29.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.4;Breast glandular cells: 9.2;Cone photoreceptor cells: 12.5;Horizontal cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 21.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 28.7;SCLC-21H: 8.0;SH-SY5Y: 17.9;T-47d: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062741	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Golgi apparatus"		Yes	No				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 14: REH - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Nuclear speckles"	"HPA062741: AB_2684860"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (3.56e-1)"	"unprognostic (8.52e-3)"	0.1	0.9	3.5	0.1	4.0	0.0	2.5	3.0	21.0	0.8	0.0	0.3	0.2	0.6	0.3	0.3	1.2	0.1	0.2	7.5	0.0	3.3	0.2	0.9	0.0	0.0	0.0	0.7	2.8	2.0	29.6	0.0	0.0	2.5	0.0	5.0	4.1	0.3	0.0	0.7	0.2	0.0	0.0	0.1	0.8	0.8	0.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.1	0.9	6.6	5.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	2.9	0.0	1.9	0.0	0.6	0.1	5.1	0.0	0.0	0.0	6.4	0.0	0.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.1	0.1	0.0	3.0	0.3	0.3	2.5	0.4	0.6	28.7	0.0	0.3	3.7	5.4	8.0	17.9	0.0	0.3	0.0	0.5	9.1	0.0	0.0	0.0	3.2	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.0	3.0	21.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.8	0.0	2.2	13.4	9.2	7.7	1.3	2.8	0.0	5.5	12.5	0.2	0.2	0.2	5.9	3.0	5.4	4.5	0.7	0.2	3.6	0.0	6.9	0.9	0.4	0.3	2.6	6.7	0.0	1.1	0.0	0.5	0.1	10.1	5.8	0.7	0.0	0.0	0.0	0.7	0.6	0.4	0.0	3.7	0.0	5.4	0.0	4.5	0.8	0.9	0.1	0.0	0.6	1.3	0.1	1.5	0.0	4.5	0.0	0.3	1.1	0.3	3.7	3.1	0.0	0.3	0.3	0.5	0.3	1.0
PRR5L	"FLJ14213, PROTOR-2"	ENSG00000135362	"Proline rich 5 like"	Q6MZQ0	11	36296288-36465204	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.9;intestine: 34.7;lymphoid tissue: 36.4"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 302.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 35.5;HMC-1: 55.7;hTERT-HME1: 57.9;SiHa: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070174			Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cytokinetic bridge, Cytosol"		"HPA070174: AB_2686231"	"unprognostic (6.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.71e-8)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.98e-2)"	3.6	1.5	10.1	8.9	27.8	4.7	2.7	21.7	16.7	11.4	2.2	34.7	3.3	2.8	2.0	1.4	6.3	7.1	2.0	9.6	21.1	7.7	2.9	13.6	9.3	36.6	23.8	12.8	1.2	0.9	2.7	3.6	33.9	2.4	27.8	0.7	7.8	2.0	0.9	1.7	12.2	5.9	24.1	36.4	3.4	1.5	23.9	3.4	3.2	0.7	3.3	4.3	3.8	46.9	0.0	5.5	10.3	0.2	1.4	0.0	0.1	13.2	8.9	25.7	27.2	0.0	0.2	0.1	4.4	15.7	5.9	0.5	2.1	5.9	12.9	5.0	3.7	1.5	35.5	0.0	3.5	0.0	55.7	3.8	9.0	2.3	57.9	25.2	9.4	0.0	0.0	0.1	13.6	3.3	0.7	0.1	0.8	0.1	2.3	4.1	1.1	1.1	27.0	6.9	0.0	0.4	40.1	0.0	2.2	6.5	0.0	0.6	7.8	22.3	6.8	0.0	16.4	0.2	0.0	0.0	9.7	1.5	6.7	36.1	2.0	24.9	34.6	21.4	8.2	0.0	12.2	29.7	2.5	1.6	2.6	18.0	11.8	9.6	24.6	7.7	0.0	15.4	10.1	27.8	21.7	16.7	9.6	21.1	36.6	23.8	33.9	24.1	23.9	46.9	2.1	19.2	4.2	17.6	0.7	0.4	0.2	5.0	0.0	0.1	1.9	0.9	0.9	1.5	6.8	7.3	0.0	0.2	25.9	44.3	1.9	1.3	17.6	1.5	0.8	7.7	1.8	7.0	1.8	2.2	0.1	2.1	1.1	2.5	5.1	0.5	22.5	0.4	8.8	0.0	1.1	22.7	10.2	11.7	0.7	54.9	0.6	5.4	0.0	16.9	4.7	1.2	58.7	31.7	302.0	3.9	37.0	0.4	4.2	0.7	13.2	0.5	9.0	0.2	6.6	1.8	2.6	0.3	0.6	0.4	0.6	0.3	14.5	0.9	17.5	0.5
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"skin 1: 59.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 4.1;Late spermatids: 10.2;Syncytiotrophoblasts: 8.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SuSa: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027714	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Nucleoplasm, Vesicles"	"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	1.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
PRRG2	PRGP2	ENSG00000126460	"Proline rich and Gla domain 2"	O14669	19	49580646-49591004	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 28.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 47.2;Proximal enterocytes: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.9;OE19: 18.0;RT4: 11.7;SK-BR-3: 13.3;T-47d: 14.4;U-266/84: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010702	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA010702: AB_1079693"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (3.82e-9)"	"unprognostic (4.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.68e-2)"	1.2	0.4	0.9	1.2	0.9	0.1	7.0	1.3	2.6	4.9	0.6	8.4	12.0	1.5	12.9	13.5	4.9	4.3	1.2	0.9	1.0	11.8	6.4	3.9	0.9	1.2	0.9	0.3	13.1	28.4	15.6	2.1	1.1	6.2	7.7	0.1	11.3	9.0	0.9	12.9	11.0	1.1	0.9	1.0	9.8	0.9	1.1	2.3	13.4	0.1	3.9	6.7	5.5	1.0	11.1	0.4	0.3	0.9	1.3	0.0	4.6	0.2	0.0	0.4	0.4	2.2	14.9	0.7	1.6	0.1	0.3	8.5	0.3	8.5	0.4	1.1	1.2	0.5	0.8	0.7	0.9	0.4	1.1	0.9	7.4	0.3	0.3	0.7	3.4	0.9	0.2	0.8	0.0	2.4	0.2	0.7	0.6	18.0	1.4	0.2	0.3	8.7	6.5	11.7	2.4	0.3	1.3	13.3	0.1	1.0	14.4	0.2	0.6	0.8	0.7	0.4	0.1	5.1	18.7	0.5	0.2	0.3	0.4	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.2	0.5	0.0	0.2	1.2	0.2	0.1	0.9	0.9	1.3	2.6	0.9	1.0	1.2	0.9	1.1	0.9	1.1	1.0	6.4	6.4	13.4	0.7	3.4	4.1	11.6	20.2	29.6	2.2	21.5	22.6	0.9	8.6	14.2	12.9	2.1	13.0	4.1	47.2	3.9	31.9	0.7	10.8	4.1	6.4	16.2	1.3	0.5	33.2	6.5	1.6	16.8	16.1	2.5	2.3	1.1	6.8	2.3	5.0	0.4	18.0	8.2	1.9	1.2	0.4	0.3	3.3	1.8	1.9	8.2	0.9	2.1	2.0	0.4	27.4	29.4	0.0	4.4	14.5	46.3	15.5	8.8	4.1	0.0	0.8	3.9	1.9	2.1	23.3	4.7	12.7	4.1	4.6	20.7	14.6
PRRX2	"PMX2, PRX2"	ENSG00000167157	"Paired related homeobox 2"	Q99811	9	129665647-129722674	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.3;skin 1: 25.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 27.4;Early spermatids: 78.7;Fibroblasts: 44.2;Langerhans cells: 28.0;Smooth muscle cells: 21.2;Suprabasal keratinocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.9;BJ: 28.7;BJ hTERT+: 20.3;fHDF/TERT166: 41.6;U-2197: 34.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 1.3"	"HPA006607, HPA026808"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA006607: AB_2667623, HPA026808: AB_10603228"	"unprognostic (4.02e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.47e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-10)"	"unprognostic (6.66e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.47e-3)"	14.2	2.4	0.5	1.2	0.5	0.0	11.7	0.4	0.7	23.3	1.0	2.2	0.2	3.9	0.2	5.4	3.4	1.3	9.5	0.6	1.2	1.2	0.1	4.6	1.1	0.5	0.5	1.3	0.9	0.5	4.5	1.4	0.6	14.1	0.3	0.0	7.5	2.7	1.6	25.5	1.6	0.6	0.4	0.1	2.8	10.7	0.5	0.3	9.5	0.6	0.8	10.7	18.3	0.5	0.0	0.7	0.0	1.1	3.3	12.9	0.1	28.7	20.3	3.6	4.0	0.0	0.0	0.0	10.2	41.6	1.5	0.3	0.8	0.0	0.3	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	1.1	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.6	0.0	0.0	4.4	2.1	6.4	0.0	0.0	0.0	0.9	0.0	0.0	2.7	1.3	0.1	0.0	1.4	2.7	0.5	0.0	0.0	8.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.7	0.6	1.2	0.5	0.5	0.6	0.4	0.5	0.5	3.9	0.0	0.0	0.7	0.1	27.4	1.1	16.0	0.6	0.0	6.0	6.0	0.3	0.0	10.1	0.0	0.0	0.2	0.1	0.0	1.9	0.1	78.7	1.0	6.3	3.0	0.0	0.0	0.4	0.0	0.4	44.2	0.5	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	2.0	0.0	28.0	10.2	2.8	0.3	8.8	0.0	0.0	0.0	0.0	5.0	0.1	0.9	0.0	3.4	0.0	4.0	0.0	0.1	7.9	0.0	0.0	0.4	21.2	3.6	6.8	0.5	29.7	0.4	0.8	0.0	0.0	6.2
PRSS27	"CAPH2, MPN"	ENSG00000172382	"Serine protease 27"	Q9BQR3	16	2712419-2720551	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 83.5;esophagus: 388.6;vagina: 134.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Horizontal cells: 11.8;Squamous epithelial cells: 9.6;Urothelial cells: 11.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;SK-BR-3: 24.4;T-47d: 14.6;U-266/70: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB024920, HPA028848"	Approved		Approved	Vesicles	"Secreted to digestive system"	NA	NA		8700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB024920: , HPA028848: "	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-2)"	1.0	0.4	0.9	0.2	0.9	0.3	1.3	1.0	2.0	83.5	0.6	1.0	0.0	1.0	0.0	388.6	0.7	0.2	0.4	0.8	1.4	1.1	0.6	0.6	0.3	1.2	1.5	0.5	0.8	0.7	1.5	0.1	1.0	1.0	0.0	0.2	52.5	0.4	0.3	3.3	0.6	0.0	1.0	0.6	0.8	2.6	1.2	0.6	0.8	0.0	29.9	0.8	134.2	0.9	0.1	0.3	0.4	2.1	0.3	0.7	6.1	0.0	0.2	0.2	0.2	0.1	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.1	0.1	0.0	1.0	0.0	0.3	1.2	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.6	0.0	2.0	0.0	1.1	1.4	0.2	0.0	1.0	0.2	0.1	0.2	0.3	0.7	2.8	0.0	24.4	0.6	0.1	14.6	1.8	0.0	0.4	0.0	0.1	0.0	5.2	3.7	0.5	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.9	1.0	2.0	0.8	1.4	1.2	1.5	1.0	1.0	1.2	0.9	1.5	9.6	5.8	0.0	0.5	1.8	2.5	1.3	0.6	5.2	5.1	6.2	1.2	1.5	5.6	1.8	4.2	0.7	0.5	1.2	0.0	1.5	3.3	0.6	1.4	1.8	0.0	0.0	0.4	1.4	0.6	1.4	1.1	1.6	3.8	1.1	0.4	0.7	0.3	11.8	0.8	0.5	0.0	0.3	3.1	1.0	0.3	0.8	1.8	1.9	0.9	2.6	0.0	0.0	0.3	1.1	1.2	0.0	0.2	1.7	0.1	0.7	3.4	6.6	0.0	2.7	1.5	3.0	3.9	9.6	2.4	3.3	1.3	0.6	1.4	11.1
PRXL2B	"C1orf93, FAM213B, MGC26818"	ENSG00000157870	"Peroxiredoxin like 2B"	Q8TBF2	1	2586491-2591469	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 5.0;Endothelial cells: 2.1;Hofbauer cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 51.8;U-2197: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006403	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA006403: AB_1853870"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.76e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (5.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.20e-2)"	8.3	18.6	11.0	4.8	12.0	3.2	9.2	5.5	16.4	9.4	2.3	24.4	18.7	9.3	1.4	12.3	10.9	6.0	6.4	12.1	10.2	15.6	7.0	11.7	5.0	9.4	10.1	6.3	6.8	5.4	8.7	6.7	11.7	10.0	5.9	2.8	7.8	5.6	1.3	7.8	20.5	3.6	7.3	15.2	14.3	6.6	11.1	4.1	8.1	0.7	3.9	11.7	8.1	8.3	15.8	8.7	9.8	9.1	3.8	4.6	1.2	5.4	6.2	13.6	5.6	6.7	18.0	4.2	13.9	9.5	5.4	12.6	8.2	9.5	4.5	11.8	3.8	9.9	6.1	11.3	10.3	5.3	3.0	6.4	5.2	9.8	3.2	6.7	19.0	6.8	13.3	6.4	13.9	7.7	12.2	2.5	10.4	19.8	31.6	14.2	12.8	10.1	14.2	8.3	11.7	18.0	12.2	51.8	16.8	2.2	9.3	2.2	28.1	11.2	12.7	46.3	5.4	5.2	8.1	3.0	11.0	19.9	2.8	1.9	1.5	0.8	2.5	1.5	4.2	1.2	2.8	2.9	1.6	0.9	2.5	3.7	1.1	4.8	1.4	0.7	4.4	2.4	11.0	12.0	5.5	16.4	12.1	10.2	9.4	10.1	11.7	7.3	11.1	8.3	5.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
PSD3	"DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942"	ENSG00000156011	"Pleckstrin and Sec7 domain containing 3"	Q9NYI0	8	18527303-19084730	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.3;Early spermatids: 686.7;Excitatory neurons: 284.7;Oligodendrocyte precursor cells: 488.1;Oligodendrocytes: 584.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.8;hTERT-RPE1: 48.0;LHCN-M2: 47.3;U-87 MG: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002455	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA002455: AB_2666597"	"unprognostic (3.87e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (7.55e-4)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.45e-1)"	2.4	17.8	24.8	3.1	46.2	1.2	5.9	62.4	46.1	11.9	0.0	6.7	4.8	8.8	3.8	5.3	2.5	7.4	27.5	51.9	4.0	1.9	18.9	4.6	2.5	3.3	10.0	18.0	9.9	18.4	7.3	6.6	1.8	3.9	7.3	19.9	4.1	5.8	1.3	4.4	5.0	5.8	0.0	10.4	9.8	16.4	7.8	2.2	6.1	2.3	3.4	5.8	4.3	17.2	11.0	5.7	25.0	0.1	8.8	53.8	1.3	5.7	8.9	5.1	10.5	3.3	4.3	6.5	3.6	23.8	22.3	0.9	7.3	10.1	9.7	0.0	6.6	0.6	4.6	0.5	15.9	0.2	0.4	14.2	6.2	28.2	4.9	48.0	6.8	1.6	0.8	4.9	47.3	3.7	0.0	1.2	4.9	9.6	14.7	5.2	21.4	3.0	12.7	14.0	10.7	11.8	2.5	1.1	3.8	5.4	0.3	2.6	28.0	15.7	10.8	37.5	5.1	0.4	0.7	14.8	49.5	2.7	5.4	0.7	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.5	0.1	0.1	0.3	0.3	0.2	0.1	0.4	0.1	24.8	46.2	62.4	46.1	51.9	4.0	3.3	10.0	1.8	0.0	7.8	17.2	8.1	3.2	2.7	558.3	3.3	21.9	13.7	26.4	13.6	191.9	14.4	10.7	119.2	7.2	23.9	9.2	118.9	3.2	0.1	48.5	1.9	13.5	686.7	12.5	69.9	8.2	6.1	0.0	284.7	8.7	1.7	44.3	43.8	6.6	0.0	87.2	4.2	42.9	13.1	18.5	121.6	20.0	44.7	16.0	25.9	217.9	33.2	9.0	1.8	148.9	59.7	78.0	0.0	488.1	584.6	27.0	13.5	53.8	0.1	11.2	20.3	0.3	41.0	52.0	13.1	29.3	17.7	16.5	17.7	32.4	9.9	1.1	1.1	114.9	17.2	23.7
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.1	22.6	44.3	26.5	80.7	39.6	28.2	62.4	56.0	28.1	48.9	49.5	50.2	25.3	26.9	35.2	22.9	31.7	18.0	47.4	51.6	35.5	31.9	32.1	22.4	73.0	63.8	22.0	22.9	35.1	11.6	43.1	71.5	24.3	46.3	23.4	22.9	23.4	18.4	38.2	49.0	27.1	55.7	22.6	31.0	32.5	60.8	26.2	36.9	23.3	30.7	35.0	19.2	119.1	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	44.3	80.7	62.4	56.0	47.4	51.6	73.0	63.8	71.5	55.7	60.8	119.1	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15510995	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 279.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm		NA	NA		24000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	32.9	40.9	67.8	46.9	72.1	62.0	27.4	83.9	89.1	45.8	52.6	40.8	23.1	57.5	36.0	26.2	42.9	30.8	34.4	71.5	79.2	32.6	22.3	32.8	80.7	65.2	66.4	86.0	17.1	30.3	52.2	39.5	64.4	36.3	30.9	154.4	19.1	41.0	38.6	26.0	34.4	43.2	65.1	54.7	28.5	81.6	68.1	129.7	37.1	29.5	69.3	31.2	32.3	72.2	117.5	76.5	254.7	187.4	54.0	65.2	56.7	138.3	98.1	121.7	143.6	32.1	59.5	248.1	31.4	73.5	68.2	32.0	160.1	75.0	174.9	164.8	96.6	860.4	194.9	60.8	65.1	101.7	91.7	54.8	21.0	102.1	74.4	121.0	108.0	115.2	144.4	134.1	80.2	42.8	211.5	250.9	395.2	2.7	117.2	194.7	138.8	50.7	68.3	40.5	161.1	176.7	123.7	54.0	67.1	157.5	54.5	134.9	76.7	88.0	88.6	66.7	133.2	57.1	85.3	221.8	70.2	100.8	51.6	13.7	2.6	5.4	6.1	2.0	7.7	11.0	12.5	8.8	3.0	17.5	18.7	11.6	8.4	9.5	5.7	3.1	12.9	2.4	67.8	72.1	83.9	89.1	71.5	79.2	65.2	66.4	64.4	65.1	68.1	72.2	93.7	54.5	31.9	27.4	98.1	31.9	49.1	8.1	48.9	231.0	22.0	35.6	57.8	31.5	23.1	47.8	66.7	122.7	82.1	24.7	62.6	9.5	95.5	92.9	62.5	84.8	38.1	160.1	73.4	8.5	76.2	74.8	23.0	35.1	15.2	104.2	65.3	18.0	32.1	138.0	76.9	34.1	2.0	36.5	45.9	58.5	125.9	45.8	40.9	20.6	47.9	162.2	83.4	49.8	67.6	3.6	20.6	134.3	60.4	19.6	14.1	54.5	42.1	279.1	124.9	85.2	89.8	217.9	243.8	34.5	21.2	41.3	111.6	68.6	45.8	20.3
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86047109-86088621	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 2.4"	"Cell type enhanced"	"Detected in single"		"Rod photoreceptor cells: 2.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 9.4"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome 20S subunit alpha 4"	P25789	15	78540405-78552417	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		No	No		13000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332"	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	92.9	105.0	62.5	106.3	64.4	107.6	87.5	66.2	98.8	78.9	65.6	105.1	108.9	89.6	74.5	118.2	71.6	66.0	108.4	64.7	69.1	98.1	152.1	87.9	136.9	67.6	65.5	64.6	67.3	73.4	54.4	85.8	67.5	97.2	109.6	50.3	70.3	64.2	180.6	78.3	101.3	99.3	69.3	115.3	88.5	109.9	65.6	156.5	70.6	121.6	128.7	118.8	81.2	69.9	274.2	386.9	327.7	290.8	202.1	189.5	256.3	250.2	199.9	301.4	320.6	404.9	386.9	590.8	359.7	232.5	337.4	363.9	669.1	271.8	289.1	244.2	465.7	497.6	271.6	330.1	326.9	512.6	294.5	154.6	166.8	255.0	250.9	185.4	330.7	319.1	544.2	225.0	249.6	392.3	347.5	477.4	309.7	315.3	224.5	297.7	432.9	198.9	309.5	469.4	287.6	209.9	401.3	289.5	327.5	402.2	267.8	414.7	265.8	223.7	298.6	249.3	434.2	204.0	517.9	556.2	209.9	756.7	252.6	126.0	251.9	172.9	136.2	403.9	140.3	156.0	142.0	144.7	327.4	119.9	111.7	137.0	112.8	209.4	394.8	185.4	216.8	405.6	62.5	64.4	66.2	98.8	64.7	69.1	67.6	65.5	67.5	69.3	65.6	69.9	119.0	128.2	118.5	17.3	124.1	231.6	269.6	765.7	84.2	57.8	88.5	95.8	163.7	105.8	327.0	121.4	10.4	478.9	128.4	145.3	311.0	296.2	689.4	158.0	183.6	162.5	146.2	153.2	18.0	292.7	450.6	159.9	78.0	126.0	174.2	152.9	114.9	178.9	320.4	72.3	19.6	216.2	506.6	143.2	201.7	399.0	151.0	176.9	133.4	23.4	308.6	63.5	149.3	11.1	21.5	256.0	165.7	147.4	108.0	249.3	195.8	367.2	280.0	39.8	151.2	95.4	241.1	417.1	181.0	106.4	212.8	447.1	128.6	166.7	234.7	258.4
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome 20S subunit beta 6"	P28072	17	4796144-4798502	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: AB_2685078"	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	92.7	107.8	130.1	82.2	133.7	126.9	107.0	138.1	141.2	92.6	137.4	116.3	76.9	101.9	150.9	140.6	99.2	68.3	201.6	132.8	138.1	134.8	184.6	86.2	90.1	135.7	134.1	63.7	99.3	173.3	82.5	119.8	138.7	84.8	118.3	62.6	100.0	114.2	358.6	114.9	77.0	135.3	136.0	90.4	103.8	76.6	133.5	147.4	88.7	339.5	140.5	110.6	89.2	140.3	279.8	478.2	251.6	216.4	209.9	188.1	289.7	144.1	300.1	431.3	336.0	358.7	220.5	215.0	277.9	348.1	246.5	273.8	388.0	404.4	418.0	281.9	409.7	128.0	315.3	422.7	242.0	133.5	194.4	178.3	305.1	377.4	355.7	241.5	426.5	335.8	199.4	316.6	336.1	331.8	237.4	221.8	214.1	356.2	328.2	261.9	178.7	284.6	326.6	185.3	146.9	179.9	206.6	158.9	148.6	261.4	194.5	147.2	205.1	210.8	158.9	286.4	355.2	130.8	191.8	132.9	301.3	242.1	259.3	410.6	603.3	343.2	347.5	589.9	355.9	668.6	373.1	384.0	624.9	640.8	319.8	329.3	210.5	424.4	549.4	585.5	556.2	817.2	130.1	133.7	138.1	141.2	132.8	138.1	135.7	134.1	138.7	136.0	133.5	140.3	156.3	134.6	113.3	8.5	118.3	229.2	184.1	410.8	112.1	65.5	124.6	153.4	454.8	141.5	253.9	134.3	16.7	587.3	142.8	178.0	358.1	321.6	245.2	110.9	108.1	164.7	148.4	183.7	7.6	349.9	418.2	171.5	105.5	116.0	105.2	156.1	99.6	235.4	346.3	32.0	7.2	173.0	311.3	111.7	272.1	52.9	109.6	159.8	236.5	4.7	298.9	183.4	109.2	9.0	16.9	351.3	163.4	123.0	244.7	191.7	188.6	564.6	193.3	81.3	111.7	119.8	486.8	175.1	84.7	178.6	277.2	664.5	125.9	172.6	177.7	217.3
PSMB7	Z	ENSG00000136930	"Proteasome 20S subunit beta 7"	Q99436	9	124353465-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	115.7	180.4	129.4	103.9	136.9	189.7	122.6	132.7	144.8	99.8	119.6	103.5	98.7	102.9	147.0	139.1	94.6	87.2	212.0	135.8	137.0	150.9	222.9	91.4	112.7	138.2	139.5	101.6	142.2	143.4	74.7	120.2	138.2	94.8	107.8	81.0	114.3	75.0	277.8	166.2	98.3	92.7	131.5	91.7	115.3	155.2	137.8	147.6	91.3	205.3	124.6	110.5	104.2	135.0	344.4	411.7	275.8	336.4	190.4	224.8	396.1	325.3	447.6	461.7	315.1	546.3	327.1	389.2	256.8	307.4	457.2	480.2	346.7	345.4	420.0	375.0	299.3	245.3	673.3	460.0	428.5	491.6	234.3	270.8	299.6	483.7	478.5	355.1	394.3	345.5	507.9	269.8	362.4	600.0	355.9	329.5	409.7	519.6	581.5	309.8	411.4	457.2	331.5	221.9	323.7	263.6	310.4	394.0	498.4	268.7	454.8	212.7	315.9	297.5	240.7	384.9	499.0	289.9	873.7	394.9	498.1	297.8	429.1	162.7	201.5	154.5	128.3	211.4	138.9	177.8	145.7	142.5	221.1	159.7	138.2	135.9	87.0	185.3	206.8	187.5	226.0	264.8	129.4	136.9	132.7	144.8	135.8	137.0	138.2	139.5	138.2	131.5	137.8	135.0	73.1	76.9	77.6	26.1	88.0	194.1	184.4	309.1	39.9	41.5	113.9	97.5	147.3	134.4	150.0	69.9	22.9	441.4	83.0	146.9	330.6	351.3	404.6	105.7	93.8	123.8	141.2	93.8	38.4	392.7	356.7	112.3	52.5	90.3	104.6	130.8	107.1	277.3	237.2	33.7	31.9	162.5	160.7	122.1	148.4	472.8	139.1	92.5	199.3	33.7	168.5	119.7	113.3	30.7	44.8	393.6	143.7	125.3	69.9	158.0	173.6	484.7	135.7	61.6	85.5	133.8	221.2	330.6	190.4	60.4	218.9	488.7	81.4	135.8	181.2	201.3
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome 20S subunit beta 8"	P28062	6	32840717-32844679	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No		2700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	62.7	76.9	3.3	11.2	3.4	9.8	56.5	3.3	7.3	42.7	3.4	79.9	12.9	41.3	3.2	59.5	41.6	5.8	34.2	3.4	3.5	63.7	99.2	78.2	18.2	4.3	3.4	32.1	29.5	8.2	26.6	4.4	3.7	45.2	20.4	0.7	44.2	6.4	14.4	58.0	93.9	8.9	4.0	150.4	57.0	5.9	3.6	13.5	40.8	0.1	17.2	41.3	48.1	4.1	15.1	3.9	0.3	0.0	5.1	13.1	11.2	4.9	22.9	29.1	39.3	0.0	20.9	45.7	9.4	10.5	25.5	8.1	6.8	16.6	8.0	19.2	0.0	27.6	5.9	0.3	30.3	5.2	7.5	14.9	10.3	12.9	6.8	1.9	18.1	11.8	1.1	8.1	6.1	0.1	12.9	11.7	0.1	0.0	7.3	29.3	1.3	24.1	21.3	4.9	0.8	0.2	8.6	10.4	8.5	0.1	7.0	41.0	4.3	8.8	7.6	7.8	0.6	21.0	15.9	11.2	2.2	27.7	9.0	56.8	70.3	94.6	58.1	88.0	51.2	73.4	49.1	61.1	67.5	71.1	34.8	49.6	90.2	63.0	78.2	58.5	81.2	156.0	3.3	3.4	3.3	7.3	3.4	3.5	4.3	3.4	3.7	4.0	3.6	4.1	237.0	38.5	55.8	2.9	162.0	84.4	64.1	183.7	54.7	1.8	85.3	92.5	8.7	71.4	103.2	62.5	0.0	2.7	211.2	219.9	86.1	219.4	0.6	63.2	74.9	158.5	65.7	45.0	0.1	247.6	18.3	60.7	93.8	81.5	50.7	51.4	114.5	75.0	165.9	6.7	0.5	243.8	120.1	143.5	94.9	1.9	39.1	128.2	56.9	10.3	214.3	39.9	279.1	3.0	0.7	179.6	287.9	30.5	153.2	100.1	319.8	78.9	103.2	3.0	39.5	33.2	56.8	0.4	1.2	60.5	79.6	2.7	181.6	110.9	222.6	121.6
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	85.3	86.1	106.8	64.7	117.3	96.1	77.9	105.3	131.0	73.7	105.8	110.2	52.2	89.9	62.5	88.7	69.0	44.0	172.1	107.8	106.3	73.8	117.7	76.2	65.3	108.6	114.7	58.2	81.4	74.1	55.4	78.8	111.0	74.2	59.1	30.9	73.0	69.8	292.0	103.4	64.0	77.5	104.6	67.8	87.7	74.7	115.2	90.6	69.4	162.9	76.5	80.8	71.7	107.0	223.7	248.2	233.5	173.3	109.6	117.3	226.5	181.5	267.4	445.7	313.8	223.3	126.8	179.5	110.1	230.1	195.7	218.3	206.7	237.7	199.0	269.4	268.1	173.1	301.1	218.5	141.4	203.7	177.0	131.4	126.1	181.6	202.5	98.4	253.8	182.7	249.2	164.7	276.0	497.0	259.5	258.4	229.5	280.7	296.1	269.3	458.8	157.3	209.5	165.2	170.0	147.1	148.7	206.9	116.2	98.2	255.7	209.8	181.3	253.7	321.1	363.8	474.7	176.5	220.0	209.2	262.4	201.7	325.1	111.5	154.3	121.8	160.8	194.6	146.7	146.8	132.9	147.8	160.6	122.4	116.5	118.6	33.9	173.3	211.6	160.0	191.0	254.7	106.8	117.3	105.3	131.0	107.8	106.3	108.6	114.7	111.0	104.6	115.2	107.0	81.5	57.7	42.0	3.9	59.5	86.3	112.8	198.5	50.7	41.2	61.4	64.1	217.6	81.5	103.7	68.0	16.7	265.9	60.0	143.9	152.6	199.2	152.5	72.0	75.7	96.0	64.5	136.6	6.4	202.6	257.9	100.4	54.0	70.1	75.3	79.2	77.1	144.2	158.2	37.0	5.3	111.5	75.3	62.4	80.0	217.6	88.6	62.5	99.6	1.9	132.0	120.2	74.2	3.0	5.2	214.2	110.8	100.1	96.3	102.8	127.7	191.3	76.9	47.4	118.3	75.1	193.3	147.0	63.6	51.3	77.3	352.9	61.8	74.1	117.6	101.6
PSMC6	p42	ENSG00000100519	"Proteasome 26S subunit, ATPase 6"	P62333	14	52707178-52728590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042823	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042823: AB_2678188"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.14e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.67e-1)"	43.4	48.4	38.8	47.3	39.2	44.1	58.1	41.2	54.0	44.0	37.4	52.2	50.0	47.6	49.2	65.1	49.2	36.5	78.7	39.8	42.1	65.9	87.1	39.6	55.4	41.1	41.0	51.0	43.7	59.9	5.5	54.9	42.0	45.3	54.3	60.1	37.9	45.6	118.1	44.6	46.6	56.8	41.5	38.8	46.5	31.4	41.0	56.3	54.3	106.7	67.0	57.2	7.9	44.1	182.0	115.0	135.4	99.0	92.4	95.8	146.0	139.3	133.1	220.8	165.1	142.6	143.5	156.8	169.8	121.6	111.5	134.0	173.9	121.9	230.6	151.2	74.5	115.0	91.3	153.5	111.0	164.9	106.8	71.8	118.4	112.1	111.6	120.1	141.2	77.4	174.2	64.7	161.8	163.2	129.5	111.8	108.7	170.1	153.8	108.4	237.2	70.7	144.6	178.5	96.0	71.2	123.8	76.5	122.3	120.8	156.4	117.0	108.9	121.2	171.0	95.8	145.2	45.6	127.0	175.8	79.1	110.5	112.9	77.5	62.4	67.0	51.2	71.9	59.5	63.4	62.7	56.4	73.9	56.4	59.6	59.0	52.7	55.6	73.0	38.5	85.4	75.4	38.8	39.2	41.2	54.0	39.8	42.1	41.1	41.0	42.0	41.5	41.0	44.1	81.2	70.5	58.9	23.5	74.2	86.2	141.9	187.1	50.1	65.5	55.3	51.3	76.6	62.9	140.6	57.0	68.8	162.2	69.4	73.5	135.0	131.0	30.4	92.8	75.3	78.2	70.4	85.2	37.4	106.9	139.9	72.1	38.7	96.3	67.7	68.7	50.0	84.4	92.1	62.2	39.0	58.9	109.9	71.3	67.9	19.9	67.1	61.4	80.0	20.6	90.9	64.6	52.5	38.2	46.7	116.2	46.2	65.5	64.0	85.2	72.5	140.2	116.4	107.6	72.3	66.5	130.6	63.4	82.8	48.9	72.0	237.5	65.0	79.7	73.4	116.6
PSMD3	"P58, Rpn3, S3, TSTA2"	ENSG00000108344	"Proteasome 26S subunit, non-ATPase 3"	O43242	17	39980807-39997959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 252.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 247.0;Syncytiotrophoblasts: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 842.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017038, HPA048972"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB017038: , HPA048972: AB_2680579"	"unprognostic (3.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.36e-3)"	"unprognostic (5.75e-3)"	"unprognostic (7.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (4.47e-7)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.45e-2)"	56.5	64.2	44.5	47.6	45.4	48.1	53.6	44.1	50.0	54.6	40.7	60.3	43.3	61.8	35.0	69.6	51.6	25.3	76.5	47.4	47.0	47.8	93.6	51.0	45.7	45.9	43.0	52.7	57.1	55.4	48.3	47.4	48.0	47.7	46.1	31.3	54.2	37.2	252.5	86.1	48.9	45.2	42.9	49.3	52.7	52.9	44.2	56.9	45.9	103.3	51.1	53.6	53.2	46.6	203.7	247.8	133.2	192.9	106.3	68.2	158.3	146.2	150.7	257.3	198.3	206.4	170.0	242.3	357.7	157.6	172.5	310.2	238.6	190.7	172.9	245.5	266.2	140.4	120.5	207.2	96.5	191.3	151.0	91.5	160.0	272.7	118.8	86.4	147.6	166.0	291.5	146.9	121.2	148.0	298.2	131.2	185.5	130.9	145.2	216.2	184.7	227.7	130.5	135.3	174.9	132.5	139.7	842.6	124.3	160.9	190.2	162.7	132.9	110.7	195.8	165.6	266.2	158.2	217.2	269.3	169.4	142.2	182.6	8.1	22.4	19.0	17.6	21.3	17.2	16.6	17.0	20.4	29.8	17.7	15.3	19.1	6.3	16.6	18.3	20.4	16.3	17.9	44.5	45.4	44.1	50.0	47.4	47.0	45.9	43.0	48.0	42.9	44.2	46.6	32.4	44.8	40.1	16.6	43.3	46.7	57.2	71.5	33.0	70.8	31.7	25.7	21.3	15.7	48.6	16.5	20.9	165.3	38.0	98.3	46.9	101.4	247.0	30.7	35.9	46.5	26.4	44.6	18.0	106.3	131.6	50.6	34.7	28.5	25.3	70.2	32.2	50.9	96.3	60.6	17.6	59.2	69.2	27.4	37.0	51.8	62.7	39.1	65.8	4.7	57.4	89.9	35.0	11.1	16.5	101.4	68.3	54.2	57.2	76.3	75.3	54.8	32.0	56.9	26.3	51.1	50.7	87.3	54.0	38.7	44.6	271.7	32.4	78.8	77.2	53.7
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842951	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol		No	No		250000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	15.0	16.5	8.8	13.4	8.4	20.4	23.4	12.0	9.8	15.9	8.5	14.5	12.6	16.4	13.9	16.6	14.1	12.5	9.4	8.4	10.2	13.5	20.5	14.6	15.9	9.3	9.4	15.2	14.3	10.7	9.8	12.7	9.5	18.1	14.3	11.7	17.9	14.3	9.1	19.7	12.5	18.6	8.9	12.0	14.3	13.8	9.7	14.5	14.3	11.2	19.0	17.1	12.1	12.8	35.0	44.3	20.7	38.6	44.9	44.1	24.4	49.4	38.1	45.3	41.5	38.7	21.7	35.4	22.1	50.2	36.1	50.5	0.0	48.9	52.5	33.1	5.3	29.7	59.2	21.6	33.9	10.2	10.6	37.3	30.6	44.2	47.4	22.7	26.9	37.7	110.2	22.6	42.8	42.9	31.5	21.0	30.6	82.6	31.4	28.0	45.0	28.0	42.1	30.0	28.8	18.3	61.8	50.2	24.7	15.2	60.5	24.5	41.5	0.1	25.0	19.3	45.3	13.0	14.8	38.0	28.6	33.4	41.1	19.3	18.1	15.6	19.8	20.9	21.6	22.2	22.7	23.9	17.7	17.8	21.9	16.9	9.7	18.7	23.7	12.7	32.7	18.1	8.8	8.4	12.0	9.8	8.4	10.2	9.3	9.4	9.5	8.9	9.7	12.8	14.3	9.6	17.0	20.2	16.7	12.4	11.8	11.7	21.1	11.6	18.9	13.5	8.1	11.5	17.5	9.2	12.5	12.1	15.3	13.6	11.7	12.9	7.7	8.1	20.6	13.7	7.8	17.2	28.4	13.4	11.7	18.4	14.8	11.9	14.5	11.8	17.2	24.9	11.8	5.0	24.5	14.1	8.2	16.1	13.9	4.7	13.1	12.7	14.2	15.0	12.3	9.9	10.3	34.2	29.0	17.1	10.1	16.1	16.0	14.1	10.5	16.8	8.1	10.3	6.6	11.7	16.3	22.4	21.3	27.0	13.5	10.9	17.3	17.7	11.0	9.7
PSMG1	"c21-LRP, DSCR2, LRPC21, PAC1"	ENSG00000183527	"Proteasome assembly chaperone 1"	O95456	21	39174769-39183488	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 673.8;Spermatocytes: 544.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057193, HPA070225"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA057193: AB_2683363, HPA070225: AB_2686236"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.38e-2)"	"unprognostic (5.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.84e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.17e-3)"	7.5	9.8	4.0	9.1	4.0	17.3	6.8	2.7	5.5	7.3	2.5	10.5	8.9	7.8	4.8	11.8	6.4	5.4	8.3	4.6	3.8	9.7	15.9	5.7	8.9	2.2	2.4	7.2	10.8	5.1	8.0	7.7	3.2	5.5	9.9	4.9	7.3	3.2	13.8	7.1	8.2	5.1	2.1	6.3	7.1	40.3	3.7	6.3	10.8	5.6	6.2	7.8	7.4	4.0	104.0	34.7	23.5	32.9	12.3	15.1	65.0	55.3	25.9	44.8	28.2	66.6	26.9	113.7	28.9	17.1	38.1	28.5	40.3	30.3	30.2	48.9	61.6	209.6	52.4	83.6	21.9	101.0	40.4	18.9	24.6	46.2	46.5	9.8	24.9	47.0	160.4	61.9	27.2	58.2	63.0	54.7	82.2	38.9	53.5	99.6	29.8	115.8	19.1	30.4	77.6	22.7	70.4	39.1	57.4	4.0	36.6	51.4	26.7	50.1	16.8	66.7	79.9	46.4	79.3	96.8	42.0	170.4	38.6	10.6	6.8	3.9	10.5	9.0	12.3	12.0	14.7	12.4	12.2	10.6	11.5	10.3	0.6	7.5	9.1	11.3	13.7	7.9	4.0	4.0	2.7	5.5	4.6	3.8	2.2	2.4	3.2	2.1	3.7	4.0	23.7	6.4	17.6	5.2	17.8	136.0	44.1	68.6	43.9	14.2	31.3	39.0	24.8	22.8	39.9	20.2	4.2	108.9	12.6	14.7	66.5	50.8	673.8	20.8	36.5	26.3	29.9	63.3	7.5	49.7	118.6	31.8	18.8	21.6	36.1	26.2	18.9	32.7	59.5	8.4	8.0	45.7	69.2	17.7	35.5	88.4	31.7	25.0	46.2	3.7	24.4	18.0	12.3	3.5	5.9	32.4	20.0	33.1	31.7	41.5	30.6	89.4	20.8	19.7	26.3	29.5	31.3	544.1	98.7	51.7	97.7	54.5	20.1	54.7	56.9	27.9
PSMG4	"C6orf86, PAC4"	ENSG00000180822	"Proteasome assembly chaperone 4"	Q5JS54	6	3231403-3303373	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067652, HPA074376, HPA075846"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA067652: AB_2685880, HPA074376: , HPA075846: "	"unprognostic (3.13e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.40e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.48e-2)"	20.3	18.3	12.8	8.2	15.7	13.8	20.0	19.8	13.7	16.9	5.0	24.1	14.1	18.9	18.6	19.9	18.4	6.9	15.1	11.5	14.6	20.1	26.9	13.7	10.2	17.6	16.0	16.6	33.4	12.0	22.2	7.0	18.1	19.3	6.9	9.9	20.2	13.4	37.1	20.8	16.8	9.5	13.5	14.4	21.4	16.2	15.9	9.3	21.1	11.1	7.7	19.8	16.8	23.8	61.8	29.0	17.5	42.8	15.3	23.1	29.5	27.2	20.0	25.9	41.4	25.1	20.6	21.0	73.1	16.4	20.2	28.9	15.0	18.9	16.9	34.7	65.2	16.9	33.4	66.6	19.2	48.7	16.9	19.8	20.1	18.8	27.8	14.8	32.4	39.9	65.0	15.1	14.0	58.2	27.6	88.9	21.4	31.3	57.7	36.5	9.5	116.2	21.1	24.0	74.3	21.3	12.9	16.7	61.4	16.5	22.0	21.0	31.7	21.4	20.4	24.6	26.6	48.7	76.4	39.4	15.2	34.1	29.3	16.2	35.5	24.4	25.3	36.9	29.4	50.2	42.1	30.8	28.4	52.1	40.9	35.7	8.9	32.3	36.3	33.9	39.4	23.9	12.8	15.7	19.8	13.7	11.5	14.6	17.6	16.0	18.1	13.5	15.9	23.8	45.2	22.4	21.2	18.6	25.3	27.9	29.1	44.2	38.7	32.0	53.1	88.4	21.9	37.1	26.9	44.1	8.4	39.3	15.2	23.6	84.1	43.9	31.4	23.6	25.9	35.2	22.8	18.5	9.6	87.5	37.8	30.4	15.8	17.1	22.2	38.8	28.2	64.5	35.1	25.2	17.8	31.1	28.5	19.2	21.1	13.3	37.0	18.4	30.2	5.6	35.7	22.0	32.0	21.6	15.7	57.8	25.8	23.0	18.9	47.0	47.3	67.2	22.6	29.4	46.0	45.5	54.0	29.6	78.2	39.6	38.2	12.0	23.7	30.0	35.4	27.1
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 173.4;Inhibitory neurons: 164.7;Spermatocytes: 171.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (7.72e-2)"	10.9	13.0	11.5	13.2	11.5	53.7	16.2	12.8	13.9	12.5	9.9	14.9	12.4	14.8	21.7	14.0	16.2	12.1	11.1	11.8	10.6	12.2	8.9	9.9	20.8	12.1	9.0	13.7	9.5	9.5	10.3	13.8	10.6	11.0	15.5	17.4	10.0	8.3	20.9	14.4	12.4	12.6	8.7	11.1	12.0	25.0	10.5	23.1	12.2	12.7	21.9	20.4	10.0	15.8	50.5	20.4	46.6	23.3	18.9	19.8	60.3	26.1	34.0	48.3	43.6	68.4	27.8	67.8	27.7	27.9	25.4	24.6	54.7	32.2	50.0	28.9	27.3	76.4	14.1	83.1	37.4	55.3	46.7	31.6	6.5	29.8	32.9	19.2	41.7	65.9	42.8	26.1	43.2	54.1	65.5	52.8	65.5	27.3	28.0	43.7	46.8	34.6	50.8	74.6	42.7	22.0	35.8	59.1	23.1	44.9	34.5	56.6	25.1	28.9	27.7	28.0	25.4	22.5	14.5	115.1	13.2	32.7	35.2	14.8	21.3	14.5	11.8	22.7	12.0	23.3	15.1	11.0	19.1	22.5	15.4	11.2	16.9	11.9	18.1	20.9	21.8	15.7	11.5	11.5	12.8	13.9	11.8	10.6	12.1	9.0	10.6	8.7	10.5	15.8	21.0	19.2	29.5	79.3	36.4	33.3	24.9	16.4	23.3	43.2	24.6	21.0	28.6	21.5	18.9	16.5	58.4	70.0	41.0	16.4	21.5	31.3	17.4	40.0	33.9	24.0	25.2	23.1	173.4	34.1	104.7	25.1	25.5	39.4	9.5	28.0	23.9	11.1	27.2	30.3	164.7	20.0	12.2	25.7	25.3	21.4	31.4	27.7	19.6	92.8	45.2	25.5	27.8	115.6	156.4	26.8	22.2	26.7	31.8	16.5	16.1	23.8	25.9	69.1	32.9	27.2	27.4	171.5	75.4	24.0	34.1	80.4	38.9	48.1	27.2	26.2
PSTK	"C10orf89, MGC35392"	ENSG00000179988	"Phosphoseryl-tRNA kinase"	Q8IV42	10	122954381-122997513	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.3;Spermatocytes: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037780, HPA037781"	Approved		Approved	"Nucleoli,Nuclear bodies,Actin filaments"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Actin filaments"	"Nucleoli, Nuclear bodies"	"HPA037780: AB_2675662, HPA037781: AB_10670530"	"unprognostic (8.95e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-4)"	"unprognostic (5.21e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (5.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.55e-4)"	0.9	2.2	1.3	0.6	1.5	6.1	2.9	1.5	2.2	1.9	0.3	1.6	1.9	1.9	3.5	1.5	1.9	0.7	1.7	1.5	1.6	2.0	4.1	1.0	0.9	1.6	1.5	1.3	2.1	1.1	2.6	1.3	2.5	2.0	1.5	0.5	1.9	1.1	3.5	1.6	1.0	1.9	1.3	1.1	1.3	3.2	1.4	1.8	2.4	0.9	1.2	1.3	1.3	2.8	4.1	3.4	1.7	0.8	1.6	3.2	2.1	2.0	3.5	3.0	3.7	4.6	3.4	4.4	3.9	2.5	2.0	2.3	0.7	3.1	3.4	2.4	8.7	2.7	1.2	4.0	4.3	6.7	3.6	3.3	5.2	2.9	5.2	2.7	2.3	3.9	4.3	6.0	4.3	6.6	2.0	3.9	3.3	1.6	4.3	4.5	3.0	4.4	4.3	2.6	1.6	2.1	3.9	3.8	5.3	1.4	1.8	0.4	3.1	2.8	2.6	1.2	4.5	2.6	1.6	5.8	2.4	4.3	0.9	0.0	5.0	6.0	7.4	3.1	8.8	6.2	5.7	7.0	6.7	5.9	7.5	7.7	0.6	6.8	3.6	6.7	3.8	5.3	1.3	1.5	1.5	2.2	1.5	1.6	1.6	1.5	2.5	1.3	1.4	2.8	3.0	9.6	7.3	14.4	4.6	4.5	5.0	11.0	5.2	8.3	7.1	11.7	5.9	10.0	7.5	5.5	8.4	7.7	8.0	1.6	9.8	4.6	31.3	5.7	5.2	3.2	4.2	3.4	18.8	6.3	3.1	6.0	1.5	11.6	2.5	8.1	3.6	6.3	4.8	5.0	20.3	2.6	14.2	2.1	4.3	5.4	5.3	3.0	5.4	4.7	6.1	8.8	5.2	12.5	29.4	3.7	3.8	5.7	3.3	3.5	3.0	7.7	8.3	11.4	0.0	5.6	8.6	37.5	20.6	5.5	4.7	9.6	6.9	10.8	4.3	3.5
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 72.4;lymphoid tissue: 63.4;skeletal muscle: 33.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 44.6;Erythroid cells: 46.7;Macrophages: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 112.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 102.0;HMC-1: 108.3"	"Low region specificity"	"Detected in all"							"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.4	4.6	0.9	11.1	0.9	72.4	8.5	0.8	1.5	4.2	1.8	4.4	3.6	2.9	1.4	5.1	4.0	5.3	2.1	0.8	1.1	3.7	10.0	11.4	6.3	1.8	1.2	3.6	3.5	3.8	2.9	12.1	1.5	8.0	5.1	2.8	5.9	2.7	33.0	8.8	4.5	4.6	1.1	63.4	6.4	1.3	1.2	3.9	2.1	5.8	4.9	9.6	4.3	1.4	2.9	0.0	3.8	0.1	0.9	6.7	20.6	15.0	7.4	5.3	4.5	11.6	4.0	0.1	0.9	5.0	0.0	36.2	20.3	28.1	6.6	0.0	3.2	102.0	4.6	0.2	5.9	6.0	108.3	5.0	34.4	5.0	16.3	4.8	10.6	0.2	24.8	0.1	23.1	3.6	0.9	0.1	2.3	0.0	0.1	0.1	7.5	4.9	11.2	37.0	0.3	2.1	2.4	10.3	0.5	28.2	32.6	12.0	7.6	0.6	8.2	0.8	0.2	0.1	0.3	0.1	1.3	0.2	0.4	77.3	25.3	112.8	10.4	35.0	3.6	0.1	6.2	7.7	25.3	0.1	7.2	8.8	13.5	2.9	36.4	0.9	4.1	20.0	0.9	0.9	0.8	1.5	0.8	1.1	1.8	1.2	1.5	1.1	1.2	1.4	1.7	12.8	11.6	0.7	2.4	13.8	19.4	44.6	15.4	0.7	11.1	17.1	3.5	2.8	24.9	0.0	0.0	26.6	21.8	0.6	3.9	9.6	2.0	4.1	2.6	3.1	1.2	46.7	1.6	3.9	3.3	4.2	11.2	11.2	43.6	20.6	7.1	17.3	14.6	0.0	1.4	4.2	6.1	42.5	5.5	7.3	2.8	58.7	7.2	2.8	37.4	10.9	25.7	2.0	0.9	17.7	0.3	2.2	3.6	39.7	0.5	4.1	13.0	0.4	6.6	3.1	7.7	1.1	1.6	7.3	10.2	8.8	17.8	7.1	2.4	21.8
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753042	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 84.2;urinary bladder: 78.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 101.2;Cytotrophoblasts: 146.0;Extravillous trophoblasts: 293.1;Syncytiotrophoblasts: 276.2"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 69.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"basophil: 28.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 147.7;BEWO: 162.7;GAMG: 292.8;HaCaT: 216.3;SK-BR-3: 157.6;U-2197: 404.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	36.7	1.4	4.1	13.9	3.6	7.8	25.5	3.9	4.5	26.1	3.5	9.2	2.8	3.7	19.0	17.8	5.4	9.0	8.5	4.5	5.1	8.1	0.7	7.8	7.6	6.1	5.8	2.2	1.6	42.1	1.9	58.4	7.1	13.7	4.2	0.0	30.8	84.2	1.3	42.3	9.1	4.1	4.1	2.5	7.1	16.9	4.7	4.2	3.7	1.1	30.7	78.6	20.0	3.5	1.5	94.9	0.1	46.6	147.7	51.9	162.7	7.4	64.2	1.1	1.7	5.6	71.7	0.1	2.7	18.0	292.8	216.3	0.7	7.2	0.6	0.3	0.5	0.0	62.5	0.4	3.5	0.0	0.0	30.9	49.0	0.9	0.3	1.4	0.0	0.9	0.0	0.1	0.7	1.7	0.2	0.0	1.2	46.7	8.2	0.2	0.0	0.3	5.3	102.2	0.8	3.6	87.1	157.6	0.8	6.3	83.3	0.0	0.5	0.1	0.4	404.8	0.0	0.0	0.0	0.0	78.8	0.1	0.7	28.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	4.0	0.0	0.0	0.3	4.1	3.6	3.9	4.5	4.5	5.1	6.1	5.8	7.1	4.1	4.7	3.5	3.4	0.0	0.0	0.3	0.3	17.8	8.9	101.2	10.8	0.0	29.7	19.7	0.1	0.0	53.2	3.7	0.0	146.0	0.6	0.0	1.9	13.4	0.6	1.6	2.3	4.0	7.3	0.0	1.0	1.1	293.1	70.7	0.0	5.0	1.3	61.5	0.0	0.0	17.5	0.0	2.8	6.6	30.5	0.0	21.6	0.4	0.3	13.2	14.2	7.5	7.2	0.0	0.0	0.0	0.2	8.1	0.2	0.0	0.3	8.2	0.3	0.5	6.7	0.0	0.0	0.8	13.5	0.3	0.0	5.5	43.0	276.2	0.8	0.2	0.4	49.2
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA020631: AB_1855887, HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	18.1	49.8	31.6	15.6	33.9	6.5	16.0	29.1	45.8	18.1	32.4	30.6	27.5	21.6	4.0	35.3	17.6	11.4	95.0	35.6	33.0	36.4	37.7	14.8	17.6	31.5	31.5	16.1	37.6	35.2	41.4	9.7	32.1	24.6	9.2	10.0	26.1	16.8	117.9	20.9	23.8	7.5	27.3	21.1	29.6	14.5	31.5	11.9	23.5	78.7	9.7	22.3	22.0	31.7	46.1	114.0	15.5	54.4	13.5	12.8	47.9	30.7	20.6	48.6	24.9	86.9	75.6	43.5	45.7	15.9	36.9	108.8	22.5	47.1	6.5	28.3	62.3	21.0	92.7	79.5	41.0	42.1	39.5	18.6	32.3	39.5	26.9	14.2	31.6	47.8	50.2	26.4	16.7	130.0	56.9	75.6	42.7	58.7	113.9	39.6	26.5	111.6	32.8	33.1	69.1	45.6	47.3	86.3	34.2	6.7	78.7	23.5	34.0	46.3	50.2	62.8	63.1	48.9	25.5	38.3	39.1	33.2	44.5	1.4	3.3	0.7	3.1	3.7	3.8	3.8	2.2	3.5	4.3	2.7	2.4	3.0	0.6	2.7	1.8	5.8	3.1	1.9	31.6	33.9	29.1	45.8	35.6	33.0	31.5	31.5	32.1	27.3	31.5	31.7	18.8	16.0	6.4	10.4	32.0	22.9	38.1	32.7	25.0	37.8	34.2	36.3	700.2	51.5	25.9	23.9	20.9	82.1	30.8	86.1	146.8	74.6	2.1	12.7	20.9	29.4	45.1	13.2	15.5	51.8	62.1	32.7	46.4	17.3	14.7	31.9	13.9	37.8	57.6	37.0	15.8	62.2	46.8	25.3	43.6	4.8	30.7	30.8	56.9	3.7	105.7	21.9	38.1	12.1	7.2	57.6	60.4	21.8	45.4	68.0	93.4	99.3	9.3	44.8	19.7	17.8	37.2	3.6	45.6	48.3	24.6	66.6	25.6	84.1	105.5	52.9
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		660000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	141.7	128.0	198.0	137.2	210.0	150.2	171.2	217.0	454.6	168.2	185.5	169.9	151.7	172.9	159.0	161.3	217.6	114.9	122.8	195.5	215.6	180.5	218.6	133.9	157.2	214.9	213.0	250.0	121.9	133.7	111.7	164.9	218.5	141.6	172.8	118.0	124.0	147.6	208.6	123.5	155.4	138.8	213.0	125.0	117.1	135.0	204.3	167.2	162.3	158.5	185.0	158.7	145.8	278.0	616.6	528.8	416.5	249.8	300.2	270.3	634.3	392.8	298.5	494.5	366.9	452.5	629.6	676.0	588.5	338.3	331.7	385.4	790.0	514.2	621.8	509.8	529.8	529.7	309.5	524.4	219.4	637.9	367.2	197.0	367.3	375.1	450.3	468.5	518.1	425.7	866.0	628.2	490.4	385.3	636.5	602.1	714.7	538.3	609.3	549.2	392.3	914.4	436.8	473.2	538.4	313.8	401.7	570.1	355.8	546.5	658.3	526.9	314.0	294.7	341.8	358.3	552.8	262.8	777.5	540.4	321.1	516.7	543.8	141.1	166.1	107.1	130.9	261.6	172.3	172.3	170.6	156.7	160.2	127.0	167.3	147.7	64.7	132.2	346.2	135.3	191.6	316.1	198.0	210.0	217.0	454.6	195.5	215.6	214.9	213.0	218.5	213.0	204.3	278.0	265.8	179.5	137.1	39.5	251.0	386.6	826.7	248.5	272.6	128.3	208.5	197.1	166.0	178.7	161.4	189.4	77.2	457.2	245.6	246.5	373.7	310.4	42.5	493.7	221.5	242.1	261.3	452.0	43.4	214.8	676.3	268.7	143.2	291.3	234.2	224.5	188.8	187.0	349.9	112.7	41.3	295.9	201.4	209.5	363.6	107.9	238.9	261.7	282.8	47.8	283.3	244.1	178.2	38.7	71.4	220.8	207.1	213.3	299.8	657.6	218.9	343.8	345.5	128.0	144.7	185.1	337.7	558.4	348.4	350.4	377.6	566.0	359.3	219.0	358.9	556.3
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680922	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;seminal vesicle: 127.4;urinary bladder: 162.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 342.9;Fibroblasts: 270.7;granulocytes: 347.6;Langerhans cells: 305.6;Macrophages: 173.1;Urothelial cells: 151.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 11.7"	"Cell line enriched"	"Detected in many"	4	"BJ hTERT+: 405.5"	"Region enhanced"	"Detected in many"		"hippocampal formation: 15.1"	"Low region specificity"	"Detected in many"			"CAB000113, HPA001335"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum, Vesicles"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	17.0	7.9	1.4	13.9	2.5	116.7	3.0	1.1	4.1	62.2	2.7	14.9	2.6	8.9	0.7	6.9	5.1	31.6	11.7	1.9	1.4	10.2	8.0	34.3	8.9	2.0	1.6	2.6	2.2	5.6	3.1	8.4	1.5	25.0	9.9	0.3	1.2	127.4	0.4	1.6	3.6	12.2	1.9	2.8	14.8	0.2	1.8	5.2	3.2	6.5	0.6	162.5	2.2	2.6	0.0	21.8	0.1	0.0	2.5	2.1	0.0	93.4	405.5	0.6	3.6	15.0	17.2	0.0	0.0	0.1	2.5	12.2	0.0	7.6	1.3	0.0	0.0	0.8	2.2	0.0	13.2	0.0	0.2	0.8	2.7	11.3	28.7	1.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	5.5	1.5	0.0	1.0	0.0	0.9	2.7	0.0	0.1	1.5	19.3	0.6	13.5	0.6	0.2	0.0	0.0	27.7	0.4	2.3	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.0	1.4	2.5	1.1	4.1	1.9	1.4	2.0	1.6	1.5	1.9	1.8	2.6	5.2	342.9	77.7	0.0	7.4	118.8	59.1	72.8	12.5	0.0	2.6	12.8	2.5	0.0	79.7	0.0	0.0	0.2	4.2	0.3	0.0	0.8	0.2	50.0	9.9	31.1	1.2	3.6	3.8	0.2	0.3	270.7	2.0	98.9	347.6	3.8	13.6	0.2	12.1	0.0	1.0	1.0	8.2	21.0	305.6	0.0	0.0	173.1	35.6	3.7	3.4	0.1	0.0	0.0	0.1	4.9	0.1	0.0	2.0	122.6	0.2	0.3	13.1	0.3	0.0	1.8	12.8	0.1	0.4	3.3	28.4	0.5	10.8	3.7	1.2	151.6
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537376	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 109.4;skin 1: 53.9;vagina: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 132.1;Gastric mucus-secreting cells: 59.1;Intestinal goblet cells: 42.5;Paneth cells: 97.6;Proximal enterocytes: 80.2;Squamous epithelial cells: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 22.1;CAPAN-2: 41.4;HaCaT: 33.9;hTCEpi: 45.0;OE19: 57.0;RT4: 26.4;T-47d: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.5	0.1	0.6	3.6	1.7	0.8	3.8	2.9	1.7	19.8	0.0	26.5	28.9	0.4	0.1	109.4	0.4	3.5	0.2	0.6	0.9	0.8	5.2	2.6	0.6	1.6	1.0	0.3	3.6	0.0	0.2	0.3	1.7	3.1	15.7	0.8	19.1	0.6	0.6	53.9	22.2	0.8	0.6	0.8	26.2	0.3	1.1	0.3	0.2	0.0	6.4	9.8	43.2	5.4	22.1	2.6	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	41.4	0.1	7.2	0.0	0.1	33.9	0.0	0.1	0.0	5.4	0.4	0.0	10.2	0.1	0.1	0.0	6.7	0.0	45.0	0.0	0.2	0.2	0.0	0.1	0.2	2.5	0.2	12.5	0.0	0.2	0.2	57.0	15.5	0.1	1.2	0.5	0.0	26.4	0.3	2.2	2.6	8.1	0.0	0.1	25.2	1.6	0.2	0.3	0.4	0.8	0.3	0.5	0.1	0.1	0.4	0.5	1.1	0.4	0.7	0.1	0.1	0.5	0.5	0.3	0.1	0.0	1.3	0.3	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.3	0.6	1.7	2.9	1.7	0.6	0.9	1.6	1.0	1.7	0.6	1.1	5.4	0.3	12.8	25.6	0.3	1.4	5.9	2.6	7.7	5.2	2.2	7.0	4.3	0.4	12.8	14.9	0.0	2.1	0.2	0.2	132.1	0.0	1.4	0.2	0.4	0.5	3.2	5.4	0.0	0.1	1.6	0.2	1.4	59.1	1.3	9.5	0.2	0.4	1.7	0.6	0.0	0.1	42.5	2.0	2.2	2.0	0.0	0.3	2.6	0.0	0.0	1.0	1.6	1.0	0.0	0.8	17.6	97.6	0.0	0.1	1.5	80.2	0.2	8.9	3.7	0.0	2.3	1.1	0.2	0.3	48.0	15.5	0.1	2.0	0.2	32.1	15.9
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713551	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047183	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA047183: AB_2679972"	"unprognostic (1.49e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	1203.7	522.8	832.1	1028.5	1020.8	2322.6	1026.6	865.2	1035.4	1185.1	644.5	1045.1	703.0	1110.9	698.4	1186.1	1022.9	565.9	541.0	779.9	898.4	1203.7	652.1	933.2	1396.2	952.9	933.7	1078.5	1090.3	481.3	398.6	688.1	919.2	722.6	985.0	437.1	765.6	604.7	305.9	1425.4	935.1	699.4	875.4	896.2	873.2	237.1	929.1	2059.3	1002.8	246.4	1523.2	896.5	999.1	1137.2	2436.8	1416.4	1990.8	1788.7	592.5	783.4	2037.5	1614.2	1346.2	1379.8	1436.6	1380.8	2759.6	3811.5	1795.4	1271.0	948.1	1252.2	2830.6	1992.5	1738.6	3027.0	2228.9	4906.7	1096.2	2266.8	732.6	5621.1	2018.0	1143.7	733.1	1226.2	1002.6	1307.0	2286.8	3049.7	2910.9	1573.5	1222.0	3433.7	7998.5	7671.0	3004.9	2381.4	1180.4	5426.1	1408.4	2601.9	1719.2	2116.3	4041.8	2483.3	1851.0	1833.5	1507.1	1552.9	1383.9	4430.2	1704.1	1154.2	2052.5	1429.4	1769.7	1887.9	999.3	7614.4	790.8	3401.9	1897.3	2067.1	1713.8	1146.7	1346.2	1695.8	1945.2	2776.6	1928.5	1640.8	1828.0	2438.2	2109.4	1808.0	321.7	1782.3	1957.1	1944.4	2506.6	4661.6	832.1	1020.8	865.2	1035.4	779.9	898.4	952.9	933.7	919.2	875.4	929.1	1137.2	3907.5	971.2	1529.2	49.6	4518.0	7745.0	3851.3	5347.3	5459.5	703.1	3534.0	3673.7	259.7	1974.5	2483.8	2273.2	294.0	2599.4	4054.7	1741.3	3785.9	3474.2	103.3	2713.9	3364.3	4186.4	1695.3	3942.3	37.4	4190.1	5153.9	2404.0	2340.5	3092.6	2928.1	2349.3	1940.1	1347.6	3134.5	812.6	40.9	3178.6	3733.2	3492.4	8474.1	201.4	1306.3	3470.5	3689.1	78.7	3334.5	2195.9	2988.7	40.7	282.0	3669.3	2492.8	1404.5	3523.3	4524.2	1624.2	3136.2	1925.7	934.2	1926.2	2766.5	4571.8	1157.6	2467.8	5778.6	7944.4	2734.1	4276.7	1312.4	3381.3	4052.2
PTMS	ParaT	ENSG00000159335	Parathymosin	P20962	12	6765516-6770952	"Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 565.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 25.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 25.6"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 672.8"									HPA038186	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes		300000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA038186: AB_10673042"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.55e-2)"	138.4	78.4	115.9	37.0	105.9	14.3	121.4	103.2	122.3	188.2	48.6	293.9	33.0	243.9	29.0	128.0	145.3	28.9	98.7	117.0	74.3	186.6	565.2	173.5	22.7	45.9	43.5	239.9	50.3	82.4	96.3	49.4	48.0	194.3	28.9	64.6	94.4	86.8	56.3	116.8	101.1	98.8	31.6	61.4	109.5	32.6	86.0	16.3	109.5	16.2	20.1	176.6	137.5	72.5	49.2	250.8	324.8	320.3	149.8	126.2	127.5	210.9	189.2	157.6	130.1	153.8	190.2	19.5	151.8	321.7	143.2	104.6	178.7	159.3	61.9	672.8	219.1	27.5	160.6	58.1	174.1	7.7	56.6	123.7	68.8	121.4	245.6	237.7	175.3	8.6	175.5	50.6	139.8	144.1	9.2	40.7	347.6	92.2	180.8	4.2	99.8	39.6	124.7	12.5	107.4	363.6	254.7	86.9	186.1	230.0	75.9	23.4	296.7	239.6	344.2	36.6	195.2	42.4	19.3	25.4	196.5	18.1	183.6	25.6	0.4	3.6	1.3	0.1	0.6	0.1	0.1	1.1	0.3	0.0	0.0	0.1	1.3	0.1	0.0	4.4	0.5	0.4	115.9	105.9	103.2	122.3	117.0	74.3	45.9	43.5	48.0	31.6	86.0	72.5	370.5	0.0	14.1	9.4	22.8	289.5	328.0	44.6	257.8	325.5	239.2	275.5	10.4	88.6	16.7	154.5	200.1	153.6	88.4	99.8	234.8	61.9	6.6	73.1	494.8	342.7	513.3	248.6	28.7	34.0	404.0	292.4	66.3	117.5	52.8	216.3	325.2	710.0	491.3	116.1	15.2	229.4	22.4	100.4	309.4	23.1	489.6	136.8	227.7	12.2	76.7	512.6	4.1	13.0	3.1	38.3	141.3	692.1	38.8	399.9	244.2	547.6	11.4	357.7	598.2	232.0	411.7	7.4	32.8	259.4	249.2	163.2	81.3	122.5	198.9	206.7
PTOV1		ENSG00000104960	"PTOV1 extended AT-hook containing adaptor protein"	Q86YD1	19	49850735-49860744	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 326.5;Late spermatids: 631.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051812, HPA075125"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA051812: , HPA075125: AB_2732280"	"unprognostic (2.70e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (9.20e-4)"	"unprognostic (4.65e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.70e-2)"	46.1	107.3	123.8	24.1	122.9	29.8	46.8	122.4	161.5	76.3	129.3	65.8	23.7	65.8	15.0	43.7	62.1	17.8	65.6	124.4	132.6	69.5	67.8	40.0	23.6	133.8	126.5	91.0	61.5	27.5	106.0	23.1	125.7	73.5	5.8	19.0	55.0	23.2	106.6	51.2	43.0	11.5	131.5	47.6	58.7	66.4	126.0	18.7	62.4	16.6	8.7	53.9	52.2	136.4	43.5	88.0	87.5	94.4	12.1	19.7	53.7	52.3	45.7	47.8	50.1	48.1	73.1	46.7	49.0	26.4	32.8	47.1	32.5	40.6	11.5	122.5	218.8	30.3	72.2	76.1	31.0	25.1	59.2	37.6	25.7	20.2	8.2	32.2	40.2	64.9	71.9	54.9	22.5	53.2	113.3	113.1	56.6	31.2	79.6	135.8	35.5	65.8	42.2	75.1	113.1	123.4	44.8	51.6	23.9	21.9	50.5	27.3	58.6	56.6	93.5	34.1	43.3	57.5	37.4	63.7	58.5	35.2	73.7	8.8	2.6	4.3	2.7	2.4	3.6	7.1	3.0	2.4	1.9	6.3	3.8	3.5	7.4	4.7	1.4	7.7	1.3	1.1	123.8	122.9	122.4	161.5	124.4	132.6	133.8	126.5	125.7	131.5	126.0	136.4	42.9	38.5	25.7	18.3	43.3	36.6	82.3	21.5	55.2	50.5	56.2	60.1	32.6	65.8	26.4	44.1	18.8	110.6	29.9	69.8	90.1	28.9	326.5	87.4	68.5	37.4	99.8	46.3	14.7	26.8	91.4	62.7	56.6	78.9	15.2	92.7	38.2	57.2	52.1	35.3	17.1	72.7	20.3	28.9	39.1	631.4	64.3	28.8	44.4	10.3	18.6	75.0	18.6	17.1	23.7	35.8	61.2	80.5	72.0	74.8	68.4	141.0	38.4	44.1	59.2	44.2	56.2	30.3	93.3	40.1	36.2	153.6	34.0	88.0	55.3	70.2
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 235.1;Late spermatids: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	38.8	56.5	15.0	5.3	16.1	9.0	37.4	15.8	17.4	31.1	16.6	31.0	7.6	32.8	7.8	34.8	29.5	4.2	27.7	14.4	16.5	37.6	40.6	36.5	6.1	15.6	16.3	28.0	44.7	9.6	41.9	6.7	15.8	32.7	3.9	4.2	37.1	5.9	41.0	28.1	23.4	4.7	16.0	28.9	39.2	105.4	17.0	4.3	30.6	5.8	4.9	27.5	28.1	16.0	34.5	19.4	2.3	17.8	17.5	11.4	7.0	20.1	17.1	19.4	16.8	27.9	17.6	27.9	22.1	14.7	16.8	30.6	16.9	20.4	16.6	31.4	57.3	12.9	43.8	43.4	25.7	25.2	17.1	12.7	21.9	8.8	24.0	11.2	13.7	26.2	32.6	19.5	14.2	65.4	21.4	41.0	18.8	3.9	37.7	38.6	16.7	22.3	22.5	23.3	15.5	21.4	33.8	11.1	23.2	7.2	53.1	32.7	16.6	13.6	23.3	28.6	33.1	27.1	22.6	18.6	13.6	23.3	10.0	11.2	38.0	38.2	24.8	36.8	23.0	33.7	22.7	26.2	44.9	30.3	22.3	21.0	3.1	26.1	34.6	64.6	28.5	28.8	15.0	16.1	15.8	17.4	14.4	16.5	15.6	16.3	15.8	16.0	17.0	16.0	26.8	22.4	35.0	14.4	31.8	17.8	15.8	58.5	34.1	14.4	64.9	78.4	5.8	45.8	38.6	40.5	4.2	72.2	34.7	19.9	72.4	95.3	235.1	48.0	23.9	24.6	31.3	30.1	8.2	85.8	66.3	23.9	28.1	25.6	17.1	16.5	29.6	39.8	62.4	5.0	10.8	45.7	48.8	32.6	21.2	640.8	46.6	45.6	46.2	6.5	56.2	74.9	41.2	9.5	14.6	106.2	38.8	46.6	61.0	26.0	37.9	72.8	57.2	15.7	19.7	17.3	28.1	179.8	28.6	55.0	17.3	76.8	25.9	21.3	62.7	22.0
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase non-receptor type 11"	Q06124	12	112418351-112509918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		74000	"Cluster 6: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli rim"	"Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	62.9	36.6	74.6	34.7	91.7	46.3	37.6	72.7	115.7	37.9	38.4	32.5	27.6	37.8	28.7	38.9	24.3	29.4	68.7	66.1	85.6	39.7	53.0	34.4	35.6	79.0	84.1	26.2	31.6	53.4	16.1	38.0	85.7	35.2	30.6	51.8	25.9	42.4	75.1	32.1	26.1	45.7	83.4	26.7	30.4	18.2	81.7	35.5	46.8	64.0	32.5	40.1	23.5	106.3	116.9	107.6	77.0	73.4	109.7	106.1	92.7	136.4	148.2	105.5	78.5	107.7	43.4	124.5	69.4	127.4	66.7	68.1	100.1	121.6	173.8	93.1	85.0	181.5	102.6	59.8	109.2	145.8	108.0	86.6	119.6	113.6	159.8	101.3	88.7	92.0	140.2	41.3	103.3	83.2	101.0	69.7	94.1	112.3	73.4	102.4	114.6	70.5	97.3	126.7	53.3	66.1	133.7	99.8	85.2	77.6	114.8	97.8	108.1	122.9	110.0	74.2	121.8	79.4	141.6	120.2	102.2	99.7	117.7	32.2	11.7	16.8	14.8	10.2	14.0	18.1	13.3	12.4	13.6	20.8	15.3	11.9	10.7	12.6	13.7	18.3	10.9	7.2	74.6	91.7	72.7	115.7	66.1	85.6	79.0	84.1	85.7	83.4	81.7	106.3	49.0	60.9	68.2	27.7	25.8	25.6	39.9	25.3	20.5	29.9	40.5	32.4	131.6	24.3	41.8	36.8	16.7	23.5	34.2	25.4	33.2	37.5	63.1	31.3	92.6	46.2	13.1	21.7	67.6	42.8	25.3	35.8	21.9	40.9	28.4	33.1	26.0	101.5	26.8	13.5	54.7	22.0	18.3	33.3	21.6	28.5	51.6	31.8	14.2	40.3	31.1	59.8	29.9	32.6	73.0	59.3	19.6	79.7	37.0	73.4	16.6	39.8	23.5	22.2	32.9	58.2	49.2	7.1	6.6	37.5	27.4	35.2	31.7	30.5	22.2	66.8
PTPN18	BDP1	ENSG00000072135	"Protein tyrosine phosphatase non-receptor type 18"	Q99952	2	130356045-130375405	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 143.4;NK-cells: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 63.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012174, HPA053367"	Uncertain		Approved	"Intermediate filaments"		NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Intermediate filaments"		"CAB012174: AB_2173224, HPA053367: AB_2732579"	"unprognostic (3.11e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.85e-3)"	22.3	12.3	19.6	23.2	19.4	28.2	21.5	21.7	21.4	21.2	18.4	35.3	21.7	15.7	6.1	17.8	19.6	14.8	15.3	18.8	19.1	25.4	37.8	22.0	42.7	21.0	19.6	12.5	34.6	9.5	19.0	12.2	20.1	33.3	24.7	6.4	31.9	13.2	7.5	12.7	39.4	13.3	18.7	63.8	27.0	4.6	20.0	11.1	20.0	7.5	48.6	18.8	18.9	19.6	12.4	8.3	3.2	16.2	19.7	13.5	32.9	6.2	5.6	7.9	8.8	16.4	18.5	46.4	6.2	15.2	3.7	13.8	14.3	14.1	7.6	21.1	8.0	16.9	9.8	19.5	10.2	16.6	44.5	16.0	11.4	8.7	12.0	1.7	15.2	10.1	16.1	34.2	15.4	24.3	3.1	28.4	3.3	26.6	8.6	28.4	9.5	63.0	15.9	7.5	20.6	5.4	10.9	38.6	18.7	3.1	13.2	24.1	14.4	11.2	12.6	6.2	5.9	5.6	1.6	44.5	17.1	14.9	12.4	8.4	7.8	6.7	6.4	11.2	4.0	7.3	4.2	6.1	6.9	5.1	2.6	5.1	4.8	3.1	19.4	7.5	6.0	10.7	19.6	19.4	21.7	21.4	18.8	19.1	21.0	19.6	20.1	18.7	20.0	19.6	37.2	28.9	23.9	12.1	43.6	6.5	28.8	15.9	12.0	13.4	52.0	53.5	9.0	18.6	17.5	36.8	4.2	15.6	85.6	75.9	54.8	19.0	0.9	20.6	14.0	30.7	48.6	32.4	18.2	45.4	30.5	16.3	65.2	24.0	35.5	12.2	25.7	21.1	92.4	10.1	18.6	52.5	30.5	113.6	35.9	1.6	19.0	143.4	33.8	35.6	65.2	18.4	148.3	5.5	6.1	29.0	66.9	11.3	23.5	37.9	41.3	37.3	20.5	11.6	19.7	15.1	21.5	2.6	6.0	19.4	5.8	11.5	39.3	16.2	47.5	28.9
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase non-receptor type 23"	Q9H3S7	3	47381011-47413435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	18.5	19.1	6.2	12.6	9.2	14.7	17.4	5.8	10.5	23.3	5.1	16.3	14.3	20.9	7.5	19.0	19.2	8.4	13.2	7.1	7.2	17.5	14.0	18.7	9.1	8.8	7.2	23.5	20.2	23.5	30.9	11.6	8.5	18.7	6.5	8.5	20.0	11.4	30.0	26.4	18.4	8.8	5.5	20.0	16.1	15.6	7.7	8.0	27.1	8.9	7.3	18.5	20.4	14.4	21.5	29.9	16.4	21.4	21.0	16.0	15.8	19.2	18.9	17.5	14.8	25.0	20.7	15.1	17.2	21.9	31.2	19.0	14.3	20.8	8.5	14.3	15.1	21.0	22.2	24.0	23.0	12.3	27.5	21.4	20.9	22.9	23.2	12.4	21.7	12.5	15.9	20.3	19.0	30.2	11.5	10.4	17.5	14.9	20.1	7.2	7.9	18.5	13.2	40.9	8.6	20.6	17.1	35.6	13.6	9.8	20.3	12.0	22.4	26.7	22.2	37.7	27.5	28.8	20.4	8.7	29.0	11.6	19.5	0.8	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	6.2	9.2	5.8	10.5	7.1	7.2	8.8	7.2	8.5	5.5	7.7	14.4	11.1	9.6	7.0	17.0	8.2	8.0	5.2	6.9	13.6	11.7	9.5	8.0	8.7	8.6	9.5	5.5	14.6	10.6	11.0	15.7	1.9	10.5	2.1	10.3	13.7	12.4	7.3	2.5	9.8	8.9	7.9	9.1	26.5	21.1	2.5	14.9	11.4	12.7	13.9	16.8	12.0	16.3	20.3	10.4	5.5	3.1	19.3	9.5	12.4	7.5	8.7	8.8	6.2	9.5	14.3	13.5	10.4	13.5	15.4	9.3	14.6	9.4	12.6	14.2	6.6	10.2	8.8	13.6	13.3	13.2	10.9	9.3	8.9	9.4	12.8	8.2
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Cell line enhanced"	"Detected in some"		"HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	1.3	4.2	0.6	10.2	9.8	39.7	0.7	1.0	1.8	0.8	0.5	2.2	4.5	1.1	0.0	1.5	0.6	3.2	0.5	0.6	1.2	1.3	1.1	2.5	20.8	2.3	1.5	0.3	0.4	0.1	0.3	0.5	1.8	0.8	2.7	0.0	1.3	0.6	0.1	1.2	5.6	1.5	1.4	9.9	2.4	8.3	2.9	31.1	0.8	0.5	20.8	3.2	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.6	0.0	54.1	0.0	0.0	0.0	118.6	150.8	0.0	0.0	0.0	0.0	0.0	0.1	40.0	2.3	5.0	0.0	0.0	16.3	51.4	0.0	0.0	0.0	2.4	0.0	39.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	53.7	0.3	0.0	0.5	0.0	0.1	22.8	6.3	33.7	0.1	84.0	0.1	17.9	1.5	24.9	13.7	1.5	12.5	2.6	9.2	14.0	2.9	3.2	6.7	8.2	9.9	14.9	0.6	3.8	12.8	4.5	0.6	9.8	1.0	1.8	0.6	1.2	2.3	1.5	1.8	1.4	2.9	2.5	3.2	3.2	5.1	3.3	46.8	2.3	1.3	0.1	0.0	2.7	1.5	1.8	0.7	1.5	0.7	0.0	0.0	0.5	112.7	0.5	0.0	0.5	0.6	0.9	0.8	5.6	0.0	35.5	0.7	0.0	0.2	2.2	1.5	0.7	140.7	6.7	3.6	0.4	15.4	0.0	0.7	0.1	0.0	11.2	31.2	2.4	5.3	21.3	8.8	1.0	10.4	3.8	99.9	1.0	4.6	0.1	0.1	2.2	63.9	0.6	0.2	0.7	0.1	3.7	0.0	0.9	1.1	0.8	0.7	0.5	2.4	0.8	127.2	54.6	0.5	0.6
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase receptor type N2"	Q92932	7	157539056-158587823	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;pancreas: 98.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 23.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	3.8	16.5	29.4	2.7	34.3	1.3	2.9	0.0	49.9	2.1	0.0	7.7	8.3	3.0	4.2	1.9	10.8	7.6	3.1	35.2	22.7	3.9	1.6	4.8	3.4	7.9	3.1	8.7	98.1	1.0	41.0	2.1	3.4	17.3	6.1	9.2	12.9	3.6	1.2	0.8	6.7	2.1	0.1	13.4	40.2	6.2	14.1	1.6	8.7	1.9	2.5	4.2	2.1	20.5	0.1	0.4	45.5	3.6	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	4.0	0.0	1.2	0.5	9.4	0.3	1.0	0.0	0.0	42.0	0.8	0.0	0.0	7.3	1.1	0.0	0.1	2.0	0.8	0.1	0.5	0.3	0.0	3.4	0.1	0.3	0.0	0.7	22.1	43.0	5.7	13.7	3.2	0.0	2.7	0.2	0.2	0.0	23.8	25.4	0.0	0.1	0.0	0.0	0.0	20.9	6.2	9.2	4.3	0.1	1.5	0.3	0.1	0.0	27.7	17.4	6.8	14.1	1.5	2.8	1.3	0.2	0.5	3.5	2.1	1.4	2.1	4.2	2.4	1.4	23.6	2.4	0.0	0.6	5.3	1.3	29.4	34.3	0.0	49.9	35.2	22.7	7.9	3.1	3.4	0.1	14.1	20.5	40.7	3.2	12.9	16.3	18.4	2.3	12.7	1.3	4.0	30.2	1.9	2.2	3.1	10.0	9.1	40.5	10.4	0.4	8.7	5.9	35.2	22.9	51.9	8.7	2.5	26.3	131.1	6.6	439.6	13.1	0.4	13.0	41.8	0.8	19.0	14.1	44.3	0.8	44.5	11.8	433.4	43.3	6.1	7.0	11.3	19.3	12.5	7.9	12.4	27.2	5.7	67.3	15.5	138.2	11.0	7.3	7.0	19.5	5.4	15.0	6.5	3.8	52.6	8.0	26.3	1.4	7.0	62.8	16.3	4.8	1.4	0.7	14.8	32.7	9.7	24.8
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase receptor type Q"		12	80402178-80680273	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 7.1;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Club cells: 4.4;Early spermatids: 10.9;Excitatory neurons: 11.2;Late spermatids: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;BJ: 3.9;HBF TERT88: 2.6;RH-30: 2.9;RT4: 3.4;SiHa: 1.9;U-2197: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	3.2	0.0	0.3	0.0	2.0	0.0	0.4	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.9	0.1	1.6	0.2	1.1	0.2	0.4	7.1	0.0	2.3	0.9	1.0	0.7	0.3	0.3	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.8	0.0	0.1	2.7	0.3	0.2	2.9	0.0	0.3	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	3.9	0.8	1.2	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.4	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.7	0.2	0.4	1.0	0.7	0.6	0.8	0.3	0.0	0.0	16.0	1.1	2.0	0.0	0.0	1.9	0.3	0.0	0.1	0.0	0.0	3.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.9	0.0	2.5	1.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;skin 1: 31.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2714.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	1.6	1.6	66.0	1.2	64.2	0.0	4.0	57.2	88.4	1.8	21.5	4.4	0.6	0.1	0.8	7.9	0.3	0.7	1.3	64.0	64.1	0.1	0.1	1.2	0.0	60.9	62.9	0.7	2.7	0.0	2.3	0.2	62.4	1.0	1.1	19.0	3.4	0.7	0.1	31.9	1.0	1.3	63.7	1.0	13.8	0.3	58.6	0.2	0.1	0.3	2.6	0.9	2.3	72.4	0.1	0.0	425.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	27.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	126.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	5.4	15.2	0.1	0.0	0.0	0.1	0.0	0.0	0.7	10.9	5.6	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.0	64.2	57.2	88.4	64.0	64.1	60.9	62.9	62.4	63.7	58.6	72.4	0.1	0.0	1.5	625.2	0.2	25.2	8.6	82.2	44.9	18.3	5.6	12.2	1.3	0.0	39.7	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	37.7	0.7	0.1	1.3	9.2	0.0	0.0	10.1	0.0	0.0	0.1	65.6	72.0	0.0	0.0	0.0	1.6	0.7	0.3	0.1	19.6	22.5	0.0	90.4	0.0	2714.3	3.6	0.9	0.3	0.0	1.2	1.8	0.0	0.1	16.9	6.6	0.0	1.2	1.7	0.1	1.6	14.8	21.5	0.3	0.2	0.5	0.0	7.8
PUS10	"CCDC139, FLJ32312"	ENSG00000162927	"Pseudouridine synthase 10"	Q3MIT2	2	60940222-61018259	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044736, HPA049582"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies, Mitochondria"		"HPA044736: AB_2679066, HPA049582: AB_2680824"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.15e-3)"	3.6	3.7	2.7	4.1	2.7	5.1	5.4	2.9	3.4	3.0	3.2	3.6	7.5	3.3	6.4	2.7	3.7	4.1	3.7	2.7	2.5	4.8	15.0	4.9	6.8	2.7	2.6	4.8	4.0	3.9	2.9	3.2	3.0	4.8	4.4	3.9	3.8	2.6	3.1	4.9	9.3	2.7	2.9	4.8	3.4	4.5	2.9	4.5	6.9	1.8	6.8	2.6	1.6	3.6	3.2	1.7	4.9	8.4	4.1	4.6	5.3	6.1	5.5	6.0	5.6	4.8	4.4	12.8	6.3	3.4	5.4	4.2	5.7	4.9	7.4	10.0	2.9	9.0	2.5	15.9	7.6	10.6	5.8	5.3	6.0	4.2	9.4	7.7	7.9	9.1	9.2	6.4	4.6	2.7	8.0	8.7	4.4	3.0	3.5	7.7	6.6	4.7	4.3	6.3	2.8	3.9	5.0	9.7	9.9	3.5	3.4	6.3	5.9	5.7	4.6	3.9	4.7	8.1	3.8	23.6	5.0	6.8	6.5	9.1	1.2	1.1	2.3	1.3	2.5	3.0	1.4	1.6	0.9	1.7	1.7	1.9	2.3	3.1	4.8	3.0	1.0	1.1	2.7	2.7	2.9	3.4	2.7	2.5	2.7	2.6	3.0	2.9	2.9	3.6	6.6	0.0	14.3	20.5	6.8	2.4	3.5	3.3	1.8	6.6	5.9	2.8	5.1	1.5	4.3	3.7	0.0	7.0	8.1	11.9	7.9	3.7	1.6	6.2	4.3	5.8	1.2	5.9	28.3	5.1	4.7	3.1	5.1	8.5	0.0	9.9	4.6	16.3	5.8	1.7	21.7	2.5	4.1	5.7	2.1	1.8	3.1	4.6	1.8	14.0	9.0	7.0	7.2	19.1	24.4	3.5	3.0	1.5	4.6	3.8	26.7	6.3	7.7	7.1	6.6	3.1	3.0	13.9	13.4	3.9	2.3	12.4	6.6	8.2	4.5	10.6
PUSL1	FLJ90811	ENSG00000169972	"Pseudouridine synthase like 1"	Q8N0Z8	1	1308597-1311677	"Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032057, HPA039999"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA032057: AB_10601251, HPA039999: AB_2676792"	"unprognostic (2.04e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (7.55e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (1.62e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-1)"	8.1	14.0	6.9	3.3	6.5	4.5	8.7	6.3	9.1	12.7	8.2	9.1	4.5	11.0	4.0	21.0	10.6	2.6	9.8	6.7	6.1	9.4	14.4	8.3	3.9	7.9	6.2	9.1	14.9	3.3	14.9	3.2	6.7	11.7	2.0	2.0	13.7	4.3	7.9	18.1	8.9	2.6	6.2	10.2	10.8	10.9	6.2	4.2	7.5	2.3	3.5	10.4	12.3	7.6	21.9	9.8	9.7	16.6	4.6	7.4	13.1	19.4	10.7	18.8	12.6	33.9	14.1	13.3	15.4	9.6	8.0	17.8	10.8	17.8	3.3	15.1	71.0	18.5	17.7	20.5	17.4	22.2	17.1	7.2	9.2	10.4	7.9	5.1	8.6	18.3	24.1	6.0	8.8	18.2	21.1	28.9	13.2	18.4	42.6	19.2	7.3	32.0	14.8	8.3	44.3	16.2	15.3	45.1	16.1	4.5	12.7	14.6	10.2	12.1	12.5	19.9	18.8	23.4	8.1	57.4	15.0	20.0	7.4	3.7	12.5	6.2	10.2	17.5	10.3	8.5	11.1	8.6	11.7	9.2	7.2	7.3	4.9	9.0	15.9	7.3	14.4	8.4	6.9	6.5	6.3	9.1	6.7	6.1	7.9	6.2	6.7	6.2	6.2	7.6	5.7	0.0	5.3	1.0	8.9	22.0	12.0	19.9	11.4	8.1	16.3	14.0	2.5	8.6	13.5	7.3	6.2	27.0	8.4	15.0	11.7	20.9	11.5	7.7	9.3	6.6	5.3	3.4	2.4	23.1	41.9	9.3	12.2	5.2	7.0	6.3	4.6	10.5	20.9	3.3	2.4	12.5	16.2	8.8	17.4	18.2	8.7	7.4	7.2	0.0	7.7	5.9	10.3	1.5	2.2	26.1	9.9	11.3	14.2	16.8	13.4	18.9	12.0	7.9	0.0	5.2	9.3	17.1	18.5	13.4	19.2	34.5	9.7	18.3	13.2	25.6
PWP1	IEF-SSP-9502	ENSG00000136045	"PWP1 homolog, endonuclein"	Q13610	12	107685799-107713162	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038708			Approved	"Nucleoli rim,Golgi apparatus"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli rim"	"Golgi apparatus"	"HPA038708: AB_2676163"	"unprognostic (7.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.65e-4)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.10e-2)"	29.7	20.9	18.6	26.4	19.0	31.9	33.7	18.8	23.6	24.9	29.5	27.7	17.7	30.3	24.8	28.7	24.7	20.4	17.3	18.9	19.1	30.4	32.2	21.4	32.0	17.4	18.0	32.8	25.8	33.0	17.8	29.5	20.0	25.2	26.0	26.9	24.4	27.5	22.9	28.8	21.7	32.3	18.1	23.7	23.1	30.1	18.8	33.2	25.9	17.6	37.4	31.4	24.5	19.0	71.0	86.9	51.8	49.4	70.9	77.2	68.5	72.9	81.9	100.8	84.8	88.5	32.9	108.8	38.4	112.9	68.4	60.7	70.8	77.0	99.2	54.7	80.6	82.9	50.5	103.2	72.7	101.8	56.9	70.2	69.1	93.5	83.0	79.0	119.8	66.0	110.8	29.8	109.1	78.3	71.6	99.3	62.0	64.8	141.2	58.3	61.2	101.4	62.7	98.3	58.4	46.9	59.6	42.4	104.1	64.8	75.3	49.7	94.9	76.7	38.9	63.0	84.1	42.5	62.8	84.9	34.3	55.3	68.7	29.4	20.8	16.2	41.7	27.8	37.8	68.5	40.6	43.9	35.0	64.1	34.5	47.9	6.6	44.2	34.4	47.3	48.6	29.7	18.6	19.0	18.8	23.6	18.9	19.1	17.4	18.0	20.0	18.1	18.8	19.0	44.1	41.7	38.1	13.7	80.1	48.4	52.3	70.6	36.5	50.4	41.0	41.3	22.1	25.8	48.9	27.6	37.5	69.1	48.4	14.6	58.7	69.7	24.4	34.5	47.3	52.0	21.0	52.2	15.6	63.0	74.5	51.6	30.5	35.8	57.6	41.5	43.5	52.0	46.2	33.7	19.0	31.9	26.4	34.3	28.0	11.1	50.4	33.2	30.2	4.7	75.2	41.4	38.1	15.1	16.7	68.0	19.8	44.0	46.0	50.2	24.5	70.8	42.8	46.2	26.3	41.8	50.9	124.3	79.2	41.9	49.7	45.7	44.0	45.8	34.1	40.5
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2 small subunit processome component"	Q15269	21	44107373-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 10.7;Basal respiratory cells: 9.6;Suprabasal keratinocytes: 8.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 82.9;Daudi: 84.3;U-266/84: 66.6"									HPA024573	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	4.0	3.2	3.3	3.2	4.4	0.9	3.3	3.6	4.4	4.2	2.4	3.6	1.5	3.3	2.6	3.5	5.7	0.5	3.7	3.5	3.2	2.6	3.0	3.2	3.0	3.5	3.5	2.9	4.1	1.9	2.2	2.5	4.2	3.0	0.3	1.2	3.4	1.4	5.0	4.9	3.7	0.5	3.2	4.5	4.6	3.1	3.4	5.6	2.9	7.2	6.9	4.1	3.2	5.7	4.7	0.5	1.5	3.6	10.4	11.4	28.5	39.2	16.9	44.3	29.5	82.9	1.4	84.3	1.4	0.0	4.5	4.2	1.5	26.4	24.7	24.4	59.5	10.8	15.6	19.2	6.2	6.8	2.9	0.7	0.0	27.1	0.0	10.1	1.7	39.2	32.5	33.8	17.1	1.1	0.2	2.1	1.5	4.1	3.3	4.8	0.2	44.1	0.0	1.2	26.8	5.4	2.2	3.0	24.2	14.6	0.9	3.2	20.9	19.6	3.1	42.4	4.3	47.6	66.6	3.7	1.8	10.6	28.4	0.5	2.2	2.5	4.7	2.7	5.8	5.1	4.0	5.1	1.8	3.4	3.7	4.6	1.1	2.7	3.7	2.2	3.3	3.0	3.3	4.4	3.6	4.4	3.5	3.2	3.5	3.5	4.2	3.2	3.4	5.7	0.4	0.0	2.0	0.3	3.2	10.7	0.1	9.6	3.4	0.7	1.1	0.3	4.5	0.0	5.4	0.0	0.0	0.1	2.3	4.6	1.9	0.0	0.1	0.2	0.2	2.0	2.4	4.8	0.0	0.0	2.0	1.8	1.1	0.4	0.0	0.3	2.2	0.3	1.9	0.0	0.0	3.8	6.1	5.4	4.9	0.0	1.2	0.4	1.8	0.0	0.6	0.5	3.1	0.0	0.0	0.0	2.4	0.0	1.5	1.2	1.8	0.3	4.6	0.3	0.0	1.4	3.7	1.4	1.7	0.8	8.5	0.7	2.6	0.5	4.6	0.3
PYCR3	"FLJ13852, PYCRL"	ENSG00000104524	"Pyrroline-5-carboxylate reductase 3"	Q53H96	8	143603210-143609773	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 14.7;Ductal cells: 10.2;Exocrine glandular cells: 9.1;Extravillous trophoblasts: 11.8;Proximal tubular cells: 12.4;Theca cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053776, HPA063416, HPA069706"	Uncertain		Supported	"Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Cytokinetic bridge, Mitotic spindle"	"HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178"	"unprognostic (2.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.54e-1)"	5.0	9.7	2.8	0.4	2.9	0.6	5.2	2.7	3.3	5.1	1.0	4.2	0.5	5.2	1.1	7.1	6.0	0.8	3.9	2.9	1.6	9.7	17.2	3.8	0.9	2.3	2.2	5.1	9.2	0.6	10.0	0.4	2.7	8.7	0.6	0.7	5.8	0.5	3.0	4.0	4.1	0.4	1.5	5.9	5.5	7.0	2.7	0.4	8.4	0.3	0.7	4.4	3.8	2.1	3.2	4.0	1.6	2.5	1.8	0.6	2.0	3.0	1.4	2.9	1.9	2.9	2.6	6.2	2.1	2.0	1.1	2.6	2.0	4.0	1.1	3.0	5.3	3.7	2.2	2.0	0.6	1.9	1.0	0.8	1.9	3.1	1.9	1.2	0.7	3.7	4.3	3.1	1.9	7.2	3.0	1.7	2.1	4.5	10.4	2.8	1.8	4.3	3.4	2.2	5.3	1.4	3.6	4.9	1.6	0.8	6.4	2.0	0.9	2.9	4.0	3.4	3.1	2.5	0.8	4.2	2.6	2.0	1.9	0.2	0.9	0.0	1.1	0.6	1.2	1.3	0.8	0.8	0.6	4.7	1.1	1.0	0.1	1.3	0.7	3.0	0.9	0.6	2.8	2.9	2.7	3.3	2.9	1.6	2.3	2.2	2.7	1.5	2.7	2.1	2.9	3.2	3.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	8.8	7.7	0.0	0.0	0.6	14.7	0.0	5.1	1.6	0.0	3.9	10.2	0.0	6.8	6.6	1.9	0.0	0.0	0.0	9.1	11.8	2.9	0.0	5.2	0.0	5.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.8	0.0	0.0	12.4	4.4	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.5	1.2	14.7	0.0	0.0
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248085-25298012	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 122.8;Distal enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 407.8;SK-MEL-30: 528.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		NA	NA		14000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.37e-4)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.43e-4)"	50.8	36.4	78.2	27.7	77.9	14.1	61.1	84.1	82.4	37.0	35.4	140.9	27.0	51.9	21.4	106.6	37.8	39.1	163.9	77.3	74.9	43.7	14.6	32.1	19.1	85.4	80.8	25.9	25.4	18.1	61.5	11.5	81.2	107.9	72.6	25.4	125.1	106.3	18.7	85.3	44.8	59.8	84.7	22.6	51.3	25.2	80.3	18.4	45.2	10.5	17.3	154.2	53.0	84.8	31.5	220.1	39.1	38.3	97.9	182.7	28.7	62.2	80.9	51.4	43.0	50.1	38.0	37.1	71.8	83.6	96.1	123.9	44.5	165.8	27.9	21.1	27.5	29.5	18.6	86.9	115.7	44.7	40.0	107.1	152.4	130.5	191.3	63.5	66.6	23.0	16.5	91.4	73.0	87.1	45.1	34.6	35.2	38.2	407.8	33.7	71.0	49.8	280.5	56.8	58.4	36.5	42.7	74.0	528.7	31.0	51.9	28.4	147.4	60.3	36.5	65.1	128.7	35.2	58.8	14.4	67.9	34.8	335.3	4.6	14.1	7.1	10.2	19.4	9.9	5.4	8.1	9.2	14.5	4.6	10.3	12.9	3.3	11.2	23.4	7.1	9.6	23.4	78.2	77.9	84.1	82.4	77.3	74.9	85.4	80.8	81.2	84.7	80.3	84.8	10.0	9.6	34.6	43.1	8.7	11.9	23.1	20.7	22.2	35.8	31.6	43.6	122.8	11.5	14.6	25.8	37.5	7.1	10.7	185.2	11.7	17.6	3.5	12.7	17.2	13.5	28.2	8.6	22.9	16.5	7.2	15.3	40.2	21.6	6.3	16.2	8.9	5.8	10.8	18.5	26.9	47.3	57.0	13.8	10.7	9.2	27.4	18.5	35.6	15.0	16.6	21.3	15.5	11.6	19.1	27.0	68.5	86.5	22.9	17.6	20.9	11.1	11.9	9.3	0.0	13.5	23.1	2.0	8.5	15.3	10.1	4.4	12.9	20.3	72.0	9.7
PYGL	GSD6	ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944483	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 145.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 151.2;Hofbauer cells: 177.6;Muller glia cells: 265.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 141.1;neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 279.1;HMC-1: 304.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	110.1	21.0	5.9	24.1	6.6	108.9	36.4	5.0	8.4	33.6	10.4	19.0	3.7	20.7	6.4	55.8	19.1	13.0	14.9	5.2	6.2	10.2	145.6	26.1	6.3	10.7	17.6	18.2	5.7	21.1	7.5	49.3	8.7	13.0	24.0	78.2	26.8	29.7	5.1	37.0	8.4	26.7	8.6	49.4	9.6	5.2	9.0	4.8	10.2	5.8	6.8	41.7	38.1	10.3	145.7	40.8	10.1	64.3	47.0	56.2	114.5	28.6	24.1	77.4	117.3	107.4	18.3	0.1	54.4	171.7	91.2	279.1	107.0	144.8	132.0	0.5	46.8	28.0	60.5	82.4	83.8	106.9	304.4	119.4	56.8	104.1	43.6	75.4	69.3	0.8	11.6	0.5	55.4	144.7	0.4	141.7	39.3	12.8	152.0	2.7	36.2	6.1	104.7	95.1	4.5	4.4	131.0	43.3	1.7	38.6	20.6	200.4	3.2	29.7	49.6	56.0	92.9	1.2	0.3	0.5	27.3	107.7	15.9	50.2	55.9	141.1	0.0	24.2	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	153.7	0.6	15.7	1.2	0.2	24.8	5.9	6.6	5.0	8.4	5.2	6.2	10.7	17.6	8.7	8.6	9.0	10.3	6.7	22.4	6.3	1.3	1.8	30.7	10.5	40.5	6.8	4.6	7.0	3.8	3.4	5.7	35.4	7.3	0.0	28.9	0.2	11.2	3.9	10.9	1.0	35.4	18.9	7.8	1.2	9.0	1.8	2.1	151.2	18.8	6.6	62.6	6.3	9.3	8.2	65.4	177.6	1.7	2.2	7.1	14.2	56.7	7.9	1.5	14.3	54.6	19.6	15.9	52.4	265.1	2.1	14.1	0.6	7.4	5.2	21.8	1.8	9.7	0.0	6.4	24.5	11.9	6.6	15.4	8.8	0.7	1.4	22.4	22.3	21.1	2.3	4.0	14.0	9.2
PYGO2		ENSG00000163348	"Pygopus family PHD finger 2"	Q9BRQ0	1	154957026-154963853	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023689, HPA074813"	Supported		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA023689: AB_1855974, HPA074813: "	"unprognostic (1.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.76e-4)"	14.6	30.6	30.0	16.7	30.3	6.5	15.3	29.3	29.8	21.4	21.1	23.5	19.0	19.1	23.5	24.2	20.3	12.7	15.5	29.9	34.0	24.7	20.1	15.7	26.5	30.5	30.8	27.2	18.1	27.5	32.4	16.3	29.1	23.5	15.3	12.7	23.2	23.3	18.9	22.4	24.4	15.7	29.8	28.2	21.6	16.1	35.3	22.5	26.2	15.9	27.8	21.2	20.0	32.3	28.1	19.4	40.4	36.0	39.8	19.5	37.0	17.1	23.0	26.5	22.7	26.1	34.2	34.9	26.4	19.9	28.7	37.2	35.6	23.7	17.4	34.7	25.1	27.9	32.7	23.6	18.5	25.8	23.9	16.2	33.8	23.9	20.0	30.0	16.5	52.5	37.1	57.6	25.2	42.8	36.0	30.0	43.3	55.7	34.2	40.2	25.7	55.6	27.1	26.1	48.4	71.8	27.0	48.5	34.9	39.1	59.7	45.9	14.1	23.5	35.1	25.6	25.1	56.8	54.3	37.1	19.6	32.4	31.8	2.3	3.9	10.9	8.0	6.5	10.0	6.9	10.3	10.7	4.1	7.5	11.0	8.7	3.8	6.3	8.4	3.9	5.8	6.2	30.0	30.3	29.3	29.8	29.9	34.0	30.5	30.8	29.1	29.8	35.3	32.3	7.0	9.6	4.9	5.5	12.6	5.5	3.8	5.8	7.4	11.8	14.3	10.0	5.3	5.7	7.4	12.9	2.1	15.5	14.1	10.3	19.6	6.2	3.4	5.7	7.5	6.8	5.4	12.4	6.3	5.9	12.6	5.8	9.7	7.4	0.0	9.3	7.1	9.4	6.5	21.9	4.3	10.6	6.1	6.6	3.5	2.2	9.0	5.6	5.4	6.5	6.4	10.6	8.2	5.5	4.7	9.7	9.1	9.1	11.5	4.9	12.0	9.8	4.0	6.0	6.6	5.4	6.9	5.9	12.2	9.8	5.3	11.6	11.7	9.3	8.4	3.7
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No		27000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	24.5	30.8	19.8	24.0	20.2	22.5	27.9	21.5	24.8	26.1	22.9	31.1	31.6	22.1	41.5	72.3	22.7	19.8	21.8	19.5	20.7	26.3	43.0	20.8	35.4	20.5	20.6	17.1	28.0	26.3	22.3	22.8	20.5	31.2	30.0	17.4	34.0	15.9	29.8	41.9	29.5	19.8	20.1	31.1	24.1	25.9	20.1	33.2	27.0	29.0	42.1	24.8	31.4	20.2	50.3	39.1	56.1	31.4	33.4	43.2	92.6	36.1	43.1	33.3	28.0	57.7	57.9	62.9	53.6	35.1	15.4	38.6	43.6	77.1	26.7	48.6	32.7	51.0	35.1	71.8	40.7	59.7	44.7	39.2	48.8	37.7	56.0	42.2	35.9	27.3	44.5	67.4	39.7	75.3	38.6	105.7	98.3	56.7	20.2	34.3	22.3	72.5	69.5	69.8	37.7	43.4	46.2	61.1	33.1	51.8	74.5	124.0	28.2	20.0	28.3	31.5	26.6	35.5	58.2	97.2	34.2	40.9	31.9	17.5	79.8	75.8	58.5	92.2	72.3	98.1	105.4	82.2	120.2	88.2	68.7	69.5	19.1	53.1	66.5	65.6	186.0	87.2	19.8	20.2	21.5	24.8	19.5	20.7	20.5	20.6	20.5	20.1	20.1	20.2	16.2	19.2	17.3	0.0	28.6	0.0	29.4	0.0	21.1	12.7	41.7	38.4	0.0	25.8	14.2	23.9	8.4	84.3	21.1	29.8	78.2	40.6	15.2	21.1	17.0	16.3	7.3	32.2	0.0	50.6	76.3	17.6	22.4	21.1	18.9	14.5	22.9	44.3	55.2	6.7	0.0	32.1	0.0	47.7	0.0	11.7	23.3	42.8	0.0	0.0	110.4	55.7	48.4	0.0	0.0	54.1	33.7	23.7	21.9	34.7	66.8	61.3	16.8	13.6	13.1	18.0	15.7	23.8	25.6	63.1	0.0	62.0	29.6	16.5	29.3	34.3
QARS1	QARS	ENSG00000172053	"Glutaminyl-tRNA synthetase 1"	P47897	3	49095932-49105130	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 55.5;Cytotrophoblasts: 193.9;Extravillous trophoblasts: 156.7;Hofbauer cells: 96.1;Syncytiotrophoblasts: 187.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		No	No		58000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favorable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	61.1	58.8	20.0	57.2	21.3	96.6	89.5	23.5	18.5	58.3	34.2	104.8	101.6	45.5	58.5	102.5	71.0	48.3	72.0	18.4	21.1	57.1	51.1	52.3	75.8	23.8	21.0	69.0	73.9	78.1	33.0	76.7	23.0	60.4	121.0	21.4	103.2	61.1	156.1	105.0	84.6	60.2	22.7	60.1	75.0	30.0	23.0	92.3	53.2	146.2	118.8	72.8	58.1	24.6	95.9	97.8	128.0	197.4	146.4	180.8	159.2	90.5	188.2	160.5	152.9	123.0	113.5	257.1	61.4	136.7	95.3	119.9	166.3	137.8	111.4	78.2	148.0	206.4	156.0	216.1	91.2	187.2	130.9	184.8	123.1	127.4	108.1	175.3	184.7	144.6	95.3	112.4	118.0	89.2	130.7	154.9	116.1	159.0	122.9	76.0	123.7	200.6	108.5	163.9	48.7	161.6	85.4	211.0	147.8	122.7	184.4	205.5	137.6	82.8	127.3	131.7	117.9	111.9	176.5	142.9	88.4	156.3	60.3	30.7	84.3	25.8	44.5	104.1	57.4	62.2	54.1	47.0	127.0	49.9	46.6	49.0	8.0	71.8	94.5	57.4	82.1	81.2	20.0	21.3	23.5	18.5	18.4	21.1	23.8	21.0	23.0	22.7	23.0	24.6	15.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	193.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	156.7	14.7	0.0	0.0	0.0	0.0	0.0	0.0	96.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	187.0	2.0	0.0	0.0	0.0
QKI	QK3	ENSG00000112531	"QKI, KH domain containing RNA binding"	Q96PU8	6	163414000-163578592	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport"	"Developmental protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 628.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1140.0;Microglial cells: 713.0;Oligodendrocyte precursor cells: 1421.0;Oligodendrocytes: 4573.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 42.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 250.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019123, CAB022602"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB022602: , HPA019123: AB_1855980"	"unprognostic (2.42e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.09e-2)"	76.3	24.2	208.2	36.8	437.7	69.7	27.8	355.8	207.9	29.2	2.5	22.2	7.9	28.4	8.7	34.4	25.3	33.8	149.3	211.1	301.1	22.7	41.1	55.9	27.4	431.2	367.9	38.2	16.0	15.0	6.9	53.0	451.4	15.3	16.7	26.9	15.3	22.3	157.0	18.6	11.9	46.3	304.5	39.8	12.1	47.3	365.7	28.5	22.1	222.1	25.3	38.2	16.4	628.6	17.8	72.0	250.8	83.7	74.3	81.9	58.4	46.8	109.0	74.5	89.4	49.3	15.8	21.3	38.6	117.2	50.8	25.9	134.4	48.4	120.2	43.7	43.3	83.4	38.4	55.3	90.4	44.8	24.9	96.8	19.5	80.0	125.8	72.4	104.4	30.9	124.3	48.2	48.6	32.8	30.1	9.5	32.4	17.3	36.0	45.9	156.5	42.3	40.5	54.4	5.2	28.7	49.9	26.7	19.2	101.2	10.5	71.8	107.2	51.3	42.7	55.9	86.1	30.9	40.9	26.3	44.2	38.7	122.8	3.6	7.1	3.4	1.8	4.7	3.0	1.2	1.3	1.6	3.7	1.2	1.1	2.0	9.2	6.3	5.1	6.2	1.0	1.1	208.2	437.7	355.8	207.9	211.1	301.1	431.2	367.9	451.4	304.5	365.7	628.6	180.6	150.6	51.5	1140.0	35.4	153.7	34.1	25.3	43.9	60.4	42.8	47.2	355.5	37.1	30.5	20.2	58.4	51.1	77.7	0.2	21.5	21.8	53.0	60.7	156.7	130.0	0.0	40.4	58.4	12.0	51.3	92.2	10.2	71.1	60.9	64.8	131.0	72.9	86.8	32.0	471.4	0.0	14.2	221.9	188.0	102.5	86.6	165.7	113.8	713.0	107.9	113.5	32.0	1421.0	4573.8	19.8	0.1	98.6	34.4	46.5	0.0	33.2	23.7	31.5	46.0	197.7	83.5	46.1	19.7	47.4	136.1	55.1	32.2	69.9	0.2	46.4
QPCTL	FLJ20084	ENSG00000011478	"Glutaminyl-peptide cyclotransferase like"	Q9NXS2	19	45692403-45703989	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 5.5;granulocytes: 5.7;Inhibitory neurons: 6.5;Plasma cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040797	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA040797: AB_10794148"	"unprognostic (6.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.14e-2)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.71e-2)"	4.1	7.8	3.9	3.1	3.9	4.1	4.9	3.6	4.8	4.9	4.1	5.9	4.7	4.8	3.7	4.7	4.8	2.5	3.4	4.2	4.0	5.3	9.2	6.2	4.7	4.5	3.8	6.6	7.5	4.4	7.0	3.7	4.5	6.5	3.9	2.1	6.7	3.4	1.5	5.2	5.5	2.5	3.2	8.5	6.1	4.4	4.2	2.4	6.7	0.8	3.5	4.6	4.4	3.9	16.7	10.8	8.5	36.9	8.6	4.1	6.4	10.3	15.7	15.0	24.7	11.2	12.3	19.7	11.1	11.5	15.4	9.5	10.0	11.9	8.9	5.0	12.7	6.7	10.9	24.6	14.6	7.5	12.0	7.6	14.9	12.6	17.3	10.7	13.6	10.8	9.7	32.1	9.5	13.0	7.0	7.7	5.5	14.2	5.4	7.8	6.4	16.5	16.2	8.0	7.6	4.7	10.6	8.8	18.2	3.7	6.4	10.6	8.4	7.4	12.4	7.3	10.4	28.6	20.2	18.2	26.0	17.2	5.8	1.4	0.3	0.2	1.4	0.5	0.9	0.9	0.6	0.3	0.8	0.6	0.5	0.7	1.3	1.4	0.3	1.0	0.3	0.2	3.9	3.9	3.6	4.8	4.2	4.0	4.5	3.8	4.5	3.2	4.2	3.9	0.5	0.0	1.5	2.3	3.3	1.3	1.2	1.1	0.6	1.1	0.7	0.6	0.8	1.5	1.2	0.0	0.0	0.8	2.1	1.2	0.0	0.6	5.4	0.9	1.4	0.7	0.0	1.3	5.5	0.4	1.4	0.7	1.5	1.4	5.7	0.7	0.0	1.3	0.9	1.7	6.5	0.4	0.0	0.6	1.8	1.3	0.0	1.6	1.8	0.0	0.7	0.3	1.0	3.5	1.6	0.6	0.1	0.0	9.8	1.2	0.7	0.1	2.2	2.4	0.0	0.6	1.1	1.0	0.3	1.4	1.1	0.8	2.4	1.5	1.0	0.5
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29663279-29698699	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 119.4;liver: 183.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 404.7;Extravillous trophoblasts: 315.1;Hepatocytes: 367.4;Proximal tubular cells: 598.8;Syncytiotrophoblasts: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.2;intermediate monocyte: 5.3;myeloid DC: 5.8;non-classical monocyte: 9.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.8;monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 597.1;Hep G2: 258.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011887, HPA076010"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		780000	"Cluster 7: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA011887: AB_2668555, HPA076010: "	"prognostic unfavorable (5.10e-5)"	"unprognostic (2.00e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (1.44e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-2)"	8.4	89.4	20.6	4.3	20.2	4.8	6.7	25.8	19.8	50.6	19.4	19.2	61.6	26.1	95.2	4.0	43.6	10.2	26.8	18.5	22.2	119.4	183.5	9.2	6.8	28.6	26.6	31.0	34.5	16.2	5.8	27.3	32.4	7.0	15.2	7.5	13.4	26.1	5.1	5.1	30.3	13.7	23.6	17.2	7.1	4.1	22.8	8.2	6.5	1.2	5.2	10.5	11.5	23.3	0.6	1.4	51.8	56.4	8.8	21.6	167.8	6.0	5.2	8.6	11.0	145.9	91.9	2.3	597.1	10.8	10.0	1.0	18.5	0.6	4.5	0.8	16.7	27.1	2.2	258.0	52.5	4.1	10.4	69.8	1.4	4.8	0.2	12.8	0.2	28.2	75.1	2.9	0.4	154.6	17.6	100.3	162.1	1.9	0.2	89.3	16.3	58.5	47.9	4.2	48.6	103.5	0.0	142.1	118.8	85.1	106.5	112.8	0.6	2.5	24.9	0.9	0.5	1.8	4.9	18.8	4.4	10.4	8.1	0.0	4.2	0.3	0.8	5.3	0.9	0.1	0.6	0.7	5.8	0.0	0.1	0.4	0.8	0.4	9.0	3.1	0.9	1.9	20.6	20.2	25.8	19.8	18.5	22.2	28.6	26.6	32.4	23.6	22.8	23.3	3.1	9.6	24.8	5.2	10.1	3.6	11.7	0.5	1.8	3.3	5.0	2.0	43.2	8.6	3.0	64.4	0.0	404.7	5.8	84.5	50.9	1.2	0.0	93.8	49.5	5.5	28.3	10.5	1.3	55.2	315.1	35.8	0.5	81.0	5.1	6.7	9.7	367.4	147.5	6.7	5.6	47.3	0.0	21.2	18.3	0.5	29.2	19.8	42.7	12.2	4.4	20.8	3.1	11.1	0.5	11.5	78.5	27.1	8.7	4.2	161.0	598.8	1.5	5.0	6.6	3.3	16.2	0.5	3.0	0.2	2.0	215.6	5.7	36.5	104.7	8.3
QTRT2	"FLJ12960, QTRTD1"	ENSG00000151576	"Queuine tRNA-ribosyltransferase accessory subunit 2"	Q9H974	3	114005833-114088422	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 20.3;Endometrial stromal cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036827, HPA036828"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Intermediate filaments"	"HPA036827: AB_2675336, HPA036828: AB_10696788"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.41e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-3)"	6.9	6.5	3.6	9.4	3.9	11.2	10.1	3.2	4.0	7.4	9.0	8.4	7.7	8.4	6.4	7.0	7.5	5.3	3.4	4.3	3.6	7.5	7.2	8.6	12.0	3.8	3.6	8.1	6.7	7.3	4.4	8.5	3.8	6.9	8.9	11.3	5.9	5.9	3.8	8.2	7.6	7.4	3.4	11.8	6.9	7.1	3.7	7.7	8.9	3.9	11.6	9.6	5.2	4.4	26.8	27.1	22.2	24.6	9.6	11.7	20.9	13.7	8.6	22.9	20.9	26.0	18.8	49.4	19.5	12.7	27.3	25.9	43.5	20.6	29.9	9.4	19.6	22.2	15.9	18.6	13.7	40.8	20.0	9.3	18.2	20.8	29.4	9.3	24.0	22.5	23.7	17.1	13.1	21.4	34.3	15.9	42.6	37.6	29.3	30.6	15.6	26.6	18.0	18.2	30.1	14.2	19.9	19.4	25.1	18.4	21.6	20.4	15.9	19.9	21.6	7.9	26.9	12.0	18.7	68.1	17.4	29.6	40.9	0.6	15.3	3.8	6.4	15.8	6.0	16.8	5.4	6.3	19.4	11.0	7.4	6.0	6.5	8.6	11.4	8.1	7.6	6.5	3.6	3.9	3.2	4.0	4.3	3.6	3.8	3.6	3.8	3.4	3.7	4.4	14.0	19.2	20.3	0.0	8.4	0.0	0.0	0.0	0.0	0.0	13.8	12.4	0.0	0.0	10.5	3.7	0.0	10.9	10.0	0.0	1.9	15.7	0.0	16.3	19.7	9.9	0.0	0.0	0.0	12.4	10.9	6.2	0.0	15.1	15.2	15.7	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	16.7	0.0	0.0	3.3	0.0	0.0	8.9	4.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	4.9	4.3	17.4	0.0	0.0
R3HCC1	DKFZp564N123	ENSG00000104679	"R3H domain and coiled-coil containing 1"	Q9Y3T6	8	23270120-23296279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2;Rod photoreceptor cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023073, HPA023153"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Nucleoplasm	"HPA023073: AB_1855987, HPA023153: AB_2237834"	"unprognostic (5.80e-2)"	"unprognostic (4.70e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (7.46e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.02e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (7.65e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.43e-1)"	20.5	21.9	41.2	15.2	52.7	29.0	19.6	53.7	43.8	23.4	36.4	33.6	19.7	23.9	14.8	16.1	22.5	16.2	33.1	39.9	42.3	20.1	28.2	16.7	22.5	60.9	49.8	27.2	42.8	29.0	22.6	13.7	63.6	22.7	15.3	62.7	35.7	19.9	54.5	22.5	20.4	22.2	49.3	20.2	28.4	30.8	48.6	20.3	17.6	31.5	18.8	22.2	17.8	73.7	38.2	48.7	36.7	35.9	15.2	20.6	25.2	24.7	23.4	41.0	29.7	35.0	17.6	38.1	25.6	30.2	28.0	28.3	38.9	45.8	27.5	24.7	41.6	35.7	33.4	29.2	36.0	24.7	25.6	24.8	35.5	35.0	16.4	30.1	31.7	42.9	41.8	31.0	24.3	33.1	55.6	43.8	29.8	40.4	35.8	37.9	44.8	22.8	20.3	41.9	47.2	41.1	28.1	32.8	41.8	25.0	30.3	29.2	27.4	37.9	31.8	32.2	51.1	23.8	22.2	39.3	29.5	34.3	48.5	38.4	50.5	82.5	64.8	44.1	56.5	56.5	52.7	55.0	56.7	42.1	40.5	47.0	31.3	59.5	50.3	52.9	61.5	51.4	41.2	52.7	53.7	43.8	39.9	42.3	60.9	49.8	63.6	49.3	48.6	73.7	25.2	25.6	14.7	4.9	15.5	14.9	16.5	35.9	10.2	28.0	22.8	32.9	24.1	24.3	20.5	5.5	27.1	18.8	19.8	17.9	56.7	32.3	36.4	15.2	17.0	21.1	19.2	17.9	5.1	50.9	21.3	25.4	20.9	10.2	22.8	24.7	20.0	21.6	30.2	18.5	5.0	21.5	22.4	18.2	12.3	113.2	17.7	16.2	21.4	5.6	18.8	59.3	42.2	4.5	9.5	37.0	22.1	21.8	34.7	11.4	41.7	38.5	22.0	115.7	13.1	19.9	31.1	49.8	32.4	13.6	16.2	7.7	18.3	30.7	22.8	13.6
RAB11FIP1	"FLJ22524, FLJ22622, Rab11-FIP1, RCP"	ENSG00000156675	"RAB11 family interacting protein 1"	Q6WKZ4	8	37858618-37899497	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 798.0;Endometrial ciliated cells: 622.9;Glandular and luminal cells: 969.7;Urothelial cells: 613.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 101.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 101.9"	"Cell line enhanced"	"Detected in many"		"K-562: 73.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017037, HPA023904, HPA024010, HPA025960"	Enhanced		Enhanced	Vesicles		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Vesicles		"CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992"	"unprognostic (1.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.32e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (4.94e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.50e-1)"	7.5	5.7	3.8	17.7	2.7	58.5	21.8	3.8	3.8	14.5	39.3	40.7	41.3	5.9	14.8	47.1	16.9	21.7	12.0	4.4	4.3	13.7	7.2	74.0	17.2	3.4	2.7	4.6	42.5	12.0	8.6	25.8	2.1	8.7	47.0	6.1	23.8	13.5	4.6	18.9	53.5	7.1	2.3	12.0	45.5	6.4	4.0	15.4	13.0	2.7	31.1	23.6	14.9	2.2	41.8	18.1	1.9	8.0	0.4	0.1	54.1	4.2	6.6	7.5	9.6	40.6	23.2	17.0	12.7	5.1	0.4	31.6	14.5	9.4	11.3	44.2	13.5	3.3	9.0	11.9	20.9	7.3	36.3	4.8	12.2	2.8	7.9	11.1	0.1	22.2	73.1	8.2	3.8	9.9	12.4	10.7	12.0	40.9	5.3	3.9	9.7	13.2	39.4	42.2	7.4	8.5	10.6	52.3	13.0	36.8	35.2	14.0	0.6	0.2	23.1	0.6	0.7	16.5	20.7	4.5	0.3	9.8	5.7	24.0	20.5	38.1	4.4	9.4	9.9	6.0	3.2	3.1	18.3	3.8	2.0	2.2	101.9	10.9	20.2	11.0	7.7	10.7	3.8	2.7	3.8	3.8	4.4	4.3	3.4	2.7	2.1	2.3	4.0	2.2	7.6	798.0	112.9	1.0	128.5	15.9	113.5	49.5	24.5	5.4	113.6	58.5	15.8	84.4	228.0	64.4	16.7	44.9	123.6	385.5	15.6	170.2	0.9	622.9	71.4	25.3	243.7	3.8	7.9	248.9	8.1	28.7	272.7	969.7	30.4	2.8	32.2	15.3	32.1	6.7	8.6	312.3	95.6	59.1	174.7	1.8	1.8	121.1	16.0	2.8	95.2	18.6	120.5	0.0	1.0	364.6	299.1	1.5	48.2	192.7	331.9	16.5	348.8	21.0	6.6	9.0	23.3	2.4	5.2	124.2	30.5	96.0	83.8	2.8	256.6	613.9
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425649-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 151.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	27.9	32.3	18.0	5.3	18.9	7.0	19.5	21.3	22.6	29.6	7.6	35.1	9.0	31.3	5.5	12.3	27.5	7.4	31.4	21.7	14.0	151.1	37.3	25.2	5.8	14.4	15.8	33.8	47.4	15.9	41.5	6.5	15.2	29.9	3.1	6.1	19.3	7.8	52.2	19.5	27.5	7.1	12.7	26.4	22.2	34.6	16.8	5.3	24.8	15.8	3.2	31.7	19.9	19.0	5.9	14.9	14.6	11.9	20.2	13.2	10.0	10.6	11.6	10.7	7.6	11.5	3.0	15.3	11.0	18.7	8.9	5.5	8.9	13.4	3.9	10.8	14.9	7.9	14.8	31.7	20.9	9.5	8.6	12.7	8.8	11.6	9.9	11.7	17.3	10.7	3.5	6.0	14.4	22.5	10.2	15.9	11.7	5.0	6.8	22.8	10.8	4.6	11.3	4.0	13.8	12.0	11.5	13.6	7.5	5.0	7.6	13.9	29.9	14.8	8.8	13.6	7.0	6.9	6.7	18.8	6.5	5.8	11.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	18.0	18.9	21.3	22.6	21.7	14.0	14.4	15.8	15.2	12.7	16.8	19.0	9.4	3.2	1.7	36.9	3.8	3.7	0.7	1.1	2.2	7.7	3.5	4.3	12.4	7.2	4.3	5.5	6.2	1.0	5.7	5.9	27.4	1.6	1.2	6.4	8.7	7.1	3.0	1.7	73.5	1.2	0.2	5.5	2.0	13.1	1.3	8.4	17.9	15.9	0.8	21.9	60.3	3.0	0.0	3.7	1.6	2.6	0.6	4.7	0.0	19.7	0.6	7.2	2.1	46.8	40.7	1.4	3.9	1.9	3.4	0.9	8.1	384.2	3.1	7.6	6.6	5.3	5.4	4.0	2.8	0.3	2.3	0.8	4.4	6.1	5.9	0.3
RAB24		ENSG00000169228	"RAB24, member RAS oncogene family"	Q969Q5	5	177301198-177303744	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 55.2;Plasma cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 125.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034945			Uncertain	"Focal adhesion sites"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Focal adhesion sites"		"HPA034945: "	"unprognostic (1.03e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (6.22e-4)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.54e-7)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-2)"	22.0	38.9	30.1	20.0	30.1	25.9	24.3	25.8	32.6	31.2	32.4	24.0	13.8	20.0	22.1	42.4	20.2	11.5	23.5	30.3	31.9	32.8	30.5	27.1	15.7	30.1	26.4	27.0	59.7	17.8	48.6	12.0	29.9	31.1	10.5	11.6	34.3	12.5	30.3	42.2	24.5	11.7	26.3	53.7	22.2	11.4	29.6	11.2	24.1	17.4	20.6	23.5	32.3	29.6	6.9	17.7	13.0	25.3	20.8	18.0	19.5	19.8	28.6	27.8	33.7	20.9	8.8	7.2	24.2	18.5	30.7	4.9	17.7	24.8	15.7	125.9	9.8	25.2	17.4	18.6	43.2	15.6	21.3	30.4	20.2	29.9	21.0	41.4	17.3	21.4	18.0	42.6	20.1	26.2	5.7	38.3	8.0	15.2	17.8	3.6	18.5	28.0	19.1	12.6	14.1	20.1	6.8	13.1	59.6	15.9	23.0	41.0	16.2	8.5	14.2	19.8	19.1	31.4	15.9	9.8	16.5	24.3	17.9	42.6	87.1	166.7	19.0	185.2	17.7	33.2	10.3	16.6	60.1	29.0	10.9	16.6	137.3	37.4	183.6	13.6	9.3	48.4	30.1	30.1	25.8	32.6	30.3	31.9	30.1	26.4	29.9	26.3	29.6	29.6	6.3	3.2	7.1	31.0	33.7	5.4	1.6	16.3	55.2	3.7	12.1	8.4	2.4	1.5	12.9	1.8	2.1	7.6	7.3	28.5	3.9	24.5	0.6	2.4	3.9	5.9	18.0	12.6	42.7	20.1	6.3	10.8	31.1	3.2	12.0	1.3	5.3	1.7	4.3	13.5	45.1	12.8	6.1	8.8	6.9	0.6	5.0	37.7	3.6	10.3	11.1	2.0	9.2	14.6	15.6	18.9	27.7	1.2	71.1	1.9	26.0	6.9	5.5	4.2	0.0	2.4	8.0	2.2	3.6	43.8	6.0	30.6	15.4	2.2	13.3	2.0
RAB26		ENSG00000167964	"RAB26, member RAS oncogene family"	Q9ULW5	16	2140803-2154165	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.9;choroid plexus: 43.0;liver: 45.9;pancreas: 42.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 36.1;Enteroendocrine cells: 99.4;Excitatory neurons: 52.0;Inhibitory neurons: 28.3;Intestinal goblet cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 20.1;HeLa: 23.2;MCF7: 13.5;SCLC-21H: 27.2;SK-BR-3: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075624			Uncertain	"Vesicles,Plasma membrane,Centrosome"	"Intracellular and membrane"	No	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Vesicles, Plasma membrane"	Centrosome	"HPA075624: "	"unprognostic (1.01e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (7.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.92e-3)"	0.3	1.1	53.5	0.1	55.8	0.2	0.9	57.7	84.9	1.7	43.0	5.7	5.6	0.2	1.8	1.6	0.6	0.8	1.8	60.7	46.2	1.4	45.9	0.3	0.3	48.0	45.4	0.2	42.7	3.4	34.0	0.0	49.1	4.9	5.1	6.8	18.4	0.8	1.1	1.5	6.4	0.1	44.0	0.7	13.7	1.0	47.6	0.3	1.7	2.1	0.8	0.8	0.7	51.9	1.7	20.1	0.1	5.1	0.3	0.1	0.1	0.9	1.6	0.7	1.3	0.6	4.0	0.3	1.4	1.3	0.6	3.2	1.1	0.4	0.1	2.2	2.1	0.8	23.2	1.8	0.8	0.0	0.6	0.8	0.2	0.2	0.3	4.6	0.4	3.2	0.4	0.0	2.3	13.5	0.1	1.0	1.2	6.5	1.8	1.7	1.6	3.5	7.7	1.4	27.2	5.4	0.6	24.9	1.0	0.3	8.2	0.3	0.9	0.0	3.5	0.4	0.4	2.9	0.1	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	53.5	55.8	57.7	84.9	60.7	46.2	48.0	45.4	49.1	44.0	47.6	51.9	0.2	0.0	1.1	6.5	1.3	1.3	1.6	1.4	8.0	36.1	1.4	1.4	1.6	1.5	3.4	0.0	4.2	0.0	0.0	2.6	0.0	0.4	0.1	1.0	0.3	0.4	99.4	0.0	52.0	1.0	0.0	0.4	12.8	0.4	0.0	0.5	1.1	8.1	0.2	1.7	28.3	41.9	4.1	0.3	0.0	0.1	0.0	0.1	3.6	8.4	0.0	10.7	0.0	20.1	3.6	0.5	1.8	0.0	3.8	1.5	10.5	0.6	2.3	9.1	0.0	0.3	0.3	0.0	2.4	1.5	0.1	0.1	0.2	0.3	3.2	2.6
RAB29	"RAB7L, RAB7L1"	ENSG00000117280	"RAB29, member RAS oncogene family"	O14966	1	205767986-205775482	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.3;monocytes: 76.4;NK-cells: 129.8;Proximal tubular cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020822, HPA026303"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB020822: , HPA026303: AB_1856016"	"unprognostic (5.38e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (9.50e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.42e-1)"	13.5	14.4	12.5	20.4	14.1	7.1	14.1	14.3	12.1	8.7	10.5	12.6	10.6	8.3	23.8	7.8	6.2	16.9	13.1	12.3	14.3	73.1	19.4	13.5	35.1	15.9	12.9	7.9	9.2	25.5	5.9	7.2	15.8	13.8	10.1	6.8	19.8	13.9	6.4	5.5	12.4	14.8	14.3	24.3	10.4	4.6	15.3	12.1	33.4	6.0	28.0	15.7	5.7	17.0	20.4	18.6	2.8	13.1	52.5	29.8	9.7	14.1	43.2	28.9	34.4	5.6	28.7	21.6	13.6	24.3	34.6	11.2	32.8	37.3	26.4	88.3	15.3	16.4	7.3	9.5	25.4	16.1	23.2	29.0	24.6	23.3	32.8	24.0	37.2	19.8	16.2	24.2	41.2	7.6	17.7	8.3	13.1	25.4	14.0	3.7	43.1	17.5	33.6	27.7	4.4	12.5	10.0	45.0	37.8	10.3	22.0	13.2	38.7	29.7	15.0	43.5	20.6	39.4	87.0	11.5	30.1	26.3	22.5	92.4	22.6	62.3	92.2	43.8	86.9	50.8	51.0	79.5	33.4	45.8	37.2	63.5	8.8	94.1	53.9	10.4	53.3	51.3	12.5	14.1	14.3	12.1	12.3	14.3	15.9	12.9	15.8	14.3	15.3	17.0	16.3	19.2	17.7	11.1	61.2	0.0	6.3	0.0	13.6	2.1	19.5	16.0	19.3	21.5	6.2	31.3	0.0	12.0	82.3	1.9	29.4	18.7	5.1	2.0	6.3	18.6	4.9	10.8	7.8	10.1	6.4	11.2	10.7	3.5	13.3	9.2	14.6	33.7	32.8	0.0	10.2	3.7	0.0	30.1	0.0	4.1	14.3	34.0	0.0	10.3	76.4	26.5	129.8	10.6	9.8	8.3	4.8	20.7	34.8	10.7	9.5	187.7	2.9	2.0	6.6	10.0	6.7	3.8	11.8	9.3	0.0	2.9	51.7	19.7	5.5	6.9
RAB3IL1	GRAB	ENSG00000167994	"RAB3A interacting protein like 1"	Q8TBN0	11	61897301-61920269	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.9;Hofbauer cells: 65.3;Late spermatids: 133.8;Leydig cells: 56.2;Peritubular cells: 45.1;Theca cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 36.9;HHSteC: 36.9;K-562: 34.4;RPMI-8226: 44.3;U-2197: 56.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039723	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Centriolar satellite, Cytosol"		"HPA039723: AB_10795406"	"unprognostic (1.62e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (1.97e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (7.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.59e-3)"	29.8	9.5	10.9	7.9	11.2	13.8	22.8	10.3	13.4	38.6	12.7	13.6	4.7	30.0	4.6	6.2	24.0	11.3	20.5	10.5	10.8	16.0	6.9	11.8	6.5	12.8	11.0	37.1	5.1	7.8	9.5	15.9	11.8	10.6	2.6	3.1	12.2	5.1	7.6	15.2	9.9	9.3	11.6	28.2	9.4	41.2	14.8	9.0	15.1	10.0	2.4	19.0	20.7	12.7	6.9	13.3	0.4	7.3	26.9	19.9	1.5	5.5	13.7	8.0	5.4	1.9	1.5	0.1	10.1	8.4	36.9	3.7	9.6	0.5	1.2	0.0	2.1	12.8	5.1	7.2	36.9	0.5	0.3	10.7	6.9	3.9	9.1	1.3	0.7	7.1	34.4	0.3	4.7	12.3	0.0	0.1	4.3	1.2	14.1	0.7	1.9	44.3	0.7	0.5	0.6	4.9	3.4	2.9	25.0	2.2	2.2	1.6	0.6	29.3	13.2	56.5	2.3	0.4	2.1	0.0	5.7	15.8	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	11.2	10.3	13.4	10.5	10.8	12.8	11.0	11.8	11.6	14.8	12.7	5.5	0.0	0.0	1.6	0.8	5.1	0.9	0.0	0.6	0.5	1.3	1.9	1.9	2.8	0.6	1.8	0.0	1.3	0.1	0.1	1.9	2.2	110.9	1.9	27.8	9.6	0.0	34.5	0.4	1.0	2.0	24.3	1.1	1.8	0.0	1.1	16.1	1.4	65.3	1.7	1.3	0.0	0.0	19.9	10.2	133.8	56.2	6.8	8.8	8.4	0.0	6.5	0.0	1.0	0.7	1.1	0.0	45.1	0.0	1.6	0.0	15.9	0.0	8.2	0.0	3.4	8.2	1.7	9.1	0.2	4.0	1.4	0.6	47.6	0.2	0.2
RAB3IP	"FLJ22548, RABIN3, RABIN8"	ENSG00000127328	"RAB3A interacting protein"	Q96QF0	12	69738860-69823204	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 210.4;Early spermatids: 287.3;Late spermatids: 453.9;Oligodendrocyte precursor cells: 261.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 156.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039794	Uncertain		Approved	"Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Intermediate filaments"		"HPA039794: AB_10960557"	"unprognostic (4.38e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.68e-13)"	"unprognostic (6.17e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.37e-1)"	3.7	15.9	17.7	6.4	22.0	25.6	19.9	79.7	16.9	8.4	51.6	21.7	19.2	5.5	44.3	8.6	15.2	15.1	18.3	18.7	18.9	48.5	16.6	14.9	13.6	25.7	21.7	3.1	22.8	26.9	20.2	12.0	26.2	20.8	22.6	88.6	12.8	9.7	9.7	11.8	22.4	4.9	12.1	6.8	18.4	74.7	19.7	12.7	16.2	14.3	15.3	11.8	4.8	25.6	44.1	23.5	14.3	22.9	6.9	3.1	41.0	4.3	9.9	16.9	22.6	67.3	19.1	34.1	13.9	2.3	21.9	33.0	14.7	22.9	29.0	51.7	25.6	25.3	8.4	32.9	6.4	29.9	15.4	7.4	23.3	15.6	52.4	17.5	24.8	44.4	12.1	30.3	9.6	46.8	30.3	12.8	35.7	46.1	25.7	35.3	22.2	35.9	55.1	53.5	56.7	10.2	16.7	28.0	6.4	57.0	47.6	11.1	7.4	7.2	18.3	3.0	20.3	14.2	63.4	156.9	17.5	18.3	11.2	1.8	5.2	7.2	4.2	1.9	8.5	9.2	7.5	6.8	5.6	8.6	9.3	9.1	6.9	7.8	2.3	5.1	12.6	4.4	17.7	22.0	79.7	16.9	18.7	18.9	25.7	21.7	26.2	12.1	19.7	25.6	4.0	60.9	51.1	19.6	17.7	23.6	55.6	28.8	19.4	210.4	44.6	13.0	50.2	85.8	48.8	51.5	110.5	21.7	6.4	33.1	37.2	64.6	287.3	79.7	5.2	8.7	40.8	14.1	22.6	31.8	8.2	6.4	39.3	119.7	2.5	19.3	7.1	16.5	3.5	28.6	186.1	39.3	46.8	1.9	7.5	453.9	4.4	8.0	5.4	9.4	16.6	96.6	4.1	261.9	104.1	51.1	38.6	3.8	25.9	77.9	46.1	82.1	54.4	95.8	6.6	31.8	12.3	48.9	37.7	24.2	29.8	8.5	15.1	3.5	45.8	76.7
RAB44	"dJ431A14.3, RASD3, RASL13"	ENSG00000255587	"RAB44, member RAS oncogene family"	Q7Z6P3	6	36697826-36733184	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"bone marrow: 58.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.4;granulocytes: 14.5;monocytes: 2.3;Squamous epithelial cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"basophil: 10.6;eosinophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 21.9;HL-60: 30.9;HMC-1: 88.9;NB-4: 76.7;THP-1: 30.1;U-937: 60.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079390			Approved	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Vesicles		"HPA079390: "	"unprognostic (8.86e-2)"	"unprognostic (5.58e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.56e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.79e-2)"	0.5	0.0	0.0	0.6	0.1	58.9	0.4	0.0	0.1	0.4	0.0	0.4	0.6	0.3	0.2	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.5	0.9	0.4	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	30.9	88.9	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	10.6	0.8	7.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.2	4.4	0.7	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	1.3	0.3	0.2	0.0	0.3	0.0	0.5	14.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	0.0	1.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.3	0.0	0.0	2.2	0.0	0.0	0.4	0.1	0.0	0.1
RAB5B		ENSG00000111540	"RAB5B, member RAS oncogene family"	P61020	12	55973913-55996683	"Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010224, HPA068337"	Approved		Supported	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB010224: AB_2175453, HPA068337: AB_2685974"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.09e-1)"	"unprognostic (8.42e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.31e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.49e-1)"	50.9	54.4	95.4	39.4	102.3	35.0	68.2	106.2	96.8	76.8	76.5	72.2	52.4	73.8	92.4	99.8	75.7	55.8	87.2	93.1	99.5	70.1	68.8	72.9	44.5	103.5	105.6	85.4	47.9	112.1	31.4	63.4	106.0	74.6	80.6	72.9	61.7	94.6	100.6	92.4	50.4	79.9	103.6	48.1	67.0	57.1	99.9	64.0	64.6	127.6	76.0	65.6	69.6	112.9	62.3	39.1	80.2	59.4	128.5	115.9	72.1	56.1	102.3	68.3	57.5	67.5	76.7	34.7	65.5	107.6	50.3	44.8	51.4	77.8	63.3	44.1	39.5	39.3	53.1	38.6	94.5	33.2	61.6	94.9	142.7	64.2	54.2	153.0	87.0	42.2	36.2	99.3	87.3	42.3	42.6	51.9	35.8	51.5	35.2	36.5	49.9	45.1	128.2	100.7	40.0	35.6	73.1	72.4	89.0	88.3	104.6	102.5	72.3	44.5	32.5	32.8	22.2	56.4	46.9	21.8	71.5	30.7	38.4	18.5	10.1	32.6	11.1	9.3	10.3	8.9	9.0	9.9	8.0	6.9	10.2	8.0	27.4	7.6	10.6	8.0	7.6	8.9	95.4	102.3	106.2	96.8	93.1	99.5	103.5	105.6	106.0	103.6	99.9	112.9	24.4	57.7	37.1	13.1	26.7	51.7	26.5	34.0	35.3	33.3	54.4	38.2	53.2	55.8	34.0	42.3	52.1	44.0	29.1	88.1	35.2	49.4	11.1	24.1	22.8	30.8	38.9	29.8	21.4	37.1	42.8	33.1	37.2	33.9	19.7	34.1	42.1	86.0	31.1	16.8	23.4	51.1	16.2	46.4	52.3	27.7	53.4	25.4	35.6	11.2	64.7	41.6	32.0	11.1	26.3	71.3	44.4	59.5	27.1	57.0	44.7	35.9	23.9	31.6	59.2	31.9	33.2	36.8	25.6	64.7	89.2	88.0	25.0	23.4	42.7	65.8
RAB8A	"MEL, RAB8"	ENSG00000167461	"RAB8A, member RAS oncogene family"	P61006	19	16111889-16134234	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041945			Approved	"Nucleoplasm,Plasma membrane"		No	No		4800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"HPA041945: "	"unprognostic (1.10e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (6.60e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (9.99e-2)"	21.3	24.5	17.4	40.4	17.5	61.3	18.7	19.5	17.6	24.6	20.7	37.4	58.5	18.5	18.9	25.9	27.8	22.0	11.5	17.2	19.1	20.8	51.5	28.6	44.3	21.1	19.5	21.5	23.4	17.7	15.3	25.0	21.6	21.7	32.8	8.7	30.7	21.2	7.0	27.5	58.7	22.8	20.3	40.4	32.4	15.4	19.0	34.3	16.3	8.1	45.1	25.9	21.2	23.3	94.2	62.6	50.5	43.0	42.7	36.7	77.9	56.0	48.8	74.2	76.8	76.1	105.7	66.1	61.9	58.6	63.5	60.6	71.2	69.1	50.9	132.6	39.9	135.9	57.1	75.6	46.7	119.4	129.3	36.6	37.6	69.5	32.1	38.9	63.5	65.0	64.4	97.0	63.4	111.6	100.1	113.7	63.3	114.3	100.5	111.6	56.2	115.6	58.2	71.9	46.9	45.3	56.6	68.0	35.9	34.2	53.8	44.2	61.7	61.4	39.2	119.2	96.6	51.4	113.4	97.3	58.7	121.5	67.0	244.5	278.6	315.0	164.3	387.5	145.7	190.5	143.3	147.5	247.5	190.0	112.5	131.7	292.2	225.9	485.1	177.8	150.9	514.1	17.4	17.5	19.5	17.6	17.2	19.1	21.1	19.5	21.6	20.3	19.0	23.3	47.2	25.6	29.1	2.3	70.2	47.7	47.4	53.5	31.3	15.2	37.0	34.7	3.0	17.2	35.7	31.3	14.6	95.7	97.9	115.9	82.2	70.7	31.0	33.7	29.7	37.3	30.4	47.5	4.2	51.5	98.6	36.3	29.6	45.0	48.7	36.2	26.0	50.3	88.9	6.7	3.5	55.3	48.8	50.6	81.5	19.0	27.7	100.9	33.8	2.8	124.8	34.9	131.8	3.0	8.8	76.8	90.0	24.8	96.5	30.7	130.7	62.6	35.4	13.9	32.9	22.0	38.1	33.3	23.4	30.4	52.6	79.6	64.8	43.4	52.0	38.4
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	37.5	45.5	49.9	29.8	67.2	51.9	35.9	43.7	69.2	33.5	30.2	59.9	39.8	38.5	10.7	57.4	36.4	15.3	86.3	47.6	35.6	55.3	24.3	41.7	26.9	47.8	41.0	39.5	101.5	22.7	69.9	21.0	41.8	67.4	21.2	15.3	42.8	20.1	154.5	45.7	51.6	16.2	35.6	50.3	61.7	50.0	47.2	28.2	42.1	60.9	18.2	43.7	35.0	45.9	75.2	97.9	68.4	80.3	27.5	30.7	178.5	65.8	42.2	63.1	45.9	109.7	77.2	104.7	40.5	52.0	66.4	159.9	76.8	58.6	21.5	110.1	97.5	64.5	127.2	129.9	49.4	120.6	79.4	34.2	59.6	39.0	42.8	38.3	66.4	88.8	142.0	50.0	43.9	149.5	130.2	82.9	128.0	91.3	82.4	167.4	81.6	103.1	41.5	65.7	223.5	92.5	117.2	135.6	83.5	36.1	116.8	120.1	81.1	80.9	69.8	86.5	109.1	42.3	51.8	85.5	68.2	57.8	77.5	0.5	1.8	1.2	1.4	2.4	1.5	2.2	1.5	1.4	1.3	2.0	1.2	1.5	0.9	2.3	0.8	1.7	2.3	0.6	49.9	67.2	43.7	69.2	47.6	35.6	47.8	41.0	41.8	35.6	47.2	45.9	36.2	28.9	41.2	24.5	25.5	18.0	17.7	12.6	38.7	39.5	38.7	33.4	35.3	0.0	13.8	25.8	20.9	25.2	35.3	172.7	31.3	34.9	13.4	42.6	40.6	25.7	52.0	25.6	37.7	58.2	33.2	28.1	43.3	43.8	15.2	85.2	0.0	0.0	31.0	38.7	34.3	78.5	20.3	0.0	26.5	18.5	19.6	37.0	40.9	8.4	27.5	22.2	24.7	18.1	26.9	62.5	80.9	26.7	67.7	36.6	59.4	55.8	18.3	38.3	0.0	19.0	33.3	18.1	28.0	55.3	19.5	28.3	29.6	41.0	94.9	26.5
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374527-6403967	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 1980.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3900000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: AB_2680167"	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (1.74e-5)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	157.4	108.0	237.0	96.8	250.4	94.5	146.4	242.4	290.7	154.8	206.5	190.5	167.4	150.7	149.9	316.9	145.1	125.9	129.4	240.2	240.6	150.5	136.2	147.5	96.4	249.4	244.8	135.8	92.2	151.1	77.5	180.2	249.2	122.8	199.6	52.2	137.9	145.0	179.5	189.2	161.9	179.3	260.2	96.6	160.6	51.6	241.1	115.3	127.2	141.1	169.6	205.3	188.6	262.9	519.9	230.9	233.0	255.1	270.1	341.8	138.6	284.9	348.0	371.6	375.8	227.3	474.8	145.5	179.7	400.9	384.2	359.4	251.5	345.9	471.9	68.3	207.8	146.6	171.7	166.5	323.7	134.0	114.6	229.7	302.8	268.4	297.6	281.7	333.4	141.3	266.2	111.7	406.4	377.3	74.0	312.4	419.1	261.9	272.3	129.2	236.9	214.6	481.7	322.7	175.8	295.9	201.7	726.1	241.4	264.7	409.6	396.3	341.8	242.4	364.3	300.7	334.5	84.1	99.5	135.4	223.9	250.9	470.6	31.0	117.3	63.0	23.8	83.0	15.1	46.8	26.8	30.9	112.8	49.9	33.0	21.8	168.6	26.1	83.5	64.5	46.1	47.0	237.0	250.4	242.4	290.7	240.2	240.6	249.4	244.8	249.2	260.2	241.1	262.9	755.4	147.4	123.6	28.7	155.9	934.1	981.6	232.1	429.2	90.4	485.3	593.8	200.6	484.7	164.8	356.8	25.0	802.8	224.1	920.9	536.1	183.5	77.6	388.7	362.9	641.2	336.7	313.3	43.3	174.2	1064.1	415.9	305.3	422.8	130.9	325.4	580.8	367.1	832.0	146.4	35.3	632.9	179.0	811.3	1066.7	58.8	476.3	705.7	458.9	66.5	607.2	341.1	191.6	23.1	56.7	299.1	754.4	472.8	212.2	1495.5	816.4	832.0	214.1	64.2	479.9	346.6	466.6	216.6	373.1	774.5	1148.6	845.4	180.0	353.6	573.7	1980.7
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.9;lymphoid tissue: 43.0;testis: 45.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 55.7;Extravillous trophoblasts: 49.4;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	5.0	2.5	5.5	13.7	8.2	38.9	7.1	6.9	6.3	5.2	3.2	16.7	10.5	5.3	1.5	21.3	4.4	6.4	2.8	5.0	6.0	9.2	4.7	6.2	23.9	6.7	7.1	2.4	2.7	5.8	1.4	14.0	6.5	3.3	18.7	5.3	4.8	3.4	4.9	14.4	11.6	12.5	5.5	6.5	9.8	45.5	7.6	43.0	3.3	4.8	30.2	7.7	8.0	7.0	193.0	174.5	135.8	86.8	24.8	29.7	113.0	195.0	97.0	207.3	140.3	174.6	144.7	107.5	86.0	108.3	99.9	127.1	137.7	93.6	219.9	203.0	85.4	137.9	165.8	58.1	8.4	146.1	109.0	16.2	17.2	140.7	111.4	60.3	71.7	96.4	101.6	159.6	197.0	136.8	122.5	72.6	96.2	108.9	112.9	113.9	163.5	78.3	54.9	95.7	113.9	97.5	161.7	102.7	53.0	68.8	199.7	64.8	64.9	136.2	119.1	86.8	144.7	83.3	225.2	126.6	67.7	97.0	81.1	24.1	3.2	4.7	6.5	4.1	5.7	8.2	7.9	9.2	2.8	4.3	4.6	6.1	0.7	11.0	2.6	1.8	19.1	5.8	5.5	8.2	6.9	6.3	5.0	6.0	6.7	7.1	6.5	5.5	7.6	7.0	2.0	6.4	6.4	2.9	4.2	12.9	2.5	4.9	6.2	1.5	4.8	5.1	1.5	2.8	3.3	5.5	4.2	21.8	4.4	3.1	19.6	1.9	15.2	2.2	3.1	2.7	0.0	55.7	7.5	2.2	49.4	5.9	7.7	4.0	2.5	14.2	5.3	2.7	13.1	1.7	8.0	5.7	20.3	11.3	8.0	17.7	1.5	7.1	1.8	1.0	4.5	2.7	6.2	6.0	12.3	2.0	1.0	3.8	10.9	2.8	1.1	2.1	2.3	0.8	13.1	3.1	5.5	79.6	32.2	19.5	12.9	8.6	6.9	2.2	11.6	2.9
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905260-34918989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.5	8.1	3.2	4.8	3.5	8.4	5.8	3.9	4.6	6.8	5.3	4.1	4.9	5.6	5.4	4.9	3.9	4.6	8.9	3.8	4.6	5.1	4.3	7.5	8.9	3.5	2.7	5.7	4.4	5.1	3.5	8.1	3.2	6.8	4.3	8.7	4.9	4.8	10.9	6.7	4.8	4.6	1.9	4.9	4.8	7.9	3.4	6.3	6.3	8.6	6.2	5.2	4.7	3.8	8.5	10.2	12.3	20.5	7.9	9.4	17.2	15.1	12.0	13.0	10.6	12.2	12.3	25.0	5.2	11.2	15.7	8.4	12.6	7.6	14.4	10.1	12.7	12.9	34.0	8.0	11.9	16.5	11.9	7.8	7.3	13.9	9.3	6.1	6.2	11.0	22.7	13.2	11.2	10.2	19.6	13.9	15.4	6.0	15.7	17.1	24.0	8.6	6.7	9.0	12.4	13.3	30.0	19.9	13.3	7.6	12.5	14.8	6.2	17.9	13.3	9.7	14.4	7.9	13.8	20.3	11.1	28.6	12.5	7.4	2.9	6.5	5.3	2.8	6.9	8.6	5.8	7.6	3.1	9.1	8.2	6.8	1.6	4.5	2.8	6.9	4.9	2.6	3.2	3.5	3.9	4.6	3.8	4.6	3.5	2.7	3.2	1.9	3.4	3.8	11.5	22.4	43.2	5.9	18.3	29.2	20.2	29.3	13.1	25.3	23.9	18.4	25.7	14.3	21.3	20.2	27.1	82.3	20.4	11.9	19.6	18.1	22.0	13.1	16.6	14.1	13.1	28.2	6.6	22.5	54.4	18.7	6.1	12.0	21.5	39.1	10.0	14.8	23.4	23.5	9.0	12.7	30.5	12.0	19.3	16.8	25.1	13.1	17.8	6.5	12.7	23.9	9.2	7.5	9.1	17.8	13.8	21.8	18.0	21.9	13.4	16.4	14.6	35.6	13.1	19.6	19.4	72.5	58.6	15.6	28.6	80.6	22.3	27.4	13.0	25.8
RAD18	RNF73	ENSG00000070950	"RAD18 E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	2.7	2.3	1.2	3.3	1.5	5.2	5.3	1.3	1.7	3.2	0.5	3.8	10.1	2.8	1.9	3.4	2.3	3.1	1.8	1.5	0.9	1.6	2.7	2.7	4.6	1.6	1.0	2.8	1.7	2.0	1.3	3.0	1.5	3.2	4.9	2.6	3.2	1.6	1.3	4.5	6.5	2.8	1.2	3.5	2.2	2.9	1.1	5.8	3.7	1.0	4.4	2.5	2.9	2.3	16.2	15.2	12.3	7.4	3.0	6.4	14.9	25.0	8.5	23.5	16.1	13.7	10.1	19.8	4.7	14.2	13.8	5.6	13.1	13.0	23.8	12.2	17.2	16.9	16.1	8.2	1.9	22.7	13.9	2.4	4.6	23.3	15.7	6.3	7.7	17.1	18.2	19.0	20.9	18.6	22.9	15.9	17.2	12.7	28.5	18.0	13.6	15.6	6.9	12.2	5.1	11.5	11.2	10.5	8.2	9.7	11.0	9.8	6.4	19.4	10.5	16.8	21.7	9.6	16.1	43.7	14.3	24.5	14.6	6.4	1.6	5.1	1.5	1.7	2.8	1.9	2.1	2.7	2.0	1.9	2.2	1.6	0.7	2.8	1.1	3.6	3.0	0.8	1.2	1.5	1.3	1.7	1.5	0.9	1.6	1.0	1.5	1.2	1.1	2.3	5.7	16.0	9.8	6.2	7.7	11.1	7.5	6.4	5.7	4.6	7.3	11.7	2.2	4.3	7.5	3.7	2.1	9.0	8.6	5.2	1.9	9.6	4.2	4.0	5.8	4.6	1.8	7.2	20.9	8.2	12.4	6.8	3.6	4.9	13.9	14.8	6.1	3.1	7.1	3.3	15.7	6.5	2.0	5.2	5.6	3.0	4.1	4.6	3.6	14.0	7.1	3.2	8.2	16.1	14.3	10.2	4.3	2.6	8.7	6.4	4.0	3.1	4.1	2.3	6.6	4.3	6.9	26.2	14.0	6.0	11.8	6.7	7.5	9.3	6.3	3.6
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332192	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 420.5;Late spermatids: 1201.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		5900000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	73.8	47.8	26.6	44.4	27.0	82.8	48.5	40.4	37.4	42.8	22.0	47.7	41.9	41.9	68.8	63.6	40.9	34.1	48.7	29.0	29.2	44.4	140.8	39.3	39.4	26.9	27.0	37.8	64.5	50.4	30.5	77.7	26.3	48.2	47.7	42.1	38.4	43.5	153.0	64.7	40.6	55.0	22.5	36.2	41.5	59.4	27.7	58.4	42.6	123.5	49.9	67.5	42.8	30.7	132.9	114.9	158.6	102.9	107.5	166.6	179.9	200.6	162.3	172.8	116.9	190.1	140.5	184.8	79.3	218.6	156.4	181.2	221.0	175.9	172.9	126.4	73.0	96.2	112.0	147.6	140.3	174.2	79.3	141.1	161.3	165.3	248.0	136.0	124.3	79.6	158.3	133.6	159.5	215.0	169.6	88.3	170.5	231.2	133.0	125.3	209.6	87.8	149.8	122.1	144.9	98.2	138.8	193.1	125.8	237.5	197.7	70.5	114.3	129.0	127.0	161.6	152.5	91.9	181.2	98.5	138.0	101.7	138.0	0.9	1.1	1.1	1.9	1.2	2.1	1.8	1.1	1.6	1.0	2.1	1.7	1.5	2.9	2.3	0.8	1.1	2.2	0.6	26.6	27.0	40.4	37.4	29.0	29.2	26.9	27.0	26.3	22.5	27.7	30.7	49.7	44.8	40.4	32.3	54.7	195.5	148.1	40.5	79.1	40.5	65.3	36.6	117.4	68.6	42.2	35.0	27.1	269.7	37.1	82.9	50.9	89.2	420.5	69.8	80.8	68.7	101.0	76.1	54.9	77.4	259.7	79.3	60.6	90.8	36.2	83.0	55.6	209.9	99.5	50.5	47.2	83.8	38.7	65.6	131.1	1201.4	75.5	70.7	74.7	38.4	83.7	40.4	39.1	50.3	54.1	81.0	50.5	87.3	89.3	146.0	51.2	95.9	47.6	43.9	78.9	71.6	88.5	45.3	74.7	126.9	240.9	291.8	50.5	91.1	74.9	141.2
RAD51AP1	PIR51	ENSG00000111247	"RAD51 associated protein 1"	Q96B01	12	4538798-4560047	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Meiosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.9;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.4;Erythroid cells: 47.8;Extravillous trophoblasts: 34.1;Hofbauer cells: 40.8;Late spermatids: 68.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051499			Approved	Nucleoplasm		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051499: AB_2681508"	"unprognostic (1.03e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (6.30e-2)"	"unprognostic (5.25e-3)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.29e-3)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.44e-15)"	"unprognostic (2.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.88e-2)"	"unprognostic (3.75e-2)"	0.9	0.8	0.3	4.8	0.4	16.9	2.7	0.4	0.7	0.9	0.3	5.2	5.2	1.2	0.6	3.2	1.0	1.1	0.5	0.3	0.3	0.8	1.8	1.4	8.9	0.4	0.4	0.5	0.4	0.6	0.3	3.8	0.4	1.3	6.5	1.5	1.0	1.0	0.5	3.2	4.8	1.9	0.4	3.4	2.7	6.3	0.4	14.4	1.0	0.6	7.9	1.7	1.3	0.5	37.5	13.0	45.3	22.7	2.7	5.7	53.0	48.2	21.2	52.6	68.9	35.4	35.4	48.6	7.0	10.4	24.7	23.1	31.8	14.5	80.0	38.7	27.0	61.4	21.6	24.8	0.6	56.6	29.9	1.2	1.5	31.6	30.4	7.5	21.4	33.0	39.2	54.4	33.7	13.6	46.5	20.5	110.4	36.3	14.4	46.0	54.3	19.2	16.1	18.3	15.1	16.6	35.9	27.7	11.6	45.5	11.3	32.6	9.5	35.5	36.5	38.8	52.4	7.8	10.0	93.3	13.3	40.0	29.4	0.0	0.5	0.7	0.1	2.3	0.5	3.1	0.4	1.0	0.4	3.4	0.1	0.2	0.0	1.4	2.0	6.9	1.0	0.6	0.3	0.4	0.4	0.7	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.5	1.4	0.0	0.5	0.7	6.1	5.2	2.3	6.6	1.2	3.1	3.4	5.7	1.4	2.8	4.5	0.0	4.2	20.3	11.3	5.7	0.0	3.0	33.4	3.3	2.9	2.9	2.4	47.8	2.7	2.7	34.1	5.2	6.1	3.6	1.3	22.6	2.5	1.2	40.8	0.0	1.1	6.4	16.2	6.2	5.6	68.1	1.2	10.1	0.0	3.7	6.8	2.7	3.1	0.5	2.4	1.5	0.8	1.5	15.5	1.0	1.2	1.5	0.9	4.8	0.0	2.4	4.2	35.9	25.0	10.0	2.6	4.7	4.6	2.0	14.6	2.7
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 117.7;Spermatocytes: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 319.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: AB_2679250"	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	10.8	20.2	15.5	10.0	15.7	23.1	15.3	19.0	18.4	10.8	13.4	12.4	7.5	12.6	22.0	13.0	11.2	11.0	25.7	16.4	15.0	12.8	13.3	8.8	22.0	14.9	13.8	12.5	10.6	20.1	10.5	15.1	16.0	17.4	14.5	13.5	10.7	12.0	18.3	10.6	8.7	13.8	13.2	12.2	11.6	20.2	14.6	21.2	12.3	17.3	19.1	10.9	8.6	18.2	63.7	72.1	43.3	48.5	22.9	19.6	100.1	34.2	14.5	43.5	55.3	31.0	39.3	37.4	48.9	23.5	58.8	23.3	59.5	46.6	81.7	91.6	123.0	53.0	84.6	119.4	23.3	69.1	45.0	12.1	42.2	47.8	38.6	24.0	50.0	60.9	83.6	48.5	37.0	319.1	96.8	95.3	12.1	42.5	66.5	62.1	69.5	69.8	26.9	39.6	54.3	49.6	27.3	12.0	53.5	11.1	39.2	71.6	16.5	37.6	100.1	34.3	42.4	44.1	187.2	111.5	38.3	67.1	42.0	27.6	9.2	12.5	15.6	14.3	15.2	18.0	16.9	17.2	15.9	17.3	18.2	17.4	5.1	15.0	12.5	14.3	27.1	11.0	15.5	15.7	19.0	18.4	16.4	15.0	14.9	13.8	16.0	13.2	14.6	18.2	20.5	19.2	13.9	10.1	20.5	11.9	18.7	42.9	15.9	15.0	25.1	34.0	63.7	7.2	20.9	16.5	6.2	67.8	15.0	7.1	58.7	25.7	117.7	17.3	13.0	19.3	6.7	43.8	21.5	18.6	94.1	19.8	7.1	13.0	22.9	23.3	15.7	15.7	33.4	16.8	17.7	11.7	32.6	16.1	47.7	65.4	17.4	21.8	24.9	13.1	18.7	31.3	21.6	23.1	22.8	13.0	10.4	15.4	28.5	17.2	5.7	24.6	14.1	26.9	32.9	14.7	23.9	140.7	98.3	15.9	10.7	36.3	20.5	28.2	15.3	13.9
RAD9A	RAD9	ENSG00000172613	"RAD9 checkpoint clamp component A"	Q99638	11	67317871-67398410	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006725, HPA048155, CAB079979"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290"	"unprognostic (7.64e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (6.16e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.52e-6)"	5.8	5.0	3.3	6.9	3.6	10.2	6.9	2.1	6.0	9.2	2.9	7.3	10.9	7.4	2.1	9.0	10.9	5.7	4.2	3.8	2.4	7.1	6.6	6.7	8.3	2.9	3.6	8.0	8.0	3.4	10.1	4.4	2.2	10.8	3.0	1.8	9.8	6.1	5.2	11.4	11.1	2.4	2.2	9.4	8.4	8.6	2.5	6.1	9.7	2.1	3.7	6.5	8.5	2.2	10.8	15.8	9.5	13.8	2.8	1.1	12.0	5.7	4.9	8.0	7.1	23.2	20.9	11.1	12.4	1.8	13.0	18.7	6.0	5.5	0.9	13.0	16.3	16.8	8.5	10.4	3.8	12.3	20.3	3.2	5.3	7.2	3.5	6.1	5.5	23.2	14.7	15.6	2.3	33.2	21.9	21.8	13.2	15.9	12.1	18.8	12.5	13.6	2.2	9.0	9.8	10.6	9.9	27.2	21.1	2.4	19.1	10.9	4.2	11.7	14.3	23.3	8.7	14.6	14.2	11.5	7.5	11.6	9.6	5.3	1.8	6.0	5.2	2.3	3.8	4.3	4.1	4.3	1.2	3.1	2.9	3.2	2.8	3.1	2.5	3.4	2.4	1.5	3.3	3.6	2.1	6.0	3.8	2.4	2.9	3.6	2.2	2.2	2.5	2.2	16.0	22.4	17.1	10.1	31.0	17.1	17.7	17.9	23.3	19.6	19.7	18.4	1.1	12.8	22.2	20.2	70.9	27.9	31.3	54.2	13.7	11.3	27.3	32.1	13.4	16.3	14.3	17.7	8.5	13.1	22.4	13.8	27.0	14.9	20.3	26.0	11.0	6.6	15.1	21.9	6.0	48.9	10.2	10.3	31.4	13.2	10.5	14.0	19.6	11.2	8.9	15.0	56.7	2.5	5.3	11.6	31.6	12.4	38.5	16.6	61.8	10.9	44.0	32.1	13.1	10.5	14.5	32.0	17.6	18.3	17.3	40.6	30.3	15.3	38.7	18.0
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"lymphoid tissue: 395.0"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Hepatic stellate cells: 8.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MOLT-4: 283.5;REH: 266.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA043939			Supported	Nucleoplasm		NA	NA				"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA043939: AB_2732512"	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.4	0.5	0.1	0.2	0.1	4.3	0.2	0.1	0.2	0.4	0.2	0.4	0.8	0.2	0.8	0.1	0.3	0.4	0.3	0.1	0.1	1.3	0.8	0.6	0.1	0.1	0.1	0.3	0.3	0.6	0.1	0.6	0.1	0.3	0.3	0.6	0.4	0.3	0.1	0.1	1.0	0.1	0.1	2.6	0.5	0.3	0.1	395.0	2.4	0.3	0.6	0.3	0.1	0.1	0.4	0.0	0.5	0.1	0.2	0.6	0.0	0.3	0.3	0.1	0.5	0.0	0.4	0.5	0.0	0.0	0.1	0.2	0.0	0.4	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.3	0.2	0.5	54.0	0.2	0.0	0.5	0.0	283.5	0.0	2.2	0.2	0.0	266.4	0.0	1.3	0.9	0.0	0.1	0.3	0.1	0.7	0.1	1.2	1.0	0.1	1.0	0.2	0.2	0.2	0.1	2.3	1.9	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.1	1.4	0.7	0.0	1.0	1.0	0.8	0.9	0.0	0.4	1.8	0.0	0.2	0.5	1.3	3.9	0.8	2.3	0.3	0.3	1.6	0.0	0.4	1.8	0.5	0.1	0.7	0.0	0.4	0.0	0.3	8.2	2.1	0.4	0.0	1.7	0.8	0.0	0.6	0.7	1.7	0.0	0.1	0.0	1.0	1.1	0.5	2.1	1.0	1.3	1.1	0.4	0.0	0.0	0.5	3.0	2.9	0.4	0.9	0.0	0.2	0.7	1.0	1.0	0.2	0.4	0.4	0.4	0.5	0.6	0.6
RALY	"HNRPCL2, P542"	ENSG00000125970	"RALY heterogeneous nuclear ribonucleoprotein"	Q9UKM9	20	33993646-34108308	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040971, HPA043614"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA		9400	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA040971: AB_2677230, HPA043614: AB_2678581"	"unprognostic (2.06e-1)"	"unprognostic (9.54e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.80e-2)"	109.7	65.4	72.1	90.4	83.2	189.2	98.2	82.6	79.3	108.9	81.8	127.2	109.8	96.9	41.6	119.6	84.8	70.7	143.2	67.6	77.4	104.4	68.3	117.4	116.9	87.8	81.9	101.2	78.2	62.1	55.6	77.6	84.2	88.3	87.6	55.0	105.3	64.3	178.4	114.6	117.7	70.1	83.7	109.6	101.9	116.5	80.9	161.7	125.5	106.0	99.9	99.3	98.4	100.7	250.4	138.1	247.6	193.9	115.3	110.3	210.1	172.9	136.0	215.1	183.0	375.8	204.0	204.3	238.7	140.6	290.9	259.4	135.8	252.7	119.2	132.2	119.3	468.3	81.4	375.4	147.8	236.2	215.0	122.4	141.6	161.9	175.4	160.7	203.0	245.6	201.7	300.9	135.8	185.9	589.3	266.6	137.5	306.0	277.2	344.4	360.6	250.7	126.7	135.4	235.8	266.6	271.8	248.4	376.6	125.8	256.2	234.4	167.5	414.4	270.7	212.3	206.6	310.7	308.3	353.5	213.0	169.9	201.3	139.3	110.7	221.3	138.8	137.1	100.2	96.5	122.2	150.4	135.3	99.6	107.8	104.0	173.3	186.1	195.5	110.0	141.4	165.3	72.1	83.2	82.6	79.3	67.6	77.4	87.8	81.9	84.2	83.7	80.9	100.7	91.8	54.5	61.3	23.2	98.3	79.2	126.9	102.3	74.6	24.2	74.9	67.8	63.4	58.6	61.7	55.2	18.8	161.3	118.3	287.4	127.2	149.1	48.1	36.4	48.5	92.1	93.0	87.9	19.3	160.5	227.7	78.2	70.8	66.9	59.7	69.7	76.8	39.8	159.6	8.4	14.6	143.2	95.6	112.2	118.1	46.7	65.6	96.9	115.6	50.6	151.3	62.6	163.7	15.6	57.1	190.3	270.7	62.1	206.4	157.5	220.7	107.3	38.8	36.3	111.7	47.7	97.7	106.6	121.1	103.7	80.7	171.4	117.2	51.6	178.6	176.2
RAMAC	"C15orf18, FAM103A1, HsT19360, MGC2560, RAM, RAMMET"	ENSG00000169612	"RNA guanine-7 methyltransferase activating subunit"	Q9BTL3	15	82986210-82991057	"Predicted intracellular proteins"	"mRNA capping, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 108.2;Extravillous trophoblasts: 82.2;Hofbauer cells: 69.4;Syncytiotrophoblasts: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041923, HPA041948"	Supported		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041923: AB_10796467, HPA041948: AB_10797270"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.45e-1)"	12.9	14.8	10.9	16.4	11.4	30.1	26.1	12.9	14.8	16.6	11.6	18.4	14.5	18.2	30.1	24.1	19.5	13.4	14.8	11.6	12.2	16.8	24.2	13.0	23.0	11.6	11.3	20.6	16.4	18.8	12.9	25.9	11.3	18.0	19.3	19.9	18.2	15.2	29.1	21.5	13.4	16.8	11.6	14.1	19.0	15.6	11.1	23.3	18.2	20.2	28.9	20.8	15.6	11.6	34.1	44.7	44.3	27.1	23.5	15.9	32.7	33.7	33.5	37.6	30.4	49.4	42.9	16.8	45.8	29.2	45.4	37.9	77.1	32.4	40.6	42.0	49.7	52.7	22.7	58.7	33.3	38.0	44.9	34.9	61.4	30.6	38.5	28.7	23.6	28.5	62.8	33.9	39.8	35.7	29.5	48.3	52.0	45.0	21.1	33.4	38.2	26.0	49.0	64.6	41.1	42.0	34.6	36.7	87.0	71.5	58.6	47.9	16.8	27.5	34.9	26.1	48.8	53.1	104.0	41.8	25.2	50.7	34.5	138.6	59.2	98.2	47.9	57.0	51.8	64.8	54.1	52.3	56.1	61.1	53.9	53.4	117.4	70.4	62.8	51.6	69.9	65.9	10.9	11.4	12.9	14.8	11.6	12.2	11.6	11.3	11.3	11.6	11.1	11.6	18.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	82.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	92.9	2.7	0.0	0.0	0.0
RAMACL	"C6orf119, dJ427A4.2, FAM103A2P, RAMMETL"	ENSG00000235272	"RNA guanine-7 methyltransferase activating subunit like (pseudogene)"		6	166585604-166587594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"brain: 2.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.5;ASC TERT1: 2.8;HEK 293: 5.9;HeLa: 2.2;HHSteC: 4.9;TIME: 1.8"									"HPA041923, HPA041948"	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 8: Neutrophils - Inflammatory response"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA041923: AB_10796467, HPA041948: AB_10797270"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.33e-2)"	0.0	0.4	1.3	0.0	1.2	0.7	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0		0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.7	0.3	0.0	0.0	1.6	0.7	0.4	0.0	0.0	0.0		2.9	0.0	0.0	0.0	0.2	3.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	2.2	0.0	4.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.3	3.9	1.7	2.1	1.9	2.9	2.0	1.9	2.6	2.8	1.9	1.7	4.4	2.2	1.1	1.7	2.6	2.1	1.3	1.2	0.2	0.8	0.7	1.0	1.8	0.9	1.5	0.7	1.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 706.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 190.0;Endometrial stromal cells: 546.4;Exocrine glandular cells: 278.2;monocytes: 433.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 152.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	18	"NK-cell: 70.1"	"Lineage enriched"	"Detected in many"	18	"NK-cells: 70.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4;HDLM-2: 146.0;PC-3: 173.8;SH-SY5Y: 201.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"		"HPA057814: AB_2683536"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.61e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.46e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.08e-3)"	18.7	29.2	170.9	21.0	171.2	0.9	7.4	168.7	253.4	362.4	153.7	349.6	57.5	706.0	25.0	9.4	256.6	28.5	287.6	176.0	181.8	26.0	82.7	32.5	6.6	198.8	164.5	45.2	225.0	1.4	15.2	8.6	163.0	142.2	6.4	0.8	10.0	54.6	212.3	11.6	73.5	125.4	171.7	12.3	103.4	5.1	183.5	2.9	6.8	68.8	2.9	171.4	75.1	173.2	29.8	0.0	0.5	0.0	12.4	17.9	1.1	2.1	3.6	1.7	1.5	0.0	47.4	0.3	0.4	0.9	0.1	0.2	7.6	0.1	0.2	146.0	4.0	0.1	0.0	1.2	40.6	0.0	0.2	15.6	22.3	0.1	0.3	0.2	0.0	0.0	0.0	0.3	3.7	2.7	0.1	1.3	0.4	0.1	173.8	0.0	1.5	0.8	0.0	0.0	1.5	201.7	3.5	0.0	0.1	1.8	1.3	0.1	0.0	0.8	0.6	0.4	0.5	0.3	0.3	0.0	0.6	0.1	2.7	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.6	0.1	1.0	0.0	0.5	0.2	0.4	70.1	0.0	0.2	0.0	3.4	170.9	171.2	168.7	253.4	176.0	181.8	198.8	164.5	163.0	171.7	183.5	173.2	1.0	0.0	1.5	64.9	3.1	11.6	13.2	26.9	10.2	2.0	4.4	4.4	190.0	78.6	43.8	11.0	0.0	3.0	44.0	2.1	0.0	62.7	0.2	26.5	546.4	6.2	115.4	4.4	14.2	278.2	5.5	41.7	31.1	11.3	1.3	0.6	30.7	104.0	22.7	1.7	19.2	73.7	10.2	3.1	50.3	0.6	8.4	20.3	64.0	13.1	433.5	6.9	61.8	71.9	11.5	63.5	87.7	11.3	1.9	66.1	96.8	0.2	97.0	2.7	6.6	16.6	78.6	0.3	5.8	2.6	5.8	2.3	7.3	0.5	105.8	28.5
RAN	"ARA24, Gsp1, TC4"	ENSG00000132341	"RAN, member RAS oncogene family"	P62826	12	130872037-130877678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063353			Enhanced	Nucleoplasm		No	No		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA063353: "	"unprognostic (2.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (9.99e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (7.86e-5)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (6.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.16e-2)"	285.3	333.2	207.7	340.1	222.3	406.0	220.5	212.1	265.0	193.6	204.5	269.1	177.8	207.6	238.1	445.6	180.6	148.9	256.9	220.6	260.3	249.0	208.2	225.9	416.4	207.2	213.3	180.7	192.9	210.6	180.1	243.0	231.0	149.7	266.6	213.3	200.4	155.5	415.0	231.2	220.0	250.1	228.5	255.9	223.4	308.6	236.5	577.6	166.8	383.7	480.6	380.9	244.7	230.2	1391.5	1850.5	1580.8	921.6	707.0	868.2	1219.5	1770.2	926.2	1695.1	1163.1	2003.5	1434.2	2260.7	1169.3	1290.0	1067.9	877.0	2327.1	1854.5	1830.8	766.9	1831.5	1331.9	1318.9	2068.9	864.1	2347.9	1100.3	821.9	1129.3	1470.6	2111.6	1119.9	1671.0	1593.5	2013.6	656.5	1686.3	1688.2	2306.9	2810.1	1857.8	1429.2	2936.2	1773.9	1347.2	1274.4	1608.2	2377.1	1441.5	875.0	1018.5	920.7	1334.4	1299.9	1817.9	1666.5	1157.6	975.6	1495.0	998.8	1694.1	905.2	1605.1	3245.4	1002.2	1410.7	1390.4	285.0	398.0	275.5	501.5	489.3	614.6	726.4	682.5	581.4	531.7	593.3	611.5	585.9	80.7	500.4	481.0	506.9	768.0	1005.0	207.7	222.3	212.1	265.0	220.6	260.3	207.2	213.3	231.0	228.5	236.5	230.2	321.3	182.7	141.5	18.6	337.4	635.3	693.4	702.0	406.3	155.3	239.0	316.0	112.6	165.8	310.5	169.2	37.5	734.2	273.6	157.0	387.4	642.1	90.2	212.9	280.8	306.2	201.9	540.9	27.8	452.8	1266.0	379.6	181.0	201.3	194.0	273.1	143.8	181.6	624.5	139.7	25.8	300.5	349.9	171.7	424.1	148.1	213.4	239.7	332.6	9.4	417.0	287.5	219.4	19.6	23.5	596.4	189.1	230.9	418.2	954.8	167.2	423.2	214.3	141.6	164.3	286.0	600.8	746.4	571.6	578.0	547.0	613.1	332.3	451.9	403.6	621.0
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.7;Excitatory neurons: 100.6;Glandular and luminal cells: 59.5;Inhibitory neurons: 152.9;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 87.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 4.0;SK-BR-3: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	0.2	0.8	0.3	0.1	0.2	0.1	0.2	2.3	0.6	0.2	0.8	0.2	0.2	0.5	0.2	0.0	0.4	0.5	0.2	0.1	1.1	0.4	0.3	0.8	0.3	0.9	0.9	0.2	1.4	0.8	0.4	0.8	1.3	0.4	0.4	0.8	0.8	0.5	0.0	0.1	0.3	0.3	0.6	0.0	0.3	1.4	0.6	0.2	1.0	0.0	0.1	0.1	0.1	1.1	0.0	0.7	4.0	3.3	1.3	0.3	2.4	2.6	1.2	1.8	1.1	1.5	0.0	0.1	2.0	2.5	0.0	0.0	0.0	1.2	3.5	0.0	2.4	0.7	1.4	0.0	1.1	0.0	0.0	2.6	0.2	0.2	0.0	0.2	1.7	0.0	0.3	0.0	1.0	1.7	0.0	0.0	0.3	0.6	0.2	0.0	2.4	0.0	0.6	1.0	0.2	1.4	0.0	3.9	1.5	1.7	0.7	1.2	2.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.3	0.6	0.1	1.1	0.9	0.9	1.3	0.6	0.6	1.1	9.4	9.6	2.0	12.7	0.0	0.3	6.2	5.8	1.8	24.8	6.1	2.8	1.3	7.2	4.8	0.0	14.6	10.4	1.7	2.3	0.0	7.3	112.7	22.4	17.5	7.9	5.4	5.5	100.6	1.4	3.2	4.9	5.1	59.5	0.0	15.6	4.2	1.6	1.9	0.0	152.9	3.7	2.0	0.6	1.4	46.5	2.8	1.0	1.8	9.4	1.2	5.5	5.2	65.4	87.1	5.3	2.9	3.0	0.8	13.0	3.9	0.9	2.4	26.9	0.0	3.0	5.1	27.2	26.7	1.4	0.0	2.5	0.8	7.5	6.3	7.6
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Excitatory neurons: 132.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007, HPA076784"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	21.8	20.3	23.3	16.7	25.2	57.3	18.3	22.2	32.4	28.3	21.5	27.5	13.2	20.6	22.2	69.1	15.3	24.6	20.0	25.5	22.6	18.7	26.4	17.9	18.5	20.3	24.3	19.7	17.4	24.1	16.7	20.0	22.7	21.3	18.0	21.0	24.3	17.2	60.5	27.7	15.5	23.5	22.0	15.1	17.9	106.4	21.7	29.7	16.5	39.5	30.8	21.6	38.2	25.4	38.1	16.3	38.7	39.3	51.9	47.8	41.0	45.6	51.6	47.2	49.5	24.8	21.9	33.4	73.0	54.0	35.7	20.3	30.5	26.8	64.6	58.0	27.5	33.6	29.9	45.9	71.7	53.0	24.5	48.7	33.8	56.0	45.9	37.4	39.0	58.3	73.3	26.2	53.1	38.5	62.1	42.0	17.1	36.2	22.6	49.1	30.2	47.1	37.7	43.2	47.9	33.7	36.9	66.3	67.0	73.4	35.6	44.6	38.3	42.3	30.2	34.7	47.4	63.5	82.3	44.9	19.4	32.8	80.1	0.3	0.5	1.8	0.7	0.7	1.4	0.7	1.5	0.7	0.5	0.7	1.3	0.9	0.8	1.2	0.8	0.8	3.6	0.4	23.3	25.2	22.2	32.4	25.5	22.6	20.3	24.3	22.7	22.0	21.7	25.4	17.2	19.2	30.5	58.1	12.5	24.9	7.8	13.5	13.1	25.1	23.3	15.0	40.1	12.8	19.2	18.4	14.6	17.9	22.3	21.7	1.9	8.2	113.6	23.5	21.8	24.0	13.2	11.6	132.9	10.8	9.1	19.8	10.2	29.6	10.1	19.5	16.8	18.3	18.0	6.7	78.3	14.5	12.2	28.0	32.3	99.9	15.8	21.8	17.8	73.1	14.9	22.8	15.5	74.9	75.6	16.6	7.3	24.8	18.3	15.5	12.2	11.4	19.8	17.5	6.6	16.5	18.5	85.4	41.9	19.3	26.1	28.5	22.9	14.3	12.0	17.7
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41244779-41286187	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Late spermatids: 1717.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes		75000	"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	27.5	72.9	78.2	26.0	86.0	48.1	29.6	70.8	102.3	34.4	47.7	29.2	18.1	24.9	12.0	79.8	23.6	17.2	45.1	79.5	85.2	43.9	88.0	41.6	30.6	102.7	77.9	32.5	60.9	12.7	57.4	22.8	105.1	39.3	13.2	32.7	38.0	17.6	43.0	96.9	30.6	17.5	68.7	42.3	39.6	178.1	82.0	40.4	34.4	14.2	31.8	34.7	45.4	109.1	228.0	112.2	75.9	77.3	38.8	31.4	85.9	194.5	103.8	182.8	98.4	135.9	71.9	118.0	154.0	137.4	94.8	203.0	135.5	145.4	125.2	95.7	199.2	103.3	115.0	107.9	46.7	171.6	72.5	30.0	69.5	132.2	123.4	67.6	102.1	45.0	127.7	83.3	111.9	186.1	96.3	130.0	84.5	217.6	127.6	118.8	73.4	126.0	72.5	123.7	66.6	44.1	139.1	117.7	71.7	74.6	72.2	64.4	146.5	141.7	138.5	78.6	154.6	60.1	92.8	124.2	99.3	119.3	82.0	2.7	7.6	6.9	8.1	9.0	9.5	5.9	8.2	7.8	5.6	6.4	7.4	5.9	2.0	5.9	12.9	5.9	9.5	8.2	78.2	86.0	70.8	102.3	79.5	85.2	102.7	77.9	105.1	68.7	82.0	109.1	10.9	3.2	20.9	8.5	15.0	23.1	22.2	10.9	18.2	16.0	22.4	16.9	19.6	25.8	9.6	9.2	14.6	22.7	20.3	22.9	3.9	33.3	270.7	21.0	14.7	16.1	25.0	16.6	28.3	20.3	35.3	13.3	25.5	25.1	6.3	74.4	8.9	21.8	16.6	15.2	20.8	19.1	16.2	13.9	20.9	1717.0	14.9	16.8	12.4	5.6	8.9	10.1	14.4	6.0	32.2	39.8	5.7	12.0	25.8	37.4	7.1	13.1	11.4	26.4	0.0	6.8	18.2	25.6	17.7	38.8	31.0	23.7	24.3	42.5	24.8	23.3
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288654-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 435.1;Late spermatids: 1448.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA057280: AB_2683393, HPA057888: AB_2683549"	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	28.3	27.6	40.9	18.8	42.4	20.5	29.2	39.9	43.8	47.4	40.6	38.1	15.8	36.9	31.9	15.7	35.1	16.9	41.6	40.6	42.5	44.2	18.6	25.3	33.0	40.6	41.3	36.3	15.1	43.8	32.7	22.7	41.1	35.5	15.9	34.8	13.1	27.6	24.1	19.4	28.1	27.1	41.4	33.3	39.0	78.4	43.1	34.0	25.1	26.0	32.3	34.7	23.3	41.0	52.8	59.5	41.0	42.7	30.0	41.0	35.4	29.7	59.9	75.3	72.7	30.4	20.3	98.4	31.7	35.9	29.7	58.0	77.7	39.3	53.7	71.2	97.6	46.6	45.0	46.6	72.9	30.7	66.2	39.6	75.1	66.4	66.4	38.9	65.5	93.4	21.2	27.1	48.9	1.3	91.7	98.4	29.7	29.8	22.7	81.1	32.0	61.8	44.4	21.3	15.7	45.2	23.5	36.2	65.0	25.9	2.8	28.3	36.3	16.4	29.5	33.0	58.4	47.5	40.0	121.4	35.1	60.8	24.1	17.2	47.6	81.5	68.2	50.7	64.4	74.7	82.8	78.1	51.5	82.0	72.3	61.6	5.9	70.1	41.0	67.8	129.9	57.5	40.9	42.4	39.9	43.8	40.6	42.5	40.6	41.3	41.1	41.4	43.1	41.0	21.2	9.6	26.1	6.2	35.8	18.1	24.3	23.5	25.0	26.2	31.4	36.2	4.7	12.8	17.5	25.8	12.5	93.2	25.4	9.4	68.4	25.5	435.1	19.0	18.8	26.0	19.8	15.4	6.2	18.3	46.4	25.3	14.8	19.3	27.8	19.0	23.9	17.3	49.3	20.2	9.0	17.4	26.4	16.4	19.2	1448.8	28.3	18.9	17.8	1.9	29.5	33.6	58.7	3.0	9.5	21.1	21.2	31.6	37.5	22.9	14.3	66.7	14.3	38.4	19.7	16.3	34.0	180.6	23.0	10.6	19.6	112.9	35.6	28.1	21.8	16.1
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 199.1;skin 1: 237.7;vagina: 113.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Microtubules"	"Cytokinetic bridge"	"HPA022895: AB_1856071"	"prognostic favorable (8.43e-4)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	6.3	4.4	38.4	6.8	36.1	4.4	9.1	12.1	58.3	48.7	1.8	53.8	48.3	4.6	9.9	199.1	6.6	8.8	6.8	55.1	12.9	3.8	10.5	8.0	2.2	12.0	11.4	3.7	7.9	1.1	14.2	2.3	10.9	17.7	44.5	6.1	27.4	6.9	12.6	237.7	40.6	4.0	8.3	7.3	31.8	10.2	15.2	3.3	4.5	2.8	20.7	21.9	113.2	30.6	5.3	2.6	13.7	10.2	1.5	3.3	6.6	1.9	1.4	2.7	3.2	6.0	7.6	4.2	1.9	2.7	2.4	92.4	2.7	3.3	3.8	7.7	6.9	2.5	3.6	6.0	1.7	5.2	8.5	3.9	45.8	2.8	1.3	4.0	4.1	13.9	1.9	2.8	2.1	14.6	4.9	6.3	4.3	26.1	2.6	8.8	1.6	2.6	1.7	27.6	26.2	5.3	3.3	31.2	1.3	11.5	80.7	3.9	7.9	3.3	6.8	3.5	3.2	4.6	4.7	3.4	7.8	3.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	38.4	36.1	12.1	58.3	55.1	12.9	12.0	11.4	10.9	8.3	15.2	30.6	1.9	0.0	1.1	7.5	1.0	45.5	9.7	14.0	13.1	5.7	2.6	3.7	2.4	11.5	10.9	1.8	6.2	0.2	0.7	87.7	0.0	0.9	2.7	5.9	2.1	2.2	4.9	2.7	47.8	0.8	0.3	1.4	32.6	9.4	5.7	1.7	3.9	4.4	0.5	1.7	32.1	31.9	6.1	1.2	5.2	2.2	3.4	1.9	5.4	1.0	2.4	2.9	1.0	8.0	5.0	1.6	44.6	3.8	0.1	10.9	55.3	0.1	6.5	4.4	0.0	2.1	1.9	12.0	15.0	95.4	97.0	0.7	1.1	1.8	44.1	39.2
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309180-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 52.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 221.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058282, HPA071548"			Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli, Actin filaments, Cytosol"	"HPA058282: AB_2683666, HPA071548: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	47.6	21.1	3.2	28.3	4.4	59.6	37.2	7.2	16.5	43.7	5.1	31.0	28.4	32.2	10.7	14.9	40.7	41.3	40.8	7.0	5.7	24.1	42.3	58.4	16.4	5.3	2.7	40.8	14.7	11.3	30.6	25.7	2.8	29.8	13.2	18.3	20.6	21.3	62.6	24.8	32.2	28.6	1.8	41.7	22.9	28.8	4.9	10.0	26.9	17.4	11.8	30.3	30.2	4.3	18.0	41.9	11.8	20.5	23.4	35.9	12.5	14.9	21.8	21.5	13.6	28.6	15.1	9.6	22.7	33.2	18.9	51.1	14.2	33.9	12.0	77.5	21.4	26.6	21.2	29.8	37.0	9.4	81.3	48.2	10.0	22.7	29.2	75.8	30.9	8.4	17.6	20.2	23.7	221.5	6.4	34.2	10.7	16.2	13.3	12.9	71.3	37.0	12.2	14.4	5.4	40.5	31.0	124.8	42.1	11.7	119.1	36.6	35.8	25.3	45.3	44.2	15.4	48.7	16.9	8.3	38.4	18.7	77.1	26.3	8.9	34.6	3.2	14.6	5.1	2.0	3.6	3.8	12.4	1.7	1.5	2.8	52.6	5.9	19.5	3.8	3.1	5.0	3.2	4.4	7.2	16.5	7.0	5.7	5.3	2.7	2.8	1.8	4.9	4.3	35.6	3.2	7.0	2.3	43.4	19.5	25.6	8.4	18.8	23.2	35.4	17.5	3.8	10.0	5.5	7.3	6.2	2.2	36.9	41.2	13.7	16.7	60.5	20.7	22.0	28.4	9.6	5.7	5.4	19.2	5.8	28.5	10.7	18.4	35.5	13.9	26.0	28.8	12.3	3.3	2.6	13.1	6.1	45.4	65.5	66.2	41.7	56.9	28.4	2.8	26.1	11.8	6.2	4.0	0.3	22.0	33.1	23.0	21.0	13.4	70.9	17.7	4.9	10.2	32.9	42.1	26.7	3.6	7.6	7.1	18.9	5.2	31.7	6.5	16.5	19.3
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616756	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 254.9;tongue: 88.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 73.9;Enteroendocrine cells: 71.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 48.9"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	38.9	17.5	22.9	10.8	18.8	6.0	31.2	22.7	23.0	37.4	3.6	29.8	10.9	37.7	4.7	10.8	28.4	6.3	14.5	22.5	22.8	29.2	2.6	22.1	13.8	21.5	25.9	25.2	12.3	12.8	24.2	13.0	17.3	23.4	4.0	13.3	12.9	18.0	254.9	17.3	21.6	7.5	17.2	16.8	16.1	5.4	22.7	4.8	17.3	88.6	7.1	26.0	29.0	16.3	1.1	1.5	14.1	2.6	1.8	5.8	0.6	16.3	7.6	4.3	4.9	6.1	3.1	9.9	11.9	24.0	0.3	12.7	0.6	0.1	1.7	1.7	2.4	3.2	4.1	1.0	2.1	2.0	4.4	6.4	1.4	1.4	0.4	18.7	2.7	6.5	5.9	17.0	1.4	4.0	8.6	7.1	1.0	6.6	7.3	17.5	2.9	16.5	0.4	5.0	12.7	25.3	2.3	2.3	1.9	7.5	1.1	5.7	3.0	48.9	22.3	4.9	4.1	28.9	18.5	7.7	4.3	4.5	5.9	0.4	7.9	0.2	1.3	8.6	3.0	3.2	2.4	1.8	10.9	2.9	2.5	1.5	1.8	1.4	1.1	9.2	3.3	3.8	22.9	18.8	22.7	23.0	22.5	22.8	21.5	25.9	17.3	17.2	22.7	16.3	26.8	12.8	10.9	15.0	8.3	3.8	4.5	1.3	0.6	73.9	2.0	3.0	1.1	2.8	5.2	3.7	16.7	0.2	7.2	5.9	13.7	1.1	0.4	3.3	13.0	24.9	71.8	5.7	5.6	0.7	0.2	5.0	3.1	2.9	1.3	13.6	3.3	1.4	6.0	28.6	6.6	11.8	0.0	11.6	22.8	0.3	8.4	13.3	1.8	4.7	14.2	9.4	6.2	5.5	1.4	1.7	2.8	7.9	4.0	2.9	19.9	8.4	6.2	11.7	13.1	21.3	10.0	3.4	3.3	1.3	3.4	0.4	6.4	5.6	2.9	4.1
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102479976-102517777	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 130.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.9;Bipolar cells: 3.3;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.2;intermediate monocyte: 2.0;myeloid DC: 3.3;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.3;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 15.1;U-138 MG: 17.0;U-2 OS: 14.9"	"Low region specificity"	"Detected in all"							HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	14.0	5.8	6.5	4.2	6.1	2.2	10.8	6.3	7.9	13.3	3.0	11.9	6.4	16.5	1.3	2.8	9.7	3.7	4.7	6.2	8.0	6.4	0.8	6.0	4.7	7.8	8.3	9.6	2.4	5.2	5.8	4.9	6.7	8.1	1.8	5.3	4.5	7.6	130.9	5.5	7.8	3.8	6.6	5.9	4.9	2.1	7.6	1.9	3.8	19.2	2.8	9.5	9.5	7.5	0.2	1.4	3.7	0.5	1.3	2.9	0.2	6.8	4.4	2.2	3.6	0.5	1.1	3.4	7.3	8.6	0.7	9.1	0.0	0.0	1.1	0.5	1.6	0.5	2.7	0.8	1.2	0.3	0.5	2.9	0.8	0.1	0.2	10.4	0.9	1.7	0.9	9.8	0.7	3.0	2.9	1.9	0.3	1.7	1.9	2.8	1.5	4.6	0.1	0.9	3.1	15.1	1.0	0.5	0.5	3.0	1.0	2.0	2.0	17.0	14.9	1.8	0.6	3.5	2.9	2.4	2.3	0.9	2.8	0.0	2.2	0.0	0.3	2.0	0.2	0.1	0.3	0.1	3.3	0.2	0.3	0.4	0.3	0.0	0.4	2.1	0.3	1.2	6.5	6.1	6.3	7.9	6.2	8.0	7.8	8.3	6.7	6.6	7.6	7.5	0.6	0.0	0.6	2.9	1.1	0.4	0.2	0.0	1.2	3.3	0.1	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.9	0.1	0.0	0.1	0.3	1.8	2.4	0.4	0.5	0.2	0.0	0.3	5.6	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.8	1.3	0.0	0.6	0.9	0.0	0.3	1.0	0.0	1.0	0.6	0.6	0.0	1.5	0.0	0.1	0.0	0.0	2.5	0.2	1.3	0.3	0.1	0.6	0.0	0.5	0.8	0.3	0.0	0.3	1.1	0.1	1.6	0.3	0.0	0.2
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464544	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 23.5;intestine: 19.8;lung: 10.6;lymphoid tissue: 39.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 39.4;dendritic cells: 70.9;granulocytes: 39.3;NK-cells: 139.0;T-cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.6;HEL: 25.5;HMC-1: 46.7;Karpas-707: 52.5;NB-4: 27.8;RPMI-8226: 23.5;TIME: 35.5;U-937: 34.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	3.7	2.6	2.8	17.3	2.9	23.5	1.9	3.1	3.6	1.8	2.9	4.2	4.5	1.5	0.7	2.8	2.2	3.6	1.4	2.9	3.2	3.7	3.6	10.6	32.8	4.2	3.3	0.9	1.4	1.2	1.5	1.0	3.9	2.8	2.3	0.1	3.5	0.9	0.7	1.5	19.8	1.2	4.1	39.4	5.4	0.5	4.2	23.8	3.8	0.4	19.4	4.2	2.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	30.6	0.0	25.5	0.0	0.0	0.4	20.4	46.7	0.1	0.0	0.0	0.0	0.0	0.2	8.0	0.0	52.5	0.0	0.4	10.9	27.8	0.0	0.0	0.0	3.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.7	35.5	0.0	0.0	0.0	0.0	0.4	10.1	15.1	0.0	34.1	0.1	6.4	2.3	12.9	18.4	4.7	10.7	3.1	11.7	20.4	3.4	3.5	9.7	11.8	3.4	12.4	12.8	4.2	9.2	5.5	2.8	2.9	3.1	3.6	2.9	3.2	4.2	3.3	3.9	4.1	4.2	5.2	4.1	3.2	5.6	0.0	39.4	0.3	0.0	0.3	0.0	0.0	2.0	2.2	2.5	2.8	1.4	0.0	0.0	0.2	70.9	0.0	0.0	0.2	0.7	5.4	0.4	5.4	0.0	7.4	0.1	0.6	0.2	1.0	2.6	0.4	39.3	0.0	3.9	4.6	11.3	0.0	0.1	0.0	0.0	11.6	3.5	1.7	0.0	17.2	0.0	13.1	14.2	0.1	139.0	0.5	0.1	0.2	0.0	1.2	23.7	0.2	0.0	1.5	5.7	0.1	0.0	0.5	1.5	0.4	0.6	0.3	0.6	0.4	76.7	1.0	0.2	0.1
RASGRP2	CALDAG-GEFI	ENSG00000068831	"RAS guanyl releasing protein 2"	Q7LDG7	11	64726911-64745456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 147.3;lymphoid tissue: 140.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 125.5;dendritic cells: 86.1;Kupffer cells: 77.3;Macrophages: 72.2;NK-cells: 98.9;Sertoli cells: 131.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 103.4;HL-60: 192.8;NB-4: 347.1;REH: 105.0;THP-1: 108.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015635, HPA015667"	Approved		Supported	"Plasma membrane"		NA	NA		1900000	"Cluster 37: B-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA015635: , HPA015667: AB_1856090"	"unprognostic (5.96e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.74e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.23e-1)"	23.8	10.1	16.1	52.9	35.5	147.3	16.8	9.6	22.4	20.1	7.1	37.5	6.6	28.3	4.6	9.1	29.2	8.7	51.7	13.4	13.4	15.8	10.1	29.5	106.0	12.4	16.3	9.1	4.1	1.0	5.5	10.9	11.9	23.2	5.3	1.3	4.6	18.6	12.2	6.1	86.4	15.0	9.5	140.5	17.5	11.9	20.7	34.6	10.6	10.2	62.0	26.7	15.5	9.8	0.1	0.1	3.0	0.1	0.0	0.3	8.7	1.3	0.2	1.2	0.8	1.5	0.2	62.8	2.7	0.2	0.8	0.7	5.4	0.9	0.3	0.3	1.7	103.4	0.0	0.4	0.3	192.8	35.9	0.0	0.0	0.5	0.0	0.0	0.1	25.9	4.1	1.1	0.0	1.4	45.4	347.1	2.5	0.4	0.0	105.0	0.2	4.4	0.0	0.0	0.5	2.3	0.1	0.1	0.0	2.2	0.6	108.5	0.6	0.0	2.0	1.5	0.1	0.5	0.1	58.9	0.0	58.2	0.0	64.4	34.1	59.9	70.4	88.0	37.3	170.7	72.9	57.2	34.5	100.2	92.7	83.1	70.9	55.3	105.8	85.9	93.8	67.5	16.1	35.5	9.6	22.4	13.4	13.4	12.4	16.3	11.9	9.5	20.7	9.8	27.4	3.2	1.8	2.6	125.5	2.3	0.1	0.0	0.0	2.6	1.6	3.7	53.1	2.8	0.0	0.0	0.0	1.7	86.1	0.1	0.0	0.0	6.6	1.9	27.1	13.5	0.0	24.2	6.0	0.0	1.3	6.6	2.6	1.2	3.8	5.7	31.4	1.7	6.1	0.0	12.2	0.1	0.0	77.3	19.7	19.5	18.0	72.2	0.0	6.5	55.8	0.7	98.9	2.5	0.9	0.0	0.0	47.8	28.6	0.1	0.4	0.9	0.7	2.5	131.5	5.4	56.8	18.0	43.9	0.9	1.3	11.8	61.0	0.8	0.3	0.2
RASL11A		ENSG00000122035	"RAS like family 11 member A"	Q6T310	13	27270830-27275192	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.6;Fibroblasts: 30.1;Gastric mucus-secreting cells: 42.3;Sertoli cells: 32.9;Smooth muscle cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"ASC diff: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004859, HPA053296"	Supported		Approved	"Nuclear bodies"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear bodies"		"HPA004859: AB_2667270, HPA053296: AB_2682106"	"unprognostic (1.59e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (3.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.34e-1)"	32.9	4.1	1.9	3.1	3.2	2.3	21.8	3.1	3.1	21.4	2.1	20.4	7.7	21.6	3.9	9.8	22.0	3.8	11.3	3.2	1.7	30.4	12.9	13.0	10.8	1.8	2.2	9.5	4.9	1.4	10.6	2.9	2.0	20.3	12.5	0.1	5.3	5.6	3.5	10.1	20.9	5.5	2.2	14.8	13.4	2.9	3.3	1.2	12.1	1.7	10.0	19.1	15.9	2.4	0.3	1.3	0.3	0.6	42.4	4.3	0.2	1.9	1.8	0.1	0.1	8.1	0.8	0.3	0.5	1.4	0.9	0.1	2.5	0.8	0.1	1.7	8.8	1.8	0.2	0.5	6.8	0.6	0.6	5.0	0.7	0.1	0.1	1.7	0.6	0.7	0.3	0.1	0.0	0.8	0.0	2.4	1.5	8.0	10.2	0.5	0.0	0.2	1.4	6.2	0.7	0.3	0.7	3.3	0.2	1.0	0.2	0.8	0.3	0.1	0.3	2.9	0.4	0.1	0.0	0.0	0.4	1.9	0.1	0.4	0.4	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.1	0.2	0.1	1.3	0.1	0.0	0.1	1.9	3.2	3.1	3.1	3.2	1.7	1.8	2.2	2.0	2.2	3.3	2.4	29.6	16.0	11.2	0.3	6.0	4.6	3.2	0.9	17.6	0.0	6.2	11.9	1.4	0.0	8.6	7.3	0.0	0.7	4.5	9.3	3.9	1.8	0.0	5.1	9.8	5.9	0.0	4.0	0.6	2.4	0.2	30.1	42.3	6.1	0.0	2.1	2.5	0.2	1.4	0.0	0.6	5.6	4.1	0.8	6.5	0.0	0.3	6.1	1.8	1.9	1.7	0.3	0.0	0.5	1.8	0.5	12.7	1.5	17.1	1.1	11.4	1.7	10.3	0.2	32.9	11.6	112.0	0.0	0.0	13.5	4.4	0.8	4.5	1.2	6.7	1.1
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823608	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 217.0;retina: 162.8"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: AB_2681386"	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	16.4	9.7	76.1	47.1	135.2	91.2	6.9	155.5	113.5	27.9	40.0	8.4	5.3	25.4	22.5	10.0	22.1	15.6	4.2	68.9	94.7	4.0	5.9	25.4	58.6	217.0	148.8	7.0	3.1	1.5	5.0	9.1	186.4	7.3	9.6	162.8	3.0	9.3	1.2	4.2	14.5	38.7	135.8	32.7	7.0	20.6	120.0	19.5	4.7	5.0	73.6	20.7	4.9	197.0	0.1	14.5	34.9	56.8	0.4	0.0	59.2	3.5	10.0	0.6	0.2	3.4	0.1	62.7	5.6	3.1	1.4	0.2	5.1	0.0	0.8	22.7	2.1	41.1	0.0	0.7	0.0	74.7	40.1	0.1	0.0	1.3	0.0	1.3	23.4	7.0	0.2	24.0	0.0	0.1	11.0	96.3	7.8	0.0	1.1	17.1	3.9	23.8	0.0	29.0	0.4	2.8	0.0	1.0	1.7	7.4	0.0	47.0	0.7	1.5	7.4	0.7	4.6	0.3	5.9	37.8	0.3	116.8	0.4	85.6	61.5	101.3	7.7	50.1	14.6	24.3	12.0	10.4	46.8	16.4	7.8	6.5	139.5	8.5	59.9	30.7	11.8	42.1	76.1	135.2	155.5	113.5	68.9	94.7	217.0	148.8	186.4	135.8	120.0	197.0	5.5	0.0	8.7	7.5	49.3	4.7	0.0	0.1	0.0	39.2	4.1	1.7	1.9	1.5	1.9	0.0	27.1	3.0	43.0	0.1	1.9	1.2	6.0	3.2	19.6	18.6	0.0	6.1	1.5	0.9	5.1	10.9	1.1	1.0	54.3	4.5	11.4	1.2	27.1	6.7	1.3	0.7	0.0	87.1	75.8	25.1	33.2	64.6	8.8	26.2	148.5	19.3	7.2	33.7	106.7	0.6	0.0	149.7	14.3	1.2	0.0	0.3	0.1	160.3	0.0	9.4	3.5	0.7	1.0	0.3	2.6	1.4	20.8	0.8	0.0	2.3
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 77.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.0;monocytes: 258.7;Muller glia cells: 260.3;Proximal tubular cells: 128.0;Skeletal myocytes: 186.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 84.8;intermediate monocyte: 63.9;myeloid DC: 84.2;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 84.2;monocytes: 84.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;RH-30: 162.7;RPMI-8226: 54.9;U-937: 85.4;WM-115: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	35.3	7.1	57.4	21.7	67.9	8.3	22.7	64.3	58.6	6.5	43.8	18.5	13.6	3.0	8.6	4.7	6.0	10.8	44.8	53.9	58.9	77.3	17.1	11.9	19.7	63.4	64.0	3.6	39.5	5.0	13.0	12.7	65.9	7.9	6.0	26.9	16.7	10.9	14.8	4.8	13.8	8.7	55.8	20.1	9.4	9.0	65.3	10.4	40.7	17.6	9.1	11.4	7.0	69.7	1.4	0.3	6.0	11.4	17.9	1.0	4.1	0.7	1.1	2.0	3.5	5.0	0.6	0.1	2.3	0.8	3.9	0.0	2.6	2.8	2.8	37.8	0.0	0.1	0.2	39.7	19.0	2.6	0.0	13.1	0.0	1.9	0.2	10.9	3.0	1.6	0.0	64.3	2.9	0.0	3.0	43.1	1.2	0.2	1.2	8.1	162.7	54.9	0.4	1.2	1.0	0.8	0.0	0.5	2.0	10.7	1.1	32.4	0.0	0.4	3.6	3.0	6.5	0.7	0.7	0.1	18.9	85.4	54.8	0.0	84.8	0.1	8.7	63.9	0.2	0.0	0.6	3.7	84.2	0.0	0.6	2.6	3.0	6.9	37.9	2.2	0.3	48.9	57.4	67.9	64.3	58.6	53.9	58.9	63.4	64.0	65.9	55.8	65.3	69.7	8.9	19.2	17.2	77.4	3.7	3.7	1.4	3.2	1.2	22.5	9.7	7.0	47.9	37.1	13.1	16.5	4.2	1.2	20.3	10.1	17.6	45.3	1.4	6.4	13.7	9.2	11.5	0.0	17.0	3.8	1.2	28.6	1.5	14.8	1.3	4.2	6.1	20.1	157.0	37.0	33.6	7.4	12.2	84.7	94.3	4.4	10.5	91.0	8.8	35.6	258.7	260.3	54.6	37.7	38.2	4.0	11.3	2.2	4.1	1.0	45.0	128.0	5.9	13.3	26.3	186.4	25.9	0.6	1.9	0.8	1.7	2.6	8.0	4.9	15.0	0.7
RB1	"OSRC, PPP1R130, RB"	ENSG00000139687	"RB transcriptional corepressor 1"	P06400	13	48303744-48599436	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 187.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000095, CAB016687, HPA050082"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008"	"unprognostic (4.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	20.7	18.7	8.9	22.8	9.7	19.3	17.8	12.0	13.0	18.8	10.9	15.1	14.6	15.7	21.2	21.9	13.1	17.3	17.8	8.5	10.9	18.4	14.5	18.1	30.7	13.9	10.3	11.5	9.2	20.5	6.5	24.9	13.4	15.1	17.1	12.5	16.9	15.9	19.0	23.6	15.6	18.3	11.6	24.8	16.3	12.9	9.3	34.2	22.4	21.2	30.1	19.8	10.6	15.1	29.1	15.8	40.9	44.2	19.8	22.8	18.5	56.6	45.9	57.4	48.3	13.4	49.8	37.3	12.8	37.4	31.7	39.6	53.7	44.8	86.6	53.0	20.8	68.5	29.4	22.7	21.1	59.5	62.0	12.9	27.0	37.3	47.1	47.8	40.1	90.1	23.4	29.6	66.4	13.7	187.2	29.8	20.0	65.6	17.3	79.8	41.1	43.0	59.6	27.6	2.0	41.8	55.1	27.3	46.2	36.2	29.8	76.3	32.1	35.3	23.3	43.7	51.2	13.1	3.9	0.4	18.8	36.7	48.9	23.8	14.9	8.8	6.9	19.9	5.6	30.2	5.7	6.9	15.2	29.4	4.8	5.6	20.6	5.9	20.9	16.9	7.4	7.1	8.9	9.7	12.0	13.0	8.5	10.9	13.9	10.3	13.4	11.6	9.3	15.1	59.2	3.2	19.6	75.4	97.3	28.4	23.3	27.6	63.2	17.3	26.9	21.0	18.3	14.3	19.2	31.3	29.2	7.1	50.1	17.8	15.6	19.3	28.1	40.1	36.2	46.4	17.5	50.7	99.5	11.9	9.6	22.2	29.0	40.4	12.0	25.9	35.7	17.3	77.4	18.5	98.9	20.0	8.2	105.3	198.9	13.9	26.1	104.2	26.6	152.7	93.7	20.4	22.6	101.0	98.3	17.4	10.7	28.6	69.9	24.0	15.7	23.6	25.3	19.6	19.7	28.5	32.3	33.0	21.3	72.1	38.2	4.4	38.3	21.2	16.6	18.0
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	32.0	38.8	19.9	33.5	21.8	34.8	38.5	24.7	21.1	40.3	21.5	33.3	27.0	42.4	35.1	32.1	45.5	25.3	31.7	18.7	21.8	31.9	30.6	28.8	62.9	21.4	21.1	46.9	38.5	34.0	31.1	34.6	23.0	30.0	45.9	56.2	38.3	30.7	42.9	33.2	35.7	42.1	22.9	32.7	37.1	75.5	21.3	58.0	45.8	21.1	91.5	35.2	31.2	30.1	68.8	59.1	166.2	120.1	49.9	47.4	66.7	55.3	44.9	103.0	99.7	85.5	135.6	206.9	54.8	61.4	62.7	42.9	184.7	53.6	110.0	80.9	88.3	194.3	112.0	111.9	72.3	183.9	79.9	52.2	66.8	78.1	50.3	83.6	77.2	139.8	138.0	142.1	89.0	48.0	239.4	57.6	185.4	67.0	67.8	228.3	173.8	181.0	72.4	143.4	156.7	94.7	122.1	41.9	83.8	161.3	71.9	83.3	64.3	63.8	61.6	80.4	70.2	113.4	128.0	229.5	75.2	146.9	99.3	79.1	99.9	68.5	74.4	99.8	77.4	79.6	69.8	75.2	115.0	60.1	61.2	67.3	24.8	87.7	95.4	95.7	77.9	151.8	19.9	21.8	24.7	21.1	18.7	21.8	21.4	21.1	23.0	22.9	21.3	30.1	61.6	41.7	53.7	32.3	115.8	71.5	68.3	76.8	120.1	106.1	105.2	57.3	22.2	77.2	59.1	73.5	143.9	129.2	132.0	55.4	84.1	84.7	26.3	51.2	89.0	65.7	97.1	201.4	38.0	58.3	87.6	81.3	70.3	71.6	49.4	93.3	64.6	76.5	80.6	106.0	41.5	83.9	79.3	78.8	74.3	17.5	79.6	80.8	49.8	22.5	90.7	77.4	91.6	44.2	49.7	76.1	42.1	88.4	201.8	59.5	44.3	65.9	50.5	109.2	98.6	47.6	76.9	154.2	88.8	132.5	77.4	85.5	95.4	79.5	86.9	58.7
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	6.3	8.2	4.7	7.2	5.3	9.5	7.9	6.4	6.4	7.8	2.7	7.0	7.1	8.1	7.5	7.0	7.5	6.1	6.4	5.7	5.3	12.4	11.0	6.6	11.3	3.4	3.8	9.5	8.2	9.4	6.1	6.5	3.8	6.9	8.0	9.8	7.6	6.9	8.7	8.5	6.7	7.1	4.3	9.3	6.7	6.1	4.5	13.2	9.8	9.9	12.8	7.5	5.2	6.4	16.3	16.9	16.0	19.0	21.8	12.5	17.3	15.2	12.9	19.0	18.8	17.9	19.1	25.3	11.3	11.1	15.5	18.2	26.9	10.1	22.4	21.6	14.5	21.2	16.4	14.6	14.1	26.9	16.6	10.1	12.9	17.6	15.0	12.7	15.4	17.9	41.6	25.2	16.0	15.0	26.1	11.3	26.1	14.2	27.9	22.9	33.9	31.6	13.2	11.7	25.0	20.1	21.3	22.3	19.2	19.0	24.2	14.9	11.8	15.6	16.6	23.1	20.2	12.2	18.3	30.6	13.9	16.5	24.5	22.0	4.9	7.9	8.0	6.4	8.5	7.8	7.4	8.1	5.4	6.2	7.1	8.7	11.6	8.2	8.3	6.0	8.1	3.5	4.7	5.3	6.4	6.4	5.7	5.3	3.4	3.8	3.8	4.3	4.5	6.4	14.7	19.2	12.2	11.4	31.0	26.9	9.7	5.9	15.9	14.5	18.9	14.6	7.1	8.6	13.4	22.0	29.2	9.1	25.2	15.8	9.8	12.1	7.3	13.1	14.0	13.2	12.1	23.1	19.9	11.6	10.7	13.5	9.7	21.0	13.9	25.6	17.2	21.8	10.9	16.8	15.7	14.0	10.2	15.6	25.9	3.2	12.8	17.9	19.6	8.4	15.6	12.6	15.5	14.6	21.2	13.6	9.8	16.1	25.9	13.5	14.7	28.8	13.2	18.3	19.7	21.9	14.1	10.2	20.4	14.6	33.8	10.8	27.9	12.6	15.8	13.4
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870362	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 440.4;Syncytiotrophoblasts: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	47.1	280.4	28.9	57.0	35.7	99.8	63.8	27.7	39.8	133.1	40.1	73.0	55.0	90.5	293.7	67.1	96.3	49.8	86.5	32.0	31.0	60.9	56.7	42.9	89.8	29.4	25.9	132.8	46.8	194.2	42.5	96.4	28.8	81.9	73.0	61.4	62.1	166.4	132.8	61.2	57.2	101.0	30.1	47.7	64.4	94.5	27.4	88.7	57.9	90.0	106.5	67.9	51.7	34.2	298.0	219.5	159.5	212.2	99.8	116.6	103.0	143.7	144.7	207.7	233.9	128.6	190.4	328.0	215.2	141.6	236.3	153.1	291.5	214.4	275.2	186.2	400.6	138.9	247.7	153.1	83.8	212.1	160.3	91.3	77.8	240.6	174.9	133.3	211.9	134.6	141.5	167.2	166.9	200.2	236.1	194.0	181.7	141.5	199.5	204.3	295.3	386.7	151.9	197.6	149.3	110.7	271.9	128.3	133.9	225.8	426.8	126.5	99.0	99.5	102.1	265.7	162.8	116.6	178.6	429.3	127.7	140.8	123.3	50.9	45.3	62.3	85.1	79.5	82.6	92.0	70.6	89.4	63.6	80.0	73.3	82.9	18.2	89.2	111.7	74.1	72.1	77.2	28.9	35.7	27.7	39.8	32.0	31.0	29.4	25.9	28.8	30.1	27.4	34.2	52.0	51.3	65.0	18.6	69.5	74.8	105.7	98.0	33.6	31.4	53.5	51.1	105.1	42.9	80.8	55.2	29.2	440.4	89.8	41.9	78.2	87.3	14.5	55.0	58.0	50.7	60.7	70.2	26.6	74.3	170.8	87.7	44.9	54.8	57.7	101.8	41.4	36.4	109.3	25.2	20.7	57.4	81.4	33.5	39.6	31.2	113.7	43.7	83.6	16.9	60.4	79.4	72.1	46.3	24.7	75.7	39.0	187.3	89.6	75.3	48.6	64.2	63.8	43.6	138.1	73.8	134.3	109.9	121.1	52.5	61.1	532.2	67.8	81.9	79.3	74.2
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713340	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 73.9;heart muscle: 25.2;skeletal muscle: 95.3;tongue: 45.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 5800.8;Inhibitory neurons: 5921.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Group enriched"	"Detected in many"	10	"basal ganglia: 28.1;cerebral cortex: 73.9;hippocampal formation: 26.6;white matter: 22.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746, HPA075862"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: , HPA075862: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		0.3	1.5	3.7	0.4	28.1	0.5	0.1	2.5	73.9	0.6	0.0	0.8	0.2	0.2	3.1	1.1	1.1	0.1	25.2	26.6	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	1.1	0.1	0.0	1.7	0.5	5.7	2.2	4.1	95.3	0.3	0.2	0.0	2.7	0.0	0.2	1.1	2.2	0.2	0.1	45.3	0.0	0.4	0.4	22.6	0.1	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	25.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.0	0.7	0.1	0.4	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.3	0.2	0.7	0.2	0.1	0.1	0.2	0.0	3.7	28.1	2.5	73.9	26.6	0.0	0.0	0.0	0.0	2.7	2.2	22.6	0.0	0.0	0.5	97.9	0.0	0.0	0.0	0.0	0.0	10.9	0.4	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	6.6	0.3	1.8	0.9	0.0	0.0	5800.8	0.2	0.0	3.5	0.0	0.1	0.0	47.8	0.0	0.0	0.1	0.0	5921.8	0.5	0.0	0.0	0.3	4.9	1.2	0.5	1.8	132.1	0.6	6.6	0.0	597.6	689.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.7	2.8	0.0	17.0	1.2	0.6	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0
RBIS	C8orf59	ENSG00000176731	"Ribosomal biogenesis factor"	Q8N0T1	8	85214048-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 56.0;Cytotrophoblasts: 105.8;dendritic cells: 39.1;Extravillous trophoblasts: 123.8;Hofbauer cells: 102.1;Syncytiotrophoblasts: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044805, HPA071903"			Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: AB_2679095, HPA071903: AB_2686469"	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	74.4	69.3	55.7	51.0	56.1	83.2	95.2	57.4	72.4	85.3	57.0	81.0	60.6	67.0	91.1	90.2	72.2	42.8	101.1	54.6	58.2	88.5	86.2	52.3	70.8	56.9	55.6	82.7	103.1	60.6	68.9	45.6	57.5	71.6	56.8	45.8	75.2	41.4	78.0	63.9	66.3	48.8	58.5	75.4	99.0	41.5	56.1	75.1	61.3	68.6	71.3	73.9	73.5	59.8	166.6	83.1	122.6	79.4	73.4	140.2	94.8	107.6	102.7	123.1	120.5	97.2	140.0	42.1	86.8	71.8	116.2	112.9	84.8	118.2	138.1	116.6	92.5	242.1	74.2	145.8	87.0	92.5	105.7	120.0	137.0	79.4	99.7	133.3	106.4	145.3	111.9	97.8	103.7	131.0	205.8	173.1	36.1	372.8	143.3	86.9	100.6	188.2	121.2	104.7	40.7	87.1	81.7	132.8	161.0	145.5	154.4	135.9	81.8	78.1	164.9	87.5	104.2	114.1	144.8	197.4	155.8	116.8	88.9	76.6	55.2	39.2	63.5	71.7	76.7	89.3	83.7	78.9	96.9	77.7	95.8	95.0	14.1	104.7	64.4	118.7	90.8	71.0	55.7	56.1	57.4	72.4	54.6	58.2	56.9	55.6	57.5	58.5	56.1	59.8	56.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	105.8	39.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	123.8	27.8	0.0	0.0	0.0	0.0	0.0	0.0	102.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	76.9	7.6	0.0	0.0	0.0
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781379-27890681	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 79.0;Proximal tubular cells: 110.9;Respiratory ciliated cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 17.8;RPTEC TERT1: 40.8;U-266/84: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		11000	"Cluster 22: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	5.8	24.8	3.9	2.0	4.3	1.8	3.9	5.2	5.1	3.5	5.0	6.1	25.2	2.8	10.9	3.1	15.5	2.7	5.2	4.1	4.4	27.5	46.5	3.1	1.7	4.4	4.6	8.1	4.6	9.3	11.0	1.8	4.3	2.4	5.2	13.8	2.1	3.4	8.2	1.5	25.6	2.2	3.9	1.7	2.8	9.2	3.9	3.1	9.8	5.9	2.2	2.2	2.3	4.4	6.4	4.9	0.5	0.6	0.4	1.7	3.9	1.3	1.7	1.5	1.1	9.3	2.9	2.4	17.8	3.6	3.0	2.3	0.6	2.7	2.1	0.9	0.3	0.1	0.7	8.2	2.7	1.7	0.2	2.4	3.3	5.8	7.8	1.5	1.2	3.8	0.5	4.0	3.6	8.2	1.5	4.6	0.8	4.6	4.3	1.8	0.3	1.4	40.8	0.5	1.7	2.5	6.1	7.7	2.8	2.3	3.9	9.3	0.2	1.2	0.9	4.3	2.7	13.6	18.2	3.8	3.6	5.6	0.2	1.6	2.5	1.4	1.9	0.9	4.2	4.4	2.7	4.8	3.5	3.7	3.1	2.3	1.0	4.5	0.2	0.4	4.2	2.3	3.9	4.3	5.2	5.1	4.1	4.4	4.4	4.6	4.3	3.9	3.9	4.4	9.9	6.4	5.0	14.7	24.0	2.0	3.1	11.7	26.7	10.7	5.1	7.1	7.1	5.7	9.7	18.4	4.2	4.2	10.5	12.2	46.9	12.6	36.9	35.2	2.4	7.8	3.6	3.0	13.9	12.3	1.3	10.9	8.6	7.4	2.5	4.6	2.9	29.5	6.5	8.4	18.3	4.7	6.1	4.4	3.4	26.4	1.5	50.8	1.8	2.8	2.4	15.5	3.1	15.6	10.3	7.0	14.9	2.6	21.2	1.0	79.0	110.9	59.0	25.6	0.0	3.3	11.2	23.8	20.0	5.2	1.6	1.5	19.6	9.5	10.7	1.9
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491648	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 468.3;Late spermatids: 209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli rim, Mitotic chromosome"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	32.5	25.4	11.1	32.3	13.6	19.1	31.7	12.5	10.4	33.5	14.8	26.6	23.3	32.2	20.2	25.0	31.8	27.7	25.6	8.7	10.5	39.2	59.5	38.9	49.7	12.3	12.0	37.8	39.0	62.7	17.7	19.3	13.0	42.9	29.3	23.1	34.2	39.9	32.4	26.3	26.1	30.7	11.7	41.0	32.6	48.4	11.4	66.6	40.2	37.7	51.2	30.9	28.9	16.9	25.9	18.1	20.7	20.6	61.2	57.9	9.4	17.8	26.4	23.1	7.9	10.1	30.9	39.0	28.4	32.8	22.3	29.6	17.9	30.1	36.0	12.5	22.4	15.9	14.7	22.0	27.3	23.4	49.0	35.6	34.0	15.3	22.4	43.0	36.3	39.6	12.7	23.2	26.6	7.1	48.6	22.0	7.8	30.8	15.0	33.6	41.8	46.1	25.4	25.3	16.9	14.3	42.2	17.2	19.1	16.8	22.7	30.0	28.3	27.5	14.3	24.1	13.7	35.7	22.9	42.4	34.4	28.2	19.0	53.9	22.5	56.5	53.4	16.2	60.5	22.5	59.7	62.8	21.7	22.0	85.5	75.3	41.8	74.4	28.8	13.1	48.2	76.2	11.1	13.6	12.5	10.4	8.7	10.5	12.3	12.0	13.0	11.7	11.4	16.9	37.9	41.7	101.1	51.2	49.5	23.1	30.1	15.3	40.9	27.8	27.0	15.5	13.5	45.8	32.5	27.6	20.9	6.0	77.0	26.3	17.6	13.4	468.3	38.9	25.8	31.4	19.8	26.5	55.1	10.2	13.0	35.8	24.5	45.9	55.1	27.9	40.7	46.1	11.2	35.3	54.1	30.0	34.6	43.6	23.7	209.1	42.0	35.4	10.6	58.1	44.9	38.3	79.3	63.3	85.7	10.8	19.0	42.9	48.7	31.4	29.2	25.3	38.3	22.5	39.5	36.2	26.1	161.4	61.3	33.7	27.6	4.1	118.9	25.2	21.7	35.6
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237622-122264840	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA057281: AB_2683394, HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favorable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	9.0	9.5	7.4	6.4	7.9	11.7	16.4	8.0	10.1	8.9	7.3	7.5	7.0	8.8	10.3	7.7	7.4	7.6	13.5	7.8	8.8	11.4	8.4	7.2	8.1	8.2	7.9	9.5	6.9	11.9	5.7	10.4	8.6	11.1	8.1	11.5	7.9	8.3	20.7	6.8	6.1	8.7	8.0	8.0	8.5	3.6	8.0	9.5	10.0	23.1	7.6	8.7	5.4	8.4	8.1	8.3	11.2	12.4	16.1	19.8	9.7	18.0	14.7	12.1	11.2	9.6	7.8	14.1	7.7	11.8	13.3	18.5	17.6	18.7	15.1	14.5	8.0	10.5	12.6	8.2	18.1	21.1	14.0	17.0	20.8	12.7	25.8	12.1	17.6	11.3	14.6	10.7	18.3	8.8	11.1	13.0	8.7	27.2	13.7	9.7	23.2	19.3	16.9	9.0	23.3	12.3	13.6	18.9	21.3	8.8	11.0	11.8	9.8	11.3	6.4	18.3	18.0	15.5	30.7	11.7	18.6	12.9	13.8	4.5	6.2	11.4	6.3	7.2	6.1	5.8	5.5	6.2	6.5	4.0	5.7	6.0	6.5	5.4	9.7	4.6	6.4	5.8	7.4	7.9	8.0	10.1	7.8	8.8	8.2	7.9	8.6	8.0	8.0	8.4	19.7	32.1	12.8	2.0	18.3	21.7	11.7	28.5	19.9	12.4	27.2	20.7	51.6	10.0	23.1	25.8	2.1	32.8	23.3	17.2	27.4	23.2	75.0	14.7	19.9	21.6	19.7	28.4	9.1	16.2	44.7	15.9	13.3	16.4	17.7	14.1	13.6	13.7	27.7	3.3	12.9	16.5	34.6	21.0	17.2	76.9	13.4	18.4	19.6	4.7	20.6	16.9	27.8	6.0	10.7	23.0	18.7	17.0	16.4	20.8	14.8	26.6	19.8	14.7	19.7	15.2	25.4	19.7	22.1	16.5	25.9	56.9	23.5	16.7	14.2	20.7
RBM3	IS1-RNPL	ENSG00000102317	"RNA binding motif protein 3"	P98179	X	48574449-48581162	"Predicted intracellular proteins"	"Stress response"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1442.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			"HPA003624, CAB062559"	Enhanced		Enhanced	Nucleoplasm		NA	NA		130000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"CAB062559: AB_2665621, HPA003624: AB_10602123"	"unprognostic (1.07e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.07e-7)"	"unprognostic (1.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	246.8	129.7	21.7	143.2	23.7	301.8	200.9	23.0	33.2	82.3	27.5	122.4	102.1	118.2	89.4	147.1	101.7	71.9	100.7	22.3	27.9	89.2	71.1	130.5	158.5	27.9	24.0	99.3	167.2	94.2	80.1	104.0	26.5	75.7	146.0	51.4	126.0	81.8	112.3	195.3	102.6	114.9	28.7	128.5	114.2	55.9	23.4	156.9	90.1	38.3	206.1	135.0	101.7	29.3	128.2	168.7	172.5	187.3	42.4	226.3	117.2	156.0	272.3	381.6	273.6	173.7	322.5	241.4	50.0	302.3	75.9	107.1	153.2	209.1	304.1	236.5	206.7	126.2	270.5	164.0	153.0	360.8	248.0	168.1	143.8	129.7	124.3	46.2	320.4	131.7	69.8	194.6	268.6	215.9	304.9	209.3	100.5	33.3	230.1	280.7	181.4	196.5	177.7	201.8	70.1	179.1	152.2	206.9	187.5	83.7	272.2	363.6	440.7	127.0	213.0	425.8	278.2	93.7	114.0	279.1	176.5	208.0	263.0	33.0	187.0	30.7	118.4	211.9	141.7	147.5	120.6	119.7	264.1	101.5	120.6	119.5	28.7	150.9	187.0	185.0	137.5	256.3	21.7	23.7	23.0	33.2	22.3	27.9	27.9	24.0	26.5	28.7	23.4	29.3	336.2	166.7	172.1	18.6	391.7	519.4	182.9	379.4	157.6	58.9	326.1	260.5	76.8	154.4	196.7	53.3	47.9	459.9	392.1	165.8	176.1	482.2	6.0	114.6	193.8	292.9	247.4	287.0	18.4	1442.0	726.9	274.2	164.1	234.3	265.2	144.9	195.9	74.6	433.2	42.1	17.7	360.2	136.3	439.5	783.6	17.1	245.7	339.3	522.9	18.7	571.7	181.8	358.4	15.1	18.0	915.3	235.9	147.4	317.7	119.0	143.3	164.3	84.6	87.0	131.5	378.4	299.4	43.6	200.8	285.2	507.8	489.3	352.5	178.2	368.0	202.6
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161283	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoli	"Nucleoplasm, Mitotic chromosome"	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	12.2	10.3	11.7	15.0	12.5	35.5	17.0	12.1	13.7	10.0	12.3	12.4	17.9	11.5	15.6	13.9	10.9	12.2	15.5	11.8	12.6	17.1	14.8	11.9	23.2	13.3	12.5	12.8	13.1	9.2	8.7	13.2	13.1	12.0	14.1	6.3	19.9	7.4	19.7	18.2	15.8	11.6	13.1	12.7	14.3	21.3	12.5	16.3	15.6	12.3	20.6	15.7	9.6	13.5	28.6	20.9	23.8	28.8	17.9	33.3	52.8	29.3	24.6	29.4	30.1	26.9	33.7	49.4	29.9	21.0	22.1	40.5	29.0	28.9	28.2	44.4	47.8	35.7	17.0	20.1	35.1	60.4	34.5	28.0	33.2	26.5	19.6	26.5	26.8	50.5	54.5	23.7	38.7	18.0	49.9	48.3	65.3	43.8	15.8	48.0	23.2	57.3	29.5	22.7	26.2	47.1	39.2	27.0	66.4	17.0	55.2	63.5	21.0	26.2	23.0	36.1	59.9	27.8	47.5	47.4	30.8	38.0	40.8	113.9	36.0	44.1	46.1	42.5	55.6	74.1	53.0	59.8	37.2	54.5	49.0	57.4	18.3	58.2	46.4	59.5	77.5	51.5	11.7	12.5	12.1	13.7	11.8	12.6	13.3	12.5	13.1	13.1	12.5	13.5	4.3	19.2	12.8	12.1	11.9	3.2	10.0	7.3	10.2	2.6	6.3	3.7	3.4	7.2	9.1	3.7	10.4	6.2	19.3	4.1	5.9	6.6	7.2	3.2	5.1	6.9	7.8	3.8	10.6	6.2	4.5	10.3	4.6	6.0	23.4	8.0	6.1	3.6	3.3	0.0	11.5	2.7	8.2	5.4	3.2	7.9	4.1	7.1	3.6	15.9	9.4	4.0	23.7	10.1	11.9	8.6	9.6	5.7	10.2	5.3	5.3	12.8	10.7	5.7	0.0	5.0	4.4	7.1	5.3	8.0	3.8	6.2	16.2	3.3	4.5	7.7
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 442.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 136.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 34.4;granulocytes: 136.2;monocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 134.0;CAPAN-2: 63.5;OE19: 56.7;SK-BR-3: 58.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006347	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	9.3	49.7	2.2	20.3	1.9	9.6	24.7	1.8	3.0	15.3	44.9	61.0	68.4	3.5	23.1	42.2	17.7	17.9	1.3	2.8	2.3	67.6	34.5	21.0	8.2	6.0	3.2	2.2	25.9	27.8	3.2	20.1	4.9	33.2	50.5	0.4	59.4	13.4	0.5	9.0	64.1	4.7	4.1	14.7	64.6	6.7	5.7	4.4	49.5	1.1	11.4	22.6	15.5	6.8	31.9	47.8	0.0	1.8	0.2	0.0	134.0	0.8	1.6	0.1	0.6	28.3	63.5	0.2	23.0	1.2	3.8	14.2	0.9	11.8	0.3	0.2	7.6	0.0	3.1	7.9	0.6	0.3	0.3	0.8	6.0	0.1	0.1	1.8	0.0	0.0	1.8	7.0	0.1	18.1	0.2	1.1	13.5	56.7	2.4	0.2	0.0	34.7	46.8	41.6	1.6	0.3	17.3	58.4	0.3	14.8	23.9	9.0	0.0	0.5	1.9	0.3	1.0	23.5	37.7	4.1	5.0	3.9	0.2	0.5	45.5	0.5	0.2	33.1	0.3	5.9	0.2	0.1	34.4	5.4	0.4	0.1	136.2	0.5	26.2	14.1	0.2	16.9	2.2	1.9	1.8	3.0	2.8	2.3	6.0	3.2	4.9	4.1	5.7	6.8	1.1	80.1	116.6	0.7	21.2	58.9	75.2	42.9	95.0	0.1	145.7	63.5	1.9	75.8	92.2	112.2	0.0	99.6	16.3	442.8	64.6	90.6	1.3	132.6	9.5	6.0	121.9	2.5	2.5	115.4	84.3	7.7	174.8	143.7	7.0	8.7	23.6	140.4	92.6	1.7	1.9	234.2	59.0	138.8	92.8	2.6	2.5	119.9	37.4	82.4	80.6	0.3	1.0	2.5	0.8	108.0	228.1	1.2	40.1	164.7	218.1	143.6	118.3	0.1	0.0	1.4	5.1	2.6	10.4	178.1	75.4	262.6	4.8	16.9	203.8	295.4
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92540481	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	8.3	8.6	8.2	5.6	9.4	14.1	8.2	10.1	12.1	9.0	6.5	8.0	5.3	8.2	4.8	7.6	8.4	3.8	10.0	8.5	7.5	7.4	9.0	6.4	8.4	9.0	7.7	9.8	8.5	4.6	7.5	4.6	9.1	8.2	4.6	6.5	8.3	3.3	13.5	8.0	9.0	3.7	7.3	11.3	8.0	8.9	8.5	6.5	8.4	7.0	6.4	7.3	8.3	12.1	5.5	4.0	6.8	11.1	6.5	7.3	5.4	6.5	5.2	6.4	6.1	4.9	6.9	8.0	11.8	4.4	9.9	6.2	6.6	4.6	7.9	7.8	9.4	5.3	12.0	5.8	5.2	10.2	7.1	5.2	8.5	7.2	6.5	8.9	6.9	10.1	11.5	13.1	6.9	5.6	12.1	10.1	6.1	6.9	5.8	6.5	6.1	9.8	5.9	5.9	7.6	9.9	5.7	11.6	8.6	8.3	3.7	8.5	4.4	11.7	6.3	9.1	8.9	8.6	11.1	13.3	5.3	8.6	11.0	67.8	12.4	30.3	23.2	16.3	25.7	28.5	25.1	23.7	12.3	28.7	32.1	27.3	19.2	26.2	13.3	14.3	25.7	16.0	8.2	9.4	10.1	12.1	8.5	7.5	9.0	7.7	9.1	7.3	8.5	12.1	13.5	12.8	7.5	8.1	23.5	8.5	13.2	11.9	12.5	12.7	8.7	7.7	16.7	5.7	10.9	3.7	0.0	10.9	18.8	6.9	7.9	9.2	9.4	9.5	12.3	13.8	0.0	8.6	20.5	6.0	5.8	11.7	6.6	12.9	30.4	11.9	7.9	3.7	6.2	11.8	15.8	4.0	14.2	6.8	6.4	5.9	5.9	8.1	5.4	5.6	9.8	11.5	26.8	11.1	34.3	5.5	6.2	6.4	16.6	10.5	7.0	9.6	7.8	13.2	13.1	15.0	13.7	24.0	15.5	9.9	11.4	15.3	18.9	8.4	5.7	11.8
RBMY1A1	"RBM1, RBM2, YRRM1, YRRM2"	ENSG00000234414	"RNA binding motif protein Y-linked family 1 member A1"	P0DJD3	Y	21511372-21549326	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	96	"testis: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"U-266/84: 15.1"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"		Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1B		ENSG00000242875	"RNA binding motif protein Y-linked family 1 member B"	A6NDE4	Y	21511338-21549094	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"			Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1D		ENSG00000244395	"RNA binding motif protein Y-linked family 1 member D"	P0C7P1	Y	21880076-21894526	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1E		ENSG00000242389	"RNA binding motif protein Y-linked family 1 member E"	A6NEQ0	Y	21903618-21918067	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 2.6"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 1.7;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"U-266/84: 2.3"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1F	MGC33094	ENSG00000169800	"RNA binding motif protein Y-linked family 1 member F"	Q15415	Y	22168542-22182982	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"testis: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	325	"U-266/70: 29.7;U-266/84: 35.2"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		"Nucleoplasm, Nucleoli"		"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1J		ENSG00000226941	"RNA binding motif protein Y-linked family 1 member J"	Q15415	Y	22403461-22417881	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"testis: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	193	"U-266/70: 25.2;U-266/84: 13.3"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	294	"intestine: 2713.5"	"Cell type enriched"	"Detected in some"	26	"Proximal enterocytes: 6095.4"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 78.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		140000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.4	1.1	4.6	1.1	3.2	0.7	0.5	0.3	3.2	0.2	0.0	4.0	2713.5	2.0	0.0	0.2	0.3	1.8	0.2	3.3	5.0	2.6	0.0	7.6	2.2	8.1	9.2	0.3	3.0	0.0	0.1	0.1	3.4	0.4	2.4	2.2	0.1	0.0	0.2	1.1	1886.7	1.0	3.4	0.1	3.6	1.0	9.0	0.0	0.5	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.2	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	78.8	0.1	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.1	0.2	0.1	0.1	0.0	11.7	0.0	0.0	4.0	10.1	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	3.2	0.3	3.2	3.3	5.0	8.1	9.2	3.4	3.4	9.0	5.3	0.0	9.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	12.9	8.4	0.0	0.0	14.0	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	1.0	6.1	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	185.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.5	0.9	6.1	226.3	0.0	0.0	0.0	6095.4	0.0	0.7	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	142.6	0.1
RCN3	RLP49	ENSG00000142552	"Reticulocalbin 3"	Q96D15	19	49528003-49546962	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.7;Fibroblasts: 105.1;Leydig cells: 38.2;Peritubular cells: 44.8;Smooth muscle cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 2.5;NK-cells: 1.8;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 166.6;ASC diff: 283.3;ASC TERT1: 175.4;BJ: 353.8;BJ hTERT+ SV40 Large T+ RasG12V: 179.6;fHDF/TERT166: 304.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043134, HPA050402"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		1600000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA043134: AB_2678332, HPA050402: AB_2681114"	"unprognostic (7.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.87e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.47e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.80e-12)"	"unprognostic (5.26e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.20e-3)"	67.9	35.3	15.8	33.6	17.2	6.8	48.2	15.5	24.1	78.8	23.5	43.5	39.9	47.4	4.4	11.4	41.4	25.2	56.7	16.0	19.1	41.2	62.3	40.8	8.7	17.4	17.0	50.0	16.4	3.9	20.7	31.1	19.0	32.4	11.4	1.4	19.1	12.1	11.7	25.3	43.2	25.7	16.8	65.9	23.4	17.2	24.5	4.0	26.4	7.5	4.1	43.2	46.3	18.8	3.2	4.3	2.7	166.6	283.3	175.4	1.9	353.8	86.5	122.0	179.6	4.2	1.3	1.3	19.5	304.0	1.3	0.3	6.8	0.5	49.2	0.1	2.5	19.5	1.5	9.1	105.7	0.1	43.0	119.5	0.2	93.2	0.4	3.2	43.8	2.3	8.7	1.0	87.8	2.9	0.1	2.0	1.4	8.8	24.5	0.5	3.9	4.0	1.4	0.0	1.7	10.5	0.3	1.1	0.3	2.8	1.3	11.5	121.4	1.7	52.4	135.3	0.1	14.9	44.5	2.6	7.9	9.6	13.4	0.0	0.2	1.6	0.7	0.0	0.7	0.4	1.7	0.6	0.4	0.2	6.8	2.3	2.5	1.8	0.3	0.2	1.6	1.1	15.8	17.2	15.5	24.1	16.0	19.1	17.4	17.0	19.0	16.8	24.5	18.8	12.0	0.0	6.1	4.6	2.8	18.6	0.6	2.9	3.4	0.8	1.7	3.3	2.1	1.5	0.8	1.8	0.0	2.5	1.4	10.5	1.9	1.6	2.2	1.5	54.7	10.6	1.2	0.0	1.0	0.5	5.0	105.1	6.6	1.6	1.3	7.0	27.1	3.7	22.6	1.7	1.1	7.6	0.0	11.4	23.2	3.0	38.2	11.9	10.6	10.3	3.1	0.6	0.0	1.5	0.8	1.5	7.9	44.8	4.8	0.9	13.1	0.6	0.9	0.8	13.1	37.5	66.5	6.5	6.8	2.8	13.9	6.2	2.2	17.2	8.0	0.4
RCOR2		ENSG00000167771	"REST corepressor 2"	Q8IZ40	11	63911230-63917164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 20.7;Excitatory neurons: 5.9;Extravillous trophoblasts: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.7;NTERA-2: 47.0;SCLC-21H: 72.6;SH-SY5Y: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021638	Uncertain		Approved	Nucleoplasm,Vesicles,Midbody		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Vesicles, Midbody"	"HPA021638: AB_10960885"	"unprognostic (1.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.33e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.06e-3)"	0.3	0.5	1.8	0.2	3.2	0.0	0.4	1.3	3.7	1.4	0.1	1.1	0.8	2.7	1.0	0.4	1.5	0.4	2.8	2.5	1.1	0.6	0.1	0.3	0.0	1.2	1.0	1.2	0.5	1.4	3.5	0.7	0.8	0.9	0.6	3.4	0.9	0.6	1.5	0.3	0.6	1.0	1.1	0.1	0.7	3.2	1.0	0.9	0.2	0.7	0.0	1.2	0.6	2.4	0.0	1.0	35.7	2.5	0.5	2.9	10.9	0.2	0.6	0.5	1.2	1.4	0.3	0.3	0.4	0.8	0.7	0.4	15.8	0.0	0.3	0.6	2.0	0.5	0.3	11.9	5.9	0.0	0.3	3.5	0.0	0.6	0.0	0.0	0.3	4.8	2.0	0.0	0.0	3.3	3.4	13.2	47.0	4.8	0.1	12.4	2.1	1.0	0.1	0.1	72.6	48.7	0.3	3.2	1.8	8.7	2.7	4.5	0.3	0.1	2.3	0.1	0.1	0.3	0.1	0.4	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.2	1.3	3.7	2.5	1.1	1.2	1.0	0.8	1.1	1.0	2.4	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	20.7	0.6	0.4	2.2	0.0	0.1	0.0	0.0	0.5	0.0	1.0	0.0	0.1	0.1	0.3	3.3	0.6	1.2	0.0	5.9	0.2	4.4	1.1	0.0	0.6	0.0	1.2	0.0	0.0	0.2	3.3	1.5	1.2	2.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	2.1	1.0	1.0	1.5	0.2	0.2	0.4	0.0	0.0	0.3	0.1	0.2	2.2	0.0	0.3	0.7	0.7	2.9	0.0	0.3	0.8	0.1	1.2	0.8	0.1
RD3L	"TDRD9-AS1, TDRD9AS1"	ENSG00000227729	"Retinal degeneration 3 like"	P0DJH9	14	103940426-103942561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"heart muscle: 23.3;retina: 13.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 78.5;Cardiomyocytes: 40.8;Cone photoreceptor cells: 29.2;Horizontal cells: 26.9;Rod photoreceptor cells: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 10.4"	"Low region specificity"	"Detected in all"			HPA067971	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"		"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"		"HPA067971: AB_2685935"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.5	0.0	0.0	40.8	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560679	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	14.4	14.5	10.6	8.3	10.8	5.4	12.6	11.0	12.4	10.1	15.7	14.6	11.6	14.2	12.2	9.8	11.9	9.4	29.8	10.5	10.8	14.0	18.5	11.8	12.5	10.8	10.5	10.0	14.1	18.7	11.3	13.0	11.3	13.3	10.4	8.3	10.7	11.0	28.1	9.6	11.4	12.0	11.1	11.5	14.6	11.5	10.7	12.5	11.1	27.1	9.5	15.5	10.2	11.7	28.6	8.9	7.3	6.0	21.8	22.9	24.7	16.8	17.7	15.2	15.0	6.9	14.6	28.2	9.7	10.3	19.7	15.3	10.8	19.9	17.6	15.6	28.8	10.8	10.6	21.4	18.6	13.7	14.1	17.5	19.9	14.8	22.9	21.2	14.2	11.2	19.9	9.2	25.2	9.2	11.8	23.7	19.9	21.9	24.1	16.5	20.1	12.1	29.9	18.4	11.2	19.3	9.3	20.4	25.8	15.4	10.1	7.2	14.4	21.5	13.1	16.6	20.6	26.0	23.1	20.8	15.1	9.0	17.1	1.4	1.4	6.5	3.3	1.7	5.5	7.3	3.9	4.9	1.9	11.6	5.5	4.5	0.5	3.1	1.7	6.1	5.1	1.3	10.6	10.8	11.0	12.4	10.5	10.8	10.8	10.5	11.3	11.1	10.7	11.7	21.7	16.0	12.8	0.0	36.1	24.5	31.0	27.9	31.3	23.5	20.1	24.5	55.6	32.9	20.9	16.5	6.2	44.6	34.8	20.6	31.3	37.8	27.4	27.4	19.7	19.4	13.2	18.7	0.0	35.3	50.3	38.5	20.4	19.7	12.7	16.4	20.3	30.0	24.2	15.2	0.0	27.1	20.3	17.2	14.6	13.6	66.8	15.4	23.2	0.0	23.2	31.3	29.9	0.0	0.0	27.0	36.3	44.8	15.6	45.1	23.3	38.1	18.8	22.4	32.9	28.5	29.6	79.5	30.6	18.9	18.6	45.7	27.1	30.9	29.2	27.3
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sensory transduction, Steroid metabolism, Vision"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 94.5;liver: 58.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Proximal enterocytes: 49.9;Rod photoreceptor cells: 62.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 28.5;ASC TERT1: 24.3;hTEC/SVTERT24-B: 15.3;hTERT-RPE1: 24.5;LHCN-M2: 15.4;U-87 MG: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA063345: AB_2684992"	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	94.5	1.8	2.2	4.1	2.5	1.0	34.2	2.2	2.6	2.5	3.5	13.6	18.5	4.2	7.8	3.1	4.6	4.2	9.2	2.0	2.2	9.0	58.9	1.9	1.8	2.7	2.5	2.1	3.5	0.3	1.7	0.6	2.4	4.4	4.4	3.2	3.3	2.2	6.1	2.7	15.5	19.5	2.5	2.2	5.9	2.4	2.8	0.9	2.7	7.6	0.7	5.5	2.2	3.4	0.7	1.4	0.8	0.5	28.5	24.3	0.6	3.8	4.2	0.7	1.4	0.5	7.9	1.0	0.7	2.1	0.2	0.3	0.3	0.1	0.6	1.0	1.3	0.1	2.0	2.1	0.8	0.1	0.3	10.5	1.0	15.3	0.1	24.5	0.3	0.5	0.2	1.3	15.4	0.7	0.4	0.2	0.3	3.7	2.3	0.6	0.4	0.5	0.2	0.8	0.2	1.1	0.2	0.5	3.4	0.2	0.7	0.6	0.5	1.5	1.5	1.1	0.9	1.1	0.5	0.2	26.7	0.4	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.5	0.2	0.0	0.2	0.0	0.2	0.3	0.2	0.5	0.0	0.0	2.2	2.5	2.2	2.6	2.0	2.2	2.7	2.5	2.4	2.5	2.8	3.4	2.5	9.6	2.2	0.0	4.6	1.9	4.5	3.9	0.6	24.3	2.7	5.0	3.9	10.0	2.4	1.8	62.6	2.2	5.3	23.5	1.9	2.1	0.8	1.8	2.9	3.7	11.5	0.0	0.0	2.6	1.2	3.9	11.2	1.5	0.0	4.9	3.6	18.4	0.6	16.8	0.0	10.3	0.0	4.5	7.9	2.3	13.4	2.3	5.4	0.0	4.7	8.2	12.3	0.0	0.0	3.6	18.6	6.8	0.7	3.2	49.9	13.0	4.7	62.9	13.1	14.0	9.3	3.9	6.4	0.8	1.7	1.5	4.8	5.3	15.9	3.1
RDH8	"PRRDH, SDR28C2"	ENSG00000080511	"Retinol dehydrogenase 8"	Q9NYR8	19	10013249-10022279	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"retina: 114.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.3;Cone photoreceptor cells: 54.2;Early spermatids: 72.6;Muller glia cells: 22.1;Rod photoreceptor cells: 203.4"	"Cancer enriched"	"Detected in some"	4	"melanoma: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064473			Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA064473: "			"unprognostic (4.12e-1)"		"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.98e-3)"		"unprognostic (4.58e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-1)"			"unprognostic (1.02e-1)"	"unprognostic (3.86e-1)"		"unprognostic (2.63e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	114.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.2	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	0.0	72.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	203.4	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296712	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 155.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		38000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	40.3	155.0	38.0	17.4	57.7	12.0	16.4	50.0	42.7	32.1	32.8	15.2	6.8	28.8	12.9	27.4	19.7	27.2	41.0	35.1	44.7	50.2	68.5	48.8	11.4	52.7	48.2	52.8	52.7	33.2	7.6	35.3	54.3	25.4	11.1	19.2	20.8	26.0	82.1	11.9	7.4	35.0	45.1	26.6	15.0	33.7	47.7	14.3	45.7	59.7	14.6	27.1	10.1	77.6	69.6	35.3	137.3	54.8	78.8	87.4	79.3	85.8	47.6	54.3	59.2	99.7	115.4	0.1	127.4	104.7	84.9	61.5	77.3	80.4	80.5	41.9	44.2	51.5	107.7	74.1	73.6	19.0	33.2	89.7	45.6	68.0	120.1	89.3	149.8	11.1	73.5	29.5	127.0	120.0	11.0	15.6	44.0	4.0	58.4	31.2	96.8	30.1	68.1	33.5	37.2	40.5	148.5	65.9	52.7	102.5	85.0	29.9	92.6	89.5	66.8	43.9	67.4	9.5	17.3	65.9	34.2	11.3	210.9	29.5	14.8	22.0	11.6	12.5	15.5	11.5	10.2	8.8	12.8	8.3	6.8	5.8	2.0	17.6	9.9	10.3	22.0	8.4	38.0	57.7	50.0	42.7	35.1	44.7	52.7	48.2	54.3	45.1	47.7	77.6	248.8	484.0	98.8	53.5	30.0	56.1	51.8	124.6	56.9	85.9	47.4	45.7	159.3	70.1	77.9	75.4	43.8	122.1	21.6	17.7	109.5	128.1	15.5	109.1	117.2	289.2	22.2	104.8	27.1	423.4	189.8	88.4	19.9	135.3	67.2	132.0	319.2	260.1	85.1	101.0	57.6	7.3	61.1	103.2	59.9	43.6	275.2	71.6	72.9	42.2	135.4	77.0	36.0	68.3	229.4	134.3	22.1	266.7	36.1	65.9	0.1	236.9	52.2	94.8	124.9	74.0	143.8	73.9	257.4	52.8	40.5	227.3	29.2	229.9	11.8	45.9
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.8	12.0	8.4	12.8	10.3	10.9	9.5	8.1	11.5	11.0	8.2	10.8	22.4	10.4	10.0	20.6	11.4	12.2	7.3	8.1	8.0	18.4	16.4	8.1	18.2	9.9	9.2	13.0	10.9	16.3	20.7	10.2	9.0	12.3	9.6	8.9	14.9	8.7	7.5	21.7	22.9	7.1	7.5	16.1	23.4	19.1	10.9	12.7	20.6	6.4	14.4	10.3	13.4	15.1	19.1	34.6	14.0	19.3	19.1	13.7	31.5	14.1	12.0	18.2	16.1	15.1	19.7	22.8	14.8	12.5	23.7	17.8	14.4	17.2	16.6	12.2	26.7	40.4	46.7	22.0	20.0	13.7	19.5	19.7	20.7	17.9	23.9	21.0	23.4	25.9	21.7	19.4	13.3	16.8	27.5	18.1	8.8	18.6	26.4	21.8	32.3	22.7	15.3	22.0	16.3	16.1	14.9	26.2	19.6	19.3	47.2	10.5	12.1	22.0	25.2	12.5	14.8	27.6	16.8	22.6	18.4	13.0	16.3	6.0	3.3	4.5	3.9	4.1	2.4	3.3	2.5	2.9	3.9	4.3	3.7	2.7	1.9	4.0	2.0	15.7	2.2	3.6	8.4	10.3	8.1	11.5	8.1	8.0	9.9	9.2	9.0	7.5	10.9	15.1	4.9	0.0	11.3	9.1	8.3	1.0	3.3	4.4	3.4	8.3	4.9	5.8	7.3	7.2	6.1	27.6	18.8	8.6	16.2	12.5	5.9	6.1	4.6	13.1	8.1	5.6	4.8	13.0	6.9	3.3	5.2	4.5	42.8	23.9	1.3	11.9	5.7	7.2	5.1	10.1	5.8	9.6	10.2	6.0	0.8	2.2	4.1	9.0	3.6	4.7	3.6	5.1	5.2	8.0	13.3	6.7	9.7	2.6	9.2	3.2	15.0	4.9	14.2	12.9	0.0	4.5	3.8	13.2	11.6	5.4	2.0	11.6	4.0	10.2	6.7	10.0
RER1		ENSG00000157916	"Retention in endoplasmic reticulum sorting receptor 1"	O15258	1	2391775-2405442	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037240, HPA051400"	Supported		Supported	"Golgi apparatus"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"		"CAB037240: AB_2179604, HPA051400: AB_2681469"	"unprognostic (2.90e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.23e-8)"	"unprognostic (1.01e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.27e-2)"	100.4	154.2	60.0	89.3	67.6	81.6	97.1	67.0	62.8	93.6	78.3	137.4	114.8	74.4	122.7	176.4	86.1	86.9	75.7	61.1	64.1	106.3	224.8	79.6	94.6	67.0	65.1	92.9	122.3	100.9	82.9	99.0	66.9	94.3	151.4	73.8	101.1	104.2	105.2	101.7	120.0	104.6	65.6	102.2	118.6	107.1	68.5	94.5	85.9	85.1	143.5	101.0	106.5	76.1	203.1	111.0	131.1	146.8	233.7	275.7	100.9	297.1	261.1	254.3	253.2	157.6	299.3	143.9	242.7	297.7	205.1	213.3	152.2	176.7	322.2	180.8	156.1	163.9	247.2	153.0	252.5	181.3	188.6	225.0	176.1	264.3	233.1	175.4	235.8	160.3	197.8	232.6	299.8	141.5	127.2	127.3	87.5	314.1	279.0	146.0	131.9	183.7	227.5	94.3	109.9	126.2	167.9	376.9	242.9	143.7	149.6	127.4	171.8	197.3	114.1	355.9	219.5	223.0	270.2	255.3	209.6	254.8	102.8	239.1	235.5	284.5	195.9	268.2	180.0	169.0	169.8	210.0	221.2	151.7	127.0	155.9	351.3	164.8	275.9	256.1	244.5	309.0	60.0	67.6	67.0	62.8	61.1	64.1	67.0	65.1	66.9	65.6	68.5	76.1	88.7	64.1	50.0	23.5	73.1	53.2	84.4	214.2	50.1	33.6	111.9	123.6	41.6	118.7	131.4	104.8	33.3	233.8	97.5	218.9	66.5	213.4	475.6	89.5	93.5	68.2	36.5	57.2	16.7	258.4	321.8	94.3	71.9	118.8	44.3	76.5	82.1	233.5	217.9	37.0	16.8	158.6	122.1	104.3	73.2	464.0	82.6	99.9	62.2	15.9	126.1	97.0	114.4	19.1	25.8	256.4	195.4	76.0	145.1	142.5	238.7	119.6	136.3	62.6	111.7	60.9	141.6	291.4	145.2	103.4	67.1	467.9	74.3	159.0	162.0	141.0
RERG	MGC15754	ENSG00000134533	"RAS like estrogen regulated growth inhibitor"	Q96A58	12	15107783-15348675	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 104.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 202.7;Breast glandular cells: 80.1;Inhibitory neurons: 94.3;Sertoli cells: 92.1;Smooth muscle cells: 80.2"	"Cancer enhanced"	"Detected in all"		"breast cancer: 19.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.2;BEWO: 34.1;T-47d: 66.0;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041387	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA041387: AB_10796669"	"unprognostic (5.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (8.72e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.61e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	30.7	45.4	8.9	6.8	21.0	0.0	42.5	5.9	16.3	32.0	3.5	37.0	4.1	104.7	50.3	15.1	72.7	11.2	14.0	10.2	12.3	37.0	2.5	16.5	4.3	20.7	12.8	29.0	9.8	4.8	1.4	33.3	21.2	17.0	9.3	0.8	10.2	77.5	5.4	10.2	18.0	83.9	7.7	31.4	20.1	9.0	12.8	2.6	5.8	5.8	2.7	17.4	20.0	9.0	0.0	1.6	0.3	15.2	6.0	0.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.0	0.1	0.0	0.2	0.2	0.0	0.0	4.3	0.1	5.9	0.0	4.7	0.0	1.9	0.8	1.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	1.4	0.7	0.2	0.3	1.7	0.0	0.9	0.1	0.0	0.2	5.8	0.3	0.1	2.2	2.5	2.6	0.0	1.0	66.0	0.0	0.0	0.9	21.5	0.4	0.0	0.1	5.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	21.0	5.9	16.3	10.2	12.3	20.7	12.8	21.2	7.7	12.8	9.0	10.7	0.0	2.2	202.7	0.4	3.8	8.6	0.9	6.2	1.3	80.1	36.2	1.0	5.7	4.0	7.3	0.0	12.0	0.7	0.0	15.6	9.8	20.9	6.5	9.8	6.0	1.8	0.0	20.2	9.8	14.6	28.7	2.6	1.0	0.0	0.1	2.2	0.0	2.1	3.3	94.3	0.0	18.3	0.0	2.3	16.1	22.1	1.1	7.2	41.2	0.0	5.0	0.0	3.0	1.1	2.2	0.0	32.0	0.0	3.5	0.0	33.7	0.1	0.5	92.1	8.2	80.2	8.3	15.0	12.6	5.5	14.0	1.2	16.1	0.0	5.8
RERGL	FLJ22655	ENSG00000111404	"RERG like"	Q9H628	12	18080869-18320107	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	37	"Sertoli cells: 164.3;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	719	"REH: 230.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041740	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041740: AB_10795694"	"unprognostic (3.53e-2)"	"unprognostic (7.03e-4)"	"unprognostic (6.29e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"		"unprognostic (5.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.66e-2)"	43.5	5.4	14.3	2.5	14.8	0.0	29.1	14.7	41.0	25.3	14.6	14.4	3.0	25.2	37.9	7.2	25.8	10.2	6.6	14.3	16.1	15.9	2.1	4.4	1.2	15.4	15.1	19.8	1.8	1.1	1.6	0.0	15.3	7.1	16.8	0.2	3.8	19.4	6.0	11.9	13.4	16.0	14.6	2.7	7.8	2.9	15.7	1.2	13.4	30.2	1.4	11.2	14.7	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.8	14.7	41.0	14.3	16.1	15.4	15.1	15.3	14.6	15.7	15.0	6.9	0.0	0.0	2.0	0.1	4.5	0.3	0.0	4.0	0.0	2.8	5.2	4.1	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.7	7.2	0.0	0.0	0.1	0.0	0.5	2.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	6.5	0.4	0.3	0.6	5.4	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.3	0.0	0.6	0.0	0.1	164.3	0.6	381.7	0.1	1.1	0.8	2.4	0.1	0.9	0.3	0.1	0.4
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 53.3;spinal cord: 19.4"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	20.8	1.0	1.3	0.9	0.4	1.1	5.1	5.6	1.0	0.2	3.4	1.4	0.6	0.3	0.4	0.5	0.6	2.2	0.3	5.5	0.9	3.0	0.4	0.6	14.4	27.3	0.4	1.3	31.8	5.3	0.5	12.0	1.8	1.4	4.7	5.1	2.0	5.9	0.9	1.4	1.0	4.8	0.2	2.2	2.7	7.6	1.6	0.8	3.1	0.2	0.6	1.4	5.8	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	42.2	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	329.3	0.1	0.0	0.1	0.5	4.1	95.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	1.0	0.9	5.1	5.6	0.3	5.5	14.4	27.3	12.0	4.8	7.6	5.8	0.4	0.0	0.5	1.6	0.0	0.3	0.8	0.0	0.0	1.7	6.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	1.5	0.0	0.3	1.1	0.0	0.0	4.2	0.2	2.3	6.8	0.0	0.0	1.3	0.5	0.0	1.2	0.1	79.1	8.6	1.9	26.4	0.0	0.6	1.5	0.3	0.5	0.0	1.0	0.0	0.8	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8	1.7	0.0	23.1	1.2	1.1	4.7	0.0	0.6	0.0	0.2	0.3	0.2	0.1
RFC3	"MGC5276, RFC38"	ENSG00000133119	"Replication factor C subunit 3"	P40938	13	33818069-33966558	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 285.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030149	Approved		Supported	Nucleoplasm,Vesicles		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"		"HPA030149: AB_10602921"	"unprognostic (3.86e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.02e-3)"	"unprognostic (4.49e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.86e-1)"	5.3	13.8	2.6	12.9	2.4	19.5	12.8	8.7	2.6	5.7	1.7	9.0	8.5	10.6	4.3	6.7	8.3	4.6	6.1	2.7	2.5	5.1	7.4	5.4	24.3	2.7	2.2	7.8	4.8	5.1	2.6	10.8	2.8	6.3	11.6	5.9	5.5	4.1	3.5	7.5	7.9	7.6	3.7	6.6	6.5	12.8	2.6	24.1	6.5	4.4	23.4	5.7	4.6	2.5	49.0	51.1	86.4	69.5	6.5	10.0	47.5	66.6	29.2	85.5	73.7	63.0	72.2	179.8	26.8	25.3	53.2	72.5	111.6	45.9	112.0	71.5	68.9	105.0	54.4	68.0	7.5	127.2	48.3	9.8	5.8	74.5	49.9	14.1	28.9	63.7	75.1	44.2	51.4	56.1	108.8	58.1	104.2	101.2	42.1	40.3	103.4	41.1	25.4	42.7	45.1	79.2	49.4	65.3	33.4	45.7	52.2	66.8	15.5	45.1	49.7	57.1	70.9	24.9	36.7	285.3	32.4	73.7	86.6	1.5	4.4	7.2	3.2	6.1	3.7	5.8	3.9	3.3	6.1	5.5	5.0	4.5	0.9	2.5	5.3	2.5	6.3	3.1	2.6	2.4	8.7	2.6	2.7	2.5	2.7	2.2	2.8	3.7	2.6	2.5	9.3	9.6	6.2	5.9	11.2	12.2	6.9	6.9	7.4	16.5	8.9	10.5	7.5	1.5	8.6	3.7	8.4	29.6	5.1	3.0	3.9	7.3	8.4	7.0	7.9	9.4	6.1	43.8	30.2	8.9	39.3	7.5	3.1	7.7	1.3	17.8	8.9	7.2	11.9	8.4	20.3	4.3	4.1	6.7	4.0	7.9	6.2	6.5	8.8	34.7	6.4	5.4	1.0	33.7	18.0	5.4	1.5	4.5	21.0	2.7	1.1	5.4	3.8	12.2	6.6	7.9	29.8	52.6	43.2	9.2	7.0	16.4	6.6	9.2	10.1	3.3
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HHSteC: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Approved	Nucleoplasm		No	No		1100000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: AB_2673989"	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	28.3	24.3	9.9	3.8	9.7	10.2	24.6	8.5	11.8	25.5	7.8	26.5	11.1	25.3	1.6	24.1	23.0	10.9	19.5	8.7	9.0	22.9	78.5	18.7	5.4	10.4	9.3	29.7	42.6	11.1	20.0	5.9	9.5	23.5	3.2	1.4	22.0	6.9	45.4	27.1	16.7	7.7	9.0	14.9	27.7	23.2	9.6	4.6	19.8	10.5	2.7	24.0	18.6	9.7	20.3	19.2	5.6	19.1	13.9	11.8	24.4	18.5	10.1	8.2	6.2	11.6	13.7	4.5	13.0	29.1	17.4	10.8	3.9	15.8	1.5	6.0	19.7	6.7	4.4	48.5	69.3	2.4	14.2	22.5	9.9	14.7	24.9	16.5	15.8	15.2	8.5	16.9	6.6	24.1	15.1	6.5	5.5	13.5	20.1	10.2	7.0	10.6	9.5	11.8	9.7	24.9	7.1	10.7	54.7	6.2	32.1	13.7	6.1	13.1	17.9	12.7	10.2	22.9	4.5	5.0	16.8	4.4	11.7	1.0	1.9	2.0	1.7	0.5	0.6	1.0	1.1	1.6	1.4	1.2	1.1	0.6	0.7	0.2	0.7	1.1	2.5	0.6	9.9	9.7	8.5	11.8	8.7	9.0	10.4	9.3	9.5	9.0	9.6	9.7	24.3	6.4	12.4	30.7	7.6	9.7	11.9	8.3	6.8	26.9	33.3	35.4	12.8	18.6	5.6	23.9	25.0	5.5	14.2	20.9	7.9	7.8	3.7	14.9	24.4	12.1	11.4	5.7	20.7	15.1	3.3	27.2	18.8	19.0	1.3	52.5	21.8	47.1	9.6	11.8	20.3	14.0	12.2	15.2	6.3	13.3	21.8	14.7	10.6	16.9	6.2	29.8	3.1	20.6	13.5	12.4	16.3	19.9	4.9	15.9	14.0	31.3	6.8	27.8	0.0	28.0	19.4	14.4	6.2	9.0	10.2	3.7	10.4	32.8	13.5	8.7
RFPL1	RNF78	ENSG00000128250	"Ret finger protein like 1"	O75677	22	29438583-29442455	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3;retina: 3.0"	"Group enriched"	"Detected in some"	7	"Early spermatids: 9.1;Hepatic stellate cells: 8.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.5;HMC-1: 2.7;Karpas-707: 3.0;SH-SY5Y: 3.7;SiHa: 1.8;THP-1: 3.5"									"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"	"Plasma membrane"	"HPA048320: AB_2680356, HPA072380: AB_2686515"		"unprognostic (4.54e-1)"				"unprognostic (6.63e-8)"						"unprognostic (3.14e-3)"			"unprognostic (1.89e-1)"			0.1	2.9	2.5	0.2	2.3	0.0	0.0	0.0	10.3	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	1.1	0.0	0.2	0.0	0.0	2.5	0.1	0.2	0.3	0.1	0.0	1.3	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.5	0.5	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.1	0.0	3.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	2.5	2.3	0.0	10.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.4	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1
RFPL2	RNF79	ENSG00000128253	"Ret finger protein like 2"	O75678	22	32190435-32205001	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"brain: 10.2;prostate: 3.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 17.6;Inhibitory neurons: 8.6"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 5.6"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046608, HPA048320, HPA072380"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	"Plasma membrane"	"HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515"	"unprognostic (3.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.29e-2)"	"unprognostic (9.66e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.64e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.04e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.62e-7)"	"unprognostic (3.50e-2)"	0.0	0.5	1.5	0.0	1.9	0.4	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.1	0.0	0.1	1.7	0.7	0.3	0.0	0.0	0.1	0.0	1.7	3.8	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.9	0.0	10.2	2.3	0.9	1.7	0.7	1.7	0.0	1.0	1.6	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.7	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1
RFPL3	RNF120	ENSG00000128276	"Ret finger protein like 3"	O75679	22	32354885-32361161	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 24.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.6;Spermatocytes: 2.0;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;NB-4: 2.2;U-266/70: 2.5;U-266/84: 2.6"									"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	"Plasma membrane"	"HPA048320: AB_2680356, HPA072380: AB_2686515"	"unprognostic (1.63e-1)"				"unprognostic (9.90e-2)"			"unprognostic (1.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.32e-2)"		0.1	0.1	0.0	0.2	0.1	1.4	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.5	0.7	0.0	0.1	0.1	0.1	0.3	0.0	2.4	0.5	0.0	0.5	1.3	0.3	0.0	0.0	0.7	0.1	24.8	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	1.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.5	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.8	0.0	0.4	0.6	2.2	0.1	0.1	0.0	1.1	0.2	0.3	0.0	0.2	0.8	0.1	0.0	0.2	0.6	0.2	0.0	0.2	0.0	0.0	0.4	0.1	0.0	2.5	2.6	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621399-74666877	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 47.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	5.2	3.9	2.5	9.9	3.5	47.7	7.6	4.0	3.2	6.4	4.4	8.0	6.5	6.2	5.3	9.4	6.8	6.5	2.9	2.3	2.9	6.7	5.8	6.1	15.4	3.3	3.1	7.0	10.2	6.8	3.8	8.0	3.2	4.9	9.3	6.2	5.8	5.1	3.3	12.6	6.1	6.1	2.8	8.1	6.2	25.2	3.4	27.1	6.6	2.7	16.7	7.2	6.8	4.7	46.1	57.5	42.6	31.2	8.8	11.9	47.8	40.5	30.9	63.0	54.5	75.4	46.8	63.6	32.1	31.8	31.6	53.9	70.3	42.1	76.9	20.0	42.1	56.3	46.0	43.0	7.6	57.3	56.3	8.6	13.2	79.6	48.7	16.3	27.3	53.2	86.7	27.7	48.1	72.8	84.0	52.2	84.0	26.8	27.7	128.7	28.8	55.9	22.7	47.8	31.5	33.6	65.2	22.8	28.8	38.2	41.7	48.4	26.7	46.0	43.9	26.2	51.4	37.4	75.1	188.3	32.8	43.5	57.0	12.1	4.4	6.5	5.5	4.1	6.1	4.9	4.5	5.1	4.6	5.4	6.7	4.8	4.9	6.2	7.7	3.5	7.2	4.4	2.5	3.5	4.0	3.2	2.3	2.9	3.3	3.1	3.2	2.8	3.4	4.7	6.0	0.0	5.9	4.2	13.2	10.8	6.8	4.0	10.2	6.6	8.4	8.3	3.9	2.8	5.4	1.8	10.4	12.1	15.3	7.6	11.7	6.2	5.4	6.9	5.7	7.2	9.5	22.5	8.9	7.6	8.3	5.9	5.1	6.6	4.5	13.5	11.7	7.4	8.9	3.3	7.1	9.7	2.0	12.2	6.0	6.3	3.7	7.8	16.0	15.0	7.6	3.0	10.3	6.6	15.2	10.0	2.7	4.1	11.6	12.7	4.3	4.6	5.9	6.7	6.6	6.4	5.6	48.5	31.7	9.5	9.2	7.5	10.6	3.6	9.5	11.4
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457550-41470871	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 415.4;lung: 694.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1286.2;Basal prostatic cells: 676.2;Langerhans cells: 590.1;Prostatic glandular cells: 1415.5;T-cells: 532.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 159.9;T-reg: 90.9"	"Lineage enriched"	"Detected in many"	15	"T-cells: 159.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.5;BJ hTERT+: 316.0;Daudi: 105.1;U-698: 111.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		910000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	197.6	21.5	186.3	27.7	226.9	415.4	132.6	218.8	236.7	36.1	148.2	34.7	16.9	43.6	7.6	18.6	31.1	42.2	145.9	195.8	196.6	56.9	25.0	694.9	38.1	209.1	204.8	9.1	41.3	48.1	35.3	150.7	205.3	61.5	9.2	5.7	111.5	19.0	47.3	58.0	29.1	33.5	186.7	37.0	37.8	24.8	198.2	70.5	144.0	61.8	21.0	47.5	39.6	241.0	1.1	0.5	34.9	0.0	6.7	57.5	1.4	0.8	316.0	0.2	1.2	44.8	0.7	105.1	0.9	4.0	0.1	1.0	1.2	2.1	0.4	11.1	5.1	0.0	7.9	3.5	3.3	3.7	1.2	4.5	6.7	1.2	43.1	0.6	36.1	24.0	8.3	0.1	1.0	0.3	24.0	2.3	0.5	4.7	0.8	0.1	0.0	0.1	0.3	0.0	1.3	0.4	0.3	0.0	0.7	3.0	0.9	20.1	24.6	0.2	3.8	2.2	0.4	0.2	0.1	111.9	0.3	2.4	0.8	0.0	0.8	0.1	5.6	0.5	5.6	5.3	46.5	14.7	6.1	10.7	159.9	35.0	0.6	0.4	0.1	1.8	90.9	10.2	186.3	226.9	218.8	236.7	195.8	196.6	209.1	204.8	205.3	186.7	198.2	241.0	1286.2	246.8	39.8	57.5	131.8	86.5	676.2	15.2	14.2	1.0	269.9	314.7	25.8	1.5	37.5	3.7	2.1	6.4	249.2	3.0	35.2	0.6	42.3	103.0	47.2	474.6	84.8	322.7	2.5	0.0	9.3	205.1	65.2	69.0	48.9	0.3	31.8	2.5	349.1	0.0	1.2	22.1	14.2	32.0	590.1	13.2	8.1	315.9	193.9	36.5	6.4	1.5	4.1	51.8	115.3	0.3	4.5	2.2	371.2	1415.5	0.1	0.8	33.7	3.1	124.9	45.4	116.0	155.3	5.0	11.2	65.1	11.1	532.4	43.8	7.8	159.7
RGR	RP44	ENSG00000148604	"Retinal G protein coupled receptor"	P47804	10	84230666-84259960	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 139.0"	"Cell type enriched"	"Detected in some"	29	"Muller glia cells: 1475.8"	"Cancer enriched"	"Detected in single"	4	"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"midbrain: 23.4;olfactory bulb: 49.7;thalamus: 27.3"	HPA059149			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Plasma membrane, Cytosol"	"HPA059149: "	"unprognostic (9.28e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.53e-2)"				"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"				"unprognostic (1.59e-1)"	"unprognostic (1.97e-1)"			0.2	0.0	11.9	0.0	11.9	0.0	0.1	4.4	14.6	0.0	14.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.5	7.4	8.5	0.0	0.0	0.2	0.0	5.2	8.2	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	139.0	0.1	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.9	4.4	14.6	7.4	8.5	5.2	8.2	5.4	3.1	10.1	6.2	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	20.6	0.1	0.1	0.4	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	10.6	0.3	0.0	0.0	0.0	0.0	1475.8	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	2.8	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357924-177372596	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 72.8;Proximal tubular cells: 113.7;Squamous epithelial cells: 95.8;Suprabasal keratinocytes: 115.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 110.4;cerebral cortex: 67.9;hippocampal formation: 56.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 112.5;HMC-1: 95.4;NB-4: 44.8;RPMI-8226: 57.9"	"Group enriched"	"Detected in many"	10	"amygdala: 66.0;basal ganglia: 57.9;cerebral cortex: 46.8;hippocampal formation: 93.6;white matter: 23.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 102.1"	"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: AB_2679836, HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	3.5	2.8	16.0	13.9	110.4	22.4	2.9	0.0	67.9	3.1	1.8	3.7	6.3	2.3	0.4	10.0	7.7	4.3	1.3	56.4	4.5	8.5	28.7	5.5	18.1	0.0	0.4	1.1	3.7	1.5	2.4	1.4	0.1	3.5	0.9	0.0	6.2	2.1	2.6	6.1	11.0	1.8	0.1	27.7	4.9	1.9	15.2	16.3	6.1	0.9	6.6	4.1	5.0	3.2	5.4	1.1	2.3	1.4	0.1	0.0	3.7	0.2	0.0	0.5	0.6	3.7	10.4	13.3	7.3	0.4	1.3	10.6	0.2	3.8	0.0	112.5	0.5	20.7	1.0	4.7	0.9	16.3	95.4	1.8	1.1	0.6	0.7	1.4	0.6	14.9	3.5	26.5	0.2	0.4	21.7	44.8	1.7	5.4	2.8	10.2	0.3	57.9	1.5	1.6	0.4	1.9	0.4	0.4	8.8	0.0	3.5	25.2	1.1	0.2	1.9	0.0	9.7	13.9	7.1	5.8	1.6	30.3	2.4	70.6	39.9	148.8	62.4	37.9	63.0	27.7	57.9	57.8	39.8	26.6	47.4	43.1	140.0	23.6	41.2	17.6	60.9	43.9	16.0	110.4	0.0	67.9	56.4	4.5	0.0	0.4	0.1	0.1	15.2	3.2	5.3	6.4	4.4	2.6	27.3	68.8	23.9	15.4	72.8	0.7	8.9	11.8	2.3	37.1	5.6	11.0	2.1	3.9	41.4	4.2	31.3	11.4	0.6	19.5	2.0	6.5	4.8	7.4	4.6	16.7	10.4	5.4	12.2	8.1	24.7	2.8	8.2	64.0	26.1	0.0	1.5	10.0	10.2	17.0	23.3	1.5	2.8	18.2	21.4	6.5	18.1	9.9	48.4	0.5	0.3	12.8	17.2	2.2	18.0	14.1	16.8	113.7	11.7	2.0	0.0	1.6	4.6	0.1	20.3	95.8	115.1	3.3	51.2	1.1	4.4	20.0
RHBDL1	"RHBDL, RRP"	ENSG00000103269	"Rhomboid like 1"	O75783	16	675671-678268	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.6;Excitatory neurons: 30.1;Inhibitory neurons: 27.1;Ionocytes: 18.3;Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8;MCF7: 9.2;U-266/70: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030359, HPA030360, HPA046593"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711"	"prognostic favorable (8.12e-4)"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.63e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.49e-2)"	0.8	5.0	9.2	0.4	9.7	1.0	1.0	9.1	17.7	2.0	0.0	2.2	2.4	1.0	0.6	1.2	1.6	0.4	2.4	7.9	6.1	4.1	2.0	1.1	0.4	5.5	4.8	2.1	2.6	0.6	8.3	0.3	4.9	2.7	0.3	2.1	2.4	0.9	0.5	2.6	2.5	0.2	3.2	0.9	2.7	4.2	7.4	1.4	0.9	0.0	0.1	1.5	1.5	7.7	1.7	2.1	1.2	1.8	0.9	2.3	6.1	0.7	1.1	0.4	0.1	4.4	1.2	0.6	1.4	0.4	0.2	1.1	0.1	0.3	0.0	1.5	7.7	0.8	9.8	1.8	0.8	1.6	1.1	1.6	2.8	0.3	0.0	0.9	0.1	2.8	1.3	1.2	0.1	9.2	0.4	4.4	1.1	2.3	0.6	7.6	1.1	1.6	0.1	1.5	1.5	2.0	0.9	0.4	2.2	0.7	3.2	4.5	0.5	2.5	2.2	0.8	0.6	10.5	1.5	2.2	0.9	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	9.2	9.7	9.1	17.7	7.9	6.1	5.5	4.8	4.9	3.2	7.4	7.7	0.6	0.0	0.0	15.3	2.8	2.2	3.8	10.3	12.5	17.6	2.5	4.2	0.9	0.0	2.4	0.0	12.5	0.2	0.3	2.7	0.0	0.7	2.7	1.4	1.1	0.3	2.4	0.0	30.1	0.5	0.2	1.1	3.1	1.0	0.0	1.9	0.4	0.7	0.3	15.2	27.1	6.1	18.3	0.9	1.2	1.4	1.5	0.4	0.0	1.9	0.2	2.9	0.0	10.6	4.1	1.4	3.8	2.6	0.9	1.6	17.3	9.9	10.8	31.8	0.0	0.4	1.2	1.5	1.7	1.4	1.8	0.3	0.6	3.0	5.5	2.8
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206053173-206102449	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.4"	"Group enriched"	"Detected in some"	14	"Endometrial ciliated cells: 202.9;Glandular and luminal cells: 337.5;granulocytes: 334.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 42.8;ovarian cancer: 41.1;renal cancer: 27.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	152	"basophil: 1312.1"	"Lineage enriched"	"Detected in single"	1544	"granulocytes: 1312.1"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 1562.9"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.1	0.4	0.0	2.9	0.0	1.3	4.7	0.0	0.0	24.4	0.0	7.5	3.3	12.8	16.3	7.7	5.3	16.3	0.9	0.0	0.0	14.3	0.9	10.7	4.1	0.0	0.0	0.2	1.4	0.3	0.4	0.6	0.0	2.8	7.4	0.0	2.8	20.0	1.0	4.5	6.7	7.3	0.0	3.0	6.4	1.0	0.1	3.1	2.0	2.5	4.6	7.7	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	143.8	0.0	0.9	0.0	75.2	1562.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	330.8	0.0	0.0	0.0	0.1	0.2	0.7	20.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.6	0.9	1.1	0.8	1312.1	0.0	8.6	0.0	0.1	0.1	0.5	0.2	0.0	0.6	0.2	0.1	0.2	0.5	0.0	0.2	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	20.2	0.0	2.3	0.7	0.0	1.9	3.6	0.0	202.9	17.6	1.3	0.0	0.0	0.0	0.2	0.2	0.4	0.0	337.5	334.3	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0
RHOBTB2	"DBC2, KIAA0717"	ENSG00000008853	"Rho related BTB domain containing 2"	Q9BYZ6	8	22987417-23020199	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 50.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 64.1;Alveolar cells type 2: 77.7;Excitatory neurons: 33.3;Proximal enterocytes: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 85.7;hTCEpi: 73.6;RT4: 126.9"	"Low region specificity"	"Detected in all"							HPA060938	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA060938: AB_2684391"	"unprognostic (2.67e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.43e-1)"	6.5	8.8	17.9	7.5	31.7	2.3	8.4	3.6	27.6	6.8	7.1	6.2	8.5	7.7	5.3	4.8	9.8	6.5	21.8	21.4	7.3	11.2	2.4	50.5	14.9	4.2	10.3	25.8	8.0	9.6	14.2	11.2	4.1	7.7	2.5	5.6	6.4	23.0	16.5	5.5	21.2	6.5	0.8	12.6	8.3	8.1	22.8	8.9	18.5	13.6	16.7	10.4	4.5	15.1	6.8	13.2	10.4	16.7	12.4	8.7	14.0	9.2	12.0	14.2	10.7	34.2	6.6	85.7	13.8	13.3	18.5	13.2	5.0	51.5	6.8	7.4	3.0	9.3	17.8	9.7	6.0	5.5	18.5	11.3	73.6	14.8	7.4	9.8	10.4	6.1	2.3	8.2	9.5	19.7	3.5	8.8	11.0	19.7	9.2	4.7	16.8	5.9	10.1	126.9	6.8	12.5	7.1	21.2	14.5	7.7	4.0	14.0	12.8	17.7	12.8	32.0	10.6	20.7	21.5	30.2	17.2	7.9	14.0	2.9	0.6	0.8	1.7	1.0	1.1	5.1	0.4	0.8	0.6	4.3	0.6	0.6	0.1	2.9	1.1	1.8	0.9	0.8	17.9	31.7	3.6	27.6	21.4	7.3	4.2	10.3	4.1	0.8	22.8	15.1	4.1	64.1	77.7	13.1	7.6	2.9	2.5	5.2	2.8	31.1	2.9	3.2	10.2	5.7	9.1	7.3	4.2	14.7	4.5	0.2	1.9	2.1	0.8	1.9	4.8	6.2	6.0	1.3	33.3	3.7	8.5	5.5	6.1	3.2	4.5	2.4	7.9	1.9	14.3	16.8	13.1	5.8	0.0	2.5	2.6	0.8	6.2	3.5	1.8	5.6	1.5	7.3	8.2	7.1	1.8	4.1	2.6	6.4	4.2	1.2	57.2	6.2	3.1	6.1	0.0	7.2	4.2	0.9	1.9	0.5	0.6	5.6	2.5	2.9	2.8	0.9
RHOQ	"ARHQ, RASL7A, TC10"	ENSG00000119729	"Ras homolog family member Q"	P17081	2	46541806-46584688	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 189.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 1.5;classical monocyte: 2.5;eosinophil: 4.2;intermediate monocyte: 2.7;memory B-cell: 1.7;myeloid DC: 1.6;naive B-cell: 2.4;neutrophil: 4.8;non-classical monocyte: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 164.0;ASC TERT1: 132.0;SK-MEL-30: 150.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044938			Approved	Vesicles,Cytosol		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"		"HPA044938: AB_2679149"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (2.01e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.52e-2)"	96.9	35.7	34.8	30.1	40.1	12.4	64.8	38.9	41.4	59.6	43.9	67.0	11.0	53.2	67.7	18.9	59.3	26.7	196.8	34.3	44.7	44.3	22.6	56.0	23.8	40.9	44.2	40.8	28.6	50.4	29.5	28.6	38.9	50.6	13.5	27.7	32.7	36.5	162.4	28.1	35.3	38.4	39.2	42.7	32.8	10.1	36.8	9.9	39.1	181.3	19.1	62.8	44.7	43.5	12.3	12.4	21.0	28.6	164.0	132.0	3.7	32.8	84.1	16.2	24.4	6.2	4.1	28.7	34.0	58.5	52.4	5.8	20.6	9.8	29.3	10.2	15.3	8.2	9.8	20.9	81.8	8.8	10.7	118.1	17.3	20.1	22.5	39.0	19.3	3.1	12.1	44.0	35.2	8.1	6.9	17.9	20.8	8.9	14.4	5.3	34.5	10.1	23.1	22.4	15.3	50.3	11.6	16.4	150.8	32.9	9.0	20.7	13.2	50.1	44.8	49.3	14.1	48.5	17.7	28.4	73.6	22.1	18.4	1.5	2.5	4.2	0.4	2.7	0.3	1.7	0.2	0.4	1.6	2.4	0.0	0.3	4.8	0.3	1.9	0.6	0.3	0.7	34.8	40.1	38.9	41.4	34.3	44.7	40.9	44.2	38.9	39.2	36.8	43.5	27.9	57.7	22.4	65.3	38.1	22.4	31.0	18.1	11.4	21.1	30.4	22.4	189.2	14.3	22.1	20.2	10.4	14.6	32.2	1.0	17.6	21.4	30.8	22.1	90.2	23.4	6.0	2.1	12.8	32.0	3.6	82.8	4.1	24.6	12.0	12.1	17.5	12.2	44.5	121.1	27.7	5.5	8.2	90.9	77.8	11.4	35.4	90.7	42.7	68.4	55.1	52.9	15.5	52.3	41.5	22.4	0.3	42.5	42.0	41.2	0.2	30.1	18.8	24.2	46.0	54.2	82.3	2.3	4.5	6.8	19.7	25.9	17.0	10.9	1.9	31.9
RHOXF2	"CT107, PEPP-2, PEPP2, THG1"	ENSG00000131721	"Rhox homeobox family member 2"	Q9BQY4	X	120158613-120165630	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.0"	"Group enriched"	"Detected in some"	22	"Spermatocytes: 6.6;Spermatogonia: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"K-562: 100.5;NB-4: 69.9;THP-1: 27.9;U-266/84: 47.2"									"HPA003314, CAB020794"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB020794: , HPA003314: AB_1855193"					"unprognostic (1.60e-1)"										"unprognostic (5.04e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.0	11.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.5	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.5	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	2.1	0.5	0.1	0.7	0.9	0.7	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHOXF2B		ENSG00000203989	"Rhox homeobox family member 2B"	P0C7M4	X	120072264-120077690	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 21.2"	"Cell type enriched"	"Detected in single"	6	"Spermatogonia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HL-60: 596.6;K-562: 903.3;NB-4: 1129.0"									HPA003314	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA003314: AB_1855193"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	596.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	903.3	0.0	0.0	0.0	0.0	1129.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	94.3	3.0	0.0	0.0	0.6	0.2	0.0	156.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIF1	"FLJ10599, FLJ12870"	ENSG00000080345	"Replication timing regulatory factor 1"	Q5UIP0	2	151409883-151508013	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036887, HPA036888"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies, Plasma membrane"		"HPA036887: AB_2675361, HPA036888: AB_2675362"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.41e-2)"	6.1	5.0	4.4	7.4	8.4	21.7	10.0	13.8	7.0	6.5	2.6	5.6	4.3	8.2	4.0	5.6	5.6	5.6	3.5	4.6	5.1	5.5	6.7	5.1	8.5	4.4	5.1	11.2	7.0	6.8	3.5	8.0	5.4	6.0	6.1	8.2	7.7	5.0	7.5	7.2	4.6	6.2	4.9	6.5	6.1	11.0	4.5	10.7	9.1	9.5	7.9	7.3	4.6	13.8	20.8	17.4	26.8	20.5	10.7	13.8	25.9	24.8	18.0	21.6	25.5	28.9	16.4	39.2	21.7	17.3	17.9	21.3	41.2	17.1	36.1	27.8	19.8	63.4	21.4	21.0	11.2	64.7	20.2	10.3	11.3	38.8	28.7	12.3	21.3	23.5	52.2	32.6	22.1	13.8	38.3	22.9	43.2	11.2	22.9	38.4	42.1	26.1	11.6	24.9	24.2	18.8	32.0	14.6	16.5	18.8	12.9	23.1	27.0	32.9	22.8	20.3	26.7	16.0	29.6	55.4	15.3	25.5	22.5	6.3	2.5	3.0	4.3	1.7	4.9	4.0	3.6	3.2	1.8	3.1	4.8	3.7	2.8	7.7	3.5	1.6	2.8	1.7	4.4	8.4	13.8	7.0	4.6	5.1	4.4	5.1	5.4	4.9	4.5	13.8	53.1	96.1	49.7	41.1	43.5	49.3	47.5	21.9	33.0	48.2	30.4	29.8	38.2	28.6	38.0	14.7	31.3	39.2	40.3	19.6	1.9	38.5	22.6	38.0	61.7	48.0	25.0	84.3	68.5	21.9	35.9	51.3	34.7	65.0	34.1	88.6	27.1	19.7	23.0	47.1	72.4	30.9	14.2	26.4	27.0	14.0	43.8	37.6	30.2	48.7	44.1	35.8	32.0	73.9	126.3	29.9	23.5	34.3	45.1	53.2	14.9	12.9	21.3	42.8	85.5	106.5	51.2	122.8	113.1	28.9	41.6	40.9	45.3	58.9	34.6	45.4
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;parathyroid gland: 24.6;pituitary gland: 32.2"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 75.5;Excitatory neurons: 128.2;Inhibitory neurons: 191.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 28.9;SH-SY5Y: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041494: , HPA044114: AB_2678815"	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.6	14.5	6.3	0.9	11.3	0.2	0.2	0.0	17.5	7.2	17.3	1.5	2.9	2.7	2.5	0.5	7.8	0.9	0.0	25.9	19.2	5.9	0.2	0.4	0.1	1.7	19.6	2.1	2.5	24.6	32.2	0.0	20.6	1.1	1.8	11.2	0.3	1.3	0.2	2.7	2.5	2.4	0.1	1.0	5.9	2.6	0.9	0.3	0.6	3.9	0.1	0.3	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.0	0.4	7.3	0.0	0.0	28.9	55.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	11.3	0.0	17.5	25.9	19.2	1.7	19.6	20.6	0.1	0.9	2.7	0.4	0.0	0.0	5.9	0.0	2.0	0.1	0.0	0.6	19.4	0.0	0.1	1.4	0.0	0.0	0.0	31.3	0.0	0.0	0.4	0.0	0.0	3.8	3.0	1.4	0.4	75.5	0.0	128.2	0.0	0.0	0.7	4.1	6.4	0.0	0.0	0.0	0.0	0.0	10.1	191.4	2.6	6.1	0.0	0.5	2.1	0.9	0.0	0.0	1.0	0.0	3.2	0.0	19.6	5.3	0.1	0.1	0.7	0.0	0.1	0.0	0.1	0.7	14.0	0.0	0.0	0.2	1.7	1.5	0.1	0.6	0.0	0.1	0.0	0.8	0.0
RIMS2	"KIAA0751, OBOE, RAB3IP3, RIM2"	ENSG00000176406	"Regulating synaptic membrane exocytosis 2"	Q9UQ26	8	103500696-104256094	"Human disease related genes, Predicted intracellular proteins"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 50.6;brain: 48.2;retina: 102.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 383.6;Cone photoreceptor cells: 706.8;Excitatory neurons: 1589.3;Inhibitory neurons: 1234.9;Oligodendrocyte precursor cells: 577.0;Rod photoreceptor cells: 1088.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 9.2;RT4: 7.3;SCLC-21H: 16.5;SuSa: 8.8;U-2 OS: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046538, HPA066498, CAB079049"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"CAB079049: , HPA046538: , HPA066498: AB_2685678"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (8.01e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.67e-5)"	"unprognostic (8.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	0.2	50.6	22.4	0.2	27.1	0.4	0.7	35.5	48.2	7.5	0.0	0.1	0.4	0.6	0.9	0.3	5.9	0.9	0.1	18.4	16.4	0.3	0.1	0.1	0.3	5.5	9.7	2.0	0.7	0.0	15.0	0.4	6.4	1.7	0.1	102.3	0.8	1.0	0.2	0.3	0.5	1.3	3.5	0.1	0.6	2.8	16.7	0.8	1.3	0.1	0.2	1.7	2.4	29.4	4.6	0.0	4.8	0.0	0.0	0.1	0.0	0.4	0.3	1.0	1.3	0.1	0.3	9.2	0.1	0.1	1.4	0.3	1.9	0.8	2.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.0	1.5	0.0	1.2	0.0	0.5	0.0	0.4	0.9	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	7.3	16.5	3.3	0.0	0.1	0.7	8.8	0.4	0.2	0.0	0.0	6.5	0.1	0.1	1.2	0.0	0.1	0.4	0.3	0.3	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	22.4	27.1	35.5	48.2	18.4	16.4	5.5	9.7	6.4	3.5	16.7	29.4	0.4	28.9	22.5	38.5	0.2	0.3	1.8	2.8	1.8	383.6	0.7	0.6	0.9	1.5	16.9	0.0	706.8	0.5	0.1	0.2	1.9	0.1	34.2	2.1	0.4	4.9	8.4	0.0	1589.3	0.0	0.3	3.7	0.0	3.7	16.4	18.0	0.7	0.3	0.3	67.3	1234.9	0.9	0.0	0.6	0.8	20.1	72.1	2.5	1.8	63.7	0.6	86.6	1.0	577.0	27.0	0.3	1.2	29.3	0.3	4.1	2.0	0.2	10.6	1088.7	0.0	0.8	1.0	34.8	15.7	0.8	0.4	0.1	2.1	0.1	1.5	1.1
RINL	FLJ45909	ENSG00000187994	"Ras and Rab interactor like"	Q6ZS11	19	38867830-38878275	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 32.5;NK-cells: 45.3;Skeletal myocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 14.2;Karpas-707: 24.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042083, HPA042103"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Vesicles"		"HPA042083: AB_10793977, HPA042103: AB_10797380"	"unprognostic (1.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (7.38e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.05e-2)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.40e-3)"	5.3	2.5	2.2	5.3	2.7	2.8	4.2	2.6	2.8	2.8	2.9	3.9	1.6	2.0	0.9	6.3	3.3	1.7	3.5	2.1	2.3	6.1	7.8	4.3	9.7	2.6	2.1	1.5	13.2	2.7	7.2	1.6	2.9	2.5	1.4	2.5	5.3	1.1	2.3	3.6	8.4	1.0	1.9	15.8	4.2	1.1	2.2	3.9	5.1	0.9	7.6	4.6	3.7	2.2	0.0	1.8	0.4	0.2	0.7	0.3	2.8	0.4	0.3	0.4	0.4	1.9	9.2	9.1	3.1	0.4	0.1	0.2	1.7	2.4	0.5	1.7	0.6	10.1	2.6	4.8	1.9	6.4	14.2	2.0	0.4	1.2	0.5	0.3	3.5	5.1	1.8	24.6	0.0	1.6	1.6	4.3	0.8	5.2	0.3	1.2	0.1	6.5	1.7	0.2	3.2	1.3	4.2	6.7	3.6	0.4	0.8	7.7	2.6	0.1	1.9	0.5	0.1	9.1	9.3	6.3	0.7	2.8	0.5	5.3	1.1	1.6	10.3	2.5	6.5	17.4	6.9	7.7	2.0	21.9	5.3	6.4	3.0	5.2	2.5	16.0	8.1	3.6	2.2	2.7	2.6	2.8	2.1	2.3	2.6	2.1	2.9	1.9	2.2	2.2	6.7	3.2	7.7	0.0	22.4	3.2	5.3	2.9	4.6	4.0	5.8	4.7	3.5	8.6	2.3	3.7	8.4	13.9	32.5	0.6	7.9	7.3	0.5	2.8	1.6	6.9	7.2	9.0	2.2	7.3	7.1	4.3	5.1	6.3	15.2	1.3	8.2	7.5	9.3	0.0	1.6	0.7	14.2	6.8	2.7	1.3	3.1	4.3	10.6	1.0	10.5	6.2	45.3	3.5	0.6	5.1	1.7	2.6	14.8	2.3	0.6	12.7	1.3	10.6	0.0	30.3	2.3	2.7	4.4	6.4	3.8	4.1	24.6	5.0	1.3	3.6
RINT1	"FLJ11785, RINT-1"	ENSG00000135249	"RAD50 interactor 1"	Q6NUQ1	7	105532169-105567677	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019875, HPA031646"	Approved		Approved	"Golgi apparatus"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019875: AB_1856283, HPA031646: AB_2673975"	"unprognostic (1.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (1.76e-1)"	7.3	6.1	2.8	9.0	3.1	15.2	10.0	6.9	3.7	8.2	5.6	8.1	9.4	8.6	7.2	11.3	8.0	6.7	8.2	3.1	3.1	9.3	10.5	6.7	13.4	2.8	2.7	8.0	11.6	9.7	5.4	8.8	3.1	7.8	9.3	10.3	11.3	6.1	16.7	8.7	7.1	6.4	3.2	8.8	9.7	11.1	2.7	9.9	8.8	13.3	13.7	8.4	5.7	4.1	28.8	23.5	12.1	27.8	18.8	24.9	15.9	27.2	19.2	26.4	29.6	27.4	18.4	31.6	31.3	24.1	29.4	19.0	22.5	21.0	34.7	17.0	25.9	18.3	26.1	18.5	14.5	38.9	17.8	17.9	16.4	28.1	16.3	20.3	29.1	16.3	39.5	23.2	30.3	46.9	29.3	28.6	26.1	23.8	23.1	17.5	20.5	45.4	14.2	23.6	20.5	22.4	28.9	47.7	20.6	20.9	19.4	12.5	20.3	30.2	24.0	83.1	34.8	46.6	59.7	61.4	20.0	31.8	34.6	4.4	3.9	4.4	6.7	5.8	11.6	9.0	9.8	9.2	6.0	7.8	8.6	9.4	0.7	9.1	4.8	4.0	10.5	6.2	2.8	3.1	6.9	3.7	3.1	3.1	2.8	2.7	3.1	3.2	2.7	4.1	6.7	3.2	9.8	10.4	12.4	6.6	9.6	7.7	8.6	5.8	5.9	5.3	10.5	1.5	9.4	3.7	8.4	11.2	13.4	6.0	9.8	8.1	10.8	9.0	6.4	6.8	5.4	4.6	25.6	6.3	10.3	9.4	12.2	5.5	10.1	7.5	4.2	5.1	7.3	6.7	26.0	5.8	10.2	5.6	3.4	6.2	8.7	5.2	5.4	9.4	5.7	7.8	7.2	9.0	18.2	6.7	4.0	9.8	17.9	6.5	5.5	6.8	18.1	8.9	6.6	8.3	8.0	29.2	12.4	8.3	7.7	12.0	10.8	7.5	6.4	8.3
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063824-3115187	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	18.5	12.0	1.9	9.3	1.9	0.5	16.2	1.8	3.8	12.8	2.4	17.5	12.3	14.5	5.3	17.6	12.8	10.6	11.8	1.8	1.9	13.7	23.6	13.5	10.1	2.2	1.9	8.5	17.4	12.2	12.3	10.9	2.0	13.7	13.0	2.4	16.4	8.9	11.7	20.7	19.9	11.9	2.0	19.4	16.5	5.3	2.0	11.9	14.4	5.0	13.0	15.5	13.7	1.9	14.4	9.8	12.9	12.4	27.6	19.2	5.5	21.4	30.8	22.8	26.7	12.4	8.0	13.8	20.9	30.1	23.2	14.3	17.9	17.2	24.3	27.8	9.4	16.7	4.5	6.9	17.2	15.6	20.1	24.8	15.1	20.4	15.3	17.6	20.6	6.2	19.4	4.6	22.0	17.8	10.7	7.7	8.8	17.4	12.7	11.8	10.9	14.5	17.3	27.2	11.3	12.2	14.7	7.8	22.4	26.0	15.2	8.7	25.1	20.6	12.1	8.2	16.4	9.8	15.3	13.5	8.9	7.0	27.7	0.1	0.4	0.9	0.6	0.9	1.0	0.3	0.9	1.7	1.0	1.2	0.7	0.7	0.0	1.5	0.5	0.5	1.7	0.8	1.9	1.9	1.8	3.8	1.8	1.9	2.2	1.9	2.0	2.0	2.0	1.9	28.6	6.4	12.0	17.3	14.7	11.0	10.3	6.6	16.5	4.4	14.7	17.8	8.6	17.2	16.7	9.2	12.5	8.9	21.9	27.1	5.9	9.4	2.0	10.5	14.0	16.7	6.6	7.2	23.1	12.9	7.7	18.3	27.0	13.4	10.8	8.7	10.0	14.6	11.6	5.0	26.7	17.7	4.1	6.7	11.1	0.8	6.8	15.3	3.6	11.2	13.8	6.6	12.3	14.6	16.2	13.8	11.7	6.0	22.3	11.3	12.7	8.7	17.4	21.4	19.7	32.5	17.9	1.2	2.8	20.5	9.9	11.9	20.8	10.6	11.3	14.5
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757806-89791064	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 156.1;Langerhans cells: 121.3;Macrophages: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.05e-4)"	4.1	1.6	4.0	5.6	4.0	8.9	5.1	4.0	5.5	4.7	3.3	2.9	1.7	5.5	2.4	3.0	2.7	9.4	4.4	4.1	5.5	3.7	5.6	6.0	6.5	4.6	4.0	2.5	4.4	4.2	1.9	4.7	5.1	5.3	2.9	1.5	5.0	2.7	0.6	4.2	2.4	5.7	5.3	4.8	2.9	2.9	3.7	2.8	4.2	1.3	6.7	9.4	2.6	6.0	17.8	6.0	3.2	4.9	7.9	10.8	5.5	19.2	36.1	10.7	13.6	4.6	9.7	14.4	28.0	11.7	7.6	4.2	8.9	6.9	20.2	8.7	8.0	11.9	2.8	5.5	22.2	4.5	5.8	8.8	5.6	15.6	49.8	11.4	11.4	0.0	5.4	4.7	10.2	3.4	0.0	9.6	1.5	8.4	14.4	3.2	4.1	7.5	26.1	8.4	0.4	3.1	4.7	12.6	10.0	4.0	12.0	5.6	10.1	6.5	6.0	11.2	9.1	8.9	4.2	8.8	16.2	0.4	4.3	13.7	6.6	23.2	3.5	12.5	4.1	7.6	5.4	4.6	8.1	4.8	4.9	5.4	5.1	4.4	14.9	2.6	1.3	4.6	4.0	4.0	4.0	5.5	4.1	5.5	4.6	4.0	5.1	5.3	3.7	6.0	19.3	35.3	18.1	25.5	29.8	57.6	33.7	13.3	16.5	2.1	17.2	8.9	5.2	4.3	22.9	3.7	0.0	13.3	32.8	2.8	5.9	80.1	6.6	82.3	23.7	15.0	0.0	9.9	12.9	60.8	45.7	27.3	9.7	156.1	43.1	7.1	6.1	3.2	41.7	3.3	9.1	5.4	24.4	32.4	121.3	2.5	7.8	105.1	19.6	15.0	42.1	12.1	8.2	15.6	12.8	50.0	2.7	6.0	22.0	59.2	2.2	10.4	11.6	0.3	13.1	19.2	19.6	7.9	12.8	14.7	48.3	83.7	30.4	7.5	8.1	49.5
RITA1	"C12orf52, FLJ14827, RITA"	ENSG00000139405	"RBPJ interacting and tubulin associated 1"	Q96K30	12	113185526-113192368	"Predicted intracellular proteins"	"Neurogenesis, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 49.0;Proximal enterocytes: 62.0;Proximal tubular cells: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039094, HPA039095, HPA061531"	Supported		Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA039094: AB_10671037, HPA039095: AB_2676345, HPA061531: AB_2684554"	"unprognostic (7.10e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	6.8	25.4	17.0	7.1	17.4	7.1	7.7	16.0	20.2	8.7	14.6	9.7	13.1	8.1	6.4	14.3	14.0	5.9	15.0	17.5	15.7	15.9	29.6	6.9	11.1	15.1	15.3	10.6	10.6	9.5	12.6	4.7	15.2	10.1	5.9	4.4	13.7	8.3	31.7	10.8	14.2	4.6	12.6	9.5	8.8	7.4	16.9	9.7	10.4	27.2	8.2	8.5	8.1	15.3	27.0	34.3	8.7	23.0	11.5	8.8	15.6	17.2	35.3	24.9	19.8	40.7	13.0	50.8	26.0	14.6	21.4	20.0	20.0	22.3	14.4	31.3	28.4	17.4	16.6	26.6	18.7	23.4	14.0	13.6	20.2	24.6	13.8	34.5	20.7	24.7	34.0	9.2	14.9	38.6	26.1	63.1	29.2	22.9	41.8	23.2	9.3	43.2	20.3	37.8	28.9	16.6	21.7	45.2	38.2	10.6	38.2	35.5	13.7	15.7	22.3	18.2	24.7	31.6	28.6	56.0	23.4	19.4	22.5	43.7	14.6	9.9	15.3	6.6	15.3	11.0	13.5	13.9	16.5	11.8	13.2	14.6	0.3	20.7	8.6	22.5	16.1	13.5	17.0	17.4	16.0	20.2	17.5	15.7	15.1	15.3	15.2	12.6	16.9	15.3	8.1	0.0	11.3	2.9	11.1	6.4	7.1	14.0	7.4	7.4	14.7	14.7	6.6	12.8	9.1	14.7	4.2	19.3	9.8	17.0	49.0	19.2	10.8	16.7	7.3	9.3	11.4	8.8	6.5	16.4	16.9	7.0	8.2	7.3	0.0	8.7	8.6	37.5	14.2	15.2	6.7	12.5	8.2	7.8	2.4	29.6	9.9	6.3	5.4	2.8	5.9	11.0	19.6	2.0	3.7	15.2	12.9	8.2	14.7	10.1	62.0	51.9	17.1	6.0	6.6	7.7	7.5	4.5	7.8	13.8	6.5	10.1	9.0	17.2	12.7	7.5
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221614	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 265.6"	"Cell type enriched"	"Detected in some"	34	"Muller glia cells: 3148.2"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	53	"SK-MEL-30: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.0	0.2	14.9	0.1	16.9	0.1	0.0	15.0	20.8	0.0	16.7	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.0	15.7	14.5	0.0	0.0	0.0	0.0	14.5	14.2	0.0	0.0	0.0	2.6	0.0	14.3	0.0	0.1	265.6	0.0	0.0	0.1	0.0	0.4	0.1	14.0	0.0	0.2	0.9	14.9	0.0	0.0	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.9	16.9	15.0	20.8	15.7	14.5	14.5	14.2	14.3	14.0	14.9	14.9	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.3	0.0	0.0	0.0	39.6	4.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	2.0	3148.2	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	20.0	0.0	0.0	0.0	0.0
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"RLF zinc finger"	Q13129	1	40161387-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	8.7	4.9	5.5	6.2	6.0	32.8	8.3	12.0	7.9	8.4	2.5	7.6	5.1	7.9	4.7	7.3	7.0	6.6	7.5	6.0	5.6	4.9	7.7	8.2	7.7	4.1	4.3	8.3	5.6	6.5	5.1	7.3	4.2	6.6	5.2	15.4	5.7	5.4	8.5	12.2	6.2	6.1	4.3	6.2	5.7	10.3	5.2	10.2	5.8	7.1	8.5	7.8	8.4	8.2	18.3	6.9	13.3	13.9	11.6	9.4	15.8	6.7	9.9	11.3	14.9	14.0	9.4	18.1	8.6	8.6	8.4	16.8	16.9	11.8	20.4	8.5	11.4	14.9	8.0	8.7	9.2	12.5	8.7	9.3	12.1	12.0	13.5	13.5	7.8	9.8	23.0	10.8	10.4	5.8	10.6	7.5	17.8	6.7	7.9	8.2	21.8	10.6	7.2	18.2	9.4	13.1	12.5	16.5	12.0	20.5	7.8	44.6	6.7	13.2	14.1	11.0	12.6	9.8	9.8	16.6	11.5	11.4	8.4	6.9	1.5	3.0	1.8	2.0	2.4	2.3	1.8	1.9	1.9	2.1	2.3	2.0	3.2	2.4	2.4	0.8	1.8	1.3	5.5	6.0	12.0	7.9	6.0	5.6	4.1	4.3	4.2	4.3	5.2	8.2	36.7	32.1	15.1	52.2	55.8	65.6	50.3	12.7	30.7	17.8	25.5	18.4	16.9	2.8	23.9	3.7	16.7	8.9	40.6	10.4	5.9	13.8	41.3	43.8	41.6	24.9	20.2	11.3	87.1	6.7	10.6	34.9	29.6	56.0	26.6	23.0	16.1	9.0	9.7	26.9	84.7	8.8	14.2	13.8	45.2	8.7	9.0	39.9	17.8	60.9	17.5	14.1	9.2	71.9	89.0	10.1	15.5	7.9	44.6	28.7	8.9	5.5	26.0	17.2	13.1	52.8	36.1	32.2	20.8	29.3	61.1	17.2	45.8	17.0	10.8	33.0
RMDN2	"FAM82A, FAM82A1, FLJ32954, RMD2"	ENSG00000115841	"Regulator of microtubule dynamics 2"	Q96LZ7	2	37923187-38067142	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 42.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 270.4;Late spermatids: 163.5;Theca cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA034705, HPA034706"	Enhanced		Supported	"Golgi apparatus,Mitotic spindle,Cytosol"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Mitotic spindle, Cytosol"	"Golgi apparatus"	"HPA034705: AB_2674292, HPA034706: AB_10696362"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.34e-1)"	4.6	42.5	3.8	4.1	3.5	3.4	5.3	4.8	4.5	7.7	2.9	12.4	8.4	5.1	9.2	3.4	3.9	6.2	4.4	4.1	2.6	7.8	29.2	11.3	4.6	3.9	2.6	2.8	4.1	3.2	3.0	3.9	2.6	7.2	10.6	4.2	3.7	12.8	5.1	2.9	13.9	5.8	3.0	20.0	4.4	21.7	3.6	5.9	5.4	3.2	2.9	4.3	3.5	3.7	3.3	4.7	2.6	1.8	10.4	11.4	1.5	7.0	9.3	3.6	3.2	1.1	10.9	2.2	2.8	9.9	2.2	3.5	0.8	5.1	4.9	5.0	3.0	3.6	1.6	3.1	5.3	0.0	3.8	16.2	4.6	4.5	0.7	5.4	2.0	1.8	4.4	2.1	6.8	1.3	0.9	4.5	5.1	6.5	3.8	0.0	0.8	0.6	9.0	2.7	2.1	7.5	5.7	0.7	7.3	2.2	1.1	5.9	3.8	4.4	5.1	2.5	2.6	3.8	7.7	4.6	5.4	1.1	4.6	0.0	2.8	0.7	2.0	4.6	3.1	4.1	1.0	1.3	1.8	2.3	1.0	2.2	2.7	3.7	3.5	3.4	0.1	1.4	3.8	3.5	4.8	4.5	4.1	2.6	3.9	2.6	2.6	3.0	3.6	3.7	3.4	28.9	29.6	25.1	6.5	2.4	6.8	16.3	8.6	3.5	1.9	4.2	5.3	11.5	20.0	5.5	2.1	2.1	6.0	20.9	7.9	5.4	270.4	3.7	11.8	4.6	4.8	3.0	33.8	3.8	1.0	9.2	2.6	3.1	15.8	13.1	5.3	15.5	4.7	5.0	24.5	11.4	6.1	6.3	1.7	163.5	9.3	4.8	5.4	19.7	4.4	4.7	6.2	39.2	7.1	2.5	6.1	6.0	1.8	2.2	29.6	6.7	10.2	2.6	6.6	6.4	5.1	9.4	4.8	1.7	2.4	0.8	3.9	77.6	15.2	2.3
RMDN3	"FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3"	ENSG00000137824	"Regulator of microtubule dynamics 3"	Q96TC7	15	40735884-40755851	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009975, HPA074840"	Supported		Enhanced	"Cytokinetic bridge,Mitochondria"		Yes	No		42000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria	"Cytokinetic bridge"	"HPA009975: AB_1078811, HPA074840: "	"unprognostic (2.54e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.94e-3)"	"prognostic favorable (6.70e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.04e-3)"	30.1	22.7	37.2	16.2	40.2	24.1	26.7	38.4	48.6	18.0	31.2	18.1	43.8	15.9	5.4	22.6	18.8	16.7	16.4	36.3	36.1	18.4	37.0	36.5	15.6	40.2	38.6	17.2	27.2	36.3	10.9	19.4	36.0	17.2	9.0	6.7	33.3	15.4	20.7	21.1	51.7	11.2	37.7	13.0	21.5	13.8	42.9	15.0	19.9	14.1	8.4	20.3	17.6	41.2	19.7	17.7	21.0	35.9	19.2	17.2	36.3	50.2	19.8	34.9	25.6	63.7	21.7	16.7	65.0	27.0	26.0	66.3	26.9	37.3	3.7	44.2	33.1	53.6	51.4	31.6	62.9	36.4	41.1	30.9	34.0	25.2	23.9	16.3	24.8	32.6	57.4	44.9	15.1	40.0	27.7	23.6	16.7	52.7	34.6	42.6	25.1	38.9	28.8	32.7	49.8	18.1	39.9	53.4	19.5	8.2	41.6	39.1	37.3	37.8	27.0	51.1	42.5	34.0	42.7	26.7	26.8	38.2	42.2	4.0	13.2	5.5	28.2	17.8	25.0	16.0	20.6	26.0	14.4	13.7	15.9	17.3	2.1	65.1	22.3	54.2	20.3	26.6	37.2	40.2	38.4	48.6	36.3	36.1	40.2	38.6	36.0	37.7	42.9	41.2	20.1	32.1	28.1	18.6	11.0	15.7	16.4	26.9	15.9	20.0	21.0	13.6	8.1	15.7	27.8	18.4	4.2	44.4	22.4	17.2	1.9	27.7	2.8	20.7	17.8	18.1	4.9	42.7	23.5	22.0	28.5	17.8	13.7	22.0	19.0	8.6	17.5	36.4	110.7	18.5	18.2	12.3	26.4	14.7	10.4	3.4	16.8	21.0	19.6	8.4	11.7	21.6	43.3	16.1	21.8	21.8	16.7	14.3	18.0	17.3	77.6	14.5	29.3	17.3	6.6	22.2	16.0	40.4	40.4	21.9	11.9	62.8	18.3	16.7	21.4	23.1
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806584-12813640	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 62.3;Extravillous trophoblasts: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	8.9	6.8	7.0	11.8	7.2	28.0	9.0	10.4	9.1	10.8	6.2	10.5	10.3	8.5	4.9	18.3	10.6	4.9	7.6	7.2	6.1	7.4	6.9	7.3	17.1	7.3	6.5	8.9	9.2	5.3	5.4	10.4	7.4	6.0	10.7	8.4	8.6	5.0	8.9	13.9	10.0	8.2	6.0	14.5	9.4	19.8	6.8	24.4	7.5	6.6	18.7	8.2	10.8	9.5	130.0	103.8	94.8	75.7	12.3	23.4	76.2	68.4	40.0	126.3	136.0	76.2	58.7	126.9	106.2	36.6	59.6	79.4	82.6	89.2	83.5	82.7	118.1	67.7	112.9	89.9	7.1	70.6	60.5	10.4	19.7	110.7	43.9	21.4	47.3	114.8	91.2	46.8	82.0	251.4	132.8	83.0	56.4	79.1	167.4	146.1	102.0	113.7	39.6	63.8	119.8	76.7	67.0	39.8	46.7	39.8	76.1	78.4	29.3	129.2	55.7	197.0	126.1	97.6	130.3	108.5	77.4	129.4	105.5	9.4	19.1	17.2	23.9	27.6	23.3	36.8	19.6	22.5	19.0	36.3	15.9	19.6	4.4	44.8	27.7	21.0	25.8	19.1	7.0	7.2	10.4	9.1	7.2	6.1	7.3	6.5	7.4	6.0	6.8	9.5	5.3	0.0	2.6	1.3	15.3	14.0	15.7	22.9	6.8	16.2	2.8	11.7	2.7	12.8	7.6	0.0	4.2	62.3	9.1	11.3	0.0	5.4	16.1	0.8	1.6	9.0	8.4	38.7	2.2	6.0	117.4	10.3	10.7	1.1	3.8	2.5	11.7	4.4	48.9	8.4	3.0	13.9	22.4	9.1	13.2	18.8	8.4	9.3	12.4	1.9	8.5	10.4	14.4	1.0	2.4	2.1	6.8	4.9	33.0	5.3	6.2	1.0	9.5	13.9	6.6	15.6	9.8	51.2	44.9	23.8	13.2	22.7	10.2	0.8	24.8	16.1
RNF10	"KIAA0262, RIE2"	ENSG00000022840	"Ring finger protein 10"	Q8N5U6	12	120533480-120577588	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 286.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052643	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Mitochondria	"HPA052643: AB_2681897"	"unprognostic (1.54e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.58e-2)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (5.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.40e-1)"	79.5	104.3	99.0	52.7	101.2	184.8	68.1	97.2	135.0	63.9	108.8	90.1	58.8	61.6	96.1	103.0	58.5	50.1	191.2	101.7	98.4	108.3	81.7	74.4	53.6	99.0	102.9	65.6	75.2	75.8	71.3	65.9	97.8	69.0	65.8	76.6	68.1	61.7	307.2	77.8	61.2	77.8	99.3	78.7	81.0	96.8	100.9	57.9	60.7	208.8	69.5	73.2	69.3	107.2	109.7	141.6	68.3	109.3	130.9	103.0	80.6	100.7	113.9	81.8	86.4	117.1	49.3	129.5	89.4	167.3	64.0	73.9	126.6	136.5	116.0	127.5	71.0	132.1	77.5	123.0	175.3	120.0	89.5	105.5	155.0	115.1	156.8	141.8	168.5	95.7	134.2	86.7	124.3	125.3	79.4	131.1	104.0	101.7	139.9	69.8	87.5	185.4	164.4	221.1	66.9	72.7	140.0	89.5	78.9	94.2	144.2	68.6	134.8	59.3	65.7	95.5	65.9	74.7	146.8	90.8	97.5	80.2	65.0	154.2	53.8	173.8	45.5	45.8	48.9	35.7	44.7	52.4	60.0	31.2	39.5	40.6	118.0	46.1	54.3	30.7	60.7	52.9	99.0	101.2	97.2	135.0	101.7	98.4	99.0	102.9	97.8	99.3	100.9	107.2	56.2	25.6	32.6	30.3	54.0	61.9	51.1	27.1	52.3	39.9	63.8	42.9	99.3	32.9	28.4	47.8	22.9	62.1	58.9	93.5	164.4	49.7	72.7	54.1	53.2	45.9	49.2	286.5	43.1	58.7	69.4	47.8	64.7	78.9	36.8	42.0	42.8	48.8	36.9	55.5	42.9	50.3	34.6	52.5	63.1	41.7	56.8	54.7	56.9	16.9	48.7	43.3	56.7	32.2	52.4	59.8	49.1	54.9	71.2	63.1	73.8	70.0	21.6	54.5	52.6	52.3	55.0	118.0	55.2	74.5	65.8	111.8	59.1	74.1	47.3	77.8
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917412-7068286	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.6;Inhibitory neurons: 101.7;Oligodendrocyte precursor cells: 194.5;Oligodendrocytes: 330.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.1;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HEL: 39.7;HMC-1: 127.9;SH-SY5Y: 39.0;SK-MEL-30: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Supported	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049939: AB_2680960"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	9.7	28.5	21.1	4.1	46.1	13.9	10.1	59.2	36.7	24.2	1.2	5.7	2.6	26.3	7.7	4.3	7.8	7.1	8.1	17.5	24.0	7.3	1.3	5.4	6.0	30.1	27.0	19.3	30.7	38.1	12.9	5.9	33.4	9.1	5.3	23.0	4.6	6.4	9.6	5.4	3.8	11.6	21.5	23.0	2.6	4.7	30.3	7.5	3.4	10.1	5.6	4.4	7.5	73.6	0.8	5.8	30.1	6.2	6.6	13.6	23.0	0.2	0.0	1.1	2.8	0.1	0.7	2.9	3.3	0.3	8.7	0.7	10.0	0.0	0.0	1.6	2.6	39.7	0.3	11.8	0.3	0.7	127.9	21.7	0.1	2.2	0.0	0.0	0.0	9.9	17.3	0.6	0.0	4.9	20.6	1.7	11.0	0.7	13.6	15.9	21.8	2.6	1.0	10.2	9.9	39.0	0.5	4.0	39.8	3.9	1.7	2.6	0.1	3.9	10.0	10.7	4.5	10.4	3.5	0.1	14.7	8.7	14.3	1.3	0.0	6.1	1.2	0.0	1.8	0.0	1.3	0.9	0.1	0.1	2.4	1.7	0.3	0.5	0.0	0.0	0.6	0.4	21.1	46.1	59.2	36.7	17.5	24.0	30.1	27.0	33.4	21.5	30.3	73.6	27.8	3.2	4.2	34.3	2.4	2.4	0.7	0.0	1.8	4.6	2.5	2.5	11.5	2.8	1.9	0.0	75.0	2.4	5.3	15.4	1.9	3.3	5.5	6.1	15.4	13.9	25.4	18.5	176.6	5.8	3.1	10.4	2.6	10.7	8.9	31.5	23.2	1.1	4.9	10.1	101.7	2.7	0.0	1.0	1.7	14.2	4.4	1.7	24.9	17.8	1.2	7.6	10.3	194.5	330.3	3.0	11.1	10.5	3.1	3.0	2.0	0.3	1.5	39.8	0.0	16.1	5.2	1.8	6.6	5.2	1.6	1.1	9.8	19.1	2.7	1.7
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468870	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 634.4;Langerhans cells: 296.9;Suprabasal keratinocytes: 1501.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 71.9"	"Group enriched"	"Detected in many"	9	"dendritic cells: 18.4;granulocytes: 36.7;monocytes: 71.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 192.8;hTCEpi: 59.1;HUVEC TERT2: 55.6;TIME: 56.1;U-698: 160.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	9.4	2.0	7.4	15.6	7.4	24.0	29.1	7.9	9.0	9.5	9.1	4.2	1.8	5.7	4.7	8.4	11.8	6.2	8.1	6.4	7.7	14.0	15.5	19.4	11.3	11.8	11.9	1.6	3.2	2.9	1.7	15.1	9.4	13.1	2.8	5.0	16.9	7.3	56.9	21.1	3.3	6.2	8.9	13.1	5.7	2.3	10.5	5.1	40.9	14.1	12.9	9.4	7.1	8.7	4.6	1.0	0.4	0.0	0.3	2.0	9.8	5.3	5.7	11.0	11.8	0.1	0.4	192.8	50.7	2.3	0.6	16.3	0.1	16.0	15.5	0.9	1.4	0.2	0.2	4.2	0.2	0.2	0.2	2.7	59.1	4.3	13.2	4.9	55.6	4.3	0.1	0.0	2.7	2.0	1.5	0.0	1.6	0.6	1.1	0.7	1.7	11.8	33.2	10.6	1.9	0.2	1.2	23.9	18.5	1.5	28.2	0.5	56.1	8.6	1.9	0.8	1.2	0.0	0.1	160.6	1.0	0.4	0.7	0.4	20.7	12.9	0.5	38.9	1.6	4.6	0.8	0.6	13.3	3.6	1.6	1.0	36.7	0.6	71.9	18.4	0.5	7.1	7.4	7.4	7.9	9.0	6.4	7.7	11.8	11.9	9.4	8.9	10.5	8.7	28.8	44.8	15.0	34.9	21.7	634.4	48.8	86.0	14.8	0.9	35.7	26.3	12.8	17.2	48.3	38.6	2.1	14.1	9.8	2.2	19.6	8.6	2.1	49.0	5.8	34.6	1.2	3.8	2.3	8.9	3.7	7.8	10.7	58.5	3.8	0.1	47.2	21.9	15.0	0.0	99.0	1.8	14.2	109.4	296.9	1.8	1.2	171.7	60.5	92.8	54.1	17.9	1.0	3.5	2.5	5.2	3.6	3.0	3.4	112.3	0.9	20.6	36.7	1.2	0.0	9.0	7.8	2.2	3.2	30.0	1501.1	1.5	4.9	0.1	2.3	42.6
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266682-127288567	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	52.9	37.0	49.5	32.4	56.0	10.6	42.7	79.4	61.2	48.1	36.2	40.5	21.9	57.4	60.8	25.3	42.4	38.6	46.9	50.7	51.6	37.1	31.8	38.7	35.1	53.2	52.1	49.5	23.3	40.0	33.3	51.8	56.8	31.7	30.9	48.1	31.2	34.5	114.9	29.5	31.1	45.9	55.2	47.1	29.9	31.3	52.5	24.3	47.1	91.5	33.3	36.9	34.3	61.5	13.2	16.2	60.3	53.6	54.7	54.3	22.2	43.5	69.0	22.8	32.4	21.3	19.3	23.6	30.3	35.7	36.2	16.4	18.1	20.4	32.9	27.6	16.0	30.3	21.8	30.0	54.0	18.0	20.6	47.6	42.1	26.1	51.1	52.5	40.6	23.2	33.0	22.5	50.7	25.2	17.9	32.0	22.1	8.1	17.1	22.6	15.7	12.1	32.4	14.3	36.0	36.6	17.1	23.6	27.7	35.5	16.1	60.8	48.3	39.7	13.1	41.8	31.7	32.3	22.0	15.6	30.5	31.0	38.5	27.5	30.0	26.6	14.3	32.4	14.7	17.4	12.2	16.3	22.8	17.9	11.0	15.5	37.0	19.8	40.1	11.7	15.0	16.1	49.5	56.0	79.4	61.2	50.7	51.6	53.2	52.1	56.8	55.2	52.5	61.5	24.6	35.3	29.3	35.6	23.7	17.7	14.3	15.1	18.8	34.7	16.9	14.7	38.9	31.5	16.7	9.2	4.2	29.0	14.7	13.5	41.1	28.0	52.5	15.7	29.5	30.5	20.4	12.8	53.5	15.8	27.2	50.6	7.1	11.5	22.2	28.1	31.4	30.5	26.3	30.3	54.5	12.1	38.7	68.4	24.6	45.4	69.6	29.9	46.2	42.2	31.1	41.1	28.8	56.3	76.5	18.0	17.0	66.5	9.3	26.3	15.7	51.7	23.9	20.9	32.9	36.2	31.9	41.7	24.9	15.0	20.0	38.4	20.8	36.0	10.9	25.9
RNF148	MGC35222	ENSG00000235631	"Ring finger protein 148"	Q8N7C7	7	122701668-122702922	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 49.3"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 405.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"cerebellum: 9.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.8;MCF7: 1.1"	"Not detected"	"Not detected"							HPA045587			Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA045587: AB_10963695"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-1)"	0.2	0.2	0.0	0.0	0.2	0.0	0.2	9.9	1.7	0.2	0.2	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.4	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.6	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	49.3	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.8	0.0	1.1	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.9	1.7	0.2	0.1	0.0	0.2	0.6	0.0	0.1	0.7	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	405.2	0.5	0.5	0.5	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.8	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	62.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.9	0.0	0.1	0.0	0.2	0.0	0.0	6.6	0.2	0.1	3.9	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696499-88706408	"Enzymes, Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 91.2;lymphoid tissue: 101.6"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 132.3;NK-cells: 111.2;T-cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 108.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	22.7	18.4	16.1	28.8	16.2	91.2	16.0	14.4	24.5	18.3	13.9	18.3	14.1	16.6	3.2	11.8	20.0	14.0	21.3	15.5	15.0	20.7	23.4	48.3	40.4	19.4	16.8	17.8	19.5	5.4	17.6	8.2	17.6	19.7	4.9	3.4	14.8	5.8	21.3	11.8	37.2	6.3	16.9	101.6	17.8	12.8	20.9	18.0	18.8	8.2	21.1	18.1	14.4	20.0	10.3	15.9	12.5	18.4	5.8	5.0	23.3	10.3	6.5	11.8	5.3	11.1	6.4	12.4	13.0	6.0	6.8	11.1	7.2	6.8	4.7	6.4	21.7	16.7	12.4	18.7	15.9	16.7	20.4	6.0	6.4	9.4	8.2	6.9	12.4	20.6	28.6	8.8	5.0	20.3	38.9	108.0	20.3	4.4	21.5	36.3	7.8	32.2	5.3	4.5	11.8	12.3	23.9	4.8	12.1	5.9	13.4	53.3	18.6	8.7	13.4	13.5	12.5	19.9	13.5	31.6	7.8	62.8	12.4	7.0	25.6	61.3	31.6	19.1	27.7	4.2	19.3	27.6	23.8	3.9	15.7	22.9	40.4	11.3	22.7	14.8	21.8	21.6	16.1	16.2	14.4	24.5	15.5	15.0	19.4	16.8	17.6	16.9	20.9	20.0	15.2	9.6	3.6	7.8	23.5	4.8	4.6	2.4	6.2	10.1	6.0	7.1	2.8	4.3	3.1	7.3	6.2	8.8	132.3	2.3	9.8	6.5	1.4	5.2	7.4	11.0	4.9	13.7	6.5	9.2	9.6	8.8	8.2	4.9	21.0	12.3	8.6	4.8	38.8	8.4	4.8	3.1	2.0	46.7	32.4	2.5	9.3	52.4	10.6	15.0	41.5	11.7	111.2	3.5	4.5	5.5	1.0	7.9	55.1	4.5	1.8	7.0	4.7	9.6	6.6	8.9	10.0	9.1	9.9	4.8	5.8	3.7	73.1	12.2	3.7	1.9
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	75.0	110.6	141.9	53.0	146.7	69.0	73.1	146.4	179.9	93.2	138.6	111.5	66.6	94.9	76.4	122.1	84.3	45.3	131.8	141.5	146.4	106.7	184.2	77.5	64.5	146.3	145.4	87.4	115.1	105.8	96.8	50.7	146.3	95.0	65.7	98.1	92.5	70.5	152.9	127.8	100.5	52.8	142.4	113.8	111.8	110.6	150.3	98.1	93.4	94.2	71.6	106.7	90.4	153.3	102.6	143.1	61.1	73.7	132.8	68.7	92.7	63.4	76.1	119.7	93.4	96.2	43.3	71.5	120.3	93.5	63.9	147.5	103.2	114.8	86.1	74.5	166.1	121.9	164.4	94.9	100.6	59.0	245.0	79.6	176.5	129.8	116.2	74.6	77.2	101.0	49.9	237.5	96.2	66.3	92.8	70.6	75.4	102.0	86.8	62.8	61.9	91.5	137.3	77.4	49.2	61.1	56.0	92.9	81.9	83.1	87.3	55.9	49.5	76.6	48.3	66.8	119.3	79.5	88.0	23.7	98.4	80.6	77.9	108.4	88.8	236.9	195.3	94.0	153.4	100.4	148.0	195.7	73.9	98.7	103.2	152.2	219.8	118.8	117.7	75.9	153.0	177.0	141.9	146.7	146.4	179.9	141.5	146.4	146.3	145.4	146.3	142.4	150.3	153.3	36.9	0.0	3.9	12.4	54.3	68.6	44.4	65.8	51.8	43.2	56.6	44.7	15.8	77.2	38.9	49.7	20.9	120.1	64.7	65.2	56.7	78.5	59.6	29.8	25.1	36.4	31.8	60.6	11.3	66.7	139.7	36.3	36.2	32.2	14.0	26.3	45.7	95.1	58.4	18.5	11.2	45.7	65.1	41.3	43.6	86.5	48.7	36.1	39.2	6.5	53.1	46.9	114.4	10.1	17.9	60.7	44.9	53.8	59.1	32.6	108.2	64.0	31.1	32.3	39.5	28.4	35.1	127.1	106.7	61.4	83.3	125.2	82.5	37.2	59.6	48.0
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748849-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	4.2	2.8	3.8	6.7	6.2	14.4	5.6	6.2	4.4	5.5	5.4	4.4	4.0	7.6	4.2	10.1	5.6	4.8	3.2	4.0	4.4	4.6	5.0	5.9	6.3	5.4	5.0	7.6	4.4	5.6	2.1	4.7	5.4	5.2	5.3	6.1	4.5	4.3	6.8	5.5	4.4	7.6	4.4	7.3	4.6	2.9	4.6	7.7	5.8	5.8	6.7	5.2	5.4	9.2	10.2	7.7	9.1	9.0	5.8	7.7	3.7	7.9	7.4	8.6	7.4	13.0	7.5	18.2	7.9	9.5	5.8	9.6	12.4	9.3	11.2	9.1	8.0	12.6	15.3	5.1	6.6	6.8	10.1	7.1	7.2	9.8	22.1	9.6	14.0	12.2	11.4	14.1	8.7	8.6	11.6	12.0	3.6	12.9	5.0	10.7	21.7	9.9	5.5	10.6	4.1	7.4	10.6	8.0	16.6	7.3	9.9	8.6	9.4	14.2	11.8	9.0	7.1	10.2	5.8	21.1	2.8	7.3	8.4	1.2	0.5	0.4	0.4	0.3	0.3	0.0	0.4	0.2	0.2	0.1	0.3	0.2	1.4	0.3	0.3	0.2	0.3	0.2	3.8	6.2	6.2	4.4	4.0	4.4	5.4	5.0	5.4	4.4	4.6	9.2	18.8	9.6	11.4	51.6	18.4	19.9	30.6	7.1	20.5	58.2	12.6	9.8	3.0	17.2	8.3	3.7	52.1	5.5	24.6	9.8	5.9	10.2	2.8	30.5	26.7	17.2	12.0	18.3	40.8	11.1	6.4	16.0	14.8	30.1	7.0	24.4	10.8	12.3	8.5	37.0	43.2	8.7	2.0	15.6	19.9	3.1	7.5	16.6	10.6	25.3	12.6	22.9	26.8	42.7	68.7	10.1	6.8	10.5	18.5	49.7	6.3	12.1	8.9	33.7	26.3	31.9	18.7	9.4	11.7	16.4	18.6	8.1	22.2	14.0	10.4	42.2
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487382-228496188	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 189.0"					"Low region specificity"	"Detected in all"			HPA030098	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	26.8	66.6	16.2	7.5	16.2	11.3	25.8	14.8	24.3	40.5	3.4	28.1	8.6	31.8	4.3	59.1	28.7	5.6	35.4	15.9	16.9	40.7	52.0	23.6	7.3	19.4	15.2	39.3	34.5	22.5	47.7	5.5	18.4	33.5	3.7	9.0	39.7	8.2	64.2	45.0	22.5	5.6	15.6	37.0	27.6	20.8	18.5	8.5	36.1	19.8	6.1	29.9	41.2	19.8	26.7	23.1	14.8	28.9	16.8	12.5	26.6	21.5	17.3	15.6	12.7	12.8	19.2	65.9	43.1	28.9	11.4	20.9	19.1	22.1	5.8	25.9	28.5	20.8	13.2	12.6	46.1	22.1	34.4	20.4	44.7	11.6	15.8	18.3	14.0	52.6	35.6	115.2	12.4	17.7	35.2	20.8	30.7	19.1	24.0	27.8	12.5	61.5	11.4	17.2	29.9	30.0	21.9	44.1	62.3	4.3	34.6	50.2	27.8	18.3	16.9	19.6	19.3	189.0	56.7	36.4	46.7	22.7	28.7	0.0	0.5	3.6	0.6	1.0	0.7	0.5	0.7	1.0	0.6	1.0	0.6	0.7	0.1	0.4	1.4	0.7	0.6	0.3	16.2	16.2	14.8	24.3	15.9	16.9	19.4	15.2	18.4	15.6	18.5	19.8	54.0	25.6	15.5	8.1	47.2	36.2	42.9	10.6	38.7	85.2	59.5	58.5	70.8	65.8	14.2	40.5	18.8	19.7	52.2	39.8	113.5	15.2	0.8	35.5	47.2	32.1	40.0	118.4	16.6	24.5	27.1	54.4	34.7	32.0	44.5	45.0	41.7	67.4	27.4	55.5	17.2	36.6	2.0	40.1	30.5	4.2	24.5	35.8	39.2	12.2	29.7	145.3	62.8	7.1	12.6	21.4	23.4	25.9	35.4	44.0	32.9	126.4	10.3	47.7	19.7	52.2	38.4	4.2	21.5	57.0	55.3	17.6	54.6	217.5	38.6	31.7
RNF215		ENSG00000099999	"Ring finger protein 215"	Q9Y6U7	22	30368811-30421771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 12.9;Cone photoreceptor cells: 12.5;Rod photoreceptor cells: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029427, HPA056498"	Approved		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	Microtubules	Nucleoli	"HPA029427: AB_2732447, HPA056498: AB_2683154"	"unprognostic (1.24e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.67e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (6.37e-10)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	8.4	8.7	19.2	5.6	19.0	7.0	9.3	18.7	22.5	17.6	17.9	11.8	7.8	15.2	9.2	6.7	13.3	6.8	9.5	19.2	20.4	12.1	11.1	8.7	4.7	20.2	18.7	13.7	13.2	10.7	10.0	6.9	18.3	13.1	3.9	8.5	6.5	8.3	8.0	6.1	7.7	7.9	16.9	11.6	8.9	10.5	20.0	2.8	12.2	2.9	3.9	12.3	10.8	17.4	6.8	14.0	14.4	23.4	13.8	14.3	14.2	11.4	10.1	11.3	6.8	3.8	7.4	2.7	20.1	9.3	21.1	8.4	8.9	13.1	9.0	15.8	10.8	4.5	17.8	5.1	18.9	3.6	18.5	19.4	15.8	19.3	10.3	36.7	13.3	7.0	4.0	12.6	13.6	11.0	2.6	8.5	4.5	9.7	15.4	12.2	8.4	10.8	14.9	10.3	6.3	16.2	11.6	8.3	8.9	13.1	7.6	3.9	18.6	30.2	13.3	8.8	6.7	13.3	3.4	3.7	17.7	2.6	11.9	0.4	0.9	1.5	0.9	0.7	1.0	1.0	1.0	0.8	0.5	1.9	1.8	1.7	0.5	2.5	0.8	1.4	0.5	0.4	19.2	19.0	18.7	22.5	19.2	20.4	20.2	18.7	18.3	16.9	20.0	17.4	7.1	3.2	3.9	8.8	1.4	0.3	1.2	1.6	2.8	12.9	3.2	3.9	2.2	1.5	2.7	0.0	12.5	1.9	3.7	1.0	0.0	1.5	0.8	3.7	6.4	3.5	0.0	0.4	5.0	1.4	1.5	5.4	6.1	6.6	0.0	8.2	4.6	2.3	1.8	8.4	4.6	0.5	2.0	1.2	0.5	0.4	0.9	1.9	1.8	1.0	2.3	11.7	1.0	2.5	1.1	1.9	0.2	1.2	1.8	1.3	0.7	1.0	0.6	13.7	6.6	4.8	4.8	2.1	0.9	0.6	0.1	1.6	2.0	5.3	0.7	1.2
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663892-218672002	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA036420: AB_2675114, HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	10.9	11.4	18.5	8.9	18.6	7.3	10.9	18.3	21.0	12.2	17.1	12.0	6.2	12.7	15.8	11.7	12.4	10.8	13.9	18.6	19.7	10.4	11.1	10.4	14.5	18.4	18.4	14.5	11.5	15.1	11.4	11.4	19.0	11.8	8.2	7.0	11.0	13.9	15.0	14.5	7.9	13.6	18.5	10.3	9.4	14.3	19.2	15.1	14.1	17.1	11.9	14.0	9.7	19.0	18.8	20.4	22.1	24.6	27.6	17.5	20.4	27.3	43.5	58.0	53.6	32.4	13.2	11.6	17.6	42.3	35.2	19.5	22.1	33.9	31.0	16.4	27.3	22.7	21.3	34.6	33.6	19.3	20.6	33.9	30.9	55.5	44.7	21.4	31.0	40.9	27.4	24.3	41.1	45.3	20.6	20.4	32.9	16.2	23.4	23.2	15.5	15.9	36.3	21.8	19.5	23.8	18.1	17.2	28.4	21.9	20.6	25.6	26.6	40.2	20.5	19.2	31.1	23.7	13.7	23.5	33.4	19.1	25.7	58.6	21.5	32.6	26.0	21.3	24.8	25.7	25.7	27.2	17.1	30.4	29.0	23.2	17.1	30.5	25.2	15.0	25.9	24.8	18.5	18.6	18.3	21.0	18.6	19.7	18.4	18.4	19.0	18.5	19.2	19.0	4.2	0.0	0.5	5.2	7.8	6.2	4.8	16.3	6.8	7.7	3.4	3.7	4.0	10.0	8.9	1.8	8.4	12.3	4.5	7.4	15.6	12.3	16.8	6.3	8.1	7.6	1.2	2.1	6.2	12.9	9.7	7.5	9.7	4.8	7.0	5.9	8.9	7.1	13.2	5.0	5.8	5.5	8.2	5.0	4.0	5.3	7.2	5.5	8.8	2.8	8.9	7.9	9.2	3.5	4.9	12.7	9.6	12.8	8.5	3.8	7.2	14.8	8.2	5.0	26.3	5.6	9.2	19.3	12.8	5.9	6.8	10.0	8.0	8.5	6.1	3.6
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	30.2	30.9	24.0	36.0	24.9	46.4	29.2	26.0	25.1	29.4	26.5	27.9	29.0	29.5	28.3	30.7	28.5	28.3	27.0	24.5	25.5	32.6	25.9	27.8	49.9	26.0	25.9	31.0	31.2	33.6	26.8	28.4	25.2	28.2	27.4	24.0	28.0	28.1	27.7	29.7	30.4	33.1	23.9	40.3	30.1	31.9	26.3	50.1	30.7	23.2	50.0	35.0	26.8	25.5	60.9	57.0	57.9	42.0	50.6	52.2	65.6	73.3	83.4	77.3	70.0	65.1	56.8	77.6	42.0	76.0	101.5	39.7	63.5	58.6	72.7	37.6	38.5	92.4	54.6	62.6	76.6	66.7	77.8	61.0	69.7	72.3	59.4	53.6	73.1	64.8	50.0	103.2	80.4	43.5	105.0	92.5	89.8	52.3	70.9	76.6	55.3	40.8	52.6	74.5	54.3	51.0	50.5	40.4	52.1	62.9	63.1	50.6	60.0	65.8	32.0	64.2	115.4	131.3	189.5	82.6	64.6	72.7	69.5	44.7	70.0	104.6	97.7	95.4	97.2	85.0	82.2	97.0	84.1	59.1	78.8	80.3	77.2	99.2	103.8	56.5	98.8	128.6	24.0	24.9	26.0	25.1	24.5	25.5	26.0	25.9	25.2	23.9	26.3	25.5	31.1	22.4	17.5	17.0	36.0	27.5	18.4	17.7	31.3	11.9	24.0	16.0	20.7	12.8	21.3	22.0	16.7	21.3	45.9	16.5	21.5	22.2	14.0	17.0	22.8	21.7	12.1	15.4	15.9	23.3	35.0	19.5	23.0	23.9	14.5	22.7	16.4	20.4	19.7	13.5	17.8	16.8	8.2	34.0	28.5	22.4	17.1	27.8	7.2	18.7	35.1	11.5	43.3	13.0	16.3	29.8	14.3	20.7	47.8	27.1	23.1	21.2	17.6	17.7	26.3	18.2	22.0	31.2	48.6	27.0	32.1	21.8	39.7	16.4	18.9	32.9
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202179-56221933	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	32.2	24.6	22.5	18.0	23.3	19.6	21.4	15.7	23.8	21.2	13.0	23.8	12.4	22.3	13.2	23.1	24.3	25.5	32.7	24.6	24.8	19.7	15.1	23.8	23.4	16.8	19.1	22.9	23.0	27.4	22.8	21.3	21.2	33.9	19.0	23.8	15.0	20.7	34.0	15.0	16.1	28.5	15.3	20.6	17.0	15.9	23.5	26.5	28.6	40.8	25.1	28.2	17.0	19.2	21.6	32.6	34.7	55.2	71.0	51.3	25.8	70.8	69.5	62.2	50.2	40.0	27.6	41.6	36.7	60.2	20.6	24.3	47.4	34.1	44.9	43.8	25.7	55.8	22.3	23.2	148.3	61.6	58.3	66.0	78.6	52.0	91.0	81.7	61.3	34.5	40.4	41.3	35.1	34.9	35.6	27.6	41.9	21.6	37.8	38.2	24.9	25.3	33.3	31.3	62.9	38.1	61.9	35.0	55.4	34.3	49.2	71.3	37.3	31.3	32.9	40.6	27.8	29.6	36.6	37.5	37.2	36.4	38.0	59.1	27.2	99.9	27.6	26.7	24.9	50.3	23.0	24.3	30.6	55.1	23.4	24.0	36.2	33.1	28.3	23.7	29.4	31.0	22.5	23.3	15.7	23.8	24.6	24.8	16.8	19.1	21.2	15.3	23.5	19.2	18.9	44.8	22.6	11.1	42.2	12.0	19.9	8.6	19.9	30.7	22.2	21.1	24.6	24.3	18.8	16.5	22.9	15.2	17.0	10.2	17.6	15.3	92.8	13.9	14.2	20.7	20.4	11.1	15.0	21.3	18.5	22.7	9.7	14.2	25.9	16.8	30.0	16.7	19.3	28.6	15.7	13.9	8.2	34.9	22.7	58.0	23.0	25.0	7.2	9.4	33.5	26.2	15.5	14.6	12.3	20.8	20.3	25.9	14.6	33.5	12.3	19.6	18.0	18.3	26.3	23.2	27.4	10.4	14.2	14.4	16.6	16.8	16.6	17.1	14.3	23.1
RNFT2	"FLJ14627, TMEM118"	ENSG00000135119	"Ring finger protein, transmembrane 2"	Q96EX2	12	116738178-116853631	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.8;pituitary gland: 5.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.9;Early spermatids: 49.3;Excitatory neurons: 22.7;Inhibitory neurons: 28.7;Late spermatids: 56.4;Oligodendrocyte precursor cells: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064161	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064161: AB_2685202"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.14e-5)"	"unprognostic (8.62e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.36e-3)"	"unprognostic (4.01e-4)"	0.4	1.0	9.8	0.5	9.8	1.0	0.2	5.7	13.8	0.2	2.9	0.3	0.5	0.2	0.8	0.4	0.3	0.4	0.4	10.6	8.4	0.7	0.1	0.3	1.1	11.8	7.6	0.4	0.2	0.4	5.1	1.0	11.9	0.2	0.3	4.9	0.6	0.2	0.6	0.6	0.5	0.2	4.2	0.8	0.3	3.7	7.9	1.4	0.5	0.1	1.2	0.2	0.1	9.3	1.3	7.3	2.9	9.8	0.1	0.1	6.8	0.5	0.5	1.6	1.2	3.3	1.2	6.5	1.9	0.1	2.2	1.3	7.8	0.6	0.9	7.0	4.6	1.1	5.5	2.4	1.1	0.5	4.9	0.2	0.1	3.6	0.8	0.9	0.3	4.4	8.0	2.1	0.1	4.0	7.6	1.1	4.5	1.9	1.3	4.1	1.5	3.4	2.0	1.2	5.0	4.8	1.8	0.8	1.9	2.6	5.0	1.7	0.4	1.0	4.5	2.2	2.5	3.6	14.9	8.5	4.0	0.5	0.6	1.1	0.2	0.2	0.3	0.1	0.1	0.7	0.3	0.3	0.1	0.8	0.6	0.7	0.7	0.5	0.3	0.7	0.2	0.2	9.8	9.8	5.7	13.8	10.6	8.4	11.8	7.6	11.9	4.2	7.9	9.3	0.9	0.0	0.5	11.8	2.2	0.0	0.3	0.2	0.0	17.9	0.7	0.3	1.2	1.5	0.2	7.3	16.7	3.1	0.3	0.5	0.0	0.9	49.3	0.7	0.3	1.9	4.2	0.4	22.7	0.2	3.0	0.6	1.1	0.6	0.0	3.8	0.4	0.2	2.2	10.1	28.7	0.8	2.0	1.9	0.8	56.4	0.6	0.7	1.8	3.7	1.0	5.5	0.0	18.6	7.0	0.6	0.1	1.5	2.0	0.2	0.6	1.0	1.4	10.3	0.0	0.7	0.9	3.8	5.2	0.2	0.0	1.6	0.5	1.1	0.8	0.2
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;retina: 15.4"	"Group enriched"	"Detected in many"	24	"Excitatory neurons: 3438.7;Inhibitory neurons: 4706.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 29.8;HEL: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013371, HPA013975"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA		1900000		"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA013371: AB_1856391, HPA013975: "	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	0.7	2.4	10.1	0.5	13.6	0.0	0.6	0.0	14.2	2.4	0.0	0.8	0.5	2.1	0.4	4.8	0.1	2.3	0.6	10.4	1.7	1.8	1.2	10.0	1.5	14.8	13.1	7.0	1.6	2.8	1.5	5.2	14.3	1.2	0.4	15.4	1.6	5.7	0.1	2.3	0.7	1.4	16.7	2.9	0.7	3.7	4.9	9.3	0.1	0.4	2.2	1.2	1.7	8.1	0.0	0.0	2.2	0.0	7.5	8.1	0.1	0.3	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	9.8	83.9	1.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.1	9.1	0.0	0.0	1.1	5.1	12.2	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	13.6	0.0	14.2	10.4	1.7	14.8	13.1	14.3	16.7	4.9	8.1	0.7	0.0	0.5	164.6	0.0	1.8	2.0	0.4	19.4	30.8	0.2	1.0	2.4	1.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	1.0	1.7	1.1	0.0	0.0	3438.7	0.0	0.1	10.6	0.0	3.2	0.0	2.3	3.3	0.7	0.1	52.2	4706.0	3.0	0.0	0.0	2.8	3.4	3.1	0.1	0.0	54.4	0.0	2.0	0.0	63.3	52.4	0.2	0.0	6.0	0.0	0.8	0.3	0.1	0.1	5.6	0.0	0.1	0.9	2.9	1.1	15.7	1.1	0.1	0.2	40.5	0.5	0.2
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615116	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	18	"retina: 1186.9"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3239.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 2.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"HSkMC: 25.2;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028910, HPA073279"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA028910: AB_2672824, HPA073279: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	12.8	7.9	57.9	2.2	60.5	1.2	9.3	56.8	67.4	9.1	48.1	9.8	1.8	7.7	4.7	7.6	10.7	4.6	8.1	54.5	59.0	7.0	7.1	6.0	2.5	67.4	61.0	13.5	3.6	5.2	7.0	1.4	62.1	8.2	2.6	1186.9	4.2	5.0	3.3	5.4	5.3	5.4	60.0	7.5	7.0	6.2	63.1	1.6	6.0	3.7	2.5	9.6	7.3	62.1	3.2	1.9	3.1	6.6	4.5	22.0	0.6	2.1	3.7	4.3	2.8	0.9	5.3	3.0	15.9	12.2	2.0	4.1	1.5	4.2	1.1	5.3	3.0	3.1	8.6	4.0	13.0	1.1	0.9	25.2	5.9	4.5	9.1	15.1	7.0	1.2	4.0	6.5	9.1	8.3	1.7	2.3	0.8	1.7	5.9	1.6	2.6	19.1	5.0	1.8	3.3	5.1	5.0	5.8	2.5	0.5	8.1	1.4	8.3	7.2	2.7	8.3	2.5	2.9	31.9	2.4	14.2	3.1	1.5	0.0	0.4	0.3	0.3	0.1	0.9	0.2	1.2	0.3	0.2	0.3	0.5	0.6	0.1	2.7	0.4	0.3	0.4	0.5	57.9	60.5	56.8	67.4	54.5	59.0	67.4	61.0	62.1	60.0	63.1	62.1	19.9	0.0	4.4	4.9	0.6	3.7	5.7	5.0	7.4	356.6	3.8	7.2	2.5	2.8	2.3	5.5	594.2	1.0	0.6	2.4	1.9	1.6	2.0	1.0	4.1	31.3	4.2	0.0	0.2	3.1	0.2	4.1	1.1	1.0	1.3	1.2	21.8	1.7	1.1	171.6	0.5	2.8	0.0	1.9	0.8	7.9	19.0	1.2	3.6	1.9	1.3	516.9	1.0	1.0	6.5	2.1	2.5	5.7	0.6	3.1	3.1	4.7	2.7	3239.7	0.0	2.5	4.3	1.6	5.1	5.3	1.0	0.7	1.5	4.0	2.9	3.1
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84498352	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	24.4	21.6	13.7	19.0	17.4	44.9	24.7	14.7	19.4	23.5	15.8	28.1	17.7	26.0	23.0	27.0	23.2	14.1	34.2	13.5	15.4	28.0	26.1	20.5	26.8	13.7	14.0	20.7	22.8	18.8	21.0	14.9	13.8	20.8	20.9	16.8	21.9	15.5	42.7	26.1	23.2	18.1	13.4	26.2	25.6	25.3	13.9	29.4	23.3	23.9	28.1	24.9	23.3	14.8	43.1	29.2	36.6	30.2	27.1	35.5	40.5	46.8	36.5	53.2	47.0	21.4	17.6	31.9	50.1	33.9	89.0	31.7	54.3	43.2	57.7	51.0	57.6	85.2	30.7	37.8	37.2	80.0	25.4	29.0	63.0	56.0	39.2	30.7	42.6	60.7	79.9	40.7	46.9	21.8	76.3	53.0	91.5	43.0	62.5	48.3	58.5	25.7	51.3	47.6	45.2	42.2	27.7	52.7	107.3	32.8	29.6	53.4	30.3	40.1	41.3	64.8	90.4	29.5	39.0	73.0	19.2	71.0	37.0	64.0	35.2	34.6	41.4	41.0	45.4	65.4	46.0	42.0	37.4	58.6	51.3	50.7	14.7	52.6	46.3	39.5	52.9	47.4	13.7	17.4	14.7	19.4	13.5	15.4	13.7	14.0	13.8	13.4	13.9	14.8	28.2	38.5	39.5	7.2	35.8	34.7	41.5	71.6	12.0	15.7	20.4	19.6	39.3	30.0	43.0	16.5	16.7	35.5	51.7	18.0	74.3	60.3	72.7	34.9	27.6	35.0	33.5	17.2	10.1	64.1	33.1	25.0	16.8	26.5	65.2	18.6	28.9	36.6	44.0	8.4	9.8	29.6	28.5	31.7	30.2	13.2	32.6	28.4	28.4	9.4	37.0	30.1	60.8	8.5	10.4	53.0	23.6	35.0	16.2	26.8	21.7	67.4	53.8	25.6	46.0	23.4	43.3	94.7	63.7	18.0	32.7	27.5	40.3	21.4	36.0	39.7
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 234.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	16.4	12.2	6.6	9.5	7.4	10.8	14.9	7.3	8.7	12.9	7.2	11.9	6.6	11.2	5.4	15.2	12.5	9.1	15.3	7.0	7.1	15.8	17.2	9.7	10.4	6.9	6.9	13.2	19.9	9.7	8.1	10.2	7.0	11.4	8.8	5.6	9.9	7.1	22.2	13.9	8.1	8.1	6.9	9.3	11.7	13.5	7.1	7.6	13.0	14.0	10.9	15.3	12.5	7.9	23.3	16.6	12.7	50.5	26.4	34.7	32.6	32.5	23.6	32.3	32.6	39.2	18.5	50.2	29.4	22.8	38.8	27.0	51.5	37.6	84.2	19.4	38.7	29.5	14.2	27.4	35.9	45.9	16.6	26.5	31.4	46.5	83.5	20.3	24.9	22.1	99.0	29.9	52.2	23.4	39.2	45.5	45.2	37.7	20.2	40.2	22.4	43.6	37.4	22.9	20.3	28.7	14.1	23.7	61.3	16.8	18.8	47.3	17.5	24.7	21.2	234.1	81.4	13.4	22.0	65.0	36.4	60.8	55.2	0.2	4.4	0.7	4.1	5.5	8.5	6.6	6.1	5.0	5.8	5.7	6.8	7.0	0.3	8.8	3.5	5.8	5.0	4.0	6.6	7.4	7.3	8.7	7.0	7.1	6.9	6.9	7.0	6.9	7.1	7.9	40.0	19.2	26.9	6.5	25.0	78.4	119.6	90.1	35.9	14.1	33.6	52.3	71.9	47.1	67.6	18.4	0.0	44.9	18.0	15.8	68.4	48.2	105.7	49.8	57.6	35.2	11.4	26.1	15.7	47.4	53.8	50.0	17.3	60.9	46.2	18.9	23.6	83.6	56.0	18.5	14.0	30.3	36.7	27.7	19.5	32.1	34.5	28.2	37.4	5.6	21.8	21.0	19.6	9.0	13.5	42.2	18.7	27.1	18.8	80.4	15.2	87.2	55.0	8.9	13.1	61.7	49.9	76.8	28.4	33.0	66.2	34.6	22.9	29.8	44.0	70.2
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691673-88750929	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.6"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 234.3;Erythroid cells: 167.9;Syncytiotrophoblasts: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		2500000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: AB_2683563"	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	17.2	11.0	7.4	19.6	7.6	89.6	16.0	8.3	8.9	13.4	8.0	22.7	22.1	13.2	9.5	24.1	14.6	11.7	16.0	7.3	8.2	10.6	7.8	12.2	28.0	7.8	7.5	13.7	17.9	7.4	8.2	33.8	7.5	8.9	23.0	4.1	15.9	8.1	29.9	11.9	18.9	12.5	7.8	19.2	18.9	9.6	8.0	40.4	9.7	17.1	32.4	16.5	12.5	7.9	29.7	17.0	33.7	26.9	23.4	23.9	73.8	16.1	15.1	26.1	17.8	61.1	38.2	150.1	34.3	18.7	35.8	17.7	42.4	13.5	40.9	71.9	55.3	60.2	11.0	60.7	23.7	111.5	42.4	22.1	11.2	23.3	35.9	13.0	37.4	78.7	65.7	25.3	24.8	46.5	123.4	97.2	30.7	97.6	27.7	63.5	40.1	36.8	21.7	47.1	24.0	27.4	19.4	24.8	39.3	18.3	13.5	45.3	21.4	15.5	40.7	51.2	46.7	19.7	17.2	149.3	15.9	99.4	22.5	10.6	16.0	36.4	16.9	16.7	21.4	31.4	23.5	25.1	22.7	23.5	33.4	27.8	3.9	21.9	21.9	10.9	22.0	20.6	7.4	7.6	8.3	8.9	7.3	8.2	7.8	7.5	7.5	7.8	8.0	7.9	38.9	12.8	13.2	4.6	43.2	37.3	21.3	31.2	21.6	8.7	22.2	18.2	13.7	14.3	22.7	20.2	2.1	234.3	37.1	20.6	9.8	21.7	8.1	28.0	23.3	35.0	19.2	167.9	13.3	34.2	98.9	23.5	31.1	43.2	21.6	30.7	24.3	7.1	43.8	13.5	15.7	26.9	26.4	23.1	33.9	4.0	19.9	23.7	40.9	11.2	32.4	5.2	60.8	13.6	13.3	22.8	28.1	18.8	35.8	41.7	20.6	18.7	10.1	4.8	19.7	19.8	18.0	28.4	33.4	37.6	40.9	225.6	38.8	37.8	58.5	43.7
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859910-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 682.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055259	Approved		Approved	Nucleoli,Cytosol		No	No		44000	"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA055259: AB_2682764"	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	1984.9	1325.9	783.3	1207.3	801.9	2675.9	2006.4	765.1	966.5	2276.5	976.5	1896.2	1072.6	1684.5	414.2	2432.1	1900.0	848.3	1178.2	738.0	778.4	1205.8	1161.2	1350.6	2511.2	806.4	757.5	3627.6	3907.4	541.6	923.3	757.2	789.9	1596.6	718.5	205.8	2590.5	635.5	2533.1	3581.5	1721.9	686.3	819.5	2048.4	1928.7	350.6	801.3	1573.9	1398.1	1213.3	1488.2	1737.1	2164.1	808.5	2623.4	2001.4	1299.0	1847.0	1923.3	3152.4	3291.2	1559.5	1979.9	2038.9	1930.5	2789.2	2550.3	3921.7	3523.0	1365.1	805.3	1913.5	1555.9	3350.6	708.6	2020.7	4206.5	1833.5	1792.6	3238.9	3314.5	2660.3	1916.4	3952.5	4349.3	1127.8	2410.2	2094.2	2265.6	3157.8	2386.5	2462.6	1313.5	4085.3	3633.0	3514.7	3067.9	2909.3	3049.2	3210.9	1376.3	4708.0	1887.0	2464.1	1879.4	2817.6	554.3	3813.0	5042.2	637.7	1814.7	5079.9	1738.1	1244.6	1438.8	2512.2	2674.5	3251.9	3283.4	2639.9	1632.9	4270.0	1580.0	1247.5	4513.0	690.0	4974.8	4521.9	8679.3	14996.3	8499.1	6207.0	6569.7	15438.5	9988.2	7821.6	433.2	5415.3	3633.6	7634.4	8027.2	21239.5	783.3	801.9	765.1	966.5	738.0	778.4	806.4	757.5	789.9	819.5	801.3	808.5	1797.3	519.2	1033.4	1.3	6570.0	8683.5	6503.8	6346.6	5314.4	252.0	7203.4	8120.9	437.2	2077.4	2572.8	923.2	127.2	4676.6	3414.9	1440.2	2387.0	3503.1	57.0	1112.5	3101.7	2919.9	1842.7	2735.0	1.8	8949.1	8763.1	2652.7	2316.6	1639.3	1447.9	3627.9	2837.8	2144.2	3317.2	131.2	2.2	3965.3	1881.8	4748.0	8399.9	194.1	4165.1	3240.6	4747.4	1.9	6119.2	908.2	3084.5	1.5	2.5	5684.1	3130.7	1627.9	3619.6	6541.4	3169.3	3629.8	1019.5	499.6	1255.6	3061.1	4561.4	199.9	834.7	6806.4	11135.4	4659.3	4511.8	4057.7	4606.2	8094.9
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204840	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"SK-BR-3: 37509.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol		NA	NA		160000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: AB_2681682"	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	2108.0	1641.8	1232.8	1325.7	1302.0	3445.4	2213.5	1236.2	1473.8	2449.2	1230.5	1983.7	1161.3	1717.3	1256.1	2160.0	1997.7	1159.4	1539.0	1175.0	1252.5	1725.6	1485.2	1453.6	2835.1	1303.7	1237.8	3638.0	3006.2	1537.0	1362.5	1050.7	1304.9	1733.7	1231.5	383.6	2136.0	1214.5	2763.0	2809.4	1733.8	1104.6	1324.2	2003.5	1872.5	615.5	1268.5	2335.8	1462.6	1879.2	2543.6	1915.1	2121.1	1325.7	1943.7	2617.7	1849.0	2258.4	3300.1	4133.6	1894.3	1788.5	3631.1	3629.7	2895.6	2872.0	1801.2	4740.4	3047.1	2580.8	2122.7	3228.2	2807.4	3714.8	1852.4	1922.4	4931.8	1693.5	1876.5	3797.5	5133.2	4201.0	2240.4	4647.6	3995.5	2805.3	5031.4	3396.2	3177.6	3991.6	3007.3	2696.5	2544.2	1939.5	5610.7	5814.7	1891.0	2269.3	1912.1	3270.3	2620.6	4777.9	3324.4	2419.1	2225.5	2457.9	1084.0	37509.3	5867.6	1982.1	3626.8	5201.1	1883.8	1410.9	1894.7	2165.8	3336.2	3504.5	3756.7	3505.5	1906.0	3147.3	1854.1	1051.1	2648.2	975.0	2486.9	2147.2	3862.3	4698.0	3984.2	3158.7	3263.9	4349.1	4920.5	4086.9	380.6	2830.2	1793.7	3012.9	3456.9	9398.3	1232.8	1302.0	1236.2	1473.8	1175.0	1252.5	1303.7	1237.8	1304.9	1324.2	1268.5	1325.7	2477.2	884.6	1438.4	49.0	5591.4	5551.7	6227.1	4092.6	3998.1	241.7	5532.9	7926.2	556.3	2332.0	2100.3	1138.5	93.8	3720.2	4011.1	1443.7	3623.4	3025.0	1451.9	1129.0	2357.2	2714.5	1957.2	2708.2	30.8	6238.2	5441.3	2425.2	1705.4	1503.7	1586.0	3024.3	2836.8	2406.3	4189.9	132.9	33.6	3550.3	1464.8	4218.0	5326.1	4539.9	3920.2	3259.8	3272.8	46.9	4282.6	1495.1	3932.1	20.1	51.1	3972.8	3267.4	2040.2	3289.0	6219.8	3226.4	5182.0	1049.1	390.5	1531.7	3215.1	3875.5	962.9	981.4	5376.4	6619.2	3899.7	4615.5	3399.1	3895.2	7406.6
RPL22	"EAP, L22"	ENSG00000116251	"Ribosomal protein L22"	P35268	1	6185020-6209389	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA068294			Approved	Nucleoplasm,Nucleoli		NA	NA		860000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoli	Nucleoplasm	"HPA068294: AB_2732781"	"unprognostic (3.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.98e-1)"	579.0	489.0	252.3	511.9	262.0	1064.4	599.4	258.1	400.1	716.0	257.9	573.4	475.0	513.3	313.9	621.7	590.5	220.4	390.9	243.7	261.0	473.0	480.3	396.9	659.8	256.3	250.3	1096.7	690.5	312.2	331.9	308.3	259.9	487.3	320.3	316.6	589.4	218.3	912.3	686.8	461.4	247.4	263.7	501.7	500.7	137.8	255.5	484.9	400.4	398.8	509.7	551.5	600.5	274.7	1443.4	400.8	836.4	858.6	576.1	897.0	659.0	1224.2	488.1	440.4	372.9	802.5	1213.4	2217.7	981.3	458.1	304.2	810.7	636.9	638.2	576.9	1093.6	1033.3	2159.0	948.8	1016.3	569.4	2893.0	828.4	799.9	516.3	393.5	808.6	907.3	560.1	610.3	1817.3	1301.1	512.9	634.7	1274.0	2340.3	522.1	953.0	880.1	1207.4	1731.8	1731.8	656.1	490.4	1149.9	1051.9	996.9	2846.8	2387.4	721.1	918.2	2247.5	1380.1	623.1	689.2	833.9	1170.4	1037.2	1544.9	3289.7	413.0	2911.2	395.5	109.0	297.7	71.2	268.2	270.0	474.9	547.1	502.6	373.2	451.6	500.6	679.0	560.8	22.0	337.5	227.9	472.2	416.3	664.1	252.3	262.0	258.1	400.1	243.7	261.0	256.3	250.3	259.9	263.7	255.5	274.7	1090.2	445.5	731.5	5.9	2372.5	1821.1	2035.3	1455.3	2241.2	217.6	1764.0	2190.8	277.9	1225.3	883.4	584.9	131.3	1816.1	1450.8	669.0	1905.6	1332.1	442.9	736.9	1377.2	1104.5	912.5	1508.9	15.3	1823.0	2751.0	1022.5	940.9	944.1	921.5	1256.6	1457.4	1491.7	1504.9	141.3	14.2	2032.2	449.6	1997.8	2098.8	320.1	2027.4	1440.8	1076.1	14.0	2435.3	890.1	1442.9	8.0	10.7	1575.3	1413.5	1234.1	1218.7	1837.3	1182.5	2505.6	437.3	390.8	775.7	1773.9	1169.1	358.6	473.0	2759.8	1935.8	1851.9	1791.5	1289.9	2231.0	2084.3
RPL22L1		ENSG00000163584	"Ribosomal protein L22 like 1"	Q6P5R6	3	170864875-170870208	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 651.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 912.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048060, HPA056207, HPA068294"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (5.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.96e-2)"	41.4	32.0	10.4	64.2	12.0	93.6	46.7	10.7	20.6	25.6	9.8	36.1	19.0	24.8	17.8	75.3	32.3	17.2	23.5	10.4	11.6	27.4	47.9	25.9	75.3	11.9	11.5	34.0	47.5	8.3	22.4	17.2	12.1	25.1	33.0	7.7	34.2	15.7	9.9	46.6	32.9	26.5	11.4	67.4	38.6	13.7	11.8	39.8	16.9	6.2	63.2	61.3	38.0	16.4	153.8	169.2	54.4	632.1	156.8	912.4	165.5	152.9	349.5	121.7	78.4	72.8	34.8	472.8	34.5	143.1	379.6	39.3	136.4	390.2	67.7	28.8	24.7	43.2	21.4	166.4	632.4	88.7	60.1	670.6	775.2	38.9	409.7	189.0	418.9	257.7	30.4	29.8	672.0	194.3	650.6	49.7	849.1	58.6	31.0	857.7	19.4	72.7	305.4	337.4	9.2	45.7	15.4	75.6	72.1	29.2	105.6	77.2	196.3	23.3	175.9	47.2	216.8	47.1	36.0	76.2	420.5	53.7	489.4	2.2	9.5	4.3	13.2	12.6	26.9	47.1	19.4	17.9	10.7	34.8	12.9	14.5	2.1	28.8	17.8	51.2	13.1	6.9	10.4	12.0	10.7	20.6	10.4	11.6	11.9	11.5	12.1	11.4	11.8	16.4	153.2	9.6	43.7	4.6	379.6	197.6	240.2	260.8	198.6	13.9	185.1	397.2	18.1	55.8	111.4	20.2	4.2	89.8	241.9	111.5	66.5	160.8	37.6	128.4	279.6	138.5	144.6	266.7	3.3	232.3	297.4	169.0	146.3	116.8	106.5	202.8	103.9	129.5	184.7	8.4	4.5	240.7	93.6	187.4	101.4	36.3	139.4	148.9	78.2	2.8	108.7	54.2	69.0	7.5	10.1	400.8	137.1	89.1	651.0	421.5	99.1	94.1	60.5	21.0	46.0	189.5	472.0	67.2	58.9	511.7	247.8	98.4	173.7	260.4	197.5	356.3
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 943.6;tongue: 422.7"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 134.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049136	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA049136: AB_2680648"	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	0.3	0.4	0.9	0.2	0.6	1.7	1.4	1.7	0.8	0.0	1.0	0.2	0.6	0.3	0.4	8.5	0.1	0.5	174.0	0.5	0.4	0.4	0.3	0.2	0.4	0.1	0.0	0.3	11.5	0.0	0.1	0.2	0.1	4.2	0.0	1.2	6.9	0.1	943.6	0.7	0.5	0.0	0.0	0.4	0.2	6.4	0.1	0.1	0.4	422.7	0.1	0.2	0.1	1.0	1.1	1.2	0.3	1.1	0.0	0.0	0.7	0.5	0.0	0.0	0.0	4.0	2.1	0.6	0.7	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.6	0.4	0.9	1.4	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.7	0.0	0.7	0.4	2.8	0.0	0.6	0.8	1.0	0.6	1.2	2.5	0.4	0.3	0.9	0.1	0.4	1.6	0.5	0.5	1.4	0.6	0.7	0.7	0.6	0.6	0.6	1.4	0.8	0.4	1.2	0.6	0.5	0.8	0.2	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.4	0.2	0.3	0.1	0.4	0.3	0.3	1.2	0.2	0.3	0.4	0.1	0.1	0.9	0.6	1.7	0.8	0.5	0.4	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.2	0.0	0.0	0.1	0.6	134.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.1	1.3	0.0	5.3	0.1	0.0	0.2	2.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	23.7	2.2	0.7	2.4	0.0	0.4	0.0	0.2	0.1	0.1	0.5
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034600	Uncertain		Approved	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"		Yes	No		1300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	831.6	565.7	367.7	738.6	404.0	1928.0	2030.6	377.1	545.7	1385.7	370.7	970.8	451.2	1276.0	1088.2	1289.4	1454.2	776.9	914.1	385.6	388.6	751.5	914.9	666.3	1630.2	376.4	380.9	3022.1	1740.5	954.0	504.0	746.1	386.6	709.1	1143.5	350.6	1234.8	1092.1	1314.7	1327.1	507.9	1353.5	383.2	776.9	643.8	296.4	373.4	1883.4	1289.5	1921.7	2451.3	1322.4	782.5	406.8	1192.9	2343.4	973.0	1646.3	4272.4	7697.6	1710.1	1416.1	2899.7	2143.0	1648.1	2611.3	2025.2	4676.6	1572.3	3396.6	1011.9	2105.0	7026.5	5476.3	2352.2	1301.4	4208.3	2872.9	1955.7	2201.2	6007.7	3042.0	1376.1	7627.4	6980.3	2334.4	9237.8	2620.8	3489.1	2180.2	2682.6	1785.2	3252.1	1956.0	2044.2	1348.1	2136.9	2634.2	1661.9	2256.2	2213.4	4588.3	2958.1	2321.4	1718.4	1794.6	872.3	2447.5	3515.4	2022.2	1812.5	4303.4	2059.2	1111.1	1662.1	1048.4	2297.9	1736.5	2937.8	3118.9	1368.2	4015.4	1281.7	46.4	455.3	62.2	359.4	370.9	668.1	711.1	698.6	506.5	586.8	644.5	888.5	721.6	26.9	478.1	361.3	372.8	589.8	1758.0	367.7	404.0	377.1	545.7	385.6	388.6	376.4	380.9	386.6	383.2	373.4	406.8	393.9	451.9	1004.9	28.1	1553.4	2423.4	2769.6	2082.8	1295.3	122.6	1594.0	1140.4	403.3	760.7	1165.2	342.1	81.3	2059.9	1055.8	364.9	1651.3	1162.8	672.5	337.9	821.0	840.2	761.1	1195.8	26.2	2141.0	3735.7	879.7	467.9	430.0	945.5	899.2	711.0	715.5	1211.2	40.4	23.9	1089.8	636.8	1281.3	2031.3	1392.4	1334.0	991.6	1088.5	27.2	1920.9	417.7	1196.8	15.1	30.0	1239.9	737.1	996.0	1019.5	2031.3	370.6	1572.3	603.9	169.9	460.2	1196.4	934.7	376.4	454.9	1632.1	2583.2	2398.3	1289.5	1184.6	1371.2	2628.6
RPL6	"L6, TAXREB107, TXREB1"	ENSG00000089009	"Ribosomal protein L6"	Q02878	12	112405189-112418838	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060903, HPA068418"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No		620000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Microtubules, Cytokinetic bridge"		"HPA060903: AB_2732653, HPA068418: AB_2685987"	"unprognostic (5.95e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.90e-2)"	1199.2	1080.7	788.0	937.3	801.7	2387.8	1856.5	776.8	1063.3	1357.1	828.3	1249.1	789.1	1236.7	1570.4	1485.5	1241.3	734.2	856.8	756.3	814.1	985.6	1026.1	803.0	1847.2	805.2	807.2	2777.7	1984.2	1103.8	1049.8	763.3	801.3	1017.4	1222.4	531.8	1632.2	850.0	1451.0	1598.1	946.0	1018.7	822.2	1015.0	1214.8	279.2	808.0	1815.8	1223.2	1298.0	2204.7	1349.1	1216.0	818.0	1973.8	1887.6	2227.1	2264.4	2725.6	4486.8	2932.4	1843.2	2670.8	2471.8	1408.6	2975.9	1213.3	4225.2	1547.6	2008.9	962.8	1881.4	2395.5	3288.1	2456.2	1682.6	3199.4	2274.7	1590.4	2693.3	2854.8	4103.6	1708.4	4171.2	4542.3	1876.9	4294.7	4571.2	2818.5	2754.1	3060.8	1134.5	2888.4	2727.7	3013.0	6699.3	3096.5	4209.0	2233.7	2731.0	2375.5	4144.9	3118.1	3283.8	2050.1	2651.9	1297.5	3446.9	3342.3	2007.3	3621.2	4189.6	1657.8	1215.8	1484.2	1572.8	2110.7	1542.6	2549.7	3377.6	1573.3	2948.5	1861.4	730.3	2260.1	463.1	2285.0	1851.6	3814.8	3463.8	3465.4	2972.5	2896.3	3116.2	3751.8	3251.5	262.6	2839.0	1688.0	3372.7	3027.9	7777.8	788.0	801.7	776.8	1063.3	756.3	814.1	805.2	807.2	801.3	822.2	808.0	818.0	1483.8	798.0	1587.2	31.0	3121.1	3145.3	3907.2	3373.8	2996.4	271.4	3790.3	6493.7	262.3	1818.7	1733.0	636.4	137.6	3077.0	2809.4	731.3	3502.2	2270.2	414.6	1133.8	2774.3	1661.9	1388.1	1929.0	42.6	3043.9	4721.2	1695.5	1135.6	1287.6	1290.2	1743.7	1854.3	1727.8	1880.0	121.1	48.2	2036.2	1112.9	2566.7	2790.5	714.3	2849.7	1964.8	1899.7	30.9	3399.6	854.8	2699.3	34.7	48.9	2582.7	1646.1	1589.9	2173.6	3165.2	1095.4	3376.3	776.7	412.3	927.0	2550.9	1835.3	376.5	461.6	3977.5	3650.1	3068.7	2710.6	2783.0	2512.8	3577.6
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619969-128681075	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 424.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		730000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	97.9	88.3	56.7	94.5	65.5	97.1	105.5	69.0	63.3	142.0	96.2	124.0	97.1	92.0	352.4	76.6	124.8	90.5	82.6	56.1	71.4	119.5	226.3	112.7	76.8	72.7	65.8	80.8	118.8	143.8	83.7	139.8	69.4	100.2	134.3	46.9	120.4	113.9	89.2	63.5	94.5	111.6	66.7	85.2	115.0	90.9	68.1	86.0	177.7	77.7	102.4	117.2	64.0	77.9	358.5	190.9	156.2	289.8	412.7	273.1	351.3	300.0	393.2	391.4	452.1	399.4	328.2	221.9	274.8	437.3	363.2	349.7	255.4	268.2	374.7	158.8	160.3	392.7	127.9	332.3	454.3	322.5	198.2	229.5	307.3	258.4	377.5	260.9	308.6	164.2	164.2	289.6	260.4	327.8	179.7	353.0	198.1	476.6	170.2	193.6	209.4	540.6	272.7	212.0	238.6	137.4	246.3	253.6	313.6	199.0	271.0	329.0	203.2	200.9	154.7	297.0	226.9	306.1	259.9	234.4	329.4	235.9	296.9	178.0	171.6	137.6	129.3	147.0	154.7	91.5	104.7	117.7	159.5	60.7	63.8	99.3	233.2	90.3	159.3	192.4	114.2	250.8	56.7	65.5	69.0	63.3	56.1	71.4	72.7	65.8	69.4	66.7	68.1	77.9	82.9	60.9	74.1	13.1	72.4	49.5	83.6	102.8	55.2	13.0	53.7	26.9	42.4	51.5	91.6	112.2	8.4	113.7	59.1	126.0	15.6	111.5	19.1	85.3	73.9	72.4	43.3	63.5	11.7	93.3	199.1	91.7	113.2	126.8	43.7	40.2	96.0	180.0	135.7	20.2	16.3	158.4	73.2	154.1	70.8	29.5	94.1	87.6	58.7	11.2	77.0	30.3	39.1	18.1	21.3	104.0	83.1	64.3	424.1	93.3	109.1	90.7	110.2	13.2	46.0	43.9	53.7	65.9	62.6	67.0	53.4	156.7	65.8	54.0	130.2	78.9
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241619	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 599.6;Syncytiotrophoblasts: 621.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		1300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.44e-4)"	112.6	132.5	48.2	131.9	50.4	180.8	146.1	49.9	55.9	161.8	98.0	156.9	125.5	108.7	344.1	106.8	122.9	119.8	107.3	49.5	56.5	145.1	212.1	129.7	109.2	54.0	50.6	94.8	159.6	180.9	79.1	257.9	53.9	164.4	175.2	117.0	158.2	157.5	110.4	91.5	110.9	156.6	53.8	118.1	145.1	144.2	55.4	108.5	232.5	75.1	143.3	165.4	87.9	61.9	328.2	290.6	302.7	401.2	413.1	308.2	586.7	426.7	516.8	544.8	459.2	939.2	564.8	255.3	501.6	572.3	506.4	468.4	318.8	516.4	492.0	121.2	196.5	295.3	308.4	634.1	398.9	468.4	467.0	294.6	505.1	432.3	447.5	519.8	530.4	239.2	458.7	805.1	389.1	300.9	270.6	451.0	240.4	839.3	415.7	242.3	549.1	852.7	371.6	304.3	246.4	261.0	517.9	1231.1	489.4	353.6	606.1	765.6	338.0	600.8	358.2	317.1	371.9	474.7	608.4	259.9	583.4	314.9	493.2	424.2	427.5	285.5	365.5	410.5	417.0	291.0	336.1	363.8	481.2	232.4	298.8	308.7	78.3	398.8	357.6	591.0	338.2	676.5	48.2	50.4	49.9	55.9	49.5	56.5	54.0	50.6	53.9	53.8	55.4	61.9	85.7	118.6	158.0	22.2	107.8	61.8	134.1	264.6	62.0	72.6	90.0	74.2	81.4	133.0	197.7	80.9	45.9	461.6	109.6	113.9	23.5	278.0	37.3	73.2	103.5	98.6	63.0	91.7	18.8	241.1	599.6	127.4	84.1	151.2	105.2	109.3	100.6	206.3	233.2	63.9	18.6	168.5	162.8	150.4	75.3	24.4	105.0	117.0	90.7	20.6	122.2	136.8	65.9	24.1	20.5	160.1	109.5	110.9	392.3	121.3	64.6	82.3	98.5	100.8	85.5	65.3	122.0	335.2	288.9	67.7	57.8	621.0	81.5	213.7	138.7	117.6
RPS19	"DBA, eS19, LOH19CR1, S19"	ENSG00000105372	"Ribosomal protein S19"	P39019	19	41860255-41872925	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063217			Supported	Nucleoplasm		NA	NA		260000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA063217: AB_2732699"	"unprognostic (8.02e-3)"	"unprognostic (9.04e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.96e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.16e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	1929.6	1900.6	1567.9	1417.3	1592.2	2933.3	2052.3	1529.9	2038.1	2531.8	1544.4	2004.3	1389.8	1628.2	679.3	3488.9	2151.1	766.0	1349.4	1501.4	1560.9	1424.1	2262.6	1640.4	2271.7	1631.4	1548.2	3787.9	3981.7	585.6	1015.9	818.9	1606.1	2231.8	1105.1	370.4	1748.9	760.8	1573.4	3885.1	2168.6	767.5	1626.1	2909.0	2099.7	639.3	1585.0	1825.5	1516.5	728.6	1869.1	2025.4	2512.4	1619.6	3536.2	4978.2	3109.1	2770.4	3924.8	5205.4	3456.4	2731.6	3132.5	3378.6	2982.1	3854.2	2341.3	5185.2	2985.2	2483.1	1670.6	1819.8	2701.4	4647.3	1563.5	2183.2	5098.9	2626.1	1471.5	4029.3	6775.6	4355.4	2564.0	7419.1	8959.5	2132.0	3942.4	5453.7	3421.0	4849.8	2911.6	3476.5	2845.7	4010.8	3975.9	3021.3	3619.2	9954.1	2087.6	4372.0	2503.1	2511.1	3188.1	3714.9	2216.7	2693.9	1539.3	4915.7	3951.2	4649.7	2787.7	6840.6	2694.1	2157.5	3396.5	1451.9	4383.8	3886.3	4520.6	5054.3	2348.3	3672.5	2498.9	1309.9	5303.2	586.8	9147.6	9536.3	13783.0	18138.6	13464.4	11872.3	8174.5	17813.4	15114.7	13788.0	724.9	12054.7	12053.9	11257.8	11367.1	30500.3	1567.9	1592.2	1529.9	2038.1	1501.4	1560.9	1631.4	1548.2	1606.1	1626.1	1585.0	1619.6	2154.8	1644.2	2318.8	17.6	7536.2	13338.7	9463.4	12098.6	8008.7	295.5	11387.2	17068.7	680.0	2778.1	4886.7	1430.8	127.2	6635.1	4648.2	1753.9	2641.3	4446.2	482.4	1178.2	3145.6	3665.9	2227.6	2708.0	15.4	8576.4	9609.3	2834.8	2442.4	1645.3	1825.2	4566.6	3793.4	3258.5	4591.9	136.3	20.2	4777.7	3497.2	6041.3	8631.8	1752.6	4036.7	4053.7	4557.0	52.5	5989.0	991.8	4541.7	13.6	42.4	7669.3	4181.6	1892.7	4036.1	8714.9	4183.2	3284.5	1889.5	479.3	1584.3	3428.0	5508.3	608.5	1952.5	7919.1	16952.4	6534.4	6030.8	3718.5	6131.8	8160.5
RPS19BP1	"FLJ21770, MGC52010"	ENSG00000187051	"Ribosomal protein S19 binding protein 1"	Q86WX3	22	39529093-39532761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042874	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA042874: AB_10793988"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.65e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.32e-2)"	98.5	123.0	122.2	43.1	124.5	61.7	94.6	126.7	159.0	73.5	115.9	117.1	43.5	65.5	31.5	94.2	65.6	19.3	114.6	121.2	119.7	123.1	158.5	80.4	48.0	126.5	124.2	68.9	109.6	47.1	66.5	30.2	123.7	108.1	19.2	23.9	94.4	42.8	104.7	80.0	78.3	19.7	124.8	100.5	101.5	65.8	128.4	40.5	96.7	45.4	34.6	99.9	73.7	123.9	94.8	117.6	54.5	80.4	60.7	39.7	110.8	102.0	87.3	92.5	74.0	131.1	62.1	118.9	107.4	64.5	74.8	73.8	87.8	111.3	32.2	163.8	261.5	110.0	105.5	118.0	88.2	166.8	142.3	60.1	83.1	80.3	96.8	49.4	64.9	87.6	128.0	83.8	61.0	108.0	80.6	164.1	95.1	210.9	209.5	127.3	70.0	182.0	99.7	95.8	121.2	66.9	85.8	137.3	203.1	33.6	98.8	134.8	74.0	77.5	168.8	85.7	141.7	140.3	145.4	188.4	103.3	116.8	183.1	126.8	147.4	187.3	133.0	141.6	123.5	159.7	135.1	140.6	122.4	173.9	129.9	132.8	168.7	128.9	119.4	193.1	165.1	138.3	122.2	124.5	126.7	159.0	121.2	119.7	126.5	124.2	123.7	124.8	128.4	123.9	113.6	44.8	51.4	13.1	109.5	137.1	94.3	124.3	84.2	98.0	178.6	205.7	73.8	105.8	83.0	97.5	52.1	152.9	114.7	205.5	217.2	174.9	23.6	68.6	69.8	121.0	142.6	83.5	8.7	192.2	231.9	92.0	76.0	81.6	69.8	62.0	116.0	184.8	204.3	35.3	10.9	207.5	130.2	116.4	233.3	40.3	137.0	110.8	108.5	8.4	147.8	139.1	162.7	5.5	18.7	233.5	202.2	126.0	193.3	206.8	274.9	362.2	54.0	103.7	78.9	74.4	100.9	61.6	138.0	87.6	147.9	131.6	115.2	103.1	165.9	132.4
RPS24	"eS24, S24"	ENSG00000138326	"Ribosomal protein S24"	P62847	10	78033760-78056813	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003364, HPA073508"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		90000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003364: AB_1079847, HPA073508: "	"prognostic favorable (1.50e-4)"	"unprognostic (1.58e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.10e-10)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.22e-2)"	2458.4	1993.8	1538.1	1424.8	1549.0	4673.1	4757.9	1530.6	2756.8	3012.3	1536.9	2576.1	1756.5	2519.4	2811.2	2293.7	2474.3	1606.6	1604.1	1488.8	1645.6	1754.0	2209.3	1458.8	2669.4	1576.3	1569.3	5844.6	2955.3	1438.5	1178.1	1754.5	1586.4	1958.8	2573.9	964.5	2512.4	1637.4	3019.3	3045.0	1693.7	1946.0	1586.5	1916.9	1651.7	776.1	1538.2	2798.0	2252.7	2553.7	2707.5	2652.8	2547.2	1623.3	3390.5	1308.2	3303.3	5221.9	4021.6	7048.4	2884.3	3654.6	5055.0	3773.7	3323.4	1878.5	2339.0	7039.0	1940.5	3205.9	1303.4	2612.8	3847.7	4674.9	3460.7	2403.0	4325.8	2868.1	822.8	1879.0	4533.9	6943.1	1575.6	6732.0	6867.2	2652.4	9675.7	7591.6	4592.2	2981.8	4007.0	1455.6	4191.8	1388.2	3770.5	11229.0	2318.2	5976.0	12085.6	2567.9	3934.7	3482.3	4773.4	1608.2	1658.6	3234.9	1805.2	6010.8	4716.9	3414.2	3356.5	7559.6	3894.3	1175.5	2712.7	1570.9	4896.7	1774.5	3875.7	5354.8	1459.5	9444.0	970.5	1058.0	2124.4	809.3	1585.0	2036.3	2627.9	2796.4	2178.6	2037.5	2932.4	2380.3	2861.9	2644.0	276.9	2801.9	1626.7	2569.0	1916.3	4390.5	1538.1	1549.0	1530.6	2756.8	1488.8	1645.6	1576.3	1569.3	1586.4	1586.5	1538.2	1623.3	2643.8	743.6	1535.6	44.1	4070.7	4105.7	5007.7	2774.6	5333.8	344.3	4139.9	6421.4	617.1	2051.8	1719.2	801.9	108.4	3406.3	3424.5	1200.3	3279.1	2335.3	1414.9	1799.8	4602.7	2194.2	2090.5	3250.6	40.4	4508.1	6260.1	2099.8	2310.4	2451.6	1237.2	3541.5	2346.6	2252.0	3311.9	151.4	42.6	3944.5	880.9	4754.9	4734.0	5440.1	5670.8	3861.9	2031.3	49.6	5590.7	1395.6	3262.7	23.1	45.9	2886.9	3231.4	2588.2	3109.6	4622.7	2703.3	3770.5	768.5	465.7	1268.8	3609.7	2661.0	653.8	709.0	7289.7	4590.1	3541.8	3518.7	4105.6	4384.9	4943.2
RPS25	S25	ENSG00000118181	"Ribosomal protein S25"	P62851	11	119015712-119018691	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031801, HPA078683"	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		150000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA031801: AB_10610419, HPA078683: "	"unprognostic (1.60e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.75e-3)"	"prognostic unfavorable (3.00e-7)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.20e-1)"	1030.5	759.2	703.6	735.1	728.1	1650.9	1487.8	698.3	1133.9	1226.7	679.4	957.6	596.1	817.3	1030.4	898.8	1058.0	573.8	771.4	675.6	730.6	879.4	830.1	672.8	1488.5	718.4	700.7	2254.5	1279.5	535.1	807.7	633.7	726.5	841.2	697.9	460.2	1068.5	606.0	1873.7	1107.6	773.8	578.5	748.0	889.7	875.5	283.5	722.1	1100.8	817.0	1278.8	1307.1	967.1	1005.4	749.3	960.2	646.9	1024.1	1063.6	1461.7	2371.7	994.2	1098.1	1159.2	724.7	635.6	1753.4	1580.0	2269.6	2031.5	853.8	782.5	1146.8	951.4	1305.8	852.5	1166.9	1278.1	3013.6	598.3	1718.0	1102.2	2122.0	924.8	2043.3	2460.8	647.0	1673.7	2154.5	1384.9	1739.3	1670.1	1288.7	1072.8	2396.1	2072.1	3727.7	1045.8	2204.6	1573.1	1447.7	1055.6	2743.5	1319.2	1228.3	830.4	1737.6	578.1	1850.5	1467.1	1175.2	1533.2	2972.9	1144.8	703.2	768.0	724.7	1198.9	1051.5	1232.2	2109.6	489.5	2563.2	806.5	997.3	1197.8	775.1	1976.3	1284.0	3220.0	3716.4	3654.3	2784.5	1945.5	3077.2	4507.9	3661.8	319.1	2123.4	1145.7	2384.0	2614.1	5186.2	703.6	728.1	698.3	1133.9	675.6	730.6	718.4	700.7	726.5	748.0	722.1	749.3	1697.5	810.9	1658.7	42.7	4105.7	3970.2	4377.8	2769.0	2486.4	284.5	3671.0	4464.2	177.0	2040.3	1857.3	932.5	114.7	3745.3	2579.2	1009.2	3273.2	1883.0	1859.4	927.5	1934.9	1947.4	1330.6	2078.2	25.4	3163.4	4115.0	1768.2	946.5	1319.1	2024.6	5691.5	2726.5	2709.6	2534.6	134.6	27.4	2786.8	895.2	3338.1	3963.7	2384.8	3824.6	2101.3	2186.0	30.9	4048.0	1305.0	2802.3	16.6	39.3	2301.3	2254.2	1713.3	1821.2	4000.4	2308.2	4494.5	909.9	475.7	1334.5	2501.7	2382.7	788.8	827.3	3140.7	4661.0	3656.0	3604.7	1427.9	2788.0	4153.7
RPS28	"eS28, S28"	ENSG00000233927	"Ribosomal protein S28"	P62857	19	8321158-8323340	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 19765.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047132	Approved		Approved	Cytosol		NA	NA		730000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA047132: AB_10962147"	"unprognostic (3.47e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (3.09e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.81e-2)"	227.9	202.9	129.8	113.7	134.6	286.7	226.8	128.6	189.9	226.5	130.2	188.9	127.8	147.3	52.5	328.4	172.3	94.9	213.0	124.0	129.7	184.6	247.5	171.0	220.2	132.2	129.3	313.0	432.4	72.1	162.7	88.2	129.5	211.1	47.8	20.3	227.8	60.6	252.9	353.8	197.1	42.6	134.1	273.4	219.4	55.7	138.6	117.3	177.4	80.8	98.0	176.7	240.0	131.6	245.9	97.7	86.6	197.5	122.3	183.2	136.6	156.9	141.7	177.6	144.5	133.2	104.7	364.4	189.3	91.7	75.9	183.0	114.9	269.0	25.6	223.2	772.6	176.4	110.4	134.5	219.6	204.6	188.5	294.9	303.7	129.7	116.4	110.9	165.2	279.0	251.6	402.9	80.2	152.5	314.8	725.0	260.8	141.4	587.2	222.7	92.9	390.9	118.6	115.5	165.7	162.3	112.7	206.7	289.3	27.6	157.0	340.9	210.4	147.0	125.1	288.1	266.5	468.3	265.8	248.1	155.7	389.3	101.2	21.3	61.7	13.2	54.5	39.3	76.6	105.0	88.5	64.5	55.9	90.7	98.9	70.0	8.8	44.6	36.3	98.0	61.0	166.2	129.8	134.6	128.6	189.9	124.0	129.7	132.2	129.3	129.5	134.1	138.6	131.6	4308.7	1458.3	2798.6	9.8	6575.7	7900.9	4267.0	4952.1	5103.9	484.0	11594.7	19765.7	382.7	3044.0	2801.5	1340.8	296.1	3851.9	4608.0	2028.0	3335.8	3189.3	262.2	1687.9	4074.7	3610.1	2654.0	3550.8	7.4	7271.1	4542.0	2535.5	2746.2	2586.9	1954.3	4062.9	5016.7	5562.8	4537.9	267.5	9.3	5334.5	1287.8	5745.6	5979.8	559.6	3915.0	3716.8	3523.6	21.5	5150.0	1694.4	3560.3	6.6	14.5	5090.4	4152.6	1644.9	4225.1	3830.4	4316.3	5555.1	1153.6	729.0	1084.7	3477.1	2508.7	367.9	953.1	7848.6	10873.6	4244.9	5017.4	2121.3	5894.5	4043.4
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099624-151104642	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No		300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	2233.9	1361.3	1032.4	1357.8	1063.0	4321.5	4603.8	1034.9	1672.3	3236.5	1041.5	1964.3	1314.5	1964.8	2303.4	2250.6	2307.9	1186.8	1430.3	992.0	1052.4	1657.2	1371.0	1471.0	3341.7	1038.8	1025.1	4877.7	3514.8	1107.6	1325.8	1372.7	1059.4	1982.7	1778.1	861.8	2107.7	1322.9	1967.9	2992.3	1848.5	1337.8	1102.5	2038.6	1898.7	586.2	1056.2	2991.3	1965.5	1499.1	2764.4	1969.9	2486.8	1089.1	2090.9	1501.8	2780.1	2751.6	3524.5	6867.8	2849.1	2150.7	3334.5	3006.4	1848.2	2933.6	2944.4	9381.3	1048.4	2383.2	1050.5	1339.3	2877.1	3624.3	2840.5	2075.6	2762.0	2023.6	1589.8	3421.2	4067.8	4855.0	1999.1	5125.5	7353.9	1849.5	4874.5	4195.4	3639.4	3417.8	3320.0	4722.3	3632.8	3124.8	5289.7	5604.8	2624.1	3296.7	1147.0	3798.0	2719.3	3175.4	3505.2	2487.1	2668.0	2635.2	971.4	3495.1	5019.9	1954.5	2341.0	5780.5	2212.2	1451.6	1915.8	1618.1	2424.7	3626.8	6367.6	5820.6	1863.4	3508.9	1758.5	1918.8	3362.4	977.5	3828.9	2626.4	6462.8	7155.1	6390.5	5052.0	5393.2	6165.0	8750.8	7174.2	495.2	5199.2	2256.0	6377.8	5103.3	18540.3	1032.4	1063.0	1034.9	1672.3	992.0	1052.4	1038.8	1025.1	1059.4	1102.5	1056.2	1089.1	2387.5	971.2	1605.1	15.0	5574.2	6158.3	8280.0	5535.6	4255.3	412.4	6080.4	8681.6	381.3	2194.8	2530.5	825.8	120.9	4538.4	4799.4	1188.9	4284.8	2316.3	1754.6	1570.1	3613.3	2564.2	2154.3	3366.6	17.8	3732.2	7502.1	2388.6	1599.9	1895.7	1468.6	3424.3	2653.9	1441.0	3403.7	163.2	18.6	4137.0	1454.6	4309.4	5658.7	4012.5	4428.4	3332.7	3260.3	20.6	5502.6	1760.6	4551.0	23.6	22.4	2788.3	3029.1	2592.3	2412.5	6111.5	2682.0	5073.3	1084.8	593.9	1768.4	4410.8	3918.5	834.4	820.8	5042.0	6756.0	4591.7	4520.4	4186.2	5049.9	7641.8
RPS6KA1	"HU-1, MAPKAPK1, p90Rsk, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.1;monocytes: 81.2;NK-cells: 88.6;Proximal enterocytes: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.6;U-937: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	7.4	17.0	7.8	17.5	9.1	23.8	8.3	9.2	9.3	6.0	11.2	37.9	33.1	3.0	1.2	16.9	7.9	5.5	3.8	7.9	9.1	26.2	10.5	33.7	20.2	10.8	9.5	1.9	19.4	12.5	13.4	4.0	10.1	17.2	20.7	1.4	21.5	4.5	1.7	17.8	51.4	3.6	9.4	47.1	20.6	5.4	10.4	11.4	24.5	1.9	20.7	9.0	9.6	11.6	27.1	9.3	7.5	9.9	0.4	0.1	9.9	2.2	4.2	11.0	10.6	10.8	21.9	50.2	11.9	1.3	13.3	31.0	16.9	61.0	7.8	41.8	11.0	55.3	21.6	19.5	3.4	65.8	77.6	1.8	22.1	10.1	18.0	5.0	4.9	19.7	9.6	17.7	0.6	15.0	2.4	64.3	19.1	52.2	29.2	34.8	9.5	22.0	31.7	7.3	10.7	4.4	18.7	17.5	8.4	7.8	11.2	55.5	3.2	0.5	13.9	1.8	9.2	10.9	14.0	27.5	6.5	86.8	10.8	37.6	57.9	131.2	24.2	52.1	20.3	14.2	17.9	21.6	68.8	15.7	11.3	15.8	108.2	26.4	58.4	26.9	19.0	65.2	7.8	9.1	9.2	9.3	7.9	9.1	10.8	9.5	10.1	9.4	10.4	11.6	2.8	16.0	25.0	0.0	23.7	18.6	8.1	19.9	16.5	1.5	12.0	10.4	1.3	11.5	7.7	9.2	4.2	1.6	53.9	91.1	7.9	16.3	1.9	19.9	2.2	6.9	16.3	29.5	1.4	18.7	17.5	1.8	18.3	20.7	31.8	3.3	7.9	3.4	47.5	0.0	2.6	41.6	12.2	53.0	14.2	1.4	0.0	44.1	1.8	12.2	81.2	0.6	88.6	1.0	12.3	28.1	41.9	0.0	14.2	18.8	93.3	17.2	13.6	1.8	6.6	0.8	2.7	1.6	3.4	10.9	11.6	4.1	36.3	2.0	43.6	9.1
RPS6KA3	"CLS, HU-3, MRX19, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 236.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	21.1	18.8	6.9	33.7	10.2	16.2	14.8	12.7	12.8	16.1	8.5	32.8	24.1	17.5	8.5	18.7	15.1	26.9	21.1	8.7	9.4	19.5	45.0	32.3	31.3	8.4	10.0	10.6	17.2	59.4	5.9	19.5	8.5	19.9	31.8	15.7	13.2	18.0	51.8	15.0	27.6	27.8	8.7	29.2	21.1	5.5	10.6	32.9	21.2	40.3	32.6	34.2	8.5	8.0	44.9	77.0	28.4	14.8	27.1	47.3	8.6	38.0	57.4	27.8	37.7	87.7	56.2	29.3	12.8	40.0	40.5	30.9	32.8	32.2	51.1	24.8	26.1	34.6	46.2	236.8	27.7	67.8	34.2	30.3	25.1	43.5	54.4	24.3	101.9	30.4	23.1	81.0	29.4	21.2	44.2	20.7	20.6	57.8	45.9	23.3	60.0	33.8	23.9	36.9	13.1	12.8	51.1	15.3	54.4	35.3	0.1	20.0	57.3	30.1	20.8	96.3	21.7	64.3	42.1	32.1	56.9	33.1	72.6	11.9	3.8	7.9	4.7	5.3	8.3	2.4	5.4	5.2	5.6	3.2	3.7	4.5	5.8	6.6	6.0	6.7	2.9	2.2	6.9	10.2	12.7	12.8	8.7	9.4	8.4	10.0	8.5	8.7	10.6	8.0	60.6	44.8	67.5	31.6	34.8	54.4	37.0	21.2	10.2	37.8	20.4	10.8	22.9	34.3	41.1	16.5	22.9	4.0	70.0	63.5	3.9	26.3	0.4	10.8	24.0	61.1	25.0	19.1	142.2	30.5	6.7	31.6	24.5	26.1	44.3	8.3	34.6	65.4	22.6	13.5	108.4	59.1	28.5	40.8	104.3	1.5	13.1	62.6	37.4	126.5	53.7	27.5	46.4	116.6	27.0	37.4	57.9	21.1	25.5	56.6	33.5	25.1	23.3	9.7	19.7	41.5	21.3	6.4	8.7	13.8	55.5	3.6	66.0	14.2	61.1	63.8
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 10.5;monocytes: 2.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	15.0	13.1	14.8	11.8	16.1	10.9	12.5	17.0	17.9	13.7	10.5	16.8	9.8	16.5	2.8	31.0	12.0	4.7	16.2	15.3	13.7	14.2	12.0	16.4	12.0	14.7	14.7	8.5	12.2	3.3	6.8	11.7	14.7	13.1	5.6	2.1	12.5	5.6	16.0	22.8	17.1	6.8	14.4	25.0	15.8	3.5	15.1	5.7	10.2	5.0	9.5	16.6	14.6	14.3	76.1	41.5	5.9	15.0	12.8	11.9	84.0	39.4	20.6	30.2	14.9	41.7	38.8	7.9	44.9	22.9	38.6	69.1	7.1	32.1	14.7	24.1	14.0	17.8	36.8	21.6	12.8	18.0	32.0	12.0	29.7	25.7	20.9	10.9	18.4	14.2	7.4	10.6	15.6	69.2	16.6	28.4	6.5	29.2	88.1	31.8	24.4	25.3	21.1	34.4	8.7	6.9	40.7	24.8	35.6	8.5	28.6	22.3	37.0	41.0	51.7	74.7	35.9	12.5	10.4	7.8	27.0	20.6	21.2	1.3	2.7	1.4	0.7	2.1	0.7	0.4	0.5	0.6	2.2	0.2	0.3	0.3	0.2	0.2	1.3	10.5	0.5	2.6	14.8	16.1	17.0	17.9	15.3	13.7	14.7	14.7	14.7	14.4	15.1	14.3	11.8	3.2	3.0	8.5	6.4	12.1	6.8	8.6	8.6	7.3	5.4	4.8	15.2	7.2	5.4	3.7	4.2	70.0	75.0	25.2	5.9	20.1	0.8	3.5	8.7	9.9	8.4	9.9	6.6	25.2	38.2	9.3	26.0	7.6	19.1	5.7	10.8	7.8	29.6	8.4	5.3	14.3	2.0	30.5	13.2	1.5	11.1	25.8	8.8	11.2	26.6	3.6	10.3	4.5	5.4	65.1	12.8	6.8	5.7	10.2	16.2	8.4	3.1	2.1	0.0	6.0	10.2	0.7	6.5	13.9	10.7	46.7	11.3	7.5	19.9	9.6
RPUSD4	FLJ14494	ENSG00000165526	"RNA pseudouridine synthase D4"	Q96CM3	11	126202096-126211692	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.5;tongue: 75.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039689	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Nucleoplasm	"HPA039689: AB_10673537"	"unprognostic (2.02e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (3.16e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.47e-2)"	14.8	12.7	10.2	9.8	10.4	10.6	14.0	10.5	11.2	13.8	10.7	12.1	10.4	12.6	7.7	15.1	12.9	8.1	27.2	10.5	10.4	11.8	20.5	9.4	13.8	10.2	10.2	18.3	26.8	7.8	8.8	6.8	10.5	11.5	10.1	6.1	14.4	7.0	135.5	17.1	12.1	9.2	10.6	14.4	20.0	8.8	10.5	13.2	10.1	75.2	15.5	12.4	13.4	10.5	15.6	14.0	17.0	19.7	24.5	34.3	12.5	16.2	22.7	16.6	15.1	46.4	27.3	35.7	16.8	14.1	23.7	25.1	40.3	25.8	17.3	32.4	23.9	84.1	15.0	40.5	18.3	42.5	17.1	29.8	35.0	18.4	22.9	24.8	33.4	28.8	51.8	25.1	20.2	13.5	26.6	46.3	18.4	49.3	29.1	31.0	25.2	33.3	25.7	19.8	29.3	20.5	21.5	29.7	16.7	17.0	46.2	21.9	20.9	18.6	13.3	15.4	19.9	10.1	12.4	30.7	8.8	47.2	19.7	1.6	12.7	1.4	15.9	11.7	19.6	14.4	18.0	14.3	16.3	14.5	20.4	16.8	0.9	14.3	14.0	7.0	18.1	13.3	10.2	10.4	10.5	11.2	10.5	10.4	10.2	10.2	10.5	10.6	10.5	10.5	10.0	3.2	8.4	6.8	15.3	27.5	20.4	13.2	17.1	9.9	13.1	9.1	35.4	12.8	7.4	7.3	8.4	14.0	12.3	7.2	9.8	12.3	1.8	6.7	7.1	11.9	15.5	6.7	7.0	19.6	17.1	10.2	10.7	7.4	5.7	15.2	13.6	11.3	13.3	11.8	8.4	10.7	2.0	15.9	8.7	2.3	9.6	8.6	10.6	8.4	21.0	5.3	14.4	6.6	7.8	13.5	7.4	8.6	12.4	17.4	15.6	14.5	7.0	8.2	6.6	15.6	9.9	10.3	16.7	13.2	24.0	13.3	13.1	18.3	18.8	14.7
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364616-89412273	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 129.1;Distal tubular cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 63.9;SCLC-21H: 33.1;U-266/70: 80.0;U-266/84: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	9.8	9.1	14.0	2.3	18.9	11.6	8.2	31.8	16.1	9.4	17.9	4.0	1.7	1.5	6.9	13.8	13.7	3.6	38.4	15.9	13.9	26.5	4.4	7.0	2.8	16.4	12.2	1.6	6.4	22.7	11.4	3.2	17.2	6.1	1.8	21.8	52.2	2.8	84.5	6.7	2.0	2.1	21.5	4.8	1.7	6.9	14.8	5.5	28.1	60.3	2.5	5.8	6.2	23.8	0.1	1.7	4.4	3.3	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.1	0.1	0.0	1.5	0.0	22.6	0.1	24.5	0.1	0.0	0.0	12.1	5.8	0.1	0.1	1.8	16.9	19.0	0.4	1.5	0.0	0.1	0.0	0.0	16.9	0.5	63.9	0.1	1.8	8.2	8.4	3.6	0.0	1.8	16.8	23.1	0.2	5.8	0.6	33.1	1.8	0.6	2.2	28.8	1.3	0.7	13.2	0.0	1.8	2.8	11.5	3.0	80.0	39.8	0.0	6.1	12.5	1.9	2.6	0.6	1.4	0.0	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.3	3.3	0.1	2.4	0.3	0.0	0.1	14.0	18.9	31.8	16.1	15.9	13.9	16.4	12.2	17.2	21.5	14.8	23.8	1.4	9.6	16.7	5.2	3.7	16.2	17.0	5.8	4.0	21.7	17.4	9.7	129.1	17.2	13.9	14.7	31.3	0.6	4.7	0.1	117.4	20.2	25.6	10.4	2.5	4.8	1.2	5.0	17.6	16.9	1.5	10.0	1.1	15.0	4.5	2.9	2.5	9.7	51.9	47.1	20.6	0.5	42.7	25.8	9.2	15.5	3.1	23.2	39.2	3.7	10.4	29.6	0.0	13.0	17.2	8.1	0.0	4.1	8.0	28.4	0.0	18.6	19.4	16.3	0.0	11.8	7.0	21.7	30.3	32.4	22.6	0.7	3.9	0.2	0.2	30.2
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138932	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Supported	Cytosol		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236"	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	16.6	21.2	5.1	24.8	5.3	32.8	22.7	7.1	6.1	16.9	4.7	25.7	19.3	16.2	10.1	26.5	15.5	11.8	16.4	5.1	5.7	13.4	18.4	12.8	34.4	6.1	5.5	16.4	14.6	24.7	7.1	20.4	6.6	18.5	29.4	23.6	14.7	16.0	30.3	36.1	20.2	20.1	6.2	13.0	17.6	17.9	5.1	56.7	15.6	30.0	45.2	15.6	18.9	6.2	221.6	117.8	188.4	110.0	28.4	56.2	73.0	198.0	98.2	220.7	225.9	106.8	163.8	237.4	47.0	100.1	95.9	173.0	176.9	143.2	259.3	117.3	187.9	121.0	159.8	83.1	11.2	208.9	84.6	26.6	37.8	121.7	86.4	48.3	107.8	140.1	161.1	107.3	186.8	99.6	246.7	41.9	118.2	152.2	119.2	196.1	147.0	84.3	59.4	61.8	159.8	88.1	175.1	104.8	30.0	75.8	102.8	71.4	62.3	203.4	106.0	206.9	147.4	70.3	103.5	252.5	114.1	137.6	130.3	8.3	4.0	4.5	11.3	11.2	21.1	9.2	22.3	16.6	7.3	5.2	17.2	15.0	0.0	10.5	15.6	4.4	41.7	10.3	5.1	5.3	7.1	6.1	5.1	5.7	6.1	5.5	6.6	6.2	5.1	6.2	12.4	19.2	14.4	4.9	17.0	33.4	26.8	31.0	17.6	15.6	15.1	14.4	33.5	14.3	24.7	18.4	6.2	62.8	14.9	13.3	7.9	25.6	69.9	11.5	14.5	15.7	18.0	81.2	11.2	22.2	62.5	22.0	20.4	13.9	7.0	27.3	10.8	15.0	28.3	18.5	12.0	25.0	16.2	11.7	10.3	83.9	13.1	13.9	10.6	6.5	10.7	24.0	5.2	12.1	11.9	15.8	10.4	16.6	31.3	10.1	12.5	8.4	15.5	22.7	13.1	19.5	27.1	102.8	63.1	36.5	29.0	39.7	23.2	18.1	34.3	20.6
RRM2	"C2orf48, FLJ25102"	ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10211725	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.2;esophagus: 18.4;intestine: 19.7;lymphoid tissue: 58.1"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 214.0;Extravillous trophoblasts: 254.1;Plasma cells: 248.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056994	Enhanced		Supported	Cytosol		Yes	Yes		13000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	1.5	1.3	0.3	12.4	0.3	44.2	2.9	0.5	0.4	3.0	1.9	14.2	9.4	2.2	0.7	18.4	0.8	1.1	0.5	0.3	0.3	0.9	3.2	2.4	35.5	0.4	0.4	0.3	1.1	0.3	0.2	4.6	0.4	0.9	19.7	0.2	2.1	0.5	0.1	3.7	7.5	6.1	0.3	11.1	6.0	2.9	0.8	58.1	0.9	0.1	37.6	6.0	4.6	0.5	110.2	25.0	127.1	49.9	7.4	22.5	116.8	209.2	128.6	170.2	187.9	70.8	59.1	114.4	9.5	88.6	151.1	55.0	188.0	136.6	198.0	210.7	41.8	146.3	52.1	105.1	0.8	146.7	87.4	8.1	3.4	234.6	16.2	27.7	103.3	110.4	63.4	328.6	214.3	57.1	167.3	90.9	83.0	133.3	103.6	87.6	187.0	67.8	87.1	62.7	67.7	56.2	198.0	116.6	17.3	51.8	69.2	31.4	57.6	93.1	125.1	66.9	289.6	212.1	184.9	195.9	51.0	134.4	107.7	0.3	0.1	0.1	1.2	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.1	0.4	0.4	0.8	0.0	0.1	0.2	0.2	0.3	0.3	0.5	0.4	0.3	0.3	0.4	0.4	0.4	0.3	0.8	0.5	0.2	3.2	1.5	0.0	25.0	10.5	3.0	9.2	1.2	0.0	3.9	4.4	1.4	1.5	2.3	0.0	0.0	42.3	5.6	12.9	1.9	1.2	3.9	2.2	3.5	4.2	0.0	214.0	0.1	0.0	254.1	11.2	11.7	3.6	5.7	12.2	3.9	3.7	47.9	0.0	0.0	26.9	2.0	7.2	8.8	6.8	0.3	5.0	0.0	1.0	0.0	0.0	7.2	0.0	0.0	0.5	0.3	0.4	248.0	1.5	2.4	2.1	4.6	0.0	0.0	0.2	14.6	22.9	34.0	51.5	1.6	48.7	11.9	1.2	36.7	5.6
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	8.0	8.2	8.0	6.5	8.7	5.3	7.3	7.4	10.2	6.9	4.8	6.4	5.0	7.1	3.3	16.0	6.4	4.0	7.0	9.2	7.2	7.6	13.0	5.3	8.1	8.9	8.1	8.0	9.7	4.8	5.5	4.9	8.0	7.2	3.0	1.7	8.1	4.2	12.9	11.9	5.9	3.4	6.6	8.2	7.5	7.9	7.6	5.0	6.0	5.3	6.1	7.3	7.9	10.8	37.6	19.6	13.5	22.6	7.3	8.2	25.6	18.5	10.9	25.7	18.1	52.1	21.6	35.5	14.9	10.4	23.8	18.8	25.2	18.5	11.7	17.7	47.9	50.4	18.8	32.1	14.9	32.6	17.5	11.0	17.0	26.0	20.6	6.7	13.7	32.9	67.3	26.9	12.2	43.2	28.7	44.7	44.8	26.1	28.7	52.0	10.7	66.4	13.4	20.5	31.6	18.8	19.3	21.0	25.3	3.8	21.5	22.1	15.6	17.2	19.1	18.2	33.0	32.1	29.8	37.1	25.7	53.7	22.6	0.1	5.0	1.7	10.7	4.8	13.4	11.0	11.0	11.1	10.2	13.0	11.9	8.0	1.1	13.1	2.3	8.8	6.8	7.0	8.0	8.7	7.4	10.2	9.2	7.2	8.9	8.1	8.0	6.6	7.6	10.8	12.9	16.0	19.4	9.4	17.3	72.3	40.2	55.9	23.3	18.7	14.4	12.7	6.1	18.6	45.3	7.3	20.9	31.4	12.7	18.6	7.9	40.0	4.2	14.9	15.5	18.8	20.9	19.0	6.2	33.1	39.0	24.5	18.8	16.1	20.3	20.1	9.3	16.0	32.7	8.4	6.3	19.3	32.6	8.4	35.0	2.7	19.3	13.6	42.7	2.8	15.3	12.3	13.4	2.5	11.6	41.4	9.1	20.7	19.2	59.4	10.5	21.0	24.3	17.6	32.9	23.8	20.6	21.4	30.0	32.2	70.2	30.4	15.0	21.4	29.5	46.1
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 90.9;skeletal muscle: 38.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 26.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	8.1	10.2	2.6	9.2	3.4	90.9	5.6	1.1	7.6	5.6	2.4	4.9	6.0	7.4	3.6	8.5	7.3	7.2	11.4	3.2	2.7	6.8	5.7	6.7	6.7	4.3	4.4	6.1	16.0	9.3	10.2	4.3	4.1	6.3	3.8	3.4	8.3	4.0	38.5	10.3	4.7	6.0	0.2	7.6	6.3	10.9	3.7	4.7	5.5	9.7	6.1	9.3	5.7	4.6	38.9	50.8	13.2	28.6	10.0	11.6	28.9	24.2	14.4	24.2	18.7	55.6	35.0	42.3	30.4	15.1	21.6	48.7	36.3	28.0	16.3	23.1	44.2	32.8	19.5	43.6	16.5	51.7	41.5	12.2	38.6	59.9	54.6	27.0	13.7	23.5	47.7	27.4	14.0	50.8	35.0	33.0	57.0	20.4	34.0	38.1	18.0	42.1	16.8	21.4	17.7	37.9	19.2	18.1	24.1	10.4	43.7	26.5	18.2	16.1	27.9	36.5	76.4	55.7	52.7	48.6	23.2	64.9	17.9	0.4	11.2	6.9	2.7	13.6	3.3	3.9	1.6	2.2	6.2	4.2	2.5	2.8	26.7	1.9	16.9	5.0	1.2	6.0	2.6	3.4	1.1	7.6	3.2	2.7	4.3	4.4	4.1	0.2	3.7	4.6	8.8	35.3	31.1	5.9	18.5	23.5	14.2	5.1	25.0	5.8	12.7	9.9	11.6	7.2	21.5	14.7	41.7	5.2	7.7	10.6	0.0	8.7	7.2	17.1	10.6	10.6	21.5	7.2	15.1	8.7	7.5	13.5	27.0	20.1	41.7	12.9	3.9	8.9	11.5	5.0	9.5	13.8	4.1	12.5	7.1	4.8	3.7	30.3	7.2	2.8	12.3	1.9	3.1	5.0	4.4	8.5	6.4	2.6	31.8	17.1	3.7	6.8	24.6	12.7	0.0	19.4	6.7	10.6	20.6	22.7	19.6	9.2	11.0	13.5	11.5	13.6
RRP15	"CGI-115, KIAA0507"	ENSG00000067533	"Ribosomal RNA processing 15 homolog"	Q9Y3B9	1	218285293-218337983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024639	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Mitochondria"	"HPA024639: AB_1844368"	"unprognostic (2.68e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.65e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-2)"	4.0	2.6	1.7	3.3	1.7	4.1	4.7	2.5	2.4	3.0	1.4	3.0	2.1	3.7	2.7	3.0	2.9	1.9	4.9	1.8	1.9	3.4	3.5	2.8	3.7	1.4	2.0	3.8	2.9	4.5	1.8	3.6	1.6	3.1	2.9	2.2	2.6	2.4	9.6	3.5	2.4	3.4	1.5	2.9	2.6	2.4	1.8	2.6	3.5	7.7	3.5	3.9	2.8	1.9	9.8	7.2	7.9	5.7	5.6	7.8	6.7	9.8	7.3	10.0	7.2	14.1	8.8	14.0	13.1	7.6	6.7	8.7	13.5	13.0	16.6	5.7	10.1	10.9	6.6	7.8	11.6	17.0	5.6	5.4	7.8	13.1	17.4	4.4	6.6	6.5	22.7	4.4	11.4	8.9	11.3	8.3	15.7	7.8	14.8	7.8	4.9	13.8	8.0	8.9	9.0	13.1	8.3	15.3	15.0	9.3	11.0	12.1	9.3	8.0	7.6	14.3	18.3	5.4	8.9	14.4	9.1	8.1	13.1	0.3	0.8	0.1	1.6	1.3	2.3	2.4	2.0	1.4	1.2	2.3	2.6	2.6	0.2	1.6	1.1	1.7	1.3	0.7	1.7	1.7	2.5	2.4	1.8	1.9	1.4	2.0	1.6	1.5	1.8	1.9	33.7	32.1	28.1	7.5	36.0	65.3	33.6	28.7	24.5	31.1	32.6	31.0	68.4	22.8	25.0	36.8	10.4	38.1	32.7	13.5	27.4	39.7	17.0	22.6	47.3	27.9	12.1	41.0	18.4	52.2	59.1	32.2	19.9	28.5	31.0	18.6	21.8	44.2	33.6	26.9	16.1	20.8	6.1	17.3	18.5	4.6	37.6	17.4	21.4	7.5	20.8	21.2	24.7	7.5	9.0	36.8	9.0	24.8	13.0	34.9	5.2	37.2	11.7	23.6	26.3	72.1	33.0	59.7	69.1	24.3	47.6	18.1	26.4	20.4	32.1	23.0
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659560-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 131.3;Early spermatids: 213.2;Late spermatids: 222.8;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	8.8	5.9	7.9	12.2	8.9	6.2	9.1	7.0	7.8	7.2	5.9	7.2	6.7	9.1	5.5	8.6	9.1	6.1	4.9	7.4	7.2	4.9	8.7	6.7	17.4	7.8	7.9	13.1	10.2	7.2	4.3	5.8	7.2	7.5	7.3	28.4	10.2	6.8	12.1	8.8	6.4	8.8	7.4	11.0	7.8	12.0	7.8	16.1	6.5	8.8	14.8	9.8	6.5	8.6	52.5	30.4	31.8	48.1	20.2	21.5	26.0	27.0	19.3	29.3	24.0	69.4	22.2	101.9	17.2	21.5	33.9	22.8	78.9	46.5	34.6	34.6	62.8	60.3	34.8	43.9	27.9	95.0	22.9	22.4	29.2	35.1	40.3	18.1	33.1	43.2	96.0	29.1	26.1	27.4	76.1	28.9	108.4	33.7	33.4	98.7	32.1	71.2	21.2	24.8	62.7	33.6	50.6	36.9	37.9	11.7	24.2	29.4	29.7	9.0	28.3	24.0	49.8	39.1	53.8	119.3	28.5	100.7	30.1	2.0	2.5	0.7	6.2	2.5	7.3	5.6	7.9	7.5	3.0	4.3	7.2	8.6	0.1	5.8	2.2	2.4	6.6	5.5	7.9	8.9	7.0	7.8	7.4	7.2	7.8	7.9	7.2	7.4	7.8	8.6	15.5	32.1	16.4	8.8	32.7	22.8	17.7	15.0	28.5	30.3	13.8	11.0	13.4	17.2	21.0	5.5	131.3	8.6	27.1	5.7	1.9	17.0	213.2	10.5	28.8	19.1	5.4	23.7	19.0	15.6	17.0	18.9	14.8	10.8	36.0	25.5	12.8	18.4	18.7	25.2	20.0	9.2	6.1	13.9	12.7	222.8	22.4	13.4	8.8	21.5	17.0	17.9	35.0	18.6	22.2	20.9	3.7	26.7	48.5	23.6	6.8	9.9	16.7	143.5	0.0	29.9	18.1	26.3	33.6	32.0	31.7	4.4	35.7	32.6	16.5	17.4
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021623-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	30.0	34.6	19.4	27.4	19.7	28.7	28.7	21.5	23.2	26.0	19.8	29.0	20.8	25.5	22.9	37.8	23.2	19.0	30.1	20.3	22.3	35.1	37.3	25.5	32.3	21.3	20.9	18.4	35.8	34.7	31.9	24.2	22.0	28.5	24.3	16.6	27.1	25.0	51.3	34.3	25.9	29.7	20.8	33.3	30.6	17.7	21.0	31.1	23.4	34.8	35.2	30.0	26.4	20.8	141.5	77.9	75.8	111.3	79.7	74.0	63.6	108.9	97.7	136.1	132.6	141.9	59.8	64.7	86.3	113.8	100.1	73.5	127.7	131.8	149.3	82.5	129.9	104.1	82.7	153.2	92.3	87.5	77.7	75.6	79.0	163.0	69.1	48.7	112.2	57.6	128.2	68.4	127.8	148.1	106.0	95.6	84.3	249.7	79.6	98.7	74.7	74.9	83.2	130.5	96.4	84.5	80.1	72.8	129.1	70.6	100.1	106.0	91.2	125.1	95.1	83.4	173.8	63.8	103.9	172.0	54.5	108.6	119.1	2.4	2.2	2.0	3.3	3.0	2.7	4.5	2.4	4.2	2.3	1.4	2.2	4.5	2.5	2.0	2.4	6.0	1.4	0.8	19.4	19.7	21.5	23.2	20.3	22.3	21.3	20.9	22.0	20.8	21.0	20.8	26.8	0.0	15.6	4.6	14.7	13.4	11.2	13.5	5.7	16.1	19.7	22.1	15.1	20.0	14.1	20.2	16.7	29.3	33.1	12.7	13.7	33.7	10.1	18.3	26.5	18.5	13.9	4.6	8.1	44.8	41.8	18.0	12.8	18.0	6.3	27.3	21.0	36.0	29.1	18.5	8.1	12.6	12.2	16.6	11.7	23.0	11.8	20.0	14.2	2.8	26.1	36.9	20.6	6.6	9.6	44.0	7.4	18.8	18.8	17.7	12.4	20.5	10.0	20.3	6.6	19.3	24.7	9.5	10.6	16.5	18.6	33.7	16.5	61.5	14.2	14.3
RRP8	"KIAA0409, NML"	ENSG00000132275	"Ribosomal RNA processing 8"	O43159	11	6595072-6603616	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038487, HPA057562"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA038487: AB_10672518, HPA057562: AB_2683468"	"unprognostic (9.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (4.64e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.87e-2)"	10.8	10.2	10.9	5.8	10.6	18.4	10.5	10.6	14.9	12.7	9.3	21.8	6.7	11.0	9.8	11.4	10.5	3.4	15.4	10.0	9.9	13.3	21.5	9.2	8.6	10.3	10.7	9.3	10.0	5.3	8.2	6.1	10.4	15.8	6.5	7.6	7.4	8.8	9.5	12.6	10.3	6.2	10.9	14.2	12.1	10.7	10.6	6.8	10.6	4.1	8.4	16.8	11.1	12.1	12.3	12.0	4.7	6.1	9.6	8.3	6.7	6.2	7.7	14.0	13.1	12.4	14.1	17.1	6.0	5.9	10.3	12.1	13.6	10.9	14.7	8.3	19.5	8.1	14.0	14.3	11.0	14.8	10.8	7.1	14.0	6.7	12.1	9.2	14.7	8.0	16.3	9.7	11.2	15.2	14.5	22.0	11.6	21.4	10.7	12.8	3.8	3.9	13.4	9.7	7.2	8.4	8.9	18.0	10.7	7.7	9.8	12.9	7.6	13.2	6.1	13.0	12.2	10.8	10.5	16.7	11.2	14.8	8.7	26.3	10.0	10.4	11.5	10.7	11.2	9.1	11.3	10.7	13.0	11.9	11.0	11.7	3.9	13.6	11.8	9.9	11.9	9.0	10.9	10.6	10.6	14.9	10.0	9.9	10.3	10.7	10.4	10.9	10.6	12.1	17.0	22.4	15.0	37.2	19.6	23.2	18.5	13.3	14.2	17.3	14.1	11.7	20.7	8.6	14.7	9.2	14.6	23.5	20.7	12.2	11.7	19.0	7.4	13.7	22.8	16.4	7.2	37.7	45.0	15.9	21.2	15.5	21.4	14.0	17.7	14.7	12.5	23.5	18.9	3.3	32.6	16.2	12.2	9.4	13.4	13.6	13.1	13.1	8.8	21.5	18.4	14.2	22.6	27.2	34.6	22.7	18.2	9.8	15.2	15.8	13.7	29.8	10.3	30.5	0.0	15.3	20.0	23.7	18.0	18.3	27.1	20.0	17.7	25.2	17.3	15.0
RSL1D1	"CSIG, DKFZP564M182, L12, PBK1, UTP30"	ENSG00000171490	"Ribosomal L1 domain containing 1"	O76021	16	11833850-11851580	"Predicted intracellular proteins, Ribosomal proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043483	Supported		Enhanced	"Nucleoli rim,Mitotic chromosome"		Yes	No		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoli rim, Mitotic chromosome"		"HPA043483: AB_2678504"	"unprognostic (4.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.88e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.95e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.68e-2)"	39.3	32.2	11.1	36.9	11.7	46.7	78.8	13.4	14.1	47.6	12.2	35.7	32.6	44.0	28.8	38.2	44.5	30.5	33.7	11.9	12.5	33.0	39.1	26.4	48.2	11.6	11.4	118.5	43.6	28.8	13.2	30.0	12.2	33.3	37.9	15.1	42.0	34.0	87.3	34.1	29.2	36.6	13.3	26.9	25.1	22.4	13.3	41.8	34.8	51.7	65.1	48.0	26.4	15.4	90.7	84.3	69.1	87.1	88.6	157.9	81.9	82.1	91.4	104.0	105.9	82.6	83.1	225.6	133.1	68.6	72.1	62.5	186.7	124.4	168.4	88.8	100.7	111.6	75.9	188.0	165.4	159.5	71.3	116.6	173.2	107.6	248.2	77.8	102.4	87.0	198.6	101.5	129.3	100.8	125.7	92.6	177.7	108.1	86.1	129.2	127.3	240.1	92.9	78.0	96.4	79.2	155.0	116.6	110.0	70.9	100.5	122.2	63.2	69.0	77.3	66.0	120.0	81.3	126.2	261.7	75.0	164.9	94.1	14.1	123.2	12.6	69.7	119.1	129.6	132.6	129.5	91.7	130.8	117.3	185.4	136.8	7.1	124.6	120.7	80.2	100.9	253.0	11.1	11.7	13.4	14.1	11.9	12.5	11.6	11.4	12.2	13.3	13.3	15.4	111.2	141.1	156.6	5.5	198.1	330.9	338.6	251.0	299.3	39.9	241.1	344.4	188.4	74.4	198.1	49.7	22.9	186.4	118.7	41.2	135.0	134.5	22.8	76.0	181.1	118.1	94.5	104.5	11.0	186.2	286.8	180.9	88.2	100.0	152.6	106.6	64.2	78.5	147.6	38.7	11.6	126.4	107.8	153.0	177.3	18.5	199.4	141.0	92.5	3.7	276.5	52.8	113.3	3.5	7.3	135.4	75.1	126.0	104.6	226.5	110.5	155.0	81.3	30.8	59.2	245.4	151.5	111.2	136.0	203.5	290.2	160.6	166.5	162.8	184.3	225.1
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head component 4A"	Q5TD94	6	116616479-116632985	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 21.0;fallopian tube: 37.2"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 92.4;Respiratory ciliated cells: 260.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 3.3;U-266/84: 2.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 14.5"	"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.6	0.5	1.5	0.3	1.6	0.9	0.6	1.3	0.6	1.7	21.0	0.3	0.3	1.6	0.5	0.2	37.2	0.5	0.4	1.5	2.0	0.7	0.5	4.6	0.3	6.1	6.2	0.8	0.8	2.0	4.3	0.1	3.8	0.5	0.2	6.0	0.4	0.2	0.9	0.5	0.5	0.4	4.5	0.9	0.5	2.8	2.4	0.5	0.8	0.2	0.3	0.3	0.3	2.8	0.0	0.1	0.6	1.4	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.3	0.5	0.4	0.1	0.0	0.5	0.1	0.1	0.2	0.2	0.3	0.5	0.2	0.2	0.5	0.0	0.3	0.4	0.1	0.1	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.7	3.3	1.3	0.2	1.2	0.5	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	2.4	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.3	0.6	1.5	2.0	6.1	6.2	3.8	4.5	2.4	2.8	0.8	3.2	3.4	7.2	0.3	0.0	0.1	4.9	0.0	3.3	0.4	0.8	0.6	0.0	22.9	0.0	2.1	0.0	0.1	0.1	1.9	0.4	33.1	92.4	1.6	2.2	0.0	0.0	10.6	0.4	0.1	1.1	0.5	1.4	2.5	0.7	1.8	0.0	0.1	1.7	12.9	0.0	10.2	0.0	0.0	9.3	0.3	0.4	1.8	0.0	0.0	2.0	0.0	3.5	5.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	260.6	3.7	0.0	2.0	2.4	9.3	1.6	0.0	0.1	0.3	0.5	5.7	0.0	0.1
RSRC2	FLJ11021	ENSG00000111011	"Arginine and serine rich coiled-coil 2"	Q7L4I2	12	122503454-122527000	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 65.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040070, HPA048183"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA040070: AB_10673430, HPA048183: AB_2680302"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-2)"	12.6	12.2	11.5	11.0	11.4	65.7	13.2	17.6	18.4	14.6	11.3	13.9	8.6	14.1	12.5	17.4	12.3	13.6	13.1	11.3	15.3	16.3	11.4	13.8	16.8	12.1	13.7	16.4	13.8	8.0	14.5	13.3	11.7	12.7	12.0	17.1	12.6	9.5	28.5	12.7	12.5	8.8	7.7	11.6	10.8	14.0	11.8	13.2	15.4	16.1	10.7	14.0	15.0	14.0	21.4	24.8	23.2	9.5	18.4	11.2	16.9	38.8	12.0	16.0	8.7	35.5	8.6	24.4	32.0	13.3	9.7	13.3	25.9	10.8	15.7	22.8	23.9	42.1	32.0	38.3	10.1	37.0	24.8	14.5	12.3	13.6	23.2	20.1	11.6	10.7	27.8	14.6	14.1	16.3	26.8	27.8	19.6	17.8	19.6	19.6	20.9	15.9	21.1	39.8	18.4	16.7	29.6	10.0	22.0	23.1	15.9	13.4	18.1	16.5	20.3	18.4	21.7	16.7	42.8	39.5	9.8	21.6	9.4	27.5	17.7	25.4	17.2	14.7	14.3	28.3	15.3	13.9	18.0	33.4	19.3	15.4	18.7	18.3	22.2	17.0	22.4	12.3	11.5	11.4	17.6	18.4	11.3	15.3	12.1	13.7	11.7	7.7	11.8	14.0	176.8	86.6	102.0	44.7	208.7	202.3	376.1	94.0	118.4	114.3	155.6	146.0	103.3	104.4	107.1	93.8	79.2	149.1	219.3	193.5	195.6	109.3	247.3	223.6	218.6	141.7	156.3	143.1	39.1	97.2	183.8	169.3	89.7	238.0	216.5	127.5	84.9	113.7	94.3	149.7	39.9	185.7	101.7	87.6	184.9	107.1	119.9	139.0	126.3	35.6	107.0	132.9	133.9	34.2	49.6	107.3	171.0	105.7	134.2	219.0	110.1	132.7	128.5	131.0	124.9	194.8	176.7	229.2	165.3	116.0	187.0	280.1	210.3	107.6	154.8	287.1
RTCA	"RPC, RTC1, RTCD1"	ENSG00000137996	"RNA 3'-terminal phosphate cyclase"	O00442	1	100266216-100292769	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027982, HPA027990, HPA028151, HPA028331"	Uncertain		Enhanced	Nucleoplasm		NA	NA		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: "	"unprognostic (4.79e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (9.55e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.94e-2)"	21.7	20.8	14.1	20.4	15.0	31.9	17.1	14.7	17.0	13.1	15.7	22.2	34.5	12.9	26.6	23.8	12.7	16.7	28.4	15.4	16.3	34.5	22.4	15.8	26.3	15.6	14.0	11.0	24.1	23.7	14.3	23.2	16.2	21.6	23.3	22.3	18.7	14.5	39.3	15.8	31.6	15.5	14.0	21.7	23.9	12.5	15.0	19.2	18.0	35.4	23.4	18.5	15.7	15.7	56.8	28.6	27.8	37.4	34.5	55.4	75.7	65.7	32.0	41.9	35.9	47.0	27.7	57.6	48.4	42.0	51.4	28.0	34.3	31.1	50.2	57.8	28.5	38.0	32.8	59.9	52.9	70.2	57.3	45.5	48.0	54.9	72.5	41.3	52.9	41.1	66.6	84.7	64.1	18.6	36.4	54.3	42.7	40.0	54.8	25.7	49.6	25.5	51.7	45.5	22.2	27.6	42.3	60.5	93.3	43.3	13.2	88.5	45.7	39.2	27.5	62.0	80.1	48.7	51.9	46.3	82.5	60.0	23.7	11.8	10.9	9.4	11.8	14.4	15.5	10.6	11.1	14.2	9.6	9.0	10.2	11.6	5.3	13.5	26.1	9.3	24.7	9.3	14.1	15.0	14.7	17.0	15.4	16.3	15.6	14.0	16.2	14.0	15.0	15.7	20.5	6.4	16.2	15.0	27.1	13.6	13.7	23.2	17.6	24.2	19.8	14.0	52.8	11.5	20.4	18.4	12.5	56.7	30.9	30.5	25.4	42.1	19.3	23.0	17.2	20.7	19.2	25.0	20.7	34.5	85.9	18.8	18.8	24.0	13.3	19.8	21.0	17.4	80.9	21.9	22.2	26.2	20.3	48.8	14.5	9.0	19.3	29.5	16.0	21.5	46.2	25.5	25.7	21.1	33.5	57.3	31.9	12.8	36.0	16.1	79.4	73.9	21.0	29.7	6.6	14.3	20.2	43.0	23.2	21.7	14.6	46.4	32.1	25.7	33.0	20.2
RTKN	B5	ENSG00000114993	Rhotekin	Q9BST9	2	74425835-74442422	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 149.6;liver: 124.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NK-cell: 2.3;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.6;NK-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 96.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030259	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA030259: AB_10601484"	"unprognostic (4.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.43e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-3)"	9.8	8.3	69.5	5.0	104.1	0.6	11.3	85.4	84.6	13.5	51.9	20.3	31.8	8.7	3.5	20.8	12.7	14.2	17.3	72.0	84.3	54.4	124.7	10.3	3.1	100.4	95.5	7.7	30.8	20.7	14.7	11.8	95.7	19.1	12.6	1.9	26.0	9.5	12.8	32.0	25.3	6.3	73.4	5.2	15.3	3.3	93.5	6.3	19.5	7.5	5.3	8.3	16.6	149.6	50.4	15.5	19.5	56.3	11.8	13.7	82.1	7.6	9.9	11.0	8.0	76.3	26.8	0.3	21.2	7.4	13.6	67.2	7.3	48.6	5.3	9.9	31.3	12.0	2.8	96.7	7.2	0.0	0.1	8.4	37.7	9.5	30.0	20.2	5.5	0.7	6.2	0.3	16.5	35.8	1.9	10.1	20.9	70.9	30.3	11.1	60.6	7.6	52.4	0.3	19.0	18.8	20.7	79.3	45.2	17.5	44.6	4.4	0.6	20.5	14.0	9.3	10.6	4.8	3.7	1.8	19.6	0.1	19.5	0.0	0.0	0.0	0.2	0.0	0.2	0.7	0.1	0.2	0.6	1.0	0.0	0.1	0.0	2.3	0.0	6.6	0.0	0.4	69.5	104.1	85.4	84.6	72.0	84.3	100.4	95.5	95.7	73.4	93.5	149.6	4.3	9.6	11.8	4.9	2.0	20.0	22.1	37.2	19.4	0.1	14.4	12.2	3.1	28.6	18.3	11.0	2.1	46.7	4.5	21.7	21.5	43.0	0.7	12.6	6.1	8.8	30.7	1.3	0.5	20.1	8.3	8.9	15.8	26.0	1.3	4.9	5.3	40.1	10.1	0.0	0.9	20.1	18.3	2.2	3.8	1.5	12.8	1.1	28.4	3.7	0.7	6.9	5.2	34.7	48.2	30.5	31.0	8.6	1.4	35.4	44.7	54.7	5.8	0.4	6.6	36.9	3.9	1.1	5.6	12.9	21.6	33.4	2.5	3.1	30.5	15.6
RTL1	"HUR1, Mar1, MART1, PEG11, SIRH2"	ENSG00000254656	"Retrotransposon Gag like 1"	A6NKG5	14	100879753-100903722	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.6;brain: 7.7;placenta: 2.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"melanoma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 572.5"					"Low region specificity"	"Detected in many"			"HPA066979, HPA077601"	Enhanced		Approved	Cytosol		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"		Cytosol		"HPA066979: AB_2685759, HPA077601: "					"unprognostic (1.61e-1)"					"unprognostic (3.30e-1)"	"unprognostic (1.26e-1)"			"unprognostic (1.42e-3)"	"unprognostic (2.10e-1)"			0.1	1.6	1.6	0.0	0.7	0.0	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	7.7	0.0	0.0	0.0	0.0	3.4	4.2	0.6	0.1	0.0	0.2	2.9	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	18.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	572.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.9	1.3	1.2	7.7	3.4	4.2	7.7	0.2	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656068-78659328	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 1.8;GAMG: 1.4;HBF TERT88: 2.4;hTEC/SVTERT24-B: 1.7;RH-30: 2.1;U-251 MG: 1.6"	"Region enriched"	"Detected in single"	9	"hippocampal formation: 2.8"					"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA					"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737"	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.0	1.1	0.0	0.0	0.0	0.0	1.8	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTN4	"ASY, KIAA0886, NOGO, NSP-CL"	ENSG00000115310	"Reticulon 4"	Q9NQC3	2	54972187-55112621	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 3547.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 95.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 1801.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005388, HPA023977"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		3400000	"Cluster 38: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"CAB005388: AB_2285559, HPA023977: AB_2671391"	"unprognostic (1.31e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.91e-2)"	586.2	302.7	376.3	150.9	461.9	115.4	253.1	465.9	534.3	118.0	297.1	186.9	236.2	153.9	176.5	217.9	130.0	196.8	166.0	411.8	431.6	442.5	551.9	211.8	83.6	498.6	456.5	132.0	122.7	236.7	84.0	177.3	524.8	223.9	179.2	640.6	127.1	183.4	996.0	252.9	292.5	246.4	440.8	110.3	124.0	78.6	453.2	87.1	130.7	777.9	88.2	291.2	147.9	591.2	402.9	285.3	273.3	71.7	908.4	845.0	153.2	1301.6	1097.4	393.5	365.7	235.5	371.7	87.1	673.8	889.9	657.7	355.6	181.5	524.4	596.2	248.3	139.4	120.3	159.6	376.6	1801.9	218.1	59.7	638.5	490.8	540.3	1041.9	792.3	751.3	215.6	249.8	195.0	1724.1	117.8	268.3	222.0	245.9	86.8	252.0	118.5	360.3	180.0	924.0	475.9	179.2	211.3	297.7	173.3	378.1	465.1	147.2	165.1	1074.9	764.8	326.1	304.8	756.5	118.0	103.4	56.1	778.7	247.9	630.1	95.8	9.5	27.5	9.2	11.6	7.6	6.8	14.7	8.2	9.2	3.8	24.1	10.2	15.6	41.1	19.0	13.7	37.6	9.9	376.3	461.9	465.9	534.3	411.8	431.6	498.6	456.5	524.8	440.8	453.2	591.2	451.4	176.3	203.4	201.4	102.3	1062.1	1456.6	367.0	225.9	644.6	297.6	260.6	182.0	243.1	251.0	676.8	379.5	529.6	173.6	408.6	291.6	559.7	459.7	316.6	264.6	308.0	222.1	98.2	454.5	323.4	611.9	421.9	98.4	324.7	150.4	161.5	181.3	633.4	669.1	425.7	370.4	280.5	231.9	339.0	578.4	266.6	167.4	371.7	341.5	215.5	396.4	3547.4	137.0	249.3	1334.3	571.2	309.7	226.1	81.6	921.4	897.1	678.3	233.6	540.0	216.9	420.5	324.6	382.7	90.1	247.1	1059.3	362.0	145.5	100.1	238.1	1226.5
RTN4RL1	"DKFZp547J144, NgR3, NGRH2"	ENSG00000185924	"Reticulon 4 receptor like 1"	Q86UN2	17	1934677-2025334	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 20.6;Cone photoreceptor cells: 37.5;Excitatory neurons: 43.5;Horizontal cells: 33.7;Inhibitory neurons: 18.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 12.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.9;HaCaT: 10.8;hTCEpi: 10.1;T-47d: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044428	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Midbody"	"Intracellular and membrane"	Yes	NA		35000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Midbody"	"HPA044428: AB_10963229"	"unprognostic (5.23e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.97e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.32e-3)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.15e-2)"	4.0	3.1	4.6	0.3	4.0	0.0	6.4	0.0	9.2	2.1	0.0	0.4	0.1	0.8	0.2	1.3	1.5	0.6	2.3	12.3	0.3	1.6	2.6	1.6	0.1	0.0	0.5	0.9	1.8	1.3	5.9	0.3	0.0	3.4	0.1	8.5	4.4	2.0	1.8	9.6	0.5	0.3	0.0	1.1	0.7	0.8	1.9	0.2	1.4	0.4	0.1	1.5	2.2	0.0	1.4	1.6	1.8	2.5	2.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.1	10.9	0.2	10.8	4.6	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.1	0.0	3.6	0.0	0.0	2.5	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.3	0.8	0.3	1.2	0.0	0.0	2.2	0.0	0.3	0.8	1.7	0.2	13.3	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	0.0	9.2	12.3	0.3	0.0	0.5	0.0	0.0	1.9	0.0	1.0	0.0	2.2	1.6	0.1	2.7	0.2	0.0	1.8	20.6	5.4	4.3	3.0	1.5	1.3	3.7	37.5	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.7	0.0	0.0	43.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.1	3.3	1.8	33.7	18.6	0.0	0.0	0.3	0.4	1.1	0.0	0.1	3.6	7.5	0.0	1.8	0.0	8.5	1.7	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.5	10.0	0.0	0.0	0.6	0.0	0.2	0.5	2.8	0.0	0.2	0.0	0.0	0.3
RUNDC1	DKFZp761H0421	ENSG00000198863	"RUN domain containing 1"	Q96C34	17	42980565-42993690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023726	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	Cytosol	"HPA023726: AB_2184078"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.39e-2)"	"prognostic favorable (6.93e-5)"	"unprognostic (9.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.77e-3)"	5.5	8.0	8.7	6.6	11.0	6.8	10.0	6.5	11.0	8.6	9.7	9.4	6.5	8.7	12.1	6.6	14.5	6.1	7.3	9.6	8.8	8.4	5.0	6.9	7.2	6.3	6.8	5.0	7.9	12.0	9.4	4.8	6.2	12.1	7.6	8.5	7.5	8.5	11.6	7.1	7.8	8.6	5.8	8.1	10.1	6.8	7.9	6.7	10.2	9.0	7.7	8.4	6.2	8.2	12.9	22.1	8.8	11.9	14.7	8.8	9.3	12.2	12.6	17.1	12.7	14.0	7.2	8.6	10.7	12.1	11.6	15.8	11.3	12.3	18.9	9.7	17.7	5.8	12.8	13.5	9.4	12.6	11.9	6.6	14.7	15.1	10.0	13.6	9.2	9.3	11.2	5.3	9.9	9.3	15.6	8.9	9.9	18.3	13.8	11.2	12.3	8.6	14.3	17.0	12.8	11.8	9.6	9.0	10.2	12.9	17.5	13.9	7.6	15.4	9.6	9.2	14.7	12.6	13.1	7.5	11.0	6.6	9.8	4.7	2.3	7.9	1.3	3.8	1.7	3.7	1.6	1.1	1.8	3.7	1.6	1.7	5.4	1.1	2.8	5.6	2.0	1.0	8.7	11.0	6.5	11.0	9.6	8.8	6.3	6.8	6.2	5.8	7.9	8.2	5.3	44.8	38.4	6.5	18.7	15.0	11.0	5.8	9.1	18.9	19.2	9.8	13.7	22.8	17.2	5.5	22.9	9.8	19.1	28.7	21.5	11.8	8.1	26.4	9.6	10.3	19.2	5.7	13.8	9.8	7.3	8.6	20.4	19.5	11.4	8.4	10.4	6.1	8.4	38.7	11.0	16.9	6.1	10.5	14.7	4.5	9.9	9.5	3.6	7.5	14.3	14.3	12.3	5.0	6.2	10.1	16.4	14.3	11.7	16.6	15.1	12.8	24.7	33.2	19.7	8.5	9.6	22.9	14.9	7.2	14.6	5.5	13.9	10.4	17.8	17.0
RUNDC3A	"RAP2IP, RPIP8"	ENSG00000108309	"RUN domain containing 3A"	Q59EK9	17	44308413-44318670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 208.4;pituitary gland: 98.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.4;Early spermatids: 24.4;Enteroendocrine cells: 39.0;Excitatory neurons: 46.1;Horizontal cells: 32.0;Inhibitory neurons: 30.4;Late spermatids: 83.4"	"Group enriched"	"Detected in many"	5	"glioma: 8.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 62.5;SH-SY5Y: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023548, HPA070733"	Enhanced	Supported	Enhanced	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA023548: AB_1856069, HPA070733: AB_2732162"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.17e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.84e-1)"	0.3	14.3	149.2	0.4	159.5	2.3	0.3	93.0	208.4	0.2	45.6	3.4	1.2	0.5	0.2	0.8	0.2	0.3	1.8	169.4	105.3	1.8	0.2	0.4	0.2	108.0	106.4	0.8	3.8	3.1	98.3	1.5	108.5	0.8	0.6	31.2	0.3	0.3	0.1	7.9	1.3	0.5	79.2	1.6	2.3	15.2	109.4	0.4	1.4	0.3	0.1	0.2	0.7	135.7	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	4.3	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.9	0.2	0.0	0.5	0.3	0.3	0.1	0.1	1.1	0.3	0.1	62.5	40.3	0.3	0.0	0.3	0.1	0.5	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.2	159.5	93.0	208.4	169.4	105.3	108.0	106.4	108.5	79.2	109.4	135.7	0.1	0.0	0.6	17.3	0.0	0.3	0.3	0.0	0.0	55.4	0.2	0.3	1.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	3.9	1.3	24.4	0.2	0.3	0.2	39.0	18.7	46.1	3.1	0.0	1.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	32.0	30.4	0.5	4.1	0.3	0.5	83.4	1.5	0.3	0.0	4.7	0.1	6.5	1.0	16.1	12.5	1.0	1.2	3.4	0.0	0.4	0.0	0.8	0.0	16.8	0.0	0.8	0.5	1.4	1.3	0.0	0.4	0.1	0.1	3.0	0.1	0.3
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"RUNX family transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 175.5;Glandular and luminal cells: 155.8;Microglial cells: 195.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 23.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 251.3;HMC-1: 145.3;JURKAT: 226.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Vesicles	"HPA004176: AB_1078412, HPA037912: AB_2675733"	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	14.8	3.8	2.9	20.3	2.1	45.5	27.1	2.6	4.0	15.3	5.1	6.7	5.1	3.3	3.1	9.2	4.7	16.0	6.3	2.8	3.2	4.6	7.0	22.4	11.3	6.0	4.3	6.3	4.0	1.5	5.1	8.5	6.5	13.5	6.5	0.3	39.2	3.5	18.9	11.6	6.8	9.2	4.9	10.2	16.9	3.8	9.1	28.2	4.8	1.4	9.9	20.8	12.8	7.9	50.9	3.8	0.1	0.3	12.5	16.0	32.0	28.1	28.4	15.3	11.6	2.5	37.7	24.9	1.8	24.9	25.5	45.0	3.0	33.6	21.4	38.7	3.8	251.3	10.1	11.6	22.9	29.4	145.3	30.9	19.8	46.6	45.6	21.2	8.8	226.3	17.3	14.1	32.7	10.7	119.3	46.5	2.2	27.4	14.5	119.2	84.6	15.3	20.7	19.9	1.4	0.0	28.9	7.2	10.5	6.8	14.7	67.8	37.0	25.1	32.4	37.8	42.8	46.4	20.7	23.3	31.2	63.4	37.4	23.9	3.1	7.1	3.4	1.4	3.2	4.1	3.0	3.2	0.9	3.6	4.5	3.7	3.4	1.5	4.7	3.4	4.5	2.2	2.9	2.1	2.6	4.0	2.8	3.2	6.0	4.3	6.5	4.9	9.1	7.9	6.2	54.5	35.4	1.6	27.0	41.6	52.7	61.2	54.7	2.3	175.5	94.6	3.2	28.6	60.8	20.2	0.0	2.1	39.5	18.7	1.9	39.7	19.4	89.6	21.5	9.2	6.0	47.3	3.5	28.1	21.4	49.2	84.6	155.8	17.7	29.2	4.6	5.4	68.4	0.0	3.2	12.4	28.5	77.0	122.5	27.1	4.7	84.4	28.4	195.8	42.2	0.5	39.1	1.5	1.6	101.0	15.8	4.5	27.7	43.6	8.3	1.6	78.6	0.8	0.0	111.3	51.2	29.0	28.0	53.7	20.2	2.5	41.6	2.7	17.0	75.3
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"RUNX family transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.8;Early spermatids: 128.3;Inhibitory neurons: 95.2;Microglial cells: 128.4;Plasma cells: 44.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 22.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 39.3;Karpas-707: 62.3;RH-30: 51.8;U-698: 55.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	1.7	0.7	1.1	4.3	1.0	9.7	2.8	1.2	1.4	6.7	0.9	3.7	2.0	1.5	0.8	1.4	0.9	3.4	0.7	1.3	1.5	1.5	0.7	2.7	4.5	1.9	1.8	2.2	0.6	0.6	1.6	1.5	1.9	4.8	3.9	0.1	10.7	2.6	0.8	2.4	6.0	1.6	1.6	3.6	3.2	0.5	2.0	4.5	1.8	0.9	5.6	3.6	4.9	1.9	3.6	1.1	0.8	0.0	3.2	8.3	0.0	3.3	7.9	10.9	15.2	0.0	1.9	0.0	3.8	4.7	4.9	4.3	0.0	3.1	19.7	13.7	1.5	0.0	2.4	0.0	16.7	14.2	0.1	22.5	2.5	9.7	10.9	39.3	0.2	5.6	0.0	62.3	19.7	1.0	0.4	24.7	0.7	3.2	0.5	0.1	51.8	0.0	10.7	7.0	0.0	0.0	2.4	0.1	4.1	9.2	3.6	1.2	0.5	11.1	8.8	17.2	12.1	19.6	0.0	55.2	12.5	5.3	5.0	8.6	0.9	4.5	1.5	0.2	12.9	0.2	3.5	4.0	2.4	0.2	0.6	1.8	6.5	22.1	0.1	15.4	3.2	1.0	1.1	1.0	1.2	1.4	1.3	1.5	1.9	1.8	1.9	1.6	2.0	1.9	0.9	0.0	2.7	4.6	5.7	2.8	16.6	5.3	1.2	0.0	2.0	1.4	2.7	0.0	4.9	3.7	0.0	0.0	55.8	0.3	0.0	0.6	128.3	0.7	3.5	0.8	0.0	3.8	17.4	0.2	0.0	7.0	4.1	0.5	2.5	0.1	1.1	0.8	3.7	0.0	95.2	1.0	20.3	6.7	20.8	20.0	1.2	16.3	7.2	128.4	18.6	0.0	7.2	6.6	5.2	0.4	0.1	2.2	44.4	16.5	0.0	3.3	5.1	0.0	6.6	1.5	6.2	0.8	0.5	1.2	1.6	0.1	21.4	0.2	0.2	28.0
RUSF1	"C16orf58, FLJ13868"	ENSG00000140688	"RUS family member 1"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.8;Cytotrophoblasts: 22.3;Extravillous trophoblasts: 21.0;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	27.1	31.8	19.6	20.0	18.9	21.5	28.8	12.0	21.3	45.4	14.2	29.6	31.3	43.2	20.7	26.5	38.2	23.0	28.5	19.9	19.7	29.5	57.9	25.0	19.8	17.0	16.0	49.6	56.8	46.2	48.4	25.7	18.5	39.1	19.1	22.4	64.8	34.2	9.4	26.9	30.3	25.6	13.8	22.3	39.5	21.4	17.0	18.0	42.0	9.8	15.6	31.8	31.4	17.0	28.6	37.2	22.7	39.7	51.7	34.3	42.3	33.4	56.6	25.5	30.2	11.3	49.1	24.5	69.4	49.8	32.9	39.0	22.9	31.0	11.8	35.8	23.0	24.8	20.6	28.8	74.8	29.4	28.6	41.7	33.1	33.7	68.5	50.2	24.9	38.4	37.3	40.9	25.3	53.9	13.7	19.8	17.8	41.8	24.1	31.1	34.2	74.8	29.3	17.6	24.8	38.2	25.2	65.3	52.8	21.5	56.6	42.9	22.0	44.3	24.7	28.7	22.1	59.0	37.0	18.8	56.7	44.7	62.5	3.1	5.7	7.6	7.8	8.4	7.2	6.7	8.2	7.8	9.7	6.3	7.9	7.0	0.9	9.4	8.1	8.9	9.4	7.2	19.6	18.9	12.0	21.3	19.9	19.7	17.0	16.0	18.5	13.8	17.0	17.0	5.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	22.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	21.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	22.3	0.4	0.0	0.0	0.0
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993562-49015970	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 614.5;Late spermatids: 945.1;Respiratory ciliated cells: 253.6;Spermatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		53000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	23.4	21.7	41.4	26.7	42.9	51.4	22.6	44.6	54.6	23.5	48.9	29.8	27.9	19.3	15.3	36.7	72.2	15.8	37.0	44.7	42.6	19.4	24.0	19.6	30.8	42.4	45.8	25.8	34.5	28.2	6.5	24.0	44.2	20.2	17.4	14.9	32.5	25.4	60.3	30.7	24.7	19.0	41.4	20.6	22.6	110.7	43.8	38.9	23.8	39.1	21.3	22.6	7.2	52.3	236.5	346.0	63.3	250.2	45.0	50.9	88.8	105.4	86.3	214.9	162.5	267.4	148.7	219.9	78.5	106.8	93.7	134.6	99.9	210.3	68.5	99.2	323.7	158.8	196.7	241.0	119.1	318.8	96.8	78.0	68.0	145.0	113.5	59.2	114.1	232.8	266.6	121.3	90.5	195.2	234.1	218.5	122.6	162.4	152.4	227.4	156.9	155.8	110.5	182.7	155.7	169.9	132.2	164.2	66.2	30.4	125.9	179.4	104.8	100.8	135.1	63.8	318.1	171.4	177.1	223.6	76.2	174.6	156.4	51.1	54.9	18.9	42.6	52.4	46.8	54.5	45.2	42.3	65.9	52.6	42.9	40.0	3.7	47.4	48.5	48.9	49.2	55.4	41.4	42.9	44.6	54.6	44.7	42.6	42.4	45.8	44.2	41.4	43.8	52.3	16.5	12.8	20.7	4.2	25.3	27.8	52.0	89.8	37.5	17.5	30.4	33.7	48.5	24.3	55.7	33.1	33.3	104.6	15.0	33.8	46.9	78.3	614.5	131.7	29.6	27.3	17.5	58.1	6.1	71.8	81.8	36.6	28.5	25.4	13.3	32.8	23.2	34.2	51.1	18.5	5.2	38.5	52.9	22.9	25.5	945.1	36.1	18.9	26.6	1.9	35.5	31.2	27.8	4.5	5.6	56.0	30.6	42.9	41.3	43.5	33.1	70.4	253.6	31.4	19.7	28.9	65.4	394.2	43.9	49.2	27.6	115.9	20.8	37.1	61.0	38.8
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193357-83198935	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.3;Spermatocytes: 65.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 11.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	2.9	6.9	7.1	2.1	7.0	0.5	3.2	6.1	8.1	3.4	6.3	2.9	2.5	3.3	9.4	1.7	3.8	4.6	4.4	6.9	7.9	4.5	5.9	2.8	2.5	5.6	6.0	4.0	9.6	4.0	5.6	2.5	5.9	11.5	2.5	4.7	6.0	4.7	2.3	1.9	2.7	3.2	5.7	2.9	3.9	8.9	8.4	1.8	6.2	4.0	2.6	2.6	1.8	6.1	2.1	1.9	4.4	8.3	5.2	3.7	3.0	4.8	10.1	3.5	4.2	2.8	1.1	1.6	3.8	5.8	8.0	2.1	3.7	2.8	5.4	2.0	3.8	1.9	3.0	6.2	8.0	0.5	1.5	4.9	4.6	4.4	9.2	11.5	6.6	4.5	3.1	2.8	4.3	3.1	0.7	1.5	1.5	1.9	1.9	2.4	9.1	1.0	7.4	2.4	1.5	5.3	2.9	4.5	4.4	6.3	2.8	2.9	7.1	2.4	1.5	3.5	2.1	6.2	2.7	0.9	2.8	0.8	2.9	0.3	0.9	0.0	1.2	0.8	1.8	1.9	1.7	1.7	1.0	1.0	2.2	2.1	0.3	0.4	2.2	3.5	2.2	1.0	7.1	7.0	6.1	8.1	6.9	7.9	5.6	6.0	5.9	5.7	8.4	6.1	2.4	0.0	6.7	9.8	4.2	3.7	3.6	5.3	3.4	5.6	3.7	3.2	5.4	2.8	3.3	1.8	0.0	7.7	3.9	2.4	5.9	8.9	52.3	4.8	4.5	3.5	5.4	0.4	10.8	9.1	3.3	6.5	3.6	4.0	0.0	7.0	5.0	6.8	5.0	1.7	11.2	6.1	8.2	1.6	2.5	14.8	9.0	2.2	8.8	3.7	3.8	11.0	0.0	13.6	4.5	5.8	2.5	6.0	11.2	8.7	4.1	13.3	4.9	5.0	6.6	7.0	5.2	65.2	10.5	1.2	2.4	5.7	2.9	6.3	3.4	2.8
RYK	"D3S3195, JTK5, JTK5A, RYK1"	ENSG00000163785	"Receptor like tyrosine kinase"	P34925	3	134065303-134250859	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034117, HPA045503, HPA075430"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293"	"unprognostic (7.84e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.85e-2)"	31.8	25.2	15.7	15.7	16.2	17.1	42.8	15.4	19.8	40.2	19.9	34.5	20.1	46.1	40.0	29.6	33.4	24.3	30.3	14.5	15.3	25.4	22.3	25.3	18.9	15.9	15.6	82.1	24.5	29.7	17.0	36.6	15.5	36.3	26.2	15.9	26.9	43.9	25.3	34.7	21.4	40.6	16.3	22.9	23.2	47.0	16.5	21.2	40.9	32.2	20.5	34.7	32.6	16.4	78.8	20.6	63.3	48.7	79.8	84.4	48.8	51.0	117.7	66.4	74.2	65.6	58.8	15.3	82.4	63.1	63.7	71.6	45.5	64.3	94.5	25.9	20.5	40.6	22.4	42.4	62.2	20.0	34.4	56.1	74.0	41.2	82.2	72.5	56.5	26.4	14.5	7.5	66.0	37.6	28.0	25.9	53.4	65.2	24.3	13.7	48.4	32.4	54.5	57.3	31.0	45.6	61.7	44.5	79.1	40.5	55.7	35.8	42.1	54.8	49.6	57.8	41.8	3.1	4.2	8.3	34.8	33.1	39.6	4.6	0.8	1.6	1.1	0.8	1.3	0.6	2.0	1.3	0.3	1.2	1.9	1.5	0.3	1.6	0.8	0.0	0.5	0.5	15.7	16.2	15.4	19.8	14.5	15.3	15.9	15.6	15.5	16.3	16.5	16.4	62.5	12.8	27.9	31.6	20.6	41.3	36.6	26.3	39.3	23.1	45.4	37.2	34.9	18.6	23.7	44.1	29.2	19.4	23.1	15.9	0.0	15.9	16.2	27.6	41.7	31.0	13.9	13.2	69.5	21.1	14.7	41.3	15.8	32.7	17.7	121.2	40.7	24.1	11.3	13.5	59.7	20.9	12.2	18.6	21.6	7.4	33.2	16.1	14.2	65.6	12.8	26.8	13.4	65.9	57.9	21.7	19.7	32.7	12.9	42.8	15.4	10.5	13.9	39.8	46.0	33.8	38.1	24.6	40.9	33.7	38.1	10.8	18.4	50.8	22.2	38.9
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3076.8;skeletal muscle: 3060.2;tongue: 4911.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	179.7	8.3	811.3	6.5	898.6	2.3	77.2	851.4	952.4	2.9	643.9	14.5	11.1	4.2	1.0	81.0	41.8	4.9	3076.8	779.4	813.6	194.9	4.5	3.9	5.1	907.6	894.8	2.0	16.8	160.9	54.6	18.1	871.2	29.0	1.2	36.5	622.1	9.3	3060.2	23.0	6.9	1.6	847.7	4.2	23.1	5.9	882.9	9.4	167.9	4911.5	4.0	4.3	2.9	967.6	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	811.3	898.6	851.4	952.4	779.4	813.6	907.6	894.8	871.2	847.7	882.9	967.6	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151993859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1760.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 3820.4;Langerhans cells: 3945.6;Pancreatic endocrine cells: 4570.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 2005.4;monocytes: 1235.2;T-cells: 1180.0"	"Cell line enhanced"	"Detected in all"		"OE19: 4936.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		270000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	775.1	376.9	71.1	244.8	76.6	133.7	519.6	75.5	139.8	478.0	78.5	867.3	461.4	110.1	56.7	1760.5	188.7	212.4	340.9	72.4	132.8	735.0	157.7	689.8	133.3	148.2	105.0	234.0	145.0	36.3	71.0	326.9	108.5	164.9	924.2	51.3	422.8	105.0	106.0	483.4	448.0	288.2	98.2	111.2	189.1	145.8	138.8	118.3	143.5	145.4	289.8	338.4	803.1	110.3	1251.3	1085.9	3.4	241.6	1351.4	1711.3	972.5	730.1	912.1	613.8	606.5	1975.4	1671.4	2.3	689.1	1208.0	661.7	2227.5	337.0	2786.6	495.3	242.5	127.1	163.8	461.5	468.1	507.0	60.2	126.7	470.8	2195.5	660.6	738.6	487.6	1326.0	78.9	2.9	3.6	753.8	940.0	11.0	376.5	163.6	4936.7	1671.4	1.6	242.4	27.1	2348.3	317.0	11.1	9.5	1259.2	374.3	539.8	1213.0	882.2	130.5	1654.9	285.5	737.2	1362.3	459.2	34.4	7.8	225.2	1709.5	51.7	977.8	359.5	1235.2	299.7	425.7	758.7	443.3	232.4	652.3	539.0	2005.4	140.1	237.7	363.1	43.6	355.0	664.7	329.6	1180.0	1313.4	71.1	76.6	75.5	139.8	72.4	132.8	148.2	105.0	108.5	98.2	138.8	110.3	1197.3	2554.5	537.7	3.9	244.0	1594.8	1171.4	2183.2	795.6	11.6	241.1	281.4	111.2	693.4	994.6	950.9	4.2	1271.5	476.2	3820.4	1524.1	1811.7	314.2	901.0	104.6	1061.2	1078.1	114.2	0.4	2105.0	527.4	1751.3	432.8	1270.7	289.5	840.0	864.5	206.9	1023.1	16.8	0.9	1723.1	272.6	795.2	3945.6	274.2	647.1	1338.1	1632.8	28.1	1544.2	24.8	285.3	4.0	0.6	4570.5	3391.8	64.7	244.5	2782.5	2146.1	495.6	620.3	32.5	144.7	801.6	529.5	30.4	115.9	1940.1	1242.0	375.8	801.0	38.5	1998.0	2290.6
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 3574.5;kidney: 1380.0;urinary bladder: 1097.4"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 11464.4;Basal prostatic cells: 4796.7;Basal respiratory cells: 10600.9;Basal squamous epithelial cells: 4741.9;Club cells: 3331.1;Prostatic glandular cells: 9446.4;Squamous epithelial cells: 9013.7;Suprabasal keratinocytes: 3626.5;Urothelial cells: 5382.7"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 848.8;head and neck cancer: 1229.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.1"	"Group enriched"	"Detected in many"	5	"HBEC3-KT: 21286.9;RT4: 8382.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	4.0	2.1	2.5	4.1	2.7	1.0	17.3	2.4	3.6	279.9	2.0	3.1	0.8	2.5	16.1	3574.5	5.6	1.8	3.9	2.3	3.2	1380.0	1.7	12.0	0.5	4.1	3.0	1.9	2.1	0.1	5.4	0.8	3.0	48.1	1.6	0.4	377.1	16.9	3.3	429.6	1.6	1.9	3.0	1.5	3.6	2.8	3.4	6.3	11.9	1.4	416.1	1097.4	747.3	3.5	827.0	9.3	1.1	0.9	10.8	4.2	1.2	10.4	11.5	9.0	7.8	2.1	26.8	1.2	418.3	17.8	18.3	2001.4	1.3	21286.9	9.9	5.4	3.7	3.8	56.2	5.0	4.5	0.7	1.9	8.8	2777.8	24.1	3135.5	21.7	13.2	0.0	0.8	1.5	47.7	3.4	0.2	0.2	2.2	22.3	155.4	1.3	497.9	2.1	502.4	8382.8	16.5	0.5	34.9	5.8	9.0	5.9	3.2	5.7	6.0	12.5	692.6	92.4	280.6	1.9	2.4	4.7	26.5	1.8	24.2	10.1	0.4	0.0	2.3	0.0	1.4	0.4	1.6	1.3	0.3	0.0	0.4	0.3	4.3	0.0	0.5	2.2	1.6	0.7	2.5	2.7	2.4	3.6	2.3	3.2	4.1	3.0	3.0	3.0	3.4	3.5	1.4	9.6	17.3	2.6	1.0	11464.4	4796.7	10600.9	4741.9	0.0	22.2	35.4	2.9	1.5	3331.1	218.8	0.0	0.7	0.8	3.2	1226.7	24.8	4.5	16.3	2.5	108.2	1.8	3.0	0.1	27.6	1.0	130.8	1.5	24.5	17.1	1.2	0.4	0.1	1.8	0.0	0.0	1.6	789.4	0.8	676.4	8.1	0.6	18.0	759.5	0.0	5.3	1.1	0.0	2.0	0.1	668.7	2.5	0.7	25.9	9446.4	0.8	11.8	560.8	0.1	0.0	5.5	207.0	0.6	3.0	9013.7	3626.5	0.3	37.8	8.9	2.0	5382.7
S100A3	S100E	ENSG00000188015	"S100 calcium binding protein A3"	P33764	1	153547329-153549258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 94.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.4;Ductal cells: 21.7;Endometrial stromal cells: 18.4;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 24.2;Skeletal myocytes: 24.7"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 26.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 3.1;non-classical monocyte: 6.2;plasmacytoid DC: 7.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.4;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 87.0;HBEC3-KT: 45.7;HeLa: 51.4;U-2197: 47.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 15.8"	"HPA042674, HPA056140"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		240000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA042674: AB_10796581, HPA056140: AB_2683050"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.34e-3)"	"unprognostic (3.97e-3)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (8.13e-2)"	"unprognostic (3.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (8.10e-2)"	7.6	1.1	0.9	3.6	1.1	1.8	4.2	0.8	1.3	6.9	0.6	2.8	0.5	3.9	0.2	17.2	3.3	1.7	2.6	0.8	1.4	13.8	0.2	16.6	1.8	1.4	1.6	1.1	0.8	0.1	0.7	2.2	1.2	3.0	1.1	0.0	4.2	1.7	1.0	94.6	1.9	2.1	1.1	0.8	1.4	0.5	2.8	0.4	1.5	1.9	5.1	6.9	9.6	1.4	7.3	87.0	0.1	0.1	8.1	5.2	0.0	6.1	31.4	7.9	12.8	2.6	2.8	0.1	19.0	16.1	10.7	22.2	0.1	45.7	3.7	0.3	0.0	0.3	51.4	15.3	2.2	0.0	0.3	4.1	24.9	17.9	19.9	4.5	1.7	0.0	0.0	0.0	39.8	0.5	0.0	0.0	0.6	0.2	11.5	0.0	5.9	4.7	26.0	18.3	1.2	0.0	5.4	6.1	2.0	24.7	0.2	0.6	8.6	2.9	4.8	47.4	6.3	1.4	1.6	0.2	38.2	0.7	19.1	0.0	0.1	0.0	0.0	3.1	0.2	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.2	7.4	0.1	0.4	0.9	1.1	0.8	1.3	0.8	1.4	1.4	1.6	1.2	1.1	2.8	1.4	2.0	3.2	0.5	0.7	0.0	10.3	2.3	15.4	4.0	0.0	0.3	0.4	0.3	1.5	5.9	0.0	0.0	0.3	0.0	0.0	1.9	21.7	0.0	2.3	18.4	7.4	0.0	1.3	0.0	24.0	4.4	8.4	0.0	1.3	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.1	0.1	4.1	0.4	1.8	0.0	3.6	0.0	0.0	0.0	0.0	24.2	0.0	0.4	0.0	1.5	0.0	0.3	1.1	0.0	0.0	24.7	9.6	0.1	0.0	5.6	6.5	1.5	0.5	1.1	0.0	2.0
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.6"	"CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		9600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	982.3	77.1	25.5	353.9	26.2	1090.8	561.9	27.5	53.1	566.3	32.0	301.7	91.7	177.8	124.5	224.0	217.6	167.6	268.5	24.7	27.4	247.0	64.3	874.2	221.0	31.7	26.4	51.0	53.8	18.1	24.8	182.9	29.8	223.7	331.5	10.0	245.4	155.8	163.0	371.5	234.3	297.7	27.8	443.0	133.3	32.2	33.7	112.6	191.9	424.6	315.4	391.6	455.2	34.1	11.8	2614.3	13.2	77.0	3300.1	2410.9	3.7	1664.4	6738.6	32.1	148.4	20.0	180.3	0.8	299.7	4819.1	3.5	65.3	8.8	20.9	23.6	405.2	2.3	1186.8	529.0	59.4	4.3	106.9	1924.6	364.2	21.5	62.2	13.0	4.9	2.6	0.7	9.9	4.2	2468.1	10.6	3.8	1273.9	7.2	189.7	1050.4	64.1	3.7	2700.2	103.5	71.3	108.5	11.6	24.9	1286.6	9.4	412.5	77.1	1493.7	3.1	8.5	13.7	2159.5	9.3	82.8	647.5	14.3	6.1	1367.9	127.2	2789.7	13536.2	1408.0	5800.5	9099.6	6077.0	761.6	5167.7	4700.0	9268.4	282.5	882.4	2641.3	12129.7	837.1	11862.4	1626.0	7406.7	24075.8	25.5	26.2	27.5	53.1	24.7	27.4	31.7	26.4	29.8	27.8	33.7	34.1	226.0	490.4	398.4	0.0	266.1	772.9	19.5	159.0	93.9	0.7	44.9	65.9	14.9	35.8	273.8	893.8	0.0	52.4	1345.4	8.9	111.6	21.9	7.3	53.0	473.0	209.1	4.8	730.9	0.0	23.5	255.5	1378.8	54.0	41.9	1395.8	0.6	96.4	18.6	1966.1	45.4	0.0	10.0	345.8	2708.8	5952.7	24.0	235.8	2786.0	1193.5	12.2	3172.6	3.6	2130.8	0.0	0.1	35.7	17.0	45.9	266.5	12.9	3.2	19.7	154.9	2.3	151.2	2034.0	1309.6	1.9	5.5	77.6	694.0	53.4	2111.1	32.5	11.3	73.1
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391073	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35382.0;esophagus: 24565.6;vagina: 11166.4"	"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"classical monocyte: 26833.7;neutrophil: 52973.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 52973.6;monocytes: 26833.7"	"Group enriched"	"Detected in some"	24	"hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA	10900000	370000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	582.3	54.3	41.7	1245.8	45.6	35382.0	70.0	43.4	88.0	5650.6	45.5	55.2	15.4	23.1	5.5	24565.6	236.1	99.0	121.1	40.9	42.7	103.0	176.7	1061.7	29.5	47.7	44.8	25.8	52.0	9.6	41.7	205.8	50.7	43.1	14.7	5.6	3988.2	5.0	48.5	267.3	47.7	430.2	44.2	3239.5	93.8	16.2	45.5	281.3	48.8	174.8	8952.6	561.9	11166.4	46.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	1.3	0.0	0.3	12.4	0.0	18.7	0.0	0.1	0.0	3.5	0.0	0.0	0.0	5.6	0.1	0.0	241.8	0.0	7.5	0.0	0.0	0.0	9.6	1.2	0.0	0.9	0.4	1.5	0.3	0.0	0.0	0.4	5.8	1.0	0.0	0.0	0.4	0.5	3.6	719.0	0.0	0.0	4.7	400.6	10.6	0.0	0.2	0.9	0.1	0.2	1.3	2.7	0.3	13.9	0.0	848.0	26833.7	3023.7	33.4	1999.2	49.2	57.2	21.8	18.2	4686.1	23.5	21.6	23.3	52973.6	27.1	493.1	188.1	37.1	24979.9	41.7	45.6	43.4	88.0	40.9	42.7	47.7	44.8	50.7	44.2	45.5	46.2	1.1	224.4	489.8	0.0	77.2	19.6	3.5	4126.5	50.7	0.0	13.2	3.9	10.0	70.1	817.0	14.7	0.0	5.8	67.1	0.3	0.0	1.0	210.7	0.5	0.6	33.1	0.0	143.5	0.0	0.9	8.5	61.3	1.1	0.5	227.1	0.1	76.1	54.6	417.5	0.0	0.0	0.2	207.5	6348.0	5.1	172.4	4.1	3758.3	0.0	0.0	6932.6	0.0	289.4	0.0	0.0	1.4	0.0	1.5	26.1	0.9	0.0	25.0	162.8	0.0	0.0	7.7	32.3	2.1	1.0	8480.1	113.2	6.7	91.4	0.0	0.0	31.3
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598604-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 1499.3;choroid plexus: 781.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 360.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 360.9"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 547.1;WM-115: 992.8"									"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		300000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	151.1	25.7	877.1	10.5	1072.5	2.3	87.0	1254.5	1191.2	28.6	781.0	121.0	7.4	2.4	12.1	14.6	6.9	14.3	28.1	858.4	989.0	3.6	3.2	6.4	21.4	1491.0	1054.2	5.6	5.0	0.3	44.7	0.8	1359.0	29.3	14.2	14.1	19.3	26.2	3.6	15.8	36.3	6.8	1162.2	26.2	23.6	2.4	998.8	18.4	5.2	6.4	20.3	15.9	26.9	1499.3	0.5	0.0	110.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	15.9	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.5	0.0	0.0	547.1	0.0	0.1	0.5	0.0	0.3	0.3	0.0	3.2	0.0	0.3	0.0	1.4	6.7	992.8	0.1	0.5	0.2	360.9	9.5	103.3	0.2	1.0	67.6	16.3	1.4	3.2	153.1	3.2	58.7	10.1	3.9	0.0	63.6	877.1	1072.5	1254.5	1191.2	858.4	989.0	1491.0	1054.2	1359.0	1162.2	998.8	1499.3	4.5	3.2	4.8	126.3	4.6	16.8	0.7	0.0	17.6	1.3	41.2	124.8	6.0	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.1	0.4	0.1	0.1	2.7	0.0	2.7	0.9	0.0	0.1	4.4	0.5	0.2	0.0	261.7	4.6	0.4	9.3	0.0	1.4	0.0	0.0	38.6	206.8	1.7	5.6	37.0	99.6	9.4	33.3	25.7	63.8	83.4	332.1	0.1	0.0	0.0	2.2	0.1	0.0	0.1	0.0	4.7	0.0	5.6	7.8	0.1	0.1	0.7	12.6	0.1	37.9	0.0	0.2	0.4
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693878-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 1410.7;stomach 1: 1742.0;urinary bladder: 1777.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 1088.3;Gastric mucus-secreting cells: 2306.9;Syncytiotrophoblasts: 2773.6;Urothelial cells: 4448.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 1789.3;eosinophil: 836.9;neutrophil: 2961.8"	"Lineage enriched"	"Detected in many"	73	"granulocytes: 2961.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 879.0;Hep G2: 1283.2;hTCEpi: 1185.6;OE19: 4335.4;RT4: 2619.8;SK-BR-3: 1057.4"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	14.0	1.7	1.0	42.4	1.4	1410.7	7.4	1.6	6.3	15.0	1.4	155.6	13.2	5.9	0.0	340.6	6.9	52.1	2.7	1.4	0.9	2.1	8.8	14.7	1.0	1.1	1.1	0.5	4.7	0.4	1.7	474.7	3.2	25.5	176.0	0.1	8.2	0.5	0.4	20.9	23.8	16.6	0.6	34.3	1742.0	1.4	1.0	10.6	0.6	12.2	96.9	1777.0	34.5	1.1	115.2	89.1	0.0	0.1	0.0	0.5	879.0	0.0	1.0	0.0	0.0	5.2	17.6	0.7	40.1	0.6	1.2	137.6	0.5	1.1	0.0	54.7	0.0	1.9	106.7	1283.2	0.0	53.4	3.2	0.6	1185.6	0.0	1.1	0.2	0.2	0.8	3.1	0.0	0.0	214.5	1.6	126.5	1.5	4335.4	149.6	0.9	0.5	0.5	0.0	2619.8	1.1	0.7	156.8	1057.4	2.4	39.9	31.0	169.6	0.5	0.0	1.4	0.2	0.9	1.2	0.7	0.8	0.1	479.1	0.2	1789.3	40.6	836.9	1.4	9.5	1.1	0.4	1.7	1.1	1.6	0.5	0.3	0.8	2961.8	0.1	5.7	0.4	1.1	16.7	1.0	1.4	1.6	6.3	1.4	0.9	1.1	1.1	3.2	0.6	1.0	1.1	0.9	9.6	48.6	0.0	6.2	1.1	318.3	568.6	4.0	0.0	3.4	3.6	1.2	27.1	1088.3	1.8	0.0	550.7	2.2	322.2	0.0	4.8	12.3	37.5	38.9	8.7	16.6	0.0	0.0	31.1	783.4	13.8	2306.9	202.5	31.6	0.0	1.4	7.4	69.2	0.0	0.0	443.7	152.5	11.8	1.0	7.4	0.0	11.0	8.8	0.0	5.6	0.0	2.1	0.0	0.1	828.1	580.9	0.0	5.9	288.4	2.2	0.5	301.5	0.0	0.0	0.1	32.1	0.5	0.6	18.6	6.3	2773.6	9.8	0.1	173.2	4448.3
S100Z	"Gm625, S100-zeta"	ENSG00000171643	"S100 calcium binding protein Z"	Q8WXG8	5	76850001-76921650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;lymphoid tissue: 3.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 7.4;Kupffer cells: 8.7;Macrophages: 11.8;Microglial cells: 32.8;monocytes: 26.1"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 35.0;eosinophil: 31.8;intermediate monocyte: 34.0;myeloid DC: 19.5;neutrophil: 11.8;non-classical monocyte: 39.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 19.5;granulocytes: 31.8;monocytes: 39.6"	"Cell line enriched"	"Detected in some"	6	"U-698: 81.9"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.3"	"Low region specificity"	"Detected in all"			HPA051929	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA051929: AB_2732571"	"unprognostic (4.17e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.47e-5)"	"unprognostic (3.39e-4)"	"unprognostic (8.94e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.62e-1)"	0.3	0.2	1.1	2.0	0.6	2.4	0.2	0.4	1.1	0.0	0.1	0.3	0.4	0.1	0.1	0.3	0.1	0.7	0.1	0.5	0.5	0.1	0.3	0.7	0.9	0.6	0.6	0.0	0.9	0.1	0.1	1.2	0.6	0.2	0.4	0.0	0.2	0.1	0.2	0.0	0.8	0.6	0.5	3.2	0.4	0.2	1.0	0.8	0.1	0.0	2.5	0.5	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	2.7	0.1	0.2	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.1	1.0	0.1	81.9	3.3	0.0	0.0	2.5	35.0	31.8	0.8	34.0	0.2	4.7	0.5	0.1	19.5	2.1	0.0	0.0	11.8	0.7	39.6	0.1	0.7	10.5	1.1	0.6	0.4	1.1	0.5	0.5	0.6	0.6	0.6	0.5	1.0	1.1	0.2	0.0	0.0	0.3	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	2.1	2.1	0.0	0.2	0.2	0.5	0.2	0.0	0.5	0.4	0.0	7.4	0.0	2.0	0.0	0.0	8.7	1.1	0.0	0.0	11.8	3.6	32.8	26.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.1	1.4	0.0	0.0	0.0
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236865-101243713	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.1;Endothelial cells: 122.3;Hepatic stellate cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1248.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 73.0;HUVEC TERT2: 198.9;TIME: 113.3;U-251 MG: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	114.7	14.4	58.8	29.8	62.7	18.5	91.9	59.8	59.0	18.5	27.8	19.5	9.4	24.7	3.9	26.8	22.9	28.0	71.8	51.3	65.1	18.0	31.3	78.3	46.3	65.2	73.0	8.2	20.3	23.3	8.7	48.1	61.3	13.7	10.1	14.6	15.0	7.8	27.9	17.9	22.3	31.2	57.6	63.1	17.1	2.6	76.5	21.4	35.9	51.5	26.9	34.3	19.2	52.6	15.6	0.2	14.2	0.0	1.4	32.7	0.1	73.0	13.5	47.9	16.6	0.1	0.7	0.0	17.8	25.2	0.4	0.0	1.8	0.8	27.0	6.1	1.2	6.8	0.3	0.0	6.6	0.0	3.5	45.0	0.3	0.1	3.7	1.7	198.9	5.8	0.2	14.4	13.5	0.0	20.6	0.0	3.9	0.4	4.8	0.0	13.4	0.5	0.1	0.0	0.0	0.1	0.7	0.0	0.2	0.9	0.0	0.2	113.3	6.8	2.9	2.0	147.1	1.3	0.0	1.0	0.7	0.0	0.4	1248.4	2.2	55.4	589.4	2.1	441.5	294.7	502.6	492.1	2.6	346.9	383.3	396.3	15.4	397.5	3.4	3.1	329.4	438.7	58.8	62.7	59.8	59.0	51.3	65.1	65.2	73.0	61.3	57.6	76.5	52.6	236.1	0.0	8.9	37.9	36.0	7.6	0.2	0.0	2.2	0.4	1.1	1.1	23.8	2.8	1.3	0.0	0.0	5.9	25.0	0.0	0.0	0.0	0.0	1.1	1.0	122.3	0.0	0.4	0.1	0.0	0.3	11.7	0.5	1.8	7.6	9.7	114.2	8.9	9.9	0.0	0.3	0.0	0.0	6.5	5.7	0.0	0.9	3.0	5.4	13.1	9.9	31.1	40.2	0.5	0.2	0.0	0.0	0.0	18.2	0.5	0.0	0.1	0.0	1.4	0.0	3.6	4.8	0.7	0.7	0.6	5.1	2.6	29.9	1.8	0.1	0.4
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	NA		67000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	43.4	40.1	27.9	34.5	31.6	55.6	44.2	37.1	33.8	52.5	24.0	50.4	28.8	49.7	14.0	45.2	45.2	17.3	46.0	27.6	31.4	39.3	42.6	45.8	39.0	32.0	29.2	54.4	44.3	22.7	43.4	27.7	31.0	46.4	17.7	32.1	42.8	19.6	85.3	60.9	48.4	20.6	23.9	58.9	43.2	43.4	32.4	43.4	42.6	30.2	29.4	43.4	47.6	44.6	94.1	81.8	95.3	62.0	41.6	36.4	111.5	68.0	43.7	56.8	47.4	124.2	52.0	149.7	52.9	33.8	48.3	86.4	92.7	55.7	58.1	101.6	94.6	109.9	75.1	118.0	39.4	136.7	93.6	33.6	50.9	50.8	53.2	40.4	45.5	65.9	156.7	75.0	43.5	84.7	146.2	109.9	128.3	63.7	81.1	144.4	105.1	104.8	44.4	76.6	88.2	76.4	76.3	61.2	76.2	54.3	56.3	74.4	71.4	57.6	71.6	72.2	106.2	121.5	112.0	133.3	55.4	112.6	77.7	65.4	47.4	84.1	55.9	47.8	57.1	53.1	55.1	54.9	53.2	47.6	56.8	55.1	53.1	54.6	79.8	44.6	58.6	55.4	27.9	31.6	37.1	33.8	27.6	31.4	32.0	29.2	31.0	23.9	32.4	44.6	34.8	32.1	21.0	33.3	59.1	65.6	50.2	41.0	51.2	41.3	28.9	30.2	43.4	17.2	47.6	16.5	35.5	53.6	47.7	41.0	25.4	44.0	10.0	56.6	55.6	38.9	29.8	29.6	28.6	35.0	55.2	42.6	33.1	46.4	50.6	52.6	23.2	28.1	38.0	50.5	29.8	43.4	32.6	23.0	52.6	8.2	35.8	37.0	30.2	30.9	55.6	30.0	50.4	34.2	41.5	32.3	29.9	25.9	50.9	44.8	33.7	28.1	72.9	47.2	19.7	44.5	45.1	89.7	94.3	37.2	65.4	62.5	52.2	44.0	40.5	38.9
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA		48000	"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: AB_2681266"	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.12e-4)"	26.8	35.8	23.3	22.4	23.8	35.2	25.8	28.0	30.3	48.4	21.0	35.3	22.2	38.2	21.0	23.1	44.0	15.6	30.8	21.7	29.6	40.6	30.7	27.8	24.4	24.2	23.9	56.2	30.5	18.0	48.6	14.2	23.1	43.0	16.1	34.7	27.6	18.6	41.5	25.8	34.3	19.3	17.5	39.9	27.8	32.5	23.9	22.3	38.9	20.4	21.2	31.5	35.0	27.5	44.9	54.8	38.8	30.4	36.7	23.7	47.6	40.9	21.3	24.4	23.3	69.9	31.4	84.9	36.9	19.9	19.6	39.9	47.2	24.9	39.2	59.8	53.5	64.4	59.5	54.6	21.2	53.0	58.2	23.5	25.4	35.2	26.9	23.9	24.6	29.3	63.6	40.6	28.7	48.9	65.7	53.1	69.9	33.1	59.9	82.2	34.2	47.6	27.7	70.5	37.6	35.3	54.7	25.3	35.3	24.4	36.5	33.0	40.5	30.7	32.7	39.3	57.6	55.2	52.2	58.6	31.2	47.1	52.2	42.8	12.6	22.0	14.6	10.8	16.8	13.9	13.2	11.7	11.3	14.9	14.5	11.7	23.4	9.4	12.3	12.5	13.4	7.9	23.3	23.8	28.0	30.3	21.7	29.6	24.2	23.9	23.1	17.5	23.9	27.5	40.6	41.7	45.1	79.7	69.7	46.7	58.1	41.4	47.3	70.2	39.1	30.6	28.7	20.0	39.3	33.1	75.0	46.8	63.0	46.4	23.5	49.7	7.6	44.5	92.6	49.0	43.0	45.8	36.2	44.4	44.7	47.3	44.4	58.3	42.3	45.4	26.7	23.3	30.6	43.7	42.7	46.5	57.0	27.6	49.5	13.3	72.4	46.6	26.6	32.8	52.2	77.5	52.5	29.7	34.6	42.2	48.6	65.8	70.0	50.3	54.1	61.5	55.3	78.4	46.0	75.4	47.9	68.3	78.8	37.3	41.9	32.3	79.1	59.7	44.8	54.2
SAGE1	"CT14, SAGE"	ENSG00000181433	"Sarcoma antigen 1"	Q9NXZ1	X	135889205-135913061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 4.8"	"Cell type enriched"	"Detected in some"	9	"Spermatogonia: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.5;K-562: 15.6;Karpas-707: 25.5;U-2 OS: 7.0;U-266/70: 8.9;U-266/84: 23.8"									"HPA003033, HPA003208"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003033: AB_1079865, HPA003208: AB_1079863"				"unprognostic (1.11e-1)"	"unprognostic (5.26e-2)"			"unprognostic (1.15e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.37e-1)"		"unprognostic (7.12e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	8.9	23.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.3	0.4	0.5	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;kidney: 36.4;liver: 36.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Cone photoreceptor cells: 25.0;Endometrial stromal cells: 17.5;Glandular and luminal cells: 14.3;Hepatocytes: 30.1;Microglial cells: 26.2;Oligodendrocytes: 47.6;Proximal tubular cells: 20.3"	"Cancer enhanced"	"Detected in many"		"glioma: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 29.5;BJ hTERT+: 25.3;NTERA-2: 48.0;RPTEC TERT1: 40.4;U-87 MG: 46.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 52.6"	"Low region specificity"	"Detected in all"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.3	0.0	18.0	0.6	29.2	0.1	0.3	29.7	21.3	19.6	2.1	2.6	1.0	17.4	0.0	0.3	11.0	0.4	0.8	17.9	21.7	36.4	36.5	0.0	0.0	41.0	32.2	4.5	1.0	6.5	6.5	3.9	36.6	0.8	2.6	4.6	0.2	1.6	0.0	0.2	1.3	8.4	31.1	0.0	2.5	1.7	26.6	0.1	23.7	0.2	0.0	2.8	7.2	40.2	0.0	1.7	29.5	0.2	0.8	0.6	0.0	10.0	25.3	0.6	1.4	0.0	0.0	0.0	11.2	14.1	8.8	0.0	18.6	0.0	0.9	0.0	11.3	0.0	0.0	18.5	0.7	0.0	8.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.8	1.9	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	46.2	0.0	10.0	0.2	0.6	0.5	0.1	0.4	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.0	0.3	0.4	0.2	0.3	18.0	29.2	29.7	21.3	17.9	21.7	41.0	32.2	36.6	31.1	26.6	40.2	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	1.4	10.0	0.0	9.2	25.0	0.0	0.0	0.0	11.7	0.5	0.7	8.9	17.5	0.9	0.0	2.7	0.2	0.0	0.0	1.6	0.0	14.3	0.0	0.0	0.7	30.1	0.1	0.0	8.2	0.0	0.0	1.0	0.3	0.1	0.0	0.4	0.0	26.2	0.0	0.5	0.0	5.0	47.6	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	1.0	0.0	0.0	0.5	0.2	2.3	0.0	0.1	0.0	0.3	0.6	0.0	0.1
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802521	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.9;thyroid gland: 5.8"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 26.9"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 25.0;AN3-CA: 17.5;BEWO: 33.2;NTERA-2: 60.2;SiHa: 15.6;SuSa: 39.7"	"Not detected"	"Not detected"							"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.2	0.3	0.2	0.2	0.2	0.8	0.2	0.4	0.2	0.2	0.3	0.2	0.1	0.2	0.4	0.2	0.2	0.0	0.1	0.2	0.4	0.8	1.6	0.2	0.1	0.2	0.3	0.1	2.1	2.0	0.5	0.2	0.2	2.4	0.2	0.5	0.9	0.2	0.1	0.2	0.4	0.1	0.2	0.5	0.2	3.9	0.3	0.0	5.8	0.0	0.1	0.4	0.1	0.4	0.0	1.7	25.0	17.5	0.0	0.1	33.2	0.0	0.2	0.1	0.3	9.0	0.2	0.0	0.3	0.3	0.3	4.3	0.2	0.1	0.3	0.4	0.0	0.0	7.0	0.4	0.1	0.0	1.9	0.7	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.8	0.0	0.1	60.2	0.2	0.4	2.3	0.0	0.0	0.0	0.5	5.7	3.1	15.6	0.1	1.5	39.7	0.1	1.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.4	0.1	0.0	2.0	1.6	0.0	0.0	1.1	0.1	0.0	0.4	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.6	0.0	0.2	0.1	0.2	1.2	0.0	4.1	0.2	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.6	0.2	26.9	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	1.0	2.0	2.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.7	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2
SAMD4B	"FLJ10211, hSmaug2, MGC99832, SMGB"	ENSG00000179134	"Sterile alpha motif domain containing 4B"	Q5PRF9	19	39342396-39385710	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016800, HPA059385"	Approved		Enhanced	Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA016800: AB_1856552, HPA059385: AB_2684000"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.17e-6)"	"unprognostic (3.41e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.24e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.91e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-2)"	46.1	39.7	37.3	24.5	48.1	20.3	42.1	31.1	37.5	56.6	18.1	47.1	18.9	49.7	16.8	65.0	47.3	26.7	39.6	34.2	34.5	33.2	31.2	45.7	15.1	51.9	45.9	60.8	34.2	36.3	48.1	26.2	39.9	41.9	15.8	23.4	42.8	33.3	36.0	54.9	34.9	27.9	35.9	32.9	40.2	41.4	40.7	19.2	44.1	19.2	15.1	46.1	52.9	53.6	97.8	131.0	65.6	49.7	62.7	75.1	54.1	55.1	60.0	43.2	35.7	114.6	53.2	32.3	70.2	88.4	56.0	46.2	65.3	50.4	29.5	65.3	106.1	32.4	55.5	48.6	64.7	35.5	32.7	74.1	58.5	70.8	52.3	52.6	41.3	42.9	97.6	34.0	53.3	65.8	38.1	17.3	52.2	63.5	51.6	45.9	42.2	28.3	36.3	77.8	66.6	65.0	72.1	48.8	39.2	49.4	39.5	37.8	54.6	70.0	50.6	153.5	97.8	64.0	62.2	35.8	93.4	26.7	70.2	1.2	1.0	1.5	1.0	0.4	0.7	1.2	0.8	0.9	0.8	0.6	1.3	0.9	2.7	0.9	0.3	0.9	0.3	0.5	37.3	48.1	31.1	37.5	34.2	34.5	51.9	45.9	39.9	35.9	40.7	53.6	28.8	12.8	30.4	55.8	21.6	33.3	62.7	22.4	12.0	56.9	37.1	32.9	8.4	24.3	18.9	36.8	166.8	25.7	21.7	26.4	5.9	26.2	6.9	44.9	42.5	31.9	51.0	19.8	26.6	27.3	23.1	39.1	19.9	55.3	18.9	39.0	36.8	26.6	20.7	52.2	31.0	28.1	10.2	25.5	38.2	5.4	43.8	28.5	19.6	25.3	18.4	31.4	16.5	34.2	106.0	41.0	19.6	33.1	19.3	65.7	20.2	12.3	30.7	67.9	65.7	43.9	30.9	70.3	42.7	15.6	43.5	54.6	20.4	33.8	24.5	65.9
SAMD5	dJ875H10.1	ENSG00000203727	"Sterile alpha motif domain containing 5"	Q5TGI4	6	147508690-147737547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 96.0;Inhibitory neurons: 276.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.6;Hep G2: 65.6;K-562: 44.7;RH-30: 29.0;WM-115: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067811	Uncertain		Supported	Vesicles		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA067811: AB_2685901"	"unprognostic (4.16e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.09e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.50e-1)"	0.6	1.8	2.8	1.3	5.6	0.1	4.1	1.0	2.6	1.4	0.1	6.0	3.0	4.2	0.8	8.9	0.9	2.2	1.2	2.7	4.0	7.4	7.5	3.4	0.3	8.7	4.1	0.4	1.3	5.7	3.8	12.2	9.1	1.4	8.1	8.9	2.3	2.4	0.2	1.9	4.4	3.1	0.0	1.4	4.5	7.6	7.2	0.1	2.1	0.1	0.7	1.5	1.9	0.8	11.2	1.4	1.4	2.0	0.0	0.0	0.1	3.6	1.3	0.3	0.2	16.6	0.1	0.6	3.6	0.0	0.6	0.1	0.3	2.5	0.4	0.0	2.0	0.8	1.5	65.6	0.2	0.0	1.3	0.0	0.1	0.3	0.1	0.0	6.8	0.0	44.7	0.6	4.8	0.1	0.0	0.0	0.1	8.4	2.8	0.0	29.0	6.5	0.1	2.3	0.5	0.1	0.9	0.2	2.8	0.3	0.0	0.0	4.9	0.5	1.5	0.5	1.3	0.1	1.1	0.0	0.1	0.1	20.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	5.6	1.0	2.6	2.7	4.0	8.7	4.1	9.1	0.0	7.2	0.8	1.7	3.2	5.9	1.3	1.0	1.8	5.6	0.5	2.2	96.0	2.9	23.5	2.6	0.0	0.0	18.4	2.1	0.2	0.0	5.4	9.8	2.2	0.5	1.1	10.7	11.1	16.9	0.0	15.7	0.2	0.3	6.9	19.4	1.8	0.0	7.0	6.1	28.1	0.8	0.0	276.9	11.6	0.0	1.0	1.4	1.3	0.3	0.7	0.0	45.0	0.0	9.2	0.0	5.5	0.9	0.6	3.4	3.4	0.1	3.0	5.2	19.7	0.0	4.0	0.0	3.1	2.0	0.5	0.2	36.4	1.6	0.3	0.5	3.6	25.7	4.2
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 1174.1;Langerhans cells: 317.9;Macrophages: 414.6;monocytes: 829.9;T-cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 273.7;K-562: 331.6;Karpas-707: 137.3"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 20.7"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	32.3	6.7	2.4	80.1	2.8	192.9	4.7	3.3	4.9	5.7	4.2	11.0	7.0	3.4	1.9	5.3	6.3	22.7	4.5	2.5	3.5	4.2	17.5	22.9	35.4	6.2	4.5	1.3	3.1	2.0	2.1	15.5	6.1	3.9	15.3	12.7	2.8	2.2	0.7	1.5	15.1	10.8	5.1	32.0	9.3	1.2	4.6	22.4	2.2	1.2	41.0	39.7	2.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	0.0	1.8	0.0	14.0	0.0	273.7	0.0	0.0	0.0	32.5	12.7	0.1	0.0	0.0	37.9	10.2	3.6	4.8	331.6	137.3	0.0	0.0	15.9	39.5	0.1	0.0	0.2	26.8	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	35.0	0.0	0.0	0.0	0.0	58.2	0.5	0.3	1.4	20.7	0.0	314.2	38.7	234.6	22.1	52.3	15.4	27.3	42.8	33.3	25.0	15.4	26.8	19.1	49.4	18.0	83.0	0.9	60.3	33.6	2.4	2.8	3.3	4.9	2.5	3.5	6.2	4.5	6.1	5.1	4.6	8.9	4.8	22.4	54.9	0.7	127.5	15.6	1.1	0.0	1.8	64.9	2.7	3.0	1.2	1.5	11.2	36.8	0.0	0.5	147.9	0.7	0.0	0.6	0.0	0.8	0.2	8.0	0.0	13.7	1.0	6.5	0.7	11.3	10.7	0.6	1174.1	0.1	4.6	1.8	62.0	0.0	0.8	0.8	0.0	183.7	317.9	0.4	0.6	414.6	21.4	131.2	829.9	1.6	24.7	2.5	0.6	0.7	1.1	0.0	119.3	0.5	0.0	0.5	8.0	4.7	0.0	2.2	3.7	0.1	0.2	1.2	13.2	0.5	332.8	0.1	0.9	0.9
SAP30L	"FLJ11526, NS4ATP2"	ENSG00000164576	"SAP30 like"	Q9HAJ7	5	154445997-154461053	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048665, HPA078308"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048665: AB_2680486, HPA078308: "	"unprognostic (3.79e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.69e-4)"	10.0	8.4	12.2	5.3	13.7	1.6	11.3	13.0	13.2	14.0	10.2	14.9	10.5	13.4	9.0	7.1	12.9	6.7	9.8	11.1	12.9	13.1	8.0	9.3	6.8	13.2	13.4	19.7	6.4	13.8	5.0	7.7	12.7	10.6	8.7	6.1	7.3	12.4	14.1	11.4	11.0	11.6	13.7	8.9	8.9	7.7	13.1	9.9	9.3	15.3	8.3	10.9	10.0	13.8	9.0	7.3	13.3	8.8	28.4	22.5	6.5	9.2	19.9	10.4	11.2	4.9	5.0	9.7	7.2	14.0	12.1	7.1	10.1	7.5	11.6	4.9	9.9	7.9	6.8	3.6	8.5	10.5	5.7	8.2	13.4	4.6	11.3	16.0	8.5	9.1	3.3	6.0	8.8	4.5	9.9	6.7	3.3	8.2	5.0	9.4	13.3	4.8	6.0	4.4	8.0	10.5	7.3	15.6	17.6	12.4	5.6	12.8	12.1	7.2	5.3	9.6	6.6	5.6	8.6	5.0	10.6	8.1	4.2	0.0	0.3	0.3	0.5	0.4	0.6	0.2	0.6	0.6	0.3	0.5	0.6	0.4	0.2	1.4	1.2	0.4	0.6	0.3	12.2	13.7	13.0	13.2	11.1	12.9	13.2	13.4	12.7	13.7	13.1	13.8	25.7	19.2	6.9	7.8	7.1	17.3	8.7	4.2	8.0	4.5	17.0	14.1	19.8	17.2	6.3	3.7	6.2	7.7	15.5	26.5	3.9	4.8	22.4	15.6	18.4	17.6	7.2	11.0	6.6	8.2	12.3	18.1	4.6	9.8	1.3	16.4	15.7	16.3	8.5	10.1	6.5	11.4	0.0	9.7	12.4	18.0	20.5	11.3	10.6	9.4	10.7	21.4	14.4	6.0	12.1	10.6	13.9	18.0	7.8	16.9	32.7	10.5	9.5	5.8	0.0	14.9	16.0	16.1	17.2	5.5	18.2	6.3	8.9	10.5	12.1	13.3
SART3	"KIAA0156, p110, RP11-13G14, TIP110"	ENSG00000075856	"Spliceosome associated factor 3, U4/U6 recycling protein"	Q15020	12	108522214-108561400	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028840, HPA044322"	Approved		Supported	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA028840: , HPA044322: AB_2678895"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.36e-2)"	14.6	15.1	14.0	18.5	14.0	25.5	14.8	17.6	15.1	18.8	12.2	15.9	12.6	19.3	13.7	19.2	17.4	11.9	13.9	13.7	14.6	13.9	16.1	14.5	26.3	12.5	12.9	23.8	13.2	18.3	18.9	15.4	13.0	16.5	15.2	20.3	14.1	14.5	17.8	19.0	17.2	13.9	13.5	19.8	15.1	16.8	14.5	25.7	18.8	15.1	23.2	15.5	16.0	16.8	34.5	61.5	45.4	53.8	24.2	18.9	43.6	29.3	35.8	50.1	37.2	51.5	23.4	51.3	20.1	26.4	32.2	32.0	68.2	33.9	44.1	61.8	43.0	74.1	40.9	47.9	39.2	74.0	44.4	26.4	31.4	31.9	46.8	38.1	30.8	42.1	85.7	33.7	30.9	34.6	69.9	57.5	90.2	27.6	59.9	67.3	44.7	59.3	26.1	57.5	56.8	40.3	45.0	17.0	30.7	38.7	49.0	51.1	26.0	39.0	21.0	30.1	30.7	42.6	68.3	75.6	34.1	42.2	46.2	6.9	6.2	6.4	8.3	5.1	9.9	7.7	6.3	8.3	9.0	7.1	9.4	6.0	1.6	8.6	7.6	6.1	10.5	7.9	14.0	14.0	17.6	15.1	13.7	14.6	12.5	12.9	13.0	13.5	14.5	16.8	14.7	19.2	24.5	16.0	25.9	14.7	16.3	15.4	16.5	42.0	11.5	11.4	19.9	10.0	23.4	18.4	35.5	21.4	21.1	12.0	7.9	14.7	53.6	15.1	21.6	20.0	12.5	23.1	22.1	12.7	14.0	17.1	15.3	15.9	17.7	21.9	11.7	12.5	13.2	35.3	22.2	9.3	24.4	14.1	13.8	30.8	10.2	17.0	16.0	16.9	18.6	23.4	14.4	19.1	24.9	13.5	7.7	17.7	29.6	16.1	9.5	8.2	27.4	39.1	32.9	22.0	18.0	27.2	31.1	19.6	18.0	23.7	24.2	19.1	14.0	17.0
SBSPON	"C8orf84, RPESP"	ENSG00000164764	"Somatomedin B and thrombospondin type 1 domain containing"	Q8IVN8	8	73064543-73124088	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 36.5;Collecting duct cells: 42.3;Muller glia cells: 48.5;Peritubular cells: 26.7;Smooth muscle cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 7.5;pons: 6.3;spinal cord: 7.7;white matter: 16.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ: 9.5;RPTEC TERT1: 16.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA029595	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA029595: AB_10600763"	"prognostic favorable (7.18e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.25e-2)"	6.4	3.0	0.4	1.4	0.5	0.3	3.4	1.2	0.6	5.2	0.6	4.7	0.9	4.4	4.5	9.5	8.2	1.3	2.3	0.8	0.8	8.3	0.6	3.9	1.5	7.5	0.9	3.3	1.2	0.1	1.6	9.4	6.3	15.1	1.1	9.0	4.6	10.8	0.6	1.9	2.5	8.9	7.7	1.1	9.6	2.6	0.4	0.2	2.5	1.4	0.2	17.9	4.7	16.7	0.2	0.2	0.4	0.5	0.0	0.0	1.3	9.5	0.0	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.3	0.9	0.5	0.2	0.2	0.1	0.0	16.9	0.1	0.5	0.5	1.0	0.4	0.1	3.1	0.2	0.1	0.5	0.1	1.5	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.5	1.2	0.6	0.8	0.8	7.5	0.9	6.3	7.7	0.4	16.7	0.6	9.6	0.0	1.0	0.2	1.3	6.9	0.0	36.5	2.4	5.8	11.6	3.8	4.3	0.0	42.3	2.1	0.2	1.0	0.5	1.9	1.3	10.3	7.2	1.4	1.7	0.0	0.0	0.5	0.0	0.4	13.2	10.7	14.9	0.0	0.2	1.4	0.2	0.4	0.0	0.4	0.2	0.0	0.0	0.4	3.2	12.2	0.4	3.6	0.0	0.0	48.5	0.0	1.0	0.2	0.6	0.0	26.7	0.0	1.8	0.0	3.6	0.0	2.2	6.6	0.9	28.7	11.4	4.4	0.6	1.3	0.4	0.5	0.2	0.1	0.5
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292681-121313410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.6"	"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 141.0;Hepatocytes: 307.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	28.6	35.3	18.4	12.6	20.4	5.7	56.6	37.1	29.3	20.7	17.6	23.2	48.2	15.1	73.2	39.6	16.5	18.2	22.0	19.9	29.9	49.1	393.6	24.6	13.5	42.9	28.0	16.9	21.5	48.6	15.6	14.7	39.1	101.4	19.9	29.5	22.4	56.6	7.7	13.8	24.7	16.2	32.2	8.8	21.7	24.3	24.6	13.5	23.9	13.0	19.5	21.5	27.1	36.5	26.5	14.3	184.8	39.5	72.1	59.9	27.8	27.8	53.5	18.2	32.4	83.1	95.9	25.4	89.0	32.3	156.6	100.8	59.2	70.9	18.1	12.5	80.0	34.6	73.4	64.4	57.9	24.8	12.5	51.0	57.4	60.4	60.2	15.6	29.8	22.8	25.0	34.6	89.0	27.4	9.4	29.2	59.8	74.4	39.7	13.2	51.0	21.6	133.6	116.5	51.1	28.8	73.4	14.6	38.0	125.4	62.2	38.6	58.3	19.0	29.7	32.5	14.0	6.4	11.2	33.3	7.0	49.5	33.5	7.8	3.7	1.0	3.5	4.9	5.9	4.4	4.7	4.2	6.5	4.1	6.8	6.7	0.3	5.3	3.6	7.7	5.5	2.6	18.4	20.4	37.1	29.3	19.9	29.9	42.9	28.0	39.1	32.2	24.6	36.5	10.4	19.2	31.9	23.8	62.6	9.7	49.9	48.9	14.8	26.8	33.7	12.4	20.8	18.6	40.8	20.2	31.3	15.9	47.5	26.4	5.9	24.1	3.0	11.5	8.8	15.7	14.4	18.1	29.6	28.9	16.7	16.3	18.3	19.6	17.7	11.1	141.0	307.1	21.0	23.5	29.4	15.3	59.0	22.1	17.0	1.3	19.3	17.6	19.6	20.6	15.6	38.7	13.4	27.6	34.0	19.3	18.8	17.0	20.9	50.1	24.1	15.8	18.7	28.3	13.1	12.9	14.7	6.7	12.7	36.2	15.5	18.6	56.5	42.8	13.3	54.4
SCAPER	"Zfp291, ZNF291"	ENSG00000140386	"S-phase cyclin A associated protein in the ER"	Q9BY12	15	76347904-76905444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 55.4"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Oligodendrocytes: 251.5;Rod photoreceptor cells: 710.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046253, HPA048077"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	No			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA046253: AB_2679600, HPA048077: "	"unprognostic (3.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.69e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.89e-3)"	5.5	7.9	9.7	4.0	12.2	7.4	6.9	18.2	10.4	6.2	6.5	6.0	6.5	7.4	7.7	8.9	6.4	5.3	13.8	9.0	12.8	9.0	7.5	6.3	4.7	11.5	10.5	12.1	8.3	14.5	8.2	6.5	11.3	7.0	4.4	55.4	7.9	6.2	13.6	6.9	6.3	6.3	9.2	5.9	6.1	21.0	10.7	8.6	12.2	12.0	6.0	5.0	6.5	16.3	6.3	5.8	7.8	4.5	3.9	7.0	6.5	8.3	5.9	3.8	5.4	6.1	5.0	6.3	7.2	2.8	10.0	6.7	18.5	3.5	5.7	14.7	9.1	3.3	6.8	3.0	4.9	9.0	7.6	5.9	6.0	4.5	7.3	8.2	5.2	12.6	4.8	17.5	6.6	2.6	8.8	2.7	2.3	5.5	3.3	7.9	12.4	2.2	3.5	6.3	18.4	8.9	11.2	3.9	9.0	9.4	5.8	7.3	6.3	8.7	8.1	4.1	7.4	10.5	23.7	8.9	5.1	11.1	5.9	40.8	6.3	17.4	11.4	3.5	13.1	16.3	11.5	10.3	3.6	17.0	18.8	12.1	10.7	17.1	4.2	9.3	9.7	4.2	9.7	12.2	18.2	10.4	9.0	12.8	11.5	10.5	11.3	9.2	10.7	16.3	28.5	99.3	61.5	190.7	33.2	20.6	28.9	10.6	18.8	91.5	13.9	15.5	191.3	12.8	27.4	12.9	252.3	33.8	26.6	17.1	1.9	14.6	59.1	10.6	13.8	23.5	16.2	1.7	151.5	6.0	11.8	22.1	17.3	18.4	22.1	41.9	21.8	9.3	14.3	77.4	201.8	9.0	6.1	13.6	11.3	24.9	20.5	14.4	10.6	135.9	12.8	51.3	34.0	203.1	251.5	6.5	11.4	19.2	28.6	15.9	72.6	7.8	12.3	710.6	19.7	39.1	23.5	143.9	68.9	15.1	18.8	52.0	30.5	26.7	13.4	19.7
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724409-246768137	"Metabolic proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 159.5"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1380.7;Spermatocytes: 822.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	20	"basophil: 872.9"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 872.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	26.6	53.7	35.1	14.4	45.5	35.7	23.6	51.5	43.2	22.6	40.8	27.2	34.4	26.2	17.6	9.3	31.6	21.6	32.8	35.3	45.4	49.8	158.2	21.0	13.5	64.0	45.2	22.4	18.8	36.5	24.3	23.8	64.3	39.4	26.8	31.7	15.3	26.0	60.7	24.1	34.6	24.0	57.0	11.5	28.0	159.5	47.3	20.1	33.5	54.7	10.6	81.5	12.0	86.8	55.3	53.2	37.7	22.8	44.5	55.7	0.5	42.3	58.8	70.1	58.3	32.7	150.6	29.3	53.8	49.0	38.9	17.7	32.4	12.6	71.6	40.8	11.9	49.6	46.9	65.9	41.6	97.1	40.7	37.6	5.9	47.4	4.8	65.7	76.4	60.0	62.9	0.1	70.9	13.5	101.6	122.6	56.5	29.6	41.7	83.8	48.5	0.3	216.6	128.2	42.7	48.0	57.3	2.5	39.0	20.2	42.1	99.6	49.8	32.1	28.5	78.7	110.5	138.0	51.1	17.4	54.7	130.2	43.3	872.9	24.3	44.1	18.1	22.2	22.4	11.2	5.4	15.7	10.7	9.4	7.1	22.0	6.4	34.1	15.4	18.2	4.0	17.1	35.1	45.5	51.5	43.2	35.3	45.4	64.0	45.2	64.3	57.0	47.3	86.8	25.0	6.4	11.5	25.8	8.0	30.1	40.6	54.6	1.8	31.2	42.4	17.5	38.0	55.8	40.5	152.6	18.8	41.4	14.6	42.4	31.3	67.2	1380.7	72.7	39.4	23.6	44.9	54.7	23.7	69.0	17.4	35.7	32.6	111.9	57.2	49.2	22.5	187.8	89.4	6.7	20.5	27.4	52.9	45.7	13.7	245.6	47.5	29.7	48.0	10.3	20.3	67.4	18.6	27.2	37.3	75.2	27.8	47.4	8.3	49.2	138.4	69.7	79.4	39.2	19.7	36.7	39.4	822.3	76.2	5.6	68.5	84.6	17.0	42.8	55.0	201.9
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347233-100364826	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1233.7;brain: 839.9;liver: 583.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 389.6;Granulosa cells: 187.3;Hepatocytes: 840.3;Oligodendrocytes: 451.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 2534.2;CAPAN-2: 1824.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	1233.7	131.2	408.7	25.7	525.8	23.0	261.5	535.7	522.1	43.2	156.6	42.9	93.1	15.4	25.5	107.8	5.0	28.7	47.1	349.1	457.5	18.5	583.8	142.8	17.2	775.0	508.9	49.6	22.6	79.5	10.3	19.9	637.8	100.1	39.7	17.9	112.6	11.2	6.1	27.0	36.0	15.9	574.4	15.3	25.2	51.8	538.7	18.4	13.0	7.2	21.0	22.5	41.9	839.9	411.2	373.3	777.6	536.4	2534.2	1449.4	158.2	43.4	948.3	101.6	536.6	323.8	1824.4	173.3	33.7	102.2	461.8	716.4	433.7	1549.5	88.9	59.4	179.6	97.5	219.3	653.4	488.4	136.9	100.9	795.5	459.4	395.0	688.9	273.1	196.2	375.3	275.4	513.3	41.7	646.8	155.9	163.3	270.7	120.7	106.3	72.6	287.4	550.4	443.8	455.3	48.9	185.3	85.8	399.7	834.9	224.2	447.7	291.3	79.0	10.0	115.9	9.1	89.8	141.4	81.5	262.9	184.4	416.0	65.9	0.0	0.8	0.0	1.4	1.6	2.3	0.6	0.5	0.7	2.7	0.9	0.4	1.3	0.1	1.4	0.0	1.5	0.0	1.2	408.7	525.8	535.7	522.1	349.1	457.5	775.0	508.9	637.8	574.4	538.7	839.9	3.8	54.5	389.6	34.0	15.7	3.7	4.5	121.8	0.6	6.5	16.1	6.2	11.2	28.6	66.2	0.0	6.2	3.0	4.7	21.5	0.0	14.6	52.6	13.9	9.0	12.5	25.8	15.8	4.8	67.9	71.7	15.9	25.0	26.9	6.3	187.3	32.9	840.3	34.1	26.9	5.2	16.4	52.9	113.5	4.2	93.0	3.7	21.2	58.7	8.4	10.2	11.9	2.1	18.6	451.5	29.6	2.7	1.5	3.7	31.4	16.2	4.9	31.0	6.2	0.0	3.6	25.7	2.0	1.2	26.7	2.3	17.4	6.6	97.8	38.9	8.2
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 385.5;skin 1: 302.7"	"Cell type enriched"	"Detected in many"	12	"Alveolar cells type 1: 679.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	3.1	0.1	0.0	0.1	0.1	0.1	19.5	0.1	0.1	69.9	0.0	1.1	0.0	0.1	0.1	385.5	0.3	0.1	0.1	0.0	0.0	0.4	0.1	59.8	0.0	0.1	0.2	0.2	0.2	0.3	0.5	0.8	0.2	0.1	2.0	0.1	57.8	0.0	1.5	302.7	0.1	0.0	0.1	0.0	0.6	2.3	0.1	0.5	2.2	0.0	76.8	0.1	121.6	0.2	16.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	1.8	0.0	0.0	54.6	0.0	25.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	74.2	14.9	0.0	0.0	0.0	107.2	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	679.5	31.6	0.0	0.0	10.7	0.1	12.9	0.0	0.0	0.0	0.0	0.2	0.0	49.7	0.0	0.0	0.3	0.0	0.7	0.0	3.2	6.6	0.7	0.1	0.2	0.0	0.0	0.2	0.2	0.0	2.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	7.8	8.2	0.0	1.1	20.9	0.0	0.3	1.8	0.0	0.0	1.6	0.0	1.0	1.7	45.5	0.2	0.0	0.0	0.1	0.0	0.1	7.1	0.0	0.0	0.0	1.2	7.9	5.0	48.8	55.8	0.1	0.3	0.8	0.1	2.7
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602361	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 360.1;brain: 426.2;pituitary gland: 269.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 212.4;Enteroendocrine cells: 283.4;Inhibitory neurons: 109.9;Ionocytes: 138.4"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.3;HSkMC: 45.9;hTERT-RPE1: 46.5;SCLC-21H: 47.6;SH-SY5Y: 20.7;WM-115: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		330000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	9.2	360.1	49.2	30.2	78.4	0.4	0.5	17.1	54.7	1.5	2.2	10.6	47.7	3.5	0.4	0.6	0.2	4.0	1.7	21.7	426.2	0.6	0.2	3.3	0.4	118.3	195.4	6.1	28.3	0.5	269.0	1.1	250.9	3.5	13.0	40.6	0.3	1.2	0.3	1.0	21.3	12.8	77.4	0.2	17.9	0.2	130.7	0.1	6.4	0.8	0.1	0.8	1.3	30.3	0.0	3.1	10.3	8.5	2.3	53.3	0.2	0.5	2.0	4.0	10.1	0.4	1.0	0.0	0.9	0.7	6.2	0.2	0.2	0.0	5.0	0.1	0.5	0.0	0.6	0.0	0.5	0.7	4.6	45.9	0.2	5.8	2.0	46.5	0.0	0.0	0.2	0.4	5.1	0.3	0.0	0.2	7.3	0.1	0.2	0.0	0.3	0.3	0.9	0.1	47.6	20.7	0.0	0.5	2.5	1.6	0.0	0.1	0.1	5.4	2.2	0.2	3.6	0.1	0.0	0.3	1.6	0.1	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	78.4	17.1	54.7	21.7	426.2	118.3	195.4	250.9	77.4	130.7	30.3	0.0	6.4	0.0	12.7	0.0	0.0	0.4	2.8	0.0	212.4	0.0	0.0	0.1	0.0	1.3	0.0	2.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	6.7	283.4	0.0	27.7	0.2	0.0	2.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	8.4	109.9	14.7	138.4	0.3	0.3	0.0	0.6	0.0	1.8	3.7	0.0	11.6	0.0	34.2	8.2	14.8	6.2	0.4	0.0	2.1	0.1	0.1	0.7	14.6	0.0	1.8	1.7	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.5	0.8
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.5;pancreas: 67.1;pituitary gland: 38.5"	"Cell type enriched"	"Detected in some"	5	"Enteroendocrine cells: 600.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2;renal cancer: 22.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 23.6;hippocampal formation: 14.5;hypothalamus: 43.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7"	"Region enriched"	"Detected in many"	16	"olfactory bulb: 82.0"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 137.1"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		3.7	3.5	1.7	3.4	1.2	0.2	3.3	23.6	2.9	0.1	0.1	16.9	12.4	0.0	0.0	0.2	0.1	0.9	11.7	14.5	43.5	1.4	4.1	0.8	0.1	1.7	2.3	0.3	67.1	0.1	38.5	3.3	6.1	2.0	19.2	1.0	2.5	0.1	0.0	0.6	11.5	1.2	1.4	0.0	18.9	0.6	0.9	0.4	1.9	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	23.6	2.9	14.5	43.5	1.7	2.3	6.1	1.4	0.9	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.6	0.5	107.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.2	600.1	0.0	0.2	0.4	0.2	0.3	9.2	0.0	0.0	0.9	3.3	0.5	0.1	0.0	1.8	14.3	4.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	4.8	3.7	0.0	0.0	3.7	1.1	3.1	0.0	0.0	13.1	0.0	9.1	0.2	1.1	0.0	0.0	0.0	0.1	0.5	2.2	0.3
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660182	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.4;kidney: 47.1;placenta: 77.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 334.8;Distal enterocytes: 100.7;Early spermatids: 124.6;Hofbauer cells: 99.9;Paneth cells: 138.6;Proximal enterocytes: 318.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 94.3;SK-BR-3: 102.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020518, HPA024264"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		2300000	"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Cytosol	"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	2.9	1.0	3.6	1.3	4.5	1.3	0.9	4.6	5.3	1.3	2.9	18.3	26.7	1.3	0.5	17.9	4.1	2.8	0.3	3.8	4.8	47.1	0.3	4.1	0.6	9.4	6.8	0.7	0.9	1.1	2.6	77.6	9.7	3.2	16.0	2.4	10.7	1.1	0.5	3.6	46.4	1.1	7.1	0.5	19.6	7.1	5.7	0.6	1.1	1.7	4.3	3.5	1.3	12.3	0.2	0.2	0.2	0.8	0.0	0.0	0.3	0.3	0.1	0.1	0.5	0.1	0.5	0.3	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	10.4	0.1	1.3	0.2	0.1	0.4	0.3	0.2	1.4	0.4	0.0	0.2	0.1	0.2	0.4	20.8	0.5	0.5	0.2	1.4	0.2	5.7	3.2	0.3	0.5	0.1	94.3	3.6	4.1	0.2	1.0	102.8	0.1	0.7	10.8	0.6	0.1	0.3	0.8	2.0	0.2	3.4	0.2	0.2	0.1	0.4	0.1	1.2	0.2	0.2	0.3	0.2	0.3	1.1	0.3	0.3	0.2	0.5	0.3	0.3	0.6	0.4	0.3	0.3	0.2	0.1	3.6	4.5	4.6	5.3	3.8	4.8	9.4	6.8	9.7	7.1	5.7	12.3	3.5	0.0	23.6	0.0	0.7	2.8	1.5	1.6	0.6	3.2	3.3	1.7	1.2	4.3	8.5	334.8	0.0	23.8	0.2	100.7	82.2	0.6	124.6	25.5	1.0	6.7	9.1	0.0	0.1	0.2	4.7	2.7	55.5	11.3	39.9	0.0	0.4	0.1	99.9	0.0	0.2	62.9	46.8	3.0	0.5	87.8	0.3	2.8	10.6	15.0	1.7	0.4	0.0	0.0	0.3	8.6	138.6	1.2	1.4	4.7	318.4	3.2	17.2	3.0	0.0	0.9	1.0	3.8	5.5	26.6	6.5	65.8	2.2	0.1	21.4	23.1
SCLY	SCL	ENSG00000132330	"Selenocysteine lyase"	Q96I15	2	238060924-238099413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 39.1"	"Group enriched"	"Detected in many"	13	"Early spermatids: 90.6;Late spermatids: 156.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020190, HPA055760"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA		300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA020190: , HPA055760: AB_2682910"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (8.65e-5)"	"unprognostic (8.96e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.73e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.98e-1)"	5.1	4.3	7.2	5.3	9.4	5.0	4.9	9.4	9.3	6.8	6.4	7.3	8.5	8.1	5.6	5.9	6.3	3.8	8.1	6.8	8.2	12.9	39.1	4.7	5.7	9.2	8.8	6.3	22.8	6.1	5.0	2.0	9.4	5.9	3.2	4.6	4.4	4.1	6.4	3.5	8.6	3.9	7.3	7.2	5.8	16.8	8.3	5.9	7.2	3.5	4.3	7.8	5.1	10.4	11.1	19.1	11.9	31.1	9.0	6.4	23.2	11.2	5.6	11.3	14.3	11.6	8.0	18.9	3.3	5.9	35.4	16.4	44.1	21.5	10.9	21.2	41.8	21.1	24.0	37.6	16.7	17.6	18.2	7.1	11.6	21.3	22.0	5.1	21.0	26.1	38.0	5.1	11.7	16.9	17.9	33.0	36.4	16.0	15.6	22.0	23.3	18.2	11.3	3.6	13.1	28.9	12.0	19.4	20.6	8.2	6.3	26.5	8.5	16.3	11.8	24.2	23.7	14.2	13.3	9.3	11.3	37.0	14.4	1.1	3.2	4.0	2.6	2.3	2.0	2.6	3.1	4.4	3.3	1.6	2.3	2.6	0.5	2.9	3.5	0.6	3.2	2.8	7.2	9.4	9.4	9.3	6.8	8.2	9.2	8.8	9.4	7.3	8.3	10.4	2.2	0.0	0.0	0.0	4.6	1.7	2.4	1.9	5.7	5.4	1.7	1.9	2.6	1.5	1.2	0.0	8.4	1.4	3.4	1.9	3.9	5.3	90.6	1.7	3.4	2.4	2.4	9.4	0.0	3.7	2.1	1.9	5.1	2.6	0.0	3.5	1.8	3.3	4.0	6.7	0.0	3.3	8.2	0.9	3.2	156.3	3.1	2.1	1.8	0.0	2.7	2.6	2.1	0.0	0.0	3.0	5.0	0.0	4.9	1.9	3.9	2.7	1.9	6.9	0.0	1.9	3.2	6.2	5.6	3.4	1.6	0.7	4.4	2.2	4.8	1.8
SCMH1	Scml3	ENSG00000010803	"Scm polycomb group protein homolog 1"	Q96GD3	1	41027200-41242154	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 125.4;Excitatory neurons: 161.3;Inhibitory neurons: 213.0;Microglial cells: 102.1;Oligodendrocyte precursor cells: 154.3;Oligodendrocytes: 77.9;Spermatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048898, HPA053292"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA048898: , HPA053292: AB_2797246"	"unprognostic (6.02e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (5.80e-4)"	22.0	24.0	15.2	11.3	15.9	17.8	23.2	16.5	18.1	32.0	18.6	54.6	12.7	35.4	20.5	14.0	33.1	15.8	39.3	16.1	16.9	29.8	19.7	20.6	10.4	13.6	14.7	36.3	40.1	34.7	27.6	11.0	13.1	40.4	17.0	21.0	27.5	30.7	44.9	13.3	23.4	24.6	12.2	15.5	32.5	32.8	16.7	16.6	24.1	34.2	10.5	38.9	21.3	14.1	19.5	12.8	29.9	27.5	13.4	25.4	0.1	15.4	26.7	25.2	26.0	12.3	24.6	35.4	11.4	28.1	21.1	4.8	23.3	20.6	21.6	24.7	17.8	16.6	17.7	31.2	58.2	35.7	26.2	27.7	20.5	16.7	40.2	30.5	25.7	43.3	15.7	26.8	25.0	10.6	36.0	30.8	27.7	16.4	13.5	39.3	31.3	21.0	20.4	24.1	21.0	22.5	26.7	21.1	22.1	20.2	18.8	90.7	19.0	26.3	20.4	16.4	28.5	27.1	16.2	38.6	16.5	31.5	24.4	0.6	0.6	1.2	1.6	1.1	2.0	2.4	1.9	1.5	1.9	1.1	1.3	1.1	0.0	1.6	0.2	3.9	1.4	0.9	15.2	15.9	16.5	18.1	16.1	16.9	13.6	14.7	13.1	12.2	16.7	14.1	7.1	9.6	10.8	125.4	9.4	6.6	25.8	11.5	26.7	17.0	16.4	17.0	14.9	18.6	7.4	12.9	16.7	7.3	10.8	7.2	1.9	11.4	9.4	7.2	13.8	9.6	8.4	16.0	161.3	21.3	3.3	11.4	15.3	13.1	5.1	11.9	8.9	7.3	6.2	8.4	213.0	7.4	8.2	3.3	6.5	12.4	16.4	3.2	8.8	102.1	2.7	6.9	2.1	154.3	77.9	12.4	6.2	18.0	20.2	23.3	10.4	18.1	5.8	14.2	19.7	11.9	10.3	54.3	26.1	6.1	3.7	4.8	7.4	3.5	12.4	14.5
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 6.1;Hep G2: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	0.0	0.0	4.2	0.0	4.2	0.0	0.0	2.1	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.1	6.9	0.0	0.0	1.4	0.0	14.2	6.2	0.0	0.0	0.0	2.0	0.0	18.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	2.1	24.7	2.1	6.9	14.2	6.2	18.5	2.2	10.9	10.9	0.0	6.4	33.9	27.4	0.0	0.0	0.0	0.0	0.0	47.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.3	1.8	0.0	409.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	494.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	18.7	0.0	2.8	0.0	692.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SCN3B	HSA243396	ENSG00000166257	"Sodium voltage-gated channel beta subunit 3"	Q9NY72	11	123629187-123655244	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.2;pituitary gland: 28.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 31.6;Excitatory neurons: 58.8;Horizontal cells: 20.2;Inhibitory neurons: 35.7;Late spermatids: 31.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Group enriched"	"Detected in many"	8	"amygdala: 34.3;basal ganglia: 40.6;cerebral cortex: 49.7;hippocampal formation: 54.2;white matter: 15.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;GAMG: 1.8;hTCEpi: 5.8;RH-30: 2.0;SCLC-21H: 5.5;SH-SY5Y: 4.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"hippocampal formation: 166.1"	HPA041707			Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Intermediate filaments"	Cytosol	"HPA041707: AB_2732493"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.13e-4)"	"unprognostic (3.93e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.29e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.34e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.16e-4)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.43e-2)"	1.9	8.4	34.3	0.6	40.6	0.4	1.8	0.0	49.7	1.0	0.0	1.4	0.8	1.5	0.7	0.7	1.2	0.5	1.4	54.2	2.4	1.4	0.1	1.0	0.3	0.0	4.7	1.0	1.1	4.4	28.0	0.1	0.5	0.8	0.8	10.0	0.7	0.5	14.1	1.5	1.3	1.4	0.9	0.5	0.7	2.2	0.9	0.2	4.1	3.3	0.2	0.8	1.0	15.3	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.1	1.8	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	5.8	0.1	0.1	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.0	0.0	0.0	0.1	5.5	4.5	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	34.3	40.6	0.0	49.7	54.2	2.4	0.0	4.7	0.5	0.9	0.9	15.3	7.7	0.0	0.5	3.9	0.0	5.7	1.1	0.0	1.2	31.6	1.3	1.0	2.1	0.0	0.0	1.8	6.2	0.1	0.0	0.3	0.0	0.3	13.9	0.2	0.3	13.0	4.2	0.0	58.8	1.0	0.1	1.5	0.0	0.2	0.0	1.4	5.3	0.0	0.2	20.2	35.7	0.0	0.0	0.0	2.3	31.3	0.0	0.4	0.0	5.6	0.0	6.3	1.0	4.5	2.5	0.3	0.0	0.4	0.0	1.0	0.1	0.5	0.0	6.0	6.6	5.7	0.8	1.0	2.0	0.4	5.5	0.0	0.1	1.4	0.1	0.5
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 35.0"	"Group enriched"	"Detected in many"	8	"Excitatory neurons: 336.7;Inhibitory neurons: 280.1;Oligodendrocyte precursor cells: 104.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 35.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.7;ASC TERT1: 13.5;WM-115: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	0.2	1.0	5.6	0.4	8.9	0.7	0.5	2.5	35.0	0.4	0.0	0.7	0.2	0.4	0.7	0.1	0.2	0.9	0.1	11.4	0.2	0.9	2.6	0.1	0.4	4.2	0.0	0.5	1.6	0.5	6.7	0.1	3.8	0.6	0.9	7.9	0.6	0.2	0.3	0.3	0.2	0.1	0.0	0.6	1.0	1.7	2.4	0.5	0.5	0.1	0.2	0.2	0.2	11.5	1.7	1.3	13.7	0.2	1.8	13.5	0.3	8.0	12.5	9.1	8.5	2.8	1.6	0.4	1.9	9.9	4.4	0.1	2.3	0.0	10.5	1.6	0.8	0.1	0.3	0.3	0.1	0.2	1.1	1.8	0.0	6.5	1.4	3.4	9.8	3.5	0.2	0.2	5.5	1.0	2.5	0.2	4.9	0.9	4.8	0.1	0.7	0.0	0.0	0.5	5.6	2.2	4.5	2.1	0.3	2.1	0.4	0.2	2.8	8.9	6.3	3.3	5.2	0.2	0.1	0.0	1.8	1.9	13.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	5.6	8.9	2.5	35.0	11.4	0.2	4.2	0.0	3.8	0.0	2.4	11.5	1.2	0.0	0.0	27.1	0.0	0.0	0.5	0.0	3.4	16.7	2.6	1.8	1.4	1.5	0.0	0.0	10.4	0.0	0.3	1.0	0.0	0.5	0.6	0.0	0.7	1.3	11.4	0.0	336.7	0.5	0.0	0.1	3.1	0.0	0.0	0.7	1.1	4.3	0.0	5.0	280.1	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	20.6	0.0	4.7	0.0	104.5	14.2	0.7	0.5	0.7	0.0	0.4	0.0	0.7	0.0	11.2	0.0	0.4	0.3	3.8	10.2	0.1	0.0	0.0	0.3	0.0	0.9	0.3
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 21.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 43.2;Hofbauer cells: 67.5;Inhibitory neurons: 48.2;Langerhans cells: 42.8;Oligodendrocyte precursor cells: 133.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.6"	"Cell line enhanced"	"Detected in many"		"BJ: 23.0;BJ hTERT+: 16.8;HHSteC: 19.0;hTERT-RPE1: 15.6"	"Region enriched"	"Detected in many"	5	"hypothalamus: 9.3"	"Low region specificity"	"Detected in many"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	1.7	1.7	5.3	0.9	4.2	2.0	0.6	0.1	3.4	0.6	0.0	3.2	0.5	0.2	0.1	0.5	0.4	1.2	0.4	2.9	21.9	1.7	3.9	2.0	0.6	8.2	19.4	0.3	2.0	0.1	1.5	4.3	12.0	0.3	3.1	0.7	0.4	0.4	0.2	0.7	1.8	2.4	2.2	3.1	0.4	5.1	18.2	1.6	0.3	0.6	0.4	0.5	0.5	1.7	0.0	2.5	0.1	0.0	9.6	7.9	0.0	23.0	16.8	5.2	1.7	0.5	0.1	0.0	0.0	2.8	0.2	0.1	6.5	0.6	8.6	0.0	2.1	1.7	1.8	1.9	19.0	0.1	0.0	0.6	0.2	9.1	1.7	15.6	1.1	1.2	6.1	6.6	0.8	0.0	3.6	0.0	1.9	0.1	0.6	0.8	3.3	9.0	2.4	9.5	1.0	9.5	0.0	0.1	0.3	4.8	0.3	0.0	0.1	0.0	1.5	0.1	0.4	0.1	0.1	0.0	3.2	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.5	0.1	23.6	0.0	0.1	5.3	4.2	0.1	3.4	2.9	21.9	8.2	19.4	12.0	2.2	18.2	1.7	0.9	12.8	23.8	0.7	1.3	1.0	0.4	0.5	0.6	0.6	0.8	0.9	2.5	8.6	4.4	5.5	0.0	0.3	43.2	9.0	3.9	23.4	2.5	0.1	0.1	5.7	33.0	4.2	15.8	31.5	0.3	2.0	0.0	0.1	3.8	18.1	13.6	9.5	67.5	0.0	48.2	19.3	10.2	1.9	42.8	3.2	1.2	11.3	3.6	2.8	1.0	2.3	0.0	133.7	0.4	12.7	7.8	0.0	1.2	0.3	14.7	11.5	2.2	0.2	0.0	7.8	1.6	1.3	0.4	0.5	0.4	1.1	0.9	4.4	12.9	0.2
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927276-53051698	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1116.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1240.7;Proximal enterocytes: 769.0;Proximal tubular cells: 881.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	203.7	125.5	68.5	92.7	71.6	111.2	196.6	74.2	90.1	153.8	79.2	256.7	336.3	94.6	165.5	140.2	119.7	144.6	162.4	65.8	76.1	319.8	1116.8	140.6	106.0	75.4	72.3	94.5	119.2	130.9	64.7	79.0	77.9	150.9	270.5	76.6	114.0	97.3	142.0	130.6	305.7	112.9	75.6	83.9	234.4	63.4	74.7	131.9	140.9	152.8	125.5	139.2	76.9	78.9	120.6	64.8	85.5	157.9	273.6	232.6	92.7	140.0	208.9	90.1	129.2	58.7	127.5	114.7	147.6	206.6	105.3	82.5	59.6	131.0	136.5	168.2	86.4	123.4	88.8	122.1	182.0	179.9	197.5	190.2	175.0	107.1	52.9	196.2	260.0	132.6	111.5	58.2	184.7	70.1	200.7	155.2	94.6	304.4	126.0	101.9	150.9	158.3	252.2	192.2	70.9	85.3	122.0	246.3	121.6	189.6	125.9	201.4	203.8	122.4	63.4	213.2	114.9	95.9	131.0	134.2	159.0	175.7	113.8	285.6	193.7	286.0	185.9	208.8	152.1	150.8	144.9	184.6	230.5	132.6	120.8	171.4	29.4	176.8	204.2	150.9	195.2	289.5	68.5	71.6	74.2	90.1	65.8	76.1	75.4	72.3	77.9	75.6	74.7	78.9	167.0	134.6	198.4	52.2	91.1	150.4	123.8	222.2	110.4	37.5	189.8	86.0	157.4	258.7	166.2	185.8	31.3	182.7	128.3	512.7	473.5	168.1	57.4	150.4	81.6	126.8	235.1	93.4	45.0	162.4	156.5	124.3	180.4	125.3	138.4	54.0	146.7	1240.7	203.5	42.1	54.4	462.7	250.3	230.1	173.1	51.4	184.2	148.8	192.1	42.2	154.6	132.0	181.3	48.2	44.3	157.4	503.4	171.9	76.6	118.1	769.0	881.0	178.2	34.1	78.9	72.0	110.6	20.4	19.4	150.0	170.8	133.9	132.9	110.3	336.4	187.8
SCRN1	KIAA0193	ENSG00000136193	"Secernin 1"	Q12765	7	29920104-29990289	"Enzymes, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 159.0"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 326.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024517	Enhanced		Approved	Cytosol		No	No		160000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA024517: AB_2184811"	"prognostic unfavorable (8.32e-4)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (2.60e-4)"	13.9	27.9	112.4	13.1	118.9	8.1	14.3	128.2	117.9	22.2	52.2	27.5	6.5	27.4	16.2	19.0	26.0	16.5	19.8	112.5	129.0	23.7	2.6	16.4	14.3	112.5	159.0	32.4	36.7	54.5	34.0	15.8	115.5	27.9	10.4	102.5	18.0	37.2	2.4	11.1	15.8	34.3	116.1	10.8	19.3	23.0	122.5	28.9	13.5	11.0	21.6	22.0	17.8	127.1	106.3	75.0	119.9	48.6	83.1	126.9	0.5	97.0	128.8	102.5	110.0	87.1	81.8	13.0	83.7	124.7	227.3	46.7	137.7	41.2	148.9	0.6	29.0	43.8	49.7	56.6	105.9	0.3	0.5	106.5	58.1	93.5	49.6	139.4	95.9	28.0	0.5	33.3	146.6	59.5	15.5	0.1	109.4	0.2	79.6	0.3	127.7	1.1	71.7	51.5	43.7	103.1	99.9	64.1	112.5	149.7	86.3	6.9	106.7	132.2	113.3	1.7	123.7	10.8	177.0	1.1	62.4	0.5	326.5	3.7	3.4	10.3	0.9	14.1	10.7	14.0	0.2	1.0	10.9	7.6	0.7	1.4	0.5	7.1	25.4	10.8	0.0	3.5	112.4	118.9	128.2	117.9	112.5	129.0	112.5	159.0	115.5	116.1	122.5	127.1	5.9	28.9	14.1	42.7	15.4	3.1	12.6	14.0	14.2	66.9	7.6	5.2	15.8	20.0	22.3	33.1	45.9	0.4	16.2	1.1	15.6	24.1	61.1	7.3	11.9	10.9	12.1	2.5	52.0	25.1	1.9	17.2	5.6	6.7	8.2	22.9	1.8	0.3	5.4	69.0	51.4	0.7	14.2	8.8	13.9	68.1	13.7	11.1	7.2	16.9	11.5	80.8	12.3	31.2	35.6	21.2	17.3	21.1	12.5	17.4	0.1	2.8	29.2	41.1	6.6	9.6	11.9	3.1	11.0	5.1	1.7	1.0	2.8	8.5	1.2	22.3
SDC3	"N-syndecan, SYND3"	ENSG00000162512	"Syndecan 3"	O75056	1	30869466-30908758	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 140.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.6;Endometrial stromal cells: 59.8;Kupffer cells: 174.8;Late spermatids: 82.4;Oligodendrocyte precursor cells: 108.6"	"Group enriched"	"Detected in all"	5	"glioma: 115.2;melanoma: 102.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 249.5;WM-115: 342.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017087, CAB025786, HPA048085"	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256"	"unprognostic (1.42e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.83e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (9.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (6.45e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.46e-1)"	33.9	99.1	103.9	22.9	123.9	3.0	17.9	97.0	105.4	36.5	38.1	57.3	12.3	62.3	12.3	17.6	29.8	30.0	22.7	91.6	111.1	10.4	22.3	22.5	36.4	140.3	121.2	9.3	7.5	13.2	11.8	18.1	107.9	26.9	14.6	27.2	15.9	52.7	27.1	10.1	16.5	66.2	112.4	91.0	19.7	3.3	124.4	6.4	9.8	9.1	7.6	32.7	13.4	91.9	12.9	10.4	80.4	36.5	60.6	14.8	13.8	31.4	48.0	15.0	9.5	2.0	12.3	0.9	68.6	95.3	21.8	16.3	8.7	7.6	10.0	5.7	6.3	0.0	4.1	1.8	56.9	0.3	8.2	35.4	35.9	1.0	15.4	86.6	20.1	3.6	6.2	0.5	30.6	15.0	0.3	0.2	36.4	10.2	9.4	0.8	75.2	2.8	19.7	14.9	28.9	17.5	40.3	5.7	249.5	50.8	5.7	6.1	19.3	18.6	28.2	2.0	7.5	0.1	0.5	0.9	1.9	0.2	342.9	1.1	0.3	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.4	0.2	0.2	0.2	103.9	123.9	97.0	105.4	91.6	111.1	140.3	121.2	107.9	112.4	124.4	91.9	37.3	0.0	2.2	64.6	0.5	2.5	3.4	4.7	4.0	9.6	14.9	25.5	4.9	14.3	2.6	47.8	0.0	2.1	0.2	0.8	0.0	10.7	17.7	14.1	59.8	17.9	3.0	0.0	14.7	3.1	3.4	16.6	3.1	28.6	0.0	17.5	20.3	1.0	14.3	0.0	13.9	1.1	6.1	174.8	3.1	82.4	2.1	24.4	19.6	18.7	4.0	2.5	1.0	108.6	6.8	6.0	1.3	7.9	1.5	8.5	0.0	0.6	0.4	27.8	0.0	1.1	9.1	0.7	0.4	1.3	2.3	3.6	2.3	15.4	1.6	5.7
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329139	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 141.8;intestine: 136.9;stomach 1: 101.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 782.5;Pancreatic endocrine cells: 755.4;Paneth cells: 948.5;Proximal enterocytes: 470.3;Urothelial cells: 641.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.6;OE19: 57.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005804, HPA064490"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA005804: , HPA064490: AB_2732713"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.37e-4)"	7.3	3.4	19.9	10.1	20.7	0.7	6.9	16.3	24.3	25.8	15.2	85.8	136.9	5.7	9.0	141.8	4.3	41.8	4.6	19.6	20.2	16.0	18.1	20.9	1.3	17.2	17.9	3.5	15.2	2.5	3.9	3.3	17.4	6.5	55.5	1.0	29.8	2.5	2.8	62.9	133.0	3.6	16.9	3.1	101.8	5.6	20.3	1.5	14.6	1.4	13.7	38.2	49.9	18.0	10.9	0.5	1.4	0.5	5.8	5.1	0.9	3.2	6.3	2.8	2.7	2.3	18.6	1.1	2.1	1.2	2.0	8.2	0.5	15.5	1.4	0.4	1.0	0.9	0.6	1.5	5.8	1.1	1.2	1.8	10.8	2.2	2.2	6.0	9.6	2.0	1.5	0.7	1.1	2.6	1.7	3.0	1.3	57.3	0.7	1.6	0.7	2.2	1.2	14.4	2.4	1.9	1.5	9.3	3.6	0.6	0.4	0.9	6.5	1.5	0.6	2.8	1.2	2.8	2.7	1.1	0.7	4.1	0.9	0.1	0.8	1.9	0.9	0.3	0.7	0.2	1.2	0.9	1.0	0.4	1.0	1.8	0.8	0.9	0.6	0.7	2.3	0.7	19.9	20.7	16.3	24.3	19.6	20.2	17.2	17.9	17.4	16.9	20.3	18.0	15.6	16.0	4.2	0.0	4.1	55.7	112.0	198.1	3.4	1.0	4.9	4.8	0.8	72.9	172.6	16.5	0.0	1.8	1.0	782.5	27.4	114.5	17.1	25.8	11.7	14.1	35.9	0.0	0.0	209.7	1.1	4.6	201.8	85.4	8.9	1.0	7.1	5.1	0.9	1.7	0.0	150.8	156.6	1.9	6.4	1.9	1.5	1.8	8.8	0.0	2.3	1.0	2.1	0.0	0.0	755.4	948.5	0.0	0.7	107.0	470.3	1.8	89.6	0.9	0.0	1.7	9.9	5.0	7.6	31.1	95.6	1.6	3.5	2.0	109.2	641.9
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-257082	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 601.0;skeletal muscle: 479.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		360000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	70.6	148.0	60.5	29.6	62.7	38.4	65.8	78.7	71.3	50.2	63.2	131.9	148.9	53.2	27.3	67.1	50.3	33.9	601.0	60.8	73.4	139.1	276.8	54.3	43.1	74.1	62.7	65.8	71.5	122.9	44.8	28.8	75.7	46.3	82.1	42.7	66.8	35.6	479.0	58.9	116.8	36.1	61.7	66.4	115.6	56.4	71.7	41.8	49.6	224.8	36.5	63.2	56.3	63.7	88.4	154.2	54.8	95.0	96.9	68.5	154.1	63.3	81.8	107.2	108.4	163.9	115.9	108.3	218.6	70.2	92.1	111.8	102.4	129.7	66.3	241.9	98.9	50.1	390.8	224.1	60.0	69.5	70.7	70.6	84.3	83.6	33.7	93.6	123.9	83.5	84.6	83.1	48.7	155.8	93.9	206.9	19.3	101.4	193.5	119.0	84.6	223.2	245.4	122.7	62.3	35.4	332.5	205.5	90.7	36.1	115.0	93.2	91.1	80.3	82.1	48.2	52.5	93.0	40.9	79.8	81.6	99.9	52.5	66.6	70.8	88.1	95.2	85.7	86.8	79.5	92.5	94.5	93.3	73.3	89.2	85.0	14.1	85.5	74.7	59.5	149.3	111.3	60.5	62.7	78.7	71.3	60.8	73.4	74.1	62.7	75.7	61.7	71.7	63.7	29.4	35.3	71.1	20.2	50.9	61.2	81.4	105.8	31.3	51.0	24.6	17.0	272.6	64.3	78.5	75.4	102.2	109.6	39.3	169.7	142.8	94.7	58.7	39.1	30.1	39.1	47.5	56.8	34.4	44.9	102.8	49.4	47.9	48.5	43.7	64.8	47.5	167.0	67.5	101.0	39.9	96.3	105.8	41.0	55.0	28.8	68.3	38.8	90.7	12.2	60.2	50.7	52.5	19.1	37.9	54.2	100.1	55.7	67.5	37.0	274.4	190.7	75.2	87.2	78.9	33.2	51.7	96.9	54.3	40.9	35.9	154.7	56.7	85.0	160.1	88.2
SDHAF1	LYRM8	ENSG00000205138	"Succinate dehydrogenase complex assembly factor 1"	A6NFY7	19	35995188-35996312	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA064277, HPA074563"			Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA064277: AB_2685231, HPA074563: "	"unprognostic (2.01e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.47e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.59e-2)"	15.4	16.2	13.7	6.3	15.2	4.2	16.1	17.8	15.5	19.1	13.3	21.5	13.6	16.3	6.1	16.3	17.0	4.8	15.0	14.1	14.4	18.5	32.7	12.8	9.5	16.0	14.4	15.0	24.7	9.6	20.1	5.5	16.3	16.5	5.0	6.8	16.9	6.6	19.0	18.3	18.9	3.0	15.4	19.1	18.9	9.9	14.5	8.5	16.4	7.6	6.0	18.7	16.6	18.4	9.6	24.7	7.2	16.7	6.9	8.7	12.5	9.2	9.8	9.8	11.3	17.8	7.1	17.8	17.3	6.1	6.7	9.5	9.5	5.1	4.7	33.6	22.3	7.9	10.7	23.6	8.4	9.5	12.5	7.7	16.4	6.0	6.4	3.9	5.5	18.5	24.6	18.9	4.3	23.5	18.2	18.6	11.2	31.4	11.8	19.6	8.0	20.3	9.7	12.2	28.2	21.1	14.8	23.9	16.5	5.9	13.7	15.9	7.3	11.2	16.8	10.7	14.2	25.4	12.6	21.0	9.8	18.1	10.1	45.6	34.0	55.2	40.3	40.7	43.8	43.0	43.4	39.5	35.8	46.5	47.8	40.5	19.2	57.7	45.7	45.0	49.6	32.1	13.7	15.2	17.8	15.5	14.1	14.4	16.0	14.4	16.3	15.4	14.5	18.4	18.7	6.4	4.1	4.6	24.6	30.0	11.4	9.7	14.2	20.9	27.1	26.4	9.5	17.2	5.9	18.4	6.2	25.1	19.9	21.7	27.4	21.9	25.0	7.9	15.8	16.9	28.8	8.8	4.0	29.6	37.7	20.0	16.3	7.3	4.5	17.3	19.6	19.9	22.7	18.5	4.6	32.7	10.2	19.6	18.5	6.5	23.0	12.1	24.9	3.7	28.2	16.6	32.0	3.0	8.1	22.9	37.2	29.3	16.8	23.1	54.1	32.8	3.3	14.8	26.3	10.9	13.8	10.5	13.9	16.1	41.6	23.1	20.1	25.4	32.0	16.4
SDHAF4	"C6orf57, Sdh8"	ENSG00000154079	"Succinate dehydrogenase complex assembly factor 4"	Q5VUM1	6	70566917-70589569	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031824	Supported		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA031824: AB_10602113"	"unprognostic (8.72e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (2.45e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.94e-2)"	11.2	12.3	7.1	4.2	7.5	4.3	10.5	6.8	10.5	6.6	7.3	6.8	5.0	5.8	9.3	7.5	10.3	4.2	14.5	7.6	9.4	12.5	8.5	5.4	6.0	6.9	6.3	6.4	6.6	14.4	12.7	6.8	7.3	7.6	6.7	10.0	8.7	5.4	23.6	8.6	5.4	4.2	5.8	5.6	7.0	5.3	7.8	6.4	7.3	10.6	5.2	6.8	6.7	7.6	13.3	4.2	18.8	11.6	9.0	13.6	3.5	7.1	5.1	3.4	5.0	3.8	11.3	9.1	12.7	3.8	8.0	2.3	6.2	5.9	5.2	18.3	4.3	6.6	1.8	3.9	15.3	6.3	5.1	9.6	19.3	2.6	14.8	11.6	8.0	14.8	4.2	13.9	11.0	9.0	5.9	15.7	8.8	6.5	4.5	6.4	12.6	10.8	14.9	4.4	16.8	12.1	4.3	2.1	9.6	8.0	9.6	16.5	6.3	3.5	2.7	2.8	7.7	6.2	4.5	3.1	3.9	15.1	8.5	4.0	4.6	4.4	3.4	4.3	3.3	3.7	3.7	4.1	5.1	4.7	3.9	3.8	3.3	4.7	4.6	6.2	4.2	3.0	7.1	7.5	6.8	10.5	7.6	9.4	6.9	6.3	7.3	5.8	7.8	7.6	5.4	12.8	13.9	4.9	3.3	0.0	7.9	0.0	3.4	7.4	6.5	7.5	21.3	10.0	5.6	7.3	8.4	10.5	5.0	2.9	23.5	9.1	5.5	20.2	8.2	5.0	3.6	2.5	7.7	11.6	8.5	6.6	2.6	6.0	5.1	6.1	4.2	11.8	10.0	18.5	7.5	5.8	0.0	5.3	0.0	2.5	12.5	6.2	0.0	2.8	10.1	10.1	3.1	12.1	7.7	13.2	5.3	6.8	2.2	9.5	6.2	16.8	13.8	6.4	13.1	5.1	4.9	10.0	6.1	5.7	0.0	5.1	3.9	6.1	5.3	8.0
SDSL	"cSDH, SDS-RS1"	ENSG00000139410	"Serine dehydratase like"	Q96GA7	12	113422380-113438276	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 78.2;Hepatocytes: 116.7;Hofbauer cells: 95.7;monocytes: 103.1;Proximal tubular cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 8.7;intermediate monocyte: 10.0;myeloid DC: 18.5;plasmacytoid DC: 17.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 18.5;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 51.4;MCF7: 90.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005740	Approved		Approved	Cytosol		NA	NA		48000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA005740: AB_10601486"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (8.58e-4)"	"unprognostic (2.93e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.33e-2)"	4.5	33.1	12.7	7.1	14.2	3.2	4.9	16.4	15.2	4.6	10.8	12.2	16.8	4.8	9.9	2.5	7.9	7.7	12.8	11.8	16.1	34.9	104.6	5.7	3.4	18.7	16.2	4.6	18.7	12.4	15.5	4.4	16.0	8.5	8.5	2.4	4.8	6.6	3.0	1.3	12.2	5.2	15.8	5.8	9.1	10.6	16.4	1.5	23.9	1.3	1.7	6.2	1.4	17.4	8.5	33.3	4.7	14.1	0.9	1.9	3.2	4.8	1.2	5.2	4.4	14.1	8.7	0.4	24.2	8.1	14.4	8.6	2.2	11.4	1.7	20.5	8.4	22.1	8.5	6.3	27.5	2.8	51.4	4.4	16.0	12.8	18.8	5.9	8.0	0.0	17.3	6.6	6.5	90.2	0.1	10.2	4.6	9.6	14.6	0.0	7.0	16.5	13.6	10.6	1.5	0.5	20.6	23.6	18.4	4.2	28.6	24.8	7.2	6.2	11.9	26.9	4.2	1.4	1.4	0.3	26.3	8.4	7.8	0.2	8.7	0.0	0.0	10.0	0.0	2.2	0.0	0.0	18.5	0.1	0.0	0.0	0.4	1.8	1.3	17.8	0.3	2.5	12.7	14.2	16.4	15.2	11.8	16.1	18.7	16.2	16.0	15.8	16.4	17.4	1.2	0.0	5.1	2.0	3.1	0.9	2.2	7.0	0.0	0.5	15.3	10.2	18.2	27.1	6.3	29.5	2.1	16.3	4.9	43.7	78.2	36.1	0.5	14.8	7.7	4.0	31.8	10.1	1.3	20.1	3.0	4.5	12.8	10.1	43.8	15.3	6.4	116.7	95.7	3.3	0.6	36.4	4.1	18.1	8.4	1.5	2.8	36.9	3.6	1.9	103.1	33.5	0.0	1.5	2.0	16.2	63.2	5.7	0.0	6.1	63.2	115.7	3.8	2.6	0.0	0.2	7.3	0.2	0.4	1.1	0.6	7.3	1.9	29.5	31.0	5.9
SEC11A	"SEC11L1, sid2895, SPC18, SPCS4A"	ENSG00000140612	"SEC11 homolog A, signal peptidase complex subunit"	P67812	15	84669538-84716460	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047533			Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane"	"Golgi apparatus"	"HPA047533: AB_2680078"	"unprognostic (8.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.19e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.99e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.89e-2)"	142.9	138.1	66.2	83.4	69.4	172.2	136.2	69.0	80.4	147.1	76.6	110.8	82.9	111.0	202.5	81.6	103.6	97.5	98.4	63.7	72.6	137.2	152.3	107.9	112.6	74.1	67.2	168.6	139.4	114.6	84.5	115.1	73.9	82.0	124.9	37.0	95.9	87.5	154.3	70.5	86.4	96.3	72.4	86.2	95.3	61.5	69.4	93.2	177.5	147.4	98.2	137.3	94.0	75.3	201.7	320.7	286.7	425.4	368.5	462.8	225.4	310.1	356.5	241.9	291.2	347.1	443.0	99.0	198.8	370.3	277.2	408.3	409.1	243.4	255.5	267.1	239.4	279.4	358.8	324.9	311.7	213.4	281.2	315.8	305.0	169.1	285.1	366.0	337.9	116.7	295.8	244.3	315.1	363.1	89.2	345.8	282.1	266.2	135.4	101.6	368.4	302.9	472.6	424.4	131.2	300.8	257.3	239.5	598.5	407.0	248.5	416.6	254.3	240.0	181.0	209.8	361.9	224.4	509.6	150.0	226.4	331.7	180.6	83.5	161.1	89.7	95.1	173.7	95.0	101.0	114.8	104.7	165.8	90.0	95.1	98.0	111.6	134.3	184.8	160.9	168.8	200.8	66.2	69.4	69.0	80.4	63.7	72.6	74.1	67.2	73.9	72.4	69.4	75.3	261.1	89.8	99.1	25.8	131.8	107.1	179.4	356.6	90.5	30.0	163.7	202.6	68.2	228.8	188.0	128.8	22.9	309.1	171.9	111.1	238.7	258.8	46.3	118.5	268.0	217.2	157.4	101.7	21.2	247.3	655.3	206.0	120.8	184.1	218.4	191.0	197.7	165.5	363.3	20.2	22.8	218.7	168.9	386.7	337.2	100.6	299.5	337.3	158.3	24.4	396.7	110.5	204.9	26.7	38.3	183.4	136.3	166.3	197.9	185.7	142.7	350.9	99.3	38.2	170.9	173.5	225.5	233.5	169.6	135.2	119.9	305.8	153.4	237.6	210.7	242.2
SEC11C	"SEC11L3, SPC21, SPCS4C"	ENSG00000166562	"SEC11 homolog C, signal peptidase complex subunit"	Q9BY50	18	59139866-59158832	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 685.6;Muller glia cells: 544.7;Plasma cells: 1164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 523.5;Karpas-707: 546.2;RPMI-8226: 1150.0;U-266/70: 587.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026816, HPA047533"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Golgi apparatus"	"HPA026816: AB_10602089, HPA047533: AB_2680078"	"unprognostic (1.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.15e-1)"	24.6	76.7	110.0	86.5	117.5	63.1	81.8	122.9	140.5	57.8	94.4	92.3	126.7	40.1	284.6	42.5	41.4	47.3	30.0	112.9	146.4	70.2	219.0	62.7	104.2	137.3	130.2	29.9	374.0	153.9	155.2	28.4	136.8	225.7	78.2	108.1	397.3	62.3	15.7	29.7	97.8	30.1	123.7	81.4	138.5	28.1	113.5	53.0	163.7	20.0	117.8	59.4	21.2	135.8	82.4	100.0	52.9	74.1	31.9	6.8	64.7	72.4	62.9	89.9	55.2	78.3	42.5	176.8	109.9	46.6	67.6	82.8	84.7	59.0	58.4	523.5	113.8	58.5	69.3	242.3	99.3	199.4	87.6	20.4	140.7	56.2	161.1	20.2	33.7	78.4	67.4	546.2	34.6	100.0	79.0	79.2	48.1	140.4	60.5	72.8	50.0	1150.0	67.5	76.1	223.2	90.5	43.1	162.5	252.8	29.9	76.0	148.5	24.7	98.5	45.4	36.5	86.9	587.3	434.4	176.0	99.4	131.8	124.5	76.4	70.7	57.9	146.1	97.6	187.6	197.8	150.4	142.5	78.8	127.9	77.7	105.4	12.2	108.3	108.8	299.6	223.7	222.1	110.0	117.5	122.9	140.5	112.9	146.4	137.3	130.2	136.8	123.7	113.5	135.8	64.8	28.9	120.7	19.2	295.9	32.6	49.3	92.4	12.5	63.6	120.0	128.3	59.3	144.4	102.5	60.7	50.1	70.8	148.7	76.3	88.0	164.4	45.4	58.7	34.2	60.3	339.3	43.8	12.2	263.1	109.1	29.2	60.6	147.1	47.5	21.5	56.4	224.7	112.9	50.5	13.3	223.1	685.6	37.1	56.9	18.8	12.5	63.9	256.1	10.3	46.4	544.7	96.8	17.1	31.2	148.9	78.4	23.0	1164.8	380.9	99.3	118.8	81.3	89.3	6.6	23.1	70.6	110.2	81.5	35.5	45.5	149.7	92.3	40.1	88.3	79.2
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747433-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 128.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 114.7;Oligodendrocyte precursor cells: 128.7;Plasma cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 82.1"	"Group enriched"	"Detected in many"	4	"memory B-cell: 42.0;naive B-cell: 41.8;plasmacytoid DC: 38.2"	"Group enriched"	"Detected in many"	4	"B-cells: 42.0;dendritic cells: 38.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 287.9;OE19: 217.9;U-698: 187.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 100.4"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	9.3	5.5	8.7	61.5	11.3	13.6	9.3	82.1	11.1	54.0	8.7	72.1	82.0	7.9	68.8	8.7	11.0	53.6	5.3	12.5	4.2	14.5	11.6	40.7	124.8	2.8	5.2	5.6	48.5	45.5	3.7	37.5	4.7	18.9	68.8	35.2	38.3	4.0	2.9	2.9	72.4	7.8	2.9	63.2	104.8	6.6	8.2	18.7	10.9	2.8	128.3	42.4	2.2	5.9	21.5	23.0	16.7	5.6	2.7	3.3	2.6	10.4	28.3	7.9	25.2	14.6	97.0	287.9	48.9	72.0	66.7	13.3	12.4	45.1	10.6	15.7	7.2	3.3	35.4	19.6	70.0	40.1	2.0	5.7	35.8	27.8	10.9	31.3	105.7	5.8	19.3	0.3	5.6	16.2	0.1	2.8	48.2	217.9	20.1	1.5	91.3	40.6	60.9	71.2	41.0	8.0	69.2	1.0	7.1	23.0	3.3	49.0	46.6	0.5	32.6	0.6	30.6	1.8	0.5	187.9	125.0	16.7	19.3	0.9	0.2	0.0	5.7	0.0	6.8	42.0	7.0	6.4	1.4	41.8	3.0	4.8	0.7	8.0	0.3	38.2	9.6	3.3	8.7	11.3	82.1	11.1	12.5	4.2	2.8	5.2	4.7	2.9	8.2	5.9	13.2	12.8	36.0	57.1	114.7	0.9	3.4	16.8	1.2	4.0	1.6	0.9	1.8	61.5	51.9	3.7	0.0	30.7	71.0	46.3	0.0	64.9	60.8	6.0	1.5	11.5	11.5	10.5	40.1	33.2	1.3	2.5	71.9	19.3	2.5	3.4	13.6	4.2	4.9	0.0	26.6	92.6	22.4	23.1	4.6	78.3	1.5	14.4	8.8	4.7	14.6	33.2	10.3	128.7	1.4	38.3	22.6	0.4	271.7	13.6	46.9	10.7	24.2	32.8	0.0	0.8	4.7	0.7	2.5	0.7	1.6	16.4	27.8	0.2	36.8	6.1
SELENOF	SEP15	ENSG00000183291	"Selenoprotein F"	O60613	1	86862445-86914424	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 248.6;Ductal cells: 235.9;Extravillous trophoblasts: 338.3;Hofbauer cells: 241.2;Syncytiotrophoblasts: 315.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054937			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No		420000	"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli	Cytosol	"HPA054937: AB_2682642"	"unprognostic (6.15e-2)"	"unprognostic (6.98e-3)"	"prognostic favorable (6.53e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.65e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.34e-2)"	118.1	137.9	77.6	118.8	80.0	107.9	147.4	80.9	106.1	156.6	97.9	127.8	113.5	117.4	211.4	83.6	130.1	123.3	84.6	75.2	84.3	160.3	173.9	114.9	140.6	82.6	79.8	124.6	93.4	115.7	88.4	155.8	84.0	121.1	134.2	90.7	104.1	116.4	45.6	66.3	111.3	107.1	86.4	107.2	116.8	66.7	79.0	135.5	234.0	64.7	126.9	146.6	72.6	92.5	203.1	133.3	118.0	129.1	383.0	396.4	178.3	249.1	317.3	251.4	254.8	176.8	261.8	245.2	309.7	248.9	195.7	131.8	135.2	150.7	296.0	222.1	180.2	252.4	108.5	178.2	245.2	336.8	166.1	272.3	233.0	152.8	253.0	180.2	220.2	207.8	241.4	262.3	253.3	90.2	254.4	227.3	170.7	211.2	197.9	207.7	205.1	251.9	355.5	198.5	149.5	122.6	241.6	235.6	349.2	104.7	104.0	298.5	205.3	180.0	122.9	347.6	277.0	155.1	158.7	251.9	107.7	268.4	216.7	170.9	111.3	113.4	89.7	115.9	116.1	161.4	98.7	97.2	107.1	194.2	98.8	102.3	109.3	82.3	132.4	166.3	115.2	171.3	77.6	80.0	80.9	106.1	75.2	84.3	82.6	79.8	84.0	86.4	79.0	92.5	131.6	118.6	155.2	0.0	52.4	0.0	0.0	0.0	0.0	0.0	142.1	107.7	0.0	0.0	74.9	108.5	0.0	248.6	89.3	0.0	74.3	235.9	0.0	102.2	119.1	73.2	0.0	0.0	0.0	193.5	338.3	85.2	0.0	98.1	64.3	68.8	0.0	0.0	241.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	64.1	0.0	0.0	0.0	0.0	197.8	0.0	0.0	19.1	0.0	0.0	151.5	70.0	0.0	0.0	0.0	61.5	0.0	0.0	0.0	0.0	315.2	53.9	122.2	0.0	0.0
SELENOH	"C11orf31, SELH"	ENSG00000211450	"Selenoprotein H"	Q8IZQ5	11	57741250-57743554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 444.1;Exocrine glandular cells: 315.1;Hofbauer cells: 416.3;Proximal tubular cells: 588.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048362	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA048362: AB_2680370"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.60e-1)"	96.0	167.2	38.4	31.6	41.1	39.4	95.6	36.4	70.0	91.4	39.5	82.0	31.7	73.7	11.9	135.0	72.7	20.6	117.5	39.9	43.2	125.6	171.2	85.9	42.5	38.2	38.7	96.4	110.8	9.2	104.6	26.2	39.6	110.6	13.1	5.4	99.4	16.2	117.0	79.6	88.0	15.0	37.5	130.1	91.3	66.8	41.1	14.5	103.2	6.2	27.9	87.0	86.3	39.7	116.5	84.5	79.8	47.6	7.6	29.1	18.8	43.1	30.3	36.4	19.8	26.7	56.2	51.0	120.7	15.4	31.0	50.9	26.6	47.1	8.3	75.7	85.3	67.8	59.0	66.4	63.7	105.1	140.0	38.4	43.3	39.0	19.4	39.9	50.4	68.9	70.2	44.0	23.7	112.6	103.5	181.1	155.6	32.8	89.6	122.5	75.6	106.7	23.6	62.2	46.0	105.1	39.1	35.2	133.6	18.3	102.2	79.7	64.1	41.1	101.2	90.3	64.2	269.8	226.2	41.3	95.3	89.0	106.1	295.2	385.8	204.5	160.2	417.6	151.4	346.4	209.6	171.4	396.4	349.2	282.1	208.8	29.7	187.7	394.2	488.1	175.3	469.5	38.4	41.1	36.4	70.0	39.9	43.2	38.2	38.7	39.6	37.5	41.1	39.7	182.7	166.7	151.8	0.0	61.0	0.0	0.0	0.0	0.0	0.0	273.3	267.0	0.0	0.0	74.3	150.8	0.0	288.7	77.7	0.0	444.1	256.7	0.0	175.5	95.2	90.2	0.0	0.0	0.0	315.1	280.8	68.4	0.0	104.1	133.7	148.5	0.0	0.0	416.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	119.1	0.0	0.0	102.4	0.0	0.0	0.0	0.0	288.7	0.0	0.0	14.8	0.0	0.0	588.6	142.8	0.0	0.0	0.0	74.7	0.0	0.0	0.0	0.0	147.2	49.0	190.5	0.0	0.0
SELENOO	SELO	ENSG00000073169	"Selenoprotein O"	Q9BVL4	22	50200979-50217616	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 21.1;Granulosa cells: 34.7;Proximal tubular cells: 41.7;Theca cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071795, HPA079100"	Approved		Supported	"Mitotic chromosome,Mitochondria"	"Intracellular and membrane"	Yes	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Mitotic chromosome"	"HPA071795: , HPA079100: "	"unprognostic (1.79e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.91e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (8.32e-4)"	6.7	6.7	2.3	4.5	3.4	13.9	4.8	11.7	6.8	5.6	2.5	5.3	8.0	5.9	2.8	8.2	5.7	4.1	5.3	3.0	1.1	6.6	27.9	4.7	6.4	4.6	2.7	5.0	13.1	3.0	4.1	3.0	3.7	5.6	2.0	2.9	7.7	4.1	12.3	8.2	6.5	2.4	2.3	6.5	7.0	3.7	3.1	4.4	5.1	4.1	3.9	5.1	6.1	6.0	12.0	7.7	4.2	4.7	5.6	4.1	8.6	11.8	5.6	7.0	5.5	10.6	7.5	7.9	9.2	4.7	3.9	26.2	6.5	10.7	1.4	2.3	29.9	5.7	17.4	6.4	2.8	10.6	6.9	5.4	7.2	4.5	3.5	4.5	5.8	5.3	7.8	5.6	2.9	18.6	5.7	16.4	3.7	2.8	15.6	17.6	5.9	11.8	4.3	15.3	8.4	9.3	12.8	11.3	7.5	2.1	8.7	7.5	9.5	6.0	8.3	6.5	7.1	13.8	3.6	4.7	6.8	6.9	3.5	0.0	1.1	1.3	0.2	0.4	0.5	0.0	0.2	0.5	1.1	0.2	0.1	0.4	0.5	0.0	0.4	0.4	0.2	0.3	2.3	3.4	11.7	6.8	3.0	1.1	4.6	2.7	3.7	2.3	3.1	6.0	11.8	0.0	21.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	13.3	13.2	0.0	0.0	5.6	9.2	0.0	3.1	12.2	0.0	15.6	3.6	0.0	11.8	10.9	3.0	0.0	0.0	0.0	4.6	2.4	6.0	0.0	15.2	3.8	34.7	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	4.5	0.0	0.0	41.7	3.6	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	1.9	5.5	29.6	0.0	0.0
SEMA4B	"KIAA1745, MGC131831, SEMAC, SemC"	ENSG00000185033	"Semaphorin 4B"	Q9NPR2	15	90160604-90229679	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 16.9;naive B-cell: 14.9;neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 182.4;RPTEC TERT1: 111.1;RT4: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013372	Approved		Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA		61000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA013372: AB_1856670"	"unprognostic (3.33e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.09e-2)"	11.9	37.6	20.3	18.0	21.9	9.8	22.5	18.8	21.6	35.1	12.8	50.2	30.2	17.1	8.2	124.4	22.6	17.1	24.9	17.3	21.0	47.7	43.2	20.5	12.0	23.5	24.0	21.6	38.5	18.1	18.6	18.3	21.4	31.4	12.1	27.1	41.2	17.6	7.8	50.9	34.7	13.3	21.0	30.3	32.2	10.7	22.9	13.2	34.2	7.9	13.0	42.2	59.8	26.8	21.2	56.3	4.2	13.2	3.8	2.6	30.4	6.4	13.9	7.8	8.3	7.0	182.4	14.9	69.2	4.7	45.0	97.8	3.7	91.2	6.4	85.4	11.7	19.7	13.5	9.4	15.1	2.6	8.7	10.8	39.1	8.5	17.5	32.5	8.8	4.4	9.6	23.0	4.3	15.6	5.4	8.4	18.7	46.8	51.1	6.4	3.1	33.1	111.1	124.0	13.3	13.5	22.3	35.4	8.5	9.3	24.7	6.0	20.0	6.3	11.4	13.1	14.5	33.0	43.2	7.5	58.8	16.1	6.3	0.0	2.4	0.3	0.9	1.4	0.6	16.9	0.5	0.5	1.2	14.9	0.5	0.6	5.1	0.4	2.8	0.2	0.2	1.5	20.3	21.9	18.8	21.6	17.3	21.0	23.5	24.0	21.4	21.0	22.9	26.8	1.8	16.0	22.5	67.3	29.2	65.0	40.0	51.4	23.9	5.7	29.1	18.9	7.8	8.6	44.6	16.5	25.0	13.9	2.4	47.8	3.9	27.3	0.9	15.6	19.6	4.4	4.2	4.0	23.5	35.5	74.5	6.4	34.1	28.3	0.0	8.6	4.6	16.8	13.3	16.8	28.2	17.5	18.3	6.9	7.5	1.2	13.1	5.5	5.4	2.8	5.3	25.1	1.0	8.0	8.3	44.7	26.1	12.0	8.0	46.9	19.6	4.5	22.6	48.3	19.7	5.7	15.3	0.7	3.2	65.3	57.1	12.4	4.3	5.2	20.2	52.0
SEMA5B	"FLJ10372, KIAA1445, SEMAG, SemG"	ENSG00000082684	"Semaphorin 5B"	Q9P283	3	122909082-123028605	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Excitatory neurons: 30.8;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 45.2;Smooth muscle cells: 14.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 79.7;NTERA-2: 15.7;SH-SY5Y: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066548	Enhanced		Supported	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA066548: AB_2685689"	"unprognostic (7.34e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.92e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (1.31e-3)"	"unprognostic (5.96e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-1)"	1.7	1.5	12.1	0.4	11.8	0.0	1.3	7.3	15.9	1.8	6.7	1.3	0.9	1.4	2.8	0.7	3.5	2.5	9.5	16.2	8.0	9.1	0.9	1.2	0.6	8.4	8.5	1.4	1.7	0.6	2.7	2.6	9.7	1.4	0.8	7.1	0.4	1.4	0.9	1.5	1.5	1.9	7.7	0.2	0.6	0.7	7.8	0.2	2.6	0.5	0.6	1.6	1.6	10.9	0.0	0.0	79.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	21.3	0.0	0.2	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	11.8	7.3	15.9	16.2	8.0	8.4	8.5	9.7	7.7	7.8	10.9	1.2	0.0	1.1	9.4	0.0	0.0	0.0	0.1	0.0	7.2	0.1	0.0	3.5	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.8	0.0	0.0	30.8	0.0	0.3	0.7	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.9	0.6	7.3	0.0	45.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	14.3	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443555-116574823	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 60.1;brain: 75.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 20.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"		NA	NA		620000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	13.4	60.1	24.1	4.9	48.6	3.5	13.1	39.9	31.9	10.0	0.3	20.6	19.9	6.0	2.8	4.4	8.2	12.9	7.1	24.5	40.3	8.6	5.6	17.9	4.5	51.9	41.0	18.1	11.2	2.0	5.8	31.9	50.0	6.0	17.5	10.4	16.6	2.5	8.2	6.9	25.5	5.8	32.9	11.2	7.0	7.5	44.1	3.6	9.1	6.5	2.2	5.6	8.1	75.2	0.3	0.1	36.9	44.3	0.2	0.0	38.2	0.7	0.4	0.2	0.2	2.2	1.5	1.6	1.7	0.6	0.7	0.4	52.0	0.0	0.1	1.6	7.7	0.7	0.7	13.1	0.5	0.5	2.6	0.7	0.0	0.0	0.0	0.5	0.2	0.3	0.3	0.4	0.2	0.8	0.7	3.9	115.2	0.2	0.3	6.9	24.2	1.8	19.0	33.7	10.3	3.7	0.2	0.7	19.7	221.1	14.4	2.6	0.9	3.6	3.1	0.4	1.5	0.6	0.7	0.8	0.6	1.8	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.1	48.6	39.9	31.9	24.5	40.3	51.9	41.0	50.0	32.9	44.1	75.2	64.7	0.0	0.6	71.8	1.1	6.5	0.7	13.1	34.7	17.9	17.0	8.3	8.6	61.5	3.1	14.7	2.1	128.9	0.3	73.3	0.0	42.9	13.6	12.2	4.8	60.9	28.1	2.7	26.9	1.3	8.1	15.4	1.1	10.6	0.0	9.7	145.6	0.9	12.5	138.0	62.2	30.7	0.0	14.8	4.6	2.4	6.5	1.1	24.9	54.4	0.1	5.8	0.0	138.7	311.3	2.0	46.7	1.9	2.6	1.5	40.7	4.4	0.6	3.5	0.0	36.1	8.1	0.9	1.5	11.3	4.1	348.1	0.8	3.5	40.3	2.2
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 322.9;tongue: 96.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.9;Cardiomyocytes: 19.1;Cone photoreceptor cells: 20.9;Inhibitory neurons: 13.7;Skeletal myocytes: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 14.1;HUVEC TERT2: 24.8;TIME: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1500000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	8.8	2.8	7.7	1.8	6.7	1.2	7.9	21.9	9.4	12.0	1.0	7.6	13.7	10.5	1.4	5.5	10.7	3.7	38.8	7.9	5.4	12.1	12.4	5.1	1.7	5.0	5.0	14.8	3.6	2.1	13.4	1.9	4.9	8.3	1.8	5.2	8.5	2.3	322.9	8.9	10.8	6.2	2.2	3.0	5.4	32.2	7.3	2.2	4.7	96.9	0.9	8.4	8.8	5.3	0.9	1.0	14.1	5.4	5.8	1.9	1.3	1.0	0.5	0.9	1.3	0.3	0.6	0.7	4.0	3.3	2.0	1.4	1.3	0.5	0.8	1.3	4.2	7.7	0.7	1.2	0.8	0.1	2.7	3.3	1.7	1.2	0.6	2.8	24.8	4.1	0.7	0.7	2.3	0.5	1.3	1.0	6.3	0.2	1.7	9.0	3.1	0.3	0.5	0.4	7.1	9.3	1.3	0.6	1.2	3.5	1.6	1.3	11.8	2.3	3.3	3.5	0.6	5.9	1.2	6.1	0.6	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	6.7	21.9	9.4	7.9	5.4	5.0	5.0	4.9	2.2	7.3	5.3	12.9	0.0	2.8	3.9	1.0	1.7	0.8	0.3	0.6	5.7	1.9	3.0	19.1	1.5	0.8	0.0	20.9	0.2	0.6	0.1	0.0	0.3	0.6	0.4	2.8	10.2	0.0	0.8	6.7	0.4	0.6	4.4	0.5	0.4	0.0	9.9	6.8	5.3	0.4	6.7	13.7	0.3	0.0	2.5	0.7	3.1	5.6	0.5	1.8	4.7	0.4	1.9	1.0	5.5	1.5	0.4	0.0	2.6	1.9	0.5	3.3	2.9	0.3	7.5	0.0	12.0	2.9	3.3	1.2	0.5	1.0	0.1	0.8	0.5	0.8	0.5
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Differentiation, Inflammatory response, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.1;retina: 34.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Extravillous trophoblasts: 58.8;Granulosa cells: 65.1;Pancreatic endocrine cells: 91.0;Rod photoreceptor cells: 58.3;Syncytiotrophoblasts: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 1.8;eosinophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 275.8;hTEC/SVTERT24-B: 108.7;U-251 MG: 166.3;U-87 MG: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles		NA	NA		38000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.45e-11)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.57e-2)"	2.0	2.5	4.6	7.0	11.0	9.9	1.9	19.1	14.4	2.2	0.9	2.4	1.5	2.9	0.9	4.8	1.4	1.8	2.3	5.1	8.2	2.8	1.6	8.1	13.2	19.9	11.6	7.8	0.9	1.9	2.7	16.3	22.9	1.8	0.9	34.6	2.2	1.2	2.0	8.5	10.8	1.1	10.6	60.1	3.5	29.5	17.2	9.4	1.3	0.3	12.9	8.2	2.5	20.2	16.7	0.2	4.8	1.4	6.0	20.1	39.7	75.2	30.1	15.5	23.8	6.5	26.6	0.1	4.3	34.2	12.6	4.9	1.5	4.8	16.0	1.3	0.9	30.0	0.1	8.3	1.3	0.9	275.8	14.3	0.2	108.7	6.0	39.0	0.2	2.0	17.5	10.1	51.2	1.4	4.3	9.9	5.2	0.4	11.3	0.6	3.3	4.4	6.5	7.1	0.3	0.5	0.5	13.4	6.1	4.1	1.0	6.0	3.0	28.8	19.2	14.1	166.3	1.8	1.3	0.3	92.4	3.4	1.5	1.8	0.0	3.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	4.6	11.0	19.1	14.4	5.1	8.2	19.9	11.6	22.9	10.6	17.2	20.2	1.8	3.2	0.0	1.0	22.6	0.4	1.6	3.1	0.6	13.7	1.2	1.3	1.4	0.0	4.0	1.8	68.8	25.6	5.2	0.6	0.0	19.8	0.5	4.6	1.5	5.3	0.0	21.7	12.4	13.9	58.8	1.8	1.5	10.6	8.2	65.1	0.7	0.7	7.2	1.7	5.9	0.0	0.0	0.3	12.0	2.5	3.7	4.8	8.8	0.0	28.6	6.8	1.0	4.0	16.3	91.0	0.1	1.9	6.4	3.3	0.1	0.1	2.0	58.3	0.0	0.2	9.0	0.9	0.8	0.2	1.4	166.4	5.7	22.0	0.0	24.4
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO specific peptidase 3"	Q9H4L4	17	7561919-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	24.2	24.0	43.7	21.0	42.6	25.4	23.7	38.5	47.9	23.7	38.5	32.4	21.2	26.7	27.4	25.4	25.9	19.3	25.2	42.6	39.8	34.1	20.5	28.6	26.5	40.4	42.2	26.8	26.4	38.1	26.4	22.5	41.1	23.0	25.4	24.7	24.8	26.0	33.5	28.6	25.2	28.9	39.5	28.3	27.0	29.0	44.0	33.8	23.9	30.9	31.2	29.7	21.8	42.0	76.4	90.8	52.7	82.5	58.6	42.8	54.8	54.8	56.0	93.4	87.2	54.9	32.5	90.3	52.6	72.7	62.3	72.0	114.4	85.8	78.0	63.7	105.0	46.7	74.8	56.9	79.1	44.0	57.9	55.1	86.5	107.1	103.5	53.3	76.0	102.1	61.5	24.7	73.0	51.4	107.9	33.6	64.2	70.9	54.5	97.1	48.8	52.4	62.9	44.0	52.5	67.6	55.3	52.7	60.0	66.6	44.1	28.5	40.5	53.0	45.9	51.3	119.0	36.3	40.4	57.3	53.9	45.7	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.7	42.6	38.5	47.9	42.6	39.8	40.4	42.2	41.1	39.5	44.0	42.0	4.5	3.2	5.4	0.0	4.9	8.5	6.4	1.6	10.2	6.1	6.7	11.0	7.1	7.2	3.6	1.8	22.9	3.0	4.8	2.6	0.0	2.3	1.4	4.0	4.2	4.7	6.6	1.3	0.0	2.4	2.3	3.8	3.6	4.7	1.3	5.2	8.2	2.7	1.5	6.7	0.0	3.0	2.0	6.0	6.4	0.7	4.1	4.9	3.6	0.0	4.7	5.5	4.1	0.0	0.0	2.1	0.8	2.2	6.4	6.1	4.0	1.1	2.1	7.3	0.0	5.2	4.4	3.7	4.0	7.4	11.6	4.1	4.9	3.0	3.7	6.4
SEPHS2	"SPS2, SPS2b"	ENSG00000179918	"Selenophosphate synthetase 2"	Q99611	16	30443631-30445874	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 402.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 385.4;Proximal tubular cells: 384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 477.5"	"Low region specificity"	"Detected in all"							HPA047931	Approved		Approved	Nucleoplasm		No	No		29000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA047931: AB_2680216"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.86e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.35e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-2)"	27.5	30.6	16.8	33.7	17.5	26.0	33.8	18.5	19.9	24.8	21.2	75.5	136.0	19.9	23.9	20.4	20.5	34.0	27.8	18.5	20.5	158.5	402.6	28.8	44.8	18.5	18.9	14.9	35.2	48.9	20.4	25.1	19.5	28.7	65.9	19.7	33.6	23.2	41.7	21.1	105.8	25.9	18.6	29.8	62.5	11.5	20.2	43.5	37.7	32.3	41.9	27.7	14.2	19.8	77.6	68.9	23.8	83.1	71.7	45.7	62.5	52.3	64.5	50.5	62.2	42.9	57.7	110.8	79.0	56.0	45.7	42.1	44.5	47.9	51.0	71.2	137.5	110.8	35.9	204.0	90.5	62.0	477.5	58.4	100.5	47.6	87.7	31.6	47.0	80.1	91.1	69.7	45.4	114.5	93.9	127.8	59.3	58.0	51.4	90.2	41.8	85.3	62.6	68.9	50.5	43.1	44.8	129.3	179.7	47.8	113.7	204.2	39.6	52.2	37.1	50.9	32.0	59.6	103.4	57.6	45.3	114.3	59.7	8.7	19.4	30.2	14.8	16.1	22.2	17.8	20.9	21.4	21.6	20.2	25.0	17.2	17.6	31.9	20.5	15.4	22.8	14.8	16.8	17.5	18.5	19.9	18.5	20.5	18.5	18.9	19.5	18.6	20.2	19.8	76.2	44.8	40.3	3.9	34.3	37.5	1.4	47.6	58.6	0.5	66.2	52.7	49.4	1.5	39.4	64.4	0.0	1.3	41.5	108.9	385.4	112.2	0.1	34.2	25.1	32.4	35.5	20.8	6.7	82.7	1.1	30.4	68.8	59.2	31.0	20.5	0.7	9.1	1.4	0.0	8.6	31.0	63.1	2.9	34.9	0.1	0.0	42.5	44.4	5.6	37.1	0.2	1.0	5.5	4.6	57.4	42.4	0.0	30.6	1.6	11.1	384.9	27.2	1.1	0.0	2.0	49.4	0.8	0.8	45.4	42.6	1.2	35.7	52.6	46.0	0.9
SEPTIN2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	246.0	155.0	192.8	159.7	216.1	125.3	177.2	208.8	220.6	233.8	183.2	179.7	140.8	209.0	176.7	161.1	168.7	193.8	211.8	180.5	209.6	212.6	117.1	184.5	157.2	227.2	203.3	221.7	214.2	220.1	112.7	217.3	232.2	186.1	188.6	114.0	163.3	218.2	160.6	119.0	154.8	253.1	224.1	164.9	152.6	145.0	198.3	141.8	224.6	163.5	180.5	221.0	116.7	245.3	245.1	207.7	561.7	370.8	511.5	555.0	289.1	517.3	508.9	329.1	417.2	118.7	258.4	96.1	119.4	599.0	176.7	209.6	377.7	347.9	535.5	241.9	262.2	388.9	200.5	444.5	311.6	374.4	228.0	495.1	224.8	275.0	259.1	369.8	576.2	240.9	357.4	138.0	491.9	171.5	226.7	227.3	412.5	215.2	152.8	216.2	707.4	204.7	483.5	359.9	401.4	270.0	363.0	245.7	353.0	397.9	146.9	333.4	555.5	399.2	166.2	392.9	320.6	267.7	251.9	340.9	344.7	225.1	571.6	172.0	165.0	98.3	101.0	184.1	125.1	87.4	97.9	104.2	183.8	77.2	84.4	89.6	58.9	191.4	144.8	138.7	108.0	241.2	192.8	216.1	208.8	220.6	180.5	209.6	227.2	203.3	232.2	224.1	198.3	245.3	89.9	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	135.9	39.9	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	190.1	50.4	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	139.0	6.5	0.0	0.0	0.0
SEPTIN7	"CDC10, CDC3, SEPT7, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 570.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 192.1;Cardiomyocytes: 227.0;Cytotrophoblasts: 171.4;dendritic cells: 196.6;Extravillous trophoblasts: 198.2;Fibroblasts: 153.5;Hofbauer cells: 191.0;Smooth muscle cells: 190.0;Syncytiotrophoblasts: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Approved	"Nucleoli,Plasma membrane,Actin filaments,Midbody,Cytosol"		Yes	No		4300000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoli, Plasma membrane, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	127.1	95.1	352.6	98.8	386.1	131.0	99.5	334.3	570.9	111.5	289.5	116.4	55.7	126.5	121.5	106.6	84.1	117.5	172.1	344.1	341.6	82.9	76.9	98.6	150.9	337.4	355.9	138.2	37.0	81.1	62.6	143.5	339.1	93.9	94.8	119.5	50.3	95.5	82.9	105.0	74.9	145.2	345.1	108.3	59.4	70.3	367.7	159.0	78.2	104.3	149.7	125.0	86.9	411.9	198.1	94.3	232.0	153.2	256.7	263.1	119.3	248.6	228.6	206.7	177.0	147.7	148.9	186.2	164.2	254.9	274.9	146.3	166.3	166.4	294.0	127.8	88.4	149.8	123.4	80.8	149.4	182.7	157.7	171.7	127.1	163.8	159.4	215.6	221.0	143.3	120.1	141.9	341.6	92.8	185.6	304.3	249.7	183.1	132.6	188.3	220.9	107.6	202.6	146.1	124.3	217.4	173.5	220.1	151.8	377.1	163.1	198.7	187.3	207.2	246.7	129.9	278.5	165.9	163.4	470.2	132.4	301.2	449.3	266.8	86.0	150.1	214.8	100.1	220.7	165.6	151.5	199.6	100.8	155.5	134.4	171.2	160.9	298.7	110.5	71.0	147.4	241.7	352.6	386.1	334.3	570.9	344.1	341.6	337.4	355.9	339.1	345.1	367.7	411.9	192.1	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.0	0.0	0.0	0.0	0.0	171.4	196.6	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	198.2	153.5	0.0	0.0	0.0	0.0	0.0	0.0	191.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.0	0.0	0.0	0.0	0.0	124.2	30.4	0.0	0.0	0.0
SEPTIN9	"AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SEPT9, SeptD1"	ENSG00000184640	"Septin 9"	Q9UHD8	17	77280569-77500596	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 29.9;Cytotrophoblasts: 78.2;dendritic cells: 34.8;Extravillous trophoblasts: 152.8;Hofbauer cells: 67.5;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042564, HPA050627"	Approved		Enhanced	"Actin filaments"		No	No		770000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA042564: AB_2678054, HPA050627: AB_2681193"	"unprognostic (7.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.23e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.80e-1)"	68.7	87.9	58.8	148.8	61.7	89.2	72.8	81.6	85.3	99.3	59.9	137.8	94.9	127.5	27.0	81.9	89.0	88.3	70.5	68.1	68.6	75.2	99.5	77.8	223.8	111.5	62.0	76.4	38.7	67.2	63.3	80.7	76.6	96.0	51.9	15.6	76.8	75.6	73.1	80.3	145.1	84.5	68.2	152.8	103.1	60.0	65.7	260.2	52.9	43.1	151.5	122.9	82.4	71.8	246.1	342.0	221.3	186.4	257.0	417.1	121.7	188.9	214.1	122.4	89.0	278.4	243.4	338.7	153.4	388.5	161.2	149.1	96.6	354.8	90.4	6.2	65.0	128.8	147.3	483.2	212.0	84.6	218.3	215.6	128.8	159.6	136.0	180.3	167.5	196.4	144.6	44.1	110.7	258.1	628.1	72.0	207.5	281.4	281.1	290.7	192.6	117.1	197.5	337.9	171.0	324.3	214.2	349.6	207.2	248.6	260.2	60.7	243.6	165.8	147.6	197.4	130.2	10.5	19.5	562.6	245.6	73.7	348.7	4.2	18.4	31.1	22.3	46.3	19.0	16.3	28.7	26.4	17.0	17.4	29.6	25.8	6.1	16.9	55.3	38.7	31.8	24.9	58.8	61.7	81.6	85.3	68.1	68.6	111.5	62.0	76.6	68.2	65.7	71.8	29.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	78.2	34.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	152.8	9.4	0.0	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	70.6	6.8	0.0	0.0	0.0
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2841959	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 466.8;esophagus: 478.3"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1424.3;Pancreatic endocrine cells: 1067.8;Urothelial cells: 984.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.3;OE19: 162.5;U-937: 144.9"					"Low region specificity"	"Detected in all"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"	"Secreted to blood"	NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cytoplasmic bodies"		"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	36.6	54.4	10.7	69.7	14.4	466.8	25.0	11.1	14.0	55.6	17.3	77.7	140.4	15.6	22.2	478.3	35.8	57.4	26.8	10.7	12.7	33.2	32.1	81.7	51.3	15.1	13.0	18.1	232.1	29.8	32.9	27.0	14.6	15.9	87.5	13.4	99.6	16.9	54.2	15.8	107.3	24.9	13.6	67.4	97.9	7.1	13.7	31.9	30.7	22.9	122.8	88.6	112.4	14.8	42.9	49.7	2.7	0.3	10.6	21.8	41.2	11.8	36.1	14.5	26.1	47.1	125.3	0.3	86.6	26.6	15.6	26.8	4.8	11.4	11.1	59.4	7.5	76.6	16.0	37.0	37.2	13.5	46.2	26.8	18.4	7.3	3.3	7.2	48.7	0.0	27.1	9.9	13.4	19.9	1.7	35.4	4.5	162.5	22.1	3.9	0.5	44.4	51.0	9.3	8.8	4.8	28.8	11.2	64.2	5.9	5.6	43.2	29.1	4.6	10.4	10.2	3.6	0.1	2.2	0.5	17.4	144.9	2.4	118.0	207.1	109.4	53.3	103.7	45.8	43.5	48.1	48.4	150.4	32.3	47.4	50.6	182.3	85.1	82.8	48.6	58.5	175.8	10.7	14.4	11.1	14.0	10.7	12.7	15.1	13.0	14.6	13.6	13.7	14.8	79.9	240.4	269.9	0.7	90.7	35.1	165.1	699.1	38.1	4.2	55.0	51.2	17.6	72.9	420.9	46.0	2.1	124.5	120.8	264.1	56.7	490.3	1.7	210.6	28.7	118.9	96.3	176.3	0.9	1424.3	149.1	89.1	345.1	104.5	452.2	32.1	124.9	20.2	183.0	10.1	0.9	263.1	109.9	332.7	308.2	3.5	34.8	387.3	71.2	15.9	589.7	48.3	139.0	4.5	6.6	1067.8	308.4	27.8	65.2	147.5	333.7	81.3	343.8	17.2	13.1	109.7	67.2	2.0	11.2	461.5	38.1	99.7	112.9	59.2	242.6	984.3
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127104-101139247	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 418.0"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 165.1;Fibroblasts: 162.1;Pancreatic endocrine cells: 231.8;Smooth muscle cells: 239.3;Syncytiotrophoblasts: 651.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"BJ: 3483.8;HUVEC TERT2: 4014.7;LHCN-M2: 3874.5;TIME: 10032.6;U-138 MG: 4609.6;U-251 MG: 4256.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"	No	No	142000000	13000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"CAB068501: AB_1642775, HPA050039: AB_2680997"	"unprognostic (5.02e-2)"	"prognostic unfavorable (5.01e-4)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.88e-8)"	"prognostic unfavorable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.51e-4)"	215.5	75.3	3.1	91.6	3.4	1.7	56.2	5.2	12.8	62.1	5.0	31.7	7.4	31.1	1.0	16.4	41.3	360.3	136.0	3.9	6.6	166.2	345.8	260.2	21.3	6.4	3.7	105.6	135.1	11.8	12.3	418.0	4.5	37.8	5.4	4.9	10.6	8.0	17.8	21.2	13.1	74.3	4.8	13.8	30.3	5.5	12.7	6.7	59.5	4.3	3.5	359.9	19.2	6.0	77.3	64.4	1.2	5.1	766.6	1511.0	89.3	3483.8	654.6	1717.6	1487.4	9.4	5.5	2.7	812.6	1117.9	2367.3	18.1	0.4	269.4	1756.2	4.3	0.7	1.1	5.2	61.4	1532.6	0.2	3.8	596.1	106.9	2641.4	1374.8	928.5	4014.7	0.2	6.4	2.5	3874.5	0.4	0.6	2.2	18.2	1.3	41.7	0.6	6.1	4.8	5.1	30.3	1.0	0.8	286.3	77.2	8.3	410.9	3.3	9.9	10032.6	4609.6	204.0	1593.8	4256.0	0.6	2.9	4.2	1150.5	2.4	45.9	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	9.5	0.0	0.3	0.0	0.8	3.1	3.4	5.2	12.8	3.9	6.6	6.4	3.7	4.5	4.8	12.7	6.0	35.8	0.0	7.7	0.0	1.1	40.0	43.7	97.4	14.2	0.3	0.3	2.3	2.5	4.3	11.0	5.5	0.0	56.0	1.0	0.4	0.0	65.1	0.0	4.7	53.8	165.1	5.3	0.0	0.5	4.5	75.1	162.1	0.5	3.2	10.2	12.4	40.4	112.3	15.9	0.0	0.3	0.2	8.2	4.6	9.6	1.1	17.7	11.1	7.2	5.6	1.1	0.7	0.0	0.0	0.0	231.8	0.0	12.0	3.6	9.7	0.1	0.0	8.2	0.3	39.5	55.4	239.3	0.0	0.1	9.0	24.7	651.7	2.3	2.1	0.5	8.1
SERPINH1	"CBP1, CBP2, colligen, HSP47, SERPINH2"	ENSG00000149257	"Serpin family H member 1"	P50454	11	75562056-75572783	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 473.6;Endometrial stromal cells: 273.3;Extravillous trophoblasts: 342.1;Fibroblasts: 287.6;Smooth muscle cells: 295.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 291.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 1018.3;fHDF/TERT166: 1215.2;HHSteC: 1029.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004441, HPA029198"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	Yes		920000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004441: AB_627757, HPA029198: AB_10601712"	"unprognostic (3.80e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.35e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.22e-15)"	"unprognostic (2.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	214.1	101.9	46.2	106.5	50.4	3.7	107.1	51.1	291.0	137.7	66.7	95.2	23.2	160.7	27.6	41.7	119.4	72.1	159.3	46.1	50.5	116.9	52.5	199.3	21.1	59.9	47.3	157.4	40.1	18.1	50.8	251.3	58.3	66.1	36.7	2.0	40.7	53.2	22.2	47.6	51.3	207.3	51.6	53.9	76.9	27.7	54.0	21.6	91.2	33.2	18.2	156.8	85.9	60.1	57.7	192.9	349.5	722.0	528.8	484.2	162.2	514.3	349.6	380.4	483.5	1018.3	294.1	0.4	470.2	1215.2	3.1	337.2	242.2	163.2	182.5	27.5	47.0	42.7	174.0	216.5	1029.5	0.9	7.2	580.9	165.2	365.0	121.3	475.5	530.8	22.1	90.5	16.1	182.5	457.6	1.2	74.8	315.6	215.8	50.7	29.3	200.3	48.8	95.6	107.8	9.1	119.1	326.9	59.7	102.0	539.6	144.4	72.7	284.6	388.6	324.6	270.6	128.3	23.1	25.5	6.1	168.0	0.2	535.6	4.1	1.1	0.1	6.0	1.1	5.2	0.9	3.9	4.0	4.4	0.7	4.0	3.3	0.2	5.9	0.1	3.7	3.5	2.1	46.2	50.4	51.1	291.0	46.1	50.5	59.9	47.3	58.3	51.6	54.0	60.1	142.3	38.5	32.0	4.9	2.9	81.8	473.6	56.5	74.0	5.3	28.3	39.5	36.6	14.3	21.0	25.8	58.4	217.0	3.2	33.0	0.0	64.5	2.9	21.8	273.3	194.9	61.1	11.4	0.4	11.9	342.1	287.6	15.3	33.0	9.5	144.1	124.9	9.9	94.2	6.7	0.2	55.7	22.4	5.7	110.0	6.0	164.4	43.6	44.4	18.7	9.8	14.3	8.2	1.0	0.5	22.5	24.3	120.7	6.5	139.8	12.4	22.8	11.9	1.2	92.1	31.4	295.1	29.3	23.0	14.1	44.5	165.8	68.8	79.8	62.8	73.4
SET	"2PP2A, IGAAD, IPP2A2, PHAPII, TAF-I, TAF-IBETA"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA		880000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: AB_2685088"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	124.9	122.7	125.2	195.6	134.6	261.8	174.2	115.9	137.6	147.7	111.0	160.1	125.5	174.7	88.0	196.3	154.9	149.1	152.7	109.1	115.3	155.5	159.8	129.3	308.5	120.3	126.1	190.6	175.3	143.3	78.6	206.2	126.9	135.8	169.7	142.4	139.4	134.9	182.5	154.1	132.2	164.6	141.1	170.4	139.8	105.3	124.2	286.8	211.2	134.5	300.4	220.8	122.9	147.6	579.4	644.4	908.7	723.6	265.2	412.2	835.7	465.8	511.8	656.9	449.9	892.0	688.8	1483.4	383.1	482.8	513.6	1053.0	1358.8	700.1	745.2	681.2	577.8	855.2	968.5	734.5	591.3	1581.1	535.5	346.7	535.7	561.6	1114.6	526.1	626.1	781.8	1692.1	583.3	545.4	974.2	1333.9	580.0	1521.8	876.7	678.6	1198.7	1128.2	1198.7	506.5	640.5	921.0	576.5	1024.4	679.0	560.5	641.6	847.6	483.9	604.4	770.6	576.9	481.4	784.1	455.0	1417.0	1737.1	367.1	824.8	753.1	165.1	207.3	182.0	224.0	235.4	277.6	287.4	253.0	240.4	215.1	258.0	241.0	286.1	141.4	329.2	199.5	271.6	223.1	335.1	125.2	134.6	115.9	137.6	109.1	115.3	120.3	126.1	126.9	141.1	124.2	147.6	249.9	121.8	145.0	25.1	337.1	673.6	507.5	134.0	352.8	187.6	372.3	250.6	204.2	238.8	134.0	196.8	43.8	316.7	365.9	136.8	389.4	254.6	43.5	318.3	502.1	266.9	256.1	355.6	41.7	218.7	504.0	194.8	126.9	438.5	132.3	308.3	193.1	198.5	239.4	124.5	40.2	261.8	93.6	264.0	436.5	33.6	164.1	249.0	327.3	22.5	274.3	240.6	211.2	38.2	36.6	294.5	132.5	173.4	356.2	647.6	106.7	338.6	87.0	132.5	131.5	323.9	297.0	124.6	259.7	448.0	702.1	314.5	292.3	238.9	342.8	580.9
SETD1A	"KIAA0339, KMT2F, Set1"	ENSG00000099381	"SET domain containing 1A, histone lysine methyltransferase"	O15047	16	30957754-30984664	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020646, HPA058376"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA020646: AB_1856752, HPA058376: AB_2683695"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.18e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.94e-1)"	10.2	10.0	6.0	7.3	5.5	20.1	10.0	8.4	8.3	11.0	3.0	13.0	6.6	13.0	2.8	9.0	10.5	4.1	8.5	5.5	5.5	8.4	10.4	8.2	8.6	5.6	5.4	12.4	10.6	8.0	11.9	5.0	5.4	10.2	3.3	3.1	9.3	6.1	15.1	12.3	10.5	6.3	4.1	11.8	10.0	20.8	6.0	10.0	11.8	7.1	5.1	10.2	9.3	6.9	13.1	24.4	15.9	19.4	8.7	6.3	18.0	13.6	10.6	11.9	10.1	20.2	12.8	34.2	15.2	13.0	12.0	16.4	15.0	14.6	9.3	18.5	56.1	16.0	47.1	23.2	8.9	26.6	26.2	11.0	11.3	17.1	10.8	9.2	9.3	19.5	32.3	19.0	6.4	27.2	32.3	27.7	23.4	9.0	15.4	48.7	15.9	21.9	7.6	13.9	17.6	18.1	18.7	15.1	10.8	8.7	16.2	22.1	12.8	17.7	17.1	11.6	14.9	28.0	36.2	32.4	14.3	22.9	13.5	0.0	0.1	0.6	0.2	0.3	0.3	0.0	0.2	0.2	0.1	0.5	0.1	0.2	0.0	0.2	0.1	0.6	0.1	0.2	6.0	5.5	8.4	8.3	5.5	5.5	5.6	5.4	5.4	4.1	6.0	6.9	7.8	3.2	9.2	9.1	8.8	15.7	5.1	3.8	15.4	8.1	9.5	8.3	3.9	5.7	4.0	7.3	6.2	4.6	11.4	6.8	0.0	4.2	3.1	6.1	8.2	9.9	10.3	6.7	6.4	4.2	3.7	7.8	6.1	8.6	3.8	9.5	7.5	9.1	6.5	13.5	6.1	7.9	2.0	4.7	7.1	2.9	9.9	5.5	8.8	6.5	4.7	4.8	7.2	2.5	5.7	5.4	4.8	11.7	7.9	8.3	5.1	2.8	4.0	5.2	6.6	10.8	7.8	17.5	23.3	15.7	12.9	2.9	8.6	10.3	6.9	4.8
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB017093: , HPA035574: AB_2674681"	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	24.9	28.1	22.3	19.3	22.0	14.9	25.4	33.7	24.9	29.5	20.9	30.5	15.2	27.6	30.2	25.0	30.2	18.8	23.0	23.5	22.3	18.3	27.6	33.5	23.1	20.5	20.3	33.2	28.5	18.0	26.5	24.0	21.1	25.6	20.9	33.9	28.3	20.4	23.9	32.8	25.6	23.2	18.6	26.1	23.9	17.8	22.2	25.5	30.5	21.5	26.7	26.5	28.1	24.2	25.3	28.6	57.8	27.0	36.5	33.6	138.5	24.9	30.2	31.6	35.4	29.1	30.2	53.5	14.3	33.4	29.8	20.0	50.6	29.8	35.5	38.4	27.6	50.6	56.4	29.8	36.7	42.0	31.9	35.0	52.2	49.3	55.1	37.3	35.7	35.6	50.0	40.0	32.6	36.4	35.7	38.1	42.2	19.5	23.9	37.7	47.6	26.2	29.6	37.7	22.3	34.6	34.2	29.8	22.6	52.6	39.7	30.8	41.6	35.3	41.6	21.0	28.9	27.4	34.2	83.6	26.9	30.4	33.2	0.4	0.4	0.2	0.9	0.2	0.8	0.7	0.6	0.7	0.3	0.7	0.5	0.5	1.1	1.1	0.2	0.8	0.1	0.1	22.3	22.0	33.7	24.9	23.5	22.3	20.5	20.3	21.1	18.6	22.2	24.2	51.5	41.7	50.6	136.1	53.6	93.9	54.4	28.5	86.6	110.6	45.1	26.2	25.5	41.5	50.0	42.3	114.7	38.9	50.4	39.1	3.9	37.3	7.9	45.9	60.3	62.5	62.4	34.3	175.0	34.0	41.3	62.2	45.9	49.4	48.1	60.6	63.1	50.1	24.4	55.5	188.5	51.9	26.4	32.4	70.7	11.7	66.8	30.8	44.4	108.7	39.7	33.4	39.1	263.9	131.7	44.2	46.2	53.8	67.7	88.2	39.4	12.8	52.9	60.9	13.1	65.3	52.8	50.6	37.8	75.2	91.5	57.3	49.6	56.2	47.8	84.2
SETD6	FLJ21148	ENSG00000103037	"SET domain containing 6, protein lysine methyltransferase"	Q8TBK2	16	58515479-58523842	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041481, HPA053546"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041481: AB_10804004, HPA053546: AB_2682182"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (3.74e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.73e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.55e-1)"	8.6	12.4	3.8	2.9	3.6	2.6	9.1	8.9	4.6	9.4	3.9	8.4	3.8	8.4	5.4	13.4	9.7	2.7	11.3	3.9	3.8	12.5	13.5	7.0	4.6	3.8	3.5	9.1	19.6	6.5	12.5	2.5	3.9	10.9	4.3	7.9	11.1	5.9	15.0	14.6	9.2	3.3	3.5	10.6	11.4	12.7	3.8	2.8	12.2	3.9	4.4	8.3	10.8	3.8	2.5	6.1	1.3	10.7	4.3	2.8	15.9	4.0	5.4	7.1	3.8	10.1	6.1	19.9	5.4	4.6	0.9	8.1	9.0	6.3	4.9	2.2	23.6	0.9	11.0	17.2	4.3	14.4	7.8	3.8	13.2	5.6	8.8	4.8	4.5	0.2	14.7	2.6	1.5	10.1	0.3	17.7	21.0	9.7	9.6	0.4	2.5	26.7	7.3	0.4	19.6	12.6	16.8	15.9	7.8	6.2	10.0	2.0	3.7	2.5	6.0	3.1	7.3	11.7	8.1	13.7	5.3	6.9	4.6	2.5	1.1	0.2	2.0	1.5	1.4	1.5	1.6	2.2	1.8	1.5	2.0	2.2	0.7	4.4	1.6	2.0	1.6	1.3	3.8	3.6	8.9	4.6	3.9	3.8	3.8	3.5	3.9	3.5	3.8	3.8	5.2	6.4	6.9	6.8	7.1	13.9	10.5	7.5	13.6	14.3	12.0	11.0	7.6	17.2	8.5	9.2	14.6	17.5	8.6	5.3	1.9	10.1	9.2	10.8	6.9	6.8	4.8	10.3	11.5	12.2	9.9	8.4	8.2	10.0	1.3	14.9	4.2	7.9	3.5	11.8	11.3	5.0	2.0	3.5	5.6	16.9	9.0	3.4	5.4	5.6	5.6	15.0	6.2	7.5	4.7	6.1	4.2	10.1	6.8	13.8	6.5	9.4	12.0	13.4	13.1	10.1	7.4	15.0	22.9	12.1	12.1	12.6	7.1	6.1	7.4	6.2
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing 7, histone lysine methyltransferase"	Q8WTS6	4	139495941-139606699	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	44.7	18.5	17.8	15.1	17.7	9.7	27.3	19.3	17.3	40.5	21.2	23.5	7.3	33.0	12.6	28.1	18.8	26.7	41.0	16.6	19.4	10.1	50.1	19.2	11.7	25.0	20.3	19.6	21.9	34.7	8.8	19.1	24.7	35.1	15.3	11.5	16.2	20.6	106.6	22.7	12.1	34.8	24.6	17.0	20.1	14.4	24.5	10.1	14.1	73.7	15.9	23.4	18.2	29.2	28.4	37.2	13.0	7.8	77.1	65.9	29.6	65.7	67.3	32.4	27.1	22.7	37.2	68.0	25.5	110.5	22.4	13.9	44.3	51.3	52.4	32.8	33.0	8.9	45.5	0.8	38.4	31.9	12.9	57.7	58.6	52.1	54.6	41.2	41.7	27.8	5.5	96.1	42.3	46.8	21.0	4.6	6.4	40.8	23.9	19.7	48.4	37.3	31.5	25.3	55.3	18.5	44.7	63.5	15.3	12.6	25.3	28.0	68.8	57.1	40.7	68.6	55.2	89.6	86.8	42.2	65.9	31.1	28.0	0.5	3.9	0.2	0.3	2.0	2.7	1.0	1.1	1.1	4.4	1.2	0.4	0.2	0.9	0.2	3.2	2.1	3.7	1.2	17.8	17.7	19.3	17.3	16.6	19.4	25.0	20.3	24.7	24.6	24.5	29.2	28.7	6.4	18.8	17.3	8.9	17.2	14.5	14.1	12.5	5.4	24.0	14.7	43.1	20.0	15.0	9.2	12.5	26.2	4.2	4.1	0.0	22.7	1.3	3.5	35.9	29.4	1.2	3.6	21.1	21.2	16.7	39.8	16.8	7.5	2.5	2.9	37.1	70.6	20.4	8.4	42.4	13.6	18.3	31.0	20.9	4.3	23.0	19.5	10.6	19.7	19.0	15.0	0.0	36.2	29.2	22.4	4.1	28.2	13.2	38.4	1.3	4.5	14.0	12.9	19.7	35.2	23.3	3.7	2.7	17.9	22.0	46.1	9.8	9.5	11.7	20.4
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated histone lysine methyltransferase 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 341.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	13.5	11.3	7.1	15.2	8.2	18.1	16.7	12.8	8.9	14.4	8.7	13.4	12.5	18.1	13.1	11.8	15.3	11.5	8.2	6.7	7.9	11.7	11.5	13.4	19.6	8.2	7.6	19.4	13.3	15.7	8.6	17.7	7.6	11.4	15.5	14.2	12.3	12.2	16.4	14.4	13.7	16.5	6.0	19.9	13.4	25.1	8.4	21.6	15.5	11.7	20.3	13.1	12.7	10.3	22.9	26.3	37.1	24.6	17.5	23.2	61.7	18.6	21.2	26.2	22.2	17.9	31.1	44.9	24.9	20.7	10.4	28.1	35.0	20.0	20.7	21.8	43.3	25.5	27.3	20.8	24.7	45.3	23.2	30.5	22.0	21.8	34.8	26.6	31.2	28.3	43.4	35.6	18.9	44.1	31.6	26.4	51.1	32.1	20.6	36.3	24.3	33.4	20.1	25.9	27.1	49.1	28.4	32.9	22.5	44.5	35.7	60.4	21.2	15.3	15.7	17.0	26.3	36.6	42.3	341.6	15.7	15.7	15.1	6.9	8.3	5.7	5.8	11.6	6.1	6.1	5.3	6.6	9.7	8.3	5.7	5.9	4.8	6.3	8.5	6.5	3.5	4.3	7.1	8.2	12.8	8.9	6.7	7.9	8.2	7.6	7.6	6.0	8.4	10.3	8.5	6.4	14.0	15.3	15.3	5.5	9.3	6.6	10.2	11.0	9.8	10.7	5.5	10.0	7.8	7.3	18.8	13.9	8.8	6.6	3.9	7.6	26.1	10.8	13.3	8.3	3.6	9.2	19.6	5.7	8.5	9.1	10.2	10.7	7.6	17.9	11.4	8.1	9.9	6.7	19.4	9.7	12.2	17.2	5.1	31.0	10.2	13.9	1.8	23.4	14.4	6.2	14.4	15.6	23.5	8.1	9.5	9.8	8.9	8.2	7.6	6.4	11.0	10.4	6.6	10.2	10.3	24.4	15.9	10.9	5.1	10.0	10.2	14.6	10.7	7.8
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated histone lysine methyltransferase 2"	Q96T68	13	49444374-49495003	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB012190: AB_2186195, HPA071677: AB_2686430"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favorable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	5.3	8.9	4.2	10.4	4.6	8.2	11.1	5.7	5.2	7.4	6.2	7.5	6.4	9.0	6.1	5.9	6.3	7.7	10.5	4.7	4.1	8.1	8.0	8.1	16.7	3.4	3.9	16.0	7.1	7.8	3.9	6.3	3.6	7.6	9.3	9.5	8.2	6.9	2.5	7.8	7.2	7.5	3.8	13.1	8.0	15.3	4.7	10.1	11.1	5.3	13.9	6.4	4.7	5.5	3.0	2.0	6.0	6.2	8.3	9.3	3.0	8.4	10.5	7.4	6.9	12.5	7.1	37.1	1.6	5.5	5.5	6.0	6.4	5.7	7.2	8.5	5.6	12.9	5.7	7.6	11.7	19.9	7.1	7.3	10.2	5.6	18.5	8.0	6.3	11.8	5.7	5.0	6.8	2.6	7.6	14.8	3.2	7.9	4.8	14.6	7.5	8.0	6.8	2.8	3.1	3.5	3.7	5.2	18.2	5.1	4.4	17.0	3.8	7.0	2.5	9.4	3.4	6.1	8.9	19.4	2.2	15.9	3.3	3.0	2.7	3.3	4.2	3.6	3.6	5.4	4.4	4.4	4.9	5.5	6.1	4.7	0.9	5.1	3.0	3.4	6.5	2.8	4.2	4.6	5.7	5.2	4.7	4.1	3.4	3.9	3.6	3.8	4.7	5.5	7.8	28.9	13.3	18.6	26.9	6.9	5.7	3.9	7.4	14.4	8.0	7.4	23.2	10.0	8.0	5.5	27.1	5.6	17.0	9.7	9.8	4.0	22.1	8.6	14.7	8.8	11.5	8.8	32.9	4.2	3.3	8.5	9.7	6.8	6.3	18.8	6.4	7.6	17.1	13.5	30.4	7.0	6.1	21.5	19.8	16.5	9.9	26.4	14.2	15.9	13.8	11.0	20.6	24.1	21.5	3.6	3.7	8.2	28.9	3.5	6.7	5.5	9.8	28.1	0.0	7.5	7.7	25.5	13.1	9.2	6.0	2.9	17.3	30.7	8.6	2.5
SETSIP	SETP18	ENSG00000230667	"SET like protein"	P0DME0	1	92074533-92075441	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 1.4;Cardiomyocytes: 3.5;Early spermatids: 1.7;granulocytes: 3.8;NK-cells: 3.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA063683	Approved		Supported	"Nucleoplasm,Lipid droplets"		NA	NA						"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Lipid droplets"	"HPA063683: AB_2685088"	"unprognostic (2.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (7.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.88e-8)"	"unprognostic (3.43e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.35e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.6	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.7	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.1	3.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.6	0.3	0.0	0.0	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.1	0.7	0.0	0.0	0.5	0.4	0.0	0.0	0.9
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354986	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	13.7	9.5	6.2	19.9	8.8	16.8	13.9	9.8	6.3	13.2	7.7	13.1	10.6	12.7	11.1	10.6	10.9	12.7	10.5	5.1	7.8	11.9	16.7	15.4	27.4	8.7	7.0	13.0	9.2	18.3	6.0	14.3	9.6	13.0	12.8	13.2	9.0	12.7	12.9	12.3	13.2	12.8	8.0	27.6	12.9	31.9	7.7	25.4	33.0	12.8	26.3	15.7	8.5	13.2	15.1	19.9	22.5	24.4	28.3	34.1	13.5	19.6	21.9	15.6	14.6	21.1	16.8	25.6	9.4	36.9	38.3	30.2	22.8	17.0	17.0	24.6	9.9	26.9	22.7	18.4	26.5	41.8	31.2	24.0	26.2	26.6	23.6	19.1	25.4	17.8	31.7	20.0	18.3	21.8	25.9	15.8	24.2	25.4	15.4	24.2	32.6	17.2	17.1	19.5	14.0	21.4	32.4	14.2	18.2	29.7	19.7	21.2	29.3	32.5	14.0	22.1	19.0	12.2	22.0	38.6	14.9	16.3	17.8	10.5	4.4	4.7	5.3	4.1	5.6	5.5	3.9	4.1	3.3	6.9	4.2	3.7	15.1	5.2	4.9	5.0	3.2	2.3	6.2	8.8	9.8	6.3	5.1	7.8	8.7	7.0	9.6	8.0	7.7	13.2	76.2	60.9	45.7	75.1	85.6	30.2	34.6	26.6	38.7	31.2	24.1	22.7	61.3	17.2	43.9	20.2	29.2	13.7	96.8	37.6	3.9	20.0	7.6	62.7	68.0	58.7	14.5	25.5	73.7	14.7	10.6	52.9	44.4	89.7	58.2	38.3	51.4	33.0	28.8	67.3	64.8	30.6	16.2	73.1	37.6	13.8	30.7	75.5	12.4	131.2	75.8	20.7	87.6	65.9	113.0	23.2	31.9	36.1	61.8	49.3	25.6	18.5	54.4	28.7	13.1	44.9	42.5	145.2	38.5	35.1	33.5	9.4	65.9	53.7	26.9	46.4
SEZ6L		ENSG00000100095	"Seizure related 6 homolog like"	Q9BYH1	22	26169462-26383597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 60.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 222.1;Inhibitory neurons: 137.7;Oligodendrocyte precursor cells: 586.1"	"Group enriched"	"Detected in some"	6	"glioma: 14.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 5.9;myeloid DC: 5.7;non-classical monocyte: 5.3"	"Group enriched"	"Detected in many"	58	"dendritic cells: 5.7;monocytes: 5.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 39.9;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045135			Approved	Vesicles		NA	NA		6700000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA045135: AB_2732518"	"unprognostic (1.01e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-6)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.18e-1)"	0.1	10.0	25.0	0.5	37.5	0.2	0.0	8.9	50.6	1.1	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	1.3	60.8	52.0	0.0	0.0	0.2	0.0	24.5	23.6	0.0	1.5	0.0	5.8	0.0	19.0	0.2	0.2	4.5	0.2	0.1	0.1	0.3	0.4	0.3	4.0	0.2	1.4	0.3	49.0	0.9	0.1	0.0	0.0	0.1	0.1	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	10.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	5.9	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.5	25.0	37.5	8.9	50.6	60.8	52.0	24.5	23.6	19.0	4.0	49.0	24.9	0.0	0.0	0.0	21.9	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.1	0.2	0.0	0.4	222.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.9	137.7	0.0	0.0	0.0	2.1	2.0	0.6	1.5	0.0	10.3	3.5	0.7	0.0	586.1	5.5	0.6	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356919	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		87000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	36.2	29.7	14.1	45.4	19.0	58.0	35.0	19.2	20.5	33.4	12.6	31.2	29.8	36.3	20.5	34.0	31.8	21.3	28.0	15.3	12.7	25.5	27.5	31.0	44.1	16.6	14.8	46.4	32.9	42.8	24.3	29.0	14.1	29.4	27.0	36.4	33.3	28.1	51.1	40.5	32.8	29.9	13.3	42.0	31.8	49.2	15.9	42.6	31.6	25.8	41.4	33.2	32.8	20.7	86.2	58.9	79.4	77.6	46.4	41.3	94.8	66.5	42.7	71.4	52.8	78.8	55.9	106.4	44.6	47.7	55.9	80.4	101.6	70.8	77.7	97.4	88.4	99.3	69.1	65.3	41.8	202.1	106.3	41.7	49.6	89.5	72.4	40.1	52.1	56.6	112.5	108.0	52.8	49.1	99.4	46.2	132.0	65.7	48.4	139.5	99.4	86.8	40.9	93.6	82.2	74.9	84.4	50.8	78.4	52.5	62.3	65.4	72.9	90.2	80.0	65.1	124.4	83.2	108.2	106.9	69.4	73.8	95.0	6.7	8.9	14.1	10.9	9.8	11.2	10.4	11.0	11.8	9.2	11.0	12.0	11.2	14.1	11.0	13.0	5.6	14.5	8.0	14.1	19.0	19.2	20.5	15.3	12.7	16.6	14.8	14.1	13.3	15.9	20.7	32.4	57.7	66.5	12.1	60.8	26.1	25.4	19.0	37.0	17.6	25.7	24.4	27.6	34.3	30.5	31.3	16.7	32.5	49.2	30.8	17.6	25.7	106.1	30.5	23.1	32.6	25.1	36.1	7.5	29.4	39.7	29.1	35.2	29.1	52.6	76.3	28.2	28.4	40.6	26.9	9.4	30.7	16.2	37.2	28.3	116.8	35.1	39.8	17.8	5.6	58.5	27.1	46.4	6.0	7.1	28.8	31.3	37.6	45.5	26.4	31.8	17.0	39.4	20.3	46.0	29.0	27.3	64.3	41.6	37.8	27.3	34.6	55.8	26.7	33.9	25.8
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523791-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA041134: AB_2677317, HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	15.7	11.2	7.9	19.2	8.2	22.2	13.8	15.9	9.6	16.3	11.4	17.1	13.6	17.0	10.2	19.9	16.4	11.6	12.1	8.8	9.7	12.5	12.3	11.7	24.3	7.0	6.9	22.3	13.8	16.8	7.9	14.1	7.5	11.6	13.2	16.3	12.6	10.7	23.6	19.9	12.9	16.0	6.5	13.9	13.2	10.2	10.4	23.7	14.5	11.7	26.6	14.2	14.4	12.0	72.4	72.6	93.4	65.3	45.5	41.6	74.0	66.3	55.5	84.5	67.3	75.6	55.8	97.1	52.6	51.8	49.9	81.4	98.0	55.7	133.0	31.5	71.1	75.1	56.7	81.0	30.6	106.1	83.9	39.8	40.1	93.9	68.8	54.1	50.9	55.3	104.6	34.2	67.4	87.5	92.9	51.6	85.2	44.8	41.9	163.2	73.3	109.7	26.9	96.4	81.4	59.8	217.7	33.8	33.8	39.2	73.9	53.0	52.7	61.9	67.8	49.2	71.6	37.4	90.4	260.7	40.9	66.9	61.3	23.4	26.1	28.1	35.8	30.8	39.3	28.4	33.1	37.5	35.3	34.3	38.8	33.7	8.3	35.5	31.2	19.1	40.2	37.4	7.9	8.2	15.9	9.6	8.8	9.7	7.0	6.9	7.5	6.5	10.4	12.0	18.9	25.6	25.7	16.6	33.0	22.4	23.2	23.4	13.1	35.5	20.5	18.3	29.3	14.3	25.4	23.9	14.6	33.6	21.6	19.7	7.9	20.7	6.3	17.8	31.9	25.4	21.1	36.8	23.2	23.2	34.7	24.2	20.4	17.5	17.7	52.3	17.5	23.6	23.6	40.4	26.5	21.8	24.4	20.6	12.8	10.3	33.8	19.2	17.8	24.4	22.7	19.4	25.7	26.2	26.7	24.9	14.0	33.1	25.1	30.2	18.1	15.7	18.8	26.7	6.6	30.2	18.8	28.7	33.3	37.6	26.1	25.4	28.3	48.2	31.6	24.7
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261962-41309473	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 299.3;choroid plexus: 509.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 710.9;Breast myoepithelial cells: 1158.6;Cardiomyocytes: 266.3;Leydig cells: 578.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 3203.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"	Yes	No		1300000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: AB_2685376"	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (3.12e-4)"	88.4	12.9	9.2	10.5	12.7	1.4	299.3	18.2	15.0	203.7	509.2	24.5	12.2	132.5	1.8	26.1	98.5	61.3	124.8	29.4	8.5	115.3	6.1	4.7	4.0	29.9	10.5	46.8	6.2	1.4	1.2	19.5	29.7	42.6	30.1	2.2	236.9	102.3	2.6	55.4	18.9	82.9	7.7	21.4	24.4	28.4	10.8	3.1	12.7	32.8	3.2	44.9	95.6	24.7	0.1	29.0	75.9	1.9	67.5	3.9	14.5	132.9	694.5	197.9	187.2	0.0	17.8	0.0	0.6	0.7	15.8	0.9	10.8	53.7	277.6	0.0	2.3	0.0	0.0	0.0	6.4	0.0	0.7	11.8	255.9	19.9	19.3	3203.5	6.2	0.2	0.0	0.0	3.7	0.0	0.0	0.2	205.8	0.1	0.3	0.0	15.7	0.0	422.6	0.0	4.1	18.5	5.5	0.0	41.5	264.7	0.1	2.1	1.9	0.1	19.6	0.2	18.3	0.0	0.0	0.0	0.2	0.0	279.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	12.7	18.2	15.0	29.4	8.5	29.9	10.5	29.7	7.7	10.8	24.7	8.4	0.0	0.0	2.0	1.2	11.2	134.0	1.4	147.4	1.8	710.9	1158.6	266.3	0.0	0.7	62.5	2.1	2.2	9.1	0.0	80.3	4.4	5.0	3.0	131.6	21.0	0.0	0.0	0.2	0.0	82.0	229.5	16.8	3.4	0.0	19.3	53.6	0.3	2.0	1.7	12.1	0.0	0.0	0.3	4.0	25.7	578.4	4.0	99.6	0.0	0.0	76.2	0.0	7.5	20.6	0.1	0.0	130.1	2.1	29.7	0.0	3.2	0.0	1.8	0.0	34.9	18.0	2.3	16.8	53.7	5.5	0.8	7.3	72.6	0.0	9.3
SFXN3	"SFX3, SLC56A3"	ENSG00000107819	"Sideroflexin 3"	Q9BWM7	10	101031234-101041244	"Metabolic proteins, Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 177.5;Proximal enterocytes: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008028, HPA048105"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA008028: AB_1079938, HPA048105: AB_2680265"	"unprognostic (2.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (3.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (3.56e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	20.1	10.7	16.2	11.8	19.0	6.2	14.9	19.4	21.2	17.9	15.7	13.9	31.7	18.0	21.5	8.1	18.3	16.4	15.1	19.7	12.9	12.0	4.3	21.3	7.9	18.5	15.8	12.7	9.1	18.3	9.0	21.0	19.2	12.0	10.4	23.4	11.1	16.5	3.6	22.2	37.5	25.4	12.7	10.7	11.0	7.2	18.2	6.4	9.9	7.9	7.1	14.9	14.7	19.3	44.4	16.9	1.7	5.2	43.5	46.0	4.4	26.4	92.7	33.0	26.4	28.1	47.4	1.9	24.8	62.1	27.7	31.8	7.9	57.7	14.4	12.3	10.2	5.3	27.1	20.4	29.8	4.2	41.2	31.8	8.3	29.1	27.3	91.8	73.5	12.5	0.4	1.4	54.4	7.3	1.9	6.4	2.1	16.2	40.3	4.3	32.5	12.0	48.5	6.8	9.0	44.1	14.4	1.7	39.3	11.8	13.8	31.2	60.9	29.0	22.7	26.0	13.1	6.6	2.7	0.2	70.7	23.7	23.7	10.6	18.1	9.1	11.0	13.4	8.5	2.4	7.4	7.6	19.1	1.1	4.5	5.6	3.2	5.5	7.8	2.9	8.7	11.7	16.2	19.0	19.4	21.2	19.7	12.9	18.5	15.8	19.2	12.7	18.2	19.3	17.1	12.8	5.3	7.5	3.9	13.9	5.0	6.3	2.8	60.2	6.9	7.0	3.2	18.6	4.6	5.5	47.9	1.2	21.2	7.3	1.9	31.7	51.9	25.2	13.4	17.5	5.4	4.8	14.2	15.3	40.9	17.4	7.7	5.6	14.5	55.5	20.0	0.9	37.4	10.1	12.2	7.8	4.1	21.3	29.9	177.5	17.4	24.3	33.8	1.0	12.0	7.7	9.2	5.0	16.0	38.5	10.8	14.7	10.4	2.9	119.1	14.3	38.8	24.0	13.1	6.7	12.0	1.4	0.7	1.3	10.9	10.9	19.7	2.7	5.6	3.4
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165714	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018028, HPA020872"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA018028: AB_1856792, HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	13.3	35.9	9.9	10.1	12.5	16.4	14.1	12.8	13.6	14.2	17.0	21.9	20.4	11.1	13.5	19.1	14.3	8.6	33.1	10.2	12.4	24.5	36.4	8.5	14.4	11.3	12.5	16.0	33.7	23.1	21.5	8.8	11.6	18.8	22.7	5.7	27.8	13.2	51.4	11.5	17.3	12.2	10.6	20.9	17.3	11.9	11.3	11.0	24.7	59.3	17.8	16.4	13.8	12.5	26.2	27.6	8.7	41.8	10.4	19.7	33.0	16.3	19.8	21.0	21.8	45.9	43.2	62.6	15.6	14.9	22.4	48.2	57.5	36.3	24.3	33.1	65.7	28.7	18.4	47.3	37.1	49.7	28.8	21.1	34.4	22.0	63.8	19.5	25.0	46.5	45.2	17.5	13.6	29.6	53.8	60.4	11.8	50.2	32.5	51.7	27.1	49.0	24.3	17.3	25.2	13.9	10.8	42.2	61.9	11.1	26.0	28.4	11.5	10.6	21.9	19.8	37.6	42.6	53.0	56.3	16.2	72.6	7.2	2.5	18.1	1.9	6.5	19.5	10.8	12.5	7.9	7.1	21.2	7.0	12.1	9.8	2.2	7.3	15.9	10.6	6.0	11.1	9.9	12.5	12.8	13.6	10.2	12.4	11.3	12.5	11.6	10.6	11.3	12.5	8.0	6.4	5.6	29.0	16.9	12.0	25.8	39.9	23.3	7.9	17.8	18.2	36.2	12.8	19.1	14.7	2.1	37.6	6.2	13.2	58.7	28.4	27.4	7.6	8.9	8.4	18.0	33.6	22.3	23.8	25.8	12.4	14.3	7.9	5.7	28.5	7.1	31.5	29.2	6.7	29.1	24.7	30.5	17.6	5.0	69.3	8.7	13.1	12.4	8.4	11.3	7.7	10.3	22.1	19.5	17.6	12.1	13.5	31.9	28.0	29.8	65.6	13.5	11.3	6.6	22.3	10.6	27.7	15.2	26.9	9.1	21.9	9.2	44.5	45.8	20.5
SGCB	"A3b, LGMD2E, SGC"	ENSG00000163069	"Sarcoglycan beta"	Q16585	4	52020706-52038299	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 105.7"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 203.7"	"Cancer enhanced"	"Detected in all"		"glioma: 56.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 104.7"	"Low region specificity"	"Detected in all"							"HPA011422, HPA058656"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA011422: AB_1856795, HPA058656: AB_2683790"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.53e-6)"	"unprognostic (3.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (7.61e-4)"	32.7	21.6	27.1	9.5	30.3	0.5	14.7	28.0	32.2	23.4	21.4	32.9	13.1	28.1	11.1	21.9	20.5	19.5	57.2	25.3	27.7	35.0	10.8	15.2	6.1	29.7	28.4	20.1	6.5	47.0	13.9	24.2	30.3	25.0	16.2	16.6	13.5	27.2	105.7	7.2	14.9	37.3	29.0	11.1	14.0	16.0	28.3	5.6	9.2	81.3	4.5	20.4	15.7	33.4	11.4	13.7	27.8	10.6	104.7	78.5	10.1	62.8	79.9	34.5	36.2	3.7	14.9	3.0	11.8	82.9	53.5	5.5	20.9	23.1	36.7	18.8	7.8	0.2	11.8	6.8	42.8	6.8	3.6	86.8	15.9	29.9	17.3	89.8	46.1	10.7	0.1	0.1	74.5	4.4	15.1	0.1	10.0	4.6	20.4	0.0	14.8	0.2	29.2	3.8	16.2	28.4	39.9	1.9	14.1	31.0	5.2	4.1	47.0	50.8	17.0	24.1	56.6	14.9	20.4	5.5	37.5	2.4	59.7	0.3	1.0	0.0	2.1	0.5	2.1	2.6	2.5	2.3	0.5	2.3	1.7	2.2	0.5	0.3	0.4	1.0	4.2	1.0	27.1	30.3	28.0	32.2	25.3	27.7	29.7	28.4	30.3	29.0	28.3	33.4	38.9	32.1	13.1	15.3	6.6	13.4	25.8	70.2	9.6	22.0	8.6	19.7	88.8	25.8	19.6	12.9	6.2	5.7	2.8	15.6	1.9	28.7	61.1	32.6	48.1	27.2	16.3	0.0	17.3	51.8	49.8	64.6	12.8	29.7	2.5	16.7	36.0	15.7	2.8	28.6	21.2	4.2	8.2	2.1	8.7	203.7	38.8	2.7	26.6	24.4	1.9	23.6	1.0	38.7	38.1	53.8	6.0	91.4	4.6	11.7	32.6	64.6	20.4	16.5	46.0	102.8	59.8	12.2	17.4	8.0	10.5	6.3	7.3	14.2	15.1	13.5
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 116.6;Oligodendrocyte precursor cells: 133.2;Oligodendrocytes: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 2.1;memory B-cell: 4.4;naive B-cell: 6.6"	"Group enriched"	"Detected in many"	4	"B-cells: 6.6;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"		Yes	No		170000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: AB_2686713"	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	43.2	63.4	19.9	9.4	21.6	0.4	36.5	22.1	31.6	45.1	20.9	51.6	8.0	43.2	27.1	13.3	40.7	27.6	38.9	19.6	21.0	19.5	14.4	30.5	16.7	23.2	20.6	92.2	21.5	10.9	30.9	52.7	22.4	18.0	12.8	16.8	21.1	31.6	8.5	8.2	19.2	41.8	21.9	25.1	23.8	18.5	20.4	12.8	23.9	19.8	7.2	35.6	34.6	26.7	13.5	42.5	39.6	61.8	63.7	110.8	7.1	51.3	92.3	40.7	60.4	24.9	78.0	12.8	70.4	86.5	83.7	9.4	60.0	21.6	49.1	2.2	32.7	1.4	36.9	28.3	44.0	4.3	0.0	95.5	31.1	64.8	79.3	104.9	30.8	0.0	0.1	93.7	43.5	42.6	0.0	0.0	32.8	8.0	29.0	19.8	51.0	25.8	78.6	13.6	26.2	20.8	0.0	52.2	65.1	44.2	17.6	0.8	0.0	131.1	45.1	11.8	81.7	50.8	67.9	14.8	51.4	0.2	74.2	0.7	0.0	0.1	2.1	0.0	0.8	4.4	0.6	1.0	0.0	6.6	0.2	0.7	0.3	1.0	0.1	0.2	0.2	0.3	19.9	21.6	22.1	31.6	19.6	21.0	23.2	20.6	22.4	21.9	20.4	26.7	39.2	70.5	33.3	66.9	6.1	5.0	18.4	16.8	1.8	18.6	9.7	44.4	18.6	30.0	28.3	20.2	4.2	90.2	1.4	0.0	5.9	42.5	1.6	4.0	17.1	18.8	1.2	0.4	85.2	4.3	26.1	116.6	1.5	6.6	2.5	37.3	58.2	11.2	6.3	20.2	68.5	0.1	12.2	2.5	7.3	3.7	75.5	1.4	51.6	15.9	0.0	31.5	0.0	133.2	116.3	2.1	0.0	58.3	2.6	5.5	0.0	14.1	13.7	30.3	85.5	68.0	60.7	17.1	13.0	0.9	4.0	82.8	2.7	44.0	0.0	2.2
SGF29	"CCDC101, FLJ32446, TDRD29"	ENSG00000176476	"SAGA complex associated factor 29"	Q96ES7	16	28553915-28591790	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 222.2;Late spermatids: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052590, HPA053608"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoli	Nucleoplasm	"HPA052590: AB_2681875, HPA053608: AB_2682205"	"unprognostic (1.38e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.42e-3)"	16.8	16.1	13.6	11.2	15.6	12.4	16.5	16.7	14.6	26.8	13.8	28.0	12.8	29.1	9.5	12.0	27.6	9.1	15.3	13.4	14.9	11.1	19.9	14.0	16.9	15.2	14.4	33.3	25.6	10.7	10.3	7.1	15.4	16.4	7.2	7.8	16.6	16.7	51.1	16.0	18.8	12.0	14.9	16.2	19.8	43.0	14.6	14.1	17.6	19.8	10.2	23.5	16.4	16.8	13.1	21.3	16.3	10.5	10.6	10.9	29.5	8.5	9.6	21.7	20.2	24.6	11.5	39.1	21.1	6.7	13.2	15.0	12.4	15.4	6.1	12.8	24.0	24.3	12.9	33.7	27.1	22.1	26.1	11.5	20.0	13.1	13.2	11.7	8.3	24.5	20.8	19.4	7.9	43.4	25.5	43.2	22.7	9.6	20.5	38.9	10.6	34.2	11.3	19.5	26.3	12.2	13.3	25.3	15.0	5.8	20.7	18.4	5.9	15.4	12.9	9.2	15.3	22.4	35.7	22.7	10.9	36.9	12.5	20.6	47.0	50.0	53.6	41.8	65.2	57.9	74.2	65.8	47.6	65.9	84.1	66.3	13.4	55.1	33.7	71.4	78.3	58.7	13.6	15.6	16.7	14.6	13.4	14.9	15.2	14.4	15.4	14.9	14.6	16.8	11.2	16.0	16.7	0.0	20.0	0.0	18.1	0.0	32.5	5.5	12.5	21.1	0.0	12.8	7.4	18.4	14.6	17.3	27.1	7.9	9.8	12.6	222.2	8.5	10.1	8.7	3.6	17.1	0.0	12.9	11.8	12.7	10.2	7.7	6.3	16.9	11.0	17.3	14.2	0.0	0.0	8.8	0.0	12.9	0.0	384.4	30.7	13.5	0.0	0.0	17.1	11.8	22.6	0.0	0.0	10.1	15.7	21.8	16.7	9.5	40.1	23.7	6.6	14.1	19.7	18.3	13.0	10.5	30.9	17.0	0.0	21.1	21.0	14.8	11.9	12.0
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.3	0.1	0.3	3.3	0.7	8.7	0.5	0.9	0.5	0.4	0.0	2.1	2.3	0.4	0.0	1.9	0.1	0.4	0.1	0.3	0.4	0.3	0.6	0.3	6.2	0.8	0.6	0.2	0.1	0.2	0.0	1.7	0.6	0.2	2.8	0.1	0.4	0.1	0.1	1.1	2.5	1.0	0.3	1.4	1.5	6.7	0.6	13.0	0.2	0.0	6.6	0.9	0.7	1.2	20.3	23.9	29.9	18.5	1.4	2.6	20.2	21.3	10.1	31.2	33.6	16.5	24.0	30.7	10.6	8.6	21.2	11.4	28.7	11.3	37.6	40.9	19.6	34.6	15.6	12.8	0.2	32.0	28.8	0.3	0.9	33.3	13.1	4.0	18.5	34.9	31.3	52.2	24.6	19.4	52.4	15.4	30.0	20.3	17.0	31.8	38.4	17.7	7.5	14.9	14.2	15.4	23.6	27.2	13.1	22.7	18.2	21.3	4.7	22.5	27.3	20.5	43.3	22.8	57.4	35.2	12.5	31.1	35.0	10.0	0.1	1.4	0.2	0.2	0.1	8.8	0.6	0.7	0.3	8.9	0.2	0.3	1.4	0.3	0.2	4.1	2.6	0.6	0.3	0.7	0.9	0.5	0.3	0.4	0.8	0.6	0.6	0.3	0.6	1.2	0.1	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.4	0.0	0.0	0.0	1.8	0.0	16.5	1.5	0.0	0.0	1.1	0.0	2.3	1.6	1.2	0.0	0.0	0.0	1.8	42.6	3.3	0.0	2.9	1.3	20.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.9	1.0	4.3	0.0	0.0
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684216-63728065	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 61.8;Oligodendrocytes: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.8;U-698: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA053149: AB_2682057, HPA064908: AB_2797270"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	7.9	10.6	5.3	6.0	6.0	3.0	6.4	5.8	7.9	6.4	3.6	7.0	3.8	7.4	6.2	4.9	5.7	5.5	4.9	5.3	5.9	15.9	19.5	6.9	13.3	6.6	6.2	5.8	12.7	10.2	5.6	12.0	6.6	7.4	5.3	4.1	4.8	4.0	4.2	3.8	8.8	4.8	7.3	9.3	5.5	5.4	5.8	5.8	5.8	2.6	12.9	5.8	6.8	8.0	19.7	6.2	3.0	8.6	10.7	9.9	35.9	15.7	10.9	9.6	10.7	2.7	10.9	43.8	4.5	8.0	8.0	20.3	4.8	9.3	15.3	17.3	5.7	4.0	3.4	4.4	13.1	7.3	12.2	7.3	14.7	8.4	13.2	9.7	4.6	8.2	2.3	1.2	14.1	7.3	8.6	0.1	2.1	3.2	13.1	2.1	8.4	3.5	15.2	9.7	1.8	5.0	11.0	10.2	8.4	9.2	13.3	2.6	5.2	13.2	9.1	9.5	7.9	10.1	6.5	57.4	9.7	0.0	5.8	6.9	0.2	1.7	0.5	1.4	0.5	1.8	0.5	0.3	0.3	0.4	0.8	0.6	0.2	0.3	2.1	0.1	1.3	0.3	5.3	6.0	5.8	7.9	5.3	5.9	6.6	6.2	6.6	7.3	5.8	8.0	5.3	12.8	16.2	22.2	22.6	9.7	6.1	4.1	8.0	4.0	9.4	5.2	3.8	24.3	3.2	51.5	0.0	23.4	10.9	11.9	0.0	6.0	2.4	6.3	12.1	6.5	18.6	9.7	32.6	9.1	27.0	12.8	3.1	10.1	11.4	5.0	6.1	43.6	23.7	10.1	38.5	10.2	2.0	61.8	20.1	1.2	6.2	18.6	17.8	21.5	6.8	8.2	2.1	31.7	60.0	13.2	13.5	17.0	5.7	8.1	3.2	22.7	2.6	5.4	6.6	8.1	11.3	7.4	3.5	4.6	13.5	33.0	10.4	10.3	10.3	5.6
SGSM2	"KIAA0397, RUTBC1"	ENSG00000141258	"Small G protein signaling modulator 2"	O43147	17	2337498-2381058	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021641, HPA024553"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA021641: AB_2188702, HPA024553: AB_1856512"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.84e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (9.00e-6)"	"unprognostic (2.78e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-2)"	22.2	30.2	84.3	20.2	83.0	28.4	31.0	52.5	102.7	32.1	53.8	37.0	15.5	26.3	51.7	36.0	27.4	21.2	27.1	83.0	81.3	36.5	19.3	28.2	24.3	64.0	67.5	28.9	27.9	27.4	80.7	15.8	62.6	53.7	10.1	15.7	41.9	21.6	21.6	33.3	32.6	17.9	58.4	37.6	33.6	30.0	76.9	17.5	41.4	13.9	14.1	31.8	28.7	68.4	20.7	31.1	27.9	39.0	15.5	18.6	41.4	17.4	20.4	23.6	23.9	31.2	38.6	9.9	18.5	25.3	8.7	28.4	17.2	20.6	8.2	14.5	35.3	17.2	55.6	33.8	13.3	10.4	25.0	20.1	13.4	24.1	13.7	34.1	24.9	26.4	10.5	14.4	14.3	43.5	22.4	14.0	13.7	14.7	13.5	48.5	14.2	8.0	30.5	42.5	13.5	31.9	21.7	16.2	13.4	17.1	41.9	12.3	29.3	18.9	21.5	28.1	23.4	11.8	1.9	9.5	16.4	13.6	17.0	7.0	0.3	1.3	0.9	0.1	0.8	0.1	0.3	0.5	0.4	0.3	1.1	0.6	0.1	0.9	0.0	0.5	0.6	0.4	84.3	83.0	52.5	102.7	83.0	81.3	64.0	67.5	62.6	58.4	76.9	68.4	9.4	6.4	24.7	52.9	5.4	6.8	8.3	13.8	5.7	59.6	31.9	24.0	15.6	11.5	23.5	12.9	135.5	13.8	9.3	7.1	0.0	6.7	18.2	9.9	11.0	11.8	13.8	5.7	39.7	4.5	8.8	10.0	14.3	14.7	20.3	18.1	14.3	8.3	7.8	30.3	38.2	9.9	16.2	7.6	9.9	38.1	8.1	9.2	5.4	16.9	6.3	11.9	7.2	22.6	10.3	6.4	4.5	12.0	4.6	15.0	7.0	4.0	16.5	51.2	19.7	9.6	11.0	4.1	6.7	11.9	7.7	14.1	11.6	15.2	8.2	13.5
SH2B1	"FLJ30542, SH2B"	ENSG00000178188	"SH2B adaptor protein 1"	Q9NRF2	16	28846600-28874212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060663, HPA076175"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA060663: , HPA076175: AB_2686782"	"unprognostic (3.60e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.27e-3)"	"unprognostic (6.10e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.38e-4)"	"unprognostic (1.39e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.60e-4)"	36.7	57.4	53.8	32.8	54.8	38.6	39.5	58.6	75.2	58.5	42.8	59.7	46.4	54.9	20.9	39.4	54.3	30.0	52.9	53.6	47.0	62.1	44.6	35.6	39.2	49.0	47.8	69.4	53.4	55.2	70.1	20.9	48.8	57.7	28.5	29.1	49.2	36.8	58.2	40.6	57.1	24.8	38.1	63.4	51.9	48.8	51.4	36.5	71.6	50.6	25.2	47.1	44.9	58.4	29.9	43.2	32.3	41.7	33.3	28.2	26.9	30.4	17.1	23.4	25.3	29.0	49.2	27.4	41.7	24.5	20.2	46.4	21.3	33.9	13.2	35.9	27.6	24.4	111.3	45.0	25.2	24.8	22.4	39.4	27.2	32.9	13.3	40.0	27.4	27.8	39.8	39.1	31.3	40.3	37.2	36.4	41.9	15.6	17.3	62.3	19.4	46.1	27.2	22.2	36.9	49.7	14.7	42.4	22.3	19.1	33.4	26.5	38.8	26.9	22.5	23.8	23.6	74.0	40.2	30.9	41.8	43.0	27.5	3.3	1.4	0.6	2.0	1.1	1.9	1.6	1.6	1.4	1.1	1.7	1.2	1.1	2.1	0.6	1.1	1.9	1.8	0.9	53.8	54.8	58.6	75.2	53.6	47.0	49.0	47.8	48.8	38.1	51.4	58.4	14.1	6.4	13.7	37.5	13.9	10.8	15.9	15.4	22.8	26.7	17.4	13.8	18.4	17.2	15.7	22.0	33.3	16.6	12.8	31.1	15.6	9.5	2.2	11.0	11.0	12.7	27.6	7.8	25.6	12.9	8.2	15.0	19.4	11.4	6.3	20.1	13.9	8.9	12.2	28.6	26.8	24.7	14.2	8.7	7.2	5.4	22.1	10.8	3.6	13.1	10.7	18.1	22.6	21.6	19.0	12.8	24.9	23.7	10.5	10.4	26.3	10.2	12.5	28.9	26.3	12.9	15.7	9.9	12.8	17.4	11.1	13.7	15.3	20.4	28.4	12.3
SH2D3A	NSP1	ENSG00000125731	"SH2 domain containing 3A"	Q9BRG2	19	6752160-6767463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 117.9;Pancreatic endocrine cells: 81.3;Urothelial cells: 87.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 43.2;HaCaT: 34.2;HBEC3-KT: 67.4"					"Not detected"	"Not detected"			"HPA035722, HPA064382"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA035722: AB_10670024, HPA064382: AB_2685251"	"unprognostic (3.32e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.63e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.21e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (7.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.81e-3)"	0.9	0.4	0.2	4.6	0.2	3.4	7.5	0.1	0.6	8.0	0.5	12.8	14.3	1.2	1.0	32.5	4.3	3.5	0.6	0.1	0.1	19.6	2.6	10.8	5.2	0.4	0.2	0.8	19.7	5.9	2.8	5.9	0.2	18.1	5.4	0.9	18.7	4.1	1.5	27.6	14.4	0.3	0.2	5.7	14.2	4.4	0.3	3.3	13.0	0.0	4.1	9.1	17.0	0.5	43.2	6.2	0.1	0.2	0.0	0.0	22.6	0.3	0.0	0.0	0.0	20.3	30.8	6.6	19.6	0.0	0.0	34.2	2.3	67.4	0.0	3.6	6.6	0.3	6.9	2.6	0.1	0.6	8.6	0.0	30.3	0.0	5.9	0.8	0.0	14.8	7.3	14.3	0.0	15.3	3.2	0.2	1.6	21.5	12.0	1.2	0.1	24.8	11.5	31.4	0.0	0.2	2.3	31.7	0.1	1.0	22.0	0.4	0.7	0.7	2.2	0.5	0.4	14.1	15.8	9.2	0.2	4.8	0.3	0.1	0.0	0.0	2.6	0.1	4.2	3.6	5.9	5.2	0.1	5.6	7.7	4.2	0.1	1.8	0.1	0.4	3.2	0.9	0.2	0.2	0.1	0.6	0.1	0.1	0.4	0.2	0.2	0.2	0.3	0.5	0.7	19.2	14.2	0.3	25.8	30.7	117.9	51.4	25.0	4.1	13.6	11.4	1.9	40.0	43.9	40.5	10.4	23.8	7.7	46.6	1.9	54.1	1.6	15.4	2.9	2.8	12.1	7.8	0.1	37.1	52.8	2.6	50.0	24.9	5.7	0.3	1.8	2.9	3.6	0.0	0.2	37.9	28.5	0.6	10.3	0.8	0.6	2.2	3.6	0.0	4.2	0.8	14.4	0.0	0.1	81.3	69.7	0.0	8.0	58.6	53.9	13.1	27.0	4.6	0.0	2.2	3.5	8.7	11.4	17.6	39.9	10.8	18.0	1.1	32.0	87.9
SH2D7	LOC646892	ENSG00000183476	"SH2 domain containing 7"	A6NKC9	15	78077808-78104909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	7	"intestine: 2.1;testis: 3.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 21.1;Late spermatids: 35.1"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA051320, HPA058382, HPA076728"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA051320: AB_2681439, HPA058382: , HPA076728: "	"unprognostic (1.22e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	1.6	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.1	1.7	0.1	0.2	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.7	1.3	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	21.1	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	3.0	0.0	0.0	0.4	0.0
SH3BGRL3		ENSG00000142669	"SH3 domain binding glutamate rich protein like 3"	Q9H299	1	26280086-26281522	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2516.1;Langerhans cells: 2368.4;Pancreatic endocrine cells: 2492.4;Urothelial cells: 2342.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030848, HPA076219"	Enhanced		Approved	"Nuclear bodies"		NA	NA		41000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nuclear bodies"		"HPA030848: AB_10602398, HPA076219: AB_2686787"	"unprognostic (4.97e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (2.17e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.43e-2)"	221.9	102.0	289.8	423.0	302.9	530.2	141.8	306.0	380.2	135.5	269.7	416.3	161.9	85.8	708.2	368.2	101.4	177.5	120.8	299.4	321.7	115.9	121.6	289.5	404.4	316.2	340.4	66.7	157.4	85.5	83.2	155.4	320.6	82.5	437.9	32.2	139.6	112.3	47.6	305.9	164.7	202.6	297.0	313.1	223.2	26.2	351.0	306.7	82.9	81.0	437.0	424.5	176.3	325.7	501.1	274.9	187.5	265.7	769.3	2090.9	23.2	895.6	1315.0	959.2	611.0	220.3	460.4	120.8	297.9	1963.3	268.2	182.6	108.9	1030.2	642.6	192.0	109.3	976.3	212.1	213.3	604.8	280.1	1447.9	836.8	652.4	912.9	742.0	1115.0	1200.3	244.7	112.2	430.6	1767.3	337.8	182.1	478.2	221.6	434.8	2003.4	341.1	229.0	170.5	762.6	216.7	119.7	189.8	331.2	338.1	374.1	199.3	65.7	431.9	1451.5	1071.0	370.8	1492.9	402.3	135.7	241.6	104.0	2253.9	792.3	532.5	4277.3	7085.6	6427.9	4340.1	6247.2	3228.5	2422.2	3706.5	4249.4	5891.3	2181.2	1591.2	3072.9	7753.8	2344.8	6190.5	3152.1	5092.0	13045.6	289.8	302.9	306.0	380.2	299.4	321.7	316.2	340.4	320.6	297.0	351.0	325.7	445.2	96.1	168.0	9.8	603.5	984.1	995.1	708.3	373.9	17.1	216.7	227.1	7.8	193.0	290.5	367.8	4.2	133.1	1060.9	1614.6	313.1	1108.5	15.8	178.9	410.9	502.9	339.8	220.0	12.9	1031.5	436.1	493.8	388.4	344.0	1017.6	67.2	346.6	121.7	2516.1	16.8	8.2	1430.3	205.4	1796.4	2368.4	52.8	139.1	2209.6	779.1	16.9	1116.8	76.9	1251.3	4.0	20.2	2492.4	1309.6	162.1	397.9	1754.9	391.7	498.6	202.8	16.4	151.2	71.9	336.4	9.1	23.5	788.1	1058.7	227.1	1380.4	99.2	507.5	2342.3
SH3BP1	ARHGAP43	ENSG00000100092	"SH3 domain binding protein 1"	Q9Y3L3	22	37634654-37656117	"Metabolic proteins, Predicted intracellular proteins"	Phagocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.5;HMC-1: 45.4;NB-4: 44.7"	"Low region specificity"	"Detected in all"							HPA000757	Supported		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA000757: AB_1079951"	"unprognostic (7.81e-3)"	"unprognostic (7.91e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.78e-1)"	"prognostic unfavorable (3.48e-7)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.37e-2)"	"unprognostic (8.48e-3)"	4.2	3.6	3.4	14.2	3.4	14.4	3.4	3.7	6.2	12.2	2.7	19.4	18.1	3.2	0.7	37.7	4.0	2.1	2.0	4.1	4.5	3.2	2.6	8.8	12.1	6.0	3.9	3.4	2.8	2.2	2.1	5.1	4.7	7.6	4.5	0.2	9.3	2.0	0.7	27.0	20.9	2.0	4.8	27.0	4.3	5.7	4.7	8.2	2.5	0.5	7.7	10.5	21.1	5.7	20.1	1.0	3.9	3.4	0.9	3.9	28.6	3.8	6.4	6.3	7.0	5.9	2.3	12.6	2.7	2.4	2.0	43.5	2.0	26.0	2.6	36.9	13.7	18.5	0.6	8.6	3.3	25.9	45.4	4.9	6.3	7.9	0.9	5.2	1.0	6.3	6.4	4.8	0.6	12.7	3.0	44.7	7.6	13.7	3.8	15.7	3.2	11.0	0.8	22.2	3.8	10.1	1.0	5.3	17.9	3.9	6.7	22.1	1.3	2.3	10.8	0.5	0.2	29.9	10.2	9.0	3.2	26.4	13.0	1.8	1.4	4.6	1.0	1.8	1.0	0.3	1.1	1.1	0.7	0.1	0.6	1.4	0.9	0.8	3.7	1.2	1.1	0.6	3.4	3.4	3.7	6.2	4.1	4.5	6.0	3.9	4.7	4.8	4.7	5.7	1.2	0.0	7.2	0.7	23.7	19.1	22.2	42.5	23.3	0.3	3.3	4.1	1.2	4.3	8.0	0.0	2.1	47.5	36.1	55.0	0.0	3.0	0.4	0.6	4.3	1.7	4.2	7.8	5.6	4.7	43.9	6.0	11.2	1.3	14.0	3.4	4.2	0.5	48.3	8.4	0.8	29.9	12.2	33.3	19.0	0.1	5.0	45.6	5.4	2.8	36.0	3.0	53.5	5.0	0.9	2.0	46.8	1.9	20.9	29.6	41.9	0.3	11.4	0.5	0.0	0.9	3.6	3.4	6.0	23.6	15.3	37.5	52.7	5.0	23.6	42.0
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254353-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 200.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.9;Early spermatids: 192.2;Extravillous trophoblasts: 356.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 349.3;MCF7: 118.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: AB_2683572"	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	78.3	200.5	21.2	35.2	22.7	72.6	72.0	38.4	26.1	71.1	16.0	27.4	15.7	77.5	13.5	26.9	85.6	45.7	24.1	23.3	21.0	52.8	17.3	73.2	59.9	21.4	20.0	116.2	15.9	47.9	35.7	40.8	22.4	25.0	8.4	27.4	49.9	34.1	71.7	25.6	27.0	37.3	20.8	30.9	16.1	30.9	20.9	37.4	51.1	19.1	35.7	33.0	50.6	35.1	27.4	16.5	6.4	14.1	53.1	46.8	349.3	13.6	10.9	9.3	10.4	10.8	13.4	21.3	6.2	40.8	16.1	3.6	2.9	14.2	5.9	19.5	12.8	15.7	72.3	1.9	21.9	4.4	8.6	36.9	9.3	41.6	7.9	34.2	116.0	31.3	18.4	8.5	10.3	118.1	57.6	23.2	13.6	3.5	20.6	1.1	27.2	115.6	8.8	53.5	16.8	7.8	18.6	19.2	21.7	21.6	18.1	10.9	84.3	22.8	29.5	21.9	12.0	3.3	7.6	15.2	44.7	16.3	31.5	8.1	7.8	9.1	52.9	2.5	15.9	19.1	24.1	36.1	8.9	24.3	12.9	16.6	13.9	25.4	4.6	3.9	11.1	20.4	21.2	22.7	38.4	26.1	23.3	21.0	21.4	20.0	22.4	20.8	20.9	35.1	195.9	0.0	16.3	2.3	115.2	17.0	6.0	8.2	11.4	41.3	23.5	32.1	0.7	5.7	13.9	68.0	14.6	12.5	73.7	0.6	3.9	2.7	192.2	13.1	33.0	150.7	2.4	7.0	49.5	8.7	356.3	97.5	3.6	13.7	2.5	28.1	165.0	7.0	33.1	65.6	38.4	2.5	12.2	87.2	133.3	97.8	49.0	113.1	33.8	26.2	33.3	5.1	167.9	12.5	60.6	3.2	1.1	118.5	67.1	8.5	4.7	36.2	7.5	44.4	6.6	56.8	13.4	3.0	4.5	14.2	12.1	173.2	51.5	81.6	1.4	10.2
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579066-17797124	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 123.8;retina: 75.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	0.3	0.2	63.0	0.1	69.0	0.0	0.1	92.3	123.8	2.3	1.9	0.5	0.2	2.2	1.2	0.5	2.0	0.0	4.3	77.7	26.6	16.8	0.2	1.1	0.0	27.9	28.5	1.8	3.0	0.3	26.2	0.0	25.9	1.8	0.6	75.0	0.1	0.1	0.1	0.1	0.5	1.7	29.3	0.1	8.7	6.5	41.1	0.7	1.5	0.0	0.0	4.3	0.4	55.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	7.5	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	9.3	0.0	21.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.1	0.2	2.5	0.0	2.4	0.0	0.0	0.0	0.0	41.8	26.5	0.0	0.3	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.2	0.0	1.5	0.0	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	69.0	92.3	123.8	77.7	26.6	27.9	28.5	25.9	29.3	41.1	55.5	0.0	0.0	0.0	16.3	0.0	0.1	0.4	0.0	0.0	89.4	0.1	0.0	1.8	0.0	0.0	7.3	22.9	0.0	0.0	0.1	11.7	0.0	16.7	0.2	0.1	0.3	5.3	0.0	390.8	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	13.5	140.9	0.7	0.0	0.0	0.3	47.4	1.2	0.1	0.0	13.1	0.1	9.0	0.0	41.7	10.2	0.2	0.1	0.4	0.0	2.2	0.0	22.2	0.0	28.0	0.0	0.0	0.1	2.4	6.1	0.0	0.0	0.1	0.0	1.2	0.7	0.4
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 634.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 301.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	106.5	38.1	20.5	55.3	22.5	66.2	56.1	21.0	25.4	39.2	15.7	53.7	48.4	35.9	31.0	79.4	27.9	47.0	72.8	19.2	23.7	40.4	45.0	49.0	40.9	25.3	19.7	24.2	64.0	41.3	30.3	57.5	24.4	34.3	57.9	39.0	56.4	36.1	172.0	35.8	47.0	50.3	23.4	46.5	36.3	109.5	21.0	34.1	38.6	98.4	51.9	63.8	41.8	27.4	78.1	28.1	44.2	40.4	180.1	155.1	72.2	115.1	114.5	106.8	112.3	81.4	63.3	39.7	72.0	143.5	132.9	44.5	39.4	75.0	101.2	86.1	28.1	94.7	39.2	87.1	108.7	51.5	92.4	111.8	85.5	118.3	128.7	114.5	171.4	41.7	36.0	108.5	145.1	23.1	46.7	32.7	43.0	56.8	47.6	53.1	184.6	29.7	92.3	132.2	47.9	34.7	64.8	82.4	140.8	65.2	32.7	51.8	151.4	102.2	61.9	129.3	96.5	56.8	56.3	58.6	50.8	52.1	63.5	153.0	59.0	66.5	43.0	64.5	42.4	36.8	40.2	43.8	45.5	35.3	19.1	34.3	301.4	62.4	77.0	43.8	65.4	49.5	20.5	22.5	21.0	25.4	19.2	23.7	25.3	19.7	24.4	23.4	21.0	27.4	192.0	83.3	65.6	39.2	75.0	89.6	119.5	124.1	44.3	31.2	96.9	69.1	157.0	60.1	104.0	55.2	52.1	84.3	145.7	182.0	86.1	145.2	634.6	86.3	104.5	135.4	86.6	64.4	49.9	169.8	203.4	99.7	45.9	110.0	113.5	61.0	157.1	79.4	143.7	16.8	50.5	130.3	128.1	149.2	99.4	236.9	70.2	116.0	81.8	40.3	163.7	71.9	124.6	46.8	65.2	201.7	173.4	85.0	123.9	103.4	108.8	134.0	90.2	55.4	78.9	146.7	111.7	403.5	86.3	100.6	118.1	101.9	90.4	57.1	87.4	199.8
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094259-169270956	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 146.3;Oligodendrocytes: 213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.2;myeloid DC: 2.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.5;monocytes: 6.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	9.8	3.7	8.7	4.4	10.0	3.4	8.2	7.6	13.1	5.7	5.9	15.1	13.8	4.3	5.7	5.9	5.6	11.9	5.7	18.2	8.6	12.2	8.0	9.4	3.3	8.8	9.7	8.5	10.4	3.7	3.7	7.4	9.4	14.3	13.6	2.4	15.8	8.4	9.4	5.1	13.1	4.0	8.2	3.9	24.7	6.1	9.5	2.0	19.9	10.0	3.2	9.3	4.4	13.0	15.2	12.2	11.0	31.9	11.5	14.3	14.1	40.5	19.7	30.0	13.8	12.5	17.8	0.0	1.9	43.1	8.1	9.8	8.9	16.2	32.4	0.1	5.2	8.7	27.4	6.5	26.0	3.1	0.3	8.5	8.6	25.7	19.9	37.3	18.7	3.3	0.1	0.0	27.8	6.0	3.1	2.9	5.6	19.2	10.5	4.5	3.6	0.6	13.6	11.8	8.3	9.9	10.4	15.7	4.2	4.7	5.2	1.3	17.1	14.2	11.0	23.6	14.7	1.1	0.0	0.1	16.0	3.0	17.3	0.0	1.0	0.0	0.0	4.2	0.0	0.3	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.2	6.7	0.2	0.0	0.6	8.7	10.0	7.6	13.1	18.2	8.6	8.8	9.7	9.4	8.2	9.5	13.0	28.0	64.1	37.7	146.3	3.4	34.3	48.3	11.9	13.6	3.5	21.1	15.6	11.2	44.3	34.4	27.6	0.0	12.7	0.4	69.3	11.7	42.2	5.5	28.5	14.2	13.0	31.3	2.1	54.9	63.7	22.1	16.5	65.7	46.5	10.2	5.6	11.4	12.4	7.4	0.0	54.9	27.1	12.2	9.3	5.3	3.5	12.2	11.1	3.6	52.5	3.9	11.3	0.0	89.5	213.0	68.4	37.2	12.0	2.4	63.2	28.9	18.4	31.7	1.2	65.7	24.1	36.9	5.4	10.7	9.4	12.6	13.1	1.7	6.5	34.4	72.0
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129205-109504634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 47.0;Excitatory neurons: 108.3;Inhibitory neurons: 160.9;Microglial cells: 164.9;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.8;RPMI-8226: 20.5;TIME: 23.2;U-266/84: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044822: AB_2679103, HPA048444: AB_2680396"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	6.1	6.7	4.7	3.0	6.1	0.8	4.3	1.3	6.5	5.5	1.6	5.6	1.1	3.7	0.7	2.8	4.8	4.4	6.0	6.3	3.2	6.8	1.1	7.2	2.1	3.0	4.5	3.2	2.0	0.5	1.9	5.2	2.8	4.7	1.4	0.6	1.6	4.4	5.7	3.1	3.3	3.8	3.1	2.1	2.9	4.2	3.9	3.2	2.5	7.3	1.2	5.5	4.2	3.5	0.0	0.1	0.1	2.2	9.0	6.9	0.0	4.2	12.2	3.1	1.1	1.1	0.0	0.0	3.1	3.1	0.7	0.0	0.2	1.8	1.3	0.0	4.2	0.0	0.2	0.0	19.8	0.1	0.0	12.0	2.9	14.1	6.3	1.8	11.4	2.2	0.0	11.7	7.3	0.0	0.0	6.5	1.1	0.0	12.0	2.6	0.0	20.5	0.0	0.0	0.7	2.5	0.0	0.0	0.4	0.1	0.2	0.0	23.2	4.0	12.0	11.5	5.5	4.0	28.6	0.0	0.0	6.3	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.7	6.1	1.3	6.5	6.3	3.2	3.0	4.5	2.8	3.1	3.9	3.5	5.3	0.0	0.0	47.0	0.2	1.9	0.4	0.2	1.8	0.5	0.6	0.5	10.7	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.0	1.1	2.6	9.4	9.6	6.7	1.8	0.0	108.3	0.2	0.2	4.8	0.0	1.1	0.0	0.2	7.5	0.0	4.7	10.1	160.9	0.8	0.0	2.5	1.5	5.2	2.1	1.2	5.4	164.9	0.0	1.7	0.0	42.3	1.9	0.1	0.0	3.0	1.6	0.2	0.0	0.6	2.1	0.0	13.1	3.2	6.8	0.7	9.6	0.8	0.9	0.1	0.5	2.3	0.1	0.0
SH3TC2	"CMT4C, KIAA1985"	ENSG00000169247	"SH3 domain and tetratricopeptide repeats 2"	Q8TF17	5	148923639-149063163	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.6;retina: 3.9"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 270.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;HBEC3-KT: 2.2;RT4: 3.6;SK-MEL-30: 5.2;WM-115: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037683, HPA037684"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No				"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA037683: AB_2675608, HPA037684: AB_10672603"	"unprognostic (6.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.18e-2)"	"unprognostic (4.53e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.40e-1)"	0.1	0.0	4.7	0.0	8.0	0.1	0.1	5.1	5.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	3.6	5.1	0.0	0.0	0.0	0.0	7.1	6.9	0.0	0.0	0.0	0.0	0.4	7.3	0.0	0.0	3.9	0.1	0.1	0.2	0.1	0.0	0.0	5.8	0.0	0.0	1.5	7.1	0.0	0.0	0.1	0.0	0.1	0.0	12.6	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.3	0.1	2.6	1.5	0.0	1.8	0.1	0.6	1.9	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	1.6	0.0	1.3	0.0	0.7	3.6	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	8.0	5.1	5.0	3.6	5.1	7.1	6.9	7.3	5.8	7.1	12.6	1.9	3.2	3.7	0.3	0.1	0.9	0.8	1.0	0.0	1.4	0.7	0.4	1.7	1.5	3.8	0.0	4.2	0.8	0.0	0.6	0.0	0.6	6.4	0.3	0.1	2.8	0.0	0.0	0.4	0.2	0.4	0.5	0.0	0.5	2.5	0.1	1.4	0.3	0.4	0.0	0.4	0.0	2.0	1.8	0.7	2.3	0.3	2.2	0.0	4.7	0.1	2.3	0.0	0.0	270.4	1.6	0.0	0.0	0.1	1.2	0.0	0.1	4.1	25.4	0.0	0.3	0.4	2.3	0.9	1.0	0.9	11.9	0.3	0.1	0.2	8.8
SHANK2	"CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3"	ENSG00000162105	"SH3 and multiple ankyrin repeat domains 2"	Q9UPX8	11	70467854-71252577	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.5;Horizontal cells: 136.3;Inhibitory neurons: 167.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"amygdala: 7.7;basal ganglia: 7.5;cerebral cortex: 9.3;hippocampal formation: 9.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.5;Karpas-707: 17.5;RT4: 15.9;T-47d: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008174, HPA017220"	Approved		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane"	"Nuclear speckles"	"HPA008174: AB_1856822, HPA017220: "	"unprognostic (3.08e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.23e-5)"	"unprognostic (1.24e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (1.94e-6)"	"unprognostic (3.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.80e-2)"	1.3	1.2	7.7	0.5	7.5	0.0	4.5	0.2	9.3	1.3	31.7	2.4	1.5	1.0	2.2	3.4	5.1	0.8	0.0	9.5	0.0	4.9	3.8	3.7	0.1	0.0	0.0	0.1	7.5	0.1	2.2	1.9	0.0	3.2	2.0	5.5	9.8	1.8	0.0	0.9	1.3	0.4	0.0	1.1	3.0	0.9	1.0	0.0	6.0	0.0	0.4	1.1	0.3	0.9	0.5	7.4	4.1	0.0	0.6	0.4	4.5	0.7	0.3	0.0	0.0	6.6	3.1	6.2	2.2	0.0	0.1	1.1	0.0	4.8	0.0	0.0	0.2	0.0	0.0	11.5	0.0	0.0	1.9	0.1	1.8	0.0	0.0	1.6	0.0	0.1	0.0	17.5	1.7	10.5	0.0	0.1	3.5	10.2	0.3	0.0	9.9	8.2	5.2	15.9	3.5	1.1	0.0	8.4	0.0	5.2	16.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	7.5	0.2	9.3	9.5	0.0	0.0	0.0	0.0	0.0	1.0	0.9	8.0	41.7	17.0	21.5	0.2	0.0	3.2	3.2	0.6	17.9	26.9	13.0	3.7	11.5	5.4	7.3	0.0	12.8	0.4	3.2	3.9	8.4	1.7	30.0	3.2	1.3	0.0	0.0	153.5	2.2	2.9	1.8	10.2	13.0	2.5	1.2	0.4	21.9	1.2	136.3	167.5	7.9	8.2	0.0	0.3	2.1	0.0	0.4	5.4	14.0	0.0	4.6	0.0	41.7	5.3	10.7	2.7	0.7	0.4	10.9	0.6	10.8	23.3	1.0	0.0	0.3	1.3	0.7	0.9	1.3	0.6	14.6	0.3	0.1	5.5	4.0
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46578591-46621379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.4;lymphoid tissue: 10.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	0.7	0.5	0.5	5.1	0.5	17.4	0.9	1.2	0.6	0.6	0.4	1.9	1.2	0.6	0.6	3.5	0.2	0.6	1.0	0.4	0.2	5.4	0.2	1.0	9.8	0.4	0.3	0.3	0.2	0.2	0.2	2.4	0.4	0.3	2.2	0.2	0.8	0.2	1.5	3.3	1.5	1.7	0.1	4.4	0.9	5.2	0.5	8.8	0.3	0.2	10.6	1.2	1.2	0.7	33.8	30.8	11.9	15.3	3.1	6.2	16.2	60.7	24.6	59.2	26.8	14.6	20.8	28.0	30.2	28.8	26.8	21.0	29.3	21.7	73.8	17.7	17.2	28.2	25.8	30.3	0.1	28.5	35.4	1.2	1.6	45.9	18.1	5.9	33.0	14.9	12.7	28.3	69.7	21.5	24.0	23.7	10.0	17.2	31.6	45.4	89.9	44.8	13.7	9.4	5.0	7.2	46.0	23.7	11.1	11.4	13.0	23.4	16.1	43.9	28.7	43.5	54.0	24.9	36.7	46.7	21.4	31.3	45.8	0.2	0.3	0.6	0.2	0.5	0.0	1.7	0.3	0.1	0.3	1.2	0.0	0.1	0.4	0.1	2.4	0.7	1.2	1.1	0.5	0.5	1.2	0.6	0.4	0.2	0.4	0.3	0.4	0.1	0.5	0.7	0.2	0.0	1.1	1.3	7.1	1.7	0.7	1.2	0.0	0.3	0.6	1.1	1.9	1.5	1.4	0.0	0.0	11.3	0.8	1.9	0.0	0.2	8.4	0.7	1.7	1.7	0.0	36.2	2.1	0.0	28.7	3.7	4.1	1.5	0.0	7.6	1.8	0.3	12.6	0.0	0.7	2.2	2.0	4.5	3.3	2.3	0.6	4.0	1.8	2.8	2.8	0.8	0.0	1.0	0.5	0.1	0.1	0.4	38.3	0.5	0.4	0.1	0.1	0.3	0.0	0.5	6.3	33.7	23.7	3.6	0.6	3.7	2.2	0.8	3.4	1.1
SHD		ENSG00000105251	"Src homology 2 domain containing transforming protein D"	Q96IW2	19	4279266-4290722	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 10.0;heart muscle: 17.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 137.5;Hepatocytes: 57.3;Intestinal goblet cells: 54.6;Paneth cells: 78.8;Proximal enterocytes: 43.1;Undifferentiated cells: 49.4"	"Cancer enhanced"	"Detected in some"		"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	178	"plasmacytoid DC: 17.8"	"Lineage enriched"	"Detected in single"	178	"dendritic cells: 17.8"	"Group enriched"	"Detected in some"	45	"RH-30: 58.4;SH-SY5Y: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017955	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite, Cytosol"		"HPA017955: AB_1856828"	"unprognostic (2.41e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.16e-4)"	0.0	0.1	4.2	0.6	3.6	0.7	0.0	7.0	8.6	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.1	17.8	2.4	9.6	0.0	1.5	0.0	0.6	7.4	6.4	0.0	0.0	0.1	0.2	0.0	5.6	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	4.6	0.1	0.0	0.1	10.0	0.1	0.0	1.7	0.3	0.1	0.0	6.0	0.0	0.0	0.7	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	58.4	0.1	0.0	0.0	0.5	193.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	4.2	3.6	7.0	8.6	2.4	9.6	7.4	6.4	5.6	4.6	10.0	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.8	21.7	137.5	1.9	0.0	0.1	0.1	0.0	0.2	13.2	5.3	2.8	0.0	0.6	0.4	0.0	0.1	8.9	0.0	0.7	57.3	0.4	10.1	4.2	54.6	0.0	0.6	0.0	0.4	0.0	0.6	0.0	1.0	0.2	0.9	0.0	9.0	0.3	0.0	78.8	0.0	0.0	0.0	43.1	0.0	0.0	0.4	0.0	2.5	0.1	0.0	2.9	0.0	0.0	4.4	0.8	0.0	49.4	0.0
SHFL	"C19orf66, FLJ11286, IRAV, RyDEN, SFL"	ENSG00000130813	"Shiftless antiviral inhibitor of ribosomal frameshifting"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Antiviral defense"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;dendritic cells: 21.7;Fibroblasts: 6.8;Hofbauer cells: 32.6;Plasma cells: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 71.8;BJ hTERT+ SV40 Large T+ RasG12V: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042001: AB_10794167"	"prognostic favorable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favorable (1.35e-4)"	12.8	18.5	27.1	14.2	27.4	15.7	12.2	26.3	30.1	17.0	24.4	12.8	14.8	15.8	16.5	8.6	17.6	18.1	8.2	27.2	28.5	14.0	75.7	16.8	22.8	27.3	27.0	18.9	9.9	16.7	14.1	12.7	27.2	11.9	9.9	15.0	16.3	19.1	4.4	9.5	18.4	15.4	28.8	19.9	11.0	4.3	29.5	20.4	12.2	6.9	16.6	14.7	12.3	28.1	9.4	3.8	5.0	3.9	20.3	23.6	1.4	7.6	46.3	71.8	81.2	0.4	7.4	4.8	2.1	24.0	25.7	3.9	3.9	20.7	12.0	30.4	0.4	15.5	3.0	10.6	32.6	4.7	9.7	34.3	11.7	11.5	4.1	27.1	22.9	20.6	1.8	20.2	15.0	6.5	20.1	13.3	1.1	7.0	5.5	16.2	0.0	8.0	14.8	13.0	0.7	3.5	12.9	1.3	42.2	0.9	1.2	12.9	14.8	6.0	3.0	9.6	1.6	24.1	7.2	1.2	16.8	6.0	12.1	16.4	12.8	18.2	23.3	11.7	31.1	13.0	19.5	25.4	10.2	10.1	16.3	17.7	16.4	32.7	20.3	2.0	21.7	15.5	27.1	27.4	26.3	30.1	27.2	28.5	27.3	27.0	27.2	28.8	29.5	28.1	23.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	6.8	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.6	3.3	0.0	0.0	0.0
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243665-44312951	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.2;endometrium 1: 33.6;smooth muscle: 29.3"	"Cell type enriched"	"Detected in single"	6	"Endometrial stromal cells: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SiHa: 36.2;U-2197: 80.8;U-87 MG: 46.3;WM-115: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol		No	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Vesicles, Cytosol"		"HPA051178: AB_2681374"	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	1.0	1.8	18.6	1.2	17.2	0.0	0.2	0.0	21.4	16.6	0.0	18.7	1.9	33.6	0.4	1.6	4.5	3.1	0.9	18.0	15.3	0.5	0.1	0.3	0.4	10.8	17.8	1.0	0.8	0.1	2.6	0.5	2.4	3.7	2.0	5.6	0.3	11.0	0.0	0.7	2.4	29.3	0.3	0.1	1.6	1.1	43.2	2.6	0.4	0.1	0.7	11.9	5.2	2.8	0.0	0.3	3.5	1.2	0.0	0.0	0.0	1.0	2.3	2.4	1.4	0.0	0.0	0.0	0.0	2.3	14.5	0.0	5.0	0.3	0.3	0.0	2.3	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	1.8	11.2	0.5	0.0	0.0	0.1	0.1	0.0	0.4	0.0	3.3	0.0	0.8	0.0	0.0	0.1	0.0	0.0	12.9	0.0	36.2	0.1	0.2	0.4	0.0	0.3	0.1	13.1	2.0	80.8	0.5	0.0	0.0	0.0	46.3	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	17.2	0.0	21.4	18.0	15.3	10.8	17.8	2.4	0.3	43.2	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SHKBP1	"PP203, Sb1"	ENSG00000160410	"SH3KBP1 binding protein 1"	Q8TBC3	19	40576853-40591399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 127.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041887	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Cell Junctions"		"HPA041887: AB_10794639"	"unprognostic (1.26e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.52e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.64e-2)"	33.7	32.1	14.6	39.4	16.5	66.8	29.1	15.3	19.4	35.3	15.4	34.9	18.4	34.4	7.7	47.0	33.3	14.4	29.6	14.8	16.1	42.3	30.0	52.3	40.9	19.7	16.6	25.2	37.6	15.8	21.8	14.3	17.2	35.1	10.4	1.3	31.7	13.5	15.8	32.6	45.5	15.8	15.6	127.1	41.2	17.2	19.4	29.5	35.0	6.8	25.0	36.5	35.6	20.0	70.9	107.1	21.1	30.2	18.0	20.0	39.7	26.8	39.9	41.1	56.2	46.9	47.5	73.9	52.1	42.3	35.0	30.2	27.3	50.8	19.4	114.6	65.1	53.9	29.4	32.1	38.8	50.6	147.9	32.4	36.2	37.4	23.3	30.0	60.8	81.7	30.7	60.2	32.0	61.6	52.1	70.5	15.3	63.5	39.2	92.9	27.4	55.7	34.0	57.0	17.4	40.2	41.4	22.3	25.1	20.2	35.5	82.7	46.4	41.2	54.0	65.1	54.1	56.4	28.4	50.6	66.2	59.5	37.4	223.9	217.9	216.7	74.2	202.2	60.1	77.5	71.4	76.5	157.3	69.0	41.1	48.2	453.9	72.3	246.4	46.4	109.8	213.1	14.6	16.5	15.3	19.4	14.8	16.1	19.7	16.6	17.2	15.6	19.4	20.0	28.8	12.8	19.9	1.3	53.1	8.5	20.5	41.7	10.2	2.1	9.5	7.2	4.3	17.2	30.8	29.5	6.2	24.5	40.8	35.2	29.4	42.5	8.6	5.4	9.3	25.0	22.8	25.0	2.1	38.6	53.1	13.5	37.2	13.3	51.5	18.2	26.7	13.2	76.5	3.3	1.8	17.9	48.8	82.0	36.3	18.4	14.6	66.8	23.2	3.7	93.3	6.3	56.7	1.5	6.4	39.0	35.9	12.4	33.9	11.5	28.1	31.7	14.2	1.8	0.0	7.0	15.2	3.5	26.8	19.3	9.8	29.6	45.0	14.4	22.0	20.7
SHLD3	"AC008560.1, CTC-534A2.2, FLJ26957, RINN1"	ENSG00000253251	"Shieldin complex subunit 3"	Q6ZNX1	5	65625027-65630928	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 17.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA066071: AB_2685609, HPA068764: AB_2686028"	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.17e-4)"	2.3	2.7	2.4	2.7	2.5	17.5	4.2	2.8	3.6	1.8	1.8	2.8	2.8	2.3	3.1	1.5	1.9	2.4	1.8	2.3	2.1	2.9	2.6	2.5	4.8	2.4	2.1	1.5	3.4	2.1	2.5	2.5	2.3	4.3	3.0	3.7	2.0	2.5	1.8	2.9	2.7	1.7	2.4	2.5	2.4	3.2	2.4	3.9	2.4	1.9	3.6	2.5	1.3	3.2	2.6	3.6	5.0	10.8	2.9	3.5	6.3	3.8	3.5	5.8	7.0	5.9	8.0	4.9	4.2	4.6	6.5	3.1	5.1	4.7	8.5	6.7	6.5	4.3	10.3	8.3	2.5	5.0	7.5	2.1	6.8	6.0	6.1	1.6	3.7	7.7	6.4	11.5	4.7	6.9	6.7	7.7	4.0	1.5	2.2	4.4	4.9	7.9	4.9	6.0	6.7	5.5	3.2	3.3	11.0	3.4	3.8	4.6	3.0	5.0	6.8	4.1	6.6	7.2	14.3	10.7	3.7	6.1	4.7	15.9	3.0	6.4	3.8	2.9	4.0	3.9	4.5	4.0	2.8	3.1	6.1	5.6	3.3	4.9	3.1	3.2	6.2	2.1	2.4	2.5	2.8	3.6	2.3	2.1	2.4	2.1	2.3	2.4	2.4	3.2	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	3.6	0.0	0.0	0.0	0.0	0.0	4.0	5.9	0.0	3.9	3.1	0.0	1.9	1.8	0.8	0.0	0.0	0.0	2.9	3.8	0.9	0.0	2.1	0.0	2.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.1	1.8	2.1	0.0	0.0
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786429-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Cone photoreceptor cells: 47.9;Microglial cells: 24.4;Peritubular cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 19.2;SK-MEL-30: 18.2;SuSa: 18.6;WM-115: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051646	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: AB_2681562"	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	0.7	1.8	4.3	0.4	6.0	0.0	1.0	3.6	10.1	2.4	5.4	1.5	0.7	1.5	2.7	5.0	1.6	3.1	0.7	5.9	4.0	3.7	4.0	4.1	0.3	4.8	5.0	6.9	3.7	2.4	4.4	7.6	4.3	5.3	1.3	20.8	3.2	2.6	0.1	4.1	0.5	0.8	4.3	0.7	1.5	3.4	4.7	3.6	1.4	0.1	1.3	2.4	3.1	5.2	6.2	0.7	11.0	1.5	0.6	1.7	6.2	0.6	2.0	2.4	3.8	7.5	0.1	0.0	2.0	1.6	0.4	4.8	5.7	15.9	2.8	0.0	4.3	0.0	0.0	1.2	3.5	0.0	7.4	0.3	10.9	18.0	0.7	3.9	13.7	0.0	0.0	0.0	3.9	6.5	0.0	0.1	9.7	0.0	0.0	0.0	12.1	0.0	10.2	19.2	1.6	0.9	0.5	0.1	18.2	18.6	6.5	0.4	6.4	17.3	2.2	0.1	0.6	0.0	0.0	0.0	11.4	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	6.0	3.6	10.1	5.9	4.0	4.8	5.0	4.3	4.3	4.7	5.2	1.1	0.0	1.5	26.4	0.0	1.9	3.3	2.8	10.8	9.5	3.4	1.7	4.1	4.3	3.1	3.7	47.9	8.9	0.0	2.0	3.9	3.0	0.5	4.8	2.5	7.2	1.2	2.7	9.5	0.0	1.3	1.5	3.1	5.9	0.0	5.4	10.0	5.7	0.7	1.7	9.5	0.3	4.1	0.8	0.0	1.0	3.7	0.2	0.0	24.4	0.0	2.4	0.0	9.5	4.6	1.6	0.1	83.1	0.0	5.4	0.1	1.0	2.8	18.0	0.0	0.6	1.8	0.1	1.1	10.8	2.0	2.1	0.5	5.5	0.9	5.3
SIGLEC7	"CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2"	ENSG00000168995	"Sialic acid binding Ig like lectin 7"	Q9Y286	19	51142299-51153526	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 31.3;Kupffer cells: 57.4;Macrophages: 33.1;monocytes: 15.5;NK-cells: 69.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 242.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Karpas-707: 55.4;RPMI-8226: 33.7;U-937: 35.0"									HPA075513			Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		2600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Vesicles	"HPA075513: "	"unprognostic (3.14e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.27e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.26e-2)"	3.7	2.9	0.9	10.6	1.0	4.6	1.0	1.0	1.9	0.6	1.2	1.9	1.6	0.5	0.4	0.4	1.2	2.6	1.3	0.8	1.3	1.6	7.4	5.0	7.7	2.1	1.5	0.4	0.5	0.7	0.6	6.2	1.9	0.7	2.4	0.2	0.7	0.4	0.2	0.2	2.2	3.8	1.4	19.2	0.9	0.9	2.2	1.5	0.5	0.3	2.4	3.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	33.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	1.2	1.1	0.0	0.2	35.0	0.0	3.2	140.2	242.1	10.6	105.8	18.9	3.8	0.2	4.8	65.5	0.2	0.3	4.4	116.7	96.8	44.0	2.9	0.0	80.9	0.9	1.0	1.0	1.9	0.8	1.3	2.1	1.5	1.9	1.4	2.2	2.4	0.4	0.0	2.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.8	0.0	0.2	8.3	0.1	0.0	0.0	0.4	0.0	0.2	0.6	0.0	8.8	0.0	0.0	0.2	0.3	0.0	0.0	1.3	0.0	6.1	0.8	31.3	0.0	0.0	0.0	0.0	57.4	3.5	0.0	1.5	33.1	0.0	0.0	15.5	0.0	69.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.5	0.4	0.0	0.0
SIK2	"DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2"	ENSG00000170145	"Salt inducible kinase 2"	Q9H0K1	11	111602449-111730855	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.3;Excitatory neurons: 217.6;Inhibitory neurons: 132.4;Oligodendrocytes: 191.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC diff: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016026, HPA071049"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"	"Nuclear speckles, Intermediate filaments, Cytosol"	"HPA016026: AB_1857321, HPA071049: "	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.17e-9)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.13e-2)"	29.7	9.3	9.2	5.3	12.4	3.1	20.7	7.9	11.1	7.6	11.0	7.9	5.9	7.3	5.0	5.9	8.1	10.0	12.3	9.5	14.7	11.4	22.7	11.7	4.4	11.9	11.9	14.9	31.8	21.3	16.6	5.8	10.6	6.7	6.2	30.7	13.8	6.2	33.1	8.9	7.5	5.9	5.5	4.6	17.6	3.0	9.3	5.4	8.7	23.2	4.3	7.7	6.1	11.6	9.2	6.0	10.3	11.1	50.3	14.8	6.1	7.9	11.2	5.9	6.7	20.5	9.6	7.2	10.7	9.2	6.9	12.7	8.2	5.9	7.6	5.4	3.4	7.9	5.2	10.1	10.9	7.7	4.9	14.5	8.6	8.7	11.1	11.7	7.1	7.1	7.4	10.3	9.4	4.3	8.0	7.0	3.5	7.6	5.9	10.6	11.0	8.7	13.1	8.2	4.8	11.3	11.6	4.7	4.5	9.4	11.5	6.2	9.9	12.9	7.7	8.3	10.9	2.9	2.4	14.8	4.2	10.6	8.8	0.3	0.7	0.6	0.7	0.7	0.3	0.4	0.5	0.5	0.6	0.4	0.2	0.4	0.3	0.5	0.6	0.3	0.5	0.5	9.2	12.4	7.9	11.1	9.5	14.7	11.9	11.9	10.6	5.5	9.3	11.6	22.1	19.2	24.8	113.3	14.1	14.7	6.2	5.2	18.2	15.7	10.5	9.9	21.3	27.1	10.0	16.5	66.7	4.4	11.4	15.6	5.9	10.4	16.5	27.7	14.9	18.8	18.0	12.4	217.6	7.9	4.6	20.1	27.5	45.3	9.5	24.3	9.3	38.7	5.4	32.0	132.4	11.3	4.1	12.4	16.9	14.1	11.5	13.3	19.6	73.1	6.0	14.5	4.1	86.0	191.9	8.4	10.3	14.7	8.9	6.9	8.3	23.1	13.4	60.9	0.0	19.1	19.0	3.9	6.4	10.3	11.9	5.2	12.6	5.0	11.5	7.1
SIM1	bHLHe14	ENSG00000112246	"SIM bHLH transcription factor 1"	P81133	6	100385009-100464921	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;kidney: 9.9;skeletal muscle: 3.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Distal tubular cells: 7.9;Ductal cells: 4.5;Skeletal myocytes: 7.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Group enriched"	"Detected in some"	5	"hypothalamus: 4.4;midbrain: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.7;BJ: 16.4;BJ hTERT+: 23.7;BJ hTERT+ SV40 Large T+: 7.2;HDLM-2: 7.3;RPTEC TERT1: 18.4"	"Region enriched"	"Detected in single"	8	"hypothalamus: 5.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.1"	HPA024385			Approved	"Nuclear speckles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favorable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			1.7	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	4.4	9.9	0.3	0.0	0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	9.7	0.0	16.4	23.7	7.2	6.7	0.0	0.0	0.0	0.0	5.2	1.5	0.0	0.0	0.0	6.1	7.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.4	0.0	1.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	20.2	0.0	0.1	0.0	0.0	7.9	4.5	1.8	0.1	0.1	0.1	1.8	0.0	0.1	1.2	0.1	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	7.6	0.3	1.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"SIM bHLH transcription factor 2"	Q14190	21	36699115-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 31.1;kidney: 61.3"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 100.7;Squamous epithelial cells: 68.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 24.9;PC-3: 43.0;RPTEC TERT1: 54.3;RT4: 33.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (2.88e-4)"	0.3	0.3	1.8	0.0	1.1	0.0	0.4	0.7	1.4	2.3	0.4	0.5	0.0	0.5	0.8	31.1	0.6	0.0	0.2	1.5	2.5	61.3	0.4	0.2	0.0	0.7	1.4	0.2	0.3	1.8	1.6	0.0	0.5	6.6	0.0	0.0	0.6	0.0	10.6	0.5	0.3	0.0	0.5	0.3	9.5	0.4	2.4	0.0	0.4	0.0	3.5	0.7	0.7	0.7	6.4	9.6	0.0	0.3	0.0	0.0	9.4	0.0	0.0	0.9	0.0	5.0	14.7	0.0	8.6	0.2	17.0	3.2	4.8	0.0	0.5	7.8	15.0	0.0	14.3	0.3	0.0	0.0	0.0	1.6	1.4	0.0	2.6	24.9	0.0	0.0	0.0	0.0	16.0	3.7	0.0	0.0	0.0	6.4	43.0	0.0	0.0	0.0	54.3	33.5	0.4	0.0	15.7	0.0	0.9	1.6	4.1	0.0	0.6	0.0	2.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	0.7	1.4	1.5	2.5	0.7	1.4	0.5	0.5	2.4	0.7	0.2	0.0	0.0	0.0	0.0	0.3	19.1	0.0	100.7	0.2	0.1	0.1	2.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	9.8	0.1	2.2	0.3	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.8	12.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	5.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	7.1	1.1	0.0	0.0	0.0	1.3	9.5	0.1	0.2	0.0	0.5	0.0	1.5	0.9	0.5	0.2	68.3	0.4	0.0	0.4	0.0	0.2	4.0
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	19.2	12.4	10.0	19.8	10.9	42.5	18.0	21.0	11.7	21.0	12.5	19.6	13.8	25.6	16.6	19.1	24.3	17.4	14.8	9.6	13.3	15.1	16.0	18.0	25.9	11.7	12.0	30.0	15.3	22.5	12.1	20.1	10.3	19.7	16.1	24.1	16.6	20.7	16.6	21.5	16.3	19.6	8.3	22.1	16.5	29.6	14.0	43.2	27.2	18.7	26.3	20.2	16.7	10.8	31.2	63.6	55.5	36.7	27.0	28.4	32.1	22.9	35.3	33.0	35.2	35.2	41.2	67.8	23.3	34.0	45.0	54.5	81.2	34.4	35.9	55.0	42.1	64.0	46.2	27.9	20.5	61.4	52.5	34.7	26.1	38.5	39.8	34.0	30.0	47.5	51.5	73.2	27.0	36.2	60.7	39.1	54.2	41.3	26.3	60.5	73.3	41.8	23.6	56.4	43.7	43.7	56.6	25.0	31.0	53.0	38.1	47.9	26.4	40.6	54.5	27.2	34.3	49.8	85.0	70.8	24.2	61.2	23.2	2.9	4.2	5.9	6.3	3.8	9.6	7.0	8.1	8.1	5.2	7.7	8.2	7.2	7.3	8.1	7.4	3.5	7.7	5.7	10.0	10.9	21.0	11.7	9.6	13.3	11.7	12.0	10.3	8.3	14.0	10.8	26.0	35.3	32.4	13.7	35.8	39.4	23.6	21.2	60.9	19.7	36.5	25.4	13.4	17.2	30.5	27.6	31.3	23.5	29.0	17.8	5.9	15.1	10.1	35.7	30.8	32.1	17.3	24.4	19.2	12.8	11.1	24.4	15.3	42.1	29.9	30.1	26.0	17.4	13.2	20.2	18.3	19.0	10.2	21.3	31.7	5.8	23.0	19.5	10.6	27.2	18.8	16.8	24.7	16.6	24.1	14.1	14.0	20.3	33.1	29.8	13.7	9.2	33.4	33.8	13.1	34.7	24.7	42.1	42.7	37.5	53.1	21.9	34.6	21.2	19.2	19.4
SIPA1L2	"KIAA1389, SPAR2"	ENSG00000116991	"Signal induced proliferation associated 1 like 2"	Q9P2F8	1	232397965-232630571	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024181, HPA027224"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus"		No	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear membrane, Nuclear bodies"	"Golgi apparatus"	"HPA024181: AB_1856886, HPA027224: AB_2672165"	"unprognostic (2.34e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.98e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.57e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.84e-3)"	"unprognostic (3.45e-3)"	12.1	3.3	8.5	6.4	7.2	5.4	9.2	9.6	11.7	10.0	0.5	19.4	3.9	4.4	2.8	20.3	4.5	8.5	31.3	9.6	16.0	7.7	6.4	16.2	3.0	44.0	21.7	11.9	3.6	4.4	8.1	18.3	44.6	8.1	18.9	14.7	8.7	4.7	7.1	9.0	9.2	7.4	14.4	9.6	5.7	7.2	18.7	2.4	8.0	9.5	3.3	12.5	14.9	9.0	0.0	7.5	69.7	0.2	0.6	0.0	29.3	1.2	2.5	3.1	2.2	2.9	0.1	5.9	13.3	26.4	2.9	1.7	13.8	2.3	2.9	0.0	12.8	0.0	7.0	0.0	5.9	1.0	7.2	3.8	9.1	0.6	6.2	0.0	15.7	25.4	0.0	0.1	1.6	3.5	7.4	0.7	53.9	0.2	10.2	0.0	0.0	3.4	8.1	11.5	3.5	11.9	23.8	0.8	9.5	15.8	1.4	0.6	5.6	8.1	0.0	17.8	2.9	6.5	0.0	0.0	10.0	6.2	46.1	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.6	0.3	0.3	0.0	0.1	8.5	7.2	9.6	11.7	9.6	16.0	44.0	21.7	44.6	14.4	18.7	9.0	53.7	6.4	1.8	22.9	0.8	8.8	9.8	8.7	15.4	23.5	10.7	8.6	62.6	12.8	10.4	3.7	52.1	4.9	4.4	29.9	0.0	7.1	11.7	19.0	21.4	22.7	7.2	0.4	80.2	0.5	7.1	15.2	5.1	47.5	1.3	16.0	1.8	3.8	10.0	5.0	95.9	29.5	14.2	16.6	7.2	9.8	0.9	19.5	14.2	183.6	6.3	12.7	1.0	104.0	21.0	1.4	39.9	1.9	0.5	13.2	9.1	0.4	7.7	35.7	0.0	21.8	23.9	6.9	24.0	45.8	7.4	14.8	2.0	11.9	23.4	23.0
SIPA1L3	"KIAA0545, SPAR3"	ENSG00000105738	"Signal induced proliferation associated 1 like 3"	O60292	19	37907208-38208369	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 93.7;Inhibitory neurons: 87.3;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 59.6"	"Low region specificity"	"Detected in all"							"HPA042072, HPA045480, HPA074988"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: "	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.96e-2)"	2.2	3.0	6.0	6.6	3.0	2.9	5.1	10.4	16.2	4.8	2.6	10.6	18.4	3.3	1.3	4.9	4.8	3.9	6.2	28.9	2.0	6.4	3.4	5.7	6.8	4.2	4.1	2.9	9.7	3.3	3.2	1.4	3.5	5.3	7.0	5.0	8.4	3.5	6.5	11.1	18.1	1.8	1.6	7.3	9.1	4.3	5.6	3.8	10.0	7.3	5.5	4.3	3.6	5.5	34.4	59.6	7.3	9.3	4.3	4.3	4.9	14.5	12.2	9.4	8.8	20.6	19.5	19.5	12.2	12.4	7.9	7.6	6.7	27.1	10.4	6.7	3.3	5.3	5.5	6.5	8.3	3.7	5.5	3.3	14.1	17.5	37.3	13.9	10.8	5.6	3.9	4.1	16.6	10.6	5.0	5.1	6.0	27.2	15.8	10.8	5.9	2.9	20.7	29.1	17.3	9.3	16.0	27.1	2.2	3.9	18.0	3.5	23.2	15.6	5.5	48.4	22.6	5.4	10.0	6.6	20.1	4.9	20.6	0.1	0.1	0.4	0.1	0.2	0.0	1.1	0.1	0.2	0.1	1.5	0.1	0.5	0.1	0.3	1.5	0.3	0.1	0.1	6.0	3.0	10.4	16.2	28.9	2.0	4.2	4.1	3.5	1.6	5.6	5.5	4.8	6.4	10.1	41.4	24.5	12.0	5.2	10.4	6.2	21.9	22.6	12.1	5.2	22.8	10.8	23.9	14.6	2.1	9.3	93.7	3.9	7.2	4.5	19.8	4.8	5.4	25.2	10.8	61.1	15.3	1.4	3.7	40.2	16.5	2.5	4.8	6.4	23.5	3.5	33.7	87.3	46.3	20.3	5.1	13.9	9.2	2.1	8.3	5.4	50.6	7.1	3.0	5.2	99.5	58.7	13.4	38.7	1.9	12.8	6.6	50.0	21.1	19.1	5.7	6.6	4.5	3.6	1.7	5.1	8.9	16.1	0.8	5.1	1.7	30.4	5.6
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884656-67918390	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 292.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	16.4	30.2	8.9	11.0	10.4	19.8	17.5	15.6	11.9	17.1	7.8	12.5	9.2	18.5	11.9	10.9	11.9	14.0	10.6	8.5	9.9	13.4	17.3	12.6	17.7	9.3	9.2	25.1	12.1	14.0	6.9	12.7	10.0	14.0	12.0	13.5	9.9	11.2	14.6	9.6	9.7	13.7	8.8	14.3	10.3	26.8	9.4	19.2	14.7	18.5	15.1	15.5	9.5	12.9	15.1	16.8	26.2	29.4	24.4	18.7	16.3	20.4	21.0	27.4	24.3	18.7	12.6	31.4	10.8	13.7	17.1	11.7	32.8	6.9	29.3	16.9	19.0	16.7	12.1	14.7	22.3	18.1	12.3	17.3	16.2	16.6	28.3	29.4	11.2	17.6	21.6	16.7	20.3	12.1	17.0	25.0	32.5	9.6	26.6	30.3	20.6	12.4	13.1	9.1	16.8	23.0	37.4	24.4	26.8	22.5	17.7	16.6	9.4	21.2	19.8	19.0	20.1	13.9	17.7	61.8	10.9	27.2	8.9	1.3	0.8	1.1	1.1	1.0	1.6	1.8	1.2	1.5	1.3	1.0	2.2	1.3	1.0	1.2	1.3	1.2	1.0	0.6	8.9	10.4	15.6	11.9	8.5	9.9	9.3	9.2	10.0	8.8	9.4	12.9	35.7	19.2	7.4	17.0	27.6	39.1	20.9	7.2	22.8	12.5	48.3	33.4	34.8	11.5	8.7	5.5	27.1	7.1	42.5	31.2	5.9	4.3	292.2	38.4	26.2	20.6	42.9	10.3	16.0	5.6	5.4	28.0	23.4	57.1	12.0	14.8	15.4	15.8	9.1	11.8	18.4	21.0	10.2	23.4	28.7	45.6	17.7	34.1	16.0	30.9	14.8	7.1	9.2	18.6	30.7	6.2	20.6	19.5	15.8	26.0	11.2	8.4	4.1	14.0	0.0	43.4	28.8	24.2	16.3	21.1	47.5	12.4	29.1	8.9	18.7	17.2
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 302.1;tongue: 218.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Cytosol"	Nucleoplasm	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	43.2	44.0	101.6	11.5	137.5	17.4	39.7	141.1	123.0	41.5	79.4	49.2	12.6	37.2	10.4	42.5	37.2	15.0	76.9	100.7	111.2	35.9	51.5	38.2	13.7	151.0	129.6	49.0	33.4	18.2	31.2	10.5	144.7	32.7	10.2	11.9	41.5	14.9	302.1	48.8	32.4	18.3	121.3	40.1	41.4	43.5	127.6	13.1	34.5	218.2	13.0	41.3	37.8	173.5	16.1	9.8	8.4	20.6	46.7	31.8	5.8	11.3	20.2	17.8	22.7	17.1	10.2	5.4	23.7	21.3	13.2	8.3	14.6	25.1	10.9	25.2	15.6	10.1	10.9	10.9	33.0	7.0	22.4	33.5	29.7	14.4	16.9	21.4	31.9	17.7	10.1	42.0	28.2	8.9	15.4	6.2	1.2	27.6	13.6	19.9	22.8	15.3	14.8	14.9	20.7	9.0	12.9	17.8	13.0	7.0	8.0	19.2	28.9	24.0	5.1	37.2	17.0	16.9	8.8	12.6	18.1	19.0	22.0	48.9	54.7	59.8	44.9	69.1	28.5	24.9	21.9	31.0	42.9	28.9	14.3	23.6	42.7	36.5	56.7	44.0	33.1	51.9	101.6	137.5	141.1	123.0	100.7	111.2	151.0	129.6	144.7	121.3	127.6	173.5	39.5	16.0	19.4	26.1	21.0	51.6	30.3	35.1	35.3	29.7	28.8	29.7	42.1	14.3	27.2	12.9	35.5	36.5	90.8	28.4	37.2	29.0	173.0	24.7	15.4	31.1	17.5	27.1	31.2	17.6	15.2	30.3	44.9	26.5	25.4	29.5	28.5	19.7	66.3	30.3	27.2	24.1	97.6	38.3	51.7	74.8	31.1	37.1	46.2	11.2	20.0	22.6	85.5	76.4	110.8	26.5	23.9	41.0	39.7	14.9	54.0	38.8	30.1	28.2	19.7	113.5	27.9	15.3	7.2	30.1	60.1	42.3	45.8	31.3	18.2	21.5
SIRT5		ENSG00000124523	"Sirtuin 5"	Q9NXA8	6	13574227-13615158	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 52.5;Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021798, HPA022002, HPA022992"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915"	"unprognostic (8.53e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.76e-10)"	"unprognostic (2.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.36e-3)"	7.2	6.0	9.4	5.2	10.6	5.8	6.6	10.4	12.2	5.4	13.5	8.1	7.7	6.1	5.6	5.6	9.2	5.2	28.6	10.5	10.6	11.5	33.5	5.4	8.3	9.2	9.6	10.1	6.7	16.2	7.3	5.6	9.9	6.4	8.7	6.1	10.6	6.8	33.4	7.9	9.8	5.9	8.4	9.6	8.2	6.8	10.9	8.2	9.0	38.0	7.2	6.0	5.4	11.1	10.5	8.9	8.1	10.4	5.7	8.9	7.6	5.1	5.3	6.1	8.0	12.9	11.1	14.1	35.7	4.3	10.9	16.9	7.4	11.1	7.6	5.9	10.3	8.5	5.6	20.5	11.0	6.7	6.7	7.8	19.9	4.5	19.9	12.7	10.3	20.3	13.8	4.6	6.5	12.3	8.2	13.2	7.7	16.9	13.7	15.4	4.4	24.4	10.3	11.0	13.7	4.5	4.3	7.9	25.9	25.0	11.6	4.9	8.6	6.6	3.4	4.2	5.8	11.6	15.4	10.7	4.5	7.3	8.4	0.7	6.0	16.7	9.9	9.2	10.7	14.0	13.0	9.5	6.3	12.7	11.8	10.8	2.6	11.8	17.3	5.9	10.7	7.9	9.4	10.6	10.4	12.2	10.5	10.6	9.2	9.6	9.9	8.4	10.9	11.1	16.6	28.9	3.2	30.0	8.2	4.1	11.4	14.9	10.8	7.3	9.7	9.9	52.5	15.7	16.8	11.0	0.0	20.5	6.6	9.4	52.8	13.0	2.9	13.1	5.4	12.3	6.1	15.8	36.6	6.7	10.5	6.7	6.6	8.1	0.0	23.5	9.7	25.7	9.4	1.7	39.2	13.2	8.2	13.9	3.8	2.0	8.1	8.4	5.4	14.0	6.3	11.6	10.3	15.1	25.8	7.2	13.4	5.7	4.7	6.2	18.1	34.1	22.5	7.2	0.0	9.8	6.6	8.5	12.0	9.8	4.5	10.7	7.9	13.2	15.0	9.0
SIRT6		ENSG00000077463	"Sirtuin 6"	Q8N6T7	19	4174109-4182566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Distal enterocytes: 199.2;Paneth cells: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049729, HPA071776"	Supported		Supported	Nucleoplasm,Vesicles		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA049729: AB_2680865, HPA071776: AB_2686445"	"unprognostic (4.58e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.13e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.84e-2)"	"prognostic favorable (9.13e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.58e-4)"	8.2	12.0	10.4	7.8	10.6	10.4	8.6	10.3	15.1	10.5	8.7	23.6	10.0	10.6	2.4	12.3	9.2	3.5	10.0	10.7	10.2	13.7	11.0	8.9	7.1	11.2	10.3	7.5	14.1	5.2	13.3	4.3	10.5	12.7	7.5	1.9	9.3	5.0	8.0	11.8	14.2	2.6	9.8	15.3	9.8	6.0	12.1	4.9	10.1	2.7	3.9	9.9	9.7	10.6	25.7	16.8	8.3	10.4	6.5	6.2	12.9	12.0	8.9	10.1	8.8	11.2	9.5	16.0	12.9	8.1	9.1	15.9	4.6	12.9	1.6	30.8	10.0	6.8	9.7	10.3	14.3	17.4	25.2	7.9	10.4	10.3	6.4	7.7	8.7	15.0	15.2	35.3	5.4	19.2	23.9	18.3	14.5	9.3	15.2	18.9	7.7	18.8	9.7	11.4	11.0	18.1	11.0	10.2	24.1	3.2	10.2	23.0	12.2	10.4	10.5	36.9	17.4	45.6	25.7	18.4	20.8	28.1	12.7	5.3	13.1	12.2	10.8	16.3	6.4	9.6	7.5	8.7	14.3	10.1	6.4	6.1	11.8	5.6	13.5	11.9	12.6	8.5	10.4	10.6	10.3	15.1	10.7	10.2	11.2	10.3	10.5	9.8	12.1	10.6	9.2	12.8	7.3	5.9	13.8	10.3	10.3	32.3	9.6	12.6	6.6	6.3	3.2	7.2	18.4	5.5	18.8	24.1	7.1	199.2	13.7	32.2	1.9	6.2	7.9	11.8	26.4	9.5	8.9	26.7	24.2	9.3	19.9	9.2	5.7	5.6	13.6	6.8	24.0	13.5	10.4	29.1	18.3	11.7	10.1	2.6	11.5	15.0	5.4	1.9	27.0	15.2	14.4	3.5	6.3	32.5	129.7	8.2	10.3	9.7	28.2	14.3	11.0	13.8	0.0	7.2	11.3	7.4	9.6	13.3	12.6	25.6	10.6	7.9	30.9	11.9
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643421-60658259	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	5.5	0.4	0.3	0.0	0.5	0.0	1.9	0.5	1.2	15.2	1.0	0.0	0.0	0.0	0.4	1.1	0.8	0.5	0.0	0.3	0.3	0.0	0.0	1.5	0.5	0.3	0.4	0.2	0.3	47.8	19.8	0.0	0.4	13.2	0.0	0.0	51.1	0.2	119.4	0.3	0.0	0.0	0.3	0.0	0.4	1.7	0.5	9.7	1.9	46.3	0.2	1.6	0.8	0.4	15.2	3.5	0.6	28.1	17.0	20.6	0.4	4.1	10.6	4.9	4.0	0.0	8.2	0.0	2.2	0.6	2.1	4.4	10.3	6.4	2.1	0.0	17.1	2.0	1.9	6.8	0.0	0.0	0.2	15.6	4.9	2.3	0.7	36.3	0.3	1.6	5.8	0.0	142.2	2.8	0.0	0.5	0.0	0.0	8.9	0.0	71.9	0.0	5.9	16.3	2.5	0.3	5.0	0.3	6.1	0.5	3.3	0.4	13.9	6.7	5.4	7.9	6.5	0.5	0.1	0.0	1.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.2	0.3	0.3	0.3	0.4	0.4	0.3	0.5	0.4	0.8	3.2	1.5	0.0	0.0	0.1	30.7	30.8	0.6	0.0	1.0	0.8	0.9	0.0	33.9	1.8	0.0	0.2	0.0	0.1	1.9	0.0	0.2	1.1	0.1	1.6	0.0	0.0	0.0	0.8	0.4	5.7	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.6	0.0	0.3	0.0	1.9	0.0	0.8	0.0	1.0	0.1	0.2	0.0	1.2	0.0	27.4	0.0	0.1	67.1	0.2	0.0	77.3	5.1	0.0	25.0	0.1	0.1	0.3	0.1	0.1	0.0	18.3
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176552	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.1;testis: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Extravillous trophoblasts: 21.0;Spermatocytes: 21.7;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Supported	"Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle"	"Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.2	2.5	0.2	4.7	0.8	0.1	0.3	0.2	0.0	1.7	1.0	0.5	0.0	1.9	0.2	0.4	0.0	0.5	0.2	0.1	0.2	0.2	4.3	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.0	3.0	0.0	0.2	0.0	0.0	1.8	2.1	1.1	0.2	0.7	1.0	6.3	0.3	12.1	0.1	0.1	3.7	0.4	0.5	0.2	26.1	13.0	25.8	20.5	0.9	5.1	19.1	35.0	14.8	42.1	28.7	23.4	27.8	35.6	10.0	19.3	18.5	24.4	34.4	15.2	54.7	30.3	15.9	47.3	7.7	12.7	0.0	39.5	17.7	1.5	1.0	34.9	15.4	4.2	20.7	30.6	26.3	14.2	33.9	21.0	60.7	37.8	27.9	42.8	23.8	36.5	50.3	15.8	12.2	9.9	30.1	11.1	11.8	17.1	8.1	17.9	15.3	33.5	8.7	16.0	23.8	17.0	43.9	9.0	19.7	34.5	4.4	31.1	51.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.2	0.2	0.1	0.3	0.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.4	0.0	0.0	0.0	2.6	2.0	0.7	2.4	0.0	0.1	0.9	0.8	0.8	0.0	1.8	0.0	0.0	8.7	1.0	2.1	0.0	1.2	6.3	2.8	0.9	1.4	0.0	12.8	0.8	1.3	21.0	2.1	1.5	1.6	0.0	5.8	1.8	0.4	5.5	0.0	0.6	1.8	2.0	1.9	2.9	7.7	1.5	1.6	0.0	1.9	0.8	0.3	3.1	0.0	0.2	1.0	1.6	1.2	8.5	0.3	0.4	0.6	2.0	0.4	0.0	0.3	2.3	21.7	18.2	5.8	2.8	2.2	1.2	0.5	5.0	0.7
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959117-31969751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	21.9	33.1	0.0	5.2	0.3	4.1	21.6	0.0	0.4	26.5	0.0	25.1	10.5	22.6	9.4	23.0	25.0	0.0	22.0	0.0	0.1	24.0	54.7	22.2	3.4	0.0	0.5	24.6	25.7	2.4	39.7	2.6	0.0	31.9	2.4	2.1	22.4	3.2	20.4	20.2	31.2	5.7	0.0	40.6	27.6	16.6	0.1	4.3	27.7	5.3	2.7	23.6	20.9	0.0	0.2	12.7	13.3	0.0	16.5	11.8	27.1	10.9	11.7	13.6	13.2	0.4	0.0	0.0	26.0	25.5	13.2	11.9	0.0	30.8	9.9	14.8	15.7	0.0	0.0	0.2	0.0	0.1	0.2	28.3	17.9	0.1	0.0	12.7	0.0	19.3	0.0	13.6	0.0	0.0	0.0	0.3	20.6	0.0	0.0	0.3	0.0	0.0	11.2	0.0	0.0	0.0	23.6	0.0	17.6	11.5	0.0	15.7	12.8	16.0	7.2	18.7	0.2	42.2	35.7	12.0	20.4	0.1	0.0	0.3	0.5	0.2	1.5	1.4	1.1	0.2	0.7	0.3	1.1	0.9	0.8	0.8	0.1	0.0	2.2	0.5	0.2	0.4	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	6.4	16.0	11.3	10.1	13.3	2.8	5.0	7.9	11.4	5.0	9.3	5.1	8.5	10.0	8.8	7.3	8.4	12.6	12.7	19.7	1.9	9.5	3.1	7.7	7.9	7.9	12.6	6.5	7.2	8.6	7.9	7.4	28.1	6.3	8.2	10.8	8.6	19.4	9.2	0.0	5.0	13.2	8.2	6.3	4.1	1.5	9.3	7.8	7.2	2.8	10.2	4.9	18.6	3.0	4.8	9.4	16.0	6.0	20.2	5.9	25.5	6.9	16.5	8.3	0.0	4.1	10.2	4.7	7.5	6.6	3.7	12.4	14.4	12.3	11.0	5.2
SKP1	"EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L"	ENSG00000113558	"S-phase kinase associated protein 1"	P63208	5	134148935-134176964	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012982, HPA053745, HPA058134"	Approved		Supported	Nucleoplasm,Cytosol		No	No		880000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.40e-1)"	430.5	566.7	442.5	194.9	463.6	363.7	559.0	471.7	648.6	455.4	486.2	529.3	230.1	441.3	490.7	401.9	437.8	330.1	650.5	470.8	492.5	588.6	442.8	346.6	305.9	465.9	457.1	525.4	266.6	776.2	501.0	394.6	474.2	420.9	350.2	484.3	366.9	550.9	1056.8	419.5	354.9	422.6	494.4	304.8	385.9	380.4	470.5	456.1	551.5	814.1	332.0	452.9	391.6	515.0	657.0	500.1	730.3	986.5	1103.6	891.8	519.2	744.6	939.1	854.0	877.1	773.0	620.0	481.9	1084.9	1009.8	974.9	356.6	738.2	1124.1	988.3	442.6	519.5	380.7	724.0	555.8	518.7	296.3	452.0	771.1	886.2	750.1	588.7	1060.4	928.4	611.2	467.4	411.8	1295.2	515.6	642.0	314.8	423.9	619.6	530.7	349.2	780.7	591.7	952.3	724.6	594.6	463.8	1010.2	254.4	726.9	942.4	738.5	454.6	705.3	547.5	338.4	578.2	766.4	254.7	459.1	717.8	762.3	555.5	608.0	1745.5	851.4	1484.9	884.6	841.7	1011.4	1202.8	1264.6	1099.9	817.8	1094.4	1495.5	1174.8	811.4	1096.1	1027.0	728.1	1416.7	2538.6	442.5	463.6	471.7	648.6	470.8	492.5	465.9	457.1	474.2	494.4	470.5	515.0	430.1	285.2	306.3	64.0	403.6	674.3	1025.7	1354.7	380.1	230.0	539.8	558.4	700.9	497.6	767.4	594.1	73.0	881.0	417.7	441.8	1696.3	644.9	593.3	511.9	405.3	410.1	356.0	617.8	66.5	376.9	749.4	561.5	270.1	439.0	336.9	433.9	340.2	376.9	471.6	223.8	65.8	402.2	1192.2	296.1	505.1	1048.6	601.4	344.8	718.6	33.7	565.4	792.8	338.8	43.7	87.0	378.1	564.0	712.8	278.2	744.7	630.0	1577.8	965.7	217.5	506.2	480.4	668.1	753.5	652.7	349.0	645.6	1347.0	511.1	500.4	410.4	837.6
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Group enriched"	"Detected in some"	7	"HEL: 91.2;JURKAT: 51.8"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	1.3	0.6	0.4	5.7	0.6	12.5	0.8	1.6	0.7	0.8	0.3	1.7	2.7	1.0	0.5	0.7	0.9	2.4	0.7	0.4	0.2	0.5	1.5	4.1	10.4	0.7	0.4	0.4	0.4	0.1	0.4	0.6	0.8	0.7	1.7	0.5	1.4	0.5	0.6	0.7	3.1	0.5	0.3	8.0	2.6	0.5	0.6	18.3	0.7	0.2	9.0	2.2	0.6	1.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	91.2	0.6	3.4	0.0	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	51.8	0.1	0.2	0.0	0.2	10.9	7.6	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	7.6	0.1	3.0	0.4	3.8	28.8	0.7	24.1	0.4	23.8	27.1	0.4	0.3	21.8	30.5	4.8	39.2	0.1	48.5	33.4	26.5	0.4	0.6	1.6	0.7	0.4	0.2	0.7	0.4	0.8	0.3	0.6	1.1	0.6	0.0	3.9	0.0	1.6	0.4	0.1	0.0	0.0	0.3	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.1	97.0	0.6	0.0	0.2	1.1	0.4	0.4	0.4	0.0	8.2	2.2	0.0	0.2	0.5	4.1	0.6	1.3	0.0	0.7	0.1	0.2	0.0	1.7	0.0	0.0	1.6	0.4	0.0	0.3	21.8	0.0	1.9	1.2	0.4	44.3	1.5	1.4	0.3	0.1	0.0	25.8	0.1	0.0	0.1	0.0	0.9	0.0	0.3	0.4	0.0	0.2	0.2	0.1	0.1	59.2	0.0	0.2	0.3
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692731-1712344	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.6;Spermatogonia: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	29.9	26.4	38.6	37.6	40.2	114.2	26.7	38.0	65.7	28.4	34.4	30.6	23.9	27.3	32.9	35.9	27.6	21.9	18.4	40.9	43.6	35.1	33.9	27.2	71.7	36.4	39.1	28.0	24.4	24.0	26.7	42.0	39.3	22.8	30.6	17.1	25.6	25.3	22.6	37.7	25.6	28.8	37.7	28.3	26.9	63.1	41.8	53.5	27.3	19.2	69.5	35.0	28.0	41.1	132.7	53.9	76.6	80.7	65.3	70.0	81.9	120.1	92.5	131.4	133.8	120.3	144.7	180.6	67.4	96.0	150.9	77.8	147.0	103.0	154.1	75.4	98.5	215.9	63.3	123.6	82.6	208.3	102.8	55.0	84.7	98.1	67.3	74.4	76.5	108.8	172.7	170.3	163.2	52.8	314.6	200.6	97.4	136.7	108.6	241.1	126.3	105.3	131.0	99.5	86.1	69.3	95.4	59.6	69.5	96.8	99.0	127.7	66.3	108.0	63.8	116.1	180.4	107.4	192.2	428.3	99.6	176.0	106.0	25.7	65.4	47.5	47.1	49.7	43.3	51.6	59.7	64.8	50.6	37.8	50.6	49.6	95.8	46.3	44.8	42.2	77.9	75.4	38.6	40.2	38.0	65.7	40.9	43.6	36.4	39.1	39.3	37.7	41.8	41.1	35.2	16.0	18.8	7.2	96.3	105.2	96.3	38.8	61.5	19.4	35.9	34.0	8.2	27.1	23.6	36.8	25.0	166.3	80.5	28.8	107.6	50.6	75.9	38.8	34.9	36.1	35.9	146.0	14.6	31.3	51.8	49.1	53.5	55.5	23.5	45.9	30.0	27.0	81.3	25.2	15.1	33.6	44.7	36.8	58.6	41.6	44.1	60.3	65.8	6.5	64.4	27.4	43.3	9.0	14.4	38.7	25.3	44.0	94.2	88.6	22.5	55.4	16.3	13.6	13.1	46.3	43.8	263.6	294.0	84.1	105.8	44.7	96.6	33.2	44.1	76.5
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	12.1	17.0	12.8	14.0	21.6	15.9	30.3	19.6	18.1	29.3	12.7	16.4	53.8	15.7	17.6	23.9	21.4	17.7	14.7	13.2	16.5	22.5	25.6	23.2	10.3	22.8	18.3	12.8	22.6	42.5	10.9	23.7	22.9	24.4	16.2	23.1	31.2	19.3	18.4	20.3	13.8	15.3	19.1	8.7	17.8	13.3	18.5	19.2	41.6	20.3	17.2	20.4	13.9	31.1	19.0	22.4	31.4	28.7	33.5	28.6	106.3	19.7	73.9	19.0	21.8	30.6	35.3	11.8	38.8	22.8	35.7	25.3	26.6	19.2	21.9	17.1	17.4	27.4	29.2	35.5	35.7	19.0	54.5	31.6	24.3	32.7	35.1	45.6	22.8	23.6	24.4	5.6	22.4	21.7	21.8	12.9	46.6	19.8	15.5	14.7	28.6	21.1	23.4	27.7	21.6	19.0	16.3	47.1	20.9	36.2	50.8	12.6	26.8	19.2	15.8	21.5	10.9	14.1	20.4	4.7	54.1	10.2	8.3	0.6	4.7	1.9	4.2	6.8	3.7	2.6	3.3	4.3	7.0	3.3	4.6	4.3	2.3	6.0	4.8	2.9	2.9	3.4	12.8	21.6	19.6	18.1	13.2	16.5	22.8	18.3	22.9	19.1	18.5	31.1	9.8	38.5	46.1	32.7	6.9	15.4	24.8	84.0	22.2	26.6	37.6	18.5	15.5	25.8	69.4	57.0	18.8	27.0	11.9	14.0	3.9	30.6	1.5	31.7	11.6	13.1	16.4	64.8	33.6	28.3	22.5	17.3	15.3	43.6	71.4	20.1	11.4	41.3	35.2	28.6	38.1	14.3	42.7	16.9	25.4	1.7	9.6	30.1	26.6	26.2	15.7	26.5	6.2	51.8	94.5	20.6	15.0	8.6	8.2	47.8	13.2	9.0	109.6	17.8	6.6	14.2	13.2	9.0	12.2	14.3	13.4	19.4	10.7	10.4	15.0	23.1
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229784-34338060	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 15.2;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	6.4	4.0	5.9	11.5	7.4	26.8	5.5	7.2	7.9	11.9	2.5	5.5	7.3	5.2	7.0	18.8	4.6	5.2	7.3	6.5	7.3	15.9	3.9	9.1	10.1	8.9	7.3	4.2	3.5	3.1	5.6	4.3	9.3	3.5	6.1	31.1	6.4	3.8	10.6	7.6	9.1	4.9	6.6	12.9	6.7	25.9	7.7	15.5	9.0	10.9	11.6	8.3	17.6	8.4	4.4	5.2	3.1	4.7	10.0	11.4	2.4	5.9	15.1	4.9	7.1	3.1	7.2	3.1	5.9	7.2	4.3	44.0	7.9	5.3	5.8	1.2	5.1	24.6	14.0	7.0	6.4	14.5	24.6	6.9	9.1	14.1	29.1	10.9	14.9	6.8	5.4	6.8	6.7	1.6	1.6	11.0	2.4	3.8	5.7	7.1	5.5	3.3	5.5	11.2	7.2	5.0	7.1	0.2	1.5	7.1	2.8	4.8	9.4	5.9	4.2	21.0	1.4	6.4	6.8	1.9	6.6	10.5	2.2	15.2	1.4	2.6	0.6	1.8	0.4	1.4	0.9	0.9	0.9	2.4	1.6	1.4	23.4	0.7	0.8	1.0	3.2	1.0	5.9	7.4	7.2	7.9	6.5	7.3	8.9	7.3	9.3	6.6	7.7	8.4	16.4	22.4	21.0	30.0	32.0	1.1	4.5	1.5	7.4	15.3	5.2	4.3	8.7	5.7	4.2	5.5	85.5	3.2	11.5	8.6	0.0	5.6	15.6	9.8	7.4	17.7	6.7	35.9	47.7	4.7	1.6	7.0	17.9	22.4	5.1	8.4	16.1	7.5	13.2	8.4	52.0	7.0	2.0	37.1	3.8	8.3	8.1	25.6	0.0	50.6	34.5	8.7	15.5	40.7	58.4	13.1	9.7	8.6	29.9	6.5	18.3	16.4	4.2	56.6	19.7	7.0	4.0	39.9	21.2	14.8	0.9	1.1	18.0	4.1	7.4	43.6
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 414.0"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.3	2.7	4.8	0.0	7.0	0.0	0.3	4.8	8.0	0.3	2.7	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.1	5.3	7.9	0.7	414.0	0.0	0.2	6.8	6.1	0.6	0.3	0.0	0.8	0.0	5.4	0.0	0.0	1.7	38.0	0.0	0.0	0.1	0.0	0.0	4.8	3.3	0.0	2.3	8.4	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	7.0	4.8	8.0	5.3	7.9	6.8	6.1	5.4	4.8	8.4	3.9	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957593	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Granulosa cells: 322.8;Muller glia cells: 184.8;Rod photoreceptor cells: 277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	20.7	10.4	35.7	11.8	36.1	4.3	7.5	37.8	99.4	7.1	37.8	46.8	32.5	28.6	22.8	15.3	13.1	14.8	67.9	33.5	35.2	11.4	55.6	4.9	9.5	38.6	35.9	7.9	2.0	10.0	5.2	34.0	37.0	14.4	35.3	68.9	3.5	11.2	67.5	13.0	16.6	39.2	37.0	6.6	26.6	29.8	38.3	11.7	8.6	59.6	11.6	11.9	7.1	38.2	111.1	24.0	86.9	74.3	61.9	52.1	272.7	64.6	51.1	52.0	80.9	85.4	67.1	113.8	82.3	61.6	32.6	113.1	126.3	124.8	96.8	75.6	105.2	108.9	63.4	112.9	104.6	123.2	9.9	72.2	144.6	75.7	146.4	79.2	131.4	53.8	131.3	78.0	61.9	19.9	70.2	70.1	271.4	36.7	74.5	67.9	130.7	92.8	67.3	1.9	86.9	46.5	121.8	3.8	97.5	130.0	3.7	48.9	80.9	45.4	72.0	89.3	93.1	39.7	33.9	116.7	137.1	78.5	56.0	0.0	1.4	0.0	1.5	1.6	1.7	0.9	1.8	2.0	2.5	0.3	0.8	1.5	0.1	0.6	0.3	0.2	6.1	0.8	35.7	36.1	37.8	99.4	33.5	35.2	38.6	35.9	37.0	37.0	38.3	38.2	15.1	0.0	2.6	8.5	16.5	89.3	6.5	39.9	87.6	16.9	16.5	9.9	126.3	10.0	5.7	0.0	158.4	77.4	20.3	99.8	0.0	2.5	107.2	14.3	70.7	22.8	3.5	20.2	9.8	3.3	67.6	32.8	67.2	35.8	8.9	322.8	6.4	37.5	15.4	20.2	11.6	17.3	20.3	9.0	15.7	118.3	11.8	12.8	39.2	20.6	4.3	184.8	0.0	9.0	23.8	7.4	7.7	7.5	25.5	16.5	9.3	10.8	3.9	277.5	0.0	38.2	22.1	45.3	23.6	29.6	39.5	46.0	20.9	49.6	23.3	1.3
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036015-7040117	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 22.8;GAMG: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	1.4	1.0	1.1	2.1	0.8	0.4	1.4	1.8	1.1	1.8	1.0	2.2	9.2	0.8	1.3	5.3	1.8	3.7	1.6	0.9	1.0	6.8	36.1	2.4	2.8	1.2	1.2	0.5	1.2	2.9	0.8	1.5	1.0	1.4	1.6	0.3	3.3	0.8	0.4	5.3	5.5	0.9	0.9	3.5	1.9	0.5	1.0	1.8	3.3	0.2	2.5	1.2	2.6	0.8	13.1	22.8	5.3	3.2	3.2	1.8	2.2	1.3	3.3	2.9	6.5	7.4	14.3	8.3	2.2	2.1	26.2	20.1	4.1	7.0	1.2	10.3	2.9	3.4	1.8	18.0	3.6	1.2	7.6	2.1	7.8	4.3	3.5	3.9	11.9	7.4	4.0	2.3	3.1	6.5	5.1	2.1	2.2	6.6	1.8	2.4	1.8	1.4	2.7	3.6	0.2	1.4	4.0	2.2	1.8	7.8	6.1	1.8	4.5	1.8	4.1	3.0	1.9	4.0	8.9	0.5	5.4	3.0	0.8	0.0	0.8	1.0	1.2	0.8	0.9	1.1	1.0	1.5	0.8	2.5	1.1	1.1	0.9	1.2	0.9	1.1	1.2	0.5	1.1	0.8	1.8	1.1	0.9	1.0	1.2	1.2	1.0	0.9	1.0	0.8	2.3	0.0	1.5	0.7	5.1	0.5	0.9	1.3	4.0	0.4	1.6	0.9	0.4	1.5	0.8	5.5	0.0	1.9	2.4	1.1	0.0	1.0	0.0	0.5	0.5	2.8	0.0	0.4	1.8	0.2	0.4	0.6	4.1	0.7	3.8	1.1	2.2	8.2	0.5	3.3	1.1	1.2	2.0	0.6	3.1	0.0	0.9	1.6	0.0	1.0	1.4	0.9	6.2	0.5	0.0	0.5	0.1	0.0	2.9	0.9	2.4	1.9	1.4	0.5	0.0	0.3	1.1	0.0	0.0	7.4	1.6	2.5	4.7	0.5	1.0	1.0
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034982-230068993	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.0;Excitatory neurons: 18.5;Inhibitory neurons: 21.1;Microglial cells: 45.0;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"eosinophil: 11.3"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 24.2;Karpas-707: 15.2;REH: 19.5;RPMI-8226: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	4.6	3.9	7.9	1.7	7.2	5.6	3.2	8.9	7.7	5.0	2.4	3.7	1.0	3.9	2.3	4.0	3.1	2.8	2.4	7.1	7.2	2.3	2.0	1.9	1.3	5.2	6.1	7.3	0.8	7.0	1.4	1.2	4.7	4.5	4.0	2.5	18.6	3.6	1.0	11.0	1.3	3.8	3.8	5.9	1.4	1.2	9.4	2.2	1.5	2.0	1.5	2.0	2.7	4.7	2.9	1.6	1.3	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.4	0.0	0.5	0.0	0.3	0.1	0.0	0.5	5.1	1.4	0.1	0.0	9.7	0.2	3.1	0.0	0.3	24.2	0.0	0.5	3.6	0.0	0.0	3.9	0.2	4.7	0.0	15.2	0.3	0.0	2.4	2.7	1.0	0.3	2.7	19.5	0.0	17.3	5.6	2.6	6.3	2.3	4.9	0.0	0.1	0.1	7.7	1.9	0.0	0.0	1.3	3.3	2.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	11.3	0.4	0.0	0.3	0.3	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	7.2	8.9	7.7	7.1	7.2	5.2	6.1	4.7	3.8	9.4	4.7	17.0	0.0	0.0	2.3	1.5	2.5	0.5	1.9	3.4	3.3	1.2	0.8	3.9	0.0	3.5	0.0	2.1	0.0	0.1	1.8	0.0	0.8	0.0	0.5	2.6	10.8	3.6	0.0	18.5	0.6	0.0	2.3	0.0	0.3	0.0	0.2	4.2	2.1	0.1	3.3	21.1	0.3	4.1	0.3	0.6	0.0	1.2	0.1	1.8	45.0	0.0	1.9	0.0	13.6	1.8	0.8	1.0	3.0	8.4	0.9	0.0	0.3	1.6	1.6	0.0	0.5	1.4	0.2	0.2	6.8	4.7	0.3	1.4	8.4	1.3	0.3
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 9.1"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 4.4;Melanocytes: 5.4;Oligodendrocytes: 4.0;Spermatogonia: 7.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;SiHa: 2.1;T-47d: 1.3;U-2 OS: 1.2;U-266/70: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075017	Approved		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	0.5	0.3	1.1	0.0	3.3	0.2	0.6	0.2	6.0	0.7	0.0	0.3	0.1	0.4	0.0	0.3	0.9	0.1	0.6	0.8	1.1	0.4	0.2	0.3	0.0	4.0	1.4	0.3	0.4	0.0	1.6	0.0	3.6	1.7	0.0	0.1	1.2	0.0	0.5	0.7	0.2	0.0	0.3	0.3	0.4	0.8	2.8	0.0	0.7	0.0	0.0	0.4	0.7	9.1	0.3	0.0	0.1	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.4	0.1	2.1	0.0	0.2	0.1	1.3	0.0	0.0	0.0	1.2	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.3	0.2	6.0	0.8	1.1	4.0	1.4	3.6	0.3	2.8	9.1	0.6	0.0	0.0	0.7	0.0	1.3	0.5	0.6	0.6	0.1	0.6	0.8	0.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.3	0.1	0.9	0.2	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.4	0.0	1.7	0.7	0.1	1.0	0.0	0.4	0.2	0.0	0.8	1.4	2.5	4.4	0.7	5.4	0.0	0.0	1.4	0.0	0.5	4.0	0.3	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	1.5	2.4	2.1	7.7	0.5	0.9	0.0	0.3	0.6	0.1	0.7
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650764-59736002	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 151.3;kidney: 191.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 83.9;Distal enterocytes: 108.6;Proximal tubular cells: 252.6;Theca cells: 99.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.8;NTERA-2: 20.1;SuSa: 10.1;U-251 MG: 10.6;U-937: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	1.2	151.3	12.8	1.2	12.8	1.7	1.7	11.9	14.8	18.5	18.4	12.5	0.4	16.2	5.2	10.9	22.0	3.1	3.4	12.9	16.6	191.1	2.5	1.1	1.7	14.0	13.7	34.1	3.0	29.2	6.9	0.1	12.0	7.8	16.7	5.6	2.9	10.2	4.3	0.4	1.2	7.2	13.3	40.8	6.0	8.9	12.3	1.2	13.9	2.8	2.8	2.2	9.0	15.0	0.0	0.3	5.2	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.9	10.8	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.1	2.3	0.0	0.5	0.2	0.0	2.8	0.1	0.4	5.4	8.0	0.1	0.6	4.2	3.0	0.0	20.1	2.0	9.3	3.6	0.2	7.2	0.0	0.3	3.4	9.6	0.1	0.4	0.0	10.1	3.4	4.5	3.2	0.5	1.1	0.1	10.6	0.0	0.0	0.0	0.0	18.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	12.8	11.9	14.8	12.9	16.6	14.0	13.7	12.0	13.3	12.3	15.0	0.3	0.0	0.0	83.9	1.0	0.1	2.1	9.4	0.6	4.3	3.1	1.5	3.9	0.0	26.2	7.3	0.0	0.0	0.0	108.6	25.4	1.0	0.2	2.3	2.0	1.5	20.0	4.2	2.5	0.0	1.7	4.1	3.6	2.4	0.0	28.4	0.4	0.0	0.1	3.3	4.8	19.1	4.1	18.8	0.7	1.5	13.7	1.5	3.6	1.9	0.6	11.8	0.0	14.6	1.0	0.1	23.2	12.0	0.0	17.7	2.2	252.6	7.4	1.0	0.0	2.4	3.4	0.3	0.2	17.0	0.1	0.0	0.7	99.4	11.9	6.5
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.1;cervix: 30.0"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 636.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"hypothalamus: 20.8;midbrain: 81.1;pons: 70.5"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Cell line enriched"	"Detected in some"	19	"HMC-1: 351.0"	"Region enhanced"	"Detected in many"		"midbrain: 62.7"	"Region enriched"	"Detected in all"	4	"midbrain: 111.6"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.1	14.6	0.1	0.9	1.1	2.4	1.8	0.1	0.3	30.0	0.2	2.3	1.5	2.6	1.6	2.5	0.5	3.6	0.7	0.2	20.8	0.9	2.8	7.4	0.6	3.8	81.1	10.4	3.4	0.2	0.2	0.1	70.5	9.2	3.5	0.4	0.8	1.3	0.8	6.3	2.1	2.3	0.0	0.3	4.4	0.9	5.0	6.1	0.0	0.5	0.9	2.9	7.9	0.2	0.2	1.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.7	18.6	0.1	0.2	0.0	1.0	351.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.7	0.0	0.1	1.0	0.3	0.2	0.3	0.6	0.2	0.4	0.2	0.0	0.2	3.4	0.7	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.1	2.5	0.3	0.8	0.5	0.4	0.2	0.4	1.9	0.3	59.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	3.8	0.0	2.0	0.1	1.1	0.1	0.3	0.2	20.8	3.8	81.1	70.5	0.0	5.0	0.2	0.0	9.6	16.2	1.0	0.2	1.9	0.0	0.0	0.0	2.1	0.2	0.0	0.3	0.0	2.5	0.0	4.2	0.0	5.7	0.4	0.0	0.0	0.0	13.1	16.1	0.7	8.9	4.2	1.1	0.0	0.0	3.4	4.1	112.4	636.0	2.4	9.7	0.3	0.8	0.0	1.7	0.0	0.0	1.0	3.6	0.2	0.6	3.5	1.8	0.0	0.1	0.4	0.0	0.5	0.6	0.1	0.1	4.9	1.9	3.8	0.0	0.1	0.7	0.8	0.0	0.4	1.3	0.2	2.1	0.0	2.7	0.0	5.6	9.8	0.1	0.1
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 88.2;testis: 28.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 17.1;Early spermatids: 35.3;Horizontal cells: 23.5;Late spermatids: 31.8;Syncytiotrophoblasts: 40.0"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in all"	6	"cerebellum: 88.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.4;NTERA-2: 6.1;U-698: 28.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 136.3"	"Region enhanced"	"Detected in all"		"cerebellum: 53.8"	"HPA041505, HPA044066"	Enhanced	Supported	Supported	"Plasma membrane,Intermediate filaments"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Intermediate filaments"	"HPA041505: AB_2677520, HPA044066: AB_2678796"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (6.88e-6)"	0.1	0.2	9.1	0.2	10.8	0.9	0.4	88.2	14.4	0.1	0.5	0.2	0.3	0.4	1.7	0.1	0.2	0.2	0.2	14.5	5.0	0.1	0.2	0.2	0.3	3.7	7.5	0.3	0.6	0.9	0.3	0.7	8.1	0.5	0.3	2.3	0.4	0.5	0.3	8.6	0.3	0.2	3.2	0.4	0.2	28.0	6.6	0.2	0.3	0.1	0.3	0.1	0.1	5.1	0.1	0.1	0.3	0.4	0.2	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.4	7.4	0.2	0.1	0.2	0.1	0.2	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.6	0.1	0.6	0.0	0.5	6.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.5	0.2	0.2	2.8	0.0	1.1	0.3	0.1	0.0	0.3	1.1	0.3	0.1	0.5	0.1	28.3	0.1	0.3	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	9.1	10.8	88.2	14.4	14.5	5.0	3.7	7.5	8.1	3.2	6.6	5.1	0.0	0.0	0.0	0.7	0.0	3.2	0.7	0.0	0.0	17.1	0.0	0.1	2.1	0.0	0.0	1.8	0.0	1.9	0.0	0.0	0.0	0.0	35.3	0.0	0.1	0.1	0.0	0.0	8.2	0.4	9.9	0.4	0.0	0.0	0.0	5.8	0.0	0.0	0.5	23.5	8.6	0.0	0.0	0.0	0.7	31.8	0.6	0.0	0.0	1.0	0.0	0.7	0.0	4.5	0.9	0.0	0.0	0.7	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.0	0.4	2.2	6.3	0.0	6.8	40.0	0.0	0.0	0.0	0.1
SLC20A1	"Glvr-1, GLVR1, PiT-1"	ENSG00000144136	"Solute carrier family 20 member 1"	Q8WUM9	2	112645939-112663825	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Phosphate transport, Symport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 353.3;Paneth cells: 261.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 522.4;U-87 MG: 507.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019279, HPA035834"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB019279: , HPA035834: AB_2674809"	"unprognostic (1.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (6.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-3)"	36.1	11.7	16.2	33.2	24.3	74.6	15.6	27.8	26.3	11.8	25.0	53.6	14.4	13.7	8.4	15.0	14.5	26.4	21.8	20.7	19.8	22.1	49.0	29.2	37.1	25.5	20.7	9.2	30.7	10.4	15.9	29.7	25.2	13.3	21.9	52.3	12.8	9.3	19.7	14.5	28.4	15.0	18.6	29.5	20.2	15.7	24.5	27.2	15.9	7.5	27.5	40.8	13.3	21.2	69.0	55.5	71.1	57.8	52.9	128.8	54.4	181.6	215.3	79.1	102.2	85.0	164.9	124.0	97.5	67.7	305.0	70.5	78.8	138.0	114.8	68.5	80.4	105.5	57.1	81.3	78.2	61.2	178.9	66.0	53.8	279.1	193.9	522.4	102.2	52.9	199.5	126.3	346.7	26.8	83.9	235.9	119.3	31.8	147.6	77.8	63.5	34.9	114.5	312.8	64.4	60.8	91.7	54.9	127.9	31.4	56.0	42.9	223.6	143.5	94.7	50.8	142.4	52.1	143.7	102.2	507.2	57.9	178.3	13.4	33.5	30.1	52.8	59.8	59.4	8.3	22.2	38.4	25.4	5.0	17.5	27.6	14.7	50.2	37.2	41.8	14.6	33.9	16.2	24.3	27.8	26.3	20.7	19.8	25.5	20.7	25.2	18.6	24.5	21.2	61.7	12.8	25.9	42.4	40.3	112.8	59.1	38.7	104.7	60.0	41.9	31.6	49.6	32.9	35.3	9.2	210.6	44.7	119.1	353.3	13.7	18.1	1.5	86.0	34.3	48.2	35.7	53.2	47.3	14.0	13.5	61.5	96.4	167.8	25.3	20.6	41.0	58.1	28.2	20.2	27.2	85.8	32.6	58.5	86.2	3.3	3.7	80.5	26.6	19.7	42.8	31.8	66.9	18.6	26.1	26.9	261.6	4.9	59.8	34.0	156.3	5.2	59.6	84.6	0.0	36.9	25.9	8.5	18.7	119.5	61.8	74.3	70.4	19.0	96.5	90.3
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887344-2903575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 17.7;kidney: 11.1;liver: 14.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 163.3;Paneth cells: 124.4;Proximal enterocytes: 75.7;Proximal tubular cells: 104.0;Syncytiotrophoblasts: 80.7;Undifferentiated cells: 48.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 7.0"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.9;granulocytes: 4.0;monocytes: 7.0"	"Cell line enhanced"	"Detected in some"		"A549: 9.4;CAPAN-2: 9.4;MCF7: 18.8;OE19: 8.4;SK-MEL-30: 35.8;WM-115: 14.8"									HPA068288	Enhanced		Approved	Nucleoplasm		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA068288: AB_2685969"	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	3.2	0.6	0.5	2.2	0.6	0.2	0.7	0.5	1.7	0.7	0.5	17.7	13.4	0.8	0.4	1.2	0.4	1.7	0.3	0.6	1.0	11.1	14.9	0.6	0.4	0.9	0.9	0.4	0.3	0.0	0.3	2.3	1.1	0.8	10.2	0.3	1.8	0.1	0.1	1.1	9.7	0.7	0.8	0.7	1.6	0.5	0.8	0.1	0.3	0.0	0.1	0.7	0.9	1.1	1.2	9.4	0.3	0.5	0.0	0.0	0.9	0.5	0.4	0.0	0.2	2.2	9.4	0.0	0.8	0.0	0.6	0.5	0.0	0.3	0.0	0.4	0.1	0.0	0.8	5.8	0.7	0.0	0.1	0.1	0.3	0.0	0.6	0.4	0.3	0.5	0.0	0.9	0.0	18.8	0.0	0.4	0.2	8.4	0.3	0.3	0.0	1.0	0.8	0.0	0.1	0.3	0.9	0.4	35.8	0.2	0.0	0.9	1.9	0.0	0.7	0.3	0.2	0.0	0.0	0.2	0.2	2.6	14.8	4.0	7.0	1.2	0.2	3.9	0.1	0.0	0.1	0.2	3.9	0.0	0.0	0.1	1.6	0.4	2.9	0.0	0.6	2.4	0.5	0.6	0.5	1.7	0.6	1.0	0.9	0.9	1.1	0.8	0.8	1.1	0.6	0.0	0.5	0.0	1.3	0.5	1.1	6.3	1.2	0.0	1.2	0.9	0.4	1.5	2.7	7.3	0.0	19.5	0.4	163.3	9.8	1.7	0.1	0.1	0.3	0.7	9.1	3.2	0.4	0.8	9.8	1.4	2.6	0.5	1.3	0.0	2.9	22.7	17.7	0.0	0.1	26.2	6.1	6.3	5.5	0.2	0.3	6.4	3.6	0.0	4.6	0.0	0.0	0.0	0.1	2.4	124.4	0.0	0.0	1.0	75.7	104.0	1.0	0.0	0.0	0.0	0.6	0.1	0.4	2.1	1.1	80.7	0.9	0.8	48.5	2.5
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348378-160452577	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 67.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 78.9;Hepatocytes: 68.8;Leydig cells: 33.8;Pancreatic endocrine cells: 57.3;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;HeLa: 38.1;Hep G2: 23.7;OE19: 12.0;RPTEC TERT1: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	11.7	15.2	2.1	3.8	2.7	0.0	6.6	3.3	2.1	15.9	1.8	8.8	1.7	18.4	27.6	7.7	18.7	11.0	1.5	2.0	3.5	6.3	34.9	16.4	16.2	6.2	3.8	21.1	0.7	0.2	1.3	44.3	4.5	43.4	2.4	0.2	51.8	52.6	67.4	10.7	5.7	26.3	3.3	0.6	6.0	2.6	4.2	0.5	2.0	8.5	4.9	6.2	15.7	3.2	0.0	27.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.4	0.0	0.0	0.0	38.1	23.7	1.2	0.0	0.0	0.8	6.9	3.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	12.0	7.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.7	3.3	2.1	2.0	3.5	6.2	3.8	4.5	3.3	4.2	3.2	0.6	16.0	78.9	6.2	0.1	4.7	0.3	2.1	2.8	0.2	0.2	0.3	2.9	5.7	6.4	0.0	0.0	0.3	0.1	0.2	5.9	8.2	0.6	0.2	10.2	1.0	0.0	0.0	0.5	3.0	0.3	10.0	12.8	0.3	2.5	0.8	0.0	68.8	0.7	0.0	25.1	1.6	2.0	1.0	2.4	1.6	33.8	0.3	3.6	7.5	0.0	0.0	0.0	19.6	0.2	57.3	0.1	24.5	0.1	6.1	2.1	2.9	0.8	0.1	0.0	29.8	12.3	0.3	0.2	3.7	6.7	0.4	1.2	0.0	2.8	0.8
SLC25A14	"BMCP1, UCP5"	ENSG00000102078	"Solute carrier family 25 member 14"	O95258	X	130339888-130373361	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 34.2;Spermatogonia: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060316			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA060316: AB_2684251"	"unprognostic (1.65e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.36e-3)"	"unprognostic (8.92e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.95e-3)"	"prognostic favorable (1.78e-4)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.52e-6)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (1.39e-5)"	2.5	5.6	10.7	2.1	11.5	2.7	3.3	8.2	12.6	3.3	7.3	3.6	1.3	4.1	6.5	2.6	5.9	2.6	4.7	11.4	14.3	3.2	2.5	2.8	2.8	8.7	9.0	4.0	3.4	4.2	10.8	2.2	9.8	3.0	2.4	10.2	3.2	3.7	3.7	2.9	2.4	4.5	8.2	2.3	3.0	6.6	11.5	3.9	3.4	2.3	3.3	2.6	2.5	8.8	9.0	11.7	8.1	6.1	5.4	5.0	4.4	6.6	8.7	12.3	12.6	4.7	5.3	6.1	22.6	9.0	14.7	4.9	11.9	5.0	12.2	7.6	15.0	2.0	10.7	11.1	7.8	7.7	3.5	4.7	5.9	15.8	4.8	7.4	7.1	8.4	4.9	8.5	20.2	13.8	8.2	10.8	6.7	9.7	18.4	6.9	10.6	12.2	7.5	3.8	10.4	9.2	7.0	7.0	11.7	5.3	4.5	4.3	4.8	6.8	4.5	15.6	13.6	7.8	21.0	5.0	12.3	9.3	6.2	3.2	3.4	2.6	3.0	2.8	3.6	3.9	2.4	2.8	3.7	2.0	1.9	3.1	4.1	3.8	2.7	4.5	4.7	2.4	10.7	11.5	8.2	12.6	11.4	14.3	8.7	9.0	9.8	8.2	11.5	8.8	4.5	6.4	2.2	5.9	5.6	9.9	8.3	13.3	7.4	10.0	6.6	6.1	4.1	8.6	5.3	3.7	2.1	9.1	4.3	4.5	17.6	10.2	15.8	16.0	5.5	5.1	9.0	3.4	12.7	9.1	8.2	5.4	5.6	4.2	3.8	9.7	7.5	4.3	5.2	6.7	11.9	3.8	12.2	4.7	4.1	7.7	5.0	4.9	8.8	5.6	4.5	8.2	3.1	4.5	5.3	9.0	4.2	8.2	9.0	4.2	4.7	10.7	34.2	13.6	6.6	5.3	9.2	29.1	37.3	7.3	8.4	5.3	5.8	6.5	4.5	6.5
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563450-17590995	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 143.8;choroid plexus: 90.7;liver: 111.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 195.2;Hepatocytes: 72.8"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;BEWO: 8.5"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	14.4	1.0	130.1	0.3	132.1	0.1	7.2	116.5	141.1	2.5	90.7	2.9	0.3	2.9	0.2	0.3	3.8	0.9	2.8	119.4	123.3	1.9	111.5	1.2	0.3	121.7	129.2	1.2	1.1	0.2	1.5	0.1	112.5	7.8	0.1	1.9	0.5	0.4	6.2	1.2	1.9	0.5	106.5	4.8	1.5	4.2	143.8	0.3	0.6	4.0	0.1	0.8	1.4	110.7	0.3	0.6	2.2	0.4	3.8	0.0	8.5	0.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.5	0.7	0.0	0.0	0.0	0.3	1.0	0.3	0.3	0.5	1.5	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.3	0.0	0.4	0.1	0.5	2.0	0.9	1.4	2.9	0.8	0.0	0.1	0.4	0.8	0.3	0.2	0.4	0.7	1.6	2.5	1.0	0.1	0.1	0.3	0.2	0.3	0.9	1.2	0.0	1.8	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.1	132.1	116.5	141.1	119.4	123.3	121.7	129.2	112.5	106.5	143.8	110.7	1.0	28.9	10.3	195.2	0.3	0.0	0.3	0.1	0.6	0.6	0.3	0.0	1.5	5.7	7.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.6	0.4	0.9	1.7	0.0	10.7	2.0	0.0	0.3	4.7	0.0	0.7	6.3	8.5	3.6	72.8	0.3	0.0	3.0	0.3	0.0	4.1	0.3	0.6	0.9	3.9	0.0	10.3	0.1	2.2	1.0	13.0	11.5	0.0	0.0	2.6	0.1	4.3	0.1	0.8	15.8	3.4	0.0	2.7	2.5	4.8	5.9	0.0	0.1	1.8	2.6	2.6	0.0	0.2
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856926-48898904	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.2;Hepatocytes: 64.2;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 96.1;RPMI-8226: 138.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	20.7	29.9	16.3	11.9	18.2	10.7	17.9	18.6	16.4	8.3	15.3	26.5	65.6	10.4	4.6	9.1	12.8	15.7	62.8	15.5	17.9	25.6	148.3	15.6	14.6	17.7	17.4	5.9	30.4	17.3	11.6	7.3	17.8	11.7	23.5	4.5	19.9	9.0	66.5	10.4	52.7	15.1	17.4	20.6	21.0	9.1	17.5	17.3	11.4	61.1	16.1	11.3	8.4	18.4	4.1	12.8	9.7	13.8	30.1	11.8	1.9	22.3	11.8	15.2	15.8	16.3	19.1	19.0	15.6	35.1	18.7	4.1	24.5	9.8	11.6	47.9	11.8	26.4	19.2	20.4	14.0	27.8	48.1	14.9	11.2	20.6	3.8	6.1	20.2	28.1	24.1	96.1	20.2	10.9	30.4	13.7	5.1	22.9	27.6	10.6	5.9	138.4	16.4	10.1	3.9	13.6	20.7	0.2	11.4	13.6	30.5	12.9	16.6	17.2	3.2	25.5	16.4	35.6	27.0	21.8	24.5	19.5	23.3	60.8	101.1	215.2	97.4	79.7	62.2	36.8	53.1	71.2	97.5	33.0	41.2	69.1	48.6	64.6	83.7	120.5	60.7	112.3	16.3	18.2	18.6	16.4	15.5	17.9	17.7	17.4	17.8	17.4	17.5	18.4	7.5	6.4	2.7	13.1	7.0	1.8	2.5	4.6	3.4	1.1	4.0	3.6	42.2	4.3	4.4	0.0	6.2	2.3	13.6	28.4	3.9	3.5	1.3	2.3	4.6	5.5	7.3	16.4	2.2	4.3	2.3	6.1	9.2	2.1	1.3	3.8	7.5	64.2	16.9	0.0	3.8	12.7	2.0	13.4	4.5	1.8	10.5	10.0	1.8	1.0	31.3	2.9	32.0	1.0	6.0	3.7	16.4	12.4	12.6	3.9	51.8	16.7	5.9	1.3	0.0	5.4	5.3	8.3	7.1	4.1	1.3	1.2	14.4	27.7	16.6	2.9
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798281	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;pancreas: 83.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	15.8	13.6	49.1	11.0	59.8	7.5	11.2	17.9	83.1	9.0	0.0	10.0	12.9	9.6	2.1	15.2	10.4	4.1	7.7	74.2	7.9	15.1	40.2	15.1	10.1	24.5	11.1	12.7	83.4	4.0	48.7	5.0	25.4	13.9	3.0	16.1	14.4	4.3	2.0	14.2	12.2	3.7	2.4	13.9	13.5	19.1	19.1	6.3	9.4	0.5	6.2	10.3	10.3	40.2	56.2	35.7	20.4	18.6	8.3	14.8	19.4	26.3	21.3	28.0	17.7	34.9	37.1	16.8	19.2	21.6	31.9	48.8	22.4	31.1	6.3	31.9	41.4	15.4	18.2	21.9	35.8	24.7	25.0	14.9	18.6	21.4	22.6	8.8	13.0	19.3	31.8	25.3	12.7	33.9	26.3	23.5	44.8	33.9	53.7	30.9	11.2	38.9	16.8	9.2	100.3	45.3	15.0	35.9	18.7	3.1	17.4	12.5	13.0	32.1	21.5	14.8	25.0	22.1	14.3	21.5	37.8	22.2	19.3	0.0	1.6	2.5	3.7	3.3	2.2	1.3	2.3	3.9	1.8	1.0	1.3	2.3	0.9	2.0	3.4	0.5	1.3	1.6	49.1	59.8	17.9	83.1	74.2	7.9	24.5	11.1	25.4	2.4	19.1	40.2	5.7	6.4	8.6	7.8	8.4	12.6	8.7	9.5	9.1	143.2	9.1	7.5	2.5	8.6	5.0	9.2	33.3	7.1	8.8	3.9	3.9	22.0	12.4	9.5	9.0	7.0	13.1	2.5	11.8	19.3	10.3	5.1	12.8	11.2	2.5	7.2	3.3	17.6	4.3	43.7	10.0	7.6	2.0	2.8	4.6	7.7	4.7	4.1	3.6	3.7	6.6	16.0	13.4	2.5	1.4	14.1	7.8	4.9	13.7	23.8	13.0	7.1	5.8	32.0	0.0	2.8	6.7	1.8	10.4	7.4	13.4	3.1	8.2	13.7	5.9	8.8
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	15.8	16.0	9.6	5.6	9.9	12.9	15.0	8.7	11.0	12.7	6.8	18.1	7.8	13.3	9.4	15.9	12.7	7.8	28.3	10.1	8.7	18.5	25.9	11.6	10.7	9.1	9.3	16.5	15.5	14.9	10.2	7.7	9.2	13.5	9.5	8.5	16.1	9.0	42.4	22.0	13.3	7.8	9.3	13.5	17.4	14.3	11.1	8.6	15.8	21.0	9.6	17.5	14.1	11.3	10.7	10.4	6.5	12.4	13.9	13.1	13.9	9.0	15.7	10.7	10.2	13.5	13.9	12.3	5.5	15.1	14.3	7.6	7.3	15.8	11.7	11.5	16.8	16.3	8.1	19.2	14.7	22.5	13.4	17.7	29.6	8.4	21.3	11.2	8.9	21.5	9.2	12.8	12.9	12.5	9.9	28.3	20.8	23.2	6.8	10.0	11.7	19.4	10.1	8.3	5.4	14.6	12.4	11.8	21.4	10.9	9.8	19.7	10.4	12.7	11.0	15.9	16.6	21.1	30.6	15.1	17.4	21.1	14.7	1.8	9.9	6.1	15.4	10.8	14.5	19.3	16.9	16.4	18.3	16.2	20.5	17.5	0.9	18.1	6.7	17.5	17.7	13.4	9.6	9.9	8.7	11.0	10.1	8.7	9.1	9.3	9.2	9.3	11.1	11.3	11.6	32.1	22.2	22.9	29.5	35.8	38.6	45.7	28.5	17.7	36.1	34.0	106.9	30.0	25.0	18.4	12.5	36.8	27.3	14.1	35.2	28.8	33.3	17.2	13.6	20.5	18.6	9.2	55.5	45.1	44.6	26.1	17.3	19.1	19.6	21.1	13.2	39.1	30.3	11.8	51.4	29.2	28.5	22.3	26.5	28.6	16.1	15.8	37.4	31.9	21.4	26.5	32.0	32.2	63.9	27.6	20.8	21.8	18.7	49.1	30.8	57.7	16.2	24.5	19.7	31.7	22.1	29.4	32.9	28.2	36.8	32.7	39.6	22.3	33.3	37.8
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1537.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1748.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		NA	NA		83000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	300.9	550.7	131.2	184.7	136.0	209.2	267.5	159.3	146.5	224.3	209.3	418.9	396.4	283.5	226.1	437.7	248.9	136.2	1237.8	132.6	160.4	419.8	370.1	255.7	201.7	148.9	149.6	290.2	392.2	499.7	216.9	192.4	153.0	209.9	347.6	167.2	302.7	220.9	1537.4	275.7	321.2	257.4	150.4	235.1	423.5	90.8	159.0	205.7	225.1	1233.2	312.8	294.7	264.6	135.4	731.4	447.1	620.0	509.6	534.1	891.5	1005.3	622.8	724.1	704.3	573.4	787.6	316.4	1003.2	376.9	633.0	320.3	573.7	616.9	741.3	680.6	402.9	651.8	589.5	297.4	563.3	683.0	665.7	416.6	857.3	616.8	494.2	681.2	994.3	990.8	488.8	654.9	240.5	782.7	436.5	642.5	724.2	605.4	540.6	988.5	703.0	730.3	1075.0	858.8	559.6	355.5	506.1	740.1	565.5	1009.8	504.4	771.0	676.3	782.0	371.2	390.0	442.8	603.4	486.5	648.5	678.1	295.6	368.3	494.9	184.7	408.9	223.2	244.7	520.2	285.6	298.5	270.8	271.4	534.7	222.6	281.3	269.8	166.6	288.5	545.2	321.7	377.4	637.0	131.2	136.0	159.3	146.5	132.6	160.4	148.9	149.6	153.0	150.4	159.0	135.4	319.2	214.7	294.8	46.0	392.2	376.0	590.6	751.4	495.1	223.1	442.5	549.3	1748.6	370.3	384.5	215.2	79.2	785.9	480.8	727.5	874.6	512.1	41.7	217.9	275.3	328.6	312.4	413.5	44.9	879.5	946.2	393.1	390.4	288.7	210.4	477.9	278.1	416.3	589.4	292.7	49.7	470.7	370.2	467.9	280.7	29.0	255.1	449.1	437.6	34.7	593.5	317.3	294.5	32.2	42.2	632.9	602.7	256.5	442.7	652.4	945.5	1029.4	201.1	230.2	302.4	470.5	733.5	126.1	169.9	796.6	362.4	814.7	356.3	536.0	729.1	769.9
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295400	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.9;Syncytiotrophoblasts: 17.4"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Mitochondria"		"HPA051720: AB_2681584"	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.91e-5)"	5.7	8.3	2.9	4.9	3.9	6.1	8.6	3.5	4.4	10.0	4.6	7.7	6.1	13.4	7.6	5.4	7.1	5.2	4.8	2.9	3.2	15.0	4.6	6.8	5.0	3.9	4.0	2.9	12.2	6.1	12.8	4.1	4.1	8.7	5.3	4.5	6.4	5.2	2.2	4.5	7.7	4.1	3.3	8.9	12.5	24.5	4.4	5.2	9.1	1.5	3.5	6.0	5.0	4.2	5.0	13.5	2.4	10.0	7.5	2.9	5.5	3.2	2.8	3.4	3.7	1.6	12.4	5.8	3.3	3.7	7.1	11.0	2.8	3.8	1.9	3.2	3.6	4.8	11.1	1.9	2.7	0.7	12.8	5.9	2.1	6.5	1.2	2.5	5.4	6.8	1.4	2.0	2.9	2.7	5.3	2.7	0.8	3.4	4.4	5.8	1.6	2.6	2.6	12.6	1.2	3.0	9.2	5.4	4.1	2.4	12.2	3.6	7.6	2.3	1.7	5.6	2.7	4.3	2.9	2.1	5.9	8.6	6.1	4.1	5.6	7.6	4.0	8.8	3.3	1.9	3.7	4.3	5.7	3.6	1.3	2.5	1.1	2.8	6.5	3.0	4.1	2.5	2.9	3.9	3.5	4.4	2.9	3.2	3.9	4.0	4.1	3.3	4.4	4.2	3.1	0.0	5.4	5.2	3.6	0.8	1.5	1.4	2.8	4.3	6.3	4.1	1.0	5.7	1.8	11.0	8.4	9.2	2.1	3.8	11.7	2.8	3.8	10.2	1.9	2.8	9.0	4.6	0.5	7.1	2.3	3.0	5.1	10.6	5.1	1.3	1.8	2.8	6.7	1.7	0.7	3.0	2.0	6.4	1.5	5.5	1.5	4.2	0.0	4.7	5.8	7.9	3.1	1.0	2.5	3.2	6.0	1.2	3.7	1.9	2.4	7.3	2.0	9.0	0.0	1.1	1.2	20.9	0.8	1.9	0.3	17.4	3.2	9.1	3.1	1.9
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063994-19113030	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.7;Hepatocytes: 52.1;Proximal tubular cells: 39.6;Rod photoreceptor cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.7;MAIT T-cell: 1.4;memory B-cell: 3.3;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.4;naive B-cell: 3.2;naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.4;NK-cell: 1.8;T-reg: 1.7"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;NK-cells: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049449	Approved		Supported	Mitochondria		Yes	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	8.5	7.5	17.2	4.3	16.9	8.3	7.9	14.5	18.3	13.1	16.7	8.4	5.1	10.1	3.7	5.2	12.5	3.5	15.8	17.9	16.9	34.1	82.0	6.6	9.0	14.9	15.2	16.9	11.3	6.0	14.4	2.6	14.7	9.9	2.4	8.4	9.2	5.2	46.5	6.7	9.3	4.9	13.9	12.7	8.3	7.0	18.0	8.1	25.6	32.6	7.5	9.6	9.1	13.9	7.3	1.0	1.8	3.2	6.8	5.6	2.8	3.5	5.2	5.3	6.0	1.4	14.3	5.2	8.0	3.3	5.3	1.3	3.7	2.9	3.0	1.3	7.0	1.8	2.0	11.8	5.4	0.8	3.6	5.6	2.0	4.0	2.4	4.3	2.4	16.8	20.9	9.2	2.8	6.6	9.0	8.4	1.0	2.0	7.4	6.8	3.2	10.2	2.1	1.3	2.0	1.5	3.7	0.1	1.6	2.4	6.5	4.1	2.2	3.9	2.2	8.2	3.4	10.7	6.2	4.1	4.1	11.2	2.0	0.0	0.1	0.1	2.7	0.3	1.4	3.3	1.5	2.4	0.2	3.2	1.0	1.4	0.0	1.8	0.3	0.4	1.7	0.9	17.2	16.9	14.5	18.3	17.9	16.9	14.9	15.2	14.7	13.9	18.0	13.9	4.6	0.0	13.1	12.4	14.2	3.2	2.8	3.3	2.8	67.7	5.9	6.6	9.7	5.7	4.1	9.2	18.8	7.7	16.5	3.1	13.7	1.5	1.2	2.5	5.4	4.1	8.4	13.7	18.6	3.1	3.8	5.1	4.1	3.6	3.8	8.3	5.3	52.1	1.8	3.3	25.0	3.8	6.1	0.6	1.9	1.6	5.0	1.4	3.6	6.5	1.3	12.5	32.0	16.1	8.6	2.5	4.6	6.4	16.4	2.4	9.2	39.6	3.0	41.4	6.6	9.6	5.8	10.6	7.6	0.9	2.8	4.7	10.9	8.0	3.1	1.7
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399336-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.7;Oligodendrocyte precursor cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035188, HPA078530"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA035188: AB_10602400, HPA078530: "	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	10.6	2.6	3.1	7.3	3.4	1.8	9.3	3.3	4.1	8.2	5.4	14.0	14.2	5.0	3.4	21.4	5.3	4.3	5.0	3.2	3.6	7.7	10.6	10.2	5.5	4.3	3.5	6.0	5.9	6.9	1.9	8.3	3.9	4.6	15.5	0.5	10.8	4.6	1.6	16.3	12.8	8.8	3.5	4.9	8.9	2.1	3.6	3.6	4.2	4.5	11.3	7.9	11.3	3.8	32.4	23.3	1.9	9.2	30.0	44.5	12.2	17.9	21.7	13.8	13.2	12.4	16.0	4.0	10.2	47.4	41.1	23.2	18.2	16.0	12.4	28.5	5.4	11.3	7.4	16.4	19.3	10.6	11.7	18.8	28.3	22.5	19.8	18.9	16.6	6.1	2.3	17.1	15.7	58.9	0.1	15.9	10.3	16.6	35.1	3.2	0.0	4.6	22.3	10.9	1.5	0.0	23.0	47.8	29.1	7.3	8.5	11.0	24.2	22.2	7.1	25.0	28.0	0.4	14.2	8.3	22.3	17.8	19.7	0.0	3.5	0.2	0.9	4.9	1.7	4.4	1.8	2.9	6.0	3.7	0.9	1.8	0.1	6.4	11.2	1.6	1.5	1.6	3.1	3.4	3.3	4.1	3.2	3.6	4.3	3.5	3.9	3.5	3.6	3.8	8.3	6.4	9.7	30.7	8.0	7.8	7.3	8.9	9.6	0.2	6.1	6.6	1.6	2.8	5.6	3.7	0.0	11.9	9.1	21.8	9.8	4.5	0.0	0.9	7.6	6.9	7.3	3.4	10.3	8.9	7.1	11.8	9.7	1.8	8.2	2.1	6.4	5.8	10.3	0.0	6.2	9.6	4.1	7.1	13.6	0.4	8.1	7.5	10.6	1.0	11.9	0.2	9.2	36.7	1.4	13.9	11.4	5.7	2.8	5.4	19.8	9.6	2.0	0.4	0.0	7.8	9.2	0.5	2.3	19.8	13.9	6.8	6.8	1.0	12.2	5.8
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 7.4;granulocytes: 12.6;monocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 53.3;MCF7: 30.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	18.9	5.0	4.1	3.3	4.1	2.5	17.7	3.3	5.7	8.3	4.6	8.8	2.4	6.3	37.7	6.1	9.8	5.7	8.3	4.0	4.1	11.1	20.4	19.0	4.7	4.2	5.6	9.2	8.0	9.2	9.9	6.4	3.9	7.1	5.0	0.6	5.1	8.0	3.1	12.3	7.7	5.8	3.6	8.6	19.3	12.2	3.9	2.3	9.4	3.7	2.8	7.4	9.5	4.0	2.6	0.5	3.1	1.5	53.3	10.8	0.8	0.5	3.9	1.2	1.0	1.8	1.8	1.1	1.6	2.4	0.6	9.3	3.0	1.5	0.7	0.4	1.4	1.5	2.8	1.9	6.7	1.4	5.8	5.5	6.6	0.3	1.4	1.1	7.0	0.3	0.8	1.4	0.3	30.8	0.3	8.1	3.4	12.2	1.4	8.6	0.6	0.9	1.5	0.9	2.7	1.7	0.6	9.6	3.0	4.1	3.9	5.5	0.0	1.5	2.8	3.3	0.1	2.4	2.4	0.3	2.5	5.7	1.2	9.5	10.7	12.6	2.1	8.8	1.3	0.6	0.6	2.1	7.4	0.7	0.2	0.6	0.9	2.5	11.1	1.0	0.2	3.4	4.1	4.1	3.3	5.7	4.0	4.1	4.2	5.6	3.9	3.6	3.9	4.0	47.3	19.2	51.8	6.5	5.5	11.7	12.6	9.0	8.0	0.9	4.4	11.3	4.6	34.3	10.1	3.7	0.0	27.2	20.7	4.2	0.0	4.3	0.6	5.1	12.1	42.4	4.2	0.4	2.6	7.3	13.0	20.3	16.8	7.9	25.4	1.8	106.1	30.6	33.2	1.7	2.6	23.7	6.1	31.7	39.8	3.2	19.0	21.3	23.2	1.9	44.6	2.0	35.0	0.5	1.6	3.1	42.3	14.3	7.9	3.4	2.5	3.6	6.6	1.0	6.6	3.4	15.7	1.7	2.9	5.5	7.7	8.8	13.0	5.2	10.7	7.0
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 24.4;fallopian tube: 21.3;heart muscle: 23.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 25.0;Cardiomyocytes: 29.6;Cytotrophoblasts: 54.8;Extravillous trophoblasts: 37.3;Muller glia cells: 33.0;Skeletal myocytes: 18.0;Syncytiotrophoblasts: 27.5"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 43.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.4	24.4	1.8	0.3	2.4	0.1	3.0	3.0	1.4	3.9	0.7	0.9	0.4	4.3	0.2	4.2	21.3	2.7	23.5	1.2	3.6	0.0	0.1	0.8	0.2	9.7	5.2	9.7	0.1	0.0	6.0	6.7	7.5	3.6	1.7	7.4	3.5	0.3	0.4	2.0	1.1	0.8	5.8	0.1	0.5	13.0	5.5	9.6	1.8	0.9	5.7	1.1	2.9	8.4	0.0	0.0	0.1	0.0	0.0	0.0	43.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	3.5	0.0	3.3	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.3	4.4	0.0	5.1	0.0	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	3.0	1.4	1.2	3.6	9.7	5.2	7.5	5.8	5.5	8.4	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	25.0	0.6	0.2	5.5	29.6	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	13.2	3.8	1.0	0.3	0.0	0.0	0.4	0.0	37.3	2.7	0.0	1.9	0.0	1.7	0.0	0.0	3.8	3.3	4.6	0.0	0.0	0.0	0.4	2.8	0.3	0.2	0.0	0.0	0.0	33.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	18.0	0.3	1.1	1.0	1.8	0.9	27.5	0.0	2.3	0.1	0.1
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319259-71381423	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.8;Hep G2: 35.9;RT4: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	4.7	2.6	3.1	4.1	3.9	1.1	4.8	3.7	3.7	7.3	2.7	4.4	2.1	6.8	2.5	2.2	5.8	4.4	2.4	3.0	3.6	2.5	9.4	6.7	7.1	4.7	3.7	9.7	5.2	3.5	1.7	11.2	4.2	5.1	3.5	0.3	4.9	2.9	1.4	2.6	3.7	5.1	4.2	6.5	6.1	3.7	4.4	3.7	3.8	0.6	3.8	9.8	4.4	5.0	2.1	12.3	1.8	7.8	6.8	5.3	31.8	2.3	2.2	0.7	0.4	13.8	8.8	7.4	6.4	4.7	3.2	18.3	5.7	2.9	0.1	5.6	5.6	2.2	1.0	35.9	3.3	1.8	4.5	5.2	12.9	0.3	0.6	1.5	3.2	8.5	6.5	6.8	0.9	19.1	4.2	3.8	4.2	19.2	4.5	5.7	0.6	5.9	2.3	29.5	8.5	9.6	6.4	20.3	1.7	5.2	3.2	4.0	5.2	0.2	3.8	2.3	0.1	1.8	3.1	4.0	7.6	24.0	1.3	4.2	19.3	2.2	5.4	15.3	4.6	4.9	4.5	5.1	29.1	1.9	3.5	5.0	1.5	9.4	10.3	20.2	5.5	9.5	3.1	3.9	3.7	3.7	3.0	3.6	4.7	3.7	4.2	4.2	4.4	5.0	2.0	3.2	1.1	2.0	3.1	0.3	1.5	4.0	1.8	2.3	2.7	3.8	0.8	1.5	3.8	0.0	0.0	46.1	6.3	2.6	0.0	6.1	3.6	1.8	3.2	1.8	1.8	4.2	2.4	8.9	45.3	4.7	7.1	2.4	2.5	10.2	3.3	5.4	34.7	0.0	1.3	2.5	8.2	11.8	4.4	15.2	2.8	10.9	1.8	16.9	8.5	3.0	3.1	2.5	2.7	7.9	13.1	1.5	6.0	3.2	0.1	2.0	2.6	0.4	0.0	0.2	2.5	0.6	5.0	0.7	0.0	31.7	2.9	10.0	2.5	1.7
SLC29A4	"ENT4, FLJ34923"	ENSG00000164638	"Solute carrier family 29 member 4"	Q7RTT9	7	5274369-5306912	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 43.3;choroid plexus: 55.5"	"Group enriched"	"Detected in many"	5	"Enteroendocrine cells: 103.2;Horizontal cells: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 49.2;SH-SY5Y: 70.7;U-2 OS: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052829			Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Microtubules, Cytokinetic bridge"		"HPA052829: AB_2681967"	"unprognostic (6.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.49e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.60e-2)"	43.3	8.2	13.2	0.7	16.2	0.6	13.3	16.0	20.0	4.9	55.5	3.1	4.6	5.4	5.0	1.1	4.0	1.6	3.7	26.3	28.5	7.9	9.2	0.9	0.2	23.2	26.1	2.2	15.4	1.7	3.6	0.6	23.6	5.8	1.8	4.1	1.3	0.7	2.6	3.0	5.5	1.8	17.2	1.6	6.5	2.6	30.0	0.3	9.7	0.4	0.1	2.4	2.0	7.4	0.0	21.7	12.6	49.2	0.6	0.2	2.4	1.8	0.1	1.6	0.9	12.3	0.4	0.0	2.4	1.9	8.1	0.3	4.8	0.4	0.5	0.1	2.8	0.2	0.7	18.3	3.8	0.2	3.0	1.5	16.2	0.3	0.9	2.9	1.5	4.5	3.6	0.1	1.2	10.8	2.0	0.9	16.0	1.5	1.3	8.3	2.1	1.9	3.2	0.5	8.4	70.7	1.3	4.4	0.9	10.7	5.5	5.9	0.7	17.3	23.4	1.6	0.5	1.1	0.0	0.1	2.2	0.7	8.0	0.8	0.3	0.2	0.2	0.1	0.4	0.2	0.1	0.2	0.1	0.4	0.2	0.2	1.3	1.6	0.1	0.3	0.1	0.1	13.2	16.2	16.0	20.0	26.3	28.5	23.2	26.1	23.6	17.2	30.0	7.4	0.5	3.2	0.5	8.8	0.0	0.1	0.2	0.1	0.0	6.9	0.7	0.6	2.5	0.0	0.2	0.0	16.7	0.3	0.2	6.3	0.0	5.3	0.1	3.3	3.0	0.6	103.2	0.0	2.4	0.2	0.4	2.2	2.0	0.7	0.0	25.7	0.0	1.0	0.4	168.2	14.3	4.4	0.0	0.3	0.7	0.7	0.3	0.3	0.0	0.0	0.1	4.8	0.0	4.0	0.6	1.4	0.5	0.4	0.1	2.3	0.8	0.2	1.4	1.6	0.0	0.5	2.2	0.4	4.2	0.1	0.3	0.3	0.3	1.7	1.0	0.2
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925353-42958893	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease variant, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 98.7;skin 1: 79.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 833.8;Erythroid cells: 520.4;Extravillous trophoblasts: 536.4;Syncytiotrophoblasts: 2482.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 241.0;CACO-2: 219.9;Hep G2: 157.4"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	6.9	3.6	24.1	2.5	26.1	41.6	7.8	33.7	27.7	28.6	43.6	6.1	0.4	5.1	1.4	54.1	8.2	1.7	10.0	20.6	28.5	14.2	1.7	3.3	1.0	31.9	29.3	5.5	2.1	4.5	4.8	98.7	34.5	6.0	1.0	24.6	17.6	5.1	2.0	79.8	4.6	0.4	24.7	7.5	8.4	2.1	41.2	1.0	3.0	1.5	2.1	19.3	54.2	29.4	60.5	52.9	66.3	6.2	3.5	1.2	241.0	47.8	36.9	15.5	27.8	219.9	96.3	22.2	138.9	6.0	26.5	43.6	12.5	52.3	14.8	16.4	10.3	29.8	20.9	157.4	12.9	16.8	8.1	3.3	21.3	18.3	20.5	96.7	2.9	12.8	81.2	1.5	11.7	46.6	7.4	11.7	35.1	22.1	17.9	8.4	20.6	23.3	21.7	17.9	27.0	23.8	47.7	95.6	11.0	70.0	3.8	16.9	14.9	25.6	28.6	6.1	83.8	5.3	6.5	11.5	57.1	8.2	25.5	0.5	0.1	1.2	10.6	0.3	8.5	10.9	5.1	6.7	3.7	8.3	3.8	4.8	0.2	4.3	0.1	18.4	6.2	4.0	24.1	26.1	33.7	27.7	20.6	28.5	31.9	29.3	34.5	24.7	41.2	29.4	3.1	0.0	1.8	12.7	25.4	286.1	48.8	286.3	66.0	15.8	41.4	21.8	26.7	20.0	159.3	27.6	66.7	833.8	33.5	53.1	5.9	53.2	4.0	112.1	46.0	100.5	18.4	520.4	2.8	11.7	536.4	25.9	11.7	118.9	6.3	6.8	2.2	2.1	84.8	5.0	3.2	22.4	65.1	1.6	34.2	0.3	7.8	5.0	21.4	71.2	36.0	350.1	18.6	8.0	9.9	120.3	51.9	14.7	11.6	31.2	1.9	2.2	118.1	32.1	0.0	9.8	32.1	0.1	2.4	99.1	238.3	2482.5	20.8	5.5	11.8	105.8
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 836.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.4	0.0	0.2	0.0	66.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.3	30.8	836.1	0.0	0.0	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.4	0.3	0.3	0.5	0.4	0.8	0.4	0.4	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 753.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.4	0.8	0.0	0.3	0.0	0.0	19.1	2.1	0.2	66.6	6.9	0.1	16.4	34.6	0.1	1.5	69.8	9.0	0.2	0.1	0.0	16.7	1.2	753.0	0.1	0.0	0.0	1.3	7.3	0.0	2.1	4.8	0.1	1.0	0.0	0.5	90.2	16.8	0.1	2.6	4.3	0.2	0.0	0.7	2.5	2.7	0.3	2.1	33.6	0.0	7.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813016	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA064001: AB_2685171"	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.30e-2)"	28.2	7.3	6.6	10.7	6.3	2.4	19.8	7.0	7.0	9.6	6.1	19.8	24.4	8.8	2.3	41.5	7.3	12.2	9.0	6.2	7.2	7.0	84.5	10.2	6.6	8.2	7.9	6.3	13.4	5.6	10.4	15.0	7.7	9.9	14.3	1.6	26.1	5.9	6.8	5.1	24.1	9.9	6.5	8.4	18.5	5.2	8.8	4.5	6.6	6.9	10.0	13.8	14.9	6.3	10.3	25.8	6.3	16.3	19.9	19.8	19.5	22.1	20.1	13.3	14.4	10.7	15.2	10.4	9.9	27.3	19.4	26.0	13.4	13.6	6.5	24.8	14.5	5.9	20.4	20.6	42.6	11.4	16.2	23.8	16.3	9.2	11.1	16.2	17.6	10.3	13.3	13.8	14.4	21.8	5.9	9.0	27.5	39.9	34.6	7.2	10.5	21.5	15.1	25.4	6.0	8.6	16.6	16.3	9.5	6.6	13.7	6.0	25.7	25.0	14.7	46.1	15.6	9.8	26.9	4.9	18.5	14.4	14.2	9.7	11.6	12.5	11.0	11.9	12.3	5.0	18.0	14.7	9.6	3.7	9.3	8.0	1.8	5.6	8.7	8.2	13.0	10.1	6.6	6.3	7.0	7.0	6.2	7.2	8.2	7.9	7.7	6.5	8.8	6.3	5.5	0.0	11.2	2.6	6.2	3.6	8.9	12.7	3.4	1.9	11.1	3.0	50.6	22.8	26.7	5.5	2.1	13.8	6.4	54.6	0.0	18.4	4.9	7.3	6.7	10.6	9.6	3.6	2.0	41.9	14.0	10.5	23.4	11.4	2.5	5.2	6.8	42.2	14.7	3.3	2.1	40.6	4.1	9.3	4.8	6.0	6.5	6.3	1.8	2.8	9.5	2.8	7.2	1.0	2.1	50.6	54.0	5.7	13.6	11.8	58.0	4.7	11.4	1.1	0.0	3.6	9.7	4.0	4.3	12.7	2.4	15.3	6.5	5.7	26.4	20.1
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	23.2	36.3	23.1	17.2	22.3	27.1	23.2	21.3	25.2	26.4	22.6	23.9	21.3	23.1	17.4	31.8	23.2	18.2	17.2	21.8	20.6	27.7	38.3	22.8	24.0	22.6	23.1	25.5	34.9	14.9	20.3	18.2	22.3	31.2	10.1	11.3	30.3	14.0	18.3	32.7	26.4	10.4	21.2	33.6	27.7	25.0	23.4	14.4	29.2	8.2	13.4	22.4	25.6	22.8	35.9	45.1	17.5	15.0	23.9	23.2	36.3	17.6	33.7	19.7	22.6	60.9	54.6	22.5	63.2	19.9	24.7	49.0	9.3	40.5	6.7	19.6	32.5	20.2	29.5	49.0	46.6	27.6	23.6	33.6	51.0	27.4	29.8	20.8	15.2	23.7	33.3	41.5	14.2	85.0	19.8	40.7	24.3	34.1	36.7	18.9	19.7	45.3	25.8	35.1	28.1	39.6	16.4	87.1	60.9	10.4	56.0	47.8	15.7	53.2	33.7	27.5	32.0	55.6	51.5	25.2	58.0	29.7	23.9	42.7	37.9	48.0	37.5	39.9	35.4	29.7	39.0	38.8	42.4	27.9	44.5	40.3	33.5	33.4	30.8	72.9	41.1	44.1	23.1	22.3	21.3	25.2	21.8	20.6	22.6	23.1	22.3	21.2	23.4	22.8	17.0	16.0	19.1	24.5	27.6	14.4	29.0	35.5	29.0	41.3	32.4	25.4	6.7	21.5	29.2	27.6	41.7	89.5	32.6	26.9	13.7	41.3	5.9	12.8	13.0	18.4	21.0	12.4	13.6	61.8	49.2	24.0	26.0	13.9	14.7	20.3	31.8	27.5	38.7	18.5	13.6	35.1	26.4	22.8	8.2	6.7	19.3	23.6	21.4	14.0	36.4	23.4	34.0	11.1	14.2	35.0	26.9	19.2	28.8	50.0	34.8	18.3	18.7	33.6	19.7	20.1	19.0	16.1	23.6	24.8	16.6	79.2	25.9	24.8	30.2	33.1
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904676-234324511	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.7"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 485.2;Inhibitory neurons: 216.1;Oligodendrocyte precursor cells: 190.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	35	"plasmacytoid DC: 3.5"	"Lineage enriched"	"Detected in single"	35	"dendritic cells: 3.5"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 111.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Nucleoli	"HPA051327: AB_2681443, HPA061582: AB_2684563"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.0	1.1	6.9	0.3	17.7	0.1	2.5	9.5	15.5	0.3	0.0	0.4	0.1	0.3	0.7	0.5	0.4	0.1	0.0	5.4	0.7	0.7	0.0	0.2	0.8	1.6	0.3	0.1	3.5	1.4	2.6	0.0	1.9	0.5	0.1	0.3	2.5	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.7	0.2	2.5	2.3	0.5	0.1	0.5	0.0	0.5	9.5	3.0	7.9	1.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.1	0.2	0.6	0.1	7.7	0.0	111.9	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.1	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	9.0	0.0	0.0	0.0	7.7	0.0	4.2	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.9	17.7	9.5	15.5	5.4	0.7	1.6	0.3	1.9	0.2	2.5	9.5	0.1	0.0	0.0	8.5	0.9	0.4	2.4	0.3	10.8	2.1	3.0	8.9	0.7	0.0	0.1	0.0	0.0	0.0	9.5	0.0	3.9	1.4	0.7	5.9	1.6	0.1	1.8	0.0	485.2	3.4	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	216.1	0.1	26.4	0.0	0.0	0.9	0.0	0.6	0.0	9.4	0.9	0.0	0.0	190.5	45.4	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.5	0.0	0.8	0.1	0.6	1.5	0.8	0.1	0.0	0.4	0.0	0.0	0.2
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470260	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pancreas: 237.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 196.3;Erythroid cells: 74.3;Exocrine glandular cells: 80.8;Pancreatic endocrine cells: 129.4;Plasma cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 214.0;HBEC3-KT: 326.7;HeLa: 300.0;hTCEpi: 237.8;Karpas-707: 282.8;RPMI-8226: 539.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	4.2	1.9	29.9	13.0	21.8	55.7	2.5	22.6	26.3	9.4	10.6	13.2	13.3	4.2	2.7	10.2	4.9	3.7	6.1	21.6	22.5	1.8	0.9	25.3	8.8	30.4	23.1	6.7	237.2	0.4	0.9	1.1	28.0	5.6	16.2	3.4	9.3	8.6	0.6	21.3	9.2	7.0	22.0	13.8	15.9	0.7	30.4	8.5	20.3	1.3	9.1	9.4	8.7	21.1	143.0	0.3	0.1	1.6	2.8	11.6	0.3	9.4	0.0	0.3	0.1	0.4	0.3	147.8	0.2	61.7	0.3	214.0	164.4	326.7	0.0	47.4	0.2	80.7	300.0	102.4	23.2	166.7	0.2	22.0	237.8	2.9	0.6	0.2	2.8	35.5	150.7	282.8	32.2	0.2	36.3	57.9	74.2	0.0	0.7	131.5	0.7	539.6	0.0	0.1	13.1	0.7	0.1	0.9	0.2	1.1	0.5	6.9	4.7	0.6	0.4	0.4	0.4	0.4	1.0	53.0	1.6	0.8	0.7	0.1	0.4	0.4	17.3	0.6	24.2	11.4	18.6	16.4	2.3	8.9	8.7	11.3	0.5	9.6	0.1	13.1	21.7	9.1	29.9	21.8	22.6	26.3	21.6	22.5	30.4	23.1	28.0	22.0	30.4	21.1	2.3	0.0	0.6	0.3	15.4	26.6	2.7	196.3	17.1	3.2	0.2	0.3	0.4	0.0	33.6	5.5	18.8	0.2	6.7	9.9	0.0	5.5	0.4	1.1	9.1	11.8	0.0	74.3	0.3	80.8	0.6	8.9	3.6	2.7	4.5	1.0	0.4	0.4	2.4	0.0	0.5	17.5	4.1	0.3	3.9	1.3	2.5	2.1	8.8	32.8	1.8	0.3	8.2	0.5	0.2	129.4	5.5	1.2	62.3	4.5	1.2	0.0	4.2	0.3	0.0	0.7	4.6	0.1	0.4	6.4	8.5	0.0	9.5	4.6	21.4	1.9
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"intestine: 237.4;kidney: 110.0;liver: 171.1;pancreas: 306.8"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 798.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 30.6;liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	53	"CACO-2: 39.9;Hep G2: 58.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.3	0.1	0.2	5.5	0.2	0.1	0.3	0.5	0.4	0.3	0.2	73.7	237.4	0.4	0.0	0.1	0.3	6.5	0.2	0.1	0.1	110.0	171.1	0.2	0.4	0.2	0.1	0.4	306.8	0.0	0.2	0.1	0.1	0.3	45.9	6.4	0.1	0.3	0.1	0.3	219.0	2.6	0.1	0.3	1.4	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.2	0.3	0.5	0.0	0.0	0.1	0.0	39.9	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.6	0.1	0.2	0.2	58.5	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.8	0.0	0.9	0.1	0.2	0.2	0.3	0.5	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.6	0.1	0.0	0.0	0.9	0.1	0.3	0.2	15.7	0.0	3.7	116.7	0.0	0.0	171.9	19.6	0.3	0.6	0.0	0.1	0.2	25.3	2.7	0.2	20.6	0.0	0.1	0.0	0.0	0.0	0.0	2.2	138.9	0.1	0.0	0.2	112.7	0.0	1.6	1.2	1.4	0.0	1.3	0.0	0.0	0.6	0.6	0.0	0.0	0.1	7.4	192.8	0.0	0.0	0.1	798.4	169.9	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.8	0.0	168.7	0.0
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856004-62888880	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 780.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 1441.0;SiHa: 1287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		170000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"		"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	103.3	105.6	130.5	46.7	138.0	122.0	108.9	140.1	160.4	101.6	115.6	60.6	51.5	97.2	65.3	112.9	94.0	35.8	52.0	123.1	133.3	171.2	71.9	117.8	34.9	138.4	132.6	93.0	109.7	189.7	65.3	55.4	134.0	100.8	23.1	22.8	110.6	41.9	122.3	127.1	79.7	33.8	135.8	77.4	90.2	65.1	154.5	30.1	110.2	26.0	28.8	77.7	95.1	130.6	155.5	675.7	60.2	213.2	89.7	69.7	596.7	267.5	106.2	154.0	126.3	643.3	293.0	173.9	290.5	185.4	284.5	540.0	123.1	588.9	84.3	319.3	114.0	117.5	422.4	299.2	825.7	136.0	169.4	144.9	1441.0	175.3	528.8	46.2	83.6	380.7	232.9	347.4	95.1	792.6	149.8	181.3	106.9	222.5	214.2	153.8	92.7	341.8	113.9	84.0	112.5	53.5	1287.0	499.6	948.5	121.2	161.5	182.6	146.2	138.3	200.0	204.4	195.5	436.0	556.1	561.2	135.0	225.1	418.0	37.8	149.0	49.7	117.9	147.4	157.7	58.3	107.3	122.1	88.6	72.1	90.1	97.2	31.2	90.3	123.9	304.7	112.5	186.3	130.5	138.0	140.1	160.4	123.1	133.3	138.4	132.6	134.0	135.8	154.5	130.6	97.8	48.1	37.3	91.1	78.8	218.1	244.2	321.7	399.5	58.4	124.2	120.8	13.4	30.0	141.1	49.7	66.7	222.5	136.2	109.6	33.2	161.9	31.5	122.0	96.3	149.2	84.3	117.7	16.9	151.1	143.7	102.9	71.4	179.7	84.3	43.2	99.2	27.0	202.9	53.8	25.1	60.4	223.8	54.1	140.9	28.9	30.4	141.5	224.1	29.0	104.7	188.4	40.2	21.1	11.3	130.6	58.7	30.5	140.9	156.9	120.7	227.4	63.4	61.2	6.6	71.8	114.6	21.3	31.9	160.7	150.6	780.7	118.1	52.4	60.7	194.9
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 subunit beta"	Q86UW2	15	65045387-65053397	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 41.8;intestine: 107.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.7	1.1	5.8	3.5	5.5	0.8	0.3	4.0	3.9	41.8	0.0	41.9	86.9	3.0	0.3	2.4	3.6	2.8	2.3	3.8	6.5	19.5	2.2	6.1	0.6	7.3	10.9	1.1	0.3	0.0	0.4	0.6	7.7	2.7	29.4	0.7	1.0	0.6	1.0	0.8	107.1	1.7	6.5	0.8	0.8	9.6	11.8	0.0	0.7	0.0	0.0	1.5	0.9	4.2	0.0	1.5	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	18.5	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.1	0.4	0.4	0.1	0.4	0.0	0.0	0.9	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	4.0	3.9	3.8	6.5	7.3	10.9	7.7	6.5	11.8	4.2	0.0	0.0	1.1	0.3	1.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.1	0.0	354.6	13.7	0.0	60.8	10.4	0.2	1.2	1.8	2.7	0.0	0.0	0.0	0.5	0.0	1.9	4.5	0.0	0.4	1.8	0.1	0.0	0.0	23.0	0.0	0.3	0.0	14.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.1	0.0	0.0	0.0	721.4	73.3	15.6	0.0	6.6	1.0	0.4	27.9	0.5	0.0	0.0	0.1	0.6	0.1	45.8	0.0
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 528.1"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.7	0.2	0.1	12.3	0.0	10.7	528.1	0.5	3.5	5.1	1.1	26.9	75.2	0.1	0.0	6.6	1.7	2.1	0.3	0.1	0.0	0.0	1.6	0.3	1.0	0.0	0.1	3.0	9.7	0.2	19.0	2.4	0.3	13.5	302.4	0.7	0.0	2.9	7.2	2.3	0.5	0.1	0.0	0.0	4.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667020-26723427	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 47.7;intestine: 30.1;kidney: 171.7"	"Group enriched"	"Detected in some"	23	"Proximal enterocytes: 286.0;Proximal tubular cells: 181.0"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;NTERA-2: 1.7;SuSa: 3.3;T-47d: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.1	0.1	0.3	0.0	0.5	0.9	0.1	0.9	0.4	0.0	0.3	0.2	4.9	0.1	47.7	0.0	0.1	0.1	4.3	0.3	0.4	171.7	1.7	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.0	0.1	0.1	0.1	0.3	30.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.2	1.7	0.3	0.0	0.0	0.0	0.3	0.0	0.5	0.8	0.1	0.7	0.1	0.0	3.3	1.2	0.2	0.2	0.2	0.1	0.2	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.9	0.4	0.3	0.4	0.2	0.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	3.7	0.0	0.1	0.0	2.4	9.8	0.0	1.4	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	286.0	181.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.6	4.5	3.5	0.1
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 119.1;Extravillous trophoblasts: 111.7;Hepatocytes: 67.7;Syncytiotrophoblasts: 227.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 310.9;SK-BR-3: 337.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	42.4	8.6	27.5	14.2	25.2	18.1	31.5	24.0	30.6	9.4	46.2	13.0	20.9	14.3	67.4	10.9	11.5	7.5	7.7	23.4	23.9	8.5	104.0	7.9	13.8	24.0	24.4	10.2	11.6	9.8	8.0	39.1	25.9	9.3	12.7	6.4	12.5	11.1	17.0	10.0	15.3	9.7	23.9	9.1	10.1	23.4	30.6	11.6	8.0	8.8	26.5	11.3	8.8	21.9	78.9	79.6	49.9	66.1	45.4	16.5	310.9	28.1	19.1	41.8	28.7	118.8	27.0	54.2	41.3	15.4	44.7	42.8	108.3	32.4	29.1	42.2	63.5	96.6	34.9	184.4	53.8	125.1	47.8	57.1	27.1	51.4	39.7	11.1	38.2	43.3	143.6	21.1	27.0	161.0	42.7	60.4	144.8	90.1	29.0	70.7	58.7	78.2	24.0	74.5	42.0	61.7	30.3	337.1	40.1	48.6	74.9	26.0	17.5	45.3	62.5	27.9	76.1	35.7	88.6	84.7	24.5	86.1	65.2	0.1	5.9	1.8	7.4	6.6	8.9	5.8	7.0	7.0	8.7	5.3	7.1	8.6	0.3	6.3	8.9	8.9	7.6	5.8	27.5	25.2	24.0	30.6	23.4	23.9	24.0	24.4	25.9	23.9	30.6	21.9	2.5	0.0	4.4	7.8	13.4	8.0	8.6	3.8	7.4	5.3	41.9	31.9	6.8	8.6	3.1	7.3	4.2	119.1	12.5	6.7	1.9	9.8	15.1	3.9	7.4	6.2	5.4	12.6	7.2	8.2	111.7	6.0	5.6	6.9	0.0	18.1	7.1	67.7	21.8	11.8	9.0	9.2	4.1	9.1	6.0	32.0	7.2	6.6	0.0	29.0	47.9	2.5	6.2	6.6	5.0	7.0	4.3	13.9	10.0	14.1	11.7	3.9	2.9	3.1	13.1	5.5	5.2	35.1	21.5	7.6	6.3	227.9	8.6	9.4	15.2	7.8
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816201-10940714	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 153.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.0	0.0	50.5	0.0	78.7	0.0	1.1	57.3	32.6	0.7	9.6	0.0	0.0	0.5	0.1	8.2	0.5	0.0	0.0	22.6	96.6	0.0	0.1	0.0	0.0	60.0	128.4	0.0	0.1	0.5	0.3	0.4	61.9	0.7	0.0	11.0	1.0	0.0	0.2	5.7	0.0	0.1	41.8	0.4	0.0	1.4	153.3	0.0	0.0	0.0	0.1	0.4	1.8	21.1	5.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.0	2.2	0.0	0.0	0.2	0.3	0.0	16.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.9	4.5	3.9	0.1	0.0	0.1	5.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	78.7	57.3	32.6	22.6	96.6	60.0	128.4	61.9	41.8	153.3	21.1	0.0	0.0	0.0	85.2	0.0	1.3	0.7	0.3	4.0	8.4	0.9	0.9	1.4	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	13.7	0.0	7.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.0	0.0	0.8	0.9	3.4	0.2	0.0	6.5	0.0	26.4	0.0	23.1	0.8	0.2	0.0	6.8	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.6	0.1	0.6	1.8	10.6	3.7	1.0	0.1	0.0	0.0	1.7
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 153.1"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 324.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 4.6;SuSa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.2	0.3	13.4	0.0	16.5	0.1	0.1	11.0	20.1	0.1	13.9	0.1	2.6	0.1	0.3	0.0	7.1	0.0	2.6	12.2	11.9	153.1	36.8	0.8	0.0	11.6	12.6	0.2	0.0	0.0	3.0	0.0	11.7	0.5	0.0	1.1	0.1	0.1	0.5	0.2	0.6	0.0	12.1	0.3	0.1	3.1	13.8	0.1	6.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.5	11.0	20.1	12.2	11.9	11.6	12.6	11.7	12.1	13.8	11.7	0.0	0.0	0.6	1.3	1.9	0.0	0.0	0.4	0.0	0.4	0.1	0.1	1.5	0.0	0.1	18.4	2.1	0.0	0.1	0.0	49.0	0.0	1.4	0.6	0.1	0.2	0.0	5.3	3.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	27.0	0.0	0.0	1.2	0.0	2.0	1.6	0.0	0.6	0.3	1.7	0.0	17.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.5	324.9	0.7	0.7	0.0	0.4	0.1	0.6	0.4	0.0	0.0	0.3	0.9	0.0	0.0	0.0
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 149.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in some"	10	"pons: 149.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"SH-SY5Y: 489.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 13.8"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	0.9	21.7	0.1	0.0	0.1	0.0	0.8	0.0	0.2	2.4	0.0	0.2	0.1	5.4	0.2	0.2	0.5	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	3.8	14.6	0.1	0.0	0.5	0.0	12.6	149.4	0.2	0.3	0.0	1.9	0.6	0.0	13.3	0.2	0.8	0.1	0.0	0.1	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.7	489.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	3.8	14.6	149.4	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	10.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	11.5	0.3	0.0	0.4	5.6	0.0	0.0	0.0	0.1
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470456-524449	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.4;intestine: 94.3;kidney: 62.5;stomach 1: 50.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Proximal tubular cells: 40.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.8"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.1"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	2.9	4.4	3.0	10.4	2.5	1.9	3.1	6.1	5.0	3.8	1.7	94.3	46.0	2.9	4.0	8.7	4.9	45.4	3.2	4.7	2.5	62.5	2.4	2.8	3.8	3.8	2.3	4.3	6.7	6.2	0.7	2.1	3.7	7.3	10.8	1.7	9.9	3.8	6.2	19.0	68.1	3.3	1.3	3.7	50.1	5.8	3.4	3.5	4.9	3.9	3.4	2.5	2.5	2.6	6.7	5.1	10.4	10.5	2.5	3.0	7.8	5.3	3.9	8.0	5.0	11.0	7.4	14.0	7.5	3.0	5.5	10.0	6.1	4.0	3.9	37.8	10.7	6.7	23.4	5.4	3.9	5.5	8.2	4.2	8.1	3.5	5.4	3.9	2.4	6.3	9.6	7.5	2.9	9.0	6.0	24.3	4.0	17.8	8.3	8.6	9.3	8.3	2.8	4.8	11.5	5.0	19.0	5.3	4.2	4.5	12.3	4.2	2.9	8.0	7.2	5.3	3.9	12.4	5.8	8.5	5.2	21.2	5.6	0.0	0.7	0.1	2.6	0.3	2.2	0.9	3.3	2.4	0.9	1.0	3.9	3.1	0.1	2.4	0.2	1.2	2.7	1.8	3.0	2.5	6.1	5.0	4.7	2.5	3.8	2.3	3.7	1.3	3.4	2.6	3.8	16.0	5.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.9	0.7	0.0	5.6	16.5	0.0	0.0	3.4	0.7	5.9	9.0	0.0	3.8	3.6	2.3	0.0	0.0	0.3	8.8	0.0	2.2	0.0	2.6	2.5	5.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.6	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.7	0.0	1.1	40.7	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.0
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 82.0;choroid plexus: 28.6"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 487.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 16.7;RPMI-8226: 12.0;SuSa: 16.1;U-266/70: 23.1;U-266/84: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.0	0.1	48.9	0.1	65.9	0.1	4.0	43.5	80.2	0.0	28.6	0.1	0.0	0.1	0.2	0.1	0.3	0.2	0.9	41.3	46.4	1.2	11.5	2.8	0.7	54.0	51.9	0.2	2.4	0.2	0.4	1.2	52.6	0.7	0.0	0.6	15.8	0.0	0.4	0.5	0.1	0.0	45.2	0.5	0.3	1.9	48.3	0.6	0.2	0.0	0.4	0.2	0.0	82.0	2.1	0.6	0.8	0.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	3.8	1.4	0.1	2.1	0.2	0.0	0.3	0.3	0.2	0.5	0.7	0.9	0.0	0.5	1.5	0.0	0.4	0.3	0.0	1.7	0.2	0.2	1.5	0.1	0.4	4.0	1.2	0.0	2.6	0.4	0.1	16.7	2.0	0.2	0.2	0.2	12.0	0.0	2.2	1.9	2.9	0.0	0.2	0.2	16.1	3.2	0.9	0.0	0.1	1.7	0.8	0.4	23.1	9.8	0.2	0.1	0.3	0.0	0.2	0.1	0.1	0.4	0.1	0.6	0.4	0.6	0.4	0.0	0.2	0.6	0.4	1.3	0.3	0.0	0.2	0.5	0.1	48.9	65.9	43.5	80.2	41.3	46.4	54.0	51.9	52.6	45.2	48.3	82.0	0.0	35.3	3.1	5.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	2.8	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.8	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	102.1	0.0	0.1	0.0	2.5	487.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 265.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 203.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 65.3;A549: 17.5;CAPAN-2: 12.6;GAMG: 13.6;HeLa: 14.2;PC-3: 17.3;U-2 OS: 14.7"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.0	16.2	0.3	0.2	0.1	0.4	0.3	0.0	0.3	0.0	0.5	0.0	0.0	265.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	65.3	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.6	0.0	4.3	0.0	13.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	14.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	203.4	0.0	0.0	0.5	0.0	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.2
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296284	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 41.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 49.7;Early spermatids: 21.6;NK-cells: 26.8;Proximal tubular cells: 32.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5;neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.5;RPTEC TERT1: 98.8;U-937: 25.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.8	0.2	0.6	0.3	8.6	0.5	0.0	0.4	0.3	0.0	1.0	2.2	0.1	0.2	0.1	0.2	2.3	0.3	0.2	0.0	41.6	7.6	7.8	0.5	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.0	0.8	0.1	2.0	3.6	0.1	0.3	1.5	0.1	0.0	1.3	0.6	0.8	0.3	1.0	1.6	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	1.1	0.0	1.0	0.2	1.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	17.5	0.0	1.3	0.1	0.3	0.8	0.0	0.0	0.0	0.0	1.2	98.8	0.1	0.7	0.5	0.0	0.3	0.0	2.3	0.0	2.4	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	25.8	0.1	9.5	1.0	7.3	3.8	0.0	0.3	0.0	0.6	2.1	0.4	0.1	0.2	1.3	9.8	2.6	0.0	0.2	0.0	1.0	0.2	0.3	0.0	0.4	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.1	6.4	49.7	0.3	0.6	0.0	0.1	1.2	0.0	0.0	1.8	0.3	0.3	1.5	6.4	5.5	0.0	0.0	9.6	1.4	1.9	0.2	21.6	0.0	0.1	0.3	0.0	5.7	9.1	0.8	0.0	0.3	0.0	1.6	5.7	0.0	0.4	11.0	0.2	0.0	6.6	0.1	2.0	0.6	0.3	2.6	0.3	2.4	0.0	1.0	3.2	0.0	26.8	1.5	0.3	0.3	0.1	0.0	1.4	0.0	1.8	32.8	3.1	0.0	0.0	0.1	0.1	2.5	2.4	0.0	0.0	0.0	3.4	0.1	1.1	0.4
SLFN11	FLJ34922	ENSG00000172716	"Schlafen family member 11"	Q7Z7L1	17	35350305-35373701	"Predicted intracellular proteins"	"Antiviral defense, DNA damage, Immunity"	"Helicase, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.6;dendritic cells: 39.9;Endothelial cells: 38.8;Langerhans cells: 53.0;Macrophages: 47.0;Smooth muscle cells: 38.8;T-cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 118.2"					"Low region specificity"	"Detected in many"			"HPA023030, HPA062062"	Uncertain		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA023030: AB_1856613, HPA062062: AB_2684673"	"unprognostic (1.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.93e-10)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (6.33e-2)"	"unprognostic (8.81e-3)"	31.7	8.2	5.6	20.0	6.1	12.8	17.1	6.4	5.2	21.1	8.2	10.2	6.2	12.1	42.2	8.4	20.6	18.3	20.0	6.0	8.0	6.4	6.8	37.7	21.2	9.5	6.3	23.1	5.4	6.1	6.5	10.5	9.7	9.1	11.1	1.4	11.8	12.3	7.3	5.2	13.9	19.1	7.6	23.3	9.0	2.7	11.0	22.9	24.1	19.0	20.9	17.9	12.6	9.4	29.3	25.6	0.1	0.0	25.4	72.0	0.4	35.3	25.2	59.9	103.9	0.0	0.0	0.2	0.6	46.4	18.8	13.9	78.8	0.0	72.1	16.6	94.2	63.0	0.3	0.0	33.0	82.4	0.1	29.5	0.9	66.5	0.2	0.0	99.4	46.8	0.1	0.3	10.1	0.0	118.2	66.4	0.6	0.0	0.1	98.9	73.3	0.2	0.7	13.8	0.2	0.1	0.0	13.0	0.1	0.0	20.7	58.6	52.1	16.3	0.4	61.9	53.7	2.3	1.0	0.2	12.2	70.3	36.0	0.5	18.2	2.1	6.1	27.6	8.4	4.6	3.8	5.5	14.0	1.5	2.8	4.1	1.4	3.1	18.2	19.4	6.3	8.7	5.6	6.1	6.4	5.2	6.0	8.0	9.5	6.3	9.7	7.6	11.0	9.4	70.6	0.0	5.2	0.3	19.5	7.5	1.1	1.1	5.7	0.4	6.7	2.8	9.2	1.5	2.7	1.8	0.0	1.4	39.9	0.1	0.0	0.0	1.4	5.9	16.0	38.8	0.0	9.9	0.3	0.6	0.5	29.2	6.6	2.2	3.8	0.3	15.0	0.4	32.8	0.0	2.6	0.1	0.0	36.5	53.0	1.7	10.2	47.0	12.4	17.8	17.2	0.3	3.1	0.0	0.1	0.1	1.2	3.0	24.7	1.3	0.1	0.2	13.3	0.1	6.6	7.9	38.8	0.0	0.2	1.9	8.5	0.8	37.3	7.7	0.1	0.7
SLFN13	FLJ31952	ENSG00000154760	"Schlafen family member 13"	Q68D06	17	35435096-35448837	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.6;salivary gland: 32.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.3;Endometrial ciliated cells: 59.9;NK-cells: 60.8;Plasma cells: 38.2;Respiratory ciliated cells: 75.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 5.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.5;NK-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 38.9;HL-60: 131.9;REH: 75.0;U-266/70: 63.2"									"HPA022532, HPA023064"	Uncertain		Approved	"Cytokinetic bridge"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Cytokinetic bridge"		"HPA022532: AB_1856615, HPA023064: AB_1856616"	"unprognostic (1.11e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	3.1	0.9	1.5	9.1	1.1	25.6	9.9	1.2	0.9	6.2	5.7	5.8	8.5	4.8	2.9	3.5	16.9	6.6	1.8	1.0	1.2	2.6	2.1	6.4	10.5	1.3	1.4	1.1	3.2	14.5	0.5	1.9	1.2	2.1	6.5	0.1	32.5	4.2	0.7	2.3	4.5	4.2	1.0	13.7	11.3	0.6	1.2	10.0	7.9	0.8	11.6	2.5	1.5	1.7	0.2	7.0	13.7	0.1	0.4	1.4	0.2	1.7	0.5	6.7	10.6	0.0	0.1	0.0	38.9	1.3	0.3	11.7	1.4	4.9	7.6	3.9	2.2	37.2	6.5	0.1	0.6	131.9	1.0	0.4	0.6	3.6	0.1	0.0	2.2	0.4	0.1	36.8	0.2	0.1	0.9	28.4	6.8	0.0	0.0	75.0	0.5	3.8	11.6	34.1	0.0	0.0	0.0	6.2	0.3	0.9	9.8	20.9	0.3	0.1	2.0	10.1	0.5	63.2	9.5	0.2	0.2	20.9	1.0	3.7	0.2	4.5	1.2	0.3	1.0	0.9	0.5	0.6	0.2	0.9	0.4	0.3	0.8	5.3	0.1	0.1	0.5	0.4	1.5	1.1	1.2	0.9	1.0	1.2	1.3	1.4	1.2	1.0	1.2	1.7	6.2	0.0	3.7	0.0	7.3	1.0	3.1	4.7	5.7	0.2	14.5	9.1	0.8	27.1	12.5	5.5	0.0	0.8	56.3	2.1	1.9	1.2	0.1	59.9	3.6	3.4	3.0	19.1	0.1	0.4	0.4	1.6	8.2	11.7	3.8	3.8	1.8	0.6	1.6	0.0	0.1	4.5	12.2	1.0	1.7	0.0	0.9	3.2	0.0	2.8	1.8	0.2	60.8	0.0	0.1	1.3	0.6	0.4	38.2	1.0	0.5	1.3	75.4	0.2	0.0	0.4	3.8	0.2	0.6	6.7	1.1	0.0	16.6	3.3	4.2	1.4
SLIRP	"C14orf156, DC50"	ENSG00000119705	"SRA stem-loop interacting RNA binding protein"	Q9GZT3	14	77708071-77761104	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1099.6;Proximal tubular cells: 1027.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020291	Approved		Supported	Mitochondria		No	Yes		32000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020291: AB_1845563"	"unprognostic (9.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.37e-1)"	121.9	131.0	241.0	80.4	251.7	122.7	155.0	250.5	391.0	92.8	228.9	161.3	112.5	91.5	196.3	163.7	89.6	68.3	336.8	249.8	251.6	203.0	211.2	81.1	82.8	251.4	247.5	82.0	110.5	145.2	120.2	91.9	248.6	95.7	141.3	109.9	105.0	90.3	364.5	92.1	107.6	97.0	248.2	92.9	140.2	122.9	245.9	97.4	94.6	442.3	113.5	123.8	101.8	261.2	422.5	867.3	340.9	330.8	226.0	227.7	441.2	240.0	234.8	484.1	419.6	1187.1	387.1	314.2	238.9	284.7	295.6	415.7	645.4	508.0	647.3	166.5	717.2	316.3	816.1	1199.5	343.4	211.8	216.6	242.5	332.3	387.3	428.2	232.4	408.7	403.2	321.2	172.8	430.0	1442.6	325.3	562.2	525.1	938.0	1211.5	294.8	282.9	345.6	508.8	840.3	425.5	274.1	253.3	533.0	360.3	373.7	555.7	360.9	227.0	237.1	422.5	254.0	416.9	184.8	374.7	605.0	325.7	407.2	309.6	88.9	276.1	103.9	105.2	275.3	112.0	169.4	139.0	104.6	239.8	143.1	143.4	120.3	87.8	93.3	288.8	247.4	154.9	216.2	241.0	251.7	250.5	391.0	249.8	251.6	251.4	247.5	248.6	248.2	245.9	261.2	130.4	109.0	140.0	8.5	112.3	178.8	164.5	542.9	92.8	68.8	168.8	154.3	1099.6	270.2	303.9	264.8	47.9	393.0	82.7	330.9	770.9	405.1	548.5	163.7	141.9	169.0	246.8	203.2	10.8	530.1	382.3	166.0	119.3	123.7	171.5	73.1	179.2	793.4	313.6	43.7	9.6	373.1	388.6	202.8	119.5	123.0	168.0	135.2	250.8	2.8	211.4	206.4	93.7	8.5	16.7	440.6	334.4	170.0	136.9	190.5	563.3	1027.1	254.5	126.8	170.9	178.6	202.7	382.6	210.3	178.5	214.4	240.5	80.6	84.7	404.0	163.8
SLITRK3	KIAA0848	ENSG00000121871	"SLIT and NTRK like family member 3"	O94933	3	165186720-165197109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.0;fallopian tube: 9.6;liver: 7.9"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 8.4;Excitatory neurons: 11.0;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 21.1"	"Cancer enriched"	"Detected in single"	22	"glioma: 7.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.6;HAP1: 2.2;SCLC-21H: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017636, HPA048042"	Enhanced		Approved	Mitochondria		No	NA		2600000		"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA017636: AB_1857232, HPA048042: AB_2732542"	"unprognostic (8.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.08e-2)"		"unprognostic (1.96e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-1)"		"unprognostic (6.74e-3)"	"unprognostic (5.03e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.03e-4)"	0.1	0.1	3.4	1.0	3.1	0.0	0.1	4.1	8.4	5.4	0.0	2.6	0.4	7.3	0.9	4.4	9.6	0.2	0.4	9.0	2.8	0.1	7.9	0.3	0.0	0.2	0.1	0.9	0.0	0.0	0.1	0.0	0.5	1.7	1.6	3.1	0.2	5.4	0.3	0.0	1.1	3.7	0.9	0.0	0.4	0.4	0.7	0.0	0.1	0.0	0.0	0.5	0.9	1.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.1	4.1	8.4	9.0	2.8	0.2	0.1	0.5	0.9	0.7	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	15.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	21.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;fallopian tube: 2.9;salivary gland: 3.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 9.7;Excitatory neurons: 20.4;Horizontal cells: 21.9;Inhibitory neurons: 13.3;Oligodendrocyte precursor cells: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;HeLa: 3.7;hTERT-RPE1: 3.2;U-138 MG: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013843, HPA073230"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA013843: AB_1857233, HPA073230: "	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.1	1.3	0.0	1.9	0.0	0.1	0.8	2.6	0.1	0.0	0.3	0.0	0.0	0.4	0.1	2.9	0.0	0.1	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.0	0.0	0.7	0.1	0.7	3.7	1.3	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.1	1.5	0.0	0.9	0.1	0.1	0.0	0.5	1.1	0.0	0.7	7.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	1.3	0.9	3.7	0.0	0.4	0.0	0.0	1.5	0.1	0.0	0.6	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.7	0.1	0.1	0.2	0.0	1.1	0.1	0.0	0.2	0.0	0.0	0.5	1.7	0.0	2.4	0.0	0.0	0.4	1.1	0.0	0.0	2.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.3	1.9	0.8	2.6	1.9	0.6	0.0	0.1	0.0	0.2	1.5	1.1	0.0	0.0	1.1	1.3	0.0	0.1	1.5	0.0	0.0	9.7	0.6	1.7	1.8	1.5	0.0	0.0	4.2	0.0	5.9	0.2	0.0	0.4	0.7	2.1	0.5	1.0	0.0	2.7	20.4	0.0	0.0	1.6	0.0	5.0	1.3	0.5	0.0	0.0	0.0	21.9	13.3	1.9	0.0	0.0	0.0	1.0	5.9	0.5	0.0	1.0	0.1	7.0	0.0	11.1	0.9	0.0	0.1	4.9	0.0	2.5	0.0	0.1	1.5	1.6	0.0	4.6	0.3	5.5	0.2	0.4	0.0	0.0	0.1	0.0	0.2	1.1
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix: 27919.2;salivary gland: 14140.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 4134.5;Basal respiratory cells: 18759.4;Club cells: 20435.8;Respiratory ciliated cells: 8096.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	79	"neutrophil: 321.8"	"Lineage enriched"	"Detected in many"	79	"granulocytes: 321.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 1719.5;hTCEpi: 2037.1;OE19: 767.9;SiHa: 622.1;THP-1: 531.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	26400000	9600000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	259.4	13.8	4.1	70.8	4.3	353.5	306.7	5.0	22.5	27919.2	28.9	97.8	4.5	107.1	16.5	1372.7	714.2	294.7	68.4	4.5	4.8	382.6	268.0	1181.7	2.0	5.6	5.5	11.5	36.1	5.5	470.2	8.3	5.5	112.6	106.7	0.6	14140.1	2946.3	599.9	272.4	19.9	14.0	4.8	22.5	154.7	28.1	10.4	47.7	30.4	51.5	215.8	226.6	685.3	4.8	4.9	19.4	0.0	0.3	0.2	0.0	1.1	0.1	0.0	0.1	0.0	1.5	318.7	0.9	1719.5	0.2	23.9	132.8	0.0	64.1	0.0	8.6	0.3	0.3	227.1	0.2	326.4	0.5	1.0	8.8	2037.1	0.1	134.0	0.0	0.2	0.0	0.2	0.3	0.0	0.4	0.4	24.4	0.4	767.9	120.1	0.6	0.7	0.1	355.5	14.6	0.3	0.0	622.1	131.4	1.8	0.4	2.8	531.8	0.3	0.4	8.5	1.2	1.1	1.2	9.7	6.1	0.0	33.0	0.5	3.6	0.9	0.4	0.1	3.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	321.8	0.0	4.0	0.0	0.0	7.9	4.1	4.3	5.0	22.5	4.5	4.8	5.6	5.5	5.5	4.8	10.4	4.8	6.3	1807.7	4134.5	0.3	5.4	100.7	1330.7	18759.4	2.2	0.0	594.2	607.6	3.9	1609.9	20435.8	3428.2	0.0	2.3	10.1	225.8	0.0	407.5	381.6	632.0	170.7	43.3	200.2	18.7	0.0	258.9	1.2	326.0	193.7	1398.8	77.0	0.0	15.7	508.5	6.8	0.0	0.0	74.7	2616.3	8.5	73.3	69.8	25.4	27.1	39.2	0.0	5.3	0.0	0.0	1.0	0.1	901.6	370.3	0.0	1.3	1289.4	2.7	3.4	8096.4	0.0	0.0	8.6	971.2	1.8	1.8	347.3	138.9	2.1	29.5	0.0	224.5	3338.5
SMARCA4	"BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2"	ENSG00000127616	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"	P51532	19	10960932-11079426	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 372.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004208, HPA048340"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nucleoli fibrillar center, Nucleoli rim"	"CAB004208: AB_626762, HPA048340: "	"unprognostic (2.68e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.19e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.80e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.8	16.2	14.4	22.6	14.3	31.8	13.0	15.3	23.7	16.1	13.2	18.1	19.9	14.5	9.5	32.9	20.8	13.3	16.2	15.4	9.6	15.7	8.6	17.9	27.0	10.4	10.4	14.9	18.3	22.9	11.1	20.2	11.0	17.7	12.9	19.7	25.9	15.6	23.7	28.1	17.2	14.5	3.9	19.5	20.4	30.2	11.8	43.1	20.6	13.9	23.7	17.4	14.7	19.3	92.5	5.0	157.2	149.8	30.3	25.4	68.9	62.7	37.2	74.6	54.9	126.9	4.0	215.4	94.2	54.9	3.0	65.9	123.6	77.5	40.8	89.5	93.3	171.3	76.5	149.6	45.7	125.5	82.0	43.1	36.7	63.1	64.5	33.3	67.5	92.0	156.7	78.3	59.2	188.0	210.0	107.5	159.9	45.1	134.7	220.6	99.5	111.7	47.9	114.8	177.8	161.7	66.6	84.4	73.5	50.1	71.9	93.3	90.9	110.3	57.3	102.5	104.9	160.6	192.2	209.1	62.6	118.5	96.0	5.7	5.8	6.4	9.3	6.9	8.2	5.3	6.8	7.9	6.1	6.8	7.6	7.5	3.4	8.5	10.8	7.9	6.4	4.7	14.4	14.3	15.3	23.7	15.4	9.6	10.4	10.4	11.0	3.9	11.8	19.3	25.4	67.3	72.6	27.4	28.5	37.0	43.7	43.8	24.5	91.3	42.2	28.4	372.9	40.0	62.7	44.1	70.9	65.9	21.2	60.1	41.1	79.8	53.0	58.8	49.2	58.3	63.2	41.8	32.2	61.4	57.3	43.8	50.0	63.5	30.4	75.3	28.5	21.9	42.3	101.0	39.6	47.7	57.0	23.8	21.5	37.6	26.1	30.4	16.0	14.0	43.8	36.1	23.7	32.6	28.1	76.4	41.8	13.5	37.6	66.0	29.8	27.6	62.5	69.1	13.1	45.1	66.4	99.4	86.0	52.2	51.7	61.0	30.4	68.1	60.5	50.1
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513702-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 307.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB005227: AB_2191863, HPA008751: AB_1857268"	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	16.9	26.0	15.1	21.1	20.1	32.7	17.6	17.6	17.3	18.1	13.5	17.2	14.9	20.4	20.5	14.1	14.6	19.3	17.1	13.0	16.6	16.7	16.8	27.9	27.0	17.9	16.8	21.2	16.4	22.6	13.5	22.8	19.1	18.1	17.9	26.4	12.4	17.0	15.3	11.1	16.4	18.4	18.3	22.8	16.2	32.6	16.0	29.9	23.1	15.3	25.7	22.7	11.0	26.0	33.4	25.8	92.5	58.5	53.4	38.4	55.5	41.5	49.4	59.5	50.0	44.3	45.8	90.0	27.9	35.7	23.7	26.0	85.9	38.9	57.1	60.2	30.2	67.7	36.9	36.7	39.3	84.2	38.3	34.0	27.8	42.1	36.0	34.5	46.9	45.1	62.0	55.4	39.2	30.1	98.7	29.4	75.7	55.6	36.6	108.2	59.1	29.4	46.6	40.4	73.6	62.2	54.0	37.9	49.5	69.2	27.4	39.1	50.0	38.9	29.7	41.0	41.2	60.0	77.4	106.8	30.6	69.5	40.3	5.8	10.7	16.0	12.7	12.8	15.3	11.4	13.1	14.2	13.3	11.2	13.4	13.6	9.4	15.8	21.5	10.0	16.7	11.5	15.1	20.1	17.6	17.3	13.0	16.6	17.9	16.8	19.1	18.3	16.0	26.0	77.3	307.7	291.0	30.7	95.7	46.4	78.9	50.6	55.2	93.9	56.4	49.0	104.1	31.5	96.9	44.1	64.6	70.6	125.6	39.8	39.2	77.9	63.2	104.5	127.1	74.3	79.9	85.4	42.5	61.4	66.4	73.8	46.4	94.2	103.1	97.3	39.3	25.4	44.8	85.8	41.7	41.3	69.2	51.9	49.4	27.9	60.3	79.2	30.2	27.2	98.6	84.7	55.6	37.7	85.2	66.0	35.3	62.1	93.9	57.7	36.6	36.8	109.6	116.4	52.6	113.9	88.3	144.4	130.8	47.4	40.9	102.1	107.9	118.7	46.2	71.2
SMARCAL1	"HARP, HHARP"	ENSG00000138375	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1"	Q9NZC9	2	216412414-216483053	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020337	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA020337: AB_2670410"	"unprognostic (4.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.35e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.16e-1)"	9.2	9.8	7.5	8.9	10.3	9.1	8.8	8.0	9.7	10.6	7.6	8.0	6.8	10.7	7.5	9.8	11.0	9.5	8.9	8.0	9.0	7.2	6.7	7.9	13.1	10.6	9.1	16.3	8.2	10.8	9.3	9.1	10.6	8.1	7.4	5.6	8.0	8.9	10.5	10.6	7.9	10.1	8.4	9.7	8.0	10.3	10.2	15.1	10.2	10.6	11.9	8.8	9.0	14.2	16.7	16.3	22.2	12.7	21.5	25.1	21.3	22.0	22.7	23.0	26.1	26.7	20.3	15.0	21.8	27.6	28.8	12.3	19.1	24.4	30.5	45.7	18.9	42.8	12.0	19.9	22.0	11.5	23.9	16.7	25.7	24.9	24.4	24.0	27.6	23.5	42.6	15.8	26.3	12.3	22.2	26.8	16.1	14.7	8.9	24.6	14.6	9.3	18.2	11.4	18.4	11.9	12.0	9.1	18.7	38.2	12.4	18.1	21.3	28.3	13.0	13.7	13.9	18.0	18.6	13.3	28.8	15.6	20.2	25.9	9.5	14.1	12.2	10.5	11.6	9.6	11.5	14.3	14.9	9.2	9.6	11.8	1.7	21.0	18.1	18.0	14.7	8.5	7.5	10.3	8.0	9.7	8.0	9.0	10.6	9.1	10.6	8.4	10.2	14.2	6.3	6.4	6.1	20.2	8.2	0.9	3.3	4.6	8.6	5.1	4.3	3.4	5.0	7.2	3.7	0.0	0.0	10.4	6.7	3.4	5.9	7.4	14.5	10.4	7.2	7.0	3.6	11.4	20.6	3.8	12.2	8.0	5.6	5.8	17.7	11.0	4.2	3.2	9.7	8.4	30.8	3.7	2.0	8.9	3.1	13.7	6.2	6.2	1.8	12.2	10.1	4.7	10.3	24.6	35.9	4.0	13.3	8.6	7.0	1.3	4.7	5.8	4.4	4.8	13.1	6.0	6.8	7.7	4.4	5.3	1.3	7.3	6.5	7.5	5.3	2.0
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Metabolic proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 126.4;skeletal muscle: 129.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.5;Peritubular cells: 88.4;Sertoli cells: 65.7"	"Cancer enhanced"	"Detected in all"		"glioma: 28.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.6;granulocytes: 1.9;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	20.7	40.3	104.0	5.0	101.9	7.1	22.1	70.7	126.4	25.0	59.8	25.2	3.0	22.8	14.7	8.4	30.6	14.6	78.9	105.3	90.4	18.8	2.8	18.8	4.6	79.5	89.8	37.6	14.3	27.2	42.2	5.7	83.2	27.7	3.8	10.0	14.3	23.2	129.0	11.5	11.0	13.4	72.4	9.2	18.3	17.4	99.9	1.9	18.1	69.4	2.5	22.7	18.2	84.8	0.8	6.1	19.6	69.3	30.0	13.3	1.6	13.3	13.0	7.5	4.3	4.5	4.2	7.7	4.7	20.4	3.0	1.3	15.7	1.3	3.0	2.4	10.2	0.0	4.5	1.4	25.9	0.4	12.5	31.8	1.8	2.4	0.2	32.7	1.5	19.5	16.4	2.5	39.5	8.3	1.3	10.3	6.1	2.0	2.5	0.5	31.7	0.3	6.6	0.0	11.2	22.6	12.4	2.1	9.5	3.1	2.0	19.7	2.6	6.1	7.7	15.7	4.9	16.1	0.0	6.5	14.2	17.6	21.6	0.4	5.5	0.0	0.1	1.3	0.1	0.1	0.5	0.0	1.6	0.0	0.3	0.5	1.9	0.0	0.2	0.0	0.4	1.3	104.0	101.9	70.7	126.4	105.3	90.4	79.5	89.8	83.2	72.4	99.9	84.8	7.5	6.4	21.7	33.6	0.7	10.7	38.3	3.1	47.8	15.2	28.5	29.6	67.5	21.5	4.6	11.0	4.2	0.4	1.2	0.2	31.3	24.8	2.5	3.9	24.4	5.2	3.5	1.3	16.7	2.6	0.5	28.0	1.5	3.4	2.5	44.3	2.9	0.5	3.6	11.8	23.9	0.3	0.0	17.0	5.7	14.0	50.7	16.0	7.2	8.4	19.7	23.7	0.0	16.1	7.4	2.8	0.1	88.4	0.1	14.6	0.0	2.1	4.7	5.7	65.7	40.9	56.9	1.7	20.0	1.5	4.7	1.1	4.7	22.8	0.2	9.0
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141419	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.7"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	5.2	4.1	2.8	11.3	4.0	18.4	6.6	4.4	3.3	7.5	1.3	8.2	7.5	6.0	2.6	7.3	4.7	4.0	7.9	2.2	4.0	6.3	4.7	4.5	16.0	4.9	3.7	4.7	3.5	5.7	1.5	6.9	4.1	4.2	8.8	5.6	3.1	4.7	2.2	7.4	7.6	5.4	3.5	7.2	6.1	12.0	3.5	25.7	7.6	5.4	15.9	4.9	3.2	5.0	59.3	45.0	49.4	45.9	10.3	14.9	46.2	53.5	25.4	46.9	39.4	39.3	44.9	112.6	25.2	27.7	40.5	97.6	72.3	34.8	63.2	71.6	30.3	67.9	68.8	25.5	2.7	41.5	65.6	9.8	7.0	63.7	25.7	15.9	33.7	71.2	55.8	89.8	43.0	28.9	109.1	21.3	42.9	47.6	34.8	72.0	141.3	42.2	20.1	21.1	46.5	35.9	63.8	29.6	15.5	20.5	59.5	28.0	27.1	56.8	59.1	79.3	67.9	32.6	118.2	64.6	36.8	59.8	70.3	15.0	2.2	2.5	4.8	5.9	5.4	7.3	4.4	4.8	2.6	7.9	5.0	5.8	0.3	7.0	7.4	4.4	6.0	2.4	2.8	4.0	4.4	3.3	2.2	4.0	4.9	3.7	4.1	3.5	3.5	5.0	19.6	25.6	11.9	6.5	19.9	27.3	16.4	27.6	11.4	39.7	16.6	19.3	45.1	7.2	17.8	16.5	8.4	54.3	15.2	13.7	35.2	18.9	40.0	114.6	21.6	21.4	4.9	95.3	10.2	20.4	93.8	20.2	13.3	16.0	22.2	40.4	21.0	7.6	44.3	28.6	15.5	14.6	26.4	19.8	19.8	24.7	18.6	22.9	7.2	7.5	19.8	15.6	22.6	5.5	18.4	15.6	6.3	12.4	40.9	7.3	10.3	15.0	12.0	19.1	13.1	25.1	37.7	84.5	93.5	27.4	23.2	25.9	18.1	28.1	35.0	14.2
SMG5	"EST1B, KIAA1089, LPTS-RP1, LPTSRP1, RP11-54H19.7, SMG-5"	ENSG00000198952	"SMG5 nonsense mediated mRNA decay factor"	Q9UPR3	1	156249224-156282825	"Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072651			Uncertain	"Cytoplasmic bodies"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cytoplasmic bodies"		"HPA072651: AB_2686544"	"unprognostic (2.09e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (3.20e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.70e-9)"	"unprognostic (1.28e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.26e-2)"	25.2	43.2	44.5	22.0	46.5	46.7	23.7	43.6	46.0	25.6	42.1	35.4	27.3	27.5	24.6	37.3	27.1	18.8	58.8	42.0	42.8	43.4	47.5	32.7	25.8	49.9	48.3	25.7	28.3	46.3	39.0	26.5	46.9	35.2	22.0	35.3	26.8	23.8	62.8	36.4	32.3	28.0	44.4	33.8	33.4	27.7	50.3	29.4	29.9	43.3	24.8	31.2	25.9	53.3	53.4	45.8	54.8	40.9	52.2	29.5	79.0	54.0	48.2	80.0	67.7	116.2	67.4	48.1	61.6	64.8	63.7	62.8	97.3	68.3	51.4	54.5	80.9	55.6	45.8	64.2	67.6	58.8	54.5	37.4	66.7	76.9	81.5	41.2	52.1	70.4	77.0	47.1	56.9	54.5	48.3	47.5	110.9	97.0	94.6	77.2	41.8	51.1	52.1	63.4	73.4	61.1	68.5	100.6	61.8	71.9	86.8	124.3	44.0	55.4	61.6	59.1	79.6	71.7	17.9	89.1	48.8	57.8	71.7	1.6	3.7	5.2	3.8	3.9	3.1	2.9	2.9	2.8	2.4	2.5	2.5	2.7	4.1	3.0	4.2	2.4	2.0	3.6	44.5	46.5	43.6	46.0	42.0	42.8	49.9	48.3	46.9	44.4	50.3	53.3	9.1	16.0	13.4	21.9	16.8	14.7	7.8	7.3	17.6	12.8	14.7	9.8	39.5	18.6	9.6	20.2	33.3	17.8	10.4	44.8	7.9	12.3	2.8	14.1	9.1	12.9	22.7	9.9	23.9	14.5	10.7	9.4	35.2	16.1	12.7	18.4	9.7	21.6	12.4	18.5	21.4	20.3	8.2	14.4	8.6	5.5	8.4	11.1	5.4	19.7	13.5	11.2	7.2	12.1	24.2	17.9	24.2	7.2	17.9	14.3	23.7	15.5	12.8	12.6	6.6	9.2	10.5	8.5	7.8	16.9	12.1	17.1	14.0	11.4	23.6	15.4
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480525	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"epididymis: 1580.8;intestine: 753.9;kidney: 844.8"	"Group enriched"	"Detected in many"	12	"Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.0	4.2	2.7	5.0	91.3	0.8	4.1	6.8	0.6	5.5	30.4	753.9	0.7	1580.8	0.4	2.8	82.0	0.1	4.7	4.3	844.8	35.8	0.4	1.6	4.3	4.6	0.3	8.0	0.2	3.5	0.1	4.3	1.0	24.5	91.6	0.3	2.3	0.3	1.2	628.2	0.8	4.0	1.2	150.1	2.9	4.6	50.4	0.2	0.1	2.0	0.2	0.2	4.4	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	154.9	0.5	0.2	7.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.0	1.0	117.7	0.0	6.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	1.5	0.1	0.1	0.0	113.8	15.8	0.0	185.0	0.3	61.5	0.1	4.3	1.6	0.1	1.4	2.3	0.1	0.1	1.6	0.4	0.0	1.9	0.0	0.0	0.4	1.2	0.1	0.0	0.0	6.5	0.0	87.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.4	1.0	0.0	5.9	0.0	1.5	1.6	0.8	4.2	5.0	4.1	6.8	4.7	4.3	4.3	4.6	4.3	4.0	4.6	4.4	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	14.1	0.1	0.8	0.2	188.8	0.0	58.8	27.1	0.0	0.5	35.1	238.7	4.0	5.1	7.7	0.8	0.3	139.0	22.3	0.7	12.4	0.2	0.3	205.4	13.0	1.3	0.2	0.4	36.3	0.1	0.0	0.1	136.6	0.0	0.6	0.0	15.0	0.3	11.6	0.0	0.0	0.7	4.1	0.0	0.0	0.2	12.4	178.9	0.0	1.7	0.3	4096.4	1884.8	0.0	34.9	0.0	0.2	0.3	0.6	0.7	0.0	0.0	0.0	7.4	0.0	141.3	0.2
SMIM6	"C17orf110, ELN"	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647975	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.1;kidney: 22.1;stomach 1: 33.1;testis: 26.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 565.7;Endometrial ciliated cells: 233.1;Enteroendocrine cells: 197.1;Late spermatids: 1243.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 34.2"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;CACO-2: 3.8;EFO-21: 8.7;HEL: 6.7;Hep G2: 3.6;OE19: 10.5;RPTEC TERT1: 4.2"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.2	0.1	3.4	0.8	5.8	1.1	0.1	4.9	5.1	2.4	2.5	6.5	9.5	1.1	2.8	0.1	24.1	9.6	0.0	3.6	3.9	22.1	6.6	2.4	0.4	5.4	5.6	0.1	5.6	2.1	0.0	0.3	5.8	0.2	6.6	0.1	0.1	1.4	0.1	0.3	5.9	0.1	4.1	0.2	33.1	26.1	4.7	0.1	0.1	0.0	0.3	1.8	0.1	8.2	0.7	11.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	3.3	0.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	6.7	0.4	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	4.2	1.9	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	34.2	0.0	0.3	3.4	5.8	4.9	5.1	3.6	3.9	5.4	5.6	5.8	4.1	4.7	8.2	0.1	3.2	3.1	0.0	0.9	0.1	3.4	2.3	0.0	0.0	0.2	0.1	0.1	35.8	5.4	35.0	0.0	0.5	9.5	56.2	137.0	35.9	565.7	233.1	2.9	0.8	197.1	0.0	0.0	16.6	3.7	0.3	70.3	22.1	0.0	0.0	0.4	7.0	0.6	0.0	0.0	51.5	8.2	0.0	0.3	1243.9	6.5	1.4	0.0	0.0	1.6	0.0	0.0	0.0	4.5	55.8	129.5	1.9	0.5	2.6	32.7	24.5	38.4	0.0	6.6	0.2	0.4	5.2	2.6	0.0	0.0	4.1	0.9	0.0	4.4	9.6
SMN1	"BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A"	ENSG00000172062	"Survival of motor neuron 1, telomeric"	Q16637	5	70925030-70953942	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Club cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 120.5;NB-4: 77.9;T-47d: 88.9;WM-115: 120.3"									"CAB016324, HPA045271, CAB069888, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies, Cytosol"		"CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: AB_2679280, HPA073601: "	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (6.62e-13)"	"unprognostic (2.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.14e-2)"	28.0	21.8	5.7	4.9	6.1	21.8	26.8	7.6	7.5	33.8	5.0	25.8	2.1	24.7	12.8	25.8	31.5	7.4	20.4	6.3	7.1	22.6	37.6	22.0	15.5	6.5	5.7	36.8	27.6	6.9	26.4	5.1	6.1	25.6	7.8	12.1	21.5	3.8	31.5	24.0	19.6	8.2	5.9	22.6	20.3	24.8	5.7	2.4	24.2	1.5	1.9	26.1	27.6	6.6	11.3	2.1	3.5	4.0	19.3	23.0	62.8	3.5	4.9	5.3	3.8	4.1	4.1	4.6	69.5	9.9	5.8	7.4	5.4	3.7	4.2	1.0	5.2	65.4	6.2	6.2	1.3	7.9	5.8	1.5	29.8	1.8	1.8	31.4	3.0	4.1	2.7	6.4	2.7	3.2	120.5	77.9	4.4	0.9	2.1	6.0	15.9	58.0	2.4	5.2	11.4	16.2	6.5	23.4	69.4	2.4	88.9	21.2	32.7	33.8	3.8	3.1	7.5	4.2	3.0	60.0	4.9	4.8	120.3	9.8	7.4	4.3	6.4	12.2	17.6	13.2	10.2	7.7	11.2	7.2	13.1	14.5	2.1	8.7	13.5	13.1	16.1	6.3	5.7	6.1	7.6	7.5	6.3	7.1	6.5	5.7	6.1	5.9	5.7	6.6	5.0	9.6	11.5	0.0	5.6	13.9	4.6	10.7	0.6	4.7	4.1	4.3	22.4	7.2	29.9	1.8	10.4	7.9	7.0	2.3	5.9	6.8	18.2	5.6	5.5	6.8	6.0	9.9	1.3	4.6	8.4	11.8	4.1	4.4	19.6	4.0	5.0	2.9	4.8	3.3	1.1	4.2	10.2	3.4	4.4	12.9	9.3	5.2	5.4	0.0	6.1	1.4	12.3	1.0	1.3	6.5	1.8	6.4	5.1	2.9	3.8	4.5	28.1	7.8	13.1	7.4	8.5	16.0	17.2	6.9	12.5	8.8	7.2	5.6	4.2	4.1
SMN2	"BCD541, GEMIN1, SMNC, TDRD16B"	ENSG00000205571	"Survival of motor neuron 2, centromeric"	Q16637	5	70049638-70078522	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 41.8;Club cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 122.7;MOLT-4: 125.1;NB-4: 106.2"									"CAB009344, HPA045271, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies, Cytosol"		"CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: "	"unprognostic (2.07e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.98e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.19e-1)"	19.7	15.6	1.6	4.5	1.8	13.8	19.4	1.0	2.3	20.3	1.0	19.2	0.5	20.0	16.9	17.1	15.2	13.6	16.0	1.1	7.2	14.4	23.2	16.4	13.8	1.7	2.0	25.9	18.3	8.4	20.5	3.8	2.0	18.8	5.6	3.0	15.1	5.8	26.0	17.0	13.6	14.0	1.3	14.7	14.5	16.5	1.6	0.1	17.3	0.0	0.1	16.0	20.9	2.3	61.3	0.6	0.6	0.4	16.1	20.9	122.7	31.7	21.1	42.0	44.0	0.4	0.4	1.2	86.6	31.8	1.1	28.8	0.9	0.0	50.1	0.8	1.2	68.6	0.0	2.1	0.0	1.1	0.0	0.3	36.0	0.0	1.1	14.3	0.7	0.0	0.0	0.6	0.0	0.6	125.1	106.2	0.5	0.0	0.5	0.0	45.8	55.3	31.5	0.3	30.5	70.7	60.2	6.7	89.7	0.0	41.4	25.2	53.4	27.2	1.3	0.4	0.7	0.6	1.1	72.4	0.4	0.0	76.2	8.0	9.9	5.2	12.1	16.5	14.6	16.8	14.4	10.1	16.6	20.0	17.0	14.8	1.8	10.9	11.4	16.3	12.7	13.4	1.6	1.8	1.0	2.3	1.1	7.2	1.7	2.0	2.0	1.3	1.6	2.3	2.0	6.4	7.8	0.0	2.7	13.6	3.4	9.7	1.8	0.3	2.7	2.8	41.8	0.0	20.2	1.8	0.0	6.9	4.0	1.1	5.9	2.7	14.1	3.3	4.0	6.6	1.8	3.4	0.0	1.0	3.3	10.1	2.6	3.2	8.2	1.2	2.5	3.1	2.6	1.7	0.0	3.1	6.1	2.6	6.8	8.9	7.2	3.3	1.8	0.0	2.9	0.6	2.1	0.0	0.0	2.3	1.6	5.3	2.5	1.7	2.7	3.8	14.0	1.1	0.0	5.3	6.4	12.0	11.4	3.1	12.6	7.1	5.0	1.0	2.5	2.8
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 48.4;Erythroid cells: 89.7;Macrophages: 73.3;Pancreatic endocrine cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.0;myeloid DC: 2.4;neutrophil: 3.6;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;granulocytes: 3.6;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 119.6;Karpas-707: 201.7;RPTEC TERT1: 91.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA047117: AB_2679940, HPA060198: AB_2684220"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.33e-6)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	8.5	4.4	50.9	4.4	61.3	32.2	5.3	54.5	60.9	17.7	32.8	5.6	10.6	10.8	7.1	8.5	7.4	15.1	6.8	46.3	51.7	20.5	8.5	4.9	4.8	56.6	54.4	12.5	32.5	25.2	13.2	6.2	53.7	12.2	1.2	2.9	12.1	7.9	4.3	11.9	8.1	4.0	53.0	6.4	20.1	5.8	55.5	4.3	6.8	2.8	2.6	8.2	12.4	54.1	11.0	119.6	8.3	6.3	5.5	8.2	14.6	15.6	29.8	11.1	7.4	49.5	29.6	0.0	5.1	14.4	18.0	21.6	6.8	7.5	4.8	0.0	3.5	21.5	4.1	50.6	35.0	4.1	8.3	31.3	13.1	23.1	9.8	13.4	19.8	16.7	4.8	201.7	6.7	3.3	8.1	12.1	10.2	10.7	16.3	7.3	10.3	29.1	91.4	8.3	1.6	7.2	28.9	3.4	54.1	4.2	0.3	5.1	24.0	12.7	12.0	2.3	12.2	9.1	1.7	0.1	10.6	5.4	9.8	0.0	1.0	0.2	0.0	0.4	0.0	0.1	0.2	0.2	2.4	0.0	0.0	0.0	3.6	0.3	0.1	1.1	0.0	16.0	50.9	61.3	54.5	60.9	46.3	51.7	56.6	54.4	53.7	53.0	55.5	54.1	4.4	0.0	0.5	38.5	3.8	12.6	12.0	14.4	6.8	0.5	6.9	4.6	1.7	12.8	6.3	11.0	0.0	0.4	0.2	1.4	0.0	48.4	4.0	9.2	15.8	11.2	6.0	89.7	1.6	30.5	0.8	11.3	6.6	18.7	5.7	10.4	13.6	2.3	20.6	0.0	3.5	3.0	6.1	3.1	10.2	7.7	14.6	73.3	8.8	5.6	22.6	25.4	1.0	9.0	6.2	131.3	1.5	13.5	7.4	13.1	4.0	3.8	1.2	1.4	0.0	2.7	10.2	19.1	7.8	2.1	10.5	0.3	2.1	1.9	3.7	12.6
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	9.9	10.8	4.2	11.1	4.9	25.4	10.9	5.3	6.2	15.5	3.1	12.1	9.5	15.5	5.0	13.8	15.9	9.2	11.7	4.0	7.0	8.6	9.2	10.6	15.7	7.5	5.0	14.6	13.3	15.2	22.7	14.9	6.3	11.8	11.1	4.7	12.9	11.7	13.3	13.5	11.5	12.9	2.4	11.2	10.3	17.7	6.0	19.8	16.0	12.0	15.7	11.8	12.3	10.0	89.1	41.5	46.2	39.2	29.1	21.8	58.7	41.5	42.0	76.3	62.8	119.2	47.0	56.2	41.2	49.9	36.3	43.8	64.0	64.4	40.4	72.7	61.2	60.5	36.2	90.1	31.2	68.5	34.7	25.6	39.4	77.0	27.2	21.1	44.9	51.4	82.2	40.8	40.7	44.3	72.2	32.0	77.0	40.1	56.4	74.3	44.2	59.0	27.0	38.6	66.8	36.3	42.8	54.5	22.7	24.9	37.8	34.8	32.8	57.0	49.3	33.0	49.4	34.3	44.0	79.2	51.4	38.7	44.0	1.8	9.2	14.8	12.9	11.2	14.3	8.9	9.6	11.6	9.6	9.1	9.0	10.5	4.3	12.1	8.1	6.0	9.2	10.4	4.2	4.9	5.3	6.2	4.0	7.0	7.5	5.0	6.3	2.4	6.0	10.0	17.4	3.2	11.3	4.9	20.8	15.0	9.1	8.8	12.0	19.8	21.5	23.0	3.9	5.7	8.0	7.3	12.5	23.8	16.4	7.9	9.8	9.2	22.7	16.0	19.7	12.0	13.1	21.2	6.9	12.2	26.5	12.2	18.8	26.3	6.3	29.0	10.4	17.3	14.1	15.2	6.7	12.8	4.1	13.2	7.7	41.7	14.6	10.2	16.0	1.0	8.8	9.9	11.3	7.5	10.4	11.8	10.5	18.4	27.0	9.4	7.7	5.9	9.9	16.0	0.0	14.1	12.8	25.0	25.6	18.7	20.6	15.6	15.6	16.0	15.2	9.6
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 156.3;Distal enterocytes: 291.5;Paneth cells: 157.5;Proximal enterocytes: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"basophil: 80.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.2;hTCEpi: 36.9;OE19: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		26000000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	15.0	23.3	4.6	18.7	5.1	22.9	23.7	8.2	9.4	72.8	8.9	60.7	45.5	13.3	6.5	13.6	7.9	17.2	5.6	5.3	5.7	47.4	80.0	14.1	21.4	5.9	5.4	9.1	20.8	32.4	7.5	44.0	5.9	21.8	65.7	6.0	13.7	16.6	39.8	64.5	77.3	8.5	5.7	27.0	30.5	2.9	5.4	5.1	9.1	55.8	16.2	35.5	30.9	7.7	0.3	2.6	6.1	2.8	44.2	19.9	19.5	10.4	27.8	3.1	6.6	3.3	2.7	0.0	1.4	6.6	8.2	4.9	1.7	5.3	2.6	0.0	5.4	2.5	9.8	9.0	28.3	0.0	0.1	24.4	36.9	3.0	5.3	12.0	5.5	0.0	3.8	0.0	12.7	9.3	0.0	0.2	1.1	58.8	8.0	0.0	10.8	0.4	15.1	4.2	4.4	0.1	1.5	18.5	27.9	3.9	3.1	1.4	11.0	5.9	3.5	0.6	6.8	0.0	0.0	0.0	8.7	4.9	13.7	80.9	4.0	1.1	0.0	4.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	7.5	0.0	0.0	1.4	4.6	5.1	8.2	9.4	5.3	5.7	5.9	5.4	5.9	5.7	5.4	7.7	11.8	3.2	17.8	5.2	2.4	53.7	24.5	13.7	15.9	3.0	12.2	6.6	4.0	25.8	9.7	5.5	4.2	156.3	0.4	291.5	56.7	24.6	0.2	4.2	12.6	7.1	48.7	5.7	7.4	25.7	40.4	46.3	34.7	5.2	10.1	0.8	18.9	77.8	62.7	3.3	10.5	61.7	59.0	126.3	10.0	1.2	15.5	33.4	35.6	11.2	9.9	11.5	2.1	11.1	11.0	19.5	157.5	14.3	0.9	16.7	383.1	129.3	7.5	6.2	13.1	12.8	9.9	1.1	3.7	15.5	76.0	115.1	2.0	11.4	38.9	16.6
SMPX	"Chisel, Csl, DFN6, DFNX4"	ENSG00000091482	"Small muscle protein X-linked"	Q9UHP9	X	21705978-21758116	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"heart muscle: 757.5;skeletal muscle: 1183.4;tongue: 1097.5"	"Cell type enriched"	"Detected in some"	22	"Cardiomyocytes: 807.6"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 7.2;stomach cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"GAMG: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077360			Approved	"Plasma membrane"		NA	NA		62000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"		"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	0.2	0.1	2.6	0.5	2.4	0.1	1.1	3.6	3.8	0.3	0.9	25.6	0.7	0.4	0.0	20.0	0.7	0.5	757.5	1.6	4.1	0.1	1.2	0.5	0.2	1.7	3.3	1.1	0.2	0.0	0.2	0.0	1.5	11.1	3.4	1.7	17.8	0.7	1183.4	0.5	4.1	12.6	1.3	0.1	7.2	0.2	5.3	1.5	0.2	1097.5	0.1	3.2	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	3.6	3.8	1.6	4.1	1.7	3.3	1.5	1.3	5.3	2.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	807.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	0.0	16.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	35.6	9.5	0.1	0.3	0.0	0.0	0.3	0.1	2.1	0.1	0.0
SMS	"MRSR, SPMSY, SpS, SRS"	ENSG00000102172	"Spermine synthase"	P52788	X	21940709-21994837	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	Transferase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 644.3;Distal tubular cells: 608.4;Syncytiotrophoblasts: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029849, HPA029852"	Approved		Approved	"Nuclear bodies,Cytosol"		No	No		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	Cytosol	"HPA029849: AB_10602072, HPA029852: AB_10611521"	"unprognostic (2.51e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (7.49e-4)"	"prognostic unfavorable (7.79e-8)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (7.85e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"	29.7	94.3	52.0	34.7	53.5	50.8	49.6	56.0	61.9	42.7	43.7	52.0	54.9	44.7	63.6	30.6	28.6	40.5	53.0	53.9	50.2	119.9	44.3	36.2	47.8	48.6	46.7	91.2	24.1	28.0	31.5	114.2	49.1	136.0	50.4	49.5	39.7	42.2	34.6	21.4	50.9	39.6	47.0	41.3	39.3	30.2	53.9	50.7	55.3	32.5	47.3	55.1	32.0	49.6	664.3	161.2	265.3	107.1	71.9	121.4	86.3	174.6	102.6	261.7	249.1	204.0	213.0	239.5	59.8	180.0	722.9	142.2	265.5	318.2	508.2	111.0	128.6	124.4	201.0	145.5	129.4	242.2	103.8	76.8	93.7	266.4	497.2	189.2	254.5	93.6	270.6	32.7	366.7	139.2	181.3	244.1	474.9	149.0	244.3	176.0	188.5	182.9	354.3	90.1	131.4	105.7	143.1	181.8	489.1	687.6	163.9	101.3	232.3	194.4	193.6	405.0	294.5	23.8	52.6	142.2	378.4	107.5	275.6	9.1	57.5	102.5	18.9	59.9	23.7	34.6	29.6	33.3	51.1	22.0	19.1	22.8	55.7	31.4	73.9	10.7	55.4	37.3	52.0	53.5	56.0	61.9	53.9	50.2	48.6	46.7	49.1	47.0	53.9	49.6	43.4	25.6	21.9	33.6	61.5	65.9	203.0	206.1	42.1	35.7	116.2	66.3	36.1	81.5	115.0	110.3	12.5	644.3	46.7	61.2	608.4	246.3	1.9	126.4	70.4	61.9	58.8	95.2	45.6	152.3	313.1	86.6	57.6	215.9	40.5	249.5	59.6	49.8	364.7	21.9	40.2	103.6	146.5	157.3	200.3	7.1	95.4	153.1	92.5	21.5	250.7	46.8	48.4	22.1	8.1	165.6	63.9	103.4	45.6	276.2	137.0	466.7	78.9	43.2	65.7	76.6	114.2	6.0	181.3	54.1	50.6	869.6	63.7	271.2	119.1	153.1
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 887.2;urinary bladder: 450.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 283.5;Hepatic stellate cells: 121.3;Sertoli cells: 184.1;Smooth muscle cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"		No	Yes		140000	"Cluster 30: Non-specific - Translation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765"	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	54.7	19.2	10.8	25.3	12.5	4.7	42.2	10.3	13.1	100.2	7.6	887.2	30.0	251.0	7.0	65.1	132.4	20.8	152.0	9.0	9.3	35.6	15.3	38.2	5.6	11.7	12.5	34.0	25.2	3.3	9.8	17.4	11.0	150.9	29.2	15.2	16.3	177.9	95.7	38.7	151.5	127.2	10.5	54.5	231.2	12.5	12.4	2.9	26.4	26.2	2.5	450.6	91.5	10.0	73.0	21.2	7.2	27.0	11.0	17.2	58.0	106.8	49.1	85.7	58.4	29.9	22.4	32.1	9.3	59.3	17.3	10.6	7.2	62.8	40.4	10.6	58.2	33.9	18.3	36.1	9.7	51.5	57.4	14.2	5.8	114.0	18.7	29.2	74.7	12.3	37.3	25.9	59.6	64.5	5.9	11.4	8.2	36.1	90.0	20.3	20.5	34.6	34.5	23.2	11.5	12.7	33.4	15.9	15.7	7.4	18.8	8.2	118.7	62.1	58.4	59.4	79.8	24.6	32.5	18.8	91.0	19.7	200.5	0.0	1.0	0.0	0.1	0.2	0.0	1.3	0.1	0.3	0.4	0.0	1.0	0.5	0.1	0.1	0.2	0.2	0.0	0.6	10.8	12.5	10.3	13.1	9.0	9.3	11.7	12.5	11.0	10.5	12.4	10.0	94.5	6.4	3.3	23.8	2.0	65.1	33.5	16.1	19.4	46.6	18.6	26.7	39.5	5.7	6.1	9.2	283.5	13.4	2.7	12.8	9.8	14.8	1.2	4.0	52.1	62.8	29.2	0.0	0.2	20.1	68.8	35.9	18.3	7.3	0.0	11.0	121.3	2.6	6.0	5.0	1.9	29.9	14.2	6.8	14.6	1.9	22.4	4.7	14.2	7.5	1.0	31.2	1.0	4.5	2.0	73.2	11.4	48.5	2.1	21.7	5.6	18.4	2.2	54.0	184.1	18.4	116.4	5.7	7.9	9.7	69.3	21.9	3.7	16.3	27.0	14.9
SNAPC1	"PTFgamma, SNAP43"	ENSG00000023608	"Small nuclear RNA activating complex polypeptide 1"	Q16533	14	61762420-61796428	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 171.9;Spermatocytes: 215.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 153.7;hTERT-HME1: 153.7;U-2 OS: 207.6;U-251 MG: 146.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067076, HPA072276"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli	Nucleoplasm	"HPA067076: AB_2732757, HPA072276: AB_2732199"	"unprognostic (7.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.26e-1)"	6.2	9.0	2.7	6.4	3.6	6.0	5.9	4.9	3.4	10.1	4.1	3.5	3.6	7.0	4.9	6.0	6.4	7.7	8.3	2.7	2.9	7.0	5.2	4.8	8.1	4.3	5.7	6.1	3.6	7.9	5.8	8.7	4.5	6.8	3.0	6.6	5.2	6.9	4.4	5.2	3.2	4.8	3.0	6.8	3.2	20.0	3.0	7.1	7.2	4.7	6.9	10.0	5.2	4.6	57.6	11.0	10.7	22.8	11.7	13.6	12.7	47.4	31.4	53.3	31.4	3.9	11.5	11.9	61.5	20.3	153.7	17.7	10.6	14.3	87.3	13.0	7.6	7.1	5.7	8.1	30.8	7.5	15.2	13.1	9.5	45.0	153.7	20.7	20.7	16.2	8.0	10.6	51.4	7.4	18.3	12.0	10.3	6.4	35.9	13.9	28.3	4.4	43.9	8.8	7.6	18.3	31.3	5.5	39.0	13.2	11.0	11.7	31.8	58.4	207.6	38.2	146.6	7.0	7.8	10.5	39.7	9.5	35.3	7.7	5.0	4.5	4.4	4.3	5.7	8.4	5.4	3.8	5.2	8.8	8.8	5.7	4.9	7.0	3.8	6.9	6.5	3.6	2.7	3.6	4.9	3.4	2.7	2.9	4.3	5.7	4.5	3.0	3.0	4.6	22.6	35.3	18.3	10.1	28.0	95.3	56.2	171.9	43.3	10.2	11.5	18.0	24.6	11.5	53.6	29.5	2.1	16.8	31.2	3.4	7.9	28.6	70.7	70.1	28.7	29.3	4.2	10.7	12.8	15.9	31.5	31.1	4.1	47.6	41.8	20.2	26.7	6.9	17.3	8.4	13.3	4.0	42.7	11.7	32.6	17.1	22.1	31.6	17.8	10.3	12.4	40.4	4.1	10.6	14.6	20.3	1.9	20.3	7.9	28.8	5.6	13.3	83.9	12.6	19.7	38.3	34.7	215.0	67.7	23.5	64.5	5.6	29.0	20.6	6.8	20.8
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028939, HPA046627, HPA073243"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028939: , HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.3	5.3	3.5	6.0	2.9	8.5	6.6	2.0	6.3	8.0	2.7	6.2	5.7	6.7	3.0	5.8	9.8	3.9	5.8	2.9	0.5	7.6	10.8	6.5	6.9	1.7	1.1	8.0	11.3	5.9	11.2	3.7	0.9	8.0	4.1	5.4	6.6	4.6	6.3	8.2	7.2	4.5	0.1	10.1	6.0	19.7	0.9	5.2	8.6	2.4	6.0	6.7	6.4	2.2	9.2	10.5	10.6	14.8	6.7	12.9	19.4	11.7	7.8	12.0	9.5	24.3	8.2	14.0	8.2	9.3	8.3	29.0	12.9	15.0	7.1	19.9	20.3	9.5	30.3	11.6	5.9	20.2	10.8	10.3	12.4	10.4	9.8	10.4	10.8	11.3	19.8	10.1	8.4	20.6	11.7	22.7	21.9	14.5	13.7	19.0	10.7	19.9	6.9	16.4	30.4	21.2	11.7	19.1	6.2	9.1	19.7	11.6	15.4	12.3	11.2	22.3	16.9	6.3	7.9	11.2	8.6	9.3	7.3	0.0	0.5	0.4	0.7	0.3	0.3	0.5	0.3	0.3	0.1	1.5	0.2	0.1	1.0	0.7	0.1	0.5	0.2	0.1	3.5	2.9	2.0	6.3	2.9	0.5	1.7	1.1	0.9	0.1	0.9	2.2	3.6	6.4	9.0	12.1	4.8	5.4	2.8	3.9	5.7	8.2	6.0	5.0	5.9	5.7	3.8	3.7	2.1	2.6	5.9	5.4	0.0	6.2	4.1	15.1	5.6	4.1	5.3	7.0	12.2	4.5	2.0	4.1	4.6	7.1	1.3	7.0	5.7	8.1	3.2	3.3	8.5	5.0	10.2	4.2	7.7	2.5	5.0	3.4	0.0	5.6	3.2	4.4	3.1	7.1	5.5	6.8	5.8	4.9	4.6	3.7	3.6	4.3	20.3	12.2	0.0	4.2	4.4	9.5	10.0	3.0	6.8	1.4	5.7	6.2	6.1	2.9
SNPH	bA314N13.5	ENSG00000101298	Syntaphilin	O15079	20	1266280-1309328	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 75.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Bipolar cells: 24.3;Excitatory neurons: 60.6;Horizontal cells: 30.3;Inhibitory neurons: 71.7;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049393	Approved		Uncertain	"Cytokinetic bridge,Mitochondria"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Cytokinetic bridge"	"HPA049393: AB_2680744"	"unprognostic (1.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.97e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	1.6	3.7	47.2	1.5	49.6	0.6	1.6	7.5	75.5	4.0	0.0	8.4	1.5	6.4	1.9	1.8	6.5	2.6	7.1	54.0	19.0	2.7	0.3	2.4	1.6	38.0	19.0	2.1	3.5	4.4	12.5	0.6	38.1	5.9	0.8	12.9	6.1	11.1	7.2	1.2	4.6	4.8	7.1	1.7	5.1	3.9	33.3	0.9	5.0	1.6	0.8	4.7	3.0	44.3	2.3	7.6	0.1	6.5	7.6	4.0	0.0	4.1	5.2	4.4	2.0	0.3	0.7	0.4	2.4	4.9	10.9	1.2	1.0	5.7	0.8	1.6	1.8	4.7	1.2	0.1	4.0	0.0	7.1	2.7	2.7	4.5	0.9	4.3	5.6	4.5	0.9	0.2	4.0	0.0	0.4	0.2	2.4	0.0	5.7	0.0	1.5	0.1	5.8	3.4	0.4	2.0	4.1	0.2	5.8	0.6	0.3	0.1	9.6	7.1	5.3	6.4	1.2	0.6	1.4	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.1	0.5	47.2	49.6	7.5	75.5	54.0	19.0	38.0	19.0	38.1	7.1	33.3	44.3	0.5	0.0	0.0	45.7	0.6	0.1	0.1	2.2	1.2	24.3	2.4	0.9	4.7	4.3	1.2	3.7	6.2	0.0	2.3	0.9	0.0	0.4	10.4	0.2	0.7	1.0	8.4	0.0	60.6	0.6	0.1	1.3	5.6	0.5	0.0	2.1	2.2	0.0	0.3	30.3	71.7	1.0	2.0	0.0	0.3	5.4	1.5	0.2	0.0	9.4	0.2	2.7	1.0	38.2	1.7	1.1	1.0	4.1	0.4	1.6	0.1	1.7	1.2	20.3	6.6	2.6	1.7	1.3	0.5	0.2	0.1	0.0	1.6	1.2	1.8	0.1
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53828-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 156.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 219.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: AB_2677353, HPA044248: AB_2678873"	"unprognostic (7.87e-2)"	"prognostic favorable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	15.2	29.3	80.7	20.6	81.4	32.7	16.1	95.2	98.3	14.0	74.4	27.2	12.9	15.9	16.3	20.1	16.0	10.4	85.3	81.7	81.0	25.0	39.2	10.8	32.6	86.3	82.7	19.8	19.7	24.6	30.7	8.7	87.0	19.8	17.5	12.4	22.9	13.8	131.6	10.9	16.5	15.1	81.8	19.0	27.6	11.0	88.0	22.5	17.7	84.5	31.2	17.2	11.9	80.1	50.1	111.2	60.7	70.8	21.2	24.9	29.5	41.4	26.5	90.7	76.1	150.4	47.5	157.3	48.3	34.2	48.6	50.4	111.8	76.2	69.2	57.3	87.8	91.6	155.3	152.9	22.4	168.9	103.9	32.1	27.0	80.8	22.4	19.6	49.6	93.5	139.2	36.5	52.2	236.5	89.5	70.0	72.8	88.4	54.5	141.9	64.6	186.9	48.6	34.7	66.2	42.9	93.4	119.8	20.7	59.0	77.5	80.8	39.3	40.0	49.6	51.8	67.2	37.6	96.9	248.2	21.3	89.5	62.3	15.1	25.5	93.3	14.9	40.3	17.9	74.3	15.1	17.9	49.6	75.1	15.9	16.3	17.2	22.5	35.9	219.7	26.1	23.2	80.7	81.4	95.2	98.3	81.7	81.0	86.3	82.7	87.0	81.8	88.0	80.1	16.5	12.8	14.3	6.8	53.4	18.6	27.2	39.5	14.8	17.9	48.1	51.9	113.0	18.6	29.3	33.1	4.2	54.6	62.3	30.9	156.5	41.6	3.0	27.3	23.8	18.9	44.0	58.5	9.9	51.4	63.3	29.3	30.1	36.9	4.5	62.3	16.4	67.5	114.5	11.8	9.8	34.5	69.2	26.4	59.8	6.5	21.5	36.2	62.2	5.6	94.3	89.0	32.0	4.5	6.5	31.0	44.8	29.7	65.9	31.5	24.0	87.6	53.2	14.5	6.6	29.4	35.7	33.7	44.8	35.8	21.9	26.1	22.4	105.0	53.5	27.7
SNRNP70	"RNPU1Z, RPU1, Snp1, SNRP70, U1-70K"	ENSG00000104852	"Small nuclear ribonucleoprotein U1 subunit 70"	P08621	19	49085419-49108605	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001718, HPA042050, HPA043516"	Supported		Enhanced	Nucleoplasm		NA	NA		74000	"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523"	"unprognostic (2.22e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (5.18e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (5.35e-5)"	77.2	106.0	30.1	41.3	28.2	49.5	79.1	29.2	46.0	108.1	29.8	90.6	39.4	96.6	21.0	103.9	95.4	13.8	88.1	28.4	32.4	83.4	96.3	81.2	43.5	28.6	28.5	107.7	95.9	28.6	104.9	26.8	27.9	107.4	21.9	18.5	92.9	23.3	104.2	95.2	90.5	20.7	24.6	106.7	94.3	72.9	28.4	45.8	103.5	16.7	33.0	81.9	94.4	34.1	178.5	224.0	142.3	101.6	56.4	34.3	155.3	125.4	81.7	136.1	118.1	140.4	103.5	203.9	127.1	89.0	123.1	152.2	176.6	128.2	101.0	137.0	468.2	185.9	103.6	164.9	29.2	209.1	125.2	48.0	35.4	99.6	67.2	64.5	103.0	107.2	195.4	65.7	84.4	175.3	218.8	338.3	175.3	102.9	167.4	254.7	133.7	124.6	87.9	113.7	112.3	136.9	158.3	96.1	94.8	94.5	98.9	132.3	147.0	101.8	190.5	86.7	223.5	164.3	156.5	263.2	84.1	135.9	95.2	0.8	2.0	1.8	1.8	1.5	1.1	4.0	1.4	0.8	2.0	1.7	2.0	1.5	0.8	4.1	1.8	1.7	1.2	0.8	30.1	28.2	29.2	46.0	28.4	32.4	28.6	28.5	27.9	24.6	28.4	34.1	86.6	19.2	63.0	198.5	107.2	139.4	166.8	78.4	93.9	108.7	97.8	109.5	31.6	55.8	66.0	75.4	89.6	179.7	97.5	89.8	46.9	108.1	23.7	101.8	141.9	84.2	118.0	76.6	81.0	105.1	208.6	92.3	110.1	123.0	55.1	111.7	61.4	97.4	125.8	114.4	99.2	121.4	77.3	58.7	97.7	21.3	130.1	77.8	69.4	74.0	75.8	82.6	76.2	110.6	151.9	116.0	80.0	110.6	112.0	177.1	95.0	77.5	59.3	109.6	124.9	102.3	101.2	109.7	108.6	92.3	130.7	176.4	96.3	115.4	119.6	154.7
SNTB2	"D16S2531E, EST25263, SNT2B2, SNT3, SNTL"	ENSG00000168807	"Syntrophin beta 2"	Q13425	16	69187129-69309052	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.4;Muller glia cells: 214.1;Rod photoreceptor cells: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SiHa: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001394			Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA001394: AB_1080170"	"unprognostic (4.86e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-3)"	"unprognostic (6.46e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.88e-1)"	11.0	5.0	3.3	5.2	3.9	2.7	8.8	1.0	6.7	11.0	10.1	6.7	3.7	10.4	5.1	7.0	8.7	7.1	5.3	4.6	0.8	6.7	3.8	8.6	5.6	2.5	0.9	6.2	4.1	12.4	4.0	5.2	0.9	8.2	5.3	21.6	5.2	5.5	5.7	8.5	6.0	8.7	0.6	5.7	6.1	7.1	1.5	5.8	10.5	3.8	4.9	8.7	8.7	3.7	7.2	10.9	7.4	5.8	26.6	35.6	9.1	13.9	19.3	10.7	11.8	10.7	6.5	9.0	8.3	16.2	5.6	12.9	10.0	6.8	13.9	4.0	5.5	4.0	11.1	9.2	8.8	0.3	5.9	25.6	4.9	17.6	7.1	11.1	32.4	2.5	2.3	13.8	13.1	8.2	3.0	1.4	5.0	4.2	8.6	18.1	6.5	16.8	5.7	10.9	2.8	6.1	42.6	6.0	4.4	5.5	7.1	0.5	25.4	20.0	9.6	14.2	13.0	3.1	5.2	10.0	12.8	1.4	9.3	0.4	0.2	0.3	0.9	0.3	0.9	0.2	0.4	0.5	0.2	0.2	0.2	1.1	0.9	0.7	0.3	0.1	0.5	0.3	3.3	3.9	1.0	6.7	4.6	0.8	2.5	0.9	0.9	0.6	1.5	3.7	55.9	19.2	11.7	36.6	9.0	38.0	28.0	17.1	70.0	33.2	19.0	25.0	9.2	10.0	10.4	27.6	41.7	9.5	33.7	29.0	3.9	9.7	25.9	20.6	61.3	81.4	10.3	4.8	151.4	24.1	7.9	53.1	20.9	28.7	1.3	15.8	126.7	11.1	6.9	5.0	62.6	16.6	8.2	33.1	29.3	27.5	59.0	12.9	30.2	33.7	8.6	214.1	47.4	30.7	27.9	16.3	32.8	65.1	20.7	40.9	12.7	34.5	10.0	136.7	6.6	26.0	35.6	27.9	15.4	30.7	38.8	3.7	32.8	20.2	19.6	28.7
SNX17	KIAA0064	ENSG00000115234	"Sorting nexin 17"	Q15036	2	27370496-27377535	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043867	Supported		Enhanced	Vesicles,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Cytosol	"HPA043867: AB_10961129"	"unprognostic (2.57e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.32e-3)"	62.5	74.6	32.2	23.1	32.6	19.8	57.0	35.3	31.8	59.7	32.1	58.5	17.3	62.8	16.6	62.2	57.7	22.1	60.3	30.3	32.7	54.6	62.9	53.8	32.3	33.5	33.1	62.4	53.9	42.5	61.1	28.1	37.1	54.2	23.3	12.8	50.3	31.6	49.2	57.0	53.3	33.4	36.3	80.8	54.1	34.1	35.0	43.9	54.3	33.9	33.8	59.8	50.9	37.0	40.1	70.0	45.3	56.4	85.9	71.5	29.0	47.3	85.2	71.8	52.2	43.5	37.8	39.5	55.4	113.9	61.9	23.7	42.4	63.8	57.9	40.7	72.5	44.8	20.3	55.4	80.9	47.6	41.6	66.9	56.7	49.6	59.5	54.1	78.3	32.7	35.5	32.8	87.2	47.7	50.2	31.3	29.2	62.5	67.1	22.7	74.0	64.9	53.5	34.1	46.3	55.1	38.6	39.0	18.1	31.9	30.5	29.6	50.6	57.4	31.6	33.8	45.5	56.8	47.5	49.4	50.0	49.8	60.9	87.5	138.7	88.9	65.6	135.2	66.9	72.7	61.2	67.6	135.6	73.2	57.5	60.6	30.8	72.2	146.9	73.8	78.5	231.9	32.2	32.6	35.3	31.8	30.3	32.7	33.5	33.1	37.1	36.3	35.0	37.0	60.8	16.0	39.1	6.5	68.3	32.5	48.2	78.3	32.5	30.9	47.1	61.3	31.5	35.8	43.3	29.5	14.6	173.5	69.3	56.9	82.2	84.0	8.9	34.4	39.9	52.7	55.1	49.2	6.8	63.9	132.7	60.3	35.2	25.6	43.1	64.5	47.5	64.9	134.9	45.4	7.7	48.3	79.3	118.1	42.7	9.7	58.4	83.4	69.4	2.8	141.9	80.1	76.2	11.1	11.2	64.8	54.1	85.0	60.3	41.4	75.4	95.3	38.6	23.2	32.9	41.4	68.4	58.0	53.2	55.0	34.4	99.6	63.2	102.1	60.0	34.9
SNX7		ENSG00000162627	"Sorting nexin 7"	Q9UNH6	1	98661701-98760500	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037419	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Cell Junctions"	"HPA037419: AB_10671754"	"unprognostic (3.19e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.10e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (9.59e-7)"	"unprognostic (1.53e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.77e-1)"	19.5	13.8	10.2	7.5	9.5	0.1	17.1	8.6	9.9	20.6	7.5	30.1	23.5	19.4	12.6	16.6	15.6	16.2	22.1	10.1	13.6	24.9	12.8	11.3	3.4	11.6	12.7	11.3	13.7	15.1	8.4	16.8	10.7	14.3	29.9	3.2	14.1	16.4	5.4	11.0	22.9	25.8	9.8	5.4	16.9	15.7	16.4	3.6	12.2	10.9	4.7	20.3	14.3	10.8	50.4	26.7	15.8	21.6	54.9	86.3	8.9	31.3	56.6	45.9	59.2	15.6	18.4	0.0	39.7	77.1	37.7	14.2	16.8	44.4	45.5	0.2	32.3	0.0	41.2	27.1	32.4	0.0	0.0	43.5	46.8	37.8	16.5	51.7	64.9	0.7	0.0	0.1	73.3	10.3	0.4	0.0	15.2	20.0	38.0	0.0	35.4	0.1	45.3	39.8	7.8	93.5	41.6	39.0	23.7	26.2	0.0	1.8	44.9	44.7	24.8	35.0	64.2	0.0	0.1	0.1	63.3	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.2	9.5	8.6	9.9	10.1	13.6	11.6	12.7	10.7	9.8	16.4	10.8	14.1	19.2	6.7	23.2	0.5	14.7	44.7	60.0	9.6	0.7	16.3	23.0	49.1	27.1	22.0	23.9	0.0	34.1	0.1	37.4	37.2	47.0	19.3	29.4	33.0	17.8	21.0	0.0	18.3	80.7	33.8	37.9	20.9	19.6	1.3	22.4	17.9	12.0	12.9	3.3	25.7	26.6	48.8	2.1	13.7	23.9	34.2	5.0	35.6	12.2	37.2	12.8	0.0	58.8	8.2	56.8	25.7	52.6	0.1	28.5	34.1	69.0	27.2	0.8	32.9	23.1	36.2	15.5	10.5	27.1	16.3	14.1	1.6	30.2	49.1	57.3
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 251.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 146.6;GAMG: 145.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Cytosol	"HPA031410: AB_10603339, HPA057203: AB_2683368"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	57.9	25.2	19.2	25.7	20.6	14.3	41.4	21.2	20.9	38.8	20.6	34.2	33.2	41.8	20.8	57.8	26.2	46.9	33.2	18.8	19.9	26.2	39.0	21.0	24.2	22.2	21.1	28.0	28.5	37.7	13.4	48.5	21.8	31.0	29.5	2.7	35.1	41.7	24.4	30.4	35.6	41.2	20.9	18.4	37.5	11.0	20.7	13.9	29.8	34.2	21.7	49.8	33.7	23.0	26.0	19.1	18.9	22.1	96.6	78.6	37.7	46.3	146.6	36.4	48.9	16.6	27.6	0.0	25.0	85.6	145.8	18.7	22.7	36.3	21.1	23.9	23.4	17.7	25.7	23.9	48.6	7.6	31.6	51.1	33.9	37.8	37.1	63.9	49.8	23.3	80.9	0.0	15.8	17.2	0.0	15.6	14.4	18.7	21.3	0.0	17.9	32.7	59.7	15.9	11.8	20.9	34.1	16.4	90.5	16.2	6.8	20.0	41.7	41.3	16.6	128.8	30.4	0.0	0.0	0.0	84.8	6.4	25.4	0.0	0.7	0.1	0.4	2.1	1.5	3.2	0.7	0.6	1.4	2.4	5.3	1.2	0.0	0.1	6.8	10.0	2.2	0.6	19.2	20.6	21.2	20.9	18.8	19.9	22.2	21.1	21.8	20.9	20.7	23.0	71.5	0.0	1.1	40.5	102.6	43.3	109.7	17.3	30.1	15.6	28.7	18.4	28.4	28.6	19.0	9.2	0.0	40.6	37.6	97.7	21.5	57.5	73.4	112.8	53.0	57.9	15.7	17.7	105.4	55.9	41.1	83.0	70.3	251.1	12.0	16.4	37.1	34.3	41.6	3.3	90.4	43.0	8.2	59.0	74.2	26.8	44.7	84.3	21.4	48.7	39.5	11.1	7.2	100.5	161.2	107.0	108.9	46.6	14.9	127.5	52.5	46.2	14.3	1.8	39.5	43.6	49.6	21.9	15.4	22.9	29.8	109.9	48.8	9.1	29.7	137.0
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"adrenal gland: 165.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	14.6	165.3	4.2	18.1	5.7	17.5	8.2	5.5	6.6	13.7	9.0	13.0	12.2	11.7	6.6	4.8	17.9	20.5	5.4	3.3	6.8	12.7	14.1	20.9	15.1	10.1	6.1	10.7	27.0	13.4	6.3	19.1	8.0	27.7	14.8	10.3	39.4	9.3	4.0	5.7	12.7	16.5	8.0	15.1	16.3	11.0	6.7	8.1	9.2	3.7	13.1	11.7	4.5	12.8	74.6	34.1	27.7	41.0	104.7	56.6	147.3	35.1	61.7	76.2	88.3	35.2	82.6	42.0	53.9	64.4	92.6	26.8	88.6	20.9	81.8	48.0	18.2	19.5	26.7	36.9	42.9	33.5	7.5	45.4	13.3	89.2	75.8	32.1	33.3	50.5	42.7	21.0	120.0	15.9	35.9	10.8	13.4	11.8	11.2	44.4	35.8	24.4	66.1	45.9	8.4	21.5	54.3	22.9	20.1	32.3	24.0	22.8	31.9	89.8	43.1	99.5	78.2	29.4	115.3	35.5	35.7	17.9	170.6	55.4	53.4	1.6	26.4	34.2	25.0	12.9	24.0	24.8	48.9	10.4	23.0	23.3	39.3	37.9	23.7	8.8	33.2	32.5	4.2	5.7	5.5	6.6	3.3	6.8	10.1	6.1	8.0	8.0	6.7	12.8	14.9	22.4	33.4	11.4	16.0	9.9	10.1	11.3	8.0	7.3	7.2	4.6	8.5	30.0	14.5	20.2	14.6	17.6	21.2	16.0	1.9	42.5	29.5	34.9	32.8	16.0	59.9	9.0	12.1	25.0	51.6	21.3	18.3	34.5	14.0	9.2	15.4	24.2	70.3	6.7	15.0	25.5	22.4	77.4	41.9	14.5	32.6	74.9	23.2	29.0	55.4	7.6	19.6	10.6	7.3	20.3	13.3	25.9	17.7	26.7	8.7	14.9	46.2	14.5	26.3	9.2	13.5	6.8	9.7	5.0	5.3	8.8	24.8	44.3	15.5	8.5
SOCS5	"CIS6, Cish5, CISH6, KIAA0671, SOCS-5"	ENSG00000171150	"Suppressor of cytokine signaling 5"	O75159	2	46698952-46780245	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 121.0;fHDF/TERT166: 121.9;U-138 MG: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020884, CAB025510"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025510: , HPA020884: AB_1857356"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (4.52e-2)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	12.0	10.2	7.6	6.3	7.7	7.7	13.0	15.9	9.6	13.0	7.5	9.7	5.2	14.1	9.1	8.5	9.3	11.3	11.3	8.1	7.6	9.2	6.7	8.7	6.7	8.3	8.3	23.2	6.2	14.2	5.6	7.3	8.5	9.9	6.6	12.7	8.7	12.4	9.0	7.5	6.7	13.9	8.5	9.0	6.6	10.3	8.2	7.6	9.9	16.0	6.7	9.3	8.5	8.6	14.5	10.8	9.3	13.8	29.9	42.3	11.4	66.5	121.0	31.5	18.6	10.3	6.9	7.5	12.7	121.9	9.7	7.1	9.9	10.8	41.2	7.3	9.4	11.8	10.0	13.2	18.4	6.9	12.7	33.9	15.8	26.7	10.7	35.8	11.0	3.0	10.2	8.1	21.5	5.3	5.9	12.0	10.4	15.1	8.7	7.8	15.9	9.5	13.2	11.1	7.3	19.8	16.4	10.7	13.0	8.9	4.4	10.3	12.8	80.0	17.7	26.9	13.2	9.7	6.4	6.5	36.9	13.7	25.5	0.5	0.4	2.5	0.9	0.4	1.1	1.8	0.5	0.6	0.5	3.0	1.1	1.5	0.4	1.0	1.7	0.5	1.0	0.7	7.6	7.7	15.9	9.6	8.1	7.6	8.3	8.3	8.5	8.5	8.2	8.6	17.2	3.2	6.1	18.9	11.3	16.6	7.2	8.3	16.5	12.8	15.1	12.2	14.2	18.6	8.0	3.7	22.9	3.7	6.2	11.0	5.9	7.3	12.3	9.9	29.2	24.3	10.8	6.1	43.4	6.8	2.5	18.8	10.2	12.0	17.1	17.4	17.2	7.9	4.5	18.5	51.5	7.1	2.0	8.4	15.2	8.1	17.4	7.7	7.2	18.7	8.4	9.7	6.2	38.2	25.4	6.8	8.8	17.0	7.0	11.0	5.1	7.3	5.3	5.5	13.1	13.8	20.1	13.3	18.8	9.9	14.5	2.7	7.0	7.3	5.6	7.8
SOD2	GClnc1	ENSG00000112096	"Superoxide dismutase 2"	P04179	6	159669069-159762529	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 1083.7;skeletal muscle: 3230.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2508.2;Prostatic glandular cells: 3524.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 4470.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 4470.5"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1611.9;GAMG: 614.3;HSkMC: 688.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA		55000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	324.8	245.9	66.8	522.8	43.2	1083.7	169.0	37.8	125.8	92.6	99.7	126.4	60.5	105.4	7.2	136.5	118.5	121.8	178.5	37.0	101.0	252.4	459.8	266.5	64.8	250.0	96.1	55.8	212.3	69.1	42.7	62.9	192.9	130.8	37.9	25.1	328.8	43.9	3230.1	90.0	83.7	108.4	62.5	81.4	120.4	39.6	153.1	38.2	67.2	312.6	65.0	514.9	97.9	85.4	35.8	46.3	37.3	85.1	229.0	378.7	20.5	52.7	1611.9	57.7	131.1	91.3	19.4	70.7	144.5	54.1	614.3	58.9	39.1	42.5	42.4	71.2	87.2	74.5	71.8	152.3	169.5	74.0	31.9	688.9	68.5	180.9	133.6	40.7	30.0	44.9	106.7	82.2	55.4	37.6	60.3	46.6	63.3	41.5	55.4	79.6	50.3	63.9	106.2	56.6	71.5	29.5	105.1	52.4	21.4	14.1	33.1	33.7	30.4	168.6	62.1	92.5	87.9	37.8	100.2	86.5	186.7	57.4	23.6	146.3	364.4	181.1	38.8	273.9	43.4	43.4	54.9	38.5	105.2	38.3	45.0	36.9	4470.5	19.1	445.3	14.8	87.9	340.0	66.8	43.2	37.8	125.8	37.0	101.0	250.0	96.1	192.9	62.5	153.1	85.4	303.2	201.9	746.1	13.4	99.0	684.7	1144.9	2508.2	114.4	45.6	150.2	96.6	0.0	287.4	613.3	237.3	45.9	18.3	43.8	153.9	86.1	1400.2	318.2	281.7	649.8	593.0	79.6	101.2	31.1	1389.7	51.2	1098.4	103.5	1080.1	112.3	23.1	58.9	395.0	292.0	32.0	30.1	92.7	339.7	333.3	1425.8	111.5	58.1	1031.2	521.2	15.9	339.9	50.4	35.0	8.5	12.2	581.6	111.3	65.1	101.2	3524.0	128.6	530.1	269.6	61.8	39.5	1164.0	407.3	91.7	51.4	258.7	681.8	27.2	119.4	38.3	148.1	1195.7
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 107.1;Bipolar cells: 70.3;Excitatory neurons: 41.4;Muller glia cells: 33.0;Oligodendrocytes: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 7.6;HaCaT: 19.6;HMC-1: 14.5;RPMI-8226: 9.1;SiHa: 14.1;THP-1: 8.4;U-937: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071818			Approved	Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA071818: "	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	2.4	1.1	13.4	3.4	18.3	1.7	1.6	11.6	15.9	8.5	0.0	4.5	1.4	4.7	3.8	2.2	3.3	3.6	2.0	12.1	11.3	9.0	4.6	4.4	0.8	18.6	17.6	5.8	0.7	0.0	2.7	0.2	14.7	5.2	1.1	12.9	1.0	2.4	1.1	1.8	2.6	6.2	11.3	0.4	1.6	1.6	14.1	3.1	3.1	1.2	1.2	3.0	3.7	22.9	0.8	1.1	1.3	0.2	0.1	0.0	0.0	0.2	0.1	1.6	0.4	0.2	0.6	0.0	7.6	5.0	1.3	19.6	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.3	0.2	0.0	14.5	0.2	4.3	6.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.4	0.0	0.9	0.0	1.6	9.1	0.2	0.0	0.8	0.7	14.1	0.0	0.0	0.8	0.0	8.4	0.0	4.9	1.4	0.0	0.1	0.0	0.0	0.0	1.6	8.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	18.3	11.6	15.9	12.1	11.3	18.6	17.6	14.7	11.3	14.1	22.9	0.1	3.2	11.3	107.1	0.0	0.1	0.3	4.6	0.0	70.3	0.1	2.4	2.0	0.0	6.9	5.5	0.0	0.0	0.3	0.0	0.0	0.2	2.2	0.4	0.4	0.3	0.0	0.0	41.4	0.0	0.0	5.0	0.0	0.9	0.0	5.4	0.4	1.6	0.2	1.7	24.3	0.0	2.0	0.3	0.0	11.6	12.8	0.4	1.8	8.4	0.1	33.0	1.0	8.0	76.2	1.1	0.0	7.9	0.1	0.4	0.4	1.4	2.0	2.7	0.0	0.9	1.0	0.1	0.3	0.0	0.4	0.0	0.3	1.5	0.0	0.6
SOS1	"GF1, GINGF, HGF"	ENSG00000115904	"SOS Ras/Rac guanine nucleotide exchange factor 1"	Q07889	2	38981549-39124345	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 226.6;Inhibitory neurons: 224.0;Microglial cells: 161.1;Oligodendrocyte precursor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 134.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005396	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB005396: AB_2270724"	"unprognostic (6.68e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-2)"	17.5	8.4	8.2	14.8	10.2	10.8	9.8	14.1	10.3	13.1	6.8	11.0	14.7	14.3	10.3	12.3	11.2	13.5	9.5	9.7	10.8	11.0	11.9	11.0	16.9	9.5	10.2	20.1	9.1	17.1	0.1	17.0	9.5	13.4	12.9	13.2	9.0	12.2	13.7	9.4	15.6	13.8	6.7	12.5	11.5	10.3	8.7	15.4	15.1	16.4	17.8	13.5	0.1	10.6	24.8	15.1	22.8	16.2	29.1	35.0	23.8	15.3	18.7	12.0	11.4	16.3	14.6	35.8	10.3	20.1	18.5	14.4	26.9	13.9	22.1	36.3	11.9	55.5	12.8	22.0	11.8	17.9	134.9	21.6	20.5	16.3	15.8	19.5	18.9	8.1	23.9	16.4	15.4	13.5	19.4	15.8	14.3	30.4	10.4	21.5	20.5	10.5	12.1	19.8	22.0	22.0	18.3	32.3	18.2	18.5	10.4	9.3	21.5	19.8	16.0	15.7	15.4	19.3	20.9	18.4	15.8	17.3	12.0	0.0	0.5	1.4	1.3	0.7	1.9	1.6	1.3	1.4	0.4	1.0	1.5	1.4	0.6	2.7	0.9	0.6	0.9	0.4	8.2	10.2	14.1	10.3	9.7	10.8	9.5	10.2	9.5	6.7	8.7	10.6	72.3	16.0	31.2	120.5	20.9	20.8	15.5	10.9	19.9	19.0	18.4	16.9	33.9	18.6	17.8	9.2	10.4	10.2	27.6	19.5	1.9	11.0	64.9	30.0	36.6	43.2	12.0	12.8	226.6	11.9	8.4	22.9	21.4	34.0	3.8	30.0	12.8	18.6	10.3	8.4	224.0	16.9	26.4	19.1	13.2	11.4	22.7	19.9	7.2	161.1	19.6	15.1	26.8	173.4	125.2	14.2	14.6	21.8	37.5	25.3	28.0	12.8	20.4	11.2	6.6	27.1	22.7	11.3	7.0	17.1	25.3	10.4	33.2	18.4	17.0	28.4
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 111.3;stomach 1: 60.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 68.5;Distal tubular cells: 29.4;Gastric mucus-secreting cells: 76.5;Horizontal cells: 30.3;Ionocytes: 128.1;Melanocytes: 32.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;EFO-21: 12.7;HEL: 4.8;NTERA-2: 4.9;RPTEC TERT1: 23.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.2;hippocampal formation: 18.4;pons and medulla: 15.1;thalamus: 11.9"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.2	0.5	1.3	0.9	2.7	0.1	17.9	1.7	3.4	2.6	111.3	10.9	11.6	4.7	0.3	3.7	5.0	0.3	3.1	3.7	0.3	22.3	0.0	39.2	0.1	0.7	0.9	1.1	0.6	0.6	2.4	0.0	0.1	1.8	15.0	3.0	15.6	3.5	0.1	16.8	8.6	1.1	0.2	0.1	60.4	1.9	2.2	0.1	8.6	0.9	3.9	1.4	3.5	1.8	0.0	0.0	7.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	12.7	0.0	0.0	0.3	0.4	0.0	0.0	0.1	2.6	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.3	0.1	0.0	0.1	0.7	0.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.7	1.7	3.4	3.7	0.3	0.7	0.9	0.1	0.2	2.2	1.8	0.4	0.0	0.0	0.0	0.2	5.6	4.3	2.1	9.1	0.6	68.5	17.8	3.8	0.0	2.0	14.7	0.0	0.0	0.4	1.2	29.4	0.0	19.7	1.0	0.1	2.9	2.4	0.0	0.0	0.0	0.0	3.9	76.5	1.5	0.0	0.0	0.4	0.1	0.0	30.3	0.0	0.2	128.1	0.0	1.2	13.0	7.2	0.4	32.0	0.0	0.0	14.2	0.0	0.0	0.0	0.4	2.2	2.6	0.4	1.1	0.0	21.8	0.0	0.7	0.0	0.1	0.3	3.4	1.2	14.1	7.2	0.0	0.9	0.0	2.3	1.5
SOWAHC	"ANKRD57, C2orf26, FLJ21870"	ENSG00000198142	"Sosondowah ankyrin repeat domain family member C"	Q53LP3	2	109614364-109618990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 147.6;Granulosa cells: 151.0;Squamous epithelial cells: 137.1;Suprabasal keratinocytes: 199.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 160.4;hTCEpi: 50.8;RT4: 66.2"	"Low region specificity"	"Detected in all"							HPA056131	Enhanced		Approved	Cytosol		No	No				"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA056131: AB_2683047"	"unprognostic (6.76e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (5.11e-3)"	"prognostic favorable (3.56e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.54e-2)"	6.3	3.6	2.5	3.5	3.2	0.6	9.4	3.0	2.7	8.0	7.6	11.3	5.1	5.1	3.9	33.3	4.5	8.4	2.0	2.7	4.3	14.0	29.3	7.0	2.9	4.8	6.2	13.0	3.6	5.2	1.9	4.2	4.1	7.0	8.7	5.5	8.3	7.3	1.1	19.3	7.3	6.2	4.0	3.3	5.9	6.5	4.2	4.3	7.9	2.1	7.5	23.1	12.0	4.5	19.3	3.6	10.8	5.9	5.3	8.8	35.1	41.3	24.1	7.1	7.4	17.0	6.0	0.0	16.6	6.3	13.4	18.1	2.5	27.1	7.7	160.4	18.0	0.0	8.6	24.3	4.9	0.0	4.8	4.7	50.8	15.3	10.9	5.9	1.8	0.0	0.3	0.1	5.5	6.4	0.0	1.7	7.6	17.5	16.2	0.0	2.4	0.3	10.7	66.2	13.5	5.8	14.2	2.5	11.3	10.5	5.3	0.4	2.7	5.6	21.6	3.3	3.0	5.3	5.5	0.1	6.6	0.6	13.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	3.2	3.0	2.7	2.7	4.3	4.8	6.2	4.1	4.0	4.2	4.5	18.9	16.0	9.8	2.9	1.2	147.6	43.2	32.0	93.9	15.7	30.5	22.7	3.6	20.0	14.7	12.9	10.4	4.3	0.7	61.1	3.9	15.9	37.8	28.7	21.1	10.8	15.6	2.7	0.2	7.1	28.6	15.6	13.3	76.9	0.0	151.0	6.8	53.2	8.0	0.0	1.2	32.7	10.2	7.0	15.1	13.7	11.8	6.2	19.6	0.0	3.4	7.3	2.1	1.5	2.4	14.2	34.2	15.1	0.6	21.0	21.5	25.1	5.5	20.7	13.1	12.1	20.8	20.8	13.2	137.1	199.3	10.0	2.2	5.3	36.7	80.9
SOX10	"DOM, WS2E, WS4"	ENSG00000100146	"SRY-box transcription factor 10"	P56693	22	37970686-37987422	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease variant, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 194.9;salivary gland: 114.3"	"Group enriched"	"Detected in some"	14	"Breast glandular cells: 32.3;Breast myoepithelial cells: 47.8;Melanocytes: 35.6;Oligodendrocyte precursor cells: 61.3;Oligodendrocytes: 59.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	510	"SK-MEL-30: 313.9;WM-115: 432.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003171, HPA068898"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"CAB003171: AB_2195374, HPA068898: AB_2686054"																		2.9	2.7	76.9	2.5	133.7	0.1	21.7	103.1	102.8	11.8	24.9	26.6	1.5	0.8	1.2	2.7	2.5	2.2	8.8	82.7	89.0	0.5	0.5	0.1	0.0	134.7	114.0	1.2	0.8	0.0	1.8	0.0	123.3	6.8	2.6	0.5	114.3	5.8	0.6	17.0	7.1	1.9	87.3	0.3	6.1	2.7	114.2	0.0	0.9	1.5	0.0	8.4	9.5	194.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.9	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.7	0.0	432.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	133.7	103.1	102.8	82.7	89.0	134.7	114.0	123.3	87.3	114.2	194.9	0.3	0.0	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.0	32.3	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.4	0.9	0.1	35.6	0.0	0.0	0.0	0.0	61.3	59.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.7	0.0	0.9	0.0	0.2	0.0	0.0	0.0
SOX11		ENSG00000176887	"SRY-box transcription factor 11"	P35716	2	5692384-5701385	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 5.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 6.4;Breast myoepithelial cells: 8.6;Cardiomyocytes: 13.9;Inhibitory neurons: 8.4;Oligodendrocyte precursor cells: 21.6;Skeletal myocytes: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.2;NTERA-2: 23.6;REH: 17.9;RH-30: 18.2;SCLC-21H: 29.1;SH-SY5Y: 44.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000448, HPA000536, CAB056152, CAB056153"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.35e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.04e-8)"	"unprognostic (2.79e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.45e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.47e-2)"	0.0	0.0	2.3	0.0	2.8	0.0	0.0	1.3	1.9	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	5.0	0.0	0.0	0.0	0.0	2.5	2.9	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.2	3.2	0.1	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	2.3	0.0	0.0	4.4	0.0	0.0	0.0	23.6	0.0	0.0	17.9	18.2	0.7	0.0	0.0	29.1	44.0	0.0	0.3	0.0	8.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	3.3	0.6	1.2	0.0	0.0	11.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.1	2.3	2.8	1.3	1.9	1.3	5.0	2.5	2.9	2.0	3.2	4.6	3.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.1	6.4	8.6	13.9	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	5.7	0.9	0.0	0.8	1.2	0.0	0.0	0.4	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.4	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	1.0	0.0	0.5	0.0	21.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	38.8	1.1	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.0
SOX12	SOX22	ENSG00000177732	"SRY-box transcription factor 12"	O15370	20	325552-330224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 52.3;Cone photoreceptor cells: 41.7;Horizontal cells: 32.0;Rod photoreceptor cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055052, HPA061627"			Enhanced	Nucleoplasm		No	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA055052: AB_2682685, HPA061627: AB_2684571"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-3)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.12e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.20e-2)"	4.0	8.2	10.1	2.4	9.1	3.0	3.8	12.3	11.4	9.7	6.7	10.6	1.8	9.9	5.1	4.8	8.5	2.1	6.7	9.2	7.5	10.4	4.8	3.9	2.6	10.2	8.1	11.7	6.5	3.7	6.8	2.3	9.2	8.1	1.2	8.5	4.1	6.1	1.1	4.4	5.3	3.7	7.1	6.1	5.4	8.9	8.3	4.0	9.8	1.3	1.7	7.2	6.4	10.6	7.9	27.1	26.0	17.7	12.3	9.0	7.8	10.6	9.2	9.5	9.4	5.5	8.0	17.5	8.0	12.3	19.9	9.2	18.9	3.5	5.4	8.8	13.3	11.3	10.9	55.3	15.8	15.7	2.9	12.4	10.9	8.0	3.2	15.4	12.6	11.8	26.9	9.0	6.2	19.2	5.4	38.4	42.3	4.4	35.3	27.7	6.6	14.2	13.5	1.0	31.7	36.9	7.1	30.9	41.0	10.6	29.4	21.7	14.3	36.5	36.0	1.0	9.5	25.5	28.8	18.1	6.8	15.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	10.1	9.1	12.3	11.4	9.2	7.5	10.2	8.1	9.2	7.1	8.3	10.6	3.8	0.0	3.2	15.3	2.6	3.4	2.5	2.7	15.4	52.3	8.5	6.2	11.3	5.7	0.8	7.3	41.7	1.4	1.6	2.3	15.6	1.3	0.9	12.1	16.2	8.6	9.1	5.5	6.5	0.4	0.4	5.3	0.5	6.6	0.0	22.8	8.9	8.7	2.3	32.0	9.2	4.5	2.0	1.3	4.5	2.0	10.2	1.7	5.4	6.5	0.8	9.9	1.0	10.6	10.1	0.4	0.8	12.4	0.8	3.3	1.1	5.1	1.2	39.1	0.0	3.2	7.6	1.3	6.9	3.9	1.1	0.7	2.9	18.4	3.9	0.5
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box transcription factor 15"	O60248	17	7588178-7590094	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 87.4;skin 1: 48.2"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 209.2;Basal squamous epithelial cells: 447.3;Squamous epithelial cells: 388.1;Suprabasal keratinocytes: 169.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 6.7;non-classical monocyte: 10.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 10.6"	"Group enriched"	"Detected in many"	8	"A-431: 130.6;HaCaT: 142.1;HBEC3-KT: 57.8;hTCEpi: 56.6"	"Not detected"	"Not detected"							"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	2.2	0.9	15.0	0.8	14.6	2.7	3.4	17.4	23.3	21.1	11.8	12.4	0.7	8.2	1.7	87.4	11.0	1.0	8.6	14.5	15.3	1.7	1.3	1.5	0.5	14.3	15.0	15.3	1.0	0.2	7.9	0.3	14.1	12.1	0.5	5.0	14.6	7.1	2.3	48.2	3.5	1.3	14.5	1.1	4.7	2.6	14.7	1.0	2.3	1.8	2.8	10.4	32.7	15.0	130.6	3.2	1.8	1.0	0.1	0.3	9.6	1.4	0.5	1.1	1.7	2.5	0.8	0.4	1.2	0.1	0.4	142.1	0.1	57.8	0.4	3.3	3.9	0.5	1.7	0.5	0.2	0.3	2.6	0.0	56.6	0.7	11.9	3.6	0.0	2.6	2.9	0.8	0.2	0.9	0.6	1.5	3.6	0.3	0.7	1.6	1.8	1.0	2.7	0.7	0.8	2.2	1.5	0.5	0.7	5.5	1.1	1.0	1.6	1.3	2.3	1.6	4.4	0.9	1.5	1.6	4.4	1.7	3.2	0.1	2.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	10.6	1.0	0.0	0.4	15.0	14.6	17.4	23.3	14.5	15.3	14.3	15.0	14.1	14.5	14.7	15.0	0.8	0.0	0.0	2.6	0.1	209.2	51.8	72.7	447.3	13.6	6.3	13.0	4.7	0.0	20.6	1.8	14.6	1.7	0.7	0.5	1.9	0.1	0.2	0.4	4.9	3.1	1.2	0.0	8.1	0.5	2.0	10.4	0.0	0.4	0.0	1.3	1.4	0.0	0.4	10.1	7.7	0.4	10.2	1.2	19.3	1.1	31.4	0.9	26.6	1.0	1.2	50.0	0.0	4.0	2.4	0.5	0.1	36.9	4.9	21.2	0.3	0.2	16.2	9.4	32.9	7.8	7.1	0.7	10.9	388.1	169.9	1.1	1.1	0.6	0.8	73.8
SOX18		ENSG00000203883	"SRY-box transcription factor 18"	P35713	20	64047582-64049639	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 78.4"	"Group enriched"	"Detected in many"	9	"Adipocytes: 370.9;Endothelial cells: 212.4;Hepatic stellate cells: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 20.8;NB-4: 35.8;REH: 8.5;TIME: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073703			Approved	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA073703: AB_2686628"	"unprognostic (2.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.63e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.40e-2)"	51.8	14.3	8.9	3.1	6.4	0.0	43.1	6.5	6.3	19.5	1.7	16.3	3.1	38.4	0.3	12.0	29.2	3.7	78.4	4.4	5.5	21.4	5.2	29.1	3.1	10.1	8.0	8.0	8.2	1.3	6.6	5.5	9.5	17.6	0.4	0.0	12.6	1.3	13.9	12.2	17.0	1.5	6.7	22.5	15.6	5.6	9.9	0.8	29.0	3.8	0.5	19.7	21.9	5.4	0.0	0.3	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	0.2	0.3	0.0	0.0	0.5	1.0	0.0	3.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	20.8	0.0	3.7	0.0	0.0	0.7	0.0	35.8	0.1	0.0	0.3	8.5	0.0	0.6	0.0	1.4	0.6	0.6	0.3	0.0	0.5	0.0	0.5	1.8	9.6	0.1	2.6	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.4	6.5	6.3	4.4	5.5	10.1	8.0	9.5	6.7	9.9	5.4	370.9	0.0	0.6	0.3	3.7	1.0	0.2	0.0	2.2	0.9	1.9	3.0	8.8	1.5	0.0	1.8	0.0	0.0	1.6	0.1	0.0	0.3	22.1	1.0	11.9	212.4	0.0	2.7	0.0	0.0	0.0	2.5	0.0	0.7	4.5	0.0	306.6	0.6	0.1	0.0	0.0	0.0	0.0	6.0	2.2	4.8	1.2	1.3	1.8	15.9	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	3.6	6.5	32.4	2.5	0.9	1.1	0.3	0.7	2.3	0.0	0.3
SOX3	PHP	ENSG00000134595	"SRY-box transcription factor 3"	P41225	X	140502985-140505069	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;fallopian tube: 9.2;testis: 2.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 2.9;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 2.0;Skeletal myocytes: 3.1;Spermatogonia: 1.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;HEK 293: 8.1;NTERA-2: 17.9;SuSa: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054720, HPA075003"			Enhanced	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA054720: AB_2682584, HPA075003: AB_2686727"					"unprognostic (6.04e-2)"					"unprognostic (3.75e-1)"			"unprognostic (8.62e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.27e-3)"		0.0	0.1	1.0	0.0	1.2	0.0	0.0	0.8	1.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.7	4.9	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	2.3	3.7	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.0	0.7	4.9	1.2	1.2	0.9	1.1	3.7	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	7.3	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SOX5	"L-SOX5, MGC35153"	ENSG00000134532	"SRY-box transcription factor 5"	P35711	12	23529504-24562544	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1531.5;Excitatory neurons: 615.9;Inhibitory neurons: 717.3;Oligodendrocyte precursor cells: 1437.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.5;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 17.3;Daudi: 18.3;HDLM-2: 38.3;K-562: 17.0;WM-115: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060499			Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA060499: AB_2684294"	"unprognostic (9.11e-4)"	"unprognostic (4.64e-3)"	"unprognostic (3.23e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.70e-4)"	"unprognostic (6.95e-2)"	"unprognostic (4.53e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.75e-2)"	5.8	1.1	6.3	1.7	9.6	0.4	1.5	0.4	10.3	6.9	0.0	1.3	0.7	5.0	1.2	1.2	3.6	3.0	2.4	6.4	7.6	1.8	11.1	2.7	3.7	2.9	5.8	7.7	1.1	0.4	0.4	8.8	5.6	2.1	1.2	3.7	3.2	3.1	0.6	6.3	1.1	2.7	3.1	1.3	1.1	32.3	6.8	0.6	2.0	1.7	3.1	1.3	0.6	5.0	0.2	0.2	17.3	0.0	9.6	5.1	0.0	0.2	0.0	0.2	0.5	3.1	0.1	18.3	0.8	0.0	0.0	0.2	9.9	0.0	0.3	38.3	2.4	3.9	0.1	8.4	6.6	0.1	0.2	2.7	0.0	0.9	0.0	2.2	0.0	0.6	17.0	0.8	0.3	0.0	7.1	0.1	5.5	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.8	0.8	0.0	0.0	6.7	4.3	0.3	3.6	0.0	0.3	2.1	0.0	1.7	0.4	0.0	1.1	4.0	0.1	14.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	6.3	9.6	0.4	10.3	6.4	7.6	2.9	5.8	5.6	3.1	6.8	5.0	4.5	6.4	11.0	1531.5	3.7	13.3	0.1	0.0	1.8	11.9	1.0	1.3	4.0	1.5	3.1	3.7	0.0	0.1	0.0	0.0	0.0	0.2	198.7	18.7	55.7	4.0	5.4	0.4	615.9	0.0	0.2	11.3	1.5	21.2	1.3	13.3	3.6	22.0	0.3	0.0	717.3	0.0	0.0	0.8	1.9	208.6	10.2	0.8	12.4	279.2	5.7	17.9	0.0	1437.1	24.4	0.0	0.0	6.8	1.2	0.1	0.4	0.6	13.8	2.6	19.7	2.8	24.7	97.0	1.4	0.5	12.1	0.3	0.7	0.2	0.2	0.2
SOX8		ENSG00000005513	"SRY-box transcription factor 8"	P57073	16	981770-986979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 127.4"	"Group enriched"	"Detected in some"	9	"Muller glia cells: 156.1;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 66.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 114.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041640, HPA058665"			Enhanced	Nucleoplasm		No	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA041640: AB_10964357, HPA058665: AB_2683792"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (6.05e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.47e-1)"	"unprognostic (9.09e-2)"	0.9	0.5	58.3	0.9	90.4	0.1	1.7	66.7	71.8	1.3	23.6	3.1	0.1	0.4	0.1	0.4	0.6	0.5	4.1	54.0	57.9	0.7	0.2	0.3	2.0	73.6	79.8	0.3	1.0	0.1	1.2	0.4	64.9	1.2	0.6	14.8	8.3	0.4	0.8	5.4	1.8	0.2	58.7	1.0	0.9	2.5	71.2	0.4	0.5	0.6	2.3	1.4	1.6	127.4	0.0	0.6	2.2	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.4	5.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	3.3	1.8	0.2	0.0	114.7	4.5	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.4	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	58.3	90.4	66.7	71.8	54.0	57.9	73.6	79.8	64.9	58.7	71.2	127.4	1.5	0.0	0.0	10.1	0.2	0.4	0.5	0.0	0.0	1.8	8.7	10.4	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.5	0.0	0.0	0.6	2.6	0.0	0.0	4.6	0.2	0.1	1.9	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.3	0.5	3.4	0.3	1.8	3.7	0.6	156.1	0.0	64.3	66.0	0.1	0.3	1.9	0.5	1.9	0.0	0.0	0.0	8.0	0.0	9.9	0.9	0.0	3.9	0.4	1.0	0.0	0.9	0.1	0.9	0.3
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box transcription factor 9"	P48436	17	72121020-72126416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.7;salivary gland: 80.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Basal squamous epithelial cells: 166.8;Breast glandular cells: 141.0;Cholangiocytes: 190.1;Gastric mucus-secreting cells: 144.8;Muller glia cells: 141.3;Squamous epithelial cells: 273.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 78.1;Hep G2: 97.0;OE19: 74.3;U-251 MG: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.2	54.7	4.4	50.4	0.1	28.0	42.3	58.5	7.4	46.8	17.1	19.7	2.9	0.9	13.7	7.5	13.0	15.8	50.6	49.3	12.7	3.5	3.1	1.1	73.7	72.2	0.3	38.4	0.1	10.3	0.3	48.8	24.8	17.8	15.0	80.1	10.9	2.7	23.3	15.1	1.2	56.9	0.2	40.5	30.7	51.4	0.5	20.2	1.2	4.4	1.9	6.4	49.0	31.1	19.2	38.9	78.1	3.9	1.1	0.1	4.8	4.2	8.2	4.4	27.0	40.8	0.0	2.9	1.1	43.8	31.3	0.0	18.6	7.5	0.0	2.5	0.0	4.2	97.0	0.3	0.0	0.1	0.7	1.6	9.5	9.0	47.0	0.0	0.0	0.0	0.1	11.7	0.4	0.0	0.1	1.5	74.3	29.1	0.0	31.4	0.4	35.2	2.0	1.9	1.9	4.0	4.7	0.1	21.0	16.7	0.2	0.0	15.8	42.0	8.5	66.5	0.0	0.0	0.1	11.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.4	42.3	58.5	50.6	49.3	73.7	72.2	48.8	56.9	51.4	49.0	1.1	12.8	5.6	160.0	1.9	55.4	88.2	28.9	166.8	3.0	141.0	108.2	13.6	190.1	21.1	36.8	0.0	0.3	2.8	52.1	7.9	55.3	5.1	18.4	0.9	3.2	59.7	0.0	3.1	46.7	0.0	26.0	144.8	21.7	4.5	1.9	0.0	3.4	0.2	0.0	1.5	99.0	24.4	0.0	3.4	14.5	4.4	2.3	12.4	9.4	1.0	141.3	0.0	4.5	11.1	40.8	39.1	0.4	2.8	81.1	17.7	61.0	36.4	6.8	6.6	59.9	14.5	10.2	3.1	273.5	17.8	0.1	2.8	0.1	103.8	77.2
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230165186-230225729	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 99.3"					"Low region specificity"	"Detected in all"			HPA058554			Supported	Nucleoplasm		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA058554: AB_2683754"	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	14.0	7.3	8.4	38.5	10.3	29.8	11.8	9.4	10.8	11.6	11.5	12.6	11.9	10.5	7.9	9.2	9.6	18.0	8.1	8.1	10.3	11.9	14.8	21.0	53.7	15.3	10.9	16.5	7.9	9.7	5.3	17.5	11.6	9.6	14.0	2.0	17.0	7.6	5.7	7.8	17.6	13.4	12.1	49.8	12.9	3.1	10.9	35.7	7.4	8.4	50.1	18.9	9.3	12.3	8.3	4.4	2.7	4.7	14.2	23.6	8.3	14.8	30.8	70.3	99.3	0.2	12.7	34.5	13.8	15.8	67.0	5.1	9.0	23.0	25.7	30.5	6.0	14.9	6.2	8.9	14.5	22.1	17.1	32.7	11.8	20.8	27.4	13.2	25.3	23.6	5.3	12.1	20.6	4.9	33.0	43.5	8.6	4.2	5.1	20.1	25.4	12.8	56.2	11.1	0.5	5.7	5.7	12.7	32.7	0.9	9.6	18.5	18.8	12.9	7.9	3.2	7.5	12.9	4.6	16.2	14.4	20.6	10.7	92.2	49.7	124.4	55.2	85.8	47.8	142.8	53.5	50.5	44.1	135.8	54.1	58.7	268.6	56.9	143.4	84.4	70.7	48.5	8.4	10.3	9.4	10.8	8.1	10.3	15.3	10.9	11.6	12.1	10.9	12.3	77.8	44.8	23.8	17.3	141.7	9.9	5.2	25.7	16.5	0.4	21.6	19.3	3.7	7.2	19.6	11.0	0.0	3.8	84.0	17.0	13.7	19.9	5.2	17.2	21.3	28.6	6.7	9.7	1.1	28.5	12.7	22.8	9.2	20.1	38.0	21.2	26.4	6.2	26.9	0.0	2.1	11.4	73.2	47.4	25.8	4.2	11.8	62.3	19.6	42.2	56.7	9.7	59.8	19.6	18.2	26.0	11.6	10.1	35.7	3.5	10.7	14.4	21.0	4.9	6.6	8.6	16.2	4.8	2.3	9.8	10.1	4.7	68.8	23.5	6.1	3.0
SP3	SPR-2	ENSG00000172845	"Sp3 transcription factor"	Q02447	2	173880850-173965702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004580, HPA032145, HPA032146"	Supported	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.54e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.76e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.46e-5)"	"unprognostic (2.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.69e-1)"	32.6	19.8	15.8	35.2	16.0	53.1	43.1	21.3	19.8	50.9	16.1	34.3	26.9	45.1	34.6	32.1	37.1	28.9	23.8	14.2	17.1	29.7	40.1	29.9	46.1	16.9	16.7	40.3	24.9	43.1	13.2	49.1	16.4	31.9	38.9	21.0	26.1	30.4	22.5	38.5	29.6	36.3	16.3	38.6	27.0	25.2	15.5	68.0	47.5	33.7	53.8	33.7	28.0	18.5	41.6	34.5	74.6	45.8	91.8	82.3	83.5	47.5	67.1	62.2	66.1	56.8	59.7	65.1	39.3	65.0	46.3	41.0	57.8	46.0	91.7	55.2	21.2	65.9	33.9	54.0	45.5	60.4	48.9	60.6	53.2	72.9	63.6	48.4	49.4	51.3	51.4	86.8	65.7	44.4	84.0	49.9	66.1	60.1	37.8	74.2	68.5	53.0	48.4	55.8	67.8	48.1	67.1	38.1	52.4	81.7	30.0	80.0	44.1	70.6	61.8	47.5	50.4	58.8	46.7	85.8	53.0	41.6	67.2	8.9	9.4	13.0	11.6	7.0	12.9	9.5	12.3	12.3	9.9	7.4	13.8	12.8	27.3	21.9	10.3	6.2	13.8	9.9	15.8	16.0	21.3	19.8	14.2	17.1	16.9	16.7	16.4	16.3	15.5	18.5	36.1	19.2	22.9	44.7	55.2	57.6	31.7	25.7	64.9	29.1	36.8	23.4	18.8	14.3	23.3	20.2	27.1	30.9	67.9	37.9	11.7	18.6	4.3	22.3	57.8	33.9	30.5	31.7	52.7	19.3	42.7	43.9	17.9	29.5	23.5	31.3	32.2	43.8	24.6	23.5	50.7	28.8	20.3	54.1	72.8	7.1	45.4	55.6	42.7	81.5	39.0	30.5	46.4	60.3	74.7	30.8	22.9	36.9	63.7	34.2	22.1	24.4	26.6	20.2	19.7	40.4	53.4	10.5	20.4	48.6	57.0	34.6	50.8	26.0	29.0	59.0
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.8;skin 1: 14.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 57.5;Syncytiotrophoblasts: 98.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 11.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 92.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"		Yes	No				"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.72e-4)"	0.9	0.9	0.1	0.6	0.1	0.0	3.9	0.4	0.1	1.3	0.1	1.4	1.6	0.3	3.9	5.5	1.1	0.1	0.3	0.1	0.2	1.0	0.0	3.1	0.6	0.7	0.4	0.9	0.4	6.2	0.2	22.8	1.0	1.8	0.7	0.1	0.9	10.2	0.1	14.6	4.7	0.3	0.5	0.8	0.3	0.2	0.2	1.1	1.1	0.1	1.9	2.7	3.9	0.1	6.8	0.8	0.0	0.0	0.0	0.0	92.3	0.4	0.4	1.8	0.4	20.1	1.9	0.0	0.6	0.0	1.3	2.8	0.1	3.4	0.5	0.2	0.7	0.1	1.5	0.6	0.1	0.0	0.0	0.1	1.8	0.0	1.8	0.2	0.2	0.2	4.7	0.1	0.1	1.8	0.0	0.1	0.0	8.2	1.6	0.0	0.0	0.2	0.5	11.9	2.9	0.1	0.1	11.9	0.0	16.8	4.8	0.0	6.3	0.4	2.6	0.0	0.5	0.8	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.2	0.7	0.4	1.0	0.5	0.2	0.1	1.3	0.0	0.0	1.0	0.2	0.1	2.6	4.6	4.0	0.0	6.0	6.1	0.5	0.0	0.8	1.8	0.0	57.5	0.3	5.2	0.0	0.7	0.1	0.4	0.1	2.7	1.8	0.0	0.2	0.8	3.9	0.7	0.0	0.7	0.0	0.2	0.7	0.1	4.1	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	3.2	0.0	0.1	3.8	13.4	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.6	1.1	0.9	98.8	0.3	0.1	3.3	6.3
SPACA9	"C9orf9, Mast"	ENSG00000165698	"Sperm acrosome associated 9"	Q96E40	9	132878027-132890201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 74.0;testis: 131.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Distal tubular cells: 33.2;Endometrial ciliated cells: 99.8;Proximal tubular cells: 23.9;Respiratory ciliated cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"JURKAT: 48.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA022243, HPA051600"	Enhanced		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA022243: AB_1845844, HPA051600: AB_2681546"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (8.31e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	5.0	7.6	17.4	1.3	17.7	1.5	5.2	17.4	19.5	9.7	18.2	11.5	1.3	8.3	74.0	9.5	39.2	5.4	10.4	16.8	19.0	12.2	2.3	7.4	2.2	20.3	22.2	11.3	5.2	3.8	11.5	3.2	19.1	7.0	1.9	8.2	9.8	7.1	1.7	11.9	3.7	4.9	21.3	3.6	6.5	131.2	18.5	7.9	15.6	1.8	3.2	6.1	8.1	19.0	3.0	3.2	4.8	3.9	6.6	8.4	5.7	1.9	3.5	2.6	2.8	0.8	9.1	0.7	4.3	8.7	5.4	4.2	2.0	5.4	2.3	3.5	3.9	0.8	2.3	1.0	9.6	2.2	0.3	9.6	11.4	6.4	6.9	10.6	3.0	48.5	0.8	2.4	7.1	6.4	7.6	8.6	1.0	5.6	3.0	3.6	1.0	2.1	10.5	1.1	1.2	4.7	8.0	1.3	6.3	3.6	10.3	0.7	2.9	5.5	3.7	5.3	0.8	1.0	1.7	2.6	10.2	0.8	2.7	4.0	1.1	1.9	1.1	1.1	1.3	3.0	1.2	0.6	1.6	2.6	1.3	1.3	1.5	4.4	1.9	0.5	2.0	0.9	17.4	17.7	17.4	19.5	16.8	19.0	20.3	22.2	19.1	21.3	18.5	19.0	3.6	3.2	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.3	17.9	0.0	0.0	5.0	23.9	0.0	18.2	0.8	0.0	33.2	8.6	0.0	99.8	7.1	1.9	0.0	0.0	0.0	7.1	12.4	3.9	0.0	8.1	0.0	6.7	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	23.9	63.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.3	0.8	7.7	0.0	0.0
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599025	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;kidney: 37.8;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 11.7;T-reg: 4.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.7;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA022008, HPA022479, HPA024418"	Approved		Supported	"Nuclear bodies,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Mitotic spindle"	Cytosol	"HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: "	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.2	3.3	7.8	7.8	7.6	37.9	2.4	5.8	9.1	2.6	3.4	8.3	7.9	1.9	2.4	8.3	1.7	1.8	1.4	7.6	7.7	37.8	14.8	3.4	14.5	6.7	6.8	2.7	1.5	1.1	4.3	5.7	6.7	2.2	10.7	10.8	2.4	0.8	1.0	5.5	9.1	3.4	5.0	7.4	3.6	74.0	7.7	22.4	8.7	0.7	17.3	2.6	3.6	7.5	84.7	87.7	103.3	78.4	5.2	8.6	42.4	65.9	42.4	98.1	78.3	69.2	25.5	59.8	34.2	46.8	91.7	70.2	114.5	42.7	103.8	108.6	72.9	62.9	87.9	80.2	0.6	83.1	76.1	2.9	3.8	78.6	40.4	14.5	52.1	90.6	69.7	101.5	80.7	52.6	109.4	92.9	54.2	68.3	44.5	72.1	144.4	70.9	29.0	43.0	78.6	45.8	96.4	114.9	31.6	84.9	82.2	70.6	25.7	56.4	91.3	46.6	114.6	46.7	72.9	87.3	37.8	60.6	91.8	11.7	0.0	0.0	0.4	0.4	0.7	0.6	1.2	0.9	0.1	1.4	1.1	0.9	0.2	0.8	0.3	0.3	4.9	0.9	7.8	7.6	5.8	9.1	7.6	7.7	6.7	6.8	6.7	5.0	7.7	7.5	0.5	3.2	1.7	0.7	3.3	2.0	0.9	1.3	1.2	5.0	1.1	1.0	0.7	0.0	1.9	0.0	0.0	9.0	1.3	4.7	1.9	0.5	126.0	6.0	1.1	1.5	13.1	37.2	5.2	0.4	12.2	2.6	5.1	1.8	1.3	12.6	3.3	6.3	6.5	3.3	6.0	4.6	4.1	2.7	4.0	25.2	0.9	6.1	0.0	1.9	0.9	0.7	0.0	2.0	1.7	0.4	4.7	0.0	13.1	0.8	8.1	12.5	7.7	3.9	6.6	2.0	2.2	72.6	21.0	5.2	1.0	3.8	2.8	0.9	5.1	1.1
SPANXN4	"CT11.9, SPANX-N4"	ENSG00000189326	"SPANX family member N4"	Q5MJ08	X	143025918-143034702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 25.9"	"Group enriched"	"Detected in some"	165	"Early spermatids: 97.7;Late spermatids: 298.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045730, HPA059094"	Uncertain		Approved	"Nuclear membrane,Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"	"Nuclear membrane"	"HPA045730: AB_10961036, HPA059094: "																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	298.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA12		ENSG00000186451	"Spermatogenesis associated 12"	Q7Z6I5	3	57060664-57075432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 20.5"	"Group enriched"	"Detected in some"	145	"Early spermatids: 464.2;Late spermatids: 1195.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;RH-30: 1.1"									"HPA043323, HPA075578"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA043323: AB_10796792, HPA075578: "	"unprognostic (2.31e-1)"	"unprognostic (2.18e-4)"	"unprognostic (3.47e-4)"	"unprognostic (2.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.71e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-3)"	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.2	0.2	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.2	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	20.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	1.1	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.7	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.2	0.6	2.0	0.8	0.7	0.5	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	464.2	1.0	0.1	0.6	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	1.3	0.0	1195.5	5.0	0.5	0.0	1.0	0.0	0.0	0.0	1.0	0.7	1.4	0.1	5.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	2.8	0.3	0.0	0.0	0.3	0.0	0.2	0.5
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051304-52097299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 68.3;testis: 28.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2341.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.5;BEWO: 24.4;BJ hTERT+: 15.9;HSkMC: 29.3;hTCEpi: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	5.0	2.4	0.7	2.2	0.0	6.3	1.3	1.0	10.7	15.6	4.1	2.1	4.2	2.0	4.6	68.3	6.7	1.8	2.5	2.7	5.3	5.4	8.0	0.3	6.8	8.3	1.8	2.0	4.5	4.9	1.9	5.5	4.2	5.6	0.1	10.1	5.6	0.8	6.6	2.2	3.1	6.0	0.6	4.9	28.8	2.6	3.2	1.2	1.3	0.9	2.8	3.4	3.8	0.0	3.8	1.8	0.0	12.7	31.5	24.4	9.3	15.9	0.6	0.7	0.0	1.5	0.0	0.0	12.3	0.2	0.3	0.1	7.1	0.3	0.0	1.1	0.0	0.0	8.0	11.2	0.0	0.0	29.3	28.7	1.0	4.5	5.1	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	2.0	1.0	0.0	0.0	9.7	0.0	0.2	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	1.3	1.0	2.5	2.7	6.8	8.3	5.5	6.0	2.6	3.8	0.3	9.6	3.0	0.3	0.0	5.2	8.5	9.4	8.6	0.0	6.0	6.7	2.2	8.6	15.1	0.0	0.0	1.7	0.3	1.8	1.9	1.2	561.1	124.6	1.8	1.2	1.8	0.0	1.7	2.6	1.8	4.3	11.2	4.7	2.5	1.9	1.4	3.4	0.3	0.0	0.5	1.6	6.1	0.6	1.6	2341.5	10.8	1.1	0.0	2.8	0.1	0.0	0.0	0.5	0.1	2.0	2.7	10.9	0.0	5.1	1.9	7.4	141.4	0.0	0.0	1.8	3.9	13.9	7.1	7.1	7.5	0.8	0.2	2.5	4.3	6.8
SPATA2	"KIAA0757, PD1, PPP1R145, tamo"	ENSG00000158480	"Spermatogenesis associated 2"	Q9UM82	20	49903391-49915529	"Predicted intracellular proteins"	Necrosis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.2;Late spermatids: 62.5;Spermatocytes: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048581, HPA052224"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA048581: AB_2680449, HPA052224: AB_2681769"	"unprognostic (4.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-3)"	"unprognostic (8.77e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (8.33e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.57e-2)"	"unprognostic (4.38e-1)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (2.52e-1)"	3.9	5.8	19.9	3.7	21.6	12.2	3.7	17.5	20.9	3.9	8.1	7.8	7.8	5.3	3.6	5.6	4.7	3.4	6.9	21.0	16.7	5.0	5.8	4.0	3.6	17.2	19.0	4.5	8.0	5.6	7.9	3.5	16.7	5.8	6.3	6.5	5.9	3.9	13.1	5.0	7.5	3.1	17.0	11.4	5.7	14.3	21.1	3.8	8.0	7.8	3.6	4.1	3.7	21.5	7.8	9.4	6.3	5.7	7.0	5.0	10.3	4.9	7.2	16.7	7.0	29.7	6.1	5.9	10.1	4.9	8.6	14.1	4.7	8.1	8.8	8.3	4.5	3.1	5.6	19.5	6.6	8.5	12.2	5.0	9.6	8.6	5.4	5.5	3.6	8.2	10.8	6.6	4.0	16.5	8.7	21.5	9.5	10.5	11.3	6.5	6.8	6.2	5.4	6.1	6.0	6.4	9.8	29.6	7.8	4.9	7.2	7.3	5.1	11.9	9.8	9.9	7.0	16.2	13.4	6.3	9.3	4.4	5.4	0.1	1.5	1.4	1.4	1.1	1.3	1.3	1.3	1.7	1.3	2.1	1.6	1.9	2.5	1.5	0.5	0.6	1.5	1.0	19.9	21.6	17.5	20.9	21.0	16.7	17.2	19.0	16.7	17.0	21.1	21.5	5.4	9.6	2.2	2.9	7.8	7.4	6.6	4.3	12.5	7.4	11.9	8.6	4.9	10.0	2.8	0.0	8.4	11.0	8.3	34.7	3.9	6.0	45.2	11.4	4.7	6.3	26.4	1.7	6.8	8.0	13.4	5.4	9.7	9.0	4.5	5.4	10.4	7.1	4.8	6.7	5.0	22.2	2.0	4.4	5.4	62.5	5.0	3.6	5.4	1.9	7.0	5.4	4.1	2.0	8.5	8.3	16.1	5.7	6.4	7.4	20.7	4.8	6.7	7.6	6.6	5.8	6.6	41.3	16.9	7.8	7.2	30.1	6.8	10.3	18.4	8.5
SPATA21	"spergen-2, spergen2"	ENSG00000187144	"Spermatogenesis associated 21"	Q7Z572	1	16387117-16437424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"testis: 7.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 40.4;Late spermatids: 44.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.7"	"Cell line enriched"	"Detected in single"	7	"Hep G2: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA032080			Approved	Vesicles,Cytosol		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Vesicles, Cytosol"		"HPA032080: "	"unprognostic (3.09e-1)"	"unprognostic (8.26e-2)"	"unprognostic (5.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.74e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.71e-2)"	0.0	0.1	0.2	0.0	0.2	0.6	0.0	1.8	0.5	0.0	0.5	0.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.1	7.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	5.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.0	1.7	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.3	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.1	0.2	0.2	1.8	0.5	0.3	0.1	0.2	0.0	0.1	0.0	0.1	0.3	0.1	0.0	1.1	1.0	0.4	0.3	0.3	0.0	0.6	1.5	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.0	40.4	0.3	0.9	0.3	0.0	0.0	1.6	0.2	0.3	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.1	5.0	1.4	0.0	0.0	0.6	0.4	44.6	0.3	0.3	0.0	0.0	0.1	0.7	0.0	1.0	1.3	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	1.2	0.0	0.9	0.3	1.2	0.4	0.4	0.4	0.3	0.3	0.1	0.3	0.2
SPATS2	"FLJ13117, SCR59, SPATA10"	ENSG00000123352	"Spermatogenesis associated serine rich 2"	Q86XZ4	12	49366584-49527425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 144.8;Spermatogonia: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 6.0;dendritic cells: 8.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038642, HPA038643, HPA076823"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA038642: AB_2676128, HPA038643: AB_10672523, HPA076823: "	"unprognostic (2.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (9.57e-8)"	"unprognostic (4.55e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.81e-1)"	7.7	7.8	9.1	10.3	11.0	6.5	9.4	15.3	12.8	12.8	10.9	11.0	11.6	11.1	7.9	6.8	6.9	11.1	7.1	11.5	6.2	9.6	4.8	8.0	15.7	10.7	7.8	8.0	12.2	21.5	13.8	8.9	11.1	9.9	11.5	10.1	18.4	6.1	11.1	16.3	10.3	11.3	4.4	10.8	13.1	26.1	8.1	13.2	12.9	6.4	18.1	10.3	13.1	10.4	17.9	39.7	33.2	38.7	19.1	29.3	10.7	20.8	29.8	34.2	29.6	36.0	39.0	44.4	47.5	18.4	22.5	20.8	28.9	39.1	43.8	33.9	17.2	40.4	28.2	29.1	34.7	11.1	23.1	25.6	19.0	53.8	50.9	111.8	82.0	19.8	21.7	38.9	35.2	32.3	22.7	16.5	34.2	29.0	40.1	32.7	56.5	53.4	31.9	22.5	37.2	33.4	45.4	28.6	49.0	20.4	49.2	12.0	75.7	15.1	36.5	13.5	13.2	52.4	65.7	37.5	19.7	18.6	22.0	1.6	1.3	0.3	1.7	0.4	1.7	6.0	1.4	1.0	4.1	3.2	1.2	1.0	0.9	1.3	0.3	8.0	1.1	1.1	9.1	11.0	15.3	12.8	11.5	6.2	10.7	7.8	11.1	4.4	8.1	10.4	35.0	19.2	19.8	34.6	33.8	58.0	48.8	52.0	25.0	44.5	29.9	29.8	9.9	35.8	19.6	36.8	22.9	9.7	19.2	9.6	5.9	26.0	77.4	28.3	63.1	44.6	36.6	22.7	114.0	27.9	12.0	34.8	23.0	45.1	10.8	37.1	29.3	5.6	8.0	42.1	67.6	21.6	20.3	9.2	39.8	46.3	31.7	15.3	19.6	27.2	15.0	22.3	16.5	59.3	30.6	46.4	11.7	33.4	144.8	36.4	13.3	12.4	10.1	5.9	52.6	20.5	27.7	137.3	138.1	17.0	60.4	5.3	16.2	31.5	30.2	29.4
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24 component of NDC80 kinetochore complex"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.0;lymphoid tissue: 14.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	1.9	1.7	1.3	4.8	1.5	26.0	1.2	3.9	2.1	2.1	1.7	4.7	4.5	2.7	0.8	5.0	1.3	2.3	2.7	1.6	1.5	0.8	1.6	1.6	6.3	1.1	0.8	1.3	1.1	0.4	0.4	3.2	1.3	1.6	4.3	1.2	1.3	2.0	4.0	3.9	4.1	8.1	0.5	3.1	2.9	4.3	1.4	14.7	0.9	1.1	6.5	2.5	2.0	2.4	73.6	26.9	36.9	30.1	5.0	9.7	16.6	42.3	15.7	38.6	43.6	28.4	24.6	58.2	46.0	18.5	22.8	38.8	29.0	30.3	28.7	30.9	24.9	78.5	68.9	43.2	1.1	55.5	33.7	1.9	1.1	27.8	12.8	10.0	34.7	62.3	42.8	118.3	27.6	48.7	76.4	32.9	25.5	19.8	43.9	59.8	56.7	18.6	11.2	23.8	38.4	27.2	37.0	22.4	9.6	17.5	22.0	19.8	33.2	36.8	38.3	49.6	51.2	70.5	39.8	55.6	26.9	53.9	30.5	1.9	0.4	0.4	0.5	0.5	0.4	0.8	0.9	1.5	0.2	0.7	0.9	0.6	2.2	2.0	0.5	0.5	1.7	0.3	1.3	1.5	3.9	2.1	1.6	1.5	1.1	0.8	1.3	0.5	1.4	2.4	0.2	0.0	0.5	0.3	1.5	1.1	1.2	1.3	0.0	0.0	1.0	0.4	9.0	1.5	0.8	5.5	6.2	10.0	0.9	2.8	0.0	0.2	0.3	1.0	2.2	2.2	2.4	35.0	0.3	0.0	15.5	3.5	3.6	1.8	5.7	6.5	4.6	0.7	14.0	0.0	0.3	2.6	0.0	3.0	2.5	3.0	0.6	1.0	0.0	1.0	0.0	2.1	2.1	0.5	0.3	0.3	0.0	0.4	6.3	0.3	0.7	0.6	0.2	0.6	0.0	1.3	2.4	6.9	10.8	2.1	0.3	2.1	2.2	0.5	6.6	1.2
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378547	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 335.1;lung: 101.0;lymphoid tissue: 172.7"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 179.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 179.7"	"Cell line enhanced"	"Detected in some"		"HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	36.5	19.7	12.0	107.3	13.1	335.1	17.7	14.3	19.4	7.9	15.8	15.6	21.5	7.3	2.1	9.1	19.1	21.3	13.5	11.7	16.4	10.6	15.6	101.0	65.0	31.2	20.9	5.2	7.8	3.1	7.6	28.0	24.7	10.3	10.2	1.0	14.6	6.1	5.0	13.8	29.3	21.9	19.8	172.7	17.0	3.7	26.2	15.7	8.8	8.3	32.0	29.9	7.6	30.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	72.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	0.0	159.7	282.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.7	0.0	0.0	0.2	267.8	0.2	0.0	0.0	48.7	0.2	47.5	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	206.7	0.3	0.0	0.5	0.5	0.1	0.1	0.3	85.3	0.3	117.5	0.1	14.1	19.2	179.7	0.0	27.4	0.0	3.9	0.0	0.0	16.4	2.4	0.0	0.0	83.8	0.0	34.7	0.9	0.0	7.3	12.0	13.1	14.3	19.4	11.7	16.4	31.2	20.9	24.7	19.8	26.2	30.3	2.1	3.2	1.1	10.4	72.6	10.5	0.5	0.0	1.2	1.3	2.1	5.0	2.9	4.3	0.6	5.5	0.0	2.3	6.3	0.5	19.6	0.1	7.5	0.1	0.3	5.5	4.2	39.7	3.1	0.4	3.1	2.6	1.1	0.3	33.7	0.2	7.9	3.2	432.9	0.0	3.3	0.3	0.0	411.9	537.6	27.5	1.8	453.3	10.6	36.5	357.5	7.0	8.2	3.5	1.5	0.0	0.1	0.0	21.8	0.4	0.2	2.3	0.7	1.7	13.1	1.5	1.4	5.1	9.3	0.8	9.9	4.2	4.8	1.1	0.4	0.5
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor Kazal type 5"	Q9NQ38	5	148025683-148137382	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 338.5;esophagus: 1015.0;skin 1: 318.2;vagina: 582.6"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 1622.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.7;HeLa: 22.7;Karpas-707: 19.3;SuSa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	NA	NA		43000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	1.1	0.3	0.0	0.5	0.1	0.0	17.5	0.0	0.2	338.5	0.0	4.8	0.3	0.6	0.3	1015.0	0.4	1.8	1.7	0.1	0.0	0.8	0.4	2.0	0.1	0.1	0.1	0.3	0.8	1.0	2.0	2.4	0.2	1.3	10.6	0.0	145.0	0.5	1.8	318.2	0.6	0.4	0.0	0.3	5.0	1.6	0.1	9.1	2.2	1.1	292.9	0.7	582.6	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	1.8	0.0	0.0	14.7	0.0	1.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.9	19.3	0.0	2.1	0.0	0.0	2.6	2.0	0.3	0.0	0.0	0.0	0.0	5.7	2.8	0.0	0.6	0.0	0.0	6.6	4.6	0.0	0.0	0.0	0.1	0.0	0.0	5.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	5.7	9.6	45.4	0.3	0.2	53.7	1.5	331.1	102.4	0.0	4.2	3.4	1.2	34.3	115.6	0.0	0.0	1.9	0.0	177.9	0.0	0.2	11.0	2.5	0.7	12.9	4.2	0.0	0.7	1.3	2.1	2.6	17.9	4.8	1.3	0.0	7.9	0.2	0.1	0.0	0.8	33.8	16.2	0.8	2.1	3.8	0.6	0.7	3.6	2.8	0.0	0.0	0.0	2.0	1.2	7.6	60.3	0.0	3.7	0.7	0.0	0.0	9.4	0.0	0.0	0.2	2.4	1.3	4.6	1622.6	64.4	1.5	1.1	1.0	97.9	2.7
SPINK9		ENSG00000204909	"Serine peptidase inhibitor Kazal type 9"	Q5DT21	5	148321203-148339852	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 16.0;Alveolar cells type 2: 27.9;Club cells: 14.9;granulocytes: 10.1;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.4;U-266/84: 26.9"					"Low region specificity"	"Detected in single"			HPA038288	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		24000	"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Vesicles"		"HPA038288: AB_10795400"	"unprognostic (1.84e-1)"	"unprognostic (4.87e-3)"			"unprognostic (2.88e-1)"	"unprognostic (9.02e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.90e-1)"	1.5	3.2	17.1	3.0	13.7	6.5	0.5	19.2	26.6	0.6	5.0	2.0	2.2	2.6	1.9	2.2	1.0	1.4	2.0	14.6	10.6	1.8	1.6	1.1	2.6	10.0	6.1	1.8	1.1	0.5	0.1	3.2	10.8	2.5	1.7	10.3	1.5	0.5	3.8	3.4	2.4	0.5	2.6	1.9	2.4	4.2	11.5	3.2	1.5	0.1	1.6	0.9	0.0	28.0	15.4	2.6	2.9	3.4	0.7	1.2	2.8	3.5	0.2	0.3	0.5	5.3	10.8	3.4	24.4	0.1	2.0	3.5	0.9	0.7	1.0	6.1	1.4	7.7	8.3	2.7	0.3	2.9	2.6	0.2	0.7	0.5	0.1	2.0	0.0	2.5	4.9	18.3	0.4	9.6	2.5	4.7	13.7	5.5	5.0	3.9	3.4	4.0	1.0	10.0	6.3	7.9	3.0	8.6	2.8	8.6	14.0	3.0	5.9	4.4	14.1	3.9	4.5	11.1	26.9	4.0	2.6	2.1	6.2	12.4	1.8	1.0	1.1	1.0	1.4	0.8	1.3	1.4	0.4	1.9	1.8	1.8	6.6	3.9	2.2	1.9	0.9	0.1	17.1	13.7	19.2	26.6	14.6	10.6	10.0	6.1	10.8	2.6	11.5	28.0	0.1	16.0	27.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.0	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	1.9	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.1	10.1	0.1	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	2.2	0.4	0.0	0.1	0.0	0.3	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.7	0.0	0.0	0.2
SPINT2	"HAI-2, Kop"	ENSG00000167642	"Serine peptidase inhibitor, Kunitz type 2"	O43291	19	38244035-38292615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1371.3;Syncytiotrophoblasts: 1413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 852.5;CAPAN-2: 1219.1;OE19: 1500.4;RPTEC TERT1: 896.7;SK-BR-3: 789.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011101, CAB018969"	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"		No	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Intermediate filaments, Cytosol"		"CAB018969: , HPA011101: AB_1079039"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.68e-2)"	10.5	44.6	56.9	65.3	57.3	81.1	178.5	47.2	66.3	145.6	80.0	297.0	247.4	44.6	269.6	351.9	189.7	105.1	13.6	58.9	92.9	216.1	14.3	138.3	37.4	52.0	54.8	83.3	234.2	252.9	435.9	156.4	56.2	181.8	251.7	23.6	503.9	111.3	1.8	257.0	267.0	19.0	47.6	50.2	219.4	215.7	70.3	82.6	321.3	0.9	101.3	140.1	157.6	51.0	852.5	603.0	3.0	3.4	0.4	0.0	387.4	16.2	1.7	1.2	2.6	426.8	1219.1	6.7	65.8	4.6	1.2	274.6	42.7	587.0	1.4	7.9	51.7	159.4	15.3	0.9	0.9	1.5	0.8	0.1	662.5	0.7	278.6	71.5	2.0	144.2	4.0	0.4	1.0	652.8	25.6	2.8	60.4	1500.4	172.1	87.9	0.6	386.2	896.7	707.4	222.2	3.4	246.5	789.2	2.1	231.0	353.7	104.5	0.7	1.2	4.7	3.4	3.2	56.1	76.4	47.6	1.0	11.2	1.0	515.9	127.4	531.9	3.8	91.1	7.9	143.2	44.2	21.5	297.7	160.4	86.1	80.4	56.4	19.0	64.4	523.5	19.1	142.8	56.9	57.3	47.2	66.3	58.9	92.9	52.0	54.8	56.2	47.6	70.3	51.0	8.0	368.6	233.9	10.4	90.9	376.9	563.9	954.0	278.9	14.3	487.2	518.2	2.8	316.0	655.6	559.1	6.2	1371.3	79.5	1028.3	101.8	866.9	61.8	401.4	47.3	24.3	360.5	83.9	20.7	659.8	502.0	34.6	234.5	490.4	115.5	371.8	32.5	2.0	230.3	3.3	39.8	672.8	734.5	55.5	139.0	55.6	19.0	133.6	88.9	24.4	364.3	129.6	1.0	4.5	9.0	910.4	889.4	17.0	61.3	684.9	918.6	208.8	495.1	17.2	52.6	1.2	76.7	545.2	264.1	507.7	428.3	1413.2	42.6	3.4	582.2	989.6
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 71.8;lung: 28.3;lymphoid tissue: 51.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 131.6;Erythroid cells: 125.9;Macrophages: 65.8;monocytes: 66.4;NK-cells: 352.2;Plasma cells: 60.3;T-cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 218.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 278.8;HL-60: 281.5;HMC-1: 158.3;MOLT-4: 122.2;REH: 98.4;THP-1: 164.1;U-937: 205.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"		NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB002666: , HPA055244: AB_2682756"	"prognostic favorable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	4.0	0.6	0.8	14.4	1.0	71.8	1.8	1.1	0.9	1.4	0.2	3.9	5.5	1.6	1.1	3.0	2.0	4.3	2.8	0.9	1.4	0.8	2.6	28.3	26.3	3.5	1.3	0.6	1.0	0.6	0.2	0.9	2.5	1.3	5.3	0.3	2.3	1.1	0.8	2.8	6.3	2.3	1.8	19.0	5.0	0.4	2.5	51.1	0.8	0.3	23.0	4.2	0.5	4.1	0.2	0.2	0.1	0.3	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.9	0.1	0.6	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	278.8	0.2	2.0	0.0	281.5	158.3	0.0	0.0	0.1	0.0	0.1	0.0	68.0	96.1	76.9	0.5	0.2	122.2	70.1	0.1	0.0	0.0	98.4	1.1	2.2	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.3	0.1	164.1	0.4	0.0	0.2	0.2	0.2	0.3	5.8	40.7	0.3	205.4	0.3	13.6	23.2	14.6	96.3	96.3	51.4	3.7	38.5	65.5	34.0	1.1	26.3	47.6	3.6	69.4	218.0	27.2	34.7	52.1	0.8	1.0	1.1	0.9	0.9	1.4	3.5	1.3	2.5	1.8	2.5	4.1	1.2	9.6	16.9	0.0	10.8	2.2	0.9	0.0	0.0	0.6	1.0	0.8	5.3	1.5	2.5	1.8	0.0	0.2	131.6	0.1	0.0	0.1	0.1	0.5	0.6	3.0	0.0	125.9	0.0	0.0	0.4	3.0	5.1	0.7	43.7	0.8	4.6	1.5	27.0	1.7	0.0	0.3	0.0	28.8	30.3	0.0	0.0	65.8	1.8	1.9	66.4	0.5	352.2	1.5	0.0	0.0	0.1	0.0	60.3	0.5	0.1	0.6	1.5	1.9	0.0	0.8	1.0	0.2	0.6	0.1	2.0	0.3	94.8	0.1	0.2	0.6
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962723-14268133	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 101.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9"	"Cancer enriched"	"Detected in all"	5	"ovarian cancer: 199.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 3.3"	"Lineage enriched"	"Detected in single"	33	"T-cells: 3.3"	"Group enriched"	"Detected in some"	36	"EFO-21: 213.7;RPTEC TERT1: 604.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	28000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	54.2	16.9	25.8	18.6	33.7	0.1	19.5	26.3	22.3	43.8	7.8	31.8	31.6	36.5	15.2	17.3	63.1	101.4	30.6	28.2	28.3	12.2	2.0	49.2	1.6	25.6	33.6	23.9	4.6	0.8	10.0	41.3	26.4	16.9	46.6	63.8	7.0	8.8	0.8	8.8	28.4	46.9	14.9	8.3	28.8	2.5	34.0	1.7	5.2	1.6	1.2	51.5	12.5	21.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	9.8	0.2	0.2	213.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.0	0.1	1.7	0.0	0.1	604.1	0.1	0.1	0.2	0.0	0.0	0.0	4.1	0.0	0.1	2.6	0.2	0.7	0.5	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.8	33.7	26.3	22.3	28.2	28.3	25.6	33.6	26.4	14.9	34.0	21.8	0.2	0.0	2.3	399.9	13.5	0.0	17.3	0.0	1.2	13.5	2.0	5.5	1.9	5.7	0.0	0.0	2.1	3.4	4.8	38.9	3.9	4.3	1.5	36.1	78.9	2.5	16.7	0.0	17.0	2.0	4.2	41.2	0.5	61.5	2.5	1.8	2.5	0.2	1.9	1.7	16.8	24.0	0.0	0.3	0.0	1.3	4.4	1.0	0.0	11.2	0.5	141.9	20.6	62.4	1.6	6.8	20.6	30.1	0.9	9.0	18.4	2.1	0.7	26.8	6.6	5.8	7.0	0.4	0.8	0.6	0.0	4.9	7.8	1.1	40.9	9.4
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 187.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 427.0;Endometrial stromal cells: 256.6;Extravillous trophoblasts: 355.8;Fibroblasts: 257.7;NK-cells: 1096.8"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 255.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 255.9"	"Group enriched"	"Detected in many"	5	"HHSteC: 303.8;HSkMC: 546.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		2600000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	66.2	40.4	4.0	18.8	7.7	19.5	50.6	15.6	3.9	161.4	3.5	51.5	18.5	187.1	4.4	40.6	49.7	32.2	35.5	3.5	0.8	37.1	79.1	63.0	3.9	2.9	1.7	34.4	18.7	0.9	15.1	19.2	3.5	111.8	7.2	0.7	28.8	8.4	19.1	38.3	63.5	42.7	0.2	26.9	43.8	4.7	1.8	1.8	16.3	6.6	1.0	68.4	94.0	1.5	0.4	0.6	0.0	0.0	10.2	79.0	3.0	6.2	5.0	0.8	1.0	0.0	0.1	1.8	9.7	26.9	0.9	45.0	0.0	0.2	0.0	0.3	0.1	0.2	3.0	12.7	303.8	0.2	1.5	546.6	0.0	0.6	0.0	0.0	0.0	4.1	0.3	9.2	0.0	0.3	5.3	12.2	3.5	9.7	0.7	1.0	3.3	7.9	0.0	0.0	1.7	1.1	1.1	0.0	2.9	1.7	0.4	1.5	0.1	0.2	0.9	20.5	0.0	1.3	2.7	0.6	0.1	6.5	0.0	3.7	0.9	1.0	255.9	1.1	5.5	0.7	33.1	105.8	0.4	1.0	14.4	96.8	9.8	50.4	2.2	42.9	0.1	123.2	4.0	7.7	15.6	3.9	3.5	0.8	2.9	1.7	3.5	0.2	1.8	1.5	9.8	0.0	5.6	1.3	6.6	36.8	2.0	82.5	2.2	3.7	5.1	3.8	4.0	24.3	43.0	1.8	0.0	3.4	427.0	9.7	1.9	3.8	0.2	12.7	256.6	5.7	13.8	4.0	8.4	1.3	355.8	257.7	10.7	6.6	6.3	0.2	15.4	40.4	12.8	0.0	0.6	9.7	73.2	5.8	15.4	0.5	29.8	9.5	26.6	6.5	9.2	0.9	1096.8	0.5	0.7	1.5	6.7	9.4	64.0	15.8	16.3	28.3	32.6	0.4	6.6	22.5	89.9	0.2	0.5	21.3	21.5	38.9	100.8	8.1	7.9	13.2
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970648-152972574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 145.4"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 54.2"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055963	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA055963: AB_2682988"		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	145.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.9	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRY4		ENSG00000187678	"Sprouty RTK signaling antagonist 4"	Q9C004	5	142310427-142326455	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 39.5;Alveolar cells type 2: 49.0;Endothelial cells: 32.8;Hepatic stellate cells: 37.1;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.2;WM-115: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008086, HPA055471, HPA072661"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"CAB008086: AB_2195454, HPA055471: AB_2682825, HPA072661: AB_2732207"	"unprognostic (9.54e-3)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (6.29e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.59e-2)"	"unprognostic (8.21e-2)"	30.6	18.9	8.4	4.8	8.4	0.0	14.3	6.6	9.9	4.9	13.1	9.3	6.4	6.6	1.5	3.2	7.4	8.1	19.7	8.7	9.4	22.1	12.4	26.8	2.7	9.5	8.2	2.6	4.6	7.0	20.1	13.8	8.5	9.1	5.2	4.3	4.4	4.7	5.1	3.9	7.8	6.2	6.4	8.7	8.7	1.8	8.4	2.0	19.5	6.5	1.4	8.1	4.0	6.3	3.0	5.0	48.4	100.2	29.0	20.7	12.7	35.9	12.0	5.7	6.0	5.2	5.1	0.0	25.0	9.2	6.1	2.4	0.0	10.6	7.2	0.1	0.0	0.2	0.0	22.9	9.5	0.0	0.2	16.7	0.2	15.8	8.6	9.3	5.5	0.1	11.7	0.1	21.9	4.3	0.0	14.0	21.5	16.8	31.3	1.1	6.8	1.3	17.7	32.2	0.6	14.1	0.7	4.7	42.5	14.1	0.4	2.1	8.3	12.6	0.2	2.5	32.4	0.1	1.7	0.2	19.4	0.1	139.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	8.4	6.6	9.9	8.7	9.4	9.5	8.2	8.5	6.4	8.4	6.3	39.5	6.4	49.0	6.8	0.2	1.7	3.8	1.7	17.1	9.1	7.6	10.2	3.2	1.5	1.1	3.7	0.0	1.0	0.9	7.3	0.0	2.0	0.8	10.1	4.6	32.8	13.8	0.0	11.2	0.4	2.1	12.4	6.1	17.1	3.8	0.5	37.1	3.2	0.3	0.0	17.1	7.3	0.0	2.6	1.2	1.7	0.3	0.5	7.2	22.5	0.0	1.6	0.0	96.5	0.8	5.1	2.5	0.4	0.1	4.3	5.6	1.2	0.6	0.6	19.7	17.1	24.3	0.1	1.0	3.5	0.3	3.4	1.4	1.3	7.6	1.8
SPRYD3	FLJ14800	ENSG00000167778	"SPRY domain containing 3"	Q8NCJ5	12	53064316-53079404	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039426, HPA039685"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	"Vesicles, Plasma membrane, Actin filaments"	"HPA039426: AB_10673358, HPA039685: AB_2676623"	"unprognostic (7.73e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.27e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.78e-15)"	"unprognostic (9.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.41e-1)"	32.2	29.2	70.6	18.4	77.9	6.4	30.2	35.6	84.2	33.6	38.1	32.8	18.9	38.1	36.2	31.7	45.1	20.4	42.4	79.9	60.4	29.5	22.1	23.6	17.4	61.7	55.1	43.5	50.0	43.3	60.7	14.0	61.5	34.5	17.0	39.3	43.9	40.6	21.2	27.0	23.4	31.6	43.8	24.3	35.8	11.5	58.0	13.7	34.6	23.1	20.6	36.5	30.7	67.9	28.4	43.0	5.6	11.5	45.4	22.4	7.3	42.6	22.2	16.1	10.1	7.4	23.8	18.6	34.2	53.5	19.2	26.0	7.6	32.9	10.5	19.4	11.3	11.5	25.5	16.9	34.0	22.3	20.1	20.2	51.6	23.1	34.9	31.6	33.5	9.3	10.4	45.3	28.5	62.3	16.3	11.7	3.2	23.1	30.8	7.1	9.5	38.4	20.6	22.3	9.4	8.9	37.3	34.6	18.1	3.0	31.8	16.7	46.4	18.1	17.9	40.9	29.0	24.7	24.1	5.4	53.8	19.5	22.4	29.9	16.7	47.5	32.7	28.9	30.9	14.6	22.4	26.9	15.5	11.3	18.8	22.7	25.8	17.0	32.8	7.4	13.5	28.9	70.6	77.9	35.6	84.2	79.9	60.4	61.7	55.1	61.5	43.8	58.0	67.9	13.4	3.2	10.1	4.9	13.3	5.7	19.5	12.0	13.1	46.4	11.3	8.8	20.4	17.2	10.4	18.4	8.4	6.2	8.8	9.1	11.7	30.4	0.9	21.2	10.9	17.1	11.5	2.1	14.4	36.5	14.6	22.9	15.8	16.1	10.1	5.1	18.9	9.1	11.8	43.7	13.5	13.8	10.2	11.7	5.7	2.7	16.1	10.3	10.6	3.7	15.0	38.5	16.5	4.5	5.6	28.6	9.3	33.1	19.1	20.8	10.7	15.6	18.2	23.8	19.7	11.1	20.0	4.5	3.9	12.0	9.5	4.2	14.9	5.1	7.9	16.4
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115413	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	35.6	32.6	24.0	27.3	27.0	23.3	44.1	26.0	34.2	43.1	28.6	42.3	34.7	40.4	41.3	54.3	36.7	34.1	21.5	24.3	26.6	42.8	23.4	33.6	25.7	27.8	27.5	43.8	26.5	48.0	17.3	42.4	28.0	32.9	44.1	19.8	31.3	28.1	14.2	41.3	37.9	31.4	27.9	26.3	37.1	26.5	25.6	25.9	53.0	18.6	34.4	37.2	34.7	31.6	73.0	48.8	46.8	41.6	120.0	92.0	78.4	74.7	94.2	65.3	66.3	31.5	150.7	38.6	45.1	93.9	78.3	198.4	49.7	68.1	73.0	39.8	36.1	36.7	32.7	51.7	80.5	65.5	49.9	82.6	92.6	68.0	74.8	72.3	62.5	43.5	83.8	46.6	91.1	69.6	34.7	47.6	67.5	97.4	57.9	39.4	58.7	33.3	84.1	37.9	35.0	37.2	104.4	81.1	61.3	62.4	39.2	54.2	72.3	58.8	48.0	73.9	56.8	33.2	44.4	23.9	74.2	39.3	79.4	32.4	33.1	20.2	16.7	36.1	17.0	15.4	18.0	17.4	30.6	15.5	21.4	16.6	33.3	18.5	34.2	18.4	25.7	25.5	24.0	27.0	26.0	34.2	24.3	26.6	27.8	27.5	28.0	27.9	25.6	31.6	40.7	38.5	38.3	27.7	22.1	10.6	13.6	14.5	26.2	6.9	33.2	20.6	4.1	4.3	25.9	36.8	14.6	12.7	24.4	8.0	9.8	53.4	94.8	34.7	42.5	23.1	2.4	7.2	35.3	56.4	15.6	32.3	13.7	47.4	24.6	26.9	6.1	4.3	11.0	6.7	32.5	7.2	12.2	5.7	10.3	26.1	6.2	24.6	12.4	20.6	22.0	13.7	7.2	36.7	52.1	60.8	7.1	6.0	26.2	9.8	11.7	28.5	28.0	8.7	13.1	12.1	23.5	35.3	25.9	27.6	9.1	21.8	21.9	33.2	6.9	14.5
SQSTM1	"A170, OSIL, p60, p62, p62B, PDB3"	ENSG00000161011	"Sequestosome 1"	Q13501	5	179806398-179838078	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Differentiation, Immunity"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1183.4"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 2045.0;Urothelial cells: 2233.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 1923.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004587, HPA064165, HPA068843"	Supported		Enhanced	Vesicles,Cytosol		No	No		81000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"		"CAB004587: AB_628279, HPA064165: AB_2685203, HPA068843: AB_2732120"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.31e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.01e-1)"	335.0	472.6	171.4	86.0	208.8	135.8	269.5	199.6	207.2	242.8	218.9	262.0	112.1	278.8	91.7	192.3	207.5	188.2	310.1	163.8	200.6	221.5	392.0	263.4	81.4	203.9	183.3	235.6	231.3	121.4	181.5	118.7	190.5	206.2	82.3	46.4	289.7	174.2	1183.4	194.7	187.4	132.7	179.5	179.0	263.6	65.7	205.7	89.4	316.4	287.2	96.4	347.3	211.0	236.5	130.1	740.6	36.9	114.3	547.8	384.8	546.3	187.9	596.3	164.1	201.2	154.6	532.9	16.0	522.7	298.9	898.3	170.8	79.9	181.9	76.9	1923.9	97.6	58.5	303.9	223.4	1167.2	59.9	365.0	337.1	181.2	273.0	441.5	390.8	152.6	17.3	68.0	472.1	327.0	111.6	26.4	62.0	93.8	410.0	195.1	54.8	78.8	213.7	243.6	609.6	79.0	74.5	253.2	274.3	662.2	62.3	143.8	120.4	286.2	243.1	103.4	252.3	271.6	723.7	819.3	73.5	521.1	111.6	338.4	807.6	412.3	422.2	194.7	268.3	231.3	156.5	170.1	174.6	227.5	168.2	131.8	139.1	672.6	196.3	260.3	89.6	262.1	439.8	171.4	208.8	199.6	207.2	163.8	200.6	203.9	183.3	190.5	179.5	205.7	236.5	411.1	185.9	248.8	36.9	280.0	297.5	1289.0	320.4	799.6	81.7	280.7	253.0	38.5	314.5	247.8	121.4	54.2	266.8	276.4	572.9	234.8	906.0	34.2	408.7	255.4	415.8	340.4	89.0	35.2	686.7	133.2	516.0	1270.6	589.7	386.3	73.8	142.5	297.8	288.3	90.9	37.2	337.2	236.0	149.8	556.3	72.2	325.3	388.3	231.3	28.1	611.3	143.3	125.7	16.6	62.2	639.4	618.9	259.2	606.5	1281.6	311.3	327.1	190.1	73.5	164.3	356.4	316.1	45.5	48.0	595.4	259.1	2045.0	259.9	133.4	242.3	2233.9
SRA1	"SRA, STRAA1"	ENSG00000213523	"Steroid receptor RNA activator 1"	Q9HD15	5	140537340-140558252	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Receptor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044598, HPA050153"	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA044598: AB_2679013, HPA050153: AB_2681033"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (8.01e-6)"	"unprognostic (9.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-1)"	12.2	34.0	8.7	7.7	9.0	9.6	9.7	15.8	12.3	10.0	9.2	12.5	5.1	8.2	6.0	9.3	9.4	5.6	12.0	9.9	9.3	12.4	25.8	15.0	6.3	8.4	8.2	14.9	7.5	4.7	22.2	5.8	8.8	12.5	4.7	7.2	14.8	6.2	14.5	9.4	11.9	5.4	8.6	17.6	14.0	22.6	8.9	5.6	12.9	2.5	5.2	9.4	8.8	9.2	9.7	22.7	11.8	12.3	5.6	7.6	16.4	16.1	9.1	10.3	10.8	41.8	5.9	8.2	11.7	6.2	5.5	6.4	2.1	12.0	4.1	12.7	13.9	7.2	25.0	16.1	12.0	13.1	9.4	14.7	6.1	5.5	2.8	9.1	4.7	13.8	7.4	12.1	6.9	29.5	10.7	20.4	3.6	5.2	18.0	11.7	10.0	7.9	5.4	11.3	8.3	9.8	9.4	8.5	11.6	4.1	10.5	14.7	7.5	9.7	5.1	8.5	13.2	15.1	10.9	8.6	12.0	16.8	6.5	16.1	26.0	20.3	10.7	23.8	9.9	15.8	10.2	10.4	25.2	14.0	8.2	9.4	43.0	13.6	23.6	15.2	19.5	26.8	8.7	9.0	15.8	12.3	9.9	9.3	8.4	8.2	8.8	8.6	8.9	9.2	43.3	6.4	49.4	13.4	46.7	52.4	68.5	126.1	38.7	23.6	57.8	48.9	71.7	57.2	86.4	33.1	8.4	103.7	56.9	87.8	113.5	102.7	104.6	59.5	33.4	39.8	38.4	35.1	15.5	148.2	117.9	48.6	64.7	43.1	68.4	21.8	42.1	69.7	93.1	15.2	17.2	71.6	107.8	61.2	71.5	150.0	25.1	82.0	67.6	7.5	90.4	59.5	42.2	9.0	11.5	186.0	78.7	29.7	113.7	82.9	83.7	131.0	84.1	23.7	26.3	26.7	76.1	77.2	30.7	62.3	45.9	179.0	47.4	66.8	49.2	142.6
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	9.7	25.3	5.7	13.3	5.2	8.4	10.1	0.4	6.2	25.1	1.5	30.3	39.8	31.9	3.2	26.1	23.8	27.9	8.8	6.4	5.5	21.4	4.3	16.1	6.3	2.6	3.4	23.6	30.8	11.1	15.9	8.1	2.2	30.8	17.1	5.5	11.8	27.4	2.4	13.0	38.8	17.2	1.7	14.2	39.9	25.2	5.0	6.1	9.8	1.5	8.1	35.6	24.6	3.0	24.6	110.8	24.9	22.6	9.3	14.7	51.6	22.0	18.9	26.3	16.6	41.9	21.5	0.7	13.4	40.2	29.9	43.5	15.1	102.6	10.3	0.1	13.7	6.2	3.9	65.9	22.0	0.3	9.3	15.7	34.2	17.3	22.8	29.4	24.3	14.2	0.6	0.2	4.4	16.7	6.0	0.8	11.7	67.3	98.8	26.5	6.6	0.7	11.0	106.3	23.1	83.6	25.0	34.5	27.2	19.1	31.1	9.0	35.8	31.4	20.9	11.7	20.1	0.3	0.8	0.3	22.1	0.1	24.0	0.0	1.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	2.3	1.4	0.0	1.0	5.7	5.2	0.4	6.2	6.4	5.5	2.6	3.4	2.2	1.7	5.0	3.0	1.0	3.2	1.7	3.3	4.1	8.2	12.5	9.5	10.8	6.5	6.2	7.5	2.2	18.6	4.7	12.9	2.1	2.3	4.9	42.0	1.9	12.2	1.8	6.4	10.7	1.4	16.8	0.4	9.5	18.7	8.3	7.2	43.8	12.4	0.0	14.8	1.1	1.6	5.7	3.3	9.1	29.2	8.2	9.4	46.3	3.3	10.8	22.8	1.8	9.4	9.7	4.4	1.0	9.0	0.6	39.1	19.2	17.3	4.3	18.0	36.7	9.3	5.6	5.2	13.1	1.8	6.7	0.3	1.1	11.2	9.1	2.3	1.0	2.9	16.9	36.6
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346213-55373100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 245.5;Club cells: 245.2;Pancreatic endocrine cells: 155.5;Respiratory ciliated cells: 195.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 79.6"					"Low region specificity"	"Detected in all"			HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	12.5	12.0	10.4	2.5	11.5	3.7	12.2	11.0	12.4	12.9	9.2	7.3	3.8	6.8	4.2	26.1	5.6	10.3	9.3	10.7	10.1	9.6	14.5	10.5	2.5	11.0	11.2	3.1	20.2	7.0	5.9	4.0	10.8	7.4	4.1	1.5	16.4	2.9	6.3	15.4	7.0	2.6	10.9	6.8	9.7	3.3	10.9	6.0	7.6	5.4	6.0	10.0	14.7	12.7	9.7	4.3	10.3	10.1	29.4	20.4	5.6	10.4	9.3	2.4	5.4	6.5	19.5	21.2	11.7	11.0	11.1	7.0	5.3	7.9	3.9	6.6	17.1	12.3	5.2	15.8	9.2	23.7	6.1	17.6	14.5	5.4	5.3	7.8	14.4	38.5	21.2	47.7	21.1	10.8	36.0	10.3	13.0	53.2	9.3	11.4	3.3	14.0	12.8	7.9	16.0	9.1	10.7	79.6	8.3	9.0	9.4	17.9	8.3	25.0	4.7	2.0	8.1	28.6	15.8	7.9	34.1	29.5	25.9	25.6	35.8	11.7	16.1	56.5	18.6	12.5	12.0	15.2	30.2	12.7	10.2	14.4	1.8	8.6	59.5	61.7	12.5	23.1	10.4	11.5	11.0	12.4	10.7	10.1	11.0	11.2	10.8	10.9	10.9	12.7	25.4	9.6	15.9	4.6	7.8	13.6	13.3	245.5	5.2	4.9	43.8	29.3	5.3	34.3	245.2	5.5	4.2	27.0	21.2	12.2	3.9	93.4	3.2	51.2	31.0	19.6	12.0	14.9	11.1	105.4	106.0	16.2	13.3	105.9	14.0	6.7	17.5	18.6	63.4	10.1	17.1	22.6	57.0	32.4	34.1	0.5	1.8	27.6	24.9	4.7	31.3	21.9	18.6	8.5	23.4	155.5	10.0	5.7	16.8	17.5	9.4	18.4	195.0	3.9	13.1	13.3	28.2	3.5	20.1	32.7	29.7	7.5	7.2	15.4	23.3	108.6
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837011	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 202.5;SK-BR-3: 178.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710"	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	42.2	219.2	26.8	7.9	41.5	20.1	46.5	20.4	37.2	51.5	9.4	37.7	28.7	23.4	8.9	68.7	42.7	14.0	27.4	20.0	25.9	24.7	128.5	26.4	9.1	30.1	29.7	41.4	17.0	8.4	37.0	7.8	24.2	37.2	6.7	3.9	89.5	16.7	34.5	47.8	34.0	5.6	23.4	17.2	25.2	35.4	35.8	14.4	27.0	2.9	6.3	32.5	48.8	41.7	54.1	122.5	12.0	85.2	24.9	55.8	23.5	18.5	60.0	16.4	39.2	23.3	104.2	33.5	17.2	14.8	14.5	144.0	16.7	47.2	4.0	21.1	7.2	16.8	86.4	19.1	36.1	2.5	29.6	42.0	19.6	21.8	12.5	12.2	17.6	64.9	36.8	105.8	2.5	118.7	46.9	26.1	17.8	38.3	23.1	32.6	10.8	202.5	9.0	23.1	16.3	70.5	24.4	178.7	48.0	8.9	62.0	32.6	21.5	8.2	40.5	19.5	12.5	32.2	3.1	15.5	48.9	24.6	45.2	0.0	0.3	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.6	1.3	0.1	0.1	0.1	0.0	0.2	26.8	41.5	20.4	37.2	20.0	25.9	30.1	29.7	24.2	23.4	35.8	41.7	6.1	6.4	26.0	66.9	11.9	9.3	12.0	29.2	14.8	24.5	58.0	30.6	9.4	18.6	29.7	20.2	29.2	4.5	11.4	44.5	1.9	16.5	2.7	30.9	37.2	10.5	29.9	24.8	12.8	23.5	15.7	24.7	31.1	31.9	14.7	13.2	12.8	72.2	12.1	58.9	11.3	30.8	24.4	14.0	13.3	4.9	29.8	15.1	8.8	15.0	11.0	51.7	1.0	10.6	56.7	16.7	20.8	10.9	8.4	19.0	33.2	6.6	32.1	31.6	13.1	15.6	12.9	11.4	4.9	40.2	18.3	19.8	13.4	27.5	41.1	25.2
SRI		ENSG00000075142	Sorcin	P30626	7	88205115-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 566.0"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1172.0;Extravillous trophoblasts: 1475.3;Paneth cells: 1606.5;Proximal enterocytes: 1342.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		1100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favorable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	98.7	89.5	139.1	95.9	147.8	85.2	95.9	148.0	177.1	87.0	115.0	566.0	178.0	70.4	122.4	68.3	147.8	52.3	81.3	135.9	159.7	104.6	42.3	84.2	69.3	146.6	150.6	83.2	75.8	56.7	75.3	64.5	158.3	69.9	447.2	50.3	74.4	64.6	37.6	49.2	252.2	94.2	155.5	60.3	66.3	38.9	147.3	54.6	70.5	53.0	78.2	136.8	81.3	165.7	181.7	59.5	188.5	193.8	295.0	247.0	89.3	106.5	177.5	121.5	143.3	56.2	414.0	198.9	108.3	168.0	296.6	182.8	237.6	244.5	160.2	155.9	92.2	103.4	177.6	0.1	173.8	139.0	108.5	250.5	221.2	127.0	185.1	218.2	365.4	123.7	87.8	175.8	170.4	106.3	211.7	94.5	159.4	261.2	119.3	86.1	256.8	110.9	229.2	179.0	131.5	151.5	323.0	188.0	154.7	179.7	88.0	61.4	218.1	223.4	185.6	201.5	192.9	159.6	79.2	222.4	220.7	130.5	387.8	620.5	151.3	580.6	169.8	217.3	202.4	173.0	185.9	194.9	201.0	151.9	137.7	158.5	93.3	224.3	262.2	161.1	210.4	216.7	139.1	147.8	148.0	177.1	135.9	159.7	146.6	150.6	158.3	155.5	147.3	165.7	258.8	86.6	123.7	63.6	84.4	95.1	389.6	494.2	75.1	34.9	117.2	129.5	107.1	35.8	402.0	156.3	12.5	166.0	104.7	1172.0	442.2	223.0	89.7	307.3	148.6	135.6	94.3	198.6	29.4	418.5	1475.3	175.7	80.0	172.7	135.6	131.3	106.7	40.5	147.6	47.1	22.9	471.7	276.7	79.5	117.9	34.0	172.1	103.2	104.9	15.9	172.5	195.6	113.3	40.2	34.9	380.9	1606.5	141.4	75.2	422.9	1342.4	182.2	660.4	25.9	111.7	111.9	183.9	80.8	106.3	86.9	108.3	197.4	117.9	126.8	536.9	488.1
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 1.6"	"Cell type enriched"	"Detected in single"	4	"Gastric mucus-secreting cells: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.3;MCF7: 3.0;OE19: 4.4;RT4: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.0	0.0	0.1	0.2	0.1	0.1	0.4	0.6	0.2	0.0	0.0	0.7	0.2	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.8	0.0	0.0	0.4	0.2	0.0	0.1	0.9	1.6	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	1.3	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.1	0.0	4.4	0.4	0.0	0.1	0.0	0.0	6.0	0.4	0.5	0.1	1.2	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035690-40039181	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli		NA	NA		440000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	309.1	307.5	330.1	118.1	327.1	252.7	300.4	323.8	426.0	301.7	320.4	272.5	121.5	311.2	282.1	257.7	270.7	155.8	390.1	317.9	349.3	391.5	229.5	220.8	168.0	357.0	402.7	323.5	192.4	324.3	306.8	143.8	339.7	264.4	158.9	212.8	237.8	158.9	354.7	201.2	215.7	163.4	321.1	219.7	247.6	165.6	326.2	276.9	275.6	338.5	172.9	266.7	253.9	355.1	131.8	163.7	399.5	301.4	300.0	275.5	189.4	232.4	265.0	213.4	223.3	297.8	113.7	107.9	245.0	305.1	319.5	216.6	322.8	260.9	207.0	257.5	230.3	258.3	530.2	364.0	231.4	238.2	211.8	276.0	298.3	177.8	213.3	391.0	360.6	297.7	280.2	204.2	356.3	204.5	370.2	291.4	217.6	520.1	301.3	247.6	176.8	192.6	477.5	401.7	287.2	255.0	231.2	243.2	171.2	243.7	332.8	448.6	290.9	240.4	160.3	229.4	171.1	161.8	494.7	291.0	234.7	255.4	229.7	729.8	525.0	875.7	484.5	485.8	473.9	600.9	547.9	549.0	562.5	509.0	522.0	510.2	452.7	525.9	459.5	1148.0	755.1	1262.6	330.1	327.1	323.8	426.0	317.9	349.3	357.0	402.7	339.7	321.1	326.2	355.1	1378.8	461.6	415.0	83.2	577.0	667.1	861.7	1395.7	427.4	432.9	617.7	914.5	880.3	649.1	906.9	995.0	125.1	867.3	812.5	742.7	2551.3	1366.9	353.1	1215.7	729.8	957.7	554.0	619.4	39.4	1087.2	1100.4	699.1	324.7	1513.6	564.0	669.5	654.7	819.4	1022.1	348.3	56.1	676.9	1226.8	631.1	882.8	377.3	1039.8	645.8	789.8	36.5	1174.3	1262.8	619.0	39.2	76.0	1240.7	894.4	986.9	610.9	826.3	874.5	2276.2	935.5	477.3	624.5	651.9	749.3	779.9	643.1	631.5	710.3	758.8	644.1	831.9	673.2	975.0
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 108.2"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1275.7;Late spermatids: 2280.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 219.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	14.3	16.2	27.2	15.0	29.7	10.7	18.3	20.1	46.8	16.3	0.0	13.3	11.4	18.1	15.8	16.4	14.6	16.0	14.7	31.0	30.0	13.8	14.2	12.8	17.9	27.9	25.5	17.3	14.7	15.1	12.9	17.1	30.4	18.8	14.8	24.2	15.1	14.4	11.3	24.4	11.4	18.3	19.3	17.8	16.3	108.2	26.7	41.4	15.5	11.8	20.6	18.2	11.6	47.1	36.9	24.0	37.3	74.5	39.3	43.8	21.0	35.4	40.8	34.5	39.9	18.9	30.5	23.4	43.7	45.8	38.5	21.6	38.3	37.3	43.7	40.5	33.2	33.1	21.8	16.5	45.1	31.8	47.1	30.6	67.5	29.2	54.6	33.0	59.8	54.4	33.0	92.2	38.5	69.3	118.3	23.9	31.1	20.8	25.9	37.9	41.3	51.1	49.5	56.1	54.8	37.8	40.1	59.0	37.7	49.1	22.1	21.8	39.7	62.9	45.9	60.8	33.4	100.6	106.6	56.5	24.8	32.3	48.1	50.3	30.2	103.3	41.4	21.0	24.8	45.0	31.1	31.6	27.3	44.0	29.3	33.6	219.5	38.7	25.1	23.6	38.6	25.2	27.2	29.7	20.1	46.8	31.0	30.0	27.9	25.5	30.4	19.3	26.7	47.1	35.8	28.9	29.5	128.9	62.9	212.9	60.6	68.1	49.5	76.9	45.2	40.0	23.3	28.6	41.5	23.9	50.1	52.4	87.1	16.6	27.4	52.9	1275.7	54.3	41.9	51.8	28.8	17.2	298.1	46.3	35.6	47.3	40.8	51.6	41.2	48.9	53.6	35.9	47.6	124.5	300.9	35.2	54.9	43.0	42.9	2280.6	76.7	39.2	58.7	168.6	57.0	73.7	103.0	172.4	399.8	36.4	24.4	95.9	54.8	100.7	15.7	25.9	54.2	67.6	46.0	40.3	59.1	198.8	66.0	36.7	103.3	64.4	58.2	61.4	26.1	67.9
SRR	"ILV1, ISO1"	ENSG00000167720	"Serine racemase"	Q9GZT4	17	2303383-2325260	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Isomerase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007529, CAB015343"	Approved		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"CAB015343: AB_2195009, HPA007529: AB_2667853"	"unprognostic (2.96e-1)"	"unprognostic (7.86e-2)"	"unprognostic (6.01e-2)"	"prognostic favorable (6.20e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.16e-4)"	"unprognostic (5.17e-2)"	"prognostic favorable (2.45e-6)"	"unprognostic (6.14e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.84e-2)"	10.5	7.8	11.0	6.6	11.5	13.9	8.9	12.5	13.1	6.8	13.0	9.4	6.9	7.5	10.3	10.9	8.7	8.3	10.9	9.4	13.4	9.0	8.2	6.1	6.6	11.2	12.4	8.4	11.9	12.3	4.9	5.4	12.7	8.4	7.5	16.6	10.7	7.7	15.6	11.8	5.9	7.0	11.1	6.9	8.0	7.1	12.5	9.0	11.8	6.7	5.4	8.4	5.3	11.8	14.8	27.0	42.7	17.9	24.9	24.4	22.8	29.8	20.2	19.4	20.5	25.3	18.1	27.5	4.1	29.1	14.3	30.2	12.2	11.4	24.6	32.6	26.0	14.6	20.3	9.6	22.5	4.3	8.0	22.9	11.5	41.4	21.0	21.2	28.6	28.2	15.2	19.8	43.9	8.4	28.7	5.8	10.0	13.8	19.9	45.5	48.8	13.3	22.9	6.9	9.2	23.4	26.8	3.3	14.3	14.6	20.7	10.3	21.3	21.4	14.7	24.7	19.0	16.7	26.0	5.1	36.9	13.7	29.8	4.3	8.1	5.6	8.8	8.4	9.1	10.1	11.2	9.1	15.6	10.2	9.2	12.1	1.0	15.7	14.0	11.0	8.8	8.5	11.0	11.5	12.5	13.1	9.4	13.4	11.2	12.4	12.7	11.1	12.5	11.8	5.0	3.2	3.7	3.6	2.1	2.9	3.5	17.4	1.8	8.5	5.5	4.6	4.2	1.5	8.4	1.8	0.0	5.9	3.4	3.0	13.7	9.6	1.9	6.6	5.5	5.4	1.8	5.2	3.5	6.6	3.2	5.7	3.6	4.6	0.0	13.2	8.2	3.2	9.3	16.8	4.9	2.5	12.2	4.6	4.9	1.5	4.1	3.7	5.4	4.7	9.3	11.0	5.2	5.0	7.8	6.7	0.8	5.3	6.1	2.9	2.9	6.3	10.2	5.6	0.0	4.6	6.5	23.3	13.1	4.7	2.4	3.4	2.3	9.7	3.5	4.0
SRRM5		ENSG00000226763	"Serine/arginine repetitive matrix 5"	B3KS81	19	43596617-43614498	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 47.8"	"Group enriched"	"Detected in some"	43	"Early spermatids: 176.5;Late spermatids: 64.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA047399, HPA052924"	Uncertain		Approved	Vesicles,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles	Centrosome	"HPA047399: AB_10963088, HPA052924: "	"unprognostic (3.95e-3)"	"unprognostic (7.56e-3)"	"unprognostic (6.72e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.68e-5)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-3)"	0.5	0.9	1.0	0.5	1.2	0.4	0.5	2.3	1.3	0.8	0.6	0.8	0.3	0.5	0.3	1.0	0.7	0.4	0.9	0.9	1.0	1.4	1.1	0.6	1.0	1.1	0.9	0.9	1.2	0.2	1.6	0.2	1.1	1.9	0.1	1.9	0.9	0.1	0.5	0.8	0.7	0.1	0.6	0.9	0.7	47.8	1.0	0.1	1.1	0.0	0.0	0.6	0.9	1.2	1.3	1.1	0.4	0.8	0.4	0.3	0.3	0.3	0.1	0.1	0.1	0.7	0.5	0.4	0.7	0.1	0.3	0.8	0.4	0.1	0.2	0.5	0.5	0.4	1.1	0.6	0.1	0.3	0.6	0.3	0.4	0.0	0.1	0.4	0.1	0.6	0.3	1.1	0.0	1.1	0.5	0.5	0.1	0.9	0.3	0.8	0.3	0.3	0.3	1.7	0.8	0.3	0.1	0.4	0.4	0.5	0.9	0.2	0.6	1.1	0.7	0.4	0.6	1.3	0.9	0.5	0.6	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	2.3	1.3	0.9	1.0	1.1	0.9	1.1	0.6	1.0	1.2	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	2.8	0.3	0.3	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	176.5	0.3	0.4	0.1	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.4	0.0	0.7	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	64.9	1.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.9	0.0	0.8	0.1	0.7	0.6	0.8	0.3	0.1	0.2	0.3	0.1	0.1
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737333	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	106.0	106.8	27.8	95.5	29.6	184.7	92.1	29.9	34.0	83.6	37.7	100.3	86.2	88.9	64.0	129.5	89.5	42.1	78.5	29.2	32.9	83.0	115.2	95.4	111.6	30.8	28.5	85.6	88.3	48.4	81.9	66.0	30.3	78.0	71.6	53.4	90.6	52.3	91.7	96.5	113.2	49.0	31.3	121.6	94.4	49.5	30.0	94.2	102.1	36.0	100.2	80.0	94.3	36.0	318.7	239.8	289.5	207.5	70.9	58.5	300.5	197.3	146.8	225.4	207.0	257.2	216.8	478.0	143.3	188.7	164.3	279.9	293.3	229.0	230.2	202.3	489.3	357.9	246.6	311.9	79.3	404.4	210.6	65.2	51.1	186.2	54.0	91.1	179.9	212.0	373.4	209.6	183.7	251.0	460.0	440.9	339.5	186.4	340.2	455.0	310.6	360.5	156.5	225.2	247.7	350.8	227.1	196.3	120.4	154.0	238.8	301.6	187.9	206.9	271.3	139.4	330.0	278.2	219.2	552.9	187.3	318.9	177.1	2.5	40.9	10.0	26.0	53.3	26.0	23.5	17.7	26.7	67.0	19.6	20.1	19.4	4.4	35.6	33.6	49.2	24.0	33.0	27.8	29.6	29.9	34.0	29.2	32.9	30.8	28.5	30.3	31.3	30.0	36.0	271.3	118.6	105.6	57.5	396.7	460.8	439.7	205.9	540.1	151.9	291.7	277.9	86.2	148.7	141.5	88.3	91.8	339.4	548.0	233.1	156.5	199.1	203.6	176.8	181.9	204.3	266.3	366.6	51.1	157.3	579.7	233.9	196.7	257.4	218.4	241.7	116.7	125.1	251.3	99.3	55.4	246.9	132.2	143.7	480.4	162.0	159.1	273.5	282.8	63.7	226.9	153.3	196.7	55.8	87.9	189.0	288.7	127.5	492.0	384.8	250.5	128.7	97.4	188.9	118.3	286.8	242.1	272.3	296.8	489.5	443.4	316.0	469.1	185.4	329.4	459.4
SRSF6	"B52, SFRS6, SRP55"	ENSG00000124193	"Serine and arginine rich splicing factor 6"	Q13247	20	43457893-43466046	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029005, CAB034889"	Supported		Supported	"Nuclear speckles"		NA	NA		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"CAB034889: AB_785899, HPA029005: AB_10610424"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-3)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.18e-2)"	43.3	53.7	34.0	34.5	37.5	115.9	56.2	41.4	43.8	44.2	52.7	37.8	36.3	52.7	59.7	32.8	47.4	31.4	31.4	33.3	39.6	47.4	50.3	40.3	48.4	34.5	34.7	58.5	66.3	41.8	48.0	39.3	35.6	48.7	43.4	38.7	45.3	30.0	30.5	48.7	45.4	39.7	35.6	55.9	47.4	30.3	35.7	53.7	50.8	18.1	40.8	29.7	30.4	47.3	52.7	79.1	88.7	57.3	50.7	67.7	86.3	79.6	38.3	55.4	47.1	112.9	55.9	95.9	73.9	73.3	45.1	77.6	91.7	116.9	71.7	40.2	85.7	74.6	83.3	94.1	62.3	94.9	78.9	115.7	61.9	51.0	46.2	85.1	52.7	83.8	63.3	54.5	52.6	112.3	144.5	107.6	57.8	87.4	107.4	100.2	54.4	76.9	63.1	93.7	69.0	90.9	89.5	108.7	105.0	61.7	70.4	103.3	54.9	57.9	61.6	49.9	67.3	98.2	67.3	131.4	69.9	67.2	42.8	26.0	19.9	9.7	19.7	33.4	22.4	16.0	20.8	19.1	24.5	15.9	27.3	25.7	10.8	21.2	29.6	20.4	18.7	22.9	34.0	37.5	41.4	43.8	33.3	39.6	34.5	34.7	35.6	35.6	35.7	47.3	78.9	64.1	80.0	49.6	75.8	94.4	61.0	58.5	50.7	48.9	110.7	78.7	28.7	75.8	61.3	46.0	39.6	97.8	103.3	67.8	88.0	60.2	12.3	60.1	87.7	62.3	101.4	71.1	32.1	43.7	108.2	80.0	70.8	79.1	97.0	103.2	60.7	94.7	56.5	32.0	37.2	97.2	46.8	73.2	93.7	14.7	55.0	77.3	101.4	26.2	61.2	45.0	37.0	89.0	79.6	46.2	74.3	44.8	49.3	68.9	66.7	67.7	47.6	46.4	59.2	166.1	99.8	53.8	61.0	51.5	98.3	139.1	76.4	90.7	105.5	55.3
SRSF8	"SFRS2B, SRP46"	ENSG00000263465	"Serine and arginine rich splicing factor 8"	Q9BRL6	11	95066919-95071225	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049905	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.99e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.75e-3)"	14.8	13.5	16.3	12.1	16.0	14.7	16.7	16.5	18.0	14.7	16.8	15.1	15.7	17.3	16.0	14.5	15.3	12.0	13.4	15.8	17.0	19.3	15.1	13.5	17.4	15.0	15.5	20.7	21.9	17.9	15.7	14.3	15.3	19.0	15.6	10.4	19.9	16.8	13.2	14.9	17.4	14.7	16.2	20.0	15.8	5.3	17.5	12.3	23.2	14.1	14.7	13.2	13.6	17.7	7.6	7.7	19.1	0.0	24.9	15.5	21.7	11.1	12.2	5.1	5.5	18.4	24.2	40.3	32.2	16.9	9.4	16.3	16.2	24.1	5.9	24.4	17.8	33.8	9.0	16.6	18.3	34.3	17.7	20.3	25.1	5.4	25.3	15.0	16.2	18.1	25.9	21.5	10.1	10.3	17.9	30.4	10.2	19.8	21.7	22.1	5.8	32.1	20.1	24.8	24.2	24.7	13.8	24.1	16.7	12.0	9.6	18.7	15.3	9.9	13.3	13.5	11.6	11.6	19.1	21.4	5.1	22.5	22.1	10.1	2.1	0.7	5.4	1.2	7.9	9.2	9.4	8.1	4.0	7.1	12.0	9.1	0.6	6.2	1.1	3.7	10.9	4.1	16.3	16.0	16.5	18.0	15.8	17.0	15.0	15.5	15.3	16.2	17.5	17.7	32.5	44.8	29.3	8.8	82.8	0.0	51.4	0.0	57.5	49.3	54.4	60.3	21.4	58.6	11.8	33.1	33.3	39.2	56.5	41.1	150.6	36.7	1.8	22.1	27.6	45.8	56.9	122.9	18.3	45.7	52.7	31.4	40.2	33.8	10.2	43.2	52.5	57.8	26.1	18.5	16.6	82.6	0.0	24.2	0.0	6.0	41.0	41.9	0.0	18.7	40.2	45.7	97.9	13.6	29.6	28.9	40.8	60.9	46.8	46.4	53.4	110.1	9.5	50.9	32.9	34.6	31.0	7.2	6.4	63.5	0.0	51.2	58.4	52.1	67.5	38.0
SRSF9	"SFRS9, SRp30c"	ENSG00000111786	"Serine and arginine rich splicing factor 9"	Q13242	12	120461672-120469748	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049849	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA049849: AB_2680911"	"unprognostic (3.80e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (9.85e-7)"	"unprognostic (9.65e-3)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	68.2	112.1	71.2	75.5	74.3	95.0	72.0	73.9	75.2	70.3	81.0	88.7	73.0	57.5	85.5	126.6	76.1	48.7	38.8	70.6	75.1	94.7	92.0	62.1	99.3	72.7	77.2	71.2	113.8	94.2	78.2	85.2	74.0	76.9	84.2	21.8	77.1	57.4	30.0	80.6	63.5	58.9	74.4	86.7	82.6	93.3	77.6	110.2	80.6	27.5	129.1	82.9	75.6	72.1	334.7	229.2	344.3	222.7	153.6	153.7	365.3	224.3	200.7	281.5	240.2	276.9	153.1	323.6	254.7	189.4	152.7	194.9	312.0	318.9	308.5	244.7	321.9	276.3	152.8	273.5	197.7	344.7	241.8	163.4	201.8	244.6	211.0	301.2	260.4	207.0	353.6	95.3	245.9	466.8	339.7	668.7	429.6	224.8	198.2	374.2	144.1	312.9	246.4	420.4	303.9	217.3	262.5	137.3	276.2	222.4	415.9	299.4	229.1	207.8	247.0	157.8	246.3	288.6	234.5	404.9	218.8	255.7	221.5	28.7	16.9	49.3	22.5	19.8	17.5	41.2	17.4	19.9	22.5	36.7	17.3	19.1	19.7	26.5	27.7	30.7	20.1	8.7	71.2	74.3	73.9	75.2	70.6	75.1	72.7	77.2	74.0	74.4	77.6	72.1	172.6	25.6	37.2	17.3	190.1	264.9	269.7	81.2	140.0	74.5	235.6	174.4	1.7	157.3	60.4	161.8	29.2	339.2	204.5	119.5	489.1	200.6	68.5	179.1	149.9	143.8	144.7	141.9	24.1	155.1	469.4	148.9	105.5	143.9	33.7	321.3	132.8	150.0	202.9	72.3	23.6	160.5	63.1	136.3	322.0	28.5	124.5	171.3	200.9	11.2	192.7	134.4	129.8	14.1	24.1	152.4	102.2	155.0	317.8	336.8	89.8	404.3	63.6	55.3	52.6	128.1	165.5	288.5	248.8	218.2	313.4	475.4	158.1	433.1	160.6	392.2
SS18L2	KIAA-iso	ENSG00000008324	"SS18 like 2"	Q9UHA2	3	42581840-42596934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047377	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA047377: AB_2680020"	"unprognostic (4.09e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (6.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.24e-3)"	21.0	17.1	27.6	18.5	28.6	33.9	21.9	28.8	37.1	19.8	26.7	17.5	19.0	12.6	17.8	21.2	15.7	10.4	18.7	28.2	28.4	24.5	32.4	19.6	35.4	28.2	27.8	19.1	21.6	13.5	25.1	9.9	28.3	35.9	13.6	13.7	19.1	8.6	16.2	24.9	25.6	7.4	28.4	31.6	22.7	10.1	27.8	23.6	20.4	11.0	30.2	19.4	18.5	31.5	32.3	14.0	29.0	26.4	34.9	27.8	17.3	20.6	22.4	28.7	32.2	27.1	29.1	43.3	18.2	13.6	31.6	17.9	33.9	28.0	30.9	21.7	40.5	46.9	28.9	45.3	25.4	62.5	36.2	22.1	17.7	23.7	21.9	20.6	31.4	39.1	43.2	65.4	23.1	29.3	44.8	76.4	45.9	42.7	34.2	23.6	20.6	61.2	32.3	38.2	16.2	23.0	17.6	27.2	29.8	30.2	35.8	57.4	19.5	18.0	29.0	42.8	38.0	46.5	76.3	73.5	26.3	66.1	17.0	60.4	56.4	84.9	88.4	66.0	121.0	120.3	116.3	106.2	62.1	104.3	99.5	101.1	75.8	83.0	50.9	74.5	139.2	90.4	27.6	28.6	28.8	37.1	28.2	28.4	28.2	27.8	28.3	28.4	27.8	31.5	39.3	12.8	16.7	5.5	96.3	107.1	70.1	101.5	91.0	16.2	78.6	77.8	19.3	42.9	46.1	27.6	8.4	57.1	102.9	39.2	56.7	43.4	4.3	47.0	37.9	37.0	55.1	67.3	13.6	49.2	75.8	39.0	39.8	71.9	45.7	39.6	32.5	61.0	66.8	23.5	11.2	51.1	79.3	38.6	51.2	3.7	34.5	43.0	51.6	6.5	69.3	38.1	88.6	3.0	25.8	50.6	58.9	15.8	72.4	75.6	121.4	85.2	28.2	26.8	13.1	26.4	32.5	19.4	24.7	84.5	138.1	37.4	103.2	34.5	53.7	99.2
SSBP2	HSPC116	ENSG00000145687	"Single stranded DNA binding protein 2"	P81877	5	81413021-81751797	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 281.7;Excitatory neurons: 263.4;Inhibitory neurons: 350.0;Microglial cells: 339.2;Oligodendrocytes: 340.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 136.8;MOLT-4: 132.4;REH: 196.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020834, HPA068605, HPA071780"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB020834: , HPA068605: AB_2732116, HPA071780: "	"unprognostic (4.62e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.04e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.39e-3)"	28.8	12.7	25.9	13.0	27.9	14.0	26.5	37.0	26.1	31.2	24.1	29.7	5.7	29.1	30.2	24.4	29.9	16.2	31.8	24.1	34.2	12.8	3.3	16.2	19.8	25.0	33.2	37.1	11.2	47.3	28.0	13.7	27.7	19.2	12.9	53.3	20.8	21.3	23.6	27.2	15.5	29.8	26.2	12.5	17.8	7.9	31.3	96.4	17.7	22.2	24.3	25.7	26.1	27.2	3.8	6.8	85.1	48.8	48.0	72.6	5.2	18.1	16.4	16.5	16.9	0.3	7.1	60.8	1.2	21.3	8.2	0.4	23.6	9.7	15.9	26.1	10.1	12.8	14.6	0.3	27.1	6.4	32.5	74.8	82.1	2.8	15.9	35.6	7.1	136.8	8.4	29.2	17.9	8.7	132.4	10.7	11.7	0.1	3.8	196.2	19.3	47.2	8.8	3.3	44.2	39.7	19.1	21.1	6.6	34.3	31.1	18.1	4.9	6.5	10.4	12.3	4.9	30.4	25.1	101.6	21.8	11.3	4.4	60.4	19.0	61.1	5.0	17.5	8.0	23.9	16.2	9.3	18.3	33.6	31.3	11.1	27.9	61.3	29.6	5.9	7.8	18.7	25.9	27.9	37.0	26.1	24.1	34.2	25.0	33.2	27.7	26.2	31.3	27.2	43.7	9.6	18.6	281.7	39.0	34.9	40.3	44.3	122.9	75.0	25.1	38.1	45.3	12.8	34.4	29.5	27.1	7.7	12.5	4.1	17.6	14.0	5.9	25.2	27.3	21.4	15.0	29.7	263.4	10.0	3.7	48.6	10.2	22.0	25.3	5.4	23.9	2.3	20.5	42.1	350.0	5.4	61.1	17.0	21.7	4.2	37.9	29.9	35.6	339.2	15.6	122.4	5.2	185.0	340.2	6.1	13.6	48.5	14.9	14.9	2.5	4.5	34.1	49.3	52.6	48.9	59.4	10.0	29.8	60.3	36.2	7.4	23.9	9.9	4.4	27.3
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519099	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 39.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 19.3;Fibroblasts: 27.0;Leydig cells: 18.0;Peritubular cells: 15.8;Skeletal myocytes: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.9;BJ: 22.7;fHDF/TERT166: 27.5;hTERT-RPE1: 23.2;U-87 MG: 27.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		88000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	13.1	2.2	2.6	3.6	4.6	0.1	8.8	3.0	2.1	23.0	1.8	33.6	1.9	39.7	3.9	5.7	17.0	12.9	17.6	1.8	2.1	3.6	1.7	9.1	1.3	3.9	2.6	14.5	1.8	0.3	17.6	1.9	4.0	8.8	2.8	1.1	3.4	12.8	3.6	5.6	8.7	20.1	2.2	11.1	9.8	2.6	3.6	2.0	3.8	2.8	0.5	10.6	15.9	2.1	0.1	1.4	0.5	0.0	3.3	26.9	0.0	22.7	5.5	3.7	4.6	0.4	0.0	1.2	0.3	27.5	1.1	0.0	0.0	0.0	1.9	0.1	0.3	5.6	1.5	0.0	5.2	0.1	9.6	12.3	0.0	5.4	0.0	23.2	0.0	0.7	0.2	0.3	0.6	0.1	0.1	0.5	0.9	0.0	0.2	0.7	1.2	0.3	2.5	0.0	2.9	0.4	0.4	0.0	0.5	0.5	0.4	1.2	7.9	1.0	1.3	1.1	3.8	0.4	0.0	0.1	27.8	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.6	3.0	2.1	1.8	2.1	3.9	2.6	4.0	2.2	3.6	2.1	3.5	3.2	0.6	4.2	0.3	1.9	0.3	0.3	0.0	5.3	0.8	1.1	2.8	0.0	0.1	0.0	2.1	0.1	0.4	0.8	1.9	0.1	0.6	1.5	19.3	3.3	0.0	0.0	1.5	0.0	0.1	27.0	2.0	0.9	0.0	0.5	2.2	0.0	1.2	3.3	1.1	0.4	0.0	1.0	3.8	1.3	18.0	2.0	1.8	2.8	0.7	2.1	0.0	0.0	0.3	0.1	0.3	15.8	0.3	0.3	4.6	0.2	0.7	1.9	0.0	32.1	6.8	0.9	1.1	0.4	1.8	0.0	0.5	0.9	1.4	0.2
SSPN	"KRAG, SPN1, SPN2"	ENSG00000123096	Sarcospan	Q14714	12	26121991-26299290	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 79.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 140.8;Leydig cells: 185.8;Peritubular cells: 267.4;Skeletal myocytes: 139.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"memory B-cell: 57.4;naive B-cell: 16.9"	"Lineage enriched"	"Detected in many"	19	"B-cells: 57.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 24.4;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066432			Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear membrane"	Nucleoplasm	"HPA066432: AB_2685669"	"unprognostic (4.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	21.3	10.7	18.0	6.4	26.5	0.1	20.1	26.2	15.4	39.5	8.6	21.2	4.4	23.9	17.8	18.3	25.2	21.9	46.0	16.1	30.1	6.1	1.4	8.9	7.0	26.5	29.1	33.8	8.0	3.2	3.8	4.6	27.9	22.4	12.7	2.9	9.4	34.4	60.7	4.4	7.7	24.3	31.5	8.7	7.7	8.3	21.5	8.7	17.1	79.0	12.1	19.2	15.4	38.4	0.8	1.6	4.0	0.0	24.4	14.5	0.2	6.9	10.8	1.1	3.1	0.1	9.5	0.0	1.8	11.0	6.0	3.0	0.0	0.5	2.1	0.1	0.0	0.0	0.1	0.0	2.9	0.1	0.0	9.3	1.0	3.5	0.8	91.6	0.4	0.0	0.0	0.1	8.4	1.9	0.6	1.9	7.9	0.6	2.7	0.3	10.7	3.2	2.4	8.3	0.4	6.3	2.7	0.6	7.0	4.0	0.9	0.3	3.0	2.5	1.8	3.4	1.8	0.3	1.2	0.2	5.3	0.0	8.6	0.0	0.0	2.7	0.0	0.0	0.5	57.4	0.0	0.0	0.1	16.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.7	18.0	26.5	26.2	15.4	16.1	30.1	26.5	29.1	27.9	31.5	21.5	38.4	10.8	3.2	3.2	39.2	30.7	13.6	23.1	21.6	30.1	2.1	21.8	89.2	95.4	10.0	14.8	18.4	0.0	74.0	1.4	36.0	5.9	11.4	4.0	12.4	52.1	10.2	4.9	1.3	3.5	7.1	7.5	140.8	3.6	6.0	0.0	10.7	9.7	0.2	15.3	6.7	5.8	10.1	0.0	0.6	11.1	5.8	185.8	6.6	19.6	18.7	18.6	41.2	0.0	41.7	18.4	2.8	7.3	267.4	41.2	19.4	0.6	3.1	7.9	2.7	39.5	139.9	56.3	0.7	3.8	7.7	7.1	27.8	2.1	30.7	7.7	24.7
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	105.4	77.3	101.9	64.1	107.4	61.0	94.8	101.9	119.7	82.1	112.6	95.9	75.1	80.4	88.3	123.3	80.6	52.7	131.5	106.2	113.3	105.5	122.4	87.9	74.3	106.6	106.6	81.9	115.0	63.4	99.9	52.0	109.0	86.8	62.7	52.1	100.6	53.6	246.7	100.2	90.8	53.8	103.4	105.9	96.1	58.9	113.2	65.1	107.8	136.3	67.7	83.6	87.2	103.9	204.6	127.6	90.2	140.3	152.1	145.4	92.2	172.8	134.1	147.6	152.5	120.8	229.7	205.4	92.1	137.0	143.7	155.0	147.4	142.5	142.8	172.8	173.9	129.3	110.7	193.8	171.5	165.6	108.4	130.7	117.8	158.4	149.8	123.2	140.1	122.6	227.9	154.1	118.6	181.4	190.8	264.5	158.5	198.9	191.5	149.5	145.5	289.8	163.7	61.8	166.1	114.0	117.1	296.3	535.3	152.0	154.6	142.0	107.8	140.8	89.2	160.9	150.7	186.5	241.2	258.1	148.0	260.1	69.9	143.4	93.0	188.6	80.0	98.9	99.3	120.7	105.9	95.9	100.2	117.7	127.6	105.1	204.1	75.3	91.7	62.9	161.5	101.0	101.9	107.4	101.9	119.7	106.2	113.3	106.6	106.6	109.0	103.4	113.2	103.9	107.5	28.9	72.7	14.7	130.6	186.2	138.9	100.0	108.1	95.9	169.6	173.7	92.4	151.5	69.2	101.2	20.9	208.6	129.9	171.2	291.6	76.3	283.0	107.8	77.6	91.5	142.0	78.8	23.3	106.6	239.4	84.4	89.7	101.0	61.5	90.6	98.6	132.7	141.1	112.7	23.8	165.8	83.4	178.4	130.0	700.2	104.7	123.3	167.2	15.9	144.8	152.3	193.6	25.6	20.1	91.9	206.7	85.7	132.5	199.6	242.8	325.8	59.0	73.4	59.2	77.6	136.6	97.1	157.4	155.9	220.4	245.3	128.1	86.2	172.1	153.2
SSX1	CT5.1	ENSG00000126752	"SSX family member 1"	Q16384	X	48255392-48267444	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 6.8"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 24.2;Spermatogonia: 30.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Daudi: 66.1;Karpas-707: 90.5;U-2197: 22.7"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "					"unprognostic (2.25e-1)"		"unprognostic (3.51e-3)"		"unprognostic (2.36e-1)"	"unprognostic (4.32e-3)"				"unprognostic (3.38e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.94e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	90.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	22.7	0.1	0.0	4.8	0.1	5.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	24.2	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX2	"CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX"	ENSG00000241476	"SSX family member 2"	Q16385	X	52696896-52707189	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 15.0"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045683, HPA071685"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 29.9"	"Cell type enriched"	"Detected in single"	9	"Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.7;PC-3: 2.5;T-47d: 1.0;U-2197: 1.5"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	29.9	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.5	0.0	0.2	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.2	0.7	0.9	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX3	CT5.3	ENSG00000165584	"SSX family member 3"	Q99909	X	48346427-48356707	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 13.5"	"Group enriched"	"Detected in some"	26	"Spermatocytes: 52.7;Spermatogonia: 118.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"Karpas-707: 2.1"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "															"unprognostic (1.86e-1)"	"unprognostic (2.13e-2)"		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.7	118.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4	CT5.4	ENSG00000268009	"SSX family member 4"	O60224	X	48383516-48393347	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 2.2;Karpas-707: 5.4;U-266/70: 4.5;U-266/84: 3.3"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"		"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4B	OTTHUMT00000056510	ENSG00000269791	"SSX family member 4B"	O60224	X	48402078-48411910	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;Karpas-707: 5.4;U-266/70: 1.9;U-266/84: 9.0"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196795	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"Spermatogonia: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"BEWO: 4.7"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 28: BEWO - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.0	0.0	0.6	0.0	0.4	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.6	0.3	0.5	0.4	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644061-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;RT4: 1.7"									"HPA045683, HPA071685"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																"unprognostic (1.29e-1)"		0.0	0.0	0.4	0.1	0.5	0.2	0.0	1.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.7	0.4	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.2	0.7	0.2	0.1	0.6	0.2	0.7	0.2	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"ST14 transmembrane serine protease matriptase"	Q9Y5Y6	11	130159782-130210362	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 10.0"	"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 25.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 25.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA047014, HPA056258"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		1100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902, HPA056258: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	4.3	3.9	0.8	26.7	1.2	4.3	17.7	1.8	2.9	18.6	1.2	124.7	130.7	5.7	21.8	104.5	37.1	32.6	0.9	0.9	1.1	43.2	6.3	18.5	11.9	1.8	1.7	0.6	59.2	36.5	19.1	15.1	3.1	23.1	60.1	0.0	58.7	23.6	0.3	50.2	144.8	5.4	1.1	9.1	64.9	1.0	10.0	10.5	28.6	0.0	20.9	34.8	42.5	2.7	167.2	0.2	0.0	0.6	0.0	0.0	86.4	0.0	0.0	0.0	0.0	224.2	443.0	163.6	16.7	0.0	0.1	311.4	0.0	99.3	0.0	0.1	0.2	0.1	0.1	0.9	0.0	22.0	0.8	0.0	49.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	128.5	0.3	1.1	1.7	240.4	0.9	0.2	0.0	301.2	28.8	134.2	17.8	0.4	1.5	203.1	0.4	1.6	308.3	32.0	0.1	0.4	2.7	0.7	0.7	0.2	0.3	218.5	0.3	50.4	0.5	0.0	3.6	3.4	0.0	2.2	0.1	5.0	0.0	0.0	6.2	3.6	0.0	0.0	0.5	0.0	0.3	25.0	0.0	1.2	0.8	1.2	1.8	2.9	0.9	1.1	1.8	1.7	3.1	1.1	10.0	2.7	0.2	32.1	28.6	0.0	18.2	40.9	51.5	45.2	26.2	0.0	36.5	21.5	1.2	77.2	61.6	62.5	0.0	45.6	26.1	489.4	3.9	115.8	37.8	43.9	5.7	1.7	123.4	0.8	1.0	91.8	14.6	3.2	112.1	79.6	11.4	0.2	0.4	2.1	58.1	0.0	0.4	201.0	148.5	22.7	13.2	13.9	1.8	28.0	7.2	0.0	13.6	0.0	1.0	0.0	0.1	153.4	327.2	0.7	5.9	108.7	251.9	10.0	76.4	0.0	6.6	0.0	4.9	0.2	0.3	61.3	43.9	39.7	2.9	0.0	216.9	286.8
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375977-70439237	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	8.6	8.3	4.7	6.4	5.8	7.4	7.2	8.4	6.5	9.3	1.6	9.2	3.5	12.5	1.1	2.6	8.2	2.5	10.5	7.1	2.9	8.2	10.3	9.0	6.3	3.1	2.6	7.2	3.6	2.6	6.4	3.2	2.6	7.1	1.6	1.7	3.2	2.8	15.8	4.2	7.1	4.1	1.9	13.2	4.7	6.7	3.3	3.6	6.0	3.1	3.4	8.4	5.6	2.9	1.7	8.6	7.7	11.2	3.9	5.4	2.3	6.1	6.0	6.2	3.0	5.5	4.0	4.6	9.8	6.3	5.8	1.9	3.2	2.5	3.3	9.9	5.0	18.0	4.5	8.7	4.7	6.7	29.4	4.1	1.5	6.7	1.3	8.2	8.6	7.6	25.1	4.2	3.7	1.5	7.5	19.8	10.1	2.9	4.5	13.9	2.9	5.9	5.1	1.5	3.7	9.4	15.8	0.6	7.1	8.1	2.4	7.3	9.9	9.0	10.0	4.0	4.7	8.6	3.9	9.7	10.0	5.9	12.5	4.2	1.9	5.2	2.0	1.8	1.7	2.0	2.3	2.0	1.0	2.9	3.8	3.0	10.1	2.8	1.3	14.3	2.6	1.1	4.7	5.8	8.4	6.5	7.1	2.9	3.1	2.6	2.6	1.9	3.3	2.9	15.4	9.6	5.2	13.4	12.6	3.3	4.2	2.1	2.2	15.7	2.8	3.0	6.8	10.0	1.9	9.2	14.6	4.7	56.1	4.5	0.0	5.7	16.9	1.7	6.5	15.0	13.2	24.8	21.3	4.4	2.5	11.0	2.6	2.2	17.7	19.7	18.2	13.1	13.7	18.5	15.2	4.5	2.0	15.4	35.1	33.2	11.8	11.9	1.8	17.8	24.9	5.6	23.7	16.6	7.4	1.8	1.5	8.2	13.5	3.0	6.8	5.7	1.3	11.1	6.6	8.5	8.8	9.3	8.9	1.1	2.4	1.8	11.5	4.7	5.6	2.3
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643786	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 61.1;intestine: 195.9;stomach 1: 64.9"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 801.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	32	"T-cells: 8.9"	"Group enriched"	"Detected in some"	4	"K-562: 65.5;OE19: 107.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		3500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.9	0.1	6.0	12.6	5.6	2.8	2.0	5.7	9.2	61.1	4.5	155.3	62.5	5.1	3.9	24.4	3.8	18.3	3.4	5.5	6.0	0.4	0.1	5.7	1.2	6.1	6.0	0.8	0.7	0.1	0.0	2.1	6.4	6.9	195.9	1.0	26.3	0.5	1.4	0.9	75.8	5.4	5.8	14.6	64.9	3.1	6.1	0.2	0.3	0.9	2.3	3.1	4.5	5.6	0.2	2.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.4	0.2	11.9	0.0	0.0	12.4	0.0	2.9	0.0	0.0	0.0	19.5	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	65.5	0.0	0.0	0.0	0.2	0.2	0.0	107.5	0.4	0.0	0.0	0.4	0.1	0.7	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	1.3	0.9	6.0	5.6	5.7	9.2	5.5	6.0	6.1	6.0	6.4	5.8	6.1	5.6	8.6	16.0	7.5	0.7	0.3	0.1	5.7	90.2	12.0	0.1	0.1	0.0	2.0	17.2	143.4	0.0	0.0	0.3	0.0	133.3	0.0	1.4	0.3	85.1	7.6	27.2	33.0	6.7	0.4	18.2	0.1	1.3	65.7	77.6	0.0	0.3	8.6	0.0	0.3	0.0	0.3	801.0	50.8	0.0	0.0	0.9	1.5	1.1	0.0	18.7	0.0	0.0	0.0	1.5	0.3	42.8	76.1	0.0	0.0	2.4	51.6	0.0	117.4	1.2	0.0	0.3	5.3	0.4	0.1	12.8	0.1	0.1	1.8	63.3	123.1	24.5
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867480-77067546	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.9"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 480.3;Inhibitory neurons: 417.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.9;hippocampal formation: 5.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.7;fHDF/TERT166: 5.4;HaCaT: 2.7;SH-SY5Y: 4.1;U-2 OS: 4.4;U-251 MG: 2.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"hippocampal formation: 51.3"	"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	Yes		180000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA065593: AB_2685515, HPA070354: AB_2686260"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.1	3.0	1.5	1.5	1.1	0.0	1.2	0.0	5.9	0.7	0.0	1.8	0.2	0.1	0.0	1.0	1.9	2.2	0.5	5.5	0.0	0.1	0.0	3.6	0.4	0.0	0.0	1.6	0.1	0.0	1.9	0.1	0.0	1.0	0.6	3.2	0.5	0.3	0.0	0.2	0.9	3.0	0.0	0.2	1.5	0.3	0.0	0.0	0.0	0.0	0.3	1.6	0.6	0.0	1.2	0.0	4.7	0.0	0.0	0.0	0.0	0.4	1.5	1.1	0.4	0.0	0.1	0.0	0.0	5.4	0.0	2.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.1	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	4.4	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	5.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.5	0.5	35.6	0.1	0.0	0.0	0.1	0.0	20.7	2.8	1.7	1.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.2	1.9	0.4	0.0	0.0	480.3	0.0	0.1	0.8	0.0	0.2	1.3	0.9	0.0	0.0	0.1	0.0	417.3	0.2	0.0	0.0	0.0	2.3	0.6	0.1	0.0	8.4	0.0	0.7	0.0	10.6	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.3	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.1
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230176	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 184.1;Early spermatids: 131.4;Excitatory neurons: 191.5;Inhibitory neurons: 176.0;Oligodendrocyte precursor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	13.5	21.7	22.6	6.7	22.0	17.8	15.2	50.6	24.7	19.9	11.1	13.6	12.1	14.5	35.8	9.7	18.6	12.3	22.4	21.8	22.6	29.4	41.3	26.1	7.6	15.0	17.4	17.4	32.9	19.0	24.5	20.9	15.9	13.8	12.4	12.6	21.7	21.2	12.5	11.5	11.0	12.6	14.6	10.4	17.3	8.7	22.5	8.6	28.4	11.2	8.6	12.6	11.1	19.7	29.4	17.2	28.2	24.4	31.0	20.5	12.3	23.0	30.2	24.4	35.2	24.0	32.8	7.7	25.5	21.4	34.7	24.6	24.2	24.5	31.3	11.1	33.9	23.4	26.5	20.2	21.8	27.4	39.4	16.1	24.3	30.7	21.8	21.6	24.9	5.2	36.0	54.6	22.3	18.1	0.2	21.0	26.9	40.1	19.3	6.7	18.8	33.6	25.5	16.2	42.2	33.8	27.8	115.5	32.0	20.6	10.1	23.3	19.1	27.6	11.0	30.5	23.3	34.7	28.2	29.6	22.9	24.0	28.6	1.5	3.1	0.4	7.3	1.2	5.1	2.2	4.4	6.2	5.7	1.0	2.9	3.0	0.0	7.0	1.1	5.6	10.3	3.0	22.6	22.0	50.6	24.7	21.8	22.6	15.0	17.4	15.9	14.6	22.5	19.7	6.3	22.4	38.1	184.1	5.0	7.5	8.6	8.8	10.8	12.2	9.0	7.4	13.5	12.8	12.9	5.5	0.0	21.1	6.4	3.1	5.9	6.0	131.4	7.1	5.9	9.5	3.6	15.8	191.5	13.4	22.8	10.6	12.8	14.2	19.6	3.5	8.6	24.5	8.7	3.3	176.0	6.8	8.2	14.4	6.0	53.5	11.1	7.9	7.2	44.0	7.5	12.8	4.1	111.1	46.9	8.8	3.6	6.0	10.3	6.7	3.6	17.3	6.3	1.3	0.0	9.9	12.1	12.8	5.8	7.4	5.5	21.2	4.6	4.6	5.3	8.8
ST8SIA2	"HsT19690, SIAT8B, ST8SIA-II, STX"	ENSG00000140557	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2"	Q92186	15	92393881-92468728	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.4;heart muscle: 3.9"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 2.9;Cardiomyocytes: 4.3;Inhibitory neurons: 3.5;Muller glia cells: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.8;LHCN-M2: 7.7;RH-30: 11.7;RPMI-8226: 8.9;SH-SY5Y: 5.0;WM-115: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA054518, HPA057819"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA054518: AB_2682514, HPA057819: "	"unprognostic (4.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.87e-2)"		"unprognostic (2.32e-1)"	"unprognostic (1.28e-5)"	"unprognostic (3.91e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.00e-1)"	0.0	0.3	0.6	0.0	0.6	0.0	0.4	0.6	2.2	0.8	0.0	0.1	0.0	0.4	0.8	0.0	0.0	0.2	3.9	1.5	1.2	0.1	0.0	0.0	0.0	8.4	1.9	0.0	0.0	0.0	0.2	0.0	8.2	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.4	1.8	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.2	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.0	4.1	0.0	0.0	0.0	11.7	8.9	0.0	0.0	0.6	5.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.2	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	2.2	1.5	1.2	8.4	1.9	8.2	0.1	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	1.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ST8SIA3	SIAT8C	ENSG00000177511	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3"	O43173	18	57352557-57371731	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.7;pituitary gland: 8.1;retina: 7.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1"	"Group enriched"	"Detected in some"	11	"glioma: 0.9;pancreatic cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063398, HPA066783"	Enhanced		Supported	"Golgi apparatus"		No	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA063398: AB_2685004, HPA066783: AB_2685721"					"unprognostic (1.75e-1)"		"unprognostic (7.85e-2)"			"unprognostic (1.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.11e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.82e-1)"			0.0	4.3	8.0	0.0	21.7	0.0	0.0	6.7	15.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.9	0.0	12.5	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	8.1	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	9.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	21.7	6.7	15.6	12.5	14.5	0.0	0.0	0.0	0.0	2.1	4.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	1.6	5.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	63.9	56.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.7	0.0	1.2	0.0	22.1	3.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.2;brain: 17.0;parathyroid gland: 6.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 106.1;Inhibitory neurons: 75.5;Oligodendrocyte precursor cells: 32.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"		Yes	NA		24000		"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Midbody"		"HPA043813: AB_2678683, HPA046771: AB_2679798"	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.1	12.2	4.0	0.0	12.9	0.2	0.0	17.0	11.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	6.2	0.0	1.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	6.2	0.5	0.0	1.4	0.1	0.0	0.7	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.2	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	87.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	12.9	17.0	11.4	6.2	0.0	0.4	0.1	1.4	0.0	0.0	7.7	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	7.8	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.9	0.0	3.1	0.0	0.1	0.2	0.0	0.0	106.1	0.0	0.0	0.2	0.0	0.0	0.0	12.9	0.0	0.0	0.1	0.0	75.5	0.2	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.7	0.0	1.1	0.0	32.2	9.1	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.6	0.0	0.6	0.2	0.8	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.1
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins, Transporters"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 439.5"	"Cell type enriched"	"Detected in many"	4	"Hepatic stellate cells: 745.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	59	"classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	60	"dendritic cells: 2.5;monocytes: 9.4"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		96000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	194.2	160.4	41.0	50.4	42.9	13.8	84.5	41.4	58.3	54.4	62.8	87.7	29.6	45.3	8.5	29.2	79.3	25.8	74.6	41.9	44.4	85.6	102.1	104.7	12.9	50.0	48.4	32.2	32.2	5.0	52.0	55.4	53.7	57.6	31.0	0.6	45.7	16.0	25.9	24.0	95.1	33.8	43.0	439.5	53.2	21.0	65.3	6.8	55.1	4.6	8.2	105.7	48.6	47.8	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.2	0.2	0.6	0.0	0.0	1.8	0.1	0.0	0.1	0.0	103.1	0.1	0.3	0.1	0.0	0.0	0.0	146.9	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.0	0.0	128.8	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	9.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	41.0	42.9	41.4	58.3	41.9	44.4	50.0	48.4	53.7	43.0	65.3	47.8	31.3	0.0	3.8	0.0	5.5	6.0	0.6	0.0	1.8	1.0	1.5	2.7	2.4	11.5	0.0	3.7	0.0	1.7	1.9	0.0	0.0	0.0	0.5	0.4	0.5	43.0	1.2	21.5	0.3	0.0	2.0	3.3	0.5	0.3	18.3	0.0	745.0	19.7	130.7	0.0	0.3	0.0	0.0	185.4	30.3	2.9	4.4	147.0	12.4	30.0	21.9	0.5	2.1	0.5	0.1	0.0	0.0	20.3	2.0	0.2	0.0	0.8	0.0	0.1	19.7	2.0	1.4	0.9	2.2	1.5	4.8	2.2	2.3	0.5	0.0	0.2
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766719	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 65.9"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 145.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 11.5;HaCaT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026871, HPA072699"	Enhanced		Supported	Cytosol		NA	NA		1200000		"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA026871: AB_1857536, HPA072699: "	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.9	0.2	0.8	0.9	0.5	0.7	0.9	0.1	0.6	1.0	0.0	2.8	0.3	0.9	1.5	0.8	1.3	1.0	0.4	1.3	0.1	0.4	14.7	0.5	3.9	0.4	0.0	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.4	0.3	0.4	0.0	0.2	0.3	0.6	0.2	0.1	65.9	0.4	2.2	0.3	0.0	1.1	0.0	0.4	0.7	0.5	0.1	0.2	0.5	0.5	0.1	0.0	0.0	11.5	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.4	0.6	0.3	0.0	0.8	0.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.1	0.6	1.3	0.1	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.7	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	4.0	0.0	0.0	2.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	145.6	4.1	0.1	0.0	1.9	0.0	0.0	11.6	0.7	12.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336236-136752403	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA035015: AB_10603117, HPA058653: AB_2683787"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	13.7	9.1	7.6	12.3	8.8	15.7	15.6	17.0	8.3	16.9	9.9	13.5	9.6	19.3	10.6	10.8	13.5	10.3	10.5	6.5	8.7	12.0	10.8	11.2	14.7	9.3	7.8	21.9	12.4	13.7	5.0	17.6	9.0	10.8	14.4	13.2	11.6	12.1	15.0	13.7	11.0	16.1	8.8	11.8	10.0	8.9	7.8	22.5	15.8	15.8	15.9	12.0	11.5	11.2	34.6	17.6	29.1	25.1	21.5	36.8	15.7	37.9	48.4	35.0	33.0	30.2	14.9	26.9	23.3	39.7	28.1	23.4	31.6	17.3	47.4	33.2	14.9	28.8	25.1	16.7	16.3	50.6	27.7	23.4	19.3	25.6	28.6	20.3	27.5	28.8	18.7	52.7	22.3	29.5	33.6	16.4	19.0	23.7	13.9	29.6	31.6	35.7	19.1	24.5	14.2	22.8	40.8	16.0	17.5	15.0	22.9	21.2	23.3	40.1	29.0	36.0	33.9	39.1	28.9	59.5	24.6	17.0	26.2	4.0	3.0	4.6	4.4	3.0	4.6	6.4	3.7	4.0	2.8	4.4	4.1	3.3	8.7	5.5	3.5	4.5	4.8	2.1	7.6	8.8	17.0	8.3	6.5	8.7	9.3	7.8	9.0	8.8	7.8	11.2	44.5	25.6	24.2	95.6	42.4	40.0	31.4	18.7	38.7	43.8	24.8	26.7	10.8	22.8	23.5	16.5	39.6	29.3	39.5	42.1	11.7	20.7	2.8	23.7	59.5	34.1	18.7	29.7	161.8	22.2	26.7	33.8	23.9	39.6	22.2	30.3	31.4	21.5	18.6	28.6	166.8	27.9	8.2	16.9	22.0	4.8	49.4	25.1	16.0	231.4	27.2	25.6	42.2	223.2	188.4	27.4	17.5	32.4	53.1	27.2	24.2	13.2	14.5	68.1	26.3	67.1	36.2	54.8	50.5	27.5	36.7	31.7	39.2	16.0	23.4	24.3
STAG2	"SA-2, SA2, SCC3B"	ENSG00000101972	"Stromal antigen 2"	Q8N3U4	X	123960212-124422664	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002857	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA002857: AB_1079861"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.67e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.97e-1)"	27.9	22.9	20.7	34.2	26.3	72.8	41.5	32.6	24.1	33.3	30.4	28.8	23.8	35.7	28.3	26.8	30.1	25.2	21.5	18.0	22.6	33.7	28.5	28.6	45.0	26.2	21.9	46.0	31.7	51.9	12.0	35.8	27.8	29.8	28.2	45.5	26.5	29.6	23.3	26.1	26.5	25.8	24.2	37.4	28.5	8.0	21.2	81.4	49.3	36.0	44.3	28.4	17.6	39.6	62.6	56.9	84.5	53.0	34.9	52.3	54.4	58.0	61.8	58.5	73.2	53.8	65.1	115.0	79.6	52.3	65.5	55.6	173.6	48.8	82.5	81.9	74.7	106.6	110.8	35.7	35.6	140.7	80.0	42.2	46.4	69.5	111.4	50.2	49.7	114.2	105.4	118.9	43.1	67.8	180.6	62.9	44.5	55.8	84.4	125.9	112.0	96.1	44.9	117.3	75.7	60.6	131.2	47.7	66.9	59.2	28.9	62.2	61.5	0.3	31.1	69.4	66.6	50.9	82.2	141.6	36.8	84.3	60.3	28.2	15.2	28.0	15.0	18.9	17.8	15.0	15.6	14.6	19.1	19.0	21.3	17.5	44.5	18.8	23.1	16.5	13.5	10.0	20.7	26.3	32.6	24.1	18.0	22.6	26.2	21.9	27.8	24.2	21.2	39.6	71.1	64.1	56.6	42.4	80.9	56.2	61.5	31.5	72.3	51.0	58.0	48.4	44.9	37.1	50.6	44.1	60.5	32.2	113.4	42.9	21.5	42.3	1.1	65.1	70.4	62.3	58.1	77.0	41.8	38.2	32.7	64.5	39.8	79.3	58.1	53.6	59.3	42.2	36.0	45.4	51.9	35.0	28.5	71.4	65.0	4.2	65.9	89.9	33.8	70.3	91.4	61.2	97.9	69.4	114.0	54.9	29.3	69.2	73.8	81.4	28.0	35.7	51.4	62.9	65.7	104.0	60.3	14.8	15.4	51.0	56.1	71.4	87.2	49.5	38.9	83.6
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 1108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	15.6	11.6	21.7	14.6	30.6	13.3	20.2	29.7	23.8	19.3	19.3	21.5	20.7	20.6	15.5	25.4	18.3	16.9	22.3	20.6	24.5	21.9	19.0	15.7	19.3	31.3	28.0	17.7	12.2	24.3	9.3	17.3	30.4	22.1	23.2	14.6	21.5	15.6	37.4	16.7	20.4	21.3	27.9	14.9	18.2	15.8	27.1	23.2	22.6	42.8	21.6	16.8	16.0	38.6	39.0	44.0	34.0	31.6	31.1	37.2	39.1	23.3	31.7	42.1	40.3	73.7	35.9	32.2	35.8	19.8	55.7	30.0	36.6	81.7	47.6	56.6	41.3	43.3	29.1	58.1	43.4	35.8	50.0	30.1	57.6	49.6	70.7	53.5	25.1	43.7	47.9	47.8	1108.9	46.8	55.9	32.4	54.9	55.1	22.7	38.6	89.4	46.1	45.2	43.0	62.0	45.8	28.4	34.6	49.1	36.4	32.3	21.4	22.0	37.5	44.5	22.9	41.9	44.8	46.9	24.9	46.4	38.1	44.7	30.7	18.9	34.2	15.9	21.4	17.2	21.5	18.3	15.6	19.9	19.3	18.9	14.4	27.6	22.3	19.9	19.5	25.8	14.9	21.7	30.6	29.7	23.8	20.6	24.5	31.3	28.0	30.4	27.9	27.1	38.6	22.1	19.2	17.7	22.9	21.5	16.3	28.9	61.7	31.3	22.3	28.8	27.7	41.1	28.6	34.4	25.8	12.5	43.0	27.4	48.7	49.0	37.9	80.8	35.6	37.3	21.4	10.3	34.9	18.5	36.3	32.5	26.0	18.8	45.8	52.6	21.2	17.5	41.1	33.0	26.9	22.1	36.4	40.7	27.7	16.2	125.0	32.6	25.2	7.2	16.9	34.1	24.9	25.7	26.2	67.2	44.5	41.8	34.6	21.5	40.9	57.2	68.8	24.5	21.0	39.5	28.2	27.2	33.1	44.2	44.5	21.6	44.5	21.4	27.5	34.3	27.1
STARD10	"CGI-52, NY-CO-28, PCTP2, SDCCAG28"	ENSG00000214530	"StAR related lipid transfer domain containing 10"	Q9Y365	11	72754729-72794047	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 709.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 520.2;Hepatocytes: 660.0;Intestinal goblet cells: 717.9;Late spermatids: 2055.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 21.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 617.7;OE19: 1316.9;SK-BR-3: 427.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026661	Uncertain		Supported	Cytosol		NA	NA		13000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA026661: AB_1857538"	"prognostic favorable (6.92e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.04e-1)"	11.8	178.2	35.1	17.7	37.6	10.3	62.1	39.2	41.8	71.9	40.9	180.6	48.5	27.3	102.9	52.0	26.4	59.5	72.5	33.9	34.1	50.1	709.7	37.7	14.5	38.0	33.0	31.0	212.6	73.2	36.2	40.2	38.2	86.2	188.1	18.7	94.5	30.9	66.7	62.6	66.0	26.7	29.9	20.2	266.9	184.3	34.4	15.6	47.9	157.9	21.8	24.5	41.1	35.7	51.2	15.3	7.7	28.7	9.8	9.6	98.3	5.6	26.2	17.3	17.3	209.8	36.7	4.4	16.7	19.2	42.3	31.8	23.4	46.8	20.2	28.3	9.0	5.9	11.1	217.6	35.2	1.6	10.0	6.6	127.0	19.1	26.7	47.2	17.8	10.0	12.1	21.5	3.9	617.7	4.8	11.1	3.4	1316.9	20.1	4.5	13.3	3.4	23.5	61.4	13.0	10.1	8.6	427.4	73.3	32.8	235.5	6.3	13.6	17.0	11.4	6.0	10.1	22.2	19.8	7.5	4.3	5.6	6.5	12.9	2.6	16.0	1.6	1.1	1.2	4.2	1.5	1.7	1.2	2.4	1.6	1.6	21.7	7.5	0.6	2.6	2.1	1.1	35.1	37.6	39.2	41.8	33.9	34.1	38.0	33.0	38.2	29.9	34.4	35.7	10.6	35.3	74.1	8.1	18.1	31.5	76.3	41.0	25.0	10.5	163.3	125.3	45.3	270.2	76.4	55.2	22.9	212.8	17.1	362.8	123.3	70.7	520.2	26.5	6.8	18.5	302.2	22.9	11.6	94.3	93.1	21.1	372.1	25.3	25.4	10.1	30.0	660.0	26.4	33.7	13.9	717.9	85.5	26.0	34.4	2055.8	26.1	12.3	16.0	5.6	7.7	64.4	7.2	8.0	11.8	93.9	398.9	25.2	13.3	150.9	73.5	58.0	34.5	16.6	6.6	11.3	19.6	101.2	22.7	30.2	55.0	352.2	15.6	7.7	440.7	132.7
STARD5	MGC10327	ENSG00000172345	"StAR related lipid transfer domain containing 5"	Q9NSY2	15	81309053-81324183	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 28.0;Plasma cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 5.8;RPMI-8226: 6.2;U-266/70: 7.1;U-937: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040662	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Cytosol	"HPA040662: AB_10959593"	"unprognostic (5.35e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.84e-3)"	"unprognostic (7.55e-3)"	1.0	0.6	0.6	6.0	0.8	4.3	0.7	3.4	1.3	7.2	1.9	2.8	2.2	4.6	5.0	3.4	1.8	1.3	0.8	0.6	0.7	0.7	5.1	1.1	7.7	0.9	1.0	1.2	0.6	0.6	0.4	1.6	1.2	3.6	3.7	0.4	1.6	2.1	0.6	7.9	4.2	1.8	0.9	6.2	2.1	0.7	0.7	0.5	0.8	0.3	1.5	2.5	5.5	1.4	0.3	0.0	0.0	0.9	2.3	2.3	0.1	0.3	0.3	0.8	1.2	0.1	0.1	4.8	0.0	1.5	0.2	4.0	1.1	1.0	0.6	0.1	0.4	1.8	0.3	0.4	0.5	2.8	5.8	2.0	2.0	0.3	0.6	1.5	0.1	1.9	0.6	1.3	0.5	0.1	0.5	4.0	0.3	0.2	0.0	0.1	0.7	6.2	0.3	1.4	0.3	0.1	0.1	0.5	0.6	0.3	0.6	0.6	0.2	1.3	0.6	1.3	0.1	7.1	1.5	1.8	0.9	6.8	0.4	5.0	1.8	2.3	3.0	2.4	2.5	1.0	2.7	3.2	2.6	0.7	3.9	3.9	1.3	2.6	2.3	1.4	3.6	3.7	0.6	0.8	3.4	1.3	0.6	0.7	0.9	1.0	1.2	0.9	0.7	1.4	3.8	0.0	1.1	0.0	11.4	13.3	12.0	28.0	10.8	1.8	2.7	4.2	0.3	0.0	4.9	0.0	6.2	2.5	4.2	22.1	3.9	1.3	15.2	2.5	14.4	2.5	11.4	2.5	2.2	1.4	4.0	8.5	15.8	2.3	10.2	1.0	3.6	25.4	5.2	1.7	2.0	24.3	2.0	7.9	10.9	1.5	5.0	8.0	1.8	1.9	0.7	1.2	2.1	0.0	0.4	1.8	14.4	9.8	31.5	3.3	23.9	0.7	4.0	0.9	0.0	3.8	2.8	0.9	0.7	19.6	16.3	4.9	4.2	6.3	19.9	9.6
STARD7	GTT1	ENSG00000084090	"StAR related lipid transfer domain containing 7"	Q9NQZ5	2	96184859-96208827	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033965, HPA064958, HPA064978"	Supported		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.56e-5)"	"prognostic favorable (3.89e-6)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.72e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.38e-6)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.42e-2)"	44.7	54.3	57.8	46.7	62.4	34.3	43.9	61.9	53.2	33.9	60.6	57.6	55.7	29.8	30.5	36.8	44.0	29.1	98.5	49.8	61.4	80.3	62.8	61.1	70.6	56.4	55.5	29.4	42.2	69.7	23.6	29.3	54.9	39.0	56.2	54.4	65.2	45.7	202.5	35.2	45.4	37.6	60.5	53.1	44.6	21.1	66.9	56.2	56.6	174.0	86.9	42.1	27.0	74.4	128.8	79.1	102.3	106.2	134.9	66.9	150.1	122.6	107.0	121.2	129.6	188.8	117.7	228.7	129.0	98.6	95.8	102.3	183.3	106.4	157.3	147.2	131.9	204.1	74.3	218.3	62.2	158.1	106.9	65.4	77.9	101.0	99.1	77.2	123.2	92.6	211.1	89.2	108.8	113.0	175.9	161.0	173.3	110.3	115.2	171.6	156.4	227.1	73.2	162.2	191.6	90.5	62.5	201.8	115.8	126.0	60.5	171.6	103.8	100.1	100.4	112.0	125.8	113.9	114.0	201.7	92.8	174.9	112.6	35.6	25.4	22.7	25.6	30.2	26.1	42.6	21.5	26.6	36.2	37.8	23.6	23.4	3.0	30.8	19.9	42.2	41.5	26.0	57.8	62.4	61.9	53.2	49.8	61.4	56.4	55.5	54.9	60.5	66.9	74.4	32.0	134.6	44.2	21.5	71.2	63.7	43.2	34.3	101.9	39.5	58.1	50.2	176.9	55.8	47.1	46.0	108.4	35.8	83.8	63.3	74.3	32.4	2.5	34.5	43.2	49.9	44.4	48.6	25.6	38.0	40.3	31.3	37.8	48.6	15.8	45.4	41.7	114.7	71.0	40.4	23.8	58.4	24.4	122.4	102.3	6.9	23.3	54.4	42.7	20.6	95.8	38.4	30.9	19.1	42.6	35.8	26.6	25.2	120.6	68.4	50.1	65.7	31.8	58.1	26.3	43.5	43.0	22.7	35.1	75.4	57.4	35.4	62.9	36.8	81.9	38.8
STK16	"MPSK, PKL12"	ENSG00000115661	"Serine/threonine kinase 16"	O75716	2	219245455-219250337	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029450	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA029450: AB_10603118"	"unprognostic (1.99e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (6.09e-4)"	"unprognostic (6.21e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	15.2	24.9	17.6	11.8	17.5	15.0	16.2	16.3	20.5	14.0	19.5	20.0	17.3	13.8	20.8	22.8	18.1	13.0	19.0	16.5	16.8	26.5	43.2	14.3	17.6	17.9	17.5	14.8	30.9	22.7	19.8	9.2	16.9	20.3	13.5	7.9	20.0	10.9	14.4	17.3	17.8	9.9	17.4	21.2	24.2	27.7	18.6	20.5	19.3	8.2	14.5	17.8	14.8	16.5	14.1	18.8	15.7	13.2	40.0	40.0	17.9	17.8	23.6	14.3	14.7	21.2	31.0	8.3	24.4	32.0	23.4	14.5	18.5	30.0	7.8	20.0	19.8	17.7	15.4	19.1	34.9	17.6	20.1	40.1	48.1	20.8	57.4	29.8	17.9	18.7	23.1	21.5	26.8	27.1	19.4	38.0	14.5	25.7	10.3	18.1	17.5	24.9	32.2	16.1	12.3	14.6	5.8	25.5	39.0	11.2	27.4	36.4	13.7	20.6	14.0	16.4	17.4	25.9	12.1	19.5	22.9	18.4	18.3	1.6	7.0	5.3	4.9	3.8	5.5	7.2	6.0	9.2	6.8	6.0	6.1	7.9	4.1	14.5	3.1	5.8	7.3	8.7	17.6	17.5	16.3	20.5	16.5	16.8	17.9	17.5	16.9	17.4	18.6	16.5	11.8	6.4	5.6	3.6	22.4	9.8	18.1	32.6	24.5	7.9	31.8	31.8	9.5	24.3	19.7	7.3	16.7	24.0	23.6	27.6	68.4	40.3	87.2	21.4	13.3	14.0	25.8	36.0	2.2	58.5	25.0	15.8	17.3	12.9	8.2	17.9	12.5	43.7	28.4	13.5	2.7	38.7	16.2	27.1	17.6	70.3	15.2	17.8	21.4	0.0	38.4	22.1	44.3	4.0	6.8	33.3	44.3	13.5	27.6	18.6	58.9	80.2	19.6	19.1	0.0	11.9	19.2	43.1	9.6	28.2	11.2	12.9	22.1	33.6	34.2	20.8
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43650713	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 644.6;T-cells: 273.7;Urothelial cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	6.7	8.1	3.9	7.9	4.2	4.8	5.2	6.9	4.9	4.0	4.0	6.4	3.2	3.5	1.2	7.2	3.9	5.3	10.8	4.0	4.1	6.3	4.6	9.4	14.4	3.4	4.4	6.2	9.1	0.8	4.2	3.2	3.6	4.3	2.4	5.5	5.8	2.1	9.9	4.6	11.5	3.3	3.6	12.6	9.5	9.0	4.3	9.0	3.8	2.5	13.5	5.6	5.0	3.1	5.8	8.2	9.0	5.3	7.8	8.3	1.9	12.3	15.1	6.6	5.9	7.5	3.1	7.9	20.2	15.3	17.8	8.5	3.6	17.4	10.4	16.9	7.0	9.3	8.2	8.4	4.9	21.1	5.6	6.4	26.4	8.2	8.6	36.4	12.6	11.0	16.7	15.1	9.6	3.6	18.2	8.0	17.3	4.1	18.3	8.4	6.9	14.2	15.6	6.7	6.9	11.2	8.1	8.5	6.1	13.6	6.5	10.8	16.9	20.7	8.3	14.3	17.2	13.3	11.2	13.5	18.4	14.0	31.7	0.5	0.0	2.7	2.0	0.0	1.5	2.4	2.0	3.2	0.1	2.2	3.0	3.0	1.6	4.9	0.1	0.4	1.3	0.9	3.9	4.2	6.9	4.9	4.0	4.1	3.4	4.4	3.6	3.6	4.3	3.1	44.2	121.8	33.1	29.0	237.8	181.9	644.6	64.5	99.6	2.9	17.7	37.8	28.7	7.2	69.8	20.2	10.4	54.8	222.3	54.4	33.2	153.0	47.0	129.1	17.4	35.2	7.2	54.1	9.5	95.4	23.3	39.1	78.0	88.3	38.8	17.7	17.9	9.6	16.9	0.0	5.6	34.3	38.7	20.3	65.9	14.7	5.9	60.9	35.6	34.7	42.1	7.9	221.4	39.2	3.7	89.4	73.0	2.6	81.2	192.6	23.8	13.2	42.4	26.3	6.6	39.4	51.3	75.8	36.1	42.3	136.1	66.8	273.7	27.0	18.0	326.1
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol		No	No		1100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavorable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favorable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	71.4	32.4	30.9	49.0	32.6	58.0	60.9	34.3	34.4	99.1	49.4	75.1	83.0	53.9	58.4	167.9	50.7	55.8	49.1	34.2	29.0	77.0	32.4	54.1	67.0	29.0	35.5	44.2	48.0	42.4	31.1	57.5	27.2	49.6	72.3	31.7	70.4	51.2	47.1	154.4	94.4	48.2	28.5	51.5	78.3	36.9	41.3	68.2	55.0	38.8	74.1	86.6	113.9	29.2	161.8	49.4	85.6	79.8	128.6	76.4	121.3	73.8	103.0	100.9	97.7	145.7	212.6	114.1	36.6	92.8	63.1	142.1	80.2	162.3	95.5	286.3	41.2	122.0	59.8	84.2	181.0	124.4	82.8	49.8	253.7	79.3	231.6	106.2	88.2	88.0	45.2	76.6	67.0	70.3	93.5	51.1	76.9	217.3	36.6	116.5	52.5	62.3	98.1	143.2	49.8	71.4	46.7	74.2	103.0	129.7	89.6	119.1	120.0	63.8	46.3	52.8	86.5	74.1	41.7	42.5	99.3	74.0	107.4	5.7	12.7	6.3	5.5	10.9	6.6	6.1	10.2	8.0	10.9	7.9	6.9	5.6	10.9	1.5	13.5	7.1	13.7	6.7	30.9	32.6	34.3	34.4	34.2	29.0	29.0	35.5	27.2	28.5	41.3	29.2	36.2	12.8	27.4	27.7	37.4	70.9	83.6	51.2	20.5	20.3	41.5	33.5	3.0	55.8	55.8	68.0	56.3	39.2	36.9	203.8	25.4	35.8	3.5	74.2	48.7	32.5	42.6	41.4	39.2	55.0	45.9	43.2	65.7	99.6	18.4	49.1	25.0	26.6	28.0	10.1	34.2	86.0	24.4	82.2	57.9	5.9	26.8	58.4	56.9	49.6	47.6	25.5	20.6	35.7	11.1	84.4	96.5	30.5	25.5	60.4	111.8	39.2	51.6	11.0	39.5	47.7	41.0	2.9	21.2	61.9	82.1	20.0	45.5	20.4	59.1	153.3
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023302-132075943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 70.0;epididymis: 56.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 140.1;U-937: 144.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		Yes	No		360000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: AB_2684163"	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	6.0	2.5	1.0	15.2	2.7	70.0	6.0	1.7	1.3	6.8	2.5	11.5	9.6	46.6	56.3	13.1	7.4	5.6	1.4	0.7	1.5	3.5	5.2	7.2	26.2	0.8	0.8	2.1	3.7	23.5	5.0	25.2	0.7	20.0	11.6	0.2	7.3	35.8	0.9	7.8	6.9	38.1	0.6	13.2	12.2	2.2	3.8	41.3	3.7	1.2	23.5	11.8	7.4	0.7	32.9	11.3	1.3	0.0	5.2	4.9	72.0	1.0	4.0	0.5	0.6	30.1	29.0	44.6	19.4	7.3	22.1	36.5	80.8	51.1	0.0	39.1	66.6	64.6	25.9	28.4	4.7	135.3	5.1	6.9	30.0	0.1	33.7	15.1	14.2	60.0	29.2	40.4	12.2	29.0	140.1	124.9	64.4	22.0	4.3	99.9	39.7	57.9	32.6	51.8	26.6	29.6	19.2	17.0	0.9	54.9	22.0	35.4	0.3	12.8	13.7	39.0	47.9	31.0	52.0	49.8	11.7	144.8	6.5	59.1	9.5	31.6	22.8	12.4	22.4	14.5	15.2	19.6	11.3	12.6	19.7	20.6	18.2	41.0	22.7	4.2	7.2	20.4	1.0	2.7	1.7	1.3	0.7	1.5	0.8	0.8	0.7	0.6	3.8	0.7	0.9	22.4	15.6	0.0	24.7	0.0	36.4	0.0	6.8	0.0	5.9	10.9	1.3	5.7	8.1	11.0	0.0	55.2	42.7	6.5	3.9	4.5	0.6	7.4	1.8	1.7	1.2	12.8	2.0	7.1	34.7	9.6	15.3	17.9	11.4	0.5	1.4	4.4	11.8	0.0	1.4	4.8	0.0	8.8	0.0	0.4	3.4	17.3	0.0	2.8	13.5	0.0	53.5	0.0	0.2	10.9	4.0	2.2	14.5	33.6	1.9	1.5	6.6	0.0	6.6	6.7	3.6	1.8	2.5	16.1	0.0	59.1	27.4	0.6	6.5	18.2
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98371228-98942827	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 152.7;Oligodendrocytes: 189.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.9;granulocytes: 8.8;monocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"A-431: 85.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	15.1	14.4	5.6	7.9	7.0	3.5	14.1	6.6	7.4	17.4	7.2	13.1	5.5	24.9	14.3	10.2	17.0	14.2	9.1	5.1	6.3	15.6	14.3	11.1	5.5	7.7	6.7	25.0	10.0	16.1	6.4	18.5	7.4	16.5	6.7	12.0	10.7	17.6	11.4	9.6	8.3	17.2	6.3	6.8	8.5	11.4	7.1	5.1	11.9	8.6	5.5	13.6	13.7	7.9	85.3	15.7	16.2	22.0	51.2	25.4	16.4	28.8	25.6	26.3	22.8	11.7	35.7	0.0	25.6	28.7	14.1	33.4	11.4	24.8	42.2	20.5	14.8	22.9	7.2	8.0	17.5	7.7	19.0	17.0	41.9	13.5	36.6	17.2	11.5	13.4	9.8	12.2	19.4	10.7	19.3	9.4	4.9	58.0	6.1	17.1	14.1	7.5	29.9	10.7	4.3	9.6	18.4	21.1	18.2	21.0	17.8	12.3	8.7	17.9	11.5	27.1	16.3	9.8	15.5	6.2	15.9	9.5	29.0	2.0	8.3	4.6	1.3	8.5	1.4	1.8	0.7	1.8	7.9	1.1	1.0	0.6	8.8	2.0	5.4	3.3	0.1	2.8	5.6	7.0	6.6	7.4	5.1	6.3	7.7	6.7	7.4	6.3	7.1	7.9	25.9	38.5	37.4	132.9	6.0	43.7	44.8	25.3	23.3	6.9	29.0	15.5	16.6	31.5	37.7	29.5	14.6	43.6	2.5	11.7	23.5	21.5	118.3	23.7	65.8	31.3	9.1	16.2	34.3	18.9	56.1	39.8	9.7	28.9	17.1	13.3	24.3	23.7	19.2	10.1	33.5	7.8	26.4	17.0	25.1	77.1	91.0	18.6	24.9	152.7	13.8	15.0	3.1	60.3	189.9	24.9	13.1	74.1	6.2	42.1	32.3	25.0	29.0	15.6	39.5	43.8	39.7	16.7	12.6	12.3	40.5	64.7	5.9	47.0	13.8	36.0
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051480-5500994	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0;lymphoid tissue: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 108.2;Late spermatids: 39.3;Microglial cells: 27.2;Oligodendrocyte precursor cells: 169.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.5;HUVEC TERT2: 27.5;REH: 25.2;U-2197: 43.8;WM-115: 112.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	3.5	0.3	2.3	1.2	7.8	1.5	4.3	1.9	2.3	3.3	1.5	1.1	0.5	3.5	0.3	1.2	1.3	1.4	0.4	2.1	4.5	15.0	0.1	0.9	1.8	3.7	3.9	0.6	1.8	0.3	0.4	3.2	3.7	0.6	1.1	0.8	1.0	0.9	1.3	2.4	1.1	2.5	3.6	0.2	6.0	4.5	3.5	19.5	1.7	1.7	1.0	3.1	1.5	3.6	0.0	14.0	0.8	0.0	0.6	1.0	0.0	9.7	1.1	6.3	0.2	0.1	0.0	0.0	2.1	19.7	27.5	0.1	1.5	0.0	2.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.2	27.5	1.4	0.0	0.1	3.4	0.0	0.0	2.0	4.1	0.0	0.0	25.2	0.1	0.0	6.2	0.0	0.4	0.0	0.0	0.1	8.5	0.6	0.0	0.0	7.1	0.2	2.8	43.8	0.0	0.9	0.1	0.0	0.1	0.0	112.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	7.8	1.9	2.3	2.1	4.5	3.7	3.9	3.7	3.6	3.5	3.6	3.6	0.0	1.1	1.6	0.0	2.3	0.2	0.0	0.0	0.0	4.2	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	17.6	1.1	108.2	0.2	0.1	3.2	0.0	0.0	3.7	0.0	0.1	5.5	4.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	14.4	0.0	0.0	0.0	1.2	39.3	1.5	1.1	5.4	27.2	0.5	0.0	0.0	169.4	1.3	0.4	0.0	1.2	0.0	0.1	0.0	18.9	0.0	0.0	0.0	0.6	0.4	1.2	5.5	0.0	1.0	0.0	0.2	0.4	0.0	0.1
STK36	"FU, KIAA1278"	ENSG00000163482	"Serine/threonine kinase 36"	Q9NRP7	2	218672069-218702716	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Respiratory ciliated cells: 38.2;Spermatocytes: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027409, HPA027453, HPA030058"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225"	"unprognostic (8.11e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.83e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-3)"	5.6	9.9	1.5	5.4	1.7	2.5	6.6	1.0	3.2	14.1	15.4	9.0	4.4	11.4	13.4	5.1	14.3	10.5	3.5	2.3	1.0	7.3	4.5	7.3	4.5	1.2	2.6	13.4	10.7	9.4	14.8	4.3	0.8	9.6	6.5	11.6	7.3	8.2	3.7	5.0	6.4	8.0	0.3	5.1	8.8	32.0	1.3	3.2	11.8	2.3	4.0	8.2	7.6	1.0	3.7	8.2	17.6	15.0	18.7	14.5	10.9	9.8	7.8	12.2	11.4	10.7	6.0	4.8	13.3	10.3	8.2	7.2	12.2	10.3	10.7	2.8	10.2	4.7	27.1	15.0	9.1	6.7	7.6	15.7	7.5	12.0	8.4	32.3	9.3	6.2	11.1	6.0	10.3	8.5	4.0	8.5	10.7	4.6	5.2	7.3	7.6	5.1	14.9	18.2	14.2	12.3	7.6	12.2	5.0	18.2	12.4	5.3	8.9	16.8	6.1	6.5	6.8	7.5	6.3	2.5	10.4	3.1	7.1	0.0	0.4	0.7	0.3	0.2	0.1	0.4	0.2	0.2	0.3	0.1	0.2	0.3	0.0	0.5	0.3	0.3	0.2	0.4	1.5	1.7	1.0	3.2	2.3	1.0	1.2	2.6	0.8	0.3	1.3	1.0	2.1	9.6	6.3	18.3	1.6	1.1	0.9	3.6	2.8	7.4	7.4	5.5	4.0	5.7	3.7	3.7	37.5	1.8	2.9	2.9	0.0	3.7	16.9	17.5	9.0	3.3	2.4	0.8	22.0	2.5	1.5	4.5	10.7	6.3	1.3	12.2	3.3	5.9	2.7	1.7	18.0	4.4	6.1	2.5	1.2	6.0	5.9	2.0	0.0	2.8	2.5	4.9	1.0	8.5	6.2	2.2	5.0	4.9	0.6	1.6	2.5	4.4	38.2	9.1	6.6	3.1	4.0	28.0	8.9	3.7	1.0	0.8	1.5	11.0	4.9	0.9
STK38	"NDR, NDR1"	ENSG00000112079	"Serine/threonine kinase 38"	Q15208	6	36493892-36547479	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (3.58e-3)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.13e-3)"	27.6	11.5	13.2	28.9	13.6	30.6	23.2	15.8	18.1	23.5	15.2	40.4	24.0	21.3	12.5	39.6	21.4	20.7	24.2	14.2	13.4	23.1	24.7	24.9	34.5	14.4	13.4	16.0	12.5	8.3	14.4	21.7	13.6	23.8	36.5	11.3	33.6	16.0	16.1	30.6	41.6	27.4	13.0	34.6	23.2	13.8	14.8	28.0	14.0	16.2	33.8	30.0	28.4	14.2	43.0	31.1	32.1	34.8	63.4	47.9	27.9	46.7	37.6	47.6	47.4	24.0	28.7	57.3	35.3	70.0	39.5	44.7	26.9	19.6	55.7	23.6	23.0	41.1	40.8	21.9	31.2	15.8	21.7	31.9	50.0	36.9	23.6	54.5	30.1	28.7	34.0	32.4	68.5	25.7	25.5	40.8	13.4	50.5	27.3	97.7	38.9	15.3	45.0	52.9	37.4	17.7	57.0	25.9	34.0	35.7	27.8	40.8	29.4	38.4	33.6	30.9	30.7	27.1	51.4	39.9	8.7	60.1	37.8	91.2	45.2	34.6	57.0	49.5	44.1	22.4	46.9	50.4	29.1	16.2	41.1	45.8	59.4	59.3	73.3	14.4	48.7	58.3	13.2	13.6	15.8	18.1	14.2	13.4	14.4	13.4	13.6	13.0	14.8	14.2	29.7	19.2	16.0	27.4	25.7	13.5	9.6	21.5	21.1	3.0	16.0	14.5	15.5	18.6	47.9	7.3	0.0	13.8	59.5	47.1	1.9	18.9	9.0	15.3	16.0	18.4	14.4	16.6	46.5	12.7	17.8	22.2	34.7	20.4	13.3	13.5	12.1	15.0	13.2	5.0	34.2	25.4	22.4	38.2	20.3	5.3	27.1	40.1	17.8	57.1	48.7	7.6	101.0	38.2	36.8	27.8	30.8	30.1	39.6	12.8	32.8	16.6	40.4	7.7	13.1	8.3	14.0	26.5	10.3	31.5	21.2	15.3	45.5	10.1	28.4	27.9
STK38L	"KIAA0965, NDR2"	ENSG00000211455	"Serine/threonine kinase 38 like"	Q9Y2H1	12	27243968-27325959	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 49.9;granulocytes: 80.7;monocytes: 33.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038623, HPA051324"	Approved		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.05e-2)"	23.9	11.6	6.5	21.6	8.6	17.2	14.0	6.9	11.1	17.2	6.4	28.9	12.9	27.1	7.5	22.7	15.1	25.7	44.9	6.7	8.6	12.9	12.5	12.3	12.4	8.1	7.5	7.0	12.3	26.9	7.2	15.7	8.4	20.2	21.2	6.6	13.8	15.0	8.8	10.8	14.3	33.3	7.6	12.0	18.6	11.2	9.5	17.8	9.2	16.4	14.8	24.6	15.5	6.8	12.0	15.7	40.1	17.7	18.6	12.4	30.8	7.7	11.5	4.8	6.5	19.8	8.5	29.3	17.7	6.4	13.6	21.9	19.0	13.4	7.2	157.8	17.3	18.7	17.5	10.0	15.5	43.7	19.7	14.7	13.3	17.6	21.7	29.3	38.1	36.8	21.2	21.1	9.7	8.3	28.5	46.3	49.6	31.2	25.4	10.6	47.8	22.4	6.8	22.0	6.7	22.3	33.1	19.9	13.3	38.6	9.8	14.0	16.4	15.5	13.9	23.7	20.3	7.7	8.1	29.1	8.0	19.9	6.7	16.3	33.0	60.8	10.0	28.4	7.0	11.6	7.7	9.8	49.9	9.3	9.4	7.6	80.7	11.6	22.4	21.2	10.8	14.7	6.5	8.6	6.9	11.1	6.7	8.6	8.1	7.5	8.4	7.6	9.5	6.8	24.4	19.2	16.2	32.7	20.8	35.4	36.3	88.2	22.2	12.7	16.2	14.7	76.0	10.0	33.7	9.2	2.1	11.0	21.7	33.6	9.8	49.8	23.1	12.5	15.3	26.2	19.2	15.4	57.2	40.1	9.1	19.7	15.3	14.9	17.7	10.9	24.3	14.5	28.8	10.1	37.5	33.8	18.3	36.4	73.7	5.9	6.5	45.7	21.4	37.5	46.2	8.1	14.4	42.3	16.0	70.5	26.3	12.0	22.8	24.8	9.2	16.2	11.9	7.9	19.7	8.6	41.1	12.1	13.4	20.5	32.0	27.8	15.7	9.7	23.0	42.0
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966479-45080021	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Cell type enhanced"	"Detected in all"		"B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	10.0	8.5	6.9	33.8	8.0	57.7	9.1	6.2	10.8	7.9	9.9	11.1	10.2	8.5	7.6	9.1	6.2	11.7	4.6	7.2	8.7	6.0	9.2	15.9	43.1	8.7	7.6	7.0	6.0	5.9	4.1	10.4	9.2	6.7	13.0	7.3	7.4	8.0	3.3	11.2	13.5	9.3	8.3	30.4	12.7	9.7	7.5	33.1	7.6	4.9	41.7	15.0	6.9	10.3	27.8	18.7	23.3	16.1	13.5	16.9	16.0	23.6	35.7	39.4	35.6	52.7	14.6	66.6	20.4	16.9	33.4	28.5	24.3	31.8	49.7	30.8	13.8	48.6	27.8	36.8	23.8	63.5	66.4	13.8	25.6	36.7	39.6	19.4	14.6	44.6	23.5	37.0	19.9	21.7	47.6	42.3	13.9	17.7	12.5	30.2	25.2	31.2	14.4	18.7	10.9	13.2	35.6	20.0	27.0	17.2	18.3	39.1	18.7	29.2	28.6	34.4	27.8	48.4	41.7	73.2	28.6	29.5	22.0	80.6	19.7	54.8	34.4	19.9	34.3	26.2	32.2	32.0	18.4	26.9	33.1	28.0	101.8	28.5	38.0	10.0	34.3	22.3	6.9	8.0	6.2	10.8	7.2	8.7	8.7	7.6	9.2	8.3	7.5	10.3	26.2	16.0	24.6	18.9	372.8	55.7	49.3	33.8	28.5	27.3	22.9	17.4	7.6	14.3	25.2	42.3	52.1	24.1	341.8	23.7	9.8	16.3	5.9	19.1	25.1	32.1	25.7	46.3	76.7	17.6	30.3	29.7	34.1	25.1	133.6	114.0	26.0	22.0	61.1	43.7	38.2	20.7	28.5	109.3	606.9	5.0	22.7	154.4	133.4	85.3	367.5	20.2	278.1	34.2	48.1	21.6	27.9	17.0	336.2	32.6	23.2	13.4	26.1	69.9	13.1	25.5	29.2	44.2	42.4	20.9	53.0	19.4	414.5	48.1	19.5	45.5
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 951.6;lymphoid tissue: 1343.2"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 2537.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 424.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 424.6;T-cells: 143.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 3270.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010107, HPA068438"	Enhanced		Approved	Cytosol		NA	NA		320000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB010107: AB_628297, HPA068438: "	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	56.4	69.1	526.8	103.8	568.0	260.5	60.6	514.2	951.6	57.7	333.6	93.2	70.5	129.8	40.7	115.9	45.2	51.1	56.0	573.2	568.2	77.7	35.8	60.7	253.2	560.1	516.8	172.4	23.2	43.8	103.5	120.1	552.4	31.7	110.6	304.7	43.4	32.7	29.5	56.3	89.1	100.0	537.1	72.8	54.5	387.0	531.7	1343.2	33.6	29.9	246.0	58.9	76.0	791.9	1026.8	226.1	2191.0	882.5	128.9	126.0	225.7	776.3	609.7	1081.9	1037.9	157.2	1018.3	1260.3	426.3	572.0	425.8	304.6	618.6	450.9	1616.1	390.4	310.9	786.0	363.3	547.6	51.9	994.6	529.3	77.0	65.6	439.6	496.8	405.5	833.6	1594.4	1074.4	1203.0	1429.6	268.0	3270.7	1441.5	1350.8	615.1	302.8	1907.9	1709.2	740.7	536.9	91.7	1479.2	1282.3	710.0	348.3	638.4	695.8	500.7	1240.1	406.2	721.8	853.6	634.3	664.8	702.5	1212.0	1535.8	357.7	1904.8	798.2	13.4	4.1	23.5	53.9	8.6	32.2	37.0	47.8	68.2	23.2	45.6	77.8	71.6	1.9	56.3	4.5	424.6	143.3	57.2	526.8	568.0	514.2	951.6	573.2	568.2	560.1	516.8	552.4	537.1	531.7	791.9	257.3	41.7	31.6	32.7	125.1	201.6	148.9	350.0	577.7	454.6	91.0	175.1	77.2	31.5	100.0	174.7	64.6	439.3	261.7	35.1	226.9	148.9	917.2	92.8	100.3	196.3	250.8	505.7	109.5	20.1	604.1	134.9	121.3	141.1	262.0	712.4	109.2	15.4	530.1	195.2	73.0	100.9	567.6	87.3	287.0	2537.2	44.7	130.0	268.6	32.8	32.1	252.4	84.5	38.2	217.4	59.0	69.3	47.0	261.7	63.5	21.0	221.4	59.1	183.6	39.5	68.0	267.6	873.0	260.8	423.9	90.4	130.4	224.9	66.5	177.1	95.7
STOX1	"C10orf24, FLJ25162"	ENSG00000165730	"Storkhead box 1"	Q6ZVD7	10	68827531-68895432	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2;choroid plexus: 30.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 85.2;Endometrial ciliated cells: 67.4;Respiratory ciliated cells: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.6;HAP1: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037844, HPA037845"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Intracellular and membrane"	No	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA037844: AB_2675700, HPA037845: AB_10671369"	"prognostic favorable (3.37e-5)"	"unprognostic (5.53e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"prognostic favorable (2.08e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.33e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.46e-2)"	6.3	5.1	26.4	0.5	23.6	0.2	4.2	14.9	33.2	1.9	30.8	1.6	1.1	1.6	7.4	1.4	12.5	0.9	0.4	23.9	22.4	2.8	0.3	1.3	1.2	16.5	24.9	1.1	1.4	6.5	7.2	0.8	17.4	1.2	1.6	0.7	1.6	1.1	1.3	0.9	2.1	0.8	16.3	0.4	3.4	2.5	26.2	6.7	3.1	0.8	1.0	2.5	0.7	20.5	1.8	2.0	4.2	8.6	1.8	0.0	2.5	0.2	0.1	1.2	1.3	1.8	2.6	1.7	2.4	0.0	3.3	0.5	8.1	0.0	0.6	2.0	3.4	0.1	0.4	2.6	0.2	2.3	3.1	0.2	0.1	0.2	0.0	0.2	0.1	4.5	0.4	0.2	0.1	1.8	3.9	2.8	1.4	0.4	1.2	2.8	0.1	0.0	2.6	4.6	1.3	3.9	3.1	0.8	0.6	2.7	1.9	1.8	0.0	0.0	0.2	0.0	1.3	0.7	1.6	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.0	1.0	0.0	0.0	26.4	23.6	14.9	33.2	23.9	22.4	16.5	24.9	17.4	16.3	26.2	20.5	0.3	0.0	0.5	85.2	0.3	1.5	4.5	0.9	1.2	0.7	5.1	4.1	0.5	0.0	5.6	1.8	0.0	1.6	3.1	0.4	3.9	0.1	0.3	67.4	1.7	0.4	0.0	1.7	11.4	0.4	0.5	0.6	0.5	4.2	2.5	0.8	0.0	0.2	0.1	0.0	9.9	2.5	2.0	0.3	0.7	0.7	1.2	0.2	0.0	1.9	0.1	1.9	2.1	6.0	2.1	0.1	0.3	0.0	0.6	1.7	0.8	1.8	42.8	0.4	6.6	1.5	5.0	1.4	8.8	0.4	0.4	1.2	0.7	6.9	5.3	1.8
STPG2	"C4orf37, MGC46496"	ENSG00000163116	"Sperm tail PG-rich repeat containing 2"	Q8N412	4	97184093-98143476	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9;testis: 1.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 81.6;Excitatory neurons: 34.7;Inhibitory neurons: 38.2;Microglial cells: 36.5;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 150.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059473			Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 21: Non-specific - Transcription"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Nucleoli	"HPA059473: "	"unprognostic (3.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.59e-3)"	"unprognostic (8.87e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.55e-3)"	"unprognostic (5.78e-2)"	0.0	0.1	0.5	0.0	1.3	0.0	0.2	0.7	0.5	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.1	0.0	0.3	1.0	0.6	0.2	0.1	0.1	1.1	0.9	0.1	0.2	0.2	0.4	0.2	1.2	0.1	0.1	0.9	0.1	0.1	0.0	0.2	0.1	0.0	0.9	0.1	0.1	1.9	0.7	0.1	0.4	0.0	0.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.7	0.5	0.3	1.0	1.1	0.9	1.2	0.9	0.7	1.9	0.2	0.0	0.0	81.6	0.7	0.0	0.4	0.0	0.0	0.9	0.4	0.1	0.4	0.0	0.1	0.0	6.2	0.1	0.0	0.0	3.9	0.0	1.8	0.6	0.1	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.7	0.1	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	36.5	0.0	0.8	0.0	21.1	150.4	0.2	0.0	0.0	0.1	0.1	0.3	0.8	0.0	1.8	0.0	0.0	0.0	3.2	1.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20 related adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.0;Excitatory neurons: 49.1;Inhibitory neurons: 47.5;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.43e-4)"	21.3	28.3	32.2	12.7	32.9	18.3	19.6	31.9	35.8	23.9	30.0	23.0	8.8	20.5	18.2	21.1	23.0	13.4	23.1	32.9	32.6	27.8	23.0	19.0	20.3	34.3	31.8	24.7	17.7	19.1	26.4	13.4	32.6	22.5	11.6	13.9	15.6	14.3	14.6	20.8	19.4	17.2	31.0	32.0	20.5	49.0	32.4	20.1	20.0	10.1	20.4	22.6	20.0	32.8	12.7	37.5	31.9	32.3	30.8	22.8	12.4	23.8	21.6	33.6	29.8	9.9	14.4	19.5	14.4	20.3	16.7	10.5	21.4	23.1	33.0	21.5	20.7	38.4	25.9	23.7	21.8	36.7	26.5	23.9	19.4	38.2	22.1	22.3	37.6	30.0	24.9	20.0	32.2	23.6	43.4	25.0	16.0	10.7	21.2	27.9	50.8	23.8	30.2	24.9	36.0	39.4	16.3	26.3	26.1	32.9	19.7	26.4	30.5	31.7	22.5	25.8	20.0	19.9	22.9	24.3	23.4	21.8	25.7	19.2	9.5	8.8	9.6	6.9	8.8	10.3	8.7	10.7	15.8	7.5	8.5	7.6	10.8	16.8	10.7	13.3	7.3	8.0	32.2	32.9	31.9	35.8	32.9	32.6	34.3	31.8	32.6	31.0	32.4	32.8	6.4	9.6	7.3	48.0	12.5	0.0	0.1	0.5	6.2	2.1	3.6	3.4	0.5	0.0	2.9	9.2	0.0	2.1	9.3	1.2	0.0	7.0	1.1	8.6	9.4	3.7	0.0	3.4	49.1	2.8	0.9	4.7	6.1	7.2	2.5	12.7	0.7	0.1	1.5	1.7	47.5	2.2	2.0	1.3	1.4	2.2	0.6	6.7	0.0	27.2	17.9	1.2	5.2	33.2	71.4	4.8	2.0	1.5	10.2	0.4	1.9	2.0	2.5	3.7	0.0	2.0	4.1	3.1	1.2	4.7	0.4	2.5	9.1	9.3	2.0	0.2
STRN	"PPP2R6A, STRN1"	ENSG00000115808	Striatin	O43815	2	36837698-36966536	"Cancer-related genes, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017286	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoplasm	"HPA017286: AB_1857618"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.43e-2)"	8.4	4.7	5.3	9.4	16.7	14.9	8.6	11.9	9.0	8.6	0.6	9.1	8.1	6.2	3.8	21.2	5.3	6.8	21.2	5.5	10.2	8.4	7.5	7.8	7.7	13.0	11.6	7.7	5.6	7.3	2.4	10.1	13.1	5.5	10.7	10.1	10.7	5.0	11.6	11.2	8.6	7.7	9.8	8.1	9.0	8.0	14.2	13.3	6.2	11.5	12.6	8.4	10.1	24.7	38.3	19.0	25.2	10.4	13.3	18.0	24.6	14.8	14.2	14.5	13.3	19.4	12.2	24.7	11.8	19.7	20.6	17.6	21.4	17.0	17.9	27.9	16.0	40.2	16.4	10.3	12.1	24.9	21.8	11.4	12.9	23.2	18.3	10.7	18.6	10.0	30.4	19.2	18.2	11.1	24.7	7.4	19.8	15.7	9.4	15.9	38.5	11.2	9.7	31.0	4.5	15.1	22.4	16.9	13.6	13.7	12.2	9.2	24.9	25.4	25.4	16.0	20.1	19.5	31.0	21.6	13.2	23.2	18.2	1.3	0.2	0.4	0.5	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.2	0.2	1.0	0.2	0.4	0.2	0.1	0.1	5.3	16.7	11.9	9.0	5.5	10.2	13.0	11.6	13.1	9.8	14.2	24.7	26.5	9.6	10.0	38.8	18.8	20.6	12.3	11.3	21.6	12.7	16.0	9.4	55.4	8.6	17.4	23.9	20.9	8.0	22.8	25.0	9.8	10.5	1.9	14.2	14.3	19.4	11.4	26.5	65.3	8.4	10.3	13.6	20.4	26.2	5.1	16.0	16.4	7.9	8.8	18.5	55.2	17.8	10.2	20.7	10.0	2.1	9.6	18.0	8.8	47.8	20.3	10.1	35.0	55.3	294.0	16.8	14.1	12.4	14.3	19.3	13.0	8.5	8.2	16.9	0.0	13.6	16.5	15.2	19.2	31.4	33.2	16.3	19.4	17.7	16.0	39.4
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3 oligosaccharyltransferase complex catalytic subunit B"	Q8TCJ2	3	31532638-31637616	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		17000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	42.8	59.9	21.1	52.2	29.5	63.7	57.1	23.3	27.0	62.1	30.9	59.7	47.9	51.8	90.3	44.8	45.3	60.2	49.4	22.6	30.7	49.6	74.8	49.3	59.9	24.3	23.1	105.5	45.7	76.6	24.8	60.3	23.9	56.3	61.4	38.6	49.9	51.3	62.1	44.7	49.1	57.7	25.4	44.2	55.1	94.3	26.1	71.8	80.7	57.8	58.8	56.6	32.1	27.6	77.9	128.0	115.4	121.7	142.0	142.3	249.7	142.3	124.9	104.2	119.9	117.7	164.5	134.0	67.8	130.0	85.8	63.9	108.1	123.5	135.9	377.1	70.2	115.0	120.7	126.4	109.4	252.0	131.1	109.8	129.7	148.8	186.7	160.7	107.1	168.3	62.8	209.6	144.0	44.4	246.8	154.8	92.9	129.6	70.7	252.3	62.6	196.0	122.0	110.7	48.7	59.4	141.3	207.2	84.5	98.3	93.4	132.8	209.3	139.8	88.6	139.7	127.3	129.0	166.4	111.4	126.9	170.0	117.6	2.1	3.3	6.2	3.1	3.9	5.0	2.4	5.6	4.4	2.9	2.7	5.3	4.3	1.2	6.1	2.9	5.5	3.0	2.0	21.1	29.5	23.3	27.0	22.6	30.7	24.3	23.1	23.9	25.4	26.1	27.6	32.1	86.6	57.7	34.6	69.6	68.1	58.4	34.1	74.6	51.0	57.2	29.5	71.1	54.3	76.0	44.1	68.8	67.3	65.3	41.8	13.7	34.1	162.8	25.0	65.9	42.0	45.1	50.9	61.5	45.3	100.5	49.6	45.3	43.5	31.1	43.6	37.9	68.2	54.8	45.4	59.4	57.5	36.7	58.0	76.0	264.9	36.4	71.5	51.6	53.4	49.1	34.2	56.7	60.3	73.3	36.5	50.0	32.7	144.2	74.1	50.5	31.5	42.2	37.4	26.3	39.0	53.3	90.9	55.2	65.0	61.8	95.4	78.3	68.4	66.1	69.4
STX12	"STX13, STX14"	ENSG00000117758	"Syntaxin 12"	Q86Y82	1	27773219-27824443	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041038, HPA055300"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA041038: AB_10794261, HPA055300: AB_2682778"	"unprognostic (3.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.24e-1)"	64.2	30.1	38.1	26.6	39.0	10.8	37.0	40.8	45.6	28.8	25.4	30.7	36.3	30.9	62.9	39.2	23.9	39.8	20.9	37.3	41.7	35.2	29.1	50.0	25.6	42.0	45.3	22.1	30.3	46.5	26.6	33.3	43.6	30.7	32.5	43.2	26.9	32.1	21.4	27.0	32.8	35.9	42.2	30.5	65.5	13.4	38.4	17.3	94.7	27.1	22.2	39.1	23.4	44.6	23.2	10.9	28.8	19.0	53.9	65.0	14.8	47.9	70.3	43.1	48.5	13.5	29.5	25.2	49.6	64.6	18.5	19.0	19.2	23.9	42.9	22.2	22.8	14.4	12.0	13.7	42.2	16.1	29.0	61.3	28.7	60.6	34.5	35.3	70.3	14.3	19.1	24.6	47.7	8.5	13.7	12.3	12.1	34.3	15.3	8.7	23.1	15.5	38.1	37.5	32.3	17.6	22.4	19.3	35.2	23.3	13.1	14.0	76.2	21.9	12.5	50.0	16.6	14.5	11.2	14.3	35.1	24.1	31.2	24.6	35.7	13.7	6.1	39.4	10.6	13.6	7.3	9.7	25.2	10.8	8.1	6.8	16.5	9.2	40.6	12.4	7.9	17.4	38.1	39.0	40.8	45.6	37.3	41.7	42.0	45.3	43.6	42.2	38.4	44.6	93.0	54.5	36.3	25.1	43.6	109.4	97.2	30.7	51.2	46.2	42.0	25.7	18.9	30.0	40.8	57.0	31.3	30.0	28.3	82.8	37.2	51.9	2.0	34.7	33.1	71.1	41.3	17.7	70.9	58.4	33.5	53.2	108.6	49.4	22.8	26.7	47.8	20.4	50.6	26.9	65.7	29.5	14.2	91.4	77.7	4.2	36.1	62.3	53.4	56.2	41.3	67.9	36.0	34.7	59.1	68.4	58.6	47.4	33.9	74.9	51.3	69.7	27.4	51.2	39.5	45.7	57.5	20.0	20.1	69.9	99.2	78.0	31.6	54.0	29.9	99.9
STXBP2	"Hunc18b, UNC18B"	ENSG00000076944	"Syntaxin binding protein 2"	Q15833	19	7636881-7647873	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 194.2"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 262.5;Macrophages: 249.1;monocytes: 368.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 248.6;classical monocyte: 471.0;eosinophil: 295.6;intermediate monocyte: 604.8;myeloid DC: 239.7;neutrophil: 356.2;non-classical monocyte: 893.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 239.7;granulocytes: 356.2;monocytes: 893.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 244.8;U-937: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015564, HPA063868"	Approved		Enhanced	Cytosol		No	No		870000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA015564: AB_1857626, HPA063868: AB_2685136"	"unprognostic (1.20e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (4.22e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.68e-4)"	"prognostic favorable (5.13e-6)"	24.2	22.8	5.2	65.9	6.3	194.2	24.3	4.8	10.9	22.2	9.3	52.5	67.4	8.4	33.2	73.1	27.7	28.4	7.5	5.1	6.2	62.4	49.0	89.6	51.0	8.3	6.6	5.3	86.7	36.1	29.4	36.3	7.9	52.1	37.0	4.2	79.4	22.8	2.9	52.3	63.9	14.6	6.7	162.2	71.9	74.9	8.8	85.3	52.0	3.0	34.6	34.6	34.8	9.3	113.0	39.1	0.9	0.5	0.0	0.9	75.6	14.2	1.5	2.7	7.4	92.5	69.6	29.6	55.4	11.3	49.5	75.5	4.1	67.5	2.7	124.1	46.9	127.8	49.7	55.8	63.6	83.2	244.8	4.4	67.4	13.4	38.0	0.3	58.5	74.7	81.4	98.5	0.0	70.9	41.2	193.2	28.7	72.7	68.0	41.8	0.3	114.7	55.0	128.1	11.5	0.6	34.0	49.6	2.2	35.6	61.9	212.7	61.7	0.4	21.8	1.5	0.8	108.4	58.6	38.8	1.2	224.8	2.7	248.6	471.0	295.6	69.9	604.8	56.7	47.3	52.7	63.8	239.7	52.2	36.6	44.3	356.2	74.7	893.3	91.5	78.9	306.9	5.2	6.3	4.8	10.9	5.1	6.2	8.3	6.6	7.9	6.7	8.8	9.3	2.1	0.0	7.7	0.7	44.1	23.6	48.2	105.1	18.8	6.0	38.0	22.9	0.9	31.5	68.5	35.0	2.1	97.7	56.2	181.4	33.2	100.3	99.9	32.5	5.4	6.7	59.8	38.3	0.6	118.8	123.2	5.7	150.3	47.6	71.8	34.6	16.4	19.6	168.4	0.0	0.4	108.2	105.8	262.5	46.6	233.5	1.8	249.1	14.2	1.0	368.2	0.9	72.1	0.0	0.0	132.8	152.6	1.9	54.7	49.1	171.7	75.9	42.5	4.0	6.6	1.0	8.6	45.7	20.2	35.3	21.3	153.0	47.7	6.0	79.3	68.7
STXBP4	"MGC50337, Synip"	ENSG00000166263	"Syntaxin binding protein 4"	Q6ZWJ1	17	54968727-55173632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 41.7;Oligodendrocyte precursor cells: 84.4;Oligodendrocytes: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007760, HPA022138, HPA022888, HPA024227"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Cytosol	"CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630"	"unprognostic (5.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.00e-5)"	"unprognostic (4.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	1.4	2.0	2.3	1.7	2.3	1.4	1.8	2.2	1.7	2.2	7.8	1.7	2.5	2.8	1.7	1.9	2.8	2.6	1.8	1.5	3.1	4.3	0.9	2.1	1.2	3.2	3.9	2.9	1.5	6.0	2.0	1.8	2.8	3.0	1.7	4.5	1.4	3.5	1.1	1.0	1.4	2.7	3.0	1.1	1.6	2.1	3.2	1.8	3.1	1.0	1.2	1.9	1.3	3.7	5.0	7.3	6.6	5.9	5.5	5.4	2.7	3.8	3.6	4.8	4.7	4.3	2.6	3.4	7.9	3.8	4.2	2.9	8.6	3.8	8.9	5.1	4.9	4.4	4.8	8.9	2.3	2.8	1.3	6.1	1.1	7.0	1.6	2.2	4.9	2.9	7.2	2.6	5.8	2.2	9.3	1.8	4.8	4.2	5.2	3.9	7.7	2.0	8.6	3.0	6.3	4.8	5.8	0.9	3.2	3.5	8.4	1.9	3.8	6.8	5.2	4.2	4.0	2.3	2.3	5.8	4.4	3.6	4.1	1.7	0.4	0.0	0.9	0.3	1.0	0.7	0.8	0.6	0.5	1.1	0.7	0.9	0.1	2.2	0.5	1.1	0.8	0.3	2.3	2.3	2.2	1.7	1.5	3.1	3.2	3.9	2.8	3.0	3.2	3.7	6.6	0.0	9.1	39.5	3.9	0.9	2.4	3.3	4.6	5.6	4.4	3.3	9.6	2.8	5.4	9.2	41.7	1.6	2.1	2.0	9.8	6.0	6.7	16.6	14.4	4.3	6.0	5.2	29.0	2.7	1.9	7.5	6.1	5.8	7.6	6.1	6.1	5.1	2.3	8.4	25.5	1.4	0.0	2.4	1.4	5.3	17.7	2.4	7.2	20.6	2.1	5.9	1.0	84.4	39.3	3.3	2.1	11.7	1.6	2.2	4.9	7.2	17.4	21.6	32.9	8.8	11.4	11.1	7.3	2.8	3.0	0.3	4.8	5.1	3.1	1.2
SUCLA2	LINC00444	ENSG00000136143	"Succinate-CoA ligase ADP-forming subunit beta"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.2;tongue: 271.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 256.2;Late spermatids: 314.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	53.9	40.6	28.4	20.2	30.8	13.6	38.7	36.6	39.2	32.4	33.6	37.1	58.2	27.2	24.8	33.1	24.7	20.3	100.2	30.7	38.2	77.5	29.0	18.2	22.0	30.6	30.0	30.9	25.4	71.2	20.4	28.1	32.3	35.8	36.3	44.2	33.9	31.3	232.2	20.5	44.7	33.1	30.6	19.9	29.7	17.9	33.8	30.7	36.4	271.9	23.9	26.0	25.3	35.1	44.9	49.5	60.6	37.1	68.4	51.3	38.9	64.8	72.4	66.9	44.5	91.3	47.9	61.3	49.3	63.9	39.9	60.0	81.9	61.9	81.6	59.8	75.9	69.2	45.8	58.0	47.6	69.9	38.9	48.4	71.2	45.3	52.6	54.4	49.0	70.7	47.7	21.1	65.8	31.4	73.1	80.8	64.4	150.2	64.7	60.9	55.4	49.3	94.4	41.9	34.7	41.2	54.5	49.3	39.1	66.5	43.8	60.8	39.0	36.2	24.1	53.0	45.7	23.0	37.4	72.7	22.8	50.9	54.8	12.6	50.2	27.8	34.4	53.7	41.9	34.6	38.0	42.2	62.5	33.1	47.7	47.5	8.8	51.8	46.1	49.8	46.6	36.5	28.4	30.8	36.6	39.2	30.7	38.2	30.6	30.0	32.3	30.6	33.8	35.1	20.8	25.6	16.8	17.6	20.1	32.4	37.7	57.5	21.1	44.8	28.9	26.5	148.8	17.2	40.2	31.3	12.5	48.7	18.1	29.1	164.4	32.3	256.2	50.9	32.0	22.0	19.2	21.0	37.0	17.8	42.7	37.7	19.9	52.6	33.7	25.2	16.1	14.7	29.9	45.4	39.0	19.5	71.2	16.7	20.4	314.2	37.0	21.7	42.7	21.5	24.9	43.3	13.4	26.2	38.2	20.2	30.6	46.3	22.1	35.9	62.3	127.4	29.9	42.4	39.5	33.3	50.0	36.3	29.0	22.8	31.7	52.1	19.7	47.3	30.4	39.0
SUCLG1		ENSG00000163541	"Succinate-CoA ligase GDP/ADP-forming subunit alpha"	P53597	2	84423528-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 554.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	118.7	73.3	70.6	43.1	73.2	48.2	80.0	76.2	92.5	49.9	91.1	156.9	231.1	42.4	78.8	86.9	54.6	41.9	258.1	71.1	74.5	554.0	193.0	41.6	47.8	71.7	70.2	45.7	93.6	244.2	46.8	48.8	72.9	54.3	165.9	38.4	120.6	66.6	274.1	55.4	195.4	63.5	73.8	39.6	81.1	36.9	73.3	61.7	97.6	368.1	63.1	66.4	58.5	76.9	90.2	94.9	73.8	91.1	137.8	91.2	127.7	98.4	85.2	126.0	91.2	224.5	72.0	122.4	67.0	119.8	100.2	126.8	156.7	118.4	149.8	119.3	141.4	105.9	75.4	129.2	116.0	110.6	82.7	109.1	95.6	106.3	143.7	76.7	115.1	97.9	110.1	98.1	117.5	137.4	158.2	101.1	39.4	334.1	170.0	98.3	172.6	134.5	172.2	106.4	89.8	49.3	78.9	163.7	162.3	69.0	99.8	85.4	93.1	96.6	94.6	119.9	124.9	84.2	131.0	107.8	113.9	150.4	88.0	101.6	91.0	80.8	79.0	110.2	88.5	70.2	72.0	88.4	115.4	55.4	79.1	84.3	49.7	102.3	114.3	63.2	107.7	142.7	70.6	73.2	76.2	92.5	71.1	74.5	71.7	70.2	72.9	73.8	73.3	76.9	52.7	64.1	96.5	32.7	61.0	35.4	108.9	129.6	44.3	33.3	105.0	109.1	408.6	131.5	115.2	141.6	22.9	232.3	49.9	218.1	935.2	131.8	49.2	67.1	56.9	57.0	106.3	68.4	45.8	113.2	129.3	69.8	79.5	80.8	91.3	46.0	57.5	210.0	131.7	45.4	43.5	202.1	105.8	71.3	46.0	35.9	54.7	82.2	119.2	16.9	89.8	68.2	58.7	28.1	46.2	67.1	215.4	74.1	57.1	64.2	647.5	2949.2	83.7	36.1	52.6	61.1	98.3	138.9	54.4	111.3	41.3	188.4	64.4	90.7	388.7	111.0
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming subunit beta"	Q96I99	3	67360460-67654612	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 278.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 402.3;Proximal tubular cells: 354.4;Undifferentiated cells: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		300000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	66.7	44.9	16.1	36.7	17.9	18.6	48.7	17.1	19.6	42.1	22.4	169.7	136.6	32.6	32.2	50.5	39.1	48.4	85.5	14.2	17.6	147.3	278.0	34.0	39.3	19.0	17.3	39.0	47.8	34.6	10.2	28.1	19.5	49.3	146.1	7.3	46.8	42.3	154.0	26.1	132.2	40.0	17.7	44.8	110.6	10.4	18.1	24.7	49.3	130.6	35.5	39.3	24.0	18.8	43.8	37.4	36.3	44.6	59.7	102.5	44.2	51.3	74.4	58.9	65.4	41.7	95.1	55.7	16.3	72.5	38.8	22.0	28.5	70.8	75.9	23.8	19.5	50.5	31.2	65.5	76.8	67.2	33.9	77.3	60.3	46.2	105.2	73.0	63.6	41.8	39.1	49.5	129.9	30.6	25.5	21.2	34.1	199.2	23.0	17.6	56.1	83.8	100.0	66.9	7.1	24.5	81.5	92.7	68.8	24.3	71.6	42.5	55.9	58.2	38.2	64.5	61.8	33.4	52.2	39.0	85.5	51.6	70.0	17.3	36.3	13.0	30.8	44.3	37.6	45.5	44.6	39.5	24.6	42.5	68.4	53.1	1.6	68.0	37.4	9.8	45.4	48.5	16.1	17.9	17.1	19.6	14.2	17.6	19.0	17.3	19.5	17.7	18.1	18.8	40.2	35.3	50.8	66.6	48.5	37.1	44.7	38.9	21.1	2.9	54.1	29.1	172.0	84.4	51.7	80.9	8.4	55.4	31.7	223.5	244.6	85.1	3.2	49.6	43.4	40.1	58.2	17.2	6.2	80.9	44.9	47.5	90.7	46.8	30.4	31.4	45.0	402.3	56.5	5.0	5.3	212.1	40.7	68.6	49.2	5.4	41.3	36.3	42.7	90.9	35.5	29.2	36.0	72.4	60.0	59.2	164.0	47.4	30.3	41.2	222.2	354.4	58.7	4.5	32.9	41.6	50.5	1.6	6.3	55.6	49.3	38.0	48.6	78.5	306.6	50.9
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870467-47886315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 1072.1"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1578.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	34	"Hep G2: 39.6;RT4: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		NA	NA		1200000	"Cluster 11: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	235.6	0.3	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.5	0.6	59.5	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	1072.1	0.0	0.2	0.2	0.3	0.1	0.1	36.9	0.0	0.1	0.2	0.1	0.9	1.0	0.1	3.1	0.1	0.3	86.6	0.0	0.0	0.4	24.4	4.2	0.2	0.0	0.1	0.0	0.1	2.0	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	39.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	26.7	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.1	2.9	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.4	0.3	0.8	0.5	0.1	0.3	0.2	0.2	0.3	0.2	0.7	0.4	0.2	0.1	0.2	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.3	2.9	0.1	0.6	0.0	0.0	1.3	0.0	0.0	0.6	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	18.7	0.3	0.0	0.0	0.3	5.1	0.1	0.0	0.1	30.0	1578.7	0.0	0.0	0.3	2.8	0.0	31.8	0.4	0.2	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	8.8	0.4	0.0	0.3	171.7	0.1	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.5	1.8	81.7	2.2	0.3
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552172-48599425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 286.0;skin 1: 186.5;vagina: 145.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041724, HPA043539, HPA076510"	Enhanced		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Cytosol	"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.3	0.2	0.5	0.4	0.4	0.1	11.5	0.6	0.8	74.4	0.4	0.8	9.3	0.5	6.8	286.0	1.2	2.7	0.2	0.5	0.5	13.0	0.3	9.4	0.0	0.5	0.7	0.1	0.7	7.9	0.4	1.5	0.5	22.6	0.2	0.0	53.6	3.7	0.4	186.5	18.2	0.1	0.4	0.1	3.5	0.5	0.9	0.4	1.9	0.0	28.3	0.7	145.9	0.5	12.6	15.8	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.9	74.2	0.1	0.1	0.0	0.7	3.9	0.1	0.3	0.0	0.5	0.4	0.0	0.5	0.5	0.0	0.0	7.2	0.2	2.1	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	46.8	0.0	0.5	0.0	122.9	0.0	0.1	0.0	0.1	0.0	3.5	0.2	0.1	0.0	6.2	0.3	0.0	36.7	0.1	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.5	0.1	0.0	0.3	0.2	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.6	0.8	0.5	0.5	0.5	0.7	0.5	0.4	0.9	0.5	0.4	19.2	0.5	1.0	0.0	24.1	30.5	11.6	0.0	0.0	16.8	12.4	0.6	5.7	40.2	9.2	0.0	3.2	0.0	4.4	0.0	12.2	0.0	15.7	1.4	0.9	4.8	0.0	1.0	1.2	3.1	1.2	2.6	17.5	0.0	0.1	0.0	0.3	0.7	0.0	0.9	12.6	24.4	0.0	4.8	0.9	0.3	0.4	12.4	1.0	0.0	1.6	0.0	0.5	0.8	18.5	7.9	0.0	0.0	62.3	75.9	1.3	6.7	0.6	0.0	0.1	2.2	0.2	11.1	56.0	137.4	1.9	0.6	2.0	9.2	114.6
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Yes	No		750000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.71e-4)"	64.1	64.6	26.1	43.0	29.7	51.5	57.5	29.3	27.1	91.3	45.0	67.4	89.2	57.5	64.8	46.8	102.6	70.6	30.8	25.1	27.8	93.4	94.8	71.6	50.2	35.2	29.6	59.7	91.8	115.8	31.8	45.5	33.4	79.3	69.1	11.0	69.5	77.1	22.4	47.5	74.4	57.7	29.9	57.0	92.7	23.7	30.8	57.6	91.2	21.4	51.3	57.2	43.6	35.9	352.3	102.9	46.0	211.8	214.4	147.5	68.9	114.5	156.1	92.6	114.5	57.2	278.0	57.1	96.5	162.4	90.4	172.3	27.4	131.3	61.1	90.6	42.9	36.4	63.5	54.2	138.4	89.7	108.7	116.8	124.5	83.7	143.3	186.9	137.7	101.4	116.4	236.6	151.3	76.8	77.2	115.7	63.5	272.0	52.2	61.5	45.4	359.0	127.7	39.1	54.0	65.6	142.4	294.2	140.9	98.9	294.5	144.5	115.2	85.6	121.1	211.1	98.6	160.8	130.8	84.0	139.7	165.7	283.2	58.1	60.3	22.0	71.1	80.5	90.9	59.8	70.9	71.8	72.3	49.1	75.3	75.2	4.4	49.0	90.3	132.6	82.7	90.2	26.1	29.7	29.3	27.1	25.1	27.8	35.2	29.6	33.4	29.9	30.8	35.9	44.0	57.7	30.5	20.5	47.3	33.8	44.1	46.1	39.9	25.7	57.9	25.4	10.4	87.2	31.0	90.1	14.6	44.5	85.3	45.1	19.6	95.3	3.8	93.1	70.2	43.7	59.3	41.7	21.2	55.7	96.7	54.7	55.5	78.9	54.5	47.0	51.0	91.3	68.1	43.7	24.4	61.8	22.4	79.8	38.7	8.0	69.6	50.4	53.4	14.0	73.0	23.8	70.0	10.6	24.2	48.4	64.6	47.4	65.0	50.7	91.8	45.6	34.5	13.5	52.6	41.6	44.1	31.6	28.6	52.8	41.9	46.7	52.7	58.7	85.8	42.7
SURF2		ENSG00000148291	"Surfeit 2"	Q15527	9	133356550-133361158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 105.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 448.9;Late spermatids: 992.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044340, HPA052213, HPA059710"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: "	"unprognostic (1.53e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	15.3	16.4	13.2	5.4	13.0	5.4	15.3	13.5	15.6	13.8	12.5	16.9	7.6	13.1	6.0	25.8	13.4	3.5	18.9	12.9	12.6	27.7	22.6	12.1	7.1	14.3	13.5	13.2	28.9	5.8	24.2	3.1	13.2	17.7	2.9	4.7	17.0	4.4	21.6	28.3	14.2	2.3	12.6	15.6	20.1	105.8	13.5	6.1	15.5	3.9	4.9	16.5	15.6	13.3	17.4	29.4	12.1	15.1	8.7	6.7	25.4	8.6	7.5	13.5	7.0	40.5	14.0	17.1	12.2	5.8	11.6	46.5	19.2	21.1	6.1	16.7	26.8	13.5	34.7	15.3	17.3	22.6	9.9	8.1	24.5	19.3	28.1	4.8	6.3	20.6	21.9	11.5	9.3	104.3	23.4	15.0	38.1	41.3	56.0	25.7	18.1	40.4	11.8	19.6	44.8	22.7	19.3	31.7	27.0	7.3	33.8	10.6	12.1	20.3	20.7	21.2	31.2	14.3	30.6	18.7	13.0	13.3	20.8	23.7	23.0	18.6	24.3	24.8	32.1	22.3	29.7	28.0	20.3	27.5	27.9	26.6	10.3	21.1	18.6	22.7	42.1	20.8	13.2	13.0	13.5	15.6	12.9	12.6	14.3	13.5	13.2	12.6	13.5	13.3	26.7	12.8	11.5	3.3	23.2	84.1	27.6	53.7	50.7	18.3	31.1	55.1	13.3	35.8	27.3	22.0	2.1	37.8	25.0	30.6	105.7	73.0	448.9	44.4	16.8	20.9	36.5	28.2	3.5	81.6	28.4	19.3	19.9	16.5	9.5	12.9	22.5	23.6	29.7	13.5	2.9	21.5	36.7	25.5	31.7	992.3	26.1	18.7	42.7	0.0	33.1	28.2	34.0	1.0	3.5	63.8	37.4	24.5	19.6	28.8	81.4	78.0	60.2	23.6	65.7	24.4	26.8	169.9	107.3	43.0	88.2	25.6	38.2	52.2	30.1	23.2
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328776-133336188	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	10.4	11.7	8.1	4.1	7.8	4.9	10.3	8.7	7.5	12.4	5.9	13.6	6.2	11.9	2.6	12.5	11.2	2.5	10.5	7.2	7.5	11.7	12.3	8.5	5.5	7.7	7.8	13.1	11.2	3.9	8.1	3.3	7.8	11.5	3.4	3.3	9.7	4.0	17.9	13.2	12.1	2.7	7.5	11.4	9.9	7.9	7.9	4.6	10.6	3.9	3.7	12.2	11.1	8.1	5.6	8.7	6.5	9.8	4.0	3.7	10.8	8.8	5.1	7.7	4.8	13.8	9.2	16.2	6.7	4.9	5.6	16.7	8.4	9.3	2.8	10.8	9.6	11.2	10.5	8.3	7.2	19.1	9.3	5.3	8.0	8.0	7.4	6.8	4.0	15.6	25.1	8.4	6.8	14.7	15.5	15.7	19.1	22.7	15.6	16.1	9.1	16.7	6.7	5.3	13.7	11.6	8.6	13.7	7.8	3.9	12.2	10.6	8.4	17.3	9.3	8.9	12.0	6.2	9.6	21.0	6.5	12.9	10.4	3.3	3.0	1.4	4.3	2.9	4.5	4.6	3.9	3.9	3.3	5.1	5.2	4.4	0.8	3.2	2.7	6.0	3.6	2.5	8.1	7.8	8.7	7.5	7.2	7.5	7.7	7.8	7.8	7.5	7.9	8.1	25.7	44.8	27.3	4.6	20.9	23.7	15.7	11.0	24.5	26.5	33.4	32.3	30.0	28.6	24.5	22.0	6.2	32.2	20.3	36.8	21.5	29.2	1.3	21.1	42.2	23.6	33.6	14.1	4.3	19.6	25.2	21.2	18.8	25.1	25.3	25.4	16.4	35.2	21.2	21.9	4.8	40.3	6.1	14.7	10.2	4.1	27.7	13.7	7.2	5.6	18.6	15.2	29.9	5.0	4.1	29.0	33.3	27.8	14.4	24.8	50.6	26.1	13.2	19.6	0.0	15.8	20.3	19.2	23.6	26.3	27.6	19.0	18.1	91.1	57.7	13.3
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937007-32001038	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	12.3	11.8	6.3	18.8	6.3	45.4	15.0	11.1	8.5	11.6	6.8	14.9	16.0	15.2	12.0	14.0	11.0	12.0	10.3	5.4	5.8	16.4	18.1	12.6	33.0	5.4	5.9	11.4	11.5	19.8	6.6	18.7	5.6	13.3	16.4	26.5	10.5	12.2	8.1	13.0	15.3	14.7	5.2	18.4	15.2	27.4	6.1	38.5	18.3	11.0	30.0	15.6	9.0	7.1	46.5	40.4	37.2	42.9	21.1	26.8	38.2	44.2	38.8	53.0	63.7	30.9	25.5	100.7	33.2	27.7	45.4	40.1	56.0	25.5	85.7	35.8	54.0	69.9	32.9	22.3	24.8	111.5	68.7	18.7	28.1	53.1	40.4	32.1	33.1	47.3	68.8	135.6	46.2	16.2	133.3	64.4	21.3	32.4	24.4	78.5	95.3	81.9	31.1	44.6	47.5	37.1	71.3	22.7	43.3	25.8	66.0	91.5	24.7	41.9	38.0	50.8	69.3	73.5	98.4	122.5	30.7	67.4	38.7	0.6	0.7	1.6	1.4	1.1	1.1	2.4	1.6	1.6	0.6	1.8	1.5	2.1	1.6	1.8	0.7	1.9	1.8	0.4	6.3	6.3	11.1	8.5	5.4	5.8	5.4	5.9	5.6	5.2	6.1	7.1	44.5	41.7	45.8	43.1	50.1	58.5	50.2	21.8	31.9	77.6	54.2	36.8	32.3	27.1	32.6	35.0	108.4	61.5	65.2	24.0	17.6	28.3	16.2	52.8	55.8	45.1	29.4	93.6	71.6	21.9	53.1	35.1	31.1	54.2	15.8	41.4	38.2	42.3	32.9	62.2	69.5	31.8	10.2	42.1	58.2	13.9	26.8	47.3	24.9	45.0	73.1	45.7	38.1	75.4	71.3	27.8	15.4	25.6	66.2	62.8	21.5	26.6	29.6	80.9	13.1	47.2	38.4	121.7	128.9	48.6	71.7	69.5	52.5	52.8	35.6	66.7
SVBP	"CCDC23, MGC45441"	ENSG00000177868	"Small vasohibin binding protein"	Q8N300	1	42807052-42817397	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.0;Erythroid cells: 135.4;Spermatocytes: 158.0;Spermatogonia: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008507	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Secreted to blood"	Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA008507: AB_2072066"	"prognostic favorable (6.33e-4)"	"unprognostic (2.68e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	34.7	15.1	36.4	13.7	37.7	43.1	29.9	39.1	49.9	30.9	33.6	29.3	11.6	24.9	26.2	17.7	27.2	15.2	24.7	37.1	38.4	25.6	19.1	17.4	23.0	38.2	37.3	36.3	12.1	22.1	30.6	20.6	37.5	20.3	15.7	22.6	15.9	15.4	28.0	17.7	19.9	19.2	38.2	22.1	19.0	52.9	37.1	48.3	19.0	23.5	23.5	23.9	24.8	40.3	25.9	12.9	75.2	26.9	30.9	48.3	37.2	21.5	18.1	28.8	29.7	22.8	20.2	29.1	23.5	28.6	22.6	18.3	14.3	23.7	35.2	53.6	23.7	54.5	12.1	43.9	25.6	41.3	35.2	31.2	37.4	16.2	15.4	29.7	29.1	56.0	46.2	14.3	35.3	12.0	41.5	50.8	40.8	23.7	14.5	30.9	55.8	19.2	29.9	25.3	45.5	40.4	26.8	14.9	31.7	76.9	11.3	120.1	22.7	25.4	28.1	19.6	35.6	14.9	19.1	20.7	16.1	27.5	24.4	60.5	40.2	76.5	26.8	40.8	23.5	56.4	46.5	32.3	39.2	59.8	42.8	37.2	70.3	37.3	43.8	33.0	115.7	24.7	36.4	37.7	39.1	49.9	37.1	38.4	38.2	37.3	37.5	38.2	37.1	40.3	46.2	9.6	6.3	0.0	25.0	0.0	33.0	0.0	23.9	6.2	33.1	53.1	0.0	28.6	9.3	20.2	2.1	53.8	20.0	19.5	54.8	51.7	149.0	32.2	34.6	32.3	18.2	135.4	0.0	24.5	66.0	36.6	14.3	18.2	11.4	22.8	42.8	45.6	70.4	6.7	0.0	19.6	0.0	51.8	0.0	61.6	42.9	48.4	0.0	0.0	70.2	33.1	29.9	0.0	0.0	43.1	21.7	53.8	16.9	21.9	20.5	43.2	7.3	15.5	59.2	28.1	28.4	158.0	153.8	21.4	0.0	61.6	21.4	24.1	23.6	31.1
SWSAP1	"C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1"	ENSG00000173928	"SWIM-type zinc finger 7 associated protein 1"	Q6NVH7	19	11374666-11376951	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052712	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA052712: AB_2681925"	"unprognostic (6.45e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-3)"	2.4	3.6	1.6	3.9	1.5	5.1	4.0	3.9	2.0	3.7	2.5	4.4	4.5	2.9	3.6	3.6	4.8	3.9	3.1	1.6	1.2	3.7	5.3	3.6	7.1	1.6	1.4	5.3	4.5	2.6	2.0	4.1	1.8	4.0	3.2	0.7	5.1	4.4	3.6	5.0	3.7	2.2	1.3	6.5	4.6	3.6	1.5	4.2	5.0	3.0	4.2	3.4	1.6	2.4	8.1	6.8	3.6	2.2	3.6	3.0	5.3	2.0	2.2	4.6	4.2	7.1	5.5	14.9	10.0	1.9	3.2	5.7	3.4	8.6	0.5	4.8	8.5	6.9	3.0	10.3	3.3	11.3	12.0	4.7	7.4	2.6	1.7	2.7	5.5	6.9	8.4	6.4	2.5	17.6	6.6	15.0	9.0	6.0	9.0	5.5	1.7	16.2	8.6	5.5	7.4	5.5	2.6	8.7	5.5	1.9	11.9	12.9	5.7	3.8	2.7	5.4	4.0	9.5	14.8	10.6	2.1	13.2	3.0	3.2	31.4	7.9	12.5	30.5	12.1	20.9	13.1	13.6	24.3	19.4	16.1	13.9	20.2	16.7	29.5	15.3	13.8	12.3	1.6	1.5	3.9	2.0	1.6	1.2	1.6	1.4	1.8	1.3	1.5	2.4	4.9	3.2	2.0	2.3	10.3	2.7	8.5	16.7	4.0	7.2	9.8	9.3	3.2	2.8	10.6	16.5	8.4	17.8	11.3	10.5	41.1	7.1	10.8	4.5	3.7	6.7	2.4	7.0	1.1	10.7	10.5	4.0	3.1	4.1	1.3	3.7	6.8	13.5	12.1	10.1	1.0	14.2	22.4	9.8	5.4	1.9	11.8	6.5	7.2	0.0	9.6	8.8	19.6	0.0	2.7	6.1	12.2	7.9	3.4	5.6	11.2	17.2	14.6	10.2	6.6	3.2	6.3	10.7	15.0	4.1	3.1	31.7	8.8	13.7	8.9	5.5
SYCE1	"bA108K14.6, C10orf94, CT76"	ENSG00000171772	"Synaptonemal complex central element protein 1"	Q8N0S2	10	133553901-133569835	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 70.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 141.2;Late spermatids: 112.6;Spermatocytes: 362.8;Spermatogonia: 170.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 18.5;U-2 OS: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040208	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040208: AB_10796450"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"		"unprognostic (1.85e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.75e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	1.9	1.6	8.5	0.6	8.5	0.0	1.4	9.1	11.6	1.3	2.0	0.9	0.1	0.9	0.3	0.7	1.2	1.2	0.7	9.0	6.3	1.2	4.0	0.4	0.2	6.6	5.4	2.0	3.8	0.0	1.2	9.4	6.4	1.7	0.4	2.3	0.2	0.4	0.9	0.5	0.5	0.6	3.7	0.9	0.6	70.9	6.7	0.2	1.4	1.7	0.5	0.4	0.4	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.5	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.1	15.5	0.2	0.4	0.2	0.3	0.4	0.0	0.1	0.0	0.0	0.5	0.1	0.9	0.6	0.8	0.2	0.6	0.2	0.3	0.3	0.3	0.8	0.0	0.0	0.8	0.6	0.7	0.4	8.5	8.5	9.1	11.6	9.0	6.3	6.6	5.4	6.4	3.7	6.7	8.1	0.7	0.0	1.5	0.7	0.3	1.0	1.2	0.0	0.0	2.7	1.0	2.4	0.3	1.5	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	141.2	1.2	3.2	1.3	0.0	0.0	29.8	1.1	0.2	5.6	0.5	0.6	0.0	0.0	0.0	7.8	0.7	10.1	19.1	0.0	0.0	0.3	0.9	112.6	5.3	0.9	0.0	0.0	0.0	0.3	0.0	7.1	0.8	0.4	0.3	3.8	0.1	0.6	0.0	0.5	1.5	2.1	26.3	0.5	0.9	362.8	170.9	0.0	1.0	0.3	0.5	7.0	0.0	0.6
SYCE1L	MRP2	ENSG00000205078	"Synaptonemal complex central element protein 1 like"	A8MT33	16	77199408-77213215	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 89.5;Breast myoepithelial cells: 125.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.1;U-698: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA062464, HPA066691"			Enhanced	"Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 35: Glandular cells - Unknown function"	"Intermediate filaments"		"HPA062464: , HPA066691: AB_2685702"	"unprognostic (5.54e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.48e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (9.27e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.73e-2)"	2.7	1.5	1.7	0.4	1.3	1.2	3.6	7.9	2.3	5.5	1.6	1.7	0.8	3.0	1.5	1.5	3.2	0.4	1.4	1.2	3.0	3.2	1.4	1.4	1.0	2.0	2.7	5.2	2.0	0.7	2.1	0.5	1.7	7.0	0.5	2.8	5.1	0.6	0.8	2.9	2.1	0.5	2.0	2.0	1.1	23.5	1.6	0.4	3.4	0.0	0.6	2.4	4.1	1.1	2.4	0.9	2.3	0.9	0.2	0.0	0.3	0.6	0.2	0.3	0.6	0.4	4.6	1.3	2.6	0.4	0.1	3.4	0.2	0.0	0.2	1.4	11.1	0.3	0.8	0.0	1.5	0.8	0.8	0.0	0.3	0.1	0.2	0.3	1.6	2.0	0.6	0.1	0.2	3.6	0.5	0.9	1.4	0.3	3.8	5.7	0.6	0.4	2.3	0.5	2.3	2.2	0.3	0.2	0.0	0.1	0.0	0.8	5.1	0.3	5.1	0.6	0.1	4.1	1.9	8.0	1.9	0.4	0.1	4.5	1.3	13.9	6.8	2.6	7.8	4.0	8.2	9.0	1.8	2.6	8.9	8.4	1.4	3.6	2.1	13.8	12.6	3.4	1.7	1.3	7.9	2.3	1.2	3.0	2.0	2.7	1.7	2.0	1.6	1.1	19.5	3.2	3.7	6.5	7.6	17.3	10.9	15.2	15.9	3.7	89.5	125.7	1.7	32.9	7.4	27.6	10.4	6.8	8.9	22.4	15.6	24.8	24.7	7.1	4.5	15.9	22.4	1.3	5.9	27.9	4.0	13.8	2.6	15.2	1.3	5.0	18.2	13.2	2.3	1.7	9.2	52.0	12.2	15.8	9.7	55.5	13.7	3.6	19.6	5.6	2.9	35.1	3.1	7.5	10.6	13.9	27.2	6.8	6.9	16.7	22.3	31.9	2.6	44.5	6.6	19.9	5.4	30.4	9.9	6.7	17.0	2.9	9.4	0.5	52.5	7.1
SYDE2	FLJ13815	ENSG00000097096	"Synapse defective Rho GTPase homolog 2"	Q5VT97	1	85156889-85201016	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Cone photoreceptor cells: 54.2;Rod photoreceptor cells: 145.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.6;SK-BR-3: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027138, HPA058378"	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim, Golgi apparatus"		"HPA027138: AB_1857686, HPA058378: AB_2683696"	"unprognostic (1.68e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.84e-3)"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.69e-2)"	1.1	0.6	0.8	0.9	0.6	0.5	2.0	0.1	1.2	0.8	4.2	4.5	1.5	1.5	0.7	1.1	0.8	2.2	3.2	1.8	0.5	2.5	3.6	3.3	0.3	0.6	0.6	1.6	1.8	4.3	0.7	2.6	0.3	1.3	1.4	7.6	1.9	1.3	0.4	0.7	1.5	2.2	0.6	0.5	1.8	1.6	0.8	0.4	2.5	1.6	0.3	1.9	0.6	0.3	2.1	0.6	0.6	0.8	2.2	0.6	14.6	2.3	1.4	1.4	2.1	4.0	0.7	0.0	0.8	1.5	2.7	3.9	7.3	1.0	2.1	0.9	2.0	1.9	1.7	1.4	2.6	1.2	0.4	1.0	1.2	1.0	0.9	0.9	0.3	1.3	2.4	0.0	1.0	2.9	1.2	0.2	3.7	1.6	0.9	0.0	3.9	0.5	1.0	5.2	0.1	0.0	1.6	8.0	2.4	3.3	1.8	1.6	0.3	1.7	3.8	0.0	2.3	0.0	0.3	0.8	0.2	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.1	1.2	1.8	0.5	0.6	0.6	0.3	0.6	0.8	0.3	3.1	51.3	12.4	9.4	1.1	8.3	8.0	1.7	8.0	6.8	10.0	6.5	24.4	4.3	6.9	1.8	54.2	10.8	0.5	2.5	7.9	1.9	3.1	11.0	2.9	2.1	19.2	3.0	12.6	4.7	4.7	7.8	3.6	5.2	1.3	4.4	3.6	8.4	1.5	0.0	5.2	4.1	2.0	0.3	4.0	1.6	2.1	0.7	19.6	1.9	1.7	9.4	1.0	5.5	0.2	3.6	1.3	2.6	0.7	6.9	8.1	5.8	14.0	145.4	0.0	6.3	5.2	16.6	9.0	8.5	4.5	2.6	3.3	6.6	4.5	4.5
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 73.8;parathyroid gland: 87.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 91.3;Hofbauer cells: 73.1;Kupffer cells: 96.7;Macrophages: 95.2;Microglial cells: 114.3;monocytes: 92.5;Plasma cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 77.3;eosinophil: 83.5;intermediate monocyte: 64.0;memory B-cell: 74.5;myeloid DC: 85.1;naive B-cell: 58.4;neutrophil: 112.1;NK-cell: 30.0;non-classical monocyte: 60.2;plasmacytoid DC: 63.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 125.8;HEL: 72.8;HL-60: 101.6;HMC-1: 64.1;REH: 84.4;THP-1: 76.8;U-698: 58.8;U-937: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		290000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.4	4.6	4.1	42.5	4.1	50.9	6.8	4.5	4.9	7.7	4.2	20.1	30.8	4.1	16.1	17.5	17.0	12.9	2.9	3.8	5.0	11.2	4.5	20.6	61.8	7.1	5.8	1.7	9.1	87.6	2.4	12.0	7.0	3.8	20.5	0.7	8.4	4.2	1.0	9.9	36.3	9.3	6.6	40.3	19.1	6.9	7.1	49.7	25.6	2.4	73.8	17.5	8.3	9.8	22.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.3	125.8	3.5	0.0	4.2	19.1	2.7	10.2	0.0	0.0	17.0	72.8	0.0	0.0	0.0	101.6	64.1	0.0	14.0	0.0	1.4	0.0	0.0	15.5	2.0	9.9	0.0	15.4	0.1	44.4	0.7	47.0	0.0	84.4	0.1	34.6	2.6	18.6	6.4	5.7	0.1	8.7	0.1	0.3	7.9	76.8	0.2	0.0	0.4	0.1	0.1	0.2	0.0	58.8	0.0	70.3	0.0	5.3	77.3	83.5	0.3	64.0	0.3	74.5	0.2	0.2	85.1	58.4	0.2	0.1	112.1	30.0	60.2	63.2	0.1	44.6	4.1	4.1	4.5	4.9	3.8	5.0	7.1	5.8	7.0	6.6	7.1	9.8	0.5	12.8	20.2	0.0	91.3	3.4	3.7	8.7	12.0	1.4	6.3	2.8	1.6	14.3	12.8	14.7	0.0	1.3	70.4	16.5	15.6	15.0	7.1	10.7	1.0	2.1	10.3	37.9	0.4	12.5	2.6	2.1	22.4	12.6	43.6	0.0	3.3	1.0	73.1	0.0	0.7	24.4	0.0	96.7	28.8	6.2	0.6	95.2	12.4	114.3	92.5	0.0	62.8	1.5	0.5	18.2	25.1	0.0	83.1	2.5	31.4	0.4	10.4	0.2	6.6	0.7	2.3	0.8	0.7	30.4	5.7	1.4	8.3	0.0	31.1	8.0
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607779-85644063	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	60.5	43.2	25.1	80.2	28.0	67.3	55.6	28.1	24.8	51.4	26.0	54.1	48.0	46.1	41.7	75.8	34.0	47.8	45.6	22.8	29.9	53.1	66.7	49.4	88.1	28.9	27.4	36.2	51.9	56.9	19.5	68.5	31.0	44.9	62.7	36.0	41.4	46.5	55.9	43.5	44.0	62.1	27.7	51.3	50.0	38.7	27.6	91.0	87.3	56.0	101.9	81.5	40.8	29.0	209.5	147.5	239.9	157.1	150.8	165.3	162.8	258.6	218.1	244.4	239.9	250.4	132.6	480.0	200.0	262.8	203.1	197.4	331.1	269.0	405.4	175.9	163.9	405.4	152.8	165.2	130.3	497.6	177.7	141.8	179.6	276.4	272.1	138.4	254.9	133.2	451.5	210.0	295.1	243.5	255.2	218.9	231.5	209.4	153.2	364.7	345.5	209.9	236.2	307.1	239.5	184.6	188.5	180.8	128.6	137.2	150.8	360.9	247.4	165.8	142.7	189.8	374.2	138.0	260.5	275.4	165.4	328.7	251.4	1.8	24.7	8.8	30.6	36.2	30.0	21.9	27.1	27.5	37.7	21.2	23.4	27.7	3.0	36.1	41.1	29.0	31.6	24.6	25.1	28.0	28.1	24.8	22.8	29.9	28.9	27.4	31.0	27.7	27.6	29.0	106.9	115.4	119.5	26.4	73.0	148.2	160.9	124.4	83.6	44.5	89.0	82.8	88.9	52.9	126.7	46.0	16.7	101.3	97.2	50.4	54.8	120.7	117.6	105.1	156.2	100.7	56.7	65.6	24.0	99.6	133.3	101.8	79.5	152.1	61.4	81.6	57.5	81.4	96.9	62.2	24.3	78.0	79.3	71.1	67.1	28.7	73.7	92.9	53.4	31.9	90.7	45.1	57.7	32.2	40.9	130.0	45.7	64.3	97.4	133.0	47.7	80.7	84.6	42.2	19.7	158.6	131.8	93.7	65.8	142.4	141.6	118.1	81.6	85.8	106.7	159.8
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63761899-64226433	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 198.5"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 454.6;Rod photoreceptor cells: 568.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 73.8"	"Group enriched"	"Detected in many"	11	"granulocytes: 73.8;T-cells: 38.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 48.8;SiHa: 29.8;U-698: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Approved	"Nuclear membrane,Intermediate filaments"		No	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear membrane, Intermediate filaments"		"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.1	6.0	8.8	3.4	9.2	7.9	28.0	21.1	8.7	15.4	89.5	13.3	4.5	18.1	9.9	24.3	14.3	5.5	58.3	9.6	7.6	29.0	19.5	18.4	8.5	7.7	9.6	35.9	37.7	66.6	16.7	9.9	7.5	11.5	4.4	24.8	16.1	3.7	198.5	39.7	11.4	4.6	7.0	10.0	12.4	13.1	11.4	5.5	24.4	96.7	6.1	13.6	19.0	6.9	23.2	8.7	11.0	3.5	11.3	3.2	12.3	1.3	1.6	2.7	4.2	2.8	3.3	48.8	2.3	1.7	2.6	11.0	6.2	3.5	3.2	8.9	3.5	0.4	7.9	0.7	3.0	1.0	0.3	4.4	15.1	3.4	2.2	2.6	7.0	7.5	0.4	4.8	1.8	11.2	6.2	0.3	3.4	5.4	3.3	6.9	14.5	1.8	20.0	13.6	9.9	8.2	29.8	3.8	7.0	5.5	5.0	0.3	7.3	4.2	7.5	1.5	4.5	4.9	3.5	27.5	1.8	0.0	5.7	0.5	0.1	73.8	38.5	0.3	27.6	5.2	24.3	28.0	0.0	5.3	11.8	18.5	30.1	3.9	0.3	1.2	30.1	3.4	8.8	9.2	21.1	8.7	9.6	7.6	7.7	9.6	7.5	7.0	11.4	6.9	414.4	307.7	140.1	8.5	44.9	111.3	138.9	46.4	174.2	27.4	70.3	59.1	261.4	105.8	184.5	202.3	183.5	168.8	226.8	51.0	19.6	108.2	9.4	249.9	71.2	238.8	46.2	10.5	9.5	55.4	65.7	59.6	126.9	365.2	25.9	454.6	73.5	33.3	17.7	6.7	13.9	60.9	59.0	5.7	13.2	14.3	100.9	12.8	48.0	128.4	8.9	107.2	300.7	33.2	6.6	71.7	27.9	53.4	180.3	65.0	35.9	72.2	196.1	568.7	111.7	73.5	167.0	13.0	17.0	104.6	87.5	224.0	222.1	69.5	80.6	80.6
SYNGR4		ENSG00000105467	"Synaptogyrin 4"	O95473	19	48364367-48376377	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 54.4"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 159.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 9.8;SCLC-21H: 24.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030075, HPA059286"	Enhanced		Approved	"Golgi apparatus"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus"		"HPA030075: AB_10610559, HPA059286: AB_2683965"	"unprognostic (1.58e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.49e-4)"	"unprognostic (2.51e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.87e-2)"	"unprognostic (6.19e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.02e-7)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	0.0	0.0	0.4	0.0	0.4	0.1	0.0	3.0	1.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.0	0.4	0.5	0.0	1.0	3.9	0.3	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	54.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	9.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.2	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.5	3.2	0.5	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.1	3.6	0.1	0.3	0.5	0.2	0.0	0.7	1.8	0.7	0.0	2.8	0.0	0.0	24.1	0.6	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.0	0.8	0.0	0.0	3.2	1.1	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	3.0	1.0	0.8	0.6	0.4	0.5	0.4	0.4	0.4	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	32.6	0.0	0.1	0.1	9.1	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	24.6	0.9	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	6.6	0.0	0.0	159.5	33.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728040	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.9;retina: 48.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.9;Inhibitory neurons: 91.5;Oligodendrocytes: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	7.6	6.9	15.0	5.3	22.8	23.8	6.5	1.1	45.9	6.2	3.5	5.6	4.0	5.1	5.1	4.6	5.0	5.2	6.4	22.1	9.8	7.4	5.7	8.0	6.3	19.5	5.6	4.8	4.8	8.4	13.8	9.8	14.8	4.5	5.4	48.4	4.7	3.7	7.7	5.1	6.3	4.9	0.0	7.9	5.0	10.2	8.7	7.1	7.3	6.4	4.8	5.5	5.4	25.9	5.5	2.9	5.0	5.7	8.9	7.1	10.3	11.3	6.2	6.8	5.7	6.1	2.6	2.0	3.8	6.9	8.9	5.0	8.9	6.8	8.4	6.8	8.1	13.8	8.7	3.5	4.8	5.6	11.7	4.1	4.9	12.0	6.1	5.8	10.8	7.3	10.6	11.6	9.0	5.5	5.5	5.1	3.4	6.4	6.0	6.1	11.1	7.4	7.5	4.3	5.6	4.5	14.0	8.4	5.6	6.9	7.8	7.2	11.2	10.0	5.3	8.2	6.4	6.0	7.8	4.4	8.0	10.7	8.7	3.4	2.9	6.9	1.2	5.2	2.0	0.1	1.9	2.0	2.5	0.3	2.2	2.2	9.1	0.5	4.7	1.4	2.6	1.1	15.0	22.8	1.1	45.9	22.1	9.8	19.5	5.6	14.8	0.0	8.7	25.9	10.2	6.4	5.4	22.9	3.9	4.8	1.9	3.1	8.0	24.8	3.8	2.5	10.0	2.8	4.0	1.8	45.9	17.7	7.0	4.8	5.9	2.0	19.9	2.4	4.7	11.9	3.0	5.0	110.9	1.3	9.8	5.3	4.1	3.6	3.8	2.2	11.0	4.2	10.1	10.1	91.5	2.0	0.0	18.6	5.7	11.3	2.8	15.7	1.8	31.9	6.5	21.8	4.1	49.3	61.0	2.8	5.3	4.5	8.6	2.7	6.2	6.5	4.6	45.4	6.6	6.1	5.8	22.1	13.3	6.7	3.3	38.0	9.9	2.8	5.4	4.3
SYNM	"DMN, KIAA0353, SYN"	ENSG00000182253	Synemin	O15061	15	99098217-99135593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 594.1;skeletal muscle: 624.7;urinary bladder: 406.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 103.5;Cardiomyocytes: 502.5;Muller glia cells: 127.8;Smooth muscle cells: 98.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.8;HeLa: 58.0;WM-115: 124.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017192, HPA040066, HPA044200, HPA077856"	Enhanced		Supported	"Intermediate filaments"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (5.92e-3)"	"unprognostic (3.26e-3)"	37.2	20.3	51.4	26.5	66.0	0.4	56.7	70.1	58.2	11.8	52.5	594.1	27.1	50.8	12.7	169.6	36.5	19.2	144.2	44.4	75.4	6.9	4.8	23.1	4.2	81.7	66.6	14.1	6.3	8.2	23.2	14.0	81.6	150.6	52.0	40.3	25.6	291.3	624.7	17.0	105.7	160.9	71.6	2.9	158.4	5.2	69.3	3.7	11.2	277.1	4.0	406.3	41.0	79.8	6.6	36.8	8.1	21.9	15.9	0.9	0.5	3.7	5.3	2.1	1.3	5.4	4.9	0.0	5.3	5.3	17.7	4.2	5.5	0.1	1.6	0.5	9.0	0.1	58.0	5.4	9.0	0.0	1.0	0.9	0.3	3.7	0.8	6.0	4.3	0.0	0.2	7.4	5.5	3.7	0.7	0.8	7.2	0.7	11.4	0.0	7.5	5.5	2.1	3.6	3.6	4.2	21.9	3.4	13.5	12.7	0.2	3.6	4.8	4.1	0.4	2.9	8.9	0.1	1.0	0.0	0.4	0.0	124.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	51.4	66.0	70.1	58.2	44.4	75.4	81.7	66.6	81.6	71.6	69.3	79.8	14.8	0.0	1.7	15.3	0.9	2.3	0.7	0.9	2.8	12.6	32.7	103.5	502.5	0.0	1.2	0.0	16.7	1.5	6.6	2.1	0.0	0.5	9.5	1.3	1.0	24.2	3.0	0.0	15.6	1.3	0.7	20.3	5.1	4.2	0.0	1.1	3.6	1.3	0.3	42.1	9.8	0.9	0.0	0.0	5.1	4.5	1.2	2.0	5.4	12.2	0.6	127.8	1.0	2.5	14.0	0.2	2.3	4.1	5.4	2.0	0.6	0.3	3.1	10.2	32.9	19.6	98.5	7.9	11.5	2.1	3.7	0.4	5.9	0.2	0.7	0.9
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659207	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 369.6;skeletal muscle: 1296.3;tongue: 502.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 264.7;Distal enterocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 88.4;EFO-21: 72.8;HUVEC TERT2: 72.7;TIME: 178.0;U-87 MG: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179"	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	91.8	112.1	103.5	21.3	60.7	0.3	48.6	0.0	88.9	23.2	0.8	37.4	31.4	38.7	20.9	31.0	30.8	32.2	369.6	91.2	5.2	60.6	38.5	72.1	10.6	18.2	8.5	34.6	32.9	17.1	21.6	23.8	5.2	46.0	17.5	10.0	21.6	29.1	1296.3	15.4	39.6	38.9	20.6	38.9	34.9	17.0	5.1	6.6	31.1	502.1	11.1	56.8	22.3	34.9	0.5	24.2	0.2	0.3	3.5	3.2	88.4	13.8	18.9	4.6	3.7	21.6	9.7	0.1	72.8	19.9	29.2	8.9	0.1	13.5	1.9	0.2	0.2	0.0	37.4	4.7	19.6	0.0	0.9	3.7	21.3	5.2	3.7	27.5	72.7	0.2	0.2	0.2	4.4	1.6	0.1	0.7	2.8	9.3	11.6	0.5	0.7	0.2	3.4	1.9	8.5	39.3	19.9	21.6	0.7	31.1	1.6	6.6	178.0	17.4	53.2	0.4	3.6	0.8	0.2	1.3	152.5	0.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.5	60.7	0.0	88.9	91.2	5.2	18.2	8.5	5.2	20.6	5.1	34.9	51.1	35.3	12.2	1.3	4.8	4.6	3.0	32.6	1.8	1.9	6.4	2.5	264.7	27.1	17.0	7.3	2.1	14.8	0.5	70.5	0.0	43.7	1.7	0.4	0.4	56.3	13.8	2.7	22.5	34.5	6.0	19.9	4.6	0.5	0.0	40.9	62.8	40.0	2.1	0.0	5.7	8.4	2.0	10.8	5.1	3.4	2.8	0.9	5.4	6.5	24.0	7.2	0.0	2.5	1.3	35.6	24.4	27.8	0.6	5.7	52.6	4.4	7.6	0.8	46.0	18.0	29.2	1.2	0.8	1.4	2.3	25.9	1.6	8.6	11.8	3.6
SYT4	"HsT1192, KIAA1342"	ENSG00000132872	"Synaptotagmin 4"	Q9H2B2	18	43267892-43277535	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.7;pituitary gland: 30.7;retina: 25.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 66.8;Cone photoreceptor cells: 22.9;Enteroendocrine cells: 28.7;Excitatory neurons: 50.9;Fibroblasts: 23.0;Inhibitory neurons: 34.1"	"Group enriched"	"Detected in some"	5	"glioma: 2.0;pancreatic cancer: 4.1;prostate cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 245.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010574	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"		"HPA010574: AB_2668309"			"unprognostic (2.91e-3)"		"unprognostic (2.03e-1)"			"unprognostic (2.37e-2)"		"unprognostic (2.87e-1)"	"unprognostic (7.67e-3)"	"unprognostic (5.30e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.80e-2)"		3.7	15.9	21.5	1.4	18.6	0.1	0.0	74.7	42.6	0.0	0.0	1.2	0.8	0.0	0.0	0.1	0.0	0.0	1.3	18.6	50.4	0.1	0.0	0.9	0.0	10.5	15.3	0.5	3.7	0.0	30.7	0.1	39.3	0.6	0.8	25.2	0.1	8.3	0.0	0.0	0.7	0.6	13.5	0.0	3.2	1.6	18.3	0.4	0.3	0.0	0.0	0.0	0.5	10.9	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	245.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	18.6	74.7	42.6	18.6	50.4	10.5	15.3	39.3	13.5	18.3	10.9	0.0	0.0	1.1	8.8	0.0	0.1	0.0	0.0	0.0	66.8	0.0	0.0	3.6	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	28.7	0.0	50.9	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.4	0.0	2.5	0.0	7.5	7.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.1
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600882-63608365	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 87.9;Proximal enterocytes: 81.2;Proximal tubular cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	12.8	18.6	16.6	8.2	17.4	8.3	10.9	18.9	18.4	8.8	17.7	17.8	18.9	11.1	9.7	13.4	9.3	5.5	42.3	16.5	17.5	30.1	69.2	7.7	10.4	17.4	17.4	8.3	12.0	18.2	9.5	8.3	17.3	9.5	16.1	9.4	11.4	9.2	61.5	11.3	16.7	9.7	16.9	11.5	15.1	12.1	17.6	9.9	9.4	55.9	12.2	11.8	9.2	16.7	39.6	61.2	19.4	20.2	16.5	23.5	25.7	28.5	26.8	56.2	44.4	40.5	23.2	32.6	21.2	33.1	38.9	35.8	43.0	41.5	52.6	17.3	58.1	32.0	29.8	72.3	45.5	38.3	21.7	29.0	28.6	48.5	51.1	20.9	29.6	24.2	44.4	24.1	26.6	71.6	44.7	28.7	16.8	42.5	62.9	28.1	47.7	40.8	33.2	27.6	29.5	32.4	19.6	64.0	55.3	25.3	53.3	29.1	26.4	39.9	29.9	27.5	50.7	25.9	27.2	38.7	30.4	26.0	29.6	2.2	9.4	9.0	9.8	8.5	10.7	7.5	13.7	9.7	10.6	9.9	12.4	10.3	1.4	17.8	7.4	7.0	10.2	9.4	16.6	17.4	18.9	18.4	16.5	17.5	17.4	17.4	17.3	16.9	17.6	16.7	9.8	3.2	6.3	2.6	12.0	2.5	8.0	21.1	8.6	8.2	7.8	10.9	54.0	17.2	11.5	14.7	2.1	32.1	8.2	32.9	54.8	29.1	15.3	8.0	11.4	14.2	13.8	17.4	4.0	27.4	28.9	14.1	16.8	6.4	9.5	16.2	8.6	87.9	26.3	6.7	3.9	21.7	12.2	10.7	3.9	46.0	11.8	9.2	10.6	2.8	22.0	15.5	14.4	1.5	3.2	30.0	25.8	11.3	10.7	11.6	81.2	109.7	9.1	13.4	19.7	10.7	14.6	26.8	13.9	18.6	4.3	19.8	10.1	40.7	32.8	7.1
TACR2	"NK2R, NKNAR, SKR, TAC2R"	ENSG00000075073	"Tachykinin receptor 2"	P21452	10	69403903-69416918	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 184.0"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 6.7;Kupffer cells: 2.4;Leydig cells: 2.8"	"Cancer enriched"	"Detected in many"	4	"stomach cancer: 6.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 4.2;U-87 MG: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076573			Approved	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA076573: AB_2732313"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.88e-4)"	"unprognostic (5.59e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.32e-1)"	0.9	0.3	1.3	2.5	1.2	0.4	0.8	1.5	1.7	10.3	0.2	184.0	5.0	25.2	0.2	14.7	20.4	0.5	3.2	1.7	0.1	0.3	0.5	0.7	0.3	0.0	0.2	1.8	0.3	0.0	0.2	0.2	0.1	6.2	9.1	4.1	0.5	1.1	2.8	1.1	31.4	33.1	0.0	0.3	37.9	0.7	0.0	0.1	0.4	0.2	0.1	32.3	8.5	0.4	0.9	0.6	0.2	0.3	1.4	0.1	0.1	0.2	0.1	0.2	0.3	0.3	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.8	0.1	0.0	1.4	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.2	1.2	0.0	0.3	0.0	0.2	0.2	0.8	0.9	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.6	1.2	4.2	0.1	0.5	0.1	0.3	1.4	0.2	0.6	0.5	0.5	0.6	0.1	2.3	0.1	0.8	0.2	0.4	0.0	0.1	1.3	0.1	0.3	0.2	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	1.2	1.5	1.7	1.7	0.1	0.0	0.2	0.1	0.0	0.0	0.4	0.5	0.0	0.5	0.3	0.1	0.6	0.2	0.2	0.0	0.2	1.1	1.4	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.3	0.6	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.6	0.0	0.2	1.4	0.1	1.2	6.7	0.1	0.3	0.0	2.4	0.4	0.1	2.8	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.4	0.1	1.5	0.2	0.0	1.1	0.7	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.4
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575433-58577252	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Tumor antigen"	"Amyloidosis, Corneal dystrophy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 989.6;salivary gland: 468.5;skin 1: 438.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 6559.0;Basal respiratory cells: 3141.0;Club cells: 2499.0;Prostatic glandular cells: 3724.1;Squamous epithelial cells: 2716.6;Urothelial cells: 8102.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.0"	"Group enriched"	"Detected in many"	79	"dendritic cells: 4.3;granulocytes: 15.0;monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"A-431: 766.6;CAPAN-2: 1005.9;HaCaT: 1010.0;RT4: 355.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"	"Nucleoli, Vesicles"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	4.8	1.2	0.2	1.3	0.4	13.5	135.8	0.2	0.4	218.6	1.9	1.1	0.7	19.1	25.3	989.6	27.7	13.0	0.8	0.3	0.3	137.9	4.0	71.2	1.0	0.2	0.3	1.5	81.1	3.5	2.4	17.7	0.2	126.8	0.9	0.0	468.5	97.1	1.9	438.8	1.2	2.0	0.2	1.0	65.7	0.5	0.3	9.2	5.0	0.3	180.0	234.6	375.0	0.6	766.6	0.1	0.0	1.5	0.0	0.0	280.1	0.2	0.0	0.0	0.1	0.7	1005.9	0.1	94.7	64.2	0.1	1010.0	0.0	186.5	0.0	0.7	0.0	0.2	19.7	0.3	0.3	0.1	0.8	0.2	274.5	0.4	11.3	0.0	42.5	0.0	0.2	1.3	0.0	166.3	0.6	1.1	0.5	167.0	1.4	0.2	0.1	0.6	137.0	355.3	0.2	0.3	32.4	264.9	1.0	3.2	173.6	1.5	45.4	1.0	1.7	0.8	1.7	0.4	0.9	0.7	1.0	0.3	0.7	0.0	4.2	15.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.8	0.2	0.4	0.2	0.4	0.3	0.3	0.2	0.3	0.2	0.2	0.3	0.6	9.0	346.1	109.2	0.0	3.1	1490.5	6559.0	3141.0	1226.5	0.0	789.8	445.6	0.4	338.8	2499.0	1278.2	0.0	107.1	9.1	2.8	43.0	2165.2	0.0	482.3	48.6	60.4	0.0	0.0	0.1	1263.4	8.1	36.3	143.2	608.7	8.8	0.2	1.4	0.5	8.8	0.0	0.0	8.5	1143.4	0.8	203.4	0.0	0.0	34.8	113.8	0.0	31.3	0.0	0.0	0.0	0.6	1778.0	3.6	0.0	1.4	3724.1	0.2	3.4	1080.4	0.0	0.0	1.3	142.4	0.4	1.1	2716.6	1531.8	78.4	32.8	0.0	1.5	8102.8
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876264	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	5.1	8.9	9.6	6.1	10.3	19.4	9.2	9.9	12.4	7.7	8.1	8.4	7.7	9.3	7.6	8.3	8.6	5.3	8.6	10.1	9.3	11.6	26.7	6.2	10.4	7.8	8.3	11.0	6.4	10.9	6.2	8.2	8.8	7.9	9.1	17.0	8.1	7.1	9.8	8.0	8.4	7.6	9.2	6.9	7.5	10.8	9.3	13.2	7.5	10.6	10.1	6.6	5.8	11.2	15.7	14.9	27.4	16.3	8.1	10.4	16.2	8.1	9.9	13.2	11.4	13.7	12.5	29.9	15.4	9.6	10.7	11.8	22.3	14.3	10.6	18.9	21.3	9.9	11.9	22.5	12.0	28.3	17.4	7.9	16.3	8.0	19.9	9.6	11.0	22.2	35.9	17.6	10.5	10.9	34.9	22.5	41.6	25.2	16.5	29.1	12.0	37.9	18.0	20.9	17.5	30.6	14.6	18.7	17.5	25.0	25.3	29.3	8.3	10.8	12.4	11.9	17.3	24.9	36.3	56.3	7.5	12.6	10.4	2.9	12.7	13.8	20.7	12.9	22.9	20.2	22.2	23.6	20.7	20.8	27.9	22.3	2.1	27.5	10.4	13.3	23.4	24.7	9.6	10.3	9.9	12.4	10.1	9.3	7.8	8.3	8.8	9.2	9.3	11.2	2.7	9.6	2.7	7.8	8.4	6.1	4.7	3.9	6.2	7.6	4.9	4.6	10.3	2.8	4.1	3.7	8.4	6.1	4.9	4.4	5.9	3.9	4.0	4.8	4.6	4.3	7.2	13.7	9.6	4.0	7.7	4.8	6.6	4.4	5.1	6.1	3.3	20.3	4.2	1.7	10.5	6.1	0.0	5.3	5.1	1.7	4.4	2.6	1.8	3.7	6.9	6.8	4.1	7.5	17.7	3.8	1.7	3.0	7.5	6.2	5.3	7.0	4.3	6.0	0.0	6.1	4.1	5.2	12.9	7.6	5.1	7.3	7.3	1.9	5.9	4.2
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271"	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	10.0	9.3	2.5	18.2	3.0	16.4	12.6	5.0	6.7	7.7	1.2	9.5	13.7	14.1	9.0	9.5	7.7	15.4	7.1	2.9	3.5	6.8	6.9	8.1	20.6	2.3	0.6	13.8	20.9	5.3	4.9	18.0	2.3	9.9	12.5	8.2	10.1	7.3	8.0	11.4	13.3	9.1	0.5	11.9	11.9	5.5	1.7	10.9	10.1	7.1	13.1	13.8	7.2	7.8	18.2	8.6	17.5	17.9	14.0	47.8	29.2	27.0	11.5	18.4	13.8	28.6	38.8	32.6	34.0	15.6	12.6	44.3	21.5	25.9	21.2	10.6	7.8	34.8	55.6	20.2	16.4	31.9	25.1	19.5	25.8	16.0	35.7	35.0	23.7	22.7	24.2	50.4	22.8	5.0	25.8	66.4	12.1	16.7	9.6	23.3	19.1	30.9	22.7	17.4	10.7	19.5	10.8	38.2	16.5	19.3	32.7	12.4	28.7	26.9	30.5	44.2	28.7	22.9	26.2	32.5	11.2	36.9	10.3	44.2	16.7	28.8	17.3	12.5	17.7	39.1	24.9	19.8	12.0	39.8	28.4	24.1	42.7	18.1	10.8	26.1	18.2	5.2	2.5	3.0	5.0	6.7	2.9	3.5	2.3	0.6	2.3	0.5	1.7	7.8	106.7	89.8	95.5	20.9	246.1	244.2	252.4	66.6	255.0	86.6	129.4	130.9	26.2	134.4	105.3	29.5	39.6	176.0	162.5	94.5	45.0	95.2	19.9	144.9	184.9	121.3	110.2	98.4	41.6	146.3	170.2	147.1	125.4	245.6	104.4	257.2	63.1	54.2	69.3	69.0	38.2	148.0	24.4	103.7	153.6	16.5	128.6	112.0	80.0	24.4	102.1	34.8	89.6	35.2	44.0	110.4	87.5	67.7	162.2	269.2	71.1	101.5	67.7	78.2	72.3	187.4	123.1	49.0	71.5	251.4	203.0	160.9	182.3	119.7	174.1	356.8
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199370-117207464	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 9628.1;intestine: 11712.2"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 279.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 41.6;non-classical monocyte: 63.1"	"Lineage enriched"	"Detected in many"	12	"monocytes: 63.1"	"Cell line enhanced"	"Detected in all"		"BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		6300000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	2235.7	512.7	118.5	963.9	144.4	12.1	1680.5	126.1	215.9	3611.3	172.5	11712.2	451.2	9628.1	693.9	1954.6	4610.6	893.8	1583.5	119.6	120.4	774.5	302.8	1258.6	245.5	137.0	127.0	1643.4	218.6	65.3	254.6	348.0	129.2	4624.1	1154.6	22.9	461.8	6383.6	356.4	619.8	1948.4	7108.7	127.2	532.0	3148.4	202.5	138.2	52.2	723.2	152.4	59.9	5521.7	2331.2	130.0	17.5	5.5	293.3	8.2	140.0	123.8	226.7	1913.4	788.1	1641.8	609.0	1531.4	28.4	3.2	2145.6	2094.4	1.7	46.1	4.4	16.8	543.3	6.8	4.4	5.0	66.9	130.2	708.7	1.7	5.2	304.6	57.5	267.1	36.1	1499.7	3.3	4.5	3.3	6.7	1377.1	4.5	1.7	15.8	84.6	18.8	2.1	2.7	23.1	12.0	4.4	25.8	1.9	9.6	29.9	11.0	1.5	807.6	9.2	5.1	182.0	1598.8	276.9	14.4	86.6	8.9	8.8	21.7	9.1	7.7	6.2	1.8	2.7	0.1	0.3	41.6	0.5	3.6	0.1	0.0	3.2	5.1	0.2	0.1	0.3	0.0	63.1	1.6	0.5	2.1	118.5	144.4	126.1	215.9	119.6	120.4	137.0	127.0	129.2	127.2	138.2	130.0	264.8	38.5	6.1	4.6	10.3	63.9	453.4	248.6	10.8	9.9	74.0	2508.6	1.3	4.3	22.5	40.5	18.8	57.0	8.6	3.1	0.0	577.8	3.3	14.6	455.5	260.3	3.0	2.7	4.5	74.5	35.3	464.4	41.3	12.8	1.3	32.4	639.7	8.9	41.5	1.7	6.5	18.3	24.4	23.1	91.8	23.9	48.4	33.8	96.0	37.5	8.1	4.9	2.1	3.0	11.9	38.4	4.5	2306.4	3.2	414.0	12.1	2.2	23.0	9.9	2866.2	177.6	4563.9	6.0	13.7	8.6	60.9	32.2	15.1	8.3	3.1	62.0
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4"	"Region enriched"	"Detected in many"	5	"midbrain: 14.3"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	7.5	2.5	4.9	1.0	4.5	29.4	6.3	4.7	4.4	2.9	3.0	2.1	0.8	2.9	0.6	1.8	3.5	2.3	5.9	4.6	4.6	4.4	1.5	13.0	1.4	6.5	7.1	1.2	0.9	0.9	1.7	6.9	6.8	2.1	1.3	0.2	1.1	0.8	2.1	1.7	3.1	2.7	6.9	7.1	1.8	0.9	6.4	0.4	5.4	2.5	0.7	2.4	2.5	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	0.1	153.7	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	0.0	0.0	31.2	60.0	48.9	0.1	0.0	0.0	26.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	34.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	4.9	4.5	4.7	4.4	4.6	4.6	6.5	7.1	6.8	6.9	6.4	6.8	23.9	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.5	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.1	18.1	0.0	151.5	0.0	0.0	0.3	0.6	0.0	0.0	36.8	0.0	26.7	0.1	10.6	0.0	0.1	0.0	0.0	1.6	1.5	18.2	0.0	4.8	1.8	29.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	1.3	0.4	0.1	1.0	0.0	2.0	0.0	0.0	0.0
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747415-765012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 820.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 2870.4;neutrophil: 3726.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		29000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	139.5	80.7	108.0	121.8	128.8	464.8	121.0	129.3	119.3	101.9	105.2	99.6	116.0	68.4	66.4	330.6	79.1	100.0	95.5	108.0	113.8	111.6	136.2	109.1	107.8	135.8	119.3	77.0	107.5	49.3	53.0	88.0	130.0	91.9	78.4	34.2	132.8	60.1	120.7	132.7	101.0	60.8	124.0	152.6	132.5	40.4	120.1	109.9	140.3	107.1	115.8	160.8	142.1	148.2	331.0	405.5	115.4	218.1	235.8	136.5	338.0	242.2	313.8	238.2	194.5	176.6	694.8	179.5	323.1	324.7	181.9	345.5	185.6	263.5	122.8	238.9	372.5	310.9	146.0	616.4	250.3	498.4	449.0	112.0	210.6	159.6	129.0	170.4	331.6	224.0	413.5	294.3	224.5	318.0	296.4	601.2	183.9	478.9	326.0	243.5	131.5	656.4	437.9	185.4	284.2	100.1	224.9	466.1	243.3	102.4	220.0	383.9	434.1	107.9	99.5	86.0	232.9	122.9	132.1	223.5	238.5	440.5	444.7	1456.7	1203.5	2870.4	94.1	432.7	102.3	145.5	125.7	115.5	654.2	127.2	100.9	94.9	3726.6	112.2	457.8	267.0	192.7	1066.0	108.0	128.8	129.3	119.3	108.0	113.8	135.8	119.3	130.0	124.0	120.1	148.2	90.2	141.1	117.2	10.7	91.1	73.5	199.8	354.0	61.5	50.3	113.0	122.2	46.4	100.1	253.4	150.8	14.6	419.8	83.8	151.0	250.5	230.4	82.1	156.5	85.4	85.6	101.5	507.0	13.1	272.1	427.6	97.3	144.3	216.7	161.4	86.0	93.5	149.7	418.3	50.5	11.6	186.0	268.5	271.8	169.4	21.2	117.8	352.8	140.5	7.5	820.0	142.1	84.5	10.6	54.8	257.6	200.3	104.2	129.4	361.9	197.7	309.1	232.6	61.7	72.3	59.6	115.0	143.2	140.6	257.6	83.1	526.6	86.8	77.5	215.1	342.6
TAMALIN	GRASP	ENSG00000161835	"Trafficking regulator and scaffold protein tamalin"	Q7Z6J2	12	52006946-52015889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 243.8;B-cells: 60.6;dendritic cells: 114.1;Macrophages: 60.6;Plasma cells: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 37.4;TIME: 27.4;WM-115: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040664, HPA062028"	Approved		Approved	"Nuclear bodies,Vesicles"		No	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles	"Nuclear bodies"	"HPA040664: AB_10794066, HPA062028: AB_2684664"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.16e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.99e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.77e-2)"	31.9	6.3	9.8	4.1	14.9	23.8	26.9	3.2	21.5	17.6	0.4	9.4	2.2	22.0	1.6	7.1	22.2	9.6	24.2	10.5	3.7	12.2	4.2	46.8	3.8	5.0	4.9	14.9	5.7	2.8	6.2	8.9	4.8	13.0	1.9	0.1	6.5	3.1	10.6	10.7	9.8	6.0	4.1	18.2	8.6	2.6	7.6	3.7	16.3	8.4	2.3	12.5	17.1	7.1	0.0	0.0	4.4	0.2	1.9	3.6	1.0	0.2	1.1	0.0	1.1	0.0	0.0	0.0	10.0	0.0	0.4	0.1	1.3	0.0	0.4	0.2	1.3	0.3	0.0	6.2	7.4	0.3	3.3	7.2	0.0	0.3	0.0	0.0	37.4	1.0	1.6	0.0	0.9	0.2	3.1	10.5	4.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	1.1	1.6	0.0	0.2	7.5	2.7	0.0	0.3	27.4	0.0	2.5	0.2	0.0	0.2	0.0	0.1	0.6	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	9.8	14.9	3.2	21.5	10.5	3.7	5.0	4.9	4.8	4.1	7.6	7.1	243.8	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.2	114.1	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0
TAOK1	"FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1"	ENSG00000160551	"TAO kinase 1"	Q7L7X3	17	29390363-29551903	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 220.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007669	Approved		Uncertain	Vesicles		NA	NA		1600000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA007669: AB_1080201"	"unprognostic (1.46e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	13.7	9.1	12.0	9.8	16.0	10.5	10.3	13.8	13.1	11.8	1.2	9.5	5.2	10.8	8.5	10.3	7.9	9.6	13.2	13.3	12.8	10.2	8.6	9.8	9.9	16.4	14.5	10.3	7.8	19.4	8.0	11.7	14.9	9.0	8.5	20.9	7.8	10.0	11.4	10.4	7.3	11.7	13.2	10.4	8.1	11.7	13.9	13.2	14.5	15.2	9.5	12.1	8.7	20.4	19.3	35.0	32.1	13.4	24.1	29.8	11.3	20.0	23.9	20.3	21.1	20.7	7.9	13.8	15.8	35.9	20.7	16.3	30.4	15.7	36.4	20.7	18.2	21.0	21.3	12.2	16.6	26.5	16.7	19.4	19.6	29.0	30.6	21.3	27.3	14.0	20.7	12.0	26.7	14.2	18.5	9.5	12.0	12.9	8.6	15.1	41.2	8.8	19.1	31.5	16.1	18.7	34.6	34.4	21.1	32.6	23.6	21.6	33.6	28.0	19.7	23.7	27.5	9.3	18.6	14.0	20.3	14.8	24.3	0.6	0.5	0.5	0.6	0.6	0.5	0.5	0.6	0.7	0.5	0.6	0.7	0.7	1.7	0.5	0.6	1.4	0.4	0.3	12.0	16.0	13.8	13.1	13.3	12.8	16.4	14.5	14.9	13.2	13.9	20.4	96.9	48.1	45.8	105.8	35.9	44.5	27.4	27.0	52.9	56.6	35.5	23.2	90.2	30.0	37.7	46.0	98.0	18.7	40.5	29.3	15.6	27.3	11.8	45.0	72.0	55.4	37.7	18.7	162.3	24.3	16.0	58.0	31.6	80.1	28.5	44.3	52.1	29.5	30.1	52.2	160.5	23.7	24.4	65.6	60.4	19.8	39.7	67.3	40.9	92.8	55.8	37.1	29.9	142.2	220.8	38.9	24.0	54.2	34.2	40.4	17.6	22.1	31.0	54.7	26.3	66.1	52.1	59.1	33.2	49.5	45.9	37.6	43.1	43.0	21.1	41.6
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973868-29992261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	31.4	36.0	23.4	14.7	21.2	12.7	30.8	18.0	26.1	24.8	11.9	21.8	17.3	25.9	11.1	20.8	22.6	12.0	32.6	23.0	18.9	22.7	17.6	34.0	14.4	21.0	20.0	24.1	19.5	17.4	29.4	19.4	18.9	22.5	8.5	14.3	20.5	13.3	23.4	22.4	24.4	13.3	15.3	33.8	21.8	34.8	20.8	13.2	25.4	12.7	10.5	22.4	21.6	19.0	22.2	41.8	22.4	35.1	25.8	17.1	34.2	40.0	21.1	26.4	24.4	33.6	28.7	23.8	32.8	28.8	18.0	33.9	20.4	20.0	14.1	37.5	43.3	25.8	46.2	34.8	18.7	25.5	47.5	20.0	17.1	28.1	11.2	18.5	44.7	22.4	23.5	23.6	25.8	41.0	29.8	36.0	21.5	16.4	27.6	54.2	32.5	22.2	16.6	20.5	26.1	20.8	22.8	30.2	12.1	14.4	37.5	28.5	62.9	45.0	20.7	32.4	23.6	34.2	23.7	22.1	27.6	28.8	33.7	0.3	0.7	0.4	0.7	0.7	0.8	0.5	0.7	0.6	0.4	0.6	0.4	0.3	1.2	0.5	0.4	0.8	0.9	0.6	23.4	21.2	18.0	26.1	23.0	18.9	21.0	20.0	18.9	15.3	20.8	19.0	52.0	9.6	11.5	21.9	6.3	10.7	4.6	7.5	7.4	14.6	10.5	5.7	9.8	7.2	9.1	9.2	39.6	7.8	7.6	27.0	1.9	8.5	3.9	8.7	9.5	35.3	13.1	3.4	7.9	12.0	6.2	9.7	14.3	8.9	3.8	16.0	47.2	11.8	9.8	10.1	10.7	16.8	12.2	11.2	11.1	4.4	12.5	8.2	7.2	7.5	9.0	8.4	11.3	9.0	12.7	16.1	14.8	12.8	5.9	7.4	27.2	8.0	10.0	21.4	6.6	8.7	8.7	19.7	21.6	9.1	9.7	12.0	9.2	16.0	14.7	7.4
TAOK3	"DPK, JIK, MAP3K18"	ENSG00000135090	"TAO kinase 3"	Q9H2K8	12	118149801-118372907	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 400.6;Rod photoreceptor cells: 323.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 123.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017160	Approved		Uncertain	Mitochondria		NA	NA		520000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA017160: AB_1851994"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	15.4	18.2	33.9	24.9	35.7	41.9	17.1	36.8	38.5	12.7	27.9	23.8	27.1	16.8	12.7	18.2	10.5	19.5	18.5	33.0	38.1	16.2	18.4	23.2	33.8	34.2	35.3	19.3	11.7	15.5	18.7	14.3	33.5	29.0	24.6	48.3	15.2	16.0	21.8	20.3	28.8	17.7	33.6	26.0	25.2	10.7	41.2	31.6	21.1	13.0	33.0	20.6	13.3	42.6	25.7	17.2	12.7	11.1	30.6	37.0	14.5	26.2	29.8	14.9	19.3	8.9	38.5	77.4	8.4	34.9	21.5	22.5	11.2	23.5	23.3	28.3	9.2	91.7	9.0	11.7	35.6	95.2	123.5	25.3	27.7	46.9	68.4	31.3	48.3	45.5	54.3	9.0	27.8	18.2	50.0	62.0	4.7	11.7	9.2	29.1	17.2	8.3	14.1	43.8	2.3	12.5	24.1	10.9	33.6	5.5	22.0	70.0	75.9	25.5	4.5	24.2	22.6	8.7	8.9	60.6	35.8	64.1	35.2	122.3	39.4	91.5	60.9	53.8	58.1	47.9	46.0	53.4	52.4	44.9	40.3	52.9	86.2	86.9	95.4	48.8	46.6	46.0	33.9	35.7	36.8	38.5	33.0	38.1	34.2	35.3	33.5	33.6	41.2	42.6	43.2	35.3	98.9	203.4	110.7	35.2	46.7	30.4	38.1	69.9	52.3	39.6	57.6	52.9	36.7	46.0	212.7	36.1	138.5	116.3	70.5	40.3	18.6	17.5	30.6	36.2	25.1	65.2	117.0	59.1	93.5	37.8	75.4	39.2	167.6	31.6	29.6	57.7	78.5	40.4	156.2	80.7	22.4	104.3	103.0	10.3	38.8	160.5	35.6	133.0	156.9	48.4	217.3	400.6	202.2	91.0	111.7	47.8	84.9	44.4	105.2	37.4	20.7	323.8	46.0	29.9	55.2	101.4	53.3	48.3	31.4	43.8	103.5	66.4	69.3	53.7
TARS1	TARS	ENSG00000113407	"Threonyl-tRNA synthetase 1"	P26639	5	33440696-33468091	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 63.4;Cytotrophoblasts: 36.6;dendritic cells: 15.9;Extravillous trophoblasts: 42.1;Hofbauer cells: 32.1;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		580000	"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavorable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavorable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	29.0	32.2	13.7	33.8	16.2	45.0	26.8	20.0	20.1	24.0	17.1	42.6	30.7	24.7	35.8	40.9	17.4	19.9	38.7	13.8	17.9	32.4	68.6	24.1	29.9	22.4	18.5	17.9	68.1	33.8	9.9	37.1	18.3	27.6	42.8	40.7	36.8	26.4	38.4	19.1	29.8	37.2	18.4	21.7	40.0	18.7	18.3	31.7	37.6	28.4	40.1	42.9	10.8	22.6	253.0	136.1	132.7	189.5	80.2	129.9	230.1	237.5	172.9	152.5	163.7	176.6	128.7	96.0	84.8	176.5	271.8	151.1	261.1	207.1	267.4	158.9	140.5	151.1	332.9	108.5	256.7	225.6	141.0	133.7	287.7	217.5	273.9	102.4	144.3	191.8	236.3	204.6	191.5	105.7	166.3	104.7	159.2	181.5	168.4	137.1	237.9	123.4	170.8	119.8	81.0	102.7	245.6	175.8	195.5	103.8	85.9	236.3	123.0	132.8	211.9	102.5	196.3	135.4	258.4	132.6	156.2	302.6	148.3	34.2	22.0	22.6	27.4	24.5	27.6	28.7	25.2	26.6	32.6	23.9	21.5	27.5	2.6	46.2	18.3	18.3	24.2	20.6	13.7	16.2	20.0	20.1	13.8	17.9	22.4	18.5	18.3	18.4	18.3	22.6	12.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	0.0	0.0	0.0	0.0	36.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	42.1	11.7	0.0	0.0	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	52.1	2.6	0.0	0.0	0.0
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	9.8	16.5	11.8	10.6	11.4	10.0	10.3	11.2	12.5	9.5	10.9	10.3	8.9	8.9	13.0	13.4	11.7	7.7	20.3	11.3	11.5	14.3	25.3	8.6	14.7	12.0	11.5	11.7	8.4	17.7	9.3	8.9	12.7	8.7	11.3	14.7	9.7	9.3	31.9	11.8	9.6	10.0	10.4	12.5	12.0	11.0	11.9	12.6	11.2	31.1	15.4	9.6	9.4	12.8	33.5	27.4	18.1	27.4	19.9	18.2	34.1	15.9	17.2	30.7	30.8	22.4	30.3	48.0	34.2	12.0	21.1	33.8	44.2	36.8	23.5	29.2	38.4	22.7	25.2	22.7	19.7	31.4	33.4	16.2	30.2	23.4	31.6	19.9	20.1	26.4	40.3	32.6	21.8	40.4	27.0	26.0	22.3	46.0	40.2	27.5	23.0	59.8	20.9	15.7	25.5	29.8	24.1	52.5	38.7	25.4	42.3	48.9	11.9	17.8	18.8	14.9	27.2	31.2	39.6	36.2	26.6	36.3	17.6	30.5	15.4	30.5	21.0	27.0	21.3	28.7	20.5	21.2	25.0	25.3	19.6	20.7	2.4	33.2	29.3	16.7	31.4	18.3	11.8	11.4	11.2	12.5	11.3	11.5	12.0	11.5	12.7	10.4	11.9	12.8	6.3	3.2	12.8	6.2	13.2	3.3	5.6	10.4	5.2	15.3	6.2	4.6	22.3	11.5	11.9	7.3	20.9	24.5	8.8	8.2	11.7	11.5	1.6	9.6	12.8	7.4	4.2	11.1	9.3	9.8	14.3	8.4	13.3	11.7	22.2	11.0	6.8	22.6	13.2	15.2	9.1	12.6	6.1	7.7	5.2	2.5	8.4	8.8	3.6	2.8	12.5	7.6	9.2	6.0	9.9	11.9	3.5	7.2	9.9	4.5	8.5	8.8	9.4	16.8	6.6	10.3	8.3	18.2	12.3	7.4	4.0	14.1	10.6	15.8	12.6	4.8
TAS2R10	"T2R10, TRB2"	ENSG00000121318	"Taste 2 receptor member 10"	Q9NYW0	12	10825317-10826358	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Astrocytes: 6.2;Excitatory neurons: 14.4;Inhibitory neurons: 14.4;Microglial cells: 4.7;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070201			Approved	"Vesicles,Plasma membrane,Actin filaments"		NA	NA						"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane"	"Actin filaments"	"HPA070201: "	"unprognostic (1.28e-1)"	"unprognostic (3.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.86e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.16e-5)"	"unprognostic (5.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.56e-3)"	0.2	0.6	0.1	0.0	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.0	0.4	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.3	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	14.1	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1
TASL	"CXorf21, FLJ11577"	ENSG00000120280	"TLR adaptor interacting with endolysosomal SLC15A4"	Q9HAI6	X	30558809-30577766	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.5;lymphoid tissue: 10.9"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 166.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001185	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	1.8	1.8	0.6	10.9	0.6	19.5	2.1	0.7	1.0	1.1	1.1	3.5	4.7	0.6	0.4	1.6	0.8	3.9	0.6	0.7	0.6	1.1	2.4	4.7	10.5	1.3	1.1	0.3	0.3	0.7	0.3	2.9	1.3	1.0	3.4	0.2	1.0	0.6	0.1	0.7	3.0	2.2	0.9	9.8	3.6	0.3	1.5	5.8	0.6	0.4	10.2	4.1	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	13.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	21.5	0.0	0.0	0.0	20.5	0.0	21.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.0	0.0	0.0	0.0	0.0	0.1	15.0	1.6	7.5	0.0	23.9	0.0	8.6	21.9	24.1	1.6	19.8	0.3	23.0	2.0	1.1	25.3	23.6	1.8	1.3	30.6	7.1	44.4	45.9	3.4	8.0	0.6	0.6	0.7	1.0	0.7	0.6	1.3	1.1	1.3	0.9	1.5	2.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TASP1	"C20orf13, dJ585I14.2, FLJ20212"	ENSG00000089123	"Taspase 1"	Q9H6P5	20	13389392-13638932	"Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 136.1;Inhibitory neurons: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030824, HPA030825"	Uncertain		Approved	"Plasma membrane"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA030824: AB_10600327, HPA030825: AB_10601575"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.44e-3)"	"unprognostic (9.85e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.67e-2)"	7.0	4.5	1.0	4.3	1.7	4.9	6.8	1.5	2.9	6.5	3.9	5.2	3.7	6.8	6.0	4.8	8.1	4.5	5.7	1.2	2.7	5.4	4.5	6.0	5.7	1.3	1.7	5.6	5.9	8.7	7.4	6.5	1.0	5.2	5.7	6.4	6.0	4.6	2.9	5.5	4.6	5.1	0.5	5.6	5.6	6.1	2.3	12.5	7.8	4.3	5.2	5.6	6.2	2.9	13.1	7.7	3.1	3.7	3.6	5.6	6.0	5.3	7.6	6.1	7.1	16.0	13.3	5.9	3.6	7.0	6.7	17.2	4.9	18.4	7.1	3.5	5.8	11.8	4.7	20.3	7.4	16.0	4.1	6.3	12.1	6.2	15.0	3.7	6.1	10.4	10.7	0.2	5.4	15.8	30.7	8.7	4.2	11.7	3.5	4.8	12.7	9.1	8.5	9.8	8.3	5.7	8.2	15.8	10.2	4.4	8.3	5.8	5.9	5.7	4.0	5.9	7.6	11.3	16.7	4.2	3.2	3.6	5.5	2.3	4.5	4.9	12.7	6.5	9.0	12.1	12.8	10.0	5.0	9.8	18.6	14.4	2.5	14.8	6.5	19.5	13.3	7.1	1.0	1.7	1.5	2.9	1.2	2.7	1.3	1.7	1.0	0.5	2.3	2.9	10.7	6.4	7.7	31.3	19.6	14.1	13.2	11.1	24.5	14.9	10.0	8.8	6.4	17.2	8.8	5.5	10.4	12.0	13.8	3.9	7.9	12.1	20.1	15.7	10.6	6.6	3.6	7.8	136.1	6.0	12.3	15.9	13.3	9.5	15.2	5.2	3.6	6.4	4.7	11.8	131.0	9.9	4.1	3.0	4.7	4.8	3.4	5.8	10.6	35.6	2.9	6.6	11.3	50.3	49.6	8.6	11.4	3.4	13.3	8.0	5.3	12.2	23.5	17.0	6.6	23.7	17.0	29.3	9.3	18.0	12.1	7.0	12.7	10.2	7.7	8.9
TBC1D13	FLJ10743	ENSG00000107021	"TBC1 domain family member 13"	Q9NVG8	9	128787253-128810430	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 55.5;Oligodendrocytes: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045865	Approved		Approved	Nucleoli		No	No		9300	"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoli		"HPA045865: AB_10965700"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.14e-6)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.58e-7)"	"unprognostic (1.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	13.5	21.6	32.3	9.1	30.8	14.7	13.4	23.2	32.3	13.8	19.9	15.3	12.3	13.9	14.0	11.8	14.5	8.6	18.7	30.9	28.1	27.8	16.6	11.2	10.8	29.8	28.9	18.7	17.5	28.4	15.4	9.9	29.6	17.3	8.3	7.1	18.6	13.8	20.7	12.2	15.9	12.9	25.6	19.3	17.0	7.2	29.9	10.9	17.8	13.6	10.9	14.1	10.9	30.0	9.5	22.5	23.1	23.2	29.3	14.1	22.5	22.4	19.0	22.7	14.7	24.6	12.5	15.9	15.2	26.6	22.6	25.1	14.2	17.8	13.3	12.6	16.1	17.0	27.4	22.7	18.1	25.9	33.3	19.8	20.7	19.7	11.8	20.1	29.6	16.6	26.7	10.5	27.4	20.5	15.8	15.2	22.0	26.3	33.5	17.7	21.4	36.1	16.7	12.3	23.2	16.3	31.1	19.7	13.4	22.3	21.0	24.1	23.7	28.3	17.7	23.2	18.4	13.3	18.5	15.5	20.7	15.4	20.8	23.0	2.7	4.8	4.2	2.7	4.4	4.7	3.3	4.2	3.0	3.2	2.9	5.0	2.0	3.4	2.1	8.3	2.6	3.6	32.3	30.8	23.2	32.3	30.9	28.1	29.8	28.9	29.6	25.6	29.9	30.0	6.9	3.2	9.0	9.4	7.2	2.3	2.6	3.4	4.6	10.1	9.6	9.1	12.1	2.8	4.2	16.5	10.4	5.2	6.6	8.8	9.8	6.1	1.5	4.2	6.7	9.4	5.4	7.8	11.2	9.9	4.7	6.4	9.7	5.9	8.2	10.9	16.1	14.8	17.6	6.7	10.5	4.7	4.1	8.5	2.5	2.9	9.3	6.7	0.0	5.6	55.5	6.5	9.2	11.1	36.6	8.5	5.2	7.5	5.4	3.5	15.9	26.0	4.8	5.8	6.6	5.6	4.9	5.1	8.6	5.7	3.1	2.5	6.5	9.7	6.8	2.1
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	26.3	42.1	42.7	31.5	41.9	15.9	27.6	38.7	43.9	19.4	50.2	26.4	22.8	20.9	22.9	34.0	23.5	17.0	30.4	42.9	44.9	44.5	27.4	24.4	29.8	49.3	45.6	28.7	19.5	41.9	27.1	23.8	44.8	24.5	26.3	18.5	31.7	20.2	51.6	49.5	26.0	22.9	45.7	34.9	58.5	30.0	48.7	40.1	19.2	41.3	26.9	19.8	22.2	44.2	34.5	36.8	40.4	45.5	32.8	27.4	24.5	27.0	29.3	24.7	21.1	38.3	69.8	54.9	15.6	32.5	62.8	24.5	68.4	61.7	30.0	15.5	22.2	91.8	23.8	40.4	22.7	42.0	197.9	21.3	85.8	23.4	38.3	31.5	23.5	51.2	88.6	19.3	30.2	22.3	64.9	42.5	54.9	41.1	40.8	80.2	53.2	59.9	36.8	23.9	61.6	44.0	22.4	24.1	84.3	31.2	33.3	39.4	23.7	27.2	20.5	24.0	40.3	36.7	91.6	55.7	25.4	53.2	26.6	2.6	13.2	5.6	8.6	8.2	13.1	8.1	9.3	9.3	10.7	8.3	6.9	6.6	40.6	8.6	3.9	11.5	11.9	10.8	42.7	41.9	38.7	43.9	42.9	44.9	49.3	45.6	44.8	45.7	48.7	44.2	8.4	6.4	17.7	22.5	15.5	9.1	7.0	15.8	15.9	10.2	21.1	16.3	4.6	10.0	14.8	14.7	14.6	12.5	16.3	17.7	19.6	11.5	68.0	12.3	10.3	7.8	6.6	7.2	25.6	10.2	7.1	9.5	14.8	11.9	7.6	18.9	8.2	24.4	26.0	25.2	25.1	15.7	10.2	33.6	8.7	41.0	7.2	27.8	19.6	27.2	24.4	13.4	16.5	51.8	27.0	11.8	14.2	8.6	15.4	12.9	12.8	19.8	10.7	6.6	0.0	12.7	7.1	17.7	18.0	19.8	11.9	16.4	16.3	12.5	19.9	10.1
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 103.8;Oligodendrocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	9.3	9.1	20.0	8.7	21.3	7.2	9.7	17.4	16.7	18.1	14.2	9.4	2.8	38.4	35.3	10.2	16.6	7.1	7.3	16.7	21.1	16.6	13.6	5.8	9.0	23.8	20.2	18.0	9.2	23.9	18.7	20.7	19.7	25.4	5.3	16.5	7.3	43.2	4.6	7.5	5.0	26.6	18.6	8.4	8.1	9.7	26.7	18.4	12.0	5.2	10.2	13.5	12.7	20.0	0.1	29.6	18.5	49.2	16.8	17.4	18.4	11.3	25.0	21.3	22.2	22.4	20.2	31.6	0.8	22.7	9.1	6.7	40.7	8.9	30.9	13.0	19.6	20.0	35.6	26.5	23.7	7.2	68.6	15.6	10.1	22.3	11.8	11.7	19.9	17.2	35.8	53.5	12.5	25.6	17.8	27.2	36.7	14.2	31.5	39.3	14.5	39.3	28.9	16.9	23.4	10.6	27.2	6.8	16.9	48.2	13.3	15.6	29.1	7.5	18.3	0.8	4.6	32.6	27.8	25.1	27.2	17.4	7.1	6.3	4.7	5.7	2.2	2.9	1.8	2.2	1.7	2.0	3.5	3.6	3.1	2.9	18.7	0.3	2.0	0.3	2.9	2.1	20.0	21.3	17.4	16.7	16.7	21.1	23.8	20.2	19.7	18.6	26.7	20.0	12.6	0.0	4.5	103.8	17.3	6.5	13.2	3.8	9.1	11.8	19.1	18.0	10.1	20.0	6.8	31.3	22.9	78.1	20.4	7.9	13.7	10.7	1.0	34.4	80.7	10.3	22.8	3.8	12.5	7.8	6.0	13.1	9.7	51.1	11.4	32.5	11.4	64.3	11.3	6.7	17.1	5.4	2.0	33.0	22.8	3.2	14.3	19.7	5.4	61.8	37.5	46.6	19.6	46.3	109.7	7.5	7.9	28.6	9.5	24.1	0.2	21.8	10.0	24.5	0.0	9.4	27.9	1.4	18.0	16.5	12.4	45.0	18.8	22.3	4.9	23.7
TCEAL1	"p21, pp21, SIIR, WEX9"	ENSG00000172465	"Transcription elongation factor A like 1"	Q15170	X	103628704-103630953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Leydig cells: 283.6;Peritubular cells: 387.8;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057345, HPA060384, HPA076762"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA057345: , HPA060384: AB_2732648, HPA076762: "	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.54e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.76e-2)"	34.9	54.7	33.9	13.8	35.6	9.9	39.4	33.6	47.1	107.9	32.6	61.1	15.2	140.8	40.3	37.8	114.3	34.8	32.2	36.0	37.8	25.1	19.0	30.5	14.1	31.7	31.4	174.8	20.3	31.9	33.9	17.8	35.2	63.3	16.8	14.7	16.1	79.3	55.1	17.3	29.2	95.0	31.4	26.2	40.3	20.1	35.8	12.2	31.9	33.6	9.8	97.9	58.3	33.6	21.8	20.6	11.4	15.8	48.2	33.2	15.2	30.2	30.3	28.9	31.2	9.1	21.1	10.0	30.4	39.3	43.9	21.2	19.2	16.0	21.4	0.0	23.9	13.6	27.2	17.8	21.7	0.1	19.7	40.9	30.4	22.4	12.3	47.7	30.1	11.4	5.1	5.5	58.7	24.1	12.1	0.3	3.8	19.3	32.9	12.4	36.8	0.1	40.4	21.3	15.7	13.2	30.6	14.4	35.4	8.3	13.5	12.7	24.0	20.9	7.7	49.3	15.7	5.4	18.6	0.3	27.4	0.1	21.3	26.8	13.2	0.8	15.3	9.4	22.5	31.9	13.7	12.9	26.4	24.9	18.2	20.8	1.4	22.6	4.0	20.9	13.2	12.8	33.9	35.6	33.6	47.1	36.0	37.8	31.7	31.4	35.2	31.4	35.8	33.6	26.5	16.0	31.2	9.4	10.4	29.7	52.7	38.4	24.5	21.8	47.3	42.8	32.9	28.6	37.2	25.8	2.1	30.0	8.9	6.2	56.7	22.9	2.5	27.5	50.0	32.2	27.6	9.1	22.1	24.6	29.8	37.4	7.7	21.9	26.6	22.7	46.1	19.7	34.7	21.9	20.4	13.2	30.5	21.0	23.1	11.7	283.6	16.5	19.6	6.5	19.7	38.6	19.6	16.6	10.3	11.7	17.5	387.8	5.1	18.4	15.0	52.8	48.0	12.3	151.2	32.6	45.3	6.0	8.5	15.5	21.3	7.3	11.3	32.5	19.4	17.6
TCEAL3	"MGC15737, WEX8"	ENSG00000196507	"Transcription elongation factor A like 3"	Q969E4	X	103607451-103629690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 165.3;Peritubular cells: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA045564, HPA058982"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (2.55e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.05e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (6.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-3)"	"unprognostic (7.19e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.64e-1)"	43.0	61.9	109.1	15.2	111.0	14.9	42.9	108.8	137.0	101.4	111.0	74.0	11.8	171.1	32.4	25.5	120.6	21.2	66.0	104.8	124.0	55.7	9.8	47.5	10.3	117.0	122.9	163.1	34.0	47.7	108.6	17.8	118.0	97.6	9.5	45.9	34.7	70.0	21.5	33.6	32.2	43.1	112.1	43.7	57.5	34.3	116.7	7.0	50.7	10.7	8.0	126.7	68.3	117.5	81.5	8.6	21.5	17.6	72.6	36.8	0.7	118.4	56.4	53.1	70.0	0.0	7.8	0.0	14.3	87.1	94.5	31.3	15.5	46.6	38.9	0.1	3.9	6.0	35.4	0.2	69.8	0.0	25.6	47.9	14.3	37.6	53.9	75.3	36.0	27.6	0.0	23.1	73.6	68.4	3.9	0.6	9.2	0.0	21.9	28.5	13.5	0.3	25.6	16.2	32.7	26.3	5.3	6.9	29.5	10.5	32.4	18.9	47.1	27.6	14.1	56.9	37.5	24.2	12.0	0.1	68.6	0.1	61.9	5.7	8.3	5.1	13.2	4.7	14.3	9.3	11.4	10.4	9.6	10.5	11.1	13.7	1.4	20.0	0.5	12.2	15.9	6.3	109.1	111.0	108.8	137.0	104.8	124.0	117.0	122.9	118.0	112.1	116.7	117.5	39.1	16.0	47.9	6.2	15.9	25.9	91.4	37.8	20.5	57.0	69.8	73.4	50.2	40.0	39.4	75.4	18.8	3.1	19.9	5.1	142.8	41.3	3.3	61.1	165.3	46.2	43.4	6.3	10.0	39.0	3.3	56.3	19.4	40.6	95.8	55.5	58.2	3.8	63.5	18.5	13.8	32.1	36.7	35.1	32.9	17.2	157.2	31.3	16.0	4.7	29.7	137.8	17.5	9.0	12.3	25.3	9.6	256.1	33.0	78.9	0.7	30.6	62.4	35.6	26.3	26.0	62.4	4.4	1.9	10.2	16.9	2.7	21.1	32.9	6.2	45.6
TCEAL5	WEX4	ENSG00000204065	"Transcription elongation factor A like 5"	Q5H9L2	X	103273691-103276750	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 67.3;choroid plexus: 35.5;pituitary gland: 62.2;retina: 23.5;testis: 60.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.4;Granulosa cells: 16.5;Late spermatids: 22.1;Muller glia cells: 75.5;Peritubular cells: 35.7"	"Cancer enhanced"	"Detected in many"		"glioma: 13.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 9.0;SH-SY5Y: 28.0"	"Low region specificity"	"Detected in all"							"HPA045564, HPA058982"	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (1.30e-3)"	"unprognostic (2.41e-1)"		"prognostic unfavorable (9.09e-4)"	"unprognostic (9.68e-2)"	"unprognostic (8.75e-4)"		"unprognostic (1.21e-1)"		"unprognostic (8.11e-2)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.03e-4)"	0.9	10.5	56.5	0.9	54.9	0.0	2.1	55.4	67.3	6.2	35.5	2.2	0.6	5.6	6.8	0.3	2.4	0.8	2.7	52.9	55.2	0.3	0.1	0.3	0.0	50.8	52.6	5.2	0.9	0.0	62.2	0.0	49.5	3.3	0.7	23.5	1.1	4.1	0.1	0.4	1.2	3.3	44.9	0.0	1.0	60.0	50.3	0.6	2.3	0.7	0.0	1.5	3.8	55.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.5	54.9	55.4	67.3	52.9	55.2	50.8	52.6	49.5	44.9	50.3	55.4	0.1	0.0	0.0	2.9	0.0	0.1	0.5	0.0	1.8	43.4	0.3	9.5	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.3	7.5	0.6	0.0	0.0	7.0	0.0	0.4	7.6	0.0	0.2	0.0	16.5	0.0	0.0	0.3	1.7	7.7	0.0	0.0	0.0	1.7	22.1	8.4	0.7	0.0	2.8	0.0	75.5	0.0	7.1	2.8	0.0	0.0	35.7	0.0	0.2	0.0	0.3	0.0	6.8	0.0	6.9	1.4	7.6	1.9	0.1	0.3	0.4	0.1	0.2	0.0	0.2
TCEAL6	WEX2	ENSG00000204071	"Transcription elongation factor A like 6"	Q6IPX3	X	102140476-102142970	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 73.4;testis: 26.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.4;Excitatory neurons: 9.1;Horizontal cells: 15.2;Inhibitory neurons: 10.4;Late spermatids: 6.7"	"Cancer enriched"	"Detected in single"	9	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045564, HPA058982"	Supported		Uncertain	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (5.43e-2)"			"unprognostic (6.54e-2)"	"unprognostic (1.87e-3)"			"unprognostic (6.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.18e-1)"		1.6	10.7	27.3	0.2	24.3	0.0	0.6	23.1	41.4	1.5	3.6	1.7	0.2	3.6	1.4	0.0	5.7	0.1	0.5	23.8	35.4	1.0	0.0	0.1	0.0	27.3	32.9	8.5	0.4	1.8	73.4	0.0	26.3	0.8	0.2	16.7	1.8	0.6	0.0	0.3	0.7	0.7	19.2	0.0	0.8	26.8	26.0	0.0	0.5	0.2	0.0	0.0	1.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	27.3	24.3	23.1	41.4	23.8	35.4	27.3	32.9	26.3	19.2	26.0	22.5	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	40.4	0.0	0.1	4.6	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.0	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	15.2	10.4	0.0	0.0	0.0	0.3	6.7	2.5	0.1	1.8	1.0	0.0	1.9	0.0	4.5	1.7	0.4	0.0	0.7	0.0	0.5	0.0	0.0	0.0	4.3	0.0	1.4	0.9	1.9	0.9	0.0	0.3	0.0	0.2	0.0	0.0	0.1
TCEAL7	"MGC23947, WEX5"	ENSG00000182916	"Transcription elongation factor A like 7"	Q9BRU2	X	103330229-103332326	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 55.2;Horizontal cells: 48.8;Leydig cells: 43.8;Muller glia cells: 88.3;Oligodendrocytes: 46.5;Peritubular cells: 39.1;Skeletal myocytes: 48.3;Smooth muscle cells: 38.7"	"Cancer enriched"	"Detected in many"	10	"glioma: 39.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 83.8;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 115.3;hTEC/SVTERT24-B: 83.8;LHCN-M2: 72.0;SCLC-21H: 210.1;U-87 MG: 78.9"	"Low region specificity"	"Detected in many"							"HPA051507, HPA065080"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA051507: AB_2681512, HPA065080: AB_2685419"	"unprognostic (1.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.35e-3)"	7.7	27.9	72.4	4.3	73.0	0.0	9.1	75.1	126.3	26.3	40.5	18.6	4.0	48.2	18.3	5.5	17.0	11.9	14.0	72.1	84.5	5.0	2.4	6.1	2.3	80.8	77.5	29.0	1.2	1.1	37.4	2.1	82.3	12.3	7.8	23.5	3.5	13.2	3.7	1.8	8.3	29.9	74.5	5.8	6.5	3.1	77.2	5.1	3.8	9.9	1.4	9.7	15.6	96.0	0.0	0.0	83.8	0.0	36.3	55.5	15.0	12.0	61.9	26.4	75.1	0.0	0.0	0.0	0.0	12.9	115.3	0.0	0.0	1.8	45.5	0.0	0.8	0.3	0.0	0.0	18.2	0.0	0.1	46.6	0.0	83.8	0.1	0.0	27.6	0.0	0.5	0.2	72.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	53.1	0.3	0.0	0.0	210.1	56.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	38.8	1.4	0.6	0.0	0.0	0.0	0.0	78.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	72.4	73.0	75.1	126.3	72.1	84.5	80.8	77.5	82.3	74.5	77.2	96.0	4.8	0.0	1.3	5.9	0.0	2.5	5.3	0.3	1.2	36.4	0.9	19.2	13.6	0.0	0.7	3.7	4.2	1.4	0.1	0.0	5.9	0.2	0.2	1.0	42.9	5.2	0.0	0.0	21.2	0.0	0.7	55.2	0.0	0.7	0.0	19.2	1.8	0.0	0.7	48.8	26.5	0.0	0.0	0.0	4.0	1.8	43.8	0.6	8.8	4.7	0.0	88.3	0.0	19.6	46.5	0.3	0.0	39.1	0.1	1.1	0.0	2.1	0.0	12.9	13.1	48.3	38.7	3.0	1.5	0.8	3.1	0.3	0.5	5.1	0.0	0.8
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 467.3;U-698: 597.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	23.8	17.9	20.7	49.2	20.0	72.8	26.1	18.1	22.7	33.4	21.9	32.3	35.5	29.6	16.2	28.2	25.5	19.8	22.8	19.1	17.8	27.2	18.9	25.9	86.6	22.0	19.3	35.1	28.4	10.2	26.2	17.9	20.4	27.3	18.7	11.0	26.4	12.0	19.5	32.9	48.0	14.4	18.3	62.5	27.3	74.8	20.3	68.4	31.6	12.5	61.0	27.4	27.4	21.8	83.6	48.6	146.4	139.8	18.6	49.6	50.4	51.9	48.0	67.8	60.6	89.8	68.7	421.7	53.5	50.1	12.7	98.4	87.9	69.2	42.8	253.7	52.4	43.2	71.2	115.2	44.8	105.7	56.8	34.0	75.1	52.4	39.2	64.0	82.5	176.1	163.8	146.6	46.0	158.2	301.1	107.8	187.1	65.1	49.2	467.3	61.7	104.3	46.5	78.5	119.3	175.7	50.1	55.9	70.8	53.0	63.8	191.7	103.2	87.1	90.5	116.0	94.1	353.5	173.5	597.2	63.1	140.3	80.1	3.3	1.2	1.0	3.6	1.5	3.6	10.0	2.1	3.1	2.8	10.6	2.8	4.3	0.4	2.8	3.2	12.9	2.2	1.7	20.7	20.0	18.1	22.7	19.1	17.8	22.0	19.3	20.4	18.3	20.3	21.8	17.3	6.4	9.1	14.7	33.9	13.9	5.3	10.0	4.6	12.3	16.6	16.1	10.7	4.3	10.8	1.8	27.1	4.3	26.5	14.7	1.9	11.4	8.6	9.9	20.4	13.5	16.2	32.2	3.9	6.9	8.9	12.3	14.8	16.6	7.0	27.8	9.7	4.8	7.7	5.0	5.6	16.5	16.2	8.9	12.3	5.2	13.7	9.4	10.6	6.5	8.1	9.2	10.3	3.0	7.3	17.6	13.3	10.1	31.1	13.0	16.4	6.3	2.9	13.8	19.7	8.2	16.9	5.5	46.2	9.0	13.2	2.9	12.5	10.4	20.1	8.5
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950247-113167678	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"brain: 244.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 244.9"	"Group enriched"	"Detected in many"	10	"intermediate monocyte: 28.9;non-classical monocyte: 86.6"	"Lineage enriched"	"Detected in many"	14	"monocytes: 86.6"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"midbrain: 67.2;thalamus: 86.6"	"Group enriched"	"Detected in all"	5	"midbrain: 146.8;pons: 97.8;thalamus: 164.3"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	28.1	9.4	47.4	8.6	6.3	7.6	25.0	0.2	12.1	18.9	1.0	22.9	20.4	25.1	6.7	9.9	18.1	9.4	11.3	4.3	46.9	9.9	22.4	13.9	5.4	5.1	98.0	22.9	12.4	11.1	9.6	17.7	1.7	12.3	21.3	4.6	14.5	13.1	8.4	17.2	19.3	16.4	1.6	22.2	23.3	7.6	244.9	5.8	12.9	6.9	3.7	13.8	14.3	3.2	15.0	37.8	40.7	39.6	20.8	13.7	48.5	10.3	20.0	7.1	8.5	24.9	45.3	0.1	11.3	19.4	9.6	10.5	14.0	17.6	9.1	1.7	13.1	10.4	25.2	23.6	22.0	4.2	3.7	24.4	6.3	11.0	18.2	29.7	12.0	8.8	11.0	0.7	8.2	28.0	6.7	2.5	29.2	16.6	21.6	19.0	29.8	6.9	15.2	20.4	0.8	12.4	15.7	15.4	17.0	31.5	10.0	2.2	27.9	6.8	18.7	16.9	21.3	2.6	0.3	0.4	6.5	8.7	14.9	0.4	4.5	0.4	1.5	28.9	0.9	0.0	0.4	1.2	4.1	0.0	0.4	0.6	6.0	0.0	86.6	0.2	0.0	3.5	47.4	6.3	0.2	12.1	4.3	46.9	5.1	98.0	1.7	1.6	244.9	3.2	62.0	22.4	26.5	264.8	3.3	42.6	27.3	35.8	64.9	2.8	53.0	54.9	13.6	52.9	35.5	40.5	6.2	44.2	9.1	260.0	11.7	39.3	8.8	40.1	140.6	46.1	19.8	4.8	35.1	43.6	231.4	90.8	90.2	64.2	0.0	37.6	52.8	74.2	17.5	5.0	16.6	87.7	16.2	99.9	20.6	5.0	59.0	54.6	32.0	107.7	22.4	34.4	5.2	192.5	34.9	59.0	211.1	48.5	6.0	38.4	75.3	16.2	26.8	6.1	92.1	37.3	51.3	9.4	28.9	61.1	39.8	28.5	6.7	13.1	73.9	49.0
TCL1A	TCL1	ENSG00000100721	"TCL1 family AKT coactivator A"	P56279	14	95709947-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 267.6"	"Group enriched"	"Detected in some"	4	"B-cells: 282.5;dendritic cells: 210.3"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	296	"memory B-cell: 874.7;naive B-cell: 2160.3;plasmacytoid DC: 1099.9"	"Group enriched"	"Detected in all"	350	"B-cells: 2160.3;dendritic cells: 1099.9"	"Group enriched"	"Detected in some"	142	"Daudi: 459.4;REH: 599.4;U-698: 616.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	1.0	0.1	0.1	34.4	0.1	20.3	0.2	0.1	0.1	0.1	0.0	2.4	0.8	0.8	0.6	0.5	0.1	3.6	0.6	0.1	0.1	0.4	0.4	1.0	267.6	0.1	0.1	0.1	0.3	0.0	0.0	0.8	0.2	0.3	2.0	0.0	4.0	0.0	0.1	0.4	14.2	0.3	0.0	56.7	3.4	7.7	0.1	19.1	1.1	0.0	216.0	2.7	0.1	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	459.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	599.4	0.3	0.8	0.0	0.0	0.2	0.2	0.4	0.7	0.1	0.3	0.1	1.0	1.0	0.2	2.8	0.6	0.2	0.5	3.9	616.2	0.2	0.1	0.1	4.6	1.4	1.8	0.5	0.5	1.3	874.7	0.9	0.4	2.2	2160.3	1.5	0.5	3.3	1.3	1.6	1099.9	1.2	92.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	1.3	0.0	282.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	210.3	0.6	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.9	0.6	2.8	0.0	0.0	2.7	0.0	3.1	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	28.7	60.2	0.0	0.0	0.0	2.7	0.0	0.3	0.0
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965822-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	10.8	13.6	5.8	15.9	6.4	18.1	12.0	6.7	7.2	10.0	7.2	13.2	11.4	11.6	9.5	17.8	8.7	12.2	9.8	6.3	6.0	8.5	12.1	9.6	21.0	5.3	5.5	9.7	9.5	10.4	9.5	17.5	5.5	9.6	15.6	10.5	9.2	7.3	9.5	12.8	13.4	10.9	4.6	11.9	11.2	4.9	5.5	25.7	10.6	9.6	19.1	17.1	11.2	7.3	42.6	21.4	64.4	37.2	15.5	13.7	69.4	32.4	12.3	42.6	23.6	39.1	18.2	99.4	18.8	26.3	6.9	27.9	76.8	36.5	32.6	42.8	66.8	76.4	31.8	17.5	14.8	95.4	55.8	16.3	48.0	31.5	24.6	25.9	42.3	58.4	91.1	15.8	20.6	45.2	107.6	53.6	76.7	33.0	34.0	107.9	32.8	35.0	46.4	61.4	84.2	58.0	38.9	42.7	28.4	37.7	70.7	52.2	26.5	13.3	21.5	14.3	37.5	34.5	49.5	81.8	14.2	52.0	25.3	55.0	53.0	45.8	28.9	39.2	22.0	43.4	28.1	24.3	34.6	39.8	28.5	25.5	35.5	33.6	40.1	92.5	30.5	17.6	5.8	6.4	6.7	7.2	6.3	6.0	5.3	5.5	5.5	4.6	5.5	7.3	35.4	38.5	23.8	12.1	54.6	79.0	49.1	63.0	38.7	51.3	61.2	54.9	25.9	37.1	49.4	33.1	27.1	66.7	68.7	35.2	37.2	68.6	6.2	44.7	44.7	45.2	81.7	69.4	30.3	53.9	82.6	38.5	47.4	45.7	40.4	27.0	39.3	36.4	44.1	35.3	30.0	55.7	87.5	44.8	42.1	3.8	27.4	42.4	16.0	23.4	41.1	24.4	43.3	20.6	20.9	79.7	39.0	30.1	52.6	52.4	28.4	30.5	40.8	39.0	46.0	37.4	38.0	11.0	23.1	52.8	102.9	156.7	49.8	25.0	42.6	61.8
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044764	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Plasma membrane"	"HPA071317: AB_2686388"	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	3.9	4.8	11.8	4.5	13.9	8.9	6.6	4.9	6.6	7.1	7.8	6.5	5.9	5.8	8.2	9.2	6.6	2.6	4.1	5.3	7.0	6.5	4.7	19.0	3.8	3.6	6.4	4.8	5.1	4.6	8.2	3.9	5.0	10.1	4.9	5.5	4.3	2.1	6.4	7.0	6.3	2.8	10.6	7.9	22.3	4.6	28.3	4.9	1.7	23.7	8.1	5.0	4.2	33.8	18.6	40.9	37.5	10.1	14.0	32.7	31.7	25.9	38.4	34.6	13.6	35.5	42.9	23.3	21.7	12.9	33.9	18.2	29.5	55.2	44.1	19.6	43.9	16.7	16.6	8.7	73.2	24.1	10.1	12.9	26.9	24.9	21.9	49.5	57.3	30.6	43.5	45.9	35.0	56.3	39.2	10.0	39.8	43.7	42.3	77.3	34.0	24.6	27.3	30.7	20.9	26.9	77.6	10.1	27.0	31.0	30.8	39.9	16.5	15.7	23.0	28.7	31.8	60.4	52.3	35.5	32.3	24.6	28.7	8.9	15.1	18.8	14.6	18.3	21.1	19.8	20.8	14.2	20.0	21.7	23.1	5.7	23.8	14.1	15.0	32.2	14.8	4.8	4.5	6.6	4.9	4.1	5.3	3.8	3.6	3.9	2.8	4.6	4.2	2.9	0.0	1.1	4.2	15.2	4.7	4.9	7.4	4.0	3.0	6.4	7.1	1.4	1.5	5.0	14.7	8.4	11.4	14.6	3.8	5.9	9.2	123.5	13.2	6.1	3.6	3.6	12.8	13.4	5.6	14.9	4.3	7.7	9.2	2.5	8.9	3.9	4.2	8.8	3.3	13.9	4.9	0.0	6.8	10.2	36.7	2.8	7.8	1.8	1.9	8.0	1.5	8.2	8.0	24.2	6.4	4.8	3.0	16.9	5.7	2.9	7.8	11.0	2.7	0.0	3.4	5.4	33.7	22.8	8.7	4.5	10.1	15.0	10.3	7.9	4.0
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649979-24666930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 183.2"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 530.9;Paneth cells: 428.1;Proximal enterocytes: 637.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 75.6;neutrophil: 228.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 228.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favorable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.47e-5)"	24.4	23.7	27.4	34.3	28.4	21.8	27.3	30.4	36.4	20.6	30.4	141.6	120.1	19.7	25.3	18.6	22.6	28.6	28.2	28.0	28.9	77.9	51.2	24.5	38.9	28.2	29.5	21.3	29.5	25.7	20.3	20.1	28.7	56.5	127.4	18.9	21.9	21.7	21.9	21.1	183.2	24.6	28.3	27.9	26.2	25.3	32.1	37.5	21.7	26.3	37.7	27.2	16.5	28.3	47.7	37.1	41.5	48.1	63.0	64.0	32.4	41.4	53.1	38.9	51.9	50.8	26.3	57.0	70.1	43.8	90.0	34.2	51.2	47.3	52.9	73.6	53.1	53.4	37.7	84.2	40.1	82.8	49.5	43.1	43.7	40.7	36.5	46.0	63.9	54.1	48.8	23.7	59.2	34.1	64.7	52.8	37.1	54.7	31.8	55.5	43.7	61.6	67.0	66.5	52.2	29.8	33.6	84.5	71.0	42.2	38.9	47.4	48.0	37.6	31.3	28.3	61.4	33.7	107.9	77.1	26.0	107.5	61.3	75.6	13.9	29.4	25.0	14.8	30.8	20.0	28.8	27.9	13.2	14.5	24.0	26.2	228.9	29.0	16.5	12.4	31.9	22.7	27.4	28.4	30.4	36.4	28.0	28.9	28.2	29.5	28.7	28.3	32.1	28.3	24.0	6.4	16.7	23.5	24.1	14.1	25.1	37.0	18.8	12.7	19.8	20.2	23.4	37.1	29.6	22.0	6.2	18.4	23.0	530.9	49.0	35.4	140.6	19.4	16.6	22.5	52.7	20.8	25.9	36.0	23.6	18.3	14.3	19.7	24.1	15.7	27.5	31.4	68.4	6.7	25.8	168.9	30.5	28.9	20.0	80.2	18.0	33.5	12.4	15.0	61.7	19.5	38.1	11.6	21.2	21.4	428.1	23.3	10.7	37.0	637.5	175.8	30.5	15.8	32.9	19.1	20.4	9.0	32.7	10.4	16.6	44.3	28.5	15.7	119.3	31.9
TDRD10	DKFZp434M202	ENSG00000163239	"Tudor domain containing 10"	Q5VZ19	1	154502219-154548147	"Cancer-related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 55.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 61.8;Late spermatids: 89.0;Spermatocytes: 103.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.0;TIME: 1.4"					"Not detected"	"Not detected"			HPA054327			Approved	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA054327: AB_2682452"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.33e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.80e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (8.04e-5)"	"unprognostic (1.62e-1)"	11.1	4.5	3.7	0.5	3.7	0.1	6.8	3.1	3.7	5.1	3.3	2.8	0.7	4.2	2.3	2.4	6.5	1.6	7.6	3.3	3.2	3.5	4.5	8.1	0.8	3.2	3.5	10.1	0.9	0.9	2.6	1.7	3.3	3.9	1.3	0.1	1.8	1.2	1.9	2.3	3.5	1.8	3.2	8.9	1.9	55.6	3.7	0.5	11.0	1.4	0.4	3.9	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.7	3.1	3.7	3.3	3.2	3.2	3.5	3.3	3.2	3.7	3.1	10.0	3.2	6.7	4.9	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.5	1.3	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.8	0.0	0.1	8.2	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	1.3	0.7	6.1	0.4	0.4	0.0	0.5	0.0	0.0	4.0	2.1	89.0	2.5	1.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	103.7	16.5	0.1	0.3	0.0	0.0	0.1	0.0	0.0
TEAD4	"EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1"	ENSG00000197905	"TEA domain transcription factor 4"	Q15561	12	2959330-3040676	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 127.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 50.3;Exocrine glandular cells: 38.3;Hepatic stellate cells: 32.2;Proximal enterocytes: 37.9;Syncytiotrophoblasts: 34.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 78.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 364.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.1"	"Low region specificity"	"Detected in all"			HPA056896	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056896: AB_2683268"	"unprognostic (3.68e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.21e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.78e-9)"	"unprognostic (5.05e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-3)"	17.4	5.2	4.2	7.1	3.6	0.4	12.0	5.6	5.5	10.4	4.0	8.1	4.8	9.7	1.0	7.8	8.3	4.5	20.0	3.5	3.9	33.7	4.6	26.0	1.6	5.3	4.8	4.5	51.1	1.6	3.4	10.9	6.1	8.5	4.1	0.5	8.0	5.0	127.3	16.4	8.4	8.9	4.0	9.0	8.1	3.7	6.4	1.6	23.6	46.7	2.4	11.3	7.1	3.6	37.6	51.5	13.0	36.2	4.0	8.7	137.8	29.5	15.6	49.7	27.8	99.6	39.0	0.3	22.2	22.5	34.0	52.5	51.2	364.1	46.1	0.2	41.2	59.1	43.7	87.7	18.8	12.8	10.7	12.2	14.8	43.3	66.7	20.8	42.9	23.4	38.4	0.5	17.5	53.2	0.7	0.3	99.5	48.0	30.0	27.4	73.7	28.9	23.6	15.3	7.4	13.2	36.4	89.9	27.1	93.8	61.2	21.8	49.4	28.7	100.1	20.2	15.7	0.1	0.2	0.4	23.3	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.6	5.6	5.5	3.5	3.9	5.3	4.8	6.1	4.0	6.4	3.6	17.1	12.8	4.7	0.0	0.1	12.2	12.6	6.1	9.1	0.1	6.6	3.7	2.4	5.7	2.3	7.3	0.0	50.3	0.4	3.7	5.9	17.7	0.3	3.0	5.1	25.9	0.0	0.0	1.6	38.3	18.3	6.6	4.1	5.0	5.7	3.4	32.2	0.4	5.2	0.0	0.5	3.7	2.0	0.8	1.5	2.3	0.0	0.5	8.8	3.7	0.0	0.0	0.0	0.0	0.4	21.1	0.9	0.4	1.2	28.9	37.9	21.1	1.5	0.1	0.0	9.3	12.2	0.5	6.4	5.4	7.7	34.6	0.5	0.4	7.1	4.9
TEDC1	C14orf80	ENSG00000185347	"Tubulin epsilon and delta complex 1"	Q86SX3	14	105489855-105499575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 66.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039049, HPA039050"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039049: AB_2676320, HPA039050: AB_10670918"	"unprognostic (8.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.73e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-3)"	5.1	1.6	5.2	4.9	5.5	6.8	4.7	4.1	7.8	4.3	0.5	5.5	5.1	3.8	1.0	6.8	4.6	1.8	4.3	5.8	3.0	4.0	5.4	4.9	5.4	7.0	3.5	2.5	3.0	1.0	5.3	1.6	4.2	4.2	1.6	0.5	4.3	2.3	2.3	8.2	5.4	1.0	3.1	6.8	5.9	4.9	3.6	4.5	5.7	0.5	3.1	3.9	4.5	5.3	17.2	38.9	9.2	13.5	0.8	1.5	24.5	13.4	5.0	15.9	14.7	14.0	31.2	25.6	27.2	2.2	6.2	43.5	3.2	14.0	3.0	29.0	16.0	6.5	22.8	13.3	0.6	12.9	17.9	0.3	4.6	10.6	3.5	2.0	6.4	23.2	10.5	31.2	2.5	66.7	26.9	29.6	11.9	14.6	41.8	21.9	13.8	17.9	4.5	14.3	25.7	15.5	13.7	15.8	9.8	2.0	26.0	12.6	7.8	10.9	18.4	33.4	22.4	17.8	8.2	15.7	13.9	14.8	18.0	0.0	0.5	0.6	0.5	0.9	0.4	0.1	0.8	1.4	0.7	0.3	0.6	0.1	0.1	0.0	0.8	2.4	0.6	0.2	5.2	5.5	4.1	7.8	5.8	3.0	7.0	3.5	4.2	3.1	3.6	5.3	4.8	3.2	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	5.9	5.3	0.0	0.0	0.6	1.8	0.0	8.0	10.1	0.0	3.9	11.6	0.0	12.0	3.0	4.0	0.0	0.0	0.0	12.7	26.6	3.4	0.0	7.2	0.0	8.1	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	11.9	0.0	0.0	0.0	0.0	14.7	0.0	0.0	4.7	0.0	0.0	2.0	3.6	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.0	4.2	2.5	0.0	0.0
TEFM	"C17orf42, FLJ22729"	ENSG00000172171	"Transcription elongation factor, mitochondrial"	Q96QE5	17	30897336-30906238	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023788, HPA053044"	Approved		Enhanced	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA023788: AB_1848818, HPA053044: AB_2682023"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.37e-3)"	4.9	6.0	4.4	5.9	4.6	2.2	6.7	5.7	6.0	4.0	5.5	5.7	5.6	4.9	4.1	5.2	4.8	4.1	8.9	4.6	4.4	9.6	8.8	4.0	7.3	4.5	4.4	4.8	3.3	6.6	3.2	6.8	4.6	5.0	6.6	6.9	5.4	4.8	6.8	5.3	4.6	5.1	4.3	5.7	5.1	4.2	4.6	5.4	5.4	11.7	6.7	5.4	2.9	5.1	12.8	19.2	10.7	14.9	12.7	12.4	10.1	13.1	9.5	23.7	21.4	15.6	7.2	17.4	12.7	8.1	15.5	21.6	18.6	9.1	22.4	5.5	23.9	8.8	15.1	15.5	8.5	18.7	11.2	7.9	11.7	13.4	6.9	7.2	11.9	12.4	19.1	14.3	13.9	11.7	16.0	24.3	8.9	19.6	12.1	10.5	22.9	17.6	19.2	14.4	16.3	7.5	9.8	11.7	15.4	10.9	23.7	14.1	7.8	10.9	14.7	11.2	13.8	7.9	14.0	16.2	7.3	13.8	13.2	2.6	7.7	6.5	6.4	12.2	8.8	9.8	8.2	6.5	8.1	6.3	9.9	9.2	2.3	8.6	9.9	7.0	10.0	7.1	4.4	4.6	5.7	6.0	4.6	4.4	4.5	4.4	4.6	4.3	4.6	5.1	10.1	16.0	10.6	13.7	11.3	4.1	8.0	22.6	9.1	17.8	6.8	6.9	5.8	11.5	13.6	9.2	8.4	26.0	11.5	5.4	25.4	13.4	10.4	12.6	15.3	9.6	5.4	6.9	27.1	8.5	17.3	10.2	5.1	7.8	5.1	17.2	10.4	10.1	20.4	16.8	27.3	7.4	22.4	7.8	3.0	6.3	8.1	9.6	7.2	21.5	14.0	15.0	16.5	27.2	32.2	12.5	5.6	7.5	7.1	5.2	9.4	17.7	17.8	19.4	19.7	11.0	11.6	27.7	17.8	8.7	4.3	17.8	10.0	18.9	7.9	4.7
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.3"	"Group enriched"	"Detected in many"	10	"Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	20.1	9.1	8.1	5.8	7.0	0.2	14.0	6.1	8.4	9.3	4.3	5.0	3.7	12.4	2.3	5.3	6.7	11.2	16.8	7.1	6.8	23.0	10.5	28.8	3.7	7.2	6.6	3.5	3.5	4.4	3.0	46.3	7.6	3.8	5.4	0.7	3.1	6.2	10.5	2.8	5.5	12.7	6.8	28.8	4.0	1.4	9.4	1.8	9.1	22.9	2.8	6.9	3.9	6.8	0.3	0.0	3.5	0.0	0.4	5.6	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	1.6	0.0	0.0	1.8	0.0	2.2	0.8	0.1	90.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	45.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	99.1	0.0	0.5	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.1	8.4	7.1	6.8	7.2	6.6	7.6	6.8	9.4	6.8	70.8	3.2	1.3	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.5	8.6	0.0	0.6	1.8	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.6	0.8	73.9	0.0	2.7	4.3	0.0	2.8	4.2	0.0	0.7	0.0	0.3	122.0	1.3	0.3	0.0	5.0	0.0	0.0	6.7	2.2	0.9	0.6	0.4	0.0	38.4	0.0	0.1	0.0	137.7	2.1	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	1.9	0.1	0.4	0.3	1.3	1.4	0.5	1.8	0.0	0.0
TEKT3	FLJ32828	ENSG00000125409	"Tektin 3"	Q9BXF9	17	15303811-15341632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 31.0"	"Group enriched"	"Detected in some"	10	"Early spermatids: 413.1;Late spermatids: 408.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;SuSa: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027293, HPA044354, HPA073565"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA027293: , HPA044354: AB_10962623, HPA073565: "	"unprognostic (1.85e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.73e-2)"	"unprognostic (5.38e-4)"	"unprognostic (4.59e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (8.63e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.09e-4)"	"unprognostic (1.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.90e-3)"	"unprognostic (7.85e-2)"	0.3	0.2	0.7	0.3	0.6	0.1	0.5	1.4	0.9	1.2	0.6	0.3	0.3	0.5	0.6	0.1	4.9	0.4	0.2	0.4	0.4	0.3	0.2	0.8	0.1	0.9	1.0	0.9	0.7	0.2	1.0	0.3	0.5	0.4	0.2	0.6	0.5	0.1	0.1	0.7	0.4	0.2	0.5	0.2	0.2	31.0	0.4	0.1	0.7	0.0	0.1	0.2	0.4	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.1	0.1	1.5	0.0	0.2	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.7	0.3	0.0	0.1	0.0	0.0	0.7	0.6	1.4	0.9	0.4	0.4	0.9	1.0	0.5	0.5	0.4	1.1	0.7	3.2	0.5	0.7	0.1	0.3	0.1	0.7	0.0	0.7	0.5	0.5	0.7	1.5	4.7	0.0	0.0	0.3	0.2	0.5	0.0	0.1	413.1	16.3	1.7	0.7	1.8	0.0	1.2	0.0	0.5	3.9	0.0	0.5	0.0	0.7	0.4	0.1	3.8	0.0	1.1	0.0	0.0	0.0	1.4	408.9	11.1	0.3	0.0	1.0	0.0	1.7	0.0	2.0	0.8	0.0	0.1	6.4	0.0	0.2	0.7	0.1	39.1	0.2	6.6	3.2	1.4	25.9	2.6	0.0	0.1	0.0	0.1	3.4	0.0	0.2
TEKT4	MGC27019	ENSG00000163060	"Tektin 4"	Q8WW24	2	94871430-94876823	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 13.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 137.1;Endometrial ciliated cells: 49.0;Late spermatids: 129.3;Respiratory ciliated cells: 51.6"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 2.7"	"Region enhanced"	"Detected in single"		"midbrain: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 2.9"	"HPA048600, HPA053929, HPA069872"	Enhanced		Uncertain	"Intermediate filaments"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"	"Intermediate filaments"		"HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: "	"unprognostic (1.49e-2)"	"unprognostic (4.00e-1)"		"prognostic favorable (1.29e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.15e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-3)"	"unprognostic (5.45e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.56e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	13.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.7	1.6	0.5	0.3	0.1	0.2	3.6	0.0	1.5	2.9	0.4	1.5	0.1	1.9	0.0	0.0	0.7	0.6	0.5	7.2	4.7	1.8	0.0	0.5	0.1	0.3	1.9	1.9	137.1	49.0	1.3	1.3	0.0	0.0	1.3	0.4	0.5	1.1	0.0	0.9	1.3	0.1	1.8	1.5	0.2	0.0	0.9	0.2	0.0	1.6	0.5	129.3	2.8	0.8	0.0	1.0	2.6	0.0	0.0	2.0	2.3	0.8	0.0	1.2	0.0	0.4	0.0	8.3	51.6	0.0	6.6	0.6	0.9	12.4	2.4	0.0	1.3	0.5	0.5	0.0	0.2	0.4
TENM2	"KIAA1127, ODZ2, Ten-M2, TEN2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 9.8;heart muscle: 35.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 512.9;Excitatory neurons: 706.2;Inhibitory neurons: 965.9"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 66.1;HBEC3-KT: 43.0;HDLM-2: 43.3;U-138 MG: 74.6;U-2 OS: 64.0;U-251 MG: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli		No	No		11000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019"	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavorable (7.52e-4)"	0.1	0.5	2.9	0.0	4.7	0.0	1.9	0.0	9.8	1.3	0.0	0.2	0.4	0.0	0.5	1.9	0.1	0.4	35.1	6.0	1.2	0.8	1.3	0.2	0.0	0.6	0.1	0.7	0.1	0.0	0.7	0.0	1.6	2.2	0.1	4.1	0.5	1.0	0.0	3.2	0.2	0.0	0.0	0.0	0.1	1.3	4.3	2.2	0.4	0.5	1.0	0.1	2.0	0.0	0.1	0.0	13.4	0.0	0.0	0.4	0.0	1.9	0.0	0.7	1.8	0.0	0.0	0.0	0.0	66.1	1.7	0.0	0.0	43.0	0.8	43.3	0.0	0.0	0.2	0.0	2.0	0.0	0.0	3.0	7.4	0.3	5.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	9.8	0.2	0.0	0.0	6.6	0.0	0.1	0.0	0.1	2.4	3.8	0.1	0.0	74.6	64.0	0.1	50.0	0.0	0.0	0.0	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.7	0.0	9.8	6.0	1.2	0.6	0.1	1.6	0.0	4.3	0.0	0.5	0.0	0.0	512.9	0.0	14.8	1.1	20.3	33.6	15.5	0.3	13.0	144.0	0.0	1.4	0.0	18.8	0.0	0.0	1.0	0.0	3.4	23.5	0.1	0.3	1.7	0.0	0.0	706.2	0.2	0.0	2.2	0.0	0.2	1.3	1.6	0.4	5.1	0.1	121.1	965.9	0.7	0.0	0.0	1.2	18.2	4.4	0.2	1.8	36.5	0.0	2.3	0.0	21.6	12.8	0.0	0.0	61.7	0.0	1.4	0.3	0.0	0.6	1.8	0.0	0.4	1.5	1.2	1.1	1.4	1.7	0.0	0.1	0.0	0.4	0.1
TENT2	"FLJ38499, GLD2, PAPD4, TUT2"	ENSG00000164329	"Terminal nucleotidyltransferase 2"	Q6PIY7	5	79612120-79686648	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 37.6;Glandular and luminal cells: 33.2;Granulosa cells: 31.9;Hofbauer cells: 33.9;Syncytiotrophoblasts: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054468			Approved	Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA054468: AB_2682497"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.37e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.67e-3)"	19.1	15.1	10.4	20.4	12.8	44.4	25.0	11.5	15.6	17.9	15.0	18.5	17.8	19.6	23.6	16.5	16.0	17.3	14.5	9.6	10.8	17.6	23.8	17.9	30.2	12.0	11.1	22.7	15.2	15.5	11.5	21.0	12.5	15.7	20.8	14.3	15.1	15.3	16.2	23.8	19.1	18.3	10.9	27.8	17.7	17.5	11.2	27.2	22.4	14.3	28.1	19.1	15.9	15.2	22.5	15.3	16.8	26.7	28.8	33.2	26.8	26.6	40.6	30.5	48.3	13.8	26.1	41.8	13.6	29.6	35.9	21.1	21.8	29.6	34.6	31.3	19.9	23.9	19.4	21.6	37.3	35.7	31.6	29.5	31.4	21.6	40.1	29.7	26.2	30.0	27.7	30.0	34.0	12.3	40.8	45.6	15.6	17.0	10.8	36.2	16.8	47.2	29.4	31.8	11.0	20.1	21.1	22.8	42.8	26.4	19.6	55.6	24.2	16.4	11.1	16.0	29.9	31.3	27.8	40.7	28.9	36.8	23.4	30.7	21.5	21.6	19.0	24.8	31.3	21.6	20.5	21.0	21.9	17.2	19.5	20.6	19.2	21.8	26.0	12.0	23.4	19.0	10.4	12.8	11.5	15.6	9.6	10.8	12.0	11.1	12.5	10.9	11.2	15.2	25.9	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	24.2	16.5	0.0	0.0	0.0	27.6	0.0	26.3	37.6	0.0	17.6	10.2	0.0	21.3	29.0	7.2	0.0	0.0	0.0	10.2	22.6	8.7	0.0	33.2	0.0	31.9	0.0	0.0	33.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	9.8	0.0	0.0	0.0	0.0	14.9	0.0	0.0	11.5	0.0	0.0	26.5	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	33.7	11.0	23.7	0.0	0.0
TENT4A	"LAK-1, PAPD7, POLK, POLS, TRF4, TRF4-1"	ENSG00000112941	"Terminal nucleotidyltransferase 4A"	Q5XG87	5	6713432-6757044	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Breast glandular cells: 13.4;Breast myoepithelial cells: 13.2;dendritic cells: 12.3;Endometrial stromal cells: 15.4;Glandular and luminal cells: 14.0;Granulosa cells: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045487, HPA046742"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA045487: AB_2679346, HPA046742: AB_2679781"	"unprognostic (1.45e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.62e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (8.55e-4)"	13.1	8.1	8.4	9.5	8.6	27.6	11.0	16.6	10.1	12.5	5.7	10.0	8.7	11.1	6.4	10.7	11.5	10.0	8.5	8.7	8.1	9.6	20.5	12.8	13.0	6.5	6.5	15.6	12.0	10.0	11.1	9.1	7.0	11.1	7.2	12.5	8.2	8.8	9.3	15.7	12.4	12.2	6.0	13.7	9.6	10.1	7.9	14.6	10.2	12.1	10.4	10.1	11.8	8.9	31.7	20.9	25.4	31.6	17.7	15.6	37.0	21.0	25.7	25.1	28.2	21.9	17.3	23.1	16.1	25.5	28.5	22.9	20.7	16.4	23.1	26.1	14.0	12.0	72.5	12.4	11.0	18.0	17.3	10.7	13.8	28.7	18.4	18.6	15.0	16.9	16.3	29.8	20.8	17.6	24.4	25.3	13.6	9.7	16.6	21.8	21.2	6.0	10.5	17.5	25.1	19.3	50.7	24.1	14.5	13.4	14.5	9.9	13.6	30.6	32.7	27.2	29.8	28.6	12.6	20.4	19.6	16.4	19.2	0.0	0.2	0.2	0.6	0.1	0.6	0.5	0.4	0.4	0.3	0.4	0.5	0.5	0.1	0.1	0.2	1.1	0.6	0.2	8.4	8.6	16.6	10.1	8.7	8.1	6.5	6.5	7.0	6.0	7.9	8.9	19.3	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	13.4	13.2	0.0	0.0	0.0	5.5	0.0	5.3	12.3	0.0	1.9	4.9	0.0	10.7	15.4	4.8	0.0	0.0	0.0	4.4	4.0	4.0	0.0	14.0	0.0	14.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	4.2	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	5.6	4.8	10.7	0.0	0.0
TERB2	"C15orf43, MGC33951"	ENSG00000167014	"Telomere repeat binding bouquet formation protein 2"	Q8NHR7	15	44956687-44979229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041780			Uncertain	Nucleoplasm,Nucleoli		No	NA				"Cluster 83: Testis - Spermatogenesis"			Nucleoli	Nucleoplasm	"HPA041780: AB_10796460"							"unprognostic (1.42e-3)"					"unprognostic (4.19e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TERF2	"TRBF2, TRF2"	ENSG00000132604	"Telomeric repeat binding factor 2"	Q15554	16	69355567-69408571	"Predicted intracellular proteins"	"Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001907, HPA002735, CAB010451"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898"	"unprognostic (2.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	15.2	14.4	19.8	17.2	20.6	18.5	14.1	22.7	29.1	15.3	9.1	15.5	13.4	17.9	15.1	15.0	15.4	13.7	15.1	21.8	21.0	13.0	14.8	12.6	35.6	17.6	19.9	19.2	16.7	18.3	12.4	16.1	16.8	13.3	14.4	21.0	11.9	14.1	31.9	15.9	14.0	19.1	14.5	15.8	12.6	16.4	18.4	21.0	16.6	22.1	44.7	15.6	13.4	23.3	21.6	34.4	30.5	30.8	28.5	20.9	26.0	21.5	26.9	50.1	38.7	31.7	28.6	98.2	28.6	26.7	17.9	34.0	37.8	26.4	46.7	18.6	29.3	28.8	18.2	29.1	24.2	28.6	23.0	21.5	26.2	40.2	48.7	22.2	35.0	38.4	54.8	14.2	32.8	29.2	57.0	36.4	35.1	23.6	16.7	78.5	20.2	56.8	21.6	15.8	34.4	27.0	71.4	16.1	19.6	27.5	30.6	32.8	21.5	31.3	27.4	21.9	25.9	36.8	42.1	124.9	27.1	25.5	30.8	14.9	3.5	4.3	5.9	3.3	4.3	13.0	5.6	5.0	3.7	8.4	6.3	6.2	4.2	4.6	3.5	5.0	5.0	2.8	19.8	20.6	22.7	29.1	21.8	21.0	17.6	19.9	16.8	14.5	18.4	23.3	16.2	16.0	10.2	15.0	20.9	12.5	12.8	5.0	5.7	25.3	13.4	8.5	17.2	5.7	5.1	9.2	18.8	8.3	13.0	15.5	1.9	5.3	33.4	15.5	20.8	17.9	10.2	8.6	18.3	7.5	7.7	13.5	8.6	20.5	14.0	14.9	14.3	18.2	12.5	45.4	19.9	11.6	2.0	15.4	12.3	19.5	9.3	11.0	3.6	16.9	8.9	19.3	16.5	18.6	26.5	7.9	7.3	14.3	11.2	14.8	9.5	8.4	8.3	13.9	19.7	18.8	12.1	8.8	13.1	9.6	12.9	8.3	12.1	17.0	11.1	12.8
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295068	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Intestinal goblet cells: 1.0;Plasma cells: 2.8;Spermatocytes: 1.5;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 438.0;fHDF/TERT166: 429.4;HBEC3-KT: 929.2;hTEC/SVTERT24-B: 560.1;LHCN-M2: 252.2;TIME: 799.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA					"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: AB_2682554, HPA065897: AB_2685576"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	213.2	438.0	3.2	0.0	173.9	31.7	59.4	0.3	0.1	3.0	0.2	429.4	0.1	0.1	1.0	929.2	29.1	0.0	1.7	0.1	0.0	0.4	0.1	0.5	1.2	0.0	22.9	560.1	6.8	1.3	1.5	1.8	2.9	0.2	252.2	0.4	0.2	9.4	2.9	0.1	1.3	2.1	0.0	5.4	23.9	0.5	0.2	2.1	0.1	0.0	0.2	0.0	0.1	0.3	799.9	0.0	0.0	0.0	0.0	0.9	0.5	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913008	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 6.7;smooth muscle: 5.3;testis: 12.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Early spermatids: 114.3;Late spermatids: 49.7;Spermatocytes: 95.4;Spermatogonia: 98.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.4;HEL: 19.3;K-562: 5.5;OE19: 4.2;SCLC-21H: 4.1"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.2"	"Low region specificity"	"Detected in many"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.2	0.4	12.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.9	0.0	8.4	1.1	0.0	1.2	3.1	19.3	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.0	0.0	0.1	0.1	0.1	3.7	4.2	0.3	0.0	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	3.6	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.1	0.4	0.7	0.3	0.3	0.6	0.7	0.2	0.4	0.2	0.1	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.3	0.1	1.3	0.5	0.0	0.0	5.7	0.0	0.0	1.2	0.0	0.0	0.0	1.7	2.5	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	49.7	1.2	0.1	0.0	1.0	0.0	1.3	0.0	0.5	0.4	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.1	13.1	0.0	0.1	95.4	98.5	0.0	0.0	0.1	0.0	4.4	0.0	0.0
TEX47	"C7orf62, MGC26647"	ENSG00000164645	"Testis expressed 47"	Q8TBZ9	7	88794106-88795737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 28.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 6.3"	"HPA023817, HPA024163"			Uncertain	Nucleoplasm,Mitochondria		NA	NA				"Cluster 78: Testis - Spermatogenesis"			"Nucleoplasm, Mitochondria"		"HPA023817: AB_1853868, HPA024163: AB_1853869"					"unprognostic (1.43e-1)"													0.0	0.0	0.5	0.0	5.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.6	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.2	0.0	1.3	0.5	1.3	0.6	0.7	0.7	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX52		ENSG00000283297	"Testis expressed 52"	A6NCN8	12	2849046-2857039	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.0"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.8;Karpas-707: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043581			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"		Nucleoplasm	Cytosol	"HPA043581: "																		0.5	0.4	0.1	1.0	0.3	0.8	0.5	0.0	0.4	0.4	2.3	0.5	1.2	0.3	0.0	0.5	0.4	0.3	0.3	0.0	0.0	0.4	0.5	0.3	1.0	0.5	0.1	0.5	1.1	0.0	0.5	0.1	0.3	0.6	0.0	2.9	1.5	0.0	2.5	3.4	1.0	0.0	0.1	0.9	0.5	8.0	0.3	0.0	1.0	0.0	0.0	0.4	0.5	1.2	0.2	0.8	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.6	0.7	0.1	2.8	0.9	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	2.9	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.1	0.4	0.3	0.0	0.3	0.1	0.7	0.4	0.2	0.5	0.1	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.5	0.1	0.3	0.1	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX9		ENSG00000151575	"Testis expressed 9"	Q8N6V9	15	56244009-56445997	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.1;Endometrial ciliated cells: 86.2;Respiratory ciliated cells: 125.6;Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"basophil: 4.3;memory B-cell: 14.4;naive B-cell: 11.4"	"Group enriched"	"Detected in many"	12	"B-cells: 14.4;granulocytes: 4.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039415	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA039415: AB_10672775"	"unprognostic (3.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	1.8	6.1	4.1	4.6	3.9	3.4	10.1	7.4	3.9	8.8	17.0	3.6	11.6	5.2	8.4	4.4	28.0	5.2	1.1	3.2	4.2	10.8	1.5	4.4	6.0	9.4	8.6	5.4	5.4	14.2	9.9	1.6	4.5	4.5	4.8	18.0	10.5	3.4	1.2	5.6	8.0	2.2	5.3	3.2	12.2	16.4	6.6	3.7	17.4	1.5	10.6	2.7	1.6	5.7	7.8	7.1	15.3	13.7	3.7	10.8	2.0	1.7	6.3	4.8	5.7	1.7	6.9	15.5	7.0	1.2	8.2	6.6	6.6	7.4	5.5	1.7	7.8	9.1	6.7	5.2	1.1	3.3	1.3	5.9	13.3	5.4	4.1	6.9	0.2	11.1	5.2	1.4	2.6	4.5	6.5	1.2	7.2	13.2	3.0	2.6	7.1	5.5	15.9	4.4	24.3	9.8	8.7	4.9	5.5	11.2	14.6	3.0	0.7	20.3	5.8	6.5	6.4	2.1	16.5	11.7	8.0	1.7	3.9	4.3	0.1	0.1	0.4	0.6	0.1	14.4	0.4	0.3	0.2	11.4	0.2	0.8	0.3	0.4	0.4	0.4	0.6	0.7	4.1	3.9	7.4	3.9	3.2	4.2	9.4	8.6	4.5	5.3	6.6	5.7	1.5	6.4	7.5	38.8	21.0	4.2	7.3	13.2	20.5	6.4	11.3	11.7	0.8	5.7	23.5	11.0	12.5	1.8	0.3	2.3	21.5	15.6	89.1	86.2	5.1	3.2	7.7	5.9	14.3	7.0	0.5	5.0	17.3	4.8	1.3	5.1	1.8	0.4	1.3	1.7	20.4	3.7	16.2	0.0	2.1	40.9	4.7	2.7	3.6	4.7	1.2	6.8	1.0	14.6	15.1	4.5	5.4	3.8	15.8	3.7	12.3	21.7	125.6	37.5	0.0	4.6	6.0	74.6	36.6	6.9	2.3	0.3	1.0	6.2	6.7	4.9
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 32.8;skin 1: 66.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 167.9;Cytotrophoblasts: 285.8;Extravillous trophoblasts: 260.6;Squamous epithelial cells: 147.7;Syncytiotrophoblasts: 700.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 4.1;medulla oblongata: 3.0;midbrain: 1.3;pons: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 104.7;hTCEpi: 97.3;SuSa: 97.3"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.9;pons and medulla: 1.0"	"Low region specificity"	"Detected in many"			"CAB000326, HPA056871"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB000326: AB_667767, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.5	0.4	0.4	0.1	0.3	0.1	32.8	4.1	0.4	7.5	0.2	1.1	0.5	0.3	21.8	29.9	0.4	0.2	0.9	0.3	0.1	7.4	0.1	0.5	0.4	3.0	1.3	0.4	0.2	0.6	0.4	29.6	2.1	9.8	0.5	8.1	23.5	9.3	0.5	66.7	0.8	0.1	0.5	0.1	1.4	2.2	0.5	0.2	0.5	0.1	5.1	3.5	16.6	0.6	51.8	17.8	0.1	87.9	0.4	0.0	19.7	40.2	30.3	31.7	31.4	2.1	19.3	3.2	4.9	12.0	17.5	53.2	4.3	66.1	30.9	104.7	45.2	0.4	44.5	0.0	0.0	1.7	1.5	0.0	97.3	0.1	66.6	18.3	0.0	0.9	3.3	0.1	0.3	12.2	0.0	17.2	0.5	3.3	24.7	5.9	5.0	2.2	18.8	21.8	12.5	0.3	44.1	82.7	82.3	97.3	56.0	1.7	0.0	9.9	2.7	7.1	25.3	0.1	5.1	0.8	5.1	1.7	59.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.1	0.4	0.3	0.1	3.0	1.3	2.1	0.5	0.5	0.6	0.5	0.0	0.0	0.0	0.4	130.6	45.5	50.3	167.9	25.9	98.2	65.7	2.7	0.0	30.5	31.3	2.1	285.8	0.5	1.0	7.9	2.2	5.3	1.2	0.7	2.1	1.2	0.0	0.0	0.4	260.6	4.2	0.0	1.5	0.0	0.1	0.0	0.0	20.4	80.8	0.0	0.5	46.8	0.0	6.1	3.8	0.6	0.5	124.5	0.0	0.0	4.3	0.0	0.0	0.1	3.7	0.5	0.0	1.2	58.2	0.1	0.3	21.5	4.6	0.0	0.3	4.1	6.5	16.8	147.7	138.4	700.1	0.3	0.3	0.5	46.7
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629306-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.1;skin 1: 53.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 132.4;Basal squamous epithelial cells: 120.1;Breast glandular cells: 66.1;Breast myoepithelial cells: 79.6;Cytotrophoblasts: 91.7;Extravillous trophoblasts: 59.7;Squamous epithelial cells: 81.0;Suprabasal keratinocytes: 149.3;Syncytiotrophoblasts: 105.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"BEWO: 190.6;MCF7: 169.2;SK-BR-3: 308.9;T-47d: 86.8;WM-115: 114.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 2.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.8	0.3	1.3	0.2	0.6	0.1	26.1	0.5	1.5	18.3	0.5	4.0	0.2	6.2	5.2	29.1	2.6	1.0	0.3	1.7	0.7	2.0	0.0	2.6	0.1	0.9	0.8	0.3	1.0	2.6	0.8	17.0	1.2	7.1	1.2	2.7	20.7	4.4	2.1	53.3	0.3	1.1	0.5	0.1	0.7	1.0	0.6	0.7	2.3	0.1	3.0	3.9	19.2	1.0	12.8	15.8	0.1	0.2	0.0	0.0	190.6	20.1	36.4	25.0	4.5	3.2	0.3	0.0	1.3	13.3	13.3	42.7	27.3	5.5	17.0	0.1	2.8	0.0	1.7	0.0	0.0	0.0	1.7	0.3	21.4	7.4	7.2	0.0	0.0	8.1	0.2	3.2	0.0	169.2	20.8	1.2	9.5	9.9	20.7	0.1	0.0	7.0	0.0	10.1	5.1	0.1	13.6	308.9	21.8	28.3	86.8	4.6	0.2	16.2	0.4	8.6	15.4	0.1	0.0	0.1	4.0	0.1	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.5	1.5	1.7	0.7	0.9	0.8	1.2	0.5	0.6	1.0	0.7	0.0	9.5	3.9	0.3	132.4	29.9	2.4	120.1	4.1	66.1	79.6	1.0	0.0	5.6	9.2	0.0	91.7	1.5	1.7	0.0	0.3	0.3	7.8	18.7	2.0	3.0	0.0	0.0	0.0	59.7	7.4	1.5	16.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	1.7	10.2	0.3	8.2	0.0	0.0	1.6	21.4	3.7	0.0	0.3	0.0	0.0	0.0	1.0	0.6	0.0	3.8	18.6	0.0	0.0	5.2	0.0	0.0	0.5	2.1	0.0	1.8	81.0	149.3	105.6	1.3	0.0	1.0	18.5
TFB2M	"FLJ22661, FLJ23182, Hkp1"	ENSG00000162851	"Transcription factor B2, mitochondrial"	Q9H5Q4	1	246540561-246566261	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028482, HPA028554, HPA030265"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209"	"unprognostic (4.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.79e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.44e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.53e-2)"	11.6	23.5	3.6	9.4	3.7	24.2	12.1	6.2	5.0	8.5	6.3	12.6	11.4	7.2	9.5	10.9	8.6	7.1	14.0	3.4	3.9	21.2	37.8	6.3	13.3	3.4	3.5	6.9	15.6	10.8	6.3	9.1	3.5	8.8	12.9	5.0	11.3	7.5	22.7	9.3	9.1	8.0	3.8	7.0	10.1	8.7	3.9	9.3	13.6	24.3	13.2	13.3	6.1	4.1	33.9	31.9	12.1	21.5	14.8	21.1	42.2	24.2	24.8	26.9	24.6	39.0	31.6	59.8	36.9	24.7	17.4	28.5	29.3	25.7	36.8	23.4	11.3	30.3	18.1	34.5	24.2	54.1	26.3	21.0	30.2	23.1	25.8	14.8	21.2	20.9	89.2	19.8	23.4	15.7	27.5	24.1	53.8	58.6	32.1	27.2	23.9	72.9	24.5	36.7	26.7	53.8	23.4	41.9	82.2	13.3	30.6	51.3	15.6	18.7	22.7	26.6	63.8	57.1	102.9	47.6	23.0	52.6	23.9	0.3	5.4	1.5	9.1	5.7	11.5	11.9	8.0	9.7	12.9	12.0	10.3	8.9	1.2	14.8	9.8	11.1	12.3	5.3	3.6	3.7	6.2	5.0	3.4	3.9	3.4	3.5	3.5	3.8	3.9	4.1	11.9	6.4	9.4	4.2	17.2	53.3	13.7	27.9	31.9	3.2	12.4	11.9	16.5	14.3	18.4	16.5	10.4	24.4	13.1	7.6	29.4	13.8	1.5	17.6	12.9	13.2	11.4	8.6	8.1	15.5	28.1	10.2	18.8	22.4	14.0	7.5	5.7	33.9	11.9	0.0	7.2	14.3	6.1	9.3	7.7	3.4	6.5	7.3	5.4	1.9	6.9	6.6	7.2	6.0	5.5	11.0	10.3	4.5	12.7	17.2	7.8	39.2	15.4	3.4	13.1	14.4	12.2	13.2	21.6	21.3	44.9	21.1	10.9	17.7	19.8	10.4
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.1;salivary gland: 97.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 79.1;Distal enterocytes: 117.9;Glandular and luminal cells: 83.0;Ionocytes: 262.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 21.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.2;HEL: 15.7;hTCEpi: 17.3;RPTEC TERT1: 42.4;RT4: 31.8;SCLC-21H: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.9	0.3	0.9	1.7	1.6	0.2	28.7	1.7	1.1	18.1	19.0	19.0	0.6	0.5	8.3	13.3	3.5	2.9	0.2	1.7	0.9	49.1	0.2	5.6	0.2	1.6	2.1	0.1	6.4	2.6	0.8	7.4	1.1	13.6	22.6	0.0	97.5	2.0	2.6	31.9	3.2	0.6	0.7	1.8	16.3	1.1	1.9	0.2	37.6	0.1	1.2	1.8	10.9	0.7	0.0	1.6	0.0	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.7	0.0	0.7	0.4	4.4	4.5	0.0	0.0	3.2	15.7	0.0	0.0	0.0	0.0	0.6	0.0	17.3	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.9	0.1	0.0	0.5	2.1	42.4	31.8	13.3	0.1	1.7	0.1	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.7	1.1	1.7	0.9	1.6	2.1	1.1	0.7	1.9	0.7	0.1	6.4	28.8	3.9	0.3	1.7	38.0	10.3	28.5	0.0	22.1	11.6	2.6	17.2	35.4	79.1	0.0	32.2	0.9	117.9	31.3	2.7	0.1	43.5	5.8	1.0	10.2	0.0	0.2	1.5	2.3	0.8	58.6	83.0	0.0	1.2	0.0	0.4	4.9	0.0	0.3	31.2	262.4	4.6	0.8	0.5	0.3	5.5	7.2	9.4	0.2	0.5	0.0	0.0	0.1	7.4	28.0	0.0	2.1	36.3	0.3	27.7	11.9	0.0	0.0	1.9	1.1	0.1	1.5	41.0	3.3	20.2	1.1	9.5	44.3	40.7
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 986.1;Late spermatids: 397.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 216.4;MOLT-4: 423.3;REH: 222.7;U-698: 366.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Vesicles, Mitotic spindle"	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	18.8	15.1	7.8	9.2	8.9	50.3	18.9	21.2	12.7	12.1	8.2	14.8	22.7	15.3	15.9	13.7	14.7	19.4	26.0	9.0	7.0	29.5	17.3	11.8	10.5	12.5	10.6	23.3	12.4	16.7	13.0	28.4	12.4	19.4	14.0	13.2	12.3	13.7	28.5	11.9	21.3	14.4	7.4	9.5	12.4	69.9	8.2	169.7	21.6	21.3	10.6	11.2	10.2	10.0	32.8	14.7	61.6	49.4	20.3	21.9	134.0	16.3	18.8	25.5	40.2	19.2	32.2	115.8	73.7	18.7	44.6	19.5	15.8	31.2	35.8	46.9	28.5	140.4	21.5	26.0	19.6	43.1	47.8	20.6	22.8	27.8	26.9	23.5	18.3	216.4	53.5	6.8	44.3	25.4	423.3	16.1	49.6	17.2	20.0	222.7	42.2	27.0	29.4	16.5	26.9	25.0	54.5	19.5	29.0	45.3	46.7	21.9	12.0	24.2	21.9	19.8	20.7	20.7	20.5	366.5	19.4	11.4	11.6	69.3	4.0	48.0	28.0	6.9	10.9	14.7	12.8	14.9	9.8	18.7	18.6	22.2	4.4	37.4	10.0	33.7	12.8	12.5	7.8	8.9	21.2	12.7	9.0	7.0	12.5	10.6	12.4	7.4	8.2	10.0	29.7	32.1	30.6	64.0	24.2	25.1	52.1	30.4	43.3	33.0	45.1	36.8	87.6	45.8	30.7	47.8	33.3	235.4	98.5	23.1	93.9	36.8	986.1	63.9	51.1	26.8	38.6	171.9	194.6	26.4	125.2	44.0	15.8	35.8	33.5	84.8	27.8	39.8	27.8	37.0	166.7	27.1	40.7	13.5	15.4	397.5	77.0	27.0	5.4	51.5	14.9	26.1	128.8	61.9	116.6	27.2	25.7	75.2	25.2	36.3	87.5	98.4	43.1	34.5	26.3	96.7	38.6	75.4	75.6	31.3	20.0	99.2	42.9	72.4	42.0	36.0
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.2;kidney: 20.5;lymphoid tissue: 22.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 45.5;Kupffer cells: 56.3;Macrophages: 61.6;Microglial cells: 60.0;monocytes: 44.1;Proximal tubular cells: 77.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 7.1;intermediate monocyte: 2.8;memory B-cell: 3.8;myeloid DC: 6.3;naive B-cell: 2.5;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	29	"B-cells: 3.8;dendritic cells: 6.3;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;HUVEC TERT2: 11.0;THP-1: 21.5;TIME: 12.5;U-937: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	3.5	2.4	1.3	19.2	1.2	17.2	2.6	1.5	1.6	1.9	2.1	2.7	4.2	1.4	0.6	1.0	1.0	4.9	1.0	0.8	1.7	20.5	3.1	9.9	22.1	3.3	1.9	1.3	1.0	0.4	0.6	4.7	2.7	1.0	4.2	0.1	1.3	0.9	0.3	0.4	9.7	3.1	2.7	14.6	3.0	1.6	3.7	2.8	0.9	0.4	12.6	4.0	0.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	1.7	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	21.5	12.5	2.1	0.2	1.3	0.0	5.5	0.0	0.0	0.1	24.4	1.1	0.0	7.1	0.0	0.0	2.8	0.0	3.8	0.0	0.0	6.3	2.5	0.0	0.0	0.1	0.0	0.4	3.3	0.0	1.5	1.3	1.2	1.5	1.6	0.8	1.7	3.3	1.9	2.7	2.7	3.7	4.8	0.5	0.0	2.2	0.3	18.1	0.5	0.0	0.0	0.0	0.0	0.3	0.8	0.8	1.5	0.0	3.7	0.0	0.2	8.3	0.0	0.0	0.0	2.4	0.0	0.0	1.7	0.0	7.2	0.6	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	45.5	0.0	0.5	0.4	0.0	56.3	17.8	3.8	0.0	61.6	0.0	60.0	44.1	0.0	1.0	1.0	0.1	0.1	0.0	0.0	1.3	0.1	15.6	77.8	0.0	0.0	0.0	0.3	0.1	0.3	2.5	0.1	0.4	0.8	0.8	0.1	0.7	0.1
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"	Q07654	21	42311667-42315651	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 305.8;intestine: 355.3;salivary gland: 340.2;thyroid gland: 416.7"	"Cell type enriched"	"Detected in many"	10	"Intestinal goblet cells: 33890.3"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 765.0"	"Region enriched"	"Detected in single"	6	"midbrain: 1.9"	"Immune cell enriched"	"Detected in single"	9	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 58.7;OE19: 126.6;T-47d: 27.8;TIME: 105.0"									"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000	6500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	11.5	5.9	0.1	27.8	0.1	2.2	26.3	0.3	0.2	305.8	0.1	355.3	208.0	2.8	0.5	22.7	49.8	82.8	3.5	0.1	0.1	5.7	6.6	9.9	3.5	0.1	1.9	3.5	6.1	0.0	1.3	0.1	0.2	9.8	305.8	0.1	340.2	1.6	0.9	6.7	290.6	8.4	0.1	23.1	7.4	0.5	0.2	1.8	416.7	1.7	0.9	3.6	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.7	0.0	0.7	0.1	126.6	12.1	0.0	9.0	0.3	0.1	0.0	16.1	0.1	0.0	1.7	0.0	0.0	27.8	0.0	105.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	1.9	0.2	0.1	0.2	0.1	36.9	16.0	25.3	0.0	15.4	41.6	15.1	196.3	3.4	0.1	804.5	444.7	21.6	919.3	595.9	22.0	0.0	0.6	3.4	2188.7	0.0	9.4	0.5	29.3	1.4	322.8	770.9	0.0	0.0	67.8	0.7	21.5	71.4	11.4	59.2	2.0	170.3	5.8	2.1	5.0	0.0	33890.3	3263.2	3.4	42.4	9.0	2.5	2.8	96.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	1855.5	7.9	6.1	73.0	2788.7	0.1	453.2	0.1	0.0	1.1	28.2	1.0	0.3	4.3	38.6	0.8	14.9	0.6	1376.3	107.7
TFG	"FLJ36137, SPG57, TF6"	ENSG00000114354	"Trafficking from ER to golgi regulator"	Q92734	3	100709295-100748964	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019473, HPA052206"	Approved		Supported	Vesicles,Cytosol		No	No		320000	"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	Cytosol	"HPA019473: AB_1857936, HPA052206: AB_2681760"	"unprognostic (1.14e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.31e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.45e-2)"	62.2	73.0	40.7	37.2	40.4	37.4	52.4	43.5	46.4	53.9	46.7	63.8	89.8	52.0	78.5	85.7	51.2	56.4	82.6	41.3	45.4	71.9	113.9	55.6	29.4	44.2	43.2	48.2	66.7	89.0	64.1	79.2	44.4	47.9	69.6	40.9	60.6	61.3	75.5	58.9	76.6	66.5	43.2	42.6	54.4	47.7	42.3	40.6	64.1	58.2	54.9	61.6	57.3	44.4	203.8	107.5	126.7	79.0	160.1	176.4	163.9	141.1	190.4	182.5	213.0	136.0	96.1	24.7	103.3	180.4	141.3	143.1	143.4	161.5	216.2	123.8	87.4	99.7	69.3	130.0	183.3	70.2	51.8	149.3	216.6	108.4	190.8	165.1	165.5	44.5	73.1	63.5	191.9	143.9	63.3	56.7	122.5	193.8	169.3	55.5	77.8	89.0	226.5	125.9	96.4	93.1	95.0	118.2	175.8	103.4	141.7	103.1	113.1	103.0	130.8	48.4	104.4	56.2	65.8	92.1	171.2	79.7	130.7	84.3	43.6	42.8	30.8	45.2	37.4	37.4	31.6	34.5	43.1	35.9	29.4	29.7	26.1	43.1	44.8	29.3	41.0	37.0	40.7	40.4	43.5	46.4	41.3	45.4	44.2	43.2	44.4	43.2	42.3	44.4	67.9	60.9	36.9	46.4	43.3	136.6	105.9	183.6	69.4	46.8	58.0	50.2	83.5	48.6	93.1	36.8	25.0	211.6	43.1	111.8	137.0	190.3	101.5	70.8	70.4	70.2	52.6	27.1	54.8	107.7	201.5	97.8	47.4	79.0	76.8	62.9	53.9	68.4	86.2	57.2	59.2	128.5	122.1	27.3	84.9	45.5	70.8	43.6	64.0	38.4	98.5	88.0	28.8	49.3	55.0	130.5	91.0	74.1	75.8	133.5	202.5	106.4	63.9	60.3	39.5	81.3	87.2	79.2	51.5	68.0	118.9	284.4	43.2	90.0	97.2	123.0
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 346.1"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 152.8;Hepatocytes: 455.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"basophil: 2.5;eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	11	"HEL: 69.7;HMC-1: 92.7;K-562: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA		410000	"Cluster 46: Basophils - DNA binding"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.0	0.1	0.0	0.0	0.0	22.5	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	346.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	0.0	7.2	0.0	1.6	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	65.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.1	0.3	0.9	0.4	0.0	8.5	0.3	0.6	1.2	10.0	0.8	0.0	8.4	0.1	1.7	0.1	0.0	0.4	5.8	0.1	0.6	1.2	0.0	152.8	5.4	0.2	1.1	0.5	1.5	0.2	0.0	0.2	7.1	455.7	0.3	21.9	5.4	0.3	0.0	8.6	1.7	8.4	0.0	0.4	0.0	1.0	0.2	0.4	6.2	1.5	0.7	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.3	1.9	0.0	0.4	0.7	0.7	2.9	0.2	0.6	0.1	2.6	0.1	0.6	0.5
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574054-94596242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 75.2;U-698: 97.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	10.4	9.4	5.3	8.2	5.5	6.0	12.4	5.6	8.2	10.4	6.3	8.0	10.2	8.0	11.8	6.9	9.2	6.8	5.4	4.9	5.6	10.9	30.0	7.1	12.9	5.6	5.4	12.1	10.0	8.1	8.4	10.1	5.9	7.9	9.5	6.9	7.7	7.6	4.1	7.5	9.2	6.7	5.6	9.2	9.1	6.0	5.3	14.1	13.3	4.3	11.0	9.1	6.4	6.6	16.7	7.2	11.6	10.6	17.2	13.5	14.1	15.3	14.9	14.2	13.4	18.9	15.9	26.0	14.8	10.9	8.8	10.4	20.1	11.9	14.9	20.3	7.7	20.7	8.1	18.1	21.0	75.2	13.8	14.9	9.5	8.0	22.8	11.1	13.2	18.9	21.3	8.9	13.3	10.8	20.6	38.4	15.2	26.8	8.3	17.1	11.4	15.9	18.3	7.4	15.9	8.9	11.6	24.2	43.5	19.1	10.2	39.8	12.2	5.6	14.5	8.6	12.6	20.0	11.4	97.5	14.9	26.5	15.5	14.7	5.5	10.8	9.6	6.6	14.9	9.5	11.6	10.7	8.7	7.1	16.8	12.5	1.6	12.1	8.3	7.6	13.8	6.9	5.3	5.5	5.6	8.2	4.9	5.6	5.6	5.4	5.9	5.6	5.3	6.6	7.4	12.8	6.8	8.1	12.8	2.4	9.2	15.9	6.8	4.3	7.8	7.9	5.2	8.6	11.9	7.3	2.1	15.7	12.5	5.8	9.8	11.9	1.2	10.4	8.9	7.0	5.4	3.4	7.7	9.1	17.7	12.9	6.1	6.0	11.4	7.7	7.9	21.4	11.2	1.7	6.7	7.7	8.2	8.8	7.2	1.0	14.3	7.5	8.8	8.4	11.1	7.0	7.2	12.1	10.4	8.9	6.6	8.2	10.7	10.9	10.0	17.6	15.9	4.7	26.3	6.7	8.1	11.9	12.3	8.5	3.7	10.4	11.0	9.2	9.1	9.7
TGFA		ENSG00000163235	"Transforming growth factor alpha"	P01135	2	70447284-70554193	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 59.3;Pancreatic endocrine cells: 74.5;Urothelial cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 11.3;eosinophil: 23.8;neutrophil: 23.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 23.8"	"Cell line enhanced"	"Detected in many"		"A-431: 72.5;CAPAN-2: 82.5;HBEC3-KT: 72.3;OE19: 54.6;RPTEC TERT1: 72.6;U-87 MG: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042297	Approved		Approved	Vesicles	"Secreted to blood"	No	No	57900		"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA042297: AB_10793878"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.69e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.21e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (9.19e-2)"	2.2	0.5	9.2	5.0	16.8	1.6	6.9	15.0	12.2	6.1	5.2	10.7	8.5	1.3	2.9	25.5	6.1	14.1	0.7	10.4	11.7	13.4	4.5	3.9	4.1	21.0	15.8	0.1	7.5	3.0	0.5	1.9	18.5	2.4	7.9	7.4	6.4	1.2	0.1	12.2	10.0	1.4	16.6	5.8	8.5	2.5	13.2	1.0	8.1	0.3	9.0	10.0	12.8	27.3	72.5	11.3	0.1	0.2	0.0	0.0	0.0	11.0	0.0	0.3	0.1	0.2	82.5	0.0	43.2	0.4	11.2	37.1	0.6	72.3	0.1	0.1	1.6	0.0	1.8	6.0	0.0	0.9	0.1	0.0	29.1	0.1	27.8	3.4	0.0	5.6	0.0	0.4	0.0	2.6	0.1	1.4	1.1	54.6	22.9	0.0	0.5	19.8	72.6	27.2	0.6	0.1	5.8	0.0	0.1	0.2	9.8	0.7	0.6	0.3	4.9	0.1	15.7	0.4	0.6	0.1	69.0	2.4	25.6	11.3	0.8	23.8	1.7	0.2	4.4	0.0	1.0	1.0	1.0	0.0	0.5	0.4	23.8	0.3	0.0	0.0	0.0	0.7	9.2	16.8	15.0	12.2	10.4	11.7	21.0	15.8	18.5	16.6	13.2	27.3	0.4	6.4	2.7	0.3	0.2	16.2	12.3	16.9	10.8	1.4	9.8	12.1	2.3	24.3	21.8	25.8	0.0	0.0	2.2	19.8	1.9	37.3	21.3	8.1	0.7	1.7	1.2	0.0	0.8	10.0	0.0	0.6	13.7	10.5	5.7	0.0	0.0	3.0	3.9	0.0	3.6	6.2	12.2	3.2	2.4	1.9	0.3	4.1	0.0	6.5	18.2	7.9	2.1	59.3	36.1	74.5	9.0	0.0	0.7	16.8	21.1	6.6	20.4	0.7	0.0	0.1	1.1	0.6	0.2	12.2	24.9	0.0	1.9	0.0	5.6	63.6
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606601-30694142	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 391.5;Endothelial cells: 236.4;Hepatic stellate cells: 478.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.6;ASC TERT1: 472.3;HSkMC: 430.0;LHCN-M2: 381.7;TIME: 418.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	230.0	56.1	16.5	73.8	12.9	29.4	145.7	13.8	19.3	90.0	30.6	96.0	44.2	69.1	18.2	44.9	69.6	91.9	95.2	10.6	13.4	67.9	59.1	148.0	70.1	17.6	16.5	26.6	52.0	59.0	16.9	81.6	16.7	44.1	54.1	2.1	49.2	60.8	31.1	39.1	77.7	107.2	17.3	111.1	63.4	7.8	21.5	49.7	91.8	62.2	60.7	98.0	55.1	17.2	16.6	100.2	5.3	0.1	313.6	472.3	15.9	83.9	116.1	28.5	27.7	22.9	86.6	2.2	298.2	117.2	32.2	33.3	4.0	125.4	42.0	7.0	8.9	10.1	10.7	104.5	128.5	14.9	76.6	430.0	93.6	126.3	114.4	117.0	296.0	10.9	1.8	0.0	381.7	1.3	16.2	10.5	2.2	75.7	39.8	14.1	36.4	2.1	113.5	40.5	0.1	5.6	24.9	6.1	22.0	6.6	0.0	14.0	418.6	134.7	33.2	61.4	32.0	2.8	0.3	12.5	80.1	16.1	55.8	9.0	3.0	11.5	3.4	3.1	3.3	4.5	4.8	3.3	2.6	6.4	16.6	7.3	13.1	1.9	8.0	6.6	0.7	3.8	16.5	12.9	13.8	19.3	10.6	13.4	17.6	16.5	16.7	17.3	21.5	17.2	391.5	144.2	99.7	0.7	77.0	37.3	18.9	23.5	39.9	5.1	23.7	24.1	84.5	50.1	39.5	27.6	0.0	6.8	85.3	10.5	3.9	13.1	2.5	28.3	57.5	236.4	8.4	20.4	0.4	15.8	5.1	129.2	39.3	30.8	29.8	0.7	478.0	55.5	30.4	0.0	1.0	12.4	22.4	147.0	58.0	3.8	32.9	67.9	30.2	170.5	47.5	0.2	56.7	6.0	2.4	37.6	12.1	47.4	37.5	8.6	13.6	7.2	14.7	1.2	32.9	60.8	53.4	0.3	1.2	8.0	30.5	3.7	68.2	1.7	14.5	10.8
TGIF2LX		ENSG00000153779	"TGFB induced factor homeobox 2 like X-linked"	Q8IUE1	X	89921908-89922883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	88	"testis: 8.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 74.1;Late spermatids: 45.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SH-SY5Y: 10.9;U-2 OS: 12.4;U-266/84: 21.4"									HPA034543	Supported		Approved	Nucleoplasm		No	No				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA034543: AB_10603037"															"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	12.4	0.3	0.0	1.1	21.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127385-38166578	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 432.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 204.5;Cytotrophoblasts: 311.1;Ductal cells: 226.7;Endometrial stromal cells: 459.1;Hepatic stellate cells: 408.0;Hepatocytes: 205.7;Pancreatic endocrine cells: 326.5;Syncytiotrophoblasts: 374.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 1546.7;EFO-21: 505.5;hTERT-RPE1: 994.3;HUVEC TERT2: 695.3;TIME: 924.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	Yes	No		1700000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	105.9	45.1	23.0	68.4	22.3	3.2	30.3	22.9	29.5	432.0	53.0	30.6	29.8	266.3	28.3	37.3	217.7	127.7	394.9	21.4	23.0	76.7	244.1	288.5	18.0	25.4	22.5	40.6	25.6	19.3	95.9	234.3	26.0	88.7	20.8	2.1	9.8	56.6	63.9	4.0	63.7	159.0	24.4	32.7	62.3	3.9	30.6	15.4	36.3	33.4	10.3	154.2	87.8	24.8	65.0	47.5	0.2	1.8	47.3	5.1	24.0	95.5	45.2	0.7	1.8	78.4	1546.7	0.1	505.5	1.0	105.4	1.7	0.1	221.7	3.4	0.7	0.2	10.3	2.6	35.0	191.9	0.0	0.5	5.2	0.4	40.2	0.3	994.3	695.3	0.0	21.4	0.1	16.0	0.3	0.0	0.6	0.8	0.9	4.6	0.0	0.1	0.3	69.0	0.0	0.0	1.3	224.4	0.2	7.6	31.6	2.2	0.6	924.2	1.6	57.6	7.8	46.3	0.0	0.6	0.8	60.7	0.1	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	22.3	22.9	29.5	21.4	23.0	25.4	22.5	26.0	24.4	30.6	24.8	58.0	9.6	18.3	0.0	7.4	0.5	10.4	41.0	0.6	0.0	8.5	8.8	204.5	31.5	55.3	14.7	2.1	311.1	0.1	11.7	3.9	226.7	3.2	16.7	459.1	183.8	0.0	74.5	0.1	145.7	38.6	37.7	0.5	13.1	2.5	2.8	408.0	205.7	54.4	0.0	0.1	1.8	6.1	23.7	2.1	5.0	1.2	35.5	0.0	28.1	6.5	0.4	0.0	0.0	0.3	326.5	1.1	6.0	0.0	68.6	63.0	27.6	23.6	0.5	0.0	5.2	49.1	0.4	4.0	0.9	0.0	374.2	3.9	2.1	3.3	26.4
THAP1	"4833431A01Rik, DYT6, FLJ10477"	ENSG00000131931	"THAP domain containing 1"	Q9NVV9	8	42836674-42843325	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071310			Supported	Nucleoplasm		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA071310: AB_2686386"	"unprognostic (8.99e-3)"	"unprognostic (3.97e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.16e-2)"	7.3	5.7	4.9	6.9	5.1	8.3	7.4	7.3	7.5	6.2	4.9	6.2	5.9	6.9	6.2	6.3	7.3	5.1	8.8	4.9	4.7	7.0	8.7	5.4	9.5	5.2	4.8	8.2	4.6	7.9	3.8	7.0	5.3	5.7	5.4	5.7	6.2	5.7	12.4	4.0	5.8	6.8	5.2	6.3	5.0	9.4	5.2	11.5	8.6	12.5	8.4	6.5	3.7	6.4	10.5	9.3	8.5	8.2	12.7	14.3	10.2	14.2	10.8	12.8	11.7	8.0	13.2	12.8	11.3	10.5	19.0	10.7	14.0	12.0	16.2	12.4	10.3	12.5	8.1	9.4	15.6	10.4	12.7	11.3	17.7	14.1	18.2	12.4	16.5	17.1	14.1	14.7	15.1	6.4	25.1	12.1	16.8	16.9	7.4	11.2	15.2	10.2	13.9	7.8	6.9	8.1	15.5	9.7	20.2	11.2	13.5	11.6	10.0	11.2	8.3	15.0	14.3	11.9	14.0	12.2	11.2	13.6	12.4	23.8	18.6	30.8	19.9	16.7	21.6	20.4	23.1	22.1	19.9	17.8	26.9	21.5	22.0	19.3	18.0	9.8	32.5	18.8	4.9	5.1	7.3	7.5	4.9	4.7	5.2	4.8	5.3	5.2	5.2	6.4	17.2	9.6	9.4	3.6	20.1	13.5	9.4	16.6	26.7	10.5	12.3	11.4	21.5	7.2	12.6	5.5	0.0	20.5	17.5	7.7	23.5	17.5	35.6	16.1	16.2	15.5	14.3	18.3	5.2	11.3	23.8	14.5	2.6	13.3	16.5	8.6	10.4	12.1	15.2	23.5	5.3	8.8	28.5	11.6	9.2	17.9	11.5	13.4	7.2	2.8	20.2	15.6	30.9	5.5	4.9	10.6	4.0	13.9	18.5	10.8	14.1	22.9	13.1	11.0	0.0	12.9	17.0	32.6	45.8	21.1	13.8	8.1	24.6	12.8	9.6	8.2
THAP10		ENSG00000129028	"THAP domain containing 10"	Q9P2Z0	15	70881342-70892433	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.5;Early spermatids: 12.6;Spermatocytes: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"U-2197: 40.4"									"HPA041416, HPA073220"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041416: AB_10795592, HPA073220: "	"unprognostic (1.00e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.15e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.25e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.44e-3)"	1.7	2.2	4.6	1.3	5.2	0.1	1.9	6.1	7.3	2.4	2.4	2.2	2.3	2.1	1.8	1.9	3.2	1.5	4.7	3.9	5.2	3.0	2.1	1.8	1.0	5.1	5.4	3.7	1.9	5.1	1.7	1.8	5.2	3.0	1.9	10.8	1.8	3.1	2.3	1.3	1.2	2.0	5.0	0.9	2.9	3.4	6.3	0.9	3.6	2.3	0.9	2.6	1.4	5.9	7.3	12.6	7.7	9.8	4.1	5.0	0.1	13.5	6.1	11.4	13.5	2.0	9.5	0.0	8.2	3.8	14.3	11.3	16.2	3.7	10.2	0.0	8.3	2.6	6.2	0.9	2.0	0.7	5.2	1.6	5.1	6.5	6.2	7.9	5.8	0.0	0.9	0.0	8.3	5.7	0.0	2.9	11.2	5.2	5.3	0.0	9.9	0.3	5.1	5.9	8.6	8.9	9.3	3.9	6.5	7.5	4.6	6.3	4.3	7.9	5.6	40.4	9.6	3.4	4.3	0.0	5.0	0.9	11.6	0.0	0.3	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.4	4.2	0.0	0.2	0.1	4.6	5.2	6.1	7.3	3.9	5.2	5.1	5.4	5.2	5.0	6.3	5.9	3.5	0.0	0.5	0.0	0.5	1.8	4.1	2.4	1.2	17.5	2.0	2.0	6.1	1.5	2.0	11.0	0.0	0.2	0.0	2.5	9.8	3.0	12.6	5.5	1.9	2.7	3.0	0.4	3.0	1.1	0.3	2.4	1.1	1.1	0.0	2.1	1.4	1.8	1.3	1.7	4.0	1.5	8.2	0.6	1.0	7.8	2.5	0.7	0.0	0.0	0.1	5.2	0.0	1.0	4.7	0.8	5.3	4.9	1.2	2.2	0.6	6.8	5.4	4.6	0.0	1.5	2.9	19.3	2.7	2.6	1.4	0.1	0.2	1.8	2.9	4.2
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206, RONIN"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842320-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	16.6	14.4	20.5	14.9	21.1	10.2	16.3	21.4	21.3	21.9	19.2	26.7	12.3	24.5	13.0	19.5	22.4	10.1	25.1	20.7	21.7	16.1	14.9	15.4	20.8	22.1	20.8	20.9	19.3	16.9	16.4	12.3	20.6	16.1	11.1	10.9	15.7	19.6	48.1	26.1	22.1	17.2	22.5	24.8	20.8	12.6	21.1	23.5	14.9	26.4	19.0	23.9	18.4	23.1	31.3	40.2	27.4	25.9	37.5	25.7	28.7	15.5	27.0	37.1	31.9	51.9	23.6	68.0	31.7	15.9	22.3	35.6	48.6	29.0	21.1	25.4	55.3	27.1	22.5	64.1	34.2	34.9	29.4	23.6	28.4	25.6	22.4	26.8	27.7	45.9	39.5	15.4	22.9	49.1	37.7	62.6	55.1	36.9	34.7	73.6	32.7	61.4	19.0	20.2	38.2	43.1	45.4	16.4	33.2	19.6	40.1	35.2	22.3	23.4	28.4	21.3	19.2	60.9	65.9	67.5	18.3	38.2	25.8	7.6	13.6	14.7	26.3	18.4	20.7	13.8	23.6	24.2	14.3	18.8	29.9	24.0	4.1	21.3	17.5	11.3	31.5	17.9	20.5	21.1	21.4	21.3	20.7	21.7	22.1	20.8	20.6	22.5	21.1	23.1	20.4	22.4	13.1	3.3	24.4	29.2	25.0	6.6	22.8	25.6	27.4	23.6	15.1	12.8	5.3	11.0	4.2	19.6	32.8	12.5	52.8	7.6	1.2	18.6	18.0	21.3	13.2	23.8	4.6	9.5	25.9	17.4	7.1	14.3	7.6	20.3	24.3	14.0	22.4	8.4	4.6	16.2	6.1	19.6	20.0	2.2	23.6	19.1	10.6	4.7	24.5	29.8	43.3	7.1	6.1	6.5	5.9	31.2	18.9	25.0	13.5	19.8	6.1	16.9	19.7	24.2	22.2	16.1	27.4	20.9	39.1	13.5	32.5	28.6	16.5	20.2
THAP3		ENSG00000041988	"THAP domain containing 3"	Q8WTV1	1	6624866-6635586	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067114	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Mitochondria"	"HPA067114: AB_2685782"	"unprognostic (1.82e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.26e-3)"	17.4	24.7	22.1	6.5	22.3	9.6	17.9	23.1	25.8	23.4	18.9	20.1	7.9	18.8	8.3	15.7	19.4	7.7	28.4	20.9	21.3	27.0	29.0	14.1	11.5	23.7	21.8	22.3	24.0	14.0	19.7	7.4	22.2	22.9	4.5	5.1	16.5	9.9	22.8	17.0	15.1	7.0	21.0	21.6	19.2	16.8	21.9	9.7	19.9	13.4	8.6	18.9	18.2	25.0	13.6	12.8	11.2	16.3	18.2	16.3	10.8	12.0	15.6	31.2	19.4	17.1	8.4	11.9	15.7	13.2	11.6	10.5	17.9	10.7	10.8	20.6	30.1	13.7	18.5	15.5	22.8	9.8	13.6	15.3	13.4	19.7	17.2	19.0	13.6	20.5	14.1	14.9	11.7	9.7	17.2	22.2	9.7	15.8	21.7	16.2	13.6	17.3	14.3	3.2	14.7	16.7	14.6	19.9	28.6	9.3	12.8	17.4	12.4	16.5	9.9	11.4	19.0	16.7	19.3	15.9	13.9	20.9	9.5	16.6	19.4	15.2	25.2	16.2	25.7	22.1	25.0	26.8	24.4	31.0	27.3	23.1	12.0	24.7	12.9	22.2	27.1	20.9	22.1	22.3	23.1	25.8	20.9	21.3	23.7	21.8	22.2	21.0	21.9	25.0	12.1	0.0	7.5	5.5	10.8	14.0	12.0	13.2	9.1	11.1	10.4	14.2	7.2	10.0	6.9	9.2	6.2	16.0	9.7	10.7	19.6	10.5	6.5	9.2	11.8	12.8	7.7	11.0	4.6	10.4	17.5	15.8	5.6	9.0	5.7	17.6	11.7	11.6	15.5	5.0	5.8	10.4	10.2	10.9	15.9	4.7	18.6	7.1	10.6	2.8	19.2	12.2	12.3	5.0	7.9	9.8	13.1	23.3	18.1	21.5	21.1	19.3	12.3	8.8	13.1	13.8	15.8	18.2	18.0	8.7	14.8	16.4	9.3	17.7	13.0	15.6
THAP9	FLJ34093	ENSG00000168152	"THAP domain containing 9"	Q9H5L6	4	82900684-82919969	"Predicted intracellular proteins, Transcription factors"	"DNA integration, DNA recombination"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 40.5;Late spermatids: 52.9;Oligodendrocytes: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA037420, HPA037421"	Uncertain		Approved	Mitochondria		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA037420: AB_2675467, HPA037421: AB_10673631"	"unprognostic (7.54e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.64e-3)"	"unprognostic (8.74e-4)"	1.3	1.6	3.0	1.0	3.6	2.0	3.2	3.3	4.5	2.0	2.6	1.5	1.5	2.5	3.6	1.3	1.7	1.3	2.7	3.1	3.3	3.0	3.2	1.6	1.8	3.4	3.2	3.2	2.5	3.2	2.7	2.1	3.6	2.4	1.6	4.3	2.0	1.9	5.2	1.7	1.5	1.4	3.2	1.4	1.4	6.7	3.1	2.5	4.1	6.8	1.7	1.5	1.6	5.8	1.1	1.5	5.7	3.2	1.7	2.0	4.0	1.1	1.8	1.1	1.0	2.3	2.0	6.3	2.0	1.5	2.1	1.4	4.6	1.8	1.3	2.4	1.7	2.7	2.2	2.9	2.0	2.5	2.1	2.1	2.9	0.5	2.8	1.7	1.7	5.1	2.4	4.2	1.4	1.5	6.1	3.0	4.6	2.2	0.8	5.5	2.4	3.7	2.0	1.3	4.8	3.3	2.2	3.0	4.1	4.7	1.8	2.2	1.1	1.4	1.6	1.1	0.8	2.7	1.3	6.0	1.7	1.5	2.2	0.0	0.9	0.1	0.5	1.4	0.7	1.3	0.4	0.5	1.0	1.1	1.2	1.0	0.0	0.6	1.0	0.6	0.2	0.5	3.0	3.6	3.3	4.5	3.1	3.3	3.4	3.2	3.6	3.2	3.1	5.8	3.2	3.2	3.6	8.5	2.8	0.8	2.8	2.3	2.2	2.8	2.4	2.3	5.0	0.0	2.2	1.8	6.2	3.2	3.6	1.3	0.0	1.6	40.5	4.0	2.8	2.0	3.0	2.5	4.6	2.5	2.0	2.3	5.6	4.2	1.3	4.2	1.4	1.3	1.3	0.0	4.7	1.7	2.0	0.8	1.3	52.9	1.8	2.6	0.0	3.7	1.3	4.0	2.1	7.5	20.8	0.9	0.7	0.0	2.3	1.8	1.1	2.5	1.9	4.7	6.6	4.6	2.8	6.1	5.2	2.6	1.7	3.3	2.0	1.4	1.5	2.0
THNSL1	"FLJ22002, TSH1"	ENSG00000185875	"Threonine synthase like 1"	Q8IYQ7	10	25016612-25026664	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6;Early spermatids: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037585	Uncertain		Approved	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"	Mitochondria	"HPA037585: AB_10696940"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.11e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.06e-2)"	1.7	6.0	4.0	1.8	4.2	0.6	3.6	3.2	4.5	4.1	2.9	2.7	2.6	3.6	4.9	1.9	5.6	2.0	3.7	4.1	4.2	9.7	21.4	1.5	2.8	3.9	3.5	7.3	3.0	5.3	3.7	1.7	4.2	2.9	3.0	4.1	3.4	2.6	4.6	2.2	2.4	2.2	3.9	2.2	2.7	5.9	4.1	3.3	8.3	5.9	2.7	1.8	1.5	4.3	7.1	8.1	5.0	10.0	5.0	6.2	1.3	3.4	1.3	3.7	2.4	5.3	8.8	32.7	10.6	1.6	4.0	3.8	7.2	6.4	3.8	4.5	3.9	12.0	2.2	3.4	5.6	0.0	2.0	3.9	11.6	2.7	5.7	6.4	2.5	13.3	10.4	3.8	8.0	11.1	6.6	2.3	9.2	12.3	3.9	3.5	1.3	14.2	10.6	1.6	8.3	4.7	6.8	6.0	12.3	2.6	6.0	0.6	2.5	4.4	3.9	5.9	3.2	2.7	3.8	0.0	7.3	6.6	3.5	0.1	0.4	0.0	2.9	0.5	5.1	5.0	4.1	3.8	2.2	3.8	9.5	6.3	0.6	10.8	0.7	3.7	2.0	3.1	4.0	4.2	3.2	4.5	4.1	4.2	3.9	3.5	4.2	3.9	4.1	4.3	1.3	3.2	3.2	2.6	3.4	0.6	3.1	5.6	2.8	4.2	2.1	2.9	8.5	1.5	6.1	3.7	0.0	6.1	0.8	0.6	15.6	3.3	29.9	5.1	3.9	1.8	1.2	2.5	4.0	1.3	3.9	2.7	1.5	2.5	0.0	7.8	2.2	9.8	2.1	3.3	5.1	1.8	2.0	0.9	0.8	5.5	2.1	0.6	0.0	4.7	1.5	6.8	0.0	2.0	5.4	1.1	1.0	1.5	0.9	1.8	2.3	11.0	8.7	4.5	0.0	4.3	1.9	8.2	13.6	2.6	1.0	1.0	2.8	11.8	3.5	1.1
THOC3	"MGC5469, TEX1"	ENSG00000051596	"THO complex 3"	Q96J01	5	175917873-176034680	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 132.1;Early spermatids: 187.0;Squamous epithelial cells: 226.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042764, HPA044009, HPA045071"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	Vesicles	"HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-3)"	"unprognostic (6.48e-3)"	"unprognostic (8.60e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.91e-1)"	12.0	14.5	22.0	11.4	15.9	35.1	21.4	23.0	40.6	23.1	19.1	27.0	12.5	13.4	63.2	82.9	15.1	8.0	9.3	40.2	14.9	16.3	22.2	11.9	29.1	15.5	13.3	18.8	15.3	10.0	15.9	17.4	15.9	14.6	21.1	12.1	22.5	14.9	12.6	26.5	16.2	12.2	13.2	17.7	17.5	51.3	15.4	39.2	20.5	17.6	45.5	17.4	33.5	15.9	82.1	44.7	47.0	102.7	44.1	39.3	168.0	48.4	44.6	104.5	120.4	63.5	65.2	105.6	68.3	27.9	112.6	69.2	71.6	206.0	109.7	73.5	103.3	57.3	46.2	70.7	14.6	94.6	49.2	33.3	85.9	90.0	45.2	23.3	58.3	98.0	88.1	46.5	66.9	98.7	64.0	57.9	40.1	82.3	160.3	110.7	59.3	110.4	75.2	60.7	89.5	51.4	100.0	48.5	52.5	67.4	55.3	86.1	45.1	35.9	40.8	55.6	88.2	23.2	44.1	64.4	26.7	90.1	28.5	16.5	26.9	15.1	39.3	33.5	48.4	49.6	81.7	48.9	43.1	70.6	99.7	62.4	3.9	42.3	31.5	39.8	133.6	59.1	22.0	15.9	23.0	40.6	40.2	14.9	15.5	13.3	15.9	13.2	15.4	15.9	14.9	12.8	8.6	2.0	35.8	44.5	34.1	64.5	132.1	12.3	17.7	18.0	4.0	10.0	24.4	25.8	10.4	40.8	25.1	8.1	41.1	25.1	187.0	50.2	18.4	16.1	16.8	63.9	5.2	19.2	84.3	15.2	26.5	44.9	12.0	18.8	13.9	20.3	24.6	6.7	3.7	16.3	26.4	13.2	14.9	122.0	14.6	14.3	8.8	1.9	15.4	8.9	27.8	4.5	2.0	21.9	11.6	19.2	55.9	18.4	10.4	46.8	15.8	12.0	19.7	10.6	22.8	107.9	48.3	226.5	40.9	20.0	33.3	25.0	27.7	31.1
THOC6	"fSAP35, MGC2655, WDR58"	ENSG00000131652	"THO complex 6"	Q86W42	16	3024027-3027755	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Developmental protein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 107.8;Extravillous trophoblasts: 121.1;Prostatic glandular cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052953	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA052953: AB_2681997"	"unprognostic (2.07e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.43e-2)"	17.0	16.9	8.6	16.1	9.1	23.5	15.3	9.6	11.2	16.1	9.7	17.9	18.8	20.3	6.0	19.3	13.9	10.5	15.8	8.6	9.2	22.2	21.3	17.5	20.8	11.6	9.1	11.6	12.9	10.8	17.4	18.2	11.8	21.1	10.1	2.1	15.2	12.2	25.9	24.9	19.2	12.5	9.2	22.7	15.6	10.4	10.2	19.6	15.7	8.4	16.1	17.1	16.5	9.5	37.3	59.6	42.0	45.0	21.1	23.9	74.4	11.3	25.7	25.7	37.8	39.6	42.8	70.0	36.0	18.9	19.1	49.9	46.3	35.6	14.0	62.3	59.9	38.0	58.6	58.7	35.9	56.2	80.0	24.3	42.6	31.4	76.9	32.4	24.1	39.7	56.1	36.5	12.8	87.0	32.0	103.3	76.2	21.4	25.3	84.7	31.6	82.4	27.1	18.6	86.4	41.0	31.8	49.9	21.7	18.1	35.9	60.0	20.1	26.8	61.1	30.6	41.3	26.3	24.3	85.5	7.0	38.1	27.3	2.4	61.3	13.6	35.2	62.2	36.2	37.8	32.6	34.7	88.6	43.2	37.1	39.1	4.4	38.8	35.7	74.3	38.0	45.4	8.6	9.1	9.6	11.2	8.6	9.2	11.6	9.1	11.8	9.2	10.2	9.5	11.0	19.2	7.4	1.6	24.7	68.2	84.9	59.0	30.7	3.7	22.1	20.8	3.3	14.3	18.9	18.4	2.1	107.8	23.3	23.2	35.2	33.1	5.4	17.9	19.0	17.9	25.8	30.3	1.9	23.5	121.1	24.6	15.3	25.8	12.0	15.6	6.4	10.3	51.8	3.3	1.7	32.3	44.7	19.4	37.3	3.2	14.9	23.4	24.9	2.8	39.6	3.2	15.5	0.5	4.2	21.5	28.0	12.0	19.7	109.4	32.1	32.0	8.7	2.4	6.6	23.4	31.9	5.3	23.3	23.3	44.9	77.2	20.4	20.9	42.2	46.8
THSD1	TMTSP	ENSG00000136114	"Thrombospondin type 1 domain containing 1"	Q9NS62	13	52377167-52416373	"Disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.0;Astrocytes: 25.5;Basal respiratory cells: 16.5;Endothelial cells: 29.9;Hepatic stellate cells: 17.2;Microglial cells: 17.8;Spermatocytes: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.9;HBEC3-KT: 19.9;hTCEpi: 19.0;hTERT-HME1: 19.5;HUVEC TERT2: 40.6;LHCN-M2: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012611, CAB020796"	Uncertain		Supported	Cytosol	"Intracellular and membrane"	No	No		1400000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB020796: , HPA012611: AB_1857990"	"unprognostic (1.21e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.90e-2)"	10.0	2.0	7.9	1.0	7.4	0.2	8.7	5.5	8.5	5.3	4.5	2.8	0.7	5.2	2.8	3.1	5.1	3.3	9.0	8.2	5.5	3.0	2.2	11.5	2.1	6.0	5.4	2.1	1.4	1.4	3.4	11.3	5.8	4.1	1.4	6.8	3.9	1.9	4.5	6.3	2.7	4.7	5.6	5.9	2.1	2.1	6.4	1.4	5.0	10.4	1.6	3.8	4.5	5.9	0.9	3.9	0.5	3.5	3.1	10.3	0.8	8.4	4.1	3.2	5.1	0.1	0.7	0.3	1.0	19.9	3.1	4.4	0.0	19.9	4.9	9.3	2.9	0.5	0.0	0.0	1.9	2.1	0.6	4.1	19.0	15.4	19.5	1.8	40.6	1.2	0.0	0.3	18.6	0.0	0.7	0.4	0.3	0.2	0.9	0.6	4.3	0.0	4.5	0.2	0.1	0.7	0.2	0.1	0.8	0.2	0.4	0.3	9.6	1.0	1.7	0.0	6.3	0.6	0.1	0.1	1.8	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	7.4	5.5	8.5	8.2	5.5	6.0	5.4	5.8	5.6	6.4	5.9	22.0	0.0	1.1	25.5	0.9	1.5	1.1	16.5	0.6	8.0	1.5	3.0	3.1	0.0	1.8	1.8	2.1	5.4	3.6	0.3	3.9	0.3	1.4	0.8	1.0	29.9	0.0	0.0	3.5	0.6	1.8	6.4	1.1	0.7	0.0	1.5	17.2	2.0	3.1	0.0	3.1	0.3	0.0	1.6	1.6	0.6	3.4	0.6	5.4	17.8	0.4	1.2	1.0	3.0	0.9	0.4	0.2	3.8	0.6	1.8	0.4	0.8	1.3	3.2	6.6	4.4	2.3	18.5	10.1	1.0	1.6	3.4	0.9	0.6	0.3	0.4
THUMPD2	"C2orf8, MGC2454"	ENSG00000138050	"THUMP domain containing 2"	Q9BTF0	2	39736060-39779267	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043042, HPA058025"	Approved		Uncertain	Nucleoplasm		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA043042: AB_10964424, HPA058025: "	"unprognostic (6.30e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.48e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-3)"	2.4	2.0	2.6	0.5	2.5	1.7	2.1	2.9	3.0	1.9	2.6	1.9	0.5	1.7	0.2	3.5	1.5	0.5	3.3	2.6	2.6	2.4	2.3	2.2	1.4	2.6	2.8	3.2	2.2	0.5	2.3	0.4	2.6	2.0	0.7	0.4	2.1	0.4	6.0	2.5	2.0	0.4	2.4	2.5	2.2	0.9	2.6	2.0	2.1	4.0	1.5	2.1	2.4	2.8	4.9	4.7	1.0	6.5	2.3	3.3	2.7	1.3	2.5	3.0	3.1	5.0	4.5	7.8	2.7	1.6	7.6	2.0	9.7	4.4	3.2	13.1	10.8	4.7	3.0	5.7	4.1	6.3	2.4	3.9	3.2	3.1	1.0	2.9	4.9	1.5	5.9	1.8	6.1	2.3	3.3	5.0	0.0	13.0	2.9	3.4	4.2	5.4	2.9	2.6	5.7	3.1	1.3	5.6	3.2	0.4	1.8	3.9	2.5	4.0	2.5	1.1	3.6	2.4	3.1	5.1	2.0	11.4	3.2	0.0	0.6	0.0	0.1	0.4	0.6	0.7	0.4	0.1	0.5	0.3	0.6	0.4	0.1	0.4	0.1	0.9	0.1	0.6	2.6	2.5	2.9	3.0	2.6	2.6	2.6	2.8	2.6	2.4	2.6	2.8	17.4	25.6	20.6	26.8	17.8	14.3	29.0	19.5	15.9	26.8	14.4	29.8	23.7	8.6	20.3	14.7	18.8	11.5	23.0	7.2	19.6	16.6	4.5	7.5	16.9	13.7	9.6	23.8	42.2	13.7	13.6	18.4	17.9	10.9	7.0	19.2	10.0	9.9	11.3	6.7	41.6	8.1	8.2	10.9	7.7	4.0	28.0	10.0	5.4	45.0	11.8	12.1	15.5	45.2	30.3	16.7	17.1	25.6	8.2	23.7	10.3	16.4	10.9	21.1	6.6	20.5	16.0	9.1	19.7	16.9	13.5	6.8	12.6	22.2	13.5	22.7
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362971-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 270.0;Late spermatids: 145.3;Spermatocytes: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: AB_2674985"	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	14.5	15.5	10.1	15.0	11.5	33.0	18.0	12.7	11.0	18.1	14.0	19.1	16.8	16.3	16.7	20.9	14.7	13.6	24.6	9.9	11.7	20.0	23.4	14.2	18.8	11.2	10.6	14.7	15.5	25.8	12.1	15.1	12.0	19.5	19.0	22.0	15.9	17.9	26.9	13.6	14.3	14.4	11.6	14.3	14.1	59.4	10.9	18.3	23.1	26.4	17.7	16.4	9.6	15.2	40.0	53.0	36.4	18.7	46.5	44.4	146.3	47.2	38.3	47.1	35.8	40.2	41.0	41.0	35.8	43.5	74.1	26.0	66.4	48.3	47.9	45.6	39.1	51.0	51.2	35.3	44.8	66.0	35.3	36.2	53.7	55.7	58.1	38.0	31.5	65.1	80.2	58.2	62.9	55.3	78.9	27.2	69.3	44.0	50.1	49.4	62.7	57.9	29.7	60.4	15.5	48.9	39.6	27.5	43.5	37.2	45.2	42.1	22.8	45.0	38.9	54.9	53.1	73.1	186.7	129.2	55.0	60.5	65.7	19.1	17.8	17.6	20.5	23.4	26.2	17.2	17.6	21.9	20.8	20.0	28.0	21.5	3.6	17.7	29.0	20.5	18.4	14.1	10.1	11.5	12.7	11.0	9.9	11.7	11.2	10.6	12.0	11.6	10.9	15.2	14.9	25.6	21.8	10.1	14.0	10.7	29.3	42.6	16.5	21.6	19.5	23.2	45.3	17.2	34.6	22.0	16.7	34.7	13.1	10.0	52.8	39.2	270.0	19.2	26.8	14.9	3.0	9.7	9.7	29.4	28.4	22.3	12.2	20.9	28.4	21.9	13.2	25.3	27.4	38.7	13.2	15.5	38.7	14.8	6.8	145.3	20.5	18.0	12.4	9.4	20.2	31.4	18.6	18.1	12.5	28.2	9.8	25.9	16.2	32.6	10.9	32.6	20.1	35.2	6.6	28.5	24.5	183.5	52.9	18.9	12.9	27.5	18.4	49.2	20.0	20.9
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 207.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 207.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	7.2	12.7	40.3	6.6	35.2	2.8	5.4	207.9	49.2	17.8	12.5	5.1	1.7	9.9	3.2	39.7	11.0	4.6	5.5	51.8	26.5	5.5	7.9	5.8	11.1	26.7	33.4	3.3	2.2	0.3	12.9	4.3	36.1	9.0	3.1	8.6	5.6	3.3	0.9	27.2	5.0	11.1	27.5	5.2	2.4	10.5	37.3	18.7	1.9	0.8	11.1	12.1	18.5	28.6	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.3	35.2	207.9	49.2	51.8	26.5	26.7	33.4	36.1	27.5	37.3	28.6	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TIAM2	STEF	ENSG00000146426	"TIAM Rac1 associated GEF 2"	Q8IVF5	6	154832697-155257723	"Metabolic proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Early spermatids: 141.5;Excitatory neurons: 74.2;Late spermatids: 347.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.4;non-classical monocyte: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 65.7;HDLM-2: 27.8;RH-30: 43.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 36.9"	"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.4	1.2	2.8	0.9	7.1	0.4	1.2	5.4	11.8	1.1	0.0	1.2	8.3	0.8	0.6	0.6	0.8	2.2	2.2	6.1	0.0	0.3	0.3	0.5	1.2	0.4	1.0	0.3	1.3	0.1	1.4	0.5	0.0	2.0	0.8	3.3	1.3	2.7	2.5	0.6	7.9	1.1	0.4	0.7	3.0	13.3	0.8	0.6	5.5	1.7	2.0	2.0	0.7	6.1	8.3	1.5	65.7	6.1	2.9	7.9	0.4	3.2	2.2	3.3	5.5	0.7	4.8	1.1	3.1	6.3	0.9	0.5	2.4	0.0	2.3	27.8	3.3	0.0	1.1	1.9	1.8	0.2	1.7	5.4	0.2	1.1	0.2	2.5	4.7	0.5	0.2	0.1	7.5	0.5	0.7	0.7	4.1	0.1	1.3	8.4	43.3	0.3	0.2	0.2	1.1	14.5	0.1	0.3	0.2	11.9	0.3	0.6	1.5	0.2	15.5	0.4	1.5	0.2	3.6	0.2	0.0	0.3	3.9	0.0	0.0	2.1	0.0	2.0	0.0	2.0	0.1	0.1	0.3	0.7	0.0	0.0	6.4	0.4	9.5	0.0	1.2	0.1	2.8	7.1	5.4	11.8	6.1	0.0	0.4	1.0	0.0	0.4	0.8	6.1	2.9	3.2	2.6	8.8	9.6	3.1	22.5	2.8	1.8	14.3	3.3	5.3	8.3	7.2	2.1	1.8	81.3	1.8	4.3	2.2	0.0	5.3	141.5	8.3	4.9	2.7	0.0	3.6	74.2	3.1	2.6	4.4	6.1	12.1	19.7	6.8	11.0	1.5	1.9	23.5	31.4	3.9	6.1	2.2	2.2	347.4	9.9	5.2	12.4	4.7	9.8	7.6	4.1	28.6	5.1	5.9	5.8	7.9	13.3	9.6	23.9	1.0	3.3	23.9	0.0	7.0	4.3	6.7	7.3	2.1	2.6	0.4	5.0	5.3	3.9	11.6
TICRR	"C15orf42, FLJ41618, MGC45866, SLD3, Treslin"	ENSG00000140534	"TOPBP1 interacting checkpoint and replication regulator"	Q7Z2Z1	15	89575469-89631056	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.4;esophagus: 4.2;lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 6.5;Extravillous trophoblasts: 6.0;Granulosa cells: 5.1;Spermatocytes: 5.4;Spermatogonia: 5.3;Squamous epithelial cells: 8.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046746, HPA049454"			Supported	Nucleoplasm		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA046746: AB_2732533, HPA049454: AB_2680773"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-5)"	"unprognostic (7.73e-3)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (1.64e-1)"	"unprognostic (1.31e-4)"	"unprognostic (5.87e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.54e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.59e-2)"	0.3	0.1	0.1	1.0	0.1	3.4	0.3	0.0	0.0	0.5	0.0	0.8	1.0	0.4	0.0	4.2	0.3	0.1	0.1	0.0	0.0	0.1	0.1	0.2	1.4	0.1	0.0	0.3	0.0	0.0	0.1	0.9	0.0	0.2	1.1	0.1	0.5	0.0	0.0	0.5	0.9	0.2	0.1	0.5	0.4	1.5	0.2	4.2	0.1	0.0	1.8	0.3	1.1	0.0	11.0	15.0	19.0	11.0	0.7	1.5	10.7	8.0	3.7	11.0	11.4	16.4	8.4	14.7	4.2	2.6	9.2	21.5	26.3	7.0	10.0	7.4	25.4	21.9	15.5	8.7	0.1	15.8	7.6	0.4	0.5	9.0	6.6	1.6	5.5	12.8	21.3	16.6	6.4	10.4	13.9	13.3	12.7	11.0	7.6	19.6	17.1	11.8	2.6	15.5	8.1	8.0	19.0	10.6	3.1	13.9	7.9	10.5	3.3	11.9	14.8	24.4	16.5	3.9	8.0	12.3	4.1	13.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.2	1.2	0.0	0.3	0.8	1.4	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.0	1.7	0.1	0.3	0.3	0.0	6.5	0.4	0.0	6.0	0.5	2.0	0.3	0.0	5.1	0.0	0.0	1.3	0.0	0.6	1.6	0.0	0.0	0.7	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.1	0.0	2.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	5.4	5.3	8.6	0.1	1.0	0.1	0.1	1.6	0.1
TIGD1	EEYORE	ENSG00000221944	"Tigger transposable element derived 1"	Q96MW7	2	232543883-232550557	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041717	Approved		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies"	"HPA041717: AB_2677636"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.40e-2)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (3.77e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-3)"	1.8	2.3	6.3	2.3	5.3	6.5	2.7	13.4	7.8	3.2	5.4	2.8	1.9	2.6	2.9	2.8	3.8	1.9	2.4	5.0	4.5	7.4	2.7	2.5	3.4	3.2	2.4	5.7	2.9	1.6	5.0	2.0	4.1	4.4	2.1	10.4	2.7	1.7	4.0	4.2	3.6	1.3	1.5	6.1	3.3	5.2	4.5	3.3	4.7	1.4	2.2	2.8	3.0	9.7	3.1	2.3	4.7	7.5	1.7	2.3	3.6	2.1	1.2	2.6	2.9	2.8	3.6	5.0	1.5	1.6	2.8	3.2	4.1	1.3	3.8	3.0	3.9	4.5	7.7	3.5	1.1	3.6	2.9	2.6	1.2	2.6	1.6	2.5	1.5	6.5	3.6	5.0	2.1	5.3	4.9	8.3	2.8	1.9	2.7	4.7	6.3	2.3	1.5	3.5	6.1	6.0	2.2	2.1	2.3	3.3	3.1	3.9	2.5	4.3	4.5	2.7	2.1	4.8	3.4	4.5	2.5	3.6	2.6	1.6	1.7	1.8	1.9	1.4	1.9	1.7	2.0	1.5	1.1	2.1	3.1	2.5	2.3	1.8	1.5	1.2	1.6	0.7	6.3	5.3	13.4	7.8	5.0	4.5	3.2	2.4	4.1	1.5	4.5	9.7	2.4	9.6	3.9	4.2	5.3	1.3	4.5	2.3	1.8	4.9	2.5	2.2	2.0	1.5	2.9	3.7	8.4	2.2	3.1	1.7	0.0	3.6	4.2	1.0	3.6	1.7	1.2	6.5	4.5	1.5	1.3	3.1	7.7	1.5	0.0	6.4	1.4	0.7	1.4	6.7	5.7	1.5	2.0	1.6	1.7	0.7	4.7	2.4	1.8	1.0	2.8	7.5	5.2	5.0	8.1	2.0	2.4	1.9	5.6	2.6	3.5	1.4	1.7	7.0	6.6	3.7	2.0	3.9	5.7	3.7	2.0	1.4	4.1	4.0	3.0	2.9
TIMELESS	"hTIM, TIM, TIM1"	ENSG00000111602	"Timeless circadian regulator"	Q9UNS1	12	56416363-56449426	"Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.5;Spermatogonia: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA060655	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA060655: AB_2684338"	"unprognostic (3.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.03e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (9.47e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.01e-2)"	3.4	3.4	1.6	11.0	2.1	22.0	4.5	2.1	2.1	4.1	2.7	6.7	6.0	4.4	2.5	6.8	3.1	3.3	1.8	1.5	2.1	3.8	9.8	4.1	15.3	2.4	2.4	1.9	5.0	5.9	5.4	8.7	2.5	3.2	8.5	13.7	3.9	3.4	3.4	5.5	6.2	5.6	2.1	6.8	5.5	6.2	2.6	19.8	4.7	1.6	17.9	4.7	3.9	2.5	39.4	89.1	111.4	51.9	9.9	9.9	62.8	41.9	25.3	58.3	46.0	45.6	56.5	113.3	41.5	24.5	29.4	32.8	82.0	32.7	53.5	54.2	45.7	86.9	47.6	33.6	5.1	66.2	62.2	6.9	10.3	41.9	25.2	16.0	31.5	67.3	82.7	99.5	49.8	77.2	94.7	51.2	79.2	49.5	36.8	93.5	56.7	55.5	22.7	49.5	85.4	58.9	78.2	43.9	12.2	45.6	77.4	51.8	18.9	45.3	45.1	41.8	35.0	37.3	50.9	62.8	21.1	39.9	55.5	0.1	0.6	0.4	1.8	1.5	0.3	3.3	1.1	1.2	1.0	4.9	0.8	0.3	0.2	1.5	1.1	1.2	1.5	1.1	1.6	2.1	2.1	2.1	1.5	2.1	2.4	2.4	2.5	2.1	2.6	2.5	2.6	0.0	5.0	2.3	8.2	3.3	3.0	3.0	6.8	57.5	3.1	3.4	2.1	2.8	6.8	7.3	2.1	15.9	1.8	2.7	0.0	4.8	6.9	2.5	3.9	5.0	1.8	16.6	0.9	5.7	20.9	3.7	6.6	4.8	5.7	15.5	4.6	10.6	8.5	6.7	1.3	5.2	4.1	2.6	3.7	2.9	1.2	4.6	0.0	1.9	4.2	4.8	4.1	0.5	3.2	3.7	0.6	1.2	18.2	4.2	1.1	2.0	3.4	17.8	0.0	2.7	7.0	1.6	24.5	12.1	1.4	9.2	6.1	3.2	8.5	3.0
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	4.3	4.3	1.5	4.9	1.4	2.9	4.5	3.1	2.4	5.4	3.6	5.3	7.6	4.5	2.5	4.4	5.3	4.5	5.3	1.3	2.1	3.9	6.3	4.2	4.1	1.9	1.8	8.0	4.7	7.2	3.6	4.9	2.1	5.7	5.5	3.1	8.0	6.4	5.3	4.3	6.9	4.7	1.0	5.0	4.3	1.5	1.6	3.1	4.8	4.9	5.1	4.5	3.3	1.1	2.2	7.0	3.7	6.2	6.2	8.5	4.4	5.7	9.3	3.9	3.7	11.0	8.3	5.7	9.6	5.9	6.9	6.2	3.9	4.4	1.5	15.3	3.7	15.4	4.2	7.1	4.9	9.6	7.9	6.4	6.0	7.4	5.1	4.7	6.5	4.6	4.2	12.9	4.6	4.0	0.3	1.5	1.7	15.9	6.3	2.0	1.0	5.4	3.1	7.8	4.6	5.8	6.8	6.7	4.6	4.8	18.2	4.9	6.5	2.2	2.1	4.5	4.3	3.6	5.6	4.2	3.4	7.5	7.0	5.3	5.8	2.9	4.0	4.5	3.7	2.1	3.1	4.2	4.6	3.8	2.5	2.4	4.9	2.6	3.2	3.2	3.5	3.7	1.5	1.4	3.1	2.4	1.3	2.1	1.9	1.8	2.1	1.0	1.6	1.1	1.7	6.4	2.6	2.3	3.7	0.4	1.8	2.0	4.0	3.5	2.7	2.0	1.3	2.8	2.8	3.7	0.0	3.4	2.2	4.2	0.0	3.3	0.0	1.1	2.3	3.2	1.2	0.8	3.7	4.0	4.9	2.7	2.0	1.7	1.3	2.0	2.5	4.8	5.2	3.3	5.0	3.9	2.0	4.4	0.8	0.3	4.7	3.7	1.8	3.7	2.1	3.6	4.1	3.0	1.8	3.6	8.1	4.5	9.2	2.0	6.5	2.2	1.6	2.5	0.0	2.0	2.5	0.1	0.6	3.5	0.1	2.6	4.2	2.3	2.4	1.5
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333220-61353295	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 192.8;liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.9;Proximal enterocytes: 415.8;Proximal tubular cells: 91.2;Theca cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 133.2;RPMI-8226: 140.7;T-47d: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Nucleoplasm	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	9.5	82.8	5.9	9.4	6.0	16.6	12.1	5.8	6.6	9.5	5.7	12.5	192.8	11.0	7.6	16.3	15.4	9.2	7.6	6.4	5.1	45.5	115.8	9.0	13.6	6.8	6.3	10.3	24.0	6.7	14.0	6.1	6.2	12.2	5.7	5.6	16.2	8.9	10.9	17.8	138.0	5.2	6.5	13.0	16.6	28.2	6.0	7.5	14.7	5.6	8.0	10.9	11.0	7.2	19.9	51.3	8.5	30.0	10.7	11.4	24.2	11.7	12.4	10.4	6.9	23.1	47.1	25.0	39.3	8.5	11.0	27.7	16.3	21.8	3.5	42.5	21.7	15.7	26.2	133.2	17.9	13.4	25.0	18.2	14.5	9.9	35.4	9.4	10.7	17.1	27.2	46.7	7.9	91.8	11.9	11.9	23.8	19.2	33.8	20.0	13.8	140.7	17.1	35.0	33.0	29.6	21.0	36.4	19.3	6.0	135.4	9.2	13.0	21.0	21.6	16.6	7.0	85.8	76.5	22.9	21.3	12.3	19.7	2.6	13.4	6.5	7.1	7.8	9.6	10.3	8.3	7.1	21.2	9.7	5.8	6.2	1.2	6.5	6.5	10.1	12.9	9.7	5.9	6.0	5.8	6.6	6.4	5.1	6.8	6.3	6.2	6.5	6.0	7.2	8.0	0.0	14.5	0.0	9.5	0.0	13.8	0.0	11.4	12.8	19.1	16.0	3.8	11.5	6.8	14.7	14.6	31.2	8.3	4.8	29.4	19.6	16.2	16.4	6.6	8.0	13.3	7.8	0.0	14.6	6.2	11.2	20.4	12.1	7.6	10.8	7.5	115.9	17.1	8.4	0.0	31.6	0.0	17.2	0.0	12.0	15.2	8.2	0.0	0.0	21.2	10.0	9.2	0.0	0.0	11.2	32.9	22.6	11.0	11.1	415.8	91.2	10.9	17.8	6.6	4.7	3.6	37.5	14.1	12.6	0.0	15.2	6.5	93.6	47.6	13.4
TKT		ENSG00000163931	Transketolase	P29401	3	53224712-53256052	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 667.0"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 696.7;monocytes: 624.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 447.9;eosinophil: 274.4;intermediate monocyte: 199.0;myeloid DC: 203.8;neutrophil: 375.3;non-classical monocyte: 242.6"	"Group enriched"	"Detected in all"	9	"dendritic cells: 203.8;granulocytes: 375.3;monocytes: 447.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		150000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	152.2	93.2	78.0	66.2	80.0	667.0	71.9	93.2	82.3	59.7	60.5	73.2	84.2	44.7	19.2	168.5	53.7	97.2	27.4	72.3	96.9	68.2	58.1	93.4	69.2	89.2	89.9	87.7	154.0	41.4	45.6	61.2	93.8	48.8	48.8	21.7	54.9	50.9	12.8	47.0	58.1	51.6	77.4	99.8	66.1	20.2	87.9	82.9	116.1	15.2	67.4	130.9	85.5	97.2	313.0	1542.9	216.0	241.5	470.8	570.8	439.5	206.2	353.8	348.8	330.8	430.1	779.3	388.5	96.8	302.9	673.3	438.3	377.9	775.8	102.4	131.0	210.3	259.6	1022.2	655.2	573.9	321.4	168.1	416.0	437.5	418.5	213.7	949.2	444.9	323.8	188.3	164.7	144.5	381.6	338.6	358.1	737.1	603.0	367.9	201.1	98.5	726.2	550.3	520.2	139.6	103.7	383.4	605.3	365.1	656.7	188.8	437.4	335.9	107.2	164.2	320.0	401.9	94.5	190.3	235.7	234.4	321.0	203.8	51.5	447.9	274.4	17.8	199.0	22.8	39.7	25.8	20.6	203.8	21.1	26.6	20.7	375.3	30.8	242.6	34.4	36.7	312.4	78.0	80.0	93.2	82.3	72.3	96.9	89.2	89.9	93.8	77.4	87.9	97.2	79.5	134.6	125.6	46.7	92.1	79.4	384.6	325.3	287.4	41.0	99.3	80.5	14.9	75.8	149.5	62.5	29.2	349.0	69.7	139.1	80.3	197.7	6.5	87.4	79.6	81.8	52.6	150.3	16.9	269.8	249.8	80.2	168.7	95.5	62.7	123.6	75.0	83.4	256.0	37.0	23.9	149.6	142.4	696.7	110.5	8.9	157.2	333.3	76.5	17.8	624.4	88.8	46.4	17.1	39.3	193.6	81.4	106.8	109.4	337.7	141.5	219.1	99.2	46.3	52.6	35.9	102.1	16.8	30.6	409.3	67.1	413.6	78.8	427.2	276.7	413.6
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295795-154330350	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"testis: 127.1"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 166.9;Spermatogonia: 491.5"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.3;medulla oblongata: 1.7"	"Group enriched"	"Detected in many"	5	"eosinophil: 60.9;gdT-cell: 24.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 60.9;T-cells: 24.4"	"Cell line enriched"	"Detected in some"	163	"THP-1: 495.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"white matter: 1.2"	"HPA000505, HPA029155, CAB032191"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.3	0.1	0.3	0.4	0.4	0.9	0.2	0.2	4.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.8	0.3	0.3	0.3	0.2	1.0	0.4	1.7	0.2	0.1	0.0	0.0	0.9	0.3	0.6	0.1	0.0	2.2	0.0	0.0	0.3	0.2	0.1	0.1	0.5	0.7	0.0	127.1	0.5	0.4	0.1	0.5	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.0	495.2	0.0	0.0	0.0	0.1	0.2	0.0	3.0	2.7	0.0	0.0	0.4	1.6	0.1	60.9	24.4	0.4	3.5	0.1	2.9	2.2	0.0	0.1	6.0	5.4	1.0	7.8	0.3	0.2	3.5	5.8	0.3	0.4	0.2	4.3	0.3	0.3	1.7	0.2	0.6	0.5	0.5	0.5	0.2	0.0	0.0	0.7	0.5	0.3	0.0	0.0	0.6	0.3	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	44.8	0.0	0.1	0.7	0.0	0.4	0.4	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2	25.2	0.4	0.0	0.0	0.3	3.7	22.5	4.1	1.9	0.0	1.0	0.6	6.0	20.6	1.0	0.1	0.0	0.0	1.9	1.3	0.0	0.0	0.1	0.0	1.0	26.3	1.4	1.6	166.9	491.5	0.1	0.1	0.0	4.1	0.1	0.0	0.0
TLCD4	"FLJ31842, TMEM56"	ENSG00000152078	"TLC domain containing 4"	Q96MV1	1	95117355-95197607	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 130.0"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 77.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 22.4;RH-30: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046762			Approved	"Nuclear speckles"		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA046762: AB_2679792"	"unprognostic (1.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	5.3	9.9	9.4	2.1	10.6	20.5	2.6	19.5	15.1	2.4	0.0	13.6	5.5	3.4	2.5	2.3	2.4	4.2	25.7	10.6	6.3	5.7	130.0	3.7	0.4	4.9	5.7	1.7	7.4	6.4	3.4	4.4	4.2	5.3	10.2	3.1	8.3	2.9	13.0	1.6	8.5	3.6	6.9	0.7	5.0	4.8	9.9	0.3	7.3	9.7	0.5	4.7	1.3	12.6	22.4	12.6	1.7	2.6	0.8	0.0	2.9	0.8	0.5	2.8	6.5	9.1	10.4	0.0	10.7	0.4	20.0	0.2	7.4	1.1	4.8	15.5	4.1	0.5	9.2	2.0	0.8	0.4	0.6	1.2	0.4	2.1	0.0	4.4	0.0	1.2	19.8	1.2	0.6	1.9	1.3	0.1	1.7	0.7	6.9	0.0	35.7	0.6	12.0	14.4	4.5	3.6	15.6	10.8	6.7	1.8	11.7	0.4	0.2	0.3	9.0	1.1	7.9	3.8	8.0	0.0	1.5	0.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.4	10.6	19.5	15.1	10.6	6.3	4.9	5.7	4.2	6.9	9.9	12.6	5.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.9	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
TLE4	"E(spl), ESG, GRG4"	ENSG00000106829	"TLE family member 4, transcriptional corepressor"	Q04727	9	79571773-79726882	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 818.9;Late spermatids: 1315.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 24.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 99.9;BJ hTERT+: 98.7;BJ hTERT+ SV40 Large T+: 89.4;fHDF/TERT166: 154.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065357			Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065357: AB_2685479"	"unprognostic (6.68e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.94e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.94e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	9.3	15.7	18.4	16.4	45.2	67.9	8.7	22.3	27.4	9.6	20.2	9.9	8.4	14.3	5.9	17.6	12.9	16.6	8.0	27.5	21.6	6.9	5.6	12.5	15.9	31.7	21.4	32.3	6.4	10.6	24.2	19.7	32.2	5.6	10.5	24.7	10.9	8.4	23.1	18.9	11.3	14.5	26.1	18.5	14.1	108.0	25.4	27.8	10.4	10.3	19.9	18.7	12.8	64.0	0.0	19.0	70.7	0.5	11.4	9.6	21.2	99.9	98.7	89.4	34.4	2.8	10.3	7.4	0.2	154.3	13.7	20.8	5.0	18.3	39.2	38.2	30.8	0.0	9.1	0.4	13.8	21.4	13.0	11.3	12.6	26.1	5.2	25.2	23.9	14.0	1.5	21.3	28.6	0.7	29.4	9.4	22.5	11.9	4.8	25.7	35.9	7.4	5.5	2.7	28.5	41.5	14.7	1.9	0.1	32.8	0.0	25.1	36.4	34.8	0.1	0.8	5.0	14.4	25.0	10.9	12.3	18.0	16.6	24.2	4.4	17.1	4.8	6.3	5.9	1.3	2.5	3.6	2.9	1.7	1.5	2.5	11.7	3.2	4.9	1.0	0.8	2.6	18.4	45.2	22.3	27.4	27.5	21.6	31.7	21.4	32.2	26.1	25.4	64.0	108.9	6.4	19.4	77.4	91.9	121.0	57.2	50.6	167.4	76.8	76.0	92.8	15.9	84.4	45.6	14.7	127.2	77.2	228.1	163.5	3.9	13.4	818.9	262.0	230.0	59.7	25.2	22.3	150.8	22.0	67.1	71.4	137.1	158.7	21.0	34.8	53.2	14.1	51.1	218.7	33.3	117.3	61.1	167.9	70.4	1315.5	105.6	101.7	42.7	77.8	75.3	31.0	88.6	301.6	381.0	31.7	207.6	46.6	152.7	37.8	122.0	18.1	50.4	290.2	72.3	280.7	83.9	38.3	146.0	140.0	90.8	65.0	141.0	86.8	96.0	99.9
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772238-38782990	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 47.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 57.2;dendritic cells: 9.4;Microglial cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 39.0;naive B-cell: 24.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 39.0"	"Group enriched"	"Detected in some"	53	"Daudi: 68.6;REH: 22.9;U-698: 24.7"					"Low region specificity"	"Detected in many"			HPA066755			Approved	Centrosome,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.9	0.3	1.0	15.8	0.9	1.4	0.8	1.0	1.2	0.2	0.5	1.4	1.2	0.4	0.4	0.5	0.5	1.3	0.1	0.9	1.2	0.2	0.4	0.8	42.3	1.9	1.5	0.0	0.1	0.1	0.2	0.2	2.0	1.0	1.9	0.1	1.4	0.4	0.2	0.5	10.0	0.3	2.0	24.3	2.9	0.1	1.4	5.1	0.4	0.1	47.9	2.7	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	22.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.4	0.0	0.1	0.0	24.7	0.0	0.1	0.0	0.3	0.4	0.9	0.0	2.8	0.0	39.0	0.0	0.0	6.4	24.0	0.1	0.1	1.3	0.1	3.6	7.2	0.0	1.8	1.0	0.9	1.0	1.2	0.9	1.2	1.9	1.5	2.0	2.0	1.4	2.2	0.2	0.0	1.1	0.0	57.2	0.4	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.2	2.7	0.3	0.0	0.0	0.9	0.0	0.2	1.3	0.0	0.4	0.3	0.8	0.0	0.3	0.2	0.0	1.9	0.8	0.0	0.0	4.5	0.0	16.9	1.0	0.2	0.0	4.5	0.1	0.0	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309248-171312139	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"brain: 9.0"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 7.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Group enriched"	"Detected in many"	6	"cerebellum: 9.0;medulla oblongata: 2.3;spinal cord: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 25.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.2"	"Region enriched"	"Detected in some"	8	"cerebellum: 15.5"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	2.3	0.6	1.0	5.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA054064: AB_2682366"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	32.2	38.3	58.9	23.5	62.8	28.2	33.9	57.0	74.7	36.7	51.4	31.1	24.6	40.8	43.5	23.9	34.2	29.6	47.8	62.0	70.1	32.2	58.1	28.1	30.5	54.9	58.7	55.7	30.3	40.6	35.7	31.7	58.5	32.7	24.2	32.3	34.4	35.3	44.5	27.0	26.2	32.1	55.9	29.2	29.1	28.0	61.1	29.5	45.2	55.7	31.7	32.8	28.5	58.0	20.1	48.9	25.6	46.6	71.9	53.1	31.3	25.9	42.6	30.0	33.4	26.4	55.5	32.5	34.9	35.5	50.7	45.9	40.3	33.3	23.7	31.2	88.4	48.7	39.9	45.4	47.2	38.4	55.8	44.2	66.3	18.1	37.4	42.1	42.1	41.5	40.6	47.8	47.9	40.8	28.3	40.2	39.5	90.4	16.2	33.9	32.3	51.0	61.5	52.0	34.3	31.3	35.8	37.4	54.3	43.7	35.5	49.8	33.7	31.6	32.5	21.2	28.9	45.0	71.2	35.3	26.9	47.5	26.7	36.4	40.6	81.9	41.2	41.9	46.4	30.6	33.6	31.6	29.1	44.8	44.1	41.4	69.6	52.4	32.4	24.6	38.4	41.3	58.9	62.8	57.0	74.7	62.0	70.1	54.9	58.7	58.5	55.9	61.1	58.0	52.4	25.6	28.7	22.2	55.8	66.3	58.5	142.3	32.5	47.1	42.6	45.8	35.7	35.8	67.9	42.3	33.3	73.7	51.9	23.0	19.6	61.0	8.0	28.1	38.2	48.8	27.0	30.3	41.5	42.3	64.7	53.7	23.0	44.8	25.3	37.6	60.3	56.6	32.3	69.0	55.3	23.2	91.6	42.1	36.4	10.8	73.7	39.2	26.6	37.5	44.4	60.6	56.7	29.1	45.8	27.8	20.7	62.8	41.3	66.6	32.6	39.5	47.2	46.8	72.3	40.1	67.0	89.3	84.2	25.0	55.4	91.0	55.1	21.5	27.8	40.0
TMA7	"CCDC72, HSPC016"	ENSG00000232112	"Translation machinery associated 7 homolog"	Q9Y2S6	3	48440257-48444208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.14e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.31e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.64e-3)"	252.5	276.8	498.7	220.7	507.8	434.6	241.9	504.6	588.9	236.5	500.2	253.3	192.8	179.4	344.5	310.5	181.7	117.9	355.4	502.2	514.7	317.6	273.2	208.0	279.3	511.7	510.0	259.6	230.3	309.8	302.0	146.6	505.9	239.6	229.3	295.4	215.9	142.7	511.6	215.1	220.4	132.7	513.0	272.9	235.5	216.0	511.9	388.3	232.4	287.4	297.7	213.3	239.3	514.5	565.0	398.8	634.2	456.6	514.0	497.1	435.6	454.1	355.7	425.1	419.3	326.3	395.9	365.2	315.3	397.8	553.6	215.5	559.8	512.5	471.6	452.6	475.5	689.4	910.3	845.8	399.0	792.2	443.0	459.7	538.2	402.6	388.8	414.2	546.0	641.1	376.6	379.0	615.3	581.2	929.4	1071.2	847.1	607.0	637.3	262.2	397.0	620.4	746.0	748.7	207.8	526.1	511.0	369.3	736.1	583.6	356.7	1156.3	412.1	358.0	650.8	560.5	902.6	626.1	1001.6	902.8	459.1	754.2	379.9	1923.2	1058.7	2195.0	1127.1	1022.5	1237.6	1412.6	1486.0	1377.1	1150.8	1172.2	1464.7	1408.1	2036.5	943.8	1028.9	1521.6	1652.1	2663.7	498.7	507.8	504.6	588.9	502.2	514.7	511.7	510.0	505.9	513.0	511.9	514.5	518.8	240.4	370.4	20.9	615.0	716.3	534.0	1308.9	618.6	219.6	866.8	1111.2	633.4	513.3	616.2	901.2	106.3	785.4	797.4	948.2	1717.8	566.9	653.6	524.8	511.4	474.5	635.3	609.1	25.8	1032.9	830.9	443.7	356.3	646.1	454.4	376.5	574.7	1098.6	854.5	119.5	25.4	985.5	695.8	652.4	790.5	1123.9	646.8	544.3	777.3	18.7	850.3	522.8	1080.3	10.1	28.3	872.9	980.3	464.6	593.9	584.6	1211.0	1438.8	466.4	321.9	355.0	393.6	448.4	547.4	689.4	805.5	898.4	440.1	757.1	351.9	937.2	572.2
TMBIM1	"LFG3, PP1201, RECS1"	ENSG00000135926	"Transmembrane BAX inhibitor motif containing 1"	Q969X1	2	218274197-218292586	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 281.2;Pancreatic endocrine cells: 294.3;Syncytiotrophoblasts: 282.1;Urothelial cells: 299.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 573.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012093, HPA070824"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA012093: AB_1858056, HPA070824: AB_2686317"	"unprognostic (4.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.81e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.76e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.50e-1)"	231.0	120.9	118.0	84.1	135.0	96.1	165.5	124.8	123.6	146.8	112.1	143.1	152.6	119.7	92.9	333.4	97.3	135.5	123.3	109.4	131.2	123.5	170.8	175.1	55.4	194.5	144.0	93.5	240.3	125.6	50.2	172.7	150.7	97.6	140.7	15.2	155.1	89.5	219.1	185.3	174.6	127.1	139.8	65.9	212.3	25.4	134.1	41.9	158.0	185.2	106.8	172.9	215.1	144.2	183.9	66.4	3.5	47.1	404.3	170.6	188.7	175.5	217.9	103.4	117.7	169.8	449.0	40.6	123.3	263.0	194.6	305.3	59.8	399.9	100.4	151.0	23.5	264.6	41.8	205.6	183.3	2.4	252.4	161.1	370.7	210.4	265.6	108.4	111.8	6.7	169.0	75.0	182.9	6.1	2.8	46.5	2.5	382.3	60.4	5.7	28.3	33.1	142.1	573.4	2.2	3.1	58.0	214.7	122.8	36.6	56.3	39.8	168.4	182.4	50.1	84.9	64.8	35.9	45.2	17.7	179.9	41.0	105.5	352.9	136.4	298.5	107.9	172.7	91.8	77.1	98.0	89.1	93.3	61.9	64.3	70.2	167.1	66.7	221.9	25.9	116.1	190.1	118.0	135.0	124.8	123.6	109.4	131.2	194.5	144.0	150.7	139.8	134.1	144.2	47.6	73.7	25.6	20.9	37.2	81.7	96.9	85.0	51.2	2.0	28.8	26.0	26.4	78.6	66.9	69.9	0.0	139.1	51.8	266.8	13.7	175.5	0.6	45.6	42.6	50.8	22.7	66.3	2.4	281.2	146.8	61.9	110.6	78.4	50.0	16.1	28.9	50.4	104.9	0.0	2.5	67.9	52.9	45.1	50.2	2.8	54.0	69.6	46.2	14.0	22.0	22.9	48.4	5.0	35.2	294.3	177.3	59.5	30.3	151.8	204.4	37.7	34.8	1.9	13.1	35.7	45.0	1.4	12.5	86.5	101.2	282.1	41.3	9.9	69.1	299.8
TMCO6	"FLJ39769, PRO1580"	ENSG00000113119	"Transmembrane and coiled-coil domains 6"	Q96DC7	5	140639435-140645408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037473, HPA037474"	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA037473: AB_10671049, HPA037474: AB_10671050"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.20e-2)"	6.6	10.5	5.7	3.9	5.7	2.9	6.6	5.5	5.8	6.1	5.5	4.9	2.9	4.8	3.4	7.2	6.9	2.9	3.1	5.5	5.8	6.7	13.3	3.6	4.6	6.0	5.9	7.1	6.6	4.0	4.9	5.6	5.9	4.8	2.5	0.7	9.8	2.9	3.6	5.2	4.8	3.0	6.3	7.2	5.2	10.4	5.9	7.7	5.3	2.6	4.0	5.4	5.6	7.0	3.9	7.5	5.0	7.4	4.9	5.2	18.1	3.0	3.4	3.8	4.1	11.6	7.2	15.6	7.8	2.3	4.4	7.7	4.2	8.8	2.0	5.5	13.7	11.9	3.7	8.3	6.5	6.7	4.4	8.6	2.3	4.6	7.7	2.9	8.9	12.6	5.1	5.0	4.7	7.5	15.3	15.5	5.7	9.2	11.3	13.1	10.3	15.5	4.6	3.5	8.6	3.7	8.6	16.6	8.0	3.4	13.6	7.9	4.2	0.1	3.7	1.4	1.3	8.4	5.7	7.4	2.4	10.7	4.6	11.6	6.5	5.7	5.2	9.1	5.7	7.8	6.9	5.1	6.9	6.1	9.5	3.9	12.7	4.4	10.3	1.9	8.2	4.1	5.7	5.7	5.5	5.8	5.5	5.8	6.0	5.9	5.9	6.3	5.9	7.0	4.0	6.4	2.0	1.3	7.5	1.9	7.3	3.4	6.8	5.2	4.6	4.3	0.6	5.7	2.4	11.0	6.2	7.7	4.2	3.9	0.0	3.8	4.1	2.2	4.0	6.3	7.3	10.3	3.8	2.4	7.4	4.6	6.6	2.5	0.0	4.6	10.0	9.7	4.8	0.0	3.3	5.0	4.1	5.1	2.7	1.5	4.1	4.1	1.8	9.4	6.6	3.3	16.5	1.0	3.9	4.5	5.2	4.9	7.3	7.4	6.2	2.4	6.2	4.3	6.6	3.9	3.4	19.2	15.8	10.3	2.3	6.3	8.2	7.7	7.7	6.9
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 237.2;Glandular and luminal cells: 507.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039739, HPA075651"			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA039739: AB_2676657, HPA075651: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	17.2	19.8	22.6	12.9	26.8	11.5	107.0	23.2	24.0	44.4	24.2	20.6	16.9	63.5	27.6	28.0	37.9	15.9	23.1	22.2	22.7	93.9	24.1	18.7	19.4	24.2	24.0	22.7	39.2	26.4	15.4	21.6	23.2	24.0	16.9	12.1	30.1	111.8	33.3	29.0	17.4	16.1	23.5	20.4	28.8	23.6	23.9	16.5	23.0	24.9	17.7	20.4	23.0	23.4	23.5	56.0	19.7	16.2	45.7	43.9	19.6	24.1	36.1	46.5	43.8	42.0	59.5	26.1	6.5	24.9	36.0	35.3	22.9	41.5	35.2	28.5	46.1	19.5	45.7	86.2	39.3	31.7	32.8	39.4	46.5	32.8	46.3	41.8	40.8	45.0	40.7	50.1	29.2	31.7	34.6	36.6	9.1	25.4	62.6	29.8	42.8	47.4	39.1	18.7	25.3	20.2	14.6	0.5	59.6	24.9	27.3	59.9	24.7	42.1	28.5	18.8	46.9	52.1	38.0	12.0	44.3	29.7	38.2	20.1	42.8	15.3	31.2	43.4	35.7	37.3	39.6	36.4	44.9	39.8	43.2	35.7	15.9	44.1	32.9	44.0	44.6	31.1	22.6	26.8	23.2	24.0	22.2	22.7	24.2	24.0	23.2	23.5	23.9	23.4	22.1	19.2	15.4	0.0	22.8	20.6	31.6	72.0	21.6	10.4	64.2	61.2	27.3	24.3	34.5	40.5	6.2	68.5	19.6	18.5	37.2	36.6	13.1	237.2	70.8	28.2	23.4	33.2	0.0	49.8	47.3	21.1	13.7	507.4	22.9	34.4	36.0	20.6	37.6	11.8	0.0	37.3	28.5	32.4	11.8	11.1	13.1	23.8	33.8	0.0	47.7	17.7	29.9	0.0	0.0	41.8	20.7	12.4	29.4	23.4	27.7	30.2	27.1	11.7	6.6	13.2	19.8	45.8	24.7	26.9	22.6	44.6	20.9	25.6	45.7	25.2
TMEM107	"JBTS29, MGC10744, MKS13"	ENSG00000179029	"Transmembrane protein 107"	Q6UX40	17	8172457-8176399	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease variant, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 110.8;Respiratory ciliated cells: 164.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052555, HPA059653"	Approved		Approved	"Nucleoplasm,Plasma membrane,Midbody ring"		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Plasma membrane"	"Midbody ring"	"HPA052555: AB_2681870, HPA059653: AB_2684096"	"unprognostic (2.87e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.49e-1)"	9.6	13.4	11.1	6.6	12.0	15.0	9.8	12.2	13.3	10.6	19.3	9.0	3.5	11.3	20.7	10.5	27.0	7.2	9.2	11.9	12.8	14.7	4.4	11.3	7.4	13.0	12.6	7.8	11.2	16.9	23.5	6.8	12.2	7.3	5.0	29.6	10.7	6.5	1.6	12.0	7.6	6.6	12.1	13.7	8.0	17.1	12.3	8.9	16.1	1.8	7.6	8.4	9.6	12.5	45.0	16.9	21.8	11.3	12.2	17.8	4.8	11.1	8.2	8.2	10.9	2.0	26.6	10.5	14.6	9.7	7.4	30.5	8.3	16.9	13.6	18.1	11.5	7.6	29.0	4.7	4.9	2.6	8.3	7.9	11.2	20.7	9.4	18.4	13.1	17.7	5.9	23.5	18.0	12.2	6.8	7.7	2.2	6.3	7.2	13.1	6.5	19.1	15.8	3.5	7.3	10.7	13.5	2.4	9.1	5.1	8.1	8.8	10.6	4.8	9.6	7.6	6.1	9.5	5.5	4.9	27.3	10.0	8.7	21.0	22.1	51.6	28.2	27.9	24.3	45.4	27.6	30.3	19.7	59.2	30.9	32.2	20.0	26.4	56.8	31.6	24.8	21.0	11.1	12.0	12.2	13.3	11.9	12.8	13.0	12.6	12.2	12.1	12.3	12.5	30.8	9.6	9.8	2.9	38.1	19.2	19.5	35.2	11.4	17.3	31.1	43.3	7.9	35.8	25.1	33.1	45.9	17.3	30.0	12.9	13.7	21.7	12.2	99.9	22.9	25.1	9.1	15.4	5.1	11.1	21.3	18.2	48.9	26.9	36.7	12.7	27.1	24.0	45.5	11.8	3.6	14.1	16.2	45.6	31.6	10.1	12.8	55.9	33.8	3.7	22.0	37.7	28.8	1.5	1.7	11.0	12.7	15.1	110.8	16.3	26.0	21.7	164.3	63.2	0.0	15.3	16.8	69.4	50.3	13.0	28.6	13.3	34.8	13.2	17.6	11.1
TMEM11	"C17orf35, PM1, PMI"	ENSG00000178307	"Transmembrane protein 11"	P17152	17	21197954-21214176	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051795, HPA062854"	Uncertain		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA051795: AB_2681612, HPA062854: AB_2684882"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.61e-2)"	17.6	11.7	18.9	12.4	19.3	37.7	10.8	21.1	25.1	10.6	18.4	13.9	12.5	11.8	18.6	14.2	9.4	9.0	21.3	19.1	19.9	9.9	9.9	11.8	13.8	20.3	19.3	12.2	30.4	14.9	1.3	17.1	19.8	12.2	10.0	10.9	23.7	9.1	81.3	16.8	14.2	9.8	18.7	11.5	13.2	7.7	19.8	15.8	12.6	54.1	9.8	15.6	1.9	19.8	25.3	27.5	22.7	22.1	33.9	24.1	31.2	38.9	17.7	35.8	31.3	74.5	13.5	27.4	29.7	36.3	29.0	35.0	30.0	35.8	17.9	23.2	46.5	19.8	27.0	32.1	36.8	25.1	22.0	26.5	27.7	36.4	26.2	17.2	22.8	19.3	23.0	9.5	26.9	39.9	37.8	46.6	30.5	68.8	15.3	27.2	49.8	19.6	25.2	21.3	13.8	24.0	17.6	19.0	36.9	87.2	18.4	24.8	21.4	25.1	29.7	42.5	49.3	9.6	13.2	69.3	24.9	31.9	22.6	31.2	70.6	76.2	33.1	58.9	29.6	49.4	33.1	31.8	47.1	47.4	37.0	31.8	58.4	40.8	67.9	38.8	40.3	68.1	18.9	19.3	21.1	25.1	19.1	19.9	20.3	19.3	19.8	18.7	19.8	19.8	35.0	48.1	21.8	5.5	26.0	84.9	61.9	77.7	35.3	32.9	40.2	39.9	49.9	22.8	49.1	36.8	18.8	80.7	36.6	49.4	50.9	55.3	20.7	23.9	23.6	36.8	31.9	51.3	4.4	40.5	80.9	33.9	20.9	29.1	27.3	23.1	32.2	28.1	54.3	23.5	5.1	67.4	73.2	25.3	34.5	16.3	35.8	26.3	40.9	8.4	48.6	31.6	33.0	6.0	8.0	47.4	60.6	57.6	19.9	63.6	55.0	55.9	33.0	39.9	32.9	25.7	42.0	40.4	38.4	34.7	92.6	90.8	28.7	31.3	49.6	80.2
TMEM123	"KCT3, PORIMIN"	ENSG00000152558	"Transmembrane protein 123"	Q8N131	11	102396332-102470384	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 988.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026001, HPA062862"			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026001: , HPA062862: AB_2732691"	"unprognostic (2.64e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.65e-2)"	56.0	80.2	53.0	120.2	60.3	225.1	153.3	56.7	68.2	114.9	67.0	120.0	63.5	174.7	47.8	100.1	91.7	99.6	71.2	48.0	61.0	93.2	393.7	119.2	196.4	71.2	68.6	86.8	82.5	70.7	15.8	98.5	65.1	105.2	97.1	9.2	224.0	104.1	20.4	95.6	78.8	130.6	61.3	111.2	125.5	73.3	61.5	238.6	312.3	49.7	142.9	146.8	70.7	89.8	220.5	195.8	186.9	174.8	233.5	185.6	135.8	169.7	352.0	324.4	358.1	247.9	988.1	370.2	423.9	387.9	234.5	228.3	212.3	272.9	339.4	228.4	82.5	192.0	67.8	352.3	207.5	404.1	137.4	219.1	280.7	240.1	352.3	433.9	361.8	187.8	134.3	0.9	257.7	71.8	353.0	135.4	115.8	340.3	181.1	214.7	532.0	359.3	291.3	207.9	90.7	110.5	201.8	267.6	109.9	197.2	161.3	154.0	451.9	211.3	249.4	190.5	126.6	139.4	84.3	366.6	62.0	432.7	143.2	159.7	113.3	207.0	102.6	121.8	155.3	70.1	158.8	123.8	126.1	95.3	208.6	181.7	72.4	223.9	111.0	33.7	183.8	248.7	53.0	60.3	56.7	68.2	48.0	61.0	71.2	68.6	65.1	61.3	61.5	89.8	93.3	125.0	78.1	33.0	179.3	160.3	257.1	307.3	157.6	0.7	144.9	118.4	53.9	143.0	202.8	163.7	0.0	45.8	91.8	48.2	80.3	153.7	41.3	141.1	47.6	140.0	90.5	68.3	1.0	118.8	41.1	82.2	88.2	161.4	58.9	126.6	271.3	317.6	107.1	1.7	2.2	163.1	160.7	249.6	419.9	23.6	94.1	189.8	161.9	63.7	229.4	4.7	83.4	25.6	114.0	127.8	55.1	93.3	117.8	324.2	31.0	52.9	257.0	1.1	65.7	181.9	80.2	23.1	74.9	146.3	177.2	30.4	164.8	109.4	146.3	270.2
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269983-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 75.7;pancreas: 89.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 121.8;Alveolar cells type 2: 136.9;Distal enterocytes: 72.7;Proximal enterocytes: 164.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.8;BEWO: 21.8;CACO-2: 20.6;CAPAN-2: 48.3;OE19: 31.3;SK-BR-3: 41.2;T-47d: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015796			Approved	Midbody,Cytosol		Yes	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favorable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.3	0.7	17.4	3.2	32.2	0.2	11.5	27.6	29.9	16.4	12.8	21.2	35.4	1.6	18.3	10.9	15.5	11.3	0.9	17.0	20.7	16.4	1.1	75.7	0.3	31.5	28.5	1.4	89.6	22.2	31.0	4.4	29.0	22.0	21.0	0.1	31.8	7.1	0.0	12.9	27.5	0.8	22.6	0.3	27.4	1.5	26.8	0.4	44.9	0.0	2.5	2.9	3.4	42.8	26.8	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	20.6	48.3	0.1	1.2	0.0	0.0	11.7	0.0	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	12.1	0.1	0.1	1.1	31.3	0.0	0.0	0.0	0.7	0.4	8.5	12.4	0.1	0.0	41.2	0.0	3.6	33.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	17.4	32.2	27.6	29.9	17.0	20.7	31.5	28.5	29.0	22.6	26.8	42.8	0.2	121.8	136.9	0.0	0.9	0.0	2.3	18.0	0.6	0.0	30.4	15.2	0.5	42.9	56.0	16.5	0.0	33.5	0.1	72.7	17.6	39.1	3.7	20.1	1.4	0.6	21.7	0.0	0.2	38.5	2.2	0.6	45.3	13.1	1.3	4.9	0.0	0.0	2.4	0.0	0.2	63.0	34.6	0.0	0.2	7.9	0.3	0.6	0.0	0.0	0.6	1.7	1.0	0.0	55.3	22.7	40.1	1.2	0.6	12.2	164.2	33.9	43.8	0.0	0.0	0.0	2.3	1.4	0.3	2.1	0.4	7.3	1.0	0.1	38.6	9.1
TMEM132A	"FLJ20539, GBP, HSPA5BP1"	ENSG00000006118	"Transmembrane protein 132A"	Q24JP5	11	60924460-60937159	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 187.8;choroid plexus: 117.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051979, HPA060492"	Enhanced	Supported	Approved	Mitochondria		No	No		4100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA051979: AB_2681681, HPA060492: "	"unprognostic (2.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.98e-5)"	"unprognostic (7.94e-3)"	"unprognostic (3.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (1.55e-9)"	"unprognostic (3.31e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.41e-3)"	7.7	21.0	137.9	8.6	134.3	0.3	7.7	119.4	187.8	12.0	117.3	5.5	2.5	13.6	1.2	19.5	4.8	5.5	13.7	134.1	136.9	13.9	2.1	10.1	1.7	154.5	131.2	18.8	6.8	12.4	23.6	16.6	126.4	9.4	1.0	28.1	25.9	1.8	3.9	6.1	6.0	3.7	123.0	5.7	32.4	6.7	144.6	1.3	4.8	3.1	5.4	4.2	9.2	114.7	37.0	50.7	44.1	88.0	3.6	1.7	78.1	27.0	84.5	24.6	20.3	18.0	33.3	0.3	174.1	7.8	79.9	67.6	10.3	46.0	9.5	0.5	14.8	1.1	33.3	32.7	30.8	0.5	1.3	7.7	8.6	45.8	7.1	38.7	42.1	7.0	2.3	2.3	7.8	177.8	0.9	0.2	58.5	1.2	26.9	0.4	18.6	4.2	36.4	18.7	43.7	104.1	19.3	176.4	16.7	22.3	123.7	0.6	49.4	9.5	43.2	2.7	52.3	0.4	0.3	2.1	78.5	0.1	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.9	134.3	119.4	187.8	134.1	136.9	154.5	131.2	126.4	123.0	144.6	114.7	11.8	0.0	0.0	82.3	0.6	1.3	2.7	56.2	5.7	62.8	17.1	11.7	0.8	4.3	22.2	5.5	18.8	31.4	0.1	0.7	1.9	80.0	0.5	12.4	7.0	11.9	15.6	0.0	22.6	13.3	28.7	7.7	9.2	27.7	0.0	57.5	11.4	0.0	3.3	254.1	29.1	2.7	20.3	0.3	1.0	1.0	1.8	0.7	0.0	7.5	3.1	188.8	0.0	12.1	3.3	63.2	1.6	3.4	0.0	9.7	0.0	0.4	4.0	165.3	6.6	4.4	15.2	1.2	4.0	5.7	0.9	27.1	0.3	19.2	2.3	7.2
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		170000	"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.3	0.1	4.6	0.0	3.0	0.0	0.1	6.1	6.4	0.4	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.5	2.6	6.2	3.6	0.4	0.1	0.1	17.9	5.1	0.2	0.0	0.0	0.1	0.1	10.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.7	0.1	8.7	0.3	0.1	1.9	6.5	0.0	0.2	0.0	0.1	0.1	0.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	4.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	3.0	6.1	6.4	2.6	6.2	17.9	5.1	10.2	8.7	6.5	11.1	0.1	0.0	0.0	2.6	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	6.4	0.0	0.0	1.9	0.7	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.2	0.5	1.2	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMEM134	FLJ21749	ENSG00000172663	"Transmembrane protein 134"	Q9H6X4	11	67461710-67469272	"Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043744	Approved		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA043744: AB_10794773"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.43e-3)"	12.6	24.3	22.5	8.6	23.2	4.7	14.8	21.2	29.9	15.6	19.9	14.0	8.3	9.6	11.0	55.5	10.2	6.5	46.8	21.6	22.2	25.2	33.9	11.2	11.9	22.8	22.6	8.6	42.9	7.9	8.7	5.3	22.4	25.7	4.5	2.8	20.6	7.3	57.4	57.5	14.5	4.4	22.7	16.2	22.4	26.5	22.9	6.6	13.5	26.0	8.8	15.9	25.4	22.5	12.3	4.6	6.5	14.0	4.3	7.3	7.2	2.5	4.6	2.9	1.2	5.8	14.3	11.7	27.2	6.2	9.2	10.0	2.9	10.7	1.8	11.3	4.9	2.2	4.5	5.9	6.6	2.3	3.2	7.3	13.4	2.3	7.7	12.7	3.0	7.9	3.0	6.6	6.3	29.0	13.3	8.6	11.0	20.4	16.3	6.5	3.8	38.5	11.3	12.5	6.0	13.3	9.1	14.2	28.6	4.4	34.5	2.3	5.8	10.4	9.0	12.5	3.3	27.8	19.4	8.2	15.6	3.0	8.5	58.2	54.3	98.5	71.4	132.7	78.8	203.7	84.2	80.6	66.6	195.7	85.6	80.6	25.7	90.2	176.0	87.3	123.9	73.3	22.5	23.2	21.2	29.9	21.6	22.2	22.8	22.6	22.4	22.7	22.9	22.5	43.3	16.0	41.5	11.8	83.0	90.0	87.7	177.7	99.0	29.3	139.9	173.4	53.4	60.1	93.5	68.0	10.4	69.5	46.5	64.7	133.1	95.0	50.2	53.0	35.3	36.6	71.4	22.3	9.4	126.0	147.9	31.3	120.3	73.4	23.4	52.5	29.3	69.6	84.0	11.8	8.2	100.3	97.6	43.6	49.3	46.2	20.8	49.0	110.3	2.8	61.2	39.5	63.8	9.5	14.1	189.9	81.7	24.8	47.2	142.6	150.8	148.9	75.0	29.5	6.6	24.4	45.9	105.8	80.1	185.1	180.1	72.8	53.3	37.6	73.5	152.2
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;retina: 3.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.4;Cone photoreceptor cells: 22.9;Excitatory neurons: 13.1;Inhibitory neurons: 13.9;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 9.3;Rod photoreceptor cells: 11.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 7.3;RPTEC TERT1: 12.3;SCLC-21H: 9.9;SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"							"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	0.5	1.0	1.4	1.0	3.0	0.3	0.2	1.5	2.6	0.7	0.0	0.4	0.7	0.3	0.7	0.2	1.0	0.8	0.4	2.3	2.1	1.8	1.7	0.6	1.0	2.6	2.1	0.3	0.3	0.1	0.8	0.1	2.8	0.4	0.3	3.4	0.2	0.3	0.3	0.5	0.6	0.4	1.0	1.0	0.2	0.3	1.7	1.0	2.6	0.3	0.7	0.2	0.1	2.8	0.0	0.3	7.3	0.1	1.0	0.0	0.0	0.3	0.2	0.2	0.8	0.3	2.4	0.0	5.8	0.3	0.4	0.1	0.9	0.0	0.2	1.4	0.3	2.9	0.1	1.4	1.9	0.1	0.5	0.6	0.6	0.5	0.7	1.8	0.0	0.9	0.0	0.3	6.3	0.8	0.2	0.1	4.1	0.0	0.0	1.4	2.0	0.0	12.3	0.0	9.9	14.5	0.3	0.1	5.7	4.0	0.5	1.0	0.0	0.2	0.4	0.0	0.4	1.7	2.2	0.4	1.9	0.2	1.4	0.8	1.0	0.1	1.2	1.0	0.9	1.5	2.0	1.4	0.0	1.4	2.1	0.9	2.3	0.3	3.2	0.1	3.7	0.7	1.4	3.0	1.5	2.6	2.3	2.1	2.6	2.1	2.8	1.0	1.7	2.8	0.3	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	14.4	0.1	0.5	0.8	4.3	0.0	5.5	22.9	0.1	0.3	0.0	0.0	0.6	0.0	0.4	0.4	0.2	4.9	0.0	13.1	0.0	0.0	0.2	0.5	0.5	0.0	0.0	1.4	0.8	0.4	0.0	13.9	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.0	3.7	0.2	2.2	3.1	11.1	9.3	0.1	0.6	0.4	0.3	0.1	0.3	2.8	0.1	11.6	0.0	3.6	0.4	0.0	0.7	0.0	0.0	0.0	0.8	0.1	0.2	0.1
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.5	28.2	13.0	8.1	13.3	12.9	17.5	15.7	24.6	14.7	12.2	15.5	8.9	17.3	6.0	14.2	14.9	10.0	19.6	12.9	13.1	16.4	33.5	16.1	16.1	14.6	13.1	12.2	23.3	9.2	30.9	7.4	14.5	19.0	3.6	10.2	21.4	8.7	19.7	17.0	17.5	6.4	11.4	26.1	19.3	13.2	12.7	8.9	21.0	4.5	6.1	16.1	13.5	13.5	4.9	9.5	5.1	7.0	23.7	12.3	11.8	13.0	8.6	7.3	10.8	4.2	20.5	4.0	7.5	12.8	12.8	8.4	4.7	9.5	3.1	9.2	11.9	8.3	14.9	4.3	13.7	4.6	14.8	17.5	11.3	6.4	4.3	5.1	4.6	8.1	8.2	30.0	6.4	16.2	11.3	17.4	3.2	5.8	24.8	7.5	3.1	11.5	7.0	5.0	14.0	12.9	8.6	5.5	7.8	2.5	24.3	11.3	6.6	13.7	3.0	16.8	9.1	23.0	5.9	7.4	13.2	9.4	11.3	36.8	32.2	27.2	20.6	41.1	13.3	19.4	17.3	15.5	29.4	21.6	12.6	17.6	27.8	17.0	39.7	47.1	18.5	21.2	13.0	13.3	15.7	24.6	12.9	13.1	14.6	13.1	14.5	11.4	12.7	13.5	17.0	12.8	8.9	26.8	20.7	6.2	8.1	21.0	12.5	26.8	15.2	14.4	10.4	8.6	17.1	14.7	4.2	24.1	19.2	13.7	1.9	8.8	6.1	11.6	12.2	10.2	16.2	3.0	42.8	11.4	10.1	16.6	17.9	11.3	7.0	10.8	10.8	24.5	15.2	47.1	37.8	9.6	34.6	14.5	9.1	4.0	12.5	15.8	19.6	15.0	9.6	38.6	15.5	25.1	29.1	7.9	16.1	16.1	16.7	6.1	16.6	8.0	13.6	28.7	13.1	10.1	12.3	24.0	14.1	12.3	7.7	18.9	15.3	29.2	7.6	8.4
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588911-9614877	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	5.8	6.1	8.6	3.6	8.9	7.7	5.2	7.9	9.7	7.5	6.8	5.7	3.2	7.3	2.0	7.0	6.3	2.2	14.5	9.4	8.4	9.5	3.4	4.0	3.2	10.8	9.7	9.4	6.1	4.4	16.0	2.5	9.5	6.4	1.3	6.1	5.5	2.9	43.2	6.4	4.7	2.7	7.9	5.4	4.6	10.4	9.6	3.2	5.5	24.3	2.0	5.2	5.5	8.3	13.6	18.2	11.1	26.3	4.6	3.1	9.9	15.7	4.8	18.3	12.9	33.1	12.0	23.5	19.4	5.5	9.0	27.9	12.4	12.4	6.2	15.7	31.2	16.7	17.4	17.0	8.4	20.4	16.6	5.7	5.5	24.6	3.9	3.9	7.3	10.9	21.7	6.6	7.5	16.0	17.8	14.8	11.2	10.3	16.4	37.1	19.0	19.3	6.6	7.3	26.6	19.9	12.3	29.9	13.5	3.8	9.1	12.7	6.7	21.7	18.8	24.0	30.0	11.0	9.9	21.0	15.0	33.0	19.6	0.0	0.2	0.0	0.3	0.2	0.1	0.5	0.3	0.5	0.3	0.2	0.2	0.2	0.0	0.1	0.1	1.3	0.5	0.3	8.6	8.9	7.9	9.7	9.4	8.4	10.8	9.7	9.5	7.9	9.6	8.3	5.2	3.2	2.0	4.9	2.2	7.0	2.5	1.8	4.6	16.0	5.3	4.7	12.1	2.8	2.1	0.0	27.1	4.1	0.8	2.6	1.9	2.3	2.0	4.2	4.9	4.9	6.7	5.2	4.1	1.0	2.5	4.0	2.6	4.4	4.5	11.7	3.6	1.6	3.6	10.1	6.0	3.7	2.0	2.5	3.5	1.8	4.1	2.4	3.6	0.0	0.9	5.0	1.0	7.1	5.9	1.7	0.9	4.5	2.8	3.2	0.6	1.9	2.4	16.9	0.0	7.3	4.2	6.8	5.4	7.9	5.5	0.8	2.8	4.6	4.3	2.3
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783540-32789201	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 6.9;retina: 18.3;testis: 3.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 572.0;Early spermatids: 129.9;Late spermatids: 302.1"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Region enriched"	"Detected in many"	4	"thalamus: 6.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"			Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA052804: AB_2681957, HPA063207: AB_2732697"	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.0	0.0	1.2	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	18.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.9	6.9	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.5	0.7	1.5	0.2	1.6	0.3	0.3	6.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	572.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	129.9	0.0	1.2	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	3.7	0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.0	0.0	302.1	2.8	0.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.1	3.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212178-37258155	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.5;Exocrine glandular cells: 16.0;Pancreatic endocrine cells: 15.9;Spermatocytes: 55.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 7.7;HUVEC TERT2: 6.4;TIME: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045432, HPA071187"			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Cytosol	"HPA045432: AB_2732519, HPA071187: AB_2732174"	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.7	3.1	0.9	0.7	1.0	2.8	0.5	1.0	1.6	0.3	0.9	0.3	1.1	0.3	1.5	1.6	0.7	1.2	0.3	0.9	0.9	0.6	0.9	0.7	0.4	0.9	0.9	0.3	2.7	1.3	0.1	0.3	1.0	0.3	0.3	0.7	1.2	0.1	0.1	1.0	0.4	0.4	0.8	0.2	0.2	9.1	1.0	0.7	0.7	0.0	0.3	2.2	0.1	1.1	0.7	0.0	0.5	0.4	0.3	2.1	0.3	2.2	3.9	1.9	5.5	1.7	1.3	0.1	0.8	0.5	2.4	1.2	0.7	0.6	2.0	0.7	1.1	7.7	1.7	0.9	0.9	0.2	3.7	1.4	1.7	5.0	0.5	1.0	6.4	0.8	2.5	0.0	0.9	0.9	0.5	3.2	0.6	0.0	0.3	1.0	0.2	0.2	2.1	0.8	0.6	0.3	0.4	0.4	1.0	0.9	0.1	0.4	17.6	1.8	0.5	0.2	0.4	0.5	0.7	1.9	0.3	1.7	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.9	1.0	1.0	1.6	0.9	0.9	0.9	0.9	1.0	0.8	1.0	1.1	2.6	0.0	0.6	2.9	0.7	2.5	8.9	2.6	0.6	0.8	3.9	1.8	0.2	1.5	3.9	1.8	0.0	0.8	1.3	3.4	3.9	15.0	20.5	8.3	1.3	3.3	1.8	0.0	2.9	16.0	0.6	3.8	2.0	5.6	5.7	1.4	0.4	0.1	0.9	3.3	2.1	0.4	2.0	0.6	6.3	14.9	0.6	2.8	1.8	0.0	0.0	6.4	0.0	1.5	3.0	15.9	1.1	0.0	0.5	6.9	0.8	1.1	5.0	0.5	0.0	4.1	1.8	55.0	0.8	3.4	3.0	1.1	1.1	1.5	1.0	13.9
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.7;ovary: 19.6"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 32.6;Skeletal myocytes: 14.6"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 25.3;NTERA-2: 9.5;RPMI-8226: 17.1;SK-MEL-30: 27.7;U-2 OS: 11.8;U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	4.7	3.3	7.4	1.8	5.8	0.7	3.2	4.8	9.2	11.9	1.7	2.6	0.7	1.9	1.6	2.8	3.8	1.1	1.3	3.8	27.4	1.4	0.6	3.0	3.6	22.7	48.7	19.6	0.4	1.4	3.8	0.2	33.0	1.4	2.3	1.5	1.2	1.8	1.4	2.6	2.3	0.9	19.9	1.7	1.8	0.2	36.8	8.1	0.4	2.7	3.8	1.9	8.5	11.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.2	0.0	0.1	0.3	0.0	2.9	0.0	1.9	0.7	0.7	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	25.3	0.4	0.0	0.0	0.1	9.5	0.0	0.0	0.1	0.0	17.1	0.0	0.0	5.1	0.1	0.5	0.0	27.7	0.3	0.0	0.3	0.0	0.0	11.8	0.0	5.1	0.0	5.2	3.7	29.7	0.0	0.0	0.0	0.3	0.0	2.8	0.1	1.4	0.2	0.2	1.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	7.4	5.8	4.8	9.2	3.8	27.4	22.7	48.7	33.0	19.9	36.8	11.5	0.1	3.2	0.0	1.6	0.0	0.4	0.1	0.1	0.6	1.9	0.2	1.3	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.2	0.0	0.0	4.4	0.0	0.4	0.0	0.3	0.4	0.0	1.3	0.0	4.3	0.0	0.0	1.0	0.7	1.6	0.6	1.6	5.4	1.9	3.7	0.3	0.0	32.6	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	14.6	0.6	0.1	0.1	0.0	1.3	0.1	0.4	0.0	0.0	0.0
TMEM256	"C17orf61, MGC40107"	ENSG00000205544	"Transmembrane protein 256"	Q8N2U0	17	7402975-7404097	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 573.1;Proximal enterocytes: 972.0;Proximal tubular cells: 801.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062732			Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA062732: AB_2684852"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.69e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-2)"	92.2	84.3	63.9	22.2	66.4	36.7	86.7	67.7	73.0	85.6	63.5	72.6	76.3	63.5	48.2	74.7	77.6	24.0	99.8	62.1	65.2	122.4	173.9	51.8	34.5	67.3	64.2	75.4	113.8	42.6	45.9	14.3	67.1	81.5	25.2	15.1	60.3	24.4	67.4	64.3	90.0	17.6	67.6	67.9	91.7	12.4	64.5	30.8	51.5	41.6	28.5	69.7	67.6	72.4	67.0	89.3	47.3	64.3	78.6	99.0	43.0	30.7	43.9	49.4	46.3	36.1	38.0	59.0	54.0	31.2	39.4	56.4	29.9	93.6	35.7	30.5	99.4	37.5	32.0	95.1	54.0	13.0	49.0	87.1	44.2	64.1	53.0	66.4	73.1	63.8	28.9	39.1	64.1	36.5	44.1	42.5	21.4	29.4	58.6	69.9	41.5	68.8	121.2	28.8	5.5	37.9	47.6	36.7	51.2	46.0	66.6	23.4	43.7	22.8	42.7	46.5	39.3	32.6	45.2	31.2	60.2	18.0	44.4	12.9	63.1	14.8	35.7	48.5	44.5	77.4	42.3	41.3	59.7	69.0	48.5	45.2	3.9	39.3	36.3	82.3	46.0	77.8	63.9	66.4	67.7	73.0	62.1	65.2	67.3	64.2	67.1	67.6	64.5	72.4	103.1	44.8	55.8	0.0	134.5	87.4	93.3	100.1	94.4	24.0	212.4	216.9	62.5	131.5	76.9	132.4	8.4	77.2	78.4	162.9	297.4	132.8	6.0	80.2	84.6	85.1	125.3	100.5	0.0	190.8	223.6	83.3	88.7	84.5	68.4	50.3	114.5	573.1	205.5	20.2	0.0	186.6	81.4	164.7	128.2	6.8	137.3	108.4	144.1	0.0	166.7	134.0	88.6	0.0	0.0	171.3	214.0	71.1	173.1	87.3	972.0	801.9	96.3	42.0	59.2	80.2	160.2	10.1	39.1	179.5	134.0	46.7	91.7	64.5	210.0	90.9
TMEM270	"MGC26719, WBSCR28"	ENSG00000175877	"Transmembrane protein 270"	Q6UE05	7	73861159-73865890	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	215	"testis: 77.6"	"Cell type enriched"	"Detected in single"	7	"Endometrial ciliated cells: 2.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077196			Approved	Vesicles		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA077196: AB_2732334"	"unprognostic (3.84e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.87e-5)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.31e-3)"		"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.23e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM45B	"BC016153, FLJ40787"	ENSG00000151715	"Transmembrane protein 45B"	Q96B21	11	129815848-129860003	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.5;intestine: 136.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 325.6;Paneth cells: 221.6;Proximal enterocytes: 288.7;Respiratory ciliated cells: 133.9;Undifferentiated cells: 122.2;Urothelial cells: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.0;naive CD4 T-cell: 3.6;neutrophil: 11.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 11.7;T-cells: 3.6"	"Group enriched"	"Detected in some"	5	"OE19: 333.1;RT4: 133.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015474, HPA015878"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA015474: , HPA015878: AB_2205046"	"unprognostic (4.92e-3)"	"unprognostic (7.94e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	0.7	0.6	1.5	8.3	1.6	1.1	13.2	1.9	1.8	14.9	7.6	95.1	136.4	1.1	13.6	66.5	21.7	24.1	0.1	2.1	2.0	20.6	24.7	6.0	0.9	1.5	2.8	0.2	1.2	12.4	4.2	1.4	1.5	3.6	94.6	0.4	15.4	8.2	0.3	25.4	127.4	2.8	0.9	0.8	24.3	0.3	2.0	0.4	6.5	0.0	15.0	30.8	27.3	1.4	0.1	0.1	0.1	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	39.1	16.8	0.2	7.0	0.0	0.2	22.3	0.0	0.0	0.0	0.1	0.5	0.3	2.1	40.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.4	0.2	0.2	0.1	0.0	13.3	0.2	1.5	0.2	333.1	49.2	0.3	0.1	2.6	21.0	133.1	4.1	0.6	0.2	10.8	0.1	0.1	37.1	0.2	0.3	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.1	0.3	0.1	1.2	0.5	0.1	0.2	0.1	0.2	0.2	3.0	0.8	0.0	0.4	3.6	0.6	11.7	0.5	0.1	0.3	0.5	0.9	1.5	1.6	1.9	1.8	2.1	2.0	1.5	2.8	1.5	0.9	2.0	1.4	0.1	19.2	12.5	0.3	1.1	3.3	16.4	29.1	0.0	0.1	6.7	2.5	0.8	18.6	68.8	46.0	0.0	3.8	0.0	325.6	13.7	26.9	0.4	27.7	2.9	1.0	55.4	0.0	0.8	8.6	0.8	0.8	17.9	29.5	2.5	0.3	0.4	8.4	0.5	0.0	0.4	49.3	20.3	0.6	0.4	0.3	0.3	2.9	3.6	2.8	0.1	0.1	0.0	0.0	0.3	50.2	221.6	0.0	0.0	23.8	288.7	1.4	133.9	0.2	0.0	0.7	3.6	0.1	0.2	4.4	20.9	0.4	1.8	0.1	122.2	162.0
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 59.5"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 999.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"plasmacytoid DC: 99.4"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 99.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Focal adhesion sites"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	12.8	12.0	5.7	4.4	9.2	6.7	12.1	6.8	8.3	6.8	6.3	14.2	16.4	8.9	6.8	6.0	7.0	6.2	13.9	5.7	7.2	18.3	59.5	10.5	4.0	8.5	8.5	10.6	8.3	6.3	10.1	3.9	8.5	7.2	6.9	7.1	7.2	3.3	7.6	6.6	14.6	4.2	5.8	6.3	10.1	34.9	8.8	3.3	7.9	3.7	2.1	7.5	6.1	15.4	12.9	14.7	13.0	9.6	16.6	12.5	15.6	3.8	11.1	7.2	10.5	4.7	39.9	4.1	11.8	3.6	27.4	11.5	3.6	7.8	3.8	6.5	9.2	4.7	6.0	22.7	16.5	3.7	16.6	14.8	11.9	14.4	3.1	7.9	4.0	9.1	2.0	5.1	4.3	7.7	4.5	11.2	7.6	9.9	8.5	6.8	1.8	40.0	21.6	13.4	9.0	8.7	4.1	15.7	21.3	9.3	4.8	9.9	1.7	5.3	8.8	7.5	4.7	3.7	4.7	2.3	13.6	9.6	6.3	14.1	12.9	6.3	7.3	23.1	6.3	13.9	7.4	6.3	6.6	14.8	3.5	4.5	1.4	7.8	16.2	99.4	8.1	7.6	5.7	9.2	6.8	8.3	5.7	7.2	8.5	8.5	8.5	5.8	8.8	15.4	10.9	6.4	12.0	8.1	3.5	1.7	9.5	24.2	1.8	6.9	9.0	7.6	35.5	10.0	20.4	20.2	4.2	14.5	9.5	53.1	45.0	18.6	188.3	14.0	4.6	8.5	14.4	10.1	2.9	25.7	15.5	6.9	8.2	5.7	6.3	8.6	10.0	93.0	34.3	18.5	3.6	22.6	44.7	12.6	0.7	999.9	9.0	14.0	8.8	1.9	3.8	17.1	5.2	3.0	4.8	17.5	51.3	12.4	2.6	8.9	74.3	45.9	32.8	13.8	26.3	3.7	10.6	15.6	13.2	3.9	2.3	9.3	3.7	8.3	18.0	12.7
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 100.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	18.1	18.2	9.2	9.8	9.7	10.4	11.3	10.5	12.3	8.0	9.5	12.6	5.8	8.9	10.6	9.3	11.3	8.9	19.3	10.3	10.2	12.0	24.4	9.0	10.1	9.6	9.1	10.5	25.0	8.3	7.6	10.3	10.1	7.4	9.7	6.1	9.9	5.9	100.7	7.7	9.5	9.1	9.5	9.6	17.8	9.8	9.5	11.0	6.0	20.5	10.3	11.3	7.4	10.1	21.2	16.4	13.1	13.8	14.9	12.7	13.6	17.6	15.8	19.4	15.3	15.8	11.9	28.4	15.0	12.0	16.4	19.1	24.9	16.8	21.4	18.9	17.5	28.3	10.0	21.2	14.7	15.5	14.5	11.8	15.3	12.2	6.4	7.3	16.4	14.2	22.0	13.5	20.5	15.9	35.8	29.6	12.3	26.6	20.6	25.4	12.8	24.2	20.5	20.0	29.7	13.1	11.0	78.0	23.3	10.2	16.0	14.1	10.6	11.1	13.7	20.7	16.9	19.9	18.7	28.1	16.4	12.1	12.5	6.3	9.1	6.7	8.0	10.2	9.1	17.7	9.0	9.3	9.6	10.9	10.3	9.6	6.7	5.8	7.9	11.0	7.9	12.0	9.2	9.7	10.5	12.3	10.3	10.2	9.6	9.1	10.1	9.5	9.5	10.1	136.2	16.0	30.1	5.5	37.1	67.3	43.7	54.8	24.5	23.9	26.2	22.2	46.3	14.3	35.7	22.0	8.4	71.2	48.1	69.0	66.5	36.6	20.3	40.8	26.2	96.4	13.8	26.5	12.8	63.5	59.6	50.2	17.3	17.1	39.9	17.0	28.5	50.3	132.4	10.1	11.4	31.7	42.7	70.0	74.5	12.1	29.8	73.2	40.9	5.6	38.9	23.1	22.6	3.5	8.1	43.6	37.9	29.0	68.6	42.1	28.8	75.4	58.7	17.5	39.5	61.9	40.8	70.6	29.5	21.5	59.7	70.3	39.8	52.6	34.1	26.2
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;heart muscle: 37.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.9;Kupffer cells: 20.7;Langerhans cells: 25.7;Macrophages: 26.2;monocytes: 25.5;NK-cells: 54.6;T-cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 9.7"	"Immune cell enhanced"	"Detected in all"		"neutrophil: 269.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.7;HDLM-2: 54.5;Karpas-707: 11.1;U-937: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	5.6	2.0	1.0	13.1	1.3	33.5	8.5	1.0	9.7	2.5	2.2	11.3	2.2	1.3	1.1	2.8	1.9	5.5	37.1	1.1	1.8	2.6	3.9	8.2	13.2	1.6	1.3	1.0	2.4	0.7	1.1	1.8	2.1	2.0	3.4	0.5	5.7	2.2	1.6	1.1	7.3	3.6	1.1	18.4	2.8	1.0	2.4	19.2	2.0	4.6	10.6	4.6	1.9	1.6	0.4	0.0	4.9	0.0	0.0	0.0	0.0	1.3	12.7	0.5	0.9	0.0	0.0	0.1	0.6	4.1	0.1	0.0	0.0	0.3	1.5	54.5	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.1	0.0	0.1	2.0	1.4	1.0	6.7	0.0	11.1	2.4	0.0	2.9	2.2	1.2	0.0	0.4	0.1	1.8	0.8	4.8	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.1	0.5	0.9	1.2	5.7	0.1	2.9	0.0	9.0	31.6	3.7	61.9	55.9	101.6	31.3	16.1	57.9	6.6	22.8	22.2	33.7	4.7	33.9	25.1	269.0	12.9	14.7	1.1	3.0	39.0	1.0	1.3	1.0	9.7	1.1	1.8	1.6	1.3	2.1	1.1	2.4	1.6	0.5	0.0	3.0	0.0	6.9	0.9	1.0	2.5	0.6	0.0	4.2	2.7	15.9	0.0	5.5	0.0	0.0	0.0	39.9	0.1	0.0	0.0	6.5	0.1	0.3	1.5	0.0	8.8	0.5	0.0	0.0	4.1	1.1	0.2	1.3	0.0	3.3	0.2	3.2	0.0	1.3	0.2	0.0	20.7	25.7	5.1	0.0	26.2	5.4	17.8	25.5	1.9	54.6	0.0	0.1	0.1	0.0	0.0	11.3	0.1	0.0	0.4	2.9	0.0	0.0	3.7	0.8	0.0	0.6	0.4	0.3	0.3	35.9	0.1	0.0	4.5
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226638-55228784	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 11.0;liver: 16.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Erythroid cells: 66.5;Hepatocytes: 33.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.6;RPMI-8226: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Centrosome	Midbody	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	0.9	2.1	4.6	2.4	5.1	6.9	0.9	4.7	6.8	1.4	3.8	1.8	9.7	1.5	0.1	1.0	1.8	11.0	0.8	4.6	3.9	1.3	16.9	1.2	1.7	4.4	3.7	1.2	0.6	0.5	2.9	0.6	4.3	1.8	0.3	0.7	0.9	0.6	1.5	1.6	10.2	0.3	3.4	3.6	4.1	3.0	4.2	1.6	2.3	0.4	1.2	1.2	1.0	4.2	1.7	0.0	0.9	1.1	0.1	0.0	3.0	1.2	0.3	0.9	0.9	5.4	1.4	2.4	0.4	0.4	0.3	0.7	0.1	0.2	0.0	0.3	4.0	1.9	0.4	7.6	0.9	1.6	0.9	0.7	1.5	0.5	0.0	0.4	0.0	3.8	3.8	1.4	0.4	1.0	3.8	5.3	0.2	0.6	1.7	3.8	0.5	8.1	0.8	1.6	0.7	1.7	0.0	0.9	4.4	0.7	1.0	1.9	1.2	1.9	1.1	1.1	0.9	1.4	1.5	4.1	1.0	5.2	0.4	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.5	0.3	0.2	0.0	0.6	0.0	0.2	4.6	5.1	4.7	6.8	4.6	3.9	4.4	3.7	4.3	3.4	4.2	4.2	1.5	6.4	2.7	4.9	1.3	3.3	0.4	1.0	1.8	6.0	1.9	1.1	0.6	37.1	1.5	0.0	2.1	0.4	1.9	2.0	0.0	1.1	3.0	2.5	1.0	1.9	10.7	66.5	5.2	0.2	0.3	0.9	12.8	1.8	0.0	2.5	1.4	33.3	1.0	10.1	4.5	2.8	4.1	5.9	2.8	4.5	0.9	2.5	3.6	0.0	3.1	1.2	2.1	2.5	3.3	1.1	0.3	0.4	2.9	1.2	14.5	1.0	3.8	3.9	0.0	0.8	1.3	1.8	1.2	0.8	2.3	0.3	3.3	1.9	2.7	2.4
TMEM9	TMEM9A	ENSG00000116857	"Transmembrane protein 9"	Q9P0T7	1	201134772-201171574	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008483			Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA008483: "	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.90e-2)"	34.1	102.3	103.1	20.8	104.4	27.8	45.0	93.5	126.6	76.8	122.7	45.0	25.4	70.9	65.4	31.1	75.4	39.5	51.3	107.8	113.2	73.8	73.8	44.5	23.5	99.4	111.5	81.4	73.9	92.2	63.4	28.5	102.8	60.3	25.4	43.9	60.7	45.9	44.9	35.5	30.4	37.5	100.2	31.2	49.8	67.0	112.5	26.3	68.5	24.9	17.7	45.7	51.8	100.2	63.1	117.0	72.6	168.9	38.5	54.5	128.5	48.6	51.5	76.0	68.2	115.7	99.8	33.2	69.2	73.4	70.1	123.3	76.5	80.1	37.3	21.3	131.9	58.1	182.4	76.6	73.8	28.2	51.9	65.0	87.0	71.2	43.0	91.3	47.7	46.2	105.6	35.5	66.2	81.0	34.1	46.1	111.0	57.3	285.3	60.7	108.4	44.0	87.9	48.0	67.6	137.7	86.7	146.9	91.8	107.4	180.3	48.5	35.7	84.8	70.0	68.5	59.8	143.9	135.2	26.1	64.4	30.1	42.0	49.8	59.8	33.7	45.7	41.8	52.2	54.5	44.0	37.8	51.5	49.2	64.6	42.7	41.0	32.9	38.5	56.1	43.0	75.5	103.1	104.4	93.5	126.6	107.8	113.2	99.4	111.5	102.8	100.2	112.5	100.2	20.9	51.3	49.5	17.0	13.4	12.9	31.4	65.6	27.3	61.0	56.2	65.7	39.3	40.0	48.0	36.8	31.3	44.4	9.3	7.9	17.6	88.8	58.0	37.3	58.6	26.3	31.8	43.6	15.7	74.7	52.1	59.9	20.9	46.4	13.3	46.3	30.0	40.4	28.1	8.4	22.1	26.9	36.7	13.4	11.9	60.9	70.8	15.6	23.2	8.4	11.8	102.3	25.7	15.6	10.1	40.3	18.8	53.0	18.8	28.5	8.3	56.9	54.5	32.8	13.1	33.3	42.1	54.8	76.7	14.5	13.9	13.0	13.0	130.7	28.4	27.8
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155489011-155719098	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 51.5;Oligodendrocyte precursor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA034589: AB_10670571, HPA040331: AB_2676929"	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	11.7	10.2	7.1	6.6	7.4	8.4	11.3	9.0	8.0	11.3	8.1	11.6	11.8	9.4	10.4	10.3	9.9	8.0	25.3	6.7	7.7	16.7	18.8	5.6	7.0	8.5	8.2	12.0	9.5	18.9	5.4	8.4	8.5	6.6	12.5	10.9	12.7	9.7	32.0	5.9	11.2	12.3	8.3	8.7	9.1	2.9	7.3	8.9	10.5	33.4	7.6	8.2	6.6	9.8	25.0	11.9	9.8	28.6	11.8	18.1	0.0	9.9	14.6	12.3	32.4	8.7	13.9	0.0	38.9	17.6	28.2	13.4	21.2	9.7	13.9	10.3	14.3	11.3	19.5	10.2	16.4	10.5	7.6	19.5	20.0	13.6	20.8	18.2	19.5	15.5	15.8	9.0	20.5	9.3	12.8	11.8	3.0	21.6	0.1	12.7	15.5	9.4	15.0	8.5	9.2	13.7	9.3	0.5	11.2	10.5	10.6	11.9	16.5	10.3	9.7	20.4	12.4	11.0	12.6	9.6	12.4	16.4	9.6	3.4	12.6	14.7	4.6	14.9	3.5	8.1	5.0	3.9	13.1	10.6	6.5	5.7	18.2	6.2	21.5	6.1	5.5	5.8	7.1	7.4	9.0	8.0	6.7	7.7	8.5	8.2	8.5	8.3	7.3	9.8	6.7	0.0	2.3	27.1	10.1	5.2	12.1	14.4	9.6	4.0	5.2	7.5	7.2	7.2	9.7	9.2	0.0	8.8	6.5	7.9	23.5	10.7	0.0	6.8	7.4	6.2	6.1	14.3	22.2	7.6	6.8	10.2	9.2	7.3	10.1	8.1	4.2	12.0	12.4	0.0	29.5	7.3	4.1	16.1	10.4	0.5	8.4	12.1	12.4	51.5	13.1	7.6	10.3	47.7	25.5	8.5	7.3	5.7	5.6	4.3	17.4	17.0	9.5	5.4	0.0	5.9	9.5	0.3	2.5	7.6	4.1	6.7	8.0	10.5	6.5	11.0
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515579-98550351	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 139.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847, HPA070805"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: "	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	17.1	13.9	8.4	44.0	9.4	93.2	24.3	19.1	15.1	23.2	10.1	34.5	34.1	30.8	34.4	27.0	22.8	17.7	11.0	9.1	9.6	21.7	37.2	21.9	78.7	9.7	8.9	56.2	25.3	17.8	8.4	29.4	9.6	17.2	36.4	20.7	16.5	19.1	12.2	22.7	39.6	22.3	8.8	39.1	35.7	23.1	9.6	139.9	15.2	12.2	78.1	20.7	20.7	14.2	180.5	117.5	283.3	145.5	23.1	30.7	166.2	145.0	77.1	193.9	139.5	129.5	88.9	314.4	86.2	85.6	70.7	113.0	240.8	110.1	177.1	217.7	148.5	269.1	103.3	86.5	21.2	315.4	170.8	17.6	35.4	115.0	61.2	66.9	112.8	192.0	231.8	118.1	122.0	114.7	514.9	248.6	170.1	167.2	108.6	421.3	187.2	218.6	69.3	167.7	221.9	132.2	248.9	155.2	79.3	110.6	174.3	149.2	60.4	111.1	96.5	76.8	150.8	125.9	231.9	344.0	32.0	179.5	151.0	48.6	30.4	13.4	18.9	54.1	20.5	22.4	21.9	21.6	23.4	27.2	30.0	23.5	2.4	20.7	75.9	12.9	28.5	30.5	8.4	9.4	19.1	15.1	9.1	9.6	9.7	8.9	9.6	8.8	9.6	14.2	45.4	32.1	27.9	3.6	70.1	27.8	23.7	18.7	28.5	21.1	21.2	28.6	9.0	25.8	33.5	31.3	12.5	36.0	48.5	63.0	31.3	19.5	42.7	29.5	29.8	38.0	28.7	172.1	20.3	31.5	89.7	32.2	56.1	42.7	29.1	70.1	34.2	50.0	38.2	10.1	15.3	63.4	16.2	63.1	34.9	32.1	28.6	73.4	17.8	23.4	63.5	20.3	54.6	14.6	19.1	26.7	28.5	40.6	81.9	21.1	33.7	33.1	25.6	52.6	19.7	27.3	32.0	54.0	59.4	62.8	23.3	11.8	60.8	32.4	62.4	21.8
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33097146	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.5"	"Cell type enhanced"	"Detected in some"		"Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	0.6	0.5	0.8	1.4	0.7	5.5	0.6	0.7	1.2	0.6	4.3	1.0	1.2	0.5	0.6	0.6	0.9	0.6	0.4	1.5	0.5	1.0	0.6	1.1	1.1	1.4	1.4	0.6	0.7	1.9	0.3	1.2	1.6	0.5	1.2	2.8	0.7	0.6	0.2	1.1	1.1	0.8	0.2	1.5	1.3	0.3	1.7	0.5	1.0	0.3	1.3	0.8	0.4	0.2	1.4	1.9	1.0	1.7	1.2	1.0	27.2	0.6	1.0	1.6	0.9	2.7	3.8	0.8	1.2	1.7	0.9	1.4	1.7	1.5	2.6	4.2	0.6	3.4	1.9	2.1	0.9	3.0	4.7	1.1	1.2	2.0	1.4	0.8	1.9	1.7	2.6	2.9	1.2	1.3	1.2	1.3	1.0	0.4	1.1	1.5	0.6	1.9	1.5	1.9	0.2	0.6	0.9	2.6	0.6	1.3	1.4	4.2	2.7	2.4	3.0	1.3	2.6	2.3	1.6	0.4	3.0	2.2	1.7	0.0	1.1	0.3	0.1	2.4	0.6	0.3	0.2	0.0	1.0	0.1	0.0	0.0	1.9	0.0	1.1	0.2	0.2	0.4	0.8	0.7	0.7	1.2	1.5	0.5	1.4	1.4	1.6	0.2	1.7	0.2	0.3	0.0	1.3	0.0	0.8	0.8	0.1	0.0	0.0	1.2	0.4	0.4	0.4	0.0	0.2	0.0	0.0	1.1	1.9	1.4	0.0	0.4	0.0	0.8	0.6	0.4	0.0	0.4	0.0	0.8	1.7	0.3	0.0	1.1	0.0	0.4	0.4	0.6	0.9	1.7	0.0	0.2	2.0	1.3	1.2	0.0	0.0	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.5	1.4	0.4	1.0	0.2	1.4	0.3	0.4	2.2	0.0	0.2	0.7	0.0	0.0	1.5	0.9	0.4	0.6	0.5	0.6	0.2
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447463-68497604	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 89.5;esophagus: 220.2;salivary gland: 56.7;vagina: 156.3"	"Cell type enriched"	"Detected in some"	14	"Ionocytes: 476.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043816, HPA051062"	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA043816: , HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavorable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	89.5	0.0	0.0	0.0	0.0	18.2	220.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.2	0.0	0.0	56.7	0.7	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	24.5	6.5	156.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	12.9	0.7	0.0	0.0	0.5	0.3	0.3	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	476.0	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.2	6.6	0.3	1.1	0.7	0.0	0.0	32.6
TMTC2	DKFZp762A217	ENSG00000179104	"Transmembrane O-mannosyltransferase targeting cadherins 2"	Q8N394	12	82686880-83134870	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 60.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 2152.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.0;WM-115: 80.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026954, HPA026955"	Uncertain		Approved	"Plasma membrane,Actin filaments"		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	"Actin filaments"	"HPA026954: AB_2256025, HPA026955: AB_10602282"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.61e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.84e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.06e-2)"	3.7	0.8	11.4	4.7	39.8	2.1	4.6	21.4	25.1	4.8	0.0	11.7	2.8	5.4	4.4	9.8	10.0	7.8	2.0	11.2	19.1	6.6	1.2	6.4	1.8	28.3	29.9	1.9	4.5	2.8	3.5	3.4	26.7	6.1	5.7	5.5	6.9	11.2	1.2	5.2	4.7	6.8	11.7	1.3	10.2	3.0	26.8	1.5	6.4	1.7	2.2	7.5	7.3	60.8	1.7	6.4	32.0	0.2	4.3	3.9	2.9	2.1	0.7	1.7	0.3	0.3	3.4	0.0	0.5	11.9	1.2	2.8	9.7	4.9	0.5	7.5	5.8	0.0	5.2	0.2	0.4	2.2	1.0	1.1	4.3	0.2	1.6	3.4	2.7	3.5	0.0	4.2	0.4	3.4	1.6	8.8	1.1	6.0	5.3	0.0	1.3	0.6	2.9	14.1	8.3	15.1	2.9	4.6	21.0	5.4	4.9	0.5	1.7	5.3	1.8	7.2	2.7	7.8	5.7	1.2	1.2	3.8	80.2	0.0	0.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	11.4	39.8	21.4	25.1	11.2	19.1	28.3	29.9	26.7	11.7	26.8	60.8	10.7	9.6	8.9	333.3	2.0	14.4	15.5	12.0	18.2	38.1	8.9	5.5	1.8	11.5	18.4	14.7	8.4	13.6	3.1	3.6	0.0	5.4	12.9	13.5	7.5	10.3	2.4	0.8	117.1	8.2	1.7	9.8	12.8	13.1	0.0	0.2	2.5	1.4	1.9	8.4	377.0	9.8	2.0	6.6	9.6	5.0	5.9	6.2	32.0	86.2	9.3	13.9	1.0	38.7	2152.4	9.4	3.3	1.2	7.3	11.9	2.7	2.1	17.0	1.6	6.6	0.8	2.2	0.6	2.2	16.2	11.5	4.1	2.8	1.0	5.9	14.5
TNFAIP8	"GG2-1, MDC-3.13, SCC-S2"	ENSG00000145779	"TNF alpha induced protein 8"	O95379	5	119268692-119399688	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 211.8;Langerhans cells: 323.4;Syncytiotrophoblasts: 292.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 155.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054434, HPA057089"	Uncertain		Enhanced	Nucleoplasm		No	Yes		470000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA054434: AB_2682487, HPA057089: AB_2683331"	"prognostic favorable (2.45e-4)"	"unprognostic (6.06e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-2)"	72.4	5.1	4.2	62.3	4.1	65.5	19.3	8.9	7.0	15.9	31.2	17.8	16.1	13.3	17.1	25.3	10.5	16.6	8.5	3.9	4.0	16.4	10.1	19.1	117.8	4.9	4.1	3.5	16.8	14.8	1.6	52.5	4.8	18.9	19.0	2.4	11.2	14.4	3.3	31.6	31.3	15.5	1.7	61.1	28.6	17.5	5.1	100.0	25.3	5.6	115.9	43.6	17.8	6.6	27.7	19.0	10.0	16.1	20.5	17.2	91.2	15.0	40.4	11.1	23.0	10.2	31.6	51.0	4.7	16.7	17.6	38.4	8.3	45.4	15.7	56.6	17.9	81.4	41.1	17.6	9.9	99.6	86.4	19.1	42.0	33.7	15.9	21.2	15.4	99.9	32.0	155.2	15.5	10.7	84.5	128.9	15.0	16.0	8.9	25.6	44.1	75.8	44.5	54.8	5.1	7.8	56.6	10.9	5.5	32.1	9.4	111.4	8.1	20.2	7.8	14.1	17.9	76.0	90.0	103.3	23.3	104.8	11.9	491.9	96.1	305.0	111.0	105.1	217.3	267.2	221.9	164.7	133.6	243.5	260.8	169.7	54.6	111.4	86.7	63.8	188.4	213.0	4.2	4.1	8.9	7.0	3.9	4.0	4.9	4.1	4.8	1.7	5.1	6.6	8.9	9.6	18.7	1.6	174.9	160.5	80.9	81.9	123.5	0.2	14.4	10.8	10.3	12.8	38.3	18.4	0.0	142.6	83.6	2.7	17.6	55.4	4.4	11.8	7.8	23.2	1.2	34.5	0.8	101.0	158.8	30.1	17.9	9.5	211.8	0.7	6.4	1.9	48.9	0.0	2.3	9.9	20.3	59.4	323.4	1.4	2.1	126.0	37.4	24.4	196.6	4.3	111.2	1.0	6.8	125.7	2.7	1.9	45.6	63.9	0.9	19.8	47.2	0.4	46.0	4.0	32.9	1.1	18.0	93.1	119.2	292.7	139.0	35.2	4.3	103.6
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 86.9;smooth muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 10.3;Inhibitory neurons: 14.4;Langerhans cells: 10.8;Smooth muscle cells: 9.3;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;ASC TERT1: 87.8;HUVEC TERT2: 78.7;LHCN-M2: 74.5;TIME: 105.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (3.51e-4)"	9.4	3.8	9.2	7.1	8.3	0.8	5.7	3.5	8.2	13.7	4.3	8.6	1.6	86.9	6.0	20.4	45.6	6.2	6.3	15.3	6.6	2.7	2.4	15.5	3.9	5.5	8.5	15.9	2.4	0.8	3.0	2.0	4.8	6.8	8.6	0.3	3.9	5.4	4.7	23.1	7.9	84.8	4.3	19.9	5.8	4.4	6.6	0.9	5.4	3.5	3.2	18.6	15.1	5.6	0.1	0.4	0.1	0.2	35.0	87.8	0.4	0.3	0.1	1.0	1.6	0.1	1.0	0.1	1.5	5.0	11.2	0.1	1.2	0.8	0.4	0.1	0.7	0.0	2.4	5.9	9.1	0.3	1.9	32.5	7.1	6.7	26.8	5.8	78.7	0.1	0.1	0.1	74.5	0.9	0.0	0.6	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.1	0.1	0.1	0.9	0.5	0.6	105.5	8.0	0.5	26.5	2.3	0.4	0.0	0.1	16.7	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.6	0.3	0.2	0.2	0.0	0.0	9.2	8.3	3.5	8.2	15.3	6.6	5.5	8.5	4.8	4.3	6.6	5.6	1.2	0.0	0.5	4.6	0.0	3.3	1.1	0.4	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.3	2.3	1.7	3.9	10.3	0.0	4.5	0.4	0.0	5.8	0.0	0.1	0.0	7.1	1.8	0.3	2.9	0.0	14.4	3.3	2.0	2.9	10.8	0.7	9.0	3.5	1.8	1.0	0.6	0.1	0.0	1.0	2.6	0.1	1.5	5.3	0.1	0.4	0.0	0.1	1.3	0.2	6.6	1.6	9.3	23.7	0.8	0.3	8.4	0.0	0.1	0.1	1.5	0.5
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 55.3;skin 1: 107.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.2;Microglial cells: 71.2;Respiratory ciliated cells: 62.4;Suprabasal keratinocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.5;BJ hTERT+: 73.2;fHDF/TERT166: 55.9;Hep G2: 83.0;SK-MEL-30: 128.4;WM-115: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 28: Keratinocytes - Keratinization"	Mitochondria	Nucleoplasm	"HPA010135: AB_1079797"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.8	2.9	1.8	0.9	1.7	1.7	9.9	1.8	1.9	7.0	4.2	2.4	1.8	8.6	13.4	9.4	30.5	3.4	22.1	2.0	2.5	15.7	1.1	17.2	0.7	3.3	3.2	2.7	2.8	0.9	8.5	8.4	2.6	27.4	1.9	4.7	55.3	7.6	2.4	107.5	1.3	3.0	3.1	5.1	5.4	2.2	2.7	6.7	3.4	2.1	1.8	4.5	4.8	2.5	0.1	3.3	3.2	0.0	4.7	46.5	3.5	3.7	73.2	2.0	2.8	23.6	0.1	0.0	0.0	55.9	0.5	0.1	3.3	2.9	3.6	0.0	2.9	0.6	2.4	83.0	2.2	0.2	0.9	22.5	0.7	23.1	0.3	1.5	0.1	0.0	0.1	0.0	13.2	1.1	0.0	0.1	2.3	29.7	5.1	0.0	13.6	0.0	8.4	0.4	30.9	4.9	0.1	0.0	128.4	3.4	0.0	0.3	0.0	11.5	0.5	0.1	3.5	0.0	0.1	0.0	4.5	0.1	76.2	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	1.8	1.7	1.8	1.9	2.0	2.5	3.3	3.2	2.6	3.1	2.7	2.5	3.1	0.0	20.8	1.0	0.2	62.2	3.0	2.0	23.9	0.8	6.3	2.9	23.4	2.8	9.3	9.2	8.4	0.1	0.3	0.1	0.0	11.1	1.7	10.4	4.4	5.1	0.0	0.0	6.9	1.0	0.0	14.4	2.6	3.9	1.3	0.5	0.0	0.5	0.1	0.0	6.7	0.0	6.1	0.0	8.5	1.0	11.5	0.2	14.2	71.2	0.0	3.3	0.0	12.5	1.1	11.3	0.0	13.9	0.0	13.3	0.0	20.9	62.4	3.3	0.0	3.2	4.9	1.5	2.3	8.3	80.3	0.0	0.6	3.5	0.0	0.6
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Host-virus interaction, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 148.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 179.9;Prostatic glandular cells: 180.8;Syncytiotrophoblasts: 178.7;Urothelial cells: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	35	"plasmacytoid DC: 69.2"	"Lineage enriched"	"Detected in single"	303	"dendritic cells: 69.2"	"Cell line enhanced"	"Detected in many"		"OE19: 208.0;RT4: 523.8;SuSa: 213.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	55.7	6.6	17.6	17.7	31.0	13.4	13.4	48.9	31.4	17.5	1.1	38.1	12.3	17.1	2.5	41.3	16.4	35.7	9.8	21.8	27.4	49.6	8.9	16.9	17.2	76.8	43.8	6.5	20.0	58.8	6.5	33.2	56.9	13.7	34.8	4.1	25.6	4.0	6.0	4.0	19.2	15.7	43.7	14.9	60.8	8.1	49.0	26.8	4.0	14.1	32.9	148.1	17.1	100.1	156.6	50.0	47.7	15.3	127.4	37.5	53.9	17.9	34.9	5.5	2.1	86.7	107.7	11.6	70.3	13.1	101.8	92.2	7.2	66.1	3.1	0.2	15.1	0.1	6.4	88.2	74.6	2.5	0.6	67.1	77.2	3.3	58.1	4.2	25.8	10.1	3.8	0.1	1.9	30.8	13.9	1.4	37.5	208.0	50.8	29.1	14.7	17.1	90.8	523.8	34.1	7.5	15.6	14.4	12.9	213.0	11.1	11.0	5.2	14.1	12.9	0.5	16.5	0.1	0.2	16.1	23.1	11.1	40.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.1	0.1	0.1	69.2	0.0	0.6	17.6	31.0	48.9	31.4	21.8	27.4	76.8	43.8	56.9	43.7	49.0	100.1	5.5	0.0	9.8	1.6	3.1	23.7	179.9	140.5	64.9	1.1	8.0	10.8	10.2	35.8	59.9	1.8	0.0	31.0	77.3	100.7	15.6	86.8	55.0	12.0	17.3	8.6	12.0	3.0	46.6	29.6	21.4	32.9	80.5	13.8	19.7	2.1	1.1	0.3	22.4	0.0	29.6	42.9	107.8	53.6	12.5	40.3	2.8	22.6	12.4	13.1	0.6	5.4	0.0	53.3	44.7	89.1	54.5	1.2	2.0	180.8	14.7	51.3	54.7	1.4	78.9	21.5	24.2	1.0	3.7	40.4	9.9	178.7	2.8	13.1	19.9	387.3
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063303-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.1;Early spermatids: 3.5;Kupffer cells: 5.3;Langerhans cells: 3.3;Late spermatids: 9.8;Macrophages: 5.8;monocytes: 5.1"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Group enriched"	"Detected in many"	4	"intermediate monocyte: 59.4;non-classical monocyte: 96.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 96.6"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 552.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.5"					"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	5.3	0.0	0.1	3.1	2.3	0.6	3.5	0.0	0.6	0.2	0.1	0.4	0.0	0.8	0.0	0.2	0.9	0.6	1.9	0.0	0.2	0.3	0.0	0.9	1.2	0.2	0.1	0.2	0.1	0.0	0.0	0.7	0.2	0.2	0.1	0.0	0.3	0.1	0.9	0.9	0.7	0.5	0.1	1.4	2.5	1.4	0.7	1.0	0.1	1.2	1.1	0.9	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.4	0.0	0.1	0.8	11.7	0.0	0.0	0.0	0.0	0.0	0.1	552.9	0.1	0.0	0.1	0.0	0.0	10.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	26.3	1.5	0.0	0.0	1.5	0.2	21.7	0.0	0.4	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.1	0.0	1.4	1.4	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	17.6	1.0	0.1	59.4	0.3	0.1	0.1	0.0	8.7	0.0	0.0	0.0	18.3	0.0	96.6	2.3	0.8	8.5	0.1	2.3	0.0	0.6	0.0	0.2	0.2	0.1	0.2	0.1	0.7	0.2	7.1	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.1	0.5	2.2	0.0	0.0	0.6	0.0	0.2	1.1	2.6	0.1	0.0	0.1	2.2	0.1	1.5	0.0	0.5	0.0	0.0	5.3	3.3	9.8	0.3	5.8	0.0	1.0	5.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.3	1.0	0.0	0.1	0.3	0.4	0.2	0.0	0.1
TNFSF12	"APO3L, DR3LG, TWEAK"	ENSG00000239697	"TNF superfamily member 12"	O43508	17	7549058-7557890	"Predicted secreted proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Cytokine, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.7;BJ hTERT+: 18.4;HDLM-2: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	853000	130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA035984: , HPA052967: AB_2682000"	"unprognostic (2.96e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.71e-2)"	"prognostic favorable (5.70e-5)"	"unprognostic (5.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.09e-2)"	"unprognostic (6.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.38e-1)"	41.6	28.5	57.4	9.8	55.3	3.1	36.6	49.4	66.5	37.6	48.9	68.2	9.7	38.2	7.0	13.9	37.7	15.6	39.6	54.8	50.4	32.9	16.5	37.7	15.8	55.7	54.2	42.7	23.2	11.1	18.0	11.2	53.2	39.4	5.7	2.9	26.1	27.2	16.9	15.8	26.7	13.3	52.8	38.4	38.8	5.6	57.0	4.8	22.9	9.3	5.5	47.1	30.1	52.1	0.0	0.5	0.7	0.0	14.9	17.7	4.0	6.9	18.4	7.7	5.7	0.1	2.5	0.0	5.8	16.3	0.8	1.4	1.4	0.6	1.6	20.3	2.0	0.9	0.4	2.3	12.8	0.0	0.0	15.0	2.6	2.8	0.3	3.0	12.1	0.0	0.0	0.0	7.0	0.0	0.0	0.5	0.6	0.1	7.5	0.1	0.0	0.1	11.6	0.0	0.0	7.9	2.5	0.0	12.6	0.1	1.4	0.6	16.1	15.1	1.1	0.1	8.8	0.0	0.0	0.0	2.4	0.0	10.5	2.6	3.5	11.6	5.1	5.9	6.0	2.9	4.3	3.1	2.2	1.8	4.1	4.2	2.0	2.8	1.5	2.5	4.0	1.1	57.4	55.3	49.4	66.5	54.8	50.4	55.7	54.2	53.2	52.8	57.0	52.1	115.9	9.6	12.2	0.0	20.4	6.1	11.1	1.5	6.8	6.7	21.7	41.7	4.3	17.2	3.4	16.5	0.0	1.6	38.3	2.5	7.9	15.2	0.4	4.1	15.2	33.9	1.2	3.2	0.0	12.1	0.8	42.7	4.6	8.5	34.3	6.8	48.5	3.4	44.3	20.2	0.0	3.4	0.0	59.7	26.8	1.2	50.7	62.1	19.6	0.0	28.6	46.6	40.2	0.0	0.0	8.1	1.7	50.4	3.6	6.7	0.4	39.6	0.6	2.6	59.2	34.4	56.7	0.2	1.1	2.1	7.5	0.8	38.7	9.4	4.1	6.0
TNFSF12-TNFSF13	TWE-PRIL	ENSG00000248871	"TNFSF12-TNFSF13 readthrough"		17	7549099-7561601	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 9.1;choroid plexus: 5.7"	"Group enriched"	"Detected in some"	17	"Alveolar cells type 2: 3.7;Club cells: 3.7;granulocytes: 3.8;Macrophages: 4.5;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;fHDF/TERT166: 1.3;HUVEC TERT2: 1.1;U-138 MG: 1.7;U-251 MG: 1.7"	"Low region specificity"	"Detected in all"							"HPA004863, HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA004863: AB_1078187, HPA035984: , HPA052967: AB_2682000"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.23e-2)"	4.0	1.3	4.7	0.7	4.7	0.7	1.8	4.5	9.1	0.7	5.7	1.4	0.2	0.4	0.0	0.3	0.4	0.1	2.3	4.5	5.0	2.3	0.7	4.6	1.0	5.1	5.1	0.4	0.5	0.1	0.4	0.2	4.7	0.7	0.0	0.1	0.6	0.2	0.7	0.8	0.8	0.3	4.6	3.1	0.7	0.1	5.0	0.2	0.4	0.0	0.5	1.1	0.3	4.8	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.5	1.7	0.6	0.9	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.1	0.0	0.5	0.0	0.0	0.0	0.5	1.7	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.2	0.4	2.4	7.2	0.2	4.5	0.3	0.7	0.5	0.3	1.8	1.5	0.3	0.1	0.3	0.2	0.2	0.9	1.0	1.4	4.7	4.7	4.5	9.1	4.5	5.0	5.1	5.1	4.7	4.6	5.0	4.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756342	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	30.0	19.9	15.8	16.5	16.6	23.9	26.3	16.3	18.5	20.9	15.7	32.1	17.7	20.2	6.4	27.2	18.1	10.6	31.4	14.8	15.9	37.1	30.1	29.9	17.6	18.0	16.9	18.8	22.8	5.5	19.7	15.7	17.0	24.5	10.5	2.6	19.2	9.2	41.5	19.6	39.4	9.9	16.9	31.2	27.8	22.9	17.3	10.8	22.3	13.6	15.9	30.2	20.8	16.3	24.4	32.6	10.1	15.4	31.5	21.6	43.7	25.8	22.9	23.6	22.9	37.2	38.5	22.1	28.7	28.3	52.9	15.8	18.3	29.8	13.8	17.2	23.0	26.4	19.9	41.9	39.0	21.9	32.2	27.9	26.5	26.1	23.5	18.1	33.9	19.8	27.4	30.4	16.5	50.6	29.0	53.6	26.6	35.9	55.0	18.9	15.3	11.6	25.5	26.9	15.1	17.0	20.2	21.0	29.6	17.2	23.0	32.0	40.0	18.2	20.1	29.0	40.4	31.3	22.8	16.0	33.3	39.1	20.2	7.6	8.9	27.1	7.4	13.9	8.1	9.6	11.3	12.5	8.7	14.4	9.2	7.6	8.4	5.7	14.8	4.0	13.3	6.3	15.8	16.6	16.3	18.5	14.8	15.9	18.0	16.9	17.0	16.9	17.3	16.3	48.2	6.4	9.8	3.6	40.7	61.3	49.3	42.5	19.4	2.0	25.3	17.8	13.2	7.2	19.0	14.7	2.1	52.4	44.6	56.0	13.7	58.2	2.3	26.0	26.4	46.7	19.2	8.2	1.1	59.6	106.1	28.4	28.5	33.3	13.3	21.4	41.0	16.7	34.5	0.0	0.7	38.0	24.4	21.2	112.7	7.5	21.5	34.6	26.6	3.7	71.8	12.4	48.4	0.5	3.4	71.8	63.0	17.7	21.2	86.6	174.3	46.8	13.0	6.8	19.7	18.7	38.0	23.6	62.4	28.1	79.0	95.6	44.9	17.1	38.0	84.7
TNKS1BP1	"FLJ45975, KIAA1741, TAB182"	ENSG00000149115	"Tankyrase 1 binding protein 1"	Q9C0C2	11	57299638-57324952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037929, HPA037930"	Enhanced		Uncertain	"Plasma membrane"		NA	NA		180000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"HPA037929: AB_10672613, HPA037930: AB_2675745"	"unprognostic (7.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-1)"	"unprognostic (9.17e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (2.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.07e-1)"	62.7	27.3	11.8	17.3	10.2	3.3	41.9	4.6	9.4	43.3	18.0	23.6	28.8	40.3	30.3	55.4	35.3	28.1	23.3	11.3	9.2	14.7	31.6	40.3	6.6	9.6	8.8	32.2	30.9	18.9	17.1	29.5	7.2	33.6	16.2	3.3	44.2	40.2	67.2	83.0	26.6	29.4	4.9	18.1	52.8	10.1	11.0	22.3	25.0	29.9	14.3	38.5	45.6	6.7	89.5	58.7	41.2	33.6	127.8	97.1	31.0	61.5	113.8	46.3	42.5	26.1	59.5	2.0	38.5	101.2	49.6	151.7	31.4	105.3	30.1	34.2	10.4	11.5	38.2	12.2	86.6	14.4	4.3	96.8	123.5	70.9	54.6	57.5	60.0	12.4	13.2	9.3	65.3	45.4	11.0	14.7	45.8	46.5	45.9	16.9	57.2	25.9	53.5	116.6	14.6	22.6	81.5	121.5	44.3	29.0	182.2	11.9	115.1	47.3	45.8	56.6	35.2	15.0	4.1	11.3	107.0	4.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.8	10.2	4.6	9.4	11.3	9.2	9.6	8.8	7.2	4.9	11.0	6.7	38.1	12.8	35.4	12.7	1.9	83.6	28.0	61.9	40.9	4.8	24.8	23.9	7.9	38.6	39.0	44.1	2.1	16.8	1.3	27.3	0.0	31.8	1.8	18.5	25.4	25.9	18.0	7.4	7.2	22.3	3.2	31.2	49.5	38.4	2.5	3.7	19.6	46.0	3.9	8.4	4.8	25.8	18.3	1.5	25.4	2.9	48.1	3.8	17.8	1.9	0.7	4.0	0.0	4.5	2.4	38.8	14.3	49.2	0.6	41.2	18.2	2.4	15.4	1.3	32.9	41.2	26.9	1.5	3.0	68.9	88.2	24.5	2.3	23.4	14.5	36.8
TNNC2	"CFAP85, FAP85"	ENSG00000101470	"Troponin C2, fast skeletal type"	P02585	20	45823214-45833745	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	109	"skeletal muscle: 30416.4;tongue: 8088.6"	"Group enriched"	"Detected in many"	4	"Proximal enterocytes: 338.7;Skeletal myocytes: 1165.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.2;head and neck cancer: 22.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Hep G2: 10.0;HSkMC: 14.8;SCLC-21H: 11.3"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 6.1"	"Low region specificity"	"Detected in some"			"HPA043174, HPA058481"	Enhanced		Approved	Nucleoplasm,Vesicles		No	NA		560000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA043174: AB_10806380, HPA058481: AB_2683729"	"unprognostic (1.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.12e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.03e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.13e-1)"	6.6	5.5	4.8	0.4	5.7	1.1	8.3	5.2	6.9	2.2	4.4	5.3	2.5	4.2	1.0	128.5	3.0	2.2	4.0	4.8	4.5	1.7	2.5	3.2	0.5	4.4	4.5	6.5	2.2	1.2	3.1	0.2	4.5	44.3	2.2	1.3	176.3	1.3	30416.4	10.1	7.8	1.0	4.1	1.8	2.4	4.6	4.8	6.7	5.1	8088.6	0.7	2.5	3.0	5.5	0.1	0.0	0.2	0.4	1.6	1.0	1.7	0.1	0.4	0.0	0.1	0.2	1.1	0.4	1.1	1.0	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.0	1.0	10.0	0.4	0.3	0.2	14.8	0.2	0.1	0.7	0.3	0.0	1.2	0.1	0.5	0.2	1.2	0.7	0.1	0.0	0.4	0.6	0.3	0.6	0.2	0.4	0.1	11.3	0.5	1.6	0.1	0.4	0.5	1.3	0.4	0.5	0.2	0.3	0.9	0.2	1.5	0.4	0.2	1.4	0.1	0.2	0.0	0.6	1.3	0.1	1.1	0.6	5.3	1.3	0.2	0.3	4.6	0.0	0.3	2.0	0.3	0.8	0.8	3.9	8.7	4.8	5.7	5.2	6.9	4.8	4.5	4.4	4.5	4.5	4.1	4.8	5.5	0.9	3.2	0.6	0.3	3.1	0.8	0.5	2.0	0.0	4.2	3.1	1.7	0.5	2.8	3.6	3.7	0.0	2.4	0.5	171.7	3.9	1.5	6.9	37.1	1.0	3.8	22.9	0.0	1.9	5.1	0.4	7.2	0.5	2.3	0.0	13.9	0.0	1.1	0.3	0.0	0.7	108.2	14.2	0.3	1.1	47.0	1.2	22.4	0.0	0.0	2.1	1.4	1.0	0.0	0.6	3.3	92.9	3.0	0.5	0.7	338.7	1.0	4.3	2.4	0.0	1165.3	9.5	2.5	5.5	0.1	8.4	0.1	4.7	7.2	37.0	0.7
TNNI2	"AMCD2B, DA2B, FSSV"	ENSG00000130598	"Troponin I2, fast skeletal type"	P48788	11	1838981-1841680	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	25	"skeletal muscle: 7969.8;tongue: 2622.3"	"Group enriched"	"Detected in many"	6	"Extravillous trophoblasts: 449.4;Skeletal myocytes: 598.7"	"Group enriched"	"Detected in many"	10	"cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 86.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 35.7;hTCEpi: 101.2"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 5.1"	"Not detected"	"Not detected"			"CAB018697, HPA055938"	Enhanced		Approved	"Plasma membrane,Intermediate filaments"		NA	NA		110000	"Cluster 52: Eosinophils - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Intermediate filaments"	"CAB018697: AB_628400, HPA055938: AB_2682976"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-2)"	3.0	1.8	0.3	1.1	0.3	6.1	7.9	0.3	0.6	1.0	0.4	1.2	0.3	0.8	0.3	66.9	0.9	5.6	1.7	0.3	0.4	0.7	1.6	7.8	1.6	0.4	0.4	0.7	8.8	0.0	0.9	3.0	0.4	14.0	0.2	0.0	216.1	3.2	7969.8	55.2	2.7	0.2	0.4	5.8	1.1	0.7	0.5	1.9	2.8	2622.3	1.0	27.4	3.2	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	35.7	1.0	0.2	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.1	8.1	101.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	3.1	0.0	0.1	1.2	2.4	0.0	1.0	0.0	1.0	0.0	0.7	0.0	0.0	12.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	13.8	5.8	53.3	0.1	12.5	0.1	3.8	0.0	0.0	8.0	4.8	0.0	0.0	39.7	0.4	17.6	86.4	0.0	2.5	0.3	0.3	0.3	0.6	0.3	0.4	0.4	0.4	0.4	0.4	0.5	0.6	1.2	3.2	4.4	0.0	9.1	25.1	2.6	1.8	15.4	0.0	0.5	23.7	5.6	21.5	3.0	0.0	0.0	33.8	15.7	0.1	0.0	1.4	0.0	1.4	0.2	2.0	0.0	0.0	0.0	0.6	449.4	2.4	1.1	0.1	10.8	0.4	0.4	0.3	39.6	0.0	0.0	0.0	2.0	18.8	10.7	0.0	0.3	25.9	0.0	0.0	16.0	0.0	1.0	0.0	0.0	1.4	0.0	0.0	4.2	0.1	0.0	0.2	13.2	0.0	0.0	598.7	2.4	0.0	0.6	2.7	6.5	87.2	1.9	4.3	0.0	0.9
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377764	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	205	"heart muscle: 10670.6"	"Cell type enriched"	"Detected in many"	32	"Cardiomyocytes: 12561.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"RH-30: 1077.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.8"	"CAB015371, HPA015774, HPA017888"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules"		No	No		57000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli"	"Focal adhesion sites, Microtubules"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	2.2	4.9	12.4	0.6	13.9	0.1	11.9	11.7	20.4	2.3	11.7	1.3	0.3	3.2	0.8	7.8	1.9	3.8	10670.6	16.8	11.6	51.9	2.3	22.0	2.7	11.6	11.6	1.3	5.0	0.0	4.5	10.3	11.6	6.1	0.1	0.4	3.6	0.7	16.5	21.7	1.6	0.1	11.6	0.7	2.0	1.7	11.6	2.1	2.0	9.4	0.5	19.3	5.0	15.8	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.5	0.0	0.0	6.7	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.0	44.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	1.1	0.0	0.0	2.2	3.3	0.0	0.0	1077.7	0.0	0.7	0.4	1.1	0.8	0.1	2.0	0.0	61.2	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	13.9	11.7	20.4	16.8	11.6	11.6	11.6	11.6	11.6	11.6	15.8	0.6	3.2	3.0	0.3	0.0	3.4	1.4	1.7	1.8	3.9	0.9	1.7	12561.8	0.0	1.1	1.8	0.0	3.5	0.0	2.3	0.0	0.4	11.6	1.2	0.2	93.3	0.0	0.0	9.4	0.4	1.2	385.3	1.1	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.5	1.7	0.0	0.0	0.8	19.3	0.6	0.3	0.0	1.9	2.6	0.0	0.0	0.5	0.7	1.2	1.4	1.2	0.0	2.1	0.8	0.9	0.7	0.6	0.0	8.7	145.8	0.5	0.2	2.5	7.2	4.2	0.1	0.8	3.2	1.5
TNPO2	"FLJ12155, IPO3, KPNB2B, TRN2"	ENSG00000105576	"Transportin 2"	O14787	19	12699194-12724011	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046446, HPA071498"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"CAB046446: AB_10603392, HPA071498: AB_2686405"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (2.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.76e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-3)"	"unprognostic (7.63e-2)"	28.3	33.0	50.3	21.7	54.4	26.8	24.8	36.7	57.3	30.9	28.2	28.4	17.3	33.3	25.5	31.3	30.3	20.5	26.6	54.6	44.1	22.5	18.4	23.0	23.4	51.3	45.4	40.3	20.6	32.3	33.6	20.9	50.9	26.6	19.8	33.0	22.2	23.9	25.7	48.1	23.4	28.1	39.5	26.3	23.5	32.7	51.5	27.8	26.8	20.1	23.9	28.6	27.6	51.2	54.4	40.5	61.0	78.3	36.3	47.6	39.5	61.0	40.1	86.5	60.6	55.9	28.5	36.6	46.5	51.7	24.1	70.5	109.2	60.3	47.9	45.6	87.6	56.5	72.1	68.4	40.9	100.6	52.0	42.9	46.8	57.5	60.4	55.8	41.0	72.7	89.4	33.9	48.5	93.4	84.8	68.8	71.0	39.8	120.8	80.7	47.6	67.0	51.2	38.9	148.6	73.8	49.6	62.2	30.7	41.2	43.5	35.2	41.5	131.5	34.9	71.3	91.2	66.8	70.4	62.3	39.2	89.9	47.9	0.2	0.2	0.1	0.6	0.3	0.9	0.4	0.4	0.5	0.4	0.4	0.8	1.0	0.8	0.1	0.4	1.5	0.2	0.2	50.3	54.4	36.7	57.3	54.6	44.1	51.3	45.4	50.9	39.5	51.5	51.2	13.2	6.4	17.9	24.2	10.7	31.0	8.9	10.6	14.8	42.4	22.8	17.1	17.6	11.5	10.0	22.0	100.1	10.9	11.0	14.1	5.9	9.7	12.2	16.2	20.6	17.0	22.9	14.9	22.3	8.5	6.6	18.0	10.2	12.9	3.8	20.7	19.2	17.8	10.5	57.2	26.6	17.7	8.2	13.0	14.9	19.5	31.1	8.7	8.8	22.5	11.1	24.6	6.2	19.6	24.7	15.2	9.1	32.4	8.7	19.3	11.9	16.7	11.3	33.6	6.6	23.8	15.3	23.8	11.3	21.9	41.5	14.5	9.5	16.5	16.6	9.3
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29052230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 34.9;choroid plexus: 25.2;fallopian tube: 20.1"	"Group enriched"	"Detected in some"	4	"dendritic cells: 20.1;Endometrial ciliated cells: 65.4;Respiratory ciliated cells: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;JURKAT: 1.2;NB-4: 1.3"	"Low region specificity"	"Detected in many"							"HPA037561, HPA037562, HPA075216"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Plasma membrane"		"HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: "	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.1	1.2	4.5	0.6	11.5	1.9	0.2	10.6	2.3	0.5	25.2	0.3	0.5	0.6	0.1	0.4	20.1	0.3	2.8	4.5	7.6	0.1	0.2	2.8	0.8	19.2	34.9	0.5	0.3	0.0	1.1	0.3	17.3	0.2	0.2	0.2	0.2	0.1	1.2	0.3	0.4	0.5	12.5	2.0	1.0	1.3	10.6	0.2	0.1	3.0	0.7	0.2	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.0	0.6	0.1	0.2	0.6	2.3	0.1	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.3	0.3	0.0	0.3	1.3	1.0	0.4	0.1	0.0	0.3	0.6	0.3	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.6	0.5	4.5	11.5	10.6	2.3	4.5	7.6	19.2	34.9	17.3	12.5	10.6	5.3	0.3	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	65.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.2	30.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	3.6	0.5	0.0	0.0
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028822-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 801.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes		7600	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	37.9	36.7	17.4	49.9	18.6	74.9	27.9	21.8	25.1	26.9	25.3	36.9	42.6	27.9	34.4	36.7	22.4	37.2	19.1	18.0	18.9	39.0	47.5	40.0	59.9	18.5	18.4	24.3	28.6	26.7	22.4	50.2	18.1	31.8	37.3	25.5	26.7	24.2	21.3	26.5	42.6	23.9	18.7	38.5	36.5	18.9	18.8	58.9	37.6	20.2	60.6	42.7	28.8	19.2	105.2	71.7	131.4	108.2	52.2	61.8	129.8	92.6	81.0	105.0	94.8	190.5	127.6	296.4	96.4	48.5	112.3	98.9	159.1	147.2	153.0	64.9	81.6	378.6	54.9	139.0	135.4	165.1	124.0	69.8	76.4	102.4	166.8	94.0	111.5	98.1	167.8	98.7	120.9	233.2	235.3	119.7	106.3	104.1	131.6	197.7	123.1	157.7	121.4	95.2	108.6	75.4	145.4	88.3	95.0	94.2	98.6	146.4	109.9	84.7	71.3	78.8	100.9	62.7	75.6	338.3	113.7	91.1	82.0	12.6	9.9	16.8	6.6	10.3	8.3	10.5	7.3	7.0	9.5	10.1	7.7	6.9	19.1	6.3	13.2	18.8	9.0	5.4	17.4	18.6	21.8	25.1	18.0	18.9	18.5	18.4	18.1	18.7	18.8	19.2	116.9	118.6	201.5	66.0	117.6	245.9	338.0	90.3	153.7	98.2	90.5	75.7	49.7	78.6	170.3	99.3	60.5	192.1	137.1	194.1	74.3	94.4	10.0	151.3	167.4	115.1	91.8	486.5	86.9	65.8	175.4	121.4	84.1	259.2	78.6	119.1	67.1	131.7	99.2	72.3	77.4	126.9	69.2	101.2	109.1	12.8	59.7	151.6	72.9	74.9	95.4	88.0	78.2	87.4	90.7	119.2	169.8	69.6	234.1	162.3	94.1	136.2	68.3	87.0	85.5	135.5	130.8	116.8	54.6	129.4	214.2	801.5	111.5	123.7	117.8	237.7
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388525-40417896	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 127.8;testis: 65.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 4.2;white matter: 8.0"	"Low region specificity"	"Detected in some"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.2	2.5	0.2	20.0	0.2	42.0	5.4	0.1	0.7	5.0	1.1	17.8	18.1	3.9	0.3	29.0	1.5	2.6	1.2	0.2	0.2	1.2	2.8	4.1	40.3	0.2	0.8	1.0	0.9	0.3	0.3	15.9	0.5	1.4	19.8	0.1	4.3	0.5	0.3	15.3	17.0	7.6	0.2	9.9	8.9	65.7	1.1	127.8	1.9	0.2	42.5	6.0	9.6	0.4	212.6	275.6	343.1	158.0	16.8	33.9	76.3	283.3	151.5	255.0	224.2	130.5	157.6	339.4	140.1	96.7	152.7	326.5	266.8	113.5	339.5	182.7	177.8	224.8	167.9	216.7	1.6	318.4	228.6	7.4	9.2	179.8	181.4	55.1	136.3	216.5	247.5	225.8	279.2	72.6	372.3	209.6	143.0	152.4	108.3	310.7	531.9	141.3	61.6	133.3	201.6	144.6	229.3	281.4	89.4	198.2	236.9	143.2	90.3	167.0	233.2	195.5	276.7	128.4	154.9	290.7	94.3	214.9	285.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.1	0.1	0.0	0.0	0.1	1.4	0.1	0.0	2.4	0.4	0.2	0.2	0.1	0.7	0.2	0.2	0.2	0.8	0.5	0.2	1.1	0.4	1.0	0.0	2.0	0.3	17.4	11.7	3.7	15.0	2.2	0.0	18.7	17.1	1.3	2.8	5.8	0.0	0.0	72.9	6.1	19.8	0.0	0.8	20.3	12.7	15.8	9.3	0.0	216.8	0.2	0.0	92.4	23.3	23.0	10.0	0.0	117.5	20.7	5.4	83.5	0.0	0.1	34.2	18.3	33.9	13.2	19.1	4.7	14.1	1.8	0.0	2.6	0.0	3.1	0.0	0.1	0.3	3.5	1.9	31.3	3.1	3.4	0.1	1.8	0.0	72.3	0.5	19.5	621.2	269.6	45.1	6.1	8.9	14.8	4.3	61.0	6.9
TOPBP1	"Dpb11, KIAA0259, TOP2BP1"	ENSG00000163781	"DNA topoisomerase II binding protein 1"	Q92547	3	133598175-133662380	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 104.1;Spermatocytes: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022451, HPA036738, HPA036739"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281"	"unprognostic (7.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.05e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (8.03e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (2.74e-3)"	"unprognostic (8.65e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.60e-1)"	7.7	4.9	3.6	13.0	4.3	33.1	10.7	5.0	4.6	6.5	3.1	9.3	8.3	8.1	5.0	8.9	5.9	6.9	6.1	4.6	3.3	5.5	7.4	7.3	19.7	3.7	3.2	7.3	7.6	6.0	3.6	12.0	3.7	6.6	11.5	8.2	7.1	5.5	6.9	11.8	9.2	8.7	3.5	10.4	8.7	22.4	3.7	29.1	7.4	7.6	18.6	8.3	7.0	4.5	44.4	27.2	43.1	35.1	8.0	10.5	32.3	33.9	26.9	41.0	52.4	37.9	27.5	80.5	29.1	24.7	49.3	50.2	62.8	22.6	62.7	48.9	28.2	75.4	38.3	23.4	7.7	81.5	57.1	12.5	13.7	40.2	23.9	15.4	28.5	46.3	47.6	55.7	32.6	30.3	79.9	43.1	35.7	50.4	23.0	53.3	53.8	58.4	14.6	30.1	40.9	45.2	41.9	22.6	35.4	41.7	37.7	74.6	19.9	43.0	38.9	43.9	37.7	33.4	53.4	150.6	25.4	42.7	38.4	1.8	0.7	2.2	0.7	0.9	1.0	0.9	0.7	0.7	0.7	0.5	0.7	0.7	0.9	1.0	0.5	1.0	1.5	0.4	3.6	4.3	5.0	4.6	4.6	3.3	3.7	3.2	3.7	3.5	3.7	4.5	17.1	22.4	21.9	10.7	22.8	12.4	8.8	7.8	20.5	15.2	14.2	14.2	10.1	12.8	19.7	11.0	2.1	20.0	33.9	11.9	9.8	12.3	69.4	8.8	16.8	16.0	7.2	42.7	24.3	13.3	19.6	14.9	16.3	13.1	7.6	34.3	7.5	9.5	11.2	3.3	19.6	13.9	6.1	16.7	8.0	104.1	10.2	18.2	8.8	11.2	27.4	10.4	28.8	16.6	13.0	14.7	11.6	9.8	37.5	10.2	6.1	6.1	8.7	9.3	13.1	20.9	12.2	81.3	43.6	22.0	11.5	14.0	23.3	17.7	14.8	10.5
TOR1AIP1	"FLJ13142, LAP1, LAP1B, LAP1C"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179920077	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 275.9;Late spermatids: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546, HPA070991"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: "	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	39.7	34.8	20.4	27.2	23.6	84.5	33.9	22.4	25.0	42.6	29.0	46.5	15.9	40.5	35.9	40.6	31.6	34.3	38.5	18.1	21.4	36.5	38.4	35.5	34.2	23.6	23.3	54.5	27.9	36.9	20.1	28.5	22.0	43.8	22.8	25.1	31.5	43.2	54.1	20.1	23.6	41.0	21.2	35.0	31.3	27.0	21.5	27.5	46.8	74.8	27.6	40.4	26.4	24.5	37.1	36.4	24.9	32.3	109.7	73.6	47.7	48.2	57.7	44.5	45.6	28.5	68.5	9.7	52.1	50.2	31.8	63.5	23.6	39.6	52.8	62.9	23.2	26.4	31.5	28.5	50.4	90.8	78.4	57.8	29.8	55.3	51.3	50.1	40.9	39.5	39.2	47.6	47.9	33.1	37.4	28.5	35.5	47.9	13.9	22.8	38.9	25.5	43.7	71.3	20.9	29.2	60.7	57.9	83.6	36.6	44.3	91.9	41.9	60.7	26.5	42.0	58.8	53.4	75.3	19.5	23.6	49.3	95.1	177.7	86.0	205.3	76.4	94.8	89.6	54.9	68.9	76.8	90.8	66.7	71.0	73.1	132.8	74.6	127.5	65.1	81.9	115.5	20.4	23.6	22.4	25.0	18.1	21.4	23.6	23.3	22.0	21.2	21.5	24.5	42.4	32.1	36.1	21.2	33.9	43.3	64.4	21.3	48.3	11.8	27.5	17.8	30.2	18.6	24.2	20.2	16.7	16.2	44.1	13.1	13.7	20.5	275.9	25.9	30.9	33.6	20.3	25.2	13.6	25.2	26.0	51.7	23.4	48.4	36.1	19.8	36.8	27.4	27.6	6.7	16.9	10.6	20.3	48.5	26.1	190.0	47.5	40.4	14.2	21.5	36.6	40.5	35.0	15.6	26.9	29.0	12.5	58.6	32.8	48.4	11.1	19.2	29.2	13.6	26.3	72.5	38.0	14.0	20.4	38.1	37.5	18.2	47.5	23.6	8.3	54.0
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876, CAB079965"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Mitochondria, Cytosol"	"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, CAB079965: , HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	19.3	13.8	10.4	27.1	12.6	19.6	22.5	10.4	16.5	19.9	10.3	29.0	18.9	24.5	12.8	28.8	31.3	13.2	11.1	10.1	11.4	14.9	16.5	15.1	34.6	18.7	13.6	27.3	18.3	9.4	7.3	23.5	12.5	17.7	27.5	4.1	18.9	15.3	12.3	37.4	20.4	24.6	12.6	31.1	22.6	10.4	12.3	47.2	17.4	6.1	45.4	20.8	19.9	13.3	81.5	145.3	81.1	57.3	37.3	43.9	82.8	28.4	66.1	78.5	100.2	4.2	40.6	190.5	126.9	58.7	77.6	174.9	119.7	80.4	72.8	42.7	76.5	77.6	76.8	70.9	111.5	1.6	37.0	55.7	93.0	38.9	106.5	45.6	79.4	24.7	3.8	6.9	41.5	145.1	130.0	96.3	80.2	10.4	2.4	252.2	56.1	66.2	59.4	87.3	46.0	80.5	94.1	62.6	24.3	39.4	109.2	7.4	100.7	91.6	30.2	1.0	48.3	47.6	37.9	82.5	23.6	9.7	80.1	1.2	21.2	3.4	13.0	21.7	15.9	21.5	13.3	14.6	30.3	19.1	13.7	15.4	2.4	17.5	19.3	27.3	17.3	14.7	10.4	12.6	10.4	16.5	10.1	11.4	18.7	13.6	12.5	12.6	12.3	13.3	21.1	9.6	12.8	16.3	26.0	28.7	14.5	24.6	24.5	2.6	36.1	30.4	2.5	18.6	15.4	20.2	0.0	36.9	24.7	16.9	9.8	24.8	12.8	11.5	29.0	24.5	30.7	21.7	2.1	18.1	39.6	17.0	11.2	19.5	1.3	31.7	22.1	18.0	24.2	0.0	3.2	43.0	18.3	27.8	20.1	3.8	23.0	19.3	12.4	7.5	31.9	4.9	25.7	9.0	8.0	15.8	16.4	17.0	7.8	15.7	10.3	10.1	8.8	2.6	13.1	25.9	20.6	0.5	4.9	28.7	32.8	22.4	16.5	27.4	54.1	11.5
TP53BP1	"53BP1, p202, TDRD30"	ENSG00000067369	"Tumor protein p53 binding protein 1"	Q12888	15	43403061-43510728	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004083, HPA008788, HPA022133, CAB079980"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382"	"unprognostic (2.12e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.07e-1)"	"unprognostic (8.06e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.38e-2)"	6.9	11.5	17.4	10.1	16.6	11.5	10.7	19.9	14.5	17.7	21.5	9.7	6.4	16.0	15.9	6.1	14.7	10.7	8.8	15.4	26.3	9.1	4.1	8.3	8.6	13.5	16.7	16.8	7.4	22.3	24.1	12.2	15.7	12.1	10.2	22.0	10.1	12.8	7.2	9.2	6.4	16.3	9.6	8.7	7.6	21.6	23.0	15.3	17.9	11.0	12.6	11.2	8.7	12.1	13.5	22.3	63.8	40.1	25.8	31.9	15.8	22.8	33.8	31.0	39.1	19.4	15.8	14.5	19.2	39.0	66.9	32.4	46.3	27.5	36.8	38.9	15.8	27.1	40.1	11.7	16.8	30.2	37.4	24.9	19.0	41.8	31.2	51.7	37.4	24.2	26.9	12.3	36.5	9.6	23.7	14.1	41.1	24.2	13.9	25.1	23.9	9.3	22.9	31.8	57.3	26.8	33.8	14.3	8.5	48.6	29.9	16.9	27.5	33.7	22.3	27.0	20.5	9.8	22.4	33.0	27.6	14.6	17.5	1.4	0.5	1.0	1.6	0.7	1.3	1.9	1.6	1.6	1.2	1.8	1.8	1.6	0.6	0.9	0.5	1.3	1.4	0.7	17.4	16.6	19.9	14.5	15.4	26.3	13.5	16.7	15.7	9.6	23.0	12.1	11.5	22.4	22.3	53.2	17.8	6.4	10.2	10.0	13.6	32.4	17.4	13.2	14.9	5.7	20.8	29.5	47.9	13.4	11.1	7.4	9.8	14.5	38.8	47.0	44.8	16.8	41.9	8.4	66.2	7.1	11.2	23.9	14.8	26.8	26.6	47.0	15.0	3.3	10.8	47.1	81.9	15.7	12.2	3.8	6.9	17.8	23.6	9.3	1.8	17.8	4.0	11.9	7.2	62.8	50.4	7.5	5.8	17.7	17.1	11.0	2.6	8.8	60.7	51.7	13.1	35.2	20.5	33.1	36.2	14.7	5.3	18.5	17.0	29.9	13.4	8.9
TP53INP1	"DKFZp434M1317, FLJ22139, P53DINP1, SIP, Teap, TP53INP1A, TP53INP1B"	ENSG00000164938	"Tumor protein p53 inducible nuclear protein 1"	Q96A56	8	94925972-94949378	"Predicted intracellular proteins"	"Apoptosis, Autophagy, Transcription, Transcription regulation"	"Activator, Antioxidant"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 101.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 175.6;Plasma cells: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 54.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 79.7;U-266/70: 85.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005856	Uncertain		Supported	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA005856: AB_10600832"	"unprognostic (1.39e-2)"	"unprognostic (4.47e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.31e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (5.45e-5)"	11.2	10.6	6.4	23.1	7.9	42.1	12.7	6.0	7.6	11.8	9.7	16.5	17.2	12.7	12.6	10.9	14.7	10.9	10.9	5.5	6.5	11.5	101.9	25.3	36.0	8.5	6.8	9.0	60.4	10.1	7.1	14.4	7.0	22.5	20.2	17.6	17.9	9.2	9.2	13.1	35.5	12.2	7.0	40.6	25.6	28.6	8.0	29.3	10.2	8.6	41.1	13.3	8.7	8.8	0.5	2.5	24.1	9.3	29.4	27.6	24.8	5.8	13.5	2.6	6.2	2.2	0.6	5.3	12.4	11.2	2.3	4.2	0.0	9.5	5.8	0.3	3.0	3.4	5.3	14.8	19.7	0.0	16.8	45.4	22.2	6.9	2.8	22.4	39.8	2.6	1.8	79.7	12.4	1.7	4.0	1.5	2.3	0.1	0.7	3.4	1.9	29.4	6.3	26.5	3.3	19.5	3.6	2.0	5.2	38.5	11.8	3.3	27.6	4.8	5.8	0.0	0.9	85.4	18.9	2.3	8.4	0.0	0.0	54.6	3.7	11.7	1.4	3.6	1.3	11.5	4.0	2.7	1.4	9.7	0.8	0.6	16.9	5.2	2.3	1.4	6.6	2.5	6.4	7.9	6.0	7.6	5.5	6.5	8.5	6.8	7.0	7.0	8.0	8.8	18.5	35.3	35.7	10.7	70.0	4.6	3.0	17.9	8.0	5.2	27.4	11.6	13.2	75.8	27.9	11.0	27.1	6.1	10.1	27.5	3.9	9.3	17.3	39.9	18.1	14.2	83.9	6.7	0.9	21.3	1.5	11.4	11.2	35.9	4.5	18.8	29.3	175.6	12.5	1.7	2.9	20.9	20.3	44.2	5.6	43.3	7.2	12.6	16.0	16.9	17.7	5.3	3.1	12.1	11.0	18.0	32.2	10.1	233.2	18.1	21.6	9.6	66.4	19.8	6.6	11.0	12.7	18.9	5.6	10.8	6.5	5.7	17.9	26.8	4.8	8.7
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631389-189897276	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.6;skin 1: 137.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	0.5	0.3	0.3	0.6	0.3	0.4	18.0	0.9	0.5	23.5	0.3	0.3	0.1	0.3	10.5	69.6	1.0	0.3	0.6	0.5	0.5	0.3	0.4	1.9	1.0	0.4	0.6	0.1	0.3	0.0	0.5	10.8	0.7	17.4	0.2	0.0	20.8	18.0	42.4	137.3	0.2	0.3	0.2	0.2	0.4	3.4	0.4	23.1	0.3	12.4	17.7	18.6	54.4	0.4	2.3	4.6	0.0	0.1	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.1	0.2	87.1	0.0	167.3	0.0	1.4	0.0	1.9	1.3	0.4	0.0	0.0	0.3	0.2	124.0	0.2	117.3	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.2	0.0	1.0	0.3	0.0	0.2	185.1	0.2	0.1	0.2	0.0	0.0	2.5	0.9	0.2	0.3	0.2	0.1	0.2	0.0	25.3	0.3	1.1	0.5	0.1	0.8	0.6	0.0	0.2	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.9	0.5	0.5	0.5	0.4	0.6	0.7	0.2	0.4	0.4	0.2	0.0	5.3	1.0	0.9	275.4	26.8	61.9	335.2	0.0	0.9	30.1	0.7	0.0	8.5	0.0	0.0	24.9	0.1	0.1	0.0	0.2	1.8	0.0	0.1	1.1	0.0	0.0	1.3	0.2	2.8	1.4	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	4.8	0.0	2.0	0.0	11.9	0.4	0.3	0.7	8.8	14.0	0.6	0.0	0.0	0.5	1.4	1.6	0.0	1.2	1.6	5.6	0.0	0.0	2.8	0.0	0.0	5.3	0.9	0.5	2.4	173.4	283.1	8.9	0.6	0.2	0.0	15.2
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2470.8;tongue: 2005.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		170000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	340.4	588.6	446.2	269.7	480.2	334.8	274.5	476.5	541.9	314.1	446.9	425.6	421.0	240.5	220.2	764.4	248.2	216.8	819.8	481.0	462.0	609.0	536.1	308.6	253.9	459.2	460.4	269.9	238.1	496.4	236.8	287.2	467.2	272.1	435.3	625.0	377.6	273.3	2470.8	410.1	404.5	301.5	429.7	291.4	329.0	239.8	503.5	200.3	269.1	2005.8	410.4	363.8	440.6	454.4	1556.8	1350.5	706.1	1094.6	666.5	696.6	1236.3	1097.5	1184.9	1999.1	2407.5	1409.9	823.0	903.4	212.7	1069.7	1042.4	748.8	1671.0	1812.3	2189.4	1196.4	1265.1	1172.0	924.4	926.2	496.8	1351.5	924.0	764.0	739.7	1537.8	1305.0	2816.1	1233.3	451.0	615.0	336.5	1554.5	1130.0	709.6	1119.5	1741.0	1302.3	855.9	413.5	1156.1	930.7	1261.4	1061.1	497.2	830.0	953.3	977.8	542.7	1452.6	224.4	1003.2	778.2	1068.0	914.6	703.1	1631.7	653.4	285.7	1327.8	2153.1	821.2	784.9	1708.8	2304.1	2375.2	824.6	2402.3	845.7	863.3	820.0	808.0	2656.1	800.9	570.5	703.0	934.3	1387.7	2165.7	482.0	1106.3	4679.5	446.2	480.2	476.5	541.9	481.0	462.0	459.2	460.4	467.2	429.7	503.5	454.4	311.5	134.6	204.2	34.6	290.6	684.8	553.8	1756.4	414.9	284.6	294.3	303.3	552.5	391.7	673.0	389.9	110.5	1017.0	278.2	850.3	1508.5	1361.5	203.0	280.8	307.0	352.0	425.5	243.3	38.4	786.5	1824.0	386.5	408.3	343.9	362.8	364.8	276.6	547.3	937.3	297.8	33.7	567.2	1151.5	386.7	750.4	683.5	279.0	482.8	674.1	18.7	1129.8	739.6	312.0	17.1	26.7	1081.5	889.4	263.3	427.9	556.2	1595.9	1642.7	401.2	298.0	197.2	270.5	551.3	14.9	79.0	690.4	615.9	1530.4	352.9	869.2	827.0	652.5
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693352	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 185.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Excitatory neurons: 45.2;Horizontal cells: 42.1;Inhibitory neurons: 32.6;Oligodendrocytes: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.4;AN3-CA: 5.4;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favorable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.8	6.6	100.8	0.7	136.7	0.2	2.5	55.3	120.4	1.8	0.0	12.8	5.2	3.3	0.5	11.0	10.4	1.7	9.8	112.3	69.9	4.4	2.7	10.2	0.3	110.3	102.3	1.8	6.0	2.1	19.5	2.2	107.7	2.3	1.8	6.3	5.7	3.6	10.5	8.2	9.5	3.6	47.5	2.6	4.9	2.2	124.6	0.4	6.9	5.3	1.4	6.8	2.7	185.2	0.2	7.4	0.3	5.4	0.8	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.5	0.0	1.9	2.9	2.9	0.0	0.0	1.5	2.5	0.2	3.6	0.2	0.8	0.2	0.3	0.0	0.7	0.0	0.1	0.2	0.0	0.1	0.1	2.7	0.0	0.2	0.2	0.5	0.2	0.8	0.7	0.3	0.1	1.0	0.2	1.0	13.2	1.6	0.8	0.3	3.6	0.3	0.7	0.2	0.1	0.2	2.7	0.0	0.2	1.0	0.2	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	100.8	136.7	55.3	120.4	112.3	69.9	110.3	102.3	107.7	47.5	124.6	185.2	1.6	38.5	10.0	6.8	0.7	4.1	1.4	0.6	9.6	21.3	3.1	2.4	18.4	2.8	5.3	1.8	0.0	0.0	1.1	5.7	1.9	2.4	9.1	26.6	0.9	2.0	10.2	0.0	45.2	0.7	0.3	3.3	3.1	5.8	4.5	0.1	2.2	4.3	3.3	42.1	32.6	6.5	0.0	0.0	2.2	7.2	0.3	1.2	1.8	4.7	0.1	0.9	0.0	6.6	104.7	0.7	5.2	0.4	3.3	0.8	10.3	1.1	13.5	2.4	0.0	1.5	4.2	2.2	0.8	6.7	3.1	0.0	4.8	0.1	4.8	4.1
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2 microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.0;lymphoid tissue: 70.3;testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.9	1.4	0.9	13.0	0.9	48.0	2.7	0.8	1.0	2.3	0.5	11.6	9.4	2.4	0.2	13.2	0.9	1.8	0.8	1.1	0.6	0.7	4.2	1.9	26.6	0.6	1.0	0.5	0.4	0.4	0.2	8.3	0.7	0.7	14.2	0.5	2.0	0.5	1.4	9.8	9.4	6.8	0.6	5.2	6.2	30.7	1.3	70.3	1.0	0.8	32.3	3.4	4.1	0.9	455.1	149.1	176.4	139.1	13.8	25.2	169.8	186.1	104.5	264.0	197.7	319.1	190.4	212.4	106.7	104.5	196.8	232.7	203.7	169.0	298.8	92.3	78.8	416.3	139.7	219.6	4.2	161.9	102.8	8.7	9.1	166.0	120.0	37.9	144.6	157.1	313.8	187.8	209.7	186.2	272.2	125.3	197.1	174.0	159.3	152.5	475.5	128.2	71.2	72.8	127.5	85.7	284.6	106.3	82.0	120.9	185.1	97.3	98.3	294.1	179.7	136.5	290.0	74.4	138.6	187.3	92.2	565.1	195.8	5.1	0.0	0.4	0.4	0.0	0.2	0.6	1.4	1.7	0.5	0.2	0.3	0.5	0.2	3.6	0.1	1.0	8.1	1.0	0.9	0.9	0.8	1.0	1.1	0.6	0.6	1.0	0.7	0.6	1.3	0.9	1.0	0.0	4.2	0.0	5.9	6.9	1.5	4.3	1.2	0.9	3.0	3.4	0.9	4.3	3.8	0.0	0.0	23.3	3.8	6.4	0.0	1.2	9.3	7.3	6.6	3.9	1.2	90.7	2.9	0.4	68.5	9.2	16.3	8.4	0.0	46.6	8.9	3.0	19.5	1.7	0.9	9.8	10.2	8.0	5.5	13.1	0.9	7.6	0.0	1.0	2.1	0.4	3.1	0.5	0.5	1.8	1.4	0.0	30.8	2.5	0.9	0.0	0.7	0.4	0.0	1.1	15.4	114.5	63.1	31.2	6.1	4.7	8.2	4.2	18.4	2.9
TRA2A	"AWMS1, htra-2-alpha"	ENSG00000164548	"Transformer 2 alpha homolog"	Q13595	7	23504780-23532041	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054018	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Nucleoplasm, Vesicles"	"HPA054018: AB_2682344"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.77e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.28e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.36e-3)"	35.1	39.1	55.7	37.0	58.2	113.4	32.1	57.4	75.7	47.1	57.9	38.7	26.4	42.8	43.9	47.3	42.7	21.3	30.4	55.3	57.8	45.9	34.9	33.5	47.6	57.2	56.5	53.1	32.6	25.6	40.4	32.9	57.6	41.3	39.2	42.0	33.2	22.1	23.1	42.8	36.8	41.0	56.6	52.8	33.0	30.9	56.8	46.1	35.9	21.3	53.6	37.9	42.9	64.9	57.2	61.2	94.1	148.4	49.1	30.9	60.4	71.4	33.6	70.5	57.4	51.2	76.4	107.4	39.9	53.7	82.3	92.1	115.6	66.9	88.4	64.6	65.7	65.9	67.9	81.8	52.0	78.0	59.2	37.1	44.9	53.1	66.1	62.7	80.9	46.7	129.5	51.0	79.7	55.6	96.5	128.7	84.5	69.5	62.5	106.1	74.8	64.3	81.8	81.0	80.7	65.8	66.0	75.8	49.8	69.1	59.6	85.5	73.8	55.4	79.0	51.0	83.4	56.6	76.1	86.9	47.7	103.8	75.3	16.8	17.1	23.6	24.6	28.8	21.6	17.6	23.3	23.1	20.6	16.1	19.6	23.7	25.4	19.1	27.0	30.0	25.2	10.2	55.7	58.2	57.4	75.7	55.3	57.8	57.2	56.5	57.6	56.6	56.8	64.9	110.6	60.9	72.2	112.3	141.9	104.4	95.6	61.7	94.4	54.5	118.5	74.8	42.5	60.1	60.8	88.3	52.1	83.2	153.3	84.9	25.4	54.8	62.1	155.7	137.1	74.8	118.5	77.5	113.1	43.9	84.6	91.5	89.2	166.7	86.7	62.5	84.6	71.4	54.8	37.0	115.4	100.3	48.8	89.5	125.4	23.7	65.0	88.9	56.9	107.7	71.5	48.1	70.0	203.1	245.1	59.2	92.0	67.7	125.4	97.7	59.7	41.8	71.3	101.8	72.3	119.2	88.2	99.8	65.0	138.6	113.1	117.9	130.4	49.1	112.6	92.1
TRAF5	RNF84	ENSG00000082512	"TNF receptor associated factor 5"	O00463	1	211326615-211374946	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 75.9;Early spermatids: 55.0;Late spermatids: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008052, CAB010277"	Enhanced		Supported	Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	Centrosome	"CAB010277: AB_2287961, HPA008052: AB_1858230"	"unprognostic (6.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.94e-10)"	"unprognostic (3.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (7.29e-5)"	8.6	3.3	3.6	17.0	4.6	4.1	6.0	1.5	3.2	10.8	26.3	14.0	5.0	17.3	7.4	5.6	17.8	8.1	3.5	3.6	2.2	5.0	1.8	5.7	29.7	2.7	2.7	6.2	21.3	1.6	2.9	5.4	2.8	9.0	9.5	0.7	7.5	10.8	1.5	2.8	17.4	20.0	2.2	16.7	9.3	6.9	3.1	13.5	3.0	2.6	27.2	13.5	6.5	2.4	6.2	4.5	7.9	7.1	6.8	4.9	2.8	8.6	10.3	12.2	10.8	2.2	11.9	18.8	4.8	13.6	6.2	1.2	15.1	1.4	6.1	36.3	5.4	0.9	7.1	0.0	9.9	3.0	13.3	5.8	2.7	6.6	2.0	18.4	8.6	16.3	7.6	8.7	3.4	4.8	8.3	3.4	9.5	9.7	3.8	12.6	11.0	17.6	9.3	4.3	14.0	14.6	6.4	0.3	18.3	29.2	4.4	0.3	5.4	7.9	6.1	2.7	9.8	2.4	3.8	20.0	2.1	0.0	3.0	13.8	0.3	0.4	9.2	0.3	17.3	22.2	11.6	12.5	1.5	19.6	10.2	10.2	0.7	21.3	0.5	1.1	17.7	7.4	3.6	4.6	1.5	3.2	3.6	2.2	2.7	2.7	2.8	2.2	3.1	2.4	15.2	12.8	7.2	3.3	75.9	3.7	4.0	2.7	9.6	2.5	13.9	13.7	2.5	0.0	6.8	11.0	0.0	9.5	31.0	3.6	0.0	0.9	55.0	5.3	23.6	9.0	14.8	4.6	13.4	9.8	2.2	16.9	16.8	8.1	15.2	5.3	6.1	0.3	10.0	0.0	14.1	11.4	4.1	4.8	12.6	47.9	14.3	17.3	8.8	20.6	16.3	1.0	32.0	7.5	2.8	7.1	11.4	27.4	11.3	3.4	1.8	0.8	8.6	0.7	13.1	7.3	29.1	3.8	2.7	4.4	4.0	1.4	41.6	5.0	14.3	2.6
TRAM1L1	MGC26568	ENSG00000174599	"Translocation associated membrane protein 1 like 1"	Q8N609	4	117083554-117085576	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.8;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 13.5;Spermatogonia: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.0;U-138 MG: 11.0;U-266/70: 9.1"	"Low region specificity"	"Detected in all"							HPA044560	Uncertain		Uncertain	Mitochondria		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA044560: AB_10796097"	"unprognostic (9.06e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	1.2	2.4	4.7	0.5	6.0	0.0	4.2	5.4	7.0	2.5	2.9	1.2	0.4	1.9	6.0	0.8	3.9	1.7	1.0	4.9	6.1	6.9	0.1	1.6	0.5	5.7	5.5	2.2	2.9	2.4	3.2	0.6	6.1	4.3	1.1	5.5	1.4	2.5	0.3	2.4	0.6	2.0	5.5	0.6	1.9	3.6	6.0	0.2	4.9	0.6	0.4	1.1	0.8	6.5	1.4	0.9	4.2	2.1	0.0	0.0	0.0	0.6	0.4	0.9	2.5	0.1	5.0	0.0	0.5	1.1	5.4	0.1	2.0	2.3	3.4	0.0	0.1	1.2	1.2	0.5	1.2	1.3	0.0	4.5	1.9	1.1	0.0	3.5	0.0	0.0	0.0	2.6	7.0	0.3	2.3	0.0	0.3	0.0	1.1	0.0	5.5	0.0	0.7	0.3	2.4	9.0	0.0	3.6	4.5	2.2	6.2	1.3	3.0	11.0	4.8	0.1	1.7	9.1	2.1	0.0	4.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	6.0	5.4	7.0	4.9	6.1	5.7	5.5	6.1	5.5	6.0	6.5	0.6	0.0	1.5	2.6	0.5	0.9	0.3	0.3	1.8	6.8	2.8	2.0	0.7	0.0	1.6	1.8	4.2	1.9	0.0	0.0	1.9	2.3	0.3	0.5	2.2	2.0	0.0	0.0	3.0	0.7	0.4	2.5	0.0	0.5	0.0	1.5	0.0	0.0	0.3	5.0	3.8	0.3	2.0	0.0	0.4	0.1	0.9	0.1	3.6	0.0	0.0	3.3	0.0	8.0	13.5	0.6	0.0	1.9	0.0	0.9	0.0	2.1	2.3	3.1	0.0	1.7	0.8	1.9	6.2	1.5	1.4	0.3	0.1	1.8	0.1	0.1
TRAPPC11	"C4orf41, FLJ12716, foigr, gry"	ENSG00000168538	"Trafficking protein particle complex 11"	Q7Z392	4	183659267-183713594	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038173			Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Vesicles	"HPA038173: "	"unprognostic (2.24e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.14e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.66e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.92e-2)"	12.1	15.9	4.3	13.4	5.5	11.4	15.5	8.3	6.4	12.4	15.4	13.2	11.0	14.1	11.8	13.8	12.4	11.0	12.4	5.5	4.8	14.8	16.9	13.6	14.9	3.4	4.1	20.8	14.2	19.1	6.8	13.8	3.7	14.1	15.0	13.8	14.8	12.1	15.1	12.1	11.7	15.7	4.4	14.2	13.5	16.0	4.9	17.8	14.8	18.7	17.6	13.6	8.0	6.0	15.1	14.4	23.2	23.1	28.5	31.3	17.6	21.6	21.7	17.8	16.2	9.0	19.1	20.7	6.0	21.8	13.9	10.8	21.2	20.5	20.4	23.1	9.3	26.0	12.0	12.8	26.2	28.3	24.8	24.2	21.5	17.8	20.6	23.2	26.5	23.9	21.1	41.8	22.5	10.8	34.1	13.8	8.7	10.2	10.7	23.4	13.8	15.8	22.8	15.3	15.6	20.7	21.1	21.6	21.4	20.5	16.6	31.0	26.7	10.1	11.9	9.7	12.4	21.8	12.7	12.4	20.6	18.7	18.0	3.8	12.9	8.2	5.7	14.9	7.6	4.7	6.2	6.1	12.8	3.4	5.7	5.9	3.7	10.0	25.6	3.3	5.4	7.6	4.3	5.5	8.3	6.4	5.5	4.8	3.4	4.1	3.7	4.4	4.9	6.0	9.5	3.2	14.5	33.0	12.3	4.5	3.1	7.4	9.1	11.0	5.7	6.2	14.8	8.6	9.1	7.3	8.4	7.9	10.0	9.8	3.9	7.4	57.7	8.2	13.3	9.1	13.1	12.0	47.5	9.3	8.4	12.0	12.2	8.0	7.6	18.7	9.3	8.5	11.6	8.4	47.4	7.2	0.0	16.0	6.8	7.3	13.4	16.1	3.6	30.0	19.5	6.4	11.3	37.2	35.2	9.0	7.1	11.3	10.6	5.5	11.7	4.6	12.9	13.6	0.0	9.9	8.6	7.7	14.9	10.4	6.1	7.0	9.4	12.4	7.9	5.9
TRAPPC9	"IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120"	ENSG00000167632	"Trafficking protein particle complex 9"	Q96Q05	8	139727725-140458579	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 89.5;Excitatory neurons: 121.8;Inhibitory neurons: 136.3;Late spermatids: 119.0;Microglial cells: 105.9;Oligodendrocyte precursor cells: 93.5;Oligodendrocytes: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026579			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA026579: AB_1854459"	"unprognostic (1.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.11e-6)"	"unprognostic (2.09e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.62e-1)"	8.6	13.4	10.3	6.9	11.0	11.1	8.9	10.7	12.7	10.3	12.5	11.1	8.0	11.3	5.1	12.3	12.2	5.8	15.0	10.8	10.3	13.8	11.6	9.5	8.0	13.1	14.1	10.5	11.9	27.4	20.7	7.2	13.9	11.7	6.0	14.2	11.6	8.3	33.5	11.4	10.9	7.2	10.2	11.3	12.5	9.0	11.9	11.3	12.9	17.6	6.8	11.1	10.8	13.0	9.6	16.6	7.4	20.8	15.5	9.0	4.9	6.0	9.9	3.1	5.0	6.2	11.2	11.6	14.0	11.9	4.7	12.2	10.0	9.4	3.4	16.8	6.1	18.6	9.8	6.2	11.2	4.7	14.5	8.9	9.3	2.5	7.9	11.1	12.9	13.1	6.7	10.1	5.1	27.0	29.2	6.2	2.3	31.3	14.0	12.2	2.7	19.4	11.6	11.6	19.1	10.6	9.8	4.7	10.6	7.6	15.3	6.8	7.7	4.6	7.9	10.8	4.9	14.1	10.9	7.8	9.6	10.1	7.4	15.4	3.5	2.9	4.2	3.3	4.6	2.7	2.9	3.3	3.5	4.4	2.8	3.6	5.0	4.9	3.4	4.2	2.1	3.5	10.3	11.0	10.7	12.7	10.8	10.3	13.1	14.1	13.9	10.2	11.9	13.0	5.1	3.2	8.3	89.5	9.6	2.3	4.7	3.1	5.7	14.2	5.5	4.1	13.9	5.7	5.3	11.0	20.9	10.9	5.4	15.2	9.8	6.5	47.9	8.4	3.7	6.5	30.5	3.4	121.8	6.2	4.4	5.3	29.6	10.2	8.8	7.9	4.6	9.2	7.5	28.6	136.3	14.4	10.2	10.5	3.7	119.0	5.9	10.3	10.6	105.9	5.3	13.6	11.3	93.5	170.6	5.1	6.6	7.9	11.0	3.7	13.4	19.9	15.7	13.7	6.6	9.0	5.3	3.6	6.6	8.7	3.0	14.6	10.5	8.6	12.0	5.4
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822770-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 79.8"	"Cell type enriched"	"Detected in some"	10	"T-cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 395.1"	"Group enriched"	"Detected in many"	155	"granulocytes: 395.1;T-cells: 313.1"	"Group enriched"	"Detected in some"	25	"JURKAT: 29.9;MOLT-4: 76.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	1.1	0.6	0.0	11.0	0.0	2.7	0.8	0.0	0.0	0.4	0.0	1.3	1.4	0.4	0.4	1.0	0.3	2.5	0.4	0.1	0.0	0.3	1.3	2.1	23.9	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	1.5	0.0	0.6	0.1	0.1	0.6	3.0	0.5	0.0	8.5	2.4	0.4	0.0	79.8	0.4	0.4	12.4	2.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	2.1	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	395.1	0.6	0.2	57.0	0.2	116.4	1.0	229.5	119.6	0.3	0.4	313.1	77.7	3.5	2.2	0.7	0.8	111.1	139.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.0	3.3	8.4	0.1	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	1.8	0.0	0.0	8.9	0.1	0.0	0.0	2.3	0.1	0.1	1.1	0.0	2.7	0.1	0.0	0.0	1.7	7.7	0.1	2.5	0.0	1.8	0.6	0.2	0.0	0.2	0.0	0.0	1.0	12.2	2.2	0.0	1.8	3.6	0.0	3.2	0.0	3.1	0.0	0.2	0.0	0.0	0.0	5.1	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.0	8.0	0.1	129.3	0.6	0.0	0.2
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.9;Inhibitory neurons: 111.4;Microglial cells: 52.5;Oligodendrocyte precursor cells: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	3.4	5.7	1.3	5.8	2.2	13.9	2.6	1.1	3.8	7.7	0.0	3.7	3.2	6.0	2.9	8.8	5.1	3.9	1.8	0.8	0.6	2.9	1.0	2.9	7.7	0.3	0.7	7.1	1.6	3.9	3.5	2.6	0.0	5.4	3.4	2.0	2.3	3.6	1.1	6.4	4.7	3.9	0.2	7.2	4.2	6.0	1.6	10.3	2.0	1.2	5.0	7.0	8.0	0.8	13.7	9.4	10.3	13.2	4.7	10.4	14.5	10.2	16.2	11.4	9.4	0.1	7.1	12.7	2.2	15.5	15.6	16.2	13.2	12.6	9.1	144.3	1.0	13.7	8.0	0.0	3.2	25.4	42.1	4.3	17.3	10.2	4.1	10.3	0.0	8.5	0.1	4.1	5.0	3.0	6.6	42.9	11.3	10.1	9.6	11.8	0.8	4.7	6.7	16.7	8.3	4.4	6.1	0.2	1.0	5.6	5.9	34.1	4.5	6.5	7.5	10.7	2.9	1.7	9.5	13.7	4.4	22.7	0.1	1.1	0.6	4.6	1.5	0.2	1.4	0.2	1.1	1.3	0.7	0.0	0.9	1.0	2.0	1.5	0.1	0.6	1.2	0.7	1.3	2.2	1.1	3.8	0.8	0.6	0.3	0.7	0.0	0.2	1.6	0.8	2.7	3.2	1.3	37.9	3.6	8.3	2.9	3.2	6.2	9.9	4.1	2.5	1.9	1.5	5.9	5.5	0.0	3.4	20.9	8.4	0.0	1.8	2.7	3.3	16.2	5.4	3.0	0.4	96.9	1.0	0.9	11.8	11.2	1.7	12.0	14.7	6.4	0.3	2.6	8.4	111.4	2.1	4.1	4.7	10.4	3.2	14.0	8.0	3.6	52.5	7.9	4.2	12.3	80.4	3.8	1.2	2.5	22.2	7.2	1.6	1.0	0.2	8.5	0.5	26.3	4.4	7.9	10.0	7.4	23.5	7.4	1.2	18.0	4.2	3.8	4.3
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430358-125438403	"Enzymes, Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 365.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 242.7;Distal enterocytes: 281.6;Endometrial stromal cells: 240.1;Plasma cells: 283.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 9.9;neutrophil: 4.7;non-classical monocyte: 3.5;T-reg: 2.8"	"Group enriched"	"Detected in many"	12	"granulocytes: 9.9;monocytes: 3.5;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"HEL: 193.9;U-266/70: 114.2;U-266/84: 123.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA063982: AB_2685165"	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	82.5	25.5	7.5	40.9	9.0	365.5	28.0	12.1	16.2	35.9	7.0	45.1	20.4	25.5	13.6	33.5	15.7	80.2	18.3	8.2	10.1	23.9	139.6	53.7	17.2	9.0	8.4	4.1	43.0	78.9	12.0	28.9	8.7	45.4	51.9	16.3	19.2	7.1	44.0	20.4	32.0	43.2	7.5	22.3	38.0	6.9	11.9	36.0	107.5	19.2	18.0	99.1	5.4	7.6	14.7	16.4	2.2	4.6	4.6	8.8	25.4	9.4	13.2	6.8	2.3	22.1	18.9	26.5	8.5	6.9	40.6	11.0	7.0	9.1	5.8	11.8	34.3	193.9	7.3	43.6	11.6	98.3	17.0	8.5	13.5	27.8	62.8	33.0	20.0	0.3	17.5	81.6	0.9	15.8	9.2	15.3	15.8	35.1	31.6	18.5	3.3	29.2	54.6	55.1	13.7	5.0	22.9	24.6	93.1	14.0	6.4	4.6	10.4	7.3	9.5	7.3	11.7	114.2	123.2	36.6	13.1	0.7	17.7	0.0	0.7	9.9	0.0	1.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	4.7	0.0	3.5	0.3	2.8	0.1	7.5	9.0	12.1	16.2	8.2	10.1	9.0	8.4	8.7	7.5	11.9	7.6	69.6	134.6	168.5	13.7	19.8	100.1	242.7	68.6	77.4	25.5	100.8	71.9	16.6	31.5	67.9	16.5	0.0	12.3	2.8	281.6	11.7	45.3	0.4	96.6	240.1	62.0	112.0	5.3	2.1	24.7	19.1	54.6	58.6	222.5	29.9	0.5	8.2	131.7	35.3	21.9	0.7	129.6	32.6	72.0	59.7	1.7	0.3	85.9	56.9	4.7	27.5	20.1	0.0	4.5	0.2	45.5	130.9	0.4	283.6	139.0	117.4	24.9	39.7	3.8	0.0	36.6	45.1	0.3	2.2	88.2	64.2	30.6	14.8	1.5	106.9	128.7
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687305-116701300	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"		"HPA050060: AB_2681000"	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (4.53e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	6.7	7.2	4.6	5.4	4.5	1.0	6.8	16.4	5.4	10.1	15.2	6.0	5.9	10.6	6.5	7.4	13.1	6.4	7.9	4.7	6.1	5.2	3.8	5.5	8.1	3.6	2.8	10.1	6.2	8.6	3.5	6.1	3.9	6.9	6.2	7.2	5.2	7.3	18.6	4.6	7.2	10.7	2.1	6.2	5.4	5.2	4.5	7.5	6.3	12.5	7.4	7.6	5.7	3.4	10.9	24.5	14.3	15.7	28.3	20.1	10.8	19.9	21.7	22.1	18.4	16.4	11.7	11.3	8.6	30.7	16.5	22.8	17.5	22.4	20.0	9.9	8.5	6.1	15.4	10.2	14.7	4.1	19.1	17.4	19.7	21.0	12.3	24.4	14.6	12.4	8.6	9.3	26.3	13.9	11.0	0.1	13.0	26.2	14.6	12.7	38.2	7.4	9.0	25.1	14.2	7.2	15.7	10.8	11.4	14.3	29.8	4.0	18.2	20.4	16.2	15.3	15.2	15.1	4.3	17.7	17.0	2.7	20.5	0.0	1.7	0.0	10.9	3.3	8.4	7.3	9.5	8.7	2.3	5.1	9.6	9.8	0.3	7.0	3.0	4.3	20.9	6.0	4.6	4.5	16.4	5.4	4.7	6.1	3.6	2.8	3.9	2.1	4.5	3.4	2.5	6.4	0.6	5.5	4.3	4.2	6.3	9.3	5.7	11.7	3.1	3.7	7.6	7.2	7.3	9.2	0.0	6.7	2.1	1.7	1.9	8.5	3.5	7.1	10.7	3.6	4.2	0.4	7.6	8.0	3.6	6.1	3.6	2.3	2.5	4.5	2.9	4.1	7.2	1.7	10.1	4.0	8.2	2.4	4.7	2.1	5.3	2.2	1.8	1.9	0.8	4.0	3.1	6.6	5.1	5.0	2.6	12.0	3.1	2.8	10.6	3.1	10.8	4.8	0.0	6.0	6.6	17.7	13.1	5.6	3.7	7.4	4.7	5.0	5.3	4.8
TRIM45	"FLJ13181, RNF99"	ENSG00000134253	"Tripartite motif containing 45"	Q9H8W5	1	117111060-117122587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 29.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cardiomyocytes: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030266, HPA054308"	Uncertain		Supported	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Cytokinetic bridge"	"HPA030266: AB_10795476, HPA054308: AB_2682445"	"prognostic favorable (1.58e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.27e-2)"	2.9	7.1	3.9	1.2	3.6	2.1	5.4	2.9	3.9	7.3	3.1	6.2	3.7	8.7	6.6	2.2	10.0	2.9	12.6	3.4	3.1	6.7	1.7	2.4	0.9	3.3	3.2	9.1	11.4	5.6	10.5	2.0	3.0	10.7	2.1	3.6	4.7	5.7	29.1	5.8	3.1	4.9	3.2	3.2	5.7	7.6	3.7	0.8	12.0	10.5	0.6	8.1	5.3	3.8	4.3	3.6	16.0	7.5	1.3	3.6	11.9	4.8	2.0	3.3	3.3	1.8	3.9	0.1	3.5	2.2	3.5	3.9	3.7	3.9	4.4	2.5	3.8	2.6	13.9	2.1	2.3	2.4	3.6	4.6	3.8	5.5	3.9	6.2	4.1	4.7	3.2	3.2	3.1	19.3	1.4	2.7	8.7	2.5	3.5	6.1	31.4	0.9	4.5	3.9	11.9	3.1	3.9	3.6	3.1	15.0	6.2	3.1	1.4	4.6	6.6	2.8	4.3	8.7	3.5	0.3	6.0	2.2	12.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.5	0.0	3.9	3.6	2.9	3.9	3.4	3.1	3.3	3.2	3.0	3.2	3.7	3.8	1.1	9.6	2.7	4.9	0.1	1.1	1.8	1.5	1.2	1.4	5.0	3.4	12.2	4.3	2.2	1.8	4.2	2.7	0.1	0.3	1.9	1.9	5.7	2.8	2.6	1.5	1.8	2.5	2.5	3.2	1.2	2.1	3.6	2.8	0.0	4.0	2.2	0.2	0.8	1.7	1.9	1.6	0.0	0.3	0.3	2.7	1.8	0.4	0.0	3.7	0.0	1.4	0.0	3.5	2.3	2.1	0.0	1.9	0.6	0.5	0.4	0.4	1.9	1.4	0.0	3.1	2.1	6.1	5.3	1.3	1.6	1.1	0.4	5.5	1.6	1.3
TRIM68	"FLJ10369, RNF137, SS-56"	ENSG00000167333	"Tripartite motif containing 68"	Q6AZZ1	11	4598672-4608231	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023455	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Cytosol"		"HPA023455: AB_1858319"	"unprognostic (4.77e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (4.14e-6)"	"unprognostic (4.23e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"	5.1	6.5	6.6	3.7	7.0	2.1	6.4	7.2	7.2	9.6	6.3	7.1	6.6	6.5	7.2	5.0	7.6	5.1	7.2	6.6	7.0	9.7	7.4	6.6	5.2	6.6	6.9	10.1	6.2	8.9	6.3	6.2	6.8	10.7	6.2	5.8	8.3	8.1	5.9	4.8	6.0	6.0	6.8	6.8	8.0	6.5	7.3	6.5	9.6	6.6	5.8	7.0	5.3	7.2	10.2	11.2	4.5	8.2	7.2	11.6	0.0	10.9	8.0	9.9	8.9	1.4	10.3	6.9	6.5	5.6	9.3	11.6	4.5	7.7	8.4	17.2	8.8	8.4	2.9	0.0	8.3	13.7	11.4	9.1	11.1	5.7	8.6	10.2	12.6	6.3	8.0	3.7	8.9	2.4	11.3	3.7	5.4	7.1	9.2	9.0	6.4	0.3	6.3	4.4	2.4	4.3	0.0	11.0	7.1	9.0	4.8	6.8	10.3	13.1	8.8	13.3	5.0	13.7	15.9	9.9	8.9	6.0	12.5	8.6	2.5	8.9	7.9	4.8	8.8	8.5	8.8	8.9	5.6	7.6	11.1	9.0	0.3	5.7	5.5	3.8	8.7	7.4	6.6	7.0	7.2	7.2	6.6	7.0	6.6	6.9	6.8	6.8	7.3	7.2	3.2	0.0	3.6	2.9	2.8	0.8	1.4	2.7	3.4	3.3	2.6	2.4	5.4	2.8	5.9	5.5	2.1	6.1	2.7	5.3	5.9	3.2	0.9	2.6	2.2	3.4	6.7	1.3	1.7	3.3	2.7	2.9	4.6	2.8	3.8	5.9	3.6	6.0	2.2	0.0	1.6	5.2	6.1	2.1	0.6	0.4	1.8	2.0	0.0	1.9	2.7	4.1	5.2	3.5	3.0	3.3	1.9	1.9	1.8	2.0	2.4	2.5	2.4	2.8	6.6	2.0	2.6	2.9	6.6	2.0	1.0	4.4	2.8	3.9	4.7	0.6
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214091-31231537	"Predicted intracellular proteins, Transporters"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 151.8;tongue: 43.0"	"Cell type enriched"	"Detected in many"	5	"Skeletal myocytes: 45.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.9"	"Region enriched"	"Detected in many"	7	"cerebellum: 9.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 7.2;LHCN-M2: 12.6;RH-30: 29.7;U-266/70: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	0.2	0.2	0.9	0.2	0.8	0.8	0.2	9.3	1.0	0.1	0.5	0.2	0.2	0.2	0.3	1.0	0.1	0.2	0.8	0.7	0.4	0.1	0.1	0.2	0.3	1.0	0.5	0.2	0.3	0.1	0.0	0.2	1.3	1.9	0.1	0.8	2.5	0.1	151.8	0.5	0.2	0.1	0.1	0.3	0.3	0.3	0.5	0.1	0.2	43.0	0.2	0.1	0.0	1.2	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.3	0.1	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.3	0.1	0.2	0.7	0.2	0.2	7.2	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.8	12.6	0.1	0.1	0.5	0.2	0.2	0.2	0.3	29.7	4.1	0.0	0.2	2.6	0.2	0.1	0.3	0.1	0.3	0.2	2.6	0.1	0.2	0.2	0.2	0.1	17.9	1.7	0.2	0.2	0.4	0.2	1.9	0.3	0.5	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.6	0.4	0.3	1.5	0.6	0.4	0.6	0.2	0.1	0.9	0.8	9.3	1.0	0.7	0.4	1.0	0.5	1.3	0.1	0.5	1.2	4.7	3.2	3.8	0.0	0.8	0.1	3.1	0.0	0.0	1.0	3.1	8.0	3.0	0.0	2.5	0.0	2.1	0.3	2.4	0.0	0.0	0.0	0.3	1.5	4.7	1.5	0.0	0.0	0.2	0.0	0.3	2.5	0.0	4.0	1.3	0.8	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.2	0.3	0.0	0.0	3.1	0.0	0.0	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.1	0.1	0.0	0.9	0.0	45.6	2.2	0.1	0.2	0.8	0.3	0.1	2.2	1.2	0.9	1.5
TRIO	ARHGEF23	ENSG00000038382	"Trio Rho guanine nucleotide exchange factor"	O75962	5	14143342-14532128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 205.7;Excitatory neurons: 400.9;Inhibitory neurons: 443.4;Microglial cells: 308.2;Oligodendrocyte precursor cells: 476.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 215.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008157, HPA064664"	Supported		Approved	Vesicles,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: AB_2685315"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.23e-1)"	35.3	20.5	31.7	11.6	33.3	5.5	31.8	32.2	38.6	23.4	34.5	36.6	6.8	38.9	15.5	14.5	21.2	18.8	31.9	37.2	33.6	24.9	22.1	25.7	10.2	28.1	28.1	52.8	20.6	9.1	28.9	11.6	26.6	28.2	13.6	10.2	17.4	11.1	20.9	18.7	27.8	19.2	26.4	38.9	22.9	17.2	31.4	13.3	17.0	17.4	10.6	27.1	20.5	27.2	43.7	15.9	37.2	18.0	78.6	101.0	41.3	40.4	49.2	32.6	36.9	10.3	17.4	10.4	28.0	56.6	79.6	13.0	6.5	19.4	66.6	25.8	8.0	5.5	46.1	13.2	40.0	13.9	14.8	47.6	19.9	114.4	36.4	30.3	28.8	6.8	1.4	6.8	78.7	8.3	0.1	9.5	9.3	4.8	13.7	9.9	22.9	34.2	31.6	20.5	17.1	67.5	34.3	9.0	18.9	47.1	5.3	2.0	66.4	61.4	38.3	44.7	48.4	0.3	2.2	12.9	215.1	8.8	14.8	0.1	0.5	0.0	0.0	0.7	0.1	0.7	0.0	0.0	0.5	1.8	0.0	0.0	0.0	1.6	0.6	1.1	0.3	0.1	31.7	33.3	32.2	38.6	37.2	33.6	28.1	28.1	26.6	26.4	31.4	27.2	33.0	19.2	25.9	205.7	16.6	16.4	13.0	15.6	17.1	30.5	21.9	15.0	19.3	10.0	21.0	11.0	14.6	9.7	5.6	24.8	0.0	21.2	2.9	11.7	24.8	28.7	18.0	6.5	400.9	14.2	22.0	38.9	7.7	34.2	17.7	17.2	14.6	17.1	14.2	28.6	443.4	20.6	14.2	15.4	22.1	6.6	78.6	20.2	5.4	308.2	12.1	7.3	2.1	476.5	80.4	38.5	14.9	42.9	29.2	52.8	9.2	5.4	18.3	2.7	6.6	27.5	20.0	3.5	6.2	7.2	13.8	8.2	3.8	11.7	19.4	20.3
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564039	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 99.5;Spermatogonia: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	4.3	3.7	2.0	3.1	2.6	2.2	4.4	2.6	2.9	1.9	1.5	3.6	4.3	2.7	3.9	3.6	5.8	3.4	2.3	1.8	2.5	4.9	9.8	2.4	4.4	2.6	2.5	3.3	5.9	3.7	2.3	3.7	2.9	4.1	3.6	2.8	3.9	2.2	3.9	3.7	4.5	2.7	2.7	3.5	4.4	9.9	2.4	4.3	6.1	2.7	4.4	2.9	2.0	4.3	8.2	5.4	10.1	5.7	6.0	8.4	7.8	9.6	3.7	5.8	4.1	4.9	9.4	10.9	3.7	5.6	5.9	4.4	10.9	5.1	8.6	13.7	5.4	8.0	4.4	7.6	5.5	19.6	7.8	5.4	14.4	5.7	14.0	3.0	6.4	10.0	17.5	9.4	4.5	9.4	16.4	3.5	6.5	13.8	5.0	9.5	10.2	7.2	8.5	6.8	6.3	5.8	5.3	28.3	9.9	8.5	9.3	7.8	4.9	6.9	7.2	5.5	11.1	7.0	12.4	10.0	4.9	10.9	4.7	2.7	3.9	2.1	1.8	3.8	1.7	3.5	3.3	3.3	5.2	5.8	3.5	3.2	4.9	3.3	3.4	3.0	3.9	1.9	2.0	2.6	2.6	2.9	1.8	2.5	2.6	2.5	2.9	2.7	2.4	4.3	7.2	3.2	10.3	8.8	8.7	8.2	5.6	8.4	10.2	4.3	12.1	8.6	6.4	11.5	6.6	11.0	4.2	16.8	6.1	10.6	43.0	13.8	46.8	33.5	12.1	7.2	7.2	2.1	5.3	19.3	16.4	6.9	8.6	21.6	8.2	11.0	8.2	32.6	8.5	5.0	4.6	11.1	12.2	8.1	4.1	17.0	6.5	5.0	5.4	1.9	8.4	8.7	5.2	3.5	19.7	14.1	11.0	7.5	10.4	4.8	19.0	31.9	20.6	5.9	13.1	5.7	8.1	99.5	55.0	10.2	9.5	17.5	5.5	8.1	10.6	6.6
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561868-101566446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	16.6	17.4	6.9	14.8	7.9	18.2	20.8	9.1	9.7	12.2	8.5	15.4	12.7	14.1	13.4	18.9	14.5	11.4	21.6	7.8	7.9	19.2	25.2	10.3	20.5	7.4	7.4	15.7	10.4	15.6	6.4	14.0	7.9	11.9	14.7	7.8	13.0	9.9	27.6	12.7	13.1	16.0	7.4	12.5	12.1	11.8	7.5	17.5	15.4	30.2	20.7	26.6	8.6	7.5	58.9	28.2	36.6	37.1	33.0	28.0	34.1	34.2	33.3	43.6	48.5	43.2	38.6	121.3	43.4	21.6	35.4	57.9	71.5	52.5	59.7	43.8	35.3	81.6	20.5	31.6	25.4	72.5	33.1	32.9	53.3	38.3	35.4	23.2	43.1	45.4	70.3	26.3	47.6	40.4	58.2	52.9	68.2	75.9	60.4	42.9	29.8	54.3	56.2	49.0	90.9	51.8	26.7	56.0	78.1	31.9	74.0	78.9	28.7	23.6	45.0	15.8	36.5	30.4	59.4	117.5	40.0	51.5	36.2	56.6	18.2	12.8	21.1	24.7	29.8	35.7	26.2	25.1	22.7	34.2	35.0	33.2	8.1	21.4	27.4	25.8	26.2	19.5	6.9	7.9	9.1	9.7	7.8	7.9	7.4	7.4	7.9	7.4	7.5	7.5	33.3	22.4	24.0	4.9	47.9	94.3	153.4	106.8	63.7	30.6	39.9	52.7	51.5	21.5	69.2	29.5	14.6	65.7	50.3	21.5	52.8	48.5	49.7	54.7	54.0	39.5	35.8	65.0	8.8	33.8	47.0	38.8	28.1	63.5	46.3	47.3	31.4	56.9	31.1	21.9	8.5	31.5	69.2	27.3	31.9	13.7	37.3	23.7	14.2	1.9	42.1	29.8	37.0	6.6	7.6	37.2	17.9	37.6	21.5	85.3	17.3	72.0	53.3	33.9	32.9	58.1	41.3	77.7	55.0	55.2	105.0	65.5	46.4	57.1	47.0	127.4
TRMT11	"C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1"	ENSG00000066651	"TRNA methyltransferase 11 homolog"	Q7Z4G4	6	125986479-126203817	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030473			Approved	"Nuclear bodies"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA030473: AB_2673493"	"unprognostic (2.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-1)"	8.4	10.2	7.3	8.1	7.5	2.9	11.7	12.9	9.9	9.5	6.6	8.8	12.8	13.5	9.9	8.0	9.7	9.0	10.9	7.3	7.8	13.3	19.8	7.9	10.5	6.7	7.4	12.5	6.4	12.6	13.3	9.4	7.2	9.1	9.4	16.9	8.8	8.5	7.6	6.6	10.7	10.7	5.8	6.8	8.8	7.7	7.2	8.7	12.9	8.8	10.4	9.6	8.9	9.0	17.4	11.0	24.2	11.4	12.9	13.7	16.6	13.1	21.7	15.6	24.3	30.8	19.8	26.0	24.2	8.3	29.1	20.7	26.1	14.3	26.4	19.5	37.6	17.8	20.1	46.2	21.9	29.0	5.4	14.3	15.5	15.9	25.6	22.4	7.6	9.1	44.5	5.3	17.7	22.0	15.3	34.6	20.4	15.4	15.1	9.1	16.3	17.6	22.3	9.8	32.4	16.9	13.9	18.0	36.3	18.0	13.1	28.3	5.4	9.7	10.7	27.3	25.8	13.9	1.3	6.6	23.2	24.5	17.7	1.0	1.6	0.0	5.6	1.3	11.0	7.0	7.9	6.5	3.5	6.0	9.5	8.6	0.5	7.7	0.7	4.3	6.0	3.2	7.3	7.5	12.9	9.9	7.3	7.8	6.7	7.4	7.2	5.8	7.2	9.0	11.0	6.4	22.0	24.8	17.4	13.4	27.8	29.4	23.3	59.5	11.2	13.7	12.2	21.5	26.1	7.3	73.0	18.7	14.9	8.5	19.6	19.2	10.1	13.1	25.5	10.4	9.1	8.4	56.1	16.3	13.7	27.3	27.0	12.3	18.4	20.0	6.8	22.5	7.2	20.2	63.8	11.1	18.3	6.0	3.7	4.7	25.7	7.1	3.6	23.4	11.8	21.1	9.2	31.7	48.5	13.2	15.5	24.5	12.3	22.6	22.6	30.2	24.3	74.7	6.6	21.0	17.2	15.6	9.2	14.3	10.1	14.9	14.7	27.2	13.7	17.9
TRMT12	"FLJ20772, Trm12, TYW2"	ENSG00000183665	"TRNA methyltransferase 12 homolog"	Q53H54	8	124450820-124462150	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.1"	"Low region specificity"	"Detected in all"							HPA023939	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA023939: AB_1848793"	"unprognostic (2.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.99e-5)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.25e-4)"	"unprognostic (1.04e-2)"	6.0	5.8	5.0	5.4	5.1	3.1	8.7	4.3	6.7	6.5	5.5	5.7	4.6	6.5	6.1	5.6	7.6	4.4	5.9	6.5	4.8	7.6	6.0	5.9	6.5	3.6	3.9	5.0	5.1	8.6	4.7	5.4	4.1	6.9	6.5	8.1	7.7	6.1	9.7	5.3	5.0	8.2	3.4	5.5	5.7	6.4	5.5	8.3	8.8	10.0	6.7	6.7	4.3	4.9	14.8	12.6	10.3	8.1	19.0	9.7	2.5	9.1	10.6	13.1	11.2	7.7	10.0	14.9	12.3	9.4	8.5	10.1	14.7	14.9	15.4	14.8	11.2	14.4	12.8	2.6	14.8	0.0	11.2	12.1	19.6	12.9	16.2	3.8	11.1	15.4	20.4	10.1	8.2	73.1	17.2	6.1	0.0	33.9	11.5	5.4	6.9	9.9	12.1	15.7	17.3	13.8	13.4	49.5	19.5	8.7	14.1	6.1	8.9	9.1	23.8	6.8	10.4	10.4	15.6	5.8	8.2	5.0	7.5	0.4	3.5	3.8	2.3	2.9	3.0	2.1	3.2	2.5	2.8	2.8	3.9	3.9	1.3	3.1	3.3	0.8	2.1	2.4	5.0	5.1	4.3	6.7	6.5	4.8	3.6	3.9	4.1	3.4	5.5	4.9	4.9	9.6	7.5	2.0	11.2	5.2	6.1	3.5	7.4	5.6	5.5	4.7	3.9	7.2	2.2	3.7	16.7	7.3	8.4	4.2	5.9	5.6	18.6	6.3	4.9	5.7	3.0	1.7	1.5	6.2	5.4	4.5	6.6	3.6	9.5	7.7	4.2	5.4	5.1	8.4	1.8	4.4	4.1	4.1	2.5	21.0	4.1	5.2	5.4	1.0	8.1	4.0	9.2	1.0	1.2	4.3	3.9	6.0	8.4	4.8	3.9	8.2	7.6	8.2	0.0	8.2	6.5	14.2	5.8	4.7	4.3	4.9	6.3	7.9	4.9	4.6
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118101-185157072	"Metabolic proteins, Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.0;Spermatocytes: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	6.8	8.6	7.8	8.4	9.1	5.7	7.6	9.7	9.7	7.9	9.1	7.7	8.5	7.3	9.4	6.9	10.6	7.0	12.1	7.6	8.4	13.1	14.5	7.4	10.8	8.7	8.2	11.4	5.0	12.1	7.0	8.2	8.9	7.6	7.2	8.9	5.6	8.1	20.8	4.8	7.0	6.9	9.1	10.6	7.2	27.7	8.2	10.2	10.4	18.7	11.9	7.0	5.5	12.3	12.4	22.3	15.1	11.3	21.8	20.0	21.5	11.7	10.5	15.7	16.4	20.4	23.1	13.5	28.5	8.1	24.0	15.6	25.7	15.3	15.4	16.1	11.2	13.0	15.9	20.9	15.2	19.3	20.6	9.6	20.3	16.1	16.1	16.6	17.5	17.9	34.5	18.0	18.9	10.5	14.7	11.2	24.9	25.3	4.6	17.1	21.7	21.6	15.2	13.5	13.4	12.0	22.8	22.0	16.2	34.2	22.4	10.7	16.9	14.3	11.4	9.9	15.8	28.7	41.5	21.3	9.4	16.8	14.0	24.0	10.6	21.9	7.5	14.7	8.1	12.3	9.9	9.3	13.3	18.1	12.3	9.7	12.3	12.8	19.2	5.5	14.2	9.2	7.8	9.1	9.7	9.7	7.6	8.4	8.7	8.2	8.9	9.1	8.2	12.3	8.2	12.8	15.6	24.2	18.0	2.7	8.1	11.6	7.4	8.7	6.9	6.5	29.5	11.5	15.1	16.5	8.4	16.3	10.0	8.9	27.4	12.2	73.0	22.4	8.9	11.7	6.1	29.0	19.8	6.0	9.9	12.0	10.7	8.2	8.8	14.5	11.0	25.0	13.0	3.3	19.6	9.2	12.2	17.5	6.2	25.0	12.5	13.7	1.8	20.6	16.3	9.6	6.2	18.6	36.8	7.6	10.9	12.0	10.7	5.9	9.6	23.9	44.2	8.6	0.0	11.0	9.6	103.8	32.0	9.7	2.4	11.4	10.7	13.6	8.3	5.3
TRMU	"FLJ10140, MTO2, MTU1, TRMT"	ENSG00000100416	"TRNA mitochondrial 2-thiouridylase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415"	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	4.2	7.5	7.7	2.3	7.8	2.9	4.0	8.3	9.6	4.3	8.3	4.5	4.7	3.6	7.5	5.6	3.4	2.6	11.2	7.6	8.5	9.1	8.8	3.5	5.0	8.5	8.6	4.0	10.2	8.0	5.3	4.1	8.5	4.4	4.1	2.8	5.5	4.7	6.9	4.8	4.0	3.9	7.9	4.2	4.3	2.3	8.5	3.0	4.6	8.4	4.3	4.2	4.1	7.8	17.8	16.0	6.6	15.1	12.2	8.6	16.6	18.1	12.6	24.9	19.2	22.7	4.5	11.5	12.5	16.2	10.9	15.3	28.5	16.0	21.1	7.5	38.4	13.6	25.0	27.1	10.4	26.5	9.0	8.2	17.6	25.8	8.1	10.3	16.2	5.8	19.3	2.7	15.3	19.1	10.4	21.5	25.5	10.6	27.5	12.2	14.4	21.2	12.5	12.1	15.9	19.0	16.0	18.5	31.7	8.2	10.7	10.9	11.9	11.1	19.8	15.8	20.7	6.5	7.8	12.6	15.7	19.1	22.8	0.0	6.2	3.8	9.4	9.0	8.3	5.4	8.2	8.9	7.1	5.5	7.3	6.9	1.3	8.0	9.8	5.8	11.0	5.9	7.7	7.8	8.3	9.6	7.6	8.5	8.5	8.6	8.5	7.9	8.5	7.8	12.7	9.6	6.1	22.9	13.2	6.2	10.8	16.8	7.4	26.4	10.6	11.8	14.7	10.0	10.7	11.0	16.7	24.9	16.1	14.1	27.4	20.1	1.6	6.3	10.2	14.5	12.5	14.3	19.4	19.6	21.0	11.9	21.9	6.6	9.5	26.8	13.9	16.8	15.9	13.5	18.0	12.3	10.2	9.9	4.0	3.3	15.2	8.8	8.8	5.6	14.9	11.9	20.6	10.1	14.6	19.5	9.9	17.0	13.8	14.2	15.3	27.9	10.2	26.4	6.6	7.6	14.4	18.5	12.9	9.6	9.7	15.3	13.1	21.0	19.3	9.9
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126933-3150879	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	9.7	10.0	7.2	8.9	7.2	3.5	8.5	7.9	8.0	7.8	7.0	8.1	4.4	8.8	5.5	9.4	7.6	8.3	8.4	7.4	7.2	17.2	10.0	8.4	9.7	7.1	7.3	8.3	8.4	8.3	10.3	10.5	7.1	11.3	7.6	4.0	7.7	6.3	9.3	6.4	7.9	8.3	7.3	10.7	9.1	6.5	7.4	9.8	11.3	7.6	10.9	13.1	7.9	8.0	20.0	29.6	18.2	9.8	24.1	21.5	20.5	19.9	17.4	21.6	20.9	25.0	20.9	35.6	12.8	22.4	32.0	12.6	24.6	18.6	26.5	24.6	13.3	28.7	25.3	24.9	31.4	32.2	20.8	17.9	25.0	20.2	6.8	15.0	21.0	24.1	25.1	9.8	35.9	37.2	22.0	21.4	15.2	29.2	19.0	20.5	28.1	32.5	26.1	25.8	10.8	15.9	31.6	20.6	18.5	26.3	18.7	16.3	14.8	22.8	18.7	23.6	25.7	12.6	31.4	43.4	17.2	27.6	25.0	49.4	12.4	36.4	16.4	18.1	16.0	25.8	20.8	18.1	16.8	15.7	22.7	20.1	16.6	19.8	19.0	15.6	18.6	11.2	7.2	7.2	7.9	8.0	7.4	7.2	7.1	7.3	7.1	7.3	7.4	8.0	20.7	16.0	13.4	15.3	30.2	14.8	29.0	19.9	24.5	13.5	12.1	11.0	14.3	2.8	16.3	18.4	14.6	25.8	23.5	10.6	45.0	19.1	2.3	15.8	19.0	21.1	8.4	16.6	23.8	9.9	17.8	19.9	23.4	12.0	22.8	20.7	12.5	9.2	13.3	10.1	27.0	10.7	16.2	11.0	13.3	2.9	10.8	13.3	7.2	23.4	20.3	17.1	18.6	23.6	34.7	10.6	9.2	8.6	30.7	30.9	11.0	32.7	11.4	15.7	0.0	14.9	17.4	20.8	17.9	23.4	13.1	28.3	22.0	24.7	13.5	23.9
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 9.4;Excitatory neurons: 14.6;Granulosa cells: 12.3;Inhibitory neurons: 20.0;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 37.1;SH-SY5Y: 33.8;SuSa: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071449			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles	"Plasma membrane, Cytosol"	"HPA071449: "	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	3.9	3.0	13.9	1.3	10.6	1.0	3.7	0.8	23.7	9.5	0.9	3.2	0.9	13.4	6.6	1.6	5.3	4.2	2.4	9.3	17.2	3.9	16.8	2.1	1.6	6.2	5.1	17.5	7.1	5.3	24.4	4.3	6.9	5.5	2.1	6.2	1.5	5.2	31.1	1.2	1.6	8.6	3.4	1.0	2.0	2.6	12.6	4.7	10.1	1.0	1.6	2.5	5.5	13.3	0.0	0.3	37.1	0.1	7.1	9.8	0.0	2.1	13.1	2.0	0.7	0.0	0.0	0.0	5.3	13.8	3.1	0.2	0.3	0.6	1.0	0.1	23.3	18.0	0.0	1.5	2.7	0.0	0.1	22.8	0.0	12.0	0.0	11.8	0.9	9.1	0.0	0.2	14.0	0.0	0.3	0.1	19.6	0.1	0.0	11.3	16.4	0.1	3.5	0.3	25.3	33.8	0.0	0.5	3.1	74.2	0.0	2.2	0.0	15.7	15.9	0.2	2.2	5.8	0.9	0.0	2.3	0.0	13.8	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	2.2	0.1	0.9	0.0	0.1	13.9	10.6	0.8	23.7	9.3	17.2	6.2	5.1	6.9	3.4	12.6	13.3	0.4	0.0	0.0	9.4	0.3	0.4	1.4	0.8	5.2	4.2	0.5	1.9	1.8	0.0	1.9	3.7	0.0	0.8	0.2	0.0	0.0	1.7	0.4	0.3	7.9	1.9	0.0	0.0	14.6	0.2	0.6	7.0	0.5	0.5	1.3	12.3	0.4	0.0	0.5	8.4	20.0	0.0	0.0	0.0	0.4	0.6	5.9	0.2	0.0	1.0	0.1	2.2	0.0	17.1	9.4	0.2	0.0	3.8	0.1	0.4	0.0	0.4	0.0	0.9	0.0	1.5	3.3	1.2	1.9	0.1	0.1	0.7	0.7	2.9	0.0	0.3
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 108.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.2;Oligodendrocytes: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	11.5	9.6	4.3	13.3	6.5	21.4	13.6	15.4	6.7	10.3	29.3	13.8	14.4	12.7	14.6	8.6	9.4	11.1	15.5	4.8	3.5	22.9	25.3	11.6	16.6	4.9	3.9	16.4	12.2	108.9	5.3	13.3	5.9	10.9	14.4	10.5	10.9	10.6	7.8	16.6	13.1	11.4	3.2	12.2	13.6	9.9	6.4	15.5	17.3	9.1	14.4	11.4	8.1	10.4	21.4	21.0	17.2	19.1	48.5	36.2	20.9	26.4	36.7	16.5	21.6	29.1	11.6	46.4	12.7	30.8	42.5	35.1	23.3	19.5	23.4	26.0	13.7	37.1	31.5	15.4	44.0	38.8	27.6	33.9	22.4	18.8	35.0	24.0	13.5	28.8	42.6	34.5	30.4	33.7	25.1	18.8	13.0	29.4	12.8	27.2	23.7	22.7	23.0	49.9	14.2	18.1	18.2	28.7	35.8	30.1	18.0	41.6	20.7	26.1	12.4	122.4	30.8	23.3	54.9	44.0	28.4	77.5	24.8	1.8	1.3	1.6	2.5	1.3	2.9	2.2	1.8	1.7	1.5	2.3	1.6	1.9	1.7	2.4	1.4	1.9	2.0	0.8	4.3	6.5	15.4	6.7	4.8	3.5	4.9	3.9	5.9	3.2	6.4	10.4	23.9	19.2	31.3	73.1	36.4	31.6	17.2	11.0	44.9	21.9	18.8	11.9	25.9	21.5	8.2	12.9	12.5	23.0	38.4	17.0	3.9	11.7	33.3	21.6	27.1	19.7	18.5	29.6	122.2	12.7	9.4	26.1	37.8	23.1	17.7	26.0	14.6	43.9	14.6	21.9	92.7	19.5	6.1	22.4	19.8	26.0	26.4	26.5	19.6	66.5	24.2	8.5	29.9	80.9	109.1	15.5	13.9	20.3	33.2	24.9	23.4	11.0	19.3	22.6	13.1	30.0	22.0	23.1	23.6	25.7	24.2	16.3	34.5	22.2	20.4	11.1
TRPS1	"GC79, LGCR"	ENSG00000104447	"Transcriptional repressor GATA binding 1"	Q9UHF7	8	115408496-115809673	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 60.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 758.7;Breast glandular cells: 243.2;Oligodendrocyte precursor cells: 280.5;Oligodendrocytes: 294.0"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 49.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 47.4;SK-BR-3: 78.1;T-47d: 244.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060380, HPA071767"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA060380: AB_2684270, HPA071767: AB_2732185"	"unprognostic (4.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (2.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.07e-3)"	4.4	3.1	15.5	5.7	14.3	7.6	60.8	10.5	14.7	10.9	10.1	5.9	0.9	9.9	3.4	14.2	5.5	10.0	3.8	17.0	13.5	5.4	2.1	4.7	4.9	32.5	31.5	5.2	1.1	5.3	2.6	2.8	24.2	9.4	2.7	4.1	12.0	8.4	2.6	10.6	2.1	10.6	18.4	4.2	2.7	12.5	27.5	2.4	5.7	3.3	4.0	5.1	14.1	16.3	3.1	0.6	5.9	0.3	5.4	19.8	0.6	4.9	11.3	3.1	5.2	0.5	4.9	2.4	0.0	12.7	2.6	0.1	22.9	4.3	3.5	0.3	6.9	0.1	10.3	0.2	7.2	0.0	0.3	9.5	4.4	8.6	15.8	8.9	2.7	0.3	1.1	37.7	6.0	47.4	0.2	0.0	1.1	1.1	4.8	0.2	0.2	30.0	4.9	0.3	5.2	3.9	2.5	78.1	3.2	2.8	244.8	2.1	0.2	13.7	6.9	4.0	9.7	10.1	0.3	4.5	14.4	0.0	9.2	0.0	4.5	0.0	0.9	1.9	0.9	0.5	1.0	1.0	1.7	0.8	0.9	0.9	0.8	1.0	1.4	0.6	0.5	0.8	15.5	14.3	10.5	14.7	17.0	13.5	32.5	31.5	24.2	18.4	27.5	16.3	10.0	6.4	3.0	758.7	13.3	9.4	20.0	10.3	34.1	9.2	243.2	125.1	4.6	2.8	9.2	18.4	43.8	0.1	18.7	0.1	11.7	2.9	95.0	58.5	35.7	7.5	0.0	5.5	128.3	2.9	0.2	26.8	4.6	63.5	12.7	0.3	3.6	1.1	16.5	0.0	148.2	0.0	8.2	55.2	104.1	163.2	25.1	55.5	21.4	171.4	32.5	10.6	5.2	280.5	294.0	2.7	0.0	28.2	10.1	16.9	0.0	23.7	8.9	35.9	6.6	60.2	28.2	1.8	8.3	73.6	12.5	0.3	25.6	19.5	0.0	11.2
TRUB1	PUS4	ENSG00000165832	"TruB pseudouridine synthase family member 1"	Q8WWH5	10	114938195-114977676	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 62.2;Theca cells: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037914, HPA057552"	Approved		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA037914: AB_10672399, HPA057552: AB_2683465"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.20e-3)"	"unprognostic (9.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-1)"	7.4	29.3	6.3	7.5	7.4	4.2	11.3	5.1	9.0	9.8	7.3	9.5	8.9	12.8	9.3	8.3	9.7	7.7	21.5	7.6	7.1	16.0	12.9	6.6	10.0	5.8	6.0	16.8	6.8	15.8	4.9	7.5	6.1	11.7	10.4	6.7	9.3	9.9	7.5	6.5	8.2	11.1	5.6	9.3	8.7	17.9	7.0	11.5	12.3	9.7	10.1	7.8	4.8	6.4	25.5	19.6	18.8	47.0	13.3	17.7	25.3	21.4	24.1	28.4	32.0	16.1	25.5	31.4	24.2	16.9	12.4	21.3	25.6	26.5	41.8	23.9	27.5	14.4	9.2	28.8	22.8	27.2	20.7	18.2	35.8	20.2	39.6	30.1	16.2	24.9	15.1	12.5	34.1	12.3	25.7	21.6	17.8	17.0	19.1	25.4	47.5	19.2	37.4	12.7	17.5	19.3	18.0	26.4	47.7	20.0	21.1	16.6	14.5	13.0	13.0	20.8	26.5	23.6	20.4	26.3	18.3	34.2	11.9	4.0	2.6	0.9	4.4	4.0	6.5	7.3	4.7	4.7	4.8	5.9	6.2	5.8	0.2	8.1	7.3	4.3	6.2	4.6	6.3	7.4	5.1	9.0	7.6	7.1	5.8	6.0	6.1	5.6	7.0	6.4	6.9	12.8	8.4	8.8	11.2	5.6	4.7	15.3	6.2	13.9	11.9	8.1	13.6	4.3	12.0	9.2	2.1	9.1	10.5	7.1	21.5	7.6	62.2	11.1	12.8	6.6	7.7	9.0	23.0	4.9	6.6	11.2	6.6	12.0	10.2	26.7	12.1	20.2	7.6	25.2	22.0	8.2	6.1	7.3	4.2	9.6	8.4	5.0	3.6	8.4	5.4	10.4	9.2	31.2	16.7	7.0	3.6	10.1	12.7	4.2	6.2	27.9	9.8	5.6	6.6	8.4	9.3	14.5	23.3	15.9	7.0	6.2	8.0	74.1	12.9	5.8
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31149979-31349436	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 32.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.0;Excitatory neurons: 34.4;Inhibitory neurons: 84.7;Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.2;RH-30: 46.4;U-138 MG: 32.8;U-87 MG: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	7.0	3.6	4.6	4.8	4.5	1.1	6.2	0.0	8.6	18.8	0.3	16.1	2.2	21.5	9.2	5.7	13.0	9.3	5.7	5.7	0.4	3.2	1.3	6.3	1.2	3.1	1.0	32.8	1.5	1.3	4.6	5.7	1.5	11.6	4.0	1.8	3.3	9.5	1.9	3.0	5.5	18.4	3.9	5.4	6.7	2.7	3.1	0.8	10.2	2.3	0.5	14.8	8.8	4.9	0.0	2.0	0.7	0.0	9.4	22.2	0.0	6.0	8.8	3.7	6.6	0.0	1.2	0.0	0.0	14.8	7.0	1.0	2.7	5.3	8.2	0.0	2.2	0.0	0.0	0.0	19.4	5.2	9.1	13.0	4.5	13.7	6.8	0.0	0.0	4.4	0.0	0.0	16.9	0.9	0.0	0.0	0.7	0.0	0.0	5.9	46.4	0.0	0.0	0.0	0.0	13.8	0.1	0.0	4.7	4.4	0.0	3.6	0.0	32.8	10.3	3.4	8.8	0.0	0.0	0.0	21.2	8.8	0.9	0.0	0.9	0.0	1.1	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.3	1.9	0.0	0.1	0.0	0.3	0.3	4.6	4.5	0.0	8.6	5.7	0.4	3.1	1.0	1.5	3.9	3.1	4.9	8.3	3.2	1.1	10.1	0.2	4.8	7.3	9.2	15.4	14.0	0.8	2.4	2.1	1.5	5.1	3.7	0.0	0.4	2.5	0.0	0.0	0.4	0.2	1.3	54.0	9.0	0.0	0.4	34.4	0.6	0.3	20.2	0.0	1.3	1.3	2.6	17.2	0.2	11.6	16.8	84.7	0.0	2.0	9.7	10.4	1.1	17.7	5.0	5.4	14.0	6.4	0.2	0.0	59.3	1.9	0.6	0.0	29.3	0.3	3.8	0.0	0.1	1.3	0.2	0.0	29.7	7.8	0.3	4.0	1.7	1.7	0.8	1.7	1.0	0.0	3.2
TSLP		ENSG00000145777	"Thymic stromal lymphopoietin"	Q969D9	5	111070062-111078026	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.5;urinary bladder: 12.0"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 108.1;Basal squamous epithelial cells: 338.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.0;HHSteC: 17.1;hTCEpi: 10.3;hTEC/SVTERT24-B: 18.9;hTERT-HME1: 12.5;hTERT-RPE1: 38.6;U-87 MG: 14.1"	"Not detected"	"Not detected"							HPA056350			Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	38400			"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Vesicles"		"HPA056350: "	"unprognostic (6.47e-4)"	"unprognostic (3.26e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.74e-3)"	1.6	0.7	0.3	1.3	0.3	0.0	1.5	0.3	0.5	1.4	0.2	1.1	0.7	0.8	0.3	3.8	0.6	8.8	4.3	0.3	0.3	1.2	11.5	1.9	0.4	0.4	0.3	0.3	0.3	0.4	0.4	0.1	0.4	6.2	0.9	0.0	1.2	4.0	1.4	0.8	1.0	0.6	0.3	0.4	1.2	4.8	1.1	0.2	2.7	1.4	0.5	12.0	1.9	0.4	0.0	0.0	0.0	1.8	2.3	15.0	0.0	0.0	2.3	0.4	2.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.5	0.8	0.0	2.4	2.8	0.1	0.0	17.1	0.5	0.0	0.3	10.3	18.9	12.5	38.6	0.0	6.6	0.3	0.0	3.2	0.0	2.5	0.0	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	1.2	0.0	1.1	0.0	0.0	0.9	0.0	0.0	4.1	0.0	0.0	14.1	0.3	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.3	0.4	0.3	0.4	0.3	1.1	0.4	6.2	0.0	3.1	0.3	0.1	55.8	26.6	108.1	338.6	0.0	6.5	8.0	7.4	0.0	35.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	38.5	0.1	0.9	10.5	0.0	0.0	0.0	0.0	0.1	10.0	0.0	0.1	0.0	0.9	7.9	9.4	0.2	0.0	0.0	0.0	24.4	1.2	5.0	26.3	0.6	0.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	24.7	0.2	1.6	3.5	0.0	0.0	6.9	3.8	0.4	0.9	38.0	25.1	0.0	0.8	1.9	0.1	3.1
TSNARE1	FLJ31164	ENSG00000171045	"T-SNARE domain containing 1"	Q96NA8	8	142212080-142403182	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 26.7;Inhibitory neurons: 23.0;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 24.5"					"Low region specificity"	"Detected in all"			HPA074249	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA074249: "	"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.33e-4)"	10.1	9.5	10.8	6.6	10.6	4.2	12.0	5.0	19.0	16.3	4.8	11.3	11.6	13.8	2.9	10.4	15.0	5.9	9.1	9.9	7.3	13.6	10.0	9.9	6.7	12.0	8.4	20.4	28.5	7.0	12.9	3.3	9.2	13.7	2.8	4.0	13.4	6.4	11.0	27.3	12.9	3.8	5.9	12.6	13.3	13.4	8.9	6.2	16.3	4.6	4.4	11.8	12.1	14.1	6.6	6.4	4.2	5.3	3.2	2.9	13.2	1.9	3.1	1.9	1.9	2.1	7.0	3.5	10.7	1.5	3.2	5.9	1.9	6.6	0.8	4.0	6.4	4.2	1.7	7.2	8.5	9.5	9.6	5.6	6.2	0.0	4.3	3.9	2.1	18.4	8.4	0.3	1.3	8.7	8.1	8.8	4.2	6.4	15.8	0.0	2.2	6.2	3.6	8.0	17.5	10.6	8.9	7.1	12.8	2.0	4.7	8.2	5.1	3.1	8.5	5.6	4.3	0.5	2.8	5.6	5.7	24.5	3.2	1.6	0.5	0.1	0.9	2.3	0.6	0.3	0.5	0.2	0.6	0.4	0.2	0.3	0.0	0.5	2.0	0.0	0.6	0.6	10.8	10.6	5.0	19.0	9.9	7.3	12.0	8.4	9.2	5.9	8.9	14.1	1.9	0.0	1.1	12.1	2.3	4.5	2.2	0.8	6.8	2.6	1.8	1.8	4.6	2.8	0.5	1.8	2.1	0.3	1.6	1.6	3.9	1.6	2.4	1.9	1.0	1.5	1.8	2.5	26.7	1.8	1.8	1.5	4.1	1.4	0.0	1.2	1.1	1.3	1.9	0.0	23.0	2.1	0.0	2.6	2.9	5.3	0.9	1.7	3.6	12.2	1.5	3.1	2.1	21.1	24.6	1.6	0.2	1.5	1.6	1.3	1.6	1.4	2.3	1.3	0.0	2.3	1.7	5.0	3.7	3.5	7.5	0.3	3.1	0.7	0.9	1.5
TSNAX	"C3PO, TRAX"	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528541-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 194.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		36000	"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	22.7	31.9	12.2	20.2	12.8	15.1	25.4	11.5	15.1	19.5	17.8	18.4	17.7	21.5	22.8	19.4	18.0	18.7	26.2	13.2	15.2	31.7	26.0	20.8	26.4	11.9	12.7	18.3	16.3	40.0	17.0	20.4	12.3	22.8	19.6	19.9	18.1	20.5	50.5	21.8	17.3	20.7	13.4	28.5	17.7	20.9	13.2	26.6	29.8	40.7	25.7	19.9	14.9	13.7	30.3	24.1	36.7	29.7	27.1	32.6	41.4	33.1	50.9	42.2	36.0	21.4	40.8	42.3	55.0	38.0	15.7	31.9	29.3	31.4	53.9	38.4	51.7	40.7	23.9	28.6	35.8	67.8	82.1	40.4	32.4	40.9	32.3	26.4	30.7	31.6	66.6	28.8	58.0	12.9	44.0	32.9	53.4	26.5	28.3	42.8	39.8	56.8	46.9	33.9	34.1	65.7	35.3	43.3	116.8	14.5	63.2	113.0	28.9	28.3	26.3	57.6	61.0	48.2	68.9	46.4	46.8	52.0	79.7	194.4	34.8	85.6	30.6	40.2	30.3	28.5	33.5	30.6	33.2	28.3	34.6	34.0	37.7	51.9	55.7	22.3	39.4	33.6	12.2	12.8	11.5	15.1	13.2	15.2	11.9	12.7	12.3	13.4	13.2	13.7	48.3	28.9	41.3	0.0	25.5	43.8	21.4	42.4	8.6	59.2	27.2	20.1	24.1	40.0	25.3	42.3	29.2	44.4	36.9	21.8	54.8	30.6	12.6	23.6	20.5	46.1	28.9	59.5	0.0	31.1	51.5	28.1	11.7	19.3	77.3	26.2	31.8	32.8	49.5	65.6	0.0	28.2	38.7	62.2	35.0	9.4	33.5	40.5	26.6	0.0	51.7	72.0	37.0	0.0	0.0	26.5	21.8	36.1	13.4	17.3	22.4	45.8	31.9	47.1	39.5	34.4	30.2	40.8	65.4	13.0	51.4	36.3	30.5	46.8	25.6	14.9
TSPAN14	"DC-TM4F2, MGC11352, TM4SF14"	ENSG00000108219	"Tetraspanin 14"	Q8NG11	10	80454166-80533124	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 156.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 276.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014773, HPA057174"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA014773: AB_2208670, HPA057174: "	"unprognostic (7.52e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.12e-3)"	"prognostic favorable (4.20e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.57e-3)"	97.9	20.7	29.1	43.1	24.2	57.2	80.1	25.1	29.7	63.1	19.4	33.4	30.9	38.4	44.1	92.1	47.1	32.9	51.2	26.2	21.4	45.7	21.1	70.8	54.2	31.7	32.2	47.2	33.1	35.7	15.7	81.9	29.7	34.8	27.1	7.9	47.7	34.1	24.9	74.3	34.8	33.3	31.2	48.5	24.7	23.2	32.8	40.1	46.5	42.1	44.6	55.0	56.1	31.4	96.2	135.6	128.3	44.5	186.6	59.3	59.6	49.3	91.8	51.1	38.0	134.8	54.6	31.5	93.2	26.4	18.9	97.0	35.9	88.5	41.4	55.9	13.9	88.9	15.8	118.2	63.5	31.8	20.3	58.8	77.2	52.8	92.1	94.8	191.5	31.8	48.8	23.0	15.0	83.3	50.0	23.3	29.5	61.2	0.1	167.9	14.9	5.3	203.9	131.9	27.5	42.3	19.7	133.7	149.5	43.7	54.1	79.8	276.3	13.0	52.8	12.4	35.1	10.7	42.0	11.8	42.2	65.4	57.5	16.2	51.5	56.3	92.1	102.1	41.3	13.8	70.7	81.1	33.9	13.7	82.3	79.3	54.7	95.2	172.8	13.6	61.8	84.3	29.1	24.2	25.1	29.7	26.2	21.4	31.7	32.2	29.7	31.2	32.8	31.4	141.9	16.0	55.1	13.1	18.5	34.9	40.3	54.6	35.3	2.1	29.5	23.2	11.3	25.8	39.0	33.1	77.2	7.8	38.4	32.8	7.9	43.8	2.4	44.7	38.9	95.3	64.2	35.6	12.9	24.8	74.4	18.8	18.3	75.1	7.6	41.2	156.7	21.1	50.5	3.3	7.4	37.0	34.6	129.3	12.9	4.1	39.1	66.5	14.2	35.6	51.8	23.7	89.6	4.5	13.5	64.2	21.6	41.0	18.4	55.7	23.4	8.0	29.6	7.1	98.6	10.2	43.1	5.0	19.0	80.2	36.4	7.7	55.7	10.4	30.6	69.7
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451465-69507666	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 19.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044657, HPA071160"	Approved		Approved	"Nuclear bodies,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear bodies, Plasma membrane"	"Vesicles, Cytosol"	"HPA044657: AB_10967927, HPA071160: "	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	70.1	5.3	22.8	15.3	37.6	1.0	61.0	35.0	34.1	16.4	14.9	62.5	38.8	32.6	8.5	10.8	24.6	27.4	16.9	23.6	25.4	25.9	4.6	34.4	8.7	36.9	33.4	3.4	20.0	3.2	6.6	28.1	33.7	34.5	39.4	3.1	26.6	24.7	17.9	10.6	38.8	31.3	30.0	26.7	75.3	9.5	34.5	3.6	14.5	5.6	7.5	46.0	14.9	62.4	51.3	103.9	2.1	0.3	2.3	0.0	12.0	0.2	1.9	2.6	6.8	45.1	154.7	0.0	211.3	2.3	9.2	101.2	7.2	11.5	3.0	42.1	20.4	2.9	3.5	10.0	1.1	0.1	1.8	2.2	3.1	1.4	1.5	7.5	39.4	20.5	1.1	0.0	1.2	168.0	0.6	0.9	2.6	153.2	266.8	4.0	2.1	2.0	29.7	92.9	34.5	13.2	0.6	134.8	17.9	17.3	59.3	2.2	34.5	0.2	0.8	0.1	17.5	1.2	6.1	1.0	1.1	0.1	0.2	0.0	0.0	0.0	2.3	0.0	19.5	0.0	3.1	2.8	3.3	0.0	1.0	0.2	0.0	0.1	0.0	0.2	1.1	0.5	22.8	37.6	35.0	34.1	23.6	25.4	36.9	33.4	33.7	30.0	34.5	62.4	108.8	32.1	6.9	4.9	1.5	3.6	10.9	59.6	2.2	2.9	45.1	15.6	1.7	31.5	29.5	29.5	6.2	2.0	1.6	125.8	3.9	125.2	27.9	25.5	3.8	48.4	40.2	8.0	1.7	189.3	11.9	8.2	71.4	36.6	1.3	2.5	10.4	0.1	25.3	1.7	1.0	106.7	36.7	8.5	16.1	6.6	0.6	9.8	28.4	15.0	15.6	44.7	0.0	11.1	75.3	193.4	120.9	0.0	0.2	50.4	68.3	1.8	27.6	1.5	13.1	39.7	26.8	4.3	18.5	2.9	3.1	3.0	3.9	7.5	66.3	29.6
TSPAN31	SAS	ENSG00000135452	"Tetraspanin 31"	Q12999	12	57738013-57750219	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	4	"glioma: 54.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030758, HPA057489"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA030758: , HPA057489: AB_2683447"	"unprognostic (2.66e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (4.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (9.91e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.58e-1)"	24.5	29.7	9.0	11.2	10.8	5.5	23.1	10.8	15.6	26.2	11.8	20.5	16.4	26.2	13.2	20.4	25.8	20.9	26.7	9.5	10.3	26.7	20.9	22.8	11.8	11.2	10.2	25.6	25.2	32.7	24.4	12.5	11.0	22.1	10.7	29.7	25.6	13.5	21.0	18.6	18.5	8.4	11.1	20.8	23.0	8.0	9.9	9.8	30.2	21.2	8.7	21.0	20.1	13.0	9.5	23.4	21.1	5.4	44.3	24.0	13.5	15.8	11.7	4.6	5.1	16.7	46.4	7.6	32.7	29.0	9.4	17.5	5.7	26.7	10.7	23.1	15.4	10.7	18.7	6.6	45.2	10.6	17.9	29.6	30.2	13.7	30.3	22.1	14.6	4.6	7.5	19.9	19.6	19.4	9.2	5.9	4.3	18.3	7.0	10.5	139.8	20.0	15.7	19.0	6.6	16.7	15.6	21.3	10.5	4.5	41.1	15.8	27.6	11.3	9.5	5.6	7.4	28.9	8.1	4.1	32.7	6.3	19.2	25.4	26.3	16.4	35.8	28.6	34.8	31.1	28.5	30.7	27.6	31.0	28.3	26.2	5.8	35.4	42.0	58.3	22.1	33.0	9.0	10.8	10.8	15.6	9.5	10.3	11.2	10.2	11.0	11.1	9.9	13.0	37.1	48.1	32.4	8.1	23.8	11.2	46.4	37.4	22.2	43.2	32.0	27.4	5.1	20.0	31.4	31.3	41.7	20.9	29.8	19.9	9.8	37.6	1.2	18.5	32.5	26.7	26.5	8.2	9.1	39.0	15.2	31.7	11.7	20.4	45.0	28.9	22.1	21.6	22.4	21.9	9.1	21.6	32.6	18.0	16.4	1.8	25.7	24.2	32.0	8.4	21.6	62.7	35.0	11.1	13.3	37.6	20.3	17.3	18.4	30.5	30.6	18.1	27.9	60.4	19.7	22.3	31.9	9.2	7.7	16.1	12.6	24.5	20.4	35.3	19.4	31.8
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318204	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 19.9;heart muscle: 11.4;lymphoid tissue: 5.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 44.6;Erythroid cells: 20.6;granulocytes: 30.4;Langerhans cells: 19.6;NK-cells: 87.6;T-cells: 21.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HEL: 15.0;HL-60: 6.6;NB-4: 5.3;THP-1: 5.6;U-937: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024135	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	0.5	0.5	0.2	1.6	0.2	19.9	0.3	0.5	0.2	1.1	0.0	0.5	0.3	0.7	0.2	0.4	0.5	1.4	11.4	0.2	0.3	0.2	0.4	2.0	5.5	0.5	0.3	0.5	0.0	0.0	0.0	0.3	0.3	0.2	0.3	0.2	0.9	0.5	0.3	0.6	0.5	0.0	0.1	3.5	0.9	0.2	0.2	0.9	0.2	0.2	2.4	0.7	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	15.0	0.0	0.1	0.6	6.6	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	8.9	0.0	40.5	31.8	4.2	25.8	40.9	16.5	2.4	9.1	22.7	32.2	1.1	7.2	27.1	17.3	58.6	46.0	1.6	13.2	21.7	0.2	0.2	0.5	0.2	0.2	0.3	0.5	0.3	0.3	0.1	0.2	0.5	0.5	0.0	6.7	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.2	0.1	15.9	0.0	0.6	0.0	0.0	0.1	44.6	0.0	0.0	0.0	0.8	0.1	0.3	0.8	0.0	20.6	0.0	0.0	0.3	1.3	0.5	0.0	30.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	6.5	19.6	4.1	0.9	13.6	1.8	1.0	14.4	0.2	87.6	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	1.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	21.9	0.0	0.0	0.1
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627108-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 422.5;Granulosa cells: 684.8;Late spermatids: 1708.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 121.7;RT4: 153.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	29.6	18.2	7.2	4.9	7.5	0.6	34.2	7.2	8.9	26.9	26.8	40.0	19.7	20.5	14.8	46.8	39.5	16.7	8.6	7.4	9.0	36.5	70.2	11.3	3.0	8.7	9.3	53.4	20.2	34.7	36.9	20.0	8.2	18.9	33.1	6.2	52.6	10.3	4.6	9.7	18.5	7.2	8.9	8.7	14.8	74.9	9.6	4.2	19.3	5.3	6.8	32.2	24.1	12.0	24.8	23.0	80.6	42.2	28.7	16.6	30.4	12.9	17.3	20.3	47.6	54.9	37.7	0.0	53.3	12.2	16.9	19.9	0.3	19.7	25.8	0.1	33.3	3.8	14.9	62.0	17.1	0.1	2.5	30.2	9.3	19.5	6.6	34.4	49.3	0.0	0.0	0.1	21.7	19.8	0.1	0.3	121.7	35.4	18.4	0.0	35.5	0.0	33.0	153.5	4.7	20.3	11.6	10.0	18.5	61.9	16.6	3.3	12.7	16.0	24.4	24.3	8.6	0.1	0.2	0.3	13.4	0.0	11.5	0.3	0.0	0.1	0.3	0.0	1.1	0.1	0.8	0.3	0.0	0.1	2.1	1.2	0.3	0.1	0.1	0.1	0.0	0.3	7.2	7.5	7.2	8.9	7.4	9.0	8.7	9.3	8.2	8.9	9.6	12.0	147.0	3.2	10.1	14.4	2.3	7.1	41.0	75.7	29.0	0.6	72.5	46.1	8.2	50.1	89.4	93.8	0.0	28.7	1.1	94.9	23.5	80.3	422.5	54.0	21.4	37.4	33.6	4.8	0.9	12.6	40.7	25.6	21.9	19.2	0.0	684.8	47.5	104.0	4.5	0.0	0.8	47.9	193.3	10.2	3.1	1708.3	32.9	3.1	10.6	1.0	1.0	48.2	0.0	9.5	0.4	18.7	55.5	35.7	0.3	33.0	43.5	43.8	193.9	1.9	19.7	17.1	43.1	20.9	32.4	23.3	5.4	13.5	2.5	49.4	94.3	89.7
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS"	ENSG00000100300	"Translocator protein"	"B1AH88, P30536"	22	43151547-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 690.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1429.2;Pancreatic endocrine cells: 1442.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 516.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011232, HPA046260, HPA072304"	Uncertain		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria	"Vesicles, Cytosol"	"CAB011232: , HPA046260: , HPA072304: "	"unprognostic (5.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-3)"	249.3	164.5	42.3	65.3	46.3	488.7	204.3	50.9	61.1	217.3	45.8	189.7	73.6	91.8	8.7	690.1	108.5	39.4	174.7	39.9	51.0	120.5	81.9	181.5	44.3	61.9	48.8	72.3	93.4	22.4	50.8	30.5	57.4	126.6	33.9	4.2	244.9	28.9	84.0	388.0	116.9	26.6	58.0	206.9	216.9	21.4	59.5	22.2	77.4	27.5	39.9	135.7	355.5	69.0	300.0	143.3	10.2	134.4	54.7	175.3	10.8	216.6	107.0	109.4	115.7	28.8	222.4	0.3	147.8	175.7	52.2	242.2	27.9	171.7	13.9	49.5	111.4	28.9	150.4	10.1	193.4	66.4	145.0	137.5	276.4	65.9	58.2	125.8	262.9	0.2	24.0	53.6	114.2	244.5	1.1	188.5	11.6	154.0	355.7	67.0	0.0	516.2	139.3	173.8	14.0	65.4	103.9	200.4	263.5	0.1	76.3	256.6	269.7	132.6	96.9	135.5	92.9	21.7	4.1	2.7	170.0	218.3	171.4	656.8	1678.5	931.0	314.7	1051.6	247.7	199.2	429.9	309.2	1170.2	266.9	325.9	264.3	1052.3	365.0	713.1	209.0	539.5	1585.6	42.3	46.3	50.9	61.1	39.9	51.0	61.9	48.8	57.4	58.0	59.5	69.0	225.5	160.3	140.0	3.6	88.9	366.8	392.3	1429.2	554.3	2.8	269.3	360.2	92.1	323.1	555.7	206.0	2.1	10.0	140.3	680.7	369.8	578.5	2.4	170.8	143.6	220.4	194.9	239.9	0.3	586.4	284.9	205.1	440.9	309.5	268.6	124.3	187.1	110.5	758.5	3.3	0.8	636.8	478.1	644.7	524.7	11.7	82.6	611.6	723.9	10.3	776.9	180.5	207.0	6.0	20.1	1442.1	705.9	157.6	76.3	526.2	471.9	180.7	283.2	19.4	105.2	108.2	197.8	2.8	4.5	1067.4	536.0	20.0	180.0	30.5	664.1	786.1
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116267760-116279930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	26.5	73.8	51.1	17.1	56.4	34.4	23.4	35.2	78.2	22.5	25.5	30.8	24.4	28.4	33.0	34.0	31.4	20.5	43.3	64.9	38.1	50.4	40.9	21.4	21.4	25.9	22.2	34.9	33.3	63.9	40.1	16.0	26.0	42.0	17.7	26.1	30.2	33.9	114.9	29.4	30.0	24.3	17.1	29.5	35.5	28.9	34.6	22.3	39.6	91.9	25.6	31.4	22.7	44.5	22.2	21.5	27.3	50.3	47.2	30.9	22.7	35.2	34.7	31.3	35.8	27.7	15.9	47.3	43.0	40.8	28.2	38.5	21.6	59.8	33.2	19.4	56.0	19.1	29.9	50.8	29.8	31.9	11.2	36.2	46.0	32.5	31.2	32.9	30.3	20.7	34.3	36.1	44.2	48.9	21.5	18.9	13.6	21.3	19.8	19.1	23.5	26.3	54.9	42.9	23.7	23.6	29.2	38.8	18.0	30.6	51.0	39.1	37.3	21.2	18.7	17.2	38.7	19.8	22.7	25.2	35.1	20.3	14.1	121.0	30.1	51.5	40.5	51.0	61.4	46.4	52.4	45.4	26.1	52.2	51.1	50.0	24.1	33.2	57.7	44.9	44.8	34.0	51.1	56.4	35.2	78.2	64.9	38.1	25.9	22.2	26.0	17.1	34.6	44.5	29.4	35.3	45.9	15.7	65.2	166.1	100.6	37.6	70.6	81.0	91.7	47.5	100.0	61.5	40.5	104.8	27.1	54.8	54.2	49.3	154.6	40.8	33.0	40.5	42.0	40.4	74.6	49.7	65.4	43.9	25.5	63.1	41.3	34.9	31.7	67.5	73.9	81.3	42.4	38.7	50.5	59.3	46.8	82.1	116.0	20.2	75.5	40.2	87.2	22.5	38.3	82.6	42.2	15.6	20.2	48.8	52.5	95.5	24.1	77.0	60.3	218.9	41.4	58.1	131.5	87.6	63.5	61.9	39.8	55.5	162.0	59.7	69.1	101.3	70.2	75.8
TSPYL5	KIAA1750	ENSG00000180543	"TSPY like 5"	Q86VY4	8	97273488-97277928	"Predicted intracellular proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.7"	"Group enriched"	"Detected in many"	8	"Early spermatids: 172.9;Late spermatids: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 34.9;K-562: 30.5;SCLC-21H: 60.8;SH-SY5Y: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031347	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Golgi apparatus"	"HPA031347: AB_10601454"	"prognostic favorable (1.21e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.31e-2)"	"unprognostic (3.13e-1)"	6.0	8.6	11.1	4.3	12.6	1.2	12.1	6.7	11.4	11.4	0.8	9.7	1.8	15.2	15.5	4.5	12.4	6.6	12.4	10.0	17.6	10.0	1.7	7.2	6.2	10.3	8.6	25.2	8.7	8.1	11.8	4.3	12.5	15.3	3.2	11.3	9.7	18.3	12.9	4.1	4.1	14.3	7.6	7.3	8.4	44.7	14.4	7.4	8.3	10.5	7.3	9.7	4.6	8.7	0.0	15.9	0.0	0.0	0.4	0.4	0.1	12.4	0.0	12.2	7.9	0.0	0.5	0.0	16.8	14.8	0.0	4.4	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	19.4	0.0	17.2	0.0	0.0	0.2	34.9	30.5	0.0	0.5	23.4	0.0	0.0	0.0	0.0	0.2	23.1	0.0	0.1	10.2	0.1	60.8	47.1	0.0	4.1	0.0	8.2	0.0	1.9	0.0	0.0	26.2	0.1	0.0	14.4	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.3	0.2	0.1	0.0	0.2	0.0	0.5	0.2	0.0	11.1	12.6	6.7	11.4	10.0	17.6	10.3	8.6	12.5	7.6	14.4	8.7	7.5	6.4	4.1	0.0	5.5	2.3	4.5	0.7	6.8	12.5	9.9	8.8	16.3	2.8	2.1	9.2	20.9	0.2	2.6	0.0	5.9	5.8	172.9	6.4	13.7	9.8	2.4	3.4	0.0	3.5	0.1	12.1	10.2	2.6	0.0	19.2	6.4	0.8	6.3	8.4	0.0	0.3	2.0	5.0	5.9	419.0	24.5	4.6	7.2	0.0	2.2	13.1	0.0	0.0	0.0	3.7	0.0	21.1	0.8	7.8	0.0	1.4	4.1	12.2	6.6	12.4	9.3	35.5	31.0	5.6	1.6	0.1	1.3	9.9	0.3	4.1
TSSK3	"SPOGA3, STK22C"	ENSG00000162526	"Testis specific serine kinase 3"	Q96PN8	1	32351521-32364312	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 12.7;testis: 34.0"	"Group enriched"	"Detected in some"	67	"Early spermatids: 335.4;Late spermatids: 1251.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037516			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA037516: AB_2675517"	"unprognostic (5.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-3)"	2.3	2.7	0.1	2.5	0.2	12.7	2.0	2.2	0.4	2.9	0.3	2.1	3.4	2.3	0.0	1.3	2.7	1.8	1.5	0.1	0.0	1.9	2.7	2.7	3.8	0.5	0.0	3.0	2.1	0.0	1.7	0.7	0.2	2.1	0.0	4.3	2.4	0.0	3.0	4.7	4.0	0.1	0.0	4.3	2.2	34.0	0.2	0.0	2.3	0.0	0.0	1.7	2.3	0.5	2.4	2.8	6.0	3.6	0.0	0.8	5.2	0.6	0.9	0.0	0.0	0.5	1.3	1.4	0.8	0.0	1.0	3.5	0.0	0.0	0.0	3.6	6.8	2.8	14.1	4.3	3.3	1.3	3.2	0.1	0.7	0.0	1.0	6.7	0.0	4.5	3.5	5.5	0.0	0.7	1.5	1.5	1.1	0.5	1.6	2.1	1.6	4.7	0.0	2.4	1.7	3.8	0.8	3.0	3.9	4.5	1.8	2.4	2.4	2.1	2.9	3.0	2.4	7.6	3.3	1.9	3.5	4.3	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	0.4	0.1	0.0	0.5	0.0	0.2	0.0	0.2	0.5	0.4	0.0	0.5	0.7	0.3	0.1	0.4	0.3	0.0	0.2	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.3	335.4	0.4	0.6	0.5	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.5	0.0	1.4	0.7	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	1251.0	9.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.3	0.1	9.4	0.0	0.2	0.7	0.8	0.8	1.2	6.6	0.2	0.2	11.7	3.7	0.0	0.0	0.3	0.2	0.5	0.3	0.3
TTC27	FLJ20272	ENSG00000018699	"Tetratricopeptide repeat domain 27"	Q6P3X3	2	32628032-32821051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031246	Approved		Approved	Nucleoli,Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria	Nucleoli	"HPA031246: AB_10603139"	"unprognostic (3.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (6.28e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	7.9	8.2	3.4	8.1	4.4	7.5	12.2	3.9	4.1	7.7	3.6	7.3	5.7	9.1	8.9	9.2	9.6	5.4	8.6	3.2	6.2	7.3	7.9	6.3	9.4	3.8	3.3	11.7	8.3	10.8	4.4	8.3	4.1	6.9	8.6	5.2	8.9	5.6	9.9	8.4	5.9	9.3	3.4	8.6	6.7	12.5	4.6	7.5	9.9	8.4	11.3	9.5	7.1	8.2	43.0	20.6	13.9	10.5	11.5	23.1	6.7	17.5	14.2	26.3	22.9	31.6	25.3	37.3	15.2	26.3	27.3	21.2	22.4	27.4	38.1	17.9	27.4	42.0	10.3	43.7	21.9	40.7	21.3	15.3	24.5	32.0	34.5	12.9	24.4	9.2	59.5	10.7	23.6	17.0	32.4	14.0	25.3	18.9	21.3	21.2	29.9	32.1	20.2	24.8	11.4	16.6	14.3	13.1	16.7	16.1	16.2	9.6	20.6	16.4	18.2	19.8	30.3	15.0	4.1	41.8	17.8	31.2	17.9	0.0	4.7	0.0	9.1	10.0	10.1	9.9	10.1	9.1	10.5	9.7	12.6	9.8	0.2	9.3	7.1	4.9	9.6	5.9	3.4	4.4	3.9	4.1	3.2	6.2	3.8	3.3	4.1	3.4	4.6	8.2	6.8	9.6	10.4	19.9	10.1	5.6	9.2	7.2	8.0	5.1	6.3	4.3	8.2	4.3	8.8	0.0	4.2	13.4	4.8	2.2	7.9	10.1	18.2	5.6	6.7	8.0	7.3	6.3	27.6	9.5	12.7	8.8	7.7	5.2	12.0	12.0	3.9	4.9	7.6	3.3	33.7	4.5	2.0	8.1	4.6	2.7	8.4	4.0	5.4	27.2	6.5	5.5	1.0	32.2	66.7	5.1	4.7	7.2	6.5	7.0	2.2	4.8	12.4	6.0	6.6	9.7	6.4	28.3	11.3	7.4	5.7	6.4	8.2	9.9	7.9	6.8
TTC28	KIAA1043	ENSG00000100154	"Tetratricopeptide repeat domain 28"	Q96AY4	22	27978014-28679865	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 291.5;Excitatory neurons: 169.6;Inhibitory neurons: 289.8;Microglial cells: 332.6;Oligodendrocyte precursor cells: 318.7;Oligodendrocytes: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001080			Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Cytosol	"HPA001080: "	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (4.30e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (4.36e-1)"	7.2	4.6	4.3	2.9	3.0	0.8	6.3	0.4	3.4	8.8	2.6	6.9	3.1	10.2	9.8	5.2	8.7	6.4	4.9	3.9	1.8	4.9	3.5	7.2	2.0	2.4	2.0	16.8	5.0	3.8	3.8	8.8	1.4	5.1	2.9	3.4	6.8	6.9	5.4	3.0	3.8	8.5	1.8	3.5	4.8	8.1	2.1	2.7	6.8	5.1	1.4	6.3	5.0	2.1	0.0	6.8	17.1	7.4	10.0	14.8	0.3	5.1	9.4	7.1	6.1	0.5	0.0	0.1	6.9	14.9	2.3	1.0	11.1	0.3	3.8	0.7	7.5	1.1	8.6	6.5	4.5	0.2	6.8	14.9	0.3	4.6	3.2	4.8	13.0	4.5	4.5	0.6	1.6	2.5	0.1	0.6	3.1	0.0	4.3	7.0	4.3	0.1	3.3	0.2	4.8	10.6	7.1	0.2	4.5	4.7	3.5	0.6	12.2	8.4	4.0	5.5	3.8	2.2	0.2	0.1	3.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.3	3.0	0.4	3.4	3.9	1.8	2.4	2.0	1.4	1.8	2.1	2.1	29.4	3.2	12.5	291.5	3.2	6.0	5.8	1.7	11.4	34.1	8.7	8.0	9.7	8.6	1.6	12.9	18.8	6.0	2.3	2.1	0.0	6.2	10.8	7.9	28.9	30.9	9.0	7.0	169.6	6.0	1.5	27.3	4.1	12.4	1.3	32.3	36.8	15.3	3.7	28.6	289.8	5.8	0.0	9.4	7.2	9.1	31.4	4.3	10.6	332.6	0.7	11.5	5.2	318.7	116.3	3.9	4.4	45.5	3.1	5.0	4.8	18.6	1.9	24.9	13.1	27.2	19.7	23.8	11.6	6.7	3.8	2.5	3.2	27.4	6.9	4.0
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	45.8	29.3	28.1	27.1	25.0	26.4	43.1	36.3	35.3	59.3	45.7	34.6	24.7	38.9	58.6	27.9	34.9	35.4	28.0	38.9	15.5	37.7	31.7	24.4	29.4	10.0	11.1	60.6	42.9	39.1	35.6	29.0	11.8	51.2	36.3	63.0	50.0	41.4	27.7	30.7	30.3	34.6	6.7	27.3	40.9	27.4	15.3	38.0	64.8	30.6	29.2	30.6	9.4	21.4	72.9	25.4	115.3	22.2	108.9	156.8	40.0	77.5	96.0	34.2	46.1	34.0	35.8	62.3	26.6	130.9	32.1	23.3	35.3	47.9	48.2	66.3	25.0	125.6	38.0	44.1	39.6	70.9	39.1	81.9	28.8	35.0	31.0	68.8	51.6	54.1	77.3	71.1	65.2	56.0	69.4	18.8	33.3	48.0	42.6	91.6	55.3	33.2	39.4	55.3	87.7	67.6	97.2	55.2	49.1	26.5	62.2	27.3	68.3	49.2	19.5	61.2	30.4	71.1	55.1	60.6	80.7	69.9	37.9	4.8	6.2	6.8	11.5	6.4	17.1	13.0	13.3	15.8	10.8	15.1	23.2	14.4	1.0	12.8	8.6	17.3	10.0	4.8	28.1	25.0	36.3	35.3	38.9	15.5	10.0	11.1	11.8	6.7	15.3	21.4	78.3	125.0	142.7	161.3	144.8	65.9	94.8	102.7	86.0	347.7	175.8	140.1	134.7	68.6	118.2	75.4	227.2	50.1	129.5	67.8	166.3	91.1	192.7	115.0	217.4	78.9	190.2	65.4	424.5	75.3	93.5	171.0	131.5	132.0	64.6	256.8	99.6	94.4	61.4	329.7	396.0	163.1	99.7	95.2	83.7	192.4	210.0	86.8	211.7	111.5	87.4	196.5	93.7	321.7	261.9	73.3	96.5	261.1	167.6	121.4	72.8	96.1	108.6	233.9	52.6	245.8	127.9	400.0	258.4	91.7	62.8	52.7	109.7	204.1	148.1	103.9
TTL	MGC46235	ENSG00000114999	"Tubulin tyrosine ligase"	Q8NG68	2	112482156-112541739	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA066819			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA066819: AB_2685728"	"unprognostic (1.05e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.95e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	1.0	0.8	2.3	0.9	3.0	1.8	0.6	1.6	3.0	0.6	0.1	0.8	0.6	1.0	0.8	1.1	0.5	1.1	1.6	2.4	1.7	0.8	0.6	1.3	1.0	1.5	1.9	0.6	0.8	0.8	0.3	1.2	1.6	0.6	0.8	1.4	0.4	0.7	3.7	1.4	0.6	1.3	0.8	0.9	0.6	0.6	2.7	1.0	0.9	3.8	0.8	1.0	0.4	3.5	2.9	2.2	2.7	6.2	3.2	4.6	1.1	4.9	4.0	5.1	4.4	2.7	1.0	2.7	2.7	4.2	3.3	2.0	4.8	2.5	6.2	1.9	2.7	2.3	3.1	3.4	1.4	3.2	1.1	2.1	1.7	7.5	4.0	2.3	4.4	1.8	3.8	2.1	4.1	1.5	2.8	1.8	2.4	0.8	4.4	3.0	3.1	1.5	1.6	2.2	5.8	4.0	3.8	1.2	6.7	1.8	1.3	1.8	4.4	6.0	4.4	4.8	3.7	1.1	2.5	2.2	6.7	2.4	2.6	0.6	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.0	2.3	3.0	1.6	3.0	2.4	1.7	1.5	1.9	1.6	0.8	2.7	3.5	14.0	12.8	6.4	19.2	7.0	20.3	4.9	8.3	4.6	15.6	6.4	6.0	39.1	2.8	6.7	12.9	12.5	3.2	10.6	8.0	0.0	7.2	12.2	8.3	28.3	18.5	11.3	16.2	34.1	9.6	2.4	12.6	2.6	10.8	0.0	11.7	15.7	10.4	11.4	8.4	24.0	5.8	16.2	24.2	19.2	5.1	3.1	17.0	7.2	20.6	17.2	9.8	8.2	24.6	72.8	9.4	5.2	5.7	9.1	6.6	2.4	6.0	4.2	20.2	6.6	15.4	12.2	4.5	5.0	6.5	18.0	1.2	7.6	7.7	6.1	4.1
TTLL1	C22orf7	ENSG00000100271	"Tubulin tyrosine ligase like 1"	O95922	22	43039516-43089419	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 39.9;Spermatogonia: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048392	Approved		Approved	Nucleoli,Mitochondria		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Mitochondria	"HPA048392: AB_2680384"	"unprognostic (1.02e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.18e-3)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (8.22e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	4.0	7.2	9.9	2.7	10.0	2.2	4.6	10.0	12.1	4.9	6.9	5.2	1.8	5.8	8.1	3.8	9.8	3.9	8.5	11.0	10.1	5.3	1.7	3.8	3.8	7.6	8.3	5.4	3.6	5.9	9.7	2.7	8.3	4.9	3.1	11.3	4.7	3.8	3.4	4.8	3.1	4.0	7.8	3.2	4.0	13.5	10.7	5.6	7.0	3.7	3.4	4.6	4.8	8.8	0.9	0.8	17.5	12.3	18.8	17.1	0.5	5.8	6.5	3.3	5.6	0.0	2.6	1.0	3.5	10.6	1.8	0.6	1.5	1.5	3.4	1.4	2.7	1.7	0.6	1.6	13.3	4.5	2.2	13.5	21.8	2.0	5.4	14.3	10.7	14.2	0.5	10.8	12.3	5.5	4.3	7.4	2.2	4.6	1.2	9.3	9.2	0.2	6.1	1.5	4.0	8.2	4.6	2.4	16.0	9.1	6.3	7.4	10.1	3.4	2.3	7.7	0.8	3.6	0.7	0.5	9.1	8.2	6.2	4.7	5.5	6.7	10.6	5.9	11.2	2.7	9.8	12.3	9.8	4.5	8.4	10.5	1.2	10.5	4.8	6.5	6.4	5.7	9.9	10.0	10.0	12.1	11.0	10.1	7.6	8.3	8.3	7.8	10.7	8.8	3.8	0.0	2.7	3.9	1.5	2.3	2.4	5.9	2.8	5.1	6.2	7.2	5.0	1.5	5.6	1.8	6.2	2.7	3.4	1.1	15.6	7.3	39.9	12.8	6.6	4.1	0.0	2.1	8.8	4.9	1.3	5.9	3.6	4.1	1.3	9.2	5.7	0.3	4.9	5.0	9.0	3.0	16.2	4.0	2.2	18.2	4.1	2.4	8.8	3.7	4.4	6.4	7.2	4.0	3.8	4.5	6.6	6.0	0.5	2.4	0.6	7.2	20.0	11.5	6.6	5.6	3.7	10.7	32.6	4.8	2.7	0.7	5.9	5.5	1.8	2.2
TTLL5	KIAA0998	ENSG00000119685	"Tubulin tyrosine ligase like 5"	Q6EMB2	14	75633625-75955079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Transcription	Ligase	"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 127.2;Early spermatids: 111.0;Excitatory neurons: 134.3;Inhibitory neurons: 114.2;Oligodendrocytes: 242.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA032128	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA032128: AB_10600835"	"unprognostic (7.35e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.21e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.15e-2)"	5.5	5.5	3.7	6.0	6.0	11.7	7.1	7.1	7.2	7.3	15.0	6.2	4.7	8.0	7.2	7.8	11.6	6.5	5.8	3.8	6.6	6.2	4.1	6.5	5.1	10.5	6.4	7.1	4.9	11.1	5.4	7.5	10.6	6.9	7.3	23.9	6.5	6.9	4.7	7.1	4.5	8.6	6.4	4.1	5.9	57.4	6.4	10.1	7.8	5.8	7.5	6.1	6.4	12.0	22.8	16.2	13.9	14.5	10.9	16.8	12.9	13.1	15.9	15.4	19.9	10.3	20.8	6.4	7.2	13.9	11.3	21.3	12.3	21.7	29.3	7.6	7.3	12.5	16.8	11.3	9.3	9.2	11.5	13.1	10.6	19.4	21.5	16.8	33.8	17.5	7.2	10.5	15.7	32.1	15.6	12.6	9.9	18.0	16.6	9.5	19.6	8.8	15.0	22.2	18.4	11.6	27.5	20.2	6.8	11.0	27.6	9.8	38.1	20.5	18.0	18.5	12.2	8.8	13.5	14.6	20.7	10.4	13.9	11.6	2.0	1.7	2.6	2.0	2.4	2.3	2.5	2.7	3.2	1.8	2.9	2.7	2.4	2.3	2.5	3.4	2.2	1.4	3.7	6.0	7.1	7.2	3.8	6.6	10.5	6.4	10.6	6.4	6.4	12.0	7.1	3.2	10.1	71.8	6.1	5.0	5.5	5.4	8.0	10.9	17.3	11.6	8.7	17.2	10.2	11.0	127.2	8.1	8.5	7.6	3.9	7.1	111.0	37.4	11.9	10.7	7.7	5.0	134.3	5.3	13.2	9.3	8.6	10.8	12.6	11.7	19.6	7.4	5.6	0.0	114.2	6.5	16.2	5.8	5.1	93.1	12.5	6.6	5.4	82.4	8.5	10.0	6.2	78.4	242.9	6.1	11.9	11.7	7.6	6.2	6.0	2.4	40.1	80.1	13.1	9.5	6.0	37.7	16.4	9.0	6.3	6.0	8.3	9.1	8.0	4.6
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249710-219278170	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 360.2;tongue: 210.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 423.0;Late spermatids: 823.0;Pancreatic endocrine cells: 613.5;Smooth muscle cells: 408.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 265.9;HBEC3-KT: 439.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	Microtubules		NA	NA		130000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (8.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (4.54e-6)"	"unprognostic (1.52e-3)"	"unprognostic (4.47e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.32e-2)"	14.3	41.4	33.6	34.1	47.5	107.1	16.4	22.3	133.1	27.7	8.1	32.9	18.6	9.8	10.1	84.8	12.6	13.5	97.7	42.6	32.3	31.9	29.5	26.7	56.7	46.3	27.3	12.9	18.2	34.6	23.1	5.0	31.4	19.7	27.8	39.2	46.9	22.4	360.2	161.4	35.5	12.8	3.9	56.8	30.6	32.4	14.9	16.9	12.3	210.3	63.4	22.6	57.3	54.0	106.0	90.0	0.0	0.3	9.1	6.9	0.3	16.2	49.7	2.8	1.9	20.4	106.7	144.2	172.2	11.7	172.7	265.9	49.3	439.9	3.9	81.7	0.7	184.2	154.5	15.4	7.3	60.9	60.8	6.7	158.0	23.7	49.2	27.4	17.3	2.4	20.5	91.3	100.6	4.3	0.3	107.9	32.3	83.2	107.4	6.5	139.0	84.5	129.7	7.5	85.8	1.5	213.2	18.7	0.7	1.8	8.0	50.9	12.3	49.8	27.4	58.4	56.7	38.0	48.8	171.4	183.3	116.4	2.5	141.7	63.3	170.2	107.1	45.7	110.1	124.9	150.3	142.8	20.9	95.5	140.2	138.4	331.2	82.0	71.9	3.8	143.8	270.9	33.6	47.5	22.3	133.1	42.6	32.3	46.3	27.3	31.4	3.9	14.9	54.0	55.3	44.8	47.1	16.3	160.6	181.8	201.2	235.3	68.9	123.3	42.3	51.6	60.9	28.6	62.0	49.7	77.2	0.7	311.6	87.3	140.8	199.3	423.0	9.8	3.3	36.5	107.9	56.2	34.8	205.6	0.5	11.5	40.8	26.1	15.8	0.1	36.0	33.0	6.0	67.3	22.5	141.9	48.8	15.3	54.9	823.0	16.8	159.5	78.2	9.4	27.8	38.6	50.4	10.6	10.6	613.5	51.2	7.5	202.3	46.7	87.5	137.5	11.1	72.9	0.0	21.1	408.5	5.7	5.0	130.6	244.5	2.5	290.1	1.4	58.9	113.0
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 2296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		170000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	229.5	164.8	74.6	243.5	81.8	541.0	186.9	46.2	367.7	228.7	87.0	250.3	87.6	333.0	174.5	246.3	227.0	158.5	245.3	73.5	119.7	137.8	236.6	205.3	369.2	80.5	74.8	467.5	138.1	74.4	97.0	194.4	99.2	145.2	194.4	82.4	160.2	194.6	185.7	211.9	159.4	371.0	57.5	195.0	172.8	77.8	94.0	620.4	142.4	98.6	487.6	222.3	213.8	63.5	2281.7	1027.3	2650.0	1458.4	733.2	1265.2	568.2	396.9	469.5	943.3	863.5	1329.2	703.9	1494.1	1105.1	1408.1	1877.8	805.3	2160.6	1968.0	160.3	892.5	1321.1	461.4	207.3	1306.7	345.8	2550.0	1223.9	943.6	455.9	416.0	443.6	967.1	1493.3	2058.1	1270.4	294.1	1844.8	1398.2	2719.0	249.3	377.3	604.1	948.6	102.6	708.5	911.6	1564.5	1071.4	940.8	1516.7	969.0	911.2	354.7	1625.5	1148.3	422.4	880.6	2712.0	1526.0	614.5	917.7	835.3	1735.4	2101.3	538.8	2494.6	3548.7	119.8	115.6	122.8	187.3	182.5	218.8	166.1	152.3	188.8	111.7	113.0	143.2	163.3	46.8	165.1	222.4	227.7	180.8	342.5	74.6	81.8	46.2	367.7	73.5	119.7	80.5	74.8	99.2	57.5	94.0	63.5	215.8	131.4	47.3	21.5	214.9	576.2	358.4	698.6	434.2	72.7	234.2	312.8	114.9	244.5	238.7	171.0	39.6	811.9	198.7	133.4	311.0	1091.0	9.1	69.1	261.6	370.8	163.6	1322.1	28.2	1061.1	2296.1	471.5	95.3	140.2	207.3	643.6	298.4	267.8	955.2	109.4	25.0	185.3	376.4	454.5	689.6	24.4	402.6	295.8	321.9	30.9	774.0	192.6	246.1	20.1	23.0	1087.0	90.7	237.3	304.6	199.5	117.9	245.9	66.6	65.4	118.3	124.0	838.6	58.0	126.5	447.0	430.6	220.4	244.0	224.9	253.2	229.0
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019429-59026654	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;lymphoid tissue: 4.3"	"Cell type enriched"	"Detected in some"	10	"Macrophages: 191.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"basophil: 63.5;neutrophil: 26.0"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 63.5"	"Cell line enriched"	"Detected in some"	19	"HEL: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		87000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.2	0.2	0.2	0.3	0.2	8.5	0.1	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.3	2.4	0.2	0.3	0.2	0.1	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.1	4.3	0.1	0.9	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	29.5	0.8	1.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.2	0.6	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.1	0.2	0.4	63.5	2.4	1.9	0.5	0.6	0.4	0.9	0.2	0.0	1.1	0.5	0.4	0.0	26.0	0.2	0.3	2.6	0.5	281.6	0.2	0.2	0.5	0.5	0.1	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.1	0.0	1.1	0.3	1.4	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.1	0.0	0.6	0.0	4.2	0.0	3.1	0.0	0.0	0.0	16.0	0.3	0.2	1.5	0.0	19.0	0.2	0.0	0.1	0.1	0.0	0.7	1.3	0.0	3.6	0.2	0.3	0.0	0.2	0.0	0.0	2.8	0.0	5.9	0.3	191.2	0.0	0.0	13.8	0.2	13.4	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.1	0.1	0.1
TUBB2A	"dJ40E16.7, TUBB, TUBB2"	ENSG00000137267	"Tubulin beta 2A class IIa"	Q13885	6	3153497-3157544	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 364.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 516.5;Suprabasal keratinocytes: 368.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.2;monocytes: 1.6;T-cells: 3.2"	"Cell line enhanced"	"Detected in all"		"AF22: 241.1;CACO-2: 247.6;SuSa: 365.5;WM-115: 280.1"	"Low region specificity"	"Detected in all"							"CAB015339, HPA043640, HPA046280"	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.57e-1)"	"unprognostic (9.86e-3)"	"unprognostic (5.90e-3)"	"unprognostic (7.98e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (1.61e-4)"	58.8	17.8	266.1	19.3	251.1	67.5	47.8	130.1	287.5	32.7	10.0	78.0	24.2	50.8	28.0	90.6	23.5	21.5	29.4	248.3	364.3	31.1	67.0	16.4	11.0	292.6	212.2	15.5	39.4	2.2	56.3	23.9	334.3	17.5	8.2	49.9	52.2	15.6	22.3	151.4	34.9	41.7	131.6	7.7	41.0	9.5	204.4	6.4	10.0	11.8	9.6	23.6	51.2	169.4	55.9	45.3	241.1	53.6	30.6	34.0	14.5	119.8	44.7	80.6	115.7	247.6	18.4	27.4	72.9	115.5	80.2	26.0	86.6	26.8	28.0	134.1	57.7	9.4	11.4	77.0	31.6	1.5	8.4	35.1	31.1	85.1	5.3	28.9	37.3	10.6	33.7	8.8	74.2	25.1	14.9	2.8	207.2	16.0	58.3	12.4	22.6	18.9	28.0	27.4	57.6	52.9	30.5	8.5	179.7	365.5	19.1	2.0	76.0	53.9	56.7	117.3	65.8	3.2	4.6	18.8	19.7	7.0	280.1	0.0	1.1	0.0	2.2	1.6	2.4	3.2	2.1	3.1	0.5	0.6	1.0	2.0	0.3	0.4	1.3	0.2	3.2	1.2	266.1	251.1	130.1	287.5	248.3	364.3	292.6	212.2	334.3	131.6	204.4	169.4	125.3	16.0	13.1	43.1	31.6	311.4	63.3	87.0	132.6	105.6	32.0	134.6	20.4	42.9	62.7	12.9	16.7	6.0	53.4	87.0	217.2	54.0	60.9	46.7	29.6	40.6	73.1	322.3	59.9	182.4	50.4	96.2	185.0	57.9	34.9	10.1	12.5	55.6	50.8	516.5	73.0	103.9	73.2	6.3	164.4	32.9	20.8	36.7	129.9	24.4	72.7	261.0	0.0	18.1	23.0	103.4	181.8	15.4	15.8	34.9	126.3	40.4	50.3	86.2	6.6	95.6	87.9	32.4	14.9	140.6	368.5	6.2	58.9	6.4	60.0	54.7
TUBB2B	"bA506K6.1, DKFZp566F223, MGC8685"	ENSG00000137285	"Tubulin beta 2B class IIb"	Q9BVA1	6	3223324-3231730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 387.9;choroid plexus: 154.0"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 414.8;Horizontal cells: 430.7;Muller glia cells: 847.3;Skeletal myocytes: 350.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 216.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 541.9;CACO-2: 415.3;NTERA-2: 268.0;RPMI-8226: 277.7;SCLC-21H: 797.7;SH-SY5Y: 390.2;SuSa: 245.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.92e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.81e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.04e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.30e-3)"	4.0	7.2	298.1	8.1	324.5	1.0	5.0	348.4	387.9	9.9	154.0	17.0	2.4	4.2	45.5	2.4	3.3	3.8	4.6	258.8	356.9	11.6	1.0	1.4	8.1	363.3	349.9	1.1	5.7	0.0	35.1	4.4	354.5	3.7	2.6	65.3	10.8	4.6	6.2	3.9	6.1	7.3	337.2	0.7	4.5	1.0	369.1	2.3	0.9	1.6	5.7	2.6	5.6	383.9	0.0	8.2	541.9	164.2	0.6	0.2	0.9	5.1	7.4	20.8	45.0	415.3	2.0	0.9	5.6	5.7	0.0	1.3	212.8	0.7	12.0	1.6	98.3	0.2	0.0	33.2	1.1	0.1	6.1	3.1	0.0	2.3	0.0	7.6	1.4	0.5	6.8	1.2	7.6	0.3	1.5	0.4	268.0	1.0	17.6	0.6	26.3	277.7	2.9	0.8	797.7	390.2	0.3	1.7	4.3	245.9	3.2	0.0	0.0	1.9	89.9	6.3	2.2	51.6	0.1	0.0	0.8	0.1	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	298.1	324.5	348.4	387.9	258.8	356.9	363.3	349.9	354.5	337.2	369.1	383.9	3.6	0.0	0.0	109.4	1.9	8.7	2.3	1.8	4.6	63.5	3.9	31.9	40.1	5.7	0.3	7.3	16.7	0.7	1.0	0.9	414.8	15.4	5.8	2.7	3.3	7.6	66.7	0.0	2.4	3.5	1.2	18.7	7.1	3.9	0.0	0.5	0.7	0.6	3.0	430.7	19.4	1.0	24.4	0.0	12.4	7.1	0.3	1.0	92.5	9.4	3.6	847.3	0.0	37.2	21.6	12.0	0.1	0.0	8.4	3.9	0.2	2.0	0.0	43.1	0.0	350.1	19.1	1.3	6.2	3.1	2.7	0.8	0.6	0.0	0.6	1.1
TUBB3	"beta-4, CFEOM3, CFEOM3A, FEOM3"	ENSG00000258947	"Tubulin beta 3 class III"	Q13509	16	89921392-89938761	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 313.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Ductal cells: 28.7;Excitatory neurons: 37.9;Exocrine glandular cells: 21.4;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 45.1;Pancreatic endocrine cells: 49.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A549: 421.3;SCLC-21H: 424.9;SH-SY5Y: 433.8"					"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		89000000	"Cluster 24: B-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.91e-2)"	5.7	24.8	99.4	12.1	93.3	3.4	2.1	100.5	127.6	3.3	0.0	18.4	3.7	9.7	0.2	3.6	2.3	8.8	5.5	88.6	313.3	13.3	0.9	4.1	7.1	208.8	132.7	3.9	3.2	0.4	55.1	1.8	266.2	3.0	2.6	24.8	10.6	0.4	0.6	5.2	8.0	12.7	74.2	1.3	7.2	38.0	183.4	1.0	2.5	0.3	5.2	7.3	5.3	82.5	30.1	421.3	152.6	173.9	17.9	170.8	6.8	181.0	31.0	105.8	48.2	57.2	53.5	89.6	93.6	136.8	74.3	112.1	148.9	26.7	26.3	22.7	15.5	0.7	32.5	383.7	6.0	0.0	67.6	98.4	7.9	161.9	14.0	136.8	88.4	5.9	9.2	2.5	122.3	288.6	1.2	31.5	274.3	11.2	237.3	0.1	54.1	9.5	131.8	8.1	424.9	433.8	251.2	4.4	137.1	27.5	15.0	1.9	110.9	142.8	156.9	197.3	185.3	1.4	19.6	35.2	150.2	11.5	260.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	99.4	93.3	100.5	127.6	88.6	313.3	208.8	132.7	266.2	74.2	183.4	82.5	0.4	0.0	0.0	20.2	0.0	0.0	0.0	0.0	3.4	1.8	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	28.7	8.2	0.5	2.6	3.8	4.9	0.0	37.9	21.4	0.7	6.1	27.0	0.7	0.0	0.0	0.0	0.0	0.2	5.0	45.1	0.1	0.0	0.0	0.0	16.8	0.3	0.2	0.0	9.4	0.0	0.3	0.0	16.1	9.2	49.2	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	5.1	0.2	0.4	3.0	0.0	1.0	0.1	0.0	0.2	0.0
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 828.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 22.2;Muller glia cells: 33.0;Oligodendrocytes: 94.1;Theca cells: 81.7"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 3.8;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.7;HAP1: 58.3;HEL: 91.7;PC-3: 49.6;REH: 43.4;SH-SY5Y: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		110000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	0.9	203.4	209.7	1.7	404.6	0.2	0.6	452.3	388.7	0.6	0.0	6.3	1.1	0.6	0.3	0.7	0.9	0.6	2.5	249.2	229.1	2.2	1.2	0.6	1.1	425.9	254.4	1.5	3.0	0.6	4.0	0.7	440.0	0.8	0.8	22.6	1.2	0.4	4.4	5.2	3.0	0.8	221.4	9.5	2.1	76.0	373.5	0.3	0.6	1.0	0.7	0.6	1.8	828.2	0.2	28.3	0.1	100.7	0.2	0.0	0.2	0.7	0.0	0.1	0.0	1.4	0.4	0.1	30.3	0.0	3.5	0.7	58.3	0.0	0.6	0.0	10.7	91.7	1.9	0.9	0.0	0.0	5.5	0.0	0.0	2.3	0.0	1.0	0.0	17.1	8.6	0.8	0.0	3.0	18.1	4.1	7.5	0.0	49.6	43.4	0.1	20.3	10.9	0.1	0.2	36.6	0.3	0.2	30.9	2.7	0.8	1.9	0.0	0.2	12.2	0.1	0.4	2.4	1.7	11.7	1.1	0.1	0.5	0.0	0.0	0.0	5.4	0.0	3.3	3.8	0.7	5.0	0.0	1.1	1.6	3.8	0.1	0.3	0.0	0.0	0.0	1.4	209.7	404.6	452.3	388.7	249.2	229.1	425.9	254.4	440.0	221.4	373.5	828.2	0.1	0.0	0.0	6.8	3.2	1.9	0.7	0.3	0.0	2.8	0.1	0.1	9.8	1.5	0.0	0.0	0.0	0.2	1.6	0.1	5.9	1.6	2.9	0.1	0.2	1.2	0.0	2.1	22.2	0.0	0.2	1.8	0.0	0.1	0.0	16.3	1.4	0.3	0.4	10.1	15.0	0.0	0.0	0.0	1.2	9.4	5.3	0.3	14.2	13.1	0.0	33.0	1.0	8.5	94.1	0.1	0.0	0.4	0.9	0.2	0.0	1.8	0.5	2.3	6.6	0.4	4.6	1.9	1.1	0.0	1.6	0.1	3.8	81.7	0.0	0.2
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241287-137243707	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 2190.0;Late spermatids: 2907.1;Spermatocytes: 1717.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (1.69e-1)"	134.5	112.6	162.0	97.2	163.4	423.9	94.4	149.4	182.7	88.1	482.7	198.3	142.0	107.7	209.1	343.3	507.2	106.0	435.8	174.0	185.2	122.5	140.1	130.5	95.5	184.1	233.6	72.9	123.8	87.8	118.0	86.3	213.9	120.2	111.9	261.8	177.9	121.5	202.5	240.0	166.4	119.8	162.9	85.6	161.4	765.7	192.6	162.9	115.7	96.6	119.7	188.3	139.4	133.9	706.2	1032.5	431.7	314.2	213.2	223.6	600.5	643.7	536.0	872.4	598.6	1101.0	840.2	429.0	480.2	631.2	848.2	1305.1	539.5	1039.2	330.2	307.9	458.5	311.2	789.6	877.8	134.5	370.0	331.5	145.0	291.5	667.5	183.1	215.7	631.7	300.6	443.0	239.7	731.2	1936.4	337.4	504.2	457.8	1234.8	1778.1	423.5	822.2	394.2	666.8	647.8	301.5	323.6	853.9	485.8	173.2	244.2	699.0	397.6	495.6	618.1	685.0	710.0	863.6	92.4	274.9	475.1	503.6	286.9	549.8	95.7	30.0	43.2	40.5	30.1	38.2	32.6	31.3	34.4	34.9	30.8	19.7	26.7	56.4	24.4	30.5	36.3	44.7	32.6	162.0	163.4	149.4	182.7	174.0	185.2	184.1	233.6	213.9	162.9	192.6	133.9	478.5	221.2	146.3	21.5	315.8	326.2	945.7	458.7	327.2	508.1	286.9	389.5	91.9	143.0	284.1	143.5	300.3	346.6	640.9	744.1	221.1	348.6	2190.0	1191.6	224.8	203.9	391.5	419.9	30.1	446.8	545.5	247.8	274.7	415.0	189.2	200.9	142.5	139.2	265.9	244.0	24.3	503.6	323.5	59.9	214.9	2907.1	254.2	299.3	138.7	22.5	224.0	299.3	49.4	15.6	19.7	477.4	697.2	153.1	264.0	475.1	540.7	345.5	1558.7	763.3	111.7	261.8	416.0	1717.5	740.9	419.1	297.6	321.1	362.9	89.8	487.3	592.7
TUBB6	"HsT1601, MGC4083"	ENSG00000176014	"Tubulin beta 6 class V"	Q9BUF5	18	12307669-12344320	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 190.2;Extravillous trophoblasts: 494.3;Pancreatic endocrine cells: 221.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 157.3"	"Group enriched"	"Detected in many"	6	"B-cells: 58.7;dendritic cells: 157.3"	"Cell line enhanced"	"Detected in many"		"TIME: 821.6"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 19.9"	"Region enhanced"	"Detected in all"		"spinal cord: 10.3"	"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		52000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.20e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (5.83e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (9.69e-4)"	197.9	37.9	12.3	82.1	11.7	34.8	134.6	14.7	14.6	106.5	28.6	193.6	31.4	173.5	24.9	217.5	121.2	66.4	166.2	11.8	13.7	66.0	40.8	92.9	31.6	19.2	16.3	81.2	52.7	5.6	33.1	59.7	15.1	84.2	28.8	3.6	69.6	91.3	37.3	78.2	75.8	151.9	14.1	34.0	89.1	28.3	18.4	12.2	52.2	20.2	31.3	129.9	124.2	12.5	211.8	142.3	149.5	76.1	149.0	208.8	108.1	648.5	424.2	492.0	459.1	113.0	65.2	1.3	281.7	440.8	148.6	99.5	84.7	653.6	380.6	1.8	46.1	32.3	159.2	73.6	151.0	2.7	59.5	219.1	146.0	429.4	222.7	148.8	366.1	12.5	159.7	2.5	432.5	216.1	0.8	162.4	79.1	3.3	70.0	1.6	260.0	2.2	99.7	5.8	19.3	27.2	360.3	34.8	113.9	153.7	76.5	203.8	821.6	600.0	510.6	565.7	574.2	11.5	3.8	3.8	458.9	46.9	219.8	2.0	19.4	0.3	0.6	7.6	0.3	42.0	0.1	0.2	25.5	58.7	0.2	0.3	0.4	0.9	7.5	157.3	0.2	13.2	12.3	11.7	14.7	14.6	11.8	13.7	19.2	16.3	15.1	14.1	18.4	12.5	67.0	83.3	7.9	0.7	16.1	69.6	42.7	151.4	16.5	1.2	30.4	44.8	54.3	8.6	37.4	7.3	0.0	53.8	23.6	0.6	1.9	167.6	190.2	6.4	76.9	128.9	0.0	12.2	0.8	104.9	494.3	112.8	1.5	7.1	45.6	7.4	82.5	0.4	69.4	0.0	0.6	0.4	42.7	13.2	85.2	114.9	70.2	36.5	33.8	12.2	65.9	0.2	0.0	0.5	0.4	221.1	0.1	91.4	1.0	51.5	0.1	1.2	18.2	1.6	26.3	89.2	130.5	4.3	6.3	55.7	66.9	22.2	3.6	9.5	0.5	65.2
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46888-74163	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.3"									"HPA043640, HPA046280"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.1	0.1	0.4	0.1	0.4	0.0	0.2	0.3	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.3	0.7	0.0	0.1	0.1	0.3	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	2.4	0.3	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.4	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	13.0	15.9	0.0	0.0	0.0	0.0	0.4	0.0	0.6
TUBB8B	TUBB8P12	ENSG00000173213	"Tubulin beta 8B"	A6NNZ2	18	47390-49557	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 2.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043640, HPA046280"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA							Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.42e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.78e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846348	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria		NA	NA		610000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	69.7	114.6	69.6	67.1	74.2	75.1	65.8	78.9	78.1	59.4	93.3	101.5	104.4	64.9	34.7	105.2	73.6	46.6	177.8	68.1	75.3	107.3	145.1	58.3	69.2	73.1	77.4	61.4	114.2	117.1	55.4	47.6	74.1	57.7	86.1	35.8	88.9	59.7	224.4	76.0	83.9	53.6	72.9	66.2	106.1	73.3	77.0	59.9	62.7	221.5	79.3	67.1	62.9	74.3	176.2	323.1	102.4	216.2	144.9	131.4	208.7	125.8	144.4	194.9	183.0	351.3	189.4	390.5	228.5	126.4	112.4	337.6	244.2	242.9	116.2	155.4	370.8	151.7	254.8	433.6	171.7	273.8	134.8	169.9	188.1	211.9	208.7	126.8	235.2	213.0	339.0	150.3	144.4	355.0	262.3	266.3	231.8	213.9	196.9	361.8	187.3	569.6	169.3	168.4	178.8	219.6	110.0	388.5	180.2	84.6	231.5	217.6	150.1	115.9	136.4	146.7	196.6	229.8	253.6	172.2	148.6	336.8	157.1	94.6	155.8	72.3	103.1	153.6	115.3	100.6	97.2	108.7	199.3	98.8	91.7	95.3	32.4	97.2	119.2	123.1	140.1	185.6	69.6	74.2	78.9	78.1	68.1	75.3	73.1	77.4	74.1	72.9	77.0	74.3	108.2	70.5	76.7	29.4	144.6	168.1	262.5	322.0	158.2	102.4	165.1	139.2	134.4	190.1	182.6	176.6	87.6	333.1	113.2	260.0	334.6	230.2	381.8	116.1	92.5	111.3	148.5	148.1	17.5	289.8	299.2	111.2	153.4	79.6	105.9	170.6	108.5	247.1	253.8	74.0	19.9	230.5	217.7	167.5	146.4	669.0	109.3	128.6	138.7	14.0	167.5	140.6	88.6	28.6	30.3	199.7	215.3	111.7	264.9	245.3	330.7	451.9	237.3	116.3	85.5	105.5	129.1	205.7	177.4	230.1	156.0	287.0	120.2	288.2	418.7	277.6
TUT4	"KIAA0191, PAPD3, TENT3A, ZCCHC11"	ENSG00000134744	"Terminal uridylyl transferase 4"	Q5TAX3	1	52408282-52553487	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 52.2;Cytotrophoblasts: 53.6;dendritic cells: 64.9;Endometrial ciliated cells: 59.5;Endometrial stromal cells: 96.1;Granulosa cells: 70.7;Theca cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	22.5	34.4	28.4	18.3	28.6	26.6	21.4	44.7	36.2	34.1	28.6	26.3	8.7	27.4	23.7	19.3	30.8	15.4	27.1	26.8	35.3	22.9	31.3	22.1	34.2	28.5	29.4	46.3	31.2	29.5	41.5	21.2	28.5	26.1	11.2	84.9	20.7	16.5	60.0	35.1	30.9	15.9	26.4	35.0	22.3	46.9	33.4	32.5	31.4	30.0	29.4	23.1	26.5	33.5	24.4	22.7	55.3	37.3	21.1	27.1	36.4	20.0	31.0	30.3	34.9	23.6	12.5	50.6	23.0	30.0	49.1	19.7	41.6	22.6	38.7	39.7	36.5	53.7	30.0	49.7	35.0	59.4	29.1	31.9	49.4	32.6	40.0	38.6	21.4	35.7	44.7	25.6	25.7	0.3	60.1	42.7	39.8	12.5	27.5	51.3	55.3	39.3	33.4	20.0	28.7	26.8	31.8	14.1	32.9	62.3	19.4	31.5	18.1	23.2	30.6	21.1	26.2	52.7	74.0	71.8	15.5	32.0	17.0	83.7	9.7	34.8	26.1	4.0	19.3	49.0	27.3	21.6	5.1	50.2	33.1	22.0	37.6	25.3	3.7	61.9	23.3	5.1	28.4	28.6	44.7	36.2	26.8	35.3	28.5	29.4	28.5	26.4	33.4	33.5	52.2	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	36.1	41.4	0.0	0.0	0.0	47.8	0.0	53.6	64.9	0.0	15.6	28.5	0.0	59.5	96.1	14.3	0.0	0.0	0.0	17.0	19.1	18.8	0.0	46.7	0.0	70.7	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	9.8	0.0	0.0	0.0	0.0	19.6	0.0	0.0	30.2	0.0	0.0	22.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	36.9	28.2	57.3	0.0	0.0
TWIST2	"bHLHa39, Dermo-1, DERMO1"	ENSG00000233608	"Twist family bHLH transcription factor 2"	Q8WVJ9	2	238848032-238910534	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 83.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 95.4;Fibroblasts: 58.9;Leydig cells: 48.1;Peritubular cells: 39.1;Theca cells: 23.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	24	"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.0;ASC TERT1: 50.5;BJ: 69.3;BJ hTERT+: 212.4;fHDF/TERT166: 97.4;U-2197: 81.3"	"Low region specificity"	"Detected in single"							HPA062870			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Nucleoli	"HPA062870: AB_2684888"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-9)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.48e-2)"	59.7	4.0	0.3	1.4	0.3	0.4	43.3	0.3	0.5	83.0	0.6	22.9	0.3	31.3	0.7	10.1	30.4	1.7	10.8	0.4	0.3	1.8	0.7	9.3	0.3	0.4	0.8	39.9	1.8	0.1	8.3	3.1	0.4	25.7	1.1	0.0	7.9	3.7	1.8	33.5	8.9	2.9	0.4	2.3	10.3	1.9	0.3	0.1	8.2	1.0	0.4	21.3	54.2	0.5	0.1	4.5	0.4	0.0	80.0	50.5	0.1	69.3	212.4	31.0	46.4	0.0	0.0	0.0	2.1	97.4	2.5	0.5	0.7	5.4	22.5	0.0	7.3	0.0	4.0	0.2	13.7	0.0	1.6	11.8	2.9	15.0	12.5	3.7	4.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.7	0.0	0.9	11.8	1.2	2.2	81.3	0.8	0.0	0.0	0.0	0.3	2.1	4.3	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.4	0.3	0.4	0.8	0.4	0.4	0.3	0.5	2.5	0.0	2.6	0.0	0.1	2.0	16.0	0.0	7.4	0.0	0.5	0.4	0.6	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.4	3.6	95.4	1.3	0.0	0.0	4.4	0.0	1.9	58.9	0.0	2.1	1.3	0.5	2.9	0.1	2.2	0.0	0.2	0.0	0.0	0.0	3.6	1.2	48.1	0.8	1.8	12.2	0.4	0.0	8.2	0.5	0.1	0.1	0.0	39.1	0.0	20.5	0.0	0.0	0.0	0.0	0.0	1.1	9.6	0.5	3.3	0.2	1.7	1.6	1.6	23.2	0.0	3.7
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.2;Peritubular cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"	No	No		3500000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	23.7	19.5	7.7	16.7	9.6	8.2	17.5	9.2	12.2	40.6	12.7	22.1	11.1	51.3	45.8	26.1	30.5	36.3	18.6	7.4	9.2	36.3	10.0	19.7	11.8	10.5	9.4	32.3	9.7	33.2	9.8	24.8	10.4	43.0	22.4	5.7	11.1	64.6	5.7	12.9	12.5	80.1	9.7	13.6	14.9	11.8	8.9	7.0	34.9	16.5	14.9	34.7	16.2	11.0	57.3	19.9	57.6	28.6	111.2	99.7	26.6	107.2	132.4	57.6	81.9	21.2	73.5	8.2	52.7	142.5	37.4	19.5	57.1	42.4	105.3	22.0	15.4	14.7	15.9	10.8	98.7	10.8	29.4	102.0	34.1	48.3	23.3	78.7	90.8	7.8	22.7	14.6	149.2	17.0	11.9	13.2	18.9	33.6	16.1	20.7	58.7	5.0	65.7	75.2	7.4	20.0	83.3	23.1	22.9	23.9	26.1	25.0	75.6	104.9	52.4	99.5	67.5	21.2	20.1	15.1	64.5	14.9	37.9	8.3	2.7	4.0	4.3	1.5	2.8	2.1	2.0	4.5	5.5	1.6	2.3	4.8	1.2	2.9	0.5	5.3	1.0	2.1	7.7	9.6	9.2	12.2	7.4	9.2	10.5	9.4	10.4	9.7	8.9	11.0	9.0	25.6	18.4	13.1	8.1	39.6	21.3	18.5	51.2	4.8	18.5	11.6	7.8	10.0	21.0	75.4	0.0	6.3	12.1	12.1	1.9	9.1	141.2	13.3	38.6	18.1	6.0	9.9	28.0	7.6	18.3	61.9	10.2	23.4	6.3	31.6	17.2	7.5	16.0	3.3	31.0	8.2	57.0	9.4	30.1	30.7	37.6	12.2	23.2	17.8	15.3	16.1	7.2	29.1	31.6	9.2	10.7	95.2	17.8	46.3	1.3	12.6	12.4	5.0	72.3	28.9	56.6	24.6	9.6	26.6	26.9	4.7	10.1	20.4	12.2	27.1
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243810-110256507	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1058.8"	"Cell type enriched"	"Detected in all"	4	"monocytes: 15775.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1642.2;granulocytes: 1355.4"	"Cell line enhanced"	"Detected in all"		"OE19: 3836.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	144.2	127.7	149.9	145.4	155.3	367.5	218.6	154.5	225.4	153.9	140.5	455.2	349.3	130.9	168.4	1058.8	240.7	142.1	90.8	156.2	161.7	430.6	436.0	158.4	131.6	163.3	156.2	83.8	119.1	73.0	61.2	105.8	163.0	113.6	435.0	46.2	391.7	128.9	84.8	240.1	332.2	140.3	158.1	105.4	222.7	36.6	156.4	261.3	93.8	76.4	208.3	218.1	230.8	164.8	672.9	920.0	238.7	265.6	601.0	782.3	352.7	792.5	756.2	555.6	419.4	606.8	785.6	598.9	331.5	754.7	1181.3	1464.8	351.0	1081.1	544.6	887.6	778.5	298.2	804.7	1061.8	684.7	747.2	864.2	556.2	703.5	809.0	607.8	504.7	498.7	369.7	515.9	553.1	775.4	557.1	621.9	1119.7	505.4	3836.3	1110.5	256.6	810.3	696.3	721.7	479.4	520.9	183.7	860.0	687.5	572.7	458.6	661.2	508.6	587.9	556.4	357.3	1050.2	1006.1	271.4	872.5	512.7	804.8	654.4	789.5	484.8	311.2	1355.4	169.2	195.5	165.2	154.2	237.7	207.3	475.7	75.9	87.4	129.3	1212.7	195.0	131.6	1642.2	337.0	279.2	149.9	155.3	154.5	225.4	156.2	161.7	163.3	156.2	163.0	158.1	156.4	164.8	458.7	391.0	298.2	12.4	165.9	1304.5	1072.4	3654.4	435.4	38.0	514.2	752.8	108.5	418.9	1810.0	263.0	20.9	637.2	443.0	1297.7	972.4	1172.8	31.2	1560.7	1465.0	587.0	556.4	388.4	18.2	1341.7	993.1	526.8	662.1	775.9	268.6	247.1	216.0	842.8	571.8	28.6	18.3	1111.2	2191.1	286.1	1752.9	31.6	403.2	682.7	763.1	10.3	15775.8	86.3	128.8	7.5	21.9	1994.7	1227.7	285.5	388.5	2151.2	1439.2	3670.6	1516.8	34.8	144.7	211.8	557.8	10.6	76.3	2725.7	1491.0	468.2	266.6	879.4	1621.8	1742.1
TXN2	MT-TRX	ENSG00000100348	"Thioredoxin 2"	Q99757	22	36467046-36481640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000994, CAB008681"	Approved		Enhanced	Mitochondria		No	No		84000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB008681: AB_1623682, HPA000994: AB_1080267"	"unprognostic (5.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.04e-4)"	"prognostic favorable (1.17e-6)"	"unprognostic (1.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	60.3	182.3	89.8	45.5	92.4	64.7	58.0	94.6	98.2	57.4	92.4	65.3	84.0	50.0	51.7	79.8	64.1	49.4	122.3	87.9	90.7	91.5	149.5	44.7	59.2	92.9	91.3	75.8	59.2	99.1	43.4	47.3	91.9	59.3	63.6	43.0	59.5	52.5	159.4	60.5	64.3	48.3	91.2	65.7	76.1	48.8	97.0	50.9	67.7	180.1	59.9	59.0	54.0	91.7	52.8	80.4	75.4	126.8	115.2	125.0	81.3	70.8	108.1	114.8	128.7	87.9	52.1	133.3	64.2	116.8	54.5	76.1	151.7	127.4	66.1	93.6	131.8	147.7	91.7	125.4	94.6	189.6	125.8	162.3	98.9	101.9	79.3	99.5	118.2	78.4	157.7	104.1	106.1	80.3	87.5	128.2	60.0	170.3	95.3	75.3	79.5	92.6	116.4	84.8	99.9	98.3	70.2	148.1	125.3	61.3	103.6	165.9	83.7	120.5	95.0	69.8	65.9	81.4	64.2	128.6	111.0	109.5	74.1	30.2	173.5	32.3	102.5	194.3	108.9	140.4	101.2	109.0	223.4	133.8	116.4	108.6	59.3	145.4	170.1	167.1	110.9	224.3	89.8	92.4	94.6	98.2	87.9	90.7	92.9	91.3	91.9	91.2	97.0	91.7	68.9	60.9	53.0	12.1	66.4	83.5	87.7	154.0	108.1	105.6	124.3	137.7	105.4	88.6	82.5	69.9	39.6	213.2	62.8	128.5	303.3	93.0	19.6	45.7	70.6	73.7	89.5	114.0	8.3	106.2	275.8	74.0	75.4	57.2	69.1	148.0	81.0	122.7	173.4	116.1	10.3	132.4	95.6	100.5	80.7	36.8	56.5	80.7	78.2	8.4	91.9	168.9	77.2	9.0	13.5	82.5	104.3	50.8	79.5	52.7	252.2	213.7	49.0	59.4	19.7	61.1	67.1	49.1	42.4	124.5	89.8	207.1	62.4	287.0	179.6	87.1
TXNDC11	EFP1	ENSG00000153066	"Thioredoxin domain containing 11"	Q6PKC3	16	11679083-11742857	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Plasma cells: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 141.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041174, HPA041390"	Supported		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"		"HPA041174: AB_10794191, HPA041390: AB_10796670"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (2.12e-5)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.34e-2)"	15.7	14.2	4.5	22.5	5.6	55.4	16.6	7.7	5.9	20.8	16.6	30.0	38.5	15.1	23.6	13.1	16.2	17.3	13.7	5.0	4.9	25.7	44.3	34.9	25.3	4.8	4.8	16.6	26.5	45.1	12.6	17.0	4.8	24.4	29.8	15.3	34.8	14.9	30.1	12.0	32.0	15.6	4.6	22.4	36.1	8.5	4.9	20.6	34.4	14.9	27.9	25.3	11.8	5.0	26.1	17.7	8.2	11.2	21.6	18.0	14.4	25.3	34.5	22.7	29.1	8.8	40.5	65.2	41.6	32.0	30.9	22.9	10.2	21.4	18.5	29.4	13.5	13.9	19.4	43.8	31.7	20.6	27.1	13.7	23.6	25.4	39.9	17.6	28.9	14.6	21.5	81.8	20.2	23.7	16.1	7.9	10.7	18.6	9.1	20.5	16.5	141.9	26.0	13.7	11.5	10.9	49.6	38.2	27.3	9.1	23.4	28.1	30.1	10.5	12.0	49.8	14.7	110.5	64.8	39.5	22.3	25.7	17.9	3.5	2.4	7.7	1.8	1.7	4.5	3.8	3.3	4.1	2.6	4.6	3.2	2.1	0.7	5.6	2.2	2.0	6.8	2.8	4.5	5.6	7.7	5.9	5.0	4.9	4.8	4.8	4.8	4.6	4.9	5.0	16.2	44.8	46.2	21.9	49.2	14.7	24.8	12.9	23.3	16.2	16.1	18.0	9.1	18.6	24.6	18.4	50.1	21.1	27.2	45.8	15.6	20.4	3.1	19.9	14.6	15.2	24.5	6.5	23.0	39.7	29.8	14.0	45.3	28.5	15.2	13.0	15.7	39.3	30.3	23.5	25.5	44.0	8.2	18.1	26.9	1.4	20.2	29.2	23.2	18.7	21.2	16.4	15.5	22.1	18.6	26.1	21.0	13.2	307.9	28.0	37.1	15.2	15.9	23.4	6.6	13.8	16.2	11.6	13.1	17.5	11.8	25.0	25.2	11.3	27.7	32.1
TXNRD2	"SELZ, TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941820	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Mitochondria,Cytosol		NA	NA		2800000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	10.5	44.4	11.9	8.9	12.0	14.5	12.3	18.1	19.3	11.7	21.2	14.9	10.3	10.6	6.2	10.2	10.6	6.2	30.0	12.9	11.9	24.8	65.4	13.6	9.1	11.8	12.1	16.5	15.9	13.5	14.4	9.8	11.5	26.8	4.6	4.4	15.4	8.2	23.0	10.9	12.0	5.1	11.3	16.9	26.4	14.6	12.4	4.9	15.2	16.1	6.1	11.8	10.4	11.8	19.4	39.2	3.5	14.9	6.9	9.6	8.8	18.8	21.1	31.8	23.4	36.7	19.4	10.9	43.2	19.0	32.7	33.2	17.8	25.2	12.1	21.6	46.5	18.8	34.4	22.4	12.9	21.1	8.4	9.2	18.5	16.2	13.8	12.9	91.3	2.2	106.4	17.4	24.8	47.1	7.2	30.1	17.7	46.9	27.6	10.5	85.2	10.0	19.3	21.0	19.1	16.4	32.0	39.9	21.8	5.8	33.7	27.6	52.2	23.0	139.5	19.8	38.4	17.6	14.0	6.9	22.4	15.5	30.3	2.7	10.5	5.8	3.5	8.2	2.6	3.9	3.0	3.2	7.8	2.6	3.9	3.2	0.9	3.8	7.9	2.9	2.1	4.6	11.9	12.0	18.1	19.3	12.9	11.9	11.8	12.1	11.5	11.3	12.4	11.8	5.6	16.0	23.6	11.1	10.3	4.2	23.1	15.1	3.4	22.1	11.4	9.1	16.7	15.7	15.7	20.2	10.4	60.7	8.8	14.7	58.7	22.0	26.4	9.8	8.4	14.4	1.2	33.1	9.2	32.0	24.3	12.4	23.4	10.0	1.3	27.6	8.9	49.5	25.9	10.1	8.5	16.9	20.3	22.0	7.8	18.2	15.5	14.6	5.4	10.3	27.2	18.7	10.3	8.5	7.2	22.3	13.9	9.1	12.2	17.8	15.6	52.0	16.6	11.0	6.6	11.3	13.3	10.9	14.0	6.4	5.3	42.0	11.4	36.4	16.4	15.7
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380572	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 206.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favorable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favorable (4.16e-4)"	53.0	60.5	69.9	37.0	71.9	82.6	52.5	70.7	82.3	55.8	72.2	51.5	29.4	44.8	22.6	46.2	49.0	26.2	65.0	69.6	68.8	77.3	111.2	72.6	51.5	75.1	71.4	56.4	65.1	28.6	66.2	20.1	71.5	64.5	25.7	25.2	50.8	20.6	41.3	51.1	73.9	23.5	70.2	140.8	54.6	16.6	71.8	54.4	60.2	33.7	51.8	49.3	46.0	76.4	29.1	41.1	24.1	38.0	31.9	44.2	23.5	38.9	39.1	48.1	52.2	31.5	18.7	44.5	44.5	43.4	32.8	28.4	29.4	45.5	24.2	78.0	45.5	81.4	90.5	80.2	49.4	34.4	89.4	43.2	31.3	54.5	32.2	29.9	46.5	56.6	35.0	116.1	42.3	90.1	50.7	206.9	7.7	28.4	71.8	49.9	21.1	45.1	40.0	90.1	22.4	28.0	37.6	38.6	28.1	18.4	21.5	57.2	41.1	61.7	22.7	74.1	45.9	97.2	81.4	40.2	32.4	70.8	36.6	9.8	20.8	27.2	12.8	15.2	7.9	7.5	7.6	11.6	23.5	8.0	5.0	7.1	33.0	8.6	15.7	13.0	10.1	13.0	69.9	71.9	70.7	82.3	69.6	68.8	75.1	71.4	71.5	70.2	71.8	76.4	18.6	12.8	17.9	13.1	17.5	6.6	5.4	7.6	13.1	9.2	10.3	11.0	25.7	11.5	11.1	9.2	4.2	7.0	23.2	14.6	52.8	7.6	2.1	10.2	12.6	12.8	4.8	8.6	10.4	11.1	9.7	11.1	27.0	12.0	19.6	17.1	15.4	27.1	14.6	0.0	9.2	8.7	8.2	28.2	14.6	8.8	7.5	30.8	16.0	12.2	25.3	8.7	17.5	11.1	11.1	11.8	12.9	9.8	19.5	5.9	12.1	29.0	11.2	11.0	0.0	10.5	12.6	1.5	4.5	8.8	7.2	6.7	19.4	13.6	11.1	6.3
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530032	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6"	"Not detected"	"Not detected"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		11000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nuclear bodies, Golgi apparatus"	Cytosol	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	46.8	19.5	6.1	77.7	6.0	22.0	37.9	7.1	7.9	32.2	12.7	20.4	26.1	7.8	0.5	58.5	30.0	7.2	26.7	6.4	8.6	38.2	82.0	63.4	31.5	22.1	18.3	4.0	13.8	4.5	8.8	15.4	15.9	21.0	3.6	0.0	40.0	5.6	10.7	24.5	32.5	9.1	10.9	86.1	31.2	3.0	18.0	15.6	25.4	1.6	15.3	22.9	27.0	12.2	27.0	2.5	0.4	0.8	1.8	2.2	5.1	3.7	0.5	6.1	17.4	0.1	40.0	1.8	4.1	5.8	1.3	21.0	0.2	1.0	0.0	9.0	16.5	1.8	3.9	3.5	95.2	1.3	26.9	4.7	4.6	5.4	0.0	0.1	0.1	0.5	2.8	68.6	0.9	1.9	1.5	9.9	0.6	1.9	9.1	5.7	0.4	35.1	0.3	1.2	0.7	5.6	22.9	17.3	6.5	0.2	4.2	13.8	6.7	0.8	4.7	1.5	1.5	68.6	15.9	5.7	1.9	1.5	1.6	19.5	135.8	74.9	2.0	98.4	1.2	6.7	2.9	1.2	39.5	6.9	1.6	1.3	114.1	9.5	77.1	9.3	3.1	10.1	6.1	6.0	7.1	7.9	6.4	8.6	22.1	18.3	15.9	10.9	18.0	12.2	122.6	12.8	29.0	0.3	122.9	58.5	57.4	169.9	53.5	3.4	101.5	90.8	3.2	50.1	88.6	33.1	4.2	17.2	65.8	154.8	29.4	340.2	2.2	55.7	56.0	55.7	16.8	19.6	0.3	643.9	300.8	81.9	38.7	59.2	53.4	3.0	38.2	93.0	477.4	0.0	0.4	50.2	24.4	371.8	409.4	8.7	5.0	561.7	113.8	4.7	2174.6	2.9	71.1	0.5	0.2	364.0	86.4	1.9	102.1	109.8	214.5	105.1	78.0	6.6	26.3	93.3	62.4	1.5	8.0	71.7	56.7	33.5	62.5	3.7	51.1	76.0
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710285	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"choroid plexus: 44.8;heart muscle: 59.9;skin 1: 145.0"	"Cell type enriched"	"Detected in some"	17	"Melanocytes: 2486.6"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"SK-MEL-30: 1395.0"	"Group enriched"	"Detected in some"	5	"olfactory bulb: 4.6;thalamus: 1.8"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Approved	Vesicles		NA	NA		51000		"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.3	0.0	0.1	0.6	0.4	0.2	4.9	0.3	0.9	0.0	44.8	2.2	5.0	0.0	1.2	10.0	0.2	4.5	59.9	2.6	0.0	16.2	0.0	3.7	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.1	2.1	0.1	5.3	2.7	1.3	0.0	4.8	145.0	4.7	1.8	0.1	0.0	2.1	1.1	0.3	0.0	0.0	7.5	0.0	1.1	0.4	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	25.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	1395.0	0.1	19.5	1.5	0.0	0.0	0.7	0.0	0.9	0.0	0.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.9	2.6	0.0	1.2	1.1	2.1	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	92.3	0.1	0.0	0.0	11.7	0.0	0.0	44.3	0.0	0.0	3.7	2.1	0.0	0.0	0.0	144.8	0.3	2.5	0.0	0.0	1.3	0.0	0.0	0.9	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	17.5	4.7	0.3	0.0	2486.6	0.0	0.0	15.9	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.6	0.0	0.0	1.4	0.7	0.7	0.0	16.8	0.0	0.5	0.0	0.0	0.2
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.8;Oligodendrocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	7.7	10.8	5.5	8.1	5.9	9.1	10.0	6.6	7.6	13.0	8.8	9.0	9.5	9.2	9.7	6.6	10.1	7.1	7.9	5.6	6.4	8.8	12.0	7.2	9.8	6.4	5.8	12.2	7.3	13.1	6.9	8.4	6.1	9.8	10.7	9.0	7.1	9.5	15.6	7.9	7.8	9.2	5.6	7.7	7.7	8.1	5.7	10.4	12.8	8.4	9.4	8.5	8.7	7.3	16.3	20.5	12.1	24.9	17.4	12.0	13.8	16.8	12.9	12.9	12.0	23.3	20.2	28.1	25.2	15.4	18.6	18.4	24.9	20.3	18.4	22.1	24.1	11.9	17.1	15.6	17.7	27.7	15.1	12.4	20.3	17.5	27.0	10.6	13.0	20.9	32.3	16.0	15.6	15.7	18.1	23.4	21.1	27.2	18.8	19.7	16.6	34.8	17.4	16.4	18.2	18.3	20.4	38.4	17.6	22.7	26.6	19.6	14.0	15.0	10.8	11.8	23.3	16.1	25.7	33.2	12.1	25.9	20.8	2.4	7.4	3.9	8.5	7.7	11.2	8.3	8.8	9.5	8.8	9.8	10.8	11.7	1.8	11.1	10.0	6.7	6.8	6.2	5.5	5.9	6.6	7.6	5.6	6.4	6.4	5.8	6.1	5.6	5.7	7.3	10.0	6.4	15.3	39.2	18.2	10.5	5.3	10.0	17.1	12.0	11.4	11.7	9.5	10.0	7.6	11.0	4.2	18.6	11.7	7.8	0.0	7.8	7.3	10.9	18.0	8.8	4.8	12.6	57.8	6.9	13.1	11.0	12.8	10.9	34.2	9.1	6.1	14.2	7.7	3.3	53.4	12.3	12.2	7.1	11.2	4.5	8.4	10.3	8.8	43.1	10.0	6.8	10.3	50.3	58.7	7.1	4.0	8.2	18.0	6.2	4.9	2.4	9.6	11.5	19.7	11.2	10.4	23.9	23.4	15.6	16.9	15.2	17.1	10.2	11.4	3.3
TYW1B	"LINC00069, MGC87315, NCRNA00069, RSAFD2"	ENSG00000277149	"TRNA-yW synthesizing protein 1 homolog B"	Q6NUM6	7	72558744-72828200	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.9;Excitatory neurons: 47.4;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (2.61e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.96e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.33e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	2.3	1.8	2.4	1.3	2.3	2.9	2.5	2.0	2.6	4.1	6.9	1.8	1.0	2.4	2.9	2.0	2.3	0.9	1.5	2.5	2.3	1.8	4.5	1.6	1.7	1.8	1.4	5.3	2.0	1.7	2.1	1.8	1.9	2.6	2.4	2.5	1.8	2.7	3.4	2.6	1.7	1.3	1.5	1.9	2.0	2.9	1.8	2.4	3.4	1.1	2.5	2.6	3.1	3.1	2.4	2.5	1.0	2.0	1.5	0.5	1.1	1.2	0.5	1.0	1.1	8.0	4.1	7.4	0.7	0.8	1.0	1.1	1.9	0.8	1.2	8.0	2.3	0.7	1.2	4.7	0.8	7.6	2.0	3.6	0.5	1.2	0.8	0.6	0.7	1.6	10.3	7.5	1.0	1.0	2.5	3.8	1.8	3.1	4.5	1.4	5.4	2.7	1.1	0.8	1.7	0.9	1.5	8.2	4.5	3.1	2.1	2.6	3.1	1.8	4.1	9.4	1.4	6.5	8.4	8.2	0.5	2.1	9.5	3.0	1.9	3.3	1.5	0.8	1.3	4.7	0.9	0.9	0.7	2.3	1.1	1.4	2.2	1.2	0.8	2.9	1.0	0.6	2.4	2.3	2.0	2.6	2.5	2.3	1.8	1.4	1.9	1.5	1.8	3.1	3.5	0.0	2.0	21.9	7.2	0.0	1.8	0.0	2.2	4.3	3.4	3.4	5.3	2.8	0.6	0.0	10.4	4.8	5.4	2.1	0.0	2.9	4.9	3.6	7.6	3.2	0.0	3.2	47.4	0.7	1.7	3.3	4.6	5.3	1.3	2.0	1.8	2.7	3.1	1.7	27.7	2.9	0.0	1.0	0.0	1.1	0.9	3.0	0.0	15.0	3.2	0.9	2.1	23.1	41.4	0.8	2.3	0.7	5.8	2.2	2.0	0.7	1.5	8.0	0.0	6.9	5.2	5.6	5.2	5.4	0.0	1.9	5.1	5.4	2.2	1.1
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	12.9	15.4	10.8	11.7	11.8	13.1	17.0	11.3	12.7	13.4	10.2	15.2	8.9	16.0	12.2	11.6	14.7	9.2	20.3	10.5	12.5	17.4	13.8	10.6	14.6	11.2	12.1	26.6	11.7	21.5	11.7	12.7	11.8	15.1	11.1	14.6	14.0	13.6	10.6	9.9	8.9	17.9	11.5	11.0	11.5	11.9	11.6	12.7	19.2	14.4	16.4	15.2	11.1	13.2	19.6	16.1	27.3	19.5	30.3	32.9	41.4	32.9	30.0	30.7	26.9	34.3	16.2	51.0	29.4	28.6	45.1	15.6	31.5	37.9	38.3	31.9	27.1	40.2	49.4	67.0	19.9	81.2	24.9	25.1	37.7	39.2	37.6	24.7	27.7	34.8	70.8	38.0	39.9	16.6	39.8	27.1	72.8	29.2	37.2	37.2	56.8	23.0	26.6	25.2	21.1	18.0	15.7	42.4	53.7	29.5	23.2	29.3	18.2	13.6	37.0	37.0	40.2	21.9	42.7	35.4	30.3	29.0	39.9	9.1	6.4	1.8	10.6	8.8	10.0	10.7	9.2	9.7	9.9	9.8	13.2	14.2	0.5	15.4	6.9	9.6	9.4	5.8	10.8	11.8	11.3	12.7	10.5	12.5	11.2	12.1	11.8	11.5	11.6	13.2	30.6	16.0	23.9	17.6	34.1	25.6	40.5	32.7	58.1	34.5	32.4	42.3	29.9	20.0	28.6	16.5	4.2	44.5	21.2	7.4	78.2	36.2	19.8	28.9	38.8	31.7	13.8	18.5	28.0	59.4	51.1	34.7	15.8	29.0	21.0	32.8	21.8	29.2	33.1	50.5	22.7	19.5	22.4	30.9	22.6	19.6	43.5	26.2	21.4	14.0	39.5	27.6	37.0	30.2	24.5	32.5	8.4	61.3	35.6	45.7	12.2	64.4	18.4	22.5	13.1	44.2	36.0	34.3	45.3	44.1	22.7	22.3	29.2	55.7	25.9	31.2
U2SURP	"fSAPa, SR140"	ENSG00000163714	"U2 snRNP associated SURP domain containing"	O15042	3	142964497-143060725	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037545, HPA037546, HPA061407"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506"	"unprognostic (2.01e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (8.86e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.12e-1)"	"prognostic favorable (6.78e-4)"	22.1	18.2	16.6	19.3	17.1	57.6	23.4	21.9	25.1	25.0	15.9	21.3	12.9	22.6	20.8	21.5	23.9	12.3	18.1	16.2	16.8	23.2	24.3	18.8	29.9	16.4	16.1	31.7	25.2	22.5	21.5	17.8	16.6	19.8	20.1	51.8	18.5	14.5	27.4	21.9	22.0	17.5	15.1	25.7	19.9	20.4	16.2	31.3	22.5	17.7	26.1	20.9	21.9	20.8	165.4	54.2	59.7	40.1	30.9	28.3	103.9	72.8	46.4	82.2	61.2	72.7	49.7	189.2	76.0	47.5	157.0	58.2	124.0	66.1	93.2	51.8	88.0	205.1	49.9	58.3	31.7	202.1	75.3	34.4	32.0	64.3	81.9	36.4	45.4	118.5	129.5	59.1	39.0	46.3	100.4	86.8	96.7	52.8	50.4	101.9	116.2	79.0	40.8	102.8	76.5	44.5	146.1	48.2	87.1	61.2	85.3	84.8	49.5	44.1	52.2	35.1	118.0	69.4	97.5	319.8	34.9	72.1	63.1	40.2	32.7	33.3	40.9	31.7	35.1	60.1	37.1	37.0	27.0	60.7	42.4	36.6	33.3	35.5	48.2	53.9	40.5	21.6	16.6	17.1	21.9	25.1	16.2	16.8	16.4	16.1	16.6	15.1	16.2	20.8	124.4	118.6	129.4	116.2	94.8	60.8	85.7	140.5	68.9	124.2	64.4	90.3	123.8	52.9	115.6	62.5	66.7	78.9	109.9	50.0	52.8	77.2	35.1	91.5	129.4	96.4	55.2	126.0	71.7	79.8	83.7	103.8	58.1	99.1	98.1	165.5	62.8	58.5	61.3	92.5	80.7	74.7	85.5	60.2	54.6	22.0	108.7	78.4	51.6	63.7	115.9	98.1	110.2	104.5	145.8	89.6	55.7	79.7	108.7	81.9	48.0	60.6	100.2	125.4	78.9	122.8	139.4	243.6	235.6	76.9	64.8	79.1	98.6	111.6	80.7	78.4
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 678.4;U-251 MG: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	96.0	43.7	12.2	33.7	13.2	51.5	58.8	13.5	14.9	37.1	16.1	65.6	43.9	18.6	29.1	33.9	33.1	39.8	45.1	13.4	13.6	27.0	172.6	36.0	14.1	11.5	16.9	39.9	68.6	12.0	28.9	22.3	11.8	33.3	66.3	20.4	76.6	31.2	41.2	25.0	56.0	24.6	11.6	13.8	55.8	90.9	13.9	11.8	24.4	45.2	22.2	77.9	37.4	11.0	204.6	14.6	39.2	31.5	185.7	147.8	26.8	292.4	107.1	220.7	178.5	38.6	93.5	8.0	64.3	225.8	79.6	35.0	44.7	85.5	359.9	32.4	66.6	36.0	43.8	75.6	87.1	61.8	23.5	69.0	39.8	242.4	678.4	100.6	137.5	62.6	206.1	81.3	298.9	37.4	36.0	40.0	29.2	207.6	64.4	31.9	76.2	99.8	34.8	23.7	41.9	43.4	128.0	78.4	70.4	45.6	38.9	70.0	235.2	110.6	102.5	281.2	463.5	135.0	51.0	67.0	63.4	28.5	71.3	1.4	2.2	11.7	16.7	2.1	20.4	10.7	10.0	17.3	4.6	11.1	9.4	12.0	2.2	8.6	1.2	7.7	5.5	7.2	12.2	13.2	13.5	14.9	13.4	13.6	11.5	16.9	11.8	11.6	13.9	11.0	58.1	6.4	30.2	15.0	42.5	134.7	163.0	47.2	47.8	11.8	59.1	42.7	30.0	27.1	57.4	16.5	8.4	27.2	82.9	94.8	72.4	27.1	78.2	28.6	58.0	35.7	54.9	13.9	12.4	64.7	63.9	195.8	45.9	40.7	33.7	21.3	22.5	98.4	14.5	6.7	12.4	139.4	40.7	10.1	82.2	20.1	50.7	24.6	85.4	3.7	18.2	16.6	41.2	8.0	6.1	73.0	74.5	41.3	152.8	94.6	88.4	26.9	56.0	13.9	19.7	59.4	88.6	212.0	125.9	43.2	81.8	97.7	50.5	18.8	70.4	141.7
UAP1L1		ENSG00000197355	"UDP-N-acetylglucosamine pyrophosphorylase 1 like 1"	Q3KQV9	9	137077517-137084539	"Metabolic proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 21.7;Horizontal cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044356	Approved		Approved	"Intermediate filaments,Cytosol"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	Cytosol	"HPA044356: AB_10959902"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.64e-3)"	11.6	14.1	13.5	5.5	18.7	3.1	9.5	14.3	16.4	15.0	15.8	8.1	5.7	6.7	5.1	6.0	7.6	5.3	11.0	14.4	14.0	14.0	2.8	12.5	7.9	16.6	15.8	3.8	9.6	7.9	15.4	6.3	15.8	13.0	3.6	2.9	11.0	5.6	2.7	10.1	10.8	3.5	12.6	22.0	10.2	3.2	19.0	2.4	14.1	2.7	5.9	10.0	9.1	24.1	0.8	5.8	0.0	15.7	26.4	12.1	4.5	8.1	21.1	22.4	15.4	11.7	2.6	3.7	4.7	8.3	40.6	12.1	29.6	2.0	4.6	10.0	2.7	7.9	9.5	11.3	58.5	0.1	31.5	8.9	2.1	12.7	10.4	10.4	17.7	7.3	2.4	18.0	15.2	13.5	0.8	8.1	2.6	28.3	8.3	12.8	0.2	11.3	8.9	1.1	9.3	5.8	2.0	44.3	18.7	3.7	23.9	21.8	14.1	40.2	8.6	28.3	3.9	19.6	30.1	7.9	34.9	8.6	11.7	0.1	1.0	0.0	0.2	0.5	0.8	0.5	0.1	0.3	0.5	0.2	0.2	0.3	0.1	0.0	0.0	0.3	0.5	0.4	13.5	18.7	14.3	16.4	14.4	14.0	16.6	15.8	15.8	12.6	19.0	24.1	2.4	0.0	8.4	16.0	6.9	6.1	0.6	2.0	4.0	6.8	4.8	3.9	4.0	5.7	1.5	0.0	2.1	0.4	7.1	2.1	11.7	1.4	0.2	2.2	4.9	3.1	1.8	0.4	3.3	0.9	5.0	4.0	1.1	3.4	4.5	0.8	7.1	0.7	21.7	20.2	5.1	1.8	6.1	10.9	9.9	0.2	2.5	11.2	8.8	6.5	9.1	4.7	3.1	6.6	18.4	0.8	1.9	3.8	5.6	2.0	0.5	3.4	1.1	5.1	0.0	3.0	16.5	0.6	1.5	3.5	4.4	1.4	4.5	1.0	3.1	0.2
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm		NA	NA		14000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.21e-2)"	98.4	157.9	102.9	98.3	113.2	94.3	98.6	103.4	115.5	127.9	133.9	101.1	71.3	127.1	64.3	155.3	119.3	64.9	117.4	106.2	102.0	131.2	114.7	109.5	105.0	106.9	104.2	136.5	89.0	107.5	135.2	67.4	109.3	103.2	68.5	95.6	119.5	78.9	201.1	119.5	100.4	117.4	94.4	131.9	98.6	98.7	110.0	119.7	160.1	114.1	110.8	101.1	124.8	121.3	269.1	273.2	307.7	471.9	207.4	186.8	135.0	175.1	187.1	248.6	200.5	219.3	201.3	201.6	111.8	357.0	361.5	254.9	392.9	375.7	180.9	163.4	391.7	126.1	295.2	180.0	145.1	215.2	258.8	177.4	193.2	362.7	279.4	176.7	330.2	236.1	138.9	173.7	250.4	343.4	203.3	188.5	329.6	163.2	417.1	233.1	215.3	343.7	198.7	287.0	197.4	148.1	520.8	250.9	116.9	329.9	349.5	130.3	241.6	183.1	210.7	266.4	166.1	117.6	132.8	286.3	189.4	150.8	224.9	31.0	39.7	40.7	39.4	51.1	34.0	39.8	31.8	35.0	43.2	29.9	24.7	31.1	44.8	38.1	49.7	29.3	40.3	39.9	102.9	113.2	103.4	115.5	106.2	102.0	106.9	104.2	109.3	94.4	110.0	121.3	37.2	51.3	34.7	45.1	37.1	33.6	38.6	55.7	26.2	24.9	48.3	39.6	51.4	51.5	50.0	82.8	16.7	46.3	34.2	133.1	35.2	77.5	29.6	84.9	56.3	40.9	57.5	33.2	27.1	90.8	68.7	45.0	74.9	97.5	18.3	60.3	43.5	51.2	60.0	11.8	35.5	78.6	30.5	49.0	37.8	61.6	42.3	51.4	19.6	31.9	57.7	20.7	13.4	32.2	46.5	147.9	74.7	65.8	44.0	55.2	82.2	61.6	56.4	25.1	39.5	38.8	56.6	10.5	34.0	51.3	42.1	71.1	34.6	56.8	68.2	55.4
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 383.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473"	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	34.3	32.3	83.7	39.4	225.9	39.1	43.4	138.0	136.2	32.1	32.1	34.5	28.8	35.8	41.0	33.9	27.5	29.7	66.6	109.7	198.7	33.9	31.2	32.2	49.6	240.4	162.7	30.0	19.3	45.6	22.9	41.7	245.4	36.6	35.8	62.0	44.9	32.2	41.5	45.0	30.3	39.8	131.0	38.9	26.4	23.7	197.1	44.8	27.1	34.7	49.8	39.4	26.6	383.0	76.6	31.4	75.8	47.1	69.0	90.9	56.1	65.9	74.4	70.4	70.2	39.2	52.2	55.2	18.6	72.5	71.3	42.1	59.1	76.5	80.2	105.0	38.5	77.0	57.7	39.6	53.8	77.1	62.4	72.0	49.8	67.9	54.9	86.7	92.3	45.2	31.9	45.6	94.0	26.8	49.5	49.7	67.5	95.4	26.9	39.6	55.9	53.0	113.2	94.6	32.8	46.2	70.3	51.0	58.4	80.9	34.3	73.3	71.4	53.0	46.9	70.6	93.3	53.2	91.8	67.3	54.5	84.3	69.7	87.9	45.7	71.0	24.3	54.0	28.1	33.6	32.2	30.3	40.1	29.7	29.6	30.5	40.9	39.8	57.1	20.1	40.8	53.0	83.7	225.9	138.0	136.2	109.7	198.7	240.4	162.7	245.4	131.0	197.1	383.0	21.9	35.3	31.4	35.9	35.5	33.8	29.2	66.2	31.9	22.9	21.6	17.9	68.5	14.3	44.5	35.0	39.6	74.5	19.8	15.8	19.6	37.1	15.2	25.1	21.2	26.9	18.6	30.7	44.6	23.6	57.2	28.3	22.4	25.6	42.4	26.0	22.9	17.2	34.1	33.7	62.8	16.3	97.6	37.1	49.6	10.3	40.4	39.6	30.2	44.0	60.6	29.1	24.7	53.3	76.7	31.5	11.7	38.0	28.3	23.7	16.7	36.9	47.3	48.9	26.3	22.2	31.0	34.2	32.1	34.9	42.8	56.8	34.0	24.3	17.5	32.5
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655722-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0;lymphoid tissue: 15.6;placenta: 13.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038606, HPA038607"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		23000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	3.4	0.7	1.1	4.8	1.5	6.7	1.1	15.0	1.9	3.0	0.1	1.2	1.3	1.0	0.2	1.1	0.5	1.9	0.9	1.2	5.5	1.7	1.3	4.6	5.7	10.3	7.1	0.2	0.6	0.4	0.3	13.8	10.2	0.7	1.4	1.9	0.7	0.7	1.1	3.4	1.7	1.9	1.2	15.6	1.4	1.2	2.8	15.1	2.3	0.3	3.2	4.4	0.5	1.4	13.1	31.5	5.6	7.5	2.4	4.4	29.1	45.6	25.1	18.1	13.9	12.5	6.8	5.3	3.5	24.3	17.2	6.4	0.1	16.3	28.7	0.2	0.9	122.2	1.0	10.8	6.7	15.0	88.9	3.9	1.0	72.9	26.9	19.7	12.4	5.3	0.1	0.1	17.8	0.5	18.5	9.6	2.5	13.3	7.4	73.3	3.3	0.7	28.6	10.9	12.7	0.2	12.1	0.9	10.1	11.7	0.2	4.0	32.3	23.4	12.6	13.9	19.1	1.0	0.0	15.1	12.4	20.6	43.4	0.0	1.3	9.9	1.8	6.3	1.9	0.3	2.3	1.7	1.7	1.1	2.6	1.4	2.7	6.4	11.1	0.2	4.7	1.8	1.1	1.5	15.0	1.9	1.2	5.5	10.3	7.1	10.2	1.2	2.8	1.4	2.2	0.0	4.7	9.1	4.6	7.1	4.2	3.4	2.8	1.8	1.2	1.3	1.1	0.0	2.0	3.7	0.0	32.5	10.0	0.6	0.0	8.4	2.4	0.6	4.0	4.5	0.0	1.7	24.8	9.7	54.9	4.9	2.0	1.5	12.7	11.5	5.0	0.6	35.7	11.8	166.3	0.5	4.1	26.0	51.2	3.9	0.0	26.5	1.8	30.0	9.1	0.2	17.5	26.2	2.7	26.3	0.3	0.4	11.4	4.7	0.2	0.6	2.5	1.1	0.0	3.8	3.4	0.1	0.8	2.4	6.0	47.6	16.8	0.1	0.4	3.1
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.5;lymphoid tissue: 113.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Erythroid cells: 182.1;Extravillous trophoblasts: 449.1;Granulosa cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.1;T-cells: 8.2"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.3;white matter: 11.4"	"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Approved	"Plasma membrane,Cytosol"		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	2.6	2.9	0.3	21.5	0.3	78.5	4.3	0.9	0.6	6.1	0.7	26.7	21.4	5.7	0.6	37.2	1.9	2.7	1.4	0.2	0.3	1.9	2.9	5.4	45.3	0.3	0.7	1.3	1.0	0.4	0.4	20.4	0.7	1.5	30.9	0.2	5.0	0.9	0.9	18.5	20.6	10.5	0.2	15.8	13.0	16.4	1.6	113.5	1.1	0.2	69.5	6.9	12.3	0.4	312.8	223.9	390.9	188.3	10.4	24.0	225.2	238.5	121.6	390.7	278.4	743.8	345.4	327.6	233.2	115.5	475.6	294.9	2.2	260.5	395.8	141.7	213.7	101.5	168.5	196.0	3.0	145.4	241.6	7.6	27.8	265.7	257.3	57.4	193.4	206.4	1.8	261.6	325.4	516.2	243.5	41.1	237.1	350.8	529.4	256.0	354.8	1.4	134.9	105.9	226.1	188.7	378.3	271.7	154.4	196.2	276.6	209.4	70.1	341.2	298.4	236.2	473.4	84.3	2.9	369.4	208.0	103.4	328.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	1.7	0.6	0.1	0.1	0.1	2.1	2.1	0.5	0.3	8.2	3.2	0.3	0.3	0.9	0.6	0.2	0.3	0.3	0.7	0.7	0.2	1.6	0.4	0.9	0.0	3.7	0.0	17.9	17.3	7.8	39.0	5.7	0.0	8.6	14.6	0.0	1.5	9.3	0.0	0.0	129.6	3.6	27.4	0.0	1.3	12.0	5.8	5.9	9.5	1.2	182.1	0.0	0.5	449.1	28.5	25.5	9.6	5.7	119.0	18.2	3.6	92.6	0.0	0.1	41.1	50.8	20.8	18.1	6.4	0.9	24.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	7.2	0.0	37.0	12.6	6.2	0.6	1.8	0.0	0.0	0.5	19.2	52.2	50.7	83.2	11.6	31.2	13.7	2.5	68.4	18.4
UBE2E1	UbcH6	ENSG00000170142	"Ubiquitin conjugating enzyme E2 E1"	P51965	3	23805955-23891640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030445, CAB073413"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB073413: , HPA030445: AB_10669599"	"unprognostic (7.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.91e-3)"	"unprognostic (7.13e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (9.97e-7)"	"unprognostic (3.69e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	68.6	54.9	84.5	67.1	91.0	123.2	89.5	91.5	121.1	74.7	83.9	76.9	50.6	66.6	68.3	80.9	63.5	61.8	62.6	82.4	94.1	69.3	71.2	71.2	102.4	92.5	88.7	79.3	53.9	103.7	34.4	96.1	93.8	71.3	79.0	73.1	64.6	73.6	89.4	63.8	51.4	77.5	93.2	73.8	60.9	51.7	87.2	98.5	61.4	94.9	108.1	92.5	65.1	101.8	199.3	101.7	202.1	99.1	129.2	170.3	151.5	141.0	256.8	172.7	234.0	80.1	235.8	182.6	121.2	166.3	146.8	65.6	232.5	208.6	228.2	202.2	201.4	235.5	75.8	97.3	177.0	260.2	138.8	172.6	162.8	230.4	324.9	207.1	278.6	118.9	177.2	210.8	136.0	86.7	188.6	235.8	268.0	117.8	255.3	201.6	80.7	531.0	262.0	129.3	54.3	176.0	146.7	131.5	215.5	202.5	146.4	329.1	183.1	132.2	144.2	85.9	109.5	154.9	99.8	363.6	152.2	231.9	110.9	1.7	4.2	3.7	1.8	4.7	2.9	3.0	2.4	1.8	3.8	2.8	3.2	2.0	1.5	4.3	2.8	4.0	2.0	2.1	84.5	91.0	91.5	121.1	82.4	94.1	92.5	88.7	93.8	93.2	87.2	101.8	30.7	44.8	28.9	66.3	52.7	72.3	62.6	89.0	59.2	31.3	37.9	24.9	68.2	31.5	59.5	18.4	4.2	97.3	27.9	56.7	56.7	90.4	25.6	37.0	28.7	58.4	46.3	41.0	47.1	78.0	99.4	43.2	25.5	32.7	40.6	40.2	43.5	22.5	98.8	20.2	50.6	37.9	150.5	69.4	156.5	55.3	40.7	61.5	97.8	127.4	98.9	81.6	36.0	90.5	102.8	71.8	61.9	48.5	40.8	78.0	21.5	43.4	60.1	27.7	52.6	47.1	63.0	35.4	59.5	61.7	90.2	72.1	35.7	27.6	52.2	72.6
UBE2E2	"FLJ25157, UbcH8"	ENSG00000182247	"Ubiquitin conjugating enzyme E2 E2"	Q96LR5	3	23203020-23591794	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 652.7;Inhibitory neurons: 399.4;Microglial cells: 402.8;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 845.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 41.7;intermediate monocyte: 50.3;memory B-cell: 35.1;myeloid DC: 57.6;naive B-cell: 40.1;non-classical monocyte: 54.4;plasmacytoid DC: 74.0"	"Group enriched"	"Detected in all"	6	"B-cells: 40.1;dendritic cells: 74.0;monocytes: 54.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003303, HPA028872, HPA030445, CAB073417"	Approved		Approved	Nucleoplasm		No	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.68e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.19e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.11e-3)"	23.9	8.9	14.3	10.6	17.2	7.0	18.3	14.5	28.1	22.9	9.4	18.2	4.6	18.2	25.7	17.4	13.7	15.4	19.9	20.2	16.8	17.1	13.4	17.8	16.4	13.2	12.8	16.2	7.0	13.5	12.0	7.4	14.4	14.7	4.8	16.6	11.9	13.3	16.0	16.8	8.3	18.9	12.6	14.3	11.6	15.1	13.7	18.1	13.9	12.4	12.6	16.2	17.8	28.4	36.7	12.9	33.3	0.6	29.0	32.1	30.3	22.6	38.2	20.8	29.0	3.6	29.2	31.7	15.1	19.9	28.5	3.5	24.5	35.2	26.5	0.2	24.6	0.0	15.3	4.3	20.8	0.0	24.5	25.6	36.2	30.0	50.0	21.1	20.2	24.5	1.9	32.4	19.0	5.9	16.8	7.2	23.7	20.7	18.6	34.9	13.0	36.8	20.4	0.8	8.5	17.7	24.8	14.4	0.4	23.8	30.7	20.9	17.8	20.4	29.1	13.8	25.7	31.2	10.9	49.4	19.2	14.2	5.8	0.1	41.7	0.2	0.7	50.3	0.9	35.1	1.4	0.6	57.6	40.1	9.1	3.5	1.1	2.5	54.4	74.0	0.7	15.7	14.3	17.2	14.5	28.1	20.2	16.8	13.2	12.8	14.4	12.6	13.7	28.4	13.3	22.4	9.8	159.3	48.4	25.6	12.2	77.2	34.7	24.0	31.3	27.1	38.2	15.7	28.1	31.3	16.7	34.8	24.2	0.9	68.4	12.0	24.2	9.6	30.8	24.6	1.8	8.2	652.7	29.2	43.1	42.1	5.6	18.8	0.0	38.5	14.6	41.4	47.7	32.0	399.4	1.1	67.1	47.3	73.9	16.0	39.4	49.2	78.2	402.8	40.5	14.8	1.0	513.2	845.2	13.9	1.2	53.0	32.8	64.6	0.0	152.7	17.3	3.6	32.9	14.9	67.3	36.3	91.0	44.1	42.3	38.6	4.6	15.1	0.7	8.6
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558954	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 1197.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No		49000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	46.3	66.1	133.2	39.2	138.8	82.2	42.8	116.7	199.7	48.9	104.0	72.5	41.7	48.1	36.3	61.8	51.3	30.9	111.0	141.2	129.3	63.2	45.6	46.3	43.4	123.5	124.4	46.0	47.5	84.5	69.7	45.0	127.7	48.3	32.5	49.7	48.5	46.1	174.0	56.6	41.6	39.5	111.9	49.3	55.8	81.0	124.4	51.7	44.3	104.5	43.7	58.3	45.8	139.1	161.8	272.1	119.3	124.8	61.7	71.9	112.2	166.0	117.4	97.8	82.8	162.7	109.7	161.9	135.5	93.4	198.1	105.9	130.1	138.6	69.2	207.3	1197.4	235.5	163.7	113.7	154.4	197.3	192.9	82.1	107.1	145.9	167.3	102.6	117.8	146.3	119.6	179.4	127.3	158.2	177.2	223.7	87.1	155.1	306.5	171.7	106.7	204.5	111.6	166.8	239.5	205.5	133.1	149.7	163.3	41.6	94.4	188.4	105.2	333.4	80.5	110.6	281.3	262.3	411.9	169.6	206.0	177.6	220.5	6.7	3.6	4.2	3.0	2.6	2.2	2.8	3.2	3.2	2.8	3.8	3.3	2.2	10.1	1.7	2.7	6.7	2.9	1.9	133.2	138.8	116.7	199.7	141.2	129.3	123.5	124.4	127.7	111.9	124.4	139.1	75.1	6.4	13.0	14.7	32.7	40.4	36.3	15.9	6.2	100.0	74.5	81.3	38.5	20.0	11.6	18.4	20.9	21.0	72.9	63.9	7.9	17.3	25.7	89.6	68.0	40.1	41.2	39.8	22.9	30.6	22.4	38.9	21.9	63.3	19.7	103.3	28.5	38.0	35.4	109.4	20.8	43.8	20.3	27.0	33.5	34.0	17.4	42.5	35.6	15.9	21.1	142.3	14.4	8.5	17.9	41.8	21.4	13.9	35.4	59.1	37.9	33.9	18.6	81.1	26.3	41.5	55.4	27.1	7.9	17.0	56.8	52.5	41.0	156.1	41.6	56.2
UBE2O	E2-230K	ENSG00000175931	"Ubiquitin conjugating enzyme E2 O"	Q9C0C9	17	76389456-76453152	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.7;Inhibitory neurons: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023605	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		No	No		220000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear bodies"	Nucleoplasm	"HPA023605: AB_2671257"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (6.84e-8)"	"unprognostic (3.54e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.34e-9)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	9.1	9.7	12.9	10.1	14.0	21.2	9.7	8.0	24.9	12.8	1.4	10.7	9.4	11.5	7.0	12.8	11.0	6.5	20.3	15.4	11.7	8.4	10.5	8.7	13.1	21.7	9.0	15.1	17.4	10.9	18.2	9.1	21.7	11.6	5.3	10.5	12.9	8.7	28.3	16.1	10.6	7.1	4.4	13.9	11.0	16.6	11.6	12.0	16.1	13.4	8.6	10.8	12.5	14.5	25.8	29.2	29.1	35.5	17.7	11.3	25.2	11.8	12.8	18.9	18.3	25.6	12.7	36.4	8.3	14.8	29.7	25.2	34.2	20.4	13.2	10.5	42.2	36.9	20.6	42.9	14.7	22.6	22.0	11.4	16.2	18.1	15.3	16.2	25.7	19.9	31.5	31.4	9.6	21.3	44.7	26.0	27.0	15.5	38.9	43.3	37.6	40.2	8.5	22.1	43.0	38.5	17.4	43.9	23.6	26.3	25.4	16.1	15.4	21.9	20.5	18.8	19.9	25.8	9.2	30.8	24.1	18.8	14.6	0.0	0.7	1.0	1.4	0.3	0.8	0.9	0.9	0.7	0.4	1.6	0.7	1.1	0.1	0.5	0.4	1.5	0.9	0.8	12.9	14.0	8.0	24.9	15.4	11.7	21.7	9.0	21.7	4.4	11.6	14.5	7.9	3.2	7.7	24.8	19.6	8.7	6.1	7.2	13.1	45.8	9.7	9.1	23.2	5.7	7.3	7.3	41.7	6.4	15.2	6.5	0.0	6.0	1.8	8.6	13.7	8.3	23.4	33.2	54.7	9.4	7.4	8.3	17.9	10.1	7.0	18.9	7.1	8.5	8.1	45.4	63.0	9.3	2.0	5.3	11.0	1.8	9.6	11.6	5.4	19.7	10.0	7.3	18.6	27.2	24.7	7.2	5.7	7.9	22.9	9.8	5.2	3.3	5.6	23.8	6.6	12.2	10.9	19.6	23.2	12.9	12.4	5.2	14.7	13.3	8.7	6.2
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	25.4	23.1	36.1	19.0	37.0	32.2	22.4	34.5	43.3	21.2	35.2	24.3	18.7	21.8	27.2	27.4	23.7	19.9	25.9	37.3	38.0	28.8	31.6	25.0	29.5	36.0	36.0	23.1	31.8	28.3	31.3	23.9	37.5	21.2	28.2	25.9	22.5	20.9	26.3	26.7	25.5	24.4	35.5	32.3	26.8	34.6	38.2	29.8	23.0	25.8	35.2	25.7	22.2	36.2	39.0	33.0	45.6	35.0	45.8	46.9	39.4	38.0	57.0	47.3	38.0	37.3	40.4	47.5	53.3	52.8	39.5	33.0	54.3	43.6	40.5	48.7	34.3	37.8	29.6	36.4	57.5	62.1	58.3	45.5	56.7	38.5	44.1	51.3	61.8	43.3	32.4	57.1	61.3	60.4	38.1	45.6	62.5	92.3	55.5	43.4	31.8	50.3	52.4	40.6	46.2	64.6	38.1	70.6	64.5	77.5	43.3	93.2	43.3	30.5	34.1	36.5	41.2	69.3	55.2	62.1	34.2	43.2	47.1	3.9	1.3	2.9	2.1	1.6	2.0	1.4	2.0	2.7	1.2	1.5	2.2	2.5	2.0	2.3	1.3	2.4	3.1	0.8	36.1	37.0	34.5	43.3	37.3	38.0	36.0	36.0	37.5	35.5	38.2	36.2	40.8	32.1	26.5	9.8	24.7	16.2	18.0	15.9	15.4	41.2	27.3	32.5	29.4	27.1	18.4	16.5	4.2	19.8	45.2	33.4	11.7	14.5	4.5	24.8	20.9	32.8	33.6	12.0	12.2	21.0	18.2	23.3	14.3	24.9	10.8	31.9	35.3	38.3	27.5	60.6	11.7	29.2	22.4	48.0	19.7	7.3	17.7	27.9	14.2	10.3	30.9	42.8	39.1	7.1	11.7	26.2	18.5	19.2	22.1	29.5	29.6	19.7	29.0	23.1	13.1	20.1	21.2	34.1	29.2	18.1	19.0	19.6	26.5	36.3	25.7	31.4
UBE2R2	"CDC34B, FLJ20419, MGC10481, UBC3B"	ENSG00000107341	"Ubiquitin conjugating enzyme E2 R2"	Q712K3	9	33817160-33920399	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061000, HPA074334"			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA061000: AB_2684408, HPA074334: "	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.82e-3)"	"unprognostic (4.61e-3)"	"unprognostic (3.05e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.43e-1)"	32.0	20.6	25.4	20.2	27.3	15.4	27.1	24.8	28.0	30.8	20.8	31.4	28.0	28.5	16.3	29.2	23.9	18.6	32.4	24.8	24.6	22.1	33.3	28.2	21.7	27.2	25.8	30.1	53.4	14.5	15.0	23.9	26.7	20.9	19.6	25.0	21.5	18.4	63.1	34.5	24.8	25.9	24.5	23.1	22.1	44.8	25.0	30.1	18.3	44.8	25.4	26.6	28.7	30.2	41.2	42.0	78.7	35.0	42.0	68.2	25.1	34.7	46.5	38.7	38.3	34.0	28.7	33.9	14.4	47.2	28.3	17.8	41.5	38.5	41.8	58.3	22.7	28.7	43.7	43.3	60.1	34.6	31.0	58.4	55.6	31.8	59.2	61.5	65.8	39.8	28.0	35.0	38.7	22.6	68.0	91.4	46.2	33.1	34.7	63.2	24.0	17.6	41.1	28.9	37.6	45.4	40.1	35.2	27.0	49.5	31.3	41.9	50.3	37.8	35.4	26.8	32.9	23.5	23.0	46.5	36.0	19.7	83.5	22.6	10.9	6.3	2.8	11.1	1.7	4.6	2.6	2.2	6.1	4.8	2.5	2.3	31.7	7.4	18.7	3.7	3.3	4.0	25.4	27.3	24.8	28.0	24.8	24.6	27.2	25.8	26.7	24.5	25.0	30.2	73.7	22.4	30.7	39.8	38.6	105.5	46.3	26.1	32.5	65.8	57.8	60.8	134.8	57.2	26.8	22.0	14.6	69.5	46.4	64.7	15.6	49.7	311.1	65.7	84.9	74.9	72.0	36.6	67.8	69.4	82.0	57.4	25.5	81.8	13.3	99.2	84.9	88.3	76.6	60.6	67.0	55.4	32.6	123.5	112.2	257.4	67.1	110.6	35.6	40.3	116.4	124.3	42.2	45.2	127.8	84.7	49.1	76.0	24.0	83.9	79.1	59.8	25.0	31.2	59.2	48.3	55.6	94.4	64.6	41.8	120.5	82.8	34.9	68.0	48.7	121.2
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA045161: AB_10960706, HPA073181: AB_2686578"	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	7.5	6.2	5.3	7.5	5.3	11.4	7.0	6.3	7.2	5.9	1.1	5.2	4.5	5.1	5.5	8.7	4.7	8.1	8.3	6.1	3.0	11.2	12.6	7.3	7.1	2.8	2.1	5.4	6.7	8.6	4.6	7.3	3.4	6.0	5.9	10.4	5.7	5.2	8.5	5.5	4.7	6.3	1.6	6.7	5.5	9.5	3.3	7.0	9.1	10.0	7.1	9.7	6.2	4.2	10.3	7.0	8.2	8.0	13.0	14.4	6.8	10.8	12.6	10.6	10.8	5.9	11.1	4.8	8.6	11.7	15.7	10.0	11.2	11.7	16.7	7.7	7.2	10.3	6.5	9.0	8.9	5.6	12.9	10.6	12.2	12.4	21.9	8.5	13.4	5.6	5.1	9.7	16.1	8.7	11.8	6.4	6.2	14.3	13.0	3.8	7.5	4.1	19.7	11.6	5.6	6.5	8.5	26.4	13.2	8.4	13.4	10.0	11.8	12.2	9.4	9.7	8.2	8.7	9.5	3.6	11.2	8.2	11.2	23.8	13.1	17.4	4.7	12.8	5.8	6.8	4.8	3.6	9.1	6.8	4.3	5.0	33.1	7.0	14.4	11.9	6.1	6.9	5.3	5.3	6.3	7.2	6.1	3.0	2.8	2.1	3.4	1.6	3.3	4.2	28.7	16.0	14.0	40.1	30.3	55.3	26.4	32.1	19.4	35.5	26.7	14.7	24.3	37.1	22.9	53.3	16.7	18.4	35.0	14.2	50.9	23.2	154.5	18.3	21.0	35.3	23.3	26.5	117.0	17.4	20.0	24.9	13.3	26.9	21.0	16.8	26.0	28.7	39.9	42.1	91.8	12.1	22.4	50.3	107.9	56.8	20.5	45.7	42.7	104.9	67.0	28.8	21.6	66.9	67.7	20.9	12.4	18.8	21.3	34.1	14.7	76.1	19.2	32.2	19.7	27.3	39.9	39.4	30.4	20.9	64.5	55.1	31.0	30.6	12.9	40.9
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908407-48929056	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favorable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	33.5	45.9	37.4	37.8	40.6	33.4	36.0	37.7	44.5	41.2	32.8	37.6	34.6	39.8	60.3	45.3	44.4	34.6	33.8	40.0	40.7	40.2	33.1	34.9	44.9	39.2	37.9	36.2	34.5	46.8	31.4	42.6	42.6	39.1	40.4	38.4	38.5	47.0	29.9	43.9	35.7	49.3	35.7	41.9	35.8	28.0	40.7	45.2	50.2	28.8	59.3	45.8	39.1	57.8	101.2	122.4	45.1	43.0	111.8	107.7	61.6	107.6	131.1	126.1	120.7	153.8	84.8	81.6	150.5	133.1	158.0	64.0	57.1	100.7	159.7	271.7	61.8	73.9	80.3	96.8	128.8	53.0	76.3	92.4	109.5	103.1	132.3	134.7	94.0	38.1	55.2	103.0	137.4	160.8	57.5	52.4	42.1	122.4	105.7	45.7	114.6	46.6	98.7	97.6	46.4	70.1	73.2	38.8	76.5	100.7	107.7	41.4	111.2	187.2	89.9	62.0	89.4	77.8	79.5	47.6	91.8	38.2	83.2	5.2	7.7	5.7	8.3	9.9	6.8	6.2	7.3	8.4	5.4	8.6	6.9	7.6	7.3	5.4	9.5	6.8	8.2	6.4	37.4	40.6	37.7	44.5	40.0	40.7	39.2	37.9	42.6	35.7	40.7	57.8	36.6	25.6	19.2	17.9	32.7	52.8	50.3	47.1	27.3	56.4	40.6	32.9	37.9	21.5	25.8	36.8	41.7	34.2	40.0	42.1	21.5	44.2	1.6	48.8	40.8	44.0	48.6	23.4	22.5	54.7	32.7	35.1	20.9	59.5	6.3	37.6	37.5	25.8	24.8	43.7	20.8	35.9	20.3	28.1	54.0	5.1	28.0	35.6	30.2	12.2	48.6	31.6	26.8	13.6	52.7	75.8	25.6	29.0	23.7	89.5	34.7	27.5	42.1	34.4	32.9	25.8	39.3	21.6	26.0	35.9	57.0	42.8	30.7	50.4	30.8	66.7
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138916-157269370	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favorable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	25.7	17.4	12.0	21.5	13.2	16.2	21.7	17.5	14.1	18.4	18.8	22.3	20.0	19.4	13.4	28.3	18.5	19.1	28.5	13.2	14.1	20.3	22.9	19.0	20.9	14.6	13.4	20.0	22.4	36.2	11.1	17.5	14.9	19.9	23.2	20.2	22.7	22.7	65.6	20.8	20.8	29.2	12.7	18.0	20.9	26.2	14.8	18.6	17.3	58.5	22.8	28.1	17.0	15.0	68.8	53.3	33.5	67.3	58.8	61.3	37.1	74.0	63.4	61.1	61.3	48.3	55.7	36.8	64.0	82.1	79.6	42.4	52.6	68.3	72.0	67.6	48.3	37.6	35.6	35.0	58.4	56.9	52.8	54.8	61.6	68.0	55.9	46.4	72.2	30.3	55.7	39.9	87.6	59.8	56.2	35.9	53.3	61.1	63.6	31.9	37.7	75.9	63.2	74.1	53.5	55.2	72.8	61.9	54.5	37.2	32.0	39.3	65.3	76.6	16.5	190.0	93.3	39.7	42.9	37.0	87.7	83.0	89.5	0.3	1.8	1.1	2.2	2.3	3.0	1.1	2.4	2.4	2.0	1.2	2.2	2.7	0.6	2.1	2.5	1.8	2.8	1.5	12.0	13.2	17.5	14.1	13.2	14.1	14.6	13.4	14.9	12.7	14.8	15.0	23.8	22.4	19.7	52.2	14.2	27.5	17.3	19.0	17.6	34.7	22.4	16.9	33.7	22.8	14.2	25.8	66.7	14.9	25.3	27.3	9.8	20.3	11.6	21.6	27.4	23.4	24.5	14.9	98.9	17.7	17.4	19.6	27.0	24.5	9.5	23.0	23.6	48.3	15.4	32.0	100.7	21.8	12.2	27.6	15.2	10.1	15.5	20.6	5.4	52.5	22.0	9.9	26.8	81.4	96.2	27.5	13.4	25.6	17.5	31.5	20.6	19.1	19.8	39.9	0.0	23.1	21.4	26.6	27.3	37.5	33.2	15.1	20.9	22.3	26.2	28.1
UBFD1	"FLJ38870, FLJ42145, UBPH"	ENSG00000103353	"Ubiquitin family domain containing 1"	O14562	16	23557721-23574389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051746			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA051746: AB_2681587"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.45e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.06e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.46e-1)"	12.8	20.7	18.8	11.9	18.3	10.8	12.7	16.6	19.0	13.7	25.0	13.6	7.4	17.1	18.3	13.1	17.3	12.0	20.7	18.4	24.3	15.5	17.0	9.9	12.4	20.1	21.2	17.4	13.5	25.2	19.6	18.0	26.2	15.4	11.7	10.7	12.4	15.2	81.2	10.6	9.6	18.8	16.5	11.1	10.7	26.0	21.9	21.0	17.7	39.0	15.7	13.4	11.1	16.7	17.1	40.0	55.0	40.0	62.3	76.9	48.8	45.8	44.2	42.3	39.1	29.9	30.1	39.3	68.5	66.9	28.5	23.6	88.4	36.1	53.9	57.1	47.3	20.8	34.0	66.3	33.2	21.9	34.7	55.1	26.5	41.3	38.4	64.9	41.4	31.1	47.6	20.7	47.1	37.4	30.9	39.5	118.0	29.2	17.2	53.6	33.7	33.0	39.5	14.9	53.5	47.6	17.6	34.3	31.8	52.7	47.1	31.6	43.1	23.3	26.1	25.7	27.2	25.0	29.8	23.6	43.0	25.3	36.6	0.0	0.5	0.5	1.4	0.7	0.7	0.6	0.9	1.3	1.1	1.3	0.5	0.8	0.0	1.2	0.3	1.5	0.8	0.4	18.8	18.3	16.6	19.0	18.4	24.3	20.1	21.2	26.2	16.5	21.9	16.7	10.0	6.4	2.6	10.1	6.8	8.8	10.2	10.3	13.1	11.6	16.5	13.8	35.1	8.6	6.6	20.2	22.9	19.2	14.9	8.1	15.6	13.0	49.3	20.7	29.4	11.6	7.2	10.3	14.6	11.5	27.2	17.2	7.1	20.6	0.0	26.4	5.3	19.0	13.4	6.7	12.3	10.2	2.0	6.6	5.1	76.1	18.6	6.6	10.6	7.5	10.7	11.0	6.2	5.0	9.8	8.8	8.9	9.8	9.8	20.4	4.8	18.3	8.8	14.9	26.3	17.1	19.2	21.3	21.7	14.0	14.2	36.0	8.3	22.2	9.3	14.8
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263290-159286036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	19.0	16.3	8.8	24.5	9.4	23.3	20.5	9.6	14.1	19.9	6.4	15.7	12.6	23.6	17.2	21.1	15.1	17.1	16.4	10.0	10.5	19.2	18.3	22.4	33.7	10.3	9.5	15.8	14.9	19.7	5.6	23.6	10.2	17.5	16.9	18.2	14.2	19.6	10.9	15.5	12.7	22.8	9.6	26.7	15.8	30.5	10.7	36.4	16.6	13.8	37.3	21.3	11.7	10.7	39.9	28.6	57.9	64.1	58.9	54.5	34.1	42.5	64.6	42.8	56.6	23.5	27.1	35.7	46.1	53.7	60.9	29.7	36.3	81.8	74.3	71.3	35.7	27.3	23.8	21.9	74.0	62.7	41.1	48.1	76.8	38.9	77.2	34.0	41.4	36.4	38.4	47.0	60.8	12.9	33.5	22.9	41.7	20.0	17.1	42.3	56.5	42.8	44.4	30.4	30.4	42.9	42.7	29.0	115.8	34.6	30.2	45.6	44.2	44.0	37.8	22.8	54.9	36.9	39.8	53.5	46.1	43.9	66.1	47.6	10.8	27.5	25.5	22.4	28.4	18.5	23.9	26.7	14.2	16.7	26.9	29.1	30.8	42.8	24.5	17.8	28.3	13.6	8.8	9.4	9.6	14.1	10.0	10.5	10.3	9.5	10.2	9.6	10.7	10.7	31.9	12.8	41.6	12.7	43.0	15.9	10.3	43.0	35.3	12.7	22.5	14.4	16.8	10.0	34.4	14.7	4.2	31.8	36.8	13.2	35.2	23.0	8.5	23.2	32.1	24.2	10.7	30.1	26.3	24.9	18.7	27.1	29.6	17.4	45.0	16.9	28.5	15.6	39.0	20.2	25.0	14.6	18.3	40.0	16.4	4.2	20.5	33.1	17.8	14.0	30.9	17.6	32.0	22.6	25.6	22.5	10.1	24.8	39.3	13.2	8.8	34.5	37.4	13.1	19.7	18.8	26.2	74.0	61.5	51.8	20.6	17.8	40.8	30.7	14.5	10.1
UBXN2B	p37	ENSG00000215114	"UBX domain protein 2B"	Q14CS0	8	58411359-58451501	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 42.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.8;monocytes: 12.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045278	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA045278: AB_10963578"	"unprognostic (1.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.42e-2)"	7.9	9.1	10.3	12.0	11.4	15.4	11.0	14.0	12.5	6.6	9.2	8.7	7.7	8.1	10.8	5.8	8.5	8.6	9.8	11.9	9.0	15.7	18.8	9.7	9.1	11.2	8.9	9.0	8.8	16.1	7.9	7.6	11.2	9.5	9.2	13.4	12.9	8.5	9.0	6.4	7.8	9.8	9.6	10.1	8.2	9.5	9.8	11.9	14.2	11.0	9.4	8.9	4.3	12.8	11.1	20.2	16.9	20.9	3.0	1.5	11.7	6.7	12.3	8.2	10.6	8.8	20.4	13.0	13.4	8.3	22.2	9.9	25.1	12.1	11.5	10.0	12.7	16.2	17.0	11.0	12.6	14.5	15.1	5.4	19.0	3.8	18.9	19.5	10.2	19.7	11.4	23.8	7.4	11.3	26.0	16.0	22.1	38.6	4.8	14.5	7.5	8.9	26.4	16.8	6.2	25.4	11.6	11.7	19.7	16.5	23.7	17.3	2.3	6.3	13.4	13.7	14.0	12.4	13.3	18.0	20.6	13.6	8.5	15.8	11.9	18.0	4.3	11.0	4.2	3.4	4.1	3.6	5.9	3.3	4.9	4.3	42.8	5.4	12.9	2.9	5.3	5.3	10.3	11.4	14.0	12.5	11.9	9.0	11.2	8.9	11.2	9.6	9.8	12.8	4.0	9.6	8.7	27.7	11.4	5.7	10.6	10.3	4.0	16.0	13.7	11.7	18.4	10.0	9.0	11.0	22.9	15.9	10.4	15.9	9.8	11.2	35.8	8.6	9.3	4.7	12.0	13.5	55.3	11.1	17.6	9.5	10.7	11.8	23.5	13.3	4.6	17.1	23.0	11.8	62.4	9.6	14.2	32.4	12.4	61.8	10.5	27.5	8.8	21.5	26.0	13.6	15.5	43.2	41.4	10.8	8.2	14.7	8.4	10.4	15.5	29.7	8.9	25.6	0.0	13.9	8.5	20.4	17.8	9.3	6.7	8.6	10.9	8.6	9.1	10.4
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 692.7;pituitary gland: 285.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4"	"Cancer enhanced"	"Detected in all"		"glioma: 129.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	30.1	104.4	211.4	19.2	188.8	0.6	13.6	83.4	342.7	18.9	0.0	49.0	9.0	13.2	3.3	3.3	9.7	12.3	26.9	229.7	692.7	62.7	1.6	8.2	12.9	255.7	205.2	35.6	11.6	0.6	285.4	2.5	446.7	12.3	6.9	38.3	3.7	5.8	27.5	4.7	18.9	9.2	122.2	2.7	14.5	16.5	150.3	4.1	9.8	7.7	7.3	31.7	29.1	231.2	3.3	712.8	146.8	0.4	18.9	19.7	0.4	681.4	352.8	236.0	243.4	149.0	0.9	0.0	1142.2	384.4	356.7	1.1	262.8	0.6	116.4	1.5	97.0	0.0	6.9	0.2	529.3	0.1	1.2	127.4	3.0	197.9	0.0	413.7	2.0	0.0	0.0	2.3	122.6	0.6	1.0	12.3	435.3	0.0	714.1	0.1	297.2	0.7	386.3	0.3	1160.6	765.7	5.1	2.8	1.8	165.4	0.8	5.0	3.3	16.8	5.2	0.4	1162.6	583.1	1138.4	3.1	1209.3	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	211.4	188.8	83.4	342.7	229.7	692.7	255.7	205.2	446.7	122.2	150.3	231.2	0.8	0.0	3.1	29.0	2.1	1.7	1.1	1.5	1.2	25.6	0.3	0.6	3.1	0.0	3.5	115.8	8.4	3.6	0.0	0.1	258.2	4.3	3.5	0.9	9.8	3.9	4.2	0.8	147.1	0.8	0.8	35.4	1.1	0.5	2.5	46.3	8.9	0.6	4.7	146.4	118.4	0.0	4.1	0.6	3.4	6.0	37.0	2.3	3.6	35.6	0.6	21.6	0.0	55.8	54.6	3.0	0.0	17.3	9.2	3.7	0.0	17.1	7.4	61.3	0.0	3.6	35.7	10.4	88.4	0.3	1.6	1.5	1.3	20.0	0.2	1.0
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol		No	No		700000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	20.7	56.9	20.6	20.2	24.2	33.5	34.2	20.3	25.2	15.3	17.2	35.4	21.6	12.4	63.2	58.0	13.0	17.7	29.3	21.7	20.5	32.2	50.9	15.0	21.3	18.6	18.9	7.4	30.9	23.9	22.9	24.6	18.5	19.5	39.5	9.7	27.2	18.2	53.9	48.6	19.9	25.1	18.9	15.9	25.1	43.3	20.5	25.7	44.4	40.6	34.6	44.3	26.6	21.0	196.0	31.9	26.9	18.8	49.9	58.6	78.6	72.3	70.3	90.7	100.5	177.5	92.1	100.4	50.2	75.7	70.2	105.8	64.1	175.3	137.1	53.8	55.9	62.2	50.7	114.9	71.6	150.4	45.7	52.6	118.7	71.7	114.2	38.4	90.1	79.6	70.0	27.9	138.9	70.2	62.4	100.2	40.3	229.0	95.1	49.5	42.9	66.3	108.4	77.9	81.0	23.8	40.8	78.3	34.5	58.2	45.7	42.0	70.8	39.6	47.9	42.7	98.2	39.5	45.5	117.1	80.4	161.3	29.0	57.6	68.7	49.3	29.9	134.4	39.6	51.5	54.1	43.0	99.5	51.5	53.0	49.5	15.6	62.7	117.9	134.9	71.8	50.1	20.6	24.2	20.3	25.2	21.7	20.5	18.6	18.9	18.5	18.9	20.5	21.0	18.2	9.6	23.4	9.1	20.3	76.3	80.4	197.5	35.9	9.3	48.8	66.2	27.2	28.6	88.2	46.0	2.1	105.2	32.9	39.0	92.0	146.2	198.2	35.4	17.4	26.6	24.0	24.4	22.5	143.1	163.6	25.1	23.9	36.2	24.1	19.3	13.9	45.7	88.0	16.8	22.3	54.6	81.4	28.8	28.8	43.5	16.8	32.8	26.6	18.7	33.3	17.3	22.6	22.6	24.9	153.1	44.3	11.7	33.3	133.1	40.4	119.6	48.0	8.9	19.7	24.5	73.5	159.3	36.8	64.8	79.1	169.0	22.1	47.6	60.8	96.2
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531264	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	21.5	25.3	40.3	10.2	41.2	16.4	20.4	40.5	45.2	21.2	37.0	26.0	11.8	20.2	18.7	21.2	19.9	12.2	28.1	38.1	39.2	29.3	52.7	17.2	15.1	41.6	41.4	22.2	29.8	22.6	24.2	14.3	40.0	26.9	9.3	13.5	25.6	17.3	43.9	19.1	18.0	11.2	40.7	20.9	24.9	20.4	42.1	17.5	23.4	26.8	11.5	20.9	17.2	40.9	13.9	30.0	33.9	43.8	23.6	16.7	28.9	22.0	32.1	37.0	28.0	30.1	12.4	15.0	12.9	26.4	28.9	26.3	31.9	28.0	15.8	27.7	29.8	14.0	46.3	19.2	33.6	23.2	19.9	18.8	25.8	29.9	21.6	22.4	23.0	36.3	17.9	11.2	27.6	55.2	31.9	11.8	40.4	27.0	29.6	30.1	52.5	25.1	24.1	13.0	45.7	28.9	31.8	23.9	34.3	15.4	46.6	13.5	17.1	40.9	20.7	25.7	21.7	22.7	31.3	19.4	20.3	16.0	29.1	2.1	5.5	9.0	7.3	7.2	9.8	7.4	8.5	6.4	5.2	8.0	11.3	5.6	3.6	7.0	2.6	5.9	12.0	5.6	40.3	41.2	40.5	45.2	38.1	39.2	41.6	41.4	40.0	40.7	42.1	40.9	13.6	16.0	5.0	7.8	12.4	14.3	10.3	9.9	12.5	18.0	16.2	20.1	14.0	4.3	6.2	14.7	8.4	33.8	12.0	20.4	29.4	22.7	21.9	9.0	10.2	14.3	12.1	3.0	4.7	26.2	17.5	15.7	6.6	9.2	2.5	16.2	13.2	20.5	26.4	26.9	6.1	11.6	16.2	10.0	13.4	33.3	17.7	14.0	16.0	4.7	20.4	22.0	9.2	2.0	6.0	18.6	12.3	19.9	8.0	14.3	21.1	31.6	3.1	13.1	19.7	12.4	17.2	32.8	33.4	11.8	12.5	25.7	10.0	14.9	14.8	8.5
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449911-19479202	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 121.1;Ductal cells: 115.7;Exocrine glandular cells: 142.2;Extravillous trophoblasts: 107.3;Pancreatic endocrine cells: 149.9;Syncytiotrophoblasts: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 782.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	43.8	39.8	23.6	36.8	26.3	64.8	37.8	27.6	29.8	33.9	25.7	42.5	32.1	46.8	54.4	48.4	31.4	29.3	44.8	24.6	28.6	36.7	51.9	37.2	43.4	28.9	26.7	31.8	39.3	44.7	31.7	35.3	29.5	32.1	38.4	21.7	38.1	30.1	98.3	42.5	35.7	39.5	27.2	38.6	40.8	53.3	27.1	61.6	34.9	42.5	47.5	40.2	37.0	29.7	187.5	132.4	110.6	168.5	89.0	62.0	86.0	150.2	148.8	202.9	187.1	147.8	78.8	129.2	114.1	126.7	93.3	157.5	131.5	132.1	175.1	239.8	138.0	136.5	88.3	119.4	84.4	218.6	177.7	57.4	133.0	173.2	84.4	59.1	164.7	67.9	782.0	240.5	125.1	268.5	142.0	133.4	79.8	232.2	111.9	170.1	262.0	50.1	126.6	172.5	90.5	102.2	118.2	126.0	123.3	114.2	75.9	103.5	180.9	169.6	230.8	143.2	164.1	102.9	221.7	168.8	142.5	110.3	158.6	150.9	90.6	158.1	107.0	140.3	103.7	87.7	122.5	112.4	81.0	82.6	104.6	102.9	167.1	105.7	140.7	113.1	224.5	129.5	23.6	26.3	27.6	29.8	24.6	28.6	28.9	26.7	29.5	27.2	27.1	29.7	68.3	25.6	34.5	0.0	16.4	0.0	0.0	0.0	0.0	0.0	39.7	55.2	0.0	0.0	16.7	27.6	0.0	121.1	44.9	0.0	84.1	115.7	0.0	43.1	36.9	32.6	0.0	0.0	0.0	142.2	107.3	25.4	0.0	44.9	27.8	36.0	0.0	0.0	88.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	149.9	0.0	0.0	7.5	0.0	0.0	81.0	27.7	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	170.3	26.3	61.5	0.0	0.0
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035021-36071358	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 14.7;skin 1: 10.3"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0"	"Low region specificity"	"Detected in many"							HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.0	0.8	0.0	0.0	0.0	6.5	1.1	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	2.6	0.6	0.0	0.0	1.0	1.1	0.0	0.0	0.1	0.9	0.2	1.2	0.4	0.0	0.1	0.1	0.0	0.1	10.3	0.0	0.0	0.1	1.2	0.1	2.9	0.6	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.3	0.4	0.0	1.3	0.0	0.5	6.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.4	0.0	5.3	0.0	0.0	29.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.2	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.0	1.1	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	1.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598770-114678225	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 266.4"	"Cell type enriched"	"Detected in many"	8	"Oligodendrocytes: 821.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 6.9;naive B-cell: 10.7"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 58.4;OE19: 123.7;RPTEC TERT1: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.6	0.6	58.6	4.6	153.7	1.1	4.6	166.2	94.5	7.0	9.7	26.8	30.3	3.8	0.3	1.5	4.4	11.0	0.3	66.2	94.7	31.0	0.2	1.1	4.9	220.9	132.8	0.4	8.5	0.2	0.2	0.2	200.6	0.5	27.7	2.2	7.3	0.7	0.5	2.2	27.7	1.6	139.2	1.7	16.8	5.0	132.4	0.6	13.5	0.4	5.0	0.6	0.6	266.4	0.6	0.2	4.4	0.6	0.3	0.0	0.7	0.2	0.0	0.1	3.4	17.7	58.4	17.6	1.2	0.2	13.8	25.8	0.0	0.1	0.1	0.3	14.3	0.3	24.6	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	5.4	0.1	0.2	16.1	3.0	0.1	0.3	0.3	1.7	6.4	123.7	8.8	1.6	28.9	0.3	55.2	0.6	31.4	4.6	0.2	5.4	0.8	1.1	0.9	5.4	1.0	1.1	19.2	0.7	19.6	6.3	0.8	0.6	29.2	0.9	17.9	0.2	0.0	0.8	0.0	0.0	0.6	6.9	0.0	0.0	0.0	10.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	58.6	153.7	166.2	94.5	66.2	94.7	220.9	132.8	200.6	139.2	132.4	266.4	0.1	6.4	1.5	1.0	22.0	0.0	1.8	0.3	6.8	0.0	5.7	6.1	0.8	8.6	3.9	25.8	0.0	0.0	0.1	19.0	9.8	1.4	9.2	9.6	1.7	0.5	48.4	0.0	1.0	13.1	0.0	0.6	19.4	21.4	0.0	0.2	0.0	0.0	0.0	0.0	3.7	27.9	0.0	0.0	0.0	3.5	1.2	0.5	1.8	2.8	0.0	0.0	0.0	98.5	821.1	10.8	14.6	0.0	4.0	0.7	24.2	1.4	1.5	0.0	0.0	0.0	0.4	20.9	34.0	5.9	0.1	0.0	0.4	0.1	26.9	0.9
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529631	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077624			Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA077624: "	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	26.8	23.3	21.2	23.3	24.6	40.3	19.3	18.1	21.2	15.1	16.6	19.2	19.1	11.7	14.1	13.3	14.4	13.7	11.6	26.0	28.3	31.2	38.1	17.5	30.8	24.9	28.5	11.9	11.0	27.8	7.8	17.1	28.3	16.2	19.6	10.5	13.5	18.5	25.8	11.9	23.4	10.8	19.8	25.4	20.0	12.2	26.1	24.6	19.4	25.9	28.9	18.1	10.5	19.4	61.9	28.4	14.6	35.8	40.7	31.9	32.7	79.7	43.2	63.9	45.7	18.6	37.8	50.2	67.8	60.0	31.2	34.9	28.2	44.1	102.4	69.1	20.4	49.8	34.3	16.9	31.3	73.4	55.5	33.0	45.8	63.2	59.9	44.6	37.4	34.2	44.1	67.7	111.4	26.0	39.3	19.4	19.4	46.1	37.8	24.9	64.9	41.9	42.6	62.8	26.4	24.3	70.5	64.6	52.2	19.9	56.0	81.0	58.5	72.7	41.0	50.8	112.6	69.2	103.5	58.0	60.5	35.3	67.3	3.6	2.0	2.4	4.8	5.3	4.9	3.2	3.5	4.0	2.3	3.6	3.5	4.0	1.3	3.7	6.1	2.6	3.1	2.6	21.2	24.6	18.1	21.2	26.0	28.3	24.9	28.5	28.3	19.8	26.1	19.4	37.6	19.2	41.2	20.9	75.6	29.4	33.7	38.5	34.7	24.4	39.4	20.2	35.1	40.0	53.8	53.3	12.5	26.2	81.0	53.9	56.7	27.6	55.6	35.1	35.7	33.4	33.5	51.6	37.0	23.2	38.1	25.5	43.3	44.4	45.7	23.3	31.1	85.1	30.0	23.5	27.4	34.1	48.8	73.5	47.5	58.4	21.5	60.0	28.4	33.7	58.0	14.6	74.2	20.6	29.5	40.4	33.0	19.5	47.2	59.9	60.8	62.2	50.9	23.0	0.0	29.2	27.8	25.1	29.6	45.2	24.6	22.4	69.4	31.4	39.3	58.3
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 27.0;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 49.7;Plasma cells: 21.0;Squamous epithelial cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.8;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 450.9;REH: 1004.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	1.0	0.9	2.1	9.6	2.7	27.0	1.7	2.1	2.3	1.6	1.8	2.9	3.7	1.0	0.1	6.5	0.4	0.8	0.5	2.0	2.2	0.6	0.9	1.3	15.8	2.8	2.8	0.3	0.6	0.2	0.2	2.1	2.7	0.6	2.6	0.4	1.5	0.2	1.2	3.4	3.9	1.9	1.9	3.7	3.3	5.2	3.5	67.2	0.3	0.3	10.3	1.6	2.5	4.6	111.3	78.7	116.6	83.4	3.3	13.3	18.5	88.3	42.0	89.9	86.8	94.6	54.9	62.7	21.1	39.4	32.7	54.1	81.2	47.7	63.0	102.7	92.2	54.3	74.3	102.4	1.3	135.1	78.9	6.5	3.5	48.9	12.6	14.1	27.2	97.2	79.3	70.5	54.5	86.7	450.9	82.5	52.5	40.0	84.3	1004.5	259.7	45.4	24.9	80.1	86.0	68.5	69.2	37.7	12.1	18.8	68.2	127.6	34.2	94.6	76.7	124.3	108.3	29.8	33.1	183.5	54.8	129.7	123.3	0.3	0.2	0.1	0.6	0.0	0.0	0.2	0.8	1.0	1.3	0.1	0.2	0.8	0.8	0.5	0.2	4.8	2.3	0.6	2.1	2.7	2.1	2.3	2.0	2.2	2.8	2.8	2.7	1.9	3.5	4.6	0.2	0.0	0.0	1.6	2.1	0.0	0.8	0.0	3.4	2.5	4.4	2.8	4.3	1.5	0.6	0.0	0.0	6.6	6.9	2.6	0.0	2.2	2.9	1.3	1.8	2.2	0.0	49.7	0.4	0.4	7.8	4.7	8.6	2.4	0.0	10.4	0.4	0.7	8.9	3.3	0.4	2.3	0.0	1.9	0.0	1.8	0.6	3.8	0.0	0.0	2.0	0.6	1.0	3.0	1.3	4.2	1.9	0.4	21.0	0.6	1.4	0.2	0.7	0.7	0.0	1.2	6.1	6.1	11.9	15.8	0.0	1.4	3.7	1.5	8.3	1.3
UHRF1BP1L	KIAA0701	ENSG00000111647	"UHRF1 binding protein 1 like"	A0JNW5	12	100028455-100142874	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039671, HPA075150"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Cytosol"	"HPA039671: AB_10794201, HPA075150: "	"unprognostic (4.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.94e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-2)"	8.7	10.9	6.2	10.2	7.7	32.9	8.8	11.0	11.5	7.2	9.9	8.3	8.4	7.5	7.0	7.0	6.3	8.9	7.9	13.2	6.2	12.3	24.6	7.7	9.2	4.9	5.4	7.5	3.8	13.6	5.2	9.0	4.8	9.0	7.9	14.6	6.4	8.0	19.8	5.9	7.1	8.8	4.6	9.2	6.0	14.0	3.7	8.4	10.9	14.6	7.0	10.1	5.2	9.2	18.6	19.7	10.8	11.2	16.4	23.1	21.6	28.3	28.4	22.4	16.3	14.8	6.2	16.0	7.2	29.1	13.1	6.9	20.4	9.7	21.5	42.7	10.0	10.7	14.1	17.3	15.1	20.4	16.8	13.1	8.0	27.0	18.6	20.7	16.0	11.0	8.6	16.2	22.1	10.3	13.1	17.5	18.7	6.3	17.7	14.7	19.2	15.7	11.4	32.2	18.3	11.4	21.4	24.5	8.5	9.2	21.9	23.0	12.7	24.6	13.2	21.5	20.1	19.1	35.2	22.3	12.4	15.1	15.2	21.6	11.4	7.8	3.6	12.3	5.3	5.5	4.0	4.1	12.8	4.5	3.4	4.2	33.9	5.9	10.9	7.6	5.2	5.4	6.2	7.7	11.0	11.5	13.2	6.2	4.9	5.4	4.8	4.6	3.7	9.2	10.6	28.9	8.7	27.1	18.2	12.7	17.2	5.0	19.9	11.9	9.3	7.5	15.7	1.5	12.6	9.2	4.2	4.7	15.0	10.9	5.9	6.0	35.1	15.7	23.7	8.6	5.4	9.4	75.2	5.9	8.9	24.7	7.7	9.9	24.1	6.3	5.3	18.5	11.2	15.2	54.2	2.1	4.1	23.3	21.4	5.3	7.2	29.5	10.6	45.0	25.7	8.3	8.2	37.2	29.5	5.9	7.4	7.9	12.5	18.5	8.9	14.9	21.8	12.0	0.0	23.3	15.1	24.1	19.1	14.9	11.6	10.9	15.7	8.3	5.7	11.9
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730433-124749273	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Approved	Cytosol		NA	NA		9200	"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	1.3	1.4	2.5	1.2	2.5	1.3	1.8	2.8	2.9	1.0	1.1	2.3	2.0	1.3	1.0	2.0	1.8	0.7	0.8	2.6	1.8	1.8	2.6	0.9	1.4	2.8	2.1	1.9	2.1	1.5	0.8	0.7	2.3	1.4	1.6	1.8	1.3	0.7	3.1	2.3	2.1	1.1	2.0	2.6	1.8	0.9	2.3	1.8	1.1	0.7	1.7	0.8	1.0	3.5	1.4	4.4	5.1	2.1	2.9	3.4	5.4	7.9	2.4	3.1	2.6	3.8	2.1	4.0	8.2	3.0	7.9	9.0	7.1	2.4	5.0	4.4	4.2	8.2	3.0	2.7	2.6	8.7	6.0	3.8	2.3	1.8	3.9	1.9	1.2	8.2	3.7	1.9	2.3	3.5	10.8	1.7	12.1	3.9	2.7	7.4	6.0	3.3	2.4	2.5	4.0	2.6	11.3	4.2	4.3	3.7	4.1	3.1	15.4	2.5	5.2	7.4	3.2	8.0	12.5	12.1	2.8	3.4	2.6	5.9	10.3	5.5	14.0	11.3	12.4	17.0	9.2	12.1	14.6	24.3	13.9	10.8	0.7	12.8	9.3	11.0	12.4	11.9	2.5	2.5	2.8	2.9	2.6	1.8	2.8	2.1	2.3	2.0	2.3	3.5	9.6	6.4	11.5	6.5	11.2	15.8	24.5	41.3	18.8	8.3	8.9	12.3	6.2	20.0	22.8	9.2	4.2	66.8	13.2	9.0	29.4	29.8	3.2	10.9	18.2	15.2	9.6	16.2	11.0	30.5	35.0	12.7	14.3	12.1	12.0	22.8	7.9	31.4	22.0	5.0	12.0	10.3	20.3	7.0	5.9	4.4	13.7	8.3	3.6	10.3	18.0	11.0	13.4	15.6	12.2	23.4	8.6	13.9	10.4	14.6	14.0	25.9	22.1	9.1	13.1	13.3	17.1	23.2	32.1	20.6	19.0	109.2	11.0	29.5	17.8	21.1
UNC13B	"hmunc13, Munc13-2, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 80.7;Cone photoreceptor cells: 95.9;Excitatory neurons: 60.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: AB_2684742"	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favorable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	12.6	12.8	10.5	5.6	13.3	1.0	10.3	6.6	14.5	12.5	15.7	22.2	11.6	10.1	7.7	17.5	10.4	11.5	13.6	11.4	7.2	21.8	12.8	38.9	1.8	8.3	9.5	7.3	21.3	15.0	11.5	6.0	7.8	22.6	25.0	41.2	17.8	23.3	24.2	12.3	13.4	11.9	7.3	4.7	17.9	15.6	10.6	3.0	12.2	10.4	5.0	10.2	12.7	9.0	9.8	12.8	13.9	22.6	26.3	14.6	11.8	15.7	7.1	11.4	15.3	10.7	4.5	0.0	7.0	20.6	20.1	4.7	35.4	18.2	14.5	0.0	11.3	5.9	36.6	13.9	12.7	2.2	6.4	11.6	14.0	18.0	18.5	18.2	37.3	15.8	13.5	8.1	13.5	7.5	2.1	0.2	12.6	30.2	13.3	0.1	8.6	3.4	15.5	12.6	14.9	15.7	11.0	6.8	11.4	23.0	11.6	7.5	34.5	7.8	7.2	12.3	12.2	12.7	16.2	0.0	8.5	18.4	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	13.3	6.6	14.5	11.4	7.2	8.3	9.5	7.8	7.3	10.6	9.0	6.7	57.7	80.7	28.7	0.8	3.1	1.1	2.1	3.4	42.3	7.3	4.4	11.4	18.6	16.7	9.2	95.9	3.7	0.1	24.4	3.9	6.0	6.9	8.2	5.1	8.5	24.6	1.7	60.4	12.2	2.1	4.8	16.3	13.9	2.5	8.7	5.7	12.5	4.9	6.7	17.7	31.9	0.0	2.4	3.0	12.3	2.1	3.7	7.2	73.1	0.1	5.7	0.0	42.3	36.7	7.8	11.9	3.0	4.2	11.7	10.5	7.8	10.0	40.8	6.6	8.4	6.5	8.7	7.5	14.3	7.4	2.9	1.0	5.7	19.5	5.7
UNC80	"C2orf21, FLJ33496, KIAA1843, UNC-80"	ENSG00000144406	"Unc-80 homolog, NALCN channel complex subunit"	Q8N2C7	2	209771832-209999300	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 13.6;retina: 18.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8;prostate cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042472, HPA050959"	Enhanced		Approved	"Nuclear bodies,Vesicles"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"	Vesicles	"HPA042472: AB_10965318, HPA050959: "	"unprognostic (7.91e-3)"	"unprognostic (2.25e-4)"	"unprognostic (1.44e-2)"	"unprognostic (3.20e-4)"	"unprognostic (1.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.16e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.40e-3)"	0.0	3.9	6.4	0.0	9.9	0.0	0.0	15.6	21.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.4	1.1	0.0	6.9	4.9	0.1	0.0	0.1	0.0	6.7	1.5	0.5	1.0	0.2	13.6	0.0	5.8	0.9	0.1	18.9	0.1	0.2	0.0	0.1	0.1	0.2	1.1	0.2	0.4	3.5	2.6	0.1	0.3	0.0	0.0	0.2	0.0	5.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.9	15.6	21.0	6.9	4.9	6.7	1.5	5.8	1.1	2.6	5.0	0.2	0.0	1.1	49.0	0.0	0.8	0.3	1.9	0.0	117.7	0.2	0.1	2.1	0.0	0.7	0.0	66.7	0.0	0.0	0.0	0.0	0.0	31.9	1.1	1.7	0.5	0.0	0.0	432.0	0.0	0.0	1.1	0.0	0.1	1.3	0.6	0.0	0.0	0.1	52.2	354.7	0.0	0.0	0.0	0.0	10.5	0.9	0.3	0.0	10.3	0.0	26.6	0.0	290.5	12.8	0.1	0.0	1.9	0.0	1.2	0.0	0.2	0.8	75.6	0.0	0.2	0.1	7.5	3.8	0.0	0.1	0.0	0.0	15.1	0.0	0.3
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991100-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 76.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 96.2;Kupffer cells: 78.3;Macrophages: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 128.9;RPMI-8226: 368.2;SK-BR-3: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176"	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	18.7	17.7	4.9	19.9	5.6	19.9	15.4	5.0	7.5	19.0	6.4	20.2	22.5	7.7	0.8	20.5	15.7	9.8	7.3	4.9	5.0	16.4	15.3	29.5	29.5	10.7	6.5	6.2	17.1	2.6	6.7	6.4	8.1	16.4	3.1	0.1	27.9	8.8	3.5	16.3	35.8	3.1	7.9	76.7	20.6	1.7	6.8	3.5	14.8	1.5	7.3	20.6	15.0	10.2	18.9	34.1	2.5	13.8	7.2	2.7	28.2	8.3	7.7	13.0	11.8	2.8	128.9	40.9	30.8	4.0	11.0	44.9	1.0	7.0	0.4	14.1	9.3	4.2	11.1	6.4	11.2	30.0	22.7	6.0	7.6	3.8	1.5	5.0	2.6	6.4	3.0	19.3	2.0	18.7	0.2	23.9	6.2	46.8	16.7	24.5	0.0	368.2	11.8	10.7	3.9	5.5	14.0	95.6	19.3	1.0	35.4	39.0	9.2	8.6	12.2	12.8	0.8	13.2	18.8	7.0	16.0	30.7	10.5	0.1	3.8	6.6	0.1	7.2	0.2	2.5	0.2	0.2	5.1	2.7	0.0	0.0	3.2	2.1	7.7	14.8	0.0	1.2	4.9	5.6	5.0	7.5	4.9	5.0	10.7	6.5	8.1	7.9	6.8	10.2	12.5	9.6	9.1	4.6	45.3	4.0	21.9	12.5	9.1	0.0	16.4	13.1	1.8	40.0	21.0	16.5	0.0	10.3	63.3	23.2	1.9	36.8	0.8	32.0	5.9	10.0	4.2	3.0	1.1	23.4	47.8	8.0	20.9	17.2	7.0	9.3	10.0	5.4	96.2	5.0	0.1	17.2	14.2	78.3	28.4	0.1	4.4	85.3	23.2	13.1	57.5	4.7	8.2	0.0	0.7	49.7	25.6	4.1	33.8	27.0	31.7	6.9	57.3	0.5	0.0	8.3	9.8	0.2	1.1	12.9	6.5	7.3	10.5	2.1	23.1	37.7
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232872-1237326	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 17.5"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"NB-4: 98.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.2"	"Region enriched"	"Detected in single"	8	"cerebellum: 7.5"	HPA063294			Approved	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA063294: AB_2684977"					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.0	0.0	0.7	0.0	0.1	0.0	0.0	17.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.4	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	17.5	0.5	0.0	2.8	2.2	3.0	3.2	0.6	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPF3B	"HUPF3B, MRX62, MRX82, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.9	8.1	17.0	10.2	17.2	13.6	9.5	21.1	30.0	11.9	16.3	11.8	11.8	11.7	10.5	12.7	9.9	6.9	7.5	16.5	20.0	11.4	12.4	9.0	15.4	17.5	17.3	13.3	8.1	11.3	12.9	8.8	17.4	10.8	10.5	22.0	8.8	9.0	12.9	15.5	10.0	9.3	16.0	11.3	8.6	15.7	17.8	14.7	11.5	10.9	15.6	10.5	11.7	18.6	29.2	17.3	35.1	28.8	15.7	10.3	22.5	27.4	15.3	20.9	18.3	32.7	20.4	51.9	22.6	11.5	29.9	27.1	45.9	16.6	26.5	29.9	33.9	48.3	57.9	17.2	17.9	52.7	23.0	8.7	12.4	35.8	43.3	19.0	19.7	30.5	47.4	41.8	17.6	35.9	36.8	65.6	67.7	37.1	46.8	35.9	40.2	38.2	17.3	14.5	46.7	32.1	55.6	22.4	42.4	36.2	11.9	30.4	17.3	21.6	16.6	34.9	58.6	23.1	27.5	69.5	17.5	76.1	25.7	8.1	4.4	6.5	5.9	4.8	4.8	12.5	5.6	4.8	3.3	13.7	6.3	6.4	4.9	7.7	5.6	8.7	7.4	2.2	17.0	17.2	21.1	30.0	16.5	20.0	17.5	17.3	17.4	16.0	17.8	18.6	26.3	32.1	25.7	31.6	47.4	37.7	31.1	31.6	47.8	50.7	26.4	28.2	19.0	17.2	38.7	25.8	56.3	39.0	46.1	33.5	5.9	31.6	157.3	26.1	23.5	31.1	27.6	52.2	30.6	26.4	48.2	25.5	23.0	33.8	58.9	32.8	23.2	22.9	28.5	28.6	39.5	35.5	26.4	19.1	43.3	31.7	30.4	28.2	24.9	27.2	44.9	32.6	56.7	33.7	45.4	21.5	33.6	32.7	32.5	33.8	30.4	16.5	35.2	99.0	13.1	34.4	42.0	65.8	41.4	38.8	38.1	64.3	39.9	28.1	37.6	25.0
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108736	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 250.1;Extravillous trophoblasts: 260.3;Macrophages: 199.5;Paneth cells: 260.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 62.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"hTERT-HME1: 362.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.4	9.4	3.8	7.5	4.4	12.5	10.0	3.0	5.8	16.8	2.0	9.8	4.3	3.9	0.8	66.9	5.7	5.9	8.9	3.1	3.9	39.8	11.9	18.8	3.7	4.2	2.8	1.9	4.6	5.0	7.4	3.8	3.7	4.9	5.3	0.5	14.2	1.1	3.7	3.1	6.5	3.4	1.3	20.3	4.1	2.2	4.4	1.2	8.0	0.9	6.6	9.1	31.2	3.7	19.5	26.0	2.4	5.2	8.9	4.0	29.7	7.9	15.5	14.5	17.5	10.8	9.9	0.0	2.5	9.7	89.9	13.9	5.2	46.1	9.4	4.1	4.5	0.8	4.8	4.6	7.4	0.9	1.3	5.0	21.8	6.4	362.8	5.9	9.1	0.4	1.5	13.5	7.6	2.3	0.0	2.9	9.4	4.2	20.7	0.0	4.8	6.0	33.7	11.5	2.3	1.6	10.2	3.0	63.4	29.3	2.4	0.9	12.4	29.6	22.9	7.3	22.6	21.4	34.7	3.7	29.6	3.0	77.8	11.5	16.0	12.2	11.8	12.1	8.9	0.2	7.8	8.7	6.5	0.6	8.1	8.1	6.2	5.4	14.8	0.5	8.4	10.9	3.8	4.4	3.0	5.8	3.1	3.9	4.2	2.8	3.7	1.3	4.4	3.7	107.4	19.2	58.5	5.2	19.1	46.8	26.3	104.4	19.4	27.6	9.0	16.1	11.6	24.3	51.0	11.0	33.3	15.1	122.9	250.1	70.5	50.5	1.0	42.1	22.4	108.1	13.1	4.4	16.5	40.5	260.3	34.1	5.1	91.1	25.9	3.8	72.5	17.5	110.0	16.8	29.4	35.0	85.5	130.5	118.1	2.4	5.3	199.5	87.2	1.0	61.4	13.3	71.1	4.0	3.6	117.9	260.8	2.2	30.3	30.4	42.8	23.3	11.9	29.2	6.6	21.1	32.2	0.3	9.5	42.9	29.8	78.7	71.0	1.5	29.1	34.9
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1 prefoldin like chaperone"	O94763	19	29923644-30016612	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 499.7;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA071709: AB_2686434"	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	25.0	30.6	29.7	24.8	39.6	36.4	36.7	57.8	40.7	27.9	21.0	26.1	23.5	34.2	32.3	28.5	30.2	25.1	28.1	25.0	36.8	25.6	30.5	22.9	39.9	35.9	32.3	44.1	21.9	31.4	11.0	24.1	34.5	37.7	32.1	32.4	27.2	30.4	52.8	44.9	23.4	22.8	28.4	30.0	25.0	51.6	30.9	31.7	55.4	36.2	37.3	24.8	10.7	45.6	64.8	85.9	39.5	61.7	27.5	39.8	66.5	41.3	34.4	29.5	33.7	45.4	41.5	99.7	79.4	48.2	23.4	44.6	84.8	52.7	66.5	69.7	48.5	90.8	44.3	59.7	39.7	88.5	37.3	35.1	70.6	25.7	95.7	31.7	22.1	58.2	109.7	27.2	37.4	55.3	58.0	37.1	37.1	83.4	26.2	56.7	73.2	40.5	19.4	75.3	63.4	49.7	47.1	56.3	62.2	41.7	23.5	54.8	29.1	72.1	63.9	35.6	63.3	74.4	86.2	67.7	35.5	76.5	44.4	3.4	1.3	1.8	2.9	1.4	2.5	1.9	2.6	3.0	1.1	4.5	3.1	3.1	0.1	2.2	1.4	1.6	2.2	0.8	29.7	39.6	57.8	40.7	25.0	36.8	35.9	32.3	34.5	28.4	30.9	45.6	51.6	44.8	38.8	59.1	48.6	57.0	95.3	19.4	40.5	60.6	67.6	68.1	52.8	48.6	28.2	40.5	25.0	19.2	84.4	21.7	105.7	16.9	499.7	48.5	82.8	32.5	28.9	38.5	79.9	27.8	28.7	45.6	41.3	41.8	30.9	54.5	31.8	50.9	15.4	52.2	122.3	36.5	18.3	33.6	24.0	514.0	43.8	32.9	32.0	74.9	25.0	58.5	70.0	137.7	178.4	19.4	23.7	41.3	53.3	123.9	19.4	85.2	38.8	59.8	13.1	82.3	48.5	72.2	52.2	44.8	73.6	13.1	74.2	91.6	37.0	94.3
USF2	"bHLHb12, FIP"	ENSG00000105698	"Upstream transcription factor 2, c-fos interacting"	Q15853	19	35268962-35279821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029764, HPA046567"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	Vesicles	"HPA029764: AB_2673190, HPA046567: AB_2679702"	"unprognostic (6.10e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.07e-2)"	"prognostic favorable (5.12e-5)"	"unprognostic (7.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.28e-4)"	126.7	132.5	188.9	130.4	191.7	177.7	105.4	190.2	192.9	109.3	147.9	120.8	105.3	104.4	51.5	104.6	104.1	66.3	196.6	181.0	180.3	97.8	185.2	102.2	154.9	192.9	185.4	164.5	121.1	109.4	149.1	63.5	187.2	99.8	54.1	90.4	97.9	57.2	359.3	122.0	112.7	52.4	186.4	160.5	104.1	51.7	191.7	101.3	125.8	195.1	96.7	100.2	99.9	183.2	189.2	190.2	93.6	91.1	161.7	81.5	89.2	101.0	119.7	90.4	69.3	87.3	95.5	183.7	157.6	86.3	96.4	56.5	88.6	79.6	45.4	306.4	135.8	107.5	111.1	143.1	97.8	182.5	177.5	71.7	108.3	58.6	89.1	151.3	62.2	119.6	135.3	260.0	70.5	218.8	200.7	69.8	78.7	171.3	61.1	190.9	123.2	171.2	74.8	119.5	159.3	120.7	188.2	200.4	346.7	80.7	81.8	142.4	107.4	150.0	101.0	99.5	134.4	260.0	286.6	199.7	139.4	114.8	201.0	44.5	8.3	11.1	6.8	11.2	8.2	10.2	7.0	9.0	13.4	13.5	6.3	6.0	7.8	11.7	6.9	50.6	13.8	7.7	188.9	191.7	190.2	192.9	181.0	180.3	192.9	185.4	187.2	186.4	191.7	183.2	58.2	6.4	22.4	29.7	72.5	23.7	23.7	18.7	20.5	66.0	42.2	38.4	71.6	35.8	15.5	31.3	33.3	24.2	108.1	50.7	56.7	33.5	1.1	25.6	31.3	36.5	52.1	37.2	19.7	57.8	38.5	32.7	30.5	34.0	20.3	45.7	38.6	50.5	107.0	94.2	16.9	33.6	20.3	66.8	42.9	3.4	32.0	91.9	26.6	28.1	37.8	118.9	35.0	12.1	19.5	36.0	37.1	31.2	63.8	23.1	58.1	51.7	11.0	53.9	13.1	40.9	35.8	9.0	10.6	34.3	24.7	17.5	56.2	52.0	33.0	35.6
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.8;kidney: 54.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 60.6;HeLa: 21.8;OE19: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.4	0.3	2.8	5.9	6.8	0.0	0.2	2.8	3.9	0.1	1.5	51.5	97.8	0.1	0.3	0.0	2.9	25.9	0.1	9.0	4.7	54.0	0.6	0.1	0.1	6.1	5.7	0.0	3.9	0.0	6.7	0.0	7.0	0.0	48.3	19.0	0.0	0.3	0.0	0.0	96.5	2.1	4.1	0.0	26.7	0.2	5.9	0.1	1.1	0.0	0.0	0.6	0.1	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	60.6	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.8	2.8	3.9	9.0	4.7	6.1	5.7	7.0	4.1	5.9	8.3	0.0	0.0	0.0	18.3	1.6	0.0	0.1	0.0	0.0	0.7	0.0	1.3	0.6	52.9	0.7	5.5	2.1	0.0	0.0	190.0	21.5	20.5	1.0	1.7	0.0	0.4	64.0	0.0	0.6	27.5	0.0	0.3	53.5	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.2	92.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	163.6	0.0	0.5	36.4	56.0	203.0	0.0	0.2	0.0	430.7	190.3	1.0	4.9	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.8	0.1	115.7	0.1
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699986-84779922	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 742.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 742.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	24.8	21.7	19.6	29.4	20.3	29.5	23.4	22.1	22.9	21.0	17.8	31.2	29.5	25.9	23.9	29.1	27.0	18.5	25.4	20.8	20.7	28.8	33.8	18.7	36.7	18.8	18.7	27.1	23.0	41.5	6.0	40.3	19.0	28.3	26.4	52.5	21.0	25.9	46.6	25.7	27.4	31.0	19.8	32.6	23.8	22.0	20.4	29.1	27.4	39.5	37.7	32.1	10.1	21.6	63.6	72.9	78.5	104.7	31.4	50.2	111.5	58.0	60.1	96.9	51.5	106.9	54.9	102.9	65.2	61.1	47.7	69.8	108.2	89.7	139.0	41.3	63.3	63.2	37.3	92.2	39.4	95.0	37.9	30.0	74.8	95.6	112.3	57.5	76.4	68.5	153.4	22.7	73.1	129.4	92.4	96.8	102.5	71.8	56.7	119.9	44.5	55.0	81.9	48.4	73.0	48.6	130.5	48.7	54.0	72.3	108.4	76.8	55.7	66.9	60.2	39.4	62.2	38.8	53.7	272.3	44.5	64.6	73.2	29.0	77.3	15.6	46.1	61.9	58.0	60.6	148.0	53.9	92.6	59.7	82.9	49.6	742.4	65.9	58.6	30.7	57.3	97.3	19.6	20.3	22.1	22.9	20.8	20.7	18.8	18.7	19.0	19.8	20.4	21.6	21.3	54.5	50.0	26.4	51.5	51.5	46.1	25.8	54.1	25.1	27.6	28.6	66.6	25.8	45.2	27.6	29.2	106.9	38.1	25.8	31.3	29.0	63.3	31.0	35.8	30.4	28.9	42.5	39.3	25.1	73.4	40.1	35.7	42.1	58.0	38.7	21.0	37.2	31.4	20.2	38.9	28.1	16.2	34.8	33.4	116.6	23.6	40.6	24.9	41.2	52.6	23.7	32.0	49.8	35.8	23.6	23.9	22.6	50.8	48.6	30.4	45.0	90.7	52.7	26.3	58.4	34.3	35.0	29.5	54.5	49.6	60.9	42.5	33.6	40.6	45.2
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232866-47248328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 203.6;Horizontal cells: 139.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	25.5	32.8	117.7	23.7	118.7	11.2	26.8	41.5	116.3	51.2	30.0	33.9	11.5	47.0	23.6	18.2	49.9	24.5	45.5	113.1	148.1	33.3	12.7	30.9	30.1	69.8	78.3	76.4	27.1	36.6	103.7	24.9	93.9	33.4	14.1	84.8	21.4	38.7	32.4	18.5	25.5	35.9	65.4	29.3	24.9	46.2	122.8	42.6	52.2	29.6	28.9	36.9	31.7	79.8	45.6	70.7	117.6	81.0	43.4	28.5	33.0	34.0	52.5	65.6	73.3	67.4	36.7	29.9	26.1	60.5	70.5	53.5	94.7	24.0	56.4	47.1	73.5	34.7	52.9	61.4	50.7	39.2	70.7	42.1	9.8	69.1	29.3	37.3	26.7	68.9	26.6	3.9	51.8	70.0	77.8	43.4	89.2	24.3	62.5	86.1	114.3	25.1	32.4	60.9	66.8	114.4	62.6	12.4	37.7	73.9	26.0	23.0	28.2	56.0	58.0	79.3	39.6	54.3	36.2	51.3	34.3	48.8	50.8	63.9	9.1	19.9	55.4	19.6	48.3	53.1	24.5	54.3	11.9	53.1	36.6	76.3	5.5	56.4	24.3	53.2	35.0	46.0	117.7	118.7	41.5	116.3	113.1	148.1	69.8	78.3	93.9	65.4	122.8	79.8	13.6	22.4	17.7	25.8	53.5	13.6	42.2	30.9	21.6	203.6	13.0	23.5	24.2	7.2	31.5	33.1	56.3	20.9	52.2	9.4	50.9	18.3	26.4	28.2	26.3	22.5	35.4	18.3	43.3	10.2	15.0	41.3	22.4	28.3	45.7	56.6	22.1	8.2	13.4	139.7	63.7	8.7	28.5	12.0	16.3	41.0	29.5	17.9	28.4	19.7	17.5	96.2	23.7	25.1	24.8	12.5	7.9	42.2	48.1	18.6	4.7	15.2	46.4	63.4	26.3	57.2	40.2	18.3	87.8	11.9	6.5	16.3	44.6	34.2	8.9	26.0
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179653032-179804366	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 149.2;tongue: 108.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 93.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.2	11.9	3.9	2.8	13.6	1.5	5.3	8.6	12.0	3.3	0.0	2.9	1.2	5.7	3.4	4.0	3.4	4.5	42.5	3.7	4.7	3.0	4.6	5.4	3.6	11.3	10.5	12.5	4.1	4.0	5.8	2.6	12.7	4.3	2.2	7.1	6.2	2.7	149.2	2.2	1.9	6.3	6.4	2.1	1.7	6.0	8.1	2.4	9.7	108.9	3.5	3.5	2.2	34.4	27.6	11.3	20.0	14.8	8.9	14.1	11.6	18.6	17.4	23.7	18.8	17.1	9.6	35.6	18.0	17.2	27.6	2.6	21.4	9.1	26.4	93.3	14.8	9.0	23.6	14.4	6.3	26.5	1.1	10.5	3.0	18.8	18.5	9.1	16.6	11.9	4.7	43.0	15.7	15.0	22.5	3.0	17.9	1.3	13.1	29.3	20.2	27.4	11.7	7.9	13.0	14.5	14.1	16.9	7.2	5.4	37.0	12.7	24.1	28.6	27.6	23.7	64.1	29.5	21.2	78.3	13.0	15.0	27.2	0.1	0.3	0.0	2.6	0.5	15.6	3.2	1.8	3.8	1.5	0.9	1.2	1.3	0.0	0.0	0.7	4.5	0.7	1.3	3.9	13.6	8.6	12.0	3.7	4.7	11.3	10.5	12.7	6.4	8.1	34.4	45.0	9.6	35.9	14.0	5.3	2.5	1.9	1.4	0.6	13.7	7.1	5.2	208.5	5.7	5.4	1.8	6.2	10.7	5.6	1.4	15.6	1.1	2.6	13.9	11.4	10.1	9.6	5.5	23.2	4.4	2.4	12.0	4.1	2.5	2.5	35.5	22.1	7.6	4.3	16.8	52.2	2.9	0.0	4.8	3.5	3.6	9.3	5.0	14.2	16.9	1.7	7.0	3.1	36.2	42.5	1.0	12.2	9.4	4.5	4.4	0.1	2.7	3.7	10.2	13.1	17.8	12.0	6.1	2.8	4.8	1.6	5.1	4.1	58.8	4.5	1.4
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	26.0	21.5	19.9	22.7	21.3	23.9	17.0	20.1	22.9	15.5	13.9	17.8	13.9	17.0	23.8	24.0	14.6	14.6	24.8	21.0	24.5	23.4	25.3	15.1	21.6	25.4	21.7	13.3	13.0	21.2	14.3	26.5	25.7	29.7	19.3	15.5	15.2	19.6	55.6	15.4	12.4	24.7	20.3	13.8	15.1	17.9	26.0	21.8	20.4	36.4	31.3	22.6	15.3	23.3	91.6	75.4	62.7	64.5	60.7	60.0	109.6	115.5	64.9	118.9	110.5	98.9	48.7	133.1	86.6	99.1	114.4	50.9	125.1	91.7	134.9	38.7	59.0	72.5	46.0	78.1	60.5	184.1	70.8	48.4	69.1	122.3	69.5	55.0	93.5	65.9	106.2	99.3	119.1	76.2	105.2	52.4	59.4	56.0	83.5	87.8	78.6	98.0	88.7	79.9	71.8	60.1	120.7	59.2	52.5	68.0	58.2	51.5	103.9	138.7	104.3	128.8	170.6	62.3	125.7	130.9	80.0	77.3	88.4	10.7	18.1	13.8	27.9	25.8	33.6	21.1	27.5	29.5	25.6	16.4	26.7	26.2	1.5	39.3	20.5	18.7	28.6	19.4	19.9	21.3	20.1	22.9	21.0	24.5	25.4	21.7	25.7	20.3	26.0	23.3	40.0	22.4	40.4	27.7	52.7	58.6	53.3	42.0	51.8	58.0	33.4	23.5	44.9	31.5	48.3	44.1	31.3	92.3	58.1	22.5	45.0	60.6	70.9	44.9	56.3	43.1	22.1	102.0	58.8	54.0	71.8	49.0	43.8	80.8	34.8	47.1	28.2	45.4	50.9	116.1	54.4	22.5	46.8	31.5	53.4	21.6	31.7	45.5	35.6	33.7	48.8	39.4	46.4	35.2	74.8	75.8	16.9	45.9	72.7	71.4	15.2	56.0	40.2	50.3	0.0	49.6	51.4	34.1	68.1	57.9	52.4	135.6	55.0	58.9	33.5	51.8
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 176.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 297.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	29.0	21.6	4.5	29.4	4.8	176.2	22.9	12.3	6.7	17.6	10.2	18.0	13.8	14.6	9.2	19.7	17.8	13.7	19.8	5.2	5.5	14.9	27.2	31.5	33.3	6.0	5.4	26.7	19.7	14.9	13.9	18.4	5.7	14.3	16.7	45.8	19.7	8.3	35.5	29.9	24.6	12.6	4.6	44.3	18.8	30.2	5.5	26.5	17.1	14.8	24.9	18.1	19.4	8.0	18.3	16.5	14.2	17.7	25.7	25.1	27.0	29.0	21.2	22.3	16.1	19.6	21.6	15.5	16.6	17.8	10.1	18.5	18.4	23.1	27.6	18.5	15.0	25.2	15.1	14.1	18.8	35.6	61.8	15.0	19.2	27.2	20.7	20.7	26.1	16.3	80.8	36.0	20.0	23.5	26.4	19.3	25.4	16.5	24.0	17.2	19.1	32.3	17.9	22.8	17.9	8.9	30.9	21.6	17.3	17.4	34.7	18.8	37.2	21.2	22.2	32.0	18.2	16.4	24.0	21.9	25.7	26.7	23.5	163.4	60.0	64.3	13.5	31.1	14.9	28.5	19.6	14.0	23.7	20.5	23.5	13.8	297.9	14.7	26.8	26.6	58.8	26.1	4.5	4.8	12.3	6.7	5.2	5.5	6.0	5.4	5.7	4.6	5.5	8.0	57.1	38.5	36.4	68.6	130.3	58.8	40.8	26.2	40.5	54.9	32.3	28.1	74.9	21.5	48.9	23.9	110.5	31.7	142.5	50.2	11.7	36.4	172.2	26.3	46.5	45.4	42.0	248.3	124.8	41.5	43.3	52.5	57.6	38.9	88.6	53.5	21.0	45.3	46.2	42.1	104.2	33.2	12.2	101.3	97.6	172.0	61.8	120.6	53.4	135.9	195.8	25.6	90.6	100.0	108.8	55.1	47.6	29.3	94.3	36.0	30.9	25.9	31.9	151.5	39.5	66.1	60.5	83.7	43.3	49.3	77.0	65.8	130.0	27.0	29.5	60.8
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 514.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	27.0	23.0	18.8	23.4	23.2	29.3	27.4	21.3	20.4	22.7	19.1	24.6	25.1	25.2	25.2	25.2	19.9	20.4	29.3	17.5	20.5	22.1	30.7	20.9	27.9	20.5	20.8	22.3	26.0	34.3	16.7	24.2	21.7	25.7	26.4	42.3	24.7	23.6	34.7	19.9	22.8	22.6	20.2	21.9	23.4	25.7	20.3	30.0	33.8	37.5	32.3	27.1	14.1	27.5	59.9	23.4	36.5	33.0	25.4	41.5	34.2	56.9	37.9	38.5	36.4	29.5	38.3	60.5	16.8	54.8	58.7	26.5	45.6	41.5	50.1	58.6	48.4	80.9	27.3	33.1	37.6	80.3	43.0	35.9	42.9	50.3	46.4	28.7	37.5	33.9	67.7	103.8	45.3	27.3	49.7	29.3	39.2	48.4	29.9	33.0	89.7	69.6	31.7	42.5	39.4	41.9	36.8	58.1	51.1	24.9	40.2	54.2	38.0	44.8	55.7	41.8	59.3	87.8	129.3	62.5	46.8	57.3	45.6	37.4	24.1	33.6	36.3	24.9	28.6	40.7	34.1	33.6	23.1	46.0	36.9	35.8	23.5	31.5	34.0	36.2	38.9	17.2	18.8	23.2	21.3	20.4	17.5	20.5	20.5	20.8	21.7	20.2	20.3	27.5	60.3	86.6	91.9	27.4	114.4	57.2	132.5	68.9	55.2	161.0	65.8	58.7	84.2	64.3	83.1	53.3	89.6	81.7	108.2	90.2	133.1	77.9	514.9	85.9	82.6	55.0	82.6	40.8	18.2	119.9	79.7	68.3	55.0	107.7	141.8	61.5	45.7	86.2	59.9	72.3	27.6	100.4	44.7	62.0	53.1	117.0	87.7	69.4	62.2	25.3	117.3	94.1	96.8	28.1	47.3	94.0	99.2	86.9	106.8	100.1	74.8	91.8	94.1	183.5	59.2	133.4	83.2	100.4	82.4	68.4	64.4	162.0	105.3	72.8	90.6	141.9
USP18		ENSG00000184979	"Ubiquitin specific peptidase 18"	Q9UMW8	22	18150170-18177397	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Extravillous trophoblasts: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 181.8;BJ hTERT+ SV40 Large T+ RasG12V: 196.2"									HPA044768	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	Vesicles	"HPA044768: AB_10963697"	"unprognostic (2.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.38e-2)"	10.8	5.0	3.6	5.1	3.8	8.1	8.3	3.3	4.5	4.0	4.0	5.0	6.0	3.2	7.8	4.0	7.3	6.6	4.4	3.7	3.9	5.9	23.6	7.9	9.2	5.1	3.9	2.9	4.2	3.6	5.7	5.7	4.2	5.3	4.4	0.7	14.0	2.5	3.8	3.4	6.7	4.0	7.0	11.0	7.2	9.7	4.1	15.0	7.3	5.5	6.5	4.0	3.6	3.7	14.4	14.6	4.2	18.2	18.2	13.5	18.4	7.3	17.5	181.8	196.2	2.2	20.1	0.2	10.8	4.0	57.5	4.9	21.6	6.4	6.2	64.4	29.4	28.3	1.9	27.0	2.1	6.9	25.7	6.0	2.5	12.8	0.0	1.0	40.8	20.6	1.4	1.7	1.8	24.9	33.4	16.7	12.7	15.6	11.0	13.1	28.4	0.0	3.6	12.4	15.2	11.9	8.8	15.0	71.9	16.3	9.9	6.6	66.7	1.3	3.5	4.1	7.5	3.4	45.4	0.2	16.3	17.1	10.5	3.2	3.9	8.3	8.5	11.0	10.7	5.3	7.2	11.1	1.8	3.4	8.2	9.6	0.7	13.3	8.6	3.3	13.1	5.3	3.6	3.8	3.3	4.5	3.7	3.9	5.1	3.9	4.2	7.0	4.1	3.7	9.7	9.6	4.8	0.7	2.5	1.7	4.5	5.7	2.2	0.2	8.4	8.3	1.4	8.6	6.9	0.0	0.0	4.6	3.0	6.2	46.9	5.9	1.6	20.1	2.5	8.4	3.0	1.3	0.5	11.1	31.9	7.1	4.1	6.3	0.0	8.5	11.0	5.5	8.7	0.0	0.6	3.5	6.1	6.3	0.8	1.7	3.7	3.8	3.6	0.0	1.6	5.1	8.2	2.0	0.3	13.4	3.2	7.2	2.3	2.5	5.4	8.0	12.2	0.3	6.6	8.0	2.5	10.9	1.0	4.0	1.0	1.5	5.0	5.5	2.8	2.9
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381711	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 168.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 460.0;Late spermatids: 1094.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 14.5;U-266/70: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	7.0	13.4	11.9	1.6	22.6	1.9	4.1	18.8	19.0	6.0	32.7	10.2	13.9	5.2	5.7	9.8	11.6	2.3	73.5	18.6	9.4	53.4	18.9	3.4	0.1	12.0	13.1	6.2	18.1	24.2	18.9	1.3	7.7	4.1	6.0	76.2	7.6	3.0	168.3	12.8	17.4	6.8	8.2	0.6	6.2	86.5	15.1	0.6	3.8	62.8	0.6	4.5	4.8	17.5	6.0	0.5	0.9	3.2	0.1	0.2	1.3	0.7	0.4	0.0	0.6	6.1	0.8	10.2	1.8	1.1	1.4	1.0	7.9	2.9	0.2	7.2	1.0	2.8	4.4	12.5	2.7	0.0	2.8	0.9	0.6	0.7	2.0	1.3	0.6	7.6	14.5	0.8	1.7	4.1	0.0	0.6	1.6	2.0	1.3	0.1	2.1	1.5	4.6	0.3	11.9	3.6	3.4	2.6	0.7	1.7	8.8	6.2	0.0	0.0	1.5	0.8	1.0	56.9	13.5	0.2	0.1	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	22.6	18.8	19.0	18.6	9.4	12.0	13.1	7.7	8.2	15.1	17.5	0.6	3.2	2.7	10.7	0.6	2.4	5.3	1.5	1.2	75.2	3.3	2.4	85.2	7.2	6.1	5.5	95.9	0.5	1.6	25.5	113.5	3.1	460.0	39.0	3.0	3.6	0.0	0.4	15.7	1.6	0.9	7.4	2.0	8.4	0.0	2.0	2.2	23.0	17.2	10.1	11.6	2.0	0.0	1.3	2.9	1094.1	6.5	2.1	0.0	1.9	0.0	49.7	0.0	8.0	12.5	1.2	11.8	7.2	0.1	1.1	41.3	41.6	35.0	140.0	19.7	43.3	24.0	50.5	16.5	12.9	4.0	1.4	1.3	0.5	2.6	2.9
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"Spermatogonia: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000424, HPA027310, HPA079124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000424: , HPA027310: , HPA079124: "	"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 36.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 15: RT4 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	12.7	8.2	5.8	5.4	7.0	21.4	11.2	36.4	5.9	11.7	15.4	13.4	6.5	12.9	4.7	10.9	10.9	5.4	6.0	5.3	6.3	10.1	8.2	13.2	6.5	6.9	6.9	16.2	18.9	3.1	6.2	2.7	7.6	10.4	5.6	6.3	12.4	6.0	10.0	14.6	13.9	4.5	5.3	17.6	15.7	5.3	8.6	7.4	9.1	3.6	6.4	12.4	11.9	7.5	10.4	21.0	12.1	8.1	5.5	7.6	8.2	6.7	9.6	7.1	5.8	6.6	13.1	8.7	15.3	9.3	3.6	12.0	11.6	11.1	5.6	12.2	5.8	10.4	8.6	9.8	6.8	6.4	11.4	11.3	7.8	7.7	10.6	8.9	12.4	17.3	9.5	9.0	3.3	5.2	11.0	8.8	16.2	13.7	5.3	22.2	8.4	11.3	4.5	23.8	9.6	9.5	3.3	13.0	6.7	7.8	5.5	9.5	13.4	7.2	16.9	3.3	10.3	9.3	24.4	18.2	7.4	13.8	7.5	120.0	84.7	12.7	24.8	66.0	28.4	34.1	34.3	26.0	59.8	34.8	34.0	25.2	169.1	19.8	65.4	13.1	28.1	45.2	5.8	7.0	36.4	5.9	5.3	6.3	6.9	6.9	7.6	5.3	8.6	7.5	23.6	38.5	69.2	76.7	63.4	52.6	34.3	24.8	23.3	31.4	27.9	20.3	9.2	25.8	41.4	16.5	12.5	19.8	48.4	37.6	41.1	41.0	21.6	37.8	32.8	26.0	43.8	15.8	11.2	37.2	57.3	28.3	39.8	74.6	27.1	64.5	11.4	24.0	24.8	13.5	40.0	35.4	30.5	78.4	109.6	77.4	15.8	74.5	42.7	75.9	101.8	25.9	41.2	80.4	40.6	39.8	35.6	18.4	69.7	40.6	33.2	28.3	33.3	17.9	13.1	25.3	34.5	14.8	40.3	33.9	59.0	34.1	64.6	40.1	40.6	37.6
USP40	FLJ10785	ENSG00000085982	"Ubiquitin specific peptidase 40"	Q9NVE5	2	233475520-233566782	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 79.3;Oligodendrocytes: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005821	Uncertain		Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles	"Focal adhesion sites"	"HPA005821: AB_1080526"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.53e-2)"	11.8	12.0	10.4	7.5	17.0	3.4	13.9	12.8	11.4	10.0	16.5	9.4	10.5	10.6	24.0	10.4	11.5	11.6	8.2	10.2	12.0	14.2	13.2	12.5	7.2	19.4	14.2	15.9	14.0	16.8	8.5	12.4	19.0	13.5	9.5	14.2	12.9	10.4	9.6	19.7	10.1	8.5	12.3	9.9	13.1	14.7	16.2	10.1	16.4	7.6	7.8	9.6	7.5	25.4	17.3	19.9	17.6	12.0	25.2	23.0	15.7	16.4	12.4	14.7	16.0	14.3	20.2	0.4	4.7	26.4	38.6	30.3	13.3	29.7	20.6	0.0	9.0	13.3	17.4	24.3	22.3	5.8	8.9	22.2	21.1	22.2	30.9	26.2	17.3	8.1	22.0	3.2	21.4	14.0	6.2	8.5	7.9	17.8	16.0	0.0	36.3	8.1	17.9	27.6	9.6	10.3	13.5	13.5	16.9	12.9	15.4	12.9	17.3	20.9	13.1	8.9	20.6	6.0	4.9	0.8	27.1	10.2	18.6	0.0	1.0	0.0	0.5	1.1	0.2	0.4	0.5	0.4	1.5	0.7	0.7	0.7	0.1	0.5	0.9	1.9	0.8	0.5	10.4	17.0	12.8	11.4	10.2	12.0	19.4	14.2	19.0	12.3	16.2	25.4	11.8	32.1	35.5	79.3	7.9	7.4	9.1	13.6	15.4	18.1	17.0	14.7	10.7	10.0	19.9	16.5	25.0	21.2	6.7	9.9	7.9	9.4	8.4	19.8	18.3	11.1	15.0	5.7	25.9	12.6	10.6	11.9	21.4	21.3	9.5	23.4	12.8	25.4	8.2	23.5	38.2	10.9	4.1	11.6	3.6	10.7	6.8	9.1	3.6	40.3	5.9	11.9	4.1	48.2	127.7	10.5	12.6	8.2	10.9	12.9	13.9	14.6	21.0	19.4	13.1	17.5	10.6	30.2	20.9	17.2	10.5	15.7	5.5	21.1	12.1	10.0
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432325-99521728	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 53.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.1;Inhibitory neurons: 44.4;Oligodendrocytes: 39.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 53.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	6.1	4.4	5.2	4.9	5.8	4.4	4.6	53.5	9.4	4.3	3.8	5.3	7.3	5.1	4.8	5.3	4.0	6.2	6.2	5.8	6.3	6.3	4.2	3.7	7.4	6.0	7.7	4.5	4.0	4.5	3.6	5.2	8.2	5.1	6.7	6.7	4.0	4.2	6.0	6.3	5.8	4.5	5.3	4.6	4.4	3.3	6.2	3.1	5.3	5.5	5.2	4.3	3.8	9.0	5.9	4.0	8.1	11.2	14.3	13.5	8.7	10.3	11.1	10.1	14.7	8.2	6.4	15.2	7.3	10.3	11.9	7.7	12.1	9.8	13.9	12.2	12.0	15.2	8.4	6.7	11.4	14.2	8.3	15.3	7.6	9.2	15.5	10.7	15.4	13.8	37.2	14.8	9.6	5.5	4.5	13.3	12.8	9.1	8.9	6.8	5.9	8.9	13.8	6.8	11.3	9.2	7.0	9.1	7.8	10.0	4.9	6.8	15.5	5.5	7.1	8.1	15.5	6.3	6.2	29.1	9.8	13.1	10.1	2.9	1.4	0.4	3.2	0.8	4.2	5.3	2.7	4.0	2.4	6.7	1.9	1.9	0.3	1.9	2.0	3.6	2.6	1.0	5.2	5.8	53.5	9.4	5.8	6.3	6.0	7.7	8.2	5.3	6.2	9.0	13.3	3.2	5.8	22.5	13.3	2.3	9.6	6.8	4.6	10.3	4.4	4.6	9.4	4.3	4.7	3.7	18.8	6.4	7.3	5.9	5.9	4.3	15.7	10.1	10.3	7.6	2.4	4.2	47.1	2.5	6.6	7.1	9.7	4.3	2.5	5.8	6.8	4.5	4.0	10.1	44.4	2.9	10.2	4.8	2.6	10.2	13.1	4.6	3.6	22.5	10.0	5.4	2.1	32.6	39.4	5.0	3.1	8.6	6.5	8.6	8.3	15.8	10.4	7.4	0.0	6.3	6.7	1.9	7.5	5.2	2.8	7.4	7.1	5.8	7.3	6.9
UTP15	"FLJ12787, FLJ23637, NET21"	ENSG00000164338	"UTP15 small subunit processome component"	Q8TED0	5	73565443-73583380	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044697			Approved	"Nucleoli,Endoplasmic reticulum"		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Endoplasmic reticulum"		"HPA044697: AB_2679050"	"unprognostic (8.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.22e-1)"	8.7	6.5	2.0	8.0	2.4	36.9	9.7	3.2	3.2	4.6	1.2	6.8	5.5	7.2	6.4	9.2	5.0	5.1	4.8	2.2	2.5	5.1	7.5	5.9	10.8	2.1	2.3	4.9	7.4	7.5	3.1	6.0	2.7	5.9	8.3	5.5	4.9	4.7	7.2	9.5	5.2	7.6	1.6	7.8	5.7	6.1	2.1	7.6	8.1	7.5	10.7	9.3	4.5	3.6	21.2	22.3	15.8	44.6	12.6	14.9	27.9	24.8	14.1	27.1	29.8	25.0	29.6	47.5	24.9	16.6	34.2	17.3	25.5	45.5	41.6	23.9	19.2	21.7	23.7	20.2	15.5	20.2	18.1	15.2	20.0	30.8	34.3	8.3	19.1	21.2	33.8	25.3	23.2	26.4	31.7	14.0	20.6	7.5	12.7	24.5	24.7	45.9	16.1	28.5	15.8	16.9	22.7	17.6	27.4	13.4	22.8	14.4	15.4	15.9	22.5	19.4	49.3	19.0	27.6	60.5	26.0	34.3	23.8	4.9	6.8	4.6	8.2	7.0	7.6	7.9	8.1	9.1	7.4	7.0	9.6	9.4	5.1	8.2	7.2	7.0	7.3	4.9	2.0	2.4	3.2	3.2	2.2	2.5	2.1	2.3	2.7	1.6	2.1	3.6	8.4	0.0	7.3	2.3	7.7	14.7	13.1	5.0	11.4	3.8	6.7	6.5	6.8	4.3	5.2	5.5	6.2	8.0	6.0	2.7	3.9	8.9	4.3	4.9	6.8	6.9	2.4	9.4	6.4	7.8	9.5	8.0	5.6	6.8	7.0	6.7	2.9	8.1	6.8	1.7	5.4	4.1	2.0	5.8	2.1	2.8	3.1	3.9	7.2	1.9	3.6	3.0	2.1	3.5	6.9	6.5	3.6	5.3	9.1	10.0	2.2	6.3	1.7	4.7	6.6	9.5	8.8	10.0	12.4	11.7	17.0	6.6	6.1	7.6	6.7	9.8
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20 small subunit processome component"	O75691	12	101280105-101386618	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	"Plasma membrane"	"HPA049341: AB_2680720"	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	4.3	4.2	2.2	5.0	3.7	4.2	5.7	2.9	2.7	5.7	2.5	3.2	2.1	4.6	2.6	4.0	3.8	2.4	3.0	2.3	2.5	3.3	3.0	3.0	5.0	2.8	2.8	6.4	4.8	5.3	2.2	4.3	2.9	3.5	4.2	3.5	5.6	3.3	5.2	4.6	3.1	4.0	2.4	3.6	3.2	5.6	3.3	4.3	4.2	3.9	4.8	5.1	3.5	5.0	8.1	19.9	14.8	6.9	13.0	15.1	18.2	13.8	10.8	21.5	11.8	23.1	5.7	21.6	7.1	15.4	16.2	16.6	33.0	14.2	27.8	9.8	13.4	22.8	10.0	17.3	7.3	38.4	10.2	9.9	7.3	29.9	10.3	8.2	15.0	10.9	36.7	4.3	15.8	10.6	16.8	10.9	38.9	11.3	20.6	18.8	24.2	16.8	9.1	24.4	17.0	11.5	25.8	16.1	15.7	12.2	17.0	8.5	17.1	25.3	12.5	17.8	27.1	7.8	12.6	35.1	13.8	17.2	39.6	0.0	0.2	0.0	0.5	0.3	0.5	0.9	0.5	0.7	0.4	0.6	0.6	0.7	0.0	0.6	0.2	0.8	0.5	0.2	2.2	3.7	2.9	2.7	2.3	2.5	2.8	2.8	2.9	2.4	3.3	5.0	14.3	9.6	9.9	16.0	16.7	10.1	9.7	7.7	11.4	9.9	8.7	8.4	10.3	7.2	13.6	3.7	10.4	7.8	4.4	3.4	5.9	7.6	1.5	11.4	24.5	12.6	6.6	14.9	17.0	11.6	8.8	13.0	7.7	10.1	13.3	18.6	7.1	7.6	5.8	21.9	17.0	6.3	4.1	6.3	3.5	1.2	9.6	8.6	3.6	8.4	3.3	3.3	4.1	16.1	34.2	5.9	1.9	8.2	13.2	14.5	1.1	3.0	9.0	9.4	6.6	24.9	11.0	22.6	22.3	17.3	11.1	2.9	10.0	23.7	9.8	7.2
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6 small subunit processome component"	Q9NYH9	17	31860904-31901708	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	"Mitotic chromosome"	"HPA025936: AB_1845588, HPA055806: AB_2682930"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	17.7	14.3	24.2	7.8	24.3	9.5	15.8	24.9	39.8	21.5	25.4	17.0	4.4	15.3	12.9	17.7	17.1	4.3	17.2	24.2	24.1	21.1	24.4	14.5	11.4	24.0	24.3	20.5	19.1	5.1	19.7	6.4	24.0	22.3	6.4	10.2	13.1	5.7	16.2	17.4	17.1	6.9	23.6	25.7	15.1	18.7	24.5	9.1	18.0	6.3	12.5	16.7	17.0	24.7	14.4	9.0	12.3	7.4	11.9	8.0	15.3	11.8	6.7	17.6	13.6	32.8	7.8	20.9	14.0	11.3	16.7	18.6	16.7	14.1	16.0	4.6	26.4	13.1	21.2	31.6	14.1	19.8	13.5	13.2	15.1	16.7	12.5	16.3	11.4	13.2	23.1	11.9	13.8	11.6	19.4	56.4	16.9	17.2	14.6	20.6	17.8	21.4	19.0	12.9	8.4	12.8	12.5	9.3	22.7	19.4	22.7	39.0	11.5	27.8	20.5	14.3	24.3	13.0	25.9	31.8	18.9	14.4	15.4	15.5	10.6	7.4	7.1	11.3	7.0	12.6	7.7	7.7	14.7	15.2	6.6	7.7	13.7	5.9	11.1	21.3	8.1	7.8	24.2	24.3	24.9	39.8	24.2	24.1	24.0	24.3	24.0	23.6	24.5	24.7	22.5	19.2	24.3	17.9	32.7	25.7	30.7	29.1	12.5	16.7	13.5	16.3	15.6	14.3	31.7	5.5	8.4	42.4	34.3	10.6	9.8	29.7	35.6	23.4	29.0	21.1	5.4	29.5	23.0	24.0	50.3	26.2	16.3	33.5	36.2	20.5	12.1	15.6	35.8	11.8	21.4	16.3	20.3	21.0	17.6	5.4	18.6	29.4	8.8	18.7	43.4	16.4	7.2	17.6	16.2	26.3	8.4	17.0	17.4	31.9	12.7	18.5	30.3	16.4	6.6	28.2	23.7	102.9	66.2	17.2	26.0	38.3	19.9	21.0	16.7	31.2
UTY	"KDM6AL, KDM6C"	ENSG00000183878	"Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked"	O14607	Y	13248379-13480673	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 66.7;Inhibitory neurons: 65.2;Oligodendrocytes: 65.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 20.6;SK-MEL-30: 14.9;U-266/84: 16.4;U-698: 20.2"	"Low region specificity"	"Detected in all"							"HPA000568, HPA001165"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Nucleoli rim"	"HPA000568: AB_1858705, HPA001165: AB_1080541"			"unprognostic (7.52e-2)"		"unprognostic (6.60e-2)"	"unprognostic (4.04e-6)"	"unprognostic (6.47e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-2)"		"unprognostic (9.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-2)"	3.6	3.5	0.9	2.4	1.5	6.8	3.5	2.0	2.2	0.0	1.6	2.9	2.5	0.0	9.4	4.1	0.0	3.5	2.9	0.9	1.2	3.1	4.1	4.2	2.1	2.1	1.1	0.0	3.4	2.9	4.0	3.4	2.1	8.1	6.2	4.5	4.3	6.2	5.7	5.1	6.3	0.0	1.3	3.4	2.9	3.8	1.4	0.0	3.8	5.2	6.0	3.6	0.0	3.2	0.0	2.5	0.0	0.0	0.0	0.0	8.7	4.5	7.7	5.0	7.5	0.0	0.0	12.4	0.0	5.1	0.0	0.0	0.0	0.0	6.9	6.9	0.0	20.6	0.0	0.0	6.4	0.0	0.0	7.8	7.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	5.5	0.0	7.1	0.1	0.0	0.0	0.0	0.0	3.1	5.6	5.4	8.3	4.9	0.0	0.0	0.0	14.9	8.5	0.0	4.4	5.9	8.7	0.0	0.0	3.1	13.5	16.4	20.2	0.8	0.0	0.0	1.8	1.7	3.8	2.6	1.9	3.7	2.9	2.6	2.1	1.8	3.2	3.6	2.7	3.9	5.8	2.2	2.9	3.2	1.1	0.9	1.5	2.0	2.2	0.9	1.2	2.1	1.1	2.1	1.3	1.4	3.2	0.0	16.0	25.3	58.4	35.4	11.3	18.4	8.2	44.3	35.2	0.0	0.0	6.1	5.7	10.7	18.4	64.6	10.0	8.0	3.0	0.0	4.8	0.4	0.0	0.0	9.0	1.8	19.6	66.7	0.0	3.7	9.3	37.8	0.0	16.4	0.0	12.5	2.1	3.0	37.0	65.2	3.3	2.0	14.2	14.5	2.0	10.8	12.7	8.8	54.4	18.1	12.8	25.7	57.8	65.8	1.5	2.2	11.7	23.2	14.0	2.9	2.6	10.7	37.4	0.0	4.7	5.0	4.0	6.8	33.2	15.3	13.3	25.1	0.0	2.9	21.3
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651796-47659180	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Centriolar satellite"	"HPA050499: AB_2681146, HPA058400: AB_2683706"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	124.7	148.6	82.1	78.8	84.9	212.0	127.1	85.6	111.7	121.8	86.5	112.3	77.2	93.6	123.6	116.6	103.3	66.7	144.6	80.1	85.1	134.2	135.1	97.8	148.7	87.1	82.5	184.6	182.3	90.5	107.0	65.3	88.4	119.7	99.7	42.8	121.6	65.9	130.7	143.6	113.8	68.2	87.7	139.5	131.7	46.3	83.7	166.9	96.3	95.2	143.0	109.6	111.9	91.1	192.0	208.6	87.4	116.0	194.3	233.4	152.3	119.2	178.5	203.6	191.7	182.1	178.1	217.3	86.4	173.5	188.0	151.8	123.5	163.8	145.3	143.7	240.8	111.6	220.8	182.4	224.2	246.6	208.1	162.9	207.5	168.6	183.8	142.2	165.9	185.6	122.2	205.1	174.8	211.5	170.7	342.1	125.4	174.7	231.2	149.5	177.2	300.9	168.1	141.4	82.1	107.1	133.1	146.7	197.8	157.7	170.4	227.2	122.4	140.7	153.2	196.2	136.7	161.7	154.5	200.7	179.8	270.1	145.1	110.1	159.7	123.4	169.5	166.1	229.8	262.7	242.6	184.2	213.3	245.2	303.2	255.4	100.7	172.1	156.9	270.3	248.2	247.9	82.1	84.9	85.6	111.7	80.1	85.1	87.1	82.5	88.4	87.7	83.7	91.1	108.3	73.7	79.5	5.5	276.8	214.9	274.3	247.9	212.3	27.3	242.1	239.6	100.7	165.8	141.4	97.5	16.7	189.4	207.2	212.1	315.0	161.2	73.5	122.3	125.2	129.6	187.2	170.0	4.0	318.9	212.6	127.6	78.0	114.0	154.1	161.4	193.5	242.4	246.5	10.1	4.3	331.9	126.1	248.0	277.4	185.2	210.3	179.8	197.5	1.9	316.0	108.2	212.1	3.5	7.7	189.3	338.0	196.0	198.3	256.4	297.8	466.1	138.0	28.6	144.7	224.3	145.2	78.7	85.6	183.3	203.7	213.7	240.5	185.5	328.5	286.0
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 8.4"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 7.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 3.1;WM-115: 2.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 5.6;hypothalamus: 3.2;olfactory bulb: 1.5"	"Low region specificity"	"Detected in some"			HPA028946	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli rim"	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.0	0.0	1.6	0.0	4.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.4	0.0	2.8	0.2	8.4	0.1	0.2	0.0	0.0	2.3	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VCAN	"CSPG2, PG-M"	ENSG00000038427	Versican	P13611	5	83471618-83582303	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 975.7;Granulosa cells: 1131.8;Kupffer cells: 547.3;Macrophages: 605.6;monocytes: 948.1;Oligodendrocyte precursor cells: 1644.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 240.0;myeloid DC: 88.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 88.9;monocytes: 240.0"	"Cell line enhanced"	"Detected in many"		"AF22: 300.5;HSkMC: 199.5;hTERT-RPE1: 959.0;RPTEC TERT1: 381.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004726, CAB008979"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"CAB008979: , HPA004726: AB_1080561"	"unprognostic (7.90e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.09e-2)"	"unprognostic (6.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (4.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.17e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.30e-3)"	42.0	23.9	18.6	74.9	20.8	32.6	15.6	24.2	23.0	29.4	5.2	11.3	3.8	17.8	1.8	3.8	8.6	30.5	45.0	25.7	27.8	6.5	2.7	34.4	2.3	36.1	19.3	2.1	3.1	2.4	2.1	73.5	31.3	6.8	10.7	0.2	7.6	4.2	3.9	11.2	5.7	48.0	28.9	13.9	7.7	4.8	44.9	2.7	6.6	6.8	1.9	48.3	7.2	42.7	0.2	5.6	300.5	0.1	119.8	81.5	0.1	2.3	6.2	2.1	1.5	3.1	0.2	0.0	45.2	111.5	3.9	0.0	0.4	0.4	1.7	0.1	9.8	2.1	0.0	2.3	5.5	0.1	0.0	199.5	0.1	127.6	1.2	959.0	0.1	0.0	0.0	0.1	64.6	0.0	0.5	0.0	51.1	0.0	10.3	0.0	63.0	0.1	381.0	0.0	3.6	15.5	0.0	0.0	0.2	33.2	0.2	0.5	116.5	90.6	0.5	168.3	179.0	0.0	0.1	0.2	41.8	0.1	16.4	8.3	240.0	0.5	0.5	31.3	0.3	0.2	0.1	0.1	88.9	0.1	0.1	0.0	3.9	0.5	3.5	1.7	0.0	94.0	18.6	20.8	24.2	23.0	25.7	27.8	36.1	19.3	31.3	28.9	44.9	42.7	23.4	19.2	19.8	128.9	5.5	38.6	10.6	14.9	1.2	0.0	1.8	1.9	8.2	44.3	17.5	25.8	0.0	5.9	7.4	0.0	0.0	1.9	3.0	64.4	975.7	29.9	0.0	5.2	1.5	0.7	7.0	348.1	3.6	241.3	12.6	1131.8	16.8	3.6	25.6	0.0	30.7	0.2	0.0	547.3	83.1	2.5	18.6	605.6	44.4	20.6	948.1	0.0	13.4	1644.7	1.5	32.3	1.1	117.8	2.5	2.5	0.0	1.8	16.2	0.0	0.0	11.0	80.6	0.9	1.2	1.1	28.7	11.5	12.7	1.6	0.3	0.9
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35053928-35072668	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 540.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		34000000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	59.8	88.4	56.8	33.7	59.0	52.0	54.2	58.9	58.0	57.8	72.0	51.8	33.8	59.0	51.6	84.9	49.4	35.3	117.5	60.4	66.2	59.1	87.5	57.2	42.5	64.4	62.0	46.1	61.2	65.7	57.3	46.0	68.2	54.5	36.5	26.3	63.2	58.9	176.0	64.0	51.8	42.5	62.3	64.1	62.5	45.1	63.7	59.6	49.7	135.3	53.3	57.9	55.3	69.8	167.6	223.8	124.6	57.5	187.4	135.3	98.3	153.8	215.0	244.1	197.6	160.0	60.1	140.8	137.2	242.9	173.1	69.5	253.1	230.7	227.6	146.2	126.0	95.3	216.5	238.0	146.5	92.4	106.2	148.5	136.4	239.2	115.6	104.4	276.2	56.3	97.6	71.4	219.2	154.7	114.3	234.9	152.2	82.7	219.1	80.7	111.8	72.8	204.1	175.7	65.7	84.1	100.4	81.2	45.1	152.2	71.5	60.3	215.5	77.5	112.5	63.7	118.6	41.9	116.5	104.3	139.5	67.0	105.4	142.0	62.7	75.0	58.8	70.0	62.4	59.2	59.0	65.6	75.3	53.0	42.3	44.4	71.1	67.1	80.4	49.8	91.2	111.8	56.8	59.0	58.9	58.0	60.4	66.2	64.4	62.0	68.2	62.3	63.7	69.8	86.5	80.1	73.7	22.9	124.3	77.0	120.8	147.6	111.5	86.6	66.0	47.2	220.4	47.1	115.1	55.2	118.9	276.8	91.0	111.9	74.3	188.6	43.6	97.8	85.6	127.7	84.2	137.0	27.4	187.5	164.7	109.7	133.5	105.8	62.1	106.2	111.0	126.0	133.1	74.0	27.7	108.3	89.5	57.9	65.6	47.0	83.9	81.5	76.5	16.9	159.6	88.7	54.6	18.6	31.4	247.9	69.0	86.9	267.6	118.3	77.2	113.4	102.5	90.0	138.1	74.1	154.9	144.5	118.7	126.2	90.6	540.6	105.4	129.6	96.4	135.6
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667231	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 20.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	Centrosome	"HPA023932: AB_2671373"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	4.6	3.6	3.2	6.0	3.6	20.2	4.8	4.1	5.1	3.7	1.8	4.4	3.8	3.0	4.5	3.5	2.9	3.7	2.9	4.1	4.7	4.4	7.0	4.1	8.6	4.0	3.6	3.9	4.0	5.6	1.6	4.4	4.4	3.6	4.1	4.5	4.2	3.1	5.3	3.3	3.6	3.3	3.4	8.8	4.5	5.7	5.0	5.3	4.2	5.3	7.7	4.1	2.4	4.3	8.5	7.6	3.8	5.1	11.5	8.1	3.7	6.7	6.7	5.0	5.8	4.5	7.8	11.5	1.9	9.0	6.2	7.4	6.2	5.6	7.2	8.6	4.5	12.8	7.5	5.6	6.9	4.3	13.2	8.7	8.1	5.5	9.9	6.1	5.5	6.1	8.8	10.8	7.5	4.1	9.4	7.4	7.3	7.1	5.2	5.9	6.0	5.8	7.3	6.6	2.2	4.3	5.2	7.8	6.0	4.8	8.0	7.0	11.1	6.6	4.9	5.9	4.5	9.5	5.0	11.9	6.6	6.0	5.1	10.0	2.7	5.9	3.4	4.3	2.8	1.7	2.1	2.5	2.9	2.2	1.7	2.2	9.7	2.4	8.3	1.1	2.8	1.7	3.2	3.6	4.1	5.1	4.1	4.7	4.0	3.6	4.4	3.4	5.0	4.3	18.6	19.2	15.2	9.8	18.5	17.0	9.3	10.3	12.5	11.0	12.6	9.4	20.3	11.5	12.8	7.3	22.9	10.4	38.9	18.4	3.9	10.2	7.5	16.7	17.1	14.2	6.0	23.4	17.6	13.6	5.5	15.0	15.3	16.4	19.0	12.4	17.2	22.9	14.9	11.8	18.1	15.5	8.2	47.3	20.4	5.2	8.1	25.6	10.6	14.0	28.6	11.9	39.1	13.6	21.1	13.0	16.6	15.8	21.8	14.2	14.7	12.8	18.6	12.1	6.6	21.7	20.2	32.9	16.6	16.3	20.6	9.9	28.6	11.8	13.2	16.9
VCPKMT	"C14orf138, METTL21D, VCP-KMT"	ENSG00000100483	"Valosin containing protein lysine methyltransferase"	Q9H867	14	50108632-50116600	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001146, HPA076561"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA001146: AB_1845558, HPA076561: AB_2732312"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (8.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.27e-2)"	2.9	4.1	1.7	3.4	2.1	5.1	2.3	2.4	5.3	3.7	3.0	3.3	1.7	3.0	2.6	4.9	2.9	2.3	2.7	2.5	2.0	2.7	3.9	3.1	4.3	2.0	1.9	2.6	2.9	1.9	3.3	1.6	2.0	2.7	1.6	1.5	2.2	1.6	2.3	3.9	3.2	1.5	1.5	4.8	3.6	2.1	2.2	4.7	2.6	1.8	4.4	3.0	3.2	2.5	4.2	4.4	4.0	4.9	2.6	3.1	4.4	4.0	4.4	4.4	3.3	2.8	4.8	12.8	2.7	2.8	1.1	7.9	4.9	7.0	4.4	6.4	3.2	2.5	1.7	2.8	3.6	6.4	3.3	2.0	3.9	4.8	4.9	3.0	5.5	4.6	3.0	5.3	3.3	5.5	13.4	6.7	3.9	6.1	7.2	9.0	7.4	3.4	5.6	6.3	6.7	7.9	5.9	1.6	7.1	3.6	4.0	5.7	1.4	7.2	5.6	2.6	4.5	5.1	11.4	5.0	2.5	5.2	3.5	12.1	2.8	0.0	9.3	4.7	10.9	27.1	9.1	11.5	3.8	21.4	11.2	12.4	0.8	11.8	2.2	5.4	7.8	4.8	1.7	2.1	2.4	5.3	2.5	2.0	2.0	1.9	2.0	1.5	2.2	2.5	11.5	12.8	9.8	7.8	38.0	30.3	17.3	7.7	30.1	6.5	12.8	10.8	3.6	8.6	9.7	7.3	10.4	10.2	25.7	5.6	9.8	5.8	39.4	14.1	9.8	8.3	5.4	9.5	12.6	5.7	8.4	9.3	7.7	17.1	17.7	7.2	6.8	7.7	5.1	1.7	11.0	8.5	12.2	7.5	16.4	10.2	7.5	8.7	10.6	3.7	9.5	3.5	15.5	10.6	17.5	5.3	8.0	4.9	48.2	15.5	7.8	6.7	8.6	8.1	0.0	9.1	9.1	14.4	16.6	24.9	37.4	11.5	22.4	10.2	7.1	17.1
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 235.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 141.7;Proximal enterocytes: 88.7;Undifferentiated cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"classical monocyte: 3.5;eosinophil: 1.9;intermediate monocyte: 6.5;myeloid DC: 5.1;neutrophil: 6.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.5;monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 55.5;HDLM-2: 80.0;U-937: 85.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.1"	"Region enhanced"	"Detected in some"		"spinal cord: 4.3"	"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.6	13.7	0.2	13.3	0.2	8.2	11.3	0.2	0.4	5.0	0.9	40.4	56.0	1.6	0.4	13.6	1.8	8.5	1.2	0.2	0.7	21.0	1.1	7.7	5.3	0.7	0.4	0.5	2.1	235.9	11.1	2.9	0.6	1.9	35.3	0.2	6.1	1.8	2.8	22.1	55.0	3.8	0.1	2.6	7.4	1.0	1.4	1.5	2.2	0.6	7.2	10.4	7.6	0.3	15.0	2.6	0.1	0.1	12.0	16.4	0.2	17.7	8.6	15.0	12.9	10.6	12.1	3.5	17.4	13.6	10.7	27.1	0.5	55.5	6.4	80.0	4.0	6.3	3.1	0.9	8.1	12.2	20.3	23.6	30.5	16.4	26.0	22.3	1.2	1.3	1.8	3.9	7.0	9.2	0.3	6.0	0.2	34.8	19.1	0.3	0.0	9.9	13.3	13.5	6.2	0.2	14.7	42.6	5.9	0.1	47.6	6.7	1.0	28.8	7.3	8.2	10.2	2.2	0.1	3.0	8.6	85.3	7.7	0.1	3.5	1.9	0.0	6.5	0.1	0.5	0.3	0.0	5.1	0.0	0.1	0.0	6.5	0.2	6.7	0.4	0.7	1.5	0.2	0.2	0.2	0.4	0.2	0.7	0.7	0.4	0.6	0.1	1.4	0.3	0.4	12.8	20.1	0.3	1.4	36.1	9.0	8.5	24.5	0.5	21.2	13.7	1.7	0.0	9.2	7.3	0.0	0.2	0.9	141.7	7.9	3.5	0.2	11.9	0.5	1.3	21.7	0.0	0.4	10.9	0.1	5.3	14.3	4.7	7.0	0.2	0.0	0.3	3.4	0.0	0.3	32.8	2.0	7.3	43.4	0.0	0.0	21.2	8.8	1.0	10.4	0.2	0.0	0.5	0.1	22.4	43.3	0.4	10.9	8.3	88.7	32.0	9.0	0.2	0.0	1.1	2.2	0.7	0.3	23.4	40.6	0.3	2.8	0.0	72.4	11.6
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165569	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 1407.4"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 128.3;Horizontal cells: 225.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Region enriched"	"Detected in all"	6	"hypothalamus: 1407.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	3100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	2.1	3.1	23.7	0.8	24.8	0.1	0.1	5.5	174.6	0.0	0.0	0.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	22.7	1407.4	3.6	0.0	0.1	0.0	235.4	69.9	0.1	16.1	0.0	117.0	0.0	158.8	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.3	0.2	16.6	0.1	1.9	0.9	48.7	0.0	0.6	0.0	0.0	0.0	0.1	27.3	2.2	1.1	1.1	9.5	0.0	0.0	10.3	0.9	0.0	0.0	0.0	2.4	0.9	0.1	3.1	0.0	1.4	1.4	0.5	0.1	0.0	1.0	0.7	0.3	0.0	0.9	0.1	0.6	4.4	0.1	0.2	0.2	0.7	0.0	0.0	0.1	3.7	2.3	0.0	23.4	0.1	2.4	17.6	1.0	2.3	0.8	0.0	0.1	0.3	0.1	14.1	172.0	0.3	0.9	511.5	1.1	0.4	0.3	0.0	0.4	85.9	0.0	2.0	0.1	0.8	4.7	13.5	0.4	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	24.8	5.5	174.6	22.7	1407.4	235.4	69.9	158.8	16.6	48.7	27.3	1.7	0.0	0.0	3.6	0.9	1.5	1.0	0.0	1.2	22.0	0.9	0.6	2.9	0.0	0.0	0.0	0.0	1.5	1.0	1.3	29.4	0.3	0.1	0.4	0.4	0.9	128.3	0.0	22.7	0.0	8.4	0.3	3.1	0.5	0.0	1.4	0.0	0.0	0.6	225.4	37.7	4.5	0.0	0.0	0.4	0.6	0.6	0.7	0.0	11.2	0.0	2.1	0.0	4.0	4.8	5.9	2.8	0.0	0.9	4.3	2.7	1.2	0.0	5.0	0.0	0.1	0.8	0.2	4.3	0.6	2.3	1.4	0.5	5.4	2.3	0.6
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 61.9;stomach 1: 97.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 221.7;Gastric mucus-secreting cells: 192.7;Paneth cells: 139.0;Proximal enterocytes: 165.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.0;OE19: 78.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA035675, HPA035676"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA035675: AB_10671223, HPA035676: "	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (1.35e-4)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	5.4	3.7	8.7	11.0	9.0	12.6	6.4	6.6	10.6	9.5	6.4	46.8	61.9	5.7	1.5	7.2	6.7	15.7	6.4	8.6	7.8	5.3	1.4	7.7	9.8	8.3	8.4	6.8	3.4	1.2	5.1	4.1	8.0	16.0	26.6	1.2	5.7	4.0	1.2	9.1	61.7	4.1	8.0	11.8	97.5	5.4	8.2	10.2	7.4	1.4	6.3	17.5	7.4	7.2	8.2	0.1	0.2	0.4	2.8	2.2	0.8	2.3	1.9	2.3	2.2	6.1	25.0	3.9	3.5	1.6	0.0	1.9	1.8	0.2	0.5	0.8	0.0	7.3	0.1	0.6	3.4	7.7	9.5	3.3	2.2	2.2	0.0	0.0	4.5	16.1	7.3	2.3	2.6	0.1	12.4	8.7	0.2	78.4	0.0	4.8	0.0	2.0	0.8	9.8	0.1	0.3	0.0	0.5	1.8	0.0	0.7	12.4	2.8	1.0	0.3	3.0	0.0	1.4	3.1	1.2	0.6	10.9	5.0	0.0	3.2	0.0	6.8	2.0	7.4	3.5	4.4	3.9	2.1	4.6	5.6	4.2	0.1	3.4	1.4	3.8	5.8	4.1	8.7	9.0	6.6	10.6	8.6	7.8	8.3	8.4	8.0	8.0	8.2	7.2	4.9	9.6	7.4	10.4	7.2	2.3	5.7	25.5	6.8	0.9	3.3	2.9	1.9	8.6	46.1	0.0	0.0	3.0	13.3	221.7	0.0	3.4	6.2	1.5	2.7	4.5	9.6	6.1	5.5	16.9	3.4	6.7	192.7	1.5	8.2	6.1	5.3	0.3	2.4	1.7	3.0	64.4	14.2	1.9	2.4	19.9	3.7	4.0	1.8	3.7	4.2	28.1	7.2	2.5	1.2	38.7	139.0	2.6	4.4	6.2	165.6	1.6	40.5	0.8	0.0	4.3	7.1	5.4	3.4	3.1	1.4	1.0	8.1	5.6	50.5	33.4
VIRMA	"DKFZP434I116, fSAP121, KIAA1429"	ENSG00000164944	"Vir like m6A methyltransferase associated"	Q69YN4	8	94487689-94553529	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 26.4;Endometrial stromal cells: 32.2;Granulosa cells: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031530	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	Nucleoplasm	"HPA031530: AB_10600818"	"unprognostic (2.51e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.87e-2)"	12.5	7.8	6.9	11.6	8.5	27.3	17.5	11.5	7.2	13.1	7.1	9.9	8.1	13.7	8.6	9.7	11.4	8.9	9.9	6.1	7.4	10.8	12.5	10.7	14.4	7.1	7.2	16.7	10.3	14.8	6.3	13.2	7.2	10.7	11.7	12.3	9.5	10.3	8.7	9.7	9.1	13.9	7.2	11.4	11.6	16.5	7.3	20.0	13.3	9.3	15.2	10.5	8.0	9.2	40.5	25.2	26.8	14.9	32.4	42.5	17.1	27.5	27.9	29.4	29.9	17.9	33.2	43.6	25.5	36.1	23.0	25.9	36.2	33.5	42.9	38.7	20.0	52.0	19.6	17.6	23.6	25.9	17.9	32.8	13.4	35.4	33.7	30.1	37.5	28.2	54.0	26.6	30.0	23.8	50.7	14.6	17.5	41.4	19.1	29.9	24.4	24.3	19.1	27.6	20.9	28.9	21.6	5.5	23.8	26.3	31.2	20.7	37.3	26.9	15.9	23.1	25.7	20.8	27.8	51.0	26.4	33.7	26.2	14.2	5.0	8.7	6.7	6.4	10.7	6.6	7.4	9.1	5.2	5.0	9.0	7.9	6.0	9.5	13.8	3.3	6.9	5.8	6.9	8.5	11.5	7.2	6.1	7.4	7.1	7.2	7.2	7.2	7.3	9.2	24.2	25.6	21.5	0.0	6.3	0.0	0.0	0.0	0.0	0.0	16.9	16.4	0.0	0.0	14.9	7.3	0.0	26.4	20.0	0.0	7.9	14.4	0.0	23.8	32.2	9.8	0.0	0.0	0.0	12.2	23.7	10.6	0.0	22.4	5.1	28.5	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	14.7	0.0	0.0	5.2	0.0	0.0	6.9	8.7	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	16.8	9.9	25.0	0.0	0.0
VLDLR	"CARMQ1, CHRMQ1, VLDLRCH"	ENSG00000147852	"Very low density lipoprotein receptor"	P98155	9	2621182-2660056	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 77.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 78.1;Cone photoreceptor cells: 104.3;Oligodendrocytes: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 6.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.3;JURKAT: 20.5;THP-1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032462, HPA051312"	Uncertain		Uncertain	"Vesicles,Cytokinetic bridge,Centriolar satellite"		Yes	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Cytokinetic bridge, Centriolar satellite"	"CAB032462: AB_2216805, HPA051312: "	"unprognostic (5.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.34e-2)"	15.7	16.3	2.7	2.2	6.4	0.8	8.5	5.3	4.2	10.3	6.4	6.6	0.5	9.6	3.2	19.2	13.8	2.9	43.7	3.2	5.3	10.6	3.1	10.7	0.7	7.7	5.6	77.5	27.4	19.5	6.5	5.9	5.9	6.6	2.0	12.3	11.6	2.0	26.2	5.3	1.9	6.8	4.0	5.5	9.0	6.0	4.9	0.8	11.6	11.7	1.7	12.5	10.4	9.8	0.1	0.8	14.3	0.4	1.5	0.5	22.3	7.0	2.2	1.7	4.3	3.6	0.3	0.0	6.4	2.8	0.6	0.3	3.4	5.6	4.5	9.7	2.4	0.1	1.6	1.8	1.9	9.2	1.7	1.5	3.3	0.7	0.1	7.6	0.7	20.5	0.0	17.4	1.1	0.9	1.1	1.1	9.9	1.5	0.9	0.1	0.4	0.0	6.4	0.4	2.5	2.4	0.6	0.6	10.4	7.5	0.3	33.3	0.3	2.8	4.5	0.1	3.3	14.1	6.1	2.6	14.7	8.2	0.6	0.0	0.0	6.3	0.2	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	2.7	6.4	5.3	4.2	3.2	5.3	7.7	5.6	5.9	4.0	4.9	9.8	4.2	16.0	8.8	1.0	0.1	2.7	1.2	18.7	4.6	23.8	4.3	3.9	78.1	1.5	9.7	5.5	104.3	13.2	1.6	9.8	1.9	11.3	5.7	8.6	6.1	3.6	10.9	0.0	8.3	10.3	29.0	17.2	3.1	19.3	0.0	5.7	2.2	2.8	2.3	11.8	10.9	1.4	24.4	1.0	1.1	2.8	7.8	0.6	10.6	2.8	1.0	3.9	0.0	8.0	39.1	8.6	4.3	10.9	0.5	5.1	0.0	8.0	11.9	32.5	0.0	2.7	9.4	8.2	6.4	5.0	2.0	3.4	1.7	15.9	1.3	6.0
VN1R1	"V1RL1, VNR19I1, ZVNH1, ZVNR1"	ENSG00000178201	"Vomeronasal 1 receptor 1"	Q9GZP7	19	57454790-57457142	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 8.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.5;Cone photoreceptor cells: 2.1;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 2.5;Rod photoreceptor cells: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;U-266/70: 2.5;U-266/84: 3.3"					"Not detected"	"Not detected"			HPA062209			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles	Nucleoplasm	"HPA062209: "	"unprognostic (7.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.59e-5)"	0.5	1.0	2.2	0.2	2.4	0.3	0.7	4.5	2.4	0.6	1.8	1.2	0.0	0.5	2.2	0.6	0.8	0.3	2.0	2.3	1.9	1.2	1.0	0.8	0.4	1.8	1.9	1.2	0.6	1.1	3.4	0.6	1.4	1.3	0.3	8.2	0.9	0.6	2.3	1.7	0.7	0.3	1.3	1.1	0.5	1.3	1.9	0.4	1.7	2.7	0.3	0.9	0.6	2.2	0.2	0.0	0.8	0.9	0.0	0.2	0.4	0.2	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.3	0.0	2.9	0.4	0.0	0.3	0.1	0.2	0.5	0.3	0.3	0.0	0.1	0.4	0.1	0.3	0.1	0.4	0.4	0.1	0.2	0.9	0.2	0.0	0.3	0.2	0.5	0.4	0.2	0.5	1.5	0.6	0.0	0.2	0.0	0.4	0.4	0.3	0.0	0.6	0.1	0.1	0.3	2.5	3.3	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	4.5	2.4	2.3	1.9	1.8	1.9	1.4	1.3	1.9	2.2	0.4	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	4.5	0.2	0.0	0.3	0.0	0.6	0.0	2.1	0.2	1.4	0.0	0.0	0.3	0.0	0.2	0.1	0.6	0.0	0.4	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.3	0.1	6.7	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.0	2.5	0.3	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	4.4	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.2
VPS4A	"FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1"	ENSG00000132612	"Vacuolar protein sorting 4 homolog A"	Q9UN37	16	69311350-69326939	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018751, CAB034411, HPA060092"	Approved		Supported	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Midbody		"CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203"	"unprognostic (2.60e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.79e-2)"	13.2	15.3	15.7	8.9	16.9	8.8	12.8	16.1	17.1	10.4	11.0	13.5	13.5	11.7	8.1	16.0	10.3	9.4	20.6	15.5	14.9	18.0	11.6	9.9	11.8	16.4	16.8	12.2	27.8	20.6	7.6	10.0	16.7	10.4	7.6	10.2	19.9	8.4	54.0	15.3	12.8	8.4	15.4	9.2	17.6	6.8	16.7	6.2	16.7	33.6	7.3	11.4	11.3	18.2	21.1	34.9	23.2	30.7	21.2	18.8	20.5	27.9	25.2	36.4	24.3	33.4	19.0	35.0	27.3	28.0	17.5	30.3	23.9	28.2	21.8	14.8	30.8	22.0	20.7	26.3	32.6	27.5	19.6	21.7	36.3	31.6	28.7	21.4	27.4	27.3	37.0	10.3	27.2	46.8	36.4	20.5	26.7	20.6	24.5	47.8	19.0	41.3	18.5	16.8	39.1	24.7	59.3	18.1	21.4	15.4	31.4	20.6	32.8	33.2	20.8	30.4	22.1	36.9	31.3	62.6	30.4	18.2	37.1	8.8	9.9	13.3	11.2	8.7	10.0	8.5	9.3	13.9	9.4	7.4	10.5	9.9	7.5	8.0	11.5	5.5	11.8	13.8	15.7	16.9	16.1	17.1	15.5	14.9	16.4	16.8	16.7	15.4	16.7	18.2	39.8	25.6	19.0	14.7	33.8	30.7	37.3	22.2	22.8	51.4	30.2	28.2	31.0	22.8	16.7	23.9	22.9	59.8	48.4	48.9	74.3	51.7	11.2	14.9	27.0	34.9	31.3	43.6	14.5	82.5	66.5	32.9	29.0	25.6	29.2	36.3	31.8	21.6	45.1	74.0	14.9	34.2	20.3	33.7	24.6	11.9	29.5	30.2	44.4	5.6	40.9	66.0	38.1	4.5	16.8	67.4	42.2	30.5	31.9	67.6	76.4	57.7	6.4	41.8	52.6	36.0	38.9	28.7	38.3	27.1	31.3	70.1	35.6	26.0	41.4	41.2
VPS4B	"SKD1, SKD1B, VPS4-2"	ENSG00000119541	"Vacuolar protein sorting 4 homolog B"	O75351	18	63389190-63422483	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040393, CAB046445, HPA057649"	Approved		Approved	"Vesicles,Intermediate filaments"		No	No		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Intermediate filaments"	"CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489"	"unprognostic (8.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	24.2	18.3	10.5	25.5	13.1	52.6	28.8	13.2	17.8	26.8	9.3	42.3	35.1	22.7	19.5	75.4	18.6	23.7	16.2	10.3	14.6	23.8	28.4	23.8	31.2	13.5	15.9	19.3	17.3	27.8	11.5	28.7	14.0	23.4	37.0	7.0	24.7	19.5	11.0	32.3	36.4	21.0	12.6	28.8	32.5	12.1	12.5	31.4	28.5	13.0	39.1	30.2	31.1	15.6	57.1	21.9	22.4	24.5	33.5	47.1	38.9	48.6	45.5	36.4	39.2	15.7	39.4	54.1	31.2	35.7	30.9	119.6	26.8	53.1	47.5	40.6	22.3	27.6	27.8	23.7	48.6	94.5	56.8	43.1	80.3	32.3	56.2	36.5	33.9	31.0	14.3	49.4	52.1	20.2	59.9	29.2	23.2	22.7	32.3	48.8	47.2	52.4	45.6	66.2	38.2	33.6	36.9	35.4	55.3	28.3	34.2	50.5	52.8	55.4	27.3	21.6	32.7	163.6	86.5	69.3	31.9	44.0	42.3	163.6	54.6	125.0	52.2	56.5	49.0	64.8	54.3	54.2	46.2	73.4	48.2	51.1	185.9	68.4	76.5	45.6	66.7	56.6	10.5	13.1	13.2	17.8	10.3	14.6	13.5	15.9	14.0	12.6	12.5	15.6	52.0	115.4	57.4	21.5	62.4	68.8	47.2	66.5	44.9	37.0	54.4	46.0	39.5	47.1	72.4	33.1	22.9	70.0	92.2	142.0	45.0	48.0	113.3	92.2	74.0	44.6	45.5	27.8	27.3	42.1	56.7	51.0	47.4	145.5	59.3	37.7	36.8	55.8	46.4	43.7	29.6	76.8	67.1	58.8	33.0	15.5	49.0	58.0	32.0	18.7	53.4	39.2	76.2	18.6	49.5	91.3	120.7	36.5	42.1	43.1	61.8	57.9	85.1	31.5	59.2	45.6	54.7	30.1	29.4	87.5	83.4	140.4	67.4	56.5	72.6	79.5
VRK1		ENSG00000100749	"VRK serine/threonine kinase 1"	Q99986	14	96797304-96954846	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.4;testis: 37.1"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 198.9;Spermatogonia: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	5.9	5.2	5.9	12.8	7.1	50.4	11.5	6.0	7.9	5.2	4.3	10.8	6.5	6.5	6.9	8.9	9.2	4.4	5.2	5.9	5.1	4.9	5.5	4.9	27.1	5.3	5.5	6.0	3.2	5.4	3.1	7.6	5.4	5.0	12.3	4.4	4.3	5.0	4.7	7.4	7.2	6.7	4.8	11.3	6.5	37.1	5.9	35.5	5.9	4.6	27.9	7.7	5.4	7.0	52.4	27.0	78.5	30.2	9.2	14.9	44.8	42.8	34.4	67.1	65.4	36.0	54.7	139.2	22.4	24.3	39.2	56.5	75.5	54.4	90.5	73.4	36.4	90.5	18.7	39.3	10.2	168.5	49.2	8.5	9.7	50.4	32.6	12.8	47.0	104.8	76.6	79.0	56.9	65.5	137.1	76.5	47.8	39.9	59.3	124.5	134.2	48.6	32.3	59.3	53.2	28.0	34.2	36.4	30.8	36.0	39.3	66.6	24.4	27.9	22.8	47.7	37.3	37.7	53.5	124.8	44.7	74.6	34.8	42.7	12.3	26.2	21.5	15.5	29.0	31.3	24.9	26.4	15.7	32.7	27.1	27.3	6.5	45.6	15.2	21.4	34.9	19.4	5.9	7.1	6.0	7.9	5.9	5.1	5.3	5.5	5.4	4.8	5.9	7.0	15.3	3.2	4.6	6.8	30.6	16.8	13.8	23.3	6.2	12.4	9.3	11.3	11.8	12.8	16.7	14.7	8.4	34.8	24.8	6.3	11.7	13.5	21.3	21.1	8.3	12.4	3.0	76.2	42.0	19.4	48.3	11.4	14.8	10.8	28.5	20.0	7.1	3.3	19.2	10.1	36.2	10.4	20.3	11.8	14.9	11.5	5.6	12.0	12.4	19.7	14.2	6.2	27.8	12.1	19.8	10.3	2.2	9.8	25.4	6.1	3.0	11.2	37.6	9.6	19.7	14.3	15.1	198.9	110.9	14.1	13.9	15.1	26.8	9.2	18.1	10.4
VTCN1	"B7-H4, B7H4, B7S1, B7x, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 100.9;fallopian tube: 32.7;pancreas: 30.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA				"Cluster 5: Breast - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	100.9	0.0	0.0	15.3	0.0	0.0	0.4	4.5	5.0	0.4	32.7	5.0	0.2	0.0	0.0	17.3	1.1	0.7	0.0	0.0	0.0	0.1	30.1	0.0	0.1	0.8	0.0	3.0	0.0	0.0	22.1	7.8	0.2	2.8	0.0	0.1	0.0	0.0	3.6	1.1	0.1	0.1	0.0	0.0	0.0	3.2	0.1	0.0	1.0	0.1	1.7	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	7.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	4.2	0.1	1.2	0.0	0.0	244.8	0.1	29.9	14.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.5	6.9	0.0	0.0	62.3	18.4	1.1	0.0	22.6	55.2	0.0	3.4	1.1	0.0	0.0	83.6	2.5	42.7	4.4	0.6	0.0	0.0	0.8	34.2	1.4	0.4	0.0	79.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	6.1	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.3	11.3	0.0	0.0	0.0	1.6	0.0	0.3	8.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	3.0	0.5	0.0	0.0	4.8
VTI1B	VTI2	ENSG00000100568	"Vesicle transport through interaction with t-SNAREs 1B"	Q9UEU0	14	67647085-67674820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 493.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044121, HPA048150, HPA060118"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206"	"unprognostic (2.26e-1)"	"unprognostic (4.83e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.11e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (8.35e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.02e-3)"	53.8	26.9	55.5	20.4	56.8	22.3	39.8	54.4	102.1	22.7	49.8	42.9	28.3	18.4	53.5	44.3	18.5	28.7	60.1	56.6	58.1	53.0	41.6	26.8	23.8	55.1	56.6	21.0	44.0	23.9	17.1	21.3	56.8	22.3	35.2	23.0	30.1	13.6	46.5	31.0	24.1	22.4	56.0	26.5	40.0	30.8	56.3	12.1	34.0	28.2	27.0	33.3	23.4	56.9	111.7	54.8	31.4	18.1	61.9	37.2	45.4	48.1	30.5	23.8	23.7	27.3	38.5	32.9	40.2	54.5	27.5	30.6	36.8	36.6	37.7	34.3	22.6	33.4	32.5	34.8	26.6	20.9	22.9	36.3	39.6	25.6	26.1	60.5	27.2	23.1	22.2	25.4	34.5	131.1	26.6	77.7	20.3	76.6	88.0	31.8	35.6	12.2	35.1	65.0	17.4	35.5	33.8	45.5	71.4	23.7	41.9	58.0	38.5	62.6	93.8	51.4	45.6	23.8	27.8	53.2	52.9	38.9	29.0	88.8	61.5	143.8	49.4	80.4	42.4	49.0	43.1	51.1	59.6	43.0	40.5	50.3	27.2	56.4	70.2	38.6	60.2	58.3	55.5	56.8	54.4	102.1	56.6	58.1	55.1	56.6	56.8	56.0	56.3	56.9	47.6	25.6	35.0	13.1	48.7	42.3	61.4	91.7	33.0	23.2	82.2	65.4	30.5	67.2	64.4	66.2	22.9	107.4	47.5	138.2	217.2	109.1	141.7	58.5	43.2	51.5	46.6	102.7	15.8	131.4	167.9	51.6	40.8	49.5	64.0	43.6	73.9	95.3	131.4	15.2	18.2	96.0	50.8	99.8	49.2	493.5	41.7	80.9	71.2	11.2	121.6	65.4	78.2	13.6	17.1	130.7	119.4	39.9	51.0	120.5	165.4	268.6	55.3	44.8	19.7	36.5	58.2	104.5	57.2	58.2	52.8	125.9	46.8	35.5	91.9	124.6
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 22.3;testis: 30.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 467.1;Late spermatids: 995.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 7.1"	"Low region specificity"	"Detected in all"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036700: AB_2675261, HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.4	0.0	1.1	0.0	0.0	0.9	0.7	0.6	5.0	0.1	0.0	0.2	0.0	0.0	22.3	0.0	0.0	1.3	1.5	0.1	0.0	2.5	0.0	7.0	5.8	0.2	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.1	30.0	1.2	0.7	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.9	0.7	1.3	1.5	7.0	5.8	3.7	4.8	1.2	2.7	0.3	0.0	1.1	11.8	0.1	0.3	1.7	2.2	0.0	1.0	0.1	0.3	0.9	0.0	12.1	1.8	31.3	0.0	0.0	0.8	0.0	0.0	467.1	53.8	0.6	0.6	1.8	0.0	1.9	0.4	0.2	0.8	4.6	1.6	0.0	0.1	1.1	0.0	0.2	0.0	1.0	2.8	6.1	0.0	0.8	995.9	4.7	0.7	0.0	3.7	0.6	0.7	0.0	1.5	0.7	0.2	2.7	5.7	0.2	0.4	0.2	0.0	124.5	0.5	0.0	0.5	1.0	17.6	6.0	0.0	0.4	0.0	0.1	0.2	1.0	0.8
WARS1	"IFI53, IFP53, WARS"	ENSG00000140105	"Tryptophanyl-tRNA synthetase 1"	P23381	14	100333790-100376805	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 324.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 1345.3;non-classical monocyte: 1608.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 908.5;SK-MEL-30: 1012.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		49000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	100.7	67.9	40.3	185.6	44.4	70.5	65.4	40.1	45.5	35.9	45.2	67.8	44.8	39.6	70.3	54.4	50.8	48.7	157.6	44.2	56.0	83.6	47.9	207.5	139.0	72.0	52.6	21.2	47.5	39.2	63.4	324.4	65.3	49.1	72.0	37.8	49.5	38.3	74.7	28.4	67.7	76.2	47.6	110.6	70.1	67.7	55.0	61.7	159.9	67.0	86.2	107.7	30.7	44.9	91.2	85.7	54.6	319.1	78.7	110.7	87.3	117.4	220.7	232.1	301.4	57.4	80.2	101.7	105.5	277.4	59.7	151.1	158.8	130.3	153.1	154.4	48.3	64.1	60.9	72.3	908.5	184.9	101.6	126.9	186.9	141.3	290.1	74.5	225.0	66.1	202.8	255.0	107.5	178.0	64.3	87.1	55.4	94.1	152.2	51.4	86.5	64.9	119.3	80.8	145.7	84.9	69.4	58.7	1012.4	70.5	153.6	234.7	153.1	25.7	58.9	269.2	61.3	446.4	277.1	191.9	295.0	144.2	205.5	96.5	471.7	610.4	41.5	1345.3	38.4	71.4	34.5	38.4	337.9	68.0	24.8	28.6	170.9	44.5	1608.2	54.7	44.8	672.7	40.3	44.4	40.1	45.5	44.2	56.0	72.0	52.6	65.3	47.6	55.0	44.9	66.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	16.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	11.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	0.0
WBP1	WBP-1	ENSG00000239779	"WW domain binding protein 1"	Q96G27	2	74458400-74460891	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 29.0;Gastric mucus-secreting cells: 33.1;Plasma cells: 57.2;Squamous epithelial cells: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057067	Approved		Approved	Cytosol		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA057067: AB_2683326"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (6.05e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (6.83e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (6.36e-4)"	36.9	70.7	141.7	19.6	145.8	31.9	37.7	139.4	171.9	48.2	133.1	46.6	29.1	39.1	44.8	35.7	56.1	36.5	49.9	137.7	136.6	71.2	80.3	33.7	32.2	144.2	141.3	55.6	62.3	73.7	60.8	24.9	138.2	69.9	17.7	24.4	56.4	37.3	31.4	34.9	33.2	19.8	138.1	42.5	58.0	31.8	145.0	44.7	66.9	53.9	20.6	45.7	37.5	139.0	20.6	91.3	56.2	66.7	69.9	54.0	45.7	20.6	40.3	22.4	17.5	47.3	41.9	19.4	39.3	48.9	33.2	28.3	24.8	55.8	19.0	74.3	49.1	27.4	41.4	68.9	47.6	10.3	27.4	76.2	58.9	30.4	42.2	93.8	44.7	51.6	11.5	72.0	54.8	133.8	40.1	25.5	43.3	53.6	46.3	36.4	63.5	33.6	55.9	83.1	35.0	81.3	28.2	49.9	62.5	49.4	65.5	26.9	26.5	53.0	41.9	20.0	23.5	106.7	38.8	22.2	56.2	27.0	48.5	24.1	28.5	19.2	26.5	23.5	22.5	28.4	23.0	25.5	30.2	27.8	31.3	28.0	18.6	34.6	20.1	47.0	39.2	27.1	141.7	145.8	139.4	171.9	137.7	136.6	144.2	141.3	138.2	138.1	145.0	139.0	1.5	3.2	4.2	0.0	14.3	0.9	0.6	2.0	29.0	1.6	3.2	2.2	0.5	0.0	4.2	1.8	2.1	1.4	1.7	3.3	1.9	5.5	2.4	3.1	2.4	3.6	1.8	9.7	0.0	3.9	1.4	7.2	33.1	1.8	1.3	1.1	0.4	0.8	1.7	0.0	0.0	4.7	2.0	2.4	1.0	1.8	2.1	7.1	0.0	0.0	6.0	1.7	2.1	0.0	0.0	5.2	3.1	1.2	57.2	1.2	5.6	3.3	13.1	1.7	0.0	0.5	5.8	0.6	0.2	28.1	1.3	1.8	10.4	0.9	3.7	0.3
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 321.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Supported	Nucleoplasm,Cytosol		No	No		440000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA065682: AB_2685530, HPA068819: AB_2686042"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	113.2	223.6	239.5	57.1	238.6	82.7	114.1	225.1	340.9	103.2	163.6	109.7	65.2	84.6	44.3	94.7	106.1	62.8	183.1	243.0	242.2	125.7	184.4	118.1	60.9	293.9	256.8	113.9	134.5	100.7	116.0	55.4	286.4	103.5	39.0	129.7	137.7	73.5	250.2	131.3	85.7	52.0	226.4	112.5	123.2	95.4	259.8	49.2	83.8	91.9	51.8	97.8	94.7	256.6	104.6	119.9	43.4	52.5	88.0	87.2	57.9	32.7	102.1	74.3	91.8	59.7	104.2	52.9	81.9	47.0	232.2	61.0	45.2	100.9	66.3	40.1	90.4	97.7	66.4	97.6	182.2	40.8	161.6	96.4	94.6	89.4	120.8	127.0	143.8	82.1	68.2	156.7	60.2	107.3	85.8	85.8	37.3	70.8	78.8	57.8	85.4	101.5	109.7	62.3	72.6	114.8	58.5	99.9	163.1	76.3	134.9	102.1	84.3	75.8	66.1	73.6	52.3	145.4	109.6	38.8	212.5	38.3	54.9	239.9	85.0	288.7	53.8	102.6	59.1	68.9	59.5	54.6	54.8	55.3	55.8	47.5	308.9	57.4	136.4	42.0	77.4	93.2	239.5	238.6	225.1	340.9	243.0	242.2	293.9	256.8	286.4	226.4	259.8	256.6	73.5	83.3	79.0	34.9	62.7	60.9	127.2	85.9	30.1	109.7	75.2	53.3	73.2	55.8	59.9	53.3	75.0	64.9	45.9	65.9	162.4	124.3	264.5	41.5	21.7	63.4	33.6	124.0	23.6	188.6	65.1	43.5	34.1	44.3	67.0	40.0	54.3	61.9	138.4	112.7	23.4	48.9	71.2	65.5	71.2	321.1	59.4	90.2	60.5	23.4	90.8	104.8	52.5	21.1	38.6	126.5	72.6	53.8	35.6	120.2	88.4	100.7	44.8	120.7	26.3	43.8	44.9	45.5	25.7	24.8	80.0	184.7	51.7	62.5	27.1	95.6
WDPCP	"BBS15, C2orf86, CPLANE5, fritz, hFrtz"	ENSG00000143951	"WD repeat containing planar cell polarity effector"	O95876	2	63119559-63827843	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 18.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 169.9;Alveolar cells type 2: 128.0;Astrocytes: 124.7;Excitatory neurons: 261.4;Inhibitory neurons: 240.9;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 296.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044144	Uncertain		Approved	"Cell Junctions"		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 6: Brain - Smell perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"		"HPA044144: AB_10969458"	"unprognostic (3.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.22e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-1)"	4.7	3.5	11.3	2.5	11.7	8.2	3.2	17.7	15.7	2.5	6.5	1.6	1.8	3.9	4.0	2.0	4.2	2.8	4.9	10.4	6.9	3.6	2.4	2.5	3.3	6.4	5.4	4.6	1.5	2.9	1.9	2.6	8.4	2.6	1.8	12.2	2.2	2.1	5.3	3.4	1.7	3.0	3.2	3.3	3.3	5.1	6.3	3.6	3.5	2.9	2.7	1.8	1.1	18.6	5.2	4.6	3.3	4.0	3.7	4.6	3.0	4.3	2.2	2.8	2.3	3.3	2.6	5.8	3.5	2.9	3.3	3.4	2.3	2.8	3.3	5.7	3.8	6.1	3.5	2.8	2.5	5.0	4.1	2.3	1.9	2.9	1.9	3.7	2.9	6.7	2.3	5.7	2.9	5.3	5.8	5.1	3.9	2.7	1.7	6.2	4.3	5.0	1.9	2.5	5.2	5.2	3.7	4.4	5.3	4.7	3.8	3.9	4.7	4.6	7.2	4.0	3.6	5.3	3.6	10.3	5.2	5.3	5.3	6.6	2.8	1.5	1.9	1.5	3.7	1.8	1.7	2.6	2.3	3.1	2.3	3.6	1.9	3.8	1.3	2.7	1.5	1.1	11.3	11.7	17.7	15.7	10.4	6.9	6.4	5.4	8.4	3.2	6.3	18.6	6.0	169.9	128.0	124.7	8.0	4.1	3.2	4.3	2.8	16.1	4.4	3.2	10.1	7.2	59.6	1.8	22.9	2.5	5.5	0.8	1.9	2.6	46.7	17.9	6.2	14.4	0.0	7.8	261.4	2.2	2.6	13.5	6.6	3.7	65.0	7.4	5.0	1.8	4.0	11.8	240.9	1.3	4.1	3.0	4.4	17.5	4.4	8.4	5.4	103.0	3.8	7.5	6.2	136.2	296.3	1.8	1.6	3.8	5.1	1.5	0.5	4.5	98.8	27.4	0.0	8.6	5.7	16.1	9.5	2.3	3.4	1.9	9.4	4.0	1.1	1.7
WDR19	"DYF-2, FAP66, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182504-39285810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 61.8;Inhibitory neurons: 82.5;Respiratory ciliated cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.3;ASC TERT1: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	7.5	8.0	3.1	5.3	2.5	3.7	9.2	5.3	3.8	10.5	10.8	6.8	1.9	16.0	13.3	3.9	20.3	8.4	4.2	2.3	2.5	8.8	6.3	8.8	4.7	5.3	3.6	17.9	5.4	8.1	9.1	6.2	2.9	7.7	4.2	13.0	5.7	8.4	2.3	5.5	4.7	9.1	3.5	4.6	6.2	14.0	2.7	6.9	16.7	2.4	4.9	6.2	6.8	3.6	6.1	5.2	10.3	12.1	45.3	47.0	4.7	7.5	17.2	8.1	10.6	2.8	6.5	10.4	4.1	7.8	17.2	4.0	10.9	5.4	8.6	0.5	8.5	2.2	10.3	6.1	16.1	9.6	2.6	30.5	11.1	11.9	7.2	24.6	10.7	11.0	8.7	9.1	9.9	2.1	7.7	8.1	3.5	3.7	5.6	8.2	10.4	4.2	7.0	2.9	11.5	10.4	10.2	2.4	6.1	13.1	5.5	3.6	7.9	7.9	5.3	17.5	7.8	7.2	7.6	7.6	11.9	3.3	3.7	0.1	0.3	0.2	0.3	0.5	0.3	0.8	0.5	0.6	0.3	1.2	0.5	0.6	0.3	0.8	0.5	0.1	0.3	0.2	3.1	2.5	5.3	3.8	2.3	2.5	5.3	3.6	2.9	3.5	2.7	3.6	5.5	12.8	9.3	26.1	5.4	4.8	4.9	4.6	2.2	10.1	7.3	7.4	4.5	2.8	9.4	18.4	10.4	1.2	1.8	0.7	0.0	5.5	5.1	32.3	14.6	6.7	2.4	4.0	61.8	3.6	3.2	10.8	2.0	12.0	2.5	13.4	4.2	10.0	3.2	25.2	82.5	2.0	12.2	3.2	3.6	3.4	16.4	3.0	1.8	19.7	1.8	6.7	1.0	18.1	19.7	2.9	0.2	18.8	3.9	3.0	0.3	4.0	46.6	21.7	0.0	10.9	7.9	33.8	10.2	3.9	4.7	1.4	2.9	13.1	1.1	1.9
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385146-224437033	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	33.7	28.3	21.9	32.1	21.3	88.9	26.7	20.0	22.0	28.9	27.5	28.9	21.2	26.5	20.8	52.1	22.7	27.1	28.0	23.4	22.8	23.7	35.4	35.1	33.8	21.5	22.0	24.3	24.4	26.4	20.6	35.6	20.2	26.1	25.4	31.5	28.7	25.0	57.1	40.9	26.5	28.6	18.8	38.2	26.7	37.4	22.1	36.0	26.0	45.0	33.2	32.6	31.5	21.9	49.7	28.0	54.6	29.7	76.8	74.6	47.6	58.4	86.4	51.7	48.0	39.0	46.8	51.9	74.4	86.3	21.7	40.6	40.2	47.2	76.1	55.3	53.6	36.2	31.5	31.0	74.7	40.3	68.6	70.8	58.4	55.0	52.1	72.6	80.8	31.7	52.7	51.4	62.4	24.8	42.4	34.7	65.7	41.5	32.0	42.6	66.1	44.2	55.1	48.3	29.5	56.0	64.8	94.9	74.9	55.5	117.5	67.0	88.7	47.7	28.7	41.5	71.3	66.8	33.6	35.2	53.3	26.1	66.8	2.1	1.0	2.1	1.4	1.4	0.8	0.8	0.8	1.0	0.9	0.6	0.7	1.0	4.8	1.5	2.4	1.0	1.1	0.8	21.9	21.3	20.0	22.0	23.4	22.8	21.5	22.0	20.2	18.8	22.1	21.9	32.6	105.8	54.2	55.2	34.4	111.4	29.6	30.9	43.3	24.6	54.1	30.5	49.2	40.0	48.2	35.0	31.3	30.4	54.3	34.8	5.9	22.2	243.3	60.6	35.2	44.2	35.4	53.7	63.4	23.8	15.7	37.9	26.5	71.0	48.1	34.1	41.4	44.2	53.4	38.7	61.3	44.4	40.7	133.4	96.4	102.1	37.0	74.5	46.2	67.5	45.7	16.3	32.0	63.3	70.0	34.2	26.2	28.2	33.0	49.0	19.2	22.8	55.4	24.2	19.7	35.2	41.4	37.1	25.8	63.9	122.3	68.3	45.1	37.9	25.0	63.7
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	9.1	6.3	2.2	8.4	2.8	2.9	9.3	2.8	2.6	7.3	7.4	5.9	5.4	6.7	4.2	6.6	7.4	3.1	4.4	2.6	3.1	5.9	11.2	4.5	7.1	2.2	2.7	7.6	5.1	9.2	3.0	6.2	2.2	5.8	7.7	4.3	4.4	4.9	10.3	5.0	4.9	8.0	2.3	6.2	6.6	11.7	2.7	8.5	6.0	7.4	11.8	9.4	4.3	2.7	35.6	22.2	21.7	33.5	23.0	18.8	24.9	24.1	15.9	27.8	24.3	23.8	11.6	42.4	32.4	18.2	17.7	23.1	55.0	28.4	44.4	34.3	28.1	39.7	22.7	19.0	19.1	74.8	20.0	18.5	19.8	35.4	53.3	16.3	27.2	29.1	49.7	20.2	24.2	20.4	35.9	15.5	78.7	30.7	34.7	33.9	75.5	32.5	13.8	23.4	33.4	30.1	27.8	33.6	39.6	29.6	13.5	29.9	24.0	20.9	33.1	38.4	54.9	29.3	36.8	64.5	30.5	47.2	55.0	0.1	6.8	0.6	9.3	7.1	12.0	9.3	8.4	11.0	13.5	8.6	12.9	11.9	0.6	9.6	8.1	7.4	12.4	7.4	2.2	2.8	2.8	2.6	2.6	3.1	2.2	2.7	2.2	2.3	2.7	2.7	11.4	9.6	14.3	5.9	13.1	20.9	21.9	13.1	15.4	11.3	11.2	9.7	14.9	8.6	23.4	7.3	6.2	10.7	8.6	4.6	9.8	12.8	33.2	11.7	20.4	13.2	3.6	10.7	12.4	13.8	9.9	14.9	8.2	7.5	16.4	11.9	8.9	27.4	7.9	15.2	12.5	6.4	14.2	7.3	5.7	43.6	12.5	7.1	10.6	5.6	8.2	7.4	10.3	13.0	7.5	12.3	4.1	11.7	10.9	31.4	3.0	7.4	17.6	7.3	13.1	23.0	13.8	52.3	50.8	21.7	22.4	5.1	10.6	31.1	9.8	15.4
WDR37	KIAA0982	ENSG00000047056	"WD repeat domain 37"	Q9Y2I8	10	1049538-1132384	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 184.8;Late spermatids: 92.9;NK-cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037376, HPA037565"	Enhanced		Approved	"Intermediate filaments"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Intermediate filaments"		"HPA037376: AB_10672789, HPA037565: AB_10696937"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.75e-5)"	"unprognostic (2.59e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.62e-2)"	"prognostic favorable (1.46e-6)"	"unprognostic (3.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (5.98e-2)"	8.4	16.5	10.4	9.3	10.5	22.2	7.8	0.4	18.7	8.1	2.0	8.9	7.3	7.9	8.9	9.1	7.8	6.1	17.6	13.1	2.5	8.7	10.3	10.3	12.5	1.5	1.9	9.7	10.1	9.8	14.6	6.3	2.9	8.1	6.7	14.9	7.6	5.1	18.3	11.5	11.2	6.6	0.0	21.0	10.3	21.2	3.1	10.3	9.5	15.7	9.8	7.0	7.9	9.7	12.4	9.0	11.6	9.4	10.9	15.8	8.2	15.5	8.4	9.5	9.4	11.3	10.4	6.1	9.2	20.3	2.0	11.2	6.1	18.1	8.1	7.4	10.0	14.8	9.6	7.7	7.7	8.8	16.0	19.8	13.6	13.6	4.8	11.3	21.0	12.1	9.1	7.3	15.2	10.9	9.8	6.9	6.4	9.6	4.8	14.9	6.5	10.5	13.2	13.8	5.2	10.1	7.2	13.3	11.9	8.8	12.8	17.9	27.7	7.5	2.5	24.8	12.5	13.4	13.3	8.2	17.4	9.9	5.4	6.0	4.8	3.5	10.0	6.2	8.7	5.5	5.6	7.4	5.2	4.4	6.3	7.3	3.8	11.2	7.1	4.8	5.3	5.2	10.4	10.5	0.4	18.7	13.1	2.5	1.5	1.9	2.9	0.0	3.1	9.7	10.5	3.2	8.1	33.6	14.5	13.4	13.0	7.5	10.2	16.3	8.4	7.2	23.3	5.7	7.9	11.0	12.5	6.2	27.4	8.6	0.0	4.8	184.8	5.7	8.6	13.6	10.7	6.5	65.3	6.1	4.2	9.0	13.3	11.1	12.0	7.3	30.7	7.0	9.0	8.4	59.7	8.1	8.2	18.8	13.7	92.9	12.5	14.8	16.0	43.1	23.7	5.3	86.5	36.7	47.3	9.5	8.3	18.0	9.6	13.6	7.2	4.8	4.9	14.7	6.6	13.0	8.5	11.6	14.3	11.9	12.4	11.4	19.1	10.1	5.9	19.7
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: "	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	9.9	9.2	5.2	9.5	5.4	12.9	9.2	6.2	5.6	7.6	6.8	10.6	9.3	7.8	4.3	13.4	7.4	6.1	7.7	5.4	5.8	9.4	12.3	8.8	10.1	6.4	5.6	7.5	11.1	6.1	9.0	7.6	6.0	8.8	10.3	4.0	10.5	5.4	9.1	11.0	11.0	6.4	5.4	12.6	10.5	4.9	5.7	7.8	7.4	6.0	10.6	8.9	7.9	5.9	13.2	18.0	8.5	34.4	12.8	10.1	23.7	12.9	15.5	13.3	15.2	31.1	17.7	12.3	16.8	16.6	24.3	16.1	11.5	22.4	10.2	11.6	9.6	14.1	15.9	12.7	12.2	14.8	25.5	12.2	12.7	18.3	9.6	9.2	14.4	13.7	9.9	9.3	14.9	19.2	14.0	13.3	8.9	18.9	15.2	11.6	12.2	11.6	15.9	19.7	8.3	11.1	17.7	51.3	20.2	10.4	36.3	15.8	13.0	17.5	9.0	20.3	17.6	15.6	12.9	9.6	22.7	19.5	10.6	6.4	10.2	7.8	11.3	16.6	11.7	8.5	10.5	9.8	9.9	7.3	8.3	8.5	9.0	10.3	14.2	7.2	12.6	10.0	5.2	5.4	6.2	5.6	5.4	5.8	6.4	5.6	6.0	5.4	5.7	5.9	17.1	9.6	16.7	5.9	16.9	14.5	10.9	9.1	9.6	13.5	15.5	10.3	5.3	5.7	16.2	18.4	12.5	21.6	28.9	31.9	21.5	20.2	29.3	20.6	13.1	12.9	14.9	13.9	7.2	28.2	42.8	12.6	25.0	13.9	19.7	16.4	12.5	14.9	20.8	23.5	7.0	22.6	8.2	16.1	13.9	9.7	9.6	18.3	8.8	1.0	20.5	5.7	23.7	4.5	6.5	27.2	39.3	7.5	23.0	15.6	24.9	20.8	17.2	8.3	13.1	13.0	14.1	7.9	9.8	15.1	13.4	23.3	21.0	14.2	26.0	16.4
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054649-36105108	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 110.3;testis: 63.7;tongue: 63.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 43.4;Cone photoreceptor cells: 85.5;Early spermatids: 42.5;Late spermatids: 46.2;Rod photoreceptor cells: 41.7;Spermatocytes: 67.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Centriolar satellite"	"HPA043255: AB_2678393, HPA043639: AB_2678593"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.4	0.4	0.3	2.1	0.5	5.4	0.4	0.9	0.7	0.9	0.2	0.9	1.1	0.6	0.2	3.7	0.7	0.2	22.1	0.4	0.2	0.4	0.7	0.7	2.9	0.5	0.5	0.3	0.2	0.1	0.4	0.5	0.5	0.7	0.5	6.7	1.3	0.2	110.3	2.7	1.2	0.7	0.2	2.0	0.9	63.7	0.4	5.0	0.4	63.1	1.8	0.3	1.4	0.8	19.9	37.8	12.3	12.6	1.1	0.3	7.8	18.0	7.6	24.1	20.8	20.0	6.7	24.7	10.9	9.3	11.3	6.1	18.6	6.8	13.5	16.1	8.8	16.9	20.5	13.5	0.8	16.8	19.6	0.3	0.7	17.7	5.2	1.7	6.0	17.3	21.7	26.8	11.3	20.6	33.1	9.0	7.3	16.0	7.4	23.3	12.5	11.7	3.3	7.5	15.3	8.6	12.1	16.7	2.8	7.6	9.6	14.3	4.1	20.8	19.9	16.7	29.6	14.0	22.1	32.0	9.1	13.0	24.6	0.5	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.2	2.7	0.1	0.5	0.1	0.3	0.5	0.9	0.7	0.4	0.2	0.5	0.5	0.5	0.2	0.4	0.8	1.8	0.0	5.5	0.3	1.0	2.2	1.3	0.5	0.6	1.6	0.9	0.6	43.4	0.0	0.8	0.0	85.5	1.9	1.2	2.5	1.9	0.4	42.5	0.8	0.8	2.0	0.0	11.0	1.4	0.9	1.9	1.8	5.6	0.8	0.0	4.3	1.1	0.8	2.2	3.3	1.0	2.2	2.0	1.3	1.6	46.2	1.2	1.9	1.8	1.0	0.8	2.1	0.0	1.0	1.0	0.5	0.2	0.4	7.1	0.8	0.3	0.3	0.2	41.7	6.6	2.8	1.9	67.6	15.4	2.0	3.7	0.3	2.2	1.2	3.0	0.7
WDR74	"FLJ10439, Nsa1"	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 565.6;choroid plexus: 711.0"	"Cell type enriched"	"Detected in all"	5	"Early spermatids: 616.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	21.3	21.8	352.4	20.5	274.3	127.1	21.2	485.9	291.6	19.5	711.0	19.6	17.1	20.8	14.6	25.8	22.3	11.4	23.1	251.8	208.5	21.5	28.5	14.9	30.6	220.8	221.4	25.6	30.9	15.1	11.4	18.3	292.3	19.5	16.4	33.7	25.0	13.7	59.3	31.2	17.7	17.0	305.3	30.1	22.0	15.4	244.7	62.3	28.4	25.3	23.9	24.8	18.9	565.6	64.2	76.2	28.8	49.4	22.9	31.4	85.9	35.8	37.5	73.6	49.1	108.8	77.0	111.6	97.6	28.5	59.0	84.1	88.8	69.0	56.8	72.7	64.2	55.5	84.1	97.5	65.9	112.3	36.0	30.9	75.7	47.8	153.9	24.8	36.1	80.5	126.1	32.5	33.7	120.6	106.7	178.7	117.1	70.9	96.7	108.9	49.9	193.6	52.7	35.6	65.7	72.1	40.8	84.1	115.4	27.8	58.8	83.1	28.0	44.4	52.4	98.3	88.2	81.0	120.3	137.1	47.5	68.3	57.2	40.1	140.9	11.7	40.2	61.4	49.7	66.0	42.1	38.6	105.0	121.5	56.8	52.0	51.0	93.2	44.9	154.3	52.4	47.8	352.4	274.3	485.9	291.6	251.8	208.5	220.8	221.4	292.3	305.3	244.7	565.6	36.8	38.5	67.9	1.6	112.5	104.5	47.2	45.7	60.9	15.2	37.6	57.0	2.0	40.0	108.7	16.5	16.7	55.2	57.9	32.0	43.0	42.8	616.0	22.4	34.0	41.7	41.0	26.5	3.6	40.5	53.8	39.1	65.2	32.4	43.6	23.5	20.7	34.0	37.9	3.3	3.0	32.1	20.3	33.1	69.2	97.1	32.9	45.0	30.2	1.0	22.4	15.4	45.3	2.0	2.8	39.8	24.2	21.4	74.3	50.3	44.8	54.0	32.0	11.4	19.7	53.0	89.3	19.4	31.4	50.3	109.3	34.8	66.3	30.4	41.5	39.8
WDR81	"CAMRQ2, FLJ33817, PPP1R166, SORF-2"	ENSG00000167716	"WD repeat domain 81"	Q562E7	17	1716523-1738599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023044, HPA063703"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Vesicles, Cytosol"	"HPA023044: AB_1858822, HPA063703: "	"unprognostic (1.00e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.90e-3)"	"unprognostic (6.10e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.60e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (3.26e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.90e-2)"	17.7	16.2	4.5	4.6	5.4	4.9	16.9	4.6	6.3	18.2	6.6	11.5	4.8	18.9	2.4	9.9	17.4	1.6	10.9	4.3	4.4	11.9	32.8	13.7	5.6	5.9	5.1	21.4	11.0	2.4	13.1	3.9	5.3	16.0	1.7	0.8	11.0	5.9	18.2	18.4	17.8	5.1	4.7	24.3	11.0	7.5	6.1	6.6	10.5	2.1	4.2	15.4	13.7	6.4	0.7	12.3	1.7	9.1	12.4	7.0	9.2	0.9	0.2	0.6	0.0	1.8	4.4	4.9	6.5	5.4	6.2	12.2	6.3	8.4	0.4	9.5	12.8	0.3	8.8	5.9	22.1	4.1	7.6	17.8	8.8	5.9	4.1	1.9	5.0	3.7	1.0	6.3	7.6	6.8	1.3	7.6	3.9	4.2	9.4	6.4	2.9	6.8	3.7	2.0	2.2	5.0	4.3	3.4	15.4	0.1	6.0	6.1	6.8	4.8	5.4	7.9	6.7	0.5	1.3	3.1	7.7	5.9	2.4	0.0	1.4	2.8	1.1	2.3	1.3	1.3	1.2	1.2	1.8	1.0	0.8	1.1	0.3	2.1	2.3	3.3	1.2	1.1	4.5	5.4	4.6	6.3	4.3	4.4	5.9	5.1	5.3	4.7	6.1	6.4	6.3	12.8	10.3	6.5	4.2	2.5	2.9	4.4	8.6	4.5	4.8	5.3	3.6	4.3	3.8	0.0	4.2	2.5	9.9	6.8	1.9	3.1	0.7	2.1	6.2	5.4	1.2	14.3	5.3	4.5	1.9	8.2	6.6	2.9	4.5	6.2	4.6	27.7	23.8	5.0	5.3	4.6	10.2	22.3	4.5	1.2	16.4	15.3	0.0	9.4	7.5	2.5	9.2	5.0	7.6	4.8	4.8	15.1	5.3	2.9	8.7	20.1	6.4	1.8	19.7	5.9	4.5	0.7	2.0	3.4	1.7	2.3	4.7	5.8	4.4	1.7
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573670-9593457	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 213.9;Glandular and luminal cells: 262.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004619, HPA068845"	Approved		Approved	Nucleoli		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli		"CAB004619: AB_628447, HPA068845: AB_2686048"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	12.7	5.6	1.5	14.1	1.3	23.0	46.1	2.4	2.3	21.5	2.8	18.4	10.6	62.6	24.5	46.3	18.6	49.0	43.0	1.2	2.3	16.8	57.8	11.6	24.8	2.8	4.0	10.9	10.1	17.8	8.4	34.6	3.6	21.2	14.4	4.5	17.4	12.7	10.4	57.1	13.5	35.0	2.2	8.1	17.2	31.5	2.0	23.7	26.6	7.2	30.2	53.0	15.4	1.9	43.1	16.4	69.1	38.8	65.2	29.8	125.9	48.8	44.8	29.3	29.8	33.8	53.3	100.7	18.0	27.6	30.8	48.8	49.0	23.3	41.1	33.3	30.7	43.1	30.1	26.2	7.0	66.6	39.7	12.0	25.3	13.8	53.8	34.9	21.6	43.6	64.0	75.8	55.7	13.2	63.5	39.4	97.6	36.9	18.5	57.6	54.5	24.6	28.1	100.0	25.0	31.8	39.9	48.6	29.2	89.3	27.1	32.9	21.7	51.1	35.2	23.0	42.2	14.4	51.1	140.1	23.3	36.5	41.0	0.0	0.0	6.0	1.7	0.0	0.2	8.0	1.7	3.0	0.1	4.7	0.1	1.3	0.1	1.9	0.0	0.1	7.1	0.6	1.5	1.3	2.4	2.3	1.2	2.3	2.8	4.0	3.6	2.2	2.0	1.9	17.2	51.3	33.9	0.0	36.8	176.4	170.4	38.5	213.9	1.8	168.5	67.2	61.1	65.8	53.5	42.3	0.0	94.8	11.2	54.7	13.7	24.9	25.0	160.1	86.2	18.7	61.1	40.4	0.1	13.6	200.1	39.2	52.5	262.4	7.0	28.5	9.7	85.0	17.0	1.7	0.4	65.6	18.3	2.5	21.9	41.7	11.8	10.0	17.8	1.0	2.4	9.9	8.2	2.0	0.1	24.8	38.5	10.9	17.2	82.7	35.9	8.3	62.6	7.1	6.6	180.7	23.7	61.4	44.4	181.4	191.1	137.2	19.0	11.8	55.5	85.5
WEE2	"FLJ16107, WEE1B"	ENSG00000214102	"WEE2 oocyte meiosis inhibiting kinase"	P0C1S8	7	141708353-141731271	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 1.9;Proximal tubular cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA					"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	0.6	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 126.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 172.7;monocytes: 187.2;NK-cells: 245.1;Oligodendrocytes: 217.2;Plasma cells: 162.8;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.1;Karpas-707: 296.8;U-266/70: 233.0"	"Low region specificity"	"Detected in all"							"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		520000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300"	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	31.0	14.7	14.2	93.0	37.2	56.8	21.0	36.1	20.5	30.6	11.1	26.0	18.2	22.4	11.5	14.2	14.4	34.8	16.0	14.9	28.8	13.0	16.4	31.8	126.9	46.2	38.6	12.3	7.3	12.9	4.8	33.5	42.3	14.9	20.8	3.4	17.7	23.0	5.9	9.9	32.5	29.1	27.9	89.7	21.8	4.7	35.1	66.4	15.4	11.5	110.5	31.5	17.0	53.8	0.7	7.0	16.3	0.2	40.4	70.9	16.9	31.1	26.4	12.1	18.7	1.9	1.4	209.1	9.2	47.0	15.6	0.5	2.8	0.0	15.1	144.8	4.1	106.5	26.9	0.0	15.1	94.9	167.2	29.6	5.1	27.7	2.6	16.0	25.0	18.7	3.3	296.8	34.4	0.1	106.6	87.1	19.1	0.0	1.4	90.0	6.6	37.9	11.3	0.7	2.6	33.8	0.3	8.8	18.7	30.4	0.4	46.8	21.2	41.0	11.5	30.1	29.9	233.0	165.2	113.7	60.4	64.7	111.7	41.5	35.4	87.2	71.6	37.3	59.4	35.1	47.6	71.1	26.1	28.6	38.0	51.4	166.1	57.4	43.7	11.2	57.7	54.7	14.2	37.2	36.1	20.5	14.9	28.8	46.2	38.6	42.3	27.9	35.1	53.8	32.1	19.2	21.7	27.7	134.5	12.5	6.3	0.9	2.8	2.1	3.3	4.3	10.5	1.5	4.6	3.7	25.0	2.0	172.7	0.3	5.9	1.7	40.2	3.3	21.9	30.8	4.9	30.1	5.3	11.6	82.5	40.5	9.7	2.1	67.2	2.1	36.8	3.7	86.2	0.0	7.2	1.6	0.0	142.2	128.0	96.9	25.1	139.8	26.6	98.4	187.2	1.2	245.1	120.6	217.2	16.8	0.8	18.0	162.8	5.0	0.2	35.9	0.1	3.4	13.1	15.7	21.4	4.4	4.1	1.2	11.1	4.1	208.1	8.8	2.1	3.1
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 127.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 165.7;Syncytiotrophoblasts: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 114.1;eosinophil: 223.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 224.3;HHSteC: 216.7;HSkMC: 180.8;SK-MEL-30: 183.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	31.3	18.8	11.2	14.1	11.2	26.6	30.5	12.5	15.1	33.1	19.1	36.4	12.8	15.3	14.4	14.8	12.6	23.3	78.4	10.6	12.9	33.3	18.7	26.2	8.7	12.5	12.0	11.2	29.8	25.2	17.8	62.4	12.5	17.4	38.5	8.2	55.0	18.3	127.2	21.9	14.8	18.8	11.4	12.5	29.3	9.6	15.5	5.9	21.1	97.5	16.7	22.0	14.4	11.9	4.9	9.8	8.6	12.5	224.3	167.2	49.0	36.3	163.5	13.7	43.6	7.2	7.3	3.0	16.0	74.2	47.9	3.7	3.3	22.1	23.9	4.4	4.6	34.7	3.2	42.6	216.7	2.4	48.5	180.8	39.5	54.2	72.0	44.2	61.3	5.3	2.5	82.0	41.1	29.9	0.5	7.1	1.8	12.7	15.0	0.4	30.3	35.7	20.2	16.7	2.4	11.4	7.7	103.8	183.4	44.4	54.8	9.5	61.2	65.4	10.1	31.0	8.6	78.2	92.0	10.5	98.9	16.5	29.7	114.1	18.4	223.6	11.9	22.7	5.3	4.4	3.1	11.7	9.0	1.4	0.2	5.6	39.0	10.7	24.7	6.3	2.7	15.0	11.2	11.2	12.5	15.1	10.6	12.9	12.5	12.0	12.5	11.4	15.5	11.9	26.2	9.6	11.5	12.7	13.3	7.8	11.9	45.6	0.6	15.0	24.1	8.9	7.3	28.6	48.5	16.5	2.1	44.0	18.3	30.2	31.3	31.2	6.3	26.3	19.9	17.2	12.0	56.6	9.4	57.2	165.7	41.2	25.5	40.0	7.0	12.3	33.9	11.7	35.6	10.1	8.2	67.6	44.7	18.2	14.5	5.2	46.3	37.1	42.7	20.6	34.2	10.6	20.6	6.0	12.2	28.8	20.1	42.2	83.3	55.3	8.5	71.8	49.6	15.7	26.3	10.1	24.1	5.0	5.1	3.3	6.8	125.1	13.6	27.8	28.2	36.7
WIZ	ZNF803	ENSG00000011451	"WIZ zinc finger"	O95785	19	15419978-15449956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: AB_2671308"	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	13.9	13.7	22.2	10.2	18.0	7.5	13.2	11.1	28.2	13.5	8.3	15.8	9.6	18.7	3.6	12.2	13.4	6.6	18.7	21.4	12.2	13.3	12.3	9.9	6.6	14.0	15.4	14.0	19.7	9.3	7.9	6.7	13.7	12.0	3.5	3.6	10.4	10.3	14.4	13.7	10.2	8.3	12.2	9.5	15.8	21.3	17.7	6.6	9.1	7.3	4.0	16.0	11.6	15.7	23.0	13.1	22.6	28.0	32.2	13.4	17.0	23.2	10.8	19.8	13.4	14.1	43.0	18.8	36.7	22.9	12.1	20.3	12.5	17.3	5.0	13.8	21.3	14.6	13.5	11.3	21.2	15.2	19.9	23.8	22.9	14.7	16.4	12.3	18.3	14.4	22.5	16.8	13.8	48.4	30.2	15.9	28.7	23.8	38.2	27.7	10.4	19.9	13.2	18.5	31.0	36.4	20.2	19.5	15.7	8.3	21.4	16.0	29.2	45.4	16.7	36.0	32.0	22.8	15.6	21.2	18.0	19.1	31.5	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.1	0.5	1.0	0.3	0.2	0.1	22.2	18.0	11.1	28.2	21.4	12.2	14.0	15.4	13.7	12.2	17.7	15.7	11.3	12.8	6.9	6.5	4.1	15.8	7.2	7.8	5.7	9.4	16.2	17.8	10.9	8.6	5.6	12.9	0.0	7.1	8.4	8.4	3.9	14.9	9.0	6.3	15.3	14.9	6.7	3.0	3.2	20.0	9.9	10.3	9.2	12.1	1.3	17.3	14.3	14.7	7.8	6.7	3.2	9.0	4.1	11.3	7.2	10.0	15.8	8.7	7.2	3.7	6.7	8.5	2.1	2.0	2.8	19.1	3.9	19.2	3.1	14.1	6.2	5.3	2.5	7.4	13.1	9.5	12.7	34.8	21.9	9.3	20.3	7.4	5.4	16.8	10.0	12.8
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP"	ENSG00000116729	"Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 22.1;neutrophil: 61.7"	"Group enriched"	"Detected in many"	46	"granulocytes: 61.7;monocytes: 22.1"	"Cell line enhanced"	"Detected in many"		"AF22: 392.1;ASC TERT1: 294.1;SuSa: 357.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	36.8	42.9	77.4	21.5	70.8	4.6	36.4	63.6	73.5	46.9	124.7	73.9	23.8	49.1	135.8	62.3	48.7	68.2	63.7	62.0	89.1	92.6	23.4	53.0	13.0	109.4	127.8	76.7	83.6	38.5	16.9	77.3	91.6	71.7	57.4	137.2	32.6	102.0	14.2	45.9	34.0	61.9	101.6	29.7	56.6	23.9	132.2	13.5	22.6	25.2	19.2	64.4	37.8	98.8	11.5	17.3	392.1	0.3	214.0	294.1	228.4	55.6	135.1	75.7	104.0	24.3	26.2	0.2	54.9	16.0	70.7	116.0	89.3	91.7	63.6	0.6	67.8	0.4	45.4	0.2	187.2	0.1	0.9	214.0	60.3	185.3	60.6	77.2	181.0	21.4	0.0	1.0	113.0	1.7	0.3	1.3	17.7	24.7	27.3	0.1	82.2	0.5	13.5	60.3	21.8	46.0	51.0	2.3	67.3	357.0	10.6	1.6	209.7	71.7	56.9	116.9	76.1	26.6	0.8	0.2	165.0	1.8	134.1	0.0	22.1	0.0	0.0	5.4	0.1	0.1	0.0	0.0	0.9	0.1	0.0	0.0	61.7	0.0	0.7	0.3	0.0	4.8	77.4	70.8	63.6	73.5	62.0	89.1	109.4	127.8	91.6	101.6	132.2	98.8	20.9	48.1	34.6	145.3	1.2	42.4	60.1	28.5	95.0	8.9	25.4	61.2	32.6	42.9	41.3	27.6	139.7	134.7	0.9	65.7	9.8	74.3	15.3	110.8	60.1	31.5	9.6	0.0	27.0	60.3	6.7	44.9	28.5	235.3	5.7	4.6	43.5	10.9	24.9	13.5	132.3	24.5	61.1	10.6	11.2	9.4	32.6	14.7	19.6	61.8	18.0	11.8	0.0	59.3	3.7	69.1	27.2	55.3	0.2	31.3	8.9	36.2	81.1	166.4	39.5	15.7	46.4	0.8	1.0	39.7	30.0	55.1	3.2	39.2	38.4	46.8
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752579-911452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 293.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA		92000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	56.7	20.6	190.8	36.4	236.8	54.2	33.5	179.4	166.1	32.8	110.8	22.8	14.4	26.7	30.4	72.1	29.4	27.1	63.8	132.3	161.1	84.0	31.6	44.6	39.2	232.3	238.4	30.1	22.5	51.1	17.0	36.0	217.0	29.7	24.2	87.4	24.0	33.4	79.7	52.0	17.4	36.1	225.4	30.2	27.6	48.3	238.0	61.3	27.7	79.8	46.9	35.8	43.8	293.0	53.9	97.5	131.8	11.3	88.1	80.0	52.2	48.3	61.6	58.2	51.3	59.4	55.7	71.0	16.8	107.8	73.5	39.8	93.8	56.7	84.3	124.7	51.4	169.4	122.2	46.1	66.7	86.9	68.2	64.0	82.1	97.6	164.4	61.6	73.4	68.0	76.4	158.2	77.8	54.1	154.6	15.6	105.8	47.8	24.3	78.0	138.8	20.8	80.6	96.8	35.1	40.7	121.8	82.9	33.6	183.3	86.8	97.2	78.3	67.1	77.3	86.2	70.8	23.8	43.1	103.8	59.4	44.6	53.2	0.7	1.8	1.6	1.9	2.1	1.9	1.7	1.9	2.1	1.4	1.2	1.2	1.9	5.6	1.4	4.7	1.2	3.4	1.6	190.8	236.8	179.4	166.1	132.3	161.1	232.3	238.4	217.0	225.4	238.0	293.0	261.1	102.5	141.6	77.1	65.3	112.8	42.3	38.3	85.4	87.9	50.6	39.5	241.6	50.1	47.1	90.1	150.1	32.5	83.0	27.8	86.1	28.0	29.7	63.0	68.6	106.7	58.7	304.2	182.3	24.4	32.9	58.3	37.2	70.2	52.6	46.2	52.5	71.7	57.3	84.1	165.0	26.3	16.2	121.4	80.8	21.2	61.8	96.7	37.4	114.3	95.7	64.0	61.8	126.7	336.4	41.7	34.8	55.7	76.5	59.0	24.2	21.8	64.6	96.1	13.1	69.6	63.8	186.5	74.6	147.2	136.0	28.5	112.9	33.2	25.8	55.2
WRNIP1	"bA420G6.2, CFAP93, FAP93, FLJ22526, WHIP"	ENSG00000124535	"WRN helicase interacting protein 1"	Q96S55	6	2765393-2786952	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031752, HPA031753"	Enhanced		Approved	Nucleoplasm		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA031752: AB_10603004, HPA031753: AB_2674028"	"unprognostic (5.52e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	23.7	31.1	45.6	22.6	47.0	49.0	28.8	47.8	46.8	29.2	46.2	29.7	23.6	26.7	37.1	48.3	35.6	24.6	39.5	47.8	46.7	35.7	33.0	30.3	34.7	44.4	44.8	30.1	43.9	46.4	43.1	43.3	43.5	28.5	29.1	45.8	46.1	26.8	44.0	37.2	27.4	23.8	43.6	28.7	29.1	31.5	47.4	43.9	39.0	76.3	34.7	32.1	31.7	45.1	86.8	42.7	42.5	70.1	44.1	37.7	56.5	38.9	54.2	69.8	69.2	67.8	39.4	77.4	103.1	50.4	75.6	65.9	70.2	78.1	67.8	77.9	77.5	80.9	50.3	107.4	50.1	51.4	53.8	38.7	62.7	64.4	69.5	48.5	89.8	71.8	62.8	27.2	51.6	84.5	76.7	92.7	36.5	59.3	52.5	60.3	62.2	78.4	75.3	52.5	127.8	36.5	45.9	46.1	93.7	66.7	59.4	57.1	49.4	52.1	39.4	45.8	95.8	34.8	65.3	59.8	20.4	55.0	72.1	9.4	1.6	2.3	4.0	1.8	1.2	2.3	2.7	2.8	1.3	1.3	3.1	3.0	0.7	2.6	0.9	2.6	4.2	1.4	45.6	47.0	47.8	46.8	47.8	46.7	44.4	44.8	43.5	43.6	47.4	45.1	16.4	19.2	14.6	14.0	12.4	32.5	13.4	20.1	23.9	24.8	22.3	19.4	23.7	24.3	12.3	11.0	8.4	30.4	11.8	29.6	3.9	14.5	45.0	21.9	19.7	20.9	39.7	26.1	23.5	13.5	25.6	15.1	11.7	17.5	9.5	12.7	28.2	25.0	12.4	8.4	20.8	21.2	24.4	16.2	17.9	13.4	22.4	12.4	21.4	23.4	15.0	20.0	10.3	26.2	23.0	18.0	16.3	22.2	10.2	18.5	14.8	13.7	24.1	17.4	6.6	19.9	17.8	22.1	23.9	32.4	32.1	25.4	12.5	20.5	25.0	16.3
WWC2	"BOMB, FLJ22029"	ENSG00000151718	"WW and C2 domain containing 2"	Q6AWC2	4	183099257-183320777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 262.8;Microglial cells: 129.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 84.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044005	Uncertain		Approved	Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Microtubules		"HPA044005: AB_10960552"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (7.16e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (3.27e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.52e-2)"	9.0	5.5	4.7	4.6	5.9	0.6	7.8	5.5	4.4	7.7	10.0	5.0	2.0	8.9	3.3	5.2	6.9	6.9	12.1	4.4	4.4	18.8	19.2	28.2	2.3	7.3	5.8	11.5	12.6	9.7	1.8	14.5	6.3	7.9	2.9	21.3	6.1	8.8	4.2	4.1	2.1	9.9	6.6	6.3	6.8	15.5	5.4	1.0	15.9	5.5	2.2	6.2	3.8	7.7	26.0	10.9	23.1	20.7	16.9	18.8	26.7	34.5	27.1	37.2	26.6	48.2	24.7	0.0	16.9	55.7	13.0	9.2	35.7	14.3	46.9	0.0	11.0	26.3	25.4	24.9	17.5	12.5	27.6	14.3	10.7	24.6	22.9	30.8	25.1	3.7	18.9	1.4	28.6	7.5	0.0	8.3	22.0	0.7	9.3	0.0	21.1	14.0	52.7	6.9	1.5	11.7	84.2	72.7	11.1	36.5	17.6	4.2	37.8	13.8	38.2	8.2	25.1	0.0	0.0	0.3	13.5	5.7	24.7	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	4.7	5.9	5.5	4.4	4.4	4.4	7.3	5.8	6.3	6.6	5.4	7.7	27.8	262.8	65.4	23.2	0.4	24.0	9.3	6.3	8.6	5.4	15.0	11.4	30.0	37.1	24.0	7.3	64.6	15.4	1.4	0.7	27.4	16.3	36.9	26.7	26.6	27.4	1.2	3.6	62.1	14.6	9.8	25.0	9.2	35.4	19.0	39.5	17.2	39.0	10.5	0.0	98.1	0.2	4.1	15.6	7.7	26.9	17.7	9.0	12.4	129.3	7.6	11.7	0.0	52.3	44.0	30.3	0.1	21.1	0.8	29.3	0.0	24.7	11.5	58.6	26.3	34.2	24.2	41.8	19.7	7.7	15.3	6.6	3.2	19.9	0.4	12.2
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342547-86478420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 171.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	33.6	22.1	16.3	25.8	21.5	18.2	40.6	19.6	16.3	23.6	24.3	26.9	26.3	23.0	24.6	33.1	18.5	45.3	50.8	14.3	20.7	40.9	111.7	27.2	39.0	18.3	19.0	24.7	28.0	116.3	9.8	36.9	19.7	33.4	33.1	43.2	25.9	25.6	171.4	40.8	28.1	24.6	18.1	45.7	34.3	29.5	19.5	22.7	32.6	122.2	30.6	33.7	15.8	23.1	59.8	27.1	18.3	13.1	23.0	22.4	16.3	21.0	22.5	16.5	19.5	18.9	35.3	24.9	14.0	36.5	22.9	49.3	26.4	34.1	28.5	31.6	21.0	28.7	24.4	44.7	16.8	11.7	14.0	20.5	42.5	18.2	33.3	25.3	74.1	29.0	14.3	28.7	28.4	29.6	27.7	8.1	11.2	82.6	30.0	18.0	21.4	22.5	37.3	44.5	5.5	12.9	21.2	104.7	23.0	39.8	31.3	10.8	84.4	23.9	28.7	26.3	10.7	33.9	22.0	25.7	29.9	1.6	19.0	6.2	2.1	3.9	5.2	1.9	4.6	2.7	6.4	5.3	1.5	2.4	7.5	4.7	1.3	2.4	2.2	1.9	6.5	2.0	16.3	21.5	19.6	16.3	14.3	20.7	18.3	19.0	19.7	18.1	19.5	23.1	51.2	25.6	22.6	29.0	13.0	35.8	26.9	15.4	26.7	28.8	41.7	23.5	82.7	44.3	19.2	29.5	58.4	28.3	19.5	23.7	43.0	20.5	42.1	22.6	20.1	32.3	23.6	3.0	55.3	37.6	3.3	27.6	35.2	35.5	3.8	18.0	62.4	88.8	55.9	40.4	134.6	25.3	14.2	95.2	28.1	12.7	32.3	43.0	30.2	61.8	18.6	23.3	18.6	60.3	103.8	45.1	16.0	36.5	18.5	45.1	15.8	45.7	17.2	52.6	6.6	18.8	16.6	12.4	21.2	28.8	39.5	23.0	32.0	25.1	19.7	38.3
WWTR1	"DKFZp586I1419, TAZ"	ENSG00000018408	"WW domain containing transcription regulator 1"	Q9GZV5	3	149517235-149736714	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 229.3;Endothelial cells: 221.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007415, CAB017483, CAB068248"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602"	"unprognostic (1.85e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.01e-3)"	41.6	13.8	19.2	22.4	20.8	0.2	37.2	18.9	19.6	41.8	32.6	74.9	8.0	42.1	13.4	35.8	33.7	39.6	36.4	20.7	53.9	45.9	19.0	41.2	7.2	52.6	39.9	43.9	31.8	14.1	13.6	44.0	35.9	34.5	13.5	4.2	27.6	32.1	13.2	24.8	21.6	43.7	37.1	19.5	32.7	7.2	23.0	4.7	31.6	15.0	6.1	59.2	34.3	41.0	58.9	80.5	40.6	48.7	48.6	86.8	43.0	32.6	57.5	17.7	17.8	46.7	53.2	0.1	212.1	45.0	53.3	36.1	28.4	28.5	17.9	22.0	19.3	0.0	18.6	37.8	27.3	0.0	0.1	45.3	7.4	61.8	26.6	65.4	136.3	0.0	0.0	0.2	61.7	9.2	0.2	0.2	8.2	0.2	96.6	0.0	50.6	0.4	151.1	9.4	0.0	0.4	21.1	17.2	160.2	31.5	26.5	1.6	94.2	29.0	16.2	24.8	67.4	0.6	0.5	0.8	66.8	0.1	78.8	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.1	19.2	20.8	18.9	19.6	20.7	53.9	52.6	39.9	35.9	37.1	23.0	41.0	125.7	64.1	89.7	60.4	1.1	51.7	229.3	34.6	60.9	2.2	58.1	56.8	46.8	141.5	87.8	49.7	4.2	12.2	2.0	0.5	7.9	72.0	21.9	136.3	89.1	221.2	0.0	3.2	8.7	27.1	82.3	77.9	10.2	144.4	7.6	45.0	111.4	21.9	4.1	0.0	6.1	1.2	10.2	6.0	32.3	7.9	57.8	4.6	30.2	94.6	2.1	11.0	0.0	7.5	12.7	45.8	0.0	126.4	2.9	86.7	1.2	59.8	53.9	2.0	59.2	76.1	58.0	2.2	0.8	46.3	35.5	14.8	6.5	48.4	2.4	93.5
XAF1	"BIRC4BP, HSXIAPAF1, XIAPAF1"	ENSG00000132530	"XIAP associated factor 1"	Q6GPH4	17	6755447-6775647	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 174.2;Endothelial cells: 90.4;Microglial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 81.8;BJ hTERT+ SV40 Large T+ RasG12V: 83.8;HHSteC: 35.3"	"Low region specificity"	"Detected in all"							HPA057302	Approved		Supported	Nucleoplasm,Mitochondria		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Mitochondria"		"HPA057302: AB_2683405"	"unprognostic (6.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.09e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.08e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.73e-7)"	"unprognostic (2.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.15e-3)"	31.9	12.8	28.3	29.7	29.8	33.4	24.2	27.7	39.6	42.3	23.8	17.5	26.8	26.5	13.0	17.0	22.5	34.0	30.9	27.5	29.2	23.5	63.6	35.8	29.7	37.5	28.4	52.9	2.9	2.9	14.3	25.9	30.8	24.9	16.8	4.8	47.6	11.2	14.1	18.4	25.4	24.3	31.9	63.4	23.6	9.2	31.5	23.8	18.2	13.5	15.5	17.3	22.1	27.5	5.2	0.3	0.7	1.4	6.7	15.1	0.7	7.1	26.3	81.8	83.8	0.7	7.5	1.3	2.0	10.2	28.9	3.1	0.0	1.3	9.3	11.4	0.3	1.9	0.9	1.0	35.3	1.2	8.0	6.9	0.0	11.3	0.3	0.4	6.9	25.5	0.7	26.1	2.6	0.4	6.3	22.1	0.6	0.2	2.2	11.3	0.4	0.5	0.2	4.9	0.5	0.6	3.6	0.5	14.3	0.6	0.8	30.4	0.7	1.1	0.8	2.3	0.5	3.9	1.4	0.5	2.6	18.4	2.2	17.4	9.6	4.3	7.8	12.7	5.7	3.6	6.0	5.6	8.0	4.6	3.8	4.0	10.6	8.0	12.5	0.8	9.9	5.6	28.3	29.8	27.7	39.6	27.5	29.2	37.5	28.4	30.8	31.9	31.5	27.5	174.2	60.9	29.9	14.0	25.7	5.2	5.7	5.5	13.1	0.5	4.1	10.3	2.7	8.6	30.0	0.0	0.0	0.4	37.1	12.4	0.0	1.3	4.0	18.9	68.4	90.4	1.8	10.7	0.3	1.9	5.1	29.8	27.5	10.4	48.7	44.4	33.5	20.1	15.9	0.0	0.3	9.2	0.0	21.3	11.2	2.6	36.4	54.4	5.4	103.0	44.5	1.1	70.0	1.5	0.6	10.1	2.7	27.4	11.4	2.5	11.4	0.3	24.3	0.4	19.7	27.3	19.0	0.2	0.8	11.8	2.7	0.4	35.1	47.3	9.2	5.6
XAGE5	"CT12.5, GAGED5, XAGE-5"	ENSG00000171405	"X antigen family member 5"	Q8WWM1	X	52812204-52818301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Spermatocytes: 3.8;Spermatogonia: 9.0;Syncytiotrophoblasts: 1.9"	"Cancer enriched"	"Detected in single"	4	"liver cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"U-2 OS: 22.0"									"HPA052507, HPA055941"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA052507: AB_2681855, HPA055941: AB_2682978"															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414742	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 42.2;intestine: 49.5;liver: 68.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 262.1;Distal enterocytes: 143.5;Hepatocytes: 46.9;Paneth cells: 48.8;Proximal enterocytes: 96.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 8.2;HBEC3-KT: 20.0;hTERT-HME1: 31.0;U-251 MG: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		77000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (8.73e-6)"	0.2	0.0	0.0	4.8	0.0	0.1	42.2	0.3	0.0	0.3	0.4	11.1	44.9	0.9	2.3	9.8	0.1	4.5	0.0	0.0	0.0	0.2	68.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.1	1.3	9.5	0.1	3.6	0.1	0.5	1.1	49.5	0.7	0.0	0.0	3.2	0.1	0.0	0.2	0.3	0.0	2.3	2.7	2.0	0.1	2.0	0.4	0.0	0.0	0.0	0.1	0.1	8.2	4.7	1.0	1.4	0.3	2.3	0.1	1.6	0.3	0.8	4.2	0.0	20.0	1.0	1.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	1.8	1.1	31.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.4	1.2	0.2	0.0	1.4	4.5	5.7	5.2	0.0	0.1	0.1	0.3	0.0	1.7	0.0	0.0	0.0	3.8	2.4	0.2	8.9	2.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	2.4	0.0	0.2	0.5	6.0	5.5	2.8	0.3	262.1	6.5	0.4	2.8	3.6	0.0	0.0	0.3	1.1	143.5	0.0	3.9	0.3	7.9	2.8	0.3	11.9	0.0	0.2	8.2	0.6	0.2	2.0	37.0	0.0	0.0	1.4	46.9	0.0	0.0	0.2	8.4	2.0	1.9	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	48.8	0.0	0.0	2.2	96.8	0.0	1.0	0.7	0.0	0.3	0.7	0.0	0.2	1.2	0.1	0.4	0.7	0.2	22.2	16.9
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685791-37732130	"Blood group antigen proteins, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;intestine: 12.2;stomach 1: 11.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 26.7;Erythroid cells: 63.5;Gastric mucus-secreting cells: 17.9;Proximal enterocytes: 21.5;Undifferentiated cells: 14.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 6.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	53	"basophil: 10.2;eosinophil: 5.8"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"HEL: 44.4;HL-60: 23.2;K-562: 29.1;NB-4: 21.1;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.2	2.1	2.5	1.4	2.5	14.2	0.7	2.3	3.0	1.2	0.2	12.2	10.8	0.7	0.5	2.0	3.8	0.9	4.3	3.2	4.9	0.9	0.8	1.0	0.2	1.6	0.9	0.7	4.9	0.7	1.3	0.7	2.0	1.5	11.2	2.1	1.2	0.9	5.4	0.7	10.6	1.8	0.5	0.5	11.5	1.4	2.8	0.2	0.9	5.8	0.5	1.1	0.8	1.4	17.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	14.7	0.3	0.0	0.8	2.7	15.4	0.1	0.0	0.0	4.2	44.4	2.4	0.0	0.0	23.2	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	29.1	10.9	0.1	1.7	0.2	21.1	5.5	0.7	5.6	0.0	0.0	20.2	0.0	1.1	4.1	0.1	0.8	1.4	0.1	0.9	2.1	5.6	0.0	0.0	0.8	0.0	2.4	9.3	16.5	0.0	0.2	12.1	0.1	10.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	2.5	2.5	2.3	3.0	3.2	4.9	1.6	0.9	2.0	0.5	2.8	1.4	0.0	0.0	1.1	2.6	0.8	0.4	0.4	0.1	1.2	0.7	1.1	0.8	7.9	0.0	0.1	0.0	6.2	0.3	0.1	26.7	0.0	0.0	1.2	4.0	0.1	0.3	6.1	63.5	11.0	3.1	0.1	0.6	17.9	0.9	0.0	0.1	0.0	0.9	0.1	3.3	12.6	10.9	2.0	0.3	0.0	0.4	0.0	0.2	1.8	1.9	0.0	0.0	0.0	4.5	1.2	1.1	9.2	0.7	2.2	0.9	21.5	0.1	1.7	1.4	0.0	0.7	1.3	10.2	6.1	3.8	1.1	0.0	0.3	0.1	14.7	1.5
XPA	"XP1, XPAC"	ENSG00000136936	"XPA, DNA damage recognition and repair factor"	P23025	9	97674909-97697340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000155, HPA056856"	Supported		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"CAB000155: , HPA056856: AB_2683258"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.55e-3)"	"prognostic favorable (4.28e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.17e-1)"	15.1	13.4	9.9	9.5	10.3	9.1	13.4	12.0	15.4	13.9	10.8	23.0	15.8	14.0	11.0	14.9	13.1	9.7	9.9	9.7	10.8	18.4	18.8	11.3	14.0	10.2	10.0	13.0	11.8	18.7	9.9	9.7	9.8	14.8	9.9	10.6	12.5	12.7	19.5	12.5	13.1	12.0	9.7	12.5	21.6	5.2	10.7	11.0	23.6	8.6	17.2	15.4	13.5	10.6	35.5	8.2	11.9	14.8	14.3	13.7	8.2	9.4	14.9	16.9	11.4	21.4	28.9	19.9	8.9	10.5	11.3	17.4	9.6	11.4	14.1	13.7	19.2	15.7	17.7	12.0	15.5	18.7	18.2	12.0	12.0	7.9	8.0	11.4	19.1	16.1	22.0	15.2	9.4	11.0	24.4	22.5	8.2	33.5	13.5	24.6	25.4	17.0	27.0	13.7	16.7	16.7	13.4	10.3	12.7	9.0	14.9	11.1	12.0	5.9	14.8	23.4	20.6	26.5	22.7	12.3	14.6	13.2	11.8	12.8	21.6	22.6	25.5	23.0	30.1	34.4	27.9	25.0	23.0	40.5	33.5	29.0	2.6	35.2	29.7	39.8	33.1	19.6	9.9	10.3	12.0	15.4	9.7	10.8	10.2	10.0	9.8	9.7	10.7	10.6	32.4	25.6	37.8	49.0	36.1	17.3	23.3	39.3	31.9	101.4	24.8	31.9	36.2	45.8	39.7	22.0	81.3	32.1	47.2	10.6	121.3	36.3	1.7	22.5	29.1	30.4	22.3	11.1	49.3	38.3	9.7	31.3	22.4	17.2	30.9	28.0	28.2	48.7	36.0	84.1	63.5	24.6	30.5	27.7	20.7	4.0	44.1	24.5	14.2	40.3	49.6	87.0	64.9	74.9	96.0	29.3	19.2	47.4	26.2	18.9	32.1	55.5	28.6	97.5	32.9	38.3	39.4	18.2	17.9	28.5	18.8	14.0	34.9	36.4	24.2	23.5
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178621	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167"	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favorable (2.46e-4)"	22.9	17.2	14.3	16.4	17.3	10.2	22.9	15.6	14.6	27.2	15.2	20.1	19.0	24.9	17.6	16.1	25.3	16.6	13.1	12.9	17.3	24.8	24.2	20.7	24.5	16.8	17.4	34.6	21.6	24.0	25.8	15.6	17.4	22.9	15.6	15.2	18.5	23.6	21.3	31.9	24.0	17.5	15.2	24.2	17.4	12.4	16.0	21.2	26.7	9.8	21.7	22.9	20.3	18.3	14.3	33.8	36.7	22.6	51.0	35.8	124.8	33.6	88.7	29.9	22.3	11.8	14.7	46.6	14.5	37.5	14.7	15.6	23.6	49.3	23.6	21.5	24.7	24.9	35.7	21.7	45.0	16.8	42.2	50.1	56.4	39.7	77.4	34.2	34.5	19.0	31.2	22.5	32.5	27.2	17.9	16.3	23.5	20.4	21.2	19.3	17.9	33.7	36.2	36.9	8.8	29.9	36.1	27.2	23.5	54.6	29.9	13.8	57.1	11.2	32.1	18.4	15.4	54.5	46.4	25.4	26.5	19.4	41.6	41.4	20.2	26.8	23.2	16.6	22.7	27.1	26.7	23.5	17.9	25.0	28.3	20.8	73.1	24.3	23.3	17.4	24.7	16.9	14.3	17.3	15.6	14.6	12.9	17.3	16.8	17.4	17.4	15.2	16.0	18.3	26.0	60.9	63.2	16.6	39.9	13.8	20.4	25.5	59.2	35.6	19.0	25.9	11.8	31.5	47.7	16.5	39.6	42.5	38.9	13.4	35.2	19.3	2.3	32.2	44.8	29.9	16.3	20.8	18.0	19.2	20.3	29.2	15.3	25.5	47.4	25.0	22.9	40.5	18.2	26.9	22.0	13.9	20.3	23.9	14.9	2.7	30.7	19.6	8.8	15.0	40.1	24.9	54.6	17.1	27.5	19.5	15.0	28.2	29.1	18.9	32.7	66.1	55.0	51.0	26.3	43.3	27.7	28.7	54.9	21.4	11.1	32.0	42.3	26.3	18.1	10.5
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097976-28211965	"Metabolic proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 202.1"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 202.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (8.80e-4)"	48.0	48.3	70.0	55.9	73.7	92.0	39.9	61.7	87.0	43.7	63.9	47.0	21.8	42.3	18.8	57.0	44.8	24.5	36.2	72.2	72.0	47.2	62.1	70.9	62.9	76.1	69.2	36.6	43.2	26.9	56.6	25.7	73.6	48.6	27.4	35.2	44.9	20.1	29.9	52.9	63.0	26.8	67.8	160.6	42.8	100.3	72.9	51.1	50.5	13.7	44.9	44.9	46.0	77.8	82.9	63.3	54.8	58.8	37.2	58.8	57.9	97.0	98.0	124.8	124.8	89.1	61.7	59.8	78.6	99.8	63.3	53.8	131.6	83.9	151.5	115.3	72.1	67.6	90.0	101.6	87.9	95.4	70.8	46.3	61.2	111.1	108.9	53.5	73.1	63.4	118.0	31.0	86.0	101.1	116.2	116.1	88.1	43.6	55.4	101.0	64.3	101.2	46.8	45.2	103.3	55.0	52.9	88.3	47.8	60.8	62.7	63.3	75.4	104.1	64.4	87.2	84.8	63.0	83.8	89.8	78.7	98.4	89.1	21.1	9.9	32.9	14.2	11.4	15.4	20.7	16.5	15.8	7.3	15.7	18.1	22.6	202.1	10.7	17.6	9.5	14.7	8.4	70.0	73.7	61.7	87.0	72.2	72.0	76.1	69.2	73.6	67.8	72.9	77.8	9.6	9.6	14.2	27.4	20.2	18.6	11.4	12.6	5.2	20.8	15.0	14.6	8.0	5.7	12.6	23.9	31.3	11.5	30.2	28.5	7.9	14.1	39.2	12.7	21.5	11.6	23.5	10.3	51.2	19.2	17.3	13.3	12.2	32.8	2.5	34.6	9.3	16.7	23.4	21.9	55.4	20.6	10.2	27.9	15.8	44.8	10.8	22.6	7.2	43.1	28.6	8.3	23.7	59.3	90.3	23.4	13.5	8.6	16.5	22.4	13.3	7.1	10.3	28.1	6.6	13.5	12.2	31.6	26.5	18.0	21.3	8.3	27.0	9.5	21.2	15.4
XRCC1	RCC	ENSG00000073050	"X-ray repair cross complementing 1"	P18887	19	43543311-43580473	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005427, HPA006717"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"CAB005427: AB_2215661, HPA006717: AB_1858896"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.07e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.69e-2)"	18.5	16.4	15.3	18.0	15.6	24.4	17.9	18.5	17.1	23.6	13.5	20.4	14.6	23.5	16.2	16.1	23.2	14.4	15.5	14.6	15.6	15.7	10.8	16.2	22.9	15.7	15.2	32.0	19.6	17.6	32.3	16.6	14.0	16.2	11.4	16.7	16.3	15.6	19.5	21.0	15.7	17.3	13.5	20.1	18.5	23.9	16.6	29.0	20.6	15.7	20.9	18.6	18.0	15.6	57.4	51.4	54.4	48.2	23.6	24.6	27.0	28.4	36.0	42.5	46.3	32.0	40.4	44.1	39.1	28.9	39.1	30.0	33.2	36.8	24.7	46.4	33.9	57.5	49.4	36.1	23.2	34.5	42.9	27.3	24.8	53.5	26.4	48.8	37.2	49.1	35.9	42.5	37.3	48.9	57.5	52.5	18.5	44.2	21.3	57.0	35.4	25.8	34.3	44.1	44.5	26.5	41.6	35.3	20.7	26.8	33.9	67.4	23.3	55.7	40.4	16.3	39.9	44.2	44.2	32.0	42.8	28.0	58.7	18.6	13.1	15.6	10.8	11.9	12.3	11.7	13.8	14.6	11.6	10.5	11.3	10.9	15.1	10.4	7.9	9.1	14.5	11.7	15.3	15.6	18.5	17.1	14.6	15.6	15.7	15.2	14.0	13.5	16.6	15.6	10.2	16.0	9.8	5.9	13.4	6.1	7.1	17.5	12.5	12.6	10.2	9.0	7.6	7.2	14.7	7.3	6.2	29.8	12.5	9.1	19.6	15.4	32.2	18.7	13.3	12.2	13.7	15.4	8.2	11.6	19.2	13.3	8.2	13.7	19.7	22.0	11.4	7.1	21.0	5.0	9.2	15.3	10.2	18.0	10.1	19.5	10.2	12.6	14.2	3.7	14.3	8.6	8.2	4.5	8.1	12.2	9.7	12.8	17.7	4.1	9.2	16.9	39.0	12.7	6.6	9.6	17.7	21.4	14.1	10.8	7.1	20.0	14.6	16.4	13.7	4.7
XRCC3		ENSG00000126215	"X-ray repair cross complementing 3"	O43542	14	103697609-103715504	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA062422, HPA068953"			Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA062422: AB_2684757, HPA068953: AB_2686062"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (6.75e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.53e-4)"	"unprognostic (2.93e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.52e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.72e-2)"	9.8	6.0	8.7	8.7	12.5	31.9	9.3	7.2	10.3	13.7	11.9	11.1	6.9	10.4	1.7	13.9	10.9	6.6	8.3	6.6	5.8	7.9	7.7	12.1	15.4	13.6	9.7	12.7	9.8	1.7	8.6	5.2	9.7	13.4	7.5	4.5	12.7	3.3	12.4	39.0	12.6	2.8	7.7	21.3	9.1	13.8	9.7	10.0	10.5	2.5	11.0	9.6	12.4	14.3	32.4	58.4	31.5	38.5	2.8	7.9	57.0	35.5	11.6	48.9	52.3	32.4	50.3	51.8	29.5	7.5	38.4	50.3	34.6	52.4	29.9	31.3	36.1	50.6	31.6	30.4	4.9	45.3	30.8	6.0	5.2	43.2	26.7	10.4	20.2	51.3	31.8	30.4	25.2	70.7	79.6	35.8	26.4	47.1	42.0	63.7	45.7	19.8	10.5	44.2	31.1	25.7	41.3	21.7	14.3	17.4	34.6	35.0	17.5	25.1	28.9	80.0	38.8	26.2	25.8	63.7	15.6	36.9	38.4	0.7	0.5	0.9	1.0	0.9	1.0	1.1	0.8	0.8	0.5	0.9	0.8	0.5	0.3	0.7	0.7	0.4	0.6	1.3	8.7	12.5	7.2	10.3	6.6	5.8	13.6	9.7	9.7	7.7	9.7	14.3	2.2	0.0	0.0	2.6	2.5	1.5	1.9	2.1	1.8	1.7	3.2	3.6	0.2	2.8	2.5	0.0	2.1	10.2	1.8	6.9	1.9	1.5	0.7	1.9	2.2	2.0	1.2	7.4	2.6	1.8	6.1	1.2	0.5	2.0	0.0	4.7	0.4	0.3	4.4	3.3	1.0	7.4	0.0	0.0	2.0	1.8	0.3	1.5	0.0	1.0	1.5	1.7	2.1	1.5	1.4	1.7	2.6	1.2	4.4	1.6	0.7	0.2	1.7	2.3	0.0	2.6	1.2	3.1	5.8	2.8	1.3	3.1	2.0	4.2	8.3	1.2
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621163-41664048	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 579.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm		No	No		700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716"	"unprognostic (5.55e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.95e-2)"	143.7	183.4	84.9	153.4	89.3	218.2	143.3	87.8	100.8	152.1	87.2	159.5	136.8	153.8	111.3	192.1	151.4	105.5	176.1	89.2	94.7	136.9	142.4	133.2	196.6	89.5	86.8	169.8	119.0	156.5	122.6	155.0	92.2	132.7	164.9	115.6	130.8	144.4	273.0	168.3	142.8	161.0	93.5	143.1	138.6	231.2	87.9	224.1	137.8	184.3	222.2	162.6	142.0	96.4	554.6	388.0	527.9	455.5	313.5	279.5	413.8	394.7	464.6	794.9	656.4	570.4	335.7	886.2	319.8	478.1	357.4	400.6	739.2	486.8	803.2	493.4	921.2	478.8	435.2	559.5	281.5	1142.2	520.5	252.7	323.1	501.2	275.0	319.8	505.6	371.6	470.2	360.1	523.1	589.9	589.0	390.6	482.1	1138.4	452.1	660.0	562.3	695.6	440.4	404.4	243.3	174.6	644.1	328.2	455.7	392.9	382.2	439.0	366.2	394.3	546.2	354.0	522.4	354.0	671.9	896.1	369.4	441.3	476.4	146.0	264.3	227.6	243.6	296.5	258.4	256.5	269.5	269.2	324.1	246.9	293.2	262.5	69.2	253.2	307.0	191.7	325.9	600.8	84.9	89.3	87.8	100.8	89.2	94.7	89.5	86.8	92.2	93.5	87.9	96.4	96.6	96.1	142.5	18.6	132.6	124.0	201.0	219.0	83.1	107.1	80.1	83.4	89.4	115.8	160.4	82.8	62.6	422.3	104.9	97.3	166.3	205.4	119.6	86.1	87.0	117.0	98.6	125.4	24.5	182.7	317.2	123.9	73.4	105.9	119.7	156.4	70.3	103.7	170.2	87.5	29.5	114.7	166.8	98.1	116.7	62.9	126.8	110.4	88.9	17.8	182.8	149.7	89.6	26.2	30.5	150.9	106.6	126.7	116.0	112.0	113.7	140.3	112.6	103.6	164.3	102.4	127.4	579.8	314.4	91.5	102.1	362.2	136.9	150.6	166.8	137.5
YARS1	"tyrRS, YARS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase 1"	P54577	1	32775237-32817380	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 17.5;Cytotrophoblasts: 41.8;Extravillous trophoblasts: 48.1;Hofbauer cells: 41.0;Syncytiotrophoblasts: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		1400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	24.9	40.3	39.9	35.0	51.2	19.9	21.3	38.1	60.4	20.5	30.1	27.5	26.0	16.9	25.0	34.4	21.6	15.3	22.4	42.1	46.6	20.6	47.7	27.8	38.2	37.5	38.4	15.1	85.6	34.1	14.8	26.2	42.3	18.8	32.4	38.0	29.6	29.0	31.9	26.0	21.6	35.4	38.5	22.0	40.8	31.2	44.2	34.6	42.3	36.6	50.0	34.6	14.0	49.6	157.1	92.1	86.1	194.5	111.2	117.7	91.7	151.0	136.7	133.2	165.0	116.6	103.0	287.5	63.1	173.2	112.7	90.8	269.0	204.4	198.9	122.6	113.9	254.2	117.2	114.2	383.4	202.9	147.3	129.0	252.3	212.7	544.2	98.3	140.9	245.8	291.8	268.7	117.8	107.8	233.0	159.3	149.1	185.3	134.5	198.3	75.2	234.9	109.8	76.5	149.5	94.2	89.0	102.7	300.8	99.2	95.2	247.5	103.6	73.6	135.7	152.1	135.7	242.8	265.2	255.7	184.8	297.7	203.6	56.1	33.3	17.8	59.0	35.2	58.4	23.8	35.4	55.1	45.8	20.3	25.2	39.0	6.9	98.1	35.0	26.9	40.9	51.5	39.9	51.2	38.1	60.4	42.1	46.6	37.5	38.4	42.3	38.5	44.2	49.6	7.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	41.8	11.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	48.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	37.6	1.4	0.0	0.0	0.0
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755897	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	6.1	6.0	4.1	6.5	3.8	7.8	6.6	4.3	4.5	5.9	3.9	5.8	4.8	5.8	5.0	7.1	5.2	4.4	6.2	3.9	3.3	4.8	6.0	4.3	8.1	3.7	3.0	6.1	5.8	6.5	3.7	7.8	4.3	4.6	6.4	4.6	8.1	4.5	7.3	5.4	5.2	5.3	3.1	6.1	5.8	4.6	3.2	7.9	4.6	8.5	8.3	7.4	5.1	4.3	19.8	23.3	13.3	15.8	14.3	16.6	42.0	14.8	15.0	17.9	17.4	58.8	24.6	35.4	23.6	15.0	25.8	24.9	26.7	38.9	20.0	15.5	41.8	23.6	16.4	33.0	20.6	25.3	13.2	15.6	24.4	16.9	30.5	23.0	28.5	18.4	33.7	15.9	19.1	16.1	18.9	30.4	73.5	13.0	28.2	21.0	28.4	21.1	22.9	27.8	20.5	10.0	22.7	19.5	14.7	51.5	36.5	22.7	19.5	16.9	17.7	27.8	25.3	9.4	10.7	37.0	15.7	18.6	14.3	10.2	6.1	3.7	8.4	8.0	8.8	7.3	8.8	8.7	8.5	9.6	9.0	10.5	1.0	11.9	9.6	8.2	8.4	5.1	4.1	3.8	4.3	4.5	3.9	3.3	3.7	3.0	4.3	3.1	3.2	4.3	14.5	6.4	4.4	25.5	16.1	10.1	20.1	27.0	14.2	16.8	11.4	8.4	7.7	1.5	15.1	11.0	20.9	34.7	15.9	5.4	7.9	19.9	6.5	19.7	17.7	10.2	7.2	21.2	22.2	16.5	36.9	12.5	6.6	24.6	7.0	18.9	6.8	5.6	20.1	15.2	31.2	7.3	16.2	9.3	6.0	4.6	10.5	10.4	5.4	18.7	16.0	12.3	16.5	26.7	44.1	14.2	7.6	8.6	9.3	13.9	7.9	11.5	9.0	19.9	13.1	10.5	19.1	6.3	12.8	12.9	8.4	17.9	13.9	24.3	12.8	12.6
YIPF2	"FinGER2, MGC3262"	ENSG00000130733	"Yip1 domain family member 2"	Q9BWQ6	19	10922185-10928681	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019902	Approved		Approved	"Golgi apparatus,Mitochondria"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus, Mitochondria"		"HPA019902: AB_1858925"	"unprognostic (1.27e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.00e-2)"	29.5	43.5	18.1	15.9	18.7	29.6	34.1	20.5	26.6	41.7	30.7	34.7	31.8	38.1	26.8	51.0	35.2	30.3	31.6	19.4	20.3	45.1	56.1	32.8	16.8	22.4	19.6	39.6	114.3	33.4	108.2	38.9	21.0	40.3	15.8	6.5	105.7	23.6	24.8	33.8	29.9	14.2	18.2	27.7	39.2	76.8	19.4	14.3	47.5	10.3	11.2	32.6	39.6	20.4	64.9	22.3	17.5	25.4	40.0	38.9	30.1	48.9	71.6	36.6	52.9	68.1	51.6	12.8	80.2	56.2	16.7	49.8	11.9	47.6	9.5	41.7	43.2	24.2	27.3	39.1	62.1	42.5	49.3	35.7	33.6	24.7	35.4	47.7	26.2	31.1	31.6	69.2	22.9	109.4	27.4	42.7	29.4	44.3	55.2	22.8	14.1	65.3	33.0	30.2	45.4	22.2	35.2	56.4	48.8	15.3	51.7	60.1	39.1	41.6	15.3	60.2	36.7	96.7	42.5	24.2	65.1	72.9	43.9	39.2	18.8	9.3	13.3	21.3	10.4	16.3	10.4	12.3	22.3	9.5	9.3	13.3	3.1	12.1	19.4	34.1	12.6	10.4	18.1	18.7	20.5	26.6	19.4	20.3	22.4	19.6	21.0	18.2	19.4	20.4	20.5	16.0	21.2	2.6	16.0	6.8	41.6	22.4	17.1	19.4	46.9	37.8	0.5	27.1	27.3	35.0	16.7	109.5	20.6	31.9	27.4	69.3	131.1	23.0	20.1	19.2	43.3	17.2	6.4	80.7	114.1	36.0	33.6	29.3	21.6	22.5	22.5	23.0	38.7	18.5	6.7	69.4	14.2	15.3	5.2	34.6	35.1	20.5	5.4	5.6	21.1	23.8	16.5	3.5	3.3	50.3	47.7	25.6	55.4	51.6	52.5	27.0	26.1	16.4	6.6	20.0	21.9	159.1	16.6	22.6	7.0	174.3	13.9	27.9	50.6	50.0
YKT6		ENSG00000106636	"YKT6 v-SNARE homolog"	O15498	7	44200959-44214294	"Metabolic proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030817, HPA030818"	Approved		Approved	Mitochondria,Cytosol		No	No		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	Mitochondria	"HPA030817: AB_10599828, HPA030818: AB_10602102"	"unprognostic (1.25e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.30e-3)"	"unprognostic (7.80e-3)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.66e-3)"	31.6	33.4	52.4	31.7	51.8	36.9	26.4	50.8	52.2	23.5	46.3	34.9	30.5	30.3	38.7	50.1	22.8	19.9	37.8	53.9	57.8	33.7	20.2	27.7	27.6	56.1	62.8	19.5	52.6	34.3	31.7	27.7	60.2	27.2	34.5	16.0	37.6	27.1	49.6	34.3	29.7	35.0	57.2	30.2	40.4	28.4	58.7	38.4	28.8	36.5	34.9	31.2	24.7	56.5	81.9	86.1	71.3	94.8	85.3	72.6	63.1	161.5	130.3	104.5	103.6	93.7	75.9	88.0	71.4	157.7	184.5	94.5	83.1	111.0	140.8	89.4	65.3	53.7	63.1	58.7	105.1	103.4	80.8	66.7	97.6	114.7	123.4	77.5	111.5	75.9	126.2	64.8	125.2	79.4	87.3	106.8	178.8	111.5	120.2	81.9	76.0	68.4	72.2	69.2	94.2	151.6	83.0	126.4	97.8	115.8	100.0	100.4	138.0	112.5	123.9	104.2	199.1	134.5	187.8	130.3	146.2	87.5	219.4	5.6	10.8	18.2	5.3	11.5	7.9	7.1	7.0	9.0	10.0	10.1	5.4	5.4	8.9	5.1	10.6	7.9	7.5	5.5	52.4	51.8	50.8	52.2	53.9	57.8	56.1	62.8	60.2	57.2	58.7	56.5	12.4	12.8	9.4	9.1	16.2	26.0	18.1	14.1	10.2	8.4	21.6	15.4	19.7	7.2	13.7	20.2	10.4	25.3	13.9	45.4	25.4	47.1	25.4	9.4	15.8	19.3	13.8	9.5	7.0	83.0	63.5	18.7	18.8	17.7	1.3	15.1	14.6	15.7	41.2	13.5	6.5	26.6	16.2	19.4	19.3	8.3	9.9	19.5	26.6	1.0	40.2	11.0	23.7	8.0	8.3	79.0	23.3	13.5	38.8	35.8	33.1	23.1	8.7	7.9	0.0	13.1	23.8	18.9	23.0	22.9	25.9	49.3	15.2	11.8	24.0	44.4
YY1	"DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1"	ENSG00000100811	"YY1 transcription factor"	P25490	14	100238298-100282788	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001119, CAB009392"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"CAB009392: AB_2218501, HPA001119: AB_1858930"	"unprognostic (7.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (6.75e-3)"	"unprognostic (8.31e-3)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	27.2	26.2	20.9	28.9	22.1	56.4	27.0	27.0	24.2	24.6	18.5	30.7	27.9	24.8	34.0	28.9	21.7	22.7	22.8	22.7	20.2	32.9	46.8	24.0	36.0	20.4	20.4	21.6	24.4	32.5	17.4	34.2	20.3	25.2	28.7	20.1	25.1	23.6	36.8	29.0	29.7	24.8	20.1	31.9	26.2	23.8	21.5	52.3	37.2	27.2	38.2	31.9	21.0	26.2	62.0	30.7	64.2	51.5	51.8	65.9	68.1	60.0	55.1	64.7	66.0	38.6	97.7	94.0	82.3	54.5	37.1	64.0	72.6	64.1	88.3	70.8	60.9	86.8	34.6	50.0	48.4	103.8	73.2	38.7	76.4	45.4	61.4	58.6	63.9	67.3	69.9	61.8	63.7	74.5	113.5	61.8	68.7	98.0	56.0	93.9	88.9	50.7	75.8	58.3	68.2	53.3	79.2	57.8	85.1	54.0	86.6	100.1	57.4	39.4	48.3	97.6	53.8	68.3	72.0	126.6	56.4	68.6	52.5	4.8	5.7	11.9	4.3	4.8	5.6	5.3	5.7	5.9	4.9	8.3	5.4	5.4	9.8	9.5	3.8	5.3	7.7	2.7	20.9	22.1	27.0	24.2	22.7	20.2	20.4	20.4	20.3	20.1	21.5	26.2	116.0	54.5	66.8	23.8	102.4	238.0	101.1	49.9	211.7	80.5	129.8	98.2	91.5	92.9	50.0	68.0	81.3	118.6	147.4	122.8	72.4	68.7	10.3	118.7	133.8	115.7	110.1	125.4	28.2	82.0	123.6	106.7	58.1	153.6	71.7	99.4	103.5	119.4	81.3	127.9	26.5	108.8	48.8	111.8	225.8	15.7	94.8	121.6	76.5	30.0	117.8	82.0	114.4	20.6	40.7	80.0	95.5	100.8	125.0	168.9	90.0	104.6	47.6	74.9	92.1	106.5	124.3	86.0	67.0	192.1	243.1	175.5	124.8	124.1	118.7	153.5
Z82206.1		ENSG00000225528	"Novel protein similar to translation machinery associated 7 homolog (S. cerevisiae) TMA7"		22	39960397-39964718	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 7.9;granulocytes: 3.8;Proximal tubular cells: 3.2;T-cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"K-562: 12.5"									HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.1	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.1	0.1	0.1	0.0	4.3	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	12.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.1	2.7	2.9	1.3	2.5	2.3	3.5	3.2	1.6	2.0	3.6	4.4	2.4	1.3	1.2	1.7	2.6	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.9	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
Z83844.2		ENSG00000285304	"Novel protein"		22	37639693-37666932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 8.8"	"Not detected"	"Not detected"							"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA000757	Approved		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"		Cytosol		"HPA000757: AB_1079951"																		1.0	0.2	0.1	7.3	0.0	8.8	1.0	0.1	1.4	3.1	0.0	5.9	5.6	1.3	0.0	4.0	1.6	1.3	0.5	0.2	0.1	0.0	0.9	3.4	7.4	0.0	0.0	1.0	0.7	2.6		3.7	0.2	0.9	5.0	0.1	2.1	2.3	0.2	1.7	8.1	2.3	0.1	3.9	1.4	0.7	0.2	6.5	0.5	0.0	6.6	4.2		0.4	14.7	2.1	7.7	5.0	2.3	6.5	8.3	4.1	12.9	15.3	15.8	9.8	3.5	8.4	1.4	4.5	5.1	12.2	9.2	22.3	4.7	10.2	7.0	21.3	0.0	10.7	4.2	33.2	25.5	7.8	9.4	17.7	1.6	6.5	0.9	6.1	5.9	7.5	0.7	13.4	1.2	1.9	7.9	23.9	1.6	12.6	4.9	7.7	1.6	4.5	4.4	7.2	1.1	4.9	8.0	5.4	6.4	14.5	1.5	2.0	7.5	1.2	0.0	12.3	4.7	8.8	5.2	21.5	14.8	0.0	0.6	0.0	0.4	0.3	0.3	0.3	0.2	0.5	0.9	0.2	0.6	0.4	0.0	0.5	0.6	0.4	0.6	0.3	0.1	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZADH2	MGC45594	ENSG00000180011	"Zinc binding alcohol dehydrogenase domain containing 2"	Q8N4Q0	18	75195113-75209139	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021468, HPA053646"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA021468: AB_1858932, HPA053646: AB_2682216"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.79e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.23e-1)"	17.7	12.9	15.6	11.8	17.8	20.7	22.2	19.2	22.0	18.8	14.0	26.3	19.0	15.5	24.8	20.0	17.9	15.8	34.3	17.0	12.9	24.2	32.5	16.3	19.3	16.8	13.9	23.9	26.6	24.7	21.5	36.6	18.3	17.1	28.7	30.6	23.8	18.2	44.9	22.0	26.0	15.2	16.5	16.1	21.3	7.0	15.5	23.3	27.8	40.7	20.6	16.6	16.9	16.8	21.7	14.1	14.8	30.4	22.6	29.0	16.3	38.5	44.6	14.8	18.5	8.7	30.0	15.2	6.0	38.3	17.4	28.7	18.5	32.6	10.4	94.6	27.1	34.1	32.7	17.0	16.0	58.0	33.2	32.2	31.9	11.9	27.2	27.5	30.9	35.2	18.6	54.0	28.6	25.5	14.6	28.6	3.8	20.9	31.9	31.0	23.7	50.2	28.9	36.2	27.2	22.4	21.4	21.7	24.5	10.4	21.8	28.4	27.7	28.9	22.0	9.2	12.4	8.8	41.2	10.5	19.1	49.5	23.8	1.7	3.4	8.9	3.2	2.9	2.3	2.1	2.6	2.9	2.3	1.5	1.4	2.2	1.7	1.7	3.8	1.7	3.2	1.8	15.6	17.8	19.2	22.0	17.0	12.9	16.8	13.9	18.3	16.5	15.5	16.8	41.5	35.3	17.9	12.4	7.5	9.7	18.7	13.9	9.6	59.0	15.3	10.8	56.3	20.0	12.5	27.6	6.2	8.4	15.9	24.8	19.6	12.3	0.5	8.5	39.0	24.1	23.4	9.9	16.6	21.1	8.1	26.4	12.8	11.1	7.0	42.6	23.6	25.0	16.4	25.2	14.1	25.1	14.2	20.2	19.1	2.1	36.7	18.3	12.4	12.2	23.9	21.3	13.4	20.6	14.9	15.5	21.9	63.2	6.2	18.5	35.2	19.0	8.1	40.9	19.7	25.5	12.3	0.4	4.9	23.7	11.1	6.7	11.0	73.0	27.2	20.9
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 47.6;thyroid gland: 71.0"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 44.8"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 54.8;EFO-21: 37.4;HaCaT: 53.1;HBEC3-KT: 119.3;RPTEC TERT1: 77.6"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.2	0.0	0.0	1.7	0.4	0.3	0.2	0.0	0.1	5.4	0.0	0.1	0.1	0.1	0.2	12.8	20.0	0.3	0.1	0.0	0.0	0.2	0.0	10.4	6.9	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.1	0.0	2.8	0.4	0.0	2.2	0.5	0.0	0.0	0.3	0.5	0.0	0.0	47.6	71.0	0.0	12.9	0.4	9.9	0.0	15.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	54.8	0.5	37.4	0.0	0.0	53.1	0.0	119.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	10.8	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	1.2	0.2	0.1	0.0	2.1	0.6	0.8	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	1.1	0.0	0.6	4.5	0.3	3.1	4.6	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	3.8	0.0	4.5	0.0	0.1	0.2
ZBTB11	"ZNF-U69274, ZNF913"	ENSG00000066422	"Zinc finger and BTB domain containing 11"	O95625	3	101648889-101677132	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015328, HPA024138"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015328: AB_1858938, HPA024138: AB_1858939"	"unprognostic (3.25e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.86e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.09e-1)"	7.3	7.2	6.1	10.6	7.0	38.0	10.0	11.8	10.3	8.2	5.9	6.7	8.3	9.8	7.2	7.6	6.8	7.4	5.6	6.9	5.9	7.3	9.6	8.2	13.5	5.6	6.0	10.4	9.6	9.9	5.5	9.2	6.2	8.1	7.6	12.4	9.2	6.7	9.1	12.4	7.2	7.1	6.6	13.1	7.8	10.5	6.3	13.7	8.4	10.0	12.7	8.6	6.8	10.0	14.8	16.5	10.7	14.0	16.7	16.3	18.7	14.4	14.2	13.0	14.3	15.0	10.0	18.1	11.4	11.0	11.6	18.0	16.3	16.4	23.3	18.8	11.3	40.1	15.8	14.1	12.8	28.8	14.2	13.1	20.8	12.1	27.8	11.6	13.0	20.6	23.7	21.2	14.1	18.4	25.5	12.8	10.1	15.7	24.0	20.6	16.7	22.1	12.2	17.4	31.0	11.4	18.7	15.0	19.1	6.5	19.1	15.3	14.7	19.6	14.2	8.2	14.5	24.2	21.7	33.4	12.2	18.6	13.9	6.7	3.7	4.2	3.6	4.6	4.7	2.9	3.1	4.0	4.6	3.8	3.5	3.0	2.4	3.0	7.3	2.7	3.8	2.8	6.1	7.0	11.8	10.3	6.9	5.9	5.6	6.0	6.2	6.6	6.3	10.0	19.0	32.1	20.8	12.7	28.2	46.4	20.0	8.4	51.8	14.2	21.4	17.4	12.1	10.0	19.3	1.8	33.3	10.2	40.3	14.0	0.0	6.6	3.2	44.7	50.4	20.1	20.2	12.4	32.7	5.5	7.5	19.4	15.8	70.2	8.8	13.7	13.2	10.3	7.9	21.9	28.2	14.5	14.2	23.0	24.4	3.9	8.4	25.9	19.6	12.2	20.3	12.0	21.6	15.1	27.6	7.6	4.4	14.3	32.6	18.3	8.2	6.2	20.1	22.8	6.6	25.0	19.1	25.5	21.8	50.0	49.0	16.8	34.1	14.3	14.2	24.1
ZBTB14	"ZFP161, ZNF478"	ENSG00000198081	"Zinc finger and BTB domain containing 14"	O43829	18	5289019-5297053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050758, HPA070819"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA050758: AB_2681226, HPA070819: AB_2686316"	"unprognostic (5.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.72e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.90e-2)"	10.3	8.6	9.3	14.7	10.5	9.6	12.5	11.4	12.2	9.6	7.4	10.4	8.7	9.9	16.4	12.4	10.6	12.0	8.6	8.7	9.6	11.2	13.4	11.1	24.7	9.5	10.3	15.6	14.4	12.0	4.8	9.1	9.6	9.8	10.0	7.3	12.2	12.1	8.5	14.0	9.3	8.7	10.2	16.2	11.9	5.9	9.5	21.8	15.5	8.4	21.8	9.6	5.2	11.4	9.0	11.8	15.1	11.2	11.0	14.5	10.0	8.8	13.0	12.0	10.5	11.3	11.5	31.2	7.6	10.7	13.9	8.2	11.2	13.2	12.2	6.0	6.0	12.4	11.1	10.5	7.8	15.8	14.4	11.6	10.9	8.5	7.9	13.0	19.2	22.3	8.1	10.1	12.4	9.9	23.8	10.5	13.4	11.1	6.0	14.0	9.7	9.2	10.0	10.8	13.3	13.0	13.4	8.8	14.3	15.0	10.5	17.9	10.7	15.6	12.8	12.2	13.3	6.4	6.9	19.9	16.4	13.3	14.0	9.8	5.5	14.1	8.7	7.8	8.6	7.5	11.0	10.0	8.2	10.4	11.6	11.1	1.2	7.6	7.5	6.1	7.6	7.3	9.3	10.5	11.4	12.2	8.7	9.6	9.5	10.3	9.6	10.2	9.5	11.4	8.8	6.4	6.7	5.9	8.5	2.4	1.6	2.9	5.2	7.4	5.6	4.3	3.6	1.5	2.2	5.5	0.0	5.3	6.3	5.5	5.9	4.9	0.8	4.3	5.5	7.4	1.2	9.1	2.9	3.3	5.5	4.6	0.5	3.7	15.9	6.0	11.7	6.9	7.1	5.0	3.1	5.1	8.2	7.5	4.5	2.8	5.9	6.3	1.8	1.0	7.8	10.8	6.2	2.5	6.6	3.5	4.0	5.7	2.2	2.4	5.7	5.5	2.5	5.9	0.0	6.0	5.7	1.0	9.3	4.2	3.0	2.2	8.8	5.1	5.2	1.5
ZBTB20	"DKFZp566F123, DPZF, ODA-8S, ZNF288"	ENSG00000181722	"Zinc finger and BTB domain containing 20"	Q9HC78	3	114314500-115147288	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1998.0;Microglial cells: 855.4;Oligodendrocyte precursor cells: 1908.5;Oligodendrocytes: 2090.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015551, HPA016815"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"		"HPA015551: AB_2669217, HPA016815: AB_1858947"	"unprognostic (1.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.81e-1)"	4.1	3.9	24.5	1.1	43.8	2.5	3.4	66.5	43.7	3.4	5.7	1.7	0.8	3.6	9.6	1.2	2.4	2.3	3.5	65.9	30.9	5.2	5.4	1.8	1.8	43.8	42.6	6.8	3.4	2.3	1.4	1.0	32.9	5.4	1.4	8.5	3.0	4.9	7.9	2.3	0.8	2.9	29.9	2.5	1.7	15.8	39.4	1.9	5.0	8.9	1.7	1.6	0.7	41.1	1.4	2.7	1.0	2.8	4.2	1.8	0.0	1.3	2.5	0.8	0.6	1.7	0.5	0.4	3.7	3.2	0.8	0.0	4.0	0.6	0.7	0.3	0.1	0.4	1.7	1.3	0.8	0.1	0.0	1.8	0.2	1.4	0.4	2.4	0.8	0.2	0.1	0.6	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	3.4	0.0	2.9	0.0	0.3	0.7	0.5	0.0	0.9	0.1	0.0	0.3	4.8	1.0	3.5	0.2	1.8	0.9	0.0	0.1	1.7	0.2	1.3	9.7	1.5	6.4	6.8	2.3	4.6	20.4	6.4	6.4	1.9	11.3	8.3	6.8	3.5	5.3	4.6	4.9	3.6	3.5	24.5	43.8	66.5	43.7	65.9	30.9	43.8	42.6	32.9	29.9	39.4	41.1	278.1	160.3	122.6	1998.0	115.4	25.7	38.2	11.3	22.2	123.6	103.7	81.8	48.5	108.7	25.2	294.3	60.5	0.2	56.1	10.3	49.0	231.4	450.3	109.8	628.3	106.4	31.8	20.4	72.3	82.9	0.6	174.5	36.7	170.5	80.6	194.5	56.0	106.0	4.3	80.8	462.3	14.5	40.7	20.4	28.5	111.1	105.6	36.0	32.0	855.4	29.3	127.7	36.0	1908.5	2090.4	107.8	10.5	120.7	58.4	28.0	19.2	198.4	36.4	108.6	85.5	301.2	124.6	6.9	8.7	14.2	18.5	0.5	67.4	140.7	17.2	25.0
ZBTB22	"BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A"	ENSG00000236104	"Zinc finger and BTB domain containing 22"	O15209	6	33314406-33317942	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043848			Approved	Nucleoplasm		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA043848: AB_10961146"	"unprognostic (1.32e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.54e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.32e-3)"	10.2	15.1	1.2	2.6	1.2	2.1	11.3	1.1	3.5	15.6	0.7	10.4	4.7	15.6	8.5	13.3	12.6	1.7	10.6	1.2	0.9	11.9	10.1	12.0	1.1	2.1	1.3	14.9	12.2	11.6	10.5	2.3	1.4	12.1	4.2	5.7	12.0	3.8	8.6	19.2	11.6	3.0	1.5	13.7	11.8	6.1	1.0	5.3	15.1	3.9	3.9	12.0	13.2	1.4	0.3	0.3	8.5	4.4	8.3	3.3	3.5	7.5	7.3	7.1	4.6	0.1	1.9	1.9	5.6	12.5	9.1	0.6	0.3	4.6	5.2	11.7	2.8	7.5	4.4	4.1	0.0	0.0	2.8	10.8	10.0	0.3	2.6	9.8	0.7	6.3	2.9	7.8	2.6	4.7	4.6	6.7	0.0	0.4	2.2	0.5	0.1	4.2	6.3	0.4	9.7	0.6	0.7	0.4	4.3	5.0	0.7	0.4	10.7	3.9	4.5	0.2	0.2	4.3	4.5	1.9	5.6	1.1	4.3	0.8	0.2	0.8	0.3	0.3	0.1	0.5	0.4	0.2	0.2	0.3	0.7	0.1	0.3	0.1	0.2	0.4	0.1	0.2	1.2	1.2	1.1	3.5	1.2	0.9	2.1	1.3	1.4	1.5	1.0	1.4	9.4	0.0	5.0	2.6	7.3	6.4	16.3	6.0	8.6	20.1	9.9	7.6	4.3	4.3	4.9	7.3	8.4	6.3	3.3	9.8	23.5	11.0	1.6	8.3	5.2	7.7	7.7	4.0	2.8	7.1	4.6	6.7	5.6	6.9	3.8	6.5	7.9	2.0	5.3	20.2	2.8	8.7	12.2	4.4	4.0	1.8	9.3	5.3	1.8	3.7	12.1	18.2	8.2	3.5	2.6	6.5	8.6	6.4	4.0	10.9	7.6	8.3	6.0	21.2	13.1	10.0	7.6	2.2	2.0	8.1	7.4	10.1	4.9	8.0	5.8	11.8
ZBTB24	"BIF1, KIAA0441, PATZ2, ZNF450"	ENSG00000112365	"Zinc finger and BTB domain containing 24"	O43167	6	109462594-109483219	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017872, HPA049003"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Centrosome"		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytokinetic bridge, Centrosome"	"HPA017872: AB_2669673, HPA049003: AB_2680596"	"unprognostic (8.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.77e-2)"	3.1	2.2	1.5	5.4	2.4	8.9	4.6	2.4	2.4	4.0	1.0	3.5	3.6	3.1	3.2	3.0	2.9	2.5	2.2	1.6	1.9	3.9	2.6	3.9	8.7	1.5	1.2	3.4	3.5	7.4	1.8	3.2	1.6	3.5	3.8	10.1	4.4	3.3	3.2	4.7	3.7	2.8	1.3	5.5	4.1	4.3	1.6	6.9	4.9	2.9	7.3	3.5	2.7	2.9	4.7	4.8	4.3	10.8	6.8	6.9	7.0	5.3	7.3	6.5	7.4	6.7	3.6	20.0	6.7	6.7	7.8	6.0	10.9	8.3	9.8	12.4	10.7	16.2	6.5	5.1	5.0	13.3	8.0	7.0	6.7	6.6	11.4	4.6	5.5	9.3	13.8	11.0	6.8	8.0	19.2	9.0	10.7	4.7	5.3	11.9	6.1	8.3	8.0	8.0	7.3	6.4	6.8	7.1	16.9	5.9	5.0	14.5	5.4	5.3	5.3	4.4	11.5	5.3	4.4	20.2	7.0	10.4	9.0	0.1	0.6	0.9	0.7	0.6	0.4	3.4	1.5	0.9	0.7	2.8	1.9	1.1	0.4	1.3	0.8	1.1	2.9	0.5	1.5	2.4	2.4	2.4	1.6	1.9	1.5	1.2	1.6	1.3	1.6	2.9	8.4	12.8	9.1	2.6	32.8	10.1	11.2	5.3	7.4	21.7	8.6	7.4	3.8	7.2	5.2	3.7	31.3	8.5	16.8	4.5	3.9	6.6	1.4	7.3	14.3	6.6	9.6	12.0	3.3	9.1	9.9	8.6	12.8	10.7	9.5	14.1	3.6	7.3	7.7	10.1	2.8	11.0	6.1	12.5	12.1	1.8	7.2	10.3	8.8	5.6	20.5	10.0	14.4	1.0	5.4	6.4	5.1	6.4	16.8	8.2	7.4	6.4	6.0	65.2	0.0	13.2	7.4	6.2	27.8	9.3	9.7	7.8	17.8	15.0	8.5	7.3
ZBTB38	"CIBZ, FLJ35036, PPP1R171, ZNF921"	ENSG00000177311	"Zinc finger and BTB domain containing 38"	Q8NAP3	3	141324213-141449792	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 284.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 261.2;RPMI-8226: 395.1;U-266/70: 259.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014865, HPA059378"			Enhanced	Nucleoplasm		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA014865: AB_2732412, HPA059378: AB_2683998"	"unprognostic (1.78e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.04e-1)"	27.1	42.3	7.7	30.4	14.4	11.3	25.4	34.1	18.1	47.8	11.9	39.1	28.8	65.5	20.3	26.8	32.3	47.3	42.1	9.8	9.6	34.1	24.2	31.7	34.4	11.8	12.8	38.2	33.6	53.5	8.3	34.8	13.9	28.1	40.8	39.0	33.0	33.9	55.1	16.7	31.5	56.0	8.0	23.9	29.2	30.1	14.0	14.3	38.0	31.0	38.7	35.0	11.6	28.3	56.4	82.0	9.3	18.7	84.8	79.4	12.5	89.0	106.7	84.6	122.8	43.0	32.4	1.9	36.1	78.1	65.7	15.5	10.8	75.4	191.5	54.5	15.2	15.8	74.4	25.2	94.0	1.0	22.4	60.1	43.8	89.9	180.6	137.8	65.6	1.5	16.9	261.2	96.9	6.0	1.0	3.5	9.7	15.7	10.1	1.1	27.5	395.1	54.3	34.3	3.6	13.7	130.7	12.4	46.0	16.4	26.8	13.8	159.5	68.5	17.5	134.9	42.2	259.7	163.4	19.8	116.7	1.8	38.5	27.9	5.5	15.2	25.9	8.2	19.3	16.6	16.7	26.4	8.1	7.2	12.9	21.0	6.3	24.1	7.2	3.9	24.4	11.5	7.7	14.4	34.1	18.1	9.8	9.6	11.8	12.8	13.9	8.0	14.0	28.3	70.7	76.9	64.6	38.2	48.0	20.4	33.8	36.3	24.5	89.8	44.0	41.1	114.8	64.3	61.2	58.8	75.0	32.6	66.5	57.8	29.4	39.3	284.2	63.4	107.9	81.2	36.0	17.7	115.4	31.8	17.0	59.3	35.2	125.9	68.9	40.0	59.3	34.9	32.6	141.3	107.9	37.0	24.4	23.4	43.1	118.6	70.5	37.9	39.2	65.6	70.8	59.3	55.6	56.8	105.3	69.6	37.0	103.0	221.9	36.8	38.9	51.1	46.6	73.3	118.3	71.9	106.9	9.4	11.4	19.0	18.6	124.9	88.4	35.6	82.5	43.5
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: AB_2685347"	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	34.8	36.1	22.1	7.4	20.6	3.0	31.4	19.9	23.1	41.9	11.7	47.2	6.3	40.3	16.2	26.4	40.5	9.6	38.8	21.2	21.0	24.1	7.8	30.0	8.3	27.1	21.7	48.4	23.1	36.1	28.6	10.8	27.0	33.1	6.6	23.1	28.0	21.4	32.4	27.2	23.0	16.4	19.7	22.1	27.3	15.9	23.3	9.5	43.9	14.8	9.0	42.3	33.9	21.5	10.7	14.4	3.6	6.9	37.1	19.1	6.5	14.7	21.0	13.0	12.9	4.8	5.1	1.1	11.4	28.0	9.5	16.7	3.6	20.6	9.5	17.0	6.2	5.3	12.3	3.4	10.4	1.0	12.2	13.4	21.1	12.5	15.9	30.6	11.5	4.0	1.8	3.4	14.5	7.1	3.7	2.2	1.5	4.3	6.8	6.8	6.2	1.6	15.9	8.9	2.1	5.3	6.5	4.6	6.9	6.3	8.6	2.4	16.1	14.6	5.7	13.9	12.3	6.1	4.5	0.7	15.7	3.3	7.7	0.4	0.3	0.5	1.0	0.5	1.0	0.5	0.8	0.8	0.2	0.5	1.0	1.0	0.2	0.6	1.7	0.4	0.4	0.6	22.1	20.6	19.9	23.1	21.2	21.0	27.1	21.7	27.0	19.7	23.3	21.5	27.4	51.3	53.1	33.6	14.6	30.7	16.3	18.4	18.8	86.6	23.6	20.6	92.6	20.0	24.8	20.2	68.8	10.3	24.5	4.6	3.9	14.4	40.8	21.1	25.2	26.1	17.4	9.5	36.9	14.4	2.2	24.8	7.1	26.0	13.9	25.7	23.9	8.1	13.5	74.0	37.3	10.1	14.2	30.0	34.6	57.0	51.9	18.6	17.8	15.9	12.0	27.0	24.7	21.6	26.7	19.0	5.3	70.0	9.5	16.2	8.2	11.2	32.2	39.9	32.9	37.8	27.4	7.3	4.3	17.3	23.4	5.2	21.1	16.3	9.0	14.7
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465072-32496686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Langerhans cells: 4.7;Oligodendrocyte precursor cells: 9.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RT4: 1.0"									"HPA055553, HPA071427"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA055553: AB_2682848, HPA071427: "	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.0	0.1	1.6	0.1	1.1	0.4	0.1	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.0	1.9	0.0	0.0	0.0	0.1	1.2	1.9	0.1	0.1	0.1	0.6	0.1	1.1	0.1	0.0	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.2	1.8	0.0	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.9	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.2	0.1	0.0	1.6	1.1	0.8	1.2	1.0	1.9	1.2	1.9	1.1	0.4	1.8	0.8	0.4	0.0	1.8	0.3	0.2	1.7	1.1	0.1	0.0	2.6	0.3	0.5	0.8	0.0	0.7	0.0	6.2	1.9	1.4	0.3	0.0	0.0	2.1	0.5	1.6	0.7	0.0	0.0	0.8	0.0	1.3	0.8	0.0	0.5	3.8	2.8	0.7	0.2	0.4	3.3	2.2	0.0	0.0	0.3	4.7	2.1	0.6	0.7	1.8	1.9	0.0	1.4	1.0	9.0	0.4	0.0	0.0	0.0	0.3	0.9	0.0	0.1	1.5	2.4	0.0	1.6	0.7	2.2	1.5	0.0	0.6	0.3	0.7	0.9	0.0	0.9
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.5;Ionocytes: 6.1;Respiratory ciliated cells: 4.3;Suprabasal keratinocytes: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.6;BEWO: 11.3;GAMG: 16.5;HMC-1: 14.2;U-698: 12.0"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	2.8	3.9	0.9	1.5	1.0	1.7	2.3	0.8	1.6	2.5	8.6	2.4	2.3	2.6	1.7	3.8	2.5	0.6	3.0	1.9	0.7	4.4	3.2	2.4	1.9	1.2	0.9	3.0	2.9	0.6	10.0	0.5	0.6	2.4	1.4	1.9	2.9	0.1	1.8	3.8	2.7	0.8	0.2	3.5	2.7	7.4	0.4	0.2	2.2	1.0	3.3	2.5	2.2	0.9	1.0	0.3	11.6	2.9	2.1	0.1	11.3	0.6	0.2	0.2	0.1	3.0	0.8	2.7	1.8	0.3	16.5	1.2	4.8	2.4	1.3	3.1	2.0	9.0	2.3	0.0	0.0	2.3	14.2	0.5	0.9	3.3	2.6	0.6	0.1	1.5	3.2	1.8	2.6	1.6	0.6	0.9	4.3	0.5	0.7	5.6	3.0	2.7	2.2	2.3	1.8	1.1	3.3	0.3	1.1	1.1	1.6	0.4	1.9	0.9	1.3	1.3	1.2	0.7	3.5	12.0	0.9	2.9	0.3	5.2	1.1	0.4	2.8	0.8	1.2	0.4	1.2	2.6	1.5	0.8	2.5	1.9	0.8	1.3	1.7	0.3	2.2	0.6	0.9	1.0	0.8	1.6	1.9	0.7	1.2	0.9	0.6	0.2	0.4	0.9	0.1	0.0	0.0	1.3	2.1	4.5	0.0	1.9	1.8	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.3	0.4	0.1	0.6	1.8	1.3	1.2	1.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.7	6.1	0.0	1.2	1.1	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.6	0.0	0.2	0.1	4.3	0.0	0.0	0.0	0.7	0.1	0.1	0.8	3.7	0.0	0.7	0.1	1.0	0.0
ZC2HC1C	"C14orf140, FAM164C"	ENSG00000119703	"Zinc finger C2HC-type containing 1C"	Q53FD0	14	75064109-75119502	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 23.9;testis: 55.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 165.2;Late spermatids: 195.1;Spermatocytes: 198.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA050928, HPA065062"	Enhanced		Approved	"Nuclear speckles,Mitochondria"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Mitochondria	"HPA050928: AB_2681277, HPA065062: AB_2732728"	"unprognostic (8.01e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (4.63e-13)"	"unprognostic (4.69e-3)"	"unprognostic (7.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.81e-1)"	1.1	2.5	2.5	0.6	2.7	0.4	1.7	2.8	2.9	1.8	5.1	2.7	3.1	1.3	23.9	1.3	11.0	1.6	5.2	2.4	2.9	5.5	8.4	2.5	0.2	3.1	3.7	0.6	5.1	6.9	6.1	0.8	2.9	1.3	2.4	2.6	2.9	3.4	4.7	1.6	2.4	1.0	2.8	0.8	1.6	55.3	2.9	2.3	7.0	1.5	0.5	1.4	0.6	3.3	3.8	2.8	0.3	3.3	0.2	0.0	1.8	0.3	1.1	1.4	0.8	4.8	6.9	3.3	2.6	0.4	2.6	1.0	0.0	0.0	1.2	3.9	0.3	0.6	1.0	2.3	2.5	0.0	1.8	0.3	0.4	1.6	0.0	1.7	1.1	0.2	5.8	1.0	0.7	0.6	0.4	0.3	0.7	2.4	1.8	0.0	0.2	0.7	4.3	0.3	5.7	1.3	2.4	2.0	1.5	0.6	2.9	0.9	0.7	0.9	0.9	1.0	0.8	4.0	4.9	1.1	1.4	0.4	0.6	0.3	0.0	0.2	0.6	0.0	0.1	0.4	0.3	0.1	0.1	0.2	0.1	0.1	0.1	1.2	0.1	0.2	0.9	0.1	2.5	2.7	2.8	2.9	2.4	2.9	3.1	3.7	2.9	2.8	2.9	3.3	0.8	6.4	9.7	2.0	0.9	1.8	1.9	1.3	4.6	4.5	7.9	5.1	7.0	2.8	6.6	11.0	10.4	2.3	1.6	2.5	3.9	4.6	165.2	21.0	2.1	2.0	5.3	0.4	2.4	1.4	1.1	2.5	1.1	1.9	1.3	1.1	2.9	4.7	1.7	11.8	2.1	2.3	0.0	1.0	0.7	195.1	3.1	1.0	3.6	1.0	0.9	3.0	8.2	0.5	1.0	1.6	0.6	2.6	0.6	2.8	4.2	7.4	32.5	8.5	6.6	5.2	2.0	198.5	5.5	1.9	0.9	5.1	0.9	2.3	3.9	1.3
ZC3H12A	"FLJ23231, MCPIP1, Regnase-1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474580-37484377	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 136.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 300.7;Basal squamous epithelial cells: 242.4;Langerhans cells: 232.8;Squamous epithelial cells: 217.6;Suprabasal keratinocytes: 225.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.8;RT4: 61.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Cytoplasmic bodies"	Nucleoplasm	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	28.9	28.0	2.4	17.3	2.3	136.3	15.1	3.6	4.1	9.1	2.7	16.3	14.1	6.6	4.6	45.4	14.3	36.0	12.1	2.5	3.8	15.7	23.3	40.0	13.6	4.1	3.7	6.0	12.4	2.5	9.2	3.7	4.1	29.5	7.9	0.3	22.9	5.2	10.8	51.5	20.1	5.7	3.0	15.5	23.5	5.2	3.7	5.7	6.5	3.2	15.5	39.0	21.4	2.8	7.8	5.5	0.6	3.5	2.7	4.0	6.2	5.5	48.8	3.5	4.5	6.1	17.2	8.7	22.8	5.3	37.8	16.8	2.2	35.4	2.0	17.8	3.2	2.3	20.9	9.7	3.9	4.6	3.5	8.6	17.8	30.0	5.3	7.9	3.9	4.4	4.3	14.1	3.1	9.4	3.5	8.3	4.2	10.4	4.8	5.2	2.2	5.1	8.8	61.2	1.6	1.1	11.0	17.4	1.3	5.3	6.0	5.1	4.1	10.3	5.7	7.7	8.5	11.2	4.5	6.6	23.5	9.7	2.0	1.2	1.4	4.0	3.1	1.4	3.3	3.1	1.3	1.9	1.7	3.9	0.7	1.5	5.6	3.5	1.2	1.5	2.0	1.7	2.4	2.3	3.6	4.1	2.5	3.8	4.1	3.7	4.1	3.0	3.7	2.8	19.1	16.0	36.2	1.6	56.9	195.9	149.8	300.7	242.4	0.4	93.6	69.8	4.2	61.5	117.6	11.0	0.0	3.7	78.1	71.5	0.0	79.5	16.9	67.6	20.8	32.2	63.9	0.4	0.1	73.9	10.0	41.0	66.3	102.2	42.6	5.0	5.3	11.4	9.7	0.0	0.1	77.3	69.2	10.5	232.8	2.7	0.9	71.2	48.0	1.0	14.0	0.9	9.2	0.5	0.9	55.4	73.2	1.2	52.1	127.9	59.5	0.6	58.4	4.5	6.6	52.7	36.1	1.6	1.3	217.6	225.2	11.8	76.6	9.5	62.2	81.9
ZC3H7B	"DKFZp434K0920, FLJ13787, KIAA1031, RoXaN"	ENSG00000100403	"Zinc finger CCCH-type containing 7B"	Q9UGR2	22	41301525-41360147	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001784, HPA076092"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA001784: AB_1080637, HPA076092: "	"unprognostic (1.71e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.19e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-1)"	29.5	42.9	37.5	20.2	37.1	16.0	22.9	31.9	43.4	25.6	15.1	25.8	24.3	31.1	13.5	20.3	27.2	17.2	26.1	34.1	38.7	31.4	42.1	26.9	21.4	56.0	35.7	41.3	30.9	44.5	30.5	18.5	58.8	26.0	13.2	17.9	44.9	26.7	24.9	20.0	25.9	20.7	30.2	25.6	24.8	11.6	37.2	25.2	45.9	19.1	15.2	23.5	19.7	36.0	59.0	32.2	42.0	25.6	37.6	33.9	49.1	65.8	69.6	53.8	42.1	35.3	23.8	33.1	79.1	92.0	30.1	39.1	35.7	61.8	27.4	76.0	58.9	29.6	40.2	45.4	50.4	57.4	24.9	42.7	34.6	46.3	56.4	45.7	58.9	25.7	60.4	17.9	46.0	59.1	45.4	29.7	30.3	44.2	24.1	68.7	26.4	37.8	45.9	41.5	27.1	20.3	60.5	36.6	31.5	29.0	24.1	38.1	119.0	52.5	54.4	16.3	40.8	30.8	18.4	33.2	44.0	28.0	46.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.0	37.5	37.1	31.9	43.4	34.1	38.7	56.0	35.7	58.8	30.2	37.2	36.0	15.4	12.8	22.2	14.4	13.1	7.1	12.7	13.4	10.2	22.4	18.2	15.6	10.1	20.0	15.7	22.0	18.8	9.0	11.3	13.5	7.9	14.0	0.9	14.2	25.8	17.9	33.6	7.8	20.1	13.3	9.0	16.4	11.2	16.9	8.2	59.0	19.2	44.0	12.0	42.1	20.6	14.6	26.4	12.9	9.8	3.1	33.2	8.2	12.4	13.1	15.2	9.8	20.6	19.1	17.6	18.8	8.1	29.0	7.4	21.2	23.0	18.5	11.7	22.2	19.7	23.1	18.0	2.0	4.9	8.9	5.8	6.2	11.1	46.9	17.1	14.8
ZDBF2	"FLJ45338, KIAA1571"	ENSG00000204186	"Zinc finger DBF-type containing 2"	Q9HCK1	2	206274663-206314427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.0;Granulosa cells: 44.4;Inhibitory neurons: 56.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039121, HPA050311"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"HPA039121: AB_2676357, HPA050311: AB_2681081"	"unprognostic (8.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.73e-3)"	"unprognostic (7.59e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.40e-1)"	2.3	4.1	1.8	0.9	3.5	0.6	1.6	3.4	1.8	3.0	7.8	2.4	0.4	2.6	1.7	1.1	3.2	1.2	2.3	2.3	3.8	1.4	1.5	1.3	1.1	1.2	1.4	9.5	5.0	1.5	8.0	2.3	1.1	1.8	0.6	5.5	1.7	1.4	2.7	1.1	1.7	1.3	0.4	1.4	2.0	1.7	3.5	0.9	2.0	1.5	0.9	1.7	2.0	0.4	1.4	0.2	4.4	0.8	1.7	1.4	6.9	1.4	1.5	0.7	0.9	0.4	1.2	0.0	0.6	1.5	2.6	0.3	3.0	1.1	1.3	1.4	2.9	0.0	3.4	0.1	2.2	1.3	2.9	1.4	1.9	1.4	2.7	5.1	2.1	1.1	0.2	1.9	2.1	0.2	0.4	0.0	6.2	0.1	1.6	0.0	4.6	0.0	0.8	0.6	2.4	5.6	2.6	0.0	2.5	10.0	0.1	0.0	2.6	0.7	2.3	0.5	1.1	4.1	1.1	0.2	3.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	3.5	3.4	1.8	2.3	3.8	1.2	1.4	1.1	0.4	3.5	0.4	6.9	3.2	3.9	15.7	19.3	4.0	1.9	3.1	7.4	26.9	4.4	3.3	9.2	1.5	4.4	11.0	14.6	5.2	9.7	0.6	0.0	2.8	4.1	1.9	7.5	5.1	7.8	0.8	75.0	2.2	6.9	11.7	4.6	0.6	12.7	44.4	3.3	3.4	0.5	8.4	56.5	1.3	4.1	0.3	4.2	5.1	4.4	2.3	1.8	18.7	0.1	8.7	0.0	26.2	3.1	1.2	0.5	5.3	23.4	3.5	1.0	2.3	10.6	18.1	0.0	19.2	9.2	4.4	9.0	6.0	3.3	9.0	13.5	24.5	0.5	0.8
ZDHHC1	"C16orf1, HSU90653, ZNF377"	ENSG00000159714	"Zinc finger DHHC-type containing 1"	Q8WTX9	16	67394152-67416833	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 84.6;Late spermatids: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.4;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 11.4;ASC TERT1: 11.3;U-138 MG: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042531, HPA048659"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA042531: AB_2678041, HPA048659: AB_2680483"	"unprognostic (8.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.05e-3)"	"prognostic favorable (1.25e-6)"	"unprognostic (1.68e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.55e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.63e-3)"	17.7	10.9	3.7	1.8	3.5	0.2	17.9	3.2	5.6	27.1	7.4	14.5	2.3	21.7	3.9	6.8	22.4	6.3	10.8	3.4	4.2	19.3	4.4	12.4	1.4	4.9	6.7	23.6	17.7	7.8	20.4	3.1	4.1	19.5	1.7	0.8	17.0	6.7	10.7	19.1	7.4	3.9	4.7	14.9	10.6	20.3	4.4	0.6	29.4	3.0	0.8	12.8	16.3	2.8	5.2	6.0	1.4	7.3	11.4	11.3	0.0	3.2	9.0	2.6	2.8	0.0	2.6	0.0	1.3	4.2	2.5	3.3	0.4	0.6	0.5	1.6	4.6	0.5	0.1	0.4	5.2	0.2	4.0	6.0	5.3	2.7	0.6	6.0	3.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	2.9	1.8	0.1	0.0	0.0	0.0	3.5	2.9	2.1	7.4	0.5	0.1	6.5	0.4	1.9	1.1	5.8	11.7	2.0	5.6	3.3	1.4	0.3	0.0	7.2	0.1	4.7	0.0	1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.3	3.7	3.5	3.2	5.6	3.4	4.2	4.9	6.7	4.1	4.7	4.4	2.8	7.0	0.0	0.0	10.4	0.9	7.1	6.7	1.3	10.8	2.2	7.5	7.0	1.1	10.0	1.4	7.3	4.2	2.0	0.3	5.2	9.8	3.4	29.3	84.6	10.9	5.2	9.0	0.4	5.7	4.0	0.2	13.6	8.6	7.3	0.0	8.5	6.1	2.0	2.0	3.3	5.0	12.9	2.0	16.4	6.8	53.0	14.6	9.3	5.4	2.8	8.2	7.9	1.0	4.0	2.5	2.2	4.9	10.9	0.7	7.2	2.0	6.6	5.5	0.5	0.0	5.1	9.4	12.4	8.6	6.2	7.1	5.7	0.7	10.4	6.8	4.8
ZDHHC11	"FLJ13153, ZNF399"	ENSG00000188818	"Zinc finger DHHC-type containing 11"	Q9H8X9	5	795606-850986	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Early spermatids: 17.0;Endometrial ciliated cells: 26.2;Excitatory neurons: 21.4;Inhibitory neurons: 16.4;Oligodendrocytes: 18.3;Respiratory ciliated cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 11.5"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.67e-1)"	"unprognostic (9.76e-3)"	"unprognostic (4.47e-5)"	"unprognostic (5.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (5.23e-5)"	"unprognostic (4.80e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-2)"	1.9	0.9	8.0	0.4	9.9	0.5	2.1	8.3	13.0	2.7	8.0	3.5	6.1	1.1	1.8	3.9	6.5	0.9	9.0	7.4	5.1	4.1	5.2	4.7	0.5	7.9	9.9	1.7	2.8	0.6	12.0	0.8	9.0	2.8	0.8	4.3	2.7	0.9	2.0	3.1	2.9	0.5	2.3	3.3	4.4	10.4	7.1	0.7	2.4	2.2	0.7	2.4	2.2	15.0	0.4	7.4	4.1	0.9	1.3	0.3	5.4	0.3	0.1	0.2	0.1	1.0	0.3	3.1	0.8	0.0	0.9	7.1	2.6	0.0	0.0	9.6	4.9	0.3	3.0	3.9	0.4	4.5	0.3	0.4	0.3	0.9	1.0	0.3	0.0	1.2	0.7	1.7	0.2	3.5	0.4	2.5	7.3	0.0	2.8	4.6	2.7	4.3	0.2	1.5	4.2	0.8	0.2	0.1	3.5	8.0	11.5	0.8	0.4	0.2	6.9	3.9	0.1	5.6	8.3	0.9	0.3	9.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	9.9	8.3	13.0	7.4	5.1	7.9	9.9	9.0	2.3	7.1	15.0	0.7	19.2	13.1	8.5	0.0	1.9	0.4	0.6	0.0	3.4	1.6	2.0	7.7	1.5	13.4	0.0	0.0	0.2	0.3	1.2	0.0	0.5	17.0	26.2	3.8	1.5	1.8	0.4	21.4	0.0	0.1	3.6	4.1	4.2	3.8	0.1	1.1	2.7	0.4	6.7	16.4	3.9	0.0	0.0	0.3	9.1	0.6	0.9	0.0	0.0	0.1	0.3	0.0	7.5	18.3	0.2	1.7	0.0	1.4	0.3	6.0	1.3	25.8	2.2	6.6	0.9	1.0	9.5	3.7	0.7	1.6	0.3	1.1	0.1	1.6	0.4
ZDHHC11B		ENSG00000206077	"Zinc finger DHHC-type containing 11B"	P0C7U3	5	710355-784729	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	6	"brain: 29.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 23.0;Excitatory neurons: 47.2;Inhibitory neurons: 38.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 70.1;Respiratory ciliated cells: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;SCLC-21H: 2.4;THP-1: 3.4"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.81e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.79e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.39e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.31e-1)"	0.7	1.2	15.1	0.2	19.6	0.0	0.8	5.9	19.9	0.5	0.0	2.0	2.7	0.4	0.1	1.5	2.0	0.3	4.5	14.6	9.0	0.7	1.2	2.4	0.0	14.2	8.6	0.6	1.8	0.4	4.5	0.2	14.9	0.5	2.3	4.3	1.7	0.5	3.6	2.2	2.4	0.4	3.3	1.2	2.3	0.7	15.5	0.0	1.1	1.6	0.3	1.0	0.6	29.5	0.0	0.8	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	2.1	0.1	0.0	0.3	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.4	0.4	0.0	0.0	0.7	0.3	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.8	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	19.6	5.9	19.9	14.6	9.0	14.2	8.6	14.9	3.3	15.5	29.5	0.2	19.2	23.0	17.0	0.0	2.7	1.0	0.1	2.2	7.0	1.1	0.9	8.9	1.5	5.7	3.7	0.0	0.0	0.4	2.0	0.0	0.8	2.5	11.9	0.7	2.8	3.0	0.0	47.2	0.8	0.1	4.7	4.1	3.6	1.3	0.0	0.7	2.3	1.7	10.1	38.3	6.7	0.0	0.6	1.1	0.4	0.9	0.8	0.0	1.9	0.0	0.6	0.0	26.7	70.1	0.1	1.4	0.0	1.7	0.3	7.7	0.5	21.8	0.3	6.6	1.4	2.4	5.0	2.5	2.3	3.1	0.0	1.5	0.5	2.4	2.6
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type palmitoyltransferase 12"	Q96GR4	9	128720870-128724127	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 224.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	18.8	23.9	7.8	15.5	7.7	41.3	19.3	7.5	9.9	16.8	8.4	40.5	26.3	12.9	7.1	67.8	12.0	14.1	13.7	7.4	8.8	30.6	52.3	23.3	20.0	9.6	7.8	7.4	67.1	9.8	11.3	16.3	8.4	26.6	13.7	0.5	43.2	12.5	15.6	42.4	36.8	6.3	8.4	31.7	49.2	24.7	10.5	12.4	16.2	4.1	13.7	18.7	30.5	9.7	53.5	127.6	6.0	31.3	17.6	12.1	59.4	32.8	28.8	34.5	22.9	109.6	61.5	37.3	29.6	25.5	62.9	139.8	13.0	65.0	3.8	65.0	31.7	20.1	92.7	49.1	34.7	33.1	87.1	19.9	44.7	29.6	11.0	17.7	25.6	65.6	18.8	93.6	7.1	187.3	45.9	66.2	26.8	118.8	107.6	21.0	21.0	108.4	28.7	43.4	42.1	30.4	46.2	64.1	18.3	9.6	98.9	35.6	27.5	0.1	36.9	25.9	45.8	58.1	106.8	17.3	61.3	38.4	41.4	231.1	122.3	385.6	105.1	123.9	91.2	94.6	95.9	101.5	100.1	111.0	99.2	91.4	269.5	90.5	150.0	244.7	130.9	101.0	7.8	7.7	7.5	9.9	7.4	8.8	9.6	7.8	8.4	8.4	10.5	9.7	10.0	16.0	12.0	1.3	31.8	16.2	43.3	94.0	10.8	1.2	55.5	30.4	14.8	77.2	59.0	46.0	0.0	183.9	39.1	171.0	13.7	106.8	73.2	20.7	11.5	21.1	51.2	51.1	0.6	200.0	224.0	14.2	38.7	52.5	18.4	13.7	35.7	55.3	137.0	0.0	0.5	108.5	67.1	62.2	20.9	30.0	9.6	46.5	42.7	6.5	115.3	18.4	81.4	0.5	2.0	133.8	167.7	7.2	43.3	56.5	186.0	48.5	20.1	2.0	6.6	5.4	16.3	36.0	18.6	55.2	28.1	134.1	34.1	22.0	110.0	77.5
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type palmitoyltransferase 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Urothelial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.8	5.7	5.2	7.8	5.2	9.7	8.9	6.6	7.1	9.3	6.6	16.9	11.2	6.7	5.1	37.2	12.9	8.7	9.1	5.4	5.7	9.2	2.2	6.1	9.6	5.5	5.0	5.3	11.2	14.9	11.7	6.2	5.8	8.2	18.2	16.1	10.2	5.4	1.6	18.8	11.3	6.1	5.3	5.7	18.5	14.4	5.0	11.7	8.7	2.9	22.4	22.4	15.4	5.2	41.6	19.3	18.0	15.5	6.3	7.2	17.3	19.4	17.8	21.3	24.4	11.7	9.7	21.1	13.1	16.3	47.9	61.3	26.0	12.8	23.3	26.4	22.6	11.1	12.6	9.7	14.6	15.2	18.5	8.3	14.7	9.0	12.5	19.9	136.8	28.9	10.7	10.3	22.1	13.5	19.6	12.2	15.1	38.7	17.6	21.3	25.0	5.0	21.9	27.0	31.3	23.0	23.2	28.0	10.7	17.3	13.2	17.6	39.6	18.9	13.2	29.2	15.8	8.7	28.5	19.2	22.6	15.5	33.6	11.6	4.7	32.7	8.5	7.9	7.8	8.7	6.6	9.6	5.9	5.5	6.2	8.3	6.0	6.3	6.4	5.6	9.4	4.6	5.2	5.2	6.6	7.1	5.4	5.7	5.5	5.0	5.8	5.3	5.0	5.2	8.1	9.6	10.7	28.7	9.6	24.2	22.3	27.2	14.2	12.0	7.5	4.8	34.1	12.8	41.3	16.5	10.4	8.7	10.6	20.1	5.9	25.1	120.5	21.5	6.6	11.3	15.6	11.6	27.2	19.2	18.8	9.2	24.5	30.8	12.0	16.2	12.8	0.9	6.1	16.8	34.9	24.7	36.7	6.8	8.3	46.6	7.8	6.2	3.6	9.4	20.8	52.8	18.6	19.6	20.9	20.4	16.4	2.2	10.4	47.4	15.5	3.5	57.0	8.8	0.0	5.4	7.4	58.1	31.7	21.3	36.2	6.3	11.4	7.7	21.4	103.0
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type palmitoyltransferase 5"	Q9C0B5	11	57667747-57701182	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	29.0	21.7	8.3	27.2	7.8	29.2	25.8	8.3	9.5	27.0	11.0	36.4	29.6	22.3	24.1	60.9	25.0	27.9	27.9	7.5	9.2	28.2	36.7	29.0	24.4	8.5	8.9	20.7	31.6	45.3	12.6	36.7	8.7	28.0	34.4	35.9	35.0	26.7	40.9	45.2	31.0	29.0	6.9	25.5	30.2	36.2	10.9	30.6	36.9	45.5	35.0	42.3	28.7	8.9	80.3	86.2	33.7	34.7	74.9	57.4	64.9	72.8	89.8	61.8	46.3	52.3	97.0	53.4	91.9	89.5	53.1	110.1	53.6	88.9	55.4	66.5	24.4	45.8	40.1	49.3	81.5	85.9	73.7	81.3	79.3	88.8	92.9	51.1	71.0	45.6	61.5	66.2	79.7	48.4	49.1	29.3	41.1	61.0	52.2	47.8	66.6	67.1	74.8	115.2	25.3	30.7	67.6	77.0	78.5	45.4	81.9	52.6	80.7	76.5	40.7	82.9	52.2	48.2	63.0	45.9	59.1	44.4	68.0	11.6	5.2	7.1	6.9	6.8	8.3	5.8	6.7	6.0	5.4	5.7	6.7	6.9	6.9	5.0	8.1	9.0	7.0	6.8	8.3	7.8	8.3	9.5	7.5	9.2	8.5	8.9	8.7	6.9	10.9	8.9	28.8	16.0	10.5	14.7	13.4	16.2	12.7	13.7	16.5	21.4	20.4	15.2	21.6	12.8	19.8	12.9	37.5	10.1	20.3	41.3	3.9	14.4	21.3	19.9	22.1	17.1	11.5	10.8	16.4	18.2	9.9	15.5	15.8	35.5	19.7	24.9	16.1	15.1	13.0	13.5	17.9	17.5	18.3	16.3	10.2	9.8	11.8	18.4	1.8	14.0	16.0	14.0	17.5	17.6	14.7	26.0	20.8	7.5	12.4	15.1	22.9	11.4	17.4	47.7	0.0	18.4	18.5	13.3	7.1	31.5	19.9	18.6	15.9	16.8	19.7	20.5
ZDHHC7	"DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370"	ENSG00000153786	"Zinc finger DHHC-type palmitoyltransferase 7"	Q9NXF8	16	84974175-85011535	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019215, HPA059054, HPA059642"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"		"HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.41e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.42e-2)"	33.0	28.1	19.0	24.7	18.8	64.2	26.8	21.4	18.6	40.0	27.1	42.5	27.1	36.8	12.8	27.6	27.7	31.2	31.2	19.1	19.8	35.4	30.0	37.2	26.5	20.1	21.0	27.7	26.9	35.5	19.6	33.4	20.3	32.8	32.4	10.3	24.1	20.0	56.5	31.8	33.5	30.0	19.1	35.4	44.7	14.1	23.5	16.1	25.5	58.4	23.5	37.4	33.1	19.6	63.8	55.0	28.5	34.5	123.1	92.3	38.9	57.4	110.8	88.4	43.7	58.3	72.4	29.1	32.7	93.5	29.0	65.6	37.1	76.1	110.9	16.4	29.7	21.0	22.0	66.5	51.5	40.0	21.2	76.7	85.4	72.5	41.5	56.0	46.1	26.7	68.9	9.7	56.8	75.8	27.0	38.1	44.3	53.2	39.5	33.6	26.2	15.7	86.4	82.5	24.2	29.8	74.3	40.9	36.1	43.0	77.6	24.0	67.9	53.1	39.9	49.8	34.3	33.5	51.0	65.5	50.1	29.1	43.0	7.5	9.7	8.3	2.1	8.2	2.6	1.4	2.0	1.7	6.3	2.2	1.5	2.2	6.4	1.4	7.2	4.3	0.5	3.6	19.0	18.8	21.4	18.6	19.1	19.8	20.1	21.0	20.3	19.1	23.5	19.6	13.3	32.1	25.2	12.1	10.8	13.3	21.5	25.4	17.1	9.2	16.2	13.2	22.5	12.8	17.9	16.5	6.2	18.5	15.7	37.7	1.9	14.1	9.7	15.5	20.1	12.2	12.6	11.6	16.4	15.6	24.9	23.0	28.5	29.1	3.8	14.3	15.0	11.6	28.1	15.2	16.2	29.4	14.2	46.8	26.7	10.9	17.4	36.2	16.0	19.7	42.9	5.9	21.6	13.6	14.7	30.0	33.9	21.1	15.2	26.2	22.1	9.5	32.6	6.7	13.1	13.7	14.9	8.3	13.0	20.1	12.8	16.1	13.4	6.8	34.7	35.3
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type palmitoyltransferase 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	31.6	31.2	13.8	18.6	15.1	10.7	30.4	11.3	26.4	32.6	0.0	22.8	12.1	31.2	7.5	29.3	27.7	13.0	31.6	13.9	7.0	30.4	36.1	31.0	17.1	12.2	10.0	34.6	35.6	14.4	41.3	16.9	9.9	28.1	7.0	7.4	27.6	15.4	23.6	32.2	24.7	13.1	6.6	35.7	26.4	14.9	12.3	13.7	37.3	10.3	11.7	25.3	30.9	12.8	30.0	18.7	29.3	38.7	42.0	25.0	26.3	55.1	37.3	36.6	32.6	9.8	15.2	0.1	22.3	46.0	19.8	40.2	15.5	42.2	18.0	43.2	59.4	14.5	57.2	23.0	34.5	0.0	19.5	43.7	27.9	28.2	23.6	22.5	41.4	21.0	101.4	22.8	33.0	14.7	17.8	39.1	14.9	13.2	29.4	37.8	25.6	10.9	15.6	35.9	46.9	23.7	22.4	10.7	26.6	13.1	0.7	20.4	48.0	82.5	59.8	46.8	25.0	32.6	11.5	11.7	24.2	18.7	24.8	1.3	0.4	0.1	0.8	0.5	0.4	0.2	0.2	0.4	0.1	0.5	0.4	0.5	0.0	0.4	0.2	1.3	0.7	0.2	13.8	15.1	11.3	26.4	13.9	7.0	12.2	10.0	9.9	6.6	12.3	12.8	17.4	3.2	3.1	17.6	3.7	9.1	3.8	3.6	5.7	11.9	8.2	8.1	7.1	4.3	3.5	11.0	14.6	3.6	9.2	4.3	1.9	5.2	0.5	4.3	15.7	11.5	4.2	0.8	16.6	4.5	8.5	9.3	10.2	8.7	5.7	8.7	10.4	9.8	4.9	13.5	9.9	5.9	10.2	5.0	5.0	2.1	10.8	5.7	5.4	9.4	3.7	7.4	1.0	13.0	13.3	7.7	5.4	14.7	2.7	7.6	2.7	2.1	1.5	10.8	6.6	10.5	6.8	1.4	3.8	5.5	9.8	3.4	4.2	8.0	5.0	3.4
ZFHX2	"KIAA1056, KIAA1762, ZFH-5, ZNF409"	ENSG00000136367	"Zinc finger homeobox 2"	Q9C0A1	14	23520857-23556192	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9;testis: 7.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Early spermatids: 38.9;Excitatory neurons: 31.0;Inhibitory neurons: 20.0;Late spermatids: 19.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 20.8;Spermatocytes: 16.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.8;SuSa: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000720, HPA005146"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA000720: AB_10603462, HPA005146: AB_1859250"	"unprognostic (7.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.08e-4)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.75e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.90e-2)"	0.5	0.7	1.8	0.5	6.3	0.1	0.4	11.9	5.3	0.4	0.0	0.7	0.1	0.7	0.4	0.2	2.2	0.4	0.3	3.2	0.0	1.3	0.2	0.5	0.3	1.5	0.1	0.5	0.4	1.7	3.4	0.2	0.2	0.6	0.2	3.1	0.4	1.2	0.7	0.5	0.3	0.6	0.0	0.2	0.4	7.3	0.9	0.2	0.7	0.5	0.2	0.3	0.2	2.3	0.1	3.1	2.4	4.8	1.6	0.2	0.1	0.7	0.2	0.3	1.2	0.3	0.2	0.2	0.3	0.0	0.3	0.1	1.2	0.1	0.5	2.2	0.8	2.5	0.0	0.6	0.2	0.4	1.7	0.3	0.1	0.5	0.1	1.3	0.3	2.1	0.4	0.4	0.1	0.8	0.3	0.3	2.9	0.3	0.7	1.4	0.0	0.0	1.3	1.2	2.7	1.7	0.4	0.6	0.1	3.6	1.0	0.6	0.1	0.0	1.2	0.7	0.3	0.3	1.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	6.3	11.9	5.3	3.2	0.0	1.5	0.1	0.2	0.0	0.9	2.3	0.5	0.0	1.1	22.5	0.7	0.1	0.6	1.1	0.0	9.0	2.2	2.3	2.5	0.0	2.4	1.8	0.0	0.3	0.1	0.6	1.9	2.8	38.9	12.2	0.6	1.1	6.7	0.0	31.0	2.4	0.0	1.4	2.0	2.5	0.0	3.2	0.7	0.2	1.0	8.4	20.0	0.7	2.0	1.0	1.9	19.1	0.6	0.8	0.0	4.7	1.0	2.7	0.0	27.2	20.8	1.2	1.2	0.4	0.1	1.4	0.4	1.4	9.8	3.8	0.0	2.5	1.3	16.5	1.2	0.7	0.0	0.3	0.4	0.2	0.6	0.3
ZFP37	ZNF906	ENSG00000136866	"ZFP37 zinc finger protein"	Q9Y6Q3	9	113038377-113056759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 15.5;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA049112	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Vesicles"		"HPA049112: AB_2680637"	"unprognostic (3.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.54e-3)"	"prognostic favorable (1.96e-4)"	"unprognostic (7.84e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.07e-1)"	1.6	1.7	2.2	1.3	2.9	0.2	2.8	4.4	2.5	3.0	0.5	1.6	0.8	4.5	1.8	1.2	2.5	1.3	1.5	1.9	2.7	2.3	0.6	1.3	1.2	2.3	2.2	7.1	1.3	2.9	3.8	1.3	2.5	2.5	1.0	6.3	0.9	1.8	1.4	1.2	1.1	2.5	2.5	2.0	1.2	2.2	3.3	1.2	2.9	1.9	1.3	1.8	1.6	4.0	0.6	1.7	7.2	6.0	3.9	7.5	3.7	2.3	3.4	2.5	2.1	0.0	1.7	4.2	1.8	2.4	3.3	1.5	0.0	0.9	3.9	5.2	0.8	0.2	3.5	1.9	2.1	0.0	0.8	2.1	0.7	3.0	5.8	6.1	1.4	0.0	0.4	3.6	5.2	0.0	0.0	0.0	7.4	4.4	0.0	0.0	10.0	0.6	1.9	0.0	6.1	5.8	7.1	1.5	1.4	3.5	6.0	0.0	0.6	5.8	2.5	6.9	3.5	1.4	2.9	0.0	4.5	0.1	3.6	0.1	0.0	0.0	0.9	0.2	0.7	0.9	0.8	0.9	0.3	0.4	0.6	0.9	0.1	0.7	0.0	0.0	2.4	0.3	2.2	2.9	4.4	2.5	1.9	2.7	2.3	2.2	2.5	2.5	3.3	4.0	3.4	0.0	0.5	5.5	2.1	0.3	0.9	1.3	2.2	10.3	1.4	2.8	8.0	0.0	0.5	0.0	6.2	0.8	1.6	0.1	3.9	1.6	1.0	0.6	4.9	3.2	1.2	0.0	9.2	0.9	1.6	3.8	2.6	0.6	5.7	2.5	2.5	1.3	0.5	6.7	15.5	0.6	4.1	0.3	0.3	0.2	2.1	0.8	0.0	3.7	0.5	3.4	3.1	23.6	29.7	0.4	1.3	2.2	1.1	0.5	0.1	3.1	0.4	6.0	6.6	6.4	4.2	5.6	3.2	2.7	0.0	0.1	1.3	2.6	0.3	0.4
ZFP41	"FLJ00028, FLJ38705, ZNF753"	ENSG00000181638	"ZFP41 zinc finger protein"	Q8N8Y5	8	143246821-143262705	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (4.92e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.20e-1)"	2.9	3.5	5.4	2.3	6.6	1.5	2.8	2.8	6.9	3.6	0.0	3.8	3.4	4.2	1.4	2.9	4.1	1.9	3.1	4.9	6.6	3.9	3.4	2.2	2.6	7.8	5.6	5.3	3.5	4.0	5.3	1.1	5.7	3.7	1.5	2.4	4.8	2.6	3.2	4.9	3.6	2.0	2.4	3.2	3.6	6.3	8.2	2.4	4.1	1.8	2.1	3.4	3.0	9.7	6.7	10.5	4.5	6.0	5.1	3.9	5.3	4.0	2.1	7.6	5.2	5.2	5.5	3.7	5.8	5.2	7.7	5.4	4.9	5.2	3.7	5.9	6.0	4.7	5.6	4.1	7.1	1.8	2.8	4.1	7.2	4.9	7.2	5.2	3.6	2.6	10.1	3.5	3.6	12.0	5.0	2.0	6.7	8.2	10.3	2.6	3.7	1.3	3.3	6.0	5.7	7.8	11.2	3.0	5.9	3.8	7.7	3.6	3.8	5.7	10.2	4.5	6.4	5.6	4.6	1.7	5.1	4.5	7.7	0.0	0.1	0.0	0.3	0.2	0.5	0.1	0.2	0.2	0.1	0.2	0.4	0.3	0.0	0.1	0.0	0.9	0.2	0.2	5.4	6.6	2.8	6.9	4.9	6.6	7.8	5.6	5.7	2.4	8.2	9.7	1.6	0.0	2.0	2.9	2.3	1.1	0.7	0.8	0.6	2.5	2.3	1.9	3.2	5.7	1.1	3.7	6.2	0.3	0.8	3.7	1.9	1.9	1.5	1.8	2.3	1.6	3.0	0.8	2.2	0.9	1.1	1.6	2.6	1.2	0.0	2.7	2.5	3.9	1.2	6.7	3.4	2.4	2.0	2.2	0.5	2.6	1.2	1.5	1.8	1.0	0.9	2.5	2.1	1.5	4.4	1.6	4.1	2.2	1.6	0.5	3.4	1.4	3.2	2.0	0.0	1.6	1.9	7.9	3.7	1.8	0.3	0.3	0.9	1.6	3.4	0.4
ZFX	ZNF926	ENSG00000005889	"Zinc finger protein X-linked"	P17010	X	24149173-24216255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001748, HPA003877, HPA071863"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.22e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.95e-2)"	13.2	6.8	9.8	8.8	13.4	29.5	10.5	21.2	10.8	12.6	8.4	9.9	6.8	15.6	9.7	7.3	12.5	6.9	8.8	7.1	12.9	8.0	10.2	8.6	11.6	10.7	13.4	17.3	9.9	15.4	6.0	13.7	9.4	14.8	6.1	10.3	7.4	11.3	15.1	8.0	8.1	14.5	9.8	12.3	8.0	4.7	12.4	17.3	10.7	12.5	10.0	9.1	11.3	14.3	13.8	17.6	19.3	20.9	23.4	16.4	9.2	12.9	11.9	13.5	14.6	11.4	9.4	15.0	17.1	19.5	31.3	17.5	19.4	23.3	18.1	15.4	26.9	14.4	63.3	6.2	9.8	18.2	24.4	14.3	7.4	27.1	34.1	15.3	17.2	9.4	16.5	16.9	9.7	6.6	14.2	12.5	10.3	6.0	13.7	18.8	15.4	13.9	8.8	21.4	9.6	14.4	37.9	14.5	11.8	11.7	9.6	10.0	18.3	12.6	7.4	18.3	8.9	9.5	13.7	15.3	9.3	7.7	14.4	9.6	6.5	10.2	6.9	7.6	7.2	5.9	6.5	7.1	7.1	9.4	6.5	6.1	11.8	6.8	7.0	4.8	4.1	5.5	9.8	13.4	21.2	10.8	7.1	12.9	10.7	13.4	9.4	9.8	12.4	14.3	35.4	19.2	12.0	38.2	37.7	22.0	18.1	14.5	19.4	19.1	29.6	17.5	16.6	30.0	19.9	7.3	20.9	56.6	60.7	21.0	5.9	14.4	2.0	29.2	48.1	26.2	20.4	16.4	32.4	16.1	13.6	29.2	16.3	30.6	27.9	39.9	24.7	26.6	17.1	15.2	33.6	16.6	4.1	24.3	26.2	5.7	35.8	31.2	30.2	47.8	28.8	15.7	22.6	49.8	52.6	14.8	17.1	35.7	34.1	21.6	14.8	11.5	15.4	22.7	32.9	47.3	36.2	18.2	27.1	15.1	20.9	20.7	34.0	29.8	14.5	20.5
ZFY	ZNF911	ENSG00000067646	"Zinc finger protein Y-linked"	P08048	Y	2935281-2982506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.7;Late spermatids: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001748, HPA071863"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA071863: AB_2686463"			"unprognostic (1.07e-1)"		"unprognostic (7.43e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"		"unprognostic (2.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.91e-1)"		"unprognostic (2.54e-2)"	2.6	1.7	0.6	2.5	0.8	8.0	2.1	3.3	2.1	0.0	1.0	2.3	2.7	0.0	3.0	4.6	0.0	3.1	1.9	0.6	1.0	1.7	4.4	1.7	1.3	0.8	0.9	0.0	2.6	1.9	1.6	3.8	0.9	5.0	5.0	2.3	2.7	4.0	3.4	1.8	4.2	0.0	0.7	2.2	2.5	7.2	0.6	0.0	2.8	7.4	3.7	3.2	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	9.3	13.6	13.5	11.5	10.7	0.0	0.0	10.0	0.0	14.6	0.0	0.0	0.0	0.0	14.7	15.5	0.0	19.2	0.2	7.6	9.6	0.0	0.0	10.6	9.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	12.8	0.0	8.5	0.0	4.9	0.0	0.0	0.0	8.1	5.2	7.6	17.7	9.8	0.0	0.0	0.0	13.4	6.4	0.0	6.5	11.7	11.3	0.0	0.1	7.3	6.7	0.0	17.5	1.8	0.0	0.0	0.0	2.7	2.2	2.3	1.8	3.1	2.0	2.5	1.3	2.8	2.4	2.7	1.4	1.5	2.9	1.5	2.0	1.6	1.8	0.6	0.8	3.3	2.1	0.6	1.0	0.8	0.9	0.9	0.7	0.6	1.2	0.0	9.6	10.5	7.2	14.7	11.1	10.6	6.8	10.2	12.4	0.0	0.0	7.6	7.2	10.3	1.8	8.4	5.0	8.0	1.0	0.0	4.4	35.7	0.0	0.0	5.8	1.8	11.1	14.1	0.0	2.8	7.8	11.7	0.0	7.0	0.0	10.0	3.7	3.4	13.5	11.3	1.9	2.0	11.3	12.6	88.9	9.9	10.5	3.6	6.5	8.0	12.1	18.6	7.5	6.7	1.3	0.0	10.9	12.2	11.7	1.9	3.3	7.5	8.6	13.1	6.5	5.9	20.3	7.7	12.8	9.5	3.7	12.7	0.1	2.4	12.0
ZFYVE16	"KIAA0305, PPP1R69"	ENSG00000039319	"Zinc finger FYVE-type containing 16"	Q7Z3T8	5	80408013-80483379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 620.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.2;neutrophil: 21.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 80.7"					"Low region specificity"	"Detected in all"			"HPA035935, HPA035936"	Supported		Enhanced	Vesicles,Cytosol		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytosol"		"HPA035935: AB_10672076, HPA035936: AB_10669662"	"unprognostic (1.11e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.23e-2)"	8.4	8.7	5.1	8.1	12.0	5.2	8.7	5.7	6.4	15.1	4.3	6.4	5.1	12.7	2.5	7.2	7.2	11.2	14.0	4.1	8.2	9.5	10.3	9.1	5.6	7.0	8.5	12.3	6.4	9.0	3.9	13.0	7.6	8.5	6.3	8.6	5.0	6.6	6.1	4.3	6.8	9.9	6.5	9.0	6.6	9.3	8.3	5.0	9.5	8.4	4.5	9.5	4.7	15.5	11.9	13.4	23.4	21.9	14.0	14.3	15.5	17.6	15.2	15.4	20.7	9.9	16.5	7.9	12.5	14.6	16.4	11.9	17.2	14.4	16.9	5.1	10.9	8.6	16.3	11.3	11.6	2.6	6.3	15.4	7.5	12.9	12.4	12.4	18.0	7.3	8.5	12.0	16.8	14.9	5.7	2.5	5.3	6.1	6.5	11.7	48.3	8.4	12.9	22.1	8.8	19.5	25.3	11.6	80.7	14.1	20.2	7.7	16.0	9.2	10.3	14.3	14.6	3.6	7.6	7.8	12.1	8.0	21.0	21.2	4.5	2.5	1.8	2.8	1.0	3.6	0.9	1.6	1.8	3.2	0.7	0.9	21.3	3.0	5.4	3.0	1.0	0.4	5.1	12.0	5.7	6.4	4.1	8.2	7.0	8.5	7.6	6.5	8.3	15.5	49.3	25.6	22.2	127.0	25.8	18.2	14.0	16.4	15.4	94.9	23.4	18.2	52.3	14.3	33.8	31.3	114.7	22.1	28.9	20.3	9.8	16.2	7.4	47.6	85.6	33.1	21.6	7.8	87.7	12.3	11.8	33.7	23.9	37.5	10.1	59.7	35.7	16.8	26.5	80.8	114.0	11.3	2.0	59.8	71.5	7.0	37.9	71.4	19.6	64.6	34.7	26.3	17.5	182.0	620.2	16.4	20.2	44.4	19.0	16.5	16.3	13.6	49.9	75.3	32.9	58.6	43.3	49.0	22.0	15.6	25.4	37.4	17.5	44.7	12.9	20.1
ZHX1		ENSG00000165156	"Zinc fingers and homeoboxes 1"	Q9UKY1	8	123248451-123275541	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 146.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055357			Supported	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA055357: AB_2682793"	"unprognostic (4.36e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (8.73e-3)"	"unprognostic (5.61e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.76e-2)"	28.2	14.8	24.5	12.1	24.3	13.5	18.7	27.0	28.1	20.8	21.3	15.6	18.4	17.4	15.2	37.0	18.5	15.1	15.2	23.3	31.9	22.9	39.5	14.4	12.6	25.4	27.7	20.8	17.2	22.8	12.7	14.3	26.5	17.9	14.8	35.0	17.4	18.6	15.5	27.8	19.3	19.2	23.1	15.8	14.8	10.1	24.1	19.8	37.7	19.4	15.0	19.8	17.9	29.4	29.7	13.2	18.0	21.3	34.3	28.3	11.6	35.3	19.6	25.6	29.6	23.5	12.4	44.7	46.1	42.8	11.4	19.6	51.3	32.5	32.4	89.5	26.5	72.6	29.1	14.2	23.3	26.9	33.3	21.4	36.9	35.1	30.0	21.9	20.5	21.2	86.0	34.1	38.3	89.7	62.0	12.1	4.8	62.1	27.7	31.3	16.2	32.0	22.9	66.0	86.3	32.1	40.3	113.6	14.1	10.5	45.4	30.6	19.3	40.1	53.4	32.6	23.8	32.1	95.1	49.6	27.2	49.7	11.2	1.5	3.6	3.6	3.8	6.4	4.8	3.3	4.8	3.5	4.9	3.9	4.5	4.8	1.3	6.5	14.0	2.7	5.7	2.9	24.5	24.3	27.0	28.1	23.3	31.9	25.4	27.7	26.5	23.1	24.1	29.4	35.0	25.6	25.7	0.0	15.7	37.1	28.0	19.7	47.3	46.3	28.8	27.1	30.7	25.8	26.8	20.2	47.9	10.4	22.8	33.5	31.3	16.6	10.9	13.0	52.5	30.8	43.3	19.8	0.0	22.3	6.6	33.0	19.4	13.8	28.5	19.1	28.9	71.5	15.0	146.4	0.0	23.1	14.2	24.2	19.0	21.7	46.6	19.4	26.6	0.0	20.5	46.3	27.8	0.0	0.0	16.7	25.8	64.3	15.3	21.2	35.8	33.2	21.4	34.3	39.5	34.4	38.0	38.5	27.6	84.4	62.5	9.6	20.0	27.0	22.8	29.2
ZIC1	"ZIC, ZNF201"	ENSG00000152977	"Zic family member 1"	Q15915	3	147393422-147510293	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 616.8"	"Group enriched"	"Detected in some"	4	"Microglial cells: 25.3;Skeletal myocytes: 61.0"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 616.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 174.0;MCF7: 43.9;U-2197: 28.5"	"Region enhanced"	"Detected in all"		"cerebellum: 207.4"	"Region enriched"	"Detected in all"	8	"cerebellum: 638.1"	HPA004098	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA004098: AB_1859065"	"unprognostic (1.33e-2)"			"unprognostic (1.82e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.19e-1)"		"unprognostic (5.01e-1)"	"unprognostic (2.61e-7)"	"unprognostic (2.95e-3)"	"unprognostic (1.67e-2)"		"unprognostic (3.01e-1)"	3.4	0.7	25.0	0.0	50.7	0.0	0.2	616.8	30.3	0.0	39.0	0.1	0.2	0.0	1.8	0.2	0.0	0.1	0.1	13.6	39.5	0.1	12.8	0.1	0.1	66.8	55.3	0.2	0.1	0.0	2.4	0.0	67.3	0.0	0.1	10.7	0.5	0.0	6.9	2.5	0.8	0.0	23.8	0.0	0.2	0.3	112.1	0.0	0.0	0.8	0.0	0.0	0.0	44.8	0.0	0.0	174.0	0.0	17.9	19.6	9.8	11.4	13.5	12.1	9.9	0.0	0.0	0.0	9.1	0.9	9.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.4	0.0	0.7	0.0	0.0	3.1	0.0	10.9	43.9	0.0	0.0	0.5	0.9	0.0	0.0	17.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	17.9	0.0	28.5	11.0	0.0	0.0	0.0	13.5	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	50.7	616.8	30.3	13.6	39.5	66.8	55.3	67.3	23.8	112.1	44.8	0.2	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.0	25.3	0.0	4.3	0.0	2.0	9.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	61.0	0.3	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566127-137577691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.8;choroid plexus: 4.0;retina: 2.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 4.7;Muller glia cells: 9.6;Rod photoreceptor cells: 1.3;Spermatocytes: 2.0;Spermatogonia: 3.7"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	35	"AF22: 38.8;NTERA-2: 42.8;SuSa: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA052936: AB_2681993, HPA069523: AB_2732136"					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.0	0.0	2.9	0.0	3.9	0.1	0.0	13.8	3.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.5	0.0	0.0	0.0	0.0	3.5	3.7	0.0	0.0	0.0	0.7	0.0	4.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	42.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	24.8	0.6	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.9	13.8	3.5	1.8	4.5	3.5	3.7	4.0	2.3	4.3	3.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.7	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZKSCAN1	"KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33"	ENSG00000106261	"Zinc finger with KRAB and SCAN domains 1"	P17029	7	100015572-100041689	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 272.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006672	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Mitochondria"	"HPA006672: AB_1080707"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.09e-3)"	12.0	18.4	20.2	11.6	29.1	8.7	22.7	17.2	22.1	16.4	7.4	21.5	18.2	15.5	17.1	18.8	21.7	13.9	10.1	14.4	23.8	13.3	52.8	10.9	11.7	21.3	23.2	19.0	26.1	16.5	10.9	11.0	23.4	23.0	23.5	15.8	25.3	10.8	10.4	32.6	16.9	13.7	13.9	13.5	32.6	11.1	24.1	14.2	11.9	8.8	11.9	12.2	17.4	37.5	17.0	12.3	31.8	34.6	32.0	38.7	12.0	18.6	22.5	10.9	11.0	7.4	15.7	19.1	23.0	20.9	19.1	13.7	18.4	16.1	20.6	18.4	11.3	15.5	15.8	19.3	18.0	29.9	17.7	26.1	25.1	14.7	49.0	29.5	24.4	22.2	36.2	16.3	21.7	22.4	28.4	17.6	12.8	31.6	15.2	16.7	16.2	17.3	18.2	26.4	36.8	44.0	28.9	37.4	32.4	17.8	19.1	19.6	36.8	23.7	23.0	27.9	18.9	18.7	35.3	19.5	16.2	20.8	31.7	16.0	4.0	4.1	5.0	3.1	4.9	3.8	3.9	4.9	5.8	4.8	5.3	3.9	4.2	8.8	9.0	3.9	3.5	3.8	20.2	29.1	17.2	22.1	14.4	23.8	21.3	23.2	23.4	13.9	24.1	37.5	45.3	25.6	55.4	57.5	37.0	15.0	45.7	43.4	71.7	93.9	77.6	38.7	42.8	140.2	61.4	46.0	150.1	41.1	40.1	84.8	15.6	55.9	46.5	89.2	90.9	52.2	220.9	24.6	70.1	43.8	15.3	47.9	103.5	68.0	35.4	120.5	44.6	140.8	19.8	89.2	77.7	99.2	77.3	32.7	18.6	18.4	51.3	31.2	40.9	62.8	45.8	61.2	34.0	102.1	272.5	46.6	81.3	53.4	27.1	93.1	70.4	32.4	153.6	70.1	19.7	87.4	43.9	32.8	16.7	62.9	21.5	65.9	32.3	74.0	114.4	62.0
ZKSCAN3	"ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35"	ENSG00000189298	"Zinc finger with KRAB and SCAN domains 3"	Q9BRR0	6	28349947-28369172	"Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA009637, HPA060116"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA009637: AB_2668244, HPA060116: AB_2732641"	"unprognostic (2.71e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.42e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.50e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (7.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.10e-3)"	2.2	2.6	1.5	2.1	1.7	1.1	3.9	3.0	2.3	3.9	2.5	3.4	2.2	3.5	4.5	2.4	3.6	1.9	2.4	1.8	1.6	3.3	2.8	3.1	3.0	1.7	1.6	5.6	2.3	4.7	2.6	4.0	1.8	4.1	3.9	3.8	2.4	4.3	2.5	3.8	2.3	4.7	1.3	3.4	4.1	2.4	1.9	4.3	4.3	2.5	3.9	2.8	2.7	2.6	3.0	1.8	6.9	12.4	6.2	4.3	2.5	2.6	2.8	4.4	5.8	2.4	1.7	4.6	6.0	2.8	4.7	4.1	7.6	3.4	4.4	4.3	3.2	6.1	4.9	3.9	4.3	6.0	1.9	3.8	3.0	4.8	4.1	5.2	7.0	5.8	15.7	2.9	5.3	0.9	3.1	5.9	3.1	1.7	1.8	8.7	5.4	6.7	4.6	2.1	5.5	6.1	4.6	2.4	4.1	8.9	3.5	6.1	4.2	4.6	3.0	3.0	3.4	3.8	6.2	4.2	1.5	7.9	3.2	1.9	1.2	5.1	2.2	2.1	2.3	2.2	1.5	1.7	1.7	2.1	1.4	2.3	1.4	1.6	1.3	2.0	2.2	1.1	1.5	1.7	3.0	2.3	1.8	1.6	1.7	1.6	1.8	1.3	1.9	2.6	1.7	0.0	3.4	4.9	1.2	0.5	0.5	0.8	1.2	1.5	1.9	1.8	2.1	0.0	0.5	3.7	8.4	2.6	0.8	1.0	0.0	1.3	0.6	1.3	2.3	3.0	0.0	3.8	6.6	1.0	1.9	1.7	0.5	1.4	2.5	3.5	3.9	2.3	2.0	0.0	7.2	1.5	4.1	3.8	1.0	2.9	2.8	1.1	0.0	1.9	2.7	2.4	2.1	5.0	4.6	1.6	0.5	1.5	0.7	0.6	1.7	1.9	3.5	2.3	0.0	2.1	1.8	0.9	1.1	1.8	0.3	1.0	2.0	2.7	2.6	0.4
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28241697-28252269	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009637	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA009637: AB_2668244"	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.90e-6)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	2.7	2.7	1.6	1.9	1.6	1.0	2.6	2.7	2.0	3.5	1.6	2.9	2.0	3.5	2.0	2.5	2.6	1.4	2.2	1.6	1.6	2.7	3.0	2.0	3.4	1.6	1.5	3.2	2.3	2.3	2.1	2.1	1.7	2.7	2.0	2.2	2.9	1.9	1.6	2.9	3.6	1.5	1.5	8.6	2.5	8.9	1.6	4.1	2.4	1.6	3.3	2.9	2.8	1.9	1.4	1.0	2.8	4.7	3.2	3.1	2.6	1.8	2.9	2.6	2.9	1.6	1.2	3.9	3.3	2.1	1.6	1.6	2.9	2.3	2.7	1.8	3.1	3.3	2.5	2.2	2.2	6.6	2.9	3.4	2.8	2.3	2.3	3.3	2.7	3.4	3.1	0.8	2.2	1.4	4.4	6.9	2.2	0.6	1.9	3.4	3.9	2.5	1.6	1.1	4.3	3.1	1.5	2.0	3.3	2.5	1.7	3.0	2.2	2.9	1.7	1.7	1.8	2.5	2.6	1.8	1.0	6.5	1.7	2.8	1.9	2.2	1.9	1.6	2.2	1.8	1.8	1.8	3.2	1.7	2.7	2.6	2.5	2.4	1.9	4.2	1.8	1.4	1.6	1.6	2.7	2.0	1.6	1.6	1.6	1.5	1.7	1.5	1.6	1.9	1.7	0.0	0.5	2.6	2.2	0.4	0.5	1.0	1.2	1.1	1.5	1.4	1.3	2.8	2.7	1.8	2.1	3.9	3.9	2.2	0.0	2.7	9.8	1.3	3.2	2.2	3.5	3.8	7.9	2.0	2.8	2.5	3.1	1.4	2.5	4.2	2.5	1.0	4.5	1.7	6.5	1.5	0.0	10.7	1.8	6.9	2.8	2.9	1.8	7.5	2.6	2.2	3.1	2.5	3.9	1.7	4.9	3.8	1.3	0.4	2.3	1.7	0.4	1.7	0.0	1.6	1.6	27.4	2.4	1.6	0.3	1.1	2.1	3.5	2.3	0.3
ZKSCAN5	"ZFP95, ZNF914, ZSCAN37"	ENSG00000196652	"Zinc finger with KRAB and SCAN domains 5"	Q9Y2L8	7	99504662-99534700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003201	Uncertain		Approved	"Intermediate filaments"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Intermediate filaments"		"HPA003201: AB_10610701"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.59e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.35e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.42e-1)"	2.7	3.2	4.8	2.9	5.1	3.1	3.4	6.0	5.7	3.1	4.1	3.0	1.6	3.3	3.5	2.3	3.0	2.6	3.2	4.8	4.8	3.2	3.1	2.9	3.4	4.5	4.8	3.6	1.5	3.8	2.9	3.3	5.0	3.3	2.7	5.4	2.0	3.5	4.7	2.4	2.4	4.1	4.3	3.1	2.5	8.4	4.9	6.0	3.7	6.8	3.8	3.1	2.6	5.2	6.6	10.6	12.4	16.5	8.5	6.4	5.3	11.1	10.6	12.7	12.4	7.6	5.9	11.3	9.9	8.3	15.5	5.2	11.1	7.2	12.7	6.5	6.6	7.2	6.9	7.1	8.9	10.8	11.4	5.7	10.2	10.9	16.7	8.1	9.1	9.9	14.8	15.0	13.7	8.5	15.0	11.8	10.9	5.9	8.6	9.4	10.6	9.4	8.1	6.5	8.8	14.0	10.0	9.4	7.4	9.8	5.7	7.5	8.7	16.2	11.7	13.1	9.5	9.6	14.6	16.9	7.5	7.5	14.6	0.8	0.8	2.4	2.0	1.2	1.6	0.7	0.7	1.0	1.6	0.6	1.6	1.6	0.7	1.7	0.8	1.1	1.4	1.0	4.8	5.1	6.0	5.7	4.8	4.8	4.5	4.8	5.0	4.3	4.9	5.2	6.9	6.4	3.2	7.8	5.8	2.7	1.9	2.3	4.6	5.8	4.7	4.4	6.1	0.0	4.8	3.7	14.6	3.8	5.6	4.3	0.0	3.3	6.2	3.8	5.8	6.4	6.0	6.5	8.5	3.5	3.4	3.7	5.6	4.4	5.7	7.5	4.6	4.2	3.4	10.1	8.6	3.0	8.2	3.9	4.0	2.9	4.1	4.9	0.0	9.4	3.5	8.7	2.1	6.0	8.4	4.3	0.8	5.7	4.4	2.4	4.1	2.5	3.0	6.3	6.6	6.5	4.1	18.0	6.6	5.9	2.8	2.6	4.4	5.9	3.3	1.8
ZKSCAN7	"FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39"	ENSG00000196345	"Zinc finger with KRAB and SCAN domains 7"	Q9P0L1	3	44555193-44594173	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Late spermatids: 17.1;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;NTERA-2: 3.1;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048312, HPA049906, HPA071850"	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear speckles"	"HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458"	"unprognostic (3.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.17e-3)"	1.5	2.7	0.8	1.0	0.8	0.3	1.6	1.8	1.0	2.8	1.2	1.9	0.4	2.8	2.3	0.8	2.5	0.9	2.1	0.7	0.8	2.7	2.2	1.3	1.3	0.7	0.7	4.2	3.0	0.8	4.2	0.7	0.6	2.4	0.7	3.0	1.6	1.3	1.0	0.6	1.7	1.4	0.4	2.0	1.7	4.1	0.7	2.2	2.6	0.6	1.2	2.4	1.5	0.9	0.0	0.0	2.6	4.0	0.8	0.3	0.0	1.3	1.1	1.4	1.5	0.0	0.0	0.0	0.4	0.9	0.4	0.0	0.0	0.8	1.7	0.0	0.0	0.1	0.9	1.1	2.4	0.0	0.0	1.8	0.9	0.7	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.2	0.0	0.7	0.3	1.9	4.8	0.0	0.1	0.0	2.9	0.0	1.9	0.4	0.8	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.2	0.3	0.8	0.1	0.2	0.3	0.5	0.6	0.2	0.7	0.3	0.7	0.4	0.6	0.3	0.6	0.5	0.3	0.8	0.8	1.8	1.0	0.7	0.8	0.7	0.7	0.6	0.4	0.7	0.9	0.3	0.0	0.5	5.2	1.4	0.1	0.4	0.9	0.6	6.6	0.9	1.1	4.8	0.0	0.4	1.8	0.0	0.0	3.3	0.2	0.0	2.1	15.4	0.6	1.8	0.9	3.0	1.3	4.3	0.5	0.1	2.1	0.0	0.4	0.0	3.1	0.4	1.4	1.1	3.3	4.7	0.3	0.0	0.3	0.4	17.1	0.9	0.7	0.0	1.0	1.4	3.8	6.2	10.6	6.4	0.9	0.0	2.6	0.4	0.5	0.4	1.3	0.3	4.2	0.0	1.0	1.1	10.8	3.6	0.5	0.4	0.1	1.0	2.9	0.6	0.2
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.5;retina: 4.4;thyroid gland: 16.3"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 220.9;Inhibitory neurons: 507.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	86	"NK-cell: 8.6"	"Lineage enriched"	"Detected in single"	86	"NK-cells: 8.6"	"Group enriched"	"Detected in some"	5	"AF22: 22.5;U-2197: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.79e-3)"	0.0	0.7	3.2	0.1	7.5	0.0	0.1	1.6	15.0	1.4	0.0	0.7	0.0	0.3	0.1	0.0	0.1	0.1	0.4	6.2	2.7	0.3	0.0	0.0	0.1	15.5	4.5	0.4	0.1	0.0	1.8	0.1	15.4	0.6	0.2	4.4	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.3	0.1	1.4	11.1	0.3	16.3	0.0	0.1	0.0	0.0	4.1	0.0	1.3	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.0	0.6	14.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	3.2	7.5	1.6	15.0	6.2	2.7	15.5	4.5	15.4	0.3	11.1	4.1	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	8.5	0.1	0.0	0.9	2.8	0.0	0.0	6.2	0.0	1.0	0.0	1.9	0.0	19.7	0.0	0.1	0.0	1.8	0.0	220.9	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	507.5	0.0	0.0	0.0	0.0	55.2	2.8	0.0	0.0	7.5	0.0	1.3	42.2	13.0	4.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.1	0.1
ZMIZ2	"DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7"	ENSG00000122515	"Zinc finger MIZ-type containing 2"	Q8NF64	7	44748581-44769881	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 70.1;Late spermatids: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040716	Supported		Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA040716: AB_10805826"	"unprognostic (2.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.15e-3)"	20.2	27.4	19.2	23.1	20.5	19.3	21.3	0.0	26.9	22.2	0.0	22.9	20.8	23.6	9.4	25.1	26.1	12.4	27.8	20.4	0.3	30.4	17.4	28.3	22.8	4.1	3.5	25.3	34.3	17.0	36.3	9.3	1.4	26.2	10.2	6.5	29.4	18.2	20.8	29.7	26.9	9.8	0.3	33.5	23.2	31.7	6.4	17.6	39.6	9.1	16.5	23.1	21.8	13.3	33.1	37.4	17.1	33.3	11.4	7.6	18.1	16.6	15.6	13.9	16.7	21.4	50.5	22.6	25.3	17.5	34.7	44.4	10.6	18.9	8.4	53.3	20.1	9.1	36.8	17.0	23.3	13.2	19.2	11.6	11.4	21.9	14.3	12.4	26.3	24.2	27.0	49.7	20.9	31.8	29.3	36.3	32.4	24.8	35.5	36.6	9.4	29.6	16.1	25.0	60.6	40.0	22.3	43.3	9.9	16.0	41.4	20.2	39.4	13.3	28.5	36.2	38.6	71.4	24.4	17.3	25.7	23.0	55.4	0.3	0.6	0.2	0.8	0.8	0.5	1.0	0.4	0.6	0.6	1.8	0.2	0.3	0.2	1.1	0.4	1.5	0.4	0.3	19.2	20.5	0.0	26.9	20.4	0.3	4.1	3.5	1.4	0.3	6.4	13.3	16.9	12.8	16.9	23.5	22.0	10.1	4.3	11.1	10.8	14.1	18.9	18.4	17.5	7.2	14.7	23.9	14.6	8.2	16.5	18.6	1.9	17.5	26.2	19.3	12.7	12.7	19.9	6.9	17.8	15.7	2.3	11.8	34.7	27.8	14.5	22.3	13.6	16.4	11.2	11.8	14.7	19.6	14.2	14.5	70.1	88.8	13.4	19.9	14.2	14.0	24.8	5.4	10.3	8.5	21.0	24.4	14.2	18.0	15.9	9.3	14.2	8.4	19.7	7.5	6.6	12.2	11.7	4.4	4.2	16.8	18.5	7.3	12.9	13.4	21.2	9.8
ZMYM4	"KIAA0425, MYM, ZNF198L3, ZNF262"	ENSG00000146463	"Zinc finger MYM-type containing 4"	Q5VZL5	1	35268709-35422058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 127.9;Inhibitory neurons: 136.5;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051301, HPA054802"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA051301: AB_2681431, HPA054802: AB_2682605"	"unprognostic (8.95e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (9.75e-9)"	"unprognostic (9.76e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.21e-1)"	12.1	11.4	13.3	12.5	14.3	13.6	17.2	23.9	15.2	17.2	12.0	11.8	8.9	16.3	15.5	12.7	14.8	13.5	11.2	11.8	14.9	13.3	12.8	12.1	14.4	12.8	13.3	21.7	13.9	18.1	9.3	17.2	14.0	15.0	11.5	24.6	12.2	13.6	14.9	10.9	9.2	13.7	13.8	14.8	13.7	34.2	14.0	20.9	18.4	15.3	17.0	14.6	9.9	16.0	28.1	22.6	67.7	35.0	19.2	41.4	24.9	32.7	49.1	39.1	50.7	24.6	27.6	52.0	19.6	41.3	19.1	17.8	47.3	24.4	56.2	29.5	27.8	63.5	25.0	21.4	35.5	54.7	28.1	31.3	21.1	38.3	35.9	32.4	44.0	28.5	70.0	14.1	47.9	17.4	47.4	32.0	56.3	15.0	19.9	52.4	43.4	26.1	28.7	37.2	39.1	37.5	39.1	29.4	45.7	42.3	23.2	41.4	53.7	36.4	37.8	16.3	35.9	15.3	29.9	40.0	26.2	41.4	35.7	1.8	3.6	2.7	3.1	5.1	2.9	3.2	2.8	2.7	3.5	2.4	2.7	2.6	0.7	6.6	7.1	7.0	2.4	1.9	13.3	14.3	23.9	15.2	11.8	14.9	12.8	13.3	14.0	13.8	14.0	16.0	33.6	12.8	21.9	94.3	17.4	11.5	16.6	14.4	17.1	30.7	31.8	29.1	32.0	25.8	20.8	27.6	31.3	14.7	20.6	6.6	5.9	22.7	59.8	25.0	45.1	22.8	22.3	22.5	127.9	23.7	12.5	27.0	21.9	33.7	14.5	49.1	18.5	16.1	13.1	23.5	136.5	14.7	14.2	23.1	12.5	91.9	26.4	21.4	5.4	109.6	27.5	22.5	26.8	174.4	132.6	19.9	8.1	23.0	13.9	22.7	5.5	11.8	21.6	33.0	19.7	33.4	29.0	34.4	13.3	13.8	11.4	14.1	13.9	45.5	14.0	22.7
ZNF131	"pHZ-10, ZBTB35"	ENSG00000172262	"Zinc finger protein 131"	P52739	5	43065176-43192021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007023, HPA027748, HPA074630"	Approved		Enhanced	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Intermediate filaments"	"HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705"	"unprognostic (1.23e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.46e-2)"	13.2	13.5	12.5	13.9	12.8	28.4	19.5	17.3	21.7	13.8	10.0	13.2	10.0	17.6	9.6	14.4	12.6	12.9	9.6	12.8	12.4	12.0	14.3	11.4	20.3	11.4	11.9	15.9	12.2	11.7	10.7	16.9	11.9	12.6	13.2	14.7	10.4	9.0	15.8	18.2	12.0	15.9	11.3	15.9	11.6	32.6	12.3	26.7	11.8	17.1	17.5	15.0	13.3	14.2	25.4	15.2	32.4	43.2	30.1	20.6	27.3	32.8	26.6	31.9	26.9	24.0	22.2	50.8	25.9	22.1	29.7	17.7	38.9	20.8	44.9	24.8	34.1	31.4	92.2	18.0	27.7	55.0	24.7	18.8	38.2	23.5	38.3	22.8	24.7	39.0	40.7	52.7	36.8	24.5	53.9	68.8	21.5	23.4	24.9	35.3	49.4	39.9	27.1	24.4	20.0	29.4	83.5	39.8	43.2	21.7	22.3	51.6	18.5	39.8	37.3	20.5	31.1	21.1	32.5	58.4	21.0	71.2	27.1	10.4	8.2	5.8	19.1	9.5	19.2	13.1	18.5	18.5	11.9	16.8	22.3	18.3	3.9	17.2	6.6	11.3	14.9	10.0	12.5	12.8	17.3	21.7	12.8	12.4	11.4	11.9	11.9	11.3	12.3	14.2	42.5	22.4	21.9	28.7	44.7	49.6	51.4	24.1	53.5	52.1	32.3	29.7	17.5	22.8	19.4	9.2	52.1	27.0	53.3	28.0	31.3	15.3	52.9	30.0	47.7	32.8	31.2	39.1	31.2	11.8	25.0	32.4	23.0	49.7	24.1	39.4	24.7	13.3	16.4	38.7	33.6	29.7	20.3	25.8	35.4	19.5	20.5	30.9	21.4	14.0	27.5	29.0	49.4	38.7	24.2	17.9	24.7	21.1	27.8	38.5	34.9	13.1	15.7	70.0	26.3	57.0	43.2	109.6	80.3	45.9	65.5	25.4	59.3	37.3	38.7	35.6
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	9.0	6.1	8.6	11.4	10.1	18.6	9.6	17.3	9.9	10.0	10.8	9.7	9.5	10.5	14.4	9.8	10.1	8.4	9.3	7.9	9.3	8.6	9.6	9.1	15.7	9.9	8.8	13.7	7.7	7.9	7.1	10.4	11.2	8.7	9.9	16.1	8.9	8.0	17.3	10.2	8.2	9.5	9.8	11.1	7.7	16.9	9.0	18.9	14.6	11.5	14.1	11.2	8.4	14.9	20.0	18.8	23.4	15.2	18.9	17.4	21.5	21.8	17.3	16.4	17.9	26.7	24.3	19.6	9.7	17.7	14.0	22.5	23.1	17.3	24.5	20.0	27.7	18.5	27.7	18.7	15.6	25.9	17.8	15.3	20.4	22.2	19.4	21.4	16.3	17.9	20.5	23.3	18.3	17.1	24.1	10.6	26.3	23.0	19.9	21.4	21.2	12.3	14.7	24.0	16.1	15.8	24.0	16.0	14.3	20.6	14.9	14.6	15.6	21.4	15.3	15.1	19.6	11.5	21.6	33.4	13.8	14.8	12.5	39.1	24.6	57.3	28.0	24.9	25.0	23.0	24.6	22.9	20.9	18.2	22.8	19.6	45.1	19.4	28.2	10.1	29.7	19.6	8.6	10.1	17.3	9.9	7.9	9.3	9.9	8.8	11.2	9.8	9.0	14.9	17.9	6.4	12.1	6.2	14.7	26.6	34.1	12.1	17.6	9.3	8.7	13.2	15.5	7.2	10.3	5.5	8.4	10.0	17.1	10.1	3.9	12.5	20.3	18.7	14.9	13.0	6.6	25.4	8.1	11.5	16.2	14.5	9.7	16.3	14.0	7.7	6.8	7.6	9.9	5.0	7.4	6.9	14.2	8.3	22.0	10.0	11.8	15.8	10.6	12.2	16.3	15.5	17.5	7.5	9.8	14.1	7.7	6.8	15.4	20.1	6.3	7.7	15.0	14.3	59.2	18.3	16.7	50.5	21.3	12.8	23.4	18.3	18.1	7.3	7.9	26.9
ZNF200		ENSG00000010539	"Zinc finger protein 200"	P98182	16	3222325-3236221	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 17.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 51.8;Spermatocytes: 39.0;Spermatogonia: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018981, HPA059310"	Uncertain		Approved	Mitochondria		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Mitochondria		"HPA018981: AB_1859021, HPA059310: AB_2683974"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.21e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.23e-3)"	3.7	3.0	2.2	5.8	2.3	2.4	4.4	3.1	3.3	3.5	2.2	3.4	4.1	3.8	3.7	3.3	4.3	3.5	3.4	2.4	2.5	3.5	3.9	4.0	7.0	2.5	2.3	4.4	2.2	4.7	2.4	6.3	2.3	3.4	3.6	4.0	2.8	3.4	2.1	3.2	3.2	3.9	2.4	6.1	3.3	17.6	2.4	5.2	3.3	3.6	6.6	4.2	2.9	2.4	7.1	7.3	16.1	11.6	5.9	6.1	19.2	9.1	11.2	12.2	11.2	11.2	5.9	13.6	6.8	7.4	7.2	5.3	13.2	9.8	14.6	12.7	12.2	11.3	9.6	9.5	7.8	19.9	26.0	6.2	8.3	9.0	8.1	7.0	10.8	9.7	12.8	10.3	11.1	6.5	14.0	10.8	25.3	8.8	6.9	16.9	22.0	16.0	7.6	4.0	9.1	13.3	8.6	6.5	7.5	11.0	9.3	21.9	7.4	12.4	11.4	4.5	8.0	25.8	27.1	11.9	3.0	12.3	9.8	32.4	5.3	18.4	10.6	6.8	10.3	7.2	9.4	12.5	6.6	6.9	9.6	10.9	22.1	11.6	6.6	4.2	12.1	7.2	2.2	2.3	3.1	3.3	2.4	2.5	2.5	2.3	2.3	2.4	2.4	2.4	10.7	3.2	3.7	4.2	6.4	3.2	4.5	4.2	1.2	5.4	5.2	5.8	3.9	5.7	5.1	3.7	12.5	7.5	7.4	3.3	3.9	5.0	51.8	3.6	3.2	8.1	6.7	9.1	5.2	4.0	6.7	5.0	0.5	3.1	5.1	5.7	10.4	3.8	7.1	0.0	4.1	3.8	4.1	6.6	5.4	22.6	5.6	6.6	7.2	1.9	6.3	6.7	13.4	5.0	3.4	3.6	6.3	3.0	5.7	4.6	3.7	2.8	3.5	8.1	6.6	7.4	4.5	39.0	44.9	4.3	3.1	5.9	8.5	6.1	3.5	4.0
ZNF202	"ZKSCAN10, ZSCAN42"	ENSG00000166261	"Zinc finger protein 202"	O95125	11	123723914-123741675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 14.7;Spermatogonia: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059229			Approved	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli rim, Mitotic chromosome"	"Nuclear bodies"	"HPA059229: "	"unprognostic (3.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (9.93e-7)"	"unprognostic (2.61e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	5.7	4.7	5.9	6.7	5.9	5.2	7.6	5.9	6.5	8.1	5.7	6.3	4.4	9.7	9.3	6.0	6.8	4.6	4.5	5.7	5.9	6.2	5.1	5.1	8.9	5.4	5.8	10.4	9.7	5.2	5.9	6.2	5.4	7.2	7.9	6.1	6.0	5.3	6.2	8.4	6.5	7.3	4.8	9.9	6.2	9.8	5.8	6.7	6.9	3.9	8.7	6.9	6.4	6.8	6.0	9.3	15.3	18.5	6.6	10.1	11.9	9.3	7.4	8.5	7.6	10.5	15.7	17.7	8.6	7.2	13.7	14.3	15.9	10.6	11.7	7.3	8.9	31.5	6.6	10.2	9.0	18.5	8.9	7.2	21.0	9.7	28.7	7.3	10.0	14.8	17.1	11.8	11.2	6.3	16.0	25.3	25.2	21.0	12.8	19.2	9.5	6.5	8.3	11.4	11.3	12.6	7.8	9.4	6.2	12.5	17.8	12.8	8.7	16.3	10.5	11.8	9.5	7.6	5.9	12.1	4.3	20.2	10.8	0.0	1.2	0.0	1.7	1.8	1.6	1.6	2.3	2.5	1.9	1.9	2.6	2.4	0.0	1.6	0.7	1.2	2.2	1.7	5.9	5.9	5.9	6.5	5.7	5.9	5.4	5.8	5.4	4.8	5.8	6.8	3.1	6.4	0.5	7.8	3.8	2.9	3.8	1.9	0.6	3.1	3.4	3.2	3.1	2.8	9.7	3.7	0.0	2.2	2.1	1.5	1.9	2.2	5.1	1.4	3.3	3.1	3.0	1.7	8.9	3.5	1.7	2.8	4.6	2.0	3.8	6.0	2.2	1.9	1.8	6.7	8.3	3.9	0.0	2.0	2.0	5.0	1.8	3.1	0.0	3.7	1.6	2.4	1.0	6.6	11.0	3.2	2.4	1.2	3.6	2.5	1.0	1.4	1.3	3.1	6.6	5.0	2.2	14.7	14.5	3.6	3.0	0.8	3.0	3.1	3.2	2.9
ZNF214		ENSG00000149050	"Zinc finger protein 214"	Q9UL59	11	6997085-7020346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 6.6;Endometrial ciliated cells: 6.6;Excitatory neurons: 10.5;Respiratory ciliated cells: 10.4;Spermatocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 3.5"									HPA055391	Uncertain		Approved	Nucleoplasm,Midbody		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Midbody	"HPA055391: AB_2682804"	"unprognostic (3.01e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.77e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.53e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-2)"	0.6	1.0	1.0	0.2	1.2	0.0	2.1	0.8	1.5	2.3	1.8	1.2	0.5	2.3	2.7	0.5	3.9	0.8	0.8	0.9	1.1	2.4	1.2	1.2	0.2	1.8	1.7	4.2	1.0	2.5	1.3	0.1	1.1	2.0	1.1	5.3	0.9	2.1	0.4	0.4	0.6	1.7	1.2	0.2	0.7	3.1	1.0	0.2	3.4	0.5	0.2	1.4	1.3	1.4	0.4	0.8	3.3	0.0	0.6	2.2	0.8	1.3	3.5	1.7	1.9	0.0	2.4	0.1	0.4	0.9	1.1	0.5	0.3	0.9	1.9	0.0	0.9	0.0	0.5	0.2	1.2	0.0	0.1	0.6	2.2	0.0	1.9	2.3	1.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	2.6	1.3	0.1	0.1	1.3	0.5	0.0	0.2	1.1	1.4	3.0	0.0	0.0	0.0	0.0	1.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.5	0.9	1.1	1.8	1.7	1.1	1.2	1.0	1.4	0.5	0.0	1.5	4.6	0.1	0.0	2.0	1.6	0.6	2.5	1.1	1.5	0.9	1.5	2.7	0.0	0.0	0.1	0.0	0.4	1.9	2.1	6.6	6.6	2.0	0.6	2.4	0.0	10.5	0.9	0.4	1.5	0.0	0.9	0.0	1.2	0.0	0.4	0.1	3.3	5.5	1.7	0.0	0.0	0.5	1.0	0.6	0.2	0.0	2.8	0.0	3.0	0.0	4.0	2.9	1.1	0.1	0.4	0.0	0.6	0.8	3.3	10.4	3.6	0.0	0.8	0.9	10.4	3.3	0.9	0.1	0.0	0.2	0.8	0.9	0.4
ZNF22	"HKR-T1, KOX15, Zfp422, ZNF422"	ENSG00000165512	"Zinc finger protein 22"	P17026	10	45000923-45005326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 184.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016736, HPA054893"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA016736: AB_1859133, HPA054893: AB_2682632"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.31e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.11e-5)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.39e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-2)"	28.3	13.5	19.8	21.9	21.3	25.7	41.1	20.5	26.1	22.8	18.1	21.0	18.9	30.6	23.5	10.9	25.7	17.6	23.9	19.1	21.0	25.2	38.7	23.1	36.1	25.1	20.7	35.8	39.6	13.3	8.6	40.0	21.5	22.8	21.6	19.2	22.7	19.6	21.1	8.4	18.2	23.9	21.4	27.1	22.8	9.0	20.9	70.4	23.9	25.7	35.1	18.1	10.9	22.9	46.7	7.4	63.3	39.3	32.1	23.2	0.5	21.6	44.5	54.7	58.8	25.5	38.6	48.4	33.5	32.5	12.0	7.8	62.1	23.2	77.3	30.3	1.1	50.3	11.3	0.3	68.8	98.5	17.0	41.6	33.3	22.3	0.9	0.5	87.7	127.8	67.8	84.9	43.7	1.4	184.0	148.5	38.0	26.8	12.9	133.8	87.8	69.4	43.0	39.2	60.5	52.7	19.3	38.8	32.3	57.5	8.4	96.7	48.4	39.2	72.2	27.2	73.3	48.0	51.0	46.4	24.4	3.6	42.6	28.2	28.1	37.6	51.7	27.5	62.5	42.2	33.6	53.8	37.8	54.4	45.3	56.6	2.9	70.8	18.3	64.7	21.1	38.1	19.8	21.3	20.5	26.1	19.1	21.0	25.1	20.7	21.5	21.4	20.9	22.9	69.3	28.9	27.4	5.9	45.7	19.2	65.5	34.1	42.1	33.6	51.2	68.6	9.9	68.6	25.2	33.1	10.4	71.7	48.0	7.0	56.7	58.7	6.3	22.1	48.7	72.9	40.0	67.5	5.0	43.3	55.8	49.5	21.4	25.4	33.5	59.1	91.8	58.6	49.3	38.7	7.6	37.2	38.7	28.7	28.4	3.6	44.4	32.7	19.6	4.7	61.4	57.2	89.6	7.5	11.3	35.7	15.1	51.1	31.9	57.9	6.9	54.6	28.4	32.7	32.9	77.1	48.4	40.1	37.1	23.9	13.2	53.2	36.4	58.7	34.7	27.6
ZNF226		ENSG00000167380	"Zinc finger protein 226"	Q9NYT6	19	44165073-44178381	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006145, CAB034353"	Uncertain		Approved	"Nuclear bodies"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"		"CAB034353: AB_2219110, HPA006145: AB_10696203"	"unprognostic (1.30e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (8.34e-4)"	"unprognostic (4.09e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.37e-5)"	13.5	31.5	14.5	12.2	18.6	11.7	20.5	23.1	20.6	13.4	18.5	14.1	13.8	13.9	25.6	10.6	16.1	16.9	16.5	15.0	18.0	18.5	17.9	12.8	20.2	16.5	16.4	20.1	9.4	21.8	32.9	12.1	18.0	21.2	14.5	31.1	12.4	15.7	10.0	12.7	14.8	12.3	18.0	18.7	16.2	17.2	16.4	20.7	23.8	7.2	15.9	15.1	11.4	26.0	18.6	20.3	22.4	16.5	20.8	33.1	10.1	19.0	42.6	20.9	38.0	14.3	22.5	6.6	23.5	24.5	28.9	10.1	9.9	18.8	25.1	10.6	23.7	26.3	25.8	10.8	18.2	17.1	17.1	37.6	24.3	25.4	50.9	40.2	27.7	19.6	5.6	6.3	40.4	6.1	18.7	7.2	10.9	10.8	15.0	11.2	17.9	13.3	20.5	50.9	16.0	25.5	38.2	13.9	9.1	21.9	22.6	24.6	21.7	19.1	23.4	10.5	22.8	31.0	30.6	19.7	17.4	11.7	20.9	53.8	14.7	10.1	22.1	15.6	25.1	19.8	22.2	21.8	17.9	28.2	25.9	22.9	11.4	26.4	13.6	19.3	26.8	13.4	14.5	18.6	23.1	20.6	15.0	18.0	16.5	16.4	18.0	18.0	16.4	26.0	15.1	16.0	13.8	20.5	19.6	4.0	17.0	48.2	8.6	39.8	14.2	14.7	27.6	14.3	30.9	11.0	27.1	13.5	19.8	13.0	35.2	22.7	20.2	24.4	12.3	17.1	12.1	19.1	13.4	27.7	7.5	15.6	16.3	17.0	11.4	25.2	16.1	24.8	18.0	21.9	14.2	18.5	30.5	16.0	7.4	7.4	19.3	12.1	21.4	9.4	22.9	29.3	36.0	17.1	35.8	26.1	19.3	22.2	7.7	20.4	20.9	47.4	37.1	30.7	6.6	13.6	15.0	15.0	21.8	9.2	5.8	12.9	18.4	36.6	10.6	20.5
ZNF230	FDZF2	ENSG00000159882	"Zinc finger protein 230"	Q9UIE0	19	44002957-44013924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA006172			Approved	Mitochondria		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA006172: AB_2667532"	"unprognostic (3.55e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.08e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.14e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.42e-5)"	2.0	2.1	1.1	2.2	1.3	3.2	3.2	2.8	2.0	2.3	1.5	2.0	1.3	2.3	2.1	1.4	2.5	1.6	1.8	1.1	1.4	1.7	2.1	2.4	3.4	1.2	1.3	4.2	1.4	2.7	2.7	2.4	1.4	2.2	2.0	4.6	1.9	2.5	0.8	2.9	2.4	1.8	1.3	3.9	1.9	1.8	1.3	4.0	3.0	1.9	3.9	2.0	1.7	1.8	2.1	1.7	3.4	3.5	2.7	3.3	1.3	2.9	2.9	2.6	4.7	1.0	1.1	1.7	1.9	2.1	1.6	1.7	2.9	2.6	3.9	2.1	3.6	2.9	4.1	1.2	1.5	3.8	2.4	2.5	2.4	2.9	3.0	3.5	1.8	2.0	0.5	0.0	2.7	1.1	4.3	2.7	2.0	1.4	1.6	3.1	4.7	0.8	1.5	2.4	1.9	4.3	4.1	1.4	2.1	2.3	1.2	8.7	2.3	4.1	3.0	1.2	2.2	2.1	2.2	0.3	2.0	2.8	2.6	6.2	3.3	8.7	3.6	4.0	3.8	4.2	4.1	3.7	3.6	4.2	4.5	4.2	11.5	2.9	2.0	2.2	3.7	2.9	1.1	1.3	2.8	2.0	1.1	1.4	1.2	1.3	1.4	1.3	1.3	1.8	4.7	0.0	2.2	1.6	8.3	2.8	2.6	3.0	4.6	8.5	3.3	3.9	6.0	10.0	3.5	3.7	16.7	4.0	9.9	2.7	3.9	3.0	2.7	2.9	3.3	4.2	1.2	2.1	4.6	2.4	3.2	4.4	2.6	1.7	1.3	4.8	3.9	2.7	3.2	8.4	3.8	2.4	10.2	4.4	3.3	1.7	6.5	3.6	3.6	3.7	7.9	5.4	7.2	2.5	4.0	1.2	0.8	4.5	1.4	2.0	4.1	1.6	2.9	9.6	6.6	3.9	4.3	13.7	7.9	2.8	2.7	3.1	6.7	3.7	3.2	2.0
ZNF25	"FLJ31890, KOX19, Zfp9"	ENSG00000175395	"Zinc finger protein 25"	P17030	10	37949573-37976647	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 44.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030190	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA030190: AB_10602687"	"unprognostic (9.42e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.61e-1)"	10.2	10.1	12.3	3.5	12.5	2.6	8.2	12.5	19.1	9.7	4.1	12.3	2.2	9.9	6.1	5.4	9.2	6.1	10.0	12.5	15.9	5.7	3.0	6.4	4.8	11.9	10.9	11.1	5.4	7.6	14.3	4.7	12.4	7.3	4.4	10.6	4.6	8.9	22.3	4.8	5.3	8.9	9.8	6.5	5.8	4.7	14.6	4.6	6.0	21.5	4.3	8.8	7.1	12.6	1.6	3.0	3.3	6.7	12.1	9.2	0.6	3.6	4.9	2.8	4.2	0.5	2.3	3.1	1.0	6.4	1.0	0.4	0.9	1.5	4.5	7.3	1.6	5.0	0.0	1.0	7.7	3.3	3.1	6.5	6.6	3.1	3.6	11.1	4.9	4.0	0.4	2.3	6.9	1.0	1.1	2.6	0.6	0.6	2.2	1.2	3.7	0.6	3.3	0.6	1.2	7.6	1.2	0.2	4.7	1.2	2.9	5.3	7.1	4.3	0.8	7.1	2.2	2.8	1.4	1.3	8.2	6.3	2.9	1.3	1.5	3.4	1.6	2.5	1.7	1.0	1.4	1.3	1.9	1.3	1.8	1.5	0.2	1.0	5.2	0.3	1.2	1.2	12.3	12.5	12.5	19.1	12.5	15.9	11.9	10.9	12.4	9.8	14.6	12.6	10.0	3.2	3.2	17.9	4.8	3.4	2.5	2.5	3.4	17.3	3.8	3.6	23.6	4.3	2.9	7.3	6.2	1.2	3.5	1.0	1.9	2.0	27.9	2.4	7.0	7.6	0.0	2.1	46.7	2.5	0.5	10.6	4.1	2.7	8.2	8.2	10.4	2.9	5.7	16.8	44.6	1.2	4.1	13.2	6.8	41.9	12.2	9.5	3.6	14.0	8.1	13.7	5.2	38.2	36.7	1.8	0.3	16.1	1.5	2.6	1.3	3.1	8.1	7.1	0.0	11.4	10.4	4.4	6.4	2.4	4.0	0.3	5.2	4.8	0.8	1.3
ZNF250	"MGC9718, ZFP647, ZNF647"	ENSG00000196150	"Zinc finger protein 250"	P15622	8	144876497-144902168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020853	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA020853: AB_1859152"	"unprognostic (1.16e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.43e-7)"	"unprognostic (2.23e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-2)"	"prognostic favorable (8.26e-4)"	4.7	3.9	3.2	3.3	3.2	2.9	5.6	10.5	4.7	9.7	2.3	6.9	4.8	7.4	2.8	6.4	7.6	3.3	4.9	2.4	4.5	7.6	4.0	5.1	3.0	3.0	3.2	9.7	4.9	6.0	7.3	5.5	3.3	7.5	3.6	7.9	6.0	5.2	4.8	10.9	5.2	4.2	1.5	5.5	4.9	4.5	3.3	4.5	10.0	5.8	3.3	6.3	8.6	3.4	5.1	2.9	13.4	11.1	6.8	5.9	4.3	5.6	6.4	9.4	7.7	2.4	3.9	12.0	9.8	6.5	3.8	6.6	5.3	4.8	6.0	3.8	7.8	10.8	14.9	3.5	2.0	1.8	3.6	3.9	6.5	5.6	4.5	7.2	3.9	7.1	8.6	11.5	7.9	6.8	12.6	4.1	4.0	6.0	12.5	14.4	5.9	5.0	7.8	3.7	13.2	10.1	11.8	4.4	5.3	5.3	6.3	6.1	5.1	9.2	8.8	7.3	5.3	5.6	5.1	8.0	4.7	6.2	4.1	3.2	5.1	5.8	10.5	2.7	8.1	10.3	7.7	5.8	6.6	9.7	8.9	7.3	2.9	6.0	3.7	2.6	11.7	4.5	3.2	3.2	10.5	4.7	2.4	4.5	3.0	3.2	3.3	1.5	3.3	3.4	5.8	12.8	3.0	10.7	10.7	5.5	3.2	7.5	10.2	8.4	4.3	6.6	4.3	1.5	3.9	5.5	0.0	2.3	18.6	2.4	3.9	7.5	7.4	5.1	6.0	5.5	4.2	1.7	11.9	1.9	1.3	5.2	2.6	4.9	2.5	6.3	5.0	2.1	1.7	8.4	17.5	1.9	12.2	2.2	8.0	3.0	4.1	3.0	5.4	4.7	2.0	3.3	5.2	11.1	7.8	2.6	1.0	5.3	8.2	3.3	3.7	3.4	5.0	9.9	13.1	4.1	6.1	14.3	8.7	4.4	5.5	1.9	10.9	4.9	3.4	2.3
ZNF263	"FPM315, ZKSCAN12, ZSCAN44"	ENSG00000006194	"Zinc finger protein 263"	O14978	16	3263800-3301401	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035085, HPA035086"	Approved		Supported	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Mitotic spindle"	"HPA035085: AB_10671099, HPA035086: AB_10603244"	"unprognostic (2.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.98e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.66e-1)"	20.8	18.3	18.3	16.8	18.1	19.1	24.1	20.4	22.5	20.2	20.3	20.1	14.5	22.9	23.2	15.4	24.5	16.7	15.1	19.1	17.7	20.4	17.6	19.4	22.6	20.1	17.6	29.2	21.5	30.7	23.4	20.4	17.2	21.4	17.0	24.6	20.2	20.2	17.3	24.0	19.3	18.7	16.6	23.2	22.0	18.1	18.2	22.3	20.0	13.7	21.5	19.5	17.5	20.5	19.7	25.1	27.6	40.8	22.7	28.8	36.6	26.1	38.6	30.0	32.2	27.5	30.3	74.2	26.5	33.6	28.6	25.7	38.6	26.4	29.9	41.6	41.3	31.4	35.6	25.6	25.7	48.8	38.5	34.0	53.3	27.6	40.0	33.5	26.2	44.5	37.9	47.4	24.8	25.5	43.9	37.2	55.7	23.2	19.2	70.4	29.8	57.6	20.7	18.4	40.6	43.8	27.9	30.0	30.9	32.5	32.8	57.7	30.1	31.4	30.9	23.3	25.4	50.8	60.8	88.0	12.9	23.6	23.8	1.4	2.5	6.4	3.5	2.4	4.0	2.5	4.2	4.7	3.5	4.4	5.4	3.8	3.0	4.5	3.4	2.9	3.1	1.9	18.3	18.1	20.4	22.5	19.1	17.7	20.1	17.6	17.2	16.6	18.2	20.5	15.9	0.0	11.5	8.8	16.6	17.5	17.1	3.7	16.5	12.5	13.9	12.8	4.6	15.7	5.0	1.8	0.0	11.5	16.1	8.7	7.9	10.2	60.9	10.5	8.8	12.8	13.2	6.3	7.9	10.0	11.1	11.9	11.2	13.5	7.0	14.3	10.0	7.1	9.1	3.3	6.7	12.1	10.2	9.4	14.3	35.1	8.1	9.5	16.0	7.5	8.4	9.8	19.6	8.0	7.8	10.3	6.0	7.9	11.8	16.3	7.5	6.3	5.7	9.0	13.1	17.5	17.3	13.0	11.1	14.3	20.6	11.1	15.0	15.2	12.3	13.6
ZNF286A	"KIAA1874, ZNF286"	ENSG00000187607	"Zinc finger protein 286A"	Q9HBT8	17	15699577-15720787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Oligodendrocytes: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 120.0"									HPA021594			Approved	Nucleoli		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA021594: AB_2670768"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.47e-4)"	"unprognostic (4.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.94e-2)"	5.4	7.8	8.9	6.7	11.2	3.8	8.1	12.0	10.4	9.3	6.6	5.8	3.8	12.7	11.7	10.1	8.6	9.0	15.9	9.5	10.4	7.8	4.1	5.1	8.6	10.8	10.4	17.4	3.9	14.4	5.7	5.7	10.7	8.4	4.7	11.3	5.0	8.7	4.0	5.6	3.8	10.8	9.0	5.6	5.5	11.0	10.0	12.9	10.3	10.0	8.7	8.9	5.9	14.9	37.4	40.5	56.3	26.4	16.6	23.9	18.7	17.9	14.1	28.1	20.7	24.6	12.8	33.9	13.9	12.5	23.5	31.4	42.4	19.7	34.6	25.1	32.3	23.8	42.2	20.6	16.1	11.0	10.0	21.2	12.1	25.5	26.1	30.8	37.3	54.0	19.7	5.9	39.5	10.2	49.5	9.9	54.5	21.6	9.4	37.0	85.3	16.6	19.5	13.9	18.9	41.1	35.4	15.4	12.1	120.0	15.0	6.3	16.1	16.3	18.0	14.6	24.9	14.0	24.2	0.2	20.4	0.3	19.8	1.2	1.5	1.0	6.1	1.7	6.4	3.7	7.0	6.3	2.5	6.8	8.1	8.6	1.0	6.0	3.9	2.2	9.4	2.5	8.9	11.2	12.0	10.4	9.5	10.4	10.8	10.4	10.7	9.0	10.0	14.9	2.4	19.2	0.0	5.9	5.5	7.0	5.1	2.5	15.4	1.6	3.5	2.7	4.3	1.5	5.5	1.8	2.1	1.3	3.0	0.4	1.9	4.1	16.1	1.3	5.0	4.4	5.4	4.6	9.5	1.6	1.8	5.2	4.1	1.5	3.8	3.4	2.5	0.8	1.3	3.3	9.9	2.2	0.0	0.8	1.5	13.0	5.0	1.5	1.8	2.8	1.1	1.6	3.1	17.6	17.9	3.7	1.5	5.3	7.8	4.8	0.7	2.7	3.4	2.0	0.0	2.3	4.1	11.9	5.3	9.0	5.5	1.2	5.9	3.5	1.7	4.9
ZNF3	"A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113"	ENSG00000166526	"Zinc finger protein 3"	P17036	7	100064033-100082548	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003719	Supported	Supported	Approved	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003719: AB_1080701"	"unprognostic (5.92e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.73e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (2.20e-4)"	13.3	11.1	18.5	9.9	21.1	27.1	19.8	20.4	20.6	17.7	20.0	16.9	20.3	21.3	22.2	13.5	36.5	11.9	11.8	18.7	19.0	15.1	18.6	12.3	12.9	21.3	21.0	21.7	16.0	19.2	13.0	11.7	21.4	14.9	18.4	14.9	14.3	15.7	18.3	13.9	21.0	14.2	20.3	13.9	16.6	8.8	19.9	18.6	18.5	19.5	15.5	14.3	13.8	26.1	13.2	14.1	39.1	54.9	18.8	14.5	23.1	16.8	18.5	23.8	20.4	18.4	19.0	19.2	28.8	15.7	19.6	17.2	29.3	18.2	19.8	20.1	23.7	15.5	20.8	26.6	22.4	28.7	13.6	18.5	21.5	16.8	37.3	26.4	21.4	27.6	44.9	29.3	22.0	36.1	67.3	28.9	54.9	24.2	25.7	27.7	31.4	49.0	22.8	25.9	40.9	60.5	20.1	57.2	26.1	37.1	16.5	27.1	17.5	29.5	21.8	22.0	22.0	39.9	47.3	38.1	14.8	24.6	29.3	13.1	10.2	19.5	14.2	9.8	16.6	13.4	11.8	14.7	10.5	15.5	13.6	14.9	3.9	18.6	14.5	11.8	12.7	10.1	18.5	21.1	20.4	20.6	18.7	19.0	21.3	21.0	21.4	20.3	19.9	26.1	13.5	12.8	31.9	8.1	16.9	7.6	10.0	8.1	12.0	18.7	15.1	12.2	10.5	14.3	13.2	3.7	16.7	12.5	12.6	17.0	7.9	19.3	2.7	42.3	16.1	17.4	26.3	26.1	5.8	11.1	7.6	16.4	15.8	13.0	15.2	28.5	14.6	14.5	6.6	18.5	6.2	20.0	10.2	12.6	5.9	1.8	15.2	7.8	3.6	2.8	11.5	16.5	30.9	9.0	20.4	16.1	18.1	15.1	11.6	12.7	32.5	13.5	32.1	19.5	6.6	9.3	12.1	16.2	17.0	9.9	8.9	10.4	11.1	14.0	20.1	8.2
ZNF302	"ZNF135L, ZNF140L, ZNF327"	ENSG00000089335	"Zinc finger protein 302"	Q9NR11	19	34677639-34686397	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 203.2;choroid plexus: 142.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA059503			Approved	"Vesicles,Cytokinetic bridge"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytokinetic bridge"		"HPA059503: AB_2684043"	"unprognostic (3.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (9.85e-5)"	13.7	18.1	139.4	10.2	142.4	4.6	24.0	142.8	203.2	17.5	142.3	20.0	12.4	19.5	21.6	9.1	18.5	11.1	25.4	139.0	140.3	19.8	19.0	14.6	17.8	140.2	141.5	28.0	24.4	21.5	16.7	11.9	141.4	18.0	15.4	45.2	13.5	18.8	37.2	12.8	15.7	14.8	140.7	19.4	14.9	15.5	140.7	17.2	19.1	30.4	16.7	18.0	12.1	147.3	10.5	16.0	33.3	13.2	30.8	23.6	11.6	17.8	21.8	16.0	17.3	11.9	9.5	16.3	21.7	13.5	12.0	8.5	16.3	10.4	17.1	1.3	13.6	31.2	18.0	0.3	16.5	0.3	2.4	22.3	15.0	9.9	1.8	20.0	13.8	11.4	0.3	0.9	25.2	5.5	16.9	16.7	15.1	18.9	10.6	12.5	27.0	9.1	16.9	14.0	14.8	24.1	16.2	6.0	21.9	17.7	12.7	24.8	13.6	7.4	17.6	6.8	8.9	18.6	35.1	5.1	6.8	2.4	33.9	28.1	10.1	17.2	14.9	10.0	20.7	23.3	17.0	14.0	8.8	25.0	28.0	22.3	7.5	19.4	13.4	20.3	14.9	9.1	139.4	142.4	142.8	203.2	139.0	140.3	140.2	141.5	141.4	140.7	140.7	147.3	32.2	28.9	27.6	41.8	33.2	26.8	34.0	16.0	19.9	56.5	24.4	30.9	58.9	25.8	22.1	22.0	52.1	16.8	26.6	10.4	45.0	17.5	31.3	12.7	29.7	34.3	19.9	20.8	41.5	11.4	6.8	41.0	21.4	11.8	29.1	63.0	28.5	11.8	10.1	48.8	42.4	13.4	14.2	14.5	44.9	6.3	59.4	15.7	24.9	29.0	17.8	73.5	42.2	54.8	76.1	10.0	16.4	51.1	14.8	40.1	20.6	14.3	25.6	88.8	52.6	73.5	40.5	67.0	40.2	15.7	21.5	5.5	29.3	44.8	11.6	30.8
ZNF32	"KOX30, Zfp637, ZNF637"	ENSG00000169740	"Zinc finger protein 32"	P17041	10	43643860-43648881	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039148			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies"	Nucleoplasm	"HPA039148: AB_2676365"	"unprognostic (1.05e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.15e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.90e-3)"	"prognostic favorable (3.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (6.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	33.2	33.2	69.4	13.2	71.9	8.3	45.9	71.0	101.5	46.0	69.0	56.7	12.7	42.9	57.5	23.1	40.0	23.4	60.0	69.0	70.8	49.9	32.4	26.5	22.1	71.3	71.0	52.8	48.1	47.7	45.1	16.6	70.4	48.5	23.4	40.8	31.0	38.1	84.3	31.5	29.6	36.8	70.1	36.0	37.8	16.2	70.9	32.8	41.9	72.9	25.9	41.2	32.9	73.3	25.0	21.8	32.3	48.9	58.1	62.1	10.6	21.9	65.5	39.9	35.8	14.8	12.5	0.1	37.7	46.7	18.8	14.5	20.7	21.2	29.2	27.5	23.0	6.6	13.2	17.2	54.4	0.7	19.7	64.1	48.0	24.7	29.7	38.2	30.6	86.8	19.5	0.0	50.9	22.8	25.2	22.8	25.2	25.2	11.3	38.5	36.3	5.7	40.8	9.7	41.2	36.7	18.1	13.3	35.4	35.3	49.0	23.0	13.1	22.3	26.8	16.4	5.4	14.3	40.2	0.1	8.0	15.9	21.1	14.0	13.9	18.2	36.5	12.9	36.8	26.0	29.2	41.1	22.9	27.2	37.0	41.6	1.1	50.4	11.6	19.3	22.8	20.7	69.4	71.9	71.0	101.5	69.0	70.8	71.3	71.0	70.4	70.1	70.9	73.3	26.1	9.6	14.3	14.0	18.8	11.0	24.4	28.6	33.0	23.2	41.4	57.8	11.7	22.8	16.9	18.4	8.4	18.0	31.9	7.5	105.7	44.7	2.3	16.2	25.6	23.8	27.7	16.8	9.7	47.4	17.1	27.3	16.3	11.5	30.4	34.1	25.7	25.5	29.4	16.8	11.1	16.0	22.4	22.3	10.1	2.1	42.3	19.0	17.8	9.4	15.8	52.7	58.7	16.6	23.0	28.4	10.3	54.5	9.5	36.2	10.0	53.1	12.6	24.1	32.9	38.3	34.2	17.0	14.3	26.4	15.3	6.7	27.1	33.0	17.9	17.9
ZNF324	"ZF5128, ZNF324A"	ENSG00000083812	"Zinc finger protein 324"	O75467	19	58467045-58475436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 37.0;Horizontal cells: 33.7;Rod photoreceptor cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 54.2"									HPA039774	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA039774: AB_10673149"	"unprognostic (8.60e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.74e-5)"	"unprognostic (6.39e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (3.56e-1)"	3.4	3.9	4.8	3.4	4.9	6.7	3.7	6.3	6.0	4.6	2.8	4.1	4.3	5.0	3.2	5.9	5.2	2.9	3.4	5.1	4.2	3.1	5.7	3.2	3.1	4.7	3.9	5.8	7.0	4.4	6.6	2.9	3.8	4.6	2.2	3.0	4.7	4.2	3.0	6.6	3.9	3.3	2.9	3.9	4.4	4.4	3.4	6.8	4.8	2.6	2.9	4.4	3.8	4.8	7.8	8.9	5.0	10.1	5.3	5.0	7.2	6.3	6.4	5.6	5.0	8.5	4.2	11.2	5.9	4.3	7.6	9.3	6.4	6.6	2.1	10.5	54.2	6.9	6.7	3.6	4.5	12.3	9.2	3.9	8.5	7.1	3.3	5.1	3.7	7.9	11.4	7.1	6.0	6.0	12.5	6.6	5.4	6.4	12.9	13.9	6.5	7.3	3.8	15.5	11.8	9.5	6.5	10.8	3.8	3.6	4.9	10.1	6.4	17.6	3.9	6.4	11.2	10.4	12.0	5.8	9.5	6.7	6.5	2.3	5.3	8.9	10.5	5.9	11.5	5.8	8.0	11.6	3.8	6.2	12.1	9.7	15.6	7.3	4.5	7.0	8.8	4.2	4.8	4.9	6.3	6.0	5.1	4.2	4.7	3.9	3.8	2.9	3.4	4.8	4.8	0.0	1.7	5.2	8.4	9.1	5.5	3.1	2.2	37.0	10.3	7.5	7.5	2.8	3.8	0.0	25.0	4.8	6.9	9.9	0.0	4.9	1.2	6.3	6.3	5.5	7.8	6.5	5.6	4.1	3.8	6.0	6.6	3.6	1.3	11.3	7.5	3.6	2.9	33.7	6.3	7.9	6.1	2.4	3.7	1.6	12.8	3.2	3.6	7.5	4.1	15.8	7.2	4.5	6.7	4.2	12.4	14.7	5.6	8.0	9.0	2.3	5.8	57.2	6.6	11.7	8.5	19.4	15.8	4.8	13.4	6.7	7.6	11.2	6.3	3.8
ZNF326	"FLJ20403, ZAN75, Zfp326, ZIRD"	ENSG00000162664	"Zinc finger protein 326"	Q5BKZ1	1	89995110-90035533	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 52.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 373.2;Rod photoreceptor cells: 458.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028450, HPA028461, HPA028466"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 79: Retina - Phototransduction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677"	"prognostic favorable (9.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.84e-4)"	11.0	9.5	5.9	5.5	7.2	21.0	11.1	8.9	6.7	13.5	6.8	12.8	8.8	12.5	7.4	15.3	11.0	5.3	10.4	7.1	5.2	12.2	12.8	8.5	6.9	7.3	6.5	17.2	17.0	4.5	10.3	6.2	7.3	9.3	8.5	52.6	13.4	3.9	9.8	10.2	12.6	5.0	6.7	8.0	10.3	6.9	5.8	5.3	10.9	2.4	6.0	9.6	12.4	10.2	9.2	6.9	17.9	7.1	6.1	4.3	16.4	11.1	4.5	6.6	5.0	7.2	8.1	13.3	5.7	5.6	6.3	9.5	10.8	7.2	8.8	5.9	7.2	10.6	14.3	7.0	2.4	12.6	6.1	4.3	4.3	6.8	5.7	8.5	4.6	7.8	11.7	5.8	7.1	4.0	13.3	9.6	11.2	6.1	8.0	11.1	11.1	3.0	6.2	15.5	11.3	10.9	10.1	10.6	5.0	10.2	7.8	4.2	8.0	9.3	7.7	8.3	8.4	7.2	3.8	8.8	2.7	10.1	5.3	1.0	1.1	1.2	0.9	1.4	0.8	0.9	0.8	0.9	0.7	1.5	0.8	1.0	0.8	2.0	1.5	1.7	0.6	0.4	5.9	7.2	8.9	6.7	7.1	5.2	7.3	6.5	7.3	6.7	5.8	10.2	43.0	22.4	50.9	48.0	40.5	65.1	61.5	43.3	37.0	140.8	35.3	39.0	39.2	28.6	43.4	23.9	373.2	46.4	46.7	81.6	19.6	54.2	5.1	45.0	50.3	43.5	70.3	66.9	29.1	54.8	85.3	35.6	35.2	48.9	51.8	68.4	29.6	35.1	26.1	69.0	35.1	47.8	38.7	19.4	38.2	7.3	43.2	34.0	39.2	28.1	40.9	57.0	28.8	58.8	61.3	47.7	70.6	33.8	33.0	53.8	61.0	19.6	44.6	458.4	26.3	45.0	53.6	58.5	35.8	53.2	45.3	49.4	31.6	71.0	50.0	82.0
ZNF33A	"FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK"	ENSG00000189180	"Zinc finger protein 33A"	Q06730	10	38010650-38065088	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.69e-3)"	"unprognostic (7.96e-3)"	"unprognostic (4.89e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.39e-3)"	9.2	12.6	5.8	12.2	7.0	12.2	17.9	17.1	7.6	14.5	9.6	12.2	13.4	15.1	10.9	9.3	14.9	11.8	9.0	5.0	7.8	15.3	16.3	10.1	14.8	9.5	7.1	14.8	16.9	17.1	14.0	11.4	9.9	15.1	15.8	20.6	14.9	14.3	13.9	13.9	13.7	10.3	6.7	14.2	16.7	4.3	6.8	14.0	15.7	15.8	16.2	11.0	10.3	8.4	16.3	9.1	16.2	14.1	7.8	9.8	12.8	7.3	7.1	9.1	10.2	9.7	14.5	31.5	7.7	9.8	5.2	10.6	19.3	12.6	8.5	18.9	22.0	25.2	18.6	13.2	7.9	36.0	20.2	8.6	22.5	6.9	10.1	17.0	7.5	17.7	13.5	16.5	9.3	10.6	15.0	8.2	16.4	8.2	10.5	12.9	11.2	14.8	12.8	15.0	12.6	19.8	11.3	12.3	6.4	11.2	14.8	9.5	7.3	8.0	11.7	9.0	5.8	13.0	17.1	18.5	7.4	19.7	3.7	12.7	3.6	6.1	5.4	5.0	4.7	6.4	4.7	3.6	3.4	6.2	5.8	4.6	15.9	4.7	6.6	6.3	3.6	3.1	5.8	7.0	17.1	7.6	5.0	7.8	9.5	7.1	9.9	6.7	6.8	8.4	28.4	60.9	73.0	39.8	47.5	11.9	33.0	25.6	19.4	38.2	33.4	28.6	70.6	31.5	49.0	27.6	33.3	28.4	43.1	27.1	25.4	34.9	4.6	62.8	19.3	31.6	34.1	30.3	47.4	29.2	20.0	23.5	25.5	37.7	33.6	47.6	21.4	39.6	19.4	30.3	63.9	28.2	18.3	22.8	16.8	6.7	23.9	26.1	10.6	58.1	46.9	21.1	38.1	56.3	81.5	32.0	29.6	24.0	32.1	38.9	22.0	39.3	80.8	31.8	26.3	32.7	22.7	15.3	18.9	18.7	12.8	35.6	34.6	33.2	27.5	38.4
ZNF33B	"KOX2, KOX31, ZNF11B"	ENSG00000196693	"Zinc finger protein 33B"	Q06732	10	42574185-42638570	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (3.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.61e-2)"	4.7	9.8	3.9	5.9	4.9	3.1	20.6	9.8	5.1	9.5	9.5	9.1	8.9	11.7	7.6	7.4	18.6	8.6	5.3	4.8	6.6	18.5	10.3	8.9	9.4	4.9	4.0	23.5	34.1	15.2	10.0	7.2	5.1	12.6	10.4	10.4	18.6	10.4	3.9	12.2	9.7	5.2	2.5	10.3	14.3	4.7	5.3	8.0	18.3	4.9	8.9	9.0	9.0	3.7	13.2	3.3	8.5	8.8	3.1	0.4	10.6	8.1	6.2	5.1	7.1	7.3	14.9	19.9	4.8	3.1	7.7	10.9	16.5	5.6	5.7	11.8	12.4	7.9	12.7	11.9	3.6	18.8	6.2	5.1	20.1	3.1	17.0	13.4	4.4	10.8	10.9	14.7	3.1	5.7	7.5	4.5	9.3	6.5	7.7	8.0	8.5	8.5	13.4	17.2	15.3	14.9	5.1	10.5	5.1	7.7	13.4	5.7	5.3	2.6	12.3	4.5	8.6	9.5	15.5	6.1	1.8	13.9	2.4	19.4	7.5	7.1	10.7	6.7	15.1	20.1	15.4	10.8	6.7	15.4	19.5	13.7	2.4	8.3	5.5	11.1	13.4	9.0	3.9	4.9	9.8	5.1	4.8	6.6	4.9	4.0	5.1	2.5	5.3	3.7	10.0	80.1	37.8	14.0	17.7	4.8	18.0	5.5	18.2	15.4	26.0	27.8	31.5	34.3	30.0	20.2	10.4	18.6	13.4	9.7	21.5	27.0	2.4	37.2	6.0	14.1	25.3	17.1	25.6	36.1	16.8	10.0	14.8	14.5	8.2	23.8	16.4	10.8	8.4	10.1	48.2	17.6	4.1	13.6	3.6	3.8	20.5	9.3	7.2	36.5	17.9	10.2	21.6	30.7	14.1	25.8	21.4	11.7	15.2	13.0	21.2	27.0	47.6	9.6	0.0	9.0	8.5	9.0	11.3	11.8	4.0	11.5	17.0	22.6	18.5	12.8
ZNF341	dJ553F4.3	ENSG00000131061	"Zinc finger protein 341"	Q9BYN7	20	33731657-33792269	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023240, HPA024607, HPA067108"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780"	"unprognostic (1.74e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.31e-2)"	"prognostic favorable (3.93e-4)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.17e-5)"	"unprognostic (4.84e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.67e-3)"	"unprognostic (3.68e-2)"	1.2	0.9	1.0	1.9	1.1	2.4	0.9	0.8	2.2	1.1	0.0	1.5	1.4	1.3	1.0	1.3	1.3	0.9	1.0	1.6	0.2	0.6	0.6	1.1	1.9	0.3	0.1	1.3	1.6	0.9	0.6	1.4	0.4	1.3	1.1	0.7	1.5	1.0	3.3	2.1	1.0	1.2	0.2	1.9	1.4	1.5	0.5	1.8	0.9	3.3	1.2	1.2	1.1	1.3	2.4	6.4	2.2	4.7	2.1	1.7	9.5	2.3	1.2	1.9	1.2	4.6	5.4	3.7	3.8	1.7	2.2	3.7	2.4	4.1	0.8	3.3	2.2	3.6	3.6	3.7	1.2	2.1	4.3	1.4	3.0	1.6	1.0	1.7	2.3	3.4	1.9	1.7	2.0	2.9	1.9	1.6	3.0	3.5	3.1	2.4	1.4	2.1	1.3	5.2	1.9	2.1	6.1	5.6	1.4	1.7	5.0	1.7	2.9	3.4	1.4	2.5	2.2	1.3	1.9	3.4	3.3	1.7	2.4	2.6	1.3	2.9	1.1	1.8	1.0	2.2	0.8	0.7	1.0	1.2	0.5	1.5	2.5	1.3	1.2	0.7	0.6	0.9	1.0	1.1	0.8	2.2	1.6	0.2	0.3	0.1	0.4	0.2	0.5	1.3	1.8	3.2	5.1	5.5	2.9	0.4	1.0	1.5	0.6	2.2	1.9	1.4	2.7	2.8	4.7	1.8	2.1	2.6	0.9	7.0	0.0	1.5	0.6	1.6	1.4	1.4	1.2	0.8	11.3	1.4	3.3	1.6	6.6	2.1	2.5	1.8	1.4	1.0	1.4	1.7	8.0	2.0	2.0	1.6	2.0	0.1	0.6	2.4	0.0	3.7	1.2	0.6	2.1	6.0	7.7	1.7	2.5	0.4	2.6	2.5	4.2	0.4	4.6	2.3	0.0	1.9	1.1	1.6	2.4	1.6	1.0	2.1	1.9	1.5	2.4	2.5
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178711512-178730659	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 49.6"	"Low region specificity"	"Detected in all"							HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: AB_2681706"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favorable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	8.3	5.3	7.8	7.7	7.6	9.4	8.3	7.4	9.3	9.5	6.8	12.4	4.3	8.6	7.6	6.9	8.8	5.8	7.7	7.8	6.9	11.7	4.8	8.1	8.4	7.1	7.3	7.6	11.1	8.1	6.5	8.5	7.3	9.7	5.8	8.5	6.3	8.4	7.5	7.5	8.2	8.0	6.7	12.6	7.9	10.5	7.7	8.4	10.8	8.1	8.8	9.9	8.3	7.9	7.6	5.8	12.0	31.9	20.4	16.4	49.6	8.6	11.4	11.7	12.5	8.7	12.5	10.1	11.1	7.9	21.5	14.9	4.5	37.6	17.8	13.7	13.8	3.1	8.0	1.1	15.4	0.0	8.3	12.9	22.9	10.3	20.8	15.1	11.3	13.5	2.5	0.0	17.2	15.4	15.5	10.2	10.5	7.0	15.0	11.6	2.1	6.5	10.9	7.6	13.1	14.3	10.9	12.3	17.0	15.7	10.1	14.9	8.8	13.2	8.6	7.5	7.4	3.3	7.2	6.3	0.5	2.3	16.9	4.5	6.0	15.6	4.9	4.0	6.1	5.4	4.3	5.5	5.4	3.5	4.8	3.6	15.8	6.1	4.1	2.0	4.4	3.6	7.8	7.6	7.4	9.3	7.8	6.9	7.1	7.3	7.3	6.7	7.7	7.9	10.7	12.8	7.4	8.8	7.5	5.0	11.7	14.1	4.0	9.0	8.2	9.3	6.6	4.3	11.3	7.3	14.6	12.8	12.6	3.7	13.7	11.3	18.8	5.9	9.0	9.0	4.8	7.8	18.6	7.6	14.6	9.5	3.6	5.7	6.3	14.3	4.6	1.5	8.9	6.7	10.9	2.7	8.2	7.7	8.2	4.7	6.8	8.2	10.6	10.3	7.6	9.2	16.5	12.5	13.3	7.2	1.4	10.5	3.2	10.7	4.1	17.0	9.5	10.5	6.6	10.1	9.4	36.2	12.0	4.8	5.5	12.2	9.2	10.9	4.3	7.7
ZNF354C	KID3	ENSG00000177932	"Zinc finger protein 354C"	Q86Y25	5	179060373-179083977	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 16.8;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.8"	"Low region specificity"	"Detected in all"							"HPA030904, HPA068570"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA030904: AB_10603842, HPA068570: "	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.56e-4)"	"unprognostic (4.76e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.83e-1)"	3.2	2.2	2.7	2.4	3.7	0.6	4.0	6.1	2.9	3.6	1.8	3.1	1.2	5.1	1.8	2.0	3.6	2.6	2.8	2.3	2.6	2.1	1.4	2.6	3.4	3.0	3.5	7.0	2.0	3.1	1.2	3.2	3.2	3.5	1.6	6.4	2.1	3.3	2.2	1.9	2.0	3.8	2.9	3.3	2.0	2.2	3.4	4.4	4.7	4.3	3.4	2.5	2.3	4.4	1.0	1.4	11.1	17.8	5.6	9.0	0.0	5.0	4.3	5.4	6.1	0.0	2.2	0.0	5.9	5.4	9.0	3.4	0.0	1.7	10.2	0.0	0.1	0.0	0.5	0.0	5.3	0.0	2.4	6.8	1.6	5.4	0.0	1.7	2.6	0.0	0.1	0.0	6.5	0.6	10.6	0.0	7.7	0.8	0.0	0.0	0.0	0.0	2.0	0.4	6.7	11.2	7.8	0.1	5.2	4.7	4.6	4.2	3.3	0.0	7.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.1	0.1	0.5	0.2	0.5	0.3	0.7	0.5	0.2	0.3	0.7	0.6	0.0	0.3	0.6	0.0	0.5	0.3	2.7	3.7	6.1	2.9	2.3	2.6	3.0	3.5	3.2	2.9	3.4	4.4	6.4	3.2	3.1	10.4	2.6	0.9	0.6	1.4	2.8	10.5	1.7	3.0	6.1	4.3	2.3	0.0	0.0	2.2	2.2	0.1	0.0	1.3	0.4	1.3	5.5	4.3	0.0	2.1	8.0	0.9	1.4	5.1	0.5	1.3	1.3	7.4	4.6	0.9	1.7	16.8	2.5	0.5	2.0	1.6	2.2	0.4	3.1	1.7	1.8	4.7	0.6	5.4	1.0	17.6	16.2	0.7	0.1	5.7	0.7	0.6	0.2	0.6	1.3	5.0	6.6	7.0	3.9	2.3	1.3	2.2	0.9	0.5	2.2	4.3	0.7	0.3
ZNF358	"FLJ10390, ZFEND"	ENSG00000198816	"Zinc finger protein 358"	Q9NW07	19	7515292-7521025	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Granulosa cells: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030887, HPA063624"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 47: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030887: AB_10602688, HPA063624: AB_2685064"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.52e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.60e-2)"	70.6	57.4	82.5	12.0	73.1	2.2	58.4	64.8	109.9	75.5	47.5	107.9	29.5	69.8	28.0	31.9	62.1	31.9	109.4	79.3	70.9	52.8	67.0	50.6	10.5	77.8	81.7	88.6	50.5	49.6	60.9	18.3	69.7	78.6	18.3	11.8	51.3	43.8	175.5	38.8	47.9	37.4	68.3	39.6	67.9	12.6	88.4	14.1	59.9	147.0	7.9	88.4	54.3	79.7	32.5	21.4	39.7	63.3	83.2	91.8	33.9	12.0	78.2	53.7	47.0	9.4	22.6	0.0	45.7	64.8	8.5	12.4	16.5	30.8	17.2	0.1	35.0	6.2	24.9	13.3	91.0	0.9	0.3	80.3	57.2	25.4	22.0	80.0	57.1	0.0	16.7	0.0	48.2	16.0	0.1	23.5	40.9	13.4	37.4	35.8	21.2	3.5	28.2	13.8	43.8	87.1	15.1	12.5	43.8	25.5	9.5	16.9	27.1	34.4	24.8	51.6	18.4	41.8	24.8	0.1	31.7	0.0	48.6	1.5	0.5	0.4	0.6	0.5	0.4	0.1	0.1	0.3	0.2	0.7	0.4	0.7	0.0	0.2	0.1	0.4	0.0	0.2	82.5	73.1	64.8	109.9	79.3	70.9	77.8	81.7	69.7	68.3	88.4	79.7	29.5	9.6	11.1	11.8	4.6	7.8	11.8	7.1	2.2	20.8	32.8	37.1	126.5	20.0	5.5	16.5	14.6	3.3	6.5	38.8	5.9	13.0	3.8	9.4	28.2	22.1	36.5	0.8	5.8	16.8	5.1	29.2	8.6	14.2	14.7	178.1	32.5	43.0	10.9	50.5	8.5	27.8	8.2	21.1	10.8	7.7	37.9	13.3	5.4	7.5	3.8	48.8	1.0	8.5	14.9	16.0	21.7	37.2	3.4	11.3	48.3	30.7	3.3	20.7	13.1	22.1	27.6	0.7	1.2	3.2	3.7	3.0	3.6	23.9	24.7	12.8
ZNF383	"FLJ35863, Zfp383"	ENSG00000188283	"Zinc finger protein 383"	Q8NA42	19	37217926-37248738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063945	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA063945: AB_2685158"	"unprognostic (1.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.27e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (3.71e-4)"	3.6	3.2	2.5	3.4	4.4	3.5	5.1	8.5	3.4	4.1	1.5	3.3	3.5	3.8	3.6	3.6	3.7	2.9	4.9	2.7	3.5	4.4	3.2	3.5	6.1	3.7	3.1	5.8	2.9	4.4	2.8	3.2	3.8	4.1	3.5	5.4	4.0	3.9	7.4	5.4	3.4	3.8	2.0	5.1	3.9	3.9	3.7	5.7	5.3	9.0	6.0	3.4	3.4	7.1	2.9	6.8	4.6	7.1	5.7	5.8	3.1	4.1	5.6	4.0	5.9	3.1	3.6	4.0	5.9	3.9	3.8	3.0	3.6	5.5	5.9	5.4	4.2	5.7	5.2	2.6	6.1	6.9	6.2	7.1	4.6	3.9	7.6	5.1	3.7	5.5	3.2	2.1	5.0	1.4	6.3	3.2	4.2	5.8	1.9	4.4	8.4	3.7	3.6	8.2	5.2	4.1	6.6	3.8	5.7	5.8	4.6	4.1	2.3	5.0	3.5	3.7	4.0	6.5	6.4	7.9	0.7	3.2	4.7	3.7	3.2	5.3	5.8	3.9	8.2	8.0	5.4	7.1	3.3	10.7	8.6	6.9	3.5	4.8	4.9	3.1	6.0	3.9	2.5	4.4	8.5	3.4	2.7	3.5	3.7	3.1	3.8	2.0	3.7	7.1	7.2	3.2	4.4	7.5	10.2	2.7	4.0	3.4	5.7	9.8	3.7	5.2	12.8	7.2	2.5	1.8	14.6	3.8	7.5	3.8	1.9	3.5	8.9	3.6	5.4	5.1	2.4	11.0	7.4	3.6	4.8	5.8	4.6	3.7	5.7	7.8	6.4	2.2	3.8	15.2	8.7	3.8	2.0	6.3	3.5	3.0	6.5	4.5	8.8	4.7	5.5	6.2	10.3	9.5	10.4	2.7	3.6	7.5	3.8	5.1	5.8	3.9	2.5	9.9	13.1	9.9	6.1	5.8	5.2	3.9	3.3	4.9	8.5	6.6	4.8	4.1
ZNF385A	"DKFZp586G1122, Hzf, ZFP385, ZNF385"	ENSG00000161642	"Zinc finger protein 385A"	Q96PM9	12	54369133-54391298	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 159.3;retina: 250.6;skin 1: 159.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 212.8;Cone photoreceptor cells: 171.0;Horizontal cells: 144.7;Muller glia cells: 142.6;Rod photoreceptor cells: 209.7;Syncytiotrophoblasts: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 29.2;intermediate monocyte: 32.8;myeloid DC: 31.9;non-classical monocyte: 25.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 31.9;monocytes: 32.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 89.5;HBEC3-KT: 85.7;HEL: 109.5;hTCEpi: 94.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039799			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA039799: AB_10795117"	"unprognostic (8.56e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.75e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.07e-3)"	43.3	10.1	76.8	28.6	87.9	32.8	22.2	96.9	86.3	29.2	57.7	13.8	7.2	7.6	16.6	99.5	9.7	14.2	13.7	60.2	89.8	10.2	6.4	19.1	15.3	105.5	111.9	5.3	3.3	26.6	26.7	19.4	93.9	34.9	8.0	250.6	28.1	15.0	21.9	159.8	15.8	14.2	95.1	24.8	10.4	2.4	159.3	12.1	40.8	23.3	20.3	38.8	55.8	65.1	2.5	10.7	15.9	20.0	17.9	12.0	43.6	2.1	8.1	8.3	7.1	21.8	7.8	5.9	7.2	4.4	6.7	89.5	6.1	85.7	2.8	5.8	8.5	109.5	6.6	4.3	8.0	1.6	73.4	10.7	94.8	9.3	23.5	20.3	5.2	15.0	53.6	0.5	3.8	49.9	5.4	15.9	9.2	10.1	8.3	19.5	1.3	21.7	6.5	71.0	7.0	31.6	0.8	59.7	4.5	18.3	71.0	45.5	5.3	4.4	10.2	5.4	5.6	1.7	0.5	5.3	18.6	5.0	11.8	3.0	29.2	0.0	0.0	32.8	0.0	1.3	0.0	0.0	31.9	1.3	0.0	0.4	2.2	0.1	25.7	3.0	0.1	16.5	76.8	87.9	96.9	86.3	60.2	89.8	105.5	111.9	93.9	95.1	159.3	65.1	8.3	0.0	0.0	12.1	7.3	36.2	21.3	76.5	49.5	212.8	16.7	13.8	3.2	1.5	20.4	9.2	171.0	63.9	2.5	0.2	9.8	3.4	0.5	13.3	9.8	8.8	4.8	9.2	5.4	0.6	9.4	29.6	3.6	2.2	1.3	4.8	4.6	1.3	56.4	144.7	13.5	0.1	12.2	71.6	54.7	0.5	14.9	78.0	8.8	6.5	49.4	142.6	3.1	3.5	0.9	1.8	0.1	9.1	2.0	13.1	0.0	2.8	12.1	209.7	0.0	4.0	12.3	2.6	3.6	68.3	66.1	108.9	2.2	0.2	0.1	29.7
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99473877-99504857	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 97.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Approved		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	13.3	9.6	8.6	10.3	9.5	97.0	12.5	16.4	8.3	11.9	8.8	12.5	10.3	10.4	6.9	12.6	12.5	7.3	12.2	7.7	9.0	10.4	10.1	13.3	13.6	9.8	9.1	13.9	9.7	7.7	9.4	8.1	9.0	13.5	8.6	5.4	10.2	7.7	12.2	15.4	14.3	7.8	8.5	19.2	11.5	10.6	9.4	12.8	10.2	9.6	11.3	11.9	12.2	10.6	10.3	10.2	6.6	14.0	10.4	7.1	13.1	8.5	11.6	9.9	9.7	11.0	11.0	12.4	12.2	9.2	13.5	9.6	9.2	11.2	9.8	9.1	12.0	12.2	12.0	12.1	8.3	17.4	20.0	9.4	9.6	9.6	10.2	7.3	11.6	10.5	17.6	24.0	9.3	19.6	18.3	28.8	15.0	12.9	12.0	10.2	7.3	22.1	11.0	14.7	7.8	16.5	10.2	24.6	16.9	16.5	6.4	21.8	11.9	11.7	12.0	17.4	10.9	19.7	22.1	20.0	8.5	17.4	12.9	56.8	20.6	36.6	31.7	25.5	33.2	24.5	31.8	34.3	22.6	23.6	38.5	30.8	37.8	36.8	26.8	32.8	37.7	24.6	8.6	9.5	16.4	8.3	7.7	9.0	9.8	9.1	9.0	8.5	9.4	10.6	29.3	16.0	19.7	5.2	37.1	35.6	36.1	16.4	16.5	9.7	20.6	14.6	11.4	8.6	16.6	11.0	12.5	15.8	56.7	26.3	17.6	15.7	10.4	17.3	12.9	22.2	20.8	31.5	4.6	14.1	18.2	17.5	25.0	24.4	58.9	17.1	17.5	12.3	18.9	15.2	5.0	16.9	8.2	25.5	29.6	2.9	15.5	29.3	28.4	1.9	19.3	13.6	45.3	7.1	5.6	16.4	20.8	13.5	31.8	29.2	29.7	11.7	19.4	11.7	13.1	22.6	19.7	41.9	30.6	21.5	35.5	29.7	54.3	24.6	18.6	65.6
ZNF410	"APA-1, APA1"	ENSG00000119725	"Zinc finger protein 410"	Q86VK4	14	73886617-73932521	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002871			Approved	"Nuclear bodies"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nuclear bodies"		"HPA002871: AB_1080712"	"unprognostic (5.84e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (5.86e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.19e-1)"	29.0	33.0	26.8	18.7	30.4	57.7	29.4	30.9	33.9	30.0	28.9	30.6	19.0	27.5	43.7	33.4	28.1	22.6	21.0	26.3	28.0	33.0	28.8	27.6	25.6	29.1	27.5	38.7	20.6	27.1	27.0	32.2	29.6	29.5	24.4	22.8	24.4	27.3	21.1	37.6	25.2	28.4	26.7	26.1	25.7	44.7	28.3	29.9	24.6	18.3	30.7	29.1	28.7	37.0	46.7	35.8	42.4	45.2	44.8	39.8	52.4	51.4	56.9	88.2	82.0	37.6	40.1	38.4	21.7	65.7	28.2	42.1	42.9	52.8	83.2	56.2	26.9	36.2	31.6	29.9	67.4	30.6	45.6	37.0	72.4	44.5	83.1	39.5	47.5	43.9	38.2	33.0	43.3	88.6	45.8	51.2	15.5	56.3	41.7	40.7	48.5	24.7	57.0	43.7	39.0	50.3	57.2	52.5	54.6	35.5	48.3	52.2	30.7	62.7	59.0	37.1	47.2	45.2	83.4	48.0	40.1	34.1	53.7	65.9	45.3	74.8	47.5	43.1	51.9	37.7	49.0	49.0	45.6	43.0	42.3	43.5	34.4	60.5	50.1	30.8	46.7	55.9	26.8	30.4	30.9	33.9	26.3	28.0	29.1	27.5	29.6	26.7	28.3	37.0	4.3	0.0	3.1	27.7	10.8	0.6	1.5	1.0	10.8	1.5	2.2	1.7	1.1	0.0	2.9	0.0	4.2	1.8	5.0	1.7	0.0	1.0	3.8	4.7	5.6	2.6	0.0	5.9	22.7	0.9	1.5	5.3	10.7	6.7	10.8	2.9	1.8	0.4	1.2	1.7	23.8	1.1	0.0	2.2	3.1	1.1	1.2	5.4	1.8	18.7	1.1	2.4	2.1	18.1	31.0	1.3	1.4	0.4	13.4	1.0	2.4	0.7	0.2	4.7	0.0	4.0	5.1	3.3	1.9	10.1	1.1	2.6	10.5	4.1	0.8	1.4
ZNF416	FLJ20557	ENSG00000083817	"Zinc finger protein 416"	Q9BWM5	19	57571566-57578911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA063318			Approved	"Nuclear bodies,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear bodies"	"HPA063318: AB_2684983"	"unprognostic (1.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.57e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.20e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-1)"	2.2	2.2	2.6	1.6	3.0	2.6	3.7	4.3	3.7	2.7	2.2	2.3	1.4	2.3	3.9	3.2	3.4	1.8	2.7	2.7	2.5	2.6	2.0	2.5	2.8	2.0	2.2	4.4	1.4	4.4	2.0	2.9	2.0	2.7	2.1	3.7	2.2	3.1	2.6	5.1	1.7	2.8	2.2	2.8	2.1	4.2	2.6	4.0	3.6	3.0	4.1	2.4	2.4	2.9	3.2	3.1	6.5	5.2	3.9	5.6	4.3	3.2	5.8	6.2	4.0	2.2	1.7	2.2	2.3	4.1	4.5	1.2	3.8	5.5	7.6	3.5	15.5	5.3	3.5	1.8	7.0	4.7	3.3	5.6	5.6	3.9	8.2	4.9	4.3	5.3	0.7	1.7	8.4	1.3	9.9	2.2	7.7	3.8	5.7	4.9	9.7	4.8	4.3	6.8	4.7	5.3	5.8	3.0	2.9	7.3	2.7	5.6	3.2	6.7	3.2	2.2	4.8	5.4	9.5	5.9	1.5	3.1	4.1	1.1	2.6	1.9	4.3	1.9	7.7	6.6	5.9	6.3	4.1	10.4	8.0	5.8	0.8	9.0	1.7	3.7	2.9	3.7	2.6	3.0	4.3	3.7	2.7	2.5	2.0	2.2	2.0	2.2	2.6	2.9	1.1	0.0	0.5	1.3	2.9	1.7	1.6	1.6	1.2	3.5	1.6	1.8	1.8	1.5	1.6	0.0	0.0	2.1	1.0	0.6	3.9	2.8	5.0	0.9	0.9	1.8	0.0	3.6	1.5	0.9	0.8	1.1	1.5	1.1	2.5	2.6	0.7	1.2	1.7	8.4	1.4	1.1	0.0	1.0	0.6	2.0	0.9	0.6	0.0	1.0	0.5	3.2	3.1	3.0	0.2	1.4	1.2	0.7	0.8	1.3	1.1	1.3	0.6	2.8	6.6	1.5	1.2	3.1	4.1	1.3	2.4	1.9	1.3	2.4	0.9	2.2
ZNF418	"FLJ31551, KIAA1956"	ENSG00000196724	"Zinc finger protein 418"	Q8TF45	19	57921882-57935402	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 9.1;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 11.1;SuSa: 7.6;T-47d: 6.9"									"HPA043800, HPA053762, HPA072145"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (4.41e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.36e-3)"	2.2	2.8	4.9	2.4	5.7	2.0	5.9	10.3	5.0	3.2	0.2	4.5	1.0	4.1	5.3	2.0	4.7	2.4	8.7	4.5	5.6	4.1	2.3	2.6	5.2	2.6	3.3	6.2	4.5	6.2	5.3	5.7	2.5	4.7	1.5	12.4	3.5	5.6	3.3	9.0	2.5	4.0	1.4	5.1	3.5	4.4	4.9	4.6	6.7	4.9	4.5	3.6	2.9	9.2	0.3	1.3	11.1	3.6	1.7	3.6	1.2	3.4	1.1	2.5	0.2	0.2	1.2	0.4	2.3	1.7	3.3	1.0	0.0	2.8	3.0	0.3	1.0	0.2	0.7	0.1	1.0	0.3	2.3	3.0	0.8	3.1	0.0	0.0	0.5	1.0	0.9	0.8	2.1	0.4	0.6	0.4	5.7	0.1	0.4	0.5	0.8	4.0	2.1	1.4	0.2	0.5	0.1	2.0	0.1	7.6	6.9	1.2	0.0	0.7	0.5	0.4	0.6	1.8	4.7	2.9	0.3	1.3	2.2	1.3	0.5	0.5	0.1	1.3	0.4	3.2	1.1	0.7	1.0	5.5	1.8	0.5	0.6	4.3	0.5	1.8	0.0	0.8	4.9	5.7	10.3	5.0	4.5	5.6	2.6	3.3	2.5	1.4	4.9	9.2	1.7	0.0	0.6	4.2	2.9	0.4	0.8	0.4	0.6	4.3	1.8	1.4	9.1	1.5	1.0	0.0	4.2	1.0	0.8	0.0	1.9	1.2	0.1	1.8	0.9	1.9	0.0	2.5	4.1	0.6	0.6	1.9	1.1	1.1	5.7	2.5	2.5	0.8	0.8	3.3	3.5	0.0	0.0	0.3	0.7	0.9	0.3	0.6	0.0	1.9	0.2	4.3	1.0	4.0	6.3	0.2	1.2	1.5	0.1	1.1	0.0	1.1	5.6	5.9	13.1	0.7	1.3	2.6	5.6	0.7	0.4	0.8	0.7	0.3	0.2	0.8
ZNF426	MGC2663	ENSG00000130818	"Zinc finger protein 426"	Q9BUY5	19	9523223-9538645	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029342	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA029342: AB_10603007"	"unprognostic (3.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.41e-3)"	"prognostic favorable (2.57e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.81e-4)"	5.1	3.3	3.1	3.9	4.0	5.7	6.9	5.4	3.4	5.5	4.9	4.1	2.8	7.6	4.5	20.6	5.8	4.3	5.4	3.2	2.9	4.3	2.2	5.1	4.1	3.4	3.4	9.2	4.3	6.3	2.4	5.6	3.4	5.9	3.8	5.1	4.0	5.3	3.7	4.1	2.9	7.8	2.9	4.7	3.7	4.8	3.8	5.7	6.7	5.5	5.7	4.7	5.8	6.0	5.7	1.8	11.2	11.8	7.4	9.7	6.2	7.1	10.8	9.4	11.4	2.4	2.5	5.7	5.6	6.9	6.6	4.8	11.7	8.4	14.0	2.7	9.0	23.7	9.5	4.3	6.7	0.7	7.4	12.4	7.1	10.5	15.0	10.2	10.2	9.7	9.6	0.5	9.1	0.3	13.7	11.4	14.0	1.3	4.4	7.4	13.9	5.9	5.1	14.7	6.3	8.5	12.1	4.3	9.7	9.5	6.0	5.5	8.3	13.2	7.7	6.0	7.7	6.4	9.7	4.8	1.9	0.3	9.6	10.0	3.2	6.1	8.8	4.5	7.8	7.6	6.8	8.7	3.8	6.5	10.0	9.3	6.7	7.8	6.3	3.4	7.1	3.4	3.1	4.0	5.4	3.4	3.2	2.9	3.4	3.4	3.4	2.9	3.8	6.0	15.0	28.9	26.5	3.3	13.2	3.4	15.6	3.2	12.5	24.8	17.1	14.6	10.1	5.7	12.4	7.3	20.9	12.8	13.4	3.8	21.5	10.9	33.5	11.5	14.2	16.4	3.6	12.6	5.4	4.2	10.2	12.4	5.1	15.5	28.4	22.4	14.3	3.0	7.6	37.0	3.9	4.2	12.2	8.9	1.6	8.2	17.1	8.2	3.6	5.6	11.2	20.1	15.5	4.5	4.7	6.9	5.1	22.2	6.7	13.3	4.7	5.4	14.6	22.0	6.6	17.9	13.2	12.2	11.8	14.7	2.8	14.2	12.1	12.3	6.3	17.9
ZNF433	FLJ40981	ENSG00000197647	"Zinc finger protein 433"	Q8N7K0	19	12014732-12035741	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 198.4;Late spermatids: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA073724	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA073724: AB_2686631"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.90e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-3)"	"prognostic favorable (8.33e-15)"	"unprognostic (1.06e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.69e-2)"	4.1	3.8	5.1	2.3	5.2	11.8	7.8	10.9	5.2	5.7	5.3	3.6	2.1	4.9	9.4	6.9	4.7	3.8	5.3	6.1	5.2	14.2	5.3	4.0	3.2	5.2	5.4	5.7	9.2	9.1	4.9	5.1	5.0	6.3	3.6	9.9	7.2	4.7	5.6	9.0	2.5	3.2	4.3	4.6	4.8	27.6	5.1	1.8	9.1	3.9	2.9	4.5	5.3	6.0	5.5	0.4	4.1	11.5	3.9	3.7	6.0	4.8	3.5	5.3	5.6	3.1	1.1	1.7	2.6	4.1	3.6	2.2	0.0	5.3	5.0	0.8	1.4	4.0	1.1	3.4	4.1	3.7	9.0	4.3	4.9	3.7	1.8	3.3	0.0	6.4	1.0	0.8	5.9	2.3	4.9	4.7	1.6	0.1	4.5	2.6	2.8	0.4	7.7	11.3	3.4	2.8	0.0	3.0	2.3	4.4	6.2	5.5	3.4	6.0	2.5	10.3	3.4	8.1	10.6	4.8	1.1	4.2	3.7	6.5	1.1	5.1	1.3	0.9	1.1	1.5	1.2	1.7	4.1	2.6	1.8	2.2	2.0	5.9	1.4	3.9	0.9	1.1	5.1	5.2	10.9	5.2	6.1	5.2	5.2	5.4	5.0	4.3	5.1	6.0	3.8	3.2	2.8	7.5	1.7	1.8	3.4	3.7	1.8	4.9	4.8	4.3	7.2	5.7	4.1	5.5	16.7	10.5	1.7	0.8	7.9	4.2	198.4	7.1	3.8	2.2	0.0	3.6	6.7	3.8	4.5	3.1	3.6	9.5	3.8	3.3	1.4	3.1	6.9	6.7	5.9	0.5	4.1	2.2	1.6	134.4	3.1	1.5	5.4	0.0	0.0	4.7	1.0	10.1	3.7	3.0	1.1	4.1	0.6	2.1	0.0	6.1	6.1	8.1	6.6	1.9	2.9	35.1	5.7	4.5	2.6	3.4	0.9	2.4	0.8	2.5
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 118.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA056895: AB_2683267, HPA065203: AB_2685431"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.87e-4)"	13.2	23.4	33.8	6.3	31.4	3.2	15.8	28.3	36.3	24.1	31.3	32.5	11.4	24.9	7.7	16.5	26.1	9.3	23.9	30.5	30.2	23.7	64.3	18.1	5.7	38.6	32.4	26.0	46.4	7.8	29.3	4.8	31.4	35.2	4.2	5.7	21.6	19.6	18.6	14.6	19.0	5.9	29.1	17.7	32.0	21.3	32.6	16.0	28.8	7.0	4.4	25.8	17.7	32.1	11.3	21.1	19.0	16.7	8.0	8.1	12.5	14.0	9.2	11.7	12.6	23.1	12.4	19.7	12.2	8.1	5.9	10.3	11.8	9.5	4.9	17.3	118.4	19.6	15.3	42.4	13.0	8.7	17.4	9.5	8.5	9.5	7.3	17.6	10.6	24.1	25.7	8.6	8.3	14.6	28.4	24.4	20.5	22.3	38.2	32.7	12.3	10.7	13.0	10.2	20.4	28.0	7.1	23.2	11.2	10.3	23.2	15.7	14.4	20.8	18.2	4.6	15.6	20.5	18.9	15.1	13.1	11.8	13.9	1.9	1.1	2.4	2.3	0.9	2.5	1.2	4.0	4.0	1.2	2.3	4.0	2.7	0.1	2.2	0.6	2.1	2.9	1.4	33.8	31.4	28.3	36.3	30.5	30.2	38.6	32.4	31.4	29.1	32.6	32.1	12.2	3.2	18.1	26.1	11.0	3.1	17.4	15.3	5.2	17.9	13.9	11.8	13.9	28.6	17.6	11.0	8.4	18.8	5.6	15.6	9.8	26.4	28.6	16.2	8.9	15.1	29.3	6.1	10.0	21.9	9.7	10.0	20.9	9.2	10.2	16.8	18.5	38.9	10.7	20.2	10.0	28.0	20.3	7.2	6.1	39.2	12.2	5.5	16.0	5.6	13.6	17.7	12.3	14.6	19.0	18.3	9.9	12.0	8.6	13.5	18.7	26.9	18.3	13.4	26.3	8.5	12.6	13.6	25.6	3.4	5.3	12.4	11.2	43.4	22.9	11.0
ZNF48	"DKFZp762K013, FLJ31751, MGC43952, ZNF553"	ENSG00000180035	"Zinc finger protein 48"	Q96MX3	16	30378106-30400108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023806	Uncertain		Approved	Mitochondria		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA023806: AB_1859335"	"unprognostic (5.35e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (5.36e-2)"	"prognostic favorable (7.50e-5)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	2.9	5.1	7.1	3.4	7.3	2.0	3.2	7.9	8.2	4.5	3.9	8.0	3.7	7.2	2.5	2.8	5.7	2.5	4.4	7.5	6.6	4.2	4.2	3.5	4.5	5.7	6.0	3.2	5.6	6.4	5.1	2.0	5.8	4.6	2.4	3.8	4.2	4.4	5.3	4.2	4.1	4.5	5.3	4.2	4.9	2.4	6.7	8.1	3.5	3.7	3.0	5.5	2.8	7.1	7.7	13.4	32.0	25.2	4.3	3.0	9.8	5.7	9.7	12.1	11.2	6.7	10.0	16.2	10.7	5.3	3.4	6.6	15.7	8.9	6.8	12.0	20.2	7.2	6.9	10.2	5.9	9.6	9.1	2.6	11.0	10.0	6.6	11.4	10.9	14.3	12.6	7.2	5.3	28.1	20.8	11.9	26.4	6.0	5.4	47.7	7.4	20.0	7.4	6.6	25.1	31.6	2.5	16.7	2.5	8.4	11.2	8.9	5.1	7.0	8.1	6.3	6.5	8.6	10.9	14.8	4.0	5.8	1.7	0.0	0.0	0.4	0.9	0.0	0.6	0.3	0.4	0.5	0.1	0.3	0.5	0.6	0.0	0.9	0.0	0.4	0.5	0.1	7.1	7.3	7.9	8.2	7.5	6.6	5.7	6.0	5.8	5.3	6.7	7.1	4.0	3.2	2.2	4.6	6.1	3.1	2.5	1.7	4.0	11.7	4.8	5.1	5.4	14.3	3.9	3.7	8.4	3.7	6.7	4.8	1.9	10.4	0.2	3.7	2.8	5.4	9.6	5.2	4.9	7.4	2.2	2.8	1.5	3.7	17.2	7.5	4.2	3.1	2.7	16.8	5.5	4.0	2.0	1.6	2.6	0.3	2.8	1.7	1.8	2.8	6.9	6.6	3.1	1.0	4.0	7.2	5.4	6.8	2.0	4.3	3.5	4.1	1.0	7.3	0.0	3.0	5.5	3.5	3.3	1.8	5.3	0.3	5.0	3.7	6.1	1.7
ZNF487	"KRBO1, ZNF487P"	ENSG00000243660	"Zinc finger protein 487"		10	43436841-43483181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 191.2;Endometrial ciliated cells: 65.7;Late spermatids: 289.9;Respiratory ciliated cells: 73.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037820			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA037820: AB_10697083"	"unprognostic (1.97e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.97e-4)"	"unprognostic (5.85e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.92e-2)"	2.9	2.1	2.1	2.0	2.1	4.3	2.8	2.0	6.3	3.2	4.5	2.6	2.4	3.8	2.1	2.1	6.0	3.7	2.1	2.3	1.9	2.3	2.2	3.0	2.4	7.5	6.0	4.2	1.6	3.6	2.4	1.9	5.0	2.3	1.9	8.9	1.5	2.7	1.2	2.1	2.5	3.0	4.7	2.4	2.3	28.2	2.2	3.6	3.3	1.6	2.2	3.3	2.1	3.8	1.7	1.6	2.0	2.1	2.4	4.8	0.6	2.7	4.7	2.5	2.7	2.6	4.7	4.3	0.4	3.4	2.4	2.7	0.6	1.0	2.4	0.5	0.9	1.4	0.4	1.5	3.1	1.4	1.7	5.0	2.3	4.2	3.0	5.2	0.9	0.9	0.7	0.6	1.9	3.0	2.9	1.1	0.4	0.8	0.9	1.5	0.7	1.8	5.7	1.9	1.7	1.3	2.4	1.3	1.1	1.2	2.2	1.6	1.5	2.4	1.5	1.4	0.7	0.3	1.1	4.7	5.6	2.0	0.9	1.8	3.0	4.5	3.3	2.2	2.6	1.9	2.4	2.9	3.9	2.5	1.9	2.3	10.4	2.9	1.2	2.9	1.6	2.1	2.1	2.1	2.0	6.3	2.3	1.9	7.5	6.0	5.0	4.7	2.2	3.8	4.0	22.4	4.8	11.8	6.2	1.8	6.3	6.6	3.4	5.4	6.6	7.7	3.3	7.2	8.3	5.5	8.4	1.4	9.8	6.1	11.7	4.5	191.2	65.7	6.5	5.3	7.8	1.3	19.4	2.1	4.0	5.4	5.6	6.3	0.0	3.4	3.3	2.7	3.3	6.7	21.1	4.4	10.2	5.6	3.1	289.9	4.7	6.3	1.8	0.0	7.3	12.6	2.1	6.0	7.1	2.1	3.9	6.8	3.6	3.2	13.0	12.7	73.5	18.7	0.0	6.3	5.1	16.7	7.5	1.9	2.8	1.6	5.6	3.8	3.5	6.1
ZNF518A	"KIAA0335, ZNF518"	ENSG00000177853	"Zinc finger protein 518A"	Q6AHZ1	10	96129715-96205288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029049			Approved	Nucleoplasm		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029049: AB_2672885"	"unprognostic (1.48e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.16e-3)"	4.1	3.2	3.8	4.4	4.5	7.6	7.3	5.7	4.7	4.3	2.1	7.1	5.0	5.6	7.8	4.3	4.3	4.1	3.4	3.5	5.1	5.1	4.6	4.5	6.1	5.0	4.5	7.4	4.5	4.0	4.1	4.4	5.4	4.8	7.0	9.3	4.1	4.2	1.9	6.0	6.4	4.4	4.5	5.4	6.7	16.1	4.7	8.1	7.7	2.3	6.1	3.8	2.8	6.8	4.2	9.4	10.3	0.0	5.1	5.8	12.4	4.4	2.5	4.7	4.8	8.9	10.0	15.5	4.1	2.8	6.7	5.9	11.8	4.2	4.3	7.1	6.3	23.2	3.2	14.5	4.5	25.3	13.5	3.8	10.1	4.9	7.8	3.4	5.7	17.8	20.1	10.1	4.7	4.2	15.0	15.3	15.9	4.7	0.6	16.7	11.8	6.2	5.6	8.5	3.0	7.2	6.2	5.8	4.5	17.0	6.9	16.0	3.7	2.2	8.5	3.0	4.8	9.3	24.9	8.8	1.5	19.0	2.4	9.8	2.6	3.2	1.8	2.8	2.7	2.5	2.1	1.8	1.7	2.2	3.0	2.1	2.5	2.3	5.3	2.9	2.5	1.4	3.8	4.5	5.7	4.7	3.5	5.1	5.0	4.5	5.4	4.5	4.7	6.8	31.1	57.7	28.2	136.8	26.1	0.0	17.1	0.0	13.1	65.0	32.5	21.2	26.5	30.0	14.9	40.5	43.8	49.1	31.6	51.0	19.6	24.1	23.6	42.6	38.8	24.0	61.2	17.1	63.9	25.5	30.8	21.6	32.6	41.3	9.5	57.9	35.3	28.3	28.1	75.7	90.5	35.8	0.0	32.8	0.0	15.0	35.1	31.3	0.0	81.5	48.7	29.1	47.4	150.3	173.0	32.9	52.4	25.2	18.3	20.8	39.5	20.4	10.2	56.9	19.7	33.8	23.2	73.1	131.2	16.2	0.0	43.8	23.3	40.9	35.2	17.6
ZNF528	KIAA1827	ENSG00000167555	"Zinc finger protein 528"	Q3MIS6	19	52397849-52418412	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 51.2;U-266/84: 69.0"									HPA065435			Approved	"Nuclear speckles,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA065435: "	"unprognostic (1.90e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.26e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-3)"	8.9	9.2	7.9	5.4	10.1	5.7	10.9	16.8	8.6	9.9	9.6	8.6	4.9	13.5	18.8	8.9	13.6	10.1	10.1	6.6	10.3	9.6	4.7	8.0	9.1	9.2	7.6	18.2	5.2	12.7	9.2	9.9	11.2	11.6	8.8	19.7	10.7	9.3	6.4	11.4	6.7	8.3	4.0	11.3	9.3	13.1	9.8	9.8	17.7	5.7	10.7	9.8	8.5	13.6	0.2	0.0	6.1	36.5	13.6	16.9	15.0	13.6	22.3	8.2	18.1	0.2	6.9	0.3	3.3	16.9	20.4	4.1	0.0	8.6	10.5	0.1	9.8	5.7	2.0	3.5	20.4	0.1	15.2	17.2	15.5	9.0	0.0	2.5	19.7	0.3	3.8	0.6	11.9	0.2	21.5	2.9	15.9	0.3	9.4	0.2	24.5	6.5	10.1	51.2	25.1	20.8	0.0	1.1	9.1	21.2	24.2	3.3	23.3	14.2	16.3	5.6	18.8	0.6	69.0	12.9	7.1	0.2	22.5	7.6	5.1	11.8	6.6	5.4	12.7	7.8	8.2	10.2	5.4	11.1	7.7	6.9	1.4	17.6	5.5	8.8	9.6	3.9	7.9	10.1	16.8	8.6	6.6	10.3	9.2	7.6	11.2	4.0	9.8	13.6	9.8	6.4	3.2	8.8	5.8	3.7	4.1	5.2	1.2	19.6	8.6	7.1	12.2	2.8	7.4	1.8	14.6	4.1	6.0	4.1	3.9	5.6	2.9	13.1	7.7	8.8	1.2	0.8	13.2	1.9	4.5	6.0	2.0	13.2	8.8	16.7	6.1	1.3	3.5	21.9	12.7	4.0	4.1	3.8	4.7	3.1	5.0	4.7	1.8	7.5	0.7	12.3	11.3	20.6	10.3	7.1	6.3	4.1	1.5	4.7	4.0	3.9	10.4	21.8	0.0	6.1	6.9	17.6	10.2	2.3	3.1	3.1	7.6	7.3	3.0	4.1
ZNF536	KIAA0390	ENSG00000198597	"Zinc finger protein 536"	O15090	19	30228290-30713538	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 80.7"	"Group enriched"	"Detected in some"	9	"Inhibitory neurons: 506.0;Oligodendrocytes: 794.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 5.0;HAP1: 11.0;SH-SY5Y: 29.5;U-937: 7.5;WM-115: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077341			Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"		"HPA077341: AB_2732340"	"unprognostic (1.98e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.68e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.46e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.45e-1)"	0.4	2.6	20.7	0.7	43.1	0.0	0.2	28.1	33.2	1.6	17.7	3.6	1.0	0.5	0.3	3.1	0.3	0.3	2.2	18.1	20.2	0.1	0.0	0.2	0.0	36.7	31.2	0.1	0.2	0.3	4.2	0.0	33.9	2.1	1.6	13.7	0.4	0.8	0.4	0.3	1.9	0.3	19.9	0.5	1.1	2.2	36.1	0.0	3.2	0.8	0.0	2.1	1.1	80.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	11.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	29.5	0.0	0.0	1.9	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	7.5	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	43.1	28.1	33.2	18.1	20.2	36.7	31.2	33.9	19.9	36.1	80.7	0.0	0.0	0.0	11.1	0.0	0.4	0.2	0.0	0.0	33.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.8	0.0	0.0	2.4	0.0	0.0	4.3	0.0	0.0	0.0	2.3	0.0	0.0	0.7	70.7	506.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	13.1	0.0	48.6	0.0	46.8	794.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	9.7	0.0	9.1	1.6	0.3	0.6	0.1	0.3	0.0	0.1	0.0	0.0	0.3
ZNF552	FLJ21603	ENSG00000178935	"Zinc finger protein 552"	Q9H707	19	57803841-57814913	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"breast cancer: 23.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 25.3"	"Cell line enhanced"	"Detected in all"		"BEWO: 30.3;RT4: 42.5;T-47d: 69.6"					"Low region specificity"	"Detected in all"			"HPA043800, HPA053762, HPA072145"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"prognostic favorable (4.57e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (9.03e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.36e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-3)"	3.0	2.3	3.0	4.7	3.1	8.1	26.0	14.9	6.5	9.8	9.3	9.4	7.1	5.0	5.4	5.5	5.6	8.7	2.9	3.4	3.0	7.1	4.7	6.0	5.3	2.8	2.0	4.2	4.2	6.0	2.5	6.5	2.3	12.4	12.1	4.0	17.5	6.9	4.9	9.7	7.3	3.0	0.5	6.0	13.9	3.0	3.5	5.0	4.1	2.7	5.5	14.7	5.8	3.4	5.6	3.2	3.7	5.9	3.0	1.5	30.3	2.0	2.4	4.5	2.5	9.6	8.8	7.6	3.8	3.6	1.0	4.8	7.6	5.0	5.4	3.4	15.1	2.6	8.4	7.1	7.1	8.5	3.4	3.3	10.9	3.1	3.2	2.8	6.0	8.0	5.5	2.5	3.0	5.0	3.7	2.5	5.2	6.9	7.3	7.6	4.7	8.0	13.4	42.5	4.9	3.5	10.2	22.6	5.1	10.4	69.6	3.5	4.5	3.8	4.2	2.5	3.5	11.0	8.1	6.1	3.1	6.4	2.2	2.1	3.3	7.4	2.7	3.3	2.5	3.7	3.4	4.3	1.7	3.7	4.5	3.8	25.3	2.4	1.4	2.3	3.0	2.4	3.0	3.1	14.9	6.5	3.4	3.0	2.8	2.0	2.3	0.5	3.5	3.4	2.9	12.8	3.1	4.2	7.8	2.5	14.8	9.7	8.0	6.2	19.4	9.8	3.1	18.6	15.0	20.2	2.1	22.1	5.3	9.4	25.4	6.9	5.7	20.2	4.9	3.7	8.4	6.1	7.7	1.8	5.2	3.8	19.4	15.0	8.8	14.2	7.1	4.2	5.2	3.3	8.1	14.5	14.2	2.4	3.1	1.5	2.8	3.6	1.8	1.9	3.1	2.3	2.1	4.5	5.1	3.1	13.4	2.2	4.8	8.3	15.6	4.8	20.5	12.7	6.6	2.9	3.5	3.8	4.6	7.0	2.7	21.3	7.1	5.4	9.3	14.2
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819868-2836735	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"							"Not detected"	"Not detected"			"HPA060247, HPA063358"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Nucleoli	"HPA060247: AB_2684230, HPA063358: AB_2684995"	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favorable (5.00e-4)"	2.0	2.0	2.9	0.6	2.8	0.5	2.5	2.7	4.0	3.0	1.5	2.6	1.3	2.6	1.2	2.5	2.3	0.6	3.3	2.7	2.8	2.9	3.1	1.4	0.6	2.9	2.4	3.7	3.1	1.5	2.9	1.1	2.9	2.7	0.8	2.5	2.7	0.9	5.2	3.5	2.3	0.6	1.8	1.9	2.5	2.5	3.5	0.9	2.6	2.1	0.7	2.7	2.6	2.4	1.2	0.2	0.9	1.3	0.7	0.9	1.3	0.7	0.6	1.0	0.7	0.1	0.3	1.5	0.6	0.4	1.1	0.7	0.2	0.7	0.8	0.0	0.5	0.5	0.8	0.4	0.6	0.2	0.5	0.7	1.0	0.4	0.7	0.9	0.3	1.1	1.1	0.8	0.5	0.6	1.1	0.3	0.7	0.2	0.1	1.3	0.6	0.3	0.5	1.1	1.5	1.8	0.5	0.3	1.1	0.9	0.4	0.8	0.2	0.4	0.4	0.6	0.4	2.3	2.8	0.4	0.6	0.7	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	0.0	0.6	0.3	0.1	0.1	0.2	0.2	0.9	0.1	0.2	2.9	2.8	2.7	4.0	2.7	2.8	2.9	2.4	2.9	1.8	3.5	2.4	2.2	12.8	12.5	2.9	3.5	1.3	2.8	1.0	4.0	4.9	2.3	2.2	4.6	1.5	4.6	0.0	8.4	2.8	1.5	3.4	3.9	2.6	0.8	2.1	1.9	3.1	3.6	3.4	4.0	1.4	1.3	3.4	1.5	2.7	0.0	4.4	3.3	2.9	1.5	3.3	4.8	2.0	2.0	2.4	2.5	0.7	3.1	1.6	0.0	1.0	1.4	4.7	5.2	3.5	2.7	1.7	1.0	2.6	3.3	3.3	5.9	3.0	5.5	4.9	0.0	3.8	2.3	7.0	12.2	2.7	1.4	8.8	2.7	3.7	2.2	2.1
ZNF557	MGC4054	ENSG00000130544	"Zinc finger protein 557"	Q8N988	19	7069703-7087968	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003151, HPA029291"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"		"HPA003151: AB_1859344, HPA029291: AB_10602357"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (2.56e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.51e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.81e-3)"	1.5	1.9	1.2	1.8	1.5	3.9	1.9	3.1	1.7	1.6	1.5	1.5	1.1	1.7	1.6	1.7	1.9	1.3	1.2	1.3	1.0	1.8	2.2	1.4	2.6	1.4	1.1	2.4	1.8	1.7	1.5	1.5	1.5	1.5	1.4	1.9	1.4	1.4	1.4	2.0	1.7	1.6	0.9	2.3	1.8	2.1	1.4	2.4	2.1	1.0	2.5	1.6	1.5	3.1	2.1	2.2	2.3	5.0	3.1	2.1	1.9	2.1	2.2	2.3	2.8	2.8	1.3	4.4	3.6	2.3	1.8	2.9	4.0	2.3	2.3	4.0	2.6	5.6	4.7	1.5	2.1	6.0	5.9	3.0	2.3	2.4	3.7	2.3	2.0	3.8	2.2	6.7	3.1	3.0	5.0	2.1	2.2	2.0	3.0	3.6	3.6	2.4	1.7	4.9	2.7	3.2	3.1	2.4	2.3	2.0	1.9	3.1	3.9	2.2	1.7	5.0	2.3	6.8	5.8	3.9	2.4	3.1	2.0	5.6	3.1	3.8	4.6	2.9	4.7	4.1	5.0	4.0	3.1	5.4	5.8	4.9	3.5	5.9	2.7	5.7	4.3	1.7	1.2	1.5	3.1	1.7	1.3	1.0	1.4	1.1	1.5	0.9	1.4	3.1	5.5	3.2	4.4	5.2	8.3	1.5	6.9	2.7	2.2	9.4	6.1	5.8	5.4	7.2	6.1	7.3	0.0	5.9	5.8	5.4	15.6	6.2	0.9	3.4	8.9	6.9	5.4	6.1	9.2	6.2	4.2	5.6	4.6	4.6	8.2	9.4	8.6	3.8	6.1	16.8	8.9	5.8	2.0	9.8	2.9	0.5	4.4	6.0	0.0	5.6	9.0	6.1	14.4	3.5	8.8	6.1	6.2	5.7	5.9	6.8	6.1	8.1	4.3	6.8	0.0	7.8	6.7	23.2	19.9	3.6	1.3	5.7	7.7	6.7	5.5	6.9
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466355-9498616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 2.0;testis: 6.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 79.2;Late spermatids: 20.1"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.5;HMC-1: 4.8;NTERA-2: 19.7;SuSa: 9.2"									"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear speckles"	"HPA045439: AB_2732520, HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.8	2.5	0.0	1.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	20.5	0.0	0.0	1.4	0.0	4.8	2.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	79.2	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.0	0.0	0.0	0.2	0.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	9.5	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF563	FLJ34797	ENSG00000188868	"Zinc finger protein 563"	Q8TA94	19	12317477-12333720	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 14.5"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.2;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 9.0"									HPA042136	Uncertain		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA042136: AB_10795395"	"unprognostic (1.40e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-2)"	2.5	2.8	1.9	2.0	1.9	1.1	3.8	3.1	1.9	3.3	1.6	2.1	1.4	2.1	2.2	2.4	3.1	1.5	3.9	1.9	1.2	3.8	10.0	1.9	2.8	1.7	1.4	3.5	2.1	2.5	2.2	1.1	1.8	4.9	2.1	2.7	2.7	2.6	1.9	3.9	2.2	2.0	0.9	2.6	1.8	14.5	1.8	3.0	5.5	3.0	3.0	2.7	3.2	2.7	2.0	0.2	0.7	2.7	2.8	1.8	0.2	2.3	4.5	2.8	4.1	2.6	0.7	4.6	2.4	2.9	3.1	1.6	2.4	5.4	2.5	0.1	0.4	0.6	0.5	9.0	2.2	0.4	2.8	3.0	3.7	2.8	1.9	2.1	0.1	2.5	0.9	1.0	2.5	1.3	2.5	0.9	1.1	1.0	2.0	0.1	2.0	0.1	3.0	2.7	0.7	1.3	0.3	0.5	0.3	3.1	2.2	0.2	0.3	4.4	0.8	5.1	1.4	4.4	3.8	0.3	0.8	0.4	1.6	0.8	1.1	0.7	2.7	1.2	1.6	3.2	4.6	2.5	1.4	4.2	8.9	5.2	0.8	1.5	1.4	1.4	3.9	2.2	1.9	1.9	3.1	1.9	1.9	1.2	1.7	1.4	1.8	0.9	1.8	2.7	3.2	3.2	1.7	2.3	4.6	1.3	2.0	3.0	4.6	8.4	2.4	3.4	5.5	5.7	2.1	1.8	0.0	0.3	2.6	1.1	1.9	4.7	200.4	3.6	2.3	3.7	0.0	19.4	4.2	4.9	0.2	2.6	2.0	2.0	0.0	9.5	3.3	8.3	2.2	5.0	2.6	2.4	2.0	1.9	0.4	32.3	7.8	1.7	5.4	3.7	1.8	13.9	8.2	3.5	2.7	2.6	4.5	5.7	1.5	2.0	2.6	7.8	4.9	3.4	13.1	3.1	3.3	15.8	6.3	2.8	2.0	0.1	4.7	3.3	2.5	0.9
ZNF568	DKFZp686B0797	ENSG00000198453	"Zinc finger protein 568"	Q3ZCX4	19	36916329-36998700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024541, HPA052061"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA024541: , HPA052061: AB_2681713"	"unprognostic (3.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.83e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.98e-3)"	4.1	6.5	5.5	3.6	5.4	3.7	5.6	12.4	6.4	6.3	7.3	4.5	2.4	7.3	4.9	3.4	5.9	3.4	5.2	5.4	8.4	4.5	3.3	4.2	4.1	5.9	6.9	9.3	4.4	8.3	5.3	5.2	5.8	4.9	2.9	11.8	4.8	5.4	5.5	4.1	3.2	5.9	3.9	6.1	4.3	6.0	6.9	4.8	7.7	5.7	4.5	4.4	4.1	9.9	0.2	5.0	8.4	2.5	7.8	8.8	2.6	7.4	7.4	6.0	8.1	0.6	2.9	0.3	8.3	9.3	4.3	1.4	0.1	4.3	6.3	1.1	6.5	2.8	0.9	1.0	10.1	0.4	6.5	10.7	5.1	6.1	0.2	7.3	2.9	3.7	0.3	0.8	9.2	0.2	1.6	1.3	6.9	0.0	0.3	0.7	6.7	2.6	5.7	11.0	8.2	10.7	0.3	0.2	6.2	8.3	6.7	1.1	4.7	3.5	11.9	6.1	4.8	9.0	13.1	6.0	0.2	0.2	12.5	19.6	1.7	6.4	7.1	1.3	6.3	9.0	6.8	5.9	2.9	6.9	8.4	6.4	1.4	7.4	2.1	2.7	6.4	3.0	5.5	5.4	12.4	6.4	5.4	8.4	5.9	6.9	5.8	3.9	6.9	9.9	7.7	3.2	7.0	12.7	7.5	5.1	3.4	4.5	2.8	18.9	5.7	6.5	6.6	10.0	3.1	9.2	14.6	5.0	6.3	0.5	3.9	7.1	28.9	5.1	7.1	7.4	0.0	1.3	22.4	3.7	4.1	7.8	2.6	3.8	16.5	13.9	6.4	1.4	3.5	40.4	22.6	1.4	14.2	2.5	3.4	19.5	6.5	3.5	1.8	10.3	3.5	9.4	12.3	25.6	25.7	2.8	0.3	9.8	3.4	3.9	0.7	5.1	5.2	17.0	6.6	13.6	6.6	18.1	12.6	3.4	4.1	2.9	7.9	7.2	1.0	2.6
ZNF573	FLJ30921	ENSG00000189144	"Zinc finger protein 573"	Q86YE8	19	37735833-37817300	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.9;Inhibitory neurons: 28.1;Oligodendrocytes: 22.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042776	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"	Cytosol	"HPA042776: AB_10961399"	"unprognostic (3.79e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.60e-2)"	1.6	1.7	0.5	1.1	1.2	2.1	2.0	4.0	1.4	1.0	0.2	0.9	1.3	1.9	2.7	0.7	1.2	1.7	0.9	0.6	2.6	1.3	0.7	1.4	1.2	0.7	0.6	2.1	1.3	1.4	0.8	1.5	0.9	1.3	1.2	2.7	0.8	0.9	0.9	2.1	1.0	0.9	0.2	1.7	2.0	1.3	0.6	1.1	2.5	0.7	1.6	0.7	0.8	2.4	0.5	1.8	1.4	1.3	0.7	1.5	0.6	1.2	1.3	0.4	1.0	1.8	1.2	1.8	1.1	1.0	0.5	1.1	1.4	1.9	1.7	0.4	1.2	2.0	2.8	0.9	0.6	1.7	1.6	1.4	0.6	2.5	1.0	0.9	1.3	1.0	0.8	0.8	0.3	0.7	1.4	1.0	2.0	0.5	0.2	1.4	2.8	0.6	0.0	1.3	1.8	1.6	2.2	0.6	0.2	0.9	1.7	1.5	0.5	1.6	1.5	1.4	1.9	2.1	2.8	2.6	0.3	0.2	1.3	2.1	0.4	1.6	1.9	0.6	1.5	1.5	1.6	2.1	0.9	2.8	2.6	2.0	0.2	1.7	1.3	1.5	1.0	0.5	0.5	1.2	4.0	1.4	0.6	2.6	0.7	0.6	0.9	0.2	0.6	2.4	3.1	0.0	3.9	7.2	7.4	1.8	2.6	2.1	1.8	15.7	2.1	2.4	11.8	2.8	1.9	3.7	12.5	4.0	7.1	0.8	1.9	2.5	37.9	1.4	3.8	4.7	1.2	3.4	22.2	0.7	3.2	4.0	1.1	1.3	0.0	7.6	5.0	1.4	4.0	16.8	28.1	1.3	0.0	1.3	2.5	16.8	8.7	2.2	3.6	12.2	3.2	7.3	7.2	21.1	22.9	1.3	1.6	6.4	1.8	1.9	2.6	2.9	2.4	12.0	0.0	5.2	3.8	7.7	7.6	2.8	2.6	1.6	5.7	3.6	2.1	1.2
ZNF574	FLJ22059	ENSG00000105732	"Zinc finger protein 574"	Q6ZN55	19	42068477-42081552	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 40.9;Spermatocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023196, HPA057274"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA023196: AB_2671105, HPA057274: AB_2683392"	"unprognostic (3.90e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	8.1	5.4	6.8	4.6	6.1	11.1	7.9	9.5	7.7	8.4	4.3	9.5	6.7	10.3	2.7	9.6	8.8	5.1	6.8	6.2	6.2	5.5	5.4	5.6	6.5	6.9	5.8	9.6	7.9	6.1	6.5	5.0	5.8	7.5	2.8	4.1	8.1	6.7	9.3	12.8	7.5	3.7	5.6	8.4	7.2	27.1	6.3	6.3	6.0	6.4	4.2	8.2	7.5	6.3	15.0	41.1	9.0	11.4	8.1	8.0	9.7	11.0	9.6	14.2	13.6	16.2	10.1	21.4	9.7	9.1	7.5	8.9	10.4	14.1	5.6	11.4	17.6	20.5	10.1	14.0	8.6	12.6	13.5	9.5	13.9	13.2	11.1	8.7	7.9	11.8	17.1	13.3	10.1	31.2	15.2	10.9	16.1	13.5	16.2	20.7	8.6	9.3	7.4	19.7	14.9	12.8	11.3	24.0	7.3	6.2	11.0	20.5	9.5	19.2	14.9	5.8	16.4	14.3	9.3	15.7	10.6	11.9	11.0	12.3	10.5	16.7	16.2	7.8	17.6	17.3	12.1	17.8	12.5	12.8	12.6	11.9	13.3	10.9	11.2	11.1	10.3	12.9	6.8	6.1	9.5	7.7	6.2	6.2	6.9	5.8	5.8	5.6	6.3	6.3	6.0	0.0	3.3	1.3	11.3	29.3	15.1	6.1	40.9	7.5	11.0	7.6	4.3	4.3	6.0	1.8	2.1	7.9	6.3	5.8	1.9	6.9	25.3	6.1	5.7	7.6	3.5	8.6	1.4	5.1	6.7	6.6	7.7	5.7	12.7	5.4	6.8	3.1	5.1	3.3	1.7	7.6	6.1	2.5	11.0	15.7	5.6	3.0	8.8	1.0	7.5	3.9	4.1	1.5	0.9	4.3	8.5	8.6	8.1	10.6	6.4	4.3	5.2	9.8	6.6	8.8	8.0	35.5	20.5	22.1	22.7	4.8	10.6	3.8	7.9	9.6
ZNF582	FLJ30927	ENSG00000018869	"Zinc finger protein 582"	Q96NG8	19	56375846-56393545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 13.7;Muller glia cells: 13.2;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028858	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA028858: AB_10603247"	"unprognostic (1.19e-3)"	"unprognostic (9.86e-4)"	"unprognostic (3.88e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.02e-7)"	"unprognostic (3.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.00e-3)"	2.3	4.5	5.8	2.2	6.8	1.6	3.3	7.5	8.6	3.2	6.2	3.1	1.1	4.1	6.9	2.5	3.1	3.3	4.4	5.8	7.0	4.0	2.5	2.7	4.8	6.5	6.2	5.1	2.1	3.8	5.0	2.9	6.3	4.3	1.3	10.5	2.1	2.7	1.8	3.0	2.0	2.3	6.2	4.1	1.9	5.1	6.2	2.6	7.4	1.6	1.9	3.0	2.1	7.3	0.0	1.3	6.9	1.4	1.6	1.7	0.0	2.9	3.0	1.8	1.4	0.0	0.4	0.0	1.8	1.6	4.0	0.0	0.9	0.4	1.3	0.0	28.3	7.0	0.0	0.5	2.9	1.8	5.4	6.1	1.5	1.1	0.0	1.8	1.1	0.7	1.6	0.0	1.1	0.0	4.1	4.5	3.9	0.1	0.0	1.9	2.3	2.5	1.5	3.9	0.0	4.5	0.0	0.9	0.0	5.1	3.1	3.8	1.2	3.6	7.4	0.9	3.9	6.0	7.0	4.4	0.2	0.4	2.1	2.9	1.4	4.2	2.8	2.3	4.2	4.3	3.4	2.8	2.3	3.2	2.4	3.1	0.4	7.6	1.7	2.3	1.1	1.9	5.8	6.8	7.5	8.6	5.8	7.0	6.5	6.2	6.3	6.2	6.2	7.3	4.9	0.0	0.0	4.2	4.0	1.3	2.4	2.3	1.2	4.4	2.5	2.8	3.5	1.5	2.1	7.3	2.1	2.7	2.9	0.2	13.7	2.5	1.0	2.8	1.7	4.6	0.0	0.4	4.5	0.6	0.7	2.6	1.1	1.9	8.2	3.2	4.6	2.4	2.8	1.7	4.9	0.5	6.1	1.0	2.0	0.9	2.1	2.3	3.6	0.0	1.6	13.2	5.2	7.1	9.2	1.4	0.3	4.1	0.1	4.2	0.7	4.9	2.2	5.5	13.1	3.5	2.8	2.8	7.9	0.9	1.0	3.6	2.7	4.5	0.6	2.3
ZNF587B		ENSG00000269343	"Zinc finger protein 587B"	E7ETH6	19	57819721-57846238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 36.2"									"HPA043800, HPA053762, HPA072145"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (4.13e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.70e-2)"	3.6	3.1	1.2	3.4	1.6	9.4	5.3	4.0	1.1	2.5	3.4	4.0	5.7	3.2	2.5	3.8	3.2	2.6	3.1	1.3	0.8	4.0	6.6	3.8	4.8	0.7	0.7	3.3	5.6	3.0	3.0	3.0	0.4	4.0	4.4	2.0	6.0	2.3	9.9	6.9	5.6	2.2	0.1	6.4	4.7	5.3	1.3	2.8	4.0	2.0	5.0	3.7	2.9	0.8	5.6	16.3	6.0	13.0	1.5	1.7	7.0	4.5	3.5	4.4	3.0	9.6	8.9	11.9	2.4	6.1	2.4	4.7	5.9	14.1	10.5	2.0	13.8	8.8	15.3	10.1	5.2	15.4	8.3	5.0	2.7	6.8	7.1	1.2	3.7	8.5	10.3	5.5	2.8	6.2	7.2	2.6	15.7	5.2	7.2	5.9	6.5	5.6	5.3	36.2	3.7	6.2	5.0	6.6	4.3	9.4	9.1	5.5	5.1	6.0	6.9	1.4	6.6	7.7	6.6	9.1	4.9	4.5	6.7	2.0	1.8	0.8	1.1	1.6	1.2	1.2	1.2	1.3	1.1	1.2	1.6	1.5	3.0	1.1	0.9	1.2	1.0	1.8	1.2	1.6	4.0	1.1	1.3	0.8	0.7	0.7	0.4	0.1	1.3	0.8	1.7	6.4	1.5	6.5	3.4	3.2	3.4	2.4	1.2	4.2	2.2	0.6	2.7	4.3	5.4	0.0	0.0	3.5	3.9	1.3	1.9	3.9	4.6	3.1	2.2	2.8	4.2	1.3	11.6	2.0	3.3	2.8	3.1	3.3	0.0	5.8	5.7	3.4	1.4	3.3	12.2	3.7	4.1	2.2	1.0	0.9	0.6	1.9	1.8	4.7	1.8	0.8	2.1	11.1	4.6	2.1	1.4	0.7	2.2	2.9	1.4	3.3	3.2	3.6	6.6	2.3	2.5	4.2	5.8	1.3	3.8	2.5	2.2	4.4	2.4	3.1
ZNF608	"DKFZp434M098, KIAA1281, NY-REN-36"	ENSG00000168916	"Zinc finger protein 608"	Q9ULD9	5	124636913-124748807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 105.4;Inhibitory neurons: 141.2;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 209.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.5;naive B-cell: 1.6"	"Group enriched"	"Detected in many"	4	"B-cells: 1.6;granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AF22: 61.0;AN3-CA: 39.2;REH: 110.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005545, HPA076984"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Mitochondria	"HPA005545: AB_1080742, HPA076984: "	"unprognostic (3.82e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.56e-2)"	6.1	9.9	10.4	4.2	14.0	1.4	6.7	12.1	10.4	7.4	4.1	5.6	11.1	4.8	2.7	3.5	9.1	6.9	9.0	11.7	12.8	5.3	2.7	10.7	8.0	14.7	12.4	6.3	8.4	3.7	4.4	3.1	12.4	5.6	7.2	23.6	5.7	4.5	6.4	3.3	6.6	4.2	9.2	2.8	6.7	9.4	12.4	4.8	9.2	3.2	8.0	3.1	4.4	17.1	0.2	1.1	61.0	39.2	8.9	14.5	0.0	0.0	1.6	0.3	3.6	6.6	18.6	20.8	20.2	0.0	9.8	0.8	4.2	3.9	0.3	0.0	9.9	0.0	0.1	0.3	13.7	0.0	1.9	14.6	11.0	1.9	1.7	9.1	13.2	0.1	2.0	0.4	3.3	0.1	0.0	0.0	25.9	0.5	0.8	110.6	5.4	0.1	8.7	0.9	9.2	32.0	0.0	0.7	14.1	34.5	3.5	1.8	3.5	12.3	22.9	0.3	3.9	9.7	10.2	36.9	3.1	0.6	17.7	2.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	10.4	14.0	12.1	10.4	11.7	12.8	14.7	12.4	12.4	9.2	12.4	17.1	25.2	32.1	35.3	105.4	7.4	1.3	10.4	5.5	31.3	35.8	8.6	7.7	20.1	18.6	36.2	14.7	39.6	0.8	1.5	13.0	3.9	16.7	16.9	30.6	3.0	23.4	40.0	1.3	17.0	8.7	3.8	9.9	11.7	16.8	0.0	7.3	11.4	2.0	0.8	42.1	141.2	6.1	4.1	0.3	2.2	8.8	2.1	1.3	7.2	28.1	2.1	31.2	0.0	219.2	209.9	6.2	7.3	1.5	3.7	3.5	8.1	8.4	13.2	36.7	0.0	13.2	7.7	19.2	7.2	11.8	0.9	0.4	1.5	19.1	9.8	2.5
ZNF614	FLJ21941	ENSG00000142556	"Zinc finger protein 614"	Q8N883	19	52012765-52030240	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Late spermatids: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA021197	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021197: AB_1859380"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.15e-3)"	4.1	3.6	4.0	3.3	4.6	6.3	5.6	8.2	5.3	4.2	2.4	3.0	2.5	5.3	3.9	3.4	4.2	3.3	4.0	3.7	4.8	3.8	2.3	3.5	4.3	4.5	4.6	7.5	1.8	5.0	3.3	6.9	4.3	8.9	3.0	8.7	3.0	4.7	4.0	4.3	2.9	4.9	4.1	4.5	3.2	6.9	5.2	5.9	8.0	5.0	4.4	3.9	2.1	6.4	4.8	3.5	8.8	11.5	6.2	6.9	1.1	6.4	4.5	5.8	7.0	4.4	2.7	12.1	3.4	5.5	5.4	2.0	13.3	8.5	8.6	3.2	18.8	18.2	6.6	9.0	5.1	3.8	8.8	5.4	4.6	5.9	8.2	5.8	6.9	10.5	9.9	2.6	7.9	1.9	16.0	7.6	10.2	0.7	6.3	10.5	17.0	10.0	6.0	12.0	11.6	7.1	3.8	4.7	3.9	10.8	6.3	9.6	7.1	5.7	7.9	3.2	7.6	5.2	8.7	18.3	5.5	5.2	7.6	2.3	2.4	1.6	3.2	3.2	3.9	3.0	2.9	3.1	3.0	2.8	4.1	2.6	1.7	5.7	2.8	1.7	3.2	1.8	4.0	4.6	8.2	5.3	3.7	4.8	4.5	4.6	4.3	4.1	5.2	6.4	5.2	0.0	2.2	3.6	4.8	3.2	5.3	2.4	4.6	6.8	4.2	4.2	5.8	4.3	4.9	5.5	4.2	6.1	6.5	1.7	0.0	2.9	47.9	2.8	6.1	5.8	5.4	7.4	6.6	0.9	7.1	3.7	5.6	3.7	7.0	5.0	8.2	1.6	2.3	16.8	6.7	2.4	2.0	4.1	2.3	34.9	4.1	3.2	1.8	4.7	2.2	5.1	10.3	6.0	9.2	1.4	0.7	7.2	5.4	4.6	1.8	2.0	0.9	5.6	0.0	7.1	5.7	2.2	5.0	4.4	2.7	14.4	4.1	2.7	2.2	5.1
ZNF625		ENSG00000257591	"Zinc finger protein 625"	Q96I27	19	12142090-12156734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 9.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA074014			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria	Nucleoplasm	"HPA074014: AB_2686652"	"unprognostic (7.88e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.62e-1)"	1.2	2.2	2.2	0.8	2.1	1.2	2.4	5.0	6.3	2.2	1.8	2.1	0.8	2.2	2.9	1.3	2.0	0.9	1.9	2.1	3.0	4.0	1.0	1.4	1.2	2.4	2.4	2.1	1.8	1.4	3.5	1.7	2.4	2.8	0.8	8.8	1.8	1.5	0.5	2.1	1.4	1.6	2.4	2.4	1.4	1.6	3.2	0.9	2.8	0.8	1.1	2.1	1.6	2.6	0.7	0.0	5.5	8.7	2.2	1.5	0.9	2.2	2.8	3.2	3.6	0.1	0.1	0.0	4.1	1.6	2.3	0.4	0.0	2.9	2.9	0.0	1.6	2.7	0.0	2.6	0.9	0.1	3.5	1.1	1.2	3.1	1.1	2.3	2.7	0.2	0.0	0.0	4.9	1.9	0.0	1.2	6.6	0.0	1.8	0.2	4.5	0.0	2.7	7.5	3.5	2.4	0.0	0.1	2.0	6.4	3.6	0.2	1.6	7.3	3.5	5.9	3.1	6.1	5.1	0.0	2.0	0.0	2.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.4	0.1	2.2	2.1	5.0	6.3	2.1	3.0	2.4	2.4	2.4	2.4	3.2	2.6	2.1	3.2	1.5	0.0	0.5	0.4	0.5	1.0	1.2	5.0	2.0	2.2	0.1	2.8	0.4	1.8	10.4	4.1	0.5	0.5	3.9	3.4	0.1	1.9	3.5	2.5	1.2	0.0	0.0	3.1	3.9	1.3	0.0	1.5	0.0	4.9	6.4	0.8	1.5	5.0	0.0	0.6	2.0	4.1	2.0	1.3	0.6	0.5	0.0	0.0	1.7	5.1	7.2	0.0	0.0	3.6	1.9	1.5	1.6	0.7	0.3	2.7	2.5	9.5	0.0	1.8	1.7	2.9	6.6	0.3	0.9	1.2	0.4	2.0	1.0	0.3
ZNF627	FLJ90365	ENSG00000198551	"Zinc finger protein 627"	Q7L945	19	11559374-11619161	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA049770, HPA073463"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"HPA049770: AB_2680871, HPA073463: AB_2686606"	"unprognostic (1.81e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.89e-3)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-1)"	"unprognostic (6.39e-3)"	5.6	4.1	5.7	4.3	5.9	7.6	11.1	7.4	6.8	8.3	6.0	5.9	5.7	10.6	8.7	4.6	12.2	5.0	5.2	5.6	5.9	9.6	7.1	6.1	6.8	6.1	6.0	13.1	7.5	8.9	5.8	6.3	5.9	8.0	6.8	8.3	5.9	6.5	4.0	5.5	5.0	6.2	6.2	6.6	6.0	8.0	6.3	9.3	13.1	5.6	5.6	6.4	5.6	7.9	6.0	5.2	15.0	18.8	6.7	6.9	8.5	8.4	10.0	9.5	9.5	3.9	4.0	4.6	8.4	6.6	4.8	5.1	6.0	8.2	10.5	8.3	2.8	12.8	2.8	7.6	12.5	6.9	6.9	8.4	11.6	6.2	14.3	14.5	10.6	10.9	11.9	6.0	12.5	12.3	11.3	6.9	11.3	4.0	10.4	12.6	11.3	6.3	10.8	9.2	20.8	15.5	11.5	6.1	12.6	12.7	11.1	19.6	9.2	10.0	4.8	6.2	5.9	8.6	9.0	4.8	4.6	11.3	8.4	14.2	4.5	7.4	4.6	4.9	5.3	9.0	5.6	5.8	7.2	5.8	7.4	6.7	2.4	7.3	4.8	2.7	3.2	4.2	5.7	5.9	7.4	6.8	5.6	5.9	6.1	6.0	5.9	6.2	6.3	7.9	2.9	12.8	5.9	6.2	11.2	1.3	3.4	4.0	6.2	4.5	6.2	5.8	15.0	7.2	3.1	9.2	4.2	5.2	5.4	3.7	17.6	5.4	7.9	7.0	4.9	4.3	5.3	8.0	4.5	2.6	4.3	4.3	10.2	3.7	1.3	6.1	6.1	6.1	3.2	6.7	4.8	3.2	10.2	4.4	4.4	4.0	5.3	3.1	0.0	3.7	3.2	4.9	3.1	6.6	7.3	4.1	3.1	5.3	6.7	4.9	3.5	7.3	11.6	5.8	0.0	3.1	4.7	15.5	4.4	3.6	2.7	4.7	4.8	3.1	4.3	3.3
ZNF652	KIAA0924	ENSG00000198740	"Zinc finger protein 652"	Q9Y2D9	17	49289206-49362473	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 18.0"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044408	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044408: AB_2678932"	"unprognostic (1.33e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.30e-2)"	2.1	2.3	4.6	2.8	11.4	3.7	9.6	6.7	4.7	3.2	1.5	2.8	2.6	2.1	2.0	2.0	2.1	2.2	1.6	3.6	6.2	2.5	4.0	2.8	2.9	10.7	8.2	2.8	2.4	3.6	1.0	2.6	11.4	3.3	2.9	4.5	4.4	2.4	10.5	6.6	2.1	2.7	5.2	4.6	3.4	3.7	7.9	3.4	3.6	2.5	3.0	2.1	1.1	18.0	4.3	2.9	3.2	4.1	4.3	2.3	4.3	1.6	2.6	1.8	2.1	6.8	2.7	9.7	5.0	3.3	1.4	3.0	2.9	3.1	2.9	3.3	2.6	3.5	5.0	4.7	1.6	2.9	5.3	3.2	2.8	1.6	2.9	1.8	2.2	4.8	2.7	8.1	1.8	6.0	4.3	1.6	3.2	2.5	2.1	3.4	6.6	4.6	2.4	5.7	5.9	4.0	2.8	3.9	4.2	4.8	7.1	4.1	3.6	5.9	4.4	2.6	2.6	10.3	7.6	6.3	3.2	2.6	2.2	7.7	3.0	3.2	2.6	2.6	3.5	1.9	1.9	2.0	2.1	2.6	1.8	1.9	5.9	2.1	3.4	1.9	0.9	2.5	4.6	11.4	6.7	4.7	3.6	6.2	10.7	8.2	11.4	5.2	7.9	18.0	28.8	19.2	19.8	37.5	38.6	16.4	14.2	7.8	18.8	56.5	63.7	50.2	16.6	21.5	15.2	29.5	64.6	24.0	60.6	22.7	13.7	18.6	19.2	56.6	45.1	24.3	12.1	22.3	49.2	19.6	18.2	24.4	16.8	59.1	5.1	24.0	29.6	41.6	12.8	43.7	70.9	20.4	14.2	41.6	32.4	17.3	48.4	25.1	26.6	65.6	37.0	30.1	45.3	76.9	152.6	18.4	18.5	44.4	21.9	24.6	17.9	12.4	21.3	47.1	0.0	30.0	22.8	60.4	29.9	15.6	24.3	13.4	33.7	27.7	24.0	12.6
ZNF654	"FLJ10997, FLJ21142"	ENSG00000175105	"Zinc finger protein 654"		3	88059255-88144660	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036172, HPA036173, HPA049262, HPA077939"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364"	"unprognostic (2.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.89e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.72e-3)"	"prognostic unfavorable (9.97e-6)"	"unprognostic (1.29e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-2)"	5.0	3.7	2.6	4.1	2.7	8.1	5.5	4.9	3.3	5.1	1.8	4.4	4.5	4.6	4.7	5.6	3.4	4.8	3.4	2.4	3.2	4.8	7.0	4.5	6.1	2.8	3.1	6.4	4.1	4.3	1.2	5.0	3.3	5.5	4.2	11.7	4.6	4.1	3.0	6.5	4.8	4.1	3.2	4.9	4.7	6.0	2.7	7.6	5.9	4.9	5.7	5.1	2.3	3.9	7.2	3.0	5.0	6.9	9.9	8.6	4.6	9.3	8.4	6.1	8.4	4.4	4.3	11.3	6.2	7.4	4.4	4.7	5.3	8.6	11.8	7.0	3.0	7.0	3.9	3.2	7.5	8.0	7.6	8.4	7.4	6.7	7.8	12.1	8.1	6.6	4.9	9.0	13.6	5.3	8.0	6.5	2.7	5.7	4.8	5.7	3.4	5.4	5.4	9.0	3.7	3.3	6.8	5.2	17.0	6.0	7.3	5.7	9.5	13.6	8.7	51.8	6.6	10.1	7.6	7.9	10.8	7.5	8.6	9.7	1.2	1.8	1.7	1.2	2.0	1.1	1.8	2.4	1.5	1.7	2.2	1.5	1.7	4.0	1.0	0.7	1.4	1.0	2.6	2.7	4.9	3.3	2.4	3.2	2.8	3.1	3.3	3.2	2.7	3.9	18.2	9.6	13.1	10.1	12.8	22.4	10.1	7.9	9.1	14.0	17.4	10.2	11.8	5.7	10.8	5.5	12.5	4.8	14.5	11.9	1.9	7.6	1.4	9.4	16.0	12.4	5.3	5.2	11.7	5.3	4.2	11.7	5.1	12.2	15.8	14.5	8.9	14.0	6.3	16.8	11.3	7.1	10.2	12.3	19.5	1.5	7.5	14.8	8.8	7.5	10.9	9.9	9.2	9.0	13.3	8.4	8.2	12.4	9.2	12.0	9.0	6.0	10.7	14.3	6.6	13.9	11.5	12.1	10.4	11.4	18.6	8.2	14.0	9.0	7.8	14.4
ZNF658	"DKFZp572C163, FLJ32813, MGC35232"	ENSG00000274349	"Zinc finger protein 658"	Q5TYW1	9	66856426-66932141	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	11	"neutrophil: 28.0"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 28.0"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA047730, HPA048668"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA047730: AB_2680136, HPA048668: AB_2680487"	"unprognostic (9.54e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.18e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	2.6	2.7	2.4	2.0	2.8	2.0	5.4	4.7	3.0	3.6	2.9	2.5	2.1	3.6	2.7	3.5	4.0	1.8	4.4	2.7	2.8	3.7	2.4	3.0	2.7	1.4	1.8	6.3	3.3	5.0	2.4	1.8	1.4	4.0	2.6	5.4	4.1	3.4	5.0	8.1	1.8	2.8	0.9	3.5	2.7	3.5	3.2	2.8	4.5	4.4	3.1	2.5	2.0	2.3	2.3	3.9	3.7	7.0	3.7	4.4	2.8	1.8	3.3	2.4	2.7	0.3	1.7	5.3	1.9	1.7	2.6	6.1	3.0	3.5	2.6	0.2	1.9	0.8	3.5	0.8	4.1	3.3	1.8	3.5	7.8	2.4	3.4	5.0	4.8	3.4	1.1	1.0	3.1	1.3	2.7	1.7	3.1	1.6	6.6	0.2	5.9	1.9	2.6	5.9	5.4	3.2	2.8	1.5	2.7	3.9	2.2	8.4	1.1	3.1	4.0	2.8	2.2	0.6	3.2	1.3	1.4	1.2	3.3	0.8	0.7	2.3	0.9	0.6	0.1	0.8	1.3	1.1	0.3	1.6	1.8	1.0	28.0	2.4	0.6	0.6	0.7	0.2	2.4	2.8	4.7	3.0	2.7	2.8	1.4	1.8	1.4	0.9	3.2	2.3	3.9	3.2	3.2	3.3	2.7	0.9	1.3	1.9	9.6	7.3	2.6	3.8	3.5	2.8	2.4	0.0	0.0	2.7	0.3	0.8	15.6	1.4	0.8	2.3	2.8	2.7	0.0	0.4	6.5	0.7	1.1	2.2	1.5	1.3	1.3	5.8	1.4	2.3	1.8	10.1	7.8	1.8	2.0	2.4	0.3	1.2	3.1	0.8	0.0	1.9	0.2	5.1	0.0	4.0	4.5	0.8	0.3	5.3	2.0	0.9	1.3	4.6	7.5	4.3	0.0	3.9	2.0	3.2	2.9	5.4	2.0	1.0	1.3	3.5	1.4	1.8
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA055779: AB_2682917, HPA062506: AB_2684786"	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.79e-5)"	13.4	14.8	13.4	11.7	14.8	13.5	13.1	17.9	14.1	13.3	14.6	16.1	11.3	14.3	7.7	19.1	14.9	7.8	30.2	12.8	13.4	22.3	26.1	17.0	14.8	17.2	14.8	11.1	18.0	16.2	17.1	9.3	14.8	24.0	8.4	10.7	17.6	8.2	49.5	17.9	16.8	8.1	14.0	19.8	16.9	16.0	14.9	15.8	20.2	35.7	14.0	16.8	13.7	15.8	19.4	21.5	17.2	19.5	9.4	6.6	33.0	17.8	9.7	12.7	13.6	11.8	19.7	22.0	18.1	11.7	9.6	18.8	9.4	13.3	8.0	32.5	5.3	33.7	20.0	16.0	12.0	14.6	24.4	7.4	10.7	16.6	11.5	10.2	11.7	15.2	41.5	17.6	8.8	13.8	26.8	14.5	20.0	22.3	36.5	49.1	16.3	17.4	12.9	15.6	25.5	22.2	16.0	24.0	15.9	10.2	13.8	30.1	10.0	17.5	10.5	11.6	37.3	52.8	22.2	13.2	16.0	25.1	14.5	9.2	16.3	11.9	8.8	15.9	7.2	11.9	6.3	8.8	24.3	15.0	6.7	6.3	9.2	12.7	15.4	13.6	7.8	14.0	13.4	14.8	17.9	14.1	12.8	13.4	17.2	14.8	14.8	14.0	14.9	15.8	10.7	3.2	15.2	5.9	22.3	13.0	28.2	10.1	6.8	22.0	12.8	9.8	20.2	14.3	8.1	16.5	12.5	32.0	22.0	19.5	21.5	18.3	7.8	9.5	5.7	12.0	18.0	17.0	2.2	10.7	19.9	10.0	10.2	8.9	28.0	12.5	7.5	17.2	16.8	10.1	4.0	17.6	8.2	16.4	16.9	14.6	5.6	20.6	12.4	1.9	17.8	19.5	20.6	2.5	5.2	14.6	19.7	5.7	9.6	21.1	26.5	15.8	9.0	30.5	6.6	17.5	11.7	32.4	23.4	5.5	14.6	71.3	13.5	10.6	16.9	22.5
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli, Mitochondria, Cytosol"		"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	2.5	3.1	2.2	3.0	3.3	3.4	3.7	3.6	2.8	3.6	1.1	2.9	2.3	3.8	2.4	2.1	3.1	3.1	1.9	2.3	4.3	2.6	2.2	3.2	4.4	3.1	2.8	4.0	3.3	2.3	1.5	4.2	2.8	4.0	4.1	5.7	2.7	2.4	1.5	1.4	2.1	2.4	2.3	3.6	3.3	3.9	3.4	4.4	5.4	2.7	4.0	2.1	2.3	5.6	2.5	4.0	13.6	15.5	1.6	3.7	8.3	3.3	3.2	4.8	4.9	3.3	2.9	9.7	8.3	1.5	2.5	4.6	8.3	2.2	7.6	4.2	15.8	4.5	2.9	2.0	3.0	8.0	12.0	3.3	3.8	2.8	6.0	3.5	4.5	10.9	12.4	15.1	5.2	2.0	11.3	2.8	12.1	3.6	6.3	8.4	8.9	3.9	3.4	7.7	5.8	11.2	4.8	5.6	2.3	6.6	7.9	9.2	3.3	5.9	5.5	5.2	6.6	4.8	11.8	10.5	2.3	1.4	6.2	5.4	0.6	0.8	1.3	0.1	1.6	3.7	1.3	0.8	1.2	2.6	1.2	1.7	0.1	1.4	0.4	1.8	1.7	0.8	2.2	3.3	3.6	2.8	2.3	4.3	3.1	2.8	2.8	2.3	3.4	5.6	10.9	3.2	7.3	21.2	7.8	2.3	4.0	2.9	2.2	12.2	5.5	2.9	4.2	4.3	4.5	3.7	4.2	2.1	8.2	6.8	1.9	4.0	0.9	4.6	6.0	6.5	9.6	10.3	11.7	5.2	2.4	6.5	7.1	4.8	3.8	9.4	5.3	3.0	1.8	1.7	17.2	4.8	4.1	3.1	3.7	0.6	7.5	3.3	0.0	17.8	3.3	4.7	5.2	38.2	44.7	3.3	7.3	2.6	5.8	5.4	1.3	1.4	5.5	7.3	0.0	12.3	4.9	7.6	10.5	3.1	0.6	1.4	5.8	4.2	3.8	3.8
ZNF687	KIAA1441	ENSG00000143373	"Zinc finger protein 687"	Q8N1G0	1	151281618-151292176	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 13.5;monocytes: 4.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021193, HPA023948"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021193: AB_1859415, HPA023948: AB_2671380"	"unprognostic (2.23e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.54e-2)"	"unprognostic (7.99e-2)"	8.5	10.9	9.0	8.2	9.9	31.2	8.7	12.6	10.2	9.9	6.9	10.7	8.6	10.5	5.5	11.0	9.7	7.0	8.9	8.5	8.4	10.2	9.7	8.6	10.1	10.5	9.6	11.7	16.0	14.1	13.0	7.1	9.5	11.3	5.7	9.4	12.0	8.6	10.9	12.3	11.3	6.1	8.9	14.4	10.8	14.5	9.7	9.3	10.8	6.9	7.5	10.4	8.7	10.5	14.8	21.5	20.4	12.6	11.3	9.5	26.3	7.6	12.9	13.8	13.1	18.1	19.6	12.6	18.7	12.3	14.7	22.3	18.1	15.2	6.1	17.3	18.3	11.9	18.8	20.1	12.1	14.3	16.7	14.7	15.3	11.6	12.1	12.3	9.4	13.4	19.5	22.6	7.8	44.8	19.2	16.8	27.6	19.8	16.5	16.9	16.1	22.8	11.6	22.1	18.5	27.7	20.8	24.6	19.7	19.2	32.2	30.1	9.2	11.0	12.1	13.9	11.6	26.2	24.1	31.3	14.0	9.4	14.2	0.5	1.8	13.5	0.5	2.3	0.5	1.0	0.5	0.4	0.9	1.1	0.7	0.8	8.8	0.4	4.5	0.8	0.4	1.2	9.0	9.9	12.6	10.2	8.5	8.4	10.5	9.6	9.5	8.9	9.7	10.5	4.3	3.2	4.6	3.6	5.8	4.7	2.8	4.9	5.7	6.7	6.0	5.5	1.4	10.0	3.5	1.8	10.4	6.7	3.8	9.3	3.9	5.5	3.1	4.3	3.7	4.4	2.4	3.0	1.6	6.0	5.3	4.2	7.7	5.3	0.0	8.5	2.9	4.5	5.3	8.4	1.9	5.6	8.2	5.2	4.1	2.8	6.2	5.8	0.0	2.8	6.0	5.2	5.2	3.0	1.7	7.3	3.5	7.2	5.8	4.7	10.2	4.1	3.4	10.8	13.1	4.4	3.9	6.9	6.8	4.3	3.4	9.4	4.3	6.5	7.3	5.1
ZNF689	"FLJ90415, TIPUH1"	ENSG00000156853	"Zinc finger protein 689"	Q96CS4	16	30602558-30624012	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.0;Late spermatids: 52.0;Spermatocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054095, HPA055385"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA054095: AB_2682377, HPA055385: AB_2682801"	"unprognostic (5.62e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	3.5	3.5	3.4	3.5	3.5	6.6	10.2	3.4	3.7	4.3	2.4	4.5	4.8	5.4	2.7	2.3	4.1	2.9	3.7	3.3	3.4	3.2	4.3	3.5	4.1	3.4	3.3	5.4	4.8	7.1	3.5	3.2	3.1	3.6	3.1	2.8	3.4	4.7	5.1	2.6	4.3	4.1	3.3	4.7	3.8	19.5	3.4	5.9	3.9	5.5	4.0	4.2	3.0	3.6	4.6	8.1	11.1	11.6	4.7	4.6	5.5	5.6	8.2	9.0	8.7	9.5	3.5	13.2	8.6	5.0	6.5	3.5	14.0	6.1	7.1	10.9	23.6	11.2	7.1	14.7	5.0	11.1	8.2	4.4	5.7	6.2	6.1	4.9	6.4	12.0	13.4	7.4	5.8	6.9	20.6	10.4	12.6	3.6	8.2	25.7	10.7	11.9	3.8	4.5	13.8	8.4	4.1	7.4	6.4	5.5	7.7	9.6	5.0	11.6	4.9	5.6	7.8	13.6	16.8	15.7	4.2	12.0	11.5	0.1	6.2	2.5	5.1	9.3	3.7	3.8	4.2	5.2	8.9	2.9	3.6	3.5	0.4	8.8	10.3	3.2	4.5	4.4	3.4	3.5	3.4	3.7	3.3	3.4	3.4	3.3	3.1	3.3	3.4	3.6	10.5	3.2	2.0	1.3	8.4	1.7	4.9	2.6	1.8	10.0	25.4	20.7	4.7	11.5	1.2	1.8	6.2	4.3	10.2	5.9	0.0	6.2	53.0	2.3	5.7	8.6	6.0	6.1	2.4	6.9	3.2	6.3	3.6	3.3	14.0	8.0	8.6	6.9	5.1	10.1	2.7	6.5	6.1	8.6	4.3	52.0	8.1	6.6	0.0	3.7	6.9	5.8	8.2	2.0	3.0	5.2	4.8	10.5	6.6	5.5	7.9	4.3	1.5	6.1	0.0	11.5	5.8	87.7	8.9	2.1	1.0	0.8	8.8	6.6	6.6	3.0
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	13.0	16.5	35.1	4.7	36.3	7.5	16.3	36.3	48.5	26.6	34.1	20.1	5.1	17.1	8.2	23.2	25.3	4.9	18.0	35.0	34.7	27.0	21.7	12.5	6.2	36.5	35.5	27.6	28.2	7.4	29.1	4.2	37.7	34.9	3.6	8.5	17.8	5.3	17.7	18.7	16.6	3.8	34.1	23.5	19.7	38.9	35.7	7.0	24.7	4.7	4.4	21.3	20.8	36.8	7.1	6.4	6.1	14.7	4.7	2.5	26.4	6.1	1.9	6.2	4.0	8.2	9.8	8.8	11.7	2.3	2.5	9.5	9.1	8.8	3.9	12.6	5.7	9.9	17.8	2.2	3.5	11.4	8.3	3.2	10.2	6.8	17.5	5.8	5.9	11.1	21.1	6.2	2.9	3.8	5.9	23.7	12.2	17.1	13.1	19.3	3.6	16.9	11.9	4.5	11.7	8.8	6.3	10.1	12.2	2.3	13.1	18.5	4.5	2.7	5.0	2.7	8.0	17.0	11.3	5.8	6.2	14.9	4.7	0.0	1.5	1.4	3.6	1.1	3.3	3.0	2.9	4.0	3.1	2.3	4.1	3.0	3.3	8.1	1.0	2.5	3.5	2.0	35.1	36.3	36.3	48.5	35.0	34.7	36.5	35.5	37.7	34.1	35.7	36.8	7.8	9.6	8.6	27.1	10.7	9.6	12.5	19.0	11.4	15.3	16.8	18.7	5.4	7.2	10.8	11.0	22.9	12.8	10.3	10.0	5.9	7.6	14.3	6.1	7.0	6.7	8.3	22.7	20.6	4.0	10.4	8.1	15.8	6.8	5.7	15.9	2.9	6.2	6.5	11.8	19.7	12.3	12.2	6.0	5.5	7.8	10.2	5.4	16.0	10.3	6.1	8.3	9.2	8.5	23.5	5.7	5.2	7.2	6.6	17.3	11.6	4.1	10.8	13.6	0.0	8.4	8.0	52.7	15.4	11.0	8.0	6.2	11.3	9.5	14.3	10.0
ZNF696	FLJ14129	ENSG00000185730	"Zinc finger protein 696"	Q9H7X3	8	143289676-143299952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA057855, HPA072473"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA057855: AB_2683545, HPA072473: AB_2686524"	"unprognostic (3.23e-2)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (3.52e-5)"	"unprognostic (2.58e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.76e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (6.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.09e-3)"	4.0	3.3	3.9	3.3	3.7	3.5	3.2	5.9	6.1	3.4	0.0	3.3	6.0	4.5	2.5	2.6	3.4	2.1	2.8	4.2	2.5	3.3	4.6	2.8	3.8	5.6	3.0	4.7	5.0	4.3	3.2	2.7	5.0	3.1	1.9	3.6	5.7	2.3	3.9	6.6	3.7	2.3	0.9	4.0	3.3	3.5	3.4	2.1	3.7	2.4	3.0	3.7	2.8	4.9	8.2	7.4	7.8	8.8	3.2	2.5	14.9	6.3	2.4	4.4	2.7	4.3	6.3	0.7	8.2	2.5	2.5	5.8	8.5	3.8	4.5	9.1	17.9	10.8	8.8	6.7	3.4	4.5	13.5	2.4	6.1	3.0	6.8	3.3	2.2	6.4	22.2	5.3	3.1	17.3	4.6	8.8	10.2	9.7	17.1	9.8	4.4	8.1	3.0	6.3	11.6	16.1	9.3	6.7	8.2	5.3	10.3	8.1	4.5	6.2	13.4	5.5	10.9	9.7	7.3	10.0	4.2	9.2	7.5	1.2	2.0	1.7	2.9	1.1	3.0	2.4	2.1	3.1	2.1	3.2	3.9	3.5	1.2	3.5	2.0	3.8	0.7	1.9	3.9	3.7	5.9	6.1	4.2	2.5	5.6	3.0	5.0	0.9	3.4	4.9	2.2	0.0	0.0	3.6	3.0	2.9	2.3	0.6	0.0	5.3	1.5	1.3	2.8	2.8	0.3	3.7	6.2	1.7	1.8	2.1	3.9	2.4	1.2	0.8	2.3	2.5	0.0	1.3	3.4	2.0	1.8	1.9	2.0	1.0	0.0	2.9	2.2	2.2	1.2	3.3	3.9	1.0	2.0	0.9	0.7	2.4	4.1	0.7	1.8	1.0	0.9	1.8	6.2	4.5	3.1	1.5	0.3	1.2	2.3	1.7	2.7	1.9	0.3	4.5	6.6	1.7	2.2	3.0	5.7	1.1	2.0	0.4	2.5	2.7	2.0	0.6
ZNF70	"Cos17, MGC48959"	ENSG00000187792	"Zinc finger protein 70"	Q9UC06	22	23738682-23751112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA018821	Uncertain		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA018821: AB_1859423"	"unprognostic (3.17e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.69e-2)"	1.4	1.2	1.0	1.3	1.4	1.6	1.3	2.8	1.1	1.9	2.2	1.4	0.8	1.9	2.3	0.8	1.9	1.1	1.6	0.9	1.0	1.0	0.7	1.2	1.4	2.0	1.4	3.9	1.8	2.1	1.6	1.2	1.1	1.5	1.2	3.0	2.0	1.5	2.6	1.1	1.2	1.6	0.8	1.4	1.3	1.2	1.6	1.2	1.8	2.1	1.6	1.4	1.3	2.5	1.2	1.5	2.9	3.0	4.2	2.0	0.9	1.1	2.2	2.5	3.5	1.5	0.8	1.7	0.7	2.4	1.6	1.3	2.0	1.5	3.1	1.1	1.8	3.3	3.0	1.3	2.5	3.0	2.7	2.0	0.9	3.3	2.7	3.2	2.0	1.3	1.2	2.4	1.8	1.6	1.7	1.4	0.7	1.1	0.6	7.2	2.8	0.4	0.9	1.6	1.6	2.0	1.6	2.0	1.2	2.0	1.0	1.4	2.6	2.7	3.4	1.8	1.2	2.4	0.4	1.5	2.4	1.3	2.4	1.5	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.3	0.8	0.5	0.2	0.4	0.1	0.1	1.0	1.4	2.8	1.1	0.9	1.0	2.0	1.4	1.1	0.8	1.6	2.5	1.2	0.0	2.8	0.7	1.0	0.4	1.1	0.0	1.2	3.8	1.1	1.4	2.6	2.8	1.8	3.7	10.4	0.4	2.1	0.3	0.0	1.1	1.4	1.6	3.9	1.7	1.2	0.8	0.8	1.1	0.6	3.2	0.5	1.0	1.3	3.8	4.2	0.5	0.8	6.7	1.2	0.6	0.0	1.6	0.6	3.3	6.2	1.0	0.0	0.0	0.8	2.1	0.0	0.0	1.6	0.4	0.0	4.1	1.5	0.7	0.8	0.9	3.6	4.0	6.6	5.4	2.7	2.7	2.5	1.0	0.0	0.3	1.2	2.8	0.7	0.9
ZNF711	"CMPX1, dJ75N13.1, MRX65, MRX97, Zfp711, ZNF4, ZNF5, ZNF6"	ENSG00000147180	"Zinc finger protein 711"	Q9Y462	X	85243991-85273362	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 37.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AF22: 34.4;HAP1: 50.3;HEK 293: 46.0;Karpas-707: 30.7;MOLT-4: 28.4;RH-30: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030654	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA030654: AB_10670561"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.11e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.62e-3)"	1.4	15.1	6.3	1.6	8.0	7.2	5.7	6.7	7.9	5.8	1.7	3.6	3.1	9.2	2.8	2.6	4.6	4.1	3.8	7.7	7.6	5.1	0.5	1.8	2.4	5.7	6.3	9.4	4.9	1.4	10.9	7.7	5.2	4.0	1.7	5.7	4.1	2.6	1.6	12.2	4.6	3.3	6.5	5.0	2.7	37.3	7.5	16.3	4.9	1.5	2.5	3.0	3.2	5.5	0.0	3.3	34.4	27.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	7.5	3.0	0.1	1.2	0.5	5.5	0.7	50.3	0.0	0.0	0.0	46.0	16.5	0.9	1.9	1.3	0.0	0.4	3.2	0.3	0.0	6.3	0.0	0.3	15.6	5.1	30.7	6.1	1.7	28.4	0.0	16.7	3.1	0.7	0.0	41.9	0.0	0.0	2.5	10.0	25.8	0.1	0.9	0.0	20.0	4.6	4.5	0.1	0.0	11.1	0.1	0.0	11.4	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	8.0	6.7	7.9	7.7	7.6	5.7	6.3	5.2	6.5	7.5	5.5	1.8	3.2	1.1	14.0	3.6	12.0	7.6	2.7	18.2	9.0	18.1	17.4	6.6	1.5	1.8	1.8	0.0	0.3	1.0	0.3	5.9	2.1	2.7	2.9	18.8	4.2	18.5	5.9	19.0	0.5	0.1	8.1	1.1	4.2	0.0	15.2	3.6	0.1	0.3	3.3	21.3	2.3	2.0	0.6	3.2	5.7	3.1	0.9	5.4	11.2	0.1	7.8	0.0	38.2	12.0	0.6	1.9	3.8	2.2	3.0	0.9	2.7	1.2	1.4	0.0	8.7	8.1	13.0	23.6	10.9	9.1	0.3	0.9	12.6	2.6	2.9
ZNF766		ENSG00000196214	"Zinc finger protein 766"	Q5HY98	19	52269587-52296046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.6;Late spermatids: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044882, HPA063496"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Centrosome		"HPA044882: AB_10965173, HPA063496: AB_2685024"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.45e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.85e-3)"	7.6	5.8	5.1	8.5	5.3	16.2	12.5	7.2	5.4	9.5	5.7	9.2	6.2	9.7	7.4	7.2	9.6	6.4	7.0	4.7	6.2	7.9	5.5	8.7	12.6	6.4	5.8	14.6	5.6	9.3	6.1	6.4	6.1	9.4	8.3	5.6	8.3	7.2	6.9	8.7	7.0	6.8	4.4	11.2	8.4	23.8	5.2	14.1	14.0	7.2	11.3	8.1	6.3	7.8	11.8	18.8	13.8	16.0	13.5	19.4	10.2	11.2	11.0	7.2	14.2	5.0	9.2	19.4	10.4	11.9	11.1	11.5	13.0	11.1	12.7	15.1	17.6	20.2	11.0	5.7	7.9	22.7	13.3	15.3	15.8	8.3	19.5	14.0	11.3	25.4	13.7	10.7	12.7	8.0	29.9	9.5	15.6	16.9	20.8	20.7	23.8	17.3	9.2	34.2	17.0	14.1	17.3	13.4	9.7	20.9	15.9	14.2	13.8	6.7	9.5	5.7	11.9	18.6	56.9	29.4	6.4	11.6	13.2	51.4	14.8	30.1	26.1	21.3	36.3	32.7	27.8	29.8	15.1	29.2	43.7	34.6	15.4	31.7	22.9	10.6	32.3	20.9	5.1	5.3	7.2	5.4	4.7	6.2	6.4	5.8	6.1	4.4	5.2	7.8	12.0	22.4	8.7	3.9	17.7	5.5	17.0	13.1	5.2	15.1	8.6	12.2	20.2	14.3	12.7	14.7	4.2	13.3	11.4	4.4	15.6	18.7	83.6	8.9	16.1	12.8	9.1	17.9	8.4	10.3	10.7	12.6	4.1	9.3	10.1	21.1	11.7	5.9	6.5	15.2	10.0	10.5	18.3	8.2	6.4	53.2	11.5	7.6	3.6	7.5	16.5	11.2	21.6	8.5	11.7	11.3	11.2	10.5	5.8	19.2	4.7	8.9	9.7	10.5	0.0	15.7	10.6	13.7	30.8	4.5	7.7	11.9	15.7	12.7	7.5	18.2
ZNF77	pT1	ENSG00000175691	"Zinc finger protein 77"	Q15935	19	2933218-2944971	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA023397	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli	Nucleoplasm	"HPA023397: AB_1859447"	"unprognostic (1.17e-2)"	"prognostic favorable (8.49e-4)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.65e-5)"	"unprognostic (2.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-6)"	"unprognostic (2.06e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.93e-3)"	"unprognostic (2.65e-3)"	"unprognostic (3.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.79e-3)"	2.7	2.7	2.3	1.2	2.3	2.2	4.6	4.6	2.6	3.5	2.0	2.5	1.4	3.0	2.8	3.1	2.9	1.4	2.6	2.1	2.2	3.4	2.7	2.8	2.5	2.2	2.2	3.4	3.0	3.3	3.1	2.9	2.3	2.8	2.1	4.0	2.6	2.1	2.6	3.2	2.1	2.9	2.1	2.6	3.2	3.6	2.2	3.4	3.0	4.1	3.4	2.6	2.9	2.7	4.3	2.1	9.4	5.5	1.9	2.5	4.2	2.5	3.8	5.0	5.9	6.5	1.7	4.8	2.1	2.8	2.7	3.4	6.1	4.1	8.3	0.7	4.7	5.9	3.4	7.3	4.8	0.2	4.6	3.9	5.6	3.9	5.7	6.2	7.0	9.2	7.7	0.0	3.4	4.7	7.2	4.2	2.1	3.7	2.8	8.1	7.3	3.3	4.1	6.5	3.8	7.2	3.9	3.6	4.6	4.5	3.5	10.0	3.5	2.1	2.7	6.0	4.7	4.8	4.9	2.2	5.4	0.1	3.9	0.0	1.6	0.8	3.0	1.7	3.5	3.7	3.1	3.2	2.2	3.5	2.3	3.4	0.1	2.4	1.8	1.7	1.6	1.9	2.3	2.3	4.6	2.6	2.1	2.2	2.2	2.2	2.3	2.1	2.2	2.7	4.2	3.2	3.9	3.6	2.2	11.6	4.7	3.3	14.2	2.8	4.6	5.3	2.2	1.5	3.4	1.8	2.1	3.6	5.7	1.9	0.0	2.1	2.1	3.3	3.6	3.7	7.2	1.3	2.9	1.8	3.0	2.9	4.6	4.0	2.5	4.0	4.2	2.2	1.7	0.0	3.2	2.5	2.0	1.6	2.8	0.3	2.8	1.7	1.8	0.0	0.7	3.3	4.1	1.0	2.6	2.4	1.9	1.5	2.0	2.8	1.5	1.4	2.0	5.6	0.0	2.5	2.3	9.7	8.1	6.8	10.9	6.2	3.3	5.4	3.4	1.8
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407414-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 35.6;REH: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	4.6	7.2	9.4	1.5	9.9	1.2	4.8	8.6	15.7	7.8	1.9	10.6	1.3	13.3	2.0	4.4	9.9	1.4	6.9	10.7	8.7	7.8	13.2	3.2	0.9	8.4	6.8	10.8	4.9	2.9	8.1	0.5	6.6	9.5	1.4	1.8	4.0	3.7	12.6	3.8	4.7	2.9	4.7	2.5	6.2	3.7	8.4	1.0	5.2	1.5	1.1	10.2	5.4	8.9	4.5	5.2	6.7	5.6	9.3	4.0	5.2	6.3	3.1	3.9	4.1	2.1	2.2	5.2	10.4	3.1	4.8	3.2	6.9	2.8	4.0	1.9	35.6	4.4	3.6	6.8	4.8	2.3	4.9	6.0	2.2	4.9	3.0	4.2	4.0	5.4	10.9	3.1	3.3	8.1	5.4	7.0	5.3	2.7	3.9	23.7	5.1	3.4	2.3	1.8	10.6	6.7	3.4	3.1	4.8	3.4	3.8	2.6	3.8	6.7	8.0	3.9	4.6	4.6	5.4	2.8	4.5	4.9	4.4	0.8	0.7	0.5	1.8	1.4	2.6	1.4	2.2	2.2	1.7	3.3	3.1	2.0	1.0	1.2	0.3	2.3	2.6	1.6	9.4	9.9	8.6	15.7	10.7	8.7	8.4	6.8	6.6	4.7	8.4	8.9	5.4	3.2	0.5	6.2	3.7	5.1	11.5	1.8	22.2	12.0	9.1	15.7	7.1	20.0	1.5	5.5	10.4	5.5	7.2	7.8	33.2	6.2	1.6	4.5	12.3	7.6	4.2	4.4	8.6	4.4	3.3	12.4	5.6	9.0	1.3	12.6	13.2	19.1	3.5	11.8	9.4	10.0	0.0	1.6	2.4	2.2	25.1	3.2	5.4	5.6	1.3	15.9	2.1	5.5	5.4	2.5	5.1	29.7	4.4	15.5	8.6	29.4	0.7	8.0	13.1	15.2	12.0	1.2	1.8	8.5	6.7	3.6	5.1	9.5	10.0	4.3
ZNF774	MGC75360	ENSG00000196391	"Zinc finger protein 774"	Q6NX45	15	90352284-90369146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Granulosa cells: 45.3;Spermatocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.0"									"HPA030839, HPA030840"	Uncertain		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Intermediate filaments"	Cytosol	"HPA030839: AB_2673630, HPA030840: AB_10602691"	"unprognostic (1.11e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.89e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.82e-2)"	0.7	2.7	2.3	1.2	4.2	1.0	3.4	4.3	3.6	2.6	0.0	4.6	2.2	2.8	4.1	1.4	3.0	2.9	2.8	1.9	2.6	1.4	1.1	1.1	0.7	0.7	1.0	1.1	3.9	3.1	3.0	0.7	0.8	2.4	7.1	4.0	3.9	5.7	6.2	3.1	2.0	1.8	0.0	0.6	2.6	2.2	2.7	1.5	2.7	7.2	0.9	1.9	1.6	3.3	1.7	0.7	2.1	2.4	0.9	0.5	5.0	1.0	1.7	1.3	1.6	2.7	2.0	0.6	2.0	1.3	3.7	2.5	2.2	3.7	1.3	1.2	4.2	1.8	9.0	1.3	1.6	1.0	1.3	0.5	4.4	1.9	1.8	3.6	2.3	3.4	2.0	0.8	2.1	1.6	1.4	0.9	0.6	4.5	2.5	1.3	1.8	0.5	2.6	4.6	4.8	2.0	2.0	3.1	0.8	2.4	2.1	0.2	1.1	1.4	1.3	1.1	2.2	5.2	3.8	0.4	2.3	2.8	0.7	1.4	0.3	0.7	0.2	0.1	0.1	0.2	0.2	0.3	0.6	0.4	0.2	0.2	1.2	0.7	0.2	0.3	0.1	0.1	2.3	4.2	4.3	3.6	1.9	2.6	0.7	1.0	0.8	0.0	2.7	3.3	0.6	6.4	3.2	0.3	0.7	0.8	2.5	1.0	2.2	6.4	2.4	2.4	4.9	0.0	1.1	0.0	0.0	1.7	0.2	6.8	1.9	2.8	15.4	1.7	2.3	1.0	2.4	0.0	2.5	2.0	1.1	0.9	4.1	3.2	0.0	45.3	0.0	1.5	0.8	8.4	2.3	3.3	0.0	0.3	0.7	11.0	0.3	0.8	0.0	0.0	0.2	2.0	0.0	1.5	1.1	1.7	5.5	2.2	0.7	1.4	1.9	1.1	0.7	5.3	0.0	1.7	1.9	11.8	4.5	1.3	0.3	1.4	0.5	0.3	5.5	2.0
ZNF776	FLJ38288	ENSG00000152443	"Zinc finger protein 776"	Q68DI1	19	57746815-57758148	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA046653, HPA068553"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA046653: AB_10961126, HPA068553: AB_2686002"	"unprognostic (6.73e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (3.99e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.86e-2)"	4.4	6.5	4.5	5.2	5.5	17.2	9.1	10.6	6.3	6.6	5.4	6.4	6.4	5.0	21.6	5.0	7.0	4.0	7.2	5.4	4.9	7.7	6.8	6.3	8.3	4.4	3.8	8.3	4.7	10.8	8.3	7.7	4.7	8.5	6.7	20.7	7.8	7.7	9.1	6.4	5.9	4.2	3.7	8.2	7.6	6.6	4.4	12.6	9.3	10.3	8.2	5.5	5.3	8.2	6.2	5.3	16.7	11.2	2.6	8.2	7.2	5.0	8.3	8.7	5.6	3.2	6.8	7.2	4.4	4.6	4.6	4.1	8.8	8.7	13.8	6.5	32.1	9.8	12.6	3.7	6.2	5.5	7.5	9.5	7.1	5.8	6.2	9.2	6.7	11.6	6.6	5.0	11.2	2.9	18.2	4.9	9.7	2.8	11.0	11.6	12.7	8.3	6.4	20.0	18.7	13.7	9.3	7.7	5.5	9.0	7.9	7.7	6.2	9.2	4.9	0.8	7.6	13.8	16.8	12.1	5.5	5.1	7.7	6.6	1.8	8.9	1.1	1.3	2.7	2.4	1.9	2.4	1.7	3.7	2.8	2.2	4.6	5.6	1.7	1.9	1.8	1.6	4.5	5.5	10.6	6.3	5.4	4.9	4.4	3.8	4.7	3.7	4.4	8.2	3.3	3.2	4.1	7.2	7.1	2.7	4.1	3.9	1.8	8.7	7.7	5.3	12.3	11.5	3.2	9.2	2.1	3.1	2.5	3.9	5.9	3.3	1.4	8.3	3.7	6.5	8.4	8.6	7.1	1.3	2.3	2.8	4.1	6.9	3.8	6.9	10.4	8.1	3.5	11.8	7.7	4.1	6.1	6.0	1.8	0.6	1.2	3.6	0.0	6.5	3.1	12.0	5.2	8.0	9.1	2.5	2.1	4.9	3.9	4.1	3.9	2.8	6.0	7.5	0.0	2.6	3.9	2.9	4.8	3.1	1.7	2.9	3.3	2.9	3.2	5.5
ZNF814		ENSG00000204514	"Zinc finger protein 814"	B7Z6K7	19	57848731-57889074	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 32.5;U-266/84: 33.4"									"HPA043800, HPA053762, HPA072145"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (3.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.78e-4)"	"unprognostic (5.05e-3)"	"unprognostic (2.41e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.54e-5)"	6.4	14.5	9.2	4.5	7.8	10.4	8.1	24.8	8.3	5.5	7.3	7.6	6.6	5.2	6.9	5.2	8.5	4.5	12.9	9.2	5.2	14.5	13.4	6.3	8.7	6.3	5.2	7.4	7.2	9.7	14.2	4.9	5.7	12.6	4.8	13.8	8.7	5.5	10.0	9.5	9.2	4.0	1.2	13.0	5.4	11.2	6.6	9.5	14.7	5.7	8.1	6.3	5.4	7.1	1.6	4.0	11.6	16.6	1.2	1.1	3.0	4.1	2.7	4.4	0.6	2.0	1.6	8.9	2.7	3.8	4.5	1.3	0.7	8.8	5.4	1.6	7.9	6.6	7.0	2.4	4.8	7.8	8.2	7.3	7.9	1.6	1.7	7.8	1.1	3.6	1.8	3.6	7.3	1.7	25.2	3.6	32.5	0.9	5.1	3.1	1.3	15.6	3.8	6.2	4.7	11.8	1.4	3.2	6.1	23.5	8.0	2.5	2.5	10.3	3.5	2.4	2.2	10.1	33.4	22.5	2.6	4.3	12.9	4.6	8.2	9.7	5.4	9.7	14.0	37.4	14.2	11.7	11.9	38.7	22.4	18.5	5.4	24.8	6.0	27.9	4.2	7.4	9.2	7.8	24.8	8.3	9.2	5.2	6.3	5.2	5.7	1.2	6.6	7.1	6.2	0.0	1.5	4.6	15.6	6.8	10.5	7.3	4.0	22.7	11.5	9.8	12.9	21.5	10.1	12.9	47.9	13.2	10.8	5.0	17.6	8.0	46.5	13.9	6.6	7.6	4.9	5.9	10.9	1.4	18.6	5.5	6.1	20.4	16.5	12.6	14.6	15.3	13.0	20.2	12.3	8.7	14.2	2.8	7.9	19.5	4.1	6.5	10.6	4.7	5.9	9.4	13.4	7.5	10.1	1.7	17.8	7.2	5.9	8.4	10.5	44.0	8.4	35.9	19.7	5.7	6.6	14.1	10.9	3.5	13.1	11.6	9.2	8.9	22.1	12.6
ZNF829	DKFZp779O175	ENSG00000185869	"Zinc finger protein 829"	Q3KNS6	19	36888124-36916291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 10.4"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 278.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 13.0"					"Low region specificity"	"Detected in all"			HPA073073			Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA073073: AB_2686567"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-4)"	"unprognostic (1.32e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.92e-4)"	1.1	0.9	0.7	1.2	0.6	1.1	2.0	1.9	1.0	1.1	0.1	0.9	0.9	1.6	1.0	0.9	1.3	0.9	1.2	0.6	0.7	1.2	0.8	1.0	1.5	0.3	0.5	2.4	0.9	1.9	0.5	1.5	0.4	1.3	0.7	1.9	1.1	1.2	0.5	1.8	0.7	1.4	0.3	1.5	0.9	10.4	0.8	1.5	1.7	0.8	1.4	1.0	0.9	0.9	0.0	0.8	2.9	0.1	1.5	2.2	1.2	3.3	1.9	3.9	5.5	0.0	0.5	0.1	3.9	2.1	3.7	0.6	0.0	2.3	4.6	0.0	4.1	1.6	0.1	0.1	1.6	0.0	4.2	2.3	2.1	4.3	0.0	1.3	0.4	1.2	0.0	0.1	3.9	0.7	0.7	0.8	5.1	0.0	0.0	0.0	3.7	1.5	1.1	4.5	3.2	4.7	0.1	0.0	2.8	3.8	3.0	0.2	1.1	2.4	3.4	3.3	3.4	7.9	13.0	5.0	0.0	0.0	6.1	1.4	0.2	0.9	0.9	0.1	1.4	0.8	1.0	1.4	0.3	1.2	1.4	1.5	0.4	0.7	0.2	0.5	1.0	0.3	0.7	0.6	1.9	1.0	0.6	0.7	0.3	0.5	0.4	0.3	0.8	0.9	3.0	0.0	3.4	2.0	4.7	1.5	1.9	1.2	1.2	6.8	2.5	2.0	5.6	2.8	3.7	3.7	4.2	4.0	5.5	0.6	0.0	2.7	278.1	3.1	4.4	3.7	0.0	1.3	4.2	1.0	2.5	3.9	0.5	3.1	1.3	5.5	2.9	0.6	1.5	11.8	3.8	1.0	0.0	1.0	4.6	58.9	5.9	1.4	3.6	1.0	1.7	2.6	5.2	6.0	4.1	0.8	0.1	7.2	1.3	1.9	0.3	1.3	1.6	11.1	0.0	5.9	4.6	10.6	11.2	1.1	2.7	4.2	3.8	3.1	0.5	1.1
ZNF843	MGC46336	ENSG00000176723	"Zinc finger protein 843"	Q8N446	16	31432593-31443160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 4.6;Cardiomyocytes: 5.3;Prostatic glandular cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;EFO-21: 1.8;HMC-1: 1.6"									"HPA030911, HPA030912, HPA077945"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nuclear speckles"	"HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: "	"unprognostic (9.27e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.43e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.86e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-5)"	"unprognostic (1.17e-1)"	0.6	0.5	1.5	0.3	1.2	0.3	0.6	2.5	1.3	1.0	0.0	0.4	0.2	1.0	0.7	0.4	1.1	0.7	1.7	1.6	1.9	0.6	0.4	0.3	0.3	1.1	1.4	3.0	2.1	0.9	1.5	0.4	0.9	0.6	0.1	1.1	1.5	0.8	2.2	0.9	0.3	0.5	1.1	0.4	0.4	0.5	1.8	0.2	1.0	0.8	0.2	0.5	0.6	0.9	0.1	0.3	0.2	1.2	2.3	0.6	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.0	1.8	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.2	1.6	1.2	0.3	0.0	0.1	0.8	0.0	0.2	0.2	0.2	0.6	0.8	0.1	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.8	0.0	0.2	0.1	0.1	0.0	0.1	0.4	1.0	0.2	0.2	0.7	0.1	0.4	0.2	0.2	0.7	0.1	0.2	0.1	0.4	0.7	1.7	0.1	0.2	0.1	1.0	1.5	1.2	2.5	1.3	1.6	1.9	1.1	1.4	0.9	1.1	1.8	0.9	0.5	0.0	0.5	2.9	0.3	0.8	4.6	0.1	0.0	2.2	0.9	1.3	5.3	0.0	0.7	0.0	2.1	0.3	0.1	0.3	0.0	0.3	0.2	0.4	2.0	1.0	1.2	0.0	1.4	0.2	0.1	1.4	0.0	0.4	1.3	1.4	1.8	0.3	0.6	0.0	1.7	0.0	0.0	0.3	2.1	0.0	1.5	0.9	0.0	0.0	0.1	1.4	2.1	1.0	1.3	0.1	0.1	1.5	0.1	3.6	0.0	0.4	0.0	1.9	0.0	2.8	1.3	0.4	0.7	0.1	1.4	0.3	1.2	0.8	0.1	1.9
ZNF852		ENSG00000178917	"Zinc finger protein 852"	Q6ZMS4	3	44494847-44510636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA048312, HPA071850"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA048312: AB_2680352, HPA071850: AB_2686458"	"unprognostic (2.64e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.62e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.11e-2)"	1.3	1.4	0.7	2.5	0.6	1.6	2.1	3.4	0.9	2.0	3.6	1.9	1.7	2.2	1.7	0.9	1.6	1.3	0.5	0.8	1.1	1.7	1.7	1.8	2.5	0.9	0.7	2.5	2.1	2.9	0.8	2.3	1.1	2.6	3.1	0.9	3.7	2.1	0.5	2.5	2.0	1.9	0.3	2.7	3.0	1.3	1.2	2.9	1.7	0.9	3.2	1.1	0.8	0.7	1.0	1.4	3.9	6.6	0.8	2.3	2.4	1.0	1.3	2.1	3.1	2.1	1.1	3.2	0.7	0.8	0.9	0.8	4.3	1.1	2.8	2.8	1.5	3.1	6.5	1.9	1.2	3.3	5.7	0.8	1.9	2.7	1.1	2.2	1.7	3.3	3.7	1.4	2.5	0.2	3.0	3.8	2.4	1.2	0.8	1.5	4.3	1.9	1.6	3.2	3.0	2.5	2.2	0.9	0.7	6.6	2.2	3.5	2.8	2.6	2.5	1.4	1.0	2.4	1.9	1.9	1.1	2.6	1.7	0.0	0.4	0.7	0.2	0.5	0.3	1.1	0.5	0.3	0.2	0.9	0.5	0.7	0.6	0.4	0.2	1.4	0.2	0.1	0.7	0.6	3.4	0.9	0.8	1.1	0.9	0.7	1.1	0.3	1.2	0.7	2.0	0.0	5.4	5.9	2.3	3.3	0.8	0.9	1.2	2.1	1.5	1.5	1.8	2.8	1.4	0.0	2.1	0.8	5.1	0.8	3.9	1.9	0.3	2.6	1.6	2.0	0.0	3.2	5.7	1.4	0.9	1.4	1.1	1.5	1.3	1.8	2.2	1.4	0.7	1.7	6.8	0.9	2.0	0.3	1.0	0.4	0.6	1.4	1.8	1.9	1.4	2.8	3.1	9.0	9.2	1.5	0.1	1.2	6.8	1.1	1.0	1.0	4.2	1.6	0.0	2.4	1.6	2.0	1.6	0.5	1.8	0.3	2.3	1.6	0.8	0.9
ZNF860		ENSG00000197385	"Zinc finger protein 860"	A6NHJ4	3	31981750-31991723	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 14.0;Extravillous trophoblasts: 3.8;Respiratory ciliated cells: 4.3;Syncytiotrophoblasts: 4.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 7.0;naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	56	"B-cells: 7.0"	"Cell line enriched"	"Detected in many"	4	"BEWO: 44.8"									HPA063386	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063386: AB_2684999"	"unprognostic (1.19e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.75e-3)"	0.3	0.2	0.2	1.4	0.2	0.1	1.4	0.0	0.2	1.5	0.5	0.6	0.2	0.9	2.3	1.7	1.0	0.6	0.2	0.4	0.3	1.0	0.0	0.7	3.1	0.1	0.6	0.6	0.1	0.0	1.4	1.3	0.3	2.8	0.8	0.7	1.4	1.2	0.1	1.2	1.2	0.7	0.0	1.6	0.6	1.0	0.3	0.4	0.9	0.2	4.2	1.1	0.8	0.1	3.0	0.9	0.0	2.3	0.0	0.1	44.8	0.2	0.1	0.2	0.3	3.0	3.5	3.3	3.3	0.0	1.4	2.8	1.0	4.5	0.3	0.0	0.4	0.0	4.4	1.5	0.0	0.0	0.0	0.2	2.0	0.3	8.6	0.3	0.8	0.0	0.0	0.0	0.4	2.6	0.0	0.0	1.2	8.1	4.7	0.0	0.0	0.1	10.2	1.2	0.2	0.0	0.6	5.3	0.0	2.1	4.0	0.0	1.7	0.3	3.5	0.0	0.3	0.0	0.0	5.2	0.4	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.4	0.3	0.1	0.6	0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.0	14.0	0.9	0.5	0.7	0.6	0.6	1.9	0.8	0.6	0.0	3.1	0.0	0.0	1.7	0.1	0.2	0.0	0.1	0.1	1.2	0.7	1.1	3.5	0.0	1.6	0.5	3.8	0.7	1.5	1.6	0.0	0.0	0.4	0.0	0.3	0.0	1.7	0.5	2.0	0.0	0.5	0.3	0.6	0.3	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.3	0.2	0.4	0.7	0.8	0.5	1.2	4.3	0.0	0.0	0.2	0.7	0.1	0.2	2.4	0.3	4.2	0.4	0.0	0.5	0.6
ZNF875	HKR1	ENSG00000181666	"Zinc finger protein 875"	P10072	19	37312837-37369365	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 141.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.1;Cardiomyocytes: 19.8;Cytotrophoblasts: 11.0;Extravillous trophoblasts: 5.7;Hofbauer cells: 7.3;Syncytiotrophoblasts: 9.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036126, HPA044855"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Mitochondria"		"HPA036126: AB_10670708, HPA044855: AB_2679113"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.92e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (4.41e-4)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	18.9	37.4	29.0	10.8	26.2	14.8	25.9	36.8	30.9	24.1	46.5	22.6	8.3	20.4	23.9	17.4	23.9	14.4	31.9	28.0	30.3	34.0	18.3	18.7	16.7	25.4	26.5	28.1	20.0	31.8	36.5	18.3	26.4	39.4	14.0	141.0	27.1	19.2	21.3	28.4	19.4	17.4	19.3	27.9	21.1	30.4	28.7	19.2	37.9	18.1	18.9	21.7	22.0	30.2	7.8	19.7	24.9	32.3	18.0	15.1	17.2	13.2	20.0	23.7	25.8	10.0	9.1	27.8	31.4	14.0	11.1	6.6	16.5	17.7	24.9	14.5	28.4	9.8	26.9	10.4	23.3	8.6	23.9	23.4	21.5	16.4	35.4	23.8	14.8	19.9	1.9	1.6	17.6	16.0	20.0	17.7	51.0	13.9	11.3	13.7	10.7	10.9	21.2	31.9	32.1	42.5	13.1	16.7	16.9	36.2	24.1	17.4	13.6	18.8	13.1	14.2	21.0	34.9	40.4	29.8	2.2	10.7	21.3	12.8	4.5	7.4	7.6	5.8	14.9	11.1	10.6	11.5	6.9	12.6	14.3	12.0	4.1	11.4	4.0	8.4	13.9	6.8	29.0	26.2	36.8	30.9	28.0	30.3	25.4	26.5	26.4	19.3	28.7	30.2	5.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	11.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	9.9	0.4	0.0	0.0	0.0
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 132.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	17.1	9.4	9.7	14.3	10.7	28.7	12.4	9.1	9.8	10.1	12.1	11.2	11.0	11.3	9.0	8.1	10.7	14.1	13.2	8.9	9.4	11.8	9.6	18.8	14.2	14.0	11.0	9.9	9.2	13.0	8.5	12.3	10.8	9.7	10.5	8.7	10.3	9.6	15.5	11.8	12.4	13.6	13.3	19.1	11.4	13.4	11.9	13.1	13.8	14.5	13.4	16.5	9.0	11.3	16.3	24.9	5.8	8.2	31.4	24.5	9.8	21.6	50.9	132.7	54.9	28.4	13.2	13.5	27.3	43.5	37.6	30.7	10.8	29.3	45.1	12.8	3.6	16.0	18.1	12.5	27.2	13.0	18.7	26.3	26.9	29.7	22.0	24.3	20.3	8.0	12.4	16.2	33.6	6.8	14.2	8.7	5.6	14.0	20.7	8.9	19.6	3.8	21.8	22.1	5.9	4.3	31.6	61.1	22.4	7.1	15.7	10.8	50.9	64.8	18.3	23.8	21.1	10.7	4.0	7.2	26.0	8.7	14.6	19.3	12.3	20.1	13.5	15.2	12.0	9.4	13.6	13.1	9.1	7.1	12.9	10.0	51.9	9.9	27.1	5.2	11.0	11.5	9.7	10.7	9.1	9.8	8.9	9.4	14.0	11.0	10.8	13.3	11.9	11.3	36.5	41.7	27.2	10.4	25.8	27.8	21.2	14.4	19.4	15.7	13.7	11.2	14.4	10.0	24.8	20.2	10.4	6.1	18.7	28.0	0.0	23.9	37.4	15.9	17.9	38.1	13.1	10.7	12.5	22.7	7.0	28.0	28.5	18.6	27.3	8.1	29.3	13.4	15.1	11.8	11.7	14.2	16.2	26.4	38.0	21.1	22.7	34.2	19.6	15.0	30.2	29.5	17.5	7.1	9.9	32.3	21.8	27.1	9.3	32.8	18.7	6.7	42.8	15.1	0.0	27.8	29.9	42.0	16.3	16.2	21.7	11.4	31.4	10.2	10.4	35.7
ZNHIT6	"BCD1, C1orf181, FLJ20729, NY-BR-75"	ENSG00000117174	"Zinc finger HIT-type containing 6"	Q9NWK9	1	85649417-85708433	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018132	Uncertain		Approved	"Nuclear speckles,Vesicles"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles, Vesicles"		"HPA018132: AB_1848789"	"unprognostic (1.37e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.08e-6)"	"unprognostic (1.11e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.37e-2)"	10.3	6.6	7.2	5.2	8.2	5.2	10.1	6.8	7.7	14.6	5.3	9.7	2.9	11.0	4.4	11.8	9.6	3.6	7.7	6.8	7.9	9.0	6.7	6.9	6.4	7.7	7.4	10.4	7.2	4.2	7.5	4.7	7.6	8.9	4.2	3.3	9.5	4.4	7.8	11.1	7.9	5.5	8.1	8.1	6.9	6.1	7.6	5.5	8.5	3.9	6.0	11.6	11.3	9.1	13.5	9.1	8.9	8.1	19.2	17.4	11.3	17.0	16.3	11.5	11.0	9.2	6.8	10.4	19.7	10.4	24.7	11.2	15.9	10.9	18.6	14.3	13.7	21.6	10.3	10.7	16.2	35.4	8.3	17.2	10.0	15.3	13.4	11.4	13.7	16.4	20.2	13.3	17.6	5.1	20.9	9.2	13.5	11.0	16.5	16.6	19.7	12.0	18.7	25.2	8.6	5.6	13.3	20.3	19.3	9.3	9.0	8.9	15.6	14.8	10.0	12.5	24.7	8.5	9.3	28.2	3.4	22.0	13.1	0.6	0.7	0.1	1.8	0.7	2.0	1.9	1.6	2.0	1.2	2.4	2.0	2.0	0.1	1.8	0.7	2.1	1.8	0.8	7.2	8.2	6.8	7.7	6.8	7.9	7.7	7.4	7.6	8.1	7.6	9.1	22.0	16.0	22.5	22.5	20.3	16.2	14.4	12.5	13.1	31.8	10.6	9.9	17.6	11.5	38.0	31.3	33.3	9.0	21.0	25.6	3.9	11.9	4.2	15.5	47.4	20.9	9.5	8.4	40.4	8.8	13.7	22.2	6.1	16.1	27.8	22.4	14.3	10.6	7.5	15.2	30.0	20.9	16.2	13.5	7.4	3.8	13.4	9.1	7.2	22.5	11.0	17.6	27.8	34.2	45.3	12.2	11.6	12.8	11.1	11.1	15.5	6.3	18.0	38.8	19.7	22.4	20.7	35.8	21.6	14.0	16.3	2.7	20.1	25.8	20.5	10.8
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;gallbladder: 2.2;retina: 2.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 4.3;Ductal cells: 3.6;Early spermatids: 2.8;Late spermatids: 5.9;Muller glia cells: 16.0;Pancreatic endocrine cells: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.5"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 2.8"	"Low region specificity"	"Detected in many"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA077519: AB_2732349"	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.2	1.1	0.2	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.1	2.2	0.0	0.1	0.3	0.5	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	1.1	0.2	0.1	0.3	1.6	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.8	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.5	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099295	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 1.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Cytotrophoblasts: 1.9"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"NTERA-2: 56.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076826			Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Centrosome	"HPA076826: "	"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.0	0.0	0.3	0.0	0.6	0.2	0.0	0.9	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	56.8	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	5.8	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.3	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.9	0.7	0.3	0.9	0.4	0.2	0.5	0.1	0.5	1.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0
ZSCAN16	"dJ265C24.3, FLJ22191, ZNF392, ZNF435"	ENSG00000196812	"Zinc finger and SCAN domain containing 16"	Q9H4T2	6	28124609-28130082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 69.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007290	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA007290: AB_1080721"	"unprognostic (1.50e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (3.29e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (3.41e-5)"	3.2	3.9	5.3	5.5	6.4	3.2	7.0	7.7	7.6	3.9	5.2	7.1	8.6	3.9	7.1	3.6	4.1	4.0	3.0	5.6	6.6	5.4	4.4	4.9	8.3	6.4	5.9	2.5	4.9	6.9	3.2	2.2	6.4	4.7	9.0	7.2	6.6	5.8	3.2	6.9	8.4	4.7	5.5	7.4	7.0	2.2	6.1	8.0	4.6	2.7	9.1	4.2	2.7	9.1	0.1	8.8	11.1	8.2	3.0	0.7	9.1	3.0	6.4	7.8	8.4	6.1	5.7	8.8	8.0	2.8	5.4	6.8	7.8	4.4	7.4	12.8	10.8	9.1	7.4	8.7	4.8	6.8	7.4	1.0	7.3	6.6	3.6	8.3	14.7	0.2	1.3	7.3	2.1	10.0	0.0	10.7	2.3	7.4	5.3	10.9	8.4	12.2	9.3	12.6	15.0	16.5	1.5	9.2	10.9	7.2	12.2	3.2	4.6	2.9	6.7	4.4	7.9	3.7	12.5	2.4	1.3	3.4	1.6	69.0	8.6	10.2	13.8	11.8	17.7	19.3	12.0	10.6	9.0	14.6	14.5	11.8	15.6	17.7	11.6	19.6	14.7	8.6	5.3	6.4	7.7	7.6	5.6	6.6	6.4	5.9	6.4	5.5	6.1	9.1	5.6	6.4	2.6	0.3	5.6	1.8	0.8	4.9	1.2	3.8	5.2	5.6	1.6	10.0	7.5	7.3	4.2	2.2	12.6	4.7	5.9	12.8	3.3	4.2	0.8	4.0	1.8	8.2	1.4	12.6	1.2	1.4	4.6	3.3	2.5	4.8	4.2	2.0	2.1	1.7	1.1	6.0	14.2	3.8	1.3	1.5	0.6	4.3	1.8	1.0	6.1	5.6	11.3	3.5	3.7	9.6	6.1	3.4	4.2	1.3	10.3	8.3	7.7	6.6	0.0	1.7	3.7	1.7	6.3	2.7	1.3	1.8	6.1	2.2	7.0	1.1
ZSCAN18	"FLJ12895, ZNF447"	ENSG00000121413	"Zinc finger and SCAN domain containing 18"	Q8TBC5	19	58083838-58118427	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 128.4;SCLC-21H: 59.3;U-266/84: 46.6"	"Low region specificity"	"Detected in all"							HPA024318	Supported		Approved	Nucleoplasm		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA024318: AB_1859494"	"unprognostic (1.85e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.59e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (3.68e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.04e-2)"	29.5	31.2	74.2	8.3	74.5	5.8	32.8	56.3	74.7	53.0	61.8	60.0	9.9	63.1	20.8	21.3	66.3	14.9	55.7	71.6	78.0	56.1	14.4	28.8	9.4	71.9	70.0	63.5	22.9	27.9	82.8	14.9	68.8	46.3	6.2	36.9	23.8	28.9	23.7	29.0	28.9	18.8	63.2	28.1	32.4	42.5	79.8	10.3	60.8	13.2	6.7	49.5	34.6	67.3	0.2	1.7	14.4	35.2	1.7	1.9	32.4	9.5	0.2	12.8	2.3	0.0	8.7	3.8	18.8	13.6	14.4	0.2	1.2	7.7	12.4	0.1	128.4	0.4	0.1	0.2	25.7	0.0	25.8	23.1	0.4	9.5	0.0	17.1	0.9	9.3	0.2	1.4	18.1	0.0	18.9	7.2	22.6	0.0	0.0	21.8	0.0	1.5	11.8	29.1	59.3	13.8	0.0	0.5	0.1	12.5	39.5	0.0	0.0	0.6	15.0	15.4	0.1	15.2	46.6	0.1	0.0	0.2	10.5	1.0	0.2	1.3	0.1	0.1	0.8	0.6	0.6	0.6	0.3	1.4	0.9	0.8	1.4	0.8	0.2	0.8	0.0	0.3	74.2	74.5	56.3	74.7	71.6	78.0	71.9	70.0	68.8	63.2	79.8	67.3	30.6	16.0	26.9	31.0	24.9	12.1	51.2	6.7	7.4	77.5	22.5	25.0	44.3	25.8	26.2	42.3	33.3	45.9	10.1	3.7	15.6	25.1	52.3	46.9	26.8	33.2	26.5	3.4	29.5	5.8	8.6	28.5	11.7	24.0	23.5	39.8	33.5	4.1	9.0	112.7	26.4	14.7	10.2	3.2	6.4	75.9	40.0	6.0	10.6	13.1	6.0	73.0	25.7	21.6	40.7	5.9	13.1	58.6	3.6	38.4	7.3	11.1	36.7	110.5	19.7	32.6	30.1	30.0	27.9	6.5	12.1	65.7	15.8	39.3	10.5	32.6
ZSCAN5A	"MGC4161, ZNF495, ZSCAN5"	ENSG00000131848	"Zinc finger and SCAN domain containing 5A"	Q9BUG6	19	56219670-56368383	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 128.5;Late spermatids: 88.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041263, HPA043123, HPA046836, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear speckles"		"HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: "	"unprognostic (1.72e-1)"	"unprognostic (3.19e-3)"	"unprognostic (8.22e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.05e-3)"	"unprognostic (6.99e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.67e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.15e-3)"	"unprognostic (3.99e-3)"	3.1	3.2	3.5	3.6	4.0	2.5	2.8	3.3	3.4	3.4	5.3	3.8	3.9	3.7	2.0	3.0	7.1	2.6	4.1	3.6	3.6	3.6	2.6	3.1	2.8	3.7	4.0	3.5	2.6	3.8	3.3	2.0	3.8	3.0	4.5	2.3	3.2	2.4	4.1	4.3	3.4	3.9	3.3	2.8	2.6	25.1	3.6	4.5	3.2	3.5	3.4	3.7	3.2	3.4	5.9	5.0	7.1	8.6	5.7	3.6	10.4	3.4	7.2	10.3	6.1	10.1	3.4	10.6	2.7	6.0	6.1	7.0	9.2	7.3	9.2	3.0	19.4	13.0	3.4	10.2	4.5	14.5	14.0	2.8	11.0	10.1	4.6	2.1	7.5	8.2	5.3	4.7	3.2	7.2	3.5	8.0	12.8	5.2	13.1	5.5	10.7	6.1	4.3	10.9	6.9	6.9	9.1	6.9	3.6	4.0	3.0	13.2	4.1	8.9	8.9	4.7	11.4	7.7	21.1	7.2	11.5	14.2	3.5	3.7	6.5	4.4	4.2	7.2	6.4	3.3	4.4	3.2	7.5	1.9	5.7	3.0	0.5	1.3	4.5	9.3	1.2	3.7	3.5	4.0	3.3	3.4	3.6	3.6	3.7	4.0	3.8	3.3	3.6	3.4	3.3	0.0	4.2	2.3	5.3	4.8	5.8	6.0	6.2	4.9	6.4	5.0	17.4	0.0	5.0	0.0	8.4	3.0	5.6	4.3	11.7	5.0	128.5	10.5	3.4	4.1	7.8	5.5	0.6	5.1	3.5	5.5	5.1	4.9	2.5	2.8	4.6	6.8	6.5	3.3	0.3	4.0	8.2	7.3	3.0	88.5	2.5	5.2	0.0	0.0	3.0	7.8	2.1	0.5	0.3	4.4	1.0	2.6	4.0	4.5	4.5	6.0	12.4	10.8	0.0	6.5	3.3	14.7	16.5	4.2	3.7	7.0	3.4	3.3	5.2	3.3
ZSCAN5B	"ZNF371, ZNF495B"	ENSG00000197213	"Zinc finger and SCAN domain containing 5B"	A6NJL1	19	56189570-56197920	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 1.3"	"Cell type enriched"	"Detected in single"	8	"Spermatogonia: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043123, HPA046836, HPA059494, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: "	"unprognostic (4.73e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.83e-2)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZSCAN5C	"ZNF495C, ZSCAN5CP"	ENSG00000204532	"Zinc finger and SCAN domain containing 5C"	A6NGD5	19	56202273-56209200	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041263, HPA043123, HPA046836, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA							"Nuclear speckles"		"HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: "	"unprognostic (3.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.53e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZSCAN9	"PRD51, ZNF193"	ENSG00000137185	"Zinc finger and SCAN domain containing 9"	O15535	6	28224886-28233487	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA054512, HPA059951"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA054512: AB_2682511, HPA059951: AB_2684176"	"unprognostic (1.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.14e-3)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.74e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.16e-5)"	9.7	11.2	11.3	8.9	12.6	10.7	13.9	15.0	13.8	14.5	14.4	13.4	9.2	14.2	13.4	7.9	11.4	9.4	11.8	11.1	12.6	15.2	9.3	10.1	8.6	12.4	12.5	14.3	12.1	11.5	14.2	11.2	12.9	14.6	14.8	17.4	11.6	11.8	9.1	6.4	12.9	11.7	12.2	16.3	11.8	20.9	12.6	4.4	13.2	7.9	10.3	12.0	10.3	13.4	11.2	7.7	25.7	30.9	9.8	10.6	8.9	13.5	11.3	12.9	14.4	7.1	5.5	0.1	19.9	8.5	12.5	7.7	12.3	12.5	14.6	7.5	10.6	17.1	16.8	13.1	12.4	20.4	13.1	9.1	19.1	10.9	16.6	19.5	16.9	0.0	25.8	9.3	19.2	6.5	0.1	33.4	9.5	5.0	8.6	10.5	17.9	11.7	16.3	15.4	22.3	30.0	11.8	8.8	16.3	19.1	10.9	13.8	13.9	26.2	18.0	6.3	23.2	20.8	22.5	4.5	5.4	24.6	15.4	4.3	3.5	5.1	3.5	1.8	2.9	4.7	1.2	2.7	5.0	4.0	0.4	0.7	1.3	11.7	0.9	2.6	0.9	2.2	11.3	12.6	15.0	13.8	11.1	12.6	12.4	12.5	12.9	12.2	12.6	13.4	6.1	9.6	3.6	5.9	4.4	0.9	5.3	8.0	0.6	7.3	5.5	4.3	5.1	12.8	10.2	3.7	0.0	5.1	5.3	3.8	1.9	8.5	21.5	2.5	4.9	6.5	5.4	4.0	4.5	6.4	3.1	5.3	2.0	3.6	5.7	7.3	5.7	2.4	5.4	6.7	4.7	6.9	4.1	5.3	4.6	5.1	3.7	5.0	3.6	10.3	3.1	4.8	4.1	8.0	10.0	6.1	6.1	4.9	3.6	3.5	4.9	3.8	4.8	6.6	6.6	5.0	5.3	23.7	15.8	3.1	1.1	12.0	2.3	5.8	6.7	2.5
ZSWIM6	KIAA1577	ENSG00000130449	"Zinc finger SWIM-type containing 6"	Q9HCJ5	5	61332258-61546172	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 500.1;Microglial cells: 365.4;Oligodendrocyte precursor cells: 765.6;Oligodendrocytes: 740.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035938	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA035938: AB_10672077"	"unprognostic (2.22e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.99e-1)"	8.1	5.4	11.0	8.9	17.0	3.8	5.8	13.0	14.3	6.6	4.1	9.6	6.0	5.0	5.5	8.8	6.3	9.5	4.8	11.0	12.0	5.1	7.8	13.4	5.7	15.7	13.6	7.2	7.7	5.8	6.4	7.8	14.9	8.3	10.7	8.3	6.9	6.4	3.4	5.3	7.5	6.2	12.4	7.0	10.0	7.4	14.2	6.9	6.5	2.5	5.0	7.6	8.4	26.5	6.0	7.8	35.4	2.5	7.5	13.6	3.0	7.9	7.1	8.6	13.2	3.1	9.4	1.5	6.7	9.9	13.7	5.1	7.9	9.6	12.0	25.0	7.4	2.9	16.3	1.7	9.9	1.9	4.1	9.9	7.0	20.2	17.2	11.8	21.3	3.3	0.9	29.3	35.4	4.3	1.6	3.8	5.4	1.8	5.8	11.8	10.3	44.4	14.1	7.7	7.2	11.3	18.7	1.1	7.3	13.7	3.1	7.7	29.8	7.1	9.2	9.9	11.4	5.1	0.8	3.2	11.0	2.3	15.4	0.9	1.1	0.5	0.0	0.9	0.3	0.2	0.1	0.1	0.5	0.3	0.1	0.1	1.6	0.4	1.3	1.3	0.1	0.2	11.0	17.0	13.0	14.3	11.0	12.0	15.7	13.6	14.9	12.4	14.2	26.5	24.5	25.6	12.6	500.1	13.3	47.4	80.2	12.0	42.1	6.9	25.8	20.4	12.2	25.8	27.1	11.0	10.4	0.4	29.5	38.4	1.9	12.0	12.7	47.4	37.4	23.6	14.2	1.7	223.4	12.9	0.5	22.7	28.1	86.1	14.5	9.6	27.8	8.0	25.9	8.4	167.7	25.8	14.2	59.3	49.0	8.5	5.6	53.3	16.0	365.4	34.0	15.6	2.1	765.6	740.4	19.2	30.2	6.4	14.3	40.6	9.4	4.9	28.8	5.1	6.6	19.5	22.7	18.9	18.8	32.2	39.9	1.4	15.7	27.1	19.8	58.3
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357227-56361273	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.6;lymphoid tissue: 43.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	2.6	2.5	1.2	15.7	1.3	41.6	6.5	1.1	1.8	3.9	1.0	18.8	13.7	3.2	1.7	12.4	2.8	2.4	1.5	1.5	1.2	4.4	4.8	2.9	26.5	1.2	1.3	1.5	2.4	5.4	0.8	10.8	1.2	2.5	22.4	0.5	3.3	1.4	0.3	10.8	14.8	6.8	1.2	5.0	12.5	26.1	1.6	43.5	3.9	0.7	33.0	5.0	4.3	1.4	199.8	154.8	107.9	120.9	7.5	10.8	88.1	143.1	108.0	169.6	153.4	275.4	116.1	102.0	53.2	49.6	79.1	99.9	153.2	108.3	156.7	259.9	80.2	101.6	120.8	129.4	0.7	169.6	131.0	5.1	6.8	157.7	64.9	20.8	86.8	134.2	140.2	121.4	151.1	160.1	150.7	108.3	77.0	135.9	188.7	151.7	209.5	54.0	53.5	87.5	99.8	61.2	135.2	304.2	35.3	62.2	197.3	163.4	47.4	73.6	189.4	76.9	223.2	105.8	55.3	176.0	103.8	210.0	94.7	0.0	0.8	0.7	2.4	3.0	0.3	1.6	5.3	3.6	1.4	0.3	6.3	3.6	0.0	3.5	2.3	1.1	17.0	3.1	1.2	1.3	1.1	1.8	1.5	1.2	1.2	1.3	1.2	1.2	1.6	1.4	0.9	3.2	1.7	0.3	11.1	18.4	6.0	20.2	4.6	2.0	9.4	5.5	1.4	2.8	7.3	5.5	0.0	73.7	3.3	17.9	0.0	9.7	74.0	7.0	4.3	5.7	0.0	133.0	1.3	13.3	108.6	10.3	16.8	8.0	0.0	27.6	7.9	3.5	49.4	0.0	0.3	22.8	14.2	8.5	8.8	208.8	5.0	9.2	7.2	0.0	2.6	1.3	0.0	0.0	0.6	8.6	16.4	2.6	42.4	1.9	8.7	6.0	2.5	0.9	0.0	1.4	10.6	121.0	100.3	24.5	8.2	23.1	7.9	6.5	39.4	8.4
ZXDC	"FLJ13861, MGC11349"	ENSG00000070476	"ZXD family zinc finger C"	Q2QGD7	3	126437601-126475891	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;granulocytes: 1.7;monocytes: 4.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049593			Approved	Nucleoli		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli		"HPA049593: AB_2680828"	"unprognostic (3.06e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.06e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.12e-3)"	6.9	5.2	6.8	6.2	9.4	39.4	6.3	8.7	9.6	8.1	9.2	5.3	5.0	7.8	5.2	7.3	8.8	6.0	5.6	6.6	5.9	6.3	7.6	7.0	7.9	9.6	8.1	10.7	14.9	10.1	3.9	7.5	8.7	7.2	5.4	7.6	8.0	6.6	16.2	9.7	5.9	6.5	6.7	8.8	6.7	6.4	8.3	10.0	8.5	9.8	6.0	6.1	5.6	14.4	15.2	7.6	9.4	8.9	10.1	7.8	16.7	6.7	7.4	9.7	8.6	11.6	6.4	11.2	11.2	6.1	8.9	12.3	12.6	7.9	7.6	6.0	10.8	8.8	9.2	7.7	10.7	13.6	13.7	6.2	15.1	6.0	10.6	9.6	10.0	13.0	9.6	14.6	8.2	8.9	13.1	7.5	13.4	10.0	7.6	14.1	6.4	14.3	6.8	10.9	17.1	9.5	13.0	9.5	18.2	6.2	12.9	11.9	10.2	8.9	11.4	13.4	8.3	12.1	6.1	14.6	9.7	10.5	10.0	1.7	0.4	0.8	0.5	0.2	0.2	0.1	0.3	0.4	0.7	0.4	0.5	0.4	1.2	0.3	4.4	1.1	0.2	0.2	6.8	9.4	8.7	9.6	6.6	5.9	9.6	8.1	8.7	6.7	8.3	14.4	10.1	25.6	15.6	84.5	11.9	6.2	8.3	4.5	10.8	30.1	6.8	6.5	5.5	12.8	7.9	5.5	45.9	7.2	10.0	8.6	7.9	4.8	1.7	8.1	7.9	7.7	3.6	12.0	51.3	6.1	2.6	7.8	9.2	12.2	2.5	16.8	7.9	14.3	5.7	13.5	44.3	6.9	0.0	5.4	4.4	0.8	7.5	9.0	1.8	47.8	7.3	23.0	7.2	67.8	99.2	4.4	5.2	7.5	12.9	6.0	8.4	9.5	7.7	30.4	0.0	13.5	8.9	3.3	9.0	9.0	4.3	6.3	11.1	10.5	6.6	6.3
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726453-52827336	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.9;tongue: 62.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Intermediate filaments"		"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favorable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	9.4	8.4	13.5	5.5	14.5	7.6	7.2	15.9	14.0	9.1	3.5	9.9	4.3	10.8	5.9	9.5	6.8	6.6	17.1	13.7	16.0	12.9	18.6	7.6	5.1	8.5	9.7	10.8	5.1	10.0	4.6	7.1	11.1	9.4	7.5	13.4	6.3	8.6	78.9	6.3	4.6	12.5	8.0	5.6	5.0	8.6	16.3	6.9	12.8	62.0	5.4	7.7	5.7	10.3	10.8	9.9	12.1	15.1	21.7	18.5	10.0	11.7	15.3	9.4	8.7	8.4	3.5	10.2	11.1	23.6	12.6	5.5	14.1	10.6	14.9	7.9	8.6	13.1	10.4	5.3	11.5	9.9	7.7	13.5	11.2	13.4	9.4	13.1	16.6	2.3	12.0	2.1	17.2	4.4	3.9	6.4	12.3	5.4	10.0	6.7	22.4	9.3	9.6	17.2	5.5	10.9	20.6	12.8	10.6	15.2	7.7	7.8	19.1	14.4	8.2	14.3	7.4	8.6	10.8	7.4	9.8	6.6	9.5	0.3	0.7	0.9	0.5	0.3	0.6	0.6	0.7	0.4	0.7	0.5	1.1	0.8	1.7	0.6	0.6	0.4	1.0	0.3	13.5	14.5	15.9	14.0	13.7	16.0	8.5	9.7	11.1	8.0	16.3	10.3	26.8	25.6	28.8	29.0	13.4	11.3	10.5	12.1	10.2	49.5	13.6	11.9	88.3	20.0	14.0	14.7	20.9	24.6	6.9	37.2	7.9	12.2	5.7	13.2	40.9	22.1	10.2	9.0	72.4	11.1	12.0	26.3	12.2	18.6	8.2	32.0	32.5	107.7	20.6	97.6	82.6	11.4	14.2	37.5	11.8	7.9	24.5	21.5	21.4	36.5	21.9	21.6	4.1	46.3	52.0	16.3	17.9	30.9	11.6	26.0	14.0	30.0	11.1	24.4	26.3	35.7	25.9	11.4	23.7	17.3	14.6	34.8	9.7	19.5	15.5	19.0
ZZZ3	"ATAC1, DKFZP564I052"	ENSG00000036549	"Zinc finger ZZ-type containing 3"	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 73.8;Excitatory neurons: 102.1;Inhibitory neurons: 100.7;Microglial cells: 77.8;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 280.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635"	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	8.9	12.2	6.3	10.2	10.8	9.7	17.1	5.6	6.9	13.0	2.6	9.6	9.0	13.0	9.2	9.8	11.2	8.6	11.1	5.3	7.5	14.5	16.7	8.2	12.8	5.7	7.2	16.9	9.7	13.9	6.0	10.5	8.0	11.9	9.5	11.3	10.4	12.2	8.7	10.8	8.1	12.0	7.1	9.8	10.4	6.5	7.9	14.3	19.8	10.2	12.4	10.4	6.5	16.0	27.9	12.4	22.4	17.9	21.3	30.3	26.0	32.6	27.9	27.7	31.3	15.5	12.9	34.8	29.3	27.2	32.3	24.3	29.3	22.2	44.4	25.9	26.9	41.1	26.9	19.8	33.2	45.5	12.0	26.0	34.2	31.0	63.4	30.1	31.2	24.2	41.4	24.0	27.3	13.1	22.0	13.7	35.1	15.9	29.5	25.9	40.3	17.1	22.5	26.1	30.0	26.5	19.2	23.0	60.6	16.4	13.0	25.7	24.9	23.7	29.9	40.2	44.6	20.3	30.8	36.7	27.2	39.2	19.3	0.1	4.3	5.3	6.1	4.5	9.6	7.3	7.6	7.7	7.4	9.0	9.5	8.6	0.8	7.8	5.0	4.9	10.4	5.1	6.3	10.8	5.6	6.9	5.3	7.5	5.7	7.2	8.0	7.1	7.9	16.0	11.3	0.0	0.0	73.8	22.2	17.2	13.6	10.9	27.9	18.1	0.0	0.0	0.0	15.7	5.6	0.0	8.4	13.3	14.3	6.9	0.0	0.0	5.1	0.0	0.0	10.5	19.8	17.4	102.1	0.0	12.3	11.0	16.3	0.0	0.0	0.0	15.0	15.1	14.1	16.8	100.7	14.1	6.1	13.2	11.8	3.9	16.8	8.2	12.4	77.8	7.5	16.1	17.5	141.8	280.3	0.0	14.0	19.5	14.9	18.7	10.1	0.0	4.2	19.7	6.6	29.6	11.4	7.8	9.7	28.1	19.6	8.5	14.2	0.0	14.2	14.2